Citrus Sinensis ID: 011360

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------
Protein Sequence
MPKFTLGNSFRFGSKRETVSNFHSESIETILQKLTKDWLGQFARQAQIQADLIGWKTMMVKINKVLDDAIEKQTKEEPVKIWLGKLQHLACDVDYLLDEFQTEAFQTMLLQDADAMSKVKEVNARLQDIAWQINVLGLKESFGGKSRNVRQRFPTTPSLISAAVRGGSRDRGPTIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL
Secondary Structure (PSIPRED)
cccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHcHHHHHHHHcHHHHHHHHHHHHcccccccccEEEEEEEEEEccccccccccHHHHHHHccccccccccccEEEEEEHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccHHHHHHHHccccccccccccccccccEEEEccccccEEEEEEEcccccccHHHHHHccccccHHHHHHHHHHHHHHHHcccccccccEEEEccccEEEEEEEccccccHHHHHcccccccccccHHHHHHHHHHHHHHHHHHcccccccEEcccccccccccccccccccccccccccccccccEEcccEEEEccccccHHHccccccccccccccHHHHHHHHHccccccccccccccccHHHHHHHHHHcccccccccccccccccHHHHHHHHHHHHHcccccccccccHHHHHHHHcccc
Secondary Structure Prediction (SSPRO)
cccEEcccccEccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccEEEHHHHHHHHHHHHHHHHHHcccccccccHHHcccccccEEEEEEEcccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEHHHHHHHHccccHHcccccccccEEEEEEcccccccEEEEEEccccccHHHHHHHHHHcccccccHHHHHHHHHHHHHHHcccHHEEEEEEEccccEEEEEEEcccccHHHHHcccccccccccHHHHHHHHHHHHHHHHHHHHHHccccccccccHHHEEEcccccEEEccccccccccHHHcEEEEEEEEEccccccHHHHHcccccccccHHHHHHEHHHHHccccccccccccccHHHHHHHHHHHHcccHHHHccHHHcccccHHHHHHHHHHHHHHHcccHcccccHHHHHHHHHHHc
Coil and Loop (DISEMBL)
mpkftlgnsfrfgskretvsnfhSESIETILQKLTKDWLGQFARQAQIQADLIGWKTMMVKINKVLDDAIEKQTKEEPVKIWLGKLQHLACDVDYLLDEFQTEAFQTMLLQDADAMSKVKEVNARLQDIAWQINVLGlkesfggksrnvrqrfpttpslISAAvrggsrdrgptifspliekedlaflkkEDCFASlekigsggcgevykaelpgsngkmiAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLlahmvrpdcHLLVYEFMKNGSLQDILDDVsrgrreldwpsrHRIALGVASGLEYLHMYHSasiihgdikprnvllndDMEACISDLGlamaipdgyTRVLISYVLGTMayiapeyfqqpelsekcdifsFGMLLISLVRgvpsfvfhqngeeicspeWLRKVmnsknpsraidprlpgngyekKMLHVLKIAYICtlhdpeerpnsqyVRCRLSQLL
Flexible Loop (DISEMBL)
mpkftlgnsfrfgskretvsnfhSESIETILQKLTKDWLGQFARQAQIQADLIGWKTMMVKINKVLDDAIEKQTKEEPVKIWLGKLQHLACDVDYLLDEFQTEAFQTMLLQDADAMSKVKEVNARLQDIAWQINVLGLkesfggksrnvrqrfpttpslisaavrggsrdrgpTIFSPLIEKEDLAFLKKEDCFASLekigsggcgevYKAELPGSNGKMIAIKKVIVYAPISAAElieedsklrdsKLRQIRSeiitasqirhrnILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRreldwpsrhRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSknpsraidprlpgngYEKKMLHVLKIAYICTlhdpeerpnsqyvRCRLSQLL
Low Complexity Region (SEG)
MPKFTLGNSFRFGSKRETVSNFHSESIETILQKLTKDWLGQFARQAQIQADLIGWKTMMVKINKVLDDAIEKQTKEEPVKIWLGKLQHLACDVDYLLDEFQTEAFQTMLLQDADAMSKVKEVNARLQDIAWQINVLGLKESFGGKSRNVRQRFPTTPSLISAAVRGGSRDRGPTIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL
Disordered region (IsUnstruct)
*********************FHSESIETILQKLTKDWLGQFARQAQIQADLIGWKTMMVKINKVLDDAIEKQTKEEPVKIWLGKLQHLACDVDYLLDEFQTEAFQTMLLQDADAMSKVKEVNARLQDIAWQINVLGLKESFG******************************TIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEE********LRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKV****************NGYEKKMLHVLKIAYICTLH*******************
Disordered Region (DISOPRED)
*PKFT**NSFRFGSKRETVSNFHSESIETILQKLTKDWLGQFARQAQIQADLIGWKTMMVKINKVLDDAIEKQTKEEPVKIWLGKLQHLACDVDYLLDEFQTEA********************RLQDIAWQINVLGLKESFGGKSRN*****************************PLIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPI*******************IRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL
Disordered Region (DISEMBL)
MPKFTLGNSFRFGSKRETVSNFHSESIETILQKLTKDWLGQFARQAQIQADLIGWKTMMVKINKVLDDAIEKQTKEEPVKIWLGKLQHLACDVDYLLDEFQTEAFQTMLLQDADAMSKVKEVNARLQDIAWQINVLGLKESFGGKSRNVRQRFPTTPSLISAAVRGGSRDRGPTIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL
Disordered Region (DISPRO)
**K****NSFRFGSKRET***FHSESIETILQKLTKDWLGQFARQAQIQADLIGWKTMMVKINKVLDDAIEKQTKEEPVKIWLGKLQHLACDVDYLLDEFQTEAFQTMLL****AMSKVKEVNARLQDIA********************************************IFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHiiiiiiiiiiHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MPKFTLGNSFRFGSKRETVSNFHSESIETILQKLTKDWLGQFARQAQIQADLIGWKTMMVKINKVLDDAIEKQTKEEPVKIWLGKLQHLACDVDYLLDEFQTEAFQTMLLQDADAMSKVKEVNARLQDIAWQINVLGLKESFGGKSRNVRQRFPTTPSLISAAVRGGSRDRGPTIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	487	2.2.26 [Sep-21-2011]
Q9SKB2	641	Leucine-rich repeat recep	yes	no	0.671	0.510	0.603	1e-111
Q9SHI2	1101	Leucine-rich repeat recep	no	no	0.540	0.238	0.378	1e-42
Q94AG2	625	Somatic embryogenesis rec	no	no	0.558	0.435	0.345	4e-41
Q94F62	615	BRASSINOSTEROID INSENSITI	no	no	0.558	0.442	0.339	8e-41
Q9SKG5	620	Somatic embryogenesis rec	no	no	0.568	0.446	0.336	2e-40
Q8GWJ7	645	Cysteine-rich receptor-li	no	no	0.546	0.412	0.319	2e-40
Q9ZWC8	1166	Serine/threonine-protein	no	no	0.556	0.232	0.347	3e-40
Q9LJF3	1164	Receptor-like protein kin	no	no	0.583	0.243	0.339	5e-40
C0LGF5	1072	Probable LRR receptor-lik	no	no	0.552	0.250	0.354	4e-39
Q9SYM9	355	Receptor-like serine/thre	no	no	0.542	0.743	0.352	6e-39

>sp|Q9SKB2|SBIR1_ARATH Leucine-rich repeat receptor-like serine/threonine/tyrosine-protein kinase SOBIR1 OS=Arabidopsis thaliana GN=SOBIR1 PE=1 SV=1

 Score =  403 bits (1035), Expect = e-111,   Method: Compositional matrix adjust.
 Identities = 199/330 (60%), Positives = 254/330 (76%), Gaps = 3/330 (0%)

Query: 159 LISAAVRGGSRDRGPTIFSPLIEK-EDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSN 217
           LI  A+RG  +  GP+IFSPLI+K EDLAFL+ E+  ASLE IG GGCGEV+KAELPGSN
Sbjct: 311 LIIQAIRGSEKPPGPSIFSPLIKKAEDLAFLENEEALASLEIIGRGGCGEVFKAELPGSN 370

Query: 218 GKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRP 277
           GK+IA+KKVI   P  A EL +EDSK  + K+RQIRSEI T   IRHRN+LPLLAH+ RP
Sbjct: 371 GKIIAVKKVI-QPPKDADELTDEDSKFLNKKMRQIRSEINTVGHIRHRNLLPLLAHVSRP 429

Query: 278 DCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGD 337
           +CH LVYE+M+ GSLQDIL DV  G +EL WP+RH+IALG+A+GLEYLHM H+  IIH D
Sbjct: 430 ECHYLVYEYMEKGSLQDILTDVQAGNQELMWPARHKIALGIAAGLEYLHMDHNPRIIHRD 489

Query: 338 IKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDI 397
           +KP NVLL+DDMEA ISD GLA A+PD  T +  S+V GT+ YIAPE++Q  + ++KCDI
Sbjct: 490 LKPANVLLDDDMEARISDFGLAKAMPDAVTHITTSHVAGTVGYIAPEFYQTHKFTDKCDI 549

Query: 398 FSFGMLLISLVRG-VPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKML 456
           +SFG++L  LV G +PS  F Q+ +E+   +W+R ++ S+NPS AIDP+L   G++++ML
Sbjct: 550 YSFGVILGILVIGKLPSDEFFQHTDEMSLIKWMRNIITSENPSLAIDPKLMDQGFDEQML 609

Query: 457 HVLKIAYICTLHDPEERPNSQYVRCRLSQL 486
            VLKIA  CTL DP++RPNS+ VR  LSQ+
Sbjct: 610 LVLKIACYCTLDDPKQRPNSKDVRTMLSQI 639

Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Promotes the activation of plant defense and cell death. Functions as an inhibitor/regulator of abscission, probably by regulating membrane trafficking during abscission.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2

 Score =  174 bits (442), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 111/293 (37%), Positives = 165/293 (56%), Gaps = 30/293 (10%)

Query: 200  IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
            +G G CG VYKAE+ G  G++IA+KK+      S  E    D+  R        +EI T 
Sbjct: 805  LGRGACGTVYKAEMSG--GEVIAVKKLN-----SRGEGASSDNSFR--------AEISTL 849

Query: 260  SQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRE--LDWPSRHRIALG 317
             +IRHRNI+ L       + +LL+YE+M  GSL +    + RG +   LDW +R+RIALG
Sbjct: 850  GKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGE---QLQRGEKNCLLDWNARYRIALG 906

Query: 318  VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGT 377
             A GL YLH      I+H DIK  N+LL++  +A + D GLA  I   Y++ + S V G+
Sbjct: 907  AAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSKSM-SAVAGS 965

Query: 378  MAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSKN 437
              YIAPEY    +++EKCDI+SFG++L+ L+ G P     + G ++ +  W+R+ + +  
Sbjct: 966  YGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQPLEQGGDLVN--WVRRSIRNMI 1023

Query: 438  PS-RAIDPRLPGNGYEKKMLH----VLKIAYICTLHDPEERPNSQYVRCRLSQ 485
            P+    D RL  N  +K+ +H    VLKIA  CT + P  RP  + V   +++
Sbjct: 1024 PTIEMFDARLDTN--DKRTVHEMSLVLKIALFCTSNSPASRPTMREVVAMITE 1074

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q94AG2|SERK1_ARATH Somatic embryogenesis receptor kinase 1 OS=Arabidopsis thaliana GN=SERK1 PE=1 SV=2

 Score =  169 bits (429), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 101/292 (34%), Positives = 163/292 (55%), Gaps = 20/292 (6%)

Query: 192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ 251
           D F++   +G GG G+VYK  L  ++G ++A+K++             ++ +    +L Q
Sbjct: 300 DGFSNKNILGRGGFGKVYKGRL--ADGTLVAVKRL-------------KEERTPGGEL-Q 343

Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
            ++E+   S   HRN+L L    + P   LLVY +M NGS+   L +    +  LDWP+R
Sbjct: 344 FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQPPLDWPTR 403

Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLI 371
            RIALG A GL YLH +    IIH D+K  N+LL+++ EA + D GLA  +    T V  
Sbjct: 404 KRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV-T 462

Query: 372 SYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ--NGEEICSPEWL 429
           + V GT+ +IAPEY    + SEK D+F +G++L+ L+ G  +F   +  N +++   +W+
Sbjct: 463 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWV 522

Query: 430 RKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPN-SQYVR 480
           + ++  K     +DP L  N  E+++  V+++A +CT   P ERP  S+ VR
Sbjct: 523 KGLLKEKKLEMLVDPDLQTNYEERELEQVIQVALLCTQGSPMERPKMSEVVR 574

Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Phosphorylates BRI1 on 'Ser-887' and CDC48 on at least one threonine residue and on 'Ser-41'. Confers embryogenic competence. Acts redundantly with SERK2 as a control point for sporophytic development controlling male gametophyte production. Involved in the brassinolide signaling pathway.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q94F62|BAK1_ARATH BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 OS=Arabidopsis thaliana GN=BAK1 PE=1 SV=2

 Score =  168 bits (426), Expect = 8e-41,   Method: Compositional matrix adjust.
 Identities = 99/292 (33%), Positives = 163/292 (55%), Gaps = 20/292 (6%)

Query: 192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ 251
           D F++   +G GG G+VYK  L  ++G ++A+K++             ++ + +  +L Q
Sbjct: 287 DNFSNKNILGRGGFGKVYKGRL--ADGTLVAVKRL-------------KEERTQGGEL-Q 330

Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
            ++E+   S   HRN+L L    + P   LLVY +M NGS+   L +    +  LDWP R
Sbjct: 331 FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKR 390

Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLI 371
            RIALG A GL YLH +    IIH D+K  N+LL+++ EA + D GLA  +    T V  
Sbjct: 391 QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV-T 449

Query: 372 SYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ--NGEEICSPEWL 429
           + V GT+ +IAPEY    + SEK D+F +G++L+ L+ G  +F   +  N +++   +W+
Sbjct: 450 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 509

Query: 430 RKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPN-SQYVR 480
           + ++  K     +D  L GN  ++++  ++++A +CT   P ERP  S+ VR
Sbjct: 510 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVR 561

Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Controls the expression of genes associated with innate immunity in the absence of pathogens or elicitors. Involved in brassinosteroid (BR) signal transduction. Phosphorylates BRI1. May be involved in changing the equilibrium between plasma membrane-located BRI1 homodimers and endocytosed BRI1-BAK1 heterodimers. Interaction with MSBP1 stimulates the endocytosis of BAK1 and suppresses brassinosteroid signaling. Acts in pathogen-associated molecular pattern (PAMP)-triggered immunity (PTI) via its interaction with FLS2 and the phosphorylation of BIK1. Involved in programmed cell death (PCD) control. Positively regulates the BR-dependent plant growth pathway and negatively regulates the BR-independent cell-death pathway.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SKG5|SERK4_ARATH Somatic embryogenesis receptor kinase 4 OS=Arabidopsis thaliana GN=SERK4 PE=1 SV=2

 Score =  167 bits (423), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 100/297 (33%), Positives = 161/297 (54%), Gaps = 20/297 (6%)

Query: 187 FLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRD 246
            L   D F++   +G GG G+VYK  L  ++G ++A+K++             ++ + + 
Sbjct: 287 LLVATDNFSNKNVLGRGGFGKVYKGRL--ADGNLVAVKRL-------------KEERTKG 331

Query: 247 SKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRREL 306
            +L Q ++E+   S   HRN+L L    + P   LLVY +M NGS+   L +   G   L
Sbjct: 332 GEL-QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPEGNPAL 390

Query: 307 DWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGY 366
           DWP R  IALG A GL YLH +    IIH D+K  N+LL+++ EA + D GLA  +    
Sbjct: 391 DWPKRKHIALGSARGLAYLHDHCDQKIIHRDVKAANILLDEEFEAVVGDFGLAKLMNYND 450

Query: 367 TRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ--NGEEIC 424
           + V  + V GT+ +IAPEY    + SEK D+F +G++L+ L+ G  +F   +  N ++I 
Sbjct: 451 SHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQKAFDLARLANDDDIM 509

Query: 425 SPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPN-SQYVR 480
             +W+++V+  K     +D  L G   E ++  ++++A +CT     ERP  S+ VR
Sbjct: 510 LLDWVKEVLKEKKLESLVDAELEGKYVETEVEQLIQMALLCTQSSAMERPKMSEVVR 566

Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Positively regulates the BR-dependent plant growth pathway and negatively regulates the BR-independent cell-death pathway.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8GWJ7|CRK19_ARATH Cysteine-rich receptor-like protein kinase 19 OS=Arabidopsis thaliana GN=CRK19 PE=2 SV=2

 Score =  167 bits (423), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 91/285 (31%), Positives = 156/285 (54%), Gaps = 19/285 (6%)

Query: 192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ 251
           +CF  + K+G GG GEVYK  L  S+G  +A+K++               SK      ++
Sbjct: 324 NCFLPINKLGQGGFGEVYKGTL--SSGLQVAVKRL---------------SKTSGQGEKE 366

Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
             +E++  ++++HRN++ LL + +  +  +LVYEF+ N SL   L D S  + +LDW  R
Sbjct: 367 FENEVVVVAKLQHRNLVKLLGYCLEGEEKILVYEFVPNKSLDHFLFD-STMKMKLDWTRR 425

Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLI 371
           ++I  G+A G+ YLH     +IIH D+K  N+LL+DDM   I+D G+A       T  + 
Sbjct: 426 YKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDDDMNPKIADFGMARIFGMDQTEAMT 485

Query: 372 SYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICS-PEWLR 430
             V+GT  Y++PEY    + S K D++SFG+L++ ++ G+ +   +Q  E + +   +  
Sbjct: 486 RRVVGTYGYMSPEYAMYGQFSMKSDVYSFGVLVLEIISGMKNSSLYQMDESVGNLVTYTW 545

Query: 431 KVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPN 475
           ++ ++ +PS  +DP    N    ++   + IA +C   D E+RP 
Sbjct: 546 RLWSNGSPSELVDPSFGDNYQTSEITRCIHIALLCVQEDAEDRPT 590

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9ZWC8|BRL1_ARATH Serine/threonine-protein kinase BRI1-like 1 OS=Arabidopsis thaliana GN=BRL1 PE=1 SV=1

 Score =  166 bits (420), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 101/291 (34%), Positives = 163/291 (56%), Gaps = 20/291 (6%)

Query: 187  FLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRD 246
             L+  + F++   +GSGG GEVYKA+L   +G ++AIKK+I               ++  
Sbjct: 852  LLEATNGFSAETMVGSGGFGEVYKAQL--RDGSVVAIKKLI---------------RITG 894

Query: 247  SKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVS--RGRR 304
               R+  +E+ T  +I+HRN++PLL +    +  LLVYE+MK GSL+ +L + S  +G  
Sbjct: 895  QGDREFMAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKWGSLETVLHEKSSKKGGI 954

Query: 305  ELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPD 364
             L+W +R +IA+G A GL +LH      IIH D+K  NVLL++D EA +SD G+A  +  
Sbjct: 955  YLNWAARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDEDFEARVSDFGMARLVSA 1014

Query: 365  GYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEIC 424
              T + +S + GT  Y+ PEY+Q    + K D++S+G++L+ L+ G       + GE+  
Sbjct: 1015 LDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSYGVILLELLSGKKPIDPGEFGEDNN 1074

Query: 425  SPEWLRKVMNSKNPSRAIDPRLPGN-GYEKKMLHVLKIAYICTLHDPEERP 474
               W +++   K  +  +DP L  +   + ++ H LKIA  C    P +RP
Sbjct: 1075 LVGWAKQLYREKRGAEILDPELVTDKSGDVELFHYLKIASQCLDDRPFKRP 1125

Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. Binds brassinolide. May be involved in cell growth and vascular differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LJF3|BRL3_ARATH Receptor-like protein kinase BRI1-like 3 OS=Arabidopsis thaliana GN=BRL3 PE=1 SV=1

 Score =  166 bits (419), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 103/303 (33%), Positives = 166/303 (54%), Gaps = 19/303 (6%)

Query: 187  FLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRD 246
             L+  + F++   IGSGG G+VYKA+L  ++G ++AIKK+I               ++  
Sbjct: 851  LLEATNGFSADSMIGSGGFGDVYKAKL--ADGSVVAIKKLI---------------QVTG 893

Query: 247  SKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDIL-DDVSRGRRE 305
               R+  +E+ T  +I+HRN++PLL +    +  LLVYE+MK GSL+ +L +   +G   
Sbjct: 894  QGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKYGSLETVLHEKTKKGGIF 953

Query: 306  LDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG 365
            LDW +R +IA+G A GL +LH      IIH D+K  NVLL+ D  A +SD G+A  +   
Sbjct: 954  LDWSARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDQDFVARVSDFGMARLVSAL 1013

Query: 366  YTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICS 425
             T + +S + GT  Y+ PEY+Q    + K D++S+G++L+ L+ G       + GE+   
Sbjct: 1014 DTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSYGVILLELLSGKKPIDPEEFGEDNNL 1073

Query: 426  PEWLRKVMNSKNPSRAIDPRLPGN-GYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLS 484
              W +++   K  +  +DP L  +   + ++LH LKIA  C    P +RP    V     
Sbjct: 1074 VGWAKQLYREKRGAEILDPELVTDKSGDVELLHYLKIASQCLDDRPFKRPTMIQVMTMFK 1133

Query: 485  QLL 487
            +L+
Sbjct: 1134 ELV 1136

Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Binds brassinolide. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. May be involved in cell growth and vascular differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGF5|Y1341_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g34110 OS=Arabidopsis thaliana GN=At1g34110 PE=2 SV=2

 Score =  163 bits (412), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 104/293 (35%), Positives = 164/293 (55%), Gaps = 24/293 (8%)

Query: 200  IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
            IG G  G VYKAE+P  NG ++A+KK+            +++++  +S +    +EI   
Sbjct: 778  IGKGCSGIVYKAEIP--NGDIVAVKKLWK---------TKDNNEEGESTIDSFAAEIQIL 826

Query: 260  SQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVA 319
              IRHRNI+ LL +       LL+Y +  NG+LQ +L    +G R LDW +R++IA+G A
Sbjct: 827  GNIRHRNIVKLLGYCSNKSVKLLLYNYFPNGNLQQLL----QGNRNLDWETRYKIAIGAA 882

Query: 320  SGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA---MAIPDGYTRVLISYVLG 376
             GL YLH     +I+H D+K  N+LL+   EA ++D GLA   M  P+ +    +S V G
Sbjct: 883  QGLAYLHHDCVPAILHRDVKCNNILLDSKYEAILADFGLAKLMMNSPNYHNA--MSRVAG 940

Query: 377  TMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSK 436
            +  YIAPEY     ++EK D++S+G++L+ ++ G  S V  Q G+ +   EW++K M + 
Sbjct: 941  SYGYIAPEYGYTMNITEKSDVYSYGVVLLEILSGR-SAVEPQIGDGLHIVEWVKKKMGTF 999

Query: 437  NPSRAI-DPRLPG--NGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL 486
             P+ ++ D +L G  +   ++ML  L IA  C    P ERP  + V   L ++
Sbjct: 1000 EPALSVLDVKLQGLPDQIVQEMLQTLGIAMFCVNPSPVERPTMKEVVTLLMEV 1052

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SYM9|Y1853_ARATH Receptor-like serine/threonine-protein kinase At1g78530 OS=Arabidopsis thaliana GN=At1g78530 PE=2 SV=1

 Score =  162 bits (410), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 103/292 (35%), Positives = 155/292 (53%), Gaps = 28/292 (9%)

Query: 187 FLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRD 246
           F+KK    ++ + +GSGG G VY+  +  S     A+K+            +   +  RD
Sbjct: 68  FMKKTHKLSNKDILGSGGFGTVYRLVIDDST--TFAVKR------------LNRGTSERD 113

Query: 247 SKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRREL 306
              R    E+   + I+HRNI+ L  +   P  +LL+YE M NGSL   L     GR+ L
Sbjct: 114 ---RGFHRELEAMADIKHRNIVTLHGYFTSPHYNLLIYELMPNGSLDSFL----HGRKAL 166

Query: 307 DWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGY 366
           DW SR+RIA+G A G+ YLH      IIH DIK  N+LL+ +MEA +SD GLA  +    
Sbjct: 167 DWASRYRIAVGAARGISYLHHDCIPHIIHRDIKSSNILLDHNMEARVSDFGLATLMEPDK 226

Query: 367 TRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF--VFHQNGEEIC 424
           T V  ++V GT  Y+APEYF   + + K D++SFG++L+ L+ G       F + G ++ 
Sbjct: 227 THV-STFVAGTFGYLAPEYFDTGKATMKGDVYSFGVVLLELLTGRKPTDDEFFEEGTKLV 285

Query: 425 SPEWLRKVMNSKNPSRAIDPRLPGNGYE--KKMLHVLKIAYICTLHDPEERP 474
           +  W++ V+  +     ID RL G+  +  ++M  V  IA +C   +P  RP
Sbjct: 286 T--WVKGVVRDQREEVVIDNRLRGSSVQENEEMNDVFGIAMMCLEPEPAIRP 335

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	487
255540437	633	BRASSINOSTEROID INSENSITIVE 1-associated	0.671	0.516	0.658	1e-120
224133744	630	predicted protein [Populus trichocarpa]	0.671	0.519	0.642	1e-117
224119518	627	predicted protein [Populus trichocarpa]	0.671	0.521	0.630	1e-116
24421095	633	receptor-like protein kinase [Nicotiana	0.671	0.516	0.627	1e-113
356508750	636	PREDICTED: leucine-rich repeat receptor-	0.665	0.509	0.633	1e-112
356516603	631	PREDICTED: leucine-rich repeat receptor-	0.665	0.513	0.626	1e-110
15225153	641	putative leucine-rich repeat transmembra	0.671	0.510	0.603	1e-109
297822929	641	hypothetical protein ARALYDRAFT_482113 [	0.671	0.510	0.603	1e-109
449440606	643	PREDICTED: leucine-rich repeat receptor-	0.671	0.508	0.6	1e-109
16648755	641	At2g31880/F20M17.8 [Arabidopsis thaliana	0.671	0.510	0.603	1e-109

>gi|255540437|ref|XP_002511283.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223550398|gb|EEF51885.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis]

 Score =  437 bits (1123), Expect = e-120,   Method: Compositional matrix adjust.
 Identities = 218/331 (65%), Positives = 260/331 (78%), Gaps = 4/331 (1%)

Query: 159 LISAAVRGGSRDRGPTIFSP-LIEK-EDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGS 216
           LI A +RGG +D GP IFSP LI+K E+LAFL+KED  ++LE IG GGCGEVYKAELPGS
Sbjct: 302 LILATIRGGGKDSGPAIFSPHLIKKAENLAFLEKEDGLSNLELIGRGGCGEVYKAELPGS 361

Query: 217 NGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVR 276
           NGKMIAIKK IV  P  AAEL EED+KL + K+RQIRSEI T  QIRHRN+LPLLAH+ R
Sbjct: 362 NGKMIAIKK-IVQPPRDAAELTEEDTKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHVSR 420

Query: 277 PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHG 336
           PDCH LVYEFMKNGSLQDIL DV +G+RELDW +RHRIA+GVASGLEYLH  HS  IIH 
Sbjct: 421 PDCHCLVYEFMKNGSLQDILSDVEQGKRELDWLARHRIAIGVASGLEYLHTSHSPRIIHR 480

Query: 337 DIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCD 396
           D+KP NVLL+DDMEA I+D GLA A+PD  T V  S V GT+ YIAPEY Q  + ++KCD
Sbjct: 481 DLKPANVLLDDDMEARIADFGLAKAMPDANTHVTTSNVAGTVGYIAPEYHQTLKFTDKCD 540

Query: 397 IFSFGMLLISLVRG-VPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKM 455
           I+SFG+LL  LV G +PS  F Q   E+   +W+R +M S+NPS+AIDP++ GNG+E++M
Sbjct: 541 IYSFGVLLGVLVMGKLPSDEFFQTTREMSLVKWMRNIMTSENPSQAIDPKMNGNGFEEQM 600

Query: 456 LHVLKIAYICTLHDPEERPNSQYVRCRLSQL 486
           L VLKIA  CTL DP +RPNS+ +RC LSQ+
Sbjct: 601 LLVLKIACFCTLDDPRQRPNSKDIRCMLSQI 631

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224133744|ref|XP_002321650.1| predicted protein [Populus trichocarpa] gi|222868646|gb|EEF05777.1| predicted protein [Populus trichocarpa]

 Score =  427 bits (1098), Expect = e-117,   Method: Compositional matrix adjust.
 Identities = 212/330 (64%), Positives = 257/330 (77%), Gaps = 3/330 (0%)

Query: 159 LISAAVRGGSRDRGPTIFSPLIEK-EDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSN 217
           ++ AAV+GG RD GP IFSPLI++ EDLAFL+K+D  A+LE IG GGCGEVYKAELPGSN
Sbjct: 300 IVLAAVKGGGRDGGPAIFSPLIKRAEDLAFLEKDDGLANLEVIGKGGCGEVYKAELPGSN 359

Query: 218 GKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRP 277
           GKMIAIKK+I   P  AAEL EEDSKL   K+RQI+SEI T   IRHRN+LPLLAH+ RP
Sbjct: 360 GKMIAIKKII-QPPKDAAELTEEDSKLLHKKMRQIQSEINTVGHIRHRNLLPLLAHVSRP 418

Query: 278 DCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGD 337
           DCH LVYE MKNGSLQD L+ V+ GRRELDW +RHRIA+GVASGLEYLH+ HS  IIH D
Sbjct: 419 DCHYLVYELMKNGSLQDALNHVTEGRRELDWLARHRIAVGVASGLEYLHLSHSPRIIHRD 478

Query: 338 IKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDI 397
           +KP NVLL+D MEA I+D GLA A+PD  T +  S V GT+ YIAPEY Q  + ++KCDI
Sbjct: 479 LKPANVLLDDSMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDI 538

Query: 398 FSFGMLLISLVRG-VPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKML 456
           +SFG++L  LV G +PS  F QN  E+   +W+R +M S+NP +AIDP+L GNG E++ML
Sbjct: 539 YSFGVVLGVLVMGKLPSDEFFQNTREMSLVKWMRNIMTSENPRQAIDPKLMGNGLEEQML 598

Query: 457 HVLKIAYICTLHDPEERPNSQYVRCRLSQL 486
            VLKIA  CT+ DP++RPNS+ VRC LSQ+
Sbjct: 599 LVLKIACFCTIDDPKQRPNSKDVRCMLSQI 628

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224119518|ref|XP_002318094.1| predicted protein [Populus trichocarpa] gi|222858767|gb|EEE96314.1| predicted protein [Populus trichocarpa]

 Score =  425 bits (1093), Expect = e-116,   Method: Compositional matrix adjust.
 Identities = 208/330 (63%), Positives = 262/330 (79%), Gaps = 3/330 (0%)

Query: 159 LISAAVRGGSRDRGPTIFSPLIEK-EDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSN 217
           ++ AAV+GG RD GP IFSPLI+K EDLAFL+K++  A+LE IG GGCGEV+KAELPGSN
Sbjct: 297 IVLAAVKGGGRDVGPAIFSPLIKKAEDLAFLEKDEGLANLEIIGRGGCGEVFKAELPGSN 356

Query: 218 GKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRP 277
           GKMIA+KK+I   P  AAEL EEDSK+ + K+RQI+SEI T   IRHRN+LPLLAH+ RP
Sbjct: 357 GKMIAVKKII-QPPKDAAELSEEDSKVLNKKMRQIQSEINTVGHIRHRNLLPLLAHVSRP 415

Query: 278 DCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGD 337
           DCH LVYEFMKNGSLQD+L+ V+ G+RELDW +RH+IA+GVASGLEYLH+ HS  IIH D
Sbjct: 416 DCHYLVYEFMKNGSLQDVLNQVTEGKRELDWLARHKIAVGVASGLEYLHLSHSPQIIHRD 475

Query: 338 IKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDI 397
           +KP NVLL+DDMEA I+D GLA A+PD  T +  S V GT+ YIAPEY Q  + +EKCDI
Sbjct: 476 LKPANVLLDDDMEARIADFGLAKAMPDAKTHITTSNVAGTVGYIAPEYHQTLKFTEKCDI 535

Query: 398 FSFGMLLISLVRG-VPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKML 456
           +SFG++L  LV G +PS  F Q+  E+   +W+R +M S+NPS+AIDP+L G+G E++ML
Sbjct: 536 YSFGVVLGVLVMGKLPSDAFFQSTRELSLVKWMRNIMISENPSQAIDPKLIGHGLEEQML 595

Query: 457 HVLKIAYICTLHDPEERPNSQYVRCRLSQL 486
            VLKIA  CT+ DP++RP+S+ VRC LSQ+
Sbjct: 596 LVLKIACFCTIDDPKQRPSSKDVRCMLSQI 625

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|24421095|dbj|BAC07504.2| receptor-like protein kinase [Nicotiana tabacum]

 Score =  415 bits (1067), Expect = e-113,   Method: Compositional matrix adjust.
 Identities = 207/330 (62%), Positives = 255/330 (77%), Gaps = 3/330 (0%)

Query: 159 LISAAVRGGSRDRGPTIFSPLIEK-EDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSN 217
           L+   VR G  D   TI+SPLI+K EDLAFL+KED  ASLE IG GGCGEVY+AELPGSN
Sbjct: 303 LVMFFVRKGKTDGSLTIYSPLIKKAEDLAFLEKEDGVASLEMIGKGGCGEVYRAELPGSN 362

Query: 218 GKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRP 277
           GK+IAIKK I+  P+ AAEL EED+K  + K+RQ++SEI    QIRHRN+LPLLAHM RP
Sbjct: 363 GKIIAIKK-ILQPPMDAAELAEEDTKALNKKMRQVKSEIQILGQIRHRNLLPLLAHMPRP 421

Query: 278 DCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGD 337
           DCH LVYE+MKNGSLQDIL  V+ G RELDW  RHRIA+G+A+GLEYLH+ HS  IIH D
Sbjct: 422 DCHYLVYEYMKNGSLQDILQQVTEGTRELDWLGRHRIAVGIATGLEYLHINHSQCIIHRD 481

Query: 338 IKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDI 397
           +KP NVLL+DDMEA I+D GLA A+PD +T V  S V GT+ YIAPEY Q  + ++KCDI
Sbjct: 482 LKPANVLLDDDMEARIADFGLAKAVPDAHTHVTTSNVAGTVGYIAPEYHQTLKFTDKCDI 541

Query: 398 FSFGMLLISLVRG-VPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKML 456
           +SFG++L  LV G +PS  F Q+  E+   +WLR VM S++P RAIDP+L G+G+E++ML
Sbjct: 542 YSFGVVLAVLVIGKLPSDEFFQHTPEMSLVKWLRNVMTSEDPKRAIDPKLIGSGFEEQML 601

Query: 457 HVLKIAYICTLHDPEERPNSQYVRCRLSQL 486
            VLKIA  CTL +P+ERPNS+ VRC L+Q+
Sbjct: 602 LVLKIACFCTLENPKERPNSKDVRCMLTQI 631

Source: Nicotiana tabacum

Species: Nicotiana tabacum

Genus: Nicotiana

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356508750|ref|XP_003523117.1| PREDICTED: leucine-rich repeat receptor-like serine/threonine/tyrosine-protein kinase SOBIR1-like [Glycine max]

 Score =  412 bits (1059), Expect = e-112,   Method: Compositional matrix adjust.
 Identities = 207/327 (63%), Positives = 253/327 (77%), Gaps = 3/327 (0%)

Query: 162 AAVRGGSRDRGPTIFSPLIEK-EDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKM 220
           A ++G  R  GP I+SPLI+K EDLAFL+KE+  ASLE IG GGCGEVYKAELPGSNGKM
Sbjct: 309 ALIKGRGRKAGPDIYSPLIKKAEDLAFLEKEEGIASLEIIGRGGCGEVYKAELPGSNGKM 368

Query: 221 IAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCH 280
           IAIKK IV  P   AEL EEDSK+ + K+RQIRSEI T  QIRHRN+LPLLAH+ RP+CH
Sbjct: 369 IAIKK-IVQPPKDGAELAEEDSKVLNKKMRQIRSEINTVGQIRHRNLLPLLAHVSRPECH 427

Query: 281 LLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKP 340
            LVYEFMKNGSLQD L  V RG  ELDW SRH+I+LGVA+GLEYLHM H+  IIH D+KP
Sbjct: 428 YLVYEFMKNGSLQDTLSKVERGESELDWLSRHKISLGVAAGLEYLHMNHNPRIIHRDLKP 487

Query: 341 RNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSF 400
            N+LL+DDMEA I+D GLA A+PD  T +  S V GT+ YIAPEY Q  + ++KCDI+S+
Sbjct: 488 ANILLDDDMEARIADFGLAKAMPDYKTHITTSNVAGTVGYIAPEYHQILKFTDKCDIYSY 547

Query: 401 GMLLISLVRG-VPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVL 459
           G++L  LV G +PS  F Q+ EE+   +W+RK ++S+NP  AI+ +L GNGYE++ML VL
Sbjct: 548 GVILGVLVIGKLPSDDFFQHTEEMSLVKWMRKTLSSENPKEAINSKLLGNGYEEQMLLVL 607

Query: 460 KIAYICTLHDPEERPNSQYVRCRLSQL 486
           KIA  CT+ DP+ERPNS+ VRC LSQ+
Sbjct: 608 KIACFCTMDDPKERPNSKDVRCMLSQI 634

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356516603|ref|XP_003526983.1| PREDICTED: leucine-rich repeat receptor-like serine/threonine/tyrosine-protein kinase SOBIR1-like [Glycine max]

 Score =  406 bits (1043), Expect = e-110,   Method: Compositional matrix adjust.
 Identities = 205/327 (62%), Positives = 249/327 (76%), Gaps = 3/327 (0%)

Query: 162 AAVRGGSRDRGPTIFSPLIEK-EDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKM 220
           A ++G  R  GP I+SPLI+K EDLAFL+KE+  ASLE IG GGCGEVYKAELPGSNGKM
Sbjct: 304 ALIKGRGRKAGPDIYSPLIKKAEDLAFLEKEEGMASLEIIGRGGCGEVYKAELPGSNGKM 363

Query: 221 IAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCH 280
           IAIKK+I   P   AEL EEDSK+ + K+RQIRSEI T  QIRHRN+LPLLAH+ RP CH
Sbjct: 364 IAIKKII-QPPKEGAELAEEDSKVLNKKMRQIRSEITTVGQIRHRNLLPLLAHVSRPGCH 422

Query: 281 LLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKP 340
            LVYEFMKNGSL D L  V  G  ELDW SRH+IALGVA+GLEYLH+ H+  IIH D+KP
Sbjct: 423 YLVYEFMKNGSLHDTLSKVEVGEFELDWLSRHKIALGVAAGLEYLHLNHNPRIIHRDLKP 482

Query: 341 RNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSF 400
            N+LL+DDMEA I+D GLA A+PD  T +  S V GT+ YIAPEY Q  + ++KCDI+SF
Sbjct: 483 ANILLDDDMEARIADFGLAKAMPDYKTHITTSNVAGTVGYIAPEYHQILKFTDKCDIYSF 542

Query: 401 GMLLISLVRG-VPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVL 459
           G++L  LV G +PS  F Q+ EE+   +W+RK+++S+NP  AID +L GNGYE +ML VL
Sbjct: 543 GVILGVLVIGKLPSHEFFQHTEEMSLVKWMRKILSSENPKEAIDTKLLGNGYEDQMLLVL 602

Query: 460 KIAYICTLHDPEERPNSQYVRCRLSQL 486
           KIA  CT+ DP+ERPNS+ V C LSQ+
Sbjct: 603 KIACFCTMDDPKERPNSKDVWCMLSQI 629

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|15225153|ref|NP_180747.1| putative leucine-rich repeat transmembrane protein kinase [Arabidopsis thaliana] gi|75265989|sp|Q9SKB2.1|SBIR1_ARATH RecName: Full=Leucine-rich repeat receptor-like serine/threonine/tyrosine-protein kinase SOBIR1; AltName: Full=Protein EVERSHED; AltName: Full=Protein SUPPRESSOR OF BIR1-1; Flags: Precursor gi|13877675|gb|AAK43915.1|AF370596_1 putative receptor-like protein kinase [Arabidopsis thaliana] gi|4887748|gb|AAD32284.1| putative receptor-like protein kinase [Arabidopsis thaliana] gi|224589537|gb|ACN59302.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|330253505|gb|AEC08599.1| putative leucine-rich repeat transmembrane protein kinase [Arabidopsis thaliana]

 Score =  403 bits (1035), Expect = e-109,   Method: Compositional matrix adjust.
 Identities = 199/330 (60%), Positives = 254/330 (76%), Gaps = 3/330 (0%)

Query: 159 LISAAVRGGSRDRGPTIFSPLIEK-EDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSN 217
           LI  A+RG  +  GP+IFSPLI+K EDLAFL+ E+  ASLE IG GGCGEV+KAELPGSN
Sbjct: 311 LIIQAIRGSEKPPGPSIFSPLIKKAEDLAFLENEEALASLEIIGRGGCGEVFKAELPGSN 370

Query: 218 GKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRP 277
           GK+IA+KKVI   P  A EL +EDSK  + K+RQIRSEI T   IRHRN+LPLLAH+ RP
Sbjct: 371 GKIIAVKKVI-QPPKDADELTDEDSKFLNKKMRQIRSEINTVGHIRHRNLLPLLAHVSRP 429

Query: 278 DCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGD 337
           +CH LVYE+M+ GSLQDIL DV  G +EL WP+RH+IALG+A+GLEYLHM H+  IIH D
Sbjct: 430 ECHYLVYEYMEKGSLQDILTDVQAGNQELMWPARHKIALGIAAGLEYLHMDHNPRIIHRD 489

Query: 338 IKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDI 397
           +KP NVLL+DDMEA ISD GLA A+PD  T +  S+V GT+ YIAPE++Q  + ++KCDI
Sbjct: 490 LKPANVLLDDDMEARISDFGLAKAMPDAVTHITTSHVAGTVGYIAPEFYQTHKFTDKCDI 549

Query: 398 FSFGMLLISLVRG-VPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKML 456
           +SFG++L  LV G +PS  F Q+ +E+   +W+R ++ S+NPS AIDP+L   G++++ML
Sbjct: 550 YSFGVILGILVIGKLPSDEFFQHTDEMSLIKWMRNIITSENPSLAIDPKLMDQGFDEQML 609

Query: 457 HVLKIAYICTLHDPEERPNSQYVRCRLSQL 486
            VLKIA  CTL DP++RPNS+ VR  LSQ+
Sbjct: 610 LVLKIACYCTLDDPKQRPNSKDVRTMLSQI 639

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297822929|ref|XP_002879347.1| hypothetical protein ARALYDRAFT_482113 [Arabidopsis lyrata subsp. lyrata] gi|297325186|gb|EFH55606.1| hypothetical protein ARALYDRAFT_482113 [Arabidopsis lyrata subsp. lyrata]

 Score =  402 bits (1034), Expect = e-109,   Method: Compositional matrix adjust.
 Identities = 199/330 (60%), Positives = 252/330 (76%), Gaps = 3/330 (0%)

Query: 159 LISAAVRGGSRDRGPTIFSPLIEK-EDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSN 217
           LI  A+RG  +  GP+IFSPLI+K EDLAFL+ E+  ASLE IG GGCGEV+KAELPGSN
Sbjct: 311 LIIQAIRGSGKPSGPSIFSPLIKKAEDLAFLENEEALASLEIIGRGGCGEVFKAELPGSN 370

Query: 218 GKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRP 277
           GK+IA+KKVI   P  A EL +EDSK  + K+RQIRSEI T  QIRHRN+LPLLAH+ RP
Sbjct: 371 GKIIAVKKVI-QPPKDADELTDEDSKFMNKKMRQIRSEISTVGQIRHRNLLPLLAHVSRP 429

Query: 278 DCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGD 337
           +CH LVYE+M+ GSLQDIL DV  G +EL WP+RH+IALG+A+GLEYLHM H+  IIH D
Sbjct: 430 ECHYLVYEYMEKGSLQDILTDVQAGNQELMWPARHKIALGIAAGLEYLHMDHNPRIIHRD 489

Query: 338 IKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDI 397
           +KP NVLL+DDMEA ISD GLA  +PD  T +  S V GT+ YIAPE++Q  + + KCDI
Sbjct: 490 LKPANVLLDDDMEARISDFGLAKVMPDAVTHITTSNVAGTVGYIAPEFYQTHKFTAKCDI 549

Query: 398 FSFGMLLISLVRG-VPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKML 456
           +SFG++L  LV G +PS  F Q+ +E+   +W+R ++ S+NPS AIDP+L   G++++ML
Sbjct: 550 YSFGVILGILVIGKLPSDEFFQHTDEMSLIKWMRNIITSENPSLAIDPKLMEQGFDEQML 609

Query: 457 HVLKIAYICTLHDPEERPNSQYVRCRLSQL 486
            VLKIA  CTL DP++RPNS+ VR  LSQ+
Sbjct: 610 LVLKIACYCTLDDPKQRPNSKDVRTMLSQI 639

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449440606|ref|XP_004138075.1| PREDICTED: leucine-rich repeat receptor-like serine/threonine/tyrosine-protein kinase SOBIR1-like [Cucumis sativus] gi|449501343|ref|XP_004161343.1| PREDICTED: leucine-rich repeat receptor-like serine/threonine/tyrosine-protein kinase SOBIR1-like [Cucumis sativus]

 Score =  402 bits (1032), Expect = e-109,   Method: Compositional matrix adjust.
 Identities = 198/330 (60%), Positives = 253/330 (76%), Gaps = 3/330 (0%)

Query: 159 LISAAVRGGSRDRGPTIFSP-LIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSN 217
           L+ AA++GGS++ GP+IF+P LI+++DLAFL++++  ASL+ IG GGCGEVYKAELP  +
Sbjct: 303 LVIAAIKGGSKNSGPSIFAPKLIKRDDLAFLERDNALASLQLIGKGGCGEVYKAELPEKS 362

Query: 218 GKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRP 277
           GKM AIKK I   P  AAELIEE+S+    K+RQI+SEI T  +IRHRN+LPL+AH+ RP
Sbjct: 363 GKMFAIKK-ITQPPKDAAELIEEESRHMSKKMRQIKSEIRTVGEIRHRNLLPLVAHVPRP 421

Query: 278 DCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGD 337
           DCH LVYE MKNGSLQD+L+ VS G +ELDW +RH IALGVASGLEYLHM H+  IIH D
Sbjct: 422 DCHYLVYELMKNGSLQDMLNQVSAGVKELDWLTRHNIALGVASGLEYLHMNHTPRIIHRD 481

Query: 338 IKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDI 397
           +KP NVLL+D MEA I+D GLA A+PD  T +  S V GT+ YIAPEY Q  + ++KCDI
Sbjct: 482 LKPANVLLDDGMEARIADFGLAKAMPDAQTHMTASNVAGTVGYIAPEYHQTLKFTDKCDI 541

Query: 398 FSFGMLLISLVRG-VPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKML 456
           + FG+LL  LV G +PS  F QN +E+   +W++ VM S NP  AIDP+L GNG+E++ML
Sbjct: 542 YGFGVLLGVLVIGKLPSDEFFQNTDEMSLVKWMKNVMTSDNPRGAIDPKLLGNGWEEQML 601

Query: 457 HVLKIAYICTLHDPEERPNSQYVRCRLSQL 486
             LKIA  CT+ +P+ERPNS+ VRC LSQ+
Sbjct: 602 LALKIACFCTMDNPKERPNSKDVRCMLSQI 631

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|16648755|gb|AAL25569.1| At2g31880/F20M17.8 [Arabidopsis thaliana]

 Score =  401 bits (1030), Expect = e-109,   Method: Compositional matrix adjust.
 Identities = 199/330 (60%), Positives = 253/330 (76%), Gaps = 3/330 (0%)

Query: 159 LISAAVRGGSRDRGPTIFSPLIEK-EDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSN 217
           LI  A+RG  +  GP+IFSPLI+K EDLAFL+ E+  ASLE IG GGCGEV+KAELPGSN
Sbjct: 311 LIIQAIRGSEKPPGPSIFSPLIKKAEDLAFLENEEALASLEIIGRGGCGEVFKAELPGSN 370

Query: 218 GKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRP 277
           GK+IA+KKVI   P  A EL +EDSK  + K+RQIRSEI T   IRHRN+LPLLAH+ RP
Sbjct: 371 GKIIAVKKVI-QPPKDADELTDEDSKFLNKKMRQIRSEINTVGHIRHRNLLPLLAHVSRP 429

Query: 278 DCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGD 337
           +CH LVYE+M+ GSLQDIL DV  G +EL WP+RH+IALG+A+GLEYLHM H+  IIH D
Sbjct: 430 ECHYLVYEYMEKGSLQDILTDVQAGNQELMWPARHKIALGIAAGLEYLHMDHNPRIIHRD 489

Query: 338 IKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDI 397
            KP NVLL+DDMEA ISD GLA A+PD  T +  S+V GT+ YIAPE++Q  + ++KCDI
Sbjct: 490 SKPANVLLDDDMEARISDFGLAKAMPDAVTHITTSHVAGTVGYIAPEFYQTHKFTDKCDI 549

Query: 398 FSFGMLLISLVRG-VPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKML 456
           +SFG++L  LV G +PS  F Q+ +E+   +W+R ++ S+NPS AIDP+L   G++++ML
Sbjct: 550 YSFGVILGILVIGKLPSDEFFQHTDEMSLIKWMRNIITSENPSLAIDPKLMDQGFDEQML 609

Query: 457 HVLKIAYICTLHDPEERPNSQYVRCRLSQL 486
            VLKIA  CTL DP++RPNS+ VR  LSQ+
Sbjct: 610 LVLKIACYCTLDDPKQRPNSKDVRTMLSQI 639

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	487
TAIR|locus:2045228	641	SOBIR1 "SUPPRESSOR OF BIR1 1"	0.749	0.569	0.556	2e-102
UNIPROTKB|Q942F3	1121	P0480C01.18-1 "cDNA clone:J033	0.480	0.208	0.348	4.7e-41
TAIR|locus:2012325	466	AT1G09440 [Arabidopsis thalian	0.509	0.532	0.324	5.2e-41
TAIR|locus:2020417	1101	AT1G17230 [Arabidopsis thalian	0.540	0.238	0.382	9.8e-41
TAIR|locus:2013021	625	SERK1 "somatic embryogenesis r	0.558	0.435	0.345	1.1e-40
TAIR|locus:2121686	645	CRK19 "cysteine-rich RLK (RECE	0.503	0.379	0.314	3.5e-40
TAIR|locus:2203000	355	AT1G78530 [Arabidopsis thalian	0.519	0.712	0.363	3.6e-40
TAIR|locus:2040461	620	SERK4 "somatic embryogenesis r	0.558	0.438	0.352	6.7e-40
TAIR|locus:2035686	676	AT1G55200 [Arabidopsis thalian	0.457	0.329	0.369	3.2e-39
TAIR|locus:2027559	492	AT1G56720 [Arabidopsis thalian	0.472	0.467	0.310	1.1e-38

TAIR|locus:2045228 SOBIR1 "SUPPRESSOR OF BIR1 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1015 (362.4 bits), Expect = 2.0e-102, P = 2.0e-102
 Identities = 208/374 (55%), Positives = 271/374 (72%)

Query:   116 MSKVKEVNARLQDIAWQIN-VLGLKESFGGKSRNVRQRFPTTPSLISAAVRGGSRDRGPT 174
             + K K+ + + +  AW +  V+G   + GG        F     LI  A+RG  +  GP+
Sbjct:   272 LKKKKKKSKKKKVAAWILGFVVG---AIGGTISGFV--FSVLFKLIIQAIRGSEKPPGPS 326

Query:   175 IFSPLIEK-EDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPIS 233
             IFSPLI+K EDLAFL+ E+  ASLE IG GGCGEV+KAELPGSNGK+IA+KKVI   P  
Sbjct:   327 IFSPLIKKAEDLAFLENEEALASLEIIGRGGCGEVFKAELPGSNGKIIAVKKVI-QPPKD 385

Query:   234 AAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQ 293
             A EL +EDSK  + K+RQIRSEI T   IRHRN+LPLLAH+ RP+CH LVYE+M+ GSLQ
Sbjct:   386 ADELTDEDSKFLNKKMRQIRSEINTVGHIRHRNLLPLLAHVSRPECHYLVYEYMEKGSLQ 445

Query:   294 DILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACI 353
             DIL DV  G +EL WP+RH+IALG+A+GLEYLHM H+  IIH D+KP NVLL+DDMEA I
Sbjct:   446 DILTDVQAGNQELMWPARHKIALGIAAGLEYLHMDHNPRIIHRDLKPANVLLDDDMEARI 505

Query:   354 SDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRG-VP 412
             SD GLA A+PD  T +  S+V GT+ YIAPE++Q  + ++KCDI+SFG++L  LV G +P
Sbjct:   506 SDFGLAKAMPDAVTHITTSHVAGTVGYIAPEFYQTHKFTDKCDIYSFGVILGILVIGKLP 565

Query:   413 SFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEE 472
             S  F Q+ +E+   +W+R ++ S+NPS AIDP+L   G++++ML VLKIA  CTL DP++
Sbjct:   566 SDEFFQHTDEMSLIKWMRNIITSENPSLAIDPKLMDQGFDEQMLLVLKIACYCTLDDPKQ 625

Query:   473 RPNSQYVRCRLSQL 486
             RPNS+ VR  LSQ+
Sbjct:   626 RPNSKDVRTMLSQI 639

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS;IDA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010942 "positive regulation of cell death" evidence=IMP

GO:0031349 "positive regulation of defense response" evidence=IMP

GO:0004713 "protein tyrosine kinase activity" evidence=IDA

GO:0060862 "negative regulation of floral organ abscission" evidence=IGI

UNIPROTKB|Q942F3 P0480C01.18-1 "cDNA clone:J033069J12, full insert sequence" [Oryza sativa Japonica Group (taxid:39947)]

 Score = 365 (133.5 bits), Expect = 4.7e-41, Sum P(3) = 4.7e-41
 Identities = 84/241 (34%), Positives = 135/241 (56%)

Query:   250 RQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWP 309
             R+  +E+ T  +I+HRN++PLL +    +  LLVY++MK GSL+D+L D  +  ++L+W 
Sbjct:   846 REFTAEMETIGKIKHRNLVPLLGYCKAGEERLLVYDYMKFGSLEDVLHDRKKIGKKLNWE 905

Query:   310 SRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA--MAIPDGYT 367
             +R +IA+G A GL +LH      IIH D+K  NVL+++ +EA +SD G+A  M++ D  T
Sbjct:   906 ARRKIAVGAARGLAFLHHNCIPHIIHRDMKSSNVLIDEQLEARVSDFGMARLMSVVD--T 963

Query:   368 RVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPE 427
              + +S + GT  Y+ PEY+Q    + K D++S+G++L+ L+ G P       GE+     
Sbjct:   964 HLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVVLLELLTGKPPTDSADFGEDNNLVG 1023

Query:   428 WLRKVMNSKNPSRAIDPRL--PGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQ 485
             W+++    K      DP L       E ++L  LKIA  C    P  RP    V     +
Sbjct:  1024 WVKQHTKLKITD-VFDPELLKEDPSVELELLEHLKIACACLDDRPSRRPTMLKVMAMFKE 1082

Query:   486 L 486
             +
Sbjct:  1083 I 1083

GO:0001578 "microtubule bundle formation" evidence=IMP

GO:0009647 "skotomorphogenesis" evidence=IMP

GO:0009729 "detection of brassinosteroid stimulus" evidence=IMP

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IMP

TAIR|locus:2012325 AT1G09440 [Arabidopsis thaliana (taxid:3702)]

 Score = 377 (137.8 bits), Expect = 5.2e-41, Sum P(2) = 5.2e-41
 Identities = 86/265 (32%), Positives = 139/265 (52%)

Query:   217 NGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVR 276
             NG ++A+KK++ +  +  AE             ++ R E+     +RH+N++ LL + + 
Sbjct:   178 NGSLVAVKKILNH--LGQAE-------------KEFRVEVDAIGHVRHKNLVRLLGYCIE 222

Query:   277 PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHG 336
                 +LVYE+M NG+L++ L    +    L W +R ++  G +  L YLH      ++H 
Sbjct:   223 GTNRILVYEYMNNGNLEEWLHGAMKHHGYLTWEARMKVLTGTSKALAYLHEAIEPKVVHR 282

Query:   337 DIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCD 396
             DIK  N+L++D   A ISD GLA  + DG + V  + V+GT  Y+APEY     L+EK D
Sbjct:   283 DIKSSNILIDDRFNAKISDFGLAKLLGDGKSHVT-TRVMGTFGYVAPEYANTGLLNEKSD 341

Query:   397 IFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKML 456
             ++SFG+L++  + G     + +   E+   EWL+ ++ SK     IDP +      + + 
Sbjct:   342 VYSFGVLVLEAITGRDPVDYARPANEVNLVEWLKMMVGSKRLEEVIDPNIAVRPATRALK 401

Query:   457 HVLKIAYICTLHDPEERPN-SQYVR 480
              VL  A  C   D E+RP  SQ VR
Sbjct:   402 RVLLTALRCIDPDSEKRPKMSQVVR 426

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009832 "plant-type cell wall biogenesis" evidence=RCA

GO:0010413 "glucuronoxylan metabolic process" evidence=RCA

GO:0045492 "xylan biosynthetic process" evidence=RCA

TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)]

 Score = 444 (161.4 bits), Expect = 9.8e-41, P = 9.8e-41
 Identities = 112/293 (38%), Positives = 165/293 (56%)

Query:   200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
             +G G CG VYKAE+ G  G++IA+KK+      S  E    D+  R        +EI T 
Sbjct:   805 LGRGACGTVYKAEMSG--GEVIAVKKLN-----SRGEGASSDNSFR--------AEISTL 849

Query:   260 SQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRE--LDWPSRHRIALG 317
              +IRHRNI+ L       + +LL+YE+M  GSL + L    RG +   LDW +R+RIALG
Sbjct:   850 GKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQ---RGEKNCLLDWNARYRIALG 906

Query:   318 VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGT 377
              A GL YLH      I+H DIK  N+LL++  +A + D GLA  I   Y++ + S V G+
Sbjct:   907 AAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSKSM-SAVAGS 965

Query:   378 MAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSKN 437
               YIAPEY    +++EKCDI+SFG++L+ L+ G P     + G ++ +  W+R+ + +  
Sbjct:   966 YGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQPLEQGGDLVN--WVRRSIRNMI 1023

Query:   438 PS-RAIDPRLPGNGYEKKMLH----VLKIAYICTLHDPEERPNSQYVRCRLSQ 485
             P+    D RL  N  +K+ +H    VLKIA  CT + P  RP  + V   +++
Sbjct:  1024 PTIEMFDARLDTN--DKRTVHEMSLVLKIALFCTSNSPASRPTMREVVAMITE 1074

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2013021 SERK1 "somatic embryogenesis receptor-like kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 433 (157.5 bits), Expect = 1.1e-40, P = 1.1e-40
 Identities = 101/292 (34%), Positives = 163/292 (55%)

Query:   192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ 251
             D F++   +G GG G+VYK  L  ++G ++A+K++             ++ +    +L Q
Sbjct:   300 DGFSNKNILGRGGFGKVYKGRL--ADGTLVAVKRL-------------KEERTPGGEL-Q 343

Query:   252 IRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
              ++E+   S   HRN+L L    + P   LLVY +M NGS+   L +    +  LDWP+R
Sbjct:   344 FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQPPLDWPTR 403

Query:   312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLI 371
              RIALG A GL YLH +    IIH D+K  N+LL+++ EA + D GLA  +    T V  
Sbjct:   404 KRIALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT 463

Query:   372 SYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ--NGEEICSPEWL 429
             + V GT+ +IAPEY    + SEK D+F +G++L+ L+ G  +F   +  N +++   +W+
Sbjct:   464 A-VRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWV 522

Query:   430 RKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPN-SQYVR 480
             + ++  K     +DP L  N  E+++  V+++A +CT   P ERP  S+ VR
Sbjct:   523 KGLLKEKKLEMLVDPDLQTNYEERELEQVIQVALLCTQGSPMERPKMSEVVR 574

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0042802 "identical protein binding" evidence=IPI

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=IDA

GO:0009793 "embryo development ending in seed dormancy" evidence=RCA;IMP

GO:0005515 "protein binding" evidence=IPI

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=TAS

GO:0009556 "microsporogenesis" evidence=IGI;IMP

GO:0010152 "pollen maturation" evidence=IMP

GO:0043234 "protein complex" evidence=IPI

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IGI;IMP

GO:0033612 "receptor serine/threonine kinase binding" evidence=IPI

GO:0007030 "Golgi organization" evidence=IGI

GO:0010227 "floral organ abscission" evidence=IGI

GO:0000226 "microtubule cytoskeleton organization" evidence=RCA

GO:0000911 "cytokinesis by cell plate formation" evidence=RCA

GO:0007062 "sister chromatid cohesion" evidence=RCA

GO:0009880 "embryonic pattern specification" evidence=RCA

GO:0010072 "primary shoot apical meristem specification" evidence=RCA

GO:0010228 "vegetative to reproductive phase transition of meristem" evidence=RCA

GO:0010431 "seed maturation" evidence=RCA

GO:0016310 "phosphorylation" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0045595 "regulation of cell differentiation" evidence=RCA

GO:0051301 "cell division" evidence=RCA

TAIR|locus:2121686 CRK19 "cysteine-rich RLK (RECEPTOR-like protein kinase) 19" [Arabidopsis thaliana (taxid:3702)]

 Score = 371 (135.7 bits), Expect = 3.5e-40, Sum P(2) = 3.5e-40
 Identities = 78/248 (31%), Positives = 138/248 (55%)

Query:   242 SKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSR 301
             SK      ++  +E++  ++++HRN++ LL + +  +  +LVYEF+ N SL   L D S 
Sbjct:   357 SKTSGQGEKEFENEVVVVAKLQHRNLVKLLGYCLEGEEKILVYEFVPNKSLDHFLFD-ST 415

Query:   302 GRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMA 361
              + +LDW  R++I  G+A G+ YLH     +IIH D+K  N+LL+DDM   I+D G+A  
Sbjct:   416 MKMKLDWTRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDDDMNPKIADFGMARI 475

Query:   362 IPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGE 421
                  T  +   V+GT  Y++PEY    + S K D++SFG+L++ ++ G+ +   +Q  E
Sbjct:   476 FGMDQTEAMTRRVVGTYGYMSPEYAMYGQFSMKSDVYSFGVLVLEIISGMKNSSLYQMDE 535

Query:   422 EICS-PEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPN-SQYV 479
              + +   +  ++ ++ +PS  +DP    N    ++   + IA +C   D E+RP  S  V
Sbjct:   536 SVGNLVTYTWRLWSNGSPSELVDPSFGDNYQTSEITRCIHIALLCVQEDAEDRPTMSSIV 595

Query:   480 RCRLSQLL 487
             +   + L+
Sbjct:   596 QMLTTSLI 603

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009751 "response to salicylic acid stimulus" evidence=IEP

GO:0042742 "defense response to bacterium" evidence=IEP

GO:0005886 "plasma membrane" evidence=IDA

GO:0010167 "response to nitrate" evidence=RCA

GO:0015706 "nitrate transport" evidence=RCA

TAIR|locus:2203000 AT1G78530 [Arabidopsis thaliana (taxid:3702)]

 Score = 388 (141.6 bits), Expect = 3.6e-40, Sum P(2) = 3.6e-40
 Identities = 97/267 (36%), Positives = 146/267 (54%)

Query:   212 ELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL 271
             ++ GS G     + VI  +   A + +   +  RD   R    E+   + I+HRNI+ L 
Sbjct:    79 DILGSGGFGTVYRLVIDDSTTFAVKRLNRGTSERD---RGFHRELEAMADIKHRNIVTLH 135

Query:   272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSA 331
              +   P  +LL+YE M NGSL   L     GR+ LDW SR+RIA+G A G+ YLH     
Sbjct:   136 GYFTSPHYNLLIYELMPNGSLDSFL----HGRKALDWASRYRIAVGAARGISYLHHDCIP 191

Query:   332 SIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPEL 391
              IIH DIK  N+LL+ +MEA +SD GLA  +    T V  ++V GT  Y+APEYF   + 
Sbjct:   192 HIIHRDIKSSNILLDHNMEARVSDFGLATLMEPDKTHVS-TFVAGTFGYLAPEYFDTGKA 250

Query:   392 SEKCDIFSFGMLLISLVRG-VPSF-VFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGN 449
             + K D++SFG++L+ L+ G  P+   F + G ++ +  W++ V+  +     ID RL G+
Sbjct:   251 TMKGDVYSFGVVLLELLTGRKPTDDEFFEEGTKLVT--WVKGVVRDQREEVVIDNRLRGS 308

Query:   450 GYEK--KMLHVLKIAYICTLHDPEERP 474
               ++  +M  V  IA +C   +P  RP
Sbjct:   309 SVQENEEMNDVFGIAMMCLEPEPAIRP 335

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2040461 SERK4 "somatic embryogenesis receptor-like kinase 4" [Arabidopsis thaliana (taxid:3702)]

 Score = 426 (155.0 bits), Expect = 6.7e-40, P = 6.7e-40
 Identities = 103/292 (35%), Positives = 160/292 (54%)

Query:   192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ 251
             D F++   +G GG G+VYK  L  ++G ++A+K+           L EE +K    +L Q
Sbjct:   292 DNFSNKNVLGRGGFGKVYKGRL--ADGNLVAVKR-----------LKEERTK--GGEL-Q 335

Query:   252 IRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
              ++E+   S   HRN+L L    + P   LLVY +M NGS+   L +   G   LDWP R
Sbjct:   336 FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPEGNPALDWPKR 395

Query:   312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLI 371
               IALG A GL YLH +    IIH D+K  N+LL+++ EA + D GLA  +    + V  
Sbjct:   396 KHIALGSARGLAYLHDHCDQKIIHRDVKAANILLDEEFEAVVGDFGLAKLMNYNDSHVTT 455

Query:   372 SYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ--NGEEICSPEWL 429
             + V GT+ +IAPEY    + SEK D+F +G++L+ L+ G  +F   +  N ++I   +W+
Sbjct:   456 A-VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQKAFDLARLANDDDIMLLDWV 514

Query:   430 RKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPN-SQYVR 480
             ++V+  K     +D  L G   E ++  ++++A +CT     ERP  S+ VR
Sbjct:   515 KEVLKEKKLESLVDAELEGKYVETEVEQLIQMALLCTQSSAMERPKMSEVVR 566

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0060548 "negative regulation of cell death" evidence=IMP

GO:1900140 "regulation of seedling development" evidence=IMP

GO:0010200 "response to chitin" evidence=IEP;RCA

GO:0008219 "cell death" evidence=IGI

GO:0033612 "receptor serine/threonine kinase binding" evidence=IPI

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IGI

GO:0010150 "leaf senescence" evidence=IGI

GO:0000165 "MAPK cascade" evidence=RCA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009814 "defense response, incompatible interaction" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

TAIR|locus:2035686 AT1G55200 [Arabidopsis thaliana (taxid:3702)]

 Score = 391 (142.7 bits), Expect = 3.2e-39, Sum P(2) = 3.2e-39
 Identities = 85/230 (36%), Positives = 129/230 (56%)

Query:   254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
             SE+   S  +HRN++ L+   +     LLVYE++ NGSL   L    R +  L WP+R +
Sbjct:   422 SEVEVLSCAQHRNVVMLIGFCIEDTRRLLVYEYICNGSLDSHL--YGRHKDTLGWPARQK 479

Query:   314 IALGVASGLEYLHMY-HSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLIS 372
             IA+G A GL YLH       I+H D++P N+L+  D E  + D GLA   PDG   V  +
Sbjct:   480 IAVGAARGLRYLHEECRVGCIVHRDMRPNNILITHDYEPLVGDFGLARWQPDGELGV-DT 538

Query:   373 YVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF-VFHQNGEEICSPEWLRK 431
              V+GT  Y+APEY Q  +++EK D++SFG++LI L+ G  +  ++   G++ C  EW R 
Sbjct:   539 RVIGTFGYLAPEYAQSGQITEKADVYSFGVVLIELITGRKAMDIYRPKGQQ-CLTEWARS 597

Query:   432 VMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPN-SQYVR 480
             ++        +DPRL     E +++ ++  A +C   DP  RP  SQ +R
Sbjct:   598 LLEEYAVEELVDPRLEKRYSETQVICMIHTASLCIRRDPHLRPRMSQVLR 647

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2027559 AT1G56720 [Arabidopsis thaliana (taxid:3702)]

 Score = 360 (131.8 bits), Expect = 1.1e-38, Sum P(2) = 1.1e-38
 Identities = 72/232 (31%), Positives = 124/232 (53%)

Query:   250 RQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWP 309
             ++ R E+     +RH+N++ LL + +     +LVYE++ NG+L+  L    R    L W 
Sbjct:   218 KEFRVEVDAIGHVRHKNLVRLLGYCIEGTHRILVYEYVNNGNLEQWLHGAMRQHGYLTWE 277

Query:   310 SRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRV 369
             +R ++ +G +  L YLH      ++H DIK  N+L+ND+  A +SD GLA  +  G + V
Sbjct:   278 ARMKVLIGTSKALAYLHEAIEPKVVHRDIKSSNILINDEFNAKVSDFGLAKLLGAGKSHV 337

Query:   370 LISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWL 429
               + V+GT  Y+APEY     L+EK D++SFG++L+  + G     + +   E+   +WL
Sbjct:   338 T-TRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRDPVDYGRPAHEVNLVDWL 396

Query:   430 RKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPN-SQYVR 480
             + ++ ++     +DP +      + +   L  A  C   D ++RP  SQ VR
Sbjct:   397 KMMVGTRRSEEVVDPNIEVKPPTRSLKRALLTALRCVDPDSDKRPKMSQVVR 448

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IDA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.824
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	487
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	4e-42
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-41
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	5e-38
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	8e-33
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-31
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-31
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	7e-31
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	8e-31
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-30
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-26
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	8e-26
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-24
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	4e-24
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	7e-24
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-22
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	3e-22
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-21
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	3e-21
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-20
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	6e-20
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-19
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	4e-19
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	4e-19
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	8e-19
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-18
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-18
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	4e-18
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	6e-18
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	7e-18
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	7e-18
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-17
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	4e-17
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	4e-17
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	5e-17
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	6e-17
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-16
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-16
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-16
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-16
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-16
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	3e-16
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	4e-16
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	7e-16
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-15
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-15
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-15
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-15
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-15
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	3e-15
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-15
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	4e-15
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	5e-15
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	6e-15
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	8e-15
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-14
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-14
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-14
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-14
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-14
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	3e-14
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	3e-14
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	4e-14
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	4e-14
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	4e-14
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	4e-14
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	5e-14
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	5e-14
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	6e-14
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-13
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-13
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-13
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-13
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-13
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	4e-13
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	5e-13
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	5e-13
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	6e-13
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	8e-13
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-12
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-12
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-12
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-12
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-12
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-12
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-12
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-12
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	3e-12
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	3e-12
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	3e-12
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	3e-12
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	4e-12
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	4e-12
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	4e-12
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	5e-12
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	6e-12
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	6e-12
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	7e-12
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	7e-12
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	8e-12
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	8e-12
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	8e-12
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-11
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-11
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-11
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-11
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-11
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	3e-11
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	3e-11
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	4e-11
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	4e-11
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	6e-11
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	6e-11
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	7e-11
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	9e-11
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	9e-11
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-10
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-10
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-10
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-10
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-10
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-10
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-10
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-10
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-10
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-10
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-10
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-10
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-10
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	3e-10
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	3e-10
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	4e-10
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	5e-10
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	6e-10
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	6e-10
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	7e-10
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	7e-10
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	7e-10
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	8e-10
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	8e-10
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	8e-10
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	9e-10
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	9e-10
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-09
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-09
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-09
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-09
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-09
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-09
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-09
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-09
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-09
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-09
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-09
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	3e-09
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	3e-09
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	3e-09
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	3e-09
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-09
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	4e-09
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	4e-09
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	4e-09
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	5e-09
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	5e-09
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	5e-09
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	5e-09
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	5e-09
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	6e-09
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	6e-09
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	6e-09
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	7e-09
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	7e-09
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	8e-09
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	9e-09
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	9e-09
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-08
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	1e-08
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-08
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-08
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-08
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-08
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-08
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-08
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-08
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-08
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-08
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-08
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-08
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-08
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-08
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-08
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-08
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-08
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-08
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-08
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-08
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-08
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	3e-08
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	3e-08
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-08
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-08
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	3e-08
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	4e-08
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	4e-08
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	4e-08
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	4e-08
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	4e-08
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	4e-08
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	5e-08
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	5e-08
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	6e-08
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	6e-08
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	6e-08
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	6e-08
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	7e-08
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	7e-08
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	8e-08
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	8e-08
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	9e-08
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-07
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-07
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-07
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-07
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-07
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-07
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-07
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-07
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-07
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	3e-07
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	3e-07
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	3e-07
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	3e-07
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	4e-07
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	5e-07
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	7e-07
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	8e-07
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	9e-07
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-06
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-06
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-06
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-06
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-06
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	2e-06
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	4e-06
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	4e-06
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	5e-06
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	5e-06
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	6e-06
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	7e-06
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-05
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-05
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-05
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-05
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-05
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-05
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-05
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	1e-05
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-05
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-05
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-05
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-05
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-05
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-05
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	3e-05
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	3e-05
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	3e-05
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	3e-05
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	3e-05
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	4e-05
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	4e-05
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	4e-05
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	5e-05
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	5e-05
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	7e-05
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	8e-05
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	9e-05
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-04
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-04
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-04
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-04
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-04
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	3e-04
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	3e-04
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	3e-04
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	3e-04
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	6e-04
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	6e-04
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	7e-04
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	8e-04
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	8e-04
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	0.001
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	0.002
TIGR03724	199	TIGR03724, arch_bud32, Kae1-associated kinase Bud3	0.002
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	0.003
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	0.004
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	0.004
PRK09605	535	PRK09605, PRK09605, bifunctional UGMP family prote	0.004

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  148 bits (377), Expect = 4e-42
 Identities = 69/210 (32%), Positives = 103/210 (49%), Gaps = 25/210 (11%)

Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G GG G VY A      GK +AIK +                +   S L ++  EI   
Sbjct: 1   LGEGGFGTVYLARDKK-TGKKVAIKII--------------KKEDSSSLLEELLREIEIL 45

Query: 260 SQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVA 319
            ++ H NI+ L       +   LV E+ + GSL+D+L        +L      RI L + 
Sbjct: 46  KKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLK---ENEGKLSEDEILRILLQIL 102

Query: 320 SGLEYLHMYHSASIIHGDIKPRNVLL-NDDMEACISDLGLAMAIPDGYTRVLISYVLGTM 378
            GLEYL   HS  IIH D+KP N+LL +D+ +  ++D GL+  +     + L+  ++GT 
Sbjct: 103 EGLEYL---HSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSD--KSLLKTIVGTP 157

Query: 379 AYIAPE-YFQQPELSEKCDIFSFGMLLISL 407
           AY+APE    +   SEK DI+S G++L  L
Sbjct: 158 AYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  148 bits (377), Expect = 1e-41
 Identities = 81/280 (28%), Positives = 121/280 (43%), Gaps = 42/280 (15%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           LEK+G G  G+VY A    + GK++AIK +                K       +I  EI
Sbjct: 4   LEKLGEGSFGKVYLARDKKT-GKLVAIKVI--------------KKKKIKKDRERILREI 48

Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL 316
               +++H NI+ L       D   LV E+ + G L D+L    RGR   D         
Sbjct: 49  KILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLK--KRGRLSEDE--ARFYLR 104

Query: 317 GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLG 376
            + S LEYLH   S  I+H D+KP N+LL++D    ++D GLA  +       L ++V G
Sbjct: 105 QILSALEYLH---SKGIVHRDLKPENILLDEDGHVKLADFGLARQLDP--GEKLTTFV-G 158

Query: 377 TMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSK 436
           T  Y+APE        +  DI+S G++L  L+ G P F       E+      +K+   K
Sbjct: 159 TPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLEL-----FKKIGKPK 213

Query: 437 NPSRAIDPRLPGNGYE--KKMLHVLKIAYICTLHDPEERP 474
            P    +  +     +  +K+L            DPE+R 
Sbjct: 214 PPFPPPEWDISPEAKDLIRKLLVK----------DPEKRL 243

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  139 bits (352), Expect = 5e-38
 Identities = 79/294 (26%), Positives = 123/294 (41%), Gaps = 44/294 (14%)

Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           +  L K+GSG  G VYKA+  G+ GK++A+K +                  +  K +  R
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGT-GKIVAVKILKK-------------RSEKSKKDQTAR 46

Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
            EI    ++ H NI+ L+      D   LV E+ + G L D L         L      +
Sbjct: 47  REIRILRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYL----SRGGPLSEDEAKK 102

Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA--MAIPDGYTRVLI 371
           IAL +  GLEYLH   S  IIH D+KP N+LL+++    I+D GLA  +          +
Sbjct: 103 IALQILRGLEYLH---SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV 159

Query: 372 SYVLGTMAYIAPE-YFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLR 430
               GT  Y+APE          K D++S G++L  L+ G P F        +   + +R
Sbjct: 160 ----GTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPF---SGENILDQLQLIR 212

Query: 431 KVMNSKNP-SRAIDPRLPGNGYE--KKMLHVLKIAYICTLHDPEERPNSQYVRC 481
           +++                   +  KK L+           DP +RP ++ +  
Sbjct: 213 RILGPPLEFDEPKWSSGSEEAKDLIKKCLNK----------DPSKRPTAEEILQ 256

Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  125 bits (315), Expect = 8e-33
 Identities = 87/285 (30%), Positives = 119/285 (41%), Gaps = 45/285 (15%)

Query: 193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQI 252
            F  LEKIG GG GEVYKA      GK +AIK             I+ +SK    K  +I
Sbjct: 1   LFEILEKIGKGGFGEVYKA-RHKRTGKEVAIKV------------IKLESK---EKKEKI 44

Query: 253 RSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRH 312
            +EI    + +H NI+      ++ D   +V EF   GSL+D+L   ++   E       
Sbjct: 45  INEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQ----- 99

Query: 313 RIA---LGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRV 369
            IA     +  GLEYLH      IIH DIK  N+LL  D E  + D GL+  + D   R 
Sbjct: 100 -IAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN 155

Query: 370 LISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWL 429
            +   +GT  ++APE         K DI+S G+  I L  G P +       E+   + L
Sbjct: 156 TM---VGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPY------SELPPMKAL 206

Query: 430 RKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERP 474
                + N      P L                  C   +PE+RP
Sbjct: 207 --FKIATNGP----PGLRNPEKWSDEFK--DFLKKCLQKNPEKRP 243

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  121 bits (305), Expect = 2e-31
 Identities = 60/217 (27%), Positives = 95/217 (43%), Gaps = 35/217 (16%)

Query: 197 LEKIGSGGCGEVYKAEL---PGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
            +K+G G  GEVYK  L          +A+K +      ++ E  EE             
Sbjct: 4   GKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTL---KEGASEEEREE-----------FL 49

Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
            E     ++ H NI+ LL    + +   +V E+M  G L D L    +   +L      +
Sbjct: 50  EEASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFL---RKHGEKLTLKDLLQ 106

Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI-PDGYTRVLIS 372
           +AL +A G+EYL    S + +H D+  RN L+ +++   ISD GL+  I  D Y      
Sbjct: 107 MALQIAKGMEYLE---SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDY------ 157

Query: 373 YVLGTMAYI-----APEYFQQPELSEKCDIFSFGMLL 404
           Y       +     APE  +  + + K D++SFG+LL
Sbjct: 158 YRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLL 194

Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  121 bits (305), Expect = 3e-31
 Identities = 80/313 (25%), Positives = 121/313 (38%), Gaps = 79/313 (25%)

Query: 198 EKIGSGGCGEVYKAELPGSNGKMI--AIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSE 255
           +K+G G  GEVYK +L G +GK    A+K            L E+ S   + + +    E
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKT-----------LKEDAS---EEERKDFLKE 46

Query: 256 IITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDIL-----DDVSRGRRELDWPS 310
                ++ H N++ LL      +   LV E+M+ G L D L        S  +  L    
Sbjct: 47  ARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKD 106

Query: 311 RHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVL 370
               A+ +A G+EYL    S   +H D+  RN L+ +D+   ISD GL+  + D      
Sbjct: 107 LLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD---- 159

Query: 371 ISYVLGTMAYI-----APEYFQQPELSEKCDIFSFGMLL---ISLVR----GVPSFVFHQ 418
             Y   T   +     APE  +    + K D++SFG+LL    +L      G+ +    +
Sbjct: 160 -YYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLE 218

Query: 419 ---NGE-----EICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDP 470
               G      E C  E L ++M S                             C   DP
Sbjct: 219 YLRKGYRLPKPEYCPDE-LYELMLS-----------------------------CWQLDP 248

Query: 471 EERPNSQYVRCRL 483
           E+RP    +  RL
Sbjct: 249 EDRPTFSELVERL 261

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  119 bits (301), Expect = 7e-31
 Identities = 61/212 (28%), Positives = 99/212 (46%), Gaps = 25/212 (11%)

Query: 197 LEKIGSGGCGEVYKAEL---PGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
            +K+G G  GEVYK  L          +A+K +      ++ + IEE             
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTL---KEDASEQQIEE-----------FL 49

Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
            E     ++ H NI+ LL      +  ++V E+M  G L D L       +EL       
Sbjct: 50  REARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYL--RKNRPKELSLSDLLS 107

Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG-YTRVLIS 372
            AL +A G+EYL    S + IH D+  RN L+ +++   ISD GL+  + D  Y +V   
Sbjct: 108 FALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGG 164

Query: 373 YVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
            +   + ++APE  ++ + + K D++SFG+LL
Sbjct: 165 KL--PIRWMAPESLKEGKFTSKSDVWSFGVLL 194

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  119 bits (301), Expect = 8e-31
 Identities = 61/224 (27%), Positives = 95/224 (42%), Gaps = 23/224 (10%)

Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           E +G G  G VY A      G+++A+K V +             S   + +L  +  EI 
Sbjct: 6   ELLGRGSFGSVYLALD-KDTGELMAVKSVEL-------------SGDSEEELEALEREIR 51

Query: 258 TASQIRHRNILPLLAHMV-RPDCHLLVY-EFMKNGSLQDILDDVSRGRRELDWPSRHRIA 315
             S ++H NI+             L ++ E++  GSL  +L    +    L  P   +  
Sbjct: 52  ILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGK----LPEPVIRKYT 107

Query: 316 LGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVL 375
             +  GL YLH   S  I+H DIK  N+L++ D    ++D G A  + D  T      V 
Sbjct: 108 RQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVR 164

Query: 376 GTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQN 419
           GT  ++APE  +  E     DI+S G  +I +  G P +    N
Sbjct: 165 GTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  118 bits (299), Expect = 1e-30
 Identities = 63/213 (29%), Positives = 101/213 (47%), Gaps = 28/213 (13%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGK---MIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
            +K+G G  GEVYK +L G  GK    +A+K +      ++ + IEE             
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTL---KEDASEQQIEE-----------FL 49

Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRE-LDWPSRH 312
            E     ++ H N++ LL      +   +V E+M+ G L   L    R  R  L      
Sbjct: 50  REARIMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYL----RKNRPKLSLSDLL 105

Query: 313 RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG-YTRVLI 371
             AL +A G+EYL    S + IH D+  RN L+ +++   ISD GL+  + D  Y R   
Sbjct: 106 SFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRG 162

Query: 372 SYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
             +   + ++APE  ++ + + K D++SFG+LL
Sbjct: 163 GKL--PIRWMAPESLKEGKFTSKSDVWSFGVLL 193

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  110 bits (275), Expect = 1e-26
 Identities = 82/292 (28%), Positives = 124/292 (42%), Gaps = 33/292 (11%)

Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           +  L K+G G  GEVY A       K++A+K             + +  + +  ++ +  
Sbjct: 2   YRILRKLGEGSFGEVYLARDR----KLVALKV------------LAKKLESKSKEVERFL 45

Query: 254 SEIITASQIRH-RNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRH 312
            EI   + + H  NI+ L           LV E++  GSL+D+L  + R    L      
Sbjct: 46  REIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGP-LSESEAL 104

Query: 313 RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN-DDMEACISDLGLAMAIPDGYTRV-- 369
            I   + S LEYLH   S  IIH DIKP N+LL+ D     + D GLA  +PD  +    
Sbjct: 105 FILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSI 161

Query: 370 --LISYVLGTMAYIAPEYFQQPEL---SEKCDIFSFGMLLISLVRGVPSFVFHQNGEEIC 424
             L S  +GT  Y+APE      L   S   DI+S G+ L  L+ G+P F     GE+  
Sbjct: 162 PALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPF----EGEKNS 217

Query: 425 SPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNS 476
           S       +  + P+ ++   L  +  E        +       DP+ R +S
Sbjct: 218 SATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSS 269

Length = 384

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  105 bits (264), Expect = 8e-26
 Identities = 62/221 (28%), Positives = 99/221 (44%), Gaps = 31/221 (14%)

Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           + IG G  G VYK  L    G  +AIK++ +              K+++  L+ I  EI 
Sbjct: 6   DLIGRGAFGVVYKG-LNLETGDFVAIKQISL-------------EKIKEEALKSIMQEID 51

Query: 258 TASQIRHRNILPLLAHMVRPDCHL-LVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL 316
               ++H NI+  +   +     L ++ E+ +NGSL+ I+         L       +A+
Sbjct: 52  LLKNLKHPNIVKYIGS-IETSDSLYIILEYAENGSLRQIIKKFGPFPESL-------VAV 103

Query: 317 GVA---SGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISY 373
            V     GL YL   H   +IH DIK  N+L   D    ++D G+A  + D       + 
Sbjct: 104 YVYQVLQGLAYL---HEQGVIHRDIKAANILTTKDGVVKLADFGVATKLND--VSKDDAS 158

Query: 374 VLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
           V+GT  ++APE  +    S   DI+S G  +I L+ G P +
Sbjct: 159 VVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPY 199

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  101 bits (254), Expect = 3e-24
 Identities = 71/287 (24%), Positives = 116/287 (40%), Gaps = 57/287 (19%)

Query: 199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT 258
            +G G  G VYK     + GK+ A+KK+ V                 +   +Q+  E+ T
Sbjct: 8   VLGQGSSGVVYKVRHKPT-GKIYALKKIHVD--------------GDEEFRKQLLRELKT 52

Query: 259 ASQIRHRNILPLLAHMVRPDCH---------LLVYEFMKNGSLQDILDDVSRGRRELDWP 309
                   +       V+  C+          +V E+M  GSL D+L      ++    P
Sbjct: 53  LRSCESPYV-------VK--CYGAFYKEGEISIVLEYMDGGSLADLL------KKVGKIP 97

Query: 310 SR--HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
                 IA  +  GL+YLH      IIH DIKP N+L+N   E  I+D G++  + +   
Sbjct: 98  EPVLAYIARQILKGLDYLH--TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD 155

Query: 368 RVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPE 427
           +   ++V GT+ Y++PE  Q    S   DI+S G+ L+    G   F       +    E
Sbjct: 156 QCN-TFV-GTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPF---LPPGQPSFFE 210

Query: 428 WLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERP 474
            ++ + +         P LP   +  +    +     C   DP++RP
Sbjct: 211 LMQAICDGP------PPSLPAEEFSPEFRDFIS---ACLQKDPKKRP 248

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  101 bits (253), Expect = 4e-24
 Identities = 83/295 (28%), Positives = 123/295 (41%), Gaps = 55/295 (18%)

Query: 197 LEKIGSGGCGEVYKAE-LPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSE 255
           +E IG G    VY A  LP  N + +AIK++              D +   + + ++R E
Sbjct: 6   IEVIGVGATAVVYAAICLP--NNEKVAIKRI--------------DLEKCQTSVDELRKE 49

Query: 256 IITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILD-DVSRGRRELDWPSRHRI 314
           +   SQ  H N++      V  D   LV  ++  GSL DI+     RG   LD      +
Sbjct: 50  VQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRG--GLDEAIIATV 107

Query: 315 ALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISY- 373
              V  GLEYLH   S   IH DIK  N+LL +D    I+D G++ ++ DG  R      
Sbjct: 108 LKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRK 164

Query: 374 -VLGTMAYIAPEYFQQ-PELSEKCDIFSFGMLLISLVRGVPSF-------VFHQNGEEIC 424
             +GT  ++APE  +Q      K DI+SFG+  I L  G   +       V         
Sbjct: 165 TFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVL-------- 216

Query: 425 SPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLK--IAYICTLHDPEERPNSQ 477
                  ++  +N      P L      KK     +  I+ +C   DP +RP ++
Sbjct: 217 -------MLTLQNDP----PSLETGADYKKYSKSFRKMIS-LCLQKDPSKRPTAE 259

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  100 bits (252), Expect = 7e-24
 Identities = 82/293 (27%), Positives = 132/293 (45%), Gaps = 55/293 (18%)

Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           + +LEKIG G  GEVYKA    +  ++ AIKK+                +LR      I 
Sbjct: 21  YKNLEKIGEGASGEVYKATDRATGKEV-AIKKM----------------RLRKQNKELII 63

Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHL------LVYEFMKNGSLQDILDDVSRGRRELD 307
           +EI+     +H NI+         D +L      +V E+M  GSL DI+    +    ++
Sbjct: 64  NEILIMKDCKHPNIVDYY------DSYLVGDELWVVMEYMDGGSLTDIIT---QNFVRMN 114

Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI-PDGY 366
            P    +   V  GLEYLH   S ++IH DIK  N+LL+ D    ++D G A  +  +  
Sbjct: 115 EPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS 171

Query: 367 TRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSP 426
            R   + V+GT  ++APE  ++ +   K DI+S G++ I +  G P ++      E   P
Sbjct: 172 KR---NSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYL-----RE--PP 221

Query: 427 EWLRKVMNSKNPSRAIDPRLP-GNGYEKKMLHVLKIAYICTLHDPEERPNSQY 478
                ++ +K       P L     +  +    L     C + DPE+RP+++ 
Sbjct: 222 LRALFLITTKGI-----PPLKNPEKWSPEFKDFLN---KCLVKDPEKRPSAEE 266

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 96.7 bits (241), Expect = 2e-22
 Identities = 82/292 (28%), Positives = 117/292 (40%), Gaps = 37/292 (12%)

Query: 192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ 251
           +    L ++G G  G V K  L   N  MI   K I   P    +             +Q
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLK--NTGMIFALKTITTDPNPDLQ-------------KQ 45

Query: 252 IRSEIITASQIRHRNILPLL-AHMVRPDCHL-LVYEFMKNGSLQDILDDV-SRGRRELDW 308
           I  E+      +   I+    A +      + +  E+ + GSL  I   V  RG R  + 
Sbjct: 46  ILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEK 105

Query: 309 PSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTR 368
               +IA  V  GL YLH   S  IIH DIKP N+LL    +  + D G++  + +    
Sbjct: 106 VL-GKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS--- 158

Query: 369 VLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSP-E 427
            L     GT  Y+APE  Q    S   D++S G+ L+ + +    F F   GE    P E
Sbjct: 159 -LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQN--RFPFPPEGEPPLGPIE 215

Query: 428 WLRKVMNSKNPSRAIDPRLPGNG--YEKKMLHVLKIAYICTLHDPEERPNSQ 477
            L  ++N  NP    D   PGNG  + ++    +K    C   DP  RP   
Sbjct: 216 LLSYIVNMPNP-ELKDE--PGNGIKWSEEFKDFIK---QCLEKDPTRRPTPW 261

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 95.8 bits (239), Expect = 3e-22
 Identities = 69/225 (30%), Positives = 104/225 (46%), Gaps = 32/225 (14%)

Query: 191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
           E+ F  LEK+G G  G VYKA +    G+++AIK V           +EED +       
Sbjct: 2   EEVFDILEKLGEGSYGSVYKA-IHKETGQVVAIKVV----------PVEEDLQ------- 43

Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPS 310
           +I  EI    Q     I+       +     +V E+   GS+ DI+   ++   E     
Sbjct: 44  EIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTE----- 98

Query: 311 RHRIAL---GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
              IA        GLEYLH   S   IH DIK  N+LLN++ +A ++D G++  +    T
Sbjct: 99  -EEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQL--TDT 152

Query: 368 RVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVP 412
               + V+GT  ++APE  Q+   + K DI+S G+  I +  G P
Sbjct: 153 MAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKP 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 98.8 bits (246), Expect = 1e-21
 Identities = 61/226 (26%), Positives = 110/226 (48%), Gaps = 23/226 (10%)

Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
           SEI    +++H NI+ L+          L++E+++  +L ++L       R L W  R +
Sbjct: 732 SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL-------RNLSWERRRK 784

Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLN--DDMEACISDLGLAMAIPDGYTRVLI 371
           IA+G+A  L +LH   S +++ G++ P  ++++  D+       L L   +       + 
Sbjct: 785 IAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR---LSLPGLLCTDTKCFIS 841

Query: 372 SYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRG-VPSFVFHQNGEEICSPEWLR 430
           S      AY+APE  +  +++EK DI+ FG++LI L+ G  P+         I   EW R
Sbjct: 842 S------AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIV--EWAR 893

Query: 431 KVMNSKNPSRAIDPRLPGNG--YEKKMLHVLKIAYICTLHDPEERP 474
              +  +    IDP + G+    + +++ V+ +A  CT  DP  RP
Sbjct: 894 YCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARP 939

Length = 968

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 92.5 bits (230), Expect = 3e-21
 Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 33/209 (15%)

Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
             IG G  G+V   +     G+ +A+K             +++DS    + L    +E  
Sbjct: 12  ATIGKGEFGDVMLGDY---RGQKVAVKC------------LKDDSTAAQAFL----AEAS 52

Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALG 317
             + +RH N++ LL  +++ +   +V E+M  GSL D L   SRGR  +    +   AL 
Sbjct: 53  VMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLR--SRGRAVITLAQQLGFALD 110

Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT--RVLISYVL 375
           V  G+EYL      + +H D+  RNVL+++D+ A +SD GLA     G    ++ + +  
Sbjct: 111 VCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT- 166

Query: 376 GTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
                 APE  ++ + S K D++SFG+LL
Sbjct: 167 ------APEALREKKFSTKSDVWSFGILL 189

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 90.5 bits (225), Expect = 2e-20
 Identities = 80/291 (27%), Positives = 130/291 (44%), Gaps = 54/291 (18%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           L ++G+G  G V K     + GK++A+K +           +E +  ++    +QI  E+
Sbjct: 6   LGELGAGNSGVVSKVLHRPT-GKIMAVKTI----------RLEINEAIQ----KQILREL 50

Query: 257 ITASQIRHRNILPLL-----AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
                I H+   P +     A     D  + + E+M  GSL  IL +V     E      
Sbjct: 51  ----DILHKCNSPYIVGFYGAFYNNGDISICM-EYMDGGSLDKILKEVQGRIPE---RIL 102

Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLI 371
            +IA+ V  GL YLH  H   IIH D+KP N+L+N   +  + D G+        +  L+
Sbjct: 103 GKIAVAVLKGLTYLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGV--------SGQLV 152

Query: 372 SYV----LGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSP- 426
           + +    +GT +Y+APE  Q  + S K DI+S G+ LI L  G   +    +  +     
Sbjct: 153 NSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD--GIF 210

Query: 427 EWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQ 477
           E L+ ++N   P     PRLP   +       +    +C + DP ERP+ +
Sbjct: 211 ELLQYIVNE--PP----PRLPSGKFSPDFQDFVN---LCLIKDPRERPSYK 252

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 88.9 bits (220), Expect = 6e-20
 Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 31/207 (14%)

Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           E IG G  G V + E     G+ +A+K   +   ++A   +EE + +             
Sbjct: 12  EIIGEGEFGAVLQGEY---TGQKVAVK--NIKCDVTAQAFLEETAVM------------- 53

Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALG 317
             +++ H+N++ LL  ++    ++ V E M  G+L + L   +RGR  +      + +L 
Sbjct: 54  --TKLHHKNLVRLLGVILHNGLYI-VMELMSKGNLVNFLR--TRGRALVSVIQLLQFSLD 108

Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGT 377
           VA G+EYL    S  ++H D+  RN+L+++D  A +SD GLA     G     +      
Sbjct: 109 VAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLP----- 160

Query: 378 MAYIAPEYFQQPELSEKCDIFSFGMLL 404
           + + APE  +  + S K D++S+G+LL
Sbjct: 161 VKWTAPEALKHKKFSSKSDVWSYGVLL 187

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 87.5 bits (217), Expect = 3e-19
 Identities = 67/227 (29%), Positives = 108/227 (47%), Gaps = 39/227 (17%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDS---KLRQ-I 252
           LE++G G  G+VYK EL G N ++ A    I                L+++   K++Q  
Sbjct: 10  LEELGEGAFGKVYKGELTGPNERLSATSVAIK--------------TLKENAEPKVQQEF 55

Query: 253 RSEIITASQIRHRNILPLLAHMVR--PDCHLLVYEFMKNGSLQDIL------DDVSRGRR 304
           R E    S ++H NI+ LL    +  P C L  +E++ +G L + L       DV     
Sbjct: 56  RQEAELMSDLQHPNIVCLLGVCTKEQPTCML--FEYLAHGDLHEFLVRNSPHSDVGAESG 113

Query: 305 E------LDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGL 358
           +      LD      IA+ +A+G+EYL  +H    +H D+  RN L+ + +   ISD GL
Sbjct: 114 DETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGL 170

Query: 359 AMAIPDG-YTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
           +  I    Y RV    +L  + ++ PE     + + + DI+SFG++L
Sbjct: 171 SRDIYSADYYRVQSKSLL-PVRWMPPEAILYGKFTTESDIWSFGVVL 216

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 86.4 bits (215), Expect = 4e-19
 Identities = 61/233 (26%), Positives = 97/233 (41%), Gaps = 41/233 (17%)

Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  G+V       + GK+ A+K       +   ++I+        ++    +E    
Sbjct: 1   LGKGSFGKVLLVRKKDT-GKLYAMKV------LKKKKIIKRK------EVEHTLTE---- 43

Query: 260 SQIRHRNILPLLAH--MVRPDC------HL-LVYEFMKNGSLQDILDDVSRGRRELDWPS 310
                RNIL  + H  +V+          L LV E+   G L   L    R         
Sbjct: 44  -----RNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGR----FSEER 94

Query: 311 RHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVL 370
               A  +   LEYLH   S  II+ D+KP N+LL+ D    ++D GLA  +    +R  
Sbjct: 95  ARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSR-- 149

Query: 371 ISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI 423
            +   GT  Y+APE        +  D +S G+LL  ++ G P F + ++ +EI
Sbjct: 150 TNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPF-YAEDRKEI 201

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 86.8 bits (215), Expect = 4e-19
 Identities = 73/284 (25%), Positives = 129/284 (45%), Gaps = 28/284 (9%)

Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           +A LE +GSG  G VYK     +   ++A+K++ V+ P        +D + RD  +  I 
Sbjct: 2   YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPA-----FGKDKRERDKSIGDIV 56

Query: 254 SEI-ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRH 312
           SE+ I   Q+RH NI+      +  D   +V + ++   L +  + +   ++        
Sbjct: 57  SEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIW 116

Query: 313 RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA-MAIPDGYTRVLI 371
            I + +   L YLH      I+H D+ P N++L +D +  I+D GLA    P+      +
Sbjct: 117 NIFVQMVLALRYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK----L 170

Query: 372 SYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRK 431
           + V+GT+ Y  PE  +     EK D+++FG +L  +    P F +  N   + +     K
Sbjct: 171 TSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPF-YSTNMLSLAT-----K 224

Query: 432 VMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPN 475
           ++ +       +P LP   Y + +  V+     C   D E RP+
Sbjct: 225 IVEAV-----YEP-LPEGMYSEDVTDVIT---SCLTPDAEARPD 259

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 85.6 bits (213), Expect = 8e-19
 Identities = 70/295 (23%), Positives = 122/295 (41%), Gaps = 59/295 (20%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           +++IG G  G+VY      S+GK+  +K++ +             S + + +     +E+
Sbjct: 5   IKQIGKGSFGKVYLVR-RKSDGKLYVLKEIDL-------------SNMSEKEREDALNEV 50

Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQD-ILDDVSRGR--RE---LDWPS 310
               ++ H NI+             +V E+   G L   I      G+   E   LDW  
Sbjct: 51  KILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDW-- 108

Query: 311 RHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVL 370
                + +   L+YLH   S  I+H DIKP+N+ L  +    + D G++        +VL
Sbjct: 109 ----FVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGIS--------KVL 153

Query: 371 ISY------VLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEIC 424
            S       V+GT  Y++PE  Q    + K DI+S G +L  L      F   +N  E+ 
Sbjct: 154 SSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFE-GENLLELA 212

Query: 425 SPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYV 479
                 K++  +       P +P + Y  ++ +++         DPEERP+   +
Sbjct: 213 -----LKILKGQY------PPIP-SQYSSELRNLVS---SLLQKDPEERPSIAQI 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 85.6 bits (212), Expect = 1e-18
 Identities = 76/297 (25%), Positives = 124/297 (41%), Gaps = 51/297 (17%)

Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           F    K+GSG  GEV++      N   +AIK            +++ D  L   K +  +
Sbjct: 8   FTLERKLGSGYFGEVWEGLW--KNRVRVAIK------------ILKSDDLL---KQQDFQ 50

Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
            E+    ++RH++++ L A     +   ++ E M+ GSL   L     G+  L   S   
Sbjct: 51  KEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRS-PEGQ-VLPVASLID 108

Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG-YT--RVL 370
           +A  VA G+ YL      + IH D+  RN+L+ +D+   ++D GLA  I +  Y      
Sbjct: 109 MACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKK 165

Query: 371 ISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR--GVPSFVFHQNGEEICSPEW 428
           I Y      + APE       S K D++SFG+LL  +     VP          + + E 
Sbjct: 166 IPY-----KWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPY-------PGMNNHEV 213

Query: 429 LRKVM-NSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLS 484
             ++    + P      + P   Y        KI   C   +PE+RP+ + +R  L 
Sbjct: 214 YDQITAGYRMPC---PAKCPQEIY--------KIMLECWAAEPEDRPSFKALREELD 259

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 84.7 bits (209), Expect = 2e-18
 Identities = 82/287 (28%), Positives = 129/287 (44%), Gaps = 41/287 (14%)

Query: 191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
           E+ F  LEKIG G  GEV+K  +     K++AIK +         +L E + ++ D    
Sbjct: 3   EELFTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKII---------DLEEAEDEIED---- 48

Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPS 310
            I+ EI   SQ     +       ++     ++ E++  GS  D+L+        LD   
Sbjct: 49  -IQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-----GPLDETQ 102

Query: 311 RHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVL 370
              I   +  GL+YLH   S   IH DIK  NVLL++  E  ++D G+A  + D  T++ 
Sbjct: 103 IATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIK 157

Query: 371 ISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLR 430
            +  +GT  ++APE  +Q     K DI+S G+  I L +G P    H        P  + 
Sbjct: 158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPP---HSE----LHPMKVL 210

Query: 431 KVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQ 477
            ++   NP     P L GN Y K +   ++    C   +P  RP ++
Sbjct: 211 FLIPKNNP-----PTLEGN-YSKPLKEFVE---ACLNKEPSFRPTAK 248

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 83.6 bits (207), Expect = 4e-18
 Identities = 83/290 (28%), Positives = 132/290 (45%), Gaps = 39/290 (13%)

Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           F   +KIG G    VYKA     +G+++A+KKV ++      E++  D+K R   L+   
Sbjct: 4   FKIEKKIGKGQFSVVYKAICL-LDGRVVALKKVQIF------EMM--DAKARQDCLK--- 51

Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
            EI    Q+ H N++  LA  +  +   +V E    G L  ++    + +R +   +  +
Sbjct: 52  -EIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWK 110

Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISY 373
             + + S LE  HM HS  I+H DIKP NV +       + DLGL        T    S 
Sbjct: 111 YFVQLCSALE--HM-HSKRIMHRDIKPANVFITATGVVKLGDLGLGR-FFSSKTTAAHSL 166

Query: 374 VLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVM 433
           V GT  Y++PE   +   + K DI+S G LL  +               + SP +  K M
Sbjct: 167 V-GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA-------------ALQSPFYGDK-M 211

Query: 434 NSKNPSRAID----PRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYV 479
           N  +  + I+    P LP + Y +++  ++     C   DPE+RP+  YV
Sbjct: 212 NLYSLCKKIEKCDYPPLPADHYSEELRDLVS---RCINPDPEKRPDISYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 83.5 bits (207), Expect = 6e-18
 Identities = 64/228 (28%), Positives = 97/228 (42%), Gaps = 36/228 (15%)

Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           +  L KIG G  G VYKA      G+++AIKK+         +L  E   +  + LR+I+
Sbjct: 1   YQKLGKIGEGTYGVVYKAR-DKLTGEIVAIKKI---------KLRFESEGIPKTALREIK 50

Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
                  ++ H NI+ LL          LV+EFM      D+   +   +R L       
Sbjct: 51  L----LKELNHPNIIKLLDVFRHKGDLYLVFEFMD----TDLYKLIKDRQRGLPESLIKS 102

Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISY 373
               +  GL + H   S  I+H D+KP N+L+N +    ++D GLA        R   S 
Sbjct: 103 YLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLA--------RSFGSP 151

Query: 374 VLGTMAYIAPEYFQQPEL-------SEKCDIFSFGMLLISLVRGVPSF 414
           V     Y+   +++ PEL       S   DI+S G +   L+   P F
Sbjct: 152 VRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLF 199

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 83.4 bits (207), Expect = 7e-18
 Identities = 84/291 (28%), Positives = 129/291 (44%), Gaps = 60/291 (20%)

Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           F  LE IG G  GEVYKA    +N +++AIK +         +L E + ++ D     I+
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTN-QVVAIKVI---------DLEEAEDEIED-----IQ 47

Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHL-LVYEFMKNGSLQDILDDVSRGRRELDWPSRH 312
            EI   SQ R   I       ++    L ++ E+   GS  D+L        +LD     
Sbjct: 48  QEIQFLSQCRSPYITKYYGSFLK-GSKLWIIMEYCGGGSCLDLLK-----PGKLDETYIA 101

Query: 313 RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLIS 372
            I   V  GLEYLH       IH DIK  N+LL+++ +  ++D G++  +    ++   +
Sbjct: 102 FILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK-RNT 157

Query: 373 YVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKV 432
           +V GT  ++APE  +Q    EK DI+S G+  I L +G P             P      
Sbjct: 158 FV-GTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEP-------------P------ 197

Query: 433 MNSKNPSRAI-------DPRLPGNGYEKKMLHVLK--IAYICTLHDPEERP 474
           ++  +P R +        P L GN + K      K  ++  C   DP+ERP
Sbjct: 198 LSDLHPMRVLFLIPKNNPPSLEGNKFSKP----FKDFVSL-CLNKDPKERP 243

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 82.7 bits (205), Expect = 7e-18
 Identities = 63/225 (28%), Positives = 99/225 (44%), Gaps = 27/225 (12%)

Query: 191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
           ++ +  +++IGSG  G+VYKA    + G+++AIK +           +E           
Sbjct: 2   QEDYELIQRIGSGTYGDVYKARDIAT-GELVAIKVI----------KLEPGDDFEI---- 46

Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPS 310
            I+ EI    + RH NI+      +R D   +V E+   GSLQDI       R  L    
Sbjct: 47  -IQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQ---VTRGPLSELQ 102

Query: 311 RHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVL 370
              +      GL YLH       IH DIK  N+LL +D +  ++D G++  +     +  
Sbjct: 103 IAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRK 159

Query: 371 ISYVLGTMAYIAPEYFQQPELS---EKCDIFSFGMLLISLVRGVP 412
            S++ GT  ++APE            KCDI++ G+  I L    P
Sbjct: 160 -SFI-GTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQP 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 82.6 bits (205), Expect = 1e-17
 Identities = 60/241 (24%), Positives = 94/241 (39%), Gaps = 41/241 (17%)

Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           F   + IG G    V  A+      K  AIK       +   +LI+E       K++ ++
Sbjct: 3   FKFGKIIGEGSFSTVVLAKEK-ETNKEYAIKI------LDKRQLIKEK------KVKYVK 49

Query: 254 SEIITASQI-RHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRH 312
            E    +++  H  I+ L       +    V E+  NG L   +         LD     
Sbjct: 50  IEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGS----LDEKCTR 105

Query: 313 RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPD-------- 364
             A  +   LEYLH   S  IIH D+KP N+LL+ DM   I+D G A  +          
Sbjct: 106 FYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNK 162

Query: 365 -----------GYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPS 413
                         R   S+V GT  Y++PE   +    +  D+++ G ++  ++ G P 
Sbjct: 163 GDATNIDSQIEKNRRRFASFV-GTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221

Query: 414 F 414
           F
Sbjct: 222 F 222

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 81.4 bits (201), Expect = 4e-17
 Identities = 81/304 (26%), Positives = 127/304 (41%), Gaps = 58/304 (19%)

Query: 188 LKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDS 247
           L+ ED   ++  +G+G  G V K +   +   M   KKV+          I   S +R  
Sbjct: 2   LRNED-LETISDLGAGNGGSVSKVKHIPTGTVMA--KKVV---------HIGAKSSVRKQ 49

Query: 248 KLRQIRSEIITASQIRHRNILPLL-----AHMVRPDCHLLVYEFMKNGSLQDILDDVSRG 302
            LR++        QI H    P +     A +   +   +  EFM  GSL  I       
Sbjct: 50  ILREL--------QIMHECRSPYIVSFYGAFLNENNI-CMCMEFMDCGSLDRIYKKGGPI 100

Query: 303 RRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLG----L 358
             E+      +IA+ V  GL YL+  H   I+H DIKP N+L+N   +  + D G    L
Sbjct: 101 PVEI----LGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVSGEL 154

Query: 359 AMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ 418
             +I D +        +GT  Y++PE  Q  + + K D++S G+ +I L  G   F F  
Sbjct: 155 INSIADTF--------VGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSN 206

Query: 419 NGEEICSP-----EWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEER 473
             ++         + L++++    P     PRLP + + +    +      C L DP ER
Sbjct: 207 IDDDGQDDPMGILDLLQQIVQE--PP----PRLPSSDFPE---DLRDFVDACLLKDPTER 257

Query: 474 PNSQ 477
           P  Q
Sbjct: 258 PTPQ 261

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 81.0 bits (200), Expect = 4e-17
 Identities = 63/215 (29%), Positives = 99/215 (46%), Gaps = 15/215 (6%)

Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           E IG G  G VY A L  + G+M+A+K+V + A I+           +   ++ +RSEI 
Sbjct: 7   ELIGKGTYGRVYLA-LNVTTGEMMAVKQVELPATIA-----GRHDSRQKDMVKALRSEIE 60

Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALG 317
           T   + H NI+  L      +   +  E++  GS+   L    R   +L    R      
Sbjct: 61  TLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL---VRF-FTEQ 116

Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGT 377
           V  GL YLH   S  I+H D+K  N+L++ D    ISD G++    D Y       + G+
Sbjct: 117 VLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGS 173

Query: 378 MAYIAPEYFQ--QPELSEKCDIFSFGMLLISLVRG 410
           + ++APE         S K DI+S G +++ +  G
Sbjct: 174 VFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAG 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 81.0 bits (200), Expect = 5e-17
 Identities = 68/235 (28%), Positives = 100/235 (42%), Gaps = 25/235 (10%)

Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR-SEIIT 258
           +G GG GEV   ++  + GKM A KK+             +  +L+  K  Q+  +E   
Sbjct: 1   LGKGGFGEVCACQVKAT-GKMYACKKL-------------DKKRLKKRKGEQMALNEKKI 46

Query: 259 ASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV 318
             ++  R I+ L       D   LV   M  G L+  + +V  G            A  +
Sbjct: 47  LEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNV--GEPGFPEARAIFYAAQI 104

Query: 319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTM 378
             GLE+LH      I++ D+KP NVLL+D     ISDLGLA+ +  G     I    GT 
Sbjct: 105 ICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IKGRAGTP 158

Query: 379 AYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVM 433
            Y+APE  Q        D F+ G  L  ++ G     F Q  E++   E  R+ +
Sbjct: 159 GYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSP--FRQRKEKVEKEELKRRTL 211

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 80.2 bits (198), Expect = 6e-17
 Identities = 66/286 (23%), Positives = 126/286 (44%), Gaps = 43/286 (15%)

Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           F  L KIG G  G V+K  +  ++ ++ A+K++         +L + + + R+  + + R
Sbjct: 2   FEILNKIGKGSFGVVFKV-VRKADKRVYAMKQI---------DLSKMNRREREEAIDEAR 51

Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRR---ELDWPS 310
                 +++    I+      +      +V E+ +NG L  +L  + RGR    +  W  
Sbjct: 52  ----VLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLK-MQRGRPLPEDQVW-- 104

Query: 311 RHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVL 370
             R  + +  GL +LH   S  I+H DIK  N+ L+      I DLG+A  + D      
Sbjct: 105 --RFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD--NTNF 157

Query: 371 ISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLR 430
            + ++GT  Y++PE  +    +EK D+++ G++L     G   F  +  G  I       
Sbjct: 158 ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALI------L 211

Query: 431 KVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNS 476
           K++      R + P +    Y +++  ++     C   D  +RP++
Sbjct: 212 KII------RGVFPPVSQ-MYSQQLAQLID---QCLTKDYRQRPDT 247

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 79.4 bits (196), Expect = 1e-16
 Identities = 76/285 (26%), Positives = 122/285 (42%), Gaps = 39/285 (13%)

Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           F  L+K+G G  G VYK +   S+ +  A+K+V +   +S  E        R+  + +IR
Sbjct: 2   FKVLKKLGKGSYGSVYKVKRL-SDNQFYALKEVDL-GSMSQKE--------REDAVNEIR 51

Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
              I AS + H NI+      +  +   +V E+   G L   +    + R+ +      R
Sbjct: 52  ---ILAS-VNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWR 107

Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISY 373
           I + +  GL+ LH      I+H D+K  N+LL  +    I DLG++  +     +  I  
Sbjct: 108 IFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI-- 162

Query: 374 VLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLR-KV 432
             GT  Y+APE ++    S K DI+S G LL  +    P F          S + LR KV
Sbjct: 163 --GTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPF----EAR---SMQDLRYKV 213

Query: 433 MNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQ 477
              K       P +P   Y + + + ++         P+ RPN  
Sbjct: 214 QRGKY------PPIPPI-YSQDLQNFIR---SMLQVKPKLRPNCD 248

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 79.7 bits (197), Expect = 1e-16
 Identities = 67/289 (23%), Positives = 122/289 (42%), Gaps = 51/289 (17%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
             KIG G  G+VY A +    G+++A+K++          + + D K     +++I  E+
Sbjct: 5   GNKIGGGTFGKVYTA-VNLDTGELMAVKEI---------RIQDNDPKT----IKEIADEM 50

Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL 316
                ++H N++      V  +   +  E+   G+L+++L       R LD        L
Sbjct: 51  KVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELL----EHGRILDEHVIRVYTL 106

Query: 317 GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYV-- 374
            +  GL YLH +    I+H DIKP N+ L+ +    + D G A+ + +  T  +   V  
Sbjct: 107 QLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN-TTTMGEEVQS 162

Query: 375 -LGTMAYIAPEYFQQPELSEK---CDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLR 430
             GT AY+APE     +        DI+S G +++ +  G   +    N       E+  
Sbjct: 163 LAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN-------EF-- 213

Query: 431 KVM---NSKNPSRAIDPRLPGNGYEKKMLHVLKIAYI--CTLHDPEERP 474
           ++M    + +      P +P    +   L      ++  C   DP++RP
Sbjct: 214 QIMFHVGAGHK-----PPIP----DSLQLSPEGKDFLDRCLESDPKKRP 253

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 80.0 bits (198), Expect = 1e-16
 Identities = 61/230 (26%), Positives = 99/230 (43%), Gaps = 23/230 (10%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           L +IG G  G V+KA      G+ +A+KKV       A   +E    + +  LR    EI
Sbjct: 5   LGRIGEGAHGIVFKA-KDRETGETVALKKV-------ALRRLEG--GIPNQALR----EI 50

Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL 316
                 +H  ++ LL         +LV E+M    L ++L D     R L          
Sbjct: 51  KALQACQHPYVVKLLDVFPHGSGFVLVMEYMP-SDLSEVLRDE---ERPLPEAQVKSYMR 106

Query: 317 GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLG 376
            +  G+ Y+H   +  I+H D+KP N+L++ D    I+D GLA  +       L S+ + 
Sbjct: 107 MLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLAR-LFSEEEPRLYSHQVA 162

Query: 377 TMAYIAPE-YFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICS 425
           T  Y APE  +   +     D+++ G +   L+ G P F    + E++  
Sbjct: 163 TRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAI 212

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 79.5 bits (197), Expect = 2e-16
 Identities = 66/244 (27%), Positives = 106/244 (43%), Gaps = 59/244 (24%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYA-----PISAAELIEEDSKLRDSKLRQ 251
           + +IG G  G+VYKA      G+++A+KK+ +       PI+A         +R+ KL Q
Sbjct: 4   IAQIGEGTYGQVYKAR-NKKTGELVALKKIRMENEKEGFPITA---------IREIKLLQ 53

Query: 252 IRSEIITASQIRHRNILPLLAHMV---RPDCHLLVYEFMKNGSLQDILDDVSRGRRELDW 308
                    ++RH NI+ L   +    +   ++ V+E+M +  L  +LD       +   
Sbjct: 54  ---------KLRHPNIVRLKEIVTSKGKGSIYM-VFEYMDH-DLTGLLDSPEV---KFTE 99

Query: 309 PSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI----PD 364
                    +  GL+YLH   S  I+H DIK  N+L+N+D    ++D GLA         
Sbjct: 100 SQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA 156

Query: 365 GYTRVLISYVLGTMAYIAPE-------YFQQPELSEKCDIFSFGMLLISLVRGVPSFVFH 417
            YT  +I     T+ Y  PE       Y        + D++S G +L  L  G P  +F 
Sbjct: 157 DYTNRVI-----TLWYRPPELLLGATRY------GPEVDMWSVGCILAELFLGKP--IFQ 203

Query: 418 QNGE 421
            + E
Sbjct: 204 GSTE 207

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 78.5 bits (193), Expect = 2e-16
 Identities = 76/291 (26%), Positives = 127/291 (43%), Gaps = 41/291 (14%)

Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ-I 252
           F   +KIG G   EVY+A     +G  +A+KKV ++              L D+K R   
Sbjct: 4   FRIEKKIGRGQFSEVYRATCL-LDGVPVALKKVQIF-------------DLMDAKARADC 49

Query: 253 RSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRH 312
             EI    Q+ H N++   A  +  +   +V E    G L  ++    + +R +   +  
Sbjct: 50  IKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVW 109

Query: 313 RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLIS 372
           +  + + S LE++H   S  ++H DIKP NV +       + DLGL        T     
Sbjct: 110 KYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA--H 164

Query: 373 YVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKV 432
            ++GT  Y++PE   +   + K DI+S G LL  +               + SP +  K 
Sbjct: 165 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA-------------ALQSPFYGDK- 210

Query: 433 MNSKNPSRAID----PRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYV 479
           MN  +  + I+    P LP + Y +++    ++  +C   DPE+RP+  YV
Sbjct: 211 MNLYSLCKKIEQCDYPPLPSDHYSEEL---RQLVNMCINPDPEKRPDITYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 78.2 bits (193), Expect = 3e-16
 Identities = 57/222 (25%), Positives = 98/222 (44%), Gaps = 30/222 (13%)

Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           E +GSG  G VY+  L   +G   A+K+V           + +D +     ++Q+  EI 
Sbjct: 6   ELLGSGSFGSVYEG-LNLDDGDFFAVKEV----------SLADDGQTGQEAVKQLEQEIA 54

Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVY-EFMKNGSLQDILDDVSRGRRELDWPSRHRIAL 316
             S+++H NI+  L    R + +L ++ E +  GSL  +L         +       I L
Sbjct: 55  LLSKLQHPNIVQYLG-TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPV-------IRL 106

Query: 317 ---GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISY 373
               +  GLEYLH     + +H DIK  N+L++ +    ++D G+A  +           
Sbjct: 107 YTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQV---VEFSFAKS 160

Query: 374 VLGTMAYIAPEYF-QQPELSEKCDIFSFGMLLISLVRGVPSF 414
             G+  ++APE   QQ       DI+S G  ++ +  G P +
Sbjct: 161 FKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPW 202

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 77.7 bits (191), Expect = 4e-16
 Identities = 55/163 (33%), Positives = 85/163 (52%), Gaps = 17/163 (10%)

Query: 246 DSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHL-LVYEFMKNGSLQDILDDVSRGRR 304
           D+  +   +E    +Q+RH N++ LL  +V     L +V E+M  GSL D L   SRGR 
Sbjct: 40  DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRS 97

Query: 305 ELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGL---AMA 361
            L      + +L V   +EYL    + + +H D+  RNVL+++D  A +SD GL   A +
Sbjct: 98  VLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 154

Query: 362 IPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
             D  T  L       + + APE  ++ + S K D++SFG+LL
Sbjct: 155 TQD--TGKL------PVKWTAPEALREKKFSTKSDVWSFGILL 189

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 77.4 bits (190), Expect = 7e-16
 Identities = 76/287 (26%), Positives = 125/287 (43%), Gaps = 41/287 (14%)

Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ-IRSEI 256
           +KIG G   EVY+A       K +A+KKV ++             ++ D+K RQ    EI
Sbjct: 8   KKIGRGQFSEVYRATCLLDR-KPVALKKVQIF-------------EMMDAKARQDCVKEI 53

Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL 316
               Q+ H N++  L   +  +   +V E    G L  ++    + +R +   +  +  +
Sbjct: 54  DLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFV 113

Query: 317 GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLG 376
            + S +E  HM HS  ++H DIKP NV +       + DLGL        T      ++G
Sbjct: 114 QLCSAVE--HM-HSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA--HSLVG 168

Query: 377 TMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSK 436
           T  Y++PE   +   + K DI+S G LL  +                 SP +  K MN  
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYEMA------ALQ-------SPFYGDK-MNLF 214

Query: 437 NPSRAID----PRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYV 479
           +  + I+    P LP   Y +K+  ++    +C   DP++RP+  YV
Sbjct: 215 SLCQKIEQCDYPPLPTEHYSEKLRELVS---MCIYPDPDQRPDIGYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 76.6 bits (188), Expect = 1e-15
 Identities = 64/222 (28%), Positives = 104/222 (46%), Gaps = 25/222 (11%)

Query: 191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
           E+ F  LE+IG G  GEV+K  +     +++AIK +         +L E + ++ D    
Sbjct: 3   EELFTKLERIGKGSFGEVFKG-IDNRTQQVVAIKII---------DLEEAEDEIED---- 48

Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPS 310
            I+ EI   SQ     +       ++     ++ E++  GS  D+L          D   
Sbjct: 49  -IQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLR-----AGPFDEFQ 102

Query: 311 RHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVL 370
              +   +  GL+YLH   S   IH DIK  NVLL++  +  ++D G+A  + D  T++ 
Sbjct: 103 IATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQIK 157

Query: 371 ISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVP 412
            +  +GT  ++APE  QQ     K DI+S G+  I L +G P
Sbjct: 158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEP 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 76.7 bits (189), Expect = 1e-15
 Identities = 55/230 (23%), Positives = 101/230 (43%), Gaps = 33/230 (14%)

Query: 190 KEDCFASLEKIGSGGCGEVYKAEL----PGSNGKMIAIKKVIVYAPISAAELIEEDSKLR 245
           + D      ++G G  G+V+  E     P ++ +++A+K +   A   A +  E ++   
Sbjct: 3   QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREA--- 59

Query: 246 DSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRE 305
                    E++T  Q  H NI+         D  ++V+E+M++G L   L         
Sbjct: 60  ---------ELLTNFQ--HENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAF 108

Query: 306 LDWP----------SRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISD 355
           L  P             +IA+ +ASG+ YL   H    +H D+  RN L+  D+   I D
Sbjct: 109 LKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVVKIGD 165

Query: 356 LGLAMAI-PDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
            G++  +    Y RV    +L  + ++ PE     + + + D++SFG++L
Sbjct: 166 FGMSRDVYTTDYYRVGGHTML-PIRWMPPESIMYRKFTTESDVWSFGVVL 214

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 76.2 bits (187), Expect = 2e-15
 Identities = 67/224 (29%), Positives = 107/224 (47%), Gaps = 25/224 (11%)

Query: 191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
           E+ F  LE+IG G  GEVYK  +     +++AIK +         +L E + ++ D    
Sbjct: 3   EELFTKLERIGKGSFGEVYKG-IDNRTKEVVAIKII---------DLEEAEDEIED---- 48

Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPS 310
            I+ EI   SQ     I       ++     ++ E++  GS  D+L     G  E  + +
Sbjct: 49  -IQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKP---GPLEETYIA 104

Query: 311 RHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVL 370
              I   +  GL+YLH   S   IH DIK  NVLL++  +  ++D G+A  + D  T++ 
Sbjct: 105 T--ILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQIK 157

Query: 371 ISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
            +  +GT  ++APE  +Q     K DI+S G+  I L +G P  
Sbjct: 158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPN 201

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 76.4 bits (189), Expect = 2e-15
 Identities = 69/222 (31%), Positives = 101/222 (45%), Gaps = 30/222 (13%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           LEK+G G  G VYKA      G+++A+KK+          L  E+  +  + LR    EI
Sbjct: 4   LEKLGEGTYGVVYKARDK-KTGEIVALKKI---------RLDNEEEGIPSTALR----EI 49

Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL 316
               +++H NI+ LL  +       LV+E+     L+  LD        L       I  
Sbjct: 50  SLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGP---LSPNLIKSIMY 105

Query: 317 GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMA--IPDG-YTRVLISY 373
            +  GL Y H   S  I+H D+KP+N+L+N D    ++D GLA A  IP   YT  ++  
Sbjct: 106 QLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-- 160

Query: 374 VLGTMAYIAPE-YFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
              T+ Y APE        S   DI+S G +   ++ G P F
Sbjct: 161 ---TLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLF 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 76.5 bits (188), Expect = 2e-15
 Identities = 64/224 (28%), Positives = 103/224 (45%), Gaps = 30/224 (13%)

Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDS-KLRQI 252
           +   EKIG G  G VY A +  + G+ +AIK++                 L+   K   I
Sbjct: 21  YTRFEKIGQGASGTVYTA-IDVATGQEVAIKQM----------------NLQQQPKKELI 63

Query: 253 RSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRH 312
            +EI+   + +H NI+  L   +  D   +V E++  GSL D++ +      ++    R 
Sbjct: 64  INEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRE 123

Query: 313 RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI-PDGYTRVLI 371
                    LE+LH   S  +IH DIK  N+LL  D    ++D G    I P+   R   
Sbjct: 124 -----CLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--- 172

Query: 372 SYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFV 415
           S ++GT  ++APE   +     K DI+S G++ I +V G P ++
Sbjct: 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 75.9 bits (186), Expect = 3e-15
 Identities = 62/223 (27%), Positives = 102/223 (45%), Gaps = 28/223 (12%)

Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           +   EKIG G  G VY A +  + G+ +AIK++ +                +  K   I 
Sbjct: 21  YTRFEKIGQGASGTVYTA-IDIATGQEVAIKQMNLQ---------------QQPKKELII 64

Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
           +EI+   + ++ NI+  L   +  D   +V E++  GSL D++ +              +
Sbjct: 65  NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM--------DEGQ 116

Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI-PDGYTRVLIS 372
           IA      L+ L   HS  +IH DIK  N+LL  D    ++D G    I P+   R   S
Sbjct: 117 IAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---S 173

Query: 373 YVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFV 415
            ++GT  ++APE   +     K DI+S G++ I +V G P ++
Sbjct: 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 75.3 bits (185), Expect = 3e-15
 Identities = 60/217 (27%), Positives = 101/217 (46%), Gaps = 22/217 (10%)

Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSK-LRQIRSEIIT 258
           IGSG  G VY   +  S+G+++A+K+V + +           SK R    L  +  EI  
Sbjct: 8   IGSGSFGSVYLG-MNASSGELMAVKQVELPSV-------SASSKDRKRSMLDALAREIAL 59

Query: 259 ASQIRHRNILPLLAHMVRPDCHLLVY-EFMKNGSLQDILDDVSRGRRELDWPSRHRIALG 317
             +++H NI+  L   +  D HL ++ E++  GS+  +L++        +          
Sbjct: 60  LKELQHENIVQYLGSSLDAD-HLNIFLEYVPGGSVAALLNNYG----AFEETLVRNFVRQ 114

Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLG----LAMAIPDGYTRVLISY 373
           +  GL YLH      IIH DIK  N+L+++     ISD G    L        T      
Sbjct: 115 ILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPS 171

Query: 374 VLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRG 410
           + G++ ++APE  +Q   + K DI+S G L++ ++ G
Sbjct: 172 LQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTG 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 74.7 bits (184), Expect = 4e-15
 Identities = 58/234 (24%), Positives = 97/234 (41%), Gaps = 39/234 (16%)

Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           F  L  IG G  G+V   +      KM A+K       ++  + +E+ S      +R + 
Sbjct: 2   FELLRVIGKGAFGKVCIVQK-RDTKKMFAMKY------MNKQKCVEKGS------VRNVL 48

Query: 254 SEIITASQIRHRNILPLLAHMV-----RPDCHLLVYEFMKNGSLQDILDDVSRGRRELDW 308
           +E     ++ H    P L ++        + +L+V + +  G L+  L   S+  +    
Sbjct: 49  NERRILQELNH----PFLVNLWYSFQDEENMYLVV-DLLLGGDLRYHL---SQKVKF--- 97

Query: 309 PSRHRIAL---GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG 365
            S  ++      +   LEYLH   S  IIH DIKP N+LL++     I+D  +A  +   
Sbjct: 98  -SEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153

Query: 366 YTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQN 419
               L +   GT  Y+APE   +   S   D +S G+     +RG   +  H  
Sbjct: 154 ---TLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSR 204

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 75.0 bits (185), Expect = 5e-15
 Identities = 57/219 (26%), Positives = 97/219 (44%), Gaps = 23/219 (10%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           L  +G G  G V K     + G+++AIKK          +  E+D  ++ + LR+++   
Sbjct: 6   LGVVGEGAYGVVLKCRNKAT-GEIVAIKKF---------KESEDDEDVKKTALREVK--- 52

Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL 316
               Q+RH NI+ L     R     LV+E+++    + +L+ +      L   +      
Sbjct: 53  -VLRQLRHENIVNLKEAFRRKGRLYLVFEYVE----RTLLELLEASPGGLPPDAVRSYIW 107

Query: 317 GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLG 376
            +   + Y H   S +IIH DIKP N+L+++     + D G A A+       L  YV  
Sbjct: 108 QLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-A 163

Query: 377 TMAYIAPEYF-QQPELSEKCDIFSFGMLLISLVRGVPSF 414
           T  Y APE         +  D+++ G ++  L+ G P F
Sbjct: 164 TRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLF 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 75.1 bits (184), Expect = 6e-15
 Identities = 75/283 (26%), Positives = 125/283 (44%), Gaps = 42/283 (14%)

Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           +   EKIG G  G VY A +  + G+ +AI+++ +                +  K   I 
Sbjct: 22  YTRFEKIGQGASGTVYTA-MDVATGQEVAIRQMNLQ---------------QQPKKELII 65

Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
           +EI+   + ++ NI+  L   +  D   +V E++  GSL D++ +              +
Sbjct: 66  NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM--------DEGQ 117

Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI-PDGYTRVLIS 372
           IA      L+ L   HS  +IH DIK  N+LL  D    ++D G    I P+   R   S
Sbjct: 118 IAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---S 174

Query: 373 YVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPS----------FVFHQNGE- 421
            ++GT  ++APE   +     K DI+S G++ I ++ G P           ++   NG  
Sbjct: 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP 234

Query: 422 EICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKML--HVLKIA 462
           E+ +PE L  +      +R +D  +   G  K++L    LKIA
Sbjct: 235 ELQNPEKLSAIFRD-FLNRCLDMDVEKRGSAKELLQHQFLKIA 276

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 74.5 bits (183), Expect = 8e-15
 Identities = 67/234 (28%), Positives = 109/234 (46%), Gaps = 33/234 (14%)

Query: 192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ 251
           D +  LEKIG G  G+VYKA    + GK++A+KK           L  ++  +  + LR+
Sbjct: 1   DAYEKLEKIGEGTYGKVYKAR-DKNTGKLVALKK---------TRLEMDEEGIPPTALRE 50

Query: 252 IRSEIITASQIRHRNILPLLA--HMVRPD---CHLLVYEFMKNGSLQDILDDVSRGR-RE 305
           I S +   S+  +  I+ LL   H+   +      LV+E++ +  L+  +D   RG  R 
Sbjct: 51  I-SLLQMLSESIY--IVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRP 106

Query: 306 LDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC-ISDLGL--AMAI 362
           L   +       +  G+ + H      ++H D+KP+N+L++       I+DLGL  A +I
Sbjct: 107 LPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI 163

Query: 363 PDG-YTRVLISYVLGTMAYIAPE-YFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
           P   YT  ++     T+ Y APE        S   DI+S G +   + R  P F
Sbjct: 164 PVKSYTHEIV-----TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLF 212

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 73.9 bits (181), Expect = 1e-14
 Identities = 59/217 (27%), Positives = 104/217 (47%), Gaps = 28/217 (12%)

Query: 199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR-SEII 257
           KIG G  G V  A +  S+GK++A+KK+                 LR  + R++  +E++
Sbjct: 27  KIGEGSTGIVCIATVK-SSGKLVAVKKM----------------DLRKQQRRELLFNEVV 69

Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALG 317
                +H N++ +    +  D   +V EF++ G+L DI   V+  R      +  +IA  
Sbjct: 70  IMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDI---VTHTRM-----NEEQIAAV 121

Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGT 377
             + L+ L + H+  +IH DIK  ++LL  D    +SD G    +     R     ++GT
Sbjct: 122 CLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR--KSLVGT 179

Query: 378 MAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
             ++APE   +     + DI+S G+++I +V G P +
Sbjct: 180 PYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 73.4 bits (181), Expect = 1e-14
 Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 20/222 (9%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           LE IG G  G V K     S+GK++  K+ I Y  ++  E              Q+ SE+
Sbjct: 5   LETIGKGSFGTVRKVRRK-SDGKILVWKE-IDYGNMTEKEKQ------------QLVSEV 50

Query: 257 ITASQIRHRNILPLLAHMVRPDCHLL--VYEFMKNGSLQDILDDVSRGRRELDWPSRHRI 314
               +++H NI+     ++      L  V E+ + G L  ++    + R+ ++     RI
Sbjct: 51  NILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRI 110

Query: 315 ALGVASGLEYLH--MYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLIS 372
              +   L   H       +++H D+KP N+ L+ +    + D GLA  +    +    +
Sbjct: 111 LTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD-SSFAKT 169

Query: 373 YVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
           YV GT  Y++PE        EK DI+S G L+  L    P F
Sbjct: 170 YV-GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPF 210

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 73.2 bits (180), Expect = 2e-14
 Identities = 59/214 (27%), Positives = 98/214 (45%), Gaps = 28/214 (13%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           L K+G+G  GEV++     +    +A+K +           ++    L ++++ +     
Sbjct: 11  LRKLGAGQFGEVWEGLWNNTTP--VAVKTL-------KPGTMDPKDFLAEAQIMK----- 56

Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL 316
               ++RH  ++ L A     +   +V E MK GSL + L       R L  P    +A 
Sbjct: 57  ----KLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQG--GAGRALKLPQLIDMAA 110

Query: 317 GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI-PDGYT-RVLISYV 374
            VASG+ YL    + + IH D+  RNVL+ ++    ++D GLA  I  D Y  R    + 
Sbjct: 111 QVASGMAYL---EAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKF- 166

Query: 375 LGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLV 408
              + + APE       S K D++SFG+LL  +V
Sbjct: 167 --PIKWTAPEAALYNRFSIKSDVWSFGILLTEIV 198

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 73.6 bits (180), Expect = 2e-14
 Identities = 61/223 (27%), Positives = 102/223 (45%), Gaps = 28/223 (12%)

Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           +   EKIG G  G V+ A    + G+ +AIK++ +                +  K   I 
Sbjct: 21  YTRYEKIGQGASGTVFTAI-DVATGQEVAIKQINLQ---------------KQPKKELII 64

Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
           +EI+   ++++ NI+  L   +  D   +V E++  GSL D++ +      +        
Sbjct: 65  NEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQ-------- 116

Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI-PDGYTRVLIS 372
           IA      L+ L   H+  +IH DIK  NVLL  D    ++D G    I P+   R   S
Sbjct: 117 IAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR---S 173

Query: 373 YVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFV 415
            ++GT  ++APE   +     K DI+S G++ I +V G P ++
Sbjct: 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 73.0 bits (180), Expect = 2e-14
 Identities = 63/225 (28%), Positives = 96/225 (42%), Gaps = 36/225 (16%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIV-YAPISAAELIEEDSKLRDSK-LRQIRS 254
           ++++G G  G VY A      G+++AIKK+   +         EE   LR+ K LR++  
Sbjct: 4   IKQLGDGTFGSVYLARNK-ETGELVAIKKMKKKFYS------WEECMNLREVKSLRKLNE 56

Query: 255 EIITASQIRHRNILPLLAHMVRPDCHL-LVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
                    H NI+ L   + R +  L  V+E+M+    Q + D   R  +         
Sbjct: 57  ---------HPNIVKLK-EVFRENDELYFVFEYMEGNLYQLMKD---RKGKPFSESVIRS 103

Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI---PDGYTRVL 370
           I   +  GL ++   H     H D+KP N+L++      I+D GLA  I   P  YT   
Sbjct: 104 IIYQILQGLAHI---HKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-YT--- 156

Query: 371 ISYVLGTMAYIAPEYF-QQPELSEKCDIFSFGMLLISLVRGVPSF 414
             YV  T  Y APE   +    S   DI++ G ++  L    P F
Sbjct: 157 -DYV-STRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLF 199

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 73.5 bits (181), Expect = 3e-14
 Identities = 66/223 (29%), Positives = 101/223 (45%), Gaps = 39/223 (17%)

Query: 191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSK-L 249
              +  +E IGSG  G V  A +   +GK +AIKK+    P +          LR+ K L
Sbjct: 4   GSRYKPIENIGSGAYGVVCSA-IDTRSGKKVAIKKI----PHAFDVPTLAKRTLRELKIL 58

Query: 250 RQIRSEIITASQIRHRNILPLLAHMVRPDCHL-----LVYEFMKNGSLQDILDDVSRGRR 304
           R  +          H NI+ +   ++RP         +V + M++  L  I+   S    
Sbjct: 59  RHFK----------HDNIIAIR-DILRPPGADFKDVYVVMDLMES-DLHHIIH--SDQPL 104

Query: 305 ELDWPSRH-RIALG-VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI 362
             +    H R  L  +  GL+Y+H   SA++IH D+KP N+L+N+D E  I D G+A  +
Sbjct: 105 TEE----HIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGL 157

Query: 363 ---PDGYTRVLISYVLGTMAYIAPE-YFQQPELSEKCDIFSFG 401
              P  +   +  YV  T  Y APE     PE +   D++S G
Sbjct: 158 SSSPTEHKYFMTEYV-ATRWYRAPELLLSLPEYTTAIDMWSVG 199

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 73.0 bits (180), Expect = 3e-14
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 21/219 (9%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
            +K+G G    VYKA      G+++AIKK+ +     A + I   + LR+ KL Q     
Sbjct: 5   GKKLGEGTYAVVYKAR-DKETGRIVAIKKIKLGERKEAKDGINFTA-LREIKLLQ----- 57

Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL 316
               +++H NI+ LL          LV+EFM+   L+ ++ D S      D  S     L
Sbjct: 58  ----ELKHPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKS---YML 109

Query: 317 GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLG 376
               GLEYLH   S  I+H D+KP N+L+  D    ++D GLA +      R +   V+ 
Sbjct: 110 MTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP-NRKMTHQVV- 164

Query: 377 TMAYIAPE-YFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
           T  Y APE  F         D++S G +   L+  VP  
Sbjct: 165 TRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFL 203

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 72.2 bits (177), Expect = 4e-14
 Identities = 72/242 (29%), Positives = 113/242 (46%), Gaps = 34/242 (14%)

Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G GG GEV   ++  + GK+ A KK+               +K R  K +     ++  
Sbjct: 1   LGKGGFGEVSACQMRAT-GKLYACKKL---------------NKKRLKKRKGYEGAMVEK 44

Query: 260 ---SQIRHRNILPL-LAHMVRPD-CHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRI 314
              +++  R I+ L  A   + D C  LV   M  G L+  + +V         P     
Sbjct: 45  RILAKVHSRFIVSLAYAFQTKTDLC--LVMTIMNGGDLRYHIYNVDEENPGFPEPRACFY 102

Query: 315 ALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYV 374
              + SGLE+LH      II+ D+KP NVLL++D    ISDLGLA+ + DG ++    Y 
Sbjct: 103 TAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTK-GYA 158

Query: 375 LGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLV--RGVPSFVFHQNGEEICSPEWLRKV 432
            GT  ++APE  Q  E     D F+ G+ L  ++  RG P   F   GE++ + E  +++
Sbjct: 159 -GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARG-P---FRARGEKVENKELKQRI 213

Query: 433 MN 434
           +N
Sbjct: 214 LN 215

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 72.3 bits (177), Expect = 4e-14
 Identities = 70/238 (29%), Positives = 112/238 (47%), Gaps = 31/238 (13%)

Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRD---SKLRQIRSEI 256
           +G GG GEV   ++  + GKM A KK+             +  +L+     K+  +  EI
Sbjct: 1   LGKGGFGEVCAVQVK-NTGKMYACKKL-------------DKKRLKKKSGEKMALLEKEI 46

Query: 257 ITASQIRHRNILPLLAHMVRPDCHL-LVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIA 315
           +   +  +   +  LA+      HL LV   M  G L+  + +V  G R L+       +
Sbjct: 47  L---EKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNV--GERGLEMERVIHYS 101

Query: 316 LGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVL 375
             +  G+  LH+ HS  I++ D+KP NVLL+D     +SDLGLA+ + DG T   I+   
Sbjct: 102 AQITCGI--LHL-HSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQRA 155

Query: 376 GTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVM 433
           GT  Y+APE  ++   S   D F+ G  +  +V G   F  H+  E++   E  R+ +
Sbjct: 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHK--EKVAKEELKRRTL 211

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 72.4 bits (178), Expect = 4e-14
 Identities = 65/225 (28%), Positives = 106/225 (47%), Gaps = 30/225 (13%)

Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           + +L  +G G  G V K +   + G+++AIKK +           E+D  ++   +R+IR
Sbjct: 3   YENLGLVGEGSYGMVMKCKHKET-GQIVAIKKFLES---------EDDKMVKKIAMREIR 52

Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
                  Q+RH N++ L+    R     LV+EF+ +     +LDD+ +    LD     +
Sbjct: 53  ----MLKQLRHENLVNLIEVFRRKKRLYLVFEFVDH----TVLDDLEKYPNGLDESRVRK 104

Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA--MAIP-DGYTRVL 370
               +  G+E+ H   S +IIH DIKP N+L++      + D G A  +A P + YT   
Sbjct: 105 YLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYT--- 158

Query: 371 ISYVLGTMAYIAPEYF-QQPELSEKCDIFSFGMLLISLVRGVPSF 414
             YV  T  Y APE      +     DI++ G L+  ++ G P F
Sbjct: 159 -DYV-ATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLF 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 71.6 bits (176), Expect = 4e-14
 Identities = 72/290 (24%), Positives = 110/290 (37%), Gaps = 57/290 (19%)

Query: 198 EKIGSGGCGEVYKAELPGSNGKMI--AIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSE 255
           +K+G G  G V + E   S GK+I  A+K                   L+  KL  I  +
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVIPVAVKC------------------LKSDKLSDIMDD 42

Query: 256 IITASQI----RHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
            +  + I     H N++ L   +V     ++V E    GSL D L             + 
Sbjct: 43  FLKEAAIMHSLDHENLIRLYG-VVLTHPLMMVTELAPLGSLLDRLRK--DALGHFLISTL 99

Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLI 371
              A+ +A+G+ YL        IH D+  RN+LL  D +  I D GL  A+P      ++
Sbjct: 100 CDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156

Query: 372 SYVLGT-MAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVF------HQNGEEIC 424
              L    A+ APE  +    S   D++ FG+ L  +      F +        +G +I 
Sbjct: 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEM------FTYGEEPWAGLSGSQI- 209

Query: 425 SPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERP 474
               L+K+   K   R   P          ML        C  H+P +RP
Sbjct: 210 ----LKKI--DKEGERLERPEACPQDIYNVMLQ-------CWAHNPADRP 246

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 71.9 bits (177), Expect = 5e-14
 Identities = 65/237 (27%), Positives = 96/237 (40%), Gaps = 38/237 (16%)

Query: 192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRD-SKLR 250
             F  +E IG G  G+VYKA      G+++AIK ++        E+ EE + LR  S   
Sbjct: 6   GIFELVEVIGEGTYGKVYKARHK-KTGQLVAIK-IMDIIEDEEEEIKEEYNILRKYSN-- 61

Query: 251 QIRSEIITASQIRHRNILP------LLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRR 304
                        H NI                D   LV E    GS+ D++  + +  +
Sbjct: 62  -------------HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGK 108

Query: 305 ELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA--MAI 362
            L       I      GL YLH      +IH DIK +N+LL  + E  + D G++  +  
Sbjct: 109 RLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDS 165

Query: 363 PDGYTRVLISYVLGTMAYIAPEYF---QQPELS--EKCDIFSFGMLLISLVRGVPSF 414
             G     I    GT  ++APE     +QP+ S   + D++S G+  I L  G P  
Sbjct: 166 TLGRRNTFI----GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL 218

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 72.5 bits (178), Expect = 5e-14
 Identities = 78/291 (26%), Positives = 122/291 (41%), Gaps = 46/291 (15%)

Query: 191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
           E  F  L +IG G  G VY A       +++AIKK + Y+   + E           K +
Sbjct: 14  EKLFTDLREIGHGSFGAVYFAR-DVRTNEVVAIKK-MSYSGKQSNE-----------KWQ 60

Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPS 310
            I  E+    Q+RH N +      +R     LV E+   GS  DIL+   +  +E++  +
Sbjct: 61  DIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAA 119

Query: 311 RHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA-MAIPDGYTRV 369
              I  G   GL YLH   S   IH DIK  N+LL +     ++D G A +  P      
Sbjct: 120 ---ICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN---- 169

Query: 370 LISYVLGTMAYIAPEY---FQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSP 426
             S+V GT  ++APE      + +   K D++S G+  I L    P   F+ N       
Sbjct: 170 --SFV-GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL-FNMNAMSA--- 222

Query: 427 EWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQ 477
             L  +  + +P+      L  N +     + +     C    P++RP+S+
Sbjct: 223 --LYHIAQNDSPT------LSSNDWSDYFRNFVD---SCLQKIPQDRPSSE 262

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 72.6 bits (179), Expect = 6e-14
 Identities = 87/325 (26%), Positives = 136/325 (41%), Gaps = 74/325 (22%)

Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSK--LRQIRSEII 257
           IGSG  G V  A +    G+ +AIKK+           + +D  L D+K  LR+I+  ++
Sbjct: 8   IGSGAYGVVCSA-VDKRTGRKVAIKKI---------SNVFDD--LIDAKRILREIK--LL 53

Query: 258 TASQIRHRNILPLLAHMVRPDCHL------LVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
               +RH NI+ LL  ++RP          +V E M     +  L  V +  + L     
Sbjct: 54  --RHLRHENIIGLL-DILRPPSPEDFNDVYIVTELM-----ETDLHKVIKSPQPLT-DDH 104

Query: 312 HR-IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI--PDGYTR 368
            +     +  GL+YLH   SA++IH D+KP N+L+N + +  I D GLA  +   +    
Sbjct: 105 IQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKG 161

Query: 369 VLISYVLGTMAYIAPE-YFQQPELSEKCDIFSFGMLLISLVRGVPSF-----------VF 416
            L  YV+ T  Y APE        ++  DI+S G +   L+   P F           + 
Sbjct: 162 FLTEYVV-TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIV 220

Query: 417 HQNG-------EEICSPEWLRKVMN-SKNPSRAIDPRLPGNGYE-----KKML------- 456
              G       + I S +    + +  K P + +    PG   E     +KML       
Sbjct: 221 EVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKR 280

Query: 457 ----HVLKIAYICTLHDPEERPNSQ 477
                 L   Y+  LHDPE+ P ++
Sbjct: 281 ITADEALAHPYLAQLHDPEDEPVAK 305

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 71.1 bits (174), Expect = 1e-13
 Identities = 75/280 (26%), Positives = 121/280 (43%), Gaps = 42/280 (15%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
            E +G G  G VYKA    +  +++A+K +    P+     ++          +QI SE+
Sbjct: 6   QEILGHGNGGTVYKAYHLLT-RRILAVKVI----PLDITVELQ----------KQIMSEL 50

Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL 316
               +     I+         +   +  EFM  GSL     DV R   E       RIA+
Sbjct: 51  EILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSL-----DVYRKIPE---HVLGRIAV 102

Query: 317 GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLG 376
            V  GL YL    S  I+H D+KP N+L+N   +  + D G++  + +   +   +YV G
Sbjct: 103 AVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAK---TYV-G 155

Query: 377 TMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICS--PEWLRKVMN 434
           T AY+APE     +     D++S G+  + L  G   F + Q  +   S  P  L + + 
Sbjct: 156 TNAYMAPERISGEQYGIHSDVWSLGISFMELALG--RFPYPQIQKNQGSLMPLQLLQCIV 213

Query: 435 SKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERP 474
            ++P     P LP   + +K +H +     C    P+ERP
Sbjct: 214 DEDP-----PVLPVGQFSEKFVHFIT---QCMRKQPKERP 245

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 70.9 bits (174), Expect = 1e-13
 Identities = 59/222 (26%), Positives = 102/222 (45%), Gaps = 28/222 (12%)

Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
             +  KIG G  G V  A    S G+ +A+KK+                 LR  + R++ 
Sbjct: 21  LDNFVKIGEGSTGIVCIAT-DKSTGRQVAVKKM----------------DLRKQQRRELL 63

Query: 254 -SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRH 312
            +E++     +H NI+ + +  +  D   +V EF++ G+L DI   V+  R  ++     
Sbjct: 64  FNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDI---VTHTR--MNEEQIA 118

Query: 313 RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLIS 372
            + L V   L +LH   +  +IH DIK  ++LL  D    +SD G    +     R    
Sbjct: 119 TVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRR--K 173

Query: 373 YVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
            ++GT  ++APE   +     + DI+S G+++I +V G P +
Sbjct: 174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPY 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 70.4 bits (172), Expect = 2e-13
 Identities = 62/222 (27%), Positives = 96/222 (43%), Gaps = 23/222 (10%)

Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           F     +G GG GEV   ++  + GKM A KK+             E  +++  K   + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRAT-GKMYACKKL-------------EKKRIKKRKGESMA 47

Query: 254 -SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRH 312
            +E     ++  R ++ L       D   LV   M  G L+        G    +     
Sbjct: 48  LNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLK--FHIYHMGEAGFEEGRAV 105

Query: 313 RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLIS 372
             A  +  GLE LH      I++ D+KP N+LL+D     ISDLGLA+ +P+G T   I 
Sbjct: 106 FYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IK 159

Query: 373 YVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
             +GT+ Y+APE  +    +   D ++ G LL  ++ G   F
Sbjct: 160 GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 69.7 bits (170), Expect = 2e-13
 Identities = 66/233 (28%), Positives = 106/233 (45%), Gaps = 30/233 (12%)

Query: 184 DLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSK 243
           DL+    ++ F  +++IGSG  G+VYKA    + G++ AIK VI   P     ++++   
Sbjct: 1   DLSRRNPQEDFELIQRIGSGTYGDVYKAR-NVNTGELAAIK-VIKLEPGEDFAVVQQ--- 55

Query: 244 LRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGR 303
                      EII     +H NI+      +R D   +  EF   GSLQDI        
Sbjct: 56  -----------EIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIY------- 97

Query: 304 RELDWP-SRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI 362
             +  P S  +IA      L+ L+  HS   +H DIK  N+LL D+    ++D G++  I
Sbjct: 98  -HVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQI 156

Query: 363 PDGYTRVLISYVLGTMAYIAPEYF---QQPELSEKCDIFSFGMLLISLVRGVP 412
                +      +GT  ++APE     ++   ++ CDI++ G+  I L    P
Sbjct: 157 TATIAKR--KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQP 207

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 69.6 bits (170), Expect = 3e-13
 Identities = 79/307 (25%), Positives = 138/307 (44%), Gaps = 52/307 (16%)

Query: 184 DLAFLKK-EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDS 242
           DL+ L+     F  +E +G+G  G+VYK     + G++ AIK + V       E  EE+ 
Sbjct: 7   DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKT-GQLAAIKVMDV------TEDEEEEI 59

Query: 243 KLRDSKLRQIRSEIITASQIRHRNILPLLAHMVR--PDCH----LLVYEFMKNGSLQDIL 296
           KL  + L++            HRNI       ++  P  H     LV EF   GS+ D++
Sbjct: 60  KLEINMLKKYS---------HHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLV 110

Query: 297 DDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDL 356
            +      + DW +   I   +  GL +LH +    +IH DIK +NVLL ++ E  + D 
Sbjct: 111 KNTKGNALKEDWIAY--ICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDF 165

Query: 357 GLAMAIPDGYTRVLISYVLGTMAYIAPEYF---QQPELS--EKCDIFSFGMLLISLVRGV 411
           G++  +     R   +  +GT  ++APE     + P+ +   + DI+S G+  I +  G 
Sbjct: 166 GVSAQLDRTVGRR--NTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGA 223

Query: 412 PSFVFHQNGEEICSPEWLRKV-MNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDP 470
           P          +C    +R + +  +NP     P+L    + KK +  ++    C + + 
Sbjct: 224 PP---------LCDMHPMRALFLIPRNPP----PKLKSKKWSKKFIDFIE---GCLVKNY 267

Query: 471 EERPNSQ 477
             RP+++
Sbjct: 268 LSRPSTE 274

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 69.3 bits (169), Expect = 4e-13
 Identities = 55/224 (24%), Positives = 101/224 (45%), Gaps = 33/224 (14%)

Query: 197 LEKIGSGGCGEVYKAEL----PGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQI 252
           +E++G    G+VYK  L    PG   + +AIK +   A     E  + ++ +R       
Sbjct: 10  MEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMR------- 62

Query: 253 RSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDIL------------DDVS 300
                  S+++H NI+ LL  + +     +++ +  +  L + L            DD  
Sbjct: 63  -------SRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDK 115

Query: 301 RGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAM 360
             +  L+      I   +A+G+E+L  +H   ++H D+  RNVL+ D +   ISDLGL  
Sbjct: 116 TVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFR 172

Query: 361 AIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
            +       L+   L  + +++PE     + S   DI+S+G++L
Sbjct: 173 EVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVL 216

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 69.4 bits (170), Expect = 5e-13
 Identities = 55/214 (25%), Positives = 88/214 (41%), Gaps = 37/214 (17%)

Query: 285 EFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVL 344
           E M  GSL  +L    R    +      +I++ V  GL YL   H   I+H D+KP N+L
Sbjct: 79  EHMDGGSLDQVLKKAGR----IPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNIL 132

Query: 345 LNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
           +N   E  + D G++  + D       S+V GT +Y++PE  Q    + + DI+S G+ L
Sbjct: 133 VNSRGEIKLCDFGVSGQLIDSMAN---SFV-GTRSYMSPERLQGTHYTVQSDIWSLGLSL 188

Query: 405 ISLVRG---VP-------SFVFHQNGEEICSPEWLRKVM---NSKNPSRAI--------- 442
           + +  G   +P         +F +   E  + E  R V           AI         
Sbjct: 189 VEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVN 248

Query: 443 --DPRLPGNGYEKKMLHVLKIAYICTLHDPEERP 474
              P+LP   +  +    +     C   +P+ER 
Sbjct: 249 EPPPKLPSGAFSDEFQDFVD---KCLKKNPKERA 279

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 69.3 bits (169), Expect = 5e-13
 Identities = 56/222 (25%), Positives = 98/222 (44%), Gaps = 28/222 (12%)

Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
             S  KIG G  G V  A    + GK +A+KK+                 LR  + R++ 
Sbjct: 24  LDSFIKIGEGSTGIVCIATEKHT-GKQVAVKKM----------------DLRKQQRRELL 66

Query: 254 -SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRH 312
            +E++      H N++ +    +  D   +V EF++ G+L DI+        ++      
Sbjct: 67  FNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----A 121

Query: 313 RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLIS 372
            + L V   L YLH   +  +IH DIK  ++LL  D    +SD G    +     +    
Sbjct: 122 TVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR--K 176

Query: 373 YVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
            ++GT  ++APE   +     + DI+S G+++I ++ G P +
Sbjct: 177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPY 218

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 68.3 bits (167), Expect = 6e-13
 Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 25/207 (12%)

Query: 199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT 258
           K+G G  GEVY+             KK   Y+   A + ++ED+   +  L+    E   
Sbjct: 13  KLGGGQYGEVYEG----------VWKK---YSLTVAVKTLKEDTMEVEEFLK----EAAV 55

Query: 259 ASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV 318
             +I+H N++ LL    R     ++ EFM  G+L D L +    R+E++      +A  +
Sbjct: 56  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQI 113

Query: 319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA-MAIPDGYTRVLISYVLGT 377
           +S +EYL      + IH D+  RN L+ ++    ++D GL+ +   D YT    +     
Sbjct: 114 SSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--P 168

Query: 378 MAYIAPEYFQQPELSEKCDIFSFGMLL 404
           + + APE     + S K D+++FG+LL
Sbjct: 169 IKWTAPESLAYNKFSIKSDVWAFGVLL 195

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 68.4 bits (167), Expect = 8e-13
 Identities = 76/300 (25%), Positives = 130/300 (43%), Gaps = 54/300 (18%)

Query: 184 DLAFLKKEDCFASLEKIGSGGCGEVYKAEL--PGSNGKMIAIKKVIVYAPISAAELIEED 241
           D++ +K E      E IG+G  GEV +  L  PG     +AIK +               
Sbjct: 2   DVSCVKIE------EVIGAGEFGEVCRGRLKLPGKREIFVAIKTL--------------K 41

Query: 242 SKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSR 301
           S   + + R   SE     Q  H NI+ L   + +    +++ EFM+NG+L   L     
Sbjct: 42  SGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLR---- 97

Query: 302 GRRELDWPSRHRIAL--GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA 359
            + +  +     + +  G+A+G++YL      + +H D+  RN+L+N ++   +SD GL+
Sbjct: 98  -QNDGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLS 153

Query: 360 MAIPDGYTRVLISYVLG---TMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVF 416
             + D  +    +  LG    + + APE     + +   D++S+G+++      V S+  
Sbjct: 154 RFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWE----VMSY-- 207

Query: 417 HQNGEEICSPEWLRKVMNSKNPSRAI--DPRLPGNGYEKKMLHVLKIAYICTLHDPEERP 474
              GE    P W    M++++   AI  D RLP        LH L +   C   D   RP
Sbjct: 208 ---GER---PYW---DMSNQDVINAIEQDYRLPPPMDCPTALHQLMLD--CWQKDRNARP 256

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 64/252 (25%), Positives = 116/252 (46%), Gaps = 32/252 (12%)

Query: 247 SKLRQIRSEIITASQIRHRNILPLLAHMVRPD------CHLLVYEFMKNGSLQDILDDVS 300
           S++    SE +   +  H N++ L+   ++          +++  FMK+G L   L    
Sbjct: 42  SEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSR 101

Query: 301 RGRRELDWPSRHRIAL--GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGL 358
            G      P++  +     +ASG+EYL    S S IH D+  RN +LN++M  C++D GL
Sbjct: 102 LGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFGL 158

Query: 359 AMAIPDG--YTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISL-VRGVPSFV 415
           +  I +G  Y +  I+ +   + +IA E       + K D++SFG+ +  +  RG   + 
Sbjct: 159 SKKIYNGDYYRQGRIAKM--PVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYP 216

Query: 416 FHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPN 475
             +N E     ++LR+    K P   +D              +  +   C L +P++RP+
Sbjct: 217 GVENSEIY---DYLRQGNRLKQPPDCLD-------------GLYSLMSSCWLLNPKDRPS 260

Query: 476 SQYVRCRLSQLL 487
            + +RC L + L
Sbjct: 261 FETLRCELEKAL 272

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 68.2 bits (167), Expect = 1e-12
 Identities = 52/215 (24%), Positives = 88/215 (40%), Gaps = 28/215 (13%)

Query: 197 LEKIGSGGCGEVYKA--ELPGSN-GKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           ++++G G  G+V     +  G N G+ +A+K +                   +       
Sbjct: 9   IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGE--------------EQHRSDFE 54

Query: 254 SEIITASQIRHRNILPL--LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
            EI     + H NI+    +          L+ E++ +GSL+D L    R R +++    
Sbjct: 55  REIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL---QRHRDQINLKRL 111

Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP--DGYTRV 369
              +  +  G++YL    S   IH D+  RN+L+  +    ISD GLA  +P    Y  V
Sbjct: 112 LLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYV 168

Query: 370 LISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
                     Y APE  +  + S   D++SFG+ L
Sbjct: 169 KEPGESPIFWY-APECLRTSKFSSASDVWSFGVTL 202

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 67.3 bits (164), Expect = 1e-12
 Identities = 82/287 (28%), Positives = 125/287 (43%), Gaps = 46/287 (16%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           ++K+G+G  GEV+     G+    +   K    +P S  E  +   KLR  KL Q+ + +
Sbjct: 11  IKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYA-V 69

Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL 316
           ++   I                   +V E+M  GSL D L D   GR  L  P+   +A 
Sbjct: 70  VSEEPI------------------YIVTEYMSKGSLLDFLKD-GEGR-ALKLPNLVDMAA 109

Query: 317 GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG-YT-RVLISYV 374
            VA+G+ Y+      + IH D++  N+L+ D +   I+D GLA  I D  YT R    + 
Sbjct: 110 QVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKF- 165

Query: 375 LGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLV-RGVPSFVFHQNGEEICSPEWLRKVM 433
              + + APE       + K D++SFG+LL  LV +G   +    N E +   E      
Sbjct: 166 --PIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE------ 217

Query: 434 NSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVR 480
                 R    R+P        LH L +   C   DPEERP  +Y++
Sbjct: 218 ------RGY--RMPCPQDCPISLHELMLQ--CWKKDPEERPTFEYLQ 254

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 67.3 bits (165), Expect = 2e-12
 Identities = 79/291 (27%), Positives = 122/291 (41%), Gaps = 47/291 (16%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
             K+G+G  GEV+       NG      K +    +S    ++E   ++           
Sbjct: 11  ERKLGAGQFGEVWMGTW---NGTTKVAVKTLKPGTMSPEAFLQEAQIMK----------- 56

Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL 316
               ++RH  ++ L A     +   +V E+M  GSL D L       ++L  P    +A 
Sbjct: 57  ----KLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKS--GEGKKLRLPQLVDMAA 110

Query: 317 GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG-YT-RVLISYV 374
            +A G+ YL    S + IH D+  RN+L+ +++   I+D GLA  I D  YT R    + 
Sbjct: 111 QIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKF- 166

Query: 375 LGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLV-RG-VPSFVFHQNGEEICSPEWLRKV 432
              + + APE       + K D++SFG+LL  +V  G VP            + E L +V
Sbjct: 167 --PIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT-------NREVLEQV 217

Query: 433 MNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRL 483
                  R   P  P   Y+  ML        C   DPEERP  +Y++  L
Sbjct: 218 ERGYRMPRP--PNCPEELYD-LMLQ-------CWDKDPEERPTFEYLQSFL 258

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 67.1 bits (164), Expect = 2e-12
 Identities = 52/241 (21%), Positives = 104/241 (43%), Gaps = 39/241 (16%)

Query: 242 SKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSR 301
           ++L + + R   +EI+  S ++H NI+    H +  +  L+  E+   G+L D +     
Sbjct: 36  TRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVR--- 92

Query: 302 GRRELDWPSRHRIAL--GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA 359
            ++   +     +     + S + Y+H    A I+H DIK  N+ L       + D G++
Sbjct: 93  -QKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGIS 148

Query: 360 MAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQN 419
             +   Y+  +   V+GT  Y++PE  Q  + + K DI++ G +L               
Sbjct: 149 KILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVL--------------- 191

Query: 420 GEEICSPEWLRKVMNSKNPSRAIDPRLPGN------GYEKKMLHVLKIAYICTLHDPEER 473
            E +     L++  ++ NP   +   + GN       Y  +++ ++   +     DPE+R
Sbjct: 192 YELLT----LKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLV---HSLLQQDPEKR 244

Query: 474 P 474
           P
Sbjct: 245 P 245

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 67.3 bits (164), Expect = 2e-12
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 37/226 (16%)

Query: 197 LEKIGSGGCGEVYKAEL--PG-SNGKMIAIKKVIVYA-PISAAELIEEDSKLRDSKLRQI 252
           +E++G    G++YK  L  PG  + +++AIK +     P    E  +E S +        
Sbjct: 10  MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLM-------- 61

Query: 253 RSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDIL-------------DDV 299
                  +++ H NI+ LL  + +     +++E++  G L + L             D+ 
Sbjct: 62  -------AELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDED 114

Query: 300 SRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA 359
              +  LD      IA+ +A+G+EYL    S   +H D+  RN+L+ + +   ISDLGL+
Sbjct: 115 GTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQLHVKISDLGLS 171

Query: 360 MAI-PDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
             I    Y RV    +L  + ++ PE     + S   DI+SFG++L
Sbjct: 172 REIYSADYYRVQPKSLL-PIRWMPPEAIMYGKFSSDSDIWSFGVVL 216

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 66.9 bits (163), Expect = 2e-12
 Identities = 73/298 (24%), Positives = 128/298 (42%), Gaps = 41/298 (13%)

Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  G V +A+L   +G    +   ++ A I ++  IEE  +           E    
Sbjct: 7   LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLR-----------EAACM 55

Query: 260 SQIRHRNILPLLAHMVRPDCH------LLVYEFMKNGSLQDILDDVSRGRRELDWPSRH- 312
            +  H N++ L+   +R          +++  FMK+G L   L     G      P +  
Sbjct: 56  KEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTL 115

Query: 313 -RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG-YTRVL 370
            R  + +ASG+EYL    S + IH D+  RN +LN++M  C++D GL+  I  G Y R  
Sbjct: 116 VRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQG 172

Query: 371 ISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLV-RGVPSFVFHQNGEEICSPEWL 429
            +  L  + ++A E       +   D+++FG+ +  ++ RG   +   +N E      +L
Sbjct: 173 CASKL-PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIY---NYL 228

Query: 430 RKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL 487
            K    K P     P    + YE        +   C   +P+ RP+ Q++R +L  + 
Sbjct: 229 IKGNRLKQP-----PDCLEDVYE--------LMCQCWSPEPKCRPSFQHLRDQLELIW 273

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 66.7 bits (163), Expect = 3e-12
 Identities = 62/223 (27%), Positives = 101/223 (45%), Gaps = 26/223 (11%)

Query: 198 EKIGSGGCGEVYKAELPGSNGKMI--AIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSE 255
             IG G  G VY   L  S+G+ I  A+K       ++    +EE  +     L+    E
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKS------LNRITDLEEVEQF----LK----E 46

Query: 256 IITASQIRHRNILPLLAHMVRPD-CHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRI 314
            I      H N+L LL   +  +   L+V  +MK+G L++ +   +      D       
Sbjct: 47  GIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIG---F 103

Query: 315 ALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYV 374
            L VA G+EYL    S   +H D+  RN +L++     ++D GLA  I D     + ++ 
Sbjct: 104 GLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHT 160

Query: 375 LGTM--AYIAPEYFQQPELSEKCDIFSFGMLLISLV-RGVPSF 414
              +   ++A E  Q  + + K D++SFG+LL  L+ RG P +
Sbjct: 161 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 203

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 67.4 bits (165), Expect = 3e-12
 Identities = 55/229 (24%), Positives = 94/229 (41%), Gaps = 44/229 (19%)

Query: 201 GSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITAS 260
                  + K +       ++A+KK+           ++  SK     L+ ++ EIIT+ 
Sbjct: 11  EDLMIVHLAKHK---PTNTLVAVKKIN----------LDSCSK---EDLKLLQQEIITSR 54

Query: 261 QIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDV-SRGRRELDWPSRHRIAL--- 316
           Q++H NILP +   +      +V   M  GS +D+L      G  EL       IA    
Sbjct: 55  QLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPEL------AIAFILK 108

Query: 317 GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDL---------GLAMAIPDGYT 367
            V + L+Y+   HS   IH  +K  ++LL+ D +  +S L         G    +   + 
Sbjct: 109 DVLNALDYI---HSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFP 165

Query: 368 RVLISYVLGTMAYIAPEYFQQPEL--SEKCDIFSFGMLLISLVRGVPSF 414
           +  +      + +++PE  QQ     +EK DI+S G+    L  G   F
Sbjct: 166 KSSVK----NLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPF 210

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 66.9 bits (164), Expect = 3e-12
 Identities = 71/231 (30%), Positives = 104/231 (45%), Gaps = 41/231 (17%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEED----SKLRD-SKLRQ 251
           L +IG G  G VYKA      G+ +A+KKV V  P+S      E+    S LR+ + L+Q
Sbjct: 4   LAEIGEGAYGTVYKARDLN-TGRFVALKKVRV--PLS------EEGIPLSTLREIALLKQ 54

Query: 252 IRSEIITASQIRHRNILPLL--AHMVRPDCHL---LVYEFMKNGSLQDILDDVSR---GR 303
           +           H NI+ LL   H  R D  L   LV+E +    L   L    +     
Sbjct: 55  L-------ESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPP 106

Query: 304 RELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
             +    R      +  G+++L   HS  I+H D+KP+N+L+  D +  I+D GLA    
Sbjct: 107 ETIKDLMRQ-----LLRGVDFL---HSHRIVHRDLKPQNILVTSDGQVKIADFGLARIY- 157

Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
             +   L S V+ T+ Y APE   Q   +   D++S G +   L R  P F
Sbjct: 158 -SFEMALTSVVV-TLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLF 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 66.7 bits (163), Expect = 3e-12
 Identities = 66/234 (28%), Positives = 112/234 (47%), Gaps = 34/234 (14%)

Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           +  +EKIG G  G VYK       G+++A+KK+          L  E+  +  + +R   
Sbjct: 2   YTKIEKIGEGTYGVVYKGR-NKKTGQIVAMKKI---------RLESEEEGVPSTAIR--- 48

Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGR---RELDWPS 310
            EI    +++H NI+ L   +++     L++EF+ +  L+  LD + +G+    EL    
Sbjct: 49  -EISLLKELQHPNIVCLQDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSY 106

Query: 311 RHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMA--IPDGYTR 368
            ++I  G+          HS  ++H D+KP+N+L+++     ++D GLA A  IP    R
Sbjct: 107 LYQILQGIL-------FCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP---VR 156

Query: 369 VLISYVLGTMAYIAPE-YFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGE 421
           V    V+ T+ Y APE     P  S   DI+S G +   +    P  +FH + E
Sbjct: 157 VYTHEVV-TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKP--LFHGDSE 207

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 67.4 bits (164), Expect = 3e-12
 Identities = 62/225 (27%), Positives = 101/225 (44%), Gaps = 33/225 (14%)

Query: 190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKL 249
           K+D F  + ++G+G  G V K +   S   +I  +K+I +  I  A              
Sbjct: 3   KDDDFERISELGAGNGGVVTKVQHKPS--GLIMARKLI-HLEIKPA-------------- 45

Query: 250 RQIRSEIITASQIRHRNILPLLAHM---VRPDCHL-LVYEFMKNGSLQDILDDVSRGRRE 305
             IR++II   Q+ H    P +         D  + +  E M  GSL  +L +  R   E
Sbjct: 46  --IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEE 103

Query: 306 LDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG 365
           +      ++++ V  GL YL   H   I+H D+KP N+L+N   E  + D G++  + D 
Sbjct: 104 I----LGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157

Query: 366 YTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRG 410
                +    GT +Y++PE  Q    S + DI+S G+ L+ L  G
Sbjct: 158 MANSFV----GTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIG 198

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 66.4 bits (162), Expect = 4e-12
 Identities = 72/304 (23%), Positives = 123/304 (40%), Gaps = 44/304 (14%)

Query: 196 SLEKI-GSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRS 254
            L KI G G  G V + +L   +G  + +    +   I     IEE             S
Sbjct: 2   KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEE-----------FLS 50

Query: 255 EIITASQIRHRNILPLL------AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDW 308
           E        H N++ L+      + + +    +++  FMK+G L   L     G      
Sbjct: 51  EAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKL 110

Query: 309 PSRH--RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG- 365
           P +   +  + +A G+EYL    + + IH D+  RN +L +DM  C++D GL+  I  G 
Sbjct: 111 PLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGD 167

Query: 366 -YTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLIS-LVRGVPSFVFHQNGEEI 423
            Y +  I+ +   + +IA E       + K D+++FG+ +     RG   +   +N E  
Sbjct: 168 YYRQGRIAKM--PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIY 225

Query: 424 CSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRL 483
              ++LR     K P   +D              +  + Y C   DP++RP    +R  L
Sbjct: 226 ---DYLRHGNRLKQPEDCLD-------------ELYDLMYSCWRADPKDRPTFTKLREVL 269

Query: 484 SQLL 487
             +L
Sbjct: 270 ENIL 273

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 66.3 bits (162), Expect = 4e-12
 Identities = 62/219 (28%), Positives = 98/219 (44%), Gaps = 31/219 (14%)

Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  G+VYKA+       + A  K+I          IE + +L D  +     EI   
Sbjct: 13  LGDGAFGKVYKAQ--HKETGLFAAAKIIQ---------IESEEELEDFMV-----EIDIL 56

Query: 260 SQIRHRNILPLL-AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV 318
           S+ +H NI+ L  A+       +L+ EF   G+L  I+ ++ RG   L  P    +   +
Sbjct: 57  SECKHPNIVGLYEAYFYENKLWILI-EFCDGGALDSIMLELERG---LTEPQIRYVCRQM 112

Query: 319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTM 378
              L +LH   S  +IH D+K  N+LL  D +  ++D G++       T       +GT 
Sbjct: 113 LEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKS--TLQKRDTFIGTP 167

Query: 379 AYIAPEY-----FQQPELSEKCDIFSFGMLLISLVRGVP 412
            ++APE      F+      K DI+S G+ LI L +  P
Sbjct: 168 YWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEP 206

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 67.1 bits (164), Expect = 4e-12
 Identities = 63/234 (26%), Positives = 102/234 (43%), Gaps = 35/234 (14%)

Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDS------KLRQIR 253
           +G G  G+V KA      GK++AIKKV +   I  +  + +D +L          LR+++
Sbjct: 17  LGEGTYGKVEKAY-DTLTGKIVAIKKVKI---IEISNDVTKDRQLVGMCGIHFTTLRELK 72

Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
             I+   +I+H NI+ L+   V  D   LV + M    L+ ++D   R    L       
Sbjct: 73  --IMN--EIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIR----LTESQVKC 123

Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAM-----AIPDGYT- 367
           I L + +GL  LH +     +H D+ P N+ +N      I+D GLA         D  + 
Sbjct: 124 ILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSK 180

Query: 368 ------RVLISYVLGTMAYIAPE-YFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
                 R  ++  + T+ Y APE      +     D++S G +   L+ G P F
Sbjct: 181 DETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLF 234

Length = 335

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 66.7 bits (163), Expect = 5e-12
 Identities = 71/240 (29%), Positives = 113/240 (47%), Gaps = 46/240 (19%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVI-VYAPISAAELIEEDSKLRDSKLRQIRSE 255
            E IG G  G V  A +    G+ +AIKK+  V+  +S A  I     LR+ KL ++   
Sbjct: 5   QEVIGKGSYGVVCSA-IDTHTGEKVAIKKINDVFEHVSDATRI-----LREIKLLRL--- 55

Query: 256 IITASQIRHRNILPLLAHMVRPDCH-----LLVYEFMKNGSLQDIL--DDVSRGRRELDW 308
                 +RH +I+ +   M+ P         +V+E M++   Q I   DD++        
Sbjct: 56  ------LRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLT-------- 101

Query: 309 PSRHRIAL-GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA-MAIPDGY 366
           P  H+  L  +   L+Y+H   +A++ H D+KP+N+L N D +  I D GLA +A  D  
Sbjct: 102 PEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 158

Query: 367 TRVLISYVLGTMAYIAPE----YFQQPELSEKCDIFSFGMLLISLVRGVPSF----VFHQ 418
           T +  +  + T  Y APE    +F +   +   DI+S G +   ++ G P F    V HQ
Sbjct: 159 TAIFWTDYVATRWYRAPELCGSFFSK--YTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQ 216

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 66.0 bits (161), Expect = 6e-12
 Identities = 56/224 (25%), Positives = 96/224 (42%), Gaps = 36/224 (16%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           L+++G G  G VYK  L    G  +A+K++ +              +L +SK  QI  E+
Sbjct: 6   LDELGKGNYGSVYKV-LHRPTGVTMAMKEIRL--------------ELDESKFNQIIMEL 50

Query: 257 ITASQIRHRNILPLLAHM----VRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRH 312
                I H+ + P +              +  E+M  GSL  +          +      
Sbjct: 51  ----DILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEG-IPEDVLR 105

Query: 313 RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLIS 372
           RI   V  GL++L   H+  IIH D+KP NVL+N + +  + D G++  +     +  I 
Sbjct: 106 RITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI- 162

Query: 373 YVLGTMAYIAPEYF------QQPELSEKCDIFSFGMLLISLVRG 410
              G  +Y+APE        Q P  + + D++S G+ ++ +  G
Sbjct: 163 ---GCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALG 203

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 65.8 bits (160), Expect = 6e-12
 Identities = 58/222 (26%), Positives = 94/222 (42%), Gaps = 23/222 (10%)

Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           F     +G GG GEV   ++  + GKM A K++             E  +++  K   + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRAT-GKMYACKRL-------------EKKRIKKRKGESMA 47

Query: 254 -SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRH 312
            +E     ++  + ++ L       D   LV   M  G L+      + G    +     
Sbjct: 48  LNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLK--FHIYNMGNPGFEEERAL 105

Query: 313 RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLIS 372
             A  +  GLE LH     + ++ D+KP N+LL+D     ISDLGLA+ IP+G     I 
Sbjct: 106 FYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE---SIR 159

Query: 373 YVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
             +GT+ Y+APE       +   D +  G L+  ++ G   F
Sbjct: 160 GRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 65.4 bits (159), Expect = 7e-12
 Identities = 54/225 (24%), Positives = 101/225 (44%), Gaps = 43/225 (19%)

Query: 193 CFASLEKIGSGGCGEVYKA--ELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
                + IG+G  GEV++   ++PG     +AIK +                   + + +
Sbjct: 6   HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTL--------------KPGYTEKQRQ 51

Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPS 310
              SE     Q  H NI+ L   + +    +++ E+M+NG+L   L D      + ++ S
Sbjct: 52  DFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRD-----HDGEFSS 106

Query: 311 RHRIAL--GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTR 368
              + +  G+A+G++YL      + +H D+  RN+L+N ++E  +SD GL        +R
Sbjct: 107 YQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGL--------SR 155

Query: 369 VLISYVLGT---------MAYIAPEYFQQPELSEKCDIFSFGMLL 404
           VL     GT         + + APE     + +   D++SFG+++
Sbjct: 156 VLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVM 200

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 65.5 bits (159), Expect = 7e-12
 Identities = 74/297 (24%), Positives = 131/297 (44%), Gaps = 53/297 (17%)

Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           F  +E +G+G  G+VYK     + G++ AIK + V          EE+         +I+
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKT-GQLAAIKVMDVTGD-------EEE---------EIK 50

Query: 254 SEI-ITASQIRHRNILPLLAHMVRP------DCHLLVYEFMKNGSLQDILDDVSRGRREL 306
            EI +      HRNI       ++       D   LV EF   GS+ D++ +      + 
Sbjct: 51  QEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKE 110

Query: 307 DWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGY 366
           +W +   I   +  GL +LH +    +IH DIK +NVLL ++ E  + D G++  +    
Sbjct: 111 EWIAY--ICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV 165

Query: 367 TRVLISYVLGTMAYIAPEYF---QQPELSE--KCDIFSFGMLLISLVRGVPSFVFHQNGE 421
            R   +  +GT  ++APE     + P+ +   K D++S G+  I +  G P         
Sbjct: 166 GRR--NTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP-------- 215

Query: 422 EICSPEWLRKV-MNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQ 477
            +C    +R + +  +NP+    PRL    + KK    ++    C + +  +RP ++
Sbjct: 216 -LCDMHPMRALFLIPRNPA----PRLKSKKWSKKFQSFIE---SCLVKNHSQRPTTE 264

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 65.3 bits (160), Expect = 8e-12
 Identities = 66/230 (28%), Positives = 102/230 (44%), Gaps = 44/230 (19%)

Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           I  G  G V+ A+   S G + AIK       I  A++I ++         Q+ +E    
Sbjct: 1   ISKGAYGRVFLAK-KKSTGDIYAIKV------IKKADMIRKNQV------DQVLTE---- 43

Query: 260 SQIRHRNIL-----PLLAHMV---RPDCHL-LVYEFMKNGSLQDILDDVSRGRRELDWPS 310
                R+IL     P +  +    +   +L LV E++  G L  +L++V  G  + D  +
Sbjct: 44  -----RDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENV--GSLDEDV-A 95

Query: 311 RHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMA------IPD 364
           R  IA  V   LEYLH   S  IIH D+KP N+L++ +    ++D GL+        I  
Sbjct: 96  RIYIAEIVL-ALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL 151

Query: 365 GYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
                    ++GT  YIAPE       S+  D +S G +L   + G+P F
Sbjct: 152 NDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPF 201

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 65.1 bits (159), Expect = 8e-12
 Identities = 72/312 (23%), Positives = 120/312 (38%), Gaps = 65/312 (20%)

Query: 192 DCFASLEKIGSGGCGEVYKA--ELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKL 249
                 + IG G  GEV +   +LPG     +AIK +   +               D + 
Sbjct: 4   SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSS--------------DKQR 49

Query: 250 RQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWP 309
               +E     Q  H NI+ L   + +    +++ E+M+NGSL   L        +    
Sbjct: 50  LDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFL---RENDGKFTVG 106

Query: 310 SRHRIALGVASGLEYL--HMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG-- 365
               +  G+ASG++YL    Y     +H D+  RN+L+N ++   +SD GL+  + D   
Sbjct: 107 QLVGMLRGIASGMKYLSEMNY-----VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA 161

Query: 366 -YTRVLISYVLGTMA------YIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ 418
            YT         T        + APE     + +   D++SFG+++      V S+    
Sbjct: 162 TYT---------TKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWE----VMSY---- 204

Query: 419 NGEEICSPEWL---RKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPN 475
            GE    P W    + V+ +         RLP        L+ L +   C   D  ERP 
Sbjct: 205 -GER---PYWDMSNQDVIKAVE----DGYRLPPPMDCPSALYQLMLD--CWQKDRNERPT 254

Query: 476 SQYVRCRLSQLL 487
              +   L +++
Sbjct: 255 FSQIVSTLDKMI 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 64.8 bits (158), Expect = 8e-12
 Identities = 67/256 (26%), Positives = 104/256 (40%), Gaps = 44/256 (17%)

Query: 198 EKIGSGGCGEVYKAELPGSNGKM-IAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           EKIG G  G+VYK  L    G   +A+K            L  +         R+   E 
Sbjct: 1   EKIGKGNFGDVYKGVL---KGNTEVAVKTCRS-------TLPPDLK-------RKFLQEA 43

Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL 316
               Q  H NI+ L+   V+     +V E +  GSL   L  + + +  L      +++L
Sbjct: 44  EILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL---LTFLRKKKNRLTVKKLLQMSL 100

Query: 317 GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG-YTRVLISYVL 375
             A+G+EYL    S + IH D+  RN L+ ++    ISD G++     G YT   +S  L
Sbjct: 101 DAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYT---VSDGL 154

Query: 376 GTM--AYIAPEYFQQPELSEKCDIFSFGMLLISLVRG----VPSFVFHQNGEEICS---- 425
             +   + APE       + + D++S+G+LL           P     Q  E I S    
Sbjct: 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRM 214

Query: 426 ------PEWLRKVMNS 435
                 PE + ++M  
Sbjct: 215 PAPQLCPEEIYRLMLQ 230

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 64.8 bits (158), Expect = 1e-11
 Identities = 84/323 (26%), Positives = 120/323 (37%), Gaps = 82/323 (25%)

Query: 180 IEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIE 239
           I+  +L FLK+         +GSG  G V+  +  G     +AIK +I    +S  + IE
Sbjct: 1   IDPSELTFLKE---------LGSGQFGVVHLGKWRGK--IDVAIK-MIREGAMSEDDFIE 48

Query: 240 EDS---KLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDIL 296
           E     KL    L Q+          + R I              +V E+M NG L + L
Sbjct: 49  EAKVMMKLSHPNLVQLYGVCT-----KQRPIF-------------IVTEYMANGCLLNYL 90

Query: 297 DDVSRGRRELDWPSRHRIALG----VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC 352
               R R+           L     V   +EYL    S   IH D+  RN L+ +D    
Sbjct: 91  ----RERKGK---LGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVK 140

Query: 353 ISDLGLA-MAIPDGYTRVLISYVLGT---MAYIAPEYFQQPELSEKCDIFSFGMLLISLV 408
           +SD GLA   + D YT        GT   + +  PE F     S K D++SFG+L+  + 
Sbjct: 141 VSDFGLARYVLDDQYTS-----SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVF 195

Query: 409 RG----VPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYI 464
                    F   +  E + +   L +            P+L           V  I Y 
Sbjct: 196 SEGKMPYERFSNSEVVESVSAGYRLYR------------PKLAPT-------EVYTIMYS 236

Query: 465 CTLHDPEERPNSQYVRCRLSQLL 487
           C    PE+RP     +  LSQL 
Sbjct: 237 CWHEKPEDRP---AFKKLLSQLT 256

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 65.1 bits (159), Expect = 1e-11
 Identities = 65/224 (29%), Positives = 97/224 (43%), Gaps = 26/224 (11%)

Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           F  L +IG G  G VY+A    S G+++A+KKV          +  E   +  S LR+I 
Sbjct: 9   FEKLNRIGEGTYGIVYRARDTTS-GEIVALKKV---------RMDNERDGIPISSLREIT 58

Query: 254 SEIITASQIRHRNILPLLAHMV--RPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
             +     +RH NI+ L   +V    D   LV E+ +   L  +LD++     E      
Sbjct: 59  LLL----NLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSE---SQV 110

Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLI 371
             + L +  GL+YLH      IIH D+K  N+LL D     I+D GLA         +  
Sbjct: 111 KCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTP 167

Query: 372 SYVLGTMAYIAPE-YFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
             V  T+ Y APE        +   D+++ G +L  L+   P  
Sbjct: 168 KVV--TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLL 209

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 64.4 bits (157), Expect = 2e-11
 Identities = 64/220 (29%), Positives = 102/220 (46%), Gaps = 31/220 (14%)

Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           F  +EKIG G  G VYKA      G+++A+KK            I  D++        IR
Sbjct: 2   FQKVEKIGEGTYGVVYKAR-NKLTGEVVALKK------------IRLDTETEGVPSTAIR 48

Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHL-LVYEFMKNGSLQDILDDVSRGRRELDWPSRH 312
            EI    ++ H NI+ LL  ++  +  L LV+EF+ +  L+  +D        +  P   
Sbjct: 49  -EISLLKELNHPNIVKLL-DVIHTENKLYLVFEFL-HQDLKKFMDASPLS--GIPLPLIK 103

Query: 313 RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMA--IP-DGYTRV 369
                +  GL + H   S  ++H D+KP+N+L+N +    ++D GLA A  +P   YT  
Sbjct: 104 SYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE 160

Query: 370 LISYVLGTMAYIAPEYFQQPEL-SEKCDIFSFGMLLISLV 408
           ++     T+ Y APE     +  S   DI+S G +   +V
Sbjct: 161 VV-----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 195

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 64.1 bits (156), Expect = 2e-11
 Identities = 68/235 (28%), Positives = 105/235 (44%), Gaps = 23/235 (9%)

Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G GG GEV   ++  + GKM A KK           L ++  K R  +   +  + I  
Sbjct: 8   LGKGGFGEVCACQVRAT-GKMYACKK-----------LEKKRIKKRKGEAMALNEKQIL- 54

Query: 260 SQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVA 319
            ++  R ++ L       D   LV   M  G L+  + ++  G    D       A  + 
Sbjct: 55  EKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNM--GNPGFDEERAVFYAAEIT 112

Query: 320 SGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMA 379
            GLE LH      I++ D+KP N+LL+D     ISDLGLA+ IP+G T   I   +GT+ 
Sbjct: 113 CGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET---IRGRVGTVG 166

Query: 380 YIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMN 434
           Y+APE  +    +   D +  G L+  ++ G     F Q  E++   E  R+V  
Sbjct: 167 YMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP--FRQRKEKVKREEVERRVKE 219

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 64.8 bits (158), Expect = 2e-11
 Identities = 60/209 (28%), Positives = 90/209 (43%), Gaps = 61/209 (29%)

Query: 194 FASLEK---IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
            + LE+   IGSG  G VYK  +    G++ A+K  ++Y                D+  R
Sbjct: 73  LSELERVNRIGSGAGGTVYKV-IHRPTGRLYALK--VIYG------------NHEDTVRR 117

Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCH---------LLVYEFMKNGSLQDILDDVSR 301
           QI  EI     + H N+       V+  CH          ++ EFM  GSL+        
Sbjct: 118 QICREIEILRDVNHPNV-------VK--CHDMFDHNGEIQVLLEFMDGGSLE-------- 160

Query: 302 GRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMA 361
           G    D      +A  + SG+ YLH  H   I+H DIKP N+L+N      I+D G++  
Sbjct: 161 GTHIADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVS-- 215

Query: 362 IPDGYTRVLISYV------LGTMAYIAPE 384
                 R+L   +      +GT+AY++PE
Sbjct: 216 ------RILAQTMDPCNSSVGTIAYMSPE 238

Length = 353

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 63.9 bits (155), Expect = 3e-11
 Identities = 55/217 (25%), Positives = 98/217 (45%), Gaps = 28/217 (12%)

Query: 199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR-SEII 257
           KIG G  G V  A    S G+ +A+K +                 LR  + R++  +E++
Sbjct: 28  KIGEGSTGIVCIAREKHS-GRQVAVKMM----------------DLRKQQRRELLFNEVV 70

Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALG 317
                +H+N++ +    +  +   ++ EF++ G+L DI+             +  +IA  
Sbjct: 71  IMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRL--------NEEQIATV 122

Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGT 377
             S L+ L   HS  +IH DIK  ++LL  D    +SD G    I     +     ++GT
Sbjct: 123 CESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR--KSLVGT 180

Query: 378 MAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
             ++APE   +     + DI+S G+++I +V G P +
Sbjct: 181 PYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPY 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 63.5 bits (154), Expect = 3e-11
 Identities = 64/238 (26%), Positives = 103/238 (43%), Gaps = 25/238 (10%)

Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR-SEIIT 258
           +G GG GEV   ++  + GKM A KK+             E  +++  K   +  +E   
Sbjct: 8   LGKGGFGEVCACQVRAT-GKMYACKKL-------------EKKRIKKRKGEAMALNEKRI 53

Query: 259 ASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV 318
             ++  R ++ L       D   LV   M  G L+      + G    D       A  +
Sbjct: 54  LEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLK--FHIYNMGNPGFDEQRAIFYAAEL 111

Query: 319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTM 378
             GLE L       I++ D+KP N+LL+D     ISDLGLA+ IP+G T   +   +GT+
Sbjct: 112 CCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET---VRGRVGTV 165

Query: 379 AYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSK 436
            Y+APE     + +   D +  G L+  +++G   F   +  E +   E  R+V   +
Sbjct: 166 GYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRK--ERVKREEVDRRVKEDQ 221

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 63.0 bits (153), Expect = 4e-11
 Identities = 51/219 (23%), Positives = 101/219 (46%), Gaps = 22/219 (10%)

Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           +++G+G     Y+A    + G ++A+K+V           +   S  ++  +  +R EI 
Sbjct: 6   QQLGTGAFSSCYQARDVKT-GTLMAVKQV---------TYVRNTSSEQEEVVEALRKEIR 55

Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVY-EFMKNGSLQDILDDVSRGRRELDWPSRHRIAL 316
             +++ H +I+ +L      D H  ++ E+M  GS+  +L      +  +      ++  
Sbjct: 56  LMARLNHPHIIRMLG-ATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLR 114

Query: 317 GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC-ISDLGLAMAIPDGYTRV--LISY 373
           G++    YLH      IIH D+K  N+L++   +   I+D G A  +    T        
Sbjct: 115 GLS----YLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQ 167

Query: 374 VLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVP 412
           +LGT+A++APE  +  +    CD++S G ++I +    P
Sbjct: 168 LLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 65.2 bits (159), Expect = 4e-11
 Identities = 56/233 (24%), Positives = 95/233 (40%), Gaps = 47/233 (20%)

Query: 199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT 258
            IG GG GEVY A  P    + +A+KK+         E + E+  L+   LR+ +     
Sbjct: 9   LIGKGGMGEVYLAYDPVC-SRRVALKKI--------REDLSENPLLKKRFLREAK----I 55

Query: 259 ASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRH------ 312
           A+ + H  I+P+ +     D       +++  +L+ +L  V    ++             
Sbjct: 56  AADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSV---WQKESLSKELAEKTSV 112

Query: 313 ----RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTR 368
                I   + + +EY+H   S  ++H D+KP N+LL    E  I D G A+        
Sbjct: 113 GAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFK-KLEEE 168

Query: 369 VLISY-----------------VLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
            L+                   ++GT  Y+APE       SE  DI++ G++L
Sbjct: 169 DLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVIL 221

Length = 932

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 62.8 bits (153), Expect = 6e-11
 Identities = 53/228 (23%), Positives = 97/228 (42%), Gaps = 36/228 (15%)

Query: 192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ 251
           + +  L KIG G  G V+K       G+++AIKK +           E+D  ++   LR+
Sbjct: 1   EKYEKLSKIGEGSYGVVFKCR-NRETGQIVAIKKFVES---------EDDPVIKKIALRE 50

Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
           IR       Q++H N++ L+    R     LV+E+  +     +L+++ +  R +     
Sbjct: 51  IR----MLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDH----TVLNELEKNPRGVPEHLI 102

Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLI 371
            +I       + + H     + IH D+KP N+L+    +  + D G A        R+L 
Sbjct: 103 KKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFA--------RILT 151

Query: 372 SYVLGTMAYIAPEYFQQPEL-------SEKCDIFSFGMLLISLVRGVP 412
                   Y+A  +++ PEL           D+++ G +   L+ G P
Sbjct: 152 GPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQP 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 63.5 bits (154), Expect = 6e-11
 Identities = 60/225 (26%), Positives = 100/225 (44%), Gaps = 33/225 (14%)

Query: 190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKL 249
           K+D F  + ++G+G  G V+K     S   +I  +K+I +  I  A              
Sbjct: 3   KDDDFEKISELGAGNGGVVFKVSHKPSG--LIMARKLI-HLEIKPA-------------- 45

Query: 250 RQIRSEIITASQIRHRNILPLLAHM---VRPDCHL-LVYEFMKNGSLQDILDDVSRGRRE 305
             IR++II   Q+ H    P +         D  + +  E M  GSL  +L    R   +
Sbjct: 46  --IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQ 103

Query: 306 LDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG 365
           +      ++++ V  GL YL   H   I+H D+KP N+L+N   E  + D G++  + D 
Sbjct: 104 I----LGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157

Query: 366 YTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRG 410
                +    GT +Y++PE  Q    S + DI+S G+ L+ +  G
Sbjct: 158 MANSFV----GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIG 198

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 62.5 bits (152), Expect = 7e-11
 Identities = 52/216 (24%), Positives = 101/216 (46%), Gaps = 31/216 (14%)

Query: 200 IGSGGCGEVYKAELPG---SNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           +G G  GEV+ A+  G     G+ + + K +           +E+ +       + R E+
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-------DENLQS------EFRREL 59

Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWP----SRH 312
               ++ H+N++ LL      + H ++ E+   G L+  L   ++ + E   P    ++ 
Sbjct: 60  DMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLR-ATKSKDEKLKPPPLSTKQ 118

Query: 313 RIALG--VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVL 370
           ++AL   +A G+++L    +A  +H D+  RN L++   E  +S L L+    D Y    
Sbjct: 119 KVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLS---KDVYNSEY 172

Query: 371 ISYV--LGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
                 L  + ++APE  Q+ + S K D++SFG+L+
Sbjct: 173 YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLM 208

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 62.1 bits (151), Expect = 9e-11
 Identities = 66/284 (23%), Positives = 120/284 (42%), Gaps = 44/284 (15%)

Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           +  LE IG G  G VY+       GK +   +V+      A ++I  D+   D  +  I+
Sbjct: 3   YQRLELIGRGAYGAVYR-------GKHVPTGRVV------ALKIINLDTP--DDDVSDIQ 47

Query: 254 SEIITASQIRH---RNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPS 310
            E+   SQ+R     NI       ++     ++ E+ + GS++ ++       +      
Sbjct: 48  REVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLM-------KAGPIAE 100

Query: 311 RHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVL 370
           ++ I++ +   L  L   H   +IH DIK  N+L+ +     + D G+A  +    ++  
Sbjct: 101 KY-ISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR- 158

Query: 371 ISYVLGTMAYIAPEYFQQ-PELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWL 429
            S  +GT  ++APE   +      K DI+S G+ +  +  G P +            +  
Sbjct: 159 -STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPY---------SDVDAF 208

Query: 430 RKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEER 473
           R +M      ++  PRL  NGY K +     +A  C   +P+ER
Sbjct: 209 RAMMLI---PKSKPPRLEDNGYSKLLREF--VAA-CLDEEPKER 246

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 61.9 bits (150), Expect = 9e-11
 Identities = 77/287 (26%), Positives = 118/287 (41%), Gaps = 60/287 (20%)

Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDS---KLRDSKLRQIRS 254
           ++IGSG  G V+         + +AIK  I    +S  + IEE     KL   KL Q+  
Sbjct: 10  QEIGSGQFGLVWLGYW--LEKRKVAIK-TIREGAMSEEDFIEEAQVMMKLSHPKLVQLYG 66

Query: 255 EIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRR-ELDWPSRHR 313
                S I                   LV+EFM++G L D L    R +R +    +   
Sbjct: 67  VCTERSPI------------------CLVFEFMEHGCLSDYL----RAQRGKFSQETLLG 104

Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA-MAIPDGYTRVLIS 372
           + L V  G+ YL    S+++IH D+  RN L+ ++    +SD G+    + D YT     
Sbjct: 105 MCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS---- 157

Query: 373 YVLGT---MAYIAPEYFQQPELSEKCDIFSFGMLLISLV-RGVPSFVFHQNGEEICSPEW 428
              GT   + + +PE F   + S K D++SFG+L+  +   G   +    N E       
Sbjct: 158 -STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE------- 209

Query: 429 LRKVMNSKNPS-RAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERP 474
              V+ + N   R   PRL           V ++   C    PE+RP
Sbjct: 210 ---VVETINAGFRLYKPRLASQ-------SVYELMQHCWKERPEDRP 246

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 62.2 bits (152), Expect = 1e-10
 Identities = 58/230 (25%), Positives = 105/230 (45%), Gaps = 34/230 (14%)

Query: 192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ 251
           D +  L +I  G  G VY+A      G+++A+KK+         ++ +E      + LR 
Sbjct: 5   DEYEKLNRIEEGTYGVVYRA-RDKKTGEIVALKKL---------KMEKEKEGFPITSLR- 53

Query: 252 IRSEIITASQIRHRNILPLLAHMV---RPDCHLLVYEFMKNGSLQDILDDVSRGRRELDW 308
              EI    +++H NI+ +   +V     D   +V E++++  L+ +++ + +   +   
Sbjct: 54  ---EINILLKLQHPNIVTV-KEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQ--- 105

Query: 309 PSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPD---G 365
                + L + SG+ +LH      I+H D+K  N+LLN+     I D GLA         
Sbjct: 106 SEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP 162

Query: 366 YTRVLISYVLGTMAYIAPE-YFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
           YT++++     T+ Y APE      E S   D++S G +   L+   P F
Sbjct: 163 YTQLVV-----TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLF 207

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 62.1 bits (151), Expect = 1e-10
 Identities = 50/173 (28%), Positives = 87/173 (50%), Gaps = 25/173 (14%)

Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           +  LEKIG G  G V+KA+   +  +++A+K+V          L ++D  +  S LR   
Sbjct: 2   YEKLEKIGEGTYGTVFKAKNRET-HEIVALKRV---------RLDDDDEGVPSSALR--- 48

Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHL-LVYEFMKNGSLQDILDDVSRGRRELDWPSRH 312
            EI    +++H+NI+  L  ++  D  L LV+E+      QD+         ++D     
Sbjct: 49  -EICLLKELKHKNIV-RLYDVLHSDKKLTLVFEYCD----QDLKKYFDSCNGDIDPEIVK 102

Query: 313 RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMA--IP 363
                +  GL + H ++   ++H D+KP+N+L+N + E  ++D GLA A  IP
Sbjct: 103 SFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIP 152

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 61.7 bits (150), Expect = 1e-10
 Identities = 70/282 (24%), Positives = 115/282 (40%), Gaps = 52/282 (18%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSE- 255
           L+ I  G  G VY A+   S G   AIK            ++++   +  +++  +++E 
Sbjct: 1   LKPISKGAFGSVYLAK-KRSTGDYFAIK------------VLKKSDMIAKNQVTNVKAER 47

Query: 256 IITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIA 315
            I   Q     +  L       D   LV E++  G    ++  +  G    DW ++  IA
Sbjct: 48  AIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTL--GGLPEDW-AKQYIA 104

Query: 316 LGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVL 375
             V  G+E LH      IIH DIKP N+L++      ++D GL+     G          
Sbjct: 105 -EVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRN---GLENKKFV--- 154

Query: 376 GTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF-------VF----------HQ 418
           GT  Y+APE        +  D +S G ++   + G P F       VF           +
Sbjct: 155 GTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPE 214

Query: 419 NGEEICSPE---WLRKVMNSKNPSRAIDPRLPGNGYEKKMLH 457
             +E CSPE    + +++   +P++    RL  NGY++   H
Sbjct: 215 EVKEFCSPEAVDLINRLLCM-DPAK----RLGANGYQEIKSH 251

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 61.9 bits (151), Expect = 1e-10
 Identities = 65/225 (28%), Positives = 105/225 (46%), Gaps = 29/225 (12%)

Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           +  +EKIG G  G VYKA      G+++A+KK+          L  ED  +  + +R   
Sbjct: 1   YQKVEKIGEGTYGVVYKA-RDKLTGEIVALKKI---------RLETEDEGVPSTAIR--- 47

Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
            EI    ++ H NI+ LL  +   +   LV+EF+ +  L+  +D        LD P    
Sbjct: 48  -EISLLKELNHPNIVRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSP--LTGLDPPLIKS 103

Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMA--IP-DGYTRVL 370
               +  G+ Y    HS  ++H D+KP+N+L++ +    ++D GLA A  +P   YT  +
Sbjct: 104 YLYQLLQGIAYC---HSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEV 160

Query: 371 ISYVLGTMAYIAPE-YFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
           +     T+ Y APE      + S   DI+S G +   +V   P F
Sbjct: 161 V-----TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLF 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 61.8 bits (150), Expect = 1e-10
 Identities = 77/284 (27%), Positives = 113/284 (39%), Gaps = 51/284 (17%)

Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ-IRSEIIT 258
           +G G  G VY A    S    IAIK++    P             RDS+  Q +  EI  
Sbjct: 16  LGKGTYGIVYAAR-DLSTQVRIAIKEI----PE------------RDSRYVQPLHEEIAL 58

Query: 259 ASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV 318
            S ++HRNI+  L          +  E +  GSL  +L     G  + +  +       +
Sbjct: 59  HSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRS-KWGPLKDNEQTIIFYTKQI 117

Query: 319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC-ISDLG----LAMAIPDGYTRVLISY 373
             GL+YLH      I+H DIK  NVL+N       ISD G    LA   P          
Sbjct: 118 LEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP------CTET 168

Query: 374 VLGTMAYIAPEYFQQPE--LSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPE-WLR 430
             GT+ Y+APE   +         DI+S G  ++ +  G P F+      E+  P+  + 
Sbjct: 169 FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFI------ELGEPQAAMF 222

Query: 431 KVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERP 474
           KV   K     I P +P +   +    +L+    C   DP++R 
Sbjct: 223 KVGMFK-----IHPEIPESLSAEAKNFILR----CFEPDPDKRA 257

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 62.0 bits (151), Expect = 1e-10
 Identities = 63/231 (27%), Positives = 102/231 (44%), Gaps = 46/231 (19%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
            + +G G  G+V KAE  G +       +    A     +++++D+  +D  L  + SE+
Sbjct: 17  GKPLGEGAFGQVVKAEAVGLDNP----NETSTVA----VKMLKDDATEKD--LSDLVSEM 66

Query: 257 ITASQI-RHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRR--------ELD 307
                I +H+NI+ LL    +     +V E+  +G+L+D L    R RR        +  
Sbjct: 67  EMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFL----RARRPPGEYASPDDP 122

Query: 308 WPSRHRI--------ALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA 359
            P    +        A  VA G+E+L    S   IH D+  RNVL+ +D    I+D GLA
Sbjct: 123 RPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLVTEDHVMKIADFGLA 179

Query: 360 MAIPDGYTRVLISYVLGT------MAYIAPEYFQQPELSEKCDIFSFGMLL 404
             I        I Y   T      + ++APE       + + D++SFG+LL
Sbjct: 180 RDIHH------IDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLL 224

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 61.7 bits (150), Expect = 1e-10
 Identities = 53/218 (24%), Positives = 83/218 (38%), Gaps = 37/218 (16%)

Query: 195 ASLEKI---GSGGCGEVYKA--ELPGSNGKM-IAIKKVIVYAPISAAELIEEDSKLRDSK 248
             LEKI   GSG  G VYK      G   K+ +AIK                   LR+  
Sbjct: 7   TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKV------------------LREET 48

Query: 249 LRQIRSEI-----ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGR 303
             +   EI     + AS + H +++ LL   +      L+ + M  G L   LD V   +
Sbjct: 49  SPKANKEILDEAYVMAS-VDHPHVVRLLGICLSSQ-VQLITQLMPLGCL---LDYVRNHK 103

Query: 304 RELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
             +         + +A G+ YL       ++H D+  RNVL+       I+D GLA  + 
Sbjct: 104 DNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160

Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFG 401
                         + ++A E       + K D++S+G
Sbjct: 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYG 198

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 75/288 (26%), Positives = 125/288 (43%), Gaps = 46/288 (15%)

Query: 199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT 258
           K+G G  GEV+     G+    I   K +    +     ++E   ++             
Sbjct: 13  KLGQGCFGEVWMGTWNGTTKVAI---KTLKPGTMMPEAFLQEAQIMK------------- 56

Query: 259 ASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV 318
             ++RH  ++PL A +V  +   +V EFM  GSL D L +     + L  P    +A  +
Sbjct: 57  --KLRHDKLVPLYA-VVSEEPIYIVTEFMGKGSLLDFLKEGDG--KYLKLPQLVDMAAQI 111

Query: 319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG-YT-RVLISYVLG 376
           A G+ Y+      + IH D++  N+L+ D++   I+D GLA  I D  YT R    +   
Sbjct: 112 ADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKF--- 165

Query: 377 TMAYIAPEYFQQPELSEKCDIFSFGMLLISLV-RGVPSFVFHQNGEEICSPEWLRKVMNS 435
            + + APE       + K D++SFG+LL  LV +G   +    N          R+V+  
Sbjct: 166 PIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN----------REVLEQ 215

Query: 436 KNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRL 483
                    R+P      + LH  ++  +C   DP+ERP  +Y++  L
Sbjct: 216 VERGY----RMPCPQGCPESLH--ELMKLCWKKDPDERPTFEYIQSFL 257

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 62/233 (26%), Positives = 103/233 (44%), Gaps = 30/233 (12%)

Query: 191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
           E  F+ L +IG G  G VY A    ++ +++AIKK            +    K  + K +
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNS-EVVAIKK------------MSYSGKQSNEKWQ 60

Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPS 310
            I  E+    ++RH N +      +R     LV E+   GS  D+L+   +  +E++  +
Sbjct: 61  DIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAA 119

Query: 311 RHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVL 370
              +  G   GL YLH   S ++IH D+K  N+LL++     + D G A  +      V 
Sbjct: 120 ---VTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV- 172

Query: 371 ISYVLGTMAYIAPEY---FQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNG 420
                GT  ++APE      + +   K D++S G+  I L    P  +F+ N 
Sbjct: 173 -----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP-LFNMNA 219

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 63/233 (27%), Positives = 104/233 (44%), Gaps = 30/233 (12%)

Query: 191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
           E+ F  L +IG G  G VY A    +N +++A+KK            +    K  + K +
Sbjct: 20  EEIFVGLHEIGHGSFGAVYFATNSHTN-EVVAVKK------------MSYSGKQTNEKWQ 66

Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPS 310
            I  E+    Q++H N +      ++     LV E+   GS  D+L+   +  +E++  +
Sbjct: 67  DIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAA 125

Query: 311 RHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVL 370
              I  G   GL YLH   S ++IH DIK  N+LL +  +  ++D G A       + V 
Sbjct: 126 ---ITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV- 178

Query: 371 ISYVLGTMAYIAPEY---FQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNG 420
                GT  ++APE      + +   K D++S G+  I L    P  +F+ N 
Sbjct: 179 -----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP-LFNMNA 225

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 68/234 (29%), Positives = 107/234 (45%), Gaps = 32/234 (13%)

Query: 191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
           E  F  L +IG G  G VY A    +N +++AIKK            +    K  + K +
Sbjct: 24  EKLFTDLREIGHGSFGAVYFARDVRTN-EVVAIKK------------MSYSGKQSNEKWQ 70

Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPS 310
            I  E+    +I+H N +      +R     LV E+   GS  D+L+   +  +E++  +
Sbjct: 71  DIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAA 129

Query: 311 RHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA-MAIPDGYTRV 369
              I  G   GL YLH   S ++IH DIK  N+LL +  +  ++D G A +A P      
Sbjct: 130 ---ITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPAN---- 179

Query: 370 LISYVLGTMAYIAPEY---FQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNG 420
             S+V GT  ++APE      + +   K D++S G+  I L    P  +F+ N 
Sbjct: 180 --SFV-GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP-LFNMNA 229

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 60.9 bits (148), Expect = 2e-10
 Identities = 63/223 (28%), Positives = 92/223 (41%), Gaps = 27/223 (12%)

Query: 192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ 251
           D    L  +G G  GEVY+    G +G  + ++  +   P S +E  E D          
Sbjct: 6   DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESD---------- 55

Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
              E +  S+  H+NI+ L+          ++ E M  G L+  L +    R   + PS 
Sbjct: 56  FLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRE---NRPRPERPSS 112

Query: 312 HR------IALGVASGLEYLHMYHSASIIHGDIKPRNVLLND---DMEACISDLGLAMAI 362
                    A  VA G +YL   H    IH DI  RN LL        A I+D G+A  I
Sbjct: 113 LTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDI 169

Query: 363 -PDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
               Y R     +L  + ++ PE F     + K D++SFG+LL
Sbjct: 170 YRASYYRKGGRAML-PIKWMPPEAFLDGIFTSKTDVWSFGVLL 211

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 61.2 bits (149), Expect = 3e-10
 Identities = 67/227 (29%), Positives = 100/227 (44%), Gaps = 37/227 (16%)

Query: 196 SLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSE 255
           +L  +GSG  G+V  A    +  K +AIKK  +  P  +A      +K      R  R E
Sbjct: 19  NLSPVGSGAYGQVCSAFDTKTGRK-VAIKK--LSRPFQSA----IHAK------RTYR-E 64

Query: 256 IITASQIRHRNILPLLAHMVRPDCHL-------LVYEFMKNGSLQDILDDVSRGRRELDW 308
           +     + H N++ LL  +  P   L       LV   M    L +I+    + ++  D 
Sbjct: 65  LRLLKHMDHENVIGLL-DVFTPASSLEDFQDVYLVTHLM-GADLNNIV----KCQKLSDD 118

Query: 309 PSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTR 368
             +  +   +  GL+Y+   HSA IIH D+KP N+ +N+D E  I D GLA    D  T 
Sbjct: 119 HIQF-LVYQILRGLKYI---HSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMT- 173

Query: 369 VLISYVLGTMAYIAPE-YFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
               YV  T  Y APE        ++  DI+S G ++  L+ G   F
Sbjct: 174 ---GYV-ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLF 216

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 60.4 bits (146), Expect = 3e-10
 Identities = 65/234 (27%), Positives = 102/234 (43%), Gaps = 41/234 (17%)

Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           +  ++++GSG  G+VYKA      G++ A+K +I   P     LI++             
Sbjct: 11  YELIQRVGSGTYGDVYKAR-NLHTGELAAVK-IIKLEPGDDFSLIQQ------------- 55

Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
            EI    + +H NI+      +  +   +  E+   GSLQDI   V+    EL      R
Sbjct: 56  -EIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYH-VTGPLSELQIAYVCR 113

Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISY 373
             L    GL YLH   S   +H DIK  N+LL D+ +  ++D G+A  I         + 
Sbjct: 114 ETL---QGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKI--------TAT 159

Query: 374 VLGTMAYIAPEYFQQPELS--EK-------CDIFSFGMLLISLVR-GVPSFVFH 417
           +    ++I   Y+  PE++  EK       CDI++ G+  I L     P F  H
Sbjct: 160 IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLH 213

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 60.8 bits (147), Expect = 3e-10
 Identities = 63/232 (27%), Positives = 103/232 (44%), Gaps = 33/232 (14%)

Query: 192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ 251
           D +  +E IG G  G+VYK     +N K  ++  V +  PIS  +              +
Sbjct: 22  DTWEIIETIGKGTYGKVYKV----TNKKDGSLAAVKILDPISDVD-------------EE 64

Query: 252 IRSEI-ITASQIRHRNILPLLAHMVRPDCHL-----LVYEFMKNGSLQDILDDVSRGRRE 305
           I +E  I  S   H N++       + D  +     LV E    GS+ +++  +    + 
Sbjct: 65  IEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQR 124

Query: 306 LDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG 365
           LD      I  G   GL++LH   +  IIH D+K  N+LL  +    + D G++  +   
Sbjct: 125 LDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS- 180

Query: 366 YTRVLISYVLGTMAYIAPEYF---QQPELS--EKCDIFSFGMLLISLVRGVP 412
            TR+  +  +GT  ++APE     QQ + S   +CD++S G+  I L  G P
Sbjct: 181 -TRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDP 231

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 60.1 bits (146), Expect = 4e-10
 Identities = 75/309 (24%), Positives = 121/309 (39%), Gaps = 80/309 (25%)

Query: 192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ 251
           D    +E++G G  G V K     + G ++A+K+                          
Sbjct: 1   DDLEVIEELGRGAYGVVDKMRHVPT-GTIMAVKR-------------------------- 33

Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHLLVY---------------EFMKNGSLQDIL 296
           IR+ + +  Q   R ++ L   M   DC   V                E M   SL    
Sbjct: 34  IRATVNSQEQ--KRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMDT-SLDKFY 90

Query: 297 DDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDL 356
             V      +      +IA+ +   LEYLH     S+IH D+KP NVL+N + +  + D 
Sbjct: 91  KKVYDKGLTIPEDILGKIAVSIVKALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDF 148

Query: 357 GLAMAIPDGYTRVLISYVLGTM-----AYIAPEYFQQPELSE-----KCDIFSFGMLLIS 406
           G++     GY   L+  V  T+      Y+APE    PEL++     K D++S G+ +I 
Sbjct: 149 GIS-----GY---LVDSVAKTIDAGCKPYMAPERI-NPELNQKGYDVKSDVWSLGITMIE 199

Query: 407 LVRGVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICT 466
           L  G   F +          + L++V+  + PS    P+LP   +  +    +     C 
Sbjct: 200 LATG--RFPYDSWKTPF---QQLKQVV--EEPS----PQLPAEKFSPEFQDFVN---KCL 245

Query: 467 LHDPEERPN 475
             + +ERPN
Sbjct: 246 KKNYKERPN 254

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 59.9 bits (145), Expect = 5e-10
 Identities = 69/294 (23%), Positives = 124/294 (42%), Gaps = 46/294 (15%)

Query: 200 IGSGGCGEVYKA--ELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           +G+G  GE+ +   +LP      +AI  +               +   D + R   +E +
Sbjct: 13  LGTGRFGELCRGCLKLPSKRELPVAIHTL--------------RAGCSDKQRRGFLAEAL 58

Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALG 317
           T  Q  H NI+ L   + R +  ++V E+M NG+L   L    +   +L       +  G
Sbjct: 59  TLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFL---RKHEGQLVAGQLMGMLPG 115

Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLG- 376
           +ASG++YL        +H  +    VL+N D+   IS       + +  +  + + + G 
Sbjct: 116 LASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFR---RLQEDKSEAIYTTMSGK 169

Query: 377 -TMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNS 435
             + + APE  Q    S   D++SFG+++      V S+     GE    P W    M+ 
Sbjct: 170 SPVLWAAPEAIQYHHFSSASDVWSFGIVMWE----VMSY-----GER---PYW---DMSG 214

Query: 436 KNPSRAIDP--RLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL 487
           ++  +A++   RLP       +LH L +   C   +  ERP    +   LS+++
Sbjct: 215 QDVIKAVEDGFRLPAPRNCPNLLHQLMLD--CWQKERGERPRFSQIHSILSKMV 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 60.0 bits (145), Expect = 6e-10
 Identities = 59/232 (25%), Positives = 104/232 (44%), Gaps = 39/232 (16%)

Query: 200 IGSGGCGEVYKA---ELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           +G G  G+V KA    L G  G          Y  + A ++++E++    S+LR + SE 
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAG----------YTTV-AVKMLKENAS--SSELRDLLSEF 54

Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDIL------------DDVSRGRR 304
               Q+ H +++ L     +    LL+ E+ K GSL+  L             D +R   
Sbjct: 55  NLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSS 114

Query: 305 ELDWPSRHRIALG--------VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDL 356
            LD P    + +G        ++ G++YL       ++H D+  RNVL+ +  +  ISD 
Sbjct: 115 YLDNPDERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDF 171

Query: 357 GLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLV 408
           GL+  + +  + V  S     + ++A E       + + D++SFG+LL  +V
Sbjct: 172 GLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 223

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 59.3 bits (143), Expect = 6e-10
 Identities = 55/214 (25%), Positives = 100/214 (46%), Gaps = 28/214 (13%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           ++K+G+G  GEV+      +N   +A+K  +    +S    +EE + ++           
Sbjct: 11  VKKLGAGQFGEVWMGYY--NNSTKVAVK-TLKPGTMSVQAFLEEANLMK----------- 56

Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL 316
                ++H  ++ L A + + +   ++ E+M  GSL D L     G+  L  P     + 
Sbjct: 57  ----TLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSA 110

Query: 317 GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG-YT-RVLISYV 374
            +A G+ Y+      + IH D++  NVL+++ +   I+D GLA  I D  YT R    + 
Sbjct: 111 QIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF- 166

Query: 375 LGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLV 408
              + + APE       + K D++SFG+LL  +V
Sbjct: 167 --PIKWTAPEAINFGSFTIKSDVWSFGILLYEIV 198

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 59.6 bits (144), Expect = 7e-10
 Identities = 57/233 (24%), Positives = 102/233 (43%), Gaps = 35/233 (15%)

Query: 188 LKKEDCFASLEKIGSGGCGEVYKAE---LPGSNGKMIAIKKVIVYAPISAAELIEEDSKL 244
           +K+ D     E +G G  G+V+ AE   L  +  KM+   K +            +D  L
Sbjct: 2   IKRRDIVLKRE-LGEGAFGKVFLAECYNLSPTKDKMLVAVKAL------------KDPTL 48

Query: 245 RDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDIL-------- 296
              K  Q  +E++T   ++H +I+         D  ++V+E+MK+G L   L        
Sbjct: 49  AARKDFQREAELLT--NLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAM 106

Query: 297 ----DDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC 352
                   + + EL       IA  +ASG+ YL   H    +H D+  RN L+  ++   
Sbjct: 107 ILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVK 163

Query: 353 ISDLGLAMAI-PDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
           I D G++  +    Y RV   + +  + ++ PE     + + + D++SFG++L
Sbjct: 164 IGDFGMSRDVYSTDYYRVG-GHTMLPIRWMPPESIMYRKFTTESDVWSFGVIL 215

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 59.6 bits (144), Expect = 7e-10
 Identities = 64/234 (27%), Positives = 104/234 (44%), Gaps = 42/234 (17%)

Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           IG GG GEVY        GKM A+K                   L   +++  + E +  
Sbjct: 2   IGRGGFGEVYGCR-KADTGKMYAMKC------------------LDKKRIKMKQGETLAL 42

Query: 260 SQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWP-SRHRI---- 314
           ++   R +L L++    P    + Y F     L  ILD ++ G  +L +  S+H +    
Sbjct: 43  NE---RIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGG--DLHYHLSQHGVFSEK 97

Query: 315 -----ALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRV 369
                A  +  GLE++H   +  +++ D+KP N+LL++     ISDLGLA      +++ 
Sbjct: 98  EMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLAC----DFSKK 150

Query: 370 LISYVLGTMAYIAPEYFQQ-PELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEE 422
                +GT  Y+APE  Q+        D FS G +L  L+RG   F  H+  ++
Sbjct: 151 KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 204

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 59.8 bits (145), Expect = 7e-10
 Identities = 63/226 (27%), Positives = 101/226 (44%), Gaps = 43/226 (19%)

Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           IG G  G+V  A+   ++GK  A+K            ++++ + L+  + + I +E    
Sbjct: 3   IGKGSFGKVLLAK-HKADGKFYAVK------------VLQKKAILKKKEQKHIMAE---- 45

Query: 260 SQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG------RRELDWP-SRH 312
                RN+L  L ++  P    L Y F     L  +LD V+ G      +RE  +P  R 
Sbjct: 46  -----RNVL--LKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRA 98

Query: 313 RI-ALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGL---AMAIPDGYTR 368
           R  A  +AS L YLH   S +II+ D+KP N+LL+      ++D GL    +        
Sbjct: 99  RFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK---- 151

Query: 369 VLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
              S   GT  Y+APE  ++       D +  G +L  ++ G+P F
Sbjct: 152 -TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 59.2 bits (144), Expect = 8e-10
 Identities = 59/219 (26%), Positives = 93/219 (42%), Gaps = 31/219 (14%)

Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G GG G V   ++   N +  A+K       +    ++E   +        I SE    
Sbjct: 1   LGVGGFGRVELVKVKSKN-RTFALKC------VKKRHIVETGQQ------EHIFSEKEIL 47

Query: 260 SQIRHRNILPLLAHMVRPDCHL-LVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV 318
            +  H  I+ L     +   ++ ++ E+   G L  IL D  RG  + ++ +R  IA  V
Sbjct: 48  EECNHPFIVKLYRTF-KDKKYIYMLMEYCLGGELWTILRD--RGLFD-EYTARFYIA-CV 102

Query: 319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG---YTRVLISYVL 375
               EYLH   +  II+ D+KP N+LL+ +    + D G A  +  G   +T        
Sbjct: 103 VLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC------ 153

Query: 376 GTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
           GT  Y+APE           D +S G+LL  L+ G P F
Sbjct: 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPF 192

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 59.7 bits (144), Expect = 8e-10
 Identities = 63/230 (27%), Positives = 108/230 (46%), Gaps = 33/230 (14%)

Query: 190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKL 249
           K D +  LEK+G G    VYK +    NGK++A+K +          L EE+     +  
Sbjct: 3   KADSYEKLEKLGEGSYATVYKGK-SKVNGKLVALKVI---------RLQEEEG----TPF 48

Query: 250 RQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWP 309
             IR E      ++H NI+ L   +   +   LV+E++    L   +D    G      P
Sbjct: 49  TAIR-EASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLH----P 102

Query: 310 SRHRIAL-GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMA--IPD-G 365
              ++ L  +  GL Y+H  +   I+H D+KP+N+L++D  E  ++D GLA A  +P   
Sbjct: 103 ENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHT 159

Query: 366 YTRVLISYVLGTMAYIAPE-YFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
           Y+  ++     T+ Y  P+      E S   D++  G + + +++GV +F
Sbjct: 160 YSNEVV-----TLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAF 204

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 59.8 bits (145), Expect = 8e-10
 Identities = 63/237 (26%), Positives = 104/237 (43%), Gaps = 28/237 (11%)

Query: 179 LIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELI 238
           +  K D +  K  D F   E +G+G  G V  A+  G+ G+  AIK             +
Sbjct: 6   MFTKPDTSSWKLSD-FEMGETLGTGSFGRVRIAKHKGT-GEYYAIK------------CL 51

Query: 239 EEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDD 298
           ++   L+  +++ +  E     ++ H  I+ ++      +    + EF+  G L   L  
Sbjct: 52  KKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLR- 110

Query: 299 VSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGL 358
              GR   D    +   L +A   EYLH   S  II+ D+KP N+LL++     ++D G 
Sbjct: 111 -KAGRFPNDVAKFYHAELVLA--FEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGF 164

Query: 359 AMAIPDGYTRVLISYVL-GTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
           A  +PD       ++ L GT  Y+APE  Q     +  D ++ G+LL   + G P F
Sbjct: 165 AKKVPDR------TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPF 215

Length = 329

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 59.4 bits (144), Expect = 9e-10
 Identities = 53/232 (22%), Positives = 97/232 (41%), Gaps = 39/232 (16%)

Query: 192 DCFASLEKIGSGGCGEVYKAEL---PGSNGKMIAIKKVIVYA-PISAAELIEEDSKLRDS 247
           D     + +  G  G ++   L        + + +K V  +A  I    L++E   L   
Sbjct: 6   DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYG- 64

Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVR-PDCHLLVYEFMKNGSLQDILDDVSRGRREL 306
                         + H+NILP+L   +   +   ++Y +M  G+L+  L     G    
Sbjct: 65  --------------LSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANN 110

Query: 307 DWPSRHR----IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI 362
                 +    +A+ +A G+ YLH      +IH DI  RN +++++++  I+D  L+  +
Sbjct: 111 PQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDL 167

Query: 363 -PDGYTRVLISYVLGT-----MAYIAPEYFQQPELSEKCDIFSFGMLLISLV 408
            P  Y      + LG      + ++A E     E S   D++SFG+LL  L+
Sbjct: 168 FPMDY------HCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELM 213

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 59.4 bits (144), Expect = 9e-10
 Identities = 66/231 (28%), Positives = 105/231 (45%), Gaps = 36/231 (15%)

Query: 192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ 251
           D +  +EKIG G  G VYKA    +N + IA+KK+          L +ED  +  + +R 
Sbjct: 2   DQYEKVEKIGEGTYGVVYKARDRVTN-ETIALKKI---------RLEQEDEGVPSTAIR- 50

Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
              EI    +++H NI+ L   +       LV+E++ +  L+  +D         D+   
Sbjct: 51  ---EISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYL-DLDLKKHMDSSP------DFAKN 100

Query: 312 HRIA----LGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC-ISDLGLAMA--IPD 364
            R+       +  G+ Y H   S  ++H D+KP+N+L++    A  ++D GLA A  IP 
Sbjct: 101 PRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP- 156

Query: 365 GYTRVLISYVLGTMAYIAPE-YFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
              R     V+ T+ Y APE        S   DI+S G +   +V   P F
Sbjct: 157 --VRTFTHEVV-TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLF 204

Length = 294

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 58.5 bits (141), Expect = 1e-09
 Identities = 57/207 (27%), Positives = 87/207 (42%), Gaps = 21/207 (10%)

Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           E+IG G  GEV+   L   N   +A+K        S  E +  D  L+   L++ R    
Sbjct: 1   ERIGRGNFGEVFSGRLRADN-TPVAVK--------SCRETLPPD--LKAKFLQEAR---- 45

Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALG 317
              Q  H NI+ L+    +     +V E ++ G     L   + G R L      ++   
Sbjct: 46  ILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLR--TEGPR-LKVKELIQMVEN 102

Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGT 377
            A+G+EYL   H    IH D+  RN L+ +     ISD G++    DG            
Sbjct: 103 AAAGMEYLESKHC---IHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIP 159

Query: 378 MAYIAPEYFQQPELSEKCDIFSFGMLL 404
           + + APE       S + D++SFG+LL
Sbjct: 160 VKWTAPEALNYGRYSSESDVWSFGILL 186

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 59.1 bits (143), Expect = 1e-09
 Identities = 61/232 (26%), Positives = 101/232 (43%), Gaps = 48/232 (20%)

Query: 194 FASLEKIGSGGCGEVYKA--ELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ 251
           +  L+ +G G  G V  A  +L G N   +AIKK++   P S   L            ++
Sbjct: 12  YVDLQPVGMGAFGLVCSARDQLTGQN---VAIKKIM--KPFSTPVLA-----------KR 55

Query: 252 IRSEIITASQIRHRNILPLLAHMVRP--DCHLLVYEFMKNGSLQDILDDVSRGRRELDWP 309
              E+     +RH NI+ L    + P  D +  V E +    L  +L       R L+  
Sbjct: 56  TYRELKLLKHLRHENIISLSDIFISPLEDIYF-VTELLGT-DLHRLLTS-----RPLEKQ 108

Query: 310 SRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRV 369
                   +  GL+Y+H   SA ++H D+KP N+L+N++ +  I D GLA        R+
Sbjct: 109 FIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLA--------RI 157

Query: 370 LISYVLGTMAYIAPEYFQQPEL-------SEKCDIFSFGMLLISLVRGVPSF 414
               + G   Y++  Y++ PE+         + DI+S G +   ++ G P F
Sbjct: 158 QDPQMTG---YVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLF 206

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 58.8 bits (142), Expect = 1e-09
 Identities = 69/233 (29%), Positives = 106/233 (45%), Gaps = 48/233 (20%)

Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           IG GG GEVY        GKM A+K +              D K    +++  + E +  
Sbjct: 2   IGRGGFGEVYGCR-KADTGKMYAMKCL--------------DKK----RIKMKQGETLAL 42

Query: 260 SQIRHRNILPLLAHMVRPDCHLLV---YEFMKNGSLQDILDDVSRGRRELDWP-SRHRI- 314
           ++   R +L L++     DC  +V   Y F     L  ILD ++ G  +L +  S+H + 
Sbjct: 43  NE---RIMLSLVS---TGDCPFIVCMSYAFHTPDKLSFILDLMNGG--DLHYHLSQHGVF 94

Query: 315 --------ALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGY 366
                   A  +  GLE  HM H+  +++ D+KP N+LL++     ISDLGLA      +
Sbjct: 95  SEAEMRFYAAEIILGLE--HM-HNRFVVYRDLKPANILLDEHGHVRISDLGLAC----DF 147

Query: 367 TRVLISYVLGTMAYIAPEYFQQ-PELSEKCDIFSFGMLLISLVRGVPSFVFHQ 418
           ++      +GT  Y+APE  Q+        D FS G +L  L+RG   F  H+
Sbjct: 148 SKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 59.2 bits (143), Expect = 1e-09
 Identities = 71/231 (30%), Positives = 105/231 (45%), Gaps = 37/231 (16%)

Query: 192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ 251
           D +  L+++GSG  G V  A L    G  +AIKK+  Y P  + EL    +K    +LR 
Sbjct: 15  DRYRDLKQVGSGAYGTVCSA-LDRRTGAKVAIKKL--YRPFQS-ELF---AKRAYRELRL 67

Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHL-------LVYEFMKNGSLQDILDDVSRGRR 304
           ++        ++H N++ LL  +  PD  L       LV  FM    L  ++        
Sbjct: 68  LK-------HMKHENVIGLL-DVFTPDLSLDRFHDFYLVMPFMGT-DLGKLM-------- 110

Query: 305 ELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPD 364
           + +  S  RI   V   L+ L   H+A IIH D+KP N+ +N+D E  I D GLA     
Sbjct: 111 KHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS 170

Query: 365 GYTRVLISYVLGTMAYIAPEY-FQQPELSEKCDIFSFGMLLISLVRGVPSF 414
             T     YV+ T  Y APE        ++  DI+S G ++  ++ G P F
Sbjct: 171 EMT----GYVV-TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLF 216

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 54/233 (23%), Positives = 103/233 (44%), Gaps = 38/233 (16%)

Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRD-SKLRQI 252
           +  + +IG G  G+V+KA    + G+ +A+K+V V        L    S +R+ + LR +
Sbjct: 3   YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPL----STIREVAVLRHL 58

Query: 253 RS----------EIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG 302
            +          ++ T S+      L L+   V  D    + +  + G   + + D    
Sbjct: 59  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKD---- 114

Query: 303 RRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI 362
                      +   +  GL++L   HS  ++H D+KP+N+L+    +  ++D GLA   
Sbjct: 115 -----------MMFQLLRGLDFL---HSHRVVHRDLKPQNILVTSSGQIKLADFGLARI- 159

Query: 363 PDGYT-RVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
              Y+ ++ ++ V+ T+ Y APE   Q   +   D++S G +   + R  P F
Sbjct: 160 ---YSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF 209

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 58.4 bits (141), Expect = 2e-09
 Identities = 44/138 (31%), Positives = 65/138 (47%), Gaps = 27/138 (19%)

Query: 281 LLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALG--------VASGLEYLHMYHSAS 332
            L+ E++  GSL+D L              +H++ L         +  G+ YLH  H   
Sbjct: 84  QLIMEYVPLGSLRDYL-------------PKHKLNLAQLLLFAQQICEGMAYLHSQH--- 127

Query: 333 IIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG--YTRVLISYVLGTMAYIAPEYFQQPE 390
            IH D+  RNVLL++D    I D GLA A+P+G  Y RV          Y A E  ++ +
Sbjct: 128 YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-AVECLKENK 186

Query: 391 LSEKCDIFSFGMLLISLV 408
            S   D++SFG+ L  L+
Sbjct: 187 FSYASDVWSFGVTLYELL 204

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 59.9 bits (145), Expect = 2e-09
 Identities = 57/235 (24%), Positives = 104/235 (44%), Gaps = 34/235 (14%)

Query: 234 AAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLL-VYEFMKNGSL 292
           A +L+  D+   + +  + R E    +++ H NI+ LL     P   L  V+E++   +L
Sbjct: 7   AIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTL 66

Query: 293 QDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLL---NDDM 349
           +++L   + G   L      R+ L V   L+ L   H+  I+H D+KP+N+++       
Sbjct: 67  REVL--AADG--ALPAGETGRLMLQV---LDALACAHNQGIVHRDLKPQNIMVSQTGVRP 119

Query: 350 EACISDLGLAMAIP-----DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
            A + D G+   +P     D  T    + VLGT  Y APE  +   ++   D++++G++ 
Sbjct: 120 HAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIF 179

Query: 405 ISLVRG--------VPSFVFHQNG-EEICSPEW---------LRKVMNSKNPSRA 441
           +  + G        V   ++ Q    ++  P W         LRK +N     RA
Sbjct: 180 LECLTGQRVVQGASVAEILYQQLSPVDVSLPPWIAGHPLGQVLRKALNKDPRQRA 234

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 72/285 (25%), Positives = 119/285 (41%), Gaps = 46/285 (16%)

Query: 199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT 258
           K+G G  GEV+     G+    I   K    +P +  +  +   KLR  KL Q+ +    
Sbjct: 13  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA---- 68

Query: 259 ASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV 318
                          +V  +   +V E+M  GSL D L       + L  P    +A  +
Sbjct: 69  ---------------VVSEEPIYIVTEYMSKGSLLDFLK--GEMGKYLRLPQLVDMAAQI 111

Query: 319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG-YT-RVLISYVLG 376
           ASG+ Y+      + +H D++  N+L+ +++   ++D GLA  I D  YT R    +   
Sbjct: 112 ASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--- 165

Query: 377 TMAYIAPEYFQQPELSEKCDIFSFGMLLISL-VRGVPSFVFHQNGEEICSPEWLRKVMNS 435
            + + APE       + K D++SFG+LL  L  +G   +    N          R+V++ 
Sbjct: 166 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----------REVLDQ 215

Query: 436 KNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVR 480
                    R+P      + LH L     C   +PEERP  +Y++
Sbjct: 216 VERGY----RMPCPPECPESLHDLMCQ--CWRKEPEERPTFEYLQ 254

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 57.7 bits (139), Expect = 2e-09
 Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 25/208 (12%)

Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           E +G G  GEV+K  L   +   +A+K        +  E + ++ K++        SE  
Sbjct: 1   ELLGKGNFGEVFKGTL--KDKTPVAVK--------TCKEDLPQELKIK------FLSEAR 44

Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALG 317
              Q  H NI+ L+    +     +V E +  G   D L  + + + EL      + AL 
Sbjct: 45  ILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG---DFLSFLRKKKDELKTKQLVKFALD 101

Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG-YTRVLISYVLG 376
            A+G+ YL    S + IH D+  RN L+ ++    ISD G++    DG Y+   +  +  
Sbjct: 102 AAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI-- 156

Query: 377 TMAYIAPEYFQQPELSEKCDIFSFGMLL 404
            + + APE       S + D++S+G+LL
Sbjct: 157 PIKWTAPEALNYGRYSSESDVWSYGILL 184

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 63/235 (26%), Positives = 106/235 (45%), Gaps = 40/235 (17%)

Query: 188 LKKEDCFASLEKIGSGGCGEVYKAE----LPGSNGKMIAIKKVIVYAPISAAELIEEDSK 243
           +K+ D     E +G G  G+V+ AE    LP  +  ++A+K     A   A+E   +D  
Sbjct: 2   IKRRDIVLKWE-LGEGAFGKVFLAECHNLLPEQDKMLVAVK-----ALKEASESARQDF- 54

Query: 244 LRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDIL------- 296
                  Q  +E++T  Q  H++I+            L+V+E+M++G L   L       
Sbjct: 55  -------QREAELLTVLQ--HQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDA 105

Query: 297 ------DDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME 350
                 +DV+ G  +L       IA  +ASG+ YL   H    +H D+  RN L+   + 
Sbjct: 106 KILAGGEDVAPG--QLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLV 160

Query: 351 ACISDLGLAMAI-PDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
             I D G++  I    Y RV    +L  + ++ PE     + + + DI+SFG++L
Sbjct: 161 VKIGDFGMSRDIYSTDYYRVGGRTML-PIRWMPPESILYRKFTTESDIWSFGVVL 214

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 58.0 bits (140), Expect = 2e-09
 Identities = 55/220 (25%), Positives = 96/220 (43%), Gaps = 24/220 (10%)

Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           E +G G  G VY      + G++IA+K+V         EL   +    + +  +++ E+ 
Sbjct: 6   EVLGKGAYGTVYCGLT--NQGQLIAVKQV---------ELDTSNVLAAEKEYEKLQEEVD 54

Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVY-EFMKNGSLQDILDDVSRGRRELDWPSRHRIAL 316
               ++H NI+  L   +  D  + ++ EF+  GS+  IL+        L  P   +   
Sbjct: 55  LLKSLKHVNIVQYLGTCLD-DNTISIFMEFVPGGSISSILNRFG----PLPEPVFCKYTK 109

Query: 317 GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLG----LAMAIPDGYTRVLIS 372
            +  G+ YLH   +  ++H DIK  NV+L  +    + D G    LA     G    ++ 
Sbjct: 110 QILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLK 166

Query: 373 YVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVP 412
            + GT  ++APE   +     K DI+S G  +  +  G P
Sbjct: 167 SMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKP 206

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 57.9 bits (140), Expect = 3e-09
 Identities = 64/245 (26%), Positives = 109/245 (44%), Gaps = 39/245 (15%)

Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI-IT 258
           +G G  G+V  AEL G++ ++ AIK            ++++D  L+D  +    +E  I 
Sbjct: 3   LGKGSFGKVMLAELKGTD-EVYAIK------------VLKKDVILQDDDVDCTMTEKRIL 49

Query: 259 ASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV 318
           A   +H  +  L       D    V E++  G   D++  + R R+  D P     A  V
Sbjct: 50  ALAAKHPFLTALHCCFQTKDRLFFVMEYVNGG---DLMFQIQRSRK-FDEPRSRFYAAEV 105

Query: 319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAM-AIPDGYTRVLISYVLGT 377
              L +LH +    +I+ D+K  N+LL+ +    ++D G+    I +G   V  +   GT
Sbjct: 106 TLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG---VTTTTFCGT 159

Query: 378 MAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF-----------VFHQNGEEICSP 426
             YIAPE  Q+ E     D ++ G+L+  ++ G P F           + H   +++  P
Sbjct: 160 PDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILH---DDVLYP 216

Query: 427 EWLRK 431
            WL K
Sbjct: 217 VWLSK 221

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 57.9 bits (140), Expect = 3e-09
 Identities = 71/249 (28%), Positives = 109/249 (43%), Gaps = 47/249 (18%)

Query: 200 IGSGGCGEVYKAELPGSNG--KMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           +G G  G+V  AEL G+N    + A+KK +V        L ++D    +  + + R  + 
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDVV--------LEDDDV---ECTMVE-RRVLA 50

Query: 258 TASQIRHRNILPLLAHM---VRPDCHLL-VYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
            A +       P L H+    +   HL  V E++  G L   +     GR +    +R R
Sbjct: 51  LAWE------HPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSS--GRFDE---ARAR 99

Query: 314 I-ALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLIS 372
             A  +  GL++LH      II+ D+K  NVLL+ D    I+D G  M   +       S
Sbjct: 100 FYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFG--MCKENMNGEGKAS 154

Query: 373 YVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEE-----ICS-- 425
              GT  YIAPE  +  + +E  D +SFG+LL  ++ G     FH   E+     I +  
Sbjct: 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSP--FHGEDEDELFDSILNDR 212

Query: 426 ---PEWLRK 431
              P W+ K
Sbjct: 213 PHFPRWISK 221

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 57.9 bits (140), Expect = 3e-09
 Identities = 64/230 (27%), Positives = 101/230 (43%), Gaps = 42/230 (18%)

Query: 197 LEKIGSGGCGEVYKAE-LPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSE 255
           L+ +G GG G+V++   + G++   I   KV+  A I                   +R++
Sbjct: 1   LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATI-------------------VRNQ 41

Query: 256 IITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGR------RE---- 305
             TA     RNIL  + H    D   L+Y F   G L  IL+ +S G       RE    
Sbjct: 42  KDTAHTKAERNILEAVKHPFIVD---LIYAFQTGGKLYLILEYLSGGELFMHLEREGIFM 98

Query: 306 LDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAM-AIPD 364
            D    +   + +A  LE+LH      II+ D+KP N+LL+      ++D GL   +I +
Sbjct: 99  EDTACFYLSEISLA--LEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE 153

Query: 365 GYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
           G    +     GT+ Y+APE   +    +  D +S G L+  ++ G P F
Sbjct: 154 G---TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPF 200

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 57.6 bits (139), Expect = 3e-09
 Identities = 54/217 (24%), Positives = 96/217 (44%), Gaps = 41/217 (18%)

Query: 200 IGSGGCGEVY--KAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           IG+G  GEV   + +LPG     +AIK +                   + + R   SE  
Sbjct: 12  IGAGEFGEVCSGRLKLPGKREIPVAIKTLKA--------------GYTEKQRRDFLSEAS 57

Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL- 316
              Q  H NI+ L   + +    ++V E+M+NGSL   L      + +  +     + + 
Sbjct: 58  IMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLR-----KHDGQFTVIQLVGML 112

Query: 317 -GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPD----GYT---- 367
            G+ASG++YL        +H D+  RN+L+N ++   +SD GL+  + D     YT    
Sbjct: 113 RGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 169

Query: 368 RVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
           ++ I +        APE     + +   D++S+G+++
Sbjct: 170 KIPIRWT-------APEAIAYRKFTSASDVWSYGIVM 199

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 58.1 bits (140), Expect = 3e-09
 Identities = 54/200 (27%), Positives = 92/200 (46%), Gaps = 29/200 (14%)

Query: 234 AAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQ 293
           A +++++ + L+  + + I SE         RN+L  L ++  P    L + F     L 
Sbjct: 24  AVKVLQKKAILKKKEEKHIMSE---------RNVL--LKNVKHPFLVGLHFSFQTADKLY 72

Query: 294 DILDDVSRG------RRELDW--PSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLL 345
            +LD ++ G      +RE  +  P     A  +AS L YLH   S +I++ D+KP N+LL
Sbjct: 73  FVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILL 129

Query: 346 NDDMEACISDLGLAMA--IPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGML 403
           +      ++D GL       +G T    S   GT  Y+APE   +       D +  G +
Sbjct: 130 DSQGHIVLTDFGLCKENIEHNGTT----STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAV 185

Query: 404 LISLVRGVPSFVFHQNGEEI 423
           L  ++ G+P F + +N  E+
Sbjct: 186 LYEMLYGLPPF-YSRNTAEM 204

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 58.0 bits (140), Expect = 4e-09
 Identities = 61/280 (21%), Positives = 107/280 (38%), Gaps = 51/280 (18%)

Query: 207 EVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIR--- 263
            V K   PGS G++    K     P     ++         K+ Q  + +I A  ++   
Sbjct: 69  TVIKTLTPGSEGRVFVATK-----PGQPDPVV--------LKIGQKGTTLIEAMLLQNVN 115

Query: 264 HRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLE 323
           H +++ +   +V      +V     +    D+   +++  R L       I   +  GL 
Sbjct: 116 HPSVIRMKDTLVSGAITCMVLPHYSS----DLYTYLTKRSRPLPIDQALIIEKQILEGLR 171

Query: 324 YLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA---MAIPDGYTRVLISYVLGTMAY 380
           YLH   +  IIH D+K  N+ +ND  + CI DLG A   +  P          + GT+  
Sbjct: 172 YLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG------LAGTVET 222

Query: 381 IAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSKNPSR 440
            APE   + + + K DI+S G++L  ++   PS +F                     PS 
Sbjct: 223 NAPEVLARDKYNSKADIWSAGIVLFEML-AYPSTIFED------------------PPST 263

Query: 441 AIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVR 480
             +     + +  K++  LK+       DP  R    ++ 
Sbjct: 264 PEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIE 303

Length = 357

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 57.2 bits (139), Expect = 4e-09
 Identities = 62/229 (27%), Positives = 96/229 (41%), Gaps = 33/229 (14%)

Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ-- 251
           F  ++ +G+G  G V        +GK  A+K       +S A+++         KL+Q  
Sbjct: 3   FEFIKTLGTGSFGRVMLVRH-KGSGKYYALKI------LSKAKIV---------KLKQVE 46

Query: 252 -IRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPS 310
            + +E      IRH  ++ L           LV E++  G L   L     GR      +
Sbjct: 47  HVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLR--KSGRFPEPV-A 103

Query: 311 RHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG-YTRV 369
           R   A  V   LEYLH   S  I++ D+KP N+LL+ D    I+D G A  +    YT  
Sbjct: 104 RFYAA-QVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYT-- 157

Query: 370 LISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ 418
               + GT  Y+APE        +  D ++ G+L+  ++ G P F    
Sbjct: 158 ----LCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN 202

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 56.8 bits (137), Expect = 4e-09
 Identities = 74/290 (25%), Positives = 126/290 (43%), Gaps = 46/290 (15%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           ++K+G+G  GEV+      +    +AIK  +    +S    + E + ++           
Sbjct: 11  VKKLGAGQFGEVWMGYY--NGHTKVAIKS-LKQGSMSPEAFLAEANLMK----------- 56

Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL 316
               Q++H  ++ L A +V  +   ++ E+M+NGSL D L     G + L       +A 
Sbjct: 57  ----QLQHPRLVRLYA-VVTQEPIYIITEYMENGSLVDFLK-TPEGIK-LTINKLIDMAA 109

Query: 317 GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG-YT-RVLISYV 374
            +A G+ ++   +    IH D++  N+L+++ +   I+D GLA  I D  YT R    + 
Sbjct: 110 QIAEGMAFIERKNY---IHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKF- 165

Query: 375 LGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSPEWLRKVM 433
              + + APE       + K D++SFG+LL  +V  G   +    N E I + E   ++ 
Sbjct: 166 --PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMP 223

Query: 434 NSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRL 483
              N         P   YE   L        C    PEERP  +Y+R  L
Sbjct: 224 RPDN--------CPEELYELMRL--------CWKEKPEERPTFEYLRSVL 257

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 57.4 bits (139), Expect = 5e-09
 Identities = 48/163 (29%), Positives = 74/163 (45%), Gaps = 21/163 (12%)

Query: 255 EIITASQIRHRNILPLLAHMVRPDCHL-------LVYEFMKNGSLQDILDDVSRGRRELD 307
           E++    + H+NI+ LL ++  P   L       LV E M     Q I       + +LD
Sbjct: 65  ELVLMKLVNHKNIIGLL-NVFTPQKSLEEFQDVYLVMELMDANLCQVI-------QMDLD 116

Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
                 +   +  G+++LH   SA IIH D+KP N+++  D    I D GLA      + 
Sbjct: 117 HERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 173

Query: 368 RVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRG 410
             +  YV+ T  Y APE        E  DI+S G ++  ++RG
Sbjct: 174 --MTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 213

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 57.3 bits (139), Expect = 5e-09
 Identities = 46/177 (25%), Positives = 76/177 (42%), Gaps = 30/177 (16%)

Query: 194 FASLEKIGSGGCGEVYKAE-LPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ- 251
           +     IG G  G VYKA+   G +GK  AIKK              +  K + + + Q 
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKF-------------KGDKEQYTGISQS 48

Query: 252 -IRSEIITASQIRHRNILPL----LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRREL 306
             R EI    +++H N++ L    L H  +     L++++ ++   Q I       R  +
Sbjct: 49  ACR-EIALLRELKHENVVSLVEVFLEHADK--SVYLLFDYAEHDLWQIIKFHRQAKRVSI 105

Query: 307 DWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC----ISDLGLA 359
                  +   + +G+ YLH   S  ++H D+KP N+L+  +        I DLGLA
Sbjct: 106 PPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 57.1 bits (138), Expect = 5e-09
 Identities = 70/292 (23%), Positives = 116/292 (39%), Gaps = 43/292 (14%)

Query: 197 LEKIGSGGCGEVYKAE---LPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           ++++G G  G V       L  + G+++A+KK            ++  +      LR   
Sbjct: 9   IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKK------------LQHSTA---EHLRDFE 53

Query: 254 SEIITASQIRHRNILP---LLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPS 310
            EI     ++H NI+    +     R +  L V E++  GSL+D L    + R  LD   
Sbjct: 54  REIEILKSLQHDNIVKYKGVCYSAGRRNLRL-VMEYLPYGSLRDYL---QKHRERLDHRK 109

Query: 311 RHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP-DGYTRV 369
               A  +  G+EYL    S   +H D+  RN+L+  +    I D GL   +P D     
Sbjct: 110 LLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYK 166

Query: 370 LISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLV------RGVPSFVFHQNGEEI 423
           +       + + APE   + + S   D++SFG++L  L          P+      G + 
Sbjct: 167 VREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDK 226

Query: 424 CSPEWLRKVMNS-KNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERP 474
                +  ++   KN  R   P  PG   E     +  I   C  +DP +RP
Sbjct: 227 QGQMIVYHLIELLKNNGRL--PAPPGCPAE-----IYAIMKECWNNDPSQRP 271

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 58.2 bits (140), Expect = 5e-09
 Identities = 44/167 (26%), Positives = 71/167 (42%), Gaps = 22/167 (13%)

Query: 251 QIRSEIITASQIRHRNIL--------PLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG 302
           Q+ +EI+   ++ H NIL            +M+       +Y FM + +           
Sbjct: 209 QLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFD-------WK 261

Query: 303 RRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI 362
            R L   +R  I   +   +EY+H      +IH DIK  N+ LN D +  + D G AM  
Sbjct: 262 DRPLLKQTR-AIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPF 317

Query: 363 PDGYTRVLISY-VLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLV 408
                R    Y  +GT+A  +PE        E  DI+S G++L+ ++
Sbjct: 318 EK--EREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDML 362

Length = 501

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 57.3 bits (138), Expect = 5e-09
 Identities = 62/225 (27%), Positives = 96/225 (42%), Gaps = 41/225 (18%)

Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           IG G  G+V  A+   S+G   A+K            ++++ + L+  +   I +E    
Sbjct: 3   IGKGSFGKVLLAKRK-SDGSFYAVK------------VLQKKTILKKKEQNHIMAE---- 45

Query: 260 SQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGR--------RELDWPSR 311
                RN+L  L ++  P    L Y F     L  +LD V+ G         R    P  
Sbjct: 46  -----RNVL--LKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRA 98

Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAM--AIPDGYTRV 369
              A  VAS + YLH   S +II+ D+KP N+LL+      ++D GL      P+  T  
Sbjct: 99  RFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT-- 153

Query: 370 LISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
             S   GT  Y+APE  ++       D +  G +L  ++ G+P F
Sbjct: 154 --STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 57.3 bits (138), Expect = 6e-09
 Identities = 68/229 (29%), Positives = 104/229 (45%), Gaps = 35/229 (15%)

Query: 200 IGSGGCGEVYKAELPGSNG--KMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           +G G  G+V  AEL G      + A+KK +V        LI++D    +  + + R   +
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVV--------LIDDDV---ECTMVEKRVLAL 51

Query: 258 TASQIRHRNILPLLAHMV---RPDCHLL-VYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
                      P L H+    +   HL  V EF+  G L   + D  +GR +L   + + 
Sbjct: 52  AWEN-------PFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQD--KGRFDLYRATFY- 101

Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISY 373
            A  +  GL++LH   S  II+ D+K  NV+L+ D    I+D G+      G  R   S 
Sbjct: 102 -AAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA--ST 155

Query: 374 VLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEE 422
             GT  YIAPE  Q  + +   D +SFG+LL  ++ G     FH + E+
Sbjct: 156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP--FHGDDED 202

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 57.1 bits (138), Expect = 6e-09
 Identities = 74/274 (27%), Positives = 114/274 (41%), Gaps = 47/274 (17%)

Query: 192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ 251
           D F  + +IG G  G+VYKA      G+++A+KKV          L  E      + +R+
Sbjct: 7   DKFDIIGQIGEGTYGQVYKAR-DKDTGELVALKKV---------RLDNEKEGFPITAIRE 56

Query: 252 IRSEIITASQIRHRNILPL----------LAHMVRPDCHLLVYEFMKN---GSLQDILDD 298
           I+       Q+ HRNI+ L          L          LV+E+M +   G L+  L  
Sbjct: 57  IK----ILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVH 112

Query: 299 VSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGL 358
                      S   I   +   LE L+  H  + +H DIK  N+LLN+  +  ++D GL
Sbjct: 113 F----------SEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGL 162

Query: 359 AMAIPDGYTRVLISYVLGTMAYIAPEYFQQPEL-SEKCDIFSFGMLLISLVRGVPSFVFH 417
           A       +R   + V+ T+ Y  PE     E      D++S G +L  L    P F   
Sbjct: 163 ARLYNSEESRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIF--- 218

Query: 418 QNGEEICSPEWLRKVMNSKNPSRAIDP---RLPG 448
           Q  +E+   E + ++  S  P  A+ P   +LP 
Sbjct: 219 QANQELAQLELISRLCGSPCP--AVWPDVIKLPY 250

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 56.9 bits (137), Expect = 6e-09
 Identities = 64/226 (28%), Positives = 100/226 (44%), Gaps = 43/226 (19%)

Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           IG G  G+V  A+    +GK  A+K            ++++   L   + + I +E    
Sbjct: 3   IGKGSFGKVLLAKRK-LDGKCYAVK------------VLQKKIVLNRKEQKHIMAE---- 45

Query: 260 SQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG------RRELDWPS-RH 312
                RN+L  L ++  P    L Y F     L  +LD V+ G      +RE  +P  R 
Sbjct: 46  -----RNVL--LKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRA 98

Query: 313 RI-ALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGL---AMAIPDGYTR 368
           R  A  +AS L YLH   S +I++ D+KP N+LL+      ++D GL    +A  D  T 
Sbjct: 99  RFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTT 155

Query: 369 VLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
                  GT  Y+APE  ++       D +  G +L  ++ G+P F
Sbjct: 156 -----FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 56.6 bits (136), Expect = 7e-09
 Identities = 62/234 (26%), Positives = 108/234 (46%), Gaps = 41/234 (17%)

Query: 190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVY----APISAAELIEEDSKLR 245
           K + +  L+K+G G    V+K         ++A+K++ +     AP +A   I E S L+
Sbjct: 3   KLETYVKLDKLGEGTYATVFKGR-SKLTENLVALKEIRLEHEEGAPCTA---IREVSLLK 58

Query: 246 DSKLRQIRSEIITASQIRHRNILPL--LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGR 303
           +               ++H NI+ L  + H  R  C  LV+E++ +  L+  LD+     
Sbjct: 59  N---------------LKHANIVTLHDIIHTER--CLTLVFEYLDS-DLKQYLDNCG--- 97

Query: 304 RELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMA-- 361
              +  S H + + +   L  L   H   I+H D+KP+N+L+N+  E  ++D GLA A  
Sbjct: 98  ---NLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKS 154

Query: 362 IPDGYTRVLISYVLGTMAYIAPE-YFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
           +P   T+   + V+ T+ Y  P+      E S   D++  G +L  +  G P F
Sbjct: 155 VP---TKTYSNEVV-TLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMF 204

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 56.7 bits (137), Expect = 7e-09
 Identities = 63/236 (26%), Positives = 108/236 (45%), Gaps = 33/236 (13%)

Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYA----PISAAELIEEDSKLRDSKL 249
           F  LEK+G G    VYK     + G+++A+K++ + A    P +A               
Sbjct: 2   FKQLEKLGEGTYATVYKG-RNRTTGEIVALKEIHLDAEEGTPSTA--------------- 45

Query: 250 RQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG-RRELDW 308
             IR EI    +++H NI+ L   +   +  +LV+E+M    L+  +D  + G R  LD 
Sbjct: 46  --IR-EISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMD--THGVRGALDP 99

Query: 309 PSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTR 368
            +       +  G+ + H      ++H D+KP+N+L+N   E  ++D GLA A   G   
Sbjct: 100 NTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAF--GIPV 154

Query: 369 VLISYVLGTMAYIAPEYFQQPEL-SEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI 423
              S  + T+ Y AP+        S   DI+S G ++  ++ G P F    N +++
Sbjct: 155 NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQL 210

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 57.0 bits (138), Expect = 8e-09
 Identities = 38/145 (26%), Positives = 57/145 (39%), Gaps = 42/145 (28%)

Query: 329 HSASIIHGDIKPRNVLLNDDMEACISDLGLAM----AIPDGYTRVLISY----------- 373
           H    IH DIKP N+LL+      +SD GL      +    + R+L              
Sbjct: 118 HKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISK 177

Query: 374 ---------------------VLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVP 412
                                 +GT  YIAPE F Q   +++CD +S G+++  ++ G P
Sbjct: 178 PMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237

Query: 413 SFVFHQNGEEICSPEWLRKVMNSKN 437
            F    N +E       RK++N K 
Sbjct: 238 PF-CSDNPQETY-----RKIINWKE 256

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 56.6 bits (136), Expect = 9e-09
 Identities = 62/225 (27%), Positives = 102/225 (45%), Gaps = 38/225 (16%)

Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAA-ELIEEDSKLRDSKLRQIRSEIIT 258
           +G G  G+V  AE        I I K     P++ A +++++D+   D  L  + SE+  
Sbjct: 20  LGEGCFGQVVMAE-------AIGIDKDKPNKPVTVAVKMLKDDAT--DKDLSDLVSEMEM 70

Query: 259 ASQI-RHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRR------------- 304
              I +H+NI+ LL    +     ++ E+   G+L++ L    R RR             
Sbjct: 71  MKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYL----RARRPPGMDYSFDTCKL 126

Query: 305 ---ELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMA 361
              +L +      A  VA G+EYL    S   IH D+  RNVL+ +D    I+D GLA  
Sbjct: 127 PEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLVTEDNVMKIADFGLARD 183

Query: 362 IP--DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
           +   D Y +     +   + ++APE       + + D++SFG+LL
Sbjct: 184 VHNIDYYKKTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLL 226

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 56.6 bits (137), Expect = 9e-09
 Identities = 52/177 (29%), Positives = 85/177 (48%), Gaps = 41/177 (23%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVY-----APISAAELIEEDSKLRDSKLRQ 251
           L K+G G  GEVYKA      G+++A+KK++++      PI+A              LR+
Sbjct: 13  LGKLGEGTFGEVYKAR-QIKTGRVVALKKILMHNEKDGFPITA--------------LRE 57

Query: 252 IRSEIITASQIRHRNILPLLAHMV--RPD-------CHLLVYEFMKNGSLQDILDDVSRG 302
           I+  I+    ++H N++PL+  M   RPD          +V  +M +  L  +L++    
Sbjct: 58  IK--ILKK--LKHPNVVPLI-DMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLEN---P 108

Query: 303 RRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA 359
             +L         L +  G+ YLH  H   I+H DIK  N+L+++     I+D GLA
Sbjct: 109 SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLA 162

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 56.5 bits (136), Expect = 1e-08
 Identities = 61/224 (27%), Positives = 104/224 (46%), Gaps = 36/224 (16%)

Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  G+V +AE  G + K    + V V     A +++++++   D  L  + SE+   
Sbjct: 20  LGEGCFGQVVRAEAYGID-KSRPDQTVTV-----AVKMLKDNAT--DKDLADLISEMELM 71

Query: 260 SQI-RHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILD-----------DVSRGRRE-L 306
             I +H+NI+ LL    +     ++ E+   G+L++ L            D+++   E L
Sbjct: 72  KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131

Query: 307 DWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGY 366
            +      A  VA G+EYL    S   IH D+  RNVL+ +D    I+D GLA  + D  
Sbjct: 132 SFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHD-- 186

Query: 367 TRVLISYVLGT------MAYIAPEYFQQPELSEKCDIFSFGMLL 404
               I Y   T      + ++APE       + + D++SFG+L+
Sbjct: 187 ----IDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILM 226

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 56.0 bits (135), Expect = 1e-08
 Identities = 48/194 (24%), Positives = 85/194 (43%), Gaps = 22/194 (11%)

Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           ++IG+G  G+V  +E+    G    + +V+V    + A   E++  L+     +I     
Sbjct: 1   QEIGNGWFGKVLLSEIYTDTG----VARVVVKELKANASSKEQNEFLQQGDPYRI----- 51

Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALG 317
               ++H NIL  L   V    +LLV+E+ + G L+  L      RR        R+A  
Sbjct: 52  ----LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACE 107

Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGT 377
           +A+G+ ++H ++    +H D+  RN  L  D+   + D G+      G +R    Y+   
Sbjct: 108 IAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGI------GPSRYKEDYIETE 158

Query: 378 MAYIAPEYFQQPEL 391
                P  +  PEL
Sbjct: 159 DDKCVPLRWLAPEL 172

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 56.4 bits (137), Expect = 1e-08
 Identities = 64/239 (26%), Positives = 109/239 (45%), Gaps = 58/239 (24%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEED--SKLRDSKLRQIRS 254
           L+K+G G  G V+KA +     +++A+KK+              D      D++ R  R 
Sbjct: 12  LQKLGKGAYGIVWKA-IDRRTKEVVALKKIF-------------DAFRNATDAQ-RTFR- 55

Query: 255 EIITASQIR-HRNILPLLAHMVRPDCHL---LVYEFM--------KNGSLQDILDDVSRG 302
           EI+   ++  H NI+ LL ++++ +      LV+E+M        +   L+D+       
Sbjct: 56  EIMFLQELGDHPNIVKLL-NVIKAENDKDIYLVFEYMETDLHAVIRANILEDV------- 107

Query: 303 RRELDWPSRHR--IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAM 360
                    H+  I   +   L+Y+H   S ++IH D+KP N+LLN D    ++D GLA 
Sbjct: 108 ---------HKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLAR 155

Query: 361 AIPDGY----TRVLISYVLGTMAYIAPE-YFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
           ++ +        VL  YV  T  Y APE        ++  D++S G +L  ++ G P F
Sbjct: 156 SLSELEENPENPVLTDYV-ATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLF 213

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 56.1 bits (135), Expect = 1e-08
 Identities = 65/245 (26%), Positives = 101/245 (41%), Gaps = 39/245 (15%)

Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  G+V+ AEL G+N +  AIK             +++D  L D  +     E    
Sbjct: 3   LGKGSFGKVFLAELKGTN-QFFAIK------------ALKKDVVLMDDDVECTMVEKRVL 49

Query: 260 SQIRHRNILPLLAHM---VRPDCHLL-VYEFMKNGSLQDILDDVSRGRRELDWPSRHRIA 315
           S        P L H+    +   +L  V E++  G L   +    +     D P     A
Sbjct: 50  SLAWEH---PFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHK----FDLPRATFYA 102

Query: 316 LGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVL 375
             +  GL++LH   S  I++ D+K  N+LL+ D    I+D G+      G  +       
Sbjct: 103 AEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKT--CTFC 157

Query: 376 GTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI---------CSP 426
           GT  YIAPE     + +   D +SFG+LL  ++ G   F    + EE+         C P
Sbjct: 158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPF-HGHDEEELFQSIRMDNPCYP 216

Query: 427 EWLRK 431
            WL +
Sbjct: 217 RWLTR 221

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 56.4 bits (136), Expect = 1e-08
 Identities = 67/257 (26%), Positives = 107/257 (41%), Gaps = 40/257 (15%)

Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  G+V  A L   +G++ A+K            ++++D  L+D  +    +E    
Sbjct: 3   LGKGSFGKVMLARLK-ESGRLYAVK------------VLKKDVILQDDDVECTMTEKRIL 49

Query: 260 SQIRHRNILPLLAHMVR-PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV 318
           S  R+   L  L    + PD    V EF+  G   D++  + + RR  D       A  +
Sbjct: 50  SLARNHPFLTQLYCCFQTPDRLFFVMEFVNGG---DLMFHIQKSRR-FDEARARFYAAEI 105

Query: 319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAM-AIPDGYTRVLISYVLGT 377
            S L +LH      II+ D+K  NVLL+ +    ++D G+    I +G      S   GT
Sbjct: 106 TSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG---KTTSTFCGT 159

Query: 378 MAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGE--------EICSPEWL 429
             YIAPE  Q+       D ++ G+LL  ++ G   F      +        E+  P WL
Sbjct: 160 PDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWL 219

Query: 430 R-------KVMNSKNPS 439
                   K   +KNP+
Sbjct: 220 SQDAVDILKAFMTKNPT 236

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 29/219 (13%)

Query: 199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT 258
           ++G G  G+VYKA+      K            ++AA++IE  S   + +L     EI  
Sbjct: 19  ELGDGAFGKVYKAK-----NKETGA--------LAAAKVIETKS---EEELEDYMVEIEI 62

Query: 259 ASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV 318
            +   H  I+ LL          ++ EF   G++  I+ ++ RG  E       +I +  
Sbjct: 63  LATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTE------PQIQVIC 116

Query: 319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTM 378
              LE L   HS  IIH D+K  NVLL  D +  ++D G++        R      +GT 
Sbjct: 117 RQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRR--DSFIGTP 174

Query: 379 AYIAPEYFQQPELSE-----KCDIFSFGMLLISLVRGVP 412
            ++APE      + +     K DI+S G+ LI + +  P
Sbjct: 175 YWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP 213

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 55.8 bits (135), Expect = 1e-08
 Identities = 45/168 (26%), Positives = 72/168 (42%), Gaps = 24/168 (14%)

Query: 313 RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLIS 372
           ++ + +   L YL   H   +IH D+KP N+LL+      + D G++  + D   +   +
Sbjct: 118 KMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK---T 172

Query: 373 YVLGTMAYIAPEYFQQPELSEKCDI----FSFGMLLISLVRGVPSFVFHQNGEEICSPEW 428
              G  AY+APE    P+ + K DI    +S G+ L+ L  G   F +     E    E 
Sbjct: 173 RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ--FPYKNCKTEF---EV 227

Query: 429 LRKVMNSKNPSRAIDPRLPGN-GYEKKMLHVLKIAYICTLHDPEERPN 475
           L K++    P     P LP N G+       +    +C   D  +RP 
Sbjct: 228 LTKILQE-EP-----PSLPPNEGFSPDFCSFVD---LCLTKDHRKRPK 266

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 55.8 bits (135), Expect = 1e-08
 Identities = 54/220 (24%), Positives = 96/220 (43%), Gaps = 21/220 (9%)

Query: 198 EKIGSGGCGEVYKAE---LPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ-IR 253
           EK+G G  GEV+  E   L   + K  A         + A +++  D+       R+   
Sbjct: 11  EKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA---SDNAREDFL 67

Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDIL-------DDVSRGRREL 306
            E+   S++   NI  LL          ++ E+M+NG L   L         ++   + L
Sbjct: 68  KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL 127

Query: 307 DWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA--MAIPD 364
            + +   +A  +ASG+ YL    S + +H D+  RN L+  +    I+D G++  +   D
Sbjct: 128 SFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSD 184

Query: 365 GYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
            Y RV     L  + ++A E     + + K D+++FG+ L
Sbjct: 185 -YYRVQGRAPL-PIRWMAWESVLLGKFTTKSDVWAFGVTL 222

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 56.3 bits (136), Expect = 1e-08
 Identities = 52/198 (26%), Positives = 80/198 (40%), Gaps = 47/198 (23%)

Query: 321 GLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRV---LISYVLGT 377
           GL+Y+H   SA+++H D+KP N+L+N D E  I D GLA    +        +  YV  T
Sbjct: 117 GLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV-AT 172

Query: 378 MAYIAPEY---FQQPELSEKCDIFSFGMLLISLVRGVPSF-----------VFHQNG--- 420
             Y APE    FQ    ++  D++S G +L  L+   P F           +    G   
Sbjct: 173 RWYRAPEIMLSFQ--SYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPD 230

Query: 421 ----EEICSPEWLRKVMNSKN-PSRAIDPRLPGNGYE-----KKMLH-----------VL 459
                 I SP+    + +  N P +  +   P          +K+L             L
Sbjct: 231 EETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEAL 290

Query: 460 KIAYICTLHDPEERPNSQ 477
           +  Y+   HDP++ P  Q
Sbjct: 291 EHPYLAIWHDPDDEPVCQ 308

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 60/232 (25%), Positives = 108/232 (46%), Gaps = 37/232 (15%)

Query: 190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVY----APISAAELIEEDSKLR 245
           K + +  L+K+G G    VYK     ++  ++A+K++ +     AP +A   I E S L+
Sbjct: 4   KLETYIKLDKLGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTA---IREVSLLK 59

Query: 246 DSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRE 305
           D               ++H NI+ L   +       LV+E++ +  L+  LDD       
Sbjct: 60  D---------------LKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCG----- 98

Query: 306 LDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMA--IP 363
            +  + H + L +   L  L+  H   ++H D+KP+N+L+N+  E  ++D GLA A  IP
Sbjct: 99  -NSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIP 157

Query: 364 DGYTRVLISYVLGTMAYIAPE-YFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
              T+   + V+ T+ Y  P+      + S + D++  G +   +  G P F
Sbjct: 158 ---TKTYSNEVV-TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLF 205

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 55.9 bits (135), Expect = 1e-08
 Identities = 48/184 (26%), Positives = 82/184 (44%), Gaps = 28/184 (15%)

Query: 254 SEIITASQIRH----RNILPLLAH--MVRPDC------HL-LVYEFMKNGSLQDILDDVS 300
            E+I   Q +H    + +L  ++H  ++R          L ++ E++  G L   L    
Sbjct: 37  PEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYL---- 92

Query: 301 RGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAM 360
           R        +    A  +   LEYLH   S  I++ D+KP N+LL+ +    ++D G A 
Sbjct: 93  RNSGRFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAK 149

Query: 361 AIPD-GYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQN 419
            + D  +T      + GT  Y+APE  Q    ++  D ++ G+L+  ++ G P F F  N
Sbjct: 150 KLRDRTWT------LCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPF-FDDN 202

Query: 420 GEEI 423
              I
Sbjct: 203 PFGI 206

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 55.3 bits (133), Expect = 1e-08
 Identities = 58/223 (26%), Positives = 101/223 (45%), Gaps = 38/223 (17%)

Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKV-IVYAPISAAELIEEDSKLRDSKLRQI 252
           +  ++KIG G  G++Y A+   S+ +   IK++ +   P+   E                
Sbjct: 2   YEIIKKIGEGSFGKIYLAK-AKSDSEHCVIKEIDLTKMPVKEKE--------------AS 46

Query: 253 RSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGR-------RE 305
           + E+I  ++++H NI+   A         +V E+   G   D++  ++R R       + 
Sbjct: 47  KKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGG---DLMKRINRQRGVLFSEDQI 103

Query: 306 LDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDD-MEACISDLGLAMAIPD 364
           L W  +  I+LG       L   H   I+H DIK +N+ L+ + M A + D G+A  + D
Sbjct: 104 LSWFVQ--ISLG-------LKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND 154

Query: 365 GYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISL 407
             +  L    +GT  Y++PE  Q    + K DI+S G +L  L
Sbjct: 155 --SMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYEL 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 58/224 (25%), Positives = 105/224 (46%), Gaps = 30/224 (13%)

Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPI-SAAELIEED--SKLRDSKLRQIRS 254
           EK+G G  GEV+  E  G    +          P+  A +++  D     R+  L++I+ 
Sbjct: 11  EKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIK- 69

Query: 255 EIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRREL-------- 306
                S++++ NI+ LL   V  D   ++ E+M+NG L   L      +RE+        
Sbjct: 70  ---IMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLS-----QREIESTFTHAN 121

Query: 307 DWPSRHR-----IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMA 361
           + PS        +A+ +ASG++YL    S + +H D+  RN L+ +     I+D G++  
Sbjct: 122 NIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRN 178

Query: 362 IPDG-YTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
           +  G Y R+    VL  + ++A E     + +   D+++FG+ L
Sbjct: 179 LYSGDYYRIQGRAVL-PIRWMAWESILLGKFTTASDVWAFGVTL 221

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 55.0 bits (133), Expect = 2e-08
 Identities = 57/219 (26%), Positives = 89/219 (40%), Gaps = 43/219 (19%)

Query: 198 EKIGSGGCGEVYKAELPGSNGKMI--AIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSE 255
           +++G G  G V K      +GK +  A+K                   L+   +   + E
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKT------------------LKQEHIAAGKKE 42

Query: 256 II----TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
            +      +Q+ H  I+ L+         +LV E    G L   L    + RRE+     
Sbjct: 43  FLREASVMAQLDHPCIVRLIGVCKGEPL-MLVMELAPLGPLLKYL----KKRREIPVSDL 97

Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLI 371
             +A  VA G+ YL   H    +H D+  RNVLL +  +A ISD G++ A+  G      
Sbjct: 98  KELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD---- 150

Query: 372 SYVLGTMA------YIAPEYFQQPELSEKCDIFSFGMLL 404
            Y   T A      + APE     + S K D++S+G+ L
Sbjct: 151 -YYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTL 188

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 55.6 bits (134), Expect = 2e-08
 Identities = 46/185 (24%), Positives = 76/185 (41%), Gaps = 39/185 (21%)

Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAP--ISAAELIEEDSKLRDSKLRQIRSEII 257
           IG G  G V++A  PG          ++ Y P  + A ++++E++          + E  
Sbjct: 13  IGQGAFGRVFQARAPG----------LLPYEPFTMVAVKMLKEEASADMQA--DFQREAA 60

Query: 258 TASQIRHRNILPLLAHMV--RPDCHLLVYEFMKNGSLQDILDDVS--------------- 300
             ++  H NI+ LL      +P C  L++E+M  G L + L   S               
Sbjct: 61  LMAEFDHPNIVKLLGVCAVGKPMC--LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSAR 118

Query: 301 ---RGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLG 357
                   L    +  IA  VA+G+ YL        +H D+  RN L+ ++M   I+D G
Sbjct: 119 KCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFG 175

Query: 358 LAMAI 362
           L+  I
Sbjct: 176 LSRNI 180

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 54/200 (27%), Positives = 87/200 (43%), Gaps = 58/200 (29%)

Query: 321 GLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAY 380
           GL+Y+H   SA IIH D+KP NV +N+D E  I D GLA    D  T            Y
Sbjct: 130 GLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMT-----------GY 175

Query: 381 IAPEYFQQPEL-------SEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI---------C 424
           +A  +++ PE+       ++  DI+S G ++  L++G   F  +   +++          
Sbjct: 176 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTP 235

Query: 425 SPEWLRKVMNSKNPSRAID--PRLPGNGYE--------------KKML-----------H 457
           SPE L+K+ +S++  + I   P +P    +              +KML            
Sbjct: 236 SPEVLKKI-SSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASE 294

Query: 458 VLKIAYICTLHDPEERPNSQ 477
            L   Y    HDPE+ P ++
Sbjct: 295 ALAHPYFSQYHDPEDEPEAE 314

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 78/324 (24%), Positives = 120/324 (37%), Gaps = 73/324 (22%)

Query: 192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ 251
           D F SL+ IG G  GEV          +++  K       I A +++ +   L   ++  
Sbjct: 1   DDFESLKVIGRGAFGEV----------RLVQKKDT---GHIYAMKILRKADMLEKEQVAH 47

Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
           IR+E     +     ++ +           L+ EF+  G +  +L        + D  S 
Sbjct: 48  IRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLL-------MKKDTLSE 100

Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI--------- 362
                 +A  +  +   H    IH DIKP N+LL+      +SD GL   +         
Sbjct: 101 EATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160

Query: 363 -------PDGYT-----------------RVLISYVLGTMAYIAPEYFQQPELSEKCDIF 398
                  P  ++                 R L    +GT  YIAPE F Q   ++ CD +
Sbjct: 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWW 220

Query: 399 SFGMLLISLVRGVPSFVFHQNGEEICSP---EWLRKVMNSKNPSRAIDPRLPGNGYEKKM 455
           S G+++  ++ G P F         CS    E  RKVMN K  +    P +P +   K +
Sbjct: 221 SLGVIMYEMLIGYPPF---------CSETPQETYRKVMNWKE-TLVFPPEVPISEKAKDL 270

Query: 456 LHVLKIAYICTLHDPEERPNSQYV 479
                I   CT  D E R  S  V
Sbjct: 271 -----ILRFCT--DSENRIGSNGV 287

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 55.5 bits (134), Expect = 2e-08
 Identities = 56/226 (24%), Positives = 100/226 (44%), Gaps = 55/226 (24%)

Query: 181 EKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYA-----PISAA 235
           ++ +  F  +   +  L KIG G  GEV+KA       +++A+KKV++       PI+A 
Sbjct: 1   DQYEFPFCDEVSKYEKLAKIGQGTFGEVFKAR-HKKTKQIVALKKVLMENEKEGFPITA- 58

Query: 236 ELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL---------AHMVRPDCHLLVYEF 286
                        LR+I+  I+    ++H N++ L+          +  +   + LV+EF
Sbjct: 59  -------------LREIK--IL--QLLKHENVVNLIEICRTKATPYNRYKGSFY-LVFEF 100

Query: 287 MKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN 346
            ++    D+   +S    +       ++   + +GL Y+   H   I+H D+K  N+L+ 
Sbjct: 101 CEH----DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYI---HRNKILHRDMKAANILIT 153

Query: 347 DDMEACISDLGLAMAI-------PDGYT-RVLISYVLGTMAYIAPE 384
            D    ++D GLA A        P+ YT RV+      T+ Y  PE
Sbjct: 154 KDGILKLADFGLARAFSLSKNSKPNRYTNRVV------TLWYRPPE 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 55.8 bits (135), Expect = 2e-08
 Identities = 69/285 (24%), Positives = 109/285 (38%), Gaps = 81/285 (28%)

Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           F  ++ IG G  GEV+         +     +V  YA                  ++ +R
Sbjct: 3   FEVIKVIGRGAFGEVWLV-------RDKDTGQV--YA------------------MKVLR 35

Query: 254 -SEIITASQIRH----RNIL-----PLLAHMV---RPDCHL-LVYEFMKNGSLQDILDDV 299
            S++I  +QI H    R+IL     P +  +    + + HL LV E+M  G L ++L   
Sbjct: 36  KSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRK 95

Query: 300 SRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA 359
                E    +R  IA  V +    L   H    IH DIKP N+L++ D    ++D GL 
Sbjct: 96  DVFPEET---ARFYIAELVLA----LDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLC 148

Query: 360 MAIPDG---------------------------YTRVLISYVLGTMAYIAPEYFQQPELS 392
             +                                RV  +  +GT  YIAPE  +     
Sbjct: 149 KKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYG 208

Query: 393 EKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSKN 437
            +CD +S G++L  ++ G P F +    +E        K++N K 
Sbjct: 209 LECDWWSLGVILYEMLYGFPPF-YSDTLQETY-----NKIINWKE 247

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 54.9 bits (132), Expect = 2e-08
 Identities = 57/226 (25%), Positives = 93/226 (41%), Gaps = 36/226 (15%)

Query: 180 IEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIE 239
           I+ +DL FLK+         +G+G  G V   +  G     +AIK +I    +S  E IE
Sbjct: 1   IDPKDLTFLKE---------LGTGQFGVVKYGKWRGQYD--VAIK-MIKEGSMSEDEFIE 48

Query: 240 EDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDV 299
           E                    ++ H  ++ L     +     +V E+M NG L   L+ +
Sbjct: 49  EAK---------------VMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCL---LNYL 90

Query: 300 SRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA 359
               +         +   V  G+ YL    S   IH D+  RN L++D     +SD GL+
Sbjct: 91  REHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLS 147

Query: 360 -MAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
              + D YT  + S     + +  PE     + S K D+++FG+L+
Sbjct: 148 RYVLDDEYTSSVGSKF--PVRWSPPEVLLYSKFSSKSDVWAFGVLM 191

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 54.8 bits (132), Expect = 2e-08
 Identities = 56/219 (25%), Positives = 94/219 (42%), Gaps = 37/219 (16%)

Query: 194 FASLEKIGSGGCGEVYKAELPGS--NGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ 251
           +  ++KIG G  G   KA L  S  +GK   IK++ +             SK+   +  +
Sbjct: 2   YVKVKKIGEGSFG---KAILVKSKEDGKQYVIKEINI-------------SKMSPKEREE 45

Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
            R E+   S ++H NI+             +V ++ + G L   ++     +R + +P  
Sbjct: 46  SRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKIN----AQRGVLFPED 101

Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLI 371
             +   V   L   H+ H   I+H DIK +N+ L  D    + D G+A        RVL 
Sbjct: 102 QILDWFVQICLALKHV-HDRKILHRDIKSQNIFLTKDGTIKLGDFGIA--------RVLN 152

Query: 372 SYV------LGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
           S V      +GT  Y++PE  +    + K DI++ G +L
Sbjct: 153 STVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVL 191

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 55.3 bits (133), Expect = 2e-08
 Identities = 54/219 (24%), Positives = 97/219 (44%), Gaps = 19/219 (8%)

Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRS--- 254
           EK+G G  GEV+  E  G    M    K           ++     LR+   +  R+   
Sbjct: 11  EKLGEGQFGEVHLCEAEGMEKFM---DKDFSLDVSGNQPVLVAVKMLREDANKNARNDFL 67

Query: 255 -EIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDIL-------DDVSRGRREL 306
            EI   S+++  NI+ LLA  +  D   ++ E+M+NG L   L                +
Sbjct: 68  KEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTI 127

Query: 307 DWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG- 365
            + +   +A  +ASG++YL    S + +H D+  RN L+  +    I+D G++  +  G 
Sbjct: 128 SYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGD 184

Query: 366 YTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
           Y R+    VL  + +++ E     + +   D+++FG+ L
Sbjct: 185 YYRIQGRAVL-PIRWMSWESILLGKFTTASDVWAFGVTL 222

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 54.7 bits (132), Expect = 3e-08
 Identities = 62/242 (25%), Positives = 110/242 (45%), Gaps = 41/242 (16%)

Query: 190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVY----APISAAELIEEDSKLR 245
           K + +  L+K+G G    VYK       G+++A+K++ +     AP +A   I E S L+
Sbjct: 3   KLETYKKLDKLGEGSYATVYKGR-SKLTGQLVALKEIRLEHEEGAPFTA---IREASLLK 58

Query: 246 DSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHL-LVYEFMKNGSLQDILDDVSRGRR 304
           D               ++H NI+  L  ++     L LV+E++    L+  +DD   G  
Sbjct: 59  D---------------LKHANIV-TLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLS 101

Query: 305 ELDWPSRHRIAL-GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMA-- 361
                   R+ L  +  GL Y H      ++H D+KP+N+L+++  E  ++D GLA A  
Sbjct: 102 ----MHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKS 154

Query: 362 IPDGYTRVLISYVLGTMAYIAPE-YFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNG 420
           +P   ++   + V+ T+ Y  P+      E S   D++  G +   +  G P F    + 
Sbjct: 155 VP---SKTYSNEVV-TLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV 210

Query: 421 EE 422
           E+
Sbjct: 211 ED 212

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 55.0 bits (133), Expect = 3e-08
 Identities = 37/97 (38%), Positives = 55/97 (56%), Gaps = 7/97 (7%)

Query: 321 GLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA-MAIPDG-YTRVLISYVLGTM 378
           GL+Y+H   SA+++H D+KP N+LLN + +  I D GLA +A P+  +T  L  YV  T 
Sbjct: 118 GLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYV-ATR 173

Query: 379 AYIAPE-YFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
            Y APE        ++  DI+S G +L  ++   P F
Sbjct: 174 WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLF 210

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 54.5 bits (131), Expect = 3e-08
 Identities = 40/157 (25%), Positives = 71/157 (45%), Gaps = 9/157 (5%)

Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
            ++E      + H NI+    + +     ++V E+   G+L + +    R    LD    
Sbjct: 46  AQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQK--RCNSLLD---E 100

Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLND-DMEACISDLGLAMAIPDGYTRVL 370
             I       L  LH  H+  I+H D+K +N+LL+   M   I D G++  +    ++  
Sbjct: 101 DTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILS---SKSK 157

Query: 371 ISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISL 407
              V+GT  YI+PE  +    ++K DI++ G +L  L
Sbjct: 158 AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYEL 194

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 55.0 bits (132), Expect = 3e-08
 Identities = 62/233 (26%), Positives = 109/233 (46%), Gaps = 39/233 (16%)

Query: 190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVY----APISAAELIEEDSKLR 245
           K + +  LEK+G G    V+K     +   ++A+K++ +     AP +A   I E S L+
Sbjct: 4   KMETYIKLEKLGEGTYATVFKGRSKLTE-NLVALKEIRLEHEEGAPCTA---IREVSLLK 59

Query: 246 DSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHL-LVYEFMKNGSLQDILDDVSRGRR 304
           D               ++H NI+ L   +V  D  L LV+E++ +  L+  +DD      
Sbjct: 60  D---------------LKHANIVTL-HDIVHTDKSLTLVFEYL-DKDLKQYMDDCG---- 98

Query: 305 ELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMA--I 362
             +  S H + + +   L  L   H   ++H D+KP+N+L+N+  E  ++D GLA A  +
Sbjct: 99  --NIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSV 156

Query: 363 PDGYTRVLISYVLGTMAYIAPE-YFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
           P   T+   + V+ T+ Y  P+      E S + D++  G +   +  G P F
Sbjct: 157 P---TKTYSNEVV-TLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLF 205

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 54.2 bits (130), Expect = 3e-08
 Identities = 67/298 (22%), Positives = 123/298 (41%), Gaps = 66/298 (22%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRS-- 254
           +  +G G  GEV       ++GK   IKK+                 LR++  R+ ++  
Sbjct: 5   VRVVGKGSYGEVSLVR-HRTDGKQYVIKKL----------------NLRNASRRERKAAE 47

Query: 255 -EIITASQIRHRNILPLLAHMVRPDCHL-LVYEFMKNGSLQDILDDVSRG-----RRELD 307
            E    SQ++H NI+         D  L +V  F + G L   L +  +G      + ++
Sbjct: 48  QEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKE-QKGKLLPENQVVE 106

Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
           W       + +A  L+YLH  H   I+H D+K +NV L       + DLG+A  + +   
Sbjct: 107 W------FVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157

Query: 368 RVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPE 427
             + S ++GT  Y++PE F     + K D+++ G  +  +                    
Sbjct: 158 --MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMAT------------------ 197

Query: 428 WLRKVMNSKNPS----RAIDPRLPG--NGYEKKMLHVLKIAYICTLHDPEERPNSQYV 479
            L+   N+K+ +    R I+ +LP     Y  ++  ++    +     PE+RP+ + +
Sbjct: 198 -LKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIA-TMLS--KRPEKRPSVKSI 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 54.0 bits (130), Expect = 4e-08
 Identities = 52/224 (23%), Positives = 90/224 (40%), Gaps = 39/224 (17%)

Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  G VY        G+ +A+K+V            + DS     ++  +  EI   
Sbjct: 10  LGQGAFGRVYLC-YDVDTGRELAVKQV----------PFDPDSPETKKEVNALECEIQLL 58

Query: 260 SQIRHRNILPLLAHMVRPDCHLLVY-EFMKNGSLQDIL-------DDVSRGRRELDWPSR 311
             ++H  I+      +R D  L ++ E+M  GS++D L       + V+R          
Sbjct: 59  KNLQHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTR---------- 107

Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA---MAIPDGYTR 368
            +    +  G+EYLH      I+H DIK  N+L +      + D G +     I    T 
Sbjct: 108 -KYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGT- 162

Query: 369 VLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVP 412
             +  V GT  +++PE         K D++S G  ++ ++   P
Sbjct: 163 -GMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 54.6 bits (132), Expect = 4e-08
 Identities = 56/249 (22%), Positives = 99/249 (39%), Gaps = 47/249 (18%)

Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           F  ++ +G G  G V+   L G+ GK+ A+K            ++++   ++ +K++++ 
Sbjct: 3   FKKIKLLGKGDVGRVFLVRLKGT-GKLFALK------------VLDKKEMIKRNKVKRVL 49

Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
           +E    + + H  +  L A         LV ++   G L  +L     G+   +  +R  
Sbjct: 50  TEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQ-RQPGKCLSEEVARFY 108

Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLI-- 371
            A  V   LEYLH+     I++ D+KP N+LL++     +SD  L+         V    
Sbjct: 109 AA-EVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKAL 164

Query: 372 --------------------------SYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLI 405
                                     S+V GT  YIAPE           D ++ G+LL 
Sbjct: 165 RKGSRRSSVNSIPSETFSEEPSFRSNSFV-GTEEYIAPEVISGDGHGSAVDWWTLGILLY 223

Query: 406 SLVRGVPSF 414
            ++ G   F
Sbjct: 224 EMLYGTTPF 232

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 54.1 bits (130), Expect = 4e-08
 Identities = 59/224 (26%), Positives = 91/224 (40%), Gaps = 42/224 (18%)

Query: 200 IGSGGCGEVYKAEL-----PGSNGKMIAIKKVIVYAPISAAELIEEDSK-LRDSKLRQIR 253
           +GSG  GEVY+        PGS    +A+K       +      +E  + L+++ L    
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKT------LRKGATDQEKKEFLKEAHL---- 52

Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRH- 312
                 S   H NI+ LL   +  +   ++ E M+ G L   L    R  R   +     
Sbjct: 53  -----MSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYL----RDARVERFGPPLL 103

Query: 313 ------RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC-----ISDLGLAMA 361
                  I L VA G  YL   H    IH D+  RN L+++          I D GLA  
Sbjct: 104 TLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD 160

Query: 362 I-PDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
           I    Y R     +L  + ++APE     + + + D++SFG+L+
Sbjct: 161 IYKSDYYRKEGEGLL-PVRWMAPESLLDGKFTTQSDVWSFGVLM 203

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 54.2 bits (130), Expect = 4e-08
 Identities = 71/265 (26%), Positives = 113/265 (42%), Gaps = 40/265 (15%)

Query: 199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT 258
           +IG G  G VYKA  P S G  +A+K V V        L    S +R+  L + R E   
Sbjct: 7   EIGVGAYGTVYKARDPHS-GHFVALKSVRVQTNEDGLPL----STVREVALLK-RLE--- 57

Query: 259 ASQIRHRNILPLL--AHMVRPDCHL---LVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
                H NI+ L+      R D      LV+E + +  L+  LD V       +  +   
Sbjct: 58  --AFDHPNIVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAE--TIKD 112

Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT-RVLIS 372
           +      GL++LH   +  I+H D+KP N+L+    +  ++D GLA      Y+ ++ ++
Sbjct: 113 LMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLARI----YSCQMALT 165

Query: 373 YVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEIC-------- 424
            V+ T+ Y APE   Q   +   D++S G +   + R  P F  +   +++         
Sbjct: 166 PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGL 225

Query: 425 --SPEWLRKVMNSKNPSRAIDPRLP 447
               +W R V     P  A  PR P
Sbjct: 226 PPEDDWPRDV---TLPRGAFSPRGP 247

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 54.1 bits (130), Expect = 4e-08
 Identities = 58/220 (26%), Positives = 99/220 (45%), Gaps = 28/220 (12%)

Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           ++IG+G  G+V   E      + ++  +V+V    ++A   E+   L++ +  +      
Sbjct: 1   DEIGNGWFGKVLLGEA----HRGMSKARVVVKELRASATPDEQLLFLQEVQPYRE----- 51

Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR--HRIA 315
               + H N+L  L   +    +LLV EF   G L++ L   +RG            R+A
Sbjct: 52  ----LNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRS-NRGMVAQMAQKDVLQRMA 106

Query: 316 LGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMA-IPDGYTRVLISYV 374
             VASGL  L + H A  IH D+  RN  L  D+   I D GLA+   P+ Y      + 
Sbjct: 107 CEVASGL--LWL-HQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHA 163

Query: 375 LGTMAYIAPEY---FQQ----PELSEKCDIFSFGMLLISL 407
           +  + ++APE      Q     + ++K +I+S G+ +  L
Sbjct: 164 V-PLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 55.3 bits (133), Expect = 4e-08
 Identities = 56/199 (28%), Positives = 89/199 (44%), Gaps = 27/199 (13%)

Query: 282 LVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPR 341
           LV ++   G L+  +   ++  R       H   L     L  +H  HS  +IH DIK  
Sbjct: 116 LVLDYANAGDLRQEIKSRAKTNRTF---REHEAGLLFIQVLLAVHHVHSKHMIHRDIKSA 172

Query: 342 NVLLNDDMEACISDLGL----AMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDI 397
           N+LL  +    + D G     A  + D   R       GT  Y+APE +++   S+K D+
Sbjct: 173 NILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFC----GTPYYVAPEIWRRKPYSKKADM 228

Query: 398 FSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLH 457
           FS G+LL  L+     F    +GE +       +VM+ K  +   DP LP +    +M  
Sbjct: 229 FSLGVLLYELLTLKRPF----DGENM------EEVMH-KTLAGRYDP-LPPS-ISPEMQE 275

Query: 458 VLKIAYICTLHDPEERPNS 476
           ++  A + +  DP+ RP+S
Sbjct: 276 IVT-ALLSS--DPKRRPSS 291

Length = 496

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 54.3 bits (130), Expect = 5e-08
 Identities = 65/226 (28%), Positives = 99/226 (43%), Gaps = 41/226 (18%)

Query: 194 FASLEKIGSGGCGEV---YKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
           + +L+ IGSG  G V   Y A L     + +AIKK+    P               +  +
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVL----DRNVAIKKL--SRPFQ-----------NQTHAK 61

Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHL-------LVYEFMKNGSLQDILDDVSRGR 303
           +   E++    + H+NI+ LL ++  P   L       LV E M     Q I       +
Sbjct: 62  RAYRELVLMKCVNHKNIISLL-NVFTPQKSLEEFQDVYLVMELMDANLCQVI-------Q 113

Query: 304 RELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
            ELD      +   +  G+++LH   SA IIH D+KP N+++  D    I D GLA    
Sbjct: 114 MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA- 169

Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR 409
            G + ++  YV+ T  Y APE        E  DI+S G ++  +VR
Sbjct: 170 -GTSFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR 213

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 53.9 bits (129), Expect = 5e-08
 Identities = 58/223 (26%), Positives = 102/223 (45%), Gaps = 26/223 (11%)

Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           F  L  +G G  G V K     +  +++AIKK          +  EE+ +++++ LR+++
Sbjct: 3   FEVLGVVGEGAYGVVLKCRHKETK-EIVAIKKF---------KDSEENEEVKETTLRELK 52

Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
                   ++  NI+ L     R     LV+E+++   L+ +L+++  G      P + R
Sbjct: 53  ----MLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLE-LLEEMPNGVP----PEKVR 103

Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLL--NDDMEACISDLGLAMAIPDGYTRVLI 371
               +   ++ +H  H   I+H DIKP N+L+  ND ++ C  D G A  + +G      
Sbjct: 104 SY--IYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLC--DFGFARNLSEGSNANYT 159

Query: 372 SYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
            YV  T  Y +PE        +  D++S G +L  L  G P F
Sbjct: 160 EYV-ATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLF 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 53.9 bits (130), Expect = 6e-08
 Identities = 70/261 (26%), Positives = 112/261 (42%), Gaps = 46/261 (17%)

Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  G+V  AEL G++ ++ A+K +         ++I +D  + +  + + R   + A
Sbjct: 3   LGKGSFGKVLLAELKGTD-ELYAVKVL-------KKDVILQDDDV-ECTMTEKR---VLA 50

Query: 260 SQIRHRNILPLLAHMV----RPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIA 315
              +H    P L  +       D    V E++  G   D++  + R  R  D P     A
Sbjct: 51  LAGKH----PFLTQLHSCFQTKDRLFFVMEYVNGG---DLMFHIQRSGR-FDEPRARFYA 102

Query: 316 LGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAM-AIPDGYTRVLISYV 374
             +  GL++LH      II+ D+K  NVLL+ +    I+D G+    I  G T    S  
Sbjct: 103 AEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT---TSTF 156

Query: 375 LGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF-------VFHQNGE-EICSP 426
            GT  YIAPE           D ++ G+LL  ++ G   F       +F    E E+  P
Sbjct: 157 CGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYP 216

Query: 427 EWLRK----VMNS---KNPSR 440
            WL K    ++ S   KNP +
Sbjct: 217 RWLSKEAKSILKSFLTKNPEK 237

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 53.6 bits (129), Expect = 6e-08
 Identities = 48/167 (28%), Positives = 76/167 (45%), Gaps = 16/167 (9%)

Query: 282 LVYEFMKNGSLQDILDDVSRG-------RRELDWPSRHRIALG-VASGLEYLHMYHSASI 333
           L Y F  +  L  ILD V+ G       +RE    S  R+ +  +   L++LH      I
Sbjct: 70  LHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLH---QLGI 126

Query: 334 IHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPEL-- 391
           I+ DIK  N+LL+ +    ++D GL+            S+  GT+ Y+APE  +      
Sbjct: 127 IYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFC-GTIEYMAPEVIRGGSGGH 185

Query: 392 SEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSKNP 438
            +  D +S G+L   L+ G   F    +GE+    E  R+++ SK P
Sbjct: 186 DKAVDWWSLGVLTFELLTGASPFTV--DGEQNSQSEISRRILKSKPP 230

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 54.3 bits (130), Expect = 6e-08
 Identities = 66/290 (22%), Positives = 109/290 (37%), Gaps = 66/290 (22%)

Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           F SL+ IG G  GEV          +++  K       + A +++ +   L   ++  IR
Sbjct: 3   FESLKVIGRGAFGEV----------RLVQKKDT---GHVYAMKILRKADMLEKEQVGHIR 49

Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
           +E     +     ++ +           L+ EF+  G +  +L        + D  +   
Sbjct: 50  AERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLL-------MKKDTLTEEE 102

Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAM------------- 360
               +A  +  +   H    IH DIKP N+LL+      +SD GL               
Sbjct: 103 TQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRN 162

Query: 361 ---AIPDGYT-----------------RVLISYVLGTMAYIAPEYFQQPELSEKCDIFSF 400
              ++P  +T                 R L    +GT  YIAPE F Q   ++ CD +S 
Sbjct: 163 LNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSL 222

Query: 401 GMLLISLVRGVPSFVFHQNGEEICSP---EWLRKVMNSKNPSRAIDPRLP 447
           G+++  ++ G P F         CS    E  +KVMN K  +    P +P
Sbjct: 223 GVIMYEMLIGYPPF---------CSETPQETYKKVMNWKE-TLIFPPEVP 262

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 53.5 bits (129), Expect = 6e-08
 Identities = 52/226 (23%), Positives = 89/226 (39%), Gaps = 49/226 (21%)

Query: 200 IGSGGCGEVY----KAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSE 255
           +G G  G VY    K  + G     +AIK V             E++ +R+    +  +E
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTV------------NENASMRER--IEFLNE 59

Query: 256 IITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRE-------LDW 308
                +    +++ LL  +      L+V E M  G L+  L    R RR        L  
Sbjct: 60  ASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYL----RSRRPEAENNPGLGP 115

Query: 309 PSRHRI---ALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI--- 362
           P+  +    A  +A G+ YL        +H D+  RN ++ +D+   I D G+   I   
Sbjct: 116 PTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYET 172

Query: 363 ----PDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
                 G   + +        ++APE  +    + K D++SFG++L
Sbjct: 173 DYYRKGGKGLLPVR-------WMAPESLKDGVFTTKSDVWSFGVVL 211

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 53.9 bits (129), Expect = 7e-08
 Identities = 65/231 (28%), Positives = 98/231 (42%), Gaps = 37/231 (16%)

Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           +  L+ IGSG  G V  A      G  +A+KK+    P               +  ++  
Sbjct: 23  YQQLKPIGSGAQGIVCAA-FDTVLGINVAVKKLS--RPFQ-----------NQTHAKRAY 68

Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHL-------LVYEFMKNGSLQDILDDVSRGRREL 306
            E++    + H+NI+ LL ++  P   L       LV E M     Q I         EL
Sbjct: 69  RELVLLKCVNHKNIISLL-NVFTPQKSLEEFQDVYLVMELMDANLCQVI-------HMEL 120

Query: 307 DWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGY 366
           D      +   +  G+++LH   SA IIH D+KP N+++  D    I D GLA      +
Sbjct: 121 DHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF 177

Query: 367 TRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFH 417
             ++  YV+ T  Y APE        E  DI+S G ++  LV+G  S +F 
Sbjct: 178 --MMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG--SVIFQ 223

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 53.9 bits (130), Expect = 7e-08
 Identities = 63/224 (28%), Positives = 99/224 (44%), Gaps = 36/224 (16%)

Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAE-LIEEDSKLRDSKL-RQIRSEII 257
           IG G  G V  A+   +N K +AIKK+      +A +  I+    LR+ KL R +  E +
Sbjct: 13  IGRGAYGIVCSAKNSETNEK-VAIKKIA-----NAFDNRIDAKRTLREIKLLRHLDHENV 66

Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALG 317
               I  ++I+P        D ++ VYE M +  L  I+    R  + L           
Sbjct: 67  ----IAIKDIMPPPHREAFNDVYI-VYELM-DTDLHQII----RSSQTLSDDHCQYFLYQ 116

Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGT 377
           +  GL+Y+H   SA+++H D+KP N+LLN + +  I D GLA        R         
Sbjct: 117 LLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLA--------RTTSEKGDFM 165

Query: 378 MAYIAPEYFQQPELSEKC-------DIFSFGMLLISLVRGVPSF 414
             Y+   +++ PEL   C       D++S G +   L+   P F
Sbjct: 166 TEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLF 209

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 52.9 bits (127), Expect = 8e-08
 Identities = 39/124 (31%), Positives = 59/124 (47%), Gaps = 9/124 (7%)

Query: 282 LVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPR 341
           +V EFM+NG L + L    +G+   D      +   V  G+EYL      S IH D+  R
Sbjct: 76  IVTEFMENGCLLNYLRQ-RQGKLSKD--MLLSMCQDVCEGMEYLE---RNSFIHRDLAAR 129

Query: 342 NVLLNDDMEACISDLGLA-MAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSF 400
           N L++      +SD G+    + D YT    S     + +  PE F   + S K D++SF
Sbjct: 130 NCLVSSTGVVKVSDFGMTRYVLDDEYTSS--SGAKFPVKWSPPEVFNFSKYSSKSDVWSF 187

Query: 401 GMLL 404
           G+L+
Sbjct: 188 GVLM 191

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 53.5 bits (128), Expect = 8e-08
 Identities = 58/250 (23%), Positives = 106/250 (42%), Gaps = 26/250 (10%)

Query: 194 FASLEKIGSGGCGEVYKA-ELPGSN-GKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ 251
           F  L+ +G+G  G+V+   ++ G + GK+ A+K +     +  A+  E            
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTE-----------H 50

Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHL-LVYEFMKNGSLQDILDDVSRGRRELDWPS 310
            R+E      IR    L  L +  + D  L L+ +++  G L   L    R         
Sbjct: 51  TRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERF-------K 103

Query: 311 RHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVL 370
              + +     +  L   H   II+ DIK  N+LL+ +    ++D GL+    +      
Sbjct: 104 EQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERA 163

Query: 371 ISYVLGTMAYIAPEYFQQPEL--SEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEW 428
            S+  GT+ Y+AP+  +  +    +  D +S G+L+  L+ G   F    +GE+    E 
Sbjct: 164 YSFC-GTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV--DGEKNSQAEI 220

Query: 429 LRKVMNSKNP 438
            R+++ S+ P
Sbjct: 221 SRRILKSEPP 230

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 53.0 bits (127), Expect = 9e-08
 Identities = 40/132 (30%), Positives = 66/132 (50%), Gaps = 15/132 (11%)

Query: 282 LVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPR 341
           L+ EF+ +GSL++ L    R + +++   + + A+ +  G++YL    S   +H D+  R
Sbjct: 85  LIMEFLPSGSLKEYL---PRNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAAR 138

Query: 342 NVLLNDDMEACISDLGLAMAIPD--GYTRV---LISYVLGTMAYIAPEYFQQPELSEKCD 396
           NVL+  + +  I D GL  AI     Y  V   L S V     + APE   Q +     D
Sbjct: 139 NVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVF----WYAPECLIQSKFYIASD 194

Query: 397 IFSFGMLLISLV 408
           ++SFG+ L  L+
Sbjct: 195 VWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 63/225 (28%), Positives = 101/225 (44%), Gaps = 38/225 (16%)

Query: 200 IGSGGCGEVYKAELPG-SNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT 258
           +G G  G+V  AE  G    K   + KV       A ++++ D+  +D  L  + SE+  
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKV-------AVKMLKSDATEKD--LSDLISEMEM 76

Query: 259 ASQI-RHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRR------------- 304
              I +H+NI+ LL    +     ++ E+   G+L++ L    R RR             
Sbjct: 77  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL----RARRPPGMEYCYNPTQV 132

Query: 305 ---ELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMA 361
              +L +      A  VA G+EYL    S   IH D+  RNVL+ +D    I+D GLA  
Sbjct: 133 PEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARD 189

Query: 362 IP--DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
           I   D Y +     +   + ++APE       + + D++SFG+LL
Sbjct: 190 IHHIDYYKKTTNGRL--PVKWMAPEALFDRIYTHQSDVWSFGVLL 232

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 53.3 bits (128), Expect = 1e-07
 Identities = 61/217 (28%), Positives = 105/217 (48%), Gaps = 42/217 (19%)

Query: 215 GSNGKMIAIKKVI------VYA--PISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRN 266
           GS GK+  ++K+       +YA   +  A L     K+RD    ++R+++        R+
Sbjct: 7   GSFGKVFLVRKITGPDAGQLYAMKVLKKATL-----KVRD----RVRTKM-------ERD 50

Query: 267 ILPLLAHMVRPDCHLLVYEFMKNGSLQDILD-----DV-SRGRRELDWPSRH-RIALG-V 318
           IL   A +  P    L Y F   G L  ILD     D+ +R  +E+ +     +  L  +
Sbjct: 51  IL---AEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAEL 107

Query: 319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVL-GT 377
           A  L++LH   S  II+ D+KP N+LL+++    ++D GL+    D   +   +Y   GT
Sbjct: 108 ALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK---AYSFCGT 161

Query: 378 MAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
           + Y+APE   +   ++  D +SFG+L+  ++ G   F
Sbjct: 162 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPF 198

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 57/232 (24%), Positives = 100/232 (43%), Gaps = 33/232 (14%)

Query: 188 LKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDS 247
           L  E+ +  + ++G G  G+VYKA+       ++A  KVI             D+K  + 
Sbjct: 1   LNPEEFWEIIGELGDGAFGKVYKAQ--NKETGVLAAAKVI-------------DTKSEE- 44

Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELD 307
           +L     EI   +   H NI+ LL      +   ++ EF   G++  ++ ++ R   E  
Sbjct: 45  ELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTE-- 102

Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
                +I +     LE L+  H   IIH D+K  N+L   D +  ++D G++       T
Sbjct: 103 ----PQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAK----NT 154

Query: 368 RVLI--SYVLGTMAYIAPEYF-----QQPELSEKCDIFSFGMLLISLVRGVP 412
           R +      +GT  ++APE       +      K D++S G+ LI + +  P
Sbjct: 155 RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEP 206

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 53.2 bits (128), Expect = 1e-07
 Identities = 52/224 (23%), Positives = 96/224 (42%), Gaps = 31/224 (13%)

Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           F  L ++G GG G+V+ A+   + G+++A+K            L+    KL  +++R + 
Sbjct: 3   FQILTQVGQGGYGQVFLAKKKDT-GEIVALK-------RMKKSLLF---KL--NEVRHVL 49

Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
           +E    +  +   ++ LL      +   L  E++  G  + +L++       L   S   
Sbjct: 50  TERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNN-------LGVLSEDH 102

Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISY 373
               +A   E +   H    IH D+KP N L++      ++D GL+  I        ++Y
Sbjct: 103 ARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGI--------VTY 154

Query: 374 ---VLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
              V+G+  Y+APE  +        D +S G +L   + G P F
Sbjct: 155 ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPF 198

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 51/216 (23%), Positives = 92/216 (42%), Gaps = 35/216 (16%)

Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           +K+G+G  GEV+ A     N       K +    +S    + E + ++            
Sbjct: 12  KKLGAGQFGEVWMATY---NKHTKVAVKTMKPGSMSVEAFLAEANVMK------------ 56

Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALG 317
               ++H  ++ L A + +   +++  EFM  GSL D L      ++ L  P     +  
Sbjct: 57  ---TLQHDKLVKLHAVVTKEPIYIIT-EFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQ 110

Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGT 377
           +A G+ ++      + IH D++  N+L++  +   I+D GLA  I D        Y    
Sbjct: 111 IAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN------EYTARE 161

Query: 378 MA-----YIAPEYFQQPELSEKCDIFSFGMLLISLV 408
            A     + APE       + K D++SFG+LL+ +V
Sbjct: 162 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIV 197

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 52.7 bits (126), Expect = 2e-07
 Identities = 33/97 (34%), Positives = 50/97 (51%), Gaps = 21/97 (21%)

Query: 321 GLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAY 380
           GL+Y+H   SA IIH D+KP N+ +N+D E  I D GLA    D  T            Y
Sbjct: 132 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GY 177

Query: 381 IAPEYFQQPEL-------SEKCDIFSFGMLLISLVRG 410
           +A  +++ PE+       ++  DI+S G ++  L+ G
Sbjct: 178 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 214

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 52.4 bits (125), Expect = 2e-07
 Identities = 51/220 (23%), Positives = 98/220 (44%), Gaps = 33/220 (15%)

Query: 199 KIGSGGCGEVYKAEL----PGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRS 254
           ++G G  G+V+ AE     P  +  ++A+K +             +D+   D+  +    
Sbjct: 12  ELGEGAFGKVFLAECYNLCPEQDKILVAVKTL-------------KDAS--DNARKDFHR 56

Query: 255 EIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDIL-----DDVSRGR----RE 305
           E    + ++H +I+      V  D  ++V+E+MK+G L   L     D V         E
Sbjct: 57  EAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAE 116

Query: 306 LDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI-PD 364
           L       IA  +A+G+ YL   H    +H D+  RN L+ +++   I D G++  +   
Sbjct: 117 LTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYST 173

Query: 365 GYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
            Y RV   + +  + ++ PE     + + + D++S G++L
Sbjct: 174 DYYRVG-GHTMLPIRWMPPESIMYRKFTTESDVWSLGVVL 212

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 52.4 bits (125), Expect = 2e-07
 Identities = 61/223 (27%), Positives = 96/223 (43%), Gaps = 34/223 (15%)

Query: 255 EIITASQIRHRNILPLLAHMVRPDCHL-------LVYEFMKNGSLQDILDDVSRGRRELD 307
           E++    + H+NI+ LL ++  P   L       +V E M     Q I       + ELD
Sbjct: 73  ELVLMKCVNHKNIIGLL-NVFTPQKSLEEFQDVYIVMELMDANLCQVI-------QMELD 124

Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
                 +   +  G+++LH   SA IIH D+KP N+++  D    I D GLA     G +
Sbjct: 125 HERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTS 179

Query: 368 RVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF-----------VF 416
            ++  YV+ T  Y APE        E  DI+S G ++  +++G   F           V 
Sbjct: 180 FMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI 238

Query: 417 HQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVL 459
            Q G     PE+++K+  +        P+  G  +EK    VL
Sbjct: 239 EQLGTP--CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVL 279

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 51.9 bits (124), Expect = 3e-07
 Identities = 66/248 (26%), Positives = 111/248 (44%), Gaps = 35/248 (14%)

Query: 178 PLIEKEDL--AFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAA 235
           PL  K  +  +F    D +  +E IG G  G+V+K  L   NG   A+K   +  PI   
Sbjct: 2   PLSGKTIIFDSFPDPSDTWEIIETIGKGTYGKVFKV-LNKKNGSKAAVK---ILDPIHD- 56

Query: 236 ELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCH-----LLVYEFMKNG 290
             I+E+ +   + L+ +           H N++       + D        LV E    G
Sbjct: 57  --IDEEIEAEYNILKALSD---------HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGG 105

Query: 291 SLQDILDD-VSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDM 349
           S+ D++   + RG R ++ P    I      GL++LH+  +   IH D+K  N+LL  + 
Sbjct: 106 SVTDLVKGFLKRGER-MEEPIIAYILHEALMGLQHLHVNKT---IHRDVKGNNILLTTEG 161

Query: 350 EACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYF---QQPELS--EKCDIFSFGMLL 404
              + D G++  +    TR+  +  +GT  ++APE     QQ + +   +CD++S G+  
Sbjct: 162 GVKLVDFGVSAQLTS--TRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITA 219

Query: 405 ISLVRGVP 412
           I L  G P
Sbjct: 220 IELGDGDP 227

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 51.5 bits (124), Expect = 3e-07
 Identities = 74/308 (24%), Positives = 126/308 (40%), Gaps = 64/308 (20%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSK-LRQIRSE 255
           L KIG G   EV KA+     GK  AIK +         + +E+ + LR+ + LR++   
Sbjct: 4   LGKIGEGTFSEVLKAQ-SRKTGKYYAIKCMK-----KHFKSLEQVNNLREIQALRRLSP- 56

Query: 256 IITASQIRHRNILPLLAHMV--RPDCHLLVYEFMKNGSLQDILDDVSRGRRE-LDWPSRH 312
                   H NIL L+  +   +     LV+E M + +L +++    +GR+  L      
Sbjct: 57  --------HPNILRLIEVLFDRKTGRLALVFELM-DMNLYELI----KGRKRPLPEKRVK 103

Query: 313 RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG--YTRVL 370
                +   L+  HM H   I H DIKP N+L+ DD    ++D G    I     YT   
Sbjct: 104 SYMYQLLKSLD--HM-HRNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYT--- 156

Query: 371 ISYVLGTMAYIAPEYFQQPE-------LSEKCDIFSFGMLLISLVRGVPSF-------VF 416
                    YI+  +++ PE          K DI++ G +   ++   P F         
Sbjct: 157 --------EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQI 208

Query: 417 HQNGEEICSPEWLRKVMNSKNPSRAIDPRLP---GNGYEKKMLHV----LKIAYICTLHD 469
            +  + + +P+   +V+     SR ++   P   G G  K + +     L +      +D
Sbjct: 209 AKIHDVLGTPD--AEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYD 266

Query: 470 PEERPNSQ 477
           P+ER  ++
Sbjct: 267 PDERITAK 274

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 51.6 bits (123), Expect = 3e-07
 Identities = 60/228 (26%), Positives = 100/228 (43%), Gaps = 44/228 (19%)

Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  G+V  AE  G +      K     A   A +++++D+  +D  L  + SE+   
Sbjct: 23  LGEGCFGQVVMAEALGID------KDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEMM 74

Query: 260 SQI-RHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIA--- 315
             I +H+NI+ LL    +     ++ E+   G+L++ L    R RR       + IA   
Sbjct: 75  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL----RARRPPGMEYSYDIARVP 130

Query: 316 -------------LGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI 362
                          VA G+EYL    S   IH D+  RNVL+ ++    I+D GLA  +
Sbjct: 131 DEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDV 187

Query: 363 PDGYTRVLISYVLGT------MAYIAPEYFQQPELSEKCDIFSFGMLL 404
            +      I Y   T      + ++APE       + + D++SFG+L+
Sbjct: 188 NN------IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 51.5 bits (123), Expect = 3e-07
 Identities = 60/228 (26%), Positives = 105/228 (46%), Gaps = 37/228 (16%)

Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYA----PISAAELIEEDSKLRDSKL 249
           + +LEK+G G    VYK  +   NG+++A+K + +      P +A   I E S L+    
Sbjct: 7   YLNLEKLGEGSYATVYKG-ISRINGQLVALKVISMKTEEGVPFTA---IREASLLK---- 58

Query: 250 RQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWP 309
                       ++H NI+ L   +   +    V+E+M      D+   + +    L   
Sbjct: 59  -----------GLKHANIVLLHDIIHTKETLTFVFEYMHT----DLAQYMIQHPGGLHPY 103

Query: 310 SRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMA--IPDGYT 367
           +       +  GL Y+H  H   I+H D+KP+N+L++   E  ++D GLA A  IP   +
Sbjct: 104 NVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP---S 157

Query: 368 RVLISYVLGTMAYIAPEYFQ-QPELSEKCDIFSFGMLLISLVRGVPSF 414
           +   S V+ T+ Y  P+      + S   DI+  G + I +++G P+F
Sbjct: 158 QTYSSEVV-TLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAF 204

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 51.9 bits (124), Expect = 3e-07
 Identities = 59/230 (25%), Positives = 95/230 (41%), Gaps = 31/230 (13%)

Query: 188 LKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDS 247
           +K ED F  +  +G+G  G V  A     +   +AIK+             E+   ++  
Sbjct: 27  MKYED-FNFIRTLGTGSFGRVILATYKNEDFPPVAIKR------------FEKSKIIKQK 73

Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELD 307
           ++  + SE    + I H   + L           LV EF+  G     L      RR   
Sbjct: 74  QVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL------RRNKR 127

Query: 308 WPSRHRI--ALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG 365
           +P+      A  +    EYL    S +I++ D+KP N+LL+ D    ++D G A  +   
Sbjct: 128 FPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD-- 182

Query: 366 YTRVLISYVL-GTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
            TR   +Y L GT  YIAPE        +  D ++ G+ +  ++ G P F
Sbjct: 183 -TR---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPF 228

Length = 340

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 51.5 bits (123), Expect = 4e-07
 Identities = 63/256 (24%), Positives = 102/256 (39%), Gaps = 39/256 (15%)

Query: 194 FASLEKIGSGGCGEVYKAELPGSN--GKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ 251
           F  L+ +G+G  G+V+       +  GK+ A+K V+  A +       E ++   + L  
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMK-VLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG-------RR 304
           +R               P L          L Y F     L  ILD VS G       +R
Sbjct: 61  VRQS-------------PFLV--------TLHYAFQTEAKLHLILDYVSGGEMFTHLYQR 99

Query: 305 ELDWPSRHRIALG-VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
           +       R   G +   LE+LH      I++ DIK  N+LL+ +    ++D GL+    
Sbjct: 100 DNFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156

Query: 364 DGYTRVLISYVLGTMAYIAPEYFQ-QPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEE 422
                   S+  GT+ Y+APE  + +    +  D +S G+L+  L+ G   F     GE 
Sbjct: 157 SEEKERTYSFC-GTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE--GER 213

Query: 423 ICSPEWLRKVMNSKNP 438
               E  R+++    P
Sbjct: 214 NTQSEVSRRILKCDPP 229

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 50.9 bits (122), Expect = 5e-07
 Identities = 57/207 (27%), Positives = 90/207 (43%), Gaps = 18/207 (8%)

Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G+G  G+V +A   G   K  A+ KV V      A   E ++         + SE+   
Sbjct: 43  LGAGAFGKVVEATAYGL-SKSDAVMKVAVKMLKPTAHSSEREA---------LMSELKIM 92

Query: 260 SQI-RHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRE-LDWPSRHRIALG 317
           S +  H NI+ LL         L++ E+   G   D+L+ + R R   L        +  
Sbjct: 93  SHLGNHENIVNLLGACTIGGPILVITEYCCYG---DLLNFLRRKRESFLTLEDLLSFSYQ 149

Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGT 377
           VA G+ +L    S + IH D+  RNVLL       I D GLA  I +    V+       
Sbjct: 150 VAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLP 206

Query: 378 MAYIAPEYFQQPELSEKCDIFSFGMLL 404
           + ++APE       + + D++S+G+LL
Sbjct: 207 VKWMAPESIFNCVYTFESDVWSYGILL 233

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 51.1 bits (122), Expect = 7e-07
 Identities = 82/333 (24%), Positives = 122/333 (36%), Gaps = 85/333 (25%)

Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           + SL+++GSG  G V  A +    G+ +AIKK+                       R  +
Sbjct: 17  YTSLKQVGSGAYGSVCSA-IDKRTGEKVAIKKL----------------------SRPFQ 53

Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILD----------DVSRGR 303
           SEI      R    L LL HM   +   L+  F    S  +  D          D+ +  
Sbjct: 54  SEIFAKRAYRE---LTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIM 110

Query: 304 -RELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI 362
              L   S  ++   V   L  L   HSA IIH D+KP N+ +N+D E  I D GLA   
Sbjct: 111 GHPL---SEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHA 167

Query: 363 PDGYTRVLISYVLGTMAYIAPEY-FQQPELSEKCDIFSFGMLL----------------- 404
               T     YV+ T  Y APE        ++  DI+S G ++                 
Sbjct: 168 DAEMT----GYVV-TRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD 222

Query: 405 ----ISLVRGVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAID---PRLPGNGYE--KKM 455
               I  V GVP   F Q  E+  +  +++ +   K P +      P+      +  +KM
Sbjct: 223 QLTQILKVTGVPGPEFVQKLEDKAAKSYIKSL--PKYPRKDFSTLFPKASPQAVDLLEKM 280

Query: 456 LHV-----------LKIAYICTLHDPEERPNSQ 477
           L +           L+  Y  +  D +E    Q
Sbjct: 281 LELDVDKRLTATEALEHPYFDSFRDADEETEQQ 313

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 50.2 bits (120), Expect = 8e-07
 Identities = 61/254 (24%), Positives = 102/254 (40%), Gaps = 62/254 (24%)

Query: 243 KLRDSKLRQIRSEIITAS---QIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDV 299
           K+  S  R   +   TAS   Q+ H++++ L    VR + +++V E++K G L   L   
Sbjct: 36  KVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVRDE-NIMVEEYVKFGPLDVFL--- 91

Query: 300 SRGRRELDWPSRH---RIALGVASGLEYLHMYHSASIIHGDIKPRNVLL--NDDMEAC-- 352
               RE +  S H    +A  +AS L YL       ++HG++  +N+L+      E    
Sbjct: 92  ---HREKNNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVP 145

Query: 353 ---ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPE--LSEKCDIFSFGMLLISL 407
              +SD G+ + +     RV          +IAPE  +  +  L+   D +SFG  L+  
Sbjct: 146 FIKLSDPGIPITVLSREERVERI------PWIAPECIRNGQASLTIAADKWSFGTTLL-- 197

Query: 408 VRGVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKK-MLHVLKIAYI-- 464
                         EICS        N + P   +        Y+ +  L +   A +  
Sbjct: 198 --------------EICS--------NGEEPLSTLSSSEKERFYQDQHRLPMPDCAELAN 235

Query: 465 ----CTLHDPEERP 474
               C  +DP +RP
Sbjct: 236 LINQCWTYDPTKRP 249

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 50.4 bits (120), Expect = 9e-07
 Identities = 56/230 (24%), Positives = 95/230 (41%), Gaps = 38/230 (16%)

Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           IG G  G+V +A +     KM A           A ++++E +   D   R    E+   
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNA-----------AIKMLKEFASENDH--RDFAGELEVL 56

Query: 260 SQI-RHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRH------ 312
            ++  H NI+ LL          +  E+   G+L D L        +  +   H      
Sbjct: 57  CKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTL 116

Query: 313 ------RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGY 366
                 + A  VA+G++YL        IH D+  RNVL+ +++ + I+D GL+       
Sbjct: 117 TSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLASKIADFGLSRG----- 168

Query: 367 TRVLISYVLGTMA--YIAPEYFQQPELSEKCDIFSFGMLLISLVR--GVP 412
             V +   +G +   ++A E       + K D++SFG+LL  +V   G P
Sbjct: 169 EEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTP 218

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 49.9 bits (119), Expect = 1e-06
 Identities = 43/166 (25%), Positives = 78/166 (46%), Gaps = 12/166 (7%)

Query: 244 LRDSKLRQIRSEIITASQIRHRNILPLLAHMV---RPDCHLLVYEFMKNGSLQDILDDVS 300
           L++   + +R E++  ++I H+   P +  M+     +  +LV E    G L   L   S
Sbjct: 30  LKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMASGGPLNKFL---S 86

Query: 301 RGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGL-- 358
             + E+   +   +   V+ G++YL      + +H D+  RNVLL +   A ISD GL  
Sbjct: 87  GKKDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSK 143

Query: 359 AMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
           A+   D Y +   S     + + APE     + S + D++S+G+ +
Sbjct: 144 ALGADDSYYKAR-SAGKWPLKWYAPECINFRKFSSRSDVWSYGITM 188

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 50.2 bits (120), Expect = 1e-06
 Identities = 54/228 (23%), Positives = 99/228 (43%), Gaps = 22/228 (9%)

Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           +  L  +G G  G V+ A +     K +A+KK+++  P S    + E   +R      I 
Sbjct: 7   YMDLRPLGCGSNGLVFSA-VDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIV 65

Query: 254 S--EIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
              E++  S       +  L  +   +   +V E+M+         D++    +      
Sbjct: 66  KVYEVLGPSGSDLTEDVGSLTEL---NSVYIVQEYMET--------DLANVLEQGPLSEE 114

Query: 312 HR--IALGVASGLEYLHMYHSASIIHGDIKPRNVLLN-DDMEACISDLGLAMAIPDGYT- 367
           H       +  GL+Y+H   SA+++H D+KP NV +N +D+   I D GLA  +   Y+ 
Sbjct: 115 HARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSH 171

Query: 368 RVLISYVLGTMAYIAPEYFQQP-ELSEKCDIFSFGMLLISLVRGVPSF 414
           +  +S  L T  Y +P     P   ++  D+++ G +   ++ G P F
Sbjct: 172 KGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLF 219

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 49.8 bits (119), Expect = 1e-06
 Identities = 34/102 (33%), Positives = 49/102 (48%), Gaps = 9/102 (8%)

Query: 315 ALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMA--IPDGYTRVLIS 372
           A  +A GL +LH   S  II+ D+K  NV+L+ +    I+D G+          TR    
Sbjct: 107 AAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFC- 162

Query: 373 YVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
              GT  YIAPE        +  D ++FG+LL  ++ G P F
Sbjct: 163 ---GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPF 201

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 47/162 (29%), Positives = 74/162 (45%), Gaps = 21/162 (12%)

Query: 253 RSEIITASQIRHRNILPLLAHMVRPDCHL-LVYEFMKNGSL-QDILDDVSRGRRE---LD 307
           R E +  ++++H NI+         D HL +V E+   G L Q I     +   E   L 
Sbjct: 46  RKEAVLLAKMKHPNIVAF-KESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQ 104

Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA--MAIPDG 365
           W  +  + LGV       H+ H   ++H DIK +N+ L  + +  + D G A  +  P  
Sbjct: 105 WFVQ--MCLGVQ------HI-HEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155

Query: 366 YTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISL 407
           Y     +YV GT  Y+ PE ++    + K DI+S G +L  L
Sbjct: 156 YA---CTYV-GTPYYVPPEIWENMPYNNKSDIWSLGCILYEL 193

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 49.6 bits (118), Expect = 2e-06
 Identities = 41/134 (30%), Positives = 61/134 (45%), Gaps = 11/134 (8%)

Query: 282 LVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPR 341
            V E++  G L   +  V R +     P     A  +A GL +LH   S  II+ D+K  
Sbjct: 78  FVMEYVNGGDLMYQIQQVGRFKE----PHAVFYAAEIAIGLFFLH---SKGIIYRDLKLD 130

Query: 342 NVLLNDDMEACISDLGLAMA-IPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSF 400
           NV+L+ +    I+D G+    + DG T        GT  YIAPE        +  D ++F
Sbjct: 131 NVMLDSEGHIKIADFGMCKENMWDGVT---TKTFCGTPDYIAPEIIAYQPYGKSVDWWAF 187

Query: 401 GMLLISLVRGVPSF 414
           G+LL  ++ G   F
Sbjct: 188 GVLLYEMLAGQAPF 201

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 48.4 bits (116), Expect = 2e-06
 Identities = 40/166 (24%), Positives = 73/166 (43%), Gaps = 28/166 (16%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEE-DSKLRDSKLRQIR-S 254
           ++ I  G   E+Y  +  G         K ++   I       E D ++R  + R  R +
Sbjct: 1   MKLIKRGAEAEIYLGDFLG--------IKAVIKWRIPKRYRHPELDERIR--RERTRREA 50

Query: 255 EIITASQIRHRNI-LPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
            I+  S+ R   + +P + + V P+  ++V E+++   L+D+++       EL       
Sbjct: 51  RIM--SRARKAGVNVPAV-YFVDPENFIIVMEYIEGEPLKDLINSNGMEELELSRE---- 103

Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA 359
             +G   G       HSA IIHGD+   N++L+   +  + D GLA
Sbjct: 104 --IGRLVG-----KLHSAGIIHGDLTTSNMILSGG-KIYLIDFGLA 141

Length = 211

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 48.0 bits (114), Expect = 4e-06
 Identities = 49/210 (23%), Positives = 88/210 (41%), Gaps = 23/210 (10%)

Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           +++G G  G VY       + K +A +++ V   I   EL         ++  Q   E  
Sbjct: 6   QRLGKGSFGTVYLV----KDKKAVAEERLKVLKEIPVGEL-------NPNETVQANQEAQ 54

Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALG 317
             S++ H  I+   A  +  D   ++ E+ +   L   L+++    + L         + 
Sbjct: 55  LLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQ 114

Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLG---LAMAIPDGYTRVLISYV 374
           +  G+ Y+H      I+H D+K +N+ L +++   I D G   L M   D     L +  
Sbjct: 115 LLLGVHYMHQRR---ILHRDLKAKNIFLKNNLLK-IGDFGVSRLLMGSCD-----LATTF 165

Query: 375 LGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
            GT  Y++PE  +      K DI+S G +L
Sbjct: 166 TGTPYYMSPEALKHQGYDSKSDIWSLGCIL 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 48.4 bits (115), Expect = 4e-06
 Identities = 46/177 (25%), Positives = 74/177 (41%), Gaps = 22/177 (12%)

Query: 253 RSEIITASQIRH----RNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDW 308
           + EI+   ++ H    RNIL        P    L + F  +  L  + D +S G  EL W
Sbjct: 28  KKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGG--ELFW 85

Query: 309 PSRH-------RIALGVAS---GLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGL 358
             +        R    +A     LE+LH Y    I++ D+KP N+LL+      + D GL
Sbjct: 86  HLQKEGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGL 142

Query: 359 AMAIPDGYTRVLISYVLGTMAYIAPE-YFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
           +    +       +   GT  Y+APE    +   ++  D +S G+L+  +  G   F
Sbjct: 143 SK--ANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPF 197

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 47.6 bits (113), Expect = 5e-06
 Identities = 46/169 (27%), Positives = 75/169 (44%), Gaps = 29/169 (17%)

Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR--SE 255
           ++IG+G  G+V   E               V +  + A+++ ++ ++  S   Q++   E
Sbjct: 1   KEIGNGWFGKVILGE---------------VNSGYTPAQVVVKELRVSASVQEQMKFLEE 45

Query: 256 IITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRREL-----DWPS 310
                 ++H N+L  L        +LLV EF   G L+  L    R  R+      D  +
Sbjct: 46  AQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYL----RSCRKAELMTPDPTT 101

Query: 311 RHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA 359
             R+A  +A GL  LH+ H  + IH D+  RN LL  D+   I D GL+
Sbjct: 102 LQRMACEIALGL--LHL-HKNNFIHSDLALRNCLLTADLTVKIGDYGLS 147

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 48.2 bits (115), Expect = 5e-06
 Identities = 33/92 (35%), Positives = 46/92 (50%), Gaps = 7/92 (7%)

Query: 321 GLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA-MAIPDGYTRVLISYVLGTMA 379
           GL+YLH   SA I+H DIKP N+L+N +    I D GLA +  PD      ++  + T  
Sbjct: 115 GLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD--ESKHMTQEVVTQY 169

Query: 380 YIAPEYFQ-QPELSEKCDIFSFGMLLISLVRG 410
           Y APE        +   DI+S G +   L+  
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGR 201

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 47.7 bits (113), Expect = 6e-06
 Identities = 53/228 (23%), Positives = 94/228 (41%), Gaps = 31/228 (13%)

Query: 191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
           +  F  +  +G G  G+V  AE  G+  ++ AIK            ++++D  ++D    
Sbjct: 1   DFNFLMV--LGKGSFGKVMLAERKGT-DELYAIK------------ILKKDVVIQDD--- 42

Query: 251 QIRSEIITASQIRHRNILPLLAHM----VRPDCHLLVYEFMKNGSLQDILDDVSRGRREL 306
            +   ++    +  ++  P L  +       D    V E++  G L   +  V + +   
Sbjct: 43  DVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKE-- 100

Query: 307 DWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGY 366
             P     A  ++ GL +LH      II+ D+K  NV+L+ +    I+D G  M      
Sbjct: 101 --PQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFG--MCKEHMV 153

Query: 367 TRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
             V      GT  YIAPE        +  D +++G+LL  ++ G P F
Sbjct: 154 DGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPF 201

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 47.6 bits (113), Expect = 7e-06
 Identities = 57/230 (24%), Positives = 101/230 (43%), Gaps = 33/230 (14%)

Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAE---LIEEDSKLRDSKLRQIRS 254
           EK+G G  GEV+  E+              +  P +  +   L+     LR    +  R+
Sbjct: 11  EKLGEGQFGEVHLCEVVNPQ------DLPTLQFPFNVRKGRPLLVAVKILRPDANKNARN 64

Query: 255 EIITASQIRHR----NILPLLAHMVRPDCHLLVYEFMKNGSLQDIL------DDVSRGRR 304
           + +   +I  R    NI+ LL   V  D   ++ E+M+NG L   L      D    G  
Sbjct: 65  DFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGND 124

Query: 305 E---------LDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISD 355
                     + + S   +AL +ASG++YL    S + +H D+  RN L+ +++   I+D
Sbjct: 125 AVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIAD 181

Query: 356 LGLAMAIPDG-YTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
            G++  +  G Y R+    VL  + ++A E     + +   D+++FG+ L
Sbjct: 182 FGMSRNLYAGDYYRIQGRAVL-PIRWMAWECILMGKFTTASDVWAFGVTL 230

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 47.2 bits (112), Expect = 1e-05
 Identities = 49/181 (27%), Positives = 76/181 (41%), Gaps = 33/181 (18%)

Query: 315 ALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI---PD----GYT 367
           +  VA G+E+L    S   IH D+  RN+LL+++    I D GLA  I   PD    G  
Sbjct: 179 SFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 235

Query: 368 RVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSP 426
           R+ +        ++APE       + + D++SFG+LL  +   G   +   Q  EE C  
Sbjct: 236 RLPLK-------WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRR 288

Query: 427 EWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL 486
             L++    + P  A                +  I   C  ++PE+RP    +   L  L
Sbjct: 289 --LKEGTRMRAPEYATP-------------EIYSIMLDCWHNNPEDRPTFSELVEILGDL 333

Query: 487 L 487
           L
Sbjct: 334 L 334

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 46.9 bits (111), Expect = 1e-05
 Identities = 33/107 (30%), Positives = 55/107 (51%), Gaps = 8/107 (7%)

Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAM-AIPDGYTRVLISYVLG 376
           + S LEYLH   S  +++ DIK  N++L+ D    I+D GL    I DG T   +    G
Sbjct: 104 IVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKTFCG 157

Query: 377 TMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI 423
           T  Y+APE  +  +     D +  G+++  ++ G   F ++Q+ E +
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHERL 203

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 47.3 bits (112), Expect = 1e-05
 Identities = 32/107 (29%), Positives = 47/107 (43%), Gaps = 5/107 (4%)

Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISY 373
           I   V   ++YLH      IIH DIK  N+ +N   + C+ D G A   P          
Sbjct: 187 IERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYG 242

Query: 374 VLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNG 420
             GT+A  APE   +       DI+S G++L  +     S +F ++G
Sbjct: 243 WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDS-LFEKDG 288

Length = 391

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 47.1 bits (112), Expect = 1e-05
 Identities = 60/246 (24%), Positives = 96/246 (39%), Gaps = 38/246 (15%)

Query: 200 IGSGGCGEVY--KAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           +G G  GEV   + +  G    M  +KK ++ A  + +   EE         R I S   
Sbjct: 9   VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEE---------RDILS--- 56

Query: 258 TASQIRHRNILPLLAHMVRPDCHL-LVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL 316
               I +   +P L +  +   +L LV E+   G   D+L  ++R   + D         
Sbjct: 57  ----ISNSPWIPQLQYAFQDKDNLYLVMEYQPGG---DLLSLLNRYEDQFD---EDMAQF 106

Query: 317 GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLG 376
            +A  +  +H  H    +H DIKP NVL++      ++D G A  +      V     +G
Sbjct: 107 YLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARL-TANKMVNSKLPVG 165

Query: 377 TMAYIAPEYFQQPELSEK------CDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLR 430
           T  YIAPE         K      CD +S G++   ++ G   F       E  S +   
Sbjct: 166 TPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPF------HEGTSAKTYN 219

Query: 431 KVMNSK 436
            +MN +
Sbjct: 220 NIMNFQ 225

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 46.9 bits (111), Expect = 1e-05
 Identities = 58/222 (26%), Positives = 95/222 (42%), Gaps = 22/222 (9%)

Query: 215 GSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHM 274
           GS GK++ ++K      I A + I +   +  S++    +E    +Q+    I+PL    
Sbjct: 4   GSFGKVMQVRKRDT-QRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSF 62

Query: 275 VRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASII 334
             P+   LV  F+  G L   L     GR +L      R     A  L  L   H  ++I
Sbjct: 63  QSPEKLYLVLAFINGGELFHHLQ--REGRFDL-----SRARFYTAELLCALENLHKFNVI 115

Query: 335 HGDIKPRNVLLNDDMEACISDLGLA---MAIPDGYTRVLISYVLGTMAYIAPEYFQQPEL 391
           + D+KP N+LL+      + D GL    M   D       +   GT  Y+APE       
Sbjct: 116 YRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK-----TNTFCGTPEYLAPELLLGHGY 170

Query: 392 SEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVM 433
           ++  D ++ G+LL  ++ G+P F + +N       E  RK++
Sbjct: 171 TKAVDWWTLGVLLYEMLTGLPPF-YDEN-----VNEMYRKIL 206

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 46.9 bits (111), Expect = 1e-05
 Identities = 30/95 (31%), Positives = 46/95 (48%), Gaps = 6/95 (6%)

Query: 325 LHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPE 384
           +H  H    +H DIKP NVLL+ +    ++D G  + +    T V  S  +GT  YI+PE
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT-VQSSVAVGTPDYISPE 173

Query: 385 YFQQPE-----LSEKCDIFSFGMLLISLVRGVPSF 414
             Q  E        +CD +S G+ +  ++ G   F
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 46.5 bits (110), Expect = 1e-05
 Identities = 44/178 (24%), Positives = 74/178 (41%), Gaps = 41/178 (23%)

Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI--PDGYTRVLISYVL 375
           V+ G++YL      + +H D+  RNVLL     A ISD GL+ A+   + Y +   ++  
Sbjct: 104 VSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK-THGK 159

Query: 376 GTMAYIAPEYFQQPELSEKCDIFSFGMLLISL----------VRGVPSFVFHQNGEEICS 425
             + + APE     + S K D++SFG+L+             ++G       ++GE +  
Sbjct: 160 WPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMEC 219

Query: 426 PEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRL 483
           P                  R P      +M  ++K   +C  +  +ERP    V  RL
Sbjct: 220 P-----------------QRCP-----PEMYDLMK---LCWTYGVDERPGFAVVELRL 252

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 46.7 bits (111), Expect = 1e-05
 Identities = 68/322 (21%), Positives = 123/322 (38%), Gaps = 69/322 (21%)

Query: 175 IFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISA 234
           I S  I+K     +K+ D  +            +YK      N K + I+          
Sbjct: 15  IESDDIDKYTSVLIKENDQNS------------IYKGIF---NNKEVIIR---------- 49

Query: 235 AELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAH---MVRPDCHL-LVYEFMKNG 290
               ++  K     +    +EI    +I   NIL +      +V     L L+ E+   G
Sbjct: 50  --TFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRG 107

Query: 291 SLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME 350
            L+++LD      ++L + ++  +A+    GL  L+ Y +    + ++   + L+ ++ +
Sbjct: 108 YLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYK 161

Query: 351 ACISDLGL--AMAIPDGYTRVLISYVLGTMAYIAPEYFQQ--PELSEKCDIFSFGMLLIS 406
             I   GL   ++ P  +  V        M Y + +       E + K DI+S G++L  
Sbjct: 162 LKIICHGLEKILSSP-PFKNV------NFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWE 214

Query: 407 LVRGVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYI-- 464
           +  G   F      E + + E    ++N KN S  +    P           L+I  I  
Sbjct: 215 IFTGKIPF------ENLTTKEIYDLIIN-KNNSLKLPLDCP-----------LEIKCIVE 256

Query: 465 -CTLHDPEERPNSQYVRCRLSQ 485
            CT HD  +RPN + +   LS 
Sbjct: 257 ACTSHDSIKRPNIKEILYNLSL 278

Length = 283

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 46.5 bits (110), Expect = 1e-05
 Identities = 60/232 (25%), Positives = 95/232 (40%), Gaps = 42/232 (18%)

Query: 200 IGSGGCGEVYKAELPGSNGKM-IAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT 258
           IG G  G+V KA +     +M  AIK++  YA        ++D        R    E+  
Sbjct: 15  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-------KDDH-------RDFAGELEV 60

Query: 259 ASQI-RHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALG 317
             ++  H NI+ LL          L  E+  +G+L D L    R  R L+      IA  
Sbjct: 61  LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL----RKSRVLETDPAFAIANS 116

Query: 318 VASGLEYLHMYHSAS-------------IIHGDIKPRNVLLNDDMEACISDLGLAMAIPD 364
            AS L    + H A+              IH D+  RN+L+ ++  A I+D GL+     
Sbjct: 117 TASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG--- 173

Query: 365 GYTRVLISYVLGTMA--YIAPEYFQQPELSEKCDIFSFGMLLISLVR--GVP 412
               V +   +G +   ++A E       +   D++S+G+LL  +V   G P
Sbjct: 174 --QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 223

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 46.2 bits (109), Expect = 2e-05
 Identities = 53/216 (24%), Positives = 88/216 (40%), Gaps = 21/216 (9%)

Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  GEVY        G+ +A+K+V    P       + DS+    ++  +  EI   
Sbjct: 10  LGRGAFGEVYLC-YDADTGRELAVKQV----PF------DPDSQETSKEVNALECEIQLL 58

Query: 260 SQIRHRNILPLLAHMVRPDCHLL--VYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALG 317
             +RH  I+     +  P+   L    E+M  GS++D L    +    L      R    
Sbjct: 59  KNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL----KAYGALTENVTRRYTRQ 114

Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGY-TRVLISYVLG 376
           +  G+ YLH   S  I+H DIK  N+L +      + D G +  I     +   I  V G
Sbjct: 115 ILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTG 171

Query: 377 TMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVP 412
           T  +++PE         K D++S    ++ ++   P
Sbjct: 172 TPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 46.6 bits (110), Expect = 2e-05
 Identities = 38/142 (26%), Positives = 64/142 (45%), Gaps = 14/142 (9%)

Query: 278 DCHL-LVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHG 336
           D +L +V E+M  G L +++ +     +   W   +   + +A     L   HS  +IH 
Sbjct: 115 DKYLYMVMEYMPGGDLVNLMSNYDVPEK---WAKFYTAEVVLA-----LDAIHSMGLIHR 166

Query: 337 DIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQP----ELS 392
           D+KP N+LL+      ++D G  M + D    V     +GT  YI+PE  +         
Sbjct: 167 DVKPDNMLLDKHGHLKLADFGTCMKM-DETGMVRCDTAVGTPDYISPEVLKSQGGDGYYG 225

Query: 393 EKCDIFSFGMLLISLVRGVPSF 414
            +CD +S G+ L  ++ G   F
Sbjct: 226 RECDWWSVGVFLFEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 46.2 bits (109), Expect = 2e-05
 Identities = 54/230 (23%), Positives = 91/230 (39%), Gaps = 38/230 (16%)

Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           IG G  G+V KA +     +M A           A + ++E +   D   R    E+   
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDA-----------AIKRMKEYASKDDH--RDFAGELEVL 49

Query: 260 SQI-RHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRH------ 312
            ++  H NI+ LL          L  E+  +G+L D L        +  +   +      
Sbjct: 50  CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 109

Query: 313 ------RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGY 366
                   A  VA G++YL        IH D+  RN+L+ ++  A I+D GL+       
Sbjct: 110 SSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRG----- 161

Query: 367 TRVLISYVLGTMA--YIAPEYFQQPELSEKCDIFSFGMLLISLVR--GVP 412
             V +   +G +   ++A E       +   D++S+G+LL  +V   G P
Sbjct: 162 QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 211

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 46.6 bits (110), Expect = 2e-05
 Identities = 56/196 (28%), Positives = 89/196 (45%), Gaps = 25/196 (12%)

Query: 281 LLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR--IALGVASGLEYLHMYHSASIIHGDI 338
            LV E++  G   D++  + R R+    P  H    A  +   L +LH      II+ D+
Sbjct: 72  FLVIEYVNGG---DLMFHMQRQRK---LPEEHARFYAAEICIALNFLH---ERGIIYRDL 122

Query: 339 KPRNVLLNDDMEACISDLGLAM-AIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDI 397
           K  NVLL+ D    ++D G+    +  G T    S   GT  YIAPE  +  E     D 
Sbjct: 123 KLDNVLLDADGHIKLTDYGMCKEGLGPGDT---TSTFCGTPNYIAPEILRGEEYGFSVDW 179

Query: 398 FSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLH 457
           ++ G+L+  ++ G   F    +  ++ + ++L +V+  K P R   PR        K  H
Sbjct: 180 WALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK-PIRI--PRF----LSVKASH 232

Query: 458 VLKIAYICTLHDPEER 473
           VLK  ++    DP+ER
Sbjct: 233 VLK-GFLNK--DPKER 245

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 46.2 bits (109), Expect = 2e-05
 Identities = 56/227 (24%), Positives = 97/227 (42%), Gaps = 29/227 (12%)

Query: 200 IGSGGCGEV--YKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           +G G  G+V   + +  G    M  +KK ++ A    A  + E   L+++          
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNT---------- 52

Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALG 317
                RH  +  L       D    V E++  G L      +SR R   +  +R   A  
Sbjct: 53  -----RHPFLTSLKYSFQTKDRLCFVMEYVNGGEL---FFHLSRERVFSEDRTRFYGA-E 103

Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAM-AIPDGYTRVLISYVLG 376
           + S L+YLH   S  I++ D+K  N++L+ D    I+D GL    I D  T   +    G
Sbjct: 104 IVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAAT---MKTFCG 157

Query: 377 TMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI 423
           T  Y+APE  +  +     D +  G+++  ++ G   F ++Q+ E++
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHEKL 203

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 46.1 bits (109), Expect = 3e-05
 Identities = 43/170 (25%), Positives = 76/170 (44%), Gaps = 15/170 (8%)

Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQD-ILDDVSRGRRELDWPS 310
           ++ E+  +    H NI+P  A  +  +   +V  FM  GS +D I      G  EL   +
Sbjct: 46  LQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSEL---A 102

Query: 311 RHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVL 370
              I  GV   L+Y+   H    +H  +K  ++L++ D +  +S L   +++ +   R+ 
Sbjct: 103 IAYILQGVLKALDYI---HHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159

Query: 371 I-----SYVLGTMAYIAPEYFQQ--PELSEKCDIFSFGMLLISLVRG-VP 412
           +      Y +  + +++PE  QQ       K DI+S G+    L  G VP
Sbjct: 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 46.0 bits (109), Expect = 3e-05
 Identities = 34/116 (29%), Positives = 55/116 (47%), Gaps = 3/116 (2%)

Query: 289 NGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDD 348
           + S     ++ +     LD     R +  VA G+++L    S + IH D+  RNVLL D 
Sbjct: 192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDG 248

Query: 349 MEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
             A I D GLA  I +    V+       + ++APE       + + D++S+G+LL
Sbjct: 249 RVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILL 304

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 45.9 bits (109), Expect = 3e-05
 Identities = 37/139 (26%), Positives = 58/139 (41%), Gaps = 17/139 (12%)

Query: 282 LVYEFMKNGSLQDILD--DVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIK 339
           +V E+M  G L +++   D+        W          A  +  L   HS   IH D+K
Sbjct: 120 MVMEYMPGGDLVNLMSNYDIPE-----KWA-----RFYTAEVVLALDAIHSMGFIHRDVK 169

Query: 340 PRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQP----ELSEKC 395
           P N+LL+      ++D G  M + D    V     +GT  YI+PE  +          +C
Sbjct: 170 PDNMLLDKSGHLKLADFGTCMKM-DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGREC 228

Query: 396 DIFSFGMLLISLVRGVPSF 414
           D +S G+ L  ++ G   F
Sbjct: 229 DWWSVGVFLYEMLVGDTPF 247

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 45.5 bits (108), Expect = 3e-05
 Identities = 33/115 (28%), Positives = 52/115 (45%), Gaps = 17/115 (14%)

Query: 322 LEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA-MAIPDGYTRVLISY------- 373
           LEYLH Y    I+H D+KP N+L+       ++D GL+ + +    T +   +       
Sbjct: 114 LEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170

Query: 374 -----VLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI 423
                V GT  YIAPE   +    +  D ++ G++L   + G   F F    EE+
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPF-FGDTPEEL 224

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 45.2 bits (108), Expect = 3e-05
 Identities = 32/111 (28%), Positives = 50/111 (45%), Gaps = 18/111 (16%)

Query: 277 PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHG 336
              H+L+ +++K+G L D+L    +   +L      +I   +   L  LH ++   IIH 
Sbjct: 81  LKGHVLIMDYIKDGDLFDLL----KKEGKLSEAEVKKIIRQLVEALNDLHKHN---IIHN 133

Query: 337 DIKPRNVLLNDDME-ACISDLGLAMAI--PDGYTRVLISYVLGTMAYIAPE 384
           DIK  NVL +   +   + D GL   I  P  Y         GT+ Y +PE
Sbjct: 134 DIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD--------GTLDYFSPE 176

Length = 267

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 45.4 bits (107), Expect = 4e-05
 Identities = 48/161 (29%), Positives = 71/161 (44%), Gaps = 25/161 (15%)

Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI---PDGYTRVLISYV 374
           VA G+E+L    S   IH D+  RN+LL+++    I D GLA  I   PD Y R   + +
Sbjct: 183 VARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-YVRKGSARL 238

Query: 375 LGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSPEWLRKVM 433
              + ++APE       + + D++SFG+LL  +   G   +   Q  EE C         
Sbjct: 239 --PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQ-------- 288

Query: 434 NSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERP 474
             K+ +R   P        + ML        C   DP+ERP
Sbjct: 289 RLKDGTRMRAPENATPEIYRIMLA-------CWQGDPKERP 322

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 45.7 bits (108), Expect = 4e-05
 Identities = 39/144 (27%), Positives = 61/144 (42%), Gaps = 7/144 (4%)

Query: 261 QIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVAS 320
           ++ H  +L LL   VR    L      K  S  D+   +    R L       +A  + S
Sbjct: 216 RLSHPAVLALLD--VRVVGGLTCLVLPKYRS--DLYTYLGARLRPLGLAQVTAVARQLLS 271

Query: 321 GLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAY 380
            ++Y+H      IIH DIK  NVL+N   + C+ D G A      ++      + GT+  
Sbjct: 272 AIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDT 328

Query: 381 IAPEYFQQPELSEKCDIFSFGMLL 404
            APE       +   DI+S G+++
Sbjct: 329 NAPEVLAGDPYTPSVDIWSAGLVI 352

Length = 461

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 45.4 bits (107), Expect = 4e-05
 Identities = 42/162 (25%), Positives = 69/162 (42%), Gaps = 23/162 (14%)

Query: 282 LVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPR 341
           +V E+M  G L +++ +     +   W   +   + +A     L   HS   IH D+KP 
Sbjct: 120 MVMEYMPGGDLVNLMSNYDVPEK---WARFYTAEVVLA-----LDAIHSMGFIHRDVKPD 171

Query: 342 NVLLNDDMEACISDLGLAMAI-PDGYTRVLISYVLGTMAYIAPEYFQQP----ELSEKCD 396
           N+LL+      ++D G  M +  +G  R      +GT  YI+PE  +          +CD
Sbjct: 172 NMLLDKSGHLKLADFGTCMKMNKEGMVRC--DTAVGTPDYISPEVLKSQGGDGYYGRECD 229

Query: 397 IFSFGMLLISLVRG-VPSFVFHQNGEEICSPEWLRKVMNSKN 437
            +S G+ L  ++ G  P +     G          K+MN KN
Sbjct: 230 WWSVGVFLYEMLVGDTPFYADSLVGT-------YSKIMNHKN 264

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 45.0 bits (106), Expect = 5e-05
 Identities = 57/227 (25%), Positives = 98/227 (43%), Gaps = 28/227 (12%)

Query: 200 IGSGGCGEV--YKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           +G G  G+V   K +  G    M  +KK ++ A    A  + E+  L++S          
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS---------- 52

Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALG 317
                RH  +  L       D    V E+   G L      +SR R   +  +R   A  
Sbjct: 53  -----RHPFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGA-E 103

Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAM-AIPDGYTRVLISYVLG 376
           + S L+YLH     ++++ D+K  N++L+ D    I+D GL    I DG T   +    G
Sbjct: 104 IVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---MKTFCG 158

Query: 377 TMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI 423
           T  Y+APE  +  +     D +  G+++  ++ G   F ++Q+ E++
Sbjct: 159 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHEKL 204

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 45.4 bits (107), Expect = 5e-05
 Identities = 39/156 (25%), Positives = 68/156 (43%), Gaps = 3/156 (1%)

Query: 253 RSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRH 312
           RSE+   +   H  I+         D  LL+ E+   G L   +    R +  L +   +
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIK--QRLKEHLPF-QEY 169

Query: 313 RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLIS 372
            + L     +  L   HS  ++H D+K  N+ L       + D G +    D  +  + S
Sbjct: 170 EVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVAS 229

Query: 373 YVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLV 408
              GT  Y+APE +++   S+K D++S G++L  L+
Sbjct: 230 SFCGTPYYLAPELWERKRYSKKADMWSLGVILYELL 265

Length = 478

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 44.7 bits (106), Expect = 7e-05
 Identities = 62/228 (27%), Positives = 94/228 (41%), Gaps = 34/228 (14%)

Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           F  L  +G G  G+V  AE   + G++ AIK            L + D   RD ++  + 
Sbjct: 1   FRCLAVLGRGHFGKVLLAEYKKT-GELYAIKA-----------LKKGDIIARD-EVESLM 47

Query: 254 SE---IITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQ-DILDDVSRGRRELDWP 309
            E     TA+  RH  ++ L A     D    V E+   G L   I  DV    R + + 
Sbjct: 48  CEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFY- 106

Query: 310 SRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA---MAIPDGY 366
                A  V  GL+YLH      I++ D+K  N+LL+ +    I+D GL    M   D  
Sbjct: 107 -----AACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD-- 156

Query: 367 TRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
                S   GT  ++APE   +   +   D +  G+L+  ++ G   F
Sbjct: 157 ---RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPF 201

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 44.5 bits (105), Expect = 8e-05
 Identities = 38/154 (24%), Positives = 56/154 (36%), Gaps = 57/154 (37%)

Query: 329 HSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI-----PDGYTRV-------------- 369
           H    IH DIKP N+L++      +SD GL+           Y ++              
Sbjct: 118 HKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRN 177

Query: 370 -------------------------LISY-VLGTMAYIAPEYFQQPELSEKCDIFSFGML 403
                                    L++Y  +GT  YIAPE F Q    ++CD +S G +
Sbjct: 178 SVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI 237

Query: 404 LISLVRGVPSFVFHQNGEEICSP---EWLRKVMN 434
           +   + G P F         CS    E  RK++N
Sbjct: 238 MFECLIGWPPF---------CSENSHETYRKIIN 262

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 44.4 bits (105), Expect = 9e-05
 Identities = 31/127 (24%), Positives = 49/127 (38%), Gaps = 41/127 (32%)

Query: 329 HSASIIHGDIKPRNVLLNDDMEACISDLGL----------------------AMAIPDGY 366
           H    IH DIKP N+L++ D    ++D GL                      +M   + +
Sbjct: 118 HKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEW 177

Query: 367 -------------------TRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISL 407
                               R L   ++GT  YIAPE   +   ++ CD +S G++L  +
Sbjct: 178 SEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237

Query: 408 VRGVPSF 414
           + G P F
Sbjct: 238 LVGQPPF 244

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 43.4 bits (102), Expect = 1e-04
 Identities = 45/173 (26%), Positives = 74/173 (42%), Gaps = 24/173 (13%)

Query: 190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKL 249
           KE  F  ++ +GSG  G VYK  L    G+ + I       P++  EL E  S   +   
Sbjct: 5   KETEFKKIKVLGSGAFGTVYKG-LWIPEGEKVKI-------PVAIKELREATSPKAN--- 53

Query: 250 RQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDIL---DDVSRGRREL 306
           ++I  E    + + + ++  LL   +     L + + M  G L D +    D    +  L
Sbjct: 54  KEILDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLL 112

Query: 307 DWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA 359
           +W       + +A G+ YL       ++H D+  RNVL+       I+D GLA
Sbjct: 113 NW------CVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLA 156

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 43.1 bits (102), Expect = 1e-04
 Identities = 42/176 (23%), Positives = 69/176 (39%), Gaps = 41/176 (23%)

Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISY 373
           IA+     L YL       IIH D+KP N+LL+ +    + D G++     G    L+  
Sbjct: 112 IAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGIS-----GQ---LVDS 161

Query: 374 VLGTM-----AYIAPEYFQQPELSE----KCDIFSFGMLLISLVRGV---PSF--VFHQN 419
           +  T       Y+APE    P   +    + D++S G+ L  +  G    P +  VF Q 
Sbjct: 162 IAKTRDAGCRPYMAPERI-DPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQ- 219

Query: 420 GEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPN 475
                    L +V+   +P     P L  +   +     +    +C + D  +RP 
Sbjct: 220 ---------LTQVVKG-DP-----PILSNSEEREFSPSFVNFINLCLIKDESKRPK 260

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 27/91 (29%), Positives = 45/91 (49%), Gaps = 6/91 (6%)

Query: 329 HSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQ 388
           H    +H DIKP N+L++ +    ++D G  + + +  T V  S  +GT  YI+PE  Q 
Sbjct: 119 HQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQA 177

Query: 389 PE-----LSEKCDIFSFGMLLISLVRGVPSF 414
            E        +CD +S G+ +  ++ G   F
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 42.9 bits (101), Expect = 2e-04
 Identities = 28/91 (30%), Positives = 44/91 (48%), Gaps = 4/91 (4%)

Query: 325 LHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAM-AIPDGYTRVLISYVLGTMAYIAP 383
           L+  H   II+ D+K  NVLL+ +    ++D G+    I  G T    S   GT  YIAP
Sbjct: 109 LNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT---TSTFCGTPNYIAP 165

Query: 384 EYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
           E  +  +     D ++ G+L+  ++ G   F
Sbjct: 166 EILRGEDYGFSVDWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 42.9 bits (101), Expect = 2e-04
 Identities = 28/94 (29%), Positives = 47/94 (50%), Gaps = 7/94 (7%)

Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAM-AIPDGYTRVLISYVLG 376
           + S L YLH   S  +++ D+K  N++L+ D    I+D GL    I DG T   +    G
Sbjct: 104 IVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKTFCG 157

Query: 377 TMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRG 410
           T  Y+APE  +  +     D +  G+++  ++ G
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 191

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 42.7 bits (100), Expect = 3e-04
 Identities = 37/122 (30%), Positives = 56/122 (45%), Gaps = 7/122 (5%)

Query: 284 YEFMKNGSLQDIL-DDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRN 342
           Y+   +  ++++L DD S G   LD  S       VA G+E+L    S + +H D+  RN
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLS---FTYQVARGMEFLA---SKNCVHRDLAARN 267

Query: 343 VLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGM 402
           VLL       I D GLA  I      V        + ++APE       +   D++S+G+
Sbjct: 268 VLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGI 327

Query: 403 LL 404
           LL
Sbjct: 328 LL 329

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 42.1 bits (99), Expect = 3e-04
 Identities = 43/189 (22%), Positives = 84/189 (44%), Gaps = 33/189 (17%)

Query: 260 SQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVA 319
           SQ+ H++++      V  D  ++V E++K GSL   L   ++    + W       L VA
Sbjct: 54  SQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKK-NKNLINISW------KLEVA 106

Query: 320 SGLEY-LHMYHSASIIHGDIKPRNVLLNDDMEAC--------ISDLGLAMAIPDGYTRVL 370
             L + LH      + HG++  +NVLL  + +          +SD G+++ +      + 
Sbjct: 107 KQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV------LP 160

Query: 371 ISYVLGTMAYIAPEYFQQPE-LSEKCDIFSFGMLL----------ISLVRGVPSFVFHQN 419
              +L  + ++ PE  + P+ LS   D +SFG  L          +S +       F+++
Sbjct: 161 KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYED 220

Query: 420 GEEICSPEW 428
             ++ +P+W
Sbjct: 221 RHQLPAPKW 229

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 42.3 bits (99), Expect = 3e-04
 Identities = 32/90 (35%), Positives = 49/90 (54%), Gaps = 9/90 (10%)

Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI---PDGYTRVLISYV 374
           VA G+E+L    S   IH D+  RN+LL+++    I D GLA  I   PD Y R   + +
Sbjct: 188 VAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-YVRKGDARL 243

Query: 375 LGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
              + ++APE       + + D++SFG+LL
Sbjct: 244 --PLKWMAPETIFDRVYTIQSDVWSFGVLL 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 42.0 bits (99), Expect = 3e-04
 Identities = 67/298 (22%), Positives = 113/298 (37%), Gaps = 51/298 (17%)

Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
             IG G  G+VY+        + IA+          A +  +  +    S   +   E  
Sbjct: 12  RCIGEGQFGDVYQGVYMSPENEKIAV----------AVKTCKNCTS--PSVREKFLQEAY 59

Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALG 317
              Q  H +I+ L+  ++  +   +V E    G L+  L      +  LD  S    +  
Sbjct: 60  IMRQFDHPHIVKLIG-VITENPVWIVMELAPLGELRSYL---QVNKYSLDLASLILYSYQ 115

Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGT 377
           +++ L YL    S   +H DI  RNVL++      + D GL+  + D       SY   +
Sbjct: 116 LSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE------SYYKAS 166

Query: 378 -----MAYIAPEYFQQPELSEKCDIFSFG--MLLISLVRGVPSFVFHQNGEEICSPEWLR 430
                + ++APE       +   D++ FG  M  I L+ GV  F   +N + I       
Sbjct: 167 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEI-LMLGVKPFQGVKNNDVI------- 218

Query: 431 KVMNSKNPSR-AIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL 487
                +N  R  + P  P   Y         +   C  +DP +RP    ++ +LS +L
Sbjct: 219 --GRIENGERLPMPPNCPPTLYS--------LMTKCWAYDPSKRPRFTELKAQLSDIL 266

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 41.7 bits (98), Expect = 6e-04
 Identities = 28/96 (29%), Positives = 47/96 (48%), Gaps = 8/96 (8%)

Query: 325 LHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI-PDGYTRVLISYVLGTMAYIAP 383
           +   H    +H DIKP NVLL+ +    ++D G  + +  DG  +  ++  +GT  YI+P
Sbjct: 115 IDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVA--VGTPDYISP 172

Query: 384 EYFQQPE-----LSEKCDIFSFGMLLISLVRGVPSF 414
           E  Q  E        +CD +S G+ +  ++ G   F
Sbjct: 173 EILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 41.0 bits (96), Expect = 6e-04
 Identities = 39/172 (22%), Positives = 65/172 (37%), Gaps = 20/172 (11%)

Query: 266 NILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRREL--DWPSRHRIALGVASGLE 323
           N++ L  ++V  D   LV +  + G L   +        E    W +   +AL       
Sbjct: 46  NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVAL------- 98

Query: 324 YLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAP 383
                H   I+  D+ P N+LL+D     ++       + D      +  +     Y AP
Sbjct: 99  --DALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----YCAP 151

Query: 384 EYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNG----EEICSPEWLRK 431
           E     E +E CD +S G +L  L+ G      H +G      +  PEW+ +
Sbjct: 152 EVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEWVSE 203

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 41.0 bits (96), Expect = 7e-04
 Identities = 42/156 (26%), Positives = 73/156 (46%), Gaps = 20/156 (12%)

Query: 260 SQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVA 319
           SQ+ H ++  +    VR   +++V EF+++G L D+     +GR  + W  +  +A  +A
Sbjct: 71  SQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPL-DVCLRKEKGRVPVAW--KITVAQQLA 127

Query: 320 SGLEYLHMYHSASIIHGDIKPRNVL-----LNDDMEACI--SDLGLAMAIPDGYTRVLIS 372
           S L YL      +++HG++  +N+L     L +     I  SD G++        RV   
Sbjct: 128 SALSYLE---DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREERV--- 181

Query: 373 YVLGTMAYIAPEYFQQ-PELSEKCDIFSFGMLLISL 407
                + +IAPE       LS   D +SFG  L+ +
Sbjct: 182 ---ERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 41.4 bits (97), Expect = 8e-04
 Identities = 29/95 (30%), Positives = 42/95 (44%), Gaps = 3/95 (3%)

Query: 322 LEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG-YTRVLISYVLGTMAY 380
           LE L   H   IIH D+K  N+ L++   A + D G A  +     T     +  GT+  
Sbjct: 195 LEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWS-GTLET 253

Query: 381 IAPEYFQQPELSEKCDIFSFGMLLIS-LVRGVPSF 414
            +PE         K DI+S G++L    V+ V  F
Sbjct: 254 NSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLF 288

Length = 392

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 41.1 bits (96), Expect = 8e-04
 Identities = 54/218 (24%), Positives = 94/218 (43%), Gaps = 24/218 (11%)

Query: 190 KEDCFASLEKIGSGGCGEVYKA-ELP-GSNGKMIAIKKVIVYAPISAAELIEEDSKLRDS 247
           KE     L+ +GSG  G V+K   +P G + K+    K I            +D   R +
Sbjct: 5   KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTI------------QDRSGRQT 52

Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHL-LVYEFMKNGSLQDILDDVSRGRREL 306
             ++I   ++    + H  I+ LL   + P   L LV +    GSL   LD V + R  L
Sbjct: 53  -FQEITDHMLAMGSLDHAYIVRLLG--ICPGASLQLVTQLSPLGSL---LDHVRQHRDSL 106

Query: 307 DWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGY 366
           D        + +A G+ YL  +    ++H ++  RN+LL  D    I+D G+A  +    
Sbjct: 107 DPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDD 163

Query: 367 TRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
            +   S     + ++A E       + + D++S+G+ +
Sbjct: 164 KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTV 201

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 40.8 bits (95), Expect = 0.001
 Identities = 31/132 (23%), Positives = 48/132 (36%), Gaps = 45/132 (34%)

Query: 329 HSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI-------------------------- 362
           H    IH DIKP N+L++ D    ++D GL                              
Sbjct: 118 HKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEW 177

Query: 363 --PDG-----------------YTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGML 403
             P                   + R L   ++GT  YIAPE   +   ++ CD +S G++
Sbjct: 178 GDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237

Query: 404 LISLVRGVPSFV 415
           L  ++ G P F+
Sbjct: 238 LYEMLVGQPPFL 249

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 40.4 bits (94), Expect = 0.002
 Identities = 32/132 (24%), Positives = 50/132 (37%), Gaps = 45/132 (34%)

Query: 329 HSASIIHGDIKPRNVLLNDDMEACISDLGL----------------------AMAIPD-- 364
           H    IH DIKP N+L++ D    ++D GL                      +M   D  
Sbjct: 118 HKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLW 177

Query: 365 ---------------------GYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGML 403
                                 + R L   ++GT  YIAPE   +   ++ CD +S G++
Sbjct: 178 DDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237

Query: 404 LISLVRGVPSFV 415
           L  ++ G P F+
Sbjct: 238 LFEMLVGQPPFL 249

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32

 Score = 39.1 bits (92), Expect = 0.002
 Identities = 12/31 (38%), Positives = 19/31 (61%), Gaps = 1/31 (3%)

Query: 329 HSASIIHGDIKPRNVLLNDDMEACISDLGLA 359
           H A I+HGD+   N+++ DD +  + D GL 
Sbjct: 107 HKAGIVHGDLTTSNIIVRDD-KLYLIDFGLG 136

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 39.7 bits (92), Expect = 0.003
 Identities = 37/135 (27%), Positives = 63/135 (46%), Gaps = 11/135 (8%)

Query: 281 LLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKP 340
             V E++  G   D++  + R R+  +  +R   A  ++  L YLH      II+ D+K 
Sbjct: 72  FFVIEYVNGG---DLMFHMQRQRKLPEEHARFYSA-EISLALNYLH---ERGIIYRDLKL 124

Query: 341 RNVLLNDDMEACISDLGLAM-AIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFS 399
            NVLL+ +    ++D G+    +  G T    S   GT  YIAPE  +  +     D ++
Sbjct: 125 DNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCGTPNYIAPEILRGEDYGFSVDWWA 181

Query: 400 FGMLLISLVRGVPSF 414
            G+L+  ++ G   F
Sbjct: 182 LGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 39.1 bits (91), Expect = 0.004
 Identities = 27/87 (31%), Positives = 43/87 (49%), Gaps = 3/87 (3%)

Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGT 377
           VA G+ +L    S + IH D+  RN+LL       I D GLA  I +    V+       
Sbjct: 223 VAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279

Query: 378 MAYIAPEYFQQPELSEKCDIFSFGMLL 404
           + ++APE       + + D++S+G+LL
Sbjct: 280 VKWMAPESIFNCVYTFESDVWSYGILL 306

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 39.5 bits (92), Expect = 0.004
 Identities = 41/166 (24%), Positives = 79/166 (47%), Gaps = 20/166 (12%)

Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           F  ++ I  G  G+VY      +N K+ A+K V        A++I ++       + Q++
Sbjct: 6   FVIVKPISRGAFGKVYLGR-KKNNSKLYAVKVV------KKADMINKN------MVHQVQ 52

Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
           +E    +  +   I+ L   +   +   LV E++  G ++ +L        E+   +   
Sbjct: 53  AERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEM---AVKY 109

Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA 359
           I+  VA  L+YLH +    IIH D+KP N+L++++    ++D GL+
Sbjct: 110 IS-EVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLS 151

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated

 Score = 39.1 bits (92), Expect = 0.004
 Identities = 14/38 (36%), Positives = 19/38 (50%), Gaps = 1/38 (2%)

Query: 323 EYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAM 360
           E +   H A I+HGD+   N ++ DD    I D GL  
Sbjct: 439 EIVAKLHKAGIVHGDLTTSNFIVRDDRLYLI-DFGLGK 475

Length = 535

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	487
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.98
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.98
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.98
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.97
KOG1152	772	consensus Signal transduction serine/threonine kin	99.97
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.97
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.96
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.96
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.96
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.96
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.95
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.95
PLN00181	793	protein SPA1-RELATED; Provisional	99.94
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.93
PRK09188	365	serine/threonine protein kinase; Provisional	99.91
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.91
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.91
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.91
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.9
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.9
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.89
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.86
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.86
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.85
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.85
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.85
PRK12274	218	serine/threonine protein kinase; Provisional	99.84
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.83
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.81
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.79
PRK10345	210	hypothetical protein; Provisional	99.77
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.75
smart00090	237	RIO RIO-like kinase.	99.75
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.74
PRK14879	211	serine/threonine protein kinase; Provisional	99.74
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.73
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.73
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.71
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.7
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.67
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.64
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.61
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.59
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.56
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.44
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.44
KOG1243	690	consensus Protein kinase [General function predict	99.4
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.34
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.3
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.29
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.28
KOG3087	229	consensus Serine/threonine protein kinase [General	99.27
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.27
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.25
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.0
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.99
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.92
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.84
COG4248	637	Uncharacterized protein with protein kinase and he	98.82
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.81
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.73
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.67
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.62
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.61
PRK09902	216	hypothetical protein; Provisional	98.54
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.23
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.23
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.21
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.16
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.16
PF01636	239	APH: Phosphotransferase enzyme family This family	98.02
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.97
KOG0576	829	consensus Mitogen-activated protein kinase kinase	97.97
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	97.96
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.94
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.88
PLN02876	822	acyl-CoA dehydrogenase	97.81
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.8
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.66
PRK10593	297	hypothetical protein; Provisional	97.37
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.33
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.32
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.32
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.28
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.22
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.19
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.09
PRK05231	319	homoserine kinase; Provisional	97.08
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	96.64
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.6
KOG2270	520	consensus Serine/threonine protein kinase involved	96.2
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.18
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	96.09
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.07
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.07
PLN02756	418	S-methyl-5-thioribose kinase	95.93
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	95.82
PRK12396	409	5-methylribose kinase; Reviewed	95.77
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	95.48
KOG1093	725	consensus Predicted protein kinase (contains TBC a	95.47
PLN02236	344	choline kinase	95.43
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.01
PF05659	147	RPW8: Arabidopsis broad-spectrum mildew resistance	94.92
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	94.68
PF12061	402	DUF3542: Protein of unknown function (DUF3542); In	94.65
KOG1236	565	consensus Predicted unusual protein kinase [Genera	94.64
PRK11768	325	serine/threonine protein kinase; Provisional	94.23
PRK06148	1013	hypothetical protein; Provisional	93.49
PRK10271	188	thiK thiamine kinase; Provisional	92.06

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-50  Score=375.98  Aligned_cols=254  Identities=29%  Similarity=0.437  Sum_probs=214.9

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      +++.+..||+|..|+||++.++ .+++.+|+|++..              ...+...+++.+|+++++..+||+||.+||
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk-~t~~i~AlK~I~~--------------~~~~~~~~Qi~rEl~il~~~~spyIV~~yg  144 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHK-PTGKIYALKVILL--------------NIDPALQKQILRELEILRSCQSPYIVGFYG  144 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEc-CCCeEEEEEeecc--------------cCCHHHHHHHHHHHHHHhhCCCCCeeeEeE
Confidence            5788899999999999999864 6899999999833              345667889999999999999999999999


Q ss_pred             EEecCC-eeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          273 HMVRPD-CHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       273 ~~~~~~-~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      .|..+. .++|+||||++|||.+++..    .+.+++...-+++.++++||.|||  ++++||||||||+|||++..|+|
T Consensus       145 aF~~~~~~isI~mEYMDgGSLd~~~k~----~g~i~E~~L~~ia~~VL~GL~YLh--~~~~IIHRDIKPsNlLvNskGeV  218 (364)
T KOG0581|consen  145 AFYSNGEEISICMEYMDGGSLDDILKR----VGRIPEPVLGKIARAVLRGLSYLH--EERKIIHRDIKPSNLLVNSKGEV  218 (364)
T ss_pred             EEEeCCceEEeehhhcCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHh--hccCeeeccCCHHHeeeccCCCE
Confidence            999998 49999999999999999975    367999999999999999999996  34679999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRK  431 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~  431 (487)
                      ||||||.|..+...    ...+++||..|||||.+.+..|+.++||||||++++|+.+|+.||..... ......+.+..
T Consensus       219 KicDFGVS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~-~~~~~~~Ll~~  293 (364)
T KOG0581|consen  219 KICDFGVSGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP-PYLDIFELLCA  293 (364)
T ss_pred             EeccccccHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC-CCCCHHHHHHH
Confidence            99999999877554    34678899999999999999999999999999999999999999966521 12233444544


Q ss_pred             HHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          432 VMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       432 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      +..+..|      ++|..   ..+.++..++..||++||.+|||++++++
T Consensus       294 Iv~~ppP------~lP~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  294 IVDEPPP------RLPEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             HhcCCCC------CCCcc---cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            4433322      23332   34467999999999999999999999875

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2e-48  Score=365.58  Aligned_cols=249  Identities=27%  Similarity=0.406  Sum_probs=202.9

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      .+|...+.||+|+||+||+|++. .++..||||.+..             ........+.+..|+.+++.++|||||+++
T Consensus        10 ~~y~~~~~iG~GsfavVykg~h~-~~~~~VAIK~i~~-------------~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~   75 (429)
T KOG0595|consen   10 GDYELSREIGSGSFAVVYKGRHK-KSGTEVAIKCIAK-------------KKLNKKLVELLLSEIKILKELKHPNIVRLL   75 (429)
T ss_pred             ccceehhhccCcceEEEEEeEec-cCCceEEeeeehh-------------hccCHHHHHHHHHHHHHHHhcCCcceeeEE
Confidence            35888899999999999999875 4669999999832             233556677889999999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC---
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDD---  348 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~---  348 (487)
                      +++..++.+|+|||||.||+|.+|+..    .+.+++.+++.++.|++.||++|   |+++||||||||.|||++..   
T Consensus        76 d~~~~~~~i~lVMEyC~gGDLs~yi~~----~~~l~e~t~r~Fm~QLA~alq~L---~~~~IiHRDLKPQNiLLs~~~~~  148 (429)
T KOG0595|consen   76 DCIEDDDFIYLVMEYCNGGDLSDYIRR----RGRLPEATARHFMQQLASALQFL---HENNIIHRDLKPQNILLSTTARN  148 (429)
T ss_pred             EEEecCCeEEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeccCCcceEEeccCCCC
Confidence            999999999999999999999999986    45899999999999999999999   77779999999999999864   


Q ss_pred             ---CCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCcccc
Q 011360          349 ---MEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICS  425 (487)
Q Consensus       349 ---~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~  425 (487)
                         -.+||+|||+|+.+..+...   .+.+|+|-|||||++....|+.|+|+||+|+++|++++|++||..      .+.
T Consensus       149 ~~~~~LKIADFGfAR~L~~~~~a---~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a------~t~  219 (429)
T KOG0595|consen  149 DTSPVLKIADFGFARFLQPGSMA---ETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA------ETP  219 (429)
T ss_pred             CCCceEEecccchhhhCCchhHH---HHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc------cCH
Confidence               45899999999998765433   578899999999999999999999999999999999999999933      233


Q ss_pred             HHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHH
Q 011360          426 PEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQY  478 (487)
Q Consensus       426 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~  478 (487)
                      .+.+..+-.+......+...+.        ..+.+++...++.+|.+|-++.+
T Consensus       220 ~eL~~~~~k~~~~~~~~~~~~s--------~~~~~Ll~~ll~~~~~~~~~~~~  264 (429)
T KOG0595|consen  220 KELLLYIKKGNEIVPVLPAELS--------NPLRELLISLLQRNPKDRISFED  264 (429)
T ss_pred             HHHHHHHhccccccCchhhhcc--------CchhhhhhHHHhcCccccCchHH
Confidence            3444444333333222222222        22456666677777777776654

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-48  Score=377.86  Aligned_cols=256  Identities=31%  Similarity=0.454  Sum_probs=207.5

Q ss_pred             ccccccccccccceeEEEEEecCCCCce-EEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKM-IAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~-vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      .+...+.+|.|+||+||+|.|+   |.. ||||++..             ........+.|.+|+.++.+++|||||+++
T Consensus        42 ~l~~~~~iG~G~~g~V~~~~~~---g~~~vavK~~~~-------------~~~~~~~~~~f~~E~~il~~l~HpNIV~f~  105 (362)
T KOG0192|consen   42 ELPIEEVLGSGSFGTVYKGKWR---GTDVVAVKIISD-------------PDFDDESRKAFRREASLLSRLRHPNIVQFY  105 (362)
T ss_pred             HhhhhhhcccCCceeEEEEEeC---CceeEEEEEecc-------------hhcChHHHHHHHHHHHHHHhCCCCCeeeEE
Confidence            3555667999999999999984   445 99998832             111222277899999999999999999999


Q ss_pred             eEEecCC-eeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCC-eeecCCCCCCEEeCCCC
Q 011360          272 AHMVRPD-CHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSAS-IIHGDIKPRNVLLNDDM  349 (487)
Q Consensus       272 ~~~~~~~-~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~g-ivH~Dlkp~Nill~~~~  349 (487)
                      |++..+. .+++||||+++|+|.+++...  ....+++..+..++.||++||.||   |+++ ||||||||+|||++.++
T Consensus       106 G~~~~~~~~~~iVtEy~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YL---H~~~~iIHrDLK~~NiLv~~~~  180 (362)
T KOG0192|consen  106 GACTSPPGSLCIVTEYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYL---HSEGPIIHRDLKSDNILVDLKG  180 (362)
T ss_pred             EEEcCCCCceEEEEEeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHH---hcCCCeeecccChhhEEEcCCC
Confidence            9999887 799999999999999999752  467899999999999999999999   7778 99999999999999998


Q ss_pred             -CEEEeccCCccccCCCCceeeEeeecccccccCCcccC--CCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccH
Q 011360          350 -EACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQ--QPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSP  426 (487)
Q Consensus       350 -~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~  426 (487)
                       ++||+|||+++......  ...+...||+.|||||++.  ...|+.|+||||||+++|||+||+.||....+      .
T Consensus       181 ~~~KI~DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~------~  252 (362)
T KOG0192|consen  181 KTLKIADFGLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP------V  252 (362)
T ss_pred             CEEEECCCccceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH------H
Confidence             99999999998765432  1123367999999999999  56999999999999999999999999944332      1


Q ss_pred             HHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          427 EWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       427 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      .....+.. ...+..++..+        ...+..++.+||+.||+.||++.+|+..|+.+
T Consensus       253 ~~~~~v~~-~~~Rp~~p~~~--------~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~  303 (362)
T KOG0192|consen  253 QVASAVVV-GGLRPPIPKEC--------PPHLSSLMERCWLVDPSRRPSFLEIVSRLESI  303 (362)
T ss_pred             HHHHHHHh-cCCCCCCCccC--------CHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHH
Confidence            22222322 22222222222        35688999999999999999999999999865

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4e-48  Score=380.59  Aligned_cols=251  Identities=27%  Similarity=0.400  Sum_probs=212.9

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ..|...+.||+|||..||.++. ..+|..||+|++..            ....+....+.+.+|+++.++|+|||||+++
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~-~~tge~~A~KvVpk------------~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~   84 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARD-LDTGEVVAVKVVPK------------KLLKKPKQREKVLNEIEIHRSLKHPNIVQFY   84 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEE-cCCCcEEEEEEeeh------------HHhcCcchHHHHHHHHHHHHhcCCCcEEeee
Confidence            4699999999999999999974 46899999999832            2334556677889999999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      ++|++.+++|||.|+|..++|..+++.    .+++++..++.++.||+.||.||   |+++|+|||||..|+|++++.++
T Consensus        85 ~~FEDs~nVYivLELC~~~sL~el~Kr----rk~ltEpEary~l~QIv~GlkYL---H~~~IiHRDLKLGNlfL~~~~~V  157 (592)
T KOG0575|consen   85 HFFEDSNNVYIVLELCHRGSLMELLKR----RKPLTEPEARYFLRQIVEGLKYL---HSLGIIHRDLKLGNLFLNENMNV  157 (592)
T ss_pred             eEeecCCceEEEEEecCCccHHHHHHh----cCCCCcHHHHHHHHHHHHHHHHH---HhcCceecccchhheeecCcCcE
Confidence            999999999999999999999999874    68899999999999999999999   88899999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRK  431 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~  431 (487)
                      ||+|||+|..+.......  .+.+|||.|.|||++....++..+||||+||++|-|++|+|||...      ...+-...
T Consensus       158 KIgDFGLAt~le~~~Erk--~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk------~vkety~~  229 (592)
T KOG0575|consen  158 KIGDFGLATQLEYDGERK--KTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK------TVKETYNK  229 (592)
T ss_pred             EecccceeeeecCccccc--ceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc------hHHHHHHH
Confidence            999999999886543332  5789999999999999999999999999999999999999999332      22222333


Q ss_pred             HHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          432 VMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       432 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      +... +.      .+|.    ..+....+||..+|++||.+|||+.+|+.
T Consensus       230 Ik~~-~Y------~~P~----~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  230 IKLN-EY------SMPS----HLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             HHhc-Cc------cccc----ccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            3222 11      1222    23345889999999999999999999985

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-49  Score=381.81  Aligned_cols=358  Identities=23%  Similarity=0.328  Sum_probs=256.8

Q ss_pred             hhccchhhhhhhhhHHHHHHhhh----chhhhhhHHHHHH----------HHHHHHHHHHhhccccCCCC-cc--ccccc
Q 011360           89 LACDVDYLLDEFQTEAFQTMLLQ----DADAMSKVKEVNA----------RLQDIAWQINVLGLKESFGG-KS--RNVRQ  151 (487)
Q Consensus        89 ~~yd~~~~~~~~~~~~~~~~l~~----~~~~~~r~~ei~~----------~l~~i~~~~~~~~l~~~~g~-~~--~~~~~  151 (487)
                      -+.|-++.+..+.++..++.+..    .+-|.+|-++-..          ........+.|+.+....++ ..  ...+.
T Consensus        77 ~l~~~~Wf~~~isR~~ae~~ll~p~~~~G~flvR~se~~~g~yslsv~~~~~~~~~~~v~hyri~~~~~~~~~~~~~~~~  156 (468)
T KOG0197|consen   77 KLSDEPWFFGKISREEAERQLLAPENKEGAFLVRESESDKGDYSLSVREGDSGGLGAKVKHYRIRQLDGGGLYPYIDERE  156 (468)
T ss_pred             ccccCCchhccccHHHHHHhhcCCCCCccceeeecccCCcCCeeEEEEeccccCCccceeeeeeeEcCCCCeecCCCHHH
Confidence            35566777888888887754432    2445544332110          00001223344555444333 23  44455


Q ss_pred             CCCCCChhhhhhhcCCCC--C--CCCcccc--CCcchh---hHHHhhhccccccccccccccceeEEEEEecCCCCceEE
Q 011360          152 RFPTTPSLISAAVRGGSR--D--RGPTIFS--PLIEKE---DLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIA  222 (487)
Q Consensus       152 ~~~s~p~~~~~~~~~~~~--~--~~~~~~~--~~~~~~---~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~va  222 (487)
                      .|++.+.++.........  .  ..+....  ..+...   ...|......+..++.||+|.||.||.|.|+  ....||
T Consensus       157 ~F~~l~~lv~~~~~~~~gl~~~l~~p~~~~~~~~p~~~~~~~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~--~~~~va  234 (468)
T KOG0197|consen  157 LFSSLQQLVNYYSKNADGLCTRLRDPCSKQGHTKPQTPDLARDPWEIPREELKLIRELGSGQFGEVWLGKWN--GSTKVA  234 (468)
T ss_pred             hhhhHHHHHhhhhccCcchhhcccCchhccCCCCCCCCccccCCeeecHHHHHHHHHhcCCccceEEEEEEc--CCCccc
Confidence            566666665544332211  1  1111110  111111   2234444556888999999999999999996  444899


Q ss_pred             EEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceEEecCCeeEEEEEecCCCCHHHHHhhhhcC
Q 011360          223 IKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG  302 (487)
Q Consensus       223 vK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~  302 (487)
                      +|.+..                .......|.+|+++|.+|+|+|||++++++..++++|||||||+.|+|.+||..  ..
T Consensus       235 vk~ik~----------------~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~--~~  296 (468)
T KOG0197|consen  235 VKTIKE----------------GSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRT--RE  296 (468)
T ss_pred             ceEEec----------------cccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhh--cC
Confidence            998843                122345677999999999999999999999999999999999999999999986  56


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccC
Q 011360          303 RRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIA  382 (487)
Q Consensus       303 ~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~a  382 (487)
                      +..+...+.+.++.|||+|++||   +++++|||||.++||||+++..+||+|||+++...++..... ....-++.|+|
T Consensus       297 ~~~l~~~~Ll~~a~qIaeGM~YL---es~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~-~~~kfPIkWtA  372 (468)
T KOG0197|consen  297 GGLLNLPQLLDFAAQIAEGMAYL---ESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTAS-EGGKFPIKWTA  372 (468)
T ss_pred             CCccchHHHHHHHHHHHHHHHHH---HhCCccchhhhhhheeeccCceEEEcccccccccCCCceeec-CCCCCCceecC
Confidence            78899999999999999999999   788899999999999999999999999999996554443322 23335789999


Q ss_pred             CcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHH
Q 011360          383 PEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKI  461 (487)
Q Consensus       383 PE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  461 (487)
                      ||.+..+.++.||||||||++||||+| |+.||...      ...+.+..+..+.+...      |..    ++..+.++
T Consensus       373 PEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~m------sn~ev~~~le~GyRlp~------P~~----CP~~vY~l  436 (468)
T KOG0197|consen  373 PEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGM------SNEEVLELLERGYRLPR------PEG----CPDEVYEL  436 (468)
T ss_pred             HHHHhhCCcccccceeehhhhHHHHhccCCCCCCCC------CHHHHHHHHhccCcCCC------CCC----CCHHHHHH
Confidence            999999999999999999999999999 79998444      34455555555544321      111    23569999


Q ss_pred             HhhccCCCCCCCCChHHHHHHHhhh
Q 011360          462 AYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       462 i~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      |..||+.+|++|||++.+...|+++
T Consensus       437 M~~CW~~~P~~RPtF~~L~~~l~~~  461 (468)
T KOG0197|consen  437 MKSCWHEDPEDRPTFETLREVLEDF  461 (468)
T ss_pred             HHHHhhCCcccCCCHHHHHHHHHHh
Confidence            9999999999999999999999876

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.3e-49  Score=351.80  Aligned_cols=259  Identities=24%  Similarity=0.374  Sum_probs=211.6

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      .|.+.++||.|.||.||++.+ ..+|..+|.|.+. +            .............|+.+|++|+|||||++|+
T Consensus        20 ~y~Il~~IG~GsFg~vykv~~-~~~g~l~a~K~i~-f------------~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~   85 (375)
T KOG0591|consen   20 DYQILKKIGRGSFGEVYKVQC-LLDGKLVALKKIQ-F------------GMMDAKARQDCVKEISLLKQLNHPNIVQYYA   85 (375)
T ss_pred             HHHHHHHHcCCcchheEEeee-ccCcchhhhhhcc-h------------hhccHHHHHHHHHHHHHHHhcCCchHHHHHH
Confidence            599999999999999999975 4689999999884 2            2233345567889999999999999999998


Q ss_pred             -EEecCCe-eEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCC-CeeecCCCCCCEEeCCCC
Q 011360          273 -HMVRPDC-HLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSA-SIIHGDIKPRNVLLNDDM  349 (487)
Q Consensus       273 -~~~~~~~-~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~-givH~Dlkp~Nill~~~~  349 (487)
                       .+..+.. ++||||||.+|+|...++.+....+.+++..+++++.|++.||.++|+.-.+ -|+||||||.||+++.+|
T Consensus        86 ~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~g  165 (375)
T KOG0591|consen   86 HSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANG  165 (375)
T ss_pred             HhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCC
Confidence             4444444 8999999999999999999888899999999999999999999999653223 389999999999999999


Q ss_pred             CEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHH
Q 011360          350 EACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWL  429 (487)
Q Consensus       350 ~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~  429 (487)
                      .+||+|||+++.+....+-  ....+|||.||+||.+.+..|+.+|||||+||++|||..-.+||.+.      ...+..
T Consensus       166 vvKLGDfGL~r~l~s~~tf--A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~L~  237 (375)
T KOG0591|consen  166 VVKLGDFGLGRFLSSKTTF--AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLSLC  237 (375)
T ss_pred             ceeeccchhHhHhcchhHH--HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHHHH
Confidence            9999999999987654332  24678999999999999999999999999999999999999999544      233333


Q ss_pred             HHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHH
Q 011360          430 RKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCR  482 (487)
Q Consensus       430 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~  482 (487)
                      .++ ..+..+     ++|   ...++.++..++..|+.+||..||+...++..
T Consensus       238 ~KI-~qgd~~-----~~p---~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~d  281 (375)
T KOG0591|consen  238 KKI-EQGDYP-----PLP---DEHYSTDLRELINMCIAVDPEQRPDTVPYVQD  281 (375)
T ss_pred             HHH-HcCCCC-----CCc---HHHhhhHHHHHHHHHccCCcccCCCcchHHHH
Confidence            333 333321     133   34566789999999999999999985444433

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-47  Score=376.05  Aligned_cols=277  Identities=36%  Similarity=0.613  Sum_probs=235.0

Q ss_pred             hhhccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCc
Q 011360          188 LKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNI  267 (487)
Q Consensus       188 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI  267 (487)
                      ....++|.....||+|+||.||+|...  ++..||||++...              .... .++|.+|+.++.+++|||+
T Consensus        71 ~~AT~~Fs~~~~ig~Ggfg~VYkG~l~--~~~~vAVK~~~~~--------------~~~~-~~eF~~Ei~~ls~l~H~Nl  133 (361)
T KOG1187|consen   71 RKATNNFSESNLIGEGGFGTVYKGVLS--DGTVVAVKRLSSN--------------SGQG-EREFLNEVEILSRLRHPNL  133 (361)
T ss_pred             HHHHhCCchhcceecCCCeEEEEEEEC--CCCEEEEEEecCC--------------CCcc-hhHHHHHHHHHhcCCCcCc
Confidence            446678999999999999999999875  5589999987321              1111 4559999999999999999


Q ss_pred             cccceEEecCC-eeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC
Q 011360          268 LPLLAHMVRPD-CHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN  346 (487)
Q Consensus       268 v~l~~~~~~~~-~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~  346 (487)
                      |+++|||.+.+ ..+||+||++.|+|.++|......  .++|..+.+|+.++|+||+|||+.....||||||||+|||+|
T Consensus       134 v~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD  211 (361)
T KOG1187|consen  134 VKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLD  211 (361)
T ss_pred             ccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeEC
Confidence            99999999988 599999999999999999752111  889999999999999999999865555699999999999999


Q ss_pred             CCCCEEEeccCCccccCC-CCceeeEeee-cccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccc
Q 011360          347 DDMEACISDLGLAMAIPD-GYTRVLISYV-LGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEIC  424 (487)
Q Consensus       347 ~~~~~kl~DFg~s~~~~~-~~~~~~~~~~-~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~  424 (487)
                      +++++||+|||+|+..+. ....   ... .||.+|+|||+...+..+.|+||||||+++.|++||+.|.....+.....
T Consensus       212 ~~~~aKlsDFGLa~~~~~~~~~~---~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~  288 (361)
T KOG1187|consen  212 EDFNAKLSDFGLAKLGPEGDTSV---STTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELS  288 (361)
T ss_pred             CCCCEEccCccCcccCCccccce---eeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCccccc
Confidence            999999999999976554 2211   122 79999999999999999999999999999999999998886655455556


Q ss_pred             cHHHHHHHHhcCCCCCccCCCCC-CCCcH-HHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          425 SPEWLRKVMNSKNPSRAIDPRLP-GNGYE-KKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       425 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      ..+|....+......+++|+++. +.... .....+..+..+|++.+|.+||+|.++++.|+.+
T Consensus       289 l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~  352 (361)
T KOG1187|consen  289 LVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI  352 (361)
T ss_pred             HHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence            78898888888899999999988 44443 6788899999999999999999999999998654

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-49  Score=389.28  Aligned_cols=357  Identities=25%  Similarity=0.328  Sum_probs=276.9

Q ss_pred             chhhhhhhhhHHHHHHhhhchhhhhhHHHHHHHHHH------HH----HHHHhhccccCCCCcccccccCCCCCChhhhh
Q 011360           93 VDYLLDEFQTEAFQTMLLQDADAMSKVKEVNARLQD------IA----WQINVLGLKESFGGKSRNVRQRFPTTPSLISA  162 (487)
Q Consensus        93 ~~~~~~~~~~~~~~~~l~~~~~~~~r~~ei~~~l~~------i~----~~~~~~~l~~~~g~~~~~~~~~~~s~p~~~~~  162 (487)
                      .+.+++-.++++++..|..+|||+.|.++.......      +.    ....||.++...+.........|++.+.++..
T Consensus        49 ~~~yHG~l~red~~~lL~~~GDfLvR~s~~~~~~~~~~~vlSv~~~~~~~~~h~vi~~~~~~~~~~~~~~F~si~~li~~  128 (474)
T KOG0194|consen   49 LPYYHGLLPREDAEKLLKNDGDFLVRASEPKEGEKREFVVLSVKWSVFKKIKHYVIKRNGNLFFFEGLRKFPTISELVNY  128 (474)
T ss_pred             CccccccccHhHHHHHhCCCCceEEEeecccCCcceeEEEEEEEeecCCceeEEEEEEcCCeeEEeccccCCcHHHHHHH
Confidence            789999999999999999999999999887643221      11    24457877776665556666889999988887


Q ss_pred             hhcCCCCCCCCcc-ccCCcchhhHHHhhhccccccccccccccceeEEEEEecCCCC---ceEEEEEeeecCchhHHHHH
Q 011360          163 AVRGGSRDRGPTI-FSPLIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNG---KMIAIKKVIVYAPISAAELI  238 (487)
Q Consensus       163 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~---~~vavK~~~~~~~~~~~~~~  238 (487)
                      ............. +...+.  ...|...+++..+.+.||+|+||.||+|++...++   ..||+|....          
T Consensus       129 ~~~~~~~~~~~~~~L~~PI~--r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~----------  196 (474)
T KOG0194|consen  129 YKFSKLEITGKNFFLKRPIP--RQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKG----------  196 (474)
T ss_pred             HHhcccceeccceeeccccc--ccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecc----------
Confidence            7665544433332 221122  33477778888999999999999999999865544   3389998732          


Q ss_pred             HHhhhhhhHHHHHHHHHHHHhccCCCCCccccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHH
Q 011360          239 EEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV  318 (487)
Q Consensus       239 ~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi  318 (487)
                        ...........+.+|+++|++++|||||++||++....++|+|||+|+||+|.++|..   ....++..++..++.++
T Consensus       197 --~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k---~~~~v~~~ek~~~~~~A  271 (474)
T KOG0194|consen  197 --SSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKK---NKKSLPTLEKLRFCYDA  271 (474)
T ss_pred             --cccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHh---CCCCCCHHHHHHHHHHH
Confidence              1234566788999999999999999999999999999999999999999999999986   23369999999999999


Q ss_pred             HHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHH
Q 011360          319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIF  398 (487)
Q Consensus       319 ~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dvw  398 (487)
                      +.||+||   |+++++||||.++|||++.++.+||+|||+++....-...  .....-+.+|+|||.+..+.|+.++|||
T Consensus       272 A~Gl~YL---h~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~~--~~~~klPirWLAPEtl~~~~~s~kTDV~  346 (474)
T KOG0194|consen  272 ARGLEYL---HSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVMK--KFLKKLPIRWLAPETLNTGIFSFKTDVW  346 (474)
T ss_pred             HhHHHHH---HHCCCcchhHhHHHheecCCCeEEeCccccccCCcceeec--cccccCcceecChhhhccCccccccchh
Confidence            9999999   7888999999999999999999999999998765311111  1112357899999999999999999999


Q ss_pred             HHHHHHHHHHh-CCCCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChH
Q 011360          399 SFGMLLISLVR-GVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQ  477 (487)
Q Consensus       399 slG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~  477 (487)
                      ||||++||+++ |..||.+...      .+....+...+.. -..++        ..+..+..++..||..+|++||||.
T Consensus       347 sfGV~~~Eif~~g~~Py~g~~~------~~v~~kI~~~~~r-~~~~~--------~~p~~~~~~~~~c~~~~p~~R~tm~  411 (474)
T KOG0194|consen  347 SFGVLLWEIFENGAEPYPGMKN------YEVKAKIVKNGYR-MPIPS--------KTPKELAKVMKQCWKKDPEDRPTMS  411 (474)
T ss_pred             heeeeEEeeeccCCCCCCCCCH------HHHHHHHHhcCcc-CCCCC--------CCHHHHHHHHHHhccCChhhccCHH
Confidence            99999999999 7889944332      2333333232222 11122        2235688888999999999999999


Q ss_pred             HHHHHHhhh
Q 011360          478 YVRCRLSQL  486 (487)
Q Consensus       478 ~il~~L~~l  486 (487)
                      ++.+.|+.+
T Consensus       412 ~i~~~l~~~  420 (474)
T KOG0194|consen  412 TIKKKLEAL  420 (474)
T ss_pred             HHHHHHHHH
Confidence            999999865

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.6e-49  Score=368.36  Aligned_cols=261  Identities=27%  Similarity=0.382  Sum_probs=208.3

Q ss_pred             hccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccc
Q 011360          190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILP  269 (487)
Q Consensus       190 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~  269 (487)
                      ..+.|.+.+.||.|+||.|-+|. +..+|+.||||++..-.      .... +. .......+.+|+++|.+|+|||||+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~-e~~tgk~vAiKIi~krk------~~~~-s~-~~~~~~~v~~EieILkkL~HP~IV~  240 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAY-EKKTGKQVAIKIINKRK------STGC-SR-AIAKTRDVQNEIEILKKLSHPNIVR  240 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEE-EcccCcEEEeeeeehhh------cccc-cc-cccchhhhHHHHHHHHhcCCCCEEE
Confidence            34568889999999999999995 67899999999984311      1000 00 1122344689999999999999999


Q ss_pred             cceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC-
Q 011360          270 LLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDD-  348 (487)
Q Consensus       270 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~-  348 (487)
                      ++++|..++..||||||++||.|.+++-.    ++.+.+..-+.++.|++.|+.||   |++||+||||||+|||+..+ 
T Consensus       241 ~~d~f~~~ds~YmVlE~v~GGeLfd~vv~----nk~l~ed~~K~~f~Qll~avkYL---H~~GI~HRDiKPeNILl~~~~  313 (475)
T KOG0615|consen  241 IKDFFEVPDSSYMVLEYVEGGELFDKVVA----NKYLREDLGKLLFKQLLTAVKYL---HSQGIIHRDIKPENILLSNDA  313 (475)
T ss_pred             EeeeeecCCceEEEEEEecCccHHHHHHh----ccccccchhHHHHHHHHHHHHHH---HHcCcccccCCcceEEeccCC
Confidence            99999999999999999999999999864    56677788889999999999999   89999999999999999866 


Q ss_pred             --CCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCC---CCchhHHHHHHHHHHHHHhCCCCccccCCCCcc
Q 011360          349 --MEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPE---LSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI  423 (487)
Q Consensus       349 --~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~---~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~  423 (487)
                        ..+||+|||+|+..+.   .....+.||||.|.|||++.+..   +..++|+||+||++|-+++|.+||......   
T Consensus       314 e~~llKItDFGlAK~~g~---~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~---  387 (475)
T KOG0615|consen  314 EDCLLKITDFGLAKVSGE---GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD---  387 (475)
T ss_pred             cceEEEecccchhhcccc---ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC---
Confidence              6799999999998753   23457889999999999998653   345889999999999999999999543221   


Q ss_pred             ccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          424 CSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       424 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                         ..+.+.+..+...      +-+....+++++..++|.+||..||++|||+.++++
T Consensus       388 ---~sl~eQI~~G~y~------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  388 ---PSLKEQILKGRYA------FGPLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             ---ccHHHHHhcCccc------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence               1122222233221      122345677888999999999999999999999875

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-47  Score=354.47  Aligned_cols=245  Identities=25%  Similarity=0.373  Sum_probs=206.8

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+++.||+|+||+|+.++.. .+++.+|+|++.            +....+....+....|..++..++||+||+++
T Consensus        25 ~dF~~lkviGkG~fGkV~~Vrk~-dt~kiYAmKvl~------------K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~   91 (357)
T KOG0598|consen   25 DDFEILKVIGKGSFGKVFQVRKK-DTGKIYAMKVLK------------KKKIVEKKEVRHTKAERNILSKIKHPFIVKLI   91 (357)
T ss_pred             hheeeeeeeeccCCceEEEEEEc-ccCceeehhhhh------------hhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeE
Confidence            45999999999999999999854 799999999773            33344456788899999999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      ..|++.+.+|+|+||+.||.|...|+.    .+.+++..++.++..|+.||.||   |++|||||||||+|||++.+|++
T Consensus        92 ysFQt~~kLylVld~~~GGeLf~hL~~----eg~F~E~~arfYlaEi~lAL~~L---H~~gIiyRDlKPENILLd~~GHi  164 (357)
T KOG0598|consen   92 YSFQTEEKLYLVLDYLNGGELFYHLQR----EGRFSEDRARFYLAEIVLALGYL---HSKGIIYRDLKPENILLDEQGHI  164 (357)
T ss_pred             EecccCCeEEEEEeccCCccHHHHHHh----cCCcchhHHHHHHHHHHHHHHHH---HhCCeeeccCCHHHeeecCCCcE
Confidence            999999999999999999999999975    67899999999999999999999   88889999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRK  431 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~  431 (487)
                      +|+|||+++........  ..+++||+.|||||++.+..|+..+|+||+|+++|||++|.+||...+      ...+...
T Consensus       165 ~LtDFgL~k~~~~~~~~--t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~------~~~~~~~  236 (357)
T KOG0598|consen  165 KLTDFGLCKEDLKDGDA--TRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED------VKKMYDK  236 (357)
T ss_pred             EEeccccchhcccCCCc--cccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc------HHHHHHH
Confidence            99999999865443332  256899999999999999999999999999999999999999994432      3344454


Q ss_pred             HHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCC
Q 011360          432 VMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERP  474 (487)
Q Consensus       432 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP  474 (487)
                      +.....+  ..+.-+        +.+..+++.++|..||++|-
T Consensus       237 I~~~k~~--~~p~~l--------s~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  237 ILKGKLP--LPPGYL--------SEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             HhcCcCC--CCCccC--------CHHHHHHHHHHhccCHHHhc
Confidence            5443311  111112        24588999999999999995

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-45  Score=346.16  Aligned_cols=266  Identities=27%  Similarity=0.382  Sum_probs=217.4

Q ss_pred             hhccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcc
Q 011360          189 KKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNIL  268 (487)
Q Consensus       189 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv  268 (487)
                      ...+.|++...||.|..+.||+|++. ..+..||||++..              ..-...+..+.+|+..++.++||||+
T Consensus        23 ~n~~~YeL~e~IG~G~sa~V~~A~c~-p~~e~VAIK~inL--------------Ekc~~~ld~l~kE~~~msl~~HPNIv   87 (516)
T KOG0582|consen   23 LNAKDYELQEVIGVGASAVVYLARCI-PTNEVVAIKIINL--------------EKCNNDLDALRKEVQTMSLIDHPNIV   87 (516)
T ss_pred             CCccceeEEEEEeccceeEeeeeeec-ccCCEEEEEEeeh--------------hhhhhhHHHHHHHHHHhhhcCCCCcc
Confidence            33456999999999999999999864 5779999999843              22233478899999999999999999


Q ss_pred             ccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC
Q 011360          269 PLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDD  348 (487)
Q Consensus       269 ~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~  348 (487)
                      +++..|..+..+|+||.||.+||+.+++..+-.  ..+++..+..++++++.||.||   |.+|.||||||+.||||+.+
T Consensus        88 ~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YL---H~~G~IHRdvKAgnILi~~d  162 (516)
T KOG0582|consen   88 TYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYP--DGLEEASIATILREVLKALDYL---HQNGHIHRDVKAGNILIDSD  162 (516)
T ss_pred             eEEEEEEecceeEEeehhhcCCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHH---HhcCceecccccccEEEcCC
Confidence            999999999999999999999999999987443  4489999999999999999999   88999999999999999999


Q ss_pred             CCEEEeccCCccccCCCCceeeE--eeecccccccCCcccCC--CCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccc
Q 011360          349 MEACISDLGLAMAIPDGYTRVLI--SYVLGTMAYIAPEYFQQ--PELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEIC  424 (487)
Q Consensus       349 ~~~kl~DFg~s~~~~~~~~~~~~--~~~~gt~~y~aPE~l~~--~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~  424 (487)
                      |.|||+|||.+-.+..+..+...  .++.||+.|||||++..  ..|+.|+|||||||+..||.+|..||....      
T Consensus       163 G~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~p------  236 (516)
T KOG0582|consen  163 GTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYP------  236 (516)
T ss_pred             CcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCC------
Confidence            99999999998776554433222  45689999999999654  379999999999999999999999994332      


Q ss_pred             cHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          425 SPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       425 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ....+...+.+. |....-..++.+........+.+++..||++||.+|||++++++
T Consensus       237 PmkvLl~tLqn~-pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  237 PMKVLLLTLQND-PPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             hHHHHHHHhcCC-CCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            233333333333 32222333344445566678999999999999999999999875

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=5.5e-46  Score=335.64  Aligned_cols=265  Identities=22%  Similarity=0.337  Sum_probs=206.3

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      .|+.+..+|+|++|.||+++. +.+|+.||||++..             +...+...+-.++|+.++++++|||+|.++.
T Consensus         3 kYE~LgkvGEGSYGvV~KCrn-k~TgqIVAIKkF~E-------------sedd~~VkKIAlREIrmLKqLkH~NLVnLiE   68 (396)
T KOG0593|consen    3 KYEKLGKVGEGSYGVVMKCRN-KDTGQIVAIKKFVE-------------SEDDPVVKKIALREIRMLKQLKHENLVNLIE   68 (396)
T ss_pred             HHhhhhccccCcceEEEEecc-CCcccEEEEEeecc-------------CCccHHHHHHHHHHHHHHHhcccchHHHHHH
Confidence            588899999999999999974 57999999999843             2333445566789999999999999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEE
Q 011360          273 HMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC  352 (487)
Q Consensus       273 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~k  352 (487)
                      +|.....+++|+|||+. ++.+-|+.   ....++...+.+++.|++.|+.|+   |++++|||||||+|||++.+|.+|
T Consensus        69 VFrrkrklhLVFE~~dh-TvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~c---Hk~n~IHRDIKPENILit~~gvvK  141 (396)
T KOG0593|consen   69 VFRRKRKLHLVFEYCDH-TVLHELER---YPNGVPSELVKKYLYQLLKAIHFC---HKNNCIHRDIKPENILITQNGVVK  141 (396)
T ss_pred             HHHhcceeEEEeeecch-HHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhh---hhcCeecccCChhheEEecCCcEE
Confidence            99999999999999977 45455553   356688899999999999999999   888999999999999999999999


Q ss_pred             EeccCCccccCCCCceeeEeeecccccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccc-------
Q 011360          353 ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQ-PELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEIC-------  424 (487)
Q Consensus       353 l~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~-------  424 (487)
                      |||||+|+.+.....  ..+.++.|.+|.|||.+.+ ..|+..+||||+||++.||++|.+.|.+.++-....       
T Consensus       142 LCDFGFAR~L~~pgd--~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG  219 (396)
T KOG0593|consen  142 LCDFGFARTLSAPGD--NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLG  219 (396)
T ss_pred             eccchhhHhhcCCcc--hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHc
Confidence            999999998864222  1245678999999999887 689999999999999999999999997665422111       


Q ss_pred             --cHHHHHHHHhcCCCCCccC-CCCC-----CCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          425 --SPEWLRKVMNSKNPSRAID-PRLP-----GNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       425 --~~~~~~~~~~~~~~~~~~~-~~~~-----~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                        .+. ...++..+..-..+. |...     ...++..+.-+.+++..||+.||.+|+|-++++.
T Consensus       220 ~L~pr-hq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  220 NLIPR-HQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             ccCHH-HHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence              111 111222211111111 0000     1123344557889999999999999999999874

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-45  Score=351.93  Aligned_cols=255  Identities=25%  Similarity=0.385  Sum_probs=211.7

Q ss_pred             hccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CCCCcc
Q 011360          190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RHRNIL  268 (487)
Q Consensus       190 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv  268 (487)
                      ...+|...++||+|+|++|++|+ +..+++.||||++.            +.-..++..++.+..|-.+|.+| .||.|+
T Consensus        71 ~~~DF~Fg~~lGeGSYStV~~A~-~~~t~keYAiKVl~------------K~~Iike~KvkYV~~Ek~~l~~L~~hPgiv  137 (604)
T KOG0592|consen   71 TPNDFKFGKILGEGSYSTVVLAR-EKATGKEYAIKVLD------------KRYIIKEKKVKYVTREKEALTQLSGHPGIV  137 (604)
T ss_pred             ChhhcchhheeccccceeEEEee-ecCCCceeeHhhhh------------HHHHHhhcccchhhHHHHHHHHhhCCCCeE
Confidence            34569999999999999999997 45699999999872            22234445566778888899999 999999


Q ss_pred             ccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC
Q 011360          269 PLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDD  348 (487)
Q Consensus       269 ~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~  348 (487)
                      ++|..|.+...+|+|+||+++|+|.++|..+    +.+++...+.++.+|+.||+||   |++|||||||||+|||+++|
T Consensus       138 kLy~TFQD~~sLYFvLe~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleyl---H~~GIIHRDlKPENILLd~d  210 (604)
T KOG0592|consen  138 KLYFTFQDEESLYFVLEYAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYL---HSNGIIHRDLKPENILLDKD  210 (604)
T ss_pred             EEEEEeecccceEEEEEecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHH---HhcCceeccCChhheeEcCC
Confidence            9999999999999999999999999999873    6799999999999999999999   89999999999999999999


Q ss_pred             CCEEEeccCCccccCCCCce-----------eeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCcccc
Q 011360          349 MEACISDLGLAMAIPDGYTR-----------VLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFH  417 (487)
Q Consensus       349 ~~~kl~DFg~s~~~~~~~~~-----------~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~  417 (487)
                      +++||+|||.+..+......           .....++||..|.+||+|.....+..+|+|+|||++|+|+.|.+||...
T Consensus       211 mhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~  290 (604)
T KOG0592|consen  211 GHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAA  290 (604)
T ss_pred             CcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccc
Confidence            99999999999887543322           1124588999999999999999999999999999999999999999443


Q ss_pred             CCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          418 QNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       418 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .      ..-.+.+++.-   ...+++.++        ..+.+|+.+.|..||++|+|.++|.+
T Consensus       291 N------eyliFqkI~~l---~y~fp~~fp--------~~a~dLv~KLLv~dp~~Rlt~~qIk~  337 (604)
T KOG0592|consen  291 N------EYLIFQKIQAL---DYEFPEGFP--------EDARDLIKKLLVRDPSDRLTSQQIKA  337 (604)
T ss_pred             c------HHHHHHHHHHh---cccCCCCCC--------HHHHHHHHHHHccCccccccHHHHhh
Confidence            2      22233444331   112223333        45889999999999999999999875

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-45  Score=348.56  Aligned_cols=264  Identities=25%  Similarity=0.339  Sum_probs=206.0

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCC-CCCccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIR-HRNILP  269 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~  269 (487)
                      .++|.+++.||.|+||.||+|+ ...+|..||||+++.              .........-++|+..+++|+ |||||+
T Consensus         9 m~RY~~i~klGDGTfGsV~la~-~~~~~~~VAIK~MK~--------------Kf~s~ee~~nLREvksL~kln~hpniik   73 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAK-SKETGELVAIKKMKK--------------KFYSWEECMNLREVKSLRKLNPHPNIIK   73 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEee-ecCCCceeeHHHHHh--------------hhccHHHHHHHHHHHHHHhcCCCCcchh
Confidence            4579999999999999999997 457889999998722              112222233478999999998 999999


Q ss_pred             cceEEecCC-eeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC
Q 011360          270 LLAHMVRPD-CHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDD  348 (487)
Q Consensus       270 l~~~~~~~~-~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~  348 (487)
                      +.+++.+.+ .+|+||||| ..+|..++..  + +..+++..+..|+.||++||+|+   |.+|++|||+||+|||+..+
T Consensus        74 L~Evi~d~~~~L~fVfE~M-d~NLYqLmK~--R-~r~fse~~irnim~QilqGL~hi---Hk~GfFHRDlKPENiLi~~~  146 (538)
T KOG0661|consen   74 LKEVIRDNDRILYFVFEFM-DCNLYQLMKD--R-NRLFSESDIRNIMYQILQGLAHI---HKHGFFHRDLKPENILISGN  146 (538)
T ss_pred             hHHHhhccCceEeeeHHhh-hhhHHHHHhh--c-CCcCCHHHHHHHHHHHHHHHHHH---HhcCcccccCChhheEeccc
Confidence            999999887 999999999 5599999985  3 78999999999999999999999   88999999999999999988


Q ss_pred             CCEEEeccCCccccCCCCceeeEeeecccccccCCcccC-CCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCcc----
Q 011360          349 MEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQ-QPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI----  423 (487)
Q Consensus       349 ~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~----  423 (487)
                      ..+||+|||+|+........   +.++.|.+|.|||+|. .+.|+.+.|+||+||+++|+.+-++.|.+.+.-...    
T Consensus       147 ~~iKiaDFGLARev~SkpPY---TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc  223 (538)
T KOG0661|consen  147 DVIKIADFGLAREVRSKPPY---TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKIC  223 (538)
T ss_pred             ceeEecccccccccccCCCc---chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHH
Confidence            89999999999987554332   4567899999999875 568999999999999999999999999655321111    


Q ss_pred             ---------ccHH--HHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          424 ---------CSPE--WLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       424 ---------~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                               ..++  .+...+. -.........+.. -.+..+.++.++|.+|+.+||++|||+++.++
T Consensus       224 ~VLGtP~~~~~~eg~~La~~mn-f~~P~~~~~~l~~-L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~  290 (538)
T KOG0661|consen  224 EVLGTPDKDSWPEGYNLASAMN-FRFPQVKPSPLKD-LLPNASSEAASLIERLLAWDPDKRPTASQALQ  290 (538)
T ss_pred             HHhCCCccccchhHHHHHHHhc-cCCCcCCCCChHH-hCcccCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence                     0011  1111111 1111111111111 12236678999999999999999999999886

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-44  Score=340.26  Aligned_cols=254  Identities=26%  Similarity=0.398  Sum_probs=200.2

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      ++...+.||+|+||.||++.. ..+|...|||.+...               .....+.+.+|+.++.+++|||||+++|
T Consensus        18 ~~~~~~~lG~Gs~G~V~l~~~-~~~g~~~AvK~v~~~---------------~~~~~~~l~~Ei~iL~~l~~p~IV~~~G   81 (313)
T KOG0198|consen   18 NWSKGKLLGRGSFGSVYLATN-KKTGELMAVKSVELE---------------DSPTSESLEREIRILSRLNHPNIVQYYG   81 (313)
T ss_pred             hhhhhccccCccceEEEEEEe-cCCCcceeeeeeecc---------------cchhHHHHHHHHHHHHhCCCCCEEeeCC
Confidence            477889999999999999975 446899999988431               1111667899999999999999999999


Q ss_pred             EEecCC--eeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC-CC
Q 011360          273 HMVRPD--CHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLND-DM  349 (487)
Q Consensus       273 ~~~~~~--~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~-~~  349 (487)
                      ......  .+++.|||+++|+|.+++...  ++ .+++..+..+++||++||.||   |++|||||||||+|||++. ++
T Consensus        82 ~~~~~~~~~~~i~mEy~~~GsL~~~~~~~--g~-~l~E~~v~~ytr~iL~GL~yl---Hs~g~vH~DiK~~NiLl~~~~~  155 (313)
T KOG0198|consen   82 SSSSRENDEYNIFMEYAPGGSLSDLIKRY--GG-KLPEPLVRRYTRQILEGLAYL---HSKGIVHCDIKPANILLDPSNG  155 (313)
T ss_pred             ccccccCeeeEeeeeccCCCcHHHHHHHc--CC-CCCHHHHHHHHHHHHHHHHHH---HhCCEeccCcccceEEEeCCCC
Confidence            755444  689999999999999999862  23 799999999999999999999   8999999999999999999 79


Q ss_pred             CEEEeccCCccccCC-CCceeeEeeecccccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHH
Q 011360          350 EACISDLGLAMAIPD-GYTRVLISYVLGTMAYIAPEYFQQP-ELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPE  427 (487)
Q Consensus       350 ~~kl~DFg~s~~~~~-~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~  427 (487)
                      .+||+|||++..... ...........||+.|||||++..+ ....++|||||||++.||+||++||...     ....+
T Consensus       156 ~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~  230 (313)
T KOG0198|consen  156 DVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAE  230 (313)
T ss_pred             eEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHH
Confidence            999999999987653 1111122356799999999999963 3345999999999999999999999443     11223


Q ss_pred             HHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHH
Q 011360          428 WLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCR  482 (487)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~  482 (487)
                      +..........+ .++..        .+.+..+++..|+..+|++|||+.+++..
T Consensus       231 ~~~~ig~~~~~P-~ip~~--------ls~~a~~Fl~~C~~~~p~~Rpta~eLL~h  276 (313)
T KOG0198|consen  231 ALLLIGREDSLP-EIPDS--------LSDEAKDFLRKCFKRDPEKRPTAEELLEH  276 (313)
T ss_pred             HHHHHhccCCCC-CCCcc--------cCHHHHHHHHHHhhcCcccCcCHHHHhhC
Confidence            333333222111 22222        33568899999999999999999999863

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.3e-44  Score=368.97  Aligned_cols=262  Identities=24%  Similarity=0.377  Sum_probs=214.9

Q ss_pred             cccccccccccccceeEEEEEecC----CCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPG----SNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNI  267 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI  267 (487)
                      .+....+.||+|+||+||+|+...    .+...||||.++.              .........|++|+++++.++||||
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd--------------~a~~~~~~dF~REaeLla~l~H~nI  551 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKD--------------KAENQARQDFRREAELLAELQHPNI  551 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcc--------------cccHHHHHHHHHHHHHHHhccCCCe
Confidence            346778899999999999998642    2446799998732              2333467789999999999999999


Q ss_pred             cccceEEecCCeeEEEEEecCCCCHHHHHhhhhc------CC----CCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecC
Q 011360          268 LPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSR------GR----RELDWPSRHRIALGVASGLEYLHMYHSASIIHGD  337 (487)
Q Consensus       268 v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~------~~----~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~D  337 (487)
                      |+++|+|..++++|+|+|||..|+|..||.....      .+    .+++..+.+.|+.|||.|+.||-   ++.+||||
T Consensus       552 VrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRD  628 (774)
T KOG1026|consen  552 VRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRD  628 (774)
T ss_pred             EEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccc
Confidence            9999999999999999999999999999975332      12    33888999999999999999994   44599999


Q ss_pred             CCCCCEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccc
Q 011360          338 IKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVF  416 (487)
Q Consensus       338 lkp~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~  416 (487)
                      |..+|+||.++..|||+|||+++...............-+++|||||.+..+.||.+||||||||+|||+++ |+.||.+
T Consensus       629 LATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~g  708 (774)
T KOG1026|consen  629 LATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYG  708 (774)
T ss_pred             hhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccc
Confidence            999999999999999999999998766655544444556899999999999999999999999999999999 8999965


Q ss_pred             cCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          417 HQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       417 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      .++.       .+...+..+..- ..+.        ..+.+++.||..||+.+|++|||+++|-..|+..
T Consensus       709 lSn~-------EVIe~i~~g~lL-~~Pe--------~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~  762 (774)
T KOG1026|consen  709 LSNQ-------EVIECIRAGQLL-SCPE--------NCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAW  762 (774)
T ss_pred             cchH-------HHHHHHHcCCcc-cCCC--------CCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHH
Confidence            5542       333444444441 1122        2335699999999999999999999999999763

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-43  Score=318.03  Aligned_cols=239  Identities=23%  Similarity=0.349  Sum_probs=202.1

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      +|+.++.||.|+||.|.+++.+ .+|..+|+|++..            ....+....++..+|-.+++.+.||+++++++
T Consensus        45 dfe~~~tlGtGSFGrV~LVr~k-~~g~yYAmKvL~k------------~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~  111 (355)
T KOG0616|consen   45 DFERLKTLGTGSFGRVHLVREK-HSGNYYAMKVLDK------------QKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYG  111 (355)
T ss_pred             hhhheeeeccCccceEEEEEEc-cCCceeehhhcCH------------HHHHHHHHHHHHhhHHHHHhhccCceeEEEEE
Confidence            5899999999999999999865 5799999998732            33445556778899999999999999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEE
Q 011360          273 HMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC  352 (487)
Q Consensus       273 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~k  352 (487)
                      .+.+.+.+|+||||++||.|.+++++    .+.+++..++.++.||+.||+||   |+++|++|||||+|||+|.+|.+|
T Consensus       112 t~~d~~~lymvmeyv~GGElFS~Lrk----~~rF~e~~arFYAAeivlAleyl---H~~~iiYRDLKPENiLlD~~G~iK  184 (355)
T KOG0616|consen  112 TFKDNSNLYMVMEYVPGGELFSYLRK----SGRFSEPHARFYAAEIVLALEYL---HSLDIIYRDLKPENLLLDQNGHIK  184 (355)
T ss_pred             eeccCCeEEEEEeccCCccHHHHHHh----cCCCCchhHHHHHHHHHHHHHHH---HhcCeeeccCChHHeeeccCCcEE
Confidence            99999999999999999999999976    56799999999999999999999   777899999999999999999999


Q ss_pred             EeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHH
Q 011360          353 ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKV  432 (487)
Q Consensus       353 l~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~  432 (487)
                      |+|||+++.....     +-+.||||.|+|||++....|+.++|+||||+++|||+.|.+||....+      .....++
T Consensus       185 itDFGFAK~v~~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~------~~iY~KI  253 (355)
T KOG0616|consen  185 ITDFGFAKRVSGR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP------IQIYEKI  253 (355)
T ss_pred             EEeccceEEecCc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh------HHHHHHH
Confidence            9999999887554     2567899999999999999999999999999999999999999954433      2223333


Q ss_pred             HhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCC
Q 011360          433 MNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEER  473 (487)
Q Consensus       433 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R  473 (487)
                      ..+. .  .    +|.    ....++.+|+..+|+.|-.+|
T Consensus       254 ~~~~-v--~----fP~----~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  254 LEGK-V--K----FPS----YFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             HhCc-c--c----CCc----ccCHHHHHHHHHHHhhhhHhh
Confidence            3322 1  1    221    122458889999999998888

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-44  Score=349.95  Aligned_cols=251  Identities=27%  Similarity=0.420  Sum_probs=211.7

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      ...|.....+|+|+.|.||.+. ...+++.||||++..               ......+-+.+|+.+|+..+|+|||++
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~-~~~~~~~VaiK~m~l---------------~~Q~~keLilnEi~Vm~~~~H~NiVnf  335 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVAR-KISTKQEVAIKRMDL---------------RKQPKKELLLNEILVMRDLHHPNIVNF  335 (550)
T ss_pred             hhhhcchhhhccccccceeeee-eccCCceEEEEEEEe---------------ccCCchhhhHHHHHHHHhccchHHHHH
Confidence            3457888899999999999996 567889999999843               222344567899999999999999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      ++.|...+.+++||||++||+|.|.+..     ..+++.++..+++.+++||+||   |.+||+|||||.+|||++.+|.
T Consensus       336 l~Sylv~deLWVVMEym~ggsLTDvVt~-----~~~~E~qIA~Icre~l~aL~fL---H~~gIiHrDIKSDnILL~~~g~  407 (550)
T KOG0578|consen  336 LDSYLVGDELWVVMEYMEGGSLTDVVTK-----TRMTEGQIAAICREILQGLKFL---HARGIIHRDIKSDNILLTMDGS  407 (550)
T ss_pred             HHHhcccceeEEEEeecCCCchhhhhhc-----ccccHHHHHHHHHHHHHHHHHH---HhcceeeeccccceeEeccCCc
Confidence            9999988999999999999999999874     4589999999999999999999   8889999999999999999999


Q ss_pred             EEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHH
Q 011360          351 ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLR  430 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~  430 (487)
                      +||+|||++..+......  ..+.+|||.|||||+.....|+.++||||||++++||+-|.+||....+-      ..+.
T Consensus       408 vKltDFGFcaqi~~~~~K--R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl------rAly  479 (550)
T KOG0578|consen  408 VKLTDFGFCAQISEEQSK--RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPL------RALY  479 (550)
T ss_pred             EEEeeeeeeeccccccCc--cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChH------HHHH
Confidence            999999999887665543  35678999999999999999999999999999999999999999653331      1223


Q ss_pred             HHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          431 KVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       431 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .+...+.|.-...+        ..+..|.+++.+||..||++|||+.++|+
T Consensus       480 LIa~ng~P~lk~~~--------klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  480 LIATNGTPKLKNPE--------KLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             HHhhcCCCCcCCcc--------ccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence            33334444333332        33467999999999999999999999986

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-43  Score=347.08  Aligned_cols=254  Identities=26%  Similarity=0.347  Sum_probs=205.5

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCC-CCCccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIR-HRNILP  269 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~  269 (487)
                      ...|.+.+.||.|+||+|++|.+ ..++..||+|++......         ... ......+.+|+.+++.++ ||||++
T Consensus        16 ~g~y~~~~~lG~GsfgkV~~a~~-~~t~~~vAiKii~~~~~~---------~~~-~~~~~~i~rEi~~~~~~~~HpnI~~   84 (370)
T KOG0583|consen   16 IGKYELGRTLGSGSFGKVKLAKH-RLTGEKVAIKIIDRKKVS---------SKS-QKLDELIKREISILRRLRSHPNIIR   84 (370)
T ss_pred             cCceeeeeeecCCCCeeEEEeee-ccCCCeEEEEEechhccc---------ccc-cccchhhHHHHHHHHHhccCCCEeE
Confidence            34699999999999999999975 467899999965321000         001 123455668999999998 999999


Q ss_pred             cceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC-
Q 011360          270 LLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDD-  348 (487)
Q Consensus       270 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~-  348 (487)
                      ++.++.....+|+|||||.||+|.+++..    ...+.+..+..+++|++.|++||   |++||+||||||+|||++.+ 
T Consensus        85 l~ev~~t~~~~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~---H~~gi~HRDLK~ENilld~~~  157 (370)
T KOG0583|consen   85 LLEVFATPTKIYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYC---HSRGIVHRDLKPENILLDGNE  157 (370)
T ss_pred             EEEEEecCCeEEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHH---HhCCEeeCCCCHHHEEecCCC
Confidence            99999999999999999999999999975    56788899999999999999999   88899999999999999999 


Q ss_pred             CCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCC-CC-chhHHHHHHHHHHHHHhCCCCccccCCCCccccH
Q 011360          349 MEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPE-LS-EKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSP  426 (487)
Q Consensus       349 ~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~-~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~  426 (487)
                      +++||+|||++....  .........+||+.|+|||++.+.. |+ .++||||+|++||.|++|..||..      ...+
T Consensus       158 ~~~Kl~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d------~~~~  229 (370)
T KOG0583|consen  158 GNLKLSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD------SNVP  229 (370)
T ss_pred             CCEEEeccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC------ccHH
Confidence            999999999998774  1222336788999999999999877 86 789999999999999999999943      2333


Q ss_pred             HHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHH
Q 011360          427 EWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVR  480 (487)
Q Consensus       427 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il  480 (487)
                      .....+.....   .    +|....   +.++..++.+||..||.+|+|+.+|+
T Consensus       230 ~l~~ki~~~~~---~----~p~~~~---S~~~~~Li~~mL~~~P~~R~t~~~i~  273 (370)
T KOG0583|consen  230 NLYRKIRKGEF---K----IPSYLL---SPEARSLIEKMLVPDPSTRITLLEIL  273 (370)
T ss_pred             HHHHHHhcCCc---c----CCCCcC---CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence            33443322221   1    222111   46689999999999999999999997

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.2e-44  Score=343.35  Aligned_cols=264  Identities=26%  Similarity=0.379  Sum_probs=208.8

Q ss_pred             hccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccc
Q 011360          190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILP  269 (487)
Q Consensus       190 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~  269 (487)
                      ..+.|+.+++||+|+||.||+|+ +..+|+.||+|++..             ....+.......+|+.+|++|.||||++
T Consensus       115 ~~~~feki~kIGeGTyg~VYkAr-~~~tgkivALKKvr~-------------d~~~~~~~~t~~REI~ILr~l~HpNIik  180 (560)
T KOG0600|consen  115 RADSFEKIEKIGEGTYGQVYKAR-DLETGKIVALKKVRF-------------DNEKEGFPITAIREIKILRRLDHPNIIK  180 (560)
T ss_pred             chHHHHHHHHhcCcchhheeEee-ecccCcEEEEEEeec-------------ccCCCcchHHHHHHHHHHHhcCCCcccc
Confidence            45679999999999999999997 567999999999965             2334556677889999999999999999


Q ss_pred             cceEEecC--CeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC
Q 011360          270 LLAHMVRP--DCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLND  347 (487)
Q Consensus       270 l~~~~~~~--~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~  347 (487)
                      +.+.....  ..+|+|+|||++ +|.-++.   ..+-.|++.++..++.|++.||.||   |++||+|||||.+||||+.
T Consensus       181 L~eivt~~~~~siYlVFeYMdh-DL~GLl~---~p~vkft~~qIKc~mkQLl~Gl~~c---H~~gvlHRDIK~SNiLidn  253 (560)
T KOG0600|consen  181 LEEIVTSKLSGSIYLVFEYMDH-DLSGLLS---SPGVKFTEPQIKCYMKQLLEGLEYC---HSRGVLHRDIKGSNILIDN  253 (560)
T ss_pred             eeeEEEecCCceEEEEEecccc-hhhhhhc---CCCcccChHHHHHHHHHHHHHHHHH---hhcCeeeccccccceEEcC
Confidence            99998876  689999999976 8888776   3466899999999999999999999   8899999999999999999


Q ss_pred             CCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccH
Q 011360          348 DMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQP-ELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSP  426 (487)
Q Consensus       348 ~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~  426 (487)
                      +|.+||+|||+|+.+....... .+..+.|.+|.|||.|.+. .|+.++|+||.|||+.||++|++.|.+.+.      .
T Consensus       254 ~G~LKiaDFGLAr~y~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tE------v  326 (560)
T KOG0600|consen  254 NGVLKIADFGLARFYTPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTE------V  326 (560)
T ss_pred             CCCEEeccccceeeccCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccH------H
Confidence            9999999999999776554333 2455689999999988865 899999999999999999999999965542      1


Q ss_pred             HHHHHHHh-cCCCCC-ccC-CCCCC-------C--------CcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          427 EWLRKVMN-SKNPSR-AID-PRLPG-------N--------GYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       427 ~~~~~~~~-~~~~~~-~~~-~~~~~-------~--------~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      +.+..++. -+.|.+ .+. ..+|.       .        .....+...++|+..+|..||.+|.|+.+++.
T Consensus       327 eQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  327 EQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             HHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            22222221 111111 010 01110       0        12223456778999999999999999998874

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=2.9e-43  Score=348.77  Aligned_cols=266  Identities=26%  Similarity=0.364  Sum_probs=204.6

Q ss_pred             hccccccccccccccceeEEEEEe----cCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CC
Q 011360          190 KEDCFASLEKIGSGGCGEVYKAEL----PGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RH  264 (487)
Q Consensus       190 ~~~~~~~~~~lg~G~~g~v~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h  264 (487)
                      ..++|.+.+.||.|+||.||+|.+    +..++..||+|++...              ........+.+|+.++..+ +|
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~--------------~~~~~~~~~~~E~~~l~~l~~h   70 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG--------------ATASEHKALMSELKILIHIGNH   70 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc--------------cchHHHHHHHHHHHHHHHhccC
Confidence            345799999999999999999974    2335678999987321              1122345688899999999 89


Q ss_pred             CCccccceEEecC-CeeEEEEEecCCCCHHHHHhhhhc------------------------------------------
Q 011360          265 RNILPLLAHMVRP-DCHLLVYEFMKNGSLQDILDDVSR------------------------------------------  301 (487)
Q Consensus       265 pnIv~l~~~~~~~-~~~~lv~E~~~~gsL~~~l~~~~~------------------------------------------  301 (487)
                      |||+++++++... +.++++|||+++|+|.+++.....                                          
T Consensus        71 ~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  150 (338)
T cd05102          71 LNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQ  150 (338)
T ss_pred             cceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccc
Confidence            9999999988764 468899999999999999874211                                          


Q ss_pred             ----------------CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEeccCCccccCCC
Q 011360          302 ----------------GRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG  365 (487)
Q Consensus       302 ----------------~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~DFg~s~~~~~~  365 (487)
                                      ....+++..+..++.|++.||.||   |++||+||||||+|||++.++.+||+|||+++.....
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~L---H~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~  227 (338)
T cd05102         151 PSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD  227 (338)
T ss_pred             cccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHH---HHCCEECCCCccceEEEcCCCcEEEeecccccccccC
Confidence                            023577888999999999999999   6788999999999999999999999999999765433


Q ss_pred             CceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccccHHHHHHHHhcCCCCCccCC
Q 011360          366 YTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDP  444 (487)
Q Consensus       366 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  444 (487)
                      ..........+++.|+|||++.+..++.++||||||+++|||++ |..||......     ..... ....+...     
T Consensus       228 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~-----~~~~~-~~~~~~~~-----  296 (338)
T cd05102         228 PDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN-----EEFCQ-RLKDGTRM-----  296 (338)
T ss_pred             cchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc-----HHHHH-HHhcCCCC-----
Confidence            22222223346788999999998899999999999999999997 99999543221     11222 22222111     


Q ss_pred             CCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhhC
Q 011360          445 RLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL  487 (487)
Q Consensus       445 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~ll  487 (487)
                      ..+.    ..+..+.+++.+||+.||++|||+.+|++.|++++
T Consensus       297 ~~~~----~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~  335 (338)
T cd05102         297 RAPE----NATPEIYRIMLACWQGDPKERPTFSALVEILGDLL  335 (338)
T ss_pred             CCCC----CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            1111    12346889999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.3e-43  Score=343.51  Aligned_cols=256  Identities=23%  Similarity=0.369  Sum_probs=205.1

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .++|.+++.||+|+||.||+|+ .+.+|..+|+|++.            +..-.....++.++.|-.+|....+|+||++
T Consensus       140 ~~DFe~Lk~IgkGAfGeVrLar-Kk~Tg~iyAmK~Lk------------KS~M~~~~Qv~hV~aERdiL~~~ds~~vVKL  206 (550)
T KOG0605|consen  140 LDDFELLKVIGKGAFGEVRLAR-KKDTGEIYAMKILK------------KSEMLKKNQVEHVRAERDILAEVDSPWVVKL  206 (550)
T ss_pred             cccchhheeeccccceeEEEEE-EccCCcEEeeeccc------------HHHHHhhhhHHHHHHHHHHhhhcCCCcEEEE
Confidence            3469999999999999999997 56799999999874            2344556678889999999999999999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      |..|.+.+++||||||++||++..+|..    ...+++..++.++.+.+.|+..+   |..|+|||||||+|+|||..|+
T Consensus       207 yYsFQD~~~LYLiMEylPGGD~mTLL~~----~~~L~e~~arfYiaE~vlAI~~i---H~~gyIHRDIKPdNlLiD~~GH  279 (550)
T KOG0605|consen  207 YYSFQDKEYLYLIMEYLPGGDMMTLLMR----KDTLTEDWARFYIAETVLAIESI---HQLGYIHRDIKPDNLLIDAKGH  279 (550)
T ss_pred             EEEecCCCeeEEEEEecCCccHHHHHHh----cCcCchHHHHHHHHHHHHHHHHH---HHcCcccccCChhheeecCCCC
Confidence            9999999999999999999999999975    67899999999999999999999   8899999999999999999999


Q ss_pred             EEEeccCCccccCCC-----------------------Cc-----ee-----------------eEeeecccccccCCcc
Q 011360          351 ACISDLGLAMAIPDG-----------------------YT-----RV-----------------LISYVLGTMAYIAPEY  385 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~-----------------------~~-----~~-----------------~~~~~~gt~~y~aPE~  385 (487)
                      +||+|||+|.-+...                       ..     ..                 .....+|||.|+|||+
T Consensus       280 iKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEV  359 (550)
T KOG0605|consen  280 IKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEV  359 (550)
T ss_pred             EeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHH
Confidence            999999998533110                       00     00                 0012579999999999


Q ss_pred             cCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhc
Q 011360          386 FQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYIC  465 (487)
Q Consensus       386 l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c  465 (487)
                      +.+..|+..+|+||||||+|||+.|.+||...++..      -.+.++.-... -..+.      ....+.+..++|++|
T Consensus       360 ll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~------T~rkI~nwr~~-l~fP~------~~~~s~eA~DLI~rl  426 (550)
T KOG0605|consen  360 LLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQE------TYRKIVNWRET-LKFPE------EVDLSDEAKDLITRL  426 (550)
T ss_pred             HhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHHHhhh-ccCCC------cCcccHHHHHHHHHH
Confidence            999999999999999999999999999996554422      12222221110 00011      112226788999999


Q ss_pred             cCCCCCCCCC---hHHHH
Q 011360          466 TLHDPEERPN---SQYVR  480 (487)
Q Consensus       466 l~~~P~~RPs---~~~il  480 (487)
                      +. ||++|..   ++||.
T Consensus       427 l~-d~~~RLG~~G~~EIK  443 (550)
T KOG0605|consen  427 LC-DPENRLGSKGAEEIK  443 (550)
T ss_pred             hc-CHHHhcCcccHHHHh
Confidence            99 9999975   55554

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.5e-43  Score=343.15  Aligned_cols=249  Identities=26%  Similarity=0.407  Sum_probs=211.6

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||+|.||.||+|+ ++.+.+.||+|.+..             ....+...+.+.+|+++++.++|||||.++
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgr-rK~t~~~vAik~i~K-------------~gr~~k~l~~l~~ev~i~r~lkHpniv~m~   67 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGR-RKYTIQVVAIKFIDK-------------SGRNEKELKNLRQEVRILRSLKHPNIVEML   67 (808)
T ss_pred             cchhHHHHhcCCccceeeecc-cccceeEEEEEEehh-------------cCCchHHHHHHHHHHHHHHhcCCcchhhHH
Confidence            358899999999999999997 567899999998732             233345678899999999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      ++|....++++|+|||.| +|..+|..    ...++++.+..++.+++.||.||   |+.+|+|||+||.|||+..+|.+
T Consensus        68 esfEt~~~~~vVte~a~g-~L~~il~~----d~~lpEe~v~~~a~~LVsaL~yL---hs~rilhrd~kPqniLl~~~~~~  139 (808)
T KOG0597|consen   68 ESFETSAHLWVVTEYAVG-DLFTILEQ----DGKLPEEQVRAIAYDLVSALYYL---HSNRILHRDMKPQNILLEKGGTL  139 (808)
T ss_pred             HhhcccceEEEEehhhhh-hHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHH---HhcCcccccCCcceeeecCCCce
Confidence            999999999999999966 99999976    67899999999999999999999   88899999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRK  431 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~  431 (487)
                      |+||||+++.+..+  ....+.+.|||-|||||.+.+..|+..+|+||+||++||+++|++||..      ....+.+..
T Consensus       140 KlcdFg~Ar~m~~~--t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a------~si~~Lv~~  211 (808)
T KOG0597|consen  140 KLCDFGLARAMSTN--TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA------RSITQLVKS  211 (808)
T ss_pred             eechhhhhhhcccC--ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH------HHHHHHHHH
Confidence            99999999987653  3344677899999999999999999999999999999999999999932      222334444


Q ss_pred             HHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          432 VMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       432 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      +..+...       .|    ...+..+..++...|.+||..|.|..+++.
T Consensus       212 I~~d~v~-------~p----~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  212 ILKDPVK-------PP----STASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             HhcCCCC-------Cc----ccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence            4332211       11    144567999999999999999999998864

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1e-43  Score=348.01  Aligned_cols=266  Identities=24%  Similarity=0.380  Sum_probs=213.0

Q ss_pred             HHhhhccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCC
Q 011360          186 AFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHR  265 (487)
Q Consensus       186 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp  265 (487)
                      .|....+.+.+...||.|.||+||+|.|.+    .||||++...             ...+...+.|++|+.++++-+|.
T Consensus       386 ~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG----dVAVK~Lnv~-------------~pt~~qlqaFKnEVa~lkkTRH~  448 (678)
T KOG0193|consen  386 EWEIPPEEVLLGERIGSGSFGTVYRGRWHG----DVAVKLLNVD-------------DPTPEQLQAFKNEVAVLKKTRHE  448 (678)
T ss_pred             ccccCHHHhhccceeccccccceeeccccc----ceEEEEEecC-------------CCCHHHHHHHHHHHHHHhhcchh
Confidence            345555568889999999999999999853    5999999653             33455788999999999999999


Q ss_pred             CccccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEe
Q 011360          266 NILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLL  345 (487)
Q Consensus       266 nIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill  345 (487)
                      ||+-|.|++..+.. .||+.+|+|-+|..++...   ...|...+...|++||++|+.||   |.++|||||||..||++
T Consensus       449 NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~---etkfdm~~~idIAqQiaqGM~YL---HAK~IIHrDLKSnNIFl  521 (678)
T KOG0193|consen  449 NILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQ---ETKFDMNTTIDIAQQIAQGMDYL---HAKNIIHRDLKSNNIFL  521 (678)
T ss_pred             hheeeehhhcCCce-eeeehhccCchhhhhccch---hhhhhHHHHHHHHHHHHHhhhhh---hhhhhhhhhccccceEE
Confidence            99999999998877 8999999999999999753   46788899999999999999999   88999999999999999


Q ss_pred             CCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCC---CCCCchhHHHHHHHHHHHHHhCCCCccccCCCCc
Q 011360          346 NDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQ---PELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEE  422 (487)
Q Consensus       346 ~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~  422 (487)
                      .++++|||+|||++..-.............|...|||||++..   .+|+..+|||||||++|||+||..||.....+..
T Consensus       522 ~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqI  601 (678)
T KOG0193|consen  522 HEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQI  601 (678)
T ss_pred             ccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhhe
Confidence            9999999999999875433322222234558889999999874   3799999999999999999999999963322221


Q ss_pred             cccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhhC
Q 011360          423 ICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL  487 (487)
Q Consensus       423 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~ll  487 (487)
                      +         +..++.....|.   ........+++.+|+..||.+++++||++.+|+..|+.++
T Consensus       602 i---------fmVGrG~l~pd~---s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~  654 (678)
T KOG0193|consen  602 I---------FMVGRGYLMPDL---SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELL  654 (678)
T ss_pred             E---------EEecccccCccc---hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhh
Confidence            1         112222111111   1233445577889999999999999999999999888764

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.1e-42  Score=309.35  Aligned_cols=264  Identities=27%  Similarity=0.377  Sum_probs=207.4

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|...+.+|+|.||.||+|+ +..+|+.||||++...             ..+........+|+..++.++||||+.++
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~-d~~t~~~VAIKKIkl~-------------~~kdGi~~talREIK~Lqel~h~nIi~Li   67 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKAR-DTETGKRVAIKKIKLG-------------NAKDGINRTALREIKLLQELKHPNIIELI   67 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEE-ecCCCcEEEEEEeecc-------------ccccCccHHHHHHHHHHHHccCcchhhhh
Confidence            358889999999999999997 5679999999999653             22233345678999999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      ++|.+.+.+.+|+||++. +|...++.   ....++...+..++.++++|++||   |++.|+||||||.|+|++.+|.+
T Consensus        68 D~F~~~~~l~lVfEfm~t-dLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~---H~~~IlHRDlKPnNLLis~~g~l  140 (318)
T KOG0659|consen   68 DVFPHKSNLSLVFEFMPT-DLEVVIKD---KNIILSPADIKSYMLMTLKGLAYC---HSKWILHRDLKPNNLLISSDGQL  140 (318)
T ss_pred             hhccCCCceEEEEEeccc-cHHHHhcc---cccccCHHHHHHHHHHHHHHHHHH---HhhhhhcccCCccceEEcCCCcE
Confidence            999999999999999954 89988874   467789999999999999999999   78889999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQP-ELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLR  430 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~  430 (487)
                      ||+|||+++.+.......  ...+.|.+|.|||.+.+. .|+..+|+||.||++.||+.|.+-|.+.++-+..   ..+-
T Consensus       141 KiADFGLAr~f~~p~~~~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL---~~If  215 (318)
T KOG0659|consen  141 KIADFGLARFFGSPNRIQ--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQL---SKIF  215 (318)
T ss_pred             EeecccchhccCCCCccc--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHH---HHHH
Confidence            999999999887654433  233679999999988765 7999999999999999999999888655431111   1111


Q ss_pred             HHHhcCCCCCccC-------------CCCC-CCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          431 KVMNSKNPSRAID-------------PRLP-GNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       431 ~~~~~~~~~~~~~-------------~~~~-~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ..+....+....+             |..+ ....+..+.+..+++..+|..||.+|+|++|.++
T Consensus       216 ~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~  280 (318)
T KOG0659|consen  216 RALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALK  280 (318)
T ss_pred             HHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhc
Confidence            1111111111000             0000 1133445567899999999999999999999875

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-44  Score=345.53  Aligned_cols=249  Identities=27%  Similarity=0.406  Sum_probs=203.3

Q ss_pred             HhhhccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCC
Q 011360          187 FLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRN  266 (487)
Q Consensus       187 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn  266 (487)
                      |...-+.+.-++.||.|+-|.||+|++   .++.||||++.                      +.-..++.-|++|+|||
T Consensus       119 WeiPFe~IsELeWlGSGaQGAVF~Grl---~netVAVKKV~----------------------elkETdIKHLRkLkH~N  173 (904)
T KOG4721|consen  119 WEIPFEEISELEWLGSGAQGAVFLGRL---HNETVAVKKVR----------------------ELKETDIKHLRKLKHPN  173 (904)
T ss_pred             ccCCHHHhhhhhhhccCcccceeeeec---cCceehhHHHh----------------------hhhhhhHHHHHhccCcc
Confidence            444344466678899999999999997   57889999762                      12235777899999999


Q ss_pred             ccccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC
Q 011360          267 ILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN  346 (487)
Q Consensus       267 Iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~  346 (487)
                      |+.|.|+|....++|||||||..|.|...|+.    +..+.......+..+||.|+.||   |.+.|||||||.-||||+
T Consensus       174 II~FkGVCtqsPcyCIiMEfCa~GqL~~VLka----~~~itp~llv~Wsk~IA~GM~YL---H~hKIIHRDLKSPNiLIs  246 (904)
T KOG4721|consen  174 IITFKGVCTQSPCYCIIMEFCAQGQLYEVLKA----GRPITPSLLVDWSKGIAGGMNYL---HLHKIIHRDLKSPNILIS  246 (904)
T ss_pred             eeeEeeeecCCceeEEeeeccccccHHHHHhc----cCccCHHHHHHHHHHhhhhhHHH---HHhhHhhhccCCCceEee
Confidence            99999999999999999999999999999975    67788889999999999999999   667799999999999999


Q ss_pred             CCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccH
Q 011360          347 DDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSP  426 (487)
Q Consensus       347 ~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~  426 (487)
                      .+..|||+|||-++......+   ...++||..|||||++.+.+.+.|+||||||++||||+||..||..-+....+   
T Consensus       247 ~~d~VKIsDFGTS~e~~~~ST---kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII---  320 (904)
T KOG4721|consen  247 YDDVVKISDFGTSKELSDKST---KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII---  320 (904)
T ss_pred             ccceEEeccccchHhhhhhhh---hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeE---
Confidence            999999999999987655422   24578999999999999999999999999999999999999999432221111   


Q ss_pred             HHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhh
Q 011360          427 EWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQ  485 (487)
Q Consensus       427 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~  485 (487)
                         . -+..+.....++..+|        .-|.-|++.||+-.|.+||||.+|+..|+-
T Consensus       321 ---w-GVGsNsL~LpvPstcP--------~GfklL~Kqcw~sKpRNRPSFrqil~HldI  367 (904)
T KOG4721|consen  321 ---W-GVGSNSLHLPVPSTCP--------DGFKLLLKQCWNSKPRNRPSFRQILLHLDI  367 (904)
T ss_pred             ---E-eccCCcccccCcccCc--------hHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence               0 0112333333334444        348888999999999999999999988763

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.1e-43  Score=326.69  Aligned_cols=249  Identities=24%  Similarity=0.393  Sum_probs=211.6

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      .+|++.+.||.|.||+|-+|. ....|+.||||.+.            ++....+..+-.+++|+++|..|+||||+.+|
T Consensus        53 HRyE~~etLGkGTYGKVk~A~-e~~sgR~VAiKsIr------------KdkIkdeqDlvhIRREIeIMSsLNHPhII~Iy  119 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAY-EHKSGREVAIKSIR------------KDKIKDEQDLVHIRREIEIMSSLNHPHIIQIY  119 (668)
T ss_pred             hHHHHHHHhcCCcccceeehh-hccCCcEeehhhhh------------hhhcccHHHHHHHHHHHHHHhhcCCCceeehh
Confidence            369999999999999999995 55689999999663            44555666788899999999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      .+|.+.+.+.|||||..+|.|.||+..    .+.+++..++++++||++|+.|+   |.++++|||||.+|||++.|+++
T Consensus       120 EVFENkdKIvivMEYaS~GeLYDYiSe----r~~LsErEaRhfFRQIvSAVhYC---HknrVvHRDLKLENILLD~N~Ni  192 (668)
T KOG0611|consen  120 EVFENKDKIVIVMEYASGGELYDYISE----RGSLSEREARHFFRQIVSAVHYC---HKNRVVHRDLKLENILLDQNNNI  192 (668)
T ss_pred             hhhcCCceEEEEEEecCCccHHHHHHH----hccccHHHHHHHHHHHHHHHHHH---hhccceecccchhheeecCCCCe
Confidence            999999999999999999999999976    57799999999999999999999   88899999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCCCC-CchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPEL-SEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLR  430 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~  430 (487)
                      ||+|||++..+.....   ..++||+|-|.+||++.+.+| ++.+|-||||++||-|..|..||.+.+.      -..++
T Consensus       193 KIADFGLSNly~~~kf---LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh------k~lvr  263 (668)
T KOG0611|consen  193 KIADFGLSNLYADKKF---LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH------KRLVR  263 (668)
T ss_pred             eeeccchhhhhccccH---HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH------HHHHH
Confidence            9999999987655432   357899999999999999888 5789999999999999999999955433      12233


Q ss_pred             HHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          431 KVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       431 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ++ ..+...   .|.-|+        +..-||++||-.||++|.|+.+|..
T Consensus       264 QI-s~GaYr---EP~~PS--------dA~gLIRwmLmVNP~RRATieDiAs  302 (668)
T KOG0611|consen  264 QI-SRGAYR---EPETPS--------DASGLIRWMLMVNPERRATIEDIAS  302 (668)
T ss_pred             Hh-hccccc---CCCCCc--------hHHHHHHHHHhcCcccchhHHHHhh
Confidence            33 333222   222332        3778999999999999999999865

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-42  Score=330.60  Aligned_cols=267  Identities=27%  Similarity=0.351  Sum_probs=203.1

Q ss_pred             hccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccc
Q 011360          190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILP  269 (487)
Q Consensus       190 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~  269 (487)
                      .-++|++.+.||.|.||+|-+|+ +..+++.||||++....-. ................+...+|+.+|+++.|||||+
T Consensus        95 ~lNqy~l~~eiG~G~yGkVkLar-~~~~~~l~AiKil~K~~~~-~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~  172 (576)
T KOG0585|consen   95 QLNQYELIKEIGSGQYGKVKLAR-DEVDGKLYAIKILPKKELR-RQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK  172 (576)
T ss_pred             ehhheehhhhhcCCccceEEEEe-ecCCCcEEEEEeechhhhh-hhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence            45679999999999999999996 5678999999998432100 000000111122234568899999999999999999


Q ss_pred             cceEEecC--CeeEEEEEecCCCCHHHHHhhhhcCCCC-CChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC
Q 011360          270 LLAHMVRP--DCHLLVYEFMKNGSLQDILDDVSRGRRE-LDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN  346 (487)
Q Consensus       270 l~~~~~~~--~~~~lv~E~~~~gsL~~~l~~~~~~~~~-l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~  346 (487)
                      ++.+..++  +.+|||+|||..|.+...     ....+ +++.++++++++++.||.||   |.+|||||||||+|+|++
T Consensus       173 LiEvLDDP~s~~~YlVley~s~G~v~w~-----p~d~~els~~~Ar~ylrDvv~GLEYL---H~QgiiHRDIKPsNLLl~  244 (576)
T KOG0585|consen  173 LIEVLDDPESDKLYLVLEYCSKGEVKWC-----PPDKPELSEQQARKYLRDVVLGLEYL---HYQGIIHRDIKPSNLLLS  244 (576)
T ss_pred             EEEeecCcccCceEEEEEeccCCccccC-----CCCcccccHHHHHHHHHHHHHHHHHH---HhcCeeccccchhheEEc
Confidence            99999875  678999999999887543     22344 89999999999999999999   888999999999999999


Q ss_pred             CCCCEEEeccCCccccCCCCc---eeeEeeecccccccCCcccCCC----CCCchhHHHHHHHHHHHHHhCCCCccccCC
Q 011360          347 DDMEACISDLGLAMAIPDGYT---RVLISYVLGTMAYIAPEYFQQP----ELSEKCDIFSFGMLLISLVRGVPSFVFHQN  419 (487)
Q Consensus       347 ~~~~~kl~DFg~s~~~~~~~~---~~~~~~~~gt~~y~aPE~l~~~----~~~~~~DvwslG~~l~elltg~~pf~~~~~  419 (487)
                      ++|++||+|||.+.....+..   ........|||.|+|||...++    ..+.+.||||+|++||.|+.|+.||...  
T Consensus       245 ~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~--  322 (576)
T KOG0585|consen  245 SDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD--  322 (576)
T ss_pred             CCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc--
Confidence            999999999999987643311   1112346799999999987763    2357889999999999999999999332  


Q ss_pred             CCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          420 GEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       420 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                          ...+...++....         +......++...+.++|.++|.+||+.|.+..+|..
T Consensus       323 ----~~~~l~~KIvn~p---------L~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~  371 (576)
T KOG0585|consen  323 ----FELELFDKIVNDP---------LEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKL  371 (576)
T ss_pred             ----hHHHHHHHHhcCc---------ccCCCcccccHHHHHHHHHHhhcChhheeehhhhee
Confidence                2334444443321         111222244567889999999999999999998753

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-42  Score=364.85  Aligned_cols=263  Identities=25%  Similarity=0.393  Sum_probs=216.3

Q ss_pred             cccccccccccccceeEEEEEecCCCCc----eEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGK----MIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNI  267 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI  267 (487)
                      +.......||+|.||.||.|.+...++.    .||+|.+..              ..+......|.+|+.+|+.++||||
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~--------------~~~~~~~~~Fl~Ea~~m~~f~HpNi  757 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKR--------------LSSEQEVSDFLKEALLMSKFDHPNI  757 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccc--------------cCCHHHHHHHHHHHHHHhcCCCcce
Confidence            3467788999999999999998766665    489998733              3445677889999999999999999


Q ss_pred             cccceEEecCCeeEEEEEecCCCCHHHHHhhhhc---CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEE
Q 011360          268 LPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSR---GRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVL  344 (487)
Q Consensus       268 v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nil  344 (487)
                      |+++|++.+....+|++|||+||+|..||+..+.   ....++....+.++.|||+|+.||+.   +.+|||||.++|||
T Consensus       758 v~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCL  834 (1025)
T KOG1095|consen  758 VSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCL  834 (1025)
T ss_pred             eeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhhee
Confidence            9999999999999999999999999999986422   25678889999999999999999954   45999999999999


Q ss_pred             eCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCcc
Q 011360          345 LNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEI  423 (487)
Q Consensus       345 l~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~  423 (487)
                      ++....+||+|||+|+.+.............-+.+|||||.+..+.++.|+|||||||++||++| |..||...++    
T Consensus       835 L~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n----  910 (1025)
T KOG1095|consen  835 LDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN----  910 (1025)
T ss_pred             ecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch----
Confidence            99999999999999996655444333333345689999999999999999999999999999999 7999954433    


Q ss_pred             ccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhhC
Q 011360          424 CSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL  487 (487)
Q Consensus       424 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~ll  487 (487)
                        .+.+..+..+++.  ..++.+|        ..++++|..||+.+|++||++..|++.+..++
T Consensus       911 --~~v~~~~~~ggRL--~~P~~CP--------~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~  962 (1025)
T KOG1095|consen  911 --FEVLLDVLEGGRL--DPPSYCP--------EKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS  962 (1025)
T ss_pred             --HHHHHHHHhCCcc--CCCCCCC--------hHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence              3445556666532  2222333        45889999999999999999999999887653

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-42  Score=343.09  Aligned_cols=247  Identities=24%  Similarity=0.335  Sum_probs=205.4

Q ss_pred             hccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CCCCcc
Q 011360          190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RHRNIL  268 (487)
Q Consensus       190 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv  268 (487)
                      ..++|.++++||+|.||+|+++..+ .+++.+|||.++.            +.......++..+.|..++... +||.++
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k-~~~e~yAIK~LKK------------~~Il~~d~Ve~~~~EkrI~~la~~HPFL~  432 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELK-GTNEYYAIKVLKK------------GDILQRDEVESLMCEKRIFELANRHPFLV  432 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEc-CCCcEEEEEEeec------------cceeccccHHHHHHHHHHHHHhccCCeEe
Confidence            3457999999999999999999875 5788999998854            3445566777888888887777 699999


Q ss_pred             ccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC
Q 011360          269 PLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDD  348 (487)
Q Consensus       269 ~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~  348 (487)
                      +++.+|.+.+++|+||||+.||++..+.+     ...+++..+..++..++.||.||   |++||||||||.+|||+|.+
T Consensus       433 ~L~~~fQT~~~l~fvmey~~Ggdm~~~~~-----~~~F~e~rarfyaAev~l~L~fL---H~~~IIYRDlKLdNiLLD~e  504 (694)
T KOG0694|consen  433 NLFSCFQTKEHLFFVMEYVAGGDLMHHIH-----TDVFSEPRARFYAAEVVLGLQFL---HENGIIYRDLKLDNLLLDTE  504 (694)
T ss_pred             ecccccccCCeEEEEEEecCCCcEEEEEe-----cccccHHHHHHHHHHHHHHHHHH---HhcCceeeecchhheEEccc
Confidence            99999999999999999999999544433     46799999999999999999999   88999999999999999999


Q ss_pred             CCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHH
Q 011360          349 MEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEW  428 (487)
Q Consensus       349 ~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~  428 (487)
                      |++||+|||+++.......  .+++++|||.|+|||++.+..|+.++|+|||||+||||+.|..||.+.+.      .+.
T Consensus       505 Gh~kiADFGlcKe~m~~g~--~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE------ee~  576 (694)
T KOG0694|consen  505 GHVKIADFGLCKEGMGQGD--RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE------EEV  576 (694)
T ss_pred             CcEEecccccccccCCCCC--ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH------HHH
Confidence            9999999999987543333  34789999999999999999999999999999999999999999955433      233


Q ss_pred             HHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCh
Q 011360          429 LRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNS  476 (487)
Q Consensus       429 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~  476 (487)
                      ...+......       .|    .-.+.+...++.++|.+||++|..+
T Consensus       577 FdsI~~d~~~-------yP----~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  577 FDSIVNDEVR-------YP----RFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             HHHHhcCCCC-------CC----CcccHHHHHHHHHHhccCcccccCC
Confidence            4444332211       11    1234678899999999999999865

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.4e-42  Score=341.13  Aligned_cols=249  Identities=26%  Similarity=0.324  Sum_probs=209.5

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      -|++.+.||.|+.|.|-+|++ ..+|+..|||++...            ..........+.+|+.+|+.+.||||+++|+
T Consensus        13 pwkLgkTLG~Gstg~vrlakh-~~TGqlaaiKii~k~------------~~~s~s~~~~IerEIviMkLi~HpnVl~Lyd   79 (786)
T KOG0588|consen   13 PWKLGKTLGKGSTGCVRLAKH-AETGQLAAIKIIPKR------------SELSSSQPAGIEREIVIMKLIEHPNVLRLYD   79 (786)
T ss_pred             ceeccccccCCCCceehhhhc-ccccceeEEEeeccc------------cccccccccchhhhhHHHHHhcCCCeeeeee
Confidence            488889999999999999985 579999999998432            1334445667889999999999999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEE
Q 011360          273 HMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC  352 (487)
Q Consensus       273 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~k  352 (487)
                      +|.+...+|+|.||++||.|++++-.    .+++++..+.+++.||+.|+.|+   |..+|+||||||+|+|++..+++|
T Consensus        80 Vwe~~~~lylvlEyv~gGELFdylv~----kG~l~e~eaa~ff~QIi~gv~yC---H~~~icHRDLKpENlLLd~~~nIK  152 (786)
T KOG0588|consen   80 VWENKQHLYLVLEYVPGGELFDYLVR----KGPLPEREAAHFFRQILDGVSYC---HAFNICHRDLKPENLLLDVKNNIK  152 (786)
T ss_pred             eeccCceEEEEEEecCCchhHHHHHh----hCCCCCHHHHHHHHHHHHHHHHH---hhhcceeccCCchhhhhhcccCEe
Confidence            99999999999999999999999965    67899999999999999999999   555699999999999999999999


Q ss_pred             EeccCCccccCCCCceeeEeeecccccccCCcccCCCCC-CchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHH
Q 011360          353 ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPEL-SEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRK  431 (487)
Q Consensus       353 l~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~  431 (487)
                      |+|||+|..-..+.   ...+.||+|.|.|||++.+..| +.++||||+||+||.|+||+.||.      +.+....+.+
T Consensus       153 IADFGMAsLe~~gk---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd------DdNir~LLlK  223 (786)
T KOG0588|consen  153 IADFGMASLEVPGK---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD------DDNIRVLLLK  223 (786)
T ss_pred             eeccceeecccCCc---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC------CccHHHHHHH
Confidence            99999997654433   3357889999999999999988 478999999999999999999993      3334444444


Q ss_pred             HHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          432 VMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       432 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      +..+...       +|    ..++.++.+|+++|+..||++|.|+++|++
T Consensus       224 V~~G~f~-------MP----s~Is~eaQdLLr~ml~VDp~~RiT~~eI~k  262 (786)
T KOG0588|consen  224 VQRGVFE-------MP----SNISSEAQDLLRRMLDVDPSTRITTEEILK  262 (786)
T ss_pred             HHcCccc-------CC----CcCCHHHHHHHHHHhccCccccccHHHHhh
Confidence            4433221       22    223456899999999999999999999986

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-43  Score=333.45  Aligned_cols=250  Identities=30%  Similarity=0.416  Sum_probs=208.4

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ..|..++.||+|.||.||+|. +..+++.||+|++..              .........+.+|+.++.++++|||.++|
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~-d~~t~k~vAiKii~L--------------e~~~deIediqqei~~Ls~~~~~~it~yy   77 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAI-DNKTKKVVAIKIIDL--------------EEAEDEIEDIQQEISVLSQCDSPNITEYY   77 (467)
T ss_pred             cccccchhccccccceeeeee-eccccceEEEEEech--------------hhcchhhHHHHHHHHHHHhcCcchHHhhh
Confidence            358888999999999999996 567899999999843              23344567788999999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +.+..+..++++||||.||++.+.+..    +..+.+..+..+++++..||.||   |..+.+|||||+.|||+..+|.+
T Consensus        78 gsyl~g~~LwiiMey~~gGsv~~lL~~----~~~~~E~~i~~ilre~l~~l~yl---H~~~kiHrDIKaanil~s~~g~v  150 (467)
T KOG0201|consen   78 GSYLKGTKLWIIMEYCGGGSVLDLLKS----GNILDEFEIAVILREVLKGLDYL---HSEKKIHRDIKAANILLSESGDV  150 (467)
T ss_pred             hheeecccHHHHHHHhcCcchhhhhcc----CCCCccceeeeehHHHHHHhhhh---hhcceecccccccceeEeccCcE
Confidence            999999999999999999999999964    45557888888999999999999   88889999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRK  431 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~  431 (487)
                      ||+|||.+..+.......  .+++|||.|||||++.+..|+.|+||||||++.+||.+|.+|+....+.+-...      
T Consensus       151 kl~DfgVa~ql~~~~~rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl------  222 (467)
T KOG0201|consen  151 KLADFGVAGQLTNTVKRR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL------  222 (467)
T ss_pred             EEEecceeeeeechhhcc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe------
Confidence            999999998876554433  578899999999999988999999999999999999999999954443222110      


Q ss_pred             HHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          432 VMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       432 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                        .....    +|.+.+    ..+.-+.+++..||.+||++|||+.++++
T Consensus       223 --Ipk~~----PP~L~~----~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  223 --IPKSA----PPRLDG----DFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             --ccCCC----CCcccc----ccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence              11111    222222    34455888899999999999999999986

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.9e-42  Score=299.93  Aligned_cols=251  Identities=25%  Similarity=0.354  Sum_probs=209.1

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|++.+.||.|-||.||+|+.+ .++..||+|++..            ..........++.+|+++-+.|+||||+++|
T Consensus        22 ~dfeigr~LgkgkFG~vYlarek-ks~~IvalKVlfK------------sqi~~~~v~~qlrREiEIqs~L~hpnilrlY   88 (281)
T KOG0580|consen   22 DDFEIGRPLGKGKFGNVYLAREK-KSLFIVALKVLFK------------SQILKTQVEHQLRREIEIQSHLRHPNILRLY   88 (281)
T ss_pred             hhccccccccCCccccEeEeeec-cCCcEEEEeeeeH------------HHHHHhcchhhhhheeEeecccCCccHHhhh
Confidence            45999999999999999999864 5788999998832            2233344567889999999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      ++|.+...+|+++||..+|+|...|..  .....+++.....++.|+|.||.|+   |.++|+||||||+|+|++..+.+
T Consensus        89 ~~fhd~~riyLilEya~~gel~k~L~~--~~~~~f~e~~~a~Yi~q~A~Al~y~---h~k~VIhRdiKpenlLlg~~~~l  163 (281)
T KOG0580|consen   89 GYFHDSKRIYLILEYAPRGELYKDLQE--GRMKRFDEQRAATYIKQLANALLYC---HLKRVIHRDIKPENLLLGSAGEL  163 (281)
T ss_pred             hheeccceeEEEEEecCCchHHHHHHh--cccccccccchhHHHHHHHHHHHHh---ccCCcccCCCCHHHhccCCCCCe
Confidence            999999999999999999999999975  4466788999999999999999999   78889999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRK  431 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~  431 (487)
                      |++|||.+...+.+..    .+.+||..|.+||...+..++..+|+|++|++.||++.|.+||....      ..+...+
T Consensus       164 kiAdfGwsV~~p~~kR----~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~------~~etYkr  233 (281)
T KOG0580|consen  164 KIADFGWSVHAPSNKR----KTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS------HSETYKR  233 (281)
T ss_pred             eccCCCceeecCCCCc----eeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh------hHHHHHH
Confidence            9999999987654332    56789999999999999999999999999999999999999995443      1122222


Q ss_pred             HHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          432 VMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       432 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      +....   -.++..+        +..+.++|.+|+..+|.+|.+..++++
T Consensus       234 I~k~~---~~~p~~i--------s~~a~dlI~~ll~~~p~~r~~l~~v~~  272 (281)
T KOG0580|consen  234 IRKVD---LKFPSTI--------SGGAADLISRLLVKNPIERLALTEVMD  272 (281)
T ss_pred             HHHcc---ccCCccc--------ChhHHHHHHHHhccCccccccHHHHhh
Confidence            22211   1111223        345889999999999999999999875

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-41  Score=320.34  Aligned_cols=256  Identities=24%  Similarity=0.381  Sum_probs=210.0

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      +.|++++.||.|..|+||++..+ .++..+|+|++..            ..........++..|-+||..+.||.+..+|
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~-~t~~~fAmKVmdK------------~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLY  143 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELR-GTNCLFAMKVMDK------------ESLASRKKLKRAQTEREILSLLDHPFLPTLY  143 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEec-CCCceEEEEEecH------------HHHhhhhHHHHHHHHHHHHHhcCCCccchhh
Confidence            45889999999999999999865 4668999998832            2233355677888999999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      ..+..++..|++||||+||+|..+++.  +.++.+++..++.++..++.||+||   |..|||+|||||+||||.++|++
T Consensus       144 a~fet~~~~cl~meyCpGGdL~~Lrqk--Qp~~~fse~~aRFYaAEvl~ALEYL---HmlGivYRDLKPENILvredGHI  218 (459)
T KOG0610|consen  144 ASFETDKYSCLVMEYCPGGDLHSLRQK--QPGKRFSESAARFYAAEVLLALEYL---HMLGIVYRDLKPENILVREDGHI  218 (459)
T ss_pred             heeeccceeEEEEecCCCccHHHHHhh--CCCCccchhhHHHHHHHHHHHHHHH---HhhceeeccCCcceeEEecCCcE
Confidence            999999999999999999999999886  6778899999999999999999999   88999999999999999999999


Q ss_pred             EEeccCCccccCCC---------------------------------Cc---------------------eeeEeeeccc
Q 011360          352 CISDLGLAMAIPDG---------------------------------YT---------------------RVLISYVLGT  377 (487)
Q Consensus       352 kl~DFg~s~~~~~~---------------------------------~~---------------------~~~~~~~~gt  377 (487)
                      -|+||.++......                                 ..                     ......++||
T Consensus       219 MLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGT  298 (459)
T KOG0610|consen  219 MLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGT  298 (459)
T ss_pred             EeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccc
Confidence            99999988543110                                 00                     0011235789


Q ss_pred             ccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHH
Q 011360          378 MAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLH  457 (487)
Q Consensus       378 ~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  457 (487)
                      -.|+|||++.+...+.++|+|+|||++|||+.|..||.+.++...      +..++..       +..+|+.  ...+..
T Consensus       299 hEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~T------l~NIv~~-------~l~Fp~~--~~vs~~  363 (459)
T KOG0610|consen  299 HEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKET------LRNIVGQ-------PLKFPEE--PEVSSA  363 (459)
T ss_pred             cccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhh------HHHHhcC-------CCcCCCC--CcchhH
Confidence            999999999999999999999999999999999999987766432      2222221       1123322  255677


Q ss_pred             HHHHHhhccCCCCCCCCC----hHHHH
Q 011360          458 VLKIAYICTLHDPEERPN----SQYVR  480 (487)
Q Consensus       458 l~~li~~cl~~~P~~RPs----~~~il  480 (487)
                      +.+||+++|.+||++|..    +.+|.
T Consensus       364 akDLIr~LLvKdP~kRlg~~rGA~eIK  390 (459)
T KOG0610|consen  364 AKDLIRKLLVKDPSKRLGSKRGAAEIK  390 (459)
T ss_pred             HHHHHHHHhccChhhhhccccchHHhh
Confidence            999999999999999998    66664

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=3e-41  Score=329.30  Aligned_cols=266  Identities=21%  Similarity=0.307  Sum_probs=202.1

Q ss_pred             cccccccccccccceeEEEEEecC---------------CCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHH
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPG---------------SNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI  256 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~---------------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~  256 (487)
                      ++|.+.+.||+|+||.||+|.++.               .++..||+|.+...              ........+.+|+
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~--------------~~~~~~~~~~~E~   70 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPD--------------ANKNARNDFLKEV   70 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCC--------------CCHHHHHHHHHHH
Confidence            468999999999999999997532               23457999987421              1223455788999


Q ss_pred             HHhccCCCCCccccceEEecCCeeEEEEEecCCCCHHHHHhhhhc---------------CCCCCChHHHHHHHHHHHHH
Q 011360          257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSR---------------GRRELDWPSRHRIALGVASG  321 (487)
Q Consensus       257 ~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~---------------~~~~l~~~~~~~i~~qi~~~  321 (487)
                      .++..++||||+++++++...+..++||||+++|+|.+++.....               ....+++..+..++.|++.|
T Consensus        71 ~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~a  150 (304)
T cd05096          71 KILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASG  150 (304)
T ss_pred             HHHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence            999999999999999999999999999999999999999864211               12346788899999999999


Q ss_pred             HHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHH
Q 011360          322 LEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFG  401 (487)
Q Consensus       322 L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG  401 (487)
                      |.||   |+.||+||||||+|||++.++.+||+|||++................++..|+|||++.+..++.++||||||
T Consensus       151 l~~l---H~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG  227 (304)
T cd05096         151 MKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFG  227 (304)
T ss_pred             HHHH---HHCCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHH
Confidence            9999   6778999999999999999999999999999866444332222334567899999999888899999999999


Q ss_pred             HHHHHHHhC--CCCccccCCCCccccHHHHHHHHhcCCCC--CccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChH
Q 011360          402 MLLISLVRG--VPSFVFHQNGEEICSPEWLRKVMNSKNPS--RAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQ  477 (487)
Q Consensus       402 ~~l~elltg--~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~  477 (487)
                      +++|+|+++  ..||.......   ..+............  ...++.        .+..+.+++.+||+.+|++|||+.
T Consensus       228 ~~l~el~~~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~li~~cl~~~p~~RPs~~  296 (304)
T cd05096         228 VTLWEILMLCKEQPYGELTDEQ---VIENAGEFFRDQGRQVYLFRPPP--------CPQGLYELMLQCWSRDCRERPSFS  296 (304)
T ss_pred             HHHHHHHHccCCCCCCcCCHHH---HHHHHHHHhhhccccccccCCCC--------CCHHHHHHHHHHccCCchhCcCHH
Confidence            999999974  56774332211   111111111111110  001111        224689999999999999999999


Q ss_pred             HHHHHHhh
Q 011360          478 YVRCRLSQ  485 (487)
Q Consensus       478 ~il~~L~~  485 (487)
                      +|.+.|++
T Consensus       297 ~i~~~l~~  304 (304)
T cd05096         297 DIHAFLTE  304 (304)
T ss_pred             HHHHHHhC
Confidence            99998864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.4e-41  Score=341.01  Aligned_cols=265  Identities=23%  Similarity=0.287  Sum_probs=205.1

Q ss_pred             ccccccccccccccceeEEEEEe----cCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CCC
Q 011360          191 EDCFASLEKIGSGGCGEVYKAEL----PGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RHR  265 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp  265 (487)
                      .++|.+.+.||+|+||.||+|++    ...++..||+|++...              ........+.+|+.++..+ +||
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~--------------~~~~~~~~~~~Ei~il~~l~~Hp   99 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPS--------------AHLTEREALMSELKVLSYLGNHI   99 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCC--------------cCcHHHHHHHHHHHHHHHhcCCc
Confidence            44699999999999999999974    2345678999987321              1122345678899999999 899


Q ss_pred             CccccceEEecCCeeEEEEEecCCCCHHHHHhhhhc--------------------------------------------
Q 011360          266 NILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSR--------------------------------------------  301 (487)
Q Consensus       266 nIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~--------------------------------------------  301 (487)
                      ||+++++++...+..++|||||++|+|.+++.....                                            
T Consensus       100 nIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  179 (375)
T cd05104         100 NIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVV  179 (375)
T ss_pred             ceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccc
Confidence            999999999999999999999999999999864210                                            


Q ss_pred             ---------------------------CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEe
Q 011360          302 ---------------------------GRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACIS  354 (487)
Q Consensus       302 ---------------------------~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~  354 (487)
                                                 ....+++..+..++.|++.||.||   |++||+||||||+|||++.++.+||+
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dlkp~Nill~~~~~~kl~  256 (375)
T cd05104         180 PTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKIC  256 (375)
T ss_pred             ccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCchhhEEEECCCcEEEe
Confidence                                       112578888999999999999999   67789999999999999999999999


Q ss_pred             ccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccccHHHHHHHH
Q 011360          355 DLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSPEWLRKVM  433 (487)
Q Consensus       355 DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  433 (487)
                      |||++................++..|+|||++.+..++.++||||||+++|||++ |..||......      .......
T Consensus       257 DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~------~~~~~~~  330 (375)
T cd05104         257 DFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD------SKFYKMI  330 (375)
T ss_pred             cCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch------HHHHHHH
Confidence            9999986644332222222345678999999999999999999999999999998 88898443221      1122222


Q ss_pred             hcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhhC
Q 011360          434 NSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL  487 (487)
Q Consensus       434 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~ll  487 (487)
                      ...... .    .+.    ..+.++.+++.+||+.||++|||+.+|++.|++.+
T Consensus       331 ~~~~~~-~----~~~----~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~~  375 (375)
T cd05104         331 KEGYRM-L----SPE----CAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQL  375 (375)
T ss_pred             HhCccC-C----CCC----CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhhC
Confidence            222111 0    111    11246889999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.3e-41  Score=340.82  Aligned_cols=265  Identities=25%  Similarity=0.332  Sum_probs=205.5

Q ss_pred             ccccccccccccccceeEEEEEec----CCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CCC
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELP----GSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RHR  265 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp  265 (487)
                      .++|.+.+.||+|+||.||+|.+.    ..++..||+|.+...              ........+.+|+.+++.+ +||
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~--------------~~~~~~~~~~~E~~il~~l~~h~  102 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKAS--------------AHTDEREALMSELKILSHLGQHK  102 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCC--------------CCHHHHHHHHHHHHHHHhhccCC
Confidence            446999999999999999999752    234468999987321              1222345678899999999 899


Q ss_pred             CccccceEEecCCeeEEEEEecCCCCHHHHHhhhhc--------------------------------------------
Q 011360          266 NILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSR--------------------------------------------  301 (487)
Q Consensus       266 nIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~--------------------------------------------  301 (487)
                      ||+++++++...+..++|||||++|+|.+++.....                                            
T Consensus       103 nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  182 (374)
T cd05106         103 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYV  182 (374)
T ss_pred             ceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhccccccccccccccccccc
Confidence            999999999999999999999999999999864210                                            


Q ss_pred             ----------------------CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEeccCCc
Q 011360          302 ----------------------GRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA  359 (487)
Q Consensus       302 ----------------------~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~DFg~s  359 (487)
                                            ....+++..+.+++.|++.||.||   |++||+||||||+||++++++.+||+|||++
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yL---H~~giiHrDLkp~Nil~~~~~~~kL~DfGla  259 (374)
T cd05106         183 EMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLA  259 (374)
T ss_pred             ccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHH---HHCCEEeccCchheEEEeCCCeEEEeeceee
Confidence                                  113478888999999999999999   7789999999999999999999999999999


Q ss_pred             cccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccccHHHHHHHHhcCCC
Q 011360          360 MAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSPEWLRKVMNSKNP  438 (487)
Q Consensus       360 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  438 (487)
                      +...............+++.|+|||++.+..++.++|||||||++|+|++ |..||......      ............
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~------~~~~~~~~~~~~  333 (374)
T cd05106         260 RDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN------SKFYKMVKRGYQ  333 (374)
T ss_pred             eeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc------HHHHHHHHcccC
Confidence            76644332222223345678999999998899999999999999999997 99999543221      111222222111


Q ss_pred             CCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhhC
Q 011360          439 SRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL  487 (487)
Q Consensus       439 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~ll  487 (487)
                       ..    .+..    .+.++.+++.+||+.+|++|||+.+|++.|++++
T Consensus       334 -~~----~~~~----~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         334 -MS----RPDF----APPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             -cc----CCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence             11    1111    1256889999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=3e-41  Score=325.75  Aligned_cols=248  Identities=21%  Similarity=0.296  Sum_probs=197.2

Q ss_pred             cccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceEEec-
Q 011360          198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVR-  276 (487)
Q Consensus       198 ~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-  276 (487)
                      ..+|+|++|.||+|.+   +|+.||||.+....            .......+.+.+|+.++.+++||||+++++++.+ 
T Consensus        26 ~~i~~g~~~~v~~~~~---~~~~vavK~~~~~~------------~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~   90 (283)
T PHA02988         26 VLIKENDQNSIYKGIF---NNKEVIIRTFKKFH------------KGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDI   90 (283)
T ss_pred             eEEeeCCceEEEEEEE---CCEEEEEEeccccc------------cccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEec
Confidence            5789999999999987   68899999884311            1122235678899999999999999999999876 


Q ss_pred             ---CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEE
Q 011360          277 ---PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACI  353 (487)
Q Consensus       277 ---~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl  353 (487)
                         ....++||||+++|+|.+++..    ...+++.....++.|++.||.|||.  ..+++||||||+||+++.++.+||
T Consensus        91 ~~~~~~~~lv~Ey~~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~~kl  164 (283)
T PHA02988         91 VDDLPRLSLILEYCTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYKLKI  164 (283)
T ss_pred             ccCCCceEEEEEeCCCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCCcEEE
Confidence               3567899999999999999964    4568899999999999999999952  247899999999999999999999


Q ss_pred             eccCCccccCCCCceeeEeeecccccccCCcccCC--CCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHH
Q 011360          354 SDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQ--PELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRK  431 (487)
Q Consensus       354 ~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~  431 (487)
                      +|||++.......     ....|++.|+|||++.+  ..++.++|||||||++|||++|..||....      ..+....
T Consensus       165 ~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~------~~~~~~~  233 (283)
T PHA02988        165 ICHGLEKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT------TKEIYDL  233 (283)
T ss_pred             cccchHhhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC------HHHHHHH
Confidence            9999987654322     12457899999999976  689999999999999999999999994332      2223333


Q ss_pred             HHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          432 VMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       432 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      ..... ....++..        .+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus       234 i~~~~-~~~~~~~~--------~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~  279 (283)
T PHA02988        234 IINKN-NSLKLPLD--------CPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY  279 (283)
T ss_pred             HHhcC-CCCCCCCc--------CcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence            32222 11111211        234688999999999999999999999999864

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-42  Score=302.64  Aligned_cols=265  Identities=25%  Similarity=0.337  Sum_probs=210.8

Q ss_pred             hccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccc
Q 011360          190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILP  269 (487)
Q Consensus       190 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~  269 (487)
                      ..++|.+.+.||+|||+.||+++ ...++..||+|++.+               ......+..++|++..++++|||+++
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~-~~s~~~~YAlKkI~c---------------~~~~~~e~~~rEid~~rkf~s~~vl~   82 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVK-GLSTGHLYALKKILC---------------HSQEDIEEALREIDNHRKFNSPNVLR   82 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeec-ccCcccchhhheeec---------------cchHHHHHHHHHHHHHHhhCCcchHH
Confidence            35689999999999999999997 457899999999854               22346677899999999999999999


Q ss_pred             cceEEecC-----CeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCC--eeecCCCCCC
Q 011360          270 LLAHMVRP-----DCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSAS--IIHGDIKPRN  342 (487)
Q Consensus       270 l~~~~~~~-----~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~g--ivH~Dlkp~N  342 (487)
                      ++++...+     ...|++++|...|+|.+.+......+..+++.+++.++.++++||++|   |+..  +.||||||.|
T Consensus        83 l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~l---H~~~~~yAH~DiKP~N  159 (302)
T KOG2345|consen   83 LVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEAL---HEKEPPYAHRDIKPAN  159 (302)
T ss_pred             HHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHH---hccCCcccccCCCcce
Confidence            99876543     458999999999999999998878888999999999999999999999   6656  9999999999


Q ss_pred             EEeCCCCCEEEeccCCccccCCCCcee-------eEeeecccccccCCcccC---CCCCCchhHHHHHHHHHHHHHhCCC
Q 011360          343 VLLNDDMEACISDLGLAMAIPDGYTRV-------LISYVLGTMAYIAPEYFQ---QPELSEKCDIFSFGMLLISLVRGVP  412 (487)
Q Consensus       343 ill~~~~~~kl~DFg~s~~~~~~~~~~-------~~~~~~gt~~y~aPE~l~---~~~~~~~~DvwslG~~l~elltg~~  412 (487)
                      ||+++++.++|.|||.++..+-.-...       .......|..|.|||.+.   +...+.++|||||||++|+|+.|..
T Consensus       160 ILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~s  239 (302)
T KOG2345|consen  160 ILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGES  239 (302)
T ss_pred             eEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCC
Confidence            999999999999999987654221110       011234789999999886   4567899999999999999999999


Q ss_pred             CccccCCCCccccHHHHHHHHhcCCCCCcc-CCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhhC
Q 011360          413 SFVFHQNGEEICSPEWLRKVMNSKNPSRAI-DPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL  487 (487)
Q Consensus       413 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~ll  487 (487)
                      ||..--..              ++...-.+ ...+.-.....+++.+.+++.+|+++||.+||++.+++..++.++
T Consensus       240 Pfe~~~~~--------------GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  240 PFERIYQQ--------------GGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             cchHHhhc--------------CCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence            99422111              11100000 011111122236678999999999999999999999999998864

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.5e-42  Score=314.27  Aligned_cols=261  Identities=23%  Similarity=0.315  Sum_probs=203.1

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      +.|++++.|++|+||.||+|+ +..+++.||+|+++...             .+...--..++|+.++.+.+|||||.+.
T Consensus        76 ~efe~lnrI~EGtyGiVYRak-dk~t~eIVALKr~kmek-------------ek~GFPItsLREIniLl~~~H~NIV~vk  141 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAK-DKKTDEIVALKRLKMEK-------------EKEGFPITSLREINILLKARHPNIVEVK  141 (419)
T ss_pred             HHHHHHhhcccCcceeEEEec-cCCcceeEEeeeccccc-------------ccCCCcchhHHHHHHHHhcCCCCeeeeE
Confidence            469999999999999999997 56799999999995421             1222233457899999999999999999


Q ss_pred             eEEecC--CeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC
Q 011360          272 AHMVRP--DCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDM  349 (487)
Q Consensus       272 ~~~~~~--~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~  349 (487)
                      .+....  +.+|||||||+. +|.++++..   ..++...+++.++.|++.|++||   |.+.|+||||||+|+|++..|
T Consensus       142 EVVvG~~~d~iy~VMe~~Eh-DLksl~d~m---~q~F~~~evK~L~~QlL~glk~l---H~~wilHRDLK~SNLLm~~~G  214 (419)
T KOG0663|consen  142 EVVVGSNMDKIYIVMEYVEH-DLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHL---HDNWILHRDLKTSNLLLSHKG  214 (419)
T ss_pred             EEEeccccceeeeeHHHHHh-hHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHH---hhceeEecccchhheeeccCC
Confidence            988753  679999999976 899999863   46899999999999999999999   788899999999999999999


Q ss_pred             CEEEeccCCccccCCCCceeeEeeecccccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHH
Q 011360          350 EACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQP-ELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEW  428 (487)
Q Consensus       350 ~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~  428 (487)
                      .+||+|||+|+.++.....  .+..+.|.+|.|||.+.+. .|+.++|+||+||++.||+++++.|.+.+.-.      .
T Consensus       215 ~lKiaDFGLAR~ygsp~k~--~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~d------Q  286 (419)
T KOG0663|consen  215 ILKIADFGLAREYGSPLKP--YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEID------Q  286 (419)
T ss_pred             cEEecccchhhhhcCCccc--CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHH------H
Confidence            9999999999988765332  2456689999999988765 79999999999999999999999996554211      1


Q ss_pred             HHHHHh-cCCCCCccCCCCCC-----------CCc-------HH--HHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          429 LRKVMN-SKNPSRAIDPRLPG-----------NGY-------EK--KMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       429 ~~~~~~-~~~~~~~~~~~~~~-----------~~~-------~~--~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      +.+++. -+.|.+.+-|.+..           ..+       ..  .+..-++++..+|..||.+|.|+++.++
T Consensus       287 l~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  287 LDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             HHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence            111111 12222222111110           000       01  2356778999999999999999999764

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.1e-42  Score=333.86  Aligned_cols=254  Identities=23%  Similarity=0.337  Sum_probs=214.4

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|..++.+|.|+||.+++.+++ .++..+++|++.....             .....+...+|+.+++++.|||||.++
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk-~~~~~~vlK~I~l~~~-------------t~~~r~~A~~E~~lis~~~hP~iv~y~   69 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHK-SDDKLYVLKKINLEKL-------------TEPERRSAIQEMDLLSKLLHPNIVEYK   69 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhc-cCCceEEEEEEecccc-------------CchhhHHHHHHHHHHHhccCCCeeeec
Confidence            46999999999999999999754 5677999999965322             222344778999999999999999999


Q ss_pred             eEEecCCe-eEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          272 AHMVRPDC-HLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       272 ~~~~~~~~-~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      +.|..++. ++|||+||+||+|.+.+...  .+..+++..+..++.|++.|+.||   |++.|+|||||+.||+++.++.
T Consensus        70 ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~--k~~~f~E~~i~~~~~Q~~~av~yl---H~~~iLHRDlK~~Nifltk~~~  144 (426)
T KOG0589|consen   70 DSFEEDGQLLCIVMEYCEGGDLAQLIKEQ--KGVLFPEERILKWFVQILLAVNYL---HENRVLHRDLKCANIFLTKDKK  144 (426)
T ss_pred             cchhcCCceEEEEEeecCCCCHHHHHHHH--hhccccHHHHHHHHHHHHHHHHHH---HhhhhhcccchhhhhhccccCc
Confidence            99999888 89999999999999999873  367899999999999999999999   5666999999999999999999


Q ss_pred             EEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHH
Q 011360          351 ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLR  430 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~  430 (487)
                      |||+|||+|+.+.....  ......||+.|+.||.+.+.+|+.|+|||||||++|||++-+++|...      +..+...
T Consensus       145 VkLgDfGlaK~l~~~~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~------~m~~Li~  216 (426)
T KOG0589|consen  145 VKLGDFGLAKILNPEDS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS------NMSELIL  216 (426)
T ss_pred             eeecchhhhhhcCCchh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc------chHHHHH
Confidence            99999999999876642  235678999999999999999999999999999999999999999433      3344555


Q ss_pred             HHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHH
Q 011360          431 KVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCR  482 (487)
Q Consensus       431 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~  482 (487)
                      ++.....      ..+|+    .++.++..++..|+..+|..||++.+++..
T Consensus       217 ki~~~~~------~Plp~----~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  217 KINRGLY------SPLPS----MYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             HHhhccC------CCCCc----cccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            5554331      11333    345679999999999999999999999864

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.3e-40  Score=328.70  Aligned_cols=201  Identities=25%  Similarity=0.422  Sum_probs=173.7

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .++|++.+.||.|+||.||+++. ..++..+|+|.+..              .........+.+|+.++++++||||+++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~~a~k~~~~--------------~~~~~~~~~~~~E~~~l~~l~h~~iv~~   68 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQH-KPSGLIMARKLIHL--------------EIKPAIRNQIIRELQVLHECNSPYIVGF   68 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEE-CCCCcEEEEEEeec--------------ccCHHHHHHHHHHHHHHHHCCCCCCCeE
Confidence            45799999999999999999975 46788999998743              1122345678899999999999999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      ++++..++..++||||+++|+|.+++..    ...+++..+..++.|++.||.|||+  ..+|+||||||+||+++.++.
T Consensus        69 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~  142 (331)
T cd06649          69 YGAFYSDGEISICMEHMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGE  142 (331)
T ss_pred             EEEEEECCEEEEEeecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCc
Confidence            9999999999999999999999999865    3568899999999999999999953  246999999999999999999


Q ss_pred             EEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccc
Q 011360          351 ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVF  416 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~  416 (487)
                      +||+|||++........    ....||+.|+|||++.+..++.++|||||||++|+|+||+.||..
T Consensus       143 ~kl~Dfg~~~~~~~~~~----~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~  204 (331)
T cd06649         143 IKLCDFGVSGQLIDSMA----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP  204 (331)
T ss_pred             EEEccCccccccccccc----ccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence            99999999876543322    345689999999999998999999999999999999999999953

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=9.2e-41  Score=319.53  Aligned_cols=259  Identities=22%  Similarity=0.300  Sum_probs=203.1

Q ss_pred             cccccccccccccceeEEEEEecC--CCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPG--SNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILP  269 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~  269 (487)
                      ++|.+.+.||+|+||.||+|.+..  ..+..||+|.+..              .........+.+|+..+.+++||||++
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~--------------~~~~~~~~~~~~e~~~l~~l~h~~iv~   70 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRA--------------GCSDKQRRGFLAEALTLGQFDHSNIVR   70 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCC--------------CCCHHHHHHHHHHHHHHhcCCCCCcCe
Confidence            358999999999999999997642  3467899998742              111233456889999999999999999


Q ss_pred             cceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC
Q 011360          270 LLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDM  349 (487)
Q Consensus       270 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~  349 (487)
                      +++++...+..++||||+++|+|.+++..   ....+++..++.++.|++.||+||   |++|++||||||+||+++.++
T Consensus        71 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~i~~al~~l---H~~~iiH~dikp~nili~~~~  144 (266)
T cd05064          71 LEGVITRGNTMMIVTEYMSNGALDSFLRK---HEGQLVAGQLMGMLPGLASGMKYL---SEMGYVHKGLAAHKVLVNSDL  144 (266)
T ss_pred             EEEEEecCCCcEEEEEeCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHH---HHCCEeeccccHhhEEEcCCC
Confidence            99999999999999999999999999864   234689999999999999999999   677899999999999999999


Q ss_pred             CEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccccHHH
Q 011360          350 EACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSPEW  428 (487)
Q Consensus       350 ~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~  428 (487)
                      .++++|||.+......... ......++..|+|||.+.+..++.++|||||||++||+++ |..||.....      .+.
T Consensus       145 ~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~------~~~  217 (266)
T cd05064         145 VCKISGFRRLQEDKSEAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG------QDV  217 (266)
T ss_pred             cEEECCCcccccccccchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH------HHH
Confidence            9999999987654222111 1112335678999999999999999999999999999775 9999943321      222


Q ss_pred             HHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhhC
Q 011360          429 LRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL  487 (487)
Q Consensus       429 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~ll  487 (487)
                      .... ...... .    .+.    ..+..+.+++.+||+.+|++|||+.+|.+.|.+++
T Consensus       218 ~~~~-~~~~~~-~----~~~----~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~~  266 (266)
T cd05064         218 IKAV-EDGFRL-P----APR----NCPNLLHQLMLDCWQKERGERPRFSQIHSILSKMV  266 (266)
T ss_pred             HHHH-HCCCCC-C----CCC----CCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhhC
Confidence            2222 222111 1    111    12345889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-41  Score=324.79  Aligned_cols=247  Identities=21%  Similarity=0.323  Sum_probs=199.8

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      +|.+.+.||.|+||.||+|.. ..+++.||+|++...            ..........+.+|+.+++.++||||+++++
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~~~aiK~~~~~------------~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~   68 (291)
T cd05612           2 DLERIKTVGTGTFGRVHLVRD-RISEHYYALKVMAIP------------EVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW   68 (291)
T ss_pred             CceeeeeeecCCCeEEEEEEE-cCCCCEEEEEEEEHH------------HHhhhHHHHHHHHHHHHHHhCCCCcHhhhHh
Confidence            588999999999999999975 457899999987321            1111223456788999999999999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEE
Q 011360          273 HMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC  352 (487)
Q Consensus       273 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~k  352 (487)
                      ++.+.+..|+||||+++|+|.+++..    ...+++..+..++.|++.||+||   |++||+||||||+|||++.++.+|
T Consensus        69 ~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~NIli~~~~~~k  141 (291)
T cd05612          69 TEHDQRFLYMLMEYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYL---HSKEIVYRDLKPENILLDKEGHIK  141 (291)
T ss_pred             hhccCCeEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCCHHHeEECCCCCEE
Confidence            99999999999999999999999865    45688999999999999999999   778999999999999999999999


Q ss_pred             EeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHH
Q 011360          353 ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKV  432 (487)
Q Consensus       353 l~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~  432 (487)
                      |+|||++.......     ....||+.|+|||++.+..++.++|||||||++|+|++|..||....      ..+....+
T Consensus       142 l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~------~~~~~~~i  210 (291)
T cd05612         142 LTDFGFAKKLRDRT-----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN------PFGIYEKI  210 (291)
T ss_pred             EEecCcchhccCCc-----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHH
Confidence            99999987654322     23468999999999999889999999999999999999999994432      12223333


Q ss_pred             HhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCC-----hHHHHH
Q 011360          433 MNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPN-----SQYVRC  481 (487)
Q Consensus       433 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~~il~  481 (487)
                      .... .      .++..    ....+.+++.+||+.||.+||+     ++++++
T Consensus       211 ~~~~-~------~~~~~----~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  253 (291)
T cd05612         211 LAGK-L------EFPRH----LDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN  253 (291)
T ss_pred             HhCC-c------CCCcc----CCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence            2221 1      11111    1245889999999999999995     777764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=7.5e-41  Score=329.28  Aligned_cols=245  Identities=20%  Similarity=0.288  Sum_probs=195.8

Q ss_pred             cccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceEEecC
Q 011360          198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRP  277 (487)
Q Consensus       198 ~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  277 (487)
                      +.||+|+||.||+++. ..+|+.||+|++..            ...........+.+|+.++..++||||+++++++...
T Consensus         1 ~~lG~G~~g~Vy~~~~-~~~~~~~aiK~~~~------------~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~   67 (323)
T cd05571           1 KLLGKGTFGKVILVRE-KATGKYYAMKILKK------------EVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTH   67 (323)
T ss_pred             CeeeeCCCeEEEEEEE-CCCCCEEEEEEEEH------------HHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcC
Confidence            4689999999999975 45889999998842            1112233455678899999999999999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEeccC
Q 011360          278 DCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLG  357 (487)
Q Consensus       278 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~DFg  357 (487)
                      +..|+||||+++|+|.+++..    ...+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||
T Consensus        68 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~l---H~~~ivHrDlkp~NIll~~~~~~kl~DfG  140 (323)
T cd05571          68 DRLCFVMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALGYL---HSCDVVYRDLKLENLMLDKDGHIKITDFG  140 (323)
T ss_pred             CEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HhCCeEeCCCCHHHEEECCCCCEEEeeCC
Confidence            999999999999999998864    45789999999999999999999   77889999999999999999999999999


Q ss_pred             CccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHHHhcCC
Q 011360          358 LAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSKN  437 (487)
Q Consensus       358 ~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  437 (487)
                      ++........  ......||+.|+|||++.+..++.++|||||||++|||++|..||...+.      ........ ...
T Consensus       141 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~------~~~~~~~~-~~~  211 (323)
T cd05571         141 LCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------EKLFELIL-MEE  211 (323)
T ss_pred             CCcccccCCC--cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH------HHHHHHHH-cCC
Confidence            9875322211  12345699999999999998999999999999999999999999943221      11222222 111


Q ss_pred             CCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCC-----ChHHHHH
Q 011360          438 PSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERP-----NSQYVRC  481 (487)
Q Consensus       438 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~~il~  481 (487)
                      .      .++.    ....++.+++.+||+.||++||     ++.++++
T Consensus       212 ~------~~p~----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         212 I------RFPR----TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             C------CCCC----CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            1      1111    1235688999999999999999     7888864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.3e-40  Score=343.87  Aligned_cols=255  Identities=19%  Similarity=0.256  Sum_probs=204.3

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      .|.+.+.||.|+||.||+|.....++..||+|.+..               ........+..|+.++..++||||+++++
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~---------------~~~~~~~~~~~E~~~l~~l~Hpniv~~~~  132 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVML---------------NDERQAAYARSELHCLAACDHFGIVKHFD  132 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEccc---------------CCHHHHHHHHHHHHHHHhCCCCCEeEEEE
Confidence            489999999999999999975433377888886522               11223446678999999999999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEE
Q 011360          273 HMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC  352 (487)
Q Consensus       273 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~k  352 (487)
                      ++...+..|+||||+++|+|.+++.........+++..+..++.|++.||.||   |++||+||||||+|||++.++.+|
T Consensus       133 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~l---H~~~ivHrDlkp~NIll~~~~~~k  209 (478)
T PTZ00267        133 DFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEV---HSRKMMHRDLKSANIFLMPTGIIK  209 (478)
T ss_pred             EEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH---HhCCEEECCcCHHhEEECCCCcEE
Confidence            99999999999999999999998865434456788999999999999999999   778899999999999999999999


Q ss_pred             EeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHH
Q 011360          353 ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKV  432 (487)
Q Consensus       353 l~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~  432 (487)
                      |+|||+++..............+||+.|+|||++.+..++.++|||||||++|+|++|..||....      ..+.....
T Consensus       210 L~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~------~~~~~~~~  283 (478)
T PTZ00267        210 LGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS------QREIMQQV  283 (478)
T ss_pred             EEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHH
Confidence            999999987654433222345679999999999999999999999999999999999999994322      22333333


Q ss_pred             HhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          433 MNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       433 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ......  .    .+.    ..+..+.+++.+||+.+|++|||+.+++.
T Consensus       284 ~~~~~~--~----~~~----~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        284 LYGKYD--P----FPC----PVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             HhCCCC--C----CCc----cCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence            322211  0    111    12246889999999999999999999864

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.2e-40  Score=322.39  Aligned_cols=267  Identities=19%  Similarity=0.240  Sum_probs=199.8

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      +|.+.+.||.|+||.||+++. ..++..||+|++...             .........+.+|+.+++.++||||+++++
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~-~~~~~~~avK~~~~~-------------~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   67 (287)
T cd07848           2 KFEVLGVVGEGAYGVVLKCRH-KETKEIVAIKKFKDS-------------EENEEVKETTLRELKMLRTLKQENIVELKE   67 (287)
T ss_pred             CceEEEEecccCCEEEEEEEE-CCCCcEEEEEEEecc-------------cccccchhhHHHHHHHHHhCCCccccchhh
Confidence            589999999999999999975 457889999988431             112223456778999999999999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEE
Q 011360          273 HMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC  352 (487)
Q Consensus       273 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~k  352 (487)
                      ++...+..|+||||++++.+..+..    ....+++..+..++.|++.||.||   |+.||+||||||+||+++.++.+|
T Consensus        68 ~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~L~~l---H~~~i~H~dlkp~Nill~~~~~~k  140 (287)
T cd07848          68 AFRRRGKLYLVFEYVEKNMLELLEE----MPNGVPPEKVRSYIYQLIKAIHWC---HKNDIVHRDIKPENLLISHNDVLK  140 (287)
T ss_pred             hEecCCEEEEEEecCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEEcCCCcEE
Confidence            9999999999999998877665443    245688999999999999999999   678899999999999999999999


Q ss_pred             EeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCcc---------
Q 011360          353 ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI---------  423 (487)
Q Consensus       353 l~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~---------  423 (487)
                      |+|||++......... ......||+.|+|||++.+..++.++|||||||++|+|++|.+||.........         
T Consensus       141 l~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~  219 (287)
T cd07848         141 LCDFGFARNLSEGSNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGP  219 (287)
T ss_pred             EeeccCcccccccccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCC
Confidence            9999999876433221 113356899999999999888999999999999999999999999654321110         


Q ss_pred             ccHHHHHHHHhcCCCCCccCCCCCC------CCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          424 CSPEWLRKVMNSKNPSRAIDPRLPG------NGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       424 ~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ....................+....      ......+.++.+++.+||+.||++|||++++++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         220 LPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             CCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            0011111111110000000000000      011123457999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.2e-40  Score=321.96  Aligned_cols=254  Identities=26%  Similarity=0.355  Sum_probs=199.0

Q ss_pred             cccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceE
Q 011360          194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAH  273 (487)
Q Consensus       194 ~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  273 (487)
                      |...+.||.|+||.||++.. ..+++.||+|.+...            ..........+.+|+.++.+++||||++++++
T Consensus         2 f~~~~~lg~G~~g~V~~~~~-~~~~~~~avK~~~~~------------~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~   68 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQV-RATGKMYACKKLEKK------------RIKKRKGEAMALNEKRILEKVNSRFVVSLAYA   68 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEE-ecCCceEEEEEeeHh------------hhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEE
Confidence            77889999999999999975 457899999987320            11112233456789999999999999999999


Q ss_pred             EecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEE
Q 011360          274 MVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACI  353 (487)
Q Consensus       274 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl  353 (487)
                      +...+..++||||+++|+|.+++..  .....+++..+..++.|++.||.||   |+.||+||||||+|||++.++.++|
T Consensus        69 ~~~~~~~~lv~e~~~~g~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~iiH~dikp~Nill~~~~~~kl  143 (285)
T cd05631          69 YETKDALCLVLTIMNGGDLKFHIYN--MGNPGFDEQRAIFYAAELCCGLEDL---QRERIVYRDLKPENILLDDRGHIRI  143 (285)
T ss_pred             EccCCeEEEEEEecCCCcHHHHHHh--hCCCCCCHHHHHHHHHHHHHHHHHH---HhCCEEeCCCCHHHEEECCCCCEEE
Confidence            9999999999999999999988754  2234688999999999999999999   7788999999999999999999999


Q ss_pred             eccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHHH
Q 011360          354 SDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVM  433 (487)
Q Consensus       354 ~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~  433 (487)
                      +|||++........   .....||+.|+|||++.+..++.++|||||||++|+|++|..||.......   ..+......
T Consensus       144 ~Dfg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~---~~~~~~~~~  217 (285)
T cd05631         144 SDLGLAVQIPEGET---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV---KREEVDRRV  217 (285)
T ss_pred             eeCCCcEEcCCCCe---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch---hHHHHHHHh
Confidence            99999977543322   134568999999999999999999999999999999999999996543211   111111111


Q ss_pred             hcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCC-----hHHHHH
Q 011360          434 NSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPN-----SQYVRC  481 (487)
Q Consensus       434 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~~il~  481 (487)
                      ..  .......        ..+.++.+++.+||+.||++|||     +.++++
T Consensus       218 ~~--~~~~~~~--------~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         218 KE--DQEEYSE--------KFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             hc--ccccCCc--------cCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            11  1111111        22356889999999999999997     677765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=8.9e-41  Score=330.51  Aligned_cols=249  Identities=22%  Similarity=0.294  Sum_probs=201.0

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||.|+||.||+|.+...++..||+|++..            ...........+.+|+.++..++||||++++
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~------------~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~   97 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEK------------SKIIKQKQVDHVFSERKILNYINHPFCVNLY   97 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEH------------HHhhhhhhHHHHHHHHHHHHhCCCCCCcceE
Confidence            4699999999999999999987655557899998732            1111233455678899999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++.+.+..|+||||+++|+|.+++..    ...+++..+..++.|++.||.||   |++||+||||||+|||++.++.+
T Consensus        98 ~~~~~~~~~~lv~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDLkp~NILl~~~~~i  170 (340)
T PTZ00426         98 GSFKDESYLYLVLEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYL---QSLNIVYRDLKPENLLLDKDGFI  170 (340)
T ss_pred             EEEEeCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeEccCCCHHHEEECCCCCE
Confidence            999999999999999999999999865    45689999999999999999999   77889999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRK  431 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~  431 (487)
                      ||+|||++.......     ....||+.|+|||++.+..++.++|||||||++|||++|..||.....      ......
T Consensus       171 kL~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~------~~~~~~  239 (340)
T PTZ00426        171 KMTDFGFAKVVDTRT-----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP------LLIYQK  239 (340)
T ss_pred             EEecCCCCeecCCCc-----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH------HHHHHH
Confidence            999999997654321     345699999999999988899999999999999999999999943321      112222


Q ss_pred             HHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCC-----ChHHHHH
Q 011360          432 VMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERP-----NSQYVRC  481 (487)
Q Consensus       432 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~~il~  481 (487)
                      ... ...  .+++.+        ...+.+++.+||+.+|.+|+     |++++++
T Consensus       240 i~~-~~~--~~p~~~--------~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~  283 (340)
T PTZ00426        240 ILE-GII--YFPKFL--------DNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE  283 (340)
T ss_pred             Hhc-CCC--CCCCCC--------CHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence            222 111  111111        24578999999999999995     8888765

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-41  Score=312.28  Aligned_cols=262  Identities=27%  Similarity=0.418  Sum_probs=205.2

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      .|..++.||.|++|.|..+. +..+|+.||||++.             +........++..+|+.+++.++|+||+.+++
T Consensus        23 ~y~~~~~iG~GAyGvVcsA~-~~~t~~~VAIKKi~-------------~~F~~~~~akRtlRElklLr~~~HeNIi~l~d   88 (359)
T KOG0660|consen   23 YYVLIEPIGRGAYGVVCSAK-DKRTGEKVAIKKIL-------------NPFENQIDAKRTLRELKLLRHLRHENIIGLLD   88 (359)
T ss_pred             eecccccccCcceeeEEEEE-EcCCCCEeehhhhh-------------hhhhchHHHHHHHHHHHHHHHhcCCCcceEEe
Confidence            46668999999999999996 55788999999883             12344556778899999999999999999999


Q ss_pred             EEec-----CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC
Q 011360          273 HMVR-----PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLND  347 (487)
Q Consensus       273 ~~~~-----~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~  347 (487)
                      ++..     -+.+|+|+|+| +.+|...++.    +..++...+..++.|+++||+|+   |+.||+||||||.|+|++.
T Consensus        89 i~~p~~~~~f~DvYiV~elM-etDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyi---HSAnViHRDLKPsNll~n~  160 (359)
T KOG0660|consen   89 IFRPPSRDKFNDVYLVFELM-ETDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYI---HSANVIHRDLKPSNLLLNA  160 (359)
T ss_pred             ecccccccccceeEEehhHH-hhHHHHHHHc----CccccHHHHHHHHHHHHHhcchh---hcccccccccchhheeecc
Confidence            8875     24679999999 6799998864    56699999999999999999999   8999999999999999999


Q ss_pred             CCCEEEeccCCccccCCCCceeeEeeecccccccCCcccC-CCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCcc---
Q 011360          348 DMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQ-QPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI---  423 (487)
Q Consensus       348 ~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~---  423 (487)
                      +..+||+|||+|+...........+..+.|.+|.|||++. ...|+.+.||||.||++.||++|++.|.+.+.....   
T Consensus       161 ~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI  240 (359)
T KOG0660|consen  161 DCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLI  240 (359)
T ss_pred             CCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHH
Confidence            9999999999999876542333335677899999999875 458999999999999999999999999765421111   


Q ss_pred             ------cc--------HHHHHHHHhc--CCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          424 ------CS--------PEWLRKVMNS--KNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       424 ------~~--------~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                            ..        .+..+.++..  ..+...+...+|     ......++++.+||..||.+|+|+++.++
T Consensus       241 ~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp-----~a~p~AidLlekmL~fdP~kRita~eAL~  309 (359)
T KOG0660|consen  241 LELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFP-----NANPLAIDLLEKMLVFDPKKRITAEEALA  309 (359)
T ss_pred             HHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcC-----CCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence                  00        1112222221  112222222222     23356889999999999999999999875

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.2e-40  Score=328.55  Aligned_cols=247  Identities=23%  Similarity=0.324  Sum_probs=200.2

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||.|+||.||+|++ ..+++.||+|.+..            ...........+.+|+.++.+++||||++++
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~~aiK~~~~------------~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~   84 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKH-KGTGEYYAIKCLKK------------REILKMKQVQHVAQEKSILMELSHPFIVNMM   84 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEE-CCCCCEEEEEEEEH------------HHHhhhhhHHHHHHHHHHHHhCCCCCCCcEE
Confidence            4599999999999999999975 45788999998842            1111223456788999999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++..++..|+||||+++|+|.+++..    ...+++..+..++.|++.||.||   |++||+||||||+|||++.++.+
T Consensus        85 ~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~L---H~~~ivH~dlkp~NIll~~~~~~  157 (329)
T PTZ00263         85 CSFQDENRVYFLLEFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYL---HSKDIIYRDLKPENLLLDNKGHV  157 (329)
T ss_pred             EEEEcCCEEEEEEcCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCCHHHEEECCCCCE
Confidence            999999999999999999999999865    45688899999999999999999   77889999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRK  431 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~  431 (487)
                      ||+|||++.......     ....||+.|+|||++.+..++.++|||||||++|+|++|..||....      .......
T Consensus       158 kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~------~~~~~~~  226 (329)
T PTZ00263        158 KVTDFGFAKKVPDRT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT------PFRIYEK  226 (329)
T ss_pred             EEeeccCceEcCCCc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC------HHHHHHH
Confidence            999999998664332     23468999999999999899999999999999999999999994322      1122222


Q ss_pred             HHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCC-----hHHHH
Q 011360          432 VMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPN-----SQYVR  480 (487)
Q Consensus       432 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~~il  480 (487)
                      ... ..+  .    ++..    ....+.+++.+||+.||.+||+     +++++
T Consensus       227 i~~-~~~--~----~p~~----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll  269 (329)
T PTZ00263        227 ILA-GRL--K----FPNW----FDGRARDLVKGLLQTDHTKRLGTLKGGVADVK  269 (329)
T ss_pred             Hhc-CCc--C----CCCC----CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence            222 211  1    1111    2245789999999999999997     57665

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-40  Score=329.59  Aligned_cols=255  Identities=19%  Similarity=0.290  Sum_probs=202.1

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      +|.+.+.||.|+||.||+|.. ..+++.||+|++...            ..........+..|+.++..++||||+++++
T Consensus         2 ~y~~~~~ig~G~~g~Vy~~~~-~~~~~~vaiK~~~~~------------~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~   68 (333)
T cd05600           2 DFQILTQVGQGGYGQVFLAKK-KDTGEIVALKRMKKS------------LLFKLNEVRHVLTERDILTTTKSEWLVKLLY   68 (333)
T ss_pred             CcEEEEEEeecCCeEEEEEEE-CCCCCEEEEEEEEHH------------HHhhhhHHHHHHHHHHHHHhCCCCCCccEEE
Confidence            589999999999999999975 457889999988421            1112234567788999999999999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEE
Q 011360          273 HMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC  352 (487)
Q Consensus       273 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~k  352 (487)
                      ++...+..|+||||+++|+|.+++..    ...+++..+..++.|++.||.||   |++||+||||||+||+++.++.+|
T Consensus        69 ~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~Nil~~~~~~~k  141 (333)
T cd05600          69 AFQDDEYLYLAMEYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDAL---HELGYIHRDLKPENFLIDASGHIK  141 (333)
T ss_pred             EEEcCCEEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCccccCCCHHHEEECCCCCEE
Confidence            99999999999999999999999964    45688999999999999999999   778899999999999999999999


Q ss_pred             EeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHH
Q 011360          353 ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKV  432 (487)
Q Consensus       353 l~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~  432 (487)
                      |+|||++.....     ......||+.|+|||++.+..++.++|||||||++|||++|..||.....      .+.....
T Consensus       142 L~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~------~~~~~~i  210 (333)
T cd05600         142 LTDFGLSKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP------NETWENL  210 (333)
T ss_pred             EEeCcCCccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH------HHHHHHH
Confidence            999999976543     12345689999999999998999999999999999999999999954322      1111111


Q ss_pred             HhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          433 MNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       433 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ......   +............+.++.+++.+||..+|++|||+.++++
T Consensus       211 ~~~~~~---~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~  256 (333)
T cd05600         211 KYWKET---LQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKN  256 (333)
T ss_pred             Hhcccc---ccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHh
Confidence            111110   0000000001223456889999999999999999999985

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=7.9e-41  Score=318.69  Aligned_cols=254  Identities=30%  Similarity=0.477  Sum_probs=195.9

Q ss_pred             ccccccccccceeEEEEEec---CCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          195 ASLEKIGSGGCGEVYKAELP---GSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       195 ~~~~~lg~G~~g~v~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      .+.+.||.|.||.||+|.+.   ...+..|+||.+..              .........+.+|+..+++++||||++++
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~--------------~~~~~~~~~~~~e~~~l~~l~h~ni~~~~   67 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP--------------SSSEEEEEEFLNEIQILRKLRHPNIVKLY   67 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST--------------TSSHHHHHHHHHHHHHHHTHSBTTBE-EE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc--------------ccccccceeeeeccccccccccccccccc
Confidence            35678999999999999986   23467899998832              22233467888999999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      |++...+..++|||||++|+|.++|..  .....+++..+..++.|++.||.||   |+++++|+||+++||+++.++.+
T Consensus        68 g~~~~~~~~~lv~e~~~~g~L~~~L~~--~~~~~~~~~~~~~i~~~i~~~l~~L---h~~~iiH~~l~~~nill~~~~~~  142 (259)
T PF07714_consen   68 GFCIENEPLFLVMEYCPGGSLDDYLKS--KNKEPLSEQQRLSIAIQIAEALSYL---HSNNIIHGNLSPSNILLDSNGQV  142 (259)
T ss_dssp             EEEESSSSEEEEEE--TTEBHHHHHHH--TCTTTSBHHHHHHHHHHHHHHHHHH---HHTTEEEST-SGGGEEEETTTEE
T ss_pred             ccccccccccccccccccccccccccc--ccccccccccccccccccccccccc---ccccccccccccccccccccccc
Confidence            999988889999999999999999986  2356789999999999999999999   56779999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccccHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSPEWLR  430 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~  430 (487)
                      ||+|||++.................+..|+|||.+.+..++.++||||||+++||+++ |..||...      ...+...
T Consensus       143 Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~------~~~~~~~  216 (259)
T PF07714_consen  143 KLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY------DNEEIIE  216 (259)
T ss_dssp             EEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS------CHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc------ccccccc
Confidence            9999999987633322222233457789999999988889999999999999999999 68888322      3333444


Q ss_pred             HHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHH
Q 011360          431 KVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRL  483 (487)
Q Consensus       431 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L  483 (487)
                      .......+.  .+..+        +..+.+++..||+.+|++|||+++|++.|
T Consensus       217 ~~~~~~~~~--~~~~~--------~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  217 KLKQGQRLP--IPDNC--------PKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             HHHTTEETT--SBTTS--------BHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             cccccccce--eccch--------hHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            443332221  12222        25588999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-40  Score=325.23  Aligned_cols=241  Identities=23%  Similarity=0.330  Sum_probs=192.3

Q ss_pred             cccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceEEecCCe
Q 011360          200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDC  279 (487)
Q Consensus       200 lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  279 (487)
                      ||+|+||.||+|.. ..+++.||+|++..            ...........+..|+.++.+++||||+++++++...+.
T Consensus         1 lg~G~~g~Vy~~~~-~~~~~~~aiK~i~~------------~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   67 (312)
T cd05585           1 IGKGSFGKVMQVRK-RDTQRIYALKTIRK------------AHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEK   67 (312)
T ss_pred             CCcCCCeEEEEEEE-CCCCCEEEEEEEEH------------HHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCe
Confidence            69999999999975 46788999998732            111223345677889999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEeccCCc
Q 011360          280 HLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA  359 (487)
Q Consensus       280 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~DFg~s  359 (487)
                      .|+||||+++|+|.+++..    ...+++..+..++.|++.||.||   |++||+||||||+||+++.++.+||+|||++
T Consensus        68 ~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~  140 (312)
T cd05585          68 LYLVLAFINGGELFHHLQR----EGRFDLSRARFYTAELLCALENL---HKFNVIYRDLKPENILLDYQGHIALCDFGLC  140 (312)
T ss_pred             EEEEEcCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HhCCeEeCCCCHHHeEECCCCcEEEEECccc
Confidence            9999999999999999864    45689999999999999999999   7788999999999999999999999999998


Q ss_pred             cccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHHHhcCCCC
Q 011360          360 MAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSKNPS  439 (487)
Q Consensus       360 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  439 (487)
                      ........  ......||+.|+|||++.+..++.++|||||||++|+|++|..||...      ...+..........  
T Consensus       141 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~------~~~~~~~~~~~~~~--  210 (312)
T cd05585         141 KLNMKDDD--KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDE------NVNEMYRKILQEPL--  210 (312)
T ss_pred             ccCccCCC--ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCC------CHHHHHHHHHcCCC--
Confidence            75432221  123456999999999999999999999999999999999999999432      22233333332211  


Q ss_pred             CccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHH
Q 011360          440 RAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYV  479 (487)
Q Consensus       440 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~i  479 (487)
                       .    ++.    .....+.+++.+||..||++||++..+
T Consensus       211 -~----~~~----~~~~~~~~li~~~L~~dp~~R~~~~~~  241 (312)
T cd05585         211 -R----FPD----GFDRDAKDLLIGLLSRDPTRRLGYNGA  241 (312)
T ss_pred             -C----CCC----cCCHHHHHHHHHHcCCCHHHcCCCCCH
Confidence             1    111    123458899999999999999865333

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.8e-41  Score=302.20  Aligned_cols=259  Identities=25%  Similarity=0.381  Sum_probs=212.4

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CCCCcccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RHRNILPL  270 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l  270 (487)
                      +.|...++||.|..+.|-++.+ ..+|..+|+|++.........       .......+.-.+|+.+++++ .||+|+.+
T Consensus        17 ~~y~pkeilgrgvss~vrRci~-k~t~~e~a~kii~~~at~~~~-------e~~~~~~EaT~~Ev~ILRqv~GHP~II~l   88 (411)
T KOG0599|consen   17 AKYEPKEILGRGVSSVVRRCIH-KETGKEFAVKIIDVTATTESG-------ETPYEMREATRQEISILRQVMGHPYIIDL   88 (411)
T ss_pred             hhcChHHHhcccchhhhhhhhh-cccccceeEEEEEecccccCC-------ccHHHHHHHHHHHHHHHHHhcCCCcEEEe
Confidence            3577889999999999999965 568889999998654432211       11223445567899999998 89999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      .+++..+..+++|+|.|+.|.|.|+|..    .-.+++...+++++|+..|+.||   |.++||||||||+|||++++.+
T Consensus        89 ~D~yes~sF~FlVFdl~prGELFDyLts----~VtlSEK~tR~iMrqlfegVeyl---Ha~~IVHRDLKpENILlddn~~  161 (411)
T KOG0599|consen   89 QDVYESDAFVFLVFDLMPRGELFDYLTS----KVTLSEKETRRIMRQLFEGVEYL---HARNIVHRDLKPENILLDDNMN  161 (411)
T ss_pred             eeeccCcchhhhhhhhcccchHHHHhhh----heeecHHHHHHHHHHHHHHHHHH---HHhhhhhcccChhheeeccccc
Confidence            9999999999999999999999999975    56789999999999999999999   7888999999999999999999


Q ss_pred             EEEeccCCccccCCCCceeeEeeecccccccCCcccC------CCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccc
Q 011360          351 ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQ------QPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEIC  424 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~------~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~  424 (487)
                      +||+|||+++.+..+...   ...+|||+|+|||.+.      .+.|+..+|+||+|+++|.|+.|.+||-..       
T Consensus       162 i~isDFGFa~~l~~GekL---relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR-------  231 (411)
T KOG0599|consen  162 IKISDFGFACQLEPGEKL---RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR-------  231 (411)
T ss_pred             eEEeccceeeccCCchhH---HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH-------
Confidence            999999999998877543   5678999999999885      457899999999999999999999999211       


Q ss_pred             cHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          425 SPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       425 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ..-.+.+++..+...      +.+....+++....++|.+||+.||.+|.|+++.++
T Consensus       232 kQmlMLR~ImeGkyq------F~speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  232 KQMLMLRMIMEGKYQ------FRSPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             HHHHHHHHHHhcccc------cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence            111222333344332      334455667788999999999999999999999875

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=3.6e-40  Score=332.00  Aligned_cols=269  Identities=24%  Similarity=0.306  Sum_probs=207.1

Q ss_pred             HhhhccccccccccccccceeEEEEEecC----CCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC
Q 011360          187 FLKKEDCFASLEKIGSGGCGEVYKAELPG----SNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI  262 (487)
Q Consensus       187 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  262 (487)
                      |....+.|.+.+.||.|+||.||+|++..    .++..||||++...              ........+.+|+.++.++
T Consensus        32 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~--------------~~~~~~~~~~~Ei~~l~~l   97 (400)
T cd05105          32 WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPT--------------ARSSEKQALMSELKIMTHL   97 (400)
T ss_pred             eeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCC--------------CChHHHHHHHHHHHHHHhc
Confidence            44456679999999999999999997532    23457999987431              1222345788999999999


Q ss_pred             C-CCCccccceEEecCCeeEEEEEecCCCCHHHHHhhhhc----------------------------------------
Q 011360          263 R-HRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSR----------------------------------------  301 (487)
Q Consensus       263 ~-hpnIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~----------------------------------------  301 (487)
                      . ||||+++++++...+..|+|||||++|+|.+++.....                                        
T Consensus        98 ~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (400)
T cd05105          98 GPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDY  177 (400)
T ss_pred             CCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccc
Confidence            5 99999999999999999999999999999999864210                                        


Q ss_pred             ----------------------------------------------------CCCCCChHHHHHHHHHHHHHHHHHHhcC
Q 011360          302 ----------------------------------------------------GRRELDWPSRHRIALGVASGLEYLHMYH  329 (487)
Q Consensus       302 ----------------------------------------------------~~~~l~~~~~~~i~~qi~~~L~~Lh~~h  329 (487)
                                                                          ....+++..+..++.|++.||.||   |
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~L---H  254 (400)
T cd05105         178 MDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL---A  254 (400)
T ss_pred             cccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHH---H
Confidence                                                                123478888899999999999999   7


Q ss_pred             CCCeeecCCCCCCEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh
Q 011360          330 SASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR  409 (487)
Q Consensus       330 ~~givH~Dlkp~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt  409 (487)
                      +.||+||||||+||+++.++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|+|++
T Consensus       255 ~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt  334 (400)
T cd05105         255 SKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS  334 (400)
T ss_pred             hCCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHH
Confidence            78899999999999999999999999999976543322222223446788999999998899999999999999999997


Q ss_pred             -CCCCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhhC
Q 011360          410 -GVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL  487 (487)
Q Consensus       410 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~ll  487 (487)
                       |..||......      ............ ..    .+    ...+..+.+++.+||+.+|++|||+.+|.+.|++++
T Consensus       335 ~g~~P~~~~~~~------~~~~~~~~~~~~-~~----~~----~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         335 LGGTPYPGMIVD------STFYNKIKSGYR-MA----KP----DHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             CCCCCCcccchh------HHHHHHHhcCCC-CC----CC----ccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence             88998433211      111112222111 01    11    122356889999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=7e-40  Score=316.19  Aligned_cols=261  Identities=27%  Similarity=0.425  Sum_probs=205.1

Q ss_pred             ccccccccccccceeEEEEEecCC----CCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcc
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGS----NGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNIL  268 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv  268 (487)
                      +|.+.+.||+|+||.||+|.....    ....||+|.+..              .........+.+|+.++..++||||+
T Consensus         6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~--------------~~~~~~~~~~~~ei~~l~~l~h~~i~   71 (283)
T cd05048           6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKE--------------NAEPKVQQEFRQEAELMSDLQHPNIV   71 (283)
T ss_pred             HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEeccc--------------CCCHHHHHHHHHHHHHHHhcCCcccc
Confidence            588999999999999999976422    236799998732              11223345678899999999999999


Q ss_pred             ccceEEecCCeeEEEEEecCCCCHHHHHhhhhcC------------CCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 011360          269 PLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG------------RRELDWPSRHRIALGVASGLEYLHMYHSASIIHG  336 (487)
Q Consensus       269 ~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~  336 (487)
                      ++++++......+++|||+++++|.+++......            ...+++..+..++.|++.||.||   |++|++||
T Consensus        72 ~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~l---H~~~i~H~  148 (283)
T cd05048          72 CLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYL---SSHHFVHR  148 (283)
T ss_pred             eEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHH---HhCCeecc
Confidence            9999999999999999999999999999753211            14578889999999999999999   77889999


Q ss_pred             CCCCCCEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCcc
Q 011360          337 DIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFV  415 (487)
Q Consensus       337 Dlkp~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~  415 (487)
                      ||||+||++++++.++|+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |..||.
T Consensus       149 dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~  228 (283)
T cd05048         149 DLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYY  228 (283)
T ss_pred             ccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCC
Confidence            9999999999999999999999976543322222233456889999999988899999999999999999998 999995


Q ss_pred             ccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          416 FHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       416 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      ....      .+... .+....... ..        ...+.++.+++.+||+.||.+|||+.+|++.|+++
T Consensus       229 ~~~~------~~~~~-~i~~~~~~~-~~--------~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05048         229 GFSN------QEVIE-MIRSRQLLP-CP--------EDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW  283 (283)
T ss_pred             CCCH------HHHHH-HHHcCCcCC-Cc--------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence            4322      12222 222222111 11        12336699999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.9e-40  Score=330.75  Aligned_cols=260  Identities=20%  Similarity=0.264  Sum_probs=196.3

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      ...|.+.+.||.|+||.||++. +..+++.||+|...                     ...+.+|+.+++.++||||+++
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~-d~~~~~~vaiK~~~---------------------~~~~~~E~~il~~l~HpnIv~~  148 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACI-DNKTCEHVVIKAGQ---------------------RGGTATEAHILRAINHPSIIQL  148 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEE-ECCCCCEEEEechh---------------------hhhhHHHHHHHHhCCCCCCCCE
Confidence            3569999999999999999996 45688999999641                     1245689999999999999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      ++++......++|||++ +++|..++..    ...+++..++.++.|++.||.||   |++||+||||||+||+++.++.
T Consensus       149 ~~~~~~~~~~~lv~e~~-~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~yl---H~~~IvHrDiKP~NIll~~~~~  220 (391)
T PHA03212        149 KGTFTYNKFTCLILPRY-KTDLYCYLAA----KRNIAICDILAIERSVLRAIQYL---HENRIIHRDIKAENIFINHPGD  220 (391)
T ss_pred             eEEEEECCeeEEEEecC-CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCChHhEEEcCCCC
Confidence            99999999999999999 5688888764    35688999999999999999999   7778999999999999999999


Q ss_pred             EEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCcccc-HHHH
Q 011360          351 ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICS-PEWL  429 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~-~~~~  429 (487)
                      +||+|||++......... ......||+.|+|||++.+..++.++|||||||++|||+||..||.........+. ...+
T Consensus       221 vkL~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l  299 (391)
T PHA03212        221 VCLGDFGAACFPVDINAN-KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQI  299 (391)
T ss_pred             EEEEeCCccccccccccc-ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHH
Confidence            999999998654322111 12345699999999999998999999999999999999999887744322111110 0011


Q ss_pred             HHHHh--cCCCCCc--------------------cCC-CCCC-CCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          430 RKVMN--SKNPSRA--------------------IDP-RLPG-NGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       430 ~~~~~--~~~~~~~--------------------~~~-~~~~-~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ..+..  +..+...                    ..+ ..+. ......+.++.+++.+||+.||++|||++++++
T Consensus       300 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        300 KLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             HHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence            11110  0000000                    000 0000 011134557889999999999999999999985

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-41  Score=326.68  Aligned_cols=262  Identities=21%  Similarity=0.333  Sum_probs=212.9

Q ss_pred             HhhhccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCC
Q 011360          187 FLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRN  266 (487)
Q Consensus       187 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn  266 (487)
                      |.....++....+||.|.||.||.|.|++ -.-.||||.+                ......++.|+.|+.+|+.++|||
T Consensus       262 WEmeRtdItMkhKLGGGQYGeVYeGvWKk-yslTvAVKtL----------------KEDtMeveEFLkEAAvMKeikHpN  324 (1157)
T KOG4278|consen  262 WEMERTDITMKHKLGGGQYGEVYEGVWKK-YSLTVAVKTL----------------KEDTMEVEEFLKEAAVMKEIKHPN  324 (1157)
T ss_pred             hhccchheeeeeccCCCcccceeeeeeec-cceeeehhhh----------------hhcchhHHHHHHHHHHHHhhcCcc
Confidence            44445567888999999999999999875 4567999977                334567889999999999999999


Q ss_pred             ccccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC
Q 011360          267 ILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN  346 (487)
Q Consensus       267 Iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~  346 (487)
                      +|+++|+|..+.+.|||+|||..|+|.+||..  -+...++....+.++.||.+|+.||   ..+++|||||.++|||+.
T Consensus       325 LVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRe--cnr~ev~avvLlyMAtQIsSaMeYL---EkknFIHRDLAARNCLVg  399 (1157)
T KOG4278|consen  325 LVQLLGVCTHEPPFYIITEFMCYGNLLDYLRE--CNRSEVPAVVLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVG  399 (1157)
T ss_pred             HHHHhhhhccCCCeEEEEecccCccHHHHHHH--hchhhcchhHHHHHHHHHHHHHHHH---HHhhhhhhhhhhhhcccc
Confidence            99999999999999999999999999999986  3455677778899999999999999   666699999999999999


Q ss_pred             CCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCcccc
Q 011360          347 DDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICS  425 (487)
Q Consensus       347 ~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~  425 (487)
                      ++..+|++|||+++.+....... ......++.|.|||.|....++.|+|||+||++|||+.| |..||.+-+      .
T Consensus       400 EnhiVKvADFGLsRlMtgDTYTA-HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid------l  472 (1157)
T KOG4278|consen  400 ENHIVKVADFGLSRLMTGDTYTA-HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID------L  472 (1157)
T ss_pred             ccceEEeeccchhhhhcCCceec-ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc------H
Confidence            99999999999999886553322 122335789999999999999999999999999999999 899994332      2


Q ss_pred             HHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhhC
Q 011360          426 PEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL  487 (487)
Q Consensus       426 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~ll  487 (487)
                      .. +..++..+ .+-.-++.+|        ..+++||..||+++|++||++.+|-+.++.++
T Consensus       473 Sq-VY~LLEkg-yRM~~PeGCP--------pkVYeLMraCW~WsPsDRPsFaeiHqafEtmf  524 (1157)
T KOG4278|consen  473 SQ-VYGLLEKG-YRMDGPEGCP--------PKVYELMRACWNWSPSDRPSFAEIHQAFETMF  524 (1157)
T ss_pred             HH-HHHHHhcc-ccccCCCCCC--------HHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence            22 22222211 1111122233        45999999999999999999999999998763

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=4.2e-40  Score=340.35  Aligned_cols=257  Identities=22%  Similarity=0.300  Sum_probs=204.6

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||.|+||.||+|.. ..+++.||||.+...             .........+.+|+..+..++|+||++++
T Consensus        32 ~rY~i~~~LG~G~fG~Vy~a~~-~~~g~~vAvK~i~~~-------------~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~   97 (496)
T PTZ00283         32 KKYWISRVLGSGATGTVLCAKR-VSDGEPFAVKVVDME-------------GMSEADKNRAQAEVCCLLNCDFFSIVKCH   97 (496)
T ss_pred             CCEEEEEEEecCCCEEEEEEEE-cCCCCEEEEEEEecc-------------cCCHHHHHHHHHHHHHHhcCCCCcEEEee
Confidence            4799999999999999999974 457899999988431             11233455678899999999999999998


Q ss_pred             eEEecCC--------eeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCE
Q 011360          272 AHMVRPD--------CHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNV  343 (487)
Q Consensus       272 ~~~~~~~--------~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Ni  343 (487)
                      ..+...+        .+++||||+++|+|.+++.........+++..+..++.|++.||.||   |++||+||||||+||
T Consensus        98 ~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~l---H~~~IiHrDLKP~NI  174 (496)
T PTZ00283         98 EDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHV---HSKHMIHRDIKSANI  174 (496)
T ss_pred             cceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHE
Confidence            7765432        36899999999999999976544556789999999999999999999   778899999999999


Q ss_pred             EeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCcc
Q 011360          344 LLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI  423 (487)
Q Consensus       344 ll~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~  423 (487)
                      |++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|..||...      
T Consensus       175 Ll~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~------  248 (496)
T PTZ00283        175 LLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE------  248 (496)
T ss_pred             EEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC------
Confidence            99999999999999998764433222234567999999999999999999999999999999999999999432      


Q ss_pred             ccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          424 CSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       424 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ...+...........  .+++.        .+.++.+++.+||+.+|++|||+.+++.
T Consensus       249 ~~~~~~~~~~~~~~~--~~~~~--------~~~~l~~li~~~L~~dP~~RPs~~ell~  296 (496)
T PTZ00283        249 NMEEVMHKTLAGRYD--PLPPS--------ISPEMQEIVTALLSSDPKRRPSSSKLLN  296 (496)
T ss_pred             CHHHHHHHHhcCCCC--CCCCC--------CCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence            222333333322211  11122        2356889999999999999999999875

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=9.7e-40  Score=322.62  Aligned_cols=201  Identities=25%  Similarity=0.422  Sum_probs=172.5

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .++|++.+.||.|+||.||++.. ..++..+|+|.+..              .........+.+|+.++..++||||+++
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~-~~~~~~~a~k~~~~--------------~~~~~~~~~~~~E~~~l~~l~h~~iv~~   68 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSH-KPSGLIMARKLIHL--------------EIKPAIRNQIIRELQVLHECNSPYIVGF   68 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEE-CCCCcEEEEEEeec--------------ccCHHHHHHHHHHHHHHHHCCCCcccce
Confidence            45799999999999999999975 45788899998732              1122344568899999999999999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      ++++...+..++||||+++|+|.+++..    ...+++..+..++.|++.||.|||+  ..+++||||||+|||++.++.
T Consensus        69 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~  142 (333)
T cd06650          69 YGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGE  142 (333)
T ss_pred             eEEEEECCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCC
Confidence            9999999999999999999999999864    3568889999999999999999952  347999999999999999999


Q ss_pred             EEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccc
Q 011360          351 ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVF  416 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~  416 (487)
                      +||+|||++........    ....|+..|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus       143 ~kL~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~  204 (333)
T cd06650         143 IKLCDFGVSGQLIDSMA----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP  204 (333)
T ss_pred             EEEeeCCcchhhhhhcc----ccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            99999999876533221    234689999999999988999999999999999999999999954

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.2e-39  Score=311.76  Aligned_cols=264  Identities=25%  Similarity=0.363  Sum_probs=210.1

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||.|+||.||+|+.. .++..||||.+....            .........+.+|+.+++.++||||++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~-~~~~~~~iK~~~~~~------------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~   68 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCL-LDRKPVALKKVQIFE------------MMDAKARQDCVKEIDLLKQLNHPNVIKYL   68 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEe-CCCCEEEEEEeeccc------------cCCHHHHHHHHHHHHHHHhCCCcceeeee
Confidence            35899999999999999999753 578899999874311            11223445678899999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++...+..+++|||+++|+|.+++.........+++..+..++.|++.||.||   |++|++|+||+|+||+++.++.+
T Consensus        69 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L---H~~~i~H~dl~~~nil~~~~~~~  145 (267)
T cd08228          69 DSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM---HSRRVMHRDIKPANVFITATGVV  145 (267)
T ss_pred             eeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHH---hhCCeeCCCCCHHHEEEcCCCCE
Confidence            999999999999999999999999876555556788999999999999999999   78899999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRK  431 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~  431 (487)
                      +|+|||++.........  .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||.....    ........
T Consensus       146 ~l~d~g~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~----~~~~~~~~  219 (267)
T cd08228         146 KLGDLGLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLFSLCQK  219 (267)
T ss_pred             EECccccceeccchhHH--HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc----cHHHHHHH
Confidence            99999998765443221  1234588899999999888899999999999999999999999843221    11222222


Q ss_pred             HHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          432 VMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       432 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      ......+         ..........+.+++.+||..+|++|||+.++++.|+++
T Consensus       220 ~~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         220 IEQCDYP---------PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             HhcCCCC---------CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence            2211111         111123346689999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=4.3e-40  Score=323.84  Aligned_cols=245  Identities=21%  Similarity=0.282  Sum_probs=194.5

Q ss_pred             cccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceEEecC
Q 011360          198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRP  277 (487)
Q Consensus       198 ~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  277 (487)
                      +.||+|+||.||++.. ..+|..||+|++...            ..........+.+|+.++..++||||+++++++...
T Consensus         1 ~~lG~G~~g~Vy~~~~-~~~~~~vaiK~~~~~------------~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~   67 (323)
T cd05595           1 KLLGKGTFGKVILVRE-KATGRYYAMKILRKE------------VIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH   67 (323)
T ss_pred             CeeeeCCCEEEEEEEE-CCCCCEEEEEEEEHH------------HhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecC
Confidence            4689999999999974 467899999988421            111223455677899999999999999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEeccC
Q 011360          278 DCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLG  357 (487)
Q Consensus       278 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~DFg  357 (487)
                      +..|+||||+++|+|..++..    ...+++..+..++.|++.||.||   |++||+||||||+|||++.++.+||+|||
T Consensus        68 ~~~~lv~E~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~~~~kL~Dfg  140 (323)
T cd05595          68 DRLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYL---HSRDVVYRDIKLENLMLDKDGHIKITDFG  140 (323)
T ss_pred             CEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHEEEcCCCCEEecccH
Confidence            999999999999999988864    45689999999999999999999   77889999999999999999999999999


Q ss_pred             CccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHHHhcCC
Q 011360          358 LAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSKN  437 (487)
Q Consensus       358 ~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  437 (487)
                      ++........  ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.      ........... 
T Consensus       141 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~------~~~~~~~~~~~-  211 (323)
T cd05595         141 LCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------ERLFELILMEE-  211 (323)
T ss_pred             HhccccCCCC--ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHhcCC-
Confidence            9875322211  11345689999999999998999999999999999999999999943321      11222222111 


Q ss_pred             CCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCC-----ChHHHHH
Q 011360          438 PSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERP-----NSQYVRC  481 (487)
Q Consensus       438 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~~il~  481 (487)
                      .      .++..    .+.++.+++.+||..||++||     ++.++++
T Consensus       212 ~------~~p~~----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         212 I------RFPRT----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             C------CCCCC----CCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            1      11111    235688999999999999998     7877764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=8.9e-40  Score=316.45  Aligned_cols=261  Identities=21%  Similarity=0.343  Sum_probs=205.1

Q ss_pred             cccccccccccccceeEEEEEec----CCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELP----GSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNI  267 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI  267 (487)
                      ++|.+.+.||.|+||+||++...    ..++..+|+|.+..               ........+.+|+.++.+++||||
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~---------------~~~~~~~~~~~e~~~l~~l~h~~i   69 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD---------------ASDNARKDFHREAELLTNLQHEHI   69 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCC---------------cCHHHHHHHHHHHHHHHhCCCCCc
Confidence            45899999999999999999742    23456789997732               122345568889999999999999


Q ss_pred             cccceEEecCCeeEEEEEecCCCCHHHHHhhhhc---------CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCC
Q 011360          268 LPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSR---------GRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDI  338 (487)
Q Consensus       268 v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~---------~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dl  338 (487)
                      +++++++...+..++||||+++++|.+++.....         ....+++..+..++.|++.||+||   |++|++||||
T Consensus        70 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~l---H~~~i~H~dl  146 (288)
T cd05093          70 VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDL  146 (288)
T ss_pred             ceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeeccc
Confidence            9999999999999999999999999999875321         123589999999999999999999   7788999999


Q ss_pred             CCCCEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCcccc
Q 011360          339 KPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFH  417 (487)
Q Consensus       339 kp~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~  417 (487)
                      ||+||++++++.++|+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |.+||...
T Consensus       147 kp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~  226 (288)
T cd05093         147 ATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL  226 (288)
T ss_pred             CcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999976543322222223345778999999998899999999999999999998 89998433


Q ss_pred             CCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          418 QNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       418 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      ..      .+........ ....     .+..    .+..+.+++.+||+.+|.+|||++++.+.|+++
T Consensus       227 ~~------~~~~~~i~~~-~~~~-----~~~~----~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~  279 (288)
T cd05093         227 SN------NEVIECITQG-RVLQ-----RPRT----CPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNL  279 (288)
T ss_pred             CH------HHHHHHHHcC-CcCC-----CCCC----CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence            21      2222222222 2111     1111    224589999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-42  Score=341.62  Aligned_cols=262  Identities=22%  Similarity=0.402  Sum_probs=217.4

Q ss_pred             hhccccccccccccccceeEEEEEecC--CCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCC
Q 011360          189 KKEDCFASLEKIGSGGCGEVYKAELPG--SNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRN  266 (487)
Q Consensus       189 ~~~~~~~~~~~lg~G~~g~v~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn  266 (487)
                      .......+.++||.|.||.|++|+++.  .....||||.++.              .-.+...+.|+.|+.+|-++.|||
T Consensus       626 Id~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~--------------GytekqrrdFL~EAsIMGQFdHPN  691 (996)
T KOG0196|consen  626 IDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKA--------------GYTEKQRRDFLSEASIMGQFDHPN  691 (996)
T ss_pred             cChhheEEEEEEecccccceecccccCCCCcceeEEEeeecc--------------CccHHHHhhhhhhhhhcccCCCCc
Confidence            344567888999999999999998753  3346899999843              233456778999999999999999


Q ss_pred             ccccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC
Q 011360          267 ILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN  346 (487)
Q Consensus       267 Iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~  346 (487)
                      |+++.|+.....+++||+|||++|+|..||..   +.+.+++.+..-+++.|+.|++||   .+.|+|||||.++|||++
T Consensus       692 IIrLEGVVTks~PvMIiTEyMENGsLDsFLR~---~DGqftviQLVgMLrGIAsGMkYL---sdm~YVHRDLAARNILVN  765 (996)
T KOG0196|consen  692 IIRLEGVVTKSKPVMIITEYMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIASGMKYL---SDMNYVHRDLAARNILVN  765 (996)
T ss_pred             EEEEEEEEecCceeEEEhhhhhCCcHHHHHhh---cCCceEeehHHHHHHHHHHHhHHH---hhcCchhhhhhhhheeec
Confidence            99999999999999999999999999999985   346699999999999999999999   888999999999999999


Q ss_pred             CCCCEEEeccCCccccCCCCceeeEeee--cccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCcc
Q 011360          347 DDMEACISDLGLAMAIPDGYTRVLISYV--LGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEI  423 (487)
Q Consensus       347 ~~~~~kl~DFg~s~~~~~~~~~~~~~~~--~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~  423 (487)
                      .+...|++|||+++.+.++.... .++.  .-+++|.|||.+....++.+|||||||++|||.++ |..||      .+.
T Consensus       766 snLvCKVsDFGLSRvledd~~~~-ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPY------Wdm  838 (996)
T KOG0196|consen  766 SNLVCKVSDFGLSRVLEDDPEAA-YTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY------WDM  838 (996)
T ss_pred             cceEEEeccccceeecccCCCcc-ccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcc------ccc
Confidence            99999999999999876544211 1111  12679999999999999999999999999999997 89999      344


Q ss_pred             ccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhhC
Q 011360          424 CSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL  487 (487)
Q Consensus       424 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~ll  487 (487)
                      ...+.+..+..+.+.+...|  +|        ..|.+||..||++|-.+||.+.+|+..|+++|
T Consensus       839 SNQdVIkaIe~gyRLPpPmD--CP--------~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI  892 (996)
T KOG0196|consen  839 SNQDVIKAIEQGYRLPPPMD--CP--------AALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI  892 (996)
T ss_pred             chHHHHHHHHhccCCCCCCC--Cc--------HHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence            44455555555444433222  33        45999999999999999999999999999875

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=5.7e-40  Score=313.00  Aligned_cols=256  Identities=23%  Similarity=0.358  Sum_probs=203.6

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .++|.+.+.||.|+||.||+|...  ++..||+|.+..                .......+.+|+.+++.++||||+++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~--~~~~v~iK~~~~----------------~~~~~~~~~~e~~~l~~l~h~~i~~~   66 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYN--NSTKVAVKTLKP----------------GTMSVQAFLEEANLMKTLQHDKLVRL   66 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEec--CCceEEEEEccC----------------CchhHHHHHHHHHHHHhCCCCCeeeE
Confidence            456999999999999999999754  567899998632                11124567889999999999999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      ++.+...+..+++|||+++++|.+++..  .....+++..+..++.|++.||+||   |+.+++||||+|+||+++.++.
T Consensus        67 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~l~~~l~~L---H~~~i~H~dl~p~nili~~~~~  141 (261)
T cd05072          67 YAVVTKEEPIYIITEYMAKGSLLDFLKS--DEGGKVLLPKLIDFSAQIAEGMAYI---ERKNYIHRDLRAANVLVSESLM  141 (261)
T ss_pred             EEEEcCCCCcEEEEecCCCCcHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccccchhhEEecCCCc
Confidence            9999999999999999999999999875  2345688889999999999999999   6678999999999999999999


Q ss_pred             EEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccccHHHH
Q 011360          351 ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSPEWL  429 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~  429 (487)
                      ++|+|||++.......... .....++..|+|||++.+..++.++||||||+++|+|+| |..||.....      ....
T Consensus       142 ~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~------~~~~  214 (261)
T cd05072         142 CKIADFGLARVIEDNEYTA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN------SDVM  214 (261)
T ss_pred             EEECCCccceecCCCceec-cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH------HHHH
Confidence            9999999998765432211 122345678999999988889999999999999999998 8999943221      1222


Q ss_pred             HHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          430 RKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       430 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      .... ..... ....        ..+.++.+++.+||..+|++|||+++|.+.|+++
T Consensus       215 ~~~~-~~~~~-~~~~--------~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         215 SALQ-RGYRM-PRME--------NCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             HHHH-cCCCC-CCCC--------CCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence            2222 11111 0011        1235688999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-42  Score=302.02  Aligned_cols=256  Identities=22%  Similarity=0.356  Sum_probs=209.7

Q ss_pred             hhccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcc
Q 011360          189 KKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNIL  268 (487)
Q Consensus       189 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv  268 (487)
                      ...+.|++-+.||+|.|+.|+++ .+..+|+.+|+|++..             ...+....+.+.+|+.+.+.|+|||||
T Consensus         8 ~f~d~y~l~e~igkG~FSvVrRc-~~~~tg~~fa~kiin~-------------~k~~~~~~e~l~rEarIC~~LqHP~Iv   73 (355)
T KOG0033|consen    8 KFSDNYDVKEELGKGAFSVVRRC-VHKTTGLEFAAKIINT-------------KKLSARDFQKLEREARICRKLQHPNIV   73 (355)
T ss_pred             ccchhhhHHHHHccCchHHHHHH-HhccchHHHHHHHhhh-------------hhhccccHHHHHHHHHHHHhcCCCcEe
Confidence            34567999999999999999999 4678999999997722             233344677889999999999999999


Q ss_pred             ccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC-
Q 011360          269 PLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLND-  347 (487)
Q Consensus       269 ~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~-  347 (487)
                      ++.+.+......|+|+|++.|++|..-+-.    ...+++..+-.+++||+.+|.|+   |.+||||||+||.|+++.. 
T Consensus        74 rL~~ti~~~~~~ylvFe~m~G~dl~~eIV~----R~~ySEa~aSH~~rQiLeal~yC---H~n~IvHRDvkP~nllLASK  146 (355)
T KOG0033|consen   74 RLHDSIQEESFHYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILEALAYC---HSNGIVHRDLKPENLLLASK  146 (355)
T ss_pred             ehhhhhcccceeEEEEecccchHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHH---HhcCceeccCChhheeeeec
Confidence            999999999999999999999999766543    24577888899999999999999   8899999999999999963 


Q ss_pred             --CCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCcccc
Q 011360          348 --DMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICS  425 (487)
Q Consensus       348 --~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~  425 (487)
                        ..-+||+|||++..+..+.   ......|||.|||||++...+|+..+|||+.|++||-|+.|.+||.+.      ..
T Consensus       147 ~~~A~vKL~~FGvAi~l~~g~---~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~------~~  217 (355)
T KOG0033|consen  147 AKGAAVKLADFGLAIEVNDGE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE------DQ  217 (355)
T ss_pred             cCCCceeecccceEEEeCCcc---ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCc------cH
Confidence              3458999999999887433   235678999999999999999999999999999999999999999332      22


Q ss_pred             HHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          426 PEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       426 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .....++..+.       ..+++.....+..+..+++++||..||.+|.|+.+.+.
T Consensus       218 ~rlye~I~~g~-------yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  218 HRLYEQIKAGA-------YDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             HHHHHHHhccc-------cCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence            23333343322       12444445556677899999999999999999998764

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=4.7e-40  Score=325.21  Aligned_cols=267  Identities=24%  Similarity=0.330  Sum_probs=204.6

Q ss_pred             hhccccccccccccccceeEEEEEec----CCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-C
Q 011360          189 KKEDCFASLEKIGSGGCGEVYKAELP----GSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-R  263 (487)
Q Consensus       189 ~~~~~~~~~~~lg~G~~g~v~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~  263 (487)
                      ...++|.+.+.||.|+||.||+|...    ..+++.||+|++...              ........+..|+.++.++ +
T Consensus         4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~--------------~~~~~~~~~~~E~~~~~~l~~   69 (337)
T cd05054           4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEG--------------ATASEYKALMTELKILIHIGH   69 (337)
T ss_pred             cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCC--------------CCHHHHHHHHHHHHHHHhhcc
Confidence            34557999999999999999999642    234578999987321              1122345677899999999 8


Q ss_pred             CCCccccceEEec-CCeeEEEEEecCCCCHHHHHhhhhc-----------------------------------------
Q 011360          264 HRNILPLLAHMVR-PDCHLLVYEFMKNGSLQDILDDVSR-----------------------------------------  301 (487)
Q Consensus       264 hpnIv~l~~~~~~-~~~~~lv~E~~~~gsL~~~l~~~~~-----------------------------------------  301 (487)
                      ||||+++++++.. +..++++|||+++++|.+++.....                                         
T Consensus        70 h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  149 (337)
T cd05054          70 HLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIE  149 (337)
T ss_pred             CcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCcccccccccccc
Confidence            9999999998765 4678899999999999999864211                                         


Q ss_pred             ----------------CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEeccCCccccCCC
Q 011360          302 ----------------GRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG  365 (487)
Q Consensus       302 ----------------~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~DFg~s~~~~~~  365 (487)
                                      ....+++..+..++.|++.||.||   |++||+||||||+||+++.++.++|+|||++..+...
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~l---H~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~  226 (337)
T cd05054         150 DKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD  226 (337)
T ss_pred             CcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCcceEEEeCCCcEEEeccccchhcccC
Confidence                            023688999999999999999999   7789999999999999999999999999999876443


Q ss_pred             CceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccccHHHHHHHHhcCCCCCccCC
Q 011360          366 YTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDP  444 (487)
Q Consensus       366 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  444 (487)
                      ..........++..|+|||++.+..++.++|||||||++|||++ |..||......      +............ .   
T Consensus       227 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~------~~~~~~~~~~~~~-~---  296 (337)
T cd05054         227 PDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID------EEFCRRLKEGTRM-R---  296 (337)
T ss_pred             cchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc------HHHHHHHhccCCC-C---
Confidence            22222223446778999999999999999999999999999998 99999543221      1122222221111 1   


Q ss_pred             CCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhhC
Q 011360          445 RLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL  487 (487)
Q Consensus       445 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~ll  487 (487)
                       .+    ...+.++.+++.+||+.+|++|||+.+|++.|++++
T Consensus       297 -~~----~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~  334 (337)
T cd05054         297 -AP----EYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLL  334 (337)
T ss_pred             -CC----ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence             11    112356889999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=9.9e-40  Score=311.78  Aligned_cols=257  Identities=21%  Similarity=0.335  Sum_probs=204.6

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ..|.+.+.||.|++|.||+|.+. .++..||+|.+..                .......+.+|+.+++.++||||++++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~~K~~~~----------------~~~~~~~~~~e~~~l~~l~h~~i~~~~   68 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWK-KYSLTVAVKTLKE----------------DTMEVEEFLKEAAVMKEIKHPNLVQLL   68 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEe-cCCceEEEEEecC----------------CchHHHHHHHHHHHHHhCCCCChhheE
Confidence            34888899999999999999764 5788999998731                122345678899999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++...+..+++|||+++++|.+++..  .....+++..+..++.|++.||+||   |++|++||||||+||++++++.+
T Consensus        69 ~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~l~~~~~~~~~~ql~~~l~~l---H~~~i~H~dlkp~nil~~~~~~~  143 (263)
T cd05052          69 GVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVNAVVLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLV  143 (263)
T ss_pred             EEEcCCCCcEEEEEeCCCCcHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHH---HhCCEeecccCcceEEEcCCCcE
Confidence            999999999999999999999999864  2345689999999999999999999   77889999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccccHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSPEWLR  430 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~  430 (487)
                      ||+|||++.......... .....+++.|+|||.+.+..++.++||||||+++|||++ |..||....      ..+...
T Consensus       144 kl~df~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~------~~~~~~  216 (263)
T cd05052         144 KVADFGLSRLMTGDTYTA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID------LSQVYE  216 (263)
T ss_pred             EeCCCccccccccceeec-cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC------HHHHHH
Confidence            999999997764432211 112234678999999998899999999999999999998 899984322      122222


Q ss_pred             HHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhhC
Q 011360          431 KVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL  487 (487)
Q Consensus       431 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~ll  487 (487)
                      .......+  ..+..        .+.++.+++.+||..+|++|||+.++++.|+.++
T Consensus       217 ~~~~~~~~--~~~~~--------~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  263 (263)
T cd05052         217 LLEKGYRM--ERPEG--------CPPKVYELMRACWQWNPSDRPSFAEIHQAFETMF  263 (263)
T ss_pred             HHHCCCCC--CCCCC--------CCHHHHHHHHHHccCCcccCCCHHHHHHHHHhhC
Confidence            22211111  11111        2356889999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=9.2e-40  Score=314.78  Aligned_cols=261  Identities=22%  Similarity=0.349  Sum_probs=205.1

Q ss_pred             cccccccccccccceeEEEEEecC----CCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPG----SNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNI  267 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI  267 (487)
                      ++|.+.+.||.|+||.||+|.+..    .++..||+|.+..              .........+.+|+.++..++||||
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~--------------~~~~~~~~~~~~e~~~l~~l~~~~i   70 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKE--------------TASNDARKDFEREAELLTNFQHENI   70 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecc--------------cCCHHHHHHHHHHHHHHHhcCCCCc
Confidence            458899999999999999997632    3467899998732              1122245678899999999999999


Q ss_pred             cccceEEecCCeeEEEEEecCCCCHHHHHhhhh----------cCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecC
Q 011360          268 LPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVS----------RGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGD  337 (487)
Q Consensus       268 v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~----------~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~D  337 (487)
                      +++++++......++||||+++++|.+++....          .....+++..+..++.|++.||.||   |++|++|||
T Consensus        71 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~l---H~~~i~h~d  147 (280)
T cd05049          71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYL---ASQHFVHRD  147 (280)
T ss_pred             hheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHH---hhCCeeccc
Confidence            999999999999999999999999999997532          1234578889999999999999999   788999999


Q ss_pred             CCCCCEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccc
Q 011360          338 IKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVF  416 (487)
Q Consensus       338 lkp~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~  416 (487)
                      |||+||+++.++.++|+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||..
T Consensus       148 lkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~  227 (280)
T cd05049         148 LATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYG  227 (280)
T ss_pred             cccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCC
Confidence            999999999999999999999876533222111123345788999999999999999999999999999998 9999843


Q ss_pred             cCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhh
Q 011360          417 HQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQ  485 (487)
Q Consensus       417 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~  485 (487)
                      ...      .+...... .+.... .+.        ..+..+.+++.+||+.||++|||+.+|++.|++
T Consensus       228 ~~~------~~~~~~~~-~~~~~~-~~~--------~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         228 LSN------EEVIECIT-QGRLLQ-RPR--------TCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             CCH------HHHHHHHH-cCCcCC-CCC--------CCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence            322      22222222 222111 111        123568899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=4.4e-40  Score=324.35  Aligned_cols=245  Identities=20%  Similarity=0.294  Sum_probs=195.4

Q ss_pred             cccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceEEecC
Q 011360          198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRP  277 (487)
Q Consensus       198 ~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  277 (487)
                      +.||.|+||.||++.. ..++..||+|++...            ..........+.+|+.+++.++||||+++++++...
T Consensus         1 ~~lG~G~~g~Vy~~~~-~~~~~~~avK~~~~~------------~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   67 (328)
T cd05593           1 KLLGKGTFGKVILVRE-KASGKYYAMKILKKE------------VIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTK   67 (328)
T ss_pred             CeeeeCCCEEEEEEEE-CCCCCEEEEEEEEHH------------HhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC
Confidence            3689999999999974 467899999988421            111233456778899999999999999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEeccC
Q 011360          278 DCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLG  357 (487)
Q Consensus       278 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~DFg  357 (487)
                      +.+|+||||+++|+|.+++..    ...+++..+..++.|++.||.||   |++||+||||||+|||++.++.+||+|||
T Consensus        68 ~~~~lv~Ey~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~L---H~~~ivHrDikp~NIll~~~~~~kL~DfG  140 (328)
T cd05593          68 DRLCFVMEYVNGGELFFHLSR----ERVFSEDRTRFYGAEIVSALDYL---HSGKIVYRDLKLENLMLDKDGHIKITDFG  140 (328)
T ss_pred             CEEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HhCCeEecccCHHHeEECCCCcEEEecCc
Confidence            999999999999999988864    45689999999999999999999   77899999999999999999999999999


Q ss_pred             CccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHHHhcCC
Q 011360          358 LAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSKN  437 (487)
Q Consensus       358 ~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  437 (487)
                      ++........  ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.      .+........ .
T Consensus       141 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~------~~~~~~~~~~-~  211 (328)
T cd05593         141 LCKEGITDAA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------EKLFELILME-D  211 (328)
T ss_pred             CCccCCCccc--ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH------HHHHHHhccC-C
Confidence            9875332211  12345699999999999988999999999999999999999999943321      1222222211 1


Q ss_pred             CCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCC-----ChHHHHH
Q 011360          438 PSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERP-----NSQYVRC  481 (487)
Q Consensus       438 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~~il~  481 (487)
                      .  .    ++..    .+.++.+++.+||..||++||     ++.++++
T Consensus       212 ~--~----~p~~----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  250 (328)
T cd05593         212 I--K----FPRT----LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR  250 (328)
T ss_pred             c--c----CCCC----CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence            1  1    1211    234688999999999999997     7888874

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=3.3e-40  Score=319.42  Aligned_cols=260  Identities=21%  Similarity=0.338  Sum_probs=195.9

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      +.|.+.+.||.|+||.||+|.. ..++..||+|.+....              .......+.+|+.+++.++||||++++
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~~vaiK~~~~~~--------------~~~~~~~~~~E~~~l~~l~h~niv~~~   69 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRS-KLTENLVALKEIRLEH--------------EEGAPCTAIREVSLLKNLKHANIVTLH   69 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEE-CCCCCEEEEEEecccc--------------cCCcchhHHHHHHHHHhCCCCCEeeEE
Confidence            4699999999999999999974 4578999999874311              111223567899999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++...+..++||||+++ +|.+++..   .+..+++..+..++.|++.||+||   |++||+||||||+|||++.++.+
T Consensus        70 ~~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~L---H~~~ivH~dlkp~Nil~~~~~~~  142 (288)
T cd07871          70 DIIHTERCLTLVFEYLDS-DLKQYLDN---CGNLMSMHNVKIFMFQLLRGLSYC---HKRKILHRDLKPQNLLINEKGEL  142 (288)
T ss_pred             EEEcCCCeEEEEEeCCCc-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEEECCCCCE
Confidence            999999999999999964 89888864   234578899999999999999999   77899999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQ-PELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLR  430 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~  430 (487)
                      ||+|||++.........  .....+++.|+|||++.+ ..++.++||||+||++|+|+||.+||......      +...
T Consensus       143 kl~DfG~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~------~~~~  214 (288)
T cd07871         143 KLADFGLARAKSVPTKT--YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVK------EELH  214 (288)
T ss_pred             EECcCcceeeccCCCcc--ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHH
Confidence            99999998765332211  133457999999998865 56899999999999999999999999544321      1111


Q ss_pred             HHHh--cCCCCCc-------------cCCCCCCC----CcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          431 KVMN--SKNPSRA-------------IDPRLPGN----GYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       431 ~~~~--~~~~~~~-------------~~~~~~~~----~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .+..  +..+...             .-+.....    .......++.+++.+||+.||.+|||++++++
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         215 LIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             HHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            1111  0000000             00000000    00112356789999999999999999999975

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.2e-39  Score=325.81  Aligned_cols=256  Identities=24%  Similarity=0.364  Sum_probs=195.3

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      +|++.+.||.|+||.||++.. ..+++.||+|++..            ...........+..|..++..++||||+++++
T Consensus         2 ~y~~~~~LG~G~~g~V~~~~~-~~~~~~~aiK~~~~------------~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~   68 (363)
T cd05628           2 DFESLKVIGRGAFGEVRLVQK-KDTGHVYAMKILRK------------ADMLEKEQVGHIRAERDILVEADSLWVVKMFY   68 (363)
T ss_pred             CceEeEEEEeCCCEEEEEEEE-CCCCCEEEEEEEEH------------HHHHHhhHHHHHHHHHHHHHhCCCCCcceEEE
Confidence            588999999999999999974 45789999998842            11122334567788999999999999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEE
Q 011360          273 HMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC  352 (487)
Q Consensus       273 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~k  352 (487)
                      .+.+...+|+|||||+||+|.+++..    ...+++..+..++.|++.||.||   |++||+||||||+|||++.++.+|
T Consensus        69 ~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~l---H~~givHrDlKp~NILi~~~~~vk  141 (363)
T cd05628          69 SFQDKLNLYLIMEFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSI---HQLGFIHRDIKPDNLLLDSKGHVK  141 (363)
T ss_pred             EEecCCeEEEEEcCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HhCCeEecCCCHHHeEECCCCCEE
Confidence            99999999999999999999999864    45789999999999999999999   788999999999999999999999


Q ss_pred             EeccCCccccCCCCce---------------------------------eeEeeecccccccCCcccCCCCCCchhHHHH
Q 011360          353 ISDLGLAMAIPDGYTR---------------------------------VLISYVLGTMAYIAPEYFQQPELSEKCDIFS  399 (487)
Q Consensus       353 l~DFg~s~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~Dvws  399 (487)
                      |+|||++.........                                 ......+||+.|+|||++.+..++.++||||
T Consensus       142 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwS  221 (363)
T cd05628         142 LSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWS  221 (363)
T ss_pred             EeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhh
Confidence            9999998754321100                                 0012347999999999999989999999999


Q ss_pred             HHHHHHHHHhCCCCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccC--CCCCCCCChH
Q 011360          400 FGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTL--HDPEERPNSQ  477 (487)
Q Consensus       400 lG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~--~~P~~RPs~~  477 (487)
                      |||++|||++|..||....      ..+....+.... ....+++..+      .+.++.+++.+++.  .++..||++.
T Consensus       222 lGvil~ell~G~~Pf~~~~------~~~~~~~i~~~~-~~~~~p~~~~------~s~~~~~li~~l~~~~~~r~~r~~~~  288 (363)
T cd05628         222 LGVIMYEMLIGYPPFCSET------PQETYKKVMNWK-ETLIFPPEVP------ISEKAKDLILRFCCEWEHRIGAPGVE  288 (363)
T ss_pred             hHHHHHHHHhCCCCCCCCC------HHHHHHHHHcCc-CcccCCCcCC------CCHHHHHHHHHHcCChhhcCCCCCHH
Confidence            9999999999999994332      122223332211 1111111111      12345566665433  3344578999


Q ss_pred             HHHH
Q 011360          478 YVRC  481 (487)
Q Consensus       478 ~il~  481 (487)
                      +|++
T Consensus       289 ei~~  292 (363)
T cd05628         289 EIKT  292 (363)
T ss_pred             HHhC
Confidence            9875

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-39  Score=311.11  Aligned_cols=260  Identities=22%  Similarity=0.347  Sum_probs=205.5

Q ss_pred             cccccccccccccceeEEEEEecCC--CCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGS--NGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILP  269 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~  269 (487)
                      ++|.+.+.||.|+||.||+|.+...  +...||+|.+..              .........+..|+.+++.++||||++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~--------------~~~~~~~~~~~~e~~~l~~l~h~~i~~   69 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKA--------------GSSDKQRLDFLTEASIMGQFDHPNIIR   69 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCC--------------CCChHHHHHHHHHHHHHHhCCCCCcce
Confidence            4689999999999999999987432  346799998732              112233456788999999999999999


Q ss_pred             cceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC
Q 011360          270 LLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDM  349 (487)
Q Consensus       270 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~  349 (487)
                      +++.+...+..+++|||+++++|.+++..   ....+++..+..++.|++.||.||   |++||+||||+|+||+++.++
T Consensus        70 ~~~~~~~~~~~~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~L---h~~~i~H~di~p~nili~~~~  143 (266)
T cd05033          70 LEGVVTKSRPVMIITEYMENGSLDKFLRE---NDGKFTVGQLVGMLRGIASGMKYL---SEMNYVHRDLAARNILVNSNL  143 (266)
T ss_pred             EeEEEecCCceEEEEEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCcceEEEcCCC
Confidence            99999999999999999999999999864   234689999999999999999999   678899999999999999999


Q ss_pred             CEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccccHHH
Q 011360          350 EACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSPEW  428 (487)
Q Consensus       350 ~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~  428 (487)
                      .++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||....      ..+.
T Consensus       144 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~------~~~~  217 (266)
T cd05033         144 VCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS------NQDV  217 (266)
T ss_pred             CEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC------HHHH
Confidence            999999999987753222222222345678999999998899999999999999999998 999984322      1222


Q ss_pred             HHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhhC
Q 011360          429 LRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL  487 (487)
Q Consensus       429 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~ll  487 (487)
                      ...........      .+.    ..+..+.+++.+||+.+|++|||+.+|++.|++++
T Consensus       218 ~~~~~~~~~~~------~~~----~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~~  266 (266)
T cd05033         218 IKAVEDGYRLP------PPM----DCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI  266 (266)
T ss_pred             HHHHHcCCCCC------CCC----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence            22222211111      111    12356889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=9e-40  Score=314.52  Aligned_cols=262  Identities=19%  Similarity=0.302  Sum_probs=201.8

Q ss_pred             ccccccccccccccceeEEEEEecC----CCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCC
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPG----SNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRN  266 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn  266 (487)
                      .++|++.+.||.|+||.||+|.+..    .++..||+|++..              .........+.+|+.+++.++|||
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~--------------~~~~~~~~~~~~e~~~l~~l~~~~   70 (277)
T cd05062           5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNE--------------AASMRERIEFLNEASVMKEFNCHH   70 (277)
T ss_pred             HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccc--------------cCCHHHHHHHHHHHHHHHhCCCCC
Confidence            4569999999999999999997532    3456799998632              111123345788999999999999


Q ss_pred             ccccceEEecCCeeEEEEEecCCCCHHHHHhhhhcC------CCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC
Q 011360          267 ILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG------RRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKP  340 (487)
Q Consensus       267 Iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp  340 (487)
                      |+++++++......++||||+++|+|.+++......      ...+++..+..++.|++.||.||   |+.|++||||||
T Consensus        71 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---H~~~~vH~dlkp  147 (277)
T cd05062          71 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYL---NANKFVHRDLAA  147 (277)
T ss_pred             eeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCcch
Confidence            999999999999999999999999999998753221      23457788899999999999999   677899999999


Q ss_pred             CCEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCC
Q 011360          341 RNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQN  419 (487)
Q Consensus       341 ~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~  419 (487)
                      +||++++++.++|+|||++................+++.|+|||++.+..++.++||||||+++|||++ |..||.... 
T Consensus       148 ~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~-  226 (277)
T cd05062         148 RNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS-  226 (277)
T ss_pred             heEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC-
Confidence            999999999999999999876544332221122345788999999998889999999999999999999 688884332 


Q ss_pred             CCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhh
Q 011360          420 GEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQ  485 (487)
Q Consensus       420 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~  485 (487)
                           ..+..........+ .     .+..    .+..+.+++.+||+.+|++|||+.++++.|++
T Consensus       227 -----~~~~~~~~~~~~~~-~-----~~~~----~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         227 -----NEQVLRFVMEGGLL-D-----KPDN----CPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             -----HHHHHHHHHcCCcC-C-----CCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence                 12222222222111 1     1111    22468899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-40  Score=328.06  Aligned_cols=255  Identities=23%  Similarity=0.359  Sum_probs=199.0

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      +|.+.+.||.|+||.||+|+. ..+++.||||++..            ...........+.+|+.++..++||||+++++
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~-~~~~~~vaiK~~~~------------~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~   68 (364)
T cd05599           2 DFESIKVIGRGAFGEVRLVQK-KDTGHIYAMKKLRK------------SEMLEKEQVAHVRAERDILAEADNPWVVKLYY   68 (364)
T ss_pred             CceEEEEEEecCCEEEEEEEE-CCCCCEEEEEEEEH------------HHhhhhhHHHHHHHHHHHHHhCCCCCCcceEE
Confidence            589999999999999999975 45789999999842            11112334566788999999999999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEE
Q 011360          273 HMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC  352 (487)
Q Consensus       273 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~k  352 (487)
                      ++.+++.+|+|||||++|+|.+++..    ...+++..+..++.|++.||.||   |++||+||||||+|||++.++.++
T Consensus        69 ~~~~~~~~~lv~E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~l---H~~~ivH~Dlkp~NIl~~~~~~~k  141 (364)
T cd05599          69 SFQDENYLYLIMEYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSI---HKLGYIHRDIKPDNLLLDAKGHIK  141 (364)
T ss_pred             EEEcCCeEEEEECCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeEeccCCHHHeEECCCCCEE
Confidence            99999999999999999999999864    45689999999999999999999   778899999999999999999999


Q ss_pred             EeccCCccccCCCCcee------------------------------------eEeeecccccccCCcccCCCCCCchhH
Q 011360          353 ISDLGLAMAIPDGYTRV------------------------------------LISYVLGTMAYIAPEYFQQPELSEKCD  396 (487)
Q Consensus       353 l~DFg~s~~~~~~~~~~------------------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~D  396 (487)
                      |+|||++..+.......                                    .....+||+.|+|||++.+..++.++|
T Consensus       142 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D  221 (364)
T cd05599         142 LSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECD  221 (364)
T ss_pred             EeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeee
Confidence            99999987543211000                                    001245899999999999989999999


Q ss_pred             HHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCC-
Q 011360          397 IFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPN-  475 (487)
Q Consensus       397 vwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-  475 (487)
                      ||||||++|||++|..||.....      .+.......... ...++..      ...+..+.+++.+|+. +|.+|++ 
T Consensus       222 iwSlG~il~el~~G~~Pf~~~~~------~~~~~~i~~~~~-~~~~~~~------~~~s~~~~~li~~ll~-~p~~R~~~  287 (364)
T cd05599         222 WWSLGVIMYEMLVGYPPFCSDNP------QETYRKIINWKE-TLQFPDE------VPLSPEAKDLIKRLCC-EAERRLGN  287 (364)
T ss_pred             eecchhHHHHhhcCCCCCCCCCH------HHHHHHHHcCCC-ccCCCCC------CCCCHHHHHHHHHHcc-CHhhcCCC
Confidence            99999999999999999943321      222222322111 1111111      1123567888889996 9999998 


Q ss_pred             --hHHHHH
Q 011360          476 --SQYVRC  481 (487)
Q Consensus       476 --~~~il~  481 (487)
                        +.++++
T Consensus       288 ~~~~~ll~  295 (364)
T cd05599         288 NGVNEIKS  295 (364)
T ss_pred             CCHHHHhc
Confidence              887765

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.4e-39  Score=320.97  Aligned_cols=247  Identities=21%  Similarity=0.299  Sum_probs=193.2

Q ss_pred             cccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CCCCccccceEEec
Q 011360          198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RHRNILPLLAHMVR  276 (487)
Q Consensus       198 ~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~  276 (487)
                      +.||.|+||.||+++. ..+++.||+|++..            ...........+..|..++..+ +||||+++++++..
T Consensus         1 ~~lG~G~~g~V~~~~~-~~~~~~~aiK~i~~------------~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~   67 (329)
T cd05588           1 RVIGRGSYAKVLLVEL-KKTRRIYAMKVIKK------------ELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQT   67 (329)
T ss_pred             CeEeeCCCeEEEEEEE-CCCCCEEEEEEEEH------------HHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEc
Confidence            3689999999999975 45789999998842            1111223455677889998888 79999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEecc
Q 011360          277 PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDL  356 (487)
Q Consensus       277 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~DF  356 (487)
                      .+.+|+||||+++|+|.+++..    ...+++..+..++.|++.||.||   |++||+||||||+||+++.++.+||+||
T Consensus        68 ~~~~~lv~e~~~~g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~Nili~~~~~~kL~Df  140 (329)
T cd05588          68 ESRLFFVIEFVSGGDLMFHMQR----QRKLPEEHARFYSAEISLALNFL---HERGIIYRDLKLDNVLLDAEGHIKLTDY  140 (329)
T ss_pred             CCEEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHeEECCCCCEEECcC
Confidence            9999999999999999988864    45789999999999999999999   7789999999999999999999999999


Q ss_pred             CCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCC--ccccHHHHHHHHh
Q 011360          357 GLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGE--EICSPEWLRKVMN  434 (487)
Q Consensus       357 g~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~--~~~~~~~~~~~~~  434 (487)
                      |++........  ......||+.|+|||++.+..++.++|+|||||++|+|+||..||.......  .....++......
T Consensus       141 g~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~  218 (329)
T cd05588         141 GMCKEGIRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVIL  218 (329)
T ss_pred             ccccccccCCC--ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHH
Confidence            99875322111  1234579999999999999999999999999999999999999996432211  1122233333333


Q ss_pred             cCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCh
Q 011360          435 SKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNS  476 (487)
Q Consensus       435 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~  476 (487)
                      .....      +|..    .+..+.+++.+||+.||.+|||+
T Consensus       219 ~~~~~------~p~~----~~~~~~~li~~~L~~dP~~R~~~  250 (329)
T cd05588         219 EKQIR------IPRS----LSVKASSVLKGFLNKDPKERLGC  250 (329)
T ss_pred             cCCCC------CCCC----CCHHHHHHHHHHhccCHHHcCCC
Confidence            22211      2211    22458899999999999999983

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1e-39  Score=321.21  Aligned_cols=247  Identities=22%  Similarity=0.333  Sum_probs=194.6

Q ss_pred             cccccccceeEEEEEec--CCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceEEe
Q 011360          198 EKIGSGGCGEVYKAELP--GSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMV  275 (487)
Q Consensus       198 ~~lg~G~~g~v~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  275 (487)
                      +.||+|+||.||+++..  ..+++.||+|.+...           ...........+..|+.+++.++||||+++++++.
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~-----------~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~   70 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKA-----------TIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQ   70 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHH-----------HHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEe
Confidence            67999999999999753  246889999988421           00111223456778999999999999999999999


Q ss_pred             cCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEec
Q 011360          276 RPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISD  355 (487)
Q Consensus       276 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~D  355 (487)
                      .++..|+||||+++|+|.+++..    ...+++..+..++.|++.||.||   |++||+||||||+|||++.++.+||+|
T Consensus        71 ~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~Nil~~~~~~~kl~D  143 (323)
T cd05584          71 TGGKLYLILEYLSGGELFMHLER----EGIFMEDTACFYLSEISLALEHL---HQQGIIYRDLKPENILLDAQGHVKLTD  143 (323)
T ss_pred             cCCeEEEEEeCCCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeEECCCCCEEEee
Confidence            99999999999999999999864    45678888999999999999999   778899999999999999999999999


Q ss_pred             cCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHHHhc
Q 011360          356 LGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNS  435 (487)
Q Consensus       356 Fg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  435 (487)
                      ||++.........  .....||+.|+|||++.+..++.++||||||+++|||++|..||.....      ..........
T Consensus       144 fg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~------~~~~~~~~~~  215 (323)
T cd05584         144 FGLCKESIHEGTV--THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR------KKTIDKILKG  215 (323)
T ss_pred             CcCCeecccCCCc--ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH------HHHHHHHHcC
Confidence            9998754322211  1335689999999999988899999999999999999999999954321      2222333222


Q ss_pred             CCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCC-----ChHHHHH
Q 011360          436 KNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERP-----NSQYVRC  481 (487)
Q Consensus       436 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~~il~  481 (487)
                      .   ..+++.+        ...+.+++.+||+.+|++||     +++++++
T Consensus       216 ~---~~~~~~~--------~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         216 K---LNLPPYL--------TPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             C---CCCCCCC--------CHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence            1   1122222        24588999999999999999     7887765

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.8e-39  Score=308.63  Aligned_cols=251  Identities=24%  Similarity=0.331  Sum_probs=198.8

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      .|.+.+.||.|+||.||++.+.  ++..+|+|.+..                .......+.+|+.+++.++||||+++++
T Consensus         5 ~~~~~~~lg~G~~~~vy~~~~~--~~~~~a~K~~~~----------------~~~~~~~~~~e~~~l~~l~h~~i~~~~~   66 (256)
T cd05114           5 ELTFMKELGSGQFGVVHLGKWR--AQIKVAIKAINE----------------GAMSEEDFIEEAKVMMKLSHPKLVQLYG   66 (256)
T ss_pred             HcEEeeEecCCcCceEEEEEec--cCceEEEEeccc----------------CCccHHHHHHHHHHHHHCCCCCceeEEE
Confidence            5888999999999999999764  456899997632                1112346788999999999999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEE
Q 011360          273 HMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC  352 (487)
Q Consensus       273 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~k  352 (487)
                      ++...+..++||||+++|+|.+++...   ...+++..+..++.|++.||.||   |++|++||||+|+||+++.++.+|
T Consensus        67 ~~~~~~~~~iv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~ni~i~~~~~~k  140 (256)
T cd05114          67 VCTQQKPLYIVTEFMENGCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYL---ERNSFIHRDLAARNCLVSSTGVVK  140 (256)
T ss_pred             EEccCCCEEEEEEcCCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHH---HHCCccccccCcceEEEcCCCeEE
Confidence            999999999999999999999988641   24588999999999999999999   677899999999999999999999


Q ss_pred             EeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccccHHHHHH
Q 011360          353 ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSPEWLRK  431 (487)
Q Consensus       353 l~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~  431 (487)
                      |+|||.+.......... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||....      ..+....
T Consensus       141 l~d~g~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~------~~~~~~~  213 (256)
T cd05114         141 VSDFGMTRYVLDDEYTS-SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS------NYEVVEM  213 (256)
T ss_pred             ECCCCCccccCCCceec-cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC------HHHHHHH
Confidence            99999987654332211 112235678999999998889999999999999999999 899994332      2233333


Q ss_pred             HHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHh
Q 011360          432 VMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLS  484 (487)
Q Consensus       432 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~  484 (487)
                      ......+.   .+..       .+..+.+++.+||+.+|++|||+.++++.|.
T Consensus       214 i~~~~~~~---~~~~-------~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         214 ISRGFRLY---RPKL-------ASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             HHCCCCCC---CCCC-------CCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            33222111   1111       1246889999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=2e-39  Score=318.20  Aligned_cols=258  Identities=21%  Similarity=0.319  Sum_probs=200.2

Q ss_pred             ccccccccccccccceeEEEEEecCCCC----ceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCC
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNG----KMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRN  266 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn  266 (487)
                      ..+|...+.||+|+||.||+|.+.. ++    ..||+|.+..              .........+.+|+.+++.++|||
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~-~~~~~~~~vaiK~~~~--------------~~~~~~~~~~~~e~~~l~~l~h~n   70 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELRE--------------ATSPKANKEILDEAYVMASVDNPH   70 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEec-CCCccceeEEEEeccc--------------cCCHHHHHHHHHHHHHHHhCCCCC
Confidence            3469999999999999999998642 33    3489998732              112234456888999999999999


Q ss_pred             ccccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC
Q 011360          267 ILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN  346 (487)
Q Consensus       267 Iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~  346 (487)
                      |+++++++... ..++++||+++|+|.+++..   ....+++..+..++.|++.||+||   |++||+||||||+||+++
T Consensus        71 iv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~L---H~~~iiH~dlkp~Nill~  143 (316)
T cd05108          71 VCRLLGICLTS-TVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYL---EERRLVHRDLAARNVLVK  143 (316)
T ss_pred             CCeEEEEEcCC-CceeeeecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHH---HhcCeeccccchhheEec
Confidence            99999988764 56799999999999999874   234688889999999999999999   778999999999999999


Q ss_pred             CCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCcccc
Q 011360          347 DDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICS  425 (487)
Q Consensus       347 ~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~  425 (487)
                      .++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||....      .
T Consensus       144 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~------~  217 (316)
T cd05108         144 TPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP------A  217 (316)
T ss_pred             CCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC------H
Confidence            999999999999987654333222222334678999999999999999999999999999998 999994321      1


Q ss_pred             HHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          426 PEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       426 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      .+ .......... ...++.        ...++.+++.+||..+|++|||+.+++..|..+
T Consensus       218 ~~-~~~~~~~~~~-~~~~~~--------~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~  268 (316)
T cd05108         218 SE-ISSILEKGER-LPQPPI--------CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  268 (316)
T ss_pred             HH-HHHHHhCCCC-CCCCCC--------CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            12 2222222111 011111        224688999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=2.4e-39  Score=315.60  Aligned_cols=263  Identities=23%  Similarity=0.306  Sum_probs=206.2

Q ss_pred             ccccccccccccccceeEEEEEe----cCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CCC
Q 011360          191 EDCFASLEKIGSGGCGEVYKAEL----PGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RHR  265 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp  265 (487)
                      .++|.+.+.||.|+||.||++..    ...++..||+|.+..              .........+.+|+.+++++ +||
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~--------------~~~~~~~~~~~~E~~~l~~l~~h~   99 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKP--------------TAHSSEREALMSELKIMSHLGNHE   99 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCc--------------cCChHHHHHHHHHHHHHHhccCCC
Confidence            34699999999999999999974    223456899998732              11223456788999999999 899


Q ss_pred             CccccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEe
Q 011360          266 NILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLL  345 (487)
Q Consensus       266 nIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill  345 (487)
                      ||+++++++...+..+++|||+++|+|.+++..  .....+++.++..++.|++.||.||   |++|++|+||||+||++
T Consensus       100 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~--~~~~~l~~~~~~~i~~~i~~~l~~l---H~~~ivH~dlkp~Nil~  174 (302)
T cd05055         100 NIVNLLGACTIGGPILVITEYCCYGDLLNFLRR--KRESFLTLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNVLL  174 (302)
T ss_pred             CcceEEEEEecCCceEEEEEcCCCCcHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeehhhhccceEEE
Confidence            999999999999999999999999999999864  2233489999999999999999999   67789999999999999


Q ss_pred             CCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccc
Q 011360          346 NDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEIC  424 (487)
Q Consensus       346 ~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~  424 (487)
                      +.++.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||.....     
T Consensus       175 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~-----  249 (302)
T cd05055         175 THGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV-----  249 (302)
T ss_pred             cCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc-----
Confidence            9999999999999986654332222223346788999999998899999999999999999998 8999843221     


Q ss_pred             cHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhhC
Q 011360          425 SPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL  487 (487)
Q Consensus       425 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~ll  487 (487)
                       .+............ .    .+.    ..+..+.+++.+||+.+|++|||+.++++.|++++
T Consensus       250 -~~~~~~~~~~~~~~-~----~~~----~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~~  302 (302)
T cd05055         250 -DSKFYKLIKEGYRM-A----QPE----HAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQL  302 (302)
T ss_pred             -hHHHHHHHHcCCcC-C----CCC----CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhhC
Confidence             11222222222111 0    111    12356889999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2.2e-39  Score=312.37  Aligned_cols=251  Identities=28%  Similarity=0.368  Sum_probs=195.3

Q ss_pred             cccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceEEecCCe
Q 011360          200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDC  279 (487)
Q Consensus       200 lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  279 (487)
                      ||.|+||.||++.. ..+++.||+|++...            ..........+..|+.+++.++||||+++++++.....
T Consensus         1 lg~G~~g~Vy~~~~-~~~~~~~avK~~~~~------------~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~   67 (280)
T cd05608           1 LGKGGFGEVSACQM-RATGKLYACKKLNKK------------RLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTD   67 (280)
T ss_pred             CCCCCceeEEEEEE-ccCCcEEEEEeeeHH------------HHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCe
Confidence            69999999999975 457899999987320            11112234567789999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEeccCCc
Q 011360          280 HLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA  359 (487)
Q Consensus       280 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~DFg~s  359 (487)
                      .|+||||+++|+|.+++.........+++..+..++.|++.||.||   |++||+||||||+||+++.++.++|+|||++
T Consensus        68 ~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nili~~~~~~~l~dfg~~  144 (280)
T cd05608          68 LCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHL---HQRRIIYRDLKPENVLLDNDGNVRISDLGLA  144 (280)
T ss_pred             EEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCCEEEeeCccc
Confidence            9999999999999988865444456789999999999999999999   6788999999999999999999999999999


Q ss_pred             cccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHHHhcCCCC
Q 011360          360 MAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSKNPS  439 (487)
Q Consensus       360 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  439 (487)
                      .........  .....||+.|+|||++.+..++.++||||||+++|+|++|..||.......  ............   .
T Consensus       145 ~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~---~  217 (280)
T cd05608         145 VELKDGQSK--TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV--ENKELKQRILND---S  217 (280)
T ss_pred             eecCCCCcc--ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch--hHHHHHHhhccc---C
Confidence            766443322  133568999999999999999999999999999999999999995433211  111111111111   0


Q ss_pred             CccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCC-----ChHHHHH
Q 011360          440 RAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERP-----NSQYVRC  481 (487)
Q Consensus       440 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~~il~  481 (487)
                      ..    ++    ...+..+.+++.+||+.||++||     |++++++
T Consensus       218 ~~----~~----~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         218 VT----YP----DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             CC----Cc----ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            11    11    12335688999999999999999     5666664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.8e-39  Score=326.68  Aligned_cols=256  Identities=22%  Similarity=0.343  Sum_probs=196.3

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      .|.+++.||+|+||.||+|+. ..++..||+|++..            ...........+.+|+.++..++||||+++++
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~-~~~~~~~aiK~i~~------------~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~   68 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACK-VDTHALYAMKTLRK------------KDVLNRNQVAHVKAERDILAEADNEWVVKLYY   68 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEE-CCCCCEEEEEEEEH------------HHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEE
Confidence            488899999999999999975 46889999998842            11122344567889999999999999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEE
Q 011360          273 HMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC  352 (487)
Q Consensus       273 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~k  352 (487)
                      ++.+.+.+|+||||+++|+|.+++..    ...+++..+..++.|++.||.||   |+.||+||||||+|||++.++.+|
T Consensus        69 ~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~L---H~~givHrDlKp~Nili~~~~~~k  141 (381)
T cd05626          69 SFQDKDNLYFVMDYIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESV---HKMGFIHRDIKPDNILIDLDGHIK  141 (381)
T ss_pred             EEecCCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HhCCeeecCCcHHHEEECCCCCEE
Confidence            99999999999999999999999864    45688899999999999999999   778899999999999999999999


Q ss_pred             EeccCCccccCCCCc---------------------------------------------eeeEeeecccccccCCcccC
Q 011360          353 ISDLGLAMAIPDGYT---------------------------------------------RVLISYVLGTMAYIAPEYFQ  387 (487)
Q Consensus       353 l~DFg~s~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~l~  387 (487)
                      |+|||++........                                             ........||+.|+|||++.
T Consensus       142 L~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~  221 (381)
T cd05626         142 LTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL  221 (381)
T ss_pred             EeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHc
Confidence            999999754311000                                             00012346999999999999


Q ss_pred             CCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhh--c
Q 011360          388 QPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYI--C  465 (487)
Q Consensus       388 ~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--c  465 (487)
                      +..++.++|||||||++|||+||..||.....      .+........... ..    ++..  ...+.++.+++.+  |
T Consensus       222 ~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~------~~~~~~i~~~~~~-~~----~~~~--~~~s~~~~dli~~ll~  288 (381)
T cd05626         222 RKGYTQLCDWWSVGVILFEMLVGQPPFLAPTP------TETQLKVINWENT-LH----IPPQ--VKLSPEAVDLITKLCC  288 (381)
T ss_pred             CCCCCCccceeehhhHHHHHHhCCCCCcCCCH------HHHHHHHHccccc-cC----CCCC--CCCCHHHHHHHHHHcc
Confidence            88899999999999999999999999954332      1122222211111 01    1110  1122456677776  5


Q ss_pred             cCCCCCCCCChHHHHH
Q 011360          466 TLHDPEERPNSQYVRC  481 (487)
Q Consensus       466 l~~~P~~RPs~~~il~  481 (487)
                      +..+|..|||+.+++.
T Consensus       289 ~~~~~~~R~~~~~~l~  304 (381)
T cd05626         289 SAEERLGRNGADDIKA  304 (381)
T ss_pred             CcccccCCCCHHHHhc
Confidence            5666777999999875

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=9.7e-40  Score=316.41  Aligned_cols=261  Identities=22%  Similarity=0.338  Sum_probs=191.4

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhc---cCCCCCccc
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITAS---QIRHRNILP  269 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~---~l~hpnIv~  269 (487)
                      +|.+.+.||.|+||.||+|.....++..||+|.+.....             .......+.+|+.++.   .+.||||++
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~~~e~~~l~~l~~~~hpniv~   68 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-------------EEGMPLSTIREVAVLRHLETFEHPNVVR   68 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccC-------------CCCchHHHHHHHHHHHhhcccCCCCcce
Confidence            588999999999999999986555678899998743211             1111123344555544   457999999


Q ss_pred             cceEEe-----cCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEE
Q 011360          270 LLAHMV-----RPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVL  344 (487)
Q Consensus       270 l~~~~~-----~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nil  344 (487)
                      +++++.     ....+++||||+. ++|.+++..  .....+++..+..++.|++.||.||   |++||+||||||+|||
T Consensus        69 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~l---H~~~iiH~dlkp~Nil  142 (290)
T cd07862          69 LFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFL---HSHRVVHRDLKPQNIL  142 (290)
T ss_pred             EEEEEecccCCCCCcEEEEEccCC-CCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeCCCCHHHEE
Confidence            999875     2456899999995 699999875  2344588999999999999999999   7788999999999999


Q ss_pred             eCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccc
Q 011360          345 LNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEIC  424 (487)
Q Consensus       345 l~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~  424 (487)
                      ++.++.+||+|||++.......   ......||+.|+|||++.+..++.++|||||||++|||++|.+||......    
T Consensus       143 ~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~----  215 (290)
T cd07862         143 VTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV----  215 (290)
T ss_pred             EcCCCCEEEccccceEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH----
Confidence            9999999999999997654331   123456899999999998889999999999999999999999999544321    


Q ss_pred             cHHHHHHHHhcC---CC----------CCccCCCCCC---CCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          425 SPEWLRKVMNSK---NP----------SRAIDPRLPG---NGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       425 ~~~~~~~~~~~~---~~----------~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                        +....+....   .+          ...+.+..+.   .........+.+++.+||+.||++|||+.++++
T Consensus       216 --~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         216 --DQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             --HHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence              1111121110   00          0000000000   000123356789999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.7e-39  Score=319.80  Aligned_cols=248  Identities=24%  Similarity=0.307  Sum_probs=192.4

Q ss_pred             cccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHH---hccCCCCCcccc
Q 011360          194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT---ASQIRHRNILPL  270 (487)
Q Consensus       194 ~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~---l~~l~hpnIv~l  270 (487)
                      |.+.+.||.|+||.||+|.. ..+++.||||++...            ..........+..|..+   +..++||||+++
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~-~~~~~~~aiK~~~~~------------~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~   67 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEY-KKTGELYAIKALKKG------------DIIARDEVESLMCEKRIFETANSERHPFLVNL   67 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEE-CCCCCEEEEEEEEHH------------HhhhhhHHHHHHHHHHHHHhccccCCCChhce
Confidence            56788999999999999975 457899999988421            11112233445555544   567789999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      ++++...+..|+||||+++|+|..++.     ...+++..+..++.|++.||.||   |++||+||||||+||+++.++.
T Consensus        68 ~~~~~~~~~~~lv~E~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~al~~l---H~~~ivHrdlkp~Nill~~~~~  139 (324)
T cd05589          68 FACFQTEDHVCFVMEYAAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGLQYL---HENKIVYRDLKLDNLLLDTEGF  139 (324)
T ss_pred             eeEEEcCCEEEEEEcCCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHH---HhCCeEecCCCHHHeEECCCCc
Confidence            999999999999999999999988875     24689999999999999999999   7788999999999999999999


Q ss_pred             EEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHH
Q 011360          351 ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLR  430 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~  430 (487)
                      +||+|||++........  ......|++.|+|||.+.+..++.++|||||||++|+|++|..||.....      .+...
T Consensus       140 ~kL~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~------~~~~~  211 (324)
T cd05589         140 VKIADFGLCKEGMGFGD--RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE------EEVFD  211 (324)
T ss_pred             EEeCcccCCccCCCCCC--cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH------HHHHH
Confidence            99999999865322211  12346689999999999998999999999999999999999999954321      22223


Q ss_pred             HHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCC-----ChHHHHH
Q 011360          431 KVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERP-----NSQYVRC  481 (487)
Q Consensus       431 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~~il~  481 (487)
                      .+... .+.  .+..        .+..+.+++.+||+.||++||     ++.++++
T Consensus       212 ~i~~~-~~~--~p~~--------~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         212 SIVND-EVR--YPRF--------LSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             HHHhC-CCC--CCCC--------CCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence            23222 111  1111        234588999999999999999     4666654

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.1e-39  Score=318.03  Aligned_cols=262  Identities=24%  Similarity=0.357  Sum_probs=195.2

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .++|.+.+.||.|+||.||+|+. ..+++.||+|++....              .......+.+|+.+++.++||||+++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~~aiK~~~~~~--------------~~~~~~~~~~E~~~l~~l~h~niv~~   68 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKS-KVNGKLVALKVIRLQE--------------EEGTPFTAIREASLLKGLKHANIVLL   68 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEE-CCCCCEEEEEEecccc--------------ccccchhHHHHHHHHhhCCCCCcCeE
Confidence            45799999999999999999975 4578899999874211              11122356789999999999999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      ++++.+.+..++||||+. ++|.+++..   ....++...+..++.|++.||.||   |++||+||||||+||+++.++.
T Consensus        69 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~l---H~~~ivH~dlkp~Nill~~~~~  141 (303)
T cd07869          69 HDIIHTKETLTLVFEYVH-TDLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYI---HQRYILHRDLKPQNLLISDTGE  141 (303)
T ss_pred             EEEEecCCeEEEEEECCC-cCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEECCCCC
Confidence            999999999999999995 688887763   245688889999999999999999   7788999999999999999999


Q ss_pred             EEEeccCCccccCCCCceeeEeeecccccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHH
Q 011360          351 ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQ-PELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWL  429 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~  429 (487)
                      +||+|||++........  ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||....+.     ....
T Consensus       142 ~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-----~~~~  214 (303)
T cd07869         142 LKLADFGLARAKSVPSH--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI-----QDQL  214 (303)
T ss_pred             EEECCCCcceeccCCCc--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH-----HHHH
Confidence            99999999875432211  1123458999999998865 46889999999999999999999999543221     1111


Q ss_pred             HHHHh-cCCCCC-c---------c-CCCC----CCCCc-----HHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          430 RKVMN-SKNPSR-A---------I-DPRL----PGNGY-----EKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       430 ~~~~~-~~~~~~-~---------~-~~~~----~~~~~-----~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ..... ...+.. .         . ...+    +....     ...+.++.+++.+||+.||++|||++++++
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         215 ERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             HHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            11110 000000 0         0 0000    00000     011246789999999999999999999975

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=2.3e-39  Score=325.97  Aligned_cols=269  Identities=23%  Similarity=0.312  Sum_probs=206.9

Q ss_pred             HhhhccccccccccccccceeEEEEEecC----CCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC
Q 011360          187 FLKKEDCFASLEKIGSGGCGEVYKAELPG----SNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI  262 (487)
Q Consensus       187 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  262 (487)
                      |....++|.+.+.||.|+||.||+|++..    .++..||+|++...              ........+.+|+.++..+
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~--------------~~~~~~~~~~~E~~~l~~l   97 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKST--------------ARSSEKQALMSELKIMSHL   97 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCC--------------CChhHHHHHHHHHHHHHhc
Confidence            44455568999999999999999998632    34568999998431              1122344678899999999


Q ss_pred             C-CCCccccceEEecCCeeEEEEEecCCCCHHHHHhhhhc----------------------------------------
Q 011360          263 R-HRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSR----------------------------------------  301 (487)
Q Consensus       263 ~-hpnIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~----------------------------------------  301 (487)
                      . ||||+++++++...+..++|||||++|+|.+++.....                                        
T Consensus        98 ~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (401)
T cd05107          98 GPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGG  177 (401)
T ss_pred             CCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCcc
Confidence            6 99999999999999999999999999999999964211                                        


Q ss_pred             ------------------------------------------------------CCCCCChHHHHHHHHHHHHHHHHHHh
Q 011360          302 ------------------------------------------------------GRRELDWPSRHRIALGVASGLEYLHM  327 (487)
Q Consensus       302 ------------------------------------------------------~~~~l~~~~~~~i~~qi~~~L~~Lh~  327 (487)
                                                                            ....+++..+..++.|++.||.||  
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~L--  255 (401)
T cd05107         178 YMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFL--  255 (401)
T ss_pred             ccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHH--
Confidence                                                                  113467778899999999999999  


Q ss_pred             cCCCCeeecCCCCCCEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHH
Q 011360          328 YHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISL  407 (487)
Q Consensus       328 ~h~~givH~Dlkp~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~el  407 (487)
                       |+.|++||||||+|||++.++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||
T Consensus       256 -H~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~  334 (401)
T cd05107         256 -ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEI  334 (401)
T ss_pred             -hcCCcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHH
Confidence             7788999999999999999999999999999765332221111233467899999999988899999999999999999


Q ss_pred             Hh-CCCCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          408 VR-GVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       408 lt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      ++ |..||.....      .+........+..     +..+.    ..+.++.+++.+||+.+|.+||++.+|+..|+.+
T Consensus       335 l~~g~~P~~~~~~------~~~~~~~~~~~~~-----~~~p~----~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         335 FTLGGTPYPELPM------NEQFYNAIKRGYR-----MAKPA----HASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             HHcCCCCCCCCCc------hHHHHHHHHcCCC-----CCCCC----CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            98 8889843321      1222222222211     11111    1235688999999999999999999999999987


Q ss_pred             C
Q 011360          487 L  487 (487)
Q Consensus       487 l  487 (487)
                      +
T Consensus       400 ~  400 (401)
T cd05107         400 L  400 (401)
T ss_pred             h
Confidence            4

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=3.1e-39  Score=306.29  Aligned_cols=251  Identities=25%  Similarity=0.337  Sum_probs=196.1

Q ss_pred             cccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceEEecC
Q 011360          198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRP  277 (487)
Q Consensus       198 ~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  277 (487)
                      +.||.|+||.||+|+. ..++..+|+|.+..              .........+.+|+.+++.++||||+++++++...
T Consensus         1 ~~lg~g~~g~vy~~~~-~~~~~~~a~k~~~~--------------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   65 (252)
T cd05084           1 ERIGRGNFGEVFSGRL-RADNTPVAVKSCRE--------------TLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK   65 (252)
T ss_pred             CccCcccCccEEEEEE-ecCCceEEEEecCc--------------cCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC
Confidence            3689999999999975 45788999997632              11233446788899999999999999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEeccC
Q 011360          278 DCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLG  357 (487)
Q Consensus       278 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~DFg  357 (487)
                      ...++||||+++++|.+++..   ....+++..++.++.|++.||.||   |++|++||||+|+||+++.++.+||+|||
T Consensus        66 ~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~l---H~~~i~H~dl~p~nil~~~~~~~kl~dfg  139 (252)
T cd05084          66 QPIYIVMELVQGGDFLTFLRT---EGPRLKVKELIQMVENAAAGMEYL---ESKHCIHRDLAARNCLVTEKNVLKISDFG  139 (252)
T ss_pred             CCeEEEEeeccCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHH---HhCCccccccchheEEEcCCCcEEECccc
Confidence            999999999999999999863   234688999999999999999999   78889999999999999999999999999


Q ss_pred             CccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccccHHHHHHHHhcC
Q 011360          358 LAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSPEWLRKVMNSK  436 (487)
Q Consensus       358 ~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  436 (487)
                      ++.................+..|+|||.+.+..++.++||||||+++|+|++ |..||.....       ..........
T Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~-------~~~~~~~~~~  212 (252)
T cd05084         140 MSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN-------QQTREAIEQG  212 (252)
T ss_pred             cCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH-------HHHHHHHHcC
Confidence            9876543221111111223567999999998899999999999999999998 8888843221       1122222221


Q ss_pred             CCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhh
Q 011360          437 NPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQ  485 (487)
Q Consensus       437 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~  485 (487)
                      ... .    .+.    ..+..+.+++.+||+.+|++|||+.++.+.|+.
T Consensus       213 ~~~-~----~~~----~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~  252 (252)
T cd05084         213 VRL-P----CPE----LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS  252 (252)
T ss_pred             CCC-C----Ccc----cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence            111 1    111    123568899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-39  Score=309.91  Aligned_cols=262  Identities=23%  Similarity=0.372  Sum_probs=202.9

Q ss_pred             cccccccccccceeEEEEEecCC--CCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          194 FASLEKIGSGGCGEVYKAELPGS--NGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       194 ~~~~~~lg~G~~g~v~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      |.+.+.||.|+||.||.|.+...  .+..||+|++..             ..........+..|+..++.++||||++++
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~-------------~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~   67 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKL-------------DIHTYSEIEEFLSEAACMKDFDHPNVMKLI   67 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEecc-------------CcCCHHHHHHHHHHHHHHHhCCCCCeeeEE
Confidence            45678999999999999986432  347899998742             112233456788999999999999999999


Q ss_pred             eEEecCCe------eEEEEEecCCCCHHHHHhhhhc--CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCE
Q 011360          272 AHMVRPDC------HLLVYEFMKNGSLQDILDDVSR--GRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNV  343 (487)
Q Consensus       272 ~~~~~~~~------~~lv~E~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Ni  343 (487)
                      +++.....      .+++|||+++|+|..++.....  ....+++..+..++.|++.||.||   |+.|++||||||+||
T Consensus        68 ~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~l---H~~~i~H~dlkp~Ni  144 (273)
T cd05035          68 GVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYL---SNRNFIHRDLAARNC  144 (273)
T ss_pred             eeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHH---HhCCeeccccchheE
Confidence            98866544      7899999999999999865322  234689999999999999999999   677899999999999


Q ss_pred             EeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCc
Q 011360          344 LLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEE  422 (487)
Q Consensus       344 ll~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~  422 (487)
                      ++++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |.+||....+   
T Consensus       145 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~---  221 (273)
T cd05035         145 MLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN---  221 (273)
T ss_pred             EECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH---
Confidence            999999999999999987644332211122335678999999988889999999999999999999 8899843321   


Q ss_pred             cccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhhC
Q 011360          423 ICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL  487 (487)
Q Consensus       423 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~ll  487 (487)
                         .+..........+.      .+.    ..+..+.+++.+||+.||++|||+.++++.|++++
T Consensus       222 ---~~~~~~~~~~~~~~------~~~----~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~~  273 (273)
T cd05035         222 ---HEIYDYLRHGNRLK------QPE----DCLDELYDLMYSCWRADPKDRPTFTKLREVLENIL  273 (273)
T ss_pred             ---HHHHHHHHcCCCCC------CCc----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence               22333232222111      111    22356899999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=3.7e-39  Score=312.58  Aligned_cols=260  Identities=21%  Similarity=0.325  Sum_probs=204.6

Q ss_pred             ccccccccccccceeEEEEEecC----CCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcc
Q 011360          193 CFASLEKIGSGGCGEVYKAELPG----SNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNIL  268 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv  268 (487)
                      +|.+.+.||.|+||.||+|++..    .++..+++|.+..               ........+.+|+.+++.++||||+
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~---------------~~~~~~~~~~~e~~~l~~l~h~~i~   70 (291)
T cd05094           6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD---------------PTLAARKDFQREAELLTNLQHEHIV   70 (291)
T ss_pred             HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCC---------------ccHHHHHHHHHHHHHHhcCCCCCcc
Confidence            48888999999999999997532    3456788887632               1122345678899999999999999


Q ss_pred             ccceEEecCCeeEEEEEecCCCCHHHHHhhhhc------------CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 011360          269 PLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSR------------GRRELDWPSRHRIALGVASGLEYLHMYHSASIIHG  336 (487)
Q Consensus       269 ~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~  336 (487)
                      ++++++...+..++||||+++++|.+++.....            ....+++..++.++.|++.||+||   |++|++||
T Consensus        71 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~l---H~~~i~H~  147 (291)
T cd05094          71 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHR  147 (291)
T ss_pred             eEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHH---HhCCeeec
Confidence            999999999999999999999999999975321            123578999999999999999999   78889999


Q ss_pred             CCCCCCEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCcc
Q 011360          337 DIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFV  415 (487)
Q Consensus       337 Dlkp~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~  415 (487)
                      ||||+||+++.++.++|+|||++................++..|+|||++.+..++.++||||||+++|+|+| |..||.
T Consensus       148 dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  227 (291)
T cd05094         148 DLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWF  227 (291)
T ss_pred             ccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999999999999999976544332222233456788999999998899999999999999999999 999984


Q ss_pred             ccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          416 FHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       416 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      ....      .+..... ........ ..        ..+..+.+++.+||+.+|++|||+.+|++.|+++
T Consensus       228 ~~~~------~~~~~~~-~~~~~~~~-~~--------~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~  282 (291)
T cd05094         228 QLSN------TEVIECI-TQGRVLER-PR--------VCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL  282 (291)
T ss_pred             CCCH------HHHHHHH-hCCCCCCC-Cc--------cCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence            3322      1222222 22221111 11        1235688999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=8.3e-41  Score=311.04  Aligned_cols=258  Identities=26%  Similarity=0.368  Sum_probs=199.7

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      .|.-.+.+|.|+||.||.|... .+++.||||++-...                   +--.+|+++|+.+.|||||++..
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~-e~~~~vAIKKv~~d~-------------------r~knrEl~im~~l~HpNIV~L~~   84 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLR-ETEEEVAIKKVLQDK-------------------RYKNRELQIMRKLDHPNIVRLLY   84 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEc-CCCceeEEEEecCCC-------------------CcCcHHHHHHHhcCCcCeeeEEE
Confidence            4777899999999999999875 458999999883311                   12246899999999999999998


Q ss_pred             EEecC--C---eeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC
Q 011360          273 HMVRP--D---CHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLND  347 (487)
Q Consensus       273 ~~~~~--~---~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~  347 (487)
                      +|...  .   +..+||||++. +|..+++.+...+..++...++-+..||.+||+||   |+.||+||||||.|+|+|.
T Consensus        85 ~f~~~~~~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yL---h~~~IcHRDIKPqNlLvD~  160 (364)
T KOG0658|consen   85 FFSSSTESDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYL---HSHGICHRDIKPQNLLVDP  160 (364)
T ss_pred             EEEecCCCchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHH---HhcCcccCCCChheEEEcC
Confidence            88743  2   34589999966 99999987777788899999999999999999999   6789999999999999997


Q ss_pred             C-CCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCccccCCCCcccc
Q 011360          348 D-MEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQP-ELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICS  425 (487)
Q Consensus       348 ~-~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~  425 (487)
                      + |.+||||||.|+.+..+..+.   .+..|..|.|||.+.+. .|+.+.||||.||++.||+-|++.|.+.+....   
T Consensus       161 ~tg~LKicDFGSAK~L~~~epni---SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQ---  234 (364)
T KOG0658|consen  161 DTGVLKICDFGSAKVLVKGEPNI---SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQ---  234 (364)
T ss_pred             CCCeEEeccCCcceeeccCCCce---eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHH---
Confidence            6 899999999999887765542   45579999999988765 899999999999999999999999976543211   


Q ss_pred             HHHHHHHH-----------hcCCCCCccCCCCCCC-----CcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          426 PEWLRKVM-----------NSKNPSRAIDPRLPGN-----GYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       426 ~~~~~~~~-----------~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ...+.+++           ..+.. ..--+.+...     .......+..+++.++|..+|.+|.++.++++
T Consensus       235 L~eIik~lG~Pt~e~I~~mn~~y~-~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  235 LVEIIKVLGTPTREDIKSMNPNYT-EFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             HHHHHHHhCCCCHHHHhhcCcccc-cccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence            11111111           11111 0001111111     22334567899999999999999999999875

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2e-39  Score=309.07  Aligned_cols=255  Identities=27%  Similarity=0.372  Sum_probs=204.7

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      .+|.+.+.||.|+||.||+|...  ++..+++|.+..               ........+..|+.+++.++||||++++
T Consensus         6 ~~y~~~~~ig~g~~~~vy~~~~~--~~~~~~~k~~~~---------------~~~~~~~~~~~e~~~l~~l~~~~i~~~~   68 (261)
T cd05148           6 EEFTLERKLGSGYFGEVWEGLWK--NRVRVAIKILKS---------------DDLLKQQDFQKEVQALKRLRHKHLISLF   68 (261)
T ss_pred             HHHHHhhhhccCCCccEEEeEec--CCCcEEEEeccc---------------cchhhHHHHHHHHHHHhcCCCcchhhee
Confidence            45899999999999999999865  378999998732               1122344678899999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++...+..++||||+++++|.+++..  ..+..+++..+..++.|++.||.||   |++|++|+||+|+||+++.++.+
T Consensus        69 ~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~i~~al~~l---H~~~i~h~dl~~~nilv~~~~~~  143 (261)
T cd05148          69 AVCSVGEPVYIITELMEKGSLLAFLRS--PEGQVLPVASLIDMACQVAEGMAYL---EEQNSIHRDLAARNILVGEDLVC  143 (261)
T ss_pred             eeEecCCCeEEEEeecccCCHHHHHhc--CCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccccCcceEEEcCCceE
Confidence            999999999999999999999999975  2345689999999999999999999   67889999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccccHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSPEWLR  430 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~  430 (487)
                      ||+|||.+..........  ....++..|+|||.+.+..++.++||||||+++|+|++ |..||....      ..+...
T Consensus       144 kl~d~g~~~~~~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~------~~~~~~  215 (261)
T cd05148         144 KVADFGLARLIKEDVYLS--SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN------NHEVYD  215 (261)
T ss_pred             EEccccchhhcCCccccc--cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC------HHHHHH
Confidence            999999997764432211  12345778999999988889999999999999999998 899994332      122233


Q ss_pred             HHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          431 KVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       431 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      .......+  ....        ..+..+.+++.+||..+|++|||+.+|++.|+.+
T Consensus       216 ~~~~~~~~--~~~~--------~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         216 QITAGYRM--PCPA--------KCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             HHHhCCcC--CCCC--------CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence            23222111  1111        1235688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=3.2e-39  Score=311.70  Aligned_cols=261  Identities=23%  Similarity=0.378  Sum_probs=203.0

Q ss_pred             cccccccccccccceeEEEEEe---cCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcc
Q 011360          192 DCFASLEKIGSGGCGEVYKAEL---PGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNIL  268 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~---~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv  268 (487)
                      +.|++.+.||+|+||.||+|.+   ...++..+++|.+..              .........+.+|+.+++.++||||+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~--------------~~~~~~~~~~~~E~~~l~~l~h~niv   70 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKD--------------INNPQQWGEFQQEASLMAELHHPNIV   70 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccC--------------CCCHHHHHHHHHHHHHHhhCCCCCee
Confidence            3588899999999999999975   233567899998732              11123345678899999999999999


Q ss_pred             ccceEEecCCeeEEEEEecCCCCHHHHHhhhhc-------------CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 011360          269 PLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSR-------------GRRELDWPSRHRIALGVASGLEYLHMYHSASIIH  335 (487)
Q Consensus       269 ~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH  335 (487)
                      ++++++...+..|++|||+++++|.+++.....             ....+++..+..++.|++.||.||   |++|++|
T Consensus        71 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~l---H~~~i~H  147 (283)
T cd05090          71 CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYL---SSHFFVH  147 (283)
T ss_pred             eEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHH---HhcCeeh
Confidence            999999999999999999999999999853211             123578888999999999999999   6778999


Q ss_pred             cCCCCCCEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCc
Q 011360          336 GDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSF  414 (487)
Q Consensus       336 ~Dlkp~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf  414 (487)
                      |||||+||+++.++.+||+|||++................++..|+|||++.+..++.++||||||+++|||++ |..||
T Consensus       148 ~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~  227 (283)
T cd05090         148 KDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPY  227 (283)
T ss_pred             hccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCC
Confidence            99999999999999999999999987644332222233446778999999988889999999999999999998 89998


Q ss_pred             cccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhh
Q 011360          415 VFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQ  485 (487)
Q Consensus       415 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~  485 (487)
                      .....       ............. ..+..        .+..+.+++.+||+.+|.+||++.+|++.|+.
T Consensus       228 ~~~~~-------~~~~~~~~~~~~~-~~~~~--------~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         228 YGFSN-------QEVIEMVRKRQLL-PCSED--------CPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             CCCCH-------HHHHHHHHcCCcC-CCCCC--------CCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            43221       1222222222111 11111        22458899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-40  Score=326.84  Aligned_cols=255  Identities=24%  Similarity=0.385  Sum_probs=202.6

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      +|.+.+.||.|+||.||+|.. ..+++.||+|++...            ..........+..|+.++..++||||+++++
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~~~aiK~~~~~------------~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~   68 (350)
T cd05573           2 DFEVIKVIGRGAFGEVWLVRD-KDTGQVYAMKVLRKS------------DMIKRNQIAHVRAERDILADADSPWIVKLYY   68 (350)
T ss_pred             CceEEEEEEeCCcEEEEEEEE-CCCCCEEEEEEEEHH------------HHhhccHHHHHHHHHHHHHhcCCCCccchhh
Confidence            588999999999999999975 457899999988421            1112234567888999999999999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEE
Q 011360          273 HMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC  352 (487)
Q Consensus       273 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~k  352 (487)
                      ++.+++..|+||||+++++|.+++..    ...+++..+..++.|++.||.||   |++||+||||||+||+++.++.+|
T Consensus        69 ~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~L---H~~giiH~Dlkp~NIll~~~~~~k  141 (350)
T cd05573          69 SFQDEEHLYLVMEYMPGGDLMNLLIR----KDVFPEETARFYIAELVLALDSV---HKLGFIHRDIKPDNILIDADGHIK  141 (350)
T ss_pred             heecCCeEEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHeEECCCCCEE
Confidence            99999999999999999999999975    35789999999999999999999   678999999999999999999999


Q ss_pred             EeccCCccccCCCC---------------------------ceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHH
Q 011360          353 ISDLGLAMAIPDGY---------------------------TRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLI  405 (487)
Q Consensus       353 l~DFg~s~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~  405 (487)
                      |+|||++.......                           .........||+.|+|||++.+..++.++|||||||++|
T Consensus       142 L~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~  221 (350)
T cd05573         142 LADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILY  221 (350)
T ss_pred             eecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhh
Confidence            99999997664432                           001123456899999999999999999999999999999


Q ss_pred             HHHhCCCCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCC-hHHHHH
Q 011360          406 SLVRGVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPN-SQYVRC  481 (487)
Q Consensus       406 elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-~~~il~  481 (487)
                      +|++|..||.....      .+....+..... ...    ++...  ..+.++.+++.+||. +|.+||+ +.++++
T Consensus       222 ell~g~~Pf~~~~~------~~~~~~i~~~~~-~~~----~p~~~--~~~~~~~~li~~ll~-dp~~R~~s~~~ll~  284 (350)
T cd05573         222 EMLYGFPPFYSDTL------QETYNKIINWKE-SLR----FPPDP--PVSPEAIDLICRLLC-DPEDRLGSFEEIKS  284 (350)
T ss_pred             hhccCCCCCCCCCH------HHHHHHHhccCC-ccc----CCCCC--CCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence            99999999954331      222222222100 000    11110  133568899999998 9999999 999875

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.5e-39  Score=315.54  Aligned_cols=265  Identities=25%  Similarity=0.338  Sum_probs=206.3

Q ss_pred             hccccccccccccccceeEEEEEecC----CCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CC
Q 011360          190 KEDCFASLEKIGSGGCGEVYKAELPG----SNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RH  264 (487)
Q Consensus       190 ~~~~~~~~~~lg~G~~g~v~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h  264 (487)
                      ..++|.+.+.||+|+||.||++.+..    .....+|+|.+..              .........+.+|+.++..+ +|
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~--------------~~~~~~~~~~~~E~~~l~~l~~h   75 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKD--------------DATEKDLSDLVSEMEMMKMIGKH   75 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccC--------------CCCHHHHHHHHHHHHHHHhhcCC
Confidence            34568999999999999999997642    2346799998732              11122345678899999999 89


Q ss_pred             CCccccceEEecCCeeEEEEEecCCCCHHHHHhhhh------------cCCCCCChHHHHHHHHHHHHHHHHHHhcCCCC
Q 011360          265 RNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVS------------RGRRELDWPSRHRIALGVASGLEYLHMYHSAS  332 (487)
Q Consensus       265 pnIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~g  332 (487)
                      |||+++++++...+..+++|||+++|+|.+++....            .....+++..+..++.|++.||.||   |+.|
T Consensus        76 ~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~L---H~~~  152 (293)
T cd05053          76 KNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFL---ASKK  152 (293)
T ss_pred             CCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHH---HHCC
Confidence            999999999999999999999999999999986421            2345688999999999999999999   6788


Q ss_pred             eeecCCCCCCEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CC
Q 011360          333 IIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GV  411 (487)
Q Consensus       333 ivH~Dlkp~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~  411 (487)
                      |+||||||+||+++.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|++++ |.
T Consensus       153 ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~  232 (293)
T cd05053         153 CIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGG  232 (293)
T ss_pred             ccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCC
Confidence            99999999999999999999999999987654332222222335678999999988899999999999999999998 88


Q ss_pred             CCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhhC
Q 011360          412 PSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL  487 (487)
Q Consensus       412 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~ll  487 (487)
                      .||....      ..+.. ......... ..+.        .....+.+++.+||..+|++|||+.++++.|+.++
T Consensus       233 ~p~~~~~------~~~~~-~~~~~~~~~-~~~~--------~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         233 SPYPGIP------VEELF-KLLKEGYRM-EKPQ--------NCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             CCCCCCC------HHHHH-HHHHcCCcC-CCCC--------CCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence            8984321      11222 222222111 1111        12346889999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.6e-39  Score=313.83  Aligned_cols=260  Identities=24%  Similarity=0.375  Sum_probs=203.7

Q ss_pred             ccccccccccccceeEEEEEecC----CCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcc
Q 011360          193 CFASLEKIGSGGCGEVYKAELPG----SNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNIL  268 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv  268 (487)
                      .|.+.+.||.|+||.||+|.+..    .++..||+|++..              .........+..|+.++..++||||+
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~--------------~~~~~~~~~~~~e~~~~~~l~h~~iv   71 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKD--------------KAEGPLREEFKHEAMMRSRLQHPNIV   71 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccC--------------CCCHHHHHHHHHHHHHHhcCCCCCcC
Confidence            48889999999999999997632    2457899998742              11122345678899999999999999


Q ss_pred             ccceEEecCCeeEEEEEecCCCCHHHHHhhhh------------cCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 011360          269 PLLAHMVRPDCHLLVYEFMKNGSLQDILDDVS------------RGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHG  336 (487)
Q Consensus       269 ~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~  336 (487)
                      ++++++...+..++++||+.+++|.+++....            .....+++..+..++.|++.||.||   |++|++||
T Consensus        72 ~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~l---H~~gi~H~  148 (283)
T cd05091          72 CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFL---SSHHVVHK  148 (283)
T ss_pred             eEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHH---HHcCcccc
Confidence            99999999999999999999999999985311            1123578888999999999999999   77889999


Q ss_pred             CCCCCCEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCcc
Q 011360          337 DIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFV  415 (487)
Q Consensus       337 Dlkp~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~  415 (487)
                      ||||+||++++++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..||.
T Consensus       149 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~  228 (283)
T cd05091         149 DLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYC  228 (283)
T ss_pred             ccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCC
Confidence            9999999999999999999999887644333222233446789999999988889999999999999999998 788884


Q ss_pred             ccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhh
Q 011360          416 FHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQ  485 (487)
Q Consensus       416 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~  485 (487)
                      ...      ..+...........  .    ++..    .+..+.+++.+||+.+|++||++.+|++.|+.
T Consensus       229 ~~~------~~~~~~~i~~~~~~--~----~~~~----~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         229 GYS------NQDVIEMIRNRQVL--P----CPDD----CPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             CCC------HHHHHHHHHcCCcC--C----CCCC----CCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            322      22333333322211  1    1111    23458899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.1e-39  Score=307.93  Aligned_cols=256  Identities=27%  Similarity=0.394  Sum_probs=202.0

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .++|.+.+.||.|++|.||+|...  ++..||+|.+...                ......+.+|+.++++++||||+++
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~--~~~~v~iK~~~~~----------------~~~~~~~~~e~~~l~~l~h~~i~~~   66 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWN--NTTPVAVKTLKPG----------------TMDPKDFLAEAQIMKKLRHPKLIQL   66 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEec--CCeEEEEEeeCCC----------------cccHHHHHHHHHHHHHCCCCCccce
Confidence            346899999999999999999753  4578999987321                1123457789999999999999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      ++++...+..+++|||+++++|.+++..  ..+..+++..+..++.|++.||.||   |+.|++||||||+||+++.++.
T Consensus        67 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~  141 (261)
T cd05068          67 YAVCTLEEPIYIVTELMKYGSLLEYLQG--GAGRALKLPQLIDMAAQVASGMAYL---EAQNYIHRDLAARNVLVGENNI  141 (261)
T ss_pred             eEEEecCCCeeeeeecccCCcHHHHHhc--cCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeeccCCcceEEEcCCCC
Confidence            9999999999999999999999999865  2245689999999999999999999   6778999999999999999999


Q ss_pred             EEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccccHHHH
Q 011360          351 ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSPEWL  429 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~  429 (487)
                      ++|+|||++.......... ......+..|+|||.+.+..++.++||||||+++|+|+| |..||.....      ....
T Consensus       142 ~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~------~~~~  214 (261)
T cd05068         142 CKVADFGLARVIKEDIYEA-REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN------AEVL  214 (261)
T ss_pred             EEECCcceEEEccCCcccc-cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH------HHHH
Confidence            9999999998765322111 111223457999999998899999999999999999999 8999943321      1122


Q ss_pred             HHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          430 RKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       430 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      ... ..... .....        ..+..+.+++.+||+.+|++||++.+|++.|+.+
T Consensus       215 ~~~-~~~~~-~~~~~--------~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         215 QQV-DQGYR-MPCPP--------GCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             HHH-HcCCC-CCCCC--------cCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence            222 22111 11111        1235688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.4e-40  Score=328.79  Aligned_cols=255  Identities=22%  Similarity=0.373  Sum_probs=196.7

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      +|.+.+.||.|+||.||++.. ..+++.||||++..            ...........+.+|+.++.+++||||+++++
T Consensus         2 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~~~aiK~~~~------------~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~   68 (377)
T cd05629           2 DFHTVKVIGKGAFGEVRLVQK-KDTGKIYAMKTLLK------------SEMFKKDQLAHVKAERDVLAESDSPWVVSLYY   68 (377)
T ss_pred             CceEeEEEeecCCEEEEEEEE-CCCCCEEEEEEEEH------------HHHHHhHHHHHHHHHHHHHHhCCCCCcceEEE
Confidence            588999999999999999974 46889999998732            11122334567888999999999999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEE
Q 011360          273 HMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC  352 (487)
Q Consensus       273 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~k  352 (487)
                      ++.+.+..|+||||+++|+|.+++..    ...+++..+..++.|++.||.||   |+.||+||||||+|||++.++.+|
T Consensus        69 ~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~L---H~~givHrDlkp~NIll~~~~~~k  141 (377)
T cd05629          69 SFQDAQYLYLIMEFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAV---HKLGFIHRDIKPDNILIDRGGHIK  141 (377)
T ss_pred             EEEcCCeeEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHEEECCCCCEE
Confidence            99999999999999999999999864    45688999999999999999999   788999999999999999999999


Q ss_pred             EeccCCccccCCCCce---------------------------------------------eeEeeecccccccCCcccC
Q 011360          353 ISDLGLAMAIPDGYTR---------------------------------------------VLISYVLGTMAYIAPEYFQ  387 (487)
Q Consensus       353 l~DFg~s~~~~~~~~~---------------------------------------------~~~~~~~gt~~y~aPE~l~  387 (487)
                      |+|||+++........                                             .......||+.|+|||++.
T Consensus       142 l~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  221 (377)
T cd05629         142 LSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFL  221 (377)
T ss_pred             EeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHc
Confidence            9999998643211000                                             0001246899999999999


Q ss_pred             CCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccC
Q 011360          388 QPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTL  467 (487)
Q Consensus       388 ~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  467 (487)
                      +..++.++|||||||++|||++|.+||.....      .+............     .++..  ...+.++.+++.+||.
T Consensus       222 ~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~------~~~~~~i~~~~~~~-----~~p~~--~~~s~~~~dli~~lL~  288 (377)
T cd05629         222 QQGYGQECDWWSLGAIMFECLIGWPPFCSENS------HETYRKIINWRETL-----YFPDD--IHLSVEAEDLIRRLIT  288 (377)
T ss_pred             cCCCCCceeeEecchhhhhhhcCCCCCCCCCH------HHHHHHHHccCCcc-----CCCCC--CCCCHHHHHHHHHHhc
Confidence            98999999999999999999999999943321      12222222211110     01111  1123568889999997


Q ss_pred             CCCCCC---CChHHHHH
Q 011360          468 HDPEER---PNSQYVRC  481 (487)
Q Consensus       468 ~~P~~R---Ps~~~il~  481 (487)
                       +|.+|   ||+.+++.
T Consensus       289 -~~~~r~~r~~~~~~l~  304 (377)
T cd05629         289 -NAENRLGRGGAHEIKS  304 (377)
T ss_pred             -CHhhcCCCCCHHHHhc
Confidence             66665   58888775

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=4.7e-39  Score=308.52  Aligned_cols=261  Identities=24%  Similarity=0.401  Sum_probs=198.5

Q ss_pred             ccccccccccceeEEEEEecCCCC-ceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceE
Q 011360          195 ASLEKIGSGGCGEVYKAELPGSNG-KMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAH  273 (487)
Q Consensus       195 ~~~~~lg~G~~g~v~~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  273 (487)
                      .+.+.||.|+||.||+|.+..... ..+|+|.+..             ..........+..|+.+++.++||||++++++
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~-------------~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   68 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKI-------------AICTRSEMEDFLSEAVCMKEFDHPNVMRLIGV   68 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEeccc-------------CcCCHHHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence            456889999999999998643222 3689997732             11223445678889999999999999999997


Q ss_pred             EecC------CeeEEEEEecCCCCHHHHHhhhh--cCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEe
Q 011360          274 MVRP------DCHLLVYEFMKNGSLQDILDDVS--RGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLL  345 (487)
Q Consensus       274 ~~~~------~~~~lv~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill  345 (487)
                      +...      ...+++|||+++|+|.+++....  .....+++..+..++.|++.||.||   |++||+||||||+||++
T Consensus        69 ~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~Nil~  145 (272)
T cd05075          69 CLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYL---SSKSFIHRDLAARNCML  145 (272)
T ss_pred             EccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHH---HHCCeeccccchhheEE
Confidence            6532      24689999999999999875322  2234588999999999999999999   67789999999999999


Q ss_pred             CCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccc
Q 011360          346 NDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEIC  424 (487)
Q Consensus       346 ~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~  424 (487)
                      +.++.+||+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||....      
T Consensus       146 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~------  219 (272)
T cd05075         146 NENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE------  219 (272)
T ss_pred             cCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCC------
Confidence            9999999999999987654332111122346778999999999899999999999999999999 789994321      


Q ss_pred             cHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhhC
Q 011360          425 SPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL  487 (487)
Q Consensus       425 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~ll  487 (487)
                      ..+..........+.  ..+.        .+..+.+++.+||+.+|++|||+.+|++.|++++
T Consensus       220 ~~~~~~~~~~~~~~~--~~~~--------~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~~  272 (272)
T cd05075         220 NSEIYDYLRQGNRLK--QPPD--------CLDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL  272 (272)
T ss_pred             HHHHHHHHHcCCCCC--CCCC--------CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence            122222222222111  1111        2245889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=7e-39  Score=306.46  Aligned_cols=263  Identities=25%  Similarity=0.382  Sum_probs=209.5

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      +|.+.+.||.|+||.||++.. ..++..+|||.+...            ..........+.+|+.+++.+.||||+++++
T Consensus         3 ~y~~~~~ig~g~~g~v~~~~~-~~~~~~~~vK~~~~~------------~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~   69 (267)
T cd08229           3 NFRIEKKIGRGQFSEVYRATC-LLDGVPVALKKVQIF------------DLMDAKARADCIKEIDLLKQLNHPNVIKYYA   69 (267)
T ss_pred             hhhhhhhhcccCCeEEEEEee-cCCCceEEEEeeeeh------------hhhhHHHHHHHHHHHHHHHHccCCchhhhhh
Confidence            588899999999999999975 357889999987431            1112234457788999999999999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEE
Q 011360          273 HMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC  352 (487)
Q Consensus       273 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~k  352 (487)
                      ++..++..+++|||+++++|.+++.........+++..+..++.|++.||.||   |++|++|+||+|+||+++.++.++
T Consensus        70 ~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L---H~~~i~H~dl~p~nili~~~~~~~  146 (267)
T cd08229          70 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM---HSRRVMHRDIKPANVFITATGVVK  146 (267)
T ss_pred             eeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEEcCCCCEE
Confidence            99999999999999999999999876545556789999999999999999999   788999999999999999999999


Q ss_pred             EeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHH
Q 011360          353 ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKV  432 (487)
Q Consensus       353 l~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~  432 (487)
                      |+|||++.........  .....++..|+|||.+.+..++.++|+||||+++|+|++|..||......    ........
T Consensus       147 l~dfg~~~~~~~~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~  220 (267)
T cd08229         147 LGDLGLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKI  220 (267)
T ss_pred             ECcchhhhccccCCcc--cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HHHHhhhh
Confidence            9999998765433221  12345889999999998888999999999999999999999999533211    11122222


Q ss_pred             HhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          433 MNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       433 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      .... .     +..+   ....+..+.+++.+||..+|++|||+.+|++.++++
T Consensus       221 ~~~~-~-----~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         221 EQCD-Y-----PPLP---SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             hcCC-C-----CCCC---cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence            1111 1     1111   123445788999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1e-39  Score=323.29  Aligned_cols=261  Identities=25%  Similarity=0.377  Sum_probs=193.7

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      +|.+.+.||.|+||.||+|.. ..++..||||++..             ..........+.+|+.+++.++||||+++++
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~-------------~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~   66 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAID-THTGEKVAIKKIND-------------VFEHVSDATRILREIKLLRLLRHPDIVEIKH   66 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEE-CCCCCEEEEEEech-------------hhccchhHHHHHHHHHHHHhCCCCCEeeecc
Confidence            378899999999999999974 46789999998732             1111223456788999999999999999999


Q ss_pred             EEecC-----CeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC
Q 011360          273 HMVRP-----DCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLND  347 (487)
Q Consensus       273 ~~~~~-----~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~  347 (487)
                      ++...     ..+|+||||| +++|.+++..    ...+++..+..++.|++.||.||   |++||+||||||+|||++.
T Consensus        67 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~dlkp~NIll~~  138 (338)
T cd07859          67 IMLPPSRREFKDIYVVFELM-ESDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYI---HTANVFHRDLKPKNILANA  138 (338)
T ss_pred             eEeccCCCCCceEEEEEecC-CCCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeEECC
Confidence            87643     2479999999 5689888864    45689999999999999999999   7788999999999999999


Q ss_pred             CCCEEEeccCCccccCCCCc-eeeEeeecccccccCCcccCC--CCCCchhHHHHHHHHHHHHHhCCCCccccCCCCc--
Q 011360          348 DMEACISDLGLAMAIPDGYT-RVLISYVLGTMAYIAPEYFQQ--PELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEE--  422 (487)
Q Consensus       348 ~~~~kl~DFg~s~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~--~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~--  422 (487)
                      ++.+||+|||+++....... ........||+.|+|||++.+  ..++.++|||||||++|+|+||++||........  
T Consensus       139 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~  218 (338)
T cd07859         139 DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLD  218 (338)
T ss_pred             CCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHH
Confidence            99999999999976432211 111234568999999999875  5789999999999999999999999954321100  


Q ss_pred             -------cccHHHHHHH--------Hh---cCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          423 -------ICSPEWLRKV--------MN---SKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       423 -------~~~~~~~~~~--------~~---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                             ..........        ..   ...+ ..+...+     ......+.+++.+||+.||++|||++++++
T Consensus       219 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-~~~~~~~-----~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         219 LITDLLGTPSPETISRVRNEKARRYLSSMRKKQP-VPFSQKF-----PNADPLALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             HHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCC-CchHHhc-----CCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence                   0000000000        00   0000 0000001     112345789999999999999999999875

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-40  Score=321.40  Aligned_cols=266  Identities=21%  Similarity=0.310  Sum_probs=212.8

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .+...+.+.||+|-||.|.++...  .+..||+|+++...              .......|.+|+++|.+++||||+++
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeve--g~lkVAVK~Lr~~a--------------~~~~r~~F~kEIkiLsqLkhPNIveL  600 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVE--GPLKVAVKILRPDA--------------TKNARNDFLKEIKILSRLKHPNIVEL  600 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEec--CceEEEEeecCccc--------------chhHHHHHHHHHHHHhccCCCCeeEE
Confidence            345788899999999999999875  46899999985422              22345789999999999999999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      +|+|..++++++|+||++.|+|..|+.....  .......-.+|+.||+.|++||   .+.++|||||.++|||++.+++
T Consensus       601 vGVC~~DePicmI~EYmEnGDLnqFl~ahea--pt~~t~~~vsi~tqiasgmaYL---es~nfVHrd~a~rNcLv~~e~~  675 (807)
T KOG1094|consen  601 LGVCVQDDPLCMITEYMENGDLNQFLSAHEL--PTAETAPGVSICTQIASGMAYL---ESLNFVHRDLATRNCLVDGEFT  675 (807)
T ss_pred             EeeeecCCchHHHHHHHhcCcHHHHHHhccC--cccccchhHHHHHHHHHHHHHH---HhhchhhccccccceeecCccc
Confidence            9999999999999999999999999986322  2234456678999999999999   7778999999999999999999


Q ss_pred             EEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh--CCCCccccCCCCccccHHH
Q 011360          351 ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR--GVPSFVFHQNGEEICSPEW  428 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt--g~~pf~~~~~~~~~~~~~~  428 (487)
                      +||+|||+++.+..+.........+-+++|||||.+..+.++.+||+|+||+++||+++  ...||....++...   +.
T Consensus       676 iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vv---en  752 (807)
T KOG1094|consen  676 IKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVV---EN  752 (807)
T ss_pred             EEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHH---Hh
Confidence            99999999998877776666666778999999999999999999999999999999987  47899544432211   22


Q ss_pred             HHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          429 LRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       429 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      ...+.........+.  .|    ..++..+.++|.+||..+..+|||++++...|.+.
T Consensus       753 ~~~~~~~~~~~~~l~--~P----~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  753 AGEFFRDQGRQVVLS--RP----PACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             hhhhcCCCCcceecc--CC----CcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            222332222211111  11    12335688999999999999999999999888753

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2.3e-39  Score=318.17  Aligned_cols=240  Identities=25%  Similarity=0.338  Sum_probs=190.1

Q ss_pred             cccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CCCCccccceEEec
Q 011360          198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RHRNILPLLAHMVR  276 (487)
Q Consensus       198 ~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~  276 (487)
                      +.||+|+||.||+|+. ..+++.||+|++..            ...........+..|..++..+ .||||+++++++..
T Consensus         1 ~~lg~G~~g~V~~~~~-~~~~~~~aiK~~~~------------~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~   67 (320)
T cd05590           1 RVLGKGSFGKVMLARL-KESGRLYAVKVLKK------------DVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQT   67 (320)
T ss_pred             CeeeeCCCeEEEEEEE-cCCCCEEEEEEEEH------------HHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEc
Confidence            3689999999999975 45788999998732            1111223445667788877766 79999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEecc
Q 011360          277 PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDL  356 (487)
Q Consensus       277 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~DF  356 (487)
                      .+.+|+||||+++|+|.+++..    ...+++..+..++.|++.||.||   |++||+||||||+|||++.++.+||+||
T Consensus        68 ~~~~~iv~Ey~~~g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~l---H~~~ivH~dlkp~NIli~~~~~~kL~Df  140 (320)
T cd05590          68 PDRLFFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEITSALMFL---HDKGIIYRDLKLDNVLLDHEGHCKLADF  140 (320)
T ss_pred             CCEEEEEEcCCCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeEeCCCCHHHeEECCCCcEEEeeC
Confidence            9999999999999999998865    45689999999999999999999   6788999999999999999999999999


Q ss_pred             CCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHHHhcC
Q 011360          357 GLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSK  436 (487)
Q Consensus       357 g~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  436 (487)
                      |++........  ......||+.|+|||++.+..++.++|||||||++|+|++|..||....      ..+....+.. .
T Consensus       141 G~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~------~~~~~~~i~~-~  211 (320)
T cd05590         141 GMCKEGIFNGK--TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN------EDDLFEAILN-D  211 (320)
T ss_pred             CCCeecCcCCC--cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC------HHHHHHHHhc-C
Confidence            99875432211  1234568999999999999899999999999999999999999995332      1222333322 1


Q ss_pred             CCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCh
Q 011360          437 NPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNS  476 (487)
Q Consensus       437 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~  476 (487)
                      .+  ..+..        ...++.+++.+||+.||.+||++
T Consensus       212 ~~--~~~~~--------~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         212 EV--VYPTW--------LSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             CC--CCCCC--------CCHHHHHHHHHHcccCHHHCCCC
Confidence            11  11111        23568899999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=4.6e-39  Score=313.90  Aligned_cols=264  Identities=22%  Similarity=0.311  Sum_probs=205.2

Q ss_pred             ccccccccccccccceeEEEEEec------CCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-C
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELP------GSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-R  263 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~  263 (487)
                      .++|.+.+.||.|+||.||+|++.      ..++..||+|.+..              .........+.+|+.++..+ +
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~--------------~~~~~~~~~~~~E~~~l~~l~~   79 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKD--------------DATEKDLSDLVSEMEMMKMIGK   79 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccc--------------ccchHHHHHHHHHHHHHHhhcc
Confidence            456899999999999999999752      12345799997631              11223456788899999999 8


Q ss_pred             CCCccccceEEecCCeeEEEEEecCCCCHHHHHhhhhc------------CCCCCChHHHHHHHHHHHHHHHHHHhcCCC
Q 011360          264 HRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSR------------GRRELDWPSRHRIALGVASGLEYLHMYHSA  331 (487)
Q Consensus       264 hpnIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~  331 (487)
                      ||||+++++++......|++|||+++|+|.+++.....            ....+++..+..++.|++.||.||   |++
T Consensus        80 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~L---H~~  156 (304)
T cd05101          80 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQ  156 (304)
T ss_pred             CCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHH---HHC
Confidence            99999999999999999999999999999999975321            124578888999999999999999   778


Q ss_pred             CeeecCCCCCCEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-C
Q 011360          332 SIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-G  410 (487)
Q Consensus       332 givH~Dlkp~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g  410 (487)
                      |++||||||+||+++.++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|+|++ |
T Consensus       157 givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g  236 (304)
T cd05101         157 KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG  236 (304)
T ss_pred             CeeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCC
Confidence            899999999999999999999999999987644332222223345678999999998889999999999999999998 7


Q ss_pred             CCCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhhC
Q 011360          411 VPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL  487 (487)
Q Consensus       411 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~ll  487 (487)
                      ..||...      ...+..... ...... .    .+    ...+.++.+++.+||+.+|++|||+.++++.|++++
T Consensus       237 ~~p~~~~------~~~~~~~~~-~~~~~~-~----~~----~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~  297 (304)
T cd05101         237 GSPYPGI------PVEELFKLL-KEGHRM-D----KP----ANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL  297 (304)
T ss_pred             CCCcccC------CHHHHHHHH-HcCCcC-C----CC----CCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence            8888332      122222222 222111 0    11    122356889999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-40  Score=314.37  Aligned_cols=250  Identities=22%  Similarity=0.307  Sum_probs=211.7

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ..|.+.+.||+|.|..|-+|++ ..+|..||||++..             .........++.+|+..|+.++|||||++|
T Consensus        18 GLYDLekTlG~GHFAVVKLArH-VFTGekVAVKviDK-------------TKlD~~st~hlfqEVRCMKLVQHpNiVRLY   83 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARH-VFTGEKVAVKVIDK-------------TKLDTLSTGHLFQEVRCMKLVQHPNIVRLY   83 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhh-hcccceeEEEEecc-------------cccchhhhhHHHHHHHHHHHhcCcCeeeee
Confidence            3588889999999999999974 57999999999832             344455667889999999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC-CCCC
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN-DDME  350 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~-~~~~  350 (487)
                      .+......+|+|+|+-++|+|++||-++   ...+.+....+++.||+.|+.|+|+.|   +|||||||+|+.+. .-|.
T Consensus        84 EViDTQTKlyLiLELGD~GDl~DyImKH---e~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGl  157 (864)
T KOG4717|consen   84 EVIDTQTKLYLILELGDGGDLFDYIMKH---EEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGL  157 (864)
T ss_pred             ehhcccceEEEEEEecCCchHHHHHHhh---hccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCc
Confidence            9999999999999999999999999864   456889999999999999999998888   99999999998875 5689


Q ss_pred             EEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCC-chhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHH
Q 011360          351 ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELS-EKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWL  429 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~  429 (487)
                      |||+|||++..+.++...   .+.+|+..|.|||++.+..|+ +++||||||++||.|.+|++||....+      .+-+
T Consensus       158 VKLTDFGFSNkf~PG~kL---~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND------SETL  228 (864)
T KOG4717|consen  158 VKLTDFGFSNKFQPGKKL---TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND------SETL  228 (864)
T ss_pred             eEeeeccccccCCCcchh---hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccc------hhhh
Confidence            999999999887766543   567899999999999999997 678999999999999999999954433      2333


Q ss_pred             HHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          430 RKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       430 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ..++....           ..+...+.++.+||..||..||.+|.|.++|..
T Consensus       229 TmImDCKY-----------tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  229 TMIMDCKY-----------TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             hhhhcccc-----------cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence            33333221           123456788999999999999999999999864

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1e-39  Score=326.86  Aligned_cols=255  Identities=21%  Similarity=0.286  Sum_probs=199.6

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||.|+||.||+++. ..++..||+|.+..            ...........+..|+.+++.++||||++++
T Consensus        43 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~~~aiK~~~~------------~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~  109 (370)
T cd05596          43 EDFDVIKVIGRGAFGEVQLVRH-KSSKQVYAMKLLSK------------FEMIKRSDSAFFWEERDIMAHANSEWIVQLH  109 (370)
T ss_pred             HHcEEEEEEeeCCCEEEEEEEE-CCCCCEEEEEEEEH------------HHhhhhhhHHHHHHHHHHHHhCCCCCcceEE
Confidence            4699999999999999999975 45789999998832            0111223345577899999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++.+++..|+||||++||+|.+++..     ..+++..+..++.|++.||.||   |++||+||||||+|||++.++.+
T Consensus       110 ~~~~~~~~~~lv~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~L---H~~~ivHrDLkp~NILl~~~~~~  181 (370)
T cd05596         110 YAFQDDKYLYMVMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAI---HSMGFIHRDVKPDNMLLDKSGHL  181 (370)
T ss_pred             EEEecCCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHEEEcCCCCE
Confidence            999999999999999999999999864     3578888999999999999999   67889999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCC----CCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQP----ELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPE  427 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~  427 (487)
                      ||+|||++......... ......||+.|+|||++.+.    .++.++|||||||++|||++|..||.....      ..
T Consensus       182 kL~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~  254 (370)
T cd05596         182 KLADFGTCMKMDANGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VG  254 (370)
T ss_pred             EEEeccceeeccCCCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH------HH
Confidence            99999999765432211 11345699999999998653    478999999999999999999999954321      22


Q ss_pred             HHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCC--CCChHHHHH
Q 011360          428 WLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEE--RPNSQYVRC  481 (487)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--RPs~~~il~  481 (487)
                      ....+...... ..    ++.  ....+.++.+++.+||..+|++  |||+.+++.
T Consensus       255 ~~~~i~~~~~~-~~----~~~--~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~  303 (370)
T cd05596         255 TYSKIMDHKNS-LT----FPD--DIEISKQAKDLICAFLTDREVRLGRNGVDEIKS  303 (370)
T ss_pred             HHHHHHcCCCc-CC----CCC--cCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence            23333322111 11    111  1123456889999999999988  999999875

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-39  Score=311.65  Aligned_cols=262  Identities=21%  Similarity=0.316  Sum_probs=203.9

Q ss_pred             ccccccccccccccceeEEEEEecC----CCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCC
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPG----SNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRN  266 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn  266 (487)
                      .++|.+.+.||.|+||.||+|....    .++..||+|.+..              .........+.+|+.++..++|||
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~--------------~~~~~~~~~~~~e~~~l~~~~~~~   70 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNE--------------NASMRERIEFLNEASVMKEFNCHH   70 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCC--------------ccCHHHHHHHHHHHHHHHhCCCCc
Confidence            4569999999999999999997642    3457899998632              111223346778999999999999


Q ss_pred             ccccceEEecCCeeEEEEEecCCCCHHHHHhhhhcC------CCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC
Q 011360          267 ILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG------RRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKP  340 (487)
Q Consensus       267 Iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp  340 (487)
                      |+++++++......++||||+++|+|.+++......      ...+++..+..++.|++.||.||   |+.|++||||||
T Consensus        71 i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~di~p  147 (277)
T cd05032          71 VVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYL---AAKKFVHRDLAA  147 (277)
T ss_pred             eeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHH---HhCCccccccCh
Confidence            999999999999999999999999999999753221      23478889999999999999999   678899999999


Q ss_pred             CCEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCC
Q 011360          341 RNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQN  419 (487)
Q Consensus       341 ~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~  419 (487)
                      +||+++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++||++| |..||...+.
T Consensus       148 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  227 (277)
T cd05032         148 RNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN  227 (277)
T ss_pred             heEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH
Confidence            999999999999999999876544322222233446789999999988889999999999999999998 8999943221


Q ss_pred             CCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhh
Q 011360          420 GEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQ  485 (487)
Q Consensus       420 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~  485 (487)
                            .+... ........     ..+..    .+..+.+++.+||+.+|++|||+.+|++.|+.
T Consensus       228 ------~~~~~-~~~~~~~~-----~~~~~----~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         228 ------EEVLK-FVIDGGHL-----DLPEN----CPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             ------HHHHH-HHhcCCCC-----CCCCC----CCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence                  12222 22222111     11111    13568899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=3.9e-39  Score=311.97  Aligned_cols=264  Identities=20%  Similarity=0.294  Sum_probs=203.0

Q ss_pred             hccccccccccccccceeEEEEEecC----CCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCC
Q 011360          190 KEDCFASLEKIGSGGCGEVYKAELPG----SNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHR  265 (487)
Q Consensus       190 ~~~~~~~~~~lg~G~~g~v~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp  265 (487)
                      ..++|.+.+.||.|+||.||+|....    ..+..||+|.+...              ........+.+|+.+++.++||
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--------------~~~~~~~~~~~e~~~l~~l~~~   69 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES--------------ASLRERIEFLNEASVMKGFTCH   69 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCc--------------CCHHHHHHHHHHHHHHHhCCCC
Confidence            34579999999999999999997532    24568999976321              1112234577899999999999


Q ss_pred             CccccceEEecCCeeEEEEEecCCCCHHHHHhhhhc------CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCC
Q 011360          266 NILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSR------GRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIK  339 (487)
Q Consensus       266 nIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlk  339 (487)
                      ||+++++++...+..|+||||+++|+|.+++.....      .....++..+..++.|++.||.||   |++||+|||||
T Consensus        70 ~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---H~~~i~H~dik  146 (288)
T cd05061          70 HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYL---NAKKFVHRDLA  146 (288)
T ss_pred             CeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHH---HhCCCcCCCCC
Confidence            999999999999999999999999999999975321      123456678889999999999999   77889999999


Q ss_pred             CCCEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccC
Q 011360          340 PRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQ  418 (487)
Q Consensus       340 p~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~  418 (487)
                      |+||+++.++.++|+|||+++...............++..|+|||.+.+..++.++|+|||||++|||++ |..||....
T Consensus       147 p~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~  226 (288)
T cd05061         147 ARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS  226 (288)
T ss_pred             hheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999999876543322111122345678999999998899999999999999999999 688884322


Q ss_pred             CCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          419 NGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       419 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                            ..+..........+.  .+..        .+..+.+++.+||+.+|++|||+.++++.|++.
T Consensus       227 ------~~~~~~~~~~~~~~~--~~~~--------~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         227 ------NEQVLKFVMDGGYLD--QPDN--------CPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             ------HHHHHHHHHcCCCCC--CCCC--------CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence                  122233232222211  1111        125689999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=9.9e-40  Score=321.64  Aligned_cols=245  Identities=20%  Similarity=0.284  Sum_probs=193.7

Q ss_pred             cccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceEEecC
Q 011360          198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRP  277 (487)
Q Consensus       198 ~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  277 (487)
                      +.||+|+||.||++.. ..++..||+|.+...            ..........+..|+.++..++||||+++++++...
T Consensus         1 ~~lG~G~~g~V~~~~~-~~~~~~~a~K~~~~~------------~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~   67 (325)
T cd05594           1 KLLGKGTFGKVILVKE-KATGRYYAMKILKKE------------VIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH   67 (325)
T ss_pred             CeeeeCCCEEEEEEEE-CCCCCEEEEEEEEHH------------HhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcC
Confidence            4689999999999974 468899999988421            111223345667899999999999999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCC-CCeeecCCCCCCEEeCCCCCEEEecc
Q 011360          278 DCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHS-ASIIHGDIKPRNVLLNDDMEACISDL  356 (487)
Q Consensus       278 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~-~givH~Dlkp~Nill~~~~~~kl~DF  356 (487)
                      +.+|+||||+++|+|..++..    ...+++..+..++.|++.||.||   |+ .||+||||||+|||++.++.+||+||
T Consensus        68 ~~~~lv~E~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~l---H~~~~ivHrDikp~NIll~~~~~~kL~Df  140 (325)
T cd05594          68 DRLCFVMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYL---HSEKNVVYRDLKLENLMLDKDGHIKITDF  140 (325)
T ss_pred             CEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HhcCCEEecCCCCCeEEECCCCCEEEecC
Confidence            999999999999999988864    45689999999999999999999   64 78999999999999999999999999


Q ss_pred             CCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHHHhcC
Q 011360          357 GLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSK  436 (487)
Q Consensus       357 g~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  436 (487)
                      |++.........  .....||+.|+|||++.+..++.++|||||||++|+|+||..||.....      ........ ..
T Consensus       141 g~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~------~~~~~~i~-~~  211 (325)
T cd05594         141 GLCKEGIKDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------EKLFELIL-ME  211 (325)
T ss_pred             CCCeecCCCCcc--cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH------HHHHHHHh-cC
Confidence            998753322111  1345699999999999988999999999999999999999999944321      12222221 11


Q ss_pred             CCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCC-----ChHHHHH
Q 011360          437 NPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERP-----NSQYVRC  481 (487)
Q Consensus       437 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~~il~  481 (487)
                      ..      .++..    ...++.+++.+||+.||++||     ++.++++
T Consensus       212 ~~------~~p~~----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  251 (325)
T cd05594         212 EI------RFPRT----LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ  251 (325)
T ss_pred             CC------CCCCC----CCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence            11      11111    224588999999999999997     8888874

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2.3e-39  Score=322.71  Aligned_cols=249  Identities=25%  Similarity=0.372  Sum_probs=191.6

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      +.|...+.||.|+||.||+|++ ..+++.||||++...              ........+.+|+.+++.++||||++++
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~~--------------~~~~~~~~~~~E~~~l~~l~h~~iv~~~  138 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIH-RPTGRLYALKVIYGN--------------HEDTVRRQICREIEILRDVNHPNVVKCH  138 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEE-CCCCCEEEEEEEecC--------------CcHHHHHHHHHHHHHHHhCCCCCcceee
Confidence            3578889999999999999975 457899999987321              1223345678999999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++...+.+++||||+++|+|.+.        ....+..+..++.|++.||.||   |++||+||||||+|||++.++.+
T Consensus       139 ~~~~~~~~~~lv~e~~~~~~L~~~--------~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlkp~NIll~~~~~~  207 (353)
T PLN00034        139 DMFDHNGEIQVLLEFMDGGSLEGT--------HIADEQFLADVARQILSGIAYL---HRRHIVHRDIKPSNLLINSAKNV  207 (353)
T ss_pred             eEeccCCeEEEEEecCCCCccccc--------ccCCHHHHHHHHHHHHHHHHHH---HHCCEeecCCCHHHEEEcCCCCE
Confidence            999999999999999999998643        2345677888999999999999   67889999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCC-----CCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQ-----PELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSP  426 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~  426 (487)
                      ||+|||++.........  .....||..|+|||++..     ...+.++|||||||++|||++|+.||......   ...
T Consensus       208 kL~DfG~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~---~~~  282 (353)
T PLN00034        208 KIADFGVSRILAQTMDP--CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG---DWA  282 (353)
T ss_pred             EEcccccceeccccccc--ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc---cHH
Confidence            99999999765433211  134568999999998753     23456899999999999999999999632211   111


Q ss_pred             HHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          427 EWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       427 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ...........+      ..+    .....++.+++.+||+.||++|||+.++++
T Consensus       283 ~~~~~~~~~~~~------~~~----~~~~~~l~~li~~~l~~~P~~Rpt~~ell~  327 (353)
T PLN00034        283 SLMCAICMSQPP------EAP----ATASREFRHFISCCLQREPAKRWSAMQLLQ  327 (353)
T ss_pred             HHHHHHhccCCC------CCC----CccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            111111111111      011    122356899999999999999999999986

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=6.2e-40  Score=323.85  Aligned_cols=255  Identities=22%  Similarity=0.273  Sum_probs=201.1

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      +|.+.+.||.|+||.||++.. ..+++.||+|++..            ...........+.+|+.++..++||||+++++
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~~~aiK~~~~------------~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~   68 (330)
T cd05601           2 DFDVKSLVGRGHFGEVQVVRE-KATGDIYAMKVMKK------------SVLLAQETVSFFEEERDILSISNSPWIPQLQY   68 (330)
T ss_pred             CceEEEEEEeccCEEEEEEEE-CCCCCEEEEEEEEH------------HHhhhhhHHHHHHHHHHHHHhCCCCCCcceee
Confidence            588999999999999999975 46789999998842            11112334566788999999999999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEE
Q 011360          273 HMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC  352 (487)
Q Consensus       273 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~k  352 (487)
                      ++.+.+..|+||||+++|+|.+++...   ...+++..+..++.|++.||.||   |+.||+||||||+||+++.++.+|
T Consensus        69 ~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~l---H~~~i~H~Dlkp~NIll~~~~~~k  142 (330)
T cd05601          69 AFQDKDNLYLVMEYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSV---HQMGYVHRDIKPENVLIDRTGHIK  142 (330)
T ss_pred             EEecCCeEEEEECCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHH---HHCCeEcccCchHheEECCCCCEE
Confidence            999999999999999999999998752   35689999999999999999999   778899999999999999999999


Q ss_pred             EeccCCccccCCCCceeeEeeecccccccCCcccC------CCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccH
Q 011360          353 ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQ------QPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSP  426 (487)
Q Consensus       353 l~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~------~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~  426 (487)
                      |+|||++......... ......||+.|+|||++.      ...++.++|||||||++|+|++|..||.....      .
T Consensus       143 L~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~------~  215 (330)
T cd05601         143 LADFGSAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS------A  215 (330)
T ss_pred             eccCCCCeECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH------H
Confidence            9999999876543322 223346899999999986      45678999999999999999999999943321      2


Q ss_pred             HHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          427 EWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       427 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .....+........     .+.  ....+..+.+++..||. +|.+|||+.++++
T Consensus       216 ~~~~~i~~~~~~~~-----~~~--~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         216 KTYNNIMNFQRFLK-----FPE--DPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             HHHHHHHcCCCccC-----CCC--CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            22333332221111     111  01123568889999998 9999999999874

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=2.4e-39  Score=319.24  Aligned_cols=247  Identities=22%  Similarity=0.311  Sum_probs=191.5

Q ss_pred             cccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CCCCccccceEEec
Q 011360          198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RHRNILPLLAHMVR  276 (487)
Q Consensus       198 ~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~  276 (487)
                      +.||+|+||.||++.. ..+++.||+|++...            ..........+..|..++.++ +||||+++++++..
T Consensus         1 ~~lG~G~~g~V~~~~~-~~~~~~~aiK~~~~~------------~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~   67 (329)
T cd05618           1 RVIGRGSYAKVLLVRL-KKTERIYAMKVVKKE------------LVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT   67 (329)
T ss_pred             CeeeeCCCeEEEEEEE-CCCCCEEEEEEEEhh------------HhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe
Confidence            4699999999999975 457889999988421            111223445677888887766 89999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEecc
Q 011360          277 PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDL  356 (487)
Q Consensus       277 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~DF  356 (487)
                      .+..|+||||+++|+|..++..    ...+++..+..++.|++.||.||   |++||+||||||+||+++.++.+||+||
T Consensus        68 ~~~~~lv~E~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~l---H~~~ivH~Dikp~Nili~~~~~~kL~Df  140 (329)
T cd05618          68 ESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYL---HERGIIYRDLKLDNVLLDSEGHIKLTDY  140 (329)
T ss_pred             CCEEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeCCCCHHHEEECCCCCEEEeeC
Confidence            9999999999999999988864    45689999999999999999999   6778999999999999999999999999


Q ss_pred             CCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCC--ccccHHHHHHHHh
Q 011360          357 GLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGE--EICSPEWLRKVMN  434 (487)
Q Consensus       357 g~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~--~~~~~~~~~~~~~  434 (487)
                      |++........  ......||+.|+|||++.+..++.++|||||||++|+|++|..||.......  ......+......
T Consensus       141 G~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~  218 (329)
T cd05618         141 GMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL  218 (329)
T ss_pred             CccccccCCCC--ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHh
Confidence            99875322211  1134568999999999999999999999999999999999999995322111  1122233333322


Q ss_pred             cCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCh
Q 011360          435 SKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNS  476 (487)
Q Consensus       435 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~  476 (487)
                      ....      .+|..    .+..+.+++.+||+.||++|||+
T Consensus       219 ~~~~------~~p~~----~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         219 EKQI------RIPRS----LSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             cCCC------CCCCC----CCHHHHHHHHHHhcCCHHHcCCC
Confidence            2221      12211    22458899999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=3.9e-39  Score=317.58  Aligned_cols=248  Identities=24%  Similarity=0.316  Sum_probs=195.4

Q ss_pred             cccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CCCCccccceEEec
Q 011360          198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RHRNILPLLAHMVR  276 (487)
Q Consensus       198 ~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~  276 (487)
                      +.||+|+||.||++.. ..+++.||+|++..            ...........+..|..++.++ +||||+++++++..
T Consensus         1 ~~lG~G~~g~V~~~~~-~~~~~~~aiK~~~~------------~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~   67 (327)
T cd05617           1 RVIGRGSYAKVLLVRL-KKNDQIYAMKVVKK------------ELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT   67 (327)
T ss_pred             CeeeeCCCeEEEEEEE-CCCCCEEEEEEEEH------------HHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe
Confidence            3699999999999975 45788999998842            1112233456678888888888 79999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEecc
Q 011360          277 PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDL  356 (487)
Q Consensus       277 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~DF  356 (487)
                      .+.+|+||||+++|+|..++..    ...+++..+..++.|++.||.||   |++||+||||||+|||++.++.+||+||
T Consensus        68 ~~~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~l---H~~~ivHrDlkp~Nili~~~~~~kl~Df  140 (327)
T cd05617          68 TSRLFLVIEYVNGGDLMFHMQR----QRKLPEEHARFYAAEICIALNFL---HERGIIYRDLKLDNVLLDADGHIKLTDY  140 (327)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHEEEeCCCCEEEecc
Confidence            9999999999999999988864    45689999999999999999999   7788999999999999999999999999


Q ss_pred             CCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHHHhcC
Q 011360          357 GLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSK  436 (487)
Q Consensus       357 g~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  436 (487)
                      |++........  ......||+.|+|||++.+..++.++|||||||++|+|++|..||............+.........
T Consensus       141 g~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  218 (327)
T cd05617         141 GMCKEGLGPGD--TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK  218 (327)
T ss_pred             ccceeccCCCC--ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC
Confidence            99875322211  1234679999999999999999999999999999999999999996544333333333443333322


Q ss_pred             CCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChH
Q 011360          437 NPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQ  477 (487)
Q Consensus       437 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~  477 (487)
                      ..      .+|..    .+..+.+++.+||..||++||+++
T Consensus       219 ~~------~~p~~----~~~~~~~li~~~L~~dP~~R~~~~  249 (327)
T cd05617         219 PI------RIPRF----LSVKASHVLKGFLNKDPKERLGCQ  249 (327)
T ss_pred             CC------CCCCC----CCHHHHHHHHHHhccCHHHcCCCC
Confidence            11      11211    224578999999999999999853

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.1e-38  Score=304.96  Aligned_cols=264  Identities=26%  Similarity=0.381  Sum_probs=210.1

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||.|+||.||+|... .+|..||+|.+....            .........+.+|+.++++++|+||++++
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~------------~~~~~~~~~~~~ei~~l~~~~~~~i~~~~   68 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICL-LDGRVVALKKVQIFE------------MMDAKARQDCLKEIDLLKQLDHPNVIKYL   68 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEc-CCCCEEEEEEeeccc------------ccchhhHHHHHHHHHHHHhCCCCCeeeee
Confidence            46899999999999999999754 578999999874311            11122356788899999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++...+..++||||+++++|.+++.........+++..+..++.+++.||.||   |+.|++||||+|+||+++.++.+
T Consensus        69 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---h~~~i~h~dl~p~nil~~~~~~~  145 (267)
T cd08224          69 ASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHM---HSKRIMHRDIKPANVFITATGVV  145 (267)
T ss_pred             eeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHH---HhCCEecCCcChhhEEECCCCcE
Confidence            999999999999999999999999876545556789999999999999999999   78899999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRK  431 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~  431 (487)
                      +|+|||++.........  .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||.....    ........
T Consensus       146 ~l~d~~~~~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~  219 (267)
T cd08224         146 KLGDLGLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKK  219 (267)
T ss_pred             EEeccceeeeccCCCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc----cHHHHHhh
Confidence            99999998765433221  1234588899999999988899999999999999999999999843321    11112221


Q ss_pred             HHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          432 VMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       432 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      .. ....     +..+   .......+.+++.+||..+|++|||+.+|++.|+++
T Consensus       220 ~~-~~~~-----~~~~---~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~  265 (267)
T cd08224         220 IE-KCDY-----PPLP---ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM  265 (267)
T ss_pred             hh-cCCC-----CCCC---hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence            11 1111     1111   113345688999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.6e-39  Score=321.12  Aligned_cols=257  Identities=20%  Similarity=0.310  Sum_probs=198.1

Q ss_pred             ccccccccccccceeEEEEEec--CCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CCCCccc
Q 011360          193 CFASLEKIGSGGCGEVYKAELP--GSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RHRNILP  269 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~  269 (487)
                      +|.+.+.||+|+||.||+++..  ..++..||+|++...           ...........+..|+.++..+ .||||++
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-----------~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~   69 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKA-----------ALVQKAKTVEHTRTERNVLEHVRQSPFLVT   69 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHH-----------HHhhhhhHHHHHHHHHHHHHhccCCCCccc
Confidence            3788999999999999999753  246889999987321           0011223345677899999999 5999999


Q ss_pred             cceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC
Q 011360          270 LLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDM  349 (487)
Q Consensus       270 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~  349 (487)
                      +++++...+.+++||||+++|+|.+++..    ...+++..+..++.|++.||.||   |++||+||||||+|||++.++
T Consensus        70 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivHrDlkp~Nili~~~~  142 (332)
T cd05614          70 LHYAFQTEAKLHLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHL---HKLGIVYRDIKLENILLDSEG  142 (332)
T ss_pred             EEEEEecCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCcEecCCCHHHeEECCCC
Confidence            99999999999999999999999999864    45689999999999999999999   778899999999999999999


Q ss_pred             CEEEeccCCccccCCCCceeeEeeecccccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHH
Q 011360          350 EACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQP-ELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEW  428 (487)
Q Consensus       350 ~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~  428 (487)
                      .+||+|||+++......... .....||+.|+|||++.+. .++.++|||||||++|+|+||..||........  ....
T Consensus       143 ~~kl~DfG~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--~~~~  219 (332)
T cd05614         143 HVVLTDFGLSKEFLSEEKER-TYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT--QSEV  219 (332)
T ss_pred             CEEEeeCcCCccccccCCCc-cccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC--HHHH
Confidence            99999999997653322211 1345699999999998865 478899999999999999999999954332111  1122


Q ss_pred             HHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCC-----ChHHHHH
Q 011360          429 LRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERP-----NSQYVRC  481 (487)
Q Consensus       429 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~~il~  481 (487)
                      ...... ..+      .++.    .....+.+++.+||+.||++||     +++++++
T Consensus       220 ~~~~~~-~~~------~~~~----~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         220 SRRILK-CDP------PFPS----FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             HHHHhc-CCC------CCCC----CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence            222221 111      1211    1234588999999999999999     6667764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=3.9e-39  Score=312.29  Aligned_cols=261  Identities=24%  Similarity=0.358  Sum_probs=202.2

Q ss_pred             cccccccccccceeEEEEEecC----CCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccc
Q 011360          194 FASLEKIGSGGCGEVYKAELPG----SNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILP  269 (487)
Q Consensus       194 ~~~~~~lg~G~~g~v~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~  269 (487)
                      |.+.+.||.|+||.||+|....    .....+++|.+..              .........+.+|+.+++.++||||++
T Consensus         2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~--------------~~~~~~~~~~~~E~~~l~~l~h~~iv~   67 (290)
T cd05045           2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKE--------------NASSSELRDLLSEFNLLKQVNHPHVIK   67 (290)
T ss_pred             ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCC--------------CCCHHHHHHHHHHHHHHhhCCCCCEee
Confidence            6788999999999999997532    1235688887632              111233467889999999999999999


Q ss_pred             cceEEecCCeeEEEEEecCCCCHHHHHhhhhc--------------------CCCCCChHHHHHHHHHHHHHHHHHHhcC
Q 011360          270 LLAHMVRPDCHLLVYEFMKNGSLQDILDDVSR--------------------GRRELDWPSRHRIALGVASGLEYLHMYH  329 (487)
Q Consensus       270 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~qi~~~L~~Lh~~h  329 (487)
                      +++.+...+..+++|||+.+++|.+++.....                    ....+++..++.++.|++.||.||   |
T Consensus        68 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~L---H  144 (290)
T cd05045          68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYL---A  144 (290)
T ss_pred             EEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHH---H
Confidence            99999999999999999999999999864221                    124578899999999999999999   6


Q ss_pred             CCCeeecCCCCCCEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh
Q 011360          330 SASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR  409 (487)
Q Consensus       330 ~~givH~Dlkp~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt  409 (487)
                      ++|++||||||+||++++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|+|+|
T Consensus       145 ~~~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t  224 (290)
T cd05045         145 EMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT  224 (290)
T ss_pred             HCCeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHh
Confidence            78899999999999999999999999999976543322211122345778999999988889999999999999999998


Q ss_pred             -CCCCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhhC
Q 011360          410 -GVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL  487 (487)
Q Consensus       410 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~ll  487 (487)
                       |..||....       ++.+.........     ...+.    ..+.++.+++.+||+.+|++|||+.++++.|++++
T Consensus       225 ~g~~p~~~~~-------~~~~~~~~~~~~~-----~~~~~----~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~  287 (290)
T cd05045         225 LGGNPYPGIA-------PERLFNLLKTGYR-----MERPE----NCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM  287 (290)
T ss_pred             cCCCCCCCCC-------HHHHHHHHhCCCC-----CCCCC----CCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence             999994332       1222222222111     11111    12356889999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=2.9e-39  Score=317.79  Aligned_cols=245  Identities=22%  Similarity=0.328  Sum_probs=193.0

Q ss_pred             cccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CCCCccccceEEec
Q 011360          198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RHRNILPLLAHMVR  276 (487)
Q Consensus       198 ~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~  276 (487)
                      +.||.|+||.||+|+. ..++..||+|++..            ...........+..|..++..+ +||||+++++++..
T Consensus         1 ~~lG~G~~g~Vy~~~~-~~~~~~~aiK~~~~------------~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~   67 (321)
T cd05591           1 KVLGKGSFGKVMLAEL-KGTDEVYAIKVLKK------------DVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQT   67 (321)
T ss_pred             CccccCCCeEEEEEEE-CCCCCEEEEEEEeH------------HHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc
Confidence            3689999999999975 45788999998732            1111233445667788888765 89999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEecc
Q 011360          277 PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDL  356 (487)
Q Consensus       277 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~DF  356 (487)
                      .+..|+||||+++|+|.+++..    ...+++..+..++.|++.||.||   |++||+||||||+||+++.++.+||+||
T Consensus        68 ~~~~~lv~E~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDikp~Nill~~~~~~kL~Df  140 (321)
T cd05591          68 KDRLFFVMEYVNGGDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFL---HRHGVIYRDLKLDNILLDAEGHCKLADF  140 (321)
T ss_pred             CCeEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHeEECCCCCEEEeec
Confidence            9999999999999999988864    45688999999999999999999   7788999999999999999999999999


Q ss_pred             CCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHHHhcC
Q 011360          357 GLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSK  436 (487)
Q Consensus       357 g~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  436 (487)
                      |++........  ......||+.|+|||++.+..++.++|||||||++|+|++|..||....      ..+.........
T Consensus       141 g~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~------~~~~~~~i~~~~  212 (321)
T cd05591         141 GMCKEGILNGV--TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN------EDDLFESILHDD  212 (321)
T ss_pred             ccceecccCCc--cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC------HHHHHHHHHcCC
Confidence            99875432221  1234568999999999999899999999999999999999999994332      122233332221


Q ss_pred             CCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCC-------ChHHHHH
Q 011360          437 NPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERP-------NSQYVRC  481 (487)
Q Consensus       437 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-------s~~~il~  481 (487)
                       .  ..+..        .+.++.+++.+||+.+|++||       +++++++
T Consensus       213 -~--~~p~~--------~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         213 -V--LYPVW--------LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             -C--CCCCC--------CCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence             1  11111        224688999999999999999       7777764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=6.2e-40  Score=322.14  Aligned_cols=242  Identities=21%  Similarity=0.304  Sum_probs=192.5

Q ss_pred             cccccccceeEEEEEec--CCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceEEe
Q 011360          198 EKIGSGGCGEVYKAELP--GSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMV  275 (487)
Q Consensus       198 ~~lg~G~~g~v~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  275 (487)
                      +.||+|+||.||+++..  ..+|..||+|++..             ..........+..|+.++.+++||||+++++++.
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~-------------~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~   68 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKK-------------ATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQ   68 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEH-------------HHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEE
Confidence            57999999999998642  34789999998842             1111223345678999999999999999999999


Q ss_pred             cCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEec
Q 011360          276 RPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISD  355 (487)
Q Consensus       276 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~D  355 (487)
                      .++..|+||||+++|+|.+++..    ...+++..+..++.|++.||.||   |++||+||||||+||+++.++.+||+|
T Consensus        69 ~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~kL~D  141 (318)
T cd05582          69 TEGKLYLILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHL---HSLGIIYRDLKPENILLDEEGHIKLTD  141 (318)
T ss_pred             cCCEEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCEecCCCCHHHeEECCCCcEEEee
Confidence            99999999999999999999864    45689999999999999999999   778899999999999999999999999


Q ss_pred             cCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHHHhc
Q 011360          356 LGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNS  435 (487)
Q Consensus       356 Fg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  435 (487)
                      ||++.........  .....||+.|+|||.+.+..++.++|||||||++|+|++|..||....      ..+........
T Consensus       142 fg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~------~~~~~~~i~~~  213 (318)
T cd05582         142 FGLSKESIDHEKK--AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD------RKETMTMILKA  213 (318)
T ss_pred             ccCCcccCCCCCc--eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC------HHHHHHHHHcC
Confidence            9998765433221  234568999999999998889999999999999999999999994332      12222222221


Q ss_pred             CCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHH
Q 011360          436 KNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQY  478 (487)
Q Consensus       436 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~  478 (487)
                      . .  .+++.        .+..+.+++.+||+.||++|||+.+
T Consensus       214 ~-~--~~p~~--------~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         214 K-L--GMPQF--------LSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             C-C--CCCCC--------CCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            1 1  11111        2245889999999999999999655

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=5.7e-39  Score=316.10  Aligned_cols=245  Identities=24%  Similarity=0.302  Sum_probs=193.2

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCC-Cccccc
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHR-NILPLL  271 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp-nIv~l~  271 (487)
                      +|.+.+.||.|+||.||+|+. ..+++.||+|++...            ..........+..|..++..+.|+ +|++++
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~~~avK~~~~~------------~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~   67 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAER-KGTDELYAIKILKKD------------VIIQDDDVECTMVEKRVLALPGKPPFLTQLH   67 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEE-CCCCCEEEEEEEEHH------------HhhhhhHHHHHHHHHHHHHhcCCCCceeeeE
Confidence            378899999999999999975 457889999988421            111233456677888899888664 688899


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++...+.+|+||||+++|+|.+++..    ...+++..+..++.|++.||.||   |++||+||||||+|||++.++.+
T Consensus        68 ~~~~~~~~~~lv~E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~l---H~~~ivH~dlkp~Nill~~~~~~  140 (324)
T cd05587          68 SCFQTMDRLYFVMEYVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFL---HSKGIIYRDLKLDNVMLDAEGHI  140 (324)
T ss_pred             EEEEcCCEEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHeEEcCCCCE
Confidence            999999999999999999999998864    45688999999999999999999   67889999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRK  431 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~  431 (487)
                      ||+|||++........  ......||+.|+|||++.+..++.++|||||||++|+|+||..||....      ..+....
T Consensus       141 kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~------~~~~~~~  212 (324)
T cd05587         141 KIADFGMCKENIFGGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED------EDELFQS  212 (324)
T ss_pred             EEeecCcceecCCCCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC------HHHHHHH
Confidence            9999999865322211  1234569999999999999899999999999999999999999995332      1222222


Q ss_pred             HHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCh
Q 011360          432 VMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNS  476 (487)
Q Consensus       432 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~  476 (487)
                      ... ..+      .++..    .+..+.+++.+||..||.+||+.
T Consensus       213 i~~-~~~------~~~~~----~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         213 IME-HNV------SYPKS----LSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             HHc-CCC------CCCCC----CCHHHHHHHHHHhhcCHHHcCCC
Confidence            222 111      11111    23468899999999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-40  Score=320.48  Aligned_cols=259  Identities=22%  Similarity=0.335  Sum_probs=210.1

Q ss_pred             ccccccccccccccceeEEEEEecCC-C--CceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGS-N--GKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNI  267 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~-~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI  267 (487)
                      .+.....++||.|-||.||.|.+... .  .-.||||.++.              .......+.|+.|+.+|+++.||||
T Consensus       388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~--------------d~t~d~tekflqEa~iMrnfdHphI  453 (974)
T KOG4257|consen  388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKT--------------DCTPDDTEKFLQEASIMRNFDHPHI  453 (974)
T ss_pred             hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhcc--------------CCChhhHHHHHHHHHHHHhCCCcch
Confidence            34456778899999999999987433 2  34588898732              2344557889999999999999999


Q ss_pred             cccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC
Q 011360          268 LPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLND  347 (487)
Q Consensus       268 v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~  347 (487)
                      |+++|++.+ .+.+||||.++.|.|..||+.   +...++......++.||+.+|+||   |+..+|||||..+|||+..
T Consensus       454 ikLIGv~~e-~P~WivmEL~~~GELr~yLq~---nk~sL~l~tL~ly~~Qi~talaYL---eSkrfVHRDIAaRNiLVsS  526 (974)
T KOG4257|consen  454 IKLIGVCVE-QPMWIVMELAPLGELREYLQQ---NKDSLPLRTLTLYCYQICTALAYL---ESKRFVHRDIAARNILVSS  526 (974)
T ss_pred             hheeeeeec-cceeEEEecccchhHHHHHHh---ccccchHHHHHHHHHHHHHHHHHH---HhhchhhhhhhhhheeecC
Confidence            999999875 578999999999999999984   456789999999999999999999   7888999999999999999


Q ss_pred             CCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccccH
Q 011360          348 DMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSP  426 (487)
Q Consensus       348 ~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~  426 (487)
                      ...+||+|||+++.+.+...... +...-++.|||||.+....++.+||||.||+++||++. |..||.+-.+...+.. 
T Consensus       527 p~CVKLaDFGLSR~~ed~~yYka-S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~-  604 (974)
T KOG4257|consen  527 PQCVKLADFGLSRYLEDDAYYKA-SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGH-  604 (974)
T ss_pred             cceeeecccchhhhccccchhhc-cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEE-
Confidence            99999999999999877654432 23445789999999999999999999999999999997 8999976655433211 


Q ss_pred             HHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhhC
Q 011360          427 EWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL  487 (487)
Q Consensus       427 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~ll  487 (487)
                           +-++.++  .    +|..|.    ..+..++.+||+.+|.+||++.+|.+.|.+++
T Consensus       605 -----iEnGeRl--P----~P~nCP----p~LYslmskcWayeP~kRPrftei~~~lsdv~  650 (974)
T KOG4257|consen  605 -----IENGERL--P----CPPNCP----PALYSLMSKCWAYEPSKRPRFTEIKAILSDVL  650 (974)
T ss_pred             -----ecCCCCC--C----CCCCCC----hHHHHHHHHHhccCcccCCcHHHHHHHHHHHH
Confidence                 1112211  1    233322    34889999999999999999999999988763

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-39  Score=317.05  Aligned_cols=254  Identities=24%  Similarity=0.356  Sum_probs=211.4

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCC-CCCccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIR-HRNILP  269 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~  269 (487)
                      .+.|.+.+.||.|.||.||+++. ..+|+.+|+|.+....            .........+.+|+.+|+++. |||||.
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~-~~tg~~~A~K~i~k~~------------~~~~~~~~~v~~Ev~il~~l~~hpniv~  100 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCRE-KSTGKEVACKVIPKRK------------LRGKEDREDVRREVAILQQLSGHPNIVQ  100 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEe-cCCCceeEEEEeehhh------------ccccccHHHHHHHHHHHHhccCCCCEEE
Confidence            34699999999999999999975 4679999999984311            111124567899999999997 999999


Q ss_pred             cceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC-
Q 011360          270 LLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDD-  348 (487)
Q Consensus       270 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~-  348 (487)
                      +++++.+.+.+++|||+|.||.|.+.+...     .+++..+..++.|++.++.||   |+.||+||||||+|+|+... 
T Consensus       101 l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~l---H~~gvvHrDlKpEN~L~~~~~  172 (382)
T KOG0032|consen  101 LKDAFEDPDSVYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYL---HSLGVVHRDLKPENLLLASKD  172 (382)
T ss_pred             EEEEEEcCCeEEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHH---HhCCceeccCCHHHeeecccc
Confidence            999999999999999999999999999763     399999999999999999999   77899999999999999643 


Q ss_pred             ---CCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCcccc
Q 011360          349 ---MEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICS  425 (487)
Q Consensus       349 ---~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~  425 (487)
                         +.+|++|||++.....+   ......+||+.|+|||++....|+..+||||+|+++|.|++|.+||.+.+..     
T Consensus       173 ~~~~~ik~~DFGla~~~~~~---~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~-----  244 (382)
T KOG0032|consen  173 EGSGRIKLIDFGLAKFIKPG---ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEF-----  244 (382)
T ss_pred             CCCCcEEEeeCCCceEccCC---ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChh-----
Confidence               57999999999987662   2336788999999999999999999999999999999999999999554432     


Q ss_pred             HHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          426 PEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       426 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                       +....+.....       .++.......+..+.+++..|+..||..|+|+.++++
T Consensus       245 -~~~~~i~~~~~-------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  245 -EIFLAILRGDF-------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             -HHHHHHHcCCC-------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence             22223332222       2444555666778999999999999999999999886

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.3e-38  Score=306.74  Aligned_cols=257  Identities=20%  Similarity=0.306  Sum_probs=198.0

Q ss_pred             cccccccccccccceeEEEEEecCCCCc----eEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGK----MIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNI  267 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI  267 (487)
                      ++|.+.+.||.|+||.||+|.+. .++.    .+++|.+..              .........+..|+..+..+.||||
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~~~~~~~~k~~~~--------------~~~~~~~~~~~~~~~~l~~l~h~~i   71 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWI-PEGDSIKIPVAIKTIQD--------------RSGRQTFQEITDHMLAMGSLDHAYI   71 (279)
T ss_pred             hhceeccccCccCCcceEEEEEc-CCCCceeeEEEEeeccc--------------ccchHHHHHHHHHHHHHhcCCCCCc
Confidence            45889999999999999999863 3343    467776521              1112234567778888999999999


Q ss_pred             cccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC
Q 011360          268 LPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLND  347 (487)
Q Consensus       268 v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~  347 (487)
                      +++++++. ....++++||+++|+|.+++..   ....+++..+..++.|++.||.||   |++|++||||||+||+++.
T Consensus        72 v~~~~~~~-~~~~~~i~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~l---H~~~iiH~dlkp~nili~~  144 (279)
T cd05111          72 VRLLGICP-GASLQLVTQLSPLGSLLDHVRQ---HRDSLDPQRLLNWCVQIAKGMYYL---EEHRMVHRNLAARNILLKS  144 (279)
T ss_pred             ceEEEEEC-CCccEEEEEeCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHH---HHCCEeccccCcceEEEcC
Confidence            99999875 4557899999999999999864   245689999999999999999999   6788999999999999999


Q ss_pred             CCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccccH
Q 011360          348 DMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSP  426 (487)
Q Consensus       348 ~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~  426 (487)
                      ++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++||+++ |..||.....       
T Consensus       145 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-------  217 (279)
T cd05111         145 DSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP-------  217 (279)
T ss_pred             CCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH-------
Confidence            99999999999987644332222234457789999999998899999999999999999998 9999943321       


Q ss_pred             HHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          427 EWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       427 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      .........+....  .+   ..    ...++..++.+||..+|++|||+.++++.|..+
T Consensus       218 ~~~~~~~~~~~~~~--~~---~~----~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~  268 (279)
T cd05111         218 HEVPDLLEKGERLA--QP---QI----CTIDVYMVMVKCWMIDENVRPTFKELANEFTRM  268 (279)
T ss_pred             HHHHHHHHCCCcCC--CC---CC----CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            11222222221111  11   11    124578899999999999999999999988764

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=9.6e-39  Score=303.91  Aligned_cols=251  Identities=22%  Similarity=0.310  Sum_probs=196.2

Q ss_pred             ccccccceeEEEEEec-CCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceEEecC
Q 011360          199 KIGSGGCGEVYKAELP-GSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRP  277 (487)
Q Consensus       199 ~lg~G~~g~v~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  277 (487)
                      .||+|+||.||+|.+. ..++..+|+|++...             .........+..|+.+++.+.||||+++++++. .
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~-------------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~   67 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKND-------------NNDPALKDELLREANVMQQLDNPYIVRMIGICE-A   67 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCC-------------CCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-C
Confidence            6899999999999753 346788999987321             112234567888999999999999999999875 4


Q ss_pred             CeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEeccC
Q 011360          278 DCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLG  357 (487)
Q Consensus       278 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~DFg  357 (487)
                      +..++||||+++|+|.+++..    ...+++..+..++.|++.||.||   |++|++||||||.||+++.++.+||+|||
T Consensus        68 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~l---H~~~i~H~dlkp~nill~~~~~~kl~Dfg  140 (257)
T cd05116          68 ESWMLVMELAELGPLNKFLQK----NKHVTEKNITELVHQVSMGMKYL---EETNFVHRDLAARNVLLVTQHYAKISDFG  140 (257)
T ss_pred             CCcEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCEeecccchhhEEEcCCCeEEECCCc
Confidence            567899999999999999864    35688999999999999999999   77889999999999999999999999999


Q ss_pred             CccccCCCCceeeE-eeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccccHHHHHHHHhc
Q 011360          358 LAMAIPDGYTRVLI-SYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSPEWLRKVMNS  435 (487)
Q Consensus       358 ~s~~~~~~~~~~~~-~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  435 (487)
                      ++............ ....++..|+|||.+....++.++|+||||+++|||++ |..||.....      .+....+...
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~------~~~~~~i~~~  214 (257)
T cd05116         141 LSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG------NEVTQMIESG  214 (257)
T ss_pred             cccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHCC
Confidence            99876543322111 12234578999999988889999999999999999998 9999943221      2222322222


Q ss_pred             CCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          436 KNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       436 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      ..+      ..+..    .+.++.+++.+||+.||++|||+.+|...|+++
T Consensus       215 ~~~------~~~~~----~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         215 ERM------ECPQR----CPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             CCC------CCCCC----CCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence            111      12221    224688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-39  Score=312.32  Aligned_cols=254  Identities=27%  Similarity=0.353  Sum_probs=199.1

Q ss_pred             cccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceE
Q 011360          194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAH  273 (487)
Q Consensus       194 ~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  273 (487)
                      |++.+.||+|+||.||++.. ..++..||+|++..            ...........+.+|+.+++.++||||++++++
T Consensus         2 y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~------------~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   68 (285)
T cd05605           2 FRHYRVLGKGGFGEVCACQV-RATGKMYACKKLEK------------KRIKKRKGEAMALNEKQILEKVNSRFVVSLAYA   68 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEE-cCCCceEEEEEEeh------------hhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeee
Confidence            78889999999999999974 45789999998732            011112234556789999999999999999999


Q ss_pred             EecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEE
Q 011360          274 MVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACI  353 (487)
Q Consensus       274 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl  353 (487)
                      +..++..++||||+++|+|.+++..  .....+++..+..++.|++.||.||   |+.|++||||||+||++++++.++|
T Consensus        69 ~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~Nil~~~~~~~~l  143 (285)
T cd05605          69 YETKDALCLVLTLMNGGDLKFHIYN--MGNPGFDEERAVFYAAEITCGLEDL---HRERIVYRDLKPENILLDDYGHIRI  143 (285)
T ss_pred             ecCCCeEEEEEeccCCCcHHHHHHh--cCcCCCCHHHHHHHHHHHHHHHHHH---HHCCcEecCCCHHHEEECCCCCEEE
Confidence            9999999999999999999988864  2345689999999999999999999   6778999999999999999999999


Q ss_pred             eccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHHH
Q 011360          354 SDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVM  433 (487)
Q Consensus       354 ~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~  433 (487)
                      +|||++.........   ....|++.|+|||++.+..++.++||||||+++|+|++|..||.......   ..+......
T Consensus       144 ~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~---~~~~~~~~~  217 (285)
T cd05605         144 SDLGLAVEIPEGETI---RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV---KREEVERRV  217 (285)
T ss_pred             eeCCCceecCCCCcc---ccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh---HHHHHHHHh
Confidence            999998765433221   23468999999999998889999999999999999999999995432211   111111111


Q ss_pred             hcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCC-----ChHHHHH
Q 011360          434 NSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERP-----NSQYVRC  481 (487)
Q Consensus       434 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~~il~  481 (487)
                      ....  ..    .    ....+..+.+++.+||+.||++||     ++.+++.
T Consensus       218 ~~~~--~~----~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         218 KEDQ--EE----Y----SEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             hhcc--cc----c----CcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence            1111  11    1    112345688999999999999999     7878754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.7e-39  Score=327.14  Aligned_cols=255  Identities=22%  Similarity=0.342  Sum_probs=194.5

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      .|.+++.||+|+||.||+|.. ..+++.||+|++..            ...........+.+|+.++++++||||+++++
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~-~~~~~~~aiK~i~~------------~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~   68 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARK-VDTKALYAMKTLRK------------KDVLLRNQVAHVKAERDILAEADNEWVVRLYY   68 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEE-CCCCCEEEEEEEeH------------HHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEE
Confidence            488999999999999999974 46789999998732            11122344567889999999999999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEE
Q 011360          273 HMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC  352 (487)
Q Consensus       273 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~k  352 (487)
                      .+.+.+.+|+|||||++|+|.+++..    ...+++..+..++.|++.||.||   |++||+||||||+|||++.++.+|
T Consensus        69 ~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~l---H~~~ivHrDlKp~NILl~~~g~~k  141 (382)
T cd05625          69 SFQDKDNLYFVMDYIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESV---HKMGFIHRDIKPDNILIDRDGHIK  141 (382)
T ss_pred             EEEeCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEECCCCCEE
Confidence            99999999999999999999999864    35688899999999999999999   778899999999999999999999


Q ss_pred             EeccCCccccCCCC---------------------------------------------ceeeEeeecccccccCCcccC
Q 011360          353 ISDLGLAMAIPDGY---------------------------------------------TRVLISYVLGTMAYIAPEYFQ  387 (487)
Q Consensus       353 l~DFg~s~~~~~~~---------------------------------------------~~~~~~~~~gt~~y~aPE~l~  387 (487)
                      |+|||++.......                                             .........||+.|+|||++.
T Consensus       142 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~  221 (382)
T cd05625         142 LTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLL  221 (382)
T ss_pred             EeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhc
Confidence            99999975321000                                             000012346899999999999


Q ss_pred             CCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccC
Q 011360          388 QPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTL  467 (487)
Q Consensus       388 ~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  467 (487)
                      +..++.++|||||||++|||++|.+||.....      .+........... ..    .+.  ....+.++.+++.+|+ 
T Consensus       222 ~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~------~~~~~~i~~~~~~-~~----~p~--~~~~s~~~~~li~~l~-  287 (382)
T cd05625         222 RTGYTQLCDWWSVGVILYEMLVGQPPFLAQTP------LETQMKVINWQTS-LH----IPP--QAKLSPEASDLIIKLC-  287 (382)
T ss_pred             CCCCCCeeeEEechHHHHHHHhCCCCCCCCCH------HHHHHHHHccCCC-cC----CCC--cccCCHHHHHHHHHHc-
Confidence            98999999999999999999999999954322      1222222221111 11    111  1112345667776665 


Q ss_pred             CCCCCCCC---hHHHHH
Q 011360          468 HDPEERPN---SQYVRC  481 (487)
Q Consensus       468 ~~P~~RPs---~~~il~  481 (487)
                      .+|.+|++   +.+++.
T Consensus       288 ~~p~~R~~~~~~~ei~~  304 (382)
T cd05625         288 RGPEDRLGKNGADEIKA  304 (382)
T ss_pred             cCHhHcCCCCCHHHHhc
Confidence            59999997   777653

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=3.4e-39  Score=316.41  Aligned_cols=244  Identities=25%  Similarity=0.342  Sum_probs=188.7

Q ss_pred             cccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhcc-CCCCCccccceEEec
Q 011360          198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQ-IRHRNILPLLAHMVR  276 (487)
Q Consensus       198 ~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~hpnIv~l~~~~~~  276 (487)
                      +.||.|+||.||+|... .+++.||+|.+...            .............|..++.. .+||||+++++++..
T Consensus         1 ~~lG~G~~g~Vy~~~~~-~~~~~vaiK~~~~~------------~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~   67 (316)
T cd05592           1 KVLGKGSFGKVMLAELK-GTNEFFAIKALKKD------------VVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQT   67 (316)
T ss_pred             CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHH------------HhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEc
Confidence            36899999999999754 57889999988421            11112233444556666554 489999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEecc
Q 011360          277 PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDL  356 (487)
Q Consensus       277 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~DF  356 (487)
                      .+..|+||||++||+|.+++..    ...+++..+..++.|++.||.||   |++||+||||||+||+++.++.+||+||
T Consensus        68 ~~~~~lv~e~~~gg~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~L---H~~~ivH~dlkp~Nill~~~~~~kL~Df  140 (316)
T cd05592          68 KEHLFFVMEYLNGGDLMFHIQS----SGRFDEARARFYAAEIICGLQFL---HKKGIIYRDLKLDNVLLDKDGHIKIADF  140 (316)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCEEeCCCCHHHeEECCCCCEEEccC
Confidence            9999999999999999998864    35689999999999999999999   6788999999999999999999999999


Q ss_pred             CCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHHHhcC
Q 011360          357 GLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSK  436 (487)
Q Consensus       357 g~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  436 (487)
                      |++........  ......||+.|+|||++.+..++.++|||||||++|+|++|..||.....      .+....+. ..
T Consensus       141 g~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~------~~~~~~i~-~~  211 (316)
T cd05592         141 GMCKENMNGEG--KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE------DELFDSIL-ND  211 (316)
T ss_pred             cCCeECCCCCC--ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH------HHHHHHHH-cC
Confidence            99976433221  12345689999999999988999999999999999999999999954321      12222222 11


Q ss_pred             CCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChH-HHH
Q 011360          437 NPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQ-YVR  480 (487)
Q Consensus       437 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~-~il  480 (487)
                      .+  .++..        ...++.+++.+||+.+|++||++. +++
T Consensus       212 ~~--~~~~~--------~~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         212 RP--HFPRW--------ISKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             CC--CCCCC--------CCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            11  11111        234578999999999999999875 443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=7e-39  Score=314.55  Aligned_cols=245  Identities=24%  Similarity=0.327  Sum_probs=193.2

Q ss_pred             cccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CCCCccccceEEec
Q 011360          198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RHRNILPLLAHMVR  276 (487)
Q Consensus       198 ~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~  276 (487)
                      +.||.|+||.||++.. ..++..||+|++..            ...........+..|..++..+ +||||+++++++..
T Consensus         1 ~~lG~G~~g~V~~~~~-~~~~~~~aiK~~~~------------~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~   67 (318)
T cd05570           1 KVLGKGSFGKVLLAEL-KGTDELYAVKVLKK------------DVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQT   67 (318)
T ss_pred             CeeeeCCCeEEEEEEE-CCCCCEEEEEEEEH------------HHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc
Confidence            4689999999999975 45788999998842            1111223445667788888777 79999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEecc
Q 011360          277 PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDL  356 (487)
Q Consensus       277 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~DF  356 (487)
                      .+.+|+||||+++|+|.+++..    ...+++..+..++.|++.||.||   |+.||+||||||+||+++.++.+||+||
T Consensus        68 ~~~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~L---H~~~ivH~dlkp~Nill~~~~~~kl~Df  140 (318)
T cd05570          68 KDRLFFVMEYVNGGDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFL---HERGIIYRDLKLDNVLLDSEGHIKIADF  140 (318)
T ss_pred             CCEEEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HhCCeEccCCCHHHeEECCCCcEEeccc
Confidence            9999999999999999988864    45689999999999999999999   7889999999999999999999999999


Q ss_pred             CCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHHHhcC
Q 011360          357 GLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSK  436 (487)
Q Consensus       357 g~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  436 (487)
                      |++.........  .....||+.|+|||++.+..++.++|||||||++|+|++|..||....      ......... ..
T Consensus       141 g~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~------~~~~~~~i~-~~  211 (318)
T cd05570         141 GMCKEGILGGVT--TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD------EDELFQSIL-ED  211 (318)
T ss_pred             CCCeecCcCCCc--ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC------HHHHHHHHH-cC
Confidence            998653222111  134568999999999999999999999999999999999999994332      112222222 21


Q ss_pred             CCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCh-----HHHHH
Q 011360          437 NPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNS-----QYVRC  481 (487)
Q Consensus       437 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~-----~~il~  481 (487)
                      .+  .++..        .+..+.+++.+||+.||++|||+     .++++
T Consensus       212 ~~--~~~~~--------~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         212 EV--RYPRW--------LSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             CC--CCCCc--------CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence            11  11111        23568899999999999999999     77754

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=6.2e-39  Score=314.54  Aligned_cols=244  Identities=26%  Similarity=0.367  Sum_probs=189.7

Q ss_pred             cccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhcc-CCCCCccccceEEec
Q 011360          198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQ-IRHRNILPLLAHMVR  276 (487)
Q Consensus       198 ~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~hpnIv~l~~~~~~  276 (487)
                      +.||.|+||.||+|.. ..++..||+|.+...            .............|..++.. +.||||+++++++.+
T Consensus         1 ~~lG~G~~g~Vy~~~~-~~~~~~vaiK~~~~~------------~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~   67 (316)
T cd05619           1 KMLGKGSFGKVFLAEL-KGTNQFFAIKALKKD------------VVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT   67 (316)
T ss_pred             CeeeeCCCEEEEEEEE-CCCCCEEEEEEEEHH------------HhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEe
Confidence            3689999999999975 457889999988421            00112233445566677765 499999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEecc
Q 011360          277 PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDL  356 (487)
Q Consensus       277 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~DF  356 (487)
                      .+.+|+||||+++|+|.+++..    ...+++..+..++.|++.||.||   |++||+||||||+|||++.++.+||+||
T Consensus        68 ~~~~~lv~ey~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~L---H~~~ivHrdikp~Nil~~~~~~~kl~Df  140 (316)
T cd05619          68 KENLFFVMEYLNGGDLMFHIQS----CHKFDLPRATFYAAEIICGLQFL---HSKGIVYRDLKLDNILLDTDGHIKIADF  140 (316)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HhCCeEeCCCCHHHEEECCCCCEEEccC
Confidence            9999999999999999999864    35688999999999999999999   7788999999999999999999999999


Q ss_pred             CCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHHHhcC
Q 011360          357 GLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSK  436 (487)
Q Consensus       357 g~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  436 (487)
                      |++........  ......||+.|+|||++.+..++.++|||||||++|+|++|..||.....      .+..... ...
T Consensus       141 g~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~------~~~~~~i-~~~  211 (316)
T cd05619         141 GMCKENMLGDA--KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE------EELFQSI-RMD  211 (316)
T ss_pred             CcceECCCCCC--ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH------HHHHHHH-HhC
Confidence            99875322211  12345689999999999998999999999999999999999999954321      1222222 211


Q ss_pred             CCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChH-HHH
Q 011360          437 NPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQ-YVR  480 (487)
Q Consensus       437 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~-~il  480 (487)
                      .+  .++..        ...++.+++.+||+.+|++||++. +++
T Consensus       212 ~~--~~~~~--------~~~~~~~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         212 NP--CYPRW--------LTREAKDILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             CC--CCCcc--------CCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence            11  11111        224588999999999999999997 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=6.4e-39  Score=306.07  Aligned_cols=256  Identities=25%  Similarity=0.357  Sum_probs=199.8

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .++|.+.+.||.|+||.||+|.+.  ++..||+|++..                .......+.+|+.+++.++||||+++
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~--~~~~valK~~~~----------------~~~~~~~~~~E~~~l~~l~~~~i~~~   66 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWN--GTTRVAIKTLKP----------------GTMSPEAFLQEAQVMKKLRHEKLVQL   66 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEec--CCceEEEEeccc----------------CccCHHHHHHHHHHHHhCCCCCcceE
Confidence            346999999999999999999764  335699998732                01112457889999999999999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      ++.+. .+..++||||+++|+|.+++..  .....+++..+..++.|++.||.||   |+.|++||||+|+||+++.++.
T Consensus        67 ~~~~~-~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~aL~~l---H~~~i~H~dl~p~Nill~~~~~  140 (262)
T cd05071          67 YAVVS-EEPIYIVTEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRDLRAANILVGENLV  140 (262)
T ss_pred             EEEEC-CCCcEEEEEcCCCCcHHHHHhh--ccccCCCHHHHHHHHHHHHHHHHHH---HHCCccccccCcccEEEcCCCc
Confidence            99774 4567999999999999999974  2345678999999999999999999   7788999999999999999999


Q ss_pred             EEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccccHHHH
Q 011360          351 ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSPEWL  429 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~  429 (487)
                      ++|+|||.+.......... .....++..|+|||+..+..++.++||||||+++|+|+| |..||.....      .+..
T Consensus       141 ~~L~dfg~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~------~~~~  213 (262)
T cd05071         141 CKVADFGLARLIEDNEYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN------REVL  213 (262)
T ss_pred             EEeccCCceeecccccccc-ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh------HHHH
Confidence            9999999997664432211 122346778999999988889999999999999999999 7888843321      1222


Q ss_pred             HHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhhC
Q 011360          430 RKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL  487 (487)
Q Consensus       430 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~ll  487 (487)
                      .........  .    .    ....+..+.+++.+||+.+|++|||+.++++.|+..+
T Consensus       214 ~~~~~~~~~--~----~----~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~  261 (262)
T cd05071         214 DQVERGYRM--P----C----PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  261 (262)
T ss_pred             HHHhcCCCC--C----C----ccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence            222211111  0    1    1123456889999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.1e-39  Score=327.90  Aligned_cols=255  Identities=22%  Similarity=0.337  Sum_probs=195.4

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      .|.+++.||.|+||.||+++. ..+++.||+|++..            ...........+.+|+.++..++||||+++++
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~-~~~~~~~avK~~~~------------~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~   68 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRK-VDTNALYAMKTLRK------------ADVLMRNQAAHVKAERDILAEADNEWVVKLYY   68 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEE-CCCCCEEEEEEEcH------------HHHHhhhhHHHHHHHHHHHHhCCCCCcceEEE
Confidence            589999999999999999975 45789999998732            11122234566788999999999999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEE
Q 011360          273 HMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC  352 (487)
Q Consensus       273 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~k  352 (487)
                      .+.+++.+|+|||||++|+|.+++..    ...+++..+..++.||+.||+||   |++||+||||||+|||++.++.+|
T Consensus        69 ~~~~~~~~~lv~E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~l---H~~~ivHrDlkp~Nill~~~~~ik  141 (376)
T cd05598          69 SFQDKDNLYFVMDYIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESV---HKMGFIHRDIKPDNILIDRDGHIK  141 (376)
T ss_pred             EEEcCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeEeCCCCHHHEEECCCCCEE
Confidence            99999999999999999999999865    45688889999999999999999   778899999999999999999999


Q ss_pred             EeccCCccccCCCC-----------------------------------------ceeeEeeecccccccCCcccCCCCC
Q 011360          353 ISDLGLAMAIPDGY-----------------------------------------TRVLISYVLGTMAYIAPEYFQQPEL  391 (487)
Q Consensus       353 l~DFg~s~~~~~~~-----------------------------------------~~~~~~~~~gt~~y~aPE~l~~~~~  391 (487)
                      |+|||++..+....                                         .........||+.|+|||++.+..+
T Consensus       142 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  221 (376)
T cd05598         142 LTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY  221 (376)
T ss_pred             EEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCC
Confidence            99999975321000                                         0000113469999999999999999


Q ss_pred             CchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCC
Q 011360          392 SEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPE  471 (487)
Q Consensus       392 ~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~  471 (487)
                      +.++|||||||++|||++|..||.....      .+....+.... ....    ++.  ....+..+.+++.+|+ .+|.
T Consensus       222 ~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~~~-~~~~----~~~--~~~~s~~~~~li~~l~-~~p~  287 (376)
T cd05598         222 TQLCDWWSVGVILYEMLVGQPPFLADTP------AETQLKVINWE-TTLH----IPS--QAKLSREASDLILRLC-CGAE  287 (376)
T ss_pred             CcceeeeeccceeeehhhCCCCCCCCCH------HHHHHHHhccC-cccc----CCC--CCCCCHHHHHHHHHHh-cCHh
Confidence            9999999999999999999999954322      12222222111 1101    111  1112345667777766 4999


Q ss_pred             CCC---ChHHHHH
Q 011360          472 ERP---NSQYVRC  481 (487)
Q Consensus       472 ~RP---s~~~il~  481 (487)
                      +||   |+.++++
T Consensus       288 ~R~~~~t~~ell~  300 (376)
T cd05598         288 DRLGKNGADEIKA  300 (376)
T ss_pred             hcCCCCCHHHHhC
Confidence            999   8888764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=8e-39  Score=308.47  Aligned_cols=259  Identities=21%  Similarity=0.330  Sum_probs=202.2

Q ss_pred             ccccccccccccceeEEEEEe----cCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcc
Q 011360          193 CFASLEKIGSGGCGEVYKAEL----PGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNIL  268 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv  268 (487)
                      ++.+...||.|+||.||++..    ...++..+|+|.+..               ........+.+|+.+++.++||||+
T Consensus         6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~---------------~~~~~~~~~~~e~~~l~~l~h~~i~   70 (280)
T cd05092           6 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE---------------ASESARQDFQREAELLTVLQHQHIV   70 (280)
T ss_pred             hceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCc---------------CCHHHHHHHHHHHHHHhcCCCCCCc
Confidence            588899999999999999964    233567889997632               2233456788899999999999999


Q ss_pred             ccceEEecCCeeEEEEEecCCCCHHHHHhhhhc-----------CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecC
Q 011360          269 PLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSR-----------GRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGD  337 (487)
Q Consensus       269 ~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~D  337 (487)
                      ++++++...+..+++|||+++++|.+++.....           ....+++..+..++.|++.||+||   |+.|++|||
T Consensus        71 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~L---H~~~i~H~d  147 (280)
T cd05092          71 RFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYL---ASLHFVHRD  147 (280)
T ss_pred             eEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHH---HHCCeeccc
Confidence            999999999999999999999999999875321           113578899999999999999999   678899999


Q ss_pred             CCCCCEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccc
Q 011360          338 IKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVF  416 (487)
Q Consensus       338 lkp~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~  416 (487)
                      |||+||++++++.+||+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |.+||..
T Consensus       148 lkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~  227 (280)
T cd05092         148 LATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQ  227 (280)
T ss_pred             ccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCcc
Confidence            999999999999999999999876543322222223345788999999998899999999999999999998 8999833


Q ss_pred             cCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhh
Q 011360          417 HQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQ  485 (487)
Q Consensus       417 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~  485 (487)
                      ..      ..+..........+ . .+..        .+..+.+++.+||+.+|++||++.+|++.|+.
T Consensus       228 ~~------~~~~~~~~~~~~~~-~-~~~~--------~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         228 LS------NTEAIECITQGREL-E-RPRT--------CPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             CC------HHHHHHHHHcCccC-C-CCCC--------CCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence            22      12222222222111 1 1111        22458899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=3.4e-39  Score=317.56  Aligned_cols=241  Identities=24%  Similarity=0.383  Sum_probs=188.2

Q ss_pred             cccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHH-HhccCCCCCccccceEEec
Q 011360          198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII-TASQIRHRNILPLLAHMVR  276 (487)
Q Consensus       198 ~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~hpnIv~l~~~~~~  276 (487)
                      +.||.|+||.||+|.. ..+|+.||+|++...            ..........+..|.. +++.++||||+++++++..
T Consensus         1 ~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~~------------~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~   67 (323)
T cd05575           1 KVIGKGSFGKVLLAKH-KADGKFYAVKVLQKK------------AILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT   67 (323)
T ss_pred             CeeeeCCCeEEEEEEE-CCCCCEEEEEEEEHH------------HHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEe
Confidence            4689999999999975 468899999988421            1111122334444444 5678899999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEecc
Q 011360          277 PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDL  356 (487)
Q Consensus       277 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~DF  356 (487)
                      .+..|+||||+++|+|.+++..    ...+++..+..++.|++.||.||   |++||+||||||+|||++.++.+||+||
T Consensus        68 ~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~l---H~~givH~dikp~NIll~~~~~~kl~Df  140 (323)
T cd05575          68 ADKLYFVLDYVNGGELFFHLQR----ERSFPEPRARFYAAEIASALGYL---HSLNIIYRDLKPENILLDSQGHVVLTDF  140 (323)
T ss_pred             CCEEEEEEcCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeEeCCCCHHHeEECCCCcEEEecc
Confidence            9999999999999999998864    45788999999999999999999   7788999999999999999999999999


Q ss_pred             CCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHHHhcC
Q 011360          357 GLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSK  436 (487)
Q Consensus       357 g~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  436 (487)
                      |++........  ......||+.|+|||++.+..++.++|||||||++|+|++|..||....      ..+.........
T Consensus       141 g~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~------~~~~~~~i~~~~  212 (323)
T cd05575         141 GLCKEGIEHSK--TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD------TAEMYDNILNKP  212 (323)
T ss_pred             CCCcccccCCC--ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC------HHHHHHHHHcCC
Confidence            99875322211  1234568999999999999899999999999999999999999994332      122223332211


Q ss_pred             CCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChH
Q 011360          437 NPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQ  477 (487)
Q Consensus       437 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~  477 (487)
                       .  .+.+.+        +..+.+++.+||+.||.+||++.
T Consensus       213 -~--~~~~~~--------~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         213 -L--RLKPNI--------SVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             -C--CCCCCC--------CHHHHHHHHHHhhcCHHhCCCCC
Confidence             1  112222        35688999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=6.8e-39  Score=313.18  Aligned_cols=263  Identities=25%  Similarity=0.335  Sum_probs=202.7

Q ss_pred             cccccccccccccceeEEEEEecC------CCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CC
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPG------SNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RH  264 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h  264 (487)
                      +.|.+.+.||+|+||.||++....      .++..+|+|.+..              .........+..|+.++..+ +|
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~--------------~~~~~~~~~~~~e~~~l~~l~~h   83 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKS--------------DATEKDLSDLISEMEMMKMIGKH   83 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccC--------------CCChHHHHHHHHHHHHHHHhcCC
Confidence            469999999999999999997532      1235799998732              11223345678899999999 89


Q ss_pred             CCccccceEEecCCeeEEEEEecCCCCHHHHHhhhhc------------CCCCCChHHHHHHHHHHHHHHHHHHhcCCCC
Q 011360          265 RNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSR------------GRRELDWPSRHRIALGVASGLEYLHMYHSAS  332 (487)
Q Consensus       265 pnIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~g  332 (487)
                      |||+++++++...+..|+||||+++|+|.+++.....            ....+++..++.++.|++.||+||   |++|
T Consensus        84 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~l---H~~g  160 (307)
T cd05098          84 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKK  160 (307)
T ss_pred             CCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHH---HHCC
Confidence            9999999999999999999999999999999975321            123588899999999999999999   6778


Q ss_pred             eeecCCCCCCEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CC
Q 011360          333 IIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GV  411 (487)
Q Consensus       333 ivH~Dlkp~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~  411 (487)
                      ++||||||+||+++.++.+||+|||.+................+++.|+|||++.+..++.++||||||+++|+|++ |.
T Consensus       161 i~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~  240 (307)
T cd05098         161 CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG  240 (307)
T ss_pred             cccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCC
Confidence            99999999999999999999999999876543221111112234578999999998889999999999999999998 78


Q ss_pred             CCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhhC
Q 011360          412 PSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL  487 (487)
Q Consensus       412 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~ll  487 (487)
                      .||....       .+.............     .+.    ..+.++.+++.+||+.+|++|||+.++++.|+.++
T Consensus       241 ~p~~~~~-------~~~~~~~~~~~~~~~-----~~~----~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~  300 (307)
T cd05098         241 SPYPGVP-------VEELFKLLKEGHRMD-----KPS----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  300 (307)
T ss_pred             CCCCcCC-------HHHHHHHHHcCCCCC-----CCC----cCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence            8883221       222222222221111     111    12356889999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=7.3e-39  Score=304.60  Aligned_cols=251  Identities=23%  Similarity=0.307  Sum_probs=198.3

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      +|.+.+.||.|+||.||+|.+.  ++..+|+|.+...                ......+.+|+.++.+++||||+++++
T Consensus         5 ~~~~~~~lg~G~~~~vy~~~~~--~~~~~aik~~~~~----------------~~~~~~~~~e~~~l~~l~h~~i~~~~~   66 (256)
T cd05113           5 DLTFLKELGTGQFGVVKYGKWR--GQYDVAIKMIKEG----------------SMSEDEFIEEAKVMMKLSHEKLVQLYG   66 (256)
T ss_pred             HeEEeeEecCcccceEEEEEec--CCCcEEEEEcCCC----------------cccHHHHHHHHHHHhcCCCCCeeeEEE
Confidence            5889999999999999999764  4456999986321                112345788999999999999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEE
Q 011360          273 HMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC  352 (487)
Q Consensus       273 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~k  352 (487)
                      ++...+..+++|||+.+|+|.+++..   ....+++..++.++.|++.||.||   |+.|++|+||+|+||+++.++.+|
T Consensus        67 ~~~~~~~~~lv~e~~~~~~l~~~i~~---~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~nili~~~~~~k  140 (256)
T cd05113          67 VCTKQRPIYIVTEYMSNGCLLNYLRE---HGKRFQPSQLLEMCKDVCEGMAYL---ESKQFIHRDLAARNCLVDDQGCVK  140 (256)
T ss_pred             EEccCCCcEEEEEcCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccccCcceEEEcCCCCEE
Confidence            99998999999999999999999864   233689999999999999999999   778899999999999999999999


Q ss_pred             EeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccccHHHHHH
Q 011360          353 ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSPEWLRK  431 (487)
Q Consensus       353 l~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~  431 (487)
                      |+|||.+.......... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||....      ..+....
T Consensus       141 l~d~g~~~~~~~~~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~------~~~~~~~  213 (256)
T cd05113         141 VSDFGLSRYVLDDEYTS-SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFN------NSETVEK  213 (256)
T ss_pred             ECCCccceecCCCceee-cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCC------HHHHHHH
Confidence            99999987654432211 112235678999999988889999999999999999999 899984322      1222222


Q ss_pred             HHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHh
Q 011360          432 VMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLS  484 (487)
Q Consensus       432 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~  484 (487)
                      ......+.      .+..    .+..+.+++.+||+.+|.+|||+.+|++.|+
T Consensus       214 ~~~~~~~~------~~~~----~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         214 VSQGLRLY------RPHL----ASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             HhcCCCCC------CCCC----CCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            22221110      1111    2356899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=2e-39  Score=302.30  Aligned_cols=264  Identities=24%  Similarity=0.354  Sum_probs=201.6

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCC-ccccc
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRN-ILPLL  271 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~l~  271 (487)
                      .|..+++||+|+||+||+|+. ..+|+.||+|++.....             .+..-....+|+.+++.++|+| ||+++
T Consensus        12 ~~~~~eklGeGtyg~Vykar~-~~~g~~VALKkirl~~~-------------~EG~P~taiREisllk~L~~~~~iv~L~   77 (323)
T KOG0594|consen   12 DYEKVEKLGEGTYGVVYKARS-KRTGKFVALKKIRLEFE-------------EEGVPSTAIREISLLKRLSHANHIVRLH   77 (323)
T ss_pred             HHHHHHHhCCCCceEEEEEEE-ecCCCEEEEEEEecccc-------------ccCCCchhhHHHHHHHHhCCCcceEEEE
Confidence            478888999999999999975 46889999999965221             0112234578999999999999 99999


Q ss_pred             eEEecCC------eeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEe
Q 011360          272 AHMVRPD------CHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLL  345 (487)
Q Consensus       272 ~~~~~~~------~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill  345 (487)
                      +++...+      .+++||||+ .-+|..+++........++...++.++.|++.||+||   |+++|+||||||.|||+
T Consensus        78 dv~~~~~~~~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~---H~~~IlHRDLKPQNlLi  153 (323)
T KOG0594|consen   78 DVIHTSNNHRGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFL---HSHGILHRDLKPQNLLI  153 (323)
T ss_pred             eeeeecccccccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHH---HhCCeecccCCcceEEE
Confidence            9999877      789999999 5599999987543334577788999999999999999   88899999999999999


Q ss_pred             CCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCccccCCCCccc
Q 011360          346 NDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQP-ELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEIC  424 (487)
Q Consensus       346 ~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~  424 (487)
                      +++|.+||+|||+|+...-....  .+..++|.+|.|||++.+. .|+...||||+||++.||+++++.|.+...     
T Consensus       154 ~~~G~lKlaDFGlAra~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se-----  226 (323)
T KOG0594|consen  154 SSSGVLKLADFGLARAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE-----  226 (323)
T ss_pred             CCCCcEeeeccchHHHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH-----
Confidence            99999999999999876533221  2455689999999999877 899999999999999999999999966543     


Q ss_pred             cHHHHHHHHh-cCCCC-CccC------------CCCC-CCC----cHHHHHHHHHHHhhccCCCCCCCCChHHHHHH
Q 011360          425 SPEWLRKVMN-SKNPS-RAID------------PRLP-GNG----YEKKMLHVLKIAYICTLHDPEERPNSQYVRCR  482 (487)
Q Consensus       425 ~~~~~~~~~~-~~~~~-~~~~------------~~~~-~~~----~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~  482 (487)
                       ...+..++. -+.|. ..++            +..+ ...    .+....+..+++.+||+.+|.+|.|++.++..
T Consensus       227 -~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  227 -IDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             -HHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence             111111111 01110 0000            0000 000    01111368899999999999999999998763

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=3.4e-39  Score=317.85  Aligned_cols=244  Identities=24%  Similarity=0.349  Sum_probs=188.4

Q ss_pred             cccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHH-HHhccCCCCCccccceEEec
Q 011360          198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI-ITASQIRHRNILPLLAHMVR  276 (487)
Q Consensus       198 ~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~-~~l~~l~hpnIv~l~~~~~~  276 (487)
                      +.||.|+||.||+|+. ..++..||+|++...            ..........+..|. .+++.++||||+++++++..
T Consensus         1 ~~lg~G~fg~V~~~~~-~~~~~~~aiK~~~~~------------~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~   67 (325)
T cd05602           1 KVIGKGSFGKVLLARH-KAEEKFYAVKVLQKK------------AILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT   67 (325)
T ss_pred             CeeeeCCCeEEEEEEE-CCCCCEEEEEEEEHH------------HHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEc
Confidence            3689999999999975 457889999988421            011111223333443 45678899999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEecc
Q 011360          277 PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDL  356 (487)
Q Consensus       277 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~DF  356 (487)
                      .+..|+||||+++|+|.+++..    ...+++..+..++.|++.||.||   |++||+||||||+|||++.++.+||+||
T Consensus        68 ~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~l---H~~giiHrDlkp~Nili~~~~~~kl~Df  140 (325)
T cd05602          68 ADKLYFVLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYL---HSLNIVYRDLKPENILLDSQGHIVLTDF  140 (325)
T ss_pred             CCeEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHeEECCCCCEEEccC
Confidence            9999999999999999998864    45678888999999999999999   7789999999999999999999999999


Q ss_pred             CCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHHHhcC
Q 011360          357 GLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSK  436 (487)
Q Consensus       357 g~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  436 (487)
                      |++........  ......||+.|+|||++.+..++.++|||||||++|+|++|.+||....      ..+.........
T Consensus       141 G~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~~~i~~~~  212 (325)
T cd05602         141 GLCKENIEHNG--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN------TAEMYDNILNKP  212 (325)
T ss_pred             CCCcccccCCC--CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC------HHHHHHHHHhCC
Confidence            99875432211  1234569999999999999999999999999999999999999994322      122223332211


Q ss_pred             CCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHH
Q 011360          437 NPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVR  480 (487)
Q Consensus       437 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il  480 (487)
                       .  .+.+.+        +..+.+++.+||+.+|.+||++.+.+
T Consensus       213 -~--~~~~~~--------~~~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         213 -L--QLKPNI--------TNSARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             -c--CCCCCC--------CHHHHHHHHHHcccCHHHCCCCCCCH
Confidence             1  112222        24588999999999999999987543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.4e-38  Score=306.62  Aligned_cols=263  Identities=22%  Similarity=0.330  Sum_probs=205.7

Q ss_pred             ccccccccccccccceeEEEEEecCC---CCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGS---NGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNI  267 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI  267 (487)
                      .++|.+.+.||+|+||.||+|.+...   ++..|++|.+..              .........+.+|+.+++.++||||
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~--------------~~~~~~~~~~~~e~~~l~~l~h~ni   70 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD--------------HASEIQVTLLLQESCLLYGLSHQNI   70 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccC--------------CCCHHHHHHHHHHHHHHHhCCCCCC
Confidence            35689999999999999999987532   267899998632              1223345677889999999999999


Q ss_pred             cccceEEec-CCeeEEEEEecCCCCHHHHHhhhhcC----CCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCC
Q 011360          268 LPLLAHMVR-PDCHLLVYEFMKNGSLQDILDDVSRG----RRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRN  342 (487)
Q Consensus       268 v~l~~~~~~-~~~~~lv~E~~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~N  342 (487)
                      +++++++.. +...+++++|+++++|.+++......    +..+++..+..++.|++.||.||   |+++++||||||+|
T Consensus        71 ~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~L---H~~~i~H~di~p~n  147 (280)
T cd05043          71 LPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYL---HKRGVIHKDIAARN  147 (280)
T ss_pred             CeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHH---HHCCEeecccCHhh
Confidence            999998765 57789999999999999999764322    25689999999999999999999   67789999999999


Q ss_pred             EEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCC
Q 011360          343 VLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGE  421 (487)
Q Consensus       343 ill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~  421 (487)
                      |+++.++.+||+|||+++.+.............++..|+|||++.+..++.++||||||+++|++++ |..||....   
T Consensus       148 il~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~---  224 (280)
T cd05043         148 CVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID---  224 (280)
T ss_pred             EEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC---
Confidence            9999999999999999986644332222223346778999999988889999999999999999999 999994321   


Q ss_pred             ccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          422 EICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       422 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                         ..++.........+..  ..        ..+.++.+++.+||..+|++|||+.++++.|+++
T Consensus       225 ---~~~~~~~~~~~~~~~~--~~--------~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~  276 (280)
T cd05043         225 ---PFEMAAYLKDGYRLAQ--PI--------NCPDELFAVMACCWALDPEERPSFSQLVQCLTDF  276 (280)
T ss_pred             ---HHHHHHHHHcCCCCCC--CC--------cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence               1222222222211111  11        1235688999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.3e-38  Score=306.85  Aligned_cols=251  Identities=25%  Similarity=0.359  Sum_probs=197.0

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      +|.+.+.||.|+||.||+|.. ..++..||+|.+...              ........+.+|+.++.+++||||+++++
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~-~~~~~~~aiK~~~~~--------------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   66 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYH-LLTRRILAVKVIPLD--------------ITVELQKQIMSELEILYKCDSPYIIGFYG   66 (279)
T ss_pred             cchheeeeccCCCeEEEEEEE-cCCCcEEEEEEEecC--------------CChHHHHHHHHHHHHHHhCCCCCeeeEEE
Confidence            578889999999999999974 457889999987421              12223456888999999999999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEE
Q 011360          273 HMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC  352 (487)
Q Consensus       273 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~k  352 (487)
                      ++...+..++||||+++++|..+.        .+++..+..++.|++.||.||   |+.||+|+||||+||+++.++.++
T Consensus        67 ~~~~~~~~~lv~e~~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nill~~~~~~~  135 (279)
T cd06619          67 AFFVENRISICTEFMDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYL---WSLKILHRDVKPSNMLVNTRGQVK  135 (279)
T ss_pred             EEEECCEEEEEEecCCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHH---HHCCEeeCCCCHHHEEECCCCCEE
Confidence            999999999999999999996542        367888899999999999999   778899999999999999999999


Q ss_pred             EeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHH
Q 011360          353 ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKV  432 (487)
Q Consensus       353 l~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~  432 (487)
                      |+|||++........    ....||..|+|||++.+..++.++|+||||+++|+|++|..||..................
T Consensus       136 l~dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  211 (279)
T cd06619         136 LCDFGVSTQLVNSIA----KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQC  211 (279)
T ss_pred             EeeCCcceecccccc----cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHH
Confidence            999999976543322    3356899999999999889999999999999999999999999653322221111111111


Q ss_pred             HhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          433 MNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       433 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .....+..     ++.   .....++.+++.+||+.+|.+||+++++++
T Consensus       212 ~~~~~~~~-----~~~---~~~~~~~~~li~~~l~~~P~~Rp~~~eil~  252 (279)
T cd06619         212 IVDEDPPV-----LPV---GQFSEKFVHFITQCMRKQPKERPAPENLMD  252 (279)
T ss_pred             HhccCCCC-----CCC---CcCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            11111111     111   112346889999999999999999999875

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=2.2e-38  Score=305.17  Aligned_cols=258  Identities=21%  Similarity=0.301  Sum_probs=199.6

Q ss_pred             ccccccccccccccceeEEEEEecCCCCc----eEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCC
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGK----MIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRN  266 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn  266 (487)
                      .++|.+.+.||.|+||.||+|++.. ++.    .||+|.+..              .........+.+|+.++..+.|||
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~-~~~~~~~~va~K~~~~--------------~~~~~~~~~~~~e~~~l~~~~~~~   70 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIP-DGENVKIPVAIKVLRE--------------NTSPKANKEILDEAYVMAGVGSPY   70 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEec-CCCccceEEEEEEecC--------------CCCHHHHHHHHHHHHHHHhcCCCC
Confidence            3468999999999999999998643 333    489998732              112233456788999999999999


Q ss_pred             ccccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC
Q 011360          267 ILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN  346 (487)
Q Consensus       267 Iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~  346 (487)
                      |+++++++.. ...+++|||+++|+|.+++..   ....+++..+..++.|++.||.||   |++|++||||||+||+++
T Consensus        71 i~~~~~~~~~-~~~~l~~~~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~l---H~~~iiH~dlkp~Nil~~  143 (279)
T cd05109          71 VCRLLGICLT-STVQLVTQLMPYGCLLDYVRE---NKDRIGSQDLLNWCVQIAKGMSYL---EEVRLVHRDLAARNVLVK  143 (279)
T ss_pred             CceEEEEEcC-CCcEEEEEcCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccccccceEEEc
Confidence            9999998875 456899999999999999864   235689999999999999999999   778899999999999999


Q ss_pred             CCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCcccc
Q 011360          347 DDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICS  425 (487)
Q Consensus       347 ~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~  425 (487)
                      +++.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||.....      
T Consensus       144 ~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~------  217 (279)
T cd05109         144 SPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA------  217 (279)
T ss_pred             CCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH------
Confidence            999999999999987654332221122335678999999998899999999999999999998 8999843221      


Q ss_pred             HHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          426 PEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       426 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                       .............. .++        ..+.++.+++.+||..||++|||+.+++..|+++
T Consensus       218 -~~~~~~~~~~~~~~-~~~--------~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~  268 (279)
T cd05109         218 -REIPDLLEKGERLP-QPP--------ICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM  268 (279)
T ss_pred             -HHHHHHHHCCCcCC-CCc--------cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence             11222222221111 011        1235688999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=5e-39  Score=315.24  Aligned_cols=244  Identities=26%  Similarity=0.337  Sum_probs=189.9

Q ss_pred             cccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhcc-CCCCCccccceEEec
Q 011360          198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQ-IRHRNILPLLAHMVR  276 (487)
Q Consensus       198 ~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~hpnIv~l~~~~~~  276 (487)
                      +.||.|+||.||+|+. ..++..||+|.+...            .............|..++.. ++||||+++++++..
T Consensus         1 ~~lg~G~~g~V~~~~~-~~~~~~~avK~~~~~------------~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~   67 (316)
T cd05620           1 KVLGKGSFGKVLLAEL-KGKGEYFAVKALKKD------------VVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQT   67 (316)
T ss_pred             CeeeeCCCeEEEEEEE-CCCCCEEEEEEEEHH------------HhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEe
Confidence            4699999999999975 457899999988420            01112234455667777765 489999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEecc
Q 011360          277 PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDL  356 (487)
Q Consensus       277 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~DF  356 (487)
                      .+.+|+||||+.+|+|.+++..    ...+++..+..++.|++.||+||   |++||+||||||+||+++.++.++|+||
T Consensus        68 ~~~~~lv~E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivHrDlkp~Nil~~~~~~~kl~Df  140 (316)
T cd05620          68 KEHLFFVMEFLNGGDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFL---HSKGIIYRDLKLDNVMLDRDGHIKIADF  140 (316)
T ss_pred             CCEEEEEECCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHeEECCCCCEEeCcc
Confidence            9999999999999999998864    45688999999999999999999   7788999999999999999999999999


Q ss_pred             CCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHHHhcC
Q 011360          357 GLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSK  436 (487)
Q Consensus       357 g~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  436 (487)
                      |++........  ......||+.|+|||++.+..++.++|||||||++|+|++|..||.....      .+..... ...
T Consensus       141 g~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~------~~~~~~~-~~~  211 (316)
T cd05620         141 GMCKENVFGDN--RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE------DELFESI-RVD  211 (316)
T ss_pred             CCCeecccCCC--ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH------HHHHHHH-HhC
Confidence            99865322211  12346689999999999999999999999999999999999999943321      1222222 111


Q ss_pred             CCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChH-HHH
Q 011360          437 NPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQ-YVR  480 (487)
Q Consensus       437 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~-~il  480 (487)
                      .+      .++..    ...++.+++.+||+.||++||++. +++
T Consensus       212 ~~------~~~~~----~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         212 TP------HYPRW----ITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             CC------CCCCC----CCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            11      11111    234688999999999999999985 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=2.9e-39  Score=330.19  Aligned_cols=258  Identities=21%  Similarity=0.294  Sum_probs=191.9

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      ...|.+.+.||.|+||.||+|.. ..++..||||++...                   .....+|+.+++.++||||+++
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~~~~vAiK~i~~~-------------------~~~~~~Ei~il~~l~h~niv~l  124 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAIC-IDTSEKVAIKKVLQD-------------------PQYKNRELLIMKNLNHINIIFL  124 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEE-CCCCCEEEEEEEecC-------------------cchHHHHHHHHHhcCCCCCcce
Confidence            34699999999999999999975 457889999987321                   0122468999999999999999


Q ss_pred             ceEEecC--------CeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCC
Q 011360          271 LAHMVRP--------DCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRN  342 (487)
Q Consensus       271 ~~~~~~~--------~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~N  342 (487)
                      ++++...        ..+++||||++ ++|.+++.........+++..+..++.|++.||.||   |++||+||||||+|
T Consensus       125 ~~~~~~~~~~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yL---H~~~IiHrDLKp~N  200 (440)
T PTZ00036        125 KDYYYTECFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYI---HSKFICHRDLKPQN  200 (440)
T ss_pred             eeeEeecccccCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCEecCCcCHHH
Confidence            9876432        24678999996 578888876555667899999999999999999999   77889999999999


Q ss_pred             EEeCCCC-CEEEeccCCccccCCCCceeeEeeecccccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCccccCCC
Q 011360          343 VLLNDDM-EACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQ-PELSEKCDIFSFGMLLISLVRGVPSFVFHQNG  420 (487)
Q Consensus       343 ill~~~~-~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwslG~~l~elltg~~pf~~~~~~  420 (487)
                      ||++.++ .+||+|||+++........   ....||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+....
T Consensus       201 ILl~~~~~~vkL~DFGla~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~  277 (440)
T PTZ00036        201 LLIDPNTHTLKLCDFGSAKNLLAGQRS---VSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV  277 (440)
T ss_pred             EEEcCCCCceeeeccccchhccCCCCc---ccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence            9999664 6999999999876443221   23568999999998865 47899999999999999999999999554321


Q ss_pred             CccccHHHHHHHHh-cCCCC---------CccCCCCCCC--------CcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          421 EEICSPEWLRKVMN-SKNPS---------RAIDPRLPGN--------GYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       421 ~~~~~~~~~~~~~~-~~~~~---------~~~~~~~~~~--------~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                            +.+..... -+.+.         ...+..++..        .....+.++.+++.+||..||.+|||+.++++
T Consensus       278 ------~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        278 ------DQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             ------HHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence                  11111110 00000         0000001100        00112357889999999999999999999874

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=6.4e-39  Score=311.70  Aligned_cols=268  Identities=21%  Similarity=0.328  Sum_probs=201.0

Q ss_pred             cccccccccccccceeEEEEEec---------------CCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHH
Q 011360          192 DCFASLEKIGSGGCGEVYKAELP---------------GSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI  256 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~---------------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~  256 (487)
                      ++|++.+.||.|+||.||++.+.               ..++..+|+|.+..              .........+.+|+
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~--------------~~~~~~~~~~~~E~   70 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRE--------------DANKNARNDFLKEI   70 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccc--------------cCCHHHHHHHHHHH
Confidence            46999999999999999998532               12345689998732              11223456788999


Q ss_pred             HHhccCCCCCccccceEEecCCeeEEEEEecCCCCHHHHHhhhhcC-------CCCCChHHHHHHHHHHHHHHHHHHhcC
Q 011360          257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG-------RRELDWPSRHRIALGVASGLEYLHMYH  329 (487)
Q Consensus       257 ~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~qi~~~L~~Lh~~h  329 (487)
                      .+++.++||||+++++++...+..+++|||+++|+|.+++......       ...+++..+..++.|++.||+||   |
T Consensus        71 ~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~l---H  147 (296)
T cd05095          71 KIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---S  147 (296)
T ss_pred             HHHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHH---H
Confidence            9999999999999999999999999999999999999998753211       23477888999999999999999   7


Q ss_pred             CCCeeecCCCCCCEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh
Q 011360          330 SASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR  409 (487)
Q Consensus       330 ~~givH~Dlkp~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt  409 (487)
                      +.|++||||||+||+++.++.++|+|||++................+++.|+|||...++.++.++|||||||++|||++
T Consensus       148 ~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~  227 (296)
T cd05095         148 SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT  227 (296)
T ss_pred             HCCeecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHH
Confidence            77899999999999999999999999999976544322222222345678999999888889999999999999999998


Q ss_pred             --CCCCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhh
Q 011360          410 --GVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQ  485 (487)
Q Consensus       410 --g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~  485 (487)
                        |..||.........   ...............++  .+.    ..+..+.+++.+||+.||++|||+.+|++.|++
T Consensus       228 ~~~~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~--~~~----~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         228 LCKEQPYSQLSDEQVI---ENTGEFFRDQGRQVYLP--KPA----LCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             hCCCCCccccChHHHH---HHHHHHHhhccccccCC--CCC----CCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence              67888433221111   11111111111100000  111    122568899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.5e-38  Score=302.02  Aligned_cols=251  Identities=24%  Similarity=0.372  Sum_probs=202.7

Q ss_pred             cccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceE
Q 011360          194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAH  273 (487)
Q Consensus       194 ~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  273 (487)
                      |.+.+.||.|++|.||++.. ..++..|++|.+..             ..........+.+|+.+++.++||||++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~-~~~~~~~~~k~~~~-------------~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   67 (256)
T cd08529           2 FEILNKIGKGSFGVVFKVVR-KADKRVYAMKQIDL-------------SKMNRREREEAIDEARVLAKLDSSYIIRYYES   67 (256)
T ss_pred             ceEeEEecCCCCeEEEEEEE-cCCCcEEEEEEeeh-------------hhCCHHHHHHHHHHHHHHHhcCCCCeehheee
Confidence            77888999999999999975 45789999998732             11223345678889999999999999999999


Q ss_pred             EecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEE
Q 011360          274 MVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACI  353 (487)
Q Consensus       274 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl  353 (487)
                      +...+..|+||||+++++|.+++...  ....+++..+..++.|++.||.||   |+.|++|+||+|+||+++.++.++|
T Consensus        68 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~l---H~~~i~h~dl~~~nili~~~~~~~l  142 (256)
T cd08529          68 FLDKGKLNIVMEYAENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHL---HSKKILHRDIKSLNLFLDAYDNVKI  142 (256)
T ss_pred             eccCCEEEEEEEeCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCcceEEEeCCCCEEE
Confidence            99999999999999999999999752  345788999999999999999999   6788999999999999999999999


Q ss_pred             eccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHHH
Q 011360          354 SDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVM  433 (487)
Q Consensus       354 ~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~  433 (487)
                      +|||++.........  .....|++.|+|||++.+..++.++|+||||+++|+|++|..||....      .........
T Consensus       143 ~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~  214 (256)
T cd08529         143 GDLGVAKLLSDNTNF--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN------QGALILKII  214 (256)
T ss_pred             cccccceeccCccch--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHH
Confidence            999998766543221  123458899999999998889999999999999999999999994332      112222222


Q ss_pred             hcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          434 NSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       434 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ....+      .++.    .....+.+++.+||+.+|++||++.+++.
T Consensus       215 ~~~~~------~~~~----~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  252 (256)
T cd08529         215 RGVFP------PVSQ----MYSQQLAQLIDQCLTKDYRQRPDTFQLLR  252 (256)
T ss_pred             cCCCC------CCcc----ccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence            22111      1111    23356899999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=2.8e-39  Score=323.38  Aligned_cols=255  Identities=21%  Similarity=0.313  Sum_probs=197.6

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||.|+||.||++.. ..+++.+|+|.+...            ..........+.+|+.+++.++||||++++
T Consensus        43 ~~y~~~~~lG~G~fg~Vy~~~~-~~~~~~~aiK~~~~~------------~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~  109 (370)
T cd05621          43 EDYDVVKVIGRGAFGEVQLVRH-KSSQKVYAMKLLSKF------------EMIKRSDSAFFWEERDIMAFANSPWVVQLF  109 (370)
T ss_pred             HHCeEEEEEEecCCeEEEEEEE-CCCCCEEEEEEEEHH------------HhhhhhhHHHHHHHHHHHHhCCCCCEeeEE
Confidence            4699999999999999999975 457889999987320            111222345677899999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++.+++..|+|||||++|+|.+++..     ..+++..+..++.|++.||.||   |++||+||||||+|||++.++.+
T Consensus       110 ~~~~~~~~~~lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~L---H~~~IvHrDLKp~NILl~~~~~~  181 (370)
T cd05621         110 CAFQDDKYLYMVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAI---HSMGLIHRDVKPDNMLLDKHGHL  181 (370)
T ss_pred             EEEEcCCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHEEECCCCCE
Confidence            999999999999999999999999864     3578889999999999999999   67889999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCC----CCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQP----ELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPE  427 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~  427 (487)
                      ||+|||++........ .......||+.|+|||++.+.    .++.++|||||||++|+|++|..||.....      ..
T Consensus       182 kL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~------~~  254 (370)
T cd05621         182 KLADFGTCMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL------VG  254 (370)
T ss_pred             EEEecccceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH------HH
Confidence            9999999987643221 112345699999999998753    378899999999999999999999954321      22


Q ss_pred             HHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCC--CCChHHHHH
Q 011360          428 WLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEE--RPNSQYVRC  481 (487)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--RPs~~~il~  481 (487)
                      ........... ..    ++.  ....+..+.+++..||..+|.+  |||+.++++
T Consensus       255 ~~~~i~~~~~~-~~----~p~--~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~  303 (370)
T cd05621         255 TYSKIMDHKNS-LN----FPE--DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQ  303 (370)
T ss_pred             HHHHHHhCCcc-cC----CCC--cccCCHHHHHHHHHHccCchhccCCCCHHHHhc
Confidence            23333322111 11    111  1123356788889999865544  889999875

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.1e-38  Score=316.47  Aligned_cols=266  Identities=24%  Similarity=0.346  Sum_probs=201.8

Q ss_pred             hccccccccccccccceeEEEEEe----cCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CC
Q 011360          190 KEDCFASLEKIGSGGCGEVYKAEL----PGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RH  264 (487)
Q Consensus       190 ~~~~~~~~~~lg~G~~g~v~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h  264 (487)
                      ..++|.+.+.||.|+||.||+|.+    ...+++.||||.+...              ........+.+|+.++.++ +|
T Consensus         5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~--------------~~~~~~~~~~~E~~~l~~l~~h   70 (343)
T cd05103           5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--------------ATHSEHRALMSELKILIHIGHH   70 (343)
T ss_pred             chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccC--------------CChHHHHHHHHHHHHHHhccCC
Confidence            345799999999999999999974    2346789999987321              1122345678899999999 78


Q ss_pred             CCccccceEEecC-CeeEEEEEecCCCCHHHHHhhhhc------------------------------------------
Q 011360          265 RNILPLLAHMVRP-DCHLLVYEFMKNGSLQDILDDVSR------------------------------------------  301 (487)
Q Consensus       265 pnIv~l~~~~~~~-~~~~lv~E~~~~gsL~~~l~~~~~------------------------------------------  301 (487)
                      |||+++++++... ...+++||||++|+|.+++.....                                          
T Consensus        71 ~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  150 (343)
T cd05103          71 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASS  150 (343)
T ss_pred             ccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccc
Confidence            9999999987654 567899999999999999864210                                          


Q ss_pred             ---------------------CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEeccCCcc
Q 011360          302 ---------------------GRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAM  360 (487)
Q Consensus       302 ---------------------~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~DFg~s~  360 (487)
                                           ....+++..+..++.|++.||+||   |++||+||||||+||+++.++.+||+|||++.
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~  227 (343)
T cd05103         151 GFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLAR  227 (343)
T ss_pred             cccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCccCeEEEcCCCcEEEEeccccc
Confidence                                 012467888899999999999999   77899999999999999999999999999987


Q ss_pred             ccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccccHHHHHHHHhcCCCC
Q 011360          361 AIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSPEWLRKVMNSKNPS  439 (487)
Q Consensus       361 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  439 (487)
                      ...............+++.|+|||.+.+..++.++||||||+++|+|++ |..||......     .. ...........
T Consensus       228 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-----~~-~~~~~~~~~~~  301 (343)
T cd05103         228 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-----EE-FCRRLKEGTRM  301 (343)
T ss_pred             ccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc-----HH-HHHHHhccCCC
Confidence            6533222111122345678999999988899999999999999999997 89998543221     11 12222221111


Q ss_pred             CccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhhC
Q 011360          440 RAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL  487 (487)
Q Consensus       440 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~ll  487 (487)
                           ..+..    ....+.+++.+||+.+|++|||+.+|++.|+.++
T Consensus       302 -----~~~~~----~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~  340 (343)
T cd05103         302 -----RAPDY----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  340 (343)
T ss_pred             -----CCCCC----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                 11111    1245889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=4.7e-39  Score=316.57  Aligned_cols=245  Identities=24%  Similarity=0.293  Sum_probs=192.9

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CCCCccccc
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RHRNILPLL  271 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~  271 (487)
                      +|.+.+.||+|+||.||+|.. ..++..||+|.+...            ..........+..|..++..+ .||+|++++
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~-~~~~~~~aiK~~~~~------------~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~   67 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAER-KGTDELYAIKILKKD------------VVIQDDDVECTMVEKRVLALSGKPPFLTQLH   67 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEE-CCCCCEEEEEEEEHH------------HhhhhhHHHHHHHHHHHHHhccCCCeEeeEE
Confidence            378889999999999999975 457889999988421            111222344566677777766 689999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++...+.+|+||||+++|+|.+++..    ...+++..+..++.|++.||.||   |++||+||||||+|||++.++.+
T Consensus        68 ~~~~~~~~~~lv~E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDlkp~Nill~~~~~~  140 (323)
T cd05616          68 SCFQTMDRLYFVMEYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFL---HSKGIIYRDLKLDNVMLDSEGHI  140 (323)
T ss_pred             EEEecCCEEEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCEEecCCCHHHeEECCCCcE
Confidence            999999999999999999999998864    35688999999999999999999   67789999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRK  431 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~  431 (487)
                      ||+|||++........  ......||+.|+|||++.+..++.++|||||||++|||+||..||.....      ......
T Consensus       141 kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~------~~~~~~  212 (323)
T cd05616         141 KIADFGMCKENMWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------DELFQS  212 (323)
T ss_pred             EEccCCCceecCCCCC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH------HHHHHH
Confidence            9999999875432211  12345689999999999999999999999999999999999999943321      222222


Q ss_pred             HHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCh
Q 011360          432 VMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNS  476 (487)
Q Consensus       432 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~  476 (487)
                      +.. ...  .    +|.    ..+.++.+++.+||+.+|++|++.
T Consensus       213 i~~-~~~--~----~p~----~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         213 IME-HNV--A----YPK----SMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             HHh-CCC--C----CCC----cCCHHHHHHHHHHcccCHHhcCCC
Confidence            222 111  1    111    123568899999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=8.5e-39  Score=307.81  Aligned_cols=249  Identities=27%  Similarity=0.370  Sum_probs=192.2

Q ss_pred             cccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceEEecCCe
Q 011360          200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDC  279 (487)
Q Consensus       200 lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  279 (487)
                      ||.|+||.||++... .+|+.||+|.+..            ...........+..|+.++..++||||+++++++..+..
T Consensus         1 lg~G~~g~Vy~~~~~-~~~~~~a~K~~~~------------~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~   67 (277)
T cd05607           1 LGKGGFGEVCAVQVK-NTGKMYACKKLDK------------KRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTH   67 (277)
T ss_pred             CCCCCceEEEEEEEc-cCCcEEEEEEEcH------------HHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCe
Confidence            699999999999754 5789999998732            001111223345669999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEeccCCc
Q 011360          280 HLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA  359 (487)
Q Consensus       280 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~DFg~s  359 (487)
                      .|+||||++|++|.+++..  .....+++..+..++.|++.||+||   |+.|++||||||+||+++.++.++|+|||++
T Consensus        68 ~~lv~e~~~g~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~l---H~~~ivH~dikp~Nili~~~~~~~l~Dfg~~  142 (277)
T cd05607          68 LCLVMSLMNGGDLKYHIYN--VGERGLEMERVIHYSAQITCGILHL---HSMDIVYRDMKPENVLLDDQGNCRLSDLGLA  142 (277)
T ss_pred             EEEEEecCCCCCHHHHHHh--ccccCCCHHHHHHHHHHHHHHHHHH---HHCCEEEccCChHhEEEcCCCCEEEeeceee
Confidence            9999999999999988854  2345688899999999999999999   7789999999999999999999999999998


Q ss_pred             cccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHHHhcCCCC
Q 011360          360 MAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSKNPS  439 (487)
Q Consensus       360 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  439 (487)
                      ........   .....|++.|+|||++.+..++.++|||||||++|+|++|..||.......  ...+........ .. 
T Consensus       143 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~-~~-  215 (277)
T cd05607         143 VELKDGKT---ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV--AKEELKRRTLED-EV-  215 (277)
T ss_pred             eecCCCce---eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh--hHHHHHHHhhcc-cc-
Confidence            76644322   123468999999999998889999999999999999999999995432211  111111211111 11 


Q ss_pred             CccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          440 RAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       440 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                         .  .+   ....+.++.+++.+||+.||++||+++++++
T Consensus       216 ---~--~~---~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~  249 (277)
T cd05607         216 ---K--FE---HQNFTEESKDICRLFLAKKPEDRLGSREKND  249 (277)
T ss_pred             ---c--cc---cccCCHHHHHHHHHHhccCHhhCCCCccchh
Confidence               0  00   0123356889999999999999999976654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.5e-38  Score=303.16  Aligned_cols=256  Identities=24%  Similarity=0.381  Sum_probs=201.5

Q ss_pred             hccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccc
Q 011360          190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILP  269 (487)
Q Consensus       190 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~  269 (487)
                      ..+.|.+.+.||.|+||.||+|...  ++..||+|.+...                ......+.+|+.+++.++||||++
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~--~~~~~a~K~~~~~----------------~~~~~~~~~E~~~l~~l~h~~i~~   65 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYN--GHTKVAIKSLKQG----------------SMSPEAFLAEANLMKQLQHPRLVR   65 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecC--CCceEEEEEecCC----------------CCcHHHHHHHHHHHHhcCCcCeee
Confidence            3456999999999999999999753  6788999987321                112346788999999999999999


Q ss_pred             cceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC
Q 011360          270 LLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDM  349 (487)
Q Consensus       270 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~  349 (487)
                      +++++. .+..+++|||+.+++|.+++..  ..+..+++..+..++.|++.||+||   |+.|++||||+|+||+++.++
T Consensus        66 ~~~~~~-~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~~i~~al~~L---H~~~i~H~dl~p~ni~i~~~~  139 (260)
T cd05067          66 LYAVVT-QEPIYIITEYMENGSLVDFLKT--PEGIKLTINKLIDMAAQIAEGMAFI---ERKNYIHRDLRAANILVSETL  139 (260)
T ss_pred             EEEEEc-cCCcEEEEEcCCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHH---hcCCeecccccHHhEEEcCCC
Confidence            999864 5678999999999999999864  3345788999999999999999999   778899999999999999999


Q ss_pred             CEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccccHHH
Q 011360          350 EACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSPEW  428 (487)
Q Consensus       350 ~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~  428 (487)
                      .++|+|||++.......... .....++..|+|||++.+..++.++||||||+++|++++ |.+||....      ..+.
T Consensus       140 ~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~------~~~~  212 (260)
T cd05067         140 CCKIADFGLARLIEDNEYTA-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT------NPEV  212 (260)
T ss_pred             CEEEccCcceeecCCCCccc-ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC------hHHH
Confidence            99999999987665322111 122345678999999998889999999999999999999 999995332      1222


Q ss_pred             HHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          429 LRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       429 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      ...+. ..... .    .+.    ..+.++.+++.+||..+|++|||++++...|+.+
T Consensus       213 ~~~~~-~~~~~-~----~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  260 (260)
T cd05067         213 IQNLE-RGYRM-P----RPD----NCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF  260 (260)
T ss_pred             HHHHH-cCCCC-C----CCC----CCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence            22222 11111 1    111    1235699999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.9e-38  Score=308.30  Aligned_cols=265  Identities=20%  Similarity=0.294  Sum_probs=202.9

Q ss_pred             cccccccccccccceeEEEEEecCC---------------CCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHH
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGS---------------NGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI  256 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~---------------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~  256 (487)
                      ++|.+.+.||+|+||.||++.....               .+..||+|.+..              .........+.+|+
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~--------------~~~~~~~~~~~~e~   70 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRP--------------DASDNAREDFLKEV   70 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecC--------------ccCHHHHHHHHHHH
Confidence            4689999999999999999975422               224689998732              11123456788999


Q ss_pred             HHhccCCCCCccccceEEecCCeeEEEEEecCCCCHHHHHhhhhc-------CCCCCChHHHHHHHHHHHHHHHHHHhcC
Q 011360          257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSR-------GRRELDWPSRHRIALGVASGLEYLHMYH  329 (487)
Q Consensus       257 ~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~qi~~~L~~Lh~~h  329 (487)
                      .++.+++||||+++++++..++..+++|||+++++|.+++.....       ....+++..++.++.|++.||.||   |
T Consensus        71 ~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~L---H  147 (296)
T cd05051          71 KILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYL---E  147 (296)
T ss_pred             HHHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHH---H
Confidence            999999999999999999999999999999999999999975321       123689999999999999999999   6


Q ss_pred             CCCeeecCCCCCCEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh
Q 011360          330 SASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR  409 (487)
Q Consensus       330 ~~givH~Dlkp~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt  409 (487)
                      +.|++||||||+||+++.++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++
T Consensus       148 ~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~  227 (296)
T cd05051         148 SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT  227 (296)
T ss_pred             HcCccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHh
Confidence            77899999999999999999999999999876544332222233456788999999988889999999999999999998


Q ss_pred             --CCCCccccCCCCccccHHHHHHHHhc---CCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHh
Q 011360          410 --GVPSFVFHQNGEEICSPEWLRKVMNS---KNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLS  484 (487)
Q Consensus       410 --g~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~  484 (487)
                        |..||.....      ...+......   .......+  .    ....+.++.+++.+||+.+|++|||+.+|++.|+
T Consensus       228 ~~~~~p~~~~~~------~~~~~~~~~~~~~~~~~~~~~--~----~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         228 LCREQPYEHLTD------QQVIENAGHFFRDDGRQIYLP--R----PPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             cCCCCCCCCcCh------HHHHHHHHhccccccccccCC--C----ccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence              5777743221      1111111111   11111000  0    1122356899999999999999999999999886


Q ss_pred             h
Q 011360          485 Q  485 (487)
Q Consensus       485 ~  485 (487)
                      +
T Consensus       296 ~  296 (296)
T cd05051         296 R  296 (296)
T ss_pred             C
Confidence            3

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.8e-39  Score=311.16  Aligned_cols=262  Identities=24%  Similarity=0.298  Sum_probs=198.1

Q ss_pred             cccccccccccceeEEEEEec---CCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          194 FASLEKIGSGGCGEVYKAELP---GSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       194 ~~~~~~lg~G~~g~v~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      |.+.+.||.|+||+||++.++   ..++..||+|.+...              ........+.+|+.+++.++||||+++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~--------------~~~~~~~~~~~E~~~l~~l~h~~i~~~   71 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRE--------------CGQQNTSGWKKEINILKTLYHENIVKY   71 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccc--------------cChHHHHHHHHHHHHHHhCCCCCEeeE
Confidence            388899999999999987642   346788999987321              111234567789999999999999999


Q ss_pred             ceEEecC--CeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC
Q 011360          271 LAHMVRP--DCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDD  348 (487)
Q Consensus       271 ~~~~~~~--~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~  348 (487)
                      ++++...  ...+++|||+++++|.+++..     ..+++..+..++.|++.||.||   |++|++||||||+||+++.+
T Consensus        72 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~l---H~~~i~H~dlkp~Nili~~~  143 (283)
T cd05080          72 KGCCSEQGGKGLQLIMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYL---HSQHYIHRDLAARNVLLDND  143 (283)
T ss_pred             EEEEecCCCceEEEEecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHH---HHCCeeccccChheEEEcCC
Confidence            9987653  467899999999999999864     3589999999999999999999   67789999999999999999


Q ss_pred             CCEEEeccCCccccCCCCceee-EeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCc-----
Q 011360          349 MEACISDLGLAMAIPDGYTRVL-ISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEE-----  422 (487)
Q Consensus       349 ~~~kl~DFg~s~~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~-----  422 (487)
                      +.++|+|||++........... .....++..|+|||.+.+..++.++||||||+++|+|+||..||........     
T Consensus       144 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~  223 (283)
T cd05080         144 RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGP  223 (283)
T ss_pred             CcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcc
Confidence            9999999999987654322111 1122356779999999888899999999999999999999999854321100     


Q ss_pred             ---cccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          423 ---ICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       423 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                         ...............     ....+    ...+..+.+++.+||+.+|++|||+++|++.|+.+
T Consensus       224 ~~~~~~~~~~~~~~~~~~-----~~~~~----~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~  281 (283)
T cd05080         224 KQGQMTVVRLIELLERGM-----RLPCP----KNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM  281 (283)
T ss_pred             cccccchhhhhhhhhcCC-----CCCCC----CCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence               000000111111000     00011    12335689999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-38  Score=302.62  Aligned_cols=258  Identities=19%  Similarity=0.293  Sum_probs=201.4

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      +.|.+.+.||.|++|.||.+.. ..++..||+|.+......          .........+.+|+.++++++||||++++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~-~~~~~~~~lk~~~~~~~~----------~~~~~~~~~~~~e~~~l~~l~~~~i~~~~   70 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYD-VDTGRELAVKQVPFDPDS----------PETKKEVNALECEIQLLKNLQHERIVQYY   70 (263)
T ss_pred             CcccccceecCCCceEEEEEEE-cCCCcEEEEEEEeecccc----------hhhHHHHHHHHHHHHHHHhCCCCCeeeeE
Confidence            3588899999999999999964 467899999987432110          11122345678899999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++...+..+++|||+++++|.+++..    ...++...+..++.|++.||.||   |+.|++||||+|+||+++.++.+
T Consensus        71 ~~~~~~~~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~l---H~~~i~H~dl~p~nilv~~~~~~  143 (263)
T cd06625          71 GCLRDDETLSIFMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYL---HSNMIVHRDIKGANILRDSAGNV  143 (263)
T ss_pred             EEEccCCeEEEEEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCCE
Confidence            999999999999999999999999875    35688899999999999999999   77889999999999999999999


Q ss_pred             EEeccCCccccCCCCceee-EeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVL-ISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLR  430 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~  430 (487)
                      +|+|||++........... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||.....      .....
T Consensus       144 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~  217 (263)
T cd06625         144 KLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA------MAAIF  217 (263)
T ss_pred             EEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch------HHHHH
Confidence            9999999876533211111 0234578899999999998899999999999999999999999943211      11112


Q ss_pred             HHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHH
Q 011360          431 KVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCR  482 (487)
Q Consensus       431 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~  482 (487)
                      ...... ....++.        .....+.+++.+||..+|++|||+.+++..
T Consensus       218 ~~~~~~-~~~~~~~--------~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         218 KIATQP-TNPQLPS--------HVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             HHhccC-CCCCCCc--------cCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence            221111 1111111        123458899999999999999999999863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=8.2e-39  Score=304.88  Aligned_cols=255  Identities=27%  Similarity=0.410  Sum_probs=199.3

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .++|.+.+.||.|+||.||+|...  ++..+|+|.+...                ......+.+|+.++++++||||+++
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~--~~~~~~~k~~~~~----------------~~~~~~~~~E~~~l~~l~~~~i~~~   66 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWN--GNTKVAVKTLKPG----------------TMSPESFLEEAQIMKKLRHDKLVQL   66 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEec--CCceeEEEEecCC----------------CCCHHHHHHHHHHHHhcCCCceEEE
Confidence            456999999999999999999754  5667999987321                0112357889999999999999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      ++++. ....+++|||+++++|.+++..  .....+++..+..++.|++.||.||   |++|++||||+|+||++++++.
T Consensus        67 ~~~~~-~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~al~~l---H~~~i~H~di~p~Nili~~~~~  140 (260)
T cd05070          67 YAVVS-EEPIYIVTEYMSKGSLLDFLKD--GEGRALKLPNLVDMAAQVAAGMAYI---ERMNYIHRDLRSANILVGDGLV  140 (260)
T ss_pred             EeEEC-CCCcEEEEEecCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCccceEEEeCCce
Confidence            99875 4568999999999999999864  2345689999999999999999999   6678999999999999999999


Q ss_pred             EEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccccHHHH
Q 011360          351 ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSPEWL  429 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~  429 (487)
                      ++|+|||++.......... .....++..|+|||.+.+..++.++|+||||+++|+|++ |.+||....      ..+..
T Consensus       141 ~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~------~~~~~  213 (260)
T cd05070         141 CKIADFGLARLIEDNEYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN------NREVL  213 (260)
T ss_pred             EEeCCceeeeeccCccccc-ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC------HHHHH
Confidence            9999999997654332211 112235678999999988889999999999999999999 899994322      12222


Q ss_pred             HHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          430 RKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       430 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      ........+      ..+.    ..+..+.+++.+||..+|++|||+.++.+.|++.
T Consensus       214 ~~~~~~~~~------~~~~----~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  260 (260)
T cd05070         214 EQVERGYRM------PCPQ----DCPISLHELMLQCWKKDPEERPTFEYLQSFLEDY  260 (260)
T ss_pred             HHHHcCCCC------CCCC----cCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence            222221111      1111    2235688999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2.2e-38  Score=303.22  Aligned_cols=260  Identities=23%  Similarity=0.367  Sum_probs=202.9

Q ss_pred             cccccccccccccceeEEEEEecCC--CCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGS--NGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILP  269 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~  269 (487)
                      .+|.+.+.||.|+||.||+|.+...  .+..+|+|.+..              .........+..|+.++.+++||||++
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~--------------~~~~~~~~~~~~e~~~l~~l~h~~i~~   69 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKA--------------GYTEKQRRDFLSEASIMGQFDHPNIIH   69 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCC--------------CCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            3588899999999999999976422  234799997732              111223457788999999999999999


Q ss_pred             cceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC
Q 011360          270 LLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDM  349 (487)
Q Consensus       270 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~  349 (487)
                      +++++...+..|+||||+++++|.+++..   ....+++..+..++.|++.||.||   |+.|++||||||+||+++.++
T Consensus        70 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~l---H~~~i~h~dlkp~nili~~~~  143 (267)
T cd05066          70 LEGVVTKSKPVMIVTEYMENGSLDAFLRK---HDGQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILVNSNL  143 (267)
T ss_pred             EEEEEecCCccEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHH---HHCCEeehhhchhcEEECCCC
Confidence            99999999999999999999999999864   234688999999999999999999   778899999999999999999


Q ss_pred             CEEEeccCCccccCCCCceeeE-eeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccccHH
Q 011360          350 EACISDLGLAMAIPDGYTRVLI-SYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSPE  427 (487)
Q Consensus       350 ~~kl~DFg~s~~~~~~~~~~~~-~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~  427 (487)
                      .++|+|||++............ ....++..|+|||.+.+..++.++|+||||+++|++++ |..||.....      .+
T Consensus       144 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~------~~  217 (267)
T cd05066         144 VCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN------QD  217 (267)
T ss_pred             eEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH------HH
Confidence            9999999999876543221111 11223568999999998889999999999999999886 9999944322      12


Q ss_pred             HHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhhC
Q 011360          428 WLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL  487 (487)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~ll  487 (487)
                      ..........+.      .+.    ..+..+.+++.+||+.+|++|||+.++++.|++++
T Consensus       218 ~~~~~~~~~~~~------~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~  267 (267)
T cd05066         218 VIKAIEEGYRLP------APM----DCPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI  267 (267)
T ss_pred             HHHHHhCCCcCC------CCC----CCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhhC
Confidence            222222221111      111    12346889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=6.1e-39  Score=321.20  Aligned_cols=255  Identities=21%  Similarity=0.294  Sum_probs=196.8

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||.|+||.||++.. ..+++.+|+|.+...            ..........+.+|..+++.++||||++++
T Consensus        43 ~~y~i~~~lG~G~fg~Vy~~~~-~~~~~~~aiK~i~~~------------~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~  109 (371)
T cd05622          43 EDYEVVKVIGRGAFGEVQLVRH-KSTRKVYAMKLLSKF------------EMIKRSDSAFFWEERDIMAFANSPWVVQLF  109 (371)
T ss_pred             hhcEEEEEEeecCCeEEEEEEE-CCCCcEEEEEEEEHH------------HhhhhHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence            4699999999999999999975 467889999987320            111222345577899999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++..++..|+||||+++|+|.+++..     ..++...+..++.|++.||.||   |++||+||||||+|||++.++.+
T Consensus       110 ~~~~~~~~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDLkp~NIll~~~~~i  181 (371)
T cd05622         110 YAFQDDRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAI---HSMGFIHRDVKPDNMLLDKSGHL  181 (371)
T ss_pred             EEEEcCCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHH---HHCCEEeCCCCHHHEEECCCCCE
Confidence            999999999999999999999999864     3578888999999999999999   77889999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCC----CCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQP----ELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPE  427 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~  427 (487)
                      ||+|||++......... ......||+.|+|||++.+.    .++.++|||||||++|||++|..||...+.      ..
T Consensus       182 kL~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~  254 (371)
T cd05622         182 KLADFGTCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VG  254 (371)
T ss_pred             EEEeCCceeEcCcCCcc-cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH------HH
Confidence            99999999876433221 12345699999999998753    378999999999999999999999943321      22


Q ss_pred             HHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCC--CCChHHHHH
Q 011360          428 WLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEE--RPNSQYVRC  481 (487)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--RPs~~~il~  481 (487)
                      ....+........     ++.  ....+..+.+++..||..++.+  ||++.+|++
T Consensus       255 ~~~~i~~~~~~~~-----~~~--~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~  303 (371)
T cd05622         255 TYSKIMNHKNSLT-----FPD--DNDISKEAKNLICAFLTDREVRLGRNGVEEIKR  303 (371)
T ss_pred             HHHHHHcCCCccc-----CCC--cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhc
Confidence            2333332221111     111  1123456888999999844433  778888876

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=4.7e-39  Score=321.32  Aligned_cols=254  Identities=25%  Similarity=0.387  Sum_probs=196.0

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      .|.+.+.||.|+||.||++.. ..+++.||+|++..            ...........+..|..++..++||||+++++
T Consensus         2 ~f~~~~~lG~G~~g~V~~~~~-~~~~~~~aiK~~~~------------~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~   68 (360)
T cd05627           2 DFESLKVIGRGAFGEVRLVQK-KDTGHIYAMKILRK------------ADMLEKEQVAHIRAERDILVEADGAWVVKMFY   68 (360)
T ss_pred             CceEEEEEeeCCCEEEEEEEE-CCCCCEEEEEEEEH------------HHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEE
Confidence            588999999999999999975 45789999998842            11122334567788999999999999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEE
Q 011360          273 HMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC  352 (487)
Q Consensus       273 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~k  352 (487)
                      .+.+.+.+|+||||++||+|.+++..    ...+++..+..++.|++.||.||   |++||+||||||+|||++.++.++
T Consensus        69 ~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~l---H~~givHrDLkp~NIli~~~~~vk  141 (360)
T cd05627          69 SFQDKRNLYLIMEFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAI---HQLGFIHRDIKPDNLLLDAKGHVK  141 (360)
T ss_pred             EEEcCCEEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeEccCCCHHHEEECCCCCEE
Confidence            99999999999999999999999864    45689999999999999999999   778999999999999999999999


Q ss_pred             EeccCCccccCCCCce---------------------------------eeEeeecccccccCCcccCCCCCCchhHHHH
Q 011360          353 ISDLGLAMAIPDGYTR---------------------------------VLISYVLGTMAYIAPEYFQQPELSEKCDIFS  399 (487)
Q Consensus       353 l~DFg~s~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~Dvws  399 (487)
                      |+|||++.........                                 ......+||+.|+|||++.+..++.++||||
T Consensus       142 L~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwS  221 (360)
T cd05627         142 LSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWS  221 (360)
T ss_pred             EeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceecc
Confidence            9999998754321100                                 0011346999999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCC---h
Q 011360          400 FGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPN---S  476 (487)
Q Consensus       400 lG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs---~  476 (487)
                      |||++|||+||.+||.....      .+........ .....+++..+      .+.++.+++.+|+ .+|.+|++   +
T Consensus       222 lGvilyel~tG~~Pf~~~~~------~~~~~~i~~~-~~~~~~p~~~~------~s~~~~~li~~l~-~~p~~R~~~~~~  287 (360)
T cd05627         222 LGVIMYEMLIGYPPFCSETP------QETYRKVMNW-KETLVFPPEVP------ISEKAKDLILRFC-TDSENRIGSNGV  287 (360)
T ss_pred             ccceeeecccCCCCCCCCCH------HHHHHHHHcC-CCceecCCCCC------CCHHHHHHHHHhc-cChhhcCCCCCH
Confidence            99999999999999954322      2222223221 11111111111      2245777777766 49999996   4


Q ss_pred             HHHH
Q 011360          477 QYVR  480 (487)
Q Consensus       477 ~~il  480 (487)
                      .+++
T Consensus       288 ~ei~  291 (360)
T cd05627         288 EEIK  291 (360)
T ss_pred             HHHh
Confidence            5554

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.5e-38  Score=302.35  Aligned_cols=249  Identities=27%  Similarity=0.399  Sum_probs=197.9

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||.|+||.||++..   .+..+|+|.+..                 ......+.+|+.++++++|||+++++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~---~~~~~~~k~~~~-----------------~~~~~~~~~e~~~l~~l~~~~i~~~~   65 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDY---RGNKVAVKCIKN-----------------DATAQAFLAEASVMTQLRHSNLVQLL   65 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEE---cCCcEEEEEeCC-----------------CchHHHHHHHHHHHHhCCCCCeeeEE
Confidence            4689999999999999999975   577899998632                 11234678899999999999999999


Q ss_pred             eEEe-cCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          272 AHMV-RPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       272 ~~~~-~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      +++. ..+..+++|||+++++|.+++..  .....+++..+..++.|++.||+||   |++|++||||||+||+++.++.
T Consensus        66 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~nil~~~~~~  140 (256)
T cd05082          66 GVIVEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYL---EANNFVHRDLAARNVLVSEDNV  140 (256)
T ss_pred             EEEEcCCCceEEEEECCCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHH---HhCCEeccccchheEEEcCCCc
Confidence            9764 45678999999999999999875  2334588999999999999999999   7889999999999999999999


Q ss_pred             EEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccccHHHH
Q 011360          351 ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSPEWL  429 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~  429 (487)
                      +||+|||++.......     ....++..|+|||++.+..++.++|||||||++|+|++ |..||...      ...+..
T Consensus       141 ~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~------~~~~~~  209 (256)
T cd05082         141 AKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI------PLKDVV  209 (256)
T ss_pred             EEecCCccceeccccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC------CHHHHH
Confidence            9999999987543322     12235678999999998899999999999999999998 89998432      112222


Q ss_pred             HHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          430 RKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       430 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      ... ...... ...+.        .+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       210 ~~~-~~~~~~-~~~~~--------~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         210 PRV-EKGYKM-DAPDG--------CPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             HHH-hcCCCC-CCCCC--------CCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence            222 222111 11111        235688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=3.6e-38  Score=301.74  Aligned_cols=260  Identities=23%  Similarity=0.366  Sum_probs=202.6

Q ss_pred             cccccccccccccceeEEEEEecCC--CCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGS--NGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILP  269 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~  269 (487)
                      +.|...+.||.|+||.||+|.....  ....+|+|.+..              .........+..|+.++.+++||||++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~--------------~~~~~~~~~~~~e~~~l~~l~h~~i~~   70 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKP--------------GYTEKQRQDFLSEASIMGQFSHHNIIR   70 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccc--------------cCCHHHHHHHHHHHHHHhcCCCCCeeE
Confidence            3588889999999999999986422  224789998732              111223456788999999999999999


Q ss_pred             cceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC
Q 011360          270 LLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDM  349 (487)
Q Consensus       270 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~  349 (487)
                      +++++...+..|+||||+++++|.+++..   ....+++..+..++.|++.||.||   |+.|++||||||+||+++.++
T Consensus        71 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~l---H~~~i~H~dlkp~Nili~~~~  144 (268)
T cd05063          71 LEGVVTKFKPAMIITEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYL---SDMNYVHRDLAARNILVNSNL  144 (268)
T ss_pred             EEEEEccCCCcEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccccchhhEEEcCCC
Confidence            99999999999999999999999999864   235688999999999999999999   677899999999999999999


Q ss_pred             CEEEeccCCccccCCCCceeeE-eeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccccHH
Q 011360          350 EACISDLGLAMAIPDGYTRVLI-SYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSPE  427 (487)
Q Consensus       350 ~~kl~DFg~s~~~~~~~~~~~~-~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~  427 (487)
                      .+||+|||++............ .....++.|+|||++.+..++.++||||||+++|++++ |..||....      ..+
T Consensus       145 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~------~~~  218 (268)
T cd05063         145 ECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS------NHE  218 (268)
T ss_pred             cEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCC------HHH
Confidence            9999999998766443222111 11223457999999998889999999999999999997 999994322      122


Q ss_pred             HHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhhC
Q 011360          428 WLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL  487 (487)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~ll  487 (487)
                      ....+........      +    ...+..+.+++.+||+.+|++||++.+|++.|++++
T Consensus       219 ~~~~i~~~~~~~~------~----~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~  268 (268)
T cd05063         219 VMKAINDGFRLPA------P----MDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL  268 (268)
T ss_pred             HHHHHhcCCCCCC------C----CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence            3333322111110      1    112356889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-39  Score=321.26  Aligned_cols=260  Identities=22%  Similarity=0.334  Sum_probs=209.8

Q ss_pred             HhhhccccccccccccccceeEEEEEecCCCCc--eEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCC
Q 011360          187 FLKKEDCFASLEKIGSGGCGEVYKAELPGSNGK--MIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRH  264 (487)
Q Consensus       187 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h  264 (487)
                      .++.++.....+.||+|.||.|++|.|...+|+  .||||.+...              .-......|++|+.+|.+|+|
T Consensus       105 clIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d--------------~l~~~mddflrEas~M~~L~H  170 (1039)
T KOG0199|consen  105 CLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDD--------------SLNAIMDDFLREASHMLKLQH  170 (1039)
T ss_pred             eeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCC--------------ccchhHHHHHHHHHHHHhccC
Confidence            344455678889999999999999999766664  6899988431              111267889999999999999


Q ss_pred             CCccccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEE
Q 011360          265 RNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVL  344 (487)
Q Consensus       265 pnIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nil  344 (487)
                      ||++++||+..+ ..+.+|||+++.|||.+.|.+  .....|.......++.|||.|+.||   .++++|||||..+|+|
T Consensus       171 ~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YL---eskrlvHRDLAARNll  244 (1039)
T KOG0199|consen  171 PHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYL---ESKRLVHRDLAARNLL  244 (1039)
T ss_pred             cceeEEeeeecc-chhhHHhhhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhhhhe
Confidence            999999999887 788999999999999999986  4567788899999999999999999   7777999999999999


Q ss_pred             eCCCCCEEEeccCCccccCCCCcee-eEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCc
Q 011360          345 LNDDMEACISDLGLAMAIPDGYTRV-LISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEE  422 (487)
Q Consensus       345 l~~~~~~kl~DFg~s~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~  422 (487)
                      +..--.|||+|||+.+.++.+.... +.....-+..|+|||.+....++.++|||+||+++|||+| |..||.+..    
T Consensus       245 lasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~----  320 (1039)
T KOG0199|consen  245 LASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR----  320 (1039)
T ss_pred             ecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC----
Confidence            9998899999999999987654433 3333445788999999999999999999999999999999 589994432    


Q ss_pred             cccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHH
Q 011360          423 ICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCR  482 (487)
Q Consensus       423 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~  482 (487)
                         ...+.+.+..+.       +++  ....+++++++++..||..+|.+||||..|.+.
T Consensus       321 ---g~qIL~~iD~~e-------rLp--RPk~csedIY~imk~cWah~paDRptFsair~~  368 (1039)
T KOG0199|consen  321 ---GIQILKNIDAGE-------RLP--RPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED  368 (1039)
T ss_pred             ---HHHHHHhccccc-------cCC--CCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence               222222322111       111  112345789999999999999999999999743

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.2e-38  Score=308.51  Aligned_cols=262  Identities=22%  Similarity=0.336  Sum_probs=203.2

Q ss_pred             ccccccccccccccceeEEEEEec----CCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCC
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELP----GSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRN  266 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn  266 (487)
                      .++|.+.+.||.|+||.||++...    ..++..||+|.+..              .........+.+|+.+++.+.|||
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~--------------~~~~~~~~~~~~ei~~l~~l~h~~   69 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKE--------------EASADMQADFQREAALMAEFDHPN   69 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCC--------------CcCHHHHHHHHHHHHHHHhcCCCc
Confidence            356999999999999999999753    23678899998732              111233456888999999999999


Q ss_pred             ccccceEEecCCeeEEEEEecCCCCHHHHHhhhh------------------cCCCCCChHHHHHHHHHHHHHHHHHHhc
Q 011360          267 ILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVS------------------RGRRELDWPSRHRIALGVASGLEYLHMY  328 (487)
Q Consensus       267 Iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~------------------~~~~~l~~~~~~~i~~qi~~~L~~Lh~~  328 (487)
                      |+++++++...+..+++|||+++|+|.+++....                  .....+++..++.++.|++.||.||   
T Consensus        70 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~l---  146 (288)
T cd05050          70 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYL---  146 (288)
T ss_pred             hheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHH---
Confidence            9999999999999999999999999999997421                  1123578888999999999999999   


Q ss_pred             CCCCeeecCCCCCCEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHH
Q 011360          329 HSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLV  408 (487)
Q Consensus       329 h~~givH~Dlkp~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ell  408 (487)
                      |++|++||||+|+||+++.++.++|+|||++.................+..|+|||.+.+..++.++|||||||++|+|+
T Consensus       147 H~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~  226 (288)
T cd05050         147 SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF  226 (288)
T ss_pred             HhCCeecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHH
Confidence            67889999999999999999999999999987553322111112223467899999998889999999999999999999


Q ss_pred             h-CCCCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhh
Q 011360          409 R-GVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQ  485 (487)
Q Consensus       409 t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~  485 (487)
                      + |..||...      ...+...... ......     .+.    ..+..+.+++.+||+.+|++|||+.++++.|++
T Consensus       227 ~~~~~p~~~~------~~~~~~~~~~-~~~~~~-----~~~----~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         227 SYGMQPYYGM------AHEEVIYYVR-DGNVLS-----CPD----NCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             hCCCCCCCCC------CHHHHHHHHh-cCCCCC-----CCC----CCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            8 78888322      2223333222 222110     111    123568899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-39  Score=331.74  Aligned_cols=258  Identities=24%  Similarity=0.282  Sum_probs=203.2

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CCCCccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RHRNILP  269 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~  269 (487)
                      ..++++.+.|.+|||+.||+|+.. ..|..||+|++..               ..+..++.+.+|+.+|++| .|+|||.
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~-~~~~~~AlKrm~~---------------~de~~L~~v~~EI~~MK~L~gh~nIV~   99 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDV-KGGKKYALKRMYV---------------NDEEALNAVKREIDIMKLLSGHKNIVS   99 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEec-CCCceeeeeeeec---------------CCHHHHHHHHHHHHHHHHhcCCCceee
Confidence            346899999999999999999864 3448999999843               2455778899999999999 5999999


Q ss_pred             cce-EEec------CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCC
Q 011360          270 LLA-HMVR------PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRN  342 (487)
Q Consensus       270 l~~-~~~~------~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~N  342 (487)
                      +++ ....      .-.++|+||||.||+|-|++...-  ...|++.++++|+.|+++|+++||.+ ..-|||||||-+|
T Consensus       100 yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rl--q~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiEN  176 (738)
T KOG1989|consen  100 YIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRL--QTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIEN  176 (738)
T ss_pred             EeccccccccCCCceeEEEeehhhccCCcHHHHHHHHH--hccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhh
Confidence            999 3322      134689999999999999998633  34499999999999999999999654 2339999999999


Q ss_pred             EEeCCCCCEEEeccCCccccCCCCceeeE-------eeecccccccCCccc---CCCCCCchhHHHHHHHHHHHHHhCCC
Q 011360          343 VLLNDDMEACISDLGLAMAIPDGYTRVLI-------SYVLGTMAYIAPEYF---QQPELSEKCDIFSFGMLLISLVRGVP  412 (487)
Q Consensus       343 ill~~~~~~kl~DFg~s~~~~~~~~~~~~-------~~~~gt~~y~aPE~l---~~~~~~~~~DvwslG~~l~elltg~~  412 (487)
                      |||+.+|+.||||||.++.....-.....       -....|+.|.|||.+   .+...+.|+|||||||+||-|+....
T Consensus       177 vLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~  256 (738)
T KOG1989|consen  177 VLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTT  256 (738)
T ss_pred             eEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCC
Confidence            99999999999999998754322211000       012368999999976   46688999999999999999999999


Q ss_pred             CccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          413 SFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       413 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      ||........                   +.-......+.+++..+.+||..||+.||++||++-+++..+..+
T Consensus       257 PFe~sg~laI-------------------lng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l  311 (738)
T KOG1989|consen  257 PFEESGKLAI-------------------LNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFEL  311 (738)
T ss_pred             CcCcCcceeE-------------------EeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHH
Confidence            9954432111                   111111122356778899999999999999999999999988765

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=2.8e-38  Score=300.77  Aligned_cols=251  Identities=23%  Similarity=0.312  Sum_probs=194.2

Q ss_pred             ccccccceeEEEEEecC-CCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceEEecC
Q 011360          199 KIGSGGCGEVYKAELPG-SNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRP  277 (487)
Q Consensus       199 ~lg~G~~g~v~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  277 (487)
                      .||.|+||.||+|.+.. .++..||+|.+..              .........+.+|+.++++++||||+++++++. .
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~--------------~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~   66 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKN--------------ENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-A   66 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEccc--------------ccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-C
Confidence            48999999999997642 3456799998732              112234467889999999999999999999875 4


Q ss_pred             CeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEeccC
Q 011360          278 DCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLG  357 (487)
Q Consensus       278 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~DFg  357 (487)
                      +..++||||+++++|.+++..   ....+++..++.++.|++.||.||   |++|++||||||+||+++.++.+||+|||
T Consensus        67 ~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~nil~~~~~~~kl~dfg  140 (257)
T cd05115          67 EALMLVMEMASGGPLNKFLSG---KKDEITVSNVVELMHQVSMGMKYL---EGKNFVHRDLAARNVLLVNQHYAKISDFG  140 (257)
T ss_pred             CCeEEEEEeCCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHH---HhcCeeecccchheEEEcCCCcEEeccCC
Confidence            578999999999999998863   245789999999999999999999   77889999999999999999999999999


Q ss_pred             CccccCCCCceee-EeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccccHHHHHHHHhc
Q 011360          358 LAMAIPDGYTRVL-ISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSPEWLRKVMNS  435 (487)
Q Consensus       358 ~s~~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  435 (487)
                      ++........... .....+++.|+|||.+.+..++.++||||||+++|++++ |..||....      ..+... ....
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~------~~~~~~-~~~~  213 (257)
T cd05115         141 LSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMK------GPEVMS-FIEQ  213 (257)
T ss_pred             ccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCC------HHHHHH-HHHC
Confidence            9976543322111 111223578999999988889999999999999999996 999994322      122222 2222


Q ss_pred             CCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          436 KNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       436 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      .... .    .+..    .+.++.+++.+||..+|++||++.+|.+.|+.+
T Consensus       214 ~~~~-~----~~~~----~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         214 GKRL-D----CPAE----CPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCC-C----CCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            2211 1    1111    235688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-40  Score=319.42  Aligned_cols=250  Identities=29%  Similarity=0.398  Sum_probs=205.7

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      +..|.-++.||.|+||.||.|+ +..+...||||++.-.+            ......-..+..|+..+.+++|||+|.+
T Consensus        25 Eklf~dLrEIGHGSFGAVYfAr-d~~n~evVAIKKMsySG------------KQs~EKWqDIlKEVrFL~~l~HPntieY   91 (948)
T KOG0577|consen   25 EKLFSDLREIGHGSFGAVYFAR-DVRNSEVVAIKKMSYSG------------KQSNEKWQDILKEVRFLRQLRHPNTIEY   91 (948)
T ss_pred             HHHHHHHHHhcCCccceeEEee-ccCccceeeeeeccccc------------cccHHHHHHHHHHHHHHHhccCCCcccc
Confidence            4468888999999999999997 45688999999985432            1223345678899999999999999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      .|+|..+...++||||| -||-.|++.-.   .+++.+..+..|+.+.+.||+||   |+.+.||||||+.|||+++.|.
T Consensus        92 kgCyLre~TaWLVMEYC-lGSAsDlleVh---kKplqEvEIAAi~~gaL~gLaYL---HS~~~IHRDiKAGNILLse~g~  164 (948)
T KOG0577|consen   92 KGCYLREHTAWLVMEYC-LGSASDLLEVH---KKPLQEVEIAAITHGALQGLAYL---HSHNRIHRDIKAGNILLSEPGL  164 (948)
T ss_pred             cceeeccchHHHHHHHH-hccHHHHHHHH---hccchHHHHHHHHHHHHHHHHHH---HHhhHHhhhccccceEecCCCe
Confidence            99999999999999999 66889988753   56788889999999999999999   7888999999999999999999


Q ss_pred             EEEeccCCccccCCCCceeeEeeecccccccCCcccC---CCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHH
Q 011360          351 ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQ---QPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPE  427 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~  427 (487)
                      |||+|||.+....+.      ..++|||.|||||++.   .+.|+-++|||||||+..||...++|+...      +...
T Consensus       165 VKLaDFGSAsi~~PA------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM------NAMS  232 (948)
T KOG0577|consen  165 VKLADFGSASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM------NAMS  232 (948)
T ss_pred             eeeccccchhhcCch------hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc------hHHH
Confidence            999999998765443      3578999999999875   568999999999999999999999998332      2222


Q ss_pred             HHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          428 WLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .+. .+..+..     |.++   ..+.+..|..++..||++-|.+|||.++++.
T Consensus       233 ALY-HIAQNes-----PtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  233 ALY-HIAQNES-----PTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             HHH-HHHhcCC-----CCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence            232 2333332     1222   3456678999999999999999999998875

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2.5e-38  Score=310.18  Aligned_cols=263  Identities=24%  Similarity=0.339  Sum_probs=202.2

Q ss_pred             ccccccccccccccceeEEEEEec------CCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-C
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELP------GSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-R  263 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~  263 (487)
                      .++|.+.+.||.|+||.||+++..      ..+...+|+|.+..              .........+..|+.++..+ .
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~--------------~~~~~~~~~~~~E~~~l~~l~~   76 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKD--------------NATDKDLADLISEMELMKLIGK   76 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCC--------------CCChHHHHHHHHHHHHHHhccC
Confidence            456899999999999999999742      12345789997632              11223355678899999999 6


Q ss_pred             CCCccccceEEecCCeeEEEEEecCCCCHHHHHhhhhc------------CCCCCChHHHHHHHHHHHHHHHHHHhcCCC
Q 011360          264 HRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSR------------GRRELDWPSRHRIALGVASGLEYLHMYHSA  331 (487)
Q Consensus       264 hpnIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~  331 (487)
                      ||||+++++++...+..|++|||+++|+|.+++.....            ....+++..+..++.|++.||.||   |++
T Consensus        77 h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~l---H~~  153 (314)
T cd05099          77 HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYL---ESR  153 (314)
T ss_pred             CCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHH---HHC
Confidence            99999999999999999999999999999999975321            124588899999999999999999   778


Q ss_pred             CeeecCCCCCCEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-C
Q 011360          332 SIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-G  410 (487)
Q Consensus       332 givH~Dlkp~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g  410 (487)
                      |++||||||+||+++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|+|++ |
T Consensus       154 gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g  233 (314)
T cd05099         154 RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLG  233 (314)
T ss_pred             CeeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCC
Confidence            999999999999999999999999999986643222111122234568999999998889999999999999999999 7


Q ss_pred             CCCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          411 VPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       411 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      ..||....      ..+... .........     .+.    ..+.++.+++.+||..+|++|||+.++++.|+++
T Consensus       234 ~~p~~~~~------~~~~~~-~~~~~~~~~-----~~~----~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~  293 (314)
T cd05099         234 GSPYPGIP------VEELFK-LLREGHRMD-----KPS----NCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV  293 (314)
T ss_pred             CCCCCCCC------HHHHHH-HHHcCCCCC-----CCC----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            88883321      112222 222221111     111    1224688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.2e-38  Score=299.98  Aligned_cols=251  Identities=27%  Similarity=0.403  Sum_probs=202.5

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .+.|.+.+.||.|+||.||+|..   .|..||+|.+..                ......++..|+.+++.++||||+++
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~---~~~~v~iK~~~~----------------~~~~~~~~~~e~~~l~~l~~~~i~~~   65 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDY---RGQKVAVKCLKD----------------DSTAAQAFLAEASVMTTLRHPNLVQL   65 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEe---cCcEEEEEEecc----------------chhHHHHHHHHHHHHHhcCCcceeee
Confidence            34688999999999999999975   578899998732                11145678889999999999999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      ++++...+..++||||+++++|.+++..  .....+++..+..++.|++.||.||   |++|++|+||||+||+++.++.
T Consensus        66 ~~~~~~~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~l---h~~~i~H~di~p~Nili~~~~~  140 (256)
T cd05039          66 LGVVLQGNPLYIVTEYMAKGSLVDYLRS--RGRAVITLAQQLGFALDVCEGMEYL---EEKNFVHRDLAARNVLVSEDLV  140 (256)
T ss_pred             EEEEcCCCCeEEEEEecCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHH---HhCCccchhcccceEEEeCCCC
Confidence            9999989999999999999999999875  2234689999999999999999999   7788999999999999999999


Q ss_pred             EEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccccHHHH
Q 011360          351 ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSPEWL  429 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~  429 (487)
                      ++|+|||.+........     ....+..|+|||.+.+..++.++||||||+++|++++ |..||....       ....
T Consensus       141 ~~l~d~g~~~~~~~~~~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-------~~~~  208 (256)
T cd05039         141 AKVSDFGLAKEASQGQD-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-------LKDV  208 (256)
T ss_pred             EEEcccccccccccccc-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC-------HHHH
Confidence            99999999987633222     2234678999999988889999999999999999997 999984321       1222


Q ss_pred             HHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          430 RKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       430 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      ......... ...+.        ..+..+.+++.+||..+|++|||+.++++.|+.+
T Consensus       209 ~~~~~~~~~-~~~~~--------~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         209 VPHVEKGYR-MEAPE--------GCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             HHHHhcCCC-CCCcc--------CCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence            222222111 11111        1235688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-38  Score=307.37  Aligned_cols=266  Identities=21%  Similarity=0.322  Sum_probs=199.5

Q ss_pred             cccccccccccccceeEEEEEecC-------------CCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHH
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPG-------------SNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT  258 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~-------------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~  258 (487)
                      ++|.+.+.||+|+||.||++....             .....||+|.+...              ........+.+|+.+
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~--------------~~~~~~~~~~~ei~~   70 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD--------------VTKTARNDFLKEIKI   70 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC--------------CCHHHHHHHHHHHHH
Confidence            469999999999999999986532             11235899987321              122334568899999


Q ss_pred             hccCCCCCccccceEEecCCeeEEEEEecCCCCHHHHHhhhhc--------CCCCCChHHHHHHHHHHHHHHHHHHhcCC
Q 011360          259 ASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSR--------GRRELDWPSRHRIALGVASGLEYLHMYHS  330 (487)
Q Consensus       259 l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~--------~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~  330 (487)
                      +.+++||||+++++++...+..++||||+++++|.+++.....        ....+++..+..++.|++.||.||   |+
T Consensus        71 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~l---H~  147 (295)
T cd05097          71 MSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---AS  147 (295)
T ss_pred             HHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHH---Hh
Confidence            9999999999999999999999999999999999999864211        112468889999999999999999   77


Q ss_pred             CCeeecCCCCCCEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-
Q 011360          331 ASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-  409 (487)
Q Consensus       331 ~givH~Dlkp~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-  409 (487)
                      .|++||||||+||+++.++.+||+|||++................++..|+|||.+.+..++.++||||||+++|+|++ 
T Consensus       148 ~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~  227 (295)
T cd05097         148 LNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTL  227 (295)
T ss_pred             cCeeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHc
Confidence            8899999999999999999999999999876543322222223345778999999988889999999999999999998 


Q ss_pred             -CCCCccccCCCCccccHHHHHHHHhcC-CC-CCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhh
Q 011360          410 -GVPSFVFHQNGEEICSPEWLRKVMNSK-NP-SRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQ  485 (487)
Q Consensus       410 -g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~  485 (487)
                       |..||.......   ............ .. ....++.        .+..+.+++.+||+.+|++|||+.+|++.|++
T Consensus       228 ~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~--------~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         228 CKEQPYSLLSDEQ---VIENTGEFFRNQGRQIYLSQTPL--------CPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             CCCCCCcccChHH---HHHHHHHhhhhccccccCCCCCC--------CCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence             566774332211   001111111110 10 0011111        22469999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=5.4e-38  Score=303.23  Aligned_cols=265  Identities=22%  Similarity=0.328  Sum_probs=199.7

Q ss_pred             cccccccccccccceeEEEEEe---cCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcc
Q 011360          192 DCFASLEKIGSGGCGEVYKAEL---PGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNIL  268 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~---~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv  268 (487)
                      +.|.+.+.||+|+||.||++.+   +..++..||+|++..               ........+.+|+.++..++||||+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~---------------~~~~~~~~~~~e~~~l~~l~h~~iv   68 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQH---------------STAEHLRDFEREIEILKSLQHDNIV   68 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEecc---------------CCHHHHHHHHHHHHHHHhCCCCCee
Confidence            4689999999999999999975   345688999998732               1223456788899999999999999


Q ss_pred             ccceEEec--CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC
Q 011360          269 PLLAHMVR--PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN  346 (487)
Q Consensus       269 ~l~~~~~~--~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~  346 (487)
                      ++++++..  ...+++||||+++|+|.+++..   ....+++..+..++.|++.||.||   |++|++||||||+||+++
T Consensus        69 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~aL~~L---H~~~i~H~dlkp~nili~  142 (284)
T cd05081          69 KYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQK---HRERLDHRKLLLYASQICKGMEYL---GSKRYVHRDLATRNILVE  142 (284)
T ss_pred             EEEEEEccCCCCceEEEEEecCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHH---HHCCceeccCCHhhEEEC
Confidence            99997754  3467899999999999999864   234588999999999999999999   788999999999999999


Q ss_pred             CCCCEEEeccCCccccCCCCceeeE-eeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCC----
Q 011360          347 DDMEACISDLGLAMAIPDGYTRVLI-SYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGE----  421 (487)
Q Consensus       347 ~~~~~kl~DFg~s~~~~~~~~~~~~-~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~----  421 (487)
                      .++.+||+|||++............ ....++..|+|||++.+..++.++||||||+++|||++|..|+.......    
T Consensus       143 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~  222 (284)
T cd05081         143 SENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMM  222 (284)
T ss_pred             CCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhc
Confidence            9999999999999876543322111 11223456999999998889999999999999999999876653221100    


Q ss_pred             ----c-cccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          422 ----E-ICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       422 ----~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                          . ......+......... ....        ...+..+.+++.+||..+|++|||+.+|++.|+.+
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~-~~~~--------~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         223 GNDKQGQMIVYHLIELLKNNGR-LPAP--------PGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             ccccccccchHHHHHHHhcCCc-CCCC--------CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence                0 0000111111111110 0001        11235688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=2.6e-38  Score=304.45  Aligned_cols=261  Identities=26%  Similarity=0.331  Sum_probs=200.9

Q ss_pred             cccccccccccccceeEEEEEecCC----CCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGS----NGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNI  267 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI  267 (487)
                      +.|.+.+.||.|++|.||+|.+...    ++..||+|.+..              .........+..|+.+++.++||||
T Consensus         6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~--------------~~~~~~~~~~~~e~~~l~~l~~~~i   71 (277)
T cd05036           6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPE--------------SCSEQDESDFLMEALIMSKFNHQNI   71 (277)
T ss_pred             HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCC--------------CCCHHHHHHHHHHHHHHHhCCCCCE
Confidence            4589999999999999999986431    467889997632              1112234567889999999999999


Q ss_pred             cccceEEecCCeeEEEEEecCCCCHHHHHhhhhc---CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEE
Q 011360          268 LPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSR---GRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVL  344 (487)
Q Consensus       268 v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nil  344 (487)
                      +++++++.+.+..++||||+++++|.+++.....   ....+++..+..++.||+.||.||   |+++++||||||+||+
T Consensus        72 ~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~L---H~~~ivH~dlkp~nil  148 (277)
T cd05036          72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYL---EENHFIHRDIAARNCL  148 (277)
T ss_pred             eeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHH---HHCCEeecccchheEE
Confidence            9999999999999999999999999999975321   123588999999999999999999   6778999999999999


Q ss_pred             eCCCC---CEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCC
Q 011360          345 LNDDM---EACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNG  420 (487)
Q Consensus       345 l~~~~---~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~  420 (487)
                      ++.++   .+||+|||+++................++.|+|||++.+..++.++|||||||++|+|++ |..||..... 
T Consensus       149 ~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~-  227 (277)
T cd05036         149 LTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN-  227 (277)
T ss_pred             EeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-
Confidence            98654   589999999987633222111112234578999999998899999999999999999997 8999953322 


Q ss_pred             CccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhh
Q 011360          421 EEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQ  485 (487)
Q Consensus       421 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~  485 (487)
                           .+..........+  ..+..+        +..+.+++.+||+.+|++|||+.+|++.|.+
T Consensus       228 -----~~~~~~~~~~~~~--~~~~~~--------~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~  277 (277)
T cd05036         228 -----QEVMEFVTGGGRL--DPPKGC--------PGPVYRIMTDCWQHTPEDRPNFATILERIQY  277 (277)
T ss_pred             -----HHHHHHHHcCCcC--CCCCCC--------CHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence                 1222222222111  111122        2468899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-40  Score=321.86  Aligned_cols=253  Identities=25%  Similarity=0.359  Sum_probs=207.5

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .+.|.++..||.|+||+||+|.. ..++..-|.|++               .......++.++-|+.+|+.+.||+||++
T Consensus        31 ~d~WeIiGELGDGAFGKVyKA~n-ket~~lAAaKvI---------------etkseEELEDylVEIeILa~CdHP~ivkL   94 (1187)
T KOG0579|consen   31 RDHWEIIGELGDGAFGKVYKAVN-KETKLLAAAKVI---------------ETKSEEELEDYLVEIEILAECDHPVIVKL   94 (1187)
T ss_pred             HHHHHHHhhhcCccchhhhhhhc-ccchhhhhhhhh---------------cccchhHHhhhhhhhhhhhcCCChHHHHH
Confidence            34578889999999999999964 456666666655               24456678889999999999999999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      ++.|...+.++|+.|||.||.+...+-..   +..+++.++..++.|++.||.||   |+++|||||||+.|||++-+|.
T Consensus        95 l~ayy~enkLwiliEFC~GGAVDaimlEL---~r~LtE~QIqvvc~q~ldALn~L---Hs~~iIHRDLKAGNiL~TldGd  168 (1187)
T KOG0579|consen   95 LSAYYFENKLWILIEFCGGGAVDAIMLEL---GRVLTEDQIQVVCYQVLDALNWL---HSQNIIHRDLKAGNILLTLDGD  168 (1187)
T ss_pred             HHHHhccCceEEEEeecCCchHhHHHHHh---ccccchHHHHHHHHHHHHHHHHH---hhcchhhhhccccceEEEecCc
Confidence            99999999999999999999998887643   67899999999999999999999   8889999999999999999999


Q ss_pred             EEEeccCCccccCCCCceeeEeeecccccccCCcccC-----CCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCcccc
Q 011360          351 ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQ-----QPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICS  425 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~  425 (487)
                      ++|+|||.+-....  +......+.|||.|||||+..     ..+|+.++||||||++|.||..+.+|-      .+...
T Consensus       169 irLADFGVSAKn~~--t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPH------helnp  240 (1187)
T KOG0579|consen  169 IRLADFGVSAKNKS--TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPH------HELNP  240 (1187)
T ss_pred             Eeeecccccccchh--HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCc------cccch
Confidence            99999999854322  122224678999999999864     568999999999999999999999997      33344


Q ss_pred             HHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          426 PEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       426 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ...+.++.....|...-+        ...+..+.+++.+||.+||..||++.+|++
T Consensus       241 MRVllKiaKSePPTLlqP--------S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  241 MRVLLKIAKSEPPTLLQP--------SHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             HHHHHHHhhcCCCcccCc--------chhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence            444555554444433322        234466999999999999999999999875

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=3.6e-39  Score=320.87  Aligned_cols=198  Identities=28%  Similarity=0.423  Sum_probs=174.2

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCC-C-----CC
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIR-H-----RN  266 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----pn  266 (487)
                      +|.+.+.||+|+||.|.+| ++..+++.||||+++                ......++...|+.+|..|+ |     -|
T Consensus       187 rY~V~e~LGkGtFGQVvk~-~d~~T~e~VAIKIiK----------------N~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n  249 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKA-YDHKTGEIVAIKIIK----------------NKKRFLRQAQIEIRILELLNKHDPDDKYN  249 (586)
T ss_pred             EEEEEEEecccccceeEEE-EecCCCcEEEEEeec----------------cChHHHHHHHHHHHHHHHHhccCCCCCee
Confidence            5889999999999999999 577899999999983                34556778889999999996 4     38


Q ss_pred             ccccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC
Q 011360          267 ILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN  346 (487)
Q Consensus       267 Iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~  346 (487)
                      +|+++++|...+++|||+|.+ ..+|.++++.  .....++...++.|+.||+.||.+|   |..||||+||||+|||+.
T Consensus       250 ~Vrm~d~F~fr~HlciVfELL-~~NLYellK~--n~f~Glsl~~ir~~~~Qil~~L~~L---~~l~IIHcDLKPENILL~  323 (586)
T KOG0667|consen  250 IVRMLDYFYFRNHLCIVFELL-STNLYELLKN--NKFRGLSLPLVRKFAQQILTALLFL---HELGIIHCDLKPENILLK  323 (586)
T ss_pred             EEEeeeccccccceeeeehhh-hhhHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeeccCChhheeec
Confidence            999999999999999999999 6699999987  4456699999999999999999999   788899999999999997


Q ss_pred             CC--CCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccC
Q 011360          347 DD--MEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ  418 (487)
Q Consensus       347 ~~--~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~  418 (487)
                      +-  ..+||+|||+|+.......     .++.+..|.|||++.+.+|+.+.|||||||++.||++|.+.|.+.+
T Consensus       324 ~~~r~~vKVIDFGSSc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~n  392 (586)
T KOG0667|consen  324 DPKRSRIKVIDFGSSCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDN  392 (586)
T ss_pred             cCCcCceeEEecccccccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCC
Confidence            53  3699999999987655432     4567889999999999999999999999999999999999885543

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1e-38  Score=318.91  Aligned_cols=263  Identities=25%  Similarity=0.335  Sum_probs=193.6

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||.|+||.||++.. ..+|..||+|++...             .........+.+|+.+++.++||||++++
T Consensus        21 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~-------------~~~~~~~~~~~~E~~~l~~l~h~niv~~~   86 (359)
T cd07876          21 KRYQQLKPIGSGAQGIVCAAFD-TVLGINVAVKKLSRP-------------FQNQTHAKRAYRELVLLKCVNHKNIISLL   86 (359)
T ss_pred             hceEEEEEeecCCCEEEEEEEE-cCCCceeEEEEeccc-------------ccchhHHHHHHHHHHHHHhCCCCCEeeee
Confidence            4699999999999999999964 467899999988321             11223345677899999999999999999


Q ss_pred             eEEecCC------eeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEe
Q 011360          272 AHMVRPD------CHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLL  345 (487)
Q Consensus       272 ~~~~~~~------~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill  345 (487)
                      +++...+      ..|+||||+++ +|...+.      ..++...+..++.|++.||.||   |++||+||||||+||++
T Consensus        87 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~~L~~L---H~~~ivHrDlkp~NIl~  156 (359)
T cd07876          87 NVFTPQKSLEEFQDVYLVMELMDA-NLCQVIH------MELDHERMSYLLYQMLCGIKHL---HSAGIIHRDLKPSNIVV  156 (359)
T ss_pred             eeeccCCCccccceeEEEEeCCCc-CHHHHHh------ccCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEEE
Confidence            9886543      46999999965 6666653      2478888999999999999999   77899999999999999


Q ss_pred             CCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCc---
Q 011360          346 NDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEE---  422 (487)
Q Consensus       346 ~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~---  422 (487)
                      +.++.+||+|||++........   .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+....   
T Consensus       157 ~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~  233 (359)
T cd07876         157 KSDCTLKILDFGLARTACTNFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNK  233 (359)
T ss_pred             CCCCCEEEecCCCccccccCcc---CCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            9999999999999976433221   1335689999999999999999999999999999999999999964432100   


Q ss_pred             ------cccHHH-------HHHHHhcCCC--CCccCCCCCC-------CCcHHHHHHHHHHHhhccCCCCCCCCChHHHH
Q 011360          423 ------ICSPEW-------LRKVMNSKNP--SRAIDPRLPG-------NGYEKKMLHVLKIAYICTLHDPEERPNSQYVR  480 (487)
Q Consensus       423 ------~~~~~~-------~~~~~~~~~~--~~~~~~~~~~-------~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il  480 (487)
                            ....++       ...+......  ...+....+.       .........+.+++.+||+.||++|||+.+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l  313 (359)
T cd07876         234 VIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEAL  313 (359)
T ss_pred             HHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHh
Confidence                  000000       1111111000  0000000000       00111235688999999999999999999998


Q ss_pred             H
Q 011360          481 C  481 (487)
Q Consensus       481 ~  481 (487)
                      .
T Consensus       314 ~  314 (359)
T cd07876         314 R  314 (359)
T ss_pred             c
Confidence            6

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=5.8e-38  Score=304.36  Aligned_cols=254  Identities=26%  Similarity=0.349  Sum_probs=199.5

Q ss_pred             hccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccc
Q 011360          190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILP  269 (487)
Q Consensus       190 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~  269 (487)
                      ..+.|++.+.||.|+||.||+|.. ..++..+++|.+..               ........+..|+.+++.++||||++
T Consensus        10 ~~~~y~i~~~lg~g~~g~vy~~~~-~~~~~~~~~k~~~~---------------~~~~~~~~~~~e~~~l~~l~h~~i~~   73 (292)
T cd06644          10 PNEVWEIIGELGDGAFGKVYKAKN-KETGALAAAKVIET---------------KSEEELEDYMVEIEILATCNHPYIVK   73 (292)
T ss_pred             cchhhhhhheecCCCCeEEEEEEE-CCCCceEEEEEecc---------------CCHHHHHHHHHHHHHHHhCCCCcEee
Confidence            345699999999999999999975 45788999998732               12334567788999999999999999


Q ss_pred             cceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC
Q 011360          270 LLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDM  349 (487)
Q Consensus       270 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~  349 (487)
                      +++.+..+...|+||||+++++|..++..   ....+++..+..++.|++.||.||   |+.|++||||+|+||+++.++
T Consensus        74 ~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~l---H~~~i~H~dlkp~Nili~~~~  147 (292)
T cd06644          74 LLGAFYWDGKLWIMIEFCPGGAVDAIMLE---LDRGLTEPQIQVICRQMLEALQYL---HSMKIIHRDLKAGNVLLTLDG  147 (292)
T ss_pred             eEEEEEeCCeEEEEEecCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHH---hcCCeeecCCCcceEEEcCCC
Confidence            99999999999999999999999888753   235688999999999999999999   788999999999999999999


Q ss_pred             CEEEeccCCccccCCCCceeeEeeecccccccCCcccC-----CCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccc
Q 011360          350 EACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQ-----QPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEIC  424 (487)
Q Consensus       350 ~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~  424 (487)
                      .++|+|||++.........  .....+++.|+|||++.     ...++.++||||||+++|+|++|.+||.....     
T Consensus       148 ~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-----  220 (292)
T cd06644         148 DIKLADFGVSAKNVKTLQR--RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-----  220 (292)
T ss_pred             CEEEccCccceeccccccc--cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH-----
Confidence            9999999998654332111  12345788999999885     34578899999999999999999999943221     


Q ss_pred             cHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          425 SPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       425 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                       ............+....        ....+.++.+++.+||..+|++||++.++++
T Consensus       221 -~~~~~~~~~~~~~~~~~--------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         221 -MRVLLKIAKSEPPTLSQ--------PSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             -HHHHHHHhcCCCccCCC--------CcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence             12222222222111111        1123346889999999999999999999975

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2.7e-38  Score=301.35  Aligned_cols=254  Identities=27%  Similarity=0.393  Sum_probs=198.0

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+...||.|++|.||+|...  .+..+|+|.+...                ......+.+|+.+++.++|||+++++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~--~~~~~~lK~~~~~----------------~~~~~~~~~E~~~l~~l~h~~i~~~~   67 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWN--GTTKVAIKTLKPG----------------TMMPEAFLQEAQIMKKLRHDKLVPLY   67 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEc--CCceEEEEEcccC----------------CccHHHHHHHHHHHHhCCCCCeeeEE
Confidence            45889999999999999999764  3456999976321                11224577899999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++. .+..+++|||+.+++|.+++..  .....+++..+..++.|++.||.||   |+.|++|+||+|+||++++++.+
T Consensus        68 ~~~~-~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~al~~l---H~~~i~H~dl~~~Nill~~~~~~  141 (260)
T cd05069          68 AVVS-EEPIYIVTEFMGKGSLLDFLKE--GDGKYLKLPQLVDMAAQIADGMAYI---ERMNYIHRDLRAANILVGDNLVC  141 (260)
T ss_pred             EEEc-CCCcEEEEEcCCCCCHHHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHH---HhCCEeecccCcceEEEcCCCeE
Confidence            8875 4568999999999999999965  2344578999999999999999999   77789999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccccHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSPEWLR  430 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~  430 (487)
                      +|+|||.+.......... .....++..|+|||.+.+..++.++||||||+++|+|+| |..||....      ..+...
T Consensus       142 ~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~------~~~~~~  214 (260)
T cd05069         142 KIADFGLARLIEDNEYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMV------NREVLE  214 (260)
T ss_pred             EECCCccceEccCCcccc-cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCC------HHHHHH
Confidence            999999997654332111 112335678999999988889999999999999999999 899994322      122222


Q ss_pred             HHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          431 KVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       431 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      .......+  .    .+    ...+..+.+++.+||..+|++|||+++|++.|+++
T Consensus       215 ~~~~~~~~--~----~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  260 (260)
T cd05069         215 QVERGYRM--P----CP----QGCPESLHELMKLCWKKDPDERPTFEYIQSFLEDY  260 (260)
T ss_pred             HHHcCCCC--C----CC----cccCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence            22221111  1    11    12335689999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=2.2e-38  Score=305.65  Aligned_cols=252  Identities=23%  Similarity=0.332  Sum_probs=197.7

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      +.|++.+.||.|+||.||+|.. ..++..+++|.+..               ........+.+|+.+++.+.||||++++
T Consensus         5 ~~~~i~~~lg~g~~g~v~~~~~-~~~~~~~~~k~~~~---------------~~~~~~~~~~~e~~~l~~l~h~~ii~~~   68 (282)
T cd06643           5 EFWEIIGELGDGAFGKVYKAQN-KETGVLAAAKVIDT---------------KSEEELEDYMVEIDILASCDHPNIVKLL   68 (282)
T ss_pred             HHHHHHhhcccCCCeEEEEEEE-CCCCeEEEEEEeCC---------------CCHHHHHHHHHHHHHHHHCCCCCeeeEE
Confidence            3478889999999999999975 45788899998732               1123455678899999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++...+..++||||+++++|..++..   ....+++..+..++.|++.||.||   |+.|++||||+|+||+++.++.+
T Consensus        69 ~~~~~~~~~~~v~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~L---H~~~i~H~dlkp~nili~~~~~~  142 (282)
T cd06643          69 DAFYYENNLWILIEFCAGGAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYL---HENKIIHRDLKAGNILFTLDGDI  142 (282)
T ss_pred             EEEeeCCEEEEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCCcccEEEccCCCE
Confidence            999999999999999999999888753   245689999999999999999999   67889999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccC-----CCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQ-----QPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSP  426 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~  426 (487)
                      +|+|||++.........  .....+++.|+|||++.     +..++.++|||||||++|+|++|.+||....      ..
T Consensus       143 kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~------~~  214 (282)
T cd06643         143 KLADFGVSAKNTRTIQR--RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN------PM  214 (282)
T ss_pred             EEccccccccccccccc--cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC------HH
Confidence            99999998765332211  13346889999999984     3457889999999999999999999994322      11


Q ss_pred             HHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          427 EWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       427 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      +..........+....+.        ..+..+.+++.+||+.+|++|||+.++++
T Consensus       215 ~~~~~~~~~~~~~~~~~~--------~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         215 RVLLKIAKSEPPTLAQPS--------RWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             HHHHHHhhcCCCCCCCcc--------ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            222222222221111111        12356889999999999999999999874

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2.2e-38  Score=301.02  Aligned_cols=252  Identities=19%  Similarity=0.310  Sum_probs=201.1

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      +|.+.+.||.|+||.||++.. ..++..+|+|.+...              ........+..|+.+++.++||||+++++
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~-~~~~~~~~iK~~~~~--------------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~   65 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQH-VNSDQKYAMKEIRLP--------------KSSSAVEDSRKEAVLLAKMKHPNIVAFKE   65 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEE-cCCCceEEEEEEEcC--------------cchHHHHHHHHHHHHHHhCCCCCcceEEE
Confidence            377889999999999999975 457889999987431              11223456778999999999999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEE
Q 011360          273 HMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC  352 (487)
Q Consensus       273 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~k  352 (487)
                      .+...+.+|++|||+++|+|.+++..  ..+..++...+..++.|++.||.||   |++|++|+||+|+||+++.++.++
T Consensus        66 ~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~i~~al~~l---H~~~i~H~dl~p~nili~~~~~~~  140 (255)
T cd08219          66 SFEADGHLYIVMEYCDGGDLMQKIKL--QRGKLFPEDTILQWFVQMCLGVQHI---HEKRVLHRDIKSKNIFLTQNGKVK  140 (255)
T ss_pred             EEEECCEEEEEEeeCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHH---hhCCcccCCCCcceEEECCCCcEE
Confidence            99999999999999999999998864  2345678999999999999999999   788999999999999999999999


Q ss_pred             EeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHH
Q 011360          353 ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKV  432 (487)
Q Consensus       353 l~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~  432 (487)
                      ++|||.+........  ......|++.|+|||++.+..++.++|+||||+++|+|++|..||....      ........
T Consensus       141 l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~------~~~~~~~~  212 (255)
T cd08219         141 LGDFGSARLLTSPGA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS------WKNLILKV  212 (255)
T ss_pred             EcccCcceeeccccc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC------HHHHHHHH
Confidence            999999876543221  1134568899999999998889999999999999999999999994321      11222222


Q ss_pred             HhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHH
Q 011360          433 MNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCR  482 (487)
Q Consensus       433 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~  482 (487)
                      .. .... .    ++.    ..+..+.+++.+||+.+|++|||+.+|+..
T Consensus       213 ~~-~~~~-~----~~~----~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         213 CQ-GSYK-P----LPS----HYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             hc-CCCC-C----CCc----ccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            22 2111 1    111    123458899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=3.2e-38  Score=302.34  Aligned_cols=259  Identities=22%  Similarity=0.365  Sum_probs=200.8

Q ss_pred             ccccccccccccceeEEEEEecCC--CCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGS--NGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .|.+.+.||.|+||.||+|.+...  ++..||+|.+..              .........+..|+.+++.+.||||+++
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~--------------~~~~~~~~~~~~e~~~l~~l~h~ni~~~   70 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKS--------------GYTEKQRRDFLSEASIMGQFDHPNIIHL   70 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCC--------------CCCHHHHHHHHHHHHHHHhCCCcCcceE
Confidence            488899999999999999986432  234699998732              1123345678899999999999999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      ++++......++||||+++++|.+++..   ....+++..+..++.|++.||.||   |++|++|+||||+||+++.++.
T Consensus        71 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~l~~al~~l---H~~g~~H~dl~p~nili~~~~~  144 (269)
T cd05065          71 EGVVTKSRPVMIITEFMENGALDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYL---SEMNYVHRDLAARNILVNSNLV  144 (269)
T ss_pred             EEEECCCCceEEEEecCCCCcHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHH---HHCCEeecccChheEEEcCCCc
Confidence            9999999999999999999999999864   245688999999999999999999   6788999999999999999999


Q ss_pred             EEEeccCCccccCCCCceee-Eeeec--ccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccccH
Q 011360          351 ACISDLGLAMAIPDGYTRVL-ISYVL--GTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSP  426 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~~-~~~~~--gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~  426 (487)
                      ++|+|||++........... .....  .+..|+|||.+.+..++.++||||||+++||+++ |..||.....      .
T Consensus       145 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~------~  218 (269)
T cd05065         145 CKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN------Q  218 (269)
T ss_pred             EEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH------H
Confidence            99999999876543322111 11111  2457999999998899999999999999999886 9999943221      1


Q ss_pred             HHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhhC
Q 011360          427 EWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL  487 (487)
Q Consensus       427 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~ll  487 (487)
                      .....+ ..... ....+        ..+..+.+++.+||..+|++||++.+|+..|++++
T Consensus       219 ~~~~~i-~~~~~-~~~~~--------~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~  269 (269)
T cd05065         219 DVINAI-EQDYR-LPPPM--------DCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKMI  269 (269)
T ss_pred             HHHHHH-HcCCc-CCCcc--------cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence            222222 11111 00111        12345889999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=6.7e-39  Score=315.71  Aligned_cols=242  Identities=24%  Similarity=0.354  Sum_probs=188.5

Q ss_pred             cccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHH-HhccCCCCCccccceEEec
Q 011360          198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII-TASQIRHRNILPLLAHMVR  276 (487)
Q Consensus       198 ~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~hpnIv~l~~~~~~  276 (487)
                      +.||.|+||.||+|.. ..+|..||+|++...            ..........+..|.. +++.++||||+++++++..
T Consensus         1 ~~lG~G~~g~V~~~~~-~~~~~~~aiK~~~~~------------~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~   67 (325)
T cd05604           1 KVIGKGSFGKVLLAKR-KLDGKCYAVKVLQKK------------IVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT   67 (325)
T ss_pred             CceeeCCCeEEEEEEE-CCCCCEEEEEEEEHH------------HhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEec
Confidence            4689999999999974 468899999988421            1111222334444544 5677899999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEecc
Q 011360          277 PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDL  356 (487)
Q Consensus       277 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~DF  356 (487)
                      ++..|+||||+++|+|..++..    ...+++..+..++.|++.||.||   |+.||+||||||+|||++.++.+||+||
T Consensus        68 ~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~l---H~~givH~Dlkp~NIll~~~~~~kL~Df  140 (325)
T cd05604          68 TEKLYFVLDFVNGGELFFHLQR----ERSFPEPRARFYAAEIASALGYL---HSINIVYRDLKPENILLDSQGHVVLTDF  140 (325)
T ss_pred             CCEEEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCCHHHeEECCCCCEEEeec
Confidence            9999999999999999988864    45789999999999999999999   7789999999999999999999999999


Q ss_pred             CCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHHHhcC
Q 011360          357 GLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSK  436 (487)
Q Consensus       357 g~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  436 (487)
                      |++.........  .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+      ..+.........
T Consensus       141 G~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~------~~~~~~~~~~~~  212 (325)
T cd05604         141 GLCKEGIAQSDT--TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD------VAEMYDNILHKP  212 (325)
T ss_pred             CCcccCCCCCCC--cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC------HHHHHHHHHcCC
Confidence            998753222111  134568999999999999999999999999999999999999994332      122233332211


Q ss_pred             CCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHH
Q 011360          437 NPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQY  478 (487)
Q Consensus       437 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~  478 (487)
                       .  .+.+.        .+..+.+++.+||..+|.+||++.+
T Consensus       213 -~--~~~~~--------~~~~~~~ll~~ll~~~p~~R~~~~~  243 (325)
T cd05604         213 -L--VLRPG--------ASLTAWSILEELLEKDRQRRLGAKE  243 (325)
T ss_pred             -c--cCCCC--------CCHHHHHHHHHHhccCHHhcCCCCC
Confidence             1  11111        2245789999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.8e-38  Score=322.04  Aligned_cols=263  Identities=21%  Similarity=0.263  Sum_probs=196.1

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      ...|.+.+.||.|+||.||++.+. .++..||||...                     ...+.+|+.++++++|||||++
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~-~~~~~vavK~~~---------------------~~~~~~E~~iL~~L~HpnIv~l  225 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHP-DYPQRVVVKAGW---------------------YASSVHEARLLRRLSHPAVLAL  225 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEEC-CCCCEEEEeccc---------------------ccCHHHHHHHHHHCCCCCCCcE
Confidence            346999999999999999999754 578899999531                     1234579999999999999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      ++++...+..++|||++ .++|.+++..   ....+++..++.++.|++.||.||   |++||+||||||+|||++.++.
T Consensus       226 ~~~~~~~~~~~lv~e~~-~~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yL---H~~gIvHrDLKP~NILl~~~~~  298 (461)
T PHA03211        226 LDVRVVGGLTCLVLPKY-RSDLYTYLGA---RLRPLGLAQVTAVARQLLSAIDYI---HGEGIIHRDIKTENVLVNGPED  298 (461)
T ss_pred             EEEEEECCEEEEEEEcc-CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHH---HHCCEEECcCCHHHEEECCCCC
Confidence            99999999999999999 5688888753   234689999999999999999999   7789999999999999999999


Q ss_pred             EEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccC-CCCccccHHHH
Q 011360          351 ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ-NGEEICSPEWL  429 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~-~~~~~~~~~~~  429 (487)
                      +||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|..|+.... ..........+
T Consensus       299 vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l  378 (461)
T PHA03211        299 ICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQI  378 (461)
T ss_pred             EEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHH
Confidence            99999999976543322222234569999999999999999999999999999999999876543221 11111111112


Q ss_pred             HHHHhcCCC-CCccC--------------------CCCCCCC---cHHHHHHHHHHHhhccCCCCCCCCChHHHHHH
Q 011360          430 RKVMNSKNP-SRAID--------------------PRLPGNG---YEKKMLHVLKIAYICTLHDPEERPNSQYVRCR  482 (487)
Q Consensus       430 ~~~~~~~~~-~~~~~--------------------~~~~~~~---~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~  482 (487)
                      ...+..... ...+.                    +......   .......+.+++.+||+.||.+|||+.|+++.
T Consensus       379 ~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        379 LRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             HHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            222211110 00000                    0000000   01123468899999999999999999999863

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=5.6e-38  Score=300.71  Aligned_cols=258  Identities=24%  Similarity=0.327  Sum_probs=190.8

Q ss_pred             cccccccceeEEEEEecC-CCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceEEec
Q 011360          198 EKIGSGGCGEVYKAELPG-SNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVR  276 (487)
Q Consensus       198 ~~lg~G~~g~v~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  276 (487)
                      +.||+|+||.||+|.+.. .++..+|+|.+...              ........+.+|+.+++.++||||+++++++.+
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~--------------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   66 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVS--------------ASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTE   66 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCC--------------CChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence            368999999999997642 35567999987321              112233467889999999999999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHHhhhhc-CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEec
Q 011360          277 PDCHLLVYEFMKNGSLQDILDDVSR-GRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISD  355 (487)
Q Consensus       277 ~~~~~lv~E~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~D  355 (487)
                      ....++||||+++|+|.+++..... .....++..+..++.|++.||.||   |+.|++|+||||+||+++.++.+||+|
T Consensus        67 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~i~H~dlkp~nil~~~~~~~kL~d  143 (269)
T cd05087          67 VTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHL---HKNNFIHSDLALRNCLLTADLTVKIGD  143 (269)
T ss_pred             CCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHH---HHCCEeccccCcceEEEcCCCcEEECC
Confidence            9999999999999999999975332 223456778889999999999999   678899999999999999999999999


Q ss_pred             cCCccccCCCCceeeEeeecccccccCCcccCCC-------CCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccccHH
Q 011360          356 LGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQP-------ELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSPE  427 (487)
Q Consensus       356 Fg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-------~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~  427 (487)
                      ||.+................++..|+|||++.+.       .++.++||||||+++|||++ |..||......      +
T Consensus       144 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~------~  217 (269)
T cd05087         144 YGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE------Q  217 (269)
T ss_pred             ccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH------H
Confidence            9998754433222222234567889999988642       35789999999999999996 99999543221      1


Q ss_pred             HHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHh
Q 011360          428 WLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLS  484 (487)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~  484 (487)
                      ........ ......++.+...    ....+.+++..|| .+|++|||+.+|...|.
T Consensus       218 ~~~~~~~~-~~~~~~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         218 VLTYTVRE-QQLKLPKPRLKLP----LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             HHHHHhhc-ccCCCCCCccCCC----CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            11111111 1111111211111    2234778889999 58999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-38  Score=301.47  Aligned_cols=250  Identities=25%  Similarity=0.339  Sum_probs=196.6

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      +|.+.+.||.|+||.||++.+.  ++..+|+|.+...                ......+.+|+.+++.++||||+++++
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~--~~~~~~iK~~~~~----------------~~~~~~~~~e~~~l~~l~~~~i~~~~~   66 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWR--GKIDVAIKMIREG----------------AMSEDDFIEEAKVMMKLSHPNLVQLYG   66 (256)
T ss_pred             HcchhhhhccCCCceEEEeEec--CCccEEEEEeccC----------------CCCHHHHHHHHHHHHhCCCCCEEEEEE
Confidence            4888999999999999999764  5668999986321                011235677999999999999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEE
Q 011360          273 HMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC  352 (487)
Q Consensus       273 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~k  352 (487)
                      ++...+..|+||||+++++|.+++..   ....+++..+..++.|++.||+||   |+.|++||||||+||+++.++.+|
T Consensus        67 ~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dl~p~ni~i~~~~~~k  140 (256)
T cd05059          67 VCTKQRPIFIVTEYMANGCLLNYLRE---RKGKLGTEWLLDMCSDVCEAMEYL---ESNGFIHRDLAARNCLVGEDNVVK  140 (256)
T ss_pred             EEcCCCceEEEEecCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHH---HHCCcccccccHhhEEECCCCcEE
Confidence            99999999999999999999999864   234689999999999999999999   778899999999999999999999


Q ss_pred             EeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccccHHHHHH
Q 011360          353 ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSPEWLRK  431 (487)
Q Consensus       353 l~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~  431 (487)
                      |+|||+++......... .....++..|+|||.+.+..++.++||||||+++|++++ |..||....+      .+....
T Consensus       141 l~dfg~~~~~~~~~~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~~  213 (256)
T cd05059         141 VSDFGLARYVLDDQYTS-SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN------SEVVES  213 (256)
T ss_pred             ECCcccceecccccccc-cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH------HHHHHH
Confidence            99999987654322111 111223457999999998899999999999999999999 7999954322      112222


Q ss_pred             HHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHH
Q 011360          432 VMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRL  483 (487)
Q Consensus       432 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L  483 (487)
                      ......+      ..+.    ..+..+.+++.+||..+|++|||+.++++.|
T Consensus       214 ~~~~~~~------~~~~----~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         214 VSAGYRL------YRPK----LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             HHcCCcC------CCCC----CCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            2211111      1111    1235699999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=3e-38  Score=307.15  Aligned_cols=258  Identities=24%  Similarity=0.338  Sum_probs=197.7

Q ss_pred             cccccccccccccceeEEEEEecCCCC--ceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CCCCcc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNG--KMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RHRNIL  268 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv  268 (487)
                      ++|.+.+.||.|+||.||+|.... ++  ..+++|.+..              .........+.+|+.++.++ +||||+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~-~~~~~~~~ik~~~~--------------~~~~~~~~~~~~E~~~l~~l~~hp~iv   66 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKK-DGLKMNAAIKMLKE--------------FASENDHRDFAGELEVLCKLGHHPNII   66 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecC-CCCcceeEEEEccc--------------cCCHHHHHHHHHHHHHHHhhcCCCchh
Confidence            358899999999999999997643 33  3468887632              11222345678899999999 799999


Q ss_pred             ccceEEecCCeeEEEEEecCCCCHHHHHhhhhc------------CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 011360          269 PLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSR------------GRRELDWPSRHRIALGVASGLEYLHMYHSASIIHG  336 (487)
Q Consensus       269 ~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~  336 (487)
                      ++++++...+..+++|||+++++|.+++.....            ....+++..+..++.|++.||+||   |++|++||
T Consensus        67 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~l---H~~~ivH~  143 (297)
T cd05089          67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYL---SEKQFIHR  143 (297)
T ss_pred             heEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHH---HHCCcccC
Confidence            999999999999999999999999999964211            123588899999999999999999   67889999


Q ss_pred             CCCCCCEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCcc
Q 011360          337 DIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFV  415 (487)
Q Consensus       337 Dlkp~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~  415 (487)
                      ||||+||+++.++.+||+|||++.........   .....+..|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus       144 dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~  220 (297)
T cd05089         144 DLAARNVLVGENLASKIADFGLSRGEEVYVKK---TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYC  220 (297)
T ss_pred             cCCcceEEECCCCeEEECCcCCCccccceecc---CCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCC
Confidence            99999999999999999999998643221111   11223567999999998889999999999999999997 999994


Q ss_pred             ccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          416 FHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       416 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      ...      ..+..........+      ..+.    ..+..+.+++.+||+.+|.+|||+.++++.|+.+
T Consensus       221 ~~~------~~~~~~~~~~~~~~------~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  275 (297)
T cd05089         221 GMT------CAELYEKLPQGYRM------EKPR----NCDDEVYELMRQCWRDRPYERPPFAQISVQLSRM  275 (297)
T ss_pred             CCC------HHHHHHHHhcCCCC------CCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            332      12222222211111      1111    1235688999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.9e-38  Score=303.48  Aligned_cols=255  Identities=25%  Similarity=0.381  Sum_probs=198.1

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||.|+||.||+|+. ..++..||+|++...               .......+.+|+.++..++||||++++
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~-~~~~~~~aik~~~~~---------------~~~~~~~~~~e~~~l~~~~h~~ii~~~   72 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARN-LHTGELAAVKIIKLE---------------PGDDFSLIQQEIFMVKECKHCNIVAYF   72 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEE-CCCCeEEEEEEEecC---------------ccchHHHHHHHHHHHHhcCCCCeeeee
Confidence            4699999999999999999975 457889999987421               111234567899999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++...+..++||||+++++|.+++..    ...+++..+..++.|++.||.||   |+.||+||||+|+||+++.++.+
T Consensus        73 ~~~~~~~~~~iv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~nill~~~~~~  145 (267)
T cd06646          73 GSYLSREKLWICMEYCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYL---HSKGKMHRDIKGANILLTDNGDV  145 (267)
T ss_pred             EEEEeCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCccccCCCHHHEEECCCCCE
Confidence            999999999999999999999998864    35688999999999999999999   67889999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccC---CCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQ---QPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEW  428 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~  428 (487)
                      +|+|||++.........  .....+++.|+|||.+.   ...++.++|+||||+++|+|++|..||....+....     
T Consensus       146 ~l~dfg~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~-----  218 (267)
T cd06646         146 KLADFGVAAKITATIAK--RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-----  218 (267)
T ss_pred             EECcCccceeecccccc--cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh-----
Confidence            99999999765432211  12345889999999874   445788999999999999999999998433221110     


Q ss_pred             HHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHH
Q 011360          429 LRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRL  483 (487)
Q Consensus       429 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L  483 (487)
                       .... ....   ..+..+.  ....+..+.+++.+||..+|++|||+++|++.|
T Consensus       219 -~~~~-~~~~---~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         219 -FLMS-KSNF---QPPKLKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             -eeee-cCCC---CCCCCcc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence             0000 0100   0111111  112345788999999999999999999998643

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=2.1e-38  Score=311.85  Aligned_cols=244  Identities=23%  Similarity=0.309  Sum_probs=192.0

Q ss_pred             cccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCC-CCCccccce
Q 011360          194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIR-HRNILPLLA  272 (487)
Q Consensus       194 ~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~  272 (487)
                      |...+.||.|+||.||+|.. ..+++.||+|++..            ...........+..|..++..+. ||+|+++++
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~-~~~~~~vaiK~~~~------------~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~   68 (323)
T cd05615           2 FNFLMVLGKGSFGKVMLAER-KGTDELYAIKILKK------------DVVIQDDDVECTMVEKRVLALQDKPPFLTQLHS   68 (323)
T ss_pred             ceEEEEEEecCCeEEEEEEE-CCCCCEEEEEEEEH------------HHhhhhhHHHHHHHHHHHHHhccCCCchhheee
Confidence            67788999999999999975 46789999998842            11112234456677888888774 577888999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEE
Q 011360          273 HMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC  352 (487)
Q Consensus       273 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~k  352 (487)
                      ++...+.+|+||||+++|+|.+++..    ...+++..+..++.|++.||.||   |++||+||||||+|||++.++.+|
T Consensus        69 ~~~~~~~~~lv~Ey~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~l---H~~~ivHrDikp~Nill~~~~~ik  141 (323)
T cd05615          69 CFQTVDRLYFVMEYVNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFL---HRRGIIYRDLKLDNVMLDSEGHIK  141 (323)
T ss_pred             EEecCCEEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHeEECCCCCEE
Confidence            99999999999999999999998864    45689999999999999999999   678899999999999999999999


Q ss_pred             EeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHH
Q 011360          353 ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKV  432 (487)
Q Consensus       353 l~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~  432 (487)
                      |+|||++........  ......||+.|+|||++.+..++.++|||||||++|+|++|..||.....      .......
T Consensus       142 L~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~------~~~~~~i  213 (323)
T cd05615         142 IADFGMCKEHMVDGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE------DELFQSI  213 (323)
T ss_pred             EeccccccccCCCCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH------HHHHHHH
Confidence            999999875432221  12345689999999999988999999999999999999999999954321      1222223


Q ss_pred             HhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCh
Q 011360          433 MNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNS  476 (487)
Q Consensus       433 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~  476 (487)
                      ... ..      ..+..    .+..+.+++.+||+.+|.+|++.
T Consensus       214 ~~~-~~------~~p~~----~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         214 MEH-NV------SYPKS----LSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             HhC-CC------CCCcc----CCHHHHHHHHHHcccCHhhCCCC
Confidence            221 11      11111    22457899999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=2e-38  Score=337.30  Aligned_cols=265  Identities=23%  Similarity=0.292  Sum_probs=201.4

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||.|+||.||+|.. ..+++.||+|++....            .........+.+|+.+++.++||||++++
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d-~~tg~~VAIK~I~~~l------------~~~e~~~~rflrEi~ILs~L~HPNIVkl~   68 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYD-PVCSRRVALKKIREDL------------SENPLLKKRFLREAKIAADLIHPGIVPVY   68 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEE-CCCCcEEEEEEECccc------------ccCHHHHHHHHHHHHHHHhCCCcCcCeEE
Confidence            3689999999999999999974 5678999999884211            11123445788999999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcC-------CCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRG-------RRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVL  344 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nil  344 (487)
                      +++.+++..|++|||++||+|.+++......       ....++..+..++.|++.||+||   |++||+||||||+||+
T Consensus        69 ~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yL---Hs~GIIHRDLKPeNIL  145 (932)
T PRK13184         69 SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYV---HSKGVLHRDLKPDNIL  145 (932)
T ss_pred             EEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHH---HHCCccccCCchheEE
Confidence            9999999999999999999999998753211       23456677889999999999999   6778999999999999


Q ss_pred             eCCCCCEEEeccCCccccCCCCc----------------eeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHH
Q 011360          345 LNDDMEACISDLGLAMAIPDGYT----------------RVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLV  408 (487)
Q Consensus       345 l~~~~~~kl~DFg~s~~~~~~~~----------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ell  408 (487)
                      ++.++.++|+|||++........                ........||+.|+|||++.+..++.++|||||||++|||+
T Consensus       146 Ld~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELL  225 (932)
T PRK13184        146 LGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQML  225 (932)
T ss_pred             EcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHH
Confidence            99999999999999976521110                00012246899999999999999999999999999999999


Q ss_pred             hCCCCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCC-ChHHHHHHHhhh
Q 011360          409 RGVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERP-NSQYVRCRLSQL  486 (487)
Q Consensus       409 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-s~~~il~~L~~l  486 (487)
                      ||..||.........     ....  ...+...       ......+..+.+++.+||+.||++|| +++++++.|+.+
T Consensus       226 TG~~PF~~~~~~ki~-----~~~~--i~~P~~~-------~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~  290 (932)
T PRK13184        226 TLSFPYRRKKGRKIS-----YRDV--ILSPIEV-------APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH  290 (932)
T ss_pred             HCCCCCCCcchhhhh-----hhhh--ccChhhc-------cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            999999543221100     0000  0111110       01112335688999999999999996 566677776654

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=2.4e-38  Score=311.27  Aligned_cols=241  Identities=24%  Similarity=0.378  Sum_probs=186.8

Q ss_pred             cccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHH-HHhccCCCCCccccceEEec
Q 011360          198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI-ITASQIRHRNILPLLAHMVR  276 (487)
Q Consensus       198 ~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~-~~l~~l~hpnIv~l~~~~~~  276 (487)
                      +.||.|+||.||+|+. ..++..||+|++...            ..........+..|. .+++.++||||+++++++.+
T Consensus         1 ~~lg~G~~g~Vy~~~~-~~~~~~~aiK~~~~~------------~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~   67 (321)
T cd05603           1 KVIGKGSFGKVLLAKR-KSDGSFYAVKVLQKK------------TILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQT   67 (321)
T ss_pred             CeeeeCCCEEEEEEEE-CCCCCEEEEEEEEHH------------HHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEc
Confidence            3689999999999975 467899999987321            111122233444454 46788999999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEecc
Q 011360          277 PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDL  356 (487)
Q Consensus       277 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~DF  356 (487)
                      .+..|+||||+++|+|...+..    ...+++..+..++.|++.||.||   |+.||+||||||+||+++.++.+||+||
T Consensus        68 ~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~l---H~~~ivH~Dlkp~NIll~~~~~~kl~Df  140 (321)
T cd05603          68 AEKLYFVLDYVNGGELFFHLQR----ERCFLEPRARFYAAEVASAIGYL---HSLNIIYRDLKPENILLDSQGHVVLTDF  140 (321)
T ss_pred             CCEEEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeEeccCCHHHeEECCCCCEEEccC
Confidence            9999999999999999888864    45688889999999999999999   7788999999999999999999999999


Q ss_pred             CCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHHHhcC
Q 011360          357 GLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSK  436 (487)
Q Consensus       357 g~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  436 (487)
                      |++........  ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+      ........... 
T Consensus       141 g~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~~~i~~~-  211 (321)
T cd05603         141 GLCKEGVEPEE--TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD------VSQMYDNILHK-  211 (321)
T ss_pred             CCCccCCCCCC--ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC------HHHHHHHHhcC-
Confidence            99875322211  1234568999999999998899999999999999999999999994332      12222222221 


Q ss_pred             CCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChH
Q 011360          437 NPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQ  477 (487)
Q Consensus       437 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~  477 (487)
                      ..      .++..    ....+.+++.+||+.+|.+||++.
T Consensus       212 ~~------~~~~~----~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         212 PL------QLPGG----KTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CC------CCCCC----CCHHHHHHHHHHccCCHhhcCCCC
Confidence            11      11211    224588999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=3.4e-38  Score=311.93  Aligned_cols=265  Identities=24%  Similarity=0.321  Sum_probs=204.1

Q ss_pred             hhccccccccccccccceeEEEEEecC------CCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC
Q 011360          189 KKEDCFASLEKIGSGGCGEVYKAELPG------SNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI  262 (487)
Q Consensus       189 ~~~~~~~~~~~lg~G~~g~v~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  262 (487)
                      ....+|.+.+.||.|+||.||+++...      ..+..||+|.+..              .........+.+|+.++.++
T Consensus         9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~--------------~~~~~~~~~~~~E~~~l~~l   74 (334)
T cd05100           9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKD--------------DATDKDLSDLVSEMEMMKMI   74 (334)
T ss_pred             cCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccc--------------ccCHHHHHHHHHHHHHHHhh
Confidence            334569999999999999999997532      1224689997632              12233456788899999999


Q ss_pred             -CCCCccccceEEecCCeeEEEEEecCCCCHHHHHhhhhc------------CCCCCChHHHHHHHHHHHHHHHHHHhcC
Q 011360          263 -RHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSR------------GRRELDWPSRHRIALGVASGLEYLHMYH  329 (487)
Q Consensus       263 -~hpnIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~~Lh~~h  329 (487)
                       +||||+++++++...+..+++|||+++|+|.+++.....            ....+++..+..++.|++.||.||   |
T Consensus        75 ~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~L---H  151 (334)
T cd05100          75 GKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL---A  151 (334)
T ss_pred             cCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHH---H
Confidence             899999999999999999999999999999999975321            124578889999999999999999   7


Q ss_pred             CCCeeecCCCCCCEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh
Q 011360          330 SASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR  409 (487)
Q Consensus       330 ~~givH~Dlkp~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt  409 (487)
                      ++|++||||||+||+++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|+|++
T Consensus       152 ~~givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~  231 (334)
T cd05100         152 SQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT  231 (334)
T ss_pred             HCCeeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHh
Confidence            78999999999999999999999999999876543322111122334568999999999899999999999999999998


Q ss_pred             -CCCCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          410 -GVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       410 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                       |..||...      ...+..........+ .     .+.    ..+..+.+++.+||+.+|++|||+.+++..|+++
T Consensus       232 ~g~~p~~~~------~~~~~~~~~~~~~~~-~-----~~~----~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~  293 (334)
T cd05100         232 LGGSPYPGI------PVEELFKLLKEGHRM-D-----KPA----NCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRV  293 (334)
T ss_pred             cCCCCCCCC------CHHHHHHHHHcCCCC-C-----CCC----CCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence             78888432      222333322222111 1     111    1234688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2.6e-38  Score=307.42  Aligned_cols=250  Identities=26%  Similarity=0.402  Sum_probs=199.2

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ..|.+.+.||.|++|.||+|. +..++..|++|.+...               .......+.+|+.+++.+.||||++++
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~-~~~~~~~v~ik~~~~~---------------~~~~~~~~~~e~~~l~~~~h~~v~~~~   83 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAM-DVATGQEVAIRQMNLQ---------------QQPKKELIINEILVMRENKNPNIVNYL   83 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEE-ECCCCcEEEEEEEecC---------------CcchHHHHHHHHHHHHhCCCCCEeeEE
Confidence            469999999999999999996 4467889999987421               112235677899999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +.+......|+||||+++++|.+++..     ..+++..+..++.|++.||.||   |+.||+||||||+||+++.++.+
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~L---H~~gi~H~dLkp~Nill~~~~~~  155 (296)
T cd06654          84 DSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFL---HSNQVIHRDIKSDNILLGMDGSV  155 (296)
T ss_pred             EEEEeCCEEEEeecccCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEEcCCCCE
Confidence            999999999999999999999999863     4578889999999999999999   77889999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRK  431 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~  431 (487)
                      +|+|||++.........  .....+++.|+|||.+.+..++.++|||||||++|+|++|..||......      .....
T Consensus       156 kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~------~~~~~  227 (296)
T cd06654         156 KLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYL  227 (296)
T ss_pred             EECccccchhccccccc--cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH------HhHHH
Confidence            99999998765432211  12345889999999999888999999999999999999999999443221      11111


Q ss_pred             HHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          432 VMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       432 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ......+...        ........+.+++.+||..+|++|||+.+|++
T Consensus       228 ~~~~~~~~~~--------~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         228 IATNGTPELQ--------NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             HhcCCCCCCC--------CccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence            2211111111        11123356889999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=2.2e-38  Score=308.94  Aligned_cols=258  Identities=24%  Similarity=0.332  Sum_probs=198.3

Q ss_pred             cccccccccccccceeEEEEEecCCCCc--eEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CCCCcc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGK--MIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RHRNIL  268 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv  268 (487)
                      ++|.+.+.||.|+||.||+|.+. .++.  .+++|.+..              .........+.+|+.++.++ +||||+
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~-~~~~~~~~~ik~~~~--------------~~~~~~~~~~~~Ei~~l~~l~~h~~iv   71 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIK-KDGLRMDAAIKRMKE--------------YASKDDHRDFAGELEVLCKLGHHPNII   71 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEc-cCCceeeEEEEEecc--------------cCCHHHHHHHHHHHHHHHHhcCCCCcc
Confidence            35889999999999999999864 3454  457776521              11223456778899999999 899999


Q ss_pred             ccceEEecCCeeEEEEEecCCCCHHHHHhhhhc------------CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 011360          269 PLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSR------------GRRELDWPSRHRIALGVASGLEYLHMYHSASIIHG  336 (487)
Q Consensus       269 ~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~  336 (487)
                      ++++++...+..|+||||+++++|.+++.....            ....+++..++.++.|++.||+||   |++|++||
T Consensus        72 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~L---H~~gi~H~  148 (303)
T cd05088          72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHR  148 (303)
T ss_pred             eEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHH---HhCCcccc
Confidence            999999999999999999999999999975321            123678999999999999999999   77899999


Q ss_pred             CCCCCCEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCcc
Q 011360          337 DIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFV  415 (487)
Q Consensus       337 Dlkp~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~  415 (487)
                      ||||+||+++.++.+||+|||++.........   ....++..|+|||.+.+..++.++||||||+++|+|+| |..||.
T Consensus       149 dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~  225 (303)
T cd05088         149 DLAARNILVGENYVAKIADFGLSRGQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC  225 (303)
T ss_pred             ccchheEEecCCCcEEeCccccCcccchhhhc---ccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcc
Confidence            99999999999999999999998643211110   11224678999999988889999999999999999998 999994


Q ss_pred             ccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          416 FHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       416 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      ....      .+..........+      ..+.    ..+..+.+++.+||+.+|++|||+.+++..|..+
T Consensus       226 ~~~~------~~~~~~~~~~~~~------~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~  280 (303)
T cd05088         226 GMTC------AELYEKLPQGYRL------EKPL----NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  280 (303)
T ss_pred             cCCh------HHHHHHHhcCCcC------CCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            3321      1222222111111      0111    1234688999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=9e-38  Score=305.37  Aligned_cols=256  Identities=24%  Similarity=0.359  Sum_probs=199.2

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      +|.+.+.||.|+||.||++.+ ..++..+|+|.+..              ........++.+|+.++.+++||||+++++
T Consensus         2 ~~~~~~~lg~G~~g~v~~~~~-~~~~~~~a~k~~~~--------------~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   66 (308)
T cd06615           2 DFEKLGELGAGNGGVVTKVLH-RPSGLIMARKLIHL--------------EIKPAIRNQIIRELKVLHECNSPYIVGFYG   66 (308)
T ss_pred             CceEEeeccCCCCeEEEEEEE-cCCCeEEEEEEecc--------------ccCHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            588999999999999999975 45788899998732              112334556888999999999999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEE
Q 011360          273 HMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC  352 (487)
Q Consensus       273 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~k  352 (487)
                      ++..++.+++||||+++++|.+++..    ...+++..+..++.|++.||.|||+  ..+++|+||+|+||+++.++.++
T Consensus        67 ~~~~~~~~~lv~ey~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~  140 (308)
T cd06615          67 AFYSDGEISICMEHMDGGSLDQVLKK----AGRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIK  140 (308)
T ss_pred             EEeeCCEEEEEeeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEE
Confidence            99999999999999999999999975    3568899999999999999999952  25899999999999999999999


Q ss_pred             EeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCcc---------
Q 011360          353 ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI---------  423 (487)
Q Consensus       353 l~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~---------  423 (487)
                      |+|||++........    ....+++.|+|||.+.+..++.++|+||||+++|+|++|..||.........         
T Consensus       141 l~dfg~~~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~  216 (308)
T cd06615         141 LCDFGVSGQLIDSMA----NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSE  216 (308)
T ss_pred             EccCCCccccccccc----ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCcccc
Confidence            999999876533221    3456889999999998888999999999999999999999998533210000         


Q ss_pred             ---------------------ccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHH
Q 011360          424 ---------------------CSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCR  482 (487)
Q Consensus       424 ---------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~  482 (487)
                                           ...+.........      .+..+..   ....++.+++.+||..+|++|||+.+|+..
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~---~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         217 GEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEP------PPKLPSG---AFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             ccccCCcccccCCCCCccchhhHHHHHHHHhcCC------CccCcCc---ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                                 0000000000000      0111111   134568899999999999999999998753

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-38  Score=304.43  Aligned_cols=253  Identities=26%  Similarity=0.391  Sum_probs=200.5

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .++|.+.+.||.|+||.||++... .++..+|+|.+..               ........+..|+.+++.++||||+++
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~-~~~~~~~iK~~~~---------------~~~~~~~~~~~e~~~l~~l~h~~i~~~   67 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHK-ETGLFAAAKIIQI---------------ESEEELEDFMVEIDILSECKHPNIVGL   67 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEc-CCCcEEEEEEEee---------------CCHHHHHHHHHHHHHHHhCCCCceeEE
Confidence            356999999999999999999764 4788999998742               122344568889999999999999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      ++.+..+...|+||||+++++|.+++..   .+..+++..+..++.|++.||.||   |+.||+|+||+|+||+++.++.
T Consensus        68 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~l---h~~~i~h~dl~p~nili~~~~~  141 (280)
T cd06611          68 YEAYFYENKLWILIEFCDGGALDSIMLE---LERGLTEPQIRYVCRQMLEALNFL---HSHKVIHRDLKAGNILLTLDGD  141 (280)
T ss_pred             EEEEecCCeEEEEeeccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCChhhEEECCCCC
Confidence            9999999999999999999999999864   235689999999999999999999   7788999999999999999999


Q ss_pred             EEEeccCCccccCCCCceeeEeeecccccccCCcccC-----CCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCcccc
Q 011360          351 ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQ-----QPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICS  425 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~  425 (487)
                      ++|+|||++.........  .....+++.|+|||.+.     ...++.++|+||||+++|+|++|..||.....      
T Consensus       142 ~~l~d~g~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~------  213 (280)
T cd06611         142 VKLADFGVSAKNKSTLQK--RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP------  213 (280)
T ss_pred             EEEccCccchhhcccccc--cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH------
Confidence            999999988765332221  13345899999999875     34578899999999999999999999944321      


Q ss_pred             HHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          426 PEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       426 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ............+....++        ..+..+.+++.+||+.+|++|||+.++++
T Consensus       214 ~~~~~~~~~~~~~~~~~~~--------~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (280)
T cd06611         214 MRVLLKILKSEPPTLDQPS--------KWSSSFNDFLKSCLVKDPDDRPTAAELLK  261 (280)
T ss_pred             HHHHHHHhcCCCCCcCCcc--------cCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence            1222223222221111111        12346889999999999999999999875

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=9.2e-38  Score=299.18  Aligned_cols=257  Identities=25%  Similarity=0.333  Sum_probs=188.8

Q ss_pred             ccccccceeEEEEEecC-CCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceEEecC
Q 011360          199 KIGSGGCGEVYKAELPG-SNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRP  277 (487)
Q Consensus       199 ~lg~G~~g~v~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  277 (487)
                      .||.|+||.||+|.... .....+++|.+..              .........+.+|+..++.++||||+++++.+...
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~--------------~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~   67 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRA--------------SATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIES   67 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCc--------------cCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCC
Confidence            68999999999997532 2445788886532              11223345678899999999999999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHHhhhhcC-CCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEecc
Q 011360          278 DCHLLVYEFMKNGSLQDILDDVSRG-RRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDL  356 (487)
Q Consensus       278 ~~~~lv~E~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~DF  356 (487)
                      ...++||||+++|+|.+++...... ....++.....++.|++.||+||   |++||+||||||+||+++.++.+||+||
T Consensus        68 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~Nill~~~~~~kl~df  144 (269)
T cd05042          68 IPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWL---HQADFIHSDLALRNCQLTADLSVKIGDY  144 (269)
T ss_pred             CceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHH---HhcCEecccccHhheEecCCCcEEEecc
Confidence            9999999999999999999763221 23356778889999999999999   7788999999999999999999999999


Q ss_pred             CCccccCCCCceeeEeeecccccccCCcccC-------CCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccccHHH
Q 011360          357 GLAMAIPDGYTRVLISYVLGTMAYIAPEYFQ-------QPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSPEW  428 (487)
Q Consensus       357 g~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~-------~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~  428 (487)
                      |++................+++.|+|||++.       ...++.++|||||||++|||++ |..||....+      .+.
T Consensus       145 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~------~~~  218 (269)
T cd05042         145 GLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD------EQV  218 (269)
T ss_pred             ccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH------HHH
Confidence            9987543332211112334577899999864       2356889999999999999999 7888843321      122


Q ss_pred             HHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHh
Q 011360          429 LRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLS  484 (487)
Q Consensus       429 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~  484 (487)
                      ......... .....+.++.    ..+..+.+++..|| .||++|||+++|++.|.
T Consensus       219 ~~~~~~~~~-~~~~~~~~~~----~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         219 LKQVVREQD-IKLPKPQLDL----KYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             HHHHhhccC-ccCCCCcccc----cCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            222222221 1111121221    22345677888898 49999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.9e-38  Score=318.46  Aligned_cols=263  Identities=23%  Similarity=0.290  Sum_probs=194.5

Q ss_pred             cccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceE
Q 011360          194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAH  273 (487)
Q Consensus       194 ~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  273 (487)
                      |++.+.||.|+||.||++.. ..+++.||+|++...             .........+.+|+.+++.++||||++++++
T Consensus         2 ~~~~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~~-------------~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~   67 (372)
T cd07853           2 VEPDRPIGYGAFGVVWSVTD-PRDGKRVALKKMPNV-------------FQNLVSCKRVFRELKMLCFFKHDNVLSALDI   67 (372)
T ss_pred             CcccceeeeCCCEEEEEEEE-CCCCCEEEEEecccc-------------ccchHHHHHHHHHHHHHHhCCCCCcCCHhhe
Confidence            77889999999999999974 468899999987321             1112234567889999999999999999999


Q ss_pred             EecCC-----eeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC
Q 011360          274 MVRPD-----CHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDD  348 (487)
Q Consensus       274 ~~~~~-----~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~  348 (487)
                      +...+     ..|+||||+. ++|.+++..    ...+++..+..++.|++.||.||   |+.|++||||||+|||++.+
T Consensus        68 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~L---H~~~ivH~dlkp~Nili~~~  139 (372)
T cd07853          68 LQPPHIDPFEEIYVVTELMQ-SDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYL---HSAGILHRDIKPGNLLVNSN  139 (372)
T ss_pred             ecCCCccccceEEEEeeccc-cCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCChHHEEECCC
Confidence            98776     7899999995 578877753    45789999999999999999999   77889999999999999999


Q ss_pred             CCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCccccCCCCccc---
Q 011360          349 MEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQP-ELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEIC---  424 (487)
Q Consensus       349 ~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~---  424 (487)
                      +.+||+|||+++......... .....+++.|+|||.+.+. .++.++|||||||++|||++|+.||..........   
T Consensus       140 ~~~kL~Dfg~a~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~  218 (372)
T cd07853         140 CVLKICDFGLARVEEPDESKH-MTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLIT  218 (372)
T ss_pred             CCEEeccccceeecccCcccc-CCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence            999999999997654332211 1234578999999998774 57999999999999999999999995443211000   


Q ss_pred             ------cHHH-------HHHHH-hcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          425 ------SPEW-------LRKVM-NSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       425 ------~~~~-------~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                            ..+.       ..... .............  ........++.+++.+||+.||++|||+.+++.
T Consensus       219 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  287 (372)
T cd07853         219 DLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLY--TLSSQATHEAVHLLCRMLVFDPDKRISAADALA  287 (372)
T ss_pred             HHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhc--ccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence                  0000       00011 0000000000000  001112456889999999999999999999875

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.8e-38  Score=314.19  Aligned_cols=193  Identities=23%  Similarity=0.345  Sum_probs=162.6

Q ss_pred             hccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccc
Q 011360          190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILP  269 (487)
Q Consensus       190 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~  269 (487)
                      ....|.+.+.||.|+||.||+|... .++..||+|....                     .....|+.++.+++||||++
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~valK~~~~---------------------~~~~~E~~~l~~l~h~~iv~  121 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKP-GQPDPVVLKIGQK---------------------GTTLIEAMLLQNVNHPSVIR  121 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEEC-CCCceEEEEeCCc---------------------cccHHHHHHHHhCCCCCCcC
Confidence            3456999999999999999999754 5678899996421                     12245888999999999999


Q ss_pred             cceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC
Q 011360          270 LLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDM  349 (487)
Q Consensus       270 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~  349 (487)
                      +++++......++|||++ .++|.+++..   ....+++..+..++.|++.||.||   |++||+||||||+|||++.++
T Consensus       122 ~~~~~~~~~~~~lv~e~~-~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlkp~Nill~~~~  194 (357)
T PHA03209        122 MKDTLVSGAITCMVLPHY-SSDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYL---HAQRIIHRDVKTENIFINDVD  194 (357)
T ss_pred             hhheEEeCCeeEEEEEcc-CCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEECCCC
Confidence            999999999999999999 5688888753   346789999999999999999999   777899999999999999999


Q ss_pred             CEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCc
Q 011360          350 EACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF  414 (487)
Q Consensus       350 ~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf  414 (487)
                      .+||+|||++........   .....||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus       195 ~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        195 QVCIGDLGAAQFPVVAPA---FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             CEEEecCccccccccCcc---cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            999999999875332211   12356899999999999999999999999999999999964443

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=9.2e-38  Score=296.96  Aligned_cols=252  Identities=26%  Similarity=0.388  Sum_probs=197.6

Q ss_pred             cccccccceeEEEEEecCCCCc--eEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceEEe
Q 011360          198 EKIGSGGCGEVYKAELPGSNGK--MIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMV  275 (487)
Q Consensus       198 ~~lg~G~~g~v~~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  275 (487)
                      +.||.|++|.||+|.+...++.  .||+|.+...             .. ....+.+.+|+.++++++||||+++++.+.
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~-------------~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   66 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSD-------------KL-SDIMDDFLKEAAIMHSLDHENLIRLYGVVL   66 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCc-------------cc-HHHHHHHHHHHHHHhhcCCCCccceeEEEc
Confidence            3689999999999987543343  6899987321             11 145677889999999999999999999988


Q ss_pred             cCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEec
Q 011360          276 RPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISD  355 (487)
Q Consensus       276 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~D  355 (487)
                      . ...+++|||+++++|.+++...  ....+++..+..++.|++.||.||   |++|++|+||+|+||+++.++.+||+|
T Consensus        67 ~-~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~L~~l---H~~~i~H~di~p~nil~~~~~~~kl~d  140 (257)
T cd05040          67 T-HPLMMVTELAPLGSLLDRLRKD--ALGHFLISTLCDYAVQIANGMRYL---ESKRFIHRDLAARNILLASDDKVKIGD  140 (257)
T ss_pred             C-CeEEEEEEecCCCcHHHHHHhc--ccccCcHHHHHHHHHHHHHHHHHH---HhCCccccccCcccEEEecCCEEEecc
Confidence            8 8899999999999999998752  115689999999999999999999   778999999999999999999999999


Q ss_pred             cCCccccCCCCcee-eEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccccHHHHHHHH
Q 011360          356 LGLAMAIPDGYTRV-LISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSPEWLRKVM  433 (487)
Q Consensus       356 Fg~s~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  433 (487)
                      ||++.......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||....      ..+......
T Consensus       141 fg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~------~~~~~~~~~  214 (257)
T cd05040         141 FGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLS------GSQILKKID  214 (257)
T ss_pred             ccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHHH
Confidence            99998765432211 1123456789999999998899999999999999999998 999994321      122222222


Q ss_pred             hcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHh
Q 011360          434 NSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLS  484 (487)
Q Consensus       434 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~  484 (487)
                      ... ....    .+    ...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus       215 ~~~-~~~~----~~----~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         215 KEG-ERLE----RP----EACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             hcC-CcCC----CC----ccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            111 1111    11    112356889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.4e-38  Score=316.99  Aligned_cols=259  Identities=22%  Similarity=0.237  Sum_probs=197.6

Q ss_pred             cccccccccccccceeEEEEEec-CCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELP-GSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .+|.+.+.||.|+||.||++... ..++..||+|.+..                    .....+|+.+++.++||||+++
T Consensus        92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~--------------------~~~~~~E~~il~~l~h~~iv~~  151 (392)
T PHA03207         92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTG--------------------GKTPGREIDILKTISHRAIINL  151 (392)
T ss_pred             CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccc--------------------cccHHHHHHHHHhcCCCCccce
Confidence            46999999999999999999753 23567899997621                    0123579999999999999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      ++++......|++||++ +++|.+++..    ...+++..+..++.|++.||.||   |++||+||||||+|||++.++.
T Consensus       152 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~----~~~l~~~~~~~i~~ql~~aL~~L---H~~givHrDlkp~Nill~~~~~  223 (392)
T PHA03207        152 IHAYRWKSTVCMVMPKY-KCDLFTYVDR----SGPLPLEQAITIQRRLLEALAYL---HGRGIIHRDVKTENIFLDEPEN  223 (392)
T ss_pred             eeeEeeCCEEEEEehhc-CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCccccCCCHHHEEEcCCCC
Confidence            99999999999999999 4688888843    46789999999999999999999   7788999999999999999999


Q ss_pred             EEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHH
Q 011360          351 ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLR  430 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~  430 (487)
                      ++|+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|..||.+............+.
T Consensus       224 ~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~  303 (392)
T PHA03207        224 AVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSII  303 (392)
T ss_pred             EEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHH
Confidence            99999999987655433333345679999999999999999999999999999999999999996554322110000010


Q ss_pred             HHHh-----------------------cCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          431 KVMN-----------------------SKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       431 ~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ....                       ...+...+++.+.   ......++.+++.+||..||++|||+.+++.
T Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~  374 (392)
T PHA03207        304 RCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIR---KYGMHMDVEYLIAKMLTFDQEFRPSAQDILS  374 (392)
T ss_pred             HHhccCccccCCccchhHHHHHHhhcccccCCccccchhh---ccCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence            0000                       0000000000000   0112346788999999999999999999875

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=9.3e-38  Score=301.67  Aligned_cols=266  Identities=21%  Similarity=0.330  Sum_probs=202.6

Q ss_pred             ccccccccccccceeEEEEEec---CCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccc
Q 011360          193 CFASLEKIGSGGCGEVYKAELP---GSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILP  269 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~  269 (487)
                      .|.+++.||+|+||.||+++++   ..++..||+|.+..              .........+.+|+.+++.+.||||++
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~--------------~~~~~~~~~~~~e~~~l~~l~h~~i~~   70 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKP--------------ESGGNHIADLKKEIEILRNLYHENIVK   70 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCc--------------cccHHHHHHHHHHHHHHHhCCCCCeee
Confidence            4788999999999999999753   34678999998732              111233456889999999999999999


Q ss_pred             cceEEecC--CeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC
Q 011360          270 LLAHMVRP--DCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLND  347 (487)
Q Consensus       270 l~~~~~~~--~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~  347 (487)
                      +++++...  ...++||||++|++|.+++..   ....+++..+..++.|++.||+||   |++|++||||||+||+++.
T Consensus        71 ~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~~i~~aL~~l---H~~gi~H~dlkp~Nil~~~  144 (284)
T cd05079          71 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPR---NKNKINLKQQLKYAVQICKGMDYL---GSRQYVHRDLAARNVLVES  144 (284)
T ss_pred             eeeEEecCCCCceEEEEEccCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHH---HHCCeeecccchheEEEcC
Confidence            99988775  568999999999999999864   234689999999999999999999   7788999999999999999


Q ss_pred             CCCEEEeccCCccccCCCCcee-eEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCC-------
Q 011360          348 DMEACISDLGLAMAIPDGYTRV-LISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQN-------  419 (487)
Q Consensus       348 ~~~~kl~DFg~s~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~-------  419 (487)
                      ++.++|+|||++.......... ......++..|+|||.+.+..++.++||||||+++|+|+|+..|+.....       
T Consensus       145 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~  224 (284)
T cd05079         145 EHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIG  224 (284)
T ss_pred             CCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcc
Confidence            9999999999998765432211 11234567789999999888899999999999999999998766522110       


Q ss_pred             -CCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhhC
Q 011360          420 -GEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL  487 (487)
Q Consensus       420 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~ll  487 (487)
                       .....................     .+.    ..+..+.+++.+||+.+|++|||++++++.|+.++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~-----~~~----~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~  284 (284)
T cd05079         225 PTHGQMTVTRLVRVLEEGKRLP-----RPP----NCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAIL  284 (284)
T ss_pred             cccccccHHHHHHHHHcCccCC-----CCC----CCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhhC
Confidence             000001111111121111110     111    13356999999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.2e-38  Score=300.01  Aligned_cols=256  Identities=27%  Similarity=0.395  Sum_probs=202.7

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .++|.+.+.||.|+||.||+|..+  ++..+|+|.+..                .......+.+|+.+++.++||||+++
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~--~~~~~~vK~~~~----------------~~~~~~~~~~e~~~l~~l~h~~i~~~   66 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWN--GTTKVAVKTLKP----------------GTMSPEAFLQEAQIMKKLRHDKLVQL   66 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEc--CCceEEEEEecC----------------CccCHHHHHHHHHHHhhCCCCCEeee
Confidence            457999999999999999999754  557799998732                11123457889999999999999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      ++++......+++|||+++++|.+++..  ..+..+++..+..++.|++.|+.||   |++|++|+||+|+||+++.++.
T Consensus        67 ~~~~~~~~~~~~v~e~~~~~~L~~~i~~--~~~~~~~~~~~~~~~~~i~~al~~l---h~~~i~h~di~p~nili~~~~~  141 (261)
T cd05034          67 YAVCSEEEPIYIVTEYMSKGSLLDFLKS--GEGKKLRLPQLVDMAAQIAEGMAYL---ESRNYIHRDLAARNILVGENLV  141 (261)
T ss_pred             eeeeecCCceEEEEeccCCCCHHHHHhc--cccCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCcchheEEEcCCCC
Confidence            9999988999999999999999999975  2345689999999999999999999   7778999999999999999999


Q ss_pred             EEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccccHHHH
Q 011360          351 ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSPEWL  429 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~  429 (487)
                      ++|+|||++.......... .....++..|+|||.+.+..++.++|+||||+++|++++ |+.||.....      ....
T Consensus       142 ~~l~d~g~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~------~~~~  214 (261)
T cd05034         142 CKIADFGLARLIEDDEYTA-REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN------REVL  214 (261)
T ss_pred             EEECccccceeccchhhhh-hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH------HHHH
Confidence            9999999987664321111 112234678999999998889999999999999999999 8999943321      1222


Q ss_pred             HHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          430 RKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       430 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      .........  ..+...        +..+.+++.+||..+|++|||+.++.+.|+.+
T Consensus       215 ~~~~~~~~~--~~~~~~--------~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~~  261 (261)
T cd05034         215 EQVERGYRM--PRPPNC--------PEELYDLMLQCWDKDPEERPTFEYLQSFLEDY  261 (261)
T ss_pred             HHHHcCCCC--CCCCCC--------CHHHHHHHHHHcccCcccCCCHHHHHHHHhcC
Confidence            222221111  111111        34688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.1e-38  Score=309.59  Aligned_cols=257  Identities=22%  Similarity=0.267  Sum_probs=195.4

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      +|.+.+.||+|+||.||+++. ..+++.||+|++..            ...........+.+|..++..++||||+++++
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~-~~~~~~~aiK~~~~------------~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~   68 (331)
T cd05597           2 DFEILKVIGRGAFGEVAVVKM-KNTGQVYAMKILNK------------WEMLKRAETACFREERDVLVNGDRRWITNLHY   68 (331)
T ss_pred             CceEEEEEEecCCeEEEEEEE-CCCCCEEEEEEEEH------------HHHhhhhhHHHHHHHHHHHHhCCCCCCCceEE
Confidence            589999999999999999975 45788999998732            11222334566788999999999999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEE
Q 011360          273 HMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC  352 (487)
Q Consensus       273 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~k  352 (487)
                      ++.+++.+|+||||+++|+|.+++..   ....+++..+..++.|++.||+||   |++||+||||||+|||++.++.+|
T Consensus        69 ~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~Nill~~~~~~k  142 (331)
T cd05597          69 AFQDENNLYLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSV---HQLGYVHRDIKPDNVLLDKNGHIR  142 (331)
T ss_pred             EEecCCeEEEEEecCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHH---HhCCeEECCCCHHHEEECCCCCEE
Confidence            99999999999999999999999864   245688999999999999999999   778899999999999999999999


Q ss_pred             EeccCCccccCCCCceeeEeeecccccccCCcccCC-----CCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHH
Q 011360          353 ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQ-----PELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPE  427 (487)
Q Consensus       353 l~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~  427 (487)
                      |+|||++.......... .....||+.|+|||++..     ..++.++|||||||++|+|++|..||....      ..+
T Consensus       143 l~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~------~~~  215 (331)
T cd05597         143 LADFGSCLRLLADGTVQ-SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES------LVE  215 (331)
T ss_pred             EEECCceeecCCCCCcc-ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC------HHH
Confidence            99999987654332211 123458999999999863     457889999999999999999999994321      122


Q ss_pred             HHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCC--CCCCChHHHHH
Q 011360          428 WLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDP--EERPNSQYVRC  481 (487)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P--~~RPs~~~il~  481 (487)
                      ........... ..+++..     ...+..+.+++.+|+..++  ..||++++++.
T Consensus       216 ~~~~i~~~~~~-~~~~~~~-----~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~  265 (331)
T cd05597         216 TYGKIMNHKEH-FQFPPDV-----TDVSEEAKDLIRRLICSPETRLGRNGLQDFKD  265 (331)
T ss_pred             HHHHHHcCCCc-ccCCCcc-----CCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence            22333221111 1111111     1133557788888775533  34789988875

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.2e-37  Score=298.33  Aligned_cols=258  Identities=21%  Similarity=0.312  Sum_probs=189.9

Q ss_pred             cccccccceeEEEEEecC-CCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceEEec
Q 011360          198 EKIGSGGCGEVYKAELPG-SNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVR  276 (487)
Q Consensus       198 ~~lg~G~~g~v~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  276 (487)
                      +.||.|+||.||+|.... .....+++|.+..              .........+.+|+.+++.++||||+++++.+..
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~--------------~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~   66 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKA--------------NASSKEQNEFLQQGDPYRILQHPNILQCLGQCVE   66 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecC--------------CCChHHHHHHHHHHHHHhccCCcchhheEEEecC
Confidence            369999999999997532 2334566776532              1112235678889999999999999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEecc
Q 011360          277 PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDL  356 (487)
Q Consensus       277 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~DF  356 (487)
                      ....|+||||+++|+|.+++..........++..+..++.|++.||.||   |+.+++||||||+|||++.++.++|+||
T Consensus        67 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~l---H~~~i~H~dikp~nil~~~~~~~~l~Df  143 (268)
T cd05086          67 AIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHM---HKHNFLHSDLALRNCFLTSDLTVKVGDY  143 (268)
T ss_pred             CCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHH---HHCCeeccCCccceEEEcCCccEEeccc
Confidence            9999999999999999999975333344567778889999999999999   6778999999999999999999999999


Q ss_pred             CCccccCCCCceeeEeeecccccccCCcccCC-------CCCCchhHHHHHHHHHHHHHhC-CCCccccCCCCccccHHH
Q 011360          357 GLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQ-------PELSEKCDIFSFGMLLISLVRG-VPSFVFHQNGEEICSPEW  428 (487)
Q Consensus       357 g~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-------~~~~~~~DvwslG~~l~elltg-~~pf~~~~~~~~~~~~~~  428 (487)
                      |++................++..|+|||++..       ..++.++||||||+++|||+++ ..||....      ..+.
T Consensus       144 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~------~~~~  217 (268)
T cd05086         144 GIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS------DREV  217 (268)
T ss_pred             ccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC------HHHH
Confidence            99864322211111123457889999998753       2457899999999999999974 77873322      2233


Q ss_pred             HHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHh
Q 011360          429 LRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLS  484 (487)
Q Consensus       429 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~  484 (487)
                      ........ .....++.++..    ....+.+++..|| .+|++|||+++|++.|.
T Consensus       218 ~~~~~~~~-~~~~~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         218 LNHVIKDQ-QVKLFKPQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             HHHHHhhc-ccccCCCccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            33333322 222223333222    2345778888999 57999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=8.5e-38  Score=298.08  Aligned_cols=254  Identities=24%  Similarity=0.331  Sum_probs=192.2

Q ss_pred             cccccccceeEEEEEecC--CCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceEEe
Q 011360          198 EKIGSGGCGEVYKAELPG--SNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMV  275 (487)
Q Consensus       198 ~~lg~G~~g~v~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  275 (487)
                      +.||.|+||.||+|.+..  ..+..+|+|.+..              .........+.+|+.+++.++||||+++++++.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~--------------~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   66 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNR--------------ITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICL   66 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCc--------------cCCHHHHHHHHHHHHHHccCCCCCcceEEEEee
Confidence            468999999999997632  2446799997622              112234567788999999999999999999765


Q ss_pred             -cCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEe
Q 011360          276 -RPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACIS  354 (487)
Q Consensus       276 -~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~  354 (487)
                       .++..+++|||+.+|+|.+++..   .....++..+..++.|++.||.||   |+.|++||||||+||+++.++.+||+
T Consensus        67 ~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlk~~nili~~~~~~kl~  140 (262)
T cd05058          67 PSEGSPLVVLPYMKHGDLRNFIRS---ETHNPTVKDLIGFGLQVAKGMEYL---ASKKFVHRDLAARNCMLDESFTVKVA  140 (262)
T ss_pred             cCCCCcEEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHH---HhCCccccccCcceEEEcCCCcEEEC
Confidence             45567899999999999999864   233467778889999999999999   67789999999999999999999999


Q ss_pred             ccCCccccCCCCcee--eEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhC-CCCccccCCCCccccHHHHHH
Q 011360          355 DLGLAMAIPDGYTRV--LISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRG-VPSFVFHQNGEEICSPEWLRK  431 (487)
Q Consensus       355 DFg~s~~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg-~~pf~~~~~~~~~~~~~~~~~  431 (487)
                      |||+++.........  ......+++.|+|||.+.+..++.++||||||+++|||++| .+||...      ...+....
T Consensus       141 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~------~~~~~~~~  214 (262)
T cd05058         141 DFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV------DSFDITVY  214 (262)
T ss_pred             CccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC------CHHHHHHH
Confidence            999987654322111  11123457789999999888899999999999999999995 6666322      12222332


Q ss_pred             HHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhhC
Q 011360          432 VMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL  487 (487)
Q Consensus       432 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~ll  487 (487)
                      ......+.  .+.        ..+..+.+++.+||+.+|++||++.+|+..|++++
T Consensus       215 ~~~~~~~~--~~~--------~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         215 LLQGRRLL--QPE--------YCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             HhcCCCCC--CCC--------cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence            32221111  111        11246889999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.1e-37  Score=297.20  Aligned_cols=256  Identities=24%  Similarity=0.401  Sum_probs=201.1

Q ss_pred             hccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccc
Q 011360          190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILP  269 (487)
Q Consensus       190 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~  269 (487)
                      ..+.|.+.+.||.|+||.||++...  .+..+|+|.+..                .......+.+|+.+++.++|+||++
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~--~~~~~~iK~~~~----------------~~~~~~~~~~e~~~l~~l~~~~i~~   65 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYN--KHTKVAVKTMKP----------------GSMSVEAFLAEANVMKTLQHDKLVK   65 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEec--CCccEEEEecCC----------------ChhHHHHHHHHHHHHHhcCCCCcce
Confidence            3457999999999999999999754  556799997631                1223456788999999999999999


Q ss_pred             cceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC
Q 011360          270 LLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDM  349 (487)
Q Consensus       270 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~  349 (487)
                      +++.+.. ...+++|||+++++|.+++..  ..+..+++..+..++.|++.||.||   |+.|++|+||+|+||+++.++
T Consensus        66 ~~~~~~~-~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~aL~~l---H~~~i~H~dl~p~ni~i~~~~  139 (260)
T cd05073          66 LHAVVTK-EPIYIITEFMAKGSLLDFLKS--DEGSKQPLPKLIDFSAQIAEGMAFI---EQRNYIHRDLRAANILVSASL  139 (260)
T ss_pred             EEEEEcC-CCeEEEEEeCCCCcHHHHHHh--CCccccCHHHHHHHHHHHHHHHHHH---HhCCccccccCcceEEEcCCC
Confidence            9998887 778999999999999999975  2345678889999999999999999   677899999999999999999


Q ss_pred             CEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccccHHH
Q 011360          350 EACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSPEW  428 (487)
Q Consensus       350 ~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~  428 (487)
                      .+||+|||.+.......... .....++..|+|||.+....++.++|+||||+++|+++| |..||....      ....
T Consensus       140 ~~~l~d~~~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~------~~~~  212 (260)
T cd05073         140 VCKIADFGLARVIEDNEYTA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS------NPEV  212 (260)
T ss_pred             cEEECCCcceeeccCCCccc-ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCC------HHHH
Confidence            99999999987654332211 122345678999999998889999999999999999999 899994322      1112


Q ss_pred             HHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          429 LRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       429 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      .. .........     .+    ...+.++.+++.+||+.+|++||++.++.+.|+.+
T Consensus       213 ~~-~~~~~~~~~-----~~----~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~  260 (260)
T cd05073         213 IR-ALERGYRMP-----RP----ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF  260 (260)
T ss_pred             HH-HHhCCCCCC-----Cc----ccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence            22 222221111     11    12235688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.7e-39  Score=315.04  Aligned_cols=250  Identities=25%  Similarity=0.376  Sum_probs=202.1

Q ss_pred             ccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceEE
Q 011360          195 ASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHM  274 (487)
Q Consensus       195 ~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  274 (487)
                      ....+||+|+|-+||+| .+..+|..||--.+           --.+....+....++..|+.+|+.|+||||+++|.+|
T Consensus        43 k~~evLGrGafKtVYka-~De~~giEVAWnqv-----------k~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW  110 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKA-FDEEEGIEVAWNQV-----------KIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSW  110 (632)
T ss_pred             ehhhhcccccceeeeec-cccccchhhHHHHH-----------hHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeehe
Confidence            45578999999999999 46677877763322           1123344556778999999999999999999999999


Q ss_pred             ecCCe--eEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC-CCCE
Q 011360          275 VRPDC--HLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLND-DMEA  351 (487)
Q Consensus       275 ~~~~~--~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~-~~~~  351 (487)
                      .+...  +.+|+|.+..|+|..|+.++    +......+..|++||+.||.|||+ |..-|+|||||.+||+|+. .|.|
T Consensus       111 ~d~~n~~in~iTEL~TSGtLr~Y~kk~----~~vn~kaik~W~RQILkGL~yLHs-~~PPIIHRDLKCDNIFinG~~G~V  185 (632)
T KOG0584|consen  111 VDTDNKTINFITELFTSGTLREYRKKH----RRVNIKAIKSWCRQILKGLVYLHS-QDPPIIHRDLKCDNIFVNGNLGEV  185 (632)
T ss_pred             ecCCCceeeeeeecccCCcHHHHHHHh----ccCCHHHHHHHHHHHHHHhhhhhc-CCCCccccccccceEEEcCCcCce
Confidence            87655  78999999999999999874    567788999999999999999988 5667999999999999986 4899


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRK  431 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~  431 (487)
                      ||+|+|+|........    ....|||.|||||... ..|+..+||||||+++.||+|+..||.      +...+..+.+
T Consensus       186 KIGDLGLAtl~r~s~a----ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYs------EC~n~AQIYK  254 (632)
T KOG0584|consen  186 KIGDLGLATLLRKSHA----KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYS------ECTNPAQIYK  254 (632)
T ss_pred             eecchhHHHHhhcccc----ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChh------hhCCHHHHHH
Confidence            9999999988766544    3467999999999988 689999999999999999999999993      3333444444


Q ss_pred             HHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          432 VMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       432 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .+..+..+..+..--.        .++.++|.+|+.. .++|||+.+++.
T Consensus       255 KV~SGiKP~sl~kV~d--------Pevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  255 KVTSGIKPAALSKVKD--------PEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             HHHcCCCHHHhhccCC--------HHHHHHHHHHhcC-chhccCHHHHhh
Confidence            4444444333332111        3588999999999 999999999985

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=2.9e-38  Score=305.39  Aligned_cols=254  Identities=26%  Similarity=0.364  Sum_probs=198.0

Q ss_pred             cccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceE
Q 011360          194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAH  273 (487)
Q Consensus       194 ~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  273 (487)
                      |+..+.||.|+||.||++.. ..+++.||+|.+...            ..........+..|+.++++++|+||+.+++.
T Consensus         2 f~~~~~ig~G~~g~v~~~~~-~~~~~~~avK~~~~~------------~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~   68 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQV-RATGKMYACKKLEKK------------RIKKRKGESMALNEKQILEKVNSRFVVSLAYA   68 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEE-cCCCceEEEEEEehh------------hccchHHHHHHHHHHHHHHhCCCCCeeeeeEE
Confidence            67778999999999999975 457899999987321            11112234456789999999999999999999


Q ss_pred             EecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEE
Q 011360          274 MVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACI  353 (487)
Q Consensus       274 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl  353 (487)
                      +...+..++||||+++++|.+++..  .....+++..+..++.|++.||.||   |+.||+||||||+||+++.++.++|
T Consensus        69 ~~~~~~~~lv~e~~~g~~L~~~l~~--~~~~~l~~~~~~~~~~qi~~~l~~l---H~~~iiH~dikp~Nil~~~~~~~~l  143 (285)
T cd05630          69 YETKDALCLVLTLMNGGDLKFHIYH--MGEAGFEEGRAVFYAAEICCGLEDL---HQERIVYRDLKPENILLDDHGHIRI  143 (285)
T ss_pred             EecCCEEEEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHH---HhCCEEeCCCCHHHEEECCCCCEEE
Confidence            9999999999999999999998864  2334688999999999999999999   6788999999999999999999999


Q ss_pred             eccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHHH
Q 011360          354 SDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVM  433 (487)
Q Consensus       354 ~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~  433 (487)
                      +|||++.........   ....|++.|+|||++.+..++.++||||||+++|+|++|..||........   .+......
T Consensus       144 ~Dfg~~~~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~---~~~~~~~~  217 (285)
T cd05630         144 SDLGLAVHVPEGQTI---KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK---REEVERLV  217 (285)
T ss_pred             eeccceeecCCCccc---cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch---HHHHHhhh
Confidence            999998765433221   234689999999999988999999999999999999999999954322110   11111111


Q ss_pred             hcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCC-----hHHHHH
Q 011360          434 NSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPN-----SQYVRC  481 (487)
Q Consensus       434 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~~il~  481 (487)
                      ....  ..    .+.    .....+.+++.+||+.||++|||     ++++++
T Consensus       218 ~~~~--~~----~~~----~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         218 KEVQ--EE----YSE----KFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             hhhh--hh----cCc----cCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence            1110  01    111    12245889999999999999999     788875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=6.5e-38  Score=309.02  Aligned_cols=261  Identities=21%  Similarity=0.329  Sum_probs=192.9

Q ss_pred             cccccccc--cceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceE
Q 011360          196 SLEKIGSG--GCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAH  273 (487)
Q Consensus       196 ~~~~lg~G--~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  273 (487)
                      ++++||+|  +||+||++.. ..+|+.||+|++..             ..........+.+|+.+++.++||||++++++
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~-~~~~~~vaiK~~~~-------------~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~   67 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARY-KPTGEYVTVRRINL-------------EACTNEMVTFLQGELHVSKLFNHPNIVPYRAT   67 (327)
T ss_pred             hhhhccccccceEEEEEEee-cccCcEEEEEEech-------------hhccHHHHHHHHHHHHHHHhcCCCCeeeEEEE
Confidence            45789999  7899999974 46899999998732             11123345567789999999999999999999


Q ss_pred             EecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEE
Q 011360          274 MVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACI  353 (487)
Q Consensus       274 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl  353 (487)
                      +..++..++||||+++|+|.+++...  ....+++..++.++.|++.||.||   |++||+||||||+||+++.++.+++
T Consensus        68 ~~~~~~~~lv~e~~~~~~l~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~L---H~~~iiH~dlkp~Nil~~~~~~~~l  142 (327)
T cd08227          68 FIADNELWVVTSFMAYGSAKDLICTH--FMDGMSELAIAYILQGVLKALDYI---HHMGYVHRSVKASHILISVDGKVYL  142 (327)
T ss_pred             EEECCEEEEEEeccCCCcHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHH---HHCCEecCCCChhhEEEecCCcEEE
Confidence            99999999999999999999998642  234588999999999999999999   7788999999999999999999999


Q ss_pred             eccCCccccCCCCcee-----eEeeecccccccCCcccCC--CCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccH
Q 011360          354 SDLGLAMAIPDGYTRV-----LISYVLGTMAYIAPEYFQQ--PELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSP  426 (487)
Q Consensus       354 ~DFg~s~~~~~~~~~~-----~~~~~~gt~~y~aPE~l~~--~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~  426 (487)
                      +||+.+..........     ......++..|+|||++.+  ..++.++|||||||++|+|++|..||......      
T Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------  216 (327)
T cd08227         143 SGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPAT------  216 (327)
T ss_pred             cccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchh------
Confidence            9998654432211100     0122346778999999876  46899999999999999999999999532210      


Q ss_pred             HHHHHHHhcCCCC------------------CccCC----------CCC-------CCCcHHHHHHHHHHHhhccCCCCC
Q 011360          427 EWLRKVMNSKNPS------------------RAIDP----------RLP-------GNGYEKKMLHVLKIAYICTLHDPE  471 (487)
Q Consensus       427 ~~~~~~~~~~~~~------------------~~~~~----------~~~-------~~~~~~~~~~l~~li~~cl~~~P~  471 (487)
                      ...........+.                  ...+.          ..+       .........++.+++.+||+.||+
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~  296 (327)
T cd08227         217 QMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPD  296 (327)
T ss_pred             HHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCch
Confidence            0111111000000                  00000          000       001123345788999999999999


Q ss_pred             CCCChHHHHH
Q 011360          472 ERPNSQYVRC  481 (487)
Q Consensus       472 ~RPs~~~il~  481 (487)
                      +|||+.++++
T Consensus       297 ~Rpt~~ell~  306 (327)
T cd08227         297 ARPSASTLLN  306 (327)
T ss_pred             hcCCHHHHhc
Confidence            9999999975

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.7e-38  Score=300.69  Aligned_cols=258  Identities=20%  Similarity=0.283  Sum_probs=200.7

Q ss_pred             cccccccccccccceeEEEEEecCCC---CceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSN---GKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNIL  268 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv  268 (487)
                      .+|.+.+.||.|+||.||+|.+....   ...+|+|.+...              ........+.+|+.++..++||||+
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~--------------~~~~~~~~~~~e~~~l~~l~h~~i~   72 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREE--------------TSPKANKEILDEAYVMASVDHPHVV   72 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCC--------------CCHHHHHHHHHHHHHHHhCCCCCcc
Confidence            45899999999999999999864221   236888876321              1133456788899999999999999


Q ss_pred             ccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC
Q 011360          269 PLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDD  348 (487)
Q Consensus       269 ~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~  348 (487)
                      ++++++.. ...++||||+++|+|.+++..   ....+++..+..++.|++.||+||   |++|++||||+|+||+++.+
T Consensus        73 ~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~L---H~~~i~H~di~p~nil~~~~  145 (279)
T cd05057          73 RLLGICLS-SQVQLITQLMPLGCLLDYVRN---HKDNIGSQYLLNWCVQIAKGMSYL---EEKRLVHRDLAARNVLVKTP  145 (279)
T ss_pred             eEEEEEec-CceEEEEecCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHH---HhCCEEecccCcceEEEcCC
Confidence            99999887 788999999999999999864   234589999999999999999999   67899999999999999999


Q ss_pred             CCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccccHH
Q 011360          349 MEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSPE  427 (487)
Q Consensus       349 ~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~  427 (487)
                      +.+||+|||+++...............++..|+|||.+....++.++|+||||+++||+++ |..||....       .+
T Consensus       146 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-------~~  218 (279)
T cd05057         146 QHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP-------AV  218 (279)
T ss_pred             CeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC-------HH
Confidence            9999999999987654332221122224678999999988889999999999999999998 999994322       12


Q ss_pred             HHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          428 WLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      ............ .    .+..    ....+.+++.+||..+|++|||+.++++.|+++
T Consensus       219 ~~~~~~~~~~~~-~----~~~~----~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~  268 (279)
T cd05057         219 EIPDLLEKGERL-P----QPPI----CTIDVYMVLVKCWMIDAESRPTFKELINEFSKM  268 (279)
T ss_pred             HHHHHHhCCCCC-C----CCCC----CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            222222222110 1    1111    124588999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-37  Score=296.48  Aligned_cols=254  Identities=26%  Similarity=0.394  Sum_probs=202.0

Q ss_pred             cccccccceeEEEEEecC--CCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceEEe
Q 011360          198 EKIGSGGCGEVYKAELPG--SNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMV  275 (487)
Q Consensus       198 ~~lg~G~~g~v~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  275 (487)
                      +.||.|+||.||+|....  ..+..|++|.+...              ........+.+|+..+..++||||+++++++.
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~--------------~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   66 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKED--------------ASEEERKDFLKEARVMKKLGHPNVVRLLGVCT   66 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccc--------------cchhHHHHHHHHHHHHhhcCCCChheeeeeec
Confidence            468999999999998642  22788999987431              11114567889999999999999999999999


Q ss_pred             cCCeeEEEEEecCCCCHHHHHhhhhcC-----CCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          276 RPDCHLLVYEFMKNGSLQDILDDVSRG-----RRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       276 ~~~~~~lv~E~~~~gsL~~~l~~~~~~-----~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      .....+++|||+++++|.+++......     ...+++..+..++.|++.||.||   |++|++|+||+|+||+++.++.
T Consensus        67 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~l---H~~~i~H~di~p~nili~~~~~  143 (262)
T cd00192          67 EEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL---ASKKFVHRDLAARNCLVGEDLV  143 (262)
T ss_pred             CCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHH---HcCCcccCccCcceEEECCCCc
Confidence            999999999999999999999763211     36789999999999999999999   7788999999999999999999


Q ss_pred             EEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccccHHHH
Q 011360          351 ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSPEWL  429 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~  429 (487)
                      ++|+|||.+................+++.|+|||.+....++.++||||||+++|+|++ |..||....      ..+..
T Consensus       144 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~------~~~~~  217 (262)
T cd00192         144 VKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS------NEEVL  217 (262)
T ss_pred             EEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC------HHHHH
Confidence            99999999987765432222234557889999999988889999999999999999999 599994431      22223


Q ss_pred             HHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHh
Q 011360          430 RKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLS  484 (487)
Q Consensus       430 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~  484 (487)
                      .........  .    .+.    ..+.++.+++.+||..+|++|||+.++++.|+
T Consensus       218 ~~~~~~~~~--~----~~~----~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         218 EYLRKGYRL--P----KPE----YCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             HHHHcCCCC--C----CCc----cCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            333221111  1    111    12356889999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.5e-38  Score=336.60  Aligned_cols=257  Identities=21%  Similarity=0.327  Sum_probs=198.6

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      +.|.+++.||.|+||.||++.. ..++..+|+|.+...             .........+..|+.++.+++|||||+++
T Consensus        13 ~~YeIl~kLG~GgFGtVYLAkd-k~tg~~vAlKvIk~~-------------~l~e~~~~~~~~EI~IL~~L~HPNIVrl~   78 (1021)
T PTZ00266         13 NEYEVIKKIGNGRFGEVFLVKH-KRTQEFFCWKAISYR-------------GLKEREKSQLVIEVNVMRELKHKNIVRYI   78 (1021)
T ss_pred             CCEEEEEEEecCCCeEEEEEEE-CCCCeEEEEEEEecc-------------ccCHHHHHHHHHHHHHHHHcCCCCcCeEE
Confidence            4699999999999999999975 457889999987431             12233456788899999999999999999


Q ss_pred             eEEec--CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcC----CCCeeecCCCCCCEEe
Q 011360          272 AHMVR--PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYH----SASIIHGDIKPRNVLL  345 (487)
Q Consensus       272 ~~~~~--~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h----~~givH~Dlkp~Nill  345 (487)
                      ++|..  ...+||||||+++|+|.++|.........+++..++.|+.||+.||.|||...    ..+||||||||+|||+
T Consensus        79 d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL  158 (1021)
T PTZ00266         79 DRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFL  158 (1021)
T ss_pred             EEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEe
Confidence            98864  35689999999999999999765444567999999999999999999996532    2569999999999999


Q ss_pred             CC-----------------CCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCC--CCCCchhHHHHHHHHHHH
Q 011360          346 ND-----------------DMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQ--PELSEKCDIFSFGMLLIS  406 (487)
Q Consensus       346 ~~-----------------~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~DvwslG~~l~e  406 (487)
                      +.                 .+.+||+|||++........   .....||+.|+|||++.+  ..++.++|||||||++|+
T Consensus       159 ~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYE  235 (1021)
T PTZ00266        159 STGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYE  235 (1021)
T ss_pred             ecCccccccccccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHH
Confidence            64                 23489999999976543322   133468999999999864  458899999999999999


Q ss_pred             HHhCCCCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          407 LVRGVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       407 lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      |+||..||.....      ...+...+... +.      ++..   ..+.++.++|..||+.+|.+|||+.+++.
T Consensus       236 LLTGk~PF~~~~~------~~qli~~lk~~-p~------lpi~---~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        236 LCSGKTPFHKANN------FSQLISELKRG-PD------LPIK---GKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             HHHCCCCCCcCCc------HHHHHHHHhcC-CC------CCcC---CCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            9999999943221      11222222211 11      1111   12356889999999999999999999884

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=7.6e-38  Score=299.99  Aligned_cols=253  Identities=25%  Similarity=0.352  Sum_probs=193.8

Q ss_pred             cccccccceeEEEEEecCCCCc--eEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CCCCccccceEE
Q 011360          198 EKIGSGGCGEVYKAELPGSNGK--MIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RHRNILPLLAHM  274 (487)
Q Consensus       198 ~~lg~G~~g~v~~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~  274 (487)
                      +.||.|+||.||+|... .++.  .+++|.+..              .........+..|+.++.++ .||||+++++++
T Consensus         1 ~~lg~g~~g~v~~~~~~-~~~~~~~~~~k~~~~--------------~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   65 (270)
T cd05047           1 DVIGEGNFGQVLKARIK-KDGLRMDAAIKRMKE--------------YASKDDHRDFAGELEVLCKLGHHPNIINLLGAC   65 (270)
T ss_pred             CcCCCCCCceEEEEEEc-CCCCeeEEEEEEccc--------------cCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEE
Confidence            36899999999999864 3443  468887631              11223445678899999999 899999999999


Q ss_pred             ecCCeeEEEEEecCCCCHHHHHhhhhc------------CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCC
Q 011360          275 VRPDCHLLVYEFMKNGSLQDILDDVSR------------GRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRN  342 (487)
Q Consensus       275 ~~~~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~N  342 (487)
                      ...+..+++|||+++|+|.+++.....            ....+++..+..++.|++.||+||   |++|++||||||+|
T Consensus        66 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~l---H~~~i~H~dikp~n  142 (270)
T cd05047          66 EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARN  142 (270)
T ss_pred             ecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHH---HHCCEeecccccce
Confidence            999999999999999999999865221            123578899999999999999999   67899999999999


Q ss_pred             EEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCC
Q 011360          343 VLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGE  421 (487)
Q Consensus       343 ill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~  421 (487)
                      |+++.++.+||+|||++.........   .....++.|+|||++.+..++.++||||||+++|+|++ |..||....   
T Consensus       143 ili~~~~~~kl~dfgl~~~~~~~~~~---~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~---  216 (270)
T cd05047         143 ILVGENYVAKIADFGLSRGQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT---  216 (270)
T ss_pred             EEEcCCCeEEECCCCCccccchhhhc---cCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccC---
Confidence            99999999999999998532211111   11224567999999988889999999999999999997 999994322   


Q ss_pred             ccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhhC
Q 011360          422 EICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL  487 (487)
Q Consensus       422 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~ll  487 (487)
                         ..+...........      ..+.    ....++.+++.+||+.+|.+|||+.+++..|+.++
T Consensus       217 ---~~~~~~~~~~~~~~------~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         217 ---CAELYEKLPQGYRL------EKPL----NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             ---HHHHHHHHhCCCCC------CCCC----cCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence               12222222211111      0111    12346889999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.4e-37  Score=297.93  Aligned_cols=267  Identities=25%  Similarity=0.435  Sum_probs=207.0

Q ss_pred             cccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhcc-CCCCCccccce
Q 011360          194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQ-IRHRNILPLLA  272 (487)
Q Consensus       194 ~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~hpnIv~l~~  272 (487)
                      |.+.+.||.|+||.||+|.....++..+|+|.+........     +...........+..|+.++.. ++||||+++++
T Consensus         2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~-----~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~   76 (269)
T cd08528           2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFG-----KDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYK   76 (269)
T ss_pred             chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccc-----cccccchHHHHHHHHHHHHHhhcCCCCCeeeEEe
Confidence            78889999999999999987654678999998754221110     0011223445667788887764 79999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEE
Q 011360          273 HMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC  352 (487)
Q Consensus       273 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~k  352 (487)
                      ++..++..+++|||+++++|.+++.........+++..++.++.|++.||.|||  +..|++|+||+|+||+++.++.++
T Consensus        77 ~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh--~~~~i~H~dl~~~nil~~~~~~~~  154 (269)
T cd08528          77 TFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLH--KEKRIVHRDLTPNNIMLGEDDKVT  154 (269)
T ss_pred             eEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhc--cCCceeecCCCHHHEEECCCCcEE
Confidence            999999999999999999999998765455667899999999999999999994  146899999999999999999999


Q ss_pred             EeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHH
Q 011360          353 ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKV  432 (487)
Q Consensus       353 l~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~  432 (487)
                      |+|||.+.......   ......|+..|+|||.+.+..++.++|+||||+++|+|++|.+||....      ........
T Consensus       155 l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~------~~~~~~~~  225 (269)
T cd08528         155 ITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN------MLSLATKI  225 (269)
T ss_pred             Eecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC------HHHHHHHH
Confidence            99999997654432   1234568899999999998889999999999999999999999994321      11222222


Q ss_pred             HhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhh
Q 011360          433 MNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQ  485 (487)
Q Consensus       433 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~  485 (487)
                      .. ......     +.   ...+..+.+++.+||+.||++|||+.++.+.+++
T Consensus       226 ~~-~~~~~~-----~~---~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~  269 (269)
T cd08528         226 VE-AVYEPL-----PE---GMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD  269 (269)
T ss_pred             hh-ccCCcC-----Cc---ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence            21 111111     11   1123568899999999999999999999998863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=5.9e-38  Score=300.90  Aligned_cols=252  Identities=26%  Similarity=0.384  Sum_probs=194.0

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CCCCccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RHRNILP  269 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~  269 (487)
                      .+.|.+.+.||.|+||.||+|.. ..++..||+|.+...                ......+..|+.++..+ +||||++
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~-~~~~~~~aik~~~~~----------------~~~~~~~~~e~~~l~~~~~h~~i~~   67 (272)
T cd06637           5 AGIFELVELVGNGTYGQVYKGRH-VKTGQLAAIKVMDVT----------------GDEEEEIKQEINMLKKYSHHRNIAT   67 (272)
T ss_pred             hhhhhHHHheeecCCeEEEEEEE-cCCCcEEEEEEEEcC----------------CccHHHHHHHHHHHHHhcCCCCeee
Confidence            34688899999999999999975 457889999987321                11234567788888888 7999999


Q ss_pred             cceEEecC------CeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCE
Q 011360          270 LLAHMVRP------DCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNV  343 (487)
Q Consensus       270 l~~~~~~~------~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Ni  343 (487)
                      +++++...      ...|++|||+++++|.+++..  .....+++..+..++.|++.||+||   |+++|+|+||+|+||
T Consensus        68 ~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~--~~~~~l~~~~~~~~~~qi~~~l~~L---H~~~ivh~dl~~~ni  142 (272)
T cd06637          68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN--TKGNTLKEEWIAYICREILRGLSHL---HQHKVIHRDIKGQNV  142 (272)
T ss_pred             EeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHH---HHCCCccCCCCHHHE
Confidence            99988753      457999999999999999875  2345688999999999999999999   667899999999999


Q ss_pred             EeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccC-----CCCCCchhHHHHHHHHHHHHHhCCCCccccC
Q 011360          344 LLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQ-----QPELSEKCDIFSFGMLLISLVRGVPSFVFHQ  418 (487)
Q Consensus       344 ll~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DvwslG~~l~elltg~~pf~~~~  418 (487)
                      +++.++.++|+|||++.........  .....|++.|+|||++.     +..++.++|||||||++|+|++|..||....
T Consensus       143 li~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~  220 (272)
T cd06637         143 LLTENAEVKLVDFGVSAQLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH  220 (272)
T ss_pred             EECCCCCEEEccCCCceeccccccc--CCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccC
Confidence            9999999999999998765432211  13456899999999986     3468889999999999999999999994322


Q ss_pred             CCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          419 NGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       419 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .      ......... .......+.        ..+.++.+++.+||..+|.+|||+.+++.
T Consensus       221 ~------~~~~~~~~~-~~~~~~~~~--------~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         221 P------MRALFLIPR-NPAPRLKSK--------KWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             H------HHHHHHHhc-CCCCCCCCC--------CcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            1      111111111 111111111        12356889999999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=2.7e-38  Score=315.33  Aligned_cols=264  Identities=25%  Similarity=0.326  Sum_probs=194.9

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .++|.+.+.||.|+||.||++. +..+++.||+|++...             .........+.+|+.+++.++||||+++
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~~vaiK~~~~~-------------~~~~~~~~~~~~E~~~l~~l~h~niv~~   81 (355)
T cd07874          16 LKRYQNLKPIGSGAQGIVCAAY-DAVLDRNVAIKKLSRP-------------FQNQTHAKRAYRELVLMKCVNHKNIISL   81 (355)
T ss_pred             hhceeEEEEeeecCCEEEEEEE-ecCCCceEEEEEeCCc-------------ccChHHHHHHHHHHHHHHHhCCCchhce
Confidence            3579999999999999999996 4567899999987421             1122334567789999999999999999


Q ss_pred             ceEEecC------CeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEE
Q 011360          271 LAHMVRP------DCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVL  344 (487)
Q Consensus       271 ~~~~~~~------~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nil  344 (487)
                      ++++...      ...|+||||+++ +|.+.+.      ..+++..+..++.|++.||.||   |++||+||||||+|||
T Consensus        82 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~------~~l~~~~~~~~~~qi~~aL~~L---H~~givHrDikp~Nil  151 (355)
T cd07874          82 LNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHL---HSAGIIHRDLKPSNIV  151 (355)
T ss_pred             eeeeeccccccccceeEEEhhhhcc-cHHHHHh------hcCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCChHHEE
Confidence            9988644      346999999965 6766664      2478888999999999999999   7889999999999999


Q ss_pred             eCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCcc-
Q 011360          345 LNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI-  423 (487)
Q Consensus       345 l~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~-  423 (487)
                      ++.++.+||+|||+++.......   .....||+.|+|||++.+..++.++|||||||++|+|++|..||......... 
T Consensus       152 l~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~  228 (355)
T cd07874         152 VKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN  228 (355)
T ss_pred             ECCCCCEEEeeCcccccCCCccc---cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            99999999999999976543322   13356899999999999989999999999999999999999999543211000 


Q ss_pred             --------ccHHH-------HHHHHhcC-CCCC-ccCCC-----CC--CCCcHHHHHHHHHHHhhccCCCCCCCCChHHH
Q 011360          424 --------CSPEW-------LRKVMNSK-NPSR-AIDPR-----LP--GNGYEKKMLHVLKIAYICTLHDPEERPNSQYV  479 (487)
Q Consensus       424 --------~~~~~-------~~~~~~~~-~~~~-~~~~~-----~~--~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~i  479 (487)
                              ..+++       ........ .... .++..     .+  ..........+.+++.+||..||++|||+.++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~el  308 (355)
T cd07874         229 KVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEA  308 (355)
T ss_pred             HHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHH
Confidence                    00010       01111100 0000 00000     00  01111234568899999999999999999999


Q ss_pred             HH
Q 011360          480 RC  481 (487)
Q Consensus       480 l~  481 (487)
                      ++
T Consensus       309 l~  310 (355)
T cd07874         309 LQ  310 (355)
T ss_pred             hc
Confidence            86

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=3.4e-38  Score=308.55  Aligned_cols=262  Identities=20%  Similarity=0.329  Sum_probs=194.9

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      +.|.+.+.||.|+||.||+|+. ..++..||+|.+....              .......+.+|+.+++.++||||++++
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~~vaiK~~~~~~--------------~~~~~~~~~~E~~~l~~l~h~~iv~~~   70 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRS-KLTENLVALKEIRLEH--------------EEGAPCTAIREVSLLKDLKHANIVTLH   70 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEe-cCCCCeEEEEEeeccc--------------cCCcchhHHHHHHHHHhCCCCCcceEE
Confidence            4699999999999999999975 4578899999884311              111223456799999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++..++..++||||+++ +|.+++..   .+..+++..+..++.|++.||.||   |++||+||||||+||+++.++.+
T Consensus        71 ~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~l---H~~~ivH~dlkp~Nill~~~~~~  143 (309)
T cd07872          71 DIVHTDKSLTLVFEYLDK-DLKQYMDD---CGNIMSMHNVKIFLYQILRGLAYC---HRRKVLHRDLKPQNLLINERGEL  143 (309)
T ss_pred             EEEeeCCeEEEEEeCCCC-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEECCCCCE
Confidence            999999999999999965 88887754   244578899999999999999999   77899999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQ-PELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLR  430 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~  430 (487)
                      ||+|||++.........  .....+++.|+|||.+.+ ..++.++||||||+++|+|+||.+||...+.....   ....
T Consensus       144 kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~---~~~~  218 (309)
T cd07872         144 KLADFGLARAKSVPTKT--YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDEL---HLIF  218 (309)
T ss_pred             EECccccceecCCCccc--cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHH
Confidence            99999998764332211  123457899999998865 46899999999999999999999999544321110   0000


Q ss_pred             HHHhcCCCCCc----------cCCCCCC-------CCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          431 KVMNSKNPSRA----------IDPRLPG-------NGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       431 ~~~~~~~~~~~----------~~~~~~~-------~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .... ..+...          .+...+.       ......+.++.+++.+||+.||.+|||+.+++.
T Consensus       219 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         219 RLLG-TPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             HHhC-CCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            0000 000000          0000000       011123456889999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=2.1e-37  Score=293.32  Aligned_cols=248  Identities=26%  Similarity=0.345  Sum_probs=194.1

Q ss_pred             cccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceEEecC
Q 011360          198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRP  277 (487)
Q Consensus       198 ~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  277 (487)
                      +.||.|+||.||+|...  ++..+|+|.+...              ........+.+|+.+++.++||||+++++++...
T Consensus         1 ~~ig~g~~g~vy~~~~~--~~~~~a~K~~~~~--------------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   64 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK--DKTPVAVKTCKED--------------LPQELKIKFLSEARILKQYDHPNIVKLIGVCTQR   64 (250)
T ss_pred             CccCCCCCceEEEEEec--CCcEEEEEecCCc--------------CCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecC
Confidence            36899999999999753  6788999987321              1122334678899999999999999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEeccC
Q 011360          278 DCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLG  357 (487)
Q Consensus       278 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~DFg  357 (487)
                      +..++||||+++++|.+++..   ....+++..+..++.|++.+|.|+   |++|++||||+|+||+++.++.+||+|||
T Consensus        65 ~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~l---H~~~~~H~dl~p~nili~~~~~~~l~d~g  138 (250)
T cd05085          65 QPIYIVMELVPGGDFLSFLRK---KKDELKTKQLVKFALDAAAGMAYL---ESKNCIHRDLAARNCLVGENNVLKISDFG  138 (250)
T ss_pred             CccEEEEECCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeecccChheEEEcCCCeEEECCCc
Confidence            999999999999999998864   234578999999999999999999   78899999999999999999999999999


Q ss_pred             CccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccccHHHHHHHHhcC
Q 011360          358 LAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSPEWLRKVMNSK  436 (487)
Q Consensus       358 ~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  436 (487)
                      ++.......... .....+++.|+|||++.+..++.++||||||+++|++++ |..||.....      ....... ...
T Consensus       139 ~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~------~~~~~~~-~~~  210 (250)
T cd05085         139 MSRQEDDGIYSS-SGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN------QQAREQV-EKG  210 (250)
T ss_pred             cceecccccccc-CCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH------HHHHHHH-HcC
Confidence            987544332211 112234678999999998889999999999999999998 8999943321      1112222 111


Q ss_pred             CCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHh
Q 011360          437 NPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLS  484 (487)
Q Consensus       437 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~  484 (487)
                      .. .....        ..+.++.+++.+||+.+|++|||+.++.+.|.
T Consensus       211 ~~-~~~~~--------~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         211 YR-MSCPQ--------KCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CC-CCCCC--------CCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            11 11111        12356899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=5.4e-38  Score=314.21  Aligned_cols=263  Identities=24%  Similarity=0.322  Sum_probs=194.2

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .++|.+.+.||.|+||.||++. +..+++.||||++...             .........+.+|+.+++.++||||+++
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~~vaiK~~~~~-------------~~~~~~~~~~~~E~~~l~~l~h~~ii~~   88 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAY-DAILERNVAIKKLSRP-------------FQNQTHAKRAYRELVLMKCVNHKNIIGL   88 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEE-ECCCCcEEEEEEeCcc-------------ccCchhHHHHHHHHHHHHhcCCCCcccc
Confidence            3469999999999999999996 4567889999987321             1122334566789999999999999999


Q ss_pred             ceEEecC------CeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEE
Q 011360          271 LAHMVRP------DCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVL  344 (487)
Q Consensus       271 ~~~~~~~------~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nil  344 (487)
                      ++++...      ...|+||||+++ +|.+++.      ..+++..+..++.|++.||.||   |++||+||||||+||+
T Consensus        89 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~L---H~~~ivH~Dlkp~NIl  158 (364)
T cd07875          89 LNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHL---HSAGIIHRDLKPSNIV  158 (364)
T ss_pred             ceeecccccccccCeEEEEEeCCCC-CHHHHHH------hcCCHHHHHHHHHHHHHHHHHH---hhCCeecCCCCHHHEE
Confidence            9987643      357999999954 7777764      2478888999999999999999   7889999999999999


Q ss_pred             eCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCcc-
Q 011360          345 LNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI-  423 (487)
Q Consensus       345 l~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~-  423 (487)
                      ++.++.+||+|||+++.......   .....+|+.|+|||++.+..++.++|||||||++|+|++|..||...+..... 
T Consensus       159 l~~~~~~kL~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~  235 (364)
T cd07875         159 VKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWN  235 (364)
T ss_pred             ECCCCcEEEEeCCCccccCCCCc---ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            99999999999999976543321   13356899999999999999999999999999999999999999543321000 


Q ss_pred             --------ccHHHH-------HHHHhcCCCCC-c--cCCCC-------CCCCcHHHHHHHHHHHhhccCCCCCCCCChHH
Q 011360          424 --------CSPEWL-------RKVMNSKNPSR-A--IDPRL-------PGNGYEKKMLHVLKIAYICTLHDPEERPNSQY  478 (487)
Q Consensus       424 --------~~~~~~-------~~~~~~~~~~~-~--~~~~~-------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~  478 (487)
                              ..+++.       ..... ..+.. .  .....       ...........+.+++.+||+.||++|||+.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e  314 (364)
T cd07875         236 KVIEQLGTPCPEFMKKLQPTVRTYVE-NRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDE  314 (364)
T ss_pred             HHHHhcCCCCHHHHHhhhHHHHHHHh-hCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHH
Confidence                    000110       00000 00000 0  00000       00111112356889999999999999999999


Q ss_pred             HHH
Q 011360          479 VRC  481 (487)
Q Consensus       479 il~  481 (487)
                      +++
T Consensus       315 ~L~  317 (364)
T cd07875         315 ALQ  317 (364)
T ss_pred             Hhc
Confidence            976

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.2e-37  Score=299.23  Aligned_cols=241  Identities=22%  Similarity=0.317  Sum_probs=184.1

Q ss_pred             ccccccceeEEEEEecC-----------------------CCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHH
Q 011360          199 KIGSGGCGEVYKAELPG-----------------------SNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSE  255 (487)
Q Consensus       199 ~lg~G~~g~v~~~~~~~-----------------------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E  255 (487)
                      .||+|+||.||+|.+..                       .....|++|.+..               ........+.+|
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~---------------~~~~~~~~~~~~   66 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDP---------------SHRDIALAFFET   66 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecCh---------------HHHHHHHHHHHH
Confidence            69999999999997521                       1123578887621               112234567788


Q ss_pred             HHHhccCCCCCccccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 011360          256 IITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIH  335 (487)
Q Consensus       256 ~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH  335 (487)
                      +.+++.++||||+++++++......++||||+++|+|..++..   ....+++..+..++.|++.||+||   |++||+|
T Consensus        67 ~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~l---H~~~iiH  140 (274)
T cd05076          67 ASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYL---EDKNLVH  140 (274)
T ss_pred             HHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHH---HcCCccC
Confidence            9999999999999999999999999999999999999988863   245688999999999999999999   7789999


Q ss_pred             cCCCCCCEEeCCCC-------CEEEeccCCccccCCCCceeeEeeecccccccCCcccCC-CCCCchhHHHHHHHHHHHH
Q 011360          336 GDIKPRNVLLNDDM-------EACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQ-PELSEKCDIFSFGMLLISL  407 (487)
Q Consensus       336 ~Dlkp~Nill~~~~-------~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwslG~~l~el  407 (487)
                      |||||+||+++.++       .+|++|||.+......      ....+++.|+|||.+.+ ..++.++||||||+++||+
T Consensus       141 ~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el  214 (274)
T cd05076         141 GNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI  214 (274)
T ss_pred             CCCCcccEEEeccCcccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHH
Confidence            99999999997644       3799999987643222      12346788999998875 5689999999999999999


Q ss_pred             H-hCCCCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHh
Q 011360          408 V-RGVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLS  484 (487)
Q Consensus       408 l-tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~  484 (487)
                      + +|..||......      + .........       .++..    ....+.+++.+||+.+|++|||+.+|++.|.
T Consensus       215 ~~~g~~p~~~~~~~------~-~~~~~~~~~-------~~~~~----~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         215 CFDGEVPLKERTPS------E-KERFYEKKH-------RLPEP----SCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             HhCCCCCccccChH------H-HHHHHHhcc-------CCCCC----CChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            5 689998543221      1 111111111       01111    1135889999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=7.6e-38  Score=299.34  Aligned_cols=253  Identities=26%  Similarity=0.383  Sum_probs=196.8

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||.|+||.||+|.. ..+++.||+|.+...               .......+.+|+.+++.++||||++++
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~~ik~~~~~---------------~~~~~~~~~~e~~~~~~l~h~~ii~~~   72 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARN-VNTGELAAIKVIKLE---------------PGEDFAVVQQEIIMMKDCKHSNIVAYF   72 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEE-cCCCcEEEEEEEecC---------------chhHHHHHHHHHHHHHhCCCCCeeeEE
Confidence            4689999999999999999974 457889999987431               112234567899999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +.+...+..|++|||+++++|.+++..    ...+++..+..++.|++.||.||   |+.|++|+||||+||+++.++.+
T Consensus        73 ~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~nili~~~~~~  145 (267)
T cd06645          73 GSYLRRDKLWICMEFCGGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYL---HSKGKMHRDIKGANILLTDNGHV  145 (267)
T ss_pred             EEEEeCCEEEEEEeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEECCCCCE
Confidence            999999999999999999999999864    45689999999999999999999   67789999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccC---CCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQ---QPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEW  428 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~  428 (487)
                      +|+|||++.........  .....|++.|+|||++.   ...++.++|+|||||++|+|++|..||......      ..
T Consensus       146 ~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~------~~  217 (267)
T cd06645         146 KLADFGVSAQITATIAK--RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM------RA  217 (267)
T ss_pred             EECcceeeeEccCcccc--cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccch------hh
Confidence            99999998765432211  13446899999999874   456889999999999999999999998433211      11


Q ss_pred             HHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          429 LRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       429 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ............    ....  ....+..+.+++.+||+.+|++|||+.+|++
T Consensus       218 ~~~~~~~~~~~~----~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         218 LFLMTKSNFQPP----KLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             HHhhhccCCCCC----cccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            111111111111    1110  0112345889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=7.1e-38  Score=304.29  Aligned_cols=250  Identities=27%  Similarity=0.420  Sum_probs=199.8

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ..|.+.+.||.|++|.||+|. +..+++.|++|.+...               .......+.+|+.+++.++||||++++
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~-~~~~~~~v~iK~~~~~---------------~~~~~~~~~~e~~~l~~l~h~~iv~~~   82 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAI-DVATGQEVAIKQINLQ---------------KQPKKELIINEILVMKELKNPNIVNFL   82 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEE-EcCCCcEEEEEEEecc---------------cCchHHHHHHHHHHHHhcCCCceeeee
Confidence            469999999999999999996 4468899999987321               112234677899999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++...+..|+||||+++++|..++..     ..+++..+..++.|++.||.||   |+.|++||||+|+||+++.++.+
T Consensus        83 ~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~L---H~~~i~H~dL~p~Nili~~~~~~  154 (296)
T cd06655          83 DSFLVGDELFVVMEYLAGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFL---HANQVIHRDIKSDNVLLGMDGSV  154 (296)
T ss_pred             eeEecCceEEEEEEecCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCCE
Confidence            999999999999999999999998863     4588999999999999999999   77889999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRK  431 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~  431 (487)
                      +|+|||++.........  .....++..|+|||.+.+..++.++||||||+++|+|++|..||.....      ......
T Consensus       155 kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~------~~~~~~  226 (296)
T cd06655         155 KLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP------LRALYL  226 (296)
T ss_pred             EEccCccchhccccccc--CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHH
Confidence            99999998765433221  1234588899999999988899999999999999999999999944322      111222


Q ss_pred             HHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          432 VMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       432 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ......+.....        ...+..+.+++.+||..+|++|||+.+|++
T Consensus       227 ~~~~~~~~~~~~--------~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         227 IATNGTPELQNP--------EKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             HHhcCCcccCCc--------ccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            222221111111        122346889999999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.5e-37  Score=295.40  Aligned_cols=253  Identities=22%  Similarity=0.354  Sum_probs=204.1

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      +|+..+.||.|+||.||.++. ..++..+++|.+...             .........+.+|+.++++++||||+++++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~-~~~~~~~~~k~~~~~-------------~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~   66 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRR-TEDDSLVVWKEVNLT-------------RLSEKERRDALNEIVILSLLQHPNIIAYYN   66 (256)
T ss_pred             CceEeeEecccCCceEEEEEE-cCCCcEEEEEEEeec-------------ccchhHHHHHHHHHHHHHhCCCCCeeEEEe
Confidence            378899999999999999974 467889999987431             122334556789999999999999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEE
Q 011360          273 HMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC  352 (487)
Q Consensus       273 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~k  352 (487)
                      ++.+.+..+++|||+++++|.+++..  .....+++..+..++.|++.||.||   |+.|++|+||+|+||+++.++.+|
T Consensus        67 ~~~~~~~~~~~~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~l---h~~~i~h~dl~p~ni~~~~~~~~k  141 (256)
T cd08221          67 HFMDDNTLLIEMEYANGGTLYDKIVR--QKGQLFEEEMVLWYLFQIVSAVSYI---HKAGILHRDIKTLNIFLTKAGLIK  141 (256)
T ss_pred             EEecCCeEEEEEEecCCCcHHHHHHh--ccccCCCHHHHHHHHHHHHHHHHHH---HhCCccccCCChHhEEEeCCCCEE
Confidence            99999999999999999999999875  2245688999999999999999999   778899999999999999999999


Q ss_pred             EeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHH
Q 011360          353 ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKV  432 (487)
Q Consensus       353 l~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~  432 (487)
                      |+|||++........  ......+++.|+|||.+.+..++.++||||||+++|+|++|..||....      ..+.....
T Consensus       142 l~d~~~~~~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~------~~~~~~~~  213 (256)
T cd08221         142 LGDFGISKILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN------PLNLVVKI  213 (256)
T ss_pred             ECcCcceEEcccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC------HHHHHHHH
Confidence            999999876644332  1234568999999999988888999999999999999999999994322      22333333


Q ss_pred             HhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHH
Q 011360          433 MNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCR  482 (487)
Q Consensus       433 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~  482 (487)
                      ...... .. .        ...+.++.+++.+||+.+|++|||++++++.
T Consensus       214 ~~~~~~-~~-~--------~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         214 VQGNYT-PV-V--------SVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             HcCCCC-CC-c--------cccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence            322211 11 1        1223568899999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.3e-37  Score=295.75  Aligned_cols=252  Identities=22%  Similarity=0.351  Sum_probs=199.4

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      .|.+.+.||.|++|.||++.. ..+++.||+|++..             ........+.+.+|+.+++.++|||++++++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~-~~~~~~~~~k~~~~-------------~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~   66 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRH-RTDGKQYVIKKLNL-------------RNASRRERKAAEQEAQLLSQLKHPNIVAYRE   66 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEE-cCCCcEEEEEEEeh-------------hhcCHHHHHHHHHHHHHHHhCCCCCeeeeee
Confidence            388899999999999999975 45788999998732             1112234456788999999999999999998


Q ss_pred             EEec-CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          273 HMVR-PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       273 ~~~~-~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      .+.. ...+|++|||+++++|.+++..  .....+++.++..++.|++.|+.+|   |+.|++||||+|+||+++.++.+
T Consensus        67 ~~~~~~~~~~lv~e~~~~~~l~~~l~~--~~~~~l~~~~~~~~~~~l~~~l~~l---H~~~i~H~di~p~nil~~~~~~~  141 (257)
T cd08223          67 SWEGEDGLLYIVMGFCEGGDLYHKLKE--QKGKLLPENQVVEWFVQIAMALQYL---HEKHILHRDLKTQNVFLTRTNII  141 (257)
T ss_pred             eecCCCCEEEEEecccCCCcHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCchhEEEecCCcE
Confidence            8764 4467999999999999999875  2345689999999999999999999   77889999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRK  431 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~  431 (487)
                      +|+|||++........  ......+++.|+|||++.+..++.++||||||+++|+|++|..||....      .......
T Consensus       142 ~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~------~~~~~~~  213 (257)
T cd08223         142 KVGDLGIARVLENQCD--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD------MNSLVYR  213 (257)
T ss_pred             EEecccceEEecccCC--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC------HHHHHHH
Confidence            9999999876543221  1134568899999999999899999999999999999999999984322      1222222


Q ss_pred             HHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          432 VMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       432 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ......+      ..+    ......+.+++.+||+.+|++|||+.+++.
T Consensus       214 ~~~~~~~------~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         214 IIEGKLP------PMP----KDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             HHhcCCC------CCc----cccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            2222211      111    123456889999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=8.5e-38  Score=302.13  Aligned_cols=254  Identities=24%  Similarity=0.334  Sum_probs=196.7

Q ss_pred             cccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceE
Q 011360          194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAH  273 (487)
Q Consensus       194 ~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  273 (487)
                      |...+.||.|+||+||++.+. .+++.||+|.+...            ..........+.+|+.+++.++|+||+.+++.
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~-~~~~~~aiK~~~~~------------~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~   68 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVR-ATGKMYACKRLEKK------------RIKKRKGESMALNEKQILEKVNSQFVVNLAYA   68 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEEC-CCCcEEEEEEeehh------------hhhhhhHHHHHHHHHHHHHHcCCcCceeEEEE
Confidence            667789999999999999754 57889999987320            11112234456789999999999999999999


Q ss_pred             EecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEE
Q 011360          274 MVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACI  353 (487)
Q Consensus       274 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl  353 (487)
                      +..++..+++|||+++++|.+++..  .....+++..+..++.|++.||.||   |+.||+||||||+||+++.++.++|
T Consensus        69 ~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~ql~~~l~~l---H~~~iiH~dikp~Nili~~~~~~kl  143 (285)
T cd05632          69 YETKDALCLVLTIMNGGDLKFHIYN--MGNPGFEEERALFYAAEILCGLEDL---HRENTVYRDLKPENILLDDYGHIRI  143 (285)
T ss_pred             EecCCEEEEEEEeccCccHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeecCCCHHHEEECCCCCEEE
Confidence            9999999999999999999988864  2344689999999999999999999   7788999999999999999999999


Q ss_pred             eccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHHH
Q 011360          354 SDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVM  433 (487)
Q Consensus       354 ~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~  433 (487)
                      +|||++.........   ....|+..|+|||.+.+..++.++|+||||+++|+|++|..||.......   ..+......
T Consensus       144 ~Dfg~~~~~~~~~~~---~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~---~~~~~~~~~  217 (285)
T cd05632         144 SDLGLAVKIPEGESI---RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV---KREEVDRRV  217 (285)
T ss_pred             ecCCcceecCCCCcc---cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhh
Confidence            999998765432211   23468999999999998899999999999999999999999995432210   011111111


Q ss_pred             hcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCC-----hHHHHH
Q 011360          434 NSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPN-----SQYVRC  481 (487)
Q Consensus       434 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~~il~  481 (487)
                      ...  .....+.        .+..+.+++..||+.||++|||     +.+++.
T Consensus       218 ~~~--~~~~~~~--------~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         218 LET--EEVYSAK--------FSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             hcc--ccccCcc--------CCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence            111  1111111        2345789999999999999999     556554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=3.4e-38  Score=305.19  Aligned_cols=260  Identities=24%  Similarity=0.342  Sum_probs=188.9

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhc---cCCCCCccc
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITAS---QIRHRNILP  269 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~---~l~hpnIv~  269 (487)
                      +|.+.+.||.|+||.||+|.. ..+++.||+|.+.....             .......+.+|+.++.   +++||||++
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~-~~~~~~~aiK~~~~~~~-------------~~~~~~~~~~e~~~l~~l~~~~h~ni~~   66 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARD-PHSGHFVALKSVRVQTN-------------EDGLPLSTVREVALLKRLEAFDHPNIVR   66 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEE-CCCCcEEEEEEeccCcC-------------CCCCchHHHHHHHHHHHhhhcCCCCeee
Confidence            378889999999999999975 46789999998743110             0011122334555444   457999999


Q ss_pred             cceEEec-----CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEE
Q 011360          270 LLAHMVR-----PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVL  344 (487)
Q Consensus       270 l~~~~~~-----~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nil  344 (487)
                      +++++..     ....+++|||+. ++|.+++..  .....+++..+..++.|++.||.||   |+.|++||||||+||+
T Consensus        67 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~l---H~~~ivH~dikp~Nil  140 (288)
T cd07863          67 LMDVCATSRTDRETKVTLVFEHVD-QDLRTYLDK--VPPPGLPAETIKDLMRQFLRGLDFL---HANCIVHRDLKPENIL  140 (288)
T ss_pred             eeeeeccccCCCCceEEEEEcccc-cCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEE
Confidence            9998764     345799999996 489888865  2234589999999999999999999   7788999999999999


Q ss_pred             eCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccc
Q 011360          345 LNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEIC  424 (487)
Q Consensus       345 l~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~  424 (487)
                      ++.++.+||+|||++.........   ....||+.|+|||++.+..++.++|||||||++|+|++|.+||......    
T Consensus       141 i~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~----  213 (288)
T cd07863         141 VTSGGQVKLADFGLARIYSCQMAL---TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA----  213 (288)
T ss_pred             ECCCCCEEECccCccccccCcccC---CCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH----
Confidence            999999999999999765433221   2345789999999999889999999999999999999999999543221    


Q ss_pred             cHHHHHHHHhc---CC----------CCCccCCCCC---CCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          425 SPEWLRKVMNS---KN----------PSRAIDPRLP---GNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       425 ~~~~~~~~~~~---~~----------~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                        .........   ..          +.....+..+   ..........+.+++.+||+.||++|||+.+++.
T Consensus       214 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         214 --DQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             --HHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence              111111110   00          0000000000   0011223456889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-37  Score=296.47  Aligned_cols=251  Identities=24%  Similarity=0.333  Sum_probs=194.8

Q ss_pred             cccccccceeEEEEEecCCC--CceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceEEe
Q 011360          198 EKIGSGGCGEVYKAELPGSN--GKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMV  275 (487)
Q Consensus       198 ~~lg~G~~g~v~~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  275 (487)
                      +.||+|+||.||+|.+...+  +..+|+|.+...              ........+..|+.+++.+.||||+++++++.
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~--------------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   66 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQE--------------HIAAGKKEFLREASVMAQLDHPCIVRLIGVCK   66 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccc--------------cchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc
Confidence            46999999999999764433  378999987321              11134567788999999999999999999775


Q ss_pred             cCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEec
Q 011360          276 RPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISD  355 (487)
Q Consensus       276 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~D  355 (487)
                       .+..++||||+++|+|.+++..    ...+++..+..++.|++.||.||   |+.|++|+||||+||+++.++.+||+|
T Consensus        67 -~~~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~l---h~~~i~H~di~p~nili~~~~~~kl~d  138 (257)
T cd05060          67 -GEPLMLVMELAPLGPLLKYLKK----RREIPVSDLKELAHQVAMGMAYL---ESKHFVHRDLAARNVLLVNRHQAKISD  138 (257)
T ss_pred             -CCceEEEEEeCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHH---hhcCeeccCcccceEEEcCCCcEEecc
Confidence             4567999999999999999975    34689999999999999999999   777899999999999999999999999


Q ss_pred             cCCccccCCCCceee-EeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccccHHHHHHHH
Q 011360          356 LGLAMAIPDGYTRVL-ISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSPEWLRKVM  433 (487)
Q Consensus       356 Fg~s~~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  433 (487)
                      ||+++.......... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.....      .+... ..
T Consensus       139 f~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~------~~~~~-~~  211 (257)
T cd05060         139 FGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG------AEVIA-ML  211 (257)
T ss_pred             ccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH------HHHHH-HH
Confidence            999986644332111 011223568999999998899999999999999999998 8999943321      22222 22


Q ss_pred             hcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          434 NSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       434 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      .......     .+.    ..+..+.+++.+||..+|++|||+.++++.|+.+
T Consensus       212 ~~~~~~~-----~~~----~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         212 ESGERLP-----RPE----ECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             HcCCcCC-----CCC----CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence            2222111     111    1235688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-41  Score=301.12  Aligned_cols=251  Identities=29%  Similarity=0.421  Sum_probs=209.7

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      ++-|.++.+||+|+||.||++.+ +.+|..+|||++..                 ...+..+..|+.++.++..|++|++
T Consensus        32 EEVFDi~~KLGEGSYGSV~KAIH-~EsG~v~AIK~VPV-----------------~sDLQEIIKEISIMQQC~S~yVVKY   93 (502)
T KOG0574|consen   32 EEVFDIVGKLGEGSYGSVHKAIH-RESGHVLAIKKVPV-----------------DTDLQEIIKEISIMQQCKSKYVVKY   93 (502)
T ss_pred             HHHHHHHHHhcCCcchHHHHHHH-hccCcEEEEEecCc-----------------cchHHHHHHHHHHHHHcCCchhhhh
Confidence            34588999999999999999965 57899999998743                 3456788999999999999999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      ||.+.....++||||||..|+..+.+..   .++++++..+..+++..+.||+|||.   ..-+|||||+.|||++.+|.
T Consensus        94 YGSYFK~sDLWIVMEYCGAGSiSDI~R~---R~K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~  167 (502)
T KOG0574|consen   94 YGSYFKHSDLWIVMEYCGAGSISDIMRA---RRKPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGI  167 (502)
T ss_pred             hhhhccCCceEeehhhcCCCcHHHHHHH---hcCCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccch
Confidence            9999999999999999999999999874   46789999999999999999999954   44799999999999999999


Q ss_pred             EEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHH
Q 011360          351 ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLR  430 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~  430 (487)
                      +||+|||.+-.+.+.....  .+..|||.|||||++..-.|+.++||||||++..||..|++||..--+.+.+       
T Consensus       168 AKLADFGVAGQLTDTMAKR--NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI-------  238 (502)
T KOG0574|consen  168 AKLADFGVAGQLTDTMAKR--NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI-------  238 (502)
T ss_pred             hhhhhccccchhhhhHHhh--CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee-------
Confidence            9999999998775543322  4678999999999999999999999999999999999999999433222211       


Q ss_pred             HHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          431 KVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       431 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                       ++....|...      .......+.++.++++.||.++|++|-|+-++++
T Consensus       239 -FMIPT~PPPT------F~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  239 -FMIPTKPPPT------FKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             -EeccCCCCCC------CCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence             1122222211      1234566778999999999999999999998876

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=8.3e-38  Score=302.20  Aligned_cols=256  Identities=24%  Similarity=0.331  Sum_probs=195.8

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CCCCccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RHRNILP  269 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~  269 (487)
                      .++|.+.+.||.|+||.||++.. ..++..+|+|.+..                .......+..|+.++..+ +||||++
T Consensus        17 ~~~~~~~~~lg~g~~~~vy~~~~-~~~~~~~~ik~~~~----------------~~~~~~~~~~e~~~l~~l~~h~~i~~   79 (286)
T cd06638          17 SDTWEIIETIGKGTYGKVFKVLN-KKNGSKAAVKILDP----------------IHDIDEEIEAEYNILKALSDHPNVVK   79 (286)
T ss_pred             ccceeeeeeeccCCCcEEEEEEE-CCCCceeEEEeecc----------------ccchHHHHHHHHHHHHHHhcCCCeee
Confidence            45799999999999999999975 45788999997632                111224566788888888 7999999


Q ss_pred             cceEEe-----cCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEE
Q 011360          270 LLAHMV-----RPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVL  344 (487)
Q Consensus       270 l~~~~~-----~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nil  344 (487)
                      +++++.     .++..++||||+++++|.+++.........+++..+..++.|++.||.||   |+.+++||||||+||+
T Consensus        80 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~nil  156 (286)
T cd06638          80 FYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHL---HVNKTIHRDVKGNNIL  156 (286)
T ss_pred             eeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHH---HhCCccccCCCHHhEE
Confidence            999874     34568999999999999998875434456788999999999999999999   7788999999999999


Q ss_pred             eCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCC-----CCCCchhHHHHHHHHHHHHHhCCCCccccCC
Q 011360          345 LNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQ-----PELSEKCDIFSFGMLLISLVRGVPSFVFHQN  419 (487)
Q Consensus       345 l~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~DvwslG~~l~elltg~~pf~~~~~  419 (487)
                      ++.++.++|+|||++.........  .....|++.|+|||++..     ..++.++|||||||++|+|++|..||.....
T Consensus       157 i~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~  234 (286)
T cd06638         157 LTTEGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP  234 (286)
T ss_pred             ECCCCCEEEccCCceeecccCCCc--cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch
Confidence            999999999999998765432211  123458999999998753     4578999999999999999999999943322


Q ss_pred             CCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHH
Q 011360          420 GEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCR  482 (487)
Q Consensus       420 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~  482 (487)
                      .      ...........+ ....+.       .....+.+++.+||+.+|++|||+.+|++.
T Consensus       235 ~------~~~~~~~~~~~~-~~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         235 M------RALFKIPRNPPP-TLHQPE-------LWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             h------HHHhhccccCCC-cccCCC-------CcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            1      111111111111 111111       123468899999999999999999999864

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=4.7e-38  Score=308.67  Aligned_cols=200  Identities=24%  Similarity=0.372  Sum_probs=159.6

Q ss_pred             cccccccceeEEEEEec-CCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceEEec
Q 011360          198 EKIGSGGCGEVYKAELP-GSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVR  276 (487)
Q Consensus       198 ~~lg~G~~g~v~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  276 (487)
                      +.||+|+||.||+|... ..++..||+|.+...                 .....+.+|+.+++.++||||+++++++..
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~-----------------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~   69 (317)
T cd07868           7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT-----------------GISMSACREIALLRELKHPNVISLQKVFLS   69 (317)
T ss_pred             cccccCCCeEEEEEEEccCCCCceEEEEEECCC-----------------CCcHHHHHHHHHHHhcCCCCCcceeeeEec
Confidence            58999999999999753 246788999987321                 012245679999999999999999998854


Q ss_pred             --CCeeEEEEEecCCCCHHHHHhhhhc-----CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEe----
Q 011360          277 --PDCHLLVYEFMKNGSLQDILDDVSR-----GRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLL----  345 (487)
Q Consensus       277 --~~~~~lv~E~~~~gsL~~~l~~~~~-----~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill----  345 (487)
                        ....|++|||+ +++|.+++.....     ....+++..+..++.|++.||.||   |++||+||||||+|||+    
T Consensus        70 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~L---H~~~ivHrDlkp~Nil~~~~~  145 (317)
T cd07868          70 HADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL---HANWVLHRDLKPANILVMGEG  145 (317)
T ss_pred             CCCcEEEEEEecc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHH---HhCCEEcCCCCHHHEEEecCC
Confidence              45688999999 4588888764221     123588899999999999999999   78899999999999999    


Q ss_pred             CCCCCEEEeccCCccccCCCCce-eeEeeecccccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCccccC
Q 011360          346 NDDMEACISDLGLAMAIPDGYTR-VLISYVLGTMAYIAPEYFQQ-PELSEKCDIFSFGMLLISLVRGVPSFVFHQ  418 (487)
Q Consensus       346 ~~~~~~kl~DFg~s~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwslG~~l~elltg~~pf~~~~  418 (487)
                      +.++.+||+|||+++........ .......||+.|+|||++.+ ..++.++||||+||++|+|++|.+||....
T Consensus       146 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         146 PERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             CCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence            45678999999999876443221 11234568999999999876 468999999999999999999999996543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=7.9e-38  Score=302.15  Aligned_cols=257  Identities=26%  Similarity=0.432  Sum_probs=203.2

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|++.+.||+|+||.||++.. ..++..||+|++...              ........+.+|+.+++.++||||++++
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~-~~~~~~~a~k~~~~~--------------~~~~~~~~~~~E~~~l~~l~h~~i~~~~   69 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKH-IPTGTVMAKKVVHIG--------------AKSSVRKQILRELQIMHECRSPYIVSFY   69 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEE-cCCCcEEEEEEEEec--------------CcchHHHHHHHHHHHHHHcCCCCcceEe
Confidence            4689999999999999999975 457889999987431              1223456788999999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++...+..++||||+++++|.+++..    ...+++..+..++.+++.||.|||+  ..|++||||+|+||+++.++.+
T Consensus        70 ~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~  143 (284)
T cd06620          70 GAFLNENNICMCMEFMDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQI  143 (284)
T ss_pred             eeEecCCEEEEEEecCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcE
Confidence            999999999999999999999998864    3568999999999999999999963  3579999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCc-----cccH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEE-----ICSP  426 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~-----~~~~  426 (487)
                      +|+|||++........    ....|+..|+|||++.+..++.++|+|||||++|+++||..||.......+     ....
T Consensus       144 ~l~d~gl~~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~  219 (284)
T cd06620         144 KLCDFGVSGELINSIA----DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGIL  219 (284)
T ss_pred             EEccCCcccchhhhcc----CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHH
Confidence            9999999865432221    234689999999999888899999999999999999999999964433211     1111


Q ss_pred             HHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHH
Q 011360          427 EWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCR  482 (487)
Q Consensus       427 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~  482 (487)
                      ++.........+      .++.   ...+.++.+++.+||+.||++|||+.++++.
T Consensus       220 ~~~~~~~~~~~~------~~~~---~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~  266 (284)
T cd06620         220 DLLQQIVQEPPP------RLPS---SDFPEDLRDFVDACLLKDPTERPTPQQLCAM  266 (284)
T ss_pred             HHHHHHhhccCC------CCCc---hhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            222222222111      1111   1234568899999999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1e-37  Score=296.27  Aligned_cols=247  Identities=27%  Similarity=0.409  Sum_probs=196.1

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      +.|.+.+.||.|+||.||++..   +++.||+|.+..                 ......+.+|+.++..++||||++++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~---~~~~~~iK~~~~-----------------~~~~~~~~~e~~~l~~~~~~~i~~~~   65 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY---TGQKVAVKNIKC-----------------DVTAQAFLEETAVMTKLHHKNLVRLL   65 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc---CCCceEEEeecC-----------------cchHHHHHHHHHHHHhCCCCCcCeEE
Confidence            4589999999999999999864   678899998732                 11234678899999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++... ..+++|||+++++|.+++..  .....+++..+..++.|++.||.||   |+.|++||||||+||+++.++.+
T Consensus        66 ~~~~~~-~~~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~qi~~al~~l---H~~~~~H~dl~p~nili~~~~~~  139 (254)
T cd05083          66 GVILHN-GLYIVMELMSKGNLVNFLRT--RGRALVSVIQLLQFSLDVAEGMEYL---ESKKLVHRDLAARNILVSEDGVA  139 (254)
T ss_pred             EEEcCC-CcEEEEECCCCCCHHHHHHh--cCcCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccccCcceEEEcCCCcE
Confidence            988654 57999999999999999875  2344688999999999999999999   77899999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccccHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSPEWLR  430 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~  430 (487)
                      +|+|||++........     ....+..|+|||.+.+..++.++|+||||+++|+|++ |.+||....      ..+...
T Consensus       140 kl~Dfg~~~~~~~~~~-----~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~------~~~~~~  208 (254)
T cd05083         140 KVSDFGLARVGSMGVD-----NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS------LKEVKE  208 (254)
T ss_pred             EECCCccceeccccCC-----CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC------HHHHHH
Confidence            9999999876433211     2234678999999988899999999999999999998 899994332      122222


Q ss_pred             HHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhh
Q 011360          431 KVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQ  485 (487)
Q Consensus       431 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~  485 (487)
                      .......+.  ...        ..+..+.+++.+||+.+|++|||+.+|+..|++
T Consensus       209 ~~~~~~~~~--~~~--------~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         209 CVEKGYRME--PPE--------GCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             HHhCCCCCC--CCC--------cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            222211110  111        123568899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.5e-37  Score=295.11  Aligned_cols=251  Identities=31%  Similarity=0.460  Sum_probs=201.7

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      ++.|.+.+.||.|+||.||+|.+. .++..+++|.+..                . .....+.+|+.+++.++||||+++
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~-~~~~~~~~k~~~~----------------~-~~~~~~~~e~~~~~~l~~~~i~~~   63 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHK-ETGQVVAIKVVPV----------------E-EDLQEIIKEISILKQCDSPYIVKY   63 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEc-CCCcEEEEEEeec----------------H-HHHHHHHHHHHHHHhCCCCcEeee
Confidence            457999999999999999999864 4678999998732                1 115678899999999999999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      ++++......|+++||+++++|.+++..   ....+++..+..++.|++.||.||   |+.|++|+||+|+||+++.++.
T Consensus        64 ~~~~~~~~~~~l~~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~l---h~~~i~H~dl~~~ni~~~~~~~  137 (256)
T cd06612          64 YGSYFKNTDLWIVMEYCGAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYL---HSNKKIHRDIKAGNILLNEEGQ  137 (256)
T ss_pred             eeeeecCCcEEEEEecCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCcceEEECCCCc
Confidence            9999999999999999999999999864   245789999999999999999999   6778999999999999999999


Q ss_pred             EEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHH
Q 011360          351 ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLR  430 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~  430 (487)
                      ++|+|||++.........  .....++..|+|||++.+..++.++||||||+++|+|++|..||.......      ...
T Consensus       138 ~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~------~~~  209 (256)
T cd06612         138 AKLADFGVSGQLTDTMAK--RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR------AIF  209 (256)
T ss_pred             EEEcccccchhcccCccc--cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh------hhh
Confidence            999999998876543321  123457889999999998899999999999999999999999995432211      111


Q ss_pred             HHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          431 KVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       431 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ...  ....    +.+.  .......++.+++.+||+.+|++|||++++++
T Consensus       210 ~~~--~~~~----~~~~--~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         210 MIP--NKPP----PTLS--DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             hhc--cCCC----CCCC--chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            111  1110    0010  11223456899999999999999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.2e-38  Score=303.19  Aligned_cols=255  Identities=29%  Similarity=0.461  Sum_probs=196.8

Q ss_pred             cccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceE
Q 011360          194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAH  273 (487)
Q Consensus       194 ~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  273 (487)
                      |++.+.||+|+||.||++.. ..+++.||+|.+....             ...........|+.++++++||||++++++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~-~~~~~~~~~K~~~~~~-------------~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~   66 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKN-KKNGQKVAVKIIDKSE-------------IEEEEREENIREIKILRRLRHPNIVQILDV   66 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEE-TTTTEEEEEEEEESTT-------------HHHHHHHHHHHHHHHHHHHTBTTBCHEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEE-CCCCeEEEEEEecccc-------------ccccccchhhhhhhcccccccccccccccc
Confidence            67889999999999999975 4578899999985421             112222233459999999999999999999


Q ss_pred             EecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEE
Q 011360          274 MVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACI  353 (487)
Q Consensus       274 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl  353 (487)
                      +......++||||+++++|.+++..    ...+++..+..++.|++.||.+|   |+.|++|+||||+||+++.++.++|
T Consensus        67 ~~~~~~~~~v~~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~L---h~~~i~H~dikp~NIl~~~~~~~~l  139 (260)
T PF00069_consen   67 FQDDNYLYIVMEYCPGGSLQDYLQK----NKPLSEEEILKIAYQILEALAYL---HSKGIVHRDIKPENILLDENGEVKL  139 (260)
T ss_dssp             EEESSEEEEEEEEETTEBHHHHHHH----HSSBBHHHHHHHHHHHHHHHHHH---HHTTEEESSBSGGGEEESTTSEEEE
T ss_pred             ccccccccccccccccccccccccc----ccccccccccccccccccccccc---ccccccccccccccccccccccccc
Confidence            9999999999999999999999973    46789999999999999999999   6678999999999999999999999


Q ss_pred             eccCCccccCCCCceeeEeeecccccccCCcccC-CCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHH
Q 011360          354 SDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQ-QPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKV  432 (487)
Q Consensus       354 ~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~  432 (487)
                      +|||.+.......  .......++..|+|||++. +..++.++||||+|+++|+|++|..||.....   ..........
T Consensus       140 ~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~---~~~~~~~~~~  214 (260)
T PF00069_consen  140 IDFGSSVKLSENN--ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS---DDQLEIIEKI  214 (260)
T ss_dssp             SSGTTTEESTSTT--SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH---HHHHHHHHHH
T ss_pred             ccccccccccccc--cccccccccccccccccccccccccccccccccccccccccccccccccccc---hhhhhhhhhc
Confidence            9999987542211  1224556899999999998 77899999999999999999999999954310   0111111111


Q ss_pred             HhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          433 MNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       433 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .......    . .  .........+.+++.+||+.||++|||+.++++
T Consensus       215 ~~~~~~~----~-~--~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  215 LKRPLPS----S-S--QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             HHTHHHH----H-T--TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             ccccccc----c-c--cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1100000    0 0  000001267999999999999999999999875

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-37  Score=295.20  Aligned_cols=254  Identities=29%  Similarity=0.433  Sum_probs=201.3

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||.|+||.||+|... .++..+++|.+...               .......+.+|+.++++++||||++++
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~-~~~~~~~ik~~~~~---------------~~~~~~~~~~e~~~l~~~~h~~i~~~~   66 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDI-ATGELVAIKVIKLE---------------PGDDFEIIQQEISMLKECRHPNIVAYF   66 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEec-CCCCEEEEEEEEcC---------------chhhHHHHHHHHHHHHhCCCCChhceE
Confidence            46999999999999999999753 46788999988431               112456778899999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++...+..|++|||+++++|.+++..   ....+++..+..++.|++.||.||   |+.|++|+||+|+||+++.++.+
T Consensus        67 ~~~~~~~~~~l~~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~l---h~~~i~h~dl~p~ni~i~~~~~~  140 (262)
T cd06613          67 GSYLRRDKLWIVMEYCGGGSLQDIYQV---TRGPLSELQIAYVCRETLKGLAYL---HETGKIHRDIKGANILLTEDGDV  140 (262)
T ss_pred             EEEEeCCEEEEEEeCCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHH---HhCCceecCCChhhEEECCCCCE
Confidence            999999999999999999999998864   235688999999999999999999   77889999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCC---CCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQP---ELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEW  428 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~---~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~  428 (487)
                      +|+|||++.........  .....++..|+|||.+.+.   .++.++|+||||+++|+|+||.+||.....      ...
T Consensus       141 ~l~d~g~~~~~~~~~~~--~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~------~~~  212 (262)
T cd06613         141 KLADFGVSAQLTATIAK--RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHP------MRA  212 (262)
T ss_pred             EECccccchhhhhhhhc--cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCH------HHH
Confidence            99999998765433211  1234578899999998776   889999999999999999999999943321      111


Q ss_pred             HHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          429 LRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       429 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ...........    +.+  ......+.++.+++.+||..+|.+|||+++|+.
T Consensus       213 ~~~~~~~~~~~----~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         213 LFLISKSNFPP----PKL--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             HHHHHhccCCC----ccc--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            11111111110    001  112234567899999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.7e-38  Score=306.45  Aligned_cols=255  Identities=26%  Similarity=0.372  Sum_probs=201.2

Q ss_pred             hccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CCCCcc
Q 011360          190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RHRNIL  268 (487)
Q Consensus       190 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv  268 (487)
                      ....|++++.||+||.++||++..  .+...||+|++.             ........+.-+.+|+..|.+| .|.+||
T Consensus       359 kg~~Yeilk~iG~GGSSkV~kV~~--s~~~iyalkkv~-------------~~~~D~qtl~gy~nEI~lL~KLkg~~~II  423 (677)
T KOG0596|consen  359 KGREYEILKQIGSGGSSKVFKVLN--SDKQIYALKKVV-------------LLEADNQTLDGYRNEIALLNKLKGHDKII  423 (677)
T ss_pred             CcchhhHHHhhcCCCcceeeeeec--CCCcchhhhHHH-------------HhhcCHHHHHHHHHHHHHHHHhcCCceEE
Confidence            344699999999999999999953  456678888762             2334455677899999999999 789999


Q ss_pred             ccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC
Q 011360          269 PLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDD  348 (487)
Q Consensus       269 ~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~  348 (487)
                      ++|+|-..++.+||||||= ..+|..+|...   ....+...++.+..|++.++.++   |.+||||.||||.|+|+-. 
T Consensus       424 qL~DYEv~d~~lYmvmE~G-d~DL~kiL~k~---~~~~~~~~lk~ywkqML~aV~~I---H~~gIVHSDLKPANFLlVk-  495 (677)
T KOG0596|consen  424 QLYDYEVTDGYLYMVMECG-DIDLNKILKKK---KSIDPDWFLKFYWKQMLLAVKTI---HQHGIVHSDLKPANFLLVK-  495 (677)
T ss_pred             EEeeeeccCceEEEEeecc-cccHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHH---HHhceeecCCCcccEEEEe-
Confidence            9999999999999999975 66999999862   22333237888999999999999   8889999999999999984 


Q ss_pred             CCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCC-----------CCCchhHHHHHHHHHHHHHhCCCCcccc
Q 011360          349 MEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQP-----------ELSEKCDIFSFGMLLISLVRGVPSFVFH  417 (487)
Q Consensus       349 ~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----------~~~~~~DvwslG~~l~elltg~~pf~~~  417 (487)
                      |.+||+|||+|..+....+.......+||+.||+||.+...           ..+.++|||||||+||+|+.|++||...
T Consensus       496 G~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~  575 (677)
T KOG0596|consen  496 GRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI  575 (677)
T ss_pred             eeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH
Confidence            58999999999999988888887888999999999988632           2467899999999999999999999322


Q ss_pred             CCCCccccHHHHHHHHhcCCCCCccC-CCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          418 QNGEEICSPEWLRKVMNSKNPSRAID-PRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       418 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .+        ...++..-..|...+. +.++..      .++.+++..||..||++|||..++++
T Consensus       576 ~n--------~~aKl~aI~~P~~~Iefp~~~~~------~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  576 IN--------QIAKLHAITDPNHEIEFPDIPEN------DELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             HH--------HHHHHHhhcCCCccccccCCCCc------hHHHHHHHHHHhcCcccCCCcHHHhc
Confidence            11        2222222222211111 222222      12889999999999999999999885

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1e-37  Score=298.66  Aligned_cols=255  Identities=27%  Similarity=0.377  Sum_probs=195.5

Q ss_pred             cccccccceeEEEEEecC-----CCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          198 EKIGSGGCGEVYKAELPG-----SNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       198 ~~lg~G~~g~v~~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      +.||.|+||.||+|++..     .++..+|+|.+..              .........+.+|+.+++.++||||+++++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~--------------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~   66 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRK--------------GATDQEKKEFLKEAHLMSNFNHPNIVKLLG   66 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhc--------------ccchhhHHHHHHHHHHHHhcCCCCeeeEee
Confidence            368999999999998632     2236788887622              111233456788999999999999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhhhhc---CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC
Q 011360          273 HMVRPDCHLLVYEFMKNGSLQDILDDVSR---GRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDM  349 (487)
Q Consensus       273 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~  349 (487)
                      ++...+..++||||+++++|.+++.....   ....+++..+..++.|++.||.||   |+.+++|+||+|+||+++.++
T Consensus        67 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---H~~~i~H~dl~p~nil~~~~~  143 (269)
T cd05044          67 VCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL---EQMHFIHRDLAARNCLVSEKG  143 (269)
T ss_pred             eecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHH---HhCCcccCCCChheEEEecCC
Confidence            99999999999999999999999975322   234578899999999999999999   677899999999999999877


Q ss_pred             -----CEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCcc
Q 011360          350 -----EACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEI  423 (487)
Q Consensus       350 -----~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~  423 (487)
                           .++|+|||++................++..|+|||++.+..++.++||||||+++|+|+| |..||.....    
T Consensus       144 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~----  219 (269)
T cd05044         144 YDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN----  219 (269)
T ss_pred             CCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH----
Confidence                 899999999876543322211122345788999999998899999999999999999998 9999943221    


Q ss_pred             ccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhh
Q 011360          424 CSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQ  485 (487)
Q Consensus       424 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~  485 (487)
                        .+..........+      ..+    ...+..+.+++.+||..+|++|||+.+|++.|+.
T Consensus       220 --~~~~~~~~~~~~~------~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         220 --QEVLQHVTAGGRL------QKP----ENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             --HHHHHHHhcCCcc------CCc----ccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence              1222222111111      011    1234568899999999999999999999998863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2.6e-37  Score=295.36  Aligned_cols=257  Identities=23%  Similarity=0.354  Sum_probs=199.0

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      +|.+.+.||.|+||.||+|..  .++..+|+|.+......         ..........+.+|+.+++.++||||+++++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~--~~~~~~avk~~~~~~~~---------~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~   69 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT--NQGQLIAVKQVELDTSN---------VLAAEKEYEKLQEEVDLLKSLKHVNIVQYLG   69 (265)
T ss_pred             CccccceEeccCCeEEEEEEE--cCCCeEEEEEeecCccc---------hhhHHHHHHHHHHHHHHHHhcCCCCEeeEee
Confidence            377889999999999999975  37889999987431110         0111233467889999999999999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEE
Q 011360          273 HMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC  352 (487)
Q Consensus       273 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~k  352 (487)
                      ++...+..+++|||+++++|.+++..    ...+++..+..++.|++.||+||   |+.|++|+||+|+||+++.++.++
T Consensus        70 ~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~nil~~~~~~~~  142 (265)
T cd06631          70 TCLDDNTISIFMEFVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYL---HNNCVVHRDIKGNNVMLMPNGIIK  142 (265)
T ss_pred             EeecCCeEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCcCHHhEEECCCCeEE
Confidence            99999999999999999999999864    34678899999999999999999   677899999999999999999999


Q ss_pred             EeccCCccccCCCC----ceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHH
Q 011360          353 ISDLGLAMAIPDGY----TRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEW  428 (487)
Q Consensus       353 l~DFg~s~~~~~~~----~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~  428 (487)
                      |+|||++.......    .........++..|+|||.+.+..++.++|+||||+++|+|++|..||.....      ...
T Consensus       143 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~------~~~  216 (265)
T cd06631         143 LIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR------LAA  216 (265)
T ss_pred             eccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCCh------HHH
Confidence            99999987643211    11111234588999999999988899999999999999999999999953321      111


Q ss_pred             HHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          429 LRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       429 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ...........    +.++.    .....+.+++.+||+.+|++|||+.+++.
T Consensus       217 ~~~~~~~~~~~----~~~~~----~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         217 MFYIGAHRGLM----PRLPD----SFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             HHHhhhccCCC----CCCCC----CCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            11111111111    11221    12356889999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=2.4e-37  Score=297.17  Aligned_cols=261  Identities=21%  Similarity=0.360  Sum_probs=201.4

Q ss_pred             cccccccccccccceeEEEEEecC----CCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPG----SNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNI  267 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI  267 (487)
                      ++|.+...||.|+||.||+|+...    .+...+++|.+..              .........+.+|+.++++++||||
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~--------------~~~~~~~~~~~~E~~~l~~l~h~~i   70 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQK--------------TKDENLQSEFRRELDMFRKLSHKNV   70 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCC--------------ccchHHHHHHHHHHHHHHhcCCcce
Confidence            458899999999999999998642    2346789987622              1112245678889999999999999


Q ss_pred             cccceEEecCCeeEEEEEecCCCCHHHHHhhhhcC-----CCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCC
Q 011360          268 LPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG-----RRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRN  342 (487)
Q Consensus       268 v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~-----~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~N  342 (487)
                      +++++++...+..++||||+++|+|.+++......     ...+++..+..++.|++.||.||   |+.||+||||||+|
T Consensus        71 v~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~L---H~~~i~H~dlkp~N  147 (275)
T cd05046          71 VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHL---SNARFVHRDLAARN  147 (275)
T ss_pred             eeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHh---hhcCcccCcCccce
Confidence            99999999989999999999999999999753211     12689999999999999999999   78889999999999


Q ss_pred             EEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCC
Q 011360          343 VLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGE  421 (487)
Q Consensus       343 ill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~  421 (487)
                      |+++.++.++++|||++........ .......++..|+|||.+.+..++.++||||||+++|++++ |..||.....  
T Consensus       148 ili~~~~~~~l~~~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~--  224 (275)
T cd05046         148 CLVSSQREVKVSLLSLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD--  224 (275)
T ss_pred             EEEeCCCcEEEcccccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch--
Confidence            9999999999999999865432211 11123346778999999988888999999999999999999 7888843221  


Q ss_pred             ccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhh
Q 011360          422 EICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQ  485 (487)
Q Consensus       422 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~  485 (487)
                          ....... ............        .+..+.+++.+||+.+|++|||+.++++.|.+
T Consensus       225 ----~~~~~~~-~~~~~~~~~~~~--------~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~  275 (275)
T cd05046         225 ----EEVLNRL-QAGKLELPVPEG--------CPSRLYKLMTRCWAVNPKDRPSFSELVSALGE  275 (275)
T ss_pred             ----HHHHHHH-HcCCcCCCCCCC--------CCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence                1222222 112211111111        22468899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.9e-37  Score=293.77  Aligned_cols=242  Identities=21%  Similarity=0.313  Sum_probs=185.5

Q ss_pred             cccccccceeEEEEEecCC-----------CCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCC
Q 011360          198 EKIGSGGCGEVYKAELPGS-----------NGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRN  266 (487)
Q Consensus       198 ~~lg~G~~g~v~~~~~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn  266 (487)
                      +.||.|+||.||+|++...           ....+++|.+..               ........+.+|+.++..++|||
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~---------------~~~~~~~~~~~~~~~l~~l~hp~   65 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDP---------------SHRDISLAFFETASMMRQVSHKH   65 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecCh---------------hhhhHHHHHHHHHHHHHhCCCCC
Confidence            3689999999999986321           123578887521               11223456778899999999999


Q ss_pred             ccccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC
Q 011360          267 ILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN  346 (487)
Q Consensus       267 Iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~  346 (487)
                      |+++++++......+++|||+++|+|..++..   ....+++..+..++.|++.||+||   |++||+||||||+|||++
T Consensus        66 iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~dlkp~Nill~  139 (262)
T cd05077          66 IVLLYGVCVRDVENIMVEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQLASALSYL---EDKDLVHGNVCTKNILLA  139 (262)
T ss_pred             EeeEEEEEecCCCCEEEEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHh---hhCCeECCCCCcccEEEe
Confidence            99999999999999999999999999888753   235689999999999999999999   788999999999999998


Q ss_pred             CCCC-------EEEeccCCccccCCCCceeeEeeecccccccCCcccC-CCCCCchhHHHHHHHHHHHHH-hCCCCcccc
Q 011360          347 DDME-------ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQ-QPELSEKCDIFSFGMLLISLV-RGVPSFVFH  417 (487)
Q Consensus       347 ~~~~-------~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~~DvwslG~~l~ell-tg~~pf~~~  417 (487)
                      .++.       ++++|||++......      ....++..|+|||.+. +..++.++||||||+++|+|+ +|..||...
T Consensus       140 ~~~~~~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~  213 (262)
T cd05077         140 REGIDGECGPFIKLSDPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDK  213 (262)
T ss_pred             cCCccCCCCceeEeCCCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCc
Confidence            7664       899999998654322      2234788999999887 467899999999999999998 478887432


Q ss_pred             CCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHh
Q 011360          418 QNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLS  484 (487)
Q Consensus       418 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~  484 (487)
                      ..      .+ ..........  ...         ....++.+++.+||+.||++||++.+|+..++
T Consensus       214 ~~------~~-~~~~~~~~~~--~~~---------~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         214 TL------AE-KERFYEGQCM--LVT---------PSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             ch------hH-HHHHHhcCcc--CCC---------CChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence            21      11 1111111110  000         11246889999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-37  Score=297.90  Aligned_cols=249  Identities=31%  Similarity=0.436  Sum_probs=200.2

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      +|.+.+.||.|++|.||+|.. ..++..||+|.+...              ........+.+|+.+++.++||||+++++
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~-~~~~~~~~ik~~~~~--------------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~   66 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAID-KRTNQVVAIKVIDLE--------------EAEDEIEDIQQEIQFLSQCRSPYITKYYG   66 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEE-CCCCeEEEEEEeecc--------------ccchHHHHHHHHHHHHHHcCCCCeeeeeE
Confidence            588889999999999999975 457899999987321              11223456778999999999999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEE
Q 011360          273 HMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC  352 (487)
Q Consensus       273 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~k  352 (487)
                      ++..+...|+|+||+++++|.+++..     ..+++..+..++.|++.||.||   |+.+++||||+|+||+++.++.++
T Consensus        67 ~~~~~~~~~~v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~l---h~~~i~h~dl~p~ni~i~~~~~~~  138 (274)
T cd06609          67 SFLKGSKLWIIMEYCGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYL---HEEGKIHRDIKAANILLSEEGDVK  138 (274)
T ss_pred             EEEECCeEEEEEEeeCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEEECCCCCEE
Confidence            99999999999999999999999864     2789999999999999999999   778899999999999999999999


Q ss_pred             EeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHH
Q 011360          353 ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKV  432 (487)
Q Consensus       353 l~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~  432 (487)
                      |+|||++.........  .....+++.|+|||.+.+..++.++||||||+++|+|+||..||.....      .......
T Consensus       139 l~d~g~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~------~~~~~~~  210 (274)
T cd06609         139 LADFGVSGQLTSTMSK--RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP------MRVLFLI  210 (274)
T ss_pred             Ecccccceeecccccc--cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch------HHHHHHh
Confidence            9999999876543211  1334678899999999988899999999999999999999999954321      1111111


Q ss_pred             HhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          433 MNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       433 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      . ...+..     ++..   ..+..+.+++.+||..+|++|||++++++
T Consensus       211 ~-~~~~~~-----~~~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         211 P-KNNPPS-----LEGN---KFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             h-hcCCCC-----Cccc---ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            1 111111     1111   03346889999999999999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=3.1e-37  Score=295.66  Aligned_cols=257  Identities=22%  Similarity=0.321  Sum_probs=199.6

Q ss_pred             cccccccccccccceeEEEEEecCC--CCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGS--NGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILP  269 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~  269 (487)
                      ++|.+.+.||.|+||.||+|.+...  +...||+|.....              ......+.+.+|+.+++.+.||||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~--------------~~~~~~~~~~~e~~~l~~~~h~~i~~   71 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNC--------------TSPSVREKFLQEAYIMRQFDHPHIVK   71 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCc--------------CCHHHHHHHHHHHHHHHhCCCCchhc
Confidence            4588899999999999999976422  2346899976321              11234557888999999999999999


Q ss_pred             cceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC
Q 011360          270 LLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDM  349 (487)
Q Consensus       270 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~  349 (487)
                      +++++.+ +..++||||+++|+|.+++..   ....+++..+..++.|++.||.||   |+.|++||||||+||+++.++
T Consensus        72 ~~~~~~~-~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~l---H~~~~~H~dl~p~nili~~~~  144 (270)
T cd05056          72 LIGVITE-NPVWIVMELAPLGELRSYLQV---NKYSLDLASLILYSYQLSTALAYL---ESKRFVHRDIAARNVLVSSPD  144 (270)
T ss_pred             eeEEEcC-CCcEEEEEcCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccccChheEEEecCC
Confidence            9998865 567899999999999999964   234589999999999999999999   678899999999999999999


Q ss_pred             CEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccccHHH
Q 011360          350 EACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSPEW  428 (487)
Q Consensus       350 ~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~  428 (487)
                      .++|+|||++.......... .....+++.|+|||.+....++.++||||||+++|++++ |..||.....      .+.
T Consensus       145 ~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~------~~~  217 (270)
T cd05056         145 CVKLGDFGLSRYLEDESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN------NDV  217 (270)
T ss_pred             CeEEccCceeeeccccccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH------HHH
Confidence            99999999987654432111 122334578999999988889999999999999999996 9999944322      122


Q ss_pred             HHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          429 LRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       429 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      .........+  ...+.        .+..+.+++.+||..+|++|||+.++++.|+.+
T Consensus       218 ~~~~~~~~~~--~~~~~--------~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~  265 (270)
T cd05056         218 IGRIENGERL--PMPPN--------CPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI  265 (270)
T ss_pred             HHHHHcCCcC--CCCCC--------CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            2222222211  11112        234688999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=7.6e-38  Score=304.28  Aligned_cols=250  Identities=26%  Similarity=0.397  Sum_probs=199.1

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ..|.+.+.||.|+||.||++.. ..++..||+|.+...               .......+.+|+.+++.++||||++++
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~-~~~~~~vaiK~~~~~---------------~~~~~~~~~~e~~~l~~~~h~~i~~~~   82 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAID-IATGQEVAIKQMNLQ---------------QQPKKELIINEILVMRENKNPNIVNYL   82 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEE-CCCCCEEEEEEEecC---------------ccchHHHHHHHHHHHHhCCCCCEeeEE
Confidence            4699999999999999999964 457889999987421               111234577899999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++..++..|+||||+++++|.+++..     ..+++..+..++.|++.||.||   |+.|++||||||+||+++.++.+
T Consensus        83 ~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~L---H~~~i~H~dL~p~Nili~~~~~~  154 (297)
T cd06656          83 DSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFL---HSNQVIHRDIKSDNILLGMDGSV  154 (297)
T ss_pred             EEEecCCEEEEeecccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCCE
Confidence            999999999999999999999999863     4578889999999999999999   77889999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRK  431 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~  431 (487)
                      +|+|||++.........  .....+++.|+|||.+.+..++.++|+||||+++|++++|..||.........      ..
T Consensus       155 ~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~------~~  226 (297)
T cd06656         155 KLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL------YL  226 (297)
T ss_pred             EECcCccceEccCCccC--cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhe------ee
Confidence            99999998765433221  12345888999999999888999999999999999999999999544321111      11


Q ss_pred             HHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          432 VMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       432 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ......+...        ........+.+++.+||..+|++|||+.++++
T Consensus       227 ~~~~~~~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         227 IATNGTPELQ--------NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             eccCCCCCCC--------CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1111111100        11122345788999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=7.8e-38  Score=304.81  Aligned_cols=260  Identities=20%  Similarity=0.319  Sum_probs=195.1

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      +.|.+.+.||.|+||.||+|.. ..++..||+|.+....              .......+.+|+.+++.++||||++++
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~-~~~~~~vaiK~~~~~~--------------~~~~~~~~~~E~~~l~~l~h~nI~~~~   70 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRS-KLTDNLVALKEIRLEH--------------EEGAPCTAIREVSLLKDLKHANIVTLH   70 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEE-cCCCcEEEEEEEeccc--------------ccCchhHHHHHHHHHHhcCCCCcceEE
Confidence            4699999999999999999975 4578899999874311              111223456799999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++..++..++||||++ ++|.+++..   ....+++..+..++.|++.||.||   |+.|++|+||||+||+++.++.+
T Consensus        71 ~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~l---H~~~i~H~dlkp~Nil~~~~~~~  143 (301)
T cd07873          71 DIIHTEKSLTLVFEYLD-KDLKQYLDD---CGNSINMHNVKLFLFQLLRGLNYC---HRRKVLHRDLKPQNLLINERGEL  143 (301)
T ss_pred             EEEecCCeEEEEEeccc-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCCHHHEEECCCCcE
Confidence            99999999999999996 589888764   245688999999999999999999   77899999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQ-PELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLR  430 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~  430 (487)
                      +|+|||++.........  .....+++.|+|||.+.+ ..++.++||||||+++|+|+||.+||...+..      +...
T Consensus       144 kl~dfg~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~------~~~~  215 (301)
T cd07873         144 KLADFGLARAKSIPTKT--YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE------EQLH  215 (301)
T ss_pred             EECcCcchhccCCCCCc--ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHH
Confidence            99999998764332211  123457889999998865 45789999999999999999999999544321      1111


Q ss_pred             HHHh--cCCCCCcc-------------CCCCCC----CCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          431 KVMN--SKNPSRAI-------------DPRLPG----NGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       431 ~~~~--~~~~~~~~-------------~~~~~~----~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .+..  ........             .+....    .........+.+++.+||+.||.+|||+++++.
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         216 FIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             HHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            1110  00000000             000000    001123456789999999999999999999985

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.2e-37  Score=309.22  Aligned_cols=256  Identities=25%  Similarity=0.369  Sum_probs=191.9

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      +.|.+.+.||.|+||.||+|.. ..++..||+|++...             .........+.+|+.+++.++||||++++
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~-------------~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   80 (343)
T cd07878          15 ERYQNLTPVGSGAYGSVCSAYD-TRLRQKVAVKKLSRP-------------FQSLIHARRTYRELRLLKHMKHENVIGLL   80 (343)
T ss_pred             hhhhhheecccCCCeEEEEEEE-CCCCCEEEEEEeCch-------------hhhhHHHHHHHHHHHHHHhcCCCchhhhh
Confidence            5699999999999999999974 457889999987321             11122345567899999999999999999


Q ss_pred             eEEecC------CeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEe
Q 011360          272 AHMVRP------DCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLL  345 (487)
Q Consensus       272 ~~~~~~------~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill  345 (487)
                      +++...      ...|++|+++ +++|.+++.     ...+++..+..++.|++.||.||   |++||+||||||+||++
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~L---H~~~ivHrdikp~Nil~  151 (343)
T cd07878          81 DVFTPATSIENFNEVYLVTNLM-GADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYI---HSAGIIHRDLKPSNVAV  151 (343)
T ss_pred             hhhcccccccccCcEEEEeecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeecccCChhhEEE
Confidence            987543      3468999998 889988775     34689999999999999999999   77889999999999999


Q ss_pred             CCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccc
Q 011360          346 NDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQ-PELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEIC  424 (487)
Q Consensus       346 ~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~  424 (487)
                      +.++.+||+|||++.......     ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||......    
T Consensus       152 ~~~~~~kl~Dfg~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----  222 (343)
T cd07878         152 NEDCELRILDFGLARQADDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI----  222 (343)
T ss_pred             CCCCCEEEcCCccceecCCCc-----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH----
Confidence            999999999999998654332     23468999999999876 57899999999999999999999999543210    


Q ss_pred             cHHHHHHHHhc-CCCC-Ccc--------------CCCCCCCC----cHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          425 SPEWLRKVMNS-KNPS-RAI--------------DPRLPGNG----YEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       425 ~~~~~~~~~~~-~~~~-~~~--------------~~~~~~~~----~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                        ..+..+... +.+. ..+              -+..+...    .......+.+++.+||+.||++|||+.++++
T Consensus       223 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         223 --DQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             --HHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence              111111000 0000 000              00000000    0011234779999999999999999999884

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.8e-37  Score=306.51  Aligned_cols=257  Identities=21%  Similarity=0.268  Sum_probs=195.8

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      +|.+.+.||+|+||.||++... .+++.+|+|.+..            ...........+..|..++..++||||+++++
T Consensus         2 ~y~~~~~lG~G~fg~V~~~~~~-~~~~~~aiK~~~~------------~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~   68 (332)
T cd05623           2 DFEILKVIGRGAFGEVAVVKLK-NADKVFAMKILNK------------WEMLKRAETACFREERDVLVNGDNQWITTLHY   68 (332)
T ss_pred             CceEEEEEEeCCCeEEEEEEEC-CCCCEEEEEEEeH------------HHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEE
Confidence            5889999999999999999764 5788999998732            11122233455778899999999999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEE
Q 011360          273 HMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC  352 (487)
Q Consensus       273 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~k  352 (487)
                      ++.+.+..|+||||+++|+|.+++..   ....+++..+..++.|++.||.||   |++||+||||||+|||++.++.+|
T Consensus        69 ~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~l~~~~~~~~~~qi~~al~~l---H~~~iiHrDlkp~Nili~~~~~~k  142 (332)
T cd05623          69 AFQDENNLYLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVIAIDSV---HQLHYVHRDIKPDNILMDMNGHIR  142 (332)
T ss_pred             EEecCCEEEEEEeccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCHHHEEECCCCCEE
Confidence            99999999999999999999999974   235688999999999999999999   678899999999999999999999


Q ss_pred             EeccCCccccCCCCceeeEeeecccccccCCcccC-----CCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHH
Q 011360          353 ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQ-----QPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPE  427 (487)
Q Consensus       353 l~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~  427 (487)
                      |+|||++......... ......||+.|+|||++.     ...++.++|||||||++|||++|..||....      ..+
T Consensus       143 L~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~------~~~  215 (332)
T cd05623         143 LADFGSCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES------LVE  215 (332)
T ss_pred             EeecchheecccCCcc-eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC------HHH
Confidence            9999998765332221 123356999999999986     3468899999999999999999999994322      222


Q ss_pred             HHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCC--CCChHHHHH
Q 011360          428 WLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEE--RPNSQYVRC  481 (487)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--RPs~~~il~  481 (487)
                      .......... ...    ++.. ....+.++.+++.+|+..+|++  ||++.++++
T Consensus       216 ~~~~i~~~~~-~~~----~p~~-~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~  265 (332)
T cd05623         216 TYGKIMNHKE-RFQ----FPAQ-VTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQ  265 (332)
T ss_pred             HHHHHhCCCc-ccc----CCCc-cccCCHHHHHHHHHHccChhhhcCCCCHHHHhC
Confidence            3333332211 111    1111 1123356788888888665544  688888865

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.6e-37  Score=298.74  Aligned_cols=254  Identities=22%  Similarity=0.373  Sum_probs=198.2

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      +|++.+.||.|+||.||++... .++..||+|.+..              .........+.+|+.++.+++||||+++++
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~-~~~~~~a~k~~~~--------------~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~   66 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHR-PTGVTMAMKEIRL--------------ELDESKFNQIIMELDILHKAVSPYIVDFYG   66 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEc-CCCcEEEEEEeec--------------ccCHHHHHHHHHHHHHHHhcCCCcHHhhhh
Confidence            5889999999999999999754 5789999998732              112234467888999999999999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEE
Q 011360          273 HMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC  352 (487)
Q Consensus       273 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~k  352 (487)
                      .+...+..|+||||+++++|..++... .....+++..+..++.|++.||.|||  ++.|++|+||+|+||+++.++.++
T Consensus        67 ~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH--~~~~i~H~dl~p~nil~~~~~~~~  143 (286)
T cd06622          67 AFFIEGAVYMCMEYMDAGSLDKLYAGG-VATEGIPEDVLRRITYAVVKGLKFLK--EEHNIIHRDVKPTNVLVNGNGQVK  143 (286)
T ss_pred             heecCCeEEEEEeecCCCCHHHHHHhc-cccCCCCHHHHHHHHHHHHHHHHHHH--hcCCEeeCCCCHHHEEECCCCCEE
Confidence            999999999999999999999988642 12347899999999999999999995  245899999999999999999999


Q ss_pred             EeccCCccccCCCCceeeEeeecccccccCCcccCCC------CCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccH
Q 011360          353 ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQP------ELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSP  426 (487)
Q Consensus       353 l~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~------~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~  426 (487)
                      |+|||++........    ....+++.|+|||.+.+.      .++.++|+|||||++|+|++|..||.......   ..
T Consensus       144 l~dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~  216 (286)
T cd06622         144 LCDFGVSGNLVASLA----KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN---IF  216 (286)
T ss_pred             EeecCCcccccCCcc----ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh---HH
Confidence            999999876543322    234578899999998543      35889999999999999999999994332111   11


Q ss_pred             HHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          427 EWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       427 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ....... ...+.     .++    .....++.+++.+||+.+|++||++.+++.
T Consensus       217 ~~~~~~~-~~~~~-----~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         217 AQLSAIV-DGDPP-----TLP----SGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             HHHHHHh-hcCCC-----CCC----cccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence            1111111 11111     111    123466889999999999999999999876

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.2e-37  Score=307.46  Aligned_cols=258  Identities=20%  Similarity=0.260  Sum_probs=196.9

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||+|+||.||+++. ..+++.||+|.+..            ...........+.+|..++..+.||||++++
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~-~~~~~~~aiK~~~~------------~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~   67 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKM-KHTERIYAMKILNK------------WEMLKRAETACFREERNVLVNGDCQWITTLH   67 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEE-CCCCCEEEEEEEeH------------HHHHhhHHHHHHHHHHHHHHhCCCCCEeeEE
Confidence            3689999999999999999975 45788999998732            0112233445677889999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++...+..|+||||++||+|.+++...   ...+++..+..++.|++.||.||   |++||+||||||+|||++.++.+
T Consensus        68 ~~~~~~~~~~lv~Ey~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~l---H~~~iiHrDlkp~Nill~~~~~~  141 (331)
T cd05624          68 YAFQDENYLYLVMDYYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSI---HQLHYVHRDIKPDNVLLDMNGHI  141 (331)
T ss_pred             EEEEcCCEEEEEEeCCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeccCchHHEEEcCCCCE
Confidence            9999999999999999999999999742   35688999999999999999999   77889999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCC-----CCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQ-----PELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSP  426 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~  426 (487)
                      ||+|||++......... ......||+.|+|||++.+     ..++.++||||||+++|+|++|..||....      ..
T Consensus       142 kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~------~~  214 (331)
T cd05624         142 RLADFGSCLKMNQDGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES------LV  214 (331)
T ss_pred             EEEeccceeeccCCCce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC------HH
Confidence            99999998766443221 1133569999999999875     467899999999999999999999994322      12


Q ss_pred             HHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCC--CCChHHHHH
Q 011360          427 EWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEE--RPNSQYVRC  481 (487)
Q Consensus       427 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--RPs~~~il~  481 (487)
                      +.......... ...++..+     ...+..+.+++.+|+...+++  |++++++++
T Consensus       215 ~~~~~i~~~~~-~~~~p~~~-----~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~  265 (331)
T cd05624         215 ETYGKIMNHEE-RFQFPSHI-----TDVSEEAKDLIQRLICSRERRLGQNGIEDFKK  265 (331)
T ss_pred             HHHHHHHcCCC-cccCCCcc-----ccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence            22232322111 11111111     123456888899999866544  457777764

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.3e-37  Score=290.67  Aligned_cols=250  Identities=26%  Similarity=0.360  Sum_probs=195.8

Q ss_pred             cccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceEEecC
Q 011360          198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRP  277 (487)
Q Consensus       198 ~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  277 (487)
                      +.||.|+||.||++...  .++.||+|.+....              .......+..|+.+++++.||||+++++++...
T Consensus         1 ~~lg~g~~g~v~~~~~~--~~~~v~~K~~~~~~--------------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   64 (251)
T cd05041           1 EKIGKGNFGDVYKGVLK--GNTEVAVKTCRSTL--------------PPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQK   64 (251)
T ss_pred             CccccCCCceEEEEEEe--CCCcEEEEeccccC--------------CHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecC
Confidence            46899999999999764  38899999874311              112445788899999999999999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEeccC
Q 011360          278 DCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLG  357 (487)
Q Consensus       278 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~DFg  357 (487)
                      ...++||||+++++|.+++..   ....+++..+..++.+++.||.||   |++|++||||+|+||+++.++.++|+|||
T Consensus        65 ~~~~~v~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~~~~~~~l~~l---H~~~i~h~di~p~nili~~~~~~~l~d~g  138 (251)
T cd05041          65 QPIYIVMELVPGGSLLTFLRK---KKNRLTVKKLLQMSLDAAAGMEYL---ESKNCIHRDLAARNCLVGENNVLKISDFG  138 (251)
T ss_pred             CCeEEEEEcCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHH---HhCCEehhhcCcceEEEcCCCcEEEeecc
Confidence            999999999999999999864   234678889999999999999999   77889999999999999999999999999


Q ss_pred             CccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccccHHHHHHHHhcC
Q 011360          358 LAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSPEWLRKVMNSK  436 (487)
Q Consensus       358 ~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  436 (487)
                      ++................++..|+|||.+.++.++.++|+||||+++|+|+| |..||.....       ..........
T Consensus       139 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~-------~~~~~~~~~~  211 (251)
T cd05041         139 MSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN-------QQTRERIESG  211 (251)
T ss_pred             ccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH-------HHHHHHHhcC
Confidence            9876543222211112234667999999988889999999999999999999 7888843322       1112222211


Q ss_pred             CCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhh
Q 011360          437 NPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQ  485 (487)
Q Consensus       437 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~  485 (487)
                      . ....+        ...+..+.+++.+||..+|++|||+.++++.|+.
T Consensus       212 ~-~~~~~--------~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~  251 (251)
T cd05041         212 Y-RMPAP--------QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI  251 (251)
T ss_pred             C-CCCCC--------ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence            1 11111        1123568999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=6.4e-38  Score=302.75  Aligned_cols=261  Identities=22%  Similarity=0.323  Sum_probs=194.3

Q ss_pred             cccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceE
Q 011360          194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAH  273 (487)
Q Consensus       194 ~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  273 (487)
                      |.+.+.||.|++|.||+|+. ..++..||+|++...             .........+.+|+.+++.++||||++++++
T Consensus         2 y~~~~~l~~g~~~~v~~~~~-~~~~~~~~ik~~~~~-------------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   67 (285)
T cd07861           2 YTKIEKIGEGTYGVVYKGRN-KKTGQIVAMKKIRLE-------------SEEEGVPSTAIREISLLKELQHPNIVCLQDV   67 (285)
T ss_pred             ceEeeEecccCceEEEEEEE-CCCCcEEEEEEeccc-------------cccCCchHHHHHHHHHHHhcCCCCEeeeEEE
Confidence            78889999999999999975 457889999987431             1112223456789999999999999999999


Q ss_pred             EecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEE
Q 011360          274 MVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACI  353 (487)
Q Consensus       274 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl  353 (487)
                      +..++..|+||||++ ++|.+++.... .+..+++..+..++.|++.||.||   |++|++||||+|+||+++.++.++|
T Consensus        68 ~~~~~~~~~v~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~l---H~~~i~H~dl~p~nil~~~~~~~~l  142 (285)
T cd07861          68 LMQESRLYLIFEFLS-MDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFC---HSRRVLHRDLKPQNLLIDNKGVIKL  142 (285)
T ss_pred             EeeCCeEEEEEecCC-CCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHH---HhCCeeecCCCHHHEEEcCCCcEEE
Confidence            999999999999996 68988886532 235689999999999999999999   7788999999999999999999999


Q ss_pred             eccCCccccCCCCceeeEeeecccccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHH
Q 011360          354 SDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQP-ELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKV  432 (487)
Q Consensus       354 ~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~  432 (487)
                      +|||++.........  .....+++.|+|||++.+. .++.++||||||+++|+|+||.+||......      ......
T Consensus       143 ~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~------~~~~~~  214 (285)
T cd07861         143 ADFGLARAFGIPVRV--YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI------DQLFRI  214 (285)
T ss_pred             CcccceeecCCCccc--ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHH------HHHHHH
Confidence            999998765332211  1223568899999988654 5789999999999999999999999543211      000000


Q ss_pred             Hhc-CCC--------------CCccCC---CCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          433 MNS-KNP--------------SRAIDP---RLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       433 ~~~-~~~--------------~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ... ..+              ....+.   ..........+.++.+++.+||+.||++|||+.+|+.
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         215 FRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             HHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            000 000              000000   0000001113456789999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5.5e-37  Score=293.31  Aligned_cols=258  Identities=24%  Similarity=0.375  Sum_probs=200.7

Q ss_pred             cccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceE
Q 011360          194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAH  273 (487)
Q Consensus       194 ~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  273 (487)
                      |.+...||.|++|.||+|.. ..++..+|+|.+.........      ..........+.+|+.++++++||||++++++
T Consensus         2 ~~~~~~ig~g~~~~v~~a~~-~~~~~~~~~k~~~~~~~~~~~------~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   74 (267)
T cd06628           2 WIKGALIGSGSFGSVYLGMN-ASSGELMAVKQVELPSVSASS------KDRKRSMLDALAREIALLKELQHENIVQYLGS   74 (267)
T ss_pred             ccccceeecCCCeEEEEEEe-cCCCcEEEEEEecCCCcccch------hHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEE
Confidence            66778999999999999974 457889999987543221110      11223345678899999999999999999999


Q ss_pred             EecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEE
Q 011360          274 MVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACI  353 (487)
Q Consensus       274 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl  353 (487)
                      +...+..+++|||+++++|.+++..    ...+++..+..++.|++.||.||   |+.|++||||+|+||++++++.++|
T Consensus        75 ~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~l---H~~~ivH~di~p~nil~~~~~~~~l  147 (267)
T cd06628          75 SLDADHLNIFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYL---HNRGIIHRDIKGANILVDNKGGIKI  147 (267)
T ss_pred             EEeCCccEEEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHH---HhcCcccccCCHHHEEEcCCCCEEe
Confidence            9999999999999999999999965    35688889999999999999999   6778999999999999999999999


Q ss_pred             eccCCccccCCCCce----eeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHH
Q 011360          354 SDLGLAMAIPDGYTR----VLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWL  429 (487)
Q Consensus       354 ~DFg~s~~~~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~  429 (487)
                      +|||.+.........    .......|+..|+|||.+.+..++.++|+||||+++|+|++|..||.....      ....
T Consensus       148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~  221 (267)
T cd06628         148 SDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ------LQAI  221 (267)
T ss_pred             cccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH------HHHH
Confidence            999998876532111    111234578899999999988899999999999999999999999953221      1111


Q ss_pred             HHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          430 RKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       430 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .......      .+.++.    ..+..+.+++.+||+.+|++||++.+|++
T Consensus       222 ~~~~~~~------~~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         222 FKIGENA------SPEIPS----NISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             HHHhccC------CCcCCc----ccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence            1111111      111221    22356889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=2.8e-37  Score=301.18  Aligned_cols=258  Identities=20%  Similarity=0.324  Sum_probs=197.7

Q ss_pred             ccccccccccccccceeEEEEEecCCCCc----eEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCC
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGK----MIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRN  266 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn  266 (487)
                      .++|...+.||.|+||.||+|.+.. ++.    .+|+|.+..              .........+.+|+.+++.++|||
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~-~~~~~~~~vaiK~~~~--------------~~~~~~~~~~~~e~~~~~~l~h~n   70 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVP-EGETVKIPVAIKILNE--------------TTGPKANVEFMDEALIMASMDHPH   70 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEec-CCCcceeeEEEEeccc--------------cCCHHHHHHHHHHHHHHHhCCCCC
Confidence            3468899999999999999997642 343    578887632              111223345788999999999999


Q ss_pred             ccccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC
Q 011360          267 ILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN  346 (487)
Q Consensus       267 Iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~  346 (487)
                      |+++++++... ..++++||+++|+|.+++..   ....+++..+..++.|++.||.||   |++||+||||||+||+++
T Consensus        71 iv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~L---H~~~ivH~dikp~Nill~  143 (303)
T cd05110          71 LVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHE---HKDNIGSQLLLNWCVQIAKGMMYL---EERRLVHRDLAARNVLVK  143 (303)
T ss_pred             cccEEEEEcCC-CceeeehhcCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHH---hhcCeeccccccceeeec
Confidence            99999988754 46799999999999999864   234688899999999999999999   778899999999999999


Q ss_pred             CCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCcccc
Q 011360          347 DDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICS  425 (487)
Q Consensus       347 ~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~  425 (487)
                      .++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++||+++ |..||....       
T Consensus       144 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~-------  216 (303)
T cd05110         144 SPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP-------  216 (303)
T ss_pred             CCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC-------
Confidence            999999999999987644322211222345778999999998899999999999999999997 889984321       


Q ss_pred             HHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          426 PEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       426 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      .............. .    .+.    ....++.+++..||..+|++||++.++++.|+.+
T Consensus       217 ~~~~~~~~~~~~~~-~----~~~----~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~  268 (303)
T cd05110         217 TREIPDLLEKGERL-P----QPP----ICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM  268 (303)
T ss_pred             HHHHHHHHHCCCCC-C----CCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            11122222222110 0    111    1224688999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=5e-37  Score=299.70  Aligned_cols=258  Identities=20%  Similarity=0.252  Sum_probs=199.1

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      +|.+.+.||.|+||.||++.. ..+++.|++|.+...            ..........+.+|+.+++.++||||+++++
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~-~~~~~~v~ik~~~~~------------~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~   68 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRH-KETRQRFAMKKINKQ------------NLILRNQIQQVFVERDILTFAENPFVVSMFC   68 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEE-CCCCcEEEEEEeehh------------hhhhHHHHHHHHHHHHHHHhCCCCCeeeeEE
Confidence            588899999999999999975 457889999987321            1112234456778999999999999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEE
Q 011360          273 HMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC  352 (487)
Q Consensus       273 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~k  352 (487)
                      .+..++..++||||++|++|.+++..    ...+++..+..++.|++.||.||   |+.|++||||+|+||+++.++.++
T Consensus        69 ~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~NIll~~~~~~~  141 (305)
T cd05609          69 SFETKRHLCMVMEYVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYL---HNYGIVHRDLKPDNLLITSMGHIK  141 (305)
T ss_pred             EEecCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCccccCCchHHEEECCCCCEE
Confidence            99999999999999999999999964    35688999999999999999999   677899999999999999999999


Q ss_pred             EeccCCccccCCCCc-------------eeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCC
Q 011360          353 ISDLGLAMAIPDGYT-------------RVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQN  419 (487)
Q Consensus       353 l~DFg~s~~~~~~~~-------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~  419 (487)
                      |+|||+++.......             ........++..|+|||.+.+..++.++|+||||+++|+|++|..||.+...
T Consensus       142 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~  221 (305)
T cd05609         142 LTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP  221 (305)
T ss_pred             EeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            999998864211100             0001123578899999999888899999999999999999999999953322


Q ss_pred             CCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHh
Q 011360          420 GEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLS  484 (487)
Q Consensus       420 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~  484 (487)
                            .+...............+.        ..+..+.+++.+||+.+|++|||+..+.+.|+
T Consensus       222 ------~~~~~~~~~~~~~~~~~~~--------~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~  272 (305)
T cd05609         222 ------EELFGQVISDDIEWPEGDE--------ALPADAQDLISRLLRQNPLERLGTGGAFEVKQ  272 (305)
T ss_pred             ------HHHHHHHHhcccCCCCccc--------cCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence                  2233333222211111111        22356889999999999999999766655554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-38  Score=310.36  Aligned_cols=244  Identities=20%  Similarity=0.271  Sum_probs=184.9

Q ss_pred             cccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC---CCCCccccceEEec
Q 011360          200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI---RHRNILPLLAHMVR  276 (487)
Q Consensus       200 lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpnIv~l~~~~~~  276 (487)
                      ||.|+||.||+|+. ..+++.||+|++...            .............|..++...   .||||+++++++..
T Consensus         1 lG~G~~g~Vy~~~~-~~~~~~~avK~~~~~------------~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~   67 (330)
T cd05586           1 IGKGTFGQVYQVRK-KDTRRIYAMKVLSKK------------EIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQT   67 (330)
T ss_pred             CCCCCceEEEEEEE-CCCCCEEEEEEEeHH------------HHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEec
Confidence            69999999999974 467899999987320            111112233444555555544   79999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEecc
Q 011360          277 PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDL  356 (487)
Q Consensus       277 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~DF  356 (487)
                      .+..|+||||+++|+|.+++..    ...+++..+..++.||+.||+||   |++||+||||||+|||++.++.+||+||
T Consensus        68 ~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~L---H~~~ivHrDlkp~Nili~~~~~~kl~Df  140 (330)
T cd05586          68 DSDLYLVTDYMSGGELFWHLQK----EGRFSEDRAKFYIAELVLALEHL---HKYDIVYRDLKPENILLDATGHIALCDF  140 (330)
T ss_pred             CCeEEEEEcCCCCChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeEeccCCHHHeEECCCCCEEEecC
Confidence            9999999999999999988864    45689999999999999999999   7788999999999999999999999999


Q ss_pred             CCccccCCCCceeeEeeecccccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHHHhc
Q 011360          357 GLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQP-ELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNS  435 (487)
Q Consensus       357 g~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  435 (487)
                      |++.........  .....||+.|+|||++.+. .++.++|||||||++|+|+||..||....      ..+........
T Consensus       141 g~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~------~~~~~~~i~~~  212 (330)
T cd05586         141 GLSKANLTDNKT--TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED------TQQMYRNIAFG  212 (330)
T ss_pred             CcCcCCCCCCCC--ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC------HHHHHHHHHcC
Confidence            998754322211  2345699999999998754 58999999999999999999999994322      12222222211


Q ss_pred             CCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCC----hHHHHH
Q 011360          436 KNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPN----SQYVRC  481 (487)
Q Consensus       436 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs----~~~il~  481 (487)
                       ..      .++..   ..+..+.+++.+||+.||++||+    +.++++
T Consensus       213 -~~------~~~~~---~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         213 -KV------RFPKN---VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             -CC------CCCCc---cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence             11      11111   12346789999999999999994    555543

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.6e-37  Score=295.79  Aligned_cols=242  Identities=21%  Similarity=0.342  Sum_probs=185.4

Q ss_pred             cccccccceeEEEEEecCC------CCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          198 EKIGSGGCGEVYKAELPGS------NGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       198 ~~lg~G~~g~v~~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      +.||.|+||.||+|.....      ....+++|.+.               .........+..|+.+++.+.||||++++
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~---------------~~~~~~~~~~~~e~~~l~~~~h~~iv~~~   65 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLD---------------KSHRNYSESFFEAASMMSQLSHKHLVLNY   65 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhc---------------chhHHHHHHHHHHHHHHHhCCCCChhhee
Confidence            3689999999999975321      12346666541               11223445678899999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC-
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME-  350 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~-  350 (487)
                      +++..++..++||||+++|+|.+++..   .+..+++..+..++.|++.||.||   |++||+||||||+||+++.++. 
T Consensus        66 ~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~l---H~~~iiH~dlkp~nili~~~~~~  139 (258)
T cd05078          66 GVCVCGDESIMVQEYVKFGSLDTYLKK---NKNLINISWKLEVAKQLAWALHFL---EDKGLTHGNVCAKNVLLIREEDR  139 (258)
T ss_pred             eEEEeCCCcEEEEecCCCCcHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCccceEEEeccccc
Confidence            999998999999999999999999864   234688999999999999999999   7788999999999999987765 


Q ss_pred             -------EEEeccCCccccCCCCceeeEeeecccccccCCcccCCC-CCCchhHHHHHHHHHHHHHhC-CCCccccCCCC
Q 011360          351 -------ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQP-ELSEKCDIFSFGMLLISLVRG-VPSFVFHQNGE  421 (487)
Q Consensus       351 -------~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DvwslG~~l~elltg-~~pf~~~~~~~  421 (487)
                             ++++|||.+......      ....+++.|+|||++.+. .++.++||||||+++|+|++| .+||.....  
T Consensus       140 ~~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~--  211 (258)
T cd05078         140 KTGNPPFIKLSDPGISITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS--  211 (258)
T ss_pred             ccCCCceEEecccccccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH--
Confidence                   699999998655332      234578899999999864 589999999999999999999 466632211  


Q ss_pred             ccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHh
Q 011360          422 EICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLS  484 (487)
Q Consensus       422 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~  484 (487)
                          ... ...... ..      .++..    ...++.+++.+||+.+|++|||+++|++.|+
T Consensus       212 ----~~~-~~~~~~-~~------~~~~~----~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         212 ----QKK-LQFYED-RH------QLPAP----KWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             ----HHH-HHHHHc-cc------cCCCC----CcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                111 111111 11      11211    1245889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=4.3e-37  Score=295.02  Aligned_cols=261  Identities=23%  Similarity=0.388  Sum_probs=199.2

Q ss_pred             cccccccccccceeEEEEEecC--CCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          194 FASLEKIGSGGCGEVYKAELPG--SNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       194 ~~~~~~lg~G~~g~v~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      |.+.+.||+|+||.||+|.+..  .++..||+|.+..             ........+.+.+|+.+++.++||||++++
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~-------------~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~   67 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKA-------------DIFSSSDIEEFLREAACMKEFDHPNVIKLI   67 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecc-------------ccCChHHHHHHHHHHHHHhcCCCCCcceEE
Confidence            4567889999999999997643  3578999998732             112233456788899999999999999999


Q ss_pred             eEEecCC------eeEEEEEecCCCCHHHHHhhhh--cCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCE
Q 011360          272 AHMVRPD------CHLLVYEFMKNGSLQDILDDVS--RGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNV  343 (487)
Q Consensus       272 ~~~~~~~------~~~lv~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Ni  343 (487)
                      +++....      ..+++++|+.+|+|.+++....  .....+++..+..++.|++.||+||   |+.||+||||||+||
T Consensus        68 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~l---H~~~i~H~dikp~ni  144 (273)
T cd05074          68 GVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYL---SSKNFIHRDLAARNC  144 (273)
T ss_pred             EEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHH---HhCCEeecccchhhE
Confidence            9886532      2478999999999998875321  1223578889999999999999999   678899999999999


Q ss_pred             EeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCc
Q 011360          344 LLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEE  422 (487)
Q Consensus       344 ll~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~  422 (487)
                      +++.++.+||+|||+++...............+++.|++||.+.+..++.++||||||+++|+|++ |.+||.....   
T Consensus       145 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---  221 (273)
T cd05074         145 MLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---  221 (273)
T ss_pred             EEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---
Confidence            999999999999999886643322211123345678999999998889999999999999999999 8899843221   


Q ss_pred             cccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          423 ICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       423 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                         .+............  .++        ..+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       222 ---~~~~~~~~~~~~~~--~~~--------~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         222 ---SEIYNYLIKGNRLK--QPP--------DCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             ---HHHHHHHHcCCcCC--CCC--------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence               12222222222111  111        1235689999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=8e-37  Score=295.61  Aligned_cols=262  Identities=25%  Similarity=0.350  Sum_probs=203.0

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      +|...+.||.|++|.||++... .++..+|+|.+...              ........+.+|+.+++.++||||+++++
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~-~~~~~~~~k~~~~~--------------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~   66 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLK-NTGMIFALKTITTD--------------PNPDLQKQILRELEINKSCKSPYIVKYYG   66 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEEC-CCCeEEEEEEEecC--------------CchHHHHHHHHHHHHHHhCCCCCeeeeee
Confidence            5888999999999999999753 57889999987421              11234566788999999999999999999


Q ss_pred             EEecC--CeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          273 HMVRP--DCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       273 ~~~~~--~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      ++...  +.+|+||||+++++|.+++.........++...+..++.|++.||.||   |+.|++|+||+|+||+++.++.
T Consensus        67 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~l---H~~~i~H~dl~~~nil~~~~~~  143 (287)
T cd06621          67 AFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYL---HSRKIIHRDIKPSNILLTRKGQ  143 (287)
T ss_pred             EEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEEecCCe
Confidence            88653  468999999999999998876544556788999999999999999999   7789999999999999999999


Q ss_pred             EEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHH
Q 011360          351 ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLR  430 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~  430 (487)
                      ++|+|||++........    ....++..|+|||.+.+..++.++||||||+++|+|++|..||...... .....+...
T Consensus       144 ~~l~dfg~~~~~~~~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~  218 (287)
T cd06621         144 VKLCDFGVSGELVNSLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEP-PLGPIELLS  218 (287)
T ss_pred             EEEeecccccccccccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCC-CCChHHHHH
Confidence            99999999865533222    2345788999999999889999999999999999999999999654321 111122222


Q ss_pred             HHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          431 KVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       431 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .......+  .++....  .....+..+.+++.+||..+|++|||+.+++.
T Consensus       219 ~~~~~~~~--~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         219 YIVNMPNP--ELKDEPG--NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             HHhcCCch--hhccCCC--CCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            22211111  1111111  11124567899999999999999999999986

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.9e-37  Score=298.29  Aligned_cols=248  Identities=28%  Similarity=0.411  Sum_probs=198.4

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      .|...+.||.|+||.||+|.. ..++..||+|.+..              .........+.+|+.+++.++||||+++++
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~-~~~~~~vaiK~~~~--------------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~   69 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGID-NRTKEVVAIKIIDL--------------EEAEDEIEDIQQEITVLSQCDSPYITRYYG   69 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEE-cCCCeEEEEEEecc--------------ccchHHHHHHHHHHHHHHcCCCCccHhhhc
Confidence            478889999999999999975 45788999998732              111223467889999999999999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEE
Q 011360          273 HMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC  352 (487)
Q Consensus       273 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~k  352 (487)
                      ++...+..|+||||+++++|.+++..     ..+++..+..++.|++.|+.||   |++|++|+||+|+||+++.++.++
T Consensus        70 ~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~l---H~~~ivH~dl~p~ni~i~~~~~~~  141 (277)
T cd06642          70 SYLKGTKLWIIMEYLGGGSALDLLKP-----GPLEETYIATILREILKGLDYL---HSERKIHRDIKAANVLLSEQGDVK  141 (277)
T ss_pred             ccccCCceEEEEEccCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHH---hcCCeeccCCChheEEEeCCCCEE
Confidence            99999999999999999999998853     4688899999999999999999   778999999999999999999999


Q ss_pred             EeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHH
Q 011360          353 ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKV  432 (487)
Q Consensus       353 l~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~  432 (487)
                      |+|||++.........  .....++..|+|||++.+..++.++|+||||+++|+|++|..||......      ......
T Consensus       142 l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~------~~~~~~  213 (277)
T cd06642         142 LADFGVAGQLTDTQIK--RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM------RVLFLI  213 (277)
T ss_pred             EccccccccccCcchh--hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh------hHHhhh
Confidence            9999998765433211  12345788999999999888999999999999999999999998432211      111111


Q ss_pred             HhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          433 MNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       433 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                       ....+     +.++    ...+..+.+++.+||+.+|++|||+.++++
T Consensus       214 -~~~~~-----~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06642         214 -PKNSP-----PTLE----GQYSKPFKEFVEACLNKDPRFRPTAKELLK  252 (277)
T ss_pred             -hcCCC-----CCCC----cccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence             11111     1111    123356889999999999999999999987

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=4.7e-37  Score=291.90  Aligned_cols=252  Identities=19%  Similarity=0.327  Sum_probs=201.8

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      +|++.+.||.|+||.+|++.. ..+++.||+|.+..             ..........+.+|+.++++++||||+++++
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~-~~~~~~~~ik~~~~-------------~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~   66 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKS-KEDGKQYVIKEINI-------------SKMSPKEREESRKEVAVLSNMKHPNIVQYQE   66 (256)
T ss_pred             CceEEEEeccCCceEEEEEEE-cCCCCEEEEEEEEh-------------HhCChHHHHHHHHHHHHHHhCCCCCeeeeEe
Confidence            378899999999999999975 45788999998742             1112234457788999999999999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEE
Q 011360          273 HMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC  352 (487)
Q Consensus       273 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~k  352 (487)
                      ++...+..++||||+++++|.+++..  .....+++..+..++.|++.||.||   |++|++|+||+|+||+++.++.++
T Consensus        67 ~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~l---h~~~i~h~~l~~~nil~~~~~~~~  141 (256)
T cd08218          67 SFEENGNLYIVMDYCEGGDLYKKINA--QRGVLFPEDQILDWFVQICLALKHV---HDRKILHRDIKSQNIFLTKDGTIK  141 (256)
T ss_pred             eecCCCeEEEEEecCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHEEEcCCCCEE
Confidence            99999999999999999999998864  2234578899999999999999999   678899999999999999999999


Q ss_pred             EeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHH
Q 011360          353 ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKV  432 (487)
Q Consensus       353 l~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~  432 (487)
                      |+|||++.........  .....|++.|+|||++.+..++.++|+||||+++|+|++|..||...      ...+.....
T Consensus       142 l~d~~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~------~~~~~~~~~  213 (256)
T cd08218         142 LGDFGIARVLNSTVEL--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG------NMKNLVLKI  213 (256)
T ss_pred             EeeccceeecCcchhh--hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC------CHHHHHHHH
Confidence            9999998765443221  12345788999999999888999999999999999999999999432      122333333


Q ss_pred             HhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          433 MNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       433 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ..+..+.      .+    .....++.+++.+||+.+|++||++.++++
T Consensus       214 ~~~~~~~------~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         214 IRGSYPP------VS----SHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             hcCCCCC------Cc----ccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            3322211      11    112356889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-38  Score=281.32  Aligned_cols=253  Identities=23%  Similarity=0.403  Sum_probs=202.5

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CCCCcccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RHRNILPL  270 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l  270 (487)
                      +....+..||.|+.|.|++++++ ++|..+|||.+..              ....+..++++..+.++..- .+|+||+.
T Consensus        92 ndl~~l~dlGsGtcG~V~k~~~r-s~~~iiAVK~M~r--------------t~Nkee~kRILmDldvv~~s~dcpyIV~c  156 (391)
T KOG0983|consen   92 NDLENLGDLGSGTCGQVWKMRFR-STGHIIAVKQMRR--------------TGNKEENKRILMDLDVVLKSHDCPYIVQC  156 (391)
T ss_pred             HHhhhHHhhcCCCccceEEEEEc-ccceEEEEEeecc--------------cCCHHHHHHHHHhhhHHhhccCCCeeeee
Confidence            34567778999999999999875 5889999999854              23344567778888877665 58999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      +|+|..+..+++.||.| ...+..++...   .+++++..+-++...++.||.||.+.|  ||+|||+||+|||+++.|+
T Consensus       157 ~GyFi~n~dV~IcMelM-s~C~ekLlkri---k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~Gn  230 (391)
T KOG0983|consen  157 FGYFITNTDVFICMELM-STCAEKLLKRI---KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGN  230 (391)
T ss_pred             eeEEeeCchHHHHHHHH-HHHHHHHHHHh---cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCC
Confidence            99999999999999998 54677777643   567899888899999999999998766  6999999999999999999


Q ss_pred             EEEeccCCccccCCCCceeeEeeecccccccCCcccC---CCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHH
Q 011360          351 ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQ---QPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPE  427 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~  427 (487)
                      +||||||++-.+-+....   +...|.+.|||||.+.   ...|+.++||||||+.++||.||..||.+...+     .+
T Consensus       231 iKlCDFGIsGrlvdSkAh---trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td-----Fe  302 (391)
T KOG0983|consen  231 IKLCDFGISGRLVDSKAH---TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD-----FE  302 (391)
T ss_pred             EEeecccccceeeccccc---ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc-----HH
Confidence            999999999877655443   4456999999999886   457999999999999999999999999554332     23


Q ss_pred             HHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          428 WLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .+..+.+ ..| ..    +++..-  .+.++.+++..||.+|+.+||...++++
T Consensus       303 ~ltkvln-~eP-P~----L~~~~g--FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  303 VLTKVLN-EEP-PL----LPGHMG--FSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             HHHHHHh-cCC-CC----CCcccC--cCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence            3444444 333 22    332211  4567999999999999999999999875

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=5.6e-37  Score=292.41  Aligned_cols=257  Identities=22%  Similarity=0.371  Sum_probs=203.9

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      +|.+.+.||.|+||.||++.. ..++..+|+|.+..             ..........+..|+.+++.++||||+++++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~-~~~~~~~~~k~~~~-------------~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~   66 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRR-KSDGKILVWKEIDY-------------GNMTEKEKQQLVSEVNILRELKHPNIVRYYD   66 (265)
T ss_pred             CceeeeeeccCCCeEEEEeee-cCCCCEEEEEEEec-------------ccCCHHHHHHHHHHHHHHHhcCCCccceeee
Confidence            378889999999999999975 45788999998742             1122334567788999999999999999999


Q ss_pred             EEec--CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcC--CCCeeecCCCCCCEEeCCC
Q 011360          273 HMVR--PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYH--SASIIHGDIKPRNVLLNDD  348 (487)
Q Consensus       273 ~~~~--~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h--~~givH~Dlkp~Nill~~~  348 (487)
                      ++..  ....+++|||+++++|.+++.........+++..++.++.|++.||.|||..+  +.+++|+||+|+||+++.+
T Consensus        67 ~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~  146 (265)
T cd08217          67 RIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDAN  146 (265)
T ss_pred             eeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecC
Confidence            7764  45679999999999999999875555678899999999999999999994332  8899999999999999999


Q ss_pred             CCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHH
Q 011360          349 MEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEW  428 (487)
Q Consensus       349 ~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~  428 (487)
                      +.+||+|||++.........  .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||....      ....
T Consensus       147 ~~~kl~d~g~~~~~~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~  218 (265)
T cd08217         147 NNVKLGDFGLAKILGHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN------QLQL  218 (265)
T ss_pred             CCEEEecccccccccCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC------HHHH
Confidence            99999999999876543321  133468999999999998889999999999999999999999995432      1122


Q ss_pred             HHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          429 LRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       429 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      . ......... .    ++    ...+..+.+++.+||+.+|++|||+.+|++
T Consensus       219 ~-~~~~~~~~~-~----~~----~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~  261 (265)
T cd08217         219 A-SKIKEGKFR-R----IP----YRYSSELNEVIKSMLNVDPDKRPSTEELLQ  261 (265)
T ss_pred             H-HHHhcCCCC-C----Cc----cccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence            2 222222211 1    11    123356889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=3.7e-37  Score=296.34  Aligned_cols=249  Identities=27%  Similarity=0.400  Sum_probs=199.9

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      .|...+.||.|+||.||.|... .++..||+|.+..              .........+.+|+.+++.+.||||+++++
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~-~~~~~vaiK~~~~--------------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~   69 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDN-RTQQVVAIKIIDL--------------EEAEDEIEDIQQEITVLSQCDSPYVTKYYG   69 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEc-cCCEEEEEEEEec--------------cccHHHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence            5888899999999999999753 5688999998732              111234567888999999999999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEE
Q 011360          273 HMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC  352 (487)
Q Consensus       273 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~k  352 (487)
                      ++.++...|+||||+++++|.+++..     ..+++..+..++.|++.||.||   |+.+++|+||+|+||+++.++.++
T Consensus        70 ~~~~~~~~~lv~e~~~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~l---h~~~ivH~dl~p~Nil~~~~~~~~  141 (277)
T cd06640          70 SYLKGTKLWIIMEYLGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYL---HSEKKIHRDIKAANVLLSEQGDVK  141 (277)
T ss_pred             EEEECCEEEEEEecCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHH---HhCCccCcCCChhhEEEcCCCCEE
Confidence            99999999999999999999998863     4578889999999999999999   778899999999999999999999


Q ss_pred             EeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHH
Q 011360          353 ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKV  432 (487)
Q Consensus       353 l~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~  432 (487)
                      |+|||++.........  .....++..|+|||.+.+..++.++|+||||+++|+|+||..||......      .... .
T Consensus       142 l~dfg~~~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~------~~~~-~  212 (277)
T cd06640         142 LADFGVAGQLTDTQIK--RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM------RVLF-L  212 (277)
T ss_pred             EcccccceeccCCccc--cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH------hHhh-h
Confidence            9999999766443211  12345788999999998888999999999999999999999999533221      1111 1


Q ss_pred             HhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHH
Q 011360          433 MNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCR  482 (487)
Q Consensus       433 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~  482 (487)
                      .....+     +    ......+..+.+++.+||+.+|++|||+.+++..
T Consensus       213 ~~~~~~-----~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         213 IPKNNP-----P----TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             hhcCCC-----C----CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            111111     1    1122345678899999999999999999999753

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4.7e-37  Score=296.39  Aligned_cols=266  Identities=21%  Similarity=0.304  Sum_probs=203.4

Q ss_pred             cccccccccccccceeEEEEEec---CCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELP---GSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNIL  268 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv  268 (487)
                      ..|.+.+.||.|+||.||++.+.   ..++..+|+|.+....              .......+.+|+.+++.+.||||+
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~--------------~~~~~~~~~~ei~~l~~l~~~~i~   69 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSG--------------EEQHRSDFEREIEILRTLDHENIV   69 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEecccc--------------chHHHHHHHHHHHHHHhCCCCChh
Confidence            35788899999999999999864   2357899999874311              113456788999999999999999


Q ss_pred             ccceEEec--CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC
Q 011360          269 PLLAHMVR--PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN  346 (487)
Q Consensus       269 ~l~~~~~~--~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~  346 (487)
                      ++++++..  ....+++|||+++++|.+++...   ...+++..+..++.|++.||.||   |+.|++|+||||+||+++
T Consensus        70 ~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~l---H~~~i~H~dl~p~nil~~  143 (284)
T cd05038          70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYL---GSQRYIHRDLAARNILVE  143 (284)
T ss_pred             eEEeeeecCCCCceEEEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHhEEEc
Confidence            99998877  56789999999999999999742   33589999999999999999999   678899999999999999


Q ss_pred             CCCCEEEeccCCccccCCCCceee-EeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCcc--
Q 011360          347 DDMEACISDLGLAMAIPDGYTRVL-ISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI--  423 (487)
Q Consensus       347 ~~~~~kl~DFg~s~~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~--  423 (487)
                      .++.++|+|||.+........... .....++..|+|||.+.+..++.++||||||+++|+|+||..||.........  
T Consensus       144 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~  223 (284)
T cd05038         144 SEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMI  223 (284)
T ss_pred             CCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccc
Confidence            999999999999987653322111 11223456799999998888999999999999999999999888443221100  


Q ss_pred             ------ccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          424 ------CSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       424 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                            .............. ....+.        ..+.++.+++.+||+.+|++|||+.+|+++|+.+
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~-~~~~~~--------~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         224 GIAQGQMIVTRLLELLKEGE-RLPRPP--------SCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             ccccccccHHHHHHHHHcCC-cCCCCc--------cCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence                  01111111221111 111011        1225688999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=4.9e-37  Score=291.81  Aligned_cols=251  Identities=24%  Similarity=0.375  Sum_probs=197.2

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      .|.+.+.||.|+||.||++.+.  ++..+|+|.+...                ......+.+|+.+++++.||||+++++
T Consensus         5 ~~~~~~~ig~g~~g~v~~~~~~--~~~~~~~k~~~~~----------------~~~~~~~~~e~~~l~~l~~~~i~~~~~   66 (256)
T cd05112           5 ELTLVQEIGSGQFGLVWLGYWL--EKRKVAIKTIREG----------------AMSEEDFIEEAQVMMKLSHPKLVQLYG   66 (256)
T ss_pred             HeEEEeeecCcccceEEEEEEe--CCCeEEEEECCCC----------------CCCHHHHHHHHHHHHhCCCCCeeeEEE
Confidence            5888999999999999999764  4678999987321                111235778999999999999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEE
Q 011360          273 HMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC  352 (487)
Q Consensus       273 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~k  352 (487)
                      ++......+++|||+++++|.+++..   ....+++..+..++.|++.||.||   |+.|++|+||+|+||+++.++.++
T Consensus        67 ~~~~~~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~l---H~~~i~h~dl~p~ni~i~~~~~~~  140 (256)
T cd05112          67 VCTERSPICLVFEFMEHGCLSDYLRA---QRGKFSQETLLGMCLDVCEGMAYL---ESSNVIHRDLAARNCLVGENQVVK  140 (256)
T ss_pred             EEccCCceEEEEEcCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHH---HHCCccccccccceEEEcCCCeEE
Confidence            99999999999999999999998864   234578899999999999999999   677899999999999999999999


Q ss_pred             EeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccccHHHHHH
Q 011360          353 ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSPEWLRK  431 (487)
Q Consensus       353 l~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~  431 (487)
                      |+|||.+.......... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||....      ..+....
T Consensus       141 l~d~g~~~~~~~~~~~~-~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~------~~~~~~~  213 (256)
T cd05112         141 VSDFGMTRFVLDDQYTS-STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS------NSEVVET  213 (256)
T ss_pred             ECCCcceeecccCcccc-cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC------HHHHHHH
Confidence            99999987654332111 112235678999999998889999999999999999998 899994322      1122222


Q ss_pred             HHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHh
Q 011360          432 VMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLS  484 (487)
Q Consensus       432 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~  484 (487)
                      .......   ..+..       .+..+.+++.+||+.+|++|||+.++++.|.
T Consensus       214 ~~~~~~~---~~~~~-------~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         214 INAGFRL---YKPRL-------ASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             HhCCCCC---CCCCC-------CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence            2221111   11111       1256899999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5.9e-37  Score=294.02  Aligned_cols=264  Identities=25%  Similarity=0.370  Sum_probs=200.2

Q ss_pred             cccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceE
Q 011360          194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAH  273 (487)
Q Consensus       194 ~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  273 (487)
                      |.+.+.||.|+||.||+|.. ..++..+|+|.+........     ..........+.+..|+.+++.++||||++++++
T Consensus         3 ~~~~~~lg~g~~~~vy~~~~-~~~~~~~a~K~~~~~~~~~~-----~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   76 (272)
T cd06629           3 WVKGELIGKGTYGRVYLALN-VTTGEMMAVKQVELPATIAG-----RHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGF   76 (272)
T ss_pred             eeecceecccCceEEEEEee-cCCCceeeeeeeechhhhhc-----ccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEE
Confidence            67788999999999999964 45788999998743111000     0001112234577889999999999999999999


Q ss_pred             EecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEE
Q 011360          274 MVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACI  353 (487)
Q Consensus       274 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl  353 (487)
                      +...+..++||||+++++|.+++..    ...+++..+..++.|++.||.||   |++|++||||+|+||+++.++.++|
T Consensus        77 ~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~~~nil~~~~~~~~l  149 (272)
T cd06629          77 ETTEEYLSIFLEYVPGGSIGSCLRT----YGRFEEQLVRFFTEQVLEGLAYL---HSKGILHRDLKADNLLVDADGICKI  149 (272)
T ss_pred             eccCCceEEEEecCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHH---hhCCeeecCCChhhEEEcCCCeEEE
Confidence            9999999999999999999999865    35688899999999999999999   7789999999999999999999999


Q ss_pred             eccCCccccCCCCceeeEeeecccccccCCcccCCCC--CCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHH
Q 011360          354 SDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPE--LSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRK  431 (487)
Q Consensus       354 ~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~  431 (487)
                      +|||++................++..|+|||.+....  ++.++|+||||+++|++++|..||.....      .+....
T Consensus       150 ~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~------~~~~~~  223 (272)
T cd06629         150 SDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA------IAAMFK  223 (272)
T ss_pred             eeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch------HHHHHH
Confidence            9999987654332222223345889999999987654  88999999999999999999999942211      111111


Q ss_pred             HHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          432 VMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       432 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ..... ....    ++.......+..+.+++.+||..+|++|||+.++++
T Consensus       224 ~~~~~-~~~~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         224 LGNKR-SAPP----IPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             hhccc-cCCc----CCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            11111 1111    111111233467889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=3.9e-37  Score=298.37  Aligned_cols=255  Identities=25%  Similarity=0.367  Sum_probs=196.3

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CCCCccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RHRNILP  269 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~  269 (487)
                      .++|.+.+.||.|+||.||++.. ..+++.+|+|.+...                ......+..|+.++.++ +|||+++
T Consensus        21 ~~~y~~~~~l~~g~~~~vy~~~~-~~~~~~~aik~~~~~----------------~~~~~~~~~e~~~l~~l~~h~ni~~   83 (291)
T cd06639          21 TDTWEIIETIGKGTYGKVYKVTN-KKDGSLAAVKILDPI----------------SDVDEEIEAEYNILQSLPNHPNVVK   83 (291)
T ss_pred             CCCeEEEEEeecCCCeEEEEEEE-CCCCCEEEEEEeccc----------------ccHHHHHHHHHHHHHHhcCCCCeEE
Confidence            45699999999999999999975 457889999987321                11234556788888888 8999999


Q ss_pred             cceEEecC-----CeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEE
Q 011360          270 LLAHMVRP-----DCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVL  344 (487)
Q Consensus       270 l~~~~~~~-----~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nil  344 (487)
                      +++++...     +..++||||+++++|.+++.........+++..+..++.|++.||.||   |+.|++||||||+||+
T Consensus        84 ~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~l---H~~~ivH~dlkp~nil  160 (291)
T cd06639          84 FYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHL---HNNRIIHRDVKGNNIL  160 (291)
T ss_pred             EEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHEE
Confidence            99988753     357999999999999999875444456789999999999999999999   7788999999999999


Q ss_pred             eCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCC-----CCCchhHHHHHHHHHHHHHhCCCCccccCC
Q 011360          345 LNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQP-----ELSEKCDIFSFGMLLISLVRGVPSFVFHQN  419 (487)
Q Consensus       345 l~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----~~~~~~DvwslG~~l~elltg~~pf~~~~~  419 (487)
                      ++.++.+||+|||++.........  .....|+..|+|||.+...     .++.++||||||+++|+|++|++||.....
T Consensus       161 i~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~  238 (291)
T cd06639         161 LTTEGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP  238 (291)
T ss_pred             EcCCCCEEEeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH
Confidence            999999999999998765432211  1234578899999988643     368899999999999999999999943221


Q ss_pred             CCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          420 GEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       420 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                            ............+ ...+       .......+.+++.+||+.+|++|||+.+|++
T Consensus       239 ------~~~~~~~~~~~~~-~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         239 ------VKTLFKIPRNPPP-TLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             ------HHHHHHHhcCCCC-CCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence                  1112222221111 1111       1122346889999999999999999999875

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-38  Score=314.57  Aligned_cols=245  Identities=27%  Similarity=0.378  Sum_probs=198.7

Q ss_pred             ccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceEEecCC
Q 011360          199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPD  278 (487)
Q Consensus       199 ~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  278 (487)
                      +||+|.+|+||-|+ +.++...+|||.+..               ........+..|+.+-++|+|.|||+++|.+..++
T Consensus       582 VLGKGTYG~VYA~R-D~~tqvrIaIKEIpe---------------kdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senG  645 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAAR-DMDTQVRIAIKEIPE---------------KDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENG  645 (1226)
T ss_pred             EeecCceeEEEeec-cccceeEEEeeeccc---------------ccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCC
Confidence            59999999999997 567888999998732               22335567889999999999999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhhhhcCCCCC--ChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC-CCCCEEEec
Q 011360          279 CHLLVYEFMKNGSLQDILDDVSRGRREL--DWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN-DDMEACISD  355 (487)
Q Consensus       279 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l--~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~-~~~~~kl~D  355 (487)
                      .+-|.||-++||||.++|...   -+++  .+.+.-.+.+||++||.||   |++.|||||||-+|+|++ -.|.+||+|
T Consensus       646 f~kIFMEqVPGGSLSsLLrsk---WGPlKDNEstm~fYtkQILeGLkYL---Hen~IVHRDIKGDNVLvNTySGvlKISD  719 (1226)
T KOG4279|consen  646 FFKIFMEQVPGGSLSSLLRSK---WGPLKDNESTMNFYTKQILEGLKYL---HENKIVHRDIKGDNVLVNTYSGVLKISD  719 (1226)
T ss_pred             eEEEEeecCCCCcHHHHHHhc---cCCCccchhHHHHHHHHHHHHhhhh---hhcceeeccccCCcEEEeeccceEEecc
Confidence            999999999999999999752   3445  6778889999999999999   566699999999999997 468999999


Q ss_pred             cCCccccCCCCceeeEeeecccccccCCcccCCC--CCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHHH
Q 011360          356 LGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQP--ELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVM  433 (487)
Q Consensus       356 Fg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~  433 (487)
                      ||-++++..-  .....++.||..|||||++..+  .|+.++|||||||++.||.||++||......      .  ..++
T Consensus       720 FGTsKRLAgi--nP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp------q--AAMF  789 (1226)
T KOG4279|consen  720 FGTSKRLAGI--NPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP------Q--AAMF  789 (1226)
T ss_pred             cccchhhccC--CccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh------h--Hhhh
Confidence            9999876432  2233678899999999999765  6899999999999999999999999543321      1  1122


Q ss_pred             hcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          434 NSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       434 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ..+...  .-|    ....+.+.+...+|.+|+.++|.+||++++++.
T Consensus       790 kVGmyK--vHP----~iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  790 KVGMYK--VHP----PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             hhccee--cCC----CCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            222211  112    234567788999999999999999999999874

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=2.8e-37  Score=299.52  Aligned_cols=250  Identities=24%  Similarity=0.434  Sum_probs=196.5

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      .|.....||.|+||.||++.. ..++..||||.+..               ........+.+|+..++.++||||+++++
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~-~~~~~~vaiK~~~~---------------~~~~~~~~~~~e~~~l~~l~h~~ii~~~~   86 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATE-KHTGKQVAVKKMDL---------------RKQQRRELLFNEVVIMRDYHHENVVDMYN   86 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEE-CCCCCEEEEEEEec---------------chHHHHHHHHHHHHHHHhCCCCcHHHHHH
Confidence            456667899999999999974 45788999998732               11223456788999999999999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEE
Q 011360          273 HMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC  352 (487)
Q Consensus       273 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~k  352 (487)
                      .+...+..|+||||+++++|.+++..     ..+++..+..++.|++.||.||   |++|++||||||+||+++.++.++
T Consensus        87 ~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~L---H~~~ivH~dlkp~Nill~~~~~~k  158 (292)
T cd06658          87 SYLVGDELWVVMEFLEGGALTDIVTH-----TRMNEEQIATVCLSVLRALSYL---HNQGVIHRDIKSDSILLTSDGRIK  158 (292)
T ss_pred             heecCCeEEEEEeCCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHH---HHCCEeecCCCHHHEEEcCCCCEE
Confidence            99999999999999999999998753     4588999999999999999999   777899999999999999999999


Q ss_pred             EeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHH
Q 011360          353 ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKV  432 (487)
Q Consensus       353 l~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~  432 (487)
                      |+|||++.........  .....|+..|+|||.+.+..++.++||||||+++|||++|..||.....      .......
T Consensus       159 L~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~------~~~~~~~  230 (292)
T cd06658         159 LSDFGFCAQVSKEVPK--RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP------LQAMRRI  230 (292)
T ss_pred             EccCcchhhccccccc--CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHH
Confidence            9999998755332221  1234588999999999888899999999999999999999999953322      1111111


Q ss_pred             HhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHH
Q 011360          433 MNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCR  482 (487)
Q Consensus       433 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~  482 (487)
                       ....+     +..+.  .......+..++.+||..+|++|||++++++.
T Consensus       231 -~~~~~-----~~~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         231 -RDNLP-----PRVKD--SHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             -HhcCC-----Ccccc--ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence             11111     11111  11223468889999999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-37  Score=294.50  Aligned_cols=255  Identities=25%  Similarity=0.392  Sum_probs=199.1

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CCCCccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RHRNILP  269 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~  269 (487)
                      .++|.+.+.||.|++|.||+|... .++..+++|.+..                .......+.+|+.+++++ .||||++
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~-~~~~~~~~k~~~~----------------~~~~~~~~~~e~~~l~~~~~h~~i~~   67 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHK-KTGQLVAIKIMDI----------------IEDEEEEIKEEYNILRKYSNHPNIAT   67 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEEC-CCCcEEEEEEEec----------------CchhHHHHHHHHHHHHHhcCCCChhe
Confidence            357999999999999999999754 4678999998732                112345678899999998 7999999


Q ss_pred             cceEEecCC------eeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCE
Q 011360          270 LLAHMVRPD------CHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNV  343 (487)
Q Consensus       270 l~~~~~~~~------~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Ni  343 (487)
                      +++++....      ..++||||+++++|.+++......+..+++..+..++.|++.||.||   |+.|++|+||+|+||
T Consensus        68 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~l---H~~~i~H~~l~p~ni  144 (275)
T cd06608          68 FYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYL---HENKVIHRDIKGQNI  144 (275)
T ss_pred             EEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHH---hcCCcccCCCCHHHE
Confidence            999987644      48999999999999999876544456789999999999999999999   788999999999999


Q ss_pred             EeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCC-----CCCCchhHHHHHHHHHHHHHhCCCCccccC
Q 011360          344 LLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQ-----PELSEKCDIFSFGMLLISLVRGVPSFVFHQ  418 (487)
Q Consensus       344 ll~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~DvwslG~~l~elltg~~pf~~~~  418 (487)
                      +++.++.++|+|||++.........  .....++..|+|||.+..     ..++.++||||||+++|+|++|..||....
T Consensus       145 ~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~  222 (275)
T cd06608         145 LLTKNAEVKLVDFGVSAQLDSTLGR--RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMH  222 (275)
T ss_pred             EEccCCeEEECCCccceecccchhh--hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccc
Confidence            9999999999999998765433221  123458899999998753     357889999999999999999999994321


Q ss_pred             CCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          419 NGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       419 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .      ........... ...     +.  .....+..+.+++.+||..||++|||+.++++
T Consensus       223 ~------~~~~~~~~~~~-~~~-----~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         223 P------MRALFKIPRNP-PPT-----LK--SPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             h------HHHHHHhhccC-CCC-----CC--chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            1      11122222211 111     11  11224457889999999999999999999975

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-38  Score=288.63  Aligned_cols=244  Identities=23%  Similarity=0.290  Sum_probs=201.1

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|..++.||+|.||+|.+++ .+.+++.+|+|+++.            .-......+..-..|-.++...+||.+..+.
T Consensus       168 ~dFdfLKvLGkGTFGKVIL~r-EKat~k~YAiKIlkK------------eviiakdEVAHTlTE~RVL~~~~HPFLt~LK  234 (516)
T KOG0690|consen  168 EDFDFLKVLGKGTFGKVILCR-EKATGKLYAIKILKK------------EVIIAKDEVAHTLTENRVLQNCRHPFLTSLK  234 (516)
T ss_pred             chhhHHHHhcCCccceEEEEe-ecccCceeehhhhhh------------hheeehHHhhhhhhHHHHHHhccCcHHHHhh
Confidence            458899999999999999997 557999999997732            2334455677788899999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      ..|...+.+|+||||+.||.|.-+|..    ...+++...+.+...|+.||.||   |+++||+||||.+|+|++.+|++
T Consensus       235 YsFQt~drlCFVMeyanGGeLf~HLsr----er~FsE~RtRFYGaEIvsAL~YL---Hs~~ivYRDlKLENLlLDkDGHI  307 (516)
T KOG0690|consen  235 YSFQTQDRLCFVMEYANGGELFFHLSR----ERVFSEDRTRFYGAEIVSALGYL---HSRNIVYRDLKLENLLLDKDGHI  307 (516)
T ss_pred             hhhccCceEEEEEEEccCceEeeehhh----hhcccchhhhhhhHHHHHHhhhh---hhCCeeeeechhhhheeccCCce
Confidence            999999999999999999999988865    57789999999999999999999   78899999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRK  431 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~  431 (487)
                      ||+|||+++.--...  ...++++|||.|+|||++....|+.++|+|.+|+++|||++|+.||-..+...   ..+.+  
T Consensus       308 KitDFGLCKE~I~~g--~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k---LFeLI--  380 (516)
T KOG0690|consen  308 KITDFGLCKEEIKYG--DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK---LFELI--  380 (516)
T ss_pred             Eeeecccchhccccc--ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH---HHHHH--
Confidence            999999997643322  23468999999999999999999999999999999999999999995443321   11111  


Q ss_pred             HHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCC
Q 011360          432 VMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERP  474 (487)
Q Consensus       432 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP  474 (487)
                      ++..-+.+..    +        +.+...++...|.+||.+|.
T Consensus       381 l~ed~kFPr~----l--------s~eAktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  381 LMEDLKFPRT----L--------SPEAKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             HhhhccCCcc----C--------CHHHHHHHHHHhhcChHhhc
Confidence            1112111111    1        23577888999999999996

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=8.7e-37  Score=289.89  Aligned_cols=251  Identities=22%  Similarity=0.352  Sum_probs=200.2

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      +|...+.||.|++|.||++.. ..++..+|+|.+...             .........+.+|+.+++.++||||+++++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~-~~~~~~~~ik~~~~~-------------~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~   66 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRR-KADQKLVIIKQIPVE-------------QMTKDERLAAQNECQVLKLLSHPNIIEYYE   66 (256)
T ss_pred             CceEEEEecccCceEEEEEEE-cCCCcEEEEEEEecc-------------ccccHHHHHHHHHHHHHhhCCCCchhheee
Confidence            378889999999999999975 457889999987431             112234567888999999999999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC-CE
Q 011360          273 HMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDM-EA  351 (487)
Q Consensus       273 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~-~~  351 (487)
                      .+...+..++||||+++++|.+++..  .....+++..+..++.+++.||.||   |++|++|+||+|+||+++.++ .+
T Consensus        67 ~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~l---h~~~i~h~dl~~~nil~~~~~~~~  141 (256)
T cd08220          67 NFLEDKALMIVMEYAPGGTLAEYIQK--RCNSLLDEDTILHFFVQILLALHHV---HTKLILHRDLKTQNILLDKHKMVV  141 (256)
T ss_pred             eEecCCEEEEEEecCCCCCHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCCEE
Confidence            99999999999999999999999975  2345688999999999999999999   778999999999999998654 57


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRK  431 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~  431 (487)
                      +|+|||.+.........   ....++..|+|||.+.+..++.++||||||+++|+|++|..||.....      ......
T Consensus       142 ~l~d~~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~------~~~~~~  212 (256)
T cd08220         142 KIGDFGISKILSSKSKA---YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL------PALVLK  212 (256)
T ss_pred             EEccCCCceecCCCccc---cccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch------HHHHHH
Confidence            99999999876543221   234588899999999988889999999999999999999999943321      222222


Q ss_pred             HHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          432 VMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       432 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .......  .+...        .+.++.+++.+||+.+|++|||+.++++
T Consensus       213 ~~~~~~~--~~~~~--------~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         213 IMSGTFA--PISDR--------YSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             HHhcCCC--CCCCC--------cCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            2222111  11111        2346889999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2.7e-37  Score=303.21  Aligned_cols=200  Identities=24%  Similarity=0.378  Sum_probs=158.7

Q ss_pred             cccccccceeEEEEEec-CCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceEEec
Q 011360          198 EKIGSGGCGEVYKAELP-GSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVR  276 (487)
Q Consensus       198 ~~lg~G~~g~v~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  276 (487)
                      ..||.|+||.||+|+.. ..++..||+|.+...                 .....+.+|+.+++.++||||+++++++..
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~-----------------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~   69 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT-----------------GISMSACREIALLRELKHPNVIALQKVFLS   69 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCC-----------------CCcHHHHHHHHHHHhCCCCCeeeEEEEEec
Confidence            57999999999999863 235678999987321                 112345679999999999999999998854


Q ss_pred             --CCeeEEEEEecCCCCHHHHHhhhhc-----CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEe----
Q 011360          277 --PDCHLLVYEFMKNGSLQDILDDVSR-----GRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLL----  345 (487)
Q Consensus       277 --~~~~~lv~E~~~~gsL~~~l~~~~~-----~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill----  345 (487)
                        +...++||||+. ++|.+++.....     ....+++..+..++.|++.||.||   |+.||+||||||+||++    
T Consensus        70 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~l---H~~~ivH~Dlkp~Nil~~~~~  145 (317)
T cd07867          70 HSDRKVWLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL---HANWVLHRDLKPANILVMGEG  145 (317)
T ss_pred             cCCCeEEEEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHH---HhCCEEcCCCCHHHEEEccCC
Confidence              567899999995 588887753211     223578889999999999999999   77889999999999999    


Q ss_pred             CCCCCEEEeccCCccccCCCCce-eeEeeecccccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCccccC
Q 011360          346 NDDMEACISDLGLAMAIPDGYTR-VLISYVLGTMAYIAPEYFQQ-PELSEKCDIFSFGMLLISLVRGVPSFVFHQ  418 (487)
Q Consensus       346 ~~~~~~kl~DFg~s~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwslG~~l~elltg~~pf~~~~  418 (487)
                      +.++.+||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||+||.+||....
T Consensus       146 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~  220 (317)
T cd07867         146 PERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             CCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence            45678999999999876443221 11133468999999999876 458999999999999999999999996543

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=3.9e-37  Score=299.26  Aligned_cols=249  Identities=23%  Similarity=0.385  Sum_probs=196.4

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      .|.....||.|+||.||++.. ..++..||+|.+...               .......+.+|+.++..+.||||+++++
T Consensus        22 ~~~~~~~ig~g~~g~v~~~~~-~~~~~~v~iK~~~~~---------------~~~~~~~~~~e~~~l~~l~hp~i~~~~~   85 (297)
T cd06659          22 LLENYIKIGEGSTGIVCIARE-KHSGRQVAVKMMDLR---------------KQQRRELLFNEVVIMRDYQHQNVVEMYK   85 (297)
T ss_pred             hHHhhhhcCCCCceeEEEEEE-cCCCCEEEEEEEEec---------------ccchHHHHHHHHHHHHhCCCCchhhhhh
Confidence            355566899999999999974 457889999987321               1122345778999999999999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEE
Q 011360          273 HMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC  352 (487)
Q Consensus       273 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~k  352 (487)
                      .+..++..|++|||+++++|..++..     ..+++..+..++.|++.||.||   |+.|++||||+|+||+++.++.++
T Consensus        86 ~~~~~~~~~iv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~L---H~~~ivH~dl~p~Nill~~~~~~k  157 (297)
T cd06659          86 SYLVGEELWVLMEFLQGGALTDIVSQ-----TRLNEEQIATVCESVLQALCYL---HSQGVIHRDIKSDSILLTLDGRVK  157 (297)
T ss_pred             heeeCCeEEEEEecCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHeEEccCCcEE
Confidence            99999999999999999999987753     4588999999999999999999   788899999999999999999999


Q ss_pred             EeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHH
Q 011360          353 ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKV  432 (487)
Q Consensus       353 l~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~  432 (487)
                      |+|||++.........  .....++..|+|||++.+..++.++||||||+++|+|++|..||.....      .+.....
T Consensus       158 L~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------~~~~~~~  229 (297)
T cd06659         158 LSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP------VQAMKRL  229 (297)
T ss_pred             EeechhHhhccccccc--ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHH
Confidence            9999998755433221  1335689999999999988899999999999999999999999953221      1222222


Q ss_pred             HhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          433 MNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       433 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .....+....        .......+.+++.+||+.+|++|||+.++++
T Consensus       230 ~~~~~~~~~~--------~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~  270 (297)
T cd06659         230 RDSPPPKLKN--------AHKISPVLRDFLERMLTREPQERATAQELLD  270 (297)
T ss_pred             hccCCCCccc--------cCCCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence            1111111110        1112345889999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=3.8e-37  Score=297.01  Aligned_cols=252  Identities=26%  Similarity=0.391  Sum_probs=193.8

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CCCCccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RHRNILP  269 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~  269 (487)
                      .+.|++.+.||.|+||.||+|... .++..+|+|.+..                .......+..|+.++.++ +||||++
T Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~a~K~~~~----------------~~~~~~~~~~e~~~l~~~~~h~~i~~   77 (282)
T cd06636          15 AGIFELVEVVGNGTYGQVYKGRHV-KTGQLAAIKVMDV----------------TEDEEEEIKLEINMLKKYSHHRNIAT   77 (282)
T ss_pred             hhhhhhheeeccCCCeEEEEEEEc-CCCcEEEEEEEec----------------ChHHHHHHHHHHHHHHHhcCCCcEEE
Confidence            346899999999999999999754 5788999998732                112334567788888888 7999999


Q ss_pred             cceEEec------CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCE
Q 011360          270 LLAHMVR------PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNV  343 (487)
Q Consensus       270 l~~~~~~------~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Ni  343 (487)
                      +++++..      .+..|++|||+++|+|.+++...  ....+++..+..++.|++.||.||   |+.|++|+||+|+||
T Consensus        78 ~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~L---H~~~ivH~dl~~~ni  152 (282)
T cd06636          78 YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNT--KGNALKEDWIAYICREILRGLAHL---HAHKVIHRDIKGQNV  152 (282)
T ss_pred             EeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHE
Confidence            9998853      45789999999999999998752  234578888999999999999999   778899999999999


Q ss_pred             EeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccC-----CCCCCchhHHHHHHHHHHHHHhCCCCccccC
Q 011360          344 LLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQ-----QPELSEKCDIFSFGMLLISLVRGVPSFVFHQ  418 (487)
Q Consensus       344 ll~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DvwslG~~l~elltg~~pf~~~~  418 (487)
                      +++.++.++|+|||++.........  .....|++.|+|||.+.     ...++.++|+||||+++|+|++|..||....
T Consensus       153 li~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~  230 (282)
T cd06636         153 LLTENAEVKLVDFGVSAQLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMH  230 (282)
T ss_pred             EECCCCCEEEeeCcchhhhhccccC--CCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccC
Confidence            9999999999999998765322111  12345889999999886     3468889999999999999999999994332


Q ss_pred             CCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          419 NGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       419 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      +..      ...... ...+...        .....+..+.+++.+||+.||.+|||+.+|+.
T Consensus       231 ~~~------~~~~~~-~~~~~~~--------~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         231 PMR------ALFLIP-RNPPPKL--------KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             HHh------hhhhHh-hCCCCCC--------cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            211      111111 1111111        11123356899999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5e-37  Score=318.36  Aligned_cols=281  Identities=19%  Similarity=0.205  Sum_probs=192.9

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecC--chhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYA--PISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILP  269 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~  269 (487)
                      +.|.+++.||+|+||+||++.++..++...++|.+....  .........+...........+.+|+.++.+++||||++
T Consensus       148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~  227 (501)
T PHA03210        148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK  227 (501)
T ss_pred             hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence            569999999999999999998765555544444221111  011111122222223345567889999999999999999


Q ss_pred             cceEEecCCeeEEEEEecCCCCHHHHHhhhhc-CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC
Q 011360          270 LLAHMVRPDCHLLVYEFMKNGSLQDILDDVSR-GRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDD  348 (487)
Q Consensus       270 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~  348 (487)
                      +++++...+..|++++++ +++|.+++..... .........+..++.|++.||.||   |++||+||||||+|||++.+
T Consensus       228 l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yL---H~~gIiHrDLKP~NILl~~~  303 (501)
T PHA03210        228 IEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYI---HDKKLIHRDIKLENIFLNCD  303 (501)
T ss_pred             EeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEECCC
Confidence            999999999999999999 5577777643111 122234566788999999999999   77899999999999999999


Q ss_pred             CCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCC-CccccCCCCccccHH
Q 011360          349 MEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVP-SFVFHQNGEEICSPE  427 (487)
Q Consensus       349 ~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~-pf~~~~~~~~~~~~~  427 (487)
                      +.+||+|||++..+....... .....||+.|+|||++.+..++.++|||||||++|||++|.. ||.......    ..
T Consensus       304 ~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~----~~  378 (501)
T PHA03210        304 GKIVLGDFGTAMPFEKEREAF-DYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKP----GK  378 (501)
T ss_pred             CCEEEEeCCCceecCcccccc-cccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCH----HH
Confidence            999999999998765432211 123569999999999999999999999999999999999865 443221111    01


Q ss_pred             HHHHHHhcCC-CCCccC-------------------CCCCCC-CcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          428 WLRKVMNSKN-PSRAID-------------------PRLPGN-GYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       428 ~~~~~~~~~~-~~~~~~-------------------~~~~~~-~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .+........ ....++                   ..++.. .......++.+++.+||+.||++|||+.++++
T Consensus       379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence            1111111000 000000                   000000 00011235677899999999999999999985

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=6.6e-37  Score=295.37  Aligned_cols=253  Identities=23%  Similarity=0.372  Sum_probs=193.0

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHH-hccCCCCCccccc
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT-ASQIRHRNILPLL  271 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~hpnIv~l~  271 (487)
                      +|.+.+.||.|+||.||++.. ..+|+.||+|++....             . ......+..|... ++.+.||||++++
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~-~~~~~~vaiK~~~~~~-------------~-~~~~~~~~~e~~~~~~~~~~~~iv~~~   66 (283)
T cd06617           2 DLEVIEELGRGAYGVVDKMRH-VPTGTIMAVKRIRATV-------------N-SQEQKRLLMDLDISMRSVDCPYTVTFY   66 (283)
T ss_pred             CceEEEEecccCCeEEEEEEE-cCCCcEEEEEEEecCC-------------C-cHHHHHHHHHHHHHHHHcCCCCeeeee
Confidence            588999999999999999975 4579999999874311             1 1112233445443 5667999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCC-CeeecCCCCCCEEeCCCCC
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSA-SIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~-givH~Dlkp~Nill~~~~~  350 (487)
                      +++..++..|++|||++ |+|.+++.........+++..++.++.|++.||.||   |++ +++||||||+||+++.++.
T Consensus        67 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~~i~h~dlkp~nil~~~~~~  142 (283)
T cd06617          67 GALFREGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYL---HSKLSVIHRDVKPSNVLINRNGQ  142 (283)
T ss_pred             EEEecCCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHH---hhcCCeecCCCCHHHEEECCCCC
Confidence            99999999999999995 689888876444456789999999999999999999   665 8999999999999999999


Q ss_pred             EEEeccCCccccCCCCceeeEeeecccccccCCcccCC----CCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccH
Q 011360          351 ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQ----PELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSP  426 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~----~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~  426 (487)
                      +||+|||++.........   ....++..|+|||.+.+    ..++.++|+||||+++|+|++|..||.....     ..
T Consensus       143 ~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~  214 (283)
T cd06617         143 VKLCDFGISGYLVDSVAK---TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT-----PF  214 (283)
T ss_pred             EEEeeccccccccccccc---ccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc-----CH
Confidence            999999998765432211   22457889999998864    4568899999999999999999999943211     11


Q ss_pred             HHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          427 EWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       427 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      +..........+      .++..   ..+.++.+++.+||..+|++|||+.++++
T Consensus       215 ~~~~~~~~~~~~------~~~~~---~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         215 QQLKQVVEEPSP------QLPAE---KFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             HHHHHHHhcCCC------CCCcc---ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            222222222111      11111   13356889999999999999999999985

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.1e-36  Score=289.41  Aligned_cols=253  Identities=27%  Similarity=0.408  Sum_probs=198.5

Q ss_pred             ccccccccccceeEEEEEecCCC---CceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          195 ASLEKIGSGGCGEVYKAELPGSN---GKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       195 ~~~~~lg~G~~g~v~~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      .+.+.||.|+||.||++......   +..||+|.+...              ........+..|+..+..++||||++++
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~--------------~~~~~~~~~~~e~~~l~~l~~~~i~~~~   67 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKED--------------ADEQQIEEFLREARIMRKLDHPNIVKLL   67 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCC--------------CChHHHHHHHHHHHHHHhcCCCchheEE
Confidence            56788999999999999875322   488999987321              1112456788899999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++...+..+++|||+++++|.+++...  ....+++..+..++.|++.||+||   |+.|++|+||+|+||+++.++.+
T Consensus        68 ~~~~~~~~~~~i~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~l---h~~~~~h~dl~~~nil~~~~~~~  142 (258)
T smart00219       68 GVCTEEEPLMIVMEYMEGGDLLDYLRKN--RPKELSLSDLLSFALQIARGMEYL---ESKNFIHRDLAARNCLVGENLVV  142 (258)
T ss_pred             EEEcCCCeeEEEEeccCCCCHHHHHHhh--hhccCCHHHHHHHHHHHHHHHHHH---hcCCeeecccccceEEEccCCeE
Confidence            9999999999999999999999998752  112289999999999999999999   78899999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccccHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSPEWLR  430 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~  430 (487)
                      +|+|||++........... ....+++.|+|||.+.+..++.++|+||||+++|+|++ |.+||...      .......
T Consensus       143 ~l~dfg~~~~~~~~~~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~------~~~~~~~  215 (258)
T smart00219      143 KISDFGLSRDLYDDDYYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM------SNEEVLE  215 (258)
T ss_pred             EEcccCCceeccccccccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC------CHHHHHH
Confidence            9999999977654422111 12236789999999988889999999999999999998 78888432      2222223


Q ss_pred             HHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHH
Q 011360          431 KVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRL  483 (487)
Q Consensus       431 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L  483 (487)
                      .......+  .    .+.    ..+.++.+++.+||..+|++|||+.++++.|
T Consensus       216 ~~~~~~~~--~----~~~----~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      216 YLKKGYRL--P----KPE----NCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             HHhcCCCC--C----CCC----cCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            22222211  1    111    1345688999999999999999999998864

Phosphotransferases. Tyrosine-specific kinase subfamily.

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=4.7e-37  Score=317.12  Aligned_cols=261  Identities=20%  Similarity=0.247  Sum_probs=184.4

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhcc------CCC
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQ------IRH  264 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~------l~h  264 (487)
                      .++|.+.+.||.|+||+||+|.. ..+++.||||++...                .........|+.++..      ..|
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~-~~~~~~vAvK~i~~~----------------~~~~~~~~~e~~~l~~l~~~~~~~~  190 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWD-RKRKEYCAVKIVRNV----------------PKYTRDAKIEIQFMEKVRQADPADR  190 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEE-cCCCeEEEEEEEecc----------------hhhHHHHHHHHHHHHHHhhcCcccC
Confidence            45799999999999999999975 457889999988421                0111222334444433      356


Q ss_pred             CCccccceEEecC-CeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCC-CCeeecCCCCCC
Q 011360          265 RNILPLLAHMVRP-DCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHS-ASIIHGDIKPRN  342 (487)
Q Consensus       265 pnIv~l~~~~~~~-~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~-~givH~Dlkp~N  342 (487)
                      ++++++++++... ..+|+|||++ |++|.+++..    ...+++..+..++.||+.||.||   |+ .|||||||||+|
T Consensus       191 ~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yL---H~~~gIiHrDlKP~N  262 (467)
T PTZ00284        191 FPLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYF---HTELHLMHTDLKPEN  262 (467)
T ss_pred             cceeeeEEEEEcCCceEEEEEecc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HhcCCeecCCCCHHH
Confidence            6789999888764 5788999998 7889888864    35689999999999999999999   54 589999999999


Q ss_pred             EEeCCCC----------------CEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHH
Q 011360          343 VLLNDDM----------------EACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLIS  406 (487)
Q Consensus       343 ill~~~~----------------~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~e  406 (487)
                      ||++.++                .+||+|||.+......     .....||+.|+|||++.+..|+.++|||||||++||
T Consensus       263 ILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~e  337 (467)
T PTZ00284        263 ILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYE  337 (467)
T ss_pred             EEEecCCcccccccccccCCCCceEEECCCCccccCccc-----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHH
Confidence            9998765                4999999987643222     134579999999999999999999999999999999


Q ss_pred             HHhCCCCccccCCCCccc---------cHHHHH--------HHHhc-CCCCCccCCC----CCC---CCcHHHHHHHHHH
Q 011360          407 LVRGVPSFVFHQNGEEIC---------SPEWLR--------KVMNS-KNPSRAIDPR----LPG---NGYEKKMLHVLKI  461 (487)
Q Consensus       407 lltg~~pf~~~~~~~~~~---------~~~~~~--------~~~~~-~~~~~~~~~~----~~~---~~~~~~~~~l~~l  461 (487)
                      |++|++||..........         ..+|..        .+... .......++.    +..   .........+.++
T Consensus       338 lltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl  417 (467)
T PTZ00284        338 LYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDL  417 (467)
T ss_pred             HHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHH
Confidence            999999996543211000         001100        00000 0000000000    000   0000113457899


Q ss_pred             HhhccCCCCCCCCChHHHHH
Q 011360          462 AYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       462 i~~cl~~~P~~RPs~~~il~  481 (487)
                      |.+||+.||++|||+.++++
T Consensus       418 i~~mL~~dP~~R~ta~e~L~  437 (467)
T PTZ00284        418 IYGLLHYDRQKRLNARQMTT  437 (467)
T ss_pred             HHHhCCcChhhCCCHHHHhc
Confidence            99999999999999999986

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=7e-37  Score=292.29  Aligned_cols=258  Identities=30%  Similarity=0.450  Sum_probs=203.2

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      +|++.+.||.|+||.||+|... .++..+++|++..              .........+.+|+..++.++||||+++++
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~--------------~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~   66 (267)
T cd06610           2 DYELIEVIGVGATAVVYAAICL-PNNEKVAIKRIDL--------------EKCQTSVDELRKEVQAMSQCNHPNVVKYYT   66 (267)
T ss_pred             cceeeeeecCCCCeEEEEEEEc-CCCcEEEEEEecc--------------CCcchHHHHHHHHHHHHHhcCCCCEEEEEE
Confidence            5889999999999999999753 4788999998732              111124567889999999999999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEE
Q 011360          273 HMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC  352 (487)
Q Consensus       273 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~k  352 (487)
                      .+..++..+++||++++++|.+++..... ...+++..+..++.|++.||.||   |+.|++||||+|+||++++++.++
T Consensus        67 ~~~~~~~~~iv~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~l---h~~~i~h~~l~p~ni~~~~~~~~~  142 (267)
T cd06610          67 SFVVGDELWLVMPYLSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYL---HSNGQIHRDIKAGNILLGEDGSVK  142 (267)
T ss_pred             EEeeCCEEEEEEeccCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHhEEEcCCCCEE
Confidence            99999999999999999999999875211 25688999999999999999999   788999999999999999999999


Q ss_pred             EeccCCccccCCCCcee--eEeeecccccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHH
Q 011360          353 ISDLGLAMAIPDGYTRV--LISYVLGTMAYIAPEYFQQP-ELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWL  429 (487)
Q Consensus       353 l~DFg~s~~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~-~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~  429 (487)
                      |+|||++..........  ......|+..|+|||.+... .++.++|+||||+++|+|++|..||......      ...
T Consensus       143 l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~------~~~  216 (267)
T cd06610         143 IADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM------KVL  216 (267)
T ss_pred             EcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh------hhH
Confidence            99999987665433221  12334588999999998876 7899999999999999999999999543221      122


Q ss_pred             HHHHhcCCCCCccCCCCCCC-CcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          430 RKVMNSKNPSRAIDPRLPGN-GYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       430 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ........+      .++.. .....+..+.+++.+||..||++|||+.+|+.
T Consensus       217 ~~~~~~~~~------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         217 MLTLQNDPP------SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             HHHhcCCCC------CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            222222111      11111 11234567889999999999999999999875

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=9.9e-37  Score=295.41  Aligned_cols=246  Identities=23%  Similarity=0.329  Sum_probs=198.9

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      +|.+.+.||.|+||.||++... .+++.+|+|.+...            ..........+.+|+.+++++.||||+++++
T Consensus         2 ~y~~~~~ig~g~~~~vy~~~~~-~~~~~~aiK~~~~~------------~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~   68 (290)
T cd05580           2 DFEFIKTLGTGSFGRVMLVRHK-GSGKYYALKILSKA------------KIVKLKQVEHVLNEKRILQSIRHPFLVNLYG   68 (290)
T ss_pred             ceEEEEEeecCCCeEEEEEEEc-CCCCEEEEEEEEHH------------HhhhhhHHHHHHHHHHHHHhCCCCCccceee
Confidence            5889999999999999999754 57889999987321            1112234567889999999999999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEE
Q 011360          273 HMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC  352 (487)
Q Consensus       273 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~k  352 (487)
                      ++...+..|+||||+++++|.+++..    ...++...+..++.|++.||.||   |+.|++|+||+|+||+++.++.+|
T Consensus        69 ~~~~~~~~~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~l---H~~~i~H~dl~p~nili~~~~~~k  141 (290)
T cd05580          69 SFQDDSNLYLVMEYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYL---HSLDIVYRDLKPENLLLDSDGYIK  141 (290)
T ss_pred             EEEcCCeEEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCEecCCCCHHHEEECCCCCEE
Confidence            99999999999999999999999865    35789999999999999999999   678899999999999999999999


Q ss_pred             EeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHH
Q 011360          353 ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKV  432 (487)
Q Consensus       353 l~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~  432 (487)
                      |+|||++......     .....+++.|+|||.+.+..++.++||||||+++|+|++|..||....      ........
T Consensus       142 l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~  210 (290)
T cd05580         142 ITDFGFAKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN------PIQIYEKI  210 (290)
T ss_pred             EeeCCCccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHH
Confidence            9999998876543     134468999999999988888999999999999999999999994332      11112222


Q ss_pred             HhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCC-----ChHHHH
Q 011360          433 MNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERP-----NSQYVR  480 (487)
Q Consensus       433 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~~il  480 (487)
                      . ...+  .++..+        ...+.+++.+||..+|.+||     ++++++
T Consensus       211 ~-~~~~--~~~~~~--------~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~  252 (290)
T cd05580         211 L-EGKV--RFPSFF--------SPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK  252 (290)
T ss_pred             h-cCCc--cCCccC--------CHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence            2 2111  111111        35688999999999999999     677765

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=7e-37  Score=292.17  Aligned_cols=254  Identities=28%  Similarity=0.452  Sum_probs=202.3

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      +|+..+.||.|++|.||++.. ..+++.+|+|.+...              ........+.+|+.+++.+.||||+++++
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~~~ik~~~~~--------------~~~~~~~~~~~e~~~l~~~~~~~i~~~~~   66 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLH-RPTGKIMAVKTIRLE--------------INEAIQKQILRELDILHKCNSPYIVGFYG   66 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEE-cCCCcEEEEEEEecc--------------cChHHHHHHHHHHHHHHHCCCCchhhhhe
Confidence            578889999999999999975 457889999987431              11234567788999999999999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCC-CCeeecCCCCCCEEeCCCCCE
Q 011360          273 HMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHS-ASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       273 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~-~givH~Dlkp~Nill~~~~~~  351 (487)
                      .+...+..+++|||+++++|.+++...   ...+++..+..++.|++.||.||   |+ .|++|+||+|+||+++.++.+
T Consensus        67 ~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~l---H~~~~i~H~dl~~~ni~~~~~~~~  140 (265)
T cd06605          67 AFYNNGDISICMEYMDGGSLDKILKEV---QGRIPERILGKIAVAVLKGLTYL---HEKHKIIHRDVKPSNILVNSRGQI  140 (265)
T ss_pred             eeecCCEEEEEEEecCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHH---cCCCCeecCCCCHHHEEECCCCCE
Confidence            999999999999999999999998752   26788999999999999999999   77 899999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRK  431 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~  431 (487)
                      +|+|||.+.........    ...++..|+|||.+.+..++.++||||||+++|+|++|..||........ ...+....
T Consensus       141 ~l~d~g~~~~~~~~~~~----~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~  215 (265)
T cd06605         141 KLCDFGVSGQLVNSLAK----TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIFELLQY  215 (265)
T ss_pred             EEeecccchhhHHHHhh----cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-cHHHHHHH
Confidence            99999998765332221    25588899999999988999999999999999999999999954322111 11222333


Q ss_pred             HHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          432 VMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       432 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ......+      .++..   ..+..+.+++.+||..+|++|||+.+++.
T Consensus       216 ~~~~~~~------~~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         216 IVNEPPP------RLPSG---KFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             HhcCCCC------CCChh---hcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence            3222211      11111   14456889999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.4e-36  Score=289.06  Aligned_cols=240  Identities=23%  Similarity=0.344  Sum_probs=186.4

Q ss_pred             cccccccceeEEEEEecCCCC---------ceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcc
Q 011360          198 EKIGSGGCGEVYKAELPGSNG---------KMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNIL  268 (487)
Q Consensus       198 ~~lg~G~~g~v~~~~~~~~~~---------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv  268 (487)
                      +.||.|+||.||+|.+....+         ..+++|.+..                .......+.+|+.+++.++||||+
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~----------------~~~~~~~~~~e~~~l~~l~h~~i~   64 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGS----------------DHRDSLAFFETASLMSQLSHKHLV   64 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeecccc----------------chhhHHHHHHHHHHHHcCCCcchh
Confidence            368999999999998643221         3467776521                111156778899999999999999


Q ss_pred             ccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC
Q 011360          269 PLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDD  348 (487)
Q Consensus       269 ~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~  348 (487)
                      ++++++.. ...++||||+++|+|.+++...   ...+++..+..++.|++.||.||   |++||+||||||+||+++.+
T Consensus        65 ~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~L---H~~~i~H~dlkp~Nill~~~  137 (259)
T cd05037          65 KLYGVCVR-DENIMVEEYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYL---EDKKLVHGNVCGKNILVARY  137 (259)
T ss_pred             heeeEEec-CCcEEEEEcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHH---hhCCeecccCccceEEEecC
Confidence            99999888 7789999999999999998752   23688999999999999999999   78899999999999999988


Q ss_pred             C-------CEEEeccCCccccCCCCceeeEeeecccccccCCcccCCC--CCCchhHHHHHHHHHHHHHh-CCCCccccC
Q 011360          349 M-------EACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQP--ELSEKCDIFSFGMLLISLVR-GVPSFVFHQ  418 (487)
Q Consensus       349 ~-------~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~~DvwslG~~l~ellt-g~~pf~~~~  418 (487)
                      +       .+||+|||++......      ....++..|+|||++.+.  .++.++||||||+++|+|++ |..||....
T Consensus       138 ~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~  211 (259)
T cd05037         138 GLNEGYVPFIKLSDPGIPITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS  211 (259)
T ss_pred             ccccCCceeEEeCCCCcccccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC
Confidence            7       7999999998765431      233467889999999876  78999999999999999999 477774432


Q ss_pred             CCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHh
Q 011360          419 NGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLS  484 (487)
Q Consensus       419 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~  484 (487)
                      .      .++..... ....       .+...    ...+.+++.+||..+|++|||+.+|++.|+
T Consensus       212 ~------~~~~~~~~-~~~~-------~~~~~----~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         212 S------SEKERFYQ-DQHR-------LPMPD----CAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             c------hhHHHHHh-cCCC-------CCCCC----chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            1      11111111 1111       11100    156889999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.4e-36  Score=290.55  Aligned_cols=255  Identities=21%  Similarity=0.338  Sum_probs=194.6

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      +|...+.||.|+||.||+|.. ..++..|++|++.....          ..........+.+|+.+++.++||||+++++
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~-~~~~~~~~~k~~~~~~~----------~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~   71 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYD-VDTGRELAAKQVQFDPE----------SPETSKEVSALECEIQLLKNLQHERIVQYYG   71 (266)
T ss_pred             CccccceecCCCCEEEEEEEE-cCCCcEEEEEEeecCcC----------CchhHHHHHHHHHHHHHHHHcCCCCeeeEEE
Confidence            588899999999999999964 45788999998743110          0111234566888999999999999999999


Q ss_pred             EEec--CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          273 HMVR--PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       273 ~~~~--~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      ++..  ....+++|||+++++|.+++..    ...+++...+.++.|++.||.||   |+.|++||||+|+||+++.++.
T Consensus        72 ~~~~~~~~~~~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~L---H~~~i~H~~l~p~nil~~~~~~  144 (266)
T cd06651          72 CLRDRAEKTLTIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYL---HSNMIVHRDIKGANILRDSAGN  144 (266)
T ss_pred             EEEcCCCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HhCCeeeCCCCHHHEEECCCCC
Confidence            8875  3567899999999999999864    34588899999999999999999   7788999999999999999999


Q ss_pred             EEEeccCCccccCCCCc-eeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHH
Q 011360          351 ACISDLGLAMAIPDGYT-RVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWL  429 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~  429 (487)
                      ++|+|||++........ ........++..|+|||.+.+..++.++|||||||++|+|++|..||....      .....
T Consensus       145 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~------~~~~~  218 (266)
T cd06651         145 VKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYE------AMAAI  218 (266)
T ss_pred             EEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccc------hHHHH
Confidence            99999999876532111 111123457889999999998889999999999999999999999994321      11222


Q ss_pred             HHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          430 RKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       430 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ........     .+.++.    .....+..++ +||..+|++|||+++|+.
T Consensus       219 ~~~~~~~~-----~~~~~~----~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         219 FKIATQPT-----NPQLPS----HISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             HHHhcCCC-----CCCCch----hcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            22211111     112221    1224466666 688899999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-38  Score=298.52  Aligned_cols=253  Identities=27%  Similarity=0.355  Sum_probs=203.2

Q ss_pred             hccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccc
Q 011360          190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILP  269 (487)
Q Consensus       190 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~  269 (487)
                      ..+.|...++||+||||.|+-++.+ .+|+.||.|++.            +..........-.++|-.++.+++.|.||.
T Consensus       183 t~n~F~~~RvlGkGGFGEV~acqvr-aTGKMYAcKkL~------------KKRiKkr~ge~maLnEk~iL~kV~s~FiVs  249 (591)
T KOG0986|consen  183 TKNTFRVYRVLGKGGFGEVCACQVR-ATGKMYACKKLD------------KKRIKKRKGETMALNEKQILEKVSSPFIVS  249 (591)
T ss_pred             cccceeeeEEEecccccceeEEEEe-cchhhHHHHHHH------------HHHHHHhhhhHHhhHHHHHHHHhccCcEEE
Confidence            3456888999999999999998764 699999999762            122223334455678999999999999999


Q ss_pred             cceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC
Q 011360          270 LLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDM  349 (487)
Q Consensus       270 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~  349 (487)
                      +-..|.+.+.+++||..|+||+|..+|..  .++..+++..+..++.+|+.||.+|   |+.+||+|||||+|||+|+.|
T Consensus       250 laYAfeTkd~LClVLtlMNGGDLkfHiyn--~g~~gF~e~ra~FYAAEi~cGLehl---H~~~iVYRDLKPeNILLDd~G  324 (591)
T KOG0986|consen  250 LAYAFETKDALCLVLTLMNGGDLKFHIYN--HGNPGFDEQRARFYAAEIICGLEHL---HRRRIVYRDLKPENILLDDHG  324 (591)
T ss_pred             EeeeecCCCceEEEEEeecCCceeEEeec--cCCCCCchHHHHHHHHHHHhhHHHH---HhcceeeccCChhheeeccCC
Confidence            99999999999999999999999998876  4457899999999999999999999   888999999999999999999


Q ss_pred             CEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHH
Q 011360          350 EACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWL  429 (487)
Q Consensus       350 ~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~  429 (487)
                      +++|+|+|+|..++.+...   ...+||.+|||||++.+..|+...|+|||||++|||+.|..||......   ...+.+
T Consensus       325 hvRISDLGLAvei~~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK---vk~eEv  398 (591)
T KOG0986|consen  325 HVRISDLGLAVEIPEGKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK---VKREEV  398 (591)
T ss_pred             CeEeeccceEEecCCCCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh---hhHHHH
Confidence            9999999999998776543   3447999999999999999999999999999999999999999543221   111122


Q ss_pred             HHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCh
Q 011360          430 RKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNS  476 (487)
Q Consensus       430 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~  476 (487)
                      .+.+....          .......+.++.++....|.+||++|...
T Consensus       399 drr~~~~~----------~ey~~kFS~eakslc~~LL~Kdp~~RLGc  435 (591)
T KOG0986|consen  399 DRRTLEDP----------EEYSDKFSEEAKSLCEGLLTKDPEKRLGC  435 (591)
T ss_pred             HHHHhcch----------hhcccccCHHHHHHHHHHHccCHHHhccC
Confidence            22221111          11222334567777778999999999643

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=5.1e-37  Score=296.51  Aligned_cols=264  Identities=21%  Similarity=0.332  Sum_probs=197.2

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|++.+.||.|++|.||+|+. ..+++.||+|++...             .......+.+.+|+.++++++||||++++
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~-~~~~~~~~iK~~~~~-------------~~~~~~~~~~~~e~~~l~~~~h~~i~~~~   66 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRN-RETGQIVAIKKFVES-------------EDDPVIKKIALREIRMLKQLKHPNLVNLI   66 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEE-CCCCcEEEEEEEeec-------------ccCccccHHHHHHHHHHHhCCCCCEeeee
Confidence            3588999999999999999975 457899999987431             11112234567899999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++......++||||+++++|..++..    ...+++..+..++.|++.||.||   |+.|++||||+|+||+++.++.+
T Consensus        67 ~~~~~~~~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~ql~~~l~~L---H~~~i~H~dl~p~nil~~~~~~~  139 (286)
T cd07847          67 EVFRRKRKLHLVFEYCDHTVLNELEKN----PRGVPEHLIKKIIWQTLQAVNFC---HKHNCIHRDVKPENILITKQGQI  139 (286)
T ss_pred             eEEeeCCEEEEEEeccCccHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHH---HHCCceecCCChhhEEEcCCCcE
Confidence            999999999999999999888777643    44689999999999999999999   67889999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQ-PELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLR  430 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~  430 (487)
                      +|+|||++.........  .....++..|+|||.+.+ ..++.++||||||+++|+|++|.+||........   .....
T Consensus       140 ~l~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~---~~~~~  214 (286)
T cd07847         140 KLCDFGFARILTGPGDD--YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ---LYLIR  214 (286)
T ss_pred             EECccccceecCCCccc--ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH---HHHHH
Confidence            99999999876543321  123457889999999876 4678999999999999999999999954332110   00001


Q ss_pred             HHH-----------hcCCCCCcc-CCCCCCC-----CcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          431 KVM-----------NSKNPSRAI-DPRLPGN-----GYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       431 ~~~-----------~~~~~~~~~-~~~~~~~-----~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ...           ......... .+.....     .....+..+.+++.+||+.+|++|||+.+++.
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         215 KTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             HHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            000           000000000 0000000     01123466889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.3e-36  Score=290.53  Aligned_cols=255  Identities=21%  Similarity=0.296  Sum_probs=196.0

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      +|.+.+.||.|+||.||.|.. ..++..||+|.+.....          ..........+.+|+.+++.+.||||+++++
T Consensus         3 ~~~~~~~l~~g~~g~v~~~~~-~~~~~~v~ik~~~~~~~----------~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~   71 (265)
T cd06652           3 NWRLGKLLGQGAFGRVYLCYD-ADTGRELAVKQVQFDPE----------SPETSKEVNALECEIQLLKNLLHERIVQYYG   71 (265)
T ss_pred             cceEeeEEecCCceEEEEEEE-cCCCcEEEEEEeecCcC----------CcccHHHHHHHHHHHHHHHhcCCCCeeeEEe
Confidence            588899999999999999974 46789999998743110          0111234567888999999999999999999


Q ss_pred             EEecC--CeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          273 HMVRP--DCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       273 ~~~~~--~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      ++.+.  ..++++|||+++++|.+++..    ...+++..+..++.|++.||.||   |+.|++|+||+|+||+++.++.
T Consensus        72 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~l---H~~~i~H~dl~p~nil~~~~~~  144 (265)
T cd06652          72 CLRDPMERTLSIFMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYL---HSNMIVHRDIKGANILRDSVGN  144 (265)
T ss_pred             EeccCCCceEEEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHEEecCCCC
Confidence            88763  567899999999999999864    34578888999999999999999   7778999999999999999999


Q ss_pred             EEEeccCCccccCCCCce-eeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHH
Q 011360          351 ACISDLGLAMAIPDGYTR-VLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWL  429 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~  429 (487)
                      ++|+|||++......... .......++..|+|||++.+..++.++||||||+++|+|++|..||.....      ....
T Consensus       145 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------~~~~  218 (265)
T cd06652         145 VKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA------MAAI  218 (265)
T ss_pred             EEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch------HHHH
Confidence            999999998765322111 111234588899999999888899999999999999999999999943211      1112


Q ss_pred             HHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          430 RKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       430 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ....... .    .+..    .......+.+++.+||. +|++|||+++|++
T Consensus       219 ~~~~~~~-~----~~~~----~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         219 FKIATQP-T----NPVL----PPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             HHHhcCC-C----CCCC----chhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence            2221111 1    1111    22344568889999995 9999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=5.3e-37  Score=296.93  Aligned_cols=257  Identities=20%  Similarity=0.333  Sum_probs=195.8

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCC-CCCccccc
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIR-HRNILPLL  271 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~  271 (487)
                      +|...+.||.|+||.||++.. ..++..+|+|.+..              .........+..|+.++.++. ||||++++
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~-~~~~~~~aiK~~~~--------------~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~   69 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLH-KPSGTIMAVKRIRS--------------TVDEKEQKRLLMDLDVVMRSSDCPYIVKFY   69 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEE-CCCCCEEEEEEehh--------------ccChHHHHHHHHHHHHHHHhcCCCCEeeee
Confidence            467778999999999999975 46789999998732              111134556788999998885 99999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhh-cCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVS-RGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      +++..+...+++|||+. ++|.++..... .....+++..+..++.|++.||+|||  +..|++||||||+||+++.++.
T Consensus        70 ~~~~~~~~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh--~~~~i~H~dlkp~Nil~~~~~~  146 (288)
T cd06616          70 GALFREGDCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLK--EELKIIHRDVKPSNILLDRNGN  146 (288)
T ss_pred             eEEecCCcEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh--hcCCeeccCCCHHHEEEccCCc
Confidence            99999999999999985 57766543221 23467899999999999999999996  3458999999999999999999


Q ss_pred             EEEeccCCccccCCCCceeeEeeecccccccCCcccCCC---CCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHH
Q 011360          351 ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQP---ELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPE  427 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~---~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~  427 (487)
                      ++|+|||++.........   ....|++.|+|||++.+.   .++.++||||||+++|+|++|..||....     ...+
T Consensus       147 ~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~  218 (288)
T cd06616         147 IKLCDFGISGQLVDSIAK---TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFD  218 (288)
T ss_pred             EEEeecchhHHhccCCcc---ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHH
Confidence            999999998765433221   233578999999998876   68999999999999999999999994332     1111


Q ss_pred             HHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          428 WLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ..........+      .++.......+..+.+++.+||+.+|++|||+.+|+.
T Consensus       219 ~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~  266 (288)
T cd06616         219 QLTQVVKGDPP------ILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE  266 (288)
T ss_pred             HHhhhcCCCCC------cCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            22222211111      1222222234567899999999999999999999876

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.7e-36  Score=290.25  Aligned_cols=251  Identities=25%  Similarity=0.339  Sum_probs=192.1

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      .+.....||+|+||.||+|.. ..++..|++|.+..               ........+.+|+.+++.++||||+++++
T Consensus         9 ~~~~~~~lg~g~~g~v~~~~~-~~~~~~v~~k~~~~---------------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~   72 (268)
T cd06624           9 ENGERVVLGKGTYGIVYAARD-LSTQVRIAIKEIPE---------------RDSRYVQPLHEEIALHSYLKHRNIVQYLG   72 (268)
T ss_pred             cCCceEEEecCCceEEEEeEe-cCCCcEEEEEEecC---------------CCHHHHHHHHHHHHHHHhcCCCCeeeeee
Confidence            344456899999999999975 35788999998732               11223457788999999999999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCC--ChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC-CC
Q 011360          273 HMVRPDCHLLVYEFMKNGSLQDILDDVSRGRREL--DWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLND-DM  349 (487)
Q Consensus       273 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l--~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~-~~  349 (487)
                      ++..++..+++|||+++++|.+++...   ...+  +...+..++.|++.||.||   |+.||+||||||+||+++. ++
T Consensus        73 ~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~qi~~al~~l---H~~~i~h~dl~p~nil~~~~~~  146 (268)
T cd06624          73 SDSENGFFKIFMEQVPGGSLSALLRSK---WGPLKDNEQTIIFYTKQILEGLKYL---HDNQIVHRDIKGDNVLVNTYSG  146 (268)
T ss_pred             eeccCCEEEEEEecCCCCCHHHHHHHh---cccCCCcHHHHHHHHHHHHHHHHHH---HHCCEeecCCCHHHEEEcCCCC
Confidence            999999999999999999999998742   2334  7788889999999999999   7789999999999999976 67


Q ss_pred             CEEEeccCCccccCCCCceeeEeeecccccccCCcccCCC--CCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHH
Q 011360          350 EACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQP--ELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPE  427 (487)
Q Consensus       350 ~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~  427 (487)
                      .++|+|||++.........  .....+++.|+|||.+...  .++.++|+||||+++|+|++|..||........    .
T Consensus       147 ~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~----~  220 (268)
T cd06624         147 VVKISDFGTSKRLAGINPC--TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA----A  220 (268)
T ss_pred             eEEEecchhheecccCCCc--cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh----h
Confidence            8999999998765432211  1234578999999998654  378999999999999999999999954321110    0


Q ss_pred             HHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          428 WLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .........      .+.++.    .....+.+++.+||+.+|++|||+.+++.
T Consensus       221 ~~~~~~~~~------~~~~~~----~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         221 MFKVGMFKI------HPEIPE----SLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             Hhhhhhhcc------CCCCCc----ccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence            111000010      111221    22356889999999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=9.4e-37  Score=289.90  Aligned_cols=252  Identities=24%  Similarity=0.351  Sum_probs=198.9

Q ss_pred             cccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceE
Q 011360          194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAH  273 (487)
Q Consensus       194 ~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  273 (487)
                      |...+.||.|++|.||+|.. ..++..|++|.+......          .......+.+.+|+.+++.++||||++++++
T Consensus         2 ~~~~~~ig~g~~~~vy~~~~-~~~~~~~~ik~~~~~~~~----------~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~   70 (258)
T cd06632           2 WRKGELLGSGSFGSVYEGLN-LDDGDFFAVKEVSLADDG----------QTGQEAVKQLEQEIALLSKLQHPNIVQYLGT   70 (258)
T ss_pred             ccccceeeecCCceEEEEEE-cCCCcEEEEEEEEEcccc----------ccchHHHHHHHHHHHHHHhcCCCCchheeee
Confidence            66778999999999999975 357889999987442110          1122345678889999999999999999999


Q ss_pred             EecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEE
Q 011360          274 MVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACI  353 (487)
Q Consensus       274 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl  353 (487)
                      +......+++|||+++++|.+++..    ...+++..+..++.|++.||.||   |+.|++|+||+|+||+++.++.+||
T Consensus        71 ~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~~~ni~~~~~~~~kl  143 (258)
T cd06632          71 EREEDNLYIFLELVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYL---HDRNTVHRDIKGANILVDTNGVVKL  143 (258)
T ss_pred             EecCCeEEEEEEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCCEEE
Confidence            9999999999999999999999864    34688999999999999999999   6778999999999999999999999


Q ss_pred             eccCCccccCCCCceeeEeeecccccccCCcccCCCC-CCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHH
Q 011360          354 SDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPE-LSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKV  432 (487)
Q Consensus       354 ~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~  432 (487)
                      +|||++.......   ......+++.|+|||.+.... ++.++|+||||+++|+|++|..||....      ........
T Consensus       144 ~d~~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~------~~~~~~~~  214 (258)
T cd06632         144 ADFGMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE------GVAAVFKI  214 (258)
T ss_pred             ccCccceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc------HHHHHHHH
Confidence            9999987654432   113456889999999988766 8999999999999999999999994332      11222222


Q ss_pred             HhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          433 MNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       433 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .... ....+++.        ....+.+++.+||+.+|++|||+.+++.
T Consensus       215 ~~~~-~~~~~~~~--------~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         215 GRSK-ELPPIPDH--------LSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             Hhcc-cCCCcCCC--------cCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence            1111 11111111        2356889999999999999999999875

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=7e-37  Score=296.92  Aligned_cols=250  Identities=28%  Similarity=0.422  Sum_probs=198.4

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||.|+||.||++. +..++..||+|.+..               ........+.+|+.+++.++||||++++
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~-~~~~~~~v~iK~~~~---------------~~~~~~~~~~~e~~~l~~l~hp~i~~~~   82 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAI-DVATGQEVAIKQMNL---------------QQQPKKELIINEILVMRENKHPNIVNYL   82 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEE-EcCCCCEEEEEEecc---------------ccchHHHHHHHHHHHHhhcCCCCeeehh
Confidence            468999999999999999996 445788999998732               1122345678899999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +.+...+..|+|+||+++++|.+++..     ..+++..+..++.|++.||.||   |++|++|+||+|+||+++.++.+
T Consensus        83 ~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~L---H~~gi~H~dL~p~Nili~~~~~~  154 (293)
T cd06647          83 DSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFL---HSNQVIHRDIKSDNILLGMDGSV  154 (293)
T ss_pred             heeeeCCcEEEEEecCCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHH---HhCCEeeccCCHHHEEEcCCCCE
Confidence            999999999999999999999999863     3578889999999999999999   78899999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRK  431 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~  431 (487)
                      +|+|||++.........  .....+++.|+|||.+.+..++.++|+||||+++|++++|..||.........      ..
T Consensus       155 kL~dfg~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~------~~  226 (293)
T cd06647         155 KLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL------YL  226 (293)
T ss_pred             EEccCcceecccccccc--cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe------ee
Confidence            99999988765433221  12345888999999998888999999999999999999999999543321111      11


Q ss_pred             HHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          432 VMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       432 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ......+.      .+  ........+.+++.+||..+|++||++.+++.
T Consensus       227 ~~~~~~~~------~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  268 (293)
T cd06647         227 IATNGTPE------LQ--NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  268 (293)
T ss_pred             hhcCCCCC------CC--CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            11111111      10  11123346889999999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=5.7e-37  Score=291.78  Aligned_cols=251  Identities=22%  Similarity=0.313  Sum_probs=202.3

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      +|.+.+.||.|+||.||++.. ..++..||+|.+...            ........+.+.+|+.++++++||||+++++
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~-~~~~~~~~ik~~~~~------------~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~   67 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQK-RDTKKMFAMKYMNKQ------------KCVEKGSVRNVLNERRILQELNHPFLVNLWY   67 (258)
T ss_pred             CceEEEEeccCCCceEEEEEE-ccCCcEEEEEEEehh------------hhcchhHHHHHHHHHHHHHhCCCCChHHHHH
Confidence            378889999999999999975 457889999988421            1112235677889999999999999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEE
Q 011360          273 HMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC  352 (487)
Q Consensus       273 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~k  352 (487)
                      .+..+...++||||+.|++|.+++..    ...+++..+..++.|+++||.||   |++|++|+||+|+||+++.++.++
T Consensus        68 ~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~l---h~~~i~h~dl~~~nil~~~~~~~~  140 (258)
T cd05578          68 SFQDEENMYLVVDLLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYL---HSKGIIHRDIKPDNILLDEQGHVH  140 (258)
T ss_pred             hhcCCCeEEEEEeCCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHeEEcCCCCEE
Confidence            99999999999999999999999875    35788999999999999999999   677899999999999999999999


Q ss_pred             EeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHH
Q 011360          353 ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKV  432 (487)
Q Consensus       353 l~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~  432 (487)
                      |+|||++........   .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||......    ........
T Consensus       141 l~d~~~~~~~~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~  213 (258)
T cd05578         141 ITDFNIATKVTPDTL---TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT----IRDQIRAK  213 (258)
T ss_pred             EeecccccccCCCcc---ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc----HHHHHHHH
Confidence            999999877654321   13355888999999999888999999999999999999999999544321    12233222


Q ss_pred             HhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCh--HHHH
Q 011360          433 MNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNS--QYVR  480 (487)
Q Consensus       433 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~--~~il  480 (487)
                      ...  .....++.+        +..+.+++.+||..+|.+||++  ++++
T Consensus       214 ~~~--~~~~~~~~~--------~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         214 QET--ADVLYPATW--------STEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             hcc--ccccCcccC--------cHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            221  111222222        3668899999999999999999  6665

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2.5e-37  Score=298.47  Aligned_cols=261  Identities=23%  Similarity=0.309  Sum_probs=193.3

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      +|.+.+.||.|+||.||+|.. ..+|..||+|.+....             ........+.+|+.+++.++||||+++++
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~-~~~g~~~~~k~~~~~~-------------~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   66 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKN-RETHEIVALKRVRLDD-------------DDEGVPSSALREICLLKELKHKNIVRLYD   66 (284)
T ss_pred             CceeEEEecccCCeEEEEEEE-CCCCcEEEEEEeeccc-------------ccccCccchhHHHHHHHhcCCCCeeeHHH
Confidence            377889999999999999975 4578899999884311             11112345667999999999999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEE
Q 011360          273 HMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC  352 (487)
Q Consensus       273 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~k  352 (487)
                      ++.+....++++||+. ++|.+++..   ....+++..++.++.|++.||.||   |++|++||||||+||+++.++.++
T Consensus        67 ~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~L---H~~~i~H~dl~~~nil~~~~~~~~  139 (284)
T cd07839          67 VLHSDKKLTLVFEYCD-QDLKKYFDS---CNGDIDPEIVKSFMFQLLKGLAFC---HSHNVLHRDLKPQNLLINKNGELK  139 (284)
T ss_pred             HhccCCceEEEEecCC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHH---HHCCEecCCCCHHHEEEcCCCcEE
Confidence            9999999999999996 578887753   245689999999999999999999   677899999999999999999999


Q ss_pred             EeccCCccccCCCCceeeEeeecccccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHH
Q 011360          353 ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQP-ELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRK  431 (487)
Q Consensus       353 l~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~  431 (487)
                      |+|||++.........  .....+++.|+|||++.+. .++.++||||||+++|+|+||..||......     .+....
T Consensus       140 l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~-----~~~~~~  212 (284)
T cd07839         140 LADFGLARAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-----DDQLKR  212 (284)
T ss_pred             ECccchhhccCCCCCC--cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH-----HHHHHH
Confidence            9999998765433211  1234578899999988764 5789999999999999999998776332211     111111


Q ss_pred             HHhc-------------CCCCCccCCCCCCC-----CcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          432 VMNS-------------KNPSRAIDPRLPGN-----GYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       432 ~~~~-------------~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ....             ..+....-+..+..     .....+.++.+++.+||+.||.+|||+++++.
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         213 IFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             HHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            1100             00000000001100     11123457889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=4.7e-37  Score=296.86  Aligned_cols=260  Identities=26%  Similarity=0.393  Sum_probs=196.0

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      .|.+.+.||.|+||.||+|.+. .+++.||+|.+..             ..........+.+|+.+++.++||||+++++
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~-~~~~~~~iK~~~~-------------~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~   67 (286)
T cd07846           2 KYENLGLVGEGSYGMVMKCKHK-ETGQIVAIKKFLE-------------SEDDKMVKKIAMREIRMLKQLRHENLVNLIE   67 (286)
T ss_pred             ceeEeeeeccCCCeEEEEEEEC-CCCCEEEEEeHhh-------------ccCcchhhHHHHHHHHHHHhcCCcchhhHHH
Confidence            5889999999999999999754 5688999998632             1111223456778999999999999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEE
Q 011360          273 HMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC  352 (487)
Q Consensus       273 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~k  352 (487)
                      ++..++..|+||||+++++|..+...    ...+++..+..++.|++.||.||   |+.|++|+||+|+||++++++.++
T Consensus        68 ~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~L---H~~~i~h~~l~p~ni~~~~~~~~~  140 (286)
T cd07846          68 VFRRKKRLYLVFEFVDHTVLDDLEKY----PNGLDESRVRKYLFQILRGIEFC---HSHNIIHRDIKPENILVSQSGVVK  140 (286)
T ss_pred             hcccCCeEEEEEecCCccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHH---HHCCccccCCCHHHEEECCCCcEE
Confidence            99999999999999999888876643    34589999999999999999999   677899999999999999999999


Q ss_pred             EeccCCccccCCCCceeeEeeecccccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHH
Q 011360          353 ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQ-PELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRK  431 (487)
Q Consensus       353 l~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~  431 (487)
                      |+|||++.........  .....++..|+|||.+.+ ..++.++||||||+++|+|++|.+||......      +....
T Consensus       141 l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~------~~~~~  212 (286)
T cd07846         141 LCDFGFARTLAAPGEV--YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI------DQLYH  212 (286)
T ss_pred             EEeeeeeeeccCCccc--cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchH------HHHHH
Confidence            9999998765443221  123457889999998875 45788999999999999999999998533210      11111


Q ss_pred             HHh--------------cCCC-CCccCCCCCC-----CCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          432 VMN--------------SKNP-SRAIDPRLPG-----NGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       432 ~~~--------------~~~~-~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ...              .... .....+....     ......+..+.+++.+||+.+|++|||+.+|++
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         213 IIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             HHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            100              0000 0000000000     001123467899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-36  Score=297.08  Aligned_cols=256  Identities=22%  Similarity=0.345  Sum_probs=200.9

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      +|...+.||.|++|.||+|... .+++.||+|.+....            .........+..|+.++..+.||||+++++
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~-~~~~~~aiK~~~~~~------------~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~   68 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLK-GTGKLFALKVLDKKE------------MIKRNKVKRVLTEQEILATLDHPFLPTLYA   68 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEc-CCCcEEEEEEEeccc------------cchHHHHHHHHHHHHHHHhCCCCCchhhee
Confidence            5888999999999999999754 478999999884311            111234567888999999999999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEE
Q 011360          273 HMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC  352 (487)
Q Consensus       273 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~k  352 (487)
                      .+......|+||||+.+++|.+++..  ..+..+++..+..++.|++.||+||   |+.|++|+||||+||+++.++.++
T Consensus        69 ~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~l~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nili~~~~~~~  143 (316)
T cd05574          69 SFQTETYLCLVMDYCPGGELFRLLQR--QPGKCLSEEVARFYAAEVLLALEYL---HLLGIVYRDLKPENILLHESGHIM  143 (316)
T ss_pred             eeecCCEEEEEEEecCCCCHHHHHHh--CCCCccCHHHHHHHHHHHHHHHHHH---HHCCeeccCCChHHeEEcCCCCEE
Confidence            99999999999999999999999874  3346789999999999999999999   778899999999999999999999


Q ss_pred             EeccCCccccCCCCce---------------------------eeEeeecccccccCCcccCCCCCCchhHHHHHHHHHH
Q 011360          353 ISDLGLAMAIPDGYTR---------------------------VLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLI  405 (487)
Q Consensus       353 l~DFg~s~~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~  405 (487)
                      |+|||++.........                           .......|+..|+|||++.+..++.++||||||+++|
T Consensus       144 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~  223 (316)
T cd05574         144 LSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLY  223 (316)
T ss_pred             EeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHH
Confidence            9999998754322110                           0011235788999999999888999999999999999


Q ss_pred             HHHhCCCCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCC----hHHHHH
Q 011360          406 SLVRGVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPN----SQYVRC  481 (487)
Q Consensus       406 elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs----~~~il~  481 (487)
                      +|++|..||......      ......... .+.      ++..  ...+..+.+++.+||+.+|++|||    +++++.
T Consensus       224 ~l~~g~~pf~~~~~~------~~~~~~~~~-~~~------~~~~--~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         224 EMLYGTTPFKGSNRD------ETFSNILKK-EVT------FPGS--PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             HHhhCCCCCCCCchH------HHHHHHhcC-Ccc------CCCc--cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            999999999543321      112222211 111      1111  113467999999999999999999    777665

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-37  Score=280.58  Aligned_cols=252  Identities=22%  Similarity=0.348  Sum_probs=201.5

Q ss_pred             cccccc-cccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CCCCccc
Q 011360          192 DCFASL-EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RHRNILP  269 (487)
Q Consensus       192 ~~~~~~-~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~  269 (487)
                      ++|.+. ++||-|-.|+|-.+. ++.+++.+|+|++.                    .....++|+++--.. .|||||.
T Consensus        61 edY~is~qvLG~GinGkV~~C~-~k~T~ekfALKvL~--------------------Ds~KARrEVeLHw~~s~h~~iV~  119 (400)
T KOG0604|consen   61 EDYSISWQVLGAGINGKVVQCV-HKRTQEKFALKVLL--------------------DSPKARREVELHWMASGHPHIVS  119 (400)
T ss_pred             hhheehhhhhccccCCceEEEE-eccchhhhHHHHHh--------------------cCHHHHhHhhhhhhhcCCCceEE
Confidence            345544 679999999999885 56799999999762                    122345666654333 8999999


Q ss_pred             cceEEec----CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEe
Q 011360          270 LLAHMVR----PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLL  345 (487)
Q Consensus       270 l~~~~~~----~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill  345 (487)
                      +++++.+    ..++.+|||+++||.|.+.++.  ++...+++..+..|+.||..|+.||   |+.+|.||||||+|+|.
T Consensus       120 IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~--~g~~afTErea~eI~~qI~~Av~~l---H~~nIAHRDlKpENLLy  194 (400)
T KOG0604|consen  120 IIDVYENSYQGRKCLLIVMECMEGGELFSRIQD--RGDQAFTEREASEIMKQIGLAVRYL---HSMNIAHRDLKPENLLY  194 (400)
T ss_pred             eehhhhhhccCceeeEeeeecccchHHHHHHHH--cccccchHHHHHHHHHHHHHHHHHH---HhcchhhccCChhheee
Confidence            9998764    4678899999999999999987  5677899999999999999999999   78889999999999999


Q ss_pred             CC---CCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCc
Q 011360          346 ND---DMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEE  422 (487)
Q Consensus       346 ~~---~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~  422 (487)
                      +.   |..+||+|||+++.......   ..+.+.||.|.|||++....|+..+|+||+|+++|-|++|.+||-...  .-
T Consensus       195 t~t~~na~lKLtDfGFAK~t~~~~~---L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~h--g~  269 (400)
T KOG0604|consen  195 TTTSPNAPLKLTDFGFAKETQEPGD---LMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH--GL  269 (400)
T ss_pred             ecCCCCcceEecccccccccCCCcc---ccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccC--Cc
Confidence            74   55699999999987654322   245678999999999999999999999999999999999999993322  22


Q ss_pred             cccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          423 ICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       423 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ...+....++..+.       ..+|.......++...++|+.+|..+|.+|.|++++++
T Consensus       270 aispgMk~rI~~gq-------y~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  270 AISPGMKRRIRTGQ-------YEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             cCChhHHhHhhccC-------ccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence            22333333333322       22666777888999999999999999999999999864

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.9e-36  Score=292.68  Aligned_cols=249  Identities=24%  Similarity=0.422  Sum_probs=197.0

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      .|...+.||.|++|.||++.. ..++..+++|++..               ........+.+|+.+++.++||||+++++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~-~~~~~~~~iK~~~~---------------~~~~~~~~~~~e~~~l~~~~h~~vv~~~~   83 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATD-KSTGRQVAVKKMDL---------------RKQQRRELLFNEVVIMRDYQHPNIVEMYS   83 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEE-CCCCCEEEEEEEec---------------cchhHHHHHHHHHHHHHHcCCCChheEEE
Confidence            356668999999999999974 45788999998732               11123445788999999999999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEE
Q 011360          273 HMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC  352 (487)
Q Consensus       273 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~k  352 (487)
                      ++...+..++++||+++++|.+++..     ..+++..+..++.|++.||+||   |++|++||||+|+||+++.++.++
T Consensus        84 ~~~~~~~~~~v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~~  155 (285)
T cd06648          84 SYLVGDELWVVMEFLEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFL---HAQGVIHRDIKSDSILLTSDGRVK  155 (285)
T ss_pred             EEEcCCeEEEEEeccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCChhhEEEcCCCcEE
Confidence            99999999999999999999998864     4588899999999999999999   778899999999999999999999


Q ss_pred             EeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHH
Q 011360          353 ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKV  432 (487)
Q Consensus       353 l~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~  432 (487)
                      |+|||.+.........  .....|++.|+|||.+.+..++.++||||||+++|+|++|..||....      ..+.....
T Consensus       156 l~d~g~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~------~~~~~~~~  227 (285)
T cd06648         156 LSDFGFCAQVSKEVPR--RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP------PLQAMKRI  227 (285)
T ss_pred             EcccccchhhccCCcc--cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC------HHHHHHHH
Confidence            9999988655432211  123458899999999988889999999999999999999999984322      12222222


Q ss_pred             HhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          433 MNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       433 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ... .+.....       ....+..+.+++.+||+.+|++|||+.++++
T Consensus       228 ~~~-~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         228 RDN-LPPKLKN-------LHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             Hhc-CCCCCcc-------cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            222 1111100       0112356899999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=4.1e-36  Score=286.49  Aligned_cols=253  Identities=26%  Similarity=0.412  Sum_probs=203.7

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      +|.+.+.||.|++|.||+|... .+++.|++|++....              .......+..|+..+..++||||+++++
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~-~~~~~~~vk~~~~~~--------------~~~~~~~~~~e~~~l~~l~~~~i~~~~~   66 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHK-PTGKIYALKKIHVDG--------------DEEFRKQLLRELKTLRSCESPYVVKCYG   66 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEc-CCCcEEEEEEeccCc--------------chHHHHHHHHHHHHHHhcCCCCeeeEEE
Confidence            5888999999999999999764 478999999874311              1134567889999999999999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCC-CCeeecCCCCCCEEeCCCCCE
Q 011360          273 HMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHS-ASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       273 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~-~givH~Dlkp~Nill~~~~~~  351 (487)
                      ++...+..++||||+++++|.+++..    ...+++..+..++.|++.||.||   |+ .|++||||+|+||+++.++.+
T Consensus        67 ~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~l---h~~~~~~H~~l~~~ni~~~~~~~~  139 (264)
T cd06623          67 AFYKEGEISIVLEYMDGGSLADLLKK----VGKIPEPVLAYIARQILKGLDYL---HTKRHIIHRDIKPSNLLINSKGEV  139 (264)
T ss_pred             EEccCCeEEEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---hccCCCccCCCCHHHEEECCCCCE
Confidence            99999999999999999999999975    36789999999999999999999   77 899999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRK  431 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~  431 (487)
                      +|+|||.+..........  ....++..|+|||.+.+..++.++|+||||+++|+|+||..||......   ...+....
T Consensus       140 ~l~df~~~~~~~~~~~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~---~~~~~~~~  214 (264)
T cd06623         140 KIADFGISKVLENTLDQC--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP---SFFELMQA  214 (264)
T ss_pred             EEccCccceecccCCCcc--cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc---CHHHHHHH
Confidence            999999988764433221  2345788999999999889999999999999999999999999554321   11122222


Q ss_pred             HHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          432 VMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       432 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ......  ..++..       ..+..+.+++.+||..+|++|||+.++++
T Consensus       215 ~~~~~~--~~~~~~-------~~~~~l~~li~~~l~~~p~~R~~~~~ll~  255 (264)
T cd06623         215 ICDGPP--PSLPAE-------EFSPEFRDFISACLQKDPKKRPSAAELLQ  255 (264)
T ss_pred             HhcCCC--CCCCcc-------cCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence            221111  111111       13356899999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2.9e-36  Score=290.16  Aligned_cols=249  Identities=28%  Similarity=0.428  Sum_probs=198.6

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      +.|...+.||.|+||.||+|.. ..++..||+|.+..              .........+.+|+.++..++||||++++
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~-~~~~~~~aiK~~~~--------------~~~~~~~~~~~~e~~~l~~l~h~~iv~~~   68 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGID-NRTQKVVAIKIIDL--------------EEAEDEIEDIQQEITVLSQCDSPYVTKYY   68 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEE-CCCCcEEEEEEecc--------------ccchHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence            3588889999999999999964 45788999998632              11122346788899999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++..++..++||||+++++|.+++..     ..+++..+..++.|++.|+.||   |+.|++|+||+|+||+++.++.+
T Consensus        69 ~~~~~~~~~~lv~e~~~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~l---h~~~i~h~dl~p~Ni~i~~~~~~  140 (277)
T cd06641          69 GSYLKDTKLWIIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYL---HSEKKIHRDIKAANVLLSEHGEV  140 (277)
T ss_pred             EEEEeCCeEEEEEEeCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHH---ccCCeecCCCCHHhEEECCCCCE
Confidence            999999999999999999999998863     4688999999999999999999   78899999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRK  431 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~  431 (487)
                      +|+|||++.........  .....++..|+|||.+.+..++.++|+||||+++|+|++|..||.....      ......
T Consensus       141 ~l~dfg~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~------~~~~~~  212 (277)
T cd06641         141 KLADFGVAGQLTDTQIK--RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP------MKVLFL  212 (277)
T ss_pred             EEeecccceecccchhh--hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch------HHHHHH
Confidence            99999998765432211  1234578899999999888889999999999999999999999943221      111221


Q ss_pred             HHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          432 VMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       432 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      . ....+ ..++..        .+..+.+++.+||+.+|++||++.++++
T Consensus       213 ~-~~~~~-~~~~~~--------~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  252 (277)
T cd06641         213 I-PKNNP-PTLEGN--------YSKPLKEFVEACLNKEPSFRPTAKELLK  252 (277)
T ss_pred             H-hcCCC-CCCCcc--------cCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            1 11111 111111        2355889999999999999999999987

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.9e-36  Score=289.71  Aligned_cols=259  Identities=23%  Similarity=0.398  Sum_probs=200.2

Q ss_pred             cccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceE
Q 011360          194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAH  273 (487)
Q Consensus       194 ~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  273 (487)
                      |...+.||.|++|.||++.. ..++..||+|.+.......         .........+..|+.+++.++||||++++++
T Consensus         2 ~~~~~~lg~g~~~~v~~~~~-~~~~~~~alk~~~~~~~~~---------~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   71 (268)
T cd06630           2 WLKGQQLGTGAFSSCYQARD-VKTGTLMAVKQVTYVRNTS---------SEQEEVVEALRKEIRLMARLNHPHIIRMLGA   71 (268)
T ss_pred             ccccceecCcCceEEEEEEE-cCCCcEEEEEEeecccCCc---------hhHHHHHHHHHHHHHHHHHcCCCceehhhce
Confidence            67788999999999999974 5688999999874321110         1112345678899999999999999999999


Q ss_pred             EecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC-CEE
Q 011360          274 MVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDM-EAC  352 (487)
Q Consensus       274 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~-~~k  352 (487)
                      +.+.+..++||||+++++|.+++..    ...+++..+..++.|++.||.||   |++|++|+||+|+||+++.++ .++
T Consensus        72 ~~~~~~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~L---H~~~i~H~~i~~~nil~~~~~~~~~  144 (268)
T cd06630          72 TCEDSHFNLFVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYL---HENQIIHRDVKGANLLIDSTGQRLR  144 (268)
T ss_pred             eccCCeEEEEEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCCEEE
Confidence            9999999999999999999999865    35688999999999999999999   778999999999999998776 599


Q ss_pred             EeccCCccccCCCCce--eeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHH
Q 011360          353 ISDLGLAMAIPDGYTR--VLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLR  430 (487)
Q Consensus       353 l~DFg~s~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~  430 (487)
                      |+|||.+.........  .......++..|+|||.+.+..++.++|+||+|+++|+|++|..||......   .......
T Consensus       145 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~  221 (268)
T cd06630         145 IADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS---NHLALIF  221 (268)
T ss_pred             EcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc---chHHHHH
Confidence            9999998766433111  1112345788999999998888999999999999999999999999533221   1111111


Q ss_pred             HHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          431 KVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       431 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ...... ..    +..    .......+.+++.+||..+|++|||+.+++.
T Consensus       222 ~~~~~~-~~----~~~----~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         222 KIASAT-TA----PSI----PEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             HHhccC-CC----CCC----chhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence            111111 11    111    1223456889999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-36  Score=293.95  Aligned_cols=258  Identities=22%  Similarity=0.364  Sum_probs=192.6

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      +.|.+.+.||.|++|.||+|.. ..+++.||+|.+....              .......+.+|+.+++.++||||++++
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~-~~~~~~~~iK~~~~~~--------------~~~~~~~~~~E~~~l~~l~h~~i~~~~   69 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRS-KLTGQLVALKEIRLEH--------------EEGAPFTAIREASLLKDLKHANIVTLH   69 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEE-cCCCcEEEEEEEeccc--------------ccCCchhHHHHHHHHhhCCCcceeeEE
Confidence            4699999999999999999974 4578899999874311              111123456799999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++...+..++||||+. ++|.+++..   ....+++..+..++.|++.||.||   |+.|++||||+|+||+++.++.+
T Consensus        70 ~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~~~ql~~al~~l---H~~~i~H~dl~p~nil~~~~~~~  142 (291)
T cd07844          70 DIIHTKKTLTLVFEYLD-TDLKQYMDD---CGGGLSMHNVRLFLFQLLRGLAYC---HQRRVLHRDLKPQNLLISERGEL  142 (291)
T ss_pred             EEEecCCeEEEEEecCC-CCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHH---HhCCeecccCCHHHEEEcCCCCE
Confidence            99999999999999997 499998864   234688999999999999999999   77889999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQ-PELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLR  430 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~  430 (487)
                      ||+|||+++........  .....++..|+|||.+.+ ..++.++||||||+++|+|++|..||.......     +...
T Consensus       143 kl~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~-----~~~~  215 (291)
T cd07844         143 KLADFGLARAKSVPSKT--YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE-----DQLH  215 (291)
T ss_pred             EECccccccccCCCCcc--ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH-----HHHH
Confidence            99999998754322111  122346889999998865 468899999999999999999999995433110     1111


Q ss_pred             HHHh---cCCCC---------------------CccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          431 KVMN---SKNPS---------------------RAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       431 ~~~~---~~~~~---------------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ....   ...+.                     ..+....+.   ......+.+++.+||+.+|++|||+.+++.
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         216 KIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPR---LDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             HHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcC---CCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence            0100   00000                     000000000   001256789999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-36  Score=291.00  Aligned_cols=249  Identities=24%  Similarity=0.401  Sum_probs=196.1

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCC---CCCccc
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIR---HRNILP  269 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~  269 (487)
                      .|...+.||.|+||.||+|.+ ..++..||+|.+...              ........+.+|+.+++.+.   |||+++
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~-~~~~~~~~iK~~~~~--------------~~~~~~~~~~~e~~~l~~l~~~~~~~vi~   66 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKH-VPTGRVVALKIINLD--------------TPDDDVSDIQREVALLSQLRQSQPPNITK   66 (277)
T ss_pred             hhhhhhheeccCCceEEEEEE-cCCCcEEEEEEecCC--------------CCchhHHHHHHHHHHHHHhccCCCCCeee
Confidence            477889999999999999975 457889999987321              11223456677888888886   999999


Q ss_pred             cceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC
Q 011360          270 LLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDM  349 (487)
Q Consensus       270 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~  349 (487)
                      +++++......++||||+++++|.+++..     ..+++..+..++.|++.||.||   |+.|++|+||+|+||+++.++
T Consensus        67 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~l---h~~~i~H~dl~p~ni~i~~~~  138 (277)
T cd06917          67 YYGSYLKGPRLWIIMEYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYI---HKVGVIHRDIKAANILVTNTG  138 (277)
T ss_pred             EeeeeeeCCEEEEEEecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCcCHHHEEEcCCC
Confidence            99999999999999999999999998863     3688999999999999999999   778899999999999999999


Q ss_pred             CEEEeccCCccccCCCCceeeEeeecccccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHH
Q 011360          350 EACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQP-ELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEW  428 (487)
Q Consensus       350 ~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~  428 (487)
                      .++|+|||++.........  .....|+..|+|||.+.++ .++.++|+||||+++|+|++|..||......      ..
T Consensus       139 ~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~------~~  210 (277)
T cd06917         139 NVKLCDFGVAALLNQNSSK--RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF------RA  210 (277)
T ss_pred             CEEEccCCceeecCCCccc--cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh------hh
Confidence            9999999998876544321  1334688999999988754 5789999999999999999999999543221      11


Q ss_pred             HHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          429 LRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       429 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .. ......+     +.++..   ..+.++.+++.+||..||++|||+.+++.
T Consensus       211 ~~-~~~~~~~-----~~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         211 MM-LIPKSKP-----PRLEDN---GYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             hh-ccccCCC-----CCCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            11 1111111     112211   13456889999999999999999999875

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.1e-36  Score=292.19  Aligned_cols=261  Identities=26%  Similarity=0.363  Sum_probs=198.2

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      +|.+.+.||.|++|.||+|.. ..+|..||+|++....             ........+.+|+.++++++||||+++++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~-~~~~~~~~vK~~~~~~-------------~~~~~~~~~~~e~~~l~~~~~~~i~~~~~   66 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKD-RETGETVALKKVALRR-------------LEGGIPNQALREIKALQACQHPYVVKLLD   66 (286)
T ss_pred             CceEEeecccCCCcEEEEEEE-CCCCceEEEEEEEccc-------------ccchhhHHHHHHHHHHHhCCCCCCcceee
Confidence            378889999999999999975 3578899999884311             11223456788999999999999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEE
Q 011360          273 HMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC  352 (487)
Q Consensus       273 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~k  352 (487)
                      ++......++||||+ +++|.+++...   ...+++..+..++.|++.||.||   |+.|++|+||+|+||+++.++.++
T Consensus        67 ~~~~~~~~~~v~e~~-~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~ni~~~~~~~~~  139 (286)
T cd07832          67 VFPHGSGFVLVMEYM-PSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYM---HANGIMHRDLKPANLLISADGVLK  139 (286)
T ss_pred             EEecCCeeEEEeccc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCcCHHHEEEcCCCcEE
Confidence            999999999999999 99999998642   35689999999999999999999   678899999999999999999999


Q ss_pred             EeccCCccccCCCCceeeEeeecccccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHH
Q 011360          353 ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQP-ELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRK  431 (487)
Q Consensus       353 l~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~  431 (487)
                      |+|||++......... ......++..|+|||.+.+. .++.++||||+|+++|+|+||.+||....+.      +....
T Consensus       140 l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~------~~~~~  212 (286)
T cd07832         140 IADFGLARLFSEEEPR-LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI------EQLAI  212 (286)
T ss_pred             EeeeeecccccCCCCC-ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH------HHHHH
Confidence            9999998876543221 11334688999999988654 5689999999999999999998888443221      11111


Q ss_pred             HHhc-CCCCC--------------ccCCCCC----CCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          432 VMNS-KNPSR--------------AIDPRLP----GNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       432 ~~~~-~~~~~--------------~~~~~~~----~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .... ..+..              ..-+..+    ..........+.+++.+||..+|++|||+++++.
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         213 VFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             HHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            1110 00000              0000000    0011123467899999999999999999999875

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=4.8e-36  Score=293.08  Aligned_cols=250  Identities=28%  Similarity=0.394  Sum_probs=195.7

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .+.|...+.||.|+||.||+|... .++..||+|++....            .........+.+|+.+++.++||||+++
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~-~~~~~v~iK~~~~~~------------~~~~~~~~~~~~Ei~~l~~l~h~niv~~   80 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDV-RTNEVVAIKKMSYSG------------KQSNEKWQDIIKEVRFLQQLRHPNTIEY   80 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEc-CCCcEEEEEEEeccc------------cCcHHHHHHHHHHHHHHHhCCCCCEEEE
Confidence            346889999999999999999753 578899999874311            1122334567889999999999999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      ++++...+..|+||||+. |+|.+++..   ....+++..+..++.|++.||.||   |+.|++||||+|+||+++.++.
T Consensus        81 ~~~~~~~~~~~lv~e~~~-g~l~~~~~~---~~~~l~~~~~~~~~~ql~~~L~~L---H~~~i~H~dl~p~nIl~~~~~~  153 (307)
T cd06607          81 KGCYLREHTAWLVMEYCL-GSASDILEV---HKKPLQEVEIAAICHGALQGLAYL---HSHERIHRDIKAGNILLTEPGT  153 (307)
T ss_pred             EEEEEeCCeEEEEHHhhC-CCHHHHHHH---cccCCCHHHHHHHHHHHHHHHHHH---HHCCceecCCCcccEEECCCCC
Confidence            999999999999999996 577777653   234689999999999999999999   7788999999999999999999


Q ss_pred             EEEeccCCccccCCCCceeeEeeecccccccCCcccC---CCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHH
Q 011360          351 ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQ---QPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPE  427 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~  427 (487)
                      ++|+|||++......      ....+++.|+|||++.   ...++.++||||||+++|+|+||.+||.....      ..
T Consensus       154 ~kL~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~------~~  221 (307)
T cd06607         154 VKLADFGSASLVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MS  221 (307)
T ss_pred             EEEeecCcceecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH------HH
Confidence            999999998755332      2345788999999874   45688999999999999999999999843221      11


Q ss_pred             HHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          428 WLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ...... ...+..     .   .....+..+.+++.+||+.+|++|||+.+|+.
T Consensus       222 ~~~~~~-~~~~~~-----~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  266 (307)
T cd06607         222 ALYHIA-QNDSPT-----L---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK  266 (307)
T ss_pred             HHHHHh-cCCCCC-----C---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            111111 111111     1   11224467899999999999999999999976

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=3.7e-36  Score=286.93  Aligned_cols=255  Identities=25%  Similarity=0.403  Sum_probs=200.0

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      +|.+.+.||.|+||.||+|.. ..++..|++|.+...             .......+.+..|+.+++.++||||+++++
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~-~~~~~~~~ik~~~~~-------------~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~   66 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVN-LDTGELMAVKEIRIQ-------------DNDPKTIKEIADEMKVLELLKHPNLVKYYG   66 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEE-CCCCcEEEEEEEECc-------------ccchHHHHHHHHHHHHHHhCCCCChhheee
Confidence            378889999999999999975 357889999987431             111345678899999999999999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEE
Q 011360          273 HMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC  352 (487)
Q Consensus       273 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~k  352 (487)
                      .+...+..++|+||+++++|.+++..    +..+++..+..++.|++.||.||   |+.|++|+||+|+||+++.++.+|
T Consensus        67 ~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~l---h~~~i~H~dl~~~nil~~~~~~~k  139 (264)
T cd06626          67 VEVHREKVYIFMEYCSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYL---HSHGIVHRDIKPANIFLDHNGVIK  139 (264)
T ss_pred             eEecCCEEEEEEecCCCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCCEE
Confidence            99999999999999999999999864    34578889999999999999999   677899999999999999999999


Q ss_pred             EeccCCccccCCCCceee--EeeecccccccCCcccCCCC---CCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHH
Q 011360          353 ISDLGLAMAIPDGYTRVL--ISYVLGTMAYIAPEYFQQPE---LSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPE  427 (487)
Q Consensus       353 l~DFg~s~~~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~---~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~  427 (487)
                      |+|||++...........  .....+++.|+|||++.+..   ++.++||||||+++|++++|..||......     ..
T Consensus       140 l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-----~~  214 (264)
T cd06626         140 LGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-----FQ  214 (264)
T ss_pred             EcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-----HH
Confidence            999999887654332211  11345788999999998765   889999999999999999999999533211     11


Q ss_pred             HHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          428 WLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ...... .. .    .+.++..  ......+.+++.+||+.+|++|||+.+++.
T Consensus       215 ~~~~~~-~~-~----~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         215 IMFHVG-AG-H----KPPIPDS--LQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             HHHHHh-cC-C----CCCCCcc--cccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            111111 11 1    1112211  112355789999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=3.8e-36  Score=292.41  Aligned_cols=262  Identities=26%  Similarity=0.348  Sum_probs=196.1

Q ss_pred             cccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceE
Q 011360          194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAH  273 (487)
Q Consensus       194 ~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  273 (487)
                      |.+.+.||.|++|.||+|.. ..++..||+|++.......          ........+..|+.+++.++||||++++++
T Consensus         2 y~~~~~lg~g~~~~vy~~~~-~~~~~~v~iK~~~~~~~~~----------~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~   70 (298)
T cd07841           2 YEKGKKLGEGTYAVVYKARD-KETGRIVAIKKIKLGERKE----------AKDGINFTALREIKLLQELKHPNIIGLLDV   70 (298)
T ss_pred             ceeeeeeeeccccEEEEEEE-CCCCcEEEEEEEecccccc----------ccchhhHHHHHHHHHHhhcCCCCChhhhhe
Confidence            77788999999999999975 3568899999985421110          012233456779999999999999999999


Q ss_pred             EecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEE
Q 011360          274 MVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACI  353 (487)
Q Consensus       274 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl  353 (487)
                      +.+.+..++||||+ +|+|.+++..   ....+++..+..++.|++.||.||   |++|++|+||+|+||+++.++.++|
T Consensus        71 ~~~~~~~~lv~e~~-~~~L~~~i~~---~~~~~~~~~~~~~~~qi~~al~~l---H~~~i~H~dl~p~nill~~~~~~~l  143 (298)
T cd07841          71 FGHKSNINLVFEFM-ETDLEKVIKD---KSIVLTPADIKSYMLMTLRGLEYL---HSNWILHRDLKPNNLLIASDGVLKL  143 (298)
T ss_pred             eecCCEEEEEEccc-CCCHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeecCCChhhEEEcCCCCEEE
Confidence            99999999999999 9999999864   123689999999999999999999   7889999999999999999999999


Q ss_pred             eccCCccccCCCCceeeEeeecccccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHH
Q 011360          354 SDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQ-PELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKV  432 (487)
Q Consensus       354 ~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~  432 (487)
                      +|||++.........  .....+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||....+.      +.....
T Consensus       144 ~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~------~~~~~~  215 (298)
T cd07841         144 ADFGLARSFGSPNRK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI------DQLGKI  215 (298)
T ss_pred             ccceeeeeccCCCcc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH------HHHHHH
Confidence            999999876443221  123346788999998854 46789999999999999999998887543221      111111


Q ss_pred             Hhc-CCC-----------CCccC----CCCC-CCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          433 MNS-KNP-----------SRAID----PRLP-GNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       433 ~~~-~~~-----------~~~~~----~~~~-~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ... ..+           .....    +..+ .......+..+.+++.+||..+|++|||+.+++.
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~  281 (298)
T cd07841         216 FEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE  281 (298)
T ss_pred             HHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence            110 000           00000    0000 0011233567889999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=3.9e-36  Score=285.59  Aligned_cols=252  Identities=22%  Similarity=0.344  Sum_probs=198.8

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      +|.+.+.||.|+||.||++.. ..++..+|+|.+..             ..........+.+|+.+++.++||||+++++
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~-~~~~~~~~ik~~~~-------------~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~   66 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKA-KSDSEHCVIKEIDL-------------TKMPVKEKEASKKEVILLAKMKHPNIVTFFA   66 (257)
T ss_pred             CceEEEEecCCCcceEEEEEE-cCCCceEEEEEeeH-------------hhccchhhHHHHHHHHHHHhCCCCChhhhhh
Confidence            377889999999999999975 45788899998732             1111223456778999999999999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC-E
Q 011360          273 HMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME-A  351 (487)
Q Consensus       273 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~-~  351 (487)
                      .+...+..++|+||+++++|.+++..  .....+++..+..++.|++.||.||   |+.+++|+||+|+||++++++. +
T Consensus        67 ~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~l---h~~~i~H~dl~~~nil~~~~~~~~  141 (257)
T cd08225          67 SFQENGRLFIVMEYCDGGDLMKRINR--QRGVLFSEDQILSWFVQISLGLKHI---HDRKILHRDIKSQNIFLSKNGMVA  141 (257)
T ss_pred             eeccCCeEEEEEecCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccccCCHHHEEEcCCCCeE
Confidence            99999999999999999999999865  2334578999999999999999999   6778999999999999998864 6


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRK  431 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~  431 (487)
                      +|+|||.+.........  .....|++.|+|||++.+..++.++|+||||+++|+|++|..||....      .......
T Consensus       142 ~l~d~~~~~~~~~~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~  213 (257)
T cd08225         142 KLGDFGIARQLNDSMEL--AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN------LHQLVLK  213 (257)
T ss_pred             EecccccchhccCCccc--ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHH
Confidence            99999998776443221  123458899999999988889999999999999999999999994322      2223332


Q ss_pred             HHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          432 VMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       432 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .......  .+.+        ..+.++.+++.+||..+|++|||+.++++
T Consensus       214 ~~~~~~~--~~~~--------~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         214 ICQGYFA--PISP--------NFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             HhcccCC--CCCC--------CCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            2222111  1111        12356889999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.8e-36  Score=292.45  Aligned_cols=260  Identities=25%  Similarity=0.341  Sum_probs=194.2

Q ss_pred             cccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceE
Q 011360          194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAH  273 (487)
Q Consensus       194 ~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  273 (487)
                      |+.++.||.|++|.||+|.. ..++..||||++...             .........+.+|+.++++++||||++++++
T Consensus         2 y~~~~~l~~g~~~~v~~~~~-~~~~~~~~ik~~~~~-------------~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~   67 (284)
T cd07860           2 FQKVEKIGEGTYGVVYKARN-KLTGEVVALKKIRLD-------------TETEGVPSTAIREISLLKELNHPNIVKLLDV   67 (284)
T ss_pred             ceeeeeecCCCceEEEEEEE-CCCCCEEEEEEcccc-------------ccccccchHHHHHHHHHHhcCCCCCcchhhh
Confidence            78889999999999999975 457889999987321             1112223467889999999999999999999


Q ss_pred             EecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEE
Q 011360          274 MVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACI  353 (487)
Q Consensus       274 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl  353 (487)
                      +.+.+..++||||+. ++|.+++..  .....+++..+..++.|++.||+||   |+.|++|+||+|+||+++.++.+||
T Consensus        68 ~~~~~~~~~v~e~~~-~~l~~~~~~--~~~~~l~~~~~~~~~~~i~~~l~~l---h~~~i~H~~l~p~nill~~~~~~~l  141 (284)
T cd07860          68 IHTENKLYLVFEFLH-QDLKKFMDA--SPLSGIPLPLIKSYLFQLLQGLAFC---HSHRVLHRDLKPQNLLINTEGAIKL  141 (284)
T ss_pred             cccCCcEEEEeeccc-cCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEECCCCCEEE
Confidence            999999999999995 689888864  2345689999999999999999999   6778999999999999999999999


Q ss_pred             eccCCccccCCCCceeeEeeecccccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHH
Q 011360          354 SDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQP-ELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKV  432 (487)
Q Consensus       354 ~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~  432 (487)
                      +|||++.........  .....+++.|+|||.+.+. .++.++||||||+++|+|+||..||......      ....+.
T Consensus       142 ~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~------~~~~~~  213 (284)
T cd07860         142 ADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI------DQLFRI  213 (284)
T ss_pred             eeccchhhcccCccc--cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH------HHHHHH
Confidence            999998765433211  1233468899999988664 4688999999999999999999999543211      111111


Q ss_pred             Hh-cCCCCCccCC----------CCC---C----CCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          433 MN-SKNPSRAIDP----------RLP---G----NGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       433 ~~-~~~~~~~~~~----------~~~---~----~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .. .+.+...+.+          ..+   .    .........+.+++.+||+.||++|||+++++.
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         214 FRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence            11 0000000000          000   0    001112345788999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-36  Score=292.13  Aligned_cols=261  Identities=24%  Similarity=0.320  Sum_probs=197.7

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      +|.+.+.||.|+||.||+|.. ..+++.||+|++..             ..........+.+|+.+++.++||||+++++
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~-~~~~~~v~vK~~~~-------------~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~   67 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRN-KATGEIVAIKKFKE-------------SEDDEDVKKTALREVKVLRQLRHENIVNLKE   67 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEe-CCCCcEEEEehhhh-------------hcccccchhHHHHHHHHHHhcCCCCeeehhh
Confidence            588999999999999999975 45688999997732             1112334567889999999999999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEE
Q 011360          273 HMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC  352 (487)
Q Consensus       273 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~k  352 (487)
                      ++..++..+++|||++++.+..+...    ...+++..+..++.|++.||.||   |+.|++|+||+|+||++++++.+|
T Consensus        68 ~~~~~~~~~iv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~L---H~~~i~H~dl~~~ni~~~~~~~~k  140 (288)
T cd07833          68 AFRRKGRLYLVFEYVERTLLELLEAS----PGGLPPDAVRSYIWQLLQAIAYC---HSHNIIHRDIKPENILVSESGVLK  140 (288)
T ss_pred             eEEECCEEEEEEecCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeEECCCCCEE
Confidence            99999999999999988766655532    45588999999999999999999   677899999999999999999999


Q ss_pred             EeccCCccccCCCCceeeEeeecccccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHH
Q 011360          353 ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQP-ELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRK  431 (487)
Q Consensus       353 l~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~  431 (487)
                      |+|||++......... ......++..|+|||++.+. .++.++||||||+++|+|++|.+||......      +....
T Consensus       141 l~d~g~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~------~~~~~  213 (288)
T cd07833         141 LCDFGFARALRARPAS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI------DQLYL  213 (288)
T ss_pred             EEeeecccccCCCccc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHH
Confidence            9999998876544321 11335678899999999887 8899999999999999999999999543211      11110


Q ss_pred             HHh--cC-------------CCC--CccCCCCCC----CCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          432 VMN--SK-------------NPS--RAIDPRLPG----NGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       432 ~~~--~~-------------~~~--~~~~~~~~~----~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ...  ..             ...  ...+...+.    ......+.++.+++.+||..+|++|||+++++.
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         214 IQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             HHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            000  00             000  000000000    001112567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=6.1e-36  Score=284.00  Aligned_cols=252  Identities=25%  Similarity=0.361  Sum_probs=203.6

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      +|.+.+.||.|++|.||++.. ..++..+++|.+...             .........+.+|+.+++.++||||+++++
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~-~~~~~~~~ik~~~~~-------------~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~   66 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKR-LSDNQFYALKEVDLG-------------SMSQKEREDAVNEIRILASVNHPNIISYKE   66 (256)
T ss_pred             CceEeeeecCCCceeEEEEEE-CCCCCEEEEEEEehh-------------hccHHHHHHHHHHHHHHHhCCCCCchhhhh
Confidence            378889999999999999975 457889999987321             112233456678999999999999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEE
Q 011360          273 HMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC  352 (487)
Q Consensus       273 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~k  352 (487)
                      ++......++||||+++++|.+++.........+++..+..++.|++.||.||   |+.|++|+||+|.||+++.++.+|
T Consensus        67 ~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~l---h~~~i~h~~l~~~ni~~~~~~~~k  143 (256)
T cd08530          67 AFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL---HEQKILHRDLKSANILLVANDLVK  143 (256)
T ss_pred             hhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH---hhCCcccCCCCcceEEEecCCcEE
Confidence            99999999999999999999999876544456789999999999999999999   788999999999999999999999


Q ss_pred             EeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHH
Q 011360          353 ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKV  432 (487)
Q Consensus       353 l~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~  432 (487)
                      |+|||++........    ....+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.      .+.....
T Consensus       144 l~d~g~~~~~~~~~~----~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~------~~~~~~~  213 (256)
T cd08530         144 IGDLGISKVLKKNMA----KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM------QDLRYKV  213 (256)
T ss_pred             EeeccchhhhccCCc----ccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHH
Confidence            999999987655421    234578899999999988899999999999999999999999943321      1222222


Q ss_pred             HhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          433 MNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       433 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      . ......     ++    .....++.+++.+||+.+|++|||+.++++
T Consensus       214 ~-~~~~~~-----~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         214 Q-RGKYPP-----IP----PIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             h-cCCCCC-----Cc----hhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            2 111111     11    134466999999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.7e-36  Score=338.49  Aligned_cols=259  Identities=26%  Similarity=0.451  Sum_probs=203.1

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      .+.....||+|+||.||+|.. ..++..||+|++....                   .....|+..+++++|||||++++
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~~vavK~~~~~~-------------------~~~~~~~~~l~~l~HpnIv~~~~  750 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKS-IKNGMQFVVKEINDVN-------------------SIPSSEIADMGKLQHPNIVKLIG  750 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEE-CCCCcEEEEEEccCCc-------------------cccHHHHHHHhhCCCCCcceEEE
Confidence            456667899999999999975 3578999999873210                   01123577888999999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEE
Q 011360          273 HMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC  352 (487)
Q Consensus       273 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~k  352 (487)
                      ++.+.+..|+||||+++|+|.+++.       .++|..+..++.|++.||+|||..++.+|+||||||+||+++.++..+
T Consensus       751 ~~~~~~~~~lv~Ey~~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~  823 (968)
T PLN00113        751 LCRSEKGAYLIHEYIEGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPH  823 (968)
T ss_pred             EEEcCCCCEEEEeCCCCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceE
Confidence            9999999999999999999999985       278999999999999999999765588999999999999999998888


Q ss_pred             EeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHH
Q 011360          353 ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKV  432 (487)
Q Consensus       353 l~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~  432 (487)
                      +. ||........      ....+|+.|+|||++.+..++.++|||||||++|||+||+.||..... ......+|....
T Consensus       824 ~~-~~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~  895 (968)
T PLN00113        824 LR-LSLPGLLCTD------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYC  895 (968)
T ss_pred             EE-eccccccccC------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHh
Confidence            75 6654332211      123578999999999999999999999999999999999999943222 222344555444


Q ss_pred             HhcCCCCCccCCCCCCC--CcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          433 MNSKNPSRAIDPRLPGN--GYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       433 ~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      .........+++.+...  ...+...++.+++.+||+.+|++|||+.++++.|+++
T Consensus       896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  951 (968)
T PLN00113        896 YSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESA  951 (968)
T ss_pred             cCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHh
Confidence            33333344445544332  3345667889999999999999999999999999876

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-36  Score=294.91  Aligned_cols=272  Identities=22%  Similarity=0.301  Sum_probs=196.4

Q ss_pred             cccccccccccceeEEEEEecCC-CCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          194 FASLEKIGSGGCGEVYKAELPGS-NGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       194 ~~~~~~lg~G~~g~v~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      |.+.+.||.|+||.||+|..... ++..||+|.+.....            ........+.+|+.++..++||||+++++
T Consensus         2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~------------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~   69 (316)
T cd07842           2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKE------------QYTGISQSACREIALLRELKHENVVSLVE   69 (316)
T ss_pred             ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccc------------cccCccHHHHHHHHHHHhcCCCCccceEE
Confidence            77889999999999999976432 688999998843110            11222345678999999999999999999


Q ss_pred             EEecC--CeeEEEEEecCCCCHHHHHhhhhcCC-CCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC--
Q 011360          273 HMVRP--DCHLLVYEFMKNGSLQDILDDVSRGR-RELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLND--  347 (487)
Q Consensus       273 ~~~~~--~~~~lv~E~~~~gsL~~~l~~~~~~~-~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~--  347 (487)
                      ++...  ..+++||||+++ +|.+++....... ..+++..++.++.|++.||.||   |+.|++||||||+||+++.  
T Consensus        70 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~h~dlkp~Nil~~~~~  145 (316)
T cd07842          70 VFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYL---HSNWVLHRDLKPANILVMGEG  145 (316)
T ss_pred             EEeCCCCceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHH---HhCCEeeCCCCHHHEEEcCCC
Confidence            99988  889999999964 7777776443332 3789999999999999999999   7788999999999999999  


Q ss_pred             --CCCEEEeccCCccccCCCCc-eeeEeeecccccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCccccCCCCcc
Q 011360          348 --DMEACISDLGLAMAIPDGYT-RVLISYVLGTMAYIAPEYFQQP-ELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI  423 (487)
Q Consensus       348 --~~~~kl~DFg~s~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~  423 (487)
                        ++.+||+|||++........ ........+++.|+|||.+.+. .++.++||||||+++|+|++|.+||.........
T Consensus       146 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~  225 (316)
T cd07842         146 PERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKK  225 (316)
T ss_pred             CccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccc
Confidence              89999999999886644322 1111234578899999987664 5789999999999999999999999655432211


Q ss_pred             ccH---HHHHHHHh---cC------------CCCC----ccCCCCCCCCc-H------HHHHHHHHHHhhccCCCCCCCC
Q 011360          424 CSP---EWLRKVMN---SK------------NPSR----AIDPRLPGNGY-E------KKMLHVLKIAYICTLHDPEERP  474 (487)
Q Consensus       424 ~~~---~~~~~~~~---~~------------~~~~----~~~~~~~~~~~-~------~~~~~l~~li~~cl~~~P~~RP  474 (487)
                      ..+   ..+..++.   ..            ....    ......+.... .      ....++.+++.+||+.||++||
T Consensus       226 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp  305 (316)
T cd07842         226 SNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRI  305 (316)
T ss_pred             cchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCc
Confidence            100   00000000   00            0000    00000110000 0      2335688999999999999999


Q ss_pred             ChHHHHH
Q 011360          475 NSQYVRC  481 (487)
Q Consensus       475 s~~~il~  481 (487)
                      |+.+++.
T Consensus       306 s~~eil~  312 (316)
T cd07842         306 TAEEALE  312 (316)
T ss_pred             CHHHHhc
Confidence            9999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-37  Score=320.94  Aligned_cols=254  Identities=26%  Similarity=0.308  Sum_probs=204.6

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.++++||+|+||.|.++++. .+++.||.|++..            ..-.+......|..|-.+|..-..+-|+++.
T Consensus        75 ~DfeilKvIGrGaFGEV~lVr~k-~t~~VYAMK~lnK------------~eMlKr~~tA~F~EERDimv~~ns~Wiv~Lh  141 (1317)
T KOG0612|consen   75 EDFEILKVIGRGAFGEVALVRHK-STEKVYAMKILNK------------WEMLKRAETACFREERDIMVFGNSEWIVQLH  141 (1317)
T ss_pred             HhhHHHHHhcccccceeEEEEee-ccccchhHHHhhH------------HHHhhchhHHHHHHHhHHHHcCCcHHHHHHH
Confidence            46999999999999999999864 6889999997732            2234455667899999999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      ..|.++.++|+||||++||+|..++..+    ..+++..++.++..|+-||.-|   |+.|+|||||||+|||++.+|++
T Consensus       142 yAFQD~~~LYlVMdY~pGGDlltLlSk~----~~~pE~~ArFY~aEiVlAldsl---H~mgyVHRDiKPDNvLld~~GHi  214 (1317)
T KOG0612|consen  142 YAFQDERYLYLVMDYMPGGDLLTLLSKF----DRLPEDWARFYTAEIVLALDSL---HSMGYVHRDIKPDNVLLDKSGHI  214 (1317)
T ss_pred             HHhcCccceEEEEecccCchHHHHHhhc----CCChHHHHHHHHHHHHHHHHHH---HhccceeccCCcceeEecccCcE
Confidence            9999999999999999999999999863    3799999999999999999999   78889999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccC----C-CCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQ----Q-PELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSP  426 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~----~-~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~  426 (487)
                      ||+|||.+-.+...+. ..+...+|||.|.+||+|.    + +.|+..+|+||+||++|||+.|..||-.      ....
T Consensus       215 kLADFGsClkm~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa------dslv  287 (1317)
T KOG0612|consen  215 KLADFGSCLKMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA------DSLV  287 (1317)
T ss_pred             eeccchhHHhcCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH------HHHH
Confidence            9999999988765443 3346678999999999986    3 5799999999999999999999999922      2223


Q ss_pred             HHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCC---hHHHH
Q 011360          427 EWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPN---SQYVR  480 (487)
Q Consensus       427 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs---~~~il  480 (487)
                      +-..+++....- ..    +|  ....++.+..++|++.+. +|+.|..   +++|.
T Consensus       288 eTY~KIm~hk~~-l~----FP--~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik  336 (1317)
T KOG0612|consen  288 ETYGKIMNHKES-LS----FP--DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIK  336 (1317)
T ss_pred             HHHHHHhchhhh-cC----CC--cccccCHHHHHHHHHHhc-ChhhhcccccHHHHH
Confidence            333334333111 11    22  112255678888888776 8888887   77664

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1e-35  Score=288.81  Aligned_cols=268  Identities=15%  Similarity=0.161  Sum_probs=187.5

Q ss_pred             cccccccccccccceeEEEEEecCCC---CceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSN---GKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNIL  268 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv  268 (487)
                      +.|.+.+.||+|+||.||+|.+.. +   +..+|+|...........+.    .............+...+..+.|+||+
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~-~~~~~~~~~~k~~~~~~~~~~~e~----~~~~~~~~~~~~~~~~~~~~~~h~~i~   86 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCAS-DHCINNQAVAKIENLENETIVMET----LVYNNIYDIDKIALWKNIHNIDHLGIP   86 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcC-CcccccceEEEeccccCCchhhHH----HHHHhhhhHHHHHHHHHhccCCCCCCC
Confidence            469999999999999999998642 3   45667775432211111110    011111112233455567788999999


Q ss_pred             ccceEEecCC----eeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEE
Q 011360          269 PLLAHMVRPD----CHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVL  344 (487)
Q Consensus       269 ~l~~~~~~~~----~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nil  344 (487)
                      ++++++....    ..+++++++ ..++.+.+..    ....++..+..++.|++.||.||   |+++|+||||||+|||
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~l---H~~~iiHrDiKp~Nil  158 (294)
T PHA02882         87 KYYGCGSFKRCRMYYRFILLEKL-VENTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYI---HEHGISHGDIKPENIM  158 (294)
T ss_pred             cEEEeeeEecCCceEEEEEEehh-ccCHHHHHHh----hccCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEE
Confidence            9998766543    336788877 4477776654    23457788899999999999999   7788999999999999


Q ss_pred             eCCCCCEEEeccCCccccCCCCce-----eeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCC
Q 011360          345 LNDDMEACISDLGLAMAIPDGYTR-----VLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQN  419 (487)
Q Consensus       345 l~~~~~~kl~DFg~s~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~  419 (487)
                      ++.++.++|+|||+++........     .......||+.|+|||++.+..++.++|||||||++|||++|..||.....
T Consensus       159 l~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~  238 (294)
T PHA02882        159 VDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGH  238 (294)
T ss_pred             EcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcccc
Confidence            999999999999999866432211     111234699999999999999999999999999999999999999965432


Q ss_pred             CCcccc---HHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHh
Q 011360          420 GEEICS---PEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLS  484 (487)
Q Consensus       420 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~  484 (487)
                      ......   .++...... +..  .    ++     ..+..+.+++..||..+|++||++.+|++.|+
T Consensus       239 ~~~~~~~~~~~~~~~~~~-~~~--~----~~-----~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        239 NGNLIHAAKCDFIKRLHE-GKI--K----IK-----NANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             chHHHHHhHHHHHHHhhh-hhh--c----cC-----CCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            211100   111111111 110  0    11     11356889999999999999999999998763

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=3.6e-36  Score=291.92  Aligned_cols=258  Identities=24%  Similarity=0.333  Sum_probs=195.4

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      +.|.+.+.||.|+||.||+|.. ..+++.+|+|.+....             ........+.+|+.++.+++||||++++
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~~ik~~~~~~-------------~~~~~~~~~~~e~~~l~~l~h~ni~~~~   70 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARD-KKTGEIVALKKLKMEK-------------EKEGFPITSLREINILLKLQHPNIVTVK   70 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEE-CCCCcEEEEEEEeecc-------------ccccchhhHHHHHHHHHhcCCCCEEEEE
Confidence            3589999999999999999975 4578899999884311             1122334567899999999999999999


Q ss_pred             eEEecC--CeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC
Q 011360          272 AHMVRP--DCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDM  349 (487)
Q Consensus       272 ~~~~~~--~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~  349 (487)
                      +++...  +..|+||||++ ++|.+++...   ...+++..+..++.|++.||.||   |+.|++|+||+|+||+++.++
T Consensus        71 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~L---H~~~i~H~dl~p~nili~~~~  143 (293)
T cd07843          71 EVVVGSNLDKIYMVMEYVE-HDLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHL---HDNWILHRDLKTSNLLLNNRG  143 (293)
T ss_pred             EEEEecCCCcEEEEehhcC-cCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeccCCHHHEEECCCC
Confidence            998877  88999999996 5999888642   34689999999999999999999   677899999999999999999


Q ss_pred             CEEEeccCCccccCCCCceeeEeeecccccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHH
Q 011360          350 EACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQP-ELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEW  428 (487)
Q Consensus       350 ~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~  428 (487)
                      .++|+|||++.........  .....+++.|+|||.+.+. .++.++|+||||+++|+|++|.+||......      ..
T Consensus       144 ~~~l~d~g~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~------~~  215 (293)
T cd07843         144 ILKICDFGLAREYGSPLKP--YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI------DQ  215 (293)
T ss_pred             cEEEeecCceeeccCCccc--cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH------HH
Confidence            9999999998876543211  1234578899999988754 4689999999999999999999999543221      11


Q ss_pred             HHHHHhc--------------------CC----CCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          429 LRKVMNS--------------------KN----PSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       429 ~~~~~~~--------------------~~----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .......                    ..    ....+...++..   .....+.+++.+||+.+|++|||+.+++.
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         216 LNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPAL---SLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             HHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhcccccc---CCChHHHHHHHHHhccCccccCCHHHHhc
Confidence            1111000                    00    000001111110   02456889999999999999999999875

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.2e-35  Score=283.37  Aligned_cols=246  Identities=24%  Similarity=0.318  Sum_probs=195.8

Q ss_pred             cccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceEEecCCe
Q 011360          200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDC  279 (487)
Q Consensus       200 lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  279 (487)
                      ||.|++|.||++... .++..+|+|.+....            .........+.+|+.+++.++||||+++++.+.++..
T Consensus         1 lg~g~~~~v~~~~~~-~~~~~~~iK~~~~~~------------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   67 (262)
T cd05572           1 LGVGGFGRVELVKVK-SKNRTFALKCVKKRH------------IVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKY   67 (262)
T ss_pred             CCCCCceEEEEEEEC-CCCcEEEEEEEehhc------------chhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCc
Confidence            699999999999754 468899999874211            1112234578889999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEeccCCc
Q 011360          280 HLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA  359 (487)
Q Consensus       280 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~DFg~s  359 (487)
                      .|++|||+++++|.+++..    ...++...+..++.|++.||.||   |++|++|+||+|+||+++.++.++|+|||++
T Consensus        68 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~l---H~~~~~h~dl~~~nilv~~~~~~~l~df~~~  140 (262)
T cd05572          68 IYMLMEYCLGGELWTILRD----RGLFDEYTARFYIACVVLAFEYL---HNRGIIYRDLKPENLLLDSNGYVKLVDFGFA  140 (262)
T ss_pred             cEEEEecCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHH---hhCCcccCCCCHHHEEEcCCCCEEEeeCCcc
Confidence            9999999999999999965    34588999999999999999999   7788999999999999999999999999999


Q ss_pred             cccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHHHhcCCCC
Q 011360          360 MAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSKNPS  439 (487)
Q Consensus       360 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  439 (487)
                      ........   .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||.....    ............... 
T Consensus       141 ~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~-  212 (262)
T cd05572         141 KKLKSGQK---TWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE----DPMEIYNDILKGNGK-  212 (262)
T ss_pred             cccCcccc---cccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC----CHHHHHHHHhccCCC-
Confidence            87654321   1234578999999999888899999999999999999999999955432    122333333321111 


Q ss_pred             CccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCC-----hHHHHH
Q 011360          440 RAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPN-----SQYVRC  481 (487)
Q Consensus       440 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~~il~  481 (487)
                      ...+...        ...+.+++.+||+.+|++|||     ++++++
T Consensus       213 ~~~~~~~--------~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         213 LEFPNYI--------DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             CCCCccc--------CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            1111111        356899999999999999999     777765

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=7.6e-36  Score=288.57  Aligned_cols=252  Identities=31%  Similarity=0.485  Sum_probs=200.2

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .+.|...+.+|.|++|.||+|.+. .++..+++|.+...               .. ....+..|+..++.++||||+++
T Consensus        18 ~~~~~~~~~l~~g~~~~v~~~~~~-~~~~~~~iK~~~~~---------------~~-~~~~~~~e~~~l~~l~~~~i~~~   80 (286)
T cd06614          18 RELYKNLEKIGEGASGEVYKATDR-ATGKEVAIKKMRLR---------------KQ-NKELIINEILIMKDCKHPNIVDY   80 (286)
T ss_pred             cccchHhHhccCCCCeEEEEEEEc-cCCcEEEEEEEecC---------------ch-hHHHHHHHHHHHHHCCCCCeeEE
Confidence            346888899999999999999764 46889999988431               11 34567889999999999999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      ++.+...+..|+++||+++++|.+++...   ...+++..+..++.|++.||.||   |+.|++|+||+|+||+++.++.
T Consensus        81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~l---H~~gi~H~dl~p~ni~i~~~~~  154 (286)
T cd06614          81 YDSYLVGDELWVVMEYMDGGSLTDIITQN---FVRMNEPQIAYVCREVLQGLEYL---HSQNVIHRDIKSDNILLSKDGS  154 (286)
T ss_pred             EEEEEECCEEEEEEeccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHH---HhCCeeeCCCChhhEEEcCCCC
Confidence            99999999999999999999999999752   13789999999999999999999   7789999999999999999999


Q ss_pred             EEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHH
Q 011360          351 ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLR  430 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~  430 (487)
                      ++|+|||++.........  .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||.....      .....
T Consensus       155 ~~l~d~~~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~------~~~~~  226 (286)
T cd06614         155 VKLADFGFAAQLTKEKSK--RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP------LRALF  226 (286)
T ss_pred             EEECccchhhhhccchhh--hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH------HHHHH
Confidence            999999988655433211  1233478899999999888899999999999999999999999943221      11122


Q ss_pred             HHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          431 KVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       431 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .......+ ...+       .......+.+++.+||+.+|.+|||+.+|+.
T Consensus       227 ~~~~~~~~-~~~~-------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         227 LITTKGIP-PLKN-------PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             HHHhcCCC-CCcc-------hhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            22111111 1101       1113356889999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.4e-35  Score=281.50  Aligned_cols=254  Identities=23%  Similarity=0.369  Sum_probs=204.6

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      +|.+.+.||.|++|.||++... .++..+++|++...             .........+..|+.+++.++|||++++++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~-~~~~~~~ik~~~~~-------------~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~   66 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRK-SDGKLYVLKEIDLS-------------NMSEKEREDALNEVKILKKLNHPNIIKYYE   66 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEc-CCCcEEEEEEeecc-------------cCChHHHHHHHHHHHHHHhcCCCChhheEE
Confidence            3788899999999999999754 47889999988431             112234556788999999999999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEE
Q 011360          273 HMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC  352 (487)
Q Consensus       273 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~k  352 (487)
                      .+...+..++||||+++++|.+++......+..+++..+..++.+++.||.||   |+.|++|+||+|+||+++.++.++
T Consensus        67 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l---h~~~~~H~dl~~~nil~~~~~~~~  143 (258)
T cd08215          67 SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL---HSRKILHRDIKPQNIFLTSNGLVK  143 (258)
T ss_pred             EEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHH---HhCCEecccCChHHeEEcCCCcEE
Confidence            99999999999999999999999976433357899999999999999999999   677999999999999999999999


Q ss_pred             EeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHH
Q 011360          353 ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKV  432 (487)
Q Consensus       353 l~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~  432 (487)
                      |+|||.+.......  .......|++.|+|||.+.+..++.++|+||+|+++|+|++|..||....      ........
T Consensus       144 l~d~~~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~------~~~~~~~~  215 (258)
T cd08215         144 LGDFGISKVLSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN------LLELALKI  215 (258)
T ss_pred             ECCccceeecccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc------HHHHHHHH
Confidence            99999987764443  12234568899999999988889999999999999999999999994332      22223333


Q ss_pred             HhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          433 MNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       433 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .... .. .    ++.    .....+.+++.+||..+|++|||+.++++
T Consensus       216 ~~~~-~~-~----~~~----~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         216 LKGQ-YP-P----IPS----QYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             hcCC-CC-C----CCC----CCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            2221 11 1    111    12356889999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-35  Score=283.33  Aligned_cols=247  Identities=22%  Similarity=0.291  Sum_probs=186.4

Q ss_pred             cccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHH-HhccCCCCCccccceEEec
Q 011360          198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII-TASQIRHRNILPLLAHMVR  276 (487)
Q Consensus       198 ~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~hpnIv~l~~~~~~  276 (487)
                      +.||.|+||.||+|.. ..+++.||+|.+....            .........+..|.. ......||||+++++++..
T Consensus         2 ~~l~~g~~~~v~~a~~-~~~~~~vavK~~~~~~------------~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~   68 (260)
T cd05611           2 KPISKGAFGSVYLAKK-RSTGDYFAIKVLKKSD------------MIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS   68 (260)
T ss_pred             ccCCcCCCeeEEEEEe-cCCCCeEEEEEecchh------------hhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc
Confidence            5689999999999975 4578899999873210            011112223334443 3455699999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEecc
Q 011360          277 PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDL  356 (487)
Q Consensus       277 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~DF  356 (487)
                      .+..|+||||+++++|.+++..    ...+++..+..++.|++.||.||   |+.|++||||+|+||+++.++.++|+||
T Consensus        69 ~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~l---H~~~i~H~dl~p~nil~~~~~~~~l~df  141 (260)
T cd05611          69 KDYLYLVMEYLNGGDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDL---HQRGIIHRDIKPENLLIDQTGHLKLTDF  141 (260)
T ss_pred             CCeEEEEEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeEECCCCcEEEeec
Confidence            9999999999999999999864    35688999999999999999999   7788999999999999999999999999


Q ss_pred             CCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHHHhcC
Q 011360          357 GLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSK  436 (487)
Q Consensus       357 g~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  436 (487)
                      |++......      ....+++.|+|||.+.+..++.++||||||+++|+|++|..||.....      .......... 
T Consensus       142 g~~~~~~~~------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~-  208 (260)
T cd05611         142 GLSRNGLEN------KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP------DAVFDNILSR-  208 (260)
T ss_pred             ccceecccc------ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhc-
Confidence            998754331      234588899999999888899999999999999999999999943321      1222222211 


Q ss_pred             CCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHH
Q 011360          437 NPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRL  483 (487)
Q Consensus       437 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L  483 (487)
                      ...      .+.......+..+.+++.+||+.+|++|||+.++.+.|
T Consensus       209 ~~~------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l  249 (260)
T cd05611         209 RIN------WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK  249 (260)
T ss_pred             ccC------CCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence            110      00011112235689999999999999999876554433

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=6.4e-36  Score=290.33  Aligned_cols=263  Identities=24%  Similarity=0.329  Sum_probs=193.4

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CCCCccccc
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RHRNILPLL  271 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~  271 (487)
                      +|.+.+.||.|+||.||+|.. ..++..||+|.+..             ..........+.+|+.+++.+ +||||++++
T Consensus         2 ~y~~~~~lg~g~~g~vy~~~~-~~~~~~v~lK~~~~-------------~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~   67 (295)
T cd07837           2 AYEKLEKIGEGTYGKVYKARD-KNTGKLVALKKTRL-------------EMDEEGIPPTALREISLLQMLSESIYIVRLL   67 (295)
T ss_pred             CceEeeEecccCCeEEEEEEE-CCCCcEEEEEeehh-------------hccccCCchHHHHHHHHHHHccCCCCcccee
Confidence            588999999999999999975 45789999998732             111112234677899999999 569999999


Q ss_pred             eEEecCCe-----eEEEEEecCCCCHHHHHhhhhcC-CCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEe
Q 011360          272 AHMVRPDC-----HLLVYEFMKNGSLQDILDDVSRG-RRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLL  345 (487)
Q Consensus       272 ~~~~~~~~-----~~lv~E~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill  345 (487)
                      +++...+.     .|+||||+++ +|.+++...... +..+++..++.++.|++.||.||   |++|++||||+|+||++
T Consensus        68 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~L---H~~~i~H~dl~~~nil~  143 (295)
T cd07837          68 DVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHC---HKHGVMHRDLKPQNLLV  143 (295)
T ss_pred             eeEeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCChHHEEE
Confidence            98887665     7999999975 898888653322 45689999999999999999999   77889999999999999


Q ss_pred             CC-CCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCccccCCCCcc
Q 011360          346 ND-DMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQ-PELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI  423 (487)
Q Consensus       346 ~~-~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~  423 (487)
                      +. ++.+||+|||++..........  ....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...+.    
T Consensus       144 ~~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~----  217 (295)
T cd07837         144 DKQKGLLKIADLGLGRAFSIPVKSY--THEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSE----  217 (295)
T ss_pred             ecCCCeEEEeecccceecCCCcccc--CCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH----
Confidence            98 8899999999987653321111  22346888999998865 4678999999999999999999999954322    


Q ss_pred             ccHHHHHHHHhc-CCCCC-cc---------------CCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          424 CSPEWLRKVMNS-KNPSR-AI---------------DPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       424 ~~~~~~~~~~~~-~~~~~-~~---------------~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                        .+....+... ..+.. ..               .+.............+.+++.+||..||.+|||+.+++.
T Consensus       218 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         218 --LQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             --HHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence              1111111110 00000 00               000000011123456889999999999999999999874

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=7.1e-36  Score=289.51  Aligned_cols=261  Identities=23%  Similarity=0.303  Sum_probs=191.3

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      +.|.+.+.||.|+||.||+|.. ..++..||+|.+....              .......+.+|+.+++.++|+||++++
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~-~~~~~~~~iK~~~~~~--------------~~~~~~~~~~e~~~l~~l~h~ni~~~~   69 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGIS-RINGQLVALKVISMKT--------------EEGVPFTAIREASLLKGLKHANIVLLH   69 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEE-cCCCcEEEEEEecccC--------------cCCCcHHHHHHHHHHHhcCCCCEeEEE
Confidence            5699999999999999999964 4578899999873211              111223456789999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++..++..|+||||+. ++|.+++..   ....+++..+..++.|++.||.||   |+.|++|+||||+||+++.++.+
T Consensus        70 ~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~l---H~~~i~H~dlkp~Nil~~~~~~~  142 (291)
T cd07870          70 DIIHTKETLTFVFEYMH-TDLAQYMIQ---HPGGLHPYNVRLFMFQLLRGLAYI---HGQHILHRDLKPQNLLISYLGEL  142 (291)
T ss_pred             EEEecCCeEEEEEeccc-CCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCChHHEEEcCCCcE
Confidence            99999999999999995 677776643   234577888899999999999999   67789999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQP-ELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLR  430 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~  430 (487)
                      +|+|||+++........  .....+++.|+|||.+.+. .++.++||||||+++|+|++|..||......     .+.+.
T Consensus       143 ~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~-----~~~~~  215 (291)
T cd07870         143 KLADFGLARAKSIPSQT--YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV-----FEQLE  215 (291)
T ss_pred             EEeccccccccCCCCCC--CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH-----HHHHH
Confidence            99999998754322111  1233478899999998754 5788999999999999999999999543221     11111


Q ss_pred             HHHhc-CCC---------------CCccCCCCCCCC-----cHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          431 KVMNS-KNP---------------SRAIDPRLPGNG-----YEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       431 ~~~~~-~~~---------------~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ..+.. +.+               ........+...     .......+.+++.+|+..||++|||+.+++.
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         216 KIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             HHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence            11110 000               000000000000     0011356789999999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.3e-35  Score=290.97  Aligned_cols=260  Identities=23%  Similarity=0.301  Sum_probs=190.6

Q ss_pred             ccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceEE
Q 011360          195 ASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHM  274 (487)
Q Consensus       195 ~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  274 (487)
                      .+.+.+|.|+++.++.+.   .+++.||+|++...             .........+.+|+.+++.++||||+++++++
T Consensus         5 ~i~~~~~~~~~v~~~~~~---~~~~~~avK~~~~~-------------~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~   68 (314)
T cd08216           5 LIGKCFEDLMIVHLAKHK---PTNTLVAVKKINLD-------------SCSKEDLKLLQQEIITSRQLQHPNILPYVTSF   68 (314)
T ss_pred             hhhHhhcCCceEEEEEec---CCCCEEEEEEEecc-------------ccchhHHHHHHHHHHHHHhcCCcchhhhhhee
Confidence            344455555555555553   37899999998431             12334567789999999999999999999999


Q ss_pred             ecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEe
Q 011360          275 VRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACIS  354 (487)
Q Consensus       275 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~  354 (487)
                      ...+..+++|||+++|+|.+++...  ....+++..+..++.|++.||.||   |++||+||||||+||+++.++.+||+
T Consensus        69 ~~~~~~~~~~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~~l~~~L~~L---H~~~ivH~dlk~~Nili~~~~~~kl~  143 (314)
T cd08216          69 IVDSELYVVSPLMAYGSCEDLLKTH--FPEGLPELAIAFILKDVLNALDYI---HSKGFIHRSVKASHILLSGDGKVVLS  143 (314)
T ss_pred             ecCCeEEEEEeccCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCcceEEEecCCceEEe
Confidence            9999999999999999999999752  234588899999999999999999   67789999999999999999999999


Q ss_pred             ccCCccccCCCCce-----eeEeeecccccccCCcccCC--CCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHH
Q 011360          355 DLGLAMAIPDGYTR-----VLISYVLGTMAYIAPEYFQQ--PELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPE  427 (487)
Q Consensus       355 DFg~s~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~--~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~  427 (487)
                      |||.+.........     .......++..|+|||++..  ..++.++|+||||+++|+|++|..||......      .
T Consensus       144 d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~------~  217 (314)
T cd08216         144 GLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT------Q  217 (314)
T ss_pred             cCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH------H
Confidence            99988655322111     11123456788999999876  35889999999999999999999999533211      1


Q ss_pred             HHHHHHhcCCCC-----------------------CccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          428 WLRKVMNSKNPS-----------------------RAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       428 ~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .......+..+.                       .......+.........++.+++.+||..||++|||++++++
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         218 MLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             HHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence            111111110000                       000000111122234567889999999999999999999875

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=9.5e-36  Score=287.03  Aligned_cols=262  Identities=24%  Similarity=0.287  Sum_probs=190.1

Q ss_pred             cccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CCCCccccce
Q 011360          194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RHRNILPLLA  272 (487)
Q Consensus       194 ~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~  272 (487)
                      |.+.+.||.|+||.||+|.. ..++..||+|++...              ...........|+..+.++ .||||+++++
T Consensus         1 y~~~~~lg~g~~~~v~~~~~-~~~~~~~aik~~~~~--------------~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~   65 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQS-RKTGKYYAIKCMKKH--------------FKSLEQVNNLREIQALRRLSPHPNILRLIE   65 (282)
T ss_pred             CceEeeccccccceEEEEEE-cCCCcEEEEEEehhc--------------cCCchhhhHHHHHHHHhhcCCCCCccceEE
Confidence            56788999999999999975 457889999987321              0111122345688888888 5999999999


Q ss_pred             EEecC--CeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          273 HMVRP--DCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       273 ~~~~~--~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      ++.+.  +..++||||++ |+|.+++..   ....+++..+..++.|++.||.||   |+.|++||||+|+||+++. +.
T Consensus        66 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~L---H~~~i~H~dl~p~ni~l~~-~~  137 (282)
T cd07831          66 VLFDRKTGRLALVFELMD-MNLYELIKG---RKRPLPEKRVKSYMYQLLKSLDHM---HRNGIFHRDIKPENILIKD-DI  137 (282)
T ss_pred             EEecCCCCcEEEEEecCC-ccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHH---HHCCceecccCHHHEEEcC-CC
Confidence            99987  88999999996 588887753   235689999999999999999999   6778999999999999999 99


Q ss_pred             EEEeccCCccccCCCCceeeEeeecccccccCCcccC-CCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCc-------
Q 011360          351 ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQ-QPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEE-------  422 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~-------  422 (487)
                      +||+|||++.........   ....++..|+|||.+. +..++.++|||||||++|||++|.+||...+....       
T Consensus       138 ~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~  214 (282)
T cd07831         138 LKLADFGSCRGIYSKPPY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDV  214 (282)
T ss_pred             eEEEecccccccccCCCc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHH
Confidence            999999999876443221   2245788999999765 45678999999999999999999999954332110       


Q ss_pred             --cccHHHHHHHHhcCCCCCccCCCCCCC---CcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          423 --ICSPEWLRKVMNSKNPSRAIDPRLPGN---GYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       423 --~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                        .....+.....................   .....+..+.+++.+||+++|++|||+++++.
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         215 LGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             cCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence              001111111100000000000000000   01234678999999999999999999999875

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.3e-36  Score=299.72  Aligned_cols=250  Identities=25%  Similarity=0.368  Sum_probs=205.3

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      ...|.+.+.||.|.|++|.++++. .++..||||.+..             ..........+.+|+.+|..++|||||++
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~-~t~~~VaiK~idk-------------t~ln~~~~~k~~rev~imk~l~HPnIvkl  120 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHI-LTGTEVAIKIIDK-------------TQLNPSKRQKLGREVDIMKSLNHPNIVKL  120 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEec-CCCceEEEEEehh-------------cccChHHHHHHHHHHHHHHhcCCcceeee
Confidence            346899999999999999999864 5789999998732             33444555668999999999999999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      +.+......+|+||||+.+|.+++++..    ........+..++.|++++++||   |+++|||||||++|||++.+.+
T Consensus       121 ~~v~~t~~~lylV~eya~~ge~~~yl~~----~gr~~e~~ar~~F~q~vsaveYc---H~k~ivHrdLk~eNilL~~~mn  193 (596)
T KOG0586|consen  121 FSVIETEATLYLVMEYASGGELFDYLVK----HGRMKEKEARAKFRQIVSAVEYC---HSKNIVHRDLKAENILLDENMN  193 (596)
T ss_pred             eeeeeecceeEEEEEeccCchhHHHHHh----cccchhhhhhhhhHHHHHHHHHH---hhcceeccccchhhcccccccc
Confidence            9999999999999999999999999976    34455588899999999999999   8889999999999999999999


Q ss_pred             EEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCC-CchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHH
Q 011360          351 ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPEL-SEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWL  429 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~  429 (487)
                      +||+|||++..+..+.   .....+|++.|.|||++.+..| ++.+|+||+|+++|.|+.|..||.+..-      .+..
T Consensus       194 ikIaDfgfS~~~~~~~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l------k~Lr  264 (596)
T KOG0586|consen  194 IKIADFGFSTFFDYGL---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL------KELR  264 (596)
T ss_pred             eeeeccccceeecccc---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc------cccc
Confidence            9999999998876443   3357889999999999998877 5789999999999999999999954432      1122


Q ss_pred             HHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          430 RKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       430 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .+.+.+..   -    ++.    -.+.++-++++++|-.+|.+|++.++|.+
T Consensus       265 ~rvl~gk~---r----Ip~----~ms~dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  265 PRVLRGKY---R----IPF----YMSCDCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             chheeeee---c----ccc----eeechhHHHHHHhhccCccccCCHHHhhh
Confidence            22222111   1    111    12245889999999999999999999875

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2.7e-35  Score=278.27  Aligned_cols=249  Identities=33%  Similarity=0.485  Sum_probs=200.0

Q ss_pred             cccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceE
Q 011360          194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAH  273 (487)
Q Consensus       194 ~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  273 (487)
                      |...+.||.|++|.||++... .++..+++|++...               .......+.+|+..++.++||||++++++
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~-~~~~~~~~k~~~~~---------------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~   65 (253)
T cd05122           2 FEILEKIGKGGFGEVYKARHK-RTGKEVAIKVIKLE---------------SKEKKEKIINEIQILKKCKHPNIVKYYGS   65 (253)
T ss_pred             ceeeeeeccCCceEEEEEEEC-CCCcEEEEEEeccc---------------chhHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence            777889999999999999754 47889999988431               11245678889999999999999999999


Q ss_pred             EecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEE
Q 011360          274 MVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACI  353 (487)
Q Consensus       274 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl  353 (487)
                      +......++++||+++++|.+++...   ...+++..+..++.|++.||.+|   |+.|++||||+|+||+++.++.++|
T Consensus        66 ~~~~~~~~l~~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~l---h~~~i~h~dl~p~ni~i~~~~~~~l  139 (253)
T cd05122          66 YLKKDELWIVMEFCSGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYL---HSNGIIHRDIKAANILLTSDGEVKL  139 (253)
T ss_pred             EecCCeEEEEEecCCCCcHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHh---hcCCEecCCCCHHHEEEccCCeEEE
Confidence            99999999999999999999998642   25789999999999999999999   7788999999999999999999999


Q ss_pred             eccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHHH
Q 011360          354 SDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVM  433 (487)
Q Consensus       354 ~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~  433 (487)
                      +|||.+........   .....++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.      ........
T Consensus       140 ~d~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~  210 (253)
T cd05122         140 IDFGLSAQLSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP------MKALFKIA  210 (253)
T ss_pred             eecccccccccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch------HHHHHHHH
Confidence            99999887655432   1345588999999999988899999999999999999999999943321      11222121


Q ss_pred             hcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          434 NSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       434 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      . .....     .+..  ......+.+++.+||+.+|++|||+.++++
T Consensus       211 ~-~~~~~-----~~~~--~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         211 T-NGPPG-----LRNP--EKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             h-cCCCC-----cCcc--cccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1 11111     1111  112356899999999999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.2e-35  Score=296.06  Aligned_cols=263  Identities=25%  Similarity=0.349  Sum_probs=194.5

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .+.|.+.+.||.|+||.||+|.. ..++..||+|.+...             .........+.+|+.+++.++||||+++
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~~~~-~~~~~~vaiK~~~~~-------------~~~~~~~~~~~~E~~~l~~l~h~~iv~~   80 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCAAYD-TVTGQNVAIKKLSRP-------------FQNVTHAKRAYRELVLMKLVNHKNIIGL   80 (353)
T ss_pred             hcceEEEEEeccCCCEEEEEEEE-CCCCCEEEEEecCcc-------------ccChhHHHHHHHHHHHHHhcCCCCCcce
Confidence            35699999999999999999964 467899999987321             1112234456789999999999999999


Q ss_pred             ceEEecC------CeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEE
Q 011360          271 LAHMVRP------DCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVL  344 (487)
Q Consensus       271 ~~~~~~~------~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nil  344 (487)
                      ++++...      ...|+||||+. ++|.+.+..      .++...+..++.|++.||.||   |+.|++||||||+||+
T Consensus        81 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~L---H~~gi~H~dlkp~Nil  150 (353)
T cd07850          81 LNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHL---HSAGIIHRDLKPSNIV  150 (353)
T ss_pred             eeeeccCCCccccCcEEEEEeccC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHH---HhCCeeeCCCCHHHEE
Confidence            9988643      34699999995 588887753      288889999999999999999   7788999999999999


Q ss_pred             eCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCc--
Q 011360          345 LNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEE--  422 (487)
Q Consensus       345 l~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~--  422 (487)
                      ++.++.+||+|||++........   .....++..|+|||.+.+..++.++|||||||++|+|++|..||...+....  
T Consensus       151 ~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~  227 (353)
T cd07850         151 VKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWN  227 (353)
T ss_pred             ECCCCCEEEccCccceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence            99999999999999986544322   1234578899999999999999999999999999999999999954321000  


Q ss_pred             -------cccHHHH-------HHHHhcCCCC---CccCCCCC--------CCCcHHHHHHHHHHHhhccCCCCCCCCChH
Q 011360          423 -------ICSPEWL-------RKVMNSKNPS---RAIDPRLP--------GNGYEKKMLHVLKIAYICTLHDPEERPNSQ  477 (487)
Q Consensus       423 -------~~~~~~~-------~~~~~~~~~~---~~~~~~~~--------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~  477 (487)
                             ....++.       ...... .+.   ..+....+        ..........+.+++.+||+.||++|||+.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  306 (353)
T cd07850         228 KIIEQLGTPSDEFMSRLQPTVRNYVEN-RPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVD  306 (353)
T ss_pred             HHHHhcCCCCHHHHHHhhhhhhHHhhc-CCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHH
Confidence                   0000000       000000 000   00000000        001223456788999999999999999999


Q ss_pred             HHHH
Q 011360          478 YVRC  481 (487)
Q Consensus       478 ~il~  481 (487)
                      +++.
T Consensus       307 eiL~  310 (353)
T cd07850         307 DALQ  310 (353)
T ss_pred             HHhc
Confidence            9974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.1e-35  Score=286.53  Aligned_cols=245  Identities=26%  Similarity=0.321  Sum_probs=184.3

Q ss_pred             ccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHH---HHhccCCCCCccccceEEe
Q 011360          199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI---ITASQIRHRNILPLLAHMV  275 (487)
Q Consensus       199 ~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~---~~l~~l~hpnIv~l~~~~~  275 (487)
                      .||+|+||.||++.. ..++..+|+|.+......            .........+|.   .++....||||+.+++++.
T Consensus         1 ~lg~G~~g~Vy~~~~-~~~~~~~aiK~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~   67 (279)
T cd05633           1 IIGRGGFGEVYGCRK-ADTGKMYAMKCLDKKRIK------------MKQGETLALNERIMLSLVSTGDCPFIVCMTYAFH   67 (279)
T ss_pred             CcccCCCeEEEEEEE-CCCCcEEEEEEEEccccc------------cchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEe
Confidence            489999999999974 457899999987431110            011111222232   3344558999999999999


Q ss_pred             cCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEec
Q 011360          276 RPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISD  355 (487)
Q Consensus       276 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~D  355 (487)
                      .++..++||||+++|+|.+++..    ...+++..+..++.|++.||.||   |+.|++||||||+||+++.++.++|+|
T Consensus        68 ~~~~~~lv~e~~~~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~l---H~~~ivH~dikp~Nil~~~~~~~~l~d  140 (279)
T cd05633          68 TPDKLCFILDLMNGGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHM---HNRFVVYRDLKPANILLDEHGHVRISD  140 (279)
T ss_pred             cCCeEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCcCCCCCCHHHEEECCCCCEEEcc
Confidence            99999999999999999998864    45689999999999999999999   678899999999999999999999999


Q ss_pred             cCCccccCCCCceeeEeeecccccccCCcccC-CCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHHHh
Q 011360          356 LGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQ-QPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMN  434 (487)
Q Consensus       356 Fg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~  434 (487)
                      ||++........    ....|++.|+|||.+. +..++.++|||||||++|+|++|..||.......    .........
T Consensus       141 fg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----~~~~~~~~~  212 (279)
T cd05633         141 LGLACDFSKKKP----HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD----KHEIDRMTL  212 (279)
T ss_pred             CCcceeccccCc----cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC----HHHHHHHhh
Confidence            999875533221    2345899999999886 4568999999999999999999999995433211    111211111


Q ss_pred             cCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCC-----ChHHHHH
Q 011360          435 SKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERP-----NSQYVRC  481 (487)
Q Consensus       435 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~~il~  481 (487)
                      ..      +..++    ...+..+.+++.+||..||++||     |++++++
T Consensus       213 ~~------~~~~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~  254 (279)
T cd05633         213 TV------NVELP----DSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE  254 (279)
T ss_pred             cC------CcCCc----cccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence            11      11121    12335688999999999999999     5888876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=9.9e-36  Score=286.44  Aligned_cols=248  Identities=29%  Similarity=0.348  Sum_probs=190.8

Q ss_pred             cccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceEEecCCe
Q 011360          200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDC  279 (487)
Q Consensus       200 lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  279 (487)
                      ||.|+||.||++.. ..+|+.||+|.+...            ..........+..|+.+++.++||||+++++++...+.
T Consensus         1 lg~g~~g~vy~~~~-~~~~~~~~ik~~~~~------------~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   67 (277)
T cd05577           1 LGKGGFGEVCACQV-KATGKMYACKKLDKK------------RLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDD   67 (277)
T ss_pred             CCCCCceeEEEEEE-cCCCcEEEEEEEehh------------hhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCe
Confidence            68999999999964 457899999987320            11112234456789999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEeccCCc
Q 011360          280 HLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA  359 (487)
Q Consensus       280 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~DFg~s  359 (487)
                      .|+||||+++++|.+++..  .....+++..+..++.|++.||.||   |+.|++||||+|+||+++.++.++|+|||.+
T Consensus        68 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~ql~~~l~~l---H~~~i~H~di~p~Nil~~~~~~~~l~dfg~~  142 (277)
T cd05577          68 LCLVMTLMNGGDLKYHIYN--VGEPGFPEARAIFYAAQIICGLEHL---HQRRIVYRDLKPENVLLDDHGNVRISDLGLA  142 (277)
T ss_pred             EEEEEecCCCCcHHHHHHH--cCcCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEEECCCCCEEEccCcch
Confidence            9999999999999999875  2234689999999999999999999   7788999999999999999999999999998


Q ss_pred             cccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHHHhcCCCC
Q 011360          360 MAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSKNPS  439 (487)
Q Consensus       360 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  439 (487)
                      ........   .....++..|+|||.+.+..++.++||||||+++|+|++|..||........  . ..+...... .  
T Consensus       143 ~~~~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~-~~~~~~~~~-~--  213 (277)
T cd05577         143 VELKGGKK---IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE--K-EELKRRTLE-M--  213 (277)
T ss_pred             hhhccCCc---cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc--H-HHHHhcccc-c--
Confidence            76543211   1234578899999999888899999999999999999999999954432111  1 111111110 0  


Q ss_pred             CccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCC-----ChHHHHH
Q 011360          440 RAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERP-----NSQYVRC  481 (487)
Q Consensus       440 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~~il~  481 (487)
                         ....+.    ....++.+++.+||+.+|++||     ++.+++.
T Consensus       214 ---~~~~~~----~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         214 ---AVEYPD----KFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             ---cccCCc----cCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence               011111    1235688999999999999999     6666653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.9e-35  Score=291.62  Aligned_cols=259  Identities=20%  Similarity=0.339  Sum_probs=190.5

Q ss_pred             cccccc--cceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceEEe
Q 011360          198 EKIGSG--GCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMV  275 (487)
Q Consensus       198 ~~lg~G--~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  275 (487)
                      ..||.|  +||.||+++. ..+|+.||+|.+...             .......+.+.+|+.+++.++||||+++++++.
T Consensus         4 ~~ig~g~~~~~~v~~a~~-~~~~~~vaiK~~~~~-------------~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~   69 (328)
T cd08226           4 VEIGRGFCNLTSVYLARH-TPTGTLVTVRITDLE-------------NCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFT   69 (328)
T ss_pred             HHhCCcccCceeEEEEEE-cCCCcEEEEEEeccc-------------cCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEe
Confidence            356666  9999999974 568999999987321             112234567888999999999999999999999


Q ss_pred             cCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEec
Q 011360          276 RPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISD  355 (487)
Q Consensus       276 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~D  355 (487)
                      .++..++||||+.+++|.+++...  ....+++..+..++.|++.||+||   |+.|++||||||+||+++.++.++++|
T Consensus        70 ~~~~~~~v~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~aL~~l---H~~~ivHrDlkp~Nill~~~~~~~~~~  144 (328)
T cd08226          70 TGSWLWVISPFMAYGSANSLLKTY--FPEGMSEALIGNILFGALRGLNYL---HQNGYIHRNIKASHILISGDGLVSLSG  144 (328)
T ss_pred             cCCceEEEEecccCCCHHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEeCCCcEEEec
Confidence            999999999999999999998753  234588899999999999999999   677899999999999999999999999


Q ss_pred             cCCccccCCCCcee--e---EeeecccccccCCcccCCC--CCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHH
Q 011360          356 LGLAMAIPDGYTRV--L---ISYVLGTMAYIAPEYFQQP--ELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEW  428 (487)
Q Consensus       356 Fg~s~~~~~~~~~~--~---~~~~~gt~~y~aPE~l~~~--~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~  428 (487)
                      |+.+..........  .   .....++..|+|||++.+.  .++.++|||||||++|+|++|..||......      ..
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~------~~  218 (328)
T cd08226         145 LSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT------QM  218 (328)
T ss_pred             hHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH------HH
Confidence            98654322211110  0   0112346679999998763  5789999999999999999999999543211      11


Q ss_pred             HHHHHhcCC------------------------------------CCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCC
Q 011360          429 LRKVMNSKN------------------------------------PSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEE  472 (487)
Q Consensus       429 ~~~~~~~~~------------------------------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~  472 (487)
                      .........                                    ........+...........+.+++.+||+.||++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  298 (328)
T cd08226         219 LLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEK  298 (328)
T ss_pred             HHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCccc
Confidence            111110000                                    00000111111122345678999999999999999


Q ss_pred             CCChHHHHH
Q 011360          473 RPNSQYVRC  481 (487)
Q Consensus       473 RPs~~~il~  481 (487)
                      |||+.++++
T Consensus       299 Rpta~e~l~  307 (328)
T cd08226         299 RPSASSLLS  307 (328)
T ss_pred             CCCHHHHhh
Confidence            999999974

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.3e-35  Score=287.76  Aligned_cols=248  Identities=24%  Similarity=0.426  Sum_probs=195.0

Q ss_pred             cccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceE
Q 011360          194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAH  273 (487)
Q Consensus       194 ~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  273 (487)
                      |.....||.|+||.||++... .++..||+|++..               ........+.+|+.+++.++||||+++++.
T Consensus        22 ~~~~~~lg~g~~g~v~~~~~~-~~~~~v~iK~~~~---------------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   85 (292)
T cd06657          22 LDNFIKIGEGSTGIVCIATVK-SSGKLVAVKKMDL---------------RKQQRRELLFNEVVIMRDYQHENVVEMYNS   85 (292)
T ss_pred             hhhHHHcCCCCCeEEEEEEEc-CCCeEEEEEEecc---------------cchhHHHHHHHHHHHHHhcCCcchhheeeE
Confidence            445578999999999999754 5789999998632               112234568889999999999999999999


Q ss_pred             EecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEE
Q 011360          274 MVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACI  353 (487)
Q Consensus       274 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl  353 (487)
                      +...+..+++|||+++++|.+++..     ..+++..+..++.|++.||+||   |+.|++||||+|+||+++.++.++|
T Consensus        86 ~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~l---H~~givH~dl~p~Nilv~~~~~~~l  157 (292)
T cd06657          86 YLVGDELWVVMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLKALSVL---HAQGVIHRDIKSDSILLTHDGRVKL  157 (292)
T ss_pred             EEeCCEEEEEEecCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEECCCCCEEE
Confidence            9999999999999999999988752     4578899999999999999999   6778999999999999999999999


Q ss_pred             eccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHHH
Q 011360          354 SDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVM  433 (487)
Q Consensus       354 ~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~  433 (487)
                      +|||++.........  .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||.....      .+... ..
T Consensus       158 ~dfg~~~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~------~~~~~-~~  228 (292)
T cd06657         158 SDFGFCAQVSKEVPR--RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP------LKAMK-MI  228 (292)
T ss_pred             cccccceeccccccc--ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHH-HH
Confidence            999988765432211  1234588999999999888889999999999999999999999953221      11111 11


Q ss_pred             hcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          434 NSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       434 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ....+..     +..  .......+.+++.+||+.+|.+||++.+++.
T Consensus       229 ~~~~~~~-----~~~--~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         229 RDNLPPK-----LKN--LHKVSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             HhhCCcc-----cCC--cccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            1111111     110  0112345788999999999999999999876

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=9.1e-36  Score=287.46  Aligned_cols=260  Identities=25%  Similarity=0.339  Sum_probs=193.5

Q ss_pred             cccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceE
Q 011360          194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAH  273 (487)
Q Consensus       194 ~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  273 (487)
                      |++.+.||.|++|.||+|.. ..+|..||+|++...             .........+.+|+.+++.++||||++++++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~-~~~~~~~~ik~~~~~-------------~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~   66 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARD-KLTGEIVALKKIRLE-------------TEDEGVPSTAIREISLLKELNHPNIVRLLDV   66 (283)
T ss_pred             CchheEecCCCCeEEEEEEE-cCCCCEEEEEEeecc-------------cccccchhHHHHHHHHHHhcCCCCccCHhhe
Confidence            56778999999999999975 457899999987431             1111223456789999999999999999999


Q ss_pred             EecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEE
Q 011360          274 MVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACI  353 (487)
Q Consensus       274 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl  353 (487)
                      +.+.+..|++|||++ ++|.+++...  ....+++..+..++.|++.||.||   |+++++||||+|+||+++.++.++|
T Consensus        67 ~~~~~~~~iv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~~L~~l---H~~~~~H~dl~p~nil~~~~~~~~l  140 (283)
T cd07835          67 VHSENKLYLVFEFLD-LDLKKYMDSS--PLTGLDPPLIKSYLYQLLQGIAYC---HSHRVLHRDLKPQNLLIDREGALKL  140 (283)
T ss_pred             eccCCeEEEEEeccC-cCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeCCCCCHHHEEEcCCCcEEE
Confidence            999999999999994 6899988652  224689999999999999999999   6678999999999999999999999


Q ss_pred             eccCCccccCCCCceeeEeeecccccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHH
Q 011360          354 SDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQP-ELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKV  432 (487)
Q Consensus       354 ~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~  432 (487)
                      +|||++.........  .....+++.|+|||++.+. .++.++|+||||+++|+|++|.+||.......      .....
T Consensus       141 ~df~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~------~~~~~  212 (283)
T cd07835         141 ADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID------QLFRI  212 (283)
T ss_pred             eecccccccCCCccc--cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHH
Confidence            999998765432211  1223468899999987654 57899999999999999999999995432210      01111


Q ss_pred             Hhc-CCCCC--------------cc---CCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          433 MNS-KNPSR--------------AI---DPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       433 ~~~-~~~~~--------------~~---~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ... ..+..              .+   ............+..+.+++.+||+.+|.+|||+++++.
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         213 FRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             HHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            110 00000              00   000000111223356889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=8.2e-36  Score=291.70  Aligned_cols=261  Identities=27%  Similarity=0.366  Sum_probs=193.9

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||.|+||.||+|.. ..+|..||+|++....             ........+.+|+.++.+++||||++++
T Consensus         7 ~~y~~~~~ig~g~~~~v~~~~~-~~~~~~vaiK~~~~~~-------------~~~~~~~~~~~E~~~l~~l~h~~i~~~~   72 (309)
T cd07845           7 TEFEKLNRIGEGTYGIVYRARD-TTSGEIVALKKVRMDN-------------ERDGIPISSLREITLLLNLRHPNIVELK   72 (309)
T ss_pred             cceeEeeeeeecCCEEEEEEEE-CCCCcEEEEEEEEecc-------------CCCCCcchhhHHHHHHHhCCCCCCcceE
Confidence            4699999999999999999975 4678999999884311             1111122446799999999999999999


Q ss_pred             eEEecC--CeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC
Q 011360          272 AHMVRP--DCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDM  349 (487)
Q Consensus       272 ~~~~~~--~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~  349 (487)
                      +++...  +..++||||+. ++|.+++...   ...+++..+..++.|++.||.||   |+.|++||||+|+||+++.++
T Consensus        73 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~nil~~~~~  145 (309)
T cd07845          73 EVVVGKHLDSIFLVMEYCE-QDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYL---HENFIIHRDLKVSNLLLTDKG  145 (309)
T ss_pred             EEEecCCCCeEEEEEecCC-CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEECCCC
Confidence            998754  56899999995 5888888642   35689999999999999999999   778899999999999999999


Q ss_pred             CEEEeccCCccccCCCCceeeEeeecccccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHH
Q 011360          350 EACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQ-PELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEW  428 (487)
Q Consensus       350 ~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~  428 (487)
                      .+||+|||++.........  .....+++.|+|||.+.+ ..++.++||||||+++|+|++|.+||...+.      .+.
T Consensus       146 ~~kL~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~------~~~  217 (309)
T cd07845         146 CLKIADFGLARTYGLPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE------IEQ  217 (309)
T ss_pred             CEEECccceeeecCCccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH------HHH
Confidence            9999999999876543211  122335788999998865 4688999999999999999999999954322      111


Q ss_pred             HHHHHhc-CCCCCcc-----------CCCCCCC-------CcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          429 LRKVMNS-KNPSRAI-----------DPRLPGN-------GYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       429 ~~~~~~~-~~~~~~~-----------~~~~~~~-------~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ...+... +.+....           ...++..       .....+.++.+++.+||+.||++|||+++++.
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         218 LDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             HHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            2111110 0000000           0000000       01113566789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=5.2e-36  Score=292.94  Aligned_cols=266  Identities=21%  Similarity=0.303  Sum_probs=191.8

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      -++|.+.+.||.|+||.||+|.. ..++..||+|.+....             ........+.+|+.++++++||||+++
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~aik~~~~~~-------------~~~~~~~~~~~e~~~l~~l~h~~iv~~   76 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARH-KKTKQIVALKKVLMEN-------------EKEGFPITALREIKILQLLKHENVVNL   76 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEE-CCCCcEEEEEEEeccC-------------CcCCchhHHHHHHHHHHhCCCCCccce
Confidence            34699999999999999999975 4578999999874311             111122345678999999999999999


Q ss_pred             ceEEecCC--------eeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCC
Q 011360          271 LAHMVRPD--------CHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRN  342 (487)
Q Consensus       271 ~~~~~~~~--------~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~N  342 (487)
                      ++++....        ..++||||+. ++|.+++..   ....+++..++.++.|++.||.||   |++|++|+||+|+|
T Consensus        77 ~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~l---H~~~i~H~dl~p~n  149 (310)
T cd07865          77 IEICRTKATPYNRYKGSFYLVFEFCE-HDLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYI---HRNKILHRDMKAAN  149 (310)
T ss_pred             EEEEecccccccCCCceEEEEEcCCC-cCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHH
Confidence            99887654        3499999995 588887753   234689999999999999999999   67789999999999


Q ss_pred             EEeCCCCCEEEeccCCccccCCCCce--eeEeeecccccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCccccCC
Q 011360          343 VLLNDDMEACISDLGLAMAIPDGYTR--VLISYVLGTMAYIAPEYFQQP-ELSEKCDIFSFGMLLISLVRGVPSFVFHQN  419 (487)
Q Consensus       343 ill~~~~~~kl~DFg~s~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~-~~~~~~DvwslG~~l~elltg~~pf~~~~~  419 (487)
                      |+++.++.+||+|||++.........  .......++..|+|||.+.+. .++.++||||||+++|+|++|.+||.....
T Consensus       150 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~  229 (310)
T cd07865         150 ILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTE  229 (310)
T ss_pred             EEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCH
Confidence            99999999999999999765432211  111234578899999988664 478899999999999999999999954332


Q ss_pred             CCccccHHHHHHHHhcCCCCCccCC----------CCCCCCc---------HHHHHHHHHHHhhccCCCCCCCCChHHHH
Q 011360          420 GEEICSPEWLRKVMNSKNPSRAIDP----------RLPGNGY---------EKKMLHVLKIAYICTLHDPEERPNSQYVR  480 (487)
Q Consensus       420 ~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~---------~~~~~~l~~li~~cl~~~P~~RPs~~~il  480 (487)
                      ..   ....+.... +..+....+.          ..+....         ......+.+++.+||..||.+|||+.+++
T Consensus       230 ~~---~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l  305 (310)
T cd07865         230 QH---QLTLISQLC-GSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTAL  305 (310)
T ss_pred             HH---HHHHHHHHh-CCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHh
Confidence            10   001111110 1111000000          0000000         00124567899999999999999999987


Q ss_pred             H
Q 011360          481 C  481 (487)
Q Consensus       481 ~  481 (487)
                      +
T Consensus       306 ~  306 (310)
T cd07865         306 N  306 (310)
T ss_pred             c
Confidence            5

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-36  Score=303.12  Aligned_cols=268  Identities=23%  Similarity=0.352  Sum_probs=199.4

Q ss_pred             cccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceE
Q 011360          194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAH  273 (487)
Q Consensus       194 ~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  273 (487)
                      +..-+.||.|+||.||+|+ +..+|+.||||.+..              .......+...+|++++++++|||||+++++
T Consensus        15 W~~~e~LG~Ga~g~V~rgr-nketG~~vAvK~~~~--------------~~~~r~~e~~~~EieilkKLnh~NIVk~f~i   79 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGR-NKETGRLVAVKTFNK--------------ESSLRPRERWCREIEILKKLNHPNIVKLFDI   79 (732)
T ss_pred             eeehhhhcCCccceeeeec-ccccccchhHHhhhh--------------hcccchHHHHHHHHHHHHHcCchhhhhhccc
Confidence            4556789999999999997 457999999998743              1233456778899999999999999999997


Q ss_pred             EecCC------eeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC-
Q 011360          274 MVRPD------CHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN-  346 (487)
Q Consensus       274 ~~~~~------~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~-  346 (487)
                      -.+..      ...+|||||.||||...|+.- .+...+++...+.++.+++.||.||   |++||+||||||.||++- 
T Consensus        80 ee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~P-EN~~GLpE~e~l~lL~d~~~al~~L---rEn~IvHRDlKP~NIvl~~  155 (732)
T KOG4250|consen   80 EETKFLGLVTRLPVLVMEYCSGGSLRKVLNSP-ENAYGLPESEFLDLLSDLVSALRHL---RENGIVHRDLKPGNIVLQI  155 (732)
T ss_pred             CCccccCcccccceEEEeecCCCcHHHHhcCc-ccccCCCHHHHHHHHHHHHHHHHHH---HHcCceeccCCCCcEEEee
Confidence            66543      457999999999999999863 4567899999999999999999999   788999999999999984 


Q ss_pred             -CCCC--EEEeccCCccccCCCCceeeEeeecccccccCCcccC-CCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCc
Q 011360          347 -DDME--ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQ-QPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEE  422 (487)
Q Consensus       347 -~~~~--~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~  422 (487)
                       .+|+  .||+|||.|+.+.++.   ......||..|++||.+. ...|+..+|.|||||++|+.+||..||........
T Consensus       156 Gedgq~IyKLtDfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~  232 (732)
T KOG4250|consen  156 GEDGQSIYKLTDFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKN  232 (732)
T ss_pred             cCCCceEEeeecccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccc
Confidence             3343  6999999999887664   346788999999999998 47899999999999999999999999965543321


Q ss_pred             cccHHHHHHHHhcCCCCCc-------------cCCCCCC--CCcHHHHHHHHHHHhhccCCCCCCCC--ChHHHHHHHhh
Q 011360          423 ICSPEWLRKVMNSKNPSRA-------------IDPRLPG--NGYEKKMLHVLKIAYICTLHDPEERP--NSQYVRCRLSQ  485 (487)
Q Consensus       423 ~~~~~~~~~~~~~~~~~~~-------------~~~~~~~--~~~~~~~~~l~~li~~cl~~~P~~RP--s~~~il~~L~~  485 (487)
                      ..  +.+..... ..+...             ....+|.  .-.......+-+++..+|..+|.+|-  .+.+..+.+..
T Consensus       233 ~~--~~~~~~~t-kkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~d  309 (732)
T KOG4250|consen  233 NK--EIMWHIIT-KKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDD  309 (732)
T ss_pred             cc--hhhhhhhc-cCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHH
Confidence            11  11111111 111111             1111221  12223344455666667777888887  55555555554


Q ss_pred             h
Q 011360          486 L  486 (487)
Q Consensus       486 l  486 (487)
                      |
T Consensus       310 I  310 (732)
T KOG4250|consen  310 I  310 (732)
T ss_pred             H
Confidence            4

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=2.9e-35  Score=279.23  Aligned_cols=253  Identities=27%  Similarity=0.391  Sum_probs=202.3

Q ss_pred             cccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceE
Q 011360          194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAH  273 (487)
Q Consensus       194 ~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  273 (487)
                      |...+.||.|++|.||+|... .++..|++|++...             .........+.+|+..+++++||||+++++.
T Consensus         2 ~~~~~~i~~g~~~~v~~~~~~-~~~~~~~ik~~~~~-------------~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~   67 (260)
T cd06606           2 WTRGELLGRGSFGSVYLALDK-DTGELMAVKSVELS-------------GDSEEELEALEREIRILSSLQHPNIVRYYGS   67 (260)
T ss_pred             ceeeeEeeecCceEEEEEEEC-CCCcEEEEEEeecc-------------ccchHHHHHHHHHHHHHHHcCCCCEeeEEEE
Confidence            677889999999999999754 47889999987431             1113456778899999999999999999999


Q ss_pred             EecC--CeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          274 MVRP--DCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       274 ~~~~--~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +...  ...+++|||+++++|.+++..    ...+++..+..++.|++.||.||   |+.|++|+||+|+||+++.++.+
T Consensus        68 ~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~l---h~~~~~h~dl~p~ni~i~~~~~~  140 (260)
T cd06606          68 ERDEEKNTLNIFLEYVSGGSLSSLLKK----FGKLPEPVIRKYTRQILEGLAYL---HSNGIVHRDIKGANILVDSDGVV  140 (260)
T ss_pred             EecCCCCeEEEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCccccCCCHHHEEEcCCCCE
Confidence            9988  889999999999999999875    23789999999999999999999   67889999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRK  431 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~  431 (487)
                      +|+|||.+................++..|+|||.+.+..++.++||||||+++|+|++|..||.....     .......
T Consensus       141 ~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~  215 (260)
T cd06606         141 KLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-----PMAALYK  215 (260)
T ss_pred             EEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----hHHHHHh
Confidence            99999999877654331112345688999999999888899999999999999999999999954431     1111111


Q ss_pred             HHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          432 VMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       432 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ....... .    .++.    .....+.+++.+||..+|++|||+.+++.
T Consensus       216 ~~~~~~~-~----~~~~----~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         216 IGSSGEP-P----EIPE----HLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             ccccCCC-c----CCCc----ccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            1111111 1    1111    12467999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.9e-35  Score=281.89  Aligned_cols=249  Identities=26%  Similarity=0.369  Sum_probs=194.3

Q ss_pred             cccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceEEecCCe
Q 011360          200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDC  279 (487)
Q Consensus       200 lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  279 (487)
                      ||.|+||.||++.. ..+++.+++|.+...            ..........+.+|+.++++++||||+++++.+.....
T Consensus         1 lg~g~~~~vy~~~~-~~~~~~~~~k~~~~~------------~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~   67 (265)
T cd05579           1 ISKGAYGRVFLAKK-KSTGDIYAIKVIKKA------------DMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKN   67 (265)
T ss_pred             CCCCCceEEEEEEE-CCCCCEEEEEEecch------------hhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcE
Confidence            68999999999975 456899999987321            11123455678889999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEeccCCc
Q 011360          280 HLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA  359 (487)
Q Consensus       280 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~DFg~s  359 (487)
                      .|++|||+++++|.+++..    ...+++..+..++.|++.||.||   |+.|++|+||+|+||+++.++.++|+|||++
T Consensus        68 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~l---H~~~i~H~di~~~nil~~~~~~~~l~dfg~~  140 (265)
T cd05579          68 LYLVMEYLPGGDLASLLEN----VGSLDEDVARIYIAEIVLALEYL---HSNGIIHRDLKPDNILIDSNGHLKLTDFGLS  140 (265)
T ss_pred             EEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHcCeecCCCCHHHeEEcCCCCEEEEecccc
Confidence            9999999999999999875    23689999999999999999999   6788999999999999999999999999998


Q ss_pred             cccCCCCc------eeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHHH
Q 011360          360 MAIPDGYT------RVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVM  433 (487)
Q Consensus       360 ~~~~~~~~------~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~  433 (487)
                      ........      ........++..|+|||.+....++.++||||||+++|++++|..||....      ..+......
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~------~~~~~~~~~  214 (265)
T cd05579         141 KVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET------PEEIFQNIL  214 (265)
T ss_pred             hhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHh
Confidence            76433311      111233457889999999988889999999999999999999999994332      122222222


Q ss_pred             hcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHH
Q 011360          434 NSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRL  483 (487)
Q Consensus       434 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L  483 (487)
                      ... ..      .+..  ...+..+.+++.+||+.+|++|||+..+.+.|
T Consensus       215 ~~~-~~------~~~~--~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l  255 (265)
T cd05579         215 NGK-IE------WPED--VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK  255 (265)
T ss_pred             cCC-cC------CCcc--ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence            211 11      1111  01235688999999999999999995555544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.3e-35  Score=288.19  Aligned_cols=262  Identities=24%  Similarity=0.304  Sum_probs=192.6

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||.|++|.||+|.. ..+++.||+|.+...             .........+.+|+.+++.++||||++++
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~-~~~~~~~~iK~~~~~-------------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~   67 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARD-RVTNETIALKKIRLE-------------QEDEGVPSTAIREISLLKEMQHGNIVRLQ   67 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEe-cCCCcEEEEEehhhc-------------cccccchHHHHHHHHHHHhccCCCEeeEE
Confidence            3588999999999999999975 457889999986321             11122345677899999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC-CCC
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLND-DME  350 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~-~~~  350 (487)
                      +++......|+||||++ ++|.+++..  .....+++..+..++.|++.||.||   |++|++|+||+|+||+++. ++.
T Consensus        68 ~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~~L---H~~~i~H~dl~p~nill~~~~~~  141 (294)
T PLN00009         68 DVVHSEKRLYLVFEYLD-LDLKKHMDS--SPDFAKNPRLIKTYLYQILRGIAYC---HSHRVLHRDLKPQNLLIDRRTNA  141 (294)
T ss_pred             EEEecCCeEEEEEeccc-ccHHHHHHh--CCCCCcCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCCcceEEEECCCCE
Confidence            99999999999999995 588887753  2233467888889999999999999   6788999999999999985 557


Q ss_pred             EEEeccCCccccCCCCceeeEeeecccccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHH
Q 011360          351 ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQP-ELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWL  429 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~  429 (487)
                      +||+|||++.........  .....+++.|+|||.+.+. .++.++||||||+++|+|+||.+||......      +..
T Consensus       142 ~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~------~~~  213 (294)
T PLN00009        142 LKLADFGLARAFGIPVRT--FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI------DEL  213 (294)
T ss_pred             EEEcccccccccCCCccc--cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH------HHH
Confidence            999999999765432111  1233578899999988664 6789999999999999999999999543221      111


Q ss_pred             HHHHh-cCCC-CCccC------------CCCCCC----CcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          430 RKVMN-SKNP-SRAID------------PRLPGN----GYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       430 ~~~~~-~~~~-~~~~~------------~~~~~~----~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ..... ...+ ....+            +..+..    .....+..+.+++.+||+.+|++||++.+++.
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        214 FKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             HHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence            11111 0000 00000            000000    01123356889999999999999999999875

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.2e-35  Score=286.65  Aligned_cols=261  Identities=25%  Similarity=0.383  Sum_probs=195.8

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      +|++.+.||.|++|.||+|+. ..++..||+|++....              .......+.+|+.++++++||||+++++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~-~~~~~~~~iK~~~~~~--------------~~~~~~~~~~E~~~l~~l~h~~i~~~~~   65 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRN-RTTGEIVALKEIHLDA--------------EEGTPSTAIREISLMKELKHENIVRLHD   65 (284)
T ss_pred             CceEeeeeccCCceEEEEEEE-CCCCeEEEEEEecccc--------------cccchHHHHHHHHHHHhhcCCCEeeeee
Confidence            378899999999999999975 4578999999884311              1122345667999999999999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEE
Q 011360          273 HMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC  352 (487)
Q Consensus       273 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~k  352 (487)
                      ++...+..++||||+++ +|.+++.... ....+++..+..++.|++.||.||   |+.|++||||+|+||++++++.++
T Consensus        66 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~h~dl~p~ni~~~~~~~~~  140 (284)
T cd07836          66 VIHTENKLMLVFEYMDK-DLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFC---HENRVLHRDLKPQNLLINKRGELK  140 (284)
T ss_pred             eEeeCCcEEEEEecCCc-cHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHH---HHCCeeeCCCCHHHEEECCCCcEE
Confidence            99999999999999975 8888886432 235689999999999999999999   778899999999999999999999


Q ss_pred             EeccCCccccCCCCceeeEeeecccccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHH
Q 011360          353 ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQ-PELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRK  431 (487)
Q Consensus       353 l~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~  431 (487)
                      |+|||++.........  .....++..|+|||.+.+ ..++.++||||||+++|+|++|..||......      +....
T Consensus       141 l~d~g~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~------~~~~~  212 (284)
T cd07836         141 LADFGLARAFGIPVNT--FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE------DQLLK  212 (284)
T ss_pred             EeecchhhhhcCCccc--cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH------HHHHH
Confidence            9999998765332211  122346889999998865 45789999999999999999999999544321      11111


Q ss_pred             HHhcC-CCC----------CccCCCCCCC-------CcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          432 VMNSK-NPS----------RAIDPRLPGN-------GYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       432 ~~~~~-~~~----------~~~~~~~~~~-------~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ..... .+.          ..+....+..       .....+..+.+++.+||+.+|.+|||+.+++.
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         213 IFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             HHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            11100 000          0000011100       11123456889999999999999999999874

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=3.6e-35  Score=288.14  Aligned_cols=250  Identities=27%  Similarity=0.403  Sum_probs=195.7

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      .|...+.||.|+||.||+++. ..++..+|+|.+....            .........+..|+.+++.++|||++++++
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~-~~~~~~valK~~~~~~------------~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~   92 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARD-VRTNEVVAIKKMSYSG------------KQSNEKWQDIIKEVKFLQRIKHPNSIEYKG   92 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEE-cCCCcEEEEEEEecCC------------CCchHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence            478889999999999999975 3578899999874311            112234456888999999999999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEE
Q 011360          273 HMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC  352 (487)
Q Consensus       273 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~k  352 (487)
                      ++..++..++||||+. |+|.+++..   ....+++..+..++.|++.||.||   |+.|++||||+|+||+++.++.++
T Consensus        93 ~~~~~~~~~lv~e~~~-g~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~l---H~~~i~H~dL~p~Nil~~~~~~~k  165 (317)
T cd06635          93 CYLREHTAWLVMEYCL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYL---HSHNMIHRDIKAGNILLTEPGQVK  165 (317)
T ss_pred             EEeeCCeEEEEEeCCC-CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCcccEEECCCCCEE
Confidence            9999999999999996 578777653   245689999999999999999999   778899999999999999999999


Q ss_pred             EeccCCccccCCCCceeeEeeecccccccCCcccC---CCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHH
Q 011360          353 ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQ---QPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWL  429 (487)
Q Consensus       353 l~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~  429 (487)
                      |+|||++......      ....+++.|+|||++.   ...++.++||||||+++|+|++|..||....      .....
T Consensus       166 l~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~------~~~~~  233 (317)
T cd06635         166 LADFGSASIASPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN------AMSAL  233 (317)
T ss_pred             EecCCCccccCCc------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc------HHHHH
Confidence            9999998654332      2345888999999874   4568899999999999999999999984321      11222


Q ss_pred             HHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHH
Q 011360          430 RKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRL  483 (487)
Q Consensus       430 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L  483 (487)
                      ........+.      .   .....+..+.+++.+||+.+|.+|||+.++++.+
T Consensus       234 ~~~~~~~~~~------~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~  278 (317)
T cd06635         234 YHIAQNESPT------L---QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM  278 (317)
T ss_pred             HHHHhccCCC------C---CCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence            2222222111      1   1112335688999999999999999999998743

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-35  Score=279.68  Aligned_cols=255  Identities=22%  Similarity=0.328  Sum_probs=196.7

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      .|.+.+.||.|+||.||+|.. ..++..||+|.+....          ...........+.+|+.++++++||||+++++
T Consensus         3 ~~~~~~~lg~g~~g~v~~~~~-~~~~~~~~ik~~~~~~----------~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   71 (264)
T cd06653           3 NWRLGKLLGRGAFGEVYLCYD-ADTGRELAVKQVPFDP----------DSQETSKEVNALECEIQLLKNLRHDRIVQYYG   71 (264)
T ss_pred             ceeeeeeEccCCCeEEEEEEE-cCCCCEEEEEEEecCc----------ccchhhHHHHHHHHHHHHHHHcCCCCcceEEE
Confidence            588999999999999999974 4678999999863211          00112234567889999999999999999999


Q ss_pred             EEecC--CeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          273 HMVRP--DCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       273 ~~~~~--~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      ++.+.  ..++++|||+++++|.+++..    ...+++..+..++.|++.||.||   |+.|++|+||+|+||+++.++.
T Consensus        72 ~~~~~~~~~~~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~L---H~~~i~H~dl~p~ni~i~~~~~  144 (264)
T cd06653          72 CLRDPEEKKLSIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYL---HSNMIVHRDIKGANILRDSAGN  144 (264)
T ss_pred             EEEcCCCCEEEEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHEEEcCCCC
Confidence            88764  457899999999999999864    34578889999999999999999   7788999999999999999999


Q ss_pred             EEEeccCCccccCCCCc-eeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHH
Q 011360          351 ACISDLGLAMAIPDGYT-RVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWL  429 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~  429 (487)
                      ++|+|||++........ ........++..|+|||.+.+..++.++|+||||+++|+|++|..||....      .....
T Consensus       145 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~  218 (264)
T cd06653         145 VKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYE------AMAAI  218 (264)
T ss_pred             EEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccC------HHHHH
Confidence            99999999976532111 111123458899999999998889999999999999999999999994321      12222


Q ss_pred             HHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          430 RKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       430 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .+..... ....    ++    ......+.+++.+||. +|..|||+.+++.
T Consensus       219 ~~~~~~~-~~~~----~p----~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         219 FKIATQP-TKPM----LP----DGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             HHHHcCC-CCCC----CC----cccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence            2222111 1111    12    1233568899999999 5799999998865

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-38  Score=329.13  Aligned_cols=253  Identities=23%  Similarity=0.348  Sum_probs=202.6

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      ++.....+|.|.||+||.|. +..+|...|+|.+....             ........+.+|..++..++|||+|++||
T Consensus      1236 rWqrg~~Ig~G~fG~VYtav-N~~tGellAvKEI~iq~-------------~~~k~~~~i~eEm~vlE~lnHpNlV~YyG 1301 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAV-NLDTGELLAVKEIKIQD-------------SDHKTFKLIAEEMKVLEGLNHPNLVRYYG 1301 (1509)
T ss_pred             eeccccccCCcceeeeEEee-cCCccchhhhhhhhcCc-------------cccccCcchHHHHHHHHhccCccccccCc
Confidence            35566789999999999995 66799999999774321             11334567788999999999999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEE
Q 011360          273 HMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC  352 (487)
Q Consensus       273 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~k  352 (487)
                      +-.+.+..+|.||||++|+|.+.++.    ++..++.....+..|++.|++||   |++|||||||||.||+++.+|.+|
T Consensus      1302 VEvHRekv~IFMEyC~~GsLa~ll~~----gri~dE~vt~vyt~qll~gla~L---H~~gIVHRDIK~aNI~Ld~~g~iK 1374 (1509)
T KOG4645|consen 1302 VEVHREKVYIFMEYCEGGSLASLLEH----GRIEDEMVTRVYTKQLLEGLAYL---HEHGIVHRDIKPANILLDFNGLIK 1374 (1509)
T ss_pred             eeecHHHHHHHHHHhccCcHHHHHHh----cchhhhhHHHHHHHHHHHHHHHH---HhcCceecCCCccceeeecCCcEE
Confidence            99999999999999999999999974    55677777888999999999999   788899999999999999999999


Q ss_pred             EeccCCccccCCCCce--eeEeeecccccccCCcccCCC---CCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHH
Q 011360          353 ISDLGLAMAIPDGYTR--VLISYVLGTMAYIAPEYFQQP---ELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPE  427 (487)
Q Consensus       353 l~DFg~s~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~---~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~  427 (487)
                      ++|||.|..+......  .......||+.|||||++.+.   ....+.||||+||++.||+||+.||...++...     
T Consensus      1375 ~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~a----- 1449 (1509)
T KOG4645|consen 1375 YGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWA----- 1449 (1509)
T ss_pred             eecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhH-----
Confidence            9999999877554211  111345799999999999864   456789999999999999999999976655322     


Q ss_pred             HHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          428 WLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .+..+-.+..|+      +|.    ..+.+-.+++..||..||++|=++.||++
T Consensus      1450 IMy~V~~gh~Pq------~P~----~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1450 IMYHVAAGHKPQ------IPE----RLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred             HHhHHhccCCCC------Cch----hhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence            122232333321      222    24556788999999999999988887775

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=4.3e-35  Score=280.44  Aligned_cols=243  Identities=20%  Similarity=0.269  Sum_probs=185.5

Q ss_pred             ccccccccc--ccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CCCCcc
Q 011360          192 DCFASLEKI--GSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RHRNIL  268 (487)
Q Consensus       192 ~~~~~~~~l--g~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv  268 (487)
                      +.|.+.+.+  |.|+||.||++.. ..++..+|+|.+...             ...     .  .|......+ +||||+
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~-~~~~~~~~~k~~~~~-------------~~~-----~--~e~~~~~~~~~h~~iv   72 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKH-KPTQKLFVQKIIKAK-------------NFN-----A--IEPMVHQLMKDNPNFI   72 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEE-cCCCcEEEEEEEehh-------------hcc-----h--hhHHHHHHhhcCCCEE
Confidence            346666665  9999999999964 467889999987321             000     0  011111112 799999


Q ss_pred             ccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC
Q 011360          269 PLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDD  348 (487)
Q Consensus       269 ~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~  348 (487)
                      ++++.+...+..|+||||+++++|.+++..    ...+++..+..++.|++.||.||   |+.|++||||+|+||+++.+
T Consensus        73 ~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~nil~~~~  145 (267)
T PHA03390         73 KLYYSVTTLKGHVLIMDYIKDGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDL---HKHNIIHNDIKLENVLYDRA  145 (267)
T ss_pred             EEEEEEecCCeeEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HhCCeeeCCCCHHHEEEeCC
Confidence            999999999999999999999999999864    34789999999999999999999   77889999999999999998


Q ss_pred             C-CEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHH
Q 011360          349 M-EACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPE  427 (487)
Q Consensus       349 ~-~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~  427 (487)
                      + .++|+|||++.......      ...++..|+|||++.+..++.++||||||+++|+|++|..||..... .......
T Consensus       146 ~~~~~l~dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~-~~~~~~~  218 (267)
T PHA03390        146 KDRIYLCDYGLCKIIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED-EELDLES  218 (267)
T ss_pred             CCeEEEecCccceecCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCc-chhhHHH
Confidence            8 99999999987654332      23588999999999988899999999999999999999999963322 1111112


Q ss_pred             HHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCC-hHHHHH
Q 011360          428 WLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPN-SQYVRC  481 (487)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-~~~il~  481 (487)
                      +....   .....     .+    ...+..+.+++.+||+.+|.+||+ ++++++
T Consensus       219 ~~~~~---~~~~~-----~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        219 LLKRQ---QKKLP-----FI----KNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             HHHhh---cccCC-----cc----cccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence            22111   11101     11    123456899999999999999996 588874

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-36  Score=284.21  Aligned_cols=267  Identities=28%  Similarity=0.412  Sum_probs=202.8

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHh--ccCCCCCcc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA--SQIRHRNIL  268 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l--~~l~hpnIv  268 (487)
                      .+.......+|+|.||.||+|++   +++.||||++..                  .....+..|-.+.  -.++|+||+
T Consensus       209 l~pl~l~eli~~Grfg~V~KaqL---~~~~VAVKifp~------------------~~kqs~~~Ek~Iy~lp~m~h~nIl  267 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFGCVWKAQL---DNRLVAVKIFPE------------------QEKQSFQNEKNIYSLPGMKHENIL  267 (534)
T ss_pred             CCchhhHHHhhcCccceeehhhc---cCceeEEEecCH------------------HHHHHHHhHHHHHhccCccchhHH
Confidence            34577788999999999999987   678999999832                  2334555555554  466999999


Q ss_pred             ccceEEecCC----eeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhc------CCCCeeecCC
Q 011360          269 PLLAHMVRPD----CHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMY------HSASIIHGDI  338 (487)
Q Consensus       269 ~l~~~~~~~~----~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~------h~~givH~Dl  338 (487)
                      +|++.-....    .++||++|.+.|||.+||..     ..++|....+++..+++||+|||+-      |...|+||||
T Consensus       268 ~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDl  342 (534)
T KOG3653|consen  268 QFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDL  342 (534)
T ss_pred             HhhchhccCCccccceeEEeeeccCCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccc
Confidence            9999776554    78999999999999999984     6799999999999999999999974      5677999999


Q ss_pred             CCCCEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCC-CCC-----chhHHHHHHHHHHHHHhCCC
Q 011360          339 KPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQP-ELS-----EKCDIFSFGMLLISLVRGVP  412 (487)
Q Consensus       339 kp~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~-----~~~DvwslG~~l~elltg~~  412 (487)
                      |..|||+..|++..|+|||+|..+..+.........+||.+|||||+|.+. ++.     .+.||||+|.++|||+++-.
T Consensus       343 kSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~  422 (534)
T KOG3653|consen  343 KSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCT  422 (534)
T ss_pred             cccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcc
Confidence            999999999999999999999988766554444557899999999999864 222     36899999999999999743


Q ss_pred             Ccc-ccCCC---------CccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHH
Q 011360          413 SFV-FHQNG---------EEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCR  482 (487)
Q Consensus       413 pf~-~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~  482 (487)
                      -+. +..+.         ......+.++..+-..+.+..++..+...   ..+.-+.+.+..||+.||+-|.|+.=+-++
T Consensus       423 ~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h---~~~~~l~et~EeCWDhDaeARLTA~Cv~eR  499 (534)
T KOG3653|consen  423 DADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKH---AGMAVLCETIEECWDHDAEARLTAGCVEER  499 (534)
T ss_pred             cccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcC---ccHHHHHHHHHHHcCCchhhhhhhHHHHHH
Confidence            321 11110         01112333444444444433333322222   455678899999999999999999988877


Q ss_pred             Hhhh
Q 011360          483 LSQL  486 (487)
Q Consensus       483 L~~l  486 (487)
                      +..+
T Consensus       500 ~~~l  503 (534)
T KOG3653|consen  500 MAEL  503 (534)
T ss_pred             HHHH
Confidence            7654

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=7.1e-36  Score=312.78  Aligned_cols=254  Identities=26%  Similarity=0.409  Sum_probs=188.4

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      ..+|+.+..||+||||.||+++ ++-+|+.||||++..              .........+.+|+..+++|+|||||++
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkVR-NKlDGr~YAIKKIpl--------------~~s~~~~skI~rEVk~LArLnHpNVVRY  542 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKVR-NKLDGREYAIKKIPL--------------KASDKLYSKILREVKLLARLNHPNVVRY  542 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEEe-ecccchhhhhhhccC--------------chHHHHHHHHHHHHHHHhhcCCcceeee
Confidence            4568899999999999999997 557999999999854              1134456778999999999999999998


Q ss_pred             ceEEecC-------------------------------------------------------------------------
Q 011360          271 LAHMVRP-------------------------------------------------------------------------  277 (487)
Q Consensus       271 ~~~~~~~-------------------------------------------------------------------------  277 (487)
                      |..|...                                                                         
T Consensus       543 ysAWVEs~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d  622 (1351)
T KOG1035|consen  543 YSAWVESTAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDD  622 (1351)
T ss_pred             ehhhhccCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccc
Confidence            8654210                                                                         


Q ss_pred             ----------------------------------------------CeeEEEEEecCCCCHHHHHhhhhcCCCCC-ChHH
Q 011360          278 ----------------------------------------------DCHLLVYEFMKNGSLQDILDDVSRGRREL-DWPS  310 (487)
Q Consensus       278 ----------------------------------------------~~~~lv~E~~~~gsL~~~l~~~~~~~~~l-~~~~  310 (487)
                                                                    ..+||-||||+...|.++++.    +... ....
T Consensus       623 ~dedg~~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~----N~~~~~~d~  698 (1351)
T KOG1035|consen  623 SDEDGRNLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRR----NHFNSQRDE  698 (1351)
T ss_pred             ccccccccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHh----cccchhhHH
Confidence                                                          014788999998888887764    1111 4678


Q ss_pred             HHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEeccCCccccC----------------CCCceeeEeee
Q 011360          311 RHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP----------------DGYTRVLISYV  374 (487)
Q Consensus       311 ~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~DFg~s~~~~----------------~~~~~~~~~~~  374 (487)
                      .++++++|++||.|+   |+.|||||||||.||++++++.|||+|||+++...                .+......+..
T Consensus       699 ~wrLFreIlEGLaYI---H~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~  775 (1351)
T KOG1035|consen  699 AWRLFREILEGLAYI---HDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQ  775 (1351)
T ss_pred             HHHHHHHHHHHHHHH---HhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccc
Confidence            899999999999999   89999999999999999999999999999998721                01111123456


Q ss_pred             cccccccCCcccCCC---CCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCc
Q 011360          375 LGTMAYIAPEYFQQP---ELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGY  451 (487)
Q Consensus       375 ~gt~~y~aPE~l~~~---~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  451 (487)
                      +||.-|+|||++.+.   .|+.|+|+||||++++||+.   ||...        .+....+..-..+.  ++..  .+..
T Consensus       776 VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts--------MERa~iL~~LR~g~--iP~~--~~f~  840 (1351)
T KOG1035|consen  776 VGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTS--------MERASILTNLRKGS--IPEP--ADFF  840 (1351)
T ss_pred             cceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCch--------HHHHHHHHhcccCC--CCCC--cccc
Confidence            799999999999865   49999999999999999996   45221        11111111111111  1111  1112


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          452 EKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       452 ~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .+....-.++|.++++.||++|||+.+++.
T Consensus       841 ~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  841 DPEHPEEASLIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             cccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence            222234558999999999999999999875

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-35  Score=276.84  Aligned_cols=250  Identities=26%  Similarity=0.410  Sum_probs=200.9

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      +|.+.+.||.|++|.||++.. ..++..|++|.+...             .........+.+|+.++.+++|||++++++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~-~~~~~~~~ik~~~~~-------------~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~   66 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLN-LETGDFVAIKQISLE-------------KIKEEALKSIMQEIDLLKNLKHPNIVKYIG   66 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEE-cCCCcEEEEEEeccc-------------ccCHHHHHHHHHHHHHHHhCCCCCccEEEE
Confidence            377889999999999999975 457789999988431             111245567889999999999999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEE
Q 011360          273 HMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC  352 (487)
Q Consensus       273 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~k  352 (487)
                      ++...+..+++|||+++++|.+++..    ...+++..+..++.|++.||.||   |+.|++||||+|+||+++.++.++
T Consensus        67 ~~~~~~~~~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~ni~i~~~~~~~  139 (254)
T cd06627          67 SIETSDSLYIILEYAENGSLRQIIKK----FGPFPESLVAVYVYQVLQGLAYL---HEQGVIHRDIKAANILTTKDGVVK  139 (254)
T ss_pred             EEEeCCEEEEEEecCCCCcHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHH---hhCCcccCCCCHHHEEECCCCCEE
Confidence            99999999999999999999999865    35789999999999999999999   788999999999999999999999


Q ss_pred             EeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHH
Q 011360          353 ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKV  432 (487)
Q Consensus       353 l~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~  432 (487)
                      |+|||.+.........  .....++..|+|||.+.+..++.++||||+|+++|+|++|..||.....      .......
T Consensus       140 l~d~~~~~~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~------~~~~~~~  211 (254)
T cd06627         140 LADFGVATKLNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP------MAALFRI  211 (254)
T ss_pred             EeccccceecCCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHH
Confidence            9999999876544321  1234578899999999888889999999999999999999999943221      1111112


Q ss_pred             HhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          433 MNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       433 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .....  ..+++.+        +..+.+++.+||..+|++|||+.+++.
T Consensus       212 ~~~~~--~~~~~~~--------~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         212 VQDDH--PPLPEGI--------SPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             hccCC--CCCCCCC--------CHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            11111  1122222        356889999999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=4.4e-35  Score=283.56  Aligned_cols=259  Identities=21%  Similarity=0.303  Sum_probs=199.1

Q ss_pred             cccccccccccceeEEEEEec--CCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CCCCcccc
Q 011360          194 FASLEKIGSGGCGEVYKAELP--GSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RHRNILPL  270 (487)
Q Consensus       194 ~~~~~~lg~G~~g~v~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l  270 (487)
                      |.+.+.||.|++|.||+++..  ..++..||+|.+...           ...........+..|+.++.++ +||||+++
T Consensus         2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~-----------~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~   70 (288)
T cd05583           2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKA-----------TIVQKAKTAEHTRTERQVLEAVRRCPFLVTL   70 (288)
T ss_pred             ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehH-----------HHHhhhhHHHHHHHHHHHHHhccCCcchhhh
Confidence            778899999999999999753  246788999987421           0111223445678899999999 69999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      ++.+..+...++||||+++|+|.+++..    ...+++..+..++.|++.||.||   |+.|++||||+|+||+++.++.
T Consensus        71 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~l---H~~~~~H~dl~p~nil~~~~~~  143 (288)
T cd05583          71 HYAFQTDTKLHLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHL---HQLGIIYRDIKLENILLDSEGH  143 (288)
T ss_pred             heeeecCCEEEEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHeEECCCCC
Confidence            9999999999999999999999998864    35688999999999999999999   6778999999999999999999


Q ss_pred             EEEeccCCccccCCCCceeeEeeecccccccCCcccCCCC--CCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHH
Q 011360          351 ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPE--LSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEW  428 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~  428 (487)
                      ++|+|||++.......... .....|+..|+|||.+.+..  ++.++|+||||+++|+|++|..||.....  .....+.
T Consensus       144 ~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~--~~~~~~~  220 (288)
T cd05583         144 VVLTDFGLSKEFLAEEEER-AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE--QNSQSEI  220 (288)
T ss_pred             EEEEECccccccccccccc-cccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcc--cchHHHH
Confidence            9999999987654432211 12345889999999987654  78899999999999999999999954322  1111222


Q ss_pred             HHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHh
Q 011360          429 LRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLS  484 (487)
Q Consensus       429 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~  484 (487)
                      .........+       .+..    ....+.+++.+||+.+|++|||+.++.+.|+
T Consensus       221 ~~~~~~~~~~-------~~~~----~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~  265 (288)
T cd05583         221 SRRILKSKPP-------FPKT----MSAEARDFIQKLLEKDPKKRLGANGADEIKN  265 (288)
T ss_pred             HHHHHccCCC-------CCcc----cCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence            2222221111       1111    2245789999999999999999988877664

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.9e-35  Score=284.36  Aligned_cols=252  Identities=23%  Similarity=0.366  Sum_probs=200.0

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCC-CCCccccc
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIR-HRNILPLL  271 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~  271 (487)
                      +|.+.+.||.|++|.||++.. ..++..||+|++...            ..........+..|..++.++. ||||++++
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~-~~~~~~~~ik~~~~~------------~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~   68 (280)
T cd05581           2 DFKFGKIIGEGSFSTVVLAKE-KETNKEYAIKILDKR------------QLIKEKKVKYVKIEKEVLTRLNGHPGIIKLY   68 (280)
T ss_pred             CceEeeeecCCCceEEEEEEE-cCCCCEEEEEEechH------------hccchHHHHHHHHHHHHHHhcccCCCchhHH
Confidence            588899999999999999975 457899999987320            1112233467788999999998 99999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++...+..++||||+++++|.+++..    ...+++..+..++.|++.||.||   |+.|++|+||+|+||+++.++.+
T Consensus        69 ~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~L---h~~~~~H~dl~~~ni~i~~~~~~  141 (280)
T cd05581          69 YTFQDEENLYFVLEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYL---HSKGIIHRDLKPENILLDKDMHI  141 (280)
T ss_pred             HHhcCCceEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCCHHHeEECCCCCE
Confidence            999999999999999999999999975    34799999999999999999999   67789999999999999999999


Q ss_pred             EEeccCCccccCCCCce------------------eeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCC
Q 011360          352 CISDLGLAMAIPDGYTR------------------VLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPS  413 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~p  413 (487)
                      +|+|||++.........                  .......++..|+|||.+....++.++|+||||++++++++|..|
T Consensus       142 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p  221 (280)
T cd05581         142 KITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP  221 (280)
T ss_pred             EecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCC
Confidence            99999998765433211                  111234578899999999888899999999999999999999999


Q ss_pred             ccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCh----HHHHH
Q 011360          414 FVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNS----QYVRC  481 (487)
Q Consensus       414 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~----~~il~  481 (487)
                      |.....      .........   ....+...+        +..+.+++.+||+.+|++|||+    +++++
T Consensus       222 ~~~~~~------~~~~~~~~~---~~~~~~~~~--------~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         222 FRGSNE------YLTFQKILK---LEYSFPPNF--------PPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             CCCccH------HHHHHHHHh---cCCCCCCcc--------CHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            954431      111222221   111111122        3568899999999999999999    77764

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=4.5e-35  Score=286.32  Aligned_cols=251  Identities=27%  Similarity=0.408  Sum_probs=194.4

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .+.|...+.||.|+||.||+|.. ..++..+|+|.+....            .........+.+|+.+++.++|||++++
T Consensus        14 ~~~~~~~~~lg~g~~g~v~~~~~-~~~~~~~~ik~~~~~~------------~~~~~~~~~~~~e~~~l~~l~h~~i~~~   80 (308)
T cd06634          14 EKLFSDLREIGHGSFGAVYFARD-VRNSEVVAIKKMSYSG------------KQSNEKWQDIIKEVRFLQKLRHPNTIQY   80 (308)
T ss_pred             HHHHHHHHheeeCCCEEEEEEEE-cCCCcEEEEEEEeccc------------ccChHHHHHHHHHHHHHHhCCCCCcccE
Confidence            34588889999999999999975 4578899999874210            1122234567789999999999999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      ++++...+..++||||+. |+|.+++..   ....+++..+..++.|++.||.||   |+.|++||||+|+||+++.++.
T Consensus        81 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~l~~~~~~~~~~~l~~~l~~L---H~~~i~H~dl~p~nil~~~~~~  153 (308)
T cd06634          81 RGCYLREHTAWLVMEYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYL---HSHNMIHRDVKAGNILLSEPGL  153 (308)
T ss_pred             EEEEEcCCeeEEEEEccC-CCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHhEEECCCCc
Confidence            999999999999999996 688777653   235688999999999999999999   6778999999999999999999


Q ss_pred             EEEeccCCccccCCCCceeeEeeecccccccCCcccC---CCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHH
Q 011360          351 ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQ---QPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPE  427 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~  427 (487)
                      ++|+|||++......      ....+++.|+|||.+.   ...++.++||||||+++|+|++|..||....      ..+
T Consensus       154 ~kl~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~------~~~  221 (308)
T cd06634         154 VKLGDFGSASIMAPA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN------AMS  221 (308)
T ss_pred             EEECCcccceeecCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcccc------HHH
Confidence            999999998765332      2345788999999874   3467889999999999999999999983321      112


Q ss_pred             HHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHH
Q 011360          428 WLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCR  482 (487)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~  482 (487)
                      ..........+ .     ..   .......+.+++.+||+.+|++||++.+++..
T Consensus       222 ~~~~~~~~~~~-~-----~~---~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~  267 (308)
T cd06634         222 ALYHIAQNESP-A-----LQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (308)
T ss_pred             HHHHHhhcCCC-C-----cC---cccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence            22222222111 1     11   11233568899999999999999999998763

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-35  Score=282.78  Aligned_cols=259  Identities=26%  Similarity=0.340  Sum_probs=191.8

Q ss_pred             cccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhcc---CCCCCcccc
Q 011360          194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQ---IRHRNILPL  270 (487)
Q Consensus       194 ~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~---l~hpnIv~l  270 (487)
                      |.+.+.||.|+||.||+|.+. .++..||+|.+.....             .......+.+|+.++.+   +.||||+++
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~-~~~~~~aiK~~~~~~~-------------~~~~~~~~~~e~~~l~~l~~~~h~~i~~~   66 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDL-NTGRFVALKKVRVPLS-------------EEGIPLSTLREIALLKQLESFEHPNIVRL   66 (287)
T ss_pred             CeEEEEecccCceEEEEEEEC-CCCCEEEEEEeccccc-------------cchhhhhHHHHHHHHHHhhccCCCCcceE
Confidence            567789999999999999864 4688999998843211             11112234456655544   479999999


Q ss_pred             ceEEecCCe-----eEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEe
Q 011360          271 LAHMVRPDC-----HLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLL  345 (487)
Q Consensus       271 ~~~~~~~~~-----~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill  345 (487)
                      ++++...+.     .+++|||+. ++|.+++...  ....+++..+..++.|++.||.||   |+.|++|+||+|+||++
T Consensus        67 ~~~~~~~~~~~~~~~~l~~e~~~-~~l~~~l~~~--~~~~l~~~~~~~~~~~i~~al~~L---H~~~i~h~~l~~~nili  140 (287)
T cd07838          67 LDVCHGPRTDRELKLTLVFEHVD-QDLATYLSKC--PKPGLPPETIKDLMRQLLRGVDFL---HSHRIVHRDLKPQNILV  140 (287)
T ss_pred             EEEEeeccCCCCceeEEEehhcc-cCHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeccCChhhEEE
Confidence            999988776     899999996 5898888652  234689999999999999999999   67789999999999999


Q ss_pred             CCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCcccc
Q 011360          346 NDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICS  425 (487)
Q Consensus       346 ~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~  425 (487)
                      +.++.++|+|||.+.........   ....++..|+|||.+.+..++.++|+||||+++|+|++|.+||.....      
T Consensus       141 ~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~------  211 (287)
T cd07838         141 TSDGQVKIADFGLARIYSFEMAL---TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE------  211 (287)
T ss_pred             ccCCCEEEeccCcceeccCCccc---ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh------
Confidence            99999999999998776433221   233478899999999988899999999999999999999999854322      


Q ss_pred             HHHHHHHHhcCCC-------------CCccCC---CCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          426 PEWLRKVMNSKNP-------------SRAIDP---RLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       426 ~~~~~~~~~~~~~-------------~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .+...........             ......   .............+.+++.+||+.||++||++.+++.
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         212 ADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             HHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence            1222222211000             000000   0011112244567889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=7.8e-35  Score=282.99  Aligned_cols=254  Identities=23%  Similarity=0.413  Sum_probs=191.3

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CCCCccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RHRNILP  269 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~  269 (487)
                      .+.|.+.+.||.|+||.||+|.++ .++..||||.+...              ........+..|+.++... .||||++
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~avK~~~~~--------------~~~~~~~~~~~e~~~~~~~~~~~~i~~   78 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFK-KTGHVMAVKQMRRT--------------GNKEENKRILMDLDVVLKSHDCPYIVK   78 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEEC-CCCeEEEEEEEecc--------------CChHHHHHHHHHHHHHHhccCCCchHh
Confidence            356899999999999999999864 45889999988431              1112233455566655555 5999999


Q ss_pred             cceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC
Q 011360          270 LLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDM  349 (487)
Q Consensus       270 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~  349 (487)
                      +++++......|++|||+ +++|.+++...   ...+++..+..++.|++.||.|||+  ..||+||||+|+||+++.++
T Consensus        79 ~~~~~~~~~~~~~v~e~~-~~~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~  152 (296)
T cd06618          79 CYGYFITDSDVFICMELM-STCLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASG  152 (296)
T ss_pred             hheeeecCCeEEEEeecc-CcCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCC
Confidence            999999999999999998 55787777542   3478999999999999999999942  25899999999999999999


Q ss_pred             CEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCC----CCchhHHHHHHHHHHHHHhCCCCccccCCCCcccc
Q 011360          350 EACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPE----LSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICS  425 (487)
Q Consensus       350 ~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~----~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~  425 (487)
                      .+||+|||++.........   ....++..|+|||.+.+..    ++.++||||||+++|+|++|+.||.....     .
T Consensus       153 ~~kL~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~  224 (296)
T cd06618         153 NVKLCDFGISGRLVDSKAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT-----E  224 (296)
T ss_pred             CEEECccccchhccCCCcc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh-----H
Confidence            9999999998765433221   2234788999999987543    78899999999999999999999943211     1


Q ss_pred             HHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          426 PEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       426 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .+..........+.      ++..  .....++.+++.+||+.+|++|||+.+++.
T Consensus       225 ~~~~~~~~~~~~~~------~~~~--~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  272 (296)
T cd06618         225 FEVLTKILQEEPPS------LPPN--EGFSPDFCSFVDLCLTKDHRKRPKYRELLQ  272 (296)
T ss_pred             HHHHHHHhcCCCCC------CCCC--CCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            12233333322111      1110  012356899999999999999999999875

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=7.5e-36  Score=295.22  Aligned_cols=265  Identities=25%  Similarity=0.339  Sum_probs=194.4

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||.|+||.||+|.. ..++..||+|++...             .........+.+|+.+++.++||||++++
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~-~~~~~~valK~~~~~-------------~~~~~~~~~~~~e~~~l~~l~h~~iv~~~   70 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAID-TRSGKKVAIKKIPHA-------------FDVPTLAKRTLRELKILRHFKHDNIIAIR   70 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEE-cCCCCEEEEEEeccc-------------cccccchHHHHHHHHHHHhcCCCCccCHH
Confidence            5699999999999999999974 467899999987321             11122345667899999999999999999


Q ss_pred             eEEec----CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC
Q 011360          272 AHMVR----PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLND  347 (487)
Q Consensus       272 ~~~~~----~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~  347 (487)
                      +++..    ....|+||||+. ++|.+++..    ...+++..+..++.|++.||.||   |++|++||||||+||+++.
T Consensus        71 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~dlkp~Nil~~~  142 (334)
T cd07855          71 DILRPPGADFKDVYVVMDLME-SDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYI---HSANVIHRDLKPSNLLVNE  142 (334)
T ss_pred             HhccccCCCCceEEEEEehhh-hhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEEcC
Confidence            98763    356799999995 688888753    45589999999999999999999   6778999999999999999


Q ss_pred             CCCEEEeccCCccccCCCCce--eeEeeecccccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCccccCCCCcc-
Q 011360          348 DMEACISDLGLAMAIPDGYTR--VLISYVLGTMAYIAPEYFQQ-PELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI-  423 (487)
Q Consensus       348 ~~~~kl~DFg~s~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~-  423 (487)
                      ++.+||+|||++.........  .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||......... 
T Consensus       143 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~  222 (334)
T cd07855         143 DCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLK  222 (334)
T ss_pred             CCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHH
Confidence            999999999998765432211  11123468899999998865 46899999999999999999999999543221000 


Q ss_pred             --------ccH--------HHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          424 --------CSP--------EWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       424 --------~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                              ...        ..............  +..+ .......+..+.+++.+||+.+|++|||+.+++.
T Consensus       223 ~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         223 LILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQ--PVPW-SKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             HHHHHhCCChhHhhhhhchhhHHHHHhhcccCC--CCCH-HHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence                    000        00000110000000  0000 0001123567999999999999999999999875

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-35  Score=293.71  Aligned_cols=267  Identities=24%  Similarity=0.360  Sum_probs=192.7

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||.|+||.||+|.. ..+|..||+|++...              ........+.+|+.+++.++||||++++
T Consensus         5 ~~y~i~~~lg~G~~g~vy~~~~-~~~~~~vaiK~~~~~--------------~~~~~~~~~~~E~~~l~~l~h~niv~~~   69 (336)
T cd07849           5 PRYQNLSYIGEGAYGMVCSATH-KPTGVKVAIKKISPF--------------EHQTFCQRTLREIKILRRFKHENIIGIL   69 (336)
T ss_pred             cceEEEEEEEecCCeEEEEEEE-cCCCCeEEEEEeccc--------------ccchhHHHHHHHHHHHHhCCCCCcCchh
Confidence            4699999999999999999975 467899999987321              1122345567899999999999999999


Q ss_pred             eEEecC-----CeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC
Q 011360          272 AHMVRP-----DCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN  346 (487)
Q Consensus       272 ~~~~~~-----~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~  346 (487)
                      +++...     ...|++|||+. ++|.+++.     ...+++..+..++.|++.||.||   |+.||+||||||+||+++
T Consensus        70 ~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~-----~~~l~~~~~~~i~~ql~~aL~~L---H~~~ivH~dlkp~Nill~  140 (336)
T cd07849          70 DIIRPPSFESFNDVYIVQELME-TDLYKLIK-----TQHLSNDHIQYFLYQILRGLKYI---HSANVLHRDLKPSNLLLN  140 (336)
T ss_pred             heeecccccccceEEEEehhcc-cCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHEEEC
Confidence            887644     35799999995 58887775     35689999999999999999999   778899999999999999


Q ss_pred             CCCCEEEeccCCccccCCCCcee-eEeeecccccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCccccCCCCcc-
Q 011360          347 DDMEACISDLGLAMAIPDGYTRV-LISYVLGTMAYIAPEYFQQ-PELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI-  423 (487)
Q Consensus       347 ~~~~~kl~DFg~s~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~-  423 (487)
                      .++.+||+|||++.......... ......|++.|+|||.+.+ ..++.++||||||+++|+|++|++||......... 
T Consensus       141 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~  220 (336)
T cd07849         141 TNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLN  220 (336)
T ss_pred             CCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            99999999999987654322111 1123468899999998654 56899999999999999999999999543210000 


Q ss_pred             --------ccHHHHHHHHhcCC--CCCcc--CCCCCC-CCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHH
Q 011360          424 --------CSPEWLRKVMNSKN--PSRAI--DPRLPG-NGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCR  482 (487)
Q Consensus       424 --------~~~~~~~~~~~~~~--~~~~~--~~~~~~-~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~  482 (487)
                              ...+..........  .....  .+..+. ......+..+.+++.+||+.+|++|||+.+++..
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         221 LILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             HHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                    00000000000000  00000  000000 0011234568899999999999999999998863

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=8e-35  Score=285.15  Aligned_cols=248  Identities=27%  Similarity=0.395  Sum_probs=193.0

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      .|...+.||.|+||.||+|+. ..++..|++|++....            .........+..|+.+++.++|||++++++
T Consensus        22 ~~~~~~~lg~g~~g~v~~~~~-~~~~~~v~ik~~~~~~------------~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   88 (313)
T cd06633          22 IFVGLHEIGHGSFGAVYFATN-SHTNEVVAVKKMSYSG------------KQTNEKWQDIIKEVKFLQQLKHPNTIEYKG   88 (313)
T ss_pred             HhhcceeeccCCCeEEEEEEE-CCCCcEEEEEEEeccc------------cCchHHHHHHHHHHHHHHhCCCCCCccEEE
Confidence            467778899999999999974 4578999999874311            112223456788999999999999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEE
Q 011360          273 HMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC  352 (487)
Q Consensus       273 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~k  352 (487)
                      ++.+.+..|+||||+. |+|.+++..   ....+++..+..++.|++.||.||   |+.|++|+||+|+||+++.++.++
T Consensus        89 ~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~L---H~~gi~H~dl~p~nili~~~~~~k  161 (313)
T cd06633          89 CYLKEHTAWLVMEYCL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYL---HSHNMIHRDIKAGNILLTEPGQVK  161 (313)
T ss_pred             EEEeCCEEEEEEecCC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCChhhEEECCCCCEE
Confidence            9999999999999995 578777753   245688999999999999999999   677899999999999999999999


Q ss_pred             EeccCCccccCCCCceeeEeeecccccccCCcccC---CCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHH
Q 011360          353 ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQ---QPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWL  429 (487)
Q Consensus       353 l~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~  429 (487)
                      |+|||++......      ....|+..|+|||++.   ...++.++||||||+++|+|++|..||.....      ....
T Consensus       162 L~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~------~~~~  229 (313)
T cd06633         162 LADFGSASKSSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSAL  229 (313)
T ss_pred             EeecCCCcccCCC------CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh------HHHH
Confidence            9999988643221      2345889999999974   45688999999999999999999999843321      1222


Q ss_pred             HHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          430 RKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       430 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ........+ ....        ...+..+.+++.+||+.+|.+|||+.+++.
T Consensus       230 ~~~~~~~~~-~~~~--------~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~  272 (313)
T cd06633         230 YHIAQNDSP-TLQS--------NEWTDSFRGFVDYCLQKIPQERPASAELLR  272 (313)
T ss_pred             HHHHhcCCC-CCCc--------cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            222222111 1111        112345889999999999999999999875

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=2.3e-35  Score=292.11  Aligned_cols=261  Identities=24%  Similarity=0.352  Sum_probs=192.9

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CCCCcccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RHRNILPL  270 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l  270 (487)
                      ++|.+.+.||.|+||.||+|.. ..++..+|+|++...             .........+.+|+.+++++ +||||+++
T Consensus         7 ~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~~vK~~~~~-------------~~~~~~~~~~~~E~~~l~~l~~h~ni~~~   72 (337)
T cd07852           7 RKYEILQKLGKGAYGIVWKAID-RRTKEVVALKKIFDA-------------FRNATDAQRTFREIMFLQELGDHPNIVKL   72 (337)
T ss_pred             hHHHHhHhhcCCCCeeEEEEEE-cCCCeEEEEEeeccc-------------cCcchhhhhhhHHHHHHHHhcCCCCccce
Confidence            4689999999999999999975 457889999987320             11122334567799999999 99999999


Q ss_pred             ceEEecC--CeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC
Q 011360          271 LAHMVRP--DCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDD  348 (487)
Q Consensus       271 ~~~~~~~--~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~  348 (487)
                      ++++...  ...|+||||++ ++|..++..     ..+++..+..++.|++.||.||   |+.||+||||+|+||+++.+
T Consensus        73 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~L---H~~~i~H~dl~p~nill~~~  143 (337)
T cd07852          73 LNVIKAENDKDIYLVFEYME-TDLHAVIRA-----NILEDVHKRYIMYQLLKALKYI---HSGNVIHRDLKPSNILLNSD  143 (337)
T ss_pred             eeeeccCCCceEEEEecccc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEEcCC
Confidence            9988653  46799999996 599888763     2678889999999999999999   67889999999999999999


Q ss_pred             CCEEEeccCCccccCCCCce---eeEeeecccccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccc
Q 011360          349 MEACISDLGLAMAIPDGYTR---VLISYVLGTMAYIAPEYFQQ-PELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEIC  424 (487)
Q Consensus       349 ~~~kl~DFg~s~~~~~~~~~---~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~  424 (487)
                      +.+||+|||++.........   .......|+..|+|||.+.+ ..++.++||||||+++|+|+||+.||.......   
T Consensus       144 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~---  220 (337)
T cd07852         144 CRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN---  220 (337)
T ss_pred             CcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH---
Confidence            99999999999866443221   12234568999999998764 467899999999999999999999995432211   


Q ss_pred             cHHHHHHHHhcC-C-------------CCCccC------CCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          425 SPEWLRKVMNSK-N-------------PSRAID------PRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       425 ~~~~~~~~~~~~-~-------------~~~~~~------~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                         ......... .             ....++      ...........+.++.+++.+||+.+|++|||+.+++.
T Consensus       221 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~  294 (337)
T cd07852         221 ---QLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE  294 (337)
T ss_pred             ---HHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhh
Confidence               001100000 0             000000      00000011113467899999999999999999999985

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=2e-37  Score=275.46  Aligned_cols=259  Identities=22%  Similarity=0.340  Sum_probs=202.0

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHh-ccCCCCCcccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA-SQIRHRNILPL  270 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l-~~l~hpnIv~l  270 (487)
                      ++.+-+..||.|+||+|++-.+ +.+|+..|||++...              .......+++.|.+.. +.-++||||++
T Consensus        64 ~~Lqdlg~iG~G~fG~V~KM~h-k~sg~~mAVKrIr~~--------------n~~keq~rll~e~d~~mks~~cp~IVkf  128 (361)
T KOG1006|consen   64 DNLQDLGEIGNGAFGTVNKMLH-KPSGKLMAVKRIRSN--------------NIEKEQKRLLMEHDTVMKSSNCPNIVKF  128 (361)
T ss_pred             chHHHHHHhcCCcchhhhhhhc-CccCcEEEEEEeeec--------------cchHHHHHHHHHHHHHHhhcCCcHHHHH
Confidence            4466778899999999999975 468999999998542              1234556777777654 44589999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhh-hhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDD-VSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDM  349 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~-~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~  349 (487)
                      ||....++..+|.||.| ..||..+... +.-....+++...-.+....+.||.||...|  .|||||+||+|||++..|
T Consensus       129 yGa~F~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G  205 (361)
T KOG1006|consen  129 YGALFSEGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHG  205 (361)
T ss_pred             hhhhhcCCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCC
Confidence            99999999999999999 6688776543 2234567888888899999999999997544  599999999999999999


Q ss_pred             CEEEeccCCccccCCCCceeeEeeecccccccCCcccCC--CCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHH
Q 011360          350 EACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQ--PELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPE  427 (487)
Q Consensus       350 ~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~  427 (487)
                      .+||||||++-.+..+...   +.-.|...|||||.+..  ..|+.+|||||||++|||+.||..||...+     ...+
T Consensus       206 ~vKLCDFGIcGqLv~SiAk---T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~-----svfe  277 (361)
T KOG1006|consen  206 DVKLCDFGICGQLVDSIAK---TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD-----SVFE  277 (361)
T ss_pred             CEeeecccchHhHHHHHHh---hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH-----HHHH
Confidence            9999999999776544332   34568999999998863  369999999999999999999999994432     2344


Q ss_pred             HHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          428 WLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .+..++.+..|.-..+     ....+.+..+...+.-|+.+|-+.||...++++
T Consensus       278 ql~~Vv~gdpp~l~~~-----~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  278 QLCQVVIGDPPILLFD-----KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             HHHHHHcCCCCeecCc-----ccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence            5555555444432222     222345567889999999999999999998875

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=3.8e-35  Score=279.53  Aligned_cols=256  Identities=20%  Similarity=0.303  Sum_probs=196.5

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      +|.+.+.||.|+||.||++... ..+..+++|.+.....          ..........+..|+.+++.++||||+++++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~-~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~   69 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDK-KAVAEERLKVLKEIPV----------GELNPNETVQANQEAQLLSKLDHPAIVKFHA   69 (260)
T ss_pred             CceeeeeecCCCCceEEEEEec-CCCCcceEEEeccccc----------cccCcchHHHHHHHHHHHHhCCCCcHHHHHH
Confidence            3778899999999999999754 3445566665422100          0111223345667889999999999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEE
Q 011360          273 HMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC  352 (487)
Q Consensus       273 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~k  352 (487)
                      ++.+....++||||+++++|.+++.........+++..+..++.|++.||.||   |+.|++|+||+|+||+++. +.++
T Consensus        70 ~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l---H~~~i~h~~l~~~nili~~-~~~~  145 (260)
T cd08222          70 SFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYM---HQRRILHRDLKAKNIFLKN-NLLK  145 (260)
T ss_pred             HHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHH---HHcCccccCCChhheEeec-CCEe
Confidence            99999999999999999999999876555567899999999999999999999   7789999999999999975 5799


Q ss_pred             EeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHH
Q 011360          353 ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKV  432 (487)
Q Consensus       353 l~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~  432 (487)
                      |+|||.+.........  .....|++.|+|||.+.+..++.++|+||||+++|+|++|..||....      ........
T Consensus       146 l~d~g~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~------~~~~~~~~  217 (260)
T cd08222         146 IGDFGVSRLLMGSCDL--ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN------FLSVVLRI  217 (260)
T ss_pred             ecccCceeecCCCccc--ccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHH
Confidence            9999998765433221  123457889999999988888999999999999999999999994221      12222222


Q ss_pred             HhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          433 MNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       433 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .....+      ..+    ...+.++.+++.+||..+|++||++.++++
T Consensus       218 ~~~~~~------~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         218 VEGPTP------SLP----ETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             HcCCCC------CCc----chhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence            222111      111    233456889999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.5e-35  Score=293.39  Aligned_cols=264  Identities=23%  Similarity=0.336  Sum_probs=193.9

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      +.|.+.+.||.|+||.||++.. ..++..||||.+...             .........+.+|+.+++.++||||++++
T Consensus         5 ~~y~~~~~lg~G~~~~vy~~~~-~~~~~~vaiK~~~~~-------------~~~~~~~~~~~~E~~~l~~l~h~ni~~~~   70 (337)
T cd07858           5 TKYVPIKPIGRGAYGIVCSAKN-SETNEKVAIKKIANA-------------FDNRIDAKRTLREIKLLRHLDHENVIAIK   70 (337)
T ss_pred             cceeEEEEeccCCCeEEEEEEe-cCCCCeEEEEEeccc-------------ccccchhHHHHHHHHHHHhcCCCCccchH
Confidence            4689999999999999999974 468899999987321             11122334566899999999999999999


Q ss_pred             eEEecC-----CeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC
Q 011360          272 AHMVRP-----DCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN  346 (487)
Q Consensus       272 ~~~~~~-----~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~  346 (487)
                      +++...     ...|++|||+. ++|.+++..    ...+++..+..++.|++.||.||   |++|++||||||+||+++
T Consensus        71 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~L---H~~~i~H~dlkp~Nil~~  142 (337)
T cd07858          71 DIMPPPHREAFNDVYIVYELMD-TDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYI---HSANVLHRDLKPSNLLLN  142 (337)
T ss_pred             HheecccccccCcEEEEEeCCC-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHEEEc
Confidence            987654     34799999995 689888754    45689999999999999999999   677899999999999999


Q ss_pred             CCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccc-
Q 011360          347 DDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQ-PELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEIC-  424 (487)
Q Consensus       347 ~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~-  424 (487)
                      .++.+||+|||++........  ......++..|+|||.+.. ..++.++||||||+++|+|++|.+||.......... 
T Consensus       143 ~~~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~  220 (337)
T cd07858         143 ANCDLKICDFGLARTTSEKGD--FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKL  220 (337)
T ss_pred             CCCCEEECcCccccccCCCcc--cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Confidence            999999999999986644321  1133457889999998765 468999999999999999999999995432100000 


Q ss_pred             --------cH--------HHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHH
Q 011360          425 --------SP--------EWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCR  482 (487)
Q Consensus       425 --------~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~  482 (487)
                              ..        ..........  ....++... ......+..+.+++.+||+.+|++|||++++++.
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         221 ITELLGSPSEEDLGFIRNEKARRYIRSL--PYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             HHHHhCCCChHHhhhcCchhhhHHHHhc--CcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence                    00        0000000000  000000000 0111234668899999999999999999998864

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-35  Score=311.93  Aligned_cols=269  Identities=23%  Similarity=0.303  Sum_probs=208.9

Q ss_pred             HHhhhccccccccccccccceeEEEEEecCCC------CceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHh
Q 011360          186 AFLKKEDCFASLEKIGSGGCGEVYKAELPGSN------GKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA  259 (487)
Q Consensus       186 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l  259 (487)
                      .|....++..+.+.||.|.||.|++|......      ...||||.+..              .......+.+..|+.+|
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~--------------~~~~~~~~~~~~El~~m  355 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKE--------------NASSSEKKDLMSELNVL  355 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEeccc--------------ccCcHHHHHHHHHHHHH
Confidence            45555555677789999999999999854222      46799998743              12225667889999999


Q ss_pred             ccC-CCCCccccceEEecCCeeEEEEEecCCCCHHHHHhhhh---c---CC------CCCChHHHHHHHHHHHHHHHHHH
Q 011360          260 SQI-RHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVS---R---GR------RELDWPSRHRIALGVASGLEYLH  326 (487)
Q Consensus       260 ~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~---~---~~------~~l~~~~~~~i~~qi~~~L~~Lh  326 (487)
                      ..+ .||||+.++|++...+.+++|+||+..|+|.+++...+   .   .+      ..++....+.++.||+.|++|| 
T Consensus       356 ~~~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L-  434 (609)
T KOG0200|consen  356 KELGKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYL-  434 (609)
T ss_pred             HHhcCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHH-
Confidence            999 79999999999999999999999999999999998644   0   00      2488899999999999999999 


Q ss_pred             hcCCCCeeecCCCCCCEEeCCCCCEEEeccCCccccCCCCceeeE-eeecccccccCCcccCCCCCCchhHHHHHHHHHH
Q 011360          327 MYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLI-SYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLI  405 (487)
Q Consensus       327 ~~h~~givH~Dlkp~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~-~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~  405 (487)
                        .+..+|||||.++|||++.+..+||+|||+++........... +...-+..|||||.+....|+.+|||||||++||
T Consensus       435 --~~~~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~  512 (609)
T KOG0200|consen  435 --ASVPCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLW  512 (609)
T ss_pred             --hhCCccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHH
Confidence              6777999999999999999999999999999976554333211 1111366799999999999999999999999999


Q ss_pred             HHHh-CCCCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHh
Q 011360          406 SLVR-GVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLS  484 (487)
Q Consensus       406 ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~  484 (487)
                      |++| |..||.+-..     ..+....+..+.+..      .|..    ...+++++|..||+.+|++||++.++.+.++
T Consensus       513 EifsLG~~PYp~~~~-----~~~l~~~l~~G~r~~------~P~~----c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~  577 (609)
T KOG0200|consen  513 EIFTLGGTPYPGIPP-----TEELLEFLKEGNRME------QPEH----CSDEIYDLMKSCWNADPEDRPTFSECVEFFE  577 (609)
T ss_pred             HHhhCCCCCCCCCCc-----HHHHHHHHhcCCCCC------CCCC----CCHHHHHHHHHHhCCCcccCCCHHHHHHHHH
Confidence            9999 6999944111     222322222222221      1212    2356889999999999999999999999998


Q ss_pred             hh
Q 011360          485 QL  486 (487)
Q Consensus       485 ~l  486 (487)
                      ..
T Consensus       578 ~~  579 (609)
T KOG0200|consen  578 KH  579 (609)
T ss_pred             HH
Confidence            64

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6e-36  Score=280.51  Aligned_cols=245  Identities=24%  Similarity=0.300  Sum_probs=198.9

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CCCCcccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RHRNILPL  270 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l  270 (487)
                      .+|..+.+||.|+||+|-+|. ++.+.+.+|||++....            ......++.-+.|-.+|+.. +-|.++.+
T Consensus       349 tDFnFl~VlGKGSFGKVlLae-rkgtdELyAiKiLkKDV------------iiQdDDvectm~EKrvLAL~~kppFL~ql  415 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAE-RKGTDELYAIKILKKDV------------IIQDDDVECTMVEKRVLALPGKPPFLVQL  415 (683)
T ss_pred             cccceEEEeccCccceeeeec-ccCcchhhhhhhhccce------------eeecCcccceehhhhheecCCCCchHHHH
Confidence            358999999999999999996 55678899999875432            22333445556677777766 67899999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      ..+|.+-+.+|+||||+.||+|-..++.+    +.+.+..+..++..|+-||-+|   |++||++||||.+||+++.+|+
T Consensus       416 HScFQTmDRLyFVMEyvnGGDLMyhiQQ~----GkFKEp~AvFYAaEiaigLFFL---h~kgIiYRDLKLDNvmLd~eGH  488 (683)
T KOG0696|consen  416 HSCFQTMDRLYFVMEYVNGGDLMYHIQQV----GKFKEPVAVFYAAEIAIGLFFL---HSKGIIYRDLKLDNVMLDSEGH  488 (683)
T ss_pred             HHHhhhhhheeeEEEEecCchhhhHHHHh----cccCCchhhhhhHHHHHHhhhh---hcCCeeeeeccccceEeccCCc
Confidence            99999999999999999999999999864    5577888899999999999999   8999999999999999999999


Q ss_pred             EEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHH
Q 011360          351 ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLR  430 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~  430 (487)
                      +||+|||+++.---+  .....+++|||.|+|||++...+|+.++|+||||++||||+.|++||.+.+      ..+...
T Consensus       489 iKi~DFGmcKEni~~--~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeD------E~elF~  560 (683)
T KOG0696|consen  489 IKIADFGMCKENIFD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED------EDELFQ  560 (683)
T ss_pred             eEeeecccccccccC--CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCC------HHHHHH
Confidence            999999999764322  223467899999999999999999999999999999999999999995433      234455


Q ss_pred             HHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCC
Q 011360          431 KVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPN  475 (487)
Q Consensus       431 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs  475 (487)
                      .++..+..       .    ....+.+...+....|.+.|.+|..
T Consensus       561 aI~ehnvs-------y----PKslSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  561 AIMEHNVS-------Y----PKSLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             HHHHccCc-------C----cccccHHHHHHHHHHhhcCCccccC
Confidence            55443321       1    1223456778888899999999953

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-35  Score=283.85  Aligned_cols=259  Identities=25%  Similarity=0.373  Sum_probs=194.3

Q ss_pred             cccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceE
Q 011360          194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAH  273 (487)
Q Consensus       194 ~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  273 (487)
                      |.+.+.||.|++|.||+|.. ..++..+|+|++....             ........+.+|+.+++.++|||+++++++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~-~~~~~~~~~K~~~~~~-------------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~   66 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARN-KKTGELVALKKIRMEN-------------EKEGFPITAIREIKLLQKLRHPNIVRLKEI   66 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEE-CCCCeEEEEEEEeccc-------------ccccchHHHHHHHHHHHhccCCCeeeheee
Confidence            56788999999999999975 4568899999985311             122234567789999999999999999999


Q ss_pred             EecC--CeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          274 MVRP--DCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       274 ~~~~--~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +...  +..++||||+++ +|.+++..   ....+++..++.++.|++.||+||   |+.|++|+||+|+||++++++.+
T Consensus        67 ~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~i~~~i~~al~~L---H~~~~~h~dl~p~nil~~~~~~~  139 (287)
T cd07840          67 VTSKGKGSIYMVFEYMDH-DLTGLLDS---PEVKFTESQIKCYMKQLLEGLQYL---HSNGILHRDIKGSNILINNDGVL  139 (287)
T ss_pred             EecCCCCcEEEEeccccc-cHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHH---HHCCceeccCcHHHeEEcCCCCE
Confidence            9888  889999999964 88888753   235789999999999999999999   67789999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQ-PELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLR  430 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~  430 (487)
                      +|+|||++......... ......++..|+|||.+.+ ..++.++||||||+++|+|+||..||.....      .....
T Consensus       140 ~l~d~g~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~------~~~~~  212 (287)
T cd07840         140 KLADFGLARPYTKRNSA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE------LEQLE  212 (287)
T ss_pred             EEccccceeeccCCCcc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh------HHHHH
Confidence            99999999876544321 1123446788999997764 4678999999999999999999999943321      11111


Q ss_pred             HHHhc---CC-----------------CCCccCCCCCCCCcHH-HHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          431 KVMNS---KN-----------------PSRAIDPRLPGNGYEK-KMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       431 ~~~~~---~~-----------------~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .....   ..                 +.......+. ..... .+..+.+++.+||+.+|.+|||+++++.
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         213 KIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLR-EFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             HHHHHhCCCchhhccccccchhhhhccccccchhHHH-HHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            11110   00                 0000000000 00011 2567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=9e-35  Score=279.94  Aligned_cols=248  Identities=25%  Similarity=0.319  Sum_probs=185.3

Q ss_pred             ccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceEEecCC
Q 011360          199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPD  278 (487)
Q Consensus       199 ~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  278 (487)
                      .||.|+||.||++.. ..+++.||+|.+........         ...............++...||||+.+++++...+
T Consensus         1 ~ig~g~~g~Vy~~~~-~~~~~~vaiK~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~   70 (278)
T cd05606           1 IIGRGGFGEVYGCRK-ADTGKMYAMKCLDKKRIKMK---------QGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD   70 (278)
T ss_pred             CcccCCCeEEEEEEE-ecCCCEEEEEEeeccccccc---------hhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCC
Confidence            489999999999964 45788999998743110000         00000111122234455568999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEeccCC
Q 011360          279 CHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGL  358 (487)
Q Consensus       279 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~DFg~  358 (487)
                      ..++||||+.||+|.+++..    ...+++..+..++.|++.||.||   |+.+++||||+|+||+++.++.++|+|||+
T Consensus        71 ~~~~v~e~~~g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~l---H~~~i~H~di~p~nili~~~~~~kl~dfg~  143 (278)
T cd05606          71 KLSFILDLMNGGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHM---HNRFVVYRDLKPANILLDEHGHVRISDLGL  143 (278)
T ss_pred             EEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCEEcCCCCHHHEEECCCCCEEEccCcC
Confidence            99999999999999988864    45789999999999999999999   678899999999999999999999999999


Q ss_pred             ccccCCCCceeeEeeecccccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHHHhcCC
Q 011360          359 AMAIPDGYTRVLISYVLGTMAYIAPEYFQQP-ELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSKN  437 (487)
Q Consensus       359 s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  437 (487)
                      +........    ....|+..|+|||.+.++ .++.++||||+|+++|+|++|..||........    .......... 
T Consensus       144 ~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~~~-  214 (278)
T cd05606         144 ACDFSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK----HEIDRMTLTM-  214 (278)
T ss_pred             ccccCccCC----cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch----HHHHHHhhcc-
Confidence            876543222    234689999999998754 689999999999999999999999954422111    1111111111 


Q ss_pred             CCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCC-----ChHHHHH
Q 011360          438 PSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERP-----NSQYVRC  481 (487)
Q Consensus       438 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~~il~  481 (487)
                           +..++..    .+.++.+++.+||..+|.+||     ++.++++
T Consensus       215 -----~~~~~~~----~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         215 -----AVELPDS----FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             -----CCCCCCc----CCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence                 1112221    235688999999999999999     9999875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-35  Score=281.59  Aligned_cols=259  Identities=26%  Similarity=0.352  Sum_probs=196.6

Q ss_pred             cccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceE
Q 011360          194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAH  273 (487)
Q Consensus       194 ~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  273 (487)
                      |.+.+.||.|++|.||++.. ..++..+++|.+...             .........+.+|+.+++.++||||++++++
T Consensus         1 y~~~~~i~~g~~~~v~~~~~-~~~~~~~~ik~~~~~-------------~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~   66 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARD-KLTGEIVAIKKIKLR-------------FESEGIPKTALREIKLLKELNHPNIIKLLDV   66 (283)
T ss_pred             CccceeeecCCCceEEEEEc-CCCCcEEEEEEeccc-------------cccchhHHHHHHHHHHHHHhcCCCcchHHHh
Confidence            56778999999999999975 457899999987331             1122344577789999999999999999999


Q ss_pred             EecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEE
Q 011360          274 MVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACI  353 (487)
Q Consensus       274 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl  353 (487)
                      +..++..++||||+++ +|.+++..   ....+++..+..++.|++.||.||   |+.|++|+||+|+||+++.++.++|
T Consensus        67 ~~~~~~~~~v~e~~~~-~l~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~L---H~~~i~H~dl~p~nili~~~~~~~l  139 (283)
T cd05118          67 FRHKGDLYLVFEFMDT-DLYKLIKD---RQRGLPESLIKSYLYQLLQGLAFC---HSHGILHRDLKPENLLINTEGVLKL  139 (283)
T ss_pred             hccCCCEEEEEeccCC-CHHHHHHh---hcccCCHHHHHHHHHHHHHHHHHH---HHCCeeecCcCHHHEEECCCCcEEE
Confidence            9999999999999965 88888764   235789999999999999999999   6778999999999999999999999


Q ss_pred             eccCCccccCCCCceeeEeeecccccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHH
Q 011360          354 SDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQP-ELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKV  432 (487)
Q Consensus       354 ~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~  432 (487)
                      +|||.+........  ......++..|+|||.+.+. .++.++|+||||+++|+|+||+.||.......      .....
T Consensus       140 ~df~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~------~~~~~  211 (283)
T cd05118         140 ADFGLARSFGSPVR--PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID------QLFKI  211 (283)
T ss_pred             eeeeeeEecCCCcc--cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHH
Confidence            99999877654431  11234578899999998776 78999999999999999999999995433211      01000


Q ss_pred             Hh-cCCCCCccC-----------CCCC-------CCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          433 MN-SKNPSRAID-----------PRLP-------GNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       433 ~~-~~~~~~~~~-----------~~~~-------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .. .+.+....-           ...+       .......+.++.+++.+||+.+|.+||++++++.
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         212 FRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             HHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence            00 000000000           0000       0112234567999999999999999999999875

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=3.8e-36  Score=272.76  Aligned_cols=270  Identities=24%  Similarity=0.331  Sum_probs=199.7

Q ss_pred             cccccccccccccceeEEEEEecCCC---CceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSN---GKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNIL  268 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv  268 (487)
                      ..|+.+..||+|++|.||+|.-...+   .+.+|||++..             ............+|+.+++.++||||+
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~-------------~kd~tGiS~SAcREiaL~REl~h~nvi   90 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKG-------------EKDGTGISMSACREIALLRELKHPNVI   90 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhc-------------cCCCCCcCHHHHHHHHHHHHhcCCcch
Confidence            35899999999999999999533222   23689997732             111223344567899999999999999


Q ss_pred             ccceEEec-CCeeEEEEEecCCCCHHHHHhhhhcC-CCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC
Q 011360          269 PLLAHMVR-PDCHLLVYEFMKNGSLQDILDDVSRG-RRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN  346 (487)
Q Consensus       269 ~l~~~~~~-~~~~~lv~E~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~  346 (487)
                      .+..++.. +..+++++||++. +|...+..++.. .+.++...+..++.||+.|+.||   |++=|+||||||.|||+.
T Consensus        91 ~Lv~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YL---H~NWvlHRDLKPaNIlvm  166 (438)
T KOG0666|consen   91 SLVKVFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYL---HSNWVLHRDLKPANILVM  166 (438)
T ss_pred             hHHHHHhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHH---hhhheeeccCCcceEEEe
Confidence            99999887 8899999999977 899988765432 35788899999999999999999   555699999999999999


Q ss_pred             CC----CCEEEeccCCccccCCCCcee-eEeeecccccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCccccCCC
Q 011360          347 DD----MEACISDLGLAMAIPDGYTRV-LISYVLGTMAYIAPEYFQQP-ELSEKCDIFSFGMLLISLVRGVPSFVFHQNG  420 (487)
Q Consensus       347 ~~----~~~kl~DFg~s~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~-~~~~~~DvwslG~~l~elltg~~pf~~~~~~  420 (487)
                      .+    |.|||+|||+++.+....... ....++.|++|.|||.+.+. .||.+.||||.||++.||+|-.+.|.+....
T Consensus       167 gdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k  246 (438)
T KOG0666|consen  167 GDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEK  246 (438)
T ss_pred             ccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhh
Confidence            88    899999999999876554332 23456789999999998875 7999999999999999999999999665322


Q ss_pred             Ccc---ccHHHHHHHHh-cCCCCCccCCCCCCC----------------CcHH------------HHHHHHHHHhhccCC
Q 011360          421 EEI---CSPEWLRKVMN-SKNPSRAIDPRLPGN----------------GYEK------------KMLHVLKIAYICTLH  468 (487)
Q Consensus       421 ~~~---~~~~~~~~~~~-~~~~~~~~~~~~~~~----------------~~~~------------~~~~l~~li~~cl~~  468 (487)
                      ...   .....+.+++. -+.|...   ++|..                ...+            -....++++..+|..
T Consensus       247 ~~~~~Pfq~dQl~rIf~vLG~Pt~~---~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~y  323 (438)
T KOG0666|consen  247 IKTKNPFQHDQLDRIFEVLGTPTDK---DWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTY  323 (438)
T ss_pred             cccCCCchHHHHHHHHHHcCCCccc---cchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhcc
Confidence            211   11122222222 1111111   11110                0000            012367889999999


Q ss_pred             CCCCCCChHHHHH
Q 011360          469 DPEERPNSQYVRC  481 (487)
Q Consensus       469 ~P~~RPs~~~il~  481 (487)
                      ||-+|.|+++.++
T Consensus       324 DP~kRIta~qAle  336 (438)
T KOG0666|consen  324 DPIKRITAEQALE  336 (438)
T ss_pred             CchhhccHHHHhc
Confidence            9999999999875

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=9.6e-35  Score=281.43  Aligned_cols=256  Identities=21%  Similarity=0.339  Sum_probs=195.0

Q ss_pred             cccccccccccceeEEEEEecC--CCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CCCCcccc
Q 011360          194 FASLEKIGSGGCGEVYKAELPG--SNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RHRNILPL  270 (487)
Q Consensus       194 ~~~~~~lg~G~~g~v~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l  270 (487)
                      |.+.+.||.|+||.||+++...  .+|..||+|.+...           .........+.+..|+.++.++ +||||+++
T Consensus         2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~-----------~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~   70 (290)
T cd05613           2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKA-----------TIVQKAKTTEHTRTERQVLEHIRQSPFLVTL   70 (290)
T ss_pred             ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehh-----------hhhhcchHHHHHHHHHHHHHhcccCCChhce
Confidence            7788999999999999997532  47889999987321           0111222345677899999999 69999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      ++++..+...|+||||+++++|.+++..    ...+++..+..++.|++.||.||   |+.|++||||+|+||+++.++.
T Consensus        71 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~l---H~~~i~H~dl~p~nil~~~~~~  143 (290)
T cd05613          71 HYAFQTDTKLHLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHL---HKLGIIYRDIKLENILLDSNGH  143 (290)
T ss_pred             eeEeecCCeEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHeEECCCCC
Confidence            9999999999999999999999999864    35688899999999999999999   7788999999999999999999


Q ss_pred             EEEeccCCccccCCCCceeeEeeecccccccCCcccCCC--CCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHH
Q 011360          351 ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQP--ELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEW  428 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~  428 (487)
                      +||+|||++.......... .....|+..|+|||.+.+.  .++.++||||||+++|+|++|..||......  ....+.
T Consensus       144 ~kl~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--~~~~~~  220 (290)
T cd05613         144 VVLTDFGLSKEFHEDEVER-AYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK--NSQAEI  220 (290)
T ss_pred             EEEeeCccceecccccccc-cccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc--ccHHHH
Confidence            9999999987654332211 1234588999999998753  5788999999999999999999999543221  111222


Q ss_pred             HHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCC-----ChHHHHH
Q 011360          429 LRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERP-----NSQYVRC  481 (487)
Q Consensus       429 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~~il~  481 (487)
                      .........+       .+.    .....+.+++.+||+.+|++||     ++.+++.
T Consensus       221 ~~~~~~~~~~-------~~~----~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         221 SRRILKSEPP-------YPQ----EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             HHHhhccCCC-------CCc----cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence            2222221111       111    1224578999999999999997     6666654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=5.9e-35  Score=284.50  Aligned_cols=265  Identities=25%  Similarity=0.356  Sum_probs=192.7

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      +.|.+.+.||.|+||.||+|... .++..||+|.+....             ........+.+|+.+++.++||||++++
T Consensus         7 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~v~iK~~~~~~-------------~~~~~~~~~~~e~~~~~~l~h~~i~~~~   72 (302)
T cd07864           7 DKFDIIGQIGEGTYGQVYKARDK-DTGELVALKKVRLDN-------------EKEGFPITAIREIKILRQLNHRNIVNLK   72 (302)
T ss_pred             hhhheeeeecccCCEEEEEEEEC-CCCcEEEEEEEeecc-------------cccCchHHHHHHHHHHHhCCCCCeeeee
Confidence            46899999999999999999764 578899999884321             1112234567799999999999999999


Q ss_pred             eEEecCC----------eeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCC
Q 011360          272 AHMVRPD----------CHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPR  341 (487)
Q Consensus       272 ~~~~~~~----------~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~  341 (487)
                      +++....          ..++||||+++ ++.+++..   ....+++..+..++.|++.||.||   |+.||+|+||+|+
T Consensus        73 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~L---H~~~i~H~dl~p~  145 (302)
T cd07864          73 EIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLES---GLVHFSEDHIKSFMKQLLEGLNYC---HKKNFLHRDIKCS  145 (302)
T ss_pred             heecCcchhhhccccCCcEEEEEcccCc-cHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHH
Confidence            9887654          78999999975 77777653   245689999999999999999999   7778999999999


Q ss_pred             CEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCccccCCC
Q 011360          342 NVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQ-PELSEKCDIFSFGMLLISLVRGVPSFVFHQNG  420 (487)
Q Consensus       342 Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwslG~~l~elltg~~pf~~~~~~  420 (487)
                      ||++++++.+||+|||++.......... .....++..|+|||.+.+ ..++.++||||||+++|+|++|++||..... 
T Consensus       146 nili~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~-  223 (302)
T cd07864         146 NILLNNKGQIKLADFGLARLYNSEESRP-YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE-  223 (302)
T ss_pred             HEEECCCCcEEeCcccccccccCCcccc-cccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-
Confidence            9999999999999999997664432211 122346788999998865 4578999999999999999999999943221 


Q ss_pred             CccccHHHHHHHHhcCCCCCc-----------cCCCC-----CCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          421 EEICSPEWLRKVMNSKNPSRA-----------IDPRL-----PGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       421 ~~~~~~~~~~~~~~~~~~~~~-----------~~~~~-----~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                        ......+........+...           .++..     ........+..+.+++.+||+.+|++|||+.+++.
T Consensus       224 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         224 --LAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             --HHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence              1011111111111100000           00000     00001112456889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=7.7e-35  Score=280.92  Aligned_cols=264  Identities=22%  Similarity=0.323  Sum_probs=192.5

Q ss_pred             cccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCC-CCCccccce
Q 011360          194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIR-HRNILPLLA  272 (487)
Q Consensus       194 ~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~  272 (487)
                      |.+.+.||.|++|.||+|.. ..+++.|+||++...              ..........+|+..+..++ ||||+++++
T Consensus         1 y~~~~~ig~g~~g~v~~~~~-~~~~~~~~ik~~~~~--------------~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~   65 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARN-KETGELVAIKKMKKK--------------FYSWEECMNLREVKSLRKLNEHPNIVKLKE   65 (283)
T ss_pred             CeeheeeccCCceEEEEEEE-CCCCcEEEEEEehhh--------------ccchhHHHHHHHHHHHHhccCCCCchhHHH
Confidence            56778999999999999975 456889999987321              01112223456888888998 999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEE
Q 011360          273 HMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC  352 (487)
Q Consensus       273 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~k  352 (487)
                      ++..++..++||||+ +|+|.+++..  .....+++..+..++.|++.+|.||   |++|++|+||+|+||+++.++.++
T Consensus        66 ~~~~~~~~~lv~e~~-~~~l~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~L---h~~~i~H~dl~~~ni~i~~~~~~~  139 (283)
T cd07830          66 VFRENDELYFVFEYM-EGNLYQLMKD--RKGKPFSESVIRSIIYQILQGLAHI---HKHGFFHRDLKPENLLVSGPEVVK  139 (283)
T ss_pred             HhhcCCcEEEEEecC-CCCHHHHHHh--cccccCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCChhhEEEcCCCCEE
Confidence            999999999999999 8899988865  2235789999999999999999999   677899999999999999999999


Q ss_pred             EeccCCccccCCCCceeeEeeecccccccCCcccC-CCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCcc--------
Q 011360          353 ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQ-QPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI--------  423 (487)
Q Consensus       353 l~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~--------  423 (487)
                      |+|||.+.........   ....++..|+|||.+. ...++.++|+||||+++|+|++|.+||.........        
T Consensus       140 l~d~~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~  216 (283)
T cd07830         140 IADFGLAREIRSRPPY---TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLG  216 (283)
T ss_pred             EeecccceeccCCCCc---CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcC
Confidence            9999998765433221   2345788999999875 446789999999999999999999999544221100        


Q ss_pred             --ccHHHHHHHHhcCCCCCccCCCCCC---CCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          424 --CSPEWLRKVMNSKNPSRAIDPRLPG---NGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       424 --~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                        ....|.............+....+.   .........+.+++.+||+.+|++|||+++++.
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         217 TPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             CCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence              0000111110000111011100000   001112356889999999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-35  Score=277.09  Aligned_cols=264  Identities=28%  Similarity=0.397  Sum_probs=208.1

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhcc--CCCCCccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQ--IRHRNILP  269 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~  269 (487)
                      .+..+.+.+|+|.||.||+|.|   .|+.||||++..                  ...+.+.+|.++.+.  |+|+||+.
T Consensus       211 rqI~L~e~IGkGRyGEVwrG~w---rGe~VAVKiF~s------------------rdE~SWfrEtEIYqTvmLRHENILg  269 (513)
T KOG2052|consen  211 RQIVLQEIIGKGRFGEVWRGRW---RGEDVAVKIFSS------------------RDERSWFRETEIYQTVMLRHENILG  269 (513)
T ss_pred             heeEEEEEecCccccceeeccc---cCCceEEEEecc------------------cchhhhhhHHHHHHHHHhccchhhh
Confidence            3578899999999999999999   578999999832                  123455666666554  59999999


Q ss_pred             cceEEecC----CeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhc-----CCCCeeecCCCC
Q 011360          270 LLAHMVRP----DCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMY-----HSASIIHGDIKP  340 (487)
Q Consensus       270 l~~~~~~~----~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~-----h~~givH~Dlkp  340 (487)
                      |++.-..+    ..++||++|.+.|||.|||..     ..++....++++..+|+||++||..     ....|.|||||+
T Consensus       270 FIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKS  344 (513)
T KOG2052|consen  270 FIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKS  344 (513)
T ss_pred             hhhccccCCCceEEEEEeeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhcccccc
Confidence            99865543    357999999999999999974     6789999999999999999999742     356699999999


Q ss_pred             CCEEeCCCCCEEEeccCCccccCCCCce--eeEeeecccccccCCcccCCCC----C-C-chhHHHHHHHHHHHHHhC--
Q 011360          341 RNVLLNDDMEACISDLGLAMAIPDGYTR--VLISYVLGTMAYIAPEYFQQPE----L-S-EKCDIFSFGMLLISLVRG--  410 (487)
Q Consensus       341 ~Nill~~~~~~kl~DFg~s~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~----~-~-~~~DvwslG~~l~elltg--  410 (487)
                      .|||+..+|..-|+|+|+|.........  ......+||.+|||||++....    + + ..+||||||.++||+..+  
T Consensus       345 KNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~  424 (513)
T KOG2052|consen  345 KNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCE  424 (513)
T ss_pred             ccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhh
Confidence            9999999999999999999876544322  2224568999999999997541    1 2 358999999999999854  


Q ss_pred             --------CCCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHH
Q 011360          411 --------VPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCR  482 (487)
Q Consensus       411 --------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~  482 (487)
                              ++||-.-.+.  ....+.+++++...+.+..+++++.+   .+.+..+.++|+.||..||.-|-|+=.|.+.
T Consensus       425 ~ggi~eey~~Pyyd~Vp~--DPs~eeMrkVVCv~~~RP~ipnrW~s---~~~l~~m~klMkeCW~~Np~aRltALriKKt  499 (513)
T KOG2052|consen  425 SGGIVEEYQLPYYDVVPS--DPSFEEMRKVVCVQKLRPNIPNRWKS---DPALRVMAKLMKECWYANPAARLTALRIKKT  499 (513)
T ss_pred             cCCEehhhcCCcccCCCC--CCCHHHHhcceeecccCCCCCccccc---CHHHHHHHHHHHHhhcCCchhhhHHHHHHHH
Confidence                    3566433222  22346677777777777666666654   4677889999999999999999999999988


Q ss_pred             Hhhh
Q 011360          483 LSQL  486 (487)
Q Consensus       483 L~~l  486 (487)
                      |.++
T Consensus       500 l~~l  503 (513)
T KOG2052|consen  500 LAKL  503 (513)
T ss_pred             HHHH
Confidence            8765

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=9e-35  Score=286.56  Aligned_cols=263  Identities=22%  Similarity=0.346  Sum_probs=193.1

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .++|.+.+.||.|+||.||++. +..++..||+|++...             .........+..|+.++..++||||+++
T Consensus         9 ~~~y~~~~~ig~g~~g~v~~~~-~~~~~~~vaiK~~~~~-------------~~~~~~~~~~~~E~~~l~~l~hpniv~~   74 (328)
T cd07856           9 TNRYVDLQPVGMGAFGLVCSAR-DQLTGQNVAIKKIMKP-------------FSTPVLAKRTYRELKLLKHLRHENIISL   74 (328)
T ss_pred             ccceEEEEeecccCCeEEEEEE-ECCCCCEEEEEEeccc-------------ccccchhHHHHHHHHHHHhcCCCCeeeE
Confidence            4579999999999999999996 4568899999987321             1112234567789999999999999999


Q ss_pred             ceEEec-CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC
Q 011360          271 LAHMVR-PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDM  349 (487)
Q Consensus       271 ~~~~~~-~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~  349 (487)
                      ++++.. ....|++|||+ +++|.+++.     ...++...+..++.|++.||.||   |+.|++||||+|+||+++.++
T Consensus        75 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~-----~~~~~~~~~~~~~~ql~~aL~~L---H~~~iiH~dl~p~Nili~~~~  145 (328)
T cd07856          75 SDIFISPLEDIYFVTELL-GTDLHRLLT-----SRPLEKQFIQYFLYQILRGLKYV---HSAGVVHRDLKPSNILINENC  145 (328)
T ss_pred             eeeEecCCCcEEEEeehh-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEeECCCC
Confidence            998865 56789999999 668988875     24578888899999999999999   778899999999999999999


Q ss_pred             CEEEeccCCccccCCCCceeeEeeecccccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCccccCCCCcc-----
Q 011360          350 EACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQ-PELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI-----  423 (487)
Q Consensus       350 ~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~-----  423 (487)
                      .++|+|||.+.......     ....++..|+|||.+.+ ..++.++||||||+++|+|+||.+||.........     
T Consensus       146 ~~~l~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~  220 (328)
T cd07856         146 DLKICDFGLARIQDPQM-----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITD  220 (328)
T ss_pred             CEEeCccccccccCCCc-----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            99999999987543322     23357889999998765 57899999999999999999999999543321000     


Q ss_pred             ----ccHHHHHHHHhcCCCCCc--cC--CCCCC-CCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          424 ----CSPEWLRKVMNSKNPSRA--ID--PRLPG-NGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       424 ----~~~~~~~~~~~~~~~~~~--~~--~~~~~-~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                          ...++.............  +.  ...+. .........+.+++.+||+.+|++|||+.+++.
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~  287 (328)
T cd07856         221 LLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA  287 (328)
T ss_pred             HhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                001111111000000000  00  00000 000112356889999999999999999999875

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-35  Score=269.13  Aligned_cols=258  Identities=24%  Similarity=0.401  Sum_probs=204.6

Q ss_pred             cccc-cccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CCCCccccc
Q 011360          194 FASL-EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RHRNILPLL  271 (487)
Q Consensus       194 ~~~~-~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~  271 (487)
                      |.+. +.||+|+++.|..+. ...+|..||||++.               +.......++.+|++++.+. .|+||+.++
T Consensus        79 YkLt~e~LGeGAyasVqtcv-~i~t~~EYAVKiid---------------Kq~gHsR~RvfREVe~f~~Cqgh~nilqLi  142 (463)
T KOG0607|consen   79 YKLTSELLGEGAYASVQTCV-SIQTGKEYAVKIID---------------KQPGHSRSRVFREVETFYQCQGHKNILQLI  142 (463)
T ss_pred             HHhHHHHhcCccceeeeeee-eeccchhhhhhhhh---------------cCCchHHHHHHHHHHHHHHhcCCccHHHHH
Confidence            4433 679999999999885 56799999999872               22344567788999999888 799999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC--
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDM--  349 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~--  349 (487)
                      ++|.++...|+|||-|.||+|...|..    ...+++..+.++.++|+.||.||   |.+||.||||||+|||...-.  
T Consensus       143 efFEdd~~FYLVfEKm~GGplLshI~~----~~~F~E~EAs~vvkdia~aLdFl---H~kgIAHRDlKPENiLC~~pn~v  215 (463)
T KOG0607|consen  143 EFFEDDTRFYLVFEKMRGGPLLSHIQK----RKHFNEREASRVVKDIASALDFL---HTKGIAHRDLKPENILCESPNKV  215 (463)
T ss_pred             HHhcccceEEEEEecccCchHHHHHHH----hhhccHHHHHHHHHHHHHHHHHH---hhcCcccccCCccceeecCCCCc
Confidence            999999999999999999999999976    57899999999999999999999   899999999999999997544  


Q ss_pred             -CEEEeccCCccccCCCC-----ceeeEeeecccccccCCcccC-----CCCCCchhHHHHHHHHHHHHHhCCCCccccC
Q 011360          350 -EACISDLGLAMAIPDGY-----TRVLISYVLGTMAYIAPEYFQ-----QPELSEKCDIFSFGMLLISLVRGVPSFVFHQ  418 (487)
Q Consensus       350 -~~kl~DFg~s~~~~~~~-----~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DvwslG~~l~elltg~~pf~~~~  418 (487)
                       -+|||||.+..-.....     ......+.+|+..|||||+..     ...|+.++|.||||+++|=|++|.+||.+..
T Consensus       216 sPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~C  295 (463)
T KOG0607|consen  216 SPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHC  295 (463)
T ss_pred             CceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCcc
Confidence             38999998875432111     111123467889999999763     3478999999999999999999999997764


Q ss_pred             CCC------cc---ccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          419 NGE------EI---CSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       419 ~~~------~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ...      +.   |....+..+..+.       ..+|......++.+..+++...|..++.+|.++.+++.
T Consensus       296 g~dCGWdrGe~Cr~CQ~~LFesIQEGk-------YeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  296 GADCGWDRGEVCRVCQNKLFESIQEGK-------YEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             CCcCCccCCCccHHHHHHHHHHHhccC-------CcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            311      11   1222233333222       23667777888889999999999999999999887754

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=6.6e-35  Score=285.24  Aligned_cols=263  Identities=22%  Similarity=0.318  Sum_probs=190.7

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||.|+||.||+|.. ..++..+|+|++.....             .......+.+|+.+++.++||||++++
T Consensus         8 ~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~~ik~~~~~~~-------------~~~~~~~~~~e~~~l~~l~h~~i~~~~   73 (311)
T cd07866           8 RDYEILGKLGEGTFGEVYKARQ-IKTGRVVALKKILMHNE-------------KDGFPITALREIKILKKLKHPNVVPLI   73 (311)
T ss_pred             ccEEEEEEeccCCCEEEEEEEE-CCCCcEEEEEEEEeccC-------------CCCcchhHHHHHHHHHhcCCCCccchh
Confidence            4699999999999999999975 45788999998854211             111123456799999999999999999


Q ss_pred             eEEecCC--------eeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCE
Q 011360          272 AHMVRPD--------CHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNV  343 (487)
Q Consensus       272 ~~~~~~~--------~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Ni  343 (487)
                      +++....        .+++||||+.+ +|...+..   ....+++..+..++.|+++||.||   |+.|++|+||||+||
T Consensus        74 ~~~~~~~~~~~~~~~~~~lv~~~~~~-~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~l---H~~~i~H~dl~p~ni  146 (311)
T cd07866          74 DMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLEN---PSVKLTESQIKCYMLQLLEGINYL---HENHILHRDIKAANI  146 (311)
T ss_pred             hheecccccccccCceEEEEEecCCc-CHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHE
Confidence            9875433        46999999954 67766653   245789999999999999999999   778899999999999


Q ss_pred             EeCCCCCEEEeccCCccccCCCCcee---------eEeeecccccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCC
Q 011360          344 LLNDDMEACISDLGLAMAIPDGYTRV---------LISYVLGTMAYIAPEYFQQP-ELSEKCDIFSFGMLLISLVRGVPS  413 (487)
Q Consensus       344 ll~~~~~~kl~DFg~s~~~~~~~~~~---------~~~~~~gt~~y~aPE~l~~~-~~~~~~DvwslG~~l~elltg~~p  413 (487)
                      +++.++.++|+|||++..........         ......+++.|+|||.+.+. .++.++||||||+++|+|++|.+|
T Consensus       147 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~  226 (311)
T cd07866         147 LIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPI  226 (311)
T ss_pred             EECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCC
Confidence            99999999999999997654322111         11233568889999987654 588999999999999999999999


Q ss_pred             ccccCCCCccccHHHHHHHHh---cCCCC---------C----ccCCCCCCC---CcHHHHHHHHHHHhhccCCCCCCCC
Q 011360          414 FVFHQNGEEICSPEWLRKVMN---SKNPS---------R----AIDPRLPGN---GYEKKMLHVLKIAYICTLHDPEERP  474 (487)
Q Consensus       414 f~~~~~~~~~~~~~~~~~~~~---~~~~~---------~----~~~~~~~~~---~~~~~~~~l~~li~~cl~~~P~~RP  474 (487)
                      |......      ........   ...+.         .    ......+..   ........+.+++.+||..+|.+||
T Consensus       227 ~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~  300 (311)
T cd07866         227 LQGKSDI------DQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRL  300 (311)
T ss_pred             CCCCCHH------HHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCc
Confidence            9543221      11111111   00000         0    000011110   0112235688999999999999999


Q ss_pred             ChHHHHH
Q 011360          475 NSQYVRC  481 (487)
Q Consensus       475 s~~~il~  481 (487)
                      |+.+++.
T Consensus       301 t~~ell~  307 (311)
T cd07866         301 TASDALE  307 (311)
T ss_pred             CHHHHhc
Confidence            9999874

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.3e-34  Score=287.25  Aligned_cols=257  Identities=26%  Similarity=0.361  Sum_probs=192.4

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .++|.+.+.||.|+||.||++.. ..++..||+|++...             .........+.+|+.+++.++||||+++
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~-------------~~~~~~~~~~~~E~~~l~~l~h~~iv~~   79 (343)
T cd07880          14 PDRYRDLKQVGSGAYGTVCSALD-RRTGAKVAIKKLYRP-------------FQSELFAKRAYRELRLLKHMKHENVIGL   79 (343)
T ss_pred             ccceEEEEEeeecCCeEEEEEEE-CCCCcEEEEEEeccc-------------ccchHHHHHHHHHHHHHHhcCCCCccce
Confidence            45699999999999999999974 467899999987321             1112234467789999999999999999


Q ss_pred             ceEEecCC------eeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEE
Q 011360          271 LAHMVRPD------CHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVL  344 (487)
Q Consensus       271 ~~~~~~~~------~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nil  344 (487)
                      ++++....      ..++||||+ +++|.+++..     ..+++..+..++.|++.||.||   |+.||+||||||+||+
T Consensus        80 ~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~L---H~~gi~H~dlkp~Nil  150 (343)
T cd07880          80 LDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYI---HAAGIIHRDLKPGNLA  150 (343)
T ss_pred             eeeecCCccccccceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEE
Confidence            99887654      358999999 7799888752     4689999999999999999999   7788999999999999


Q ss_pred             eCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCccccCCCCcc
Q 011360          345 LNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQ-PELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI  423 (487)
Q Consensus       345 l~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~  423 (487)
                      ++.++.++|+|||++.......     ....+++.|+|||.+.+ ..++.++|+||||+++|++++|..||.....    
T Consensus       151 l~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~----  221 (343)
T cd07880         151 VNEDCELKILDFGLARQTDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDH----  221 (343)
T ss_pred             EcCCCCEEEeecccccccccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH----
Confidence            9999999999999987654322     23457889999998876 4688999999999999999999999954321    


Q ss_pred             ccHHHHHHHHhcC-CCCCccC------------CCCCC-------CCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          424 CSPEWLRKVMNSK-NPSRAID------------PRLPG-------NGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       424 ~~~~~~~~~~~~~-~~~~~~~------------~~~~~-------~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                        ........... .+...+.            ..++.       .........+.+++.+|++.||++|||+.+++.
T Consensus       222 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         222 --LDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             --HHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence              01111111100 0000000            00000       001122345889999999999999999999873

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2e-34  Score=286.14  Aligned_cols=257  Identities=24%  Similarity=0.333  Sum_probs=190.8

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .++|.+.+.||+|+||.||+|.. ..++..||+|++...             .........+.+|+.++.+++||||+++
T Consensus        16 ~~~y~~~~~lg~G~~g~v~~~~~-~~~~~~vaiK~~~~~-------------~~~~~~~~~~~~Ei~~l~~l~h~~iv~~   81 (345)
T cd07877          16 PERYQNLSPVGSGAYGSVCAAFD-TKTGLRVAVKKLSRP-------------FQSIIHAKRTYRELRLLKHMKHENVIGL   81 (345)
T ss_pred             cCceEEEEEeeecCCeEEEEEEE-cCCCeEEEEEEecCc-------------chhhHHHHHHHHHHHHHHHcCCCcccce
Confidence            46799999999999999999964 457899999987321             1112234557789999999999999999


Q ss_pred             ceEEecC------CeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEE
Q 011360          271 LAHMVRP------DCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVL  344 (487)
Q Consensus       271 ~~~~~~~------~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nil  344 (487)
                      ++++...      ...|++++++ +++|.+++..     ..+++..+..++.|++.||.||   |+.||+||||||+||+
T Consensus        82 ~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~L---H~~~ivH~dlkp~NIl  152 (345)
T cd07877          82 LDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYI---HSADIIHRDLKPSNLA  152 (345)
T ss_pred             eeeeeecccccccccEEEEehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCChHHEE
Confidence            9987643      3467888887 8899888753     4589999999999999999999   6788999999999999


Q ss_pred             eCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCccccCCCCcc
Q 011360          345 LNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQ-PELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI  423 (487)
Q Consensus       345 l~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~  423 (487)
                      ++.++.+||+|||++.......     ....++..|+|||.+.+ ..++.++|||||||++|+|++|..||......   
T Consensus       153 l~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~---  224 (345)
T cd07877         153 VNEDCELKILDFGLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI---  224 (345)
T ss_pred             EcCCCCEEEecccccccccccc-----cccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---
Confidence            9999999999999987653321     23457889999998866 56889999999999999999999999533211   


Q ss_pred             ccHHHHHHHHhc-CCCCCccC---------------CCCCCCC----cHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          424 CSPEWLRKVMNS-KNPSRAID---------------PRLPGNG----YEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       424 ~~~~~~~~~~~~-~~~~~~~~---------------~~~~~~~----~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                         ......... ..+...+-               +..+...    ......++.+++.+||+.+|.+|||+.+++.
T Consensus       225 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  299 (345)
T cd07877         225 ---DQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  299 (345)
T ss_pred             ---HHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence               111111000 00000000               0000000    0012346889999999999999999999874

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.1e-34  Score=284.41  Aligned_cols=261  Identities=26%  Similarity=0.369  Sum_probs=197.1

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      +|.+.+.||.|++|.||+|+. ..++..||+|++...             .........+.+|+.+++.++||||+++++
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~-~~~~~~~~iK~~~~~-------------~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~   66 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVD-KRTGRKVAIKKISNV-------------FDDLIDAKRILREIKLLRHLRHENIIGLLD   66 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEe-CCCCcEEEEEeeccc-------------cccchhhhhHHHHHHHHHhcCCcchhhhhh
Confidence            378889999999999999975 456889999987321             111334567888999999999999999999


Q ss_pred             EEecCC-----eeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC
Q 011360          273 HMVRPD-----CHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLND  347 (487)
Q Consensus       273 ~~~~~~-----~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~  347 (487)
                      ++...+     .+|++|||++ ++|.+++..    ...+++..+..++.|++.||.||   |+.|++||||||+||+++.
T Consensus        67 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~L---H~~gi~H~dlkp~nili~~  138 (330)
T cd07834          67 ILRPPSPEDFNDVYIVTELME-TDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYL---HSANVIHRDLKPSNILVNS  138 (330)
T ss_pred             hhcccCcccccceEEEecchh-hhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcC
Confidence            988775     7899999996 588888753    34789999999999999999999   7788999999999999999


Q ss_pred             CCCEEEeccCCccccCCCCce-eeEeeecccccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCccccCCCCcccc
Q 011360          348 DMEACISDLGLAMAIPDGYTR-VLISYVLGTMAYIAPEYFQQP-ELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICS  425 (487)
Q Consensus       348 ~~~~kl~DFg~s~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~-~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~  425 (487)
                      ++.++|+|||.+......... .......++..|+|||.+.+. .++.++|+||||+++|+|++|.+||.....      
T Consensus       139 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~------  212 (330)
T cd07834         139 NCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDY------  212 (330)
T ss_pred             CCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCH------
Confidence            999999999999876544210 111334578899999999877 889999999999999999999999954331      


Q ss_pred             HHHHHHHHhc-CCCC-Ccc---------------CCC--CC-CCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          426 PEWLRKVMNS-KNPS-RAI---------------DPR--LP-GNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       426 ~~~~~~~~~~-~~~~-~~~---------------~~~--~~-~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .+........ +.+. ..+               ...  .+ .......+..+.+++.+||+.+|++|||+.+++.
T Consensus       213 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  288 (330)
T cd07834         213 IDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA  288 (330)
T ss_pred             HHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence            1111111110 0000 000               000  00 0001123467889999999999999999999986

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-34  Score=270.28  Aligned_cols=239  Identities=26%  Similarity=0.350  Sum_probs=191.2

Q ss_pred             cccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceEEecCCe
Q 011360          200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDC  279 (487)
Q Consensus       200 lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  279 (487)
                      ||.|+||.||++... .++..+|+|.+...            ..........+..|+.++++++||||+++++.+..++.
T Consensus         1 lg~G~~~~v~~~~~~-~~~~~~~~k~~~~~------------~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   67 (250)
T cd05123           1 LGKGSFGKVLLVRKK-DTGKLYAMKVLKKK------------KIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEK   67 (250)
T ss_pred             CCCCCceEEEEEEEC-CCCcEEEEEEeehh------------hhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCe
Confidence            699999999999764 46889999987431            11222345678889999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEeccCCc
Q 011360          280 HLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA  359 (487)
Q Consensus       280 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~DFg~s  359 (487)
                      .|++|||+++++|.+++..    ...+++..+..++.|++.||.||   |+.+++|+||+|+||+++.++.++|+|||.+
T Consensus        68 ~~~v~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~l---h~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~  140 (250)
T cd05123          68 LYLVLEYAPGGELFSHLSK----EGRFSEERARFYAAEIVLALEYL---HSLGIIYRDLKPENILLDADGHIKLTDFGLA  140 (250)
T ss_pred             eEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCceecCCCcceEEEcCCCcEEEeecCcc
Confidence            9999999999999999975    34689999999999999999999   6688999999999999999999999999998


Q ss_pred             cccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHHHhcCCCC
Q 011360          360 MAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSKNPS  439 (487)
Q Consensus       360 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  439 (487)
                      ........  ......++..|+|||.+.+..++.++|+||||+++|++++|..||.....      ......... .  .
T Consensus       141 ~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~~-~--~  209 (250)
T cd05123         141 KELSSEGS--RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR------KEIYEKILK-D--P  209 (250)
T ss_pred             eecccCCC--cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHhc-C--C
Confidence            76544321  12345578899999999888889999999999999999999999943322      222222222 1  1


Q ss_pred             CccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChH
Q 011360          440 RAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQ  477 (487)
Q Consensus       440 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~  477 (487)
                      ..++..+        ...+.+++.+||..+|++|||+.
T Consensus       210 ~~~~~~~--------~~~l~~~i~~~l~~~p~~R~~~~  239 (250)
T cd05123         210 LRFPEFL--------SPEARDLISGLLQKDPTKRLGSG  239 (250)
T ss_pred             CCCCCCC--------CHHHHHHHHHHhcCCHhhCCCcc
Confidence            1122222        24588999999999999999994

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-35  Score=296.32  Aligned_cols=257  Identities=21%  Similarity=0.308  Sum_probs=208.3

Q ss_pred             ccccccccccccceeEEEEEecCCC---CceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccc
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSN---GKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILP  269 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~  269 (487)
                      .....++||+|+||+||+|.|-...   +.+||||++..              .........++.|+-+|.++.|||+++
T Consensus       697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~--------------~t~~~~s~e~LdeAl~masldHpnl~R  762 (1177)
T KOG1025|consen  697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIE--------------FTSPKASIELLDEALRMASLDHPNLLR  762 (1177)
T ss_pred             hhhhhceeccccceeEEeeeEecCCceecceeEEEEeec--------------cCCchhhHHHHHHHHHHhcCCCchHHH
Confidence            3566789999999999999884331   35789998743              333445678899999999999999999


Q ss_pred             cceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC
Q 011360          270 LLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDM  349 (487)
Q Consensus       270 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~  349 (487)
                      +++++.... +.||++|+++|+|.+|++.   ....+.....+.|..||++||.||   |.+++|||||.++|+|+..-.
T Consensus       763 LLgvc~~s~-~qlvtq~mP~G~LlDyvr~---hr~~igsq~lLnw~~QIAkgM~YL---e~qrlVHrdLaaRNVLVksP~  835 (1177)
T KOG1025|consen  763 LLGVCMLST-LQLVTQLMPLGCLLDYVRE---HRDNIGSQDLLNWCYQIAKGMKYL---EEQRLVHRDLAARNVLVKSPN  835 (1177)
T ss_pred             Hhhhcccch-HHHHHHhcccchHHHHHHH---hhccccHHHHHHHHHHHHHHHHHH---HhcchhhhhhhhhheeecCCC
Confidence            999998766 7899999999999999985   356678889999999999999999   788899999999999999999


Q ss_pred             CEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccccHHH
Q 011360          350 EACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSPEW  428 (487)
Q Consensus       350 ~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~  428 (487)
                      .+|+.|||+++.+.............-++.|||-|.+....|+.++||||||+++||++| |..|+.+...       +.
T Consensus       836 hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~-------~e  908 (1177)
T KOG1025|consen  836 HVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA-------EE  908 (1177)
T ss_pred             eEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH-------HH
Confidence            999999999998877655544444456789999999999999999999999999999999 8889844322       22


Q ss_pred             HHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          429 LRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       429 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      +...++.+.- -.-+|        -...++..++.+||..|+..||+++++...+.++
T Consensus       909 I~dlle~geR-LsqPp--------iCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~  957 (1177)
T KOG1025|consen  909 IPDLLEKGER-LSQPP--------ICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRM  957 (1177)
T ss_pred             hhHHHhcccc-CCCCC--------CccHHHHHHHHHHhccCcccCccHHHHHHHHHHH
Confidence            3333332211 11122        2335799999999999999999999999988764

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.4e-34  Score=287.03  Aligned_cols=257  Identities=26%  Similarity=0.386  Sum_probs=193.7

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .++|.+...||.|++|.||+|... .++..||+|++...             .........+.+|+.+++.+.||||+++
T Consensus        14 ~~~y~~~~~ig~g~~g~vy~~~~~-~~~~~~aiK~~~~~-------------~~~~~~~~~~~~E~~~l~~l~h~~iv~~   79 (343)
T cd07851          14 PDRYQNLSPVGSGAYGQVCSAFDT-KTGRKVAIKKLSRP-------------FQSAIHAKRTYRELRLLKHMDHENVIGL   79 (343)
T ss_pred             cCceEEEEEeccCCceEEEEEEEC-CCCcEEEEEecccc-------------cchhhHHHHHHHHHHHHHhccCCCHHHH
Confidence            346999999999999999999753 57889999987321             1112234556789999999999999999


Q ss_pred             ceEEecCCe------eEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEE
Q 011360          271 LAHMVRPDC------HLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVL  344 (487)
Q Consensus       271 ~~~~~~~~~------~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nil  344 (487)
                      ++++...+.      .++|+||+ +++|.+++..     ..+++..+..++.|++.||.||   |+.||+||||+|+||+
T Consensus        80 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~L---H~~gi~H~dlkp~Nil  150 (343)
T cd07851          80 LDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYI---HSAGIIHRDLKPSNIA  150 (343)
T ss_pred             HHHhhccccccccccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeE
Confidence            998776554      89999999 7799998863     4689999999999999999999   7788999999999999


Q ss_pred             eCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCccccCCCCcc
Q 011360          345 LNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQ-PELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI  423 (487)
Q Consensus       345 l~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~  423 (487)
                      ++.++.++|+|||++.......     ....++..|+|||.+.+ ..++.++||||||+++|++++|..||......   
T Consensus       151 l~~~~~~kL~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~---  222 (343)
T cd07851         151 VNEDCELKILDFGLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI---  222 (343)
T ss_pred             ECCCCCEEEccccccccccccc-----cCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH---
Confidence            9999999999999997654331     23457889999998865 36789999999999999999999999543221   


Q ss_pred             ccHHHHHHHHhc-CCCCCccCCC---------------CCCCC----cHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          424 CSPEWLRKVMNS-KNPSRAIDPR---------------LPGNG----YEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       424 ~~~~~~~~~~~~-~~~~~~~~~~---------------~~~~~----~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                         .....+... ..+...+...               .....    ....+..+.+++.+||+.+|++|||+.+|+.
T Consensus       223 ---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         223 ---DQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             ---HHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence               111111110 0000000000               00000    0112467889999999999999999999875

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.3e-34  Score=285.43  Aligned_cols=255  Identities=25%  Similarity=0.346  Sum_probs=188.8

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||.|+||.||+|.. ..+|..||+|++...             .........+.+|+.+++.++||||++++
T Consensus        15 ~~y~~~~~ig~g~~g~v~~~~~-~~~~~~vaiK~~~~~-------------~~~~~~~~~~~~e~~~l~~l~h~niv~~~   80 (342)
T cd07879          15 ERYTSLKQVGSGAYGSVCSAID-KRTGEKVAIKKLSRP-------------FQSEIFAKRAYRELTLLKHMQHENVIGLL   80 (342)
T ss_pred             cceEEEEEeeecCCeEEEEEEe-CCCCcEEEEEEecCc-------------cccccchhHHHHHHHHHHhcCCCCccchh
Confidence            4699999999999999999975 457899999987321             11122334577899999999999999999


Q ss_pred             eEEecCC------eeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEe
Q 011360          272 AHMVRPD------CHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLL  345 (487)
Q Consensus       272 ~~~~~~~------~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill  345 (487)
                      +++....      ..++||||+. .+|..++      +..+++..+..++.|++.||.||   |+.|++||||+|+||++
T Consensus        81 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~------~~~~~~~~~~~~~~qi~~aL~~L---H~~~i~H~dlkp~NIll  150 (342)
T cd07879          81 DVFTSAVSGDEFQDFYLVMPYMQ-TDLQKIM------GHPLSEDKVQYLVYQMLCGLKYI---HSAGIIHRDLKPGNLAV  150 (342)
T ss_pred             heecccccCCCCceEEEEecccc-cCHHHHH------cCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEE
Confidence            9887543      4589999995 4776654      24588999999999999999999   77889999999999999


Q ss_pred             CCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccc
Q 011360          346 NDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQ-PELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEIC  424 (487)
Q Consensus       346 ~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~  424 (487)
                      +.++.+||+|||++.......     ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......    
T Consensus       151 ~~~~~~kL~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~----  221 (342)
T cd07879         151 NEDCELKILDFGLARHADAEM-----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL----  221 (342)
T ss_pred             CCCCCEEEeeCCCCcCCCCCC-----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH----
Confidence            999999999999987653322     23457889999999876 46889999999999999999999999543211    


Q ss_pred             cHHHHHHHHhc-CCCCC-------------cc--CCCCCCC----CcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          425 SPEWLRKVMNS-KNPSR-------------AI--DPRLPGN----GYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       425 ~~~~~~~~~~~-~~~~~-------------~~--~~~~~~~----~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                        ......... +.+..             ..  .+..+..    ........+.+++.+||+.||++|||+.+++.
T Consensus       222 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~  296 (342)
T cd07879         222 --DQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE  296 (342)
T ss_pred             --HHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence              111111110 00000             00  0000000    00112346889999999999999999999984

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-35  Score=277.49  Aligned_cols=259  Identities=20%  Similarity=0.285  Sum_probs=202.0

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCC--CC---
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIR--HR---  265 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--hp---  265 (487)
                      .++|.++..+|+|.||+|-.+ ++..++..||||+++                .-....+..+-|+.++.++.  .|   
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec-~D~~~~~~vAlKIik----------------~V~kYreAa~iEi~vLqki~~~DP~g~  150 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVEC-WDRETKEHVALKIIK----------------NVDKYREAALIEIEVLQKINESDPNGK  150 (415)
T ss_pred             ccceehhhhhcCCcccceEEE-eecCCCceehHHHHH----------------HHHHHhhHHHHHHHHHHHHHhcCCCCc
Confidence            467999999999999999999 455669999999762                22334556677899999883  23   


Q ss_pred             -CccccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEE
Q 011360          266 -NILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVL  344 (487)
Q Consensus       266 -nIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nil  344 (487)
                       -+|.+.++|+..++.|||+|.+ |-|+.++|..  ++-.+++...+..++.|+++++++|   |+.+++|-||||+|||
T Consensus       151 ~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~--N~y~~fpi~~ir~m~~QL~~sv~fL---h~~kl~HTDLKPENIL  224 (415)
T KOG0671|consen  151 FRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKE--NNYIPFPIDHIRHMGYQLLESVAFL---HDLKLTHTDLKPENIL  224 (415)
T ss_pred             eEEEeeehhhhccCceEEEEecc-ChhHHHHhcc--CCccccchHHHHHHHHHHHHHHHHH---HhcceeecCCChheEE
Confidence             3677888899999999999998 7799999976  5667899999999999999999999   8888999999999999


Q ss_pred             eCC--------------------CCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHH
Q 011360          345 LND--------------------DMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL  404 (487)
Q Consensus       345 l~~--------------------~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l  404 (487)
                      +.+                    +..++|+|||.++.-....     +..+.|..|.|||++.+-.++..+||||+||+|
T Consensus       225 fvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL  299 (415)
T KOG0671|consen  225 FVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCIL  299 (415)
T ss_pred             EeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEE
Confidence            942                    3348999999997654433     456689999999999999999999999999999


Q ss_pred             HHHHhCCCCccccCCCCccccHHHHHHHHhcCCCCCccCCC-----------------------------CCC----CCc
Q 011360          405 ISLVRGVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPR-----------------------------LPG----NGY  451 (487)
Q Consensus       405 ~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------------------~~~----~~~  451 (487)
                      +|+.||...|...++.+...   .+..+ -+..|..++...                             .|-    ...
T Consensus       300 ~ElytG~~LFqtHen~EHLa---MMerI-lGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~  375 (415)
T KOG0671|consen  300 VELYTGETLFQTHENLEHLA---MMERI-LGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQD  375 (415)
T ss_pred             EEeeccceecccCCcHHHHH---HHHHh-hCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccC
Confidence            99999999997776433221   11111 112222221111                             000    123


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          452 EKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       452 ~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ......|++|+.+||..||.+|+|+.|++.
T Consensus       376 d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  376 DLEHVQLFDLLRRMLEFDPARRITLREALS  405 (415)
T ss_pred             cHHHhHHHHHHHHHHccCccccccHHHHhc
Confidence            355667999999999999999999999875

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-34  Score=277.32  Aligned_cols=258  Identities=26%  Similarity=0.354  Sum_probs=194.8

Q ss_pred             cccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceE
Q 011360          194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAH  273 (487)
Q Consensus       194 ~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  273 (487)
                      |...+.||.|++|.||+|+. ..+++.+|+|.+....             ........+..|+.+++.++||||++++++
T Consensus         1 y~~~~~ig~g~~~~vy~~~~-~~~~~~~~iK~~~~~~-------------~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~   66 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARD-KKTGEIVALKKIRLDN-------------EEEGIPSTALREISLLKELKHPNIVKLLDV   66 (282)
T ss_pred             CeeehcccccCcceEEEeee-cCCCcEEEEEEecccc-------------ccccccHHHHHHHHHHHhcCCCCHHHHHhh
Confidence            45678899999999999975 4568999999884311             122234556789999999999999999999


Q ss_pred             EecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEE
Q 011360          274 MVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACI  353 (487)
Q Consensus       274 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl  353 (487)
                      +...+..++||||++ ++|.+++...   ...+++..+..++.|++.||.||   |+.|++||||+|+||+++.++.++|
T Consensus        67 ~~~~~~~~~v~e~~~-~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~L---H~~~i~H~~l~~~ni~~~~~~~~~l  139 (282)
T cd07829          67 IHTERKLYLVFEYCD-MDLKKYLDKR---PGPLSPNLIKSIMYQLLRGLAYC---HSHRILHRDLKPQNILINRDGVLKL  139 (282)
T ss_pred             hhcCCceEEEecCcC-cCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCChheEEEcCCCCEEE
Confidence            999999999999996 5899998752   24689999999999999999999   6778999999999999999999999


Q ss_pred             eccCCccccCCCCceeeEeeecccccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHH
Q 011360          354 SDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQP-ELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKV  432 (487)
Q Consensus       354 ~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~  432 (487)
                      +|||.+.........  .....++..|+|||.+.+. .++.++||||||+++|++++|.+||......      +.....
T Consensus       140 ~d~g~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~------~~~~~~  211 (282)
T cd07829         140 ADFGLARAFGIPLRT--YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI------DQLFKI  211 (282)
T ss_pred             ecCCcccccCCCccc--cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH------HHHHHH
Confidence            999998766443221  1223457789999998766 7899999999999999999999999543321      111111


Q ss_pred             Hh---cC----------C--CCCccCCCCCC----CCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          433 MN---SK----------N--PSRAIDPRLPG----NGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       433 ~~---~~----------~--~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ..   ..          .  ..... +....    .........+.+++.+||..+|++||++.+++.
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         212 FQILGTPTEESWPGVTKLPDYKPTF-PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             HHHhCCCcHHHHHhhcccccccccc-cccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            00   00          0  00000 00000    011122467999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.5e-34  Score=286.87  Aligned_cols=259  Identities=24%  Similarity=0.379  Sum_probs=188.8

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      .+|.+.+.||.|+||.||+|.. ..++..||+|++...               .....+.+.+|+.+++.++||||++++
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~-~~~~~~v~iK~i~~~---------------~~~~~~~~~~Ei~~l~~l~h~~i~~~~   68 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVD-SDCDKRVAVKKIVLT---------------DPQSVKHALREIKIIRRLDHDNIVKVY   68 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEE-CCCCcEEEEEEEecC---------------CCchHHHHHHHHHHHHhcCCCcchhhH
Confidence            5699999999999999999964 567899999987431               112345677899999999999999999


Q ss_pred             eEEecC--------------CeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecC
Q 011360          272 AHMVRP--------------DCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGD  337 (487)
Q Consensus       272 ~~~~~~--------------~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~D  337 (487)
                      +++...              ...|+||||++ ++|.+++..     ..+++..++.++.|++.||.||   |+.|++|||
T Consensus        69 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~L---H~~givH~d  139 (342)
T cd07854          69 EVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYI---HSANVLHRD  139 (342)
T ss_pred             hhhcccccccccccccccccceEEEEeeccc-ccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHH---HhCCcccCC
Confidence            876543              35789999996 588888752     4688999999999999999999   677899999


Q ss_pred             CCCCCEEeC-CCCCEEEeccCCccccCCCCcee-eEeeecccccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCc
Q 011360          338 IKPRNVLLN-DDMEACISDLGLAMAIPDGYTRV-LISYVLGTMAYIAPEYFQQ-PELSEKCDIFSFGMLLISLVRGVPSF  414 (487)
Q Consensus       338 lkp~Nill~-~~~~~kl~DFg~s~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwslG~~l~elltg~~pf  414 (487)
                      |||+||+++ .++.++|+|||.+.......... ......++..|+|||.+.. ..++.++|||||||++|+|++|..||
T Consensus       140 ikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf  219 (342)
T cd07854         140 LKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLF  219 (342)
T ss_pred             CCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCC
Confidence            999999997 45678999999987653321111 1122357889999998754 46788999999999999999999999


Q ss_pred             cccCCCCccccHHHHHHHHhcCC--------------CCC----ccCCCCC-CCCcHHHHHHHHHHHhhccCCCCCCCCC
Q 011360          415 VFHQNGEEICSPEWLRKVMNSKN--------------PSR----AIDPRLP-GNGYEKKMLHVLKIAYICTLHDPEERPN  475 (487)
Q Consensus       415 ~~~~~~~~~~~~~~~~~~~~~~~--------------~~~----~~~~~~~-~~~~~~~~~~l~~li~~cl~~~P~~RPs  475 (487)
                      ......      +..........              +..    ...+..+ .........++.+++.+||..||.+|||
T Consensus       220 ~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  293 (342)
T cd07854         220 AGAHEL------EQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLT  293 (342)
T ss_pred             CCCCHH------HHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccC
Confidence            533210      11111100000              000    0000000 0001123356889999999999999999


Q ss_pred             hHHHHH
Q 011360          476 SQYVRC  481 (487)
Q Consensus       476 ~~~il~  481 (487)
                      +.+++.
T Consensus       294 ~~ell~  299 (342)
T cd07854         294 AEEALM  299 (342)
T ss_pred             HHHHhC
Confidence            999874

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=3.7e-34  Score=282.84  Aligned_cols=262  Identities=23%  Similarity=0.314  Sum_probs=189.2

Q ss_pred             ccccccccccccceeEEEEEecCCC--CceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CCCCccc
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSN--GKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RHRNILP  269 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~  269 (487)
                      +|.+.+.||.|+||.||++... .+  +..||+|++...             .........+.+|+.++.++ .||||++
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~-~~~~~~~~aiK~~~~~-------------~~~~~~~~~~~~E~~~l~~l~~h~~iv~   66 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNA-ETSEEETVAIKKITNV-------------FSKKILAKRALRELKLLRHFRGHKNITC   66 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeC-CCCcCceEEEEEeccc-------------cccchhHHHHHHHHHHHHHhcCCCChhe
Confidence            3778899999999999999764 34  788999987321             11122345667899999988 6999999


Q ss_pred             cceEEec----CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEe
Q 011360          270 LLAHMVR----PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLL  345 (487)
Q Consensus       270 l~~~~~~----~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill  345 (487)
                      +++....    ....|++|+|+. ++|.+++..    ...+++..+..++.|++.||.||   |+.|++||||||+||++
T Consensus        67 ~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~L---H~~givH~dlkp~Nili  138 (332)
T cd07857          67 LYDMDIVFPGNFNELYLYEELME-ADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYI---HSANVLHRDLKPGNLLV  138 (332)
T ss_pred             eeeeeeeccccCCcEEEEEeccc-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHeEE
Confidence            9986543    245788999984 689888853    46789999999999999999999   77889999999999999


Q ss_pred             CCCCCEEEeccCCccccCCCCce--eeEeeecccccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCccccCCCCc
Q 011360          346 NDDMEACISDLGLAMAIPDGYTR--VLISYVLGTMAYIAPEYFQQ-PELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEE  422 (487)
Q Consensus       346 ~~~~~~kl~DFg~s~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~  422 (487)
                      +.++.+||+|||++.........  .......|++.|+|||.+.+ ..++.++||||||+++|+|++|.+||........
T Consensus       139 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~  218 (332)
T cd07857         139 NADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQ  218 (332)
T ss_pred             cCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHH
Confidence            99999999999999865432211  11123468999999998765 4689999999999999999999999954321000


Q ss_pred             ---------cccHHHHHHHHh----------cCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          423 ---------ICSPEWLRKVMN----------SKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       423 ---------~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                               ....+.......          ...+...+..     ........+.+++.+||+.+|++|||+.+++.
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         219 LNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFES-----IFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHh-----hCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                     000001100000          0000000000     01112356889999999999999999999864

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=5.9e-34  Score=304.40  Aligned_cols=149  Identities=26%  Similarity=0.388  Sum_probs=129.5

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      +.|.+.+.||.|+||.||+|.. ..+++.||||++...            ..........+..|+.++..++||||++++
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~-~~~~~~vAiKvi~~~------------~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~   70 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRK-KNNSKLYAVKVVKKA------------DMINKNMVHQVQAERDALALSKSPFIVHLY   70 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEE-CCCCcEEEEEEEehh------------hccCHHHHHHHHHHHHHHHhcCCCCcCeEE
Confidence            4699999999999999999975 457899999988431            111233456778899999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++...+.+|+||||+.|++|.+++..    ...+++..++.++.||+.||.||   |.+||+||||||+|||++.++.+
T Consensus        71 ~~~~~~~~~~lVmEy~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yL---H~~gIiHrDLKP~NILl~~~g~v  143 (669)
T cd05610          71 YSLQSANNVYLVMEYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYL---HRHGIIHRDLKPDNMLISNEGHI  143 (669)
T ss_pred             EEEEECCEEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HhCCEEeCCccHHHEEEcCCCCE
Confidence            999999999999999999999999864    34678889999999999999999   67799999999999999999999


Q ss_pred             EEeccCCcc
Q 011360          352 CISDLGLAM  360 (487)
Q Consensus       352 kl~DFg~s~  360 (487)
                      ||+|||+++
T Consensus       144 kL~DFGls~  152 (669)
T cd05610         144 KLTDFGLSK  152 (669)
T ss_pred             EEEeCCCCc
Confidence            999999885

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=4.5e-34  Score=282.61  Aligned_cols=276  Identities=22%  Similarity=0.266  Sum_probs=193.8

Q ss_pred             ccccc-ccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          192 DCFAS-LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       192 ~~~~~-~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      ++|.. .+.||.|+||.||+|.. ..+++.||+|++............. ...........+.+|+.+++.++||||+++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~   85 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYD-TLTGKIVAIKKVKIIEISNDVTKDR-QLVGMCGIHFTTLRELKIMNEIKHENIMGL   85 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEE-CCCCCeEEEEEeeccccccccccch-hhhcccccchhHHHHHHHHHhCCCcceeee
Confidence            34654 57799999999999974 4578999999884321110000000 000000112246789999999999999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      ++++...+..++||||+. |+|.+++..    ...+++.....++.|++.||.||   |+.|++|+||+|+||+++.++.
T Consensus        86 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~L---H~~~i~H~dl~~~nill~~~~~  157 (335)
T PTZ00024         86 VDVYVEGDFINLVMDIMA-SDLKKVVDR----KIRLTESQVKCILLQILNGLNVL---HKWYFMHRDLSPANIFINSKGI  157 (335)
T ss_pred             eEEEecCCcEEEEEeccc-cCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HhCCeecccccHHHeEECCCCC
Confidence            999999999999999996 689888864    45689999999999999999999   7788999999999999999999


Q ss_pred             EEEeccCCccccCCCC------------ceeeEeeecccccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCcccc
Q 011360          351 ACISDLGLAMAIPDGY------------TRVLISYVLGTMAYIAPEYFQQP-ELSEKCDIFSFGMLLISLVRGVPSFVFH  417 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~------------~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DvwslG~~l~elltg~~pf~~~  417 (487)
                      ++|+|||++.......            .........+++.|+|||.+.+. .++.++|+||||+++|+|++|.+||...
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~  237 (335)
T PTZ00024        158 CKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE  237 (335)
T ss_pred             EEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999987654111            00111223467889999998764 4789999999999999999999999544


Q ss_pred             CCCCccccHHHHHHHHhcCCCCCccC------------CCCCC---CCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          418 QNGEEICSPEWLRKVMNSKNPSRAID------------PRLPG---NGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       418 ~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~---~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ....   ....+....... ....+.            ...+.   ......+.++.+++.+||+.+|++|||+.+++.
T Consensus       238 ~~~~---~~~~i~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        238 NEID---QLGRIFELLGTP-NEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             CHHH---HHHHHHHHhCCC-chhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            3211   001111111000 000000            00000   001122456889999999999999999999875

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-35  Score=284.19  Aligned_cols=245  Identities=22%  Similarity=0.304  Sum_probs=199.3

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      ++.++..||.||||.|-+++.+.. ...+|+|.+            ++.........+++..|-.+|...+.|.||++|.
T Consensus       421 dl~~iaTLGvGgFGRVELV~~~~~-~~~fAlKil------------kK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYr  487 (732)
T KOG0614|consen  421 DLKRIATLGVGGFGRVELVKVNSQ-KATFALKIL------------KKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYR  487 (732)
T ss_pred             hhhhhhhcccCccceEEEEEeccc-chHHHHHHH------------hHhhccchhHHHHHHhHHHHHHhcCchHHHHHHH
Confidence            467788899999999999987533 224677754            3444455667788899999999999999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEE
Q 011360          273 HMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC  352 (487)
Q Consensus       273 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~k  352 (487)
                      .|.+...+|++||-|-||.|+..|..    .+.++..+...++..+++|+.||   |++|||+|||||+|++++.+|-+|
T Consensus       488 Tfrd~kyvYmLmEaClGGElWTiLrd----Rg~Fdd~tarF~~acv~EAfeYL---H~k~iIYRDLKPENllLd~~Gy~K  560 (732)
T KOG0614|consen  488 TFRDSKYVYMLMEACLGGELWTILRD----RGSFDDYTARFYVACVLEAFEYL---HRKGIIYRDLKPENLLLDNRGYLK  560 (732)
T ss_pred             HhccchhhhhhHHhhcCchhhhhhhh----cCCcccchhhhhHHHHHHHHHHH---HhcCceeccCChhheeeccCCceE
Confidence            99999999999999999999999976    67899999999999999999999   788899999999999999999999


Q ss_pred             EeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHH
Q 011360          353 ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKV  432 (487)
Q Consensus       353 l~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~  432 (487)
                      |.|||+++.+..+...   -+++|||.|.|||++.+...+.++|.||||+++|||++|.+||.+.++...      ...+
T Consensus       561 LVDFGFAKki~~g~KT---wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmkt------Yn~I  631 (732)
T KOG0614|consen  561 LVDFGFAKKIGSGRKT---WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKT------YNLI  631 (732)
T ss_pred             EeehhhHHHhccCCce---eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHH------HHHH
Confidence            9999999988766443   468899999999999999999999999999999999999999966554221      1111


Q ss_pred             HhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCC
Q 011360          433 MNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPN  475 (487)
Q Consensus       433 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs  475 (487)
                      +.+-.. -.++        ..+.....+++.+....+|.+|..
T Consensus       632 LkGid~-i~~P--------r~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  632 LKGIDK-IEFP--------RRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             Hhhhhh-hhcc--------cccchhHHHHHHHHHhcCcHhhhc
Confidence            211111 0111        122345778888888889999976

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-34  Score=284.49  Aligned_cols=240  Identities=22%  Similarity=0.299  Sum_probs=191.3

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CCCCccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RHRNILP  269 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~  269 (487)
                      .+.|.....+|.|+|+.|..+. ...+++..++|++...                   .....+|+.++... +||||++
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~-~~~t~~~~~vkii~~~-------------------~~~~~~e~~~~~~~~~h~niv~  380 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCE-SSPTDQEPAVKIISKR-------------------ADDNQDEIPISLLVRDHPNIVK  380 (612)
T ss_pred             chhhccccccCCCCccceeeee-ccccccchhheecccc-------------------ccccccccchhhhhcCCCccee
Confidence            4568888889999999999996 4568889999987321                   12223455444433 8999999


Q ss_pred             cceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEe-CCC
Q 011360          270 LLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLL-NDD  348 (487)
Q Consensus       270 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill-~~~  348 (487)
                      +.+++.+..+.|+|||.+.|+-|.+.+..    ...+. ..+..|+.+|+.++.||   |++|+|||||||+|||+ +..
T Consensus       381 ~~~v~~~~~~~~~v~e~l~g~ell~ri~~----~~~~~-~e~~~w~~~lv~Av~~L---H~~gvvhRDLkp~NIL~~~~~  452 (612)
T KOG0603|consen  381 SHDVYEDGKEIYLVMELLDGGELLRRIRS----KPEFC-SEASQWAAELVSAVDYL---HEQGVVHRDLKPGNILLDGSA  452 (612)
T ss_pred             ecceecCCceeeeeehhccccHHHHHHHh----cchhH-HHHHHHHHHHHHHHHHH---HhcCeeecCCChhheeecCCC
Confidence            99999999999999999999988777653    22333 67778999999999999   77889999999999999 688


Q ss_pred             CCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHH
Q 011360          349 MEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEW  428 (487)
Q Consensus       349 ~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~  428 (487)
                      ++++|+|||.++.....     +.+.+-|..|.|||++....|+.++||||||++||+|++|+.||.....+      ..
T Consensus       453 g~lrltyFG~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~------~e  521 (612)
T KOG0603|consen  453 GHLRLTYFGFWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG------IE  521 (612)
T ss_pred             CcEEEEEechhhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch------HH
Confidence            99999999999877655     23445688999999999999999999999999999999999999766553      11


Q ss_pred             HHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          429 LRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       429 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      +...+..+..            ....+....+|+.+||+.||.+||++.++..
T Consensus       522 i~~~i~~~~~------------s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  522 IHTRIQMPKF------------SECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             HHHhhcCCcc------------ccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence            2222222211            1344567889999999999999999999864

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-35  Score=282.93  Aligned_cols=245  Identities=23%  Similarity=0.365  Sum_probs=198.8

Q ss_pred             cccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceEEecC
Q 011360          198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRP  277 (487)
Q Consensus       198 ~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  277 (487)
                      +.||.|.||+||-|+++ .+|+.||||++..-             ........++++|+.++.++.||.||.+--.|.++
T Consensus       570 evLGSGQFG~VYgg~hR-ktGrdVAvKvIdKl-------------rFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~  635 (888)
T KOG4236|consen  570 EVLGSGQFGTVYGGKHR-KTGRDVAVKVIDKL-------------RFPTKQESQLRNEVAILQNLHHPGIVNLECMFETP  635 (888)
T ss_pred             hhccCCcceeeecceec-ccCceeeeeeeecc-------------cCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCC
Confidence            67999999999999864 69999999998431             22233347889999999999999999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC---CCEEEe
Q 011360          278 DCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDD---MEACIS  354 (487)
Q Consensus       278 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~---~~~kl~  354 (487)
                      +.+++|||-+ .|+....+-.  ...+.+++..-..+..||+.||.||   |.+||+|+||||+|||+...   .++|||
T Consensus       636 ervFVVMEKl-~GDMLEMILS--sEkgRL~er~TkFlvtQIL~ALr~L---H~knIvHCDLKPENVLLas~~~FPQvKlC  709 (888)
T KOG4236|consen  636 ERVFVVMEKL-HGDMLEMILS--SEKGRLPERITKFLVTQILVALRYL---HFKNIVHCDLKPENVLLASASPFPQVKLC  709 (888)
T ss_pred             ceEEEEehhh-cchHHHHHHH--hhcccchHHHHHHHHHHHHHHHHHh---hhcceeeccCCchheeeccCCCCCceeec
Confidence            9999999999 5566555533  3457789999999999999999999   77889999999999999753   479999


Q ss_pred             ccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHHHh
Q 011360          355 DLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMN  434 (487)
Q Consensus       355 DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~  434 (487)
                      |||+++..+...-.   ...+|||.|+|||++....|...-|+||.|+++|--++|..||....+   +  .+.   +.+
T Consensus       710 DFGfARiIgEksFR---rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd---I--ndQ---IQN  778 (888)
T KOG4236|consen  710 DFGFARIIGEKSFR---RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED---I--NDQ---IQN  778 (888)
T ss_pred             cccceeecchhhhh---hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc---h--hHH---hhc
Confidence            99999988665433   567899999999999999999999999999999999999999943322   1  111   111


Q ss_pred             cCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHH
Q 011360          435 SKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVR  480 (487)
Q Consensus       435 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il  480 (487)
                      ...       -.|.....+++...+++|...|+..-.+|-|...-+
T Consensus       779 AaF-------MyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~l  817 (888)
T KOG4236|consen  779 AAF-------MYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSL  817 (888)
T ss_pred             ccc-------ccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence            111       145566777888899999999999999998887644

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=9.4e-34  Score=266.26  Aligned_cols=220  Identities=20%  Similarity=0.232  Sum_probs=172.6

Q ss_pred             ccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceEEecCCeeEE
Q 011360          203 GGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLL  282 (487)
Q Consensus       203 G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l  282 (487)
                      |.+|+||++. +..+++.||+|.+....                    ....|...+....||||+++++++...+..++
T Consensus         4 g~~~~v~~~~-~~~~~~~~~~K~i~~~~--------------------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l   62 (237)
T cd05576           4 GVIDKVLLVM-DTRTQQTFILKGLRKSS--------------------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFL   62 (237)
T ss_pred             cccceEEEEE-EccCCcEEEEEeecchh--------------------hhhhHHHHHHhcCCCceeehhhheecCCeEEE
Confidence            8999999996 45688999999884310                    11223334445579999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEeccCCcccc
Q 011360          283 VYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI  362 (487)
Q Consensus       283 v~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~DFg~s~~~  362 (487)
                      +|||+++|+|.+++..    ...+++..+..++.|++.||.||   |++|++||||||+||+++.++.++++|||.+...
T Consensus        63 v~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~  135 (237)
T cd05576          63 VLQHAEGGKLWSHISK----FLNIPEECVKRWAAEMVVALDAL---HREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEV  135 (237)
T ss_pred             EEecCCCCCHHHHHHH----hcCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHEEEcCCCCEEEecccchhcc
Confidence            9999999999999865    34589999999999999999999   6788999999999999999999999999987655


Q ss_pred             CCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHHHhcCCCCCcc
Q 011360          363 PDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAI  442 (487)
Q Consensus       363 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  442 (487)
                      ....     ....++..|+|||.+.+..++.++|+||+|+++|+|++|..||.......             ....    
T Consensus       136 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-------------~~~~----  193 (237)
T cd05576         136 EDSC-----DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-------------NTHT----  193 (237)
T ss_pred             cccc-----ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-------------cccc----
Confidence            4322     22345778999999988889999999999999999999998873221100             0000    


Q ss_pred             CCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCh
Q 011360          443 DPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNS  476 (487)
Q Consensus       443 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~  476 (487)
                      ...++.    .....+.+++.+||+.||++|||+
T Consensus       194 ~~~~~~----~~~~~~~~li~~~l~~dp~~R~~~  223 (237)
T cd05576         194 TLNIPE----WVSEEARSLLQQLLQFNPTERLGA  223 (237)
T ss_pred             ccCCcc----cCCHHHHHHHHHHccCCHHHhcCC
Confidence            001221    123568899999999999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-34  Score=265.68  Aligned_cols=264  Identities=20%  Similarity=0.263  Sum_probs=211.1

Q ss_pred             hccccccccccccccceeEEEEEecCCC----CceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCC
Q 011360          190 KEDCFASLEKIGSGGCGEVYKAELPGSN----GKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHR  265 (487)
Q Consensus       190 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp  265 (487)
                      ..+++.....+.+|.||.||+|.|...+    .+.|-+|.+              ....++..+..++.|...+..+.||
T Consensus       282 ~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTv--------------k~~AS~iQv~~~L~es~lly~~sH~  347 (563)
T KOG1024|consen  282 QRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTV--------------KQHASQIQVNLLLQESMLLYGASHP  347 (563)
T ss_pred             hhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHH--------------HhcccHHHHHHHHHHHHHHhcCcCC
Confidence            4456788888999999999999875322    223334432              1233455677889999999999999


Q ss_pred             CccccceEEec-CCeeEEEEEecCCCCHHHHHhhhh----cCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC
Q 011360          266 NILPLLAHMVR-PDCHLLVYEFMKNGSLQDILDDVS----RGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKP  340 (487)
Q Consensus       266 nIv~l~~~~~~-~~~~~lv~E~~~~gsL~~~l~~~~----~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp  340 (487)
                      |+..+.+++.. ....++++.++.-|+|..||...+    .+.+.++..+...++.|++.|++||   |++|+||.||.+
T Consensus       348 nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hl---h~~~ViHkDiAa  424 (563)
T KOG1024|consen  348 NLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHL---HNHGVIHKDIAA  424 (563)
T ss_pred             CccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHH---HhcCcccchhhh
Confidence            99999998765 466788999999999999997332    2345677788899999999999999   888999999999


Q ss_pred             CCEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCC
Q 011360          341 RNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQN  419 (487)
Q Consensus       341 ~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~  419 (487)
                      +|++|++..++||+|=.+++.+-+............+..||+||.+.+..|+.++|+||||+++|||+| |+.||.    
T Consensus       425 RNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Pya----  500 (563)
T KOG1024|consen  425 RNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYA----  500 (563)
T ss_pred             hcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCcc----
Confidence            999999999999999999998877766655555667899999999999999999999999999999999 799993    


Q ss_pred             CCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          420 GEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       420 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                        +++..+....+.++.+..+.+          +++.+++.+|..||...|++||+++++..-|.++
T Consensus       501 --eIDPfEm~~ylkdGyRlaQP~----------NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF  555 (563)
T KOG1024|consen  501 --EIDPFEMEHYLKDGYRLAQPF----------NCPDELFTVMACCWALLPEERPSFSQLVICLSEF  555 (563)
T ss_pred             --ccCHHHHHHHHhccceecCCC----------CCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence              444444444444444443322          2335699999999999999999999999988765

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-34  Score=242.81  Aligned_cols=260  Identities=24%  Similarity=0.353  Sum_probs=195.9

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      .|...++||+|.+|+||+|+ +..+++.||+|++.....             .+..-....+|+.+++.++|.|||++++
T Consensus         3 ~ydkmekigegtygtvfkar-n~~t~eivalkrvrlddd-------------degvpssalreicllkelkhknivrl~d   68 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKAR-NRETHEIVALKRVRLDDD-------------DEGVPSSALREICLLKELKHKNIVRLHD   68 (292)
T ss_pred             chHHHHhhcCCcceeeEecc-cCCccceEEEEEEeccCC-------------CCCCcHHHHHHHHHHHHhhhcceeehhh
Confidence            47778899999999999997 557899999999865321             1122335678999999999999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEE
Q 011360          273 HMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC  352 (487)
Q Consensus       273 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~k  352 (487)
                      +...+..+-+|+||| ..+|..+...   -++.++.+.++.++.|+++||.++   |++++.|||+||.|.|++.+|.+|
T Consensus        69 vlhsdkkltlvfe~c-dqdlkkyfds---lng~~d~~~~rsfmlqllrgl~fc---hshnvlhrdlkpqnllin~ngelk  141 (292)
T KOG0662|consen   69 VLHSDKKLTLVFEFC-DQDLKKYFDS---LNGDLDPEIVRSFMLQLLRGLGFC---HSHNVLHRDLKPQNLLINRNGELK  141 (292)
T ss_pred             hhccCceeEEeHHHh-hHHHHHHHHh---cCCcCCHHHHHHHHHHHHhhhhhh---hhhhhhhccCCcceEEeccCCcEE
Confidence            999999999999999 5589888875   356788999999999999999999   777899999999999999999999


Q ss_pred             EeccCCccccCCCCceeeEeeecccccccCCcccCCC-CCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccccHHHHH
Q 011360          353 ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQP-ELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSPEWLR  430 (487)
Q Consensus       353 l~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~  430 (487)
                      ++|||+++.++....  ..+..+.|.+|.+|.++.+. -|+...|+||.||++.|+.. |.+.|.+.+...      .+.
T Consensus       142 ladfglarafgipvr--cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvdd------qlk  213 (292)
T KOG0662|consen  142 LADFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD------QLK  213 (292)
T ss_pred             ecccchhhhcCCceE--eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHH------HHH
Confidence            999999998765432  22445679999999998875 68999999999999999998 677775543321      122


Q ss_pred             HHHh-cCCCCCc-c-----------CCCCCCC-CcH----HHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          431 KVMN-SKNPSRA-I-----------DPRLPGN-GYE----KKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       431 ~~~~-~~~~~~~-~-----------~~~~~~~-~~~----~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      +++. -+.+.+. .           -|..|.. ...    .....=.+++...+.-+|.+|.+++..++
T Consensus       214 rif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  214 RIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             HHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            2211 1111110 0           0111110 111    11222346666777779999999998765

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-34  Score=245.16  Aligned_cols=225  Identities=23%  Similarity=0.354  Sum_probs=182.8

Q ss_pred             hhhccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhcc-CCCCC
Q 011360          188 LKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQ-IRHRN  266 (487)
Q Consensus       188 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~hpn  266 (487)
                      ....+....+..||+|++|.|-+-++ ..+|...|+|.+...              .......+.+.|+.+..+ ..+|.
T Consensus        42 eV~ad~L~~i~elGrGayG~vekmrh-~~sg~imAvKri~~t--------------vn~q~q~r~L~dldi~~r~~~CPf  106 (282)
T KOG0984|consen   42 EVPADDLVGIEELGRGAYGVVEKMRH-IQSGTIMAVKRIRAT--------------VNSQEQKRLLMDLDIIMRTVDCPF  106 (282)
T ss_pred             ccchhhhhhhhhhcCCccchhhheee-ccCCeEEEEeeehhh--------------cChHHHHHHHHhhhhhccCCCCCe
Confidence            34455677888999999999988875 468999999998432              223455677788877554 48999


Q ss_pred             ccccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC
Q 011360          267 ILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN  346 (487)
Q Consensus       267 Iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~  346 (487)
                      +|.+||.......++|.||.| ..||..+-...-..+..+++..+-+|+..+++||.|||+  ...++|||+||+|||++
T Consensus       107 ~V~FyGa~~regdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn  183 (282)
T KOG0984|consen  107 TVHFYGALFREGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILIN  183 (282)
T ss_pred             EEEeehhhhccccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEc
Confidence            999999999999999999999 569999887777778999999999999999999999984  45699999999999999


Q ss_pred             CCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccC----CCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCc
Q 011360          347 DDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQ----QPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEE  422 (487)
Q Consensus       347 ~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~----~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~  422 (487)
                      .+|++|+||||.+-.+.++-..   +...|...|||||.+.    ...|+.++||||||+++.||.+++.||..     .
T Consensus       184 ~~GqVKiCDFGIsG~L~dSiAk---t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~-----w  255 (282)
T KOG0984|consen  184 YDGQVKICDFGISGYLVDSIAK---TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES-----W  255 (282)
T ss_pred             cCCcEEEcccccceeehhhhHH---HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc-----c
Confidence            9999999999999766554332   2245888999999875    33799999999999999999999999943     3


Q ss_pred             cccHHHHHHHHhcCCC
Q 011360          423 ICSPEWLRKVMNSKNP  438 (487)
Q Consensus       423 ~~~~~~~~~~~~~~~~  438 (487)
                      .+..+.+.+++....|
T Consensus       256 ~tpF~qLkqvVeep~P  271 (282)
T KOG0984|consen  256 GTPFQQLKQVVEEPSP  271 (282)
T ss_pred             CCHHHHHHHHhcCCCC
Confidence            3445566666655444

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-34  Score=289.62  Aligned_cols=252  Identities=26%  Similarity=0.392  Sum_probs=203.6

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CCCCccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RHRNILP  269 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~  269 (487)
                      .+.|++...+|.|.+|+||+++. ..++...|+|+...                ....-+.+..|..++..+ .|||++.
T Consensus        18 ~d~~ei~evig~Gtygkv~k~k~-~~~~~~aa~kI~~~----------------~~d~deEiE~eynil~~~~~hpnv~~   80 (953)
T KOG0587|consen   18 ADIFEIIEVIGNGTYGKVYKGRH-VKTGQLAAIKIMDP----------------TEDEEEEIELEYNMLKKYSHHPNVAT   80 (953)
T ss_pred             CCccEEEEEEeeccceeEEEEee-eecCceeeeEeecC----------------CccccHHHHHHHHHHHhccCCCCcce
Confidence            45689999999999999999974 46888899998733                122334566788888877 8999999


Q ss_pred             cceEEec-----CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEE
Q 011360          270 LLAHMVR-----PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVL  344 (487)
Q Consensus       270 l~~~~~~-----~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nil  344 (487)
                      +||++..     ++.++||||||.|||..|+++...  +..+.|..+..|++.++.||.+|   |.+.++|||+|-.|||
T Consensus        81 fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HL---H~nkviHRDikG~NiL  155 (953)
T KOG0587|consen   81 FYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHL---HNNKVIHRDIKGQNVL  155 (953)
T ss_pred             EEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHH---hhcceeeecccCceEE
Confidence            9999873     578999999999999999998754  77899999999999999999999   5556999999999999


Q ss_pred             eCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCC-----CCCCchhHHHHHHHHHHHHHhCCCCccccCC
Q 011360          345 LNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQ-----PELSEKCDIFSFGMLLISLVRGVPSFVFHQN  419 (487)
Q Consensus       345 l~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~DvwslG~~l~elltg~~pf~~~~~  419 (487)
                      ++.++.|||+|||.+..+......  ..+..|||.|||||++..     ..|+..+|+||||++..||.-|.+|+...-+
T Consensus       156 LT~e~~VKLvDFGvSaQldsT~gr--RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP  233 (953)
T KOG0587|consen  156 LTENAEVKLVDFGVSAQLDSTVGR--RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP  233 (953)
T ss_pred             EeccCcEEEeeeeeeeeeeccccc--ccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch
Confidence            999999999999999887554332  245679999999999863     4688899999999999999999999943322


Q ss_pred             CCccccHHHHHHHH-hcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          420 GEEICSPEWLRKVM-NSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       420 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .         +.++ ....|+.      .-.......+++.++|..||.+|..+||++.++++
T Consensus       234 m---------raLF~IpRNPPP------kLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  234 M---------RALFLIPRNPPP------KLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             h---------hhhccCCCCCCc------cccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence            1         1111 1222211      11235567789999999999999999999998874

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-33  Score=277.31  Aligned_cols=209  Identities=24%  Similarity=0.434  Sum_probs=178.8

Q ss_pred             cccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceE
Q 011360          194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAH  273 (487)
Q Consensus       194 ~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  273 (487)
                      |..++.||-|+||.|.+++ +..+...||.|.+.            +...+....+..+..|-.||+.-..+-||++|..
T Consensus       631 Fvkik~iGvGAFGeV~Lv~-KvDT~~lYAmKTLr------------KaDVl~rnQvaHVKAERDILAEADn~WVVrLyyS  697 (1034)
T KOG0608|consen  631 FVKIKTIGVGAFGEVCLVR-KVDTRALYAMKTLR------------KADVLMRNQVAHVKAERDILAEADNEWVVRLYYS  697 (1034)
T ss_pred             eEEEeeecccccceeEEEe-ecchhhHHHHhhhH------------HHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEE
Confidence            7788899999999999996 45678889999763            3445556677888899999999999999999999


Q ss_pred             EecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEE
Q 011360          274 MVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACI  353 (487)
Q Consensus       274 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl  353 (487)
                      |.+.+++|+||+|++||++-.+|-.    -+-|++..++.++..+.+|+++.   |..|+|||||||+|||||.+|++||
T Consensus       698 FQDkdnLYFVMdYIPGGDmMSLLIr----mgIFeE~LARFYIAEltcAiesV---HkmGFIHRDiKPDNILIDrdGHIKL  770 (1034)
T KOG0608|consen  698 FQDKDNLYFVMDYIPGGDMMSLLIR----MGIFEEDLARFYIAELTCAIESV---HKMGFIHRDIKPDNILIDRDGHIKL  770 (1034)
T ss_pred             eccCCceEEEEeccCCccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHH---HhccceecccCccceEEccCCceee
Confidence            9999999999999999999999875    46788999999999999999999   8889999999999999999999999


Q ss_pred             eccCCccccC---------CCCc-------------------------------eeeEeeecccccccCCcccCCCCCCc
Q 011360          354 SDLGLAMAIP---------DGYT-------------------------------RVLISYVLGTMAYIAPEYFQQPELSE  393 (487)
Q Consensus       354 ~DFg~s~~~~---------~~~~-------------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~  393 (487)
                      +|||++.-+.         .+..                               .......+||+.|+|||++....|+.
T Consensus       771 TDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q  850 (1034)
T KOG0608|consen  771 TDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQ  850 (1034)
T ss_pred             eeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccc
Confidence            9999985331         0000                               00012247999999999999999999


Q ss_pred             hhHHHHHHHHHHHHHhCCCCccccCCCCc
Q 011360          394 KCDIFSFGMLLISLVRGVPSFVFHQNGEE  422 (487)
Q Consensus       394 ~~DvwslG~~l~elltg~~pf~~~~~~~~  422 (487)
                      .+|+||.|++||||+.|++||...++.+.
T Consensus       851 ~cdwws~gvil~em~~g~~pf~~~tp~~t  879 (1034)
T KOG0608|consen  851 LCDWWSVGVILYEMLVGQPPFLADTPGET  879 (1034)
T ss_pred             cchhhHhhHHHHHHhhCCCCccCCCCCcc
Confidence            99999999999999999999987776554

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-34  Score=271.85  Aligned_cols=264  Identities=24%  Similarity=0.354  Sum_probs=202.9

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|-.+..||+|||+.||+| ++...++.||+|+-..-..+.        ...+....+...+|..+-..|.||.||++|
T Consensus       463 ~RYLlLhLLGrGGFSEVyKA-FDl~EqRYvAvKIHqlNK~Wr--------dEKKeNYhKHAcREyrIHKeLDHpRIVKlY  533 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKA-FDLTEQRYVAVKIHQLNKNWR--------DEKKENYHKHACREYRIHKELDHPRIVKLY  533 (775)
T ss_pred             HHHHHHHHhccccHHHHHHh-cccchhheeeEeeehhccchh--------hHhhhhHHHHHHHHHhhhhccCcceeeeee
Confidence            45788899999999999999 566778999999764322221        223445677889999999999999999999


Q ss_pred             eEEec-CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC---C
Q 011360          272 AHMVR-PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN---D  347 (487)
Q Consensus       272 ~~~~~-~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~---~  347 (487)
                      ++|.- .+.+|-|+|||+|-+|.-||..    .+.+++..++.|+.||+.||.||.+. ..-|||-||||.|||+-   .
T Consensus       534 DyfslDtdsFCTVLEYceGNDLDFYLKQ----hklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~Gta  608 (775)
T KOG1151|consen  534 DYFSLDTDSFCTVLEYCEGNDLDFYLKQ----HKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTA  608 (775)
T ss_pred             eeeeeccccceeeeeecCCCchhHHHHh----hhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcc
Confidence            99874 5778899999999999999975    57789999999999999999999764 45599999999999995   4


Q ss_pred             CCCEEEeccCCccccCCCCce-----eeEeeecccccccCCcccCC----CCCCchhHHHHHHHHHHHHHhCCCCccccC
Q 011360          348 DMEACISDLGLAMAIPDGYTR-----VLISYVLGTMAYIAPEYFQQ----PELSEKCDIFSFGMLLISLVRGVPSFVFHQ  418 (487)
Q Consensus       348 ~~~~kl~DFg~s~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~----~~~~~~~DvwslG~~l~elltg~~pf~~~~  418 (487)
                      .|.+||+|||+++.+.+....     ...+...||.+|++||++.-    +..+.|+||||.|+++|..+.|+.||....
T Consensus       609 cGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnq  688 (775)
T KOG1151|consen  609 CGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQ  688 (775)
T ss_pred             cceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCch
Confidence            578999999999988665433     23356789999999998753    357899999999999999999999995443


Q ss_pred             CCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHH
Q 011360          419 NGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVR  480 (487)
Q Consensus       419 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il  480 (487)
                      ...++....-+   +......      +|..  +..+.+...+|++||+..-++|....++.
T Consensus       689 sQQdILqeNTI---lkAtEVq------FP~K--PvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  689 SQQDILQENTI---LKATEVQ------FPPK--PVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             hHHHHHhhhch---hcceecc------CCCC--CccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence            32222111111   1111111      1111  12334578899999999999998887764

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-34  Score=255.84  Aligned_cols=266  Identities=23%  Similarity=0.352  Sum_probs=196.3

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      ...|....++|+|.||.||+|+. +.+|+.||+|++..          .   ..+...-....+|+.++..++|+|++.+
T Consensus        16 ~~~yek~~kigqGtfgeVFkAr~-~n~~kkvalkkvlm----------e---neKeGfpitalreikiL~~lkHenv~nl   81 (376)
T KOG0669|consen   16 VSKYEKLAKIGQGTFGEVFKARS-KNTGKKVALKKVLM----------E---NEKEGFPITALREIKILQLLKHENVVNL   81 (376)
T ss_pred             chHHHHHHhcCCchHHHHHHHhh-cCccchhHHHHHHH----------h---ccccCCcHHHHHHHHHHHHhcchhHHHH
Confidence            44688889999999999999975 45788899986522          1   1122234456789999999999999999


Q ss_pred             ceEEec--------CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCC
Q 011360          271 LAHMVR--------PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRN  342 (487)
Q Consensus       271 ~~~~~~--------~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~N  342 (487)
                      +..|..        ...+|+||.+|+. +|..+|..   ....++...+.+++.++..||.|+   |+..|+|||+||.|
T Consensus        82 iEic~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn---~~vr~sls~Ikk~Mk~Lm~GL~~i---Hr~kilHRDmKaaN  154 (376)
T KOG0669|consen   82 IEICRTKATPTNRDRATFYLVFDFCEH-DLAGLLSN---RKVRFSLSEIKKVMKGLMNGLYYI---HRNKILHRDMKAAN  154 (376)
T ss_pred             HHHHhhccCCcccccceeeeeHHHhhh-hHHHHhcC---ccccccHHHHHHHHHHHHHHHHHH---HHhhHHhhcccHhh
Confidence            987753        2347999999966 88888863   346789999999999999999999   77779999999999


Q ss_pred             EEeCCCCCEEEeccCCccccCCCCce--eeEeeecccccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCccccCC
Q 011360          343 VLLNDDMEACISDLGLAMAIPDGYTR--VLISYVLGTMAYIAPEYFQQP-ELSEKCDIFSFGMLLISLVRGVPSFVFHQN  419 (487)
Q Consensus       343 ill~~~~~~kl~DFg~s~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~-~~~~~~DvwslG~~l~elltg~~pf~~~~~  419 (487)
                      +||+.+|.+||+|||+++.+......  ...++.+.|.+|.+||.+.+. .|+.+.|||..||++.||+||.+.+.+.+.
T Consensus       155 vLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnte  234 (376)
T KOG0669|consen  155 VLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTE  234 (376)
T ss_pred             EEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChH
Confidence            99999999999999999776433221  112345679999999988765 799999999999999999999998855443


Q ss_pred             CCccccHHHHHHHHhcCCCCCccC-------------CCCCCCC---cHHHHH------HHHHHHhhccCCCCCCCCChH
Q 011360          420 GEEICSPEWLRKVMNSKNPSRAID-------------PRLPGNG---YEKKML------HVLKIAYICTLHDPEERPNSQ  477 (487)
Q Consensus       420 ~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~---~~~~~~------~l~~li~~cl~~~P~~RPs~~  477 (487)
                      ....    .+.....+....+.++             +.++...   ..+...      +..+++..++..||.+||++.
T Consensus       235 qqql----~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad  310 (376)
T KOG0669|consen  235 QQQL----HLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDAD  310 (376)
T ss_pred             HHHH----HHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchH
Confidence            2111    1111222222222221             1122211   112222      577889999999999999999


Q ss_pred             HHHH
Q 011360          478 YVRC  481 (487)
Q Consensus       478 ~il~  481 (487)
                      +++.
T Consensus       311 ~aln  314 (376)
T KOG0669|consen  311 QALN  314 (376)
T ss_pred             hhhc
Confidence            8864

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.98  E-value=2.1e-31  Score=249.94  Aligned_cols=240  Identities=30%  Similarity=0.416  Sum_probs=189.2

Q ss_pred             cceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceEEecCCeeEEE
Q 011360          204 GCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLV  283 (487)
Q Consensus       204 ~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv  283 (487)
                      +||.||+|... .++..+|+|++.....              ......+.+|+..+++++|+||+++++.+......+++
T Consensus         1 ~~g~v~~~~~~-~~~~~~~~k~~~~~~~--------------~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~   65 (244)
T smart00220        1 SFGKVYLARDK-KTGKLVAIKVIKKEKI--------------KKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLV   65 (244)
T ss_pred             CceEEEEEEEC-CCCcEEEEEEeccccc--------------ccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEE
Confidence            58999999764 4688999998843111              11156788899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEeccCCccccC
Q 011360          284 YEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP  363 (487)
Q Consensus       284 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~DFg~s~~~~  363 (487)
                      |||+++++|.+++..    ...+++..+..++.+++.++.+|   |+.|++|+||+|+||+++.++.++|+|||.+....
T Consensus        66 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~l---h~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~  138 (244)
T smart00220       66 MEYCDGGDLFDLLKK----RGRLSEDEARFYARQILSALEYL---HSNGIIHRDLKPENILLDEDGHVKLADFGLARQLD  138 (244)
T ss_pred             EeCCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHH---HHcCeecCCcCHHHeEECCCCcEEEccccceeeec
Confidence            999999999999865    22388899999999999999999   66789999999999999999999999999998765


Q ss_pred             CCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHHHhcCCCCCccC
Q 011360          364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAID  443 (487)
Q Consensus       364 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  443 (487)
                      ...   ......++..|++||.+.+..++.++||||||+++|++++|..||.....      ..................
T Consensus       139 ~~~---~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~------~~~~~~~~~~~~~~~~~~  209 (244)
T smart00220      139 PGG---LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ------LLELFKKIGKPKPPFPPP  209 (244)
T ss_pred             ccc---ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc------HHHHHHHHhccCCCCccc
Confidence            542   12345578899999999888889999999999999999999999944211      112222222221111000


Q ss_pred             CCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          444 PRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       444 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                       .      .....++.+++.+||..+|++||++.++++
T Consensus       210 -~------~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      210 -E------WKISPEAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             -c------ccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence             0      002356889999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=2.1e-32  Score=250.61  Aligned_cols=257  Identities=22%  Similarity=0.287  Sum_probs=199.0

Q ss_pred             HhhhccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CCC
Q 011360          187 FLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RHR  265 (487)
Q Consensus       187 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp  265 (487)
                      +....++|.++..||+|++.+|-++++. .+.+.||+|+++.            ......+...-...|-.+..+- +||
T Consensus       245 ~~l~l~df~ll~vigrgsyakvl~~~~~-~t~qiyamkvvkk------------el~nddedidwvqtek~vfe~asn~p  311 (593)
T KOG0695|consen  245 QGLGLQDFDLLRVIGRGSYAKVLLVRLK-KTDQIYAMKVVKK------------ELVNDDEDIDWVQTEKHVFEQASNNP  311 (593)
T ss_pred             cccccccceeeeeecCcchhhhhheehc-ccceeeehhhHHH------------HhcCCcccchhHHhhHHHHHhccCCC
Confidence            3344567999999999999999999864 5788999997622            1122233344445555555555 899


Q ss_pred             CccccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEe
Q 011360          266 NILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLL  345 (487)
Q Consensus       266 nIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill  345 (487)
                      .+|-+..+|.++..+++|.||++||+|--.++.    ++.++++.++.+...|+-||.||   |++||++||||.+|+|+
T Consensus       312 flvglhscfqtesrlffvieyv~ggdlmfhmqr----qrklpeeharfys~ei~lal~fl---h~rgiiyrdlkldnvll  384 (593)
T KOG0695|consen  312 FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEICLALNFL---HERGIIYRDLKLDNVLL  384 (593)
T ss_pred             eEEehhhhhcccceEEEEEEEecCcceeeehhh----hhcCcHHHhhhhhHHHHHHHHHH---hhcCeeeeeccccceEE
Confidence            999999999999999999999999999888765    67799999999999999999999   89999999999999999


Q ss_pred             CCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCcccc-CCCCccc
Q 011360          346 NDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFH-QNGEEIC  424 (487)
Q Consensus       346 ~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~-~~~~~~~  424 (487)
                      +..|++||+|+|+++.--....  ..++++|||.|.|||++.+..|+..+|+|+||++++||+.|+.||..- ....+.+
T Consensus       385 daeghikltdygmcke~l~~gd--~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~n  462 (593)
T KOG0695|consen  385 DAEGHIKLTDYGMCKEGLGPGD--TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMN  462 (593)
T ss_pred             ccCCceeecccchhhcCCCCCc--ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccc
Confidence            9999999999999986433322  236889999999999999999999999999999999999999999532 2223333


Q ss_pred             cHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCC
Q 011360          425 SPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPN  475 (487)
Q Consensus       425 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs  475 (487)
                      ...++-+++-....      ++|..    .+.....+++.-|.+||.+|..
T Consensus       463 tedylfqvilekqi------riprs----lsvkas~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  463 TEDYLFQVILEKQI------RIPRS----LSVKASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             hhHHHHHHHhhhcc------cccce----eehhhHHHHHHhhcCCcHHhcC
Confidence            33444444332221      12211    1233556777889999999853

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.98  E-value=7.5e-32  Score=281.44  Aligned_cols=262  Identities=21%  Similarity=0.262  Sum_probs=164.6

Q ss_pred             hccccccccccccccceeEEEEEecCCC----CceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCC
Q 011360          190 KEDCFASLEKIGSGGCGEVYKAELPGSN----GKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHR  265 (487)
Q Consensus       190 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp  265 (487)
                      ..++|.+.+.||+|+||.||+|++. .+    +..||+|++.....                 .+....+  .+....+.
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~-~~~~~~~~~vAvK~~~~~~~-----------------~e~~~~e--~l~~~~~~  189 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLV-NKQSKKEGKYVLKKATEYGA-----------------VEIWMNE--RVRRACPN  189 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEc-CCccccCcEEEEEEecccch-----------------hHHHHHH--HHHhhchh
Confidence            3467999999999999999999764 45    78999998742110                 0000001  01111122


Q ss_pred             CccccceE------EecCCeeEEEEEecCCCCHHHHHhhhhc----------------CCCCCChHHHHHHHHHHHHHHH
Q 011360          266 NILPLLAH------MVRPDCHLLVYEFMKNGSLQDILDDVSR----------------GRRELDWPSRHRIALGVASGLE  323 (487)
Q Consensus       266 nIv~l~~~------~~~~~~~~lv~E~~~~gsL~~~l~~~~~----------------~~~~l~~~~~~~i~~qi~~~L~  323 (487)
                      ++..+...      .......++||||+.+++|.+++.....                .+.......+..++.|++.||.
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~  269 (566)
T PLN03225        190 SCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALD  269 (566)
T ss_pred             hHHHHHHhhhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHH
Confidence            22222211      2355678999999999999999864210                0011123345679999999999


Q ss_pred             HHHhcCCCCeeecCCCCCCEEeCC-CCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCC-------------
Q 011360          324 YLHMYHSASIIHGDIKPRNVLLND-DMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQP-------------  389 (487)
Q Consensus       324 ~Lh~~h~~givH~Dlkp~Nill~~-~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-------------  389 (487)
                      ||   |++||+||||||+|||++. ++.+||+|||+++.+...... ......+++.|+|||.+...             
T Consensus       270 yL---H~~gIiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~  345 (566)
T PLN03225        270 GL---HSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVAT  345 (566)
T ss_pred             HH---HHCCEEeCcCCHHHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccc
Confidence            99   7788999999999999985 578999999999865433222 12346789999999966422             


Q ss_pred             ---------CCCchhHHHHHHHHHHHHHhCCCCccccC-------CCCccccHHHHHHHHhcCCCCCccCCCCCC--CCc
Q 011360          390 ---------ELSEKCDIFSFGMLLISLVRGVPSFVFHQ-------NGEEICSPEWLRKVMNSKNPSRAIDPRLPG--NGY  451 (487)
Q Consensus       390 ---------~~~~~~DvwslG~~l~elltg~~pf~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~  451 (487)
                               .++.++|||||||++|||+++..|+....       .........|.... ...     ..+.+..  ...
T Consensus       346 ~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~-~~~-----~~~~~~~~~~~~  419 (566)
T PLN03225        346 ALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLV-EPR-----ASPDLRRGFEVL  419 (566)
T ss_pred             cccchhccccCCCCcccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhh-ccc-----cchhhhhhhhhc
Confidence                     23456799999999999999765542110       00000011111110 000     0000000  000


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          452 EKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       452 ~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ........+++.+||+.||++|||+.++++
T Consensus       420 d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~  449 (566)
T PLN03225        420 DLDGGAGWELLKSMMRFKGRQRISAKAALA  449 (566)
T ss_pred             cccchHHHHHHHHHccCCcccCCCHHHHhC
Confidence            011223568999999999999999999985

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=3.5e-32  Score=275.67  Aligned_cols=247  Identities=24%  Similarity=0.362  Sum_probs=186.1

Q ss_pred             ccccccccccccee-EEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CCCCccccc
Q 011360          194 FASLEKIGSGGCGE-VYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RHRNILPLL  271 (487)
Q Consensus       194 ~~~~~~lg~G~~g~-v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~  271 (487)
                      |.-.+++|.|+.|+ ||+|.+   .|+.||||++.                  .+....+.+|+..++.- .|||||++|
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y---e~R~VAVKrll------------------~e~~~~A~rEi~lL~eSD~H~NviRyy  569 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY---EGREVAVKRLL------------------EEFFDFAQREIQLLQESDEHPNVIRYY  569 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee---CCceehHHHHh------------------hHhHHHHHHHHHHHHhccCCCceEEEE
Confidence            55567899999876 799987   67899999762                  23345667899988877 899999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC---C
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLND---D  348 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~---~  348 (487)
                      +.-.+.+..||..|.| ..+|.++++..........-...+....|++.||++|   |+.+||||||||.||||+.   +
T Consensus       570 c~E~d~qF~YIalELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHL---Hsl~iVHRDLkPQNILI~~~~~~  645 (903)
T KOG1027|consen  570 CSEQDRQFLYIALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHL---HSLKIVHRDLKPQNILISVPSAD  645 (903)
T ss_pred             eeccCCceEEEEehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHH---HhcccccccCCCceEEEEccCCC
Confidence            9999999999999999 5699999975211011111134577899999999999   6677999999999999975   3


Q ss_pred             --CCEEEeccCCccccCCCCceee-EeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhC-CCCccccCCCCccc
Q 011360          349 --MEACISDLGLAMAIPDGYTRVL-ISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRG-VPSFVFHQNGEEIC  424 (487)
Q Consensus       349 --~~~kl~DFg~s~~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg-~~pf~~~~~~~~~~  424 (487)
                        ..++|+|||+++.+..+..... .+...||-+|+|||++....-+.++||||+||++|+.++| ..||...-.     
T Consensus       646 ~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~-----  720 (903)
T KOG1027|consen  646 GTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE-----  720 (903)
T ss_pred             cceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHH-----
Confidence              4589999999998876544322 2456799999999999988888899999999999999997 999932211     


Q ss_pred             cHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          425 SPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       425 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                         ....+..+......+.+.      ...  +..+||.+|++++|..||++.+|+.
T Consensus       721 ---R~~NIl~~~~~L~~L~~~------~d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  721 ---RQANILTGNYTLVHLEPL------PDC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             ---hhhhhhcCccceeeeccC------chH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence               111122222221111111      111  5789999999999999999999873

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-30  Score=250.28  Aligned_cols=133  Identities=29%  Similarity=0.425  Sum_probs=113.7

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCC-----C--
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIR-----H--  264 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h--  264 (487)
                      .+|.+.++||.|.|++||++ |+..+.+.||+|+.+                ......+..+.|+.+|.+++     |  
T Consensus        78 gRY~v~rKLGWGHFSTVWLa-wDtq~~r~VAlKVvK----------------SAqhYtEaAlDEIklL~~v~~~Dp~~~~  140 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLA-WDTQNKRYVALKVVK----------------SAQHYTEAALDEIKLLQQVREGDPNDPG  140 (590)
T ss_pred             ceEEEEEeccccccceeEEE-eeccCCeEEEEEEEe----------------hhhHHHHHHHHHHHHHHHHHhcCCCCCC
Confidence            67899999999999999999 688899999999983                23345567788999988872     3  


Q ss_pred             -CCccccceEEec----CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCC
Q 011360          265 -RNILPLLAHMVR----PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIK  339 (487)
Q Consensus       265 -pnIv~l~~~~~~----~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlk  339 (487)
                       .+||++++.|..    +.++|||+|++ |-+|..+|..  .+.+.++...++.|++|++.||.|||  ...||||-|||
T Consensus       141 ~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~--s~YrGlpl~~VK~I~~qvL~GLdYLH--~ecgIIHTDlK  215 (590)
T KOG1290|consen  141 KKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKY--SNYRGLPLSCVKEICRQVLTGLDYLH--RECGIIHTDLK  215 (590)
T ss_pred             CceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHH--hCCCCCcHHHHHHHHHHHHHHHHHHH--HhcCccccCCC
Confidence             369999999875    46789999999 8899999986  45677999999999999999999998  56799999999


Q ss_pred             CCCEEeC
Q 011360          340 PRNVLLN  346 (487)
Q Consensus       340 p~Nill~  346 (487)
                      |+|||+.
T Consensus       216 PENvLl~  222 (590)
T KOG1290|consen  216 PENVLLC  222 (590)
T ss_pred             cceeeee
Confidence            9999993

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=1.5e-30  Score=265.28  Aligned_cols=276  Identities=19%  Similarity=0.234  Sum_probs=181.4

Q ss_pred             ccccccccccccccceeEEEEEec---------------CCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHH
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELP---------------GSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSE  255 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~---------------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E  255 (487)
                      .++|.+.++||+|+||.||+|...               ...++.||||++.........++.++.... ....+....|
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~-~~~~e~~~vE  222 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLA-KGSAETGMVE  222 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhh-hcccchhHHH
Confidence            457999999999999999999641               124567999998543322222222111111 1122334557


Q ss_pred             HHHhccCCCCCc-----cccceEEec--------CCeeEEEEEecCCCCHHHHHhhhhc--------------------C
Q 011360          256 IITASQIRHRNI-----LPLLAHMVR--------PDCHLLVYEFMKNGSLQDILDDVSR--------------------G  302 (487)
Q Consensus       256 ~~~l~~l~hpnI-----v~l~~~~~~--------~~~~~lv~E~~~~gsL~~~l~~~~~--------------------~  302 (487)
                      +.++.+++|.++     +++++++..        .+..++||||+++++|.+++.....                    .
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777777766554     677777653        3567999999999999999864210                    1


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccC
Q 011360          303 RRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIA  382 (487)
Q Consensus       303 ~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~a  382 (487)
                      ...+++..+..++.|++.+|.||   |+.+|+||||||+||+++.++.+||+|||++.......... .....+|+.|+|
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~l---H~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~g~~tp~Y~a  378 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKL---HRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN-PLYGMLDPRYSP  378 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccC-ccccCCCcceeC
Confidence            12346778889999999999999   67789999999999999999999999999997654332111 112235789999


Q ss_pred             CcccCCCC--------------------C--CchhHHHHHHHHHHHHHhCCC-CccccCCCC------ccccHHHHHHHH
Q 011360          383 PEYFQQPE--------------------L--SEKCDIFSFGMLLISLVRGVP-SFVFHQNGE------EICSPEWLRKVM  433 (487)
Q Consensus       383 PE~l~~~~--------------------~--~~~~DvwslG~~l~elltg~~-pf~~~~~~~------~~~~~~~~~~~~  433 (487)
                      ||.+....                    |  ..+.||||+||++|+|++|.. ||.......      ......|..  .
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~--~  456 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM--Y  456 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh--h
Confidence            99876432                    1  124799999999999999964 763221100      001111111  1


Q ss_pred             hcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCC---CCCCChHHHHH
Q 011360          434 NSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDP---EERPNSQYVRC  481 (487)
Q Consensus       434 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P---~~RPs~~~il~  481 (487)
                      .....    +  ++  ..........+++.+||..+|   .+|+|++++++
T Consensus       457 ~~~~~----~--~~--~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        457 KGQKY----D--FS--LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             cccCC----C--cc--cccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            11111    1  11  122234568899999999766   68999999875

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.97  E-value=7.1e-32  Score=259.79  Aligned_cols=260  Identities=22%  Similarity=0.263  Sum_probs=201.1

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCC------
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRH------  264 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h------  264 (487)
                      .+.|.+....|.|-|++|.+|.. ...|..||||++..                .+...+.=+.|+++|.+|..      
T Consensus       431 D~RY~V~~~~GkGvFs~Vvra~D-~~r~~~vAiKIIRn----------------NE~M~KtGl~EleiLkKL~~AD~Edk  493 (752)
T KOG0670|consen  431 DSRYEVQGYTGKGVFSTVVRARD-QARGQEVAIKIIRN----------------NEVMHKTGLKELEILKKLNDADPEDK  493 (752)
T ss_pred             cceeEEEeccccceeeeeeeccc-cCCCCeeEEEEeec----------------chHHhhhhhHHHHHHHHhhccCchhh
Confidence            35688889999999999999974 45677999999843                22233445678999999843      


Q ss_pred             CCccccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEE
Q 011360          265 RNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVL  344 (487)
Q Consensus       265 pnIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nil  344 (487)
                      -|.++++..|...+++|||+|-+ ..+|.+.|..+.. +-.+.+..+..++.|+.-||..|   ...||+|.||||+|||
T Consensus       494 ~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklL---K~c~vlHaDIKPDNiL  568 (752)
T KOG0670|consen  494 FHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLL---KKCGVLHADIKPDNIL  568 (752)
T ss_pred             hHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHH---HhcCeeecccCccceE
Confidence            48999999999999999999988 6699999998744 45678889999999999999999   6778999999999999


Q ss_pred             eCCC-CCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCcc
Q 011360          345 LNDD-MEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI  423 (487)
Q Consensus       345 l~~~-~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~  423 (487)
                      ++++ ..+||||||.|........    +.+..+..|.|||++.+-+|+...|+||.||+||||.||+..|.+.++....
T Consensus       569 VNE~k~iLKLCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~ML  644 (752)
T KOG0670|consen  569 VNESKNILKLCDFGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQML  644 (752)
T ss_pred             eccCcceeeeccCccccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHH
Confidence            9976 4579999999977654432    3345677899999999999999999999999999999999999776653321


Q ss_pred             ccHHHHHHHHhcCCCCCcc----------C--------------------------------------CCCCCCCcHHHH
Q 011360          424 CSPEWLRKVMNSKNPSRAI----------D--------------------------------------PRLPGNGYEKKM  455 (487)
Q Consensus       424 ~~~~~~~~~~~~~~~~~~~----------~--------------------------------------~~~~~~~~~~~~  455 (487)
                      -..    .-+.+..|..++          |                                      ++++ .......
T Consensus       645 rl~----me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~-deq~~~~  719 (752)
T KOG0670|consen  645 RLF----MELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLP-DEQPKIV  719 (752)
T ss_pred             HHH----HHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCC-chhHHHH
Confidence            000    000011111111          0                                      1111 1233556


Q ss_pred             HHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          456 LHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       456 ~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .+|.+|+..||..||++|.|..+.++
T Consensus       720 ~~~rdLLdkml~LdP~KRit~nqAL~  745 (752)
T KOG0670|consen  720 QQLRDLLDKMLILDPEKRITVNQALK  745 (752)
T ss_pred             HHHHHHHHHHhccChhhcCCHHHHhc
Confidence            78999999999999999999999875

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-31  Score=260.82  Aligned_cols=203  Identities=29%  Similarity=0.419  Sum_probs=170.0

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCC---CCCccc
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIR---HRNILP  269 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~  269 (487)
                      .|..++.+|.|+||+|++|.++ .+...|+||.+...+      ++ .+.-.+...+-.+-.|+++|+.++   |+||++
T Consensus       562 ~yttlq~lG~GAyGkV~lai~K-~n~~eVViK~I~KeR------IL-~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlK  633 (772)
T KOG1152|consen  562 DYTTLQPLGEGAYGKVNLAIHK-ENNYEVVIKMIFKER------IL-VDTWVRDRKLGTVPSEIQILATLNKHSHENILK  633 (772)
T ss_pred             cceeeeeccccccceEEEeeec-ccceEEEeeehhhhh------hh-hhhhhcccccCccchhHHHHHHhhhcCccchhh
Confidence            4899999999999999999875 457889999763211      11 111122222334567999999996   999999


Q ss_pred             cceEEecCCeeEEEEEec-CCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC
Q 011360          270 LLAHMVRPDCHLLVYEFM-KNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDD  348 (487)
Q Consensus       270 l~~~~~~~~~~~lv~E~~-~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~  348 (487)
                      ++++|.+++.+||+||-. +|.+|.++++.    ...+++..+..|++|++.|+++|   |+.||||||||-+|+.++.+
T Consensus       634 lLdfFEddd~yyl~te~hg~gIDLFd~IE~----kp~m~E~eAk~IFkQV~agi~hl---h~~~ivhrdikdenvivd~~  706 (772)
T KOG1152|consen  634 LLDFFEDDDYYYLETEVHGEGIDLFDFIEF----KPRMDEPEAKLIFKQVVAGIKHL---HDQGIVHRDIKDENVIVDSN  706 (772)
T ss_pred             hhheeecCCeeEEEecCCCCCcchhhhhhc----cCccchHHHHHHHHHHHhccccc---cccCceecccccccEEEecC
Confidence            999999999999999976 56789999975    67789999999999999999999   99999999999999999999


Q ss_pred             CCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCC-CchhHHHHHHHHHHHHHhCCCCc
Q 011360          349 MEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPEL-SEKCDIFSFGMLLISLVRGVPSF  414 (487)
Q Consensus       349 ~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DvwslG~~l~elltg~~pf  414 (487)
                      |-+||+|||.+.....+.-    ..++||..|.|||++.+..| +...|||++|++||.++....||
T Consensus       707 g~~klidfgsaa~~ksgpf----d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy  769 (772)
T KOG1152|consen  707 GFVKLIDFGSAAYTKSGPF----DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY  769 (772)
T ss_pred             CeEEEeeccchhhhcCCCc----ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence            9999999999977655433    45779999999999999887 45689999999999999998888

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.1e-32  Score=243.20  Aligned_cols=264  Identities=24%  Similarity=0.303  Sum_probs=192.8

Q ss_pred             cccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceE
Q 011360          194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAH  273 (487)
Q Consensus       194 ~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  273 (487)
                      .+.-+.||.|+||.||.++ +..+|+.||+|++..             -..+-...+.+.+|+.++..++|.|++..++.
T Consensus        55 i~PDRPIGYGAFGVVWsVT-DPRdgrrvalkK~pn-------------vfq~L~s~krvFre~kmLcfFkHdNVLSaLDI  120 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVT-DPRSGKRVALKKMPN-------------VFQNLASCKRVFREIKMLSSFRHDNVLSLLDI  120 (449)
T ss_pred             CCCCCcccccceeEEEecc-CCCCccchhHhhcch-------------HHHHHHHHHHHHHHHHHHHhhccccHHHHHHh
Confidence            4556789999999999997 456899999998843             12233355678899999999999999999998


Q ss_pred             EecCC-----eeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC
Q 011360          274 MVRPD-----CHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDD  348 (487)
Q Consensus       274 ~~~~~-----~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~  348 (487)
                      ..-..     .+|+++|.+. .+|..++-    ....++...++-+..||++||+||   |+.||.||||||.|.|++.|
T Consensus       121 LQPph~dfFqEiYV~TELmQ-SDLHKIIV----SPQ~Ls~DHvKVFlYQILRGLKYL---HsA~ILHRDIKPGNLLVNSN  192 (449)
T KOG0664|consen  121 LQPANPSFFQELYVLTELMQ-SDLHKIIV----SPQALTPDHVKVFVYQILRGLKYL---HTANILHRDIKPGNLLVNSN  192 (449)
T ss_pred             cCCCCchHHHHHHHHHHHHH-hhhhheec----cCCCCCcchhhhhHHHHHhhhHHH---hhcchhhccCCCccEEeccC
Confidence            76543     4578899884 47777663    367888899999999999999999   88999999999999999999


Q ss_pred             CCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCccccCCCCccc---
Q 011360          349 MEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQP-ELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEIC---  424 (487)
Q Consensus       349 ~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~---  424 (487)
                      ..+||||||+++.........+ +..+.|..|.|||++.+. .|+.+.||||.||++.|++..+..|...++-....   
T Consensus       193 CvLKICDFGLARvee~d~~~hM-TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lIt  271 (449)
T KOG0664|consen  193 CILKICDFGLARTWDQRDRLNM-THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMII  271 (449)
T ss_pred             ceEEecccccccccchhhhhhh-HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHH
Confidence            9999999999987655544333 344578999999999876 79999999999999999999999885544322110   


Q ss_pred             ------cHHHHHH--------HHhcCCCCCcc--CCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHH
Q 011360          425 ------SPEWLRK--------VMNSKNPSRAI--DPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCR  482 (487)
Q Consensus       425 ------~~~~~~~--------~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~  482 (487)
                            ..+.++.        +.+...-...+  -..+.+.  ...-.+...++..++.++|+.|.+..+.+..
T Consensus       272 dLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~--~~~~heav~~~~~~l~~d~dkris~~~A~~~  343 (449)
T KOG0664|consen  272 DLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASP--DDKNHEAVDLLQKLLHFDPDKRISVEEALQH  343 (449)
T ss_pred             HHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCC--cccchHHHHHHHHHhCCCCcccccHhhhccc
Confidence                  1111111        11111100000  0011110  1111234567778999999999998887654

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=1.8e-30  Score=226.40  Aligned_cols=258  Identities=21%  Similarity=0.317  Sum_probs=194.2

Q ss_pred             hccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCC-CCCcc
Q 011360          190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIR-HRNIL  268 (487)
Q Consensus       190 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv  268 (487)
                      ..++|++.+.+|+|-++.||.|. +..+++.++||++.                  +-..+.+.+|+.++..|. ||||+
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~-~~~~~eK~ViKiLK------------------PVkkkKIkREikIL~nL~gg~NIi   96 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGI-NITNNEKCVIKILK------------------PVKKKKIKREIKILQNLRGGPNII   96 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhccc-ccCCCceEEEeeec------------------hHHHHHHHHHHHHHHhccCCCCee
Confidence            34569999999999999999996 45678899999872                  334567889999999995 99999


Q ss_pred             ccceEEecC--CeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC
Q 011360          269 PLLAHMVRP--DCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN  346 (487)
Q Consensus       269 ~l~~~~~~~--~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~  346 (487)
                      +++++..++  ....+|+||+.+.+...+..       .++...+..++.+++.||.|+   |+.||+|||+||.|++++
T Consensus        97 ~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~-------tl~d~dIryY~~elLkALdyC---HS~GImHRDVKPhNvmId  166 (338)
T KOG0668|consen   97 KLLDIVKDPESKTPSLIFEYVNNTDFKQLYP-------TLTDYDIRYYIYELLKALDYC---HSMGIMHRDVKPHNVMID  166 (338)
T ss_pred             ehhhhhcCccccCchhHhhhhccccHHHHhh-------hhchhhHHHHHHHHHHHHhHH---HhcCcccccCCcceeeec
Confidence            999998875  45679999999888776653       366778899999999999999   899999999999999999


Q ss_pred             CC-CCEEEeccCCccccCCCCceeeEeeecccccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccc
Q 011360          347 DD-MEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQ-PELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEIC  424 (487)
Q Consensus       347 ~~-~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~  424 (487)
                      .. -.++|+|+|++....++...   ...+.+..|--||.+.. +.|+..-|+|||||++..|++.+.||..+....+..
T Consensus       167 h~~rkLrlIDWGLAEFYHp~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQL  243 (338)
T KOG0668|consen  167 HELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL  243 (338)
T ss_pred             hhhceeeeeecchHhhcCCCcee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHH
Confidence            54 56899999999887665443   23346778889998864 478999999999999999999999986544333221


Q ss_pred             c-------HHHHHHHHhcCCCCCccCCC----------------CCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          425 S-------PEWLRKVMNSKNPSRAIDPR----------------LPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       425 ~-------~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .       .+.+...+..-  .-.+|+.                ++++...-...+..+++.+.|..|..+|||+++.+.
T Consensus       244 VkIakVLGt~el~~Yl~KY--~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  244 VKIAKVLGTDELYAYLNKY--QIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             HHHHHHhChHHHHHHHHHH--ccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence            0       11111111110  0011211                111111122356889999999999999999999764

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.96  E-value=5.7e-30  Score=233.94  Aligned_cols=262  Identities=26%  Similarity=0.348  Sum_probs=192.8

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      ..+|.-+..+|.|.- .|..+ .+.-.+.+||+|++...             .......++..+|..++..+.|+||+++
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a-~D~v~~~~v~ikk~~~p-------------f~n~~~akra~rel~l~~~v~~~nii~l   80 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAA-FDQVLGRPVAIKKLSRP-------------FQNQTHAKRAYRELKLMKCVNHKNIISL   80 (369)
T ss_pred             eeeeeeecccCCCCc-eEEec-chhhccCceehhhhcCc-------------cccCccchhhhhhhhhhhhhcccceeee
Confidence            346777888898887 55555 46668899999987432             1112345667889999999999999999


Q ss_pred             ceEEecCC------eeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEE
Q 011360          271 LAHMVRPD------CHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVL  344 (487)
Q Consensus       271 ~~~~~~~~------~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nil  344 (487)
                      +.++.-..      ..|+|||+| .++|...+.      ..++-.++..+..|+++|++||   |+.||+||||||+||+
T Consensus        81 ~n~ftP~~~l~~~~e~y~v~e~m-~~nl~~vi~------~elDH~tis~i~yq~~~~ik~l---hs~~IihRdLkPsniv  150 (369)
T KOG0665|consen   81 LNVFTPQKTLEEFQEVYLVMELM-DANLCQVIL------MELDHETISYILYQMLCGIKHL---HSAGIIHRDLKPSNIV  150 (369)
T ss_pred             eeccCccccHHHHHhHHHHHHhh-hhHHHHHHH------HhcchHHHHHHHHHHHHHHHHH---HhcceeecccCcccce
Confidence            99887543      469999999 668988875      3456678899999999999999   8999999999999999


Q ss_pred             eCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCC---
Q 011360          345 LNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGE---  421 (487)
Q Consensus       345 l~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~---  421 (487)
                      +..+..+||.|||+++.....   ...+.++.|..|.|||++.+..|...+||||+||++.||++|...|.+.+.-.   
T Consensus       151 v~~~~~lKi~dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~  227 (369)
T KOG0665|consen  151 VNSDCTLKILDFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWN  227 (369)
T ss_pred             ecchhheeeccchhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHH
Confidence            999999999999999865443   23356778999999999998889999999999999999999999886442100   


Q ss_pred             ------ccccHHHH-------HHHHhcCCCC---CccCCCCCCC-------CcHHHHHHHHHHHhhccCCCCCCCCChHH
Q 011360          422 ------EICSPEWL-------RKVMNSKNPS---RAIDPRLPGN-------GYEKKMLHVLKIAYICTLHDPEERPNSQY  478 (487)
Q Consensus       422 ------~~~~~~~~-------~~~~~~~~~~---~~~~~~~~~~-------~~~~~~~~l~~li~~cl~~~P~~RPs~~~  478 (487)
                            +...+.+.       +.+.. ..+.   ..+...+|..       ...-....+.+++.+||-.||++|.|+++
T Consensus       228 ki~~~lgtpd~~F~~qL~~~~r~yv~-~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~d  306 (369)
T KOG0665|consen  228 KIIEQLGTPDPSFMKQLQPTVRNYVE-NRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDD  306 (369)
T ss_pred             HHHHHhcCCCHHHHHHhhHHHHHHhh-cChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHH
Confidence                  00001111       11111 1110   1111111111       11123345789999999999999999999


Q ss_pred             HHH
Q 011360          479 VRC  481 (487)
Q Consensus       479 il~  481 (487)
                      ++.
T Consensus       307 aL~  309 (369)
T KOG0665|consen  307 ALR  309 (369)
T ss_pred             Hhc
Confidence            875

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.96  E-value=5.5e-28  Score=221.18  Aligned_cols=212  Identities=34%  Similarity=0.537  Sum_probs=179.7

Q ss_pred             cccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceEEecCCe
Q 011360          200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDC  279 (487)
Q Consensus       200 lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~  279 (487)
                      ||.|++|.||++... .++..+++|++.....              ......+.+|+..++.+.|++|+++++++.....
T Consensus         1 l~~g~~~~v~~~~~~-~~~~~~~~K~~~~~~~--------------~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~   65 (215)
T cd00180           1 LGEGGFGTVYLARDK-KTGKKVAIKIIKKEDS--------------SSLLEELLREIEILKKLNHPNIVKLYGVFEDENH   65 (215)
T ss_pred             CCcCCceEEEEEEec-CCCcEEEEEEeccccc--------------hhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Confidence            689999999999764 3588999998843111              0034678899999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC-CCCEEEeccCC
Q 011360          280 HLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLND-DMEACISDLGL  358 (487)
Q Consensus       280 ~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~-~~~~kl~DFg~  358 (487)
                      .+++||++.+++|.+++...   ...+++..+..++.+++.++.+|   |+.|++|+||+|.||+++. ++.++|+|||.
T Consensus        66 ~~~~~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~l---h~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~  139 (215)
T cd00180          66 LYLVMEYCEGGSLKDLLKEN---EGKLSEDEILRILLQILEGLEYL---HSNGIIHRDLKPENILLDSDNGKVKLADFGL  139 (215)
T ss_pred             EEEEEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHhhEEEeCCCCcEEEecCCc
Confidence            99999999999999998752   14688999999999999999999   6779999999999999999 89999999999


Q ss_pred             ccccCCCCceeeEeeecccccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHHHhcCC
Q 011360          359 AMAIPDGYTRVLISYVLGTMAYIAPEYFQQP-ELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSKN  437 (487)
Q Consensus       359 s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  437 (487)
                      +........  ......+...|++||.+... .++.++|+|++|++++++                              
T Consensus       140 ~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------  187 (215)
T cd00180         140 SKLLTSDKS--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------  187 (215)
T ss_pred             eEEccCCcc--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------
Confidence            976654321  11234578899999999887 888999999999999998                              


Q ss_pred             CCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHH
Q 011360          438 PSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCR  482 (487)
Q Consensus       438 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~  482 (487)
                                        ..+.+++..|++.+|++||++.++++.
T Consensus       188 ------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 ------------------PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             ------------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence                              237899999999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=4.2e-29  Score=223.12  Aligned_cols=252  Identities=19%  Similarity=0.285  Sum_probs=185.7

Q ss_pred             hhccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CCCCc
Q 011360          189 KKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RHRNI  267 (487)
Q Consensus       189 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnI  267 (487)
                      ...+.|.+.+.||+|.||++-++.++ .++..+++|-+..                .....+.|.+|...--.| .|.||
T Consensus        21 ~l~d~y~I~k~lgeG~FgkIlL~eHr-~s~t~ivlKavp~----------------p~tt~~dF~rEfhY~~~Ls~H~hI   83 (378)
T KOG1345|consen   21 DLEDVYTINKQLGEGRFGKILLAEHR-QSKTRIVLKAVPR----------------PQTTQADFVREFHYSFFLSPHQHI   83 (378)
T ss_pred             chhhhhhHHHHhcccceeeEEeeecc-CCceEEEeeccCc----------------chhhHHHHHHHhccceeeccchhh
Confidence            34567999999999999999999875 5778899997732                233567788888776666 78999


Q ss_pred             cccceE-EecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC
Q 011360          268 LPLLAH-MVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN  346 (487)
Q Consensus       268 v~l~~~-~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~  346 (487)
                      +.-|++ |...+.+++++||++.|+|.+-+..     ..+.+..-.+++.|+++|+.|+   |++++||||||.+||||-
T Consensus        84 i~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fM---HsknlVHRdlK~eNiLif  155 (378)
T KOG1345|consen   84 IDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFM---HSKNLVHRDLKAENILIF  155 (378)
T ss_pred             hHHHHHHhhcCceEEEeeccCccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHh---hccchhhcccccceEEEe
Confidence            999965 5566778899999999999887753     4577788889999999999999   889999999999999994


Q ss_pred             --CCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCC---C--CCCchhHHHHHHHHHHHHHhCCCCccccCC
Q 011360          347 --DDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQ---P--ELSEKCDIFSFGMLLISLVRGVPSFVFHQN  419 (487)
Q Consensus       347 --~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~--~~~~~~DvwslG~~l~elltg~~pf~~~~~  419 (487)
                        +...+||||||..+..+...     ....-+..|.+||....   .  ...+.+|+|.||+++|..+||.+||.....
T Consensus       156 ~~df~rvKlcDFG~t~k~g~tV-----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~  230 (378)
T KOG1345|consen  156 DADFYRVKLCDFGLTRKVGTTV-----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI  230 (378)
T ss_pred             cCCccEEEeeecccccccCcee-----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhc
Confidence              34579999999987653322     22334667999996542   2  346789999999999999999999963322


Q ss_pred             CCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHH
Q 011360          420 GEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYV  479 (487)
Q Consensus       420 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~i  479 (487)
                       .+....+|.  .+..+...     .+| ..+...+..+.++.++-|.++|++|=-..+.
T Consensus       231 -~d~~Y~~~~--~w~~rk~~-----~~P-~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~  281 (378)
T KOG1345|consen  231 -MDKPYWEWE--QWLKRKNP-----ALP-KKFNPFSEKALRLFKKSLTPRFKDRCKIWTA  281 (378)
T ss_pred             -cCchHHHHH--HHhcccCc-----cCc-hhhcccCHHHHHHHHHhcCCcccccchhHHH
Confidence             122222332  22222211     122 2233445667888889999999999444333

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.96  E-value=7.2e-30  Score=252.77  Aligned_cols=253  Identities=27%  Similarity=0.400  Sum_probs=199.7

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .++|..+..+|.|++|.||+++ +..+++..|+|.+....               .....-+.+|+.+++..+|||||.+
T Consensus        14 ~ddyellqrvgsgTygdvyKaR-d~~s~elaavkvVkLep---------------~dd~~~iqqei~~~~dc~h~nivay   77 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKAR-DKRSGELAAVKVVKLEP---------------GDDFSGIQQEIGMLRDCRHPNIVAY   77 (829)
T ss_pred             ccchhheeeecCCcccchhhhc-ccccCchhhheeeeccC---------------CccccccccceeeeecCCCcChHHH
Confidence            4579999999999999999997 56789999999985432               2234456778999999999999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      ++.+...+.++++||||.||+|.+.-.    .-.++++.++...++...+||+||   |+.|-+|||||-.||++++.|.
T Consensus        78 ~gsylr~dklwicMEycgggslQdiy~----~TgplselqiayvcRetl~gl~yl---hs~gk~hRdiKGanilltd~gD  150 (829)
T KOG0576|consen   78 FGSYLRRDKLWICMEYCGGGSLQDIYH----VTGPLSELQIAYVCRETLQGLKYL---HSQGKIHRDIKGANILLTDEGD  150 (829)
T ss_pred             HhhhhhhcCcEEEEEecCCCcccceee----ecccchhHHHHHHHhhhhccchhh---hcCCcccccccccceeecccCc
Confidence            999999999999999999999998764    357899999999999999999999   8899999999999999999999


Q ss_pred             EEEeccCCccccCCCCceeeEeeecccccccCCcccC---CCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHH
Q 011360          351 ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQ---QPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPE  427 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~  427 (487)
                      +|++|||.+-.+......  ...+.||+.|||||+-.   .+.|...+|||++|+...|+---++|-.      +.....
T Consensus       151 vklaDfgvsaqitati~K--rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplf------dlhpmr  222 (829)
T KOG0576|consen  151 VKLADFGVSAQITATIAK--RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLF------DLHPMR  222 (829)
T ss_pred             eeecccCchhhhhhhhhh--hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccc------ccchHH
Confidence            999999998766443322  24578999999999764   5689999999999999999998877651      111111


Q ss_pred             HHHHHHhcCC-CCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          428 WLRKVMNSKN-PSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       428 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .+.-+.+.+. +...-|+       ......|-++++.|+-++|++|||++.++.
T Consensus       223 ~l~LmTkS~~qpp~lkDk-------~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  223 ALFLMTKSGFQPPTLKDK-------TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             HHHHhhccCCCCCcccCC-------ccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            1211222211 1111111       223345778888899999999999998764

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.95  E-value=3.1e-28  Score=230.64  Aligned_cols=199  Identities=25%  Similarity=0.367  Sum_probs=163.9

Q ss_pred             cccccccccccccceeEEEEEecCC--CCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CCCCcc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGS--NGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RHRNIL  268 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv  268 (487)
                      +.|..++++|.|.|+.||++.....  .++.||+|.+....                 ...++..|++++..+ .+.||+
T Consensus        36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-----------------~p~ri~~El~~L~~~gG~~ni~   98 (418)
T KOG1167|consen   36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-----------------SPSRILNELEMLYRLGGSDNII   98 (418)
T ss_pred             hhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-----------------CchHHHHHHHHHHHhccchhhh
Confidence            4589999999999999999976542  67899999884322                 234578899999988 789999


Q ss_pred             ccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC-
Q 011360          269 PLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLND-  347 (487)
Q Consensus       269 ~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~-  347 (487)
                      ++.+++..++...+||||+++....++...       ++...+..+++.+..||.++   |.+|||||||||+|+|.+. 
T Consensus        99 ~~~~~~rnnd~v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~---h~~GIvHRDiKpsNFL~n~~  168 (418)
T KOG1167|consen   99 KLNGCFRNNDQVAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHL---HKNGIVHRDIKPSNFLYNRR  168 (418)
T ss_pred             cchhhhccCCeeEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhh---hccCccccCCCccccccccc
Confidence            999999999999999999999999998754       66889999999999999999   8999999999999999985 


Q ss_pred             CCCEEEeccCCccccC-----------------C--C-----------------------CceeeEeeecccccccCCcc
Q 011360          348 DMEACISDLGLAMAIP-----------------D--G-----------------------YTRVLISYVLGTMAYIAPEY  385 (487)
Q Consensus       348 ~~~~kl~DFg~s~~~~-----------------~--~-----------------------~~~~~~~~~~gt~~y~aPE~  385 (487)
                      .+.-.|.|||++....                 .  +                       ..........||++|.|||+
T Consensus       169 t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEv  248 (418)
T KOG1167|consen  169 TQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEV  248 (418)
T ss_pred             cCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHH
Confidence            4667899999986210                 0  0                       00001123569999999999


Q ss_pred             cCC-CCCCchhHHHHHHHHHHHHHhCCCCcccc
Q 011360          386 FQQ-PELSEKCDIFSFGMLLISLVRGVPSFVFH  417 (487)
Q Consensus       386 l~~-~~~~~~~DvwslG~~l~elltg~~pf~~~  417 (487)
                      +.. +..+.++||||.|+++..++++..||...
T Consensus       249 L~k~~~QttaiDiws~GVI~Lslls~~~PFf~a  281 (418)
T KOG1167|consen  249 LFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKA  281 (418)
T ss_pred             HhhccCcCCccceeeccceeehhhccccccccC
Confidence            875 46789999999999999999999999433

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.95  E-value=6.7e-27  Score=217.03  Aligned_cols=200  Identities=31%  Similarity=0.448  Sum_probs=167.6

Q ss_pred             cccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceE
Q 011360          194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAH  273 (487)
Q Consensus       194 ~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  273 (487)
                      |.+.+.||.|++|.||++... .++..+++|.+......              .....+.+|+..++.++|+|+++++++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~--------------~~~~~~~~e~~~~~~~~~~~i~~~~~~   65 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDK-GTGELVAVKVLKKEKTE--------------KQREEFLREIRILKKLKHPNIVKLYGV   65 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEc-CCCcEEEEEeeccccch--------------HHHHHHHHHHHHHHhCCCCChhhheee
Confidence            456788999999999999764 45789999988431110              245678889999999999999999999


Q ss_pred             EecCCeeEEEEEecCCCCHHHHHhhhhcCCCC-CChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEE
Q 011360          274 MVRPDCHLLVYEFMKNGSLQDILDDVSRGRRE-LDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC  352 (487)
Q Consensus       274 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~-l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~k  352 (487)
                      +......++++||+++++|.+++...    .. +++..+..++.+++.++.+|   |+.+++|+||+|.||+++.++.++
T Consensus        66 ~~~~~~~~~v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~l---h~~~i~h~di~~~ni~v~~~~~~~  138 (225)
T smart00221       66 FEDPEPLYLVMEYCEGGDLFDYLRKK----GGKLSEEEARFYLRQILEALEYL---HSLGIVHRDLKPENILLGMDGLVK  138 (225)
T ss_pred             eecCCceEEEEeccCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCCEE
Confidence            99989999999999999999998752    22 78899999999999999999   667899999999999999999999


Q ss_pred             EeccCCccccCCCCceeeEeeecccccccCCccc-CCCCCCchhHHHHHHHHHHHHHhCCCCccc
Q 011360          353 ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYF-QQPELSEKCDIFSFGMLLISLVRGVPSFVF  416 (487)
Q Consensus       353 l~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l-~~~~~~~~~DvwslG~~l~elltg~~pf~~  416 (487)
                      |+|||.+......... ......++..|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus       139 l~d~g~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      139 LADFGLARFIHRDLAA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             EeeCceeeEecCcccc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            9999998876544211 11334578899999998 666788899999999999999999999933

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.94  E-value=2.2e-27  Score=259.78  Aligned_cols=196  Identities=15%  Similarity=0.147  Sum_probs=139.0

Q ss_pred             cCCC-CCccccceEE-------ecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCC
Q 011360          261 QIRH-RNILPLLAHM-------VRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSAS  332 (487)
Q Consensus       261 ~l~h-pnIv~l~~~~-------~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~g  332 (487)
                      .+.| +||+++++++       ....+++++|||+ +++|.++|..   ....+++..++.++.||+.||.||   |++|
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~l---H~~g  100 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAA---HSQG  100 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHH---HhCC
Confidence            3456 6888888877       2335677889987 6799999963   245689999999999999999999   7889


Q ss_pred             eeecCCCCCCEEeCCC-------------------CCEEEeccCCccccCCCCc--------------eeeEeeeccccc
Q 011360          333 IIHGDIKPRNVLLNDD-------------------MEACISDLGLAMAIPDGYT--------------RVLISYVLGTMA  379 (487)
Q Consensus       333 ivH~Dlkp~Nill~~~-------------------~~~kl~DFg~s~~~~~~~~--------------~~~~~~~~gt~~  379 (487)
                      |+||||||+|||++..                   +.+|++|||+++.......              ........||+.
T Consensus       101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  180 (793)
T PLN00181        101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW  180 (793)
T ss_pred             eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence            9999999999999653                   4456666666653211000              000112357889


Q ss_pred             ccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHH
Q 011360          380 YIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVL  459 (487)
Q Consensus       380 y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  459 (487)
                      |+|||++.+..|+.++|||||||++|||++|.+|+....        ...........     ++...     .......
T Consensus       181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--------~~~~~~~~~~~-----~~~~~-----~~~~~~~  242 (793)
T PLN00181        181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--------RTMSSLRHRVL-----PPQIL-----LNWPKEA  242 (793)
T ss_pred             eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--------HHHHHHHHhhc-----Chhhh-----hcCHHHH
Confidence            999999999999999999999999999999988873211        11111111111     11110     1112356


Q ss_pred             HHHhhccCCCCCCCCChHHHHH
Q 011360          460 KIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       460 ~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .++.+||+++|.+|||+.++++
T Consensus       243 ~~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        243 SFCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HHHHHhCCCChhhCcChHHHhh
Confidence            7888999999999999999975

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.93  E-value=1.3e-25  Score=200.81  Aligned_cols=166  Identities=20%  Similarity=0.195  Sum_probs=124.3

Q ss_pred             CCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEeccCCccccCCCCcee
Q 011360          290 GSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRV  369 (487)
Q Consensus       290 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~DFg~s~~~~~~~~~~  369 (487)
                      |+|.+++..   .+..+++..++.++.|++.||.||   |+.+      ||+||+++.++.+|+  ||++.......   
T Consensus         1 GsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~l---H~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---   63 (176)
T smart00750        1 VSLADILEV---RGRPLNEEEIWAVCLQCLRALREL---HRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ---   63 (176)
T ss_pred             CcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHH---HhcC------CcccEeEcCccceee--ccceEeecccc---
Confidence            689999874   245699999999999999999999   5554      999999999999999  99987654321   


Q ss_pred             eEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCC
Q 011360          370 LISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGN  449 (487)
Q Consensus       370 ~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  449 (487)
                          ..||+.|+|||++.+..++.++|||||||++|||+||..||......     ...............  ....  .
T Consensus        64 ----~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~-----~~~~~~~~~~~~~~~--~~~~--~  130 (176)
T smart00750       64 ----SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL-----SAILEILLNGMPADD--PRDR--S  130 (176)
T ss_pred             ----CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh-----cHHHHHHHHHhccCC--cccc--c
Confidence                25899999999999999999999999999999999999999433221     112222222111110  0000  1


Q ss_pred             CcHHHHH--HHHHHHhhccCCCCCCCCChHHHHHHHhh
Q 011360          450 GYEKKML--HVLKIAYICTLHDPEERPNSQYVRCRLSQ  485 (487)
Q Consensus       450 ~~~~~~~--~l~~li~~cl~~~P~~RPs~~~il~~L~~  485 (487)
                      .......  .+.+++.+||..+|.+|||+.++++.+..
T Consensus       131 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~  168 (176)
T smart00750      131 NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA  168 (176)
T ss_pred             cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence            1122223  58999999999999999999999987754

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.91  E-value=2.3e-24  Score=211.01  Aligned_cols=169  Identities=20%  Similarity=0.202  Sum_probs=128.0

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      +.|.+.+.||+|+||+||+|.+...++..+|||++.....          ..........+.+|+.++.+++|+||+..+
T Consensus        18 ~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~----------~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l   87 (365)
T PRK09188         18 ARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVP----------WWSKPLARHLAAREIRALKTVRGIGVVPQL   87 (365)
T ss_pred             CCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEeccccc----------ccccHHHHHHHHHHHHHHHhccCCCCCcEE
Confidence            4699999999999999999987655778889998631100          000122345688999999999999998633


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCC-CCCCEEeCCCCC
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDI-KPRNVLLNDDME  350 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dl-kp~Nill~~~~~  350 (487)
                      ..   .+..|+||||++|++|.. +.   . .   .   ...++.+++++|.||   |++||+|||| ||+|||++.++.
T Consensus        88 ~~---~~~~~LVmE~~~G~~L~~-~~---~-~---~---~~~~~~~i~~aL~~l---H~~gIiHrDL~KP~NILv~~~~~  150 (365)
T PRK09188         88 LA---TGKDGLVRGWTEGVPLHL-AR---P-H---G---DPAWFRSAHRALRDL---HRAGITHNDLAKPQNWLMGPDGE  150 (365)
T ss_pred             EE---cCCcEEEEEccCCCCHHH-hC---c-c---c---hHHHHHHHHHHHHHH---HHCCCeeCCCCCcceEEEcCCCC
Confidence            22   245799999999999962 21   1 1   1   146788999999999   7789999999 999999999999


Q ss_pred             EEEeccCCccccCCCCceee------EeeecccccccCCcccC
Q 011360          351 ACISDLGLAMAIPDGYTRVL------ISYVLGTMAYIAPEYFQ  387 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~~------~~~~~gt~~y~aPE~l~  387 (487)
                      +||+|||+++..........      ..+..+++.|+|||.+.
T Consensus       151 ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~  193 (365)
T PRK09188        151 AAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT  193 (365)
T ss_pred             EEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence            99999999987654432211      13456888999999886

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.91  E-value=8.5e-25  Score=195.64  Aligned_cols=251  Identities=24%  Similarity=0.361  Sum_probs=189.1

Q ss_pred             cccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceE
Q 011360          194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAH  273 (487)
Q Consensus       194 ~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  273 (487)
                      ...+.+|.+...|..|+|+|.   |..+++|++..             ........+.|..|.-.++-+.||||+.+++.
T Consensus       192 lnl~tkl~e~hsgelwrgrwq---gndivakil~v-------------r~~t~risrdfneefp~lrifshpnilpvlga  255 (448)
T KOG0195|consen  192 LNLITKLAESHSGELWRGRWQ---GNDIVAKILNV-------------REVTARISRDFNEEFPALRIFSHPNILPVLGA  255 (448)
T ss_pred             hhhhhhhccCCCccccccccc---Ccchhhhhhhh-------------hhcchhhcchhhhhCcceeeecCCchhhhhhh
Confidence            566678899999999999994   55677776622             22333455678889999999999999999999


Q ss_pred             EecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEE
Q 011360          274 MVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACI  353 (487)
Q Consensus       274 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl  353 (487)
                      |..+.++.++..||+.|||...|..  ..+-..+-.++.+++.++++|++|||+... -|.---|....++++++.+++|
T Consensus       256 cnsppnlv~isq~mp~gslynvlhe--~t~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltari  332 (448)
T KOG0195|consen  256 CNSPPNLVIISQYMPFGSLYNVLHE--QTSVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARI  332 (448)
T ss_pred             ccCCCCceEeeeeccchHHHHHHhc--CccEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhhe
Confidence            9999999999999999999999975  344556778899999999999999987643 2555568889999999988776


Q ss_pred             e--ccCCccccCCCCceeeEeeecccccccCCcccCCCCCC---chhHHHHHHHHHHHHHhCCCCccccCCCCccccHHH
Q 011360          354 S--DLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELS---EKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEW  428 (487)
Q Consensus       354 ~--DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~---~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~  428 (487)
                      +  |--++...         ....-.|.|++||.++..+-+   .++|+|||++++||+.|...||..-++.+..     
T Consensus       333 smad~kfsfqe---------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg-----  398 (448)
T KOG0195|consen  333 SMADTKFSFQE---------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG-----  398 (448)
T ss_pred             ecccceeeeec---------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh-----
Confidence            3  43332221         122357899999999865433   4789999999999999999999655443221     


Q ss_pred             HHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhhC
Q 011360          429 LRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL  487 (487)
Q Consensus       429 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~ll  487 (487)
                       .++.     -+.+...+|+.    .+.++.+++.-|+..||.+||.+..|+-.|++++
T Consensus       399 -mkia-----leglrv~ippg----is~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  399 -MKIA-----LEGLRVHIPPG----ISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             -hhhh-----hccccccCCCC----ccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence             1111     11122223322    3356889999999999999999999999888763

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=1.9e-23  Score=192.06  Aligned_cols=200  Identities=25%  Similarity=0.315  Sum_probs=169.8

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CCCCccccc
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RHRNILPLL  271 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~  271 (487)
                      .|.+.++||+|+||.++.|+ +.-++++||||.-                 ...+..-++..|....+.| ..++|...|
T Consensus        29 hyrVGkKIGeGsFG~lf~G~-Nl~nne~VAIKfE-----------------PrkS~APQLrdEYr~YKlL~g~~GIP~vY   90 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGK-NLYNNEPVAIKFE-----------------PRKSEAPQLRDEYRTYKLLGGTEGIPQVY   90 (449)
T ss_pred             cceeccccccCcceeeeccc-ccccCceEEEEec-----------------cccCCcchHHHHHHHHHHHcCCCCCCcee
Confidence            49999999999999999996 5678999999953                 2334456778888888877 679999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC---
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDD---  348 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~---  348 (487)
                      .+...+-+..+|||.+ |.||.|+++-   .++.|+..++..++.|++.-++|+   |++.+|+|||||+|+||..-   
T Consensus        91 YFGqeG~~NiLVidLL-GPSLEDLFD~---CgR~FSvKTV~miA~Qmi~rie~v---H~k~LIYRDIKPdNFLIGrp~~k  163 (449)
T KOG1165|consen   91 YFGQEGKYNILVIDLL-GPSLEDLFDL---CGRRFSVKTVAMIAKQMITRIEYV---HEKDLIYRDIKPDNFLIGRPGTK  163 (449)
T ss_pred             eeccccchhhhhhhhh-CcCHHHHHHH---hcCcccHHhHHHHHHHHHHHHHHH---HhcceeecccCccceeecCCCCC
Confidence            8888888888999998 8999999873   578899999999999999999999   56669999999999999743   


Q ss_pred             --CCEEEeccCCccccCCCCceee-----EeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCcccc
Q 011360          349 --MEACISDLGLAMAIPDGYTRVL-----ISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFH  417 (487)
Q Consensus       349 --~~~kl~DFg~s~~~~~~~~~~~-----~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~  417 (487)
                        ..+.++|||+++...+..+...     .....||.+||+-..+.+..-+.+-|+-|||-++++.+.|..||.+-
T Consensus       164 ~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGL  239 (449)
T KOG1165|consen  164 DANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL  239 (449)
T ss_pred             CCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccc
Confidence              3478999999998766544322     23457999999999999988899999999999999999999999554

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=4.6e-24  Score=187.94  Aligned_cols=263  Identities=24%  Similarity=0.267  Sum_probs=195.5

Q ss_pred             hccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCC-CCCcc
Q 011360          190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIR-HRNIL  268 (487)
Q Consensus       190 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv  268 (487)
                      ....|.+++.||.|+||.+|+|. ...+|..||||.-..                 .....++..|..+...|+ ...|.
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~-~i~~ge~VAiK~Es~-----------------~a~hpqL~yEskvY~iL~~g~GiP   74 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGI-SITSGEEVAIKLESS-----------------KAKHPQLLYESKVYRILQGGVGIP   74 (341)
T ss_pred             eccceEEEEeecCCchhheeeee-eccCCceEEEEeecc-----------------cCCCcchhHHHHHHHHhccCCCCc
Confidence            34569999999999999999996 456899999997521                 222345677888888885 46788


Q ss_pred             ccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC-
Q 011360          269 PLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLND-  347 (487)
Q Consensus       269 ~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~-  347 (487)
                      .+..+..+.+.-.+||+.. |.||.+++..   ....++..+++-++-|++.-++|+   |.++++||||||+|+|+.- 
T Consensus        75 ~i~~y~~e~~ynvlVMdLL-GPsLEdLfnf---C~R~ftmkTvLMLaDQml~RiEyv---H~r~fiHRDIKPdNFLMGlg  147 (341)
T KOG1163|consen   75 HIRHYGTEKDYNVLVMDLL-GPSLEDLFNF---CSRRFTMKTVLMLADQMLSRIEYV---HLRNFIHRDIKPDNFLMGLG  147 (341)
T ss_pred             hhhhhccccccceeeeecc-CccHHHHHHH---HhhhhhHHhHHHHHHHHHHHHHHH---HhhccccccCCccceeeccc
Confidence            8888888888889999998 8999999874   356799999999999999999999   7778999999999999974 


Q ss_pred             --CCCEEEeccCCccccCCCCcee-----eEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCC
Q 011360          348 --DMEACISDLGLAMAIPDGYTRV-----LISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNG  420 (487)
Q Consensus       348 --~~~~kl~DFg~s~~~~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~  420 (487)
                        ...+.++|||+|+...+..+..     ......||.+|.+-..+.+..-+.+-|+-|+|.++.++-.|..||.+-...
T Consensus       148 rh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~  227 (341)
T KOG1163|consen  148 RHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA  227 (341)
T ss_pred             cccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchh
Confidence              3568899999998765433221     123467999999988888777788999999999999999999999655433


Q ss_pred             CccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          421 EEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       421 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      ......+.+...- -..+.+.+-..+|        .++.-.+..|-..--++-|...-|.+.++.+
T Consensus       228 tk~QKyEkI~EkK-~s~~ie~LC~G~P--------~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriL  284 (341)
T KOG1163|consen  228 TKKQKYEKISEKK-MSTPIEVLCKGFP--------AEFAMYLNYCRGLGFEEKPDYMYLRQLFRIL  284 (341)
T ss_pred             hHHHHHHHHHHhh-cCCCHHHHhCCCc--------HHHHHHHHHHhhcCCCCCCcHHHHHHHHHHH
Confidence            2222222222111 1112222222222        4577777778777777888887777666543

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.90  E-value=2.7e-23  Score=203.83  Aligned_cols=261  Identities=23%  Similarity=0.239  Sum_probs=186.8

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCC----CCCcc
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIR----HRNIL  268 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~----hpnIv  268 (487)
                      .|.+.+.||.|+||.||.+.........+|+|.......               .....+..|..++..+.    .+++.
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~---------------~~~~~l~~E~~vl~~l~~~~~~~~~~   83 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELG---------------SKPSVLKIEIQVLKKLEKKNGPSHFP   83 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEeccc---------------CCCccchhHHHHHHHHhhhcCCCCCC
Confidence            699999999999999999975433346788887633110               00114555666666664    36889


Q ss_pred             ccceEE-ecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC
Q 011360          269 PLLAHM-VRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLND  347 (487)
Q Consensus       269 ~l~~~~-~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~  347 (487)
                      .+++.. ......|+||+.+ |.+|.++.....  .+.++..++..++.|++.+|.++   |+.|++||||||.|+++..
T Consensus        84 ~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~l---H~~G~iHRDiKp~N~~~g~  157 (322)
T KOG1164|consen   84 KLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDL---HSKGFIHRDIKPENFVVGQ  157 (322)
T ss_pred             EEEEeccCCCceeEEEEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHH---HhcCcccCCcCHHHeeecC
Confidence            999888 4777889999988 889999886532  57899999999999999999999   8889999999999999986


Q ss_pred             C-----CCEEEeccCCcc--ccCCCCce------eeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCc
Q 011360          348 D-----MEACISDLGLAM--AIPDGYTR------VLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF  414 (487)
Q Consensus       348 ~-----~~~kl~DFg~s~--~~~~~~~~------~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf  414 (487)
                      .     -.+.|.|||+++  ........      .......||.+|+++.++.+...+.+.|+||++.++.++..|..||
T Consensus       158 ~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW  237 (322)
T KOG1164|consen  158 SSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPW  237 (322)
T ss_pred             CCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCC
Confidence            5     358999999998  32111110      1012356999999999999999999999999999999999999999


Q ss_pred             cccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          415 VFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       415 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      ........   ...............      .....+   ..+.++...+-..+...+|....+...|++.
T Consensus       238 ~~~~~~~~---~~~~~~~~~~~~~~~------~~~~~~---~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~  297 (322)
T KOG1164|consen  238 EALEMTDL---KSKFEKDPRKLLTDR------FGDLKP---EEFAKILEYIDSLDYEDKPDYEKLAELLKDV  297 (322)
T ss_pred             ccccccch---HHHHHHHhhhhcccc------ccCCCh---HHHHHHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence            54433221   111111111111100      011111   2344555555557999999999998887653

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.90  E-value=2.6e-24  Score=224.21  Aligned_cols=261  Identities=22%  Similarity=0.234  Sum_probs=190.9

Q ss_pred             ccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceEE
Q 011360          195 ASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHM  274 (487)
Q Consensus       195 ~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  274 (487)
                      .....+|.|++|.++.... ....+.++.|.+... ..        ...........+..|+.+-..+.|||++..+..+
T Consensus       321 ~~~~~~g~ga~g~~~~~~~-~~~~~~~~~~~~r~~-~~--------~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~  390 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKR-RSDLKSFPEKEFRVR-VK--------PTESERKYNYNITSEFCIGSSLSHPNIIETLDIV  390 (601)
T ss_pred             CccceeeecccCceEEEEe-cCCCccchhhhhhcc-cC--------CcccHHHHhhhhhhheeecccccCCchhhhHHHH
Confidence            4567899999997777753 234444555543211 00        0111122222377888889999999999988877


Q ss_pred             ecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEe
Q 011360          275 VRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACIS  354 (487)
Q Consensus       275 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~  354 (487)
                      .+....+-.||||++ +|..++..    ...+....+..++.|+..|++|+   |+.||.|||+|++|++++.+|.+||+
T Consensus       391 ~~~~~~~~~mE~~~~-Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~---h~~GiahrdlK~enll~~~~g~lki~  462 (601)
T KOG0590|consen  391 QEIDGILQSMEYCPY-DLFSLVMS----NGKLTPLEADCFFKQLLRGVKYL---HSMGLAHRDLKLENLLVTENGILKII  462 (601)
T ss_pred             hhcccchhhhhcccH-HHHHHHhc----ccccchhhhhHHHHHHHHHHHHH---HhcCceeccCccccEEEecCCceEEe
Confidence            776666666999999 99999864    34678888999999999999999   88999999999999999999999999


Q ss_pred             ccCCccccCCCCce--eeEeeecccccccCCcccCCCCCCc-hhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHH
Q 011360          355 DLGLAMAIPDGYTR--VLISYVLGTMAYIAPEYFQQPELSE-KCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRK  431 (487)
Q Consensus       355 DFg~s~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~-~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~  431 (487)
                      |||.+.........  ......+|+..|+|||++.+..|++ ..||||.|++++.|++|+.||..........      .
T Consensus       463 Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~------~  536 (601)
T KOG0590|consen  463 DFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF------K  536 (601)
T ss_pred             ecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch------h
Confidence            99999877655544  4456678999999999999998876 5799999999999999999996655433221      0


Q ss_pred             HHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          432 VMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       432 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .........  ...-+.......+.+...+|.++|+.+|.+|.|+++|++
T Consensus       537 ~~~~~~~~~--~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  537 TNNYSDQRN--IFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             hhccccccc--cccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            000000000  000011122334456889999999999999999999975

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.89  E-value=1e-21  Score=192.20  Aligned_cols=264  Identities=30%  Similarity=0.415  Sum_probs=194.0

Q ss_pred             cccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCC-Cccccce
Q 011360          194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHR-NILPLLA  272 (487)
Q Consensus       194 ~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp-nIv~l~~  272 (487)
                      |.+...||.|+||.||.+...    ..+++|.+....            .........+.+|+.+++.+.|+ +|+++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~----~~~~~k~~~~~~------------~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~   65 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR----KLVALKVLAKKL------------ESKSKEVERFLREIQILASLNHPPNIVKLYD   65 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec----cEEEEEeechhh------------ccchhHHHHHHHHHHHHHHccCCcceeeEEE
Confidence            567788999999999999753    678999873311            11113567788899999999888 7999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC-CE
Q 011360          273 HMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDM-EA  351 (487)
Q Consensus       273 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~-~~  351 (487)
                      .+......+++++++.++++.+++...... ..++......+..|++.++.|+   |..|++|||+||+||+++..+ .+
T Consensus        66 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~---H~~~~~hrd~kp~nil~~~~~~~~  141 (384)
T COG0515          66 FFQDEGSLYLVMEYVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYL---HSKGIIHRDIKPENILLDRDGRVV  141 (384)
T ss_pred             EEecCCEEEEEEecCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHeeecCCCCeE
Confidence            997777789999999999999776542111 3688889999999999999999   778899999999999999988 69


Q ss_pred             EEeccCCccccCCCCcee----eEeeecccccccCCcccCC---CCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccc
Q 011360          352 CISDLGLAMAIPDGYTRV----LISYVLGTMAYIAPEYFQQ---PELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEIC  424 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~----~~~~~~gt~~y~aPE~l~~---~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~  424 (487)
                      +++|||.+..........    ......|+..|+|||.+.+   ..++..+|+||+|++++++++|..||......   .
T Consensus       142 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~  218 (384)
T COG0515         142 KLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---S  218 (384)
T ss_pred             EEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---c
Confidence            999999998654433221    2356679999999999987   57889999999999999999999997444321   0


Q ss_pred             cHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          425 SPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       425 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ............... .................+.+++..|+..+|..|.+..+...
T Consensus       219 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~  274 (384)
T COG0515         219 ATSQTLKIILELPTP-SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS  274 (384)
T ss_pred             cHHHHHHHHHhcCCc-ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhh
Confidence            111122222211111 00001111100222346778899999999999999887654

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.86  E-value=1.8e-21  Score=175.47  Aligned_cols=155  Identities=19%  Similarity=0.196  Sum_probs=111.5

Q ss_pred             ccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHH--HHH---------HhhhhhhHHHHHHHHHHHHhccCCCC
Q 011360          197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAE--LIE---------EDSKLRDSKLRQIRSEIITASQIRHR  265 (487)
Q Consensus       197 ~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~--~~~---------~~~~~~~~~~~~~~~E~~~l~~l~hp  265 (487)
                      ...||.|+||.||+|...  +|+.||||++....+.....  ...         ...............|+..+..+.++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~--~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   79 (190)
T cd05147           2 NGCISTGKEANVYHATTA--NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTA   79 (190)
T ss_pred             CCccccccceEEEEEECC--CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHC
Confidence            468999999999999753  79999999996543211110  000         00001111123445699999999888


Q ss_pred             CccccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEe
Q 011360          266 NILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLL  345 (487)
Q Consensus       266 nIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill  345 (487)
                      ++.....+...  ..+|||||++|+++......    ...++...+..++.|++.+|.++|  |+.||+||||||+||++
T Consensus        80 ~v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~----~~~~~~~~~~~i~~qi~~~L~~l~--H~~giiHrDlkP~NIli  151 (190)
T cd05147          80 GIPCPEPILLK--SHVLVMEFIGDDGWAAPRLK----DAPLSESKARELYLQVIQIMRILY--QDCRLVHADLSEYNLLY  151 (190)
T ss_pred             CCCCCcEEEec--CCEEEEEEeCCCCCcchhhh----cCCCCHHHHHHHHHHHHHHHHHHH--HhCCcccCCCCHHHEEE
Confidence            87554443322  23899999988877654321    356888999999999999999996  67789999999999999


Q ss_pred             CCCCCEEEeccCCcccc
Q 011360          346 NDDMEACISDLGLAMAI  362 (487)
Q Consensus       346 ~~~~~~kl~DFg~s~~~  362 (487)
                      + ++.++|+|||+|...
T Consensus       152 ~-~~~v~LiDFG~a~~~  167 (190)
T cd05147         152 H-DGKLYIIDVSQSVEH  167 (190)
T ss_pred             E-CCcEEEEEccccccC
Confidence            8 478999999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.86  E-value=2.3e-22  Score=209.77  Aligned_cols=249  Identities=24%  Similarity=0.317  Sum_probs=178.3

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      .+...+.||.+.|=+|.+|+++  .|. |+||++....+.-           .-....+...|+. ...++|||.+++.-
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~--eG~-vVvKVFvk~~p~~-----------sL~~~~qrL~~ik-~~l~~~pn~lPfqk   88 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDR--EGL-VVVKVFVKQDPTI-----------SLRPFKQRLEEIK-FALMKAPNCLPFQK   88 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCC--Cce-EEEEEEeccCCCC-----------CchHHHHHHHHHH-HHhhcCCcccchHH
Confidence            4777889999999999999764  454 9999986533221           1112223334444 55679999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEE
Q 011360          273 HMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC  352 (487)
Q Consensus       273 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~k  352 (487)
                      +.......|+|=+|..+ +|.|.+..    +.-+...+.+.|+.|++.||..+   |..||+|||||.+|||++.=+-+.
T Consensus        89 ~~~t~kAAylvRqyvkh-nLyDRlST----RPFL~~iEKkWiaFQLL~al~qc---H~~gVcHGDIKsENILiTSWNW~~  160 (1431)
T KOG1240|consen   89 VLVTDKAAYLVRQYVKH-NLYDRLST----RPFLVLIEKKWIAFQLLKALSQC---HKLGVCHGDIKSENILITSWNWLY  160 (1431)
T ss_pred             HHHhhHHHHHHHHHHhh-hhhhhhcc----chHHHHHHHHHHHHHHHHHHHHH---HHcCccccccccceEEEeeechhh
Confidence            88888888999999844 89998864    45567778889999999999999   889999999999999999888899


Q ss_pred             EeccCCccccC--CCCce---eeEeeecccccccCCcccCC-----------CCCCchhHHHHHHHHHHHHHh-CCCCcc
Q 011360          353 ISDLGLAMAIP--DGYTR---VLISYVLGTMAYIAPEYFQQ-----------PELSEKCDIFSFGMLLISLVR-GVPSFV  415 (487)
Q Consensus       353 l~DFg~s~~~~--~~~~~---~~~~~~~gt~~y~aPE~l~~-----------~~~~~~~DvwslG~~l~ellt-g~~pf~  415 (487)
                      |+||..-+...  .....   ....+...-.+|.|||.+-.           +..+++.||||+||++.||++ |++||.
T Consensus       161 LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~  240 (1431)
T KOG1240|consen  161 LTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT  240 (1431)
T ss_pred             hhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence            99998764331  11111   11112223357999997642           126789999999999999999 799993


Q ss_pred             ccC-----CCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhh
Q 011360          416 FHQ-----NGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQ  485 (487)
Q Consensus       416 ~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~  485 (487)
                      ...     .+. ...++.....             ++.       ..++.++..|++.||++|.|+++.++..+.
T Consensus       241 LSQL~aYr~~~-~~~~e~~Le~-------------Ied-------~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG  294 (1431)
T KOG1240|consen  241 LSQLLAYRSGN-ADDPEQLLEK-------------IED-------VSLRNLILSMIQRDPSKRLSAEDYLQKYRG  294 (1431)
T ss_pred             HHHHHhHhccC-ccCHHHHHHh-------------CcC-------ccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence            221     110 1111111111             111       138899999999999999999999987543

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.85  E-value=2.1e-21  Score=182.27  Aligned_cols=238  Identities=21%  Similarity=0.280  Sum_probs=150.0

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCC--------
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRH--------  264 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--------  264 (487)
                      .+.....||.|+++.||.+++ ..+|+.+|+|++.......            ....+.+.+|.-....+.+        
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d-~~t~~~~avkvf~~~~~~~------------~~~~~~~~~e~l~~~~~~~~~~p~~a~   79 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTD-VETGEEFAVKVFLLPADAS------------ANEYEQLKEEQLAITLFPGVKNPKEAY   79 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEE-TTTTEEEEEEEEEESSTTH------------TTHHHHHHHHHHGGGGSTT--SHHHHH
T ss_pred             EEEEccccccCCceEEEEEEE-ccCCceEEEEEEecccccc------------hHHHHHHHHHHHHhhhhccCCCHHHHH
Confidence            356778999999999999974 5789999999997654221            2234444444444333221        


Q ss_pred             --CCccccceEEe---------cC---C-----eeEEEEEecCCCCHHHHHhhhhc---CCCCCChHHHHHHHHHHHHHH
Q 011360          265 --RNILPLLAHMV---------RP---D-----CHLLVYEFMKNGSLQDILDDVSR---GRRELDWPSRHRIALGVASGL  322 (487)
Q Consensus       265 --pnIv~l~~~~~---------~~---~-----~~~lv~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~qi~~~L  322 (487)
                        -.++-.++...         ..   .     +.+++|+-+ .++|.+++.....   ....+....+..+..|+++.+
T Consensus        80 ~~~r~l~P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lv  158 (288)
T PF14531_consen   80 RHLRFLVPLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLV  158 (288)
T ss_dssp             HHH-B---SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHH
T ss_pred             HhceEEeeeEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHH
Confidence              12222222221         11   1     236788877 5689888654222   122344555677789999999


Q ss_pred             HHHHhcCCCCeeecCCCCCCEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCC--------CCCCch
Q 011360          323 EYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQ--------PELSEK  394 (487)
Q Consensus       323 ~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~~~~  394 (487)
                      ++|   |+.|+||+||+|+|++++.+|.++|+||+.....+....     ....+..|.+||....        ..++.+
T Consensus       159 A~L---h~~GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~-----~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~  230 (288)
T PF14531_consen  159 ANL---HSYGLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYR-----CSEFPVAFTPPELESCAGQFGQNNAPYTFA  230 (288)
T ss_dssp             HHH---HHTTEEEST-SGGGEEE-TTS-EEE--GGGEEETTEEEE-----GGGS-TTTS-HHHHHHHTSCHHSEEEE-HH
T ss_pred             HHH---hhcceEecccceeeEEEcCCCCEEEcChHHHeecCceee-----ccCCCcccCChhhhhhhcccCcccceeeec
Confidence            999   788999999999999999999999999988765433211     1235678999997643        257889


Q ss_pred             hHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCC
Q 011360          395 CDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEER  473 (487)
Q Consensus       395 ~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R  473 (487)
                      .|.|+||+++|.|++|..||...........           .        + ..|. +.++.+..+|..+|+.||.+|
T Consensus       231 ~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~-----------~--------f-~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  231 TDAWQLGITLYSLWCGRLPFGLSSPEADPEW-----------D--------F-SRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHHHHHHHHHHHHHSS-STCCCGGGSTSGG-----------G--------G-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             cCHHHHHHHHHHHHHccCCCCCCCccccccc-----------c--------c-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence            9999999999999999999965433222110           0        1 1333 566779999999999999988

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.85  E-value=4.1e-21  Score=191.42  Aligned_cols=217  Identities=24%  Similarity=0.371  Sum_probs=164.0

Q ss_pred             hccCCCCCccccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCC
Q 011360          259 ASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDI  338 (487)
Q Consensus       259 l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dl  338 (487)
                      |+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+..   ....+++.....+.++|+.||.|+|  ++....|+.+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh--~s~i~~hg~l   75 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLH--NSPIGYHGAL   75 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHh--cCcceeeeee
Confidence            4568999999999999999999999999999999999974   3567888899999999999999997  4454599999


Q ss_pred             CCCCEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCC-------CCCchhHHHHHHHHHHHHHhCC
Q 011360          339 KPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQP-------ELSEKCDIFSFGMLLISLVRGV  411 (487)
Q Consensus       339 kp~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-------~~~~~~DvwslG~~l~elltg~  411 (487)
                      ++.|++++....+||+|||+.................-..-|.|||.+...       ..+.+.||||||++++|+++..
T Consensus        76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~  155 (484)
T KOG1023|consen   76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS  155 (484)
T ss_pred             ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence            999999999999999999998766431111111122234569999998763       1467799999999999999999


Q ss_pred             CCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          412 PSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       412 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      .||.........  .+.+..+..  .....+.|.+....  +....+..++..||..+|.+||++.+|...++.+
T Consensus       156 ~~~~~~~~~~~~--~eii~~~~~--~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~  224 (484)
T KOG1023|consen  156 GPFDLRNLVEDP--DEIILRVKK--GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI  224 (484)
T ss_pred             CccccccccCCh--HHHHHHHHh--cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence            999654333222  233333322  12222333333221  3334688999999999999999999999888754

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.85  E-value=1.5e-21  Score=177.99  Aligned_cols=181  Identities=13%  Similarity=0.132  Sum_probs=130.4

Q ss_pred             hccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccc
Q 011360          190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILP  269 (487)
Q Consensus       190 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~  269 (487)
                      -.++|..++.+|.|+||.||++..   ++..+|+|.+....+......      ..-.....+.+|+..+.++.||+|..
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~---~~~~~iiKvf~~~~~~~~~~~------~~f~~g~~~e~Ea~~l~rL~~~GI~~   99 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT---DYGKYILKVFAPKVKRTERFL------KSFVKGDYYENLIVQTDRVRSEGLAS   99 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec---CCCcEEEEEechhcCchHHHH------HhhhhhHHHHHHHHHHHHHHHCCCCc
Confidence            356799999999999999999743   466899998843221111000      00001223678999999999999999


Q ss_pred             cceEEecC--------CeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCC
Q 011360          270 LLAHMVRP--------DCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPR  341 (487)
Q Consensus       270 l~~~~~~~--------~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~  341 (487)
                      +..++...        ...+++|||++|.+|.++..        ++.    ....+++.++..+   |+.|++|||++|+
T Consensus       100 ~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~l---H~~gi~H~Dikp~  164 (232)
T PRK10359        100 LNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESL---HQHGMVSGDPHKG  164 (232)
T ss_pred             ceEeeeecccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHH---HHcCCccCCCChH
Confidence            99886543        35789999999999987632        222    2456888999999   8889999999999


Q ss_pred             CEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh
Q 011360          342 NVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR  409 (487)
Q Consensus       342 Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt  409 (487)
                      ||+++++| ++|+|||...........              .-++....|+.++|+|+||+++..+..
T Consensus       165 Nili~~~g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~~  217 (232)
T PRK10359        165 NFIVSKNG-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYKK  217 (232)
T ss_pred             HEEEeCCC-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHHH
Confidence            99999988 999999987654221110              013334456778999999998865543

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.84  E-value=2.5e-20  Score=166.27  Aligned_cols=191  Identities=17%  Similarity=0.088  Sum_probs=137.4

Q ss_pred             ccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CCCCccccceE
Q 011360          195 ASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RHRNILPLLAH  273 (487)
Q Consensus       195 ~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~  273 (487)
                      .+...|+.|+||+|+++.-   .+..++.+.+.....           -........+.+|+.+++++ .|++|.+++++
T Consensus         5 ~~~~~l~~~~f~~v~~~~~---~~~k~~~~~l~~~~~-----------~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~   70 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG---GERKFVRRDLSAAPW-----------WLRGVAWWLARREALALRQLDGLPRTPRLLHW   70 (218)
T ss_pred             ccceeecCCCcceEEEeec---CCceeeecccccchh-----------hhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE
Confidence            4567899999999997742   677788776522110           01111223578999999999 45889999886


Q ss_pred             EecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCC-CCCCEEeCCCCCEE
Q 011360          274 MVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDI-KPRNVLLNDDMEAC  352 (487)
Q Consensus       274 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dl-kp~Nill~~~~~~k  352 (487)
                          +..+++|||+.|.+|...+..           ....++.|++.+|.++   |++||+|||| ||.|||++.++.++
T Consensus        71 ----~~~~lvmeyI~G~~L~~~~~~-----------~~~~~~~qi~~~L~~l---H~~GIvHrDL~kp~NILv~~~g~i~  132 (218)
T PRK12274         71 ----DGRHLDRSYLAGAAMYQRPPR-----------GDLAYFRAARRLLQQL---HRCGVAHNDLAKEANWLVQEDGSPA  132 (218)
T ss_pred             ----cCEEEEEeeecCccHHhhhhh-----------hhHHHHHHHHHHHHHH---HHCcCccCCCCCcceEEEcCCCCEE
Confidence                446899999999998654321           1134678999999999   8889999999 79999999999999


Q ss_pred             EeccCCccccCCCCce----e-------eEeeecccccccCCcccCCC-CCC-chhHHHHHHHHHHHHHhCCCCcccc
Q 011360          353 ISDLGLAMAIPDGYTR----V-------LISYVLGTMAYIAPEYFQQP-ELS-EKCDIFSFGMLLISLVRGVPSFVFH  417 (487)
Q Consensus       353 l~DFg~s~~~~~~~~~----~-------~~~~~~gt~~y~aPE~l~~~-~~~-~~~DvwslG~~l~elltg~~pf~~~  417 (487)
                      |+|||++.........    .       .......++.|++|+.-.-. ..+ ...++++-|+.+|.++|+..|+-..
T Consensus       133 LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        133 VIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             EEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence            9999999865443210    0       00112357778888754322 233 5679999999999999998887443

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.83  E-value=5.4e-20  Score=166.35  Aligned_cols=155  Identities=21%  Similarity=0.255  Sum_probs=112.5

Q ss_pred             ccccccccceeEEEEEecCCCCceEEEEEeeecCchhH--HHHHHHh---------hhhhhHHHHHHHHHHHHhccCCCC
Q 011360          197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISA--AELIEED---------SKLRDSKLRQIRSEIITASQIRHR  265 (487)
Q Consensus       197 ~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~---------~~~~~~~~~~~~~E~~~l~~l~hp  265 (487)
                      ...||.|++|.||+|...  +|+.||||++....+...  .+.....         .............|...+.++.|+
T Consensus         2 ~~~ig~G~~~~Vy~a~~~--~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   79 (190)
T cd05145           2 NGCISTGKEANVYHARTG--DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA   79 (190)
T ss_pred             CceeecCCCcEEEEEEcC--CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence            468999999999999754  799999999876432111  1110000         001111223446789999999999


Q ss_pred             CccccceEEecCCeeEEEEEecCCCCHHHH-HhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCC-CCeeecCCCCCCE
Q 011360          266 NILPLLAHMVRPDCHLLVYEFMKNGSLQDI-LDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHS-ASIIHGDIKPRNV  343 (487)
Q Consensus       266 nIv~l~~~~~~~~~~~lv~E~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~-~givH~Dlkp~Ni  343 (487)
                      +|.....+....  .++||||++|+++... +.     ...++......++.|++.++.++   |. .||+||||||+||
T Consensus        80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~-----~~~~~~~~~~~i~~~l~~~l~~l---H~~~givHrDlkP~NI  149 (190)
T cd05145          80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLK-----DVPLEEEEAEELYEQVVEQMRRL---YQEAGLVHGDLSEYNI  149 (190)
T ss_pred             CCCCceEEEecC--CEEEEEEecCCCchhhhhh-----hccCCHHHHHHHHHHHHHHHHHH---HHhCCEecCCCChhhE
Confidence            886655544432  4899999988755433 32     24567788899999999999999   55 8999999999999


Q ss_pred             EeCCCCCEEEeccCCccccCC
Q 011360          344 LLNDDMEACISDLGLAMAIPD  364 (487)
Q Consensus       344 ll~~~~~~kl~DFg~s~~~~~  364 (487)
                      +++ ++.++|+|||++.....
T Consensus       150 ll~-~~~~~liDFG~a~~~~~  169 (190)
T cd05145         150 LYH-DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             EEE-CCCEEEEEcccceecCC
Confidence            999 88999999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.81  E-value=2.9e-21  Score=192.40  Aligned_cols=229  Identities=21%  Similarity=0.244  Sum_probs=174.5

Q ss_pred             ccccccceeEEEEEe--cCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCC-CCCccccceEEe
Q 011360          199 KIGSGGCGEVYKAEL--PGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIR-HRNILPLLAHMV  275 (487)
Q Consensus       199 ~lg~G~~g~v~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~  275 (487)
                      .+|.|.||+|+++.-  ....+.-+|.|..........             .......|..++...+ ||.+|++...+.
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~-------------~~~~t~~er~il~~~~~~~f~v~lhyafq   67 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVR-------------DRTHTKQERIILAFVHNTPFLVKLHYAFQ   67 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccc-------------cccccccHHHHHhhccCCCceeeeeeeec
Confidence            379999999997742  122466788887643221111             1114455667777775 999999999999


Q ss_pred             cCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEec
Q 011360          276 RPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISD  355 (487)
Q Consensus       276 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~D  355 (487)
                      .+...+++++|..||.|...+..    ...+.......+...++-+++++   |..|++|||+|++||+++.+|++++.|
T Consensus        68 t~~kl~l~ld~~rgg~lft~l~~----~~~f~~~~~~~~~aelaLald~l---h~l~iiyrd~k~enilld~~Ghi~~td  140 (612)
T KOG0603|consen   68 TDGKLYLILDFLRGGDLFTRLSK----EVMFDELDVAFYLAELALALDHL---HKLGIAYRDYKLENVLLLLEGHIKLTD  140 (612)
T ss_pred             cccchhHhhhhcccchhhhcccc----CCchHHHHHHHHHHHHHHHHhhc---chhHHHHhcccccceeecccCccccCC
Confidence            99999999999999999887753    55677777888888899999999   899999999999999999999999999


Q ss_pred             cCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHHHhc
Q 011360          356 LGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNS  435 (487)
Q Consensus       356 Fg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  435 (487)
                      ||+++..-....      .+||..|||||++.  ..+.++|+||||++++||+||..||..          +....+...
T Consensus       141 fglske~v~~~~------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----------~~~~~Il~~  202 (612)
T KOG0603|consen  141 FGLSKEAVKEKI------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----------DTMKRILKA  202 (612)
T ss_pred             chhhhHhHhhhh------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----------HHHHHHhhh
Confidence            999987544322      27999999999998  567889999999999999999999944          233333322


Q ss_pred             CCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCh
Q 011360          436 KNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNS  476 (487)
Q Consensus       436 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~  476 (487)
                      ..+           ...+....+..++..++..+|.+|--.
T Consensus       203 ~~~-----------~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  203 ELE-----------MPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             ccC-----------CchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            111           122344557778888888899888755

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.79  E-value=1.3e-18  Score=185.25  Aligned_cols=195  Identities=23%  Similarity=0.283  Sum_probs=154.9

Q ss_pred             hccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCC---CCC
Q 011360          190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIR---HRN  266 (487)
Q Consensus       190 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpn  266 (487)
                      ..+.|.+-+.+|.|+||+||+|...  +|+.||+|+-....++..-                  --.+++.+|+   -+.
T Consensus       696 ~~~~~~I~~e~G~g~y~~vy~a~~~--~~~~~alK~e~P~~~WEfY------------------I~~q~~~RLk~~~~~~  755 (974)
T KOG1166|consen  696 GGEKFCISKEIGEGSYGSVYVATHS--NGKLVALKVEKPPNPWEFY------------------ICLQVMERLKPQMLPS  755 (974)
T ss_pred             cceeEEEEeeeccccceEEEEeecC--CCcEEEEEeecCCCceeee------------------ehHHHHHhhchhhhcc
Confidence            4456889999999999999999865  4999999987554433210                  1111222222   245


Q ss_pred             ccccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC
Q 011360          267 ILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN  346 (487)
Q Consensus       267 Iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~  346 (487)
                      |..+...+...+..++|+||.+.|+|.++++    ..+..++..+..++.|++..+.+|   |..+||||||||+|+++.
T Consensus       756 ~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~l---H~~~IIHgDiKPDNfll~  828 (974)
T KOG1166|consen  756 IMHISSAHVFQNASVLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHL---HAMGIIHGDIKPDNFLLR  828 (974)
T ss_pred             hHHHHHHHccCCcceeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHH---HhcceecccCCcceeEee
Confidence            6666666666778889999999999999996    467789999999999999999999   677799999999999995


Q ss_pred             C-------CCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCC
Q 011360          347 D-------DMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGV  411 (487)
Q Consensus       347 ~-------~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~  411 (487)
                      .       +..++|+|||.+..+.--.........++|-.+-.+|...+..++..+|.|.|+.+++.|+.|+
T Consensus       829 ~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~  900 (974)
T KOG1166|consen  829 REICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGK  900 (974)
T ss_pred             cccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHH
Confidence            2       3458999999998764433333446677899999999999999999999999999999999994

>PRK10345 hypothetical protein; Provisional

Probab=99.77  E-value=2.2e-18  Score=156.76  Aligned_cols=136  Identities=17%  Similarity=0.235  Sum_probs=101.2

Q ss_pred             ccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-----CCCCccc
Q 011360          195 ASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-----RHRNILP  269 (487)
Q Consensus       195 ~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~  269 (487)
                      .-...||+|+||.||.  +. .++.. +||++....               ....+.+.+|+.+++.+     .||||++
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp-~~~~k-~IKv~~~~~---------------~~~~~~~~rEi~~l~~L~~~~~~h~nIvr   65 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HP-EDAQR-CIKIVYHRG---------------DGGDKEIRRELKYYAHLSRRLIDWSGIPR   65 (210)
T ss_pred             CCcceecCCCceEEEE--CC-CCcCe-EEEEEeccc---------------cchHHHHHHHHHHHHHhhccCCCCcccce
Confidence            3457899999999995  33 34444 688874311               11335678999999999     5799999


Q ss_pred             cceEEecCC---eeE-EEEEe--cCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHH-HHHHhcCCCCeeecCCCCCC
Q 011360          270 LLAHMVRPD---CHL-LVYEF--MKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGL-EYLHMYHSASIIHGDIKPRN  342 (487)
Q Consensus       270 l~~~~~~~~---~~~-lv~E~--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L-~~Lh~~h~~givH~Dlkp~N  342 (487)
                      +++++.++.   .++ +||||  +.+|+|.+++..     ..+++.  ..++.+++.++ +||   |+++|+||||||+|
T Consensus        66 ~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yL---h~~~IvhrDlKp~N  135 (210)
T PRK10345         66 YYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYL---LDNRIVTMELKPQN  135 (210)
T ss_pred             eeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHH---HHCCEeecCCCHHH
Confidence            999998864   334 78999  557999999964     235544  35677777777 899   77789999999999


Q ss_pred             EEeCC----CCCEEEeccCCc
Q 011360          343 VLLND----DMEACISDLGLA  359 (487)
Q Consensus       343 ill~~----~~~~kl~DFg~s  359 (487)
                      ||++.    ++.++|+||+-+
T Consensus       136 ILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345        136 ILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             EEEeccCCCCCcEEEEECCCC
Confidence            99974    347999995433

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.75  E-value=5.7e-18  Score=159.65  Aligned_cols=198  Identities=20%  Similarity=0.283  Sum_probs=134.9

Q ss_pred             CCCCccccceEEec---------------------------CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHH
Q 011360          263 RHRNILPLLAHMVR---------------------------PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIA  315 (487)
Q Consensus       263 ~hpnIv~l~~~~~~---------------------------~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~  315 (487)
                      +|||||++.+.|.+                           +..+|+||...+ .+|..++..     ...+.....-++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~-----~~~s~r~~~~~l  347 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT-----RHRSYRTGRVIL  347 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc-----CCCchHHHHHHH
Confidence            69999999987743                           224689999884 489999874     445666778899


Q ss_pred             HHHHHHHHHHHhcCCCCeeecCCCCCCEEeC--CCC--CEEEeccCCccccCCCCcee----eEeeecccccccCCcccC
Q 011360          316 LGVASGLEYLHMYHSASIIHGDIKPRNVLLN--DDM--EACISDLGLAMAIPDGYTRV----LISYVLGTMAYIAPEYFQ  387 (487)
Q Consensus       316 ~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~--~~~--~~kl~DFg~s~~~~~~~~~~----~~~~~~gt~~y~aPE~l~  387 (487)
                      .|+++|+.||   |.+||.|||+|.+|||+.  +|+  .+.|+|||.+-.-....-..    ..-..-|.-.-||||+..
T Consensus       348 aQlLEav~hL---~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t  424 (598)
T KOG4158|consen  348 AQLLEAVTHL---HKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT  424 (598)
T ss_pred             HHHHHHHHHH---HHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence            9999999999   888999999999999984  444  47899999764322211100    001123667789999876


Q ss_pred             CCC------CCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHH
Q 011360          388 QPE------LSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKI  461 (487)
Q Consensus       388 ~~~------~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  461 (487)
                      ..+      --.|+|.|+.|.+.||+++...||-....  ...         .....++.--|.+|+.    .+..+.++
T Consensus       425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe--m~L---------~~r~Yqe~qLPalp~~----vpp~~rql  489 (598)
T KOG4158|consen  425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE--MLL---------DTRTYQESQLPALPSR----VPPVARQL  489 (598)
T ss_pred             cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccch--hee---------chhhhhhhhCCCCccc----CChHHHHH
Confidence            321      12489999999999999999999944211  000         0011111111222222    22348889


Q ss_pred             HhhccCCCCCCCCChHHHHHHHh
Q 011360          462 AYICTLHDPEERPNSQYVRCRLS  484 (487)
Q Consensus       462 i~~cl~~~P~~RPs~~~il~~L~  484 (487)
                      +...|+.||++|||..-....|.
T Consensus       490 V~~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  490 VFDLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             HHHHhcCCccccCCccHHHhHHH
Confidence            99999999999999876555543

>smart00090 RIO RIO-like kinase

Probab=99.75  E-value=9.6e-18  Score=156.34  Aligned_cols=163  Identities=18%  Similarity=0.138  Sum_probs=113.8

Q ss_pred             hhhccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhH-HHHHH----H----hhhhhhHHHHHHHHHHHH
Q 011360          188 LKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISA-AELIE----E----DSKLRDSKLRQIRSEIIT  258 (487)
Q Consensus       188 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~----~----~~~~~~~~~~~~~~E~~~  258 (487)
                      ....-.|.+.+.||.|++|.||+|..+..+|..||+|++........ .....    .    ...........+..|+.+
T Consensus        24 ~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~  103 (237)
T smart00090       24 LNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRN  103 (237)
T ss_pred             HhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHH
Confidence            33444588999999999999999963445899999999865332110 00000    0    000111122346789999


Q ss_pred             hccCCCCC--ccccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCC-eee
Q 011360          259 ASQIRHRN--ILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSAS-IIH  335 (487)
Q Consensus       259 l~~l~hpn--Iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~g-ivH  335 (487)
                      +.++.+.+  +.++++.    ...++||||++|++|......    ...........++.|++.++.+|   |+.| ++|
T Consensus       104 L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~L---H~~g~iiH  172 (237)
T smart00090      104 LQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK----DVEPEEEEEFELYDDILEEMRKL---YKEGELVH  172 (237)
T ss_pred             HHHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccc----cCCcchHHHHHHHHHHHHHHHHH---HhcCCEEe
Confidence            99996533  3333332    235899999999888665421    23455666788999999999999   8888 999


Q ss_pred             cCCCCCCEEeCCCCCEEEeccCCcccc
Q 011360          336 GDIKPRNVLLNDDMEACISDLGLAMAI  362 (487)
Q Consensus       336 ~Dlkp~Nill~~~~~~kl~DFg~s~~~  362 (487)
                      |||||+||+++ ++.++|+|||.+...
T Consensus       173 ~Dikp~NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      173 GDLSEYNILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             CCCChhhEEEE-CCCEEEEEChhhhcc
Confidence            99999999999 889999999998654

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.74  E-value=1.3e-17  Score=152.05  Aligned_cols=139  Identities=21%  Similarity=0.323  Sum_probs=108.1

Q ss_pred             ccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceEEecCC
Q 011360          199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPD  278 (487)
Q Consensus       199 ~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~  278 (487)
                      .||+|+||.||+|.+   ++..+++|.........       ..........++.+|+.++..+.|+++.....++...+
T Consensus         1 ~ig~G~~~~vy~~~~---~~~~~viK~~~~~~~~~-------~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~   70 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF---LGLKAVIKERVPKSYRH-------PELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPD   70 (199)
T ss_pred             CCCCCceEEEEEeec---CCccEEEEEecCCcCcC-------chHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECC
Confidence            479999999999975   56789999863211000       00111223466788999999999888776666666777


Q ss_pred             eeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEeccCC
Q 011360          279 CHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGL  358 (487)
Q Consensus       279 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~DFg~  358 (487)
                      ..++||||++|++|.+++...    ..       .++.+++.+|.+|   |+.|++|||++|.||+++ ++.++++|||+
T Consensus        71 ~~~lv~e~~~g~~l~~~~~~~----~~-------~~~~~i~~~l~~l---H~~gi~H~Dl~~~Nil~~-~~~~~liDfg~  135 (199)
T TIGR03724        71 NKTIVMEYIEGKPLKDVIEEG----ND-------ELLREIGRLVGKL---HKAGIVHGDLTTSNIIVR-DDKLYLIDFGL  135 (199)
T ss_pred             CCEEEEEEECCccHHHHHhhc----HH-------HHHHHHHHHHHHH---HHCCeecCCCCcceEEEE-CCcEEEEECCC
Confidence            789999999999999887531    10       7899999999999   788999999999999999 78999999999


Q ss_pred             cccc
Q 011360          359 AMAI  362 (487)
Q Consensus       359 s~~~  362 (487)
                      +...
T Consensus       136 a~~~  139 (199)
T TIGR03724       136 GKYS  139 (199)
T ss_pred             CcCC
Confidence            8653

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.74  E-value=1.9e-17  Score=152.49  Aligned_cols=142  Identities=23%  Similarity=0.317  Sum_probs=112.9

Q ss_pred             cccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceEEecC
Q 011360          198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRP  277 (487)
Q Consensus       198 ~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  277 (487)
                      +.||+|++|.||+|.+   +|..+++|+.........       ..........+.+|+.++..+.|++|.....++...
T Consensus         2 ~~l~~G~~~~vy~~~~---~~~~~~vK~~~~~~~~~~-------~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~   71 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF---LGIKAVIKWRIPKRYRHP-------ELDERIRRERTRREARIMSRARKAGVNVPAVYFVDP   71 (211)
T ss_pred             cccccCceEEEEEEee---CCCceEEEEeCCcCCcCh-------HHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeC
Confidence            5789999999999976   667899997632111000       011112335678899999999999998888887777


Q ss_pred             CeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEeccC
Q 011360          278 DCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLG  357 (487)
Q Consensus       278 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~DFg  357 (487)
                      +..+++|||++|++|.+++...       .. ....++.+++.+|.++   |+.|++|||++|.||+++ ++.++|+|||
T Consensus        72 ~~~~lv~e~~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~l---H~~~i~H~Dl~p~Nil~~-~~~~~liDf~  139 (211)
T PRK14879         72 ENFIIVMEYIEGEPLKDLINSN-------GM-EELELSREIGRLVGKL---HSAGIIHGDLTTSNMILS-GGKIYLIDFG  139 (211)
T ss_pred             CCCEEEEEEeCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHH---HhCCcccCCCCcccEEEE-CCCEEEEECC
Confidence            8889999999999999998641       11 7788999999999999   778899999999999999 7889999999


Q ss_pred             Cccc
Q 011360          358 LAMA  361 (487)
Q Consensus       358 ~s~~  361 (487)
                      .+..
T Consensus       140 ~a~~  143 (211)
T PRK14879        140 LAEF  143 (211)
T ss_pred             cccC
Confidence            8864

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.73  E-value=4.8e-18  Score=177.73  Aligned_cols=212  Identities=23%  Similarity=0.297  Sum_probs=144.5

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      +++|..++.+-.|++|.||+.++. .+..++|+|+- .             ..       .+.+.  ++..-..|.+   
T Consensus        82 e~df~~IklisngAygavylvrh~-~trqrfa~kiN-k-------------q~-------lilRn--ilt~a~npfv---  134 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHK-ETRQRFAMKIN-K-------------QN-------LILRN--ILTFAGNPFV---  134 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeecc-ccccchhhccc-c-------------cc-------hhhhc--cccccCCcce---
Confidence            346999999999999999999753 56778888531 0             00       00000  1111122322   


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                                  |      |+-...+..    -++++..        .+.+++||   |+.||+|||+||+|.+|+.-|+
T Consensus       135 ------------v------gDc~tllk~----~g~lPvd--------mvla~Eyl---h~ygivhrdlkpdnllIT~mGh  181 (1205)
T KOG0606|consen  135 ------------V------GDCATLLKN----IGPLPVD--------MVLAVEYL---HSYGIVHRDLKPDNLLITSMGH  181 (1205)
T ss_pred             ------------e------chhhhhccc----CCCCcch--------hhHHhHhh---ccCCeecCCCCCCcceeeeccc
Confidence                        2      444444432    2344432        27789999   8999999999999999999999


Q ss_pred             EEEeccCCccccCCCCc------------e-eeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCcccc
Q 011360          351 ACISDLGLAMAIPDGYT------------R-VLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFH  417 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~------------~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~  417 (487)
                      +|++|||+++.......            . ......+|||.|.|||++....|+..+|+|++|+++||.+-|..||.+.
T Consensus       182 iKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGd  261 (1205)
T KOG0606|consen  182 IKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD  261 (1205)
T ss_pred             ccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCC
Confidence            99999999865321111            1 1123468999999999999999999999999999999999999999655


Q ss_pred             CCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCh
Q 011360          418 QNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNS  476 (487)
Q Consensus       418 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~  476 (487)
                      ++      .+.+..++.....-.--|+.+        ..++.+++.++|+.+|-.|--.
T Consensus       262 tp------eelfg~visd~i~wpE~dea~--------p~Ea~dli~~LL~qnp~~Rlgt  306 (1205)
T KOG0606|consen  262 TP------EELFGQVISDDIEWPEEDEAL--------PPEAQDLIEQLLRQNPLCRLGT  306 (1205)
T ss_pred             CH------HHHHhhhhhhhccccccCcCC--------CHHHHHHHHHHHHhChHhhccc
Confidence            44      233444443222111113333        3568899999999999999643

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.73  E-value=1e-18  Score=171.19  Aligned_cols=173  Identities=25%  Similarity=0.378  Sum_probs=127.4

Q ss_pred             eeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEeccCC
Q 011360          279 CHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGL  358 (487)
Q Consensus       279 ~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~DFg~  358 (487)
                      ++||.|++|...+|.++|... ......++...+.++.|++.|+.|      +|.+|+|+||.||+...+..+||+|||+
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr-~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl  402 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRR-RTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGL  402 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCC-CcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhh
Confidence            578999999999999999632 345567788889999999999998      6799999999999999999999999999


Q ss_pred             ccccCCCC----ceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhC-CCCccccCCCCccccHHHHHHHH
Q 011360          359 AMAIPDGY----TRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRG-VPSFVFHQNGEEICSPEWLRKVM  433 (487)
Q Consensus       359 s~~~~~~~----~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg-~~pf~~~~~~~~~~~~~~~~~~~  433 (487)
                      ........    .....+...||..||+||.+.+..|+.++||||||++++|+++- ..+|...         ..+..+ 
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~---------~t~~d~-  472 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI---------ATLTDI-  472 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH---------Hhhhhh-
Confidence            87765443    11222456799999999999999999999999999999999983 3343100         001111 


Q ss_pred             hcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChH
Q 011360          434 NSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQ  477 (487)
Q Consensus       434 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~  477 (487)
                      +.+    .+++....+    ++ +-..++.++++..|.+||++.
T Consensus       473 r~g----~ip~~~~~d----~p-~e~~ll~~lls~~p~~RP~~~  507 (516)
T KOG1033|consen  473 RDG----IIPPEFLQD----YP-EEYTLLQQLLSPSPEERPSAI  507 (516)
T ss_pred             hcC----CCChHHhhc----Cc-HHHHHHHHhcCCCcccCchHH
Confidence            111    111111111    11 234677889999999999443

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.71  E-value=4.8e-17  Score=170.35  Aligned_cols=142  Identities=23%  Similarity=0.319  Sum_probs=110.9

Q ss_pred             cccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceE
Q 011360          194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAH  273 (487)
Q Consensus       194 ~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  273 (487)
                      |...+.||+|+||.||+|.+.   +..+++|+.....       ..............+.+|+.++..++|++++..+.+
T Consensus       335 ~~~~~~iG~G~~g~Vy~~~~~---~~~~v~k~~~~~~-------~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~  404 (535)
T PRK09605        335 KIPDHLIGKGAEADIKKGEYL---GRDAVIKERVPKG-------YRHPELDERLRTERTRAEARLLSEARRAGVPTPVIY  404 (535)
T ss_pred             cCccceeccCCcEEEEEEeec---CccceeEEEeccc-------ccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEE
Confidence            456789999999999999763   3445555432110       000011122234567899999999999999988887


Q ss_pred             EecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEE
Q 011360          274 MVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACI  353 (487)
Q Consensus       274 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl  353 (487)
                      +......++||||++|++|.+++.            ....++.+++.+|.+|   |+.|++||||||+||++ .++.++|
T Consensus       405 ~~~~~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~l---H~~giiHrDlkp~NILl-~~~~~~l  468 (535)
T PRK09605        405 DVDPEEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKL---HKAGIVHGDLTTSNFIV-RDDRLYL  468 (535)
T ss_pred             EEeCCCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHH---HhCCCccCCCChHHEEE-ECCcEEE
Confidence            777778899999999999999874            2467899999999999   77899999999999999 6779999


Q ss_pred             eccCCccc
Q 011360          354 SDLGLAMA  361 (487)
Q Consensus       354 ~DFg~s~~  361 (487)
                      +|||+++.
T Consensus       469 iDFGla~~  476 (535)
T PRK09605        469 IDFGLGKY  476 (535)
T ss_pred             EeCccccc
Confidence            99999865

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.70  E-value=1.5e-16  Score=145.00  Aligned_cols=153  Identities=17%  Similarity=0.176  Sum_probs=108.7

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHH-----HHHHHh--hhhhhHHHHHHHHHHHHhccCCCC
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAA-----ELIEED--SKLRDSKLRQIRSEIITASQIRHR  265 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~-----~~~~~~--~~~~~~~~~~~~~E~~~l~~l~hp  265 (487)
                      .|.+.+.||.|+||.||++...  +|..||||++....+....     +.....  .............|..++..+.|+
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   93 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDP--DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEE   93 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcC--CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHc
Confidence            3777899999999999999753  7899999987653311100     000000  000011223467788888888777


Q ss_pred             C--ccccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCE
Q 011360          266 N--ILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNV  343 (487)
Q Consensus       266 n--Iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Ni  343 (487)
                      +  +...++    ....++||||++|++|......          .....++.+++.++.++   |..|++||||+|+||
T Consensus        94 ~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~l---h~~gi~H~Dl~p~Ni  156 (198)
T cd05144          94 GFPVPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKA---YKHGIIHGDLSEFNI  156 (198)
T ss_pred             CCCCCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHH---HHCCCCcCCCCcccE
Confidence            4  344433    2456899999999998765420          23567889999999999   668899999999999


Q ss_pred             EeCCCCCEEEeccCCccccCC
Q 011360          344 LLNDDMEACISDLGLAMAIPD  364 (487)
Q Consensus       344 ll~~~~~~kl~DFg~s~~~~~  364 (487)
                      ++++++.++|+|||.+.....
T Consensus       157 ll~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         157 LVDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             EEcCCCcEEEEECCccccCCC
Confidence            999999999999999865543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.67  E-value=5.1e-18  Score=177.22  Aligned_cols=258  Identities=20%  Similarity=0.275  Sum_probs=191.7

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCC-CCCccccc
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIR-HRNILPLL  271 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~  271 (487)
                      .|.+.+.||.|+|+.+-.......+...+|.|.+....             .......+...|..+-..+. |+|++.++
T Consensus        21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-------------~~~~~~~~i~~e~~~~~~~s~h~n~~~~~   87 (601)
T KOG0590|consen   21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-------------KSEDSSEHIDTETDIQKKLSKHSNTVHMI   87 (601)
T ss_pred             cccccccccccccchhhhhhhcCCCcceeeccCCCCCC-------------CccchhhhcCccccccccccccccccccC
Confidence            47788889999999999886544556667777653321             12223445556777777776 99999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcC-CCCeeecCCCCCCEEeCCCC-
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYH-SASIIHGDIKPRNVLLNDDM-  349 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h-~~givH~Dlkp~Nill~~~~-  349 (487)
                      +...+.+..++.++|..|+++.+.+..  ......+......++.|+..++.|+   | ..++.|+|+||+|.+++..+ 
T Consensus        88 ~~~~~~~~~~~~~~~s~g~~~f~~i~~--~~~~~~~~~~~~~~~~ql~s~l~~~---H~~~~~~h~~ikP~n~~l~~s~~  162 (601)
T KOG0590|consen   88 EPSSSPRSYLLSLSYSDGGSLFSKISH--PDSTGTSSSSASRYLPQLNSGLSYL---HPENGVTHRDIKPSNSLLDESGS  162 (601)
T ss_pred             CccCCCcccccccCccccccccccccc--CCccCCCCcchhhhhhhhccCcccc---CcccccccCCCCCccchhccCCC
Confidence            999999999999999999999887731  1222556667788999999999999   7 88999999999999999999 


Q ss_pred             CEEEeccCCccccCC-CCceeeEeeecc-cccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccH
Q 011360          350 EACISDLGLAMAIPD-GYTRVLISYVLG-TMAYIAPEYFQQP-ELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSP  426 (487)
Q Consensus       350 ~~kl~DFg~s~~~~~-~~~~~~~~~~~g-t~~y~aPE~l~~~-~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~  426 (487)
                      ..+++|||++..... ..........+| ++.|+|||...+. ......|+||.|+++.-+++|..|+......... ..
T Consensus       163 ~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~  241 (601)
T KOG0590|consen  163 ALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YS  241 (601)
T ss_pred             cccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-ce
Confidence            999999999998877 555555566778 9999999999885 4467789999999999999999999655432211 11


Q ss_pred             HHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHH
Q 011360          427 EWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVR  480 (487)
Q Consensus       427 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il  480 (487)
                      .|...-   ......        ..........+++..++..+|+.|.+.+++.
T Consensus       242 ~~~~~~---~~~~~~--------~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~  284 (601)
T KOG0590|consen  242 SWKSNK---GRFTQL--------PWNSISDQAHDLLHKILKENPSNRLSIEELK  284 (601)
T ss_pred             eecccc---cccccC--------ccccCChhhhhcccccccCCchhcccccccc
Confidence            111100   010011        1111223466788889989999999988764

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.64  E-value=2e-15  Score=141.06  Aligned_cols=147  Identities=15%  Similarity=0.172  Sum_probs=106.1

Q ss_pred             cccc-cccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCc--cccceEE
Q 011360          198 EKIG-SGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNI--LPLLAHM  274 (487)
Q Consensus       198 ~~lg-~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI--v~l~~~~  274 (487)
                      ..|| .||.|+||.+..   .+..++||.+.....  ..++..............+.+|+.++..+.|++|  +..+++.
T Consensus        37 ~~lg~~~g~gtv~~v~~---~~~~~vlk~~~r~~~--i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~  111 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQT---PGVNWVLRHYRRGGL--IGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAAR  111 (239)
T ss_pred             ceeecCCCCccEEEEEe---CCceEEEEEeeEcch--HHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeee
Confidence            5687 889999998865   477899998854221  1122211111122344677889999999988875  6666654


Q ss_pred             ecCCe----eEEEEEecCC-CCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC
Q 011360          275 VRPDC----HLLVYEFMKN-GSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDM  349 (487)
Q Consensus       275 ~~~~~----~~lv~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~  349 (487)
                      .....    .++|||+++| .+|.+++..     ..++..    .+.+++.+|.+|   |++||+||||||.|||++.++
T Consensus       112 ~~~~~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~l---H~~GI~HrDlkp~NILv~~~~  179 (239)
T PRK01723        112 VVRHGLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARF---HDAGVYHADLNAHNILLDPDG  179 (239)
T ss_pred             eeecCcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHH---HHCCCCCCCCCchhEEEcCCC
Confidence            43222    2599999997 689888753     234433    357899999999   888999999999999999999


Q ss_pred             CEEEeccCCccc
Q 011360          350 EACISDLGLAMA  361 (487)
Q Consensus       350 ~~kl~DFg~s~~  361 (487)
                      .++|+|||.+..
T Consensus       180 ~v~LIDfg~~~~  191 (239)
T PRK01723        180 KFWLIDFDRGEL  191 (239)
T ss_pred             CEEEEECCCccc
Confidence            999999998864

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.61  E-value=4e-15  Score=128.81  Aligned_cols=135  Identities=20%  Similarity=0.208  Sum_probs=109.3

Q ss_pred             cccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCC--CCccccceE
Q 011360          196 SLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRH--RNILPLLAH  273 (487)
Q Consensus       196 ~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--pnIv~l~~~  273 (487)
                      +.+.+|.|.++.||++...   +..+++|.....              ..   ...+..|+..+..+.|  +++.+++.+
T Consensus         2 ~~~~i~~g~~~~v~~~~~~---~~~~~iK~~~~~--------------~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~   61 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK---DEDYVLKINPSR--------------EK---GADREREVAILQLLARKGLPVPKVLAS   61 (155)
T ss_pred             cceecccccccceEEEEec---CCeEEEEecCCC--------------Cc---hhHHHHHHHHHHHHHHcCCCCCeEEEE
Confidence            3567999999999999863   468999976321              00   3457778888888866  588899888


Q ss_pred             EecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEE
Q 011360          274 MVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACI  353 (487)
Q Consensus       274 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl  353 (487)
                      ....+..+++|||++++++..+           +......++.+++.+++++|..+..+++|+|++|+||++++++.+++
T Consensus        62 ~~~~~~~~~v~e~~~g~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l  130 (155)
T cd05120          62 GESDGWSYLLMEWIEGETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGI  130 (155)
T ss_pred             cCCCCccEEEEEecCCeecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEE
Confidence            8877889999999988776543           44566778999999999998766678999999999999999899999


Q ss_pred             eccCCccc
Q 011360          354 SDLGLAMA  361 (487)
Q Consensus       354 ~DFg~s~~  361 (487)
                      .|||.+..
T Consensus       131 ~Df~~~~~  138 (155)
T cd05120         131 IDWEYAGY  138 (155)
T ss_pred             EecccccC
Confidence            99998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.59  E-value=8.5e-15  Score=132.10  Aligned_cols=152  Identities=22%  Similarity=0.222  Sum_probs=97.0

Q ss_pred             ccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHH--H-----HHhhh--hhhHHHHHHHHHHHHhccCCCCC-
Q 011360          197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAEL--I-----EEDSK--LRDSKLRQIRSEIITASQIRHRN-  266 (487)
Q Consensus       197 ~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~--~-----~~~~~--~~~~~~~~~~~E~~~l~~l~hpn-  266 (487)
                      .+.||.|+||.||+|...  ++..||||++...........  .     .....  ...........|...+..+.+.+ 
T Consensus         2 ~~~lg~G~~g~Vy~a~~~--~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~   79 (187)
T cd05119           2 GGPIGTGKEADVYLALDG--DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV   79 (187)
T ss_pred             CcccccccceeEEEEECC--CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence            467999999999999753  789999998854322111100  0     00000  00001111234555555554432 


Q ss_pred             -ccccceEEecCCeeEEEEEecCCCCHHH-HHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCC-CCeeecCCCCCCE
Q 011360          267 -ILPLLAHMVRPDCHLLVYEFMKNGSLQD-ILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHS-ASIIHGDIKPRNV  343 (487)
Q Consensus       267 -Iv~l~~~~~~~~~~~lv~E~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~-~givH~Dlkp~Ni  343 (487)
                       +.+.+++    ...++||||++++++.. .+....     .. .....++.+++.++.++   |. .||+|+||||+||
T Consensus        80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~l---h~~~~ivH~Dl~p~Ni  146 (187)
T cd05119          80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKL---YREAGLVHGDLSEYNI  146 (187)
T ss_pred             CCCceEec----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHH---hhccCcCcCCCChhhE
Confidence             3444432    24589999999854321 122110     11 56778999999999999   55 8899999999999


Q ss_pred             EeCCCCCEEEeccCCccccCC
Q 011360          344 LLNDDMEACISDLGLAMAIPD  364 (487)
Q Consensus       344 ll~~~~~~kl~DFg~s~~~~~  364 (487)
                      +++ ++.++|+|||.+.....
T Consensus       147 li~-~~~~~liDfg~a~~~~~  166 (187)
T cd05119         147 LVD-DGKVYIIDVPQAVEIDH  166 (187)
T ss_pred             EEE-CCcEEEEECcccccccC
Confidence            999 88999999999865433

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.56  E-value=8.6e-15  Score=135.33  Aligned_cols=205  Identities=18%  Similarity=0.261  Sum_probs=143.5

Q ss_pred             HHhccCCCCCccccceEEecCC-----eeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCC
Q 011360          257 ITASQIRHRNILPLLAHMVRPD-----CHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSA  331 (487)
Q Consensus       257 ~~l~~l~hpnIv~l~~~~~~~~-----~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~  331 (487)
                      ..+-++.|.|||++..+|.+..     ...+++||+..|+|..+|+....++..+....-.+|+.||..||.|||.+ +.
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~P  197 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DP  197 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CC
Confidence            3455668999999999987643     46789999999999999998888888899999999999999999999886 45


Q ss_pred             CeeecCCCCCCEEeCCCCCEEEeccCCccccCC--CCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh
Q 011360          332 SIIHGDIKPRNVLLNDDMEACISDLGLAMAIPD--GYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR  409 (487)
Q Consensus       332 givH~Dlkp~Nill~~~~~~kl~DFg~s~~~~~--~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt  409 (487)
                      -|+|+++..+.|++..+|-+|++--.-......  .......+...+-++|.|||.=.....+.++|||+||++..+|.-
T Consensus       198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai  277 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI  277 (458)
T ss_pred             ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence            599999999999999999888842111110000  000001122346789999998777777889999999999999998


Q ss_pred             CCCCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          410 GVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       410 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      +..--.....  .....+......      ..+...+           =...+..|+...|+.||++.+++-
T Consensus       278 lEiq~tnseS--~~~~ee~ia~~i------~~len~l-----------qr~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  278 LEIQSTNSES--KVEVEENIANVI------IGLENGL-----------QRGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             heeccCCCcc--eeehhhhhhhhe------eeccCcc-----------ccCcCcccccCCCCCCcchhhhhc
Confidence            8543211110  000001111111      1111111           124567899999999999998763

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.44  E-value=1.1e-13  Score=138.54  Aligned_cols=253  Identities=21%  Similarity=0.220  Sum_probs=179.8

Q ss_pred             ccccccccccc--ccceeEEEEEe-cCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CCCCc
Q 011360          192 DCFASLEKIGS--GGCGEVYKAEL-PGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RHRNI  267 (487)
Q Consensus       192 ~~~~~~~~lg~--G~~g~v~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnI  267 (487)
                      ..+.+...+|.  |.+|.+|.+.. ...++..+|+|+-....-             .+.....-.+|+.....+ .|+|.
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s-------------~p~~~~~k~~~~~s~~~i~~~~~~  180 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFS-------------PPLDSKRKLREFLSHHKIDSHENP  180 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCC-------------CccccccccchhhcccccCccccc
Confidence            35678889999  99999999975 245778899987422110             001111223455555555 69999


Q ss_pred             cccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHH----HHHHHHhcCCCCeeecCCCCCCE
Q 011360          268 LPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVAS----GLEYLHMYHSASIIHGDIKPRNV  343 (487)
Q Consensus       268 v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~----~L~~Lh~~h~~givH~Dlkp~Ni  343 (487)
                      ++.+..+...+..|+-+|+| +.+|..+...   ....++....+....+..+    ||.++   |+.+++|-|+||.||
T Consensus       181 v~~~~~~e~~~~lfiqtE~~-~~sl~~~~~~---~~~~~p~~~l~~~~~~~~~~~~~al~~~---hs~~~~~~~~kp~~i  253 (524)
T KOG0601|consen  181 VRDSPAWEGSGILFIQTELC-GESLQSYCHT---PCNFLPDNLLWNSLRDWLSRDVTALSHL---HSNNIVHDDLKPANI  253 (524)
T ss_pred             cccCcccccCCcceeeeccc-cchhHHhhhc---ccccCCchhhhhHHhhhhhccccccccc---CCCcccccccchhhe
Confidence            99999999999999999999 5688777653   2344777788888888888    99999   888899999999999


Q ss_pred             EeCCC-CCEEEeccCCccccCCCCceee---EeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCC
Q 011360          344 LLNDD-MEACISDLGLAMAIPDGYTRVL---ISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQN  419 (487)
Q Consensus       344 ll~~~-~~~kl~DFg~s~~~~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~  419 (487)
                      ++..+ ...+++|||+...+........   .....|...|++||.+.+ .++...|+|++|.+..+..++..+....-+
T Consensus       254 ~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~  332 (524)
T KOG0601|consen  254 FTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKN  332 (524)
T ss_pred             ecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCC
Confidence            99999 8899999999988766542211   122257889999998876 678999999999999999999766643321


Q ss_pred             CCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          420 GEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       420 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ....           ..+...     ++.+........+...+..+++.+|-.|++.+.+..
T Consensus       333 ~~W~-----------~~r~~~-----ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  333 SSWS-----------QLRQGY-----IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             CCcc-----------cccccc-----CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            1111           001000     111111112234555888899999999999987653

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.44  E-value=1.2e-12  Score=133.01  Aligned_cols=156  Identities=20%  Similarity=0.250  Sum_probs=98.5

Q ss_pred             cccccccceeEEEEEecCCCCceEEEEEeeecCchhHH---HHHHHh----------------hhhhhHHH------HHH
Q 011360          198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAA---ELIEED----------------SKLRDSKL------RQI  252 (487)
Q Consensus       198 ~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~----------------~~~~~~~~------~~~  252 (487)
                      +.||.|++|.||+|++.  +|+.||||+..........   +.+..-                ...-....      -.+
T Consensus       123 ~plasaSigQVh~A~l~--~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf  200 (437)
T TIGR01982       123 KPLAAASIAQVHRARLV--DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL  200 (437)
T ss_pred             cceeeeehhheEEEEec--CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence            57999999999999874  7899999998543211111   000000                00000011      124


Q ss_pred             HHHHHHhccC----C-CCCccccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHH-HHHHHH
Q 011360          253 RSEIITASQI----R-HRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVAS-GLEYLH  326 (487)
Q Consensus       253 ~~E~~~l~~l----~-hpnIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~-~L~~Lh  326 (487)
                      .+|+..+.++    + +|+|.-..-+.......++||||++|++|.++.....   ...   ....++..++. .+..+ 
T Consensus       201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~---~~~---~~~~ia~~~~~~~l~ql-  273 (437)
T TIGR01982       201 RREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE---AGL---DRKALAENLARSFLNQV-  273 (437)
T ss_pred             HHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh---cCC---CHHHHHHHHHHHHHHHH-
Confidence            5566665555    2 3443322222233445689999999999988765311   111   23445555554 34455 


Q ss_pred             hcCCCCeeecCCCCCCEEeCCCCCEEEeccCCccccCC
Q 011360          327 MYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPD  364 (487)
Q Consensus       327 ~~h~~givH~Dlkp~Nill~~~~~~kl~DFg~s~~~~~  364 (487)
                        |..|++|+|++|.||+++.++.++++|||++..+..
T Consensus       274 --~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       274 --LRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             --HhCCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence              788999999999999999999999999999977653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.40  E-value=1.1e-11  Score=125.65  Aligned_cols=166  Identities=17%  Similarity=0.235  Sum_probs=124.0

Q ss_pred             CCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceEEecCCeeEEEEEecCCCCHHH
Q 011360          215 GSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQD  294 (487)
Q Consensus       215 ~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~gsL~~  294 (487)
                      +.++.+|.|......               .........+.+..++.++||||++++..+...+..|+|+|-+  ..|..
T Consensus        34 k~~~~~vsVF~~~~~---------------~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~   96 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRS---------------NGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLET   96 (690)
T ss_pred             eccCCceEEEEEeCC---------------CchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHH
Confidence            346777777766321               1133455667788899999999999999999999999999987  47888


Q ss_pred             HHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEeccCCccccCCCCceeeEeee
Q 011360          295 ILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYV  374 (487)
Q Consensus       295 ~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~  374 (487)
                      +++..       ....+...+.||+.||.|||  ++.+++|++|.-+.|+++..|..||++|-++.........  ....
T Consensus        97 ~lk~l-------~~~~v~~Gl~qIl~AL~FL~--~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~--~~~~  165 (690)
T KOG1243|consen   97 VLKEL-------GKEEVCLGLFQILAALSFLN--DDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAP--AKSL  165 (690)
T ss_pred             HHHHh-------HHHHHHHHHHHHHHHHHHHh--ccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcc--cccc
Confidence            88752       24566778999999999997  6788999999999999999999999999887654332210  0111


Q ss_pred             cccccccCCcccCCCCCCchhHHHHHHHHHHHHHhC
Q 011360          375 LGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRG  410 (487)
Q Consensus       375 ~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg  410 (487)
                      .--..|..|+.+....  ...|.|-|||++++++.|
T Consensus       166 ~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  166 YLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             hhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence            1122456666543322  457999999999999999

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.34  E-value=6.6e-12  Score=129.00  Aligned_cols=162  Identities=17%  Similarity=0.172  Sum_probs=93.4

Q ss_pred             cccccccccccceeEEEEEecCCCCceEEEEEeeecCchhH---HHHHH-------Hh---------hhhhhHHHHH---
Q 011360          194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISA---AELIE-------ED---------SKLRDSKLRQ---  251 (487)
Q Consensus       194 ~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~-------~~---------~~~~~~~~~~---  251 (487)
                      |.. +.||.|++|.||+|+++ .+|+.||||+.........   .+.+.       ..         ...-.+..+.   
T Consensus       122 fd~-~PlasaSiaQVh~A~l~-~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~  199 (537)
T PRK04750        122 FDI-KPLASASIAQVHFARLK-DNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD  199 (537)
T ss_pred             cCh-hhhcCCCccEEEEEEEC-CCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence            555 68999999999999875 3599999999864321110   00000       00         0000111222   


Q ss_pred             ---HHHHHHHhccC----CCCCccccceEEec-CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHH
Q 011360          252 ---IRSEIITASQI----RHRNILPLLAHMVR-PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLE  323 (487)
Q Consensus       252 ---~~~E~~~l~~l----~hpnIv~l~~~~~~-~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~  323 (487)
                         +.+|+..+.++    .+.+.+.+-.++.+ ....++||||++|+++.++-.- ..  ...+.   ..++...+.  .
T Consensus       200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l-~~--~g~d~---~~la~~~v~--~  271 (537)
T PRK04750        200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAAL-RA--AGTDM---KLLAERGVE--V  271 (537)
T ss_pred             hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHH-Hh--cCCCH---HHHHHHHHH--H
Confidence               33444444433    23333333333322 4456799999999999875321 11  11111   112222221  1


Q ss_pred             HHHhcCCCCeeecCCCCCCEEeCCCC----CEEEeccCCccccCCC
Q 011360          324 YLHMYHSASIIHGDIKPRNVLLNDDM----EACISDLGLAMAIPDG  365 (487)
Q Consensus       324 ~Lh~~h~~givH~Dlkp~Nill~~~~----~~kl~DFg~s~~~~~~  365 (487)
                      |+.+....|++|+|++|.||+++.+|    .++++|||++..++..
T Consensus       272 ~~~Qif~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~  317 (537)
T PRK04750        272 FFTQVFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE  317 (537)
T ss_pred             HHHHHHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence            22333567899999999999999888    8999999999776543

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.30  E-value=2.8e-11  Score=108.23  Aligned_cols=154  Identities=17%  Similarity=0.181  Sum_probs=100.1

Q ss_pred             cccccccceeEEEEEecCC-----CCceEEEEEeeecCc-hhHHHH-HHHhhh-----hhhHHHH----HHHHHHHHhcc
Q 011360          198 EKIGSGGCGEVYKAELPGS-----NGKMIAIKKVIVYAP-ISAAEL-IEEDSK-----LRDSKLR----QIRSEIITASQ  261 (487)
Q Consensus       198 ~~lg~G~~g~v~~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~-~~~~~~-----~~~~~~~----~~~~E~~~l~~  261 (487)
                      ..||.|--+.||.|.-...     .+..+|||+...... ....+. +..+..     .+.....    -..+|+..|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            5789999999999963211     357899998865331 111111 111100     0111222    23489999988


Q ss_pred             CCC--CCccccceEEecCCeeEEEEEecCCCCHHH-HHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCC
Q 011360          262 IRH--RNILPLLAHMVRPDCHLLVYEFMKNGSLQD-ILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDI  338 (487)
Q Consensus       262 l~h--pnIv~l~~~~~~~~~~~lv~E~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dl  338 (487)
                      +..  -++..++++    ...++||||+.+..+.. .+..     ..++......+..+++.+|..++  |..|+|||||
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~--H~~glVHGDL  151 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLY--KECNLVHADL  151 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHH--HhCCeecCCC
Confidence            843  345555543    45679999996643321 2221     23444556677889999999885  6778999999


Q ss_pred             CCCCEEeCCCCCEEEeccCCccccC
Q 011360          339 KPRNVLLNDDMEACISDLGLAMAIP  363 (487)
Q Consensus       339 kp~Nill~~~~~~kl~DFg~s~~~~  363 (487)
                      ++.||++. ++.+.|+|||.+....
T Consensus       152 s~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         152 SEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             CHHHEEEE-CCcEEEEECCCceeCC
Confidence            99999997 4689999999887654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.29  E-value=3.3e-11  Score=104.03  Aligned_cols=139  Identities=22%  Similarity=0.329  Sum_probs=103.2

Q ss_pred             cccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceEEecC
Q 011360          198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRP  277 (487)
Q Consensus       198 ~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  277 (487)
                      ..+++|+-+.++.+.+   -|.++++|.= ..      +.+........-...+..+|+.++++++--.|...+-+..++
T Consensus         2 ~~i~~GAEa~i~~~~~---~g~~av~K~R-i~------K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~   71 (204)
T COG3642           2 DLIKQGAEAIIYLTDF---LGLPAVVKER-IP------KRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDP   71 (204)
T ss_pred             chhhCCcceeEEeeec---cCcceEEEee-cC------cccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcC
Confidence            3578899999999976   3445566642 11      112222223333456678899999998777777777778888


Q ss_pred             CeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEeccC
Q 011360          278 DCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLG  357 (487)
Q Consensus       278 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~DFg  357 (487)
                      +...|+|||++|..|.+++...           ...++..+-.-+.-|   |..||+|+||.++||++..++ +.++|||
T Consensus        72 ~~~~I~me~I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~l---H~~givHGDLTtsNiIl~~~~-i~~IDfG  136 (204)
T COG3642          72 DNGLIVMEYIEGELLKDALEEA-----------RPDLLREVGRLVGKL---HKAGIVHGDLTTSNIILSGGR-IYFIDFG  136 (204)
T ss_pred             CCCEEEEEEeCChhHHHHHHhc-----------chHHHHHHHHHHHHH---HhcCeecCCCccceEEEeCCc-EEEEECC
Confidence            8889999999999999898751           134566666677778   899999999999999999765 9999999


Q ss_pred             Cccc
Q 011360          358 LAMA  361 (487)
Q Consensus       358 ~s~~  361 (487)
                      ++..
T Consensus       137 Lg~~  140 (204)
T COG3642         137 LGEF  140 (204)
T ss_pred             cccc
Confidence            9863

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.28  E-value=5.1e-12  Score=133.18  Aligned_cols=252  Identities=22%  Similarity=0.278  Sum_probs=168.7

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      +.+.+++-+-.|.++.++.+. ....|...++|....            .........+....+-.++-...+|.+++..
T Consensus       804 d~~~i~~p~qS~sp~ss~p~~-pa~sgh~~~~~v~~~------------ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~  870 (1205)
T KOG0606|consen  804 DGFEITKPSQSGSPSSSFPAS-PAGSGHTRPSKVHGL------------APKIRTNDYESIRSKSNILITPRSPAVVRSF  870 (1205)
T ss_pred             ccceecccccCCCCcccccCC-ccccccccchhhhcc------------chhhccccccccCCccCccccCCCCceeccc
Confidence            346777788889999998885 333454444443311            1111122223333343444445678888877


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      ..+....+.+++++|..+++|...|...    ...+..-.......+..++++|   |...+.|+|++|.|.+...+|..
T Consensus       871 ~s~~~rsP~~L~~~~~~~~~~~Skl~~~----~~~saepaRs~i~~~vqs~e~L---~s~~r~h~~~~p~~~l~~~~gh~  943 (1205)
T KOG0606|consen  871 PSFPCRSPLPLVGHYLNGGDLPSKLHNS----GCLSAEPARSPILERVQSLESL---HSSLRKHRDLKPDSLLIAYDGHR  943 (1205)
T ss_pred             CCCCCCCCcchhhHHhccCCchhhhhcC----CCcccccccchhHHHHhhhhcc---ccchhhcccccccchhhcccCCc
Confidence            7777778899999999999999988752    2445555667777888999999   77779999999999999999999


Q ss_pred             EEeccCCccccCC------C---------------Cc----e----eeEeeecccccccCCcccCCCCCCchhHHHHHHH
Q 011360          352 CISDLGLAMAIPD------G---------------YT----R----VLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGM  402 (487)
Q Consensus       352 kl~DFg~s~~~~~------~---------------~~----~----~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~  402 (487)
                      +++|||.....+.      .               ..    .    .......+|+.|.+||.+.+......+|+|++|+
T Consensus       944 ~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~ 1023 (1205)
T KOG0606|consen  944 PLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGV 1023 (1205)
T ss_pred             ccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhh
Confidence            9999983322110      0               00    0    0112356899999999999999999999999999


Q ss_pred             HHHHHHhCCCCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChH
Q 011360          403 LLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQ  477 (487)
Q Consensus       403 ~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~  477 (487)
                      +++|.++|.+||....+...      +..+.....+       ++ ...........+++...+..+|.+|-.+.
T Consensus      1024 ~l~e~l~g~pp~na~tpq~~------f~ni~~~~~~-------~p-~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1024 CLFEVLTGIPPFNAETPQQI------FENILNRDIP-------WP-EGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             hhhhhhcCCCCCCCcchhhh------hhccccCCCC-------CC-CCccccChhhhhhhhhhhccCchhccCcc
Confidence            99999999999954433211      1111111111       11 11223334567777788888999887765

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.27  E-value=6e-11  Score=101.94  Aligned_cols=151  Identities=21%  Similarity=0.267  Sum_probs=109.0

Q ss_pred             cccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceEEe
Q 011360          196 SLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMV  275 (487)
Q Consensus       196 ~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  275 (487)
                      .+..+-+|+-+.|+++.+   .|+.+.||.=..       +-++.......-...+..+|+..+.++.--.|.-..-++.
T Consensus        11 ~l~likQGAEArv~~~~~---~Ge~~iIK~Rf~-------K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~   80 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF---SGEAAIIKERFS-------KRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFI   80 (229)
T ss_pred             cceeeeccceeeEeeecc---CCceeEEeeccc-------ccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEE
Confidence            456788999999999987   678888885311       1122222223334566788999998886666666666777


Q ss_pred             cCCeeEEEEEecCC-CCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC---E
Q 011360          276 RPDCHLLVYEFMKN-GSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME---A  351 (487)
Q Consensus       276 ~~~~~~lv~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~---~  351 (487)
                      +...-.|+|||++| -++.+++....  ...........++..|-+.+.-|   |..+|+||||..+||++..++.   +
T Consensus        81 D~~~~~i~ME~~~g~~~vk~~i~~~~--~~~~~d~~~~~~~~~iG~~igkl---H~ndiiHGDLTTSNill~~~~~~~~~  155 (229)
T KOG3087|consen   81 DTYGGQIYMEFIDGASTVKDFILSTM--EDESEDEGLAELARRIGELIGKL---HDNDIIHGDLTTSNILLRSDGNQITP  155 (229)
T ss_pred             ecCCCeEEEEeccchhHHHHHHHHHc--cCcccchhHHHHHHHHHHHHHHh---hhCCeecccccccceEEecCCCcCce
Confidence            77778899999966 47888876532  22223333367888999999999   7888999999999999976553   5


Q ss_pred             EEeccCCccc
Q 011360          352 CISDLGLAMA  361 (487)
Q Consensus       352 kl~DFg~s~~  361 (487)
                      .++|||++..
T Consensus       156 ~lIdfgls~~  165 (229)
T KOG3087|consen  156 ILIDFGLSSV  165 (229)
T ss_pred             EEEeecchhc
Confidence            8999999854

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.27  E-value=1.4e-11  Score=109.12  Aligned_cols=130  Identities=22%  Similarity=0.211  Sum_probs=89.9

Q ss_pred             ccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcc-ccceEEe
Q 011360          197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNIL-PLLAHMV  275 (487)
Q Consensus       197 ~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv-~l~~~~~  275 (487)
                      ++.++.|.++.||+++.   .+..|++|......                .....+..|+.++..+.+.+++ +++... 
T Consensus         3 ~~~l~~G~~~~vy~~~~---~~~~~~lK~~~~~~----------------~~~~~~~~E~~~l~~l~~~~~~P~~~~~~-   62 (170)
T cd05151           3 ISPLKGGMTNKNYRVEV---ANKKYVVRIPGNGT----------------ELLINRENEAENSKLAAEAGIGPKLYYFD-   62 (170)
T ss_pred             eeecCCcccCceEEEEE---CCeEEEEEeCCCCc----------------ccccCHHHHHHHHHHHHHhCCCCceEEEe-
Confidence            35688999999999975   47789999752210                0112345677777777555544 344432 


Q ss_pred             cCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcC--CCCeeecCCCCCCEEeCCCCCEEE
Q 011360          276 RPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYH--SASIIHGDIKPRNVLLNDDMEACI  353 (487)
Q Consensus       276 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h--~~givH~Dlkp~Nill~~~~~~kl  353 (487)
                       ....++||||++|.++... .        .   .....+.+++.+|+.||...  ..+++|+|++|.||+++ ++.+++
T Consensus        63 -~~~~~lv~e~i~G~~l~~~-~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~l  128 (170)
T cd05151          63 -PETGVLITEFIEGSELLTE-D--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWL  128 (170)
T ss_pred             -CCCCeEEEEecCCCccccc-c--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEE
Confidence             3345899999999877542 0        0   11345678999999995432  23369999999999999 668999


Q ss_pred             eccCCcc
Q 011360          354 SDLGLAM  360 (487)
Q Consensus       354 ~DFg~s~  360 (487)
                      +||+.+.
T Consensus       129 iDf~~a~  135 (170)
T cd05151         129 IDWEYAG  135 (170)
T ss_pred             Eeccccc
Confidence            9999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.25  E-value=8.3e-12  Score=125.26  Aligned_cols=245  Identities=21%  Similarity=0.240  Sum_probs=171.5

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CCCCcccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RHRNILPL  270 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l  270 (487)
                      .+|..+..||.|.|+.++....+..++..|++|.+.........+             ..-..|+.+...+ .|.++++.
T Consensus       265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~d-------------i~sl~ev~l~~~l~~~~~~~g~  331 (524)
T KOG0601|consen  265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASD-------------IFSLGEVILEAILGSHLPSVGK  331 (524)
T ss_pred             CCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhh-------------hcchhhhhHhhHhhcccccCCC
Confidence            457888999999999999987555788899999775433222221             1223455554444 78999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC-C
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDD-M  349 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~-~  349 (487)
                      +..|...++.|+--|||+++++...+..    ...+....++++..|++.++.++   |+..++|+|++|+||++..+ +
T Consensus       332 ~~~W~~~r~~~ip~e~~~~~s~~l~~~~----~~~~d~~~~~~~~~q~~~~l~~i---~s~~~~~~d~~psni~i~~~~~  404 (524)
T KOG0601|consen  332 NSSWSQLRQGYIPLEFCEGGSSSLRSVT----SQMLDEDPRLRLTAQILTALNVI---HSKLFVHLDVKPSNILISNDGF  404 (524)
T ss_pred             CCCccccccccCchhhhcCcchhhhhHH----HHhcCcchhhhhHHHHHhccccc---cchhhhcccccccceeeccchh
Confidence            9989888899999999999988876632    34567778889999999999999   78889999999999999986 7


Q ss_pred             CEEEeccCCccccCCCCceeeEeeeccccccc--CCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHH
Q 011360          350 EACISDLGLAMAIPDGYTRVLISYVLGTMAYI--APEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPE  427 (487)
Q Consensus       350 ~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~--aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~  427 (487)
                      ..+++|||....+.-..     ......-++.  +|.......+..+.|++|||..+.+.+++...-.....        
T Consensus       405 ~~~~~~~~~~t~~~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~--------  471 (524)
T KOG0601|consen  405 FSKLGDFGCWTRLAFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ--------  471 (524)
T ss_pred             hhhccccccccccceec-----ccccccccccccchhhccccccccccccccccccccccccCcccCccccc--------
Confidence            78899999876422111     1122333444  55555666888999999999999999999543211110        


Q ss_pred             HHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          428 WLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      |..  ...+..     +..++.     ..++..+...+...++..||.+.++..
T Consensus       472 ~~~--i~~~~~-----p~~~~~-----~~~~q~~~kv~~~~~~~~~~l~~~l~~  513 (524)
T KOG0601|consen  472 SLT--IRSGDT-----PNLPGL-----KLQLQVLLKVMINPDRKRRPSAVELSL  513 (524)
T ss_pred             cee--eecccc-----cCCCch-----HHhhhhhhhhhcCCccccchhhhhhcc
Confidence            110  111111     111111     144666777789999999999987654

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.00  E-value=1.9e-09  Score=99.68  Aligned_cols=143  Identities=21%  Similarity=0.240  Sum_probs=100.0

Q ss_pred             cccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCC--CCccccceEEe
Q 011360          198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRH--RNILPLLAHMV  275 (487)
Q Consensus       198 ~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--pnIv~l~~~~~  275 (487)
                      +.++.|.++.+|++...  +|..+++|.......              ......+..|+.++..+.+  .++.+++.+..
T Consensus         4 ~~l~~G~~n~~~~v~~~--~g~~~ilK~~~~~~~--------------~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~   67 (223)
T cd05154           4 RQLSGGQSNLTYLLTAG--GGRRLVLRRPPPGAL--------------LPSAHDVAREYRVLRALAGTGVPVPKVLALCE   67 (223)
T ss_pred             eecCCCccceEEEEEec--CCcceEEEeCCCccc--------------CcccccHHHHHHHHHHhhCCCCCCCCEEEECC
Confidence            56899999999999763  357899997632110              0123456778888888865  34566676655


Q ss_pred             cC---CeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhc------------------------
Q 011360          276 RP---DCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMY------------------------  328 (487)
Q Consensus       276 ~~---~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~------------------------  328 (487)
                      ..   +..++||||++|.++.+.+..     ..++......++.+++.+|..||+.                        
T Consensus        68 ~~~~~~~~~~v~e~i~G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~  142 (223)
T cd05154          68 DPSVLGTPFYVMERVDGRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARW  142 (223)
T ss_pred             CCCccCCceEEEEEeCCEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHH
Confidence            53   256899999999888665420     2355556666677777777777631                        


Q ss_pred             -----------------------------CCCCeeecCCCCCCEEeCC--CCCEEEeccCCccc
Q 011360          329 -----------------------------HSASIIHGDIKPRNVLLND--DMEACISDLGLAMA  361 (487)
Q Consensus       329 -----------------------------h~~givH~Dlkp~Nill~~--~~~~kl~DFg~s~~  361 (487)
                                                   -...++|+|+.|.||+++.  ++.+.|+||+.+..
T Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         143 RRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                                         1356899999999999998  56689999998753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.99  E-value=7.4e-09  Score=92.35  Aligned_cols=142  Identities=19%  Similarity=0.225  Sum_probs=85.1

Q ss_pred             eEEEEEecCCCCceEEEEEeeecCchh-HHHHHH-H---------hhhhhhHHHHHHHHHHHHhccCCCC--CccccceE
Q 011360          207 EVYKAELPGSNGKMIAIKKVIVYAPIS-AAELIE-E---------DSKLRDSKLRQIRSEIITASQIRHR--NILPLLAH  273 (487)
Q Consensus       207 ~v~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~-~---------~~~~~~~~~~~~~~E~~~l~~l~hp--nIv~l~~~  273 (487)
                      .||.|..  .+|..+|+|......... ..+.+. .         .............+|+..|.++..-  ++.+++.+
T Consensus         1 ~Vy~~~~--~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~   78 (188)
T PF01163_consen    1 DVYHAID--PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY   78 (188)
T ss_dssp             EEEEEEE--CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE
T ss_pred             CEEEEEC--CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE
Confidence            4888864  378899999987653211 111110 0         1111223345668899999999665  45555544


Q ss_pred             EecCCeeEEEEEecC--CCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          274 MVRPDCHLLVYEFMK--NGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       274 ~~~~~~~~lv~E~~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      .    ..+|||||++  |..+..+...      .++......++.+++..+..+.  |..||+||||.+.||+++++ .+
T Consensus        79 ~----~~~ivME~I~~~G~~~~~l~~~------~~~~~~~~~~~~~il~~~~~~~--~~~givHGDLs~~NIlv~~~-~~  145 (188)
T PF01163_consen   79 N----RNVIVMEYIGEDGVPLPRLKDV------DLSPEEPKELLEEILEEIIKML--HKAGIVHGDLSEYNILVDDG-KV  145 (188)
T ss_dssp             E----TTEEEEE--EETTEEGGCHHHC------GGGGSTHHHHHHHHHHHHHHHH--HCTTEEESS-STTSEEEETT-CE
T ss_pred             e----CCEEEEEecCCCccchhhHHhc------cccchhHHHHHHHHHHHHHHHH--HhcCceecCCChhhEEeecc-eE
Confidence            2    3469999998  6666554331      1113345667777877566543  78899999999999999987 89


Q ss_pred             EEeccCCccccC
Q 011360          352 CISDLGLAMAIP  363 (487)
Q Consensus       352 kl~DFg~s~~~~  363 (487)
                      .++|||.+....
T Consensus       146 ~iIDf~qav~~~  157 (188)
T PF01163_consen  146 YIIDFGQAVDSS  157 (188)
T ss_dssp             EE--GTTEEETT
T ss_pred             EEEecCcceecC
Confidence            999999886543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.92  E-value=1.9e-08  Score=95.15  Aligned_cols=147  Identities=20%  Similarity=0.134  Sum_probs=94.2

Q ss_pred             ccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCc--cccceEEec----
Q 011360          203 GGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNI--LPLLAHMVR----  276 (487)
Q Consensus       203 G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI--v~l~~~~~~----  276 (487)
                      .....|.++.+   .|+.|.||......   ..+..+.-... ......+.+|...+..+..-+|  ..++++...    
T Consensus        33 ~~~rrvvr~~~---~g~~~~vKr~~~~~---~~~~~k~l~~~-~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~  105 (268)
T PRK15123         33 LEGRRTLRFEL---AGKSYFLKWHRGTG---WGEIFKNLLSL-RMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP  105 (268)
T ss_pred             CCCceEEEEEE---CCEEEEEEEecCCc---HHHHhhhhccc-ccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence            33344667765   57789999763221   11111110000 0111235677777766633333  233444432    


Q ss_pred             -CCeeEEEEEecCCC-CHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC-------
Q 011360          277 -PDCHLLVYEFMKNG-SLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLND-------  347 (487)
Q Consensus       277 -~~~~~lv~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~-------  347 (487)
                       ....++|||++++. +|.+++....  ....+......++.+++..+.-|   |..||+|+|+++.|||++.       
T Consensus       106 ~~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~L---H~~Gi~HgDL~~~NiLl~~~~~~~~~  180 (268)
T PRK15123        106 ATRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDM---HAAGINHRDCYICHFLLHLPFPGREE  180 (268)
T ss_pred             ccceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHH---HHCcCccCCCChhhEEEeccccCCCC
Confidence             23468999999876 8999885321  23445567778999999999999   8899999999999999975       


Q ss_pred             CCCEEEeccCCccc
Q 011360          348 DMEACISDLGLAMA  361 (487)
Q Consensus       348 ~~~~kl~DFg~s~~  361 (487)
                      ++.+.++||+.+..
T Consensus       181 ~~~~~LIDl~r~~~  194 (268)
T PRK15123        181 DLKLSVIDLHRAQI  194 (268)
T ss_pred             CceEEEEECCcccc
Confidence            46789999998753

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.84  E-value=3.7e-08  Score=90.48  Aligned_cols=149  Identities=20%  Similarity=0.205  Sum_probs=102.0

Q ss_pred             cccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhh------hh--hHHHHHHHHHHHHhccCCCC
Q 011360          194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSK------LR--DSKLRQIRSEIITASQIRHR  265 (487)
Q Consensus       194 ~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~------~~--~~~~~~~~~E~~~l~~l~hp  265 (487)
                      ..+...||.|--+.||.|..  ..|.++|||.-..+ ..+..++......      .+  ........+|.++|.+|...
T Consensus        93 e~iG~~IGvGKEsdVY~~~~--~~g~~~~vKfHR~G-rtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~  169 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAID--PKGRKVAVKFHRLG-RTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPE  169 (304)
T ss_pred             HhhccccccCccceEEEEEC--CCCCEEEEEEeecC-chhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhc
Confidence            45668999999999999975  37899999965544 4444433222222      11  12344568899999998554


Q ss_pred             --CccccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCE
Q 011360          266 --NILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNV  343 (487)
Q Consensus       266 --nIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Ni  343 (487)
                        .|.+.+++    +...+||||++|-.|...-         +.......++..|+.-+..+   -..|+||||+.+=||
T Consensus       170 G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~---~~~GiVHGDlSefNI  233 (304)
T COG0478         170 GVKVPKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKA---YRRGIVHGDLSEFNI  233 (304)
T ss_pred             CCCCCCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHH---HHcCccccCCchheE
Confidence              67777664    4457999999887665431         12233344455555555544   356799999999999


Q ss_pred             EeCCCCCEEEeccCCccc
Q 011360          344 LLNDDMEACISDLGLAMA  361 (487)
Q Consensus       344 ll~~~~~~kl~DFg~s~~  361 (487)
                      ++++||.+.++||-.+..
T Consensus       234 lV~~dg~~~vIDwPQ~v~  251 (304)
T COG0478         234 LVTEDGDIVVIDWPQAVP  251 (304)
T ss_pred             EEecCCCEEEEeCccccc
Confidence            999999999999987654

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.82  E-value=5.1e-08  Score=94.09  Aligned_cols=198  Identities=16%  Similarity=0.153  Sum_probs=125.5

Q ss_pred             eEEEEEecCCC-CHHHHHhh--hhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEecc
Q 011360          280 HLLVYEFMKNG-SLQDILDD--VSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDL  356 (487)
Q Consensus       280 ~~lv~E~~~~g-sL~~~l~~--~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~DF  356 (487)
                      +-+.|..+.|. ....+++.  .+..-....|...++.++.++.+.+.|   |..|.+-||+.++|+|+++++.+.|.|=
T Consensus        85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~l---H~~Gh~vGDVn~~~~lVsd~~~V~LVds  161 (637)
T COG4248          85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATL---HEHGHVVGDVNQNSFLVSDDSKVVLVDS  161 (637)
T ss_pred             eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHH---HhcCCcccccCccceeeecCceEEEEcc
Confidence            56778877654 23333321  123345678999999999999999999   7889999999999999999999999884


Q ss_pred             CCccccCCCCceeeEeeecccccccCCcccC-----CCCCCchhHHHHHHHHHHHHHhC-CCCccccCCCCccc-cHH--
Q 011360          357 GLAMAIPDGYTRVLISYVLGTMAYIAPEYFQ-----QPELSEKCDIFSFGMLLISLVRG-VPSFVFHQNGEEIC-SPE--  427 (487)
Q Consensus       357 g~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DvwslG~~l~elltg-~~pf~~~~~~~~~~-~~~--  427 (487)
                      ..-. +.  .........+|...|++||.-.     +-.-+...|.|.||+++++++.| +.||.+-.-..... ..|  
T Consensus       162 Dsfq-i~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~  238 (637)
T COG4248         162 DSFQ-IN--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETD  238 (637)
T ss_pred             ccee-ec--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhh
Confidence            3221 11  1222224556889999999654     23456789999999999999997 99996542111111 111  


Q ss_pred             HHHHHH----hcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCC--CCCCCCChHHHHHHHhhh
Q 011360          428 WLRKVM----NSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLH--DPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       428 ~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~--~P~~RPs~~~il~~L~~l  486 (487)
                      .....+    ....+...-+-.+   ........+.-+..+|+..  ++.-|||++-++..|..+
T Consensus       239 Ia~g~f~ya~~~~~g~~p~P~~~---P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al  300 (637)
T COG4248         239 IAHGRFAYASDQRRGLKPPPRSI---PLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDAL  300 (637)
T ss_pred             hhcceeeechhccCCCCCCCCCC---ChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHH
Confidence            000000    0111111111111   1222233455566678765  366899999998887653

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.81  E-value=1.4e-09  Score=111.04  Aligned_cols=149  Identities=18%  Similarity=0.272  Sum_probs=102.0

Q ss_pred             HHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEeccCCccccCCCCc-------eeeEeeecccccccCCcccCCC
Q 011360          317 GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT-------RVLISYVLGTMAYIAPEYFQQP  389 (487)
Q Consensus       317 qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~DFg~s~~~~~~~~-------~~~~~~~~gt~~y~aPE~l~~~  389 (487)
                      +++.|+.|+|  .+.++||++|.|++|.++.++.+||+.|+++........       ............|.|||++.+.
T Consensus       107 ~v~dgl~flh--~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~  184 (700)
T KOG2137|consen  107 NVADGLAFLH--RSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT  184 (700)
T ss_pred             cccchhhhhc--cCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence            3458999998  567899999999999999999999999998765443211       1111112235579999999998


Q ss_pred             CCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCC
Q 011360          390 ELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLH  468 (487)
Q Consensus       390 ~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~  468 (487)
                      ..+.++|+||+|+++|.+.. |+.-+.........    .. .....+-......        .+.+.++.+-+.+++..
T Consensus       185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~----~~-~~~~~~~~~~~~s--------~~~p~el~~~l~k~l~~  251 (700)
T KOG2137|consen  185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY----SF-SRNLLNAGAFGYS--------NNLPSELRESLKKLLNG  251 (700)
T ss_pred             cccccccceeeeeEEEEEecCCcchhhccCCcchh----hh-hhccccccccccc--------ccCcHHHHHHHHHHhcC
Confidence            88999999999999999994 56555433221110    00 0111111111112        23345688888899999


Q ss_pred             CCCCCCChHHHH
Q 011360          469 DPEERPNSQYVR  480 (487)
Q Consensus       469 ~P~~RPs~~~il  480 (487)
                      ++.-||++..+.
T Consensus       252 ~~~~rp~~~~l~  263 (700)
T KOG2137|consen  252 DSAVRPTLDLLL  263 (700)
T ss_pred             CcccCcchhhhh
Confidence            999999777654

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.73  E-value=1.6e-07  Score=93.01  Aligned_cols=218  Identities=16%  Similarity=0.166  Sum_probs=142.9

Q ss_pred             ceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceEEe----cCCee
Q 011360          205 CGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMV----RPDCH  280 (487)
Q Consensus       205 ~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~----~~~~~  280 (487)
                      ..++|++. ...+|..|++|++...+..+.               .....-++.++++.|+|||++..++.    .+..+
T Consensus       289 ~~Ttyk~~-s~~DG~~YvLkRlhg~r~~~~---------------nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~Sl  352 (655)
T KOG3741|consen  289 SITTYKAT-SNVDGNAYVLKRLHGDRDQST---------------NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSL  352 (655)
T ss_pred             cceeEeee-eccCCceeeeeeeccccccCc---------------ccchHHHHHHHHhccCceeehhhhhhhhccCcceE
Confidence            35678885 456899999999833221111               01122356678899999999999887    34677


Q ss_pred             EEEEEecCC-CCHHHHHhhh-----------hcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC
Q 011360          281 LLVYEFMKN-GSLQDILDDV-----------SRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDD  348 (487)
Q Consensus       281 ~lv~E~~~~-gsL~~~l~~~-----------~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~  348 (487)
                      ++|++|.++ ++|.++.-..           ...+...++..+|.++.|++.||.++   |+.|+..+-|.|.+|+++.+
T Consensus       353 vlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sI---HssGLAck~L~~~kIlv~G~  429 (655)
T KOG3741|consen  353 VLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSI---HSSGLACKTLDLKKILVTGK  429 (655)
T ss_pred             EEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHH---HhcCceeecccHhHeEeeCc
Confidence            999999875 5666643210           11244567889999999999999999   88899999999999999999


Q ss_pred             CCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHH
Q 011360          349 MEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEW  428 (487)
Q Consensus       349 ~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~  428 (487)
                      ..++|+..|....+.....                +.+.+   -.+-|.=.||.++..|.||..--    +..+.. ...
T Consensus       430 ~RIriS~C~i~Dvl~~d~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns----~~~d~~-~~s  485 (655)
T KOG3741|consen  430 MRIRISGCGIMDVLQEDPT----------------EPLES---QQQNDLRDLGLLLLALATGTENS----NRTDST-QSS  485 (655)
T ss_pred             ceEEEecccceeeecCCCC----------------cchhH---HhhhhHHHHHHHHHHHhhccccc----ccccch-HHH
Confidence            8999988887654433220                11111   13468889999999999994321    001110 011


Q ss_pred             HHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHH
Q 011360          429 LRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRL  483 (487)
Q Consensus       429 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L  483 (487)
                      ....                 ....++.++.+++......++++ -+.++++..+
T Consensus       486 ~~~~-----------------I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~  522 (655)
T KOG3741|consen  486 HLTR-----------------ITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI  522 (655)
T ss_pred             HHHH-----------------hhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence            0111                 11234456777777777777776 5666666543

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.67  E-value=5.7e-08  Score=99.52  Aligned_cols=157  Identities=20%  Similarity=0.221  Sum_probs=95.9

Q ss_pred             cccccccceeEEEEEecCCCCceEEEEEeeecCchhH--------------------------HHHHHHhhhhhhHHHHH
Q 011360          198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISA--------------------------AELIEEDSKLRDSKLRQ  251 (487)
Q Consensus       198 ~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~--------------------------~~~~~~~~~~~~~~~~~  251 (487)
                      ..++.++.|.||+|+++  +|+.||||+....-....                          ..+..+.... -...-.
T Consensus       131 ~PiAsASIaQVH~A~L~--sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~-l~~ElD  207 (517)
T COG0661         131 EPIASASIAQVHRAVLK--SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKR-LREELD  207 (517)
T ss_pred             CchhhhhHhhheeEEec--CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHH-HHHHhC
Confidence            56899999999999986  699999998854331110                          0000000000 001112


Q ss_pred             HHHHHHHhccC-----CCCCccccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHH
Q 011360          252 IRSEIITASQI-----RHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLH  326 (487)
Q Consensus       252 ~~~E~~~l~~l-----~hpnIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh  326 (487)
                      +.+|+..+.++     ..|++.-..=++.-...-.++|||++|..+.+......   ...+.   ..++..++++  |+.
T Consensus       208 y~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~---~g~d~---k~ia~~~~~~--f~~  279 (517)
T COG0661         208 YRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS---AGIDR---KELAELLVRA--FLR  279 (517)
T ss_pred             HHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh---cCCCH---HHHHHHHHHH--HHH
Confidence            34555555544     33444433334444566689999999999998843211   22332   2233333322  111


Q ss_pred             hcCCCCeeecCCCCCCEEeCCCCCEEEeccCCccccCCC
Q 011360          327 MYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG  365 (487)
Q Consensus       327 ~~h~~givH~Dlkp~Nill~~~~~~kl~DFg~s~~~~~~  365 (487)
                      +.-..|++|+|.+|.||++..+|.+.+.|||+...+...
T Consensus       280 q~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         280 QLLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             HHHhcCccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence            113468999999999999999999999999998776543

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.62  E-value=2.5e-07  Score=84.54  Aligned_cols=105  Identities=25%  Similarity=0.316  Sum_probs=77.8

Q ss_pred             HHHHHHHHHhccCCCC--CccccceEEecC----CeeEEEEEecCCC-CHHHHHhhhhcCCCCCChHHHHHHHHHHHHHH
Q 011360          250 RQIRSEIITASQIRHR--NILPLLAHMVRP----DCHLLVYEFMKNG-SLQDILDDVSRGRRELDWPSRHRIALGVASGL  322 (487)
Q Consensus       250 ~~~~~E~~~l~~l~hp--nIv~l~~~~~~~----~~~~lv~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L  322 (487)
                      ....+|...+..+..-  .+.+.+++....    ...++|+|++++. +|.+++...    ...+......++.+++..+
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~----~~~~~~~~~~ll~~l~~~i  131 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW----EQLDPSQRRELLRALARLI  131 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh----cccchhhHHHHHHHHHHHH
Confidence            3456677666665332  234444444432    2458999999874 799988752    2255667788999999999


Q ss_pred             HHHHhcCCCCeeecCCCCCCEEeCCCC---CEEEeccCCccc
Q 011360          323 EYLHMYHSASIIHGDIKPRNVLLNDDM---EACISDLGLAMA  361 (487)
Q Consensus       323 ~~Lh~~h~~givH~Dlkp~Nill~~~~---~~kl~DFg~s~~  361 (487)
                      .-|   |..||+|+|+++.|||++.++   .+.++||+-++.
T Consensus       132 ~~l---H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  132 AKL---HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHH---HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            999   888999999999999999887   789999997754

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.61  E-value=7e-07  Score=80.53  Aligned_cols=148  Identities=17%  Similarity=0.199  Sum_probs=92.3

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      ..+|...+++-......|.+...   +|..+++|....-.......+   .+..+.....+.......+....-.....+
T Consensus        30 ~~~~~~~kv~k~~~r~~ValIei---~~~kyIlK~pr~~~~r~er~~---~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~  103 (229)
T PF06176_consen   30 DNNYKIIKVFKNTKRNYVALIEI---DGKKYILKEPREENRRPERRF---KSFFKGSEYSRLINNTDKIRNEGFTEPADP  103 (229)
T ss_pred             hCCceEEEeecCCCccEEEEEEE---CCcEEEEeccchhhhhHHHHH---HHHhccHHHHHHHHHHHHHHHcCccccccc
Confidence            45688888888888888888765   677899997643211111111   112222333334444444444333444444


Q ss_pred             ceEEec-----CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEe
Q 011360          271 LAHMVR-----PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLL  345 (487)
Q Consensus       271 ~~~~~~-----~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill  345 (487)
                      +.+...     ....+++|||++|..|.++..        ++.    .++..+.+++.-+   |..|++|+|..|.|+++
T Consensus       104 yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikql---H~~G~~HGD~hpgNFlv  168 (229)
T PF06176_consen  104 YLAAEKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQL---HKHGFYHGDPHPGNFLV  168 (229)
T ss_pred             eeeeeeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHH---HHcCCccCCCCcCcEEE
Confidence            433332     234568999999988876542        221    2445566677777   88999999999999999


Q ss_pred             CCCCCEEEeccCCcc
Q 011360          346 NDDMEACISDLGLAM  360 (487)
Q Consensus       346 ~~~~~~kl~DFg~s~  360 (487)
                      ++++ +++.||+..+
T Consensus       169 ~~~~-i~iID~~~k~  182 (229)
T PF06176_consen  169 SNNG-IRIIDTQGKR  182 (229)
T ss_pred             ECCc-EEEEECcccc
Confidence            9664 9999998654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PRK09902 hypothetical protein; Provisional

Probab=98.54  E-value=9.9e-07  Score=79.28  Aligned_cols=147  Identities=19%  Similarity=0.122  Sum_probs=100.7

Q ss_pred             cccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCC--ccccceEEe
Q 011360          198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRN--ILPLLAHMV  275 (487)
Q Consensus       198 ~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~l~~~~~  275 (487)
                      ..-|.||.+-|+...+   .|..+-+|........+         -..+.....+.+|...+.+|..-+  +.+......
T Consensus        24 pN~~rgG~SgV~r~~~---~g~~~ylKrq~nhl~~s---------~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~   91 (216)
T PRK09902         24 PNYRRNGMSGVQCVER---NGKKLYVKRMTHHLFHS---------VRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEA   91 (216)
T ss_pred             CCcCCCCcceEEEEEe---CCcEEEEEeccCccccc---------ccCCCCchHHHHHHHHHHHHHHcCCCCCccceeee
Confidence            4467899999999876   44578888763211000         000234456788888888774322  444442211


Q ss_pred             c--C--CeeEEEEEecCC-CCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          276 R--P--DCHLLVYEFMKN-GSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       276 ~--~--~~~~lv~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      .  +  ...+||+|-++| -+|.+++..  ..-.+.+......+..+++..+.-|   |+.|+.|+|+.+.||+++.++.
T Consensus        92 ~k~~~~~rA~LVTe~L~g~~~L~~~l~~--~~~~~~~~~~k~~il~~va~~ia~L---H~~Gv~Hgdly~khIll~~~g~  166 (216)
T PRK09902         92 VKIEGEWRALLVTEDMAGFISIADWYAQ--HAVSPYSDEVRQAMLKAVALAFKKM---HSVNRQHGCCYVRHIYVKTEGK  166 (216)
T ss_pred             eccCCceEEEEEEEeCCCCccHHHHHhc--CCcCCcchHHHHHHHHHHHHHHHHH---HHCCCcCCCCCHhheeecCCCC
Confidence            1  1  235799997743 588888754  2223456677788999999999999   8889999999999999986677


Q ss_pred             --EEEeccCCccc
Q 011360          351 --ACISDLGLAMA  361 (487)
Q Consensus       351 --~kl~DFg~s~~  361 (487)
                        ++++||--++.
T Consensus       167 ~~v~lIDlEk~r~  179 (216)
T PRK09902        167 AEAGFLDLEKSRR  179 (216)
T ss_pred             eeEEEEEhhccch
Confidence              99999987654

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.23  E-value=6.1e-07  Score=98.02  Aligned_cols=117  Identities=14%  Similarity=0.122  Sum_probs=93.0

Q ss_pred             HHHHHHHHHHHhHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHHhhccCCChhHHHHHHHhhhhhccchhhhhhhhhHH
Q 011360           25 ESIETILQKLTKDWLGQFARQAQIQADLIGWKTMMVKINKVLDDAIEKQTKEEPVKIWLGKLQHLACDVDYLLDEFQTEA  104 (487)
Q Consensus        25 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~a~~~~~~~~~~~~w~~~l~~~~yd~~~~~~~~~~~~  104 (487)
                      +.+++.++|+.+++..++....|+++.+..|++.|..++.+|+||++++.....++.|...+++++|++||+++.|..+.
T Consensus         3 ~~~s~~~~~~~~~l~~~~~~~~~~~~~i~~Lk~~L~~l~~~l~d~~a~~~~~~~~~~~~e~~~~~~~~~e~~~~~~~v~~   82 (889)
T KOG4658|consen    3 ACVSFGVEKLDQLLNRESECLDGKDNYILELKENLKALQSALEDLDAKRDDLERRVNWEEDVGDLVYLAEDIIWLFLVEE   82 (889)
T ss_pred             eEEEEehhhHHHHHHHHHHHHhchHHHHHHHHHHHHHHHHHHHHHHhhcchHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence            34455678899999999999999999999999999999999999999999999999999999999999999999998888


Q ss_pred             HHHHhhh-----------------chhhhhhHHHHHHHHHHHHHHHHhhccccC
Q 011360          105 FQTMLLQ-----------------DADAMSKVKEVNARLQDIAWQINVLGLKES  141 (487)
Q Consensus       105 ~~~~l~~-----------------~~~~~~r~~ei~~~l~~i~~~~~~~~l~~~  141 (487)
                      ...+...                 .+.....+..+..++..+..++..++.+..
T Consensus        83 ~~~~~~~~l~~~~~~~~~~c~~~~~~~~~~~~~~~~~rv~~~l~~ve~l~~~~~  136 (889)
T KOG4658|consen   83 IERKANDLLSTRSVERQRLCLCGFCSKNVSDSYKYGKRVSKVLREVESLGSKGV  136 (889)
T ss_pred             HHHHHhHHhhhhHHHHHHHhhhhhHhHhhhhhHhHHHHHHHHHHHHHHhccccc
Confidence            6653221                 011222334455666666666777765543

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.23  E-value=1.3e-05  Score=74.37  Aligned_cols=140  Identities=16%  Similarity=0.196  Sum_probs=79.5

Q ss_pred             cccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCC--ccccceEEe
Q 011360          198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRN--ILPLLAHMV  275 (487)
Q Consensus       198 ~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~l~~~~~  275 (487)
                      ..+|.|..+.||+.     .+..+++|.....              .   ......+|.++++.+..-+  +.+.+++..
T Consensus         7 ~~i~~G~t~~~y~~-----~~~~~VlR~~~~~--------------~---~~~~i~~E~~~l~~l~~~glpvP~~~~~~~   64 (226)
T TIGR02172         7 TQTGEGGNGESYTH-----KTGKWMLKLYNPG--------------F---DKETIKREFDASRKVFSLGIPTPHPFDLVE   64 (226)
T ss_pred             eeecCCCCcceeEe-----cCCCEEEEeCCCC--------------C---CHHHHHHHHHHHHHHHHcCCCCCceEEEEe
Confidence            57899999999974     2445778865221              0   1223466888887774332  456677776


Q ss_pred             cCCeeEEEEEecCCCC-HHHHH--------------hh----hhc-CCCCCChHHHH-HHHH----------HHHH-HHH
Q 011360          276 RPDCHLLVYEFMKNGS-LQDIL--------------DD----VSR-GRRELDWPSRH-RIAL----------GVAS-GLE  323 (487)
Q Consensus       276 ~~~~~~lv~E~~~~gs-L~~~l--------------~~----~~~-~~~~l~~~~~~-~i~~----------qi~~-~L~  323 (487)
                      ..+...+|||+++|.+ +...+              ..    .-. .....+..... .+..          .+.. ...
T Consensus        65 ~~~~~glv~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~  144 (226)
T TIGR02172        65 DGGRLGLIYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARA  144 (226)
T ss_pred             cCCeeeeeeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHH
Confidence            7777889999998863 21111              00    000 00011111110 0100          0011 112


Q ss_pred             HHHh-cCCCCeeecCCCCCCEEeCCCCCEEEeccCCcc
Q 011360          324 YLHM-YHSASIIHGDIKPRNVLLNDDMEACISDLGLAM  360 (487)
Q Consensus       324 ~Lh~-~h~~givH~Dlkp~Nill~~~~~~kl~DFg~s~  360 (487)
                      +|.. .-...++|+|+.|.||++++++ +.++||+.+.
T Consensus       145 ~l~~~~~~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       145 FIKEVPDTSTCLHGDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             HHHhCCCCCceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence            2211 1234578999999999999888 9999999774

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.21  E-value=1.1e-05  Score=82.63  Aligned_cols=156  Identities=20%  Similarity=0.254  Sum_probs=90.4

Q ss_pred             cccccccceeEEEEEecCCCCceEEEEEeeecCchhH-HH-----H----HHHhhh------hhhHHHH------HHHHH
Q 011360          198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISA-AE-----L----IEEDSK------LRDSKLR------QIRSE  255 (487)
Q Consensus       198 ~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~-~~-----~----~~~~~~------~~~~~~~------~~~~E  255 (487)
                      +.||..+.|.||+|+.+  +|+.||||+.+..-.... .+     .    +.+...      .-++..+      .|.+|
T Consensus       167 ~piaaASlaQVhrA~L~--~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E  244 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLK--NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE  244 (538)
T ss_pred             chhhhcchhheEEEEec--CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence            56999999999999886  699999998754332110 00     0    000000      0001111      23444


Q ss_pred             HHHhcc----CCCCC------ccccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHH
Q 011360          256 IITASQ----IRHRN------ILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYL  325 (487)
Q Consensus       256 ~~~l~~----l~hpn------Iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~L  325 (487)
                      ++...+    +.|-+      |.++|-.  -...-.++||||+|..+.|.-. ..  ...++..   .++..+.++.  +
T Consensus       245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~i~Dl~~-i~--~~gi~~~---~i~~~l~~~~--~  314 (538)
T KOG1235|consen  245 AKNAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIKINDLDA-ID--KRGISPH---DILNKLVEAY--L  314 (538)
T ss_pred             HHhHHHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCccCCCHHH-HH--HcCCCHH---HHHHHHHHHH--H
Confidence            443332    34444      3333322  2345579999999998877532 11  1223333   3333333332  2


Q ss_pred             HhcCCCCeeecCCCCCCEEeCC----CCCEEEeccCCccccCCC
Q 011360          326 HMYHSASIIHGDIKPRNVLLND----DMEACISDLGLAMAIPDG  365 (487)
Q Consensus       326 h~~h~~givH~Dlkp~Nill~~----~~~~kl~DFg~s~~~~~~  365 (487)
                      +..-..|++|+|-.|.||++..    ++.+.+.|||+.......
T Consensus       315 ~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~  358 (538)
T KOG1235|consen  315 EQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK  358 (538)
T ss_pred             HHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence            2224567999999999999984    678999999998766543

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.16  E-value=3.4e-05  Score=83.80  Aligned_cols=198  Identities=18%  Similarity=0.196  Sum_probs=135.8

Q ss_pred             HHHHHHHHHHhccCCCCCccccceEEecCCe----eEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHH
Q 011360          249 LRQIRSEIITASQIRHRNILPLLAHMVRPDC----HLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEY  324 (487)
Q Consensus       249 ~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~----~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~  324 (487)
                      ......|...+.+..|+|++.++.+......    ..+..++|...++.+.+..    -..++..+.+.+..++.+||.|
T Consensus       226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~----v~~i~~~~~r~~~~~~~~GL~~  301 (1351)
T KOG1035|consen  226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS----VGSIPLETLRILHQKLLEGLAY  301 (1351)
T ss_pred             HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh----ccccCHHHHHHHHHHHhhhHHH
Confidence            3344567777888899999999988765432    2355688888888888865    4567888999999999999999


Q ss_pred             HHhcCCCCeeecCCCCC---CEEeCCCCCEEEe--ccCCccccCCCCceeeEeeecccccccCCcccCCCCCCch--hHH
Q 011360          325 LHMYHSASIIHGDIKPR---NVLLNDDMEACIS--DLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEK--CDI  397 (487)
Q Consensus       325 Lh~~h~~givH~Dlkp~---Nill~~~~~~kl~--DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~--~Dv  397 (487)
                      +|..   ...|.-+..+   +--.+..+.+..+  ||+.+...+......   ....+..|.+||.+....++.+  .|+
T Consensus       302 ~h~~---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~~~~~~~~~e~~~~~~~~~~r~~dL  375 (1351)
T KOG1035|consen  302 LHSL---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF---SDLLAEIRNADEDLKENTAKKSRLTDL  375 (1351)
T ss_pred             HHHh---ccceeEEecccccccccCccceeecchhhhcccccCCCcccch---hhcCccccccccccccccchhhhhhHH
Confidence            9654   3555444444   4444566667766  999887765543322   2235667889998887766554  799


Q ss_pred             HHHHHHHHHHHhCCCCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChH
Q 011360          398 FSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQ  477 (487)
Q Consensus       398 wslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~  477 (487)
                      |.+|.....+..|..+-....         ....++         +....        ....+....|+..++++|+++.
T Consensus       376 ~~lgll~~~~~~~~~i~~~~~---------~~~~~l---------~~~~~--------~~~~d~~~~~~~~~~~~Rl~~~  429 (1351)
T KOG1035|consen  376 WCLGLLLLQLSQGEDISEKSA---------VPVSLL---------DVLST--------SELLDALPKCLDEDSEERLSAL  429 (1351)
T ss_pred             HHHHHHHhhhhhcCccccccc---------chhhhh---------ccccc--------hhhhhhhhhhcchhhhhccchh
Confidence            999999999998854431110         001111         11011        0256777889999999999999


Q ss_pred             HHHHH
Q 011360          478 YVRCR  482 (487)
Q Consensus       478 ~il~~  482 (487)
                      +++..
T Consensus       430 ~ll~~  434 (1351)
T KOG1035|consen  430 ELLTH  434 (1351)
T ss_pred             hhhhc
Confidence            88753

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.16  E-value=2.4e-05  Score=71.57  Aligned_cols=152  Identities=24%  Similarity=0.294  Sum_probs=89.6

Q ss_pred             ccccccceeEEEEEecCCCCceEEEEEeeecCchhHH-H-HHH-------HhhhhhhHHHHHHHHHHHHhccCC--CCCc
Q 011360          199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAA-E-LIE-------EDSKLRDSKLRQIRSEIITASQIR--HRNI  267 (487)
Q Consensus       199 ~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~-~-~~~-------~~~~~~~~~~~~~~~E~~~l~~l~--hpnI  267 (487)
                      .|..|--.+||+|.-  .++..+|+|++......... + .+.       .....+.....=...|+..|.++.  +-.+
T Consensus        55 ~istGKEA~Vy~a~~--~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv  132 (268)
T COG1718          55 CISTGKEANVYLAET--GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV  132 (268)
T ss_pred             eecCCcceEEEeecc--CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence            566777788999853  46889999998653321111 0 000       000000111111256777776662  3334


Q ss_pred             cccceEEecCCeeEEEEEecCCCCH-HHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC
Q 011360          268 LPLLAHMVRPDCHLLVYEFMKNGSL-QDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN  346 (487)
Q Consensus       268 v~l~~~~~~~~~~~lv~E~~~~gsL-~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~  346 (487)
                      .+.+.+.    ...+||||+..... .=.|.     .-++.......+..++++.+.-|-  +..|+||+||..=|||+.
T Consensus       133 P~Pi~~~----~nVLvMEfIg~~g~pAP~Lk-----Dv~~e~~e~~~~~~~~v~~~~~l~--~~a~LVHgDLSEyNiL~~  201 (268)
T COG1718         133 PEPIAFR----NNVLVMEFIGDDGLPAPRLK-----DVPLELEEAEGLYEDVVEYMRRLY--KEAGLVHGDLSEYNILVH  201 (268)
T ss_pred             CCceeec----CCeEEEEeccCCCCCCCCcc-----cCCcCchhHHHHHHHHHHHHHHHH--HhcCcccccchhhheEEE
Confidence            4444433    23599999944310 00111     122222246667777877777773  347899999999999999


Q ss_pred             CCCCEEEeccCCccccCC
Q 011360          347 DDMEACISDLGLAMAIPD  364 (487)
Q Consensus       347 ~~~~~kl~DFg~s~~~~~  364 (487)
                       ++.+.++|||.|.....
T Consensus       202 -~~~p~iID~~QaV~~~h  218 (268)
T COG1718         202 -DGEPYIIDVSQAVTIDH  218 (268)
T ss_pred             -CCeEEEEECccccccCC
Confidence             77999999998876543

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.02  E-value=7e-05  Score=69.54  Aligned_cols=144  Identities=19%  Similarity=0.212  Sum_probs=78.2

Q ss_pred             ccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCC--CccccceEE
Q 011360          197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHR--NILPLLAHM  274 (487)
Q Consensus       197 ~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp--nIv~l~~~~  274 (487)
                      ++.++.|..+.||+....   +..+++|....                 ......+..|..+++.+...  .+.+++...
T Consensus         2 i~~l~~G~~n~~~~v~~~---~~~~vlK~~~~-----------------~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~   61 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTD---DGRYVLKFYRP-----------------PDAAERLRREAAVLRQLAEHGIPVPRVLAFD   61 (239)
T ss_dssp             EEEEEESSSSEEEEEEET---TSEEEEEEESS-----------------HHHHHHHHHHHHHHHHHHHTTSBS--EEEEE
T ss_pred             CccCCCCCeeeEEEEEEC---CcEEEEEEeCC-----------------CCCHHHHHHHHHHHHHHHhcCCCCceEEeec
Confidence            357889999999999763   35899998622                 12334555677776666322  345555533


Q ss_pred             e---cCCeeEEEEEecCCCCHHH----------------HHhhhhc---CCCCCChHHH--HHH----------------
Q 011360          275 V---RPDCHLLVYEFMKNGSLQD----------------ILDDVSR---GRRELDWPSR--HRI----------------  314 (487)
Q Consensus       275 ~---~~~~~~lv~E~~~~gsL~~----------------~l~~~~~---~~~~l~~~~~--~~i----------------  314 (487)
                      .   .....+++|++++|.++..                .+.....   ....+.....  ...                
T Consensus        62 ~~~~~~~~~~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  141 (239)
T PF01636_consen   62 TSDEFNGFPYLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASEL  141 (239)
T ss_dssp             EETEETSEEEEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred             ccccccccceEEEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhh
Confidence            2   2334689999999988887                1111101   1111111100  000                


Q ss_pred             ---HHHHHH-HHHHHHh----cCCCCeeecCCCCCCEEeC-CCCCEEEeccCCcc
Q 011360          315 ---ALGVAS-GLEYLHM----YHSASIIHGDIKPRNVLLN-DDMEACISDLGLAM  360 (487)
Q Consensus       315 ---~~qi~~-~L~~Lh~----~h~~givH~Dlkp~Nill~-~~~~~kl~DFg~s~  360 (487)
                         ...+.. .+..++.    .....++|+|+.|.||+++ +++.+-|+||+.+.
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  142 FDDLEELEERLLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             hhhhHHHHHHHHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence               011111 2333322    2457799999999999999 55666799998763

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.97  E-value=6.4e-05  Score=67.19  Aligned_cols=140  Identities=19%  Similarity=0.294  Sum_probs=89.2

Q ss_pred             cccccccccccccc-eeEEEEEecCCCCceEEEEEeeecCchhHH---HHHH-Hh--hhhhhHHHHHHHHHHHHhccC--
Q 011360          192 DCFASLEKIGSGGC-GEVYKAELPGSNGKMIAIKKVIVYAPISAA---ELIE-ED--SKLRDSKLRQIRSEIITASQI--  262 (487)
Q Consensus       192 ~~~~~~~~lg~G~~-g~v~~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~-~~--~~~~~~~~~~~~~E~~~l~~l--  262 (487)
                      ..++.++.||.|.- |.||+++.   +|+.+|+|.+..+......   .... ..  ..........|..|.+...+|  
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I---~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke  113 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI---DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKE  113 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE---CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHh
Confidence            56899999999999 99999987   6789999994333221111   1010 00  001113445678888877766  


Q ss_pred             -CCCCc--cccceEEecC------------------CeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHH
Q 011360          263 -RHRNI--LPLLAHMVRP------------------DCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASG  321 (487)
Q Consensus       263 -~hpnI--v~l~~~~~~~------------------~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~  321 (487)
                       .+.++  |+.+|+..-.                  ....||.||.+...             .+....    +.++.+-
T Consensus       114 ~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~~~~----~~~~~~d  176 (207)
T PF13095_consen  114 AGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQIRD----IPQMLRD  176 (207)
T ss_pred             ccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccchhH----HHHHHHH
Confidence             45566  9999987422                  11257888775543             122222    2334444


Q ss_pred             HHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEeccCCc
Q 011360          322 LEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA  359 (487)
Q Consensus       322 L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~DFg~s  359 (487)
                      +..+   |..||+-+|+++.|..     .-||+|||.+
T Consensus       177 l~~~---~k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  177 LKIL---HKLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHH---HHCCeeeccCcccccc-----CCEEEecccC
Confidence            4445   8899999999999986     2489999965

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=97.97  E-value=1.1e-06  Score=89.38  Aligned_cols=187  Identities=18%  Similarity=0.134  Sum_probs=130.8

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCC-ccccc
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRN-ILPLL  271 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~l~  271 (487)
                      .+.....+++|+++++++.+. ..+ +....+.+..                    .....-++++|.+++||| .+..+
T Consensus       243 ws~~fh~fvK~altknpKkRp-tae-klL~h~fvs~--------------------~l~~rl~~eLLdK~n~P~~~v~~~  300 (829)
T KOG0576|consen  243 WSEFFHNFVKGALTKNPKKRP-TAE-KLLQHPFVSQ--------------------TLSRRLAIELLDKVNNPNPVVRYL  300 (829)
T ss_pred             chHHHHHHHHHHhcCCCccCC-Chh-hheeceeecc--------------------chhhHHHHHHHHHccCCCCccccc
Confidence            345566789999999998853 222 2222443311                    023345778899999999 77777


Q ss_pred             eEEecCCeeEEEEEecCCC-CHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          272 AHMVRPDCHLLVYEFMKNG-SLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      +-+..++...+.|+++.++ +-.....   .....+...+...+.+.-+.+++++   |+.--+|+|    ||+..+ +.
T Consensus       301 ~d~~~E~~~~i~~~i~s~~rs~~~~~~---~se~~~~~~~~~~~~r~et~~l~~l---~~~~~~~~d----~~l~s~-~~  369 (829)
T KOG0576|consen  301 EDYDGEDYLWIPMRICSTGRSSALEMT---VSEIALEQYQFAYPLRKETRPLAEL---HSSYKVHRD----NILGSE-EE  369 (829)
T ss_pred             ccCCcccccchhhhhhcCCccccccCC---hhhHhhhhhhhhhhhhhhccccccc---ccccccCcc----cccccc-cc
Confidence            7777788889999999776 2222111   1112233334455666777888888   554458888    777665 57


Q ss_pred             EEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCcc
Q 011360          351 ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFV  415 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~  415 (487)
                      .+.+||+....+.....   .....+|+.|+|||+.....+....|+|++|.-..++.-|.+|-.
T Consensus       370 ~~~~~~~v~~~L~~~~~---~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  370 VKLLDFAVPPQLTRTMK---PRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             cccccccCCcccCcccc---cccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence            99999999887766542   245679999999999999999999999999987778888876653

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=97.96  E-value=8.1e-05  Score=69.98  Aligned_cols=140  Identities=11%  Similarity=0.068  Sum_probs=78.5

Q ss_pred             cccccc-eeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CCCCccccceEEecC
Q 011360          200 IGSGGC-GEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RHRNILPLLAHMVRP  277 (487)
Q Consensus       200 lg~G~~-g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~  277 (487)
                      |-.|.+ ..||+...   ++..+.+|......                  ...+..|+.++..+ .+--+.+++++....
T Consensus         6 ~~~g~~~~~v~~~~~---~~~~~~vk~~~~~~------------------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~   64 (244)
T cd05150           6 VTEGQSGATVYRLDG---KNPGLYLKIAPSGP------------------TYELEREAERLRWLAGKLPVPEVIDYGSDD   64 (244)
T ss_pred             cCCCCCcCeEEEEcC---CCCcEEEEecCCCc------------------ccchHHHHHHHHHHHhcCCCCeEEEEEecC
Confidence            444555 77888853   34578888652110                  12345577776666 233455667766666


Q ss_pred             CeeEEEEEecCCCCHHHHHh----------------hh-hc--CCCCCChH--HHHHH-HH-------------------
Q 011360          278 DCHLLVYEFMKNGSLQDILD----------------DV-SR--GRRELDWP--SRHRI-AL-------------------  316 (487)
Q Consensus       278 ~~~~lv~E~~~~gsL~~~l~----------------~~-~~--~~~~l~~~--~~~~i-~~-------------------  316 (487)
                      +..++|||+++|.+|.....                .. ..  ...++...  ..... ..                   
T Consensus        65 ~~~~lv~e~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  144 (244)
T cd05150          65 GRAWLLTSAVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGW  144 (244)
T ss_pred             CccEEEEEeeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCC
Confidence            67889999999988764321                00 00  01111100  00000 00                   


Q ss_pred             HHHHHHHHHHh----cCCCCeeecCCCCCCEEeCCCCCEEEeccCCcc
Q 011360          317 GVASGLEYLHM----YHSASIIHGDIKPRNVLLNDDMEACISDLGLAM  360 (487)
Q Consensus       317 qi~~~L~~Lh~----~h~~givH~Dlkp~Nill~~~~~~kl~DFg~s~  360 (487)
                      .+...+..|-.    .....++|+|+.|.||++++++.+.|+||+.+.
T Consensus       145 ~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         145 SAEELYAELEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             CHHHHHHHHHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            01111222211    134569999999999999998778899998763

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.94  E-value=3.6e-05  Score=66.54  Aligned_cols=130  Identities=22%  Similarity=0.257  Sum_probs=88.2

Q ss_pred             cccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccc-cce
Q 011360          194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILP-LLA  272 (487)
Q Consensus       194 ~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~-l~~  272 (487)
                      ..+...||+|++|.||+|.|   .|..+|+|+-.                 .++....+..|++++..+.-.++-+ +|.
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~~---~~~~~a~Kvrr-----------------~ds~r~~l~kEakiLeil~g~~~~p~vy~   83 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGEW---RGGEVALKVRR-----------------RDSPRRNLEKEAKILEILAGEGVTPEVYF   83 (201)
T ss_pred             hhhhhhhhcccccEEEEeec---cCceEEEEEec-----------------CCcchhhHHHHHHHHHHhhhcCCCceEEE
Confidence            45667899999999999988   56689999753                 2334567788999988887666543 333


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCC-CCCEEeCCCCCE
Q 011360          273 HMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIK-PRNVLLNDDMEA  351 (487)
Q Consensus       273 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlk-p~Nill~~~~~~  351 (487)
                      +.    ..++.|||+.|-+|.+.-..       .+..+    ...+++.-.-|   ...||-|+.|. |...++..++.+
T Consensus        84 yg----~~~i~me~i~G~~L~~~~~~-------~~rk~----l~~vlE~a~~L---D~~GI~H~El~~~~k~vlv~~~~~  145 (201)
T COG2112          84 YG----EDFIRMEYIDGRPLGKLEIG-------GDRKH----LLRVLEKAYKL---DRLGIEHGELSRPWKNVLVNDRDV  145 (201)
T ss_pred             ec----hhhhhhhhhcCcchhhhhhc-------ccHHH----HHHHHHHHHHH---HHhccchhhhcCCceeEEecCCcE
Confidence            32    22466999999888776542       12222    23344443344   66789999886 444555555589


Q ss_pred             EEeccCCccc
Q 011360          352 CISDLGLAMA  361 (487)
Q Consensus       352 kl~DFg~s~~  361 (487)
                      .|+||..++.
T Consensus       146 ~iIDFd~At~  155 (201)
T COG2112         146 YIIDFDSATF  155 (201)
T ss_pred             EEEEccchhh
Confidence            9999998863

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.88  E-value=4.8e-05  Score=68.14  Aligned_cols=104  Identities=24%  Similarity=0.246  Sum_probs=79.6

Q ss_pred             HHHHHhccCCC-CCccccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCC
Q 011360          254 SEIITASQIRH-RNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSAS  332 (487)
Q Consensus       254 ~E~~~l~~l~h-pnIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~g  332 (487)
                      .|.-++..+.+ +++.+++|+|-    .+++.||...+++...-... ..-...+|..+.+++.+++..+.++++.....
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l-~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPL-SQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCcccccccccc-ccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            46777777755 69999999883    35789999877664210000 01134689999999999999999997655556


Q ss_pred             eeecCCCCCCEEeCCCCCEEEeccCCcccc
Q 011360          333 IIHGDIKPRNVLLNDDMEACISDLGLAMAI  362 (487)
Q Consensus       333 ivH~Dlkp~Nill~~~~~~kl~DFg~s~~~  362 (487)
                      +.-.|++|+|+-++++|.+|++|...+...
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            888999999999999999999999876543

Proteins in this uncharacterised family are described as transmembrane proteins.

>PLN02876 acyl-CoA dehydrogenase

Probab=97.81  E-value=0.00018  Score=79.69  Aligned_cols=82  Identities=10%  Similarity=0.167  Sum_probs=53.2

Q ss_pred             ccccccccceeEEEEEecCCC-CceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCC-CCCc--cccce
Q 011360          197 LEKIGSGGCGEVYKAELPGSN-GKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIR-HRNI--LPLLA  272 (487)
Q Consensus       197 ~~~lg~G~~g~v~~~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnI--v~l~~  272 (487)
                      +..++.|.++.+|+....... ...+++|+.....              .......+.+|+.+++.+. |+++  .+++.
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~--------------~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~  108 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGK--------------LLQSAHAVEREYQVLRALGEHTDVPVPKVYC  108 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCc--------------cCccHHHHHHHHHHHHHHhhcCCCCCCcEEE
Confidence            567899999999998764211 1467777642110              0011235678888888884 6665  66777


Q ss_pred             EEecC---CeeEEEEEecCCCCH
Q 011360          273 HMVRP---DCHLLVYEFMKNGSL  292 (487)
Q Consensus       273 ~~~~~---~~~~lv~E~~~~gsL  292 (487)
                      ++.+.   +..|+||||++|..+
T Consensus       109 ~~~d~~v~G~~flVME~v~G~~~  131 (822)
T PLN02876        109 LCTDASVIGTAFYIMEYLEGRIF  131 (822)
T ss_pred             EecCCCcCCCceEEEEecCCccc
Confidence            66654   457899999988643

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.80  E-value=0.00048  Score=62.08  Aligned_cols=144  Identities=20%  Similarity=0.242  Sum_probs=88.6

Q ss_pred             ccccccccceeEEEEEecCCCCceEEEEEeeecCchhHH---HHHHHhhhhhhHHHHHHHHHHHHhccC------CCCCc
Q 011360          197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAA---ELIEEDSKLRDSKLRQIRSEIITASQI------RHRNI  267 (487)
Q Consensus       197 ~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~E~~~l~~l------~hpnI  267 (487)
                      ...||.|+.-.||.-    ..+...+||+..........   ..++  ........++..+|+.-...+      .+.+|
T Consensus         6 ~~~i~~G~~R~cy~H----P~dp~~cIKV~~~~~~~~~~~~~~~~k--~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i   79 (199)
T PF10707_consen    6 SDLIAQGGERDCYQH----PDDPNLCIKVMRPDRGERRRPFKRWLK--RLRPKSRYRQNRRELRYYKQLSLRRGVDWSHI   79 (199)
T ss_pred             CcccccCCCceEEEC----CCCCCeEEEEEccccccccccchhHHH--hhcccchhHHHHHHHHHHHHHhhccCCccccc
Confidence            457999999999854    24556788887554411000   0010  001112344555555544444      48899


Q ss_pred             cccceEEecCCeeEEEEEecCC------CCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCC
Q 011360          268 LPLLAHMVRPDCHLLVYEFMKN------GSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPR  341 (487)
Q Consensus       268 v~l~~~~~~~~~~~lv~E~~~~------gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~  341 (487)
                      .+++|+..++...-+|+|.+.+      -+|.+++..     ..++. .....+.++   ..||   -+.+|+.+|++|.
T Consensus        80 ~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-----~~~~~-~~~~~L~~f---~~~l---~~~~Iv~~dl~~~  147 (199)
T PF10707_consen   80 PRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKE-----GGLTE-ELRQALDEF---KRYL---LDHHIVIRDLNPH  147 (199)
T ss_pred             ccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHc-----CCccH-HHHHHHHHH---HHHH---HHcCCeecCCCcc
Confidence            9999999999989999998732      357777642     34544 333344433   4455   3445999999999


Q ss_pred             CEEeCCC--C--CEEEec-cCC
Q 011360          342 NVLLNDD--M--EACISD-LGL  358 (487)
Q Consensus       342 Nill~~~--~--~~kl~D-Fg~  358 (487)
                      ||++..+  +  .+.|+| ||.
T Consensus       148 NIv~~~~~~~~~~lvlIDG~G~  169 (199)
T PF10707_consen  148 NIVVQRRDSGEFRLVLIDGLGE  169 (199)
T ss_pred             cEEEEecCCCceEEEEEeCCCC
Confidence            9999643  2  477777 454

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.66  E-value=0.00026  Score=66.16  Aligned_cols=32  Identities=28%  Similarity=0.482  Sum_probs=26.4

Q ss_pred             CCCCeeecCCCCCCEEeCCCCCEEEeccCCcc
Q 011360          329 HSASIIHGDIKPRNVLLNDDMEACISDLGLAM  360 (487)
Q Consensus       329 h~~givH~Dlkp~Nill~~~~~~kl~DFg~s~  360 (487)
                      ...+++|+|+.|.||++++++..-|+||+.+.
T Consensus       162 ~~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~  193 (235)
T cd05155         162 GPPVWFHGDLAPGNLLVQDGRLSAVIDFGCLG  193 (235)
T ss_pred             CCceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence            34569999999999999876556799999764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PRK10593 hypothetical protein; Provisional

Probab=97.37  E-value=0.0024  Score=61.85  Aligned_cols=79  Identities=14%  Similarity=0.083  Sum_probs=51.9

Q ss_pred             cccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCC---CCcccc
Q 011360          194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRH---RNILPL  270 (487)
Q Consensus       194 ~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h---pnIv~l  270 (487)
                      ..-.+.||.|..+.||.....  ++ .+.+|....                 ......+..|+..++.+..   -.+.++
T Consensus        16 ~~~~~~i~~G~~~~vy~~~~~--~~-~~~~k~~~~-----------------~~~~~~~~~Ea~~L~~L~~~~~vpVP~V   75 (297)
T PRK10593         16 LSRVECISEQPYAALWALYDS--QG-NPMPLMARS-----------------FSTPGVAQQEAWKLSMLARSGTVRMPTV   75 (297)
T ss_pred             hheeeecCCccceeEEEEEcC--CC-CEEEEEecc-----------------cccchHHHHHHHHHHHHccCCCCCcCcE
Confidence            444567999999999998532  33 466665411                 0012356677777776632   356777


Q ss_pred             ceEEec---CCeeEEEEEecCCCCH
Q 011360          271 LAHMVR---PDCHLLVYEFMKNGSL  292 (487)
Q Consensus       271 ~~~~~~---~~~~~lv~E~~~~gsL  292 (487)
                      ++++..   .+..++|||+++|+++
T Consensus        76 ~~~~~~~~~~g~~~LVmE~i~G~~~  100 (297)
T PRK10593         76 YGVMTHEQSPGPDVLLLERLRGVSV  100 (297)
T ss_pred             EEEeccCCcCCCeEEEEeccCCEec
Confidence            776653   3668999999998765

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.33  E-value=7.8e-05  Score=83.00  Aligned_cols=161  Identities=12%  Similarity=0.052  Sum_probs=114.8

Q ss_pred             HHHHHHHhccCCCCCccccceEEec--CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcC
Q 011360          252 IRSEIITASQIRHRNILPLLAHMVR--PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYH  329 (487)
Q Consensus       252 ~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h  329 (487)
                      ...|..-.+...|+++...+.-...  ....+.+++|+.+|.+.+.+-+.......+...-+.....+.+....-+|...
T Consensus      1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred             hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence            3445555566789988877764443  34558999999999999998764333344444434333333344444443322


Q ss_pred             C--CCeeecCCCCCCEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHH
Q 011360          330 S--ASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISL  407 (487)
Q Consensus       330 ~--~givH~Dlkp~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~el  407 (487)
                      +  +-.+|+++|+.|.++..+..+|++++|+.+...+..  ...+...+++-|++|++...-.++.++|+|..|+.+|+.
T Consensus      1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~--sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVL--SFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred             cCCccchhhhhhhhccceecCCcccccccccccccCchH--hhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence            2  237899999999999999999999999998332221  112445678899999998888889899999999999999


Q ss_pred             HhCCCCc
Q 011360          408 VRGVPSF  414 (487)
Q Consensus       408 ltg~~pf  414 (487)
                      .-|.++|
T Consensus      1434 s~~n~~f 1440 (2724)
T KOG1826|consen 1434 SDGNAYF 1440 (2724)
T ss_pred             hcccHHH
Confidence            9999888

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.32  E-value=0.004  Score=57.97  Aligned_cols=32  Identities=19%  Similarity=0.226  Sum_probs=27.5

Q ss_pred             CCCeeecCCCCCCEEeCC-CCCEEEeccCCccc
Q 011360          330 SASIIHGDIKPRNVLLND-DMEACISDLGLAMA  361 (487)
Q Consensus       330 ~~givH~Dlkp~Nill~~-~~~~kl~DFg~s~~  361 (487)
                      ..+++|+|+.+.||++++ ++.+.++||..+..
T Consensus       169 ~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~  201 (235)
T cd05157         169 PIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY  201 (235)
T ss_pred             CEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence            457999999999999998 57899999987743

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.32  E-value=0.0027  Score=63.54  Aligned_cols=82  Identities=16%  Similarity=0.206  Sum_probs=49.4

Q ss_pred             cccccccceeEEEEEecCCCC-ceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC---CCCCccccceE
Q 011360          198 EKIGSGGCGEVYKAELPGSNG-KMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI---RHRNILPLLAH  273 (487)
Q Consensus       198 ~~lg~G~~g~v~~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpnIv~l~~~  273 (487)
                      +.||.|.++.||++...  +| +.++||.-.......        ...-+....+...|...|..+   ...++.+++.+
T Consensus        32 ~elggGn~N~VyrV~~~--~g~~svIVKqa~p~~r~~--------g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~  101 (401)
T PRK09550         32 REIGDGNLNLVFRVSDT--EGGKSVIVKQALPYVRVV--------GESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY  101 (401)
T ss_pred             eEcCCCceEEEEEEEeC--CCCeEEEEEecCcccccc--------cccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE
Confidence            57899999999999753  44 589999742110000        000012334555666666665   22456666665


Q ss_pred             EecCCeeEEEEEecCCCC
Q 011360          274 MVRPDCHLLVYEFMKNGS  291 (487)
Q Consensus       274 ~~~~~~~~lv~E~~~~gs  291 (487)
                        +++..++||||+++..
T Consensus       102 --D~~~~~lVME~L~~~~  117 (401)
T PRK09550        102 --DEELAVTVMEDLSDHK  117 (401)
T ss_pred             --CCCCCEEEEecCCCcc
Confidence              4466789999997643

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.28  E-value=0.00033  Score=66.41  Aligned_cols=150  Identities=15%  Similarity=0.156  Sum_probs=94.8

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHh------hhhhhHH--HHHHHHHHHHhccCC-
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEED------SKLRDSK--LRQIRSEIITASQIR-  263 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~------~~~~~~~--~~~~~~E~~~l~~l~-  263 (487)
                      -+.+.+.||-|--+.+|.+..  ..|.+.++|.-..++. +...+..+.      ....-..  .-...+|...|..|. 
T Consensus        93 v~svGnqIGVGKESDIY~v~d--~~G~~~~lK~HRLGRt-SFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e  169 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVAD--EEGNPLILKLHRLGRT-SFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYE  169 (465)
T ss_pred             hhhhccccccccccceEEEec--CCCCchhHHHHhhhhh-hHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHH
Confidence            367788999999999999964  3788999986544332 222111111      1111111  123467787777773 


Q ss_pred             C-CCccccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCC
Q 011360          264 H-RNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRN  342 (487)
Q Consensus       264 h-pnIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~N  342 (487)
                      | --+.+.++    .+..++|||++.|-+|...-.       .....+   +...+...+--|   -.+|+||||..-=|
T Consensus       170 ~gfpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~-------v~d~~~---ly~~lm~~Iv~l---a~~GlIHgDFNEFN  232 (465)
T KOG2268|consen  170 RGFPVPKPID----HNRHCVVMELVDGYPLRQVRH-------VEDPPT---LYDDLMGLIVRL---ANHGLIHGDFNEFN  232 (465)
T ss_pred             cCCCCCCccc----ccceeeHHHhhcccceeeeee-------cCChHH---HHHHHHHHHHHH---HHcCceecccchhe
Confidence            2 22333333    245679999999988765421       122222   333344444455   67899999999999


Q ss_pred             EEeCCCCCEEEeccCCcccc
Q 011360          343 VLLNDDMEACISDLGLAMAI  362 (487)
Q Consensus       343 ill~~~~~~kl~DFg~s~~~  362 (487)
                      |++.+++.++++||--....
T Consensus       233 imv~dd~~i~vIDFPQmvS~  252 (465)
T KOG2268|consen  233 IMVKDDDKIVVIDFPQMVST  252 (465)
T ss_pred             eEEecCCCEEEeechHhhcc
Confidence            99999999999999765443

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.22  E-value=0.0033  Score=61.29  Aligned_cols=33  Identities=30%  Similarity=0.466  Sum_probs=28.5

Q ss_pred             CCCCeeecCCCCCCEEeCCCCCEEEeccCCccc
Q 011360          329 HSASIIHGDIKPRNVLLNDDMEACISDLGLAMA  361 (487)
Q Consensus       329 h~~givH~Dlkp~Nill~~~~~~kl~DFg~s~~  361 (487)
                      ...+++|+|+.+.|+++++++.+.|+||+.+..
T Consensus       185 ~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       185 LPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT  217 (307)
T ss_pred             CCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence            357899999999999999887778999998743

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.19  E-value=0.0015  Score=63.26  Aligned_cols=32  Identities=28%  Similarity=0.412  Sum_probs=27.6

Q ss_pred             CCCeeecCCCCCCEEeCCCCCEEEeccCCccc
Q 011360          330 SASIIHGDIKPRNVLLNDDMEACISDLGLAMA  361 (487)
Q Consensus       330 ~~givH~Dlkp~Nill~~~~~~kl~DFg~s~~  361 (487)
                      ..+++|+|+.|.|+++++++.+.|.||+.+..
T Consensus       174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         174 PRGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            35799999999999999887778999998753

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.09  E-value=0.0041  Score=58.85  Aligned_cols=30  Identities=17%  Similarity=0.189  Sum_probs=26.1

Q ss_pred             CCeeecCCCCCCEEeCCCCCEEEeccCCccc
Q 011360          331 ASIIHGDIKPRNVLLNDDMEACISDLGLAMA  361 (487)
Q Consensus       331 ~givH~Dlkp~Nill~~~~~~kl~DFg~s~~  361 (487)
                      ..++|+|+.|.||++++++ +.|+||..+..
T Consensus       146 ~~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       146 LAPLHMDVHAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             CeeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence            4589999999999999877 78999998754

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK05231 homoserine kinase; Provisional

Probab=97.08  E-value=0.014  Score=57.26  Aligned_cols=32  Identities=28%  Similarity=0.370  Sum_probs=27.1

Q ss_pred             CCCeeecCCCCCCEEeCCCCCEEEeccCCccc
Q 011360          330 SASIIHGDIKPRNVLLNDDMEACISDLGLAMA  361 (487)
Q Consensus       330 ~~givH~Dlkp~Nill~~~~~~kl~DFg~s~~  361 (487)
                      ..|+||+|+.|.||+++++...-|+||+.+..
T Consensus       186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             CcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence            45899999999999999765568999998754

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=96.64  E-value=0.014  Score=56.65  Aligned_cols=31  Identities=23%  Similarity=0.358  Sum_probs=27.2

Q ss_pred             CCCeeecCCCCCCEEeCCC----CCEEEeccCCcc
Q 011360          330 SASIIHGDIKPRNVLLNDD----MEACISDLGLAM  360 (487)
Q Consensus       330 ~~givH~Dlkp~Nill~~~----~~~kl~DFg~s~  360 (487)
                      ..+++|+|+.|.||+++++    +.+.++||..+.
T Consensus       178 ~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         178 PVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             CceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            4569999999999999985    789999999874

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.60  E-value=0.02  Score=56.24  Aligned_cols=34  Identities=18%  Similarity=0.447  Sum_probs=27.6

Q ss_pred             CCCCeeecCCCCCCEEeCCCCCEEEeccCCccccC
Q 011360          329 HSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP  363 (487)
Q Consensus       329 h~~givH~Dlkp~Nill~~~~~~kl~DFg~s~~~~  363 (487)
                      +...++|||+.+.||++++++ ++++||..+..-+
T Consensus       190 ~~~~llHGDl~~gNi~~~~~~-~~~iD~e~~~~G~  223 (370)
T TIGR01767       190 SAETLLHGDLHSGSIFVSEHE-TKVIDPEFAFYGP  223 (370)
T ss_pred             CcceeeeccCCcccEEEcCCC-CEEEcCcccccCc
Confidence            456699999999999998764 7899998776543

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=96.20  E-value=0.049  Score=53.05  Aligned_cols=160  Identities=17%  Similarity=0.150  Sum_probs=92.9

Q ss_pred             ccccccccccceeEEEEEecCCCCceEEEEEeeecCchh-HHH-HH-------HHhhh--hhhHHHHHHHHHHHHhccCC
Q 011360          195 ASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPIS-AAE-LI-------EEDSK--LRDSKLRQIRSEIITASQIR  263 (487)
Q Consensus       195 ~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~-~~~-~~-------~~~~~--~~~~~~~~~~~E~~~l~~l~  263 (487)
                      .+..+|..|--..||.+.-  .+|..+|||++.-.--.. ..+ ..       .....  .+....-=...|+..|.++.
T Consensus       147 ~inGCiSTGKEANVYHat~--~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~  224 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATE--EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLN  224 (520)
T ss_pred             ecccccccCccceeEeeec--CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHH
Confidence            4556778888899999963  488889999874321000 000 00       00000  11111111245666666665


Q ss_pred             CCCccccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCE
Q 011360          264 HRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNV  343 (487)
Q Consensus       264 hpnIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Ni  343 (487)
                      ...|...--+..  ....|||+|+. ++=+-   .-....-.++...+..+-.+++..+.-|-  +..++||.||.-=|+
T Consensus       225 ~aGIP~PePIlL--k~hVLVM~FlG-rdgw~---aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY--~~c~LVHADLSEfN~  296 (520)
T KOG2270|consen  225 NAGIPCPEPILL--KNHVLVMEFLG-RDGWA---APKLKDASLSTSKARELYQQCVRIMRRLY--QKCRLVHADLSEFNL  296 (520)
T ss_pred             hcCCCCCCceee--ecceEeeeecc-CCCCc---CcccccccCChHHHHHHHHHHHHHHHHHH--HHhceeccchhhhhh
Confidence            444332222211  22469999994 22110   00011344666677778888888777775  556699999999999


Q ss_pred             EeCCCCCEEEeccCCccccCCC
Q 011360          344 LLNDDMEACISDLGLAMAIPDG  365 (487)
Q Consensus       344 ll~~~~~~kl~DFg~s~~~~~~  365 (487)
                      |+. +|.+.++|-+-|......
T Consensus       297 Lyh-dG~lyiIDVSQSVE~DHP  317 (520)
T KOG2270|consen  297 LYH-DGKLYIIDVSQSVEHDHP  317 (520)
T ss_pred             eEE-CCEEEEEEccccccCCCh
Confidence            998 458999999988765443

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.18  E-value=0.045  Score=52.34  Aligned_cols=32  Identities=25%  Similarity=0.561  Sum_probs=26.1

Q ss_pred             CCCeeecCCCCCCEEeCCCCC-EEEeccCCccc
Q 011360          330 SASIIHGDIKPRNVLLNDDME-ACISDLGLAMA  361 (487)
Q Consensus       330 ~~givH~Dlkp~Nill~~~~~-~kl~DFg~s~~  361 (487)
                      ...++|+|+.|.||++++++. .-|.||+.+..
T Consensus       184 ~~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         184 HTVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CCeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            455899999999999997555 46999998754

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=96.09  E-value=0.077  Score=48.35  Aligned_cols=78  Identities=17%  Similarity=0.228  Sum_probs=52.1

Q ss_pred             ccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCC---CCCccccc
Q 011360          195 ASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIR---HRNILPLL  271 (487)
Q Consensus       195 ~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~l~  271 (487)
                      .-.+.+..|..-..|....   ...++-+|.-                  .......+..|+.-|..|.   .-++.+++
T Consensus        19 ~er~~v~gG~inea~~v~d---g~~~~FvK~n------------------~~~~~~~f~AEa~gL~~la~s~ti~VP~vi   77 (286)
T COG3001          19 KEREEVSGGDINEAWRLRD---GTDPFFVKCN------------------QREQLSMFTAEADGLELLARSNTITVPKVI   77 (286)
T ss_pred             hcccccCCccccceeEeec---CCcceEEEec------------------chhhHHHHHHHHHHHHHHHhcCCccccceE
Confidence            3345566677777776643   4456777742                  2233455666776666663   34567778


Q ss_pred             eEEecCCeeEEEEEecCCCCHH
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQ  293 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~  293 (487)
                      .+....++.|+||||++.+++.
T Consensus        78 ~~G~~~~~sylVle~L~~~~~d   99 (286)
T COG3001          78 AVGASRDHSYLVLEYLPTGPLD   99 (286)
T ss_pred             EecCCCCeeEEEEeeccCCCCC
Confidence            8888889999999999987766

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.07  E-value=0.06  Score=52.12  Aligned_cols=36  Identities=22%  Similarity=0.392  Sum_probs=30.5

Q ss_pred             CCCCeeecCCCCCCEEeCCCCCEEEeccCCccccCC
Q 011360          329 HSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPD  364 (487)
Q Consensus       329 h~~givH~Dlkp~Nill~~~~~~kl~DFg~s~~~~~  364 (487)
                      +...++|||+.+.|+++++++-+-+.||+++..-.+
T Consensus       196 ~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP  231 (321)
T COG3173         196 GPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP  231 (321)
T ss_pred             CCceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence            345699999999999999988899999999875433

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.07  E-value=0.037  Score=53.10  Aligned_cols=76  Identities=20%  Similarity=0.292  Sum_probs=43.9

Q ss_pred             cccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC---CCCCcccc
Q 011360          194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI---RHRNILPL  270 (487)
Q Consensus       194 ~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpnIv~l  270 (487)
                      ..-.+.++.|....+|+..   .++..+-||.-.                  ......+..|+.-|+.|   ..-.+.++
T Consensus        19 i~~~~~v~GG~i~~a~~~~---~~~~~~FvK~~~------------------~~~~~~f~~Ea~gL~~L~~~~~~~vP~v   77 (288)
T PF03881_consen   19 ITSIEPVSGGDINEAYRLD---TDGGSYFVKVNS------------------ESGRDMFEGEAEGLKALAEANPIRVPKV   77 (288)
T ss_dssp             --EEEEE--SSSSEEEEEE---TTS-EEEEEEEE------------------GGGCCHHHHHHHHHHHHCHTTTSBS--E
T ss_pred             eeeeEecCCCChhheEEEE---CCCccEEEEecC------------------hhhHHHHHHHHHHHHHHHhcCCCCCCeE
Confidence            4455678889999999986   367789999752                  11123445566666555   34467788


Q ss_pred             ceEEecCCeeEEEEEecCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNG  290 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~g  290 (487)
                      +++....+..++||||++.+
T Consensus        78 i~~G~~~~~~fLlle~l~~~   97 (288)
T PF03881_consen   78 IAWGEYDDDAFLLLEFLEMG   97 (288)
T ss_dssp             EEEEE-SSCCEEEEE-----
T ss_pred             EEEEeecCCceEEEEeecCC
Confidence            88887777789999999776

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PLN02756 S-methyl-5-thioribose kinase

Probab=95.93  E-value=0.085  Score=52.83  Aligned_cols=80  Identities=11%  Similarity=0.135  Sum_probs=46.7

Q ss_pred             ccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCC---CCCccccceE
Q 011360          197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIR---HRNILPLLAH  273 (487)
Q Consensus       197 ~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~l~~~  273 (487)
                      .+.+|.|....||+...   .+..++||.-..+.....        ..-+....+...|+..|..+.   ..++.+++.+
T Consensus        37 ~~eiggGn~N~VyrV~~---~~~svVVKqa~p~~r~vg--------a~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~  105 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVS---SSGSFVIKQALPYIRCIG--------ESWPMTKERAYFEATALREHGRLCPDHVPEVYHF  105 (418)
T ss_pred             EEEcCCCceeeEEEEEc---CCccEEEEeCCccccCCC--------ccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEE
Confidence            56789999999999864   345688997532111000        000012233344455554442   2467777776


Q ss_pred             EecCCeeEEEEEecCC
Q 011360          274 MVRPDCHLLVYEFMKN  289 (487)
Q Consensus       274 ~~~~~~~~lv~E~~~~  289 (487)
                      +.  +..+++||++++
T Consensus       106 de--d~~vlvME~L~~  119 (418)
T PLN02756        106 DR--TMALIGMRYLEP  119 (418)
T ss_pred             CC--CCCEEEEeecCC
Confidence            65  456789999976

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=95.82  E-value=0.18  Score=49.03  Aligned_cols=30  Identities=27%  Similarity=0.372  Sum_probs=26.0

Q ss_pred             CCCeeecCCCCCCEEeCCCCCEEEeccCCcc
Q 011360          330 SASIIHGDIKPRNVLLNDDMEACISDLGLAM  360 (487)
Q Consensus       330 ~~givH~Dlkp~Nill~~~~~~kl~DFg~s~  360 (487)
                      ..+++|||+.+.||+++. +.+.|+||+.+.
T Consensus       186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            467999999999999987 578999999664

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PRK12396 5-methylribose kinase; Reviewed

Probab=95.77  E-value=0.032  Score=55.57  Aligned_cols=81  Identities=15%  Similarity=0.030  Sum_probs=47.9

Q ss_pred             ccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC--CCC-CccccceE
Q 011360          197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI--RHR-NILPLLAH  273 (487)
Q Consensus       197 ~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l--~hp-nIv~l~~~  273 (487)
                      .+.||.|....||++... ..++.|+||.-..+.        + ....-+....+..-|...|+..  -.| ++.++|. 
T Consensus        34 ~~eigdGnlN~VfrV~~~-~~~~svIVKQAlp~v--------R-v~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~-  102 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDE-QKNISVIVKQAGDTA--------R-ISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL-  102 (409)
T ss_pred             eeEcCCCceEEEEEEeeC-CCCceEEEEeccHhh--------c-cCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE-
Confidence            467899999999999752 135679999642211        1 0111123445556666666655  234 3444543 


Q ss_pred             EecCCeeEEEEEecCC
Q 011360          274 MVRPDCHLLVYEFMKN  289 (487)
Q Consensus       274 ~~~~~~~~lv~E~~~~  289 (487)
                       .++....+|||+++.
T Consensus       103 -~D~e~~~~vMEdL~~  117 (409)
T PRK12396        103 -FDSVMNCCVMEDLSD  117 (409)
T ss_pred             -ECcHHhhHHHHhCcc
Confidence             345566789998854

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=95.48  E-value=0.22  Score=48.44  Aligned_cols=32  Identities=13%  Similarity=0.269  Sum_probs=28.3

Q ss_pred             CCCeeecCCCCCCEEeCCCCCEEEeccCCccc
Q 011360          330 SASIIHGDIKPRNVLLNDDMEACISDLGLAMA  361 (487)
Q Consensus       330 ~~givH~Dlkp~Nill~~~~~~kl~DFg~s~~  361 (487)
                      ..+++|+|+.+.|+++++++.+.++||..+..
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            45799999999999999999999999987743

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=95.47  E-value=0.025  Score=57.30  Aligned_cols=47  Identities=26%  Similarity=0.305  Sum_probs=37.0

Q ss_pred             HHHHHHHHhccCCCCCccccceEEecC-CeeEEEEEecCCCCHHHHHhh
Q 011360          251 QIRSEIITASQIRHRNILPLLAHMVRP-DCHLLVYEFMKNGSLQDILDD  298 (487)
Q Consensus       251 ~~~~E~~~l~~l~hpnIv~l~~~~~~~-~~~~lv~E~~~~gsL~~~l~~  298 (487)
                      ++.-....++.+.|+|....+.+-... ....+|||++ +.||.+++..
T Consensus        28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~   75 (725)
T KOG1093|consen   28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKT   75 (725)
T ss_pred             HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHh
Confidence            455567788889999999998876643 4467899999 7799998864

>PLN02236 choline kinase

Probab=95.43  E-value=0.13  Score=50.99  Aligned_cols=33  Identities=18%  Similarity=0.320  Sum_probs=27.8

Q ss_pred             CCCCeeecCCCCCCEEeCC-CCCEEEeccCCccc
Q 011360          329 HSASIIHGDIKPRNVLLND-DMEACISDLGLAMA  361 (487)
Q Consensus       329 h~~givH~Dlkp~Nill~~-~~~~kl~DFg~s~~  361 (487)
                      +...++|+|+++.||++++ ++.+.++||..+..
T Consensus       198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             CCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            4557999999999999986 46799999988754

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.01  E-value=0.071  Score=51.88  Aligned_cols=75  Identities=13%  Similarity=0.107  Sum_probs=57.7

Q ss_pred             cCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEec
Q 011360          276 RPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISD  355 (487)
Q Consensus       276 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~D  355 (487)
                      +....|++|++- |+++...        ....+.++..++.+.+..+.-+..  .-..-|||+.-.||||+ +|++.|+|
T Consensus       297 e~~y~yl~~kdh-gt~is~i--------k~~~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~GnvtLID  364 (488)
T COG5072         297 ETLYLYLHFKDH-GTPISII--------KADRSEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EGNVTLID  364 (488)
T ss_pred             CceEEEEEEecC-Cceeeee--------ecccHHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cCceEEEE
Confidence            344567888876 6666422        335677888999998888877753  33478999999999999 99999999


Q ss_pred             cCCcccc
Q 011360          356 LGLAMAI  362 (487)
Q Consensus       356 Fg~s~~~  362 (487)
                      |-+++.-
T Consensus       365 fklsRl~  371 (488)
T COG5072         365 FKLSRLS  371 (488)
T ss_pred             eeeeecc
Confidence            9999843

>PF05659 RPW8: Arabidopsis broad-spectrum mildew resistance protein RPW8; InterPro: IPR008808 This entry represents the RPW8 domain found in several broad-spectrum mildew resistance proteins from Arabidopsis thaliana and other dicots

Probab=94.92  E-value=0.59  Score=39.84  Aligned_cols=107  Identities=10%  Similarity=0.157  Sum_probs=82.7

Q ss_pred             HHHHHHHHHHHHHHHHhHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHHhhccCC-ChhHHHHHHHhhhhhccchhhhh
Q 011360           20 SNFHSESIETILQKLTKDWLGQFARQAQIQADLIGWKTMMVKINKVLDDAIEKQTK-EEPVKIWLGKLQHLACDVDYLLD   98 (487)
Q Consensus        20 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~a~~~~~~-~~~~~~w~~~l~~~~yd~~~~~~   98 (487)
                      |-+.+|+++.+++.|-..+.........++.-++.|.+||.+|.-+++.-+.-... |.+-+.=+++|++..-++++++.
T Consensus         4 eL~~gaalG~~~~eLlk~v~~~~~k~~~fk~~l~~L~sTl~~i~P~i~eI~~~~~eld~~~~ee~e~L~~~L~~g~~LV~   83 (147)
T PF05659_consen    4 ELVGGAALGAVFGELLKAVIDASKKSLSFKSILKRLESTLESIIPIIKEIDKLNVELDRPRQEEIERLKELLEKGKELVE   83 (147)
T ss_pred             HHHHHHHHHHHHHHHHHHHHHHHHHHHhhhhHHHHHHHHHHHhhhHHHHHHHHhhhcCCchhHHHHHHHHHHHHHHHHHH
Confidence            44678889999999999999999999999999999999999999999998876553 44557778899999999999999


Q ss_pred             hhhhHHHHHHhhhchhhhhhHHHHHHHHH
Q 011360           99 EFQTEAFQTMLLQDADAMSKVKEVNARLQ  127 (487)
Q Consensus        99 ~~~~~~~~~~l~~~~~~~~r~~ei~~~l~  127 (487)
                      .+..-.+.... ....+..+++++.+.+.
T Consensus        84 k~sk~~r~n~~-kk~~y~~Ki~~le~~l~  111 (147)
T PF05659_consen   84 KCSKVRRWNLY-KKPRYARKIEELEESLR  111 (147)
T ss_pred             HhccccHHHHH-hhHhHHHHHHHHHHHHH
Confidence            88765432222 33345566666555444

Plant disease resistance (R) genes control the recognition of specific pathogens and activate subsequent defence responses. The R protein-mediated defences typically involve a rapid, localized necrosis, or hypersensitive response (HR), at the site of infection, and the localised formation of antimicrobial chemicals and proteins that restrict growth of the pathogen. The A. thaliana locus Resistance to Powdery Mildew 8 (RPW8) contains two naturally polymorphic, dominant R genes: RPW8.1 and RPW8.2, which individually control resistance to a broad range of powdery mildew pathogens. They induce localised, salicylic acid-dependent defences similar to those induced by R genes that control specific resistance. Apparently, broad-spectrum resistance mediated by RPW8 uses the same mechanisms as specific resistance [, ]. RPW8.1 and RPW8.2 share similarity with an ~150 amino acid module forming the N terminus of a group of disease resistance proteins, which have a nucleotide-binding site (NBS) and leucine-rich repeats (LRRs) [, ]. The RPW8 domain sequences contain a predicted N-terminal transmembrane (TM) region or possibly a signal peptide, and a coiled-coil (CC) motif [].

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=94.68  E-value=0.15  Score=50.26  Aligned_cols=31  Identities=19%  Similarity=0.305  Sum_probs=26.4

Q ss_pred             CeeecCCCCCCEEeCC-CCCEEEeccCCcccc
Q 011360          332 SIIHGDIKPRNVLLND-DMEACISDLGLAMAI  362 (487)
Q Consensus       332 givH~Dlkp~Nill~~-~~~~kl~DFg~s~~~  362 (487)
                      -++|.|+.+.||++++ ++.++++||..|..-
T Consensus       183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag~n  214 (330)
T PLN02421        183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYS  214 (330)
T ss_pred             EEEECCCCcccEEEeCCCCcEEEEcccccCCC
Confidence            4799999999999975 578999999988543

>PF12061 DUF3542: Protein of unknown function (DUF3542); InterPro: IPR021929 R1 is a gene for resistance to late blight, the most destructive disease in potato cultivation worldwide

Probab=94.65  E-value=0.072  Score=50.13  Aligned_cols=80  Identities=14%  Similarity=0.176  Sum_probs=66.2

Q ss_pred             HHHHHHHHHHHhHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHHh-hccCCChhHHHHHHHhhhhhccchhhhhhhhhH
Q 011360           25 ESIETILQKLTKDWLGQFARQAQIQADLIGWKTMMVKINKVLDDAI-EKQTKEEPVKIWLGKLQHLACDVDYLLDEFQTE  103 (487)
Q Consensus        25 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~a~-~~~~~~~~~~~w~~~l~~~~yd~~~~~~~~~~~  103 (487)
                      |.+..+|.+|-.....--..+--++.+|+..+.+|+++|.+|+... +...+...+..+..++-+.||..|+++|..-..
T Consensus       296 GyVdFlL~NLkdfq~rysdSlaflKnQiqvIQ~elesLqpFLk~V~ee~~nkh~~~ed~a~~ii~kAyevEYVVDaCi~k  375 (402)
T PF12061_consen  296 GYVDFLLKNLKDFQGRYSDSLAFLKNQIQVIQTELESLQPFLKHVVEEPHNKHDTNEDCATQIIRKAYEVEYVVDACISK  375 (402)
T ss_pred             cHHHHHHhhHHHHhccccchHHHHHHHHHHHHHHHHHhhHHHHHHHhccchhhhhhhhHHHHHHHHHhheeeeeehhhcC
Confidence            4567788888888777777777788899999999999999999984 445555559999999999999999999976444


Q ss_pred             H
Q 011360          104 A  104 (487)
Q Consensus       104 ~  104 (487)
                      .
T Consensus       376 ~  376 (402)
T PF12061_consen  376 S  376 (402)
T ss_pred             C
Confidence            3

The R1 gene belongs to the class of plant genes for pathogen resistance that have a leucine zipper motif, a putative nucleotide binding domain and a leucine-rich repeat domain []. Most proteins matching this entry are found associated with PF00931 from PFAM.

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=94.64  E-value=0.1  Score=51.60  Aligned_cols=60  Identities=18%  Similarity=0.190  Sum_probs=41.4

Q ss_pred             EEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC
Q 011360          281 LLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLND  347 (487)
Q Consensus       281 ~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~  347 (487)
                      .++=+|..|.++..++..     ...++....+++.--+.|+--+-  --.+++|.|+.|.||++-.
T Consensus       321 vl~E~~~~Gl~v~~~v~~-----~~~pe~l~kkva~lg~~AllkMl--~vDNFvHaDlHPGNVlirf  380 (565)
T KOG1236|consen  321 VLVETYERGLSVLRFVKW-----KSQPEALVKKVAKLGVNALLKML--IVDNFVHADLHPGNVLIRF  380 (565)
T ss_pred             eeeeeccccccHHhhhhc-----ccChHHHHHHHHHHHHHHHHHHH--HhhcceecccCCCcEEEEe
Confidence            456678889999988863     34455556666665555554432  2345999999999999953

>PRK11768 serine/threonine protein kinase; Provisional

Probab=94.23  E-value=1.1  Score=43.88  Aligned_cols=30  Identities=33%  Similarity=0.429  Sum_probs=25.2

Q ss_pred             CCCeeecCCCCCCEEeCCCCCEEEeccCCccc
Q 011360          330 SASIIHGDIKPRNVLLNDDMEACISDLGLAMA  361 (487)
Q Consensus       330 ~~givH~Dlkp~Nill~~~~~~kl~DFg~s~~  361 (487)
                      ..++||+|+.+.||+++ + .+.++||+.+..
T Consensus       195 ~~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~  224 (325)
T PRK11768        195 RLLRLHGDCHPGNILWR-D-GPHFVDLDDARM  224 (325)
T ss_pred             CccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence            56799999999999995 4 578999998753

>PRK06148 hypothetical protein; Provisional

Probab=93.49  E-value=0.89  Score=51.77  Aligned_cols=32  Identities=31%  Similarity=0.503  Sum_probs=26.9

Q ss_pred             CCCeeecCCCCCCEEeCCCC--CEE-EeccCCccc
Q 011360          330 SASIIHGDIKPRNVLLNDDM--EAC-ISDLGLAMA  361 (487)
Q Consensus       330 ~~givH~Dlkp~Nill~~~~--~~k-l~DFg~s~~  361 (487)
                      ..++||+|+.+.||+++.++  .+. |+|||.+..
T Consensus       202 p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        202 PAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             CcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            46799999999999999875  555 999998754

>PRK10271 thiK thiamine kinase; Provisional

Probab=92.06  E-value=0.12  Score=45.99  Aligned_cols=29  Identities=17%  Similarity=0.163  Sum_probs=25.7

Q ss_pred             CeeecCCCCCCEEeCCCCCEEEeccCCccc
Q 011360          332 SIIHGDIKPRNVLLNDDMEACISDLGLAMA  361 (487)
Q Consensus       332 givH~Dlkp~Nill~~~~~~kl~DFg~s~~  361 (487)
                      ..+|+|+.|.|+++++++ ++|+||+.+..
T Consensus        78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~  106 (188)
T PRK10271         78 APLHMDVHAGNLVHSASG-LRLIDWEYAGD  106 (188)
T ss_pred             eeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence            479999999999998887 89999998854

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	487
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-41
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-40
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-28
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-28
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		5e-28
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-27
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-21
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-21
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		8e-18
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-17
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		5e-17
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-16
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-16
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-16
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-16
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		4e-16
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		4e-16
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-16
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-16
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		7e-16
3a7f_A	303	Human Mst3 Kinase Length = 303		7e-16
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		5e-15
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		6e-15
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		8e-15
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		9e-15
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-14
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-14
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-14
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-14
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-14
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-14
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		4e-14
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		4e-14
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		6e-14
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		7e-14
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		8e-14
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		8e-14
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		8e-14
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		8e-14
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		9e-14
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		9e-14
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		9e-14
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-13
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-13
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-13
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-13
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-13
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-13
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-13
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-13
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-13
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-13
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-13
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-13
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-13
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-13
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-13
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		2e-13
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-13
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		2e-13
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-13
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-13
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-13
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-13
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-13
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-13
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-13
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-13
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-13
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-13
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-13
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-13
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-13
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-13
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-13
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		2e-13
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		3e-13
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-13
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		3e-13
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		3e-13
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		3e-13
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		3e-13
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		3e-13
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		3e-13
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-13
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		3e-13
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-13
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		4e-13
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		4e-13
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		4e-13
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		4e-13
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		4e-13
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		4e-13
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		4e-13
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-13
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		4e-13
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		4e-13
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-13
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		4e-13
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		4e-13
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		4e-13
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		4e-13
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		4e-13
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-13
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		4e-13
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		4e-13
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		4e-13
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		4e-13
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		4e-13
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		4e-13
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-13
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		4e-13
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		4e-13
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		4e-13
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		4e-13
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		5e-13
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		5e-13
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-13
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		5e-13
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		5e-13
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		5e-13
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		5e-13
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		5e-13
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		5e-13
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		5e-13
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		5e-13
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		5e-13
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		5e-13
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		5e-13
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		5e-13
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		5e-13
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		5e-13
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		5e-13
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-13
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		5e-13
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		5e-13
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		6e-13
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		6e-13
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		6e-13
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		6e-13
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		6e-13
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		6e-13
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		6e-13
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		6e-13
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		6e-13
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		6e-13
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		7e-13
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		7e-13
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		8e-13
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		8e-13
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		9e-13
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		9e-13
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		9e-13
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		9e-13
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		9e-13
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-12
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-12
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-12
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-12
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-12
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-12
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-12
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-12
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-12
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		3e-12
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		3e-12
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-12
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		3e-12
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-12
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		3e-12
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		4e-12
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		4e-12
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		4e-12
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-12
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		5e-12
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		5e-12
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		5e-12
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-12
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		6e-12
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-12
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-12
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		9e-12
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-11
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-11
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		1e-11
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		1e-11
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		1e-11
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		1e-11
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		1e-11
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		1e-11
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		1e-11
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-11
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-11
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-11
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-11
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-11
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-11
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-11
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-11
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-11
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		3e-11
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-11
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		3e-11
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		3e-11
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-11
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-11
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-11
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-11
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-11
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-11
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		3e-11
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		3e-11
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-11
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		3e-11
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		3e-11
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-11
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		3e-11
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		3e-11
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		4e-11
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		4e-11
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		4e-11
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		4e-11
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		4e-11
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		4e-11
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		4e-11
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-11
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		4e-11
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-11
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		4e-11
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		4e-11
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		4e-11
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		4e-11
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		4e-11
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		4e-11
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-11
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		5e-11
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		5e-11
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		5e-11
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-11
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		6e-11
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		6e-11
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		6e-11
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-11
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		6e-11
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		6e-11
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		6e-11
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		6e-11
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		6e-11
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		6e-11
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		7e-11
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		7e-11
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		7e-11
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		7e-11
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		7e-11
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-11
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		7e-11
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		7e-11
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		8e-11
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		8e-11
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		8e-11
2pl0_A	289	Lck Bound To Imatinib Length = 289		8e-11
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		8e-11
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-11
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		9e-11
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		9e-11
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		9e-11
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		9e-11
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-10
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-10
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		1e-10
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-10
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-10
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-10
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-10
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-10
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		1e-10
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-10
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-10
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-10
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-10
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-10
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-10
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-10
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-10
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-10
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-10
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-10
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-10
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-10
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-10
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-10
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-10
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-10
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-10
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-10
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		3e-10
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-10
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		3e-10
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		3e-10
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		3e-10
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-10
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		3e-10
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		4e-10
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		4e-10
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		4e-10
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		4e-10
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		4e-10
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		4e-10
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		4e-10
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-10
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		5e-10
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-10
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		5e-10
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		5e-10
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		6e-10
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		6e-10
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		6e-10
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		6e-10
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		7e-10
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		7e-10
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-10
3kk9_A	282	Camkii Substrate Complex B Length = 282		7e-10
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		7e-10
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		8e-10
3kk8_A	284	Camkii Substrate Complex A Length = 284		8e-10
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		8e-10
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		9e-10
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-10
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-09
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-09
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-09
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-09
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-09
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-09
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-09
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-09
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-09
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-09
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-09
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-09
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-09
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-09
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-09
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-09
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-09
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-09
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-09
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-09
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-09
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-09
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-09
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-09
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-09
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-09
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-09
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-09
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-09
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-09
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-09
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-09
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-09
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-09
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-09
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-09
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-09
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-09
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-09
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-09
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-09
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-09
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-09
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-09
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-09
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-09
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-09
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-09
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-09
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-09
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-09
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-09
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-09
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-09
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-09
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-09
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-09
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-09
3a4o_X	286	Lyn Kinase Domain Length = 286		3e-09
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		3e-09
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		3e-09
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		3e-09
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		3e-09
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		3e-09
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-09
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-09
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-09
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-09
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		4e-09
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		4e-09
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		4e-09
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		4e-09
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-09
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-09
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-09
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		4e-09
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-09
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		5e-09
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-09
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		5e-09
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		5e-09
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-09
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		5e-09
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		5e-09
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		5e-09
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		5e-09
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		5e-09
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		5e-09
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		5e-09
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		5e-09
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		5e-09
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		5e-09
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		5e-09
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		6e-09
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		6e-09
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		6e-09
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		6e-09
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		6e-09
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		6e-09
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		6e-09
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		6e-09
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		6e-09
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		7e-09
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		7e-09
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		8e-09
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		8e-09
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		9e-09
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		9e-09
3soa_A	444	Full-Length Human Camkii Length = 444		9e-09
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		9e-09
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		9e-09
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-08
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		1e-08
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-08
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		1e-08
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-08
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-08
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-08
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-08
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-08
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-08
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-08
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-08
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-08
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-08
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-08
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		2e-08
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-08
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-08
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-08
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-08
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-08
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-08
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-08
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-08
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-08
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-08
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-08
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-08
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-08
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-08
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-08
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-08
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-08
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-08
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-08
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-08
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		3e-08
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		3e-08
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-08
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		3e-08
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-08
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-08
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		3e-08
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-08
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		3e-08
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-08
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		3e-08
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		3e-08
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-08
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		3e-08
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		3e-08
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		3e-08
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		3e-08
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-08
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		3e-08
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		3e-08
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		3e-08
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		3e-08
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		3e-08
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		3e-08
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		3e-08
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		3e-08
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-08
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-08
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-08
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-08
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		3e-08
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		3e-08
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		3e-08
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		3e-08
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		3e-08
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-08
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		3e-08
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		3e-08
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		3e-08
2oza_B	366	Structure Of P38alpha Complex Length = 366		3e-08
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		3e-08
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		3e-08
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		3e-08
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		3e-08
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		3e-08
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-08
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		3e-08
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		3e-08
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		3e-08
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		3e-08
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		3e-08
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-08
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-08
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		3e-08
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-08
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		3e-08
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		3e-08
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		3e-08
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-08
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		4e-08
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		4e-08
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-08
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		4e-08
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		4e-08
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		4e-08
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		4e-08
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		4e-08
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		4e-08
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		4e-08
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		4e-08
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		4e-08
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		4e-08
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		4e-08
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		4e-08
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		4e-08
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		4e-08
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		4e-08
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		4e-08
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		4e-08
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		4e-08
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		4e-08
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		4e-08
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		4e-08
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		4e-08
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		4e-08
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		4e-08
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		4e-08
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		4e-08
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		4e-08
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		4e-08
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		4e-08
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		4e-08
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		5e-08
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-08
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		5e-08
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		5e-08
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		5e-08
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		5e-08
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		5e-08
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		5e-08
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		5e-08
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		5e-08
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		5e-08
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		5e-08
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		5e-08
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		5e-08
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		5e-08
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		5e-08
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		5e-08
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		5e-08
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		5e-08
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		5e-08
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		6e-08
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		6e-08
3hec_A	348	P38 In Complex With Imatinib Length = 348		6e-08
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		6e-08
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		6e-08
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		6e-08
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		6e-08
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		6e-08
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		6e-08
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		6e-08
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-08
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		6e-08
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		6e-08
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		6e-08
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		6e-08
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		6e-08
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		6e-08
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		6e-08
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		6e-08
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		6e-08
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		6e-08
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		6e-08
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		6e-08
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		7e-08
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		7e-08
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		7e-08
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		7e-08
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		7e-08
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		7e-08
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		7e-08
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		7e-08
2oza_A	356	Structure Of P38alpha Complex Length = 356		7e-08
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		7e-08
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		7e-08
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		7e-08
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		7e-08
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		8e-08
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		8e-08
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		8e-08
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		8e-08
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		8e-08
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		8e-08
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		8e-08
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		8e-08
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		8e-08
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-08
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		9e-08
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		9e-08
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		9e-08
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		9e-08
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-07
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-07
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-07
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-07
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-07
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-07
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		1e-07
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		1e-07
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-07
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-07
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-07
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		1e-07
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-07
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-07
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		1e-07
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-07
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-07
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-07
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		1e-07
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-07
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		1e-07
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-07
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-07
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-07
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-07
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-07
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		2e-07
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-07
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-07
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-07
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-07
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-07
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-07
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-07
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-07
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-07
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-07
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		2e-07
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-07
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-07
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-07
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-07
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-07
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-07
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-07
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-07
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-07
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-07
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-07
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-07
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-07
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-07
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-07
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-07
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-07
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-07
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-07
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-07
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-07
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-07
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		3e-07
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-07
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-07
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-07
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		3e-07
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		3e-07
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		3e-07
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-07
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		3e-07
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		3e-07
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		3e-07
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		3e-07
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-07
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		3e-07
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		3e-07
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-07
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		3e-07
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-07
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-07
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		3e-07
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		3e-07
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		3e-07
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		3e-07
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		3e-07
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		3e-07
4exu_A	371	Mapk13, Inactive Form Length = 371		3e-07
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		3e-07
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		3e-07
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-07
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		3e-07
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		3e-07
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		3e-07
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		4e-07
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		4e-07
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		4e-07
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		4e-07
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		4e-07
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		4e-07
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		4e-07
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		4e-07
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		4e-07
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		4e-07
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		4e-07
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		4e-07
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		4e-07
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		4e-07
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		4e-07
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		4e-07
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		4e-07
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		4e-07
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		4e-07
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		4e-07
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		4e-07
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		4e-07
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		4e-07
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		5e-07
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		5e-07
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		5e-07
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		5e-07
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		5e-07
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		5e-07
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-07
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		5e-07
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		5e-07
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		5e-07
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-07
3b2t_A	311	Structure Of Phosphotransferase Length = 311		5e-07
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		5e-07
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		5e-07
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		5e-07
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		5e-07
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		5e-07
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		6e-07
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		6e-07
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		6e-07
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		6e-07
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		6e-07
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		6e-07
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		6e-07
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		6e-07
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		6e-07
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		6e-07
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		6e-07
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		6e-07
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		7e-07
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		7e-07
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		7e-07
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		7e-07
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		7e-07
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		7e-07
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		8e-07
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		8e-07
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		8e-07
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		8e-07
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		8e-07
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		8e-07
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		8e-07
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		8e-07
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		9e-07
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		9e-07
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		9e-07
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		9e-07
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		9e-07
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		9e-07
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		9e-07
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		9e-07
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		9e-07
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		9e-07
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		9e-07
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		9e-07
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-06
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-06
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-06
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-06
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-06
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-06
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-06
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		1e-06
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-06
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-06
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-06
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-06
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-06
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-06
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-06
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-06
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-06
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-06
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-06
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-06
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-06
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-06
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-06
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-06
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-06
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		2e-06
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		2e-06
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		2e-06
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-06
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		2e-06
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-06
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-06
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-06
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		3e-06
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		3e-06
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		3e-06
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		3e-06
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-06
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		3e-06
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		3e-06
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		3e-06
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-06
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-06
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		3e-06
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		3e-06
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-06
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		4e-06
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-06
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		5e-06
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		5e-06
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		5e-06
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		5e-06
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		5e-06
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		5e-06
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		5e-06
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		5e-06
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		6e-06
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		6e-06
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		6e-06
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		6e-06
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		6e-06
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		6e-06
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		6e-06
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		7e-06
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		7e-06
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-05
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-05
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-05
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-05
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-05
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-05
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-05
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-05
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-05
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-05
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-05
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-05
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-05
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-05
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		3e-05
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		3e-05
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		3e-05
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-05
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-05
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		3e-05
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		3e-05
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		3e-05
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-05
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		4e-05
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-05
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		4e-05
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		4e-05
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		5e-05
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		5e-05
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		5e-05
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		6e-05
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		6e-05
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		6e-05
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		7e-05
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		8e-05
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		8e-05
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		8e-05
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		8e-05
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-05
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		8e-05
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		8e-05
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		9e-05
4fl3_A	635	Structural And Biophysical Characterization Of The		9e-05
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		9e-05
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		9e-05
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		9e-05
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		9e-05
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-04
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-04
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-04
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-04
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-04
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-04
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-04
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		1e-04
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		2e-04
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-04
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		2e-04
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		2e-04
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-04
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-04
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-04
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-04
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-04
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		3e-04
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		3e-04
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		3e-04
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		3e-04
3gni_B	389	Structure Of Strad And Mo25 Length = 389		3e-04
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-04
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		4e-04
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		6e-04
3sv0_A	483	Crystal Structure Of Casein Kinase-1 Like Protein I		6e-04
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		7e-04
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-04
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		8e-04
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-04
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		8e-04
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		8e-04
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-04
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		8e-04
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		9e-04
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		9e-04
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		9e-04
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		9e-04
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		9e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  166 bits (421), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 98/292 (33%), Positives = 162/292 (55%), Gaps = 20/292 (6%)
Query: 192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ 251
           D F++   +G GG G+VYK  L  ++G ++A+K++             ++ + +  +L Q
Sbjct: 38  DNFSNKNILGRGGFGKVYKGRL--ADGTLVAVKRL-------------KEERXQGGEL-Q 81
Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
            ++E+   S   HRN+L L    + P   LLVY +M NGS+   L +    +  LDWP R
Sbjct: 82  FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKR 141
Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLI 371
            RIALG A GL YLH +    IIH D+K  N+LL+++ EA + D GLA  + D     + 
Sbjct: 142 QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA-KLMDYKDXHVX 200
Query: 372 SYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ--NGEEICSPEWL 429
             V GT+ +IAPEY    + SEK D+F +G++L+ L+ G  +F   +  N +++   +W+
Sbjct: 201 XAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 260
Query: 430 RKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPN-SQYVR 480
           + ++  K     +D  L GN  ++++  ++++A +CT   P ERP  S+ VR
Sbjct: 261 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVR 312

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  164 bits (415), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 97/292 (33%), Positives = 160/292 (54%), Gaps = 20/292 (6%)
Query: 192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ 251
           D F +   +G GG G+VYK  L  ++G ++A+K++             ++ + +  +L Q
Sbjct: 30  DNFXNKNILGRGGFGKVYKGRL--ADGXLVAVKRL-------------KEERTQGGEL-Q 73
Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
            ++E+   S   HRN+L L    + P   LLVY +M NGS+   L +    +  LDWP R
Sbjct: 74  FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKR 133
Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLI 371
            RIALG A GL YLH +    IIH D+K  N+LL+++ EA + D GLA  + D     + 
Sbjct: 134 QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA-KLMDYKDXHVX 192
Query: 372 SYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ--NGEEICSPEWL 429
             V G + +IAPEY    + SEK D+F +G++L+ L+ G  +F   +  N +++   +W+
Sbjct: 193 XAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252
Query: 430 RKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPN-SQYVR 480
           + ++  K     +D  L GN  ++++  ++++A +CT   P ERP  S+ VR
Sbjct: 253 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVR 304

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 81/220 (36%), Positives = 118/220 (53%), Gaps = 19/220 (8%)
Query: 199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT 258
           K+G GG G VYK  +   N   +A+KK+     I+  EL +           Q   EI  
Sbjct: 38  KMGEGGFGVVYKGYV---NNTTVAVKKLAAMVDITTEELKQ-----------QFDQEIKV 83
Query: 259 ASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV 318
            ++ +H N++ LL      D   LVY +M NGSL D L  +  G   L W  R +IA G 
Sbjct: 84  MAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGA 142
Query: 319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTM 378
           A+G+ +LH  H    IH DIK  N+LL++   A ISD GLA A       V+ S ++GT 
Sbjct: 143 ANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTT 199
Query: 379 AYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ 418
           AY+APE   + E++ K DI+SFG++L+ ++ G+P+   H+
Sbjct: 200 AYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHR 238

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 80/220 (36%), Positives = 117/220 (53%), Gaps = 19/220 (8%)
Query: 199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT 258
           K+G GG G VYK  +   N   +A+KK+     I+  EL +           Q   EI  
Sbjct: 38  KMGEGGFGVVYKGYV---NNTTVAVKKLAAMVDITTEELKQ-----------QFDQEIKV 83
Query: 259 ASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV 318
            ++ +H N++ LL      D   LVY +M NGSL D L  +  G   L W  R +IA G 
Sbjct: 84  MAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGA 142
Query: 319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTM 378
           A+G+ +LH  H    IH DIK  N+LL++   A ISD GLA A       V+   ++GT 
Sbjct: 143 ANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTT 199
Query: 379 AYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ 418
           AY+APE   + E++ K DI+SFG++L+ ++ G+P+   H+
Sbjct: 200 AYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHR 238

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  122 bits (306), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 80/220 (36%), Positives = 117/220 (53%), Gaps = 19/220 (8%)
Query: 199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT 258
           K+G GG G VYK  +   N   +A+KK+     I+  EL +           Q   EI  
Sbjct: 32  KMGEGGFGVVYKGYV---NNTTVAVKKLAAMVDITTEELKQ-----------QFDQEIKV 77
Query: 259 ASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV 318
            ++ +H N++ LL      D   LVY +M NGSL D L  +  G   L W  R +IA G 
Sbjct: 78  MAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGA 136
Query: 319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTM 378
           A+G+ +LH  H    IH DIK  N+LL++   A ISD GLA A       V+   ++GT 
Sbjct: 137 ANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTT 193
Query: 379 AYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ 418
           AY+APE   + E++ K DI+SFG++L+ ++ G+P+   H+
Sbjct: 194 AYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHR 232

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 80/220 (36%), Positives = 114/220 (51%), Gaps = 19/220 (8%)
Query: 199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT 258
           K G GG G VYK  +   N   +A+KK+     I+  EL +           Q   EI  
Sbjct: 29  KXGEGGFGVVYKGYV---NNTTVAVKKLAAMVDITTEELKQ-----------QFDQEIKV 74
Query: 259 ASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV 318
            ++ +H N++ LL      D   LVY +  NGSL D L  +  G   L W  R +IA G 
Sbjct: 75  XAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLD-GTPPLSWHXRCKIAQGA 133
Query: 319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTM 378
           A+G+ +LH  H    IH DIK  N+LL++   A ISD GLA A       V  S ++GT 
Sbjct: 134 ANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTT 190
Query: 379 AYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ 418
           AY APE   + E++ K DI+SFG++L+ ++ G+P+   H+
Sbjct: 191 AYXAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHR 229

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 107/216 (49%), Gaps = 3/216 (1%)
Query: 260 SQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVA 319
           S  RH +++ L+      +  +L+Y++M+NG+L+  L         + W  R  I +G A
Sbjct: 90  SFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAA 149
Query: 320 SGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMA 379
            GL YLH   + +IIH D+K  N+LL+++    I+D G++    +     L   V GT+ 
Sbjct: 150 RGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLG 206
Query: 380 YIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSKNPS 439
           YI PEYF +  L+EK D++SFG++L  ++    + V     E +   EW  +  N+    
Sbjct: 207 YIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE 266
Query: 440 RAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPN 475
           + +DP L      + +      A  C     E+RP+
Sbjct: 267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPS 302

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 79/276 (28%), Positives = 132/276 (47%), Gaps = 20/276 (7%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           IG G  G+VYK  L   +G  +A+K+     P S+              + +  +EI T 
Sbjct: 47  IGHGVFGKVYKGVL--RDGAKVALKR---RTPESS------------QGIEEFETEIETL 89
Query: 260 SQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVA 319
           S  RH +++ L+      +  +L+Y++M+NG+L+  L         + W  R  I +G A
Sbjct: 90  SFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAA 149
Query: 320 SGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMA 379
            GL YLH   + +IIH D+K  N+LL+++    I+D G++    +     L   V GT+ 
Sbjct: 150 RGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLG 206
Query: 380 YIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSKNPS 439
           YI PEYF +  L+EK D++SFG++L  ++    + V     E +   EW  +  N+    
Sbjct: 207 YIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE 266
Query: 440 RAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPN 475
           + +DP L      + +      A  C     E+RP+
Sbjct: 267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPS 302

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 117/233 (50%), Gaps = 27/233 (11%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           +  ++K+G GG   VY AE    N K +AIK + +              + ++  L++  
Sbjct: 13  YKIVDKLGGGGMSTVYLAEDTILNIK-VAIKAIFI------------PPREKEETLKRFE 59
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
            E+  +SQ+ H+NI+ ++      DC+ LV E+++  +L + ++  S G   +D      
Sbjct: 60  REVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIE--SHGPLSVDT----- 112
Query: 314 IALGVASG-LEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLIS 372
            A+   +  L+ +   H   I+H DIKP+N+L++ +    I D G+A A+ +  +    +
Sbjct: 113 -AINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET-SLTQTN 170
Query: 373 YVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICS 425
           +VLGT+ Y +PE  +     E  DI+S G++L  ++ G P F    NGE   S
Sbjct: 171 HVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPF----NGETAVS 219

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 105/211 (49%), Gaps = 20/211 (9%)
Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           EKIG+G  G V++AE  GS+   +A+K            L+E+D      ++ +   E+ 
Sbjct: 43  EKIGAGSFGTVHRAEWHGSD---VAVKI-----------LMEQD--FHAERVNEFLREVA 86
Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALG 317
              ++RH NI+  +  + +P    +V E++  GSL  +L   S  R +LD   R  +A  
Sbjct: 87  IMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-SGAREQLDERRRLSMAYD 145
Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGT 377
           VA G+ YLH   +  I+H D+K  N+L++      + D GL+      +  +      GT
Sbjct: 146 VAKGMNYLH-NRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXF--LXSKXAAGT 202
Query: 378 MAYIAPEYFQQPELSEKCDIFSFGMLLISLV 408
             ++APE  +    +EK D++SFG++L  L 
Sbjct: 203 PEWMAPEVLRDEPSNEKSDVYSFGVILWELA 233

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 105/211 (49%), Gaps = 20/211 (9%)
Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           EKIG+G  G V++AE  GS+   +A+K            L+E+D      ++ +   E+ 
Sbjct: 43  EKIGAGSFGTVHRAEWHGSD---VAVKI-----------LMEQD--FHAERVNEFLREVA 86
Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALG 317
              ++RH NI+  +  + +P    +V E++  GSL  +L   S  R +LD   R  +A  
Sbjct: 87  IMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-SGAREQLDERRRLSMAYD 145
Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGT 377
           VA G+ YLH   +  I+H ++K  N+L++      + D GL+       T +      GT
Sbjct: 146 VAKGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGT 202
Query: 378 MAYIAPEYFQQPELSEKCDIFSFGMLLISLV 408
             ++APE  +    +EK D++SFG++L  L 
Sbjct: 203 PEWMAPEVLRDEPSNEKSDVYSFGVILWELA 233

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 136/300 (45%), Gaps = 48/300 (16%)
Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           ++IG GG G V+K  L   +  ++AIK +I+       E+IE        K ++ + E+ 
Sbjct: 25  KQIGKGGFGLVHKGRLV-KDKSVVAIKSLILGDSEGETEMIE--------KFQEFQREVF 75
Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALG 317
             S + H NI+ L   M  P    +V EF+  G L   L D +     + W  + R+ L 
Sbjct: 76  IMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAH---PIKWSVKLRLMLD 130
Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLL-----NDDMEACISDLGLAMAIPDGYTRVLIS 372
           +A G+EY+    +  I+H D++  N+ L     N  + A ++D GL+       +   +S
Sbjct: 131 IALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-----SVHSVS 184
Query: 373 YVLGTMAYIAPEYF--QQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGE----EICSP 426
            +LG   ++APE    ++   +EK D +SF M+L +++ G   F  +  G+     +   
Sbjct: 185 GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE 244
Query: 427 EWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL 486
           E LR  +    P R                 +  +  +C   DP++RP+  Y+   LS+L
Sbjct: 245 EGLRPTIPEDCPPR-----------------LRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/237 (29%), Positives = 117/237 (49%), Gaps = 31/237 (13%)
Query: 182 KEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEED 241
           +E+L F    + +  LEK+G G  G VYKA+   S G+++A+K++          L  ED
Sbjct: 11  RENLYFQGLMEKYQKLEKVGEGTYGVVYKAK--DSQGRIVALKRI---------RLDAED 59
Query: 242 SKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSR 301
             +  + +R    EI    ++ H NI+ L+  +    C  LV+EFM+   L+ +LD+   
Sbjct: 60  EGIPSTAIR----EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKT 114
Query: 302 GRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMA 361
           G ++       +I + +   L  +   H   I+H D+KP+N+L+N D    ++D GLA A
Sbjct: 115 GLQD------SQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARA 168
Query: 362 --IP-DGYTRVLISYVLGTMAYIAPEYFQ-QPELSEKCDIFSFGMLLISLVRGVPSF 414
             IP   YT  ++     T+ Y AP+      + S   DI+S G +   ++ G P F
Sbjct: 169 FGIPVRSYTHEVV-----TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLF 220

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/237 (29%), Positives = 117/237 (49%), Gaps = 31/237 (13%)
Query: 182 KEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEED 241
           +E+L F    + +  LEK+G G  G VYKA+   S G+++A+K++          L  ED
Sbjct: 11  RENLYFQGLMEKYQKLEKVGEGTYGVVYKAK--DSQGRIVALKRI---------RLDAED 59
Query: 242 SKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSR 301
             +  + +R    EI    ++ H NI+ L+  +    C  LV+EFM+   L+ +LD+   
Sbjct: 60  EGIPSTAIR----EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKT 114
Query: 302 GRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMA 361
           G ++       +I + +   L  +   H   I+H D+KP+N+L+N D    ++D GLA A
Sbjct: 115 GLQD------SQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARA 168
Query: 362 --IP-DGYTRVLISYVLGTMAYIAPEYFQ-QPELSEKCDIFSFGMLLISLVRGVPSF 414
             IP   YT  ++     T+ Y AP+      + S   DI+S G +   ++ G P F
Sbjct: 169 FGIPVRSYTHEVV-----TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLF 220

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 108/232 (46%), Gaps = 26/232 (11%)
Query: 183 EDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDS 242
           ED    + E+ F  LEK+G G  G VYKA +    G+++AIK+V V              
Sbjct: 20  EDSLTKQPEEVFDVLEKLGEGSYGSVYKA-IHKETGQIVAIKQVPV-------------- 64
Query: 243 KLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG 302
              +S L++I  EI    Q    +++       +     +V E+   GS+ DI+   ++ 
Sbjct: 65  ---ESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT 121
Query: 303 RRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI 362
             E +  +   I      GLEYLH       IH DIK  N+LLN +  A ++D G+A  +
Sbjct: 122 LTEDEIAT---ILQSTLKGLEYLHFMRK---IHRDIKAGNILLNTEGHAKLADFGVAGQL 175
Query: 363 PDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
            D   +   + V+GT  ++APE  Q+   +   DI+S G+  I +  G P +
Sbjct: 176 TDXMAKR--NXVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPY 225

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 84/297 (28%), Positives = 132/297 (44%), Gaps = 43/297 (14%)
Query: 183 EDLAF--LKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEE 240
           E+L F  +  E+ F  LEKIG G  GEV+K  +     K++AIK +              
Sbjct: 16  ENLYFQSMDPEELFTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKII-------------- 60
Query: 241 DSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVS 300
           D +  + ++  I+ EI   SQ     +       ++     ++ E++  GS  D+L+   
Sbjct: 61  DLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-- 118
Query: 301 RGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAM 360
                LD      I   +  GL+YLH   S   IH DIK  NVLL++  E  ++D G+A 
Sbjct: 119 ---GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAG 172
Query: 361 AIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNG 420
            + D  T++  +  +GT  ++APE  +Q     K DI+S G+  I L RG P    H   
Sbjct: 173 QLTD--TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP---HSE- 226
Query: 421 EEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQ 477
                P  +  ++   NP     P L GN Y K +   ++    C   +P  RP ++
Sbjct: 227 ---LHPMKVLFLIPKNNP-----PTLEGN-YSKPLKEFVE---ACLNKEPSFRPTAK 271

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 135/300 (45%), Gaps = 48/300 (16%)
Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           ++IG GG G V+K  L   +  ++AIK +I+       E+IE        K ++ + E+ 
Sbjct: 25  KQIGKGGFGLVHKGRLV-KDKSVVAIKSLILGDSEGETEMIE--------KFQEFQREVF 75
Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALG 317
             S + H NI+ L   M  P    +V EF+  G L   L D +     + W  + R+ L 
Sbjct: 76  IMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAH---PIKWSVKLRLMLD 130
Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLL-----NDDMEACISDLGLAMAIPDGYTRVLIS 372
           +A G+EY+    +  I+H D++  N+ L     N  + A ++D G +       +   +S
Sbjct: 131 IALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQ-----SVHSVS 184
Query: 373 YVLGTMAYIAPEYF--QQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGE----EICSP 426
            +LG   ++APE    ++   +EK D +SF M+L +++ G   F  +  G+     +   
Sbjct: 185 GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE 244
Query: 427 EWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL 486
           E LR  +    P R                 +  +  +C   DP++RP+  Y+   LS+L
Sbjct: 245 EGLRPTIPEDCPPR-----------------LRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 105/225 (46%), Gaps = 25/225 (11%)
Query: 188 LKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDS 247
           L  E+ F  LEKIG G  GEV+K  +     K++AIK +              D +  + 
Sbjct: 3   LDPEELFTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKII--------------DLEEAED 47
Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELD 307
           ++  I+ EI   SQ     +       ++     ++ E++  GS  D+L+        LD
Sbjct: 48  EIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-----GPLD 102
Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
                 I   +  GL+YLH   S   IH DIK  NVLL++  E  ++D G+A  + D  T
Sbjct: 103 ETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD--T 157
Query: 368 RVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVP 412
           ++  +  +GT  ++APE  +Q     K DI+S G+  I L RG P
Sbjct: 158 QIKRNXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEP 202

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 82/290 (28%), Positives = 128/290 (44%), Gaps = 41/290 (14%)
Query: 188 LKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDS 247
           L  E+ F  LEKIG G  GEV+K  +     K++AIK +              D +  + 
Sbjct: 3   LDPEELFTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKII--------------DLEEAED 47
Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELD 307
           ++  I+ EI   SQ     +       ++     ++ E++  GS  D+L+        LD
Sbjct: 48  EIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-----GPLD 102
Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
                 I   +  GL+YLH   S   IH DIK  NVLL++  E  ++D G+A  + D  T
Sbjct: 103 ETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD--T 157
Query: 368 RVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPE 427
           ++  +  +GT  ++APE  +Q     K DI+S G+  I L RG P    H        P 
Sbjct: 158 QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP---HSE----LHPM 210
Query: 428 WLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQ 477
            +  ++   NP     P L GN Y K +   ++    C   +P  RP ++
Sbjct: 211 KVLFLIPKNNP-----PTLEGN-YSKPLKEFVE---ACLNKEPSFRPTAK 251

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 135/300 (45%), Gaps = 48/300 (16%)
Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           ++IG GG G V+K  L   +  ++AIK +I+       E+IE        K ++ + E+ 
Sbjct: 25  KQIGKGGFGLVHKGRL-VKDKSVVAIKSLILGDSEGETEMIE--------KFQEFQREVF 75
Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALG 317
             S + H NI+ L   M  P    +V EF+  G L   L D +     + W  + R+ L 
Sbjct: 76  IMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAH---PIKWSVKLRLMLD 130
Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLL-----NDDMEACISDLGLAMAIPDGYTRVLIS 372
           +A G+EY+    +  I+H D++  N+ L     N  + A ++D  L+       +   +S
Sbjct: 131 IALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQ-----SVHSVS 184
Query: 373 YVLGTMAYIAPEYF--QQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGE----EICSP 426
            +LG   ++APE    ++   +EK D +SF M+L +++ G   F  +  G+     +   
Sbjct: 185 GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE 244
Query: 427 EWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL 486
           E LR  +    P R                 +  +  +C   DP++RP+  Y+   LS+L
Sbjct: 245 EGLRPTIPEDCPPR-----------------LRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 104/222 (46%), Gaps = 25/222 (11%)
Query: 191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
           E+ F  LEKIG G  GEV+K  +     K++AIK +              D +  + ++ 
Sbjct: 21  EELFTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKII--------------DLEEAEDEIE 65
Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPS 310
            I+ EI   SQ     +       ++     ++ E++  GS  D+L+        LD   
Sbjct: 66  DIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-----GPLDETQ 120
Query: 311 RHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVL 370
              I   +  GL+YLH   S   IH DIK  NVLL++  E  ++D G+A  + D  T++ 
Sbjct: 121 IATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIK 175
Query: 371 ISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVP 412
            +  +GT  ++APE  +Q     K DI+S G+  I L RG P
Sbjct: 176 RNXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEP 217

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 86/288 (29%), Positives = 127/288 (44%), Gaps = 56/288 (19%)
Query: 182 KEDLAFLKKEDCFASLEKIGSGGCGEVY--KAELPGSNGKMIAIKKVIVYAPISAAELIE 239
           +E+L F    D +  ++K+GSG  GEV   K +L G+   +  IKK  V    ++  L++
Sbjct: 11  RENLYFQGLSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLD 70
Query: 240 EDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQD--ILD 297
           E + L+               Q+ H NI+ L         + LV E  + G L D  IL 
Sbjct: 71  EVAVLK---------------QLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIIL- 114
Query: 298 DVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLND---DMEACIS 354
                R++        I   V SG  YLH ++   I+H D+KP N+LL     D    I 
Sbjct: 115 -----RQKFSEVDAAVIMKQVLSGTTYLHKHN---IVHRDLKPENLLLESKSRDALIKIV 166
Query: 355 DLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
           D GL+     G     +   LGT  YIAPE  ++ +  EKCD++S G++L  L+ G P F
Sbjct: 167 DFGLSAHFEVGGK---MKERLGTAYYIAPEVLRK-KYDEKCDVWSCGVILYILLCGYPPF 222
Query: 415 VFHQNGEEICS-----------PEW---------LRKVMNSKNPSRAI 442
              Q  +EI             P+W         L K+M +  PS+ I
Sbjct: 223 G-GQTDQEILKRVEKGKFSFDPPDWTQVSDEAKQLVKLMLTYEPSKRI 269

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 125/283 (44%), Gaps = 42/283 (14%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           +   EKIG G  G VY A +  + G+ +AI+++ +                +  K   I 
Sbjct: 22  YTRFEKIGQGASGTVYTA-MDVATGQEVAIRQMNLQ---------------QQPKKELII 65
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
           +EI+   + ++ NI+  L   +  D   +V E++  GSL D++ +              +
Sbjct: 66  NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM--------DEGQ 117
Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI-PDGYTRVLIS 372
           IA      L+ L   HS  +IH DIK  N+LL  D    ++D G    I P+   R   S
Sbjct: 118 IAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---S 174
Query: 373 YVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPS----------FVFHQNGE- 421
            ++GT  ++APE   +     K DI+S G++ I ++ G P           ++   NG  
Sbjct: 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP 234
Query: 422 EICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKML--HVLKIA 462
           E+ +PE L  +      +R +D  +   G  K++L    LKIA
Sbjct: 235 ELQNPEKLSAIFRD-FLNRCLDMDVEKRGSAKELLQHQFLKIA 276

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 125/283 (44%), Gaps = 42/283 (14%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           +   EKIG G  G VY A +  + G+ +AI+++ +                +  K   I 
Sbjct: 22  YTRFEKIGQGASGTVYTA-MDVATGQEVAIRQMNLQ---------------QQPKKELII 65
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
           +EI+   + ++ NI+  L   +  D   +V E++  GSL D++ +              +
Sbjct: 66  NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM--------DEGQ 117
Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI-PDGYTRVLIS 372
           IA      L+ L   HS  +IH DIK  N+LL  D    ++D G    I P+   R   S
Sbjct: 118 IAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---S 174
Query: 373 YVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPS----------FVFHQNGE- 421
            ++GT  ++APE   +     K DI+S G++ I ++ G P           ++   NG  
Sbjct: 175 EMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP 234
Query: 422 EICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKML--HVLKIA 462
           E+ +PE L  +      +R +D  +   G  K++L    LKIA
Sbjct: 235 ELQNPEKLSAIFRD-FLNRCLDMDVEKRGSAKELLQHQFLKIA 276

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 102/223 (45%), Gaps = 28/223 (12%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           +   EKIG G  G VY A +  + G+ +AI+++ +                +  K   I 
Sbjct: 22  YTRFEKIGQGASGTVYTA-MDVATGQEVAIRQMNLQ---------------QQPKKELII 65
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
           +EI+   + ++ NI+  L   +  D   +V E++  GSL D++ +              +
Sbjct: 66  NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM--------DEGQ 117
Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI-PDGYTRVLIS 372
           IA      L+ L   HS  +IH DIK  N+LL  D    ++D G    I P+   R   S
Sbjct: 118 IAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---S 174
Query: 373 YVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFV 415
            ++GT  ++APE   +     K DI+S G++ I ++ G P ++
Sbjct: 175 XMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL 217

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/237 (31%), Positives = 112/237 (47%), Gaps = 22/237 (9%)
Query: 192 DCFASLEKIGSGGCGEVYKA-ELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
           + +  + K+GSG  GEV    E  G + K I   KVI  +         +D+K  +    
Sbjct: 36  ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAI---KVIKKSQFDKGRY-SDDNKNIEKFHE 91
Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSL-QDILDDVSRGRRELDWP 309
           +I +EI     + H NI+ L           LV EF + G L + I++     R + D  
Sbjct: 92  EIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN-----RHKFDEC 146
Query: 310 SRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLL---NDDMEACISDLGLAMAIPDGY 366
               I   + SG+ YLH +   +I+H DIKP N+LL   N  +   I D GL+      Y
Sbjct: 147 DAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY 203
Query: 367 TRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI 423
               +   LGT  YIAPE  ++   +EKCD++S G+++  L+ G P F   QN ++I
Sbjct: 204 K---LRDRLGTAYYIAPEVLKKK-YNEKCDVWSCGVIMYILLCGYPPFG-GQNDQDI 255

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 102/223 (45%), Gaps = 28/223 (12%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           +   EKIG G  G VY A +  + G+ +AI+++ +                +  K   I 
Sbjct: 23  YTRFEKIGQGASGTVYTA-MDVATGQEVAIRQMNLQ---------------QQPKKELII 66
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
           +EI+   + ++ NI+  L   +  D   +V E++  GSL D++ +              +
Sbjct: 67  NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM--------DEGQ 118
Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI-PDGYTRVLIS 372
           IA      L+ L   HS  +IH DIK  N+LL  D    ++D G    I P+   R   S
Sbjct: 119 IAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---S 175
Query: 373 YVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFV 415
            ++GT  ++APE   +     K DI+S G++ I ++ G P ++
Sbjct: 176 XMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL 218

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 100/217 (46%), Gaps = 39/217 (17%)
Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           E +G G  G V KA+      K +AIK++            E + K    +LRQ+     
Sbjct: 15  EVVGRGAFGVVCKAKW---RAKDVAIKQIES----------ESERKAFIVELRQL----- 56
Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVS-----RGRRELDWPSRH 312
             S++ H NI+ L    + P C  LV E+ + GSL ++L              + W    
Sbjct: 57  --SRVNHPNIVKLYGACLNPVC--LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW---- 108
Query: 313 RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC-ISDLGLAMAIPDGYTRVLI 371
              L  + G+ YLH     ++IH D+KP N+LL        I D G A  I     +  +
Sbjct: 109 --CLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI-----QTHM 161
Query: 372 SYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLV 408
           +   G+ A++APE F+    SEKCD+FS+G++L  ++
Sbjct: 162 TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVI 198

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 100/217 (46%), Gaps = 39/217 (17%)
Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           E +G G  G V KA+      K +AIK++            E + K    +LRQ+     
Sbjct: 14  EVVGRGAFGVVCKAKW---RAKDVAIKQIES----------ESERKAFIVELRQL----- 55
Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVS-----RGRRELDWPSRH 312
             S++ H NI+ L    + P C  LV E+ + GSL ++L              + W    
Sbjct: 56  --SRVNHPNIVKLYGACLNPVC--LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW---- 107
Query: 313 RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC-ISDLGLAMAIPDGYTRVLI 371
              L  + G+ YLH     ++IH D+KP N+LL        I D G A  I     +  +
Sbjct: 108 --CLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI-----QTHM 160
Query: 372 SYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLV 408
           +   G+ A++APE F+    SEKCD+FS+G++L  ++
Sbjct: 161 TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVI 197

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 83/278 (29%), Positives = 122/278 (43%), Gaps = 56/278 (20%)
Query: 192 DCFASLEKIGSGGCGEVY--KAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKL 249
           D +  ++K+GSG  GEV   K +L G+   +  IKK  V    ++  L++E + L+    
Sbjct: 4   DRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLK---- 59
Query: 250 RQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQD--ILDDVSRGRRELD 307
                      Q+ H NI+ L         + LV E  + G L D  IL      R++  
Sbjct: 60  -----------QLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIIL------RQKFS 102
Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLND---DMEACISDLGLAMAIPD 364
                 I   V SG  YLH +   +I+H D+KP N+LL     D    I D GL+     
Sbjct: 103 EVDAAVIMKQVLSGTTYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEV 159
Query: 365 GYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEIC 424
           G     +   LGT  YIAPE  ++ +  EKCD++S G++L  L+ G P F   Q  +EI 
Sbjct: 160 GGK---MKERLGTAYYIAPEVLRK-KYDEKCDVWSCGVILYILLCGYPPFG-GQTDQEIL 214
Query: 425 S-----------PEW---------LRKVMNSKNPSRAI 442
                       P+W         L K+M +  PS+ I
Sbjct: 215 KRVEKGKFSFDPPDWTQVSDEAKQLVKLMLTYEPSKRI 252

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 102/223 (45%), Gaps = 28/223 (12%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           +   EKIG G  G VY A +  + G+ +AI+++ +                +  K   I 
Sbjct: 23  YTRFEKIGQGASGTVYTA-MDVATGQEVAIRQMNLQ---------------QQPKKELII 66
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
           +EI+   + ++ NI+  L   +  D   +V E++  GSL D++ +              +
Sbjct: 67  NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM--------DEGQ 118
Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI-PDGYTRVLIS 372
           IA      L+ L   HS  +IH +IK  N+LL  D    ++D G    I P+   R   S
Sbjct: 119 IAAVCRECLQALEFLHSNQVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---S 175
Query: 373 YVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFV 415
            ++GT  ++APE   +     K DI+S G++ I ++ G P ++
Sbjct: 176 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL 218

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 91/222 (40%), Gaps = 24/222 (10%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  G VY A       K I   KV+    +  A +             Q+R E+   
Sbjct: 20  LGKGKFGNVYLAR--ERQSKFILALKVLFKTQLEKAGVEH-----------QLRREVEIQ 66
Query: 260 SQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVA 319
           S +RH NIL L  +        L+ E+   G++   L  +SR           R A  + 
Sbjct: 67  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRF-------DEQRTATYIT 119
Query: 320 SGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMA 379
                L   HS  +IH DIKP N+LL  + E  I+D G ++  P      L     GT+ 
Sbjct: 120 ELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTTLC----GTLD 175
Query: 380 YIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGE 421
           Y+ PE  +     EK D++S G+L    + G+P F  H   E
Sbjct: 176 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQE 217

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 91/222 (40%), Gaps = 24/222 (10%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  G VY A       K I   KV+    +  A +             Q+R E+   
Sbjct: 20  LGKGKFGNVYLAR--ERQSKFILALKVLFKTQLEKAGVEH-----------QLRREVEIQ 66
Query: 260 SQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVA 319
           S +RH NIL L  +        L+ E+   G++   L  +SR           R A  + 
Sbjct: 67  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRF-------DEQRTATYIT 119
Query: 320 SGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMA 379
                L   HS  +IH DIKP N+LL  + E  I+D G ++  P      L     GT+ 
Sbjct: 120 ELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDTLC----GTLD 175
Query: 380 YIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGE 421
           Y+ PE  +     EK D++S G+L    + G+P F  H   E
Sbjct: 176 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQE 217

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 89/215 (41%), Gaps = 24/215 (11%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  G VY A     N K I   KV+  A +  A +             Q+R E+   
Sbjct: 16  LGKGKFGNVYLAR--EKNSKFILALKVLFKAQLEKAGVEH-----------QLRREVEIQ 62
Query: 260 SQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVA 319
           S +RH NIL L  +        L+ E+   G++   L  +S+           R A  + 
Sbjct: 63  SHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKF-------DEQRTATYIT 115
Query: 320 SGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMA 379
                L   HS  +IH DIKP N+LL    E  I+D G ++  P      L     GT+ 
Sbjct: 116 ELANALSYCHSKKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALC----GTLD 171
Query: 380 YIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
           Y+ PE  +     EK D++S G+L    + G P F
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 65/245 (26%), Positives = 114/245 (46%), Gaps = 35/245 (14%)
Query: 178 PLIEKEDLAFLKKEDCFAS--LEKIGSGGCGEVYKAEL----PGSNGKMIAIKKVIVYAP 231
           PLI +   A LK+    A   +E++G    G+VYK  L    PG   + +AIK +   A 
Sbjct: 10  PLINQHKQAKLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA- 68
Query: 232 ISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGS 291
                    +  LR+    + R E +  ++++H N++ LL  + +     +++ +  +G 
Sbjct: 69  ---------EGPLRE----EFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGD 115
Query: 292 LQDIL------------DDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIK 339
           L + L            DD    +  L+ P    +   +A+G+EYL  +H   ++H D+ 
Sbjct: 116 LHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLA 172
Query: 340 PRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFS 399
            RNVL+ D +   ISDLGL   +       L+   L  + ++APE     + S   DI+S
Sbjct: 173 TRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWS 232
Query: 400 FGMLL 404
           +G++L
Sbjct: 233 YGVVL 237

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 107/229 (46%), Gaps = 27/229 (11%)
Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           ++IGSG  G VYK +  G     +A+K + V AP                +L+  ++E+ 
Sbjct: 41  QRIGSGSFGTVYKGKWHGD----VAVKMLNVTAPTP-------------QQLQAFKNEVG 83
Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALG 317
              + RH NIL  + +  +P    +V ++ +  SL   L  +     + +      IA  
Sbjct: 84  VLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIET---KFEMIKLIDIARQ 139
Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGT 377
            A G++YLH   + SIIH D+K  N+ L++D+   I D GLA              + G+
Sbjct: 140 TAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 196
Query: 378 MAYIAPEYFQQPE---LSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI 423
           + ++APE  +  +    S + D+++FG++L  L+ G   +    N ++I
Sbjct: 197 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 245

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 115/274 (41%), Gaps = 38/274 (13%)
Query: 215 GSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHM 274
           G  G+ I +        +   ELI  D + + + L++++        + H N+L  +  +
Sbjct: 21  GCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVK----VMRCLEHPNVLKFIGVL 76
Query: 275 VRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASII 334
            +      + E++K G+L+ I+  +     +  W  R   A  +ASG+ YL   HS +II
Sbjct: 77  YKDKRLNFITEYIKGGTLRGIIKSMD---SQYPWSQRVSFAKDIASGMAYL---HSMNII 130
Query: 335 HGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT------------RVLISYVLGTMAYIA 382
           H D+   N L+ ++    ++D GLA  + D  T            R     V+G   ++A
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 383 PEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMN-SKNPSRA 441
           PE        EK D+FSFG++L  ++           G     P++L + M+   N    
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEII-----------GRVNADPDYLPRTMDFGLNVRGF 239
Query: 442 IDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPN 475
           +D   P N           I   C   DPE+RP+
Sbjct: 240 LDRYCPPNCPPS----FFPITVRCCDLDPEKRPS 269

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 72/248 (29%), Positives = 118/248 (47%), Gaps = 31/248 (12%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           +  LEKIG G  G VYKA+   + G+  A+KK+          L +ED  +  + +R   
Sbjct: 4   YHGLEKIGEGTYGVVYKAQ--NNYGETFALKKI---------RLEKEDEGIPSTTIR--- 49
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
            EI    +++H NI+ L   +      +LV+E + +  L+ +LD    G   L+  +   
Sbjct: 50  -EISILKELKHSNIVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGG---LESVTAKS 104
Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMA--IP-DGYTRVL 370
             L + +G+ Y H      ++H D+KP+N+L+N + E  I+D GLA A  IP   YT  +
Sbjct: 105 FLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEI 161
Query: 371 ISYVLGTMAYIAPEYFQ-QPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWL 429
           +     T+ Y AP+      + S   DI+S G +   +V G P F      +++     +
Sbjct: 162 V-----TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRI 216
Query: 430 RKVMNSKN 437
               NSKN
Sbjct: 217 LGTPNSKN 224

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 107/229 (46%), Gaps = 27/229 (11%)
Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           ++IGSG  G VYK +  G     +A+K + V AP                +L+  ++E+ 
Sbjct: 42  QRIGSGSFGTVYKGKWHGD----VAVKMLNVTAPTP-------------QQLQAFKNEVG 84
Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALG 317
              + RH NIL  + +  +P    +V ++ +  SL   L  +     + +      IA  
Sbjct: 85  VLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIET---KFEMIKLIDIARQ 140
Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGT 377
            A G++YLH   + SIIH D+K  N+ L++D+   I D GLA              + G+
Sbjct: 141 TAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 197
Query: 378 MAYIAPEYFQQPE---LSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI 423
           + ++APE  +  +    S + D+++FG++L  L+ G   +    N ++I
Sbjct: 198 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 246

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 102/222 (45%), Gaps = 25/222 (11%)
Query: 191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
           E+ F  LE+IG G  GEV+K  +     +++AIK +              D +  + ++ 
Sbjct: 22  EELFTKLERIGKGSFGEVFKG-IDNRTQQVVAIKII--------------DLEEAEDEIE 66
Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPS 310
            I+ EI   SQ     +       ++     ++ E++  GS  D+L          D   
Sbjct: 67  DIQQEITVLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLR-----AGPFDEFQ 121
Query: 311 RHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVL 370
              +   +  GL+YLH   S   IH DIK  NVLL++  +  ++D G+A  + D  T++ 
Sbjct: 122 IATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQIK 176
Query: 371 ISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVP 412
            +  +GT  ++APE  QQ     K DI+S G+  I L +G P
Sbjct: 177 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEP 218

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 72/248 (29%), Positives = 118/248 (47%), Gaps = 31/248 (12%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           +  LEKIG G  G VYKA+   + G+  A+KK+          L +ED  +  + +R   
Sbjct: 4   YHGLEKIGEGTYGVVYKAQ--NNYGETFALKKI---------RLEKEDEGIPSTTIR--- 49
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
            EI    +++H NI+ L   +      +LV+E + +  L+ +LD    G   L+  +   
Sbjct: 50  -EISILKELKHSNIVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGG---LESVTAKS 104
Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMA--IP-DGYTRVL 370
             L + +G+ Y H      ++H D+KP+N+L+N + E  I+D GLA A  IP   YT  +
Sbjct: 105 FLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEV 161
Query: 371 ISYVLGTMAYIAPEYFQ-QPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWL 429
           +     T+ Y AP+      + S   DI+S G +   +V G P F      +++     +
Sbjct: 162 V-----TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRI 216
Query: 430 RKVMNSKN 437
               NSKN
Sbjct: 217 LGTPNSKN 224

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 107/229 (46%), Gaps = 27/229 (11%)
Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           ++IGSG  G VYK +  G     +A+K + V AP                +L+  ++E+ 
Sbjct: 34  QRIGSGSFGTVYKGKWHGD----VAVKMLNVTAPTP-------------QQLQAFKNEVG 76
Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALG 317
              + RH NIL  + +  +P    +V ++ +  SL   L  +     + +      IA  
Sbjct: 77  VLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIET---KFEMIKLIDIARQ 132
Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGT 377
            A G++YLH   + SIIH D+K  N+ L++D+   I D GLA              + G+
Sbjct: 133 TAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGS 189
Query: 378 MAYIAPEYFQQPE---LSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI 423
           + ++APE  +  +    S + D+++FG++L  L+ G   +    N ++I
Sbjct: 190 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 238

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 102/216 (47%), Gaps = 27/216 (12%)
Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           ++IGSG  G VYK +  G     +A+K + V AP                +L+  ++E+ 
Sbjct: 19  QRIGSGSFGTVYKGKWHGD----VAVKMLNVTAPTP-------------QQLQAFKNEVG 61
Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALG 317
              + RH NIL  + +  +P    +V ++ +  SL   L  +     + +      IA  
Sbjct: 62  VLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQ 117
Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGT 377
            A G++YLH   + SIIH D+K  N+ L++D+   I D GLA              + G+
Sbjct: 118 TAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 174
Query: 378 MAYIAPEYFQQPE---LSEKCDIFSFGMLLISLVRG 410
           + ++APE  +  +    S + D+++FG++L  L+ G
Sbjct: 175 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTG 210

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 102/216 (47%), Gaps = 27/216 (12%)
Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           ++IGSG  G VYK +  G     +A+K + V AP                +L+  ++E+ 
Sbjct: 16  QRIGSGSFGTVYKGKWHGD----VAVKMLNVTAPTP-------------QQLQAFKNEVG 58
Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALG 317
              + RH NIL  + +  +P    +V ++ +  SL   L  +     + +      IA  
Sbjct: 59  VLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQ 114
Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGT 377
            A G++YLH   + SIIH D+K  N+ L++D+   I D GLA              + G+
Sbjct: 115 TAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 171
Query: 378 MAYIAPEYFQQPE---LSEKCDIFSFGMLLISLVRG 410
           + ++APE  +  +    S + D+++FG++L  L+ G
Sbjct: 172 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTG 207

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/248 (29%), Positives = 118/248 (47%), Gaps = 31/248 (12%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           +  LEKIG G  G VYKA+   + G+  A+KK+          L +ED  +  + +R   
Sbjct: 4   YHGLEKIGEGTYGVVYKAQ--NNYGETFALKKI---------RLEKEDEGIPSTTIR--- 49
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
            EI    +++H NI+ L   +      +LV+E + +  L+ +LD    G   L+  +   
Sbjct: 50  -EISILKELKHSNIVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGG---LESVTAKS 104
Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMA--IP-DGYTRVL 370
             L + +G+ Y H      ++H D+KP+N+L+N + E  I+D GLA A  IP   YT  +
Sbjct: 105 FLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEV 161
Query: 371 ISYVLGTMAYIAPEYFQ-QPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWL 429
           +     T+ Y AP+      + S   DI+S G +   +V G P F      +++     +
Sbjct: 162 V-----TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRI 216
Query: 430 RKVMNSKN 437
               NSKN
Sbjct: 217 LGTPNSKN 224

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 107/229 (46%), Gaps = 27/229 (11%)
Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           ++IGSG  G VYK +  G     +A+K + V AP                +L+  ++E+ 
Sbjct: 42  QRIGSGSFGTVYKGKWHGD----VAVKMLNVTAPTP-------------QQLQAFKNEVG 84
Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALG 317
              + RH NIL  + +  +P    +V ++ +  SL   L  +     + +      IA  
Sbjct: 85  VLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIET---KFEMIKLIDIARQ 140
Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGT 377
            A G++YLH   + SIIH D+K  N+ L++D+   I D GLA              + G+
Sbjct: 141 TAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGS 197
Query: 378 MAYIAPEYFQQPE---LSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI 423
           + ++APE  +  +    S + D+++FG++L  L+ G   +    N ++I
Sbjct: 198 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 246

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 102/216 (47%), Gaps = 27/216 (12%)
Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           ++IGSG  G VYK +  G     +A+K + V AP                +L+  ++E+ 
Sbjct: 19  QRIGSGSFGTVYKGKWHGD----VAVKMLNVTAPTP-------------QQLQAFKNEVG 61
Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALG 317
              + RH NIL  + +  +P    +V ++ +  SL   L  +     + +      IA  
Sbjct: 62  VLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQ 117
Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGT 377
            A G++YLH   + SIIH D+K  N+ L++D+   I D GLA              + G+
Sbjct: 118 TAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 174
Query: 378 MAYIAPEYFQQPE---LSEKCDIFSFGMLLISLVRG 410
           + ++APE  +  +    S + D+++FG++L  L+ G
Sbjct: 175 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTG 210

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 102/216 (47%), Gaps = 27/216 (12%)
Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           ++IGSG  G VYK +  G     +A+K + V AP                +L+  ++E+ 
Sbjct: 14  QRIGSGSFGTVYKGKWHGD----VAVKMLNVTAPTP-------------QQLQAFKNEVG 56
Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALG 317
              + RH NIL  + +  +P    +V ++ +  SL   L  +     + +      IA  
Sbjct: 57  VLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQ 112
Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGT 377
            A G++YLH   + SIIH D+K  N+ L++D+   I D GLA              + G+
Sbjct: 113 TAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 169
Query: 378 MAYIAPEYFQQPE---LSEKCDIFSFGMLLISLVRG 410
           + ++APE  +  +    S + D+++FG++L  L+ G
Sbjct: 170 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTG 205

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 88/215 (40%), Gaps = 24/215 (11%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  G VY A    S  K I   KV+  A +  A +             Q+R E+   
Sbjct: 21  LGKGKFGNVYLAREKQS--KFILALKVLFKAQLEKAGVEH-----------QLRREVEIQ 67
Query: 260 SQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVA 319
           S +RH NIL L  +        L+ E+   G +   L  +S+           R A  + 
Sbjct: 68  SHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKF-------DEQRTATYIT 120
Query: 320 SGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMA 379
                L   HS  +IH DIKP N+LL    E  I+D G ++  P      L     GT+ 
Sbjct: 121 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLD 176
Query: 380 YIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
           Y+ PE  +     EK D++S G+L    + G P F
Sbjct: 177 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 211

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 89/215 (41%), Gaps = 24/215 (11%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  G VY A    S  K I   KV+  A +  A +             Q+R E+   
Sbjct: 21  LGKGKFGNVYLAREKQS--KFILALKVLFKAQLEKAGVEH-----------QLRREVEIQ 67
Query: 260 SQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVA 319
           S +RH NIL L  +        L+ E+   G++   L  +S+           R A  + 
Sbjct: 68  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-------DEQRTATYIT 120
Query: 320 SGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMA 379
                L   HS  +IH DIKP N+LL    E  I+D G ++  P      L     GT+ 
Sbjct: 121 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLD 176
Query: 380 YIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
           Y+ PE  +     EK D++S G+L    + G P F
Sbjct: 177 YLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPF 211

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 123/283 (43%), Gaps = 33/283 (11%)
Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR-QIRSEI 256
           +KIG G   EVY+A     +G  +A+KKV ++              L D+K R     EI
Sbjct: 38  KKIGRGQFSEVYRAAC-LLDGVPVALKKVQIF-------------DLMDAKARADCIKEI 83
Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL 316
               Q+ H N++   A  +  +   +V E    G L  ++    + +R +   +  +  +
Sbjct: 84  DLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFV 143
Query: 317 GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLG 376
            + S LE++H   S  ++H DIKP NV +       + DLGL        T      ++G
Sbjct: 144 QLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA--HSLVG 198
Query: 377 TMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSK 436
           T  Y++PE   +   + K DI+S G LL  +      F     G+++      +K+    
Sbjct: 199 TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY----GDKMNLYSLCKKIEQCD 254
Query: 437 NPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYV 479
            P       LP + Y +++  ++    +C   DPE+RP+  YV
Sbjct: 255 YPP------LPSDHYSEELRQLVN---MCINPDPEKRPDVTYV 288

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 102/216 (47%), Gaps = 27/216 (12%)
Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           ++IGSG  G VYK +  G     +A+K + V AP                +L+  ++E+ 
Sbjct: 14  QRIGSGSFGTVYKGKWHGD----VAVKMLNVTAPTP-------------QQLQAFKNEVG 56
Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALG 317
              + RH NIL  + +  +P    +V ++ +  SL   L  +     + +      IA  
Sbjct: 57  VLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQ 112
Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGT 377
            A G++YLH   + SIIH D+K  N+ L++D+   I D GLA              + G+
Sbjct: 113 TAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGS 169
Query: 378 MAYIAPEYFQQPE---LSEKCDIFSFGMLLISLVRG 410
           + ++APE  +  +    S + D+++FG++L  L+ G
Sbjct: 170 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTG 205

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 84/299 (28%), Positives = 132/299 (44%), Gaps = 45/299 (15%)
Query: 192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ 251
           D +   E IGSG    V +A       + +AIK++           +E+     D  L++
Sbjct: 15  DDYELQEVIGSGATA-VVQAAYCAPKKEKVAIKRIN----------LEKCQTSMDELLKE 63
Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDD-VSRGRRE---LD 307
           I++     SQ  H NI+      V  D   LV + +  GS+ DI+   V++G  +   LD
Sbjct: 64  IQA----MSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLD 119
Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG-- 365
             +   I   V  GLEYLH       IH D+K  N+LL +D    I+D G++  +  G  
Sbjct: 120 ESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGD 176
Query: 366 --YTRVLISYVLGTMAYIAPEYFQQPELSE-KCDIFSFGMLLISLVRGVPSFVFHQNGEE 422
               +V  ++V GT  ++APE  +Q    + K DI+SFG+  I L  G     +H+    
Sbjct: 177 ITRNKVRKTFV-GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP--YHKY--- 230
Query: 423 ICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLH-----VLKIAYICTLHDPEERPNS 476
              P  +  +    +P     P L     +K+ML        K+  +C   DPE+RP +
Sbjct: 231 --PPMKVLMLTLQNDP-----PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTA 282

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 89/215 (41%), Gaps = 24/215 (11%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  G VY A    S  K I   KV+  A +  A +             Q+R E+   
Sbjct: 33  LGKGKFGNVYLAREKQS--KFILALKVLFKAQLEKAGV-----------EHQLRREVEIQ 79
Query: 260 SQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVA 319
           S +RH NIL L  +        L+ E+   G++   L  +S+           R A  + 
Sbjct: 80  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-------DEQRTATYIT 132
Query: 320 SGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMA 379
                L   HS  +IH DIKP N+LL    E  I+D G ++  P      L     GT+ 
Sbjct: 133 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLD 188
Query: 380 YIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
           Y+ PE  +     EK D++S G+L    + G P F
Sbjct: 189 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 223

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 105/222 (47%), Gaps = 25/222 (11%)
Query: 191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
           E+ F  L++IG G  GEVYK  +     +++AIK +              D +  + ++ 
Sbjct: 18  EELFTKLDRIGKGSFGEVYKG-IDNHTKEVVAIKII--------------DLEEAEDEIE 62
Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPS 310
            I+ EI   SQ     I       ++     ++ E++  GS  D+L     G  E  + +
Sbjct: 63  DIQQEITVLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLLKP---GPLEETYIA 119
Query: 311 RHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVL 370
              I   +  GL+YLH   S   IH DIK  NVLL++  +  ++D G+A  + D  T++ 
Sbjct: 120 T--ILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQIK 172
Query: 371 ISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVP 412
            +  +GT  ++APE  +Q     K DI+S G+  I L +G P
Sbjct: 173 RNXFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEP 214

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 88/215 (40%), Gaps = 24/215 (11%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  G VY A    S  K I   KV+  A +  A +             Q+R E+   
Sbjct: 21  LGKGKFGNVYLAREKQS--KFILALKVLFKAQLEKAGVEH-----------QLRREVEIQ 67
Query: 260 SQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVA 319
           S +RH NIL L  +        L+ E+   G +   L  +S+           R A  + 
Sbjct: 68  SHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKF-------DEQRTATYIT 120
Query: 320 SGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMA 379
                L   HS  +IH DIKP N+LL    E  I+D G ++  P      L     GT+ 
Sbjct: 121 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLX----GTLD 176
Query: 380 YIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
           Y+ PE  +     EK D++S G+L    + G P F
Sbjct: 177 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 211

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/244 (29%), Positives = 111/244 (45%), Gaps = 30/244 (12%)
Query: 247 SKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDD-VSRGRRE 305
           + + ++  EI   SQ  H NI+      V  D   LV + +  GS+ DI+   V++G  +
Sbjct: 50  TSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHK 109
Query: 306 ---LDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI 362
              LD  +   I   V  GLEYLH       IH D+K  N+LL +D    I+D G++  +
Sbjct: 110 SGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFL 166
Query: 363 PDG----YTRVLISYVLGTMAYIAPEYFQQPELSE-KCDIFSFGMLLISLVRGVPSFVFH 417
             G      +V  ++V GT  ++APE  +Q    + K DI+SFG+  I L  G     +H
Sbjct: 167 ATGGDITRNKVRKTFV-GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP--YH 223
Query: 418 QNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLH-----VLKIAYICTLHDPEE 472
           +       P  +  +    +P     P L     +K+ML        K+  +C   DPE+
Sbjct: 224 KY-----PPMKVLMLTLQNDP-----PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEK 273
Query: 473 RPNS 476
           RP +
Sbjct: 274 RPTA 277

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 109/234 (46%), Gaps = 41/234 (17%)
Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           LE +G G  GEV++    G N   +A+K   +++              RD K     +E+
Sbjct: 13  LECVGKGRYGEVWRGSWQGEN---VAVK---IFSS-------------RDEKSWFRETEL 53
Query: 257 ITASQIRHRNILPLLAHMVRPDCH----LLVYEFMKNGSLQDILDDVSRGRRELDWPSRH 312
                +RH NIL  +A  +          L+  + + GSL D L   +     LD  S  
Sbjct: 54  YNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT-----LDTVSCL 108
Query: 313 RIALGVASGLEYLHM-----YHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
           RI L +ASGL +LH+         +I H D+K +N+L+  + + CI+DLGLA+       
Sbjct: 109 RIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTN 168
Query: 368 RVLISY--VLGTMAYIAPEYFQQP------ELSEKCDIFSFGMLLISLVRGVPS 413
           ++ +     +GT  Y+APE   +       +  ++ DI++FG++L  + R + S
Sbjct: 169 QLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVS 222

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 83/181 (45%), Gaps = 7/181 (3%)
Query: 234 AAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQ 293
           A +++E+   ++++K+  +  E    S++ H   + L       +       + KNG L 
Sbjct: 61  AIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLL 120
Query: 294 DILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACI 353
             +  +       D          + S LEYLH      IIH D+KP N+LLN+DM   I
Sbjct: 121 KYIRKIG----SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQI 173
Query: 354 SDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPS 413
           +D G A  +     +   +  +GT  Y++PE   +   S+  D+++ G ++  LV G+P 
Sbjct: 174 TDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSASKSSDLWALGCIIYQLVAGLPP 233
Query: 414 F 414
           F
Sbjct: 234 F 234

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 109/234 (46%), Gaps = 41/234 (17%)
Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           LE +G G  GEV++    G N   +A+K   +++              RD K     +E+
Sbjct: 13  LECVGKGRYGEVWRGSWQGEN---VAVK---IFSS-------------RDEKSWFRETEL 53
Query: 257 ITASQIRHRNILPLLAHMVRPDCH----LLVYEFMKNGSLQDILDDVSRGRRELDWPSRH 312
                +RH NIL  +A  +          L+  + + GSL D L   +     LD  S  
Sbjct: 54  YNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT-----LDTVSCL 108
Query: 313 RIALGVASGLEYLHM-----YHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
           RI L +ASGL +LH+         +I H D+K +N+L+  + + CI+DLGLA+       
Sbjct: 109 RIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTN 168
Query: 368 RVLISY--VLGTMAYIAPEYFQQP------ELSEKCDIFSFGMLLISLVRGVPS 413
           ++ +     +GT  Y+APE   +       +  ++ DI++FG++L  + R + S
Sbjct: 169 QLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVS 222

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 88/215 (40%), Gaps = 24/215 (11%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  G VY A       K I   KV+  A +  A +             Q+R E+   
Sbjct: 42  LGKGKFGNVYLAR--EKQSKFILALKVLFKAQLEKAGVE-----------HQLRREVEIQ 88
Query: 260 SQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVA 319
           S +RH NIL L  +        L+ E+   G++   L  +S+           R A  + 
Sbjct: 89  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-------DEQRTATYIT 141
Query: 320 SGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMA 379
                L   HS  +IH DIKP N+LL    E  I+D G ++  P      L     GT+ 
Sbjct: 142 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLD 197
Query: 380 YIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
           Y+ PE  +     EK D++S G+L    + G P F
Sbjct: 198 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 232

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 104/217 (47%), Gaps = 28/217 (12%)
Query: 199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR-SEII 257
           KIG G  G V  A +  S+GK++A+KK+                 LR  + R++  +E++
Sbjct: 36  KIGEGSTGIVCIATV-RSSGKLVAVKKM----------------DLRKQQRRELLFNEVV 78
Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALG 317
                +H N++ +    +  D   +V EF++ G+L DI   V+  R      +  +IA  
Sbjct: 79  IMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDI---VTHTRM-----NEEQIAAV 130
Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGT 377
             + L+ L + H+  +IH DIK  ++LL  D    +SD G    +     R     ++GT
Sbjct: 131 CLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR--KXLVGT 188
Query: 378 MAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
             ++APE   +     + DI+S G+++I +V G P +
Sbjct: 189 PYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY 225

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 107/229 (46%), Gaps = 27/229 (11%)
Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           ++IGSG  G VYK +  G     +A+K + V AP                +L+  ++E+ 
Sbjct: 18  QRIGSGSFGTVYKGKWHGD----VAVKMLNVTAPTP-------------QQLQAFKNEVG 60
Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALG 317
              + RH NIL  + +  +P    +V ++ +  SL   L   S  + E+       IA  
Sbjct: 61  VLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLH-ASETKFEMK--KLIDIARQ 116
Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGT 377
            A G++YLH   + SIIH D+K  N+ L++D    I D GLA              + G+
Sbjct: 117 TARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGS 173
Query: 378 MAYIAPEYFQQPE---LSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI 423
           + ++APE  +  +    S + D+++FG++L  L+ G   +    N ++I
Sbjct: 174 ILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 222

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 89/215 (41%), Gaps = 24/215 (11%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  G VY A    S  K I   KV+  A +  A +             Q+R E+   
Sbjct: 19  LGKGKFGNVYLAREKQS--KFILALKVLFKAQLEKAGVEH-----------QLRREVEIQ 65
Query: 260 SQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVA 319
           S +RH NIL L  +        L+ E+   G++   L  +S+           R A  + 
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-------DEQRTATYIT 118
Query: 320 SGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMA 379
                L   HS  +IH DIKP N+LL    E  I+D G ++  P      L     GT+ 
Sbjct: 119 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLD 174
Query: 380 YIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
           Y+ PE  +     EK D++S G+L    + G P F
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 209

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 104/217 (47%), Gaps = 28/217 (12%)
Query: 199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR-SEII 257
           KIG G  G V  A +  S+GK++A+KK+                 LR  + R++  +E++
Sbjct: 38  KIGEGSTGIVCIATV-RSSGKLVAVKKM----------------DLRKQQRRELLFNEVV 80
Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALG 317
                +H N++ +    +  D   +V EF++ G+L DI   V+  R      +  +IA  
Sbjct: 81  IMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDI---VTHTRM-----NEEQIAAV 132
Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGT 377
             + L+ L + H+  +IH DIK  ++LL  D    +SD G    +     R     ++GT
Sbjct: 133 CLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR--KXLVGT 190
Query: 378 MAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
             ++APE   +     + DI+S G+++I +V G P +
Sbjct: 191 PYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY 227

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 104/217 (47%), Gaps = 28/217 (12%)
Query: 199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR-SEII 257
           KIG G  G V  A +  S+GK++A+KK+                 LR  + R++  +E++
Sbjct: 27  KIGEGSTGIVCIATV-RSSGKLVAVKKM----------------DLRKQQRRELLFNEVV 69
Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALG 317
                +H N++ +    +  D   +V EF++ G+L DI   V+  R      +  +IA  
Sbjct: 70  IMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDI---VTHTRM-----NEEQIAAV 121
Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGT 377
             + L+ L + H+  +IH DIK  ++LL  D    +SD G    +     R     ++GT
Sbjct: 122 CLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR--KXLVGT 179
Query: 378 MAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
             ++APE   +     + DI+S G+++I +V G P +
Sbjct: 180 PYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY 216

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 107/229 (46%), Gaps = 27/229 (11%)
Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           ++IGSG  G VYK +  G     +A+K + V AP                +L+  ++E+ 
Sbjct: 30  QRIGSGSFGTVYKGKWHGD----VAVKMLNVTAPTP-------------QQLQAFKNEVG 72
Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALG 317
              + RH NIL  + +  +P    +V ++ +  SL   L   S  + E+       IA  
Sbjct: 73  VLRKTRHVNILLFMGYSTKPQL-AIVTQWCEGSSLYHHLH-ASETKFEMK--KLIDIARQ 128
Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGT 377
            A G++YLH   + SIIH D+K  N+ L++D    I D GLA              + G+
Sbjct: 129 TARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGS 185
Query: 378 MAYIAPEYFQQPE---LSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI 423
           + ++APE  +  +    S + D+++FG++L  L+ G   +    N ++I
Sbjct: 186 ILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 234

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 102/217 (47%), Gaps = 28/217 (12%)
Query: 199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR-SEII 257
           KIG G  G V  A +  S+GK++A+KK+                 LR  + R++  +E++
Sbjct: 158 KIGEGSTGIVCIATV-RSSGKLVAVKKM----------------DLRKQQRRELLFNEVV 200
Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALG 317
                +H N++ +    +  D   +V EF++ G+L DI+             +  +IA  
Sbjct: 201 IMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRM--------NEEQIAAV 252
Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGT 377
             + L+ L + H+  +IH DIK  ++LL  D    +SD G    +     R     ++GT
Sbjct: 253 CLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR--KXLVGT 310
Query: 378 MAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
             ++APE   +     + DI+S G+++I +V G P +
Sbjct: 311 PYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY 347

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 89/215 (41%), Gaps = 24/215 (11%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  G VY A    S  K I   KV+  A +  A +             Q+R E+   
Sbjct: 17  LGKGKFGNVYLAREKQS--KFILALKVLFKAQLEKAGVEH-----------QLRREVEIQ 63
Query: 260 SQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVA 319
           S +RH NIL L  +        L+ E+   G++   L  +S+           R A  + 
Sbjct: 64  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-------DEQRTATYIT 116
Query: 320 SGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMA 379
                L   HS  +IH DIKP N+LL    E  I+D G ++  P      L     GT+ 
Sbjct: 117 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLC----GTLD 172
Query: 380 YIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
           Y+ PE  +     EK D++S G+L    + G P F
Sbjct: 173 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 207

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 88/215 (40%), Gaps = 24/215 (11%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  G VY A       K I   KV+  A +  A +             Q+R E+   
Sbjct: 19  LGKGKFGNVYLAR--EKQSKFILALKVLFKAQLEKAGVEH-----------QLRREVEIQ 65
Query: 260 SQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVA 319
           S +RH NIL L  +        L+ E+   G++   L  +S+           R A  + 
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-------DEQRTATYIT 118
Query: 320 SGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMA 379
                L   HS  +IH DIKP N+LL    E  I+D G ++  P      L     GT+ 
Sbjct: 119 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLD 174
Query: 380 YIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
           Y+ PE  +     EK D++S G+L    + G P F
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 209

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 89/215 (41%), Gaps = 24/215 (11%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  G VY A    S  K I   KV+  A +  A +             Q+R E+   
Sbjct: 16  LGKGKFGNVYLAREKQS--KFILALKVLFKAQLEKAGVEH-----------QLRREVEIQ 62
Query: 260 SQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVA 319
           S +RH NIL L  +        L+ E+   G++   L  +S+           R A  + 
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-------DEQRTATYIT 115
Query: 320 SGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMA 379
                L   HS  +IH DIKP N+LL    E  I+D G ++  P      L     GT+ 
Sbjct: 116 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLD 171
Query: 380 YIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
           Y+ PE  +     EK D++S G+L    + G P F
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 25/216 (11%)
Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           ++ +G G  GEV  A +     + +A+K V +   +   E               I+ EI
Sbjct: 11  VQTLGEGAAGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPE--------------NIKKEI 55
Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILD-DVSRGRRELDWPSRHRIA 315
                + H N++    H    +   L  E+   G L D ++ D+      +  P   R  
Sbjct: 56  CINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFF 110
Query: 316 LGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVL 375
             + +G+ YLH      I H DIKP N+LL++     ISD GLA          L++ + 
Sbjct: 111 HQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 167
Query: 376 GTMAYIAPEYFQQPEL-SEKCDIFSFGMLLISLVRG 410
           GT+ Y+APE  ++ E  +E  D++S G++L +++ G
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 89/215 (41%), Gaps = 24/215 (11%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  G VY A    S  K I   KV+  A +  A +             Q+R E+   
Sbjct: 21  LGKGKFGNVYLAREKQS--KFILALKVLFKAQLEKAGVEH-----------QLRREVEIQ 67
Query: 260 SQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVA 319
           S +RH NIL L  +        L+ E+   G++   L  +S+           R A  + 
Sbjct: 68  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-------DEQRTATYIT 120
Query: 320 SGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMA 379
                L   HS  +IH DIKP N+LL    E  I+D G ++  P      L     GT+ 
Sbjct: 121 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLD 176
Query: 380 YIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
           Y+ PE  +     EK D++S G+L    + G P F
Sbjct: 177 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 211

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 104/217 (47%), Gaps = 28/217 (12%)
Query: 199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR-SEII 257
           KIG G  G V  A +  S+GK++A+KK+                 LR  + R++  +E++
Sbjct: 31  KIGEGSTGIVCIATV-RSSGKLVAVKKM----------------DLRKQQRRELLFNEVV 73
Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALG 317
                +H N++ +    +  D   +V EF++ G+L DI   V+  R      +  +IA  
Sbjct: 74  IMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDI---VTHTRM-----NEEQIAAV 125
Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGT 377
             + L+ L + H+  +IH DIK  ++LL  D    +SD G    +     R     ++GT
Sbjct: 126 CLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR--KXLVGT 183
Query: 378 MAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
             ++APE   +     + DI+S G+++I +V G P +
Sbjct: 184 PYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY 220

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 103/236 (43%), Gaps = 36/236 (15%)
Query: 177 SPLIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAE 236
           +P +E  DL           ++ +G G  GEV  A +     + +A+K V +   +   E
Sbjct: 1   APFVEDWDL-----------VQTLGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPE 48
Query: 237 LIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDIL 296
                          I+ EI     + H N++    H    +   L  E+   G L D +
Sbjct: 49  --------------NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI 94
Query: 297 D-DVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISD 355
           + D+      +  P   R    + +G+ YLH      I H DIKP N+LL++     ISD
Sbjct: 95  EPDIG-----MPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISD 146
Query: 356 LGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPEL-SEKCDIFSFGMLLISLVRG 410
            GLA          L++ + GT+ Y+APE  ++ E  +E  D++S G++L +++ G
Sbjct: 147 FGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 202

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 107/230 (46%), Gaps = 41/230 (17%)
Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           LE +G G  GEV++    G N   +A+K   +++              RD K     +E+
Sbjct: 42  LECVGKGRYGEVWRGSWQGEN---VAVK---IFSS-------------RDEKSWFRETEL 82
Query: 257 ITASQIRHRNILPLLAHMVRPDCH----LLVYEFMKNGSLQDILDDVSRGRRELDWPSRH 312
                +RH NIL  +A  +          L+  + + GSL D L   +     LD  S  
Sbjct: 83  YNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT-----LDTVSCL 137
Query: 313 RIALGVASGLEYLHM-----YHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
           RI L +ASGL +LH+         +I H D+K +N+L+  + + CI+DLGLA+       
Sbjct: 138 RIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTN 197
Query: 368 RVLISYV--LGTMAYIAPEYFQQP------ELSEKCDIFSFGMLLISLVR 409
           ++ +     +GT  Y+APE   +       +  ++ DI++FG++L  + R
Sbjct: 198 QLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR 247

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 101/216 (46%), Gaps = 27/216 (12%)
Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           ++IGSG  G VYK +  G     +A+K + V AP                +L+  ++E+ 
Sbjct: 14  QRIGSGSFGTVYKGKWHGD----VAVKMLNVTAPTP-------------QQLQAFKNEVG 56
Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALG 317
              + RH NIL  + +   P    +V ++ +  SL   L  +     + +      IA  
Sbjct: 57  VLRKTRHVNILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQ 112
Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGT 377
            A G++YLH   + SIIH D+K  N+ L++D+   I D GLA              + G+
Sbjct: 113 TAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 169
Query: 378 MAYIAPEYFQQPE---LSEKCDIFSFGMLLISLVRG 410
           + ++APE  +  +    S + D+++FG++L  L+ G
Sbjct: 170 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTG 205

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 89/215 (41%), Gaps = 24/215 (11%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  G VY A    S  K I   KV+  A +  A +             Q+R E+   
Sbjct: 18  LGKGKFGNVYLAREKQS--KFILALKVLFKAQLEKAGVEH-----------QLRREVEIQ 64
Query: 260 SQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVA 319
           S +RH NIL L  +        L+ E+   G++   L  +S+           R A  + 
Sbjct: 65  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-------DEQRTATYIT 117
Query: 320 SGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMA 379
                L   HS  +IH DIKP N+LL    E  I+D G ++  P      L     GT+ 
Sbjct: 118 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GTLD 173
Query: 380 YIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
           Y+ PE  +     EK D++S G+L    + G P F
Sbjct: 174 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 208

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 88/215 (40%), Gaps = 24/215 (11%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  G VY A       K I   KV+  A +  A +             Q+R E+   
Sbjct: 15  LGKGKFGNVYLAR--EKQSKFILALKVLFKAQLEKAGVEH-----------QLRREVEIQ 61
Query: 260 SQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVA 319
           S +RH NIL L  +        L+ E+   G++   L  +S+           R A  + 
Sbjct: 62  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-------DEQRTATYIT 114
Query: 320 SGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMA 379
                L   HS  +IH DIKP N+LL    E  I+D G ++  P      L     GT+ 
Sbjct: 115 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLD 170
Query: 380 YIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
           Y+ PE  +     EK D++S G+L    + G P F
Sbjct: 171 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 205

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 102/217 (47%), Gaps = 28/217 (12%)
Query: 199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR-SEII 257
           KIG G  G V  A +  S+GK++A+KK+                 LR  + R++  +E++
Sbjct: 81  KIGEGSTGIVCIATV-RSSGKLVAVKKM----------------DLRKQQRRELLFNEVV 123
Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALG 317
                +H N++ +    +  D   +V EF++ G+L DI+             +  +IA  
Sbjct: 124 IMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRM--------NEEQIAAV 175
Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGT 377
             + L+ L + H+  +IH DIK  ++LL  D    +SD G    +     R     ++GT
Sbjct: 176 CLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR--KXLVGT 233
Query: 378 MAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
             ++APE   +     + DI+S G+++I +V G P +
Sbjct: 234 PYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY 270

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 105/224 (46%), Gaps = 33/224 (14%)
Query: 197 LEKIGSGGCGEVYKAEL----PGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQI 252
           +E++G    G+VYK  L    PG   + +AIK +   A          +  LR+    + 
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA----------EGPLRE----EF 59
Query: 253 RSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDIL------------DDVS 300
           R E +  ++++H N++ LL  + +     +++ +  +G L + L            DD  
Sbjct: 60  RHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDR 119
Query: 301 RGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAM 360
             +  L+ P    +   +A+G+EYL  +H   ++H D+  RNVL+ D +   ISDLGL  
Sbjct: 120 TVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFR 176
Query: 361 AIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
            +       L+   L  + ++APE     + S   DI+S+G++L
Sbjct: 177 EVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVL 220

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 88/215 (40%), Gaps = 24/215 (11%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  G VY A       K I   KV+  A +  A +             Q+R E+   
Sbjct: 20  LGKGKFGNVYLAR--EKQSKFILALKVLFKAQLEKAGVEH-----------QLRREVEIQ 66
Query: 260 SQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVA 319
           S +RH NIL L  +        L+ E+   G++   L  +S+           R A  + 
Sbjct: 67  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-------DEQRTATYIT 119
Query: 320 SGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMA 379
                L   HS  +IH DIKP N+LL    E  I+D G ++  P      L     GT+ 
Sbjct: 120 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLD 175
Query: 380 YIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
           Y+ PE  +     EK D++S G+L    + G P F
Sbjct: 176 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 210

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 90/215 (41%), Gaps = 24/215 (11%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  G VY A    S  K I   KV+  A +  A +             Q+R E+   
Sbjct: 17  LGKGKFGNVYLAREKQS--KFILALKVLFKAQLEKAGVEH-----------QLRREVEIQ 63
Query: 260 SQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVA 319
           S +RH NIL L  +        L+ E+   G++   L  +S+           R A  + 
Sbjct: 64  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-------DEQRTATYIT 116
Query: 320 SGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMA 379
                L   HS  +IH DIKP N+LL    E  I+D G +   P    R  +S   GT+ 
Sbjct: 117 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSS-RRTTLS---GTLD 172
Query: 380 YIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
           Y+ PE  +     EK D++S G+L    + G P F
Sbjct: 173 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 207

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 102/235 (43%), Gaps = 36/235 (15%)
Query: 178 PLIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAEL 237
           P +E  DL           ++ +G G  GEV  A +     + +A+K V +   +   E 
Sbjct: 4   PFVEDWDL-----------VQTLGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPE- 50
Query: 238 IEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILD 297
                         I+ EI   + + H N++    H    +   L  E+   G L D ++
Sbjct: 51  -------------NIKKEICINAMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE 97
Query: 298 -DVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDL 356
            D+         P   R    + +G+ YLH      I H DIKP N+LL++     ISD 
Sbjct: 98  PDIGMPE-----PDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDF 149
Query: 357 GLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPEL-SEKCDIFSFGMLLISLVRG 410
           GLA          L++ + GT+ Y+APE  ++ E  +E  D++S G++L +++ G
Sbjct: 150 GLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 82/181 (45%), Gaps = 7/181 (3%)
Query: 234 AAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQ 293
           A +++E+   ++++K+  +  E    S++ H   + L       +       + KNG L 
Sbjct: 38  AIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELL 97
Query: 294 DILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACI 353
             +  +       D          + S LEYLH      IIH D+KP N+LLN+DM   I
Sbjct: 98  KYIRKIG----SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQI 150
Query: 354 SDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPS 413
           +D G A  +     +   +  +GT  Y++PE   +    +  D+++ G ++  LV G+P 
Sbjct: 151 TDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 210
Query: 414 F 414
           F
Sbjct: 211 F 211

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 82/181 (45%), Gaps = 7/181 (3%)
Query: 234 AAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQ 293
           A +++E+   ++++K+  +  E    S++ H   + L       +       + KNG L 
Sbjct: 37  AIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELL 96
Query: 294 DILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACI 353
             +  +       D          + S LEYLH      IIH D+KP N+LLN+DM   I
Sbjct: 97  KYIRKIG----SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQI 149
Query: 354 SDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPS 413
           +D G A  +     +   +  +GT  Y++PE   +    +  D+++ G ++  LV G+P 
Sbjct: 150 TDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 209
Query: 414 F 414
           F
Sbjct: 210 F 210

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 88/215 (40%), Gaps = 24/215 (11%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  G VY A       K I   KV+  A +  A +             Q+R E+   
Sbjct: 19  LGKGKFGNVYLAR--EKQSKFILALKVLFKAQLEKAGVEH-----------QLRREVEIQ 65
Query: 260 SQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVA 319
           S +RH NIL L  +        L+ E+   G++   L  +S+           R A  + 
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-------DEQRTATYIT 118
Query: 320 SGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMA 379
                L   HS  +IH DIKP N+LL    E  I+D G ++  P      L     GT+ 
Sbjct: 119 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GTLD 174
Query: 380 YIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
           Y+ PE  +     EK D++S G+L    + G P F
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 209

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 94/209 (44%), Gaps = 31/209 (14%)
Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           L+ IG G  G+V   +  G+   +  IK                     D+  +   +E 
Sbjct: 198 LQTIGKGEFGDVMLGDYRGNKVAVKCIKN--------------------DATAQAFLAEA 237
Query: 257 ITASQIRHRNILPLLAHMVRPDCHL-LVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIA 315
              +Q+RH N++ LL  +V     L +V E+M  GSL D L   SRGR  L      + +
Sbjct: 238 SVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFS 295
Query: 316 LGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVL 375
           L V   +EYL      + +H D+  RNVL+++D  A +SD GL            +    
Sbjct: 296 LDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP--- 349
Query: 376 GTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
             + + APE  ++ + S K D++SFG+LL
Sbjct: 350 --VKWTAPEALREKKFSTKSDVWSFGILL 376

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 94/209 (44%), Gaps = 31/209 (14%)
Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           L+ IG G  G+V   +  G+   +  IK                     D+  +   +E 
Sbjct: 11  LQTIGKGEFGDVMLGDYRGNKVAVKCIKN--------------------DATAQAFLAEA 50
Query: 257 ITASQIRHRNILPLLAHMVRPDCHL-LVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIA 315
              +Q+RH N++ LL  +V     L +V E+M  GSL D L   SRGR  L      + +
Sbjct: 51  SVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFS 108
Query: 316 LGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVL 375
           L V   +EYL      + +H D+  RNVL+++D  A +SD GL            +    
Sbjct: 109 LDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP--- 162
Query: 376 GTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
             + + APE  ++ + S K D++SFG+LL
Sbjct: 163 --VKWTAPEALREKKFSTKSDVWSFGILL 189

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 82/181 (45%), Gaps = 7/181 (3%)
Query: 234 AAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQ 293
           A +++E+   ++++K+  +  E    S++ H   + L       +       + KNG L 
Sbjct: 36  AIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELL 95
Query: 294 DILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACI 353
             +  +       D          + S LEYLH      IIH D+KP N+LLN+DM   I
Sbjct: 96  KYIRKIG----SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQI 148
Query: 354 SDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPS 413
           +D G A  +     +   +  +GT  Y++PE   +    +  D+++ G ++  LV G+P 
Sbjct: 149 TDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 208
Query: 414 F 414
           F
Sbjct: 209 F 209

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 94/209 (44%), Gaps = 31/209 (14%)
Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           L+ IG G  G+V   +  G+   +  IK                     D+  +   +E 
Sbjct: 26  LQTIGKGEFGDVMLGDYRGNKVAVKCIKN--------------------DATAQAFLAEA 65
Query: 257 ITASQIRHRNILPLLAHMVRPDCHL-LVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIA 315
              +Q+RH N++ LL  +V     L +V E+M  GSL D L   SRGR  L      + +
Sbjct: 66  SVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFS 123
Query: 316 LGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVL 375
           L V   +EYL      + +H D+  RNVL+++D  A +SD GL            +    
Sbjct: 124 LDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP--- 177
Query: 376 GTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
             + + APE  ++ + S K D++SFG+LL
Sbjct: 178 --VKWTAPEALREKKFSTKSDVWSFGILL 204

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 88/215 (40%), Gaps = 24/215 (11%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  G VY A       K I   KV+  A +  A +             Q+R E+   
Sbjct: 16  LGKGKFGNVYLAR--EKQSKFILALKVLFKAQLEKAGVEH-----------QLRREVEIQ 62
Query: 260 SQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVA 319
           S +RH NIL L  +        L+ E+   G++   L  +S+           R A  + 
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-------DEQRTATYIT 115
Query: 320 SGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMA 379
                L   HS  +IH DIKP N+LL    E  I+D G ++  P      L     GT+ 
Sbjct: 116 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GTLD 171
Query: 380 YIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
           Y+ PE  +     EK D++S G+L    + G P F
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 25/216 (11%)
Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           ++ +G G  GEV  A +     + +A+K V +   +   E               I+ EI
Sbjct: 11  VQTLGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPE--------------NIKKEI 55
Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILD-DVSRGRRELDWPSRHRIA 315
                + H N++    H    +   L  E+   G L D ++ D+      +  P   R  
Sbjct: 56  CINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFF 110
Query: 316 LGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVL 375
             + +G+ YLH      I H DIKP N+LL++     ISD GLA          L++ + 
Sbjct: 111 HQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 167
Query: 376 GTMAYIAPEYFQQPEL-SEKCDIFSFGMLLISLVRG 410
           GT+ Y+APE  ++ E  +E  D++S G++L +++ G
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 101/235 (42%), Gaps = 36/235 (15%)
Query: 178 PLIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAEL 237
           P +E  DL           ++ +G G  GEV  A +     + +A+K V +   +   E 
Sbjct: 3   PFVEDWDL-----------VQTLGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPE- 49
Query: 238 IEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILD 297
                         I+ EI     + H N++    H    +   L  E+   G L D ++
Sbjct: 50  -------------NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE 96
Query: 298 -DVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDL 356
            D+         P   R    + +G+ YLH      I H DIKP N+LL++     ISD 
Sbjct: 97  PDIGMPE-----PDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDF 148
Query: 357 GLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPEL-SEKCDIFSFGMLLISLVRG 410
           GLA          L++ + GT+ Y+APE  ++ E  +E  D++S G++L +++ G
Sbjct: 149 GLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 88/215 (40%), Gaps = 24/215 (11%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  G VY A       K I   KV+  A +  A +             Q+R E+   
Sbjct: 16  LGKGKFGNVYLAR--EKQSKFILALKVLFKAQLEKAGVEH-----------QLRREVEIQ 62
Query: 260 SQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVA 319
           S +RH NIL L  +        L+ E+   G++   L  +S+           R A  + 
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-------DEQRTATYIT 115
Query: 320 SGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMA 379
                L   HS  +IH DIKP N+LL    E  I+D G ++  P      L     GT+ 
Sbjct: 116 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALC----GTLD 171
Query: 380 YIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
           Y+ PE  +     EK D++S G+L    + G P F
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 82/181 (45%), Gaps = 7/181 (3%)
Query: 234 AAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQ 293
           A +++E+   ++++K+  +  E    S++ H   + L       +       + KNG L 
Sbjct: 39  AIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELL 98
Query: 294 DILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACI 353
             +  +       D          + S LEYLH      IIH D+KP N+LLN+DM   I
Sbjct: 99  KYIRKIG----SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQI 151
Query: 354 SDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPS 413
           +D G A  +     +   +  +GT  Y++PE   +    +  D+++ G ++  LV G+P 
Sbjct: 152 TDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 211
Query: 414 F 414
           F
Sbjct: 212 F 212

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 96/216 (44%), Gaps = 25/216 (11%)
Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           ++ +G G  GEV  A +     + +A+K V +   +   E               I+ EI
Sbjct: 11  VQTLGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPE--------------NIKKEI 55
Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILD-DVSRGRRELDWPSRHRIA 315
                + H N++    H    +   L  E+   G L D ++ D+         P   R  
Sbjct: 56  CINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE-----PDAQRFF 110
Query: 316 LGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVL 375
             + +G+ YLH      I H DIKP N+LL++     ISD GLA          L++ + 
Sbjct: 111 HQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 167
Query: 376 GTMAYIAPEYFQQPEL-SEKCDIFSFGMLLISLVRG 410
           GT+ Y+APE  ++ E  +E  D++S G++L +++ G
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 88/215 (40%), Gaps = 24/215 (11%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  G VY A       K I   KV+  A +  A +             Q+R E+   
Sbjct: 16  LGKGKFGNVYLAR--EKQSKFILALKVLFKAQLEKAGVEH-----------QLRREVEIQ 62
Query: 260 SQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVA 319
           S +RH NIL L  +        L+ E+   G++   L  +S+           R A  + 
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-------DEQRTATYIT 115
Query: 320 SGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMA 379
                L   HS  +IH DIKP N+LL    E  I+D G ++  P      L     GT+ 
Sbjct: 116 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTXLC----GTLD 171
Query: 380 YIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
           Y+ PE  +     EK D++S G+L    + G P F
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 96/216 (44%), Gaps = 25/216 (11%)
Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           ++ +G G  GEV  A +     + +A+K V +   +   E               I+ EI
Sbjct: 11  VQTLGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPE--------------NIKKEI 55
Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILD-DVSRGRRELDWPSRHRIA 315
                + H N++    H    +   L  E+   G L D ++ D+         P   R  
Sbjct: 56  CINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE-----PDAQRFF 110
Query: 316 LGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVL 375
             + +G+ YLH      I H DIKP N+LL++     ISD GLA          L++ + 
Sbjct: 111 HQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMX 167
Query: 376 GTMAYIAPEYFQQPEL-SEKCDIFSFGMLLISLVRG 410
           GT+ Y+APE  ++ E  +E  D++S G++L +++ G
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 89/215 (41%), Gaps = 24/215 (11%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  G VY A    S  K I   KV+  A +  A +             Q+R E+   
Sbjct: 19  LGKGKFGNVYLAREKQS--KFILALKVLFKAQLEKAGVEH-----------QLRREVEIQ 65
Query: 260 SQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVA 319
           S +RH NIL L  +        L+ E+   G++   L  +S+           R A  + 
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-------DEQRTATYIT 118
Query: 320 SGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMA 379
                L   HS  +IH DIKP N+LL    E  I+D G ++  P      L     GT+ 
Sbjct: 119 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALC----GTLD 174
Query: 380 YIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
           Y+ PE  +     EK D++S G+L    + G P F
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 209

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 25/216 (11%)
Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           ++ +G G  GEV  A +     + +A+K V +   +   E               I+ EI
Sbjct: 11  VQTLGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPE--------------NIKKEI 55
Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILD-DVSRGRRELDWPSRHRIA 315
                + H N++    H    +   L  E+   G L D ++ D+      +  P   R  
Sbjct: 56  CINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFF 110
Query: 316 LGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVL 375
             + +G+ YLH      I H DIKP N+LL++     ISD GLA          L++ + 
Sbjct: 111 HQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMX 167
Query: 376 GTMAYIAPEYFQQPEL-SEKCDIFSFGMLLISLVRG 410
           GT+ Y+APE  ++ E  +E  D++S G++L +++ G
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 96/216 (44%), Gaps = 25/216 (11%)
Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           ++ +G G  GEV  A +     + +A+K V +   +   E               I+ EI
Sbjct: 11  VQTLGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPE--------------NIKKEI 55
Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILD-DVSRGRRELDWPSRHRIA 315
                + H N++    H    +   L  E+   G L D ++ D+         P   R  
Sbjct: 56  CINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE-----PDAQRFF 110
Query: 316 LGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVL 375
             + +G+ YLH      I H DIKP N+LL++     ISD GLA          L++ + 
Sbjct: 111 HQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 167
Query: 376 GTMAYIAPEYFQQPEL-SEKCDIFSFGMLLISLVRG 410
           GT+ Y+APE  ++ E  +E  D++S G++L +++ G
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 82/315 (26%), Positives = 141/315 (44%), Gaps = 54/315 (17%)
Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           E IG G  GEV++ +     G+ +A+K   +++        EE S  R++       EI 
Sbjct: 15  ESIGKGRFGEVWRGKW---RGEEVAVK---IFSSR------EERSWFREA-------EIY 55
Query: 258 TASQIRHRNILPLLAHMVRPDCHL----LVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
               +RH NIL  +A   + +       LV ++ ++GSL D L+     R  +      +
Sbjct: 56  QTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIK 110
Query: 314 IALGVASGLEYLHM-----YHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTR 368
           +AL  ASGL +LHM         +I H D+K +N+L+  +   CI+DLGLA+        
Sbjct: 111 LALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDT 170
Query: 369 VLIS--YVLGTMAYIAPEYF------QQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNG 420
           + I+  + +GT  Y+APE        +  E  ++ DI++ G++   + R       H++ 
Sbjct: 171 IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 230
Query: 421 E--------EICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVL-KIAYICTLHDPE 471
           +           S E +RKV+  +     + P +P      + L V+ KI   C   +  
Sbjct: 231 QLPYYDLVPSDPSVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGA 286
Query: 472 ERPNSQYVRCRLSQL 486
            R  +  ++  LSQL
Sbjct: 287 ARLTALRIKKTLSQL 301

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 82/181 (45%), Gaps = 7/181 (3%)
Query: 234 AAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQ 293
           A +++E+   ++++K+  +  E    S++ H   + L       +       + KNG L 
Sbjct: 59  AIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELL 118
Query: 294 DILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACI 353
             +  +       D          + S LEYLH      IIH D+KP N+LLN+DM   I
Sbjct: 119 KYIRKIG----SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQI 171
Query: 354 SDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPS 413
           +D G A  +     +   +  +GT  Y++PE   +    +  D+++ G ++  LV G+P 
Sbjct: 172 TDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
Query: 414 F 414
           F
Sbjct: 232 F 232

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 25/216 (11%)
Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           ++ +G G  GEV  A +     + +A+K V +   +   E               I+ EI
Sbjct: 11  VQTLGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPE--------------NIKKEI 55
Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILD-DVSRGRRELDWPSRHRIA 315
                + H N++    H    +   L  E+   G L D ++ D+      +  P   R  
Sbjct: 56  CINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFF 110
Query: 316 LGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVL 375
             + +G+ YLH      I H DIKP N+LL++     ISD GLA          L++ + 
Sbjct: 111 HQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMX 167
Query: 376 GTMAYIAPEYFQQPEL-SEKCDIFSFGMLLISLVRG 410
           GT+ Y+APE  ++ E  +E  D++S G++L +++ G
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 78/162 (48%), Gaps = 10/162 (6%)
Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILD-DVSRGRRELDWP 309
            I+ EI     + H N++    H    +   L  E+   G L D ++ D+      +  P
Sbjct: 50  NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEP 104
Query: 310 SRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRV 369
              R    + +G+ YLH      I H DIKP N+LL++     ISD GLA          
Sbjct: 105 DAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 161
Query: 370 LISYVLGTMAYIAPEYFQQPEL-SEKCDIFSFGMLLISLVRG 410
           L++ + GT+ Y+APE  ++ E  +E  D++S G++L +++ G
Sbjct: 162 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 82/181 (45%), Gaps = 7/181 (3%)
Query: 234 AAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQ 293
           A +++E+   ++++K+  +  E    S++ H   + L       +       + KNG L 
Sbjct: 62  AIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELL 121
Query: 294 DILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACI 353
             +  +       D          + S LEYLH      IIH D+KP N+LLN+DM   I
Sbjct: 122 KYIRKIG----SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQI 174
Query: 354 SDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPS 413
           +D G A  +     +   +  +GT  Y++PE   +    +  D+++ G ++  LV G+P 
Sbjct: 175 TDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 234
Query: 414 F 414
           F
Sbjct: 235 F 235

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 102/235 (43%), Gaps = 36/235 (15%)
Query: 178 PLIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAEL 237
           P +E  DL           ++ +G G  GEV  A +     + +A+K V +   +   E 
Sbjct: 4   PFVEDWDL-----------VQTLGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPE- 50
Query: 238 IEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILD 297
                         I+ EI     + H N++    H    +   L  E+   G L D ++
Sbjct: 51  -------------NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE 97
Query: 298 -DVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDL 356
            D+      +  P   R    + +G+ YLH      I H DIKP N+LL++     ISD 
Sbjct: 98  PDIG-----MPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDF 149
Query: 357 GLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPEL-SEKCDIFSFGMLLISLVRG 410
           GLA          L++ + GT+ Y+APE  ++ E  +E  D++S G++L +++ G
Sbjct: 150 GLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 83/315 (26%), Positives = 141/315 (44%), Gaps = 54/315 (17%)
Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           E IG G  GEV++ +     G+ +A+K       I ++   EE S  R++       EI 
Sbjct: 10  ESIGKGRFGEVWRGKW---RGEEVAVK-------IFSSR--EERSWFREA-------EIY 50
Query: 258 TASQIRHRNILPLLAHMVRPDCHL----LVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
               +RH NIL  +A   + +       LV ++ ++GSL D L+     R  +      +
Sbjct: 51  QTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIK 105
Query: 314 IALGVASGLEYLHM-----YHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTR 368
           +AL  ASGL +LHM         +I H D+K +N+L+  +   CI+DLGLA+        
Sbjct: 106 LALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDT 165
Query: 369 VLIS--YVLGTMAYIAPEYF------QQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNG 420
           + I+  + +GT  Y+APE        +  E  ++ DI++ G++   + R       H++ 
Sbjct: 166 IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 225
Query: 421 E--------EICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVL-KIAYICTLHDPE 471
           +           S E +RKV+  +     + P +P      + L V+ KI   C   +  
Sbjct: 226 QLPYYDLVPSDPSVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGA 281
Query: 472 ERPNSQYVRCRLSQL 486
            R  +  ++  LSQL
Sbjct: 282 ARLTALRIKKTLSQL 296

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 25/216 (11%)
Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           ++ +G G  GEV  A +     + +A+K V +   +   E               I+ EI
Sbjct: 11  VQTLGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPE--------------NIKKEI 55
Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILD-DVSRGRRELDWPSRHRIA 315
                + H N++    H    +   L  E+   G L D ++ D+      +  P   R  
Sbjct: 56  XINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFF 110
Query: 316 LGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVL 375
             + +G+ YLH      I H DIKP N+LL++     ISD GLA          L++ + 
Sbjct: 111 HQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMX 167
Query: 376 GTMAYIAPEYFQQPEL-SEKCDIFSFGMLLISLVRG 410
           GT+ Y+APE  ++ E  +E  D++S G++L +++ G
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 82/181 (45%), Gaps = 7/181 (3%)
Query: 234 AAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQ 293
           A +++E+   ++++K+  +  E    S++ H   + L       +       + KNG L 
Sbjct: 59  AIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELL 118
Query: 294 DILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACI 353
             +  +       D          + S LEYLH      IIH D+KP N+LLN+DM   I
Sbjct: 119 KYIRKIG----SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQI 171
Query: 354 SDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPS 413
           +D G A  +     +   +  +GT  Y++PE   +    +  D+++ G ++  LV G+P 
Sbjct: 172 TDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
Query: 414 F 414
           F
Sbjct: 232 F 232

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 25/216 (11%)
Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           ++ +G G  GEV  A +     + +A+K V +   +   E               I+ EI
Sbjct: 12  VQTLGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPE--------------NIKKEI 56
Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILD-DVSRGRRELDWPSRHRIA 315
                + H N++    H    +   L  E+   G L D ++ D+      +  P   R  
Sbjct: 57  XINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFF 111
Query: 316 LGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVL 375
             + +G+ YLH      I H DIKP N+LL++     ISD GLA          L++ + 
Sbjct: 112 HQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMX 168
Query: 376 GTMAYIAPEYFQQPEL-SEKCDIFSFGMLLISLVRG 410
           GT+ Y+APE  ++ E  +E  D++S G++L +++ G
Sbjct: 169 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 25/216 (11%)
Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           ++ +G G  GEV  A +     + +A+K V +   +   E               I+ EI
Sbjct: 12  VQTLGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPE--------------NIKKEI 56
Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILD-DVSRGRRELDWPSRHRIA 315
                + H N++    H    +   L  E+   G L D ++ D+      +  P   R  
Sbjct: 57  CINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFF 111
Query: 316 LGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVL 375
             + +G+ YLH      I H DIKP N+LL++     ISD GLA          L++ + 
Sbjct: 112 HQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 168
Query: 376 GTMAYIAPEYFQQPEL-SEKCDIFSFGMLLISLVRG 410
           GT+ Y+APE  ++ E  +E  D++S G++L +++ G
Sbjct: 169 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 25/216 (11%)
Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           ++ +G G  GEV  A +     + +A+K V +   +   E               I+ EI
Sbjct: 11  VQTLGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPE--------------NIKKEI 55
Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILD-DVSRGRRELDWPSRHRIA 315
                + H N++    H    +   L  E+   G L D ++ D+      +  P   R  
Sbjct: 56  XINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFF 110
Query: 316 LGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVL 375
             + +G+ YLH      I H DIKP N+LL++     ISD GLA          L++ + 
Sbjct: 111 HQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 167
Query: 376 GTMAYIAPEYFQQPEL-SEKCDIFSFGMLLISLVRG 410
           GT+ Y+APE  ++ E  +E  D++S G++L +++ G
Sbjct: 168 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 101/235 (42%), Gaps = 36/235 (15%)
Query: 178 PLIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAEL 237
           P +E  DL           ++ +G G  GEV  A +     + +A+K V +   +   E 
Sbjct: 3   PFVEDWDL-----------VQTLGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPE- 49
Query: 238 IEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILD 297
                         I+ EI     + H N++    H    +   L  E+   G L D ++
Sbjct: 50  -------------NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE 96
Query: 298 -DVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDL 356
            D+         P   R    + +G+ YLH      I H DIKP N+LL++     ISD 
Sbjct: 97  PDIGMPE-----PDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDF 148
Query: 357 GLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPEL-SEKCDIFSFGMLLISLVRG 410
           GLA          L++ + GT+ Y+APE  ++ E  +E  D++S G++L +++ G
Sbjct: 149 GLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 82/181 (45%), Gaps = 7/181 (3%)
Query: 234 AAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQ 293
           A +++E+   ++++K+  +  E    S++ H   + L       +       + KNG L 
Sbjct: 61  AIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELL 120
Query: 294 DILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACI 353
             +  +       D          + S LEYLH      IIH D+KP N+LLN+DM   I
Sbjct: 121 KYIRKIG----SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQI 173
Query: 354 SDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPS 413
           +D G A  +     +   +  +GT  Y++PE   +    +  D+++ G ++  LV G+P 
Sbjct: 174 TDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233
Query: 414 F 414
           F
Sbjct: 234 F 234

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 82/181 (45%), Gaps = 7/181 (3%)
Query: 234 AAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQ 293
           A +++E+   ++++K+  +  E    S++ H   + L       +       + KNG L 
Sbjct: 61  AIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELL 120
Query: 294 DILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACI 353
             +  +       D          + S LEYLH      IIH D+KP N+LLN+DM   I
Sbjct: 121 KYIRKIG----SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQI 173
Query: 354 SDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPS 413
           +D G A  +     +   +  +GT  Y++PE   +    +  D+++ G ++  LV G+P 
Sbjct: 174 TDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233
Query: 414 F 414
           F
Sbjct: 234 F 234

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 82/181 (45%), Gaps = 7/181 (3%)
Query: 234 AAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQ 293
           A +++E+   ++++K+  +  E    S++ H   + L       +       + KNG L 
Sbjct: 59  AIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELL 118
Query: 294 DILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACI 353
             +  +       D          + S LEYLH      IIH D+KP N+LLN+DM   I
Sbjct: 119 KYIRKIG----SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQI 171
Query: 354 SDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPS 413
           +D G A  +     +   +  +GT  Y++PE   +    +  D+++ G ++  LV G+P 
Sbjct: 172 TDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
Query: 414 F 414
           F
Sbjct: 232 F 232

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 82/181 (45%), Gaps = 7/181 (3%)
Query: 234 AAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQ 293
           A +++E+   ++++K+  +  E    S++ H   + L       +       + KNG L 
Sbjct: 43  AIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELL 102
Query: 294 DILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACI 353
             +  +       D          + S LEYLH      IIH D+KP N+LLN+DM   I
Sbjct: 103 KYIRKIG----SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQI 155
Query: 354 SDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPS 413
           +D G A  +     +   +  +GT  Y++PE   +    +  D+++ G ++  LV G+P 
Sbjct: 156 TDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 215
Query: 414 F 414
           F
Sbjct: 216 F 216

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 82/181 (45%), Gaps = 7/181 (3%)
Query: 234 AAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQ 293
           A +++E+   ++++K+  +  E    S++ H   + L       +       + KNG L 
Sbjct: 61  AIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELL 120
Query: 294 DILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACI 353
             +  +       D          + S LEYLH      IIH D+KP N+LLN+DM   I
Sbjct: 121 KYIRKIG----SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQI 173
Query: 354 SDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPS 413
           +D G A  +     +   +  +GT  Y++PE   +    +  D+++ G ++  LV G+P 
Sbjct: 174 TDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233
Query: 414 F 414
           F
Sbjct: 234 F 234

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 78/162 (48%), Gaps = 10/162 (6%)
Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILD-DVSRGRRELDWP 309
            I+ EI     + H N++    H    +   L  E+   G L D ++ D+      +  P
Sbjct: 51  NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEP 105
Query: 310 SRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRV 369
              R    + +G+ YLH      I H DIKP N+LL++     ISD GLA          
Sbjct: 106 DAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162
Query: 370 LISYVLGTMAYIAPEYFQQPEL-SEKCDIFSFGMLLISLVRG 410
           L++ + GT+ Y+APE  ++ E  +E  D++S G++L +++ G
Sbjct: 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 78/162 (48%), Gaps = 10/162 (6%)
Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILD-DVSRGRRELDWP 309
            I+ EI     + H N++    H    +   L  E+   G L D ++ D+      +  P
Sbjct: 51  NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEP 105
Query: 310 SRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRV 369
              R    + +G+ YLH      I H DIKP N+LL++     ISD GLA          
Sbjct: 106 DAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162
Query: 370 LISYVLGTMAYIAPEYFQQPEL-SEKCDIFSFGMLLISLVRG 410
           L++ + GT+ Y+APE  ++ E  +E  D++S G++L +++ G
Sbjct: 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 78/162 (48%), Gaps = 10/162 (6%)
Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILD-DVSRGRRELDWP 309
            I+ EI     + H N++    H    +   L  E+   G L D ++ D+      +  P
Sbjct: 51  NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEP 105
Query: 310 SRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRV 369
              R    + +G+ YLH      I H DIKP N+LL++     ISD GLA          
Sbjct: 106 DAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162
Query: 370 LISYVLGTMAYIAPEYFQQPEL-SEKCDIFSFGMLLISLVRG 410
           L++ + GT+ Y+APE  ++ E  +E  D++S G++L +++ G
Sbjct: 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 83/315 (26%), Positives = 141/315 (44%), Gaps = 54/315 (17%)
Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           E IG G  GEV++ +     G+ +A+K       I ++   EE S  R++       EI 
Sbjct: 35  ESIGKGRFGEVWRGKW---RGEEVAVK-------IFSSR--EERSWFREA-------EIY 75
Query: 258 TASQIRHRNILPLLAHMVRPDCHL----LVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
               +RH NIL  +A   + +       LV ++ ++GSL D L+     R  +      +
Sbjct: 76  QTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIK 130
Query: 314 IALGVASGLEYLHM-----YHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTR 368
           +AL  ASGL +LHM         +I H D+K +N+L+  +   CI+DLGLA+        
Sbjct: 131 LALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDT 190
Query: 369 VLIS--YVLGTMAYIAPEYF------QQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNG 420
           + I+  + +GT  Y+APE        +  E  ++ DI++ G++   + R       H++ 
Sbjct: 191 IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 250
Query: 421 E--------EICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVL-KIAYICTLHDPE 471
           +           S E +RKV+  +     + P +P      + L V+ KI   C   +  
Sbjct: 251 QLPYYDLVPSDPSVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGA 306
Query: 472 ERPNSQYVRCRLSQL 486
            R  +  ++  LSQL
Sbjct: 307 ARLTALRIKKTLSQL 321

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 89/215 (41%), Gaps = 24/215 (11%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  G VY A    S  K I   KV+  A +  A +             Q+R E+   
Sbjct: 16  LGKGKFGNVYLAREKQS--KFILALKVLFKAQLEKAGVEH-----------QLRREVEIQ 62
Query: 260 SQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVA 319
           S +RH NIL L  +        L+ E+   G++   L  +S+           R A  + 
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-------DEQRTATYIT 115
Query: 320 SGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMA 379
                L   HS  +IH DIKP N+LL    E  I+D G ++  P      L     GT+ 
Sbjct: 116 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTELC----GTLD 171
Query: 380 YIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
           Y+ PE  +     EK D++S G+L    + G P F
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 82/181 (45%), Gaps = 7/181 (3%)
Query: 234 AAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQ 293
           A +++E+   ++++K+  +  E    S++ H   + L       +       + KNG L 
Sbjct: 61  AIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELL 120
Query: 294 DILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACI 353
             +  +       D          + S LEYLH      IIH D+KP N+LLN+DM   I
Sbjct: 121 KYIRKIG----SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQI 173
Query: 354 SDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPS 413
           +D G A  +     +   +  +GT  Y++PE   +    +  D+++ G ++  LV G+P 
Sbjct: 174 TDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAXKSSDLWALGCIIYQLVAGLPP 233
Query: 414 F 414
           F
Sbjct: 234 F 234

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 89/215 (41%), Gaps = 24/215 (11%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  G VY A    S  K I   KV+  A +  A +             Q+R E+   
Sbjct: 17  LGKGKFGNVYLAREKQS--KFILALKVLFKAQLEKAGVEH-----------QLRREVEIQ 63
Query: 260 SQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVA 319
           S +RH NIL L  +        L+ E+   G++   L  +S+           R A  + 
Sbjct: 64  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-------DEQRTATYIT 116
Query: 320 SGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMA 379
                L   HS  +IH DIKP N+LL    E  I+D G ++  P      L     GT+ 
Sbjct: 117 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTLD 172
Query: 380 YIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
           Y+ PE  +     EK D++S G+L    + G P F
Sbjct: 173 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 207

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 82/181 (45%), Gaps = 7/181 (3%)
Query: 234 AAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQ 293
           A +++E+   ++++K+  +  E    S++ H   + L       +       + KNG L 
Sbjct: 61  AIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELL 120
Query: 294 DILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACI 353
             +  +       D          + S LEYLH      IIH D+KP N+LLN+DM   I
Sbjct: 121 KYIRKIG----SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQI 173
Query: 354 SDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPS 413
           +D G A  +     +   +  +GT  Y++PE   +    +  D+++ G ++  LV G+P 
Sbjct: 174 TDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233
Query: 414 F 414
           F
Sbjct: 234 F 234

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 101/235 (42%), Gaps = 36/235 (15%)
Query: 178 PLIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAEL 237
           P +E  DL           ++ +G G  GEV  A +     + +A+K V +   +   E 
Sbjct: 4   PFVEDWDL-----------VQTLGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPE- 50
Query: 238 IEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILD 297
                         I+ EI     + H N++    H    +   L  E+   G L D ++
Sbjct: 51  -------------NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE 97
Query: 298 -DVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDL 356
            D+         P   R    + +G+ YLH      I H DIKP N+LL++     ISD 
Sbjct: 98  PDIGMPE-----PDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDF 149
Query: 357 GLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPEL-SEKCDIFSFGMLLISLVRG 410
           GLA          L++ + GT+ Y+APE  ++ E  +E  D++S G++L +++ G
Sbjct: 150 GLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 83/315 (26%), Positives = 140/315 (44%), Gaps = 54/315 (17%)
Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           E IG G  GEV++ +     G+ +A+K       I ++   EE S  R++       EI 
Sbjct: 48  ESIGKGRFGEVWRGKW---RGEEVAVK-------IFSSR--EERSWFREA-------EIY 88
Query: 258 TASQIRHRNILPLLAHMVRPDCHL----LVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
               +RH NIL  +A   + +       LV ++ ++GSL D L+     R  +      +
Sbjct: 89  QTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIK 143
Query: 314 IALGVASGLEYLHM-----YHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTR 368
           +AL  ASGL +LHM         +I H D+K +N+L+  +   CI+DLGLA+        
Sbjct: 144 LALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDT 203
Query: 369 VLIS--YVLGTMAYIAPEYFQQP------ELSEKCDIFSFGMLLISLVRGVPSFVFHQNG 420
           + I+  + +GT  Y+APE           E  ++ DI++ G++   + R       H++ 
Sbjct: 204 IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 263
Query: 421 E--------EICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVL-KIAYICTLHDPE 471
           +           S E +RKV+  +     + P +P      + L V+ KI   C   +  
Sbjct: 264 QLPYYDLVPSDPSVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGA 319
Query: 472 ERPNSQYVRCRLSQL 486
            R  +  ++  LSQL
Sbjct: 320 ARLTALRIKKTLSQL 334

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 83/315 (26%), Positives = 141/315 (44%), Gaps = 54/315 (17%)
Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           E IG G  GEV++ +     G+ +A+K       I ++   EE S  R++       EI 
Sbjct: 12  ESIGKGRFGEVWRGKW---RGEEVAVK-------IFSSR--EERSWFREA-------EIY 52
Query: 258 TASQIRHRNILPLLAHMVRPDCHL----LVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
               +RH NIL  +A   + +       LV ++ ++GSL D L+     R  +      +
Sbjct: 53  QTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIK 107
Query: 314 IALGVASGLEYLHM-----YHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTR 368
           +AL  ASGL +LHM         +I H D+K +N+L+  +   CI+DLGLA+        
Sbjct: 108 LALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDT 167
Query: 369 VLIS--YVLGTMAYIAPEYF------QQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNG 420
           + I+  + +GT  Y+APE        +  E  ++ DI++ G++   + R       H++ 
Sbjct: 168 IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 227
Query: 421 E--------EICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVL-KIAYICTLHDPE 471
           +           S E +RKV+  +     + P +P      + L V+ KI   C   +  
Sbjct: 228 QLPYYDLVPSDPSVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGA 283
Query: 472 ERPNSQYVRCRLSQL 486
            R  +  ++  LSQL
Sbjct: 284 ARLTALRIKKTLSQL 298

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 83/315 (26%), Positives = 141/315 (44%), Gaps = 54/315 (17%)
Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           E IG G  GEV++ +     G+ +A+K       I ++   EE S  R++       EI 
Sbjct: 9   ESIGKGRFGEVWRGKW---RGEEVAVK-------IFSSR--EERSWFREA-------EIY 49
Query: 258 TASQIRHRNILPLLAHMVRPDCHL----LVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
               +RH NIL  +A   + +       LV ++ ++GSL D L+     R  +      +
Sbjct: 50  QTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIK 104
Query: 314 IALGVASGLEYLHM-----YHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTR 368
           +AL  ASGL +LHM         +I H D+K +N+L+  +   CI+DLGLA+        
Sbjct: 105 LALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDT 164
Query: 369 VLIS--YVLGTMAYIAPEYF------QQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNG 420
           + I+  + +GT  Y+APE        +  E  ++ DI++ G++   + R       H++ 
Sbjct: 165 IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 224
Query: 421 E--------EICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVL-KIAYICTLHDPE 471
           +           S E +RKV+  +     + P +P      + L V+ KI   C   +  
Sbjct: 225 QLPYYDLVPSDPSVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGA 280
Query: 472 ERPNSQYVRCRLSQL 486
            R  +  ++  LSQL
Sbjct: 281 ARLTALRIKKTLSQL 295

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 82/181 (45%), Gaps = 7/181 (3%)
Query: 234 AAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQ 293
           A +++E+   ++++K+  +  E    S++ H   + L       +       + KNG L 
Sbjct: 58  AIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELL 117
Query: 294 DILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACI 353
             +  +       D          + S LEYLH      IIH D+KP N+LLN+DM   I
Sbjct: 118 KYIRKIG----SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQI 170
Query: 354 SDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPS 413
           +D G A  +     +   +  +GT  Y++PE   +    +  D+++ G ++  LV G+P 
Sbjct: 171 TDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 230
Query: 414 F 414
           F
Sbjct: 231 F 231

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 89/215 (41%), Gaps = 24/215 (11%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  G VY A    S  K I   KV+  A +  A +             Q+R E+   
Sbjct: 16  LGKGKFGNVYLAREKQS--KFILALKVLFKAQLEKAGVEH-----------QLRREVEIQ 62
Query: 260 SQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVA 319
           S +RH NIL L  +        L+ E+   G++   L  +S+           R A  + 
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-------DEQRTATYIT 115
Query: 320 SGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMA 379
                L   HS  +IH DIKP N+LL    E  I+D G ++  P      L     GT+ 
Sbjct: 116 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTLD 171
Query: 380 YIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
           Y+ PE  +     EK D++S G+L    + G P F
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 113/233 (48%), Gaps = 43/233 (18%)
Query: 195 ASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRS 254
           A +E +G G  GEV++      +G+ +A+K       I ++   +E S  R++       
Sbjct: 11  ALVECVGKGRYGEVWRGLW---HGESVAVK-------IFSSR--DEQSWFRET------- 51
Query: 255 EIITASQIRHRNILPLLAH-MVRPDCH---LLVYEFMKNGSLQDILDDVSRGRRELDWPS 310
           EI     +RH NIL  +A  M   +      L+  + ++GSL D L      R+ L+   
Sbjct: 52  EIYNTVLLRHDNILGFIASDMTSRNSSTQLWLITHYHEHGSLYDFLQ-----RQTLEPHL 106
Query: 311 RHRIALGVASGLEYLHM-----YHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG 365
             R+A+  A GL +LH+         +I H D K RNVL+  +++ CI+DLGLA+    G
Sbjct: 107 ALRLAVSAACGLAHLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQG 166
Query: 366 --YTRVLISYVLGTMAYIAPEYFQQPELSEKC-------DIFSFGMLLISLVR 409
             Y  +  +  +GT  Y+APE   + ++   C       DI++FG++L  + R
Sbjct: 167 SDYLDIGNNPRVGTKRYMAPEVLDE-QIRTDCFESYKWTDIWAFGLVLWEIAR 218

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 88/215 (40%), Gaps = 24/215 (11%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  G VY A       K I   KV+  A +  A +             Q+R E+   
Sbjct: 42  LGKGKFGNVYLAR--EKQSKFILALKVLFKAQLEKAGVE-----------HQLRREVEIQ 88
Query: 260 SQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVA 319
           S +RH NIL L  +        L+ E+   G++   L  +S+           R A  + 
Sbjct: 89  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-------DEQRTATYIT 141
Query: 320 SGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMA 379
                L   HS  +IH DIKP N+LL    E  I+D G ++  P      L     GT+ 
Sbjct: 142 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLC----GTLD 197
Query: 380 YIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
           Y+ PE  +     EK D++S G+L    + G P F
Sbjct: 198 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 232

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 82/181 (45%), Gaps = 7/181 (3%)
Query: 234 AAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQ 293
           A +++E+   ++++K+  +  E    S++ H   + L       +       + KNG L 
Sbjct: 59  AIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELL 118
Query: 294 DILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACI 353
             +  +       D          + S LEYLH      IIH D+KP N+LLN+DM   I
Sbjct: 119 KYIRKIG----SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQI 171
Query: 354 SDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPS 413
           +D G A  +     +   +  +GT  Y++PE   +    +  D+++ G ++  LV G+P 
Sbjct: 172 TDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
Query: 414 F 414
           F
Sbjct: 232 F 232

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 82/181 (45%), Gaps = 7/181 (3%)
Query: 234 AAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQ 293
           A +++E+   ++++K+  +  E    S++ H   + L       +       + KNG L 
Sbjct: 64  AIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELL 123
Query: 294 DILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACI 353
             +  +       D          + S LEYLH      IIH D+KP N+LLN+DM   I
Sbjct: 124 KYIRKIG----SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQI 176
Query: 354 SDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPS 413
           +D G A  +     +   +  +GT  Y++PE   +    +  D+++ G ++  LV G+P 
Sbjct: 177 TDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 236
Query: 414 F 414
           F
Sbjct: 237 F 237

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 88/215 (40%), Gaps = 24/215 (11%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  G VY A       K I   KV+  A +  A +             Q+R E+   
Sbjct: 13  LGKGKFGNVYLAR--EKQRKFILALKVLFKAQLEKAGVEH-----------QLRREVEIQ 59
Query: 260 SQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVA 319
           S +RH NIL L  +        L+ E+   G++   L  +S+           R A  + 
Sbjct: 60  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-------DEQRTATYIT 112
Query: 320 SGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMA 379
                L   HS  +IH DIKP N+LL    E  I+D G ++  P      L     GT+ 
Sbjct: 113 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLD 168
Query: 380 YIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
           Y+ PE  +     EK D++S G+L    + G P F
Sbjct: 169 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 203

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 82/181 (45%), Gaps = 7/181 (3%)
Query: 234 AAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQ 293
           A +++E+   ++++K+  +  E    S++ H   + L       +       + KNG L 
Sbjct: 62  AIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELL 121
Query: 294 DILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACI 353
             +  +       D          + S LEYLH      IIH D+KP N+LLN+DM   I
Sbjct: 122 KYIRKIG----SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQI 174
Query: 354 SDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPS 413
           +D G A  +     +   +  +GT  Y++PE   +    +  D+++ G ++  LV G+P 
Sbjct: 175 TDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 234
Query: 414 F 414
           F
Sbjct: 235 F 235

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 89/215 (41%), Gaps = 24/215 (11%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  G VY A    S  K I   KV+  A +  A +             Q+R E+   
Sbjct: 21  LGKGKFGNVYLAREKQS--KFILALKVLFKAQLEKAGVEH-----------QLRREVEIQ 67
Query: 260 SQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVA 319
           S +RH NIL L  +        L+ E+   G++   L  +S+           R A  + 
Sbjct: 68  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-------DEQRTATYIT 120
Query: 320 SGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMA 379
                L   HS  +IH DIKP N+LL    E  I+D G ++  P      L     GT+ 
Sbjct: 121 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTLD 176
Query: 380 YIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
           Y+ PE  +     EK D++S G+L    + G P F
Sbjct: 177 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 211

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 106/229 (46%), Gaps = 27/229 (11%)
Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           ++IGSG  G VYK +  G     +A+K + V AP                +L+  ++E+ 
Sbjct: 30  QRIGSGSFGTVYKGKWHGD----VAVKMLNVTAPTP-------------QQLQAFKNEVG 72
Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALG 317
              + RH NIL  + +   P    +V ++ +  SL   L   S  + E+       IA  
Sbjct: 73  VLRKTRHVNILLFMGYSTAPQL-AIVTQWCEGSSLYHHLH-ASETKFEMK--KLIDIARQ 128
Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGT 377
            A G++YLH   + SIIH D+K  N+ L++D    I D GLA              + G+
Sbjct: 129 TARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGS 185
Query: 378 MAYIAPEYFQQPE---LSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI 423
           + ++APE  +  +    S + D+++FG++L  L+ G   +    N ++I
Sbjct: 186 ILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 234

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 93/209 (44%), Gaps = 31/209 (14%)
Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           L+ IG G  G+V   +  G+   +  IK                     D+  +   +E 
Sbjct: 17  LQTIGKGEFGDVMLGDYRGNKVAVKCIKN--------------------DATAQAFLAEA 56
Query: 257 ITASQIRHRNILPLLAHMVRPDCHL-LVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIA 315
              +Q+RH N++ LL  +V     L +V E+M  GSL D L   SRGR  L      + +
Sbjct: 57  SVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFS 114
Query: 316 LGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVL 375
           L V   +EYL      + +H D+  RNVL+++D  A +SD GL            +    
Sbjct: 115 LDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP--- 168
Query: 376 GTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
             + + APE  ++   S K D++SFG+LL
Sbjct: 169 --VKWTAPEALREAAFSTKSDVWSFGILL 195

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 85/181 (46%), Gaps = 21/181 (11%)
Query: 244 LRDSKLRQIRSEIITASQIRHRNILPLLAHMVRP---DCHL-LVYEFMKNGSLQDILDDV 299
           ++D +  Q   E+ +   ++H NIL  +    R    D  L L+  F + GSL D L   
Sbjct: 57  IQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK-- 114
Query: 300 SRGRRELDWPSRHRIALGVASGLEYLHM-------YHSASIIHGDIKPRNVLLNDDMEAC 352
                 + W     IA  +A GL YLH         H  +I H DIK +NVLL +++ AC
Sbjct: 115 ---ANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC 171
Query: 353 ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQ-----QPELSEKCDIFSFGMLLISL 407
           I+D GLA+    G +       +GT  Y+APE  +     Q +   + D+++ G++L  L
Sbjct: 172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWEL 231
Query: 408 V 408
Sbjct: 232 A 232

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 89/215 (41%), Gaps = 24/215 (11%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  G VY A    S  K I   KV+  A +  A +             Q+R E+   
Sbjct: 18  LGKGKFGNVYLAREKQS--KFILALKVLFKAQLEKAGVEH-----------QLRREVEIQ 64
Query: 260 SQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVA 319
           S +RH NIL L  +        L+ E+   G++   L  +S+           R A  + 
Sbjct: 65  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-------DEQRTATYIT 117
Query: 320 SGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMA 379
                L   HS  +IH DIKP N+LL    E  I++ G ++  P      L     GT+ 
Sbjct: 118 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLC----GTLD 173
Query: 380 YIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
           Y+ PE  +     EK D++S G+L    + G P F
Sbjct: 174 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 208

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 89/215 (41%), Gaps = 24/215 (11%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  G VY A    S  K I   KV+  A +  A +             Q+R E+   
Sbjct: 16  LGKGKFGNVYLAREKQS--KFILALKVLFKAQLEKAGVEH-----------QLRREVEIQ 62
Query: 260 SQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVA 319
           S +RH NIL L  +        L+ E+   G++   L  +S+           R A  + 
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-------DEQRTATYIT 115
Query: 320 SGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMA 379
                L   HS  +IH DIKP N+LL    E  I+D G ++  P      L     GT+ 
Sbjct: 116 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTLD 171
Query: 380 YIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
           Y+ PE  +     EK D++S G+L    + G P F
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 82/181 (45%), Gaps = 7/181 (3%)
Query: 234 AAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQ 293
           A +++E+   ++++K+  +  E    S++ H   + L       +       + KNG L 
Sbjct: 66  AIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFCFQDDEKLYFGLSYAKNGELL 125
Query: 294 DILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACI 353
             +  +       D          + S LEYLH      IIH D+KP N+LLN+DM   I
Sbjct: 126 KYIRKIG----SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQI 178
Query: 354 SDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPS 413
           +D G A  +     +   +  +GT  Y++PE   +    +  D+++ G ++  LV G+P 
Sbjct: 179 TDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 238
Query: 414 F 414
           F
Sbjct: 239 F 239

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 82/181 (45%), Gaps = 7/181 (3%)
Query: 234 AAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQ 293
           A +++E+   ++++K+  +  E    S++ H   + L       +       + KNG L 
Sbjct: 58  AIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELL 117
Query: 294 DILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACI 353
             +  +       D          + S LEYLH      IIH D+KP N+LLN+DM   I
Sbjct: 118 KYIRKIG----SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQI 170
Query: 354 SDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPS 413
           +D G A  +     +   +  +GT  Y++PE   +    +  D+++ G ++  LV G+P 
Sbjct: 171 TDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 230
Query: 414 F 414
           F
Sbjct: 231 F 231

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 110/242 (45%), Gaps = 34/242 (14%)
Query: 204 GCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIR 263
           G   V +  +  + G   A+K + V A   + E +EE   +R++  R+     I      
Sbjct: 105 GVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEE---VREATRRETH---ILRQVAG 158
Query: 264 HRNILPLLAHMVRPDCHLLVYEFMKNGSLQDIL-DDVSRGRRELDWPSRHRIALGVASGL 322
           H +I+ L+          LV++ M+ G L D L + V+   +E     R        S L
Sbjct: 159 HPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMR--------SLL 210
Query: 323 EYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIA 382
           E +   H+ +I+H D+KP N+LL+D+M+  +SD G +  +  G     +  + GT  Y+A
Sbjct: 211 EAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK---LRELCGTPGYLA 267
Query: 383 PEYFQ------QPELSEKCDIFSFGMLLISLVRGVPSF----------VFHQNGEEICSP 426
           PE  +       P   ++ D+++ G++L +L+ G P F          +  +   +  SP
Sbjct: 268 PEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSP 327
Query: 427 EW 428
           EW
Sbjct: 328 EW 329

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 88/215 (40%), Gaps = 24/215 (11%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  G VY A       K I   KV+  A +  A +             Q+R E+   
Sbjct: 19  LGKGKFGNVYLAR--EKQSKFILALKVLFKAQLEKAGVEH-----------QLRREVEIQ 65
Query: 260 SQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVA 319
           S +RH NIL L  +        L+ E+   G++   L  +S+           R A  + 
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-------DEQRTATYIT 118
Query: 320 SGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMA 379
                L   HS  +IH DIKP N+LL    E  I++ G ++  P      L     GT+ 
Sbjct: 119 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLC----GTLD 174
Query: 380 YIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
           Y+ PE  +     EK D++S G+L    + G P F
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 209

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 99/222 (44%), Gaps = 27/222 (12%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           F  L  +G+G  G V+       NG+  A+K            +++++  +R  ++    
Sbjct: 8   FQILRTLGTGSFGRVHLIR-SRHNGRYYAMK------------VLKKEIVVRLKQVEHTN 54
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
            E +  S + H  I+ +           ++ ++++ G L  +L    R  +    P    
Sbjct: 55  DERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLL----RKSQRFPNPVAKF 110
Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISY 373
            A  V   LEYLH   S  II+ D+KP N+LL+ +    I+D G A  +PD      ++Y
Sbjct: 111 YAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD------VTY 161
Query: 374 VL-GTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
            L GT  YIAPE       ++  D +SFG+L+  ++ G   F
Sbjct: 162 XLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF 203

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 69/247 (27%), Positives = 108/247 (43%), Gaps = 26/247 (10%)
Query: 191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
           ED F     +G GG GEV+  ++  + GK+ A KK+             + + +    L 
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMK-ATGKLYACKKLNKKRLKKRKGY--QGAMVEKKILA 240
Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHL-LVYEFMKNGSLQDILDDVSRGRRELDWP 309
           ++ S  I +           LA+       L LV   M  G ++  + +V         P
Sbjct: 241 KVHSRFIVS-----------LAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEP 289
Query: 310 SRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRV 369
                   + SGLE+LH     +II+ D+KP NVLL+DD    ISDLGLA+ +  G T+ 
Sbjct: 290 RAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT 346
Query: 370 LISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLV--RGVPSFVFHQNGEEICSPE 427
                 GT  ++APE     E     D F+ G+ L  ++  RG     F   GE++ + E
Sbjct: 347 --KGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARG----PFRARGEKVENKE 400
Query: 428 WLRKVMN 434
             ++V+ 
Sbjct: 401 LKQRVLE 407

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 91/223 (40%), Gaps = 24/223 (10%)
Query: 192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ 251
           D F  +  +G G  G VY A       K I   KV+  + +   E +E           Q
Sbjct: 14  DDFDIVRPLGKGKFGNVYLAR--EKQNKFIMALKVLFKSQLEK-EGVEH----------Q 60
Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
           +R EI   S +RH NIL +  +        L+ EF   G L   L    R          
Sbjct: 61  LRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRF-------DE 113
Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLI 371
            R A  +    + LH  H   +IH DIKP N+L+    E  I+D G ++  P    R + 
Sbjct: 114 QRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMC 173
Query: 372 SYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
               GT+ Y+ PE  +     EK D++  G+L    + G+P F
Sbjct: 174 ----GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPF 212

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 69/247 (27%), Positives = 108/247 (43%), Gaps = 26/247 (10%)
Query: 191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
           ED F     +G GG GEV+  ++  + GK+ A KK+             + + +    L 
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMK-ATGKLYACKKLNKKRLKKRKGY--QGAMVEKKILA 240
Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHL-LVYEFMKNGSLQDILDDVSRGRRELDWP 309
           ++ S  I +           LA+       L LV   M  G ++  + +V         P
Sbjct: 241 KVHSRFIVS-----------LAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEP 289
Query: 310 SRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRV 369
                   + SGLE+LH     +II+ D+KP NVLL+DD    ISDLGLA+ +  G T+ 
Sbjct: 290 RAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT 346
Query: 370 LISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLV--RGVPSFVFHQNGEEICSPE 427
                 GT  ++APE     E     D F+ G+ L  ++  RG     F   GE++ + E
Sbjct: 347 --KGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARG----PFRARGEKVENKE 400
Query: 428 WLRKVMN 434
             ++V+ 
Sbjct: 401 LKQRVLE 407

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 69/247 (27%), Positives = 108/247 (43%), Gaps = 26/247 (10%)
Query: 191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
           ED F     +G GG GEV+  ++  + GK+ A KK+             + + +    L 
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMK-ATGKLYACKKLNKKRLKKRKGY--QGAMVEKKILA 240
Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHL-LVYEFMKNGSLQDILDDVSRGRRELDWP 309
           ++ S  I +           LA+       L LV   M  G ++  + +V         P
Sbjct: 241 KVHSRFIVS-----------LAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEP 289
Query: 310 SRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRV 369
                   + SGLE+LH     +II+ D+KP NVLL+DD    ISDLGLA+ +  G T+ 
Sbjct: 290 RAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT 346
Query: 370 LISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLV--RGVPSFVFHQNGEEICSPE 427
                 GT  ++APE     E     D F+ G+ L  ++  RG     F   GE++ + E
Sbjct: 347 --KGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARG----PFRARGEKVENKE 400
Query: 428 WLRKVMN 434
             ++V+ 
Sbjct: 401 LKQRVLE 407

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 88/215 (40%), Gaps = 24/215 (11%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  G VY A       K I   KV+  A +  A +             Q+R E+   
Sbjct: 19  LGKGKFGNVYLAR--EKQSKFILALKVLFKAQLEKAGVEH-----------QLRREVEIQ 65
Query: 260 SQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVA 319
           S +RH NIL L  +        L+ E+   G++   L  +S+           R A  + 
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF-------DEQRTATYIT 118
Query: 320 SGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMA 379
                L   HS  +IH DIKP N+LL    E  I+D G ++  P      L     GT+ 
Sbjct: 119 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLC----GTLD 174
Query: 380 YIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
           Y+ PE  +     EK D++S G+L    + G P F
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 209

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/247 (27%), Positives = 108/247 (43%), Gaps = 26/247 (10%)
Query: 191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
           ED F     +G GG GEV+  ++  + GK+ A KK+             + + +    L 
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMK-ATGKLYACKKLNKKRLKKRKGY--QGAMVEKKILA 240
Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHL-LVYEFMKNGSLQDILDDVSRGRRELDWP 309
           ++ S  I +           LA+       L LV   M  G ++  + +V         P
Sbjct: 241 KVHSRFIVS-----------LAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEP 289
Query: 310 SRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRV 369
                   + SGLE+LH     +II+ D+KP NVLL+DD    ISDLGLA+ +  G T+ 
Sbjct: 290 RAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT 346
Query: 370 LISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLV--RGVPSFVFHQNGEEICSPE 427
                 GT  ++APE     E     D F+ G+ L  ++  RG     F   GE++ + E
Sbjct: 347 --KGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARG----PFRARGEKVENKE 400
Query: 428 WLRKVMN 434
             ++V+ 
Sbjct: 401 LKQRVLE 407

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 29/206 (14%)
Query: 239 EEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDD 298
           EE  +LR++ L+++    I      H NI+ L           LV++ MK G L D L +
Sbjct: 48  EEVQELREATLKEVD---ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE 104
Query: 299 VSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGL 358
               +  L      +I   +   LE +   H  +I+H D+KP N+LL+DDM   ++D G 
Sbjct: 105 ----KVTLSEKETRKIMRAL---LEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGF 157
Query: 359 AMAIPDGYTRVLISYVLGTMAYIAPEYFQ------QPELSEKCDIFSFGMLLISLVRGVP 412
           +  +  G     +  V GT +Y+APE  +       P   ++ D++S G+++ +L+ G P
Sbjct: 158 SCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 214
Query: 413 SF----------VFHQNGEEICSPEW 428
            F          +      +  SPEW
Sbjct: 215 PFWHRKQMLMLRMIMSGNYQFGSPEW 240

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 95/207 (45%), Gaps = 31/207 (14%)
Query: 239 EEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDD 298
           EE  +LR++ L+++    I      H NI+ L           LV++ MK G L D L +
Sbjct: 61  EEVQELREATLKEVD---ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE 117
Query: 299 -VSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLG 357
            V+   +E     R        + LE +   H  +I+H D+KP N+LL+DDM   ++D G
Sbjct: 118 KVTLSEKETRKIMR--------ALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFG 169
Query: 358 LAMAIPDGYTRVLISYVLGTMAYIAPEYFQ------QPELSEKCDIFSFGMLLISLVRGV 411
            +  +  G     +  V GT +Y+APE  +       P   ++ D++S G+++ +L+ G 
Sbjct: 170 FSCQLDPGEK---LRSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 226
Query: 412 PSF----------VFHQNGEEICSPEW 428
           P F          +      +  SPEW
Sbjct: 227 PPFWHRKQMLMLRMIMSGNYQFGSPEW 253

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 93/203 (45%), Gaps = 16/203 (7%)
Query: 215 GSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHM 274
           GS G+++  K  I     +   + +  +K +D+    I  E+    ++ H NI+ L   +
Sbjct: 33  GSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS--TILREVELLKKLDHPNIMKLFEIL 90
Query: 275 VRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASII 334
                  +V E    G L    D++ + R+        RI   V SG+ Y+H ++   I+
Sbjct: 91  EDSSSFYIVGELYTGGEL---FDEIIK-RKRFSEHDAARIIKQVFSGITYMHKHN---IV 143
Query: 335 HGDIKPRNVLLNDDMEAC---ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPEL 391
           H D+KP N+LL    + C   I D GL+           +   +GT  YIAPE  +    
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN---TKMKDRIGTAYYIAPEVLRGT-Y 199
Query: 392 SEKCDIFSFGMLLISLVRGVPSF 414
            EKCD++S G++L  L+ G P F
Sbjct: 200 DEKCDVWSAGVILYILLSGTPPF 222

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 93/203 (45%), Gaps = 16/203 (7%)
Query: 215 GSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHM 274
           GS G+++  K  I     +   + +  +K +D+    I  E+    ++ H NI+ L   +
Sbjct: 33  GSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS--TILREVELLKKLDHPNIMKLFEIL 90
Query: 275 VRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASII 334
                  +V E    G L    D++ + R+        RI   V SG+ Y+H +   +I+
Sbjct: 91  EDSSSFYIVGELYTGGEL---FDEIIK-RKRFSEHDAARIIKQVFSGITYMHKH---NIV 143
Query: 335 HGDIKPRNVLLNDDMEAC---ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPEL 391
           H D+KP N+LL    + C   I D GL+           +   +GT  YIAPE  +    
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN---TKMKDRIGTAYYIAPEVLRGT-Y 199
Query: 392 SEKCDIFSFGMLLISLVRGVPSF 414
            EKCD++S G++L  L+ G P F
Sbjct: 200 DEKCDVWSAGVILYILLSGTPPF 222

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 95/207 (45%), Gaps = 31/207 (14%)
Query: 239 EEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDD 298
           EE  +LR++ L+++    I      H NI+ L           LV++ MK G L D L +
Sbjct: 61  EEVQELREATLKEVD---ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE 117
Query: 299 -VSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLG 357
            V+   +E     R        + LE +   H  +I+H D+KP N+LL+DDM   ++D G
Sbjct: 118 KVTLSEKETRKIMR--------ALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFG 169
Query: 358 LAMAIPDGYTRVLISYVLGTMAYIAPEYFQ------QPELSEKCDIFSFGMLLISLVRGV 411
            +  +  G     +  V GT +Y+APE  +       P   ++ D++S G+++ +L+ G 
Sbjct: 170 FSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 226
Query: 412 PSF----------VFHQNGEEICSPEW 428
           P F          +      +  SPEW
Sbjct: 227 PPFWHRKQMLMLRMIMSGNYQFGSPEW 253

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 81/319 (25%), Positives = 137/319 (42%), Gaps = 60/319 (18%)
Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           +++IG G  GEV+  +     G+ +A+K              EE S  R++       EI
Sbjct: 42  VKQIGKGRYGEVWMGKW---RGEKVAVKVFFT---------TEEASWFRET-------EI 82
Query: 257 ITASQIRHRNILPLLAHMVRPDCH----LLVYEFMKNGSLQDILDDVSRGRRELDWPSRH 312
                +RH NIL  +A  ++         L+ ++ +NGSL D L   +     LD  S  
Sbjct: 83  YQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT-----LDAKSML 137
Query: 313 RIALGVASGLEYLHM-----YHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
           ++A    SGL +LH          +I H D+K +N+L+  +   CI+DLGLA+       
Sbjct: 138 KLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTN 197
Query: 368 RVLI--SYVLGTMAYIAPE---------YFQQPELSEKCDIFSFGMLLISLVRGVPS--- 413
            V I  +  +GT  Y+ PE         +FQ   ++   D++SFG++L  + R   S   
Sbjct: 198 EVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMA---DMYSFGLILWEVARRCVSGGI 254
Query: 414 -----FVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVL-KIAYICTL 467
                  +H       S E +R+++  K     + P  P      + L  + K+   C  
Sbjct: 255 VEEYQLPYHDLVPSDPSYEDMREIVCIKK----LRPSFPNRWSSDECLRQMGKLMTECWA 310
Query: 468 HDPEERPNSQYVRCRLSQL 486
           H+P  R  +  V+  L+++
Sbjct: 311 HNPASRLTALRVKKTLAKM 329

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 108/260 (41%), Gaps = 55/260 (21%)
Query: 168 SRDRGPTIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKA-ELPGSNGKMIAIKKV 226
           S +RGP    P             +CF  L  +G GG G+V++  ++ G+N   I   KV
Sbjct: 6   SVNRGPEKIRP-------------ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKV 52
Query: 227 IVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEF 286
           +  A I                   +R+   TA     RNIL  + H    D   L+Y F
Sbjct: 53  LKKAMI-------------------VRNAKDTAHTKAERNILEEVKHPFIVD---LIYAF 90
Query: 287 MKNGSLQDILDDVSRGR------RE----LDWPSRHRIALGVASGLEYLHMYHSASIIHG 336
              G L  IL+ +S G       RE     D    +   + +A G    H+ H   II+ 
Sbjct: 91  QTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALG----HL-HQKGIIYR 145
Query: 337 DIKPRNVLLNDDMEACISDLGLAM-AIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKC 395
           D+KP N++LN      ++D GL   +I DG    +     GT+ Y+APE   +   +   
Sbjct: 146 DLKPENIMLNHQGHVKLTDFGLCKESIHDG---TVTHXFCGTIEYMAPEILMRSGHNRAV 202
Query: 396 DIFSFGMLLISLVRGVPSFV 415
           D +S G L+  ++ G P F 
Sbjct: 203 DWWSLGALMYDMLTGAPPFT 222

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 108/260 (41%), Gaps = 55/260 (21%)
Query: 168 SRDRGPTIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKA-ELPGSNGKMIAIKKV 226
           S +RGP    P             +CF  L  +G GG G+V++  ++ G+N   I   KV
Sbjct: 6   SVNRGPEKIRP-------------ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKV 52
Query: 227 IVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEF 286
           +  A I                   +R+   TA     RNIL  + H    D   L+Y F
Sbjct: 53  LKKAMI-------------------VRNAKDTAHTKAERNILEEVKHPFIVD---LIYAF 90
Query: 287 MKNGSLQDILDDVSRGR------RE----LDWPSRHRIALGVASGLEYLHMYHSASIIHG 336
              G L  IL+ +S G       RE     D    +   + +A G    H+ H   II+ 
Sbjct: 91  QTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALG----HL-HQKGIIYR 145
Query: 337 DIKPRNVLLNDDMEACISDLGLAM-AIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKC 395
           D+KP N++LN      ++D GL   +I DG    +     GT+ Y+APE   +   +   
Sbjct: 146 DLKPENIMLNHQGHVKLTDFGLCKESIHDG---TVTHTFCGTIEYMAPEILMRSGHNRAV 202
Query: 396 DIFSFGMLLISLVRGVPSFV 415
           D +S G L+  ++ G P F 
Sbjct: 203 DWWSLGALMYDMLTGAPPFT 222

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 93/203 (45%), Gaps = 16/203 (7%)
Query: 215 GSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHM 274
           GS G+++  K  I     +   + +  +K +D+    I  E+    ++ H NI+ L   +
Sbjct: 33  GSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS--TILREVELLKKLDHPNIMKLFEIL 90
Query: 275 VRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASII 334
                  +V E    G L    D++ + R+        RI   V SG+ Y+H +   +I+
Sbjct: 91  EDSSSFYIVGELYTGGEL---FDEIIK-RKRFSEHDAARIIKQVFSGITYMHKH---NIV 143
Query: 335 HGDIKPRNVLLNDDMEAC---ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPEL 391
           H D+KP N+LL    + C   I D GL+           +   +GT  YIAPE  +    
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN---TKMKDRIGTAYYIAPEVLRGT-Y 199
Query: 392 SEKCDIFSFGMLLISLVRGVPSF 414
            EKCD++S G++L  L+ G P F
Sbjct: 200 DEKCDVWSAGVILYILLSGTPPF 222

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 101/225 (44%), Gaps = 27/225 (12%)
Query: 187 FLKKED--CFASLEKIGSGGCGEVYKA--ELPGSNGKMIAIKKVIVYAPISAAELIEEDS 242
           F K+ D  C    + IG+G  GEV     +LPG     +AIK +               S
Sbjct: 26  FAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTL--------------KS 71
Query: 243 KLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG 302
              + + R   SE     Q  H N++ L   + +    +++ EFM+NGSL   L      
Sbjct: 72  GYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQ 131
Query: 303 RRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI 362
              +      R   G+A+G++YL      + +H D+  RN+L+N ++   +SD GL+  +
Sbjct: 132 FTVIQLVGMLR---GIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 185
Query: 363 PDGYTRVLISYVLG---TMAYIAPEYFQQPELSEKCDIFSFGMLL 404
            D  +    +  LG    + + APE  Q  + +   D++S+G+++
Sbjct: 186 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVM 230

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 90/223 (40%), Gaps = 24/223 (10%)
Query: 192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ 251
           D F     +G G  G VY A       K I   KV+  + +   E +E           Q
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAR--EKQNKFIMALKVLFKSQLEK-EGVEH----------Q 61
Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
           +R EI   S +RH NIL +  +        L+ EF   G L   L    R          
Sbjct: 62  LRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRF-------DE 114
Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLI 371
            R A  +    + LH  H   +IH DIKP N+L+    E  I+D G ++  P    R + 
Sbjct: 115 QRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMC 174
Query: 372 SYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
               GT+ Y+ PE  +     EK D++  G+L    + G+P F
Sbjct: 175 ----GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPF 213

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 99/222 (44%), Gaps = 28/222 (12%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
            A+  KIG G  G V  A      GK +A+KK+                 LR  + R++ 
Sbjct: 47  LANFIKIGEGSTGIVCIAT-EKHTGKQVAVKKM----------------DLRKQQRRELL 89
Query: 254 -SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRH 312
            +E++      H N++ + +  +  D   +V EF++ G+L DI+        ++      
Sbjct: 90  FNEVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA----- 144
Query: 313 RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLIS 372
            + L V   L YLH   +  +IH DIK  ++LL  D    +SD G    +     +    
Sbjct: 145 TVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR--K 199
Query: 373 YVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
            ++GT  ++APE   +     + DI+S G+++I ++ G P +
Sbjct: 200 XLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPY 241

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 75/301 (24%), Positives = 127/301 (42%), Gaps = 48/301 (15%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR---SEI 256
           +G G  G V +  L   +G  +   KV V           +  KL +S  R+I    SE 
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSL---KVAV-----------KTMKLDNSSQREIEEFLSEA 87
Query: 257 ITASQIRHRNILPLLAHMVRPDCH-----LLVYEFMKNGSLQDIL--DDVSRGRRELDWP 309
                  H N++ LL   +          +++  FMK G L   L    +  G + +   
Sbjct: 88  ACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQ 147
Query: 310 SRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG--YT 367
           +  +  + +A G+EYL    + + +H D+  RN +L DDM  C++D GL+  I  G  Y 
Sbjct: 148 TLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYR 204
Query: 368 RVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISL-VRGVPSFVFHQNGEEICSP 426
           +  I+ +   + +IA E       + K D+++FG+ +  +  RG+  +   QN E     
Sbjct: 205 QGRIAKM--PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMY--- 259
Query: 427 EWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL 486
           ++L      K P   +D              + +I Y C   DP +RP    +R +L +L
Sbjct: 260 DYLLHGHRLKQPEDCLD-------------ELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306
Query: 487 L 487
           L
Sbjct: 307 L 307

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 71/301 (23%), Positives = 125/301 (41%), Gaps = 45/301 (14%)
Query: 179 LIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELI 238
           L +K+ +  LK +D F  + ++G+G  G V+K     S    + + + +++  I  A   
Sbjct: 13  LTQKQKVGELKDDD-FEKISELGAGNGGVVFKVSHKPSG---LVMARKLIHLEIKPA--- 65
Query: 239 EEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHM---VRPDCHL-LVYEFMKNGSLQD 294
                        IR++II   Q+ H    P +         D  + +  E M  GSL  
Sbjct: 66  -------------IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ 112
Query: 295 ILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACIS 354
           +L    R   ++      ++++ V  GL YL   H   I+H D+KP N+L+N   E  + 
Sbjct: 113 VLKKAGRIPEQI----LGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLC 166
Query: 355 DLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
           D G++  + D      +    GT +Y++PE  Q    S + DI+S G+ L+ +  G   +
Sbjct: 167 DFGVSGQLIDSMANSFV----GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG--RY 220
Query: 415 VFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERP 474
                   +   E L  ++N         P+LP   +    L        C + +P ER 
Sbjct: 221 PIGSGSGSMAIFELLDYIVNEP------PPKLPSGVFS---LEFQDFVNKCLIKNPAERA 271
Query: 475 N 475
           +
Sbjct: 272 D 272

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 110/251 (43%), Gaps = 40/251 (15%)
Query: 192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ 251
           + +  ++K+GSG  GEV           ++   KV     +  A  I   + +  S   +
Sbjct: 37  EMYQRVKKLGSGAYGEV-----------LLCRDKV---THVERAIKIIRKTSVSTSSNSK 82
Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
           +  E+     + H NI+ L         + LV E  K G L    D++   R + +    
Sbjct: 83  LLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGEL---FDEIIH-RMKFNEVDA 138
Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLND---DMEACISDLGLAMAIPDGYTR 368
             I   V SG+ YLH ++   I+H D+KP N+LL     D    I D GL+    +   +
Sbjct: 139 AVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN---Q 192
Query: 369 VLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEIC---- 424
             +   LGT  YIAPE  ++ +  EKCD++S G++L  L+ G P F   Q  +EI     
Sbjct: 193 KKMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFG-GQTDQEILRKVE 250
Query: 425 -------SPEW 428
                  SPEW
Sbjct: 251 KGKYTFDSPEW 261

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 103/227 (45%), Gaps = 36/227 (15%)
Query: 194 FASLEKIGSGGCGEVY--KAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ 251
           F  +E +GSG   EV+  K  L    GK+ A+K             I++    RDS L  
Sbjct: 11  FIFMEVLGSGAFSEVFLVKQRL---TGKLFALK------------CIKKSPAFRDSSLE- 54
Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG-RRELDWPS 310
             +EI    +I+H NI+ L         + LV + +  G L D +  + RG   E D   
Sbjct: 55  --NEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRI--LERGVYTEKD--- 107
Query: 311 RHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLL---NDDMEACISDLGLAMAIPDGYT 367
              +   V S ++YLH      I+H D+KP N+L     ++ +  I+D GL+    +G  
Sbjct: 108 ASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-- 162
Query: 368 RVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
             ++S   GT  Y+APE   Q   S+  D +S G++   L+ G P F
Sbjct: 163 --IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPF 207

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 69/237 (29%), Positives = 106/237 (44%), Gaps = 44/237 (18%)
Query: 194 FASL---EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
           FA L   E IG GG G+VY+A   G     +A+K        +A    +ED       + 
Sbjct: 6   FAELTLEEIIGIGGFGKVYRAFWIGDE---VAVK--------AARHDPDEDIS---QTIE 51
Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRR-----E 305
            +R E    + ++H NI+ L    ++     LV EF + G L  +L     G+R      
Sbjct: 52  NVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS----GKRIPPDIL 107
Query: 306 LDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLL-----NDDMEA---CISDLG 357
           ++W      A+ +A G+ YLH      IIH D+K  N+L+     N D+      I+D G
Sbjct: 108 VNW------AVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161
Query: 358 LAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
           LA      + R       G  A++APE  +    S+  D++S+G+LL  L+ G   F
Sbjct: 162 LARE----WHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF 214

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 83/169 (49%), Gaps = 19/169 (11%)
Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPS 310
           +IR EI      RH +I+ L   +  P    +V E++  G L D +     GR  LD   
Sbjct: 62  KIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYI--CKNGR--LDEKE 117
Query: 311 RHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVL 370
             R+   + SG++Y H +    ++H D+KP NVLL+  M A I+D GL+  + DG     
Sbjct: 118 SRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG---EF 171
Query: 371 ISYVLGTMAYIAPEY-----FQQPELSEKCDIFSFGMLLISLVRGVPSF 414
           +    G+  Y APE      +  PE+    DI+S G++L +L+ G   F
Sbjct: 172 LRXSCGSPNYAAPEVISGRLYAGPEV----DIWSSGVILYALLCGTLPF 216

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 105/228 (46%), Gaps = 27/228 (11%)
Query: 199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT 258
           +IGSG  G VYK +  G     +A+K + V  P                + +  R+E+  
Sbjct: 43  RIGSGSFGTVYKGKWHGD----VAVKILKVVDPTP-------------EQFQAFRNEVAV 85
Query: 259 ASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV 318
             + RH NIL  + +M + D   +V ++ +  SL   L  V   + ++       IA   
Sbjct: 86  LRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLH-VQETKFQMF--QLIDIARQT 141
Query: 319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTM 378
           A G++YLH   + +IIH D+K  N+ L++ +   I D GLA           +    G++
Sbjct: 142 AQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSV 198
Query: 379 AYIAPEYFQQPE---LSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI 423
            ++APE  +  +    S + D++S+G++L  L+ G   +    N ++I
Sbjct: 199 LWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQI 246

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 110/250 (44%), Gaps = 33/250 (13%)
Query: 168 SRDRGPTIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVI 227
           +R+ G +  S   + ED+     +  F   E +G+G   EV  AE   + GK+ A+K + 
Sbjct: 3   ARENGESSSSWKKQAEDI-----KKIFEFKETLGTGAFSEVVLAE-EKATGKLFAVKCI- 55
Query: 228 VYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFM 287
                          K    K   I +EI    +I+H NI+ L      P+   LV + +
Sbjct: 56  -------------PKKALKGKESSIENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLV 102
Query: 288 KNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLL-- 345
             G L D +  V +G     + +    +  +   L+ ++  H   I+H D+KP N+L   
Sbjct: 103 SGGELFDRI--VEKG-----FYTEKDASTLIRQVLDAVYYLHRMGIVHRDLKPENLLYYS 155
Query: 346 -NDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
            +++ +  ISD GL+     G    ++S   GT  Y+APE   Q   S+  D +S G++ 
Sbjct: 156 QDEESKIMISDFGLSKMEGKG---DVMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIA 212
Query: 405 ISLVRGVPSF 414
             L+ G P F
Sbjct: 213 YILLCGYPPF 222

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 105/236 (44%), Gaps = 34/236 (14%)
Query: 179 LIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELI 238
           L +K+ +  LK +D F  + ++G+G  G V+K     S    + + + +++  I  A   
Sbjct: 56  LTQKQKVGELKDDD-FEKISELGAGNGGVVFKVSHKPSG---LVMARKLIHLEIKPA--- 108
Query: 239 EEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHM---VRPDCHL-LVYEFMKNGSLQD 294
                        IR++II   Q+ H    P +         D  + +  E M  GSL  
Sbjct: 109 -------------IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ 155
Query: 295 ILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACIS 354
           +L    R   ++      ++++ V  GL YL   H   I+H D+KP N+L+N   E  + 
Sbjct: 156 VLKKAGRIPEQI----LGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLC 209
Query: 355 DLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRG 410
           D G++  + D      +    GT +Y++PE  Q    S + DI+S G+ L+ +  G
Sbjct: 210 DFGVSGQLIDSMANSFV----GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 261

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 105/236 (44%), Gaps = 34/236 (14%)
Query: 179 LIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELI 238
           L +K+ +  LK +D F  + ++G+G  G V+K     S    + + + +++  I  A   
Sbjct: 21  LTQKQKVGELKDDD-FEKISELGAGNGGVVFKVSHKPSG---LVMARKLIHLEIKPA--- 73
Query: 239 EEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHM---VRPDCHL-LVYEFMKNGSLQD 294
                        IR++II   Q+ H    P +         D  + +  E M  GSL  
Sbjct: 74  -------------IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ 120
Query: 295 ILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACIS 354
           +L    R   ++      ++++ V  GL YL   H   I+H D+KP N+L+N   E  + 
Sbjct: 121 VLKKAGRIPEQI----LGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLC 174
Query: 355 DLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRG 410
           D G++  + D      +    GT +Y++PE  Q    S + DI+S G+ L+ +  G
Sbjct: 175 DFGVSGQLIDSMANSFV----GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 226

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 106/236 (44%), Gaps = 34/236 (14%)
Query: 179 LIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELI 238
           L +K  +  LK +D F  + ++G+G  G V K +   S   +I  +K+I +  I  A   
Sbjct: 4   LTQKAKVGELKDDD-FERISELGAGNGGVVTKVQHRPSG--LIMARKLI-HLEIKPA--- 56
Query: 239 EEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHM---VRPDCHL-LVYEFMKNGSLQD 294
                        IR++II   Q+ H    P +         D  + +  E M  GSL  
Sbjct: 57  -------------IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ 103
Query: 295 ILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACIS 354
           +L +  R   E+      ++++ V  GL YL   H   I+H D+KP N+L+N   E  + 
Sbjct: 104 VLKEAKRIPEEI----LGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLC 157
Query: 355 DLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRG 410
           D G++  + D      +    GT +Y+APE  Q    S + DI+S G+ L+ L  G
Sbjct: 158 DFGVSGQLIDSMANSFV----GTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVG 209

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 69/296 (23%), Positives = 128/296 (43%), Gaps = 37/296 (12%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAA----ELIEEDSKLRDSKLRQIRSE 255
           +G G  G V +A+L   +G  + +   ++ A I A+    E + E + +++     +   
Sbjct: 31  LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 256 IITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRH--R 313
           +  + + R +  LP+          +++  FMK+G L   L     G    + P +   R
Sbjct: 91  VGVSLRSRAKGRLPI---------PMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVR 141
Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG-YTRVLIS 372
             + +A G+EYL    S + IH D+  RN +L +DM  C++D GL+  I  G Y R   +
Sbjct: 142 FMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCA 198
Query: 373 YVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLV-RGVPSFVFHQNGEEICSPEWLRK 431
             L  + ++A E       +   D+++FG+ +  ++ RG   +   +N E      +L  
Sbjct: 199 SKL-PVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY---NYLIG 254
Query: 432 VMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL 487
               K P   ++              V  + Y C   DP++RP+   +R  L  +L
Sbjct: 255 GNRLKQPPECME-------------EVYDLMYQCWSADPKQRPSFTCLRMELENIL 297

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/253 (28%), Positives = 115/253 (45%), Gaps = 49/253 (19%)
Query: 198 EKIGSGGCGEVYKAELPGSNGKMI--AIKKVIVYAPISAAELIEEDSKLRD-SKLRQIRS 254
           E IG G  G VY   L  ++GK I  A+K +               +++ D  ++ Q  +
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL---------------NRITDIGEVSQFLT 80
Query: 255 EIITASQIRHRNILPLLAHMVRPD-CHLLVYEFMKNGSLQDILDDVSRGRRELDWPS-RH 312
           E I      H N+L LL   +R +   L+V  +MK+G L++ +      R E   P+ + 
Sbjct: 81  EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI------RNETHNPTVKD 134
Query: 313 RIALG--VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVL 370
            I  G  VA G++YL    S   +H D+  RN +L++     ++D GLA    D Y +  
Sbjct: 135 LIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLAR---DMYDKEY 188
Query: 371 ISYVLGTMA-----YIAPEYFQQPELSEKCDIFSFGMLLISLV-RGVPSF---------V 415
            S    T A     ++A E  Q  + + K D++SFG+LL  L+ RG P +         V
Sbjct: 189 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 248
Query: 416 FHQNGEEICSPEW 428
           +   G  +  PE+
Sbjct: 249 YLLQGRRLLQPEY 261

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/253 (28%), Positives = 115/253 (45%), Gaps = 49/253 (19%)
Query: 198 EKIGSGGCGEVYKAELPGSNGKMI--AIKKVIVYAPISAAELIEEDSKLRD-SKLRQIRS 254
           E IG G  G VY   L  ++GK I  A+K +               +++ D  ++ Q  +
Sbjct: 35  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL---------------NRITDIGEVSQFLT 79
Query: 255 EIITASQIRHRNILPLLAHMVRPD-CHLLVYEFMKNGSLQDILDDVSRGRRELDWPS-RH 312
           E I      H N+L LL   +R +   L+V  +MK+G L++ +      R E   P+ + 
Sbjct: 80  EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI------RNETHNPTVKD 133
Query: 313 RIALG--VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVL 370
            I  G  VA G++YL    S   +H D+  RN +L++     ++D GLA    D Y +  
Sbjct: 134 LIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLAR---DMYDKEX 187
Query: 371 ISYVLGTMA-----YIAPEYFQQPELSEKCDIFSFGMLLISLV-RGVPSF---------V 415
            S    T A     ++A E  Q  + + K D++SFG+LL  L+ RG P +         V
Sbjct: 188 XSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 247
Query: 416 FHQNGEEICSPEW 428
           +   G  +  PE+
Sbjct: 248 YLLQGRRLLQPEY 260

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/253 (28%), Positives = 115/253 (45%), Gaps = 49/253 (19%)
Query: 198 EKIGSGGCGEVYKAELPGSNGKMI--AIKKVIVYAPISAAELIEEDSKLRD-SKLRQIRS 254
           E IG G  G VY   L  ++GK I  A+K +               +++ D  ++ Q  +
Sbjct: 35  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL---------------NRITDIGEVSQFLT 79
Query: 255 EIITASQIRHRNILPLLAHMVRPD-CHLLVYEFMKNGSLQDILDDVSRGRRELDWPS-RH 312
           E I      H N+L LL   +R +   L+V  +MK+G L++ +      R E   P+ + 
Sbjct: 80  EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI------RNETHNPTVKD 133
Query: 313 RIALG--VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVL 370
            I  G  VA G++YL    S   +H D+  RN +L++     ++D GLA    D Y +  
Sbjct: 134 LIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLAR---DMYDKEY 187
Query: 371 ISYVLGTMA-----YIAPEYFQQPELSEKCDIFSFGMLLISLV-RGVPSF---------V 415
            S    T A     ++A E  Q  + + K D++SFG+LL  L+ RG P +         V
Sbjct: 188 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 247
Query: 416 FHQNGEEICSPEW 428
           +   G  +  PE+
Sbjct: 248 YLLQGRRLLQPEY 260

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/253 (28%), Positives = 115/253 (45%), Gaps = 49/253 (19%)
Query: 198 EKIGSGGCGEVYKAELPGSNGKMI--AIKKVIVYAPISAAELIEEDSKLRD-SKLRQIRS 254
           E IG G  G VY   L  ++GK I  A+K +               +++ D  ++ Q  +
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL---------------NRITDIGEVSQFLT 80
Query: 255 EIITASQIRHRNILPLLAHMVRPD-CHLLVYEFMKNGSLQDILDDVSRGRRELDWPS-RH 312
           E I      H N+L LL   +R +   L+V  +MK+G L++ +      R E   P+ + 
Sbjct: 81  EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI------RNETHNPTVKD 134
Query: 313 RIALG--VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVL 370
            I  G  VA G++YL    S   +H D+  RN +L++     ++D GLA    D Y +  
Sbjct: 135 LIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLAR---DMYDKEY 188
Query: 371 ISYVLGTMA-----YIAPEYFQQPELSEKCDIFSFGMLLISLV-RGVPSF---------V 415
            S    T A     ++A E  Q  + + K D++SFG+LL  L+ RG P +         V
Sbjct: 189 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 248
Query: 416 FHQNGEEICSPEW 428
           +   G  +  PE+
Sbjct: 249 YLLQGRRLLQPEY 261

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/253 (28%), Positives = 115/253 (45%), Gaps = 49/253 (19%)
Query: 198 EKIGSGGCGEVYKAELPGSNGKMI--AIKKVIVYAPISAAELIEEDSKLRD-SKLRQIRS 254
           E IG G  G VY   L  ++GK I  A+K +               +++ D  ++ Q  +
Sbjct: 28  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL---------------NRITDIGEVSQFLT 72
Query: 255 EIITASQIRHRNILPLLAHMVRPD-CHLLVYEFMKNGSLQDILDDVSRGRRELDWPS-RH 312
           E I      H N+L LL   +R +   L+V  +MK+G L++ +      R E   P+ + 
Sbjct: 73  EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI------RNETHNPTVKD 126
Query: 313 RIALG--VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVL 370
            I  G  VA G++YL    S   +H D+  RN +L++     ++D GLA    D Y +  
Sbjct: 127 LIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLAR---DMYDKEY 180
Query: 371 ISYVLGTMA-----YIAPEYFQQPELSEKCDIFSFGMLLISLV-RGVPSF---------V 415
            S    T A     ++A E  Q  + + K D++SFG+LL  L+ RG P +         V
Sbjct: 181 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 240
Query: 416 FHQNGEEICSPEW 428
           +   G  +  PE+
Sbjct: 241 YLLQGRRLLQPEY 253

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/253 (28%), Positives = 115/253 (45%), Gaps = 49/253 (19%)
Query: 198 EKIGSGGCGEVYKAELPGSNGKMI--AIKKVIVYAPISAAELIEEDSKLRD-SKLRQIRS 254
           E IG G  G VY   L  ++GK I  A+K +               +++ D  ++ Q  +
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL---------------NRITDIGEVSQFLT 77
Query: 255 EIITASQIRHRNILPLLAHMVRPD-CHLLVYEFMKNGSLQDILDDVSRGRRELDWPS-RH 312
           E I      H N+L LL   +R +   L+V  +MK+G L++ +      R E   P+ + 
Sbjct: 78  EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI------RNETHNPTVKD 131
Query: 313 RIALG--VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVL 370
            I  G  VA G++YL    S   +H D+  RN +L++     ++D GLA    D Y +  
Sbjct: 132 LIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLAR---DMYDKEY 185
Query: 371 ISYVLGTMA-----YIAPEYFQQPELSEKCDIFSFGMLLISLV-RGVPSF---------V 415
            S    T A     ++A E  Q  + + K D++SFG+LL  L+ RG P +         V
Sbjct: 186 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 245
Query: 416 FHQNGEEICSPEW 428
           +   G  +  PE+
Sbjct: 246 YLLQGRRLLQPEY 258

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/253 (28%), Positives = 115/253 (45%), Gaps = 49/253 (19%)
Query: 198 EKIGSGGCGEVYKAELPGSNGKMI--AIKKVIVYAPISAAELIEEDSKLRD-SKLRQIRS 254
           E IG G  G VY   L  ++GK I  A+K +               +++ D  ++ Q  +
Sbjct: 55  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL---------------NRITDIGEVSQFLT 99
Query: 255 EIITASQIRHRNILPLLAHMVRPD-CHLLVYEFMKNGSLQDILDDVSRGRRELDWPS-RH 312
           E I      H N+L LL   +R +   L+V  +MK+G L++ +      R E   P+ + 
Sbjct: 100 EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI------RNETHNPTVKD 153
Query: 313 RIALG--VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVL 370
            I  G  VA G++YL    S   +H D+  RN +L++     ++D GLA    D Y +  
Sbjct: 154 LIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLAR---DMYDKEY 207
Query: 371 ISYVLGTMA-----YIAPEYFQQPELSEKCDIFSFGMLLISLV-RGVPSF---------V 415
            S    T A     ++A E  Q  + + K D++SFG+LL  L+ RG P +         V
Sbjct: 208 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 267
Query: 416 FHQNGEEICSPEW 428
           +   G  +  PE+
Sbjct: 268 YLLQGRRLLQPEY 280

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/253 (28%), Positives = 115/253 (45%), Gaps = 49/253 (19%)
Query: 198 EKIGSGGCGEVYKAELPGSNGKMI--AIKKVIVYAPISAAELIEEDSKLRD-SKLRQIRS 254
           E IG G  G VY   L  ++GK I  A+K +               +++ D  ++ Q  +
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL---------------NRITDIGEVSQFLT 75
Query: 255 EIITASQIRHRNILPLLAHMVRPD-CHLLVYEFMKNGSLQDILDDVSRGRRELDWPS-RH 312
           E I      H N+L LL   +R +   L+V  +MK+G L++ +      R E   P+ + 
Sbjct: 76  EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI------RNETHNPTVKD 129
Query: 313 RIALG--VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVL 370
            I  G  VA G++YL    S   +H D+  RN +L++     ++D GLA    D Y +  
Sbjct: 130 LIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLAR---DMYDKEY 183
Query: 371 ISYVLGTMA-----YIAPEYFQQPELSEKCDIFSFGMLLISLV-RGVPSF---------V 415
            S    T A     ++A E  Q  + + K D++SFG+LL  L+ RG P +         V
Sbjct: 184 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 243
Query: 416 FHQNGEEICSPEW 428
           +   G  +  PE+
Sbjct: 244 YLLQGRRLLQPEY 256

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/253 (28%), Positives = 115/253 (45%), Gaps = 49/253 (19%)
Query: 198 EKIGSGGCGEVYKAELPGSNGKMI--AIKKVIVYAPISAAELIEEDSKLRD-SKLRQIRS 254
           E IG G  G VY   L  ++GK I  A+K +               +++ D  ++ Q  +
Sbjct: 54  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL---------------NRITDIGEVSQFLT 98
Query: 255 EIITASQIRHRNILPLLAHMVRPD-CHLLVYEFMKNGSLQDILDDVSRGRRELDWPS-RH 312
           E I      H N+L LL   +R +   L+V  +MK+G L++ +      R E   P+ + 
Sbjct: 99  EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI------RNETHNPTVKD 152
Query: 313 RIALG--VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVL 370
            I  G  VA G++YL    S   +H D+  RN +L++     ++D GLA    D Y +  
Sbjct: 153 LIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLAR---DMYDKEY 206
Query: 371 ISYVLGTMA-----YIAPEYFQQPELSEKCDIFSFGMLLISLV-RGVPSF---------V 415
            S    T A     ++A E  Q  + + K D++SFG+LL  L+ RG P +         V
Sbjct: 207 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 266
Query: 416 FHQNGEEICSPEW 428
           +   G  +  PE+
Sbjct: 267 YLLQGRRLLQPEY 279

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/253 (28%), Positives = 115/253 (45%), Gaps = 49/253 (19%)
Query: 198 EKIGSGGCGEVYKAELPGSNGKMI--AIKKVIVYAPISAAELIEEDSKLRD-SKLRQIRS 254
           E IG G  G VY   L  ++GK I  A+K +               +++ D  ++ Q  +
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL---------------NRITDIGEVSQFLT 78
Query: 255 EIITASQIRHRNILPLLAHMVRPDCH-LLVYEFMKNGSLQDILDDVSRGRRELDWPS-RH 312
           E I      H N+L LL   +R +   L+V  +MK+G L++ +      R E   P+ + 
Sbjct: 79  EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI------RNETHNPTVKD 132
Query: 313 RIALG--VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVL 370
            I  G  VA G++YL    S   +H D+  RN +L++     ++D GLA    D Y +  
Sbjct: 133 LIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLAR---DMYDKEY 186
Query: 371 ISYVLGTMA-----YIAPEYFQQPELSEKCDIFSFGMLLISLV-RGVPSF---------V 415
            S    T A     ++A E  Q  + + K D++SFG+LL  L+ RG P +         V
Sbjct: 187 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 246
Query: 416 FHQNGEEICSPEW 428
           +   G  +  PE+
Sbjct: 247 YLLQGRRLLQPEY 259

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 78/287 (27%), Positives = 119/287 (41%), Gaps = 40/287 (13%)
Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           ++++G+G  GEV+     G+    I   K    +P S  E  +   KL+  KL Q+ +  
Sbjct: 14  IKRLGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPESFLEEAQIMKKLKHDKLVQLYA-- 71
Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL 316
                            +V  +   +V E+M  GSL D L D   GR  L  P+   +A 
Sbjct: 72  -----------------VVSEEPIYIVTEYMNKGSLLDFLKD-GEGR-ALKLPNLVDMAA 112
Query: 317 GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLG 376
            VA+G+ Y+      + IH D++  N+L+ + +   I+D GLA  I D            
Sbjct: 113 QVAAGMAYIE---RMNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKF- 168
Query: 377 TMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSK 436
            + + APE       + K D++SFG+LL  LV          N  E+     L +V    
Sbjct: 169 PIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREV-----LEQVERGY 223
Query: 437 NPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRL 483
                   R+P        LH L I   C   DPEERP  +Y++  L
Sbjct: 224 --------RMPCPQDCPISLHELMIH--CWKKDPEERPTFEYLQSFL 260

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 110/246 (44%), Gaps = 30/246 (12%)
Query: 232 ISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGS 291
           + A +++ +   L+  +  ++ +EI     + + +++         D   +V E  +  S
Sbjct: 69  VFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRS 128
Query: 292 LQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA 351
           L ++     + R+ +  P           G++YLH   +  +IH D+K  N+ LNDDM+ 
Sbjct: 129 LLEL----HKRRKAVTEPEARYFMRQTIQGVQYLH---NNRVIHRDLKLGNLFLNDDMDV 181
Query: 352 CISDLGLAMAIP-DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRG 410
            I D GLA  I  DG  +     + GT  YIAPE   +   S + DI+S G +L +L+ G
Sbjct: 182 KIGDFGLATKIEFDGERK---KXLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVG 238
Query: 411 VPSFVFHQNGEEICSPE-WLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHD 469
            P F      E  C  E ++R   N  +  R I+P    +   ++MLH           D
Sbjct: 239 KPPF------ETSCLKETYIRIKKNEYSVPRHINPV--ASALIRRMLHA----------D 280
Query: 470 PEERPN 475
           P  RP+
Sbjct: 281 PTLRPS 286

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 107/234 (45%), Gaps = 24/234 (10%)
Query: 180 IEKEDLAFLKKEDC--FASLEKIGSGGCGEVYKAELPGSNGKMIA--IKKVIVYAPISAA 235
           +E E LA  + E    ++++  +GSG  G V+ A     N +++   IKK          
Sbjct: 10  VELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKK---------- 59
Query: 236 ELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDI 295
           E + ED  + D KL ++  EI   S++ H NI+ +L          LV E  K+GS  D+
Sbjct: 60  EKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVME--KHGSGLDL 117
Query: 296 LDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISD 355
              + R  R LD P    I   + S + YL +     IIH DIK  N+++ +D    + D
Sbjct: 118 FAFIDRHPR-LDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLID 173
Query: 356 LGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQ-QPELSEKCDIFSFGMLLISLV 408
            G A  +  G    L     GT+ Y APE     P    + +++S G+ L +LV
Sbjct: 174 FGSAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLV 224

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 110/246 (44%), Gaps = 30/246 (12%)
Query: 232 ISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGS 291
           + A +++ +   L+  +  ++ +EI     + + +++         D   +V E  +  S
Sbjct: 69  VFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRS 128
Query: 292 LQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA 351
           L ++     + R+ +  P           G++YLH   +  +IH D+K  N+ LNDDM+ 
Sbjct: 129 LLEL----HKRRKAVTEPEARYFMRQTIQGVQYLH---NNRVIHRDLKLGNLFLNDDMDV 181
Query: 352 CISDLGLAMAIP-DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRG 410
            I D GLA  I  DG  +     + GT  YIAPE   +   S + DI+S G +L +L+ G
Sbjct: 182 KIGDFGLATKIEFDGERK---KTLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVG 238
Query: 411 VPSFVFHQNGEEICSPE-WLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHD 469
            P F      E  C  E ++R   N  +  R I+P    +   ++MLH           D
Sbjct: 239 KPPF------ETSCLKETYIRIKKNEYSVPRHINPV--ASALIRRMLHA----------D 280
Query: 470 PEERPN 475
           P  RP+
Sbjct: 281 PTLRPS 286

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 91/204 (44%), Gaps = 17/204 (8%)
Query: 215 GSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHM 274
           GS G++I  K  I     +   + +   K +  K   +R E+    Q+ H NI+ L    
Sbjct: 43  GSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLR-EVQLLKQLDHPNIMKLYEFF 101
Query: 275 VRPDCHLLVYEFMKNGSLQDILDDVSRGR-RELDWPSRHRIALGVASGLEYLHMYHSASI 333
                  LV E    G L D +  +SR R  E+D     RI   V SG+ Y+H      I
Sbjct: 102 EDKGYFYLVGEVYTGGELFDEI--ISRKRFSEVDAA---RIIRQVLSGITYMH---KNKI 153
Query: 334 IHGDIKPRNVLL---NDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPE 390
           +H D+KP N+LL   + D    I D GL+           +   +GT  YIAPE      
Sbjct: 154 VHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK---MKDKIGTAYYIAPEVLHGT- 209
Query: 391 LSEKCDIFSFGMLLISLVRGVPSF 414
             EKCD++S G++L  L+ G P F
Sbjct: 210 YDEKCDVWSTGVILYILLSGCPPF 233

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 131/297 (44%), Gaps = 53/297 (17%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           F  +E +G+G  G+VYK     + G++ AIK + V          EE+         +I+
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKT-GQLAAIKVMDVTGD-------EEE---------EIK 68
Query: 254 SEI-ITASQIRHRNILPLLAHMVRP------DCHLLVYEFMKNGSLQDILDDVSRGRREL 306
            EI +      HRNI       ++       D   LV EF   GS+ D++ +      + 
Sbjct: 69  QEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKE 128
Query: 307 DWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGY 366
           +W +   I   +  GL +LH +    +IH DIK +NVLL ++ E  + D G++  +    
Sbjct: 129 EWIAY--ICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV 183
Query: 367 TRVLISYVLGTMAYIAPEYF---QQPELSE--KCDIFSFGMLLISLVRGVPSFVFHQNGE 421
            R   +  +GT  ++APE     + P+ +   K D++S G+  I +  G P         
Sbjct: 184 GRR--NTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP-------- 233
Query: 422 EICSPEWLRKV-MNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQ 477
            +C    +R + +  +NP+    PRL    + KK    ++    C + +  +RP ++
Sbjct: 234 -LCDMHPMRALFLIPRNPA----PRLKSKKWSKKFQSFIE---SCLVKNHSQRPATE 282

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 110/246 (44%), Gaps = 30/246 (12%)
Query: 232 ISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGS 291
           + A +++ +   L+  +  ++ +EI     + + +++         D   +V E  +  S
Sbjct: 53  VFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRS 112
Query: 292 LQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA 351
           L ++     + R+ +  P           G++YLH   +  +IH D+K  N+ LNDDM+ 
Sbjct: 113 LLEL----HKRRKAVTEPEARYFMRQTIQGVQYLH---NNRVIHRDLKLGNLFLNDDMDV 165
Query: 352 CISDLGLAMAIP-DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRG 410
            I D GLA  I  DG  +     + GT  YIAPE   +   S + DI+S G +L +L+ G
Sbjct: 166 KIGDFGLATKIEFDGERK---KDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVG 222
Query: 411 VPSFVFHQNGEEICSPE-WLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHD 469
            P F      E  C  E ++R   N  +  R I+P    +   ++MLH           D
Sbjct: 223 KPPF------ETSCLKETYIRIKKNEYSVPRHINPV--ASALIRRMLHA----------D 264
Query: 470 PEERPN 475
           P  RP+
Sbjct: 265 PTLRPS 270

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 99/225 (44%), Gaps = 33/225 (14%)
Query: 190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKL 249
           K+D F  + ++G+G  G V+K     S    + + + +++  I  A              
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSG---LVMARKLIHLEIKPA-------------- 46
Query: 250 RQIRSEIITASQIRHRNILPLLAHM---VRPDCHL-LVYEFMKNGSLQDILDDVSRGRRE 305
             IR++II   Q+ H    P +         D  + +  E M  GSL  +L    R   +
Sbjct: 47  --IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQ 104
Query: 306 LDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG 365
           +      ++++ V  GL YL   H   I+H D+KP N+L+N   E  + D G++  + D 
Sbjct: 105 I----LGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158
Query: 366 YTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRG 410
                +    GT +Y++PE  Q    S + DI+S G+ L+ +  G
Sbjct: 159 MANSFV----GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 199

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 91/204 (44%), Gaps = 17/204 (8%)
Query: 215 GSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHM 274
           GS G++I  K  I     +   + +   K +  K   +R E+    Q+ H NI+ L    
Sbjct: 37  GSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLR-EVQLLKQLDHPNIMKLYEFF 95
Query: 275 VRPDCHLLVYEFMKNGSLQDILDDVSRGR-RELDWPSRHRIALGVASGLEYLHMYHSASI 333
                  LV E    G L D +  +SR R  E+D     RI   V SG+ Y+H      I
Sbjct: 96  EDKGYFYLVGEVYTGGELFDEI--ISRKRFSEVDAA---RIIRQVLSGITYMH---KNKI 147
Query: 334 IHGDIKPRNVLL---NDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPE 390
           +H D+KP N+LL   + D    I D GL+           +   +GT  YIAPE      
Sbjct: 148 VHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK---MKDKIGTAYYIAPEVLHGT- 203
Query: 391 LSEKCDIFSFGMLLISLVRGVPSF 414
             EKCD++S G++L  L+ G P F
Sbjct: 204 YDEKCDVWSTGVILYILLSGCPPF 227

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 99/225 (44%), Gaps = 33/225 (14%)
Query: 190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKL 249
           K+D F  + ++G+G  G V+K     S    + + + +++  I  A              
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSG---LVMARKLIHLEIKPA-------------- 46
Query: 250 RQIRSEIITASQIRHRNILPLLAHM---VRPDCHL-LVYEFMKNGSLQDILDDVSRGRRE 305
             IR++II   Q+ H    P +         D  + +  E M  GSL  +L    R   +
Sbjct: 47  --IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQ 104
Query: 306 LDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG 365
           +      ++++ V  GL YL   H   I+H D+KP N+L+N   E  + D G++  + D 
Sbjct: 105 I----LGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158
Query: 366 YTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRG 410
                +    GT +Y++PE  Q    S + DI+S G+ L+ +  G
Sbjct: 159 MANSFV----GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 199

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 99/225 (44%), Gaps = 33/225 (14%)
Query: 190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKL 249
           K+D F  + ++G+G  G V+K     S    + + + +++  I  A              
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSG---LVMARKLIHLEIKPA-------------- 46
Query: 250 RQIRSEIITASQIRHRNILPLLAHM---VRPDCHL-LVYEFMKNGSLQDILDDVSRGRRE 305
             IR++II   Q+ H    P +         D  + +  E M  GSL  +L    R   +
Sbjct: 47  --IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQ 104
Query: 306 LDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG 365
           +      ++++ V  GL YL   H   I+H D+KP N+L+N   E  + D G++  + D 
Sbjct: 105 I----LGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158
Query: 366 YTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRG 410
                +    GT +Y++PE  Q    S + DI+S G+ L+ +  G
Sbjct: 159 MANSFV----GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 199

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 110/246 (44%), Gaps = 30/246 (12%)
Query: 232 ISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGS 291
           + A +++ +   L+  +  ++ +EI     + + +++         D   +V E  +  S
Sbjct: 69  VFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRS 128
Query: 292 LQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA 351
           L ++     + R+ +  P           G++YLH   +  +IH D+K  N+ LNDDM+ 
Sbjct: 129 LLEL----HKRRKAVTEPEARYFMRQTIQGVQYLH---NNRVIHRDLKLGNLFLNDDMDV 181
Query: 352 CISDLGLAMAIP-DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRG 410
            I D GLA  I  DG  +     + GT  YIAPE   +   S + DI+S G +L +L+ G
Sbjct: 182 KIGDFGLATKIEFDGERK---KDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVG 238
Query: 411 VPSFVFHQNGEEICSPE-WLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHD 469
            P F      E  C  E ++R   N  +  R I+P    +   ++MLH           D
Sbjct: 239 KPPF------ETSCLKETYIRIKKNEYSVPRHINPV--ASALIRRMLHA----------D 280
Query: 470 PEERPN 475
           P  RP+
Sbjct: 281 PTLRPS 286

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 99/225 (44%), Gaps = 33/225 (14%)
Query: 190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKL 249
           K+D F  + ++G+G  G V+K     S    + + + +++  I  A              
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSG---LVMARKLIHLEIKPA-------------- 46
Query: 250 RQIRSEIITASQIRHRNILPLLAHM---VRPDCHL-LVYEFMKNGSLQDILDDVSRGRRE 305
             IR++II   Q+ H    P +         D  + +  E M  GSL  +L    R   +
Sbjct: 47  --IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQ 104
Query: 306 LDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG 365
           +      ++++ V  GL YL   H   I+H D+KP N+L+N   E  + D G++  + D 
Sbjct: 105 I----LGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158
Query: 366 YTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRG 410
                +    GT +Y++PE  Q    S + DI+S G+ L+ +  G
Sbjct: 159 MANSFV----GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 199

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 99/225 (44%), Gaps = 33/225 (14%)
Query: 190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKL 249
           K+D F  + ++G+G  G V+K     S    + + + +++  I  A              
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSG---LVMARKLIHLEIKPA-------------- 46
Query: 250 RQIRSEIITASQIRHRNILPLLAHM---VRPDCHL-LVYEFMKNGSLQDILDDVSRGRRE 305
             IR++II   Q+ H    P +         D  + +  E M  GSL  +L    R   +
Sbjct: 47  --IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQ 104
Query: 306 LDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG 365
           +      ++++ V  GL YL   H   I+H D+KP N+L+N   E  + D G++  + D 
Sbjct: 105 I----LGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158
Query: 366 YTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRG 410
                +    GT +Y++PE  Q    S + DI+S G+ L+ +  G
Sbjct: 159 MANSFV----GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 199

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 96/217 (44%), Gaps = 25/217 (11%)
Query: 193 CFASLEKIGSGGCGEVYKA--ELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
           C    + IG+G  GEV     +LPG     +AIK +               S   + + R
Sbjct: 8   CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTL--------------KSGYTEKQRR 53
Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPS 310
              SE     Q  H N++ L   + +    +++ EFM+NGSL   L         +    
Sbjct: 54  DFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVG 113
Query: 311 RHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVL 370
             R   G+A+G++YL      + +H  +  RN+L+N ++   +SD GL+  + D  +   
Sbjct: 114 MLR---GIAAGMKYL---ADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPT 167
Query: 371 ISYVLG---TMAYIAPEYFQQPELSEKCDIFSFGMLL 404
            +  LG    + + APE  Q  + +   D++S+G+++
Sbjct: 168 YTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVM 204

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 91/204 (44%), Gaps = 17/204 (8%)
Query: 215 GSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHM 274
           GS G++I  K  I     +   + +   K +  K   +R E+    Q+ H NI+ L    
Sbjct: 60  GSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLR-EVQLLKQLDHPNIMKLYEFF 118
Query: 275 VRPDCHLLVYEFMKNGSLQDILDDVSRGR-RELDWPSRHRIALGVASGLEYLHMYHSASI 333
                  LV E    G L D +  +SR R  E+D     RI   V SG+ Y+H      I
Sbjct: 119 EDKGYFYLVGEVYTGGELFDEI--ISRKRFSEVDAA---RIIRQVLSGITYMH---KNKI 170
Query: 334 IHGDIKPRNVLL---NDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPE 390
           +H D+KP N+LL   + D    I D GL+           +   +GT  YIAPE      
Sbjct: 171 VHRDLKPENLLLESKSKDANIRIIDFGLSTHFE---ASKKMKDKIGTAYYIAPEVLHGT- 226
Query: 391 LSEKCDIFSFGMLLISLVRGVPSF 414
             EKCD++S G++L  L+ G P F
Sbjct: 227 YDEKCDVWSTGVILYILLSGCPPF 250

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 23/206 (11%)
Query: 199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT 258
           K+G G  GEVY+             KK   Y+   A + ++ED+     ++ +   E   
Sbjct: 33  KLGGGQYGEVYEG----------VWKK---YSLTVAVKTLKEDT----MEVEEFLKEAAV 75
Query: 259 ASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV 318
             +I+H N++ LL    R     ++ EFM  G+L D L + +  R+E++      +A  +
Sbjct: 76  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN--RQEVNAVVLLYMATQI 133
Query: 319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTM 378
           +S +EYL      + IH D+  RN L+ ++    ++D GL+  +  G T    +     +
Sbjct: 134 SSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPI 189
Query: 379 AYIAPEYFQQPELSEKCDIFSFGMLL 404
            + APE     + S K D+++FG+LL
Sbjct: 190 KWTAPESLAYNKFSIKSDVWAFGVLL 215

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 91/204 (44%), Gaps = 17/204 (8%)
Query: 215 GSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHM 274
           GS G++I  K  I     +   + +   K +  K   +R E+    Q+ H NI+ L    
Sbjct: 61  GSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLR-EVQLLKQLDHPNIMKLYEFF 119
Query: 275 VRPDCHLLVYEFMKNGSLQDILDDVSRGR-RELDWPSRHRIALGVASGLEYLHMYHSASI 333
                  LV E    G L D +  +SR R  E+D     RI   V SG+ Y+H      I
Sbjct: 120 EDKGYFYLVGEVYTGGELFDEI--ISRKRFSEVDAA---RIIRQVLSGITYMH---KNKI 171
Query: 334 IHGDIKPRNVLL---NDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPE 390
           +H D+KP N+LL   + D    I D GL+           +   +GT  YIAPE      
Sbjct: 172 VHRDLKPENLLLESKSKDANIRIIDFGLSTHFE---ASKKMKDKIGTAYYIAPEVLHGT- 227
Query: 391 LSEKCDIFSFGMLLISLVRGVPSF 414
             EKCD++S G++L  L+ G P F
Sbjct: 228 YDEKCDVWSTGVILYILLSGCPPF 251

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 23/206 (11%)
Query: 199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT 258
           K+G G  GEVY+             KK   Y+   A + ++ED+     ++ +   E   
Sbjct: 21  KLGGGQYGEVYEG----------VWKK---YSLTVAVKTLKEDT----MEVEEFLKEAAV 63
Query: 259 ASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV 318
             +I+H N++ LL    R     ++ EFM  G+L D L + +  R+E++      +A  +
Sbjct: 64  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN--RQEVNAVVLLYMATQI 121
Query: 319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTM 378
           +S +EYL      + IH D+  RN L+ ++    ++D GL+  +  G T    +     +
Sbjct: 122 SSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAPAGAKFPI 177
Query: 379 AYIAPEYFQQPELSEKCDIFSFGMLL 404
            + APE     + S K D+++FG+LL
Sbjct: 178 KWTAPESLAYNKFSIKSDVWAFGVLL 203

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 71/253 (28%), Positives = 115/253 (45%), Gaps = 49/253 (19%)
Query: 198 EKIGSGGCGEVYKAELPGSNGKMI--AIKKVIVYAPISAAELIEEDSKLRD-SKLRQIRS 254
           E IG G  G VY   L  ++GK I  A+K +               +++ D  ++ Q  +
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL---------------NRITDIGEVSQFLT 80
Query: 255 EIITASQIRHRNILPLLAHMVRPDCH-LLVYEFMKNGSLQDILDDVSRGRRELDWPS-RH 312
           E I      H N+L LL   +R +   L+V  +MK+G L++ +      R E   P+ + 
Sbjct: 81  EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI------RNETHNPTVKD 134
Query: 313 RIALG--VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVL 370
            I  G  VA G+++L    S   +H D+  RN +L++     ++D GLA    D Y +  
Sbjct: 135 LIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLAR---DMYDKEF 188
Query: 371 ISYVLGTMA-----YIAPEYFQQPELSEKCDIFSFGMLLISLV-RGVPSF---------V 415
            S    T A     ++A E  Q  + + K D++SFG+LL  L+ RG P +         V
Sbjct: 189 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 248
Query: 416 FHQNGEEICSPEW 428
           +   G  +  PE+
Sbjct: 249 YLLQGRRLLQPEY 261

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 23/206 (11%)
Query: 199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT 258
           K+G G  GEVY+             KK   Y+   A + ++ED+     ++ +   E   
Sbjct: 20  KLGGGQYGEVYEG----------VWKK---YSLTVAVKTLKEDT----MEVEEFLKEAAV 62
Query: 259 ASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV 318
             +I+H N++ LL    R     ++ EFM  G+L D L + +  R+E++      +A  +
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN--RQEVNAVVLLYMATQI 120
Query: 319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTM 378
           +S +EYL      + IH D+  RN L+ ++    ++D GL+  +  G T    +     +
Sbjct: 121 SSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPI 176
Query: 379 AYIAPEYFQQPELSEKCDIFSFGMLL 404
            + APE     + S K D+++FG+LL
Sbjct: 177 KWTAPESLAYNKFSIKSDVWAFGVLL 202

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 23/206 (11%)
Query: 199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT 258
           K+G G  GEVY+             KK   Y+   A + ++ED+     ++ +   E   
Sbjct: 20  KLGGGQYGEVYEG----------VWKK---YSLTVAVKTLKEDT----MEVEEFLKEAAV 62
Query: 259 ASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV 318
             +I+H N++ LL    R     ++ EFM  G+L D L + +  R+E++      +A  +
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN--RQEVNAVVLLYMATQI 120
Query: 319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTM 378
           +S +EYL      + IH D+  RN L+ ++    ++D GL+  +  G T    +     +
Sbjct: 121 SSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPI 176
Query: 379 AYIAPEYFQQPELSEKCDIFSFGMLL 404
            + APE     + S K D+++FG+LL
Sbjct: 177 KWTAPESLAYNKFSIKSDVWAFGVLL 202

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 23/206 (11%)
Query: 199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT 258
           K+G G  GEVY+             KK   Y+   A + ++ED+     ++ +   E   
Sbjct: 22  KLGGGQYGEVYEG----------VWKK---YSLTVAVKTLKEDT----MEVEEFLKEAAV 64
Query: 259 ASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV 318
             +I+H N++ LL    R     ++ EFM  G+L D L + +  R+E++      +A  +
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN--RQEVNAVVLLYMATQI 122
Query: 319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTM 378
           +S +EYL      + IH D+  RN L+ ++    ++D GL+  +  G T    +     +
Sbjct: 123 SSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAPAGAKFPI 178
Query: 379 AYIAPEYFQQPELSEKCDIFSFGMLL 404
            + APE     + S K D+++FG+LL
Sbjct: 179 KWTAPESLAYNKFSIKSDVWAFGVLL 204

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 23/206 (11%)
Query: 199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT 258
           K+G G  GEVY+             KK   Y+   A + ++ED+     ++ +   E   
Sbjct: 21  KLGGGQYGEVYEG----------VWKK---YSLTVAVKTLKEDT----MEVEEFLKEAAV 63
Query: 259 ASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV 318
             +I+H N++ LL    R     ++ EFM  G+L D L + +  R+E++      +A  +
Sbjct: 64  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECN--RQEVNAVVLLYMATQI 121
Query: 319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTM 378
           +S +EYL      + IH D+  RN L+ ++    ++D GL+  +  G T    +     +
Sbjct: 122 SSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGAKFPI 177
Query: 379 AYIAPEYFQQPELSEKCDIFSFGMLL 404
            + APE     + S K D+++FG+LL
Sbjct: 178 KWTAPESLAYNKFSIKSDVWAFGVLL 203

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 82/182 (45%), Gaps = 22/182 (12%)
Query: 244 LRDSKLRQIRSEIITASQIRHRNILPLLAHMVRP---DCHL-LVYEFMKNGSLQDILDDV 299
           L+D +  Q   EI +   ++H N+L  +A   R    +  L L+  F   GSL D L   
Sbjct: 48  LQDKQSWQSEREIFSTPGMKHENLLQFIAAEKRGSNLEVELWLITAFHDKGSLTDYLKG- 106
Query: 300 SRGRRELDWPSRHRIALGVASGLEYLHM--------YHSASIIHGDIKPRNVLLNDDMEA 351
                 + W     +A  ++ GL YLH          H  SI H D K +NVLL  D+ A
Sbjct: 107 ----NIITWNELCHVAETMSRGLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTA 162
Query: 352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQ-----QPELSEKCDIFSFGMLLIS 406
            ++D GLA+    G         +GT  Y+APE  +     Q +   + D+++ G++L  
Sbjct: 163 VLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWE 222
Query: 407 LV 408
           LV
Sbjct: 223 LV 224

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 19/221 (8%)
Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           E++G+GG G V +  +    G+ +AIK+          + +   ++ R     QI  ++ 
Sbjct: 21  ERLGTGGFGYVLRW-IHQDTGEQVAIKQ--------CRQELSPKNRERWCLEIQIMKKLN 71
Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALG 317
             + +  R +   L  +   D  LL  E+ + G L+  L+         + P R  ++  
Sbjct: 72  HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS-D 130
Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACIS---DLGLAMAIPDGYTRVLISYV 374
           ++S L YLH      IIH D+KP N++L    +  I    DLG A  +  G    L +  
Sbjct: 131 ISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEF 184
Query: 375 LGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFV 415
           +GT+ Y+APE  +Q + +   D +SFG L    + G   F+
Sbjct: 185 VGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFL 225

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 71/253 (28%), Positives = 115/253 (45%), Gaps = 49/253 (19%)
Query: 198 EKIGSGGCGEVYKAELPGSNGKMI--AIKKVIVYAPISAAELIEEDSKLRD-SKLRQIRS 254
           E IG G  G VY   L  ++GK I  A+K +               +++ D  ++ Q  +
Sbjct: 37  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL---------------NRITDIGEVSQFLT 81
Query: 255 EIITASQIRHRNILPLLAHMVRPDCH-LLVYEFMKNGSLQDILDDVSRGRRELDWPS-RH 312
           E I      H N+L LL   +R +   L+V  +MK+G L++ +      R E   P+ + 
Sbjct: 82  EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI------RNETHNPTVKD 135
Query: 313 RIALG--VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVL 370
            I  G  VA G+++L    S   +H D+  RN +L++     ++D GLA    D Y +  
Sbjct: 136 LIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLAR---DMYDKEF 189
Query: 371 ISYVLGTMA-----YIAPEYFQQPELSEKCDIFSFGMLLISLV-RGVPSF---------V 415
            S    T A     ++A E  Q  + + K D++SFG+LL  L+ RG P +         V
Sbjct: 190 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 249
Query: 416 FHQNGEEICSPEW 428
           +   G  +  PE+
Sbjct: 250 YLLQGRRLLQPEY 262

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 99/210 (47%), Gaps = 23/210 (10%)
Query: 199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT 258
           K+G G  GEVY+             KK   Y+   A + ++ED+     ++ +   E   
Sbjct: 25  KLGGGQYGEVYEG----------VWKK---YSLTVAVKTLKEDTM----EVEEFLKEAAV 67
Query: 259 ASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV 318
             +I+H N++ LL    R     ++ EFM  G+L D L + +  R+E++      +A  +
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN--RQEVNAVVLLYMATQI 125
Query: 319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTM 378
           +S +EYL      + IH D+  RN L+ ++    ++D GL+  +  G T    +     +
Sbjct: 126 SSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGAKFPI 181
Query: 379 AYIAPEYFQQPELSEKCDIFSFGMLLISLV 408
            + APE     + S K D+++FG+LL  + 
Sbjct: 182 KWTAPESLAYNKFSIKSDVWAFGVLLWEIA 211

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 99/210 (47%), Gaps = 23/210 (10%)
Query: 199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT 258
           K+G G  GEVY+             KK   Y+   A + ++ED+     ++ +   E   
Sbjct: 25  KLGGGQYGEVYEG----------VWKK---YSLTVAVKTLKEDTM----EVEEFLKEAAV 67
Query: 259 ASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV 318
             +I+H N++ LL    R     ++ EFM  G+L D L + +  R+E++      +A  +
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN--RQEVNAVVLLYMATQI 125
Query: 319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTM 378
           +S +EYL      + IH D+  RN L+ ++    ++D GL+  +  G T    +     +
Sbjct: 126 SSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPI 181
Query: 379 AYIAPEYFQQPELSEKCDIFSFGMLLISLV 408
            + APE     + S K D+++FG+LL  + 
Sbjct: 182 KWTAPESLAYNKFSIKSDVWAFGVLLWEIA 211

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 19/221 (8%)
Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           E++G+GG G V +  +    G+ +AIK+          + +   ++ R     QI  ++ 
Sbjct: 20  ERLGTGGFGYVLRW-IHQDTGEQVAIKQ--------CRQELSPKNRERWCLEIQIMKKLN 70
Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALG 317
             + +  R +   L  +   D  LL  E+ + G L+  L+         + P R  ++  
Sbjct: 71  HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS-D 129
Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACIS---DLGLAMAIPDGYTRVLISYV 374
           ++S L YLH      IIH D+KP N++L    +  I    DLG A  +  G    L +  
Sbjct: 130 ISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEF 183
Query: 375 LGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFV 415
           +GT+ Y+APE  +Q + +   D +SFG L    + G   F+
Sbjct: 184 VGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFL 224

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 23/206 (11%)
Query: 199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT 258
           K+G G  GEVY+             KK   Y+   A + ++ED+     ++ +   E   
Sbjct: 25  KLGGGQYGEVYEG----------VWKK---YSLTVAVKTLKEDTM----EVEEFLKEAAV 67
Query: 259 ASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV 318
             +I+H N++ LL    R     ++ EFM  G+L D L + +  R+E++      +A  +
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN--RQEVNAVVLLYMATQI 125
Query: 319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTM 378
           +S +EYL      + IH D+  RN L+ ++    ++D GL+  +  G T    +     +
Sbjct: 126 SSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPI 181
Query: 379 AYIAPEYFQQPELSEKCDIFSFGMLL 404
            + APE     + S K D+++FG+LL
Sbjct: 182 KWTAPESLAYNKFSIKSDVWAFGVLL 207

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 99/210 (47%), Gaps = 23/210 (10%)
Query: 199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT 258
           K+G G  GEVY+             KK   Y+   A + ++ED+     ++ +   E   
Sbjct: 24  KLGGGQYGEVYEG----------VWKK---YSLTVAVKTLKEDTM----EVEEFLKEAAV 66
Query: 259 ASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV 318
             +I+H N++ LL    R     ++ EFM  G+L D L + +  R+E++      +A  +
Sbjct: 67  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN--RQEVNAVVLLYMATQI 124
Query: 319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTM 378
           +S +EYL      + IH D+  RN L+ ++    ++D GL+  +  G T    +     +
Sbjct: 125 SSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPI 180
Query: 379 AYIAPEYFQQPELSEKCDIFSFGMLLISLV 408
            + APE     + S K D+++FG+LL  + 
Sbjct: 181 KWTAPESLAYNKFSIKSDVWAFGVLLWEIA 210

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 71/253 (28%), Positives = 115/253 (45%), Gaps = 49/253 (19%)
Query: 198 EKIGSGGCGEVYKAELPGSNGKMI--AIKKVIVYAPISAAELIEEDSKLRD-SKLRQIRS 254
           E IG G  G VY   L  ++GK I  A+K +               +++ D  ++ Q  +
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL---------------NRITDIGEVSQFLT 78
Query: 255 EIITASQIRHRNILPLLAHMVRPD-CHLLVYEFMKNGSLQDILDDVSRGRRELDWPS-RH 312
           E I      H N+L LL   +R +   L+V  +MK+G L++ +      R E   P+ + 
Sbjct: 79  EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI------RNETHNPTVKD 132
Query: 313 RIALG--VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVL 370
            I  G  VA G+++L    S   +H D+  RN +L++     ++D GLA    D Y +  
Sbjct: 133 LIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLAR---DMYDKEF 186
Query: 371 ISYVLGTMA-----YIAPEYFQQPELSEKCDIFSFGMLLISLV-RGVPSF---------V 415
            S    T A     ++A E  Q  + + K D++SFG+LL  L+ RG P +         V
Sbjct: 187 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 246
Query: 416 FHQNGEEICSPEW 428
           +   G  +  PE+
Sbjct: 247 YLLQGRRLLQPEY 259

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 105/233 (45%), Gaps = 24/233 (10%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           F  LEK+G+G    VYK  L  + G  +A+K+V           ++ +     + +R   
Sbjct: 7   FKQLEKLGNGTYATVYKG-LNKTTGVYVALKEVK----------LDSEEGTPSTAIR--- 52
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGR--RELDWPSR 311
            EI    +++H NI+ L   +   +   LV+EFM N  L+  +D  + G   R L+    
Sbjct: 53  -EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLV 110
Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLI 371
                 +  GL + H      I+H D+KP+N+L+N   +  + D GLA A   G      
Sbjct: 111 KYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAF--GIPVNTF 165
Query: 372 SYVLGTMAYIAPEYFQQPE-LSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI 423
           S  + T+ Y AP+        S   DI+S G +L  ++ G P F    + E++
Sbjct: 166 SSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQL 218

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 23/206 (11%)
Query: 199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT 258
           K+G G  GEVY+             KK   Y+   A + ++ED+     ++ +   E   
Sbjct: 22  KLGGGQYGEVYEG----------VWKK---YSLTVAVKTLKEDT----MEVEEFLKEAAV 64
Query: 259 ASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV 318
             +I+H N++ LL    R     ++ EFM  G+L D L + +  R+E++      +A  +
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN--RQEVNAVVLLYMATQI 122
Query: 319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTM 378
           +S +EYL      + IH D+  RN L+ ++    ++D GL+  +  G T    +     +
Sbjct: 123 SSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPI 178
Query: 379 AYIAPEYFQQPELSEKCDIFSFGMLL 404
            + APE     + S K D+++FG+LL
Sbjct: 179 KWTAPESLAYNKFSIKSDVWAFGVLL 204

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 71/253 (28%), Positives = 115/253 (45%), Gaps = 49/253 (19%)
Query: 198 EKIGSGGCGEVYKAELPGSNGKMI--AIKKVIVYAPISAAELIEEDSKLRD-SKLRQIRS 254
           E IG G  G VY   L  ++GK I  A+K +               +++ D  ++ Q  +
Sbjct: 41  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL---------------NRITDIGEVSQFLT 85
Query: 255 EIITASQIRHRNILPLLAHMVRPD-CHLLVYEFMKNGSLQDILDDVSRGRRELDWPS-RH 312
           E I      H N+L LL   +R +   L+V  +MK+G L++ +      R E   P+ + 
Sbjct: 86  EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI------RNETHNPTVKD 139
Query: 313 RIALG--VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVL 370
            I  G  VA G+++L    S   +H D+  RN +L++     ++D GLA    D Y +  
Sbjct: 140 LIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLAR---DMYDKEF 193
Query: 371 ISYVLGTMA-----YIAPEYFQQPELSEKCDIFSFGMLLISLV-RGVPSF---------V 415
            S    T A     ++A E  Q  + + K D++SFG+LL  L+ RG P +         V
Sbjct: 194 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 253
Query: 416 FHQNGEEICSPEW 428
           +   G  +  PE+
Sbjct: 254 YLLQGRRLLQPEY 266

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 23/206 (11%)
Query: 199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT 258
           K+G G  GEVY+             KK   Y+   A + ++ED+     ++ +   E   
Sbjct: 22  KLGGGQYGEVYEG----------VWKK---YSLTVAVKTLKEDT----MEVEEFLKEAAV 64
Query: 259 ASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV 318
             +I+H N++ LL    R     ++ EFM  G+L D L + +  R+E++      +A  +
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN--RQEVNAVVLLYMATQI 122
Query: 319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTM 378
           +S +EYL      + IH D+  RN L+ ++    ++D GL+  +  G T    +     +
Sbjct: 123 SSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPI 178
Query: 379 AYIAPEYFQQPELSEKCDIFSFGMLL 404
            + APE     + S K D+++FG+LL
Sbjct: 179 KWTAPESLAYNKFSIKSDVWAFGVLL 204

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 71/253 (28%), Positives = 115/253 (45%), Gaps = 49/253 (19%)
Query: 198 EKIGSGGCGEVYKAELPGSNGKMI--AIKKVIVYAPISAAELIEEDSKLRD-SKLRQIRS 254
           E IG G  G VY   L  ++GK I  A+K +               +++ D  ++ Q  +
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL---------------NRITDIGEVSQFLT 80
Query: 255 EIITASQIRHRNILPLLAHMVRPD-CHLLVYEFMKNGSLQDILDDVSRGRRELDWPS-RH 312
           E I      H N+L LL   +R +   L+V  +MK+G L++ +      R E   P+ + 
Sbjct: 81  EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI------RNETHNPTVKD 134
Query: 313 RIALG--VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVL 370
            I  G  VA G+++L    S   +H D+  RN +L++     ++D GLA    D Y +  
Sbjct: 135 LIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLAR---DMYDKEF 188
Query: 371 ISYVLGTMA-----YIAPEYFQQPELSEKCDIFSFGMLLISLV-RGVPSF---------V 415
            S    T A     ++A E  Q  + + K D++SFG+LL  L+ RG P +         V
Sbjct: 189 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 248
Query: 416 FHQNGEEICSPEW 428
           +   G  +  PE+
Sbjct: 249 YLLQGRRLLQPEY 261

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 23/206 (11%)
Query: 199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT 258
           K+G G  GEVY+             KK   Y+   A + ++ED+     ++ +   E   
Sbjct: 25  KLGGGQYGEVYEG----------VWKK---YSLTVAVKTLKEDTM----EVEEFLKEAAV 67
Query: 259 ASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV 318
             +I+H N++ LL    R     ++ EFM  G+L D L + +  R+E++      +A  +
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECN--RQEVNAVVLLYMATQI 125
Query: 319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTM 378
           +S +EYL      + IH D+  RN L+ ++    ++D GL+  +  G T    +     +
Sbjct: 126 SSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPI 181
Query: 379 AYIAPEYFQQPELSEKCDIFSFGMLL 404
            + APE     + S K D+++FG+LL
Sbjct: 182 KWTAPESLAYNKFSIKSDVWAFGVLL 207

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 99/215 (46%), Gaps = 18/215 (8%)
Query: 232 ISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGS 291
           + A +++ +   L+  +  ++  EI     + H++++         D   +V E  +  S
Sbjct: 42  VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRS 101
Query: 292 LQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA 351
           L ++     + R+ L  P        +  G +YLH      +IH D+K  N+ LN+D+E 
Sbjct: 102 LLEL----HKRRKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEV 154
Query: 352 CISDLGLAMAIP-DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRG 410
            I D GLA  +  DG  + ++    GT  YIAPE   +   S + D++S G ++ +L+ G
Sbjct: 155 KIGDFGLATKVEYDGERKKVLC---GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG 211
Query: 411 VPSFVFHQNGEEICSPE-WLRKVMNSKNPSRAIDP 444
            P F      E  C  E +LR   N  +  + I+P
Sbjct: 212 KPPF------ETSCLKETYLRIKKNEYSIPKHINP 240

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 103/216 (47%), Gaps = 23/216 (10%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G    VY+AE     G  +AIK            +I++ +  +   ++++++E+   
Sbjct: 19  LGKGSFAGVYRAE-SIHTGLEVAIK------------MIDKKAMYKAGMVQRVQNEVKIH 65
Query: 260 SQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVA 319
            Q++H +IL L  +    +   LV E   NG +   L +  +   E +  +RH +   + 
Sbjct: 66  CQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENE--ARHFMH-QII 122
Query: 320 SGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVL-GTM 378
           +G+ YLH   S  I+H D+   N+LL  +M   I+D GLA  +   + +    Y L GT 
Sbjct: 123 TGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK---HYTLCGTP 176
Query: 379 AYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
            YI+PE   +     + D++S G +  +L+ G P F
Sbjct: 177 NYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPF 212

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 71/253 (28%), Positives = 115/253 (45%), Gaps = 49/253 (19%)
Query: 198 EKIGSGGCGEVYKAELPGSNGKMI--AIKKVIVYAPISAAELIEEDSKLRD-SKLRQIRS 254
           E IG G  G VY   L  ++GK I  A+K +               +++ D  ++ Q  +
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL---------------NRITDIGEVSQFLT 139
Query: 255 EIITASQIRHRNILPLLAHMVRPD-CHLLVYEFMKNGSLQDILDDVSRGRRELDWPS-RH 312
           E I      H N+L LL   +R +   L+V  +MK+G L++ +      R E   P+ + 
Sbjct: 140 EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI------RNETHNPTVKD 193
Query: 313 RIALG--VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVL 370
            I  G  VA G+++L    S   +H D+  RN +L++     ++D GLA    D Y +  
Sbjct: 194 LIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLAR---DMYDKEF 247
Query: 371 ISYVLGTMA-----YIAPEYFQQPELSEKCDIFSFGMLLISLV-RGVPSF---------V 415
            S    T A     ++A E  Q  + + K D++SFG+LL  L+ RG P +         V
Sbjct: 248 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 307
Query: 416 FHQNGEEICSPEW 428
           +   G  +  PE+
Sbjct: 308 YLLQGRRLLQPEY 320

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 106/228 (46%), Gaps = 32/228 (14%)
Query: 192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ 251
           D +   + +G+G   EV  AE   +  K++AIK +       A E +E        K   
Sbjct: 18  DIYDFRDVLGTGAFSEVILAEDKRTQ-KLVAIKCI-------AKEALE-------GKEGS 62
Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHL-LVYEFMKNGSLQDILDDVSRG-RRELDWP 309
           + +EI    +I+H NI+ L   +     HL L+ + +  G L D +  V +G   E D  
Sbjct: 63  MENEIAVLHKIKHPNIVAL-DDIYESGGHLYLIMQLVSGGELFDRI--VEKGFYTERD-- 117
Query: 310 SRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVL---LNDDMEACISDLGLAMAIPDGY 366
              R+   V   ++YLH      I+H D+KP N+L   L++D +  ISD GL+     G 
Sbjct: 118 -ASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG- 172
Query: 367 TRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
              ++S   GT  Y+APE   Q   S+  D +S G++   L+ G P F
Sbjct: 173 --SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 106/228 (46%), Gaps = 32/228 (14%)
Query: 192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ 251
           D +   + +G+G   EV  AE   +  K++AIK +       A E +E        K   
Sbjct: 18  DIYDFRDVLGTGAFSEVILAEDKRTQ-KLVAIKCI-------AKEALE-------GKEGS 62
Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHL-LVYEFMKNGSLQDILDDVSRG-RRELDWP 309
           + +EI    +I+H NI+ L   +     HL L+ + +  G L D +  V +G   E D  
Sbjct: 63  MENEIAVLHKIKHPNIVAL-DDIYESGGHLYLIMQLVSGGELFDRI--VEKGFYTERD-- 117
Query: 310 SRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVL---LNDDMEACISDLGLAMAIPDGY 366
              R+   V   ++YLH      I+H D+KP N+L   L++D +  ISD GL+     G 
Sbjct: 118 -ASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG- 172
Query: 367 TRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
              ++S   GT  Y+APE   Q   S+  D +S G++   L+ G P F
Sbjct: 173 --SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 99/225 (44%), Gaps = 33/225 (14%)
Query: 190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKL 249
           K+D F  + ++G+G  G V+K     S    + + + +++  I  A              
Sbjct: 7   KDDDFEKISELGAGNGGVVFKVSHKPSG---LVMARKLIHLEIKPA-------------- 49
Query: 250 RQIRSEIITASQIRHRNILPLLAHM---VRPDCHL-LVYEFMKNGSLQDILDDVSRGRRE 305
             IR++II   Q+ H    P +         D  + +  E M  GSL  +L    R   +
Sbjct: 50  --IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQ 107
Query: 306 LDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG 365
           +      ++++ V  GL YL   H   I+H D+KP N+L+N   E  + D G++  + D 
Sbjct: 108 I----LGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDE 161
Query: 366 YTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRG 410
                +    GT +Y++PE  Q    S + DI+S G+ L+ +  G
Sbjct: 162 MANEFV----GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 202

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 23/206 (11%)
Query: 199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT 258
           K+G G  GEVY+             KK   Y+   A + ++ED+     ++ +   E   
Sbjct: 18  KLGGGQFGEVYEG----------VWKK---YSLTVAVKTLKEDT----MEVEEFLKEAAV 60
Query: 259 ASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV 318
             +I+H N++ LL    R     ++ EFM  G+L D L + +  R+E+       +A  +
Sbjct: 61  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQI 118
Query: 319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTM 378
           +S +EYL      + IH D+  RN L+ ++    ++D GL+  +  G T    +     +
Sbjct: 119 SSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGAKFPI 174
Query: 379 AYIAPEYFQQPELSEKCDIFSFGMLL 404
            + APE     + S K D+++FG+LL
Sbjct: 175 KWTAPESLAYNKFSIKSDVWAFGVLL 200

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 84/309 (27%), Positives = 139/309 (44%), Gaps = 54/309 (17%)
Query: 182 KEDLAFLKK-EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEE 240
           +E+L F    +D F    K+GSG  G+V+  E   S      +++VI        + I +
Sbjct: 11  RENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSS-----GLERVI--------KTINK 57
Query: 241 DSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCH--LLVYEFMKNGSL-QDILD 297
           D       + QI +EI     + H NI+ +    V  D H   +V E  + G L + I+ 
Sbjct: 58  DRS--QVPMEQIEAEIEVLKSLDHPNIIKIFE--VFEDYHNMYIVMETCEGGELLERIVS 113
Query: 298 DVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC---IS 354
             +RG+      S   +A  +   +  L  +HS  ++H D+KP N+L  D        I 
Sbjct: 114 AQARGKA----LSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKII 169
Query: 355 DLGLA-MAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPS 413
           D GLA +   D ++    +   GT  Y+APE F++ +++ KCDI+S G+++  L+ G   
Sbjct: 170 DFGLAELFKSDEHS----TNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLP 224
Query: 414 FVFHQNGEEICSPEWLRKVMNSKNPSRAIDPR-LPGNGYE--KKMLHVLKIAYICTLHDP 470
           F          S E +++    K P+ A++ R L     +  K+ML            DP
Sbjct: 225 FTG-------TSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQML----------TKDP 267
Query: 471 EERPNSQYV 479
           E RP++  V
Sbjct: 268 ERRPSAAQV 276

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 70/292 (23%), Positives = 126/292 (43%), Gaps = 42/292 (14%)
Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           +E++G+G  GEV+     G     +A+K             +++ S   D+ L    +E 
Sbjct: 18  VERLGAGQAGEVWMGYYNGHTK--VAVKS------------LKQGSMSPDAFL----AEA 59
Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL 316
               Q++H+ ++ L A + +   +++  E+M+NGSL D L   S  +  ++      +A 
Sbjct: 60  NLMKQLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTIN--KLLDMAA 116
Query: 317 GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLG 376
            +A G+ ++      + IH D++  N+L++D +   I+D GLA  I D            
Sbjct: 117 QIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKF- 172
Query: 377 TMAYIAPEYFQQPELSEKCDIFSFGMLLISLV-RGVPSFVFHQNGEEICSPEWLRKVMNS 435
            + + APE       + K D++SFG+LL  +V  G   +    N E I            
Sbjct: 173 PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI------------ 220
Query: 436 KNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL 487
           +N  R      P N  E+    + ++  +C    PE+RP   Y+R  L    
Sbjct: 221 QNLERGYRMVRPDNCPEE----LYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 23/206 (11%)
Query: 199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT 258
           K+G G  GEVY+             KK   Y+   A + ++ED+     ++ +   E   
Sbjct: 20  KLGGGQYGEVYEG----------VWKK---YSLTVAVKTLKEDTM----EVEEFLKEAAV 62
Query: 259 ASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV 318
             +I+H N++ LL    R     ++ EFM  G+L D L + +  R+E+       +A  +
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQI 120
Query: 319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTM 378
           +S +EYL      + IH D+  RN L+ ++    ++D GL+  +  G T    +     +
Sbjct: 121 SSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPI 176
Query: 379 AYIAPEYFQQPELSEKCDIFSFGMLL 404
            + APE     + S K D+++FG+LL
Sbjct: 177 KWTAPESLAYNKFSIKSDVWAFGVLL 202

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 23/206 (11%)
Query: 199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT 258
           K+G G  GEVY+             KK   Y+   A + ++ED+     ++ +   E   
Sbjct: 18  KLGGGQYGEVYEG----------VWKK---YSLTVAVKTLKEDTM----EVEEFLKEAAV 60
Query: 259 ASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV 318
             +I+H N++ LL    R     ++ EFM  G+L D L + +  R+E+       +A  +
Sbjct: 61  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQI 118
Query: 319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTM 378
           +S +EYL      + IH D+  RN L+ ++    ++D GL+  +  G T    +     +
Sbjct: 119 SSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGAKFPI 174
Query: 379 AYIAPEYFQQPELSEKCDIFSFGMLL 404
            + APE     + S K D+++FG+LL
Sbjct: 175 KWTAPESLAYNKFSIKSDVWAFGVLL 200

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 99/215 (46%), Gaps = 18/215 (8%)
Query: 232 ISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGS 291
           + A +++ +   L+  +  ++  EI     + H++++         D   +V E  +  S
Sbjct: 68  VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRS 127
Query: 292 LQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA 351
           L ++     + R+ L  P        +  G +YLH      +IH D+K  N+ LN+D+E 
Sbjct: 128 LLEL----HKRRKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEV 180
Query: 352 CISDLGLAMAIP-DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRG 410
            I D GLA  +  DG  + ++    GT  YIAPE   +   S + D++S G ++ +L+ G
Sbjct: 181 KIGDFGLATKVEYDGERKKVLC---GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG 237
Query: 411 VPSFVFHQNGEEICSPE-WLRKVMNSKNPSRAIDP 444
            P F      E  C  E +LR   N  +  + I+P
Sbjct: 238 KPPF------ETSCLKETYLRIKKNEYSIPKHINP 266

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 99/215 (46%), Gaps = 18/215 (8%)
Query: 232 ISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGS 291
           + A +++ +   L+  +  ++  EI     + H++++         D   +V E  +  S
Sbjct: 66  VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRS 125
Query: 292 LQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA 351
           L ++     + R+ L  P        +  G +YLH      +IH D+K  N+ LN+D+E 
Sbjct: 126 LLEL----HKRRKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEV 178
Query: 352 CISDLGLAMAIP-DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRG 410
            I D GLA  +  DG  + ++    GT  YIAPE   +   S + D++S G ++ +L+ G
Sbjct: 179 KIGDFGLATKVEYDGERKKVLC---GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG 235
Query: 411 VPSFVFHQNGEEICSPE-WLRKVMNSKNPSRAIDP 444
            P F      E  C  E +LR   N  +  + I+P
Sbjct: 236 KPPF------ETSCLKETYLRIKKNEYSIPKHINP 264

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 72/294 (24%), Positives = 128/294 (43%), Gaps = 46/294 (15%)
Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           +E++G+G  GEV+     G     +   K    +P         D+ L ++ L +     
Sbjct: 24  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP---------DAFLAEANLMK----- 69
Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL 316
               Q++H+ ++ L A + +   +++  E+M+NGSL D L   S  +  ++      +A 
Sbjct: 70  ----QLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTIN--KLLDMAA 122
Query: 317 GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG-YT-RVLISYV 374
            +A G+ ++      + IH D++  N+L++D +   I+D GLA  I D  YT R    + 
Sbjct: 123 QIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF- 178
Query: 375 LGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLV-RGVPSFVFHQNGEEICSPEWLRKVM 433
              + + APE       + K D++SFG+LL  +V  G   +    N E I          
Sbjct: 179 --PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI---------- 226
Query: 434 NSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL 487
             +N  R      P N  E+    + ++  +C    PE+RP   Y+R  L    
Sbjct: 227 --QNLERGYRMVRPDNCPEE----LYQLMRLCWKERPEDRPTFDYLRSVLEDFF 274

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 72/294 (24%), Positives = 128/294 (43%), Gaps = 46/294 (15%)
Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           +E++G+G  GEV+     G     +   K    +P         D+ L ++ L +     
Sbjct: 23  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP---------DAFLAEANLMK----- 68
Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL 316
               Q++H+ ++ L A + +   +++  E+M+NGSL D L   S  +  ++      +A 
Sbjct: 69  ----QLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTIN--KLLDMAA 121
Query: 317 GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG-YT-RVLISYV 374
            +A G+ ++      + IH D++  N+L++D +   I+D GLA  I D  YT R    + 
Sbjct: 122 QIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF- 177
Query: 375 LGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLV-RGVPSFVFHQNGEEICSPEWLRKVM 433
              + + APE       + K D++SFG+LL  +V  G   +    N E I          
Sbjct: 178 --PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI---------- 225
Query: 434 NSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL 487
             +N  R      P N  E+    + ++  +C    PE+RP   Y+R  L    
Sbjct: 226 --QNLERGYRMVRPDNCPEE----LYQLMRLCWKERPEDRPTFDYLRSVLEDFF 273

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 23/206 (11%)
Query: 199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT 258
           K+G G  GEVY+             KK   Y+   A + ++ED+     ++ +   E   
Sbjct: 20  KLGGGQYGEVYEG----------VWKK---YSLTVAVKTLKEDT----MEVEEFLKEAAV 62
Query: 259 ASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV 318
             +I+H N++ LL    R     ++ EFM  G+L D L + +  R+E+       +A  +
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQI 120
Query: 319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTM 378
           +S +EYL      + IH D+  RN L+ ++    ++D GL+  +  G T    +     +
Sbjct: 121 SSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPI 176
Query: 379 AYIAPEYFQQPELSEKCDIFSFGMLL 404
            + APE     + S K D+++FG+LL
Sbjct: 177 KWTAPESLAYNKFSIKSDVWAFGVLL 202

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 23/206 (11%)
Query: 199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT 258
           K+G G  GEVY+             KK   Y+   A + ++ED+     ++ +   E   
Sbjct: 25  KLGGGQYGEVYEG----------VWKK---YSLTVAVKTLKEDTM----EVEEFLKEAAV 67
Query: 259 ASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV 318
             +I+H N++ LL    R     ++ EFM  G+L D L + +  R+E+       +A  +
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQI 125
Query: 319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTM 378
           +S +EYL      + IH D+  RN L+ ++    ++D GL+  +  G T    +     +
Sbjct: 126 SSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPI 181
Query: 379 AYIAPEYFQQPELSEKCDIFSFGMLL 404
            + APE     + S K D+++FG+LL
Sbjct: 182 KWTAPESLAYNKFSIKSDVWAFGVLL 207

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 72/294 (24%), Positives = 128/294 (43%), Gaps = 46/294 (15%)
Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           +E++G+G  GEV+     G     +   K    +P         D+ L ++ L +     
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP---------DAFLAEANLMK----- 63
Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL 316
               Q++H+ ++ L A + +   +++  E+M+NGSL D L   S  +  ++      +A 
Sbjct: 64  ----QLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTIN--KLLDMAA 116
Query: 317 GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG-YT-RVLISYV 374
            +A G+ ++      + IH D++  N+L++D +   I+D GLA  I D  YT R    + 
Sbjct: 117 QIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF- 172
Query: 375 LGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLV-RGVPSFVFHQNGEEICSPEWLRKVM 433
              + + APE       + K D++SFG+LL  +V  G   +    N E I          
Sbjct: 173 --PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI---------- 220
Query: 434 NSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL 487
             +N  R      P N  E+    + ++  +C    PE+RP   Y+R  L    
Sbjct: 221 --QNLERGYRMVRPDNCPEE----LYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 100/216 (46%), Gaps = 24/216 (11%)
Query: 193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQI 252
           C    + IG+G  GEVYK  L  S+GK    K+V    P++   L    +   + +    
Sbjct: 45  CVTRQKVIGAGEFGEVYKGMLKTSSGK----KEV----PVAIKTL---KAGYTEKQRVDF 93
Query: 253 RSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRH 312
             E     Q  H NI+ L   + +    +++ E+M+NG+L   L +       L      
Sbjct: 94  LGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGML 153
Query: 313 RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPD----GYTR 368
           R   G+A+G++YL    + + +H D+  RN+L+N ++   +SD GL+  + D     YT 
Sbjct: 154 R---GIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT- 206
Query: 369 VLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
              S     + + APE     + +   D++SFG+++
Sbjct: 207 --TSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVM 240

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 106/228 (46%), Gaps = 32/228 (14%)
Query: 192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ 251
           D +   + +G+G   EV  AE   +  K++AIK +       A E +E        K   
Sbjct: 18  DIYDFRDVLGTGAFSEVILAEDKRTQ-KLVAIKCI-------AKEALE-------GKEGS 62
Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHL-LVYEFMKNGSLQDILDDVSRG-RRELDWP 309
           + +EI    +I+H NI+ L   +     HL L+ + +  G L D +  V +G   E D  
Sbjct: 63  MENEIAVLHKIKHPNIVAL-DDIYESGGHLYLIMQLVSGGELFDRI--VEKGFYTERD-- 117
Query: 310 SRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVL---LNDDMEACISDLGLAMAIPDGY 366
              R+   V   ++YLH      I+H D+KP N+L   L++D +  ISD GL+     G 
Sbjct: 118 -ASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG- 172
Query: 367 TRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
              ++S   GT  Y+APE   Q   S+  D +S G++   L+ G P F
Sbjct: 173 --SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 23/206 (11%)
Query: 199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT 258
           K+G G  GEVY+             KK   Y+   A + ++ED+     ++ +   E   
Sbjct: 20  KLGGGQYGEVYEG----------VWKK---YSLTVAVKTLKEDTM----EVEEFLKEAAV 62
Query: 259 ASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV 318
             +I+H N++ LL    R     ++ EFM  G+L D L + +  R+E+       +A  +
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQI 120
Query: 319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTM 378
           +S +EYL      + IH D+  RN L+ ++    ++D GL+  +  G T    +     +
Sbjct: 121 SSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPI 176
Query: 379 AYIAPEYFQQPELSEKCDIFSFGMLL 404
            + APE     + S K D+++FG+LL
Sbjct: 177 KWTAPESLAYNKFSIKSDVWAFGVLL 202

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 23/206 (11%)
Query: 199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT 258
           K+G G  GEVY+             KK   Y+   A + ++ED+     ++ +   E   
Sbjct: 20  KLGGGQYGEVYEG----------VWKK---YSLTVAVKTLKEDTM----EVEEFLKEAAV 62
Query: 259 ASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV 318
             +I+H N++ LL    R     ++ EFM  G+L D L + +  R+E+       +A  +
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQI 120
Query: 319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTM 378
           +S +EYL      + IH D+  RN L+ ++    ++D GL+  +  G T    +     +
Sbjct: 121 SSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPI 176
Query: 379 AYIAPEYFQQPELSEKCDIFSFGMLL 404
            + APE     + S K D+++FG+LL
Sbjct: 177 KWTAPESLAYNKFSIKSDVWAFGVLL 202

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 73/319 (22%), Positives = 132/319 (41%), Gaps = 70/319 (21%)
Query: 188 LKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDS 247
           L+    F  +  +G G  G+V KA     + +  AIKK+                +  + 
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKAR-NALDSRYYAIKKI----------------RHTEE 44
Query: 248 KLRQIRSEIITASQIRH-------------RNILPLLAHMVRPDCHLLVYEFMKNGSLQD 294
           KL  I SE++  + + H             RN +  +  + +     +  E+ +NG+L D
Sbjct: 45  KLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYD 104
Query: 295 IL--DDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC 352
           ++  +++++ R E  W    R+   +   L Y+H   S  IIH D+KP N+ +++     
Sbjct: 105 LIHSENLNQQRDEY-W----RLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVK 156
Query: 353 ISDLGLAMAIPD-------------GYTRVLISYVLGTMAYIAPEYFQ-QPELSEKCDIF 398
           I D GLA  +               G +  L S  +GT  Y+A E        +EK D++
Sbjct: 157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTS-AIGTAMYVATEVLDGTGHYNEKIDMY 215
Query: 399 SFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHV 458
           S G++   ++     + F    E +     L+K+       R++    P +  + KM   
Sbjct: 216 SLGIIFFEMI-----YPFSTGMERV---NILKKL-------RSVSIEFPPDFDDNKMKVE 260
Query: 459 LKIAYICTLHDPEERPNSQ 477
            KI  +   HDP +RP ++
Sbjct: 261 KKIIRLLIDHDPNKRPGAR 279

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 104/228 (45%), Gaps = 32/228 (14%)
Query: 192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ 251
           D +   + +G+G   EV  AE   +  K++AIK +                K  + K   
Sbjct: 18  DIYDFRDVLGTGAFSEVILAEDKRTQ-KLVAIKCIA--------------KKALEGKEGS 62
Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHL-LVYEFMKNGSLQDILDDVSRG-RRELDWP 309
           + +EI    +I+H NI+ L   +     HL L+ + +  G L D +  V +G   E D  
Sbjct: 63  MENEIAVLHKIKHPNIVAL-DDIYESGGHLYLIMQLVSGGELFDRI--VEKGFYTERD-- 117
Query: 310 SRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVL---LNDDMEACISDLGLAMAIPDGY 366
              R+   V   ++YLH      I+H D+KP N+L   L++D +  ISD GL+     G 
Sbjct: 118 -ASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG- 172
Query: 367 TRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
              ++S   GT  Y+APE   Q   S+  D +S G++   L+ G P F
Sbjct: 173 --SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 98/215 (45%), Gaps = 18/215 (8%)
Query: 232 ISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGS 291
           + A +++ +   L+  +  ++  EI     + H++++         D   +V E  +  S
Sbjct: 44  VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRS 103
Query: 292 LQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA 351
           L ++     + R+ L  P        +  G +YLH      +IH D+K  N+ LN+D+E 
Sbjct: 104 LLEL----HKRRKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEV 156
Query: 352 CISDLGLAMAIP-DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRG 410
            I D GLA  +  DG  +     + GT  YIAPE   +   S + D++S G ++ +L+ G
Sbjct: 157 KIGDFGLATKVEYDGERK---KTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG 213
Query: 411 VPSFVFHQNGEEICSPE-WLRKVMNSKNPSRAIDP 444
            P F      E  C  E +LR   N  +  + I+P
Sbjct: 214 KPPF------ETSCLKETYLRIKKNEYSIPKHINP 242

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 124/292 (42%), Gaps = 42/292 (14%)
Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           +E++G+G  GEV+     G     +   K    +P         D+ L ++ L +     
Sbjct: 19  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP---------DAFLAEANLMK----- 64
Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL 316
               Q++H+ ++ L A + +   +++  E+M+NGSL D L   S  +  ++      +A 
Sbjct: 65  ----QLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTIN--KLLDMAA 117
Query: 317 GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLG 376
            +A G+ ++      + IH D++  N+L++D +   I+D GLA  I D            
Sbjct: 118 QIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF- 173
Query: 377 TMAYIAPEYFQQPELSEKCDIFSFGMLLISLV-RGVPSFVFHQNGEEICSPEWLRKVMNS 435
            + + APE       + K D++SFG+LL  +V  G   +    N E I            
Sbjct: 174 PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI------------ 221
Query: 436 KNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL 487
           +N  R      P N  E+    + ++  +C    PE+RP   Y+R  L    
Sbjct: 222 QNLERGYRMVRPDNCPEE----LYQLMRLCWKERPEDRPTFDYLRSVLEDFF 269

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 98/215 (45%), Gaps = 18/215 (8%)
Query: 232 ISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGS 291
           + A +++ +   L+  +  ++  EI     + H++++         D   +V E  +  S
Sbjct: 44  VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRS 103
Query: 292 LQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA 351
           L ++     + R+ L  P        +  G +YLH      +IH D+K  N+ LN+D+E 
Sbjct: 104 LLEL----HKRRKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEV 156
Query: 352 CISDLGLAMAIP-DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRG 410
            I D GLA  +  DG  +     + GT  YIAPE   +   S + D++S G ++ +L+ G
Sbjct: 157 KIGDFGLATKVEYDGERK---KTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG 213
Query: 411 VPSFVFHQNGEEICSPE-WLRKVMNSKNPSRAIDP 444
            P F      E  C  E +LR   N  +  + I+P
Sbjct: 214 KPPF------ETSCLKETYLRIKKNEYSIPKHINP 242

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 89/214 (41%), Gaps = 43/214 (20%)
Query: 192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ 251
           D    LE IG G  G VYK  L   + + +A+K   V++  +    I E +         
Sbjct: 13  DNLKLLELIGRGRYGAVYKGSL---DERPVAVK---VFSFANRQNFINEKN--------- 57
Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDC-----HLLVYEFMKNGSLQDILDDVSRGRREL 306
               I     + H NI   +    R        +LLV E+  NGSL   L          
Sbjct: 58  ----IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL-----SLHTS 108
Query: 307 DWPSRHRIALGVASGLEYLHM------YHSASIIHGDIKPRNVLLNDDMEACISDLGLAM 360
           DW S  R+A  V  GL YLH       ++  +I H D+  RNVL+ +D    ISD GL+M
Sbjct: 109 DWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSM 168
Query: 361 AI-------PDGYTRVLISYVLGTMAYIAPEYFQ 387
            +       P       IS V GT+ Y+APE  +
Sbjct: 169 RLTGNRLVRPGEEDNAAISEV-GTIRYMAPEVLE 201

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 73/294 (24%), Positives = 130/294 (44%), Gaps = 46/294 (15%)
Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           +E++G+G  GEV+     G     +A+K             +++ S   D+ L    +E 
Sbjct: 28  VERLGAGQFGEVWMGYYNGHTK--VAVKS------------LKQGSMSPDAFL----AEA 69
Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL 316
               Q++H+ ++ L A + +   +++  E+M+NGSL D L   S  +  ++      +A 
Sbjct: 70  NLMKQLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTIN--KLLDMAA 126
Query: 317 GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG-YT-RVLISYV 374
            +A G+ ++      + IH D++  N+L++D +   I+D GLA  I D  YT R    + 
Sbjct: 127 QIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF- 182
Query: 375 LGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLV-RGVPSFVFHQNGEEICSPEWLRKVM 433
              + + APE       + K D++SFG+LL  +V  G   +    N E I          
Sbjct: 183 --PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI---------- 230
Query: 434 NSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL 487
             +N  R      P N  E+    + ++  +C    PE+RP   Y+R  L    
Sbjct: 231 --QNLERGYRMVRPDNCPEE----LYQLMRLCWKERPEDRPTFDYLRSVLEDFF 278

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 124/292 (42%), Gaps = 42/292 (14%)
Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           +E++G+G  GEV+     G     +   K    +P         D+ L ++ L +     
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP---------DAFLAEANLMK----- 63
Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL 316
               Q++H+ ++ L A + +   +++  E+M+NGSL D L   S  +  ++      +A 
Sbjct: 64  ----QLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTIN--KLLDMAA 116
Query: 317 GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLG 376
            +A G+ ++      + IH D++  N+L++D +   I+D GLA  I D            
Sbjct: 117 QIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF- 172
Query: 377 TMAYIAPEYFQQPELSEKCDIFSFGMLLISLV-RGVPSFVFHQNGEEICSPEWLRKVMNS 435
            + + APE       + K D++SFG+LL  +V  G   +    N E I            
Sbjct: 173 PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI------------ 220
Query: 436 KNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL 487
           +N  R      P N  E+    + ++  +C    PE+RP   Y+R  L    
Sbjct: 221 QNLERGYRMVRPDNCPEE----LYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 23/206 (11%)
Query: 199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT 258
           K+G G  GEVY+             KK   Y+   A + ++ED+     ++ +   E   
Sbjct: 18  KLGGGQYGEVYEG----------VWKK---YSLTVAVKTLKEDT----MEVEEFLKEAAV 60
Query: 259 ASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV 318
             +I+H N++ LL    R     ++ EFM  G+L D L + +  R+E+       +A  +
Sbjct: 61  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQI 118
Query: 319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTM 378
           +S +EYL      + IH D+  RN L+ ++    ++D GL+  +  G T    +     +
Sbjct: 119 SSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTFTAHAGAKFPI 174
Query: 379 AYIAPEYFQQPELSEKCDIFSFGMLL 404
            + APE     + S K D+++FG+LL
Sbjct: 175 KWTAPESLAYNKFSIKSDVWAFGVLL 200

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 102/226 (45%), Gaps = 20/226 (8%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           +  L  IG+G  G   K     S+GK++  K+ + Y  ++ AE             + + 
Sbjct: 8   YEVLYTIGTGSYGRCQKIRRK-SDGKILVWKE-LDYGSMTEAEK------------QMLV 53
Query: 254 SEIITASQIRHRNILPLLAHMV-RPDCHL-LVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
           SE+    +++H NI+     ++ R +  L +V E+ + G L  ++   ++ R+ LD    
Sbjct: 54  SEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV 113
Query: 312 HRIALGVASGLEYLHMYHSA--SIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRV 369
            R+   +   L+  H       +++H D+KP NV L+      + D GLA  +   +   
Sbjct: 114 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTS 171
Query: 370 LISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFV 415
                +GT  Y++PE   +   +EK DI+S G LL  L   +P F 
Sbjct: 172 FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT 217

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 70/292 (23%), Positives = 126/292 (43%), Gaps = 42/292 (14%)
Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           +E++G+G  GEV+     G     +A+K             +++ S   D+ L    +E 
Sbjct: 27  VERLGAGQFGEVWMGYYNGHTK--VAVKS------------LKQGSMSPDAFL----AEA 68
Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL 316
               Q++H+ ++ L A + +   +++  E+M+NGSL D L   S  +  ++      +A 
Sbjct: 69  NLMKQLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTIN--KLLDMAA 125
Query: 317 GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLG 376
            +A G+ ++      + IH D++  N+L++D +   I+D GLA  I D            
Sbjct: 126 QIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF- 181
Query: 377 TMAYIAPEYFQQPELSEKCDIFSFGMLLISLV-RGVPSFVFHQNGEEICSPEWLRKVMNS 435
            + + APE       + K D++SFG+LL  +V  G   +    N E I            
Sbjct: 182 PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI------------ 229
Query: 436 KNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL 487
           +N  R      P N  E+    + ++  +C    PE+RP   Y+R  L    
Sbjct: 230 QNLERGYRMVRPDNCPEE----LYQLMRLCWKERPEDRPTFDYLRSVLEDFF 277

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 124/292 (42%), Gaps = 42/292 (14%)
Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           +E++G+G  GEV+     G     +   K    +P         D+ L ++ L +     
Sbjct: 20  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP---------DAFLAEANLMK----- 65
Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL 316
               Q++H+ ++ L A + +   +++  E+M+NGSL D L   S  +  ++      +A 
Sbjct: 66  ----QLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTIN--KLLDMAA 118
Query: 317 GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLG 376
            +A G+ ++      + IH D++  N+L++D +   I+D GLA  I D            
Sbjct: 119 QIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF- 174
Query: 377 TMAYIAPEYFQQPELSEKCDIFSFGMLLISLV-RGVPSFVFHQNGEEICSPEWLRKVMNS 435
            + + APE       + K D++SFG+LL  +V  G   +    N E I            
Sbjct: 175 PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI------------ 222
Query: 436 KNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL 487
           +N  R      P N  E+    + ++  +C    PE+RP   Y+R  L    
Sbjct: 223 QNLERGYRMVRPDNCPEE----LYQLMRLCWKERPEDRPTFDYLRSVLEDFF 270

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 70/292 (23%), Positives = 126/292 (43%), Gaps = 42/292 (14%)
Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           +E++G+G  GEV+     G     +A+K             +++ S   D+ L    +E 
Sbjct: 24  VERLGAGQFGEVWMGYYNGHTK--VAVKS------------LKQGSMSPDAFL----AEA 65
Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL 316
               Q++H+ ++ L A + +   +++  E+M+NGSL D L   S  +  ++      +A 
Sbjct: 66  NLMKQLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTIN--KLLDMAA 122
Query: 317 GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLG 376
            +A G+ ++      + IH D++  N+L++D +   I+D GLA  I D            
Sbjct: 123 QIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF- 178
Query: 377 TMAYIAPEYFQQPELSEKCDIFSFGMLLISLV-RGVPSFVFHQNGEEICSPEWLRKVMNS 435
            + + APE       + K D++SFG+LL  +V  G   +    N E I            
Sbjct: 179 PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI------------ 226
Query: 436 KNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL 487
           +N  R      P N  E+    + ++  +C    PE+RP   Y+R  L    
Sbjct: 227 QNLERGYRMVRPDNCPEE----LYQLMRLCWKERPEDRPTFDYLRSVLEDFF 274

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 70/292 (23%), Positives = 126/292 (43%), Gaps = 42/292 (14%)
Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           +E++G+G  GEV+     G     +A+K             +++ S   D+ L    +E 
Sbjct: 26  VERLGAGQFGEVWMGYYNGHTK--VAVKS------------LKQGSMSPDAFL----AEA 67
Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL 316
               Q++H+ ++ L A + +   +++  E+M+NGSL D L   S  +  ++      +A 
Sbjct: 68  NLMKQLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTIN--KLLDMAA 124
Query: 317 GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLG 376
            +A G+ ++      + IH D++  N+L++D +   I+D GLA  I D            
Sbjct: 125 QIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF- 180
Query: 377 TMAYIAPEYFQQPELSEKCDIFSFGMLLISLV-RGVPSFVFHQNGEEICSPEWLRKVMNS 435
            + + APE       + K D++SFG+LL  +V  G   +    N E I            
Sbjct: 181 PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI------------ 228
Query: 436 KNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL 487
           +N  R      P N  E+    + ++  +C    PE+RP   Y+R  L    
Sbjct: 229 QNLERGYRMVRPDNCPEE----LYQLMRLCWKERPEDRPTFDYLRSVLEDFF 276

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 98/215 (45%), Gaps = 18/215 (8%)
Query: 232 ISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGS 291
           + A +++ +   L+  +  ++  EI     + H++++         D   +V E  +  S
Sbjct: 48  VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRS 107
Query: 292 LQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA 351
           L ++     + R+ L  P        +  G +YLH      +IH D+K  N+ LN+D+E 
Sbjct: 108 LLEL----HKRRKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEV 160
Query: 352 CISDLGLAMAIP-DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRG 410
            I D GLA  +  DG  +     + GT  YIAPE   +   S + D++S G ++ +L+ G
Sbjct: 161 KIGDFGLATKVEYDGERK---KTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG 217
Query: 411 VPSFVFHQNGEEICSPE-WLRKVMNSKNPSRAIDP 444
            P F      E  C  E +LR   N  +  + I+P
Sbjct: 218 KPPF------ETSCLKETYLRIKKNEYSIPKHINP 246

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/250 (26%), Positives = 114/250 (45%), Gaps = 43/250 (17%)
Query: 198 EKIGSGGCGEVYKAELPGSNGKMI--AIKKVIVYAPISAAELIEEDSKLRD-SKLRQIRS 254
           E IG G  G VY   L  ++GK I  A+K +               +++ D  ++ Q  +
Sbjct: 37  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL---------------NRITDIGEVSQFLT 81
Query: 255 EIITASQIRHRNILPLLAHMVRPDCH-LLVYEFMKNGSLQDILDDVSRGRRELDWPS-RH 312
           E I      H N+L LL   +R +   L+V  +MK+G L++ +      R E   P+ + 
Sbjct: 82  EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI------RNETHNPTVKD 135
Query: 313 RIALG--VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVL 370
            I  G  VA G+++L    S   +H D+  RN +L++     ++D GLA  + D     +
Sbjct: 136 LIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSV 192
Query: 371 ISYVLGTMA--YIAPEYFQQPELSEKCDIFSFGMLLISLV-RGVPSF---------VFHQ 418
            +     +   ++A E  Q  + + K D++SFG+LL  L+ RG P +         V+  
Sbjct: 193 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 252
Query: 419 NGEEICSPEW 428
            G  +  PE+
Sbjct: 253 QGRRLLQPEY 262

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 70/292 (23%), Positives = 126/292 (43%), Gaps = 42/292 (14%)
Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           +E++G+G  GEV+     G     +A+K             +++ S   D+ L    +E 
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTK--VAVKS------------LKQGSMSPDAFL----AEA 59
Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL 316
               Q++H+ ++ L A + +   +++  E+M+NGSL D L   S  +  ++      +A 
Sbjct: 60  NLMKQLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTIN--KLLDMAA 116
Query: 317 GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLG 376
            +A G+ ++      + IH D++  N+L++D +   I+D GLA  I D            
Sbjct: 117 QIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF- 172
Query: 377 TMAYIAPEYFQQPELSEKCDIFSFGMLLISLV-RGVPSFVFHQNGEEICSPEWLRKVMNS 435
            + + APE       + K D++SFG+LL  +V  G   +    N E I            
Sbjct: 173 PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI------------ 220
Query: 436 KNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL 487
           +N  R      P N  E+    + ++  +C    PE+RP   Y+R  L    
Sbjct: 221 QNLERGYRMVRPDNCPEE----LYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/288 (23%), Positives = 127/288 (44%), Gaps = 52/288 (18%)
Query: 196 SLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR-S 254
           S  KIG G  G V  A    S G+ +A+K +                 LR  + R++  +
Sbjct: 49  SYVKIGEGSTGIVCLAREKHS-GRQVAVKMM----------------DLRKQQRRELLFN 91
Query: 255 EIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRI 314
           E++     +H N++ +    +  +   ++ EF++ G+L DI+  V          +  +I
Sbjct: 92  EVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRL--------NEEQI 143
Query: 315 ALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYV 374
           A    + L+ L   H+  +IH DIK  ++LL  D    +SD G    I     +     +
Sbjct: 144 ATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR--KXL 201
Query: 375 LGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSP-EWLRKVM 433
           +GT  ++APE   +   + + DI+S G+++I +V G P +          SP + ++++ 
Sbjct: 202 VGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSD-------SPVQAMKRLR 254
Query: 434 NSKNP----SRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQ 477
           +S  P    S  + P L    + ++ML          + DP+ER  +Q
Sbjct: 255 DSPPPKLKNSHKVSPVL--RDFLERML----------VRDPQERATAQ 290

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 102/226 (45%), Gaps = 20/226 (8%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           +  L  IG+G  G   K     S+GK++  K+ + Y  ++ AE             + + 
Sbjct: 8   YEVLYTIGTGSYGRCQKIRRK-SDGKILVWKE-LDYGSMTEAEK------------QMLV 53
Query: 254 SEIITASQIRHRNILPLLAHMV-RPDCHL-LVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
           SE+    +++H NI+     ++ R +  L +V E+ + G L  ++   ++ R+ LD    
Sbjct: 54  SEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV 113
Query: 312 HRIALGVASGLEYLHMYHSA--SIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRV 369
            R+   +   L+  H       +++H D+KP NV L+      + D GLA  +   +   
Sbjct: 114 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTS 171
Query: 370 LISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFV 415
                +GT  Y++PE   +   +EK DI+S G LL  L   +P F 
Sbjct: 172 FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT 217

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 102/226 (45%), Gaps = 20/226 (8%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           +  L  IG+G  G   K     S+GK++  K+ + Y  ++ AE             + + 
Sbjct: 8   YEVLYTIGTGSYGRCQKIRRK-SDGKILVWKE-LDYGSMTEAEK------------QMLV 53
Query: 254 SEIITASQIRHRNILPLLAHMV-RPDCHL-LVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
           SE+    +++H NI+     ++ R +  L +V E+ + G L  ++   ++ R+ LD    
Sbjct: 54  SEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV 113
Query: 312 HRIALGVASGLEYLHMYHSA--SIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRV 369
            R+   +   L+  H       +++H D+KP NV L+      + D GLA  +   +   
Sbjct: 114 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDED 171
Query: 370 LISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFV 415
                +GT  Y++PE   +   +EK DI+S G LL  L   +P F 
Sbjct: 172 FAKEFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT 217

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 77/301 (25%), Positives = 118/301 (39%), Gaps = 36/301 (11%)
Query: 183 EDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDS 242
           + L  L  E     LEK+G G  G V + E    +GK +++          A + ++ D 
Sbjct: 3   QSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSV----------AVKCLKPDV 52
Query: 243 KLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG 302
             +   +     E+     + HRN++ L   ++ P   + V E    GSL   LD + + 
Sbjct: 53  LSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSL---LDRLRKH 108
Query: 303 RRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI 362
           +      +  R A+ VA G+ YL    S   IH D+  RN+LL       I D GL  A+
Sbjct: 109 QGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 165
Query: 363 P---DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQN 419
           P   D Y  V+  +     A+ APE  +    S   D + FG+ L  +           N
Sbjct: 166 PQNDDHY--VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN 223
Query: 420 GEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYV 479
           G +I     L K+   K   R   P       E     +  +   C  H PE+RP    +
Sbjct: 224 GSQI-----LHKI--DKEGERLPRP-------EDCPQDIYNVMVQCWAHKPEDRPTFVAL 269
Query: 480 R 480
           R
Sbjct: 270 R 270

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 113/242 (46%), Gaps = 40/242 (16%)
Query: 194 FASLEKIGSGGCGEVYKAELPGS----NGKMIAIKKVIVYAPISAAELIEEDSKLRDSKL 249
           F  + K+ S   GE   A++ G+    NGK  A+K            +IE+ +    S+ 
Sbjct: 10  FEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVK------------IIEKQAG--HSRS 55
Query: 250 RQIRSEIITASQIR-HRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDW 308
           R  R E+ T  Q + ++NIL L+          LV+E ++ GS   IL  + + ++  + 
Sbjct: 56  RVFR-EVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGS---ILAHIQK-QKHFNE 110
Query: 309 PSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDD-----MEACISDLGLAMAIP 363
               R+   VA+ L++LH   +  I H D+KP N+L         ++ C  DLG  M + 
Sbjct: 111 REASRVVRDVAAALDFLH---TKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLN 167
Query: 364 DGYTRVL---ISYVLGTMAYIAPEYF-----QQPELSEKCDIFSFGMLLISLVRGVPSFV 415
           +  T +    ++   G+  Y+APE       Q     ++CD++S G++L  ++ G P FV
Sbjct: 168 NSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFV 227
Query: 416 FH 417
            H
Sbjct: 228 GH 229

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 72/294 (24%), Positives = 128/294 (43%), Gaps = 46/294 (15%)
Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           +E++G+G  GEV+     G     +   K    +P         D+ L ++ L +     
Sbjct: 13  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP---------DAFLAEANLMK----- 58
Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL 316
               Q++H+ ++ L A + +   +++  E+M+NGSL D L   S  +  ++      +A 
Sbjct: 59  ----QLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTIN--KLLDMAA 111
Query: 317 GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG-YT-RVLISYV 374
            +A G+ ++      + IH D++  N+L++D +   I+D GLA  I D  YT R    + 
Sbjct: 112 QIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF- 167
Query: 375 LGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLV-RGVPSFVFHQNGEEICSPEWLRKVM 433
              + + APE       + K D++SFG+LL  +V  G   +    N E I          
Sbjct: 168 --PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI---------- 215
Query: 434 NSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL 487
             +N  R      P N  E+    + ++  +C    PE+RP   Y+R  L    
Sbjct: 216 --QNLERGYRMVRPDNCPEE----LYQLMRLCWKERPEDRPTFDYLRSVLEDFF 263

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 82/318 (25%), Positives = 125/318 (39%), Gaps = 46/318 (14%)
Query: 167 GSRDRGP-TIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKK 225
           GS   GP    + LI ++DL  L         EK+G G  G V + E    +GK +++  
Sbjct: 1   GSAGEGPLQSLTCLIGEKDLRLL---------EKLGDGSFGVVRRGEWDAPSGKTVSV-- 49
Query: 226 VIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYE 285
                   A + ++ D   +   +     E+     + HRN++ L   ++ P   + V E
Sbjct: 50  --------AVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTE 100
Query: 286 FMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLL 345
               GSL   LD + + +      +  R A+ VA G+ YL    S   IH D+  RN+LL
Sbjct: 101 LAPLGSL---LDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLL 154
Query: 346 NDDMEACISDLGLAMAIP---DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGM 402
                  I D GL  A+P   D Y  V+  +     A+ APE  +    S   D + FG+
Sbjct: 155 ATRDLVKIGDFGLMRALPQNDDHY--VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGV 212
Query: 403 LLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIA 462
            L  +           NG +I     L K+   K   R   P       E     +  + 
Sbjct: 213 TLWEMFTYGQEPWIGLNGSQI-----LHKI--DKEGERLPRP-------EDCPQDIYNVM 258
Query: 463 YICTLHDPEERPNSQYVR 480
             C  H PE+RP    +R
Sbjct: 259 VQCWAHKPEDRPTFVALR 276

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 100/220 (45%), Gaps = 27/220 (12%)
Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           L+ IG G   +V K       GK +A+K             I + ++L  S L+++  E+
Sbjct: 19  LKTIGKGNFAKV-KLARHILTGKEVAVK-------------IIDKTQLNSSSLQKLFREV 64
Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGR-RELDWPSRHRIA 315
                + H NI+ L   +       LV E+   G + D L  V+ GR +E +  ++ R  
Sbjct: 65  RIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYL--VAHGRMKEKEARAKFR-- 120
Query: 316 LGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVL 375
             + S ++Y H      I+H D+K  N+LL+ DM   I+D G +     G     +    
Sbjct: 121 -QIVSAVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK---LDTFC 173
Query: 376 GTMAYIAPEYFQQPEL-SEKCDIFSFGMLLISLVRGVPSF 414
           G+  Y APE FQ  +    + D++S G++L +LV G   F
Sbjct: 174 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 213

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 100/220 (45%), Gaps = 27/220 (12%)
Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           L+ IG G   +V K       GK +A+K             I + ++L  S L+++  E+
Sbjct: 19  LKTIGKGNFAKV-KLARHILTGKEVAVK-------------IIDKTQLNSSSLQKLFREV 64
Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGR-RELDWPSRHRIA 315
                + H NI+ L   +       LV E+   G + D L  V+ GR +E +  ++ R  
Sbjct: 65  RIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYL--VAHGRMKEKEARAKFR-- 120
Query: 316 LGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVL 375
             + S ++Y H      I+H D+K  N+LL+ DM   I+D G +     G     +    
Sbjct: 121 -QIVSAVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK---LDTFC 173
Query: 376 GTMAYIAPEYFQQPEL-SEKCDIFSFGMLLISLVRGVPSF 414
           G+  Y APE FQ  +    + D++S G++L +LV G   F
Sbjct: 174 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 213

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 77/301 (25%), Positives = 118/301 (39%), Gaps = 36/301 (11%)
Query: 183 EDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDS 242
           + L  L  E     LEK+G G  G V + E    +GK +++          A + ++ D 
Sbjct: 3   QSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSV----------AVKCLKPDV 52
Query: 243 KLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG 302
             +   +     E+     + HRN++ L   ++ P   + V E    GSL   LD + + 
Sbjct: 53  LSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSL---LDRLRKH 108
Query: 303 RRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI 362
           +      +  R A+ VA G+ YL    S   IH D+  RN+LL       I D GL  A+
Sbjct: 109 QGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 165
Query: 363 P---DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQN 419
           P   D Y  V+  +     A+ APE  +    S   D + FG+ L  +           N
Sbjct: 166 PQNDDHY--VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN 223
Query: 420 GEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYV 479
           G +I     L K+   K   R   P       E     +  +   C  H PE+RP    +
Sbjct: 224 GSQI-----LHKI--DKEGERLPRP-------EDCPQDIYNVMVQCWAHKPEDRPTFVAL 269
Query: 480 R 480
           R
Sbjct: 270 R 270

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 114/287 (39%), Gaps = 36/287 (12%)
Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           LEK+G G  G V + E    +GK +++          A + ++ D   +   +     E+
Sbjct: 13  LEKLGDGSFGVVRRGEWDAPSGKTVSV----------AVKCLKPDVLSQPEAMDDFIREV 62
Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL 316
                + HRN++ L   ++ P   + V E    GSL   LD + + +      +  R A+
Sbjct: 63  NAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSL---LDRLRKHQGHFLLGTLSRYAV 118
Query: 317 GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP---DGYTRVLISY 373
            VA G+ YL    S   IH D+  RN+LL       I D GL  A+P   D Y  V+  +
Sbjct: 119 QVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY--VMQEH 173
Query: 374 VLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVM 433
                A+ APE  +    S   D + FG+ L  +           NG +I     L K+ 
Sbjct: 174 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI-----LHKI- 227
Query: 434 NSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVR 480
             K   R   P       E     +  +   C  H PE+RP    +R
Sbjct: 228 -DKEGERLPRP-------EDCPQDIYNVMVQCWAHKPEDRPTFVALR 266

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 102/222 (45%), Gaps = 26/222 (11%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           F  +E IGSGG G+V+KA+    +GK   IK+V  Y    A   ++  +KL    +    
Sbjct: 13  FKEIELIGSGGFGQVFKAK-HRIDGKTYVIKRV-KYNNEKAEREVKALAKLDHVNIVHYN 70
Query: 254 S-------EIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRREL 306
                   +  T+S+   R+         +  C  +  EF   G+L+  ++   R   +L
Sbjct: 71  GCWDGFDYDPETSSKNSSRS---------KTKCLFIQMEFCDKGTLEQWIE--KRRGEKL 119
Query: 307 DWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGY 366
           D      +   +  G++Y+H   S  +I+ D+KP N+ L D  +  I D GL  ++ +  
Sbjct: 120 DKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG 176
Query: 367 TRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLV 408
            R       GT+ Y++PE     +  ++ D+++ G++L  L+
Sbjct: 177 KRXRSK---GTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 114/287 (39%), Gaps = 36/287 (12%)
Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           LEK+G G  G V + E    +GK +++          A + ++ D   +   +     E+
Sbjct: 13  LEKLGDGSFGVVRRGEWDAPSGKTVSV----------AVKCLKPDVLSQPEAMDDFIREV 62
Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL 316
                + HRN++ L   ++ P   + V E    GSL   LD + + +      +  R A+
Sbjct: 63  NAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSL---LDRLRKHQGHFLLGTLSRYAV 118
Query: 317 GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP---DGYTRVLISY 373
            VA G+ YL    S   IH D+  RN+LL       I D GL  A+P   D Y  V+  +
Sbjct: 119 QVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY--VMQEH 173
Query: 374 VLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVM 433
                A+ APE  +    S   D + FG+ L  +           NG +I     L K+ 
Sbjct: 174 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI-----LHKI- 227
Query: 434 NSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVR 480
             K   R   P       E     +  +   C  H PE+RP    +R
Sbjct: 228 -DKEGERLPRP-------EDCPQDIYNVMVQCWAHKPEDRPTFVALR 266

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 99/210 (47%), Gaps = 23/210 (10%)
Query: 199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT 258
           K+G G  GEVY+             KK   Y+   A + ++ED+     ++ +   E   
Sbjct: 266 KLGGGQYGEVYEG----------VWKK---YSLTVAVKTLKEDTM----EVEEFLKEAAV 308
Query: 259 ASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV 318
             +I+H N++ LL    R     ++ EFM  G+L D L + +  R+E++      +A  +
Sbjct: 309 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN--RQEVNAVVLLYMATQI 366
Query: 319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTM 378
           +S +EYL      + IH ++  RN L+ ++    ++D GL+  +  G T    +     +
Sbjct: 367 SSAMEYL---EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPI 422
Query: 379 AYIAPEYFQQPELSEKCDIFSFGMLLISLV 408
            + APE     + S K D+++FG+LL  + 
Sbjct: 423 KWTAPESLAYNKFSIKSDVWAFGVLLWEIA 452

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 101/226 (44%), Gaps = 25/226 (11%)
Query: 191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
           ++ F     +G GG GEV   ++  + GKM A KK+         +   E   L + ++ 
Sbjct: 183 KNTFRQYRVLGKGGFGEVCACQV-RATGKMYACKKLEK---KRIKKRKGEAMALNEKQIL 238
Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPS 310
           +         ++  R ++ L       D   LV   M  G L+  +  + +      +P 
Sbjct: 239 E---------KVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQA----GFPE 285
Query: 311 RHRI--ALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTR 368
              +  A  +  GLE LH      I++ D+KP N+LL+D     ISDLGLA+ +P+G T 
Sbjct: 286 ARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT- 341
Query: 369 VLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
             I   +GT+ Y+APE  +    +   D ++ G LL  ++ G   F
Sbjct: 342 --IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF 385

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 88/204 (43%), Gaps = 17/204 (8%)
Query: 215 GSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHM 274
           GS G++I  K  I     +   + +   K +  K   +R E+    Q+ H NI  L    
Sbjct: 37  GSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLR-EVQLLKQLDHPNIXKLYEFF 95
Query: 275 VRPDCHLLVYEFMKNGSLQDILDDVSRGR-RELDWPSRHRIALGVASGLEYLHMYHSASI 333
                  LV E    G L D +  +SR R  E+D     RI   V SG+ Y H      I
Sbjct: 96  EDKGYFYLVGEVYTGGELFDEI--ISRKRFSEVDAA---RIIRQVLSGITYXH---KNKI 147
Query: 334 IHGDIKPRNVLL---NDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPE 390
           +H D+KP N+LL   + D    I D GL+               +GT  YIAPE      
Sbjct: 148 VHRDLKPENLLLESKSKDANIRIIDFGLSTHFE---ASKKXKDKIGTAYYIAPEVLHGT- 203
Query: 391 LSEKCDIFSFGMLLISLVRGVPSF 414
             EKCD++S G++L  L+ G P F
Sbjct: 204 YDEKCDVWSTGVILYILLSGCPPF 227

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 101/226 (44%), Gaps = 25/226 (11%)
Query: 191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
           ++ F     +G GG GEV   ++  + GKM A KK+         +   E   L + ++ 
Sbjct: 183 KNTFRQYRVLGKGGFGEVCACQV-RATGKMYACKKLEK---KRIKKRKGEAMALNEKQIL 238
Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPS 310
           +         ++  R ++ L       D   LV   M  G L+  +  + +      +P 
Sbjct: 239 E---------KVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQA----GFPE 285
Query: 311 RHRI--ALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTR 368
              +  A  +  GLE LH      I++ D+KP N+LL+D     ISDLGLA+ +P+G T 
Sbjct: 286 ARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT- 341
Query: 369 VLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
             I   +GT+ Y+APE  +    +   D ++ G LL  ++ G   F
Sbjct: 342 --IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF 385

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 80/316 (25%), Positives = 123/316 (38%), Gaps = 42/316 (13%)
Query: 167 GSRDRGP-TIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKK 225
           GS   GP    + LI ++DL  L         EK+G G  G V + E    +GK +++  
Sbjct: 1   GSAGEGPLQSLTCLIGEKDLRLL---------EKLGDGSFGVVRRGEWDAPSGKTVSV-- 49
Query: 226 VIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYE 285
                   A + ++ D   +   +     E+     + HRN++ L   ++ P   + V E
Sbjct: 50  --------AVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTE 100
Query: 286 FMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLL 345
               GSL   LD + + +      +  R A+ VA G+ YL    S   IH D+  RN+LL
Sbjct: 101 LAPLGSL---LDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLL 154
Query: 346 NDDMEACISDLGLAMAIPDGYTR-VLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
                  I D GL  A+P      V+  +     A+ APE  +    S   D + FG+ L
Sbjct: 155 ATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTL 214
Query: 405 ISLVRGVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYI 464
             +           NG +I     L K+   K   R   P       E     +  +   
Sbjct: 215 WEMFTYGQEPWIGLNGSQI-----LHKI--DKEGERLPRP-------EDCPQDIYNVMVQ 260
Query: 465 CTLHDPEERPNSQYVR 480
           C  H PE+RP    +R
Sbjct: 261 CWAHKPEDRPTFVALR 276

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 99/220 (45%), Gaps = 27/220 (12%)
Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           L+ IG G   +V K       GK +A+K             I + ++L  S L+++  E+
Sbjct: 19  LKTIGKGNFAKV-KLARHILTGKEVAVK-------------IIDKTQLNSSSLQKLFREV 64
Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGR-RELDWPSRHRIA 315
                + H NI+ L   +       LV E+   G + D L  V+ GR +E +  ++ R  
Sbjct: 65  RIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYL--VAHGRMKEKEARAKFR-- 120
Query: 316 LGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVL 375
             + S ++Y H      I+H D+K  N+LL+ DM   I+D G +     G     +    
Sbjct: 121 -QIVSAVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK---LDAFC 173
Query: 376 GTMAYIAPEYFQQPEL-SEKCDIFSFGMLLISLVRGVPSF 414
           G   Y APE FQ  +    + D++S G++L +LV G   F
Sbjct: 174 GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 213

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 92/194 (47%), Gaps = 27/194 (13%)
Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPS 310
           +I+ EI      RH +I+ L   +  P    +V E++  G L D +     GR E +  +
Sbjct: 57  KIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYI--CKHGRVE-EMEA 113
Query: 311 RHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVL 370
           R R+   + S ++Y H +    ++H D+KP NVLL+  M A I+D GL+  + DG     
Sbjct: 114 R-RLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE---F 166
Query: 371 ISYVLGTMAYIAPEY-----FQQPELSEKCDIFSFGMLLISLVRG--------VPSFVFH 417
           +    G+  Y APE      +  PE+    DI+S G++L +L+ G        VP+    
Sbjct: 167 LRTSCGSPNYAAPEVISGRLYAGPEV----DIWSCGVILYALLCGTLPFDDEHVPTLFKK 222
Query: 418 QNGEEICSPEWLRK 431
             G     PE+L +
Sbjct: 223 IRGGVFYIPEYLNR 236

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 112/285 (39%), Gaps = 32/285 (11%)
Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           LEK+G G  G V + E    +GK +++          A + ++ D   +   +     E+
Sbjct: 13  LEKLGDGSFGVVRRGEWDAPSGKTVSV----------AVKCLKPDVLSQPEAMDDFIREV 62
Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL 316
                + HRN++ L   ++ P   + V E    GSL   LD + + +      +  R A+
Sbjct: 63  NAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSL---LDRLRKHQGHFLLGTLSRYAV 118
Query: 317 GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTR-VLISYVL 375
            VA G+ YL    S   IH D+  RN+LL       I D GL  A+P      V+  +  
Sbjct: 119 QVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRK 175
Query: 376 GTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNS 435
              A+ APE  +    S   D + FG+ L  +           NG +I     L K+   
Sbjct: 176 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI-----LHKI--D 228
Query: 436 KNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVR 480
           K   R   P       E     +  +   C  H PE+RP    +R
Sbjct: 229 KEGERLPRP-------EDCPQDIYNVMVQCWAHKPEDRPTFVALR 266

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 78/313 (24%), Positives = 135/313 (43%), Gaps = 51/313 (16%)
Query: 183 EDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDS 242
           E+L F   E  + +L  +G G  G V K       G+++AIKK +           ++D 
Sbjct: 17  ENLYFQSMEK-YENLGLVGEGSYGMVMKCR-NKDTGRIVAIKKFLES---------DDDK 65
Query: 243 KLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG 302
            ++   +R+I+       Q+RH N++ LL    +     LV+EF+ +     ILDD+   
Sbjct: 66  MVKKIAMREIK----LLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH----TILDDLELF 117
Query: 303 RRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI 362
              LD+    +    + +G+ + H   S +IIH DIKP N+L        +S  G+    
Sbjct: 118 PNGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENIL--------VSQSGVVKLC 166
Query: 363 PDGYTRVLISYVLGTMAYIAPEYFQQPEL-------SEKCDIFSFGMLLISLVRGVPSFV 415
             G+ R L +        +A  +++ PEL        +  D+++ G L+  +  G P F 
Sbjct: 167 DFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFP 226
Query: 416 FHQNGEEI-----CSPEWL--RKVMNSKNPSRA------IDPRLP-GNGYEKKMLHVLKI 461
              + +++     C    +   + + +KNP  A      I  R P    Y K    V+ +
Sbjct: 227 GDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDL 286
Query: 462 AYICTLHDPEERP 474
           A  C   DP++RP
Sbjct: 287 AKKCLHIDPDKRP 299

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 86/179 (48%), Gaps = 13/179 (7%)
Query: 238 IEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILD 297
           I + ++L  S L+++  E+     + H NI+ L   +       LV E+   G + D L 
Sbjct: 46  IIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYL- 104
Query: 298 DVSRGR-RELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDL 356
            V+ GR +E +  ++ R    + S ++Y H      I+H D+K  N+LL+ DM   I+D 
Sbjct: 105 -VAHGRMKEKEARAKFR---QIVSAVQYCH---QKFIVHRDLKAENLLLDADMNIKIADF 157
Query: 357 GLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPEL-SEKCDIFSFGMLLISLVRGVPSF 414
           G +     G     +    G+  Y APE FQ  +    + D++S G++L +LV G   F
Sbjct: 158 GFSNEFTFGNK---LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 213

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 69/136 (50%), Gaps = 10/136 (7%)
Query: 282 LVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV-ASGLEYLHMYHSASIIHGDIKP 340
           +V E++   +L+DI+          + P   + A+ V A   + L+  H   IIH D+KP
Sbjct: 93  IVMEYVDGVTLRDIV--------HTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKP 144
Query: 341 RNVLLNDDMEACISDLGLAMAIPD-GYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFS 399
            N+L++      + D G+A AI D G +    + V+GT  Y++PE  +   +  + D++S
Sbjct: 145 ANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARGDSVDARSDVYS 204
Query: 400 FGMLLISLVRGVPSFV 415
            G +L  ++ G P F 
Sbjct: 205 LGCVLYEVLTGEPPFT 220

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 97/206 (47%), Gaps = 23/206 (11%)
Query: 199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT 258
           K+G G  GEVY+             KK   Y+   A + ++ED+     ++ +   E   
Sbjct: 227 KLGGGQYGEVYEG----------VWKK---YSLTVAVKTLKEDTM----EVEEFLKEAAV 269
Query: 259 ASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV 318
             +I+H N++ LL    R     ++ EFM  G+L D L + +  R+E+       +A  +
Sbjct: 270 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQI 327
Query: 319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTM 378
           +S +EYL      + IH ++  RN L+ ++    ++D GL+  +  G T    +     +
Sbjct: 328 SSAMEYL---EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPI 383
Query: 379 AYIAPEYFQQPELSEKCDIFSFGMLL 404
            + APE     + S K D+++FG+LL
Sbjct: 384 KWTAPESLAYNKFSIKSDVWAFGVLL 409

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 102/228 (44%), Gaps = 25/228 (10%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR--- 250
           F  +E IGSGG G+V+KA+    +GK   I++V  Y    A   ++  +KL    +    
Sbjct: 14  FKEIELIGSGGFGQVFKAK-HRIDGKTYVIRRV-KYNNEKAEREVKALAKLDHVNIVHYN 71
Query: 251 ----------QIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVS 300
                     +   + + +S     N     +   +  C  +  EF   G+L+  ++   
Sbjct: 72  GCWDGFDYDPETSDDSLESSDYDPEN--SKNSSRSKTKCLFIQMEFCDKGTLEQWIE--K 127
Query: 301 RGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAM 360
           R   +LD      +   +  G++Y+H   S  +IH D+KP N+ L D  +  I D GL  
Sbjct: 128 RRGEKLDKVLALELFEQITKGVDYIH---SKKLIHRDLKPSNIFLVDTKQVKIGDFGLVT 184
Query: 361 AIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLV 408
           ++ +   R       GT+ Y++PE     +  ++ D+++ G++L  L+
Sbjct: 185 SLKNDGKRTRSK---GTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 100/226 (44%), Gaps = 31/226 (13%)
Query: 187 FLKKED--CFASLEKIGSGGCGEVY--KAELPGSNGKMIAIKKVIVYAPISAAELIEEDS 242
           F K+ D  C      IG+G  GEV   + +LPG     +AIK + V              
Sbjct: 36  FAKELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKV-------------- 81
Query: 243 KLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG 302
              + + R    E     Q  H N++ L   + R    ++V EFM+NG+L   L      
Sbjct: 82  GYTEKQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLR----- 136
Query: 303 RRELDWPSRHRIAL--GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAM 360
           + +  +     + +  G+A+G+ YL        +H D+  RN+L+N ++   +SD GL+ 
Sbjct: 137 KHDGQFTVIQLVGMLRGIAAGMRYLA---DMGYVHRDLAARNILVNSNLVCKVSDFGLSR 193
Query: 361 AIPDGYTRVLISYVLGTMA--YIAPEYFQQPELSEKCDIFSFGMLL 404
            I D    V  +   G +   + APE  Q  + +   D++S+G+++
Sbjct: 194 VIEDDPEAVYTT-TGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVM 238

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 102/228 (44%), Gaps = 35/228 (15%)
Query: 184 DLAFLKKEDCFASLEKIGSGGCGEVYKAEL--PGSNGKMIAIKKVIVYAPISAAELIEED 241
           D++++K E      E IG+G  GEV +  L  PG     +AIK +               
Sbjct: 12  DVSYVKIE------EVIGAGEFGEVCRGRLKAPGKKESCVAIKTL--------------K 51
Query: 242 SKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDIL--DDV 299
               + + R+  SE     Q  H NI+ L   +      +++ EFM+NG+L   L  +D 
Sbjct: 52  GGYTERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDG 111
Query: 300 SRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA 359
                +L    R     G+ASG+ YL      S +H D+  RN+L+N ++   +SD GL+
Sbjct: 112 QFTVIQLVGMLR-----GIASGMRYLA---EMSYVHRDLAARNILVNSNLVCKVSDFGLS 163
Query: 360 MAIPDGYTRVLISYVLG---TMAYIAPEYFQQPELSEKCDIFSFGMLL 404
             + +  +    +  LG    + + APE     + +   D +S+G+++
Sbjct: 164 RFLEENSSDPTYTSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVM 211

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 86/179 (48%), Gaps = 13/179 (7%)
Query: 238 IEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILD 297
           I + ++L  S L+++  E+     + H NI+ L   +       LV E+   G + D L 
Sbjct: 46  IIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYL- 104
Query: 298 DVSRGR-RELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDL 356
            V+ GR +E +  ++ R    + S ++Y H      I+H D+K  N+LL+ DM   I+D 
Sbjct: 105 -VAHGRMKEKEARAKFR---QIVSAVQYCH---QKFIVHRDLKAENLLLDADMNIKIADF 157
Query: 357 GLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPEL-SEKCDIFSFGMLLISLVRGVPSF 414
           G +     G     +    G+  Y APE FQ  +    + D++S G++L +LV G   F
Sbjct: 158 GFSNEFTFGNK---LDEFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 213

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 92/194 (47%), Gaps = 27/194 (13%)
Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPS 310
           +I+ EI      RH +I+ L   +  P    +V E++  G L D +     GR E +  +
Sbjct: 57  KIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYI--CKHGRVE-EMEA 113
Query: 311 RHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVL 370
           R R+   + S ++Y H +    ++H D+KP NVLL+  M A I+D GL+  + DG     
Sbjct: 114 R-RLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE---F 166
Query: 371 ISYVLGTMAYIAPEY-----FQQPELSEKCDIFSFGMLLISLVRG--------VPSFVFH 417
           +    G+  Y APE      +  PE+    DI+S G++L +L+ G        VP+    
Sbjct: 167 LRDSCGSPNYAAPEVISGRLYAGPEV----DIWSCGVILYALLCGTLPFDDEHVPTLFKK 222
Query: 418 QNGEEICSPEWLRK 431
             G     PE+L +
Sbjct: 223 IRGGVFYIPEYLNR 236

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 38/136 (27%), Positives = 69/136 (50%), Gaps = 10/136 (7%)
Query: 282 LVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV-ASGLEYLHMYHSASIIHGDIKP 340
           +V E++   +L+DI+          + P   + A+ V A   + L+  H   IIH D+KP
Sbjct: 93  IVMEYVDGVTLRDIV--------HTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKP 144
Query: 341 RNVLLNDDMEACISDLGLAMAIPD-GYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFS 399
            N++++      + D G+A AI D G +    + V+GT  Y++PE  +   +  + D++S
Sbjct: 145 ANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYS 204
Query: 400 FGMLLISLVRGVPSFV 415
            G +L  ++ G P F 
Sbjct: 205 LGCVLYEVLTGEPPFT 220

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 103/233 (44%), Gaps = 30/233 (12%)
Query: 191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
           E  F+ L +IG G  G VY A     N +++AIKK            +    K  + K +
Sbjct: 14  EKLFSDLREIGHGSFGAVYFAR-DVRNSEVVAIKK------------MSYSGKQSNEKWQ 60
Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPS 310
            I  E+    ++RH N +      +R     LV E+   GS  D+L+   +  +E++  +
Sbjct: 61  DIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAA 119
Query: 311 RHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVL 370
              +  G   GL YLH   S ++IH D+K  N+LL++     + D G A  +        
Sbjct: 120 ---VTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----- 168
Query: 371 ISYVLGTMAYIAPEY---FQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNG 420
            +  +GT  ++APE      + +   K D++S G+  I L    P  +F+ N 
Sbjct: 169 -NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP-LFNMNA 219

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 38/136 (27%), Positives = 69/136 (50%), Gaps = 10/136 (7%)
Query: 282 LVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV-ASGLEYLHMYHSASIIHGDIKP 340
           +V E++   +L+DI+          + P   + A+ V A   + L+  H   IIH D+KP
Sbjct: 93  IVMEYVDGVTLRDIV--------HTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKP 144
Query: 341 RNVLLNDDMEACISDLGLAMAIPD-GYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFS 399
            N++++      + D G+A AI D G +    + V+GT  Y++PE  +   +  + D++S
Sbjct: 145 ANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYS 204
Query: 400 FGMLLISLVRGVPSFV 415
            G +L  ++ G P F 
Sbjct: 205 LGCVLYEVLTGEPPFT 220

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 38/136 (27%), Positives = 69/136 (50%), Gaps = 10/136 (7%)
Query: 282 LVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV-ASGLEYLHMYHSASIIHGDIKP 340
           +V E++   +L+DI+          + P   + A+ V A   + L+  H   IIH D+KP
Sbjct: 93  IVMEYVDGVTLRDIV--------HTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKP 144
Query: 341 RNVLLNDDMEACISDLGLAMAIPD-GYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFS 399
            N++++      + D G+A AI D G +    + V+GT  Y++PE  +   +  + D++S
Sbjct: 145 ANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYS 204
Query: 400 FGMLLISLVRGVPSFV 415
            G +L  ++ G P F 
Sbjct: 205 LGCVLYEVLTGEPPFT 220

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 38/136 (27%), Positives = 69/136 (50%), Gaps = 10/136 (7%)
Query: 282 LVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV-ASGLEYLHMYHSASIIHGDIKP 340
           +V E++   +L+DI+          + P   + A+ V A   + L+  H   IIH D+KP
Sbjct: 93  IVMEYVDGVTLRDIV--------HTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKP 144
Query: 341 RNVLLNDDMEACISDLGLAMAIPD-GYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFS 399
            N++++      + D G+A AI D G +    + V+GT  Y++PE  +   +  + D++S
Sbjct: 145 ANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYS 204
Query: 400 FGMLLISLVRGVPSFV 415
            G +L  ++ G P F 
Sbjct: 205 LGCVLYEVLTGEPPFT 220

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 72/294 (24%), Positives = 130/294 (44%), Gaps = 46/294 (15%)
Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           +E++G+G  GEV+     G     +A+K             +++ S   D+ L    +E 
Sbjct: 14  VERLGAGQFGEVWMGYYNGHTK--VAVKS------------LKQGSMSPDAFL----AEA 55
Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL 316
               Q++H+ ++ L A + +   +++  E+M+NGSL D L   S  +  ++      +A 
Sbjct: 56  NLMKQLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTIN--KLLDMAA 112
Query: 317 GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG-YT-RVLISYV 374
            +A G+ ++      + IH +++  N+L++D +   I+D GLA  I D  YT R    + 
Sbjct: 113 QIAEGMAFIE---ERNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF- 168
Query: 375 LGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLV-RGVPSFVFHQNGEEICSPEWLRKVM 433
              + + APE       + K D++SFG+LL  +V  G   +    N E I          
Sbjct: 169 --PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI---------- 216
Query: 434 NSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL 487
             +N  R      P N  E+    + ++  +C    PE+RP   Y+R  L    
Sbjct: 217 --QNLERGYRMVRPDNCPEE----LYQLMRLCWKERPEDRPTFDYLRSVLEDFF 264

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 91/183 (49%), Gaps = 14/183 (7%)
Query: 234 AAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQ 293
           A ++I++ ++L  + L+++  E+     + H NI+ L   +       LV E+   G + 
Sbjct: 44  AVKIIDK-TQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVF 102
Query: 294 DILDDVSRGR-RELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC 352
           D L  V+ GR +E +  ++ R    + S ++Y H  +   I+H D+K  N+LL+ DM   
Sbjct: 103 DYL--VAHGRMKEKEARAKFR---QIVSAVQYCHQKY---IVHRDLKAENLLLDGDMNIK 154
Query: 353 ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPEL-SEKCDIFSFGMLLISLVRGV 411
           I+D G +     G     +    G+  Y APE FQ  +    + D++S G++L +LV G 
Sbjct: 155 IADFGFSNEFTVGNK---LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS 211
Query: 412 PSF 414
             F
Sbjct: 212 LPF 214

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 100/216 (46%), Gaps = 23/216 (10%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           F  +EKIG G  G VYKA      G+++A+KK+          L  E   +  + +R   
Sbjct: 7   FQKVEKIGEGTYGVVYKAR-NKLTGEVVALKKI---------RLDTETEGVPSTAIR--- 53
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
            EI    ++ H NI+ LL  +   +   LV+EF+ +  L+D +D  +     +  P    
Sbjct: 54  -EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMD--ASALTGIPLPLIKS 109
Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISY 373
               +  GL + H   S  ++H D+KP+N+L+N +    ++D GLA A   G       +
Sbjct: 110 YLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXH 164
Query: 374 VLGTMAYIAPEYFQQPE-LSEKCDIFSFGMLLISLV 408
            + T+ Y APE     +  S   DI+S G +   +V
Sbjct: 165 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 200

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 103/233 (44%), Gaps = 30/233 (12%)
Query: 191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
           E  F+ L +IG G  G VY A     N +++AIKK            +    K  + K +
Sbjct: 53  EKLFSDLREIGHGSFGAVYFAR-DVRNSEVVAIKK------------MSYSGKQSNEKWQ 99
Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPS 310
            I  E+    ++RH N +      +R     LV E+   GS  D+L+   +  +E++  +
Sbjct: 100 DIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAA 158
Query: 311 RHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVL 370
              +  G   GL YLH   S ++IH D+K  N+LL++     + D G A  +        
Sbjct: 159 ---VTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----- 207
Query: 371 ISYVLGTMAYIAPEY---FQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNG 420
            +  +GT  ++APE      + +   K D++S G+  I L    P  +F+ N 
Sbjct: 208 -NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP-LFNMNA 258

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 100/216 (46%), Gaps = 23/216 (10%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           F  +EKIG G  G VYKA      G+++A+KK+          L  E   +  + +R   
Sbjct: 8   FQKVEKIGEGTYGVVYKAR-NKLTGEVVALKKI---------RLDTETEGVPSTAIR--- 54
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
            EI    ++ H NI+ LL  +   +   LV+EF+ +  L+D +D  +     +  P    
Sbjct: 55  -EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMD--ASALTGIPLPLIKS 110
Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISY 373
               +  GL + H   S  ++H D+KP+N+L+N +    ++D GLA A   G       +
Sbjct: 111 YLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXH 165
Query: 374 VLGTMAYIAPEYFQQPE-LSEKCDIFSFGMLLISLV 408
            + T+ Y APE     +  S   DI+S G +   +V
Sbjct: 166 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 201

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 98/216 (45%), Gaps = 23/216 (10%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           F  +EKIG G  G VYKA      G+++A+KK+          L  E   +  + +R   
Sbjct: 5   FQKVEKIGEGTYGVVYKAR-NKLTGEVVALKKI---------RLDTETEGVPSTAIR--- 51
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
            EI    ++ H NI+ LL  +   +   LV+EF+    L+D +D  +     +  P    
Sbjct: 52  -EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKDFMD--ASALTGIPLPLIKS 107
Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISY 373
               +  GL + H   S  ++H D+KP N+L+N +    ++D GLA A   G       +
Sbjct: 108 YLFQLLQGLAFCH---SHRVLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXH 162
Query: 374 VLGTMAYIAPEYFQQPE-LSEKCDIFSFGMLLISLV 408
            + T+ Y APE     +  S   DI+S G +   +V
Sbjct: 163 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 38/136 (27%), Positives = 69/136 (50%), Gaps = 10/136 (7%)
Query: 282 LVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV-ASGLEYLHMYHSASIIHGDIKP 340
           +V E++   +L+DI+          + P   + A+ V A   + L+  H   IIH D+KP
Sbjct: 110 IVMEYVDGVTLRDIV--------HTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKP 161
Query: 341 RNVLLNDDMEACISDLGLAMAIPD-GYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFS 399
            N++++      + D G+A AI D G +    + V+GT  Y++PE  +   +  + D++S
Sbjct: 162 ANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYS 221
Query: 400 FGMLLISLVRGVPSFV 415
            G +L  ++ G P F 
Sbjct: 222 LGCVLYEVLTGEPPFT 237

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 81/287 (28%), Positives = 118/287 (41%), Gaps = 58/287 (20%)
Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDS---KLRDSKLRQIR 253
           +++IGSG  G V+       N   +AIK  I    +S  + IEE     KL   KL Q+ 
Sbjct: 12  VQEIGSGQFGLVHLGYWL--NKDKVAIK-TIREGAMSEEDFIEEAEVMMKLSHPKLVQLY 68
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRREL-DWPSRH 312
              +  +                P C  LV+EFM++G L D L    R +R L    +  
Sbjct: 69  GVCLEQA----------------PIC--LVFEFMEHGCLSDYL----RTQRGLFAAETLL 106
Query: 313 RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA-MAIPDGYTRVLI 371
            + L V  G+ YL     AS+IH D+  RN L+ ++    +SD G+    + D YT    
Sbjct: 107 GMCLDVCEGMAYLE---EASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS--- 160
Query: 372 SYVLGT---MAYIAPEYFQQPELSEKCDIFSFGMLLISLV-RGVPSFVFHQNGEEICSPE 427
               GT   + + +PE F     S K D++SFG+L+  +   G   +    N E      
Sbjct: 161 --STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE------ 212
Query: 428 WLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERP 474
               V +     R   PRL          HV +I   C    PE+RP
Sbjct: 213 ---VVEDISTGFRLYKPRLAST-------HVYQIMNHCWKERPEDRP 249

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 112/247 (45%), Gaps = 28/247 (11%)
Query: 234 AAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQ 293
           AA++I    KL     +++  E     +++H NI+ L   +     H LV++ +  G L 
Sbjct: 35  AAKIINT-KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELF 93
Query: 294 DILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC- 352
           +  D V+R     ++ S    +  +   LE +   HS  I+H ++KP N+LL    +   
Sbjct: 94  E--DIVAR-----EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAA 146
Query: 353 --ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRG 410
             ++D GLA+ + D       +   GT  Y++PE  ++   S+  DI++ G++L  L+ G
Sbjct: 147 VKLADFGLAIEVNDSEAWHGFA---GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203
Query: 411 VPSF-------VFHQ---NGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKML-HVL 459
            P F       ++ Q      +  SPEW      +K+    ID  L  N  ++      L
Sbjct: 204 YPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKS---LIDSMLTVNPKKRITADQAL 260
Query: 460 KIAYICT 466
           K+ +IC 
Sbjct: 261 KVPWICN 267

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 112/247 (45%), Gaps = 28/247 (11%)
Query: 234 AAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQ 293
           AA++I    KL     +++  E     +++H NI+ L   +     H LV++ +  G L 
Sbjct: 58  AAKIINT-KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELF 116
Query: 294 DILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC- 352
           +  D V+R     ++ S    +  +   LE +   HS  I+H ++KP N+LL    +   
Sbjct: 117 E--DIVAR-----EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAA 169
Query: 353 --ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRG 410
             ++D GLA+ + D       +   GT  Y++PE  ++   S+  DI++ G++L  L+ G
Sbjct: 170 VKLADFGLAIEVNDSEAWHGFA---GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226
Query: 411 VPSF-------VFHQ---NGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKML-HVL 459
            P F       ++ Q      +  SPEW      +K+    ID  L  N  ++      L
Sbjct: 227 YPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKS---LIDSMLTVNPKKRITADQAL 283
Query: 460 KIAYICT 466
           K+ +IC 
Sbjct: 284 KVPWICN 290

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 100/220 (45%), Gaps = 27/220 (12%)
Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           L+ IG G   +V K       G+ +AIK             I + ++L  + L+++  E+
Sbjct: 17  LKTIGKGNFAKV-KLARHILTGREVAIK-------------IIDKTQLNPTSLQKLFREV 62
Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGR-RELDWPSRHRIA 315
                + H NI+ L   +       L+ E+   G + D L  V+ GR +E +  S+ R  
Sbjct: 63  RIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYL--VAHGRMKEKEARSKFR-- 118
Query: 316 LGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVL 375
             + S ++Y H      I+H D+K  N+LL+ DM   I+D G +     G     +    
Sbjct: 119 -QIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK---LDTFC 171
Query: 376 GTMAYIAPEYFQQPEL-SEKCDIFSFGMLLISLVRGVPSF 414
           G+  Y APE FQ  +    + D++S G++L +LV G   F
Sbjct: 172 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 211

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 99/216 (45%), Gaps = 23/216 (10%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           F  +EKIG G  G VYKA      G+++A+KK+          L  E   +  + +R   
Sbjct: 5   FQKVEKIGEGTYGVVYKAR-NKLTGEVVALKKI---------RLDTETEGVPSTAIR--- 51
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
            EI    ++ H NI+ LL  +   +   LV+EF+    L+  +D  +     +  P    
Sbjct: 52  -EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMD--ASALTGIPLPLIKS 107
Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISY 373
               +  GL + H   S  ++H D+KP+N+L+N +    ++D GLA A   G      ++
Sbjct: 108 YLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTH 162
Query: 374 VLGTMAYIAPEYFQQPE-LSEKCDIFSFGMLLISLV 408
            + T+ Y APE     +  S   DI+S G +   +V
Sbjct: 163 EVVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMV 198

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 102/228 (44%), Gaps = 35/228 (15%)
Query: 184 DLAFLKKEDCFASLEKIGSGGCGEVYKAEL--PGSNGKMIAIKKVIVYAPISAAELIEED 241
           D++++K E      E IG+G  GEV +  L  PG     +AIK +               
Sbjct: 14  DVSYVKIE------EVIGAGEFGEVCRGRLKAPGKKESCVAIKTL--------------K 53
Query: 242 SKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDIL--DDV 299
               + + R+  SE     Q  H NI+ L   +      +++ EFM+NG+L   L  +D 
Sbjct: 54  GGYTERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDG 113
Query: 300 SRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA 359
                +L    R     G+ASG+ YL      S +H D+  RN+L+N ++   +SD GL+
Sbjct: 114 QFTVIQLVGMLR-----GIASGMRYLA---EMSYVHRDLAARNILVNSNLVCKVSDFGLS 165
Query: 360 MAIPDGYTRVLISYVLG---TMAYIAPEYFQQPELSEKCDIFSFGMLL 404
             + +  +    +  LG    + + APE     + +   D +S+G+++
Sbjct: 166 RFLEENSSDPTETSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVM 213

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 72/319 (22%), Positives = 131/319 (41%), Gaps = 70/319 (21%)
Query: 188 LKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDS 247
           L+    F  +  +G G  G+V KA     + +  AIKK+                +  + 
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKAR-NALDSRYYAIKKI----------------RHTEE 44
Query: 248 KLRQIRSEIITASQIRH-------------RNILPLLAHMVRPDCHLLVYEFMKNGSLQD 294
           KL  I SE++  + + H             RN +  +  + +     +  E+ +N +L D
Sbjct: 45  KLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYD 104
Query: 295 IL--DDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC 352
           ++  +++++ R E  W    R+   +   L Y+H   S  IIH D+KP N+ +++     
Sbjct: 105 LIHSENLNQQRDEY-W----RLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVK 156
Query: 353 ISDLGLAMAIPD-------------GYTRVLISYVLGTMAYIAPEYFQ-QPELSEKCDIF 398
           I D GLA  +               G +  L S  +GT  Y+A E        +EK D++
Sbjct: 157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTS-AIGTAMYVATEVLDGTGHYNEKIDMY 215
Query: 399 SFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHV 458
           S G++   ++     + F    E +     L+K+       R++    P +  + KM   
Sbjct: 216 SLGIIFFEMI-----YPFSTGMERV---NILKKL-------RSVSIEFPPDFDDNKMKVE 260
Query: 459 LKIAYICTLHDPEERPNSQ 477
            KI  +   HDP +RP ++
Sbjct: 261 KKIIRLLIDHDPNKRPGAR 279

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 112/247 (45%), Gaps = 28/247 (11%)
Query: 234 AAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQ 293
           AA++I    KL     +++  E     +++H NI+ L   +     H LV++ +  G L 
Sbjct: 34  AAKIINT-KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELF 92
Query: 294 DILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC- 352
           +  D V+R     ++ S    +  +   LE +   HS  I+H ++KP N+LL    +   
Sbjct: 93  E--DIVAR-----EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAA 145
Query: 353 --ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRG 410
             ++D GLA+ + D       +   GT  Y++PE  ++   S+  DI++ G++L  L+ G
Sbjct: 146 VKLADFGLAIEVNDSEAWHGFA---GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 202
Query: 411 VPSF-------VFHQ---NGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKML-HVL 459
            P F       ++ Q      +  SPEW      +K+    ID  L  N  ++      L
Sbjct: 203 YPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKS---LIDSMLTVNPKKRITADQAL 259
Query: 460 KIAYICT 466
           K+ +IC 
Sbjct: 260 KVPWICN 266

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 69/252 (27%), Positives = 112/252 (44%), Gaps = 42/252 (16%)
Query: 199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSE-II 257
           ++G G  GEV++ E     G   A+KKV                     +L   R+E ++
Sbjct: 100 RLGRGSFGEVHRME-DKQTGFQCAVKKV---------------------RLEVFRAEELM 137
Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALG 317
             + +    I+PL   +       +  E ++ GSL  ++ +  +G    D   R    LG
Sbjct: 138 ACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKE--QGCLPED---RALYYLG 192
Query: 318 VA-SGLEYLHMYHSASIIHGDIKPRNVLLNDD-MEACISDLGLAMAI-PDGYTRVLIS-- 372
            A  GLEYLH   S  I+HGD+K  NVLL+ D   A + D G A+ + PDG  + L++  
Sbjct: 193 QALEGLEYLH---SRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGD 249
Query: 373 YVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKV 432
           Y+ GT  ++APE         K D++S   +++ ++ G   +     G  +C      K+
Sbjct: 250 YIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRG-PLC-----LKI 303
Query: 433 MNSKNPSRAIDP 444
            +   P R I P
Sbjct: 304 ASEPPPVREIPP 315

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 99/216 (45%), Gaps = 23/216 (10%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           F  +EKIG G  G VYKA      G+++A+KK+          L  E   +  + +R   
Sbjct: 12  FQKVEKIGEGTYGVVYKAR-NKLTGEVVALKKI---------RLDTETEGVPSTAIR--- 58
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
            EI    ++ H NI+ LL  +   +   LV+EF+    L+  +D  +     +  P    
Sbjct: 59  -EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMD--ASALTGIPLPLIKS 114
Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISY 373
               +  GL + H   S  ++H D+KP+N+L+N +    ++D GLA A   G      ++
Sbjct: 115 YLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTH 169
Query: 374 VLGTMAYIAPEYFQQPE-LSEKCDIFSFGMLLISLV 408
            + T+ Y APE     +  S   DI+S G +   +V
Sbjct: 170 EVVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMV 205

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 112/247 (45%), Gaps = 28/247 (11%)
Query: 234 AAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQ 293
           AA++I    KL     +++  E     +++H NI+ L   +     H LV++ +  G L 
Sbjct: 35  AAKIINT-KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELF 93
Query: 294 DILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC- 352
           +  D V+R     ++ S    +  +   LE +   HS  I+H ++KP N+LL    +   
Sbjct: 94  E--DIVAR-----EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAA 146
Query: 353 --ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRG 410
             ++D GLA+ + D       +   GT  Y++PE  ++   S+  DI++ G++L  L+ G
Sbjct: 147 VKLADFGLAIEVNDSEAWHGFA---GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203
Query: 411 VPSF-------VFHQ---NGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKML-HVL 459
            P F       ++ Q      +  SPEW      +K+    ID  L  N  ++      L
Sbjct: 204 YPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKS---LIDSMLTVNPKKRITADQAL 260
Query: 460 KIAYICT 466
           K+ +IC 
Sbjct: 261 KVPWICN 267

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 27/220 (12%)
Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           L+ IG G   +V K       G+ +AIK             I + ++L  + L+++  E+
Sbjct: 20  LKTIGKGNFAKV-KLARHILTGREVAIK-------------IIDKTQLNPTSLQKLFREV 65
Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGR-RELDWPSRHRIA 315
                + H NI+ L   +       L+ E+   G + D L  V+ GR +E +  S+ R  
Sbjct: 66  RIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYL--VAHGRMKEKEARSKFR-- 121
Query: 316 LGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVL 375
             + S ++Y H      I+H D+K  N+LL+ DM   I+D G +     G     +    
Sbjct: 122 -QIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK---LDAFC 174
Query: 376 GTMAYIAPEYFQQPEL-SEKCDIFSFGMLLISLVRGVPSF 414
           G   Y APE FQ  +    + D++S G++L +LV G   F
Sbjct: 175 GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 214

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 27/220 (12%)
Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           L+ IG G   +V K       GK +A+K             I + ++L  S L+++  E+
Sbjct: 12  LKTIGKGNFAKV-KLARHILTGKEVAVK-------------IIDKTQLNSSSLQKLFREV 57
Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG-RRELDWPSRHRIA 315
                + H NI+ L   +       LV E+   G + D L  V+ G  +E +  ++ R  
Sbjct: 58  RIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYL--VAHGWMKEKEARAKFR-- 113
Query: 316 LGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVL 375
             + S ++Y H      I+H D+K  N+LL+ DM   I+D G +     G     +    
Sbjct: 114 -QIVSAVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK---LDTFC 166
Query: 376 GTMAYIAPEYFQQPEL-SEKCDIFSFGMLLISLVRGVPSF 414
           G+  Y APE FQ  +    + D++S G++L +LV G   F
Sbjct: 167 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 206

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 98/220 (44%), Gaps = 27/220 (12%)
Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           L+ IG G   +V K       GK +A+K             I + ++L  S L+++  E+
Sbjct: 19  LKTIGKGNFAKV-KLARHILTGKEVAVK-------------IIDKTQLNSSSLQKLFREV 64
Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGR-RELDWPSRHRIA 315
                + H NI+ L   +       LV E+   G + D L  V+ GR +E +  ++ R  
Sbjct: 65  RIXKVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYL--VAHGRXKEKEARAKFR-- 120
Query: 316 LGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVL 375
             + S ++Y H      I+H D+K  N+LL+ D    I+D G +     G     +    
Sbjct: 121 -QIVSAVQYCHQ---KFIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNK---LDAFC 173
Query: 376 GTMAYIAPEYFQQPEL-SEKCDIFSFGMLLISLVRGVPSF 414
           G   Y APE FQ  +    + D++S G++L +LV G   F
Sbjct: 174 GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 213

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 99/216 (45%), Gaps = 23/216 (10%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           F  +EKIG G  G VYKA      G+++A+KK+          L  E   +  + +R   
Sbjct: 5   FQKVEKIGEGTYGVVYKAR-NKLTGEVVALKKI---------RLDTETEGVPSTAIR--- 51
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
            EI    ++ H NI+ LL  +   +   LV+EF+    L+  +D  +     +  P    
Sbjct: 52  -EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMD--ASALTGIPLPLIKS 107
Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISY 373
               +  GL + H   S  ++H D+KP+N+L+N +    ++D GLA A   G      ++
Sbjct: 108 YLFQLLQGLSFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTH 162
Query: 374 VLGTMAYIAPEYFQQPE-LSEKCDIFSFGMLLISLV 408
            + T+ Y APE     +  S   DI+S G +   +V
Sbjct: 163 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 69/252 (27%), Positives = 112/252 (44%), Gaps = 42/252 (16%)
Query: 199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSE-II 257
           ++G G  GEV++ E     G   A+KKV                     +L   R+E ++
Sbjct: 81  RLGRGSFGEVHRME-DKQTGFQCAVKKV---------------------RLEVFRAEELM 118
Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALG 317
             + +    I+PL   +       +  E ++ GSL  ++ +  +G    D   R    LG
Sbjct: 119 ACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKE--QGCLPED---RALYYLG 173
Query: 318 VA-SGLEYLHMYHSASIIHGDIKPRNVLLNDD-MEACISDLGLAMAI-PDGYTRVLIS-- 372
            A  GLEYLH   S  I+HGD+K  NVLL+ D   A + D G A+ + PDG  + L++  
Sbjct: 174 QALEGLEYLH---SRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGD 230
Query: 373 YVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKV 432
           Y+ GT  ++APE         K D++S   +++ ++ G   +     G  +C      K+
Sbjct: 231 YIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRG-PLC-----LKI 284
Query: 433 MNSKNPSRAIDP 444
            +   P R I P
Sbjct: 285 ASEPPPVREIPP 296

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 73/287 (25%), Positives = 125/287 (43%), Gaps = 44/287 (15%)
Query: 199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT 258
           K+G G  GEV+     G+    I   K    +P         ++ L+++++ +       
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---------EAFLQEAQVMK------- 68
Query: 259 ASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV 318
             +IRH  ++ L A +V  +   +V E+M  GSL D L       + L  P    +A  +
Sbjct: 69  --KIRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLK--GEMGKYLRLPQLVDMAAQI 123
Query: 319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG-YTRVLISYVLGT 377
           ASG+ Y+      + +H D++  N+L+ +++   ++D GLA  I D  YT    +     
Sbjct: 124 ASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--P 178
Query: 378 MAYIAPEYFQQPELSEKCDIFSFGMLLISL-VRGVPSFVFHQNGEEICSPEWLRKVMNSK 436
           + + APE       + K D++SFG+LL  L  +G   +    N          R+V++  
Sbjct: 179 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----------REVLDQV 228
Query: 437 NPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRL 483
                   R+P      + LH L     C   DPEERP  +Y++  L
Sbjct: 229 ERGY----RMPCPPECPESLHDLMCQ--CWRKDPEERPTFEYLQAFL 269

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 99/216 (45%), Gaps = 23/216 (10%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           F  +EKIG G  G VYKA      G+++A+KK+          L  E   +  + +R   
Sbjct: 4   FQKVEKIGEGTYGVVYKAR-NKLTGEVVALKKI---------RLDTETEGVPSTAIR--- 50
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
            EI    ++ H NI+ LL  +   +   LV+EF+    L+  +D  +     +  P    
Sbjct: 51  -EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMD--ASALTGIPLPLIKS 106
Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISY 373
               +  GL + H   S  ++H D+KP+N+L+N +    ++D GLA A   G      ++
Sbjct: 107 YLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTH 161
Query: 374 VLGTMAYIAPEYFQQPE-LSEKCDIFSFGMLLISLV 408
            + T+ Y APE     +  S   DI+S G +   +V
Sbjct: 162 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 197

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 105/232 (45%), Gaps = 32/232 (13%)
Query: 178 PLIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAEL 237
           PL++ E+         F  +EKIG G  G VYKA      G+++A+KK+          L
Sbjct: 2   PLVDMEN---------FQKVEKIGEGTYGVVYKAR-NKLTGEVVALKKI---------RL 42
Query: 238 IEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILD 297
             E   +  + +R    EI    ++ H NI+ LL  +   +   LV+EF+    L+  +D
Sbjct: 43  DTETEGVPSTAIR----EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMD 97
Query: 298 DVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLG 357
             +     +  P        +  GL + H   S  ++H D+KP+N+L+N +    ++D G
Sbjct: 98  --ASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFG 152
Query: 358 LAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPE-LSEKCDIFSFGMLLISLV 408
           LA A   G      ++ + T+ Y APE     +  S   DI+S G +   +V
Sbjct: 153 LARAF--GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 202

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 99/216 (45%), Gaps = 23/216 (10%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           F  +EKIG G  G VYKA      G+++A+KK+          L  E   +  + +R   
Sbjct: 5   FQKVEKIGEGTYGVVYKAR-NKLTGEVVALKKI---------RLDTETEGVPSTAIR--- 51
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
            EI    ++ H NI+ LL  +   +   LV+EF+    L+  +D  +     +  P    
Sbjct: 52  -EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMD--ASALTGIPLPLIKS 107
Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISY 373
               +  GL + H   S  ++H D+KP+N+L+N +    ++D GLA A   G      ++
Sbjct: 108 YLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTH 162
Query: 374 VLGTMAYIAPEYFQQPE-LSEKCDIFSFGMLLISLV 408
            + T+ Y APE     +  S   DI+S G +   +V
Sbjct: 163 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 99/216 (45%), Gaps = 23/216 (10%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           F  +EKIG G  G VYKA      G+++A+KK+          L  E   +  + +R   
Sbjct: 12  FQKVEKIGEGTYGVVYKAR-NKLTGEVVALKKI---------RLDTETEGVPSTAIR--- 58
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
            EI    ++ H NI+ LL  +   +   LV+EF+    L+  +D  +     +  P    
Sbjct: 59  -EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMD--ASALTGIPLPLIKS 114
Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISY 373
               +  GL + H   S  ++H D+KP+N+L+N +    ++D GLA A   G      ++
Sbjct: 115 YLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTH 169
Query: 374 VLGTMAYIAPEYFQQPE-LSEKCDIFSFGMLLISLV 408
            + T+ Y APE     +  S   DI+S G +   +V
Sbjct: 170 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 205

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 97/226 (42%), Gaps = 25/226 (11%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +GSG CGEV K        K +AIK +I     +     E D  L       + +EI   
Sbjct: 18  LGSGACGEV-KLAFERKTCKKVAIK-IISKRKFAIGSAREADPAL------NVETEIEIL 69
Query: 260 SQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVA 319
            ++ H  I+ +       D + +V E M+ G L D +     G + L   +       + 
Sbjct: 70  KKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKV----VGNKRLKEATCKLYFYQML 124
Query: 320 SGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC---ISDLGLAMAIPDGYTRVLISYVLG 376
             ++YLH      IIH D+KP NVLL+   E C   I+D G +  +  G T  L+  + G
Sbjct: 125 LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETS-LMRTLCG 178
Query: 377 TMAYIAPEYF---QQPELSEKCDIFSFGMLLISLVRGVPSFVFHQN 419
           T  Y+APE          +   D +S G++L   + G P F  H+ 
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 224

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 99/216 (45%), Gaps = 23/216 (10%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           F  +EKIG G  G VYKA      G+++A+KK+          L  E   +  + +R   
Sbjct: 6   FQKVEKIGEGTYGVVYKAR-NKLTGEVVALKKI---------RLDTETEGVPSTAIR--- 52
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
            EI    ++ H NI+ LL  +   +   LV+EF+    L+  +D  +     +  P    
Sbjct: 53  -EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMD--ASALTGIPLPLIKS 108
Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISY 373
               +  GL + H   S  ++H D+KP+N+L+N +    ++D GLA A   G      ++
Sbjct: 109 YLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTH 163
Query: 374 VLGTMAYIAPEYFQQPE-LSEKCDIFSFGMLLISLV 408
            + T+ Y APE     +  S   DI+S G +   +V
Sbjct: 164 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 199

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/258 (25%), Positives = 109/258 (42%), Gaps = 25/258 (9%)
Query: 168 SRDRGPTIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVI 227
           SR++    F   ++ + +      D +   + +GSG CGEV K        K +AI+ +I
Sbjct: 111 SRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEV-KLAFERKTCKKVAIR-II 168
Query: 228 VYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFM 287
                +     E D  L       + +EI    ++ H  I+ +       D + +V E M
Sbjct: 169 SKRKFAIGSAREADPAL------NVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELM 221
Query: 288 KNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLND 347
           + G L D +     G + L   +       +   ++YLH      IIH D+KP NVLL+ 
Sbjct: 222 EGGELFDKV----VGNKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSS 274
Query: 348 DMEAC---ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYF---QQPELSEKCDIFSFG 401
             E C   I+D G +  +  G T  L+  + GT  Y+APE          +   D +S G
Sbjct: 275 QEEDCLIKITDFGHSKIL--GETS-LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLG 331
Query: 402 MLLISLVRGVPSFVFHQN 419
           ++L   + G P F  H+ 
Sbjct: 332 VILFICLSGYPPFSEHRT 349

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 71/292 (24%), Positives = 120/292 (41%), Gaps = 52/292 (17%)
Query: 154 PTTPSLISAAVRGGS-RDRGPTIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAE 212
           PTT +L      G +  DR PT F    E+  L FL         +++G G  G V    
Sbjct: 15  PTTENLYFQGAMGSAFEDRDPTQF----EERHLKFL---------QQLGKGNFGSVEMCR 61
Query: 213 ---LPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILP 269
              L  + G+++A+KK+                   +  LR    EI     ++H NI+ 
Sbjct: 62  YDPLQDNTGEVVAVKKL---------------QHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 270 L--LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHM 327
              + +        L+ E++  GSL+D L    + +  +D     +    +  G+EYL  
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLG- 162
Query: 328 YHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP-DGYTRVLISYVLGTMAYIAPEYF 386
             +   IH D+  RN+L+ ++    I D GL   +P D     +       + + APE  
Sbjct: 163 --TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 220
Query: 387 QQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSP--EWLRKVMNSK 436
            + + S   D++SFG++L  L   +         E+  SP  E++R + N K
Sbjct: 221 TESKFSVASDVWSFGVVLYELFTYI---------EKSKSPPAEFMRMIGNDK 263

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 113/272 (41%), Gaps = 47/272 (17%)
Query: 192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ 251
           D F    ++G G    VY+ +  G+  K  A+K +                K  D K+  
Sbjct: 53  DFFEVESELGRGATSIVYRCKQKGTQ-KPYALKVL---------------KKTVDKKI-- 94
Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
           +R+EI    ++ H NI+ L      P    LV E +  G L D +  V +G     + S 
Sbjct: 95  VRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRI--VEKG-----YYSE 147
Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLND---DMEACISDLGLAMAIPDGYTR 368
              A  V   LE +   H   I+H D+KP N+L      D    I+D GL+  +     +
Sbjct: 148 RDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH---Q 204
Query: 369 VLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEE------ 422
           VL+  V GT  Y APE  +      + D++S G++   L+ G   F + + G++      
Sbjct: 205 VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPF-YDERGDQFMFRRI 263
Query: 423 ------ICSPEWLRKVMNSKNPSR---AIDPR 445
                   SP W    +N+K+  R    +DP+
Sbjct: 264 LNCEYYFISPWWDEVSLNAKDLVRKLIVLDPK 295

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 99/216 (45%), Gaps = 23/216 (10%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           F  +EKIG G  G VYKA      G+++A+KK+          L  E   +  + +R   
Sbjct: 5   FQKVEKIGEGTYGVVYKAR-NKLTGEVVALKKI---------RLDTETEGVPSTAIR--- 51
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
            EI    ++ H NI+ LL  +   +   LV+EF+    L+  +D  +     +  P    
Sbjct: 52  -EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMD--ASALTGIPLPLIKS 107
Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISY 373
               +  GL + H   S  ++H D+KP+N+L+N +    ++D GLA A   G      ++
Sbjct: 108 YLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTH 162
Query: 374 VLGTMAYIAPEYFQQPE-LSEKCDIFSFGMLLISLV 408
            + T+ Y APE     +  S   DI+S G +   +V
Sbjct: 163 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 99/216 (45%), Gaps = 23/216 (10%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           F  +EKIG G  G VYKA      G+++A+KK+          L  E   +  + +R   
Sbjct: 4   FQKVEKIGEGTYGVVYKAR-NKLTGEVVALKKI---------RLDTETEGVPSTAIR--- 50
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
            EI    ++ H NI+ LL  +   +   LV+EF+    L+  +D  +     +  P    
Sbjct: 51  -EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMD--ASALTGIPLPLIKS 106
Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISY 373
               +  GL + H   S  ++H D+KP+N+L+N +    ++D GLA A   G      ++
Sbjct: 107 YLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTH 161
Query: 374 VLGTMAYIAPEYFQQPE-LSEKCDIFSFGMLLISLV 408
            + T+ Y APE     +  S   DI+S G +   +V
Sbjct: 162 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 197

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 97/226 (42%), Gaps = 25/226 (11%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +GSG CGEV K        K +AIK +I     +     E D  L       + +EI   
Sbjct: 18  LGSGACGEV-KLAFERKTCKKVAIK-IISKRKFAIGSAREADPAL------NVETEIEIL 69
Query: 260 SQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVA 319
            ++ H  I+ +       D + +V E M+ G L D +     G + L   +       + 
Sbjct: 70  KKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKV----VGNKRLKEATCKLYFYQML 124
Query: 320 SGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC---ISDLGLAMAIPDGYTRVLISYVLG 376
             ++YLH      IIH D+KP NVLL+   E C   I+D G +  +  G T  L+  + G
Sbjct: 125 LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETS-LMRTLCG 178
Query: 377 TMAYIAPEYF---QQPELSEKCDIFSFGMLLISLVRGVPSFVFHQN 419
           T  Y+APE          +   D +S G++L   + G P F  H+ 
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 224

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 106/237 (44%), Gaps = 48/237 (20%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           IG GG GEVY        GKM A+K                   L   +++  + E +  
Sbjct: 196 IGRGGFGEVYGCR-KADTGKMYAMKC------------------LDKKRIKMKQGETLAL 236
Query: 260 SQIRHRNILPLLAHMVRPDCHLLV---YEFMKNGSLQDILDDVSRGRRELDWP-SRHRI- 314
           ++   R +L L++     DC  +V   Y F     L  ILD ++ G  +L +  S+H + 
Sbjct: 237 NE---RIMLSLVS---TGDCPFIVCMSYAFHTPDKLSFILDLMNGG--DLHYHLSQHGVF 288
Query: 315 --------ALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGY 366
                   A  +  GLE++H   +  +++ D+KP N+LL++     ISDLGLA      +
Sbjct: 289 SEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLAC----DF 341
Query: 367 TRVLISYVLGTMAYIAPEYFQQP-ELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEE 422
           ++      +GT  Y+APE  Q+        D FS G +L  L+RG   F  H+  ++
Sbjct: 342 SKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 398

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 106/237 (44%), Gaps = 48/237 (20%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           IG GG GEVY        GKM A+K                   L   +++  + E +  
Sbjct: 197 IGRGGFGEVYGCR-KADTGKMYAMKC------------------LDKKRIKMKQGETLAL 237
Query: 260 SQIRHRNILPLLAHMVRPDCHLLV---YEFMKNGSLQDILDDVSRGRRELDWP-SRHRI- 314
           ++   R +L L++     DC  +V   Y F     L  ILD ++ G  +L +  S+H + 
Sbjct: 238 NE---RIMLSLVS---TGDCPFIVCMSYAFHTPDKLSFILDLMNGG--DLHYHLSQHGVF 289
Query: 315 --------ALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGY 366
                   A  +  GLE++H   +  +++ D+KP N+LL++     ISDLGLA      +
Sbjct: 290 SEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLAC----DF 342
Query: 367 TRVLISYVLGTMAYIAPEYFQQP-ELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEE 422
           ++      +GT  Y+APE  Q+        D FS G +L  L+RG   F  H+  ++
Sbjct: 343 SKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 399

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/170 (25%), Positives = 79/170 (46%), Gaps = 11/170 (6%)
Query: 255 EIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRI 314
           E++  + +    I+PL   +       +  E ++ GSL  ++       +++      R 
Sbjct: 100 ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI-------KQMGCLPEDRA 152
Query: 315 ALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDD-MEACISDLGLAMAI-PDGYTRVLIS 372
              +   LE L   H+  I+HGD+K  NVLL+ D   A + D G A+ + PDG  + L++
Sbjct: 153 LYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLT 212
Query: 373 --YVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNG 420
             Y+ GT  ++APE         K DI+S   +++ ++ G   +  +  G
Sbjct: 213 GDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG 262

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 98/226 (43%), Gaps = 25/226 (11%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +GSG CGEV K        K +AIK +I     +     E D  L       + +EI   
Sbjct: 17  LGSGACGEV-KLAFERKTCKKVAIK-IISKRKFAIGSAREADPAL------NVETEIEIL 68
Query: 260 SQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVA 319
            ++ H  I+ +       D + +V E M+ G L D +    R +        +++ L V 
Sbjct: 69  KKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV- 126
Query: 320 SGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC---ISDLGLAMAIPDGYTRVLISYVLG 376
              +YLH      IIH D+KP NVLL+   E C   I+D G +  +  G T  L+  + G
Sbjct: 127 ---QYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETS-LMRTLCG 177
Query: 377 TMAYIAPEYF---QQPELSEKCDIFSFGMLLISLVRGVPSFVFHQN 419
           T  Y+APE          +   D +S G++L   + G P F  H+ 
Sbjct: 178 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 223

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 97/226 (42%), Gaps = 25/226 (11%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +GSG CGEV K        K +AIK +I     +     E D  L       + +EI   
Sbjct: 18  LGSGACGEV-KLAFERKTCKKVAIK-IISKRKFAIGSAREADPAL------NVETEIEIL 69
Query: 260 SQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVA 319
            ++ H  I+ +       D + +V E M+ G L D +     G + L   +       + 
Sbjct: 70  KKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKV----VGNKRLKEATCKLYFYQML 124
Query: 320 SGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC---ISDLGLAMAIPDGYTRVLISYVLG 376
             ++YLH      IIH D+KP NVLL+   E C   I+D G +  +  G T  L+  + G
Sbjct: 125 LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETS-LMRTLCG 178
Query: 377 TMAYIAPEYF---QQPELSEKCDIFSFGMLLISLVRGVPSFVFHQN 419
           T  Y+APE          +   D +S G++L   + G P F  H+ 
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 224

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 106/237 (44%), Gaps = 48/237 (20%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           IG GG GEVY        GKM A+K                   L   +++  + E +  
Sbjct: 197 IGRGGFGEVYGCR-KADTGKMYAMKC------------------LDKKRIKMKQGETLAL 237
Query: 260 SQIRHRNILPLLAHMVRPDCHLLV---YEFMKNGSLQDILDDVSRGRRELDWP-SRHRI- 314
           ++   R +L L++     DC  +V   Y F     L  ILD ++ G  +L +  S+H + 
Sbjct: 238 NE---RIMLSLVS---TGDCPFIVCMSYAFHTPDKLSFILDLMNGG--DLHYHLSQHGVF 289
Query: 315 --------ALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGY 366
                   A  +  GLE++H   +  +++ D+KP N+LL++     ISDLGLA      +
Sbjct: 290 SEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLAC----DF 342
Query: 367 TRVLISYVLGTMAYIAPEYFQQP-ELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEE 422
           ++      +GT  Y+APE  Q+        D FS G +L  L+RG   F  H+  ++
Sbjct: 343 SKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 399

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 106/237 (44%), Gaps = 48/237 (20%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           IG GG GEVY        GKM A+K                   L   +++  + E +  
Sbjct: 197 IGRGGFGEVYGCR-KADTGKMYAMKC------------------LDKKRIKMKQGETLAL 237
Query: 260 SQIRHRNILPLLAHMVRPDCHLLV---YEFMKNGSLQDILDDVSRGRRELDWP-SRHRI- 314
           ++   R +L L++     DC  +V   Y F     L  ILD ++ G  +L +  S+H + 
Sbjct: 238 NE---RIMLSLVS---TGDCPFIVCMSYAFHTPDKLSFILDLMNGG--DLHYHLSQHGVF 289
Query: 315 --------ALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGY 366
                   A  +  GLE++H   +  +++ D+KP N+LL++     ISDLGLA      +
Sbjct: 290 SEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLAC----DF 342
Query: 367 TRVLISYVLGTMAYIAPEYFQQP-ELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEE 422
           ++      +GT  Y+APE  Q+        D FS G +L  L+RG   F  H+  ++
Sbjct: 343 SKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 399

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/258 (25%), Positives = 109/258 (42%), Gaps = 25/258 (9%)
Query: 168 SRDRGPTIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVI 227
           SR++    F   ++ + +      D +   + +GSG CGEV K        K +AI+ +I
Sbjct: 125 SRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEV-KLAFERKTCKKVAIR-II 182
Query: 228 VYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFM 287
                +     E D  L       + +EI    ++ H  I+ +       D + +V E M
Sbjct: 183 SKRKFAIGSAREADPAL------NVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELM 235
Query: 288 KNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLND 347
           + G L D +     G + L   +       +   ++YLH      IIH D+KP NVLL+ 
Sbjct: 236 EGGELFDKV----VGNKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSS 288
Query: 348 DMEAC---ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYF---QQPELSEKCDIFSFG 401
             E C   I+D G +  +  G T  L+  + GT  Y+APE          +   D +S G
Sbjct: 289 QEEDCLIKITDFGHSKIL--GETS-LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLG 345
Query: 402 MLLISLVRGVPSFVFHQN 419
           ++L   + G P F  H+ 
Sbjct: 346 VILFICLSGYPPFSEHRT 363

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/235 (24%), Positives = 105/235 (44%), Gaps = 25/235 (10%)
Query: 218 GKMIAIKKVIVYAPIS--AAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMV 275
           G    +++ +   P    AA++I    KL     +++  E      ++H NI+ L   + 
Sbjct: 42  GAFSVVRRCVKKTPTQEYAAKIINT-KKLSARDHQKLEREARICRLLKHPNIVRLHDSIS 100
Query: 276 RPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIH 335
               H LV++ +  G L +  D V+R     ++ S    +  +   LE ++  H   I+H
Sbjct: 101 EEGFHYLVFDLVTGGELFE--DIVAR-----EYYSEADASHCIHQILESVNHIHQHDIVH 153
Query: 336 GDIKPRNVLLNDDMEAC---ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELS 392
            D+KP N+LL    +     ++D GLA+ +  G  +    +  GT  Y++PE  ++    
Sbjct: 154 RDLKPENLLLASKCKGAAVKLADFGLAIEV-QGEQQAWFGFA-GTPGYLSPEVLRKDPYG 211
Query: 393 EKCDIFSFGMLLISLVRGVPSF-------VFHQ---NGEEICSPEWLRKVMNSKN 437
           +  DI++ G++L  L+ G P F       ++ Q      +  SPEW      +KN
Sbjct: 212 KPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKN 266

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 116/286 (40%), Gaps = 56/286 (19%)
Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDS---KLRDSKLRQIR 253
           +++IGSG  G V+       N   +AIK  I    +S  + IEE     KL   KL Q+ 
Sbjct: 15  VQEIGSGQFGLVHLGYWL--NKDKVAIK-TIREGAMSEEDFIEEAEVMMKLSHPKLVQLY 71
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
              +  +                P C  LV+EFM++G L D L    RG    +  +   
Sbjct: 72  GVCLEQA----------------PIC--LVFEFMEHGCLSDYLR-TQRGLFAAE--TLLG 110
Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA-MAIPDGYTRVLIS 372
           + L V  G+ YL     A +IH D+  RN L+ ++    +SD G+    + D YT     
Sbjct: 111 MCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS---- 163
Query: 373 YVLGT---MAYIAPEYFQQPELSEKCDIFSFGMLLISLV-RGVPSFVFHQNGEEICSPEW 428
              GT   + + +PE F     S K D++SFG+L+  +   G   +    N E       
Sbjct: 164 -STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE------- 215
Query: 429 LRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERP 474
              V +     R   PRL          HV +I   C    PE+RP
Sbjct: 216 --VVEDISTGFRLYKPRLAST-------HVYQIMNHCWRERPEDRP 252

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 73/287 (25%), Positives = 120/287 (41%), Gaps = 44/287 (15%)
Query: 199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT 258
           K+G G  GEV+     G+    I   K    +P +  +  +   KLR  KL Q+ + +++
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 83
Query: 259 ASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV 318
              I                   +V E+M  GSL D L       + L  P    +A  +
Sbjct: 84  EEPI------------------YIVTEYMSKGSLLDFLK--GEMGKYLRLPQLVDMAAQI 123
Query: 319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG-YTRVLISYVLGT 377
           ASG+ Y+      + +H D++  N+L+ +++   ++D GLA  I D  YT    +     
Sbjct: 124 ASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--P 178
Query: 378 MAYIAPEYFQQPELSEKCDIFSFGMLLISL-VRGVPSFVFHQNGEEICSPEWLRKVMNSK 436
           + + APE       + K D++SFG+LL  L  +G   +    N          R+V++  
Sbjct: 179 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----------REVLDQV 228
Query: 437 NPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRL 483
                   R+P      + LH L     C   DPEERP  +Y++  L
Sbjct: 229 ERGY----RMPCPPECPESLHDLMCQ--CWRKDPEERPTFEYLQAFL 269

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 98/226 (43%), Gaps = 25/226 (11%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +GSG CGEV K        K +AIK +I     +     E D  L       + +EI   
Sbjct: 24  LGSGACGEV-KLAFERKTCKKVAIK-IISKRKFAIGSAREADPAL------NVETEIEIL 75
Query: 260 SQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVA 319
            ++ H  I+ +       D + +V E M+ G L D +    R +        +++ L V 
Sbjct: 76  KKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV- 133
Query: 320 SGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC---ISDLGLAMAIPDGYTRVLISYVLG 376
              +YLH      IIH D+KP NVLL+   E C   I+D G +  +  G T  L+  + G
Sbjct: 134 ---QYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETS-LMRTLCG 184
Query: 377 TMAYIAPEYF---QQPELSEKCDIFSFGMLLISLVRGVPSFVFHQN 419
           T  Y+APE          +   D +S G++L   + G P F  H+ 
Sbjct: 185 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 230

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 103/242 (42%), Gaps = 28/242 (11%)
Query: 215 GSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIR-HRNILPLLAH 273
           GS GK + + +V     + A +++++D  L+D  +    +E    S  R H  +  L   
Sbjct: 34  GSFGK-VMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCC 92
Query: 274 MVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASI 333
              PD    V EF+  G   D++  + + RR  D       A  + S L +LH      I
Sbjct: 93  FQTPDRLFFVMEFVNGG---DLMFHIQKSRR-FDEARARFYAAEIISALMFLH---DKGI 145
Query: 334 IHGDIKPRNVLLNDDMEACISDLGLAM-AIPDGYTRVLISYVLGTMAYIAPEYFQQPELS 392
           I+ D+K  NVLL+ +    ++D G+    I +G T    +   GT  YIAPE  Q+    
Sbjct: 146 IYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT---TATFCGTPDYIAPEILQEMLYG 202
Query: 393 EKCDIFSFGMLLISLVRGVPSFVFHQN--------GEEICSPEWLR-------KVMNSKN 437
              D ++ G+LL  ++ G   F              +E+  P WL        K   +KN
Sbjct: 203 PAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKSFMTKN 262
Query: 438 PS 439
           P+
Sbjct: 263 PT 264

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/170 (25%), Positives = 79/170 (46%), Gaps = 11/170 (6%)
Query: 255 EIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRI 314
           E++  + +    I+PL   +       +  E ++ GSL  ++       +++      R 
Sbjct: 114 ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI-------KQMGCLPEDRA 166
Query: 315 ALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDD-MEACISDLGLAMAI-PDGYTRVLIS 372
              +   LE L   H+  I+HGD+K  NVLL+ D   A + D G A+ + PDG  + L++
Sbjct: 167 LYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLT 226
Query: 373 --YVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNG 420
             Y+ GT  ++APE         K DI+S   +++ ++ G   +  +  G
Sbjct: 227 GDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG 276

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 73/287 (25%), Positives = 120/287 (41%), Gaps = 44/287 (15%)
Query: 199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT 258
           K+G G  GEV+     G+    I   K    +P +  +  +   KLR  KL Q+ + +++
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 83
Query: 259 ASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV 318
              I                   +V E+M  GSL D L       + L  P    +A  +
Sbjct: 84  EEPI------------------YIVIEYMSKGSLLDFLK--GEMGKYLRLPQLVDMAAQI 123
Query: 319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG-YTRVLISYVLGT 377
           ASG+ Y+      + +H D++  N+L+ +++   ++D GLA  I D  YT    +     
Sbjct: 124 ASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--P 178
Query: 378 MAYIAPEYFQQPELSEKCDIFSFGMLLISL-VRGVPSFVFHQNGEEICSPEWLRKVMNSK 436
           + + APE       + K D++SFG+LL  L  +G   +    N          R+V++  
Sbjct: 179 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----------REVLDQV 228
Query: 437 NPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRL 483
                   R+P      + LH L     C   DPEERP  +Y++  L
Sbjct: 229 ERGY----RMPCPPECPESLHDLMCQ--CWRKDPEERPTFEYLQAFL 269

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 73/287 (25%), Positives = 120/287 (41%), Gaps = 44/287 (15%)
Query: 199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT 258
           K+G G  GEV+     G+    I   K    +P +  +  +   KLR  KL Q+ + +++
Sbjct: 16  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 74
Query: 259 ASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV 318
              I                   +V E+M  GSL D L       + L  P    +A  +
Sbjct: 75  EEPI------------------YIVTEYMSKGSLLDFLK--GEMGKYLRLPQLVDMAAQI 114
Query: 319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG-YTRVLISYVLGT 377
           ASG+ Y+      + +H D++  N+L+ +++   ++D GLA  I D  YT    +     
Sbjct: 115 ASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--P 169
Query: 378 MAYIAPEYFQQPELSEKCDIFSFGMLLISL-VRGVPSFVFHQNGEEICSPEWLRKVMNSK 436
           + + APE       + K D++SFG+LL  L  +G   +    N          R+V++  
Sbjct: 170 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----------REVLDQV 219
Query: 437 NPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRL 483
                   R+P      + LH L     C   DPEERP  +Y++  L
Sbjct: 220 ERGY----RMPCPPECPESLHDLMCQ--CWRKDPEERPTFEYLQAFL 260

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 80/287 (27%), Positives = 117/287 (40%), Gaps = 58/287 (20%)
Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDS---KLRDSKLRQIR 253
           +++IGSG  G V+       N   +AIK  I    +S  + IEE     KL   KL Q+ 
Sbjct: 10  VQEIGSGQFGLVHLGYWL--NKDKVAIK-TIREGAMSEEDFIEEAEVMMKLSHPKLVQLY 66
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRREL-DWPSRH 312
              +  +                P C  LV+EFM++G L D L    R +R L    +  
Sbjct: 67  GVCLEQA----------------PIC--LVFEFMEHGCLSDYL----RTQRGLFAAETLL 104
Query: 313 RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA-MAIPDGYTRVLI 371
            + L V  G+ YL     A +IH D+  RN L+ ++    +SD G+    + D YT    
Sbjct: 105 GMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS--- 158
Query: 372 SYVLGT---MAYIAPEYFQQPELSEKCDIFSFGMLLISLV-RGVPSFVFHQNGEEICSPE 427
               GT   + + +PE F     S K D++SFG+L+  +   G   +    N E      
Sbjct: 159 --STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE------ 210
Query: 428 WLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERP 474
               V +     R   PRL          HV +I   C    PE+RP
Sbjct: 211 ---VVEDISTGFRLYKPRLAST-------HVYQIMNHCWKERPEDRP 247

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 73/287 (25%), Positives = 120/287 (41%), Gaps = 44/287 (15%)
Query: 199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT 258
           K+G G  GEV+     G+    I   K    +P +  +  +   KLR  KL Q+ + +++
Sbjct: 14  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 72
Query: 259 ASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV 318
              I                   +V E+M  GSL D L       + L  P    +A  +
Sbjct: 73  EEPI------------------YIVTEYMSKGSLLDFLK--GEMGKYLRLPQLVDMAAQI 112
Query: 319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG-YTRVLISYVLGT 377
           ASG+ Y+      + +H D++  N+L+ +++   ++D GLA  I D  YT    +     
Sbjct: 113 ASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--P 167
Query: 378 MAYIAPEYFQQPELSEKCDIFSFGMLLISL-VRGVPSFVFHQNGEEICSPEWLRKVMNSK 436
           + + APE       + K D++SFG+LL  L  +G   +    N          R+V++  
Sbjct: 168 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----------REVLDQV 217
Query: 437 NPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRL 483
                   R+P      + LH L     C   DPEERP  +Y++  L
Sbjct: 218 ERGY----RMPCPPECPESLHDLMCQ--CWRKDPEERPTFEYLQAFL 258

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 106/222 (47%), Gaps = 22/222 (9%)
Query: 194 FASLEKIGSGGCGEVYKAE-LPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQI 252
           F  L+ +G G  G+V+  + + GS+ + +   KV+  A +          K+RD    ++
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATL----------KVRDRVRTKM 75
Query: 253 RSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRH 312
             +I+   ++ H  I+ L           L+ +F++ G L       +R  +E+ + +  
Sbjct: 76  ERDILV--EVNHPFIVKLHYAFQTEGKLYLILDFLRGGDL------FTRLSKEVMF-TEE 126
Query: 313 RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLIS 372
            +   +A     L   HS  II+ D+KP N+LL+++    ++D GL+    D + +   S
Sbjct: 127 DVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID-HEKKAYS 185
Query: 373 YVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
           +  GT+ Y+APE   +   ++  D +SFG+L+  ++ G   F
Sbjct: 186 FC-GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPF 226

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 71/286 (24%), Positives = 117/286 (40%), Gaps = 42/286 (14%)
Query: 199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT 258
           K+G G  GEV+     G+    I   K    +P +  +  +   KLR  KL Q+ + +++
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 83
Query: 259 ASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV 318
              I                   +V E+M  GSL D L       + L  P    +A  +
Sbjct: 84  EEPI------------------YIVIEYMSKGSLLDFLK--GEMGKYLRLPQLVDMAAQI 123
Query: 319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTM 378
           ASG+ Y+      + +H D++  N+L+ +++   ++D GLA  I D             +
Sbjct: 124 ASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKF-PI 179
Query: 379 AYIAPEYFQQPELSEKCDIFSFGMLLISL-VRGVPSFVFHQNGEEICSPEWLRKVMNSKN 437
            + APE       + K D++SFG+LL  L  +G   +    N          R+V++   
Sbjct: 180 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----------REVLDQVE 229
Query: 438 PSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRL 483
                  R+P      + LH L     C   DPEERP  +Y++  L
Sbjct: 230 RGY----RMPCPPECPESLHDLMCQ--CWRKDPEERPTFEYLQAFL 269

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 73/287 (25%), Positives = 120/287 (41%), Gaps = 44/287 (15%)
Query: 199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT 258
           K+G G  GEV+     G+    I   K    +P +  +  +   KLR  KL Q+ + +++
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 83
Query: 259 ASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV 318
              I                   +V E+M  GSL D L       + L  P    +A  +
Sbjct: 84  EEPI------------------YIVCEYMSKGSLLDFLK--GEMGKYLRLPQLVDMAAQI 123
Query: 319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG-YTRVLISYVLGT 377
           ASG+ Y+      + +H D++  N+L+ +++   ++D GLA  I D  YT    +     
Sbjct: 124 ASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--P 178
Query: 378 MAYIAPEYFQQPELSEKCDIFSFGMLLISL-VRGVPSFVFHQNGEEICSPEWLRKVMNSK 436
           + + APE       + K D++SFG+LL  L  +G   +    N          R+V++  
Sbjct: 179 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----------REVLDQV 228
Query: 437 NPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRL 483
                   R+P      + LH L     C   DPEERP  +Y++  L
Sbjct: 229 ERGY----RMPCPPECPESLHDLMCQ--CWRKDPEERPTFEYLQAFL 269

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/170 (25%), Positives = 79/170 (46%), Gaps = 11/170 (6%)
Query: 255 EIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRI 314
           E++  + +    I+PL   +       +  E ++ GSL  ++       +++      R 
Sbjct: 116 ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI-------KQMGCLPEDRA 168
Query: 315 ALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDD-MEACISDLGLAMAI-PDGYTRVLIS 372
              +   LE L   H+  I+HGD+K  NVLL+ D   A + D G A+ + PDG  + L++
Sbjct: 169 LYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLT 228
Query: 373 --YVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNG 420
             Y+ GT  ++APE         K DI+S   +++ ++ G   +  +  G
Sbjct: 229 GDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG 278

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 80/287 (27%), Positives = 117/287 (40%), Gaps = 58/287 (20%)
Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDS---KLRDSKLRQIR 253
           +++IGSG  G V+       N   +AIK  I    +S  + IEE     KL   KL Q+ 
Sbjct: 12  VQEIGSGQFGLVHLGYWL--NKDKVAIK-TIREGAMSEEDFIEEAEVMMKLSHPKLVQLY 68
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRREL-DWPSRH 312
              +  +                P C  LV+EFM++G L D L    R +R L    +  
Sbjct: 69  GVCLEQA----------------PIC--LVFEFMEHGCLSDYL----RTQRGLFAAETLL 106
Query: 313 RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA-MAIPDGYTRVLI 371
            + L V  G+ YL     A +IH D+  RN L+ ++    +SD G+    + D YT    
Sbjct: 107 GMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS--- 160
Query: 372 SYVLGT---MAYIAPEYFQQPELSEKCDIFSFGMLLISLV-RGVPSFVFHQNGEEICSPE 427
               GT   + + +PE F     S K D++SFG+L+  +   G   +    N E      
Sbjct: 161 --STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE------ 212
Query: 428 WLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERP 474
               V +     R   PRL          HV +I   C    PE+RP
Sbjct: 213 ---VVEDISTGFRLYKPRLAST-------HVYQIMNHCWKERPEDRP 249

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 98/216 (45%), Gaps = 23/216 (10%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           F  +EKIG G  G VYKA      G+++A+KK+          L  E   +  + +R   
Sbjct: 4   FQKVEKIGEGTYGVVYKAR-NKLTGEVVALKKI---------RLDTETEGVPSTAIR--- 50
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
            EI    ++ H NI+ LL  +   +   LV+EF+    L+  +D  +     +  P    
Sbjct: 51  -EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMD--ASALTGIPLPLIKS 106
Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISY 373
               +  GL + H   S  ++H D+KP+N+L+N +    ++D GLA A   G       +
Sbjct: 107 YLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXH 161
Query: 374 VLGTMAYIAPEYFQQPE-LSEKCDIFSFGMLLISLV 408
            + T+ Y APE     +  S   DI+S G +   +V
Sbjct: 162 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 197

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 98/216 (45%), Gaps = 23/216 (10%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           F  +EKIG G  G VYKA      G+++A+KK+          L  E   +  + +R   
Sbjct: 5   FQKVEKIGEGTYGVVYKAR-NKLTGEVVALKKI---------RLDTETEGVPSTAIR--- 51
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
            EI    ++ H NI+ LL  +   +   LV+EF+    L+  +D  +     +  P    
Sbjct: 52  -EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMD--ASALTGIPLPLIKS 107
Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISY 373
               +  GL + H   S  ++H D+KP+N+L+N +    ++D GLA A   G       +
Sbjct: 108 YLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXH 162
Query: 374 VLGTMAYIAPEYFQQPE-LSEKCDIFSFGMLLISLV 408
            + T+ Y APE     +  S   DI+S G +   +V
Sbjct: 163 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 98/216 (45%), Gaps = 23/216 (10%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           F  +EKIG G  G VYKA      G+++A+KK+          L  E   +  + +R   
Sbjct: 5   FQKVEKIGEGTYGVVYKAR-NKLTGEVVALKKI---------RLDTETEGVPSTAIR--- 51
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
            EI    ++ H NI+ LL  +   +   LV+EF+    L+  +D  +     +  P    
Sbjct: 52  -EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMD--ASALTGIPLPLIKS 107
Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISY 373
               +  GL + H   S  ++H D+KP+N+L+N +    ++D GLA A   G       +
Sbjct: 108 YLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXH 162
Query: 374 VLGTMAYIAPEYFQQPE-LSEKCDIFSFGMLLISLV 408
            + T+ Y APE     +  S   DI+S G +   +V
Sbjct: 163 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 106/222 (47%), Gaps = 22/222 (9%)
Query: 194 FASLEKIGSGGCGEVYKAE-LPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQI 252
           F  L+ +G G  G+V+  + + GS+ + +   KV+  A +          K+RD    ++
Sbjct: 27  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATL----------KVRDRVRTKM 76
Query: 253 RSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRH 312
             +I+   ++ H  I+ L           L+ +F++ G L       +R  +E+ + +  
Sbjct: 77  ERDILV--EVNHPFIVKLHYAFQTEGKLYLILDFLRGGDL------FTRLSKEVMF-TEE 127
Query: 313 RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLIS 372
            +   +A     L   HS  II+ D+KP N+LL+++    ++D GL+    D + +   S
Sbjct: 128 DVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID-HEKKAYS 186
Query: 373 YVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
           +  GT+ Y+APE   +   ++  D +SFG+L+  ++ G   F
Sbjct: 187 FC-GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPF 227

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 106/222 (47%), Gaps = 22/222 (9%)
Query: 194 FASLEKIGSGGCGEVYKAE-LPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQI 252
           F  L+ +G G  G+V+  + + GS+ + +   KV+  A +          K+RD    ++
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATL----------KVRDRVRTKM 75
Query: 253 RSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRH 312
             +I+   ++ H  I+ L           L+ +F++ G L       +R  +E+ + +  
Sbjct: 76  ERDILV--EVNHPFIVKLHYAFQTEGKLYLILDFLRGGDL------FTRLSKEVMF-TEE 126
Query: 313 RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLIS 372
            +   +A     L   HS  II+ D+KP N+LL+++    ++D GL+    D + +   S
Sbjct: 127 DVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID-HEKKAYS 185
Query: 373 YVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
           +  GT+ Y+APE   +   ++  D +SFG+L+  ++ G   F
Sbjct: 186 FC-GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPF 226

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 100/228 (43%), Gaps = 27/228 (11%)
Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           E +G G  G+V+K E   +  K+ A  K+I    +   E              ++++EI 
Sbjct: 95  EILGGGRFGQVHKCEETATGLKLAA--KIIKTRGMKDKE--------------EVKNEIS 138
Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALG 317
             +Q+ H N++ L       +  +LV E++  G L D + D S    ELD        L 
Sbjct: 139 VMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELD------TILF 192
Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVL-LNDDMEAC-ISDLGLAMAIPDGYTRVLISYVL 375
           +    E +   H   I+H D+KP N+L +N D +   I D GLA        R  +    
Sbjct: 193 MKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYK---PREKLKVNF 249
Query: 376 GTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI 423
           GT  ++APE      +S   D++S G++   L+ G+  F+   + E +
Sbjct: 250 GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETL 297

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 98/216 (45%), Gaps = 23/216 (10%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           F  +EKIG G  G VYKA      G+++A+KK+          L  E   +  + +R   
Sbjct: 5   FQKVEKIGEGTYGVVYKAR-NKLTGEVVALKKI---------RLDTETEGVPSTAIR--- 51
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
            EI    ++ H NI+ LL  +   +   LV+EF+    L+  +D  +     +  P    
Sbjct: 52  -EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMD--ASALTGIPLPLIKS 107
Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISY 373
               +  GL + H   S  ++H D+KP+N+L+N +    ++D GLA A   G       +
Sbjct: 108 YLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXH 162
Query: 374 VLGTMAYIAPEYFQQPE-LSEKCDIFSFGMLLISLV 408
            + T+ Y APE     +  S   DI+S G +   +V
Sbjct: 163 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 98/216 (45%), Gaps = 23/216 (10%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           F  +EKIG G  G VYKA      G+++A+KK+          L  E   +  + +R   
Sbjct: 8   FQKVEKIGEGTYGVVYKAR-NKLTGEVVALKKI---------RLDTETEGVPSTAIR--- 54
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
            EI    ++ H NI+ LL  +   +   LV+EF+    L+  +D  +     +  P    
Sbjct: 55  -EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMD--ASALTGIPLPLIKS 110
Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISY 373
               +  GL + H   S  ++H D+KP+N+L+N +    ++D GLA A   G       +
Sbjct: 111 YLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXH 165
Query: 374 VLGTMAYIAPEYFQQPE-LSEKCDIFSFGMLLISLV 408
            + T+ Y APE     +  S   DI+S G +   +V
Sbjct: 166 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 201

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 98/216 (45%), Gaps = 23/216 (10%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           F  +EKIG G  G VYKA      G+++A+KK+          L  E   +  + +R   
Sbjct: 7   FQKVEKIGEGTYGVVYKAR-NKLTGEVVALKKI---------RLDTETEGVPSTAIR--- 53
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
            EI    ++ H NI+ LL  +   +   LV+EF+    L+  +D  +     +  P    
Sbjct: 54  -EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMD--ASALTGIPLPLIKS 109
Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISY 373
               +  GL + H   S  ++H D+KP+N+L+N +    ++D GLA A   G       +
Sbjct: 110 YLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXH 164
Query: 374 VLGTMAYIAPEYFQQPE-LSEKCDIFSFGMLLISLV 408
            + T+ Y APE     +  S   DI+S G +   +V
Sbjct: 165 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 200

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/128 (33%), Positives = 66/128 (51%), Gaps = 9/128 (7%)
Query: 282 LVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPR 341
           LV E++  GSL+D L   S G  +L        A  +  G+ YLH  H    IH D+  R
Sbjct: 112 LVMEYVPLGSLRDYLPRHSIGLAQLLL-----FAQQICEGMAYLHAQH---YIHRDLAAR 163
Query: 342 NVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGT-MAYIAPEYFQQPELSEKCDIFSF 400
           NVLL++D    I D GLA A+P+G+    +     + + + APE  ++ +     D++SF
Sbjct: 164 NVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEYKFYYASDVWSF 223
Query: 401 GMLLISLV 408
           G+ L  L+
Sbjct: 224 GVTLYELL 231

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 98/216 (45%), Gaps = 23/216 (10%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           F  +EKIG G  G VYKA      G+++A+KK+          L  E   +  + +R   
Sbjct: 6   FQKVEKIGEGTYGVVYKAR-NKLTGEVVALKKI---------RLDTETEGVPSTAIR--- 52
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
            EI    ++ H NI+ LL  +   +   LV+EF+    L+  +D  +     +  P    
Sbjct: 53  -EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMD--ASALTGIPLPLIKS 108
Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISY 373
               +  GL + H   S  ++H D+KP+N+L+N +    ++D GLA A   G       +
Sbjct: 109 YLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXH 163
Query: 374 VLGTMAYIAPEYFQQPE-LSEKCDIFSFGMLLISLV 408
            + T+ Y APE     +  S   DI+S G +   +V
Sbjct: 164 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 199

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 81/310 (26%), Positives = 132/310 (42%), Gaps = 57/310 (18%)
Query: 171 RGPTIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGEV---YKAELPGSNGKMIAIKKVI 227
           R    +S  I       LK+   + +L+ IGSG  G V   Y A L     + +AIKK+ 
Sbjct: 6   RDNNFYSVEIGDSTFTVLKR---YQNLKPIGSGAQGIVVAAYDAILE----RNVAIKKL- 57
Query: 228 VYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHL------ 281
              P               +  ++   E++    + H+NI+ LL ++  P   L      
Sbjct: 58  -SRPFQ-----------NQTHAKRAYRELVLMKVVNHKNIIGLL-NVFTPQKSLEEFQDV 104
Query: 282 -LVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKP 340
            +V E M + +L  ++      + ELD      +   +  G+++LH   SA IIH D+KP
Sbjct: 105 YIVMELM-DANLSQVI------QMELDHERMSYLLYQMLVGIKHLH---SAGIIHRDLKP 154
Query: 341 RNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSF 400
            N+++  D    I D GLA     G + ++  YV+ T  Y APE        E  DI+S 
Sbjct: 155 SNIVVKSDATLKILDFGLARTA--GTSFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSV 211
Query: 401 GMLLISLVRGVPSF-----------VFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGN 449
           G+++  +++G   F           V  Q G    SPE+++K+  +        P+  G 
Sbjct: 212 GVIMGEMIKGGVLFPGTDHIDQWNKVIEQLG--TPSPEFMKKLQPTVRTYVENRPKYAGY 269
Query: 450 GYEKKMLHVL 459
            +EK    VL
Sbjct: 270 SFEKLFPDVL 279

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 98/216 (45%), Gaps = 23/216 (10%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           F  +EKIG G  G VYKA      G+++A+KK+          L  E   +  + +R   
Sbjct: 7   FQKVEKIGEGTYGVVYKAR-NKLTGEVVALKKI---------RLDTETEGVPSTAIR--- 53
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
            EI    ++ H NI+ LL  +   +   LV+EF+    L+  +D  +     +  P    
Sbjct: 54  -EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMD--ASALTGIPLPLIKS 109
Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISY 373
               +  GL + H   S  ++H D+KP+N+L+N +    ++D GLA A   G       +
Sbjct: 110 YLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXH 164
Query: 374 VLGTMAYIAPEYFQQPE-LSEKCDIFSFGMLLISLV 408
            + T+ Y APE     +  S   DI+S G +   +V
Sbjct: 165 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 200

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 98/216 (45%), Gaps = 23/216 (10%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           F  +EKIG G  G VYKA      G+++A+KK+          L  E   +  + +R   
Sbjct: 6   FQKVEKIGEGTYGVVYKAR-NKLTGEVVALKKI---------RLDTETEGVPSTAIR--- 52
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
            EI    ++ H NI+ LL  +   +   LV+EF+    L+  +D  +     +  P    
Sbjct: 53  -EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMD--ASALTGIPLPLIKS 108
Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISY 373
               +  GL + H   S  ++H D+KP+N+L+N +    ++D GLA A   G       +
Sbjct: 109 YLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXH 163
Query: 374 VLGTMAYIAPEYFQQPE-LSEKCDIFSFGMLLISLV 408
            + T+ Y APE     +  S   DI+S G +   +V
Sbjct: 164 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 199

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 98/216 (45%), Gaps = 23/216 (10%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           F  +EKIG G  G VYKA      G+++A+KK+          L  E   +  + +R   
Sbjct: 8   FQKVEKIGEGTYGVVYKAR-NKLTGEVVALKKI---------RLDTETEGVPSTAIR--- 54
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
            EI    ++ H NI+ LL  +   +   LV+EF+    L+  +D  +     +  P    
Sbjct: 55  -EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMD--ASALTGIPLPLIKS 110
Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISY 373
               +  GL + H   S  ++H D+KP+N+L+N +    ++D GLA A   G       +
Sbjct: 111 YLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXH 165
Query: 374 VLGTMAYIAPEYFQQPE-LSEKCDIFSFGMLLISLV 408
            + T+ Y APE     +  S   DI+S G +   +V
Sbjct: 166 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 201

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 98/216 (45%), Gaps = 23/216 (10%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           F  +EKIG G  G VYKA      G+++A+KK+          L  E   +  + +R   
Sbjct: 4   FQKVEKIGEGTYGVVYKAR-NKLTGEVVALKKI---------RLDTETEGVPSTAIR--- 50
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
            EI    ++ H NI+ LL  +   +   LV+EF+    L+  +D  +     +  P    
Sbjct: 51  -EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMD--ASALTGIPLPLIKS 106
Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISY 373
               +  GL + H   S  ++H D+KP+N+L+N +    ++D GLA A   G       +
Sbjct: 107 YLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXH 161
Query: 374 VLGTMAYIAPEYFQQPE-LSEKCDIFSFGMLLISLV 408
            + T+ Y APE     +  S   DI+S G +   +V
Sbjct: 162 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 197

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 98/216 (45%), Gaps = 23/216 (10%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           F  +EKIG G  G VYKA      G+++A+KK+          L  E   +  + +R   
Sbjct: 9   FQKVEKIGEGTYGVVYKAR-NKLTGEVVALKKI---------RLDTETEGVPSTAIR--- 55
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
            EI    ++ H NI+ LL  +   +   LV+EF+    L+  +D  +     +  P    
Sbjct: 56  -EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMD--ASALTGIPLPLIKS 111
Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISY 373
               +  GL + H   S  ++H D+KP+N+L+N +    ++D GLA A   G       +
Sbjct: 112 YLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXH 166
Query: 374 VLGTMAYIAPEYFQQPE-LSEKCDIFSFGMLLISLV 408
            + T+ Y APE     +  S   DI+S G +   +V
Sbjct: 167 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 202

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 81/310 (26%), Positives = 132/310 (42%), Gaps = 57/310 (18%)
Query: 171 RGPTIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGEV---YKAELPGSNGKMIAIKKVI 227
           R    +S  I       LK+   + +L+ IGSG  G V   Y A L     + +AIKK+ 
Sbjct: 6   RDNNFYSVEIGDSTFTVLKR---YQNLKPIGSGAQGIVCAAYDAILE----RNVAIKKL- 57
Query: 228 VYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHL------ 281
              P               +  ++   E++    + H+NI+ LL ++  P   L      
Sbjct: 58  -SRPFQ-----------NQTHAKRAYRELVLMKVVNHKNIIGLL-NVFTPQKSLEEFQDV 104
Query: 282 -LVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKP 340
            +V E M + +L  ++      + ELD      +   +  G+++LH   SA IIH D+KP
Sbjct: 105 YIVMELM-DANLSQVI------QMELDHERMSYLLYQMLVGIKHLH---SAGIIHRDLKP 154
Query: 341 RNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSF 400
            N+++  D    I D GLA     G + ++  YV+ T  Y APE        E  DI+S 
Sbjct: 155 SNIVVKSDATLKILDFGLARTA--GTSFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSV 211
Query: 401 GMLLISLVRGVPSF-----------VFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGN 449
           G+++  +++G   F           V  Q G    SPE+++K+  +        P+  G 
Sbjct: 212 GVIMGEMIKGGVLFPGTDHIDQWNKVIEQLG--TPSPEFMKKLQPTVRTYVENRPKYAGY 269
Query: 450 GYEKKMLHVL 459
            +EK    VL
Sbjct: 270 SFEKLFPDVL 279

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 98/216 (45%), Gaps = 23/216 (10%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           F  +EKIG G  G VYKA      G+++A+KK+          L  E   +  + +R   
Sbjct: 5   FQKVEKIGEGTYGVVYKAR-NKLTGEVVALKKI---------RLDTETEGVPSTAIR--- 51
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
            EI    ++ H NI+ LL  +   +   LV+EF+    L+  +D  +     +  P    
Sbjct: 52  -EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMD--ASALTGIPLPLIKS 107
Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISY 373
               +  GL + H   S  ++H D+KP+N+L+N +    ++D GLA A   G       +
Sbjct: 108 YLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXH 162
Query: 374 VLGTMAYIAPEYFQQPE-LSEKCDIFSFGMLLISLV 408
            + T+ Y APE     +  S   DI+S G +   +V
Sbjct: 163 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 98/216 (45%), Gaps = 23/216 (10%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           F  +EKIG G  G VYKA      G+++A+KK+          L  E   +  + +R   
Sbjct: 8   FQKVEKIGEGTYGVVYKAR-NKLTGEVVALKKI---------RLDTETEGVPSTAIR--- 54
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
            EI    ++ H NI+ LL  +   +   LV+EF+    L+  +D  +     +  P    
Sbjct: 55  -EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKTFMD--ASALTGIPLPLIKS 110
Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISY 373
               +  GL + H   S  ++H D+KP+N+L+N +    ++D GLA A   G       +
Sbjct: 111 YLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXH 165
Query: 374 VLGTMAYIAPEYFQQPE-LSEKCDIFSFGMLLISLV 408
            + T+ Y APE     +  S   DI+S G +   +V
Sbjct: 166 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 201

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 100/214 (46%), Gaps = 28/214 (13%)
Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           ++++G+G  GEV+      +N   +A+K  +    +S    +EE + ++           
Sbjct: 18  VKRLGAGQFGEVWMGYY--NNSTKVAVK-TLKPGTMSVQAFLEEANLMK----------- 63
Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL 316
                ++H  ++ L A + R +   ++ E+M  GSL D L     G+  L  P     + 
Sbjct: 64  ----TLQHDKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSA 117
Query: 317 GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG-YT-RVLISYV 374
            +A G+ Y+      + IH D++  NVL+++ +   I+D GLA  I D  YT R    + 
Sbjct: 118 QIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF- 173
Query: 375 LGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLV 408
              + + APE       + K D++SFG+LL  +V
Sbjct: 174 --PIKWTAPEAINFGCFTIKSDVWSFGILLYEIV 205

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 28/222 (12%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           +  + KIG G  G V+K       G+++AIKK +           E+D  ++   LR+IR
Sbjct: 5   YEKIGKIGEGSYGVVFKCR-NRDTGQIVAIKKFLES---------EDDPVIKKIALREIR 54
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
                  Q++H N++ LL    R     LV+E+  +  L + LD   RG  E      H 
Sbjct: 55  ----MLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHE-LDRYQRGVPE------HL 103
Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI--PDGYTRVLI 371
           +       L+ ++  H  + IH D+KP N+L+       + D G A  +  P  Y    +
Sbjct: 104 VKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEV 163
Query: 372 SYVLGTMAYIAPEYF-QQPELSEKCDIFSFGMLLISLVRGVP 412
           +    T  Y +PE      +     D+++ G +   L+ GVP
Sbjct: 164 A----TRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVP 201

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/247 (24%), Positives = 103/247 (41%), Gaps = 40/247 (16%)
Query: 167 GSRDRGPTIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAE---LPGSNGKMIAI 223
           GS DR PT F    E+  L FL         +++G G  G V       L  + G+++A+
Sbjct: 1   GSEDRDPTQF----EERHLKFL---------QQLGKGNFGSVEMCRYDPLQDNTGEVVAV 47
Query: 224 KKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL--LAHMVRPDCHL 281
           KK+                   +  LR    EI     ++H NI+    + +        
Sbjct: 48  KKL---------------QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 92
Query: 282 LVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPR 341
           L+ E++  GSL+D L    + +  +D     +    +  G+EYL    +   IH D+  R
Sbjct: 93  LIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATR 146
Query: 342 NVLLNDDMEACISDLGLAMAIP-DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSF 400
           N+L+ ++    I D GL   +P D     +       + + APE   + + S   D++SF
Sbjct: 147 NILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSF 206
Query: 401 GMLLISL 407
           G++L  L
Sbjct: 207 GVVLYEL 213

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 80/287 (27%), Positives = 117/287 (40%), Gaps = 58/287 (20%)
Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDS---KLRDSKLRQIR 253
           +++IGSG  G V+       N   +AIK  I    +S  + IEE     KL   KL Q+ 
Sbjct: 32  VQEIGSGQFGLVHLGYWL--NKDKVAIK-TIKEGSMSEDDFIEEAEVMMKLSHPKLVQLY 88
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRREL-DWPSRH 312
              +  +                P C  LV+EFM++G L D L    R +R L    +  
Sbjct: 89  GVCLEQA----------------PIC--LVFEFMEHGCLSDYL----RTQRGLFAAETLL 126
Query: 313 RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA-MAIPDGYTRVLI 371
            + L V  G+ YL     A +IH D+  RN L+ ++    +SD G+    + D YT    
Sbjct: 127 GMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS--- 180
Query: 372 SYVLGT---MAYIAPEYFQQPELSEKCDIFSFGMLLISLV-RGVPSFVFHQNGEEICSPE 427
               GT   + + +PE F     S K D++SFG+L+  +   G   +    N E      
Sbjct: 181 --STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE------ 232
Query: 428 WLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERP 474
               V +     R   PRL          HV +I   C    PE+RP
Sbjct: 233 ---VVEDISTGFRLYKPRLAST-------HVYQIMNHCWKERPEDRP 269

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 73/287 (25%), Positives = 119/287 (41%), Gaps = 44/287 (15%)
Query: 199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT 258
           K+G G  GEV+     G+    I   K    +P +  +  +   KLR  KL Q+ + +++
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 83
Query: 259 ASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV 318
              I                   +V E+M  GSL D L       + L  P    +A  +
Sbjct: 84  EEPI------------------YIVTEYMSKGSLLDFLK--GEMGKYLRLPQLVDMAAQI 123
Query: 319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG-YTRVLISYVLGT 377
           ASG+ Y+      + +H D+   N+L+ +++   ++D GLA  I D  YT    +     
Sbjct: 124 ASGMAYVE---RMNYVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--P 178
Query: 378 MAYIAPEYFQQPELSEKCDIFSFGMLLISL-VRGVPSFVFHQNGEEICSPEWLRKVMNSK 436
           + + APE       + K D++SFG+LL  L  +G   +    N          R+V++  
Sbjct: 179 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----------REVLDQV 228
Query: 437 NPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRL 483
                   R+P      + LH L     C   DPEERP  +Y++  L
Sbjct: 229 ERGY----RMPCPPECPESLHDLMCQ--CWRKDPEERPTFEYLQAFL 269

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 101/219 (46%), Gaps = 24/219 (10%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           +  LEKIG G  G V+KA+   ++ +++A+K+V          L ++D  +  S LR   
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETH-EIVALKRV---------RLDDDDEGVPSSALR--- 50
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
            EI    +++H+NI+ L   +       LV+EF      QD+         +LD      
Sbjct: 51  -EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD----QDLKKYFDSCNGDLDPEIVKS 105
Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISY 373
               +  GL + H   S +++H D+KP+N+L+N + E  ++D GLA A   G      S 
Sbjct: 106 FLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLADFGLARAF--GIPVRCYSA 160
Query: 374 VLGTMAYIAPEYFQQPEL-SEKCDIFSFGMLLISLVRGV 411
            + T+ Y  P+     +L S   D++S G +   L    
Sbjct: 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAA 199

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 97/216 (44%), Gaps = 23/216 (10%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           F  +EKIG G  G VYKA      G+++A+KK+          L  E   +  + +R   
Sbjct: 7   FQKVEKIGEGTYGVVYKAR-NKLTGEVVALKKI---------RLDTETEGVPSTAIR--- 53
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
            EI    ++ H NI+ LL  +   +   LV+EF+    L+  +D  +     +  P    
Sbjct: 54  -EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMD--ASALTGIPLPLIKS 109
Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISY 373
               +  GL + H   S  ++H D+KP N+L+N +    ++D GLA A   G       +
Sbjct: 110 YLFQLLQGLAFCH---SHRVLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXH 164
Query: 374 VLGTMAYIAPEYFQQPE-LSEKCDIFSFGMLLISLV 408
            + T+ Y APE     +  S   DI+S G +   +V
Sbjct: 165 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 200

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 97/216 (44%), Gaps = 23/216 (10%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           F  +EKIG G  G VYKA      G+++A+KK+          L  E   +  + +R   
Sbjct: 6   FQKVEKIGEGTYGVVYKAR-NKLTGEVVALKKI---------RLDTETEGVPSTAIR--- 52
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
            EI    ++ H NI+ LL  +   +   LV+EF+    L+  +D  +     +  P    
Sbjct: 53  -EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMD--ASALTGIPLPLIKS 108
Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISY 373
               +  GL + H   S  ++H D+KP N+L+N +    ++D GLA A   G       +
Sbjct: 109 YLFQLLQGLAFCH---SHRVLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXH 163
Query: 374 VLGTMAYIAPEYFQQPE-LSEKCDIFSFGMLLISLV 408
            + T+ Y APE     +  S   DI+S G +   +V
Sbjct: 164 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 199

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 121/287 (42%), Gaps = 44/287 (15%)
Query: 199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT 258
           K+G G  GEV+     G+    I   K    +P +  +  +   KLR  KL Q+ + +++
Sbjct: 18  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 76
Query: 259 ASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV 318
              I                   +V E+M  GSL D L   +   + L  P    +A  +
Sbjct: 77  EEPI------------------YIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQI 116
Query: 319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG-YTRVLISYVLGT 377
           ASG+ Y+      + +H D++  N+L+ +++   ++D GLA  I D  YT    +     
Sbjct: 117 ASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--P 171
Query: 378 MAYIAPEYFQQPELSEKCDIFSFGMLLISL-VRGVPSFVFHQNGEEICSPEWLRKVMNSK 436
           + + APE       + K D++SFG+LL  L  +G   +    N          R+V++  
Sbjct: 172 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----------REVLDQV 221
Query: 437 NPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRL 483
                   R+P      + LH L     C   +PEERP  +Y++  L
Sbjct: 222 ERGY----RMPCPPECPESLHDLMCQ--CWRKEPEERPTFEYLQAFL 262

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 89/212 (41%), Gaps = 31/212 (14%)
Query: 200 IGSGGCGEVYKAEL--PGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           IGSG  GEV    L  PG     +AIK +               +   + + R   SE  
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKAL--------------KAGYTERQRRDFLSEAS 102
Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL- 316
              Q  H NI+ L   + R    ++V E+M+NGSL   L        +  +     + + 
Sbjct: 103 IMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRT-----HDGQFTIMQLVGML 157
Query: 317 -GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI---PDGYTRVLIS 372
            GV +G+ YL        +H D+  RNVL++ ++   +SD GL+  +   PD        
Sbjct: 158 RGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGG 214
Query: 373 YVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
            +   + + APE       S   D++SFG+++
Sbjct: 215 KI--PIRWTAPEAIAFRTFSSASDVWSFGVVM 244

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 70/286 (24%), Positives = 118/286 (41%), Gaps = 42/286 (14%)
Query: 199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT 258
           K+G G  GEV+     G+    I   K    +P +  +  +   KLR  KL Q+ + +++
Sbjct: 15  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 73
Query: 259 ASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV 318
              I                   +V E+M  GSL D L   +   + L  P    +A  +
Sbjct: 74  EEPIX------------------IVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQI 113
Query: 319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTM 378
           ASG+ Y+      + +H D++  N+L+ +++   ++D GLA  I D             +
Sbjct: 114 ASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKF-PI 169
Query: 379 AYIAPEYFQQPELSEKCDIFSFGMLLISL-VRGVPSFVFHQNGEEICSPEWLRKVMNSKN 437
            + APE       + K D++SFG+LL  L  +G   +    N          R+V++   
Sbjct: 170 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----------REVLDQVE 219
Query: 438 PSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRL 483
                  R+P      + LH L     C   +PEERP  +Y++  L
Sbjct: 220 RGY----RMPCPPECPESLHDLMCQ--CWRKEPEERPTFEYLQAFL 259

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 125/287 (43%), Gaps = 44/287 (15%)
Query: 199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT 258
           K+G G  GEV+     G+    +AIK  +    +S    ++E   ++             
Sbjct: 191 KLGQGCFGEVWMGTWNGTT--RVAIK-TLKPGTMSPEAFLQEAQVMK------------- 234
Query: 259 ASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV 318
             ++RH  ++ L A +V  +   +V E+M  GSL D L   +   + L  P    +A  +
Sbjct: 235 --KLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQI 289
Query: 319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG-YTRVLISYVLGT 377
           ASG+ Y+      + +H D++  N+L+ +++   ++D GLA  I D  YT    +     
Sbjct: 290 ASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--P 344
Query: 378 MAYIAPEYFQQPELSEKCDIFSFGMLLISL-VRGVPSFVFHQNGEEICSPEWLRKVMNSK 436
           + + APE       + K D++SFG+LL  L  +G   +    N          R+V++  
Sbjct: 345 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----------REVLDQV 394
Query: 437 NPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRL 483
                   R+P      + LH L     C   +PEERP  +Y++  L
Sbjct: 395 ERGY----RMPCPPECPESLHDLMCQ--CWRKEPEERPTFEYLQAFL 435

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 82/315 (26%), Positives = 128/315 (40%), Gaps = 57/315 (18%)
Query: 166 GGSRDRGPTIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGEV---YKAELPGSNGKMIA 222
           G    R    +S  I       LK+   + +L+ IGSG  G V   Y A L     + +A
Sbjct: 2   GSRSKRDNNFYSVEIGDSTFTVLKR---YQNLKPIGSGAQGIVCAAYDAILE----RNVA 54
Query: 223 IKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHL- 281
           IKK+    P               +  ++   E++    + H+NI+ LL ++  P   L 
Sbjct: 55  IKKL--SRPFQ-----------NQTHAKRAYRELVLMKCVNHKNIIGLL-NVFTPQKSLE 100
Query: 282 ------LVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIH 335
                 +V E M     Q I       + ELD      +   +  G+++LH   SA IIH
Sbjct: 101 EFQDVYIVMELMDANLCQVI-------QMELDHERMSYLLYQMLCGIKHLH---SAGIIH 150
Query: 336 GDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKC 395
            D+KP N+++  D    I D GLA     G + ++  YV+ T  Y APE        E  
Sbjct: 151 RDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVV-TRYYRAPEVILGMGYKENV 207
Query: 396 DIFSFGMLLISLVRGVPSF-----------VFHQNGEEICSPEWLRKVMNSKNPSRAIDP 444
           DI+S G ++  +++G   F           V  Q G     PE+++K+  +        P
Sbjct: 208 DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP--CPEFMKKLQPTVRTYVENRP 265
Query: 445 RLPGNGYEKKMLHVL 459
           +  G  +EK    VL
Sbjct: 266 KYAGYSFEKLFPDVL 280

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 125/287 (43%), Gaps = 44/287 (15%)
Query: 199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT 258
           K+G G  GEV+     G+    +AIK  +    +S    ++E   ++             
Sbjct: 191 KLGQGCFGEVWMGTWNGTT--RVAIK-TLKPGTMSPEAFLQEAQVMK------------- 234
Query: 259 ASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV 318
             ++RH  ++ L A +V  +   +V E+M  GSL D L   +   + L  P    +A  +
Sbjct: 235 --KLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQI 289
Query: 319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG-YTRVLISYVLGT 377
           ASG+ Y+      + +H D++  N+L+ +++   ++D GLA  I D  YT    +     
Sbjct: 290 ASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--P 344
Query: 378 MAYIAPEYFQQPELSEKCDIFSFGMLLISL-VRGVPSFVFHQNGEEICSPEWLRKVMNSK 436
           + + APE       + K D++SFG+LL  L  +G   +    N          R+V++  
Sbjct: 345 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----------REVLDQV 394
Query: 437 NPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRL 483
                   R+P      + LH L     C   +PEERP  +Y++  L
Sbjct: 395 ERGY----RMPCPPECPESLHDLMCQ--CWRKEPEERPTFEYLQAFL 435

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 82/310 (26%), Positives = 128/310 (41%), Gaps = 57/310 (18%)
Query: 171 RGPTIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGEV---YKAELPGSNGKMIAIKKVI 227
           R    +S  I       LK+   + +L+ IGSG  G V   Y A L     + +AIKK+ 
Sbjct: 6   RDNNFYSVEIGDSTFTVLKR---YQNLKPIGSGAQGIVCAAYDAILE----RNVAIKKL- 57
Query: 228 VYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHL------ 281
              P               +  ++   E++    + H+NI+ LL ++  P   L      
Sbjct: 58  -SRPFQ-----------NQTHAKRAYRELVLMKCVNHKNIIGLL-NVFTPQKSLEEFQDV 104
Query: 282 -LVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKP 340
            +V E M     Q I       + ELD      +   +  G+++LH   SA IIH D+KP
Sbjct: 105 YIVMELMDANLCQVI-------QMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKP 154
Query: 341 RNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSF 400
            N+++  D    I D GLA     G + ++  YV+ T  Y APE        E  DI+S 
Sbjct: 155 SNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSV 211
Query: 401 GMLLISLVRGVPSF-----------VFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGN 449
           G ++  +++G   F           V  Q G    SPE+++K+  +        P+  G 
Sbjct: 212 GCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP--SPEFMKKLQPTVRTYVENRPKYAGY 269
Query: 450 GYEKKMLHVL 459
            +EK    VL
Sbjct: 270 SFEKLFPDVL 279

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 81/310 (26%), Positives = 131/310 (42%), Gaps = 57/310 (18%)
Query: 171 RGPTIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGEV---YKAELPGSNGKMIAIKKVI 227
           R    +S  I       LK+   + +L+ IGSG  G V   Y A L     + +AIKK+ 
Sbjct: 6   RDNNFYSVEIGDSTFTVLKR---YQNLKPIGSGAQGIVCAAYDAILE----RNVAIKKL- 57
Query: 228 VYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHL------ 281
              P               +  ++   E++    + H+NI+ LL ++  P   L      
Sbjct: 58  -SRPFQ-----------NQTHAKRAYRELVLMKVVNHKNIIGLL-NVFTPQKSLEEFQDV 104
Query: 282 -LVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKP 340
            +V E M + +L  ++      + ELD      +   +  G+++LH   SA IIH D+KP
Sbjct: 105 YIVMELM-DANLSQVI------QMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKP 154
Query: 341 RNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSF 400
            N+++  D    I D GLA     G + ++  YV+ T  Y APE        E  DI+S 
Sbjct: 155 SNIVVKSDATLKILDFGLARTA--GTSFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSV 211
Query: 401 GMLLISLVRGVPSF-----------VFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGN 449
           G ++  +++G   F           V  Q G    SPE+++K+  +        P+  G 
Sbjct: 212 GCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP--SPEFMKKLQPTVRTYVENRPKYAGY 269
Query: 450 GYEKKMLHVL 459
            +EK    VL
Sbjct: 270 SFEKLFPDVL 279

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 98/216 (45%), Gaps = 23/216 (10%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           F  +EKIG G  G VYKA      G+++A+KK+          L  E   +  + +R   
Sbjct: 6   FQKVEKIGEGTYGVVYKAR-NKLTGEVVALKKI---------RLDTETEGVPSTAIR--- 52
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
            EI    ++ H NI+ LL  +   +   LV+EF+ +  L+  +D  +     +  P    
Sbjct: 53  -EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKKFMD--ASALTGIPLPLIKS 108
Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISY 373
               +  GL + H   S  ++H D+KP N+L+N +    ++D GLA A   G       +
Sbjct: 109 YLFQLLQGLAFCH---SHRVLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXH 163
Query: 374 VLGTMAYIAPEYFQQPE-LSEKCDIFSFGMLLISLV 408
            + T+ Y APE     +  S   DI+S G +   +V
Sbjct: 164 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 199

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 119/287 (41%), Gaps = 44/287 (15%)
Query: 199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT 258
           K+G G  GEV+     G+    I   K    +P +  +  +   KLR  KL Q+ + +++
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 83
Query: 259 ASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV 318
              I                   +V E+M  G L D L       + L  P    +A  +
Sbjct: 84  EEPI------------------YIVMEYMSKGCLLDFLK--GEMGKYLRLPQLVDMAAQI 123
Query: 319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG-YTRVLISYVLGT 377
           ASG+ Y+      + +H D++  N+L+ +++   ++D GLA  I D  YT    +     
Sbjct: 124 ASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--P 178
Query: 378 MAYIAPEYFQQPELSEKCDIFSFGMLLISL-VRGVPSFVFHQNGEEICSPEWLRKVMNSK 436
           + + APE       + K D++SFG+LL  L  +G   +    N          R+V++  
Sbjct: 179 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----------REVLDQV 228
Query: 437 NPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRL 483
                   R+P      + LH L     C   DPEERP  +Y++  L
Sbjct: 229 ERGY----RMPCPPECPESLHDLMCQ--CWRKDPEERPTFEYLQAFL 269

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 98/216 (45%), Gaps = 23/216 (10%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           F  +EKIG G  G VYKA      G+++A+KK+          L  E   +  + +R   
Sbjct: 8   FQKVEKIGEGTYGVVYKAR-NKLTGEVVALKKI---------RLDTETEGVPSTAIR--- 54
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
            EI    ++ H NI+ LL  +   +   LV+EF+ +  L+  +D  +     +  P    
Sbjct: 55  -EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKKFMD--ASALTGIPLPLIKS 110
Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISY 373
               +  GL + H   S  ++H D+KP N+L+N +    ++D GLA A   G       +
Sbjct: 111 YLFQLLQGLAFCH---SHRVLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXH 165
Query: 374 VLGTMAYIAPEYFQQPE-LSEKCDIFSFGMLLISLV 408
            + T+ Y APE     +  S   DI+S G +   +V
Sbjct: 166 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 201

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 115/286 (40%), Gaps = 56/286 (19%)
Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDS---KLRDSKLRQIR 253
           +++IGSG  G V+       N   +AIK  I    +S  + IEE     KL   KL Q+ 
Sbjct: 13  VQEIGSGQFGLVHLGYWL--NKDKVAIK-TIREGAMSEEDFIEEAEVMMKLSHPKLVQLY 69
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
              +  +                P C  LV EFM++G L D L    RG    +  +   
Sbjct: 70  GVCLEQA----------------PIC--LVTEFMEHGCLSDYLR-TQRGLFAAE--TLLG 108
Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA-MAIPDGYTRVLIS 372
           + L V  G+ YL     A +IH D+  RN L+ ++    +SD G+    + D YT     
Sbjct: 109 MCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS---- 161
Query: 373 YVLGT---MAYIAPEYFQQPELSEKCDIFSFGMLLISLV-RGVPSFVFHQNGEEICSPEW 428
              GT   + + +PE F     S K D++SFG+L+  +   G   +    N E       
Sbjct: 162 -STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE------- 213
Query: 429 LRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERP 474
              V +     R   PRL          HV +I   C    PE+RP
Sbjct: 214 --VVEDISTGFRLYKPRLAST-------HVYQIMNHCWRERPEDRP 250

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 87/210 (41%), Gaps = 27/210 (12%)
Query: 200 IGSGGCGEVYKAEL--PGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           IGSG  GEV    L  PG     +AIK +               +   + + R   SE  
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKAL--------------KAGYTERQRRDFLSEAS 102
Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALG 317
              Q  H NI+ L   + R    ++V E+M+NGSL   L         +      R   G
Sbjct: 103 IMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLR---G 159
Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI---PDGYTRVLISYV 374
           V +G+ YL        +H D+  RNVL++ ++   +SD GL+  +   PD         +
Sbjct: 160 VGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKI 216
Query: 375 LGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
              + + APE       S   D++SFG+++
Sbjct: 217 --PIRWTAPEAIAFRTFSSASDVWSFGVVM 244

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 95/229 (41%), Gaps = 24/229 (10%)
Query: 191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
           ED +   E++GSG    V K    G+  +  A  K I    +S++         R     
Sbjct: 11  EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAA--KFIKKRRLSSSR--------RGVSRE 60
Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPS 310
           +I  E+    +IRH NI+ L          +L+ E +  G L D L +    +  L    
Sbjct: 61  EIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAE----KESLTEDE 116
Query: 311 RHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLND----DMEACISDLGLAMAIPDGY 366
             +    +  G+ YLH   S  I H D+KP N++L D    +    + D G+A  I  G 
Sbjct: 117 ATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN 173
Query: 367 TRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFV 415
                  + GT  ++APE      L  + D++S G++   L+ G   F+
Sbjct: 174 E---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 219

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 94/206 (45%), Gaps = 23/206 (11%)
Query: 199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT 258
           K+G G  GEVY           + + K   Y+   A + ++ED+     ++ +   E   
Sbjct: 39  KLGGGQYGEVY-----------VGVWKK--YSLTVAVKTLKEDTM----EVEEFLKEAAV 81
Query: 259 ASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV 318
             +I+H N++ LL          +V E+M  G+L D L + +  R E+       +A  +
Sbjct: 82  MKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECN--REEVTAVVLLYMATQI 139
Query: 319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTM 378
           +S +EYL      + IH D+  RN L+ ++    ++D GL+  +  G T    +     +
Sbjct: 140 SSAMEYL---EKKNFIHRDLAARNCLVGENHVVKVADFGLSRLM-TGDTYTAHAGAKFPI 195
Query: 379 AYIAPEYFQQPELSEKCDIFSFGMLL 404
            + APE       S K D+++FG+LL
Sbjct: 196 KWTAPESLAYNTFSIKSDVWAFGVLL 221

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 98/216 (45%), Gaps = 23/216 (10%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           F  +EKIG G  G VYKA      G+++A+ K+          L  E   +  + +R   
Sbjct: 5   FQKVEKIGEGTYGVVYKAR-NKLTGEVVALXKI---------RLDTETEGVPSTAIR--- 51
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
            EI    ++ H NI+ LL  +   +   LV+EF+    L+  +D  +     +  P    
Sbjct: 52  -EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMD--ASALTGIPLPLIKS 107
Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISY 373
               +  GL + H   S  ++H D+KP+N+L+N +    ++D GLA A   G      ++
Sbjct: 108 YLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTH 162
Query: 374 VLGTMAYIAPEYFQQPE-LSEKCDIFSFGMLLISLV 408
            + T+ Y APE     +  S   DI+S G +   +V
Sbjct: 163 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 98/216 (45%), Gaps = 23/216 (10%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           F  +EKIG G  G VYKA      G+++A+ K+          L  E   +  + +R   
Sbjct: 4   FQKVEKIGEGTYGVVYKAR-NKLTGEVVALXKI---------RLDTETEGVPSTAIR--- 50
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
            EI    ++ H NI+ LL  +   +   LV+EF+    L+  +D  +     +  P    
Sbjct: 51  -EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMD--ASALTGIPLPLIKS 106
Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISY 373
               +  GL + H   S  ++H D+KP+N+L+N +    ++D GLA A   G      ++
Sbjct: 107 YLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTH 161
Query: 374 VLGTMAYIAPEYFQQPE-LSEKCDIFSFGMLLISLV 408
            + T+ Y APE     +  S   DI+S G +   +V
Sbjct: 162 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 197

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 81/310 (26%), Positives = 131/310 (42%), Gaps = 57/310 (18%)
Query: 171 RGPTIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGEV---YKAELPGSNGKMIAIKKVI 227
           R    +S  I       LK+   + +L+ IGSG  G V   Y A L     + +AIKK+ 
Sbjct: 6   RDNNFYSVEIGDSTFTVLKR---YQNLKPIGSGAQGIVCAAYDAILE----RNVAIKKL- 57
Query: 228 VYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHL------ 281
              P               +  ++   E++    + H+NI+ LL ++  P   L      
Sbjct: 58  -SRPFQ-----------NQTHAKRAYRELVLMKVVNHKNIIGLL-NVFTPQKSLEEFQDV 104
Query: 282 -LVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKP 340
            +V E M + +L  ++      + ELD      +   +  G+++LH   SA IIH D+KP
Sbjct: 105 YIVMELM-DANLSQVI------QMELDHERMSYLLYQMLVGIKHLH---SAGIIHRDLKP 154
Query: 341 RNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSF 400
            N+++  D    I D GLA     G + ++  YV+ T  Y APE        E  DI+S 
Sbjct: 155 SNIVVKSDATLKILDFGLARTA--GTSFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSV 211
Query: 401 GMLLISLVRGVPSF-----------VFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGN 449
           G ++  +++G   F           V  Q G    SPE+++K+  +        P+  G 
Sbjct: 212 GCIMGEMIKGGVLFPGTDHIDQWNKVIEQLG--TPSPEFMKKLQPTVRTYVENRPKYAGY 269
Query: 450 GYEKKMLHVL 459
            +EK    VL
Sbjct: 270 SFEKLFPDVL 279

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/246 (24%), Positives = 110/246 (44%), Gaps = 27/246 (10%)
Query: 234 AAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQ 293
           AA++I    KL     +++  E      ++H NI+ L   +     H LV++ +  G L 
Sbjct: 33  AAKIIN-TKKLSARDHQKLEREARICRLLKHSNIVRLHDSISEEGFHYLVFDLVTGGELF 91
Query: 294 DILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC- 352
           +  D V+R     ++ S    +  +   LE +   H   ++H D+KP N+LL    +   
Sbjct: 92  E--DIVAR-----EYYSEADASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKCKGAA 144
Query: 353 --ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRG 410
             ++D GLA+ +  G  +    +  GT  Y++PE  ++    +  DI++ G++L  L+ G
Sbjct: 145 VKLADFGLAIEV-QGDQQAWFGFA-GTPGYLSPEVLRKEAYGKPVDIWACGVILYILLVG 202
Query: 411 VPSF-------VFHQ---NGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLH-VL 459
            P F       ++ Q      +  SPEW      +KN    I+  L  N  ++   H  L
Sbjct: 203 YPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKN---LINQMLTINPAKRITAHEAL 259
Query: 460 KIAYIC 465
           K  ++C
Sbjct: 260 KHPWVC 265

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 119/287 (41%), Gaps = 44/287 (15%)
Query: 199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT 258
           K+G G  GEV+     G+    I   K    +P +  +  +   KLR  KL Q+ + +++
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 83
Query: 259 ASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV 318
              I                   +V E+M  G L D L       + L  P    +A  +
Sbjct: 84  EEPI------------------YIVTEYMSKGCLLDFLK--GEMGKYLRLPQLVDMAAQI 123
Query: 319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG-YTRVLISYVLGT 377
           ASG+ Y+      + +H D++  N+L+ +++   ++D GLA  I D  YT    +     
Sbjct: 124 ASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--P 178
Query: 378 MAYIAPEYFQQPELSEKCDIFSFGMLLISL-VRGVPSFVFHQNGEEICSPEWLRKVMNSK 436
           + + APE       + K D++SFG+LL  L  +G   +    N          R+V++  
Sbjct: 179 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----------REVLDQV 228
Query: 437 NPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRL 483
                   R+P      + LH L     C   DPEERP  +Y++  L
Sbjct: 229 ERGY----RMPCPPECPESLHDLMCQ--CWRKDPEERPTFEYLQAFL 269

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 81/310 (26%), Positives = 131/310 (42%), Gaps = 57/310 (18%)
Query: 171 RGPTIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGEV---YKAELPGSNGKMIAIKKVI 227
           R    +S  I       LK+   + +L+ IGSG  G V   Y A L     + +AIKK+ 
Sbjct: 6   RDNNFYSVEIGDSTFTVLKR---YQNLKPIGSGAQGIVCAAYDAILE----RNVAIKKL- 57
Query: 228 VYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHL------ 281
              P               +  ++   E++    + H+NI+ LL ++  P   L      
Sbjct: 58  -SRPFQ-----------NQTHAKRAYRELVLMKCVNHKNIIGLL-NVFTPQKSLEEFQDV 104
Query: 282 -LVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKP 340
            +V E M + +L  ++      + ELD      +   +  G+++LH   SA IIH D+KP
Sbjct: 105 YIVMELM-DANLSQVI------QMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKP 154
Query: 341 RNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSF 400
            N+++  D    I D GLA     G + ++  YV+ T  Y APE        E  DI+S 
Sbjct: 155 SNIVVKSDATLKILDFGLARTA--GTSFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSV 211
Query: 401 GMLLISLVRGVPSF-----------VFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGN 449
           G ++  +++G   F           V  Q G    SPE+++K+  +        P+  G 
Sbjct: 212 GCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP--SPEFMKKLQPTVRTYVENRPKYAGY 269
Query: 450 GYEKKMLHVL 459
            +EK    VL
Sbjct: 270 SFEKLFPDVL 279

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 95/229 (41%), Gaps = 24/229 (10%)
Query: 191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
           ED +   E++GSG    V K    G+  +  A  K I    +S++         R     
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAA--KFIKKRRLSSSR--------RGVSRE 53
Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPS 310
           +I  E+    +IRH NI+ L          +L+ E +  G L D L +    +  L    
Sbjct: 54  EIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAE----KESLTEDE 109
Query: 311 RHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLND----DMEACISDLGLAMAIPDGY 366
             +    +  G+ YLH   S  I H D+KP N++L D    +    + D G+A  I  G 
Sbjct: 110 ATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN 166
Query: 367 TRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFV 415
                  + GT  ++APE      L  + D++S G++   L+ G   F+
Sbjct: 167 E---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 212

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 81/310 (26%), Positives = 131/310 (42%), Gaps = 57/310 (18%)
Query: 171 RGPTIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGEV---YKAELPGSNGKMIAIKKVI 227
           R    +S  I       LK+   + +L+ IGSG  G V   Y A L     + +AIKK+ 
Sbjct: 6   RDNNFYSVEIGDSTFTVLKR---YQNLKPIGSGAQGIVCAAYDAILE----RNVAIKKL- 57
Query: 228 VYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHL------ 281
              P               +  ++   E++    + H+NI+ LL ++  P   L      
Sbjct: 58  -SRPFQ-----------NQTHAKRAYRELVLMKCVNHKNIIGLL-NVFTPQKSLEEFQDV 104
Query: 282 -LVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKP 340
            +V E M + +L  ++      + ELD      +   +  G+++LH   SA IIH D+KP
Sbjct: 105 YIVMELM-DANLSQVI------QMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKP 154
Query: 341 RNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSF 400
            N+++  D    I D GLA     G + ++  YV+ T  Y APE        E  DI+S 
Sbjct: 155 SNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSV 211
Query: 401 GMLLISLVRGVPSF-----------VFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGN 449
           G ++  +++G   F           V  Q G    SPE+++K+  +        P+  G 
Sbjct: 212 GCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP--SPEFMKKLQPTVRTYVENRPKYAGY 269
Query: 450 GYEKKMLHVL 459
            +EK    VL
Sbjct: 270 SFEKLFPDVL 279

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 100/214 (46%), Gaps = 28/214 (13%)
Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           ++K+G+G  GEV+      +N   +A+K  +    +S    +EE + ++           
Sbjct: 17  VKKLGAGQFGEVWMGYY--NNSTKVAVK-TLKPGTMSVQAFLEEANLMK----------- 62
Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL 316
                ++H  ++ L A + + +   ++ EFM  GSL D L     G+  L  P     + 
Sbjct: 63  ----TLQHDKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLL--PKLIDFSA 116
Query: 317 GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG-YT-RVLISYV 374
            +A G+ Y+      + IH D++  NVL+++ +   I+D GLA  I D  YT R    + 
Sbjct: 117 QIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF- 172
Query: 375 LGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLV 408
              + + APE       + K +++SFG+LL  +V
Sbjct: 173 --PIKWTAPEAINFGCFTIKSNVWSFGILLYEIV 204

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 97/196 (49%), Gaps = 24/196 (12%)
Query: 234 AAELIE-EDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSL 292
           A ++IE +   +R    R++  E++   Q  HRN+L L+      D   LV+E M+ GS 
Sbjct: 42  AVKIIEKQPGHIRSRVFREV--EMLYQCQ-GHRNVLELIEFFEEEDRFYLVFEKMRGGS- 97
Query: 293 QDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN-----D 347
             IL  + + RR  +      +   VAS L++LH   +  I H D+KP N+L        
Sbjct: 98  --ILSHIHK-RRHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVS 151
Query: 348 DMEACISDLGLAMAIPDGYTRVLISYVL---GTMAYIAPE----YFQQPELSEK-CDIFS 399
            ++ C  DLG  + +    + +    +L   G+  Y+APE    + ++  + +K CD++S
Sbjct: 152 PVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWS 211
Query: 400 FGMLLISLVRGVPSFV 415
            G++L  L+ G P FV
Sbjct: 212 LGVILYILLSGYPPFV 227

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 125/287 (43%), Gaps = 44/287 (15%)
Query: 199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT 258
           K+G G  GEV+     G+    +AIK  +    +S    ++E   ++             
Sbjct: 191 KLGQGCFGEVWMGTWNGTT--RVAIK-TLKPGTMSPEAFLQEAQVMK------------- 234
Query: 259 ASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV 318
             ++RH  ++ L A +V  +   +V E+M  GSL D L   +   + L  P    +A  +
Sbjct: 235 --KLRHEKLVQLYA-VVSEEPIYIVGEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQI 289
Query: 319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG-YTRVLISYVLGT 377
           ASG+ Y+      + +H D++  N+L+ +++   ++D GLA  I D  YT    +     
Sbjct: 290 ASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--P 344
Query: 378 MAYIAPEYFQQPELSEKCDIFSFGMLLISL-VRGVPSFVFHQNGEEICSPEWLRKVMNSK 436
           + + APE       + K D++SFG+LL  L  +G   +    N          R+V++  
Sbjct: 345 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----------REVLDQV 394
Query: 437 NPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRL 483
                   R+P      + LH L     C   +PEERP  +Y++  L
Sbjct: 395 ERGY----RMPCPPECPESLHDLMCQ--CWRKEPEERPTFEYLQAFL 435

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 104/223 (46%), Gaps = 25/223 (11%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           +  LEKIG G  G V+KA+   ++ +++A+K+V          L ++D  +  S LR   
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETH-EIVALKRV---------RLDDDDEGVPSSALR--- 50
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
            EI    +++H+NI+ L   +       LV+EF      QD+         +LD      
Sbjct: 51  -EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD----QDLKKYFDSCNGDLDPEIVKS 105
Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISY 373
               +  GL + H   S +++H D+KP+N+L+N + E  +++ GLA A   G      S 
Sbjct: 106 FLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAF--GIPVRCYSA 160
Query: 374 VLGTMAYIAPEYFQQPEL-SEKCDIFSFGMLLISLVR-GVPSF 414
            + T+ Y  P+     +L S   D++S G +   L   G P F
Sbjct: 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 46/129 (35%), Positives = 65/129 (50%), Gaps = 11/129 (8%)
Query: 282 LVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPR 341
           LV E++  GSL+D L   S G  +L        A  +  G+ YLH  H    IH ++  R
Sbjct: 95  LVMEYVPLGSLRDYLPRHSIGLAQLLL-----FAQQICEGMAYLHAQH---YIHRNLAAR 146
Query: 342 NVLLNDDMEACISDLGLAMAIPDG--YTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFS 399
           NVLL++D    I D GLA A+P+G  Y RV          Y APE  ++ +     D++S
Sbjct: 147 NVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APECLKEYKFYYASDVWS 205
Query: 400 FGMLLISLV 408
           FG+ L  L+
Sbjct: 206 FGVTLYELL 214

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 111/243 (45%), Gaps = 32/243 (13%)
Query: 180 IEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIE 239
           +EK+ L   + +  +  + +IG G  G+V+KA    + G+ +A+K+V V        L  
Sbjct: 1   MEKDGLC--RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPL-- 56
Query: 240 EDSKLRD-SKLRQIRSEIITASQIRHRNILPL-----LAHMVRPDCHLLVYEFMKNGSLQ 293
             S +R+ + LR + +         H N++ L     ++   R     LV+E + +  L 
Sbjct: 57  --STIREVAVLRHLET-------FEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLT 106
Query: 294 DILDDVSRGRRELDWPSR--HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA 351
             LD V     E   P+     +   +  GL++L   HS  ++H D+KP+N+L+    + 
Sbjct: 107 TYLDKVP----EPGVPTETIKDMMFQLLRGLDFL---HSHRVVHRDLKPQNILVTSSGQI 159
Query: 352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGV 411
            ++D GLA      +   L S V+ T+ Y APE   Q   +   D++S G +   + R  
Sbjct: 160 KLADFGLARIY--SFQMALTSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
Query: 412 PSF 414
           P F
Sbjct: 217 PLF 219

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 111/243 (45%), Gaps = 32/243 (13%)
Query: 180 IEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIE 239
           +EK+ L   + +  +  + +IG G  G+V+KA    + G+ +A+K+V V        L  
Sbjct: 1   MEKDGLC--RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPL-- 56
Query: 240 EDSKLRD-SKLRQIRSEIITASQIRHRNILPL-----LAHMVRPDCHLLVYEFMKNGSLQ 293
             S +R+ + LR + +         H N++ L     ++   R     LV+E + +  L 
Sbjct: 57  --STIREVAVLRHLET-------FEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLT 106
Query: 294 DILDDVSRGRRELDWPSR--HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA 351
             LD V     E   P+     +   +  GL++L   HS  ++H D+KP+N+L+    + 
Sbjct: 107 TYLDKVP----EPGVPTETIKDMMFQLLRGLDFL---HSHRVVHRDLKPQNILVTSSGQI 159
Query: 352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGV 411
            ++D GLA      +   L S V+ T+ Y APE   Q   +   D++S G +   + R  
Sbjct: 160 KLADFGLARIY--SFQMALTSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
Query: 412 PSF 414
           P F
Sbjct: 217 PLF 219

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 125/287 (43%), Gaps = 44/287 (15%)
Query: 199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT 258
           K+G G  GEV+     G+    +AIK  +    +S    ++E   ++             
Sbjct: 274 KLGQGCFGEVWMGTWNGTT--RVAIK-TLKPGTMSPEAFLQEAQVMK------------- 317
Query: 259 ASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV 318
             ++RH  ++ L A +V  +   +V E+M  GSL D L   +   + L  P    +A  +
Sbjct: 318 --KLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQI 372
Query: 319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG-YTRVLISYVLGT 377
           ASG+ Y+   +    +H D++  N+L+ +++   ++D GLA  I D  YT    +     
Sbjct: 373 ASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--P 427
Query: 378 MAYIAPEYFQQPELSEKCDIFSFGMLLISL-VRGVPSFVFHQNGEEICSPEWLRKVMNSK 436
           + + APE       + K D++SFG+LL  L  +G   +    N          R+V++  
Sbjct: 428 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----------REVLDQV 477
Query: 437 NPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRL 483
                   R+P      + LH L     C   +PEERP  +Y++  L
Sbjct: 478 ERGY----RMPCPPECPESLHDLMCQ--CWRKEPEERPTFEYLQAFL 518

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 71/287 (24%), Positives = 121/287 (42%), Gaps = 44/287 (15%)
Query: 199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT 258
           K+G G  GEV+     G+    I   K    +P +  +  +   KLR  KL Q+ + +++
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 80
Query: 259 ASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV 318
              I                   +V E+M  GSL D L   +   + L  P    ++  +
Sbjct: 81  EEPI------------------YIVTEYMNKGSLLDFLKGETG--KYLRLPQLVDMSAQI 120
Query: 319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG-YTRVLISYVLGT 377
           ASG+ Y+      + +H D++  N+L+ +++   ++D GLA  I D  YT    +     
Sbjct: 121 ASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--P 175
Query: 378 MAYIAPEYFQQPELSEKCDIFSFGMLLISL-VRGVPSFVFHQNGEEICSPEWLRKVMNSK 436
           + + APE       + K D++SFG+LL  L  +G   +    N          R+V++  
Sbjct: 176 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----------REVLDQV 225
Query: 437 NPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRL 483
                   R+P      + LH L     C   +PEERP  +Y++  L
Sbjct: 226 ERGY----RMPCPPECPESLHDLMCQ--CWRKEPEERPTFEYLQAFL 266

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 111/243 (45%), Gaps = 32/243 (13%)
Query: 180 IEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIE 239
           +EK+ L   + +  +  + +IG G  G+V+KA    + G+ +A+K+V V        L  
Sbjct: 1   MEKDGLC--RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPL-- 56
Query: 240 EDSKLRD-SKLRQIRSEIITASQIRHRNILPL-----LAHMVRPDCHLLVYEFMKNGSLQ 293
             S +R+ + LR + +         H N++ L     ++   R     LV+E + +  L 
Sbjct: 57  --STIREVAVLRHLET-------FEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLT 106
Query: 294 DILDDVSRGRRELDWPSR--HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA 351
             LD V     E   P+     +   +  GL++L   HS  ++H D+KP+N+L+    + 
Sbjct: 107 TYLDKVP----EPGVPTETIKDMMFQLLRGLDFL---HSHRVVHRDLKPQNILVTSSGQI 159
Query: 352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGV 411
            ++D GLA      +   L S V+ T+ Y APE   Q   +   D++S G +   + R  
Sbjct: 160 KLADFGLARIY--SFQMALTSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
Query: 412 PSF 414
           P F
Sbjct: 217 PLF 219

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 96/230 (41%), Gaps = 37/230 (16%)
Query: 193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQI 252
            +  L+ +GSG  G V  A + G  G  +AIKK+  Y P  + EL            ++ 
Sbjct: 26  VYRDLQPVGSGAYGAVCSA-VDGRTGAKVAIKKL--YRPFQS-ELFA----------KRA 71
Query: 253 RSEIITASQIRHRNILPLLAHMVRPDCHL-------LVYEFMKNGSLQDILDDVSRGRRE 305
             E+     +RH N++ LL  +  PD  L       LV  FM    L  ++     G   
Sbjct: 72  YRELRLLKHMRHENVIGLL-DVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGE-- 127
Query: 306 LDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG 365
                  RI   V   L+ L   H+A IIH D+KP N+ +N+D E  I D GLA      
Sbjct: 128 ------DRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE 181
Query: 366 YTRVLISYVLGTMAYIAPEY-FQQPELSEKCDIFSFGMLLISLVRGVPSF 414
               ++     T  Y APE        ++  DI+S G ++  ++ G   F
Sbjct: 182 MXGXVV-----TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF 226

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 102/221 (46%), Gaps = 23/221 (10%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           +  L+ +G G    VYKA    +N +++AIKK+           +   S+ +D   R   
Sbjct: 12  YEKLDFLGEGQFATVYKARDKNTN-QIVAIKKIK----------LGHRSEAKDGINRTAL 60
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
            EI    ++ H NI+ LL          LV++FM+   L+ I+ D S     +  PS  +
Sbjct: 61  REIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSL----VLTPSHIK 115
Query: 314 -IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLIS 372
              L    GLEYLH +    I+H D+KP N+LL+++    ++D GLA +   G       
Sbjct: 116 AYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSF--GSPNRAYX 170
Query: 373 YVLGTMAYIAPE-YFQQPELSEKCDIFSFGMLLISLVRGVP 412
           + + T  Y APE  F         D+++ G +L  L+  VP
Sbjct: 171 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVP 211

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 97/217 (44%), Gaps = 22/217 (10%)
Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           + +G+G  G+V +A   G  GK  A+ KV V    S A   E+++ + + K        I
Sbjct: 52  KTLGAGAFGKVVEATAFGL-GKEDAVLKVAVKMLKSTAHADEKEALMSELK--------I 102
Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALG 317
            +   +H NI+ LL         L++ E+   G   D+L+ + R  R L+      IA  
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYG---DLLNFLRRKSRVLETDPAFAIANS 159
Query: 318 VASGLEYLHMYH----------SASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
            AS  + LH             S + IH D+  RNVLL +   A I D GLA  I +   
Sbjct: 160 TASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 219
Query: 368 RVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
            ++       + ++APE       + + D++S+G+LL
Sbjct: 220 YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILL 256

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 46/129 (35%), Positives = 65/129 (50%), Gaps = 11/129 (8%)
Query: 282 LVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPR 341
           LV E++  GSL+D L   S G  +L        A  +  G+ YLH  H    IH ++  R
Sbjct: 95  LVMEYVPLGSLRDYLPRHSIGLAQLLL-----FAQQICEGMAYLHSQH---YIHRNLAAR 146
Query: 342 NVLLNDDMEACISDLGLAMAIPDG--YTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFS 399
           NVLL++D    I D GLA A+P+G  Y RV          Y APE  ++ +     D++S
Sbjct: 147 NVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APECLKEYKFYYASDVWS 205
Query: 400 FGMLLISLV 408
           FG+ L  L+
Sbjct: 206 FGVTLYELL 214

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 123/287 (42%), Gaps = 44/287 (15%)
Query: 199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT 258
           K+G G  GEV+     G+    +AIK  +    +S    ++E   ++             
Sbjct: 192 KLGQGCFGEVWMGTWNGTT--RVAIK-TLKPGNMSPEAFLQEAQVMK------------- 235
Query: 259 ASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV 318
             ++RH  ++ L A +V  +   +V E+M  GSL D L       + L  P    +A  +
Sbjct: 236 --KLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLK--GEMGKYLRLPQLVDMAAQI 290
Query: 319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG-YTRVLISYVLGT 377
           ASG+ Y+      + +H D++  N+L+ +++   ++D GL   I D  YT    +     
Sbjct: 291 ASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKF--P 345
Query: 378 MAYIAPEYFQQPELSEKCDIFSFGMLLISL-VRGVPSFVFHQNGEEICSPEWLRKVMNSK 436
           + + APE       + K D++SFG+LL  L  +G   +    N          R+V++  
Sbjct: 346 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----------REVLDQV 395
Query: 437 NPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRL 483
                   R+P      + LH L     C   DPEERP  +Y++  L
Sbjct: 396 ERGY----RMPCPPECPESLHDLMCQ--CWRKDPEERPTFEYLQAFL 436

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 59/250 (23%), Positives = 108/250 (43%), Gaps = 31/250 (12%)
Query: 215 GSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHM 274
           G     +  + V V A    A  I    KL     +++  E      ++H NI+ L   +
Sbjct: 31  GKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI 90
Query: 275 VRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASII 334
                H L+++ +  G L +  D V+R     ++ S    +  +   LE +   H   ++
Sbjct: 91  SEEGHHYLIFDLVTGGELFE--DIVAR-----EYYSEADASHCIQQILEAVLHCHQMGVV 143
Query: 335 HGDIKPRNVLLNDDMEAC---ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPEL 391
           H D+KP N+LL   ++     ++D GLA+ + +G  +    +  GT  Y++PE  ++   
Sbjct: 144 HRDLKPENLLLASKLKGAAVKLADFGLAIEV-EGEQQAWFGFA-GTPGYLSPEVLRKDPY 201
Query: 392 SEKCDIFSFGMLLISLVRGVPSF-------VFHQ---NGEEICSPEW---------LRKV 432
            +  D+++ G++L  L+ G P F       ++ Q      +  SPEW         L   
Sbjct: 202 GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINK 261
Query: 433 MNSKNPSRAI 442
           M + NPS+ I
Sbjct: 262 MLTINPSKRI 271

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 69/286 (24%), Positives = 118/286 (41%), Gaps = 42/286 (14%)
Query: 199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT 258
           K+G G  GEV+     G+    I   K    +P +  +  +   KLR  KL Q+ + +++
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 80
Query: 259 ASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV 318
              I                   +V E+M  GSL D L   +   + L  P    ++  +
Sbjct: 81  EEPI------------------YIVTEYMNKGSLLDFLKGETG--KYLRLPQLVDMSAQI 120
Query: 319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTM 378
           ASG+ Y+      + +H D++  N+L+ +++   ++D GLA  I D             +
Sbjct: 121 ASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKF-PI 176
Query: 379 AYIAPEYFQQPELSEKCDIFSFGMLLISL-VRGVPSFVFHQNGEEICSPEWLRKVMNSKN 437
            + APE       + K D++SFG+LL  L  +G   +    N          R+V++   
Sbjct: 177 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----------REVLDQVE 226
Query: 438 PSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRL 483
                  R+P      + LH L     C   +PEERP  +Y++  L
Sbjct: 227 RGY----RMPCPPECPESLHDLMCQ--CWRKEPEERPTFEYLQAFL 266

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 98/228 (42%), Gaps = 35/228 (15%)
Query: 187 FLKKED--CFASLEKIGSGGCGEVYKAEL--PGSNGKMIAIKKVIVYAPISAAELIEEDS 242
           F K+ D  C    + IG G  GEV    L  PG     +AIK +               +
Sbjct: 22  FAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTL--------------KA 67
Query: 243 KLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG 302
              D + R   SE     Q  H NI+ L   + +    +++ E+M+NGSL   L   + G
Sbjct: 68  GYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRK-NDG 126
Query: 303 RRELDWPSRHRIAL-----GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLG 357
           R  +       I L     G+ SG++YL      S +H D+  RN+L+N ++   +SD G
Sbjct: 127 RFTV-------IQLVGMLRGIGSGMKYLS---DMSAVHRDLAARNILVNSNLVCKVSDFG 176
Query: 358 LAMAIPDGYTRVLISYVLGT-MAYIAPEYFQQPELSEKCDIFSFGMLL 404
           ++  + D       +      + + APE     + +   D++S+G+++
Sbjct: 177 MSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVM 224

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 98/228 (42%), Gaps = 35/228 (15%)
Query: 187 FLKKED--CFASLEKIGSGGCGEVYKAEL--PGSNGKMIAIKKVIVYAPISAAELIEEDS 242
           F K+ D  C    + IG G  GEV    L  PG     +AIK +               +
Sbjct: 7   FAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTL--------------KA 52
Query: 243 KLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG 302
              D + R   SE     Q  H NI+ L   + +    +++ E+M+NGSL   L   + G
Sbjct: 53  GYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRK-NDG 111
Query: 303 RRELDWPSRHRIAL-----GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLG 357
           R  +       I L     G+ SG++YL      S +H D+  RN+L+N ++   +SD G
Sbjct: 112 RFTV-------IQLVGMLRGIGSGMKYLS---DMSYVHRDLAARNILVNSNLVCKVSDFG 161
Query: 358 LAMAIPDGYTRVLISYVLGT-MAYIAPEYFQQPELSEKCDIFSFGMLL 404
           ++  + D       +      + + APE     + +   D++S+G+++
Sbjct: 162 MSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVM 209

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/250 (23%), Positives = 109/250 (43%), Gaps = 31/250 (12%)
Query: 215 GSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHM 274
           G     +  + V V A    A +I    KL     +++  E      ++H NI+ L   +
Sbjct: 20  GKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI 79
Query: 275 VRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASII 334
                H L+++ +  G L +  D V+R     ++ S    +  +   LE +   H   ++
Sbjct: 80  SEEGHHYLIFDLVTGGELFE--DIVAR-----EYYSEADASHCIQQILEAVLHCHQMGVV 132
Query: 335 HGDIKPRNVLLNDDMEAC---ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPEL 391
           H ++KP N+LL   ++     ++D GLA+ + +G  +    +  GT  Y++PE  ++   
Sbjct: 133 HRNLKPENLLLASKLKGAAVKLADFGLAIEV-EGEQQAWFGFA-GTPGYLSPEVLRKDPY 190
Query: 392 SEKCDIFSFGMLLISLVRGVPSF-------VFHQ---NGEEICSPEW---------LRKV 432
            +  D+++ G++L  L+ G P F       ++ Q      +  SPEW         L   
Sbjct: 191 GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINK 250
Query: 433 MNSKNPSRAI 442
           M + NPS+ I
Sbjct: 251 MLTINPSKRI 260

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 73/290 (25%), Positives = 113/290 (38%), Gaps = 44/290 (15%)
Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           +  +G G  GEVY+ ++ G       ++  +   P   +E  E D  +          E 
Sbjct: 53  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM----------EA 102
Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRH---- 312
           +  S+  H+NI+  +   ++     ++ E M  G L+  L +    R     PS      
Sbjct: 103 LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRET---RPRPSQPSSLAMLD 159
Query: 313 --RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN---DDMEACISDLGLAMAI-PDGY 366
              +A  +A G +YL   H    IH DI  RN LL        A I D G+A  I   GY
Sbjct: 160 LLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGY 216
Query: 367 TRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICS 425
            R     +L  + ++ PE F +   + K D +SFG+LL  +   G   +    N E +  
Sbjct: 217 YRKGGCAML-PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL-- 273
Query: 426 PEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPN 475
            E++        P     P             V +I   C  H PE+RPN
Sbjct: 274 -EFVTSGGRMDPPKNCPGP-------------VYRIMTQCWQHQPEDRPN 309

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 59/250 (23%), Positives = 108/250 (43%), Gaps = 26/250 (10%)
Query: 194 FASLEKIGSGGCGEVYKA-ELPGSN-GKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ 251
           F  L+ +G+G  G+V+   ++ G + GK+ A+K +     +  A+  E            
Sbjct: 56  FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTE-----------H 104
Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHL-LVYEFMKNGSLQDILDDVSRGRRELDWPS 310
            R+E      IR    L  L +  + +  L L+ +++  G L   L    R        +
Sbjct: 105 TRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER-------FT 157
Query: 311 RHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVL 370
            H + + V   +  L   H   II+ DIK  N+LL+ +    ++D GL+       T   
Sbjct: 158 EHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERA 217
Query: 371 ISYVLGTMAYIAPEYFQQPELS--EKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEW 428
             +  GT+ Y+AP+  +  +    +  D +S G+L+  L+ G   F    +GE+    E 
Sbjct: 218 YDFC-GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTV--DGEKNSQAEI 274
Query: 429 LRKVMNSKNP 438
            R+++ S+ P
Sbjct: 275 SRRILKSEPP 284

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 114/292 (39%), Gaps = 48/292 (16%)
Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           +  +G G  GEVY+ ++ G       ++  +   P   +E  E D  +          E 
Sbjct: 76  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM----------EA 125
Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRH---- 312
           +  S+  H+NI+  +   ++     ++ E M  G L+  L +    R     PS      
Sbjct: 126 LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRET---RPRPSQPSSLAMLD 182
Query: 313 --RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN---DDMEACISDLGLAMAI-PDGY 366
              +A  +A G +YL   H    IH DI  RN LL        A I D G+A  I   GY
Sbjct: 183 LLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGY 239
Query: 367 TRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICS 425
            R     +L  + ++ PE F +   + K D +SFG+LL  +   G   +    N E    
Sbjct: 240 YRKGGCAML-PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---- 294
Query: 426 PEWLRKVMNSKNPSRAIDP--RLPGNGYEKKMLHVLKIAYICTLHDPEERPN 475
                 V+        +DP    PG  Y        +I   C  H PE+RPN
Sbjct: 295 ------VLEFVTSGGRMDPPKNCPGPVY--------RIMTQCWQHQPEDRPN 332

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 94/198 (47%), Gaps = 28/198 (14%)
Query: 234 AAELIE-EDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSL 292
           A ++IE +   +R    R++  E++   Q  HRN+L L+      D   LV+E M+ GS 
Sbjct: 42  AVKIIEKQPGHIRSRVFREV--EMLYQCQ-GHRNVLELIEFFEEEDRFYLVFEKMRGGS- 97
Query: 293 QDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLL---NDDM 349
             IL  + + RR  +      +   VAS L++LH   +  I H D+KP N+L    N   
Sbjct: 98  --ILSHIHK-RRHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVS 151
Query: 350 EACISDLGLAMAI-------PDGYTRVLISYVLGTMAYIAPE----YFQQPELSEK-CDI 397
              I D GL   I       P     +L     G+  Y+APE    + ++  + +K CD+
Sbjct: 152 PVKICDFGLGSGIKLNGDCSPISTPELLTP--CGSAEYMAPEVVEAFSEEASIYDKRCDL 209
Query: 398 FSFGMLLISLVRGVPSFV 415
           +S G++L  L+ G P FV
Sbjct: 210 WSLGVILYILLSGYPPFV 227

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 96/226 (42%), Gaps = 17/226 (7%)
Query: 191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
           ED +   E IG G    V +  +    G+  A+K V V    S+  L  ED         
Sbjct: 23  EDVYELCEVIGKGAFSVVRRC-INRETGQQFAVKIVDVAKFTSSPGLSTED--------- 72
Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQ-DILDDVSRGRRELDWP 309
            ++ E      ++H +I+ LL          +V+EFM    L  +I+     G    +  
Sbjct: 73  -LKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAV 131
Query: 310 SRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLG-LAMAIPDGYTR 368
           + H +       LE L   H  +IIH D+KP NVLL     +    LG   +AI  G + 
Sbjct: 132 ASHYMR----QILEALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESG 187
Query: 369 VLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
           ++    +GT  ++APE  ++    +  D++  G++L  L+ G   F
Sbjct: 188 LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPF 233

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 100/230 (43%), Gaps = 39/230 (16%)
Query: 187 FLKKED--CFASLEKIGSGGCGEVYKAEL--PGSNGKMIAIKKVIVYAPISAAELIEEDS 242
           F K+ D  C    + IG G  GEV    L  PG     +AIK +               +
Sbjct: 1   FAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTL--------------KA 46
Query: 243 KLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG 302
              D + R   SE     Q  H NI+ L   + +    +++ E+M+NGSL   L   + G
Sbjct: 47  GYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRK-NDG 105
Query: 303 RRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI 362
           R  +       +  G+ SG++YL      S +H D+  RN+L+N ++   +SD G++  +
Sbjct: 106 RFTV--IQLVGMLRGIGSGMKYLS---DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVL 160
Query: 363 PD----GYT----RVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
            D     YT    ++ I +        APE     + +   D++S+G+++
Sbjct: 161 EDDPEAAYTTRGGKIPIRWT-------APEAIAYRKFTSASDVWSYGIVM 203

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 103/233 (44%), Gaps = 41/233 (17%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSK-LRQI 252
           + +L  IG G  G V  A     N   +AIKK+   +P       +    LR+ K L + 
Sbjct: 45  YTNLSYIGEGAYGMVCSA-YDNVNKVRVAIKKI---SPFEHQTYCQR--TLREIKILLRF 98
Query: 253 RSE-------IITASQIRHRNILPLLAHMVRPDCH-LLVYEFMKNGSLQDILDDVSRGRR 304
           R E       II A  I     + L+ H++  D + LL  + + N  +   L  + RG  
Sbjct: 99  RHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRG-- 156
Query: 305 ELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA-MAIP 363
                            L+Y+H   SA+++H D+KP N+LLN   +  I D GLA +A P
Sbjct: 157 -----------------LKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADP 196
Query: 364 D-GYTRVLISYVLGTMAYIAPEYFQQPE-LSEKCDIFSFGMLLISLVRGVPSF 414
           D  +T  L  YV  T  Y APE     +  ++  DI+S G +L  ++   P F
Sbjct: 197 DHDHTGFLTEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 248

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/248 (24%), Positives = 102/248 (41%), Gaps = 40/248 (16%)
Query: 166 GGSRDRGPTIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAE---LPGSNGKMIA 222
           G   DR PT F    E+  L FL         +++G G  G V       L  + G+++A
Sbjct: 2   GAFEDRDPTQF----EERHLKFL---------QQLGKGNFGSVEMCRYDPLQDNTGEVVA 48
Query: 223 IKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL--LAHMVRPDCH 280
           +KK+                   +  LR    EI     ++H NI+    + +       
Sbjct: 49  VKKL---------------QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 93
Query: 281 LLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKP 340
            L+ E++  GSL+D L    + +  +D     +    +  G+EYL    +   IH D+  
Sbjct: 94  KLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLAT 147
Query: 341 RNVLLNDDMEACISDLGLAMAIP-DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFS 399
           RN+L+ ++    I D GL   +P D     +       + + APE   + + S   D++S
Sbjct: 148 RNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWS 207
Query: 400 FGMLLISL 407
           FG++L  L
Sbjct: 208 FGVVLYEL 215

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/248 (24%), Positives = 102/248 (41%), Gaps = 40/248 (16%)
Query: 166 GGSRDRGPTIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAE---LPGSNGKMIA 222
           G   DR PT F    E+  L FL         +++G G  G V       L  + G+++A
Sbjct: 4   GAFEDRDPTQF----EERHLKFL---------QQLGKGNFGSVEMCRYDPLQDNTGEVVA 50
Query: 223 IKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL--LAHMVRPDCH 280
           +KK+                   +  LR    EI     ++H NI+    + +       
Sbjct: 51  VKKL---------------QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 95
Query: 281 LLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKP 340
            L+ E++  GSL+D L    + +  +D     +    +  G+EYL    +   IH D+  
Sbjct: 96  KLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLAT 149
Query: 341 RNVLLNDDMEACISDLGLAMAIP-DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFS 399
           RN+L+ ++    I D GL   +P D     +       + + APE   + + S   D++S
Sbjct: 150 RNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWS 209
Query: 400 FGMLLISL 407
           FG++L  L
Sbjct: 210 FGVVLYEL 217

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 94/229 (41%), Gaps = 24/229 (10%)
Query: 191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
           ED +   E++GSG    V K    G+ GK  A K +      S+          R     
Sbjct: 25  EDHYEMGEELGSGQFAIVRKCRQKGT-GKEYAAKFIKKRRLXSSR---------RGVSRE 74
Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPS 310
           +I  E+    +IRH NI+ L          +L+ E +  G L D L +    +  L    
Sbjct: 75  EIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAE----KESLTEDE 130
Query: 311 RHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLND----DMEACISDLGLAMAIPDGY 366
             +    +  G+ YLH   S  I H D+KP N++L D    +    + D G+A  I  G 
Sbjct: 131 ATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN 187
Query: 367 TRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFV 415
                  + GT  ++APE      L  + D++S G++   L+ G   F+
Sbjct: 188 E---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 233

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 97/226 (42%), Gaps = 37/226 (16%)
Query: 193 CFASLEKIGSGGCGEVY--KAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
           C      IG+G  GEV   + +LPG     +AIK + V                 + + R
Sbjct: 23  CITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKV--------------GYTEKQRR 68
Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPS 310
               E     Q  H NI+ L   + +    ++V E+M+NGSL   L    +   +     
Sbjct: 69  DFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFL---KKNDGQFTVIQ 125
Query: 311 RHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPD----GY 366
              +  G+++G++YL        +H D+  RN+L+N ++   +SD GL+  + D     Y
Sbjct: 126 LVGMLRGISAGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 182
Query: 367 T----RVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLV 408
           T    ++ I +        APE     + +   D++S+G+++  +V
Sbjct: 183 TTRGGKIPIRWT-------APEAIAFRKFTSASDVWSYGIVMWEVV 221

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 99/226 (43%), Gaps = 41/226 (18%)
Query: 194 FASLEKIGSGGCGEV---YKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
           + +L+ IGSG  G V   Y A L     + +AIKK+    P               +  +
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVL----DRNVAIKKL--SRPFQ-----------NQTHAK 68
Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHL-------LVYEFMKNGSLQDILDDVSRGR 303
           +   E++    + H+NI+ LL ++  P   L       LV E M     Q I       +
Sbjct: 69  RAYRELVLMKXVNHKNIISLL-NVFTPQKTLEEFQDVYLVMELMDANLXQVI-------Q 120
Query: 304 RELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
            ELD      +   +  G+++LH   SA IIH D+KP N+++  D    I D GLA    
Sbjct: 121 MELDHERMSYLLYQMLXGIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTA- 176
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR 409
            G + ++  YV+ T  Y APE        E  DI+S G ++  +VR
Sbjct: 177 -GTSFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR 220

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 95/217 (43%), Gaps = 41/217 (18%)
Query: 200 IGSGGCGEVY--KAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           +G+G  GEV   + +LP      +AIK + V                 + + R    E  
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKV--------------GYTEKQRRDFLGEAS 98
Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL- 316
              Q  H NI+ L   + +    ++V E+M+NGSL   L      + +  +     + + 
Sbjct: 99  IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR-----KHDAQFTVIQLVGML 153
Query: 317 -GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPD----GYT---- 367
            G+ASG++YL        +H D+  RN+L+N ++   +SD GLA  + D     YT    
Sbjct: 154 RGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGG 210
Query: 368 RVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
           ++ I +        +PE     + +   D++S+G++L
Sbjct: 211 KIPIRWT-------SPEAIAYRKFTSASDVWSYGIVL 240

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 98/216 (45%), Gaps = 23/216 (10%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           F  +EKIG G  G VYKA      G+++A+KK+          L  E   +  + +R   
Sbjct: 4   FQKVEKIGEGTYGVVYKAR-NKLTGEVVALKKI---------RLDTETEGVPSTAIR--- 50
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
            EI    ++ H NI+ LL  +   +   LV+E +    L+  +D  +     +  P    
Sbjct: 51  -EISLLKELNHPNIVKLLDVIHTENKLYLVFEHVHQ-DLKTFMD--ASALTGIPLPLIKS 106
Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISY 373
               +  GL + H   S  ++H D+KP+N+L+N +    ++D GLA A   G      ++
Sbjct: 107 YLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTH 161
Query: 374 VLGTMAYIAPEYFQQPE-LSEKCDIFSFGMLLISLV 408
            + T+ Y APE     +  S   DI+S G +   +V
Sbjct: 162 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 197

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 81/310 (26%), Positives = 127/310 (40%), Gaps = 57/310 (18%)
Query: 171 RGPTIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGEV---YKAELPGSNGKMIAIKKVI 227
           R    +S  I       LK+   + +L+ IGSG  G V   Y A L     + +AIKK+ 
Sbjct: 6   RDNNFYSVEIGDSTFTVLKR---YQNLKPIGSGAQGIVCAAYDAILE----RNVAIKKL- 57
Query: 228 VYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHL------ 281
              P               +  ++   E++    + H+NI+ LL ++  P   L      
Sbjct: 58  -SRPFQ-----------NQTHAKRAYRELVLMKCVNHKNIIGLL-NVFTPQKSLEEFQDV 104
Query: 282 -LVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKP 340
            +V E M     Q I       + ELD      +   +  G+++LH   SA IIH D+KP
Sbjct: 105 YIVMELMDANLCQVI-------QMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKP 154
Query: 341 RNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSF 400
            N+++  D    I D GLA     G + ++  YV+ T  Y APE        E  DI+S 
Sbjct: 155 SNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSV 211
Query: 401 GMLLISLVRGVPSF-----------VFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGN 449
           G ++  +++G   F           V  Q G     PE+++K+  +        P+  G 
Sbjct: 212 GCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP--CPEFMKKLQPTVRTYVENRPKYAGY 269
Query: 450 GYEKKMLHVL 459
            +EK    VL
Sbjct: 270 SFEKLFPDVL 279

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 80/310 (25%), Positives = 128/310 (41%), Gaps = 57/310 (18%)
Query: 171 RGPTIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGEV---YKAELPGSNGKMIAIKKVI 227
           R    +S  I       LK+   + +L+ IGSG  G V   Y A L     + +AIKK+ 
Sbjct: 8   RDNNFYSVEIGDSTFTVLKR---YQNLKPIGSGAQGIVCAAYDAILE----RNVAIKKL- 59
Query: 228 VYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHL------ 281
              P               +  ++   E++    + H+NI+ LL ++  P   L      
Sbjct: 60  -SRPFQ-----------NQTHAKRAYRELVLMKCVNHKNIIGLL-NVFTPQKSLEEFQDV 106
Query: 282 -LVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKP 340
            +V E M     Q I       + ELD      +   +  G+++LH   SA IIH D+KP
Sbjct: 107 YIVMELMDANLCQVI-------QMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKP 156
Query: 341 RNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSF 400
            N+++  D    I D GLA     G + +++ +V+ T  Y APE        E  DI+S 
Sbjct: 157 SNIVVKSDCTLKILDFGLARTA--GTSFMMVPFVV-TRYYRAPEVILGMGYKENVDIWSV 213
Query: 401 GMLLISLVRGVPSF-----------VFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGN 449
           G ++  +++G   F           V  Q G     PE+++K+  +        P+  G 
Sbjct: 214 GCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP--CPEFMKKLQPTVRTYVENRPKYAGY 271
Query: 450 GYEKKMLHVL 459
            +EK    VL
Sbjct: 272 SFEKLFPDVL 281

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 99/226 (43%), Gaps = 41/226 (18%)
Query: 194 FASLEKIGSGGCGEV---YKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
           + +L+ IGSG  G V   Y A L     + +AIKK+    P               +  +
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVL----DRNVAIKKL--SRPFQ-----------NQTHAK 68
Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHL-------LVYEFMKNGSLQDILDDVSRGR 303
           +   E++    + H+NI+ LL ++  P   L       LV E M     Q I       +
Sbjct: 69  RAYRELVLMKXVNHKNIISLL-NVFTPQKTLEEFQDVYLVMELMDANLXQVI-------Q 120
Query: 304 RELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
            ELD      +   +  G+++LH   SA IIH D+KP N+++  D    I D GLA    
Sbjct: 121 MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTA- 176
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR 409
            G + ++  YV+ T  Y APE        E  DI+S G ++  +VR
Sbjct: 177 -GTSFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR 220

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 97/222 (43%), Gaps = 36/222 (16%)
Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           E IG G  G+VY     G     +AI+ +           IE D+   + +L+  + E++
Sbjct: 39  ELIGKGRFGQVYHGRWHGE----VAIRLID----------IERDN---EDQLKAFKREVM 81
Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALG 317
              Q RH N++  +   + P    ++    K  +L  ++ D    +  LD     +IA  
Sbjct: 82  AYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQE 138
Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGL---AMAIPDGYTRVLISYV 374
           +  G+ YLH   +  I+H D+K +NV   D+ +  I+D GL   +  +  G     +   
Sbjct: 139 IVKGMGYLH---AKGILHKDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRIQ 194
Query: 375 LGTMAYIAPEYFQQ--PE-------LSEKCDIFSFGMLLISL 407
            G + ++APE  +Q  P+        S+  D+F+ G +   L
Sbjct: 195 NGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYEL 236

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 99/226 (43%), Gaps = 41/226 (18%)
Query: 194 FASLEKIGSGGCGEV---YKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
           + +L+ IGSG  G V   Y A L     + +AIKK+    P               +  +
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVL----DRNVAIKKL--SRPFQ-----------NQTHAK 68
Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHL-------LVYEFMKNGSLQDILDDVSRGR 303
           +   E++    + H+NI+ LL ++  P   L       LV E M     Q I       +
Sbjct: 69  RAYRELVLMKXVNHKNIISLL-NVFTPQKTLEEFQDVYLVMELMDANLCQVI-------Q 120
Query: 304 RELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
            ELD      +   +  G+++LH   SA IIH D+KP N+++  D    I D GLA    
Sbjct: 121 MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTA- 176
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR 409
            G + ++  YV+ T  Y APE        E  DI+S G ++  +VR
Sbjct: 177 -GTSFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR 220

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/267 (23%), Positives = 109/267 (40%), Gaps = 35/267 (13%)
Query: 188 LKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDS 247
           L  ED +  + ++G G  G+VYKA+       ++A  KVI             D+K  + 
Sbjct: 33  LNPEDFWEIIGELGDGAFGKVYKAQ--NKETSVLAAAKVI-------------DTK-SEE 76
Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELD 307
           +L     EI   +   H NI+ LL      +   ++ EF   G++  ++ ++ R   E  
Sbjct: 77  ELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTE-- 134
Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
                +I +     L+ L+  H   IIH D+K  N+L   D +  ++D G++        
Sbjct: 135 ----SQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQ 190
Query: 368 RVLISYVLGTMAYIAPEYF-----QQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEE 422
           R      +GT  ++APE       +      K D++S G+ LI +    P         E
Sbjct: 191 RR--DXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPH------HE 242
Query: 423 ICSPEWLRKVMNSKNPSRAIDPRLPGN 449
           +     L K+  S+ P+ A   R   N
Sbjct: 243 LNPMRVLLKIAKSEPPTLAQPSRWSSN 269

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/267 (23%), Positives = 109/267 (40%), Gaps = 35/267 (13%)
Query: 188 LKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDS 247
           L  ED +  + ++G G  G+VYKA+       ++A  KVI             D+K  + 
Sbjct: 33  LNPEDFWEIIGELGDGAFGKVYKAQ--NKETSVLAAAKVI-------------DTK-SEE 76
Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELD 307
           +L     EI   +   H NI+ LL      +   ++ EF   G++  ++ ++ R   E  
Sbjct: 77  ELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTE-- 134
Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
                +I +     L+ L+  H   IIH D+K  N+L   D +  ++D G++        
Sbjct: 135 ----SQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ 190
Query: 368 RVLISYVLGTMAYIAPEYF-----QQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEE 422
           R      +GT  ++APE       +      K D++S G+ LI +    P         E
Sbjct: 191 RR--DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPH------HE 242
Query: 423 ICSPEWLRKVMNSKNPSRAIDPRLPGN 449
           +     L K+  S+ P+ A   R   N
Sbjct: 243 LNPMRVLLKIAKSEPPTLAQPSRWSSN 269

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 74/170 (43%), Gaps = 16/170 (9%)
Query: 251 QIRSEIITASQIRHRNILPLL-AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWP 309
           +I  E+    Q+ H N++ L   +  R D  +L+ E +  G L D L      +  L   
Sbjct: 61  EIEREVSILRQVLHHNVITLHDVYENRTDV-VLILELVSGGELFDFLAQ----KESLSEE 115
Query: 310 SRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDM----EACISDLGLAMAIPDG 365
                   +  G+ YLH   +  I H D+KP N++L D         + D GLA  I DG
Sbjct: 116 EATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172
Query: 366 YTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFV 415
              V    + GT  ++APE      L  + D++S G++   L+ G   F+
Sbjct: 173 ---VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 219

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 74/170 (43%), Gaps = 16/170 (9%)
Query: 251 QIRSEIITASQIRHRNILPLL-AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWP 309
           +I  E+    Q+ H N++ L   +  R D  +L+ E +  G L D L      +  L   
Sbjct: 61  EIEREVSILRQVLHHNVITLHDVYENRTDV-VLILELVSGGELFDFLAQ----KESLSEE 115
Query: 310 SRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDM----EACISDLGLAMAIPDG 365
                   +  G+ YLH   +  I H D+KP N++L D         + D GLA  I DG
Sbjct: 116 EATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172
Query: 366 YTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFV 415
              V    + GT  ++APE      L  + D++S G++   L+ G   F+
Sbjct: 173 ---VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 219

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 74/170 (43%), Gaps = 16/170 (9%)
Query: 251 QIRSEIITASQIRHRNILPLL-AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWP 309
           +I  E+    Q+ H N++ L   +  R D  +L+ E +  G L D L      +  L   
Sbjct: 61  EIEREVSILRQVLHHNVITLHDVYENRTDV-VLILELVSGGELFDFLAQ----KESLSEE 115
Query: 310 SRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDM----EACISDLGLAMAIPDG 365
                   +  G+ YLH   +  I H D+KP N++L D         + D GLA  I DG
Sbjct: 116 EATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172
Query: 366 YTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFV 415
              V    + GT  ++APE      L  + D++S G++   L+ G   F+
Sbjct: 173 ---VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 219

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 74/170 (43%), Gaps = 16/170 (9%)
Query: 251 QIRSEIITASQIRHRNILPLL-AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWP 309
           +I  E+    Q+ H N++ L   +  R D  +L+ E +  G L D L      +  L   
Sbjct: 61  EIEREVSILRQVLHHNVITLHDVYENRTDV-VLILELVSGGELFDFLAQ----KESLSEE 115
Query: 310 SRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDM----EACISDLGLAMAIPDG 365
                   +  G+ YLH   +  I H D+KP N++L D         + D GLA  I DG
Sbjct: 116 EATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172
Query: 366 YTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFV 415
              V    + GT  ++APE      L  + D++S G++   L+ G   F+
Sbjct: 173 ---VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 219

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 74/170 (43%), Gaps = 16/170 (9%)
Query: 251 QIRSEIITASQIRHRNILPLL-AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWP 309
           +I  E+    Q+ H N++ L   +  R D  +L+ E +  G L D L      +  L   
Sbjct: 61  EIEREVSILRQVLHHNVITLHDVYENRTDV-VLILELVSGGELFDFLAQ----KESLSEE 115
Query: 310 SRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDM----EACISDLGLAMAIPDG 365
                   +  G+ YLH   +  I H D+KP N++L D         + D GLA  I DG
Sbjct: 116 EATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172
Query: 366 YTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFV 415
              V    + GT  ++APE      L  + D++S G++   L+ G   F+
Sbjct: 173 ---VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 219

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/267 (23%), Positives = 109/267 (40%), Gaps = 35/267 (13%)
Query: 188 LKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDS 247
           L  ED +  + ++G G  G+VYKA+       ++A  KVI             D+K  + 
Sbjct: 33  LNPEDFWEIIGELGDGAFGKVYKAQ--NKETSVLAAAKVI-------------DTK-SEE 76
Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELD 307
           +L     EI   +   H NI+ LL      +   ++ EF   G++  ++ ++ R   E  
Sbjct: 77  ELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTE-- 134
Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
                +I +     L+ L+  H   IIH D+K  N+L   D +  ++D G++        
Sbjct: 135 ----SQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQ 190
Query: 368 RVLISYVLGTMAYIAPEYF-----QQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEE 422
           R      +GT  ++APE       +      K D++S G+ LI +    P         E
Sbjct: 191 RR--DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPH------HE 242
Query: 423 ICSPEWLRKVMNSKNPSRAIDPRLPGN 449
           +     L K+  S+ P+ A   R   N
Sbjct: 243 LNPMRVLLKIAKSEPPTLAQPSRWSSN 269

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 95/217 (43%), Gaps = 41/217 (18%)
Query: 200 IGSGGCGEVY--KAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           +G+G  GEV   + +LP      +AIK + V                 + + R    E  
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKV--------------GYTEKQRRDFLGEAS 98
Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL- 316
              Q  H NI+ L   + +    ++V E+M+NGSL   L      + +  +     + + 
Sbjct: 99  IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR-----KHDAQFTVIQLVGML 153
Query: 317 -GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPD----GYT---- 367
            G+ASG++YL        +H D+  RN+L+N ++   +SD GL+  + D     YT    
Sbjct: 154 RGIASGMKYLS---DMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 210
Query: 368 RVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
           ++ I +        +PE     + +   D++S+G++L
Sbjct: 211 KIPIRWT-------SPEAIAYRKFTSASDVWSYGIVL 240

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 71/288 (24%), Positives = 109/288 (37%), Gaps = 46/288 (15%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  GEVY+ ++ G       ++  +   P   +E  E D  +          E +  
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM----------EALII 114
Query: 260 SQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRH------R 313
           S+  H+NI+  +   ++     ++ E M  G L+  L +    R     PS         
Sbjct: 115 SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRET---RPRPSQPSSLAMLDLLH 171
Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLN---DDMEACISDLGLAMAIPDGYTRVL 370
           +A  +A G +YL   H    IH DI  RN LL        A I D G+A  I        
Sbjct: 172 VARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRK 228
Query: 371 ISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSPEWL 429
               +  + ++ PE F +   + K D +SFG+LL  +   G   +    N E        
Sbjct: 229 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-------- 280
Query: 430 RKVMNSKNPSRAIDP--RLPGNGYEKKMLHVLKIAYICTLHDPEERPN 475
             V+        +DP    PG  Y        +I   C  H PE+RPN
Sbjct: 281 --VLEFVTSGGRMDPPKNCPGPVY--------RIMTQCWQHQPEDRPN 318

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 105/228 (46%), Gaps = 31/228 (13%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           + +L  IG G  G V  A     N   +AIKK+   +P       +          R +R
Sbjct: 25  YTNLSYIGEGAYGMVCSA-YDNVNKVRVAIKKI---SPFEHQTYCQ----------RTLR 70
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSL-QDILD-DVSRGRRELDWPSR 311
            EI    + RH NI+ +   +  P       E MK+  + QD+++ D+ +  +     + 
Sbjct: 71  -EIKILLRFRHENIIGINDIIRAPTI-----EQMKDVYIVQDLMETDLYKLLKTQHLSND 124
Query: 312 H--RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA-MAIPD-GYT 367
           H       +  GL+Y+H   SA+++H D+KP N+LLN   +  I D GLA +A PD  +T
Sbjct: 125 HICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHT 181
Query: 368 RVLISYVLGTMAYIAPEYFQQPE-LSEKCDIFSFGMLLISLVRGVPSF 414
             L  YV  T  Y APE     +  ++  DI+S G +L  ++   P F
Sbjct: 182 GFLTEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 228

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 67/250 (26%), Positives = 107/250 (42%), Gaps = 69/250 (27%)
Query: 190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKL 249
           +E  +   + IG+G  G VY+A+L  S G+++AIKKV+            +D + ++ +L
Sbjct: 31  QEVSYTDTKVIGNGSFGVVYQAKLCDS-GELVAIKKVL------------QDKRFKNREL 77
Query: 250 RQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQD------ILDDVSRGR 303
           + +R       ++ H NI       VR     L Y F  +G  +D      +LD V    
Sbjct: 78  QIMR-------KLDHCNI-------VR-----LRYFFYSSGEKKDEVYLNLVLDYVPETV 118
Query: 304 RELDWPSRHRIALGVASGLEYLHMY-----------HSASIIHGDIKPRNVLLNDDMEAC 352
             +   +RH         + Y+ +Y           HS  I H DIKP+N+LL+ D    
Sbjct: 119 YRV---ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVL 175
Query: 353 -ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPEL-------SEKCDIFSFGMLL 404
            + D G A  +  G   V         +YI   Y++ PEL       +   D++S G +L
Sbjct: 176 KLCDFGSAKQLVRGEPNV---------SYICSRYYRAPELIFGATDYTSSIDVWSAGCVL 226
Query: 405 ISLVRGVPSF 414
             L+ G P F
Sbjct: 227 AELLLGQPIF 236

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 23/208 (11%)
Query: 234 AAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQ 293
           AA++I    KL     +++  E      ++H NI+ L   +     H LV++ +  G L 
Sbjct: 33  AAKIIN-TKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELF 91
Query: 294 DILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC- 352
           +  D V+R     ++ S    +  +   LE ++  H   I+H D+KP N+LL    +   
Sbjct: 92  E--DIVAR-----EYYSEADASHCIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAA 144
Query: 353 --ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRG 410
             ++D GLA+ +  G  +    +  GT  Y++PE  ++    +  D+++ G++L  L+ G
Sbjct: 145 VKLADFGLAIEV-QGDQQAWFGFA-GTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVG 202
Query: 411 VPSF-------VFHQ---NGEEICSPEW 428
            P F       ++ Q      +  SPEW
Sbjct: 203 YPPFWDEDQHRLYQQIKAGAYDFPSPEW 230

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 69/293 (23%), Positives = 123/293 (41%), Gaps = 48/293 (16%)
Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           +K+G+G  GEV+ A    +    +A+K +                K     +    +E  
Sbjct: 21  KKLGAGQFGEVWMATY--NKHTKVAVKTM----------------KPGSMSVEAFLAEAN 62
Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALG 317
               ++H  ++ L A + +   +++  EFM  GSL D L      ++ L  P     +  
Sbjct: 63  VMKTLQHDKLVKLHAVVTKEPIYIIT-EFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQ 119
Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG-YT-RVLISYVL 375
           +A G+ ++      + IH D++  N+L++  +   I+D GLA  I D  YT R    +  
Sbjct: 120 IAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF-- 174
Query: 376 GTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR--GVPSFVFHQNGEEICSPEWLRKVM 433
             + + APE       + K D++SFG+LL+ +V    +P          + +PE +R + 
Sbjct: 175 -PIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY-------PGMSNPEVIRALE 226
Query: 434 NSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL 486
                 R      P N  E+    +  I   C  + PEERP  +Y++  L   
Sbjct: 227 RGYRMPR------PENCPEE----LYNIMMRCWKNRPEERPTFEYIQSVLDDF 269

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 105/228 (46%), Gaps = 31/228 (13%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           + +L  IG G  G V  A     N   +AIKK+   +P       +          R +R
Sbjct: 25  YTNLSYIGEGAYGMVCSA-YDNVNKVRVAIKKI---SPFEHQTYCQ----------RTLR 70
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSL-QDILD-DVSRGRRELDWPSR 311
            EI    + RH NI+ +   +  P       E MK+  + QD+++ D+ +  +     + 
Sbjct: 71  -EIKILLRFRHENIIGINDIIRAPTI-----EQMKDVYIVQDLMETDLYKLLKTQHLSND 124
Query: 312 H--RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA-MAIPD-GYT 367
           H       +  GL+Y+H   SA+++H D+KP N+LLN   +  I D GLA +A PD  +T
Sbjct: 125 HICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHT 181
Query: 368 RVLISYVLGTMAYIAPEYFQQPE-LSEKCDIFSFGMLLISLVRGVPSF 414
             L  YV  T  Y APE     +  ++  DI+S G +L  ++   P F
Sbjct: 182 GFLTEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 228

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 105/228 (46%), Gaps = 31/228 (13%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           + +L  IG G  G V  A     N   +AIKK+   +P       +          R +R
Sbjct: 25  YTNLSYIGEGAYGMVCSA-YDNVNKVRVAIKKI---SPFEHQTYCQ----------RTLR 70
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSL-QDILD-DVSRGRRELDWPSR 311
            EI    + RH NI+ +   +  P       E MK+  + QD+++ D+ +  +     + 
Sbjct: 71  -EIKILLRFRHENIIGINDIIRAP-----TIEQMKDVYIVQDLMETDLYKLLKTQHLSND 124
Query: 312 H--RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA-MAIPD-GYT 367
           H       +  GL+Y+H   SA+++H D+KP N+LLN   +  I D GLA +A PD  +T
Sbjct: 125 HICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHT 181
Query: 368 RVLISYVLGTMAYIAPEYFQQPE-LSEKCDIFSFGMLLISLVRGVPSF 414
             L  YV  T  Y APE     +  ++  DI+S G +L  ++   P F
Sbjct: 182 GFLTEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 228

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/229 (24%), Positives = 99/229 (43%), Gaps = 33/229 (14%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  G+V KA           +K    Y  ++   L E  S    S+LR + SE    
Sbjct: 31  LGEGEFGKVVKA-------TAFHLKGRAGYTTVAVKMLKENASP---SELRDLLSEFNVL 80
Query: 260 SQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSR------------GRRELD 307
            Q+ H +++ L     +    LL+ E+ K GSL+  L +  +                LD
Sbjct: 81  KQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLD 140
Query: 308 WPSRHRIALG--------VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA 359
            P    + +G        ++ G++YL      S++H D+  RN+L+ +  +  ISD GL+
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYL---AEMSLVHRDLAARNILVAEGRKMKISDFGLS 197
Query: 360 MAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLV 408
             + +  + V  S     + ++A E       + + D++SFG+LL  +V
Sbjct: 198 RDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 246

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 71/291 (24%), Positives = 110/291 (37%), Gaps = 46/291 (15%)
Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           +  +G G  GEVY+ ++ G       ++  +   P   +E  E D  +          E 
Sbjct: 36  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM----------EA 85
Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRH---- 312
           +  S+  H+NI+  +   ++     ++ E M  G L+  L +    R     PS      
Sbjct: 86  LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRET---RPRPSQPSSLAMLD 142
Query: 313 --RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN---DDMEACISDLGLAMAIPDGYT 367
              +A  +A G +YL   H    IH DI  RN LL        A I D G+A  I     
Sbjct: 143 LLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASY 199
Query: 368 RVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSP 426
                  +  + ++ PE F +   + K D +SFG+LL  +   G   +    N E     
Sbjct: 200 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE----- 254
Query: 427 EWLRKVMNSKNPSRAIDP--RLPGNGYEKKMLHVLKIAYICTLHDPEERPN 475
                V+        +DP    PG  Y        +I   C  H PE+RPN
Sbjct: 255 -----VLEFVTSGGRMDPPKNCPGPVY--------RIMTQCWQHQPEDRPN 292

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 71/291 (24%), Positives = 111/291 (38%), Gaps = 46/291 (15%)
Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           +  +G G  GEVY+ ++ G       ++  +   P   +E  E D  +          E 
Sbjct: 36  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM----------EA 85
Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRH---- 312
           +  S++ H+NI+  +   ++     ++ E M  G L+  L +    R     PS      
Sbjct: 86  LIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRET---RPRPSQPSSLAMLD 142
Query: 313 --RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN---DDMEACISDLGLAMAIPDGYT 367
              +A  +A G +YL   H    IH DI  RN LL        A I D G+A  I     
Sbjct: 143 LLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 199
Query: 368 RVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSP 426
                  +  + ++ PE F +   + K D +SFG+LL  +   G   +    N E     
Sbjct: 200 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE----- 254
Query: 427 EWLRKVMNSKNPSRAIDP--RLPGNGYEKKMLHVLKIAYICTLHDPEERPN 475
                V+        +DP    PG  Y        +I   C  H PE+RPN
Sbjct: 255 -----VLEFVTSGGRMDPPKNCPGPVY--------RIMTQCWQHQPEDRPN 292

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/250 (26%), Positives = 106/250 (42%), Gaps = 69/250 (27%)
Query: 190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKL 249
           +E  +   + IG+G  G VY+A+L  S G+++AIKKV+            +D + ++ +L
Sbjct: 46  QEVSYTDTKVIGNGSFGVVYQAKLCDS-GELVAIKKVL------------QDKRFKNREL 92
Query: 250 RQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQD------ILDDVSRGR 303
           + +R       ++ H NI+             L Y F  +G  +D      +LD V    
Sbjct: 93  QIMR-------KLDHCNIV------------RLRYFFYSSGEKKDEVYLNLVLDYVPETV 133
Query: 304 RELDWPSRHRIALGVASGLEYLHMY-----------HSASIIHGDIKPRNVLLNDDMEAC 352
             +   +RH         + Y+ +Y           HS  I H DIKP+N+LL+ D    
Sbjct: 134 YRV---ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVL 190
Query: 353 -ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPEL-------SEKCDIFSFGMLL 404
            + D G A  +  G   V         +YI   Y++ PEL       +   D++S G +L
Sbjct: 191 KLCDFGSAKQLVRGEPNV---------SYICSRYYRAPELIFGATDYTSSIDVWSAGCVL 241
Query: 405 ISLVRGVPSF 414
             L+ G P F
Sbjct: 242 AELLLGQPIF 251

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 99/226 (43%), Gaps = 41/226 (18%)
Query: 194 FASLEKIGSGGCGEV---YKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
           + +L+ IGSG  G V   Y A L     + +AIKK+    P               +  +
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVL----DRNVAIKKL--SRPFQ-----------NQTHAK 68
Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHL-------LVYEFMKNGSLQDILDDVSRGR 303
           +   E++    + H+NI+ LL ++  P   L       LV E M     Q I       +
Sbjct: 69  RAYRELVLMKCVNHKNIISLL-NVFTPQKTLEEFQDVYLVMELMDANLXQVI-------Q 120
Query: 304 RELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
            ELD      +   +  G+++LH   SA IIH D+KP N+++  D    I D GLA    
Sbjct: 121 MELDHERMSYLLYQMLXGIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTA- 176
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR 409
            G + ++  YV+ T  Y APE        E  DI+S G ++  +VR
Sbjct: 177 -GTSFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR 220

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 67/250 (26%), Positives = 107/250 (42%), Gaps = 69/250 (27%)
Query: 190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKL 249
           +E  +   + IG+G  G VY+A+L  S G+++AIKKV+            +D + ++ +L
Sbjct: 23  QEVSYTDTKVIGNGSFGVVYQAKLCDS-GELVAIKKVL------------QDKRFKNREL 69
Query: 250 RQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQD------ILDDVSRGR 303
           + +R       ++ H NI       VR     L Y F  +G  +D      +LD V    
Sbjct: 70  QIMR-------KLDHCNI-------VR-----LRYFFYSSGEKKDEVYLNLVLDYVPETV 110
Query: 304 RELDWPSRHRIALGVASGLEYLHMY-----------HSASIIHGDIKPRNVLLNDDMEAC 352
             +   +RH         + Y+ +Y           HS  I H DIKP+N+LL+ D    
Sbjct: 111 YRV---ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVL 167
Query: 353 -ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPEL-------SEKCDIFSFGMLL 404
            + D G A  +  G   V         +YI   Y++ PEL       +   D++S G +L
Sbjct: 168 KLCDFGSAKQLVRGEPNV---------SYICSRYYRAPELIFGATDYTSSIDVWSAGCVL 218
Query: 405 ISLVRGVPSF 414
             L+ G P F
Sbjct: 219 AELLLGQPIF 228

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 105/228 (46%), Gaps = 31/228 (13%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           + +L  IG G  G V  A     N   +AIKK+   +P       +          R +R
Sbjct: 25  YTNLSYIGEGAYGMVCSA-YDNVNKVRVAIKKI---SPFEHQTYCQ----------RTLR 70
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSL-QDILD-DVSRGRRELDWPSR 311
            EI    + RH NI+ +   +  P       E MK+  + QD+++ D+ +  +     + 
Sbjct: 71  -EIKILLRFRHENIIGINDIIRAP-----TIEQMKDVYIVQDLMETDLYKLLKTQHLSND 124
Query: 312 H--RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA-MAIPD-GYT 367
           H       +  GL+Y+H   SA+++H D+KP N+LLN   +  I D GLA +A PD  +T
Sbjct: 125 HICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 181
Query: 368 RVLISYVLGTMAYIAPEYFQQPE-LSEKCDIFSFGMLLISLVRGVPSF 414
             L  YV  T  Y APE     +  ++  DI+S G +L  ++   P F
Sbjct: 182 GFLTEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 228

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/129 (34%), Positives = 63/129 (48%), Gaps = 11/129 (8%)
Query: 282 LVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPR 341
           LV E++  GSL+D L     G  +L        A  +  G+ YLH  H    IH  +  R
Sbjct: 89  LVMEYVPLGSLRDYLPRHCVGLAQLLL-----FAQQICEGMAYLHAQH---YIHRALAAR 140
Query: 342 NVLLNDDMEACISDLGLAMAIPDG--YTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFS 399
           NVLL++D    I D GLA A+P+G  Y RV          Y APE  ++ +     D++S
Sbjct: 141 NVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APECLKECKFYYASDVWS 199
Query: 400 FGMLLISLV 408
           FG+ L  L+
Sbjct: 200 FGVTLYELL 208

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/129 (34%), Positives = 63/129 (48%), Gaps = 11/129 (8%)
Query: 282 LVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPR 341
           LV E++  GSL+D L     G  +L        A  +  G+ YLH  H    IH  +  R
Sbjct: 90  LVMEYVPLGSLRDYLPRHCVGLAQLLL-----FAQQICEGMAYLHAQH---YIHRALAAR 141
Query: 342 NVLLNDDMEACISDLGLAMAIPDG--YTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFS 399
           NVLL++D    I D GLA A+P+G  Y RV          Y APE  ++ +     D++S
Sbjct: 142 NVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APECLKECKFYYASDVWS 200
Query: 400 FGMLLISLV 408
           FG+ L  L+
Sbjct: 201 FGVTLYELL 209

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 105/228 (46%), Gaps = 31/228 (13%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           + +L  IG G  G V  A     N   +AIKK+  +          E        LR+I+
Sbjct: 29  YTNLSYIGEGAYGMVCSA-YDNLNKVRVAIKKISPF----------EHQTYXQRTLREIK 77
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSL-QDILD-DVSRGRRELDWPSR 311
             +    + RH NI+ +   +  P       E MK+  + QD+++ D+ +  +     + 
Sbjct: 78  ILL----RFRHENIIGINDIIRAP-----TIEQMKDVYIVQDLMETDLYKLLKTQHLSND 128
Query: 312 H--RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA-MAIPD-GYT 367
           H       +  GL+Y+H   SA+++H D+KP N+LLN   +  I D GLA +A PD  +T
Sbjct: 129 HICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHT 185
Query: 368 RVLISYVLGTMAYIAPEYFQQPE-LSEKCDIFSFGMLLISLVRGVPSF 414
             L  YV  T  Y APE     +  ++  DI+S G +L  ++   P F
Sbjct: 186 GFLTEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 96/217 (44%), Gaps = 22/217 (10%)
Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           + +G+G  G+V +A   G  GK  A+ KV V    S A   E+++ + + K        I
Sbjct: 52  KTLGAGAFGKVVEATAFGL-GKEDAVLKVAVKMLKSTAHADEKEALMSELK--------I 102
Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALG 317
            +   +H NI+ LL         L++ E+   G   D+L+ + R  R L+      IA  
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYG---DLLNFLRRKSRVLETDPAFAIANS 159
Query: 318 VASGLEYLHM----------YHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
             S  + LH             S + IH D+  RNVLL +   A I D GLA  I +   
Sbjct: 160 TLSTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 219
Query: 368 RVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
            ++       + ++APE       + + D++S+G+LL
Sbjct: 220 YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILL 256

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 74/170 (43%), Gaps = 16/170 (9%)
Query: 251 QIRSEIITASQIRHRNILPLL-AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWP 309
           +I  E+    Q+ H NI+ L   +  R D  +L+ E +  G L D L      +  L   
Sbjct: 61  EIEREVSILRQVLHPNIITLHDVYENRTDV-VLILELVSGGELFDFLAQ----KESLSEE 115
Query: 310 SRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDM----EACISDLGLAMAIPDG 365
                   +  G+ YLH   +  I H D+KP N++L D         + D GLA  I DG
Sbjct: 116 EATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172
Query: 366 YTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFV 415
              V    + GT  ++APE      L  + D++S G++   L+ G   F+
Sbjct: 173 ---VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 219

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 106/228 (46%), Gaps = 31/228 (13%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           + +L  IG G  G V  A     N   +AIKK+  +          E        LR+I+
Sbjct: 27  YTNLSYIGEGAYGMVCSA-YDNVNKVRVAIKKISPF----------EHQTYCQRTLREIK 75
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSL-QDILD-DVSRGRRELDWPSR 311
             I+ A   RH NI+ +   +  P       E MK+  + QD+++ D+ +  +     + 
Sbjct: 76  --ILLA--FRHENIIGINDIIRAP-----TIEQMKDVYIVQDLMETDLYKLLKTQHLSND 126
Query: 312 H--RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA-MAIPD-GYT 367
           H       +  GL+Y+H   SA+++H D+KP N+LLN   +  I D GLA +A PD  +T
Sbjct: 127 HICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 183
Query: 368 RVLISYVLGTMAYIAPEYFQQPE-LSEKCDIFSFGMLLISLVRGVPSF 414
             L  YV  T  Y APE     +  ++  DI+S G +L  ++   P F
Sbjct: 184 GFLTEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 230

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 98/216 (45%), Gaps = 23/216 (10%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           F  +EKIG G  G VYKA      G+++A+KK+          L  E   +  + +R   
Sbjct: 8   FQKVEKIGEGTYGVVYKAR-NKLTGEVVALKKI---------RLDTETEGVPSTAIR--- 54
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
            EI    ++ H NI+ LL  +   +   LV+E + +  L+  +D  +     +  P    
Sbjct: 55  -EISLLKELNHPNIVKLLDVIHTENKLYLVFEHV-DQDLKKFMD--ASALTGIPLPLIKS 110
Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISY 373
               +  GL + H   S  ++H D+KP+N+L+N +    ++D GLA A   G       +
Sbjct: 111 YLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXH 165
Query: 374 VLGTMAYIAPEYFQQPE-LSEKCDIFSFGMLLISLV 408
            + T+ Y APE     +  S   DI+S G +   +V
Sbjct: 166 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 201

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 67/250 (26%), Positives = 107/250 (42%), Gaps = 69/250 (27%)
Query: 190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKL 249
           +E  +   + IG+G  G VY+A+L  S G+++AIKKV+            +D + ++ +L
Sbjct: 18  QEVSYTDTKVIGNGSFGVVYQAKLCDS-GELVAIKKVL------------QDKRFKNREL 64
Query: 250 RQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQD------ILDDVSRGR 303
           + +R       ++ H NI       VR     L Y F  +G  +D      +LD V    
Sbjct: 65  QIMR-------KLDHCNI-------VR-----LRYFFYSSGEKKDEVYLNLVLDYVPETV 105
Query: 304 RELDWPSRHRIALGVASGLEYLHMY-----------HSASIIHGDIKPRNVLLNDDMEAC 352
             +   +RH         + Y+ +Y           HS  I H DIKP+N+LL+ D    
Sbjct: 106 YRV---ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVL 162
Query: 353 -ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPEL-------SEKCDIFSFGMLL 404
            + D G A  +  G   V         +YI   Y++ PEL       +   D++S G +L
Sbjct: 163 KLCDFGSAKQLVRGEPNV---------SYICSRYYRAPELIFGATDYTSSIDVWSAGCVL 213
Query: 405 ISLVRGVPSF 414
             L+ G P F
Sbjct: 214 AELLLGQPIF 223

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 105/228 (46%), Gaps = 31/228 (13%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           + +L  IG G  G V  A     N   +AIKK+   +P       +          R +R
Sbjct: 27  YTNLSYIGEGAYGMVCSA-YDNVNKVRVAIKKI---SPFEHQTYCQ----------RTLR 72
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSL-QDILD-DVSRGRRELDWPSR 311
            EI    + RH NI+ +   +  P       E MK+  + QD+++ D+ +  +     + 
Sbjct: 73  -EIKILLRFRHENIIGINDIIRAP-----TIEQMKDVYIVQDLMETDLYKLLKTQHLSND 126
Query: 312 H--RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA-MAIPD-GYT 367
           H       +  GL+Y+H   SA+++H D+KP N+LLN   +  I D GLA +A PD  +T
Sbjct: 127 HICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 183
Query: 368 RVLISYVLGTMAYIAPEYFQQPE-LSEKCDIFSFGMLLISLVRGVPSF 414
             L  YV  T  Y APE     +  ++  DI+S G +L  ++   P F
Sbjct: 184 GFLTEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 230

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 83/176 (47%), Gaps = 24/176 (13%)
Query: 249 LRQIRSEIITASQIRHRNILPLLAHMVRP--DCHLLVYEFMKNGSLQDI--LDDVSRGRR 304
           + Q+  EI    ++ H N++ L+  +  P  D   +V+E +  G + ++  L  +S  + 
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQA 139
Query: 305 ELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPD 364
              +         +  G+EYLH      IIH DIKP N+L+ +D    I+D G++     
Sbjct: 140 RFYFQD-------LIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG 189
Query: 365 GYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVP--SFVFHQ 418
             +  L+S  +GT A++APE      LSE   IFS G  L     GV    FVF Q
Sbjct: 190 --SDALLSNTVGTPAFMAPE-----SLSETRKIFS-GKALDVWAMGVTLYCFVFGQ 237

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/261 (24%), Positives = 110/261 (42%), Gaps = 51/261 (19%)
Query: 167 GSRDRGPTIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKV 226
           GS++R PT +   + K      +  + + +L  +GSG  G V  A      G  +A+KK+
Sbjct: 1   GSQER-PTFYRQELNK---TIWEVPERYQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKL 55
Query: 227 ------IVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCH 280
                 I++A  +  EL      ++   +  +      A  +   N + L+ H++  D +
Sbjct: 56  SRPFQSIIHAKRTYREL-RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN 114
Query: 281 LLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKP 340
            +V         Q + DD               +   +  GL+Y+H   SA IIH D+KP
Sbjct: 115 NIV-------KCQKLTDD-----------HVQFLIYQILRGLKYIH---SADIIHRDLKP 153
Query: 341 RNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPEL-------SE 393
            N+ +N+D E  I D GLA    D  T            Y+A  +++ PE+       ++
Sbjct: 154 SNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWYRAPEIMLNWMHYNQ 202
Query: 394 KCDIFSFGMLLISLVRGVPSF 414
             DI+S G ++  L+ G   F
Sbjct: 203 TVDIWSVGCIMAELLTGRTLF 223

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 95/217 (43%), Gaps = 41/217 (18%)
Query: 200 IGSGGCGEVY--KAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           +G+G  GEV   + +LP      +AIK + V                 + + R    E  
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKV--------------GYTEKQRRDFLGEAS 69
Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL- 316
              Q  H NI+ L   + +    ++V E+M+NGSL   L      + +  +     + + 
Sbjct: 70  IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR-----KHDAQFTVIQLVGML 124
Query: 317 -GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPD----GYT---- 367
            G+ASG++YL        +H D+  RN+L+N ++   +SD GL+  + D     YT    
Sbjct: 125 RGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 181
Query: 368 RVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
           ++ I +        +PE     + +   D++S+G++L
Sbjct: 182 KIPIRWT-------SPEAIAYRKFTSASDVWSYGIVL 211

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 73/294 (24%), Positives = 132/294 (44%), Gaps = 53/294 (18%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           ++ L++IGSGG  +V++          +  +K  +YA I    L E D++  DS     R
Sbjct: 30  YSILKQIGSGGSSKVFQ----------VLNEKKQIYA-IKYVNLEEADNQTLDS----YR 74
Query: 254 SEIITASQIRHRN--ILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
           +EI   ++++  +  I+ L  + +       +Y  M+ G++   L+   + ++ +D   R
Sbjct: 75  NEIAYLNKLQQHSDKIIRLYDYEITDQ---YIYMVMECGNID--LNSWLKKKKSIDPWER 129
Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLI 371
                 +   LE +H  H   I+H D+KP N L+ D M   I D G+A  +    T V+ 
Sbjct: 130 KSYWKNM---LEAVHTIHQHGIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVK 185
Query: 372 SYVLGTMAYIAPEYFQQPELSEK-----------CDIFSFGMLLISLVRGVPSFVFHQNG 420
              +GT+ Y+ PE  +    S +            D++S G +L  +  G   F      
Sbjct: 186 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------ 239
Query: 421 EEICSPEWLRKVMNSKNPSRAID-PRLPGNGYEKKMLHVLKIAYICTLHDPEER 473
           ++I +   + K+    +P+  I+ P +P    EK +  VLK    C   DP++R
Sbjct: 240 QQIINQ--ISKLHAIIDPNHEIEFPDIP----EKDLQDVLK---CCLKRDPKQR 284

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 103/242 (42%), Gaps = 41/242 (16%)
Query: 190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKV--IVYAPISAAELIEEDSKLRDS 247
           K   F  L+ IG G  G+V           ++A  K   + YA     +++++ + L+  
Sbjct: 36  KPSDFHFLKVIGKGSFGKV-----------LLARHKAEEVFYA----VKVLQKKAILKKK 80
Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG----- 302
           + + I SE         RN+L  L ++  P    L + F     L  +LD ++ G     
Sbjct: 81  EEKHIMSE---------RNVL--LKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYH 129
Query: 303 -RRELDW--PSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA 359
            +RE  +  P     A  +AS L YLH   S +I++ D+KP N+LL+      ++D GL 
Sbjct: 130 LQRERCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLC 186
Query: 360 MAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQN 419
               +  +    S   GT  Y+APE   +       D +  G +L  ++ G+P F     
Sbjct: 187 KENIEHNSTT--STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT 244
Query: 420 GE 421
            E
Sbjct: 245 AE 246

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 101/244 (41%), Gaps = 40/244 (16%)
Query: 170 DRGPTIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAE---LPGSNGKMIAIKKV 226
           DR PT F    E+  L FL         +++G G  G V       L  + G+++A+KK+
Sbjct: 5   DRDPTQF----EERHLKFL---------QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL 51
Query: 227 IVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL--LAHMVRPDCHLLVY 284
                              +  LR    EI     ++H NI+    + +        L+ 
Sbjct: 52  ---------------QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIM 96
Query: 285 EFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVL 344
           E++  GSL+D L    + +  +D     +    +  G+EYL    +   IH D+  RN+L
Sbjct: 97  EYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNIL 150
Query: 345 LNDDMEACISDLGLAMAIP-DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGML 403
           + ++    I D GL   +P D     +       + + APE   + + S   D++SFG++
Sbjct: 151 VENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVV 210
Query: 404 LISL 407
           L  L
Sbjct: 211 LYEL 214

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 89/223 (39%), Gaps = 24/223 (10%)
Query: 192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ 251
           D F     +G G  G VY A    S+   I   KV+  + I            ++    Q
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSH--FIVALKVLFKSQIE-----------KEGVEHQ 69
Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
           +R EI   + + H NIL L  +        L+ E+   G L   L          D    
Sbjct: 70  LRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSC----TFDEQRT 125
Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLI 371
             I   +A  L Y H      +IH DIKP N+LL    E  I+D G ++  P    + + 
Sbjct: 126 ATIMEELADALMYCH---GKKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKTMC 182
Query: 372 SYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
               GT+ Y+ PE  +    +EK D++  G+L   L+ G P F
Sbjct: 183 ----GTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPF 221

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 97/222 (43%), Gaps = 28/222 (12%)
Query: 200 IGSGGCGEVYKAEL--PGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           IG G  G VY  E      N    AIK +         E+ + ++ LR+  L +      
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLS-----RITEMQQVEAFLREGLLMR------ 77
Query: 258 TASQIRHRNILPLLAHMVRPDC--HLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIA 315
               + H N+L L+  M+ P+   H+L+  +M +G L   +    R     D  S     
Sbjct: 78  ---GLNHPNVLALIGIMLPPEGLPHVLL-PYMCHGDLLQFIRSPQRNPTVKDLIS---FG 130
Query: 316 LGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG--YTRVLISY 373
           L VA G+EYL        +H D+  RN +L++     ++D GLA  I D   Y+     +
Sbjct: 131 LQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRH 187
Query: 374 VLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLV-RGVPSF 414
               + + A E  Q    + K D++SFG+LL  L+ RG P +
Sbjct: 188 ARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPY 229

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 98/221 (44%), Gaps = 30/221 (13%)
Query: 200 IGSGGCGEVYKAELPG-SNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT 258
           +G G  G+V  AE  G    K   + KV       A ++++ D+  +D  L  + SE+  
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKV-------AVKMLKSDATEKD--LSDLISEMEM 86
Query: 259 ASQI-RHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR---- 313
              I +H+NI+ LL    +     ++ E+   G+L++ L        E  +   H     
Sbjct: 87  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQ 146
Query: 314 --------IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP-- 363
                    A  VA G+EYL    S   IH D+  RNVL+ +D    I+D GLA  I   
Sbjct: 147 LSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 203
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
           D Y +     +   + ++APE       + + D++SFG+LL
Sbjct: 204 DYYKKTTNGRL--PVKWMAPEALFDRIYTHQSDVWSFGVLL 242

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/250 (26%), Positives = 106/250 (42%), Gaps = 69/250 (27%)
Query: 190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKL 249
           +E  +   + IG+G  G VY+A+L  S G+++AIKKV+            +D + ++ +L
Sbjct: 52  QEVSYTDTKVIGNGSFGVVYQAKLCDS-GELVAIKKVL------------QDKRFKNREL 98
Query: 250 RQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQD------ILDDVSRGR 303
           + +R       ++ H NI+             L Y F  +G  +D      +LD V    
Sbjct: 99  QIMR-------KLDHCNIV------------RLRYFFYSSGEKKDEVYLNLVLDYVPETV 139
Query: 304 RELDWPSRHRIALGVASGLEYLHMY-----------HSASIIHGDIKPRNVLLNDDMEAC 352
             +   +RH         + Y+ +Y           HS  I H DIKP+N+LL+ D    
Sbjct: 140 YRV---ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVL 196
Query: 353 -ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPEL-------SEKCDIFSFGMLL 404
            + D G A  +  G   V         +YI   Y++ PEL       +   D++S G +L
Sbjct: 197 KLCDFGSAKQLVRGEPNV---------SYICSRYYRAPELIFGATDYTSSIDVWSAGCVL 247
Query: 405 ISLVRGVPSF 414
             L+ G P F
Sbjct: 248 AELLLGQPIF 257

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 99/226 (43%), Gaps = 41/226 (18%)
Query: 194 FASLEKIGSGGCGEV---YKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
           + +L+ IGSG  G V   Y A L     + +AIKK+    P               +  +
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVL----DRNVAIKKL--SRPFQ-----------NQTHAK 61
Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHL-------LVYEFMKNGSLQDILDDVSRGR 303
           +   E++    + H+NI+ LL ++  P   L       LV E M     Q I       +
Sbjct: 62  RAYRELVLMKCVNHKNIISLL-NVFTPQKTLEEFQDVYLVMELMDANLXQVI-------Q 113
Query: 304 RELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
            ELD      +   +  G+++LH   SA IIH D+KP N+++  D    I D GLA    
Sbjct: 114 MELDHERMSYLLYQMLXGIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTA- 169
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR 409
            G + ++  YV+ T  Y APE        E  DI+S G ++  +VR
Sbjct: 170 -GTSFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR 213

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/250 (26%), Positives = 106/250 (42%), Gaps = 69/250 (27%)
Query: 190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKL 249
           +E  +   + IG+G  G VY+A+L  S G+++AIKKV+            +D + ++ +L
Sbjct: 54  QEVSYTDTKVIGNGSFGVVYQAKLCDS-GELVAIKKVL------------QDKRFKNREL 100
Query: 250 RQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQD------ILDDVSRGR 303
           + +R       ++ H NI+             L Y F  +G  +D      +LD V    
Sbjct: 101 QIMR-------KLDHCNIV------------RLRYFFYSSGEKKDEVYLNLVLDYVPETV 141
Query: 304 RELDWPSRHRIALGVASGLEYLHMY-----------HSASIIHGDIKPRNVLLNDDMEAC 352
             +   +RH         + Y+ +Y           HS  I H DIKP+N+LL+ D    
Sbjct: 142 YRV---ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVL 198
Query: 353 -ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPEL-------SEKCDIFSFGMLL 404
            + D G A  +  G   V         +YI   Y++ PEL       +   D++S G +L
Sbjct: 199 KLCDFGSAKQLVRGEPNV---------SYICSRYYRAPELIFGATDYTSSIDVWSAGCVL 249
Query: 405 ISLVRGVPSF 414
             L+ G P F
Sbjct: 250 AELLLGQPIF 259

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 104/234 (44%), Gaps = 37/234 (15%)
Query: 188 LKKEDCFASLEKIGSGGCGEVYKAEL----PGSNGKMIAIKKVIVYAPISAAELIEEDSK 243
           +K+ D     E +G G  G+V+ AE     P  +  ++A+K +             +D  
Sbjct: 12  IKRRDIVLKRE-LGEGAFGKVFLAECYNLSPTKDKMLVAVKAL-------------KDPT 57
Query: 244 LRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDIL------- 296
           L   K  Q  +E++T   ++H +I+         D  ++V+E+MK+G L   L       
Sbjct: 58  LAARKDFQREAELLT--NLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDA 115
Query: 297 ----DDVSR-GRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA 351
               D   R  + EL       IA  +ASG+ YL   H    +H D+  RN L+  ++  
Sbjct: 116 MILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLV 172
Query: 352 CISDLGLAMAI-PDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
            I D G++  +    Y RV   + +  + ++ PE     + + + D++SFG++L
Sbjct: 173 KIGDFGMSRDVYSTDYYRVG-GHTMLPIRWMPPESIMYRKFTTESDVWSFGVIL 225

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 95/217 (43%), Gaps = 41/217 (18%)
Query: 200 IGSGGCGEVY--KAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           +G+G  GEV   + +LP      +AIK + V                 + + R    E  
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKV--------------GYTEKQRRDFLGEAS 98
Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL- 316
              Q  H NI+ L   + +    ++V E+M+NGSL   L      + +  +     + + 
Sbjct: 99  IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR-----KHDAQFTVIQLVGML 153
Query: 317 -GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPD----GYT---- 367
            G+ASG++YL        +H D+  RN+L+N ++   +SD GL+  + D     YT    
Sbjct: 154 RGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 210
Query: 368 RVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
           ++ I +        +PE     + +   D++S+G++L
Sbjct: 211 KIPIRWT-------SPEAIAYRKFTSASDVWSYGIVL 240

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 105/228 (46%), Gaps = 31/228 (13%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           + +L  IG G  G V  A     N   +AIKK+   +P       +          R +R
Sbjct: 33  YTNLSYIGEGAYGMVCSA-YDNVNKVRVAIKKI---SPFEHQTYCQ----------RTLR 78
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSL-QDILD-DVSRGRRELDWPSR 311
            EI    + RH NI+ +   +  P       E MK+  + QD+++ D+ +  +     + 
Sbjct: 79  -EIKILLRFRHENIIGINDIIRAP-----TIEQMKDVYIVQDLMETDLYKLLKTQHLSND 132
Query: 312 H--RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA-MAIPD-GYT 367
           H       +  GL+Y+H   SA+++H D+KP N+LLN   +  I D GLA +A PD  +T
Sbjct: 133 HICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 189
Query: 368 RVLISYVLGTMAYIAPEYFQQPE-LSEKCDIFSFGMLLISLVRGVPSF 414
             L  YV  T  Y APE     +  ++  DI+S G +L  ++   P F
Sbjct: 190 GFLTEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 236

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 105/228 (46%), Gaps = 31/228 (13%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           + +L  IG G  G V  A     N   +AIKK+   +P       +          R +R
Sbjct: 25  YTNLSYIGEGAYGMVCSA-YDNVNKVRVAIKKI---SPFEHQTYCQ----------RTLR 70
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSL-QDILD-DVSRGRRELDWPSR 311
            EI    + RH NI+ +   +  P       E MK+  + QD+++ D+ +  +     + 
Sbjct: 71  -EIKILLRFRHENIIGINDIIRAP-----TIEQMKDVYIVQDLMETDLYKLLKTQHLSND 124
Query: 312 H--RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA-MAIPD-GYT 367
           H       +  GL+Y+H   SA+++H D+KP N+LLN   +  I D GLA +A PD  +T
Sbjct: 125 HICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 181
Query: 368 RVLISYVLGTMAYIAPEYFQQPE-LSEKCDIFSFGMLLISLVRGVPSF 414
             L  YV  T  Y APE     +  ++  DI+S G +L  ++   P F
Sbjct: 182 GFLTEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 228

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 98/221 (44%), Gaps = 30/221 (13%)
Query: 200 IGSGGCGEVYKAELPG-SNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT 258
           +G G  G+V  AE  G    K   + KV       A ++++ D+  +D  L  + SE+  
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKV-------AVKMLKSDATEKD--LSDLISEMEM 75
Query: 259 ASQI-RHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR---- 313
              I +H+NI+ LL    +     ++ E+   G+L++ L        E  +   H     
Sbjct: 76  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 135
Query: 314 --------IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP-- 363
                    A  VA G+EYL    S   IH D+  RNVL+ +D    I+D GLA  I   
Sbjct: 136 LSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 192
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
           D Y +     +   + ++APE       + + D++SFG+LL
Sbjct: 193 DYYKKTTNGRL--PVKWMAPEALFDRIYTHQSDVWSFGVLL 231

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 73/294 (24%), Positives = 132/294 (44%), Gaps = 53/294 (18%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           ++ L++IGSGG  +V++          +  +K  +YA I    L E D++  DS     R
Sbjct: 11  YSILKQIGSGGSSKVFQ----------VLNEKKQIYA-IKYVNLEEADNQTLDS----YR 55
Query: 254 SEIITASQIRHRN--ILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
           +EI   ++++  +  I+ L  + +       +Y  M+ G++   L+   + ++ +D   R
Sbjct: 56  NEIAYLNKLQQHSDKIIRLYDYEITDQ---YIYMVMECGNID--LNSWLKKKKSIDPWER 110
Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLI 371
                 +   LE +H  H   I+H D+KP N L+ D M   I D G+A  +    T V+ 
Sbjct: 111 KSYWKNM---LEAVHTIHQHGIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVK 166
Query: 372 SYVLGTMAYIAPEYFQQPELSEK-----------CDIFSFGMLLISLVRGVPSFVFHQNG 420
              +GT+ Y+ PE  +    S +            D++S G +L  +  G   F      
Sbjct: 167 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------ 220
Query: 421 EEICSPEWLRKVMNSKNPSRAID-PRLPGNGYEKKMLHVLKIAYICTLHDPEER 473
           ++I +   + K+    +P+  I+ P +P    EK +  VLK    C   DP++R
Sbjct: 221 QQIINQ--ISKLHAIIDPNHEIEFPDIP----EKDLQDVLK---CCLKRDPKQR 265

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 98/234 (41%), Gaps = 47/234 (20%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKV------IVYAPISAAELIEEDSKLRDS 247
           + +L  IGSG  G V  A      G  +A+KK+      I++A  +  EL      ++  
Sbjct: 29  YQNLSPIGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYREL-RLLKHMKHE 86
Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELD 307
            +  +      A  +   N + L+ H++  D + +V         Q + DD         
Sbjct: 87  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-------KCQKLTDD--------- 130
Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
                 +   +  GL+Y+H   SA IIH D+KP N+ +N+D E  I D GLA    D  T
Sbjct: 131 --HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMT 185
Query: 368 RVLISYVLGTMAYIAPEYFQQPEL-------SEKCDIFSFGMLLISLVRGVPSF 414
                       Y+A  +++ PE+       ++  DI+S G ++  L+ G   F
Sbjct: 186 -----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 228

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 94/217 (43%), Gaps = 41/217 (18%)
Query: 200 IGSGGCGEVYKA--ELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           +G+G  GEV     +LP      +AIK + V                 + + R    E  
Sbjct: 41  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKV--------------GYTEKQRRDFLGEAS 86
Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL- 316
              Q  H NI+ L   + +    ++V E+M+NGSL   L      + +  +     + + 
Sbjct: 87  IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR-----KHDAQFTVIQLVGML 141
Query: 317 -GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPD----GYT---- 367
            G+ASG++YL        +H D+  RN+L+N ++   +SD GL+  + D     YT    
Sbjct: 142 RGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 198
Query: 368 RVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
           ++ I +        +PE     + +   D++S+G++L
Sbjct: 199 KIPIRWT-------SPEAIAYRKFTSASDVWSYGIVL 228

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/250 (26%), Positives = 106/250 (42%), Gaps = 69/250 (27%)
Query: 190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKL 249
           +E  +   + IG+G  G VY+A+L  S G+++AIKKV+            +D + ++ +L
Sbjct: 56  QEVSYTDTKVIGNGSFGVVYQAKLCDS-GELVAIKKVL------------QDKRFKNREL 102
Query: 250 RQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQD------ILDDVSRGR 303
           + +R       ++ H NI+             L Y F  +G  +D      +LD V    
Sbjct: 103 QIMR-------KLDHCNIV------------RLRYFFYSSGEKKDEVYLNLVLDYVPETV 143
Query: 304 RELDWPSRHRIALGVASGLEYLHMY-----------HSASIIHGDIKPRNVLLNDDMEAC 352
             +   +RH         + Y+ +Y           HS  I H DIKP+N+LL+ D    
Sbjct: 144 YRV---ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVL 200
Query: 353 -ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPEL-------SEKCDIFSFGMLL 404
            + D G A  +  G   V         +YI   Y++ PEL       +   D++S G +L
Sbjct: 201 KLCDFGSAKQLVRGEPNV---------SYICSRYYRAPELIFGATDYTSSIDVWSAGCVL 251
Query: 405 ISLVRGVPSF 414
             L+ G P F
Sbjct: 252 AELLLGQPIF 261

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 23/208 (11%)
Query: 234 AAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQ 293
           AA++I    KL     +++  E      ++H NI+ L   +     H LV++ +  G L 
Sbjct: 33  AAKIINT-KKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELF 91
Query: 294 DILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC- 352
           +  D V+R     ++ S    +  +   LE ++  H   I+H D+KP N+LL    +   
Sbjct: 92  E--DIVAR-----EYYSEADASHCIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAA 144
Query: 353 --ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRG 410
             ++D GLA+ +  G  +    +  GT  Y++PE  ++    +  D+++ G++L  L+ G
Sbjct: 145 VKLADFGLAIEV-QGDQQAWFGFA-GTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVG 202
Query: 411 VPSF-------VFHQ---NGEEICSPEW 428
            P F       ++ Q      +  SPEW
Sbjct: 203 YPPFWDEDQHRLYQQIKAGAYDFPSPEW 230

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 71/291 (24%), Positives = 110/291 (37%), Gaps = 46/291 (15%)
Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           +  +G G  GEVY+ ++ G       ++  +   P   +E  E D  +          E 
Sbjct: 36  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM----------EA 85
Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRH---- 312
           +  S+  H+NI+  +   ++     ++ E M  G L+  L +    R     PS      
Sbjct: 86  LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRET---RPRPSQPSSLAMLD 142
Query: 313 --RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN---DDMEACISDLGLAMAIPDGYT 367
              +A  +A G +YL   H    IH DI  RN LL        A I D G+A  I     
Sbjct: 143 LLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 199
Query: 368 RVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSP 426
                  +  + ++ PE F +   + K D +SFG+LL  +   G   +    N E     
Sbjct: 200 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE----- 254
Query: 427 EWLRKVMNSKNPSRAIDP--RLPGNGYEKKMLHVLKIAYICTLHDPEERPN 475
                V+        +DP    PG  Y        +I   C  H PE+RPN
Sbjct: 255 -----VLEFVTSGGRMDPPKNCPGPVY--------RIMTQCWQHQPEDRPN 292

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 69/289 (23%), Positives = 110/289 (38%), Gaps = 42/289 (14%)
Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           +  +G G  GEVY+ ++ G       ++  +   P   +E  E D  +          E 
Sbjct: 50  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM----------EA 99
Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRH---- 312
           +  S++ H+NI+  +   ++     ++ E M  G L+  L +    R     PS      
Sbjct: 100 LIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRET---RPRPSQPSSLAMLD 156
Query: 313 --RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN---DDMEACISDLGLAMAIPDGYT 367
              +A  +A G +YL   H    IH DI  RN LL        A I D G+A  I     
Sbjct: 157 LLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 213
Query: 368 RVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSP 426
                  +  + ++ PE F +   + K D +SFG+LL  +   G   +    N E +   
Sbjct: 214 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL--- 270
Query: 427 EWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPN 475
           E++        P     P             V +I   C  H PE+RPN
Sbjct: 271 EFVTSGGRMDPPKNCPGP-------------VYRIMTQCWQHQPEDRPN 306

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 95/217 (43%), Gaps = 41/217 (18%)
Query: 200 IGSGGCGEVY--KAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           +G+G  GEV   + +LP      +AIK + V                 + + R    E  
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKV--------------GYTEKQRRDFLGEAS 98
Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL- 316
              Q  H NI+ L   + +    ++V E+M+NGSL   L      + +  +     + + 
Sbjct: 99  IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR-----KHDAQFTVIQLVGML 153
Query: 317 -GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPD----GYT---- 367
            G+ASG++YL        +H D+  RN+L+N ++   +SD GL+  + D     YT    
Sbjct: 154 RGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 210
Query: 368 RVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
           ++ I +        +PE     + +   D++S+G++L
Sbjct: 211 KIPIRWT-------SPEAIAYRKFTSASDVWSYGIVL 240

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 95/217 (43%), Gaps = 41/217 (18%)
Query: 200 IGSGGCGEVY--KAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           +G+G  GEV   + +LP      +AIK + V                 + + R    E  
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKV--------------GYTEKQRRDFLGEAS 98
Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL- 316
              Q  H NI+ L   + +    ++V E+M+NGSL   L      + +  +     + + 
Sbjct: 99  IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR-----KHDAQFTVIQLVGML 153
Query: 317 -GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPD----GYT---- 367
            G+ASG++YL        +H D+  RN+L+N ++   +SD GL+  + D     YT    
Sbjct: 154 RGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 210
Query: 368 RVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
           ++ I +        +PE     + +   D++S+G++L
Sbjct: 211 KIPIRWT-------SPEAIAYRKFTSASDVWSYGIVL 240

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 99/234 (42%), Gaps = 47/234 (20%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKV------IVYAPISAAELIEEDSKLRDS 247
           + +L  +GSG  G V  A      G  +A+KK+      I++A  +  EL      ++  
Sbjct: 30  YQNLSPVGSGAYGSVCAA-FDTKTGHRVAVKKLSRPFQSIIHAKRTYREL-RLLKHMKHE 87
Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELD 307
            +  +      A  +   N + L+ H++  D + +V         Q + DD  +      
Sbjct: 88  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-------KCQKLTDDHVQF----- 135
Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
                 +   +  GL+Y+H   SA IIH D+KP N+ +N+D E  I D GLA    D  T
Sbjct: 136 ------LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 186
Query: 368 RVLISYVLGTMAYIAPEYFQQPEL-------SEKCDIFSFGMLLISLVRGVPSF 414
                       Y+A  +++ PE+       ++  DI+S G ++  L+ G   F
Sbjct: 187 -----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 229

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 73/294 (24%), Positives = 132/294 (44%), Gaps = 53/294 (18%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           ++ L++IGSGG  +V++          +  +K  +YA I    L E D++  DS     R
Sbjct: 58  YSILKQIGSGGSSKVFQ----------VLNEKKQIYA-IKYVNLEEADNQTLDS----YR 102
Query: 254 SEIITASQIRHRN--ILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
           +EI   ++++  +  I+ L  + +       +Y  M+ G++   L+   + ++ +D   R
Sbjct: 103 NEIAYLNKLQQHSDKIIRLYDYEITDQ---YIYMVMECGNID--LNSWLKKKKSIDPWER 157
Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLI 371
                 +   LE +H  H   I+H D+KP N L+ D M   I D G+A  +    T V+ 
Sbjct: 158 KSYWKNM---LEAVHTIHQHGIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVK 213
Query: 372 SYVLGTMAYIAPEYFQQPELSEK-----------CDIFSFGMLLISLVRGVPSFVFHQNG 420
              +GT+ Y+ PE  +    S +            D++S G +L  +  G   F      
Sbjct: 214 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------ 267
Query: 421 EEICSPEWLRKVMNSKNPSRAID-PRLPGNGYEKKMLHVLKIAYICTLHDPEER 473
           ++I +   + K+    +P+  I+ P +P    EK +  VLK    C   DP++R
Sbjct: 268 QQIINQ--ISKLHAIIDPNHEIEFPDIP----EKDLQDVLK---CCLKRDPKQR 312

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 98/234 (41%), Gaps = 47/234 (20%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKV------IVYAPISAAELIEEDSKLRDS 247
           + +L  +GSG  G V  A      G  +A+KK+      I++A  +  EL      ++  
Sbjct: 20  YQNLSPVGSGAYGSVCAA-FDTKTGHRVAVKKLSRPFQSIIHAKRTYREL-RLLKHMKHE 77
Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELD 307
            +  +      A  +   N + L+ H++  D + +V         Q + DD         
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-------KCQKLTDD--------- 121
Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
                 +   +  GL+Y+H   SA IIH D+KP N+ +N+D E  I D GLA    D  T
Sbjct: 122 --HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 176
Query: 368 RVLISYVLGTMAYIAPEYFQQPEL-------SEKCDIFSFGMLLISLVRGVPSF 414
                       Y+A  +++ PE+       ++  DI+S G ++  L+ G   F
Sbjct: 177 -----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 219

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 93/222 (41%), Gaps = 22/222 (9%)
Query: 183 EDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDS 242
           +D   L  ED     E+IG G  GEV+   L   N  ++A+K        S  E +  D 
Sbjct: 106 KDKWVLNHEDLVLG-EQIGRGNFGEVFSGRLRADN-TLVAVK--------SCRETLPPDL 155
Query: 243 KLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG 302
           K   +K  Q   E     Q  H NI+ L+    +     +V E ++ G     L   + G
Sbjct: 156 K---AKFLQ---EARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLR--TEG 207
Query: 303 RRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI 362
            R L   +  ++    A+G+EYL    S   IH D+  RN L+ +     ISD G++   
Sbjct: 208 AR-LRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREE 263
Query: 363 PDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
            DG            + + APE       S + D++SFG+LL
Sbjct: 264 ADGVXAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILL 305

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 99/226 (43%), Gaps = 41/226 (18%)
Query: 194 FASLEKIGSGGCGEV---YKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
           + +L+ IGSG  G V   Y A L     + +AIKK+    P               +  +
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVL----DRNVAIKKL--SRPFQ-----------NQTHAK 106
Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHL-------LVYEFMKNGSLQDILDDVSRGR 303
           +   E++    + H+NI+ LL ++  P   L       LV E M     Q I       +
Sbjct: 107 RAYRELVLMKCVNHKNIISLL-NVFTPQKTLEEFQDVYLVMELMDANLCQVI-------Q 158
Query: 304 RELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
            ELD      +   +  G+++LH   SA IIH D+KP N+++  D    I D GLA    
Sbjct: 159 MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA- 214
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR 409
            G + ++  YV+ T  Y APE        E  DI+S G ++  +VR
Sbjct: 215 -GTSFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR 258

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 98/234 (41%), Gaps = 47/234 (20%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKV------IVYAPISAAELIEEDSKLRDS 247
           + +L  +GSG  G V  A      G  +A+KK+      I++A  +  EL      ++  
Sbjct: 24  YQNLSPVGSGAYGSVCAA-FDTKTGHRVAVKKLSRPFQSIIHAKRTYREL-RLLKHMKHE 81
Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELD 307
            +  +      A  +   N + L+ H++  D + +V         Q + DD         
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-------KCQKLTDD--------- 125
Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
                 +   +  GL+Y+H   SA IIH D+KP N+ +N+D E  I D GLA    D  T
Sbjct: 126 --HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 180
Query: 368 RVLISYVLGTMAYIAPEYFQQPEL-------SEKCDIFSFGMLLISLVRGVPSF 414
                       Y+A  +++ PE+       ++  DI+S G ++  L+ G   F
Sbjct: 181 -----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 71/291 (24%), Positives = 110/291 (37%), Gaps = 46/291 (15%)
Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           +  +G G  GEVY+ ++ G       ++  +   P   +E  E D  +          E 
Sbjct: 42  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM----------EA 91
Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRH---- 312
           +  S+  H+NI+  +   ++     ++ E M  G L+  L +    R     PS      
Sbjct: 92  LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRET---RPRPSQPSSLAMLD 148
Query: 313 --RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN---DDMEACISDLGLAMAIPDGYT 367
              +A  +A G +YL   H    IH DI  RN LL        A I D G+A  I     
Sbjct: 149 LLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 205
Query: 368 RVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSP 426
                  +  + ++ PE F +   + K D +SFG+LL  +   G   +    N E     
Sbjct: 206 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE----- 260
Query: 427 EWLRKVMNSKNPSRAIDP--RLPGNGYEKKMLHVLKIAYICTLHDPEERPN 475
                V+        +DP    PG  Y        +I   C  H PE+RPN
Sbjct: 261 -----VLEFVTSGGRMDPPKNCPGPVY--------RIMTQCWQHQPEDRPN 298

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 99/226 (43%), Gaps = 41/226 (18%)
Query: 194 FASLEKIGSGGCGEV---YKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
           + +L+ IGSG  G V   Y A L     + +AIKK+    P               +  +
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVL----DRNVAIKKL--SRPFQ-----------NQTHAK 106
Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHL-------LVYEFMKNGSLQDILDDVSRGR 303
           +   E++    + H+NI+ LL ++  P   L       LV E M     Q I       +
Sbjct: 107 RAYRELVLMKCVNHKNIISLL-NVFTPQKTLEEFQDVYLVMELMDANLCQVI-------Q 158
Query: 304 RELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
            ELD      +   +  G+++LH   SA IIH D+KP N+++  D    I D GLA    
Sbjct: 159 MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA- 214
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR 409
            G + ++  YV+ T  Y APE        E  DI+S G ++  +VR
Sbjct: 215 -GTSFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR 258

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 98/221 (44%), Gaps = 30/221 (13%)
Query: 200 IGSGGCGEVYKAELPG-SNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT 258
           +G G  G+V  AE  G    K   + KV       A ++++ D+  +D  L  + SE+  
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKV-------AVKMLKSDATEKD--LSDLISEMEM 127
Query: 259 ASQI-RHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR---- 313
              I +H+NI+ LL    +     ++ E+   G+L++ L        E  +   H     
Sbjct: 128 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 187
Query: 314 --------IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP-- 363
                    A  VA G+EYL    S   IH D+  RNVL+ +D    I+D GLA  I   
Sbjct: 188 LSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 244
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
           D Y +     +   + ++APE       + + D++SFG+LL
Sbjct: 245 DYYKKTTNGRL--PVKWMAPEALFDRIYTHQSDVWSFGVLL 283

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 71/291 (24%), Positives = 110/291 (37%), Gaps = 46/291 (15%)
Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           +  +G G  GEVY+ ++ G       ++  +   P   +E  E D  +          E 
Sbjct: 52  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM----------EA 101
Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRH---- 312
           +  S+  H+NI+  +   ++     ++ E M  G L+  L +    R     PS      
Sbjct: 102 LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRET---RPRPSQPSSLAMLD 158
Query: 313 --RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN---DDMEACISDLGLAMAIPDGYT 367
              +A  +A G +YL   H    IH DI  RN LL        A I D G+A  I     
Sbjct: 159 LLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 215
Query: 368 RVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSP 426
                  +  + ++ PE F +   + K D +SFG+LL  +   G   +    N E     
Sbjct: 216 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE----- 270
Query: 427 EWLRKVMNSKNPSRAIDP--RLPGNGYEKKMLHVLKIAYICTLHDPEERPN 475
                V+        +DP    PG  Y        +I   C  H PE+RPN
Sbjct: 271 -----VLEFVTSGGRMDPPKNCPGPVY--------RIMTQCWQHQPEDRPN 308

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 95/217 (43%), Gaps = 41/217 (18%)
Query: 200 IGSGGCGEVY--KAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           +G+G  GEV   + +LP      +AIK + V                 + + R    E  
Sbjct: 51  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKV--------------GYTEKQRRDFLGEAS 96
Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL- 316
              Q  H NI+ L   + +    ++V E+M+NGSL   L      + +  +     + + 
Sbjct: 97  IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR-----KHDAQFTVIQLVGML 151
Query: 317 -GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPD----GYT---- 367
            G+ASG++YL        +H D+  RN+L+N ++   +SD GL+  + D     YT    
Sbjct: 152 RGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 208
Query: 368 RVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
           ++ I +        +PE     + +   D++S+G++L
Sbjct: 209 KIPIRWT-------SPEAIAYRKFTSASDVWSYGIVL 238

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 95/217 (43%), Gaps = 41/217 (18%)
Query: 200 IGSGGCGEVY--KAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           +G+G  GEV   + +LP      +AIK + V                 + + R    E  
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKV--------------GYTEKQRRDFLGEAS 98
Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL- 316
              Q  H NI+ L   + +    ++V E+M+NGSL   L      + +  +     + + 
Sbjct: 99  IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR-----KHDAQFTVIQLVGML 153
Query: 317 -GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPD----GYT---- 367
            G+ASG++YL        +H D+  RN+L+N ++   +SD GL+  + D     YT    
Sbjct: 154 RGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 210
Query: 368 RVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
           ++ I +        +PE     + +   D++S+G++L
Sbjct: 211 KIPIRWT-------SPEAIAYRKFTSASDVWSYGIVL 240

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 98/221 (44%), Gaps = 30/221 (13%)
Query: 200 IGSGGCGEVYKAELPG-SNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT 258
           +G G  G+V  AE  G    K   + KV       A ++++ D+  +D  L  + SE+  
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKV-------AVKMLKSDATEKD--LSDLISEMEM 79
Query: 259 ASQI-RHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR---- 313
              I +H+NI+ LL    +     ++ E+   G+L++ L        E  +   H     
Sbjct: 80  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 139
Query: 314 --------IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP-- 363
                    A  VA G+EYL    S   IH D+  RNVL+ +D    I+D GLA  I   
Sbjct: 140 LSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 196
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
           D Y +     +   + ++APE       + + D++SFG+LL
Sbjct: 197 DYYKKTTNGRL--PVKWMAPEALFDRIYTHQSDVWSFGVLL 235

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 101/244 (41%), Gaps = 40/244 (16%)
Query: 170 DRGPTIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAE---LPGSNGKMIAIKKV 226
           DR PT F    E+  L FL         +++G G  G V       L  + G+++A+KK+
Sbjct: 7   DRDPTQF----EERHLKFL---------QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL 53
Query: 227 IVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL--LAHMVRPDCHLLVY 284
                              +  LR    EI     ++H NI+    + +        L+ 
Sbjct: 54  ---------------QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIM 98
Query: 285 EFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVL 344
           E++  GSL+D L    + +  +D     +    +  G+EYL    +   IH D+  RN+L
Sbjct: 99  EYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNIL 152
Query: 345 LNDDMEACISDLGLAMAIP-DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGML 403
           + ++    I D GL   +P D     +       + + APE   + + S   D++SFG++
Sbjct: 153 VENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVV 212
Query: 404 LISL 407
           L  L
Sbjct: 213 LYEL 216

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 99/226 (43%), Gaps = 41/226 (18%)
Query: 194 FASLEKIGSGGCGEV---YKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
           + +L+ IGSG  G V   Y A L     + +AIKK+    P               +  +
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAVL----DRNVAIKKL--SRPFQ-----------NQTHAK 69
Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHL-------LVYEFMKNGSLQDILDDVSRGR 303
           +   E++    + H+NI+ LL ++  P   L       LV E M     Q I       +
Sbjct: 70  RAYRELVLMKCVNHKNIISLL-NVFTPQKTLEEFQDVYLVMELMDANLCQVI-------Q 121
Query: 304 RELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
            ELD      +   +  G+++LH   SA IIH D+KP N+++  D    I D GLA    
Sbjct: 122 MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA- 177
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR 409
            G + ++  YV+ T  Y APE        E  DI+S G ++  +VR
Sbjct: 178 -GTSFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR 221

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 73/294 (24%), Positives = 132/294 (44%), Gaps = 53/294 (18%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           ++ L++IGSGG  +V++          +  +K  +YA I    L E D++  DS     R
Sbjct: 58  YSILKQIGSGGSSKVFQ----------VLNEKKQIYA-IKYVNLEEADNQTLDS----YR 102
Query: 254 SEIITASQIRHRN--ILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
           +EI   ++++  +  I+ L  + +       +Y  M+ G++   L+   + ++ +D   R
Sbjct: 103 NEIAYLNKLQQHSDKIIRLYDYEITDQ---YIYMVMECGNID--LNSWLKKKKSIDPWER 157
Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLI 371
                 +   LE +H  H   I+H D+KP N L+ D M   I D G+A  +    T V+ 
Sbjct: 158 KSYWKNM---LEAVHTIHQHGIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVK 213
Query: 372 SYVLGTMAYIAPEYFQQPELSEK-----------CDIFSFGMLLISLVRGVPSFVFHQNG 420
              +GT+ Y+ PE  +    S +            D++S G +L  +  G   F      
Sbjct: 214 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------ 267
Query: 421 EEICSPEWLRKVMNSKNPSRAID-PRLPGNGYEKKMLHVLKIAYICTLHDPEER 473
           ++I +   + K+    +P+  I+ P +P    EK +  VLK    C   DP++R
Sbjct: 268 QQIINQ--ISKLHAIIDPNHEIEFPDIP----EKDLQDVLK---CCLKRDPKQR 312

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 69/293 (23%), Positives = 123/293 (41%), Gaps = 48/293 (16%)
Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           +K+G+G  GEV+ A     N       K +    +S    + E + ++            
Sbjct: 194 KKLGAGQFGEVWMATY---NKHTKVAVKTMKPGSMSVEAFLAEANVMK------------ 238
Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALG 317
               ++H  ++ L A + +   +++  EFM  GSL D L      ++ L  P     +  
Sbjct: 239 ---TLQHDKLVKLHAVVTKEPIYIIT-EFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQ 292
Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG-YT-RVLISYVL 375
           +A G+ ++      + IH D++  N+L++  +   I+D GLA  I D  YT R    +  
Sbjct: 293 IAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF-- 347
Query: 376 GTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR--GVPSFVFHQNGEEICSPEWLRKVM 433
             + + APE       + K D++SFG+LL+ +V    +P          + +PE +R + 
Sbjct: 348 -PIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY-------PGMSNPEVIRALE 399
Query: 434 NSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL 486
                 R      P N  E+    +  I   C  + PEERP  +Y++  L   
Sbjct: 400 RGYRMPR------PENCPEE----LYNIMMRCWKNRPEERPTFEYIQSVLDDF 442

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 98/234 (41%), Gaps = 47/234 (20%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKV------IVYAPISAAELIEEDSKLRDS 247
           + +L  +GSG  G V  A      G  +A+KK+      I++A  +  EL      ++  
Sbjct: 44  YQNLSPVGSGAYGSVCAA-FDTKTGHRVAVKKLSRPFQSIIHAKRTYREL-RLLKHMKHE 101
Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELD 307
            +  +      A  +   N + L+ H++  D + +V         Q + DD         
Sbjct: 102 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-------KCQKLTDD--------- 145
Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
                 +   +  GL+Y+H   SA IIH D+KP N+ +N+D E  I D GLA    D  T
Sbjct: 146 --HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 200
Query: 368 RVLISYVLGTMAYIAPEYFQQPEL-------SEKCDIFSFGMLLISLVRGVPSF 414
                       Y+A  +++ PE+       ++  DI+S G ++  L+ G   F
Sbjct: 201 -----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 243

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 93/222 (41%), Gaps = 22/222 (9%)
Query: 183 EDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDS 242
           +D   L  ED     E+IG G  GEV+   L   N  ++A+K        S  E +  D 
Sbjct: 106 KDKWVLNHEDLVLG-EQIGRGNFGEVFSGRLRADN-TLVAVK--------SCRETLPPDL 155
Query: 243 KLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG 302
           K   +K  Q   E     Q  H NI+ L+    +     +V E ++ G     L   + G
Sbjct: 156 K---AKFLQ---EARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLR--TEG 207
Query: 303 RRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI 362
            R L   +  ++    A+G+EYL    S   IH D+  RN L+ +     ISD G++   
Sbjct: 208 AR-LRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREE 263
Query: 363 PDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
            DG            + + APE       S + D++SFG+LL
Sbjct: 264 ADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILL 305

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 106/228 (46%), Gaps = 31/228 (13%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           + +L  IG G  G V  A     N   +AIKK+  +          E        LR+I+
Sbjct: 27  YTNLSYIGEGAYGMVCSA-YDNVNKVRVAIKKISPF----------EHQTYCQRTLREIK 75
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSL-QDILD-DVSRGRRELDWPSR 311
             I+ A   RH NI+ +   +  P       E MK+  + QD+++ D+ +  +     + 
Sbjct: 76  --ILLA--FRHENIIGINDIIRAP-----TIEQMKDVYIVQDLMETDLYKLLKTQHLSND 126
Query: 312 H--RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA-MAIPD-GYT 367
           H       +  GL+Y+H   SA+++H D+KP N+LLN   +  I D GLA +A PD  +T
Sbjct: 127 HICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHT 183
Query: 368 RVLISYVLGTMAYIAPEYFQQPE-LSEKCDIFSFGMLLISLVRGVPSF 414
             L  YV  T  Y APE     +  ++  DI+S G +L  ++   P F
Sbjct: 184 GFLTEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 230

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 98/221 (44%), Gaps = 30/221 (13%)
Query: 200 IGSGGCGEVYKAELPG-SNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT 258
           +G G  G+V  AE  G    K   + KV       A ++++ D+  +D  L  + SE+  
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKV-------AVKMLKSDATEKD--LSDLISEMEM 78
Query: 259 ASQI-RHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR---- 313
              I +H+NI+ LL    +     ++ E+   G+L++ L        E  +   H     
Sbjct: 79  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 138
Query: 314 --------IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP-- 363
                    A  VA G+EYL    S   IH D+  RNVL+ +D    I+D GLA  I   
Sbjct: 139 LSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 195
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
           D Y +     +   + ++APE       + + D++SFG+LL
Sbjct: 196 DYYKKTTNGRL--PVKWMAPEALFDRIYTHQSDVWSFGVLL 234

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 65/250 (26%), Positives = 106/250 (42%), Gaps = 69/250 (27%)
Query: 190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKL 249
           +E  +   + IG+G  G VY+A+L  S G+++AIKKV+            +D + ++ +L
Sbjct: 97  QEVSYTDTKVIGNGSFGVVYQAKLCDS-GELVAIKKVL------------QDKRFKNREL 143
Query: 250 RQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQD------ILDDVSRGR 303
           + +R       ++ H NI+             L Y F  +G  +D      +LD V    
Sbjct: 144 QIMR-------KLDHCNIV------------RLRYFFYSSGEKKDEVYLNLVLDYVPETV 184
Query: 304 RELDWPSRHRIALGVASGLEYLHMY-----------HSASIIHGDIKPRNVLLNDDMEAC 352
             +   +RH         + Y+ +Y           HS  I H DIKP+N+LL+ D    
Sbjct: 185 YRV---ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVL 241
Query: 353 -ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPEL-------SEKCDIFSFGMLL 404
            + D G A  +  G   V         +YI   Y++ PEL       +   D++S G +L
Sbjct: 242 KLCDFGSAKQLVRGEPNV---------SYICSRYYRAPELIFGATDYTSSIDVWSAGCVL 292
Query: 405 ISLVRGVPSF 414
             L+ G P F
Sbjct: 293 AELLLGQPIF 302

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 98/234 (41%), Gaps = 47/234 (20%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKV------IVYAPISAAELIEEDSKLRDS 247
           + +L  +GSG  G V  A      G  +A+KK+      I++A  +  EL      ++  
Sbjct: 24  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYREL-RLLKHMKHE 81
Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELD 307
            +  +      A  +   N + L+ H++  D + +V         Q + DD         
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-------KXQKLTDD--------- 125
Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
                 +   +  GL+Y+H   SA IIH D+KP N+ +N+D E  I D GLA    D  T
Sbjct: 126 --HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMT 180
Query: 368 RVLISYVLGTMAYIAPEYFQQPEL-------SEKCDIFSFGMLLISLVRGVPSF 414
                       Y+A  +++ PE+       ++  DI+S G ++  L+ G   F
Sbjct: 181 -----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 101/244 (41%), Gaps = 40/244 (16%)
Query: 170 DRGPTIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAE---LPGSNGKMIAIKKV 226
           DR PT F    E+  L FL++         +G G  G V       L  + G+++A+KK+
Sbjct: 4   DRDPTQF----EERHLKFLRQ---------LGKGNFGSVEMCRYDPLQDNTGEVVAVKKL 50
Query: 227 IVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL--LAHMVRPDCHLLVY 284
                              +  LR    EI     ++H NI+    + +        L+ 
Sbjct: 51  ---------------QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIM 95
Query: 285 EFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVL 344
           EF+  GSL++ L    + +  +D     +    +  G+EYL    +   IH D+  RN+L
Sbjct: 96  EFLPYGSLREYL---QKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNIL 149
Query: 345 LNDDMEACISDLGLAMAIP-DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGML 403
           + ++    I D GL   +P D     +       + + APE   + + S   D++SFG++
Sbjct: 150 VENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVV 209
Query: 404 LISL 407
           L  L
Sbjct: 210 LYEL 213

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 99/226 (43%), Gaps = 41/226 (18%)
Query: 194 FASLEKIGSGGCGEV---YKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
           + +L+ IGSG  G V   Y A L     + +AIKK+    P               +  +
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVL----DRNVAIKKL--SRPFQ-----------NQTHAK 68
Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHL-------LVYEFMKNGSLQDILDDVSRGR 303
           +   E++    + H+NI+ LL ++  P   L       LV E M     Q I       +
Sbjct: 69  RAYRELVLMKCVNHKNIISLL-NVFTPQKTLEEFQDVYLVMELMDANLCQVI-------Q 120
Query: 304 RELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
            ELD      +   +  G+++LH   SA IIH D+KP N+++  D    I D GLA    
Sbjct: 121 MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA- 176
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR 409
            G + ++  YV+ T  Y APE        E  DI+S G ++  +VR
Sbjct: 177 -GTSFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR 220

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 71/291 (24%), Positives = 110/291 (37%), Gaps = 46/291 (15%)
Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           +  +G G  GEVY+ ++ G       ++  +   P   +E  E D  +          E 
Sbjct: 35  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM----------EA 84
Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRH---- 312
           +  S+  H+NI+  +   ++     ++ E M  G L+  L +    R     PS      
Sbjct: 85  LIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRET---RPRPSQPSSLAMLD 141
Query: 313 --RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN---DDMEACISDLGLAMAIPDGYT 367
              +A  +A G +YL   H    IH DI  RN LL        A I D G+A  I     
Sbjct: 142 LLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 198
Query: 368 RVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSP 426
                  +  + ++ PE F +   + K D +SFG+LL  +   G   +    N E     
Sbjct: 199 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE----- 253
Query: 427 EWLRKVMNSKNPSRAIDP--RLPGNGYEKKMLHVLKIAYICTLHDPEERPN 475
                V+        +DP    PG  Y        +I   C  H PE+RPN
Sbjct: 254 -----VLEFVTSGGRMDPPKNCPGPVY--------RIMTQCWQHQPEDRPN 291

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 99/226 (43%), Gaps = 41/226 (18%)
Query: 194 FASLEKIGSGGCGEV---YKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
           + +L+ IGSG  G V   Y A L     + +AIKK+    P               +  +
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAVL----DRNVAIKKL--SRPFQ-----------NQTHAK 69
Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHL-------LVYEFMKNGSLQDILDDVSRGR 303
           +   E++    + H+NI+ LL ++  P   L       LV E M     Q I       +
Sbjct: 70  RAYRELVLMKCVNHKNIISLL-NVFTPQKTLEEFQDVYLVMELMDANLCQVI-------Q 121
Query: 304 RELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
            ELD      +   +  G+++LH   SA IIH D+KP N+++  D    I D GLA    
Sbjct: 122 MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA- 177
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR 409
            G + ++  YV+ T  Y APE        E  DI+S G ++  +VR
Sbjct: 178 -GTSFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR 221

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 71/291 (24%), Positives = 110/291 (37%), Gaps = 46/291 (15%)
Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           +  +G G  GEVY+ ++ G       ++  +   P   +E  E D  +          E 
Sbjct: 35  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM----------EA 84
Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRH---- 312
           +  S+  H+NI+  +   ++     ++ E M  G L+  L +    R     PS      
Sbjct: 85  LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRET---RPRPSQPSSLAMLD 141
Query: 313 --RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN---DDMEACISDLGLAMAIPDGYT 367
              +A  +A G +YL   H    IH DI  RN LL        A I D G+A  I     
Sbjct: 142 LLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 198
Query: 368 RVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSP 426
                  +  + ++ PE F +   + K D +SFG+LL  +   G   +    N E     
Sbjct: 199 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE----- 253
Query: 427 EWLRKVMNSKNPSRAIDP--RLPGNGYEKKMLHVLKIAYICTLHDPEERPN 475
                V+        +DP    PG  Y        +I   C  H PE+RPN
Sbjct: 254 -----VLEFVTSGGRMDPPKNCPGPVY--------RIMTQCWQHQPEDRPN 291

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 99/226 (43%), Gaps = 41/226 (18%)
Query: 194 FASLEKIGSGGCGEV---YKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
           + +L+ IGSG  G V   Y A L     + +AIKK+    P               +  +
Sbjct: 25  YQNLKPIGSGAQGIVCAAYDAVL----DRNVAIKKL--SRPFQ-----------NQTHAK 67
Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHL-------LVYEFMKNGSLQDILDDVSRGR 303
           +   E++    + H+NI+ LL ++  P   L       LV E M     Q I       +
Sbjct: 68  RAYRELVLMKCVNHKNIISLL-NVFTPQKTLEEFQDVYLVMELMDANLCQVI-------Q 119
Query: 304 RELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
            ELD      +   +  G+++LH   SA IIH D+KP N+++  D    I D GLA    
Sbjct: 120 MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA- 175
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR 409
            G + ++  YV+ T  Y APE        E  DI+S G ++  +VR
Sbjct: 176 -GTSFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR 219

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 98/221 (44%), Gaps = 30/221 (13%)
Query: 200 IGSGGCGEVYKAELPG-SNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT 258
           +G G  G+V  AE  G    K   + KV       A ++++ D+  +D  L  + SE+  
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKV-------AVKMLKSDATEKD--LSDLISEMEM 86
Query: 259 ASQI-RHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR---- 313
              I +H+NI+ LL    +     ++ E+   G+L++ L        E  +   H     
Sbjct: 87  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 146
Query: 314 --------IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP-- 363
                    A  VA G+EYL    S   IH D+  RNVL+ +D    I+D GLA  I   
Sbjct: 147 LSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 203
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
           D Y +     +   + ++APE       + + D++SFG+LL
Sbjct: 204 DYYKKTTNGRL--PVKWMAPEALFDRIYTHQSDVWSFGVLL 242

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 98/234 (41%), Gaps = 47/234 (20%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKV------IVYAPISAAELIEEDSKLRDS 247
           + +L  +GSG  G V  A      G  +A+KK+      I++A  +  EL      ++  
Sbjct: 43  YQNLSPVGSGAYGSVCAA-FDTKTGHRVAVKKLSRPFQSIIHAKRTYREL-RLLKHMKHE 100
Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELD 307
            +  +      A  +   N + L+ H++  D + +V         Q + DD         
Sbjct: 101 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-------KCQKLTDD--------- 144
Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
                 +   +  GL+Y+H   SA IIH D+KP N+ +N+D E  I D GLA    D  T
Sbjct: 145 --HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 199
Query: 368 RVLISYVLGTMAYIAPEYFQQPEL-------SEKCDIFSFGMLLISLVRGVPSF 414
                       Y+A  +++ PE+       ++  DI+S G ++  L+ G   F
Sbjct: 200 -----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 242

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 99/226 (43%), Gaps = 41/226 (18%)
Query: 194 FASLEKIGSGGCGEV---YKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
           + +L+ IGSG  G V   Y A L     + +AIKK+    P               +  +
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVL----DRNVAIKKL--SRPFQ-----------NQTHAK 68
Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHL-------LVYEFMKNGSLQDILDDVSRGR 303
           +   E++    + H+NI+ LL ++  P   L       LV E M     Q I       +
Sbjct: 69  RAYRELVLMKCVNHKNIISLL-NVFTPQKTLEEFQDVYLVMELMDANLCQVI-------Q 120
Query: 304 RELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
            ELD      +   +  G+++LH   SA IIH D+KP N+++  D    I D GLA    
Sbjct: 121 MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA- 176
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR 409
            G + ++  YV+ T  Y APE        E  DI+S G ++  +VR
Sbjct: 177 -GTSFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR 220

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 64/262 (24%), Positives = 110/262 (41%), Gaps = 51/262 (19%)
Query: 166 GGSRDRGPTIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKK 225
           G S++R PT +   + K      +  + + +L  +GSG  G V  A      G  +A+KK
Sbjct: 11  GMSQER-PTFYRQELNK---TIWEVPERYQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKK 65
Query: 226 V------IVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDC 279
           +      I++A  +  EL      ++   +  +      A  +   N + L+ H++  D 
Sbjct: 66  LSRPFQSIIHAKRTYREL-RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 124
Query: 280 HLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIK 339
           + +V         Q + DD               +   +  GL+Y+H   SA IIH D+K
Sbjct: 125 NNIV-------KCQKLTDD-----------HVQFLIYQILRGLKYIH---SADIIHRDLK 163
Query: 340 PRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPEL-------S 392
           P N+ +N+D E  I D GLA    D  T            Y+A  +++ PE+       +
Sbjct: 164 PSNLAVNEDXELKILDFGLARHTDDEMT-----------GYVATRWYRAPEIMLNWMHYN 212
Query: 393 EKCDIFSFGMLLISLVRGVPSF 414
           +  DI+S G ++  L+ G   F
Sbjct: 213 QTVDIWSVGCIMAELLTGRTLF 234

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 69/253 (27%), Positives = 107/253 (42%), Gaps = 40/253 (15%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           +  L+ IGSG  G +  A      G  +A+KK+    P               +  ++  
Sbjct: 24  YQQLKPIGSGAQG-IVCAAFDTVLGINVAVKKL--SRPFQ-----------NQTHAKRAY 69
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHL-------LVYEFMKNGSLQDILDDVSRGRREL 306
            E++    + H+NI+ LL ++  P   L       LV E M     Q I         EL
Sbjct: 70  RELVLLKCVNHKNIISLL-NVFTPQKTLEEFQDVYLVMELMDANLCQVI-------HMEL 121
Query: 307 DWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGY 366
           D      +   +  G+++LH   SA IIH D+KP N+++  D    I D GLA      +
Sbjct: 122 DHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTASTNF 178
Query: 367 TRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSP 426
             ++  YV+ T  Y APE        E  DI+S G ++  LV+G  S +F Q  + I   
Sbjct: 179 --MMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG--SVIF-QGTDHI--D 230
Query: 427 EWLRKVMNSKNPS 439
           +W + +     PS
Sbjct: 231 QWNKVIEQLGTPS 243

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 99/226 (43%), Gaps = 41/226 (18%)
Query: 194 FASLEKIGSGGCGEV---YKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
           + +L+ IGSG  G V   Y A L     + +AIKK+    P               +  +
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAVL----DRNVAIKKL--SRPFQ-----------NQTHAK 62
Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHL-------LVYEFMKNGSLQDILDDVSRGR 303
           +   E++    + H+NI+ LL ++  P   L       LV E M     Q I       +
Sbjct: 63  RAYRELVLMKCVNHKNIISLL-NVFTPQKTLEEFQDVYLVMELMDANLCQVI-------Q 114
Query: 304 RELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
            ELD      +   +  G+++LH   SA IIH D+KP N+++  D    I D GLA    
Sbjct: 115 MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA- 170
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR 409
            G + ++  YV+ T  Y APE        E  DI+S G ++  +VR
Sbjct: 171 -GTSFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR 214

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 94/217 (43%), Gaps = 41/217 (18%)
Query: 200 IGSGGCGEVY--KAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           +G+G  GEV   + +LP      +AIK + V                 + + R    E  
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKV--------------GYTEKQRRDFLGEAS 98
Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL- 316
              Q  H NI+ L   + +    ++V E+M+NGSL   L      + +  +     + + 
Sbjct: 99  IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR-----KHDAQFTVIQLVGML 153
Query: 317 -GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPD----GYT---- 367
            G+ASG++YL        +H D+  RN+L+N ++   +SD GL   + D     YT    
Sbjct: 154 RGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGG 210
Query: 368 RVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
           ++ I +        +PE     + +   D++S+G++L
Sbjct: 211 KIPIRWT-------SPEAIAYRKFTSASDVWSYGIVL 240

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 98/234 (41%), Gaps = 47/234 (20%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKV------IVYAPISAAELIEEDSKLRDS 247
           + +L  +GSG  G V  A      G  +A+KK+      I++A  +  EL      ++  
Sbjct: 34  YQNLAPVGSGAYGSVCAA-FDTKTGHRVAVKKLSRPFQSIIHAKRTYREL-RLLKHMKHE 91
Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELD 307
            +  +      A  +   N + L+ H++  D + +V         Q + DD         
Sbjct: 92  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-------KCQKLTDD--------- 135
Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
                 +   +  GL+Y+H   SA IIH D+KP N+ +N+D E  I D GLA    D  T
Sbjct: 136 --HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 190
Query: 368 RVLISYVLGTMAYIAPEYFQQPEL-------SEKCDIFSFGMLLISLVRGVPSF 414
                       Y+A  +++ PE+       ++  DI+S G ++  L+ G   F
Sbjct: 191 -----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 233

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 105/228 (46%), Gaps = 31/228 (13%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           + +L  IG G  G V  A     N   +AIKK+   +P       +          R +R
Sbjct: 23  YTNLSYIGEGAYGMVCSA-YDNLNKVRVAIKKI---SPFEHQTYCQ----------RTLR 68
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSL-QDILD-DVSRGRRELDWPSR 311
            EI    + RH NI+ +   +  P       E MK+  + QD+++ D+ +  +     + 
Sbjct: 69  -EIKILLRFRHENIIGINDIIRAP-----TIEQMKDVYIVQDLMETDLYKLLKTQHLSND 122
Query: 312 H--RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA-MAIPD-GYT 367
           H       +  GL+Y+H   SA+++H D+KP N+LLN   +  I D GLA +A PD  +T
Sbjct: 123 HICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 179
Query: 368 RVLISYVLGTMAYIAPEYFQQPE-LSEKCDIFSFGMLLISLVRGVPSF 414
             L  YV  T  Y APE     +  ++  DI+S G +L  ++   P F
Sbjct: 180 GFLTEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 226

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 69/289 (23%), Positives = 109/289 (37%), Gaps = 42/289 (14%)
Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           +  +G G  GEVY+ ++ G       ++  +   P   +E  E D  +          E 
Sbjct: 50  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM----------EA 99
Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRH---- 312
           +  S+  H+NI+  +   ++     ++ E M  G L+  L +    R     PS      
Sbjct: 100 LIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRET---RPRPSQPSSLAMLD 156
Query: 313 --RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN---DDMEACISDLGLAMAIPDGYT 367
              +A  +A G +YL   H    IH DI  RN LL        A I D G+A  I     
Sbjct: 157 LLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 213
Query: 368 RVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSP 426
                  +  + ++ PE F +   + K D +SFG+LL  +   G   +    N E +   
Sbjct: 214 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL--- 270
Query: 427 EWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPN 475
           E++        P     P             V +I   C  H PE+RPN
Sbjct: 271 EFVTSGGRMDPPKNCPGP-------------VYRIMTQCWQHQPEDRPN 306

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 105/228 (46%), Gaps = 31/228 (13%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           + +L  IG G  G V  A     N   +AIKK+   +P       +          R +R
Sbjct: 29  YTNLSYIGEGAYGMVCSA-YDNLNKVRVAIKKI---SPFEHQTYCQ----------RTLR 74
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSL-QDILD-DVSRGRRELDWPSR 311
            EI    + RH NI+ +   +  P       E MK+  + QD+++ D+ +  +     + 
Sbjct: 75  -EIKILLRFRHENIIGINDIIRAP-----TIEQMKDVYIVQDLMETDLYKLLKTQHLSND 128
Query: 312 H--RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA-MAIPD-GYT 367
           H       +  GL+Y+H   SA+++H D+KP N+LLN   +  I D GLA +A PD  +T
Sbjct: 129 HICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHT 185
Query: 368 RVLISYVLGTMAYIAPEYFQQPE-LSEKCDIFSFGMLLISLVRGVPSF 414
             L  YV  T  Y APE     +  ++  DI+S G +L  ++   P F
Sbjct: 186 GFLTEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 105/228 (46%), Gaps = 31/228 (13%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           + +L  IG G  G V  A     N   +AIKK+   +P       +          R +R
Sbjct: 23  YTNLSYIGEGAYGMVCSA-YDNLNKVRVAIKKI---SPFEHQTYCQ----------RTLR 68
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSL-QDILD-DVSRGRRELDWPSR 311
            EI    + RH NI+ +   +  P       E MK+  + QD+++ D+ +  +     + 
Sbjct: 69  -EIKILLRFRHENIIGINDIIRAP-----TIEQMKDVYIVQDLMETDLYKLLKTQHLSND 122
Query: 312 H--RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA-MAIPD-GYT 367
           H       +  GL+Y+H   SA+++H D+KP N+LLN   +  I D GLA +A PD  +T
Sbjct: 123 HICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 179
Query: 368 RVLISYVLGTMAYIAPEYFQQPE-LSEKCDIFSFGMLLISLVRGVPSF 414
             L  YV  T  Y APE     +  ++  DI+S G +L  ++   P F
Sbjct: 180 GFLTEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 226

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 105/228 (46%), Gaps = 31/228 (13%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           + +L  IG G  G V  A     N   +AIKK+   +P       +          R +R
Sbjct: 45  YTNLSYIGEGAYGMVCSA-YDNVNKVRVAIKKI---SPFEHQTYCQ----------RTLR 90
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSL-QDILD-DVSRGRRELDWPSR 311
            EI    + RH NI+ +   +  P       E MK+  + QD+++ D+ +  +     + 
Sbjct: 91  -EIKILLRFRHENIIGINDIIRAP-----TIEQMKDVYIVQDLMETDLYKLLKTQHLSND 144
Query: 312 H--RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA-MAIPD-GYT 367
           H       +  GL+Y+H   SA+++H D+KP N+LLN   +  I D GLA +A PD  +T
Sbjct: 145 HICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 201
Query: 368 RVLISYVLGTMAYIAPEYFQQPE-LSEKCDIFSFGMLLISLVRGVPSF 414
             L  YV  T  Y APE     +  ++  DI+S G +L  ++   P F
Sbjct: 202 GFLTEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 248

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 99/226 (43%), Gaps = 41/226 (18%)
Query: 194 FASLEKIGSGGCGEV---YKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
           + +L+ IGSG  G V   Y A L     + +AIKK+    P               +  +
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAVL----DRNVAIKKL--SRPFQ-----------NQTHAK 62
Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHL-------LVYEFMKNGSLQDILDDVSRGR 303
           +   E++    + H+NI+ LL ++  P   L       LV E M     Q I       +
Sbjct: 63  RAYRELVLMKCVNHKNIISLL-NVFTPQKTLEEFQDVYLVMELMDANLCQVI-------Q 114
Query: 304 RELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
            ELD      +   +  G+++LH   SA IIH D+KP N+++  D    I D GLA    
Sbjct: 115 MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA- 170
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR 409
            G + ++  YV+ T  Y APE        E  DI+S G ++  +VR
Sbjct: 171 -GTSFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR 214

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 133/295 (45%), Gaps = 55/295 (18%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           ++ L++IGSGG  +V++          +  +K  +YA I    L E D++  DS     R
Sbjct: 10  YSILKQIGSGGSSKVFQ----------VLNEKKQIYA-IKYVNLEEADNQTLDS----YR 54
Query: 254 SEIITASQIRHRN--ILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELD-WPS 310
           +EI   ++++  +  I+ L  + +       +Y  M+ G++   L+   + ++ +D W  
Sbjct: 55  NEIAYLNKLQQHSDKIIRLYDYEITDQ---YIYMVMECGNID--LNSWLKKKKSIDPWER 109
Query: 311 RHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVL 370
           +        + LE +H  H   I+H D+KP N L+ D M   I D G+A  +    T V+
Sbjct: 110 KSYWK----NMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVV 164
Query: 371 ISYVLGTMAYIAPEYFQQPELSEK-----------CDIFSFGMLLISLVRGVPSFVFHQN 419
               +GT+ Y+ PE  +    S +            D++S G +L  +  G   F     
Sbjct: 165 KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF----- 219
Query: 420 GEEICSPEWLRKVMNSKNPSRAID-PRLPGNGYEKKMLHVLKIAYICTLHDPEER 473
            ++I +   + K+    +P+  I+ P +P    EK +  VLK    C   DP++R
Sbjct: 220 -QQIINQ--ISKLHAIIDPNHEIEFPDIP----EKDLQDVLK---CCLKRDPKQR 264

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 98/234 (41%), Gaps = 47/234 (20%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKV------IVYAPISAAELIEEDSKLRDS 247
           + +L  +GSG  G V  A      G  +A+KK+      I++A  +  EL      ++  
Sbjct: 31  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYREL-RLLKHMKHE 88
Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELD 307
            +  +      A  +   N + L+ H++  D + +V         Q + DD         
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-------KCQKLTDD--------- 132
Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
                 +   +  GL+Y+H   SA IIH D+KP N+ +N+D E  I D GLA    D  T
Sbjct: 133 --HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT 187
Query: 368 RVLISYVLGTMAYIAPEYFQQPEL-------SEKCDIFSFGMLLISLVRGVPSF 414
                       Y+A  +++ PE+       ++  DI+S G ++  L+ G   F
Sbjct: 188 -----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 230

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 105/228 (46%), Gaps = 31/228 (13%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           + +L  IG G  G V  A     N   +AIKK+   +P       +          R +R
Sbjct: 30  YTNLSYIGEGAYGMVCSA-YDNLNKVRVAIKKI---SPFEHQTYCQ----------RTLR 75
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSL-QDILD-DVSRGRRELDWPSR 311
            EI    + RH NI+ +   +  P       E MK+  + QD+++ D+ +  +     + 
Sbjct: 76  -EIKILLRFRHENIIGINDIIRAP-----TIEQMKDVYIVQDLMETDLYKLLKTQHLSND 129
Query: 312 H--RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA-MAIPD-GYT 367
           H       +  GL+Y+H   SA+++H D+KP N+LLN   +  I D GLA +A PD  +T
Sbjct: 130 HICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 186
Query: 368 RVLISYVLGTMAYIAPEYFQQPE-LSEKCDIFSFGMLLISLVRGVPSF 414
             L  YV  T  Y APE     +  ++  DI+S G +L  ++   P F
Sbjct: 187 GFLTEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 233

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 105/228 (46%), Gaps = 31/228 (13%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           + +L  IG G  G V  A     N   +AIKK+   +P       +          R +R
Sbjct: 31  YTNLSYIGEGAYGMVCSA-YDNLNKVRVAIKKI---SPFEHQTYCQ----------RTLR 76
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSL-QDILD-DVSRGRRELDWPSR 311
            EI    + RH NI+ +   +  P       E MK+  + QD+++ D+ +  +     + 
Sbjct: 77  -EIKILLRFRHENIIGINDIIRAP-----TIEQMKDVYIVQDLMETDLYKLLKTQHLSND 130
Query: 312 H--RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA-MAIPD-GYT 367
           H       +  GL+Y+H   SA+++H D+KP N+LLN   +  I D GLA +A PD  +T
Sbjct: 131 HICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 187
Query: 368 RVLISYVLGTMAYIAPEYFQQPE-LSEKCDIFSFGMLLISLVRGVPSF 414
             L  YV  T  Y APE     +  ++  DI+S G +L  ++   P F
Sbjct: 188 GFLTEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 234

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 105/228 (46%), Gaps = 31/228 (13%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           + +L  IG G  G V  A     N   +AIKK+   +P       +          R +R
Sbjct: 22  YTNLSYIGEGAYGMVCSA-YDNLNKVRVAIKKI---SPFEHQTYCQ----------RTLR 67
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSL-QDILD-DVSRGRRELDWPSR 311
            EI    + RH NI+ +   +  P       E MK+  + QD+++ D+ +  +     + 
Sbjct: 68  -EIKILLRFRHENIIGINDIIRAP-----TIEQMKDVYIVQDLMETDLYKLLKTQHLSND 121
Query: 312 H--RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA-MAIPD-GYT 367
           H       +  GL+Y+H   SA+++H D+KP N+LLN   +  I D GLA +A PD  +T
Sbjct: 122 HICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 178
Query: 368 RVLISYVLGTMAYIAPEYFQQPE-LSEKCDIFSFGMLLISLVRGVPSF 414
             L  YV  T  Y APE     +  ++  DI+S G +L  ++   P F
Sbjct: 179 GFLTEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 225

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 105/228 (46%), Gaps = 31/228 (13%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           + +L  IG G  G V  A     N   +AIKK+   +P       +          R +R
Sbjct: 29  YTNLSYIGEGAYGMVCSA-YDNLNKVRVAIKKI---SPFEHQTYCQ----------RTLR 74
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSL-QDILD-DVSRGRRELDWPSR 311
            EI    + RH NI+ +   +  P       E MK+  + QD+++ D+ +  +     + 
Sbjct: 75  -EIKILLRFRHENIIGINDIIRAP-----TIEQMKDVYIVQDLMETDLYKLLKTQHLSND 128
Query: 312 H--RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA-MAIPD-GYT 367
           H       +  GL+Y+H   SA+++H D+KP N+LLN   +  I D GLA +A PD  +T
Sbjct: 129 HICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 185
Query: 368 RVLISYVLGTMAYIAPEYFQQPE-LSEKCDIFSFGMLLISLVRGVPSF 414
             L  YV  T  Y APE     +  ++  DI+S G +L  ++   P F
Sbjct: 186 GFLTEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 98/234 (41%), Gaps = 47/234 (20%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKV------IVYAPISAAELIEEDSKLRDS 247
           + +L  +GSG  G V  A      G  +A+KK+      I++A  +  EL      ++  
Sbjct: 29  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYREL-RLLKHMKHE 86
Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELD 307
            +  +      A  +   N + L+ H++  D + +V         Q + DD         
Sbjct: 87  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-------KCQKLTDD--------- 130
Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
                 +   +  GL+Y+H   SA IIH D+KP N+ +N+D E  I D GLA    D  T
Sbjct: 131 --HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMT 185
Query: 368 RVLISYVLGTMAYIAPEYFQQPEL-------SEKCDIFSFGMLLISLVRGVPSF 414
                       Y+A  +++ PE+       ++  DI+S G ++  L+ G   F
Sbjct: 186 -----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 228

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 98/234 (41%), Gaps = 47/234 (20%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKV------IVYAPISAAELIEEDSKLRDS 247
           + +L  +GSG  G V  A      G  +A+KK+      I++A  +  EL      ++  
Sbjct: 31  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYREL-RLLKHMKHE 88
Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELD 307
            +  +      A  +   N + L+ H++  D + +V         Q + DD         
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-------KCQKLTDD--------- 132
Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
                 +   +  GL+Y+H   SA IIH D+KP N+ +N+D E  I D GLA    D  T
Sbjct: 133 --HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT 187
Query: 368 RVLISYVLGTMAYIAPEYFQQPEL-------SEKCDIFSFGMLLISLVRGVPSF 414
                       Y+A  +++ PE+       ++  DI+S G ++  L+ G   F
Sbjct: 188 -----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 230

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 103/251 (41%), Gaps = 40/251 (15%)
Query: 234 AAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQ 293
           A ++I+E S   D    +   E  T  ++ H  ++       +     +V E++ NG L 
Sbjct: 36  AVKMIKEGSMSED----EFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLL 91
Query: 294 DILDDVSRGRRELDWPSRH-RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC 352
           + L    +G      PS+   +   V  G+ +L    S   IH D+  RN L++ D+   
Sbjct: 92  NYLRSHGKGLE----PSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVK 144
Query: 353 ISDLGLAMAIPDGYTRVLISYV--LGT---MAYIAPEYFQQPELSEKCDIFSFGMLLISL 407
           +SD G+   + D        YV  +GT   + + APE F   + S K D+++FG+L+  +
Sbjct: 145 VSDFGMTRYVLDD------QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEV 198
Query: 408 VR-GVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICT 466
              G   +  + N E          V+      R   P L  +        + +I Y C 
Sbjct: 199 FSLGKMPYDLYTNSE---------VVLKVSQGHRLYRPHLASDT-------IYQIMYSCW 242
Query: 467 LHDPEERPNSQ 477
              PE+RP  Q
Sbjct: 243 HELPEKRPTFQ 253

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 99/226 (43%), Gaps = 41/226 (18%)
Query: 194 FASLEKIGSGGCGEV---YKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
           + +L+ IGSG  G V   Y A L     + +AIKK+    P               +  +
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVL----DRNVAIKKL--SRPFQ-----------NQTHAK 61
Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHL-------LVYEFMKNGSLQDILDDVSRGR 303
           +   E++    + H+NI+ LL ++  P   L       LV E M     Q I       +
Sbjct: 62  RAYRELVLMKCVNHKNIISLL-NVFTPQKTLEEFQDVYLVMELMDANLCQVI-------Q 113
Query: 304 RELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
            ELD      +   +  G+++LH   SA IIH D+KP N+++  D    I D GLA    
Sbjct: 114 MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA- 169
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR 409
            G + ++  YV+ T  Y APE        E  DI+S G ++  +VR
Sbjct: 170 -GTSFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR 213

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 71/291 (24%), Positives = 110/291 (37%), Gaps = 46/291 (15%)
Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           +  +G G  GEVY+ ++ G       ++  +   P   +E  E D  +          E 
Sbjct: 27  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM----------EA 76
Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRH---- 312
           +  S+  H+NI+  +   ++     ++ E M  G L+  L +    R     PS      
Sbjct: 77  LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRET---RPRPSQPSSLAMLD 133
Query: 313 --RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN---DDMEACISDLGLAMAIPDGYT 367
              +A  +A G +YL   H    IH DI  RN LL        A I D G+A  I     
Sbjct: 134 LLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 190
Query: 368 RVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSP 426
                  +  + ++ PE F +   + K D +SFG+LL  +   G   +    N E     
Sbjct: 191 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE----- 245
Query: 427 EWLRKVMNSKNPSRAIDP--RLPGNGYEKKMLHVLKIAYICTLHDPEERPN 475
                V+        +DP    PG  Y        +I   C  H PE+RPN
Sbjct: 246 -----VLEFVTSGGRMDPPKNCPGPVY--------RIMTQCWQHQPEDRPN 283

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 98/234 (41%), Gaps = 47/234 (20%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKV------IVYAPISAAELIEEDSKLRDS 247
           + +L  +GSG  G V  A      G  +A+KK+      I++A  +  EL      ++  
Sbjct: 24  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYREL-RLLKHMKHE 81
Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELD 307
            +  +      A  +   N + L+ H++  D + +V         Q + DD         
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-------KXQKLTDD--------- 125
Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
                 +   +  GL+Y+H   SA IIH D+KP N+ +N+D E  I D GLA    D  T
Sbjct: 126 --HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 180
Query: 368 RVLISYVLGTMAYIAPEYFQQPEL-------SEKCDIFSFGMLLISLVRGVPSF 414
                       Y+A  +++ PE+       ++  DI+S G ++  L+ G   F
Sbjct: 181 -----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 109/224 (48%), Gaps = 26/224 (11%)
Query: 194 FASLEKIGSGGCGEVY---KAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
           F  L+ +G G  G+V+   K   P S G + A+K V+  A +          K+RD    
Sbjct: 30  FELLKVLGQGSFGKVFLVRKVTRPDS-GHLYAMK-VLKKATL----------KVRDRVRT 77
Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPS 310
           ++  +I+  + + H  ++ L           L+ +F++ G   D+   +S+     +   
Sbjct: 78  KMERDIL--ADVNHPFVVKLHYAFQTEGKLYLILDFLRGG---DLFTRLSKEVMFTEEDV 132
Query: 311 RHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVL 370
           +  +A  +A GL++LH   S  II+ D+KP N+LL+++    ++D GL+    D + +  
Sbjct: 133 KFYLA-ELALGLDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAID-HEKKA 187
Query: 371 ISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
            S+  GT+ Y+APE   +   S   D +S+G+L+  ++ G   F
Sbjct: 188 YSFC-GTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPF 230

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 73/294 (24%), Positives = 132/294 (44%), Gaps = 53/294 (18%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           ++ L++IGSGG  +V++          +  +K  +YA I    L E D++  DS     R
Sbjct: 14  YSILKQIGSGGSSKVFQ----------VLNEKKQIYA-IKYVNLEEADNQTLDS----YR 58
Query: 254 SEIITASQIRHRN--ILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
           +EI   ++++  +  I+ L  + +       +Y  M+ G++   L+   + ++ +D   R
Sbjct: 59  NEIAYLNKLQQHSDKIIRLYDYEITDQ---YIYMVMECGNID--LNSWLKKKKSIDPWER 113
Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLI 371
                 +   LE +H  H   I+H D+KP N L+ D M   I D G+A  +    T V+ 
Sbjct: 114 KSYWKNM---LEAVHTIHQHGIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVK 169
Query: 372 SYVLGTMAYIAPEYFQQPELSEK-----------CDIFSFGMLLISLVRGVPSFVFHQNG 420
              +GT+ Y+ PE  +    S +            D++S G +L  +  G   F      
Sbjct: 170 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------ 223
Query: 421 EEICSPEWLRKVMNSKNPSRAID-PRLPGNGYEKKMLHVLKIAYICTLHDPEER 473
           ++I +   + K+    +P+  I+ P +P    EK +  VLK    C   DP++R
Sbjct: 224 QQIINQ--ISKLHAIIDPNHEIEFPDIP----EKDLQDVLK---CCLKRDPKQR 268

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 98/234 (41%), Gaps = 47/234 (20%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKV------IVYAPISAAELIEEDSKLRDS 247
           + +L  +GSG  G V  A      G  +A+KK+      I++A  +  EL      ++  
Sbjct: 31  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYREL-RLLKHMKHE 88
Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELD 307
            +  +      A  +   N + L+ H++  D + +V         Q + DD         
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-------KCQKLTDD--------- 132
Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
                 +   +  GL+Y+H   SA IIH D+KP N+ +N+D E  I D GLA    D  T
Sbjct: 133 --HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT 187
Query: 368 RVLISYVLGTMAYIAPEYFQQPEL-------SEKCDIFSFGMLLISLVRGVPSF 414
                       Y+A  +++ PE+       ++  DI+S G ++  L+ G   F
Sbjct: 188 -----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 230

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 98/234 (41%), Gaps = 47/234 (20%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKV------IVYAPISAAELIEEDSKLRDS 247
           + +L  +GSG  G V  A      G  +A+KK+      I++A  +  EL      ++  
Sbjct: 26  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYREL-RLLKHMKHE 83
Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELD 307
            +  +      A  +   N + L+ H++  D + +V         Q + DD         
Sbjct: 84  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-------KCQKLTDD--------- 127
Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
                 +   +  GL+Y+H   SA IIH D+KP N+ +N+D E  I D GLA    D  T
Sbjct: 128 --HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 182
Query: 368 RVLISYVLGTMAYIAPEYFQQPEL-------SEKCDIFSFGMLLISLVRGVPSF 414
                       Y+A  +++ PE+       ++  DI+S G ++  L+ G   F
Sbjct: 183 -----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 225

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 98/234 (41%), Gaps = 47/234 (20%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKV------IVYAPISAAELIEEDSKLRDS 247
           + +L  +GSG  G V  A      G  +A+KK+      I++A  +  EL      ++  
Sbjct: 24  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYREL-RLLKHMKHE 81
Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELD 307
            +  +      A  +   N + L+ H++  D + +V         Q + DD         
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-------KCQKLTDD--------- 125
Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
                 +   +  GL+Y+H   SA IIH D+KP N+ +N+D E  I D GLA    D  T
Sbjct: 126 --HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 180
Query: 368 RVLISYVLGTMAYIAPEYFQQPEL-------SEKCDIFSFGMLLISLVRGVPSF 414
                       Y+A  +++ PE+       ++  DI+S G ++  L+ G   F
Sbjct: 181 -----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 74/286 (25%), Positives = 120/286 (41%), Gaps = 52/286 (18%)
Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           L K+     GE++K    G N  ++ + KV  ++   + +  EE  +LR           
Sbjct: 15  LTKLNENHSGELWKGRWQG-NDIVVKVLKVRDWSTRKSRDFNEECPRLR----------- 62
Query: 257 ITASQIRHRNILPLLAHMVRPDCH--LLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRI 314
                  H N+LP+L     P      L+  +M  GSL ++L + +     +D     + 
Sbjct: 63  ----IFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNF--VVDQSQAVKF 116
Query: 315 ALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACIS--DLGLAMAIPDGYTRVLIS 372
           AL +A G+ +LH        H  +  R+V++++DM A IS  D+  +   P         
Sbjct: 117 ALDMARGMAFLHTLEPLIPRHA-LNSRSVMIDEDMTARISMADVKFSFQSPGR------- 168
Query: 373 YVLGTMAYIAPEYFQQ-PELSEK--CDIFSFGMLLISLV-RGVPSFVFHQNGEEICSPEW 428
             +   A++APE  Q+ PE + +   D++SF +LL  LV R VP F    N E       
Sbjct: 169 --MYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVP-FADLSNME------- 218
Query: 429 LRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERP 474
               +  K     + P +P         HV K+  IC   DP +RP
Sbjct: 219 ----IGMKVALEGLRPTIPPGISP----HVSKLMKICMNEDPAKRP 256

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 82/168 (48%), Gaps = 25/168 (14%)
Query: 313 RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLIS 372
           +IA+ +   LE+LH     S+IH D+KP NVL+N   +  + D G++  + D   + + +
Sbjct: 157 KIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDA 214
Query: 373 YVLGTMAYIAPEYFQQPELSE-----KCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPE 427
              G   Y+APE    PEL++     K DI+S G+ +I L   +  F +   G      +
Sbjct: 215 ---GCKPYMAPERI-NPELNQKGYSVKSDIWSLGITMIEL--AILRFPYDSWGTPF---Q 265
Query: 428 WLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPN 475
            L++V+  + PS    P+LP + +  + +        C   + +ERP 
Sbjct: 266 QLKQVV--EEPS----PQLPADKFSAEFVD---FTSQCLKKNSKERPT 304

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 18/211 (8%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G+G  G+V +A   G  GK  A+ KV V    S A   E+++ + + K        I +
Sbjct: 54  LGAGAFGKVVEATAFGL-GKEDAVLKVAVKMLKSTAHADEKEALMSELK--------IMS 104
Query: 260 SQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDIL------DDVSRGRRELDWPSRHR 313
              +H NI+ LL         L++ E+   G L + L      D      R L+      
Sbjct: 105 HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLH 164
Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISY 373
            +  VA G+ +L    S + IH D+  RNVLL +   A I D GLA  I +    ++   
Sbjct: 165 FSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 221
Query: 374 VLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
               + ++APE       + + D++S+G+LL
Sbjct: 222 ARLPVKWMAPESIFDCVYTVQSDVWSYGILL 252

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 98/234 (41%), Gaps = 47/234 (20%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKV------IVYAPISAAELIEEDSKLRDS 247
           + +L  +GSG  G V  A      G  +A+KK+      I++A  +  EL      ++  
Sbjct: 24  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYREL-RLLKHMKHE 81
Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELD 307
            +  +      A  +   N + L+ H++  D + +V         Q + DD         
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-------KCQKLTDD--------- 125
Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
                 +   +  GL+Y+H   SA IIH D+KP N+ +N+D E  I D GLA    D  T
Sbjct: 126 --HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 180
Query: 368 RVLISYVLGTMAYIAPEYFQQPEL-------SEKCDIFSFGMLLISLVRGVPSF 414
                       Y+A  +++ PE+       ++  DI+S G ++  L+ G   F
Sbjct: 181 -----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 64/262 (24%), Positives = 110/262 (41%), Gaps = 51/262 (19%)
Query: 166 GGSRDRGPTIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKK 225
           G S++R PT +   + K      +  + + +L  +GSG  G V  A      G  +A+KK
Sbjct: 11  GMSQER-PTFYRQELNK---TIWEVPERYQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKK 65
Query: 226 V------IVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDC 279
           +      I++A  +  EL      ++   +  +      A  +   N + L+ H++  D 
Sbjct: 66  LSRPFQSIIHAKRTYREL-RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 124
Query: 280 HLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIK 339
           + +V         Q + DD               +   +  GL+Y+H   SA IIH D+K
Sbjct: 125 NNIV-------KCQKLTDD-----------HVQFLIYQILRGLKYIH---SADIIHRDLK 163
Query: 340 PRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPEL-------S 392
           P N+ +N+D E  I D GLA    D  T            Y+A  +++ PE+       +
Sbjct: 164 PSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWYRAPEIMLNWMHYN 212
Query: 393 EKCDIFSFGMLLISLVRGVPSF 414
           +  DI+S G ++  L+ G   F
Sbjct: 213 QTVDIWSVGCIMAELLTGRTLF 234

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 98/234 (41%), Gaps = 47/234 (20%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKV------IVYAPISAAELIEEDSKLRDS 247
           + +L  +GSG  G V  A      G  +A+KK+      I++A  +  EL      ++  
Sbjct: 36  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSKPFQSIIHAKRTYREL-RLLKHMKHE 93
Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELD 307
            +  +      A  +   N + L+ H++  D + +V         Q + DD         
Sbjct: 94  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-------KCQKLTDD--------- 137
Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
                 +   +  GL+Y+H   SA IIH D+KP N+ +N+D E  I D GLA    D  T
Sbjct: 138 --HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 192
Query: 368 RVLISYVLGTMAYIAPEYFQQPEL-------SEKCDIFSFGMLLISLVRGVPSF 414
                       Y+A  +++ PE+       ++  DI+S G ++  L+ G   F
Sbjct: 193 -----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 235

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 98/234 (41%), Gaps = 47/234 (20%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKV------IVYAPISAAELIEEDSKLRDS 247
           + +L  +GSG  G V  A      G  +A+KK+      I++A  +  EL      ++  
Sbjct: 21  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYREL-RLLKHMKHE 78
Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELD 307
            +  +      A  +   N + L+ H++  D + +V         Q + DD         
Sbjct: 79  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-------KCQKLTDD--------- 122
Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
                 +   +  GL+Y+H   SA IIH D+KP N+ +N+D E  I D GLA    D  T
Sbjct: 123 --HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 177
Query: 368 RVLISYVLGTMAYIAPEYFQQPEL-------SEKCDIFSFGMLLISLVRGVPSF 414
                       Y+A  +++ PE+       ++  DI+S G ++  L+ G   F
Sbjct: 178 -----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 220

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 98/234 (41%), Gaps = 47/234 (20%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKV------IVYAPISAAELIEEDSKLRDS 247
           + +L  +GSG  G V  A      G  +A+KK+      I++A  +  EL      ++  
Sbjct: 24  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYREL-RLLKHMKHE 81
Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELD 307
            +  +      A  +   N + L+ H++  D + +V         Q + DD         
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-------KCQKLTDD--------- 125
Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
                 +   +  GL+Y+H   SA IIH D+KP N+ +N+D E  I D GLA    D  T
Sbjct: 126 --HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 180
Query: 368 RVLISYVLGTMAYIAPEYFQQPEL-------SEKCDIFSFGMLLISLVRGVPSF 414
                       Y+A  +++ PE+       ++  DI+S G ++  L+ G   F
Sbjct: 181 -----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 99/234 (42%), Gaps = 47/234 (20%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKV------IVYAPISAAELIEEDSKLRDS 247
           + +L  +GSG  G V  A      G  +A+KK+      I++A  +  EL      ++  
Sbjct: 30  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYREL-RLLKHMKHE 87
Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELD 307
            +  +      A  +   N + L+ H++  D + +V         Q + DD  +      
Sbjct: 88  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-------KCQKLTDDHVQF----- 135
Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
                 +   +  GL+Y+H   SA IIH D+KP N+ +N+D E  I D GLA    D  T
Sbjct: 136 ------LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 186
Query: 368 RVLISYVLGTMAYIAPEYFQQPEL-------SEKCDIFSFGMLLISLVRGVPSF 414
                       Y+A  +++ PE+       ++  DI+S G ++  L+ G   F
Sbjct: 187 -----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 229

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 98/234 (41%), Gaps = 47/234 (20%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKV------IVYAPISAAELIEEDSKLRDS 247
           + +L  +GSG  G V  A      G  +A+KK+      I++A  +  EL      ++  
Sbjct: 30  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYREL-RLLKHMKHE 87
Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELD 307
            +  +      A  +   N + L+ H++  D + +V         Q + DD         
Sbjct: 88  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-------KCQKLTDD--------- 131
Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
                 +   +  GL+Y+H   SA IIH D+KP N+ +N+D E  I D GLA    D  T
Sbjct: 132 --HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 186
Query: 368 RVLISYVLGTMAYIAPEYFQQPEL-------SEKCDIFSFGMLLISLVRGVPSF 414
                       Y+A  +++ PE+       ++  DI+S G ++  L+ G   F
Sbjct: 187 -----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 229

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 98/234 (41%), Gaps = 47/234 (20%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKV------IVYAPISAAELIEEDSKLRDS 247
           + +L  +GSG  G V  A      G  +A+KK+      I++A  +  EL      ++  
Sbjct: 24  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYREL-RLLKHMKHE 81
Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELD 307
            +  +      A  +   N + L+ H++  D + +V         Q + DD         
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-------KCQKLTDD--------- 125
Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
                 +   +  GL+Y+H   SA IIH D+KP N+ +N+D E  I D GLA    D  T
Sbjct: 126 --HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 180
Query: 368 RVLISYVLGTMAYIAPEYFQQPEL-------SEKCDIFSFGMLLISLVRGVPSF 414
                       Y+A  +++ PE+       ++  DI+S G ++  L+ G   F
Sbjct: 181 -----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 98/234 (41%), Gaps = 47/234 (20%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKV------IVYAPISAAELIEEDSKLRDS 247
           + +L  +GSG  G V  A      G  +A+KK+      I++A  +  EL      ++  
Sbjct: 31  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYREL-RLLKHMKHE 88
Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELD 307
            +  +      A  +   N + L+ H++  D + +V         Q + DD         
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-------KCQKLTDD--------- 132
Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
                 +   +  GL+Y+H   SA IIH D+KP N+ +N+D E  I D GLA    D  T
Sbjct: 133 --HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 187
Query: 368 RVLISYVLGTMAYIAPEYFQQPEL-------SEKCDIFSFGMLLISLVRGVPSF 414
                       Y+A  +++ PE+       ++  DI+S G ++  L+ G   F
Sbjct: 188 -----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 230

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 95/213 (44%), Gaps = 18/213 (8%)
Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           + +G+G  G+V +A   G  GK  A+ KV V    S A   E+++ + + K        I
Sbjct: 44  KTLGAGAFGKVVEATAFGL-GKEDAVLKVAVKMLKSTAHADEKEALMSELK--------I 94
Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDIL------DDVSRGRRELDWPSR 311
            +   +H NI+ LL         L++ E+   G L + L      D      R L+    
Sbjct: 95  MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDL 154
Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLI 371
              +  VA G+ +L    S + IH D+  RNVLL +   A I D GLA  I +    ++ 
Sbjct: 155 LHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVK 211
Query: 372 SYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
                 + ++APE       + + D++S+G+LL
Sbjct: 212 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILL 244

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 98/234 (41%), Gaps = 47/234 (20%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKV------IVYAPISAAELIEEDSKLRDS 247
           + +L  +GSG  G V  A      G  +A+KK+      I++A  +  EL      ++  
Sbjct: 36  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYREL-RLLKHMKHE 93
Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELD 307
            +  +      A  +   N + L+ H++  D + +V         Q + DD         
Sbjct: 94  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-------KCQKLTDD--------- 137
Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
                 +   +  GL+Y+H   SA IIH D+KP N+ +N+D E  I D GLA    D  T
Sbjct: 138 --HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 192
Query: 368 RVLISYVLGTMAYIAPEYFQQPEL-------SEKCDIFSFGMLLISLVRGVPSF 414
                       Y+A  +++ PE+       ++  DI+S G ++  L+ G   F
Sbjct: 193 -----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 235

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 98/234 (41%), Gaps = 47/234 (20%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKV------IVYAPISAAELIEEDSKLRDS 247
           + +L  +GSG  G V  A      G  +A+KK+      I++A  +  EL      ++  
Sbjct: 26  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYREL-RLLKHMKHE 83
Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELD 307
            +  +      A  +   N + L+ H++  D + +V         Q + DD         
Sbjct: 84  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-------KCQKLTDD--------- 127
Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
                 +   +  GL+Y+H   SA IIH D+KP N+ +N+D E  I D GLA    D  T
Sbjct: 128 --HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMT 182
Query: 368 RVLISYVLGTMAYIAPEYFQQPEL-------SEKCDIFSFGMLLISLVRGVPSF 414
                       Y+A  +++ PE+       ++  DI+S G ++  L+ G   F
Sbjct: 183 -----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 225

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 98/234 (41%), Gaps = 47/234 (20%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKV------IVYAPISAAELIEEDSKLRDS 247
           + +L  +GSG  G V  A      G  +A+KK+      I++A  +  EL      ++  
Sbjct: 20  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYREL-RLLKHMKHE 77
Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELD 307
            +  +      A  +   N + L+ H++  D + +V         Q + DD         
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-------KCQKLTDD--------- 121
Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
                 +   +  GL+Y+H   SA IIH D+KP N+ +N+D E  I D GLA    D  T
Sbjct: 122 --HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 176
Query: 368 RVLISYVLGTMAYIAPEYFQQPEL-------SEKCDIFSFGMLLISLVRGVPSF 414
                       Y+A  +++ PE+       ++  DI+S G ++  L+ G   F
Sbjct: 177 -----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 219

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 98/234 (41%), Gaps = 47/234 (20%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKV------IVYAPISAAELIEEDSKLRDS 247
           + +L  +GSG  G V  A      G  +A+KK+      I++A  +  EL      ++  
Sbjct: 36  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYREL-RLLKHMKHE 93
Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELD 307
            +  +      A  +   N + L+ H++  D + +V         Q + DD         
Sbjct: 94  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-------KCQKLTDD--------- 137
Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
                 +   +  GL+Y+H   SA IIH D+KP N+ +N+D E  I D GLA    D  T
Sbjct: 138 --HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 192
Query: 368 RVLISYVLGTMAYIAPEYFQQPEL-------SEKCDIFSFGMLLISLVRGVPSF 414
                       Y+A  +++ PE+       ++  DI+S G ++  L+ G   F
Sbjct: 193 -----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 235

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 98/234 (41%), Gaps = 47/234 (20%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKV------IVYAPISAAELIEEDSKLRDS 247
           + +L  +GSG  G V  A      G  +A+KK+      I++A  +  EL      ++  
Sbjct: 24  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYREL-RLLKHMKHE 81
Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELD 307
            +  +      A  +   N + L+ H++  D + +V         Q + DD         
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-------KCQKLTDD--------- 125
Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
                 +   +  GL+Y+H   SA IIH D+KP N+ +N+D E  I D GLA    D  T
Sbjct: 126 --HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 180
Query: 368 RVLISYVLGTMAYIAPEYFQQPEL-------SEKCDIFSFGMLLISLVRGVPSF 414
                       Y+A  +++ PE+       ++  DI+S G ++  L+ G   F
Sbjct: 181 -----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 99/225 (44%), Gaps = 25/225 (11%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           + +L  IG G  G V  A     N   +AIKK+   +P       +          R +R
Sbjct: 29  YTNLSYIGEGAYGMVCSA-YDNLNKVRVAIKKI---SPFEHQTYCQ----------RTLR 74
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSL-QDILDDVSRGRRELDWPSRH 312
            EI    + RH NI+ +   +  P       E MK+  + QD+++       +    S  
Sbjct: 75  -EIKILLRFRHENIIGINDIIRAP-----TIEQMKDVYIVQDLMETDLYKLLKCQHLSND 128
Query: 313 RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA-MAIPD-GYTRVL 370
            I   +   L  L   HSA+++H D+KP N+LLN   +  I D GLA +A PD  +T  L
Sbjct: 129 HICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 188
Query: 371 ISYVLGTMAYIAPEYFQQPE-LSEKCDIFSFGMLLISLVRGVPSF 414
             YV  T  Y APE     +  ++  DI+S G +L  ++   P F
Sbjct: 189 TEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 98/234 (41%), Gaps = 47/234 (20%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKV------IVYAPISAAELIEEDSKLRDS 247
           + +L  +GSG  G V  A      G  +A+KK+      I++A  +  EL      ++  
Sbjct: 29  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYREL-RLLKHMKHE 86
Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELD 307
            +  +      A  +   N + L+ H++  D + +V         Q + DD         
Sbjct: 87  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-------KCQKLTDD--------- 130
Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
                 +   +  GL+Y+H   SA IIH D+KP N+ +N+D E  I D GLA    D  T
Sbjct: 131 --HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 185
Query: 368 RVLISYVLGTMAYIAPEYFQQPEL-------SEKCDIFSFGMLLISLVRGVPSF 414
                       Y+A  +++ PE+       ++  DI+S G ++  L+ G   F
Sbjct: 186 -----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 228

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 98/234 (41%), Gaps = 47/234 (20%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKV------IVYAPISAAELIEEDSKLRDS 247
           + +L  +GSG  G V  A      G  +A+KK+      I++A  +  EL      ++  
Sbjct: 23  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYREL-RLLKHMKHE 80
Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELD 307
            +  +      A  +   N + L+ H++  D + +V         Q + DD         
Sbjct: 81  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-------KCQKLTDD--------- 124
Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
                 +   +  GL+Y+H   SA IIH D+KP N+ +N+D E  I D GLA    D  T
Sbjct: 125 --HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 179
Query: 368 RVLISYVLGTMAYIAPEYFQQPEL-------SEKCDIFSFGMLLISLVRGVPSF 414
                       Y+A  +++ PE+       ++  DI+S G ++  L+ G   F
Sbjct: 180 -----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 222

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 98/234 (41%), Gaps = 47/234 (20%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKV------IVYAPISAAELIEEDSKLRDS 247
           + +L  +GSG  G V  A      G  +A+KK+      I++A  +  EL      ++  
Sbjct: 21  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYREL-RLLKHMKHE 78
Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELD 307
            +  +      A  +   N + L+ H++  D + +V         Q + DD         
Sbjct: 79  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-------KCQKLTDD--------- 122
Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
                 +   +  GL+Y+H   SA IIH D+KP N+ +N+D E  I D GLA    D  T
Sbjct: 123 --HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 177
Query: 368 RVLISYVLGTMAYIAPEYFQQPEL-------SEKCDIFSFGMLLISLVRGVPSF 414
                       Y+A  +++ PE+       ++  DI+S G ++  L+ G   F
Sbjct: 178 -----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 220

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 98/234 (41%), Gaps = 47/234 (20%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKV------IVYAPISAAELIEEDSKLRDS 247
           + +L  +GSG  G V  A      G  +A+KK+      I++A  +  EL      ++  
Sbjct: 26  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYREL-RLLKHMKHE 83
Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELD 307
            +  +      A  +   N + L+ H++  D + +V         Q + DD         
Sbjct: 84  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-------KCQKLTDD--------- 127
Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
                 +   +  GL+Y+H   SA IIH D+KP N+ +N+D E  I D GLA    D  T
Sbjct: 128 --HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 182
Query: 368 RVLISYVLGTMAYIAPEYFQQPEL-------SEKCDIFSFGMLLISLVRGVPSF 414
                       Y+A  +++ PE+       ++  DI+S G ++  L+ G   F
Sbjct: 183 -----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 225

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 74/321 (23%), Positives = 130/321 (40%), Gaps = 74/321 (23%)
Query: 188 LKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDS 247
           L+    F  +  +G G  G+V KA     + +  AIKK+                +  + 
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKAR-NALDSRYYAIKKI----------------RHTEE 44
Query: 248 KLRQIRSEIITASQIRHRNILPLLA------HMVRPDCHL-------LVYEFMKNGSLQD 294
           KL  I SE+   + + H+ ++   A      + V+P   +       +  E+ +N +L D
Sbjct: 45  KLSTILSEVXLLASLNHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYD 104
Query: 295 IL--DDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC 352
           ++  +++++ R E  W    R+   +   L Y+H   S  IIH ++KP N+ +++     
Sbjct: 105 LIHSENLNQQRDEY-W----RLFRQILEALSYIH---SQGIIHRNLKPXNIFIDESRNVK 156
Query: 353 ISDLGLAMAIPD-------------GYTRVLISYVLGTMAYIAPEYFQ-QPELSEKCDIF 398
           I D GLA  +               G +  L S  +GT  Y+A E        +EK D +
Sbjct: 157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTS-AIGTAXYVATEVLDGTGHYNEKIDXY 215
Query: 399 SFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGY--EKKML 456
           S G++    +     + F    E +   + LR V      S    P    N    EKK++
Sbjct: 216 SLGIIFFEXI-----YPFSTGXERVNILKKLRSV------SIEFPPDFDDNKXKVEKKII 264
Query: 457 HVLKIAYICTLHDPEERPNSQ 477
            +L        HDP +RP ++
Sbjct: 265 RLL------IDHDPNKRPGAR 279

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 98/234 (41%), Gaps = 47/234 (20%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKV------IVYAPISAAELIEEDSKLRDS 247
           + +L  +GSG  G V  A      G  +A+KK+      I++A  +  EL      ++  
Sbjct: 24  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYREL-RLLKHMKHE 81
Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELD 307
            +  +      A  +   N + L+ H++  D + +V         Q + DD         
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-------KCQKLTDD--------- 125
Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
                 +   +  GL+Y+H   SA IIH D+KP N+ +N+D E  I D GLA    D  T
Sbjct: 126 --HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 180
Query: 368 RVLISYVLGTMAYIAPEYFQQPEL-------SEKCDIFSFGMLLISLVRGVPSF 414
                       Y+A  +++ PE+       ++  DI+S G ++  L+ G   F
Sbjct: 181 -----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 107/230 (46%), Gaps = 37/230 (16%)
Query: 192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVY----APISAAELIEEDSKLRDS 247
           + +  L+K+G G    VYK +   ++  ++A+K++ +     AP +A   I E S L+D 
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDN-LVALKEIRLEHEEGAPCTA---IREVSLLKD- 56
Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELD 307
                         ++H NI+ L   +       LV+E++ +  L+  LDD        +
Sbjct: 57  --------------LKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCG------N 95
Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMA--IPDG 365
             + H + L +   L  L   H   ++H D+KP+N+L+N+  E  ++D GLA A  IP  
Sbjct: 96  IINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP-- 153
Query: 366 YTRVLISYVLGTMAYIAPE-YFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
            T+   + V+ T+ Y  P+      + S + D++  G +   +  G P F
Sbjct: 154 -TKTYDNEVV-TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLF 201

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 98/234 (41%), Gaps = 47/234 (20%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKV------IVYAPISAAELIEEDSKLRDS 247
           + +L  +GSG  G V  A      G  +A+KK+      I++A  +  EL      ++  
Sbjct: 44  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYREL-RLLKHMKHE 101
Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELD 307
            +  +      A  +   N + L+ H++  D + +V         Q + DD         
Sbjct: 102 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-------KCQKLTDD--------- 145
Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
                 +   +  GL+Y+H   SA IIH D+KP N+ +N+D E  I D GLA    D  T
Sbjct: 146 --HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 200
Query: 368 RVLISYVLGTMAYIAPEYFQQPEL-------SEKCDIFSFGMLLISLVRGVPSF 414
                       Y+A  +++ PE+       ++  DI+S G ++  L+ G   F
Sbjct: 201 -----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 243

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 98/234 (41%), Gaps = 47/234 (20%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKV------IVYAPISAAELIEEDSKLRDS 247
           + +L  +GSG  G V  A      G  +A+KK+      I++A  +  EL      ++  
Sbjct: 29  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYREL-RLLKHMKHE 86
Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELD 307
            +  +      A  +   N + L+ H++  D + +V         Q + DD         
Sbjct: 87  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-------KCQKLTDD--------- 130
Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
                 +   +  GL+Y+H   SA IIH D+KP N+ +N+D E  I D GLA    D  T
Sbjct: 131 --HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 185
Query: 368 RVLISYVLGTMAYIAPEYFQQPEL-------SEKCDIFSFGMLLISLVRGVPSF 414
                       Y+A  +++ PE+       ++  DI+S G ++  L+ G   F
Sbjct: 186 -----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 228

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 98/234 (41%), Gaps = 47/234 (20%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKV------IVYAPISAAELIEEDSKLRDS 247
           + +L  +GSG  G V  A      G  +A+KK+      I++A  +  EL      ++  
Sbjct: 22  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYREL-RLLKHMKHE 79
Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELD 307
            +  +      A  +   N + L+ H++  D + +V         Q + DD         
Sbjct: 80  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-------KCQKLTDD--------- 123
Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
                 +   +  GL+Y+H   SA IIH D+KP N+ +N+D E  I D GLA    D  T
Sbjct: 124 --HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 178
Query: 368 RVLISYVLGTMAYIAPEYFQQPEL-------SEKCDIFSFGMLLISLVRGVPSF 414
                       Y+A  +++ PE+       ++  DI+S G ++  L+ G   F
Sbjct: 179 -----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 221

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 98/234 (41%), Gaps = 47/234 (20%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKV------IVYAPISAAELIEEDSKLRDS 247
           + +L  +GSG  G V  A      G  +A+KK+      I++A  +  EL      ++  
Sbjct: 26  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYREL-RLLKHMKHE 83
Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELD 307
            +  +      A  +   N + L+ H++  D + +V         Q + DD         
Sbjct: 84  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-------KCQKLTDD--------- 127
Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
                 +   +  GL+Y+H   SA IIH D+KP N+ +N+D E  I D GLA    D  T
Sbjct: 128 --HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 182
Query: 368 RVLISYVLGTMAYIAPEYFQQPEL-------SEKCDIFSFGMLLISLVRGVPSF 414
                       Y+A  +++ PE+       ++  DI+S G ++  L+ G   F
Sbjct: 183 -----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 225

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 98/234 (41%), Gaps = 47/234 (20%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKV------IVYAPISAAELIEEDSKLRDS 247
           + +L  +GSG  G V  A      G  +A+KK+      I++A  +  EL      ++  
Sbjct: 43  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYREL-RLLKHMKHE 100
Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELD 307
            +  +      A  +   N + L+ H++  D + +V         Q + DD         
Sbjct: 101 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-------KCQKLTDD--------- 144
Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
                 +   +  GL+Y+H   SA IIH D+KP N+ +N+D E  I D GLA    D  T
Sbjct: 145 --HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 199
Query: 368 RVLISYVLGTMAYIAPEYFQQPEL-------SEKCDIFSFGMLLISLVRGVPSF 414
                       Y+A  +++ PE+       ++  DI+S G ++  L+ G   F
Sbjct: 200 -----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 242

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 98/234 (41%), Gaps = 47/234 (20%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKV------IVYAPISAAELIEEDSKLRDS 247
           + +L  +GSG  G V  A      G  +A+KK+      I++A  +  EL      ++  
Sbjct: 30  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYREL-RLLKHMKHE 87
Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELD 307
            +  +      A  +   N + L+ H++  D + +V         Q + DD         
Sbjct: 88  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-------KCQKLTDD--------- 131
Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
                 +   +  GL+Y+H   SA IIH D+KP N+ +N+D E  I D GLA    D  T
Sbjct: 132 --HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMT 186
Query: 368 RVLISYVLGTMAYIAPEYFQQPEL-------SEKCDIFSFGMLLISLVRGVPSF 414
                       Y+A  +++ PE+       ++  DI+S G ++  L+ G   F
Sbjct: 187 -----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 229

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 95/226 (42%), Gaps = 36/226 (15%)
Query: 180 IEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIE 239
           I+ +DL FLK+         +G+G  G V   +  G     +AIK +I    +S  E IE
Sbjct: 5   IDPKDLTFLKE---------LGTGQFGVVKYGKWRGQYD--VAIK-MIKEGSMSEDEFIE 52
Query: 240 EDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDV 299
           E   + +               + H  ++ L     +     ++ E+M NG L + L ++
Sbjct: 53  EAKVMMN---------------LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM 97
Query: 300 SRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA 359
              R          +   V   +EYL    S   +H D+  RN L+ND     +SD GL+
Sbjct: 98  ---RHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLS 151
Query: 360 -MAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
              + D YT  + S     + +  PE     + S K DI++FG+L+
Sbjct: 152 RYVLDDEYTSSVGSKF--PVRWSPPEVLMYSKFSSKSDIWAFGVLM 195

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 49/96 (51%), Gaps = 8/96 (8%)
Query: 326 HMYHSASIIHGDIKPRNVLL---NDDMEACISDLGLA-MAIPDGYTRVLISYVLGTMAYI 381
           HM H   ++H D+KP N+L    ND++E  I D G A +  PD        +   T+ Y 
Sbjct: 121 HM-HDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCF---TLHYA 176
Query: 382 APEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFH 417
           APE   Q    E CD++S G++L +++ G   F  H
Sbjct: 177 APELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSH 212

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 99/234 (42%), Gaps = 47/234 (20%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKV------IVYAPISAAELIEEDSKLRDS 247
           + +L  +GSG  G V  A      G  +A+KK+      I++A  +  EL      ++  
Sbjct: 20  YQNLSPVGSGAYGSVCAA-FDTKTGHRVAVKKLSRPFQSIIHAKRTYREL-RLLKHMKHE 77
Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELD 307
            +  +      A  +   N + L+ H++  D + +V    K   L D  D V        
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCAKLTD--DHV-------- 123
Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
                 +   +  GL+Y+H   SA IIH D+KP N+ +N+D E  I D GLA    D  T
Sbjct: 124 ----QFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 176
Query: 368 RVLISYVLGTMAYIAPEYFQQPEL-------SEKCDIFSFGMLLISLVRGVPSF 414
                       Y+A  +++ PE+       ++  DI+S G ++  L+ G   F
Sbjct: 177 -----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 219

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 98/234 (41%), Gaps = 47/234 (20%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKV------IVYAPISAAELIEEDSKLRDS 247
           + +L  +GSG  G V  A      G  +A+KK+      I++A  +  EL      ++  
Sbjct: 47  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYREL-RLLKHMKHE 104
Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELD 307
            +  +      A  +   N + L+ H++  D + +V         Q + DD         
Sbjct: 105 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-------KCQKLTDD--------- 148
Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
                 +   +  GL+Y+H   SA IIH D+KP N+ +N+D E  I D GLA    D  T
Sbjct: 149 --HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 203
Query: 368 RVLISYVLGTMAYIAPEYFQQPEL-------SEKCDIFSFGMLLISLVRGVPSF 414
                       Y+A  +++ PE+       ++  DI+S G ++  L+ G   F
Sbjct: 204 -----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 246

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 39/139 (28%), Positives = 60/139 (43%), Gaps = 11/139 (7%)
Query: 279 CHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDI 338
           C L+V E +  G L   + D  RG +         I   +   ++YLH   S +I H D+
Sbjct: 133 CLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDV 187
Query: 339 KPRNVLLNDDMEACI---SDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKC 395
           KP N+L        I   +D G A       +     Y   T  Y+APE     +  + C
Sbjct: 188 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEVLGPEKYDKSC 244
Query: 396 DIFSFGMLLISLVRGVPSF 414
           D++S G+++  L+ G P F
Sbjct: 245 DMWSLGVIMYILLCGYPPF 263

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 39/139 (28%), Positives = 60/139 (43%), Gaps = 11/139 (7%)
Query: 279 CHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDI 338
           C L+V E +  G L   + D  RG +         I   +   ++YLH   S +I H D+
Sbjct: 95  CLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDV 149
Query: 339 KPRNVLLNDDMEACI---SDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKC 395
           KP N+L        I   +D G A       +     Y   T  Y+APE     +  + C
Sbjct: 150 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEVLGPEKYDKSC 206
Query: 396 DIFSFGMLLISLVRGVPSF 414
           D++S G+++  L+ G P F
Sbjct: 207 DMWSLGVIMYILLCGYPPF 225

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 95/226 (42%), Gaps = 36/226 (15%)
Query: 180 IEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIE 239
           I+ +DL FLK+         +G+G  G V   +  G     +AIK +I    +S  E IE
Sbjct: 6   IDPKDLTFLKE---------LGTGQFGVVKYGKWRGQYD--VAIK-MIKEGSMSEDEFIE 53
Query: 240 EDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDV 299
           E   + +               + H  ++ L     +     ++ E+M NG L + L ++
Sbjct: 54  EAKVMMN---------------LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM 98
Query: 300 SRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA 359
              R          +   V   +EYL    S   +H D+  RN L+ND     +SD GL+
Sbjct: 99  ---RHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLS 152
Query: 360 -MAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
              + D YT  + S     + +  PE     + S K DI++FG+L+
Sbjct: 153 RYVLDDEYTSSVGSKF--PVRWSPPEVLMYSKFSSKSDIWAFGVLM 196

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 69/289 (23%), Positives = 109/289 (37%), Gaps = 42/289 (14%)
Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           +  +G G  GEVY+ ++ G       ++  +   P   +E  E D  +          E 
Sbjct: 50  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLM----------EA 99
Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRH---- 312
           +  S+  H+NI+  +   ++     ++ E M  G L+  L +    R     PS      
Sbjct: 100 LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRET---RPRPSQPSSLAMLD 156
Query: 313 --RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN---DDMEACISDLGLAMAIPDGYT 367
              +A  +A G +YL   H    IH DI  RN LL        A I D G+A  I     
Sbjct: 157 LLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 213
Query: 368 RVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSP 426
                  +  + ++ PE F +   + K D +SFG+LL  +   G   +    N E +   
Sbjct: 214 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL--- 270
Query: 427 EWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPN 475
           E++        P     P             V +I   C  H PE+RPN
Sbjct: 271 EFVTSGGRMDPPKNCPGP-------------VYRIMTQCWQHQPEDRPN 306

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 95/228 (41%), Gaps = 35/228 (15%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           +  L+ IGSG  G V  A      G  +A+KK+    P               +  ++  
Sbjct: 26  YQQLKPIGSGAQGIVCAA-FDTVLGINVAVKKL--SRPFQ-----------NQTHAKRAY 71
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHL-------LVYEFMKNGSLQDILDDVSRGRREL 306
            E++    + H+NI+ LL ++  P   L       LV E M     Q I         EL
Sbjct: 72  RELVLLKCVNHKNIISLL-NVFTPQKTLEEFQDVYLVMELMDANLCQVI-------HMEL 123
Query: 307 DWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGY 366
           D      +   +  G+++LH   SA IIH D+KP N+++  D    I D GLA       
Sbjct: 124 DHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART---AC 177
Query: 367 TRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
           T  +++  + T  Y APE       +   DI+S G ++  LV+G   F
Sbjct: 178 TNFMMTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGELVKGCVIF 225

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 98/234 (41%), Gaps = 47/234 (20%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKV------IVYAPISAAELIEEDSKLRDS 247
           + +L  +GSG  G V  A      G  +A+KK+      I++A  +  EL      ++  
Sbjct: 24  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYREL-RLLKHMKHE 81
Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELD 307
            +  +      A  +   N + L+ H++  D + +V         Q + DD         
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-------KCQKLTDD--------- 125
Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
                 +   +  GL+Y+H   SA IIH D+KP N+ +N+D E  I D GLA    D  T
Sbjct: 126 --HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 180
Query: 368 RVLISYVLGTMAYIAPEYFQQPEL-------SEKCDIFSFGMLLISLVRGVPSF 414
                       Y+A  +++ PE+       ++  DI+S G ++  L+ G   F
Sbjct: 181 -----------GYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/229 (24%), Positives = 98/229 (42%), Gaps = 33/229 (14%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  G+V KA           +K    Y  ++   L E  S    S+LR + SE    
Sbjct: 31  LGEGEFGKVVKA-------TAFHLKGRAGYTTVAVKMLKENASP---SELRDLLSEFNVL 80
Query: 260 SQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSR------------GRRELD 307
            Q+ H +++ L     +    LL+ E+ K GSL+  L +  +                LD
Sbjct: 81  KQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLD 140
Query: 308 WPSRHRIALG--------VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA 359
            P    + +G        ++ G++YL       ++H D+  RN+L+ +  +  ISD GL+
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLS 197
Query: 360 MAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLV 408
             + +  + V  S     + ++A E       + + D++SFG+LL  +V
Sbjct: 198 RDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 246

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 39/139 (28%), Positives = 60/139 (43%), Gaps = 11/139 (7%)
Query: 279 CHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDI 338
           C L+V E +  G L   + D  RG +         I   +   ++YLH   S +I H D+
Sbjct: 87  CLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDV 141
Query: 339 KPRNVLLNDDMEACI---SDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKC 395
           KP N+L        I   +D G A       +     Y   T  Y+APE     +  + C
Sbjct: 142 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEVLGPEKYDKSC 198
Query: 396 DIFSFGMLLISLVRGVPSF 414
           D++S G+++  L+ G P F
Sbjct: 199 DMWSLGVIMYILLCGYPPF 217

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 39/139 (28%), Positives = 60/139 (43%), Gaps = 11/139 (7%)
Query: 279 CHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDI 338
           C L+V E +  G L   + D  RG +         I   +   ++YLH   S +I H D+
Sbjct: 89  CLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDV 143
Query: 339 KPRNVLLNDDMEACI---SDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKC 395
           KP N+L        I   +D G A       +     Y   T  Y+APE     +  + C
Sbjct: 144 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEVLGPEKYDKSC 200
Query: 396 DIFSFGMLLISLVRGVPSF 414
           D++S G+++  L+ G P F
Sbjct: 201 DMWSLGVIMYILLCGYPPF 219

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 39/139 (28%), Positives = 60/139 (43%), Gaps = 11/139 (7%)
Query: 279 CHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDI 338
           C L+V E +  G L   + D  RG +         I   +   ++YLH   S +I H D+
Sbjct: 139 CLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDV 193
Query: 339 KPRNVLLNDDMEACI---SDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKC 395
           KP N+L        I   +D G A       +     Y   T  Y+APE     +  + C
Sbjct: 194 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEVLGPEKYDKSC 250
Query: 396 DIFSFGMLLISLVRGVPSF 414
           D++S G+++  L+ G P F
Sbjct: 251 DMWSLGVIMYILLCGYPPF 269

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 95/226 (42%), Gaps = 36/226 (15%)
Query: 180 IEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIE 239
           I+ +DL FLK+         +G+G  G V   +  G     +AIK +I    +S  E IE
Sbjct: 1   IDPKDLTFLKE---------LGTGQFGVVKYGKWRGQYD--VAIK-MIKEGSMSEDEFIE 48
Query: 240 EDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDV 299
           E   + +               + H  ++ L     +     ++ E+M NG L + L ++
Sbjct: 49  EAKVMMN---------------LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM 93
Query: 300 SRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA 359
              R          +   V   +EYL    S   +H D+  RN L+ND     +SD GL+
Sbjct: 94  ---RHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLS 147
Query: 360 -MAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
              + D YT  + S     + +  PE     + S K DI++FG+L+
Sbjct: 148 RYVLDDEYTSSVGSKF--PVRWSPPEVLMYSKFSSKSDIWAFGVLM 191

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 39/139 (28%), Positives = 60/139 (43%), Gaps = 11/139 (7%)
Query: 279 CHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDI 338
           C L+V E +  G L   + D  RG +         I   +   ++YLH   S +I H D+
Sbjct: 94  CLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDV 148
Query: 339 KPRNVLLNDDMEACI---SDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKC 395
           KP N+L        I   +D G A       +     Y   T  Y+APE     +  + C
Sbjct: 149 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEVLGPEKYDKSC 205
Query: 396 DIFSFGMLLISLVRGVPSF 414
           D++S G+++  L+ G P F
Sbjct: 206 DMWSLGVIMYILLCGYPPF 224

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 98/221 (44%), Gaps = 30/221 (13%)
Query: 200 IGSGGCGEVYKAELPG-SNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT 258
           +G G  G+V  AE  G    K   + KV       A ++++ D+  +D  L  + SE+  
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKV-------AVKMLKSDATEKD--LSDLISEMEM 71
Query: 259 ASQI-RHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR---- 313
              I +H+NI+ LL    +     ++ E+   G+L++ L        E  +   H     
Sbjct: 72  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQ 131
Query: 314 --------IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP-- 363
                    A  VA G+EYL    S   IH D+  RNVL+ +D    I+D GLA  I   
Sbjct: 132 LSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
           D Y +     +   + ++APE       + + D++SFG+LL
Sbjct: 189 DYYKKTTNGRL--PVKWMAPEALFDRIYTHQSDVWSFGVLL 227

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 39/139 (28%), Positives = 60/139 (43%), Gaps = 11/139 (7%)
Query: 279 CHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDI 338
           C L+V E +  G L   + D  RG +         I   +   ++YLH   S +I H D+
Sbjct: 93  CLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDV 147
Query: 339 KPRNVLLNDDMEACI---SDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKC 395
           KP N+L        I   +D G A       +     Y   T  Y+APE     +  + C
Sbjct: 148 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEVLGPEKYDKSC 204
Query: 396 DIFSFGMLLISLVRGVPSF 414
           D++S G+++  L+ G P F
Sbjct: 205 DMWSLGVIMYILLCGYPPF 223

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 95/226 (42%), Gaps = 36/226 (15%)
Query: 180 IEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIE 239
           I+ +DL FLK+         +G+G  G V   +  G     +AIK +I    +S  E IE
Sbjct: 21  IDPKDLTFLKE---------LGTGQFGVVKYGKWRGQYD--VAIK-MIKEGSMSEDEFIE 68
Query: 240 EDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDV 299
           E   + +               + H  ++ L     +     ++ E+M NG L + L ++
Sbjct: 69  EAKVMMN---------------LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM 113
Query: 300 SRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA 359
              R          +   V   +EYL    S   +H D+  RN L+ND     +SD GL+
Sbjct: 114 ---RHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLS 167
Query: 360 -MAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
              + D YT  + S     + +  PE     + S K DI++FG+L+
Sbjct: 168 RYVLDDEYTSSVGSKF--PVRWSPPEVLMYSKFSSKSDIWAFGVLM 211

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 39/139 (28%), Positives = 60/139 (43%), Gaps = 11/139 (7%)
Query: 279 CHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDI 338
           C L+V E +  G L   + D  RG +         I   +   ++YLH   S +I H D+
Sbjct: 89  CLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDV 143
Query: 339 KPRNVLLNDDMEACI---SDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKC 395
           KP N+L        I   +D G A       +     Y   T  Y+APE     +  + C
Sbjct: 144 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEVLGPEKYDKSC 200
Query: 396 DIFSFGMLLISLVRGVPSF 414
           D++S G+++  L+ G P F
Sbjct: 201 DMWSLGVIMYILLCGYPPF 219

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 79/310 (25%), Positives = 125/310 (40%), Gaps = 57/310 (18%)
Query: 171 RGPTIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGEV---YKAELPGSNGKMIAIKKVI 227
           R    +S  I       LK+   + +L+ IGSG  G V   Y A L     + +AIKK+ 
Sbjct: 6   RDNNFYSVEIGDSTFTVLKR---YQNLKPIGSGAQGIVCAAYDAIL----ERNVAIKKL- 57
Query: 228 VYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHL------ 281
              P               +  ++   E++    + H+NI+ LL ++  P   L      
Sbjct: 58  -SRPFQ-----------NQTHAKRAYRELVLMKCVNHKNIIGLL-NVFTPQKSLEEFQDV 104
Query: 282 -LVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKP 340
            +V E M     Q I       + ELD      +   +  G+++LH   SA IIH D+KP
Sbjct: 105 YIVMELMDANLCQVI-------QMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKP 154
Query: 341 RNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSF 400
            N+++  D    I D GLA       T  +++  + T  Y APE        E  DI+S 
Sbjct: 155 SNIVVKSDCTLKILDFGLART---AGTSFMMTPEVVTRYYRAPEVILGMGYKENVDIWSV 211
Query: 401 GMLLISLVRGVPSF-----------VFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGN 449
           G ++  +++G   F           V  Q G     PE+++K+  +        P+  G 
Sbjct: 212 GCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP--CPEFMKKLQPTVRTYVENRPKYAGY 269
Query: 450 GYEKKMLHVL 459
            +EK    VL
Sbjct: 270 SFEKLFPDVL 279

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 72/160 (45%), Gaps = 18/160 (11%)
Query: 282 LVYEFMKNGSLQD-ILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKP 340
           LV E M+ G L D IL       RE  +     +   +   +EYLH   S  ++H D+KP
Sbjct: 98  LVTELMRGGELLDKILRQKFFSEREASF-----VLHTIGKTVEYLH---SQGVVHRDLKP 149
Query: 341 RNVLLNDDM--EAC--ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCD 396
            N+L  D+     C  I D G A  +       L+     T  ++APE  ++    E CD
Sbjct: 150 SNILYVDESGNPECLRICDFGFAKQLRA--ENGLLMTPCYTANFVAPEVLKRQGYDEGCD 207
Query: 397 IFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSK 436
           I+S G+LL +++ G   F    NG      E L ++ + K
Sbjct: 208 IWSLGILLYTMLAGYTPFA---NGPSDTPEEILTRIGSGK 244

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 39/139 (28%), Positives = 60/139 (43%), Gaps = 11/139 (7%)
Query: 279 CHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDI 338
           C L+V E +  G L   + D  RG +         I   +   ++YLH   S +I H D+
Sbjct: 88  CLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDV 142
Query: 339 KPRNVLLNDDMEACI---SDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKC 395
           KP N+L        I   +D G A       +     Y   T  Y+APE     +  + C
Sbjct: 143 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEVLGPEKYDKSC 199
Query: 396 DIFSFGMLLISLVRGVPSF 414
           D++S G+++  L+ G P F
Sbjct: 200 DMWSLGVIMYILLCGYPPF 218

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 39/139 (28%), Positives = 60/139 (43%), Gaps = 11/139 (7%)
Query: 279 CHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDI 338
           C L+V E +  G L   + D  RG +         I   +   ++YLH   S +I H D+
Sbjct: 103 CLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDV 157
Query: 339 KPRNVLLNDDMEACI---SDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKC 395
           KP N+L        I   +D G A       +     Y   T  Y+APE     +  + C
Sbjct: 158 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEVLGPEKYDKSC 214
Query: 396 DIFSFGMLLISLVRGVPSF 414
           D++S G+++  L+ G P F
Sbjct: 215 DMWSLGVIMYILLCGYPPF 233

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 105/228 (46%), Gaps = 31/228 (13%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           + +L  IG G  G V  A     N   +AI+K+   +P       +          R +R
Sbjct: 29  YTNLSYIGEGAYGMVCSA-YDNLNKVRVAIRKI---SPFEHQTYCQ----------RTLR 74
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSL-QDILD-DVSRGRRELDWPSR 311
            EI    + RH NI+ +   +  P       E MK+  + QD+++ D+ +  +     + 
Sbjct: 75  -EIKILLRFRHENIIGINDIIRAP-----TIEQMKDVYIVQDLMETDLYKLLKTQHLSND 128
Query: 312 H--RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA-MAIPD-GYT 367
           H       +  GL+Y+H   SA+++H D+KP N+LLN   +  I D GLA +A PD  +T
Sbjct: 129 HICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 185
Query: 368 RVLISYVLGTMAYIAPEYFQQPE-LSEKCDIFSFGMLLISLVRGVPSF 414
             L  YV  T  Y APE     +  ++  DI+S G +L  ++   P F
Sbjct: 186 GFLTEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 95/226 (42%), Gaps = 36/226 (15%)
Query: 180 IEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIE 239
           I+ +DL FLK+         +G+G  G V   +  G     +AIK +I    +S  E IE
Sbjct: 12  IDPKDLTFLKE---------LGTGQFGVVKYGKWRGQYD--VAIK-MIKEGSMSEDEFIE 59
Query: 240 EDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDV 299
           E   + +               + H  ++ L     +     ++ E+M NG L + L ++
Sbjct: 60  EAKVMMN---------------LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM 104
Query: 300 SRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA 359
              R          +   V   +EYL    S   +H D+  RN L+ND     +SD GL+
Sbjct: 105 ---RHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLS 158
Query: 360 -MAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
              + D YT  + S     + +  PE     + S K DI++FG+L+
Sbjct: 159 RYVLDDEYTSSVGSKF--PVRWSPPEVLMYSKFSSKSDIWAFGVLM 202

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 98/234 (41%), Gaps = 47/234 (20%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKV------IVYAPISAAELIEEDSKLRDS 247
           + +L  +GSG  G V  A      G  +A+KK+      I++A  +  EL      ++  
Sbjct: 24  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYREL-RLLKHMKHE 81
Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELD 307
            +  +      A  +   N + L+ H++  D + +V         Q + DD         
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-------KCQKLTDD--------- 125
Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
                 +   +  GL+Y+H   SA IIH D+KP N+ +N+D E  I D GLA    D  T
Sbjct: 126 --HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMT 180
Query: 368 RVLISYVLGTMAYIAPEYFQQPEL-------SEKCDIFSFGMLLISLVRGVPSF 414
                       Y+A  +++ PE+       ++  DI+S G ++  L+ G   F
Sbjct: 181 -----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 55/229 (24%), Positives = 98/229 (42%), Gaps = 33/229 (14%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  G+V KA           +K    Y  ++   L E  S    S+LR + SE    
Sbjct: 31  LGEGEFGKVVKA-------TAFHLKGRAGYTTVAVKMLKENASP---SELRDLLSEFNVL 80
Query: 260 SQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSR------------GRRELD 307
            Q+ H +++ L     +    LL+ E+ K GSL+  L +  +                LD
Sbjct: 81  KQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLD 140
Query: 308 WPSRHRIALG--------VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA 359
            P    + +G        ++ G++YL       ++H D+  RN+L+ +  +  ISD GL+
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLS 197
Query: 360 MAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLV 408
             + +  + V  S     + ++A E       + + D++SFG+LL  +V
Sbjct: 198 RDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 246

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 68/257 (26%), Positives = 103/257 (40%), Gaps = 40/257 (15%)
Query: 188 LKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDS 247
           LK ED F   + +G G  G+V+ AE   +N +  AIK             +++D  L D 
Sbjct: 14  LKIED-FILHKMLGKGSFGKVFLAEFKKTN-QFFAIKA------------LKKDVVLMDD 59
Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMV----RPDCHLLVYEFMKNGSLQDILDDVSRGR 303
            +     E    S        P L HM       +    V E++  G L   +    +  
Sbjct: 60  DVECTMVEKRVLSLAWEH---PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-- 114
Query: 304 RELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
              D       A  +  GL++LH   S  I++ D+K  N+LL+ D    I+D G+     
Sbjct: 115 --FDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM 169
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI 423
            G  +   +   GT  YIAPE     + +   D +SFG+LL  ++ G   F   Q+ EE+
Sbjct: 170 LGDAKT--NXFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF-HGQDEEEL 226
Query: 424 CS---------PEWLRK 431
                      P WL K
Sbjct: 227 FHSIRMDNPFYPRWLEK 243

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 98/221 (44%), Gaps = 30/221 (13%)
Query: 200 IGSGGCGEVYKAELPG-SNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT 258
           +G G  G+V  AE  G    K   + KV       A ++++ D+  +D  L  + SE+  
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKV-------AVKMLKSDATEKD--LSDLISEMEM 86
Query: 259 ASQI-RHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR---- 313
              I +H+NI+ LL    +     ++ E+   G+L++ L        E  +   H     
Sbjct: 87  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQ 146
Query: 314 --------IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP-- 363
                    A  VA G+EYL    S   IH D+  RNVL+ +D    I+D GLA  I   
Sbjct: 147 LSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 203
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
           D Y +     +   + ++APE       + + D++SFG+LL
Sbjct: 204 DYYKKTTNGRL--PVKWMAPEALFDRIYTHQSDVWSFGVLL 242

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 89/211 (42%), Gaps = 19/211 (9%)
Query: 232 ISAAELIEEDSKLRDSKLRQIRSEI-ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNG 290
           +  A  +E   K+ D   R    EI I     +H NI+ L           LV E M+ G
Sbjct: 47  VHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGG 106
Query: 291 SLQD-ILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDM 349
            L D IL       RE  +     +   +   +EYLH   S  ++H D+KP N+L  D+ 
Sbjct: 107 ELLDKILRQKFFSEREASF-----VLHTIGKTVEYLH---SQGVVHRDLKPSNILYVDES 158
Query: 350 --EAC--ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLI 405
               C  I D G A  +       L+     T  ++APE  ++    E CDI+S G+LL 
Sbjct: 159 GNPECLRICDFGFAKQLRA--ENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLY 216
Query: 406 SLVRGVPSFVFHQNGEEICSPEWLRKVMNSK 436
           +++ G   F    NG      E L ++ + K
Sbjct: 217 TMLAGYTPFA---NGPSDTPEEILTRIGSGK 244

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 93/206 (45%), Gaps = 30/206 (14%)
Query: 282 LVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPR 341
           LV E++ +G L+D L    R R  LD       +  +  G+EYL    S   +H D+  R
Sbjct: 90  LVMEYLPSGCLRDFLQ---RHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAAR 143
Query: 342 NVLLNDDMEACISDLGLAMAIP-DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSF 400
           N+L+  +    I+D GLA  +P D    V+       + + APE       S + D++SF
Sbjct: 144 NILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSF 203
Query: 401 GMLLISLVRGVPSFVFHQNGEEICSP--EWLRKVMNSKNPSRAID---------PRLPGN 449
           G++L  L      F +    ++ CSP  E+LR +M S+    A+           RLP  
Sbjct: 204 GVVLYEL------FTY---CDKSCSPSAEFLR-MMGSERDVPALSRLLELLEEGQRLPAP 253
Query: 450 GYEKKMLHVLKIAYICTLHDPEERPN 475
                 +H  ++  +C    P++RP+
Sbjct: 254 PACPAEVH--ELMKLCWAPSPQDRPS 277

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 94/217 (43%), Gaps = 41/217 (18%)
Query: 200 IGSGGCGEVY--KAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           +G+G  GEV   + +LP      +AIK + V                 + + R    E  
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKV--------------GYTEKQRRDFLGEAS 69
Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL- 316
              Q  H NI+ L   + +    ++V E M+NGSL   L      + +  +     + + 
Sbjct: 70  IMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLR-----KHDAQFTVIQLVGML 124
Query: 317 -GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPD----GYT---- 367
            G+ASG++YL        +H D+  RN+L+N ++   +SD GL+  + D     YT    
Sbjct: 125 RGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 181
Query: 368 RVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
           ++ I +        +PE     + +   D++S+G++L
Sbjct: 182 KIPIRWT-------SPEAIAYRKFTSASDVWSYGIVL 211

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 98/234 (41%), Gaps = 47/234 (20%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKV------IVYAPISAAELIEEDSKLRDS 247
           + +L  +GSG  G V  A      G  +A+KK+      I++A  +  EL      ++  
Sbjct: 24  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYREL-RLLKHMKHE 81
Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELD 307
            +  +      A  +   N + L+ H++  D + +V         Q + DD         
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-------KCQKLTDD--------- 125
Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
                 +   +  GL+Y+H   SA IIH D+KP N+ +N+D E  I D GLA    D  T
Sbjct: 126 --HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMT 180
Query: 368 RVLISYVLGTMAYIAPEYFQQPEL-------SEKCDIFSFGMLLISLVRGVPSF 414
                       Y+A  +++ PE+       ++  DI+S G ++  L+ G   F
Sbjct: 181 -----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 93/217 (42%), Gaps = 41/217 (18%)
Query: 200 IGSGGCGEVYKA--ELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           +G+G  GEV     +LP      +AIK + V                 + + R    E  
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKV--------------GYTEKQRRDFLGEAS 98
Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL- 316
              Q  H NI+ L   + +    ++V E M+NGSL   L      + +  +     + + 
Sbjct: 99  IMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLR-----KHDAQFTVIQLVGML 153
Query: 317 -GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPD----GYT---- 367
            G+ASG++YL        +H D+  RN+L+N ++   +SD GL+  + D     YT    
Sbjct: 154 RGIASGMKYLS---DMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 210
Query: 368 RVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
           ++ I +        +PE     + +   D++S+G++L
Sbjct: 211 KIPIRWT-------SPEAIAYRKFTSASDVWSYGIVL 240

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 68/257 (26%), Positives = 103/257 (40%), Gaps = 40/257 (15%)
Query: 188 LKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDS 247
           LK ED F   + +G G  G+V+ AE   +N +  AIK             +++D  L D 
Sbjct: 15  LKIED-FELHKMLGKGSFGKVFLAEFKKTN-QFFAIKA------------LKKDVVLMDD 60
Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMV----RPDCHLLVYEFMKNGSLQDILDDVSRGR 303
            +     E    S        P L HM       +    V E++  G L   +    +  
Sbjct: 61  DVECTMVEKRVLSLAWEH---PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-- 115
Query: 304 RELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
              D       A  +  GL++LH   S  I++ D+K  N+LL+ D    I+D G+     
Sbjct: 116 --FDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM 170
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI 423
            G  +   +   GT  YIAPE     + +   D +SFG+LL  ++ G   F   Q+ EE+
Sbjct: 171 LGDAKT--NEFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF-HGQDEEEL 227
Query: 424 CS---------PEWLRK 431
                      P WL K
Sbjct: 228 FHSIRMDNPFYPRWLEK 244

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 93/217 (42%), Gaps = 41/217 (18%)
Query: 200 IGSGGCGEVYKA--ELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           +G+G  GEV     +LP      +AIK + V                 + + R    E  
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKV--------------GYTEKQRRDFLGEAS 98
Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL- 316
              Q  H NI+ L   + +    ++V E M+NGSL   L      + +  +     + + 
Sbjct: 99  IMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLR-----KHDAQFTVIQLVGML 153
Query: 317 -GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPD----GYT---- 367
            G+ASG++YL        +H D+  RN+L+N ++   +SD GL+  + D     YT    
Sbjct: 154 RGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 210
Query: 368 RVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
           ++ I +        +PE     + +   D++S+G++L
Sbjct: 211 KIPIRWT-------SPEAIAYRKFTSASDVWSYGIVL 240

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 72/157 (45%), Gaps = 14/157 (8%)
Query: 279 CHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDI 338
           C L++ E M+ G L   + +  RG +         I   + + +++LH   S +I H D+
Sbjct: 100 CLLIIMECMEGGELFSRIQE--RGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDV 154
Query: 339 KPRNVLLND---DMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKC 395
           KP N+L      D    ++D G A       T+  +     T  Y+APE     +  + C
Sbjct: 155 KPENLLYTSKEKDAVLKLTDFGFAKET----TQNALQTPCYTPYYVAPEVLGPEKYDKSC 210
Query: 396 DIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKV 432
           D++S G+++  L+ G P   F+ N  +  SP   R++
Sbjct: 211 DMWSLGVIMYILLCGFPP--FYSNTGQAISPGMKRRI 245

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 72/157 (45%), Gaps = 14/157 (8%)
Query: 279 CHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDI 338
           C L++ E M+ G L   + +  RG +         I   + + +++LH   S +I H D+
Sbjct: 81  CLLIIMECMEGGELFSRIQE--RGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDV 135
Query: 339 KPRNVLLND---DMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKC 395
           KP N+L      D    ++D G A       T+  +     T  Y+APE     +  + C
Sbjct: 136 KPENLLYTSKEKDAVLKLTDFGFAKET----TQNALQTPCYTPYYVAPEVLGPEKYDKSC 191
Query: 396 DIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKV 432
           D++S G+++  L+ G P   F+ N  +  SP   R++
Sbjct: 192 DMWSLGVIMYILLCGFPP--FYSNTGQAISPGMKRRI 226

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 14/168 (8%)
Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
           I  E+    +I+H N++ L          +L+ E +  G L D L +    +  L     
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE----KESLTEEEA 116
Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLND----DMEACISDLGLAMAIPDGYT 367
                 + +G+ YLH   S  I H D+KP N++L D         I D GLA  I  G  
Sbjct: 117 TEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 173
Query: 368 RVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFV 415
                 + GT A++APE      L  + D++S G++   L+ G   F+
Sbjct: 174 ---FKNIFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 92/217 (42%), Gaps = 27/217 (12%)
Query: 197 LEKIGSGGCGEVYKAE---LPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           L+++G G  G V       L  + G+++A+KK+                   +  LR   
Sbjct: 13  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---------------QHSTEEHLRDFE 57
Query: 254 SEIITASQIRHRNILPL--LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
            EI     ++H NI+    + +        L+ E++  GSL+D L    + +  +D    
Sbjct: 58  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKL 114
Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP-DGYTRVL 370
            +    +  G+EYL    +   IH D+  RN+L+ ++    I D GL   +P D     +
Sbjct: 115 LQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 171
Query: 371 ISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISL 407
                  + + APE   + + S   D++SFG++L  L
Sbjct: 172 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 208

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 98/234 (41%), Gaps = 47/234 (20%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKV------IVYAPISAAELIEEDSKLRDS 247
           + +L  +GSG  G V  A      G  +A+KK+      I++A  +  EL      ++  
Sbjct: 24  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYREL-RLLKHMKHE 81
Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELD 307
            +  +      A  +   N + L+ H++  D + +V         Q + DD         
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-------KCQKLTDD--------- 125
Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
                 +   +  GL+Y+H   SA IIH D+KP N+ +N+D E  I D GLA    D  T
Sbjct: 126 --HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMT 180
Query: 368 RVLISYVLGTMAYIAPEYFQQPEL-------SEKCDIFSFGMLLISLVRGVPSF 414
                       Y+A  +++ PE+       ++  DI+S G ++  L+ G   F
Sbjct: 181 -----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 82/183 (44%), Gaps = 16/183 (8%)
Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
           ++ EI   +  RHRNIL L       +  ++++EF+   S  DI + ++    EL+    
Sbjct: 48  VKKEISILNIARHRNILHLHESFESMEELVMIFEFI---SGLDIFERINTSAFELN---E 101
Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACIS--DLGLAMAI-PDGYTR 368
             I   V    E L   HS +I H DI+P N++      + I   + G A  + P    R
Sbjct: 102 REIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR 161
Query: 369 VLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNG---EEICS 425
           +L +       Y APE  Q   +S   D++S G L+  L+ G+  F+   N    E I +
Sbjct: 162 LLFT----APEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMN 217
Query: 426 PEW 428
            E+
Sbjct: 218 AEY 220

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 65/261 (24%), Positives = 111/261 (42%), Gaps = 51/261 (19%)
Query: 167 GSRDRGPTIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKV 226
           GS++R PT +   + K      +  + + +L  +GSG  G V  A      G  +A+KK+
Sbjct: 1   GSQER-PTFYRQELNK---TIWEVPERYQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKL 55
Query: 227 ------IVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCH 280
                 I++A  +  EL      ++   +  +      A  +   N + L+ H++  D +
Sbjct: 56  SRPFQSIIHAKRTYREL-RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN 114
Query: 281 LLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKP 340
            +V    K+  L D  D V              +   +  GL+Y+H   SA IIH D+KP
Sbjct: 115 NIV----KSQKLTD--DHV------------QFLIYQILRGLKYIH---SADIIHRDLKP 153
Query: 341 RNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPEL-------SE 393
            N+ +N+D E  I D GL     D  T            Y+A  +++ PE+       ++
Sbjct: 154 SNLAVNEDSELKILDFGLCRHTDDEMT-----------GYVATRWYRAPEIMLNWMHYNQ 202
Query: 394 KCDIFSFGMLLISLVRGVPSF 414
             DI+S G ++  L+ G   F
Sbjct: 203 TVDIWSVGCIMAELLTGRTLF 223

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 67/250 (26%), Positives = 107/250 (42%), Gaps = 69/250 (27%)
Query: 190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKL 249
           +E  +   + IG+G  G VY+A+L  S G+++AIKKV+            +D + ++ +L
Sbjct: 18  QEVSYTDTKVIGNGSFGVVYQAKLCDS-GELVAIKKVL------------QDKRFKNREL 64
Query: 250 RQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDIL----------DDV 299
           + +R       ++ H NI       VR     L Y F  +G  +D++          + V
Sbjct: 65  QIMR-------KLDHCNI-------VR-----LRYFFYSSGEKKDVVYLNLVLDYVPETV 105
Query: 300 SRGRRELDWPSRHRIALGVASGLEYLHMY-------HSASIIHGDIKPRNVLLNDDMEAC 352
            R  R     SR +  L V     Y++         HS  I H DIKP+N+LL+ D    
Sbjct: 106 YRVARHY---SRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVL 162
Query: 353 -ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPEL-------SEKCDIFSFGMLL 404
            + D G A  +  G   V         + I   Y++ PEL       +   D++S G +L
Sbjct: 163 KLCDFGSAKQLVRGEPNV---------SXICSRYYRAPELIFGATDYTSSIDVWSAGCVL 213
Query: 405 ISLVRGVPSF 414
             L+ G P F
Sbjct: 214 AELLLGQPIF 223

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 72/294 (24%), Positives = 131/294 (44%), Gaps = 53/294 (18%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           ++ L++IGSGG  +V++          +  +K  +YA I    L E D++  DS     R
Sbjct: 58  YSILKQIGSGGSSKVFQ----------VLNEKKQIYA-IKYVNLEEADNQTLDS----YR 102
Query: 254 SEIITASQIRHRN--ILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
           +EI   ++++  +  I+ L  + +       +Y  M+ G++   L+   + ++ +D   R
Sbjct: 103 NEIAYLNKLQQHSDKIIRLYDYEITDQ---YIYMVMECGNID--LNSWLKKKKSIDPWER 157
Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLI 371
                 +   LE +H  H   I+H D+KP N L+ D M   I D G+A  +    T V+ 
Sbjct: 158 KSYWKNM---LEAVHTIHQHGIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVK 213
Query: 372 SYVLGTMAYIAPEYFQQPELSEK-----------CDIFSFGMLLISLVRGVPSFVFHQNG 420
              +G + Y+ PE  +    S +            D++S G +L  +  G   F      
Sbjct: 214 DSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------ 267
Query: 421 EEICSPEWLRKVMNSKNPSRAID-PRLPGNGYEKKMLHVLKIAYICTLHDPEER 473
           ++I +   + K+    +P+  I+ P +P    EK +  VLK    C   DP++R
Sbjct: 268 QQIINQ--ISKLHAIIDPNHEIEFPDIP----EKDLQDVLK---CCLKRDPKQR 312

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 92/217 (42%), Gaps = 27/217 (12%)
Query: 197 LEKIGSGGCGEVYKAE---LPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           L+++G G  G V       L  + G+++A+KK+                   +  LR   
Sbjct: 14  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---------------QHSTEEHLRDFE 58
Query: 254 SEIITASQIRHRNILPL--LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
            EI     ++H NI+    + +        L+ E++  GSL+D L    + +  +D    
Sbjct: 59  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKL 115
Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP-DGYTRVL 370
            +    +  G+EYL    +   IH D+  RN+L+ ++    I D GL   +P D     +
Sbjct: 116 LQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 172
Query: 371 ISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISL 407
                  + + APE   + + S   D++SFG++L  L
Sbjct: 173 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 209

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 92/217 (42%), Gaps = 27/217 (12%)
Query: 197 LEKIGSGGCGEVYKAE---LPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           L+++G G  G V       L  + G+++A+KK+                   +  LR   
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---------------QHSTEEHLRDFE 59
Query: 254 SEIITASQIRHRNILPL--LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
            EI     ++H NI+    + +        L+ E++  GSL+D L    + +  +D    
Sbjct: 60  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKL 116
Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP-DGYTRVL 370
            +    +  G+EYL    +   IH D+  RN+L+ ++    I D GL   +P D     +
Sbjct: 117 LQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 173
Query: 371 ISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISL 407
                  + + APE   + + S   D++SFG++L  L
Sbjct: 174 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 210

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 94/226 (41%), Gaps = 36/226 (15%)
Query: 180 IEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIE 239
           I+ +DL FLK+         +G+G  G V   +  G     +AIK +I    +S  E IE
Sbjct: 6   IDPKDLTFLKE---------LGTGQFGVVKYGKWRGQYD--VAIK-MIKEGSMSEDEFIE 53
Query: 240 EDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDV 299
           E   + +               + H  ++ L     +     ++ E+M NG L + L ++
Sbjct: 54  EAKVMMN---------------LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM 98
Query: 300 SRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA 359
              R          +   V   +EYL    S   +H D+  RN L+ND     +SD GL+
Sbjct: 99  ---RHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLS 152
Query: 360 -MAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
              + D YT    S     + +  PE     + S K DI++FG+L+
Sbjct: 153 RYVLDDEYTSSRGSKF--PVRWSPPEVLMYSKFSSKSDIWAFGVLM 196

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/139 (28%), Positives = 60/139 (43%), Gaps = 11/139 (7%)
Query: 279 CHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDI 338
           C L+V E +  G L   + D  RG +         I   +   ++YLH   S +I H D+
Sbjct: 87  CLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDV 141
Query: 339 KPRNVLLNDDMEACI---SDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKC 395
           KP N+L        I   +D G A       +     Y   T  Y+APE     +  + C
Sbjct: 142 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCY---TPYYVAPEVLGPEKYDKSC 198
Query: 396 DIFSFGMLLISLVRGVPSF 414
           D++S G+++  L+ G P F
Sbjct: 199 DMWSLGVIMYILLCGYPPF 217

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 72/294 (24%), Positives = 131/294 (44%), Gaps = 53/294 (18%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           ++ L++IGSGG  +V++          +  +K  +YA I    L E D++  DS     R
Sbjct: 30  YSILKQIGSGGSSKVFQ----------VLNEKKQIYA-IKYVNLEEADNQTLDS----YR 74
Query: 254 SEIITASQIRHRN--ILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
           +EI   ++++  +  I+ L  + +       +Y  M+ G++   L+   + ++ +D   R
Sbjct: 75  NEIAYLNKLQQHSDKIIRLYDYEITDQ---YIYMVMECGNID--LNSWLKKKKSIDPWER 129
Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLI 371
                 +   LE +H  H   I+H D+KP N L+ D M   I D G+A  +      V+ 
Sbjct: 130 KSYWKNM---LEAVHTIHQHGIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDXXXVVK 185
Query: 372 SYVLGTMAYIAPEYFQQPELSEK-----------CDIFSFGMLLISLVRGVPSFVFHQNG 420
              +GT+ Y+ PE  +    S +            D++S G +L  +  G   F      
Sbjct: 186 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------ 239
Query: 421 EEICSPEWLRKVMNSKNPSRAID-PRLPGNGYEKKMLHVLKIAYICTLHDPEER 473
           ++I +   + K+    +P+  I+ P +P    EK +  VLK    C   DP++R
Sbjct: 240 QQIINQ--ISKLHAIIDPNHEIEFPDIP----EKDLQDVLK---CCLKRDPKQR 284

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 97/226 (42%), Gaps = 17/226 (7%)
Query: 191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
           ED +   E IG G    V +  +    G+  A+K V V    S+  L  ED         
Sbjct: 23  EDVYELCEVIGKGPFSVVRRC-INRETGQQFAVKIVDVAKFTSSPGLSTED--------- 72
Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQ-DILDDVSRGRRELDWP 309
            ++ E      ++H +I+ LL          +V+EFM    L  +I+     G    +  
Sbjct: 73  -LKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAV 131
Query: 310 SRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLL-NDDMEACISDLGLAMAIPDGYTR 368
           + H +       LE L   H  +IIH D+KP  VLL + +  A +   G  +AI  G + 
Sbjct: 132 ASHYMR----QILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG 187
Query: 369 VLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
           ++    +GT  ++APE  ++    +  D++  G++L  L+ G   F
Sbjct: 188 LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPF 233

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 92/217 (42%), Gaps = 27/217 (12%)
Query: 197 LEKIGSGGCGEVYKAE---LPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           L+++G G  G V       L  + G+++A+KK+                   +  LR   
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---------------QHSTEEHLRDFE 59
Query: 254 SEIITASQIRHRNILPL--LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
            EI     ++H NI+    + +        L+ E++  GSL+D L    + +  +D    
Sbjct: 60  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKL 116
Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP-DGYTRVL 370
            +    +  G+EYL    +   IH D+  RN+L+ ++    I D GL   +P D     +
Sbjct: 117 LQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 173
Query: 371 ISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISL 407
                  + + APE   + + S   D++SFG++L  L
Sbjct: 174 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 210

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 102/227 (44%), Gaps = 29/227 (12%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           + +L  IG G  G V  A     N   +AIKK+   +P       +          R +R
Sbjct: 29  YTNLSYIGEGAYGMVCSA-YDNLNKVRVAIKKI---SPFEHQTYCQ----------RTLR 74
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSL-QDILD-DVSRGRRELDWPSR 311
            EI    + RH NI+ +   +  P       E MK+  + QD+++ D+ +  +     + 
Sbjct: 75  -EIKILLRFRHENIIGINDIIRAP-----TIEQMKDVYIVQDLMETDLYKLLKTQHLSND 128
Query: 312 H--RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA-MAIPDGYTR 368
           H       +  GL+Y+H   SA+++H D+KP N+LLN   +  I D GLA +A PD    
Sbjct: 129 HICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 185
Query: 369 VLISYVLGTMAYIAPEYFQQPE-LSEKCDIFSFGMLLISLVRGVPSF 414
             +   + T  Y APE     +  ++  DI+S G +L  ++   P F
Sbjct: 186 GFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 102/227 (44%), Gaps = 29/227 (12%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           + +L  IG G  G V  A     N   +AIKK+   +P       +          R +R
Sbjct: 30  YTNLSYIGEGAYGMVCSA-YDNLNKVRVAIKKI---SPFEHQTYCQ----------RTLR 75
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSL-QDILD-DVSRGRRELDWPSR 311
            EI    + RH NI+ +   +  P       E MK+  + QD+++ D+ +  +     + 
Sbjct: 76  -EIKILLRFRHENIIGINDIIRAP-----TIEQMKDVYIVQDLMETDLYKLLKTQHLSND 129
Query: 312 H--RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA-MAIPDGYTR 368
           H       +  GL+Y+H   SA+++H D+KP N+LLN   +  I D GLA +A PD    
Sbjct: 130 HICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 186
Query: 369 VLISYVLGTMAYIAPEYFQQPE-LSEKCDIFSFGMLLISLVRGVPSF 414
             +   + T  Y APE     +  ++  DI+S G +L  ++   P F
Sbjct: 187 GFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 233

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 80/174 (45%), Gaps = 22/174 (12%)
Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCH--LLVYEFMKNGSLQDILDDVSRGRRELDW 308
            ++ EI    ++RH+N++ L+  +   +     +V E+   G +Q++LD V   R  +  
Sbjct: 52  NVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVC- 109
Query: 309 PSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTR 368
              H     +  GLEYLH   S  I+H DIKP N+LL       IS LG+A A+      
Sbjct: 110 -QAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAAD 165
Query: 369 VLISYVLGTMAYIAPEYFQQPELSE--------KCDIFSFGMLLISLVRGVPSF 414
                  G+ A      FQ PE++         K DI+S G+ L ++  G+  F
Sbjct: 166 DTCRTSQGSPA------FQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPF 213

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 26/219 (11%)
Query: 200 IGSGGCGEVYKAELPG-SNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT 258
           +G G  G+V  AE  G    K   + KV       A ++++ D+  +D  L  + SE+  
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKV-------AVKMLKSDATEKD--LSDLISEMEM 86
Query: 259 ASQI-RHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR---- 313
              I +H+NI+ LL    +     ++ E+   G+L++ L        E  +   H     
Sbjct: 87  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQ 146
Query: 314 --------IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG 365
                    A  VA G+EYL    S   IH D+  RNVL+ +D    I+D GLA  I   
Sbjct: 147 LSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 203
Query: 366 YTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
                 +     + ++APE       + + D++SFG+LL
Sbjct: 204 DXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLL 242

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 97/226 (42%), Gaps = 17/226 (7%)
Query: 191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
           ED +   E IG G    V +  +    G+  A+K V V    S+  L  ED         
Sbjct: 25  EDVYELCEVIGKGPFSVVRRC-INRETGQQFAVKIVDVAKFTSSPGLSTED--------- 74
Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQ-DILDDVSRGRRELDWP 309
            ++ E      ++H +I+ LL          +V+EFM    L  +I+     G    +  
Sbjct: 75  -LKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAV 133
Query: 310 SRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLL-NDDMEACISDLGLAMAIPDGYTR 368
           + H +       LE L   H  +IIH D+KP  VLL + +  A +   G  +AI  G + 
Sbjct: 134 ASHYMR----QILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG 189
Query: 369 VLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
           ++    +GT  ++APE  ++    +  D++  G++L  L+ G   F
Sbjct: 190 LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPF 235

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 97/219 (44%), Gaps = 29/219 (13%)
Query: 199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT 258
           ++G G  G+VYKA+   +               ++AA++IE  S   + +L     EI  
Sbjct: 26  ELGDGAFGKVYKAKNKETGA-------------LAAAKVIETKS---EEELEDYIVEIEI 69
Query: 259 ASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV 318
            +   H  I+ LL          ++ EF   G++  I+ ++ RG  E       +I +  
Sbjct: 70  LATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTE------PQIQVVC 123
Query: 319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTM 378
              LE L+  HS  IIH D+K  NVL+  + +  ++D G++    +  T       +GT 
Sbjct: 124 RQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAK--NLKTLQKRDSFIGTP 181
Query: 379 AYIAPEYFQQPELSE-----KCDIFSFGMLLISLVRGVP 412
            ++APE      + +     K DI+S G+ LI + +  P
Sbjct: 182 YWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP 220

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 97/219 (44%), Gaps = 29/219 (13%)
Query: 199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT 258
           ++G G  G+VYKA+   +               ++AA++IE  S   + +L     EI  
Sbjct: 18  ELGDGAFGKVYKAKNKETGA-------------LAAAKVIETKS---EEELEDYIVEIEI 61
Query: 259 ASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV 318
            +   H  I+ LL          ++ EF   G++  I+ ++ RG  E       +I +  
Sbjct: 62  LATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTE------PQIQVVC 115
Query: 319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTM 378
              LE L+  HS  IIH D+K  NVL+  + +  ++D G++    +  T       +GT 
Sbjct: 116 RQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAK--NLKTLQKRDSFIGTP 173
Query: 379 AYIAPEYFQQPELSE-----KCDIFSFGMLLISLVRGVP 412
            ++APE      + +     K DI+S G+ LI + +  P
Sbjct: 174 YWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP 212

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 100/244 (40%), Gaps = 40/244 (16%)
Query: 170 DRGPTIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAE---LPGSNGKMIAIKKV 226
           DR PT F    E+  L FL         +++G G  G V       L  + G+++A+KK+
Sbjct: 4   DRDPTQF----EERHLKFL---------QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL 50
Query: 227 IVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL--LAHMVRPDCHLLVY 284
                              +  LR    EI     ++H NI+    + +        L+ 
Sbjct: 51  ---------------QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIM 95
Query: 285 EFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVL 344
           E++  GSL+D L   +     +D     +    +  G+EYL    +   IH D+  RN+L
Sbjct: 96  EYLPYGSLRDYLQAHAE---RIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNIL 149
Query: 345 LNDDMEACISDLGLAMAIP-DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGML 403
           + ++    I D GL   +P D     +       + + APE   + + S   D++SFG++
Sbjct: 150 VENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVV 209
Query: 404 LISL 407
           L  L
Sbjct: 210 LYEL 213

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 66/291 (22%), Positives = 120/291 (41%), Gaps = 54/291 (18%)
Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           +K+G+G  GEV+ A     N       K +    +S    + E + ++            
Sbjct: 188 KKLGAGQFGEVWMATY---NKHTKVAVKTMKPGSMSVEAFLAEANVMK------------ 232
Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALG 317
               ++H  ++ L A + +   +++  EFM  GSL D L      ++ L  P     +  
Sbjct: 233 ---TLQHDKLVKLHAVVTKEPIYIIT-EFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQ 286
Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGT 377
           +A G+ ++      + IH D++  N+L++  +   I+D GLA        RV   +    
Sbjct: 287 IAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLA--------RVGAKF---P 332
Query: 378 MAYIAPEYFQQPELSEKCDIFSFGMLLISLVR--GVPSFVFHQNGEEICSPEWLRKVMNS 435
           + + APE       + K D++SFG+LL+ +V    +P          + +PE +R +   
Sbjct: 333 IKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY-------PGMSNPEVIRALERG 385
Query: 436 KNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL 486
               R      P N  E+    +  I   C  + PEERP  +Y++  L   
Sbjct: 386 YRMPR------PENCPEE----LYNIMMRCWKNRPEERPTFEYIQSVLDDF 426

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 101/233 (43%), Gaps = 28/233 (12%)
Query: 194 FASLEKIGSGGCGEV--YKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ 251
           F  L+ +G G  G+V   K +  G    M  +KK ++ A    A  + E+  L++S    
Sbjct: 153 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS---- 208
Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
                      RH  +  L       D    V E+   G L      +SR R   +  +R
Sbjct: 209 -----------RHPFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRAR 254
Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAM-AIPDGYTRVL 370
              A  + S L+YLH     ++++ D+K  N++L+ D    I+D GL    I DG T   
Sbjct: 255 FYGA-EIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--- 308
Query: 371 ISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI 423
           +    GT  Y+APE  +  +     D +  G+++  ++ G   F ++Q+ E++
Sbjct: 309 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHEKL 360

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 52/101 (51%), Gaps = 21/101 (20%)
Query: 321 GLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAY 380
           GL+Y+H   SA IIH D+KP NV +N+D E  I D GLA    +  T            Y
Sbjct: 143 GLKYIH---SAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMT-----------GY 188
Query: 381 IAPEYFQQPEL-------SEKCDIFSFGMLLISLVRGVPSF 414
           +A  +++ PE+       ++  DI+S G ++  L++G   F
Sbjct: 189 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALF 229

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 80/181 (44%), Gaps = 33/181 (18%)
Query: 315 ALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI---PD----GYT 367
           +  VA G+E+L    S   IH D+  RN+LL+++    I D GLA  I   PD    G T
Sbjct: 205 SFQVARGMEFLS---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDT 261
Query: 368 RVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSP 426
           R+        + ++APE       S K D++S+G+LL  +   G   +   Q  E+ CS 
Sbjct: 262 RL-------PLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDEDFCSR 314
Query: 427 EWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL 486
             LR+ M  + P             E     + +I   C   DP+ERP    +  +L  L
Sbjct: 315 --LREGMRMRAP-------------EYSTPEIYQIMLDCWHRDPKERPRFAELVEKLGDL 359
Query: 487 L 487
           L
Sbjct: 360 L 360

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 101/233 (43%), Gaps = 28/233 (12%)
Query: 194 FASLEKIGSGGCGEV--YKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ 251
           F  L+ +G G  G+V   K +  G    M  +KK ++ A    A  + E+  L++S    
Sbjct: 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS---- 205
Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
                      RH  +  L       D    V E+   G L      +SR R   +  +R
Sbjct: 206 -----------RHPFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRAR 251
Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAM-AIPDGYTRVL 370
              A  + S L+YLH     ++++ D+K  N++L+ D    I+D GL    I DG T   
Sbjct: 252 FYGA-EIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--- 305
Query: 371 ISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI 423
           +    GT  Y+APE  +  +     D +  G+++  ++ G   F ++Q+ E++
Sbjct: 306 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHEKL 357

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 92/217 (42%), Gaps = 27/217 (12%)
Query: 197 LEKIGSGGCGEVYKAE---LPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           L+++G G  G V       L  + G+++A+KK+                   +  LR   
Sbjct: 33  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---------------QHSTEEHLRDFE 77
Query: 254 SEIITASQIRHRNILPL--LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
            EI     ++H NI+    + +        L+ E++  GSL+D L    + +  +D    
Sbjct: 78  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKL 134
Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP-DGYTRVL 370
            +    +  G+EYL    +   IH D+  RN+L+ ++    I D GL   +P D     +
Sbjct: 135 LQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 191
Query: 371 ISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISL 407
                  + + APE   + + S   D++SFG++L  L
Sbjct: 192 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 228

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 98/234 (41%), Gaps = 47/234 (20%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKV------IVYAPISAAELIEEDSKLRDS 247
           + +L  +GSG  G V  A      G  +A+KK+      I++A  +  EL      ++  
Sbjct: 24  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYREL-RLLKHMKHE 81
Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELD 307
            +  +      A  +   N + L+ H++  D + +V         Q + DD         
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-------KCQKLTDD--------- 125
Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
                 +   +  GL+Y+H   SA IIH D+KP N+ +N+D E  I D GLA    D  T
Sbjct: 126 --HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMT 180
Query: 368 RVLISYVLGTMAYIAPEYFQQPEL-------SEKCDIFSFGMLLISLVRGVPSF 414
                       Y+A  +++ PE+       ++  DI+S G ++  L+ G   F
Sbjct: 181 -----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/139 (28%), Positives = 58/139 (41%), Gaps = 11/139 (7%)
Query: 279 CHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDI 338
           C L+V E +  G L   + D  RG +         I   +   ++YLH   S +I H D+
Sbjct: 133 CLLIVXECLDGGELFSRIQD--RGDQAFTEREASEIXKSIGEAIQYLH---SINIAHRDV 187
Query: 339 KPRNVLLNDDMEACI---SDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKC 395
           KP N+L        I   +D G A       +     Y   T  Y+APE     +  + C
Sbjct: 188 KPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEVLGPEKYDKSC 244
Query: 396 DIFSFGMLLISLVRGVPSF 414
           D +S G++   L+ G P F
Sbjct: 245 DXWSLGVIXYILLCGYPPF 263

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 100/229 (43%), Gaps = 41/229 (17%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +GSG  G+V  A   G +   ++I+         A ++++E  K   S+   + SE+   
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQ--------VAVKMLKE--KADSSEREALMSELKMM 102
Query: 260 SQI-RHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRE------LDWPSRH 312
           +Q+  H NI+ LL          L++E+   G L + L    R +RE      +++ ++ 
Sbjct: 103 TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYL----RSKREKFSEDEIEYENQK 158
Query: 313 RI-----------------ALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISD 355
           R+                 A  VA G+E+L      S +H D+  RNVL+       I D
Sbjct: 159 RLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICD 215
Query: 356 LGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
            GLA  I      V+       + ++APE   +   + K D++S+G+LL
Sbjct: 216 FGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILL 264

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 52/101 (51%), Gaps = 21/101 (20%)
Query: 321 GLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAY 380
           GL+Y+H   SA IIH D+KP NV +N+D E  I D GLA    +  T            Y
Sbjct: 135 GLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADEEMT-----------GY 180
Query: 381 IAPEYFQQPEL-------SEKCDIFSFGMLLISLVRGVPSF 414
           +A  +++ PE+       ++  DI+S G ++  L++G   F
Sbjct: 181 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALF 221

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 73/294 (24%), Positives = 130/294 (44%), Gaps = 46/294 (15%)
Query: 197 LEKIGSGGCG--EVYKAELPGSN-GKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           + ++G G  G  E+ + +  G N G ++A+K++    P       + D +     L+ + 
Sbjct: 12  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ-----QRDFQREIQILKALH 66
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
           S+ I    +++R +        RP+  L V E++ +G L+D L    R R  LD      
Sbjct: 67  SDFI----VKYRGVS---YGPGRPELRL-VMEYLPSGCLRDFL---QRHRARLDASRLLL 115
Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP-DGYTRVLIS 372
            +  +  G+EYL    S   +H D+  RN+L+  +    I+D GLA  +P D    V+  
Sbjct: 116 YSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVRE 172
Query: 373 YVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSP--EWLR 430
                + + APE       S + D++SFG++L  L      F +    ++ CSP  E+LR
Sbjct: 173 PGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYEL------FTY---CDKSCSPSAEFLR 223
Query: 431 KVMNSKNPSRAI---------DPRLPGNGYEKKMLHVLKIAYICTLHDPEERPN 475
            +M  +    A+           RLP        +H  ++  +C    P++RP+
Sbjct: 224 -MMGCERDVPALCRLLELLEEGQRLPAPPACPAEVH--ELMKLCWAPSPQDRPS 274

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 99/233 (42%), Gaps = 29/233 (12%)
Query: 194 FASLEKIGSGGCGEV--YKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ 251
           F  L+ +G G  G+V   + +  G    M  ++K ++ A    A  + E   L+++    
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT---- 62
Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
                      RH  +  L       D    V E+   G L      +SR R   +  +R
Sbjct: 63  -----------RHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERAR 108
Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAM-AIPDGYTRVL 370
              A  + S LEYLH   S  +++ DIK  N++L+ D    I+D GL    I DG T   
Sbjct: 109 FYGA-EIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--- 161
Query: 371 ISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI 423
           +    GT  Y+APE  +  +     D +  G+++  ++ G   F ++Q+ E +
Sbjct: 162 MKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHERL 213

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 92/217 (42%), Gaps = 27/217 (12%)
Query: 197 LEKIGSGGCGEVYKAE---LPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           L+++G G  G V       L  + G+++A+KK+                   +  LR   
Sbjct: 33  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---------------QHSTEEHLRDFE 77
Query: 254 SEIITASQIRHRNILPL--LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
            EI     ++H NI+    + +        L+ E++  GSL+D L    + +  +D    
Sbjct: 78  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKL 134
Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP-DGYTRVL 370
            +    +  G+EYL    +   IH D+  RN+L+ ++    I D GL   +P D     +
Sbjct: 135 LQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 191
Query: 371 ISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISL 407
                  + + APE   + + S   D++SFG++L  L
Sbjct: 192 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 228

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 99/218 (45%), Gaps = 33/218 (15%)
Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           E +G G  G+V  A    +  K +A+K       IS   L + D  +R      +  EI 
Sbjct: 15  ETLGEGSFGKVKLATHYKTQQK-VALKF------ISRQLLKKSDMHMR------VEREIS 61
Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALG 317
               +RH +I+ L   +  P   ++V E+       ++ D +   +R  +   R R    
Sbjct: 62  YLKLLRHPHIIKLYDVITTPTDIVMVIEYAGG----ELFDYIVEKKRMTEDEGR-RFFQQ 116
Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGT 377
           +   +EY H +    I+H D+KP N+LL+D++   I+D GL+  + DG     +    G+
Sbjct: 117 IICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN---FLKTSCGS 170
Query: 378 MAYIAPEY-----FQQPELSEKCDIFSFGMLLISLVRG 410
             Y APE      +  PE+    D++S G++L  ++ G
Sbjct: 171 PNYAAPEVINGKLYAGPEV----DVWSCGIVLYVMLVG 204

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 52/101 (51%), Gaps = 21/101 (20%)
Query: 321 GLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAY 380
           GL+Y+H   SA IIH D+KP NV +N+D E  I D GLA    +  T            Y
Sbjct: 143 GLKYIH---SAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMT-----------GY 188
Query: 381 IAPEYFQQPEL-------SEKCDIFSFGMLLISLVRGVPSF 414
           +A  +++ PE+       ++  DI+S G ++  L++G   F
Sbjct: 189 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALF 229

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/230 (24%), Positives = 99/230 (43%), Gaps = 47/230 (20%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKV------IVYAPISAAELIEEDSKLRDS 247
           + +L  +GSG  G V  +     +G  IA+KK+      I++A  +  EL      ++  
Sbjct: 53  YQTLSPVGSGAYGSVCSS-YDVKSGLKIAVKKLSRPFQSIIHAKRTYREL-RLLKHMKHE 110
Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELD 307
            +  +      A+ +   N + L+ H++  D + +V         Q + DD  +      
Sbjct: 111 NVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIV-------KCQKLTDDHVQF----- 158
Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
                 +   +  GL+Y+H   SA IIH D+KP N+ +N+D E  I D GLA    D  T
Sbjct: 159 ------LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 209
Query: 368 RVLISYVLGTMAYIAPEYFQQPEL-------SEKCDIFSFGMLLISLVRG 410
                       Y+A  +++ PE+       +   DI+S G ++  L+ G
Sbjct: 210 -----------GYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTG 248

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 101/220 (45%), Gaps = 28/220 (12%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  G+V  AE  G +      K     A   A +++++D+  +D  L  + SE+   
Sbjct: 43  LGEGAFGQVVMAEAVGID------KDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEMM 94
Query: 260 SQI-RHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILD-----------DVSRGRRE-L 306
             I +H+NI+ LL    +     ++ E+   G+L++ L            D++R   E +
Sbjct: 95  KMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 307 DWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP--D 364
            +         +A G+EYL    S   IH D+  RNVL+ ++    I+D GLA  I   D
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 365 GYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
            Y +     +   + ++APE       + + D++SFG+L+
Sbjct: 212 YYKKTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLM 249

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 82/168 (48%), Gaps = 25/168 (14%)
Query: 313 RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLIS 372
           +IA+ +   LE+LH     S+IH D+KP NVL+N   +  + D G++  + D   + + +
Sbjct: 113 KIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA 170
Query: 373 YVLGTMAYIAPEYFQQPELSE-----KCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPE 427
              G   Y+APE    PEL++     K DI+S G+ +I L   +  F +   G      +
Sbjct: 171 ---GCKPYMAPERI-NPELNQKGYSVKSDIWSLGITMIEL--AILRFPYDSWGTPF---Q 221
Query: 428 WLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPN 475
            L++V+  + PS    P+LP + +  +    +     C   + +ERP 
Sbjct: 222 QLKQVV--EEPS----PQLPADKFSAEF---VDFTSQCLKKNSKERPT 260

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 105/244 (43%), Gaps = 57/244 (23%)
Query: 190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKL 249
           +E  +   + IG+G  G VY+A+L  S G+++AIKKV+            +D + ++ +L
Sbjct: 37  QEVSYTDTKVIGNGSFGVVYQAKLCDS-GELVAIKKVL------------QDKRFKNREL 83
Query: 250 RQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQD------ILDDVSRGR 303
           + +R       ++ H NI+             L Y F  +G  +D      +LD V    
Sbjct: 84  QIMR-------KLDHCNIV------------RLRYFFYSSGEKKDEVYLNLVLDYVPETV 124
Query: 304 RELDWPSRHRIALGVASGLEYLHMY-----------HSASIIHGDIKPRNVLLNDDMEAC 352
             +   +RH         + Y+ +Y           HS  I H DIKP+N+LL+ D    
Sbjct: 125 YRV---ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVL 181
Query: 353 -ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEY-FQQPELSEKCDIFSFGMLLISLVRG 410
            + D G A  +  G   V     + +  Y APE  F   + +   D++S G +L  L+ G
Sbjct: 182 KLCDFGSAKQLVRGEPNV---SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 238
Query: 411 VPSF 414
            P F
Sbjct: 239 QPIF 242

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/234 (24%), Positives = 97/234 (41%), Gaps = 47/234 (20%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKV------IVYAPISAAELIEEDSKLRDS 247
           + +L  +GSG  G V  A      G  +A+KK+      I++A  +  EL      ++  
Sbjct: 47  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYREL-RLLKHMKHE 104
Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELD 307
            +  +      A  +   N + L+ H++  D + +V         Q + DD         
Sbjct: 105 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-------KCQKLTDD--------- 148
Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
                 +   +  GL+Y+H   SA IIH D+KP N+ +N+D E  I D GLA    D   
Sbjct: 149 --HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD--- 200
Query: 368 RVLISYVLGTMAYIAPEYFQQPEL-------SEKCDIFSFGMLLISLVRGVPSF 414
                       Y+A  +++ PE+       ++  DI+S G ++  L+ G   F
Sbjct: 201 --------EMXGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 246

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 106/244 (43%), Gaps = 57/244 (23%)
Query: 190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKL 249
           +E  +   + IG+G  G VY+A+L  S G+++AIKKV+            +D + ++ +L
Sbjct: 19  QEVSYTDTKVIGNGSFGVVYQAKLCDS-GELVAIKKVL------------QDKRFKNREL 65
Query: 250 RQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQD------ILDDVSRGR 303
           + +R       ++ H NI       VR     L Y F  +G  +D      +LD V    
Sbjct: 66  QIMR-------KLDHCNI-------VR-----LRYFFYSSGEKKDEVYLNLVLDYVPETV 106
Query: 304 RELDWPSRHRIALGVASGLEYLHMY-----------HSASIIHGDIKPRNVLLNDDMEAC 352
             +   +RH         + Y+ +Y           HS  I H DIKP+N+LL+ D    
Sbjct: 107 YRV---ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVL 163
Query: 353 -ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEY-FQQPELSEKCDIFSFGMLLISLVRG 410
            + D G A  +  G   V     + +  Y APE  F   + +   D++S G +L  L+ G
Sbjct: 164 KLCDFGSAKQLVRGEPNV---SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 220
Query: 411 VPSF 414
            P F
Sbjct: 221 QPIF 224

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 105/244 (43%), Gaps = 57/244 (23%)
Query: 190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKL 249
           +E  +   + IG+G  G VY+A+L  S G+++AIKKV+            +D + ++ +L
Sbjct: 26  QEVSYTDTKVIGNGSFGVVYQAKLCDS-GELVAIKKVL------------QDKRFKNREL 72
Query: 250 RQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQD------ILDDVSRGR 303
           + +R       ++ H NI+             L Y F  +G  +D      +LD V    
Sbjct: 73  QIMR-------KLDHCNIV------------RLRYFFYSSGEKKDEVYLNLVLDYVPETV 113
Query: 304 RELDWPSRHRIALGVASGLEYLHMY-----------HSASIIHGDIKPRNVLLNDDMEAC 352
             +   +RH         + Y+ +Y           HS  I H DIKP+N+LL+ D    
Sbjct: 114 YRV---ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVL 170
Query: 353 -ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEY-FQQPELSEKCDIFSFGMLLISLVRG 410
            + D G A  +  G   V     + +  Y APE  F   + +   D++S G +L  L+ G
Sbjct: 171 KLCDFGSAKQLVRGEPNV---SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 227
Query: 411 VPSF 414
            P F
Sbjct: 228 QPIF 231

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/241 (24%), Positives = 99/241 (41%), Gaps = 33/241 (13%)
Query: 173 PTIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPI 232
           P +F    E ED+ F    D F  L  IG G  G+V   +      KM A+K       +
Sbjct: 3   PPVFD---ENEDVNF----DHFEILRAIGKGSFGKVCIVQ-KNDTKKMYAMKY------M 48
Query: 233 SAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSL 292
           +  + +E +      ++R +  E+     + H  ++ L       +   +V + +  G L
Sbjct: 49  NKQKCVERN------EVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDL 102
Query: 293 QDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC 352
           +  L      + E        + L +   +  L    +  IIH D+KP N+LL++     
Sbjct: 103 RYHLQQNVHFKEET-------VKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVH 155
Query: 353 ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPE---LSEKCDIFSFGMLLISLVR 409
           I+D  +A  +P       I+ + GT  Y+APE F   +    S   D +S G+    L+R
Sbjct: 156 ITDFNIAAMLP---RETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLR 212
Query: 410 G 410
           G
Sbjct: 213 G 213

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 105/244 (43%), Gaps = 57/244 (23%)
Query: 190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKL 249
           +E  +   + IG+G  G VY+A+L  S G+++AIKKV+            +D + ++ +L
Sbjct: 30  QEVSYTDTKVIGNGSFGVVYQAKLCDS-GELVAIKKVL------------QDKRFKNREL 76
Query: 250 RQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQD------ILDDVSRGR 303
           + +R       ++ H NI+             L Y F  +G  +D      +LD V    
Sbjct: 77  QIMR-------KLDHCNIV------------RLRYFFYSSGEKKDEVYLNLVLDYVPETV 117
Query: 304 RELDWPSRHRIALGVASGLEYLHMY-----------HSASIIHGDIKPRNVLLNDDMEAC 352
             +   +RH         + Y+ +Y           HS  I H DIKP+N+LL+ D    
Sbjct: 118 YRV---ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVL 174
Query: 353 -ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEY-FQQPELSEKCDIFSFGMLLISLVRG 410
            + D G A  +  G   V     + +  Y APE  F   + +   D++S G +L  L+ G
Sbjct: 175 KLCDFGSAKQLVRGEPNV---SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 231
Query: 411 VPSF 414
            P F
Sbjct: 232 QPIF 235

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/247 (24%), Positives = 103/247 (41%), Gaps = 42/247 (17%)
Query: 167 GSRDRGPTIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAE---LPGSNGKMIAI 223
           GSRD  PT F    E+  L FL         +++G G  G V       L  + G+++A+
Sbjct: 1   GSRD--PTQF----EERHLKFL---------QQLGKGNFGSVEMCRYDPLQDNTGEVVAV 45
Query: 224 KKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL--LAHMVRPDCHL 281
           KK+                   +  LR    EI     ++H NI+    + +        
Sbjct: 46  KKL---------------QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 90
Query: 282 LVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPR 341
           L+ E++  GSL+D L    + +  +D     +    +  G+EYL    +   IH ++  R
Sbjct: 91  LIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRNLATR 144
Query: 342 NVLLNDDMEACISDLGLAMAIP-DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSF 400
           N+L+ ++    I D GL   +P D     +       + + APE   + + S   D++SF
Sbjct: 145 NILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSF 204
Query: 401 GMLLISL 407
           G++L  L
Sbjct: 205 GVVLYEL 211

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 109/265 (41%), Gaps = 52/265 (19%)
Query: 167 GSRDRGPTIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKM-IAIKK 225
           G  +  PTI+ P+++  D+ F          + IG G  G+V KA +     +M  AIK+
Sbjct: 10  GKNNPDPTIY-PVLDWNDIKFQ---------DVIGEGNFGQVLKARIKKDGLRMDAAIKR 59
Query: 226 VIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHR-NILPLLAHMVRPDCHLLVY 284
           +  YA        ++D        R    E+    ++ H  NI+ LL          L  
Sbjct: 60  MKEYAS-------KDDH-------RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI 105
Query: 285 EFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSAS------------ 332
           E+  +G+L D L    R  R L+      IA   AS L    + H A+            
Sbjct: 106 EYAPHGNLLDFL----RKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK 161
Query: 333 -IIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMA--YIAPEYFQQP 389
             IH D+  RN+L+ ++  A I+D GL+         V +   +G +   ++A E     
Sbjct: 162 QFIHRDLAARNILVGENYVAKIADFGLSRG-----QEVYVKKTMGRLPVRWMAIESLNYS 216
Query: 390 ELSEKCDIFSFGMLLISLVR--GVP 412
             +   D++S+G+LL  +V   G P
Sbjct: 217 VYTTNSDVWSYGVLLWEIVSLGGTP 241

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 101/224 (45%), Gaps = 36/224 (16%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  G+V  AE  G +      K     A   A +++++D+  +D  L  + SE+   
Sbjct: 43  LGEGAFGQVVMAEAVGID------KDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEMM 94
Query: 260 SQI-RHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILD-----------DVSRGRRE-L 306
             I +H+NI+ LL    +     ++ E+   G+L++ L            D++R   E +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 307 DWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGY 366
            +         +A G+EYL    S   IH D+  RNVL+ ++    I+D GLA  I +  
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINN-- 209
Query: 367 TRVLISYVLGT------MAYIAPEYFQQPELSEKCDIFSFGMLL 404
               I Y   T      + ++APE       + + D++SFG+L+
Sbjct: 210 ----IDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 249

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 99/233 (42%), Gaps = 29/233 (12%)
Query: 194 FASLEKIGSGGCGEV--YKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ 251
           F  L+ +G G  G+V   + +  G    M  ++K ++ A    A  + E   L+++    
Sbjct: 12  FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT---- 67
Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
                      RH  +  L       D    V E+   G L      +SR R   +  +R
Sbjct: 68  -----------RHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERAR 113
Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAM-AIPDGYTRVL 370
              A  + S LEYLH   S  +++ DIK  N++L+ D    I+D GL    I DG T   
Sbjct: 114 FYGA-EIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--- 166
Query: 371 ISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI 423
           +    GT  Y+APE  +  +     D +  G+++  ++ G   F ++Q+ E +
Sbjct: 167 MKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHERL 218

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 106/244 (43%), Gaps = 57/244 (23%)
Query: 190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKL 249
           +E  +   + IG+G  G VY+A+L  S G+++AIKKV+            +D + ++ +L
Sbjct: 18  QEVSYTDTKVIGNGSFGVVYQAKLCDS-GELVAIKKVL------------QDKRFKNREL 64
Query: 250 RQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQD------ILDDVSRGR 303
           + +R       ++ H NI       VR     L Y F  +G  +D      +LD V    
Sbjct: 65  QIMR-------KLDHCNI-------VR-----LRYFFYSSGEKKDEVYLNLVLDYVPETV 105
Query: 304 RELDWPSRHRIALGVASGLEYLHMY-----------HSASIIHGDIKPRNVLLNDDMEAC 352
             +   +RH         + Y+ +Y           HS  I H DIKP+N+LL+ D    
Sbjct: 106 YRV---ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVL 162
Query: 353 -ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEY-FQQPELSEKCDIFSFGMLLISLVRG 410
            + D G A  +  G   V     + +  Y APE  F   + +   D++S G +L  L+ G
Sbjct: 163 KLCDFGSAKQLVRGEPNV---SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 219
Query: 411 VPSF 414
            P F
Sbjct: 220 QPIF 223

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 106/244 (43%), Gaps = 57/244 (23%)
Query: 190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKL 249
           +E  +   + IG+G  G VY+A+L  S G+++AIKKV+            +D + ++ +L
Sbjct: 18  QEVSYTDTKVIGNGSFGVVYQAKLCDS-GELVAIKKVL------------QDKRFKNREL 64
Query: 250 RQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQD------ILDDVSRGR 303
           + +R       ++ H NI       VR     L Y F  +G  +D      +LD V    
Sbjct: 65  QIMR-------KLDHCNI-------VR-----LRYFFYSSGEKKDEVYLNLVLDYVPETV 105
Query: 304 RELDWPSRHRIALGVASGLEYLHMY-----------HSASIIHGDIKPRNVLLNDDMEAC 352
             +   +RH         + Y+ +Y           HS  I H DIKP+N+LL+ D    
Sbjct: 106 YRV---ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVL 162
Query: 353 -ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEY-FQQPELSEKCDIFSFGMLLISLVRG 410
            + D G A  +  G   V     + +  Y APE  F   + +   D++S G +L  L+ G
Sbjct: 163 KLCDFGSAKQLVRGEPNV---SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 219
Query: 411 VPSF 414
            P F
Sbjct: 220 QPIF 223

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 24/217 (11%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G+G  G+V +A   G  GK  A+ KV V    S A   E+++ + + K        I +
Sbjct: 54  LGAGAFGKVVEATAFGL-GKEDAVLKVAVKMLKSTAHADEKEALMSELK--------IMS 104
Query: 260 SQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRH------- 312
              +H NI+ LL         L++ E+   G L + L        E  +   H       
Sbjct: 105 HLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLS 164
Query: 313 -----RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
                  +  VA G+ +L    S + IH D+  RNVLL +   A I D GLA  I +   
Sbjct: 165 SRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 221
Query: 368 RVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
            ++       + ++APE       + + D++S+G+LL
Sbjct: 222 YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILL 258

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 99/233 (42%), Gaps = 29/233 (12%)
Query: 194 FASLEKIGSGGCGEV--YKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ 251
           F  L+ +G G  G+V   + +  G    M  ++K ++ A    A  + E   L+++    
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT---- 62
Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
                      RH  +  L       D    V E+   G L      +SR R   +  +R
Sbjct: 63  -----------RHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERAR 108
Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAM-AIPDGYTRVL 370
              A  + S LEYLH   S  +++ DIK  N++L+ D    I+D GL    I DG T   
Sbjct: 109 FYGA-EIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--- 161
Query: 371 ISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI 423
           +    GT  Y+APE  +  +     D +  G+++  ++ G   F ++Q+ E +
Sbjct: 162 MKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHERL 213

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/255 (22%), Positives = 107/255 (41%), Gaps = 34/255 (13%)
Query: 192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ 251
           D +  LE++GSG  G V++  +  + G++   K +    P+                   
Sbjct: 51  DYYDILEELGSGAFGVVHRC-VEKATGRVFVAKFINTPYPLDKY---------------T 94
Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
           +++EI   +Q+ H  ++ L          +L+ EF+  G L D +        E +  + 
Sbjct: 95  VKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINY 154
Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACIS--DLGLAMAI-PDGYTR 368
            R A     GL+++H +   SI+H DIKP N++      + +   D GLA  + PD   +
Sbjct: 155 MRQA---CEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK 208
Query: 369 VLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI----- 423
           V       T  + APE   +  +    D+++ G+L   L+ G+  F    + E +     
Sbjct: 209 V----TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKR 264
Query: 424 CSPEWLRKVMNSKNP 438
           C  E+     +S +P
Sbjct: 265 CDWEFDEDAFSSVSP 279

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 99/233 (42%), Gaps = 29/233 (12%)
Query: 194 FASLEKIGSGGCGEV--YKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ 251
           F  L+ +G G  G+V   + +  G    M  ++K ++ A    A  + E   L+++    
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT---- 62
Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
                      RH  +  L       D    V E+   G L      +SR R   +  +R
Sbjct: 63  -----------RHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERAR 108
Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAM-AIPDGYTRVL 370
              A  + S LEYLH   S  +++ DIK  N++L+ D    I+D GL    I DG T   
Sbjct: 109 FYGA-EIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--- 161
Query: 371 ISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI 423
           +    GT  Y+APE  +  +     D +  G+++  ++ G   F ++Q+ E +
Sbjct: 162 MKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHERL 213

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 105/244 (43%), Gaps = 57/244 (23%)
Query: 190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKL 249
           +E  +   + IG+G  G VY+A+L  S G+++AIKKV+            +D + ++ +L
Sbjct: 30  QEVSYTDTKVIGNGSFGVVYQAKLCDS-GELVAIKKVL------------QDKRFKNREL 76
Query: 250 RQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQD------ILDDVSRGR 303
           + +R       ++ H NI+             L Y F  +G  +D      +LD V    
Sbjct: 77  QIMR-------KLDHCNIV------------RLRYFFYSSGEKKDEVYLNLVLDYVPETV 117
Query: 304 RELDWPSRHRIALGVASGLEYLHMY-----------HSASIIHGDIKPRNVLLNDDMEAC 352
             +   +RH         + Y+ +Y           HS  I H DIKP+N+LL+ D    
Sbjct: 118 YRV---ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVL 174
Query: 353 -ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEY-FQQPELSEKCDIFSFGMLLISLVRG 410
            + D G A  +  G   V     + +  Y APE  F   + +   D++S G +L  L+ G
Sbjct: 175 KLCDFGSAKQLVRGEPNV---SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 231
Query: 411 VPSF 414
            P F
Sbjct: 232 QPIF 235

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 105/244 (43%), Gaps = 57/244 (23%)
Query: 190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKL 249
           +E  +   + IG+G  G VY+A+L  S G+++AIKKV+            +D + ++ +L
Sbjct: 52  QEVSYTDTKVIGNGSFGVVYQAKLCDS-GELVAIKKVL------------QDKRFKNREL 98
Query: 250 RQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQD------ILDDVSRGR 303
           + +R       ++ H NI+             L Y F  +G  +D      +LD V    
Sbjct: 99  QIMR-------KLDHCNIV------------RLRYFFYSSGEKKDEVYLNLVLDYVPETV 139
Query: 304 RELDWPSRHRIALGVASGLEYLHMY-----------HSASIIHGDIKPRNVLLNDDMEAC 352
             +   +RH         + Y+ +Y           HS  I H DIKP+N+LL+ D    
Sbjct: 140 YRV---ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVL 196
Query: 353 -ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEY-FQQPELSEKCDIFSFGMLLISLVRG 410
            + D G A  +  G   V     + +  Y APE  F   + +   D++S G +L  L+ G
Sbjct: 197 KLCDFGSAKQLVRGEPNV---SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 253
Query: 411 VPSF 414
            P F
Sbjct: 254 QPIF 257

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 99/233 (42%), Gaps = 29/233 (12%)
Query: 194 FASLEKIGSGGCGEV--YKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ 251
           F  L+ +G G  G+V   + +  G    M  ++K ++ A    A  + E   L+++    
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT---- 62
Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
                      RH  +  L       D    V E+   G L      +SR R   +  +R
Sbjct: 63  -----------RHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERAR 108
Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAM-AIPDGYTRVL 370
              A  + S LEYLH   S  +++ DIK  N++L+ D    I+D GL    I DG T   
Sbjct: 109 FYGA-EIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--- 161
Query: 371 ISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI 423
           +    GT  Y+APE  +  +     D +  G+++  ++ G   F ++Q+ E +
Sbjct: 162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHERL 213

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/217 (23%), Positives = 92/217 (42%), Gaps = 27/217 (12%)
Query: 197 LEKIGSGGCGEVYKAE---LPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           L+++G G  G V       L  + G+++A+KK+                   +  LR   
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---------------QHSTEEHLRDFE 59
Query: 254 SEIITASQIRHRNILPL--LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
            EI     ++H NI+    + +        L+ E++  GSL+D L    + +  +D    
Sbjct: 60  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKL 116
Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLI 371
            +    +  G+EYL    +   IH D+  RN+L+ ++    I D GL   +P       +
Sbjct: 117 LQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKV 173
Query: 372 SYVLGT-MAYIAPEYFQQPELSEKCDIFSFGMLLISL 407
                + + + APE   + + S   D++SFG++L  L
Sbjct: 174 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 210

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 99/233 (42%), Gaps = 29/233 (12%)
Query: 194 FASLEKIGSGGCGEV--YKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ 251
           F  L+ +G G  G+V   + +  G    M  ++K ++ A    A  + E   L+++    
Sbjct: 10  FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT---- 65
Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
                      RH  +  L       D    V E+   G L      +SR R   +  +R
Sbjct: 66  -----------RHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERAR 111
Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAM-AIPDGYTRVL 370
              A  + S LEYLH   S  +++ DIK  N++L+ D    I+D GL    I DG T   
Sbjct: 112 FYGA-EIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--- 164
Query: 371 ISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI 423
           +    GT  Y+APE  +  +     D +  G+++  ++ G   F ++Q+ E +
Sbjct: 165 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHERL 216

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 99/233 (42%), Gaps = 29/233 (12%)
Query: 194 FASLEKIGSGGCGEV--YKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ 251
           F  L+ +G G  G+V   + +  G    M  ++K ++ A    A  + E   L+++    
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT---- 62
Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
                      RH  +  L       D    V E+   G L      +SR R   +  +R
Sbjct: 63  -----------RHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERAR 108
Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAM-AIPDGYTRVL 370
              A  + S LEYLH   S  +++ DIK  N++L+ D    I+D GL    I DG T   
Sbjct: 109 FYGA-EIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--- 161
Query: 371 ISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI 423
           +    GT  Y+APE  +  +     D +  G+++  ++ G   F ++Q+ E +
Sbjct: 162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHERL 213

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/234 (24%), Positives = 98/234 (41%), Gaps = 47/234 (20%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKV------IVYAPISAAELIEEDSKLRDS 247
           + +L  +GSG  G V  A      G  +A+KK+      I++A  +  EL      ++  
Sbjct: 24  YQNLSPVGSGAYGSVCAA-FDTKTGHRVAVKKLSRPFQSIIHAKRTYREL-RLLKHMKHE 81
Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELD 307
            +  +      A  +   N + L+ H++  D + +V         Q + DD  +      
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-------KCQKLTDDHVQF----- 129
Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
                 +   +  GL+Y+H   SA IIH D+KP N+ +N+D E  I D  LA    D  T
Sbjct: 130 ------LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMT 180
Query: 368 RVLISYVLGTMAYIAPEYFQQPEL-------SEKCDIFSFGMLLISLVRGVPSF 414
                       Y+A  +++ PE+       ++  DI+S G ++  L+ G   F
Sbjct: 181 -----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 106/244 (43%), Gaps = 57/244 (23%)
Query: 190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKL 249
           +E  +   + IG+G  G VY+A+L  S G+++AIKKV+            +D + ++ +L
Sbjct: 22  QEVSYTDTKVIGNGSFGVVYQAKLCDS-GELVAIKKVL------------QDKRFKNREL 68
Query: 250 RQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQD------ILDDVSRGR 303
           + +R       ++ H NI       VR     L Y F  +G  +D      +LD V    
Sbjct: 69  QIMR-------KLDHCNI-------VR-----LRYFFYSSGEKKDEVYLNLVLDYVPETV 109
Query: 304 RELDWPSRHRIALGVASGLEYLHMY-----------HSASIIHGDIKPRNVLLNDDMEAC 352
             +   +RH         + Y+ +Y           HS  I H DIKP+N+LL+ D    
Sbjct: 110 YRV---ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVL 166
Query: 353 -ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEY-FQQPELSEKCDIFSFGMLLISLVRG 410
            + D G A  +  G   V     + +  Y APE  F   + +   D++S G +L  L+ G
Sbjct: 167 KLCDFGSAKQLVRGEPNV---SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 223
Query: 411 VPSF 414
            P F
Sbjct: 224 QPIF 227

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/220 (23%), Positives = 98/220 (44%), Gaps = 33/220 (15%)
Query: 199 KIGSGGCGEVYKAEL----PGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRS 254
           ++G G  G+V+ AE     P  +  ++A+K +             +D+   D+  +    
Sbjct: 20  ELGEGAFGKVFLAECYNLCPEQDKILVAVKTL-------------KDAS--DNARKDFHR 64
Query: 255 EIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDIL-----DDVSRGR----RE 305
           E    + ++H +I+      V  D  ++V+E+MK+G L   L     D V         E
Sbjct: 65  EAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTE 124
Query: 306 LDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI-PD 364
           L       IA  +A+G+ YL   H    +H D+  RN L+ +++   I D G++  +   
Sbjct: 125 LTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYST 181
Query: 365 GYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
            Y RV   + +  + ++ PE     + + + D++S G++L
Sbjct: 182 DYYRV-GGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVL 220

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 79/325 (24%), Positives = 130/325 (40%), Gaps = 68/325 (20%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVY-APISAAELIEEDSKLRDSKLRQIRSEIIT 258
           +G G  G V  A      G+++AIKK+  +  P+ A              LR +R EI  
Sbjct: 19  LGEGAYGVVCSATH-KPTGEIVAIKKIEPFDKPLFA--------------LRTLR-EIKI 62
Query: 259 ASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV 318
               +H NI+ +  ++ RPD       F +   +Q+++             S   I   +
Sbjct: 63  LKHFKHENIITIF-NIQRPDS---FENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFI 118
Query: 319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI---------PDGYTRV 369
              L  + + H +++IH D+KP N+L+N + +  + D GLA  I         P G    
Sbjct: 119 YQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 370 LISYVLGTMAYIAPE-YFQQPELSEKCDIFSFGMLLISLVRGVPSF-----------VF- 416
           +  YV  T  Y APE      + S   D++S G +L  L    P F           +F 
Sbjct: 179 MTEYV-ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFG 237
Query: 417 -----HQNGEEIC--SP---EWLRKV-MNSKNPSRAIDPRLPGNGYE--KKML------- 456
                H + +  C  SP   E+++ + M    P   + PR+   G +  ++ML       
Sbjct: 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKR 297
Query: 457 ----HVLKIAYICTLHDPEERPNSQ 477
                 L+  Y+ T HDP + P  +
Sbjct: 298 ITAKEALEHPYLQTYHDPNDEPEGE 322

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 105/225 (46%), Gaps = 34/225 (15%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           +  ++ +G G  G+V K     + G+ +A+K       I+   L + D + R      I 
Sbjct: 15  YQIVKTLGEGSFGKV-KLAYHTTTGQKVALK------IINKKVLAKSDMQGR------IE 61
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
            EI     +RH +I+ L   +   D  ++V E+  N    ++ D + + R ++      R
Sbjct: 62  REISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGN----ELFDYIVQ-RDKMSEQEARR 116
Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISY 373
               + S +EY H +    I+H D+KP N+LL++ +   I+D GL+  + DG     +  
Sbjct: 117 FFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN---FLKT 170
Query: 374 VLGTMAYIAPEY-----FQQPELSEKCDIFSFGMLL-ISLVRGVP 412
             G+  Y APE      +  PE+    D++S G++L + L R +P
Sbjct: 171 SCGSPNYAAPEVISGKLYAGPEV----DVWSCGVILYVMLCRRLP 211

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 101/220 (45%), Gaps = 28/220 (12%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  G+V  AE  G +      K     A   A +++++D+  +D  L  + SE+   
Sbjct: 43  LGEGAFGQVVMAEAVGID------KDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEMM 94
Query: 260 SQI-RHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILD-----------DVSRGRRE-L 306
             I +H+NI+ LL    +     ++ E+   G+L++ L            D++R   E +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 307 DWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP--D 364
            +         +A G+EYL    S   IH D+  RNVL+ ++    I+D GLA  I   D
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMRIADFGLARDINNID 211
Query: 365 GYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
            Y +     +   + ++APE       + + D++SFG+L+
Sbjct: 212 YYKKTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLM 249

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 71/168 (42%), Gaps = 14/168 (8%)
Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
           I  E+    +I+H N++ L          +L+ E +  G L D L +    +  L     
Sbjct: 60  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE----KESLTEEEA 115
Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLND----DMEACISDLGLAMAIPDGYT 367
                 + +G+ YLH   S  I H D+KP N++L D         I D GLA  I  G  
Sbjct: 116 TEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 172
Query: 368 RVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFV 415
                 + GT  ++APE      L  + D++S G++   L+ G   F+
Sbjct: 173 ---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 217

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 89/205 (43%), Gaps = 28/205 (13%)
Query: 282 LVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPR 341
           LV E++ +G L+D L    R R  LD       +  +  G+EYL    S   +H D+  R
Sbjct: 103 LVMEYLPSGCLRDFLQ---RHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAAR 156
Query: 342 NVLLNDDMEACISDLGLAMAIP-DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSF 400
           N+L+  +    I+D GLA  +P D    V+       + + APE       S + D++SF
Sbjct: 157 NILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSF 216
Query: 401 GMLLISLVRGVPSFVFHQNGEEICSP--EWLR--------KVMNSKNPSRAIDPRLPGNG 450
           G++L  L      F +    ++ CSP  E+LR          ++          RLP   
Sbjct: 217 GVVLYEL------FTY---CDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPP 267
Query: 451 YEKKMLHVLKIAYICTLHDPEERPN 475
                +H  ++  +C    P++RP+
Sbjct: 268 ACPAEVH--ELMKLCWAPSPQDRPS 290

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 101/220 (45%), Gaps = 28/220 (12%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  G+V  AE  G +      K     A   A +++++D+  +D  L  + SE+   
Sbjct: 43  LGEGAFGQVVMAEAVGID------KDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEMM 94
Query: 260 SQI-RHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILD-----------DVSRGRRE-L 306
             I +H+NI+ LL    +     ++ E+   G+L++ L            D++R   E +
Sbjct: 95  KMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 307 DWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP--D 364
            +         +A G+EYL    S   IH D+  RNVL+ ++    I+D GLA  I   D
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 365 GYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
            Y +     +   + ++APE       + + D++SFG+L+
Sbjct: 212 YYKKTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLM 249

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 73/178 (41%), Gaps = 14/178 (7%)
Query: 242 SKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSR 301
           S  R      I  E+    +I+H N++ L          +L+ E +  G L D L +   
Sbjct: 51  SSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE--- 107
Query: 302 GRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLND----DMEACISDLG 357
            +  L           + +G+ YLH   S  I H D+KP N++L D         I D G
Sbjct: 108 -KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163
Query: 358 LAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFV 415
           LA  I  G        + GT  ++APE      L  + D++S G++   L+ G   F+
Sbjct: 164 LAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 105/225 (46%), Gaps = 34/225 (15%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           +  ++ +G G  G+V K     + G+ +A+K       I+   L + D + R      I 
Sbjct: 16  YQIVKTLGEGSFGKV-KLAYHTTTGQKVALK------IINKKVLAKSDMQGR------IE 62
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
            EI     +RH +I+ L   +   D  ++V E+  N    ++ D + + R ++      R
Sbjct: 63  REISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGN----ELFDYIVQ-RDKMSEQEARR 117
Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISY 373
               + S +EY H +    I+H D+KP N+LL++ +   I+D GL+  + DG     +  
Sbjct: 118 FFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN---FLKT 171
Query: 374 VLGTMAYIAPEY-----FQQPELSEKCDIFSFGMLL-ISLVRGVP 412
             G+  Y APE      +  PE+    D++S G++L + L R +P
Sbjct: 172 SCGSPNYAAPEVISGKLYAGPEV----DVWSCGVILYVMLCRRLP 212

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 75/175 (42%), Gaps = 17/175 (9%)
Query: 253 RSEIITASQIRHR-NILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG------RR- 304
           + +++   QI H  N   +L  +  P    L Y F  N +L  +++ V  G      RR 
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRI 135
Query: 305 -ELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
                P     A  +    EYLH   S  +I+ D+KP N+L++      ++D G A  + 
Sbjct: 136 GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV- 191
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ 418
            G T  L     GT  Y+APE       ++  D ++ G+L+  +  G P F   Q
Sbjct: 192 KGRTWXLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 75/175 (42%), Gaps = 17/175 (9%)
Query: 253 RSEIITASQIRHR-NILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG------RR- 304
           + +++   QI H  N   +L  +  P    L Y F  N +L  +++ V  G      RR 
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRI 135
Query: 305 -ELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
                P     A  +    EYLH   S  +I+ D+KP N+L++      ++D G A  + 
Sbjct: 136 GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV- 191
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ 418
            G T  L     GT  Y+APE       ++  D ++ G+L+  +  G P F   Q
Sbjct: 192 KGRTWXLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 78/325 (24%), Positives = 131/325 (40%), Gaps = 68/325 (20%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVY-APISAAELIEEDSKLRDSKLRQIRSEIIT 258
           +G G  G V  A      G+++AIKK+  +  P+ A              LR +R EI  
Sbjct: 19  LGEGAYGVVCSATH-KPTGEIVAIKKIEPFDKPLFA--------------LRTLR-EIKI 62
Query: 259 ASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV 318
               +H NI+ +  ++ RPD       F +   +Q+++             S   I   +
Sbjct: 63  LKHFKHENIITIF-NIQRPDS---FENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFI 118
Query: 319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI---------PDGYTRV 369
              L  + + H +++IH D+KP N+L+N + +  + D GLA  I         P G    
Sbjct: 119 YQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 370 LISYVLGTMAYIAPE-YFQQPELSEKCDIFSFGMLLISLVRGVPSF-----------VF- 416
           ++ +V  T  Y APE      + S   D++S G +L  L    P F           +F 
Sbjct: 179 MVEFV-ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFG 237
Query: 417 -----HQNGEEIC--SP---EWLRKV-MNSKNPSRAIDPRLPGNGYE--KKML------- 456
                H + +  C  SP   E+++ + M    P   + PR+   G +  ++ML       
Sbjct: 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKR 297
Query: 457 ----HVLKIAYICTLHDPEERPNSQ 477
                 L+  Y+ T HDP + P  +
Sbjct: 298 ITAKEALEHPYLQTYHDPNDEPEGE 322

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 77/175 (44%), Gaps = 17/175 (9%)
Query: 253 RSEIITASQIRHR-NILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG------RR- 304
           + +++   QI H  N   +L  +  P    L + F  N +L  +++ V+ G      RR 
Sbjct: 63  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI 122
Query: 305 -ELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
                P     A  +    EYLH   S  +I+ D+KP N+L+++     ++D G A  + 
Sbjct: 123 GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRV- 178
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ 418
            G T  L     GT  Y+APE       ++  D ++ G+L+  +  G P F   Q
Sbjct: 179 KGRTWXLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 229

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 101/238 (42%), Gaps = 54/238 (22%)
Query: 193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQI 252
            + S   +GSG  G V  A +   +G+ +AIKK+               S+   S++   
Sbjct: 43  TYVSPTHVGSGAYGSVCSA-IDKRSGEKVAIKKL---------------SRPFQSEIFAK 86
Query: 253 RS--EIITASQIRHRNILPLLAHMVRPDCHL-------LVYEFMKNGSLQDILDDVSRGR 303
           R+  E++    ++H N++ LL  +  P   L       LV  FM+   LQ I+       
Sbjct: 87  RAYRELLLLKHMQHENVIGLL-DVFTPASSLRNFYDFYLVMPFMQT-DLQKIMG------ 138
Query: 304 RELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
            E        +   +  GL+Y+H   SA ++H D+KP N+ +N+D E  I D GLA    
Sbjct: 139 MEFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 195
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPEL-------SEKCDIFSFGMLLISLVRGVPSF 414
              T            Y+   +++ PE+       ++  DI+S G ++  ++ G   F
Sbjct: 196 AEMT-----------GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF 242

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 96/228 (42%), Gaps = 35/228 (15%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKV------IVYAPISAAELIEEDSKLRDS 247
           + +L  +GSG  G V  A      G  +A+KK+      I++A  +  EL      ++  
Sbjct: 20  YQNLSPVGSGAYGSVCAA-FDTKTGHRVAVKKLSRPFQSIIHAKRTYREL-RLLKHMKHE 77
Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELD 307
            +  +      A  +   N + L+ H++  D + +V         Q + DD         
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-------KCQKLTDD--------- 121
Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
                 +   +  GL+Y+H   SA IIH D+KP N+ +N+D E  I D GLA    D   
Sbjct: 122 --HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-- 174
Query: 368 RVLISYVLGTMAYIAPE-YFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
              ++  + T  Y APE        ++  DI+S G ++  L+ G   F
Sbjct: 175 ---MAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 219

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 96/228 (42%), Gaps = 35/228 (15%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKV------IVYAPISAAELIEEDSKLRDS 247
           + +L  +GSG  G V  A      G  +A+KK+      I++A  +  EL      ++  
Sbjct: 24  YQNLSPVGSGAYGSVCAA-FDTKTGHRVAVKKLSRPFQSIIHAKRTYREL-RLLKHMKHE 81
Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELD 307
            +  +      A  +   N + L+ H++  D + +V         Q + DD         
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-------KCQKLTDD--------- 125
Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
                 +   +  GL+Y+H   SA IIH D+KP N+ +N+D E  I D GLA    D   
Sbjct: 126 --HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-- 178
Query: 368 RVLISYVLGTMAYIAPE-YFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
              ++  + T  Y APE        ++  DI+S G ++  L+ G   F
Sbjct: 179 ---MAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 100/231 (43%), Gaps = 34/231 (14%)
Query: 183 EDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGS--NGKMIAIKKVIVYAPISAAELIEE 240
           E+L F   E  +  L+KIG G  G   KA L  S  +G+   IK++ +            
Sbjct: 16  ENLYFQSMEK-YVRLQKIGEGSFG---KAILVKSTEDGRQYVIKEINI------------ 59
Query: 241 DSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDD-- 298
            S++   +  + R E+   + ++H NI+             +V ++ + G L   ++   
Sbjct: 60  -SRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQK 118
Query: 299 --VSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDL 356
             + +  + LDW  +  +AL         H+ H   I+H DIK +N+ L  D    + D 
Sbjct: 119 GVLFQEDQILDWFVQICLALK--------HV-HDRKILHRDIKSQNIFLTKDGTVQLGDF 169
Query: 357 GLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISL 407
           G+A  +    T  L    +GT  Y++PE  +    + K DI++ G +L  L
Sbjct: 170 GIARVLNS--TVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYEL 218

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 71/168 (42%), Gaps = 14/168 (8%)
Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
           I  E+    +I+H N++ L          +L+ E +  G L D L +    +  L     
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE----KESLTEEEA 116
Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLND----DMEACISDLGLAMAIPDGYT 367
                 + +G+ YLH   S  I H D+KP N++L D         I D GLA  I  G  
Sbjct: 117 TEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 173
Query: 368 RVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFV 415
                 + GT  ++APE      L  + D++S G++   L+ G   F+
Sbjct: 174 ---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 75/175 (42%), Gaps = 17/175 (9%)
Query: 253 RSEIITASQIRHR-NILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG------RR- 304
           + +++   QI H  N   +L  +  P    L Y F  N +L  +++ V  G      RR 
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRI 135
Query: 305 -ELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
                P     A  +    EYLH   S  +I+ D+KP N+L++      ++D G A  + 
Sbjct: 136 GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV- 191
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ 418
            G T  L     GT  Y+APE       ++  D ++ G+L+  +  G P F   Q
Sbjct: 192 KGRTWXLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 105/250 (42%), Gaps = 69/250 (27%)
Query: 190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKL 249
           +E  +   + IG+G  G VY+A+L  S G+++AIKKV+            +    ++ +L
Sbjct: 18  QEVSYTDTKVIGNGSFGVVYQAKLCDS-GELVAIKKVL------------QGKAFKNREL 64
Query: 250 RQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQD------ILDDVSRGR 303
           + +R       ++ H NI       VR     L Y F  +G  +D      +LD V    
Sbjct: 65  QIMR-------KLDHCNI-------VR-----LRYFFYSSGEKKDEVYLNLVLDYVPETV 105
Query: 304 RELDWPSRHRIALGVASGLEYLHMY-----------HSASIIHGDIKPRNVLLNDDMEAC 352
             +   +RH         + Y+ +Y           HS  I H DIKP+N+LL+ D    
Sbjct: 106 YRV---ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVL 162
Query: 353 -ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPEL-------SEKCDIFSFGMLL 404
            + D G A  +  G   V         +YI   Y++ PEL       +   D++S G +L
Sbjct: 163 KLCDFGSAKQLVRGEPNV---------SYICSRYYRAPELIFGATDYTSSIDVWSAGCVL 213
Query: 405 ISLVRGVPSF 414
             L+ G P F
Sbjct: 214 AELLLGQPIF 223

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 104/233 (44%), Gaps = 35/233 (15%)
Query: 190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKL 249
           +E  +   + IG+G  G VY+A+L  S G+++AIKKV+        EL +   KL    +
Sbjct: 18  QEVSYTDTKVIGNGSFGVVYQAKLCDS-GELVAIKKVLQGKAFKNREL-QIMRKLDHCNI 75
Query: 250 RQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWP 309
            ++R    ++ + +    L L+   V P+    VY   ++          SR ++ L  P
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYV-PET---VYRVARH---------YSRAKQTL--P 120
Query: 310 SRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC-ISDLGLAMAIPDGYTR 368
             + + L +      L   HS  I H DIKP+N+LL+ D     + D G A  +  G   
Sbjct: 121 VIY-VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 179
Query: 369 VLISYVLGTMAYIAPEYFQQPEL-------SEKCDIFSFGMLLISLVRGVPSF 414
           V         +YI   Y++ PEL       +   D++S G +L  L+ G P F
Sbjct: 180 V---------SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 71/168 (42%), Gaps = 14/168 (8%)
Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
           I  E+    +I+H N++ L          +L+ E +  G L D L +    +  L     
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE----KESLTEEEA 116
Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLND----DMEACISDLGLAMAIPDGYT 367
                 + +G+ YLH   S  I H D+KP N++L D         I D GLA  I  G  
Sbjct: 117 TEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 173
Query: 368 RVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFV 415
                 + GT  ++APE      L  + D++S G++   L+ G   F+
Sbjct: 174 ---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 71/168 (42%), Gaps = 14/168 (8%)
Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
           I  E+    +I+H N++ L          +L+ E +  G L D L +    +  L     
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE----KESLTEEEA 116
Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLND----DMEACISDLGLAMAIPDGYT 367
                 + +G+ YLH   S  I H D+KP N++L D         I D GLA  I  G  
Sbjct: 117 TEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 173
Query: 368 RVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFV 415
                 + GT  ++APE      L  + D++S G++   L+ G   F+
Sbjct: 174 ---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 71/168 (42%), Gaps = 14/168 (8%)
Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
           I  E+    +I+H N++ L          +L+ E +  G L D L +    +  L     
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE----KESLTEEEA 116
Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLND----DMEACISDLGLAMAIPDGYT 367
                 + +G+ YLH   S  I H D+KP N++L D         I D GLA  I  G  
Sbjct: 117 TEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 173
Query: 368 RVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFV 415
                 + GT  ++APE      L  + D++S G++   L+ G   F+
Sbjct: 174 ---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 71/168 (42%), Gaps = 14/168 (8%)
Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
           I  E+    +I+H N++ L          +L+ E +  G L D L +    +  L     
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE----KESLTEEEA 116
Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLND----DMEACISDLGLAMAIPDGYT 367
                 + +G+ YLH   S  I H D+KP N++L D         I D GLA  I  G  
Sbjct: 117 TEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 173
Query: 368 RVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFV 415
                 + GT  ++APE      L  + D++S G++   L+ G   F+
Sbjct: 174 ---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 96/228 (42%), Gaps = 35/228 (15%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKV------IVYAPISAAELIEEDSKLRDS 247
           + +L  +GSG  G V  A      G  +A+KK+      I++A  +  EL      ++  
Sbjct: 24  YQNLSPVGSGAYGSVCAA-FDTKTGHRVAVKKLSRPFQSIIHAKRTYREL-RLLKHMKHE 81
Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELD 307
            +  +      A  +   N + L+ H++  D + +V         Q + DD         
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-------KCQKLTDD--------- 125
Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
                 +   +  GL+Y+H   SA IIH D+KP N+ +N+D E  I D GLA    D   
Sbjct: 126 --HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-- 178
Query: 368 RVLISYVLGTMAYIAPE-YFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
              ++  + T  Y APE        ++  DI+S G ++  L+ G   F
Sbjct: 179 ---MAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 105/225 (46%), Gaps = 34/225 (15%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           +  ++ +G G  G+V K     + G+ +A+K       I+   L + D + R      I 
Sbjct: 6   YQIVKTLGEGSFGKV-KLAYHTTTGQKVALKI------INKKVLAKSDMQGR------IE 52
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
            EI     +RH +I+ L   +   D  ++V E+  N    ++ D + + R ++      R
Sbjct: 53  REISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGN----ELFDYIVQ-RDKMSEQEARR 107
Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISY 373
               + S +EY H +    I+H D+KP N+LL++ +   I+D GL+  + DG     +  
Sbjct: 108 FFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN---FLKT 161
Query: 374 VLGTMAYIAPEY-----FQQPELSEKCDIFSFGMLL-ISLVRGVP 412
             G+  Y APE      +  PE+    D++S G++L + L R +P
Sbjct: 162 SCGSPNYAAPEVISGKLYAGPEV----DVWSCGVILYVMLCRRLP 202

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 71/168 (42%), Gaps = 14/168 (8%)
Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
           I  E+    +I+H N++ L          +L+ E +  G L D L +    +  L     
Sbjct: 60  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE----KESLTEEEA 115
Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLND----DMEACISDLGLAMAIPDGYT 367
                 + +G+ YLH   S  I H D+KP N++L D         I D GLA  I  G  
Sbjct: 116 TEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 172
Query: 368 RVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFV 415
                 + GT  ++APE      L  + D++S G++   L+ G   F+
Sbjct: 173 ---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 217

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 76/175 (43%), Gaps = 17/175 (9%)
Query: 253 RSEIITASQIRHR-NILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG------RR- 304
           + +++   QI H  N   +L  +  P    L + F  N +L  +++ V+ G      RR 
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI 135
Query: 305 -ELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
                P     A  +    EYLH   S  +I+ D+KP N+L++      ++D G A  + 
Sbjct: 136 GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV- 191
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ 418
            G T  L     GT  Y+APE       ++  D ++ G+L+  +  G P F   Q
Sbjct: 192 KGRTWXLA----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 71/168 (42%), Gaps = 14/168 (8%)
Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
           I  E+    +I+H N++ L          +L+ E +  G L D L +    +  L     
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE----KESLTEEEA 116
Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLND----DMEACISDLGLAMAIPDGYT 367
                 + +G+ YLH   S  I H D+KP N++L D         I D GLA  I  G  
Sbjct: 117 TEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 173
Query: 368 RVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFV 415
                 + GT  ++APE      L  + D++S G++   L+ G   F+
Sbjct: 174 ---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 76/175 (43%), Gaps = 17/175 (9%)
Query: 253 RSEIITASQIRHR-NILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG------RR- 304
           + +++   QI H  N   +L  +  P    L + F  N +L  +++ V+ G      RR 
Sbjct: 97  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI 156
Query: 305 -ELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
                P     A  +    EYLH   S  +I+ D+KP N+L++      ++D G A  + 
Sbjct: 157 GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV- 212
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ 418
            G T  L     GT  Y+APE       ++  D ++ G+L+  +  G P F   Q
Sbjct: 213 KGATWTLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 263

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 102/238 (42%), Gaps = 54/238 (22%)
Query: 193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQI 252
            + S   +GSG  G V  A +   +G+ +AIKK+               S+   S++   
Sbjct: 25  TYVSPTHVGSGAYGSVCSA-IDKRSGEKVAIKKL---------------SRPFQSEIFAK 68
Query: 253 RS--EIITASQIRHRNILPLLAHMVRPDCHL-------LVYEFMKNGSLQDILDDVSRGR 303
           R+  E++    ++H N++ LL  +  P   L       LV  FM+   LQ I+     G 
Sbjct: 69  RAYRELLLLKHMQHENVIGLL-DVFTPASSLRNFYDFYLVMPFMQT-DLQKIM-----GL 121
Query: 304 RELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
           +     S  +I   V   L+ L   HSA ++H D+KP N+ +N+D E  I D GLA    
Sbjct: 122 KF----SEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 177
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPEL-------SEKCDIFSFGMLLISLVRGVPSF 414
              T            Y+   +++ PE+       ++  DI+S G ++  ++ G   F
Sbjct: 178 AEMT-----------GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF 224

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 71/168 (42%), Gaps = 14/168 (8%)
Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
           I  E+    +I+H N++ L          +L+ E +  G L D L +    +  L     
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE----KESLTEEEA 116
Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLND----DMEACISDLGLAMAIPDGYT 367
                 + +G+ YLH   S  I H D+KP N++L D         I D GLA  I  G  
Sbjct: 117 TEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 173
Query: 368 RVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFV 415
                 + GT  ++APE      L  + D++S G++   L+ G   F+
Sbjct: 174 ---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 95/228 (41%), Gaps = 35/228 (15%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKV------IVYAPISAAELIEEDSKLRDS 247
           + +L  +GSG  G V  A      G  +A+KK+      I++A  +  EL      ++  
Sbjct: 24  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYREL-RLLKHMKHE 81
Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELD 307
            +  +      A  +   N + L+ H++  D + +V         Q + DD         
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-------KCQKLTDD--------- 125
Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
                 +   +  GL+Y+H   SA IIH D+KP N+ +N+D E  I D GLA    D  T
Sbjct: 126 --HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 180
Query: 368 RVLISYVLGTMAYIAPE-YFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
                  + T  Y APE        ++  DI+S G ++  L+ G   F
Sbjct: 181 G-----XVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 76/175 (43%), Gaps = 17/175 (9%)
Query: 253 RSEIITASQIRHR-NILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG------RR- 304
           + +++   QI H  N   +L  +  P    L + F  N +L  +++ V+ G      RR 
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI 135
Query: 305 -ELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
                P     A  +    EYLH   S  +I+ D+KP N+L++      ++D G A  + 
Sbjct: 136 GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV- 191
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ 418
            G T  L     GT  Y+APE       ++  D ++ G+L+  +  G P F   Q
Sbjct: 192 KGRTWXL----XGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 71/168 (42%), Gaps = 14/168 (8%)
Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
           I  E+    +I+H N++ L          +L+ E +  G L D L +    +  L     
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE----KESLTEEEA 116
Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLND----DMEACISDLGLAMAIPDGYT 367
                 + +G+ YLH   S  I H D+KP N++L D         I D GLA  I  G  
Sbjct: 117 TEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 173
Query: 368 RVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFV 415
                 + GT  ++APE      L  + D++S G++   L+ G   F+
Sbjct: 174 ---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 101/233 (43%), Gaps = 28/233 (12%)
Query: 194 FASLEKIGSGGCGEV--YKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ 251
           F  L+ +G G  G+V   K +  G    M  +KK ++ A    A  + E+  L++S    
Sbjct: 10  FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS---- 65
Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
                      RH  +  L       D    V E+   G L      +SR R   +  +R
Sbjct: 66  -----------RHPFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRAR 111
Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAM-AIPDGYTRVL 370
              A  + S L+YLH     ++++ D+K  N++L+ D    I+D GL    I DG T   
Sbjct: 112 FYGA-EIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--- 165
Query: 371 ISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI 423
           +    GT  Y+APE  +  +     D +  G+++  ++ G   F ++Q+ E++
Sbjct: 166 MKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHEKL 217

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/234 (24%), Positives = 97/234 (41%), Gaps = 47/234 (20%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKV------IVYAPISAAELIEEDSKLRDS 247
           + +L  +GSG  G V  A      G  +A+KK+      I++A  +  EL      ++  
Sbjct: 24  YQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYREL-RLLKHMKHE 81
Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELD 307
            +  +      A  +   N + L+ H++  D + +V         Q + DD         
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-------KCQKLTDD--------- 125
Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
                 +   +  GL+Y+H   SA IIH D+KP N+ +N+D E  I   GLA    D  T
Sbjct: 126 --HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMT 180
Query: 368 RVLISYVLGTMAYIAPEYFQQPEL-------SEKCDIFSFGMLLISLVRGVPSF 414
                       Y+A  +++ PE+       ++  DI+S G ++  L+ G   F
Sbjct: 181 -----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 223

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 101/233 (43%), Gaps = 28/233 (12%)
Query: 194 FASLEKIGSGGCGEV--YKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ 251
           F  L+ +G G  G+V   K +  G    M  +KK ++ A    A  + E+  L++S    
Sbjct: 11  FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS---- 66
Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
                      RH  +  L       D    V E+   G L      +SR R   +  +R
Sbjct: 67  -----------RHPFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRAR 112
Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAM-AIPDGYTRVL 370
              A  + S L+YLH     ++++ D+K  N++L+ D    I+D GL    I DG T   
Sbjct: 113 FYGA-EIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--- 166
Query: 371 ISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI 423
           +    GT  Y+APE  +  +     D +  G+++  ++ G   F ++Q+ E++
Sbjct: 167 MKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHEKL 218

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 92/225 (40%), Gaps = 34/225 (15%)
Query: 180 IEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIE 239
           I+ +DL FLK+         +G+G  G V   +  G     +AIK +I    +S  E IE
Sbjct: 21  IDPKDLTFLKE---------LGTGQFGVVKYGKWRGQYD--VAIK-MIKEGSMSEDEFIE 68
Query: 240 EDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDV 299
           E   + +               + H  ++ L     +     ++ E+M NG L + L ++
Sbjct: 69  EAKVMMN---------------LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM 113
Query: 300 SRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA 359
              R          +   V   +EYL    S   +H D+  RN L+ND     +SD GL+
Sbjct: 114 ---RHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLS 167
Query: 360 MAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
             + D      +      + +  PE     + S K DI++FG+L+
Sbjct: 168 RYVLDDEETSSVGSKF-PVRWSPPEVLMYSKFSSKSDIWAFGVLM 211

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 76/175 (43%), Gaps = 17/175 (9%)
Query: 253 RSEIITASQIRHR-NILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG------RR- 304
           + +++   QI H  N   +L  +  P    L + F  N +L  +++ V+ G      RR 
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI 135
Query: 305 -ELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
                P     A  +    EYLH   S  +I+ D+KP N+L++      ++D G A  + 
Sbjct: 136 GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV- 191
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ 418
            G T  L     GT  Y+APE       ++  D ++ G+L+  +  G P F   Q
Sbjct: 192 KGRTWXLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 76/175 (43%), Gaps = 17/175 (9%)
Query: 253 RSEIITASQIRHR-NILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG------RR- 304
           + +++   QI H  N   +L  +  P    L + F  N +L  +++ V+ G      RR 
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI 135
Query: 305 -ELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
                P     A  +    EYLH   S  +I+ D+KP N+L++      ++D G A  + 
Sbjct: 136 GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV- 191
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ 418
            G T  L     GT  Y+APE       ++  D ++ G+L+  +  G P F   Q
Sbjct: 192 KGRTWXLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAGYPPFFADQ 242

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 76/175 (43%), Gaps = 17/175 (9%)
Query: 253 RSEIITASQIRHR-NILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG------RR- 304
           + +++   QI H  N   +L  +  P    L + F  N +L  +++ V+ G      RR 
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI 135
Query: 305 -ELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
                P     A  +    EYLH   S  +I+ D+KP N+L++      ++D G A  + 
Sbjct: 136 GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV- 191
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ 418
            G T  L     GT  Y+APE       ++  D ++ G+L+  +  G P F   Q
Sbjct: 192 KGRTWXLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 92/206 (44%), Gaps = 30/206 (14%)
Query: 282 LVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPR 341
           LV E++ +G L+D L    R R  LD       +  +  G+EYL    S   +H D+  R
Sbjct: 91  LVMEYLPSGCLRDFLQ---RHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAAR 144
Query: 342 NVLLNDDMEACISDLGLAMAIP-DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSF 400
           N+L+  +    I+D GLA  +P D    V+       + + APE       S + D++SF
Sbjct: 145 NILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSF 204
Query: 401 GMLLISLVRGVPSFVFHQNGEEICSP--EWLRKVMNSKNPSRAI---------DPRLPGN 449
           G++L  L      F +    ++ CSP  E+LR +M  +    A+           RLP  
Sbjct: 205 GVVLYEL------FTY---CDKSCSPSAEFLR-MMGCERDVPALCRLLELLEEGQRLPAP 254
Query: 450 GYEKKMLHVLKIAYICTLHDPEERPN 475
                 +H  ++  +C    P++RP+
Sbjct: 255 PACPAEVH--ELMKLCWAPSPQDRPS 278

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 105/225 (46%), Gaps = 34/225 (15%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           +  ++ +G G  G+V K     + G+ +A+K       I+   L + D + R      I 
Sbjct: 10  YQIVKTLGEGSFGKV-KLAYHTTTGQKVALKI------INKKVLAKSDMQGR------IE 56
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
            EI     +RH +I+ L   +   D  ++V E+  N    ++ D + + R ++      R
Sbjct: 57  REISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGN----ELFDYIVQ-RDKMSEQEARR 111
Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISY 373
               + S +EY H +    I+H D+KP N+LL++ +   I+D GL+  + DG     +  
Sbjct: 112 FFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN---FLKT 165
Query: 374 VLGTMAYIAPEY-----FQQPELSEKCDIFSFGMLL-ISLVRGVP 412
             G+  Y APE      +  PE+    D++S G++L + L R +P
Sbjct: 166 SCGSPNYAAPEVISGKLYAGPEV----DVWSCGVILYVMLCRRLP 206

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 76/175 (43%), Gaps = 17/175 (9%)
Query: 253 RSEIITASQIRHR-NILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG------RR- 304
           + +++   QI H  N   +L  +  P    L + F  N +L  +++ V+ G      RR 
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI 135
Query: 305 -ELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
                P     A  +    EYLH   S  +I+ D+KP N+L++      ++D G A  + 
Sbjct: 136 GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV- 191
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ 418
            G T  L     GT  Y+APE       ++  D ++ G+L+  +  G P F   Q
Sbjct: 192 KGRTWXLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 76/175 (43%), Gaps = 17/175 (9%)
Query: 253 RSEIITASQIRHR-NILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG------RR- 304
           + +++   QI H  N   +L  +  P    L + F  N +L  +++ V+ G      RR 
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI 135
Query: 305 -ELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
                P     A  +    EYLH   S  +I+ D+KP N+L++      ++D G A  + 
Sbjct: 136 GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV- 191
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ 418
            G T  L     GT  Y+APE       ++  D ++ G+L+  +  G P F   Q
Sbjct: 192 KGRTWXLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 101/233 (43%), Gaps = 28/233 (12%)
Query: 194 FASLEKIGSGGCGEV--YKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ 251
           F  L+ +G G  G+V   K +  G    M  +KK ++ A    A  + E+  L++S    
Sbjct: 12  FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS---- 67
Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
                      RH  +  L       D    V E+   G L      +SR R   +  +R
Sbjct: 68  -----------RHPFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRAR 113
Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAM-AIPDGYTRVL 370
              A  + S L+YLH     ++++ D+K  N++L+ D    I+D GL    I DG T   
Sbjct: 114 FYGA-EIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--- 167
Query: 371 ISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI 423
           +    GT  Y+APE  +  +     D +  G+++  ++ G   F ++Q+ E++
Sbjct: 168 MKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHEKL 219

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 76/175 (43%), Gaps = 17/175 (9%)
Query: 253 RSEIITASQIRHR-NILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG------RR- 304
           + +++   QI H  N   +L  +  P    L + F  N +L  +++ V+ G      RR 
Sbjct: 77  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI 136
Query: 305 -ELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
                P     A  +    EYLH   S  +I+ D+KP N+L++      ++D G A  + 
Sbjct: 137 GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV- 192
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ 418
            G T  L     GT  Y+APE       ++  D ++ G+L+  +  G P F   Q
Sbjct: 193 KGRTWXLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 243

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 100/220 (45%), Gaps = 28/220 (12%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  G+V  AE  G +      K     A   A +++++D+   D  L  + SE+   
Sbjct: 43  LGEGAFGQVVMAEAVGID------KDKPKEAVTVAVKMLKDDATEED--LSDLVSEMEMM 94
Query: 260 SQI-RHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILD-----------DVSRGRRE-L 306
             I +H+NI+ LL    +     ++ E+   G+L++ L            D++R   E +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 307 DWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP--D 364
            +         +A G+EYL    S   IH D+  RNVL+ ++    I+D GLA  I   D
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 365 GYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
            Y +     +   + ++APE       + + D++SFG+L+
Sbjct: 212 YYKKTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLM 249

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 71/168 (42%), Gaps = 14/168 (8%)
Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
           I  E+    +I+H N++ L          +L+ E +  G L D L +    +  L     
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE----KESLTEEEA 116
Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLND----DMEACISDLGLAMAIPDGYT 367
                 + +G+ YLH   S  I H D+KP N++L D         I D GLA  I  G  
Sbjct: 117 TEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 173
Query: 368 RVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFV 415
                 + GT  ++APE      L  + D++S G++   L+ G   F+
Sbjct: 174 ---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 69/269 (25%), Positives = 110/269 (40%), Gaps = 35/269 (13%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           +  + +IG G  G VYKA  P S G  +A+K V V         +   +    + LR++ 
Sbjct: 11  YEPVAEIGVGAYGTVYKARDPHS-GHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLE 69
Query: 254 SEIITASQIRHRNILPLL--AHMVRPDCHL---LVYEFMKNGSLQDILDDVSRGRRELDW 308
           +         H N++ L+      R D  +   LV+E + +  L+  LD        L  
Sbjct: 70  A-------FEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPP--GLPA 119
Query: 309 PSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTR 368
            +   +      GL++LH   +  I+H D+KP N+L+       ++D GLA      Y  
Sbjct: 120 ETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIY--SYQM 174
Query: 369 VLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI----- 423
            L   V+ T+ Y APE   Q   +   D++S G +   + R  P F  +   +++     
Sbjct: 175 ALTPVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFD 233
Query: 424 ---CSPE--WLRKVMNSKNPSRAIDPRLP 447
                PE  W R V     P  A  PR P
Sbjct: 234 LIGLPPEDDWPRDV---SLPRGAFPPRGP 259

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 76/175 (43%), Gaps = 17/175 (9%)
Query: 253 RSEIITASQIRHR-NILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG------RR- 304
           + +++   QI H  N   +L  +  P    L + F  N +L  +++ V+ G      RR 
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI 135
Query: 305 -ELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
                P     A  +    EYLH   S  +I+ D+KP N+L++      ++D G A  + 
Sbjct: 136 GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV- 191
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ 418
            G T  L     GT  Y+APE       ++  D ++ G+L+  +  G P F   Q
Sbjct: 192 KGRTWXLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 71/274 (25%), Positives = 110/274 (40%), Gaps = 48/274 (17%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYA-----PISAAELIEEDSKLRDSK 248
           +  + +IG G  G VYKA  P S G  +A+K V V       PIS    + E + LR  +
Sbjct: 6   YEPVAEIGVGAYGTVYKARDPHS-GHFVALKSVRVPNGEEGLPIST---VREVALLRRLE 61
Query: 249 LRQ----IRSEIITASQIRHRNI-LPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGR 303
             +    +R   + A+    R I + L+   V  D    + +    G   + + D+ R  
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQ- 120
Query: 304 RELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
                            GL++LH   +  I+H D+KP N+L+       ++D GLA    
Sbjct: 121 --------------FLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIY- 162
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI 423
             Y   L   V+ T+ Y APE   Q   +   D++S G +   + R  P F  +   +++
Sbjct: 163 -SYQMALFPVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL 220
Query: 424 --------CSPE--WLRKVMNSKNPSRAIDPRLP 447
                     PE  W R V     P  A  PR P
Sbjct: 221 GKIFDLIGLPPEDDWPRDV---SLPRGAFPPRGP 251

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 101/220 (45%), Gaps = 28/220 (12%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  G+V  AE  G +      K     A   A +++++D+  +D  L  + SE+   
Sbjct: 30  LGEGCFGQVVMAEAVGID------KDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEMM 81
Query: 260 SQI-RHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILD-----------DVSRGRRE-L 306
             I +H+NI+ LL    +     ++ E+   G+L++ L            D++R   E +
Sbjct: 82  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 141
Query: 307 DWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP--D 364
            +         +A G+EYL    S   IH D+  RNVL+ ++    I+D GLA  I   D
Sbjct: 142 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLTARNVLVTENNVMKIADFGLARDINNID 198
Query: 365 GYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
            Y +     +   + ++APE       + + D++SFG+L+
Sbjct: 199 YYKKTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLM 236

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 99/218 (45%), Gaps = 24/218 (11%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  G+V  AE  G +      K     A   A +++++D+  +D  L  + SE+   
Sbjct: 43  LGEGAFGQVVMAEAVGID------KDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEMM 94
Query: 260 SQI-RHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILD-----------DVSRGRRE-L 306
             I +H+NI+ LL    +     ++ E+   G+L++ L            D++R   E +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQM 154
Query: 307 DWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGY 366
            +         +A G+EYL    S   IH D+  RNVL+ ++    I+D GLA  I +  
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 367 TRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
                +     + ++APE       + + D++SFG+L+
Sbjct: 212 XXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 249

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 101/220 (45%), Gaps = 28/220 (12%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  G+V  AE  G +      K     A   A +++++D+  +D  L  + SE+   
Sbjct: 35  LGEGCFGQVVMAEAVGID------KDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEMM 86
Query: 260 SQI-RHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILD-----------DVSRGRRE-L 306
             I +H+NI+ LL    +     ++ E+   G+L++ L            D++R   E +
Sbjct: 87  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 146
Query: 307 DWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP--D 364
            +         +A G+EYL    S   IH D+  RNVL+ ++    I+D GLA  I   D
Sbjct: 147 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 203
Query: 365 GYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
            Y +     +   + ++APE       + + D++SFG+L+
Sbjct: 204 YYKKTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLM 241

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 73/174 (41%), Gaps = 10/174 (5%)
Query: 245 RDSKLRQ-IRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGR 303
           RDS+  Q +  EI     ++H+NI+  L          +  E +  GSL  +L    R +
Sbjct: 58  RDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALL----RSK 113
Query: 304 RELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC-ISDLGLAMAI 362
                 +   I       LE L   H   I+H DIK  NVL+N       ISD G +  +
Sbjct: 114 WGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRL 173
Query: 363 PDGYTRVLISYVLGTMAYIAPEYFQQPE--LSEKCDIFSFGMLLISLVRGVPSF 414
             G      ++  GT+ Y+APE   +      +  DI+S G  +I +  G P F
Sbjct: 174 A-GINPCTETFT-GTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPF 225

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 101/220 (45%), Gaps = 28/220 (12%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  G+V  AE  G +      K     A   A +++++D+  +D  L  + SE+   
Sbjct: 32  LGEGCFGQVVMAEAVGID------KDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEMM 83
Query: 260 SQI-RHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILD-----------DVSRGRRE-L 306
             I +H+NI+ LL    +     ++ E+   G+L++ L            D++R   E +
Sbjct: 84  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 143
Query: 307 DWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP--D 364
            +         +A G+EYL    S   IH D+  RNVL+ ++    I+D GLA  I   D
Sbjct: 144 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 200
Query: 365 GYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
            Y +     +   + ++APE       + + D++SFG+L+
Sbjct: 201 YYKKTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLM 238

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 76/175 (43%), Gaps = 17/175 (9%)
Query: 253 RSEIITASQIRHR-NILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG------RR- 304
           + +++   QI H  N   +L  +  P    L + F  N +L  +++ V+ G      RR 
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI 135
Query: 305 -ELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
                P     A  +    EYLH   S  +I+ D+KP N+L++      ++D G A  + 
Sbjct: 136 GRFXEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV- 191
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ 418
            G T  L     GT  Y+APE       ++  D ++ G+L+  +  G P F   Q
Sbjct: 192 KGRTWXLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 76/175 (43%), Gaps = 17/175 (9%)
Query: 253 RSEIITASQIRHR-NILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG------RR- 304
           + +++   QI H  N   +L  +  P    L + F  N +L  +++ V+ G      RR 
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI 135
Query: 305 -ELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
                P     A  +    EYLH   S  +I+ D+KP N+L++      ++D G A  + 
Sbjct: 136 GRFXEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV- 191
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ 418
            G T  L     GT  Y+APE       ++  D ++ G+L+  +  G P F   Q
Sbjct: 192 KGRTWXLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 71/168 (42%), Gaps = 14/168 (8%)
Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
           I  E+    +I+H N++ L          +L+ E +  G L D L +    +  L     
Sbjct: 61  IEREVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAE----KESLTEEEA 116
Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLND----DMEACISDLGLAMAIPDGYT 367
                 + +G+ YLH   S  I H D+KP N++L D         I D GLA  I  G  
Sbjct: 117 TEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 173
Query: 368 RVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFV 415
                 + GT  ++APE      L  + D++S G++   L+ G   F+
Sbjct: 174 ---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 76/175 (43%), Gaps = 17/175 (9%)
Query: 253 RSEIITASQIRHR-NILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG------RR- 304
           + +++   QI H  N   +L  +  P    L + F  N +L  +++ V+ G      RR 
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI 135
Query: 305 -ELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
                P     A  +    EYLH   S  +I+ D+KP N+L++      ++D G A  + 
Sbjct: 136 GRFXEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV- 191
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ 418
            G T  L     GT  Y+APE       ++  D ++ G+L+  +  G P F   Q
Sbjct: 192 KGRTWXLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 75/171 (43%), Gaps = 17/171 (9%)
Query: 253 RSEIITASQIRHR-NILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG------RR- 304
           + +++   QI H  N   +L  +  P    L + F  N +L  +++ V+ G      RR 
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI 135
Query: 305 -ELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
                P     A  +    EYLH   S  +I+ D+KP N+L++      ++D G A  + 
Sbjct: 136 GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV- 191
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
            G T  L     GT  Y+APE       ++  D ++ G+L+  +  G P F
Sbjct: 192 KGRTWXLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 76/175 (43%), Gaps = 17/175 (9%)
Query: 253 RSEIITASQIRHR-NILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG------RR- 304
           + +++   QI H  N   +L  +  P    L + F  N +L  +++ V+ G      RR 
Sbjct: 71  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI 130
Query: 305 -ELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
                P     A  +    EYLH   S  +I+ D+KP N+L++      ++D G A  + 
Sbjct: 131 GRFXEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV- 186
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ 418
            G T  L     GT  Y+APE       ++  D ++ G+L+  +  G P F   Q
Sbjct: 187 KGRTWXLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 237

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 99/218 (45%), Gaps = 24/218 (11%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  G+V  AE  G +      K     A   A +++++D+  +D  L  + SE+   
Sbjct: 43  LGEGAFGQVVMAEAVGID------KDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEMM 94
Query: 260 SQI-RHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILD-----------DVSRGRRE-L 306
             I +H+NI+ LL    +     ++ E+   G+L++ L            D++R   E +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 307 DWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGY 366
            +         +A G+EYL    S   IH D+  RNVL+ ++    I+D GLA  I +  
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 367 TRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
                +     + ++APE       + + D++SFG+L+
Sbjct: 212 XXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 249

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 101/220 (45%), Gaps = 28/220 (12%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  G+V  AE  G +      K     A   A +++++D+  +D  L  + SE+   
Sbjct: 89  LGEGCFGQVVMAEAVGID------KDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEMM 140
Query: 260 SQI-RHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILD-----------DVSRGRRE-L 306
             I +H+NI+ LL    +     ++ E+   G+L++ L            D++R   E +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 307 DWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP--D 364
            +         +A G+EYL    S   IH D+  RNVL+ ++    I+D GLA  I   D
Sbjct: 201 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 257
Query: 365 GYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
            Y +     +   + ++APE       + + D++SFG+L+
Sbjct: 258 YYKKTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLM 295

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 105/235 (44%), Gaps = 40/235 (17%)
Query: 188 LKKEDCFASLEKIGSGGCGEVYKAE----LPGSNGKMIAIKKVIVYAPISAAELIEEDSK 243
           +K+ D     E +G G  G+V+ AE    LP  +  ++A+K     A   A+E   +D  
Sbjct: 15  IKRRDIVLKWE-LGEGAFGKVFLAECHNLLPEQDKMLVAVK-----ALKEASESARQDF- 67
Query: 244 LRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDIL------- 296
                  Q  +E++T  Q  H++I+            L+V+E+M++G L   L       
Sbjct: 68  -------QREAELLTMLQ--HQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDA 118
Query: 297 ------DDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME 350
                 +DV+ G   L       +A  VA+G+ YL   H    +H D+  RN L+   + 
Sbjct: 119 KLLAGGEDVAPG--PLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLV 173
Query: 351 ACISDLGLAMAI-PDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
             I D G++  I    Y RV    +L  + ++ PE     + + + D++SFG++L
Sbjct: 174 VKIGDFGMSRDIYSTDYYRVGGRTML-PIRWMPPESILYRKFTTESDVWSFGVVL 227

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 66/259 (25%), Positives = 107/259 (41%), Gaps = 52/259 (20%)
Query: 173 PTIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKM-IAIKKVIVYAP 231
           PTI+ P+++  D+ F          + IG G  G+V KA +     +M  AIK++  YA 
Sbjct: 6   PTIY-PVLDWNDIKFQ---------DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS 55
Query: 232 ISAAELIEEDSKLRDSKLRQIRSEIITASQIRHR-NILPLLAHMVRPDCHLLVYEFMKNG 290
                  ++D        R    E+    ++ H  NI+ LL          L  E+  +G
Sbjct: 56  -------KDDH-------RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 101
Query: 291 SLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSAS-------------IIHGD 337
           +L D L    R  R L+      IA   AS L    + H A+              IH D
Sbjct: 102 NLLDFL----RKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRD 157
Query: 338 IKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMA--YIAPEYFQQPELSEKC 395
           +  RN+L+ ++  A I+D GL+         V +   +G +   ++A E       +   
Sbjct: 158 LAARNILVGENYVAKIADFGLSRG-----QEVYVKKTMGRLPVRWMAIESLNYSVYTTNS 212
Query: 396 DIFSFGMLLISLVR--GVP 412
           D++S+G+LL  +V   G P
Sbjct: 213 DVWSYGVLLWEIVSLGGTP 231

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 76/175 (43%), Gaps = 17/175 (9%)
Query: 253 RSEIITASQIRHR-NILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG------RR- 304
           + +++   QI H  N   +L  +  P    L + F  N +L  +++ V+ G      RR 
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI 135
Query: 305 -ELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
                P     A  +    EYLH   S  +I+ D+KP N+L++      ++D G A  + 
Sbjct: 136 GRFAEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV- 191
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ 418
            G T  L     GT  Y+APE       ++  D ++ G+L+  +  G P F   Q
Sbjct: 192 KGRTWXLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 75/175 (42%), Gaps = 17/175 (9%)
Query: 253 RSEIITASQIRHR-NILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG------RR- 304
           + +++   QI H  N   +L  +  P    L + F  N +L  +++ V  G      RR 
Sbjct: 77  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRI 136
Query: 305 -ELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
                P     A  +    EYLH   S  +I+ D+KP N+L++      ++D G A  + 
Sbjct: 137 GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV- 192
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ 418
            G T  L     GT  Y+APE       ++  D ++ G+L+  +  G P F   Q
Sbjct: 193 KGRTWTLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 243

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 80/310 (25%), Positives = 125/310 (40%), Gaps = 57/310 (18%)
Query: 171 RGPTIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGEV---YKAELPGSNGKMIAIKKVI 227
           R    +S  I       LK+   + +L+ IGSG  G V   Y A L     + +AIKK+ 
Sbjct: 11  RDNNFYSVEIGDSTFTVLKR---YQNLKPIGSGAQGIVCAAYDAILE----RNVAIKKL- 62
Query: 228 VYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHL------ 281
              P               +  ++   E++    + H+NI+ LL ++  P   L      
Sbjct: 63  -SRPFQ-----------NQTHAKRAYRELVLMKCVNHKNIIGLL-NVFTPQKSLEEFQDV 109
Query: 282 -LVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKP 340
            +V E M     Q I       + ELD      +   +  G+++LH   SA IIH D+KP
Sbjct: 110 YIVMELMDANLCQVI-------QMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKP 159
Query: 341 RNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSF 400
            N+++  D    I D GLA     G + ++  YV+ T  Y APE        E  D++S 
Sbjct: 160 SNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVV-TRYYRAPEVILGMGYKENVDLWSV 216
Query: 401 GMLLISLVRGVPSF-----------VFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGN 449
           G ++  +V     F           V  Q G     PE+++K+  +        P+  G 
Sbjct: 217 GCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTP--CPEFMKKLQPTVRTYVENRPKYAGY 274
Query: 450 GYEKKMLHVL 459
            +EK    VL
Sbjct: 275 SFEKLFPDVL 284

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 106/235 (45%), Gaps = 40/235 (17%)
Query: 188 LKKEDCFASLEKIGSGGCGEVYKAE----LPGSNGKMIAIKKVIVYAPISAAELIEEDSK 243
           +K+ D     E +G G  G+V+ AE    LP  +  ++A+K     A   A+E   +D  
Sbjct: 9   IKRRDIVLKWE-LGEGAFGKVFLAECHNLLPEQDKMLVAVK-----ALKEASESARQDF- 61
Query: 244 LRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDIL------- 296
                  Q  +E++T   ++H++I+            L+V+E+M++G L   L       
Sbjct: 62  -------QREAELLT--MLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDA 112
Query: 297 ------DDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME 350
                 +DV+ G   L       +A  VA+G+ YL   H    +H D+  RN L+   + 
Sbjct: 113 KLLAGGEDVAPG--PLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLV 167
Query: 351 ACISDLGLAMAI-PDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
             I D G++  I    Y RV    +L  + ++ PE     + + + D++SFG++L
Sbjct: 168 VKIGDFGMSRDIYSTDYYRVGGRTML-PIRWMPPESILYRKFTTESDVWSFGVVL 221

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 59/245 (24%), Positives = 110/245 (44%), Gaps = 34/245 (13%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           +  ++K+G GG   V   E    +G   A+K+++ +      E  + +   R++ + ++ 
Sbjct: 31  YLFIQKLGEGGFSYVDLVE-GLHDGHFYALKRILCH------EQQDREEAQREADMHRL- 82
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCH----LLVYEFMKNGSLQDILDDVSRGRRELDWP 309
                     H NIL L+A+ +R         L+  F K G+L + ++ +      L   
Sbjct: 83  --------FNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTED 134
Query: 310 SRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLG---LAMAIPDGY 366
               + LG+  GLE +H   +    H D+KP N+LL D+ +  + DLG    A    +G 
Sbjct: 135 QILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGS 191
Query: 367 TRVLI----SYVLGTMAYIAPEYFQQPE---LSEKCDIFSFGMLLISLVRGV-PSFVFHQ 418
            + L     +    T++Y APE F       + E+ D++S G +L +++ G  P  +  Q
Sbjct: 192 RQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQ 251
Query: 419 NGEEI 423
            G+ +
Sbjct: 252 KGDSV 256

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 89/213 (41%), Gaps = 23/213 (10%)
Query: 232 ISAAELIEEDSKLRDSKLRQIRSEI-ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNG 290
           I  A  +E   K+ D   R    EI I     +H NI+ L           +V E MK G
Sbjct: 42  IHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGG 101
Query: 291 SLQD-ILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDM 349
            L D IL       RE        +   +   +EYLH   +  ++H D+KP N+L  D+ 
Sbjct: 102 ELLDKILRQKFFSEREAS-----AVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDES 153
Query: 350 ----EACISDLGLA--MAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGML 403
                  I D G A  +   +G    L+     T  ++APE  ++      CDI+S G+L
Sbjct: 154 GNPESIRICDFGFAKQLRAENG----LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVL 209
Query: 404 LISLVRGVPSFVFHQNGEEICSPEWLRKVMNSK 436
           L +++ G   F    NG +    E L ++ + K
Sbjct: 210 LYTMLTGYTPFA---NGPDDTPEEILARIGSGK 239

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 92/225 (40%), Gaps = 27/225 (12%)
Query: 192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ 251
           D +   E++G+G  G V++     + G   A K V+                  +S    
Sbjct: 51  DHYDIHEELGTGAFGVVHRV-TERATGNNFAAKFVMT---------------PHESDKET 94
Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
           +R EI T S +RH  ++ L       +  +++YEFM  G L + + D      E +    
Sbjct: 95  VRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY 154
Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLND--DMEACISDLGLAMAIPDGYTRV 369
            R    V  GL   HM H  + +H D+KP N++       E  + D GL   +     + 
Sbjct: 155 MR---QVCKGL--CHM-HENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD---PKQ 205
Query: 370 LISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
            +    GT  + APE  +   +    D++S G+L   L+ G+  F
Sbjct: 206 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPF 250

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 76/175 (43%), Gaps = 17/175 (9%)
Query: 253 RSEIITASQIRHR-NILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG------RR- 304
           + +++   QI H  N   +L  +  P    L + F  N +L  +++ V+ G      RR 
Sbjct: 97  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI 156
Query: 305 -ELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
                P     A  +    EYLH   S  +I+ D+KP N+L++      ++D G A  + 
Sbjct: 157 GRFXEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV- 212
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ 418
            G T  L     GT  Y+APE       ++  D ++ G+L+  +  G P F   Q
Sbjct: 213 KGRTWXLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 263

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 63/259 (24%), Positives = 109/259 (42%), Gaps = 39/259 (15%)
Query: 166 GGSRDRGPTIFSPL-----IEKEDLAFLKKE---------DCFASLEKIGSGGCGEVYKA 211
           G +   GP    P      +  ++LA LK           D +  +E IG+G  G V  A
Sbjct: 14  GSAEPPGPVKAEPAHTAASVAAKNLALLKARSFDVTFDVGDEYEIIETIGNGAYGVVSSA 73
Query: 212 ELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL 271
                 G+ +AIKK+    P +   +      LR+ K+ +           +H NI+  +
Sbjct: 74  RR-RLTGQQVAIKKI----PNAFDVVTNAKRTLRELKILK---------HFKHDNII-AI 118
Query: 272 AHMVRPDCHLLVYE--FMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYH 329
             ++RP      ++  ++    ++  L  +    + L           +  GL+Y+H   
Sbjct: 119 KDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMH--- 175
Query: 330 SASIIHGDIKPRNVLLNDDMEACISDLGLAMAI---PDGYTRVLISYVLGTMAYIAPE-Y 385
           SA +IH D+KP N+L+N++ E  I D G+A  +   P  +   +  YV  T  Y APE  
Sbjct: 176 SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYV-ATRWYRAPELM 234
Query: 386 FQQPELSEKCDIFSFGMLL 404
               E ++  D++S G + 
Sbjct: 235 LSLHEYTQAIDLWSVGCIF 253

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 95/228 (41%), Gaps = 35/228 (15%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKV------IVYAPISAAELIEEDSKLRDS 247
           + +L  +GSG  G V  A      G  +A+KK+      I++A  +  EL      ++  
Sbjct: 44  YQNLSPVGSGAYGSVCAA-FDTKTGHRVAVKKLSRPFQSIIHAKRTYREL-RLLKHMKHE 101
Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELD 307
            +  +      A  +   N + L+ H++  D + +V         Q + DD         
Sbjct: 102 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-------KCQKLTDD--------- 145
Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
                 +   +  GL+Y+H   SA IIH D+KP N+ +N+D E  I D GLA    D   
Sbjct: 146 --HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-- 198
Query: 368 RVLISYVLGTMAYIAPE-YFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
              +   + T  Y APE        ++  DI+S G ++  L+ G   F
Sbjct: 199 ---MXGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 243

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 118/287 (41%), Gaps = 54/287 (18%)
Query: 194 FASLEKIGSGGCGEV---YKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
           + +L+ IGSG  G V   Y A L     + +AIKK+    P               +  +
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAIL----ERNVAIKKL--SRPFQ-----------NQTHAK 62
Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHL-------LVYEFMKNGSLQDILDDVSRGR 303
           +   E++    + H+NI+ LL ++  P   L       +V E M     Q I       +
Sbjct: 63  RAYRELVLMKCVNHKNIIGLL-NVFTPQKSLEEFQDVYIVMELMDANLCQVI-------Q 114
Query: 304 RELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
            ELD      +   +  G+++LH   SA IIH D+KP N+++  D    I D GLA    
Sbjct: 115 MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA- 170
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF--------- 414
            G + ++  YV+ T  Y APE        E  D++S G ++  +V     F         
Sbjct: 171 -GTSFMMTPYVV-TRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQW 228
Query: 415 --VFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVL 459
             V  Q G     PE+++K+  +        P+  G  +EK    VL
Sbjct: 229 NKVIEQLGTP--CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVL 273

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 52/105 (49%), Gaps = 13/105 (12%)
Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI-PDGYTRVLIS 372
           I L +A  +E+LH   S  ++H D+KP N+    D    + D GL  A+  D   + +++
Sbjct: 123 IFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179
Query: 373 YV---------LGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLV 408
            +         +GT  Y++PE       S K DIFS G++L  L+
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 64/128 (50%), Gaps = 7/128 (5%)
Query: 282 LVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPR 341
           L+ EF+ +GSL++ L    + + +++   + + A+ +  G++YL    S   +H D+  R
Sbjct: 102 LIMEFLPSGSLKEYL---PKNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAAR 155
Query: 342 NVLLNDDMEACISDLGLAMAI-PDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSF 400
           NVL+  + +  I D GL  AI  D     +       + + APE   Q +     D++SF
Sbjct: 156 NVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSF 215
Query: 401 GMLLISLV 408
           G+ L  L+
Sbjct: 216 GVTLHELL 223

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 105/227 (46%), Gaps = 24/227 (10%)
Query: 185 LAFLKKEDCFASLEKIGSGGCGEVYKAE-LP-GSNGKMIAIKKVIVYAPISAAELIEEDS 242
           LA + KE     L+ +GSG  G V+K   +P G + K+    KVI            ED 
Sbjct: 24  LARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI------------EDK 71
Query: 243 KLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHL-LVYEFMKNGSLQDILDDVSR 301
             R S  + +   ++    + H +I+ LL   + P   L LV +++  GSL   LD V +
Sbjct: 72  SGRQS-FQAVTDHMLAIGSLDHAHIVRLLG--LCPGSSLQLVTQYLPLGSL---LDHVRQ 125
Query: 302 GRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMA 361
            R  L         + +A G+ YL  +    ++H ++  RNVLL    +  ++D G+A  
Sbjct: 126 HRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADL 182
Query: 362 IPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLV 408
           +P    ++L S     + ++A E     + + + D++S+G+ +  L+
Sbjct: 183 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELM 229

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 75/175 (42%), Gaps = 17/175 (9%)
Query: 253 RSEIITASQIRHR-NILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG------RR- 304
           + +++   QI H  N   +L  +  P    L + F  N +L  +++ V  G      RR 
Sbjct: 62  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRI 121
Query: 305 -ELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
                P     A  +    EYLH   S  +I+ D+KP N+L++      ++D G A  + 
Sbjct: 122 GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV- 177
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ 418
            G T  L     GT  Y+APE       ++  D ++ G+L+  +  G P F   Q
Sbjct: 178 KGRTWTLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 228

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 63/259 (24%), Positives = 109/259 (42%), Gaps = 39/259 (15%)
Query: 166 GGSRDRGPTIFSPL-----IEKEDLAFLKKE---------DCFASLEKIGSGGCGEVYKA 211
           G +   GP    P      +  ++LA LK           D +  +E IG+G  G V  A
Sbjct: 15  GSAEPPGPVKAEPAHTAASVAAKNLALLKARSFDVTFDVGDEYEIIETIGNGAYGVVSSA 74
Query: 212 ELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL 271
                 G+ +AIKK+    P +   +      LR+ K+ +           +H NI+  +
Sbjct: 75  RR-RLTGQQVAIKKI----PNAFDVVTNAKRTLRELKILK---------HFKHDNII-AI 119
Query: 272 AHMVRPDCHLLVYE--FMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYH 329
             ++RP      ++  ++    ++  L  +    + L           +  GL+Y+H   
Sbjct: 120 KDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMH--- 176
Query: 330 SASIIHGDIKPRNVLLNDDMEACISDLGLAMAI---PDGYTRVLISYVLGTMAYIAPE-Y 385
           SA +IH D+KP N+L+N++ E  I D G+A  +   P  +   +  YV  T  Y APE  
Sbjct: 177 SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYV-ATRWYRAPELM 235
Query: 386 FQQPELSEKCDIFSFGMLL 404
               E ++  D++S G + 
Sbjct: 236 LSLHEYTQAIDLWSVGCIF 254

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 71/274 (25%), Positives = 110/274 (40%), Gaps = 48/274 (17%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYA-----PISAAELIEEDSKLRDSK 248
           +  + +IG G  G VYKA  P S G  +A+K V V       PIS    + E + LR  +
Sbjct: 6   YEPVAEIGVGAYGTVYKARDPHS-GHFVALKSVRVPNGEEGLPIST---VREVALLRRLE 61
Query: 249 LRQ----IRSEIITASQIRHRNI-LPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGR 303
             +    +R   + A+    R I + L+   V  D    + +    G   + + D+ R  
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQ- 120
Query: 304 RELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
                            GL++LH   +  I+H D+KP N+L+       ++D GLA    
Sbjct: 121 --------------FLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIY- 162
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI 423
             Y   L   V+ T+ Y APE   Q   +   D++S G +   + R  P F  +   +++
Sbjct: 163 -SYQMALAPVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL 220
Query: 424 --------CSPE--WLRKVMNSKNPSRAIDPRLP 447
                     PE  W R V     P  A  PR P
Sbjct: 221 GKIFDLIGLPPEDDWPRDV---SLPRGAFPPRGP 251

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 106/235 (45%), Gaps = 40/235 (17%)
Query: 188 LKKEDCFASLEKIGSGGCGEVYKAE----LPGSNGKMIAIKKVIVYAPISAAELIEEDSK 243
           +K+ D     E +G G  G+V+ AE    LP  +  ++A+K     A   A+E   +D  
Sbjct: 38  IKRRDIVLKWE-LGEGAFGKVFLAECHNLLPEQDKMLVAVK-----ALKEASESARQDF- 90
Query: 244 LRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDIL------- 296
                  Q  +E++T   ++H++I+            L+V+E+M++G L   L       
Sbjct: 91  -------QREAELLT--MLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDA 141
Query: 297 ------DDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME 350
                 +DV+ G   L       +A  VA+G+ YL   H    +H D+  RN L+   + 
Sbjct: 142 KLLAGGEDVAPG--PLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLV 196
Query: 351 ACISDLGLAMAI-PDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
             I D G++  I    Y RV    +L  + ++ PE     + + + D++SFG++L
Sbjct: 197 VKIGDFGMSRDIYSTDYYRVGGRTML-PIRWMPPESILYRKFTTESDVWSFGVVL 250

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 75/175 (42%), Gaps = 17/175 (9%)
Query: 253 RSEIITASQIRHR-NILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG------RR- 304
           + +++   QI H  N   +L  +  P    L + F  N +L  +++ V  G      RR 
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRI 135
Query: 305 -ELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
                P     A  +    EYLH   S  +I+ D+KP N+L++      ++D G A  + 
Sbjct: 136 GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV- 191
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ 418
            G T  L     GT  Y+APE       ++  D ++ G+L+  +  G P F   Q
Sbjct: 192 KGRTWXLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 105/227 (46%), Gaps = 24/227 (10%)
Query: 185 LAFLKKEDCFASLEKIGSGGCGEVYKAE-LP-GSNGKMIAIKKVIVYAPISAAELIEEDS 242
           LA + KE     L+ +GSG  G V+K   +P G + K+    KVI            ED 
Sbjct: 6   LARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI------------EDK 53
Query: 243 KLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHL-LVYEFMKNGSLQDILDDVSR 301
             R S  + +   ++    + H +I+ LL   + P   L LV +++  GSL   LD V +
Sbjct: 54  SGRQS-FQAVTDHMLAIGSLDHAHIVRLLG--LCPGSSLQLVTQYLPLGSL---LDHVRQ 107
Query: 302 GRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMA 361
            R  L         + +A G+ YL  +    ++H ++  RNVLL    +  ++D G+A  
Sbjct: 108 HRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADL 164
Query: 362 IPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLV 408
           +P    ++L S     + ++A E     + + + D++S+G+ +  L+
Sbjct: 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELM 211

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 75/175 (42%), Gaps = 17/175 (9%)
Query: 253 RSEIITASQIRHR-NILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG------RR- 304
           + +++   QI H  N   +L  +  P    L + F  N +L  +++ V  G      RR 
Sbjct: 77  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRI 136
Query: 305 -ELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
                P     A  +    EYLH   S  +I+ D+KP N+L++      ++D G A  + 
Sbjct: 137 GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV- 192
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ 418
            G T  L     GT  Y+APE       ++  D ++ G+L+  +  G P F   Q
Sbjct: 193 KGRTWXLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 243

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 75/175 (42%), Gaps = 17/175 (9%)
Query: 253 RSEIITASQIRHR-NILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG------RR- 304
           + +++   QI H  N   +L  +  P    L + F  N +L  +++ V  G      RR 
Sbjct: 77  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRI 136
Query: 305 -ELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
                P     A  +    EYLH   S  +I+ D+KP N+L++      ++D G A  + 
Sbjct: 137 GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV- 192
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ 418
            G T  L     GT  Y+APE       ++  D ++ G+L+  +  G P F   Q
Sbjct: 193 KGRTWXLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 243

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 73/174 (41%), Gaps = 10/174 (5%)
Query: 245 RDSKLRQ-IRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGR 303
           RDS+  Q +  EI     ++H+NI+  L          +  E +  GSL  +L    R +
Sbjct: 44  RDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALL----RSK 99
Query: 304 RELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC-ISDLGLAMAI 362
                 +   I       LE L   H   I+H DIK  NVL+N       ISD G +  +
Sbjct: 100 WGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRL 159
Query: 363 PDGYTRVLISYVLGTMAYIAPEYFQQPE--LSEKCDIFSFGMLLISLVRGVPSF 414
             G      ++  GT+ Y+APE   +      +  DI+S G  +I +  G P F
Sbjct: 160 A-GINPCTETFT-GTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPF 211

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 75/175 (42%), Gaps = 17/175 (9%)
Query: 253 RSEIITASQIRHR-NILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG------RR- 304
           + +++   QI H  N   +L  +  P    L + F  N +L  +++ V  G      RR 
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRI 135
Query: 305 -ELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
                P     A  +    EYLH   S  +I+ D+KP N+L++      ++D G A  + 
Sbjct: 136 GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV- 191
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ 418
            G T  L     GT  Y+APE       ++  D ++ G+L+  +  G P F   Q
Sbjct: 192 KGRTWXLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 64/128 (50%), Gaps = 7/128 (5%)
Query: 282 LVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPR 341
           L+ EF+ +GSL++ L    + + +++   + + A+ +  G++YL    S   +H D+  R
Sbjct: 90  LIMEFLPSGSLKEYL---PKNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAAR 143
Query: 342 NVLLNDDMEACISDLGLAMAI-PDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSF 400
           NVL+  + +  I D GL  AI  D     +       + + APE   Q +     D++SF
Sbjct: 144 NVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSF 203
Query: 401 GMLLISLV 408
           G+ L  L+
Sbjct: 204 GVTLHELL 211

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 75/175 (42%), Gaps = 17/175 (9%)
Query: 253 RSEIITASQIRHR-NILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG------RR- 304
           + +++   QI H  N   +L  +  P    L + F  N +L  +++ V  G      RR 
Sbjct: 77  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRI 136
Query: 305 -ELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
                P     A  +    EYLH   S  +I+ D+KP N+L++      ++D G A  + 
Sbjct: 137 GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV- 192
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ 418
            G T  L     GT  Y+APE       ++  D ++ G+L+  +  G P F   Q
Sbjct: 193 KGRTWXLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 243

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 94/231 (40%), Gaps = 33/231 (14%)
Query: 192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ 251
           D F  ++ IG+G  G V   +     G   A+K +                K +  KL+Q
Sbjct: 41  DQFERIKTIGTGSFGRVMLVK-HMETGNHYAMKIL---------------DKQKVVKLKQ 84
Query: 252 IRSEIITASQIRHRNILPLLAHM---VRPDCHL-LVYEFMKNGSLQDILDDVSRGRRELD 307
           I   +     ++  N  P L  +    + + +L +V E+M  G +   L  + R      
Sbjct: 85  IEHTLNEKRILQAVN-FPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGR----FS 139
Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
            P     A  +    EYLH   S  +I+ D+KP N+L++      ++D G A  +  G T
Sbjct: 140 EPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV-KGRT 195
Query: 368 RVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ 418
             L     GT  Y+APE       ++  D ++ G+L+  +  G P F   Q
Sbjct: 196 WXLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 75/175 (42%), Gaps = 17/175 (9%)
Query: 253 RSEIITASQIRHR-NILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG------RR- 304
           + +++   QI H  N   +L  +  P    L + F  N +L  +++ V  G      RR 
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRI 135
Query: 305 -ELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
                P     A  +    EYLH   S  +I+ D+KP N+L++      ++D G A  + 
Sbjct: 136 GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV- 191
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ 418
            G T  L     GT  Y+APE       ++  D ++ G+L+  +  G P F   Q
Sbjct: 192 KGRTWXLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 94/231 (40%), Gaps = 33/231 (14%)
Query: 192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ 251
           D F  ++ IG+G  G V   +     G   A+K +                K +  KL+Q
Sbjct: 41  DQFERIKTIGTGSFGRVMLVK-HMETGNHYAMKIL---------------DKQKVVKLKQ 84
Query: 252 IRSEIITASQIRHRNILPLLAHM---VRPDCHL-LVYEFMKNGSLQDILDDVSRGRRELD 307
           I   +     ++  N  P L  +    + + +L +V E+M  G +   L  + R      
Sbjct: 85  IEHTLNEKRILQAVN-FPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGR----FS 139
Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
            P     A  +    EYLH   S  +I+ D+KP N+L++      ++D G A  +  G T
Sbjct: 140 EPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV-KGRT 195
Query: 368 RVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ 418
             L     GT  Y+APE       ++  D ++ G+L+  +  G P F   Q
Sbjct: 196 WXLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 92/225 (40%), Gaps = 27/225 (12%)
Query: 192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ 251
           D +   E++G+G  G V++     + G   A K V+                  +S    
Sbjct: 157 DHYDIHEELGTGAFGVVHRV-TERATGNNFAAKFVMT---------------PHESDKET 200
Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
           +R EI T S +RH  ++ L       +  +++YEFM  G L + + D      E +    
Sbjct: 201 VRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY 260
Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLND--DMEACISDLGLAMAIPDGYTRV 369
            R    V  GL   HM H  + +H D+KP N++       E  + D GL   +     + 
Sbjct: 261 MR---QVCKGL--CHM-HENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD---PKQ 311
Query: 370 LISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
            +    GT  + APE  +   +    D++S G+L   L+ G+  F
Sbjct: 312 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPF 356

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 75/175 (42%), Gaps = 17/175 (9%)
Query: 253 RSEIITASQIRHR-NILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG------RR- 304
           + +++   QI H  N   +L  +  P    L + F  N +L  +++ V  G      RR 
Sbjct: 77  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRI 136
Query: 305 -ELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
                P     A  +    EYLH   S  +I+ D+KP N+L++      ++D G A  + 
Sbjct: 137 GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV- 192
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ 418
            G T  L     GT  Y+APE       ++  D ++ G+L+  +  G P F   Q
Sbjct: 193 KGRTWXLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 243

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 76/175 (43%), Gaps = 17/175 (9%)
Query: 253 RSEIITASQIRHR-NILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG------RR- 304
           + +++   QI H  N   +L  +  P    L + F  N +L  +++ V+ G      RR 
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI 135
Query: 305 -ELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
                P     A  +    EYLH   S  +I+ D+KP N++++      ++D G A  + 
Sbjct: 136 GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRV- 191
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ 418
            G T  L     GT  Y+APE       ++  D ++ G+L+  +  G P F   Q
Sbjct: 192 KGRTWXLC----GTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 75/175 (42%), Gaps = 17/175 (9%)
Query: 253 RSEIITASQIRHR-NILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG------RR- 304
           + +++   QI H  N   +L  +  P    L + F  N +L  +++ V  G      RR 
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRI 135
Query: 305 -ELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
                P     A  +    EYLH   S  +I+ D+KP N+L++      ++D G A  + 
Sbjct: 136 GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV- 191
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ 418
            G T  L     GT  Y+APE       ++  D ++ G+L+  +  G P F   Q
Sbjct: 192 KGRTWXLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 75/175 (42%), Gaps = 17/175 (9%)
Query: 253 RSEIITASQIRHR-NILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG------RR- 304
           + +++   QI H  N   +L  +  P    L + F  N +L  +++ V  G      RR 
Sbjct: 97  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRI 156
Query: 305 -ELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
                P     A  +    EYLH   S  +I+ D+KP N+L++      ++D G A  + 
Sbjct: 157 GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV- 212
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ 418
            G T  L     GT  Y+APE       ++  D ++ G+L+  +  G P F   Q
Sbjct: 213 KGRTWXLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 263

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 75/175 (42%), Gaps = 17/175 (9%)
Query: 253 RSEIITASQIRHR-NILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG------RR- 304
           + +++   QI H  N   +L  +  P    L + F  N +L  +++ V  G      RR 
Sbjct: 69  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRI 128
Query: 305 -ELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
                P     A  +    EYLH   S  +I+ D+KP N+L++      ++D G A  + 
Sbjct: 129 GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV- 184
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ 418
            G T  L     GT  Y+APE       ++  D ++ G+L+  +  G P F   Q
Sbjct: 185 KGRTWXLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 235

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 52/105 (49%), Gaps = 13/105 (12%)
Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI-PDGYTRVLIS 372
           I + +A  +E+LH   S  ++H D+KP N+    D    + D GL  A+  D   + +++
Sbjct: 169 IFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 225
Query: 373 YV---------LGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLV 408
            +         +GT  Y++PE       S K DIFS G++L  L+
Sbjct: 226 PMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 75/175 (42%), Gaps = 17/175 (9%)
Query: 253 RSEIITASQIRHR-NILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG------RR- 304
           + +++   QI H  N   +L  +  P    L + F  N +L  +++ V  G      RR 
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRI 135
Query: 305 -ELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
                P     A  +    EYLH   S  +I+ D+KP N+L++      ++D G A  + 
Sbjct: 136 GRFXEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV- 191
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ 418
            G T  L     GT  Y+APE       ++  D ++ G+L+  +  G P F   Q
Sbjct: 192 KGRTWXLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 75/175 (42%), Gaps = 17/175 (9%)
Query: 253 RSEIITASQIRHR-NILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG------RR- 304
           + +++   QI H  N   +L  +  P    L + F  N +L  +++ V  G      RR 
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRI 135
Query: 305 -ELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
                P     A  +    EYLH   S  +I+ D+KP N+L++      ++D G A  + 
Sbjct: 136 GRFXEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV- 191
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ 418
            G T  L     GT  Y+APE       ++  D ++ G+L+  +  G P F   Q
Sbjct: 192 KGRTWXLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 100/220 (45%), Gaps = 28/220 (12%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  G+V  AE  G +      K     A   A +++++D+  +D  L  + SE+   
Sbjct: 43  LGEGAFGQVVMAEAVGID------KDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEMM 94
Query: 260 SQI-RHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILD-----------DVSRGRRE-L 306
             I +H+NI+ LL    +     ++  +   G+L++ L            D++R   E +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 307 DWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP--D 364
            +         +A G+EYL    S   IH D+  RNVL+ ++    I+D GLA  I   D
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 365 GYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
            Y +     +   + ++APE       + + D++SFG+L+
Sbjct: 212 YYKKTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLM 249

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 79/168 (47%), Gaps = 25/168 (14%)
Query: 313 RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLIS 372
           +IA+ +   LE+LH     S+IH D+KP NVL+N   +    D G++  + D   + + +
Sbjct: 140 KIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDA 197
Query: 373 YVLGTMAYIAPEYFQQPELSE-----KCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPE 427
              G   Y APE    PEL++     K DI+S G+  I L   +  F +   G      +
Sbjct: 198 ---GCKPYXAPERI-NPELNQKGYSVKSDIWSLGITXIEL--AILRFPYDSWGTPF---Q 248
Query: 428 WLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPN 475
            L++V+  + PS    P+LP + +  +    +     C   + +ERP 
Sbjct: 249 QLKQVV--EEPS----PQLPADKFSAEF---VDFTSQCLKKNSKERPT 287

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 75/175 (42%), Gaps = 17/175 (9%)
Query: 253 RSEIITASQIRHR-NILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG------RR- 304
           + +++   QI H  N   +L  +  P    L + F  N +L  +++ V  G      RR 
Sbjct: 69  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRI 128
Query: 305 -ELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
                P     A  +    EYLH   S  +I+ D+KP N+L++      ++D G A  + 
Sbjct: 129 GRFXEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV- 184
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ 418
            G T  L     GT  Y+APE       ++  D ++ G+L+  +  G P F   Q
Sbjct: 185 KGRTWXLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 235

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 75/175 (42%), Gaps = 17/175 (9%)
Query: 253 RSEIITASQIRHR-NILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG------RR- 304
           + +++   QI H  N   +L  +  P    L + F  N +L  +++ V  G      RR 
Sbjct: 77  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRI 136
Query: 305 -ELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
                P     A  +    EYLH   S  +I+ D+KP N+L++      ++D G A  + 
Sbjct: 137 GRFXEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV- 192
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ 418
            G T  L     GT  Y+APE       ++  D ++ G+L+  +  G P F   Q
Sbjct: 193 KGRTWXLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 243

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 105/242 (43%), Gaps = 34/242 (14%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  G+V +A+  G + K    + V       A ++++E +    S+ R + SE+   
Sbjct: 37  LGRGAFGQVIEADAFGID-KTATXRTV-------AVKMLKEGAT--HSEHRALMSELKIL 86
Query: 260 SQIRHR-NILPLLAHMVRPDCHLLV-YEFMKNGSLQDILDDVSRGRRELDWPSR------ 311
             I H  N++ LL    +P   L+V  EF K G+L   L    R +R    P +      
Sbjct: 87  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----RSKRNEFVPYKPEDLYK 142
Query: 312 ------HRI--ALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
                 H I  +  VA G+E+L    S   IH D+  RN+LL++     I D GLA  I 
Sbjct: 143 DFLTLEHLIXYSFQVAKGMEFLA---SRKXIHRDLAARNILLSEKNVVKICDFGLARDIX 199
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEE 422
                V        + ++APE       + + D++SFG+LL  +   G   +   +  EE
Sbjct: 200 KDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 259
Query: 423 IC 424
            C
Sbjct: 260 FC 261

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 71/274 (25%), Positives = 110/274 (40%), Gaps = 48/274 (17%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYA-----PISAAELIEEDSKLRDSK 248
           +  + +IG G  G VYKA  P S G  +A+K V V       PIS    + E + LR  +
Sbjct: 6   YEPVAEIGVGAYGTVYKARDPHS-GHFVALKSVRVPNGEEGLPIST---VREVALLRRLE 61
Query: 249 LRQ----IRSEIITASQIRHRNI-LPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGR 303
             +    +R   + A+    R I + L+   V  D    + +    G   + + D+ R  
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQ- 120
Query: 304 RELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
                            GL++LH   +  I+H D+KP N+L+       ++D GLA    
Sbjct: 121 --------------FLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIY- 162
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI 423
             Y   L   V+ T+ Y APE   Q   +   D++S G +   + R  P F  +   +++
Sbjct: 163 -SYQMALDPVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL 220
Query: 424 --------CSPE--WLRKVMNSKNPSRAIDPRLP 447
                     PE  W R V     P  A  PR P
Sbjct: 221 GKIFDLIGLPPEDDWPRDV---SLPRGAFPPRGP 251

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 66/240 (27%), Positives = 105/240 (43%), Gaps = 32/240 (13%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  G+V +A+  G + K    + V       A ++++E +    S+ R + SE+   
Sbjct: 35  LGRGAFGQVIEADAFGID-KTATXRTV-------AVKMLKEGAT--HSEHRALMSELKIL 84
Query: 260 SQIRHR-NILPLLAHMVRPDCHLLV-YEFMKNGSLQDILDDVSRGRRELDWPSR------ 311
             I H  N++ LL    +P   L+V  EF K G+L   L    R +R    P +      
Sbjct: 85  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----RSKRNEFVPYKDLYKDF 140
Query: 312 ----HRI--ALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG 365
               H I  +  VA G+E+L    S   IH D+  RN+LL++     I D GLA  I   
Sbjct: 141 LTLEHLICYSFQVAKGMEFLA---SRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKD 197
Query: 366 YTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEIC 424
              V        + ++APE       + + D++SFG+LL  +   G   +   +  EE C
Sbjct: 198 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 257

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 66/243 (27%), Positives = 105/243 (43%), Gaps = 35/243 (14%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  G+V +A+  G + K    + V       A ++++E +    S+ R + SE+   
Sbjct: 36  LGRGAFGQVIEADAFGID-KTATCRTV-------AVKMLKEGAT--HSEHRALMSELKIL 85
Query: 260 SQIRHR-NILPLLAHMVRPDCHLLV-YEFMKNGSLQDILDDVSRGRRELDWPSR------ 311
             I H  N++ LL    +P   L+V  EF K G+L   L    R +R    P +      
Sbjct: 86  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----RSKRNEFVPYKTPEDLY 141
Query: 312 -------HRI--ALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI 362
                  H I  +  VA G+E+L    S   IH D+  RN+LL++     I D GLA  I
Sbjct: 142 KDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDI 198
Query: 363 PDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGE 421
                 V        + ++APE       + + D++SFG+LL  +   G   +   +  E
Sbjct: 199 XKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 258
Query: 422 EIC 424
           E C
Sbjct: 259 EFC 261

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 105/244 (43%), Gaps = 36/244 (14%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  G+V +A+  G + K    + V       A ++++E +    S+ R + SE+   
Sbjct: 26  LGRGAFGQVIEADAFGID-KTATCRTV-------AVKMLKEGAT--HSEHRALMSELKIL 75
Query: 260 SQIRHR-NILPLLAHMVRPDCHLLV-YEFMKNGSLQDILDDVSRGRRELDWPSR------ 311
             I H  N++ LL    +P   L+V  EF K G+L   L    R +R    P +      
Sbjct: 76  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----RSKRNEFVPYKVAPEDL 131
Query: 312 --------HRI--ALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMA 361
                   H I  +  VA G+E+L    S   IH D+  RN+LL++     I D GLA  
Sbjct: 132 YKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARD 188
Query: 362 IPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNG 420
           I      V        + ++APE       + + D++SFG+LL  +   G   +   +  
Sbjct: 189 IXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 248
Query: 421 EEIC 424
           EE C
Sbjct: 249 EEFC 252

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 105/244 (43%), Gaps = 36/244 (14%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  G+V +A+  G + K    + V       A ++++E +    S+ R + SE+   
Sbjct: 26  LGRGAFGQVIEADAFGID-KTATCRTV-------AVKMLKEGAT--HSEHRALMSELKIL 75
Query: 260 SQIRHR-NILPLLAHMVRPDCHLLVY-EFMKNGSLQDILDDVSRGRRELDWPSR------ 311
             I H  N++ LL    +P   L+V  EF K G+L   L    R +R    P +      
Sbjct: 76  IHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYL----RSKRNEFVPYKVAPEDL 131
Query: 312 --------HRI--ALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMA 361
                   H I  +  VA G+E+L    S   IH D+  RN+LL++     I D GLA  
Sbjct: 132 YKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARD 188
Query: 362 IPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNG 420
           I      V        + ++APE       + + D++SFG+LL  +   G   +   +  
Sbjct: 189 IXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 248
Query: 421 EEIC 424
           EE C
Sbjct: 249 EEFC 252

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 100/220 (45%), Gaps = 28/220 (12%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  G+V  AE  G +      K     A   A +++++D+  +D  L  + SE+   
Sbjct: 43  LGEGAFGQVVMAEAVGID------KDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEMM 94
Query: 260 SQI-RHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILD-----------DVSRGRRE-L 306
             I +H+NI+ LL    +     ++  +   G+L++ L            D++R   E +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 307 DWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP--D 364
            +         +A G+EYL    S   IH D+  RNVL+ ++    I+D GLA  I   D
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 365 GYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
            Y +     +   + ++APE       + + D++SFG+L+
Sbjct: 212 YYKKTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLM 249

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 65/259 (25%), Positives = 107/259 (41%), Gaps = 52/259 (20%)
Query: 173 PTIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKM-IAIKKVIVYAP 231
           PTI+ P+++  D+ F          + IG G  G+V KA +     +M  AIK++  YA 
Sbjct: 13  PTIY-PVLDWNDIKFQ---------DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS 62
Query: 232 ISAAELIEEDSKLRDSKLRQIRSEIITASQIRHR-NILPLLAHMVRPDCHLLVYEFMKNG 290
                  ++D        R    E+    ++ H  NI+ LL          L  E+  +G
Sbjct: 63  -------KDDH-------RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 108
Query: 291 SLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSAS-------------IIHGD 337
           +L D L    R  R L+      IA   AS L    + H A+              IH +
Sbjct: 109 NLLDFL----RKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRN 164
Query: 338 IKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMA--YIAPEYFQQPELSEKC 395
           +  RN+L+ ++  A I+D GL+         V +   +G +   ++A E       +   
Sbjct: 165 LAARNILVGENYVAKIADFGLSRG-----QEVYVKKTMGRLPVRWMAIESLNYSVYTTNS 219
Query: 396 DIFSFGMLLISLVR--GVP 412
           D++S+G+LL  +V   G P
Sbjct: 220 DVWSYGVLLWEIVSLGGTP 238

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 54/99 (54%), Gaps = 5/99 (5%)
Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA-MAIPDGYTRVLISYVLG 376
           +  GL+Y+H   SA+++H D+KP N+L+N   +  I D GLA +A P+      ++  + 
Sbjct: 153 ILRGLKYIH---SANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVA 209
Query: 377 TMAYIAPEYFQQPE-LSEKCDIFSFGMLLISLVRGVPSF 414
           T  Y APE     +  ++  DI+S G +L  ++   P F
Sbjct: 210 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 248

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 98/219 (44%), Gaps = 31/219 (14%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  G+V +A+  G + K    + V       A ++++E +    S+ R + SE+   
Sbjct: 35  LGRGAFGQVIEADAFGID-KTATXRTV-------AVKMLKEGAT--HSEHRALMSELKIL 84
Query: 260 SQIRHR-NILPLLAHMVRPDCHLLV-YEFMKNGSLQDILDDVSRGRRELDWPSR------ 311
             I H  N++ LL    +P   L+V  EF K G+L   L    R +R    P +      
Sbjct: 85  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----RSKRNEFVPYKDLYKDF 140
Query: 312 ----HRI--ALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG 365
               H I  +  VA G+E+L    S   IH D+  RN+LL++     I D GLA  I   
Sbjct: 141 LTLEHLIXYSFQVAKGMEFLA---SRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKD 197
Query: 366 YTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
              V        + ++APE       + + D++SFG+LL
Sbjct: 198 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 236

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 105/244 (43%), Gaps = 36/244 (14%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  G+V +A+  G + K    + V       A ++++E +    S+ R + SE+   
Sbjct: 35  LGRGAFGQVIEADAFGID-KTATCRTV-------AVKMLKEGAT--HSEHRALMSELKIL 84
Query: 260 SQIRHR-NILPLLAHMVRPDCHLLV-YEFMKNGSLQDILDDVSRGRRELDWPSR------ 311
             I H  N++ LL    +P   L+V  EF K G+L   L    R +R    P +      
Sbjct: 85  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----RSKRNEFVPYKVAPEDL 140
Query: 312 --------HRI--ALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMA 361
                   H I  +  VA G+E+L    S   IH D+  RN+LL++     I D GLA  
Sbjct: 141 YKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARD 197
Query: 362 IPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNG 420
           I      V        + ++APE       + + D++SFG+LL  +   G   +   +  
Sbjct: 198 IXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 257
Query: 421 EEIC 424
           EE C
Sbjct: 258 EEFC 261

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 71/153 (46%), Gaps = 16/153 (10%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           F  LEKIGSG  G V+K  +   +G + AIK+     P++ +  ++E + LR+     + 
Sbjct: 11  FHELEKIGSGEFGSVFKC-VKRLDGCIYAIKRS--KKPLAGS--VDEQNALREVYAHAVL 65
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
            +        H +++   +     D  L+  E+   GSL D + +  R            
Sbjct: 66  GQ--------HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKD 117
Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLN 346
           + L V  GL Y+H   S S++H DIKP N+ ++
Sbjct: 118 LLLQVGRGLRYIH---SMSLVHMDIKPSNIFIS 147

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 71/153 (46%), Gaps = 16/153 (10%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           F  LEKIGSG  G V+K  +   +G + AIK+     P++ +  ++E + LR+     + 
Sbjct: 11  FHELEKIGSGEFGSVFKC-VKRLDGCIYAIKRS--KKPLAGS--VDEQNALREVYAHAVL 65
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
            +        H +++   +     D  L+  E+   GSL D + +  R            
Sbjct: 66  GQ--------HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKD 117
Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLN 346
           + L V  GL Y+H   S S++H DIKP N+ ++
Sbjct: 118 LLLQVGRGLRYIH---SMSLVHMDIKPSNIFIS 147

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 71/153 (46%), Gaps = 16/153 (10%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           F  LEKIGSG  G V+K  +   +G + AIK+     P++ +  ++E + LR+     + 
Sbjct: 13  FHELEKIGSGEFGSVFKC-VKRLDGCIYAIKRS--KKPLAGS--VDEQNALREVYAHAVL 67
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
            +        H +++   +     D  L+  E+   GSL D + +  R            
Sbjct: 68  GQ--------HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKD 119
Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLN 346
           + L V  GL Y+H   S S++H DIKP N+ ++
Sbjct: 120 LLLQVGRGLRYIH---SMSLVHMDIKPSNIFIS 149

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 75/175 (42%), Gaps = 17/175 (9%)
Query: 253 RSEIITASQIRHR-NILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG------RR- 304
           + +++   QI H  N   +L  +  P    L + F  N +L  +++ V+ G      RR 
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI 135
Query: 305 -ELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
                P     A  +    EYLH   S  +I+ D+KP N+L++      ++D G A  + 
Sbjct: 136 GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV- 191
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ 418
            G T  L     GT  Y+AP        ++  D ++ G+L+  +  G P F   Q
Sbjct: 192 KGRTWXLC----GTPEYLAPAIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 71/153 (46%), Gaps = 16/153 (10%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           F  LEKIGSG  G V+K  +   +G + AIK+     P++ +  ++E + LR+     + 
Sbjct: 9   FHELEKIGSGEFGSVFKC-VKRLDGCIYAIKRS--KKPLAGS--VDEQNALREVYAHAVL 63
Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
            +        H +++   +     D  L+  E+   GSL D + +  R            
Sbjct: 64  GQ--------HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKD 115
Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLN 346
           + L V  GL Y+H   S S++H DIKP N+ ++
Sbjct: 116 LLLQVGRGLRYIH---SMSLVHMDIKPSNIFIS 145

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 98/226 (43%), Gaps = 31/226 (13%)
Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           + +G+G  G+V +A   G  GK  A+ KV V    S A   E+++ + + K        I
Sbjct: 37  KTLGAGAFGKVVEATAFGL-GKEDAVLKVAVKMLKSTAHADEKEALMSELK--------I 87
Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDIL---------DDVSRGR----- 303
            +   +H NI+ LL         L++ E+   G L + L           ++ G+     
Sbjct: 88  MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGL 147
Query: 304 -----RELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGL 358
                R L+       +  VA G+ +L    S + IH D+  RNVLL +   A I D GL
Sbjct: 148 DKEDGRPLELRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGL 204
Query: 359 AMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
           A  I +    ++       + ++APE       + + D++S+G+LL
Sbjct: 205 ARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILL 250

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 75/175 (42%), Gaps = 17/175 (9%)
Query: 248 KLRQIRSEIITASQIRHRNILPLLAHM---VRPDCHL-LVYEFMKNGSLQDILDDVSRGR 303
           KL+QI    +   +I+     P L  +    + + +L +V E+   G +   L  + R  
Sbjct: 82  KLKQI-EHTLNEKRIQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGR-- 138
Query: 304 RELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
                P     A  +    EYLH   S  +I+ D+KP N+L++      ++D G A  + 
Sbjct: 139 --FSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV- 192
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ 418
            G T  L     GT  Y+APE       ++  D ++ G+L+  +  G P F   Q
Sbjct: 193 KGRTWXLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 243

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 78/325 (24%), Positives = 129/325 (39%), Gaps = 68/325 (20%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVY-APISAAELIEEDSKLRDSKLRQIRSEIIT 258
           +G G  G V  A      G+++AIKK+  +  P+ A              LR +R EI  
Sbjct: 19  LGEGAYGVVCSATH-KPTGEIVAIKKIEPFDKPLFA--------------LRTLR-EIKI 62
Query: 259 ASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV 318
               +H NI+ +  ++ RPD       F +   +Q+++             S   I   +
Sbjct: 63  LKHFKHENIITIF-NIQRPDS---FENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFI 118
Query: 319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI---------PDGYTRV 369
              L  + + H +++IH D+KP N+L+N + +  + D GLA  I         P G    
Sbjct: 119 YQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 370 LISYVLGTMAYIAPE-YFQQPELSEKCDIFSFGMLLISLVRGVPSF-----------VF- 416
           +   V  T  Y APE      + S   D++S G +L  L    P F           +F 
Sbjct: 179 MTEXV-ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFG 237
Query: 417 -----HQNGEEIC--SP---EWLRKV-MNSKNPSRAIDPRLPGNGYE--KKML------- 456
                H + +  C  SP   E+++ + M    P   + PR+   G +  ++ML       
Sbjct: 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKR 297
Query: 457 ----HVLKIAYICTLHDPEERPNSQ 477
                 L+  Y+ T HDP + P  +
Sbjct: 298 ITAKEALEHPYLQTYHDPNDEPEGE 322

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 60/246 (24%), Positives = 112/246 (45%), Gaps = 50/246 (20%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           +  ++K+G G  G V+K+ +    G+++A+KK+              D+    +  ++  
Sbjct: 11  YELVKKLGKGAYGIVWKS-IDRRTGEVVAVKKIF-------------DAFQNSTDAQRTF 56
Query: 254 SEIITASQIR-HRNILPLLAHMVRPDCH---LLVYEFMKNGSLQDILDDVSRGRRELDWP 309
            EI+  +++  H NI+ LL +++R D      LV+++M+       L  V R    L+  
Sbjct: 57  REIMILTELSGHENIVNLL-NVLRADNDRDVYLVFDYMETD-----LHAVIRANI-LEPV 109
Query: 310 SRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMA-------- 361
            +  +   +   ++YLH   S  ++H D+KP N+LLN +    ++D GL+ +        
Sbjct: 110 HKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVT 166
Query: 362 --IP----------DGYTRVLISYVLGTMAYIAPE-YFQQPELSEKCDIFSFGMLLISLV 408
             IP          D    +L  YV  T  Y APE      + ++  D++S G +L  ++
Sbjct: 167 NNIPLSINENTENFDDDQPILTDYV-ATRWYRAPEILLGSTKYTKGIDMWSLGCILGEIL 225
Query: 409 RGVPSF 414
            G P F
Sbjct: 226 CGKPIF 231

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 69/166 (41%), Gaps = 20/166 (12%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           I SG  G V       S G  +AIK+V           I  DS L    LR+IR      
Sbjct: 30  ISSGSYGAVCAG--VDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIR----LL 83
Query: 260 SQIRHRNILPL---LAHMVRPDCH--LLVYEFMKNGSLQDILDD-VSRGRRELDWPSRHR 313
           +   H NIL L     H   P  H   LV E M+    Q I D  +    + + +   H 
Sbjct: 84  NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYH- 142
Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA 359
           I LG       LH+ H A ++H D+ P N+LL D+ +  I D  LA
Sbjct: 143 ILLG-------LHVLHEAGVVHRDLHPGNILLADNNDITICDFNLA 181

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 69/166 (41%), Gaps = 20/166 (12%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           I SG  G V       S G  +AIK+V           I  DS L    LR+IR      
Sbjct: 30  ISSGSYGAVCAG--VDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIR----LL 83
Query: 260 SQIRHRNILPL---LAHMVRPDCH--LLVYEFMKNGSLQDILDD-VSRGRRELDWPSRHR 313
           +   H NIL L     H   P  H   LV E M+    Q I D  +    + + +   H 
Sbjct: 84  NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYH- 142
Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA 359
           I LG       LH+ H A ++H D+ P N+LL D+ +  I D  LA
Sbjct: 143 ILLG-------LHVLHEAGVVHRDLHPGNILLADNNDITICDFNLA 181

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 105/244 (43%), Gaps = 36/244 (14%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  G+V +A+  G + K    + V       A ++++E +    S+ R + SE+   
Sbjct: 35  LGRGAFGQVIEADAFGID-KTATCRTV-------AVKMLKEGAT--HSEHRALMSELKIL 84
Query: 260 SQIRHR-NILPLLAHMVRPDCHLLV-YEFMKNGSLQDILDDVSRGRRELDWPSR------ 311
             I H  N++ LL    +P   L+V  EF K G+L   L    R +R    P +      
Sbjct: 85  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----RSKRNEFVPYKVAPEDL 140
Query: 312 --------HRI--ALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMA 361
                   H I  +  VA G+E+L    S   IH D+  RN+LL++     I D GLA  
Sbjct: 141 YKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARD 197
Query: 362 IPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNG 420
           I      V        + ++APE       + + D++SFG+LL  +   G   +   +  
Sbjct: 198 IYKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 257
Query: 421 EEIC 424
           EE C
Sbjct: 258 EEFC 261

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 105/244 (43%), Gaps = 36/244 (14%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  G+V +A+  G + K    + V       A ++++E +    S+ R + SE+   
Sbjct: 26  LGRGAFGQVIEADAFGID-KTATCRTV-------AVKMLKEGAT--HSEHRALMSELKIL 75
Query: 260 SQIRHR-NILPLLAHMVRPDCHLLVY-EFMKNGSLQDILDDVSRGRRELDWPSR------ 311
             I H  N++ LL    +P   L+V  EF K G+L   L    R +R    P +      
Sbjct: 76  IHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYL----RSKRNEFVPYKVAPEDL 131
Query: 312 --------HRI--ALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMA 361
                   H I  +  VA G+E+L    S   IH D+  RN+LL++     I D GLA  
Sbjct: 132 YKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARD 188
Query: 362 IPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNG 420
           I      V        + ++APE       + + D++SFG+LL  +   G   +   +  
Sbjct: 189 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 248
Query: 421 EEIC 424
           EE C
Sbjct: 249 EEFC 252

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/175 (25%), Positives = 74/175 (42%), Gaps = 17/175 (9%)
Query: 253 RSEIITASQIRHR-NILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG------RR- 304
           + +++   QI H  N   +L  +  P    L + F  N +L  +++    G      RR 
Sbjct: 77  KQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRI 136
Query: 305 -ELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
                P     A  +    EYLH   S  +I+ D+KP N++++      ++D G A  + 
Sbjct: 137 GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV- 192
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ 418
            G T  L     GT  Y+APE       ++  D ++ G+L+  +  G P F   Q
Sbjct: 193 KGRTWXLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 243

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/175 (25%), Positives = 74/175 (42%), Gaps = 17/175 (9%)
Query: 253 RSEIITASQIRHR-NILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG------RR- 304
           + +++   QI H  N   +L  +  P    L + F  N +L  +++    G      RR 
Sbjct: 77  KQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRI 136
Query: 305 -ELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
                P     A  +    EYLH   S  +I+ D+KP N++++      ++D G A  + 
Sbjct: 137 GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV- 192
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ 418
            G T  L     GT  Y+APE       ++  D ++ G+L+  +  G P F   Q
Sbjct: 193 KGRTWXLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 243

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 105/244 (43%), Gaps = 36/244 (14%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  G+V +A+  G + K    + V       A ++++E +    S+ R + SE+   
Sbjct: 37  LGRGAFGQVIEADAFGID-KTATCRTV-------AVKMLKEGAT--HSEHRALMSELKIL 86
Query: 260 SQIRHR-NILPLLAHMVRPDCHLLV-YEFMKNGSLQDILDDVSRGRRELDWPSR------ 311
             I H  N++ LL    +P   L+V  EF K G+L   L    R +R    P +      
Sbjct: 87  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----RSKRNEFVPYKEAPEDL 142
Query: 312 --------HRI--ALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMA 361
                   H I  +  VA G+E+L    S   IH D+  RN+LL++     I D GLA  
Sbjct: 143 YKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARD 199
Query: 362 IPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNG 420
           I      V        + ++APE       + + D++SFG+LL  +   G   +   +  
Sbjct: 200 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 259
Query: 421 EEIC 424
           EE C
Sbjct: 260 EEFC 263

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 105/244 (43%), Gaps = 36/244 (14%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  G+V +A+  G + K    + V       A ++++E +    S+ R + SE+   
Sbjct: 26  LGRGAFGQVIEADAFGID-KTATCRTV-------AVKMLKEGAT--HSEHRALMSELKIL 75
Query: 260 SQIRHR-NILPLLAHMVRPDCHLLVY-EFMKNGSLQDILDDVSRGRRELDWPSR------ 311
             I H  N++ LL    +P   L+V  EF K G+L   L    R +R    P +      
Sbjct: 76  IHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYL----RSKRNEFVPYKVAPEDL 131
Query: 312 --------HRI--ALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMA 361
                   H I  +  VA G+E+L    S   IH D+  RN+LL++     I D GLA  
Sbjct: 132 YKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARD 188
Query: 362 IPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNG 420
           I      V        + ++APE       + + D++SFG+LL  +   G   +   +  
Sbjct: 189 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 248
Query: 421 EEIC 424
           EE C
Sbjct: 249 EEFC 252

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 105/244 (43%), Gaps = 36/244 (14%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  G+V +A+  G + K    + V       A ++++E +    S+ R + SE+   
Sbjct: 35  LGRGAFGQVIEADAFGID-KTATCRTV-------AVKMLKEGAT--HSEHRALMSELKIL 84
Query: 260 SQIRHR-NILPLLAHMVRPDCHLLV-YEFMKNGSLQDILDDVSRGRRELDWPSR------ 311
             I H  N++ LL    +P   L+V  EF K G+L   L    R +R    P +      
Sbjct: 85  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----RSKRNEFVPYKVAPEDL 140
Query: 312 --------HRI--ALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMA 361
                   H I  +  VA G+E+L    S   IH D+  RN+LL++     I D GLA  
Sbjct: 141 YKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARD 197
Query: 362 IPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNG 420
           I      V        + ++APE       + + D++SFG+LL  +   G   +   +  
Sbjct: 198 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 257
Query: 421 EEIC 424
           EE C
Sbjct: 258 EEFC 261

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 105/244 (43%), Gaps = 36/244 (14%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  G+V +A+  G + K    + V       A ++++E +    S+ R + SE+   
Sbjct: 72  LGRGAFGQVIEADAFGID-KTATCRTV-------AVKMLKEGAT--HSEHRALMSELKIL 121
Query: 260 SQIRHR-NILPLLAHMVRPDCHLLV-YEFMKNGSLQDILDDVSRGRRELDWPSR------ 311
             I H  N++ LL    +P   L+V  EF K G+L   L    R +R    P +      
Sbjct: 122 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----RSKRNEFVPYKVAPEDL 177
Query: 312 --------HRI--ALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMA 361
                   H I  +  VA G+E+L    S   IH D+  RN+LL++     I D GLA  
Sbjct: 178 YKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARD 234
Query: 362 IPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNG 420
           I      V        + ++APE       + + D++SFG+LL  +   G   +   +  
Sbjct: 235 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 294
Query: 421 EEIC 424
           EE C
Sbjct: 295 EEFC 298

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 27/80 (33%), Positives = 43/80 (53%), Gaps = 1/80 (1%)
Query: 335 HGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEK 394
           H D+KP N+L++ D  A + D G+A A  D     L + V GT+ Y APE F +   + +
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-GTLYYXAPERFSESHATYR 215
Query: 395 CDIFSFGMLLISLVRGVPSF 414
            DI++   +L   + G P +
Sbjct: 216 ADIYALTCVLYECLTGSPPY 235

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 98/233 (42%), Gaps = 35/233 (15%)
Query: 190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKL 249
           +E  +   + IG+G  G VY+A+L  S G+++AIKKV+        EL +   KL    +
Sbjct: 18  QEVSYTDTKVIGNGSFGVVYQAKLCDS-GELVAIKKVLQGKAFKNREL-QIMRKLDHCNI 75
Query: 250 RQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWP 309
            ++R    ++ + +    L L+   V               ++  +    SR ++ L   
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYV-------------PATVYRVARHYSRAKQTLPVI 122
Query: 310 SRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC-ISDLGLAMAIPDGYTR 368
                   +   L Y+H   S  I H DIKP+N+LL+ D     + D G A  +  G   
Sbjct: 123 YVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 179
Query: 369 VLISYVLGTMAYIAPEYFQQPEL-------SEKCDIFSFGMLLISLVRGVPSF 414
           V         + I   Y++ PEL       +   D++S G +L  L+ G P F
Sbjct: 180 V---------SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 44/175 (25%), Positives = 74/175 (42%), Gaps = 17/175 (9%)
Query: 253 RSEIITASQIRHR-NILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG------RR- 304
           + +++   QI H  N   +L  +  P    L + F  N +L  +++    G      RR 
Sbjct: 77  KQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRI 136
Query: 305 -ELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
                P     A  +    EYLH   S  +I+ D+KP N++++      ++D G A  + 
Sbjct: 137 GRFXEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV- 192
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ 418
            G T  L     GT  Y+APE       ++  D ++ G+L+  +  G P F   Q
Sbjct: 193 KGRTWXLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 243

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 37/137 (27%), Positives = 60/137 (43%), Gaps = 12/137 (8%)
Query: 282 LVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPR 341
           +V E+   G +   L  + R       P     A  +    EYLH   S  +I+ D+KP 
Sbjct: 118 MVMEYAPGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPE 170
Query: 342 NVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFG 401
           N++++      ++D GLA  +  G T  L     GT  Y+APE       ++  D ++ G
Sbjct: 171 NLMIDQQGYIKVTDFGLAKRV-KGRTWXLC----GTPEYLAPEIILSKGYNKAVDWWALG 225
Query: 402 MLLISLVRGVPSFVFHQ 418
           +L+  +  G P F   Q
Sbjct: 226 VLIYEMAAGYPPFFADQ 242

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 37/137 (27%), Positives = 60/137 (43%), Gaps = 12/137 (8%)
Query: 282 LVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPR 341
           +V E+   G +   L  + R       P     A  +    EYLH   S  +I+ D+KP 
Sbjct: 118 MVMEYAPGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPE 170
Query: 342 NVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFG 401
           N++++      ++D GLA  +  G T  L     GT  Y+APE       ++  D ++ G
Sbjct: 171 NLMIDQQGYIQVTDFGLAKRV-KGRTWXLC----GTPEYLAPEIILSKGYNKAVDWWALG 225
Query: 402 MLLISLVRGVPSFVFHQ 418
           +L+  +  G P F   Q
Sbjct: 226 VLIYEMAAGYPPFFADQ 242

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 44/175 (25%), Positives = 74/175 (42%), Gaps = 17/175 (9%)
Query: 253 RSEIITASQIRHR-NILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG------RR- 304
           + +++   QI H  N   +L  +  P    L + F  N +L  +++    G      RR 
Sbjct: 77  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRI 136
Query: 305 -ELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
                P     A  +    EYLH   S  +I+ D+KP N++++      ++D G A  + 
Sbjct: 137 GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV- 192
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ 418
            G T  L     GT  Y+APE       ++  D ++ G+L+  +  G P F   Q
Sbjct: 193 KGRTWXLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 243

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 44/175 (25%), Positives = 74/175 (42%), Gaps = 17/175 (9%)
Query: 253 RSEIITASQIRHR-NILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG------RR- 304
           + +++   QI H  N   +L  +  P    L + F  N +L  +++    G      RR 
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRI 135
Query: 305 -ELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
                P     A  +    EYLH   S  +I+ D+KP N++++      ++D G A  + 
Sbjct: 136 GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV- 191
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ 418
            G T  L     GT  Y+APE       ++  D ++ G+L+  +  G P F   Q
Sbjct: 192 KGRTWXLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 44/175 (25%), Positives = 74/175 (42%), Gaps = 17/175 (9%)
Query: 253 RSEIITASQIRHR-NILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG------RR- 304
           + +++   QI H  N   +L  +  P    L + F  N +L  +++    G      RR 
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRI 135
Query: 305 -ELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
                P     A  +    EYLH   S  +I+ D+KP N++++      ++D G A  + 
Sbjct: 136 GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRV- 191
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ 418
            G T  L     GT  Y+APE       ++  D ++ G+L+  +  G P F   Q
Sbjct: 192 KGRTWXLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 70/162 (43%), Gaps = 22/162 (13%)
Query: 282 LVYEFMKNGSLQD-ILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKP 340
           +V E  K G L D IL       RE        +   +   +EYLH   +  ++H D+KP
Sbjct: 93  VVTELXKGGELLDKILRQKFFSEREAS-----AVLFTITKTVEYLH---AQGVVHRDLKP 144
Query: 341 RNVLLNDDM----EACISDLGLA--MAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEK 394
            N+L  D+        I D G A  +   +G    L+     T  ++APE  ++      
Sbjct: 145 SNILYVDESGNPESIRICDFGFAKQLRAENG----LLXTPCYTANFVAPEVLERQGYDAA 200
Query: 395 CDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSK 436
           CDI+S G+LL + + G   F    NG +    E L ++ + K
Sbjct: 201 CDIWSLGVLLYTXLTGYTPFA---NGPDDTPEEILARIGSGK 239

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 75/175 (42%), Gaps = 17/175 (9%)
Query: 253 RSEIITASQIRHR-NILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG------RR- 304
           + +++   QI H  N   +L  +  P    L + F  N +L  +++ V+ G      RR 
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI 135
Query: 305 -ELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
                P     A  +    EYLH   S  +I+ D+KP N+L++      ++D G A  + 
Sbjct: 136 GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV- 191
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ 418
            G T  L     GT   +APE       ++  D ++ G+L+  +  G P F   Q
Sbjct: 192 KGRTWXLC----GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 62/247 (25%), Positives = 108/247 (43%), Gaps = 62/247 (25%)
Query: 189 KKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSK 248
           ++E  + + + IG+G  G V++A+L  S+   +AIKKV+            +D + ++ +
Sbjct: 37  QREIAYTNCKVIGNGSFGVVFQAKLVESDE--VAIKKVL------------QDKRFKNRE 82
Query: 249 LRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQD--ILDDVSRGRREL 306
           L+ +R        ++H N++ L A             F  NG  +D   L+ V     E 
Sbjct: 83  LQIMRI-------VKHPNVVDLKAF------------FYSNGDKKDEVFLNLVLEYVPET 123
Query: 307 DW-PSRHRIALGVASGLEYLHMY-----------HSASIIHGDIKPRNVLLNDDMEACIS 354
            +  SRH   L     +  + +Y           HS  I H DIKP+N+LL+        
Sbjct: 124 VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPS----- 178
Query: 355 DLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPEL-------SEKCDIFSFGMLLISL 407
             G+   I  G  ++LI+     ++ I   Y++ PEL       +   DI+S G ++  L
Sbjct: 179 --GVLKLIDFGSAKILIAGE-PNVSXICSRYYRAPELIFGATNYTTNIDIWSTGCVMAEL 235
Query: 408 VRGVPSF 414
           ++G P F
Sbjct: 236 MQGQPLF 242

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 66/248 (26%), Positives = 102/248 (41%), Gaps = 44/248 (17%)
Query: 171 RGPTIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGEV---YKAELPGSNGKMIAIKKVI 227
           R    +S  I       LK+   + +L+ IGSG  G V   Y A L     + +AIKK+ 
Sbjct: 6   RDNNFYSVEIGDSTFTVLKR---YQNLKPIGSGAQGIVCAAYDAILE----RNVAIKKL- 57
Query: 228 VYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHL------ 281
              P               +  ++   E++    + H+NI+ LL ++  P   L      
Sbjct: 58  -SRPFQ-----------NQTHAKRAYRELVLMKCVNHKNIIGLL-NVFTPQKSLEEFQDV 104
Query: 282 -LVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKP 340
            +V E M     Q I       + ELD      +   +  G+++LH   SA IIH D+KP
Sbjct: 105 YIVMELMDANLCQVI-------QMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKP 154
Query: 341 RNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSF 400
            N+++  D    I D GLA       T  ++   + T  Y APE        E  DI+S 
Sbjct: 155 SNIVVKSDCTLKILDFGLART---AGTSFMMEPEVVTRYYRAPEVILGMGYKENVDIWSV 211
Query: 401 GMLLISLV 408
           G ++  +V
Sbjct: 212 GCIMGEMV 219

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 44/175 (25%), Positives = 74/175 (42%), Gaps = 17/175 (9%)
Query: 253 RSEIITASQIRHR-NILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG------RR- 304
           + +++   QI H  N   +L  +  P    L + F  N +L  +++    G      RR 
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRI 135
Query: 305 -ELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
                P     A  +    EYLH   S  +I+ D+KP N++++      ++D G A  + 
Sbjct: 136 GRFXEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV- 191
Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ 418
            G T  L     GT  Y+APE       ++  D ++ G+L+  +  G P F   Q
Sbjct: 192 KGRTWXLC----GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 63/268 (23%), Positives = 112/268 (41%), Gaps = 46/268 (17%)
Query: 173 PTIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPI 232
           P +  P+    DL  +   D +  ++ IGSG  G V +      + +++A+K       I
Sbjct: 4   PAVSGPM----DLPIMHDSDRYELVKDIGSGNFG-VARLMRDKQSNELVAVKY------I 52
Query: 233 SAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSL 292
              E I+E+          ++ EII    +RH NI+     ++ P    +V E+   G L
Sbjct: 53  ERGEKIDEN----------VKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 102
Query: 293 QDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC 352
            + + +  R   +            + SG+ Y    H+  + H D+K  N LL+      
Sbjct: 103 FERICNAGRFSED----EARFFFQQLISGVSYC---HAMQVCHRDLKLENTLLDGSPAPR 155
Query: 353 ISDLGLAMAIPDGYTRVLISY-----VLGTMAYIAPEYFQQPELSEK-CDIFSFGMLLIS 406
           +           GY++  + +      +GT AYIAPE   + E   K  D++S G+ L  
Sbjct: 156 LKICAF------GYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYV 209
Query: 407 LVRGVPSFVFHQNGEEICSPEWLRKVMN 434
           ++ G   F   ++ EE   P+  RK ++
Sbjct: 210 MLVGAYPF---EDPEE---PKNFRKTIH 231

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 41/134 (30%), Positives = 60/134 (44%), Gaps = 11/134 (8%)
Query: 282 LVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPR 341
            V E++  G L   +  V R +     P     A  +A GL +L    S  II+ D+K  
Sbjct: 419 FVMEYVNGGDLMYHIQQVGRFKE----PHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLD 471
Query: 342 NVLLNDDMEACISDLGLAMA-IPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSF 400
           NV+L+ +    I+D G+    I DG T        GT  YIAPE        +  D ++F
Sbjct: 472 NVMLDSEGHIKIADFGMCKENIWDGVT---TKXFCGTPDYIAPEIIAYQPYGKSVDWWAF 528
Query: 401 GMLLISLVRGVPSF 414
           G+LL  ++ G   F
Sbjct: 529 GVLLYEMLAGQAPF 542

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 64/251 (25%), Positives = 102/251 (40%), Gaps = 40/251 (15%)
Query: 170 DRGPTIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVY 229
           DR P    PL    D+  +   D +  ++ IGSG  G V +        +++A+K     
Sbjct: 2   DRAPVTTGPL----DMPIMHDSDRYDFVKDIGSGNFG-VARLMRDKLTKELVAVKY---- 52
Query: 230 APISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKN 289
             I     I+E+          ++ EII    +RH NI+     ++ P    ++ E+   
Sbjct: 53  --IERGAAIDEN----------VQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASG 100
Query: 290 GSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDM 349
           G L + + +  R   +            + SG+ Y    HS  I H D+K  N LL+   
Sbjct: 101 GELYERICNAGRFSED----EARFFFQQLLSGVSYC---HSMQICHRDLKLENTLLDGSP 153
Query: 350 EA--CISDLGLAMAIPDGYTRVLISY---VLGTMAYIAPEYFQQPELSEK-CDIFSFGML 403
                I D G +       + VL S     +GT AYIAPE   + E   K  D++S G+ 
Sbjct: 154 APRLKICDFGYSK------SSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVT 207
Query: 404 LISLVRGVPSF 414
           L  ++ G   F
Sbjct: 208 LYVMLVGAYPF 218

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 64/287 (22%), Positives = 120/287 (41%), Gaps = 47/287 (16%)
Query: 196 SLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSE 255
           +L ++GSG CG+V+K       G +IA+K           ++    +K  + ++      
Sbjct: 29  NLGEMGSGTCGQVWKMRFR-KTGHVIAVK-----------QMRRSGNKEENKRILMDLDV 76
Query: 256 IITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR--HR 313
           ++ +    +  I+      +      +  E M  G+  + L    + R +   P R   +
Sbjct: 77  VLKSHDCPY--IVQCFGTFITNTDVFIAMELM--GTCAEKL----KKRMQGPIPERILGK 128
Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISY 373
           + + +   L YL   H   +IH D+KP N+LL++  +  + D G++  + D   +     
Sbjct: 129 MTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK---DR 183
Query: 374 VLGTMAYIAPEYFQQPELSE-----KCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEW 428
             G  AY+APE    P+ ++     + D++S G+ L+ L  G   F +     +    E 
Sbjct: 184 SAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATG--QFPYKNCKTDF---EV 238
Query: 429 LRKVMNSKNPSRAIDPRLPGN-GYEKKMLHVLKIAYICTLHDPEERP 474
           L KV+  +       P LPG+ G+       +K    C   D  +RP
Sbjct: 239 LTKVLQEE------PPLLPGHMGFSGDFQSFVK---DCLTKDHRKRP 276

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 66/268 (24%), Positives = 111/268 (41%), Gaps = 46/268 (17%)
Query: 173 PTIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPI 232
           P +  P+    DL  +   D +  ++ IG+G  G V +        +++A+K       I
Sbjct: 4   PAVAGPM----DLPIMHDSDRYELVKDIGAGNFG-VARLMRDKQANELVAVKY------I 52
Query: 233 SAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSL 292
              E I+E+          ++ EII    +RH NI+     ++ P    +V E+   G L
Sbjct: 53  ERGEKIDEN----------VKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 102
Query: 293 QDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA- 351
            + + +  R   +            + SG+ Y    H+  + H D+K  N LL+      
Sbjct: 103 FERICNAGRFSED----EARFFFQQLISGVSYA---HAMQVAHRDLKLENTLLDGSPAPR 155
Query: 352 -CISDLGLAMAIPDGYTRVLISY---VLGTMAYIAPEYFQQPELSEK-CDIFSFGMLLIS 406
             I+D G + A       VL S     +GT AYIAPE   + E   K  D++S G+ L  
Sbjct: 156 LKIADFGYSKA------SVLHSQPKSAVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYV 209
Query: 407 LVRGVPSFVFHQNGEEICSPEWLRKVMN 434
           ++ G   F      E+   P+  RK ++
Sbjct: 210 MLVGAYPF------EDPEEPKNFRKTIH 231

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 78/310 (25%), Positives = 122/310 (39%), Gaps = 57/310 (18%)
Query: 171 RGPTIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGEV---YKAELPGSNGKMIAIKKVI 227
           R    +S  I       LK+   + +L+ IGSG  G V   Y A L     + +AIKK+ 
Sbjct: 6   RDNNFYSVEIGDSTFTVLKR---YQNLKPIGSGAQGIVCAAYDAIL----ERNVAIKKL- 57
Query: 228 VYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHL------ 281
              P               +  ++   E++    + H+NI+ LL ++  P   L      
Sbjct: 58  -SRPFQ-----------NQTHAKRAYRELVLMKCVNHKNIIGLL-NVFTPQKSLEEFQDV 104
Query: 282 -LVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKP 340
            +V E M     Q I       + ELD      +   +  G+++LH   SA IIH D+KP
Sbjct: 105 YIVMELMDANLCQVI-------QMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKP 154
Query: 341 RNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSF 400
            N+++  D    I D GLA       T  ++   + T  Y APE        E  D++S 
Sbjct: 155 SNIVVKSDCTLKILDFGLART---AGTSFMMEPEVVTRYYRAPEVILGMGYKENVDLWSV 211
Query: 401 GMLLISLVRGVPSF-----------VFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGN 449
           G ++  +V     F           V  Q G     PE+++K+  +        P+  G 
Sbjct: 212 GCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTP--CPEFMKKLQPTVRTYVENRPKYAGY 269
Query: 450 GYEKKMLHVL 459
            +EK    VL
Sbjct: 270 SFEKLFPDVL 279

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 41/134 (30%), Positives = 60/134 (44%), Gaps = 11/134 (8%)
Query: 282 LVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPR 341
            V E++  G L   +  V R +     P     A  +A GL +L    S  II+ D+K  
Sbjct: 98  FVMEYVNGGDLMYHIQQVGRFKE----PHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLD 150
Query: 342 NVLLNDDMEACISDLGLAMA-IPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSF 400
           NV+L+ +    I+D G+    I DG T        GT  YIAPE        +  D ++F
Sbjct: 151 NVMLDSEGHIKIADFGMCKENIWDGVT---TKXFCGTPDYIAPEIIAYQPYGKSVDWWAF 207
Query: 401 GMLLISLVRGVPSF 414
           G+LL  ++ G   F
Sbjct: 208 GVLLYEMLAGQAPF 221

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 63/268 (23%), Positives = 112/268 (41%), Gaps = 46/268 (17%)
Query: 173 PTIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPI 232
           P +  P+    DL  +   D +  ++ IGSG  G V +      + +++A+K       I
Sbjct: 4   PAVSGPM----DLPIMHDSDRYELVKDIGSGNFG-VARLMRDKQSNELVAVKY------I 52
Query: 233 SAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSL 292
              E I+E+          ++ EII    +RH NI+     ++ P    +V E+   G L
Sbjct: 53  ERGEKIDEN----------VKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 102
Query: 293 QDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC 352
            + + +  R   +            + SG+ Y    H+  + H D+K  N LL+      
Sbjct: 103 FERICNAGRFSED----EARFFFQQLISGVSYC---HAMQVCHRDLKLENTLLDGSPAPR 155
Query: 353 ISDLGLAMAIPDGYTRVLISY-----VLGTMAYIAPEYFQQPELSEK-CDIFSFGMLLIS 406
           +           GY++  + +      +GT AYIAPE   + E   K  D++S G+ L  
Sbjct: 156 LKICAF------GYSKSSVLHSQPKDTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYV 209
Query: 407 LVRGVPSFVFHQNGEEICSPEWLRKVMN 434
           ++ G   F   ++ EE   P+  RK ++
Sbjct: 210 MLVGAYPF---EDPEE---PKNFRKTIH 231

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 65/257 (25%), Positives = 109/257 (42%), Gaps = 42/257 (16%)
Query: 184 DLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSK 243
           DL  +   D +  ++ IGSG  G V +      + +++A+K       I   E I+E+  
Sbjct: 10  DLPIMHDSDRYELVKDIGSGNFG-VARLMRDKQSNELVAVKY------IERGEKIDEN-- 60
Query: 244 LRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGR 303
                   ++ EII    +RH NI+     ++ P    +V E+   G L + + +  R  
Sbjct: 61  --------VKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFS 112
Query: 304 RELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA--CISDLGLAMA 361
            +            + SG+ Y    H+  + H D+K  N LL+        I D G +  
Sbjct: 113 ED----EARFFFQQLISGVSYC---HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK- 164
Query: 362 IPDGYTRVLISY---VLGTMAYIAPEYFQQPELSEK-CDIFSFGMLLISLVRGVPSFVFH 417
                + VL S     +GT AYIAPE   + E   K  D++S G+ L  ++ G   F   
Sbjct: 165 -----SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPF--- 216
Query: 418 QNGEEICSPEWLRKVMN 434
           ++ EE   P+  RK ++
Sbjct: 217 EDPEE---PKNFRKTIH 230

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/137 (26%), Positives = 61/137 (44%), Gaps = 13/137 (9%)
Query: 282 LVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPR 341
           +V E+M  G L +++ +     +   W   +   + +A     L   HS  +IH D+KP 
Sbjct: 152 MVMEYMPGGDLVNLMSNYDVPEK---WAKFYTAEVVLA-----LDAIHSMGLIHRDVKPD 203
Query: 342 NVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQP----ELSEKCDI 397
           N+LL+      ++D G  M + D    V     +GT  YI+PE  +          +CD 
Sbjct: 204 NMLLDKHGHLKLADFGTCMKM-DETGMVHCDTAVGTPDYISPEVLKSQGGDGYYGRECDW 262
Query: 398 FSFGMLLISLVRGVPSF 414
           +S G+ L  ++ G   F
Sbjct: 263 WSVGVFLFEMLVGDTPF 279

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 72/286 (25%), Positives = 113/286 (39%), Gaps = 52/286 (18%)
Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           L K+     GE++K    G N  ++ + KV  ++   + +  EE  +LR           
Sbjct: 15  LTKLNENHSGELWKGRWQG-NDIVVKVLKVRDWSTRKSRDFNEECPRLR----------- 62
Query: 257 ITASQIRHRNILPLLAHMVRPDCH--LLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRI 314
                  H N+LP+L     P      L+  +   GSL ++L + +     +D     + 
Sbjct: 63  ----IFSHPNVLPVLGACQSPPAPHPTLITHWXPYGSLYNVLHEGTNF--VVDQSQAVKF 116
Query: 315 ALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACIS--DLGLAMAIPDGYTRVLIS 372
           AL  A G  +LH        H  +  R+V +++D  A IS  D+  +   P         
Sbjct: 117 ALDXARGXAFLHTLEPLIPRHA-LNSRSVXIDEDXTARISXADVKFSFQSPGRXY----- 170
Query: 373 YVLGTMAYIAPEYFQQ-PELSEK--CDIFSFGMLLISLV-RGVPSFVFHQNGEEICSPEW 428
                 A++APE  Q+ PE + +   D +SF +LL  LV R VP F    N E       
Sbjct: 171 ----APAWVAPEALQKKPEDTNRRSADXWSFAVLLWELVTREVP-FADLSNXE------- 218
Query: 429 LRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERP 474
               +  K     + P +P         HV K+  IC   DP +RP
Sbjct: 219 ----IGXKVALEGLRPTIPPGISP----HVSKLXKICXNEDPAKRP 256

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 108/244 (44%), Gaps = 30/244 (12%)
Query: 178 PLIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAEL 237
           P   K     L +ED F  L+ IG G  GEV   +L  ++ K+ A+K +  +  +  AE 
Sbjct: 61  PFTSKVKQMRLHRED-FEILKVIGRGAFGEVAVVKLKNAD-KVFAMKILNKWEMLKRAET 118
Query: 238 IEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHL-LVYEFMKNGSLQDIL 296
                    +  R+ R  ++          +  L +  + D +L LV ++   G L  +L
Sbjct: 119 ---------ACFREERDVLVNGDS----KWITTLHYAFQDDNNLYLVMDYYVGGDLLTLL 165
Query: 297 DDV-SRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISD 355
                R   E+   +R  +A  V + ++ +H  H    +H DIKP N+L++ +    ++D
Sbjct: 166 SKFEDRLPEEM---ARFYLAEMVIA-IDSVHQLH---YVHRDIKPDNILMDMNGHIRLAD 218
Query: 356 LGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPE-----LSEKCDIFSFGMLLISLVRG 410
            G  + + +  T V  S  +GT  YI+PE  Q  E        +CD +S G+ +  ++ G
Sbjct: 219 FGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYG 277
Query: 411 VPSF 414
              F
Sbjct: 278 ETPF 281

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/256 (24%), Positives = 107/256 (41%), Gaps = 37/256 (14%)
Query: 188 LKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDS 247
           +K ED +  ++ IG G  GEV          +  + +KV     +S  E+I    K  DS
Sbjct: 66  MKAED-YEVVKVIGRGAFGEVQLV-------RHKSTRKVYAMKLLSKFEMI----KRSDS 113
Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHL-LVYEFMKNGSLQDILDDVSRGRREL 306
                  +I+  +   +   +  L +  + D +L +V E+M  G L +++ +     +  
Sbjct: 114 AFFWEERDIMAFA---NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK-- 168
Query: 307 DWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI-PDG 365
            W   +   + +A     L   HS   IH D+KP N+LL+      ++D G  M +  +G
Sbjct: 169 -WARFYTAEVVLA-----LDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 222
Query: 366 YTRVLISYVLGTMAYIAPEYFQQP----ELSEKCDIFSFGMLLISLVRGVPSFVFHQNGE 421
             R      +GT  YI+PE  +          +CD +S G+ L  ++ G   F      +
Sbjct: 223 MVRC--DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY----AD 276
Query: 422 EICSPEWLRKVMNSKN 437
            +       K+MN KN
Sbjct: 277 SLVGT--YSKIMNHKN 290

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/256 (24%), Positives = 107/256 (41%), Gaps = 37/256 (14%)
Query: 188 LKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDS 247
           +K ED +  ++ IG G  GEV          +  + +KV     +S  E+I    K  DS
Sbjct: 71  MKAED-YEVVKVIGRGAFGEVQLV-------RHKSTRKVYAMKLLSKFEMI----KRSDS 118
Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHL-LVYEFMKNGSLQDILDDVSRGRREL 306
                  +I+  +   +   +  L +  + D +L +V E+M  G L +++ +     +  
Sbjct: 119 AFFWEERDIMAFA---NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK-- 173
Query: 307 DWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI-PDG 365
            W   +   + +A     L   HS   IH D+KP N+LL+      ++D G  M +  +G
Sbjct: 174 -WARFYTAEVVLA-----LDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 227
Query: 366 YTRVLISYVLGTMAYIAPEYFQQP----ELSEKCDIFSFGMLLISLVRGVPSFVFHQNGE 421
             R      +GT  YI+PE  +          +CD +S G+ L  ++ G   F      +
Sbjct: 228 MVRC--DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY----AD 281
Query: 422 EICSPEWLRKVMNSKN 437
            +       K+MN KN
Sbjct: 282 SLVGT--YSKIMNHKN 295

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 101/234 (43%), Gaps = 30/234 (12%)
Query: 188 LKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDS 247
           L +ED F  ++ IG G  GEV   ++  +  ++ A+K +  +  +  AE          +
Sbjct: 71  LHRED-FEIIKVIGRGAFGEVAVVKMKNTE-RIYAMKILNKWEMLKRAET---------A 119
Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHL-LVYEFMKNGSLQDILDDVSRGRREL 306
             R+ R  ++          +  L +  + + HL LV ++   G L  +L        E 
Sbjct: 120 CFREERDVLVNGDC----QWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPE- 174
Query: 307 DWPSRHRIALG-VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG 365
                 R  +G +   ++ +H  H    +H DIKP NVLL+ +    ++D G  + + D 
Sbjct: 175 ---DMARFYIGEMVLAIDSIHQLH---YVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDD 228
Query: 366 YTRVLISYVLGTMAYIAPEYFQQPE-----LSEKCDIFSFGMLLISLVRGVPSF 414
            T V  S  +GT  YI+PE  Q  E        +CD +S G+ +  ++ G   F
Sbjct: 229 GT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 281

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 101/234 (43%), Gaps = 30/234 (12%)
Query: 188 LKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDS 247
           L +ED F  ++ IG G  GEV   ++  +  ++ A+K +  +  +  AE          +
Sbjct: 87  LHRED-FEIIKVIGRGAFGEVAVVKMKNTE-RIYAMKILNKWEMLKRAET---------A 135
Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHL-LVYEFMKNGSLQDILDDVSRGRREL 306
             R+ R  ++          +  L +  + + HL LV ++   G L  +L        E 
Sbjct: 136 CFREERDVLVNGDC----QWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPE- 190
Query: 307 DWPSRHRIALG-VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG 365
                 R  +G +   ++ +H  H    +H DIKP NVLL+ +    ++D G  + + D 
Sbjct: 191 ---DMARFYIGEMVLAIDSIHQLH---YVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDD 244
Query: 366 YTRVLISYVLGTMAYIAPEYFQQPE-----LSEKCDIFSFGMLLISLVRGVPSF 414
            T V  S  +GT  YI+PE  Q  E        +CD +S G+ +  ++ G   F
Sbjct: 245 GT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 297

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/256 (24%), Positives = 107/256 (41%), Gaps = 37/256 (14%)
Query: 188 LKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDS 247
           +K ED +  ++ IG G  GEV          +  + +KV     +S  E+I    K  DS
Sbjct: 71  MKAED-YEVVKVIGRGAFGEVQLV-------RHKSTRKVYAMKLLSKFEMI----KRSDS 118
Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHL-LVYEFMKNGSLQDILDDVSRGRREL 306
                  +I+  +   +   +  L +  + D +L +V E+M  G L +++ +     +  
Sbjct: 119 AFFWEERDIMAFA---NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK-- 173
Query: 307 DWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI-PDG 365
            W   +   + +A     L   HS   IH D+KP N+LL+      ++D G  M +  +G
Sbjct: 174 -WARFYTAEVVLA-----LDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 227
Query: 366 YTRVLISYVLGTMAYIAPEYFQQP----ELSEKCDIFSFGMLLISLVRGVPSFVFHQNGE 421
             R      +GT  YI+PE  +          +CD +S G+ L  ++ G   F      +
Sbjct: 228 MVRC--DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY----AD 281
Query: 422 EICSPEWLRKVMNSKN 437
            +       K+MN KN
Sbjct: 282 SLVGT--YSKIMNHKN 295

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 61/134 (45%), Gaps = 11/134 (8%)
Query: 282 LVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPR 341
            V E++  G L   +  V + +     P     A  ++ GL +LH      II+ D+K  
Sbjct: 97  FVMEYVNGGDLMYHIQQVGKFKE----PQAVFYAAEISIGLFFLH---KRGIIYRDLKLD 149
Query: 342 NVLLNDDMEACISDLGLAMA-IPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSF 400
           NV+L+ +    I+D G+    + DG T        GT  YIAPE        +  D +++
Sbjct: 150 NVMLDSEGHIKIADFGMCKEHMMDGVT---TREFCGTPDYIAPEIIAYQPYGKSVDWWAY 206
Query: 401 GMLLISLVRGVPSF 414
           G+LL  ++ G P F
Sbjct: 207 GVLLYEMLAGQPPF 220

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 66/268 (24%), Positives = 111/268 (41%), Gaps = 46/268 (17%)
Query: 173 PTIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPI 232
           P +  P+    DL  +   D +  ++ IGSG  G V +      + +++A+K        
Sbjct: 4   PAVSGPM----DLPIMHDSDRYELVKDIGSGNFG-VARLMRDKQSNELVAVK-------- 50
Query: 233 SAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSL 292
                IE   K+       ++ EII    +RH NI+     ++ P    +V E+   G L
Sbjct: 51  ----YIERGEKI----AANVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 102
Query: 293 QDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA- 351
            + + +  R   +            + SG+ Y    H+  + H D+K  N LL+      
Sbjct: 103 FERICNAGRFSED----EARFFFQQLISGVSYC---HAMQVCHRDLKLENTLLDGSPAPR 155
Query: 352 -CISDLGLAMAIPDGYTRVLISY---VLGTMAYIAPEYFQQPELSEK-CDIFSFGMLLIS 406
             I D G +       + VL S     +GT AYIAPE   + E   K  D++S G+ L  
Sbjct: 156 LKICDFGYSK------SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYV 209
Query: 407 LVRGVPSFVFHQNGEEICSPEWLRKVMN 434
           ++ G   F   ++ EE   P+  RK ++
Sbjct: 210 MLVGAYPF---EDPEE---PKNFRKTIH 231

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 99/244 (40%), Gaps = 27/244 (11%)
Query: 246 DSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRE 305
           DS   +   E +T  Q  H +I+ L+  ++  +   ++ E    G L+  L      +  
Sbjct: 55  DSVREKFLQEALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQ---VRKYS 110
Query: 306 LDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG 365
           LD  S    A  +++ L YL    S   +H DI  RNVL++ +    + D GL+  + D 
Sbjct: 111 LDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 167
Query: 366 YTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLIS-LVRGVPSFVFHQNGEEIC 424
            T    S     + ++APE       +   D++ FG+ +   L+ GV  F   +N + I 
Sbjct: 168 -TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG 226
Query: 425 SPEWLRKVMNSKNPSR-AIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRL 483
             E         N  R  + P  P   Y         +   C  +DP  RP    ++ +L
Sbjct: 227 RIE---------NGERLPMPPNCPPTLY--------SLMTKCWAYDPSRRPRFTELKAQL 269
Query: 484 SQLL 487
           S +L
Sbjct: 270 STIL 273

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 84/188 (44%), Gaps = 21/188 (11%)
Query: 255 EIITASQIRHRNILPLLAHMV---RPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
           E++  +QI H+   P +  ++   + +  +LV E    G L   L  V + R E+   + 
Sbjct: 56  EMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFL--VGK-REEIPVSNV 112
Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI-PDGYTRVL 370
             +   V+ G++YL      + +H D+  RNVLL +   A ISD GL+ A+  D      
Sbjct: 113 AELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 169
Query: 371 ISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLV----------RGVPSFVFHQNG 420
            S     + + APE     + S + D++S+G+ +   +          +G     F + G
Sbjct: 170 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG 229
Query: 421 EEI-CSPE 427
           + + C PE
Sbjct: 230 KRMECPPE 237

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 99/244 (40%), Gaps = 27/244 (11%)
Query: 246 DSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRE 305
           DS   +   E +T  Q  H +I+ L+  ++  +   ++ E    G L+  L      +  
Sbjct: 57  DSVREKFLQEALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQ---VRKYS 112
Query: 306 LDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG 365
           LD  S    A  +++ L YL    S   +H DI  RNVL++ +    + D GL+  + D 
Sbjct: 113 LDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 169
Query: 366 YTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLIS-LVRGVPSFVFHQNGEEIC 424
            T    S     + ++APE       +   D++ FG+ +   L+ GV  F   +N + I 
Sbjct: 170 -TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG 228
Query: 425 SPEWLRKVMNSKNPSR-AIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRL 483
             E         N  R  + P  P   Y         +   C  +DP  RP    ++ +L
Sbjct: 229 RIE---------NGERLPMPPNCPPTLY--------SLMTKCWAYDPSRRPRFTELKAQL 271
Query: 484 SQLL 487
           S +L
Sbjct: 272 STIL 275

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 99/244 (40%), Gaps = 27/244 (11%)
Query: 246 DSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRE 305
           DS   +   E +T  Q  H +I+ L+  ++  +   ++ E    G L+  L      +  
Sbjct: 49  DSVREKFLQEALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQ---VRKYS 104
Query: 306 LDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG 365
           LD  S    A  +++ L YL    S   +H DI  RNVL++ +    + D GL+  + D 
Sbjct: 105 LDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161
Query: 366 YTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLIS-LVRGVPSFVFHQNGEEIC 424
            T    S     + ++APE       +   D++ FG+ +   L+ GV  F   +N + I 
Sbjct: 162 -TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG 220
Query: 425 SPEWLRKVMNSKNPSR-AIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRL 483
             E         N  R  + P  P   Y         +   C  +DP  RP    ++ +L
Sbjct: 221 RIE---------NGERLPMPPNCPPTLY--------SLMTKCWAYDPSRRPRFTELKAQL 263
Query: 484 SQLL 487
           S +L
Sbjct: 264 STIL 267

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 75/174 (43%), Gaps = 22/174 (12%)
Query: 277 PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGL-EYLHMYHSASIIH 335
           P+C+    E   NGS+          R  LD+  R ++   +   +   LH  H+  I H
Sbjct: 143 PECN----EEAINGSIHGF-------RESLDFVQREKLISNIMRQIFSALHYLHNQGICH 191
Query: 336 GDIKPRNVLL--NDDMEACISDLGLA---MAIPDGYTRVLISYVLGTMAYIAPEYFQQPE 390
            DIKP N L   N   E  + D GL+     + +G    + +   GT  ++APE      
Sbjct: 192 RDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTN 250
Query: 391 LS--EKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAI 442
            S   KCD +S G+LL  L+ G   F    + + I   + L K +  +NP+  +
Sbjct: 251 ESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTI--SQVLNKKLCFENPNYNV 302

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 99/244 (40%), Gaps = 27/244 (11%)
Query: 246 DSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRE 305
           DS   +   E +T  Q  H +I+ L+  ++  +   ++ E    G L+  L      +  
Sbjct: 54  DSVREKFLQEALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQ---VRKYS 109
Query: 306 LDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG 365
           LD  S    A  +++ L YL    S   +H DI  RNVL++ +    + D GL+  + D 
Sbjct: 110 LDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 166
Query: 366 YTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLIS-LVRGVPSFVFHQNGEEIC 424
            T    S     + ++APE       +   D++ FG+ +   L+ GV  F   +N + I 
Sbjct: 167 -TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG 225
Query: 425 SPEWLRKVMNSKNPSR-AIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRL 483
             E         N  R  + P  P   Y         +   C  +DP  RP    ++ +L
Sbjct: 226 RIE---------NGERLPMPPNCPPTLY--------SLMTKCWAYDPSRRPRFTELKAQL 268
Query: 484 SQLL 487
           S +L
Sbjct: 269 STIL 272

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 99/244 (40%), Gaps = 27/244 (11%)
Query: 246 DSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRE 305
           DS   +   E +T  Q  H +I+ L+  ++  +   ++ E    G L+  L      +  
Sbjct: 432 DSVREKFLQEALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFL---QVRKFS 487
Query: 306 LDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG 365
           LD  S    A  +++ L YL    S   +H DI  RNVL++ +    + D GL+  + D 
Sbjct: 488 LDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 544
Query: 366 YTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLIS-LVRGVPSFVFHQNGEEIC 424
            T    S     + ++APE       +   D++ FG+ +   L+ GV  F   +N + I 
Sbjct: 545 -TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG 603
Query: 425 SPEWLRKVMNSKNPSR-AIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRL 483
             E         N  R  + P  P   Y         +   C  +DP  RP    ++ +L
Sbjct: 604 RIE---------NGERLPMPPNCPPTLY--------SLMTKCWAYDPSRRPRFTELKAQL 646
Query: 484 SQLL 487
           S +L
Sbjct: 647 STIL 650

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 99/244 (40%), Gaps = 27/244 (11%)
Query: 246 DSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRE 305
           DS   +   E +T  Q  H +I+ L+  ++  +   ++ E    G L+  L      +  
Sbjct: 52  DSVREKFLQEALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQ---VRKYS 107
Query: 306 LDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG 365
           LD  S    A  +++ L YL    S   +H DI  RNVL++ +    + D GL+  + D 
Sbjct: 108 LDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 164
Query: 366 YTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLIS-LVRGVPSFVFHQNGEEIC 424
            T    S     + ++APE       +   D++ FG+ +   L+ GV  F   +N + I 
Sbjct: 165 -TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG 223
Query: 425 SPEWLRKVMNSKNPSR-AIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRL 483
             E         N  R  + P  P   Y         +   C  +DP  RP    ++ +L
Sbjct: 224 RIE---------NGERLPMPPNCPPTLY--------SLMTKCWAYDPSRRPRFTELKAQL 266
Query: 484 SQLL 487
           S +L
Sbjct: 267 STIL 270

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 99/244 (40%), Gaps = 27/244 (11%)
Query: 246 DSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRE 305
           DS   +   E +T  Q  H +I+ L+  ++  +   ++ E    G L+  L      +  
Sbjct: 80  DSVREKFLQEALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQ---VRKYS 135
Query: 306 LDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG 365
           LD  S    A  +++ L YL    S   +H DI  RNVL++ +    + D GL+  + D 
Sbjct: 136 LDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 192
Query: 366 YTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLIS-LVRGVPSFVFHQNGEEIC 424
            T    S     + ++APE       +   D++ FG+ +   L+ GV  F   +N + I 
Sbjct: 193 -TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG 251
Query: 425 SPEWLRKVMNSKNPSR-AIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRL 483
             E         N  R  + P  P   Y         +   C  +DP  RP    ++ +L
Sbjct: 252 RIE---------NGERLPMPPNCPPTLY--------SLMTKCWAYDPSRRPRFTELKAQL 294
Query: 484 SQLL 487
           S +L
Sbjct: 295 STIL 298

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 99/244 (40%), Gaps = 27/244 (11%)
Query: 246 DSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRE 305
           DS   +   E +T  Q  H +I+ L+  ++  +   ++ E    G L+  L      +  
Sbjct: 52  DSVREKFLQEALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQ---VRKYS 107
Query: 306 LDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG 365
           LD  S    A  +++ L YL    S   +H DI  RNVL++ +    + D GL+  + D 
Sbjct: 108 LDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 164
Query: 366 YTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLIS-LVRGVPSFVFHQNGEEIC 424
            T    S     + ++APE       +   D++ FG+ +   L+ GV  F   +N + I 
Sbjct: 165 -TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG 223
Query: 425 SPEWLRKVMNSKNPSR-AIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRL 483
             E         N  R  + P  P   Y         +   C  +DP  RP    ++ +L
Sbjct: 224 RIE---------NGERLPMPPNCPPTLY--------SLMTKCWAYDPSRRPRFTELKAQL 266
Query: 484 SQLL 487
           S +L
Sbjct: 267 STIL 270

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 99/244 (40%), Gaps = 27/244 (11%)
Query: 246 DSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRE 305
           DS   +   E +T  Q  H +I+ L+  ++  +   ++ E    G L+  L      +  
Sbjct: 52  DSVREKFLQEALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQ---VRKFS 107
Query: 306 LDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG 365
           LD  S    A  +++ L YL    S   +H DI  RNVL++ +    + D GL+  + D 
Sbjct: 108 LDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 164
Query: 366 YTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLIS-LVRGVPSFVFHQNGEEIC 424
            T    S     + ++APE       +   D++ FG+ +   L+ GV  F   +N + I 
Sbjct: 165 -TXXKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG 223
Query: 425 SPEWLRKVMNSKNPSR-AIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRL 483
             E         N  R  + P  P   Y         +   C  +DP  RP    ++ +L
Sbjct: 224 RIE---------NGERLPMPPNCPPTLY--------SLMTKCWAYDPSRRPRFTELKAQL 266
Query: 484 SQLL 487
           S +L
Sbjct: 267 STIL 270

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 48/218 (22%), Positives = 89/218 (40%), Gaps = 27/218 (12%)
Query: 197 LEKIGSGGCGEVYKAE----LPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQI 252
           L ++G G  G VY+      + G     +A+K V             E + LR+      
Sbjct: 22  LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTV------------NESASLRERIEFLN 69
Query: 253 RSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDV------SRGRREL 306
            + ++      H  ++ LL  + +    L+V E M +G L+  L  +      + GR   
Sbjct: 70  EASVMKGFTCHH--VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP 127
Query: 307 DWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGY 366
                 ++A  +A G+ YL+   +   +H D+  RN ++  D    I D G+   I +  
Sbjct: 128 TLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETD 184
Query: 367 TRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
                   L  + ++APE  +    +   D++SFG++L
Sbjct: 185 XXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVL 222

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 37/105 (35%), Positives = 53/105 (50%), Gaps = 22/105 (20%)
Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLL-----NDDMEACISDLGLAMAIPDG-YTRVLI 371
             SGL +LH   S +I+H D+KP N+L+     +  ++A ISD GL   +  G ++    
Sbjct: 127 TTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRR 183
Query: 372 SYVLGTMAYIAPEYFQQPELSEKC--------DIFSFGMLLISLV 408
           S V GT  +IAPE      LSE C        DIFS G +   ++
Sbjct: 184 SGVPGTEGWIAPEM-----LSEDCKENPTYTVDIFSAGCVFYYVI 223

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 48/218 (22%), Positives = 89/218 (40%), Gaps = 27/218 (12%)
Query: 197 LEKIGSGGCGEVYKAE----LPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQI 252
           L ++G G  G VY+      + G     +A+K V             E + LR+      
Sbjct: 19  LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTV------------NESASLRERIEFLN 66
Query: 253 RSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDV------SRGRREL 306
            + ++      H  ++ LL  + +    L+V E M +G L+  L  +      + GR   
Sbjct: 67  EASVMKGFTCHH--VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP 124
Query: 307 DWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGY 366
                 ++A  +A G+ YL+   +   +H D+  RN ++  D    I D G+   I +  
Sbjct: 125 TLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETD 181
Query: 367 TRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
                   L  + ++APE  +    +   D++SFG++L
Sbjct: 182 XXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVL 219

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 48/218 (22%), Positives = 89/218 (40%), Gaps = 27/218 (12%)
Query: 197 LEKIGSGGCGEVYKAE----LPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQI 252
           L ++G G  G VY+      + G     +A+K V             E + LR+      
Sbjct: 22  LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTV------------NESASLRERIEFLN 69
Query: 253 RSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDV------SRGRREL 306
            + ++      H  ++ LL  + +    L+V E M +G L+  L  +      + GR   
Sbjct: 70  EASVMKGFTCHH--VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP 127
Query: 307 DWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGY 366
                 ++A  +A G+ YL+   +   +H D+  RN ++  D    I D G+   I +  
Sbjct: 128 TLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETD 184
Query: 367 TRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
                   L  + ++APE  +    +   D++SFG++L
Sbjct: 185 XXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVL 222

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 57/234 (24%), Positives = 100/234 (42%), Gaps = 40/234 (17%)
Query: 192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ 251
           D +  + K+G G  GEVYKA +     + +AIK++          L  E+  +  + +R 
Sbjct: 34  DRYRRITKLGEGTYGEVYKA-IDTVTNETVAIKRI---------RLEHEEEGVPGTAIR- 82
Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
              E+    +++HRNI+ L + +       L++E+ +N  L+  +D              
Sbjct: 83  ---EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMD------------KN 126
Query: 312 HRIALGVASGLEY-----LHMYHSASIIHGDIKPRNVLL--NDDMEAC---ISDLGLAMA 361
             +++ V     Y     ++  HS   +H D+KP+N+LL  +D  E     I D GLA A
Sbjct: 127 PDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186
Query: 362 IPDGYTRVLISYVLGTMAYIAPE-YFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
              G      ++ + T+ Y  PE        S   DI+S   +   ++   P F
Sbjct: 187 F--GIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLF 238

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 48/218 (22%), Positives = 89/218 (40%), Gaps = 27/218 (12%)
Query: 197 LEKIGSGGCGEVYKAE----LPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQI 252
           L ++G G  G VY+      + G     +A+K V             E + LR+      
Sbjct: 22  LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTV------------NESASLRERIEFLN 69
Query: 253 RSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDV------SRGRREL 306
            + ++      H  ++ LL  + +    L+V E M +G L+  L  +      + GR   
Sbjct: 70  EASVMKGFTCHH--VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP 127
Query: 307 DWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGY 366
                 ++A  +A G+ YL+   +   +H D+  RN ++  D    I D G+   I +  
Sbjct: 128 TLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETA 184
Query: 367 TRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
                   L  + ++APE  +    +   D++SFG++L
Sbjct: 185 YYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVL 222

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 62/289 (21%), Positives = 119/289 (41%), Gaps = 39/289 (13%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  GEVY+       G+ I +          A +  ++D  L D+K  +  SE +  
Sbjct: 16  LGEGFFGEVYEGVYTNHKGEKINV----------AVKTCKKDCTL-DNK-EKFMSEAVIM 63
Query: 260 SQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVA 319
             + H +I+ L+  ++  +   ++ E    G L   L+   R +  L   +    +L + 
Sbjct: 64  KNLDHPHIVKLIG-IIEEEPTWIIMELYPYGELGHYLE---RNKNSLKVLTLVLYSLQIC 119
Query: 320 SGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPD-GYTRVLISYVLGTM 378
             + YL    S + +H DI  RN+L+       + D GL+  I D  Y +  ++ +   +
Sbjct: 120 KAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PI 174
Query: 379 AYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSPEWLRKVMNSKN 437
            +++PE       +   D++ F + +  ++  G   F + +N + I        V+   +
Sbjct: 175 KWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI-------GVLEKGD 227
Query: 438 PSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL 486
                  RLP       +L+ L     C  +DP +RP    + C LS +
Sbjct: 228 -------RLPKPDLCPPVLYTLMTR--CWDYDPSDRPRFTELVCSLSDV 267

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 65/281 (23%), Positives = 123/281 (43%), Gaps = 42/281 (14%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           +  L+ +G GG G V+ A +     K +AIKK+++  P S    + E   +R    R   
Sbjct: 13  YMDLKPLGCGGNGLVFSA-VDNDCDKRVAIKKIVLTDPQSVKHALREIKIIR----RLDH 67
Query: 254 SEIITASQI---RHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPS 310
             I+   +I       +   +  +   +   +V E+M+     D+ + + +G   L+  +
Sbjct: 68  DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET----DLANVLEQGPL-LEEHA 122
Query: 311 RHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN-DDMEACISDLGLAMAIPDGYT-R 368
           R      +  GL+Y+H   SA+++H D+KP N+ +N +D+   I D GLA  +   Y+ +
Sbjct: 123 R-LFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHK 178
Query: 369 VLISYVLGTMAYIAPEYFQQP-ELSEKCDIFSFGMLLISLVRGVPSF------------- 414
             +S  L T  Y +P     P   ++  D+++ G +   ++ G   F             
Sbjct: 179 GHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLIL 238
Query: 415 -----VFHQNGEEICS--PEWLRKVMNSKNPSRAIDPRLPG 448
                V  ++ +E+ S  P ++R  M    P + +   LPG
Sbjct: 239 ESIPVVHEEDRQELLSVIPVYIRNDMTE--PHKPLTQLLPG 277

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 32/134 (23%), Positives = 56/134 (41%), Gaps = 27/134 (20%)
Query: 309 PSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVL--------LNDDMEAC-------- 352
           P    +A  +   L +LH      + H D+KP N+L        L ++ ++C        
Sbjct: 132 PHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNT 188
Query: 353 ---ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR 409
              ++D G A    + +T ++      T  Y  PE   +   ++ CD++S G +L    R
Sbjct: 189 SIRVADFGSATFDHEHHTTIV-----ATRHYRPPEVILELGWAQPCDVWSIGCILFEYYR 243
Query: 410 GVPSFVFHQNGEEI 423
           G   F  H+N E +
Sbjct: 244 GFTLFQTHENREHL 257

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 36/160 (22%), Positives = 63/160 (39%), Gaps = 38/160 (23%)
Query: 283 VYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRN 342
            +EF+K  + Q               P    +A  +   L +LH      + H D+KP N
Sbjct: 108 TFEFLKENNFQP-----------YPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPEN 153
Query: 343 VL--------LNDDMEAC-----------ISDLGLAMAIPDGYTRVLISYVLGTMAYIAP 383
           +L        L ++ ++C           ++D G A    + +T ++      T  Y  P
Sbjct: 154 ILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIV-----ATRHYRPP 208
Query: 384 EYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI 423
           E   +   ++ CD++S G +L    RG   F  H+N E +
Sbjct: 209 EVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL 248

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 62/289 (21%), Positives = 119/289 (41%), Gaps = 39/289 (13%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  GEVY+       G+ I +          A +  ++D  L D+K  +  SE +  
Sbjct: 32  LGEGFFGEVYEGVYTNHKGEKINV----------AVKTCKKDCTL-DNK-EKFMSEAVIM 79
Query: 260 SQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVA 319
             + H +I+ L+  ++  +   ++ E    G L   L+   R +  L   +    +L + 
Sbjct: 80  KNLDHPHIVKLIG-IIEEEPTWIIMELYPYGELGHYLE---RNKNSLKVLTLVLYSLQIC 135
Query: 320 SGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPD-GYTRVLISYVLGTM 378
             + YL    S + +H DI  RN+L+       + D GL+  I D  Y +  ++ +   +
Sbjct: 136 KAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PI 190
Query: 379 AYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSPEWLRKVMNSKN 437
            +++PE       +   D++ F + +  ++  G   F + +N + I        V+   +
Sbjct: 191 KWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI-------GVLEKGD 243
Query: 438 PSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL 486
                  RLP       +L+ L     C  +DP +RP    + C LS +
Sbjct: 244 -------RLPKPDLCPPVLYTLMTR--CWDYDPSDRPRFTELVCSLSDV 283

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 62/289 (21%), Positives = 119/289 (41%), Gaps = 39/289 (13%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  GEVY+       G+ I +          A +  ++D  L D+K  +  SE +  
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINV----------AVKTCKKDCTL-DNK-EKFMSEAVIM 67
Query: 260 SQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVA 319
             + H +I+ L+  ++  +   ++ E    G L   L+   R +  L   +    +L + 
Sbjct: 68  KNLDHPHIVKLIG-IIEEEPTWIIMELYPYGELGHYLE---RNKNSLKVLTLVLYSLQIC 123
Query: 320 SGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPD-GYTRVLISYVLGTM 378
             + YL    S + +H DI  RN+L+       + D GL+  I D  Y +  ++ +   +
Sbjct: 124 KAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PI 178
Query: 379 AYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSPEWLRKVMNSKN 437
            +++PE       +   D++ F + +  ++  G   F + +N + I        V+   +
Sbjct: 179 KWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI-------GVLEKGD 231
Query: 438 PSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL 486
                  RLP       +L+ L     C  +DP +RP    + C LS +
Sbjct: 232 -------RLPKPDLCPPVLYTLMTR--CWDYDPSDRPRFTELVCSLSDV 271

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 39/158 (24%), Positives = 75/158 (47%), Gaps = 13/158 (8%)
Query: 252 IRSEIITASQIRHRNILPLLAHMV---RPDCHLLVYEFMKNGSLQDILDDVSRGRRELDW 308
           ++ E++  + +  +   P +  M+     +  +LV E  + G L   L    +  R +  
Sbjct: 71  LKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYL----QQNRHVKD 126
Query: 309 PSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI--PDGY 366
            +   +   V+ G++YL     ++ +H D+  RNVLL     A ISD GL+ A+   + Y
Sbjct: 127 KNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 183
Query: 367 TRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
            +   ++    + + APE     + S K D++SFG+L+
Sbjct: 184 YKAQ-THGKWPVKWYAPECINYYKFSSKSDVWSFGVLM 220

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 39/158 (24%), Positives = 75/158 (47%), Gaps = 13/158 (8%)
Query: 252 IRSEIITASQIRHRNILPLLAHMV---RPDCHLLVYEFMKNGSLQDILDDVSRGRRELDW 308
           ++ E++  + +  +   P +  M+     +  +LV E  + G L   L    +  R +  
Sbjct: 71  LKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYL----QQNRHVKD 126
Query: 309 PSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI--PDGY 366
            +   +   V+ G++YL     ++ +H D+  RNVLL     A ISD GL+ A+   + Y
Sbjct: 127 KNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 183
Query: 367 TRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
            +   ++    + + APE     + S K D++SFG+L+
Sbjct: 184 YKAQ-THGKWPVKWYAPECINYYKFSSKSDVWSFGVLM 220

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 32/134 (23%), Positives = 56/134 (41%), Gaps = 27/134 (20%)
Query: 309 PSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVL--------LNDDMEAC-------- 352
           P    +A  +   L +LH      + H D+KP N+L        L ++ ++C        
Sbjct: 155 PHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNT 211
Query: 353 ---ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR 409
              ++D G A    + +T ++      T  Y  PE   +   ++ CD++S G +L    R
Sbjct: 212 SIRVADFGSATFDHEHHTTIV-----ATRHYRPPEVILELGWAQPCDVWSIGCILFEYYR 266
Query: 410 GVPSFVFHQNGEEI 423
           G   F  H+N E +
Sbjct: 267 GFTLFQTHENREHL 280

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 39/158 (24%), Positives = 74/158 (46%), Gaps = 13/158 (8%)
Query: 252 IRSEIITASQIRHRNILPLLAHMV---RPDCHLLVYEFMKNGSLQDILDDVSRGRRELDW 308
           ++ E++  + +  +   P +  M+     +  +LV E  + G L   L       R +  
Sbjct: 55  LKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQ----NRHVKD 110
Query: 309 PSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI--PDGY 366
            +   +   V+ G++YL     ++ +H D+  RNVLL     A ISD GL+ A+   + Y
Sbjct: 111 KNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 167
Query: 367 TRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
            +   ++    + + APE     + S K D++SFG+L+
Sbjct: 168 YKAQ-THGKWPVKWYAPECINYYKFSSKSDVWSFGVLM 204

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 48/218 (22%), Positives = 89/218 (40%), Gaps = 27/218 (12%)
Query: 197 LEKIGSGGCGEVYKAE----LPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQI 252
           L ++G G  G VY+      + G     +A+K V             E + LR+      
Sbjct: 22  LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTV------------NESASLRERIEFLN 69
Query: 253 RSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDV------SRGRREL 306
            + ++      H  ++ LL  + +    L+V E M +G L+  L  +      + GR   
Sbjct: 70  EASVMKGFTCHH--VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP 127
Query: 307 DWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGY 366
                 ++A  +A G+ YL+   +   +H D+  RN ++  D    I D G+   I +  
Sbjct: 128 TLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETD 184
Query: 367 TRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
                   L  + ++APE  +    +   D++SFG++L
Sbjct: 185 YYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVL 222

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 39/158 (24%), Positives = 74/158 (46%), Gaps = 13/158 (8%)
Query: 252 IRSEIITASQIRHRNILPLLAHMV---RPDCHLLVYEFMKNGSLQDILDDVSRGRRELDW 308
           ++ E++  + +  +   P +  M+     +  +LV E  + G L   L       R +  
Sbjct: 61  LKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQ----NRHVKD 116
Query: 309 PSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI--PDGY 366
            +   +   V+ G++YL     ++ +H D+  RNVLL     A ISD GL+ A+   + Y
Sbjct: 117 KNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 173
Query: 367 TRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
            +   ++    + + APE     + S K D++SFG+L+
Sbjct: 174 YKAQ-THGKWPVKWYAPECINYYKFSSKSDVWSFGVLM 210

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 39/158 (24%), Positives = 74/158 (46%), Gaps = 13/158 (8%)
Query: 252 IRSEIITASQIRHRNILPLLAHMV---RPDCHLLVYEFMKNGSLQDILDDVSRGRRELDW 308
           ++ E++  + +  +   P +  M+     +  +LV E  + G L   L       R +  
Sbjct: 49  LKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQ----NRHVKD 104
Query: 309 PSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI--PDGY 366
            +   +   V+ G++YL     ++ +H D+  RNVLL     A ISD GL+ A+   + Y
Sbjct: 105 KNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 161
Query: 367 TRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
            +   ++    + + APE     + S K D++SFG+L+
Sbjct: 162 YKAQ-THGKWPVKWYAPECINYYKFSSKSDVWSFGVLM 198

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 39/158 (24%), Positives = 74/158 (46%), Gaps = 13/158 (8%)
Query: 252 IRSEIITASQIRHRNILPLLAHMV---RPDCHLLVYEFMKNGSLQDILDDVSRGRRELDW 308
           ++ E++  + +  +   P +  M+     +  +LV E  + G L   L       R +  
Sbjct: 51  LKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQ----NRHVKD 106
Query: 309 PSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI--PDGY 366
            +   +   V+ G++YL     ++ +H D+  RNVLL     A ISD GL+ A+   + Y
Sbjct: 107 KNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 163
Query: 367 TRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
            +   ++    + + APE     + S K D++SFG+L+
Sbjct: 164 YKAQ-THGKWPVKWYAPECINYYKFSSKSDVWSFGVLM 200

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 49/89 (55%), Gaps = 6/89 (6%)
Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI--PDGYTRVLISYVL 375
           V+ G++YL     ++ +H D+  RNVLL     A ISD GL+ A+   + Y +   ++  
Sbjct: 478 VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ-THGK 533
Query: 376 GTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
             + + APE     + S K D++SFG+L+
Sbjct: 534 WPVKWYAPECINYYKFSSKSDVWSFGVLM 562

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 72/157 (45%), Gaps = 11/157 (7%)
Query: 252 IRSEIITASQIRHRNILPLLAHMV---RPDCHLLVYEFMKNGSLQDILDDVSRGRRELDW 308
           ++ E++  + +  +   P +  M+     +  +LV E  + G L   L       R +  
Sbjct: 55  LKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQ----NRHVKD 110
Query: 309 PSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI-PDGYT 367
            +   +   V+ G++YL     ++ +H D+  RNVLL     A ISD GL+ A+  D   
Sbjct: 111 KNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENX 167
Query: 368 RVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
               ++    + + APE     + S K D++SFG+L+
Sbjct: 168 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLM 204

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 29/105 (27%), Positives = 52/105 (49%), Gaps = 10/105 (9%)
Query: 322 LEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVL-----ISYVLG 376
           LE ++  H  +I+H D+KP+N+LL     + I  LG    +  G +R +     +  ++G
Sbjct: 141 LEGVYYLHQNNIVHLDLKPQNILL-----SSIYPLGDIKIVDFGMSRKIGHACELREIMG 195
Query: 377 TMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGE 421
           T  Y+APE      ++   D+++ G++   L+     FV   N E
Sbjct: 196 TPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE 240

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 98/244 (40%), Gaps = 27/244 (11%)
Query: 246 DSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRE 305
           DS   +   E +T  Q  H +I+ L+  ++  +   ++ E    G L+  L      +  
Sbjct: 432 DSVREKFLQEALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFL---QVRKFS 487
Query: 306 LDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG 365
           LD  S    A  +++ L YL    S   +H DI  RNVL++      + D GL+  + D 
Sbjct: 488 LDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDS 544
Query: 366 YTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLIS-LVRGVPSFVFHQNGEEIC 424
            T    S     + ++APE       +   D++ FG+ +   L+ GV  F   +N + I 
Sbjct: 545 -TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG 603
Query: 425 SPEWLRKVMNSKNPSR-AIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRL 483
             E         N  R  + P  P   Y         +   C  +DP  RP    ++ +L
Sbjct: 604 RIE---------NGERLPMPPNCPPTLY--------SLMTKCWAYDPSRRPRFTELKAQL 646
Query: 484 SQLL 487
           S +L
Sbjct: 647 STIL 650

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 39/158 (24%), Positives = 74/158 (46%), Gaps = 13/158 (8%)
Query: 252 IRSEIITASQIRHRNILPLLAHMV---RPDCHLLVYEFMKNGSLQDILDDVSRGRRELDW 308
           ++ E++  + +  +   P +  M+     +  +LV E  + G L   L       R +  
Sbjct: 69  LKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQ----NRHVKD 124
Query: 309 PSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI--PDGY 366
            +   +   V+ G++YL     ++ +H D+  RNVLL     A ISD GL+ A+   + Y
Sbjct: 125 KNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 181
Query: 367 TRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
            +   ++    + + APE     + S K D++SFG+L+
Sbjct: 182 YKAQ-THGKWPVKWYAPECINYYKFSSKSDVWSFGVLM 218

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 49/89 (55%), Gaps = 6/89 (6%)
Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI--PDGYTRVLISYVL 375
           V+ G++YL     ++ +H D+  RNVLL     A ISD GL+ A+   + Y +   ++  
Sbjct: 479 VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ-THGK 534
Query: 376 GTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
             + + APE     + S K D++SFG+L+
Sbjct: 535 WPVKWYAPECINYYKFSSKSDVWSFGVLM 563

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 98/244 (40%), Gaps = 27/244 (11%)
Query: 246 DSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRE 305
           DS   +   E +T  Q  H +I+ L+  ++  +   ++ E    G L+  L      +  
Sbjct: 52  DSVREKFLQEALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQ---VRKFS 107
Query: 306 LDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG 365
           LD  S    A  +++ L YL    S   +H DI  RNVL++      + D GL+  + D 
Sbjct: 108 LDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDS 164
Query: 366 YTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLIS-LVRGVPSFVFHQNGEEIC 424
            T    S     + ++APE       +   D++ FG+ +   L+ GV  F   +N + I 
Sbjct: 165 -TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG 223
Query: 425 SPEWLRKVMNSKNPSR-AIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRL 483
             E         N  R  + P  P   Y         +   C  +DP  RP    ++ +L
Sbjct: 224 RIE---------NGERLPMPPNCPPTLY--------SLMTKCWAYDPSRRPRFTELKAQL 266
Query: 484 SQLL 487
           S +L
Sbjct: 267 STIL 270

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/218 (22%), Positives = 89/218 (40%), Gaps = 27/218 (12%)
Query: 197 LEKIGSGGCGEVYKAE----LPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQI 252
           L ++G G  G VY+      + G     +A+K V             E + LR+      
Sbjct: 21  LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTV------------NESASLRERIEFLN 68
Query: 253 RSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDV------SRGRREL 306
            + ++      H  ++ LL  + +    L+V E M +G L+  L  +      + GR   
Sbjct: 69  EASVMKGFTCHH--VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP 126
Query: 307 DWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGY 366
                 ++A  +A G+ YL+   +   +H D+  RN ++  D    I D G+   I +  
Sbjct: 127 TLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETD 183
Query: 367 TRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
                   L  + ++APE  +    +   D++SFG++L
Sbjct: 184 YYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVL 221

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 74/174 (42%), Gaps = 12/174 (6%)
Query: 247 SKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQ--DILDDVSRGRR 304
           SK    ++E+   + I++   L     +   D   ++YE+M+N S+   D    V     
Sbjct: 85  SKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY 144
Query: 305 ELDWPSR--HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI 362
               P +    I   V +   Y+H  +  +I H D+KP N+L++ +    +SD G +  +
Sbjct: 145 TCFIPIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYM 202
Query: 363 PDGYTRVLISYVLGTMAYIAPEYFQQPELSE--KCDIFSFGMLLISLVRGVPSF 414
            D      I    GT  ++ PE+F         K DI+S G+ L  +   V  F
Sbjct: 203 VDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF 252

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/239 (22%), Positives = 99/239 (41%), Gaps = 55/239 (23%)
Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPIS--AAELIEEDSKLRDSKLRQIRS 254
           +  IG G  G V++A  PG          ++ Y P +  A ++++E++          + 
Sbjct: 52  VRDIGEGAFGRVFQARAPG----------LLPYEPFTMVAVKMLKEEASA--DMQADFQR 99
Query: 255 EIITASQIRHRNILPLLA--HMVRPDCHLLVYEFMKNGSLQDILDDVSR----------- 301
           E    ++  + NI+ LL    + +P C  L++E+M  G L + L  +S            
Sbjct: 100 EAALMAEFDNPNIVKLLGVCAVGKPMC--LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 157
Query: 302 ---------GRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC 352
                    G   L    +  IA  VA+G+ YL        +H D+  RN L+ ++M   
Sbjct: 158 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVK 214
Query: 353 ISDLGLAMAI-------PDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
           I+D GL+  I        DG   + I        ++ PE       + + D++++G++L
Sbjct: 215 IADFGLSRNIYSADYYKADGNDAIPIR-------WMPPESIFYNRYTTESDVWAYGVVL 266

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 63/270 (23%), Positives = 118/270 (43%), Gaps = 42/270 (15%)
Query: 177 SPLIEKEDLA----FLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPI 232
           SP  + E+L     FLK+++   +  ++G G  G V         G     KK I     
Sbjct: 317 SPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSV-------RQGVYRMRKKQI----D 365
Query: 233 SAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMV---RPDCHLLVYEFMKN 289
            A +++++ ++  D++      E++  +QI H+   P +  ++   + +  +LV E    
Sbjct: 366 VAIKVLKQGTEKADTE------EMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGG 419
Query: 290 GSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDM 349
           G L   L  V + R E+   +   +   V+ G++YL      + +H ++  RNVLL +  
Sbjct: 420 GPLHKFL--VGK-REEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRH 473
Query: 350 EACISDLGLAMAI-PDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLV 408
            A ISD GL+ A+  D       S     + + APE     + S + D++S+G+ +   +
Sbjct: 474 YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEAL 533
Query: 409 ----------RGVPSFVFHQNGEEI-CSPE 427
                     +G     F + G+ + C PE
Sbjct: 534 SYGQKPYKKMKGPEVMAFIEQGKRMECPPE 563

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 92/212 (43%), Gaps = 53/212 (25%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYA-----PISAAELIEEDSKLRDSK 248
           +  L KIG G  GEV+KA      G+ +A+KKV++       PI+A         LR+ K
Sbjct: 20  YEKLAKIGQGTFGEVFKAR-HRKTGQKVALKKVLMENEKEGFPITA---------LREIK 69
Query: 249 LRQIRSEIITASQIRHRNILPLLAHMVRPDCH---------LLVYEFMKNGSLQDILDDV 299
           + Q+         ++H N++ L+  + R              LV++F ++    D+   +
Sbjct: 70  ILQL---------LKHENVVNLI-EICRTKASPYNRCKGSIYLVFDFCEH----DLAGLL 115
Query: 300 SRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA 359
           S    +       R+   + +GL Y+H      I+H D+K  NVL+  D    ++D GLA
Sbjct: 116 SNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA 172
Query: 360 MAI-------PDGYTRVLISYVLGTMAYIAPE 384
            A        P+ Y   ++     T+ Y  PE
Sbjct: 173 RAFSLAKNSQPNRYXNRVV-----TLWYRPPE 199

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 101/245 (41%), Gaps = 51/245 (20%)
Query: 189 KKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSK 248
           K+ D F      G G  G V   +   S G  +AIKKVI            +D + R+ +
Sbjct: 20  KEMDRFQVERMAGQGTFGTVQLGK-EKSTGMSVAIKKVI------------QDPRFRNRE 66
Query: 249 LRQIRSEIITASQIRHRNILPLLAHMV------RPDCHL-LVYEFMKNGSLQDILDDVSR 301
           L QI  ++     + H NI+ L ++        R D +L +V E++      D L    R
Sbjct: 67  L-QIMQDLAV---LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-----DTLHRCCR 117
Query: 302 G--RRELDWPSR--HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLND-DMEACISDL 356
              RR++  P          +   +  LH+  S ++ H DIKP NVL+N+ D    + D 
Sbjct: 118 NYYRRQVAPPPILIKVFLFQLIRSIGCLHL-PSVNVCHRDIKPHNVLVNEADGTLKLCDF 176
Query: 357 GLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPEL-------SEKCDIFSFGMLLISLVR 409
           G A  +      V         AYI   Y++ PEL       +   DI+S G +   ++ 
Sbjct: 177 GSAKKLSPSEPNV---------AYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMML 227
Query: 410 GVPSF 414
           G P F
Sbjct: 228 GEPIF 232

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 61/265 (23%), Positives = 110/265 (41%), Gaps = 53/265 (20%)
Query: 191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
           +D +  + K+G G   EV++A    +N K++    V +  P+               K  
Sbjct: 36  QDDYQLVRKLGRGKYSEVFEAINITNNEKVV----VKILKPV---------------KKN 76
Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCH---LLVYEFMKNGSLQDILDDVSRGRRELD 307
           +I+ EI     +R    +  LA +V+        LV+E + N   + +   ++      D
Sbjct: 77  KIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLT------D 130
Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC-ISDLGLAMAIPDGY 366
           +  R  +   +   L+Y H   S  I+H D+KP NV+++ +     + D GLA     G 
Sbjct: 131 YDIRFYM-YEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 186
Query: 367 TRVLISYVLGTMAYIAPEYFQQPEL-------SEKCDIFSFGMLLISLV-RGVPSFVFHQ 418
                         +A  YF+ PEL           D++S G +L S++ R  P F  H 
Sbjct: 187 E---------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 237
Query: 419 NGEEICSPEWLRKVMNSKNPSRAID 443
           N +++     + KV+ +++    ID
Sbjct: 238 NYDQLVR---IAKVLGTEDLYDYID 259

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 94/215 (43%), Gaps = 59/215 (27%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYA-----PISAAELIEEDSKLRDSK 248
           +  L KIG G  GEV+KA      G+ +A+KKV++       PI+A         LR+ K
Sbjct: 19  YEKLAKIGQGTFGEVFKAR-HRKTGQKVALKKVLMENEKEGFPITA---------LREIK 68
Query: 249 LRQIRSEIITASQIRHRNILPLLAHMVRPDCH---------LLVYEFMKN---GSLQDIL 296
           + Q+         ++H N++ L+  + R              LV++F ++   G L ++L
Sbjct: 69  ILQL---------LKHENVVNLI-EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL 118
Query: 297 DDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDL 356
              +    +       R+   + +GL Y+H      I+H D+K  NVL+  D    ++D 
Sbjct: 119 VKFTLSEIK-------RVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADF 168
Query: 357 GLAMAI-------PDGYTRVLISYVLGTMAYIAPE 384
           GLA A        P+ Y   ++     T+ Y  PE
Sbjct: 169 GLARAFSLAKNSQPNRYXNRVV-----TLWYRPPE 198

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 51/105 (48%), Gaps = 21/105 (20%)
Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLN-------------DDMEACISDLGLAMAIPD 364
           +ASG+ +LH   S  IIH D+KP+N+L++             +++   ISD GL   +  
Sbjct: 142 IASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 198
Query: 365 GYT--RVLISYVLGTMAYIAPEYFQQP---ELSEKCDIFSFGMLL 404
           G    R  ++   GT  + APE  ++     L+   DIFS G + 
Sbjct: 199 GQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVF 243

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 51/105 (48%), Gaps = 21/105 (20%)
Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLN-------------DDMEACISDLGLAMAIPD 364
           +ASG+ +LH   S  IIH D+KP+N+L++             +++   ISD GL   +  
Sbjct: 142 IASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 198
Query: 365 GYT--RVLISYVLGTMAYIAPEYFQQP---ELSEKCDIFSFGMLL 404
           G    R  ++   GT  + APE  ++     L+   DIFS G + 
Sbjct: 199 GQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVF 243

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 92/212 (43%), Gaps = 53/212 (25%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYA-----PISAAELIEEDSKLRDSK 248
           +  L KIG G  GEV+KA      G+ +A+KKV++       PI+A         LR+ K
Sbjct: 20  YEKLAKIGQGTFGEVFKAR-HRKTGQKVALKKVLMENEKEGFPITA---------LREIK 69
Query: 249 LRQIRSEIITASQIRHRNILPLLAHMVRPDCH---------LLVYEFMKNGSLQDILDDV 299
           + Q+         ++H N++ L+  + R              LV++F ++    D+   +
Sbjct: 70  ILQL---------LKHENVVNLI-EICRTKASPYNRCKASIYLVFDFCEH----DLAGLL 115
Query: 300 SRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA 359
           S    +       R+   + +GL Y+H      I+H D+K  NVL+  D    ++D GLA
Sbjct: 116 SNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA 172
Query: 360 MAI-------PDGYTRVLISYVLGTMAYIAPE 384
            A        P+ Y   ++     T+ Y  PE
Sbjct: 173 RAFSLAKNSQPNRYXNRVV-----TLWYRPPE 199

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 96/230 (41%), Gaps = 41/230 (17%)
Query: 194 FASLEK-IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQI 252
           + +LE  IG G  GEV  A   G+  +  A KK+  Y        +E+        + + 
Sbjct: 10  YYTLENTIGRGSWGEVKIAVQKGTRIRRAA-KKIPKY-------FVED--------VDRF 53
Query: 253 RSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGR--RELDWPS 310
           + EI     + H NI+ L           LV E    G L    + V   R  RE D   
Sbjct: 54  KQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGEL---FERVVHKRVFRESD--- 107
Query: 311 RHRIALGVASGLEYLHMYHSASIIHGDIKPRNVL-LNDDMEACIS--DLGLAMAIPDGYT 367
             RI   V S + Y H     ++ H D+KP N L L D  ++ +   D GLA     G  
Sbjct: 108 AARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK- 163
Query: 368 RVLISYVLGTMAYIAPEYFQ---QPELSEKCDIFSFGMLLISLVRGVPSF 414
             ++   +GT  Y++P+  +    PE    CD +S G+++  L+ G P F
Sbjct: 164 --MMRTKVGTPYYVSPQVLEGLYGPE----CDEWSAGVMMYVLLCGYPPF 207

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 96/230 (41%), Gaps = 41/230 (17%)
Query: 194 FASLEK-IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQI 252
           + +LE  IG G  GEV  A   G+  +  A KK+  Y        +E+        + + 
Sbjct: 27  YYTLENTIGRGSWGEVKIAVQKGTRIRRAA-KKIPKY-------FVED--------VDRF 70
Query: 253 RSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGR--RELDWPS 310
           + EI     + H NI+ L           LV E    G L    + V   R  RE D   
Sbjct: 71  KQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGEL---FERVVHKRVFRESD--- 124
Query: 311 RHRIALGVASGLEYLHMYHSASIIHGDIKPRNVL-LNDDMEACIS--DLGLAMAIPDGYT 367
             RI   V S + Y H     ++ H D+KP N L L D  ++ +   D GLA     G  
Sbjct: 125 AARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG-- 179
Query: 368 RVLISYVLGTMAYIAPEYFQ---QPELSEKCDIFSFGMLLISLVRGVPSF 414
             ++   +GT  Y++P+  +    PE    CD +S G+++  L+ G P F
Sbjct: 180 -KMMRTKVGTPYYVSPQVLEGLYGPE----CDEWSAGVMMYVLLCGYPPF 224

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 92/212 (43%), Gaps = 53/212 (25%)
Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYA-----PISAAELIEEDSKLRDSK 248
           +  L KIG G  GEV+KA      G+ +A+KKV++       PI+A         LR+ K
Sbjct: 20  YEKLAKIGQGTFGEVFKAR-HRKTGQKVALKKVLMENEKEGFPITA---------LREIK 69
Query: 249 LRQIRSEIITASQIRHRNILPLLAHMVRPDCH---------LLVYEFMKNGSLQDILDDV 299
           + Q+         ++H N++ L+  + R              LV++F ++    D+   +
Sbjct: 70  ILQL---------LKHENVVNLI-EICRTKASPYNRCKGSIYLVFDFCEH----DLAGLL 115
Query: 300 SRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA 359
           S    +       R+   + +GL Y+H      I+H D+K  NVL+  D    ++D GLA
Sbjct: 116 SNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA 172
Query: 360 MAI-------PDGYTRVLISYVLGTMAYIAPE 384
            A        P+ Y   ++     T+ Y  PE
Sbjct: 173 RAFSLAKNSQPNRYXNRVV-----TLWYRPPE 199

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 82/188 (43%), Gaps = 26/188 (13%)
Query: 177 SPLIEKEDLAFLK--KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISA 234
           SP  E  + A L+  KE  F  ++ +GSG  G VYK  L    G+ + I       P++ 
Sbjct: 2   SPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKG-LWIPEGEKVKI-------PVAI 53
Query: 235 AELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQD 294
            EL E  S   +   ++I  E    + + + ++  LL   +     L++ + M  G L D
Sbjct: 54  KELREATSPKAN---KEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLD 109
Query: 295 IL---DDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA 351
            +    D    +  L+W       + +A G+ YL       ++H D+  RNVL+      
Sbjct: 110 YVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHV 160
Query: 352 CISDLGLA 359
            I+D GLA
Sbjct: 161 KITDFGLA 168

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 97/222 (43%), Gaps = 42/222 (18%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           I  GG G +Y A     NG+ + +K ++           + +++      RQ  +E++  
Sbjct: 88  IAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--------DAEAQAMAMAERQFLAEVV-- 137
Query: 260 SQIRHRNILPLLAHMVRPDCH-----LLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRI 314
               H +I+ +   +   D H      +V E++   SL+      S+G++    P    I
Sbjct: 138 ----HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKR-----SKGQK---LPVAEAI 185
Query: 315 A--LGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLIS 372
           A  L +   L YLH   S  +++ D+KP N++L ++    I DLG    I          
Sbjct: 186 AYLLEILPALSYLH---SIGLVYNDLKPENIMLTEEQLKLI-DLGAVSRINS------FG 235
Query: 373 YVLGTMAYIAPEYFQQ-PELSEKCDIFSFGMLLISLVRGVPS 413
           Y+ GT  + APE  +  P ++   DI++ G  L +L   +P+
Sbjct: 236 YLYGTPGFQAPEIVRTGPTVA--TDIYTVGRTLAALTLDLPT 275

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 51/106 (48%), Gaps = 25/106 (23%)
Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLN-------------DDMEACISDLGLAMAIPD 364
           +ASG+ +LH   S  IIH D+KP+N+L++             +++   ISD GL   +  
Sbjct: 124 IASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180
Query: 365 GYT--RVLISYVLGTMAYIAPEYFQQPE-------LSEKCDIFSFG 401
           G +  R  ++   GT  + APE  ++         L+   DIFS G
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMG 226

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 47/218 (21%), Positives = 89/218 (40%), Gaps = 27/218 (12%)
Query: 197 LEKIGSGGCGEVYKAE----LPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQI 252
           L ++G G  G VY+      + G     +A+K V             E + LR+      
Sbjct: 22  LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTV------------NESASLRERIEFLN 69
Query: 253 RSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDV------SRGRREL 306
            + ++      H  ++ LL  + +    L+V E M +G L+  L  +      + GR   
Sbjct: 70  EASVMKGFTCHH--VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP 127
Query: 307 DWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGY 366
                 ++A  +A G+ YL+   +   +H ++  RN ++  D    I D G+   I +  
Sbjct: 128 TLQEMIQMAAEIADGMAYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETD 184
Query: 367 TRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
                   L  + ++APE  +    +   D++SFG++L
Sbjct: 185 YYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVL 222

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 47/218 (21%), Positives = 89/218 (40%), Gaps = 27/218 (12%)
Query: 197 LEKIGSGGCGEVYKAE----LPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQI 252
           L ++G G  G VY+      + G     +A+K V             E + LR+      
Sbjct: 23  LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTV------------NESASLRERIEFLN 70
Query: 253 RSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDV------SRGRREL 306
            + ++      H  ++ LL  + +    L+V E M +G L+  L  +      + GR   
Sbjct: 71  EASVMKGFTCHH--VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP 128
Query: 307 DWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGY 366
                 ++A  +A G+ YL+   +   +H ++  RN ++  D    I D G+   I +  
Sbjct: 129 TLQEMIQMAAEIADGMAYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETD 185
Query: 367 TRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
                   L  + ++APE  +    +   D++SFG++L
Sbjct: 186 YYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVL 223

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 73/167 (43%), Gaps = 14/167 (8%)
Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQD-ILDDVSRGRRELDWPS 310
           ++ E+  +    H NI+P  A  +  +   +V  FM  GS +D I      G  EL   +
Sbjct: 73  LQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNEL---A 129
Query: 311 RHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDL--GLAMAIPDGYTR 368
              I  GV   L+Y+   H    +H  +K  ++L++ D +  +S L   L+M       R
Sbjct: 130 IAYILQGVLKALDYI---HHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQR 186
Query: 369 VL---ISYVLGTMAYIAPEYFQQ--PELSEKCDIFSFGMLLISLVRG 410
           V+     Y +  + +++PE  QQ       K DI+S G+    L  G
Sbjct: 187 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANG 233

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 73/167 (43%), Gaps = 14/167 (8%)
Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQD-ILDDVSRGRRELDWPS 310
           ++ E+  +    H NI+P  A  +  +   +V  FM  GS +D I      G  EL   +
Sbjct: 57  LQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNEL---A 113
Query: 311 RHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDL--GLAMAIPDGYTR 368
              I  GV   L+Y+   H    +H  +K  ++L++ D +  +S L   L+M       R
Sbjct: 114 IAYILQGVLKALDYI---HHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQR 170
Query: 369 VL---ISYVLGTMAYIAPEYFQQ--PELSEKCDIFSFGMLLISLVRG 410
           V+     Y +  + +++PE  QQ       K DI+S G+    L  G
Sbjct: 171 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANG 217

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 81/189 (42%), Gaps = 26/189 (13%)
Query: 176 FSPLIEKEDLAFLK--KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPIS 233
            +P  E  + A L+  KE  F  ++ +GSG  G VYK  L    G+ + I       P++
Sbjct: 31  LTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKG-LWIPEGEKVKI-------PVA 82
Query: 234 AAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQ 293
             EL E  S   +   ++I  E    + + + ++  LL   +     L+  + M  G L 
Sbjct: 83  IMELREATSPKAN---KEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLL 138
Query: 294 DIL---DDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME 350
           D +    D    +  L+W       + +A G+ YL       ++H D+  RNVL+     
Sbjct: 139 DYVREHKDNIGSQYLLNW------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQH 189
Query: 351 ACISDLGLA 359
             I+D GLA
Sbjct: 190 VKITDFGLA 198

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 66/167 (39%), Gaps = 40/167 (23%)
Query: 281 LLVYEFMK-NGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIK 339
           L  Y+F+K NG L   LD + +            +A  +   + +LH   S  + H D+K
Sbjct: 101 LSTYDFIKENGFLPFRLDHIRK------------MAYQICKSVNFLH---SNKLTHTDLK 145
Query: 340 PRNVLL--NDDMEAC-----------------ISDLGLAMAIPDGYTRVLISYVLGTMAY 380
           P N+L   +D  EA                  + D G A    D +   L+S    T  Y
Sbjct: 146 PENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA-TYDDEHHSTLVS----TRHY 200
Query: 381 IAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPE 427
            APE       S+ CD++S G +LI    G   F  H + E +   E
Sbjct: 201 RAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMME 247

>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 96/221 (43%), Gaps = 34/221 (15%)
Query: 199 KIGSGGCGEVYKAELPGSNGKM-IAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           KIGSG  GE+Y      +N ++ I ++ V    P    +L+ E      SK+ +I     
Sbjct: 14  KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLLYE------SKIYRILQGGT 63
Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALG 317
               +R           V  D ++LV + +   SL+D+ +  SR   +L   +   +A  
Sbjct: 64  GIPNVRW--------FGVEGDYNVLVMDLL-GPSLEDLFNFCSR---KLSLKTVLMLADQ 111
Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA---CISDLGLAMAIPDGYTRVLISY- 373
           + + +E++H   S S +H DIKP N L+     A    I D GLA    D  T   I Y 
Sbjct: 112 MINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYR 168
Query: 374 ----VLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRG 410
               + GT  Y +       E S + D+ S G +L+  +RG
Sbjct: 169 ENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRG 209

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 50/106 (47%), Gaps = 25/106 (23%)
Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLN-------------DDMEACISDLGLAMAIPD 364
           +ASG+ +LH   S  IIH D+KP+N+L++             +++   ISD GL   +  
Sbjct: 124 IASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180
Query: 365 GYT--RVLISYVLGTMAYIAPEYFQQPE-------LSEKCDIFSFG 401
           G    R  ++   GT  + APE  ++         L+   DIFS G
Sbjct: 181 GQXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMG 226

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 75/173 (43%), Gaps = 24/173 (13%)
Query: 190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKL 249
           KE  F  ++ +GSG  G VYK  L    G+ + I       P++  EL E  S   +   
Sbjct: 14  KETEFKKIKVLGSGAFGTVYKG-LWIPEGEKVKI-------PVAIKELREATSPKAN--- 62
Query: 250 RQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDIL---DDVSRGRREL 306
           ++I  E    + + + ++  LL   +     L++ + M  G L D +    D    +  L
Sbjct: 63  KEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGXLLDYVREHKDNIGSQYLL 121
Query: 307 DWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA 359
           +W       + +A G+ YL       ++H D+  RNVL+       I+D GLA
Sbjct: 122 NW------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLA 165

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 98/233 (42%), Gaps = 37/233 (15%)
Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +GSGG G VY   +  S+   +AIK V         + I +  +L +     +   ++  
Sbjct: 16  LGSGGFGSVYSG-IRVSDNLPVAIKHV-------EKDRISDWGELPNGTRVPMEVVLLKK 67
Query: 260 SQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVS-RGR------RELDWPSRH 312
                  ++ LL    RPD  +L+ E M+   +QD+ D ++ RG       R   W    
Sbjct: 68  VSSGFSGVIRLLDWFERPDSFVLILERME--PVQDLFDFITERGALQEELARSFFW---- 121
Query: 313 RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN-DDMEACISDLGLAMAIPDGYTRVLI 371
                    LE +   H+  ++H DIK  N+L++ +  E  + D G    + D     + 
Sbjct: 122 -------QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD----TVY 170
Query: 372 SYVLGTMAYIAPEYFQQPELSEK-CDIFSFGMLLISLVRGVPSFVFHQNGEEI 423
           +   GT  Y  PE+ +      +   ++S G+LL  +V G   F   ++ EEI
Sbjct: 171 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF---EHDEEI 220

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 75/173 (43%), Gaps = 24/173 (13%)
Query: 190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKL 249
           KE  F  ++ +GSG  G VYK  L    G+ + I       P++  EL E  S   +   
Sbjct: 13  KETEFKKIKVLGSGAFGTVYKG-LWIPEGEKVKI-------PVAIKELREATSPKAN--- 61
Query: 250 RQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDIL---DDVSRGRREL 306
           ++I  E    + + + ++  LL   +     L++ + M  G L D +    D    +  L
Sbjct: 62  KEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLL 120
Query: 307 DWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA 359
           +W       + +A G+ YL       ++H D+  RNVL+       I+D GLA
Sbjct: 121 NW------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLA 164

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 74/173 (42%), Gaps = 24/173 (13%)
Query: 190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKL 249
           KE  F  ++ +GSG  G VYK  L    G+ + I       P++  EL E  S   +   
Sbjct: 38  KETEFKKIKVLGSGAFGTVYKG-LWIPEGEKVKI-------PVAIKELREATSPKAN--- 86
Query: 250 RQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDIL---DDVSRGRREL 306
           ++I  E    + + + ++  LL   +     L+  + M  G L D +    D    +  L
Sbjct: 87  KEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLL 145
Query: 307 DWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA 359
           +W       + +A G+ YL       ++H D+  RNVL+       I+D GLA
Sbjct: 146 NW------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLA 189

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 74/173 (42%), Gaps = 24/173 (13%)
Query: 190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKL 249
           KE  F  ++ +GSG  G VYK  L    G+ + I       P++  EL E  S   +   
Sbjct: 13  KETEFKKIKVLGSGAFGTVYKG-LWIPEGEKVKI-------PVAIKELREATSPKAN--- 61
Query: 250 RQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDIL---DDVSRGRREL 306
           ++I  E    + + + ++  LL   +     L+  + M  G L D +    D    +  L
Sbjct: 62  KEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGXLLDYVREHKDNIGSQYLL 120
Query: 307 DWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA 359
           +W       + +A G+ YL       ++H D+  RNVL+       I+D GLA
Sbjct: 121 NW------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLA 164

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 75/173 (43%), Gaps = 24/173 (13%)
Query: 190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKL 249
           KE  F  ++ +GSG  G VYK  L    G+ + I       P++  EL E  S   +   
Sbjct: 14  KETEFKKIKVLGSGAFGTVYKG-LWIPEGEKVKI-------PVAIKELREATSPKAN--- 62
Query: 250 RQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDIL---DDVSRGRREL 306
           ++I  E    + + + ++  LL   +     L++ + M  G L D +    D    +  L
Sbjct: 63  KEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLL 121
Query: 307 DWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA 359
           +W       + +A G+ YL       ++H D+  RNVL+       I+D GLA
Sbjct: 122 NW------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLA 165

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 74/173 (42%), Gaps = 24/173 (13%)
Query: 190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKL 249
           KE  F  ++ +GSG  G VYK  L    G+ + I       P++  EL E  S   +   
Sbjct: 23  KETEFKKIKVLGSGAFGTVYKG-LWIPEGEKVKI-------PVAIKELREATSPKAN--- 71
Query: 250 RQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDIL---DDVSRGRREL 306
           ++I  E    + + + ++  LL   +     L+  + M  G L D +    D    +  L
Sbjct: 72  KEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLL 130
Query: 307 DWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA 359
           +W       + +A G+ YL       ++H D+  RNVL+       I+D GLA
Sbjct: 131 NW------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLA 174

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 51/111 (45%), Gaps = 4/111 (3%)
Query: 315 ALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYV 374
           +  VA G+E+L    S   IH D+  RN+LL++     I D GLA  I      V     
Sbjct: 204 SFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 260
Query: 375 LGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEIC 424
              + ++APE       + + D++SFG+LL  +   G   +   +  EE C
Sbjct: 261 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 311

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 75/173 (43%), Gaps = 24/173 (13%)
Query: 190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKL 249
           KE  F  ++ +GSG  G VYK  L    G+ + I       P++  EL E  S   +   
Sbjct: 15  KETEFKKIKVLGSGAFGTVYKG-LWIPEGEKVKI-------PVAIKELREATSPKAN--- 63
Query: 250 RQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDIL---DDVSRGRREL 306
           ++I  E    + + + ++  LL   +     L++ + M  G L D +    D    +  L
Sbjct: 64  KEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLL 122
Query: 307 DWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA 359
           +W       + +A G+ YL       ++H D+  RNVL+       I+D GLA
Sbjct: 123 NW------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLA 166

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 74/173 (42%), Gaps = 24/173 (13%)
Query: 190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKL 249
           KE  F  ++ +GSG  G VYK  L    G+ + I       P++  EL E  S   +   
Sbjct: 13  KETEFKKIKVLGSGAFGTVYKG-LWIPEGEKVKI-------PVAIKELREATSPKAN--- 61
Query: 250 RQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDIL---DDVSRGRREL 306
           ++I  E    + + + ++  LL   +     L+  + M  G L D +    D    +  L
Sbjct: 62  KEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLL 120
Query: 307 DWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA 359
           +W       + +A G+ YL       ++H D+  RNVL+       I+D GLA
Sbjct: 121 NW------CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLA 164

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 30/114 (26%), Positives = 52/114 (45%), Gaps = 29/114 (25%)
Query: 321 GLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI---PDGYTRVLISYVLGT 377
           G++Y+H   SA I+H D+KP N L+N D    + D GLA  +    +G +++ IS     
Sbjct: 168 GVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDD 224
Query: 378 M----------------AYIAPEYFQQPEL-------SEKCDIFSFGMLLISLV 408
           M                 ++   +++ PEL       +E  D++S G +   L+
Sbjct: 225 MNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 33/108 (30%), Positives = 50/108 (46%), Gaps = 4/108 (3%)
Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGT 377
           VA G+E+L    S   IH D+  RN+LL++     I D GLA  I      V        
Sbjct: 200 VAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 378 MAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEIC 424
           + ++APE       + + D++SFG+LL  +   G   +   +  EE C
Sbjct: 257 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 304

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	487
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-80
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	8e-69
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	7e-67
3soc_A	322	Activin receptor type-2A; structural genomics cons	3e-59
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	6e-49
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-48
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-48
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-47
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-46
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-45
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-44
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-44
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	7e-44
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	4e-43
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	4e-42
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-38
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	4e-38
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	3e-37
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	5e-33
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-30
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	3e-29
3an0_A	340	Dual specificity mitogen-activated protein kinase;	3e-28
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	7e-28
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	9e-28
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-27
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-27
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-27
3fme_A	290	Dual specificity mitogen-activated protein kinase;	3e-27
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-27
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	3e-27
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	4e-27
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	5e-27
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	8e-27
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	9e-27
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-26
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-26
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-26
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	4e-26
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	7e-26
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	7e-26
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	7e-26
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	8e-26
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-25
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-25
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-25
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-25
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	4e-25
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-24
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-24
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-24
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-24
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-24
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-24
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-24
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	3e-24
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-24
3aln_A	327	Dual specificity mitogen-activated protein kinase;	3e-24
2a19_B	284	Interferon-induced, double-stranded RNA-activated	5e-24
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	8e-24
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-23
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-23
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-23
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-23
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-23
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-23
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-23
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-23
2dyl_A	318	Dual specificity mitogen-activated protein kinase	4e-23
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	4e-23
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	4e-23
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	5e-23
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	7e-23
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	9e-23
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-22
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-22
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-22
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-22
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-22
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	3e-22
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	3e-22
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-22
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	7e-22
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-21
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-21
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-21
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-21
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-21
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-21
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-21
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-21
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-21
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-21
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-21
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-21
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	4e-21
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	5e-21
3ork_A	311	Serine/threonine protein kinase; structural genomi	6e-21
3pls_A	298	Macrophage-stimulating protein receptor; protein k	8e-21
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-20
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-20
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	3e-20
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	3e-20
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	3e-20
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	4e-20
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	4e-20
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	5e-20
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	6e-20
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	6e-20
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	8e-20
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	9e-20
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	9e-20
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	9e-20
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-19
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-19
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-19
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-19
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-19
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-19
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-19
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-19
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-19
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	4e-19
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	7e-19
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	8e-19
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	8e-19
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-18
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-18
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-18
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-18
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-18
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-18
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-18
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-18
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-18
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-18
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-18
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	3e-18
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	4e-18
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	5e-18
3niz_A	311	Rhodanese family protein; structural genomics, str	5e-18
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	6e-18
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	6e-18
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	9e-18
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-17
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-17
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-17
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-17
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-17
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-17
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	3e-17
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	4e-17
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	4e-17
3uqc_A	286	Probable conserved transmembrane protein; structur	4e-17
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	5e-17
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	5e-17
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	5e-17
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	6e-17
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	6e-17
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	9e-17
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	9e-17
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-16
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-16
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-16
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-16
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-16
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-16
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-16
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-16
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-16
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-16
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-16
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-16
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	5e-16
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	6e-16
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	7e-16
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	8e-16
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-15
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-15
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-15
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-15
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-15
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-15
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	5e-15
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	5e-15
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	5e-15
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	6e-15
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	6e-15
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	6e-15
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-14
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	3e-14
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	4e-14
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	6e-14
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	8e-14
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-13
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-13
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-13
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-13
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	4e-13
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	5e-13
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	9e-13
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-12
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	4e-12
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	7e-12
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	9e-12
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	6e-11
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	9e-11
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-10
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-10
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-10
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	4e-05
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	4e-10
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	5e-10
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-09
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	7e-09
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	8e-09
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-08
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-08
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-08
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-08
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	7e-08
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	7e-08
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	8e-08
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	9e-08
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-07
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-07
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-07
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-07
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	7e-07
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	8e-07
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-06
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-06
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-06
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	5e-06
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-06
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-06
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	3e-06
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-05
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	3e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  252 bits (645), Expect = 2e-80
 Identities = 101/292 (34%), Positives = 161/292 (55%), Gaps = 20/292 (6%)

Query: 192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ 251
           D F++   +G GG G+VYK  L   +G ++A+K+           L EE ++  +    Q
Sbjct: 30  DNFSNKNILGRGGFGKVYKGRLA--DGTLVAVKR-----------LKEERTQGGE---LQ 73

Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
            ++E+   S   HRN+L L    + P   LLVY +M NGS+   L +    +  LDWP R
Sbjct: 74  FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKR 133

Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLI 371
            RIALG A GL YLH +    IIH D+K  N+LL+++ EA + D GLA  +    T V  
Sbjct: 134 QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV-T 192

Query: 372 SYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ--NGEEICSPEWL 429
           + V GT+ +IAPEY    + SEK D+F +G++L+ L+ G  +F   +  N +++   +W+
Sbjct: 193 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252

Query: 430 RKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPN-SQYVR 480
           + ++  K     +D  L GN  ++++  ++++A +CT   P ERP  S+ VR
Sbjct: 253 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVR 304

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  222 bits (567), Expect = 8e-69
 Identities = 79/297 (26%), Positives = 134/297 (45%), Gaps = 35/297 (11%)

Query: 192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSK--L 249
           + F     IG G  G+VYK  L   +G  +A+K+                    +S   +
Sbjct: 39  NNFDHKFLIGHGVFGKVYKGVLR--DGAKVALKRR-----------------TPESSQGI 79

Query: 250 RQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWP 309
            +  +EI T S  RH +++ L+      +  +L+Y++M+NG+L+  L         + W 
Sbjct: 80  EEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWE 139

Query: 310 SRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGY--- 366
            R  I +G A GL YLH   + +IIH D+K  N+LL+++    I+D G++    +     
Sbjct: 140 QRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTH 196

Query: 367 --TRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEIC 424
             T V      GT+ YI PEYF +  L+EK D++SFG++L  ++    + V     E + 
Sbjct: 197 LSTVVK-----GTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVN 251

Query: 425 SPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPN-SQYVR 480
             EW  +  N+    + +DP L      + +      A  C     E+RP+    + 
Sbjct: 252 LAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLW 308

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  216 bits (552), Expect = 7e-67
 Identities = 83/286 (29%), Positives = 137/286 (47%), Gaps = 28/286 (9%)

Query: 199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSK--LRQIRSEI 256
           K+G GG G VYK  +   N   +A+KK+                    ++   +Q   EI
Sbjct: 38  KMGEGGFGVVYKGYV---NNTTVAVKKL-------------AAMVDITTEELKQQFDQEI 81

Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL 316
              ++ +H N++ LL      D   LVY +M NGSL D L     G   L W  R +IA 
Sbjct: 82  KVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC-LDGTPPLSWHMRCKIAQ 140

Query: 317 GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLG 376
           G A+G+ +LH       IH DIK  N+LL++   A ISD GLA A       V+ S ++G
Sbjct: 141 GAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVG 197

Query: 377 TMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSK 436
           T AY+APE  +  E++ K DI+SFG++L+ ++ G+P+   H+  + +   +   ++ + +
Sbjct: 198 TTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL--DIKEEIEDEE 254

Query: 437 NP-SRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPN-SQYVR 480
                 ID ++  +     +  +  +A  C      +RP+  +  +
Sbjct: 255 KTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQ 299

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  196 bits (501), Expect = 3e-59
 Identities = 74/318 (23%), Positives = 123/318 (38%), Gaps = 46/318 (14%)

Query: 191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
                 LE    G  G V+KA+L     + +A+K            + ++ S        
Sbjct: 23  SMPLQLLEVKARGRFGCVWKAQL---LNEYVAVKIF---------PIQDKQSWQN----- 65

Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCH----LLVYEFMKNGSLQDILDDVSRGRREL 306
               E+ +   ++H NIL  +    R         L+  F + GSL D L         +
Sbjct: 66  --EYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK-----ANVV 118

Query: 307 DWPSRHRIALGVASGLEYLHMYHSAS-------IIHGDIKPRNVLLNDDMEACISDLGLA 359
            W     IA  +A GL YLH             I H DIK +NVLL +++ ACI+D GLA
Sbjct: 119 SWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA 178

Query: 360 MAIPDGYTRVLISYVLGTMAYIAPEYFQ-----QPELSEKCDIFSFGMLLISLVRGVPSF 414
           +    G +       +GT  Y+APE  +     Q +   + D+++ G++L  L     + 
Sbjct: 179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAA 238

Query: 415 VFHQNGEEICSPEWLRKV-----MNSKNPSRAIDPRLPGNGYEKKMLHVL-KIAYICTLH 468
               +   +   E + +      M      +   P L     +   + +L +    C  H
Sbjct: 239 DGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDH 298

Query: 469 DPEERPNSQYVRCRLSQL 486
           D E R ++  V  R++Q+
Sbjct: 299 DAEARLSAGCVGERITQM 316

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  170 bits (431), Expect = 6e-49
 Identities = 72/325 (22%), Positives = 119/325 (36%), Gaps = 61/325 (18%)

Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           E IG G  G VYK  L   + + +A+K   V++  +    I E               I 
Sbjct: 19  ELIGRGRYGAVYKGSL---DERPVAVK---VFSFANRQNFINE-------------KNIY 59

Query: 258 TASQIRHRNILPLLAHMVRPDCH-----LLVYEFMKNGSLQDILDDVSRGRRELDWPSRH 312
               + H NI   +    R         LLV E+  NGSL   L          DW S  
Sbjct: 60  RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS-----LHTSDWVSSC 114

Query: 313 RIALGVASGLEYLHM------YHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGY 366
           R+A  V  GL YLH       ++  +I H D+  RNVL+ +D    ISD GL+M +    
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174

Query: 367 TRVLIS------YVLGTMAYIAPEYFQQ-------PELSEKCDIFSFGMLLISLVRGVPS 413
                         +GT+ Y+APE  +            ++ D+++ G++   +      
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234

Query: 414 FVFHQNGEEI-----------CSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIA 462
               ++  E             + E ++ +++ +            N    + L   +  
Sbjct: 235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSL--KETI 292

Query: 463 YICTLHDPEERPNSQYVRCRLSQLL 487
             C   D E R  +Q    R+++L+
Sbjct: 293 EDCWDQDAEARLTAQXAEERMAELM 317

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  167 bits (426), Expect = 2e-48
 Identities = 77/311 (24%), Positives = 129/311 (41%), Gaps = 54/311 (17%)

Query: 179 LIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELI 238
           +I+ +++            E +G G  G V KA+      K +AIK++            
Sbjct: 4   MIDYKEIEVE---------EVVGRGAFGVVCKAKW---RAKDVAIKQI------------ 39

Query: 239 EEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDD 298
                  +S+ +    E+   S++ H NI+ L    + P C  LV E+ + GSL ++L  
Sbjct: 40  -----ESESERKAFIVELRQLSRVNHPNIVKLYGACLNPVC--LVMEYAEGGSLYNVLHG 92

Query: 299 VSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC-ISDLG 357
            +               L  + G+ YLH     ++IH D+KP N+LL        I D G
Sbjct: 93  -AEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFG 151

Query: 358 LAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLV-RGVPSFVF 416
            A  I    T        G+ A++APE F+    SEKCD+FS+G++L  ++ R  P    
Sbjct: 152 TACDIQTHMTN-----NKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPF--- 203

Query: 417 HQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNS 476
               +EI  P +          +R   P L      K +  ++     C   DP +RP+ 
Sbjct: 204 ----DEIGGPAFRIMWAVHNG-TR---PPLI-KNLPKPIESLMT---RCWSKDPSQRPSM 251

Query: 477 QYVRCRLSQLL 487
           + +   ++ L+
Sbjct: 252 EEIVKIMTHLM 262

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  168 bits (427), Expect = 3e-48
 Identities = 77/342 (22%), Positives = 131/342 (38%), Gaps = 63/342 (18%)

Query: 172 GPTIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAP 231
           G  +       + +  +         ++IG G  GEV+  +     G+ +A+K       
Sbjct: 26  GLPLLVQRTIAKQIQMV---------KQIGKGRYGEVWMGKW---RGEKVAVKVF----- 68

Query: 232 ISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDC----HLLVYEFM 287
                         +       +EI     +RH NIL  +A  ++         L+ ++ 
Sbjct: 69  -----------FTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYH 117

Query: 288 KNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHM-----YHSASIIHGDIKPRN 342
           +NGSL D L         LD  S  ++A    SGL +LH          +I H D+K +N
Sbjct: 118 ENGSLYDYLK-----STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKN 172

Query: 343 VLLNDDMEACISDLGLAMAIPDGYTRVLIS--YVLGTMAYIAPE------YFQQPELSEK 394
           +L+  +   CI+DLGLA+        V I     +GT  Y+ PE           +    
Sbjct: 173 ILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIM 232

Query: 395 CDIFSFGMLLISLVRGVPSFV--------FHQNGEEICSPEWLRKVMNSKNPSRAIDPRL 446
            D++SFG++L  + R   S          +H       S E +R+++  K   R   P  
Sbjct: 233 ADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKK-LR---PSF 288

Query: 447 PGNGYEKKMLHVL-KIAYICTLHDPEERPNSQYVRCRLSQLL 487
           P      + L  + K+   C  H+P  R  +  V+  L+++ 
Sbjct: 289 PNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS 330

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  165 bits (420), Expect = 1e-47
 Identities = 80/316 (25%), Positives = 135/316 (42%), Gaps = 54/316 (17%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           LE +G G  GEV++       G+ +A+K              +E S  R++       E+
Sbjct: 13  LECVGKGRYGEVWRGSW---QGENVAVKIF---------SSRDEKSWFRET-------EL 53

Query: 257 ITASQIRHRNILPLLAHMVRPDC----HLLVYEFMKNGSLQDILDDVSRGRRELDWPSRH 312
                +RH NIL  +A  +          L+  + + GSL D L         LD  S  
Sbjct: 54  YNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL-----QLTTLDTVSCL 108

Query: 313 RIALGVASGLEYLHMYHSAS-----IIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
           RI L +ASGL +LH+    +     I H D+K +N+L+  + + CI+DLGLA+       
Sbjct: 109 RIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTN 168

Query: 368 RVLISY--VLGTMAYIAPE------YFQQPELSEKCDIFSFGMLLISLVRGVPSFV---- 415
           ++ +     +GT  Y+APE           +  ++ DI++FG++L  + R + S      
Sbjct: 169 QLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED 228

Query: 416 ----FHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVL-KIAYICTLHDP 470
               F+       S E +RKV+      R   P +P   +    L  L K+   C   +P
Sbjct: 229 YKPPFYDVVPNDPSFEDMRKVVCVDQ-QR---PNIPNRWFSDPTLTSLAKLMKECWYQNP 284

Query: 471 EERPNSQYVRCRLSQL 486
             R  +  ++  L+++
Sbjct: 285 SARLTALRIKKTLTKI 300

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  159 bits (403), Expect = 3e-45
 Identities = 59/239 (24%), Positives = 100/239 (41%), Gaps = 36/239 (15%)

Query: 173 PTIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPI 232
           P    P +   ++ +          ++IG GG G V+K  L   +  ++AIK +I+    
Sbjct: 9   PKSRLPTLADNEIEYE---------KQIGKGGFGLVHKGRLV-KDKSVVAIKSLILGD-- 56

Query: 233 SAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSL 292
                  E       K ++ + E+   S + H NI+ L   M  P    +V EF+  G L
Sbjct: 57  ------SEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDL 108

Query: 293 QDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC 352
              L         + W  + R+ L +A G+EY+    +  I+H D++  N+ L    E  
Sbjct: 109 YHRL---LDKAHPIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENA 164

Query: 353 -----ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPEL--SEKCDIFSFGMLL 404
                ++D GL+       +      +LG   ++APE     E   +EK D +SF M+L
Sbjct: 165 PVCAKVADFGLSQQSVHSVSG-----LLGNFQWMAPETIGAEEESYTEKADTYSFAMIL 218

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  158 bits (401), Expect = 1e-44
 Identities = 57/207 (27%), Positives = 100/207 (48%), Gaps = 20/207 (9%)

Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           EKIG+G  G V++AE    +G  +A+K +              +      ++ +   E+ 
Sbjct: 43  EKIGAGSFGTVHRAEW---HGSDVAVKIL-------------MEQDFHAERVNEFLREVA 86

Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALG 317
              ++RH NI+  +  + +P    +V E++  GSL  +L   S  R +LD   R  +A  
Sbjct: 87  IMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-SGAREQLDERRRLSMAYD 145

Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGT 377
           VA G+ YLH   +  I+H ++K  N+L++      + D GL+       T +      GT
Sbjct: 146 VAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS--TFLSSKSAAGT 202

Query: 378 MAYIAPEYFQQPELSEKCDIFSFGMLL 404
             ++APE  +    +EK D++SFG++L
Sbjct: 203 PEWMAPEVLRDEPSNEKSDVYSFGVIL 229

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  158 bits (402), Expect = 1e-44
 Identities = 79/316 (25%), Positives = 135/316 (42%), Gaps = 52/316 (16%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
            E IG G  GEV++ +     G+ +A+K              EE S  R++       EI
Sbjct: 47  QESIGKGRFGEVWRGKW---RGEEVAVKIF---------SSREERSWFREA-------EI 87

Query: 257 ITASQIRHRNILPLLAHMVRPD----CHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRH 312
                +RH NIL  +A   + +       LV ++ ++GSL D L+     R  +      
Sbjct: 88  YQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMI 142

Query: 313 RIALGVASGLEYLHM-----YHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
           ++AL  ASGL +LHM         +I H D+K +N+L+  +   CI+DLGLA+       
Sbjct: 143 KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD 202

Query: 368 RVLIS--YVLGTMAYIAPE------YFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQN 419
            + I+  + +GT  Y+APE        +  E  ++ DI++ G++   + R       H++
Sbjct: 203 TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262

Query: 420 GE--------EICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPE 471
            +           S E +RKV+  +     I  R       + M  +++    C   +  
Sbjct: 263 YQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR---ECWYANGA 319

Query: 472 ERPNSQYVRCRLSQLL 487
            R  +  ++  LSQL 
Sbjct: 320 ARLTALRIKKTLSQLS 335

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  154 bits (392), Expect = 7e-44
 Identities = 57/233 (24%), Positives = 93/233 (39%), Gaps = 40/233 (17%)

Query: 180 IEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIE 239
           I+  +L            E IG GG G+VY+A      G  +A+K               
Sbjct: 4   IDFAELTLE---------EIIGIGGFGKVYRAFW---IGDEVAVKA-----------ARH 40

Query: 240 EDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDV 299
           +  +     +  +R E    + ++H NI+ L    ++     LV EF + G L  +L   
Sbjct: 41  DPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS-- 98

Query: 300 SRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC------- 352
               + +        A+ +A G+ YLH      IIH D+K  N+L+   +E         
Sbjct: 99  ---GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKIL 155

Query: 353 -ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
            I+D GLA                G  A++APE  +    S+  D++S+G+LL
Sbjct: 156 KITDFGLAREWHRTTKMSAA----GAYAWMAPEVIRASMFSKGSDVWSYGVLL 204

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  154 bits (390), Expect = 4e-43
 Identities = 71/303 (23%), Positives = 121/303 (39%), Gaps = 50/303 (16%)

Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           E +G G  G+  K     + G+++ +K++I               +  +   R    E+ 
Sbjct: 16  EVLGKGCFGQAIKVTHRET-GEVMVMKELI---------------RFDEETQRTFLKEVK 59

Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALG 317
               + H N+L  +  + +      + E++K G+L+ I+        +  W  R   A  
Sbjct: 60  VMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKD 116

Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT---------- 367
           +ASG+ YLH   S +IIH D+   N L+ ++    ++D GLA  + D  T          
Sbjct: 117 IASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKK 173

Query: 368 --RVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICS 425
             R     V+G   ++APE        EK D+FSFG++L  ++  V +            
Sbjct: 174 PDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNAD----------- 222

Query: 426 PEWL-RKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLS 484
           P++L R +    N    +D   P N           I   C   DPE+RP+   +   L 
Sbjct: 223 PDYLPRTMDFGLNVRGFLDRYCPPNCPPS----FFPITVRCCDLDPEKRPSFVKLEHWLE 278

Query: 485 QLL 487
            L 
Sbjct: 279 TLR 281

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  150 bits (380), Expect = 4e-42
 Identities = 53/230 (23%), Positives = 87/230 (37%), Gaps = 40/230 (17%)

Query: 180 IEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIE 239
           I+ + L FL          K+     GE++K       G  I +K +             
Sbjct: 7   IDFKQLNFL---------TKLNENHSGELWKGRW---QGNDIVVKVL------------- 41

Query: 240 EDSKLRDSKLRQIRSEIITASQIRHRNILPLL-AHMVRPDCHL-LVYEFMKNGSLQDILD 297
           +       K R    E        H N+LP+L A    P  H  L+  +M  GSL ++L 
Sbjct: 42  KVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLH 101

Query: 298 DVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLG 357
           +       +D     + AL +A G+ +LH      I    +  R+V++++DM A IS   
Sbjct: 102 E--GTNFVVDQSQAVKFALDMARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMAD 158

Query: 358 LAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPEL---SEKCDIFSFGMLL 404
           +  +                 A++APE  Q+          D++SF +LL
Sbjct: 159 VKFSFQSPGRM-------YAPAWVAPEALQKKPEDTNRRSADMWSFAVLL 201

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  141 bits (357), Expect = 2e-38
 Identities = 48/220 (21%), Positives = 92/220 (41%), Gaps = 36/220 (16%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
            E IG G  G+VY       +G+ +AI+ +             +  +  + +L+  + E+
Sbjct: 38  GELIGKGRFGQVYHGRW---HGE-VAIRLI-------------DIERDNEDQLKAFKREV 80

Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL 316
           +   Q RH N++  +   + P    ++    K  +L  ++      +  LD     +IA 
Sbjct: 81  MAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVV---RDAKIVLDVNKTRQIAQ 137

Query: 317 GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA---MAIPDGYTRVLISY 373
            +  G+ YL   H+  I+H D+K +NV   D+ +  I+D GL      +  G     +  
Sbjct: 138 EIVKGMGYL---HAKGILHKDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRI 193

Query: 374 VLGTMAYIAPEYFQQPEL---------SEKCDIFSFGMLL 404
             G + ++APE  +Q            S+  D+F+ G + 
Sbjct: 194 QNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIW 233

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  139 bits (353), Expect = 4e-38
 Identities = 63/294 (21%), Positives = 122/294 (41%), Gaps = 38/294 (12%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
            ++IGSG  G VYK +    +G  +A+K +               +     +L+  ++E+
Sbjct: 29  GQRIGSGSFGTVYKGKW---HGD-VAVKML-------------NVTAPTPQQLQAFKNEV 71

Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL 316
               + RH NIL  +          +V ++ +  SL   L        + +      IA 
Sbjct: 72  GVLRKTRHVNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLH---ASETKFEMKKLIDIAR 127

Query: 317 GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLG 376
             A G++YLH   + SIIH D+K  N+ L++D    I D GLA              + G
Sbjct: 128 QTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSG 184

Query: 377 TMAYIAPEYFQQPEL---SEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVM 433
           ++ ++APE  +  +    S + D+++FG++L  L+ G   +    N ++I     +  V 
Sbjct: 185 SILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI-----IEMV- 238

Query: 434 NSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL 487
             +        ++  N  ++    + ++   C     +ERP+   +   + +L 
Sbjct: 239 -GRGSLSPDLSKVRSNCPKR----MKRLMAECLKKKRDERPSFPRILAEIEELA 287

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  125 bits (317), Expect = 5e-33
 Identities = 57/282 (20%), Positives = 112/282 (39%), Gaps = 43/282 (15%)

Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
            +IG G    VYK  L       +A  ++             +D KL  S+ ++ + E  
Sbjct: 32  IEIGRGSFKTVYKG-LDTETTVEVAWCEL-------------QDRKLTKSERQRFKEEAE 77

Query: 258 TASQIRHRNILPLL---AHMVRPDCHLLVY-EFMKNGSLQDILDDVSRGRRELDWPSRHR 313
               ++H NI+         V+    +++  E M +G+L+  L       + +       
Sbjct: 78  MLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF----KVMKIKVLRS 133

Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC-ISDLGLAMAIPDGYTRVLIS 372
               +  GL++LH   +  IIH D+K  N+ +     +  I DLGLA      + +    
Sbjct: 134 WCRQILKGLQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA--- 189

Query: 373 YVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKV 432
            V+GT  ++APE +++ +  E  D+++FGM ++ +      +       E  +   + + 
Sbjct: 190 -VIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPY------SECQNAAQIYRR 241

Query: 433 MNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERP 474
           + S     + D        +  +  V +I   C   + +ER 
Sbjct: 242 VTSGVKPASFD--------KVAIPEVKEIIEGCIRQNKDERY 275

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  119 bits (300), Expect = 2e-30
 Identities = 64/309 (20%), Positives = 117/309 (37%), Gaps = 57/309 (18%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           ++K+G GG   V   E    +G   A+K+++ +                     + + E 
Sbjct: 34  IQKLGEGGFSYVDLVE-GLHDGHFYALKRILCH---------------EQQDREEAQREA 77

Query: 257 ITASQIRHRNILPLLAHMVRPDCH----LLVYEFMKNGSLQDILDDVSRGRRELDWPSRH 312
                  H NIL L+A+ +R         L+  F K G+L + ++ +      L      
Sbjct: 78  DMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQIL 137

Query: 313 RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA----MAIPDGYTR 368
            + LG+  GLE +H   +    H D+KP N+LL D+ +  + DLG      + +      
Sbjct: 138 WLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQA 194

Query: 369 VLISYVL---GTMAYIAPEYFQQP---ELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEE 422
           + +        T++Y APE F       + E+ D++S G +L +++ G   +    +   
Sbjct: 195 LTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPY----DMVF 250

Query: 423 ICSPEWLRKVMNSKNPSRAIDPRLPGNGYE-----KKMLHVLKIAYICTLHDPEERPNSQ 477
                    V N  +      P+ P +          M+ V          DP +RP+  
Sbjct: 251 QKGDSVALAVQNQLSI-----PQSPRHSSALWQLLNSMMTV----------DPHQRPHIP 295

Query: 478 YVRCRLSQL 486
            +  +L  L
Sbjct: 296 LLLSQLEAL 304

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  117 bits (294), Expect = 3e-29
 Identities = 72/326 (22%), Positives = 124/326 (38%), Gaps = 53/326 (16%)

Query: 179 LIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELI 238
           L +K+ +  LK +D F  + ++G+G  G V+K     S G ++A K +            
Sbjct: 21  LTQKQKVGELKDDD-FEKISELGAGNGGVVFKVSHKPS-GLVMARKLI------------ 66

Query: 239 EEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDD 298
               +++ +   QI  E+    +     I+             +  E M  GSL  +L  
Sbjct: 67  --HLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK 124

Query: 299 VSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGL 358
             R    +      ++++ V  GL YL   H   I+H D+KP N+L+N   E  + D G+
Sbjct: 125 AGR----IPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGV 178

Query: 359 AMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ 418
           +  + D       S+V GT +Y++PE  Q    S + DI+S G+ L+ +  G        
Sbjct: 179 SGQLIDSMAN---SFV-GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 234

Query: 419 NGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKI----AYI---------- 464
             E         +   ++ P R   P  P N +       + I     YI          
Sbjct: 235 AKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPS 294

Query: 465 -------------CTLHDPEERPNSQ 477
                        C + +P ER + +
Sbjct: 295 GVFSLEFQDFVNKCLIKNPAERADLK 320

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  112 bits (283), Expect = 7e-28
 Identities = 57/218 (26%), Positives = 92/218 (42%), Gaps = 28/218 (12%)

Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR-QIRSEIIT 258
           +G GG  + ++     +  ++ A K             I   S L     R ++  EI  
Sbjct: 49  LGKGGFAKCFEISDADT-KEVFAGK-------------IVPKSLLLKPHQREKMSMEISI 94

Query: 259 ASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV 318
              + H++++         D   +V E  +  SL ++     R    L  P        +
Sbjct: 95  HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELH--KRRKA--LTEPEARYYLRQI 150

Query: 319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI-PDGYTRVLISYVL-G 376
             G +YLH      +IH D+K  N+ LN+D+E  I D GLA  +  DG  +     VL G
Sbjct: 151 VLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK----KVLCG 203

Query: 377 TMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
           T  YIAPE   +   S + D++S G ++ +L+ G P F
Sbjct: 204 TPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF 241

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  111 bits (280), Expect = 9e-28
 Identities = 55/217 (25%), Positives = 92/217 (42%), Gaps = 26/217 (11%)

Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR-QIRSEIIT 258
           +G GG  + ++     +  ++ A K             I   S L     R ++  EI  
Sbjct: 23  LGKGGFAKCFEISDADT-KEVFAGK-------------IVPKSLLLKPHQREKMSMEISI 68

Query: 259 ASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV 318
              + H++++         D   +V E  +  SL ++     R    L  P        +
Sbjct: 69  HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELH--KRRKA--LTEPEARYYLRQI 124

Query: 319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI-PDGYTRVLISYVLGT 377
             G +YLH      +IH D+K  N+ LN+D+E  I D GLA  +  DG  + ++    GT
Sbjct: 125 VLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---GT 178

Query: 378 MAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
             YIAPE   +   S + D++S G ++ +L+ G P F
Sbjct: 179 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF 215

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  110 bits (277), Expect = 2e-27
 Identities = 68/305 (22%), Positives = 110/305 (36%), Gaps = 61/305 (20%)

Query: 191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
              F  LEKIGSG  G V+K  +   +G + AIK+          +     S    + LR
Sbjct: 10  TTEFHELEKIGSGEFGSVFKC-VKRLDGCIYAIKRS---------KKPLAGSVDEQNALR 59

Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPS 310
           ++      A   +H +++   +     D  L+  E+   GSL D + +  R         
Sbjct: 60  EVY---AHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAE 116

Query: 311 RHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC------------------ 352
              + L V  GL Y+H   S S++H DIKP N+ ++                        
Sbjct: 117 LKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMF 173

Query: 353 -ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQ-PELSEKCDIFSFGMLLISLVRG 410
            I DLG    I             G   ++A E  Q+      K DIF+  + ++     
Sbjct: 174 KIGDLGHVTRISSPQVEE------GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGA 227

Query: 411 VPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDP 470
            P     +NG++          +          PR+P     ++   +LK   +    DP
Sbjct: 228 EPLP---RNGDQW-------HEIRQGRL-----PRIPQV-LSQEFTELLK---VMIHPDP 268

Query: 471 EERPN 475
           E RP+
Sbjct: 269 ERRPS 273

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  110 bits (278), Expect = 2e-27
 Identities = 61/316 (19%), Positives = 114/316 (36%), Gaps = 76/316 (24%)

Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           F  +  +G G  G+V KA     + +  AIKK+                +  + KL  I 
Sbjct: 8   FEEIAVLGQGAFGQVVKAR-NALDSRYYAIKKI----------------RHTEEKLSTIL 50

Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHL-------------LVYEFMKNGSLQDILDDVS 300
           SE++  + + H+ ++   A  +     +             +  E+ +NG+L D++    
Sbjct: 51  SEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIH--- 107

Query: 301 RGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAM 360
                       R+   +   L Y+H   S  IIH D+KP N+ +++     I D GLA 
Sbjct: 108 SENLNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAK 164

Query: 361 AIPDGYTRVLISY------------VLGTMAYIAPEYFQQ-PELSEKCDIFSFGMLLISL 407
            +      + +               +GT  Y+A E        +EK D++S G++   +
Sbjct: 165 NVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM 224

Query: 408 VRGVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYE------KKMLHVLKI 461
           +     F        I     L+K+ +         P    N  +      + ++     
Sbjct: 225 IYP---FSTGMERVNI-----LKKLRSVSIE---FPPDFDDNKMKVEKKIIRLLID---- 269

Query: 462 AYICTLHDPEERPNSQ 477
                 HDP +RP ++
Sbjct: 270 ------HDPNKRPGAR 279

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  112 bits (280), Expect = 2e-27
 Identities = 38/360 (10%), Positives = 87/360 (24%), Gaps = 70/360 (19%)

Query: 147 RNVRQRFPTTPSLISAAVRGGSRDRGPTIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCG 206
               +      +++ A           T    L+ + +      E        +  G   
Sbjct: 24  YCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVE-------PLRVGDRS 76

Query: 207 EVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRN 266
            V+         +  A+K            +    ++   S+L ++      A+++   +
Sbjct: 77  VVFLVRDVER-LEDFALK------------VFTMGAENSRSELERLHEATFAAARLLGES 123

Query: 267 ILPLLAHM--------------------------VRPDCHLLVYEFMK--NGSLQDILDD 298
                                                  +LL+          L   LD 
Sbjct: 124 PEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDF 183

Query: 299 VSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGL 358
           V   R +    + H +   +      L    S  ++HG   P N+ +  D    + D+  
Sbjct: 184 VYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSA 240

Query: 359 AMAIPDGYTRVLISYVLGTMAYIAPEYFQQPEL--SEKCDIFSFGMLLISLVRGVPSFVF 416
              +               + Y   E+        +   + +  G+ +  +      F  
Sbjct: 241 LWKVGTRGPA-----SSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL 295

Query: 417 HQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYE--KKMLHVLKIAYICTLHDPEERP 474
              G +        +V  + + +      LP        + L+           D   R 
Sbjct: 296 VTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNF----------DRRRRL 345

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  110 bits (276), Expect = 3e-27
 Identities = 63/292 (21%), Positives = 118/292 (40%), Gaps = 42/292 (14%)

Query: 190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKL 249
           K D    + ++G G  G V K     S G+++A+K++               + +   + 
Sbjct: 5   KADDLEPIMELGRGAYGVVEKMRHVPS-GQIMAVKRI--------------RATVNSQEQ 49

Query: 250 RQIRSEI-ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDW 308
           +++  ++ I+   +     +     + R     +  E M + SL      V    + +  
Sbjct: 50  KRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPE 108

Query: 309 PSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTR 368
               +IA+ +   LE+LH   S  +IH D+KP NVL+N   +  + D G++  + D    
Sbjct: 109 DILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVD--DV 164

Query: 369 VLISYVLGTMAYIAPE----YFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEIC 424
                  G   Y+APE       Q   S K DI+S G+ +I L      +      +   
Sbjct: 165 AKDIDA-GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPY------DSWG 217

Query: 425 SP-EWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPN 475
           +P + L++V+    PS    P+LP + +  + +        C   + +ERP 
Sbjct: 218 TPFQQLKQVVE--EPS----PQLPADKFSAEFVDFTS---QCLKKNSKERPT 260

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  109 bits (275), Expect = 3e-27
 Identities = 57/220 (25%), Positives = 102/220 (46%), Gaps = 31/220 (14%)

Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR-QIRSEIIT 258
           +G G    VY+AE   + G  +AIK             + +   +  + +  ++++E+  
Sbjct: 19  LGKGSFAGVYRAESIHT-GLEVAIK-------------MIDKKAMYKAGMVQRVQNEVKI 64

Query: 259 ASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV 318
             Q++H +IL L  +    +   LV E   NG +   L   +R +   +  +RH +   +
Sbjct: 65  HCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYL--KNRVKPFSENEARHFMH-QI 121

Query: 319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA--MAIPDG--YTRVLISYV 374
            +G+ YLH +    I+H D+   N+LL  +M   I+D GLA  + +P    YT      +
Sbjct: 122 ITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT------L 172

Query: 375 LGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
            GT  YI+PE   +     + D++S G +  +L+ G P F
Sbjct: 173 CGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPF 212

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  111 bits (280), Expect = 3e-27
 Identities = 49/235 (20%), Positives = 90/235 (38%), Gaps = 36/235 (15%)

Query: 191 EDCFASLEKIGSGGC--GEVYKA-ELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDS 247
             C+  L  IG G      V  A   P   G+ + ++++           +E  S   + 
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKP--TGEYVTVRRI----------NLEACS---NE 68

Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELD 307
            +  ++ E+  +    H NI+P  A  +  +   +V  FM  GS +D++           
Sbjct: 69  MVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNEL 128

Query: 308 WPSRHRIAL---GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPD 364
                 IA    GV   L+Y+H       +H  +K  ++L++ D +  +S L   +++  
Sbjct: 129 A-----IAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180

Query: 365 GYTR-----VLISYVLGTMAYIAPEYFQQPEL--SEKCDIFSFGMLLISLVRGVP 412
              R         Y +  + +++PE  QQ       K DI+S G+    L  G  
Sbjct: 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHV 235

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  110 bits (276), Expect = 4e-27
 Identities = 64/291 (21%), Positives = 113/291 (38%), Gaps = 51/291 (17%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           L++IGSGG  +V++        ++ AIK V                +  +  L   R+EI
Sbjct: 33  LKQIGSGGSSKVFQVL--NEKKQIYAIKYV-------------NLEEADNQTLDSYRNEI 77

Query: 257 ITASQIRHRN--ILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRI 314
              ++++  +  I+ L  + +      +V E   N  L   L    +    +D   R   
Sbjct: 78  AYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWL--KKKKS--IDPWERKSY 132

Query: 315 ALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYV 374
              +   +  +H      I+H D+KP N L+ D M   + D G+A  +    T V+    
Sbjct: 133 WKNMLEAVHTIH---QHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQ 188

Query: 375 LGTMAYIAPEYFQQ-----------PELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI 423
           +GT+ Y+ PE  +             ++S K D++S G +L  +  G   F    N    
Sbjct: 189 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 248

Query: 424 CSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERP 474
                L  +++  +         P +  EK +  VLK    C   DP++R 
Sbjct: 249 -----LHAIIDPNHE-----IEFP-DIPEKDLQDVLK---CCLKRDPKQRI 285

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  110 bits (276), Expect = 5e-27
 Identities = 64/291 (21%), Positives = 112/291 (38%), Gaps = 51/291 (17%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           L++IGSGG  +V++        ++ AIK V                +  +  L   R+EI
Sbjct: 14  LKQIGSGGSSKVFQVL--NEKKQIYAIKYV-------------NLEEADNQTLDSYRNEI 58

Query: 257 ITASQIRH--RNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRI 314
              ++++     I+ L  + +      +V E   N  L   L    +    +D   R   
Sbjct: 59  AYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL--KKKKS--IDPWERKSY 113

Query: 315 ALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYV 374
              +   +  +H      I+H D+KP N L+ D M   + D G+A  +    T V+    
Sbjct: 114 WKNMLEAVHTIH---QHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQ 169

Query: 375 LGTMAYIAPEYFQQ-----------PELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI 423
           +GT+ Y+ PE  +             ++S K D++S G +L  +  G   F    N    
Sbjct: 170 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 229

Query: 424 CSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERP 474
                L  +++  +         P +  EK +  VLK    C   DP++R 
Sbjct: 230 -----LHAIIDPNHE-----IEFP-DIPEKDLQDVLK---CCLKRDPKQRI 266

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  108 bits (273), Expect = 8e-27
 Identities = 77/308 (25%), Positives = 119/308 (38%), Gaps = 45/308 (14%)

Query: 181 EKEDLAFLKKEDCFASLEKIGSGGCGEVYKA-ELPGSNGKMIAIKKVIVYAPISAAELIE 239
           +   L +    D +   E IGSG    V  A   P    + +AIK++          L +
Sbjct: 4   DSSALPWSINRDDYELQEVIGSGATAVVQAAYCAP--KKEKVAIKRI---------NLEK 52

Query: 240 EDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDV 299
             + + +     +  EI   SQ  H NI+      V  D   LV + +  GS+ DI+  +
Sbjct: 53  CQTSMDE-----LLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHI 107

Query: 300 SRGRRELDWP-SRHRIAL---GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISD 355
                          IA     V  GLEYLH       IH D+K  N+LL +D    I+D
Sbjct: 108 VAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIAD 164

Query: 356 LGLAMAIPDGYTRVLISY---VLGTMAYIAPEYFQQPEL-SEKCDIFSFGMLLISLVRGV 411
            G++  +  G            +GT  ++APE  +Q      K DI+SFG+  I L  G 
Sbjct: 165 FGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224

Query: 412 PSFV-FHQNGEEICSPEWLRKV--MNSKNPSRAIDPRLPGNGYEKKMLHVLK--IAYICT 466
             +  +              KV  +  +N   +++  +      KK     +  I+  C 
Sbjct: 225 APYHKYPPM-----------KVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISL-CL 272

Query: 467 LHDPEERP 474
             DPE+RP
Sbjct: 273 QKDPEKRP 280

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  110 bits (277), Expect = 9e-27
 Identities = 59/269 (21%), Positives = 96/269 (35%), Gaps = 35/269 (13%)

Query: 143 GGKSRNVRQRFPTTPSLIS--AAVRGGSRDRGPTIFSPLIEKEDLAFLKKEDCFASLEKI 200
               R   + FP+ P LI    + +     +   +    + K+        +     E+I
Sbjct: 65  DNLYRLEGEGFPSIPLLIDHLLSTQQPLTKKSGVVLHRAVPKDKWVL--NHEDLVLGEQI 122

Query: 201 GSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITAS 260
           G G  GEV+   L   N   +A+K               E          +   E     
Sbjct: 123 GRGNFGEVFSGRLRADNTL-VAVK------------SCRETLPPDL--KAKFLQEARILK 167

Query: 261 QIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVAS 320
           Q  H NI+ L+    +     +V E ++ G     L         L   +  ++    A+
Sbjct: 168 QYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAA 224

Query: 321 GLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAY 380
           G+EYL    S   IH D+  RN L+ +     ISD G++    DG     +    G +  
Sbjct: 225 GMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG-----VYAASGGLRQ 276

Query: 381 I-----APEYFQQPELSEKCDIFSFGMLL 404
           +     APE       S + D++SFG+LL
Sbjct: 277 VPVKWTAPEALNYGRYSSESDVWSFGILL 305

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  107 bits (269), Expect = 2e-26
 Identities = 59/215 (27%), Positives = 90/215 (41%), Gaps = 24/215 (11%)

Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  G VY A     +  ++A+K V+  A +  A +             Q+R E+   
Sbjct: 17  LGKGKFGNVYLAREK-QSKFILALK-VLFKAQLEKAGVEH-----------QLRREVEIQ 63

Query: 260 SQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVA 319
           S +RH NIL L  +        L+ E+   G++   L      +   D          +A
Sbjct: 64  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSK--FDEQRTATYITELA 119

Query: 320 SGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMA 379
           + L Y H      +IH DIKP N+LL    E  I+D G ++  P      L     GT+ 
Sbjct: 120 NALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTLD 172

Query: 380 YIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
           Y+ PE  +     EK D++S G+L    + G P F
Sbjct: 173 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 207

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  108 bits (271), Expect = 3e-26
 Identities = 37/247 (14%), Positives = 77/247 (31%), Gaps = 34/247 (13%)

Query: 191 EDCFASLEKIGSGGCGEVYKAELPGSN----GKMIAIKKVIVYAPISAAELIEEDSKLRD 246
                    +G G   +VY+A     N     +   +K              +  +    
Sbjct: 64  SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKV------------QKPANPWEF 111

Query: 247 SKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGR-RE 305
               Q+   +           +   +  +  +  +LV E    G+L + ++       + 
Sbjct: 112 YIGTQLMERL---KPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKV 168

Query: 306 LDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA-----------CIS 354
           +        A+ +   +E +H      IIHGDIKP N +L +                + 
Sbjct: 169 MPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALI 225

Query: 355 DLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
           DLG ++ +       + +    T  +   E       + + D F     +  ++ G    
Sbjct: 226 DLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMK 285

Query: 415 VFHQNGE 421
           V ++ GE
Sbjct: 286 VKNEGGE 292

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  107 bits (269), Expect = 3e-26
 Identities = 71/283 (25%), Positives = 120/283 (42%), Gaps = 31/283 (10%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
            +KIG G   EVY+A     +G  +A+KKV ++  + A                    EI
Sbjct: 37  EKKIGRGQFSEVYRA-ACLLDGVPVALKKVQIFDLMDAKAR------------ADCIKEI 83

Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL 316
               Q+ H N++   A  +  +   +V E    G L  ++    + +R +   +  +  +
Sbjct: 84  DLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFV 143

Query: 317 GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLG 376
            + S LE++H   S  ++H DIKP NV +       + DLGL        T    S V G
Sbjct: 144 QLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLV-G 198

Query: 377 TMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSK 436
           T  Y++PE   +   + K DI+S G LL  +      F     G+++      +K+    
Sbjct: 199 TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF----YGDKMNLYSLCKKIEQCD 254

Query: 437 NPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYV 479
                  P LP + Y +++  ++    +C   DPE+RP+  YV
Sbjct: 255 Y------PPLPSDHYSEELRQLVN---MCINPDPEKRPDVTYV 288

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  108 bits (272), Expect = 4e-26
 Identities = 57/293 (19%), Positives = 106/293 (36%), Gaps = 55/293 (18%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           L++IGSGG  +V++        ++ AIK V                +  +  L   R+EI
Sbjct: 61  LKQIGSGGSSKVFQVL--NEKKQIYAIKYV-------------NLEEADNQTLDSYRNEI 105

Query: 257 ITASQIRH--RNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRI 314
              ++++     I+ L  + +      +V E   N  L   L    +    +D   R   
Sbjct: 106 AYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL--KKKKS--IDPWERKSY 160

Query: 315 ALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYV 374
              +   +  +H      I+H D+KP N L+  D    + D G+A  +    T V+    
Sbjct: 161 WKNMLEAVHTIH---QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQ 216

Query: 375 LGTMAYIAPEYFQ-----------QPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI 423
           +G + Y+ PE  +           + ++S K D++S G +L  +  G   F    N    
Sbjct: 217 VGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 276

Query: 424 CSPEWLRKVMNSKNPSRAIDPRLPGNGYE--KKMLHVLKIAYICTLHDPEERP 474
                L  +++  +           +  +  K  L            DP++R 
Sbjct: 277 -----LHAIIDPNHEIE-FPDIPEKDLQDVLKCCLKR----------DPKQRI 313

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  107 bits (268), Expect = 7e-26
 Identities = 52/253 (20%), Positives = 98/253 (38%), Gaps = 32/253 (12%)

Query: 164 VRGGSRDRGPTIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAI 223
           +   + D    + +  ++  D  + ++        ++G G  GEV++       G   A+
Sbjct: 30  LGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRM-KDKQTGFQCAV 88

Query: 224 KKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLV 283
           KKV                +L   +      E++  + +    I+PL   +       + 
Sbjct: 89  KKV----------------RLEVFR----VEELVACAGLSSPRIVPLYGAVREGPWVNIF 128

Query: 284 YEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNV 343
            E ++ GSL  ++    +    L              GLEYLH   +  I+HGD+K  NV
Sbjct: 129 MELLEGGSLGQLI----KQMGCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNV 181

Query: 344 LLNDDMEAC-ISDLGLAMAIPDGY---TRVLISYVLGTMAYIAPEYFQQPELSEKCDIFS 399
           LL+ D     + D G A+ +       + +   Y+ GT  ++APE         K DI+S
Sbjct: 182 LLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWS 241

Query: 400 FGMLLISLVRGVP 412
              +++ ++ G  
Sbjct: 242 SCCMMLHMLNGCH 254

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  109 bits (274), Expect = 7e-26
 Identities = 57/269 (21%), Positives = 102/269 (37%), Gaps = 42/269 (15%)

Query: 150 RQRFPTTPSLIS----AAVRGGSRDRGPTIFSPLIEKEDLAFLKKE-----DCFASLEKI 200
             RF T   L+      A    +    P           ++    +            K+
Sbjct: 169 ESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTIYGVSPNYDKWEMERTDITMKHKL 228

Query: 201 GSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITAS 260
           G G  GEVY+      +   +A+K +     +   E ++E + ++               
Sbjct: 229 GGGQYGEVYEGVWKKYSLT-VAVKTLKEDT-MEVEEFLKEAAVMK--------------- 271

Query: 261 QIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVAS 320
           +I+H N++ LL    R     ++ EFM  G+L D L      R+E+       +A  ++S
Sbjct: 272 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISS 329

Query: 321 GLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAY 380
            +EYL      + IH ++  RN L+ ++    ++D GL+  +          Y     A 
Sbjct: 330 AMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT------YTAHAGAK 380

Query: 381 I-----APEYFQQPELSEKCDIFSFGMLL 404
                 APE     + S K D+++FG+LL
Sbjct: 381 FPIKWTAPESLAYNKFSIKSDVWAFGVLL 409

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  106 bits (267), Expect = 7e-26
 Identities = 58/285 (20%), Positives = 94/285 (32%), Gaps = 44/285 (15%)

Query: 191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
           +  F  L ++G G  GEV+K      +G++ A+K+ +               K R  KL 
Sbjct: 56  QQSFQRLSRLGHGSYGEVFKVRSK-EDGRLYAVKRSM---------SPFRGPKDRARKLA 105

Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPS 310
           ++          +H   + L           L  E     SLQ            L    
Sbjct: 106 EV---GSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHC---EAWGASLPEAQ 158

Query: 311 RHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI-PDGYTRV 369
                      L +LH   S  ++H D+KP N+ L       + D GL + +   G   V
Sbjct: 159 VWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV 215

Query: 370 LISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWL 429
                 G   Y+APE  Q        D+FS G+ ++ +   +        GE        
Sbjct: 216 QE----GDPRYMAPELLQGS-YGTAADVFSLGLTILEVACNMELP---HGGEGW------ 261

Query: 430 RKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERP 474
           +++     P     P     G   ++  VL    +    DP+ R 
Sbjct: 262 QQLRQGYLP-----PEFT-AGLSSELRSVLV---MMLEPDPKLRA 297

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  107 bits (268), Expect = 8e-26
 Identities = 46/228 (20%), Positives = 86/228 (37%), Gaps = 21/228 (9%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKV--IVYAPISAAELIEEDSKLRDSKLRQIRS 254
           +  +  G   ++   E    + K  A+KK    +            D     SK    ++
Sbjct: 36  IRTLNQGKFNKIILCE---KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKN 92

Query: 255 EIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRH-- 312
           E+   + I++   L     +   D   ++YE+M+N S+            + ++      
Sbjct: 93  ELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFD--EYFFVLDKNYTCFIPI 150

Query: 313 ----RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTR 368
                I   V +   Y+H   +  I H D+KP N+L++ +    +SD G +  + D   +
Sbjct: 151 QVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK 208

Query: 369 VLISYVLGTMAYIAPEYFQ--QPELSEKCDIFSFGMLLISLVRGVPSF 414
                  GT  ++ PE+F         K DI+S G+ L  +   V  F
Sbjct: 209 GS----RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF 252

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  105 bits (263), Expect = 2e-25
 Identities = 64/310 (20%), Positives = 110/310 (35%), Gaps = 71/310 (22%)

Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           F  ++ +G GG G V++A+    +    AIK++                  R+    ++ 
Sbjct: 7   FEPIQCLGRGGFGVVFEAKN-KVDDCNYAIKRI--------------RLPNRELAREKVM 51

Query: 254 SEIITASQIRHRNIL---------PLLAHMVRPDCHLLVY---EFMKNGSLQDILDDVSR 301
            E+   +++ H  I+              +      + +Y   +  +  +L+D ++    
Sbjct: 52  REVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNG-RC 110

Query: 302 GRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA-- 359
              E +      I L +A  +E+LH   S  ++H D+KP N+    D    + D GL   
Sbjct: 111 TIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTA 167

Query: 360 --------MAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGV 411
                     +         +  +GT  Y++PE       S K DIFS G++L  L+   
Sbjct: 168 MDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL--Y 225

Query: 412 PSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYE------KKMLHVLKIAYIC 465
           P   F    E + +   L  V N K       P L    Y       + ML         
Sbjct: 226 P---FSTQMERVRT---LTDVRNLKF------PPLFTQKYPCEYVMVQDMLS-------- 265

Query: 466 TLHDPEERPN 475
               P ERP 
Sbjct: 266 --PSPMERPE 273

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  106 bits (267), Expect = 3e-25
 Identities = 58/303 (19%), Positives = 108/303 (35%), Gaps = 74/303 (24%)

Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           F   + +G G  G +    +   + + +A+K+++                          
Sbjct: 26  FCPKDVLGHGAEGTIVYRGM--FDNRDVAVKRILP------------------ECFSFAD 65

Query: 254 SEIITASQI-----RHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDW 308
            E+    Q+      H N++             +  E     +LQ+ ++        L+ 
Sbjct: 66  REV----QLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLE- 119

Query: 309 PSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLL-----NDDMEACISDLGLA-MAI 362
                +     SGL +LH   S +I+H D+KP N+L+     +  ++A ISD GL     
Sbjct: 120 --PITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174

Query: 363 PDGYTRVLISYVLGTMAYIAPEYFQQPE---LSEKCDIFSFGMLL-ISLVRGVPSFVFHQ 418
              ++    S V GT  +IAPE   +      +   DIFS G +    +  G   F    
Sbjct: 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPF---- 230

Query: 419 NGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYE-------KKMLHVLKIAYICTLHDPE 471
                   + L++  N    + ++D   P    +       +KM+ +          DP+
Sbjct: 231 -------GKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAM----------DPQ 273

Query: 472 ERP 474
           +RP
Sbjct: 274 KRP 276

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  103 bits (260), Expect = 3e-25
 Identities = 60/215 (27%), Positives = 89/215 (41%), Gaps = 24/215 (11%)

Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  G VY A     N  ++A+K V+  + +    +             Q+R EI   
Sbjct: 22  LGKGKFGNVYLAREK-QNKFIMALK-VLFKSQLEKEGVEH-----------QLRREIEIQ 68

Query: 260 SQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVA 319
           S +RH NIL +  +        L+ EF   G L   L     GR   D          +A
Sbjct: 69  SHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKEL--QKHGR--FDEQRSATFMEELA 124

Query: 320 SGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMA 379
             L Y H      +IH DIKP N+L+    E  I+D G ++  P    R +     GT+ 
Sbjct: 125 DALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC----GTLD 177

Query: 380 YIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
           Y+ PE  +     EK D++  G+L    + G+P F
Sbjct: 178 YLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPF 212

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  104 bits (261), Expect = 3e-25
 Identities = 80/294 (27%), Positives = 126/294 (42%), Gaps = 55/294 (18%)

Query: 191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
           E+ F  LEKIG G  GEV+K  +     K++AIK +         +L E + ++ D    
Sbjct: 21  EELFTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKII---------DLEEAEDEIED---- 66

Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPS 310
            I+ EI   SQ     +       ++     ++ E++  GS  D+L+        LD   
Sbjct: 67  -IQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-----GPLDETQ 120

Query: 311 RHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVL 370
              I   +  GL+YLH   S   IH DIK  NVLL++  E  ++D G+A  + D   +  
Sbjct: 121 IATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK-- 175

Query: 371 ISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLR 430
            +  +GT  ++APE  +Q     K DI+S G+  I L RG P             P    
Sbjct: 176 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEP-------------P---- 218

Query: 431 KVMNSKNPSRAID-------PRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQ 477
              +  +P + +        P L GN Y K +   ++    C   +P  RP ++
Sbjct: 219 --HSELHPMKVLFLIPKNNPPTLEGN-YSKPLKEFVE---ACLNKEPSFRPTAK 266

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  103 bits (260), Expect = 4e-25
 Identities = 58/222 (26%), Positives = 99/222 (44%), Gaps = 26/222 (11%)

Query: 191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
           +  +   EKIG G  G VY A +  + G+ +AI+++     +      E           
Sbjct: 19  KKKYTRFEKIGQGASGTVYTA-MDVATGQEVAIRQM----NLQQQPKKEL---------- 63

Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPS 310
            I +EI+   + ++ NI+  L   +  D   +V E++  GSL D++         +D   
Sbjct: 64  -IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQ 117

Query: 311 RHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVL 370
              +       LE+LH   S  +IH DIK  N+LL  D    ++D G    I    ++  
Sbjct: 118 IAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR- 173

Query: 371 ISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVP 412
            S ++GT  ++APE   +     K DI+S G++ I ++ G P
Sbjct: 174 -STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  103 bits (258), Expect = 1e-24
 Identities = 52/222 (23%), Positives = 96/222 (43%), Gaps = 26/222 (11%)

Query: 191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
                S  KIG G  G V  A     +G+ +A+K +     +   +  E           
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLA-REKHSGRQVAVKMM----DLRKQQRREL---------- 88

Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPS 310
            + +E++     +H N++ +    +  +   ++ EF++ G+L DI+      +  L+   
Sbjct: 89  -LFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS-----QVRLNEEQ 142

Query: 311 RHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVL 370
              +   V   L YLH   +  +IH DIK  ++LL  D    +SD G    I     +  
Sbjct: 143 IATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-- 197

Query: 371 ISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVP 412
              ++GT  ++APE   +   + + DI+S G+++I +V G P
Sbjct: 198 RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEP 239

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  102 bits (257), Expect = 1e-24
 Identities = 55/230 (23%), Positives = 93/230 (40%), Gaps = 35/230 (15%)

Query: 191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
            + +  + ++G G  G+VYKA      G + A K +         E   E+      +L 
Sbjct: 18  NEVWEIVGELGDGAFGKVYKA-KNKETGALAAAKVI---------ETKSEE------ELE 61

Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPS 310
               EI   +   H  I+ LL          ++ EF   G++  I+ ++ RG  E     
Sbjct: 62  DYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTE----- 116

Query: 311 RHRIAL---GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
             +I +    +   L +LH   S  IIH D+K  NVL+  + +  ++D G++       T
Sbjct: 117 -PQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK--T 170

Query: 368 RVLISYVLGT---MA--YIAPEYFQQPELSEKCDIFSFGMLLISLVRGVP 412
                  +GT   MA   +  E  +      K DI+S G+ LI + +  P
Sbjct: 171 LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP 220

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  102 bits (256), Expect = 2e-24
 Identities = 67/225 (29%), Positives = 102/225 (45%), Gaps = 32/225 (14%)

Query: 191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
           E+ F  LEK+G G  G VYKA      G+++AIK+V V                 +S L+
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAI-HKETGQIVAIKQVPV-----------------ESDLQ 69

Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPS 310
           +I  EI    Q    +++       +     +V E+   GS+ DI+   ++   E     
Sbjct: 70  EIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTE----- 124

Query: 311 RHRIAL---GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
              IA        GLEYLH       IH DIK  N+LLN +  A ++D G+A  + D   
Sbjct: 125 -DEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA 180

Query: 368 RVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVP 412
           +   + V+GT  ++APE  Q+   +   DI+S G+  I +  G P
Sbjct: 181 K--RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKP 223

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  102 bits (257), Expect = 2e-24
 Identities = 53/302 (17%), Positives = 114/302 (37%), Gaps = 43/302 (14%)

Query: 192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ 251
           + +  L+KIG G  G+    +    +G+   IK++ +             S++   +  +
Sbjct: 24  EKYVRLQKIGEGSFGKAILVK-STEDGRQYVIKEINI-------------SRMSSKEREE 69

Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
            R E+   + ++H NI+             +V ++ + G L   ++   +          
Sbjct: 70  SRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINA--QKGVLFQEDQI 127

Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLI 371
               + +   L+++H      I+H DIK +N+ L  D    + D G+A  +    T  L 
Sbjct: 128 LDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL--NSTVELA 182

Query: 372 SYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRK 431
              +GT  Y++PE  +    + K DI++ G +L  L     +F        +     + K
Sbjct: 183 RACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAF----EAGSM--KNLVLK 236

Query: 432 VMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERP------NSQYVRCRLSQ 485
           +++         P +    Y   +  ++         +P +RP         ++  R+ +
Sbjct: 237 IISGSF------PPVS-LHYSYDLRSLVS---QLFKRNPRDRPSVNSILEKGFIAKRIEK 286

Query: 486 LL 487
            L
Sbjct: 287 FL 288

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  101 bits (254), Expect = 2e-24
 Identities = 64/301 (21%), Positives = 119/301 (39%), Gaps = 58/301 (19%)

Query: 192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ 251
           + +  L  IG+G  G   K     S+GK++  K++                 + +++ + 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRK-SDGKILVWKELDY-------------GSMTEAEKQM 51

Query: 252 IRSEIITASQIRHRNILPLLAHMV-RPDCHL-LVYEFMKNGSLQDILDDVSRGRRELD-- 307
           + SE+    +++H NI+     ++ R +  L +V E+ + G L  ++   ++ R+ LD  
Sbjct: 52  LVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEE 111

Query: 308 --WPSRHRIALGVASGLEYLH--MYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
                  R+   +   L+  H       +++H D+KP NV L+      + D GLA  + 
Sbjct: 112 FVL----RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL- 166

Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI 423
             +        +GT  Y++PE   +   +EK DI+S G LL  L   +P F         
Sbjct: 167 -NHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF----TAFSQ 221

Query: 424 CSPEWLRKVMNSKNPSRAIDPRLPGNGYE-------KKMLHVLKIAYICTLHDPEERPNS 476
              E   K+   K        R+P   Y         +ML++              RP+ 
Sbjct: 222 --KELAGKIREGKF------RRIP-YRYSDELNEIITRMLNL----------KDYHRPSV 262

Query: 477 Q 477
           +
Sbjct: 263 E 263

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  102 bits (256), Expect = 2e-24
 Identities = 73/309 (23%), Positives = 125/309 (40%), Gaps = 71/309 (22%)

Query: 191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
              F  +E +G+G  G+VYK       G++ AIK +         ++  ++ +       
Sbjct: 23  AGIFELVELVGNGTYGQVYKG-RHVKTGQLAAIKVM---------DVTGDEEEE------ 66

Query: 251 QIRSEIITASQI-RHRNILP-----LLAHMVRPDCHL-LVYEFMKNGSLQDILDDVSRGR 303
            I+ EI    +   HRNI       +  +    D  L LV EF   GS+ D++ +     
Sbjct: 67  -IKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT 125

Query: 304 RELDWPSRHRIAL---GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAM 360
            + +W     IA     +  GL +LH      +IH DIK +NVLL ++ E  + D G++ 
Sbjct: 126 LKEEW-----IAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 177

Query: 361 AIPDGYTRVLISYVLGTMAYIAPEYFQQPELSE-----KCDIFSFGMLLISLVRGVPSFV 415
            +     R   +  +GT  ++APE     E  +     K D++S G+  I +  G P   
Sbjct: 178 QLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP--- 232

Query: 416 FHQNGEEICSPEWLRKVMNSKNPSRAI-------DPRLPGNGYEKKMLHVLKIAYICTLH 468
                     P      +   +P RA+        PRL    + KK    ++    C + 
Sbjct: 233 ----------P------LCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIE---SCLVK 273

Query: 469 DPEERPNSQ 477
           +  +RP ++
Sbjct: 274 NHSQRPATE 282

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  103 bits (258), Expect = 3e-24
 Identities = 28/241 (11%), Positives = 65/241 (26%), Gaps = 31/241 (12%)

Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
             +G        +A      G+   +   + Y          +  K    +LR +R    
Sbjct: 84  TVLGQEDPYAYLEATDQ-ETGESFEVH--VPYFTERPPSNAIKQMKEEVLRLRLLRGIKN 140

Query: 258 TASQIRHRNILPLLAHMVRPDCH-----------------LLVYEFMK--NGSLQDILDD 298
                 H   +     +  P                      +Y  M+    +  ++L  
Sbjct: 141 QKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLS 200

Query: 299 VSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGL 358
            S   + L   +R ++ L V   L  LH      ++H  ++P +++L+      ++    
Sbjct: 201 HSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEH 257

Query: 359 AMAIPDGYTRVLISYVLGTMAYIAPE-----YFQQPELSEKCDIFSFGMLLISLVRGVPS 413
            +          I          A             ++   D ++ G+ +  +      
Sbjct: 258 LVR-DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316

Query: 414 F 414
            
Sbjct: 317 N 317

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  104 bits (261), Expect = 3e-24
 Identities = 64/282 (22%), Positives = 111/282 (39%), Gaps = 51/282 (18%)

Query: 139 KESFGGKSRNVRQRFPTTPSLI---------------SAAVRGGSRDRGPTIFSPLIEKE 183
           K   GG     R +F +   L+               +       + +G    +  I +E
Sbjct: 208 KLDSGGFYITSRTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRE 267

Query: 184 DLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSK 243
            L    K         +G G  GEV+     G+    +AIK             ++  + 
Sbjct: 268 SLRLEVK---------LGQGCFGEVWMGTWNGT--TRVAIK------------TLKPGTM 304

Query: 244 LRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGR 303
             ++ L     E     ++RH  ++ L A +V  +   +V E+M  GSL D L       
Sbjct: 305 SPEAFL----QEAQVMKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFL--KGETG 357

Query: 304 RELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
           + L  P    +A  +ASG+ Y+      + +H D++  N+L+ +++   ++D GLA  I 
Sbjct: 358 KYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIE 414

Query: 364 DG-YTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
           D  YT          + + APE       + K D++SFG+LL
Sbjct: 415 DNEYTAR--QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 454

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  104 bits (260), Expect = 3e-24
 Identities = 64/282 (22%), Positives = 111/282 (39%), Gaps = 51/282 (18%)

Query: 139 KESFGGKSRNVRQRFPTTPSLI---------------SAAVRGGSRDRGPTIFSPLIEKE 183
           K   GG     R +F +   L+               +       + +G    +  I +E
Sbjct: 125 KLDSGGFYITSRTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRE 184

Query: 184 DLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSK 243
            L    K         +G G  GEV+     G+    +AIK             ++  + 
Sbjct: 185 SLRLEVK---------LGQGCFGEVWMGTWNGT--TRVAIK------------TLKPGTM 221

Query: 244 LRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGR 303
             ++ L     E     ++RH  ++ L A +V  +   +V E+M  GSL D L       
Sbjct: 222 SPEAFL----QEAQVMKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFL--KGETG 274

Query: 304 RELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
           + L  P    +A  +ASG+ Y+      + +H D++  N+L+ +++   ++D GLA  I 
Sbjct: 275 KYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIE 331

Query: 364 DG-YTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
           D  YT          + + APE       + K D++SFG+LL
Sbjct: 332 DNEYTAR--QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 371

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  102 bits (255), Expect = 3e-24
 Identities = 56/296 (18%), Positives = 102/296 (34%), Gaps = 50/296 (16%)

Query: 192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ 251
           +    L +IG G  G V K     S G+++A+K++               S + + + +Q
Sbjct: 22  EDLKDLGEIGRGAYGSVNKMVHKPS-GQIMAVKRI--------------RSTVDEKEQKQ 66

Query: 252 IRSEI-ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGR-RELDWP 309
           +  ++ +         I+     + R     +  E M + S       V       +   
Sbjct: 67  LLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEE 125

Query: 310 SRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRV 369
              +I L     L +L       IIH DIKP N+LL+      + D G++  + D   + 
Sbjct: 126 ILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK- 182

Query: 370 LISYVLGTMAYIAPEYFQQPEL----SEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICS 425
             +   G   Y+APE             + D++S G+ L  L  G   +           
Sbjct: 183 --TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPY----------- 229

Query: 426 PEW------LRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPN 475
           P+W      L +V+    P            +    ++ +    +C   D  +RP 
Sbjct: 230 PKWNSVFDQLTQVVKGDPPQ---LSNSEEREFSPSFINFVN---LCLTKDESKRPK 279

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  100 bits (251), Expect = 5e-24
 Identities = 60/298 (20%), Positives = 109/298 (36%), Gaps = 65/298 (21%)

Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           F  +E IGSGG G+V+KA+    +GK   IK+V                        +  
Sbjct: 13  FKEIELIGSGGFGQVFKAKHR-IDGKTYVIKRV-------------------KYNNEKAE 52

Query: 254 SEIITASQIRHRNI---------------LPLLAHMVRPDCHL-LVYEFMKNGSLQDILD 297
            E+   +++ H NI                            L +  EF   G+L+  ++
Sbjct: 53  REVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE 112

Query: 298 DVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLG 357
              R   +LD      +   +  G++Y+H   S  +I+ D+KP N+ L D  +  I D G
Sbjct: 113 K--RRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFG 167

Query: 358 LAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFH 417
           L  ++             GT+ Y++PE     +  ++ D+++ G++L  L+         
Sbjct: 168 LVTSL--KNDGKRTRSK-GTLRYMSPEQISSQDYGKEVDLYALGLILAELLH--VCDTAF 222

Query: 418 QNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPN 475
           +  +          + +        D +       +K+L             PE+RPN
Sbjct: 223 ETSKFFT------DLRDGIISDI-FDKKE--KTLLQKLLSK----------KPEDRPN 261

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  100 bits (252), Expect = 8e-24
 Identities = 50/274 (18%), Positives = 92/274 (33%), Gaps = 38/274 (13%)

Query: 191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
              +   + +G G    V++       G + AIK                ++      + 
Sbjct: 8   NHLWLLSDILGQGATANVFRGRHK-KTGDLFAIKVF--------------NNISFLRPVD 52

Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHL--LVYEFMKNGSLQDILDDVSRGRRELDW 308
               E     ++ H+NI+ L A           L+ EF   GSL  +L++ S     L  
Sbjct: 53  VQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYG-LPE 111

Query: 309 PSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC----ISDLGLAMAIPD 364
                +   V  G+ +L       I+H +IKP N++     +      ++D G A  + D
Sbjct: 112 SEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED 168

Query: 365 GYTRVLISYVLGTMAYIAPEYFQQPEL--------SEKCDIFSFGMLLISLVRGVPSFVF 416
                    + GT  Y+ P+ +++  L            D++S G+       G   F  
Sbjct: 169 D---EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225

Query: 417 HQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNG 450
            +        E + K++  K        +   NG
Sbjct: 226 FEGPRRN--KEVMYKIITGKPSGAISGVQKAENG 257

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  100 bits (252), Expect = 1e-23
 Identities = 60/311 (19%), Positives = 111/311 (35%), Gaps = 58/311 (18%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
              +  GG   VY+A+    +G+  A+K+++                    K R I  E+
Sbjct: 33  RRVLAEGGFAFVYEAQ-DVGSGREYALKRLLSNEE---------------EKNRAIIQEV 76

Query: 257 ITASQIR-HRNILPLLAH-------MVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDW 308
               ++  H NI+   +                L+   +  G L + L  +      L  
Sbjct: 77  CFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGP-LSC 135

Query: 309 PSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA---MAIPDG 365
            +  +I       ++++H      IIH D+K  N+LL++     + D G A      PD 
Sbjct: 136 DTVLKIFYQTCRAVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDY 194

Query: 366 YTRVLISYVL-------GTMAYIAPE---YFQQPELSEKCDIFSFGMLLISLVRGVPSFV 415
                   ++        T  Y  PE    +    + EK DI++ G +L  L      F 
Sbjct: 195 SWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF- 253

Query: 416 FHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPN 475
                E+        +++N K         +P +  +  + H L I  +  + +PEER +
Sbjct: 254 -----ED----GAKLRIVNGK-------YSIPPHDTQYTVFHSL-IRAMLQV-NPEERLS 295

Query: 476 SQYVRCRLSQL 486
              V  +L ++
Sbjct: 296 IAEVVHQLQEI 306

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  101 bits (253), Expect = 1e-23
 Identities = 33/246 (13%), Positives = 79/246 (32%), Gaps = 40/246 (16%)

Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEE--DSKLRDSKLRQIRSE 255
             +G        +A    + G+   +  V  +     +  I++  +  LR   LR I+++
Sbjct: 79  TVLGQEDPYAYLEATDQET-GESFEVH-VPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQ 136

Query: 256 IITASQIRHRNILPLLAHMVRPDCH--------------LLVYEFMK--NGSLQDILDDV 299
                 +R      L+    +                    +Y  M+    +  ++L   
Sbjct: 137 KQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSH 196

Query: 300 SRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA 359
           S   + L   +R ++ L V   L  LH      ++H  ++P +++L+      ++     
Sbjct: 197 SSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 253

Query: 360 MAIPDGYTRVLISYVLGTMAYIAPEYFQQPEL-----------SEKCDIFSFGMLLISLV 408
           +   DG   V       +  +  PE   +              +   D ++ G+++  + 
Sbjct: 254 V--RDGARVV----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW 307

Query: 409 RGVPSF 414
                 
Sbjct: 308 CADLPI 313

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  100 bits (252), Expect = 1e-23
 Identities = 81/351 (23%), Positives = 130/351 (37%), Gaps = 65/351 (18%)

Query: 141 SFGGKSRNVRQRFPTTPSLISAAVRGGSRDRGPTIFSPLIEKEDLAFLKK-EDCFASLEK 199
           S+     +     PTT +L            G        +  +L F    E  F+ L +
Sbjct: 2   SYYHHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLRE 61

Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           IG G  G VY A     N +++AIKK+                K  + K + I  E+   
Sbjct: 62  IGHGSFGAVYFA-RDVRNSEVVAIKKMSY------------SGKQSNEKWQDIIKEVRFL 108

Query: 260 SQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL--- 316
            ++RH N +      +R     LV E+   GS  D+L+   +  +E        IA    
Sbjct: 109 QKLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQE------VEIAAVTH 161

Query: 317 GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLG 376
           G   GL YLH   S ++IH D+K  N+LL++     + D G A  +    + V      G
Sbjct: 162 GALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV------G 212

Query: 377 TMAYIAPE---YFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVM 433
           T  ++APE      + +   K D++S G+  I L    P             P      +
Sbjct: 213 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP-------------P------L 253

Query: 434 NSKNPSRAI-------DPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQ 477
            + N   A+        P L    + +   + +     C    P++RP S+
Sbjct: 254 FNMNAMSALYHIAQNESPALQSGHWSEYFRNFVD---SCLQKIPQDRPTSE 301

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  102 bits (255), Expect = 1e-23
 Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 44/228 (19%)

Query: 180 IEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIE 239
           +  ++L  L+          IG G  G+V   +     G  +A+K             I+
Sbjct: 190 LNMKELKLLQT---------IGKGEFGDVMLGDY---RGNKVAVKC------------IK 225

Query: 240 EDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHL-LVYEFMKNGSLQDILDD 298
            D+  +        +E    +Q+RH N++ LL  +V     L +V E+M  GSL D L  
Sbjct: 226 NDATAQA-----FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL-- 278

Query: 299 VSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGL 358
            SRGR  L      + +L V   +EYL      + +H D+  RNVL+++D  A +SD GL
Sbjct: 279 RSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGL 335

Query: 359 A--MAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL 404
               +      ++ +        + APE  ++ + S K D++SFG+LL
Sbjct: 336 TKEASSTQDTGKLPVK-------WTAPEALREKKFSTKSDVWSFGILL 376

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  101 bits (254), Expect = 1e-23
 Identities = 61/318 (19%), Positives = 111/318 (34%), Gaps = 67/318 (21%)

Query: 191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
           ++   S + +G G  G V         G+ +A+K++++                      
Sbjct: 14  KNLVVSEKILGYGSSGTVVFQGS--FQGRPVAVKRMLI------------------DFCD 53

Query: 251 QIRSEI-ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDIL---DDVSRGRREL 306
               EI +      H N++             +  E   N +LQD++   +      +  
Sbjct: 54  IALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQ 112

Query: 307 DWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLL-------------NDDMEACI 353
              +   +   +ASG+ +LH   S  IIH D+KP+N+L+              +++   I
Sbjct: 113 KEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILI 169

Query: 354 SDLGLAMAIPDG--YTRVLISYVLGTMAYIAPEYFQQPE-------LSEKCDIFSFGMLL 404
           SD GL   +  G    R  ++   GT  + APE  ++         L+   DIFS G + 
Sbjct: 170 SDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVF 229

Query: 405 -ISLVRGVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYE--KKMLHVLKI 461
              L +G   F      +       +R + +        D  L     +   +M+     
Sbjct: 230 YYILSKGKHPF----GDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDH--- 282

Query: 462 AYICTLHDPEERPNSQYV 479
                  DP +RP +  V
Sbjct: 283 -------DPLKRPTAMKV 293

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 98.9 bits (247), Expect = 2e-23
 Identities = 56/230 (24%), Positives = 95/230 (41%), Gaps = 42/230 (18%)

Query: 180 IEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIE 239
           +E+ D+    K         +G G  GEVY+      +   +A+K             ++
Sbjct: 10  MERTDITMKHK---------LGGGQYGEVYEGVWKKYSLT-VAVKT------------LK 47

Query: 240 EDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDV 299
           ED+   +  L     E     +I+H N++ LL    R     ++ EFM  G+L D L   
Sbjct: 48  EDTMEVEEFL----KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-- 101

Query: 300 SRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA 359
              R+E+       +A  ++S +EYL      + IH D+  RN L+ ++    ++D GL+
Sbjct: 102 ECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLS 158

Query: 360 MAIPDGYTRVLISYVLGTMAYI-----APEYFQQPELSEKCDIFSFGMLL 404
             +          Y     A       APE     + S K D+++FG+LL
Sbjct: 159 RLMTGDT------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLL 202

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 98.5 bits (246), Expect = 3e-23
 Identities = 67/281 (23%), Positives = 106/281 (37%), Gaps = 41/281 (14%)

Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSK-LRQIRSEI 256
             +G G  G VY      SN   IAIK++                  RDS+  + +  EI
Sbjct: 28  VVLGKGTYGIVYAG-RDLSNQVRIAIKEI----------------PERDSRYSQPLHEEI 70

Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL 316
                ++H+NI+  L          +  E +  GSL  +L     G  + +  +      
Sbjct: 71  ALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRS-KWGPLKDNEQTIGFYTK 129

Query: 317 GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC-ISDLGLAMAIPDGYTRVLISYVL 375
            +  GL+YLH      I+H DIK  NVL+N       ISD G +  +         ++  
Sbjct: 130 QILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTE-TFT- 184

Query: 376 GTMAYIAPEYFQQPEL--SEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVM 433
           GT+ Y+APE   +      +  DI+S G  +I +  G P F      +       + KV 
Sbjct: 185 GTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA-----MFKVG 239

Query: 434 NSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERP 474
             K       P +P +    +    +     C   DP++R 
Sbjct: 240 MFKVH-----PEIPES-MSAEAKAFIL---KCFEPDPDKRA 271

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 98.9 bits (247), Expect = 3e-23
 Identities = 61/286 (21%), Positives = 114/286 (39%), Gaps = 47/286 (16%)

Query: 197 LEKIGSGGCGEVYKAE---LPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ-I 252
              +G GG G+VY+AE         +++A+K       + +  L        D   R  +
Sbjct: 39  RRLVGRGGMGDVYEAEDTVR----ERIVALK-------LMSETLS------SDPVFRTRM 81

Query: 253 RSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRH 312
           + E  TA +++  +++P+           +    +    L  +L    +G   L  P   
Sbjct: 82  QREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRR--QGP--LAPPRAV 137

Query: 313 RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPD-GYTRVLI 371
            I   + S L+  H   +A   H D+KP N+L++ D  A + D G+A A  D   T++  
Sbjct: 138 AIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQL-- 192

Query: 372 SYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRK 431
              +GT+ Y+APE F +   + + DI++   +L   + G P +     G+       +  
Sbjct: 193 GNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPY----QGD---QLSVMGA 245

Query: 432 VMNSKNPS-RAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNS 476
            +N   P    + P +P             +       +PE+R  +
Sbjct: 246 HINQAIPRPSTVRPGIPVA--------FDAVIARGMAKNPEDRYVT 283

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 99.0 bits (247), Expect = 4e-23
 Identities = 56/289 (19%), Positives = 111/289 (38%), Gaps = 45/289 (15%)

Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
             +L ++GSG CG+V+K     + G +IA+K++                     + ++I 
Sbjct: 27  LENLGEMGSGTCGQVWKMRFRKT-GHVIAVKQM--------------RRSGNKEENKRIL 71

Query: 254 SEI-ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRH 312
            ++ +         I+      +      +  E M     + +   +     E       
Sbjct: 72  MDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPE---RILG 127

Query: 313 RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLIS 372
           ++ + +   L YL   H   +IH D+KP N+LL++  +  + D G++  + D   +    
Sbjct: 128 KMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKD--R 183

Query: 373 YVLGTMAYIAPEYFQQPELSE-----KCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPE 427
              G  AY+APE    P+ ++     + D++S G+ L+ L  G   +       + C  +
Sbjct: 184 SA-GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPY-------KNCKTD 235

Query: 428 WLRKVMNSKNPSRAIDPRLPGN-GYEKKMLHVLKIAYICTLHDPEERPN 475
           +       +       P LPG+ G+       +K    C   D  +RP 
Sbjct: 236 FEVLTKVLQEEP----PLLPGHMGFSGDFQSFVK---DCLTKDHRKRPK 277

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 98.1 bits (245), Expect = 4e-23
 Identities = 55/233 (23%), Positives = 93/233 (39%), Gaps = 43/233 (18%)

Query: 180 IEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKM-IAIK--KVIVYAPISAAE 236
           ++++ L    KE        +GSG  G V K           +A+K  K     P    E
Sbjct: 13  LDRKLLTLEDKE--------LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDE 64

Query: 237 LIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDIL 296
           L+ E + ++               Q+ +  I+ ++  +   +  +LV E  + G L   L
Sbjct: 65  LLAEANVMQ---------------QLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYL 108

Query: 297 DDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDL 356
               +  R +   +   +   V+ G++YL     ++ +H D+  RNVLL     A ISD 
Sbjct: 109 ----QQNRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDF 161

Query: 357 GLAMAIPDGYTRVLISYVLGTMAYI-----APEYFQQPELSEKCDIFSFGMLL 404
           GL+ A+          Y   T         APE     + S K D++SFG+L+
Sbjct: 162 GLSKALRADEN----YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLM 210

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  101 bits (253), Expect = 4e-23
 Identities = 56/226 (24%), Positives = 91/226 (40%), Gaps = 33/226 (14%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
            E++G+GG G V +     + G+ +AIK+                 +L      +   EI
Sbjct: 19  KERLGTGGFGYVLRWIHQDT-GEQVAIKQC--------------RQELSPKNRERWCLEI 63

Query: 257 ITASQIRHRNILPLLA------HMVRPDCHLLVYEFMKNGSLQDILDDVSRGRR-ELDWP 309
               ++ H N++           +   D  LL  E+ + G L+  L          L   
Sbjct: 64  QIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYL--NQFENCCGLKEG 121

Query: 310 SRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC---ISDLGLAMAIPDGY 366
               +   ++S L YLH      IIH D+KP N++L    +     I DLG A  +  G 
Sbjct: 122 PIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG- 177

Query: 367 TRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVP 412
             +   +V GT+ Y+APE  +Q + +   D +SFG L    + G  
Sbjct: 178 -ELCTEFV-GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 98.1 bits (245), Expect = 5e-23
 Identities = 68/286 (23%), Positives = 124/286 (43%), Gaps = 45/286 (15%)

Query: 197 LEKIGSGGCGEVYKAE---LPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           ++K+G GG   VY AE   L       +AIK              E++  L+     +  
Sbjct: 16  VDKLGGGGMSTVYLAEDTIL----NIKVAIK-------AIFIPPREKEETLK-----RFE 59

Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
            E+  +SQ+ H+NI+ ++      DC+ LV E+++  +L + ++    G   L   +   
Sbjct: 60  REVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIES--HGP--LSVDTAIN 115

Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISY 373
               +  G+++ H      I+H DIKP+N+L++ +    I D G+A A+    +    ++
Sbjct: 116 FTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKAL-SETSLTQTNH 171

Query: 374 VLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSP-EWLRKV 432
           VLGT+ Y +PE  +     E  DI+S G++L  ++ G P F    NGE   +      K 
Sbjct: 172 VLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPF----NGE---TAVSIAIKH 224

Query: 433 MNSKNPS--RAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNS 476
           +    P+    +   +P +        +  +    T  D   R  +
Sbjct: 225 IQDSVPNVTTDVRKDIPQS--------LSNVILRATEKDKANRYKT 262

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 99.5 bits (248), Expect = 7e-23
 Identities = 50/274 (18%), Positives = 92/274 (33%), Gaps = 38/274 (13%)

Query: 191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
              +   + +G G    V++       G + AIK                ++      + 
Sbjct: 8   NHLWLLSDILGQGATANVFRGRHK-KTGDLFAIKVF--------------NNISFLRPVD 52

Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHL--LVYEFMKNGSLQDILDDVSRGRRELDW 308
               E     ++ H+NI+ L A           L+ EF   GSL  +L++ S     L  
Sbjct: 53  VQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYG-LPE 111

Query: 309 PSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC----ISDLGLAMAIPD 364
                +   V  G+ +L       I+H +IKP N++     +      ++D G A  + D
Sbjct: 112 SEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED 168

Query: 365 GYTRVLISYVLGTMAYIAPEYFQQPEL--------SEKCDIFSFGMLLISLVRGVPSFVF 416
                    + GT  Y+ P+ +++  L            D++S G+       G   F  
Sbjct: 169 D---EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225

Query: 417 HQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNG 450
            +        E + K++  K        +   NG
Sbjct: 226 FEGPRRN--KEVMYKIITGKPSGAISGVQKAENG 257

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 96.9 bits (242), Expect = 9e-23
 Identities = 49/233 (21%), Positives = 96/233 (41%), Gaps = 43/233 (18%)

Query: 180 IEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKM-IAIKKVIVYAPISAAELI 238
           +++++L             ++G G  G V +        ++ +AIK             +
Sbjct: 6   LKRDNLLIADI--------ELGCGNFGSVRQGVYRMRKKQIDVAIKV------------L 45

Query: 239 EEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDD 298
           ++ ++  D+   ++  E     Q+ +  I+ L+  + + +  +LV E    G L   L  
Sbjct: 46  KQGTEKADT--EEMMREAQIMHQLDNPYIVRLIG-VCQAEALMLVMEMAGGGPLHKFL-- 100

Query: 299 VSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGL 358
               R E+   +   +   V+ G++YL      + +H D+  RNVLL +   A ISD GL
Sbjct: 101 -VGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGL 156

Query: 359 AMAIP--DGYTRVLISYVLGTMAYI-----APEYFQQPELSEKCDIFSFGMLL 404
           + A+   D Y      Y   +         APE     + S + D++S+G+ +
Sbjct: 157 SKALGADDSY------YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTM 203

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  100 bits (250), Expect = 1e-22
 Identities = 51/231 (22%), Positives = 99/231 (42%), Gaps = 35/231 (15%)

Query: 182 KEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKM-IAIKKVIVYAPISAAELIEE 240
           K+   FLK+++   +  ++G G  G V +        ++ +AIK             +++
Sbjct: 326 KDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKV------------LKQ 373

Query: 241 DSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVS 300
            ++  D+   ++  E     Q+ +  I+ L+  + + +  +LV E    G L   L    
Sbjct: 374 GTEKADT--EEMMREAQIMHQLDNPYIVRLIG-VCQAEALMLVMEMAGGGPLHKFL---V 427

Query: 301 RGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAM 360
             R E+   +   +   V+ G++YL      + +H ++  RNVLL +   A ISD GL+ 
Sbjct: 428 GKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSK 484

Query: 361 AIP--DGYTRVLISYVLGTMAYI-----APEYFQQPELSEKCDIFSFGMLL 404
           A+   D Y      Y   +         APE     + S + D++S+G+ +
Sbjct: 485 ALGADDSY------YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTM 529

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 99.4 bits (248), Expect = 1e-22
 Identities = 60/271 (22%), Positives = 101/271 (37%), Gaps = 38/271 (14%)

Query: 143 GGKSRNVRQRFPTTPSLIS--AAVRGGSRDRGPTIFSPLIEKEDLAFLKKE---DCFASL 197
           GG   + R  F T   L+        G   +          ++       E   +     
Sbjct: 134 GGFYISPRSTFSTLQELVDHYKKGNDGLCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLE 193

Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           +K+G+G  GEV+ A         +A+K            +      +         +E  
Sbjct: 194 KKLGAGQFGEVWMATYNKH--TKVAVKT-----------MKPGSMSVEA-----FLAEAN 235

Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALG 317
               ++H  ++ L A +V  +   ++ EFM  GSL D L   S    +   P     +  
Sbjct: 236 VMKTLQHDKLVKLHA-VVTKEPIYIITEFMAKGSLLDFL--KSDEGSKQPLPKLIDFSAQ 292

Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG-YTRVLISYVLG 376
           +A G+ ++      + IH D++  N+L++  +   I+D GLA  I D  YT        G
Sbjct: 293 IAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA-----REG 344

Query: 377 TMAYI---APEYFQQPELSEKCDIFSFGMLL 404
               I   APE       + K D++SFG+LL
Sbjct: 345 AKFPIKWTAPEAINFGSFTIKSDVWSFGILL 375

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 97.9 bits (244), Expect = 2e-22
 Identities = 59/269 (21%), Positives = 103/269 (38%), Gaps = 33/269 (12%)

Query: 146 SRNVRQRFPTTPSLISAAVRGGSRDRGPTIFSPLIEKEDLAFLKKED--CFASLEKIGSG 203
                  +    S         +     +  +P + +     +           E IG G
Sbjct: 41  EELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRG 100

Query: 204 GCGEVYKAELPGSNGKMI--AIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQ 261
             G VY   L  ++GK I  A+K +               + + +  + Q  +E I    
Sbjct: 101 HFGCVYHGTLLDNDGKKIHCAVKSL------------NRITDIGE--VSQFLTEGIIMKD 146

Query: 262 IRHRNILPLLAHMVRPDC-HLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVAS 320
             H N+L LL   +R +   L+V  +MK+G L++ + +                 L VA 
Sbjct: 147 FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAK 203

Query: 321 GLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAY 380
           G+++L    S   +H D+  RN +L++     ++D GLA  +   Y +   S    T A 
Sbjct: 204 GMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDM---YDKEFDSVHNKTGAK 257

Query: 381 I-----APEYFQQPELSEKCDIFSFGMLL 404
           +     A E  Q  + + K D++SFG+LL
Sbjct: 258 LPVKWMALESLQTQKFTTKSDVWSFGVLL 286

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 97.1 bits (242), Expect = 2e-22
 Identities = 65/329 (19%), Positives = 118/329 (35%), Gaps = 66/329 (20%)

Query: 180 IEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAE---LPGSNGKMIAIKKVIVYAPISAAE 236
            E+  L FL++         +G G  G V       L  + G+++A+KK           
Sbjct: 38  FEERHLKFLQQ---------LGKGNFGSVEMCRYDPLQDNTGEVVAVKK----------- 77

Query: 237 LIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCH--LLVYEFMKNGSLQD 294
            ++  +   +  LR    EI     ++H NI+               L+ E++  GSL+D
Sbjct: 78  -LQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRD 133

Query: 295 ILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACIS 354
            L    + +  +D     +    +  G+EYL    +   IH D+  RN+L+ ++    I 
Sbjct: 134 YL---QKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIG 187

Query: 355 DLGLAMAIPDGYTRVLISYVLGTMAYI-----APEYFQQPELSEKCDIFSFGMLL---IS 406
           D GL   +P         Y +           APE   + + S   D++SFG++L    +
Sbjct: 188 DFGLTKVLPQDKE----YYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243

Query: 407 LVRGVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDP--RL------PGNGYEKKMLHV 458
            +    S             +     M   +    +    RL      P   Y   M   
Sbjct: 244 YIEKSKSPPAEFMRMIGNDKQGQ---MIVFHLIELLKNNGRLPRPDGCPDEIYM-IMTE- 298

Query: 459 LKIAYICTLHDPEERPNSQYVRCRLSQLL 487
                 C  ++  +RP+ + +  R+ Q+ 
Sbjct: 299 ------CWNNNVNQRPSFRDLALRVDQIR 321

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 96.2 bits (240), Expect = 2e-22
 Identities = 64/329 (19%), Positives = 118/329 (35%), Gaps = 66/329 (20%)

Query: 180 IEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAE---LPGSNGKMIAIKKVIVYAPISAAE 236
            E+  L FL++         +G G  G V       L  + G+++A+KK           
Sbjct: 7   FEERHLKFLQQ---------LGKGNFGSVEMCRYDPLQDNTGEVVAVKK----------- 46

Query: 237 LIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCH--LLVYEFMKNGSLQD 294
            ++  +   +  LR    EI     ++H NI+               L+ E++  GSL+D
Sbjct: 47  -LQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRD 102

Query: 295 ILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACIS 354
            L    + +  +D     +    +  G+EYL    +   IH D+  RN+L+ ++    I 
Sbjct: 103 YL---QKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIG 156

Query: 355 DLGLAMAIPDGYTRVLISYVLGTMAYI-----APEYFQQPELSEKCDIFSFGMLL---IS 406
           D GL   +P         + +           APE   + + S   D++SFG++L    +
Sbjct: 157 DFGLTKVLPQDKE----FFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

Query: 407 LVRGVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDP--RL------PGNGYEKKMLHV 458
            +    S             +     M   +    +    RL      P   Y   M   
Sbjct: 213 YIEKSKSPPAEFMRMIGNDKQGQ---MIVFHLIELLKNNGRLPRPDGCPDEIYM-IMTE- 267

Query: 459 LKIAYICTLHDPEERPNSQYVRCRLSQLL 487
                 C  ++  +RP+ + +  R+ Q+ 
Sbjct: 268 ------CWNNNVNQRPSFRDLALRVDQIR 290

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 97.8 bits (244), Expect = 3e-22
 Identities = 62/234 (26%), Positives = 99/234 (42%), Gaps = 29/234 (12%)

Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           + +GSG CGEV  A       K +AI+ +I     +     E D  L       + +EI 
Sbjct: 141 KTLGSGACGEVKLAFER-KTCKKVAIR-IISKRKFAIGSAREADPALN------VETEIE 192

Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQD-ILDDVSRGR-RELDWPSRHRIA 315
              ++ H  I+ +       D ++ V E M+ G L D +   V   R +E     +    
Sbjct: 193 ILKKLNHPCIIKIKNFFDAEDYYI-VLELMEGGELFDKV---VGNKRLKEAT--CKL-YF 245

Query: 316 LGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC---ISDLGLAMAIPDGYTRVLIS 372
             +   ++YLH      IIH D+KP NVLL+   E C   I+D G +  + +     L+ 
Sbjct: 246 YQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET---SLMR 299

Query: 373 YVLGTMAYIAPEYFQQPEL---SEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI 423
            + GT  Y+APE          +   D +S G++L   + G P F  H+    +
Sbjct: 300 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL 353

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 95.8 bits (239), Expect = 3e-22
 Identities = 59/217 (27%), Positives = 93/217 (42%), Gaps = 33/217 (15%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMI--AIKKVIVYAPISAAELIEEDSKLRDSKLRQIRS 254
            E IG G  G VY   L  ++GK I  A+K +               + + +  + Q  +
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL------------NRITDIGE--VSQFLT 75

Query: 255 EIITASQIRHRNILPLLAHMVRPDC-HLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
           E I      H N+L LL   +R +   L+V  +MK+G L++ +                 
Sbjct: 76  EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIG 132

Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG-YTRVLIS 372
             L VA G++YL    S   +H D+  RN +L++     ++D GLA  + D  Y  V   
Sbjct: 133 FGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK 189

Query: 373 YVLGTMAYI-----APEYFQQPELSEKCDIFSFGMLL 404
               T A +     A E  Q  + + K D++SFG+LL
Sbjct: 190 ----TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 222

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 96.2 bits (240), Expect = 3e-22
 Identities = 59/246 (23%), Positives = 91/246 (36%), Gaps = 53/246 (21%)

Query: 178 PLIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKM-IAIKKVIVYAPISAAE 236
           P+++  D+ F            IG G  G+V KA +     +M  AIK++  YA      
Sbjct: 20  PVLDWNDIKFQDV---------IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS----- 65

Query: 237 LIEEDSKLRDSKLRQIRSEIITASQI-RHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDI 295
                        R    E+    ++  H NI+ LL          L  E+  +G+L D 
Sbjct: 66  ---------KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDF 116

Query: 296 L------------DDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNV 343
           L               +     L        A  VA G++YL        IH D+  RN+
Sbjct: 117 LRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNI 173

Query: 344 LLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYI-----APEYFQQPELSEKCDIF 398
           L+ ++  A I+D GL+        R    YV  TM  +     A E       +   D++
Sbjct: 174 LVGENYVAKIADFGLS--------RGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVW 225

Query: 399 SFGMLL 404
           S+G+LL
Sbjct: 226 SYGVLL 231

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 98.0 bits (244), Expect = 7e-22
 Identities = 54/286 (18%), Positives = 106/286 (37%), Gaps = 61/286 (21%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQI-RSE 255
              I  GG G +Y A     NG+ + +K  +V++               D++ + +  +E
Sbjct: 85  KGCIAHGGLGWIYLALDRNVNGRPVVLK-GLVHS--------------GDAEAQAMAMAE 129

Query: 256 IITASQIRHRNILPLLAHMVRPDCHL-----LVYEFMKNGSLQDILDDVSRGRRELDWPS 310
               +++ H +I+ +   +   D H      +V E++   SL+          ++L    
Sbjct: 130 RQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK------GQKLPVAE 183

Query: 311 RHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVL 370
                L +   L YLH   S  +++ D+KP N++L ++ +  + DLG    I        
Sbjct: 184 AIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI----NSF- 234

Query: 371 ISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLR 430
             Y+ GT  + APE  +    +   DI++ G  L +L   +P+     NG  +       
Sbjct: 235 -GYLYGTPGFQAPEIVRT-GPTVATDIYTVGRTLAALTLDLPTR----NGRYVDGL---- 284

Query: 431 KVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNS 476
                  P      +   +        + +        DP +R  +
Sbjct: 285 -------PEDDPVLKTYDSYGRL----LRR----AIDPDPRQRFTT 315

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 94.7 bits (236), Expect = 1e-21
 Identities = 53/227 (23%), Positives = 90/227 (39%), Gaps = 45/227 (19%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMI--AIKKVIVYAPISAAELIEEDSKLRDSKLRQIRS 254
            + +G G  G V +  L   +G  +  A+K            +  ++S  R+  + +  S
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKT-----------MKLDNSSQRE--IEEFLS 85

Query: 255 EIITASQIRHRNILPLLA-----HMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWP 309
           E        H N++ LL              +++  FMK G L   L       R    P
Sbjct: 86  EAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYL----LYSRLETGP 141

Query: 310 SR------HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
                    +  + +A G+EYL    + + +H D+  RN +L DDM  C++D GL+  I 
Sbjct: 142 KHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIY 198

Query: 364 DG-YTRVLISYVLGTMAYI-----APEYFQQPELSEKCDIFSFGMLL 404
            G Y      Y  G +A +     A E       + K D+++FG+ +
Sbjct: 199 SGDY------YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTM 239

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 93.4 bits (233), Expect = 1e-21
 Identities = 57/229 (24%), Positives = 92/229 (40%), Gaps = 42/229 (18%)

Query: 180 IEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIE 239
           I+  +L F+++         IGSG  G V+       +   +AIK             I 
Sbjct: 5   IDPSELTFVQE---------IGSGQFGLVHLGYWLNKD--KVAIKT------------IR 41

Query: 240 EDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDV 299
           E +   +  +     E     ++ H  ++ L    +      LV EFM++G L D L   
Sbjct: 42  EGAMSEEDFIE----EAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYL--- 94

Query: 300 SRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA 359
              R      +   + L V  G+ YL     A +IH D+  RN L+ ++    +SD G+ 
Sbjct: 95  RTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMT 151

Query: 360 MAIPDG-YTRVLISYVLGTMAYI---APEYFQQPELSEKCDIFSFGMLL 404
             + D  YT        GT   +   +PE F     S K D++SFG+L+
Sbjct: 152 RFVLDDQYTS-----STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLM 195

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 94.2 bits (235), Expect = 1e-21
 Identities = 63/240 (26%), Positives = 92/240 (38%), Gaps = 33/240 (13%)

Query: 172 GPTIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMI--AIKKVIVY 229
           G     PL   + L  L  E     LEK+G G  G V + E    +GK +  A+K     
Sbjct: 1   GSAGEGPL---QSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKC---- 53

Query: 230 APISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKN 289
                   ++ D   +   +     E+     + HRN++ L   +V      +V E    
Sbjct: 54  --------LKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG-VVLTPPMKMVTELAPL 104

Query: 290 GSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDM 349
           GSL D L    + +      +  R A+ VA G+ YL    S   IH D+  RN+LL    
Sbjct: 105 GSLLDRL---RKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRD 158

Query: 350 EACISDLGLAMAIPDGYTRVLISYVLGTMAYI-----APEYFQQPELSEKCDIFSFGMLL 404
              I D GL  A+P         YV+     +     APE  +    S   D + FG+ L
Sbjct: 159 LVKIGDFGLMRALPQNDD----HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTL 214

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 93.8 bits (234), Expect = 1e-21
 Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 42/229 (18%)

Query: 180 IEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIE 239
           + +E L  +++         +G+G  GEV+     G     +A+K             ++
Sbjct: 10  VPRETLKLVER---------LGAGQFGEVWMGYYNGHT--KVAVKS------------LK 46

Query: 240 EDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDV 299
           + S   D+ L    +E     Q++H+ ++ L A +V  +   ++ E+M+NGSL D L   
Sbjct: 47  QGSMSPDAFL----AEANLMKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLK-- 99

Query: 300 SRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA 359
           +    +L       +A  +A G+ ++      + IH D++  N+L++D +   I+D GLA
Sbjct: 100 TPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLA 156

Query: 360 MAIPDG-YTRVLISYVLGTMAYI---APEYFQQPELSEKCDIFSFGMLL 404
             I D  YT        G    I   APE       + K D++SFG+LL
Sbjct: 157 RLIEDNEYTA-----REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 200

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 94.6 bits (236), Expect = 1e-21
 Identities = 61/328 (18%), Positives = 112/328 (34%), Gaps = 93/328 (28%)

Query: 190 KEDCFASLEKIGSGGCGEVYKAEL--PGSNGKM-IAIKKVIVYAPISAAELIEEDSKLRD 246
           KE  F  ++ +GSG  G VYK      G   K+ +AIK+                  LR+
Sbjct: 13  KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE------------------LRE 54

Query: 247 SKLRQIRSEIIT-AS---QIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG 302
           +   +   EI+  A     + + ++  LL  +       L+ + M  G L D +      
Sbjct: 55  ATSPKANKEILDEAYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYV---REH 110

Query: 303 RRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI 362
           +  +         + +A G+ YL       ++H D+  RNVL+       I+D GLA  +
Sbjct: 111 KDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167

Query: 363 PDG---YTRVLISYVLGTMAYI---APEYFQQPELSEKCDIFSFGMLL---ISL------ 407
                 Y         G    I   A E       + + D++S+G+ +   ++       
Sbjct: 168 GAEEKEYHAE------GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

Query: 408 ---VRGVPSFVFHQNGE-----EICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVL 459
                 + S +  + GE      IC+ + +  +M                          
Sbjct: 222 GIPASEISSIL--EKGERLPQPPICTID-VYMIMRK------------------------ 254

Query: 460 KIAYICTLHDPEERPNSQYVRCRLSQLL 487
                C + D + RP  + +    S++ 
Sbjct: 255 -----CWMIDADSRPKFRELIIEFSKMA 277

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 93.9 bits (234), Expect = 1e-21
 Identities = 50/237 (21%), Positives = 88/237 (37%), Gaps = 47/237 (19%)

Query: 180 IEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGK---MIAIKKVIVYAPISAAE 236
            EK  L  ++          +G G  G+V               +A+K            
Sbjct: 18  FEKRFLKRIRD---------LGEGHFGKVELCRYDPEGDNTGEQVAVKS----------- 57

Query: 237 LIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA----HMVRPDCHLLVYEFMKNGSL 292
           L  E      + +  ++ EI     + H NI+                 L+ EF+ +GSL
Sbjct: 58  LKPESG---GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK--LIMEFLPSGSL 112

Query: 293 QDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC 352
           ++ L    + + +++   + + A+ +  G++YL    S   +H D+  RNVL+  + +  
Sbjct: 113 KEYL---PKNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVK 166

Query: 353 ISDLGLAMAIPDGYTRVLISYVLGTMAYI-----APEYFQQPELSEKCDIFSFGMLL 404
           I D GL  AI          Y +           APE   Q +     D++SFG+ L
Sbjct: 167 IGDFGLTKAIETDKE----YYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTL 219

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 94.3 bits (235), Expect = 1e-21
 Identities = 48/229 (20%), Positives = 89/229 (38%), Gaps = 45/229 (19%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGK----MIAIKKVIVYAPISAAELIEEDSKLRDSKLRQI 252
             ++G G  G+V+ AE      +    ++A+K +            +E S   +S  +  
Sbjct: 46  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL------------KEAS---ESARQDF 90

Query: 253 RSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDIL-----------DDVSR 301
           + E    + ++H++I+            L+V+E+M++G L   L                
Sbjct: 91  QREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDV 150

Query: 302 GRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMA 361
               L       +A  VA+G+ YL        +H D+  RN L+   +   I D G++  
Sbjct: 151 APGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRD 207

Query: 362 IPDG-YTRVLISYVLGTMAYI-----APEYFQQPELSEKCDIFSFGMLL 404
           I    Y RV      G    +      PE     + + + D++SFG++L
Sbjct: 208 IYSTDYYRV------GGRTMLPIRWMPPESILYRKFTTESDVWSFGVVL 250

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 93.4 bits (233), Expect = 1e-21
 Identities = 52/218 (23%), Positives = 85/218 (38%), Gaps = 35/218 (16%)

Query: 192 DCFASLEKIGSGGCGEVYKAELPGSNGKM-IAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
                L+++G+G  G V   +     G+  +AIK             I+E S   D  + 
Sbjct: 24  KDLTFLKELGTGQFGVVKYGKW---RGQYDVAIKM------------IKEGSMSEDEFIE 68

Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPS 310
               E      + H  ++ L     +     ++ E+M NG L + L      R       
Sbjct: 69  ----EAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL---REMRHRFQTQQ 121

Query: 311 RHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG-YTRV 369
              +   V   +EYL    S   +H D+  RN L+ND     +SD GL+  + D  YT  
Sbjct: 122 LLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS- 177

Query: 370 LISYVLGTMAYI---APEYFQQPELSEKCDIFSFGMLL 404
                +G+   +    PE     + S K DI++FG+L+
Sbjct: 178 ----SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLM 211

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 94.6 bits (235), Expect = 2e-21
 Identities = 60/352 (17%), Positives = 102/352 (28%), Gaps = 106/352 (30%)

Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKV--------------------------- 226
           F  ++ +G GG G V++A+    +    AIK++                           
Sbjct: 8   FEPIQCMGRGGFGVVFEAKNK-VDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 66

Query: 227 ----------------IVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL 270
                                I   +   +      S +     +I        +N +  
Sbjct: 67  VRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQ 126

Query: 271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHS 330
           L          +  +  +  +L+D ++       + +      I + +A  +E+LH   S
Sbjct: 127 LQPSSPKVYLYIQMQLCRKENLKDWMNR-RCSLEDREHGVCLHIFIQIAEAVEFLH---S 182

Query: 331 ASIIHGDIKPRNVLLNDDMEACISDLGLA-----------MAIPDGYTRVLISYVLGTMA 379
             ++H D+KP N+    D    + D GL            +  P          V GT  
Sbjct: 183 KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQV-GTKL 241

Query: 380 YIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSP--------EWLRK 431
           Y++PE       S K DIFS G++L                 E+             +  
Sbjct: 242 YMSPEQIHGNNYSHKVDIFSLGLILF----------------ELLYSFSTQMERVRIITD 285

Query: 432 VMNSKNPSRAIDPRLPGNGYE------KKMLHVLKIAYICTLHDPEERPNSQ 477
           V N K P       L    Y       + ML             P ERP + 
Sbjct: 286 VRNLKFPL------LFTQKYPQEHMMVQDMLS----------PSPTERPEAT 321

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 93.9 bits (234), Expect = 2e-21
 Identities = 53/227 (23%), Positives = 87/227 (38%), Gaps = 39/227 (17%)

Query: 190 KEDCFASLEKIGSGGCGEVYKAE---LPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRD 246
           +E     + ++G G  G V       L  + G ++A+K++    P    +   E   L+ 
Sbjct: 21  EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK- 79

Query: 247 SKLRQIRSEIITASQIRHRNILPLLAHMVRPDCH--LLVYEFMKNGSLQDILDDVSRGRR 304
                          +    I+        P      LV E++ +G L+D L    R R 
Sbjct: 80  --------------ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL---QRHRA 122

Query: 305 ELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP- 363
            LD       +  +  G+EYL    S   +H D+  RN+L+  +    I+D GLA  +P 
Sbjct: 123 RLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL 179

Query: 364 -DGYTRVLISYVLGTMAYI-----APEYFQQPELSEKCDIFSFGMLL 404
              Y      YV+           APE       S + D++SFG++L
Sbjct: 180 DKDY------YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVL 220

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 93.0 bits (232), Expect = 2e-21
 Identities = 62/231 (26%), Positives = 99/231 (42%), Gaps = 50/231 (21%)

Query: 180 IEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIE 239
           +  ++L  L+          IG G  G+V   +     G  +A+K             I+
Sbjct: 18  LNMKELKLLQT---------IGKGEFGDVMLGDY---RGNKVAVKC------------IK 53

Query: 240 EDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHL-LVYEFMKNGSLQDILDD 298
            D+  +        +E    +Q+RH N++ LL  +V     L +V E+M  GSL D L  
Sbjct: 54  NDATAQA-----FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR- 107

Query: 299 VSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGL 358
            SRGR  L      + +L V   +EYL      + +H D+  RNVL+++D  A +SD GL
Sbjct: 108 -SRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGL 163

Query: 359 AMAIPDGYTRVLISYVLGTMAYI-----APEYFQQPELSEKCDIFSFGMLL 404
                    +            +     APE  ++ + S K D++SFG+LL
Sbjct: 164 T--------KEA--SSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILL 204

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 93.6 bits (233), Expect = 2e-21
 Identities = 54/257 (21%), Positives = 97/257 (37%), Gaps = 55/257 (21%)

Query: 168 SRDRGPTIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMI--AIKK 225
           S +    +   LI ++     +          +G G  G V +A+L   +G  +  A+K 
Sbjct: 8   SDELKEKLEDVLIPEQQFTLGRM---------LGKGEFGSVREAQLKQEDGSFVKVAVKM 58

Query: 226 VIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA------HMVRPDC 279
           +             +   +  S + +   E     +  H ++  L+          R   
Sbjct: 59  L-------------KADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPI 105

Query: 280 HLLVYEFMKNGSLQDILDDVSRGRRELDWPSR------HRIALGVASGLEYLHMYHSASI 333
            +++  FMK+G L   L       R  + P         R  + +A G+EYL    S + 
Sbjct: 106 PMVILPFMKHGDLHAFL----LASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNF 158

Query: 334 IHGDIKPRNVLLNDDMEACISDLGLAMAIPDG-YTRVLISYVLGTMAYI-----APEYFQ 387
           IH D+  RN +L +DM  C++D GL+  I  G Y      Y  G  + +     A E   
Sbjct: 159 IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDY------YRQGCASKLPVKWLALESLA 212

Query: 388 QPELSEKCDIFSFGMLL 404
               +   D+++FG+ +
Sbjct: 213 DNLYTVHSDVWAFGVTM 229

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 91.9 bits (229), Expect = 4e-21
 Identities = 53/230 (23%), Positives = 95/230 (41%), Gaps = 44/230 (19%)

Query: 180 IEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKM-IAIKKVIVYAPISAAELI 238
           +++E++  LK+         +GSG  G V   +     G+  +A+K             I
Sbjct: 5   LKREEITLLKE---------LGSGQFGVVKLGKW---KGQYDVAVKM------------I 40

Query: 239 EEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDD 298
           +E S   D   +    E  T  ++ H  ++       +     +V E++ NG L + L  
Sbjct: 41  KEGSMSEDEFFQ----EAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYL-- 94

Query: 299 VSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGL 358
                + L+      +   V  G+ +L    S   IH D+  RN L++ D+   +SD G+
Sbjct: 95  -RSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGM 150

Query: 359 AMAIPDG-YTRVLISYVLGTMAYI---APEYFQQPELSEKCDIFSFGMLL 404
              + D  Y        +GT   +   APE F   + S K D+++FG+L+
Sbjct: 151 TRYVLDDQYVS-----SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILM 195

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 92.7 bits (231), Expect = 5e-21
 Identities = 45/224 (20%), Positives = 85/224 (37%), Gaps = 39/224 (17%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGK----MIAIKKVIVYAPISAAELIEEDSKLRDSKLRQI 252
             ++G G  G VY+    G         +AIK V             E + +R+    + 
Sbjct: 30  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV------------NEAASMRE--RIEF 75

Query: 253 RSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDIL------DDVSRGRREL 306
            +E     +    +++ LL  + +    L++ E M  G L+  L         +      
Sbjct: 76  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPP 135

Query: 307 DWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG- 365
                 ++A  +A G+ YL+   +   +H D+  RN ++ +D    I D G+   I +  
Sbjct: 136 SLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 192

Query: 366 YTRVLISYVLGTMAYI-----APEYFQQPELSEKCDIFSFGMLL 404
           Y      Y  G    +     +PE  +    +   D++SFG++L
Sbjct: 193 Y------YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVL 230

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 92.3 bits (230), Expect = 6e-21
 Identities = 64/290 (22%), Positives = 111/290 (38%), Gaps = 48/290 (16%)

Query: 197 LEKIGSGGCGEVYKAE---LPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
            E +G GG  EV+ A          + +A+K       +  A+L  + S       R  R
Sbjct: 17  GEILGFGGMSEVHLARDLRD----HRDVAVK-------VLRADLARDPSFYL----R-FR 60

Query: 254 SEIITASQIRHRNILPLL----AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWP 309
            E   A+ + H  I+ +     A         +V E++   +L+DI+     G   +   
Sbjct: 61  REAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT--EGP--MTPK 116

Query: 310 SRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRV 369
               +       L + H      IIH D+KP N++++      + D G+A AI D    V
Sbjct: 117 RAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSV 173

Query: 370 LI-SYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEW 428
              + V+GT  Y++PE  +   +  + D++S G +L  ++ G P F     G+   SP  
Sbjct: 174 TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF----TGD---SPVS 226

Query: 429 --LRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNS 476
              + V     P  A    L  +        +  +       +PE R  +
Sbjct: 227 VAYQHVREDPIPPSARHEGLSAD--------LDAVVLKALAKNPENRYQT 268

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 91.6 bits (228), Expect = 8e-21
 Identities = 53/216 (24%), Positives = 83/216 (38%), Gaps = 33/216 (15%)

Query: 198 EKIGSGGCGEVYKAELPGSNGKMI--AIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSE 255
             IG G  G VY  E        I  AIK +               ++++   +     E
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL------------SRITEMQQ--VEAFLRE 72

Query: 256 IITASQIRHRNILPLLAHMVRPDCHLL-VYEFMKNGSLQDILDDVSRGRRELDWPSRHRI 314
            +    + H N+L L+  M+ P+     +  +M +G L   +      +R          
Sbjct: 73  GLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRS---PQRNPTVKDLISF 129

Query: 315 ALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG-YTRVLISY 373
            L VA G+EYL        +H D+  RN +L++     ++D GLA  I D  Y  V    
Sbjct: 130 GLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQ--- 183

Query: 374 VLGTMAYI-----APEYFQQPELSEKCDIFSFGMLL 404
                A +     A E  Q    + K D++SFG+LL
Sbjct: 184 -QHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLL 218

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 91.6 bits (228), Expect = 1e-20
 Identities = 57/229 (24%), Positives = 86/229 (37%), Gaps = 49/229 (21%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGK----MIAIKKVIVYAPISA-AELIEEDSKLRDSKLRQ 251
           +  +G G  GEVY+ ++ G         +A+K +          + + E           
Sbjct: 35  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLME----------- 83

Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRR------- 304
             + II  S+  H+NI+  +   ++     ++ E M  G L+  L    R  R       
Sbjct: 84  --ALII--SKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFL----RETRPRPSQPS 135

Query: 305 ELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN---DDMEACISDLGLAMA 361
            L       +A  +A G +YL        IH DI  RN LL        A I D G+A  
Sbjct: 136 SLAMLDLLHVARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 192

Query: 362 IPDG-YTRVLISYVLGTMAYI-----APEYFQQPELSEKCDIFSFGMLL 404
           I    Y R       G  A +      PE F +   + K D +SFG+LL
Sbjct: 193 IYRASYYRK------GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLL 235

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 92.4 bits (230), Expect = 1e-20
 Identities = 53/220 (24%), Positives = 89/220 (40%), Gaps = 31/220 (14%)

Query: 192 DCFASLEKIGSGGCGEVYKAELPGSNGKMI--AIKKVIVYAPISAAELIEEDSKLRDSKL 249
              +  + +G+G  GEV    L   + K I  AIK + V              K R   L
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY----------TEKQRRDFL 94

Query: 250 RQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWP 309
                E     Q  H NI+ L   + +    ++V E+M+NGSL   L    +   +    
Sbjct: 95  G----EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL---RKHDAQFTVI 147

Query: 310 SRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRV 369
               +  G+ASG++YL        +H D+  RN+L+N ++   +SD GL   + D     
Sbjct: 148 QLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPE-- 202

Query: 370 LISYVLGTMAYI-----APEYFQQPELSEKCDIFSFGMLL 404
             +        I     +PE     + +   D++S+G++L
Sbjct: 203 --AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVL 240

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 90.4 bits (225), Expect = 3e-20
 Identities = 72/337 (21%), Positives = 117/337 (34%), Gaps = 105/337 (31%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGK----MIAIKKVIVYAPISAAELIEEDSKLRDSKLRQI 252
            + +G G  G+V +A+  G +       +A+K +            +E +   +   R +
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML------------KEGATHSE--HRAL 77

Query: 253 RSEIITASQI-RHRNILPLLAHMVRPDCHLLV-YEFMKNGSLQDILDDVSRGRRELDWPS 310
            SE+     I  H N++ LL    +P   L+V  EF K G+L   L    R +R    P 
Sbjct: 78  MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----RSKRNEFVPY 133

Query: 311 RH----------------RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACIS 354
           +                   +  VA G+E+L    S   IH D+  RN+LL++     I 
Sbjct: 134 KVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKIC 190

Query: 355 DLGLAMAI-PDGYTRVLISYVLGTMAYI-----APEYFQQPELSEKCDIFSFGMLL---- 404
           D GLA  I  D        YV    A +     APE       + + D++SFG+LL    
Sbjct: 191 DFGLARDIYKDPD------YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 244

Query: 405 ---------ISLVRGVPSFVFHQNGE-----EICSPEWLRKVMNSKNPSRAIDPRLPGNG 450
                    + +       +  + G      +  +PE + + M                 
Sbjct: 245 SLGASPYPGVKIDEEFCRRL--KEGTRMRAPDYTTPE-MYQTMLD--------------- 286

Query: 451 YEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL 487
                         C   +P +RP    +   L  LL
Sbjct: 287 --------------CWHGEPSQRPTFSELVEHLGNLL 309

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 90.9 bits (226), Expect = 3e-20
 Identities = 57/229 (24%), Positives = 86/229 (37%), Gaps = 49/229 (21%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGK----MIAIKKVIVYAPISA-AELIEEDSKLRDSKLRQ 251
           +  +G G  GEVY+ ++ G         +A+K +          + + E           
Sbjct: 76  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLME----------- 124

Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRR------- 304
             + II  S+  H+NI+  +   ++     ++ E M  G L+  L    R  R       
Sbjct: 125 --ALII--SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL----RETRPRPSQPS 176

Query: 305 ELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN---DDMEACISDLGLAMA 361
            L       +A  +A G +YL        IH DI  RN LL        A I D G+A  
Sbjct: 177 SLAMLDLLHVARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 233

Query: 362 IPDG-YTRVLISYVLGTMAYI-----APEYFQQPELSEKCDIFSFGMLL 404
           I    Y R       G  A +      PE F +   + K D +SFG+LL
Sbjct: 234 IYRAGYYRK------GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLL 276

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 90.4 bits (225), Expect = 3e-20
 Identities = 56/215 (26%), Positives = 87/215 (40%), Gaps = 31/215 (14%)

Query: 197 LEKIGSGGCGEVYKAEL--PGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRS 254
            + IGSG  GEV    L  PG     +AIK             ++      + + R   S
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKA------------LKAGYT--ERQRRDFLS 99

Query: 255 EIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRI 314
           E     Q  H NI+ L   + R    ++V E+M+NGSL   L        +        +
Sbjct: 100 EASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL---RTHDGQFTIMQLVGM 156

Query: 315 ALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYV 374
             GV +G+ YL        +H D+  RNVL++ ++   +SD GL+  + D       +  
Sbjct: 157 LRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD----AAY 209

Query: 375 LGTMAYI-----APEYFQQPELSEKCDIFSFGMLL 404
             T   I     APE       S   D++SFG+++
Sbjct: 210 TTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVM 244

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 89.6 bits (223), Expect = 4e-20
 Identities = 46/222 (20%), Positives = 82/222 (36%), Gaps = 34/222 (15%)

Query: 190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMI--AIKKVIVYAPISAAELIEEDSKLRDS 247
           + +       IG G  G+V++          +  AIK                     DS
Sbjct: 13  QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS--------------DS 58

Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELD 307
              +   E +T  Q  H +I+ L+  ++  +   ++ E    G L+  L      +  LD
Sbjct: 59  VREKFLQEALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFL---QVRKYSLD 114

Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
             S    A  +++ L YL    S   +H DI  RNVL++ +    + D GL+  + D   
Sbjct: 115 LASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-- 169

Query: 368 RVLISYVLGTMAYI-----APEYFQQPELSEKCDIFSFGMLL 404
               +Y   +   +     APE       +   D++ FG+ +
Sbjct: 170 ----TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCM 207

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 90.1 bits (224), Expect = 4e-20
 Identities = 55/219 (25%), Positives = 95/219 (43%), Gaps = 28/219 (12%)

Query: 192 DCFASLEKIGSGGCGEVYKAELPGSNGKM---IAIKKVIVYAPISAAELIEEDSKLRDSK 248
            C    + IG+G  GEVYK  L  S+GK    +AIK            L    +   + +
Sbjct: 44  SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKT-----------LKAGYT---EKQ 89

Query: 249 LRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDW 308
                 E     Q  H NI+ L   + +    +++ E+M+NG+L   L        E   
Sbjct: 90  RVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFL---REKDGEFSV 146

Query: 309 PSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTR 368
                +  G+A+G++YL    + + +H D+  RN+L+N ++   +SD GL+  + D    
Sbjct: 147 LQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 203

Query: 369 VLISYVLGTMAYI---APEYFQQPELSEKCDIFSFGMLL 404
              +   G    I   APE     + +   D++SFG+++
Sbjct: 204 TYTT--SGGKIPIRWTAPEAISYRKFTSASDVWSFGIVM 240

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 89.6 bits (223), Expect = 5e-20
 Identities = 48/230 (20%), Positives = 93/230 (40%), Gaps = 46/230 (20%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGK----MIAIKKVIVYAPISAAELIEEDSKLRDSKLRQI 252
             ++G G  G+V+ AE    +      ++A+K +            ++ +    +  +  
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL------------KDPT---LAARKDF 64

Query: 253 RSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDIL------------DDVS 300
           + E    + ++H +I+         D  ++V+E+MK+G L   L                
Sbjct: 65  QREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPR 124

Query: 301 RGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAM 360
           + + EL       IA  +ASG+ YL    S   +H D+  RN L+  ++   I D G++ 
Sbjct: 125 QAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSR 181

Query: 361 AIPDG-YTRVLISYVLGTMAYI-----APEYFQQPELSEKCDIFSFGMLL 404
            +    Y RV      G    +      PE     + + + D++SFG++L
Sbjct: 182 DVYSTDYYRV------GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVIL 225

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 89.7 bits (223), Expect = 6e-20
 Identities = 63/234 (26%), Positives = 99/234 (42%), Gaps = 29/234 (12%)

Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           + +GSG CGEV  A       K +AIK +I     +     E D  L       + +EI 
Sbjct: 16  KTLGSGACGEVKLAFE-RKTCKKVAIK-IISKRKFAIGSAREADPALN------VETEIE 67

Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQD-ILDDVSRGR-RELDWPSRHRIA 315
              ++ H  I+ +       D ++ V E M+ G L D +   V   R +E     +    
Sbjct: 68  ILKKLNHPCIIKIKNFFDAEDYYI-VLELMEGGELFDKV---VGNKRLKEAT--CKL-YF 120

Query: 316 LGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC---ISDLGLAMAIPDGYTRVLIS 372
             +   ++YLH      IIH D+KP NVLL+   E C   I+D G +  + +     L+ 
Sbjct: 121 YQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET---SLMR 174

Query: 373 YVLGTMAYIAPEYFQQPEL---SEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI 423
            + GT  Y+APE          +   D +S G++L   + G P F  H+    +
Sbjct: 175 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL 228

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 89.3 bits (222), Expect = 6e-20
 Identities = 57/237 (24%), Positives = 89/237 (37%), Gaps = 49/237 (20%)

Query: 180 IEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSN---GKMIAIKKVIVYAPISAAE 236
             K  L  ++          +G G  G+V       +N   G+M+A+K            
Sbjct: 28  FHKRYLKKIRD---------LGEGHFGKVSLYCYDPTNDGTGEMVAVKA----------- 67

Query: 237 LIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA--HMVRPDCHLLVYEFMKNGSLQD 294
           L  +            + EI     + H +I+               LV E++  GSL+D
Sbjct: 68  LKADAG---PQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRD 124

Query: 295 ILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACIS 354
            L      R  +        A  +  G+ YLH   +   IH D+  RNVLL++D    I 
Sbjct: 125 YLP-----RHSIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIG 176

Query: 355 DLGLAMAIPDG--YTRVLISYVLGTMAYI-----APEYFQQPELSEKCDIFSFGMLL 404
           D GLA A+P+G  Y      Y +           APE  ++ +     D++SFG+ L
Sbjct: 177 DFGLAKAVPEGHEY------YRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTL 227

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 88.5 bits (220), Expect = 8e-20
 Identities = 48/241 (19%), Positives = 94/241 (39%), Gaps = 53/241 (21%)

Query: 180 IEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKM------IAIKKVIVYAPIS 233
           I  EDL F +          +G G   +++K                + +K         
Sbjct: 5   IRNEDLIFNES---------LGQGTFTKIFKGVRREVGDYGQLHETEVLLKV-------- 47

Query: 234 AAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQ 293
              L +      +S            S++ H++++      V  D ++LV EF+K GSL 
Sbjct: 48  ---LDKAHRNYSESFFE----AASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLD 100

Query: 294 DILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC- 352
             L    + +  ++   +  +A  +A+ + +L      ++IHG++  +N+LL  + +   
Sbjct: 101 TYL---KKNKNCINILWKLEVAKQLAAAMHFL---EENTLIHGNVCAKNILLIREEDRKT 154

Query: 353 -------ISDLGLAMAI-PDGYTRVLISYVLGTMAYIAPEYFQQP-ELSEKCDIFSFGML 403
                  +SD G+++ + P    +  I +V        PE  + P  L+   D +SFG  
Sbjct: 155 GNPPFIKLSDPGISITVLPKDILQERIPWV-------PPECIENPKNLNLATDKWSFGTT 207

Query: 404 L 404
           L
Sbjct: 208 L 208

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 90.9 bits (226), Expect = 9e-20
 Identities = 72/243 (29%), Positives = 104/243 (42%), Gaps = 36/243 (14%)

Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           +K+GSG  GEV             AIK +               + +  S   ++  E+ 
Sbjct: 43  KKLGSGAYGEVLLCRDK-VTHVERAIKII-------------RKTSVSTSSNSKLLEEVA 88

Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGR-RELDWPSRHRIAL 316
               + H NI+ L         + LV E  K G L D +  + R +  E+D      I  
Sbjct: 89  VLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEI--IHRMKFNEVD---AAVIIK 143

Query: 317 GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC---ISDLGLAMAIPDGYTRVLISY 373
            V SG+ YLH     +I+H D+KP N+LL    +     I D GL+    +      +  
Sbjct: 144 QVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK---MKE 197

Query: 374 VLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVM 433
            LGT  YIAPE  ++    EKCD++S G++L  L+ G P F   Q  +EI     LRKV 
Sbjct: 198 RLGTAYYIAPEVLRKK-YDEKCDVWSIGVILFILLAGYPPF-GGQTDQEI-----LRKVE 250

Query: 434 NSK 436
             K
Sbjct: 251 KGK 253

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 88.8 bits (221), Expect = 9e-20
 Identities = 67/246 (27%), Positives = 106/246 (43%), Gaps = 44/246 (17%)

Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           E +GSG   EV+  +     GK+ A+K +                K    +   + +EI 
Sbjct: 15  EVLGSGAFSEVFLVK-QRLTGKLFALKCI---------------KKSPAFRDSSLENEIA 58

Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQD-ILDDVSRGR-RELDWPSRHRIA 315
              +I+H NI+ L         + LV + +  G L D I   + RG   E D  +   + 
Sbjct: 59  VLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRI---LERGVYTEKD--ASL-VI 112

Query: 316 LGVASGLEYLHMYHSASIIHGDIKPRNVLL---NDDMEACISDLGLAMAIPDGYTRVLIS 372
             V S ++YLH      I+H D+KP N+L     ++ +  I+D GL+    +G    ++S
Sbjct: 113 QQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IMS 165

Query: 373 YVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF-------VFHQ--NGE-E 422
              GT  Y+APE   Q   S+  D +S G++   L+ G P F       +F +   G  E
Sbjct: 166 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYE 225

Query: 423 ICSPEW 428
             SP W
Sbjct: 226 FESPFW 231

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 88.9 bits (221), Expect = 9e-20
 Identities = 49/227 (21%), Positives = 86/227 (37%), Gaps = 42/227 (18%)

Query: 190 KEDCFASLEKIGSGGCGEVYKAEL--PGSNGKM-IAIKKVIVYAPISAAELIEEDSKLRD 246
           KE  F  ++ +GSG  G VYK      G   K+ +AIK+                  LR+
Sbjct: 13  KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE------------------LRE 54

Query: 247 SKLRQIRSEIIT-AS---QIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG 302
           +   +   EI+  A     + + ++  LL  +       L+ + M  G L D +      
Sbjct: 55  ATSPKANKEILDEAYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYV---REH 110

Query: 303 RRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI 362
           +  +         + +A G+ YL       ++H D+  RNVL+       I+D GLA  +
Sbjct: 111 KDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167

Query: 363 P--DGYTRVLISYVLGTMAYI---APEYFQQPELSEKCDIFSFGMLL 404
              +           G    I   A E       + + D++S+G+ +
Sbjct: 168 GAEEKEYH-----AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTV 209

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 88.0 bits (219), Expect = 1e-19
 Identities = 42/225 (18%), Positives = 79/225 (35%), Gaps = 40/225 (17%)

Query: 190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMI--AIKKVIVYAPISAAELIEEDSKLRDS 247
             +       +G G  GEVY+       G+ I  A+K                    +  
Sbjct: 10  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKT------------------CKKD 51

Query: 248 KLRQIRSEIIT-AS---QIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGR 303
                + + ++ A     + H +I+ L+  ++  +   ++ E    G L   L    R +
Sbjct: 52  CTLDNKEKFMSEAVIMKNLDHPHIVKLIG-IIEEEPTWIIMELYPYGELGHYL---ERNK 107

Query: 304 RELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
             L   +    +L +   + YL    S + +H DI  RN+L+       + D GL+  I 
Sbjct: 108 NSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIE 164

Query: 364 DG-YTRVLISYVLGTMAYI---APEYFQQPELSEKCDIFSFGMLL 404
           D  Y +        T   I   +PE       +   D++ F + +
Sbjct: 165 DEDYYK-----ASVTRLPIKWMSPESINFRRFTTASDVWMFAVCM 204

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 88.9 bits (221), Expect = 1e-19
 Identities = 55/233 (23%), Positives = 95/233 (40%), Gaps = 48/233 (20%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGK------MIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
            + +G G  G+V  AE  G +         +A+K +            ++D+  +D  L 
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML------------KDDATEKD--LS 85

Query: 251 QIRSEIITASQI-RHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDIL------------D 297
            + SE+     I +H+NI+ LL    +     ++ E+   G+L++ L            D
Sbjct: 86  DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 145

Query: 298 DVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLG 357
                  ++ +         +A G+EYL    S   IH D+  RNVL+ ++    I+D G
Sbjct: 146 INRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFG 202

Query: 358 LAMAI-PDGYTRVLISYVLGTMAYI-----APEYFQQPELSEKCDIFSFGMLL 404
           LA  I    Y      Y   T   +     APE       + + D++SFG+L+
Sbjct: 203 LARDINNIDY------YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 249

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 88.1 bits (219), Expect = 2e-19
 Identities = 49/223 (21%), Positives = 92/223 (41%), Gaps = 34/223 (15%)

Query: 190 KEDCFASLEKIGSGGCGEVYKAEL--PGSNGKM-IAIKKVIVYAPISAAELIEEDSKLRD 246
           KE     L+ +GSG  G V+K      G + K+ + IK             IE+ S  + 
Sbjct: 11  KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKV------------IEDKSGRQS 58

Query: 247 SKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRREL 306
              + +   ++    + H +I+ LL  +       LV +++  GSL D +    + R  L
Sbjct: 59  --FQAVTDHMLAIGSLDHAHIVRLLG-LCPGSSLQLVTQYLPLGSLLDHV---RQHRGAL 112

Query: 307 DWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGY 366
                    + +A G+ YL       ++H ++  RNVLL    +  ++D G+A  +P   
Sbjct: 113 GPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD- 168

Query: 367 TRVLISYVLGTMAYI-----APEYFQQPELSEKCDIFSFGMLL 404
                  +L + A       A E     + + + D++S+G+ +
Sbjct: 169 ----DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTV 207

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 89.8 bits (223), Expect = 2e-19
 Identities = 65/221 (29%), Positives = 94/221 (42%), Gaps = 29/221 (13%)

Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
             +G G  GEV   +     G+  A+K       IS  ++ ++  K        +  E+ 
Sbjct: 32  RVLGKGSFGEVILCKDK-ITGQECAVKV------ISKRQVKQKTDK------ESLLREVQ 78

Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGR-RELDWPSRHRIAL 316
              Q+ H NI+ L           LV E    G L D +  +SR R  E+D     RI  
Sbjct: 79  LLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI--ISRKRFSEVD---AARIIR 133

Query: 317 GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC---ISDLGLAMAIPDGYTRVLISY 373
            V SG+ Y+H      I+H D+KP N+LL    +     I D GL+           +  
Sbjct: 134 QVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK---MKD 187

Query: 374 VLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
            +GT  YIAPE        EKCD++S G++L  L+ G P F
Sbjct: 188 KIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPF 227

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 89.8 bits (223), Expect = 2e-19
 Identities = 72/243 (29%), Positives = 112/243 (46%), Gaps = 25/243 (10%)

Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
            K+GSG  GEV   +   +     AIK VI  +        +++  +      +I +EI 
Sbjct: 42  RKLGSGAYGEVLLCKEK-NGHSEKAIK-VIKKSQFDKGRYSDDNKNIEKFH-EEIYNEIS 98

Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGR-RELDWPSRHRIAL 316
               + H NI+ L           LV EF + G L + +  ++R +  E D      I  
Sbjct: 99  LLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI--INRHKFDECD---AANIMK 153

Query: 317 GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC---ISDLGLAMAIPDGYTRVLISY 373
            + SG+ YLH     +I+H DIKP N+LL +        I D GL+      Y    +  
Sbjct: 154 QILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK---LRD 207

Query: 374 VLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVM 433
            LGT  YIAPE  ++ + +EKCD++S G+++  L+ G P F   QN ++I     ++KV 
Sbjct: 208 RLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPF-GGQNDQDI-----IKKVE 260

Query: 434 NSK 436
             K
Sbjct: 261 KGK 263

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 87.3 bits (217), Expect = 2e-19
 Identities = 60/251 (23%), Positives = 100/251 (39%), Gaps = 40/251 (15%)

Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           E +G G    V +        K  A+K       I         ++           E+ 
Sbjct: 23  EILGRGVSSVVRRCIHK-PTCKEYAVKI------IDVTGGGSFSAEEVQELREATLKEV- 74

Query: 258 TASQI-----RHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGR-RELDWPSR 311
               I      H NI+ L           LV++ MK G L D L    +    E +  +R
Sbjct: 75  ---DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL--TEKVTLSEKE--TR 127

Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLI 371
             I   +   +  LH     +I+H D+KP N+LL+DDM   ++D G +  +  G     +
Sbjct: 128 K-IMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG---EKL 180

Query: 372 SYVLGTMAYIAPE------YFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICS 425
             V GT +Y+APE          P   ++ D++S G+++ +L+ G P F +H+    +  
Sbjct: 181 REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF-WHRKQMLM-- 237

Query: 426 PEWLRKVMNSK 436
              LR +M+  
Sbjct: 238 ---LRMIMSGN 245

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 89.9 bits (223), Expect = 3e-19
 Identities = 49/232 (21%), Positives = 87/232 (37%), Gaps = 43/232 (18%)

Query: 180 IEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMI--AIKKVIVYAPISAAEL 237
           I++E +   +          IG G  G+V++          +  AIK             
Sbjct: 387 IQRERIELGRC---------IGEGQFGDVHQGIYMSPENPAMAVAIKT-----------C 426

Query: 238 IEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILD 297
               S   DS   +   E +T  Q  H +I+ L+  ++  +   ++ E    G L+  L 
Sbjct: 427 KNCTS---DSVREKFLQEALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFL- 481

Query: 298 DVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLG 357
                +  LD  S    A  +++ L YL    S   +H DI  RNVL++ +    + D G
Sbjct: 482 --QVRKFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFG 536

Query: 358 LAMAIPDGYTRVLISYVLGTMAYI-----APEYFQQPELSEKCDIFSFGMLL 404
           L+  + D       +Y   +   +     APE       +   D++ FG+ +
Sbjct: 537 LSRYMEDS------TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCM 582

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 86.9 bits (216), Expect = 3e-19
 Identities = 55/232 (23%), Positives = 101/232 (43%), Gaps = 49/232 (21%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGK----MIAIKKVIVYAPISAAELIEEDSKLRDSKLRQI 252
           +E++G    G+VYK  L G         +AIK +            ++ ++       + 
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL------------KDKAEGPL--REEF 59

Query: 253 RSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDIL------------DDVS 300
           R E +  ++++H N++ LL  + +     +++ +  +G L + L            DD  
Sbjct: 60  RHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDR 119

Query: 301 RGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAM 360
             +  L+ P    +   +A+G+EYL    S  ++H D+  RNVL+ D +   ISDLGL  
Sbjct: 120 TVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLF- 175

Query: 361 AIPDGYTRVLIS---YVLGTMAYI-----APEYFQQPELSEKCDIFSFGMLL 404
                  R + +   Y L   + +     APE     + S   DI+S+G++L
Sbjct: 176 -------REVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVL 220

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 88.2 bits (219), Expect = 3e-19
 Identities = 55/233 (23%), Positives = 95/233 (40%), Gaps = 48/233 (20%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGK------MIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
            + +G G  G+V  AE  G +         +A+K +            ++D+  +D  L 
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML------------KDDATEKD--LS 131

Query: 251 QIRSEIITASQI-RHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDIL------------D 297
            + SE+     I +H+NI+ LL    +     ++ E+   G+L++ L            D
Sbjct: 132 DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 191

Query: 298 DVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLG 357
                  ++ +         +A G+EYL    S   IH D+  RNVL+ ++    I+D G
Sbjct: 192 INRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFG 248

Query: 358 LAMAI-PDGYTRVLISYVLGTMAYI-----APEYFQQPELSEKCDIFSFGMLL 404
           LA  I    Y      Y   T   +     APE       + + D++SFG+L+
Sbjct: 249 LARDINNIDY------YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 295

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 87.4 bits (217), Expect = 4e-19
 Identities = 55/277 (19%), Positives = 97/277 (35%), Gaps = 35/277 (12%)

Query: 166 GGSRDRGPTIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKK 225
           G     G       +  +D+ F   ED +   E IG G    V +       G+  A+K 
Sbjct: 1   GSPGISGGGGGILDMADDDVLF---EDVYELCEVIGKGPFSVVRRCINR-ETGQQFAVKI 56

Query: 226 VIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYE 285
                 +  A+         +     ++ E      ++H +I+ LL          +V+E
Sbjct: 57  ------VDVAKFTSSPGLSTED----LKREASICHMLKHPHIVELLETYSSDGMLYMVFE 106

Query: 286 FMKNGSLQDILDDVSRGRRELDWPSRH--RIALGVASGLEYLHMYHSASIIHGDIKPRNV 343
           FM    L   +  V R      +           +   L Y H     +IIH D+KP  V
Sbjct: 107 FMDGADLCFEI--VKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCV 161

Query: 344 LL---NDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSF 400
           LL    +     +   G+A+ + +          +GT  ++APE  ++    +  D++  
Sbjct: 162 LLASKENSAPVKLGGFGVAIQLGESGLV--AGGRVGTPHFMAPEVVKREPYGKPVDVWGC 219

Query: 401 GMLLISLVRGVPSFVFHQNG--EEIC-------SPEW 428
           G++L  L+ G   F   +    E I          +W
Sbjct: 220 GVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQW 256

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 86.6 bits (215), Expect = 7e-19
 Identities = 52/240 (21%), Positives = 89/240 (37%), Gaps = 57/240 (23%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGK----MIAIKKVIVYAPISAAELIEEDSKLRDSKLRQI 252
           +  IG G  G V++A  PG        M+A+K +            +E++          
Sbjct: 52  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML------------KEEASADM--QADF 97

Query: 253 RSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDIL---------------- 296
           + E    ++  + NI+ LL          L++E+M  G L + L                
Sbjct: 98  QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 157

Query: 297 ----DDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC 352
                  S G   L    +  IA  VA+G+ YL        +H D+  RN L+ ++M   
Sbjct: 158 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVK 214

Query: 353 ISDLGLAMAIPDGYTRVLIS---YVLGTMAYI-----APEYFQQPELSEKCDIFSFGMLL 404
           I+D GL+        R + S   Y       I      PE       + + D++++G++L
Sbjct: 215 IADFGLS--------RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVL 266

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 86.3 bits (214), Expect = 8e-19
 Identities = 59/216 (27%), Positives = 89/216 (41%), Gaps = 20/216 (9%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           +  +GSG  G V+ A       K + +K           E + ED  + D KL ++  EI
Sbjct: 29  MSPLGSGAFGFVWTAVDK-EKNKEVVVK-------FIKKEKVLEDCWIEDPKLGKVTLEI 80

Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGS-LQDILDDVSRGRRELDWPSRHRIA 315
              S++ H NI+ +L          LV E   +G  L   +      R  LD P    I 
Sbjct: 81  AILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFI--DRHPR--LDEPLASYIF 136

Query: 316 LGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVL 375
             + S + YL       IIH DIK  N+++ +D    + D G A  +  G    L     
Sbjct: 137 RQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK---LFYTFC 190

Query: 376 GTMAYIAPEYFQ-QPELSEKCDIFSFGMLLISLVRG 410
           GT+ Y APE     P    + +++S G+ L +LV  
Sbjct: 191 GTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFE 226

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 87.0 bits (216), Expect = 8e-19
 Identities = 58/232 (25%), Positives = 93/232 (40%), Gaps = 46/232 (19%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGK------MIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
            + +G G  G+V  AE  G +         +A+K +            + D+  +D  L 
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML------------KSDATEKD--LS 119

Query: 251 QIRSEIITASQI-RHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDIL------------D 297
            + SE+     I +H+NI+ LL    +     ++ E+   G+L++ L            +
Sbjct: 120 DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYN 179

Query: 298 DVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLG 357
                  +L        A  VA G+EYL    S   IH D+  RNVL+ +D    I+D G
Sbjct: 180 PSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFG 236

Query: 358 LAMAIPDGYTRVLISYVLGTMAYI-----APEYFQQPELSEKCDIFSFGMLL 404
           LA  I          Y   T   +     APE       + + D++SFG+LL
Sbjct: 237 LARDIHHIDY-----YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLL 283

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 86.0 bits (213), Expect = 1e-18
 Identities = 58/283 (20%), Positives = 91/283 (32%), Gaps = 66/283 (23%)

Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
             IG G  G V  A        + AIK       ++  ++ + + K  +     I++E+ 
Sbjct: 32  GAIGQGSYGVVRVAIEN-QTRAIRAIKI------MNKNKIRQINPKDVER----IKTEVR 80

Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALG 317
              ++ H NI  L           LV E    G L D L             +   +   
Sbjct: 81  LMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKL--NVFIDDSTGKCAMDVVKTQ 138

Query: 318 --------------------------------------VASGLEYLHMYHSASIIHGDIK 339
                                                 + S L YLH   +  I H DIK
Sbjct: 139 ICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIK 195

Query: 340 PRNVLLNDDMEAC--ISDLGLAMAIP--DGYTRVLISYVLGTMAYIAPE--YFQQPELSE 393
           P N L + +      + D GL+      +      ++   GT  ++APE           
Sbjct: 196 PENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP 255

Query: 394 KCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSK 436
           KCD +S G+LL  L+ G   F    N  +      + +V+N K
Sbjct: 256 KCDAWSAGVLLHLLLMGAVPF-PGVNDADT-----ISQVLNKK 292

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 86.3 bits (214), Expect = 1e-18
 Identities = 65/229 (28%), Positives = 103/229 (44%), Gaps = 37/229 (16%)

Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           + +L+ IGSG  G V  A       + +AIKK      +S     +  +K      R  R
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAIL-ERNVAIKK------LSRPFQNQTHAK------RAYR 73

Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHL-------LVYEFMKNGSLQDILDDVSRGRREL 306
            E++    + H+NI+ LL ++  P   L       +V E M + +L  ++      + EL
Sbjct: 74  -ELVLMKCVNHKNIIGLL-NVFTPQKSLEEFQDVYIVMELM-DANLCQVI------QMEL 124

Query: 307 DWPSRHRIAL-GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG 365
           D   R    L  +  G+++LH   SA IIH D+KP N+++  D    I D GLA      
Sbjct: 125 D-HERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 180

Query: 366 YTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
           +  ++  YV  T  Y APE        E  DI+S G ++  +++G   F
Sbjct: 181 F--MMTPYV-VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 226

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 85.0 bits (211), Expect = 2e-18
 Identities = 67/244 (27%), Positives = 103/244 (42%), Gaps = 38/244 (15%)

Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
             +G G  GEV K +      +  A+K +               +  ++     I  E+ 
Sbjct: 28  CMLGKGSFGEVLKCK-DRITQQEYAVKVI-------------NKASAKNKDTSTILREVE 73

Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQD-ILDDVSRGR-RELDWPSRHRIA 315
              ++ H NI+ L   +       +V E    G L D I   + R R  E D     RI 
Sbjct: 74  LLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI---IKRKRFSEHD---AARII 127

Query: 316 LGVASGLEYLHMYHSASIIHGDIKPRNVLL---NDDMEACISDLGLAMAIPDGYTRVLIS 372
             V SG+ Y+H     +I+H D+KP N+LL     D +  I D GL+           + 
Sbjct: 128 KQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MK 181

Query: 373 YVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKV 432
             +GT  YIAPE  +     EKCD++S G++L  L+ G P F + +N  +I     L++V
Sbjct: 182 DRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPF-YGKNEYDI-----LKRV 234

Query: 433 MNSK 436
              K
Sbjct: 235 ETGK 238

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 85.0 bits (211), Expect = 2e-18
 Identities = 54/229 (23%), Positives = 91/229 (39%), Gaps = 27/229 (11%)

Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIK-----------KVIVYAPISAAELIEEDSKLRD 246
           ++IG G  G V  A          A+K                 P               
Sbjct: 19  DEIGKGSYGVVKLAYNEND-NTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPR 77

Query: 247 SKLRQIRSEIITASQIRHRNILPLLAHMVRP-DCHL-LVYEFMKNGSLQDILDDVSRGRR 304
             + Q+  EI    ++ H N++ L+  +  P + HL +V+E +  G + ++    +    
Sbjct: 78  GPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV---PTLKP- 133

Query: 305 ELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPD 364
            L           +  G+EYLH      IIH DIKP N+L+ +D    I+D G++     
Sbjct: 134 -LSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVS-NEFK 188

Query: 365 GYTRVLISYVLGTMAYIAPEYFQQPELS---EKCDIFSFGMLLISLVRG 410
           G   +L + V GT A++APE   +       +  D+++ G+ L   V G
Sbjct: 189 GSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFG 236

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 84.5 bits (210), Expect = 2e-18
 Identities = 60/250 (24%), Positives = 103/250 (41%), Gaps = 49/250 (19%)

Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           E++G G    V +     + G   A K +I               KL     +++  E  
Sbjct: 12  EELGKGAFSVVRRCVHK-TTGLEFAAK-II------------NTKKLSARDFQKLEREAR 57

Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGR-RELDWPSRHRIAL 316
              +++H NI+ L   +     H LV++ +  G L + +  V+R    E D  + H    
Sbjct: 58  ICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI--VAREFYSEAD--ASH-CIQ 112

Query: 317 GVASGLEYLHMYHSASIIHGDIKPRNVLL---NDDMEACISDLGLAMAIPDG---YTRVL 370
            +   + Y H   S  I+H ++KP N+LL          ++D GLA+ + D    +    
Sbjct: 113 QILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA- 168

Query: 371 ISYVLGTMAYIAPEYFQQPELSEKCDIFSFG-MLLISLVRGVPSFVFHQNGEEIC----- 424
                GT  Y++PE  ++   S+  DI++ G +L I LV G P F + ++   +      
Sbjct: 169 -----GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLV-GYPPF-WDEDQHRLYAQIKA 221

Query: 425 ------SPEW 428
                 SPEW
Sbjct: 222 GAYDYPSPEW 231

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 87.0 bits (216), Expect = 2e-18
 Identities = 66/243 (27%), Positives = 103/243 (42%), Gaps = 36/243 (14%)

Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
             +G G  GEV K +      +  A+K +               +  ++     I  E+ 
Sbjct: 28  CMLGKGSFGEVLKCKDR-ITQQEYAVKVI-------------NKASAKNKDTSTILREVE 73

Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGR-RELDWPSRHRIAL 316
              ++ H NI+ L   +       +V E    G L D +  + R R  E D     RI  
Sbjct: 74  LLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI--IKRKRFSEHD---AARIIK 128

Query: 317 GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC---ISDLGLAMAIPDGYTRVLISY 373
            V SG+ Y+H     +I+H D+KP N+LL    + C   I D GL+           +  
Sbjct: 129 QVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKD 182

Query: 374 VLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVM 433
            +GT  YIAPE  +     EKCD++S G++L  L+ G P F + +N  +I     L++V 
Sbjct: 183 RIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPF-YGKNEYDI-----LKRVE 235

Query: 434 NSK 436
             K
Sbjct: 236 TGK 238

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 85.4 bits (212), Expect = 2e-18
 Identities = 57/219 (26%), Positives = 95/219 (43%), Gaps = 25/219 (11%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           L+ IG G   +V  A    + G+ +AIK             I + ++L  + L+++  E+
Sbjct: 20  LKTIGKGNFAKVKLARHILT-GREVAIK-------------IIDKTQLNPTSLQKLFREV 65

Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL 316
                + H NI+ L   +       L+ E+   G + D L  V+ GR  +          
Sbjct: 66  RIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYL--VAHGR--MKEKEARSKFR 121

Query: 317 GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLG 376
            + S ++Y H      I+H D+K  N+LL+ DM   I+D G +     G     +    G
Sbjct: 122 QIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG---KLDAFCG 175

Query: 377 TMAYIAPEYFQ-QPELSEKCDIFSFGMLLISLVRGVPSF 414
              Y APE FQ +     + D++S G++L +LV G   F
Sbjct: 176 APPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 214

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 85.0 bits (211), Expect = 2e-18
 Identities = 53/240 (22%), Positives = 92/240 (38%), Gaps = 57/240 (23%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGK----MIAIKKVIVYAPISAAELIEEDSKLRDSKLRQI 252
            + +G G  G+V KA      G+     +A+K +            +E++   +  LR +
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML------------KENASPSE--LRDL 73

Query: 253 RSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDIL---------------- 296
            SE     Q+ H +++ L     +    LL+ E+ K GSL+  L                
Sbjct: 74  LSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGS 133

Query: 297 ----DDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC 352
                      R L        A  ++ G++YL       ++H D+  RN+L+ +  +  
Sbjct: 134 RNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMK 190

Query: 353 ISDLGLAMAIPDGYTRVLIS---YVLGTMAYI-----APEYFQQPELSEKCDIFSFGMLL 404
           ISD GL+        R +     YV  +   I     A E       + + D++SFG+LL
Sbjct: 191 ISDFGLS--------RDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLL 242

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 85.4 bits (212), Expect = 2e-18
 Identities = 59/250 (23%), Positives = 102/250 (40%), Gaps = 49/250 (19%)

Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           E++G G    V +     + G   A K +                KL     +++  E  
Sbjct: 35  EELGKGAFSVVRRCVHK-TTGLEFAAKII-------------NTKKLSARDFQKLEREAR 80

Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGR-RELDWPSRHRIAL 316
              +++H NI+ L   +     H LV++ +  G L + +  V+R    E D  + H    
Sbjct: 81  ICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI--VAREFYSEAD--ASH-CIQ 135

Query: 317 GVASGLEYLHMYHSASIIHGDIKPRNVLL---NDDMEACISDLGLAMAIPDG---YTRVL 370
            +   + Y H   S  I+H ++KP N+LL          ++D GLA+ + D    +    
Sbjct: 136 QILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA- 191

Query: 371 ISYVLGTMAYIAPEYFQQPELSEKCDIFSFG-MLLISLVRGVPSFVFHQNGEEI------ 423
                GT  Y++PE  ++   S+  DI++ G +L I LV G P F + ++   +      
Sbjct: 192 -----GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLV-GYPPF-WDEDQHRLYAQIKA 244

Query: 424 -----CSPEW 428
                 SPEW
Sbjct: 245 GAYDYPSPEW 254

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 86.8 bits (215), Expect = 2e-18
 Identities = 50/226 (22%), Positives = 89/226 (39%), Gaps = 27/226 (11%)

Query: 191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
            D +   E++G+G  G V++     + G   A K V                   +S   
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERAT-GNNFAAKFV---------------MTPHESDKE 199

Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPS 310
            +R EI T S +RH  ++ L       +  +++YEFM  G L    + V+    ++    
Sbjct: 200 TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGEL---FEKVADEHNKMSEDE 256

Query: 311 RHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACI--SDLGLAMAIPDGYTR 368
                  V  GL ++H     + +H D+KP N++        +   D GL   +    + 
Sbjct: 257 AVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS- 312

Query: 369 VLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
             +    GT  + APE  +   +    D++S G+L   L+ G+  F
Sbjct: 313 --VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPF 356

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 84.6 bits (210), Expect = 2e-18
 Identities = 54/237 (22%), Positives = 90/237 (37%), Gaps = 56/237 (23%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGK----MIAIKKVIVYAPISAAELIEEDSKLRDSKLRQI 252
            + +G+G  G+V +A   G         +A+K +            +  + L +     +
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML------------KPSAHLTE--REAL 73

Query: 253 RSEIITASQI-RHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
            SE+   S +  H NI+ LL         L++ E+   G L + L    R +R+    S+
Sbjct: 74  MSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL----RRKRDSFICSK 129

Query: 312 H------------------RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACI 353
                                +  VA G+ +L    S + IH D+  RN+LL       I
Sbjct: 130 TSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKI 186

Query: 354 SDLGLAMAI-PDGYTRVLISYVLGTMAYI-----APEYFQQPELSEKCDIFSFGMLL 404
            D GLA  I  D        YV+   A +     APE       + + D++S+G+ L
Sbjct: 187 CDFGLARDIKNDSN------YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFL 237

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 83.8 bits (208), Expect = 3e-18
 Identities = 60/245 (24%), Positives = 100/245 (40%), Gaps = 37/245 (15%)

Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
            K+GSG  G+V+  E   S G    IK +              +       + QI +EI 
Sbjct: 28  RKLGSGAFGDVHLVEERSS-GLERVIKTI--------------NKDRSQVPMEQIEAEIE 72

Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQD-ILDDVSRGRR--ELDWPSRHRI 314
               + H NI+ +           +V E  + G L + I+   +RG+   E        +
Sbjct: 73  VLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGY---VAEL 129

Query: 315 ALGVASGLEYLHMYHSASIIHGDIKPRNVLL---NDDMEACISDLGLAMAIPDGYTRVLI 371
              + + L Y H   S  ++H D+KP N+L    +      I D GLA            
Sbjct: 130 MKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD---EHS 183

Query: 372 SYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRK 431
           +   GT  Y+APE F++ +++ KCDI+S G+++  L+ G   F    + EE+      +K
Sbjct: 184 TNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPF-TGTSLEEV-----QQK 236

Query: 432 VMNSK 436
               +
Sbjct: 237 ATYKE 241

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 84.2 bits (209), Expect = 4e-18
 Identities = 58/236 (24%), Positives = 102/236 (43%), Gaps = 40/236 (16%)

Query: 192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYA-----PISAAELIEEDSKLRD 246
             +  + +IG G  G+V+KA    + G+ +A+K+V V       P+S          +R+
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLST---------IRE 61

Query: 247 -SKLRQIRSEIITASQIRHRNILPLL--AHMVRPDCHL---LVYEFMKNGSLQDILDDVS 300
            + LR + +         H N++ L     + R D      LV+E +    L   LD V 
Sbjct: 62  VAVLRHLETF-------EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVP 113

Query: 301 RGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAM 360
                +   +   +   +  GL++L   HS  ++H D+KP+N+L+    +  ++D GLA 
Sbjct: 114 EPG--VPTETIKDMMFQLLRGLDFL---HSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 168

Query: 361 A--IPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
                   T V++     T+ Y APE   Q   +   D++S G +   + R  P F
Sbjct: 169 IYSFQMALTSVVV-----TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF 219

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 86.0 bits (213), Expect = 5e-18
 Identities = 66/249 (26%), Positives = 102/249 (40%), Gaps = 31/249 (12%)

Query: 192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ 251
           + F     +G GG GEV   ++  + GKM A KK            +E+    +      
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRAT-GKMYACKK------------LEKKRIKKRKGEAM 230

Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
             +E     ++  R ++ L       D   LV   M  G L+  +  + +         R
Sbjct: 231 ALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEA---R 287

Query: 312 HRI-ALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG---YT 367
               A  +  GLE LH      I++ D+KP N+LL+D     ISDLGLA+ +P+G     
Sbjct: 288 AVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG 344

Query: 368 RVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPE 427
           RV      GT+ Y+APE  +    +   D ++ G LL  ++ G     F Q  ++I   E
Sbjct: 345 RV------GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP--FQQRKKKIKREE 396

Query: 428 WLRKVMNSK 436
             R V    
Sbjct: 397 VERLVKEVP 405

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 83.8 bits (208), Expect = 5e-18
 Identities = 71/246 (28%), Positives = 115/246 (46%), Gaps = 41/246 (16%)

Query: 178 PLIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYA-----PI 232
               +E+L F    + +  LEK+G G  G VYKA+   S G+++A+K++ + A     P 
Sbjct: 7   HSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAK--DSQGRIVALKRIRLDAEDEGIPS 64

Query: 233 SAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSL 292
           +A                 IR EI    ++ H NI+ L+  +    C  LV+EFM+   L
Sbjct: 65  TA-----------------IR-EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DL 105

Query: 293 QDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC 352
           + +LD+   G   L           +  G+ + H +    I+H D+KP+N+L+N D    
Sbjct: 106 KKVLDENKTG---LQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALK 159

Query: 353 ISDLGLAMA--IPDG-YTRVLISYVLGTMAYIAPEY-FQQPELSEKCDIFSFGMLLISLV 408
           ++D GLA A  IP   YT  ++     T+ Y AP+      + S   DI+S G +   ++
Sbjct: 160 LADFGLARAFGIPVRSYTHEVV-----TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMI 214

Query: 409 RGVPSF 414
            G P F
Sbjct: 215 TGKPLF 220

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 83.9 bits (208), Expect = 6e-18
 Identities = 52/229 (22%), Positives = 89/229 (38%), Gaps = 44/229 (19%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGK----MIAIKKVIVYAPISAAELIEEDSKLRDSKLRQI 252
            + +G+G  G+V +A   G   +     +A+K +            +  +   +     +
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML------------KSTAHADE--KEAL 96

Query: 253 RSEIITASQI-RHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDIL----------DDVSR 301
            SE+   S + +H NI+ LL         L++ E+   G L + L             + 
Sbjct: 97  MSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAI 156

Query: 302 GRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMA 361
                        +  VA G+ +L    S + IH D+  RNVLL +   A I D GLA  
Sbjct: 157 ANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARD 213

Query: 362 I-PDGYTRVLISYVLGTMAYI-----APEYFQQPELSEKCDIFSFGMLL 404
           I  D        Y++   A +     APE       + + D++S+G+LL
Sbjct: 214 IMNDSN------YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILL 256

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 83.8 bits (208), Expect = 6e-18
 Identities = 59/228 (25%), Positives = 100/228 (43%), Gaps = 32/228 (14%)

Query: 192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ 251
           + + +L  +G G  G V K       G+++AIKK +           ++D  ++   +R 
Sbjct: 25  EKYENLGLVGEGSYGMVMKCR-NKDTGRIVAIKKFL---------ESDDDKMVKKIAMR- 73

Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHL-LVYEFMKNGSLQDILDDVSRGRRELDWPS 310
              EI    Q+RH N++ LL  + +      LV+EF+       ILDD+      LD+  
Sbjct: 74  ---EIKLLKQLRHENLVNLL-EVCKKKKRWYLVFEFVD----HTILDDLELFPNGLDYQV 125

Query: 311 RHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI---PDGYT 367
             +    + +G+ + H   S +IIH DIKP N+L++      + D G A  +    + Y 
Sbjct: 126 VQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYD 182

Query: 368 RVLISYVLGTMAYIAPEY-FQQPELSEKCDIFSFGMLLISLVRGVPSF 414
                 V  T  Y APE      +  +  D+++ G L+  +  G P F
Sbjct: 183 ----DEVA-TRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLF 225

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 83.6 bits (207), Expect = 9e-18
 Identities = 58/229 (25%), Positives = 86/229 (37%), Gaps = 26/229 (11%)

Query: 191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
           ED +   E++GSG    V K     S G   A K       I   +        R     
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCR-EKSTGLEYAAKF------IKKRQSRASR---RGVCRE 60

Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQD-ILDDVSRGRRELDWP 309
           +I  E+    Q+ H NI+ L          +L+ E +  G L D +    S    E    
Sbjct: 61  EIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEA--- 117

Query: 310 SRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLL----NDDMEACISDLGLAMAIPDG 365
                   +  G+ YLH   +  I H D+KP N++L           + D GLA  I DG
Sbjct: 118 --TSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172

Query: 366 YTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
                   + GT  ++APE      L  + D++S G++   L+ G   F
Sbjct: 173 VE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 83.6 bits (207), Expect = 2e-17
 Identities = 65/243 (26%), Positives = 106/243 (43%), Gaps = 53/243 (21%)

Query: 189 KKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSK 248
            +E  +   + IG+G  G VY+A+L  S G+++AIKKV          L ++  K R   
Sbjct: 51  PQEVSYTDTKVIGNGSFGVVYQAKLCDS-GELVAIKKV----------LQDKRFKNR--- 96

Query: 249 LRQIRSEIITASQIRHRNILPLLAHMVRP-----DCHL-LVYEFMKNGSLQDILDDVSRG 302
                 E+    ++ H NI+ L            + +L LV +++   ++  +    SR 
Sbjct: 97  ------ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRA 149

Query: 303 RRELDWPSRH---------RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC- 352
           ++ L  P  +         R        L Y+H   S  I H DIKP+N+LL+ D     
Sbjct: 150 KQTL--PVIYVKLYMYQLFR-------SLAYIH---SFGICHRDIKPQNLLLDPDTAVLK 197

Query: 353 ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEY-FQQPELSEKCDIFSFGMLLISLVRGV 411
           + D G A  +  G     +SY+  +  Y APE  F   + +   D++S G +L  L+ G 
Sbjct: 198 LCDFGSAKQLVRG--EPNVSYIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

Query: 412 PSF 414
           P F
Sbjct: 255 PIF 257

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 81.5 bits (202), Expect = 2e-17
 Identities = 60/229 (26%), Positives = 90/229 (39%), Gaps = 26/229 (11%)

Query: 191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
           ED +   E++GSG    V K       GK  A K       I    L    S  R     
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCR-QKGTGKEYAAKF------IKKRRLS---SSRRGVSRE 53

Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGR-RELDWP 309
           +I  E+    +IRH NI+ L          +L+ E +  G L D L    +    E +  
Sbjct: 54  EIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL--AEKESLTEDE-- 109

Query: 310 SRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLL----NDDMEACISDLGLAMAIPDG 365
              +    +  G+ YLH   S  I H D+KP N++L      +    + D G+A  I  G
Sbjct: 110 -ATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG 165

Query: 366 YTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
                   + GT  ++APE      L  + D++S G++   L+ G   F
Sbjct: 166 NE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 211

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 82.3 bits (204), Expect = 2e-17
 Identities = 58/229 (25%), Positives = 88/229 (38%), Gaps = 26/229 (11%)

Query: 191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
           ED +   E++GSG    V K     S G   A K       I   +     +  R     
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCR-EKSTGLEYAAKF------IKKRQSR---ASRRGVSRE 60

Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQD-ILDDVSRGRRELDWP 309
           +I  E+    Q+ H N++ L          +L+ E +  G L D +    S    E    
Sbjct: 61  EIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEA--- 117

Query: 310 SRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC----ISDLGLAMAIPDG 365
                   +  G+ YLH   +  I H D+KP N++L D         + D GLA  I DG
Sbjct: 118 --TSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172

Query: 366 YTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
                   + GT  ++APE      L  + D++S G++   L+ G   F
Sbjct: 173 VE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 82.4 bits (204), Expect = 2e-17
 Identities = 70/301 (23%), Positives = 112/301 (37%), Gaps = 51/301 (16%)

Query: 144 GKSRNVRQRFPTTPSLISAAVRGGSRDRGPTIFSPLIEKEDLAFLKKEDCFASLEKIGSG 203
           G        +  + S ++A+   G+    P  +     ++ L      D F    ++G G
Sbjct: 10  GVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDAL-----SDFFEVESELGRG 64

Query: 204 GCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIR 263
               VY+ +      K  A+K +                K  D K+  +R+EI    ++ 
Sbjct: 65  ATSIVYRCK-QKGTQKPYALKVL---------------KKTVDKKI--VRTEIGVLLRLS 106

Query: 264 HRNILPLLAHMVRPDCHLLVYEFMKNGSLQD-ILDDVSRGR-RELDWPSRHRIALGVASG 321
           H NI+ L      P    LV E +  G L D I   V +G   E D          +   
Sbjct: 107 HPNIIKLKEIFETPTEISLVLELVTGGELFDRI---VEKGYYSERD---AADAVKQILEA 160

Query: 322 LEYLHMYHSASIIHGDIKPRNVLL---NDDMEACISDLGLAMAIPDGYTRVLISYVLGTM 378
           + YLH      I+H D+KP N+L      D    I+D GL+  +      VL+  V GT 
Sbjct: 161 VAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ---VLMKTVCGTP 214

Query: 379 AYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEIC-----------SPE 427
            Y APE  +      + D++S G++   L+ G   F   +  + +            SP 
Sbjct: 215 GYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPW 274

Query: 428 W 428
           W
Sbjct: 275 W 275

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 82.4 bits (204), Expect = 2e-17
 Identities = 70/342 (20%), Positives = 111/342 (32%), Gaps = 109/342 (31%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGK----MIAIKKVIVYAPISAAELIEEDSKLRDSKLRQI 252
            + +GSG  G+V  A   G +       +A+K +            +E +   +     +
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML------------KEKADSSE--REAL 95

Query: 253 RSEIITASQI-RHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
            SE+   +Q+  H NI+ LL          L++E+   G L + L    R +RE      
Sbjct: 96  MSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYL----RSKREKFSEDE 151

Query: 312 H-----------------------RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDD 348
                                     A  VA G+E+L      S +H D+  RNVL+   
Sbjct: 152 IEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHG 208

Query: 349 MEACISDLGLAMAIPDGYTRVLISYVLGTMAYI-----APEYFQQPELSEKCDIFSFGML 403
               I D GLA  I          YV+   A +     APE   +   + K D++S+G+L
Sbjct: 209 KVVKICDFGLARDIMSDSN-----YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGIL 263

Query: 404 L-------------ISLVRGVPSFVFHQNGE-----EICSPEWLRKVMNSKNPSRAIDPR 445
           L             I +       +  QNG         + E +  +M S          
Sbjct: 264 LWEIFSLGVNPYPGIPVDANFYKLI--QNGFKMDQPFYATEE-IYIIMQS---------- 310

Query: 446 LPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL 487
                              C   D  +RP+   +   L   L
Sbjct: 311 -------------------CWAFDSRKRPSFPNLTSFLGCQL 333

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 82.1 bits (203), Expect = 3e-17
 Identities = 58/247 (23%), Positives = 107/247 (43%), Gaps = 33/247 (13%)

Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI- 256
           + IG G    V +     + G   A+K ++       +    E+ +         R E  
Sbjct: 100 DVIGRGVSSVVRRCVHR-ATGHEFAVK-IMEVTAERLSPEQLEEVR------EATRRETH 151

Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGR-RELDWPSRHRIA 315
           I      H +I+ L+          LV++ M+ G L D L    +    E +  +R  I 
Sbjct: 152 ILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL--TEKVALSEKE--TRS-IM 206

Query: 316 LGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVL 375
             +   + +LH   + +I+H D+KP N+LL+D+M+  +SD G +  +  G     +  + 
Sbjct: 207 RSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG---EKLRELC 260

Query: 376 GTMAYIAPE------YFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWL 429
           GT  Y+APE          P   ++ D+++ G++L +L+ G P F +H+    +     L
Sbjct: 261 GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPF-WHRRQILM-----L 314

Query: 430 RKVMNSK 436
           R +M  +
Sbjct: 315 RMIMEGQ 321

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 81.2 bits (201), Expect = 4e-17
 Identities = 59/285 (20%), Positives = 104/285 (36%), Gaps = 39/285 (13%)

Query: 155 TTPSLISAAVRGGSRDRGPTIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELP 214
           ++  +   +      D   T  +P  EKE       E  +     +GSGG G VY     
Sbjct: 11  SSGLVPRGSHMAPCNDLHATKLAPGKEKE-----PLESQYQVGPLLGSGGFGSVYSGI-R 64

Query: 215 GSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHR--NILPLLA 272
            S+   +AIK  +    I                  ++  E++   ++      ++ LL 
Sbjct: 65  VSDNLPVAIK-HVEKDRI--------SDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115

Query: 273 HMVRPDCHLLVYEFMKN-GSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSA 331
              RPD  +L+ E  +    L D +    RG   L           V   + + H   + 
Sbjct: 116 WFERPDSFVLILERPEPVQDLFDFI--TERGA--LQEELARSFFWQVLEAVRHCH---NC 168

Query: 332 SIIHGDIKPRNVLLN-DDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQ-QP 389
            ++H DIK  N+L++ +  E  + D G    + D     + +   GT  Y  PE+ +   
Sbjct: 169 GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHR 224

Query: 390 ELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICS-----PEWL 429
                  ++S G+LL  +V G   F   ++ EEI        + +
Sbjct: 225 YHGRSAAVWSLGILLYDMVCGDIPF---EHDEEIIRGQVFFRQRV 266

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 81.5 bits (202), Expect = 4e-17
 Identities = 55/232 (23%), Positives = 98/232 (42%), Gaps = 41/232 (17%)

Query: 192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYA----PISAAELIEEDSKLRDS 247
           + +  L+K+G G    VYK +       ++A+K++ +      P +A             
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSK-LTDNLVALKEIRLEHEEGAPCTA------------- 47

Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELD 307
               IR E+     ++H NI+ L   +       LV+E++    L+  LDD       ++
Sbjct: 48  ----IR-EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNI---IN 98

Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMA--IPDG 365
             +       +  GL Y H      ++H D+KP+N+L+N+  E  ++D GLA A  IP  
Sbjct: 99  MHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 155

Query: 366 -YT-RVLISYVLGTMAYIAPEY-FQQPELSEKCDIFSFGMLLISLVRGVPSF 414
            Y   V+      T+ Y  P+      + S + D++  G +   +  G P F
Sbjct: 156 TYDNEVV------TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLF 201

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 80.6 bits (199), Expect = 4e-17
 Identities = 43/287 (14%), Positives = 79/287 (27%), Gaps = 67/287 (23%)

Query: 197 LEKIGSGGCGEVYKAE---LPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           L   G     + ++A    L     + +A+    V       +            L++  
Sbjct: 36  LIFHGGVPPLQFWQALDTAL----DRQVALT--FVDPQGVLPD----------DVLQETL 79

Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
           S  +  S+I    +  +L  +      L+V E+++ GSLQ++                 R
Sbjct: 80  SRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA------DTSPSPVGAIR 133

Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISY 373
               +A+  +  H    A +      P  V ++ D        G                
Sbjct: 134 AMQSLAAAADAAH---RAGVALSIDHPSRVRVSID--------GDV-------------- 168

Query: 374 VLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVM 433
           VL   A +          + + DI   G  L +L+         + G         R   
Sbjct: 169 VLAYPATMPDA-------NPQDDIRGIGASLYALLVNRWP--LPEAGVRSGLAPAERDTA 219

Query: 434 NSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVR 480
                   ID  +P          +  +A      D   R  S  + 
Sbjct: 220 GQPIEPADIDRDIPF--------QISAVAARSVQGDGGIRSASTLLN 258

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 80.7 bits (200), Expect = 5e-17
 Identities = 57/228 (25%), Positives = 95/228 (41%), Gaps = 32/228 (14%)

Query: 192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ 251
           + +  + KIG G  G V+K       G+++AIKK +           E+D  ++   LR 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCR-NRDTGQIVAIKKFL---------ESEDDPVIKKIALR- 51

Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHL-LVYEFMKNGSLQDILDDVSRGRRELDWPS 310
              EI    Q++H N++ LL  + R    L LV+E+  + ++   LD   RG   +    
Sbjct: 52  ---EIRMLKQLKHPNLVNLL-EVFRRKRRLHLVFEYCDH-TVLHELDRYQRG---VPEHL 103

Query: 311 RHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI---PDGYT 367
              I       + + H     + IH D+KP N+L+       + D G A  +    D Y 
Sbjct: 104 VKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYD 160

Query: 368 RVLISYVLGTMAYIAPEY-FQQPELSEKCDIFSFGMLLISLVRGVPSF 414
                 V  T  Y +PE      +     D+++ G +   L+ GVP +
Sbjct: 161 ----DEVA-TRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLW 203

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 80.8 bits (200), Expect = 5e-17
 Identities = 56/258 (21%), Positives = 94/258 (36%), Gaps = 37/258 (14%)

Query: 186 AFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLR 245
            F +  D     + +G G      K     S  +  A+K +I                  
Sbjct: 5   PFYQHYDLDLKDKPLGEGSFSICRKCVHKKS-NQAFAVK-II-----------------S 45

Query: 246 DSKLRQIRSEIITASQIR-HRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDD-VSRGR 303
                  + EI        H NI+ L           LV E +  G L    +    +  
Sbjct: 46  KRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL---FERIKKKKH 102

Query: 304 -RELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLL---NDDMEACISDLGLA 359
             E +      I   + S + ++H      ++H D+KP N+L    ND++E  I D G A
Sbjct: 103 FSETE---ASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFA 156

Query: 360 MAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFH-Q 418
              P    + L +    T+ Y APE   Q    E CD++S G++L +++ G   F  H +
Sbjct: 157 RLKPPD-NQPLKTPC-FTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDR 214

Query: 419 NGEEICSPEWLRKVMNSK 436
           +     + E ++K+    
Sbjct: 215 SLTCTSAVEIMKKIKKGD 232

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 80.7 bits (200), Expect = 5e-17
 Identities = 63/233 (27%), Positives = 102/233 (43%), Gaps = 38/233 (16%)

Query: 192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYA----PISAAELIEEDSKLRDS 247
             F  LEK+G+G    VYK  L  + G  +A+K+V + +    P +A             
Sbjct: 5   SQFKQLEKLGNGTYATVYKG-LNKTTGVYVALKEVKLDSEEGTPSTA------------- 50

Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELD 307
               IR EI    +++H NI+ L   +   +   LV+EFM +  L+  +D  + G     
Sbjct: 51  ----IR-EISLMKELKHENIVRLYDVIHTENKLTLVFEFM-DNDLKKYMDSRTVGNTPRG 104

Query: 308 WPSRH--RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMA--IP 363
                       +  GL + H      I+H D+KP+N+L+N   +  + D GLA A  IP
Sbjct: 105 LELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP 161

Query: 364 DG-YTRVLISYVLGTMAYIAPEY-FQQPELSEKCDIFSFGMLLISLVRGVPSF 414
              ++  ++     T+ Y AP+        S   DI+S G +L  ++ G P F
Sbjct: 162 VNTFSSEVV-----TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLF 209

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 82.2 bits (203), Expect = 6e-17
 Identities = 65/228 (28%), Positives = 101/228 (44%), Gaps = 35/228 (15%)

Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           + +L+ IGSG  G V  A       + +AIKK      +S     +  +K      R  R
Sbjct: 64  YQNLKPIGSGAQGIVCAA-YDAVLDRNVAIKK------LSRPFQNQTHAK------RAYR 110

Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHL-------LVYEFMKNGSLQDILDDVSRGRREL 306
            E++    + H+NI+ LL ++  P   L       LV E M + +L  ++      + EL
Sbjct: 111 -ELVLMKCVNHKNIISLL-NVFTPQKTLEEFQDVYLVMELM-DANLCQVI------QMEL 161

Query: 307 DWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGY 366
           D      +   +  G+++LH   SA IIH D+KP N+++  D    I D GLA       
Sbjct: 162 DHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-- 216

Query: 367 TRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
           + ++  YV  T  Y APE        E  DI+S G ++  +VR    F
Sbjct: 217 SFMMTPYV-VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF 263

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 79.9 bits (198), Expect = 6e-17
 Identities = 55/212 (25%), Positives = 90/212 (42%), Gaps = 23/212 (10%)

Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  GEV  A       + +A+K             I +  +  D     I+ EI   
Sbjct: 15  LGEGAYGEVQLAV-NRVTEEAVAVK-------------IVDMKRAVDC-PENIKKEICIN 59

Query: 260 SQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVA 319
             + H N++    H    +   L  E+   G L D +         +  P   R    + 
Sbjct: 60  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIG--MPEPDAQRFFHQLM 115

Query: 320 SGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMA 379
           +G+ YLH      I H DIKP N+LL++     ISD GLA          L++ + GT+ 
Sbjct: 116 AGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172

Query: 380 YIAPEYFQ-QPELSEKCDIFSFGMLLISLVRG 410
           Y+APE  + +   +E  D++S G++L +++ G
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 81.6 bits (202), Expect = 9e-17
 Identities = 52/248 (20%), Positives = 97/248 (39%), Gaps = 44/248 (17%)

Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           E++G G    V +       G+  A   +                KL     +++  E  
Sbjct: 17  EELGKGAFSVVRRCV-KVLAGQEYAAMIINT-------------KKLSARDHQKLEREAR 62

Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDD-VSRGR-RELDWPSRHRIA 315
               ++H NI+ L   +     H L+++ +  G L    +D V+R    E D  + H   
Sbjct: 63  ICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGEL---FEDIVAREYYSEAD--ASH-CI 116

Query: 316 LGVASGLEYLHMYHSASIIHGDIKPRNVLL---NDDMEACISDLGLAMAIPDGYTRVLIS 372
             +   + + H      ++H ++KP N+LL          ++D GLA+ +     +    
Sbjct: 117 QQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE--QQAWF 171

Query: 373 YVLGTMAYIAPEYFQQPELSEKCDIFSFG-MLLISLVRGVPSFVFHQNGEEIC------- 424
              GT  Y++PE  ++    +  D+++ G +L I LV G P F + ++   +        
Sbjct: 172 GFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLV-GYPPF-WDEDQHRLYQQIKAGA 229

Query: 425 ----SPEW 428
               SPEW
Sbjct: 230 YDFPSPEW 237

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 80.5 bits (199), Expect = 9e-17
 Identities = 52/248 (20%), Positives = 91/248 (36%), Gaps = 46/248 (18%)

Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI- 256
           + +G G  G+V +       G+  A+K +                        + R E+ 
Sbjct: 35  QVLGLGVNGKVLECFHR-RTGQKCALKLL--------------------YDSPKARQEVD 73

Query: 257 ITASQIRHRNILPLLA----HMVRPDCHLLVYEFMKNGSLQDILDD-VSRGRRELDWPSR 311
                    +I+ +L           C L++ E M+ G L         RG +       
Sbjct: 74  HHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGEL---FSRIQERGDQAFTEREA 130

Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLL---NDDMEACISDLGLAMAIPDG--Y 366
             I   + + +++LH   S +I H D+KP N+L      D    ++D G A         
Sbjct: 131 AEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQ 187

Query: 367 TRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSP 426
           T         T  Y+APE     +  + CD++S G+++  L+ G P   F+ N  +  SP
Sbjct: 188 TPC------YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP--FYSNTGQAISP 239

Query: 427 EWLRKVMN 434
              R++  
Sbjct: 240 GMKRRIRL 247

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 79.2 bits (196), Expect = 1e-16
 Identities = 57/221 (25%), Positives = 85/221 (38%), Gaps = 32/221 (14%)

Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
             IG G  GEV  A   G+     A KK+                 + D    + + EI 
Sbjct: 15  NTIGRGSWGEVKIAVQKGT-RIRRAAKKI-------------PKYFVEDVD--RFKQEIE 58

Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGR-RELDWPSRHRIAL 316
               + H NI+ L           LV E    G L + +  V +   RE D     RI  
Sbjct: 59  IMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERV--VHKRVFRESD---AARIMK 113

Query: 317 GVASGLEYLHMYHSASIIHGDIKPRNVLL---NDDMEACISDLGLAMAIPDGYTRVLISY 373
            V S + Y H     ++ H D+KP N L    + D    + D GLA     G     +  
Sbjct: 114 DVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM---MRT 167

Query: 374 VLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
            +GT  Y++P+  +      +CD +S G+++  L+ G P F
Sbjct: 168 KVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPF 207

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 80.8 bits (200), Expect = 1e-16
 Identities = 58/243 (23%), Positives = 100/243 (41%), Gaps = 56/243 (23%)

Query: 190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKL 249
           +E  + + + IG+G  G V++A+L  S+   +AIKKV          L ++  K R    
Sbjct: 38  REIAYTNCKVIGNGSFGVVFQAKLVESD--EVAIKKV----------LQDKRFKNR---- 81

Query: 250 RQIRSEIITASQIRHRNILPLLAHMVRPDCHL-------LVYEFMKNGSLQDILDDVSRG 302
                E+     ++H N++ L       +          LV E++   ++       ++ 
Sbjct: 82  -----ELQIMRIVKHPNVVDLK-AFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKL 134

Query: 303 RRELDWPSRH---------RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC- 352
           ++ +  P            R        L Y+H   S  I H DIKP+N+LL+       
Sbjct: 135 KQTM--PMLLIKLYMYQLLR-------SLAYIH---SIGICHRDIKPQNLLLDPPSGVLK 182

Query: 353 ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPE-YFQQPELSEKCDIFSFGMLLISLVRGV 411
           + D G A  +  G     +SY+  +  Y APE  F     +   DI+S G ++  L++G 
Sbjct: 183 LIDFGSAKILIAG--EPNVSYIC-SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

Query: 412 PSF 414
           P F
Sbjct: 240 PLF 242

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 80.5 bits (199), Expect = 1e-16
 Identities = 49/228 (21%), Positives = 94/228 (41%), Gaps = 31/228 (13%)

Query: 191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
            D +  LE++GSG  G V++     + G++   K +               +        
Sbjct: 50  YDYYDILEELGSGAFGVVHRCVEK-ATGRVFVAKFI---------------NTPYPLDKY 93

Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRR--ELDW 308
            +++EI   +Q+ H  ++ L          +L+ EF+  G L D +   +   +  E + 
Sbjct: 94  TVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRI--AAEDYKMSEAEV 151

Query: 309 PSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACI--SDLGLAMAIPDGY 366
            +  R A     GL+++H     SI+H DIKP N++      + +   D GLA  +    
Sbjct: 152 INYMRQAC---EGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD- 204

Query: 367 TRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
              ++     T  + APE   +  +    D+++ G+L   L+ G+  F
Sbjct: 205 --EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPF 250

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 80.0 bits (198), Expect = 1e-16
 Identities = 58/229 (25%), Positives = 88/229 (38%), Gaps = 26/229 (11%)

Query: 191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
           +D + + E++GSG    V K     S G   A K       I         S  R     
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCR-EKSTGLQYAAKF------IKKRRTK---SSRRGVSRE 59

Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQD-ILDDVSRGRRELDWP 309
            I  E+    +I+H N++ L          +L+ E +  G L D + +  S    E    
Sbjct: 60  DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEA--- 116

Query: 310 SRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLL----NDDMEACISDLGLAMAIPDG 365
                   + +G+ YLH   S  I H D+KP N++L           I D GLA  I  G
Sbjct: 117 --TEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG 171

Query: 366 YTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
                   + GT  ++APE      L  + D++S G++   L+ G   F
Sbjct: 172 NE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 79.6 bits (197), Expect = 1e-16
 Identities = 56/227 (24%), Positives = 87/227 (38%), Gaps = 46/227 (20%)

Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSK--LRQIRSEII 257
           +G G  G+V +           A+K             I +  KLR        ++ EI 
Sbjct: 13  LGEGSYGKVKEVL-DSETLCRRAVK-------------ILKKKKLRRIPNGEANVKKEIQ 58

Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDI---LDDVSRGRREL-DWPSRHR 313
              ++RH+N++ L              + + N   Q +   ++    G +E+ D     R
Sbjct: 59  LLRRLRHKNVIQL-------------VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKR 105

Query: 314 IALGVA--------SGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG 365
             +  A         GLEYLH   S  I+H DIKP N+LL       IS LG+A A+   
Sbjct: 106 FPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162

Query: 366 YTRVLISYVLGTMAYIAPEYFQQPELSE--KCDIFSFGMLLISLVRG 410
                     G+ A+  PE     +     K DI+S G+ L ++  G
Sbjct: 163 AADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTG 209

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 81.4 bits (201), Expect = 1e-16
 Identities = 64/251 (25%), Positives = 102/251 (40%), Gaps = 32/251 (12%)

Query: 192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ 251
           D F     +G GG GEV+  ++  + GK+ A KK            + +    +    + 
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKAT-GKLYACKK------------LNKKRLKKRKGYQG 231

Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHL-LVYEFMKNGSLQDILDDVSRGRRELDWPS 310
              E    +++  R I+ L          L LV   M  G ++  + +V           
Sbjct: 232 AMVEKKILAKVHSRFIVSLAYAFETKT-DLCLVMTIMNGGDIRYHIYNVDEDNPGFQ-EP 289

Query: 311 RHRI-ALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG---- 365
           R       + SGLE+LH     +II+ D+KP NVLL+DD    ISDLGLA+ +  G    
Sbjct: 290 RAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT 346

Query: 366 YTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICS 425
                     GT  ++APE     E     D F+ G+ L  ++       F   GE++ +
Sbjct: 347 KGYA------GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP--FRARGEKVEN 398

Query: 426 PEWLRKVMNSK 436
            E  ++V+   
Sbjct: 399 KELKQRVLEQA 409

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 79.3 bits (196), Expect = 2e-16
 Identities = 56/212 (26%), Positives = 91/212 (42%), Gaps = 23/212 (10%)

Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           +G G  GEV  A       + +A+K             I +  +  D     I+ EI   
Sbjct: 15  LGEGAYGEVQLAV-NRVTEEAVAVK-------------IVDMKRAVDC-PENIKKEICIN 59

Query: 260 SQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVA 319
             + H N++    H    +   L  E+   G L D +         +  P   R    + 
Sbjct: 60  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIG--MPEPDAQRFFHQLM 115

Query: 320 SGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMA 379
           +G+ YLH      I H DIKP N+LL++     ISD GLA          L++ + GT+ 
Sbjct: 116 AGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172

Query: 380 YIAPEYFQQPE-LSEKCDIFSFGMLLISLVRG 410
           Y+APE  ++ E  +E  D++S G++L +++ G
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 79.6 bits (197), Expect = 2e-16
 Identities = 64/229 (27%), Positives = 98/229 (42%), Gaps = 38/229 (16%)

Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           + S   +GSG  G V  A +   +G+ +AIKK      +S     E  +K      R  R
Sbjct: 26  YVSPTHVGSGAYGSVCSA-IDKRSGEKVAIKK------LSRPFQSEIFAK------RAYR 72

Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHL-------LVYEFMKNGSLQDILDDVSRGRREL 306
            E++    ++H N++ LL  +  P   L       LV  FM    LQ I+        + 
Sbjct: 73  -ELLLLKHMQHENVIGLL-DVFTPASSLRNFYDFYLVMPFM-QTDLQKIM------GLKF 123

Query: 307 DWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGY 366
                  +   +  GL+Y+H   SA ++H D+KP N+ +N+D E  I D GLA       
Sbjct: 124 SEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM 180

Query: 367 TRVLISYVLGTMAYIAPE-YFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
           T     YV  T  Y APE        ++  DI+S G ++  ++ G   F
Sbjct: 181 T----GYV-VTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF 224

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 78.3 bits (194), Expect = 2e-16
 Identities = 67/232 (28%), Positives = 107/232 (46%), Gaps = 41/232 (17%)

Query: 192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYA-----PISAAELIEEDSKLRD 246
           + +  LEKIG G  G VYKA+   + G+  A+KK+ +       P +             
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQ--NNYGETFALKKIRLEKEDEGIPSTT------------ 47

Query: 247 SKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRREL 306
                IR EI    +++H NI+ L   +      +LV+E +    L+ +LD    G   L
Sbjct: 48  -----IR-EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGG---L 97

Query: 307 DWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMA--IPD 364
           +  +     L + +G+ Y H      ++H D+KP+N+L+N + E  I+D GLA A  IP 
Sbjct: 98  ESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154

Query: 365 G-YTRVLISYVLGTMAYIAPEY-FQQPELSEKCDIFSFGMLLISLVRGVPSF 414
             YT  ++     T+ Y AP+      + S   DI+S G +   +V G P F
Sbjct: 155 RKYTHEIV-----TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLF 201

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 78.8 bits (195), Expect = 3e-16
 Identities = 59/239 (24%), Positives = 97/239 (40%), Gaps = 44/239 (18%)

Query: 192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKV--------IVYAPISAAELIEEDSK 243
             +  + +IG G  G VYKA     +G  +A+K V            PIS          
Sbjct: 9   SRYEPVAEIGVGAYGTVYKA-RDPHSGHFVALKSVRVPNGGGGGGGLPIST--------- 58

Query: 244 LRD-SKLRQIRSEIITASQIRHRNILPLL--AHMVRPDCHL---LVYEFMKNGSLQDILD 297
           +R+ + LR++ +         H N++ L+      R D  +   LV+E +    L+  LD
Sbjct: 59  VREVALLRRLEAF-------EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLD 110

Query: 298 DVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLG 357
                   L   +   +      GL++LH   +  I+H D+KP N+L+       ++D G
Sbjct: 111 K--APPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFG 165

Query: 358 LAMA--IPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
           LA         T V++     T+ Y APE   Q   +   D++S G +   + R  P F
Sbjct: 166 LARIYSYQMALTPVVV-----TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLF 219

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 79.4 bits (196), Expect = 3e-16
 Identities = 53/225 (23%), Positives = 92/225 (40%), Gaps = 31/225 (13%)

Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
            +  E +G G  G+V+K E   + G  +A K +         +  EE           ++
Sbjct: 91  VSKTEILGGGRFGQVHKCEET-ATGLKLAAKII----KTRGMKDKEE-----------VK 134

Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRR--ELDWPSR 311
           +EI   +Q+ H N++ L       +  +LV E++  G L D +  +       ELD    
Sbjct: 135 NEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRI--IDESYNLTELD---T 189

Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACI--SDLGLAMAIPDGYTRV 369
                 +  G+ ++H      I+H D+KP N+L  +     I   D GLA          
Sbjct: 190 ILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-- 244

Query: 370 LISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
            +    GT  ++APE      +S   D++S G++   L+ G+  F
Sbjct: 245 -LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPF 288

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 78.5 bits (194), Expect = 3e-16
 Identities = 51/245 (20%), Positives = 87/245 (35%), Gaps = 36/245 (14%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
              +G GG G V+      ++   +AIK VI    +              S       E+
Sbjct: 36  GPLLGKGGFGTVFAGHRL-TDRLQVAIK-VIPRNRV--------LGWSPLSDSVTCPLEV 85

Query: 257 ITASQIR----HRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDD-VSRGRRELDWPSR 311
               ++     H  ++ LL      +  +LV E       QD+ D    +G   L     
Sbjct: 86  ALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPA--QDLFDYITEKGP--LGEGPS 141

Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDM-EACISDLGLAMAIPDGYTRVL 370
                 V + +++ H   S  ++H DIK  N+L++     A + D G    + D      
Sbjct: 142 RCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE----P 194

Query: 371 ISYVLGTMAYIAPEYFQ-QPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICS---- 425
            +   GT  Y  PE+       +    ++S G+LL  +V G   F   +  +EI      
Sbjct: 195 YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPF---ERDQEILEAELH 251

Query: 426 -PEWL 429
            P  +
Sbjct: 252 FPAHV 256

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 78.5 bits (194), Expect = 5e-16
 Identities = 58/244 (23%), Positives = 96/244 (39%), Gaps = 49/244 (20%)

Query: 189 KKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSK 248
           K+ D F      G G  G V   +   S G  +AIKKVI            +D +    +
Sbjct: 20  KEMDRFQVERMAGQGTFGTVQLGKEK-STGMSVAIKKVI------------QDPRF---R 63

Query: 249 LRQIRSEIITASQIRHRNILPLLAHMVRP------DCHL-LVYEFMKNGSLQDILDDVSR 301
            R+++  +   + + H NI+ L ++          D +L +V E++   +L     +  R
Sbjct: 64  NRELQ-IMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYR 121

Query: 302 GRRELDWPSRH---------RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN-DDMEA 351
            +     P            R        +  LH+  S ++ H DIKP NVL+N  D   
Sbjct: 122 RQVAP--PPILIKVFLFQLIR-------SIGCLHL-PSVNVCHRDIKPHNVLVNEADGTL 171

Query: 352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEY-FQQPELSEKCDIFSFGMLLISLVRG 410
            + D G A  +        ++Y+  +  Y APE  F     +   DI+S G +   ++ G
Sbjct: 172 KLCDFGSAKKLSPS--EPNVAYIC-SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG 228

Query: 411 VPSF 414
            P F
Sbjct: 229 EPIF 232

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 78.1 bits (193), Expect = 6e-16
 Identities = 76/328 (23%), Positives = 110/328 (33%), Gaps = 62/328 (18%)

Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           +     I SG  G V       S G  +AIK+V           I  DS     K R +R
Sbjct: 24  YTVQRFISSGSYGAVCAGV--DSEGIPVAIKRVFNTVSDGRTVNILSDSF--LCK-RVLR 78

Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHL------LVYEFMKNGSLQDILDDVSRGRRELD 307
            EI   +   H NIL L   +             LV E M+   L  ++      R  + 
Sbjct: 79  -EIRLLNHFHHPNILGLR-DIFVHFEEPAMHKLYLVTELMRT-DLAQVI---HDQRIVIS 132

Query: 308 WPSRHR-IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGY 366
            P   +     +  GL  LH    A ++H D+ P N+LL D+ +  I D  LA       
Sbjct: 133 -PQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTA-- 186

Query: 367 TRVLISYVLGTMAYIAPEY-FQQPELSEKCDIFSFGMLLISLVRGVPSF----VFHQ--- 418
                 YV     Y APE   Q    ++  D++S G ++  +      F     ++Q   
Sbjct: 187 DANKTHYV-THRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNK 245

Query: 419 --------NGEE---ICSPEWLRKVMNS--KNPSRAIDPRLPGNGYE-----KKMLH--- 457
                     E+     SP     + NS    P+RA    +P           KML    
Sbjct: 246 IVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNP 305

Query: 458 --------VLKIAYICTLHDPEERPNSQ 477
                    L+  Y  +L DP +     
Sbjct: 306 QRRISTEQALRHPYFESLFDPLDLTEGL 333

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 77.7 bits (192), Expect = 7e-16
 Identities = 44/222 (19%), Positives = 86/222 (38%), Gaps = 28/222 (12%)

Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           +++G G    V +     S G+  A K       +      ++          +I  EI 
Sbjct: 35  KELGRGKFAVVRQCI-SKSTGQEYAAKF------LKKRRRGQDCRA-------EILHEIA 80

Query: 258 TASQIRHR-NILPLLAHMVRPDCHLLVYEFMKNGSLQD-ILDDVSRGRRELDWPSRHRIA 315
                +    ++ L          +L+ E+   G +    L +++    E D     R+ 
Sbjct: 81  VLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSEND---VIRLI 137

Query: 316 LGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC---ISDLGLAMAIPDGYTRVLIS 372
             +  G+ YLH     +I+H D+KP+N+LL+         I D G++  I        + 
Sbjct: 138 KQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE---LR 191

Query: 373 YVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
            ++GT  Y+APE      ++   D+++ G++   L+     F
Sbjct: 192 EIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPF 233

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 76.5 bits (189), Expect = 8e-16
 Identities = 58/213 (27%), Positives = 96/213 (45%), Gaps = 26/213 (12%)

Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR-QIRSEIIT 258
           +G G  G+V   E   + G  +A+K             I    K+R   +  +I+ EI  
Sbjct: 19  LGVGTFGKVKIGEHQLT-GHKVAVK-------------ILNRQKIRSLDVVGKIKREIQN 64

Query: 259 ASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV 318
               RH +I+ L   +  P    +V E++  G L D +     GR  ++     R+   +
Sbjct: 65  LKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYI--CKHGR--VEEMEARRLFQQI 120

Query: 319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTM 378
            S ++Y H      ++H D+KP NVLL+  M A I+D GL+  + DG     +    G+ 
Sbjct: 121 LSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE---FLRTSCGSP 174

Query: 379 AYIAPEYFQ-QPELSEKCDIFSFGMLLISLVRG 410
            Y APE    +     + DI+S G++L +L+ G
Sbjct: 175 NYAAPEVISGRLYAGPEVDIWSCGVILYALLCG 207

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 77.8 bits (192), Expect = 1e-15
 Identities = 66/229 (28%), Positives = 96/229 (41%), Gaps = 37/229 (16%)

Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           +  L+ +GSG  G V  A + G  G  +AIKK      +      E  +K      R  R
Sbjct: 27  YRDLQPVGSGAYGAVCSA-VDGRTGAKVAIKK------LYRPFQSELFAK------RAYR 73

Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHL-------LVYEFMKNGSLQDILDDVSRGRREL 306
            E+     +RH N++ LL  +  PD  L       LV  FM    L  ++        +L
Sbjct: 74  -ELRLLKHMRHENVIGLL-DVFTPDETLDDFTDFYLVMPFM-GTDLGKLM-----KHEKL 125

Query: 307 DWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGY 366
                  +   +  GL Y+H   +A IIH D+KP N+ +N+D E  I D GLA       
Sbjct: 126 GEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM 182

Query: 367 TRVLISYVLGTMAYIAPEY-FQQPELSEKCDIFSFGMLLISLVRGVPSF 414
           T     YV  T  Y APE        ++  DI+S G ++  ++ G   F
Sbjct: 183 T----GYV-VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF 226

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 76.9 bits (190), Expect = 1e-15
 Identities = 50/228 (21%), Positives = 89/228 (39%), Gaps = 32/228 (14%)

Query: 191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
            + +   E +G G  G V++     S+ K    K V                K++ +   
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCV-ETSSKKTYMAKFV----------------KVKGTDQV 46

Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRR--ELDW 308
            ++ EI   +  RHRNIL L       +  ++++EF+    + + +   +      E + 
Sbjct: 47  LVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERI--NTSAFELNERE- 103

Query: 309 PSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC--ISDLGLAMAIPDGY 366
                    V   L++LH   S +I H DI+P N++      +   I + G A  +  G 
Sbjct: 104 --IVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG- 157

Query: 367 TRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
                  +     Y APE  Q   +S   D++S G L+  L+ G+  F
Sbjct: 158 --DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPF 203

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 76.0 bits (188), Expect = 1e-15
 Identities = 57/219 (26%), Positives = 95/219 (43%), Gaps = 40/219 (18%)

Query: 192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYA-----PISAAELIEEDSKLRD 246
             +  LEKIG G  G V+KA       +++A+K+V +       P SA            
Sbjct: 2   QKYEKLEKIGEGTYGTVFKA-KNRETHEIVALKRVRLDDDDEGVPSSA------------ 48

Query: 247 SKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRREL 306
                +R EI    +++H+NI+ L   +       LV+EF     L+   D  +     L
Sbjct: 49  -----LR-EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGD---L 98

Query: 307 DWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMA--IPD 364
           D          +  GL + H  +   ++H D+KP+N+L+N + E  +++ GLA A  IP 
Sbjct: 99  DPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155

Query: 365 G-YTRVLISYVLGTMAYIAPEY-FQQPELSEKCDIFSFG 401
             Y+  ++     T+ Y  P+  F     S   D++S G
Sbjct: 156 RCYSAEVV-----TLWYRPPDVLFGAKLYSTSIDMWSAG 189

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 76.9 bits (190), Expect = 1e-15
 Identities = 57/247 (23%), Positives = 90/247 (36%), Gaps = 43/247 (17%)

Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           E IG G      +     +     A+K +                    SK        I
Sbjct: 28  EDIGVGSYSVCKRCIHK-ATNMEFAVKII------------------DKSKRDPTEEIEI 68

Query: 258 TASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDD-VSRGR---RELDWPSRHR 313
                +H NI+ L           +V E MK G L   LD  + +     RE        
Sbjct: 69  LLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL---LDKILRQKFFSEREA-----SA 120

Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC----ISDLGLAMAIPDGYTRV 369
           +   +   +EYLH   +  ++H D+KP N+L  D+        I D G A  +       
Sbjct: 121 VLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE--NG 175

Query: 370 LISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWL 429
           L+     T  ++APE  ++      CDI+S G+LL +++ G   F    NG +    E L
Sbjct: 176 LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFA---NGPDDTPEEIL 232

Query: 430 RKVMNSK 436
            ++ + K
Sbjct: 233 ARIGSGK 239

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 78.4 bits (193), Expect = 1e-15
 Identities = 66/256 (25%), Positives = 103/256 (40%), Gaps = 45/256 (17%)

Query: 192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ 251
           + F+    IG GG GEVY        GKM A+K             +++           
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKAD-TGKMYAMKC------------LDKKRIKMKQGETL 235

Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWP-S 310
             +E         R +L L++    P    + Y F     L  ILD ++ G  +L +  S
Sbjct: 236 ALNE---------RIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGG--DLHYHLS 284

Query: 311 RHRI---------ALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMA 361
           +H +         A  +  GLE++H   +  +++ D+KP N+LL++     ISDLGLA  
Sbjct: 285 QHGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACD 341

Query: 362 IPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKC-DIFSFGMLLISLVRGVPSFVFHQNG 420
                     + V GT  Y+APE  Q+    +   D FS G +L  L+RG   F   +  
Sbjct: 342 FSKKKPH---ASV-GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF---RQH 394

Query: 421 EEICSPEWLRKVMNSK 436
           +     E  R  +   
Sbjct: 395 KTKDKHEIDRMTLTMA 410

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 76.5 bits (189), Expect = 2e-15
 Identities = 66/232 (28%), Positives = 102/232 (43%), Gaps = 37/232 (15%)

Query: 192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRD----S 247
             +  L+ +G G    VYKA    +  +++AIKK+           +   S+ +D    +
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDK-NTNQIVAIKKI----------KLGHRSEAKDGINRT 58

Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELD 307
            LR    EI    ++ H NI+ LL          LV++FM+   L+ I+ D S     L 
Sbjct: 59  ALR----EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLV---LT 110

Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA--MAIPDG 365
                   L    GLEYLH      I+H D+KP N+LL+++    ++D GLA     P+ 
Sbjct: 111 PSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 167

Query: 366 -YT-RVLISYVLGTMAYIAPEY-FQQPELSEKCDIFSFGMLLISLVRGVPSF 414
            YT +V+      T  Y APE  F         D+++ G +L  L+  VP  
Sbjct: 168 AYTHQVV------TRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFL 213

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 75.9 bits (187), Expect = 5e-15
 Identities = 49/251 (19%), Positives = 90/251 (35%), Gaps = 47/251 (18%)

Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI- 256
           + +G G  G+V +     +  +  A+K +                        + R E+ 
Sbjct: 68  QVLGLGINGKVLQIFNKRT-QEKFALKML--------------------QDCPKARREVE 106

Query: 257 ITASQIRHRNILPLLA----HMVRPDCHLLVYEFMKNGSLQDILDD-VSRGRRELDWPSR 311
           +     +  +I+ ++           C L+V E +  G L         RG +       
Sbjct: 107 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGEL---FSRIQDRGDQAFTEREA 163

Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLL---NDDMEACISDLGLAMAIPDG--- 365
             I   +   ++YLH   S +I H D+KP N+L      +    ++D G A         
Sbjct: 164 SEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL 220

Query: 366 YTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICS 425
            T         T  Y+APE     +  + CD++S G+++  L+ G P   F+ N     S
Sbjct: 221 TTPC------YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP--FYSNHGLAIS 272

Query: 426 PEWLRKVMNSK 436
           P    ++   +
Sbjct: 273 PGMKTRIRMGQ 283

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 75.0 bits (185), Expect = 5e-15
 Identities = 58/237 (24%), Positives = 99/237 (41%), Gaps = 46/237 (19%)

Query: 192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYA-----PISAAELIEEDSKLRD 246
           D +  + K+G G  GEVYKA       + +AIK++ +       P +A            
Sbjct: 34  DRYRRITKLGEGTYGEVYKAI-DTVTNETVAIKRIRLEHEEEGVPGTA------------ 80

Query: 247 SKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRREL 306
                IR E+    +++HRNI+ L + +       L++E+ +N  L+  +D       ++
Sbjct: 81  -----IR-EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDK----NPDV 129

Query: 307 DWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC-----ISDLGLAMA 361
                      + +G+ + H   S   +H D+KP+N+LL+    +      I D GLA A
Sbjct: 130 SMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186

Query: 362 --IPDG-YTRVLISYVLGTMAYIAPEY-FQQPELSEKCDIFSFGMLLISLVRGVPSF 414
             IP   +T  +I     T+ Y  PE        S   DI+S   +   ++   P F
Sbjct: 187 FGIPIRQFTHEII-----TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLF 238

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 75.3 bits (186), Expect = 5e-15
 Identities = 60/257 (23%), Positives = 103/257 (40%), Gaps = 54/257 (21%)

Query: 180 IEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYA-----PISA 234
            +  +  F  +   +  L KIG G  GEV+KA      G+ +A+KKV++       PI+A
Sbjct: 5   YDSVECPFCDEVSKYEKLAKIGQGTFGEVFKA-RHRKTGQKVALKKVLMENEKEGFPITA 63

Query: 235 AELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHL--------LVYEF 286
                            +R EI     ++H N++ L+                  LV++F
Sbjct: 64  -----------------LR-EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDF 105

Query: 287 MKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN 346
            ++  L  +L +      +       R+   + +GL Y+   H   I+H D+K  NVL+ 
Sbjct: 106 CEH-DLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYI---HRNKILHRDMKAANVLIT 158

Query: 347 DDMEACISDLGLAMAI-------PDGYT-RVLISYVLGTMAYIAPEY-FQQPELSEKCDI 397
            D    ++D GLA A        P+ YT RV+      T+ Y  PE    + +     D+
Sbjct: 159 RDGVLKLADFGLARAFSLAKNSQPNRYTNRVV------TLWYRPPELLLGERDYGPPIDL 212

Query: 398 FSFGMLLISLVRGVPSF 414
           +  G ++  +    P  
Sbjct: 213 WGAGCIMAEMWTRSPIM 229

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 75.4 bits (186), Expect = 6e-15
 Identities = 65/229 (28%), Positives = 100/229 (43%), Gaps = 37/229 (16%)

Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           + +L  +GSG  G V  A    + G  +A+KK      +S        +K      R  R
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKT-GLRVAVKK------LSRPFQSIIHAK------RTYR 77

Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHL-------LVYEFMKNGSLQDILDDVSRGRREL 306
            E+     ++H N++ LL  +  P   L       LV   M      D L+++ + ++  
Sbjct: 78  -ELRLLKHMKHENVIGLL-DVFTPARSLEEFNDVYLVTHLMGA----D-LNNIVKCQKLT 130

Query: 307 DWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGY 366
           D   +  +   +  GL+Y+H   SA IIH D+KP N+ +N+D E  I D GLA    D  
Sbjct: 131 DDHVQF-LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM 186

Query: 367 TRVLISYVLGTMAYIAPE-YFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
           T     YV  T  Y APE        ++  DI+S G ++  L+ G   F
Sbjct: 187 T----GYV-ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 230

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 74.6 bits (184), Expect = 6e-15
 Identities = 59/241 (24%), Positives = 91/241 (37%), Gaps = 41/241 (17%)

Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           + +G G    V          +  A+K +             E          ++  E+ 
Sbjct: 19  DVLGEGAHARVQTCINL-ITSQEYAVKII-------------EKQPGHIRS--RVFREVE 62

Query: 258 TASQIR-HRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDD-VSRGR-RELDWPSRHRI 314
              Q + HRN+L L+      D   LV+E M+ GS+   L     R    EL+      +
Sbjct: 63  MLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI---LSHIHKRRHFNELE---ASVV 116

Query: 315 ALGVASGLEYLHMYHSASIIHGDIKPRNVLL---NDDMEACISDLGLAMAIPDGYTRVLI 371
              VAS L++LH   +  I H D+KP N+L    N      I D  L   I        I
Sbjct: 117 VQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPI 173

Query: 372 SY-----VLGTMAYIAPEYFQQPELS-----EKCDIFSFGMLLISLVRGVPSFVFHQNGE 421
           S        G+  Y+APE  +          ++CD++S G++L  L+ G P FV     +
Sbjct: 174 STPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSD 233

Query: 422 E 422
            
Sbjct: 234 C 234

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 75.0 bits (185), Expect = 6e-15
 Identities = 65/247 (26%), Positives = 93/247 (37%), Gaps = 69/247 (27%)

Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           + +L  IG G  G V  A     N   +AIKK      IS  E           + R +R
Sbjct: 29  YTNLSYIGEGAYGMVCSA-YDNLNKVRVAIKK------ISPFE------HQTYCQ-RTLR 74

Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHL------LVYEFM--------KNGSLQD----- 294
            EI    + RH NI+ +   ++R           +V + M        K   L +     
Sbjct: 75  -EIKILLRFRHENIIGIN-DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY 132

Query: 295 ----ILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME 350
               IL                        GL+Y+H   SA+++H D+KP N+LLN   +
Sbjct: 133 FLYQIL-----------------------RGLKYIH---SANVLHRDLKPSNLLLNTTCD 166

Query: 351 ACISDLGLA--MAIPDGYTRVLISYVLGTMAYIAPEY-FQQPELSEKCDIFSFGMLLISL 407
             I D GLA        +T  L  YV  T  Y APE        ++  DI+S G +L  +
Sbjct: 167 LKICDFGLARVADPDHDHTGFLTEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM 225

Query: 408 VRGVPSF 414
           +   P F
Sbjct: 226 LSNRPIF 232

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 73.4 bits (181), Expect = 2e-14
 Identities = 57/232 (24%), Positives = 96/232 (41%), Gaps = 21/232 (9%)

Query: 192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ 251
           + F   + +G G    V  A    +  +  AIK       +    +I+E+      K+  
Sbjct: 30  EDFKFGKILGEGSFSTVVLAREL-ATSREYAIKI------LEKRHIIKEN------KVPY 76

Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
           +  E    S++ H   + L       +       + KNG L   +    +     +  +R
Sbjct: 77  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTR 133

Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLI 371
              A  + S LEYLH      IIH D+KP N+LLN+DM   I+D G A  +     +   
Sbjct: 134 FYTA-EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 189

Query: 372 SYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI 423
           +  +GT  Y++PE   +    +  D+++ G ++  LV G+P F    N   I
Sbjct: 190 NSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF-RAGNEYLI 240

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 72.7 bits (179), Expect = 3e-14
 Identities = 57/254 (22%), Positives = 91/254 (35%), Gaps = 76/254 (29%)

Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           F     +G G  G V  A      G+++AIKK+  +             K   +  R +R
Sbjct: 13  FQLKSLLGEGAYGVVCSA-THKPTGEIVAIKKIEPF------------DKPLFAL-RTLR 58

Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHL------LVYEFM--------KNGSLQD----- 294
            EI      +H NI+ +  ++ RPD         ++ E M            L D     
Sbjct: 59  -EIKILKHFKHENIITIF-NIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQY 116

Query: 295 ----ILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME 350
                L                         ++ LH    +++IH D+KP N+L+N + +
Sbjct: 117 FIYQTL-----------------------RAVKVLH---GSNVIHRDLKPSNLLINSNCD 150

Query: 351 ACISDLGLA---------MAIPDGYTRVLISYVLGTMAYIAPEY-FQQPELSEKCDIFSF 400
             + D GLA          + P G    ++ +V  T  Y APE      + S   D++S 
Sbjct: 151 LKVCDFGLARIIDESAADNSEPTGQQSGMVEFV-ATRWYRAPEVMLTSAKYSRAMDVWSC 209

Query: 401 GMLLISLVRGVPSF 414
           G +L  L    P F
Sbjct: 210 GCILAELFLRRPIF 223

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 71.9 bits (177), Expect = 4e-14
 Identities = 54/237 (22%), Positives = 96/237 (40%), Gaps = 40/237 (16%)

Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           +  L+ +G GG G V+ A +     K +AIKK+++  P S                  +R
Sbjct: 13  YMDLKPLGCGGNGLVFSA-VDNDCDKRVAIKKIVLTDPQSV--------------KHALR 57

Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDI----------LDDVSRGR 303
            EI    ++ H NI+ +   ++ P    L  +      L  +          L +V    
Sbjct: 58  -EIKIIRRLDHDNIVKVF-EILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQG 115

Query: 304 RELDWPSRHR--IALGVASGLEYLHMYHSASIIHGDIKPRNVLLN-DDMEACISDLGLA- 359
             L+    H       +  GL+Y+H   SA+++H D+KP N+ +N +D+   I D GLA 
Sbjct: 116 PLLE---EHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLAR 169

Query: 360 -MAIPDGYTRVLISYVLGTMAYIAPE-YFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
            M     +   L   +  T  Y +P         ++  D+++ G +   ++ G   F
Sbjct: 170 IMDPHYSHKGHLSEGL-VTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLF 225

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 72.0 bits (177), Expect = 8e-14
 Identities = 53/244 (21%), Positives = 92/244 (37%), Gaps = 52/244 (21%)

Query: 192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ 251
           D F  L  IG G  G+V   +      KM A+K  +                   +K   
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKND-TKKMYAMK-YM-------------------NK--- 50

Query: 252 IRSEIITASQIRH----RNILPLLAH--MVR-------PDCHLLVYEFMKNGSLQDILDD 298
              + +  +++R+      I+  L H  +V         +   +V + +  G L+  L  
Sbjct: 51  --QKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHL-- 106

Query: 299 VSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGL 358
             +     +   +  I   +   L+YL       IIH D+KP N+LL++     I+D  +
Sbjct: 107 -QQNVHFKEETVKLFIC-ELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNI 161

Query: 359 AMAIPDGYTRVLISYVLGTMAYIAPEYFQQPEL---SEKCDIFSFGMLLISLVRGVPSFV 415
           A  +P       ++   GT  Y+APE F   +    S   D +S G+    L+RG   + 
Sbjct: 162 AAMLPRETQITTMA---GTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYH 218

Query: 416 FHQN 419
              +
Sbjct: 219 IRSS 222

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 71.4 bits (175), Expect = 1e-13
 Identities = 45/174 (25%), Positives = 73/174 (41%), Gaps = 33/174 (18%)

Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           +     IG+G  G V +A       +++AIKK++                L D K R +R
Sbjct: 55  YEIRHLIGTGSYGHVCEA-YDKLEKRVVAIKKIL-----------RVFEDLIDCK-RILR 101

Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHL------LVYEFMKNGSLQDILDDVSRGRRELD 307
            EI   +++ H +++ +L  +V P          +V E        D    + R    L 
Sbjct: 102 -EIAILNRLNHDHVVKVL-DIVIPKDVEKFDELYVVLEIAD----SD-FKKLFRTPVYL- 153

Query: 308 WPSRHR--IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA 359
               H   +   +  G++Y+H   SA I+H D+KP N L+N D    + D GLA
Sbjct: 154 -TELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLA 203

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 71.7 bits (176), Expect = 1e-13
 Identities = 61/213 (28%), Positives = 96/213 (45%), Gaps = 26/213 (12%)

Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR-QIRSEIIT 258
           +G G  G+V   +     G  +A+K             I    K+R   +  +IR EI  
Sbjct: 24  LGVGTFGKVKVGK-HELTGHKVAVK-------------ILNRQKIRSLDVVGKIRREIQN 69

Query: 259 ASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV 318
               RH +I+ L   +  P    +V E++  G L D +     GR  LD     R+   +
Sbjct: 70  LKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYI--CKNGR--LDEKESRRLFQQI 125

Query: 319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTM 378
            SG++Y H      ++H D+KP NVLL+  M A I+D GL+  + DG     +    G+ 
Sbjct: 126 LSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE---FLRTSCGSP 179

Query: 379 AYIAPEYFQ-QPELSEKCDIFSFGMLLISLVRG 410
            Y APE    +     + DI+S G++L +L+ G
Sbjct: 180 NYAAPEVISGRLYAGPEVDIWSSGVILYALLCG 212

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 70.1 bits (172), Expect = 3e-13
 Identities = 63/357 (17%), Positives = 111/357 (31%), Gaps = 94/357 (26%)

Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAEL---------------- 237
           ++  + +G+G  G V +     S GK  A+KKV+        EL                
Sbjct: 9   YSLGKTLGTGSFGIVCEVFDIES-GKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVD 67

Query: 238 --IEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHL-LVYEFMKNGSLQD 294
                  +             +        N    +      + +L ++ E++ + +L  
Sbjct: 68  YFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHK 126

Query: 295 ILDDVSRGRRELDWPSRH---------RIALGVASGLEYLHMYHSASIIHGDIKPRNVLL 345
           +L    R  R +  P            R        + ++H   S  I H DIKP+N+L+
Sbjct: 127 VLKSFIRSGRSI--PMNLISIYIYQLFR-------AVGFIH---SLGICHRDIKPQNLLV 174

Query: 346 N-DDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPE-YFQQPELSEKCDIFSFGML 403
           N  D    + D G A  +        ++Y+  +  Y APE      E +   D++S G +
Sbjct: 175 NSKDNTLKLCDFGSAKKLIPS--EPSVAYIC-SRFYRAPELMLGATEYTPSIDLWSIGCV 231

Query: 404 LISLVRGVPSF----VFHQ-----------NGEEICS----------PEW----LRKVMN 434
              L+ G P F       Q             E++            P       RK++ 
Sbjct: 232 FGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILP 291

Query: 435 SKNPSRAIDPRLPGNGYEKKMLH-----------VLKIAYICTLHDPEERPNSQYVR 480
              PS AID         +++L             +   +   L +  E        
Sbjct: 292 EGTPSLAID-------LLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSN 341

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 69.6 bits (171), Expect = 3e-13
 Identities = 53/233 (22%), Positives = 97/233 (41%), Gaps = 56/233 (24%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSK-LRQIRSE 255
           + K+G G   EV++A +  +N + + +K +         + +++    R+ K L  +R  
Sbjct: 41  VRKLGRGKYSEVFEA-INITNNEKVVVKIL---------KPVKKKKIKREIKILENLRG- 89

Query: 256 IITASQIRHRNILPLLAHMVRPDCH---LLVYEFMKNGSLQDILDDVSRGRRELDWPSRH 312
                     NI+ L   +V+        LV+E + N   + +   ++      D+  R 
Sbjct: 90  --------GPNIITLA-DIVKDPVSRTPALVFEHVNNTDFKQLYQTLT------DYDIRF 134

Query: 313 RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN-DDMEACISDLGLA-MAIPDG-YTRV 369
            +   +   L+Y H   S  I+H D+KP NV+++ +  +  + D GLA    P   Y   
Sbjct: 135 YM-YEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYN-- 188

Query: 370 LISYVLGTMAYIAPEYFQQPEL-------SEKCDIFSFGMLLISLV-RGVPSF 414
                      +A  YF+ PEL           D++S G +L S++ R  P F
Sbjct: 189 ---------VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 232

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 70.2 bits (172), Expect = 4e-13
 Identities = 49/205 (23%), Positives = 77/205 (37%), Gaps = 33/205 (16%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
              IG G  G VY A    +  K +AIKK      ++       D K      R +R EI
Sbjct: 31  KHLIGRGSYGYVYLAYDK-NTEKNVAIKK------VNRMFEDLIDCK------RILR-EI 76

Query: 257 ITASQIRHRNILPLLAHMVRPDCHL------LVYEFMKNGSLQDILDDVSRGRRELDWPS 310
              ++++   I+ L   ++ PD  L      +V E        D L  + +    L    
Sbjct: 77  TILNRLKSDYIIRLY-DLIIPDDLLKFDELYIVLEIAD----SD-LKKLFKTPIFLT--E 128

Query: 311 RHR--IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTR 368
            H   I   +  G  ++H    + IIH D+KP N LLN D    + D GLA  I      
Sbjct: 129 EHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDT 185

Query: 369 VLISYVLGTMAYIAPEYFQQPELSE 393
            +++ +             + +L+ 
Sbjct: 186 NIVNDLEENEEPGPHNKNLKKQLTS 210

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 69.4 bits (170), Expect = 5e-13
 Identities = 54/250 (21%), Positives = 98/250 (39%), Gaps = 38/250 (15%)

Query: 181 EKEDLAFLKKEDCFASL-EKIGSGGCGEVYKA-ELPGSNGKMIAIKKVIVYAPISAAELI 238
            K      + ED F     K+G G  G VYKA    G + K  A+K++            
Sbjct: 9   VKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQI------------ 56

Query: 239 EEDSKLRDSKLRQIRSEIITASQIRHRNILPLL-AHMVRPDCHL-LVYEFMKN--GSLQD 294
            E + +  S  R    EI    +++H N++ L    +   D  + L++++ ++    +  
Sbjct: 57  -EGTGISMSACR----EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIK 111

Query: 295 ILDDVSRGRRELDWPSRHR--IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC 352
                   ++ +  P      +   +  G+ YLH   +  ++H D+KP N+L+  +    
Sbjct: 112 FHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPER 168

Query: 353 ----ISDLGLA--MAIPD-GYTRVLISYVLGTMAYIAPEY-FQQPELSEKCDIFSFGMLL 404
               I+D+G A     P      +    V  T  Y APE        ++  DI++ G + 
Sbjct: 169 GRVKIADMGFARLFNSPLKPLADLDPVVV--TFWYRAPELLLGARHYTKAIDIWAIGCIF 226

Query: 405 ISLVRGVPSF 414
             L+   P F
Sbjct: 227 AELLTSEPIF 236

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 68.6 bits (168), Expect = 9e-13
 Identities = 65/280 (23%), Positives = 102/280 (36%), Gaps = 59/280 (21%)

Query: 176 FSPLIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAA 235
           +   I K     +K ED +  ++ IG G  GEV          K+ A+K +         
Sbjct: 54  YKDTINKIRDLRMKAED-YEVVKVIGRGAFGEVQLVRHKS-TRKVYAMKLL--------- 102

Query: 236 ELIEEDSKLRDSKLRQIRSEIITASQIRH----RNILPLLAH--MVR-------PDCHLL 282
                      SK      E+I  S        R+I+       +V+            +
Sbjct: 103 -----------SK-----FEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 146

Query: 283 VYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRN 342
           V E+M  G L +++   S       W +R   A  V   L+ +H   S   IH D+KP N
Sbjct: 147 VMEYMPGGDLVNLM---SNYDVPEKW-ARFYTA-EVVLALDAIH---SMGFIHRDVKPDN 198

Query: 343 VLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEK----CDIF 398
           +LL+      ++D G  M +         + V GT  YI+PE  +           CD +
Sbjct: 199 MLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWW 257

Query: 399 SFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSKNP 438
           S G+ L  ++ G   F +  +           K+MN KN 
Sbjct: 258 SVGVFLYEMLVGDTPF-YADSLVGTY-----SKIMNHKNS 291

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 67.3 bits (165), Expect = 2e-12
 Identities = 52/213 (24%), Positives = 92/213 (43%), Gaps = 27/213 (12%)

Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR-QIRSEIIT 258
           +G G  G+V  A       + +A+K                   L+ S +  ++  EI  
Sbjct: 17  LGEGSFGKVKLAT-HYKTQQKVALK-------------FISRQLLKKSDMHMRVEREISY 62

Query: 259 ASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV 318
              +RH +I+ L   +  P   ++V E+   G L D +  V + R  +      R    +
Sbjct: 63  LKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYI--VEKKR--MTEDEGRRFFQQI 117

Query: 319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTM 378
              +EY H      I+H D+KP N+LL+D++   I+D GL+  + DG     +    G+ 
Sbjct: 118 ICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN---FLKTSCGSP 171

Query: 379 AYIAPEYFQ-QPELSEKCDIFSFGMLLISLVRG 410
            Y APE    +     + D++S G++L  ++ G
Sbjct: 172 NYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVG 204

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 67.1 bits (164), Expect = 4e-12
 Identities = 61/282 (21%), Positives = 105/282 (37%), Gaps = 60/282 (21%)

Query: 176 FSPLIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAA 235
             P   K     L +ED F  L+ IG G  GEV   +L     K+ A+K +         
Sbjct: 59  AKPFTSKVKQMRLHRED-FEILKVIGRGAFGEVAVVKLKN-ADKVFAMKIL--------- 107

Query: 236 ELIEEDSKLRDSKLRQIRSEIITASQIRH----RNILPLLAH--MVR-------PDCHLL 282
                      +K      E++  ++       R++L       +          +   L
Sbjct: 108 -----------NK-----WEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYL 151

Query: 283 VYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALG-VASGLEYLHMYHSASIIHGDIKPR 341
           V ++   G L  +L   S+    L      R  L  +   ++ +H       +H DIKP 
Sbjct: 152 VMDYYVGGDLLTLL---SKFEDRLP-EEMARFYLAEMVIAIDSVH---QLHYVHRDIKPD 204

Query: 342 NVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEK-----CD 396
           N+L++ +    ++D G  + + +  T      V GT  YI+PE  Q  E  +      CD
Sbjct: 205 NILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQAMEGGKGRYGPECD 263

Query: 397 IFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSKNP 438
            +S G+ +  ++ G   F + ++  E        K+MN K  
Sbjct: 264 WWSLGVCMYEMLYGETPF-YAESLVETY-----GKIMNHKER 299

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 66.3 bits (162), Expect = 7e-12
 Identities = 57/273 (20%), Positives = 105/273 (38%), Gaps = 40/273 (14%)

Query: 176 FSPLIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAA 235
             P++ +     L+++D F  L+ IG G   EV   ++  + G++ A+K       ++  
Sbjct: 46  AEPIVVRLKEVRLQRDD-FEILKVIGRGAFSEVAVVKMKQT-GQVYAMKI------MNKW 97

Query: 236 ELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDI 295
           +++      +  ++   R E         R I  L       +   LV E+   G   D+
Sbjct: 98  DML------KRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGG---DL 148

Query: 296 LDDVSRGRRELDWPSRHRIALG-VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACIS 354
           L  +S+    +      R  L  +   ++ +H       +H DIKP N+LL+      ++
Sbjct: 149 LTLLSKFGERIP-AEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLA 204

Query: 355 DLGLAMA-IPDGYTRVLISYVL-GTMAYIAPEYFQQPELSEK-------CDIFSFGMLLI 405
           D G  +    DG  R   S V  GT  Y++PE  Q              CD ++ G+   
Sbjct: 205 DFGSCLKLRADGTVR---SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAY 261

Query: 406 SLVRGVPSFVFHQNGEEICSPEWLRKVMNSKNP 438
            +  G   F +  +  E        K+++ K  
Sbjct: 262 EMFYGQTPF-YADSTAETY-----GKIVHYKEH 288

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 65.3 bits (158), Expect = 9e-12
 Identities = 42/248 (16%), Positives = 73/248 (29%), Gaps = 37/248 (14%)

Query: 181 EKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEE 240
                +     +     EKIG G  GEV++      +   +AIK + +  P       ++
Sbjct: 9   GPVPFSHCLPTEKLQRCEKIGEGVFGEVFQTIA---DHTPVAIKIIAIEGPDLVNGSHQK 65

Query: 241 DSK--LRDSKLRQIRSEIITASQIRHRNILPLLAHMV----RPDCHLLVYEFM--KNGSL 292
             +  L +  + +  S +      R    + L +        P   L  ++      GS 
Sbjct: 66  TFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSA 125

Query: 293 QDILDDVSR-------------------GRRELDWPSRHRIALGVASGLEYLHMYHSASI 333
            D  D                         +     +   I   + + L       S   
Sbjct: 126 NDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAE--ASLRF 183

Query: 334 IHGDIKPRNVLLNDDMEACISD--LGLAMAIPD-GYTRVLISYVLGTMAYIAPEYFQQPE 390
            H D+   NVLL       +     G +  IP  G    +I Y L  +       F   +
Sbjct: 184 EHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFC--D 241

Query: 391 LSEKCDIF 398
           +S   D+F
Sbjct: 242 VSMDEDLF 249

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 62.8 bits (153), Expect = 6e-11
 Identities = 53/214 (24%), Positives = 82/214 (38%), Gaps = 30/214 (14%)

Query: 200 IGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA 259
           IGSG  G         +  +++A+K               E     D     ++ EII  
Sbjct: 28  IGSGNFGVARLMRDKLT-KELVAVK-------------YIERGAAIDEN---VQREIINH 70

Query: 260 SQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVA 319
             +RH NI+     ++ P    ++ E+   G L + +   + GR              + 
Sbjct: 71  RSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERI--CNAGR--FSEDEARFFFQQLL 126

Query: 320 SGLEYLHMYHSASIIHGDIKPRNVLL--NDDMEACISDLGLAMAIPDGYTRVLISYVLGT 377
           SG+ Y H   S  I H D+K  N LL  +      I D G + +          S V GT
Sbjct: 127 SGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--SQPKSTV-GT 180

Query: 378 MAYIAPEYFQ-QPELSEKCDIFSFGMLLISLVRG 410
            AYIAPE    Q    +  D++S G+ L  ++ G
Sbjct: 181 PAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVG 214

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 62.8 bits (153), Expect = 9e-11
 Identities = 56/286 (19%), Positives = 113/286 (39%), Gaps = 25/286 (8%)

Query: 139 KESFGGKSRNVRQRFPTTPSLISAAVRGGSRDRGPTIFSPLIEKEDLAFLKKEDCFASLE 198
           +E +    + V        +       G   D        +   +    +   + F  L+
Sbjct: 96  REEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNE-FEYLK 154

Query: 199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT 258
            +G G  G+V   +   + G+  A+K            +++++  +   ++    +E   
Sbjct: 155 LLGKGTFGKVILVKEKAT-GRYYAMK------------ILKKEVIVAKDEVAHTLTENRV 201

Query: 259 ASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGV 318
               RH  +  L       D    V E+   G   ++   +SR R   +  +R   A  +
Sbjct: 202 LQNSRHPFLTALKYSFQTHDRLCFVMEYANGG---ELFFHLSRERVFSEDRARFYGA-EI 257

Query: 319 ASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA-MAIPDGYTRVLISYVLGT 377
            S L+YLH   +  +++ D+K  N++L+ D    I+D GL    I DG T   +    GT
Sbjct: 258 VSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---MKTFCGT 312

Query: 378 MAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI 423
             Y+APE  +  +     D +  G+++  ++ G   F ++Q+ E++
Sbjct: 313 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHEKL 357

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 62.4 bits (152), Expect = 1e-10
 Identities = 53/272 (19%), Positives = 106/272 (38%), Gaps = 90/272 (33%)

Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSK--LRDSK-LR 250
           +  ++K+G G  G V+K+ +    G+++A+KK      I  A     D++   R+   L 
Sbjct: 11  YELVKKLGKGAYGIVWKS-IDRRTGEVVAVKK------IFDAFQNSTDAQRTFREIMILT 63

Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCHL---LVYEFM--------KNGSLQD----- 294
           ++           H NI+ LL +++R D      LV+++M        +   L+      
Sbjct: 64  ELSG---------HENIVNLL-NVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQY 113

Query: 295 ----ILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME 350
               ++                         ++YLH   S  ++H D+KP N+LLN +  
Sbjct: 114 VVYQLI-----------------------KVIKYLH---SGGLLHRDMKPSNILLNAECH 147

Query: 351 ACISDLGLAMAIPDGYTRVLISYVLGTMA-------------YIAPEYFQQPEL------ 391
             ++D GL+ +  +         +                  Y+A  +++ PE+      
Sbjct: 148 VKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTK 207

Query: 392 -SEKCDIFSFGMLLISLVRGVPSF----VFHQ 418
            ++  D++S G +L  ++ G P F      +Q
Sbjct: 208 YTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ 239

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 61.7 bits (150), Expect = 1e-10
 Identities = 56/303 (18%), Positives = 109/303 (35%), Gaps = 28/303 (9%)

Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
             IG GG G +Y A++  S         V+   P     L  E    + +   +   + I
Sbjct: 41  LPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWI 100

Query: 258 TASQIRHRNILPL----LAHMVRPDCHLLVYEFMKNG-SLQDILDDVSRGRRELDWPSRH 312
              ++++  +       L          ++ +    G  LQ I +  ++        +  
Sbjct: 101 RTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAK---RFSRKTVL 155

Query: 313 RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACI--SDLGLAMAIPDGYTRVL 370
           +++L +   LEY+H       +HGDIK  N+LLN      +   D GLA           
Sbjct: 156 QLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKA 212

Query: 371 ISY-----VLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRG-VPSFVFHQNGEEIC 424
            +        GT+ + + +       S + D+   G  +I  + G +P     ++  +  
Sbjct: 213 YAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP----WEDNLKDP 268

Query: 425 SPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLS 484
                 K+   +N +  +D   P      ++   ++   +  L D  E+P  + +R  L 
Sbjct: 269 KYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYME--TVKLL-DYTEKPLYENLRDILL 325

Query: 485 QLL 487
           Q L
Sbjct: 326 QGL 328

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 61.1 bits (148), Expect = 2e-10
 Identities = 52/224 (23%), Positives = 84/224 (37%), Gaps = 32/224 (14%)

Query: 273 HMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRH---RIALGVASGLEYLHMYH 329
             +          F++  SL D+ ++ +      D+ +       +  VA G+E+L    
Sbjct: 154 DSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA--- 210

Query: 330 SASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYI-----APE 384
           S   IH D+  RN+LL++     I D GLA  I          YV    A +     APE
Sbjct: 211 SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-----YVRKGDARLPLKWMAPE 265

Query: 385 YFQQPELSEKCDIFSFGMLLISLV-RGVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAID 443
                  + + D++SFG+LL  +   G   +   +  EE C    L++    + P     
Sbjct: 266 TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC--RRLKEGTRMRAPDYT-- 321

Query: 444 PRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL 487
                  Y+  ML        C   +P +RP    +   L  LL
Sbjct: 322 ---TPEMYQ-TMLD-------CWHGEPSQRPTFSELVEHLGNLL 354

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 44.5 bits (105), Expect = 4e-05
 Identities = 36/155 (23%), Positives = 63/155 (40%), Gaps = 31/155 (20%)

Query: 198 EKIGSGGCGEVYKAELPGSNG----KMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           + +G G  G+V +A+  G +     + +A+K +            +E +   +   R + 
Sbjct: 28  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKML------------KEGATHSE--HRALM 73

Query: 254 SEIITASQI-RHRNILPLLAHMVRPDCHLLV-YEFMKNGSLQDILDDVSRGRRELDWPSR 311
           SE+     I  H N++ LL    +P   L+V  EF K G+L   L    R +R    P +
Sbjct: 74  SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----RSKRNEFVPYK 129

Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN 346
            + A     G +Y+        I  D+K R   + 
Sbjct: 130 TKGA-RFRQGKDYVGA------IPVDLKRRLDSIT 157

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 60.5 bits (147), Expect = 4e-10
 Identities = 56/252 (22%), Positives = 97/252 (38%), Gaps = 36/252 (14%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVI----VYAPISAAELIEEDSKLRDSKLRQI 252
           + K+G G    V+ A     N   +A+K ++    VY   +  E+     KL    L+++
Sbjct: 24  VRKLGWGHFSTVWLA-KDMVNNTHVAMK-IVRGDKVYTEAAEDEI-----KL----LQRV 72

Query: 253 RSEIITASQIR-HRNILPLL---AHMVRPDCHL-LVYEFMKNGSLQDILDDVSRGRRELD 307
                T        +IL LL    H      H+ +V+E +   +L  ++       R + 
Sbjct: 73  NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKK--YEHRGIP 129

Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC------ISDLGLAMA 361
                +I+  +  GL+Y+H      IIH DIKP NVL+             I+DLG A  
Sbjct: 130 LIYVKQISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC- 186

Query: 362 IPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGE 421
               +     +  + T  Y +PE           DI+S   L+  L+ G   F   +   
Sbjct: 187 ----WYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHS 242

Query: 422 EICSPEWLRKVM 433
                + + +++
Sbjct: 243 YTKDDDHIAQII 254

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 60.5 bits (147), Expect = 5e-10
 Identities = 53/244 (21%), Positives = 87/244 (35%), Gaps = 54/244 (22%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           L+ IG G  G+V KA       + +A+K ++               +      RQ   EI
Sbjct: 102 LKVIGKGSFGQVVKA-YDHKVHQHVALK-MV---------------RNEKRFHRQAAEEI 144

Query: 257 ITASQIRHR------NILPLLAH--------MVRPDCHLLVYEFMKNGSLQDI-LDDVSR 301
                +R +      N++ +L +        M      + +YE +K    Q   L  V  
Sbjct: 145 RILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLV-- 202

Query: 302 GRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACIS--DLGLA 359
                      + A  +   L+ LH      IIH D+KP N+LL     + I   D G +
Sbjct: 203 ----------RKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249

Query: 360 MAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQN 419
                 Y    +   + +  Y APE           D++S G +L  L+ G P       
Sbjct: 250 C-----YEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE 304

Query: 420 GEEI 423
           G+++
Sbjct: 305 GDQL 308

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 58.1 bits (141), Expect = 2e-09
 Identities = 51/240 (21%), Positives = 92/240 (38%), Gaps = 42/240 (17%)

Query: 192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIK----KVIVYAPISAAELIEEDSKLRDS 247
           D F  ++ +G+G  G V   +    +G   A+K    + +V                   
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKE-SGNHYAMKILDKQKVV------------------- 80

Query: 248 KLRQ---IRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRR 304
           KL+Q     +E      +    ++ L           +V E++  G +   L    R  R
Sbjct: 81  KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGR 137

Query: 305 ELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPD 364
             +  +R   A  +    EYLH   S  +I+ D+KP N+L++      ++D G A  +  
Sbjct: 138 FSEPHARFYAA-QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193

Query: 365 G-YTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI 423
             +T      + GT   +APE       ++  D ++ G+L+  +  G P F F     +I
Sbjct: 194 RTWT------LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF-FADQPIQI 246

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 56.7 bits (137), Expect = 7e-09
 Identities = 32/173 (18%), Positives = 60/173 (34%), Gaps = 23/173 (13%)

Query: 198 EKIGSGGCGEVYKAE-------LPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLR 250
                   G +Y+A          G   +  ++K              E++   R +K  
Sbjct: 48  SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK----LDAKDGRLFNEQNFFQRAAKPL 103

Query: 251 QIRSEIITASQIRHRNILPLLAHMVRPDCH-LLVYEFMKNG-SLQDILDDVSRGRRELDW 308
           Q+              I   +   V  D +  LV   +  G SLQ  LD     +  L  
Sbjct: 104 QVNKWKKL-YSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDV--SPKHVLSE 158

Query: 309 PSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACI--SDLGLA 359
            S  ++A  +   LE+LH       +HG++   N+ ++ + ++ +  +  G A
Sbjct: 159 RSVLQVACRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFA 208

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 55.8 bits (135), Expect = 8e-09
 Identities = 50/273 (18%), Positives = 95/273 (34%), Gaps = 63/273 (23%)

Query: 172 GPTIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAP 231
           GP + S L  K++      +D   + + +G G  G+V +        +  A+K +     
Sbjct: 1   GPHVKSGLQIKKNAII---DDYKVTSQVLGLGINGKVLQIFNK-RTQEKFALKML----- 51

Query: 232 ISAAELIEEDSKLRDSKLRQIRSEI-ITASQIRHRNILPLLA----HMVRPDCHLLVYEF 286
                              + R E+ +     +  +I+ ++           C L+V E 
Sbjct: 52  ---------------QDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC 96

Query: 287 MKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLL- 345
           +  G L   +    RG +         I   +   ++YLH   S +I H D+KP N+L  
Sbjct: 97  LDGGELFSRI--QDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYT 151

Query: 346 --NDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGML 403
               +    ++D G A                        E   +    + CD++S G++
Sbjct: 152 SKRPNAILKLTDFGFA-----------------------KETTGEK-YDKSCDMWSLGVI 187

Query: 404 LISLVRGVPSFVFHQNGEEICSPEWLRKVMNSK 436
           +  L+ G P   F+ N     SP    ++   +
Sbjct: 188 MYILLCGYPP--FYSNHGLAISPGMKTRIRMGQ 218

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 56.1 bits (135), Expect = 1e-08
 Identities = 62/313 (19%), Positives = 99/313 (31%), Gaps = 84/313 (26%)

Query: 175 IFSPLIEKEDLAFLKKE--------DCFAS----LEKIGSGGCGEVYKAELPGSNGKMIA 222
           + S   E+ED     K         D F      + K+G G    V+ +       K +A
Sbjct: 8   LGSDDDEQEDPNDYCKGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSW-DIQGKKFVA 66

Query: 223 IKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAH--MVRPD-C 279
           +K V      +   L E         L+ +R+     +      ++ LL    +   +  
Sbjct: 67  MKVVKSAEHYTETALDEIRL------LKSVRN--SDPNDPNREMVVQLLDDFKISGVNGT 118

Query: 280 HL-LVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDI 338
           H+ +V+E + +  L   +   S  +  L  P   +I   V  GL+YLH      IIH DI
Sbjct: 119 HICMVFEVLGH-HLLKWIIK-SNYQG-LPLPCVKKIIQQVLQGLDYLH--TKCRIIHTDI 173

Query: 339 KPRNVLLN-------------------------------------------------DDM 349
           KP N+LL+                                                 + +
Sbjct: 174 KPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKL 233

Query: 350 EACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR 409
           +  I+DLG A      +    I     T  Y + E       +   DI+S   +   L  
Sbjct: 234 KVKIADLGNAC-WVHKHFTEDIQ----TRQYRSLEVLIGSGYNTPADIWSTACMAFELAT 288

Query: 410 GVPSFVFHQNGEE 422
           G   F  H   E 
Sbjct: 289 GDYLFEPHSGEEY 301

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 55.1 bits (133), Expect = 1e-08
 Identities = 57/223 (25%), Positives = 91/223 (40%), Gaps = 36/223 (16%)

Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
            KIGSG  G++Y      + G+ +AIK             +E       +K  Q+  E  
Sbjct: 15  RKIGSGSFGDIYLGTDI-AAGEEVAIK-------------LEC----VKTKHPQLHIESK 56

Query: 258 TASQIRHRNILP-LLAHMVRPDCHLLVYEFMKNG-SLQDILDDVSRGRRELDWPSRHRIA 315
               ++    +P +       D +++V E +  G SL+D+ +  SR   +    +   +A
Sbjct: 57  IYKMMQGGVGIPTIRWCGAEGDYNVMVMELL--GPSLEDLFNFCSR---KFSLKTVLLLA 111

Query: 316 LGVASGLEYLHMYHSASIIHGDIKPRNVLL---NDDMEACISDLGLAMAIPDGYTRVLIS 372
             + S +EY+H   S + IH D+KP N L+          I D GLA    D  T   I 
Sbjct: 112 DQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIP 168

Query: 373 Y-----VLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRG 410
           Y     + GT  Y +       E S + D+ S G +L+    G
Sbjct: 169 YRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLG 211

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 55.2 bits (134), Expect = 1e-08
 Identities = 51/185 (27%), Positives = 83/185 (44%), Gaps = 30/185 (16%)

Query: 254 SEIITASQIRH----RNILPLLAH--MVRPDCHLLVYEFMKNGSLQDILDDVSRG----- 302
             ++   Q+ H    R +L ++ H  ++R     +   F     +  I+D +  G     
Sbjct: 42  EIVVRLKQVEHTNDERLMLSIVTHPFIIR-----MWGTFQDAQQIFMIMDYIEGGELFSL 96

Query: 303 -RRELDWP-SRHRI-ALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA 359
            R+   +P    +  A  V   LEYLH   S  II+ D+KP N+LL+ +    I+D G A
Sbjct: 97  LRKSQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFA 153

Query: 360 MAIPDG-YTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ 418
             +PD  YT      + GT  YIAPE       ++  D +SFG+L+  ++ G   F +  
Sbjct: 154 KYVPDVTYT------LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF-YDS 206

Query: 419 NGEEI 423
           N  + 
Sbjct: 207 NTMKT 211

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 54.9 bits (133), Expect = 2e-08
 Identities = 31/107 (28%), Positives = 57/107 (53%), Gaps = 8/107 (7%)

Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA-MAIPDGYTRVLISYVLG 376
           +A  L++LH   S  II+ D+KP N+LL+++    ++D GL+  +I             G
Sbjct: 135 LALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK---AYSFCG 188

Query: 377 TMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI 423
           T+ Y+APE   +   ++  D +SFG+L+  ++ G   F   ++ +E 
Sbjct: 189 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPF-QGKDRKET 234

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 53.1 bits (128), Expect = 7e-08
 Identities = 51/226 (22%), Positives = 91/226 (40%), Gaps = 40/226 (17%)

Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
            +IG G  G +++      N + +AIK              E     R S   Q+R E  
Sbjct: 16  RRIGEGSFGVIFEGT-NLLNNQQVAIKF-------------EP----RRSDAPQLRDEYR 57

Query: 258 TASQIRHRNILP-LLAHMVRPDCHLLVYEFMKNG-SLQDILDDVSRGRRELDWPSRHRIA 315
           T   +     +P +         ++LV + +  G SL+D+LD   R   +    +    A
Sbjct: 58  TYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGR---KFSVKTVAMAA 112

Query: 316 LGVASGLEYLHMYHSASIIHGDIKPRNVLL------NDDMEACISDLGLAMAIPDGYTRV 369
             + + ++ +H     S+++ DIKP N L+      N +M   + D G+     D  T+ 
Sbjct: 113 KQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVV-DFGMVKFYRDPVTKQ 168

Query: 370 LISY-----VLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRG 410
            I Y     + GT  Y++       E S + D+ + G + +  +RG
Sbjct: 169 HIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRG 214

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 53.3 bits (129), Expect = 7e-08
 Identities = 31/107 (28%), Positives = 52/107 (48%), Gaps = 8/107 (7%)

Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA-MAIPDGYTRVLISYVLG 376
           ++  L +LH      II+ D+KP N++LN      ++D GL   +I DG          G
Sbjct: 130 ISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV---THTFCG 183

Query: 377 TMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI 423
           T+ Y+APE   +   +   D +S G L+  ++ G P F   +N ++ 
Sbjct: 184 TIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPF-TGENRKKT 229

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 53.2 bits (128), Expect = 8e-08
 Identities = 53/225 (23%), Positives = 90/225 (40%), Gaps = 38/225 (16%)

Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           +KIG G  GE+   +      + +AIK             +E       S+  Q+  E  
Sbjct: 15  KKIGCGNFGELRLGKNL-YTNEYVAIK-------------LEP----MKSRAPQLHLEYR 56

Query: 258 TASQIRHRNILP-LLAHMVRPDCHLLVYEFMKNG-SLQDILDDVSRGRRELDWPSRHRIA 315
              Q+   + +P +         + +V E +  G SL+D+ D   R        +   IA
Sbjct: 57  FYKQLGSGDGIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDR---TFSLKTVLMIA 111

Query: 316 LGVASGLEYLHMYHSASIIHGDIKPRNVLL-----NDDMEACISDLGLAMAIPDGYTRVL 370
           + + S +EY+H   S ++I+ D+KP N L+            I D  LA    D  T+  
Sbjct: 112 IQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKH 168

Query: 371 ISY-----VLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRG 410
           I Y     + GT  Y++       E S + D+ + G + +  +RG
Sbjct: 169 IPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRG 213

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 53.5 bits (128), Expect = 9e-08
 Identities = 54/236 (22%), Positives = 96/236 (40%), Gaps = 30/236 (12%)

Query: 192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ 251
             F  L  +G G  G+V  +E  G+  ++ A+K            ++++D  ++D  +  
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGT-DELYAVK------------ILKKDVVIQDDDVEC 387

Query: 252 IRSE-IITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPS 310
              E  + A   +   +  L +     D    V E++  G L   +  V R +       
Sbjct: 388 TMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP----- 442

Query: 311 RHRI-ALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMA--IPDGYT 367
                A  +A GL +L    S  II+ D+K  NV+L+ +    I+D G+          T
Sbjct: 443 HAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT 499

Query: 368 RVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI 423
           +       GT  YIAPE        +  D ++FG+LL  ++ G   F   ++ +E+
Sbjct: 500 KTFC----GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF-EGEDEDEL 550

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 52.8 bits (127), Expect = 1e-07
 Identities = 50/248 (20%), Positives = 87/248 (35%), Gaps = 50/248 (20%)

Query: 192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ 251
           D +     IG G  G+V KA       + +AIK +I               K + + L Q
Sbjct: 54  DRYEIDSLIGKGSFGQVVKA-YDRVEQEWVAIK-II---------------KNKKAFLNQ 96

Query: 252 IRSEIITASQIRHR------NILPLLAH--------MVRPDCHLLVYEFMKNGSLQDILD 297
            + E+     +          I+ L  H        +V       +Y+ ++N        
Sbjct: 97  AQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRN-------- 148

Query: 298 DVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACIS--D 355
                 R +      + A  + + L +L      SIIH D+KP N+LL +   + I   D
Sbjct: 149 ---TNFRGVSLNLTRKFAQQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVD 204

Query: 356 LGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFV 415
            G +           I   + +  Y +PE           D++S G +L+ +  G P F 
Sbjct: 205 FGSSC-----QLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFS 259

Query: 416 FHQNGEEI 423
                +++
Sbjct: 260 GANEVDQM 267

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 52.3 bits (126), Expect = 1e-07
 Identities = 59/263 (22%), Positives = 108/263 (41%), Gaps = 52/263 (19%)

Query: 192 DCFASLEKIGSGGCGEVYKAELPGS--NGKMIAIKKVIVYAPISAAELIEEDSKLRDSKL 249
           + F  L+ +G+G  G+V+          GK+ A+K       +  A +++     +    
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKV------LKKATIVQ-----KAKTT 102

Query: 250 RQIRSEIITASQIRHRNILPLLAH---MVRPDCHLLVYEFMKNGSLQDILDDVSRG---- 302
              R+E         R +L  +     +V      L Y F     L  ILD ++ G    
Sbjct: 103 EHTRTE---------RQVLEHIRQSPFLVT-----LHYAFQTETKLHLILDYINGGELFT 148

Query: 303 --RRELDWP-SRHRIALG-VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGL 358
              +   +     +I +G +   LE+LH      II+ DIK  N+LL+ +    ++D GL
Sbjct: 149 HLSQRERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGL 205

Query: 359 A---MAIPDGYTRVLISYVLGTMAYIAPEYFQQPEL--SEKCDIFSFGMLLISLVRGVPS 413
           +   +A              GT+ Y+AP+  +  +    +  D +S G+L+  L+ G   
Sbjct: 206 SKEFVADETERAYDF----CGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261

Query: 414 FVFHQNGEEICSPEWLRKVMNSK 436
             F  +GE+    E  R+++ S+
Sbjct: 262 --FTVDGEKNSQAEISRRILKSE 282

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 60/223 (26%), Positives = 93/223 (41%), Gaps = 36/223 (16%)

Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
            KIGSG  GE+Y         + +AIK               E+     +K  Q+  E  
Sbjct: 13  RKIGSGSFGEIYLGTNI-QTNEEVAIKL--------------EN---VKTKHPQLLYESK 54

Query: 258 TASQIR-HRNILPLLAHMVRPDCHLLVYEFMKNG-SLQDILDDVSRGRRELDWPSRHRIA 315
               ++    I  +    V  D ++LV + +  G SL+D+ +  SR   +L   +   +A
Sbjct: 55  IYRILQGGTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSR---KLSLKTVLMLA 109

Query: 316 LGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA---CISDLGLAMAIPDGYTRVLIS 372
             + + +E++H   S S +H DIKP N L+     A    I D GLA    D  T   I 
Sbjct: 110 DQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP 166

Query: 373 Y-----VLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRG 410
           Y     + GT  Y +       E S + D+ S G +L+  +RG
Sbjct: 167 YRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRG 209

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 51.5 bits (124), Expect = 2e-07
 Identities = 33/107 (30%), Positives = 55/107 (51%), Gaps = 8/107 (7%)

Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA-MAIPDGYTRVLISYVLG 376
           + S LEYLH   S  +++ DIK  N++L+ D    I+D GL    I DG T   +    G
Sbjct: 114 IVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKTFCG 167

Query: 377 TMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI 423
           T  Y+APE  +  +     D +  G+++  ++ G   F ++Q+ E +
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHERL 213

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 50.3 bits (121), Expect = 7e-07
 Identities = 33/108 (30%), Positives = 53/108 (49%), Gaps = 10/108 (9%)

Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA-MAIPDGYTRVLISYVL- 375
           +AS L YLH   S +I++ D+KP N+LL+      ++D GL    I    T    +    
Sbjct: 148 IASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST----TSTFC 200

Query: 376 GTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI 423
           GT  Y+APE   +       D +  G +L  ++ G+P F + +N  E+
Sbjct: 201 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPF-YSRNTAEM 247

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 50.1 bits (120), Expect = 8e-07
 Identities = 47/271 (17%), Positives = 85/271 (31%), Gaps = 50/271 (18%)

Query: 165 RGGSRDRGPTIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIK 224
                +       P  E + L  ++    +   +KIGSGG G +Y A  P +  +  A  
Sbjct: 11  VDLGTENLYFQSMPFPEGKVLDDMEGNQ-WVLGKKIGSGGFGLIYLAF-PTNKPEKDARH 68

Query: 225 KVIVYAPISAAELIEEDSKLRDSKLRQIRSEI------ITASQIRHRNILPLLAHMVRPD 278
            V                K+   +   + SE+           I+       L ++  P 
Sbjct: 69  VV----------------KVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPL 112

Query: 279 CHLLVYEFMKNG------------SLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLH 326
            +       K               LQ I              +  ++ + +   LEY+H
Sbjct: 113 FYGSGLTEFKGRSYRFMVMERLGIDLQKISGQ----NGTFKKSTVLQLGIRMLDVLEYIH 168

Query: 327 MYHSASIIHGDIKPRNVLLNDDMEACI--SDLGLAMAIPDGYTRVLISY-----VLGTMA 379
                  +HGDIK  N+LL       +  +D GL+                     GT+ 
Sbjct: 169 ---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIE 225

Query: 380 YIAPEYFQQPELSEKCDIFSFGMLLISLVRG 410
           + + +  +   LS + D+   G  ++  + G
Sbjct: 226 FTSLDAHKGVALSRRSDVEILGYCMLRWLCG 256

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 49.5 bits (119), Expect = 1e-06
 Identities = 42/162 (25%), Positives = 64/162 (39%), Gaps = 35/162 (21%)

Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMA--IPDGYTRVLISYVL 375
           + S L +LH      II+ D+K  NVLL+ +    ++D G+          T        
Sbjct: 133 IISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFC---- 185

Query: 376 GTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEE----ICS-----P 426
           GT  YIAPE  Q+       D ++ G+LL  ++ G   F   +N ++    I +     P
Sbjct: 186 GTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPF-EAENEDDLFEAILNDEVVYP 244

Query: 427 EW--------LRKVMNSKNPSRAIDPRL---PGNGYEKKMLH 457
            W        L+  M  KNP+     RL      G    + H
Sbjct: 245 TWLHEDATGILKSFMT-KNPTM----RLGSLTQGGEHAILRH 281

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 49.6 bits (119), Expect = 1e-06
 Identities = 48/311 (15%), Positives = 93/311 (29%), Gaps = 87/311 (27%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           +  +G G  G+V +          +A+K +I               +         R EI
Sbjct: 24  VGNLGEGTFGKVVECLDHARGKSQVALK-II---------------RNVGKYREAARLEI 67

Query: 257 ITASQIRHR------NILPLLAH--------MVRPDCHLL---VYEFMKNGSLQDI-LDD 298
               +I+ +        + +           +      LL    +EF+K  + Q   L  
Sbjct: 68  NVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIA---FELLGKNTFEFLKENNFQPYPLPH 124

Query: 299 VSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGL 358
           V              +A  +   L +LH      + H D+KP N+L  +     + +   
Sbjct: 125 V------------RHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHK 169

Query: 359 AMAIPDG--------------YTRVLISYVLGTMAYIAPE------YFQQPELSEKCDIF 398
           +                    +     + ++ T  Y  PE      +      ++ CD++
Sbjct: 170 SCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGW------AQPCDVW 223

Query: 399 SFGMLLISLVRGVPSFVFHQNGE------EICSP---EWLRKVMNSKNPSRAIDPRLPGN 449
           S G +L    RG   F  H+N E      +I  P     + +    K   +        +
Sbjct: 224 SIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENS 283

Query: 450 GYEKKMLHVLK 460
              + +    K
Sbjct: 284 SDGRYVKENCK 294

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 49.1 bits (118), Expect = 1e-06
 Identities = 32/99 (32%), Positives = 49/99 (49%), Gaps = 9/99 (9%)

Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMA--IPDGYTRVLISYVL 375
           +  GL++LH   S  I++ D+K  N+LL+ D    I+D G+     + D  T        
Sbjct: 127 IILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC---- 179

Query: 376 GTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
           GT  YIAPE     + +   D +SFG+LL  ++ G   F
Sbjct: 180 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF 218

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 48.8 bits (117), Expect = 2e-06
 Identities = 30/99 (30%), Positives = 46/99 (46%), Gaps = 9/99 (9%)

Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMA--IPDGYTRVLISYVL 375
           +A GL +L    S  II+ D+K  NV+L+ +    I+D G+          T+       
Sbjct: 130 IAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC---- 182

Query: 376 GTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF 414
           GT  YIAPE        +  D ++FG+LL  ++ G   F
Sbjct: 183 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF 221

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 49.5 bits (117), Expect = 2e-06
 Identities = 71/443 (16%), Positives = 135/443 (30%), Gaps = 133/443 (30%)

Query: 23  HSESIETILQKLT-KDWLGQFARQAQIQADLIGWKTMMVKINKVLDDAIEKQTKEEPVKI 81
           H    ET   +   KD L  F  +     +             V D      +KEE    
Sbjct: 5   HHMDFETGEHQYQYKDILSVF--EDAFVDNF--------DCKDVQDMPKSILSKEE---- 50

Query: 82  WLGKLQHLACDVDYLLDEFQTEA-----FQTMLLQDADAMSK-VKEVNARLQDIAWQINV 135
                      +D+++      +     F T+L +  + + K V+EV     +  +    
Sbjct: 51  -----------IDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLR--INYKF---- 93

Query: 136 LGLKESFGGKSRNVRQRFPTTPSLISAAVRGGSRDR---GPTIFSPL-IEKEDLAFLKKE 191
             L           RQ    T   I        RDR      +F+   + +    +LK  
Sbjct: 94  --LMSPI---KTEQRQPSMMTRMYIEQ------RDRLYNDNQVFAKYNVSRLQP-YLKLR 141

Query: 192 DCFASLEKI------GSGGCG------EVYKAE--LPGSNGKM--IAIKKVIVYAPISAA 235
                L         G  G G      +V  +       + K+  + +K        S  
Sbjct: 142 QALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCN-----SPE 196

Query: 236 ELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDI 295
            ++E   KL    L QI       S+  H + + L  H ++ +   L+        L  +
Sbjct: 197 TVLEMLQKL----LYQIDPNW--TSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCL-LV 249

Query: 296 LDDVSRGRRELDWPSRH--------RIAL-----GVASGLEYLHMYHSASIIHGDI---- 338
           L +V          ++         +I L      V   L      H  S+ H  +    
Sbjct: 250 LLNV--------QNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTH-ISLDHHSMTLTP 300

Query: 339 -KPRNVLLN------DDM--EAC-ISDLGLAM---------AIPDGYTRV----LISYVL 375
            + +++LL        D+  E    +   L++         A  D +  V    L + + 
Sbjct: 301 DEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIE 360

Query: 376 GTMAYIAPEYFQQPELSEKCDIF 398
            ++  + P  +++  + ++  +F
Sbjct: 361 SSLNVLEPAEYRK--MFDRLSVF 381

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 48.3 bits (114), Expect = 5e-06
 Identities = 76/593 (12%), Positives = 157/593 (26%), Gaps = 233/593 (39%)

Query: 2   PKFTLGNSFRFGSKRETVSN-------FHSESIETILQKLTKDWLGQFARQAQIQADLI- 53
            +     +  +  +R+ + N       ++   ++  L+   +  L     + +   +++ 
Sbjct: 102 QRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLK--LRQAL----LELRPAKNVLI 155

Query: 54  ------GWKTMMVKINKVLDDAIEKQTKEEPVKI-WLGKLQHLACDVDYLLDEFQTEAFQ 106
                 G KT +     V      K   +   KI WL  L++       +L+  Q   +Q
Sbjct: 156 DGVLGSG-KTWVA--LDVCLS--YKVQCKMDFKIFWL-NLKNCNSPET-VLEMLQKLLYQ 208

Query: 107 --TMLLQDADAMSKVK----EVNARLQ----------------DIAWQINVLGLKESFGG 144
                   +D  S +K     + A L+                ++           +F  
Sbjct: 209 IDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNV-QNAKAW---NAFNL 264

Query: 145 KSRNVRQRFPTTPSLISAAVRGGSRDR-------GPTIFSPLIEKEDLAFLKKE--DCFA 195
             +           L++      +R +         T     ++   +     E      
Sbjct: 265 SCK----------ILLT------TRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLL 308

Query: 196 SLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSE 255
                      +    +LP        +       P   + +I E           IR  
Sbjct: 309 K--------YLDCRPQDLP------REVLTT---NPRRLS-IIAE----------SIRDG 340

Query: 256 IITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIA 315
           + T    +H N   L                +++ SL ++L+           P+     
Sbjct: 341 LATWDNWKHVNCDKLT-------------TIIES-SL-NVLE-----------PA----- 369

Query: 316 LGVASGLEYLHMYHSASIIHGDIK-PRNVL-------LNDDMEACISDL---GLA----- 359
                  EY  M+   S+       P  +L       +  D+   ++ L    L      
Sbjct: 370 -------EYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPK 422

Query: 360 ---MAIPDGYT-------------RVLISYVLGTMAYIAPEYFQQPELSEKCD---IFSF 400
              ++IP  Y              R ++ +      Y  P+ F   +L         +S 
Sbjct: 423 ESTISIPSIYLELKVKLENEYALHRSIVDH------YNIPKTFDSDDLIPPYLDQYFYSH 476

Query: 401 GMLLISLVRGVPSFVFH----QNGEEICSPE-------WL-RKVMNSKNPSRAIDPRLPG 448
                           H    ++ E +           +L +K+ +      A    L  
Sbjct: 477 -------------IGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILN- 522

Query: 449 NGYEKKMLHVLKI--AYICTLHDPE------------ERPNSQYVRCRLSQLL 487
                  L  LK    YIC  +DP+             +     +  + + LL
Sbjct: 523 ------TLQQLKFYKPYICD-NDPKYERLVNAILDFLPKIEENLICSKYTDLL 568

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 48.8 bits (117), Expect = 2e-06
 Identities = 54/315 (17%), Positives = 98/315 (31%), Gaps = 95/315 (30%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           ++ +G G  G+V +     + G+ +A+K            +++   +  +      RSEI
Sbjct: 19  VDTLGEGAFGKVVECIDHKAGGRHVAVK------------IVKNVDRYCE----AARSEI 62

Query: 257 ITASQIRHR------NILPLLAH--------MVRPDCHLL---VYEFMK-NG----SLQD 294
                +           + +L          +V     LL    Y+F+K NG     L  
Sbjct: 63  QVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIV---FELLGLSTYDFIKENGFLPFRLDH 119

Query: 295 ILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACIS 354
           I                 ++A  +   + +LH   S  + H D+KP N+L          
Sbjct: 120 I----------------RKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAY 160

Query: 355 DLGLAMAIPDGYTRVL--------------ISYVLGTMAYIAPE------YFQQPELSEK 394
           +  +           +               S ++ T  Y APE      +      S+ 
Sbjct: 161 NPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGW------SQP 214

Query: 395 CDIFSFGMLLISLVRGVPSFVFHQNGE------EICSP---EWLRKVMNSKNPSRAIDPR 445
           CD++S G +LI    G   F  H + E       I  P     ++K    K         
Sbjct: 215 CDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDW 274

Query: 446 LPGNGYEKKMLHVLK 460
              +   + +    K
Sbjct: 275 DEHSSAGRYVSRACK 289

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 48.8 bits (117), Expect = 2e-06
 Identities = 29/106 (27%), Positives = 49/106 (46%), Gaps = 7/106 (6%)

Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMA-IPDGYTRVLISYVLG 376
           ++  L YLH      II+ D+K  NVLL+ +    ++D G+    +  G T    S   G
Sbjct: 119 ISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCG 172

Query: 377 TMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEE 422
           T  YIAPE  +  +     D ++ G+L+  ++ G   F    + + 
Sbjct: 173 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN 218

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 48.5 bits (116), Expect = 3e-06
 Identities = 29/106 (27%), Positives = 49/106 (46%), Gaps = 7/106 (6%)

Query: 318 VASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMA-IPDGYTRVLISYVLG 376
           ++  L YLH      II+ D+K  NVLL+ +    ++D G+    +  G T    S   G
Sbjct: 162 ISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCG 215

Query: 377 TMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEE 422
           T  YIAPE  +  +     D ++ G+L+  ++ G   F    + + 
Sbjct: 216 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN 261

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 30/166 (18%), Positives = 51/166 (30%), Gaps = 48/166 (28%)

Query: 283 VYEFMKNGSLQDI-LDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPR 341
           +YE +   +     ++D+                + +   L YL      S+ H D+KP 
Sbjct: 122 LYEIITRNNYNGFHIEDI------------KLYCIEILKALNYLR---KMSLTHTDLKPE 166

Query: 342 NVLLNDDMEACISDLGLAMAIPDGYTRVL--------------------ISYVLGTMAYI 381
           N+LL+D            +                                 ++ T  Y 
Sbjct: 167 NILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYR 226

Query: 382 APE------YFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGE 421
           APE      +          D++SFG +L  L  G   F  H++ E
Sbjct: 227 APEVILNLGW------DVSSDMWSFGCVLAELYTGSLLFRTHEHME 266

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540

 Score = 42.3 bits (100), Expect = 3e-04
 Identities = 20/116 (17%), Positives = 41/116 (35%), Gaps = 19/116 (16%)

Query: 246 DSKLRQIR--SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGR 303
           D  +R+ R   E    + ++   I       V  D   ++  ++     +D+++D     
Sbjct: 378 DENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIEDNLDIA 437

Query: 304 RELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA 359
            ++                E +   H   +IH D+   N + + D+   I D GL 
Sbjct: 438 YKIG---------------EIVGKLHKNDVIHNDLTTSNFIFDKDL--YIIDFGLG 476

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	487
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.94
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.88
3qfl_A	115	MLA10; coiled-coil, (CC) domain, NLRS, nucleotide-	99.84
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.78
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.66
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.26
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.05
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.0
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.9
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.61
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.41
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.4
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.14
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.1
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.96
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.82
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.7
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.67
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.35
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.23
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.11
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.09
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.01
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.91
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.71
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	96.67
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.51
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.18
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	95.93
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.58
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	95.33
3mes_A	424	Choline kinase; malaria, structural genomics, stru	94.42
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	88.96
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	88.02

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.3e-56  Score=432.00  Aligned_cols=261  Identities=21%  Similarity=0.344  Sum_probs=212.0

Q ss_pred             cccccccccccccceeEEEEEecC----CCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPG----SNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNI  267 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI  267 (487)
                      ++|.+.+.||+|+||+||+|++..    .++..||||++..               ......+.+.+|+.++++++||||
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~---------------~~~~~~~~f~~E~~il~~l~HpnI   77 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD---------------ASDNARKDFHREAELLTNLQHEHI   77 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECS---------------CCHHHHHHHHHHHHHHTTCCCTTB
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCC---------------CChHHHHHHHHHHHHHHhCCCCCC
Confidence            468999999999999999998642    3578999999842               123345678999999999999999


Q ss_pred             cccceEEecCCeeEEEEEecCCCCHHHHHhhhh---------cCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCC
Q 011360          268 LPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVS---------RGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDI  338 (487)
Q Consensus       268 v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dl  338 (487)
                      |++++++.+++.+|||||||++|+|.++|....         .....+++..+..++.||+.||.||   |+++||||||
T Consensus        78 V~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yL---H~~~iiHRDl  154 (299)
T 4asz_A           78 VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDL  154 (299)
T ss_dssp             CCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCC
T ss_pred             ccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCcc
Confidence            999999999999999999999999999997532         2345799999999999999999999   6678999999


Q ss_pred             CCCCEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCcccc
Q 011360          339 KPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFH  417 (487)
Q Consensus       339 kp~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~  417 (487)
                      ||+|||++.++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||...
T Consensus       155 Kp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~  234 (299)
T 4asz_A          155 ATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL  234 (299)
T ss_dssp             SGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             CHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence            99999999999999999999987655443333344569999999999999999999999999999999999 89999433


Q ss_pred             CCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          418 QNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       418 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                            ...+....+..+..+.      .|..    .+.++.+++.+||+.||++|||+++|.+.|+++
T Consensus       235 ------~~~~~~~~i~~~~~~~------~p~~----~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~  287 (299)
T 4asz_A          235 ------SNNEVIECITQGRVLQ------RPRT----CPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL  287 (299)
T ss_dssp             ------CHHHHHHHHHHTCCCC------CCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------CHHHHHHHHHcCCCCC------CCcc----chHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                  2234444444433221      1222    225688999999999999999999999999875

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=4.3e-56  Score=434.29  Aligned_cols=261  Identities=21%  Similarity=0.331  Sum_probs=204.5

Q ss_pred             cccccccccccccceeEEEEEec----CCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELP----GSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNI  267 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI  267 (487)
                      +++.+.+.||+|+||+||+|++.    ..++..||||++..               ......+.|.+|+.++++++||||
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~---------------~~~~~~~~f~~E~~il~~l~HpnI  105 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE---------------ASESARQDFQREAELLTMLQHQHI  105 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESC---------------CSHHHHHHHHHHHHHHTTCCCTTB
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECc---------------CCHHHHHHHHHHHHHHHhCCCCCC
Confidence            45888899999999999999864    24678999999842               123345678999999999999999


Q ss_pred             cccceEEecCCeeEEEEEecCCCCHHHHHhhhhc-----------CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 011360          268 LPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSR-----------GRRELDWPSRHRIALGVASGLEYLHMYHSASIIHG  336 (487)
Q Consensus       268 v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~  336 (487)
                      |++++++.+++.+|||||||++|+|.+++.....           ...++++..+..++.||+.||.||   |+++||||
T Consensus       106 V~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yL---H~~~iiHR  182 (329)
T 4aoj_A          106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHR  182 (329)
T ss_dssp             CCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHH---HHTTCCCS
T ss_pred             CcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHH---hcCCeecc
Confidence            9999999999999999999999999999975321           235699999999999999999999   56789999


Q ss_pred             CCCCCCEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCcc
Q 011360          337 DIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFV  415 (487)
Q Consensus       337 Dlkp~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~  415 (487)
                      ||||+|||++.++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||.
T Consensus       183 DLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~  262 (329)
T 4aoj_A          183 DLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWY  262 (329)
T ss_dssp             CCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred             cccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCC
Confidence            9999999999999999999999987655444333455679999999999999999999999999999999999 899994


Q ss_pred             ccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          416 FHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       416 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      ..      ...+.+..+..+..+.      .|..    .+.++.+++.+||+.||++|||+.+|++.|+.+
T Consensus       263 ~~------~~~~~~~~i~~g~~~~------~p~~----~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l  317 (329)
T 4aoj_A          263 QL------SNTEAIDCITQGRELE------RPRA----CPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL  317 (329)
T ss_dssp             SS------CHHHHHHHHHHTCCCC------CCTT----CCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHH
T ss_pred             CC------CHHHHHHHHHcCCCCC------Cccc----ccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence            33      2233444444333221      2222    225688999999999999999999999999875

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=3.9e-55  Score=421.94  Aligned_cols=265  Identities=24%  Similarity=0.358  Sum_probs=203.9

Q ss_pred             HhhhccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCC
Q 011360          187 FLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRN  266 (487)
Q Consensus       187 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn  266 (487)
                      |....+++.+.+.||+|+||+||+|+++    ..||||++...             .......+.+.+|+.++++++|||
T Consensus        31 Wei~~~~l~l~~~iG~G~fG~Vy~~~~~----~~vAvK~~~~~-------------~~~~~~~~~f~~E~~il~~l~HpN   93 (307)
T 3omv_A           31 WEIEASEVMLSTRIGSGSFGTVYKGKWH----GDVAVKILKVV-------------DPTPEQFQAFRNEVAVLRKTRHVN   93 (307)
T ss_dssp             CBCCTTSCCEEEECCCCSSSEEEEEESS----SEEEEEECCCS-------------SCCHHHHHHHHHHHHHHTTCCCTT
T ss_pred             cEEcHHHeEEeeEEeeCCCcEEEEEEEC----CcEEEEEEEec-------------CCCHHHHHHHHHHHHHHHhCCCCC
Confidence            3344556889999999999999999863    25999988431             122345678999999999999999


Q ss_pred             ccccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC
Q 011360          267 ILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN  346 (487)
Q Consensus       267 Iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~  346 (487)
                      ||++++++.. +.+|||||||+||+|.++|..   ....+++..+..++.||+.||+||   |+++||||||||+|||++
T Consensus        94 IV~l~g~~~~-~~~~iVmEy~~gGsL~~~l~~---~~~~l~~~~~~~i~~qia~gL~yL---H~~~IiHRDlKp~NILl~  166 (307)
T 3omv_A           94 ILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHV---QETKFQMFQLIDIARQTAQGMDYL---HAKNIIHRDMKSNNIFLH  166 (307)
T ss_dssp             BCCEEEEECS-SSCEEEEECCSSCBHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHH---HHTTCBCSCCCSSSEEEE
T ss_pred             EeeEEEEEEC-CeEEEEEEcCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHH---HHCCccCCccCHHHEEEC
Confidence            9999998754 578999999999999999964   345799999999999999999999   667899999999999999


Q ss_pred             CCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCC---CCCCchhHHHHHHHHHHHHHhCCCCccccCCCCcc
Q 011360          347 DDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQ---PELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI  423 (487)
Q Consensus       347 ~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~  423 (487)
                      +++.+||+|||+|+..............+||+.|||||++.+   ..|+.++|||||||++|||+||+.||....+    
T Consensus       167 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~----  242 (307)
T 3omv_A          167 EGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN----  242 (307)
T ss_dssp             TTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC----
T ss_pred             CCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh----
Confidence            999999999999987655443333456789999999999853   4699999999999999999999999943322    


Q ss_pred             ccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          424 CSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       424 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                        ...+............+ +.++    ...+..+.+++.+||+.||++|||+.+|++.|+.+
T Consensus       243 --~~~~~~~~~~~~~~p~~-~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l  298 (307)
T 3omv_A          243 --RDQIIFMVGRGYASPDL-SKLY----KNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL  298 (307)
T ss_dssp             --HHHHHHHHHTTCCCCCS-TTSC----TTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred             --HHHHHHHHhcCCCCCCc-cccc----ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence              22333333332221111 1111    12335688999999999999999999999988754

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=6.6e-56  Score=428.95  Aligned_cols=261  Identities=24%  Similarity=0.386  Sum_probs=210.3

Q ss_pred             ccccccccccccceeEEEEEec----CCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcc
Q 011360          193 CFASLEKIGSGGCGEVYKAELP----GSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNIL  268 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv  268 (487)
                      .+.+.+.||+|+||+||+|.+.    ..+++.||||++...              ......+.|.+|+.++++++|||||
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~--------------~~~~~~~~f~~E~~il~~l~HpNIV   92 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDK--------------AEGPLREEFRHEAMLRARLQHPNVV   92 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC---------------CCC-CHHHHHHHHHHHHHCCCTTBC
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcc--------------cChHHHHHHHHHHHHHHhCCCCCCC
Confidence            4778899999999999999873    346789999998431              1222346789999999999999999


Q ss_pred             ccceEEecCCeeEEEEEecCCCCHHHHHhhhhc------------CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 011360          269 PLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSR------------GRRELDWPSRHRIALGVASGLEYLHMYHSASIIHG  336 (487)
Q Consensus       269 ~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~  336 (487)
                      +++|++.+++.++||||||++|+|.++|.....            ....+++..+..++.||+.||.||   |+++||||
T Consensus        93 ~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yL---H~~~iiHR  169 (308)
T 4gt4_A           93 CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHK  169 (308)
T ss_dssp             CEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHH---HHTTCCCS
T ss_pred             CcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHH---HhCCCCCC
Confidence            999999999999999999999999999964221            124689999999999999999999   66789999


Q ss_pred             CCCCCCEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCcc
Q 011360          337 DIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFV  415 (487)
Q Consensus       337 Dlkp~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~  415 (487)
                      ||||+|||+++++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |..||.
T Consensus       170 DLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~  249 (308)
T 4gt4_A          170 DLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYC  249 (308)
T ss_dssp             CCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             CccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCC
Confidence            9999999999999999999999987654433333345679999999999999999999999999999999998 899994


Q ss_pred             ccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          416 FHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       416 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      +.+      ..+....+..+..+.      .|..    .+..+.+++.+||+.||++|||+.+|++.|+.+
T Consensus       250 ~~~------~~~~~~~i~~~~~~~------~p~~----~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          250 GYS------NQDVVEMIRNRQVLP------CPDD----CPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             TCC------HHHHHHHHHTTCCCC------CCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             CCC------HHHHHHHHHcCCCCC------Cccc----chHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            432      233333333332221      2222    235688999999999999999999999999864

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.2e-55  Score=431.38  Aligned_cols=253  Identities=19%  Similarity=0.338  Sum_probs=205.2

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+++.||+|+||+||+|++ ..+|+.||||++...             .......+.+.+|+.++++++|||||+++
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~-~~~~~~vAiK~i~~~-------------~~~~~~~~~~~~E~~il~~l~HpnIV~~~   89 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKS-TEDGRQYVIKEINIS-------------RMSSKEREESRREVAVLANMKHPNIVQYR   89 (350)
T ss_dssp             CCEEEEEEC------CEEEEEE-TTTCCEEEEEEEECT-------------TSCHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cceEEeEEEecCCCeEEEEEEE-CCCCCEEEEEEEehH-------------HCCHHHHHHHHHHHHHHHHCCCCCCCcEE
Confidence            5799999999999999999975 568999999998531             12233456789999999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++.+++.+|||||||+||+|.++|..  ..+..+++..++.++.||+.||.||   |++|||||||||+|||++.+|.+
T Consensus        90 ~~~~~~~~~yiVmEy~~gg~L~~~i~~--~~~~~~~e~~~~~~~~qi~~aL~yl---H~~~IiHRDlKp~NILl~~~g~v  164 (350)
T 4b9d_A           90 ESFEENGSLYIVMDYCEGGDLFKRINA--QKGVLFQEDQILDWFVQICLALKHV---HDRKILHRDIKSQNIFLTKDGTV  164 (350)
T ss_dssp             EEEEETTEEEEEEECCTTCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHH---HHTTCEETTCCGGGEEECTTCCE
T ss_pred             EEEEECCEEEEEEeCCCCCcHHHHHHH--cCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeccCCHHHEEECCCCCE
Confidence            999999999999999999999999975  3355678999999999999999999   67889999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRK  431 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~  431 (487)
                      ||+|||+|+.......  .....+||+.|||||++.+..|+.++|||||||++|||+||.+||.+.      ...+.+..
T Consensus       165 Kl~DFGla~~~~~~~~--~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~------~~~~~~~~  236 (350)
T 4b9d_A          165 QLGDFGIARVLNSTVE--LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG------SMKNLVLK  236 (350)
T ss_dssp             EECSTTEESCCCHHHH--HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS------SHHHHHHH
T ss_pred             EEcccccceeecCCcc--cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc------CHHHHHHH
Confidence            9999999987643221  123467999999999999999999999999999999999999999433      23344455


Q ss_pred             HHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          432 VMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       432 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      +.....+.  ++..        .+.++.+++.+||+.||++|||+.++++
T Consensus       237 i~~~~~~~--~~~~--------~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          237 IISGSFPP--VSLH--------YSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             HHHTCCCC--CCTT--------SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHcCCCCC--CCcc--------CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            55443321  1112        2356889999999999999999999975

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=5.2e-55  Score=426.32  Aligned_cols=250  Identities=24%  Similarity=0.401  Sum_probs=206.9

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      +.|.+.+.||+|+||+||+|++ ..+|+.||||++....               ....+.+.+|+.++++++|||||+++
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~-~~tg~~vAiK~i~~~~---------------~~~~~~~~~Ei~il~~l~HpnIV~l~  137 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATV-RSSGKLVAVKKMDLRK---------------QQRRELLFNEVVIMRDYQHENVVEMY  137 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEE-TTTCCEEEEEEEEGGG---------------CSSGGGGHHHHHHHHHCCCTTBCCEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEE-CCCCCEEEEEEEecCc---------------hhHHHHHHHHHHHHHhCCCCCCCcEE
Confidence            4699999999999999999975 5689999999984311               11234577899999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++.+++.+|||||||+||+|.+++..     ..+++..+..++.||+.||.||   |++|||||||||+|||++.+|.+
T Consensus       138 ~~~~~~~~~~ivmEy~~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~yl---H~~~IiHRDlKp~NILl~~~g~v  209 (346)
T 4fih_A          138 NSYLVGDELWVVMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVL---HAQGVIHRDIKSDSILLTHDGRV  209 (346)
T ss_dssp             EEEEETTEEEEEECCCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTCCE
T ss_pred             EEEEECCEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHH---HHCCcccccCCHHHEEECCCCCE
Confidence            999999999999999999999999874     4699999999999999999999   67789999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRK  431 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~  431 (487)
                      ||+|||+|+.+......  ....+||+.|||||++.+..|+.++|||||||++|||++|.+||...      ...+.+..
T Consensus       210 Kl~DFGla~~~~~~~~~--~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~------~~~~~~~~  281 (346)
T 4fih_A          210 KLSDFGFCAQVSKEVPR--RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE------PPLKAMKM  281 (346)
T ss_dssp             EECCCTTCEECCSSSCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS------CHHHHHHH
T ss_pred             EEecCcCceecCCCCCc--ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc------CHHHHHHH
Confidence            99999999877544322  24578999999999999999999999999999999999999999432      22233333


Q ss_pred             HHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          432 VMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       432 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      +.....+...        .....+.++.+++.+||..||++|||+.|+++
T Consensus       282 i~~~~~~~~~--------~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          282 IRDNLPPRLK--------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             HHHSSCCCCS--------CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHcCCCCCCC--------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            3332222111        12233467899999999999999999999875

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=5e-55  Score=420.24  Aligned_cols=252  Identities=22%  Similarity=0.336  Sum_probs=210.6

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||+|+||+||+|+. ..+|+.||||++..            ...........+.+|+.++++++|||||+++
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~-~~~~~~~AiK~i~k------------~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~   98 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARE-LATSREYAIKILEK------------RHIIKENKVPYVTRERDVMSRLDHPFFVKLY   98 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEE-TTTCCEEEEEEEEH------------HHHHHTTCHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred             cccEEEEEEecccCeEEEEEEE-CCCCCEEEEEEEEH------------HHCCCHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence            3599999999999999999975 56899999999842            1112233456789999999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++.+++.+|||||||+||+|.+++..    ...+++..+..++.||+.||.||   |++||+||||||+|||++.+|.+
T Consensus        99 ~~~~~~~~~yivmEy~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~yl---H~~~IiHRDlKPeNILl~~~g~v  171 (311)
T 4aw0_A           99 FTFQDDEKLYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYL---HGKGIIHRDLKPENILLNEDMHI  171 (311)
T ss_dssp             EEEECSSEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTSCE
T ss_pred             EEEEeCCEEEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCCccCCCCHHHeEEcCCCCE
Confidence            999999999999999999999999975    35799999999999999999999   67789999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRK  431 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~  431 (487)
                      ||+|||+|+.+............+||+.|||||++.+..|+.++||||+||++|+|+||.+||...      ...+....
T Consensus       172 Kl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~------~~~~~~~~  245 (311)
T 4aw0_A          172 QITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG------NEGLIFAK  245 (311)
T ss_dssp             EECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHH
T ss_pred             EEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC------CHHHHHHH
Confidence            999999999876544444445678999999999999999999999999999999999999999432      22334444


Q ss_pred             HHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHH
Q 011360          432 VMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVR  480 (487)
Q Consensus       432 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il  480 (487)
                      +.... +      .+|..    .+.++.+++.+||.+||++|||++|++
T Consensus       246 i~~~~-~------~~p~~----~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          246 IIKLE-Y------DFPEK----FFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             HHHTC-C------CCCTT----CCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             HHcCC-C------CCCcc----cCHHHHHHHHHHccCCHhHCcChHHHc
Confidence            44332 1      12222    234688999999999999999999863

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=3.5e-55  Score=426.33  Aligned_cols=253  Identities=23%  Similarity=0.328  Sum_probs=205.2

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      +.|.+.+.||+|+||.||+|++ ..+|+.||||++...             .       ...+|+.+++.++|||||+++
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~-~~~g~~vAiK~i~~~-------------~-------~~~~E~~il~~l~HpnIV~l~  116 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKD-KQTGFQCAVKKVRLE-------------V-------FRVEELVACAGLSSPRIVPLY  116 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEE-TTTCCEEEEEEEETT-------------T-------CCTHHHHTTTTCCCTTBCCEE
T ss_pred             hheEeCcEeccCCCeEEEEEEE-CCCCCEEEEEEECHH-------------H-------hHHHHHHHHHhCCCCCCCcEE
Confidence            4588889999999999999975 468999999998421             0       124699999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC-C
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDM-E  350 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~-~  350 (487)
                      +++.+++.+|||||||+||+|.+++..    ...+++..+..++.||+.||.||   |++|||||||||+|||++.+| .
T Consensus       117 ~~~~~~~~~~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~yl---H~~~IiHRDlKp~NILl~~~g~~  189 (336)
T 4g3f_A          117 GAVREGPWVNIFMELLEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYL---HTRRILHGDVKADNVLLSSDGSR  189 (336)
T ss_dssp             EEEEETTEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH---HTTTEECSCCCGGGEEECTTSCC
T ss_pred             EEEEECCEEEEEEeccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCceecccCHHHEEEeCCCCE
Confidence            999999999999999999999999975    35699999999999999999999   788999999999999999987 5


Q ss_pred             EEEeccCCccccCCCCce---eeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHH
Q 011360          351 ACISDLGLAMAIPDGYTR---VLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPE  427 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~  427 (487)
                      +||+|||+|+.+......   ......+||+.|||||++.+..|+.++|||||||++|||+||.+||.......      
T Consensus       190 vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~------  263 (336)
T 4g3f_A          190 AALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP------  263 (336)
T ss_dssp             EEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC------
T ss_pred             EEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH------
Confidence            999999999876543221   11234679999999999999999999999999999999999999996543322      


Q ss_pred             HHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          428 WLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      ....+.....+...+++.+        +..+.+++.+||++||++|||+.||++.|...
T Consensus       264 ~~~~i~~~~~~~~~~~~~~--------s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~  314 (336)
T 4g3f_A          264 LCLKIASEPPPIREIPPSC--------APLTAQAIQEGLRKEPVHRASAMELRRKVGKA  314 (336)
T ss_dssp             CHHHHHHSCCGGGGSCTTS--------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHcCCCCchhcCccC--------CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence            1233333332222222223        35688999999999999999999999887654

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=5.8e-54  Score=410.77  Aligned_cols=248  Identities=23%  Similarity=0.351  Sum_probs=199.8

Q ss_pred             cccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceE
Q 011360          194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAH  273 (487)
Q Consensus       194 ~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  273 (487)
                      |.+.+.||+|+||.||+|.+ ..++..||+|++..             ..........+.+|+.++++++|||||+++++
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~-~~~~~~vAiK~i~~-------------~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~   93 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLD-TETTVEVAWCELQD-------------RKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS   93 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEE-TTTCCEEEEEEEEG-------------GGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEE-CCCCeEEEEEEEch-------------hhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence            35667899999999999975 46889999999843             12233455778999999999999999999999


Q ss_pred             Eec----CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCC--eeecCCCCCCEEeC-
Q 011360          274 MVR----PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSAS--IIHGDIKPRNVLLN-  346 (487)
Q Consensus       274 ~~~----~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~g--ivH~Dlkp~Nill~-  346 (487)
                      +.+    .+.+|||||||+||+|.+++..    ...+++..+..++.||+.||+||   |++|  ||||||||+|||++ 
T Consensus        94 ~~~~~~~~~~~~lvmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~yl---H~~~~~IiHRDlKp~NILl~~  166 (290)
T 3fpq_A           94 WESTVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFL---HTRTPPIIHRDLKCDNIFITG  166 (290)
T ss_dssp             EEEEETTEEEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH---HTSSSCCCCCCCCGGGEEESS
T ss_pred             EeeccCCCcEEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCCCEEecccChhheeEEC
Confidence            865    3568999999999999999975    45799999999999999999999   6666  99999999999998 


Q ss_pred             CCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccH
Q 011360          347 DDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSP  426 (487)
Q Consensus       347 ~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~  426 (487)
                      .+|.+||+|||+|+.......    ...+||+.|||||++.+ .|+.++|||||||++|||+||.+||....      ..
T Consensus       167 ~~g~vKl~DFGla~~~~~~~~----~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~------~~  235 (290)
T 3fpq_A          167 PTGSVKIGDLGLATLKRASFA----KAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ------NA  235 (290)
T ss_dssp             TTSCEEECCTTGGGGCCTTSB----EESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS------SH
T ss_pred             CCCCEEEEeCcCCEeCCCCcc----CCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCC------cH
Confidence            479999999999986544322    45689999999999875 69999999999999999999999994332      12


Q ss_pred             HHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          427 EWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       427 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ..+............++...        +.++.+++.+||+.||++|||+.++++
T Consensus       236 ~~~~~~i~~~~~~~~~~~~~--------~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          236 AQIYRRVTSGVKPASFDKVA--------IPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             HHHHHHHTTTCCCGGGGGCC--------CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHcCCCCCCCCccC--------CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            22333333332222222222        245889999999999999999999985

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.1e-53  Score=427.06  Aligned_cols=251  Identities=24%  Similarity=0.389  Sum_probs=207.1

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .+.|.+++.||+|+||.||+|++ ..+|+.||||++....               ....+.+.+|+.+++.++|||||++
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~-~~tg~~vAiK~i~~~~---------------~~~~~~~~~Ei~il~~l~HpnIV~l  213 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATV-RSSGKLVAVKKMDLRK---------------QQRRELLFNEVVIMRDYQHENVVEM  213 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEE-TTTCCEEEEEEEESTT---------------CSSGGGHHHHHHHHHHCCCTTBCCE
T ss_pred             hHhcEeeeEeccCcCcEEEEEEE-CCCCCEEEEEEEeccc---------------hhHHHHHHHHHHHHHhCCCCCCCce
Confidence            35699999999999999999975 4689999999985321               1122457889999999999999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      ++++.+++.+|||||||+||+|.+++..     ..+++..+..++.||+.||.||   |++|||||||||+|||++.+|.
T Consensus       214 ~~~~~~~~~~~iVmEy~~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~yl---H~~~IiHRDiKp~NILl~~~g~  285 (423)
T 4fie_A          214 YNSYLVGDELWVVMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVL---HAQGVIHRDIKSDSILLTHDGR  285 (423)
T ss_dssp             EEEEEETTEEEEEEECCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSTTTEEECTTCC
T ss_pred             EEEEEECCEEEEEEeCCCCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHH---HHCCeecccCCHHHEEEcCCCC
Confidence            9999999999999999999999999864     4589999999999999999999   6778999999999999999999


Q ss_pred             EEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHH
Q 011360          351 ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLR  430 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~  430 (487)
                      +||+|||+|+.+......  ....+||+.|||||++.+..|+.++|||||||++|||++|.+||...      ...+.+.
T Consensus       286 vKl~DFGla~~~~~~~~~--~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~------~~~~~~~  357 (423)
T 4fie_A          286 VKLSDFGFCAQVSKEVPR--RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE------PPLKAMK  357 (423)
T ss_dssp             EEECCCTTCEECCSSCCC--BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS------CHHHHHH
T ss_pred             EEEecCccceECCCCCcc--ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc------CHHHHHH
Confidence            999999999876544322  24578999999999999999999999999999999999999999432      2223333


Q ss_pred             HHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          431 KVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       431 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .+.....+......        ..+.++.+++.+||..||++|||+.|+++
T Consensus       358 ~i~~~~~~~~~~~~--------~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          358 MIRDNLPPRLKNLH--------KVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             HHHHSCCCCCSCTT--------SSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHcCCCCCCcccc--------cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            33332222111111        22356889999999999999999999875

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=8.4e-54  Score=421.42  Aligned_cols=270  Identities=25%  Similarity=0.342  Sum_probs=217.0

Q ss_pred             HHhhhccccccccccccccceeEEEEEecC----CCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhcc
Q 011360          186 AFLKKEDCFASLEKIGSGGCGEVYKAELPG----SNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQ  261 (487)
Q Consensus       186 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~  261 (487)
                      .|....++|.+.+.||+|+||+||+|.+..    .+++.||||.+..              .......+.+.+|+.++.+
T Consensus        58 ~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~--------------~~~~~~~~~~~~E~~il~~  123 (353)
T 4ase_A           58 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKE--------------GATHSEHRALMSELKILIH  123 (353)
T ss_dssp             HHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECT--------------TCCHHHHHHHHHHHHHHHH
T ss_pred             ccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcc--------------ccChHHHHHHHHHHHHHHH
Confidence            466667789999999999999999998743    2346899998842              1223345678999999999


Q ss_pred             CCC-CCccccceEEecC-CeeEEEEEecCCCCHHHHHhhhhc------------CCCCCChHHHHHHHHHHHHHHHHHHh
Q 011360          262 IRH-RNILPLLAHMVRP-DCHLLVYEFMKNGSLQDILDDVSR------------GRRELDWPSRHRIALGVASGLEYLHM  327 (487)
Q Consensus       262 l~h-pnIv~l~~~~~~~-~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~~Lh~  327 (487)
                      +.| ||||++++++..+ +.+|||||||++|+|.++|.....            ....+++..+..++.||+.||.||  
T Consensus       124 l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yL--  201 (353)
T 4ase_A          124 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL--  201 (353)
T ss_dssp             HCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHH--
T ss_pred             cCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhH--
Confidence            965 9999999998764 678999999999999999975322            134589999999999999999999  


Q ss_pred             cCCCCeeecCCCCCCEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHH
Q 011360          328 YHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISL  407 (487)
Q Consensus       328 ~h~~givH~Dlkp~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~el  407 (487)
                       |+++||||||||+|||++.++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||
T Consensus       202 -H~~~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El  280 (353)
T 4ase_A          202 -ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI  280 (353)
T ss_dssp             -HHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred             -hhCCeecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHH
Confidence             6778999999999999999999999999999987665554444567799999999999999999999999999999999


Q ss_pred             Hh-CCCCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          408 VR-GVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       408 lt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      +| |..||.+....     ......+..+..+      ..|..+    +.++.+++.+||+.||++|||+.+|++.|+++
T Consensus       281 ~t~G~~Pf~~~~~~-----~~~~~~i~~g~~~------~~p~~~----~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l  345 (353)
T 4ase_A          281 FSLGASPYPGVKID-----EEFCRRLKEGTRM------RAPDYT----TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  345 (353)
T ss_dssp             TTTSCCSSTTCCCS-----HHHHHHHHHTCCC------CCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HhCCCCCCCCCCHH-----HHHHHHHHcCCCC------CCCccC----CHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence            98 89999543321     1222223222222      122222    24688999999999999999999999999876


Q ss_pred             C
Q 011360          487 L  487 (487)
Q Consensus       487 l  487 (487)
                      |
T Consensus       346 l  346 (353)
T 4ase_A          346 L  346 (353)
T ss_dssp             H
T ss_pred             H
Confidence            4

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=3.6e-53  Score=410.44  Aligned_cols=266  Identities=28%  Similarity=0.421  Sum_probs=203.5

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      +|.+.+.||+|+||.||+|++   +|+.||||++..                ..........|+..+.+++|||||++++
T Consensus         4 ~i~L~~~iG~G~fG~Vy~~~~---~g~~VAvK~l~~----------------~~~~~~~~e~Ei~~~~~l~HpNIv~l~g   64 (303)
T 3hmm_A            4 TIVLQESIGKGRFGEVWRGKW---RGEEVAVKIFSS----------------REERSWFREAEIYQTVMLRHENILGFIA   64 (303)
T ss_dssp             GEEEEEEEEECSSSEEEEEEE---TTEEEEEEEECG----------------GGHHHHHHHHHHHTSTTCCCTTBCCEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEE---CCEEEEEEEECc----------------cchhhHHHHHHHHHHhcCCCCCCCcEEE
Confidence            478889999999999999987   688999999832                1111122345777778899999999999


Q ss_pred             EEecCC----eeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhc-----CCCCeeecCCCCCCE
Q 011360          273 HMVRPD----CHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMY-----HSASIIHGDIKPRNV  343 (487)
Q Consensus       273 ~~~~~~----~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~-----h~~givH~Dlkp~Ni  343 (487)
                      ++..++    .+|||||||++|+|.+++..     ..+++..+.+++.|++.||+|||+.     |+.+||||||||+||
T Consensus        65 ~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NI  139 (303)
T 3hmm_A           65 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNI  139 (303)
T ss_dssp             EEEEECSSSEEEEEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGE
T ss_pred             EEEecCCCceEEEEEecCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccE
Confidence            998654    57999999999999999974     4689999999999999999999753     355899999999999


Q ss_pred             EeCCCCCEEEeccCCccccCCCCcee--eEeeecccccccCCcccCCC------CCCchhHHHHHHHHHHHHHhCCCCcc
Q 011360          344 LLNDDMEACISDLGLAMAIPDGYTRV--LISYVLGTMAYIAPEYFQQP------ELSEKCDIFSFGMLLISLVRGVPSFV  415 (487)
Q Consensus       344 ll~~~~~~kl~DFg~s~~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~------~~~~~~DvwslG~~l~elltg~~pf~  415 (487)
                      |++.++.+||+|||+|+.........  .....+||+.|||||++.+.      .|+.++|||||||++|||+||.+||.
T Consensus       140 Ll~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~  219 (303)
T 3hmm_A          140 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG  219 (303)
T ss_dssp             EECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred             EECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCC
Confidence            99999999999999998765443221  22345799999999999764      36789999999999999999988875


Q ss_pred             ccCCCCc--------cccHHHHHHHHhcCCCCCccCCCCCCC-CcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          416 FHQNGEE--------ICSPEWLRKVMNSKNPSRAIDPRLPGN-GYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       416 ~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      .......        ....+.+........    +++.+|.. ...+.+..+.+++.+||+.||++|||+.+|++.|+++
T Consensus       220 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~----~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l  295 (303)
T 3hmm_A          220 IHEDYQLPYYDLVPSDPSVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  295 (303)
T ss_dssp             BCCCCCCTTTTTSCSSCCHHHHHHHHTTSC----CCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccccccccchhcccccchHHHHHHHHhccc----CCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence            4332111        112233333333222    23334432 2235667789999999999999999999999999876

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=3.7e-53  Score=401.69  Aligned_cols=249  Identities=22%  Similarity=0.334  Sum_probs=191.8

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|++.+.||+|+||.||+|.. ..+|+.||||++....            .........+.+|+.+++.++|||||+++
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~-~~~~~~vAiK~i~~~~------------~~~~~~~~~~~~Ei~il~~l~HpnIv~~~   79 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYH-TTTGQKVALKIINKKV------------LAKSDMQGRIEREISYLRLLRHPHIIKLY   79 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEEC-TTTCCEEEEEEEECC------------------CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEE-CCCCCEEEEEEEeHHH------------cCCHHHHHHHHHHHHHHHHCCCCCCCeEE
Confidence            4699999999999999999974 5689999999984311            11223345788999999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++.+++.+|+||||| +|+|.+++..    ...+++..+..++.|++.||+||   |++||+||||||+|||++.++.+
T Consensus        80 ~~~~~~~~~~ivmEy~-~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~yl---H~~~IiHRDiKP~NILl~~~~~v  151 (275)
T 3hyh_A           80 DVIKSKDEIIMVIEYA-GNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYC---HRHKIVHRDLKPENLLLDEHLNV  151 (275)
T ss_dssp             EEEECSSEEEEEEECC-CEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCTTTEEECTTCCE
T ss_pred             EEEEECCEEEEEEeCC-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCcccccCChHHeEECCCCCE
Confidence            9999999999999999 7899999875    46799999999999999999999   67889999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCCCC-CchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPEL-SEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLR  430 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~  430 (487)
                      ||+|||+|+.......   ....+||+.|+|||++.+..| +.++||||+||++|+|+||..||...      ...+...
T Consensus       152 kl~DFGla~~~~~~~~---~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~------~~~~~~~  222 (275)
T 3hyh_A          152 KIADFGLSNIMTDGNF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE------SIPVLFK  222 (275)
T ss_dssp             EECCSSCC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHH
T ss_pred             EEeecCCCeecCCCCc---cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC------CHHHHHH
Confidence            9999999987544322   245679999999999998876 57999999999999999999999432      2233344


Q ss_pred             HHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          431 KVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       431 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .+... .+.  ++..+        +.++.+++.+||+.||++|||+.++++
T Consensus       223 ~i~~~-~~~--~p~~~--------s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          223 NISNG-VYT--LPKFL--------SPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             HHHHT-CCC--CCTTS--------CHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHcC-CCC--CCCCC--------CHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            33332 221  11222        356889999999999999999999986

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.1e-53  Score=410.83  Aligned_cols=251  Identities=21%  Similarity=0.297  Sum_probs=197.4

Q ss_pred             cccccccccccccceeEEEEEec--CCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELP--GSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILP  269 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~  269 (487)
                      ++|++++.||+|+||+||+|+..  ..+++.||||++.....             .......+.+|+.++++++|||||+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~-------------~~~~~~~~~~E~~il~~l~HpnIv~   90 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATL-------------KVRDRVRTKMERDILVEVNHPFIVK   90 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEE-------------EEEECC------CCCCCCCCTTEEC
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHc-------------ChHHHHHHHHHHHHHHHCCCCCCCe
Confidence            35999999999999999999753  34678999999843211             1111235678999999999999999


Q ss_pred             cceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC
Q 011360          270 LLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDM  349 (487)
Q Consensus       270 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~  349 (487)
                      +++++.+++.+|+|||||+||+|.+++..    ...+++..+..++.|++.||.||   |++||+||||||+|||++.+|
T Consensus        91 l~~~~~~~~~~~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~yl---H~~~IiHRDlKp~NILl~~~g  163 (304)
T 3ubd_A           91 LHYAFQTEGKLYLILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHL---HSLGIIYRDLKPENILLDEEG  163 (304)
T ss_dssp             EEEEEEETTEEEEEECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSSCCGGGEEECTTS
T ss_pred             EEEEEEECCEEEEEEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCCcCCCCCHHHeEEcCCC
Confidence            99999999999999999999999999976    35799999999999999999999   677899999999999999999


Q ss_pred             CEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHH
Q 011360          350 EACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWL  429 (487)
Q Consensus       350 ~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~  429 (487)
                      .+||+|||+|+........  ....+||+.|||||++.+..|+.++|||||||++|||+||.+||.+.      ...+..
T Consensus       164 ~vKl~DFGla~~~~~~~~~--~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~------~~~~~~  235 (304)
T 3ubd_A          164 HIKLTDFGLSKESIDHEKK--AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK------DRKETM  235 (304)
T ss_dssp             CEEEESSEEEEC-----CC--CCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHH
T ss_pred             CEEecccccceeccCCCcc--ccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc------CHHHHH
Confidence            9999999999865433221  24568999999999999999999999999999999999999999432      223344


Q ss_pred             HHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCh-----HHHHH
Q 011360          430 RKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNS-----QYVRC  481 (487)
Q Consensus       430 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~-----~~il~  481 (487)
                      ..+......       +|..    .+.++.+++.+||+.||++|||+     +++++
T Consensus       236 ~~i~~~~~~-------~p~~----~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          236 TMILKAKLG-------MPQF----LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             HHHHHCCCC-------CCTT----SCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             HHHHcCCCC-------CCCc----CCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence            444433211       2221    23568899999999999999995     56653

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=3.6e-51  Score=394.71  Aligned_cols=252  Identities=23%  Similarity=0.350  Sum_probs=187.1

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      +|++++.||+|+||.||+|++ ..+|+.||||++....              .....+.+.+|+.++++++|||||++++
T Consensus         6 dy~~~~~lG~G~fg~V~~a~~-~~~~~~vAiK~i~~~~--------------~~~~~~~~~~E~~il~~l~HpnIV~~~~   70 (299)
T 4g31_A            6 DFEPIQCLGRGGFGVVFEAKN-KVDDCNYAIKRIRLPN--------------RELAREKVMREVKALAKLEHPGIVRYFN   70 (299)
T ss_dssp             HEEEEEEEEECC--EEEEEEE-TTTCCEEEEEEEEECS--------------SHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             hCEEeeEEecCCCeEEEEEEE-CCCCCEEEEEEEeccC--------------CHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            599999999999999999975 4689999999985421              2234457889999999999999999999


Q ss_pred             EEecCC------------eeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC
Q 011360          273 HMVRPD------------CHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKP  340 (487)
Q Consensus       273 ~~~~~~------------~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp  340 (487)
                      ++.+.+            .+|+|||||+||+|.+++... ......++..++.++.||+.||+||   |++||+||||||
T Consensus        71 ~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~al~yl---H~~~IiHRDlKp  146 (299)
T 4g31_A           71 AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGR-CTIEERERSVCLHIFLQIAEAVEFL---HSKGLMHRDLKP  146 (299)
T ss_dssp             EEEEEC----------CEEEEEEEECCCSCCHHHHHHTC-CSGGGSCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCG
T ss_pred             EEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhc-CCCChhHHHHHHHHHHHHHHHHHHH---HHCcCccccCcH
Confidence            987644            369999999999999999742 1122345667889999999999999   677899999999


Q ss_pred             CCEEeCCCCCEEEeccCCccccCCCCcee----------eEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhC
Q 011360          341 RNVLLNDDMEACISDLGLAMAIPDGYTRV----------LISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRG  410 (487)
Q Consensus       341 ~Nill~~~~~~kl~DFg~s~~~~~~~~~~----------~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg  410 (487)
                      +|||++.++.+||+|||+|+.........          .....+||+.|||||++.+..|+.++|||||||++|||++ 
T Consensus       147 ~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~-  225 (299)
T 4g31_A          147 SNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY-  225 (299)
T ss_dssp             GGEEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS-
T ss_pred             HHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc-
Confidence            99999999999999999998765432211          1234579999999999999999999999999999999996 


Q ss_pred             CCCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          411 VPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       411 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                        ||....     .....+.... ...        .| .........+.+++.+||+.||++|||+.++++
T Consensus       226 --Pf~~~~-----~~~~~~~~~~-~~~--------~p-~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          226 --PFSTQM-----ERVRTLTDVR-NLK--------FP-PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             --CCSSHH-----HHHHHHHHHH-TTC--------CC-HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --CCCCcc-----HHHHHHHHHh-cCC--------CC-CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence              773211     1111122221 111        11 112233345678999999999999999999986

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.7e-49  Score=397.29  Aligned_cols=262  Identities=24%  Similarity=0.341  Sum_probs=200.0

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+++.||+|+||.||+|.+ ..+|+.||||++..             ........+.+.+|+.+|+.++|||||+++
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~-~~t~~~vAiK~i~~-------------~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~  119 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARR-RLTGQQVAIKKIPN-------------AFDVVTNAKRTLRELKILKHFKHDNIIAIK  119 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEE-TTTCCEEEEEEETT-------------TTSSHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CCeEEEEEEecccCeEEEEEEE-CCCCCEEEEEEECc-------------cccchHHHHHHHHHHHHHHhcCCCCcceEe
Confidence            5699999999999999999974 56899999999832             112233456788999999999999999999


Q ss_pred             eEEec------CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEe
Q 011360          272 AHMVR------PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLL  345 (487)
Q Consensus       272 ~~~~~------~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill  345 (487)
                      +++..      .+.+|||||||+ |+|.+++..    ...+++..+..++.||+.||.||   |++|||||||||+|||+
T Consensus       120 ~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~~----~~~l~~~~~~~~~~qil~al~yl---H~~~iiHRDlKP~NIl~  191 (398)
T 4b99_A          120 DILRPTVPYGEFKSVYVVLDLME-SDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYM---HSAQVIHRDLKPSNLLV  191 (398)
T ss_dssp             EECCCSSCTTTCCCEEEEEECCS-EEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEE
T ss_pred             eeeecccccccCCEEEEEEeCCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCcCcCCCcCcccccc
Confidence            98764      367899999995 689998864    56799999999999999999999   67889999999999999


Q ss_pred             CCCCCEEEeccCCccccCCCC--ceeeEeeecccccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCccccCCCCc
Q 011360          346 NDDMEACISDLGLAMAIPDGY--TRVLISYVLGTMAYIAPEYFQQP-ELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEE  422 (487)
Q Consensus       346 ~~~~~~kl~DFg~s~~~~~~~--~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~  422 (487)
                      +.+|.+||+|||+|+.+....  ........+||+.|+|||++.+. .|+.++||||+||++|||++|.+||.+.+.   
T Consensus       192 ~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~---  268 (398)
T 4b99_A          192 NENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNY---  268 (398)
T ss_dssp             CTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSH---
T ss_pred             CCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCH---
Confidence            999999999999998764322  12223457899999999998775 579999999999999999999999954321   


Q ss_pred             cccHHHHHHHHh-cCCCCCcc----------------CCCCCCC---CcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          423 ICSPEWLRKVMN-SKNPSRAI----------------DPRLPGN---GYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       423 ~~~~~~~~~~~~-~~~~~~~~----------------~~~~~~~---~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                         .+.+..+.. .+.+....                .+..+..   .....+.++.+++.+||..||++|||+.++++
T Consensus       269 ---~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          269 ---VHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             ---HHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---HHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence               122222211 11111100                0000000   00112356889999999999999999999875

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2.2e-48  Score=385.17  Aligned_cols=200  Identities=26%  Similarity=0.386  Sum_probs=167.8

Q ss_pred             ccccccccccccccceeEEEEEec--CCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CCCCc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELP--GSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RHRNI  267 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnI  267 (487)
                      .+.|.+.+.||+|+||+||+|+.+  ..+++.||+|++...                 ....++.+|+.++..+ +||||
T Consensus        20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~-----------------~~~~~~~~E~~~l~~~~~h~nI   82 (361)
T 4f9c_A           20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT-----------------SHPIRIAAELQCLTVAGGQDNV   82 (361)
T ss_dssp             GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT-----------------SCHHHHHHHHHHHHHTCSBTTB
T ss_pred             cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc-----------------cCHHHHHHHHHHHHHhcCCCCC
Confidence            457999999999999999999753  346789999987321                 1123567899999888 79999


Q ss_pred             cccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC
Q 011360          268 LPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLND  347 (487)
Q Consensus       268 v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~  347 (487)
                      |++++++.+.+.+|+|||||+||+|.+++.       .+++..+..++.|++.||+||   |++||+||||||+|||++.
T Consensus        83 v~l~~~~~~~~~~~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~yl---H~~gIiHRDiKPeNiLl~~  152 (361)
T 4f9c_A           83 MGVKYCFRKNDHVVIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRI---HQFGIVHRDVKPSNFLYNR  152 (361)
T ss_dssp             CCCSEEEEETTEEEEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEET
T ss_pred             ceEEEEEEECCEEEEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHH---HHCCeEeCcCCHHHeEEeC
Confidence            999999999999999999999999999884       388999999999999999999   7788999999999999987


Q ss_pred             C-CCEEEeccCCccccCCCCc--------------------------eeeEeeecccccccCCcccCCC-CCCchhHHHH
Q 011360          348 D-MEACISDLGLAMAIPDGYT--------------------------RVLISYVLGTMAYIAPEYFQQP-ELSEKCDIFS  399 (487)
Q Consensus       348 ~-~~~kl~DFg~s~~~~~~~~--------------------------~~~~~~~~gt~~y~aPE~l~~~-~~~~~~Dvws  399 (487)
                      + +.+||+|||+|+.......                          .......+||+.|+|||++.+. .|+.++||||
T Consensus       153 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWS  232 (361)
T 4f9c_A          153 RLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWS  232 (361)
T ss_dssp             TTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHH
T ss_pred             CCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhh
Confidence            6 7999999999976543211                          0112345799999999998765 6899999999


Q ss_pred             HHHHHHHHHhCCCCcccc
Q 011360          400 FGMLLISLVRGVPSFVFH  417 (487)
Q Consensus       400 lG~~l~elltg~~pf~~~  417 (487)
                      +||++|||+||+.||...
T Consensus       233 lG~il~ell~G~~Pf~~~  250 (361)
T 4f9c_A          233 AGVIFLSLLSGRYPFYKA  250 (361)
T ss_dssp             HHHHHHHHHHTCSSSSCC
T ss_pred             hHHHHHHHHHCCCCCCCC
Confidence            999999999999999544

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=6.1e-48  Score=402.46  Aligned_cols=254  Identities=26%  Similarity=0.336  Sum_probs=202.0

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+++.||+|+||+||+|+. ..+|+.||||++...      .+.   .............++.+++.++|||||+++
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~-~~tg~~~AiK~i~K~------~i~---~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~  258 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRK-ADTGKMYAMKCLDKK------RIK---MKQGETLALNERIMLSLVSTGDCPFIVCMS  258 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEE-TTTCCEEEEEEEEHH------HHH---HTTCHHHHHHHHHHHHHHSSSCCTTBCCEE
T ss_pred             HHeEEEEEEecccCeEEEEEEE-CCCCCEEEEEEEeHH------Hcc---hhhhHHHHHHHHHHHHHHhhCCCCCEeEEE
Confidence            5699999999999999999975 568999999998431      000   011112233344567788899999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++.+.+.+|||||||+||+|.++|..    ...+++..++.++.||+.||.||   |++|||||||||+|||++.+|.+
T Consensus       259 ~~f~~~~~lylVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yL---H~~gIiHRDLKPeNILld~~G~v  331 (689)
T 3v5w_A          259 YAFHTPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHM---HNRFVVYRDLKPANILLDEHGHV  331 (689)
T ss_dssp             EEEECSSEEEEEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCSGGGEEECTTSCE
T ss_pred             EEEEECCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCccccCCchHHeEEeCCCCE
Confidence            999999999999999999999999976    35699999999999999999999   78899999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQ-PELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLR  430 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~  430 (487)
                      ||+|||+|+.......    ...+||+.|||||++.. ..|+.++|||||||++|||++|.+||.......   ..+...
T Consensus       332 KL~DFGlA~~~~~~~~----~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~---~~~i~~  404 (689)
T 3v5w_A          332 RISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD---KHEIDR  404 (689)
T ss_dssp             EECCCTTCEECSSCCC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC---HHHHHH
T ss_pred             EecccceeeecCCCCC----CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHH
Confidence            9999999987655432    35689999999999974 589999999999999999999999996543321   122222


Q ss_pred             HHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCC-----hHHHH
Q 011360          431 KVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPN-----SQYVR  480 (487)
Q Consensus       431 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~~il  480 (487)
                      ..... .+      .+|..    .+.++.+++.+||..||++|++     +++|+
T Consensus       405 ~i~~~-~~------~~p~~----~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~  448 (689)
T 3v5w_A          405 MTLTM-AV------ELPDS----FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK  448 (689)
T ss_dssp             HHHHC-CC------CCCTT----SCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHT
T ss_pred             hhcCC-CC------CCCcc----CCHHHHHHHHHHccCCHhHCCCCCCCCHHHHh
Confidence            22222 11      12211    2356889999999999999998     57765

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=9.7e-48  Score=402.92  Aligned_cols=252  Identities=23%  Similarity=0.335  Sum_probs=207.6

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||+|+||.||+|.. ..+|+.||+|++...               .......+.+|+.+|+.++|||||+++
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~-~~tg~~~AiK~i~~~---------------~~~~~~~~~~Ei~il~~l~hpnIv~l~  220 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTE-RATGNNFAAKFVMTP---------------HESDKETVRKEIQTMSVLRHPTLVNLH  220 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEE-TTTCCEEEEEEEECC---------------SHHHHHHHHHHHHHHHHTCCTTBCCEE
T ss_pred             cccEEEEEEeeccCeEEEEEEE-CCCCCEEEEEEEecc---------------chhhHHHHHHHHHHHHhCCCCCCCeEE
Confidence            5699999999999999999975 568999999988431               122345678899999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC--C
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDD--M  349 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~--~  349 (487)
                      +++.+++.+|||||||+||+|.+++..   ....+++..+..++.||+.||.||   |++||+||||||+|||++.+  +
T Consensus       221 ~~~~~~~~~~iv~E~~~gg~L~~~i~~---~~~~l~e~~~~~~~~qi~~al~yl---H~~~iiHRDlKp~Nill~~~~~~  294 (573)
T 3uto_A          221 DAFEDDNEMVMIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHM---HENNYVHLDLKPENIMFTTKRSN  294 (573)
T ss_dssp             EEEECSSEEEEEEECCCCCBHHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEESSSSCC
T ss_pred             EEEEECCEEEEEEeecCCCcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeccCChhhccccCCCCC
Confidence            999999999999999999999998853   245789999999999999999999   67789999999999999854  8


Q ss_pred             CEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHH
Q 011360          350 EACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWL  429 (487)
Q Consensus       350 ~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~  429 (487)
                      .+||+|||+|+.+.....   ....+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+..      ..+.+
T Consensus       295 ~vKl~DFG~a~~~~~~~~---~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~------~~~~~  365 (573)
T 3uto_A          295 ELKLIDFGLTAHLDPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN------DDETL  365 (573)
T ss_dssp             CEEECCCSSCEECCTTSE---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS------HHHHH
T ss_pred             CEEEeeccceeEccCCCc---eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC------HHHHH
Confidence            999999999998765433   245679999999999999999999999999999999999999994332      22333


Q ss_pred             HHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          430 RKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       430 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ..+......       ++.......+.++.++|.+||+.||++|||+.++++
T Consensus       366 ~~i~~~~~~-------~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          366 RNVKSCDWN-------MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             HHHHTTCCC-------CCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHhCCCC-------CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            333332211       111112223466889999999999999999999986

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=5.2e-47  Score=371.44  Aligned_cols=276  Identities=29%  Similarity=0.475  Sum_probs=233.4

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .++|.+.+.||.|+||.||+|.+.  ++..||+|++...               .......+.+|+.+++.++||||+++
T Consensus        38 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~---------------~~~~~~~~~~E~~~l~~l~h~~iv~~  100 (321)
T 2qkw_B           38 TNNFDHKFLIGHGVFGKVYKGVLR--DGAKVALKRRTPE---------------SSQGIEEFETEIETLSFCRHPHLVSL  100 (321)
T ss_dssp             CCCCSCCCCSCBCSSSEEEEEECT--TCCEEEEEECCSC---------------CSSHHHHHHHHHHGGGSCCCTTBCCE
T ss_pred             HhccCccceeecCCCeeEEEEEEC--CCCEEEEEEeccc---------------ChHHHHHHHHHHHHHHhCCCCCEeeE
Confidence            457999999999999999999853  6889999987431               12235578899999999999999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      ++++...+..++||||+++|+|.+++.........+++..++.++.|++.||.||   |++||+||||||+||+++.++.
T Consensus       101 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l---H~~~ivH~dlkp~Nil~~~~~~  177 (321)
T 2qkw_B          101 IGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYL---HTRAIIHRDVKSINILLDENFV  177 (321)
T ss_dssp             EEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCSTTEEECTTCC
T ss_pred             EEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHh---cCCCeecCCCCHHHEEECCCCC
Confidence            9999999999999999999999999865333345689999999999999999999   6678999999999999999999


Q ss_pred             EEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHH
Q 011360          351 ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLR  430 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~  430 (487)
                      +||+|||++................||+.|+|||++.+..++.++||||||+++|+|+||..||....+........|..
T Consensus       178 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~  257 (321)
T 2qkw_B          178 PKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAV  257 (321)
T ss_dssp             EEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTH
T ss_pred             EEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhh
Confidence            99999999986543332222234568999999999988899999999999999999999999997766655555566665


Q ss_pred             HHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          431 KVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       431 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      ...........+++.+........+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  313 (321)
T 2qkw_B          258 ESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA  313 (321)
T ss_dssp             HHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             hccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            55556666677777777777788899999999999999999999999999999875

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=2e-48  Score=390.08  Aligned_cols=356  Identities=19%  Similarity=0.255  Sum_probs=254.3

Q ss_pred             ccchhhhhhhhhHHHHHHhhhchhhhhhHHHHHHH--H-HHHHHHHHhhccccCCCCcccccccCCCCCChhhhhhhcCC
Q 011360           91 CDVDYLLDEFQTEAFQTMLLQDADAMSKVKEVNAR--L-QDIAWQINVLGLKESFGGKSRNVRQRFPTTPSLISAAVRGG  167 (487)
Q Consensus        91 yd~~~~~~~~~~~~~~~~l~~~~~~~~r~~ei~~~--l-~~i~~~~~~~~l~~~~g~~~~~~~~~~~s~p~~~~~~~~~~  167 (487)
                      -..++++..+++++.+++|..+|+|++|.++-...  + ........||.+....+ ........|++.+.++.......
T Consensus        11 ~~~~wyhg~i~r~~a~~lL~~~G~flvR~s~~~~~~~lsv~~~~~~~h~~i~~~~~-~~~~~~~~F~sl~~LI~~y~~~~   89 (377)
T 3cbl_A           11 HEQLWYHGAIPRAEVAELLVHSGDFLVRESQGKQEYVLSVLWDGLPRHFIIQSLDN-LYRLEGEGFPSIPLLIDHLLSTQ   89 (377)
T ss_dssp             GGCTTBCTTCCHHHHHHHCCSTTEEEEEECC--CCEEEEC-----CCEEEC----C-CCCC----CCSHHHHHHHHHHHT
T ss_pred             ccCCccCCCCCHHHHHHHHhcCCCEEEEEeCCCCcEEEEEEECCCccchhhccccc-eEEecceeccchHHHHHHHhhcc
Confidence            34578899999999999999999999986543210  0 00122345666654322 34444566888887776654332


Q ss_pred             CCCCC--CccccCCcchhhHHHhhhccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhh
Q 011360          168 SRDRG--PTIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLR  245 (487)
Q Consensus       168 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~  245 (487)
                      .....  .........  ...|....++|.+.+.||.|+||.||+|.+. .++..||||.+...              ..
T Consensus        90 ~~l~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~--------------~~  152 (377)
T 3cbl_A           90 QPLTKKSGVVLHRAVP--KDKWVLNHEDLVLGEQIGRGNFGEVFSGRLR-ADNTLVAVKSCRET--------------LP  152 (377)
T ss_dssp             CCC-----CCCCEECC--CCTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTCCEEEEEECCTT--------------SC
T ss_pred             CCcccccCcccccCcc--ccccEEchHHeEEeeEeccCCCCeEEEEEEe-cCCeEEEEEEcccc--------------CC
Confidence            22111  111111111  1234455667999999999999999999864 57889999987421              12


Q ss_pred             hHHHHHHHHHHHHhccCCCCCccccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHH
Q 011360          246 DSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYL  325 (487)
Q Consensus       246 ~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~L  325 (487)
                      ......+.+|+.++++++||||+++++++...+..|+||||+++|+|.+++...   +..+++..+..++.|++.||+||
T Consensus       153 ~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~L  229 (377)
T 3cbl_A          153 PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYL  229 (377)
T ss_dssp             HHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHH
Confidence            234456788999999999999999999999999999999999999999999752   34689999999999999999999


Q ss_pred             HhcCCCCeeecCCCCCCEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHH
Q 011360          326 HMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLI  405 (487)
Q Consensus       326 h~~h~~givH~Dlkp~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~  405 (487)
                         |++||+||||||+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|
T Consensus       230 ---H~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~  306 (377)
T 3cbl_A          230 ---ESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLW  306 (377)
T ss_dssp             ---HHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHH
T ss_pred             ---HHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHH
Confidence               67789999999999999999999999999998654432222112234678899999999888999999999999999


Q ss_pred             HHHh-CCCCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHh
Q 011360          406 SLVR-GVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLS  484 (487)
Q Consensus       406 ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~  484 (487)
                      ||+| |..||....      ..+ .......... ..    .+..    .+..+.+++.+||+.||++|||+.+|++.|+
T Consensus       307 el~t~g~~p~~~~~------~~~-~~~~~~~~~~-~~----~~~~----~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~  370 (377)
T 3cbl_A          307 ETFSLGASPYPNLS------NQQ-TREFVEKGGR-LP----CPEL----CPDAVFRLMEQCWAYEPGQRPSFSTIYQELQ  370 (377)
T ss_dssp             HHHTTSCCSSTTSC------HHH-HHHHHHTTCC-CC----CCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHhCCCCCCCCCC------HHH-HHHHHHcCCC-CC----CCCC----CCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence            9998 899994332      122 2222222211 11    1111    1246889999999999999999999999998


Q ss_pred             hh
Q 011360          485 QL  486 (487)
Q Consensus       485 ~l  486 (487)
                      .+
T Consensus       371 ~i  372 (377)
T 3cbl_A          371 SI  372 (377)
T ss_dssp             HH
T ss_pred             HH
Confidence            75

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=3.8e-46  Score=366.01  Aligned_cols=280  Identities=35%  Similarity=0.610  Sum_probs=232.1

Q ss_pred             hhccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcc
Q 011360          189 KKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNIL  268 (487)
Q Consensus       189 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv  268 (487)
                      ...++|.+.+.||+|+||.||+|..  .++..||||++....              .......+.+|+.++..++||||+
T Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~--------------~~~~~~~~~~e~~~l~~l~h~~iv   90 (326)
T 3uim_A           27 VASDNFSNKNILGRGGFGKVYKGRL--ADGTLVAVKRLKEER--------------TQGGELQFQTEVEMISMAVHRNLL   90 (326)
T ss_dssp             TTTTSSCSTTEEECCSSSEEEEECC--SSSCCEEEEECCC-------------------CCCHHHHHHHGGGTCCCTTBC
T ss_pred             HHhhccccceeEecCCCcEEEEEEe--cCCCEEEEEEecccc--------------CchHHHHHHHHHHHHHhccCCCcc
Confidence            3456799999999999999999974  368899999884311              111122578899999999999999


Q ss_pred             ccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC
Q 011360          269 PLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDD  348 (487)
Q Consensus       269 ~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~  348 (487)
                      ++++++...+..++||||+++|+|.+++.........+++..+..++.|++.||.|||..+..||+||||||+|||++.+
T Consensus        91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~  170 (326)
T 3uim_A           91 RLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEE  170 (326)
T ss_dssp             CCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTT
T ss_pred             ceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCC
Confidence            99999999999999999999999999998654455679999999999999999999976555599999999999999999


Q ss_pred             CCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccC--CCCccccH
Q 011360          349 MEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ--NGEEICSP  426 (487)
Q Consensus       349 ~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~--~~~~~~~~  426 (487)
                      +.+||+|||++.......... .....||+.|+|||++.+..++.++||||||+++|+|+||..||....  ........
T Consensus       171 ~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~  249 (326)
T 3uim_A          171 FEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL  249 (326)
T ss_dssp             CCEEECCCSSCEECCSSSSCE-ECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHH
T ss_pred             CCEEeccCccccccCcccccc-cccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHH
Confidence            999999999998765433322 244569999999999988889999999999999999999999995332  22333445


Q ss_pred             HHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhh
Q 011360          427 EWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQ  485 (487)
Q Consensus       427 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~  485 (487)
                      .|..............+..+........+..+.+++.+||+.||++|||+.+|++.|+.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          250 DWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             HHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             HHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence            55555555666666677777777788889999999999999999999999999999975

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=4.3e-45  Score=353.89  Aligned_cols=251  Identities=26%  Similarity=0.400  Sum_probs=205.8

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .++|.+.+.||.|+||.||+|. +..+++.||+|++....               ......+.+|+.+++.++||||+++
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~~vaiK~~~~~~---------------~~~~~~~~~E~~~l~~l~hp~iv~~   82 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAM-DVATGQEVAIRQMNLQQ---------------QPKKELIINEILVMRENKNPNIVNY   82 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEE-BTTTCCEEEEEEEEGGG---------------CSCHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             hhceeeeeeeccCCCeEEEEEE-ECCCCcEEEEEEeeccc---------------ccHHHHHHHHHHHHhcCCCCCCCeE
Confidence            3469999999999999999996 45689999999884311               1123457889999999999999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      ++++...+..|+||||+++|+|.+++..     ..+++..+..++.|++.||.||   |++||+||||||+||+++.++.
T Consensus        83 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~Dlkp~Nil~~~~~~  154 (297)
T 3fxz_A           83 LDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFL---HSNQVIHRDIKSDNILLGMDGS  154 (297)
T ss_dssp             EEEEEETTEEEEEEECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTCC
T ss_pred             eEEEEECCEEEEEEECCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHH---HhCCceeCCCCHHHEEECCCCC
Confidence            9999999999999999999999999975     3589999999999999999999   6778999999999999999999


Q ss_pred             EEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHH
Q 011360          351 ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLR  430 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~  430 (487)
                      +||+|||++.........  .....||+.|+|||++.+..++.++||||||+++|+|++|..||....      ......
T Consensus       155 ~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------~~~~~~  226 (297)
T 3fxz_A          155 VKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN------PLRALY  226 (297)
T ss_dssp             EEECCCTTCEECCSTTCC--BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHH
T ss_pred             EEEeeCCCceecCCcccc--cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC------HHHHHH
Confidence            999999999876544332  234579999999999999999999999999999999999999994332      222233


Q ss_pred             HHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          431 KVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       431 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .......+....++        ..+..+.+++.+||+.||++|||+.++++
T Consensus       227 ~~~~~~~~~~~~~~--------~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          227 LIATNGTPELQNPE--------KLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             HHHHHCSCCCSCGG--------GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHhCCCCCCCCcc--------ccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            33333332222222        23356889999999999999999999875

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=2.7e-45  Score=359.44  Aligned_cols=267  Identities=28%  Similarity=0.392  Sum_probs=207.9

Q ss_pred             hccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccc
Q 011360          190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILP  269 (487)
Q Consensus       190 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~  269 (487)
                      ..++|.+.+.||+|+||.||+|++   .++.||||++..                ..........|+.++.+++||||++
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~----------------~~~~~~~~~~E~~~l~~l~hpniv~   82 (322)
T 3soc_A           22 QSMPLQLLEVKARGRFGCVWKAQL---LNEYVAVKIFPI----------------QDKQSWQNEYEVYSLPGMKHENILQ   82 (322)
T ss_dssp             TTEEEEEEEEEECSTTCEEEEEEE---TTEEEEEEEECG----------------GGHHHHHHHHHHHTSTTCCCTTBCC
T ss_pred             chhhchhhheecccCceEEEEEEE---CCCEEEEEEeec----------------CchHHHHHHHHHHHHhcCCCCCchh
Confidence            345799999999999999999986   478999999832                1122344566899999999999999


Q ss_pred             cceEEecCCe----eEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCC----------Ceee
Q 011360          270 LLAHMVRPDC----HLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSA----------SIIH  335 (487)
Q Consensus       270 l~~~~~~~~~----~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~----------givH  335 (487)
                      +++++.....    +++||||+++|+|.+++..     ..+++..++.++.|++.||.||   |+.          ||+|
T Consensus        83 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~L---H~~~~~l~~~~~~~ivH  154 (322)
T 3soc_A           83 FIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYL---HEDIPGLKDGHKPAISH  154 (322)
T ss_dssp             EEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHH---TCCEEEETTEEECEEEC
T ss_pred             hcceeccCCCCCceEEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHH---HhhccccccccCCCEEe
Confidence            9999987543    6999999999999999974     4589999999999999999999   666          9999


Q ss_pred             cCCCCCCEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCC-----CCCchhHHHHHHHHHHHHHhC
Q 011360          336 GDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQP-----ELSEKCDIFSFGMLLISLVRG  410 (487)
Q Consensus       336 ~Dlkp~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----~~~~~~DvwslG~~l~elltg  410 (487)
                      |||||+|||++.++.+||+|||+++...............||+.|+|||++.+.     .++.++|||||||++|||+||
T Consensus       155 ~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg  234 (322)
T 3soc_A          155 RDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASR  234 (322)
T ss_dssp             SCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhC
Confidence            999999999999999999999999876554333222345799999999999863     456789999999999999999


Q ss_pred             CCCccccCCCCccc---------cHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          411 VPSFVFHQNGEEIC---------SPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       411 ~~pf~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ..||..........         .................++..+   .....+..+.+++.+||+.||++|||+.+|++
T Consensus       235 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          235 CTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYW---QKHAGMAMLCETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             BTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGG---GSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccc---cccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            99997654322211         1122222222222222111111   12245567999999999999999999999999


Q ss_pred             HHhhh
Q 011360          482 RLSQL  486 (487)
Q Consensus       482 ~L~~l  486 (487)
                      .|+++
T Consensus       312 ~L~~l  316 (322)
T 3soc_A          312 RITQM  316 (322)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            99875

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=6.9e-45  Score=354.37  Aligned_cols=259  Identities=26%  Similarity=0.399  Sum_probs=200.4

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .++|.+.+.||.|+||.||+|++   ++..||+|++...             .........+.+|+.++++++||||+++
T Consensus        36 ~~~y~i~~~lG~G~~g~V~~~~~---~~~~vavK~~~~~-------------~~~~~~~~~~~~E~~~l~~l~hp~iv~~   99 (309)
T 3p86_A           36 WCDLNIKEKIGAGSFGTVHRAEW---HGSDVAVKILMEQ-------------DFHAERVNEFLREVAIMKRLRHPNIVLF   99 (309)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEE---TTEEEEEEEECCC-------------CCSHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             hhHceeeeEeecCCCeEEEEEEE---CCCcEEEEEecCC-------------CCCHHHHHHHHHHHHHHHhCCCCCEeeE
Confidence            45699999999999999999976   6789999998431             1223345678899999999999999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCC--eeecCCCCCCEEeCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSAS--IIHGDIKPRNVLLNDD  348 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~g--ivH~Dlkp~Nill~~~  348 (487)
                      ++++...+..++||||+++|+|.+++.... ....+++..++.++.|++.||+||   |++|  |+||||||+||+++.+
T Consensus       100 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~L---H~~~~~ivH~Dikp~NIll~~~  175 (309)
T 3p86_A          100 MGAVTQPPNLSIVTEYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYL---HNRNPPIVHRNLKSPNLLVDKK  175 (309)
T ss_dssp             EEEECSTTCCEEEEECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHH---HTSSSCCCCTTCCGGGEEECTT
T ss_pred             EEEEEECCceEEEEecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHH---HcCCCCEECCCCChhhEEEeCC
Confidence            999999999999999999999999997411 112489999999999999999999   7788  9999999999999999


Q ss_pred             CCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHH
Q 011360          349 MEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEW  428 (487)
Q Consensus       349 ~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~  428 (487)
                      +.+||+|||+++........  .....||+.|+|||++.+..++.++||||||+++|+|++|..||....      ..+.
T Consensus       176 ~~~kL~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~------~~~~  247 (309)
T 3p86_A          176 YTVKVCDFGLSRLKASTFLS--SKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN------PAQV  247 (309)
T ss_dssp             CCEEECCCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSC------HHHH
T ss_pred             CcEEECCCCCCccccccccc--cccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHH
Confidence            99999999999764433211  234569999999999999999999999999999999999999994332      1222


Q ss_pred             HHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          429 LRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       429 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      ..... .......++..+        +..+.+++.+||+.||++|||+.+|++.|+.+
T Consensus       248 ~~~~~-~~~~~~~~~~~~--------~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~  296 (309)
T 3p86_A          248 VAAVG-FKCKRLEIPRNL--------NPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL  296 (309)
T ss_dssp             HHHHH-HSCCCCCCCTTS--------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHH-hcCCCCCCCccC--------CHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            22221 122211222222        24688999999999999999999999999876

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=6.5e-45  Score=363.45  Aligned_cols=265  Identities=23%  Similarity=0.329  Sum_probs=211.3

Q ss_pred             hccccccccccccccceeEEEEEecC------CCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-
Q 011360          190 KEDCFASLEKIGSGGCGEVYKAELPG------SNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-  262 (487)
Q Consensus       190 ~~~~~~~~~~lg~G~~g~v~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-  262 (487)
                      ..++|.+.+.||+|+||.||+|++..      .++..||||++..              .........+.+|+.++..+ 
T Consensus        79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~--------------~~~~~~~~~~~~E~~~l~~l~  144 (370)
T 2psq_A           79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD--------------DATEKDLSDLVSEMEMMKMIG  144 (370)
T ss_dssp             CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCT--------------TCBHHHHHHHHHHHHHHHHSC
T ss_pred             cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecC--------------CcCHHHHHHHHHHHHHHHHhc
Confidence            34679999999999999999998632      3456799998842              12233556789999999999 


Q ss_pred             CCCCccccceEEecCCeeEEEEEecCCCCHHHHHhhhhc------------CCCCCChHHHHHHHHHHHHHHHHHHhcCC
Q 011360          263 RHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSR------------GRRELDWPSRHRIALGVASGLEYLHMYHS  330 (487)
Q Consensus       263 ~hpnIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~  330 (487)
                      +||||+++++++...+.+|+||||+++|+|.+++.....            ....+++..+..++.|++.||.||   |+
T Consensus       145 ~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L---H~  221 (370)
T 2psq_A          145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---AS  221 (370)
T ss_dssp             CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHH---HH
T ss_pred             CCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHH---Hh
Confidence            899999999999999999999999999999999976321            124588999999999999999999   67


Q ss_pred             CCeeecCCCCCCEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-
Q 011360          331 ASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-  409 (487)
Q Consensus       331 ~givH~Dlkp~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-  409 (487)
                      +||+||||||+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||+| 
T Consensus       222 ~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~  301 (370)
T 2psq_A          222 QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL  301 (370)
T ss_dssp             TTEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTT
T ss_pred             CCeeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcC
Confidence            7899999999999999999999999999986654332222233457889999999999999999999999999999999 


Q ss_pred             CCCCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhhC
Q 011360          410 GVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL  487 (487)
Q Consensus       410 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~ll  487 (487)
                      |..||.....      .+..........+      ..+..    .+..+.+++.+||+.||++|||+.++++.|+.++
T Consensus       302 g~~p~~~~~~------~~~~~~~~~~~~~------~~~~~----~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il  363 (370)
T 2psq_A          302 GGSPYPGIPV------EELFKLLKEGHRM------DKPAN----CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  363 (370)
T ss_dssp             SCCSSTTCCG------GGHHHHHHTTCCC------CCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCCCCH------HHHHHHHhcCCCC------CCCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            9999954322      1222222222211      11111    2246889999999999999999999999999864

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=2.4e-44  Score=350.67  Aligned_cols=260  Identities=25%  Similarity=0.414  Sum_probs=208.6

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .++|.+.+.||.|+||.||+|.+ ..++..||+|++..               ........+.+|+.++++++||||+++
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~~va~K~~~~---------------~~~~~~~~~~~E~~~l~~l~hp~iv~~   72 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTH-RETGEVMVMKELIR---------------FDEETQRTFLKEVKVMRCLEHPNVLKF   72 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEE-TTTCCEEEEEEESC---------------CCHHHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred             hhHeeccceecCCCCEEEEEEEE-CCCCcEEEEEEecc---------------CCHHHHHHHHHHHHHHHhCCCcCcccE
Confidence            34699999999999999999975 45789999998732               223455678899999999999999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      ++++.+++..++||||+++|+|.+++..   ....+++..+..++.|++.||.||   |++||+||||||+||+++.++.
T Consensus        73 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~l---H~~~ivH~dlkp~Nil~~~~~~  146 (310)
T 3s95_A           73 IGVLYKDKRLNFITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYL---HSMNIIHRDLNSHNCLVRENKN  146 (310)
T ss_dssp             EEEEEETTEEEEEEECCTTCBHHHHHHH---CCTTSCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSTTSEEECTTSC
T ss_pred             EEEEecCCeeEEEEEecCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHH---HhCCccCCCCCcCeEEECCCCC
Confidence            9999999999999999999999999975   246789999999999999999999   6778999999999999999999


Q ss_pred             EEEeccCCccccCCCCcee------------eEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccC
Q 011360          351 ACISDLGLAMAIPDGYTRV------------LISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ  418 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~------------~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~  418 (487)
                      +||+|||++..........            ......||+.|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus       147 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~  226 (310)
T 3s95_A          147 VVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYL  226 (310)
T ss_dssp             EEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTS
T ss_pred             EEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchh
Confidence            9999999998764432211            0114569999999999999999999999999999999999999986543


Q ss_pred             CCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          419 NGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       419 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      ........ ..........     ++.++.        .+.+++.+||+.||++|||+.++++.|+.+
T Consensus       227 ~~~~~~~~-~~~~~~~~~~-----~~~~~~--------~l~~li~~~l~~dP~~Rps~~~l~~~L~~l  280 (310)
T 3s95_A          227 PRTMDFGL-NVRGFLDRYC-----PPNCPP--------SFFPITVRCCDLDPEKRPSFVKLEHWLETL  280 (310)
T ss_dssp             CBCTTSSB-CHHHHHHHTC-----CTTCCT--------THHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             hhHHHHhh-hhhccccccC-----CCCCCH--------HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            32211110 0111111111     122332        388999999999999999999999999875

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.3e-44  Score=355.19  Aligned_cols=249  Identities=24%  Similarity=0.342  Sum_probs=205.6

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||+|+||.||+|.+ ..+|+.||||++..             ..........+.+|+.+++.++||||++++
T Consensus        15 ~~y~~~~~lG~G~~g~V~~a~~-~~~~~~vaiK~~~~-------------~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~   80 (328)
T 3fe3_A           15 GNYRLLKTIGKGNFAKVKLARH-ILTGREVAIKIIDK-------------TQLNPTSLQKLFREVRIMKILNHPNIVKLF   80 (328)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEE-TTTCCEEEEEEEEG-------------GGSCHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CCEEEEEEEeeCCCEEEEEEEE-CCCCCEEEEEEEEh-------------hcCCHHHHHHHHHHHHHHHhCCCCCEeeEE
Confidence            4699999999999999999975 46889999999843             122334566788999999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++...+..|+||||+++|+|.+++..    ...+++..+..++.|++.||.||   |++||+||||||+|||++.++.+
T Consensus        81 ~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~l---H~~~ivHrDlkp~NIll~~~~~~  153 (328)
T 3fe3_A           81 EVIETEKTLYLIMEYASGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYC---HQKRIVHRDLKAENLLLDADMNI  153 (328)
T ss_dssp             EEEECSSEEEEEECCCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTSCE
T ss_pred             EEEEECCEEEEEEECCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCEeccCCCHHHEEEcCCCCE
Confidence            999999999999999999999999975    35689999999999999999999   67789999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCC-chhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELS-EKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLR  430 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~  430 (487)
                      ||+|||++.........   ...+||+.|+|||++.+..++ .++|||||||++|+|++|..||...      ...+...
T Consensus       154 kl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~------~~~~~~~  224 (328)
T 3fe3_A          154 KIADFGFSNEFTVGGKL---DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ------NLKELRE  224 (328)
T ss_dssp             EECSTTCCGGGSSSCGG---GTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHH
T ss_pred             EEeeccCceecCCCCcc---ccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCC------CHHHHHH
Confidence            99999999876543321   346799999999999887765 7999999999999999999999432      2233333


Q ss_pred             HHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          431 KVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       431 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ........       +|..    .+.++.+++.+||..||.+|||++++++
T Consensus       225 ~i~~~~~~-------~p~~----~s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          225 RVLRGKYR-------IPFY----MSTDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             HHHHCCCC-------CCTT----SCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             HHHhCCCC-------CCCC----CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            33332211       1111    2246889999999999999999999875

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=4e-44  Score=346.54  Aligned_cols=264  Identities=25%  Similarity=0.405  Sum_probs=207.4

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .++|.+.+.||+|+||.||+|.. ..++..||+|++....            .........+.+|+.++.+++||||+++
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~~~------------~~~~~~~~~~~~e~~~l~~l~hp~iv~~   76 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAED-TILNIKVAIKAIFIPP------------REKEETLKRFEREVHNSSQLSHQNIVSM   76 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEE-TTTCSEEEEEEEECCS------------SCCHHHHHHHHHHHHHHTTCCBTTBCCE
T ss_pred             hccEEEEEEEccCCCEEEEEEEE-CCCCCeEEEEEeccCc------------cccHHHHHHHHHHHHHHhcCCCCCCceE
Confidence            35699999999999999999974 4678999999884321            1223455678899999999999999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      ++++...+..|+||||++|++|.+++..    ...+++..+..++.|++.||.||   |++||+||||||+||+++.++.
T Consensus        77 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~Dlkp~Nil~~~~~~  149 (294)
T 4eqm_A           77 IDVDEEDDCYYLVMEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHA---HDMRIVHRDIKPQNILIDSNKT  149 (294)
T ss_dssp             EEEEECSSEEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTSC
T ss_pred             EEeeeeCCeEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCCCC
Confidence            9999999999999999999999999975    35689999999999999999999   6778999999999999999999


Q ss_pred             EEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHH
Q 011360          351 ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLR  430 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~  430 (487)
                      +||+|||++......... ......||+.|+|||++.+..++.++||||||+++|+|+||..||....      ......
T Consensus       150 ~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~------~~~~~~  222 (294)
T 4eqm_A          150 LKIFDFGIAKALSETSLT-QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET------AVSIAI  222 (294)
T ss_dssp             EEECCCSSSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC------HHHHHH
T ss_pred             EEEEeCCCcccccccccc-ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC------hHHHHH
Confidence            999999999876443221 1234569999999999999999999999999999999999999994332      222223


Q ss_pred             HHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCC-ChHHHHHHHhhhC
Q 011360          431 KVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERP-NSQYVRCRLSQLL  487 (487)
Q Consensus       431 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-s~~~il~~L~~ll  487 (487)
                      .......+..  ....    ....+..+.+++.+||+.||++|| +++++.+.|+.++
T Consensus       223 ~~~~~~~~~~--~~~~----~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~  274 (294)
T 4eqm_A          223 KHIQDSVPNV--TTDV----RKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL  274 (294)
T ss_dssp             HHHSSCCCCH--HHHS----CTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred             HHhhccCCCc--chhc----ccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence            3333222211  0001    111235688999999999999999 9999999998764

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.1e-43  Score=349.65  Aligned_cols=251  Identities=21%  Similarity=0.292  Sum_probs=204.2

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||+|+||.||+|+. ..+|+.||+|++..            ...........+.+|+.++..++||||++++
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~-~~~~~~vaiK~~~~------------~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~   71 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVRE-KATGRYYAMKILRK------------EVIIAKDEVAHTVTESRVLQNTRHPFLTALK   71 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEE-TTTCCEEEEEEEEH------------HHHHHTTCHHHHHHHHHHHHSCCCTTBCCEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEE-CCCCCEEEEEEEeH------------HHhhhhhHHHHHHHHHHHHHhCCCCcCcceE
Confidence            4699999999999999999975 46889999999842            1111223456778899999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++.+.+.+|+||||++||+|.+++..    ...+++..++.++.||+.||.||   |++||+||||||+|||++.+|.+
T Consensus        72 ~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDlkp~NIll~~~g~v  144 (337)
T 1o6l_A           72 YAFQTHDRLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYL---HSRDVVYRDIKLENLMLDKDGHI  144 (337)
T ss_dssp             EEEECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTSCE
T ss_pred             EEEEeCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCcCCHHHEEECCCCCE
Confidence            999999999999999999999999875    35689999999999999999999   67789999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRK  431 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~  431 (487)
                      ||+|||+++........  ....+||+.|+|||++.+..++.++|||||||++|||++|..||....      .......
T Consensus       145 kL~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~------~~~~~~~  216 (337)
T 1o6l_A          145 KITDFGLCKEGISDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD------HERLFEL  216 (337)
T ss_dssp             EECCCTTCBCSCCTTCC--BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHH
T ss_pred             EEeeccchhhcccCCCc--ccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC------HHHHHHH
Confidence            99999999864332221  245679999999999999999999999999999999999999994322      2223333


Q ss_pred             HHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCC-----ChHHHHH
Q 011360          432 VMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERP-----NSQYVRC  481 (487)
Q Consensus       432 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~~il~  481 (487)
                      +... ..      .+|..    .+.++.+++.+||+.||++||     ++++|++
T Consensus       217 i~~~-~~------~~p~~----~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          217 ILME-EI------RFPRT----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             HHHC-CC------CCCTT----SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             HHcC-CC------CCCCC----CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence            3322 11      12211    225688999999999999999     8888864

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-44  Score=352.47  Aligned_cols=251  Identities=22%  Similarity=0.333  Sum_probs=205.6

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||+|+||.||+|.. ..++..||+|.+..                .......+.+|+.+++.++||||++++
T Consensus         5 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~~a~K~~~~----------------~~~~~~~~~~E~~~l~~l~hpnIv~~~   67 (321)
T 1tki_A            5 EKYMIAEDLGRGEFGIVHRCVE-TSSKKTYMAKFVKV----------------KGTDQVLVKKEISILNIARHRNILHLH   67 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEE-TTTTEEEEEEEECC----------------CTHHHHHHHHHHHHHHHSCCTTBCCEE
T ss_pred             hceEeeeEEecCCCeEEEEEEE-CCCCcEEEEEEEec----------------CcccHHHHHHHHHHHHhCCCCCCCeEe
Confidence            5699999999999999999975 46889999998742                122345678899999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC--CC
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLND--DM  349 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~--~~  349 (487)
                      +++.+.+..++|||||+||+|.+++..   ....+++..+..++.|++.||.||   |++||+||||||+|||++.  ++
T Consensus        68 ~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~l---H~~givH~Dlkp~NIl~~~~~~~  141 (321)
T 1tki_A           68 ESFESMEELVMIFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFL---HSHNIGHFDIRPENIIYQTRRSS  141 (321)
T ss_dssp             EEEEETTEEEEEECCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEESSSSCC
T ss_pred             EEEecCCEEEEEEEeCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHH---HHCCCCcCCCCHHHEEEccCCCC
Confidence            999999999999999999999999863   345689999999999999999999   6778999999999999987  78


Q ss_pred             CEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHH
Q 011360          350 EACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWL  429 (487)
Q Consensus       350 ~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~  429 (487)
                      .+||+|||++........   .....||+.|+|||++.+..++.++||||||+++|+|++|..||....      ..+..
T Consensus       142 ~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~------~~~~~  212 (321)
T 1tki_A          142 TIKIIEFGQARQLKPGDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET------NQQII  212 (321)
T ss_dssp             CEEECCCTTCEECCTTCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS------HHHHH
T ss_pred             CEEEEECCCCeECCCCCc---cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC------HHHHH
Confidence            999999999987755432   234569999999999999889999999999999999999999994332      22333


Q ss_pred             HHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          430 RKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       430 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ..+......       .+.......+.++.+++.+||..||++|||+.++++
T Consensus       213 ~~i~~~~~~-------~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          213 ENIMNAEYT-------FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HHHHHTCCC-------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHcCCCC-------CChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            333332211       111111123456899999999999999999999986

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=8.1e-44  Score=349.38  Aligned_cols=261  Identities=23%  Similarity=0.319  Sum_probs=207.1

Q ss_pred             ccccccccccccccceeEEEEEecC--CCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPG--SNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNIL  268 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv  268 (487)
                      .++|.+.+.||.|+||.||+|.+..  ..+..||||++..              .........+.+|+.++..++||||+
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~--------------~~~~~~~~~~~~E~~~l~~l~h~~iv  113 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKA--------------GYTERQRRDFLSEASIMGQFDHPNII  113 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECT--------------TCCHHHHHHHHHHHHHHTTCCCTTBC
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCC--------------CCCHHHHHHHHHHHHHHHhCCCCCCC
Confidence            4569999999999999999998642  2345699999842              11233456788999999999999999


Q ss_pred             ccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC
Q 011360          269 PLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDD  348 (487)
Q Consensus       269 ~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~  348 (487)
                      ++++++.+.+..|+||||+++|+|.+++..   ....+++..+..++.|++.||.||   |+.||+||||||+|||++.+
T Consensus       114 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~L---H~~~ivH~Dlkp~NIll~~~  187 (325)
T 3kul_A          114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSN  187 (325)
T ss_dssp             CEEEEECGGGCCEEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTT
T ss_pred             cEEEEEEeCCccEEEeeCCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHH---HHCCeeCCCCCcceEEECCC
Confidence            999999999999999999999999999964   245799999999999999999999   67789999999999999999


Q ss_pred             CCEEEeccCCccccCCCCcee-eEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccccH
Q 011360          349 MEACISDLGLAMAIPDGYTRV-LISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSP  426 (487)
Q Consensus       349 ~~~kl~DFg~s~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~  426 (487)
                      +.+||+|||+++......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...      ...
T Consensus       188 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~------~~~  261 (325)
T 3kul_A          188 LVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNM------TNR  261 (325)
T ss_dssp             CCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTS------CHH
T ss_pred             CCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccC------CHH
Confidence            999999999998765432221 1223346788999999998899999999999999999999 99999432      222


Q ss_pred             HHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhhC
Q 011360          427 EWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL  487 (487)
Q Consensus       427 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~ll  487 (487)
                      +....+.....+.  .+..        .+..+.+++.+||+.||++|||+.+|++.|+.++
T Consensus       262 ~~~~~~~~~~~~~--~~~~--------~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~  312 (325)
T 3kul_A          262 DVISSVEEGYRLP--APMG--------CPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI  312 (325)
T ss_dssp             HHHHHHHTTCCCC--CCTT--------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHcCCCCC--CCCC--------cCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            3333333322211  1112        2256889999999999999999999999998763

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=6.8e-44  Score=363.45  Aligned_cols=255  Identities=17%  Similarity=0.286  Sum_probs=205.2

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .+.|.+.+.||.|+||.||+|.. ..+|+.||+|++...             .........+.+|+.+++.++||||+++
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~-~~~~~~~a~K~i~~~-------------~~~~~~~~~~~~E~~il~~l~hpnIv~l   75 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVK-VLAGQEYAAMIINTK-------------KLSARDHQKLEREARICRLLKHPNIVRL   75 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEE-TTTTEEEEEEEEESC-------------SCHHHHHHHHHHHHHHHHHCCBTTBCCE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEE-CCCCcEEEEEEEEcc-------------cCCHHHHHHHHHHHHHHHhCCCcCCCeE
Confidence            45699999999999999999964 568999999988431             1223345678899999999999999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC---C
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN---D  347 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~---~  347 (487)
                      ++++.+.+..|+|||||+||+|.+++..    ...+++..+..++.|++.||.||   |++||+||||||+|||++   .
T Consensus        76 ~~~~~~~~~~~lv~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~l---H~~givHrDlKp~NIll~~~~~  148 (444)
T 3soa_A           76 HDSISEEGHHYLIFDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHC---HQMGVVHRNLKPENLLLASKLK  148 (444)
T ss_dssp             EEEEECSSEEEEEECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCSSTTEEESBSST
T ss_pred             EEEEEECCEEEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCccccCCCHHHEEEeccCC
Confidence            9999999999999999999999999875    46699999999999999999999   677899999999999998   5


Q ss_pred             CCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHH
Q 011360          348 DMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPE  427 (487)
Q Consensus       348 ~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~  427 (487)
                      ++.+||+|||++.........  .....||+.|+|||++.+..|+.++|||||||++|+|++|.+||...      ...+
T Consensus       149 ~~~vkL~DFG~a~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~------~~~~  220 (444)
T 3soa_A          149 GAAVKLADFGLAIEVEGEQQA--WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDE------DQHR  220 (444)
T ss_dssp             TCCEEECCCSSCBCCCTTCCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCS------SHHH
T ss_pred             CCcEEEccCceeEEecCCCce--eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCc------cHHH
Confidence            678999999999876543322  13457999999999999999999999999999999999999999432      2223


Q ss_pred             HHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          428 WLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ....+......       .+.......+..+.+++.+||+.||++|||+.++++
T Consensus       221 ~~~~i~~~~~~-------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          221 LYQQIKAGAYD-------FPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             HHHHHHHTCCC-------CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHhCCCC-------CCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            33333332211       111111223356889999999999999999999986

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=5.2e-44  Score=353.19  Aligned_cols=267  Identities=21%  Similarity=0.325  Sum_probs=212.4

Q ss_pred             hhhccccccccccccccceeEEEEEecC----CCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCC
Q 011360          188 LKKEDCFASLEKIGSGGCGEVYKAELPG----SNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIR  263 (487)
Q Consensus       188 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  263 (487)
                      ....++|.+.+.||.|+||.||+|++..    .++..||+|.+..              .........+.+|+.+++.++
T Consensus        43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~--------------~~~~~~~~~~~~E~~~l~~l~  108 (343)
T 1luf_A           43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKE--------------EASADMQADFQREAALMAEFD  108 (343)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCT--------------TCCHHHHHHHHHHHHHHHTCC
T ss_pred             EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecc--------------ccCHHHHHHHHHHHHHHHhCC
Confidence            3355679999999999999999998753    3558999998742              112334567889999999999


Q ss_pred             CCCccccceEEecCCeeEEEEEecCCCCHHHHHhhhhcC--------------------CCCCChHHHHHHHHHHHHHHH
Q 011360          264 HRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG--------------------RRELDWPSRHRIALGVASGLE  323 (487)
Q Consensus       264 hpnIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~qi~~~L~  323 (487)
                      ||||+++++++...+..++||||+++|+|.+++......                    ...+++..++.++.|++.||.
T Consensus       109 hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~  188 (343)
T 1luf_A          109 NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMA  188 (343)
T ss_dssp             CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHH
T ss_pred             CCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHH
Confidence            999999999999999999999999999999999763211                    257899999999999999999


Q ss_pred             HHHhcCCCCeeecCCCCCCEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHH
Q 011360          324 YLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGML  403 (487)
Q Consensus       324 ~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~  403 (487)
                      ||   |++||+||||||+||+++.++.+||+|||++................+|+.|+|||++.+..++.++||||||++
T Consensus       189 ~L---H~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i  265 (343)
T 1luf_A          189 YL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVV  265 (343)
T ss_dssp             HH---HHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred             HH---HhCCeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHH
Confidence            99   677899999999999999999999999999976543322222234568899999999998899999999999999


Q ss_pred             HHHHHh-CCCCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHH
Q 011360          404 LISLVR-GVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCR  482 (487)
Q Consensus       404 l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~  482 (487)
                      +|+|+| |..||...      ...+....+.....+  ..+..+        +..+.+++.+||+.||++|||+.++++.
T Consensus       266 l~el~t~g~~p~~~~------~~~~~~~~~~~~~~~--~~~~~~--------~~~l~~li~~~l~~~p~~Rps~~~~~~~  329 (343)
T 1luf_A          266 LWEIFSYGLQPYYGM------AHEEVIYYVRDGNIL--ACPENC--------PLELYNLMRLCWSKLPADRPSFCSIHRI  329 (343)
T ss_dssp             HHHHHTTTCCTTTTS------CHHHHHHHHHTTCCC--CCCTTC--------CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhcCCCcCCCC------ChHHHHHHHhCCCcC--CCCCCC--------CHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence            999999 99999432      222333333322211  111122        2468899999999999999999999999


Q ss_pred             HhhhC
Q 011360          483 LSQLL  487 (487)
Q Consensus       483 L~~ll  487 (487)
                      |+++.
T Consensus       330 L~~~~  334 (343)
T 1luf_A          330 LQRMC  334 (343)
T ss_dssp             HHHTT
T ss_pred             HHHHH
Confidence            99863

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.9e-44  Score=357.32  Aligned_cols=270  Identities=24%  Similarity=0.330  Sum_probs=213.0

Q ss_pred             HHhhhccccccccccccccceeEEEEEe----cCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhcc
Q 011360          186 AFLKKEDCFASLEKIGSGGCGEVYKAEL----PGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQ  261 (487)
Q Consensus       186 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~  261 (487)
                      .|....++|.+.+.||.|+||.||+|++    +..+++.||||++..              .......+.+.+|+.++.+
T Consensus        16 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~--------------~~~~~~~~~~~~E~~~l~~   81 (359)
T 3vhe_A           16 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKE--------------GATHSEHRALMSELKILIH   81 (359)
T ss_dssp             HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECT--------------TCCHHHHHHHHHHHHHHHH
T ss_pred             cccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecC--------------cCCHHHHHHHHHHHHHHHh
Confidence            3455567899999999999999999975    345678999999842              1223345678899999999


Q ss_pred             C-CCCCccccceEEecCC-eeEEEEEecCCCCHHHHHhhhhcC-------------------------------------
Q 011360          262 I-RHRNILPLLAHMVRPD-CHLLVYEFMKNGSLQDILDDVSRG-------------------------------------  302 (487)
Q Consensus       262 l-~hpnIv~l~~~~~~~~-~~~lv~E~~~~gsL~~~l~~~~~~-------------------------------------  302 (487)
                      + +||||+++++++...+ ..++|||||++|+|.+++......                                     
T Consensus        82 l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (359)
T 3vhe_A           82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQS  161 (359)
T ss_dssp             HCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------
T ss_pred             hcCCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccc
Confidence            9 8999999999988754 489999999999999999753211                                     


Q ss_pred             -------------------------CCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEeccC
Q 011360          303 -------------------------RRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLG  357 (487)
Q Consensus       303 -------------------------~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~DFg  357 (487)
                                               ...+++..++.++.|++.||.||   |++||+||||||+|||++.++.+||+|||
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~L---H~~~ivH~Dikp~NIll~~~~~~kl~Dfg  238 (359)
T 3vhe_A          162 SASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFG  238 (359)
T ss_dssp             ----------------------CTTTTCBCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECGGGCEEECCCG
T ss_pred             ccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHH---HHCCcccCCCChhhEEEcCCCcEEEEecc
Confidence                                     12288999999999999999999   67789999999999999999999999999


Q ss_pred             CccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccccHHHHHHHHhcC
Q 011360          358 LAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSPEWLRKVMNSK  436 (487)
Q Consensus       358 ~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  436 (487)
                      ++................||+.|+|||++.+..++.++||||||+++|+|+| |..||......      +.........
T Consensus       239 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------~~~~~~~~~~  312 (359)
T 3vhe_A          239 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID------EEFCRRLKEG  312 (359)
T ss_dssp             GGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS------HHHHHHHHHT
T ss_pred             ceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh------HHHHHHHHcC
Confidence            9987655444333445678999999999999999999999999999999998 99999544321      1222222222


Q ss_pred             CCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhhC
Q 011360          437 NPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL  487 (487)
Q Consensus       437 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~ll  487 (487)
                      ....     .+..    .+..+.+++.+||+.||++|||+.++++.|+.++
T Consensus       313 ~~~~-----~~~~----~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  354 (359)
T 3vhe_A          313 TRMR-----APDY----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  354 (359)
T ss_dssp             CCCC-----CCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCC-----CCCC----CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence            2111     1111    2246889999999999999999999999998763

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=4.8e-44  Score=355.36  Aligned_cols=258  Identities=24%  Similarity=0.320  Sum_probs=206.2

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .+.|.+.+.||.|+||.||+|.. ..+|..||+|.+........         ........+.+|+.++.+++||||+++
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~-~~~~~~~avK~i~~~~~~~~---------~~~~~~~~~~~E~~il~~l~hpnIv~l   80 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCRE-KSTGLEYAAKFIKKRQSRAS---------RRGVCREEIEREVSILRQVLHPNIITL   80 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEE-TTTCCEEEEEEEEBCSSTTC---------SSSBCHHHHHHHHHHHTTCCCTTBCCE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEE-CCCCCEEEEEEEEccccccc---------cchhHHHHHHHHHHHHHhCCCcCCCcE
Confidence            35699999999999999999975 46889999999854321110         001123567899999999999999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC-
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDM-  349 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~-  349 (487)
                      ++++.+.+.+|+||||++||+|.+++..    ...+++..+..++.|++.||.||   |++||+||||||+|||++.++ 
T Consensus        81 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~L---H~~givHrDlkp~NIll~~~~~  153 (361)
T 2yab_A           81 HDVYENRTDVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYL---HTKKIAHFDLKPENIMLLDKNI  153 (361)
T ss_dssp             EEEEECSSEEEEEEECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEESCTTS
T ss_pred             EEEEEeCCEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEEeCCCC
Confidence            9999999999999999999999999964    46799999999999999999999   677899999999999998877 


Q ss_pred             ---CEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccH
Q 011360          350 ---EACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSP  426 (487)
Q Consensus       350 ---~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~  426 (487)
                         .+||+|||++........   .....||+.|+|||++.+..++.++|||||||++|+|++|.+||.+..      ..
T Consensus       154 ~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~------~~  224 (361)
T 2yab_A          154 PIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT------KQ  224 (361)
T ss_dssp             SSCCEEECCCSSCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS------HH
T ss_pred             CccCEEEEecCCceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC------HH
Confidence               799999999987655322   134569999999999999999999999999999999999999994432      22


Q ss_pred             HHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          427 EWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       427 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      +....+......       ++.......+..+.+++.+||..||++|||+.++++
T Consensus       225 ~~~~~i~~~~~~-------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          225 ETLANITAVSYD-------FDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             HHHHHHHTTCCC-------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHhcCCC-------CCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            333333322111       111111122356889999999999999999999874

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=4.5e-44  Score=354.94  Aligned_cols=261  Identities=20%  Similarity=0.264  Sum_probs=206.2

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .+.|.+.+.||+|+||.||+|.. ..+++.||||++....          ...........+.+|+.+++.++||||+++
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~~~vavK~~~~~~----------~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~   91 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCIN-RETGQQFAVKIVDVAK----------FTSSPGLSTEDLKREASICHMLKHPHIVEL   91 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEE-TTTCCEEEEEEEEHHH----------HHTSSSCCHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEE-CCCCCEEEEEEEEhhh----------ccccccchHHHHHHHHHHHHhCCCCCCCcE
Confidence            34699999999999999999974 4688999999883210          000011124568899999999999999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      ++++...+.+|+|||||+||+|.+++......+..+++..+..++.|++.||.||   |++||+||||||+|||++.++.
T Consensus        92 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~l---H~~~ivHrDlkp~NIl~~~~~~  168 (351)
T 3c0i_A           92 LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYC---HDNNIIHRDVKPHCVLLASKEN  168 (351)
T ss_dssp             EEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECSSST
T ss_pred             EEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHH---HHCCceeccCChHHeEEecCCC
Confidence            9999999999999999999999998876545556789999999999999999999   6778999999999999986654


Q ss_pred             ---EEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHH
Q 011360          351 ---ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPE  427 (487)
Q Consensus       351 ---~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~  427 (487)
                         +||+|||++.........  .....||+.|+|||++.+..++.++|||||||++|+|++|..||...       ..+
T Consensus       169 ~~~vkl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-------~~~  239 (351)
T 3c0i_A          169 SAPVKLGGFGVAIQLGESGLV--AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-------KER  239 (351)
T ss_dssp             TCCEEECCCTTCEECCTTSCB--CCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-------HHH
T ss_pred             CCcEEEecCcceeEecCCCee--ecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-------HHH
Confidence               999999999876543321  23457999999999999999999999999999999999999999432       122


Q ss_pred             HHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          428 WLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ............       +.......+..+.+++.+||+.||++|||+.++++
T Consensus       240 ~~~~i~~~~~~~-------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          240 LFEGIIKGKYKM-------NPRQWSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             HHHHHHHTCCCC-------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHcCCCCC-------CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            233333222110       00001122356889999999999999999999875

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=7.5e-44  Score=344.64  Aligned_cols=266  Identities=21%  Similarity=0.325  Sum_probs=203.3

Q ss_pred             ccccccccccccccceeEEEEEe---cCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAEL---PGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNI  267 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~---~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI  267 (487)
                      .++|.+.+.||+|+||.||+|++   +..+++.||||++..               ......+.+.+|+.++.+++||||
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~---------------~~~~~~~~~~~E~~~l~~l~h~~i   73 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH---------------STEEHLRDFEREIEILKSLQHDNI   73 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESC---------------CCHHHHHHHHHHHHHHHTCCCTTB
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEccc---------------CCHHHHHHHHHHHHHHHhCCCCCE
Confidence            45699999999999999999985   455789999998842               123345678899999999999999


Q ss_pred             cccceEEec--CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEe
Q 011360          268 LPLLAHMVR--PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLL  345 (487)
Q Consensus       268 v~l~~~~~~--~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill  345 (487)
                      +++++++..  ....++||||+++|+|.+++...   ...+++..+..++.|++.||.||   |++||+||||||+||++
T Consensus        74 v~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dikp~Nil~  147 (295)
T 3ugc_A           74 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILV  147 (295)
T ss_dssp             CCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEE
T ss_pred             eeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHH---hcCCcccCCCCHhhEEE
Confidence            999999865  35689999999999999999752   34589999999999999999999   67789999999999999


Q ss_pred             CCCCCEEEeccCCccccCCCCce-eeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCC-----
Q 011360          346 NDDMEACISDLGLAMAIPDGYTR-VLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQN-----  419 (487)
Q Consensus       346 ~~~~~~kl~DFg~s~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~-----  419 (487)
                      +.++.+||+|||++......... .......+|+.|+|||++.+..++.++||||||+++|+|+||..||.....     
T Consensus       148 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~  227 (295)
T 3ugc_A          148 ENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM  227 (295)
T ss_dssp             EETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHH
T ss_pred             cCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhh
Confidence            99999999999999876543221 112234577889999999988999999999999999999999988843210     


Q ss_pred             ----CCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          420 ----GEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       420 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                          ................... ...+..        .+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~--------~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l  289 (295)
T 3ugc_A          228 IGNDKQGQMIVFHLIELLKNNGR-LPRPDG--------CPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI  289 (295)
T ss_dssp             HCTTCCTHHHHHHHHHHHHTTCC-CCCCTT--------CCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             hcCccccchhHHHHHHHHhccCc-CCCCcC--------cCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence                0000011111222221111 111112        235688999999999999999999999999876

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=9e-44  Score=354.05  Aligned_cols=253  Identities=21%  Similarity=0.348  Sum_probs=205.4

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      +.|.+.+.||+|+||.||+|.. ..++..||+|++...             .........+.+|+.+++.++||||++++
T Consensus        29 ~~y~~~~~lG~G~~g~V~~~~~-~~~~~~~avK~~~~~-------------~~~~~~~~~~~~E~~il~~l~hpnIv~~~   94 (362)
T 2bdw_A           29 DNYDVKEELGKGAFSVVRRCVH-KTTGLEFAAKIINTK-------------KLSARDFQKLEREARICRKLQHPNIVRLH   94 (362)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEE-TTTCCEEEEEEEETT-------------TCCHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cCeEEeeEEecCCCeEEEEEEE-CCCCCEEEEEEEEcc-------------cCCHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence            4699999999999999999975 467899999998431             12233456788999999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC---
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDD---  348 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~---  348 (487)
                      +++.+.+..|+||||++||+|.+++..    ...+++..+..++.|++.||.||   |++||+||||||+|||++.+   
T Consensus        95 ~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~l---H~~~ivH~Dlkp~NIll~~~~~~  167 (362)
T 2bdw_A           95 DSIQEESFHYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYC---HSNGIVHRNLKPENLLLASKAKG  167 (362)
T ss_dssp             EEEECSSEEEEEECCCCSCBHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCSGGGEEESCSSTT
T ss_pred             EEEEeCCEEEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeEeccCchHHEEEecCCCC
Confidence            999999999999999999999998864    46789999999999999999999   67789999999999999865   


Q ss_pred             CCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHH
Q 011360          349 MEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEW  428 (487)
Q Consensus       349 ~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~  428 (487)
                      +.+||+|||++........   .....||+.|+|||++.+..++.++|||||||++|+|++|.+||....      ..+.
T Consensus       168 ~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~------~~~~  238 (362)
T 2bdw_A          168 AAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED------QHRL  238 (362)
T ss_dssp             CCEEECCCTTCBCCTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHH
T ss_pred             CCEEEeecCcceEecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC------HHHH
Confidence            4599999999987654322   134579999999999999899999999999999999999999994322      2233


Q ss_pred             HHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          429 LRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       429 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ...+......       .+.......+..+.+++.+||+.||++|||+.++++
T Consensus       239 ~~~i~~~~~~-------~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  284 (362)
T 2bdw_A          239 YAQIKAGAYD-------YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  284 (362)
T ss_dssp             HHHHHHTCCC-------CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             HHHHHhCCCC-------CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            3333322211       111122233467899999999999999999999874

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=8.2e-44  Score=357.07  Aligned_cols=253  Identities=22%  Similarity=0.308  Sum_probs=199.3

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CCCCcccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RHRNILPL  270 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l  270 (487)
                      ++|.+.+.||+|+||+||+|+. ..+++.||+|++....            .........+..|..++.++ +||||+++
T Consensus        52 ~~y~~~~~LG~G~fG~V~~~~~-~~~~~~~AvK~~~k~~------------~~~~~~~~~~~~E~~il~~~~~hp~Iv~l  118 (396)
T 4dc2_A           52 QDFDLLRVIGRGSYAKVLLVRL-KKTDRIYAMRVVKKEL------------VNDDEDIDWVQTEKHVFEQASNHPFLVGL  118 (396)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEE-TTTTEEEEEEEEEGGG------------TC----CCHHHHHHHHHHHHTTCTTBCCE
T ss_pred             hHcEEEEEEeeCCCeEEEEEEE-CCCCCEEEEEEEEhhh------------ccCHHHHHHHHHHHHHHHhcCCCCCcCee
Confidence            4699999999999999999975 4678999999984311            11223345577888888776 89999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      ++++.+.+.+|+||||++||+|.+++..    ...+++..++.++.||+.||.||   |++||+||||||+|||++.+|.
T Consensus       119 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~L---H~~givHrDLKp~NILl~~~g~  191 (396)
T 4dc2_A          119 HSCFQTESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYL---HERGIIYRDLKLDNVLLDSEGH  191 (396)
T ss_dssp             EEEEECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTSC
T ss_pred             EEEEEECCEEEEEEEcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCEEeccCCHHHEEECCCCC
Confidence            9999999999999999999999999975    35699999999999999999999   6778999999999999999999


Q ss_pred             EEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCC--ccccHHH
Q 011360          351 ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGE--EICSPEW  428 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~--~~~~~~~  428 (487)
                      +||+|||+++........  ....+||+.|+|||++.+..|+.++|||||||++|||++|.+||.......  .......
T Consensus       192 ikL~DFGla~~~~~~~~~--~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~  269 (396)
T 4dc2_A          192 IKLTDYGMCKEGLRPGDT--TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY  269 (396)
T ss_dssp             EEECCCTTCBCCCCTTCC--BCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHH
T ss_pred             EEEeecceeeecccCCCc--cccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHH
Confidence            999999999863322221  245679999999999999999999999999999999999999996443211  1112222


Q ss_pred             HHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCh
Q 011360          429 LRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNS  476 (487)
Q Consensus       429 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~  476 (487)
                      +........+.      +|..    .+.++.+++.+||+.||++||++
T Consensus       270 ~~~~i~~~~~~------~p~~----~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          270 LFQVILEKQIR------IPRS----LSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             HHHHHHHCCCC------CCTT----SCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             HHHHHhccccC------CCCc----CCHHHHHHHHHHhcCCHhHcCCC
Confidence            33333222221      2211    22568899999999999999996

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-43  Score=355.22  Aligned_cols=265  Identities=23%  Similarity=0.311  Sum_probs=212.3

Q ss_pred             hhccccccccccccccceeEEEEEecC------CCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC
Q 011360          189 KKEDCFASLEKIGSGGCGEVYKAELPG------SNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI  262 (487)
Q Consensus       189 ~~~~~~~~~~~lg~G~~g~v~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  262 (487)
                      ...++|.+.+.||+|+||.||+|.+..      ..+..||+|++..              .........+.+|+.++..+
T Consensus        66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~--------------~~~~~~~~~~~~E~~~l~~l  131 (382)
T 3tt0_A           66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS--------------DATEKDLSDLISEMEMMKMI  131 (382)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECT--------------TCCHHHHHHHHHHHHHHHHH
T ss_pred             cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecc--------------ccCHHHHHHHHHHHHHHHHh
Confidence            345679999999999999999998632      2346799998842              12234456788999999999


Q ss_pred             -CCCCccccceEEecCCeeEEEEEecCCCCHHHHHhhhhc------------CCCCCChHHHHHHHHHHHHHHHHHHhcC
Q 011360          263 -RHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSR------------GRRELDWPSRHRIALGVASGLEYLHMYH  329 (487)
Q Consensus       263 -~hpnIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~~Lh~~h  329 (487)
                       +||||+++++++...+..++||||+++|+|.+++.....            ....+++..++.++.|++.||.||   |
T Consensus       132 ~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L---H  208 (382)
T 3tt0_A          132 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---A  208 (382)
T ss_dssp             CCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHH---H
T ss_pred             cCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHH---H
Confidence             999999999999999999999999999999999986321            124589999999999999999999   6


Q ss_pred             CCCeeecCCCCCCEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh
Q 011360          330 SASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR  409 (487)
Q Consensus       330 ~~givH~Dlkp~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt  409 (487)
                      +.||+||||||+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|+|++
T Consensus       209 ~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt  288 (382)
T 3tt0_A          209 SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT  288 (382)
T ss_dssp             HTTCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHT
T ss_pred             hCCEecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHh
Confidence            77899999999999999999999999999987654332222234557899999999999999999999999999999999


Q ss_pred             -CCCCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          410 -GVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       410 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                       |..||....      ..+....+.....+.  .+..+        +.++.+++.+||+.||++|||+.+|++.|+.+
T Consensus       289 ~g~~p~~~~~------~~~~~~~~~~~~~~~--~~~~~--------~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  350 (382)
T 3tt0_A          289 LGGSPYPGVP------VEELFKLLKEGHRMD--KPSNC--------TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  350 (382)
T ss_dssp             TSCCSSTTCC------HHHHHHHHHTTCCCC--CCSSC--------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCCCCC------HHHHHHHHHcCCCCC--CCccC--------CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence             999994322      223333332222211  11112        25688999999999999999999999999876

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=6.4e-44  Score=340.41  Aligned_cols=257  Identities=24%  Similarity=0.330  Sum_probs=207.4

Q ss_pred             hhccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcc
Q 011360          189 KKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNIL  268 (487)
Q Consensus       189 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv  268 (487)
                      ...++|.+.+.||+|+||.||+|.+.  ++..||+|++....                ...+.+.+|+.++++++||||+
T Consensus         7 i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~----------------~~~~~~~~E~~~l~~l~h~~i~   68 (269)
T 4hcu_A            7 IDPSELTFVQEIGSGQFGLVHLGYWL--NKDKVAIKTIREGA----------------MSEEDFIEEAEVMMKLSHPKLV   68 (269)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEET--TTEEEEEEEECTTS----------------BCHHHHHHHHHHHHTCCCTTBC
T ss_pred             eChhhceeeheecCCCccEEEEEEec--CCCeEEEEEecccc----------------cCHHHHHHHHHHHHhCCCCCEe
Confidence            34457999999999999999999864  67789999984311                1124578899999999999999


Q ss_pred             ccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC
Q 011360          269 PLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDD  348 (487)
Q Consensus       269 ~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~  348 (487)
                      ++++++.+.+..++||||+++++|.+++..   ....+++..++.++.|++.||.||   |++||+||||||+||+++.+
T Consensus        69 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~l---H~~~i~H~dikp~Nil~~~~  142 (269)
T 4hcu_A           69 QLYGVCLEQAPICLVFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYL---EEACVIHRDLAARNCLVGEN  142 (269)
T ss_dssp             CEEEEECSSSSEEEEEECCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECGG
T ss_pred             eEEEEEecCCceEEEEEeCCCCcHHHHHHh---cCcccCHHHHHHHHHHHHHHHHHH---HhCCeecCCcchheEEEcCC
Confidence            999999999999999999999999999964   345689999999999999999999   67789999999999999999


Q ss_pred             CCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccccHH
Q 011360          349 MEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSPE  427 (487)
Q Consensus       349 ~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~  427 (487)
                      +.+||+|||++.......... .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||....      ..+
T Consensus       143 ~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~------~~~  215 (269)
T 4hcu_A          143 QVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS------NSE  215 (269)
T ss_dssp             GCEEECCTTGGGGBCCHHHHS-TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC------HHH
T ss_pred             CCEEecccccccccccccccc-ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC------HHH
Confidence            999999999998654432111 123446788999999998899999999999999999999 899994322      223


Q ss_pred             HHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          428 WLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      ..........+  ..+..        .+..+.+++.+||+.||++|||+.++++.|+++
T Consensus       216 ~~~~~~~~~~~--~~~~~--------~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l  264 (269)
T 4hcu_A          216 VVEDISTGFRL--YKPRL--------ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI  264 (269)
T ss_dssp             HHHHHHTTCCC--CCCTT--------SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHhcCccC--CCCCc--------CCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence            33333322111  11111        125688999999999999999999999999876

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.9e-44  Score=357.47  Aligned_cols=263  Identities=24%  Similarity=0.327  Sum_probs=206.8

Q ss_pred             ccccccccccccccceeEEEEEec----CCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCC
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELP----GSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRN  266 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn  266 (487)
                      .++|.+.+.||+|+||.||+|++.    ..++..||||++..              .........+.+|+.++.+++|||
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~--------------~~~~~~~~~~~~E~~~l~~l~hpn  135 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE--------------VCSEQDELDFLMEALIISKFNHQN  135 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCS--------------SCCHHHHHHHHHHHHHHHHCCCTT
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccc--------------ccChhhHHHHHHHHHHHHhCCCCC
Confidence            356999999999999999999853    34677899998732              112234456788999999999999


Q ss_pred             ccccceEEecCCeeEEEEEecCCCCHHHHHhhhhc---CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCE
Q 011360          267 ILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSR---GRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNV  343 (487)
Q Consensus       267 Iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Ni  343 (487)
                      |+++++++......++|||||++|+|.+++.....   ....+++..++.++.|++.||.||   |++||+||||||+||
T Consensus       136 Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlkp~NI  212 (367)
T 3l9p_A          136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL---EENHFIHRDIAARNC  212 (367)
T ss_dssp             BCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGE
T ss_pred             CCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHH---HhCCeeCCCCChhhE
Confidence            99999999999999999999999999999986432   224589999999999999999999   677899999999999


Q ss_pred             EeCCCC---CEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCC
Q 011360          344 LLNDDM---EACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQN  419 (487)
Q Consensus       344 ll~~~~---~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~  419 (487)
                      |++.++   .+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||.... 
T Consensus       213 ll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~-  291 (367)
T 3l9p_A          213 LLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-  291 (367)
T ss_dssp             EESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-
T ss_pred             EEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC-
Confidence            999555   599999999975422211111234567999999999998899999999999999999998 999994332 


Q ss_pred             CCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          420 GEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       420 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                           ..+..........+.  ....+        +..+.+++.+||+.||++|||+.+|++.|+.+
T Consensus       292 -----~~~~~~~i~~~~~~~--~~~~~--------~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~  343 (367)
T 3l9p_A          292 -----NQEVLEFVTSGGRMD--PPKNC--------PGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  343 (367)
T ss_dssp             -----HHHHHHHHHTTCCCC--CCTTC--------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----HHHHHHHHHcCCCCC--CCccC--------CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                 223333333322211  11112        24588999999999999999999999999764

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=5.3e-44  Score=348.43  Aligned_cols=269  Identities=21%  Similarity=0.274  Sum_probs=214.9

Q ss_pred             HhhhccccccccccccccceeEEEEEe----cCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC
Q 011360          187 FLKKEDCFASLEKIGSGGCGEVYKAEL----PGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI  262 (487)
Q Consensus       187 ~~~~~~~~~~~~~lg~G~~g~v~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  262 (487)
                      +....++|.+.+.||.|+||.||+|++    +..++..||+|++...              ......+.+.+|+.++.++
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--------------~~~~~~~~~~~E~~~l~~l   83 (313)
T 1t46_A           18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS--------------AHLTEREALMSELKVLSYL   83 (313)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT--------------CCHHHHHHHHHHHHHHHHH
T ss_pred             cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcc--------------hhHHHHHHHHHHHHHHhhc
Confidence            334456799999999999999999985    4457789999998431              1123456788999999999


Q ss_pred             -CCCCccccceEEecCCeeEEEEEecCCCCHHHHHhhhhc--------------CCCCCChHHHHHHHHHHHHHHHHHHh
Q 011360          263 -RHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSR--------------GRRELDWPSRHRIALGVASGLEYLHM  327 (487)
Q Consensus       263 -~hpnIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~qi~~~L~~Lh~  327 (487)
                       +||||+++++++...+..++||||+++|+|.+++.....              ....+++..++.++.|++.||.||  
T Consensus        84 ~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l--  161 (313)
T 1t46_A           84 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL--  161 (313)
T ss_dssp             CCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHH--
T ss_pred             ccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHH--
Confidence             999999999999999999999999999999999976321              123589999999999999999999  


Q ss_pred             cCCCCeeecCCCCCCEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHH
Q 011360          328 YHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISL  407 (487)
Q Consensus       328 ~h~~givH~Dlkp~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~el  407 (487)
                       |++||+||||||+||+++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|
T Consensus       162 -H~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el  240 (313)
T 1t46_A          162 -ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL  240 (313)
T ss_dssp             -HHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred             -HHCCeecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHH
Confidence             6778999999999999999999999999999877655443333445678899999999888999999999999999999


Q ss_pred             Hh-CCCCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          408 VR-GVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       408 lt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      +| |..||......      ............ ...+..        .+..+.+++.+||+.||.+|||+.++++.|+++
T Consensus       241 lt~g~~p~~~~~~~------~~~~~~~~~~~~-~~~~~~--------~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  305 (313)
T 1t46_A          241 FSLGSSPYPGMPVD------SKFYKMIKEGFR-MLSPEH--------APAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (313)
T ss_dssp             HTTTCCSSTTCCSS------HHHHHHHHHTCC-CCCCTT--------SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HhCCCCCCCcccch------hHHHHHhccCCC-CCCccc--------CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence            99 99999544321      122222222211 111111        225688999999999999999999999999876


Q ss_pred             C
Q 011360          487 L  487 (487)
Q Consensus       487 l  487 (487)
                      +
T Consensus       306 ~  306 (313)
T 1t46_A          306 I  306 (313)
T ss_dssp             H
T ss_pred             H
Confidence            3

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-43  Score=350.97  Aligned_cols=269  Identities=23%  Similarity=0.274  Sum_probs=212.0

Q ss_pred             HhhhccccccccccccccceeEEEEEec----CCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC
Q 011360          187 FLKKEDCFASLEKIGSGGCGEVYKAELP----GSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI  262 (487)
Q Consensus       187 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  262 (487)
                      |....++|.+.+.||.|+||.||+|.+.    ..++..||+|++...              ........+.+|+.++.++
T Consensus        40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--------------~~~~~~~~~~~E~~~l~~l  105 (344)
T 1rjb_A           40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK--------------ADSSEREALMSELKMMTQL  105 (344)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------------------CHHHHHHHHHHHHH
T ss_pred             cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccc--------------cCHHHHHHHHHHHHHHHhh
Confidence            4445567999999999999999999862    345678999998421              1223446788999999999


Q ss_pred             -CCCCccccceEEecCCeeEEEEEecCCCCHHHHHhhhhcC-------------------CCCCChHHHHHHHHHHHHHH
Q 011360          263 -RHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG-------------------RRELDWPSRHRIALGVASGL  322 (487)
Q Consensus       263 -~hpnIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~qi~~~L  322 (487)
                       +||||+++++++...+..++||||+++|+|.+++......                   ...+++..++.++.|++.||
T Consensus       106 ~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL  185 (344)
T 1rjb_A          106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGM  185 (344)
T ss_dssp             CCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHH
T ss_pred             cCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHH
Confidence             9999999999999999999999999999999999753211                   13478999999999999999


Q ss_pred             HHHHhcCCCCeeecCCCCCCEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHH
Q 011360          323 EYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGM  402 (487)
Q Consensus       323 ~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~  402 (487)
                      .||   |++||+||||||+||+++.++.+||+|||++................||+.|+|||++.+..++.++||||||+
T Consensus       186 ~~L---H~~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~  262 (344)
T 1rjb_A          186 EFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGI  262 (344)
T ss_dssp             HHH---HHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred             HHH---HhCCcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHH
Confidence            999   67789999999999999999999999999998765444333334556789999999998889999999999999


Q ss_pred             HHHHHHh-CCCCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          403 LLISLVR-GVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       403 ~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ++|+|+| |..||......      ............ ...+..        .+..+.+++.+||+.||.+|||+.+|++
T Consensus       263 il~el~t~g~~p~~~~~~~------~~~~~~~~~~~~-~~~~~~--------~~~~l~~li~~~l~~dp~~Rps~~~l~~  327 (344)
T 1rjb_A          263 LLWEIFSLGVNPYPGIPVD------ANFYKLIQNGFK-MDQPFY--------ATEEIYIIMQSCWAFDSRKRPSFPNLTS  327 (344)
T ss_dssp             HHHHHTTTSCCSSTTCCCS------HHHHHHHHTTCC-CCCCTT--------CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHcCCCCCcccCCcH------HHHHHHHhcCCC-CCCCCC--------CCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            9999998 99999544321      122223322211 111111        2356889999999999999999999999


Q ss_pred             HHhhhC
Q 011360          482 RLSQLL  487 (487)
Q Consensus       482 ~L~~ll  487 (487)
                      .|+.++
T Consensus       328 ~l~~~~  333 (344)
T 1rjb_A          328 FLGCQL  333 (344)
T ss_dssp             HHHHHC
T ss_pred             HHHHHH
Confidence            998764

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.1e-43  Score=351.78  Aligned_cols=251  Identities=24%  Similarity=0.323  Sum_probs=200.2

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CCCCcccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RHRNILPL  270 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l  270 (487)
                      ++|.+.+.||+|+||.||+|+. ..+++.||+|++..            ...........+..|..++..+ +||||+++
T Consensus        23 ~~y~~~~~lG~G~fg~V~~~~~-~~~~~~~AvK~~~~------------~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l   89 (353)
T 3txo_A           23 DNFEFIRVLGKGSFGKVMLARV-KETGDLYAVKVLKK------------DVILQDDDVECTMTEKRILSLARNHPFLTQL   89 (353)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEE-TTTCCEEEEEEEEH------------HHHHHHTTHHHHHHHHHHHHHTTTCTTBCCE
T ss_pred             hheEEEEEEeeCCCEEEEEEEE-cCCCCEEEEEEEEH------------HHhcchhHHHHHHHHHHHHHhccCCCceeeE
Confidence            4699999999999999999975 46789999999842            1112223456678899999888 79999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      ++++.+.+.+|+|||||+||+|.+++..    ...+++..++.++.|++.||.||   |++||+||||||+|||++.+|.
T Consensus        90 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~L---H~~givHrDlkp~NILl~~~g~  162 (353)
T 3txo_A           90 FCCFQTPDRLFFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFL---HDKGIIYRDLKLDNVLLDHEGH  162 (353)
T ss_dssp             EEEEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTSC
T ss_pred             EEEEEeCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCCcccCCCHHHEEECCCCC
Confidence            9999999999999999999999999975    35699999999999999999999   6778999999999999999999


Q ss_pred             EEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHH
Q 011360          351 ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLR  430 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~  430 (487)
                      +||+|||+++.......  .....+||+.|+|||++.+..|+.++|||||||++|||++|..||...+      ..+...
T Consensus       163 ikL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~------~~~~~~  234 (353)
T 3txo_A          163 CKLADFGMCKEGICNGV--TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN------EDDLFE  234 (353)
T ss_dssp             EEECCCTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHH
T ss_pred             EEEccccceeecccCCc--cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC------HHHHHH
Confidence            99999999976433222  2245679999999999998889999999999999999999999994332      223334


Q ss_pred             HHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCh------HHHHH
Q 011360          431 KVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNS------QYVRC  481 (487)
Q Consensus       431 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~------~~il~  481 (487)
                      .+......       ++..    .+..+.+++.+||..||++||++      ++|++
T Consensus       235 ~i~~~~~~-------~p~~----~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          235 AILNDEVV-------YPTW----LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             HHHHCCCC-------CCTT----SCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             HHHcCCCC-------CCCC----CCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence            44332211       1111    22468899999999999999998      66654

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=6.1e-43  Score=341.69  Aligned_cols=248  Identities=25%  Similarity=0.383  Sum_probs=204.1

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||+|+||.||+|+. ..+|+.||+|++..            ...........+.+|..++..++||||++++
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~-~~~~~~~aiK~~~~------------~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~   72 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRS-RHNGRYYAMKVLKK------------EIVVRLKQVEHTNDERLMLSIVTHPFIIRMW   72 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEE-TTTCCEEEEEEEEH------------HHHHHTTCHHHHHHHHHHHHSCCBTTBCCEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEE-CCCCCEEEEEEEEH------------HHhhhhhHHHHHHHHHHHHhhCCCCCCceEe
Confidence            4699999999999999999975 46889999999842            0111122345678899999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++.+.+.+|+||||++||+|.+++..    ...+++..+..++.|++.||.||   |++||+||||||+|||++.+|.+
T Consensus        73 ~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDlkp~NIll~~~g~~  145 (318)
T 1fot_A           73 GTFQDAQQIFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYL---HSKDIIYRDLKPENILLDKNGHI  145 (318)
T ss_dssp             EEEECSSEEEEEECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCCGGGEEECTTSCE
T ss_pred             EEEEeCCEEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCccccCCChheEEEcCCCCE
Confidence            999999999999999999999999975    45789999999999999999999   77899999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRK  431 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~  431 (487)
                      ||+|||++.......     ...+||+.|+|||++.+..++.++|||||||++|||++|..||...      ...+....
T Consensus       146 kL~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~------~~~~~~~~  214 (318)
T 1fot_A          146 KITDFGFAKYVPDVT-----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS------NTMKTYEK  214 (318)
T ss_dssp             EECCCSSCEECSSCB-----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS------SHHHHHHH
T ss_pred             EEeecCcceecCCcc-----ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC------CHHHHHHH
Confidence            999999998754322     3457999999999999999999999999999999999999999432      22233333


Q ss_pred             HHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCC-----ChHHHHH
Q 011360          432 VMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERP-----NSQYVRC  481 (487)
Q Consensus       432 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~~il~  481 (487)
                      +.... .      .++..    .+.++.+++.+||..||++||     ++++|++
T Consensus       215 i~~~~-~------~~p~~----~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          215 ILNAE-L------RFPPF----FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             HHHCC-C------CCCTT----SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             HHhCC-C------CCCCC----CCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence            43322 1      11211    225688999999999999999     8888874

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=6.3e-44  Score=366.06  Aligned_cols=355  Identities=21%  Similarity=0.315  Sum_probs=247.7

Q ss_pred             cchhhhhhhhhHHHHHHhh----hchhhhhhHHHHHHHHHHH---------HHHHHhhccccC-CCCcccccccCCCCCC
Q 011360           92 DVDYLLDEFQTEAFQTMLL----QDADAMSKVKEVNARLQDI---------AWQINVLGLKES-FGGKSRNVRQRFPTTP  157 (487)
Q Consensus        92 d~~~~~~~~~~~~~~~~l~----~~~~~~~r~~ei~~~l~~i---------~~~~~~~~l~~~-~g~~~~~~~~~~~s~p  157 (487)
                      +.+++++.+++++.++++.    .+|.|+.|.++.......+         .....||.+... .|+........|++..
T Consensus        69 ~~~W~~g~i~r~~ae~~L~~~~~~~G~FLvR~s~~~~g~y~lsv~~~~~~~~~~v~H~~I~~~~~g~~~i~~~~~F~sl~  148 (454)
T 1qcf_A           69 TEEWFFKGISRKDAERQLLAPGNMLGSFMIRDSETTKGSYSLSVRDYDPRQGDTVKHYKIRTLDNGGFYISPRSTFSTLQ  148 (454)
T ss_dssp             GSTTEETTCCHHHHHHHHHSTTCCTTCEEEEECSSSTTSEEEEEEEEETTTEEEEEEEEEEECTTSCEESSSSSCBSSHH
T ss_pred             cccccccccchhhhhhhhhcCCCCCceEEEEECcCCCCeEEEEEEecccCCCCceEEEEEEEcCCCcEEEeCccccCCHH
Confidence            3566888888998888773    5688888754321100000         112234444432 2222333334555555


Q ss_pred             hhhhhhhcCCCCC----CCCccc-cCCcchhhHHHhhhccccccccccccccceeEEEEEecCCCCceEEEEEeeecCch
Q 011360          158 SLISAAVRGGSRD----RGPTIF-SPLIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPI  232 (487)
Q Consensus       158 ~~~~~~~~~~~~~----~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~  232 (487)
                      .++..........    ..+... .+........|....++|.+.+.||+|+||.||+|.+.  ++..||||++...   
T Consensus       149 eLv~~y~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~~vavK~~~~~---  223 (454)
T 1qcf_A          149 ELVDHYKKGNDGLCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYN--KHTKVAVKTMKPG---  223 (454)
T ss_dssp             HHHHHHTSSCTTSSSCCCSBCCCCCCCCCCCTTCSBCCGGGEEEEEEEECCSSEEEEEEEET--TTEEEEEEEECTT---
T ss_pred             HHHHHHHhccCCccccccccccccCccccccccceeechHHeEEEEEcccCCceEEEEEEEC--CccEEEEEEecCC---
Confidence            4444332221110    001000 00011112234455677999999999999999999874  5778999998421   


Q ss_pred             hHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHH
Q 011360          233 SAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRH  312 (487)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~  312 (487)
                                   ....+.+.+|+.++++++||||+++++++. .+..|+||||+++|+|.+++...  ....+++..+.
T Consensus       224 -------------~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~  287 (454)
T 1qcf_A          224 -------------SMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSD--EGSKQPLPKLI  287 (454)
T ss_dssp             -------------SBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSH--HHHTCCHHHHH
T ss_pred             -------------CccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhc--cCCCCCHHHHH
Confidence                         112457889999999999999999999886 66789999999999999999742  12357889999


Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCC
Q 011360          313 RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELS  392 (487)
Q Consensus       313 ~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~  392 (487)
                      .++.|++.||.||   |++||+||||||+|||++.++.+||+|||+++......... .....+|+.|+|||++....++
T Consensus       288 ~~~~qi~~~l~~L---H~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~  363 (454)
T 1qcf_A          288 DFSAQIAEGMAFI---EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA-REGAKFPIKWTAPEAINFGSFT  363 (454)
T ss_dssp             HHHHHHHHHHHHH---HHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHT-TCSSSSCGGGSCHHHHHHCCCC
T ss_pred             HHHHHHHHHHHHH---HhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceec-cCCCcccccccCHHHhccCCCC
Confidence            9999999999999   66789999999999999999999999999998764322111 1223467899999999988999


Q ss_pred             chhHHHHHHHHHHHHHh-CCCCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCC
Q 011360          393 EKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPE  471 (487)
Q Consensus       393 ~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~  471 (487)
                      .++||||||+++|||+| |..||...      ...+....+.......      .+.    ..+..+.+++.+||+.||+
T Consensus       364 ~~~DvwslG~~l~el~t~g~~P~~~~------~~~~~~~~i~~~~~~~------~~~----~~~~~l~~li~~cl~~dp~  427 (454)
T 1qcf_A          364 IKSDVWSFGILLMEIVTYGRIPYPGM------SNPEVIRALERGYRMP------RPE----NCPEELYNIMMRCWKNRPE  427 (454)
T ss_dssp             HHHHHHHHHHHHHHHHTTSCCSSTTC------CHHHHHHHHHHTCCCC------CCT----TSCHHHHHHHHHHTCSSGG
T ss_pred             cHHHHHhHHHHHHHHHhCCCCCCCCC------CHHHHHHHHHcCCCCC------CCC----CCCHHHHHHHHHHccCChh
Confidence            99999999999999999 99999432      2233333333332211      111    1235688999999999999


Q ss_pred             CCCChHHHHHHHhhhC
Q 011360          472 ERPNSQYVRCRLSQLL  487 (487)
Q Consensus       472 ~RPs~~~il~~L~~ll  487 (487)
                      +|||+.+|++.|+.+.
T Consensus       428 ~RPt~~~i~~~L~~~~  443 (454)
T 1qcf_A          428 ERPTFEYIQSVLDDFY  443 (454)
T ss_dssp             GSCCHHHHHHHHHTSS
T ss_pred             HCcCHHHHHHHHHHHH
Confidence            9999999999998863

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.5e-43  Score=337.50  Aligned_cols=255  Identities=22%  Similarity=0.306  Sum_probs=207.2

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .++|.+.+.||.|+||.||+|.+.  ++..||+|++....                .....+.+|+.++.+++||||+++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~----------------~~~~~~~~E~~~l~~l~h~~i~~~   68 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWK--GQYDVAVKMIKEGS----------------MSEDEFFQEAQTMMKLSHPKLVKF   68 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET--TTEEEEEEEECBTT----------------BCHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             hhheeeeeeeccCCCceEEEEEec--CceeEEEEEeccCC----------------CcHHHHHHHHHHHHhCCCCCEeeE
Confidence            457999999999999999999764  67789999984311                112457889999999999999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      ++++...+..++||||+++++|.+++...   +..+++..++.++.|++.||.||   |+.||+||||||+||+++.++.
T Consensus        69 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dikp~Nil~~~~~~  142 (268)
T 3sxs_A           69 YGVCSKEYPIYIVTEYISNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFL---ESHQFIHRDLAARNCLVDRDLC  142 (268)
T ss_dssp             EEEECSSSSEEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHH---HHTTEEESSCSGGGEEECTTCC
T ss_pred             EEEEccCCceEEEEEccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCcCcceEEECCCCC
Confidence            99999999999999999999999999752   34689999999999999999999   6778999999999999999999


Q ss_pred             EEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccccHHHH
Q 011360          351 ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSPEWL  429 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~  429 (487)
                      +||+|||++.......... .....+|+.|+|||.+.+..++.++||||||+++|+|+| |..||....      ..+..
T Consensus       143 ~~l~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~------~~~~~  215 (268)
T 3sxs_A          143 VKVSDFGMTRYVLDDQYVS-SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT------NSEVV  215 (268)
T ss_dssp             EEECCTTCEEECCTTCEEE-CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSC------HHHHH
T ss_pred             EEEccCccceecchhhhhc-ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccC------hHHHH
Confidence            9999999998765543322 233456778999999998889999999999999999999 999994322      22333


Q ss_pred             HHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          430 RKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       430 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      .........  ..+..        .+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus       216 ~~~~~~~~~--~~~~~--------~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l  262 (268)
T 3sxs_A          216 LKVSQGHRL--YRPHL--------ASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPL  262 (268)
T ss_dssp             HHHHTTCCC--CCCTT--------SCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGG
T ss_pred             HHHHcCCCC--CCCCc--------ChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence            333322211  11111        124688999999999999999999999999986

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=6e-44  Score=348.21  Aligned_cols=265  Identities=22%  Similarity=0.327  Sum_probs=211.7

Q ss_pred             hccccccccccccccceeEEEEEec----CCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCC
Q 011360          190 KEDCFASLEKIGSGGCGEVYKAELP----GSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHR  265 (487)
Q Consensus       190 ~~~~~~~~~~lg~G~~g~v~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp  265 (487)
                      ..++|.+.+.||.|+||.||+|...    ..++..||+|++..              .......+.+.+|+.+++.++||
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~--------------~~~~~~~~~~~~E~~~l~~l~hp   86 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKE--------------NASPSELRDLLSEFNVLKQVNHP   86 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCT--------------TCCHHHHHHHHHHHHHHTTCCCT
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccC--------------CCCHHHHHHHHHHHHHHhhCCCC
Confidence            3457999999999999999999753    23568899998742              12234556788999999999999


Q ss_pred             CccccceEEecCCeeEEEEEecCCCCHHHHHhhhhc--------------------CCCCCChHHHHHHHHHHHHHHHHH
Q 011360          266 NILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSR--------------------GRRELDWPSRHRIALGVASGLEYL  325 (487)
Q Consensus       266 nIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~qi~~~L~~L  325 (487)
                      ||+++++++...+..++||||+++|+|.+++.....                    ....+++..++.++.|++.||.||
T Consensus        87 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l  166 (314)
T 2ivs_A           87 HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL  166 (314)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHH
T ss_pred             ceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHH
Confidence            999999999999999999999999999999976322                    123488999999999999999999


Q ss_pred             HhcCCCCeeecCCCCCCEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHH
Q 011360          326 HMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLI  405 (487)
Q Consensus       326 h~~h~~givH~Dlkp~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~  405 (487)
                         |++||+||||||+||+++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|
T Consensus       167 ---H~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~  243 (314)
T 2ivs_A          167 ---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLW  243 (314)
T ss_dssp             ---HHTTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHH
T ss_pred             ---HHCCCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHH
Confidence               67789999999999999999999999999998765544333333445788999999999888999999999999999


Q ss_pred             HHHh-CCCCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHh
Q 011360          406 SLVR-GVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLS  484 (487)
Q Consensus       406 ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~  484 (487)
                      +|+| |..||......      .... ........ ..+..        .+..+.+++.+||+.||++|||+.++++.|+
T Consensus       244 el~t~g~~p~~~~~~~------~~~~-~~~~~~~~-~~~~~--------~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~  307 (314)
T 2ivs_A          244 EIVTLGGNPYPGIPPE------RLFN-LLKTGHRM-ERPDN--------CSEEMYRLMLQCWKQEPDKRPVFADISKDLE  307 (314)
T ss_dssp             HHHTTSCCSSTTCCGG------GHHH-HHHTTCCC-CCCTT--------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHhCCCCCCCCCCHH------HHHH-HhhcCCcC-CCCcc--------CCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            9999 99999543321      1222 22222111 11111        2356889999999999999999999999998


Q ss_pred             hhC
Q 011360          485 QLL  487 (487)
Q Consensus       485 ~ll  487 (487)
                      +++
T Consensus       308 ~~~  310 (314)
T 2ivs_A          308 KMM  310 (314)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            763

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=2e-43  Score=346.24  Aligned_cols=265  Identities=24%  Similarity=0.410  Sum_probs=195.0

Q ss_pred             ccccccccccccccceeEEEEEecCCCC--ceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNG--KMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNIL  268 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv  268 (487)
                      .++|.+.+.||+|+||.||+|.+...++  ..||||++..             ........+.+.+|+.++++++||||+
T Consensus        22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~-------------~~~~~~~~~~~~~E~~~l~~l~h~~iv   88 (323)
T 3qup_A           22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKA-------------DIIASSDIEEFLREAACMKEFDHPHVA   88 (323)
T ss_dssp             ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------------------CHHHHHHHHHHHHHTTCCCTTBC
T ss_pred             hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecc-------------cccCHHHHHHHHHHHHHHHHCCCCcee
Confidence            4579999999999999999997643222  3799998732             122334467789999999999999999


Q ss_pred             ccceEEecCCee------EEEEEecCCCCHHHHHhhhhc--CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC
Q 011360          269 PLLAHMVRPDCH------LLVYEFMKNGSLQDILDDVSR--GRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKP  340 (487)
Q Consensus       269 ~l~~~~~~~~~~------~lv~E~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp  340 (487)
                      ++++++......      ++||||+++|+|.+++.....  ....+++..++.++.|++.||.||   |++||+||||||
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~L---H~~~ivH~Dikp  165 (323)
T 3qup_A           89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYL---SSRNFIHRDLAA  165 (323)
T ss_dssp             CCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSG
T ss_pred             hhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHH---HcCCcccCCCCc
Confidence            999999877655      999999999999999975432  223689999999999999999999   677899999999


Q ss_pred             CCEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCC
Q 011360          341 RNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQN  419 (487)
Q Consensus       341 ~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~  419 (487)
                      +||+++.++.+||+|||++................+|+.|+|||.+.+..++.++|||||||++|+|++ |..||.....
T Consensus       166 ~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~  245 (323)
T 3qup_A          166 RNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN  245 (323)
T ss_dssp             GGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred             ceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccCh
Confidence            999999999999999999987654433222234457889999999999899999999999999999999 8999954332


Q ss_pred             CCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhhC
Q 011360          420 GEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL  487 (487)
Q Consensus       420 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~ll  487 (487)
                            .+..........+.  ..+.        .+..+.+++.+||+.||++|||+.++++.|++++
T Consensus       246 ------~~~~~~~~~~~~~~--~~~~--------~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l  297 (323)
T 3qup_A          246 ------AEIYNYLIGGNRLK--QPPE--------CMEEVYDLMYQCWSADPKQRPSFTCLRMELENIL  297 (323)
T ss_dssp             ------GGHHHHHHTTCCCC--CCTT--------CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ------HHHHHHHhcCCCCC--CCCc--------cCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                  12233333222211  1112        2256899999999999999999999999998864

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=3.3e-43  Score=347.55  Aligned_cols=253  Identities=22%  Similarity=0.305  Sum_probs=200.9

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CCCCcccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RHRNILPL  270 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l  270 (487)
                      ++|.+.+.||+|+||.||+|+. ..+++.||+|++...            ..........+.+|..++.++ +||||+++
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~-~~~~~~~aiK~~~~~------------~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l   75 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRL-KKTDRIYAMKVVKKE------------LVNDDEDIDWVQTEKHVFEQASNHPFLVGL   75 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEE-TTTTEEEEEEEEEGG------------GSCSHHHHHHHHHHHHHHHHTTTCTTBCCE
T ss_pred             hheEEEEEEEecCCeEEEEEEE-CCCCCEEEEEEEEhH------------HhcchHHHHHHHHHHHHHHhcCCCCccCeE
Confidence            4699999999999999999975 467899999998431            112234456778899999887 89999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      ++++.+.+.+|+||||++||+|.+++..    ...+++..++.++.|++.||.||   |++||+||||||+|||++.+|.
T Consensus        76 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~L---H~~~ivHrDlkp~NIll~~~g~  148 (345)
T 3a8x_A           76 HSCFQTESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYL---HERGIIYRDLKLDNVLLDSEGH  148 (345)
T ss_dssp             EEEEECSSEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTSC
T ss_pred             EEEEEeCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCceecCCCHHHEEECCCCC
Confidence            9999999999999999999999999975    35689999999999999999999   6778999999999999999999


Q ss_pred             EEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCc--cccHHH
Q 011360          351 ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEE--ICSPEW  428 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~--~~~~~~  428 (487)
                      +||+|||+++........  ....+||+.|+|||++.+..++.++|||||||++|||++|..||........  ......
T Consensus       149 ~kL~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~  226 (345)
T 3a8x_A          149 IKLTDYGMCKEGLRPGDT--TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY  226 (345)
T ss_dssp             EEECCGGGCBCSCCTTCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHH
T ss_pred             EEEEeccccccccCCCCc--ccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHH
Confidence            999999999864332221  2456799999999999999999999999999999999999999954322111  111222


Q ss_pred             HHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCh
Q 011360          429 LRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNS  476 (487)
Q Consensus       429 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~  476 (487)
                      ...........      +|..    .+..+.+++.+||+.||++||++
T Consensus       227 ~~~~i~~~~~~------~p~~----~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          227 LFQVILEKQIR------IPRS----LSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             HHHHHHHCCCC------CCTT----SCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             HHHHHHcCCCC------CCCC----CCHHHHHHHHHHhcCCHhHCCCC
Confidence            22222222221      2211    23568899999999999999996

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2e-43  Score=361.85  Aligned_cols=350  Identities=21%  Similarity=0.298  Sum_probs=246.8

Q ss_pred             ccchhhhhhhhhHHHHHHhh--hchhhhhhHHHHHHHHHH----HHHHHHhhccccCCCCcccccccCCCCCChhhhhhh
Q 011360           91 CDVDYLLDEFQTEAFQTMLL--QDADAMSKVKEVNARLQD----IAWQINVLGLKESFGGKSRNVRQRFPTTPSLISAAV  164 (487)
Q Consensus        91 yd~~~~~~~~~~~~~~~~l~--~~~~~~~r~~ei~~~l~~----i~~~~~~~~l~~~~g~~~~~~~~~~~s~p~~~~~~~  164 (487)
                      -+.+++++.+++++.+++|.  .+|.|+.|.++-...-..    -.....|+.+....++........|.+...++....
T Consensus        78 ~~~~wyhg~i~r~~ae~~L~~~~~G~FlvR~S~~~~g~~~Lsv~~~~~v~H~~I~~~~~~~~i~~~~~F~sl~eLv~~y~  157 (450)
T 1k9a_A           78 SLMPWFHGKITREQAERLLYPPETGLFLVRESTNYPGDYTLCVSCEGKVEHYRIMYHASKLSIDEEVYFENLMQLVEHYT  157 (450)
T ss_dssp             ESCTTBCTTCCHHHHHHHTCSCCTTEEEEEECSSSTTSEEEEEECSSSEEEEEEEEETTEEESSSSSCBSSHHHHHHHHH
T ss_pred             ccccccccCcCHHHhhhhhccCCCceEEEEecCCCCCceEEEEEeCCeeeEEEEEecCCceEeccccccccHHHHHhhhc
Confidence            44578889999999999887  468888875432100000    001123444433333333344455666655554443


Q ss_pred             cCCCCC--C--CCccccCCcc-hh---hHHHhhhccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHH
Q 011360          165 RGGSRD--R--GPTIFSPLIE-KE---DLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAE  236 (487)
Q Consensus       165 ~~~~~~--~--~~~~~~~~~~-~~---~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~  236 (487)
                      ......  .  .+........ ..   ...|....++|.+.+.||+|+||.||+|.+   ++..||||++...       
T Consensus       158 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~---~~~~vavK~~~~~-------  227 (450)
T 1k9a_A          158 TDADGLCTRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDY---RGNKVAVKCIKND-------  227 (450)
T ss_dssp             HCCTTSSSCCCEECCCTTCEEHHHHHHHTTCBCCGGGEEEEEEEEECSSEEEEEEEE---TTEEEEEEEESSC-------
T ss_pred             ccccchhhhccccccccCcccchhhhcccccccChHHeEEEeeecCcCCeeEEEEEe---cCCeEEEEEeCCc-------
Confidence            222110  0  0111100000 11   112334556799999999999999999986   4779999998421       


Q ss_pred             HHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceEEecCC-eeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHH
Q 011360          237 LIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPD-CHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIA  315 (487)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~  315 (487)
                                ...+.+.+|+.++++++||||+++++++...+ ..|+||||+++|+|.+++..  .....+++..+..++
T Consensus       228 ----------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~  295 (450)
T 1k9a_A          228 ----------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFS  295 (450)
T ss_dssp             ----------TTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHH--HCTTTCCHHHHHHHH
T ss_pred             ----------hHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHh--cCCCCCCHHHHHHHH
Confidence                      12356889999999999999999999987665 78999999999999999976  233457899999999


Q ss_pred             HHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchh
Q 011360          316 LGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKC  395 (487)
Q Consensus       316 ~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~  395 (487)
                      .|++.||.||   |++||+||||||+|||++.++.+||+|||+++......     ....+|+.|+|||++.+..++.++
T Consensus       296 ~qi~~~l~~L---H~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~s  367 (450)
T 1k9a_A          296 LDVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKS  367 (450)
T ss_dssp             HHHHHHHHHH---HHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-----------CCCTTTSCHHHHHSSCCCHHH
T ss_pred             HHHHHHHHHH---HhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc-----cCCCCCcceeCHHHhcCCCCCcHH
Confidence            9999999999   67789999999999999999999999999997543221     223578899999999999999999


Q ss_pred             HHHHHHHHHHHHHh-CCCCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCC
Q 011360          396 DIFSFGMLLISLVR-GVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERP  474 (487)
Q Consensus       396 DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP  474 (487)
                      ||||||+++|||+| |..||......      +....+..+..+  .    .+..    .+..+.++|.+||+.||++||
T Consensus       368 DvwslG~~l~el~t~g~~P~~~~~~~------~~~~~i~~~~~~--~----~p~~----~~~~l~~li~~cl~~dp~~Rp  431 (450)
T 1k9a_A          368 DVWSFGILLWEIYSFGRVPYPRIPLK------DVVPRVEKGYKM--D----APDG----CPPAVYDVMKNCWHLDAATRP  431 (450)
T ss_dssp             HHHHHHHHHHHHHTTTCCSSTTSCTT------THHHHHHTTCCC--C----CCTT----CCHHHHHHHHHHTCSSGGGSC
T ss_pred             HHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHcCCCC--C----CCCc----CCHHHHHHHHHHcCCChhHCc
Confidence            99999999999998 99999654332      122223222211  1    1211    225688999999999999999


Q ss_pred             ChHHHHHHHhhh
Q 011360          475 NSQYVRCRLSQL  486 (487)
Q Consensus       475 s~~~il~~L~~l  486 (487)
                      |+.+|++.|+.+
T Consensus       432 t~~~l~~~L~~i  443 (450)
T 1k9a_A          432 TFLQLREQLEHI  443 (450)
T ss_dssp             CHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHH
Confidence            999999999875

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=4.5e-43  Score=343.47  Aligned_cols=248  Identities=24%  Similarity=0.392  Sum_probs=201.9

Q ss_pred             cccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceE
Q 011360          194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAH  273 (487)
Q Consensus       194 ~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  273 (487)
                      |...+.||.|+||.||+|+. ..+|+.||||++...               .....+.+.+|+.+++.++||||++++++
T Consensus        47 ~~~~~~lg~G~~g~V~~a~~-~~~g~~vavK~~~~~---------------~~~~~~~~~~E~~~l~~l~h~niv~~~~~  110 (321)
T 2c30_A           47 LDSYVKIGEGSTGIVCLARE-KHSGRQVAVKMMDLR---------------KQQRRELLFNEVVIMRDYQHFNVVEMYKS  110 (321)
T ss_dssp             EEEEEEEEEETTEEEEEEEE-TTTCCEEEEEEEETT---------------TCCSHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             hhccEEeccCCCeEEEEEEE-CCCCcEEEEEEEecc---------------chhHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence            67778999999999999975 457899999988431               11223567889999999999999999999


Q ss_pred             EecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEE
Q 011360          274 MVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACI  353 (487)
Q Consensus       274 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl  353 (487)
                      +...+..++||||+++++|.+++..     ..+++..+..++.|++.||.||   |+.||+||||||+||+++.++.+||
T Consensus       111 ~~~~~~~~lv~e~~~~~~L~~~l~~-----~~l~~~~~~~i~~qi~~~L~~L---H~~~ivH~Dlkp~NIll~~~~~~kl  182 (321)
T 2c30_A          111 YLVGEELWVLMEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALAYL---HAQGVIHRDIKSDSILLTLDGRVKL  182 (321)
T ss_dssp             EEETTEEEEEECCCCSCBHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTCCEEE
T ss_pred             EEECCEEEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEECCCCcEEE
Confidence            9999999999999999999999863     4689999999999999999999   6678999999999999999999999


Q ss_pred             eccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHHH
Q 011360          354 SDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVM  433 (487)
Q Consensus       354 ~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~  433 (487)
                      +|||++.........  .....||+.|+|||++.+..++.++||||||+++|+|++|..||....      ..+......
T Consensus       183 ~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~------~~~~~~~~~  254 (321)
T 2c30_A          183 SDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS------PVQAMKRLR  254 (321)
T ss_dssp             CCCTTCEECCSSSCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHHHH
T ss_pred             eeeeeeeecccCccc--cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHh
Confidence            999999876543222  134579999999999999999999999999999999999999994322      222333333


Q ss_pred             hcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          434 NSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       434 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ....+....        ....+..+.+++.+||+.||++|||+.++++
T Consensus       255 ~~~~~~~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          255 DSPPPKLKN--------SHKVSPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             HSSCCCCTT--------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cCCCCCcCc--------cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            322221111        1122356889999999999999999999986

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=3.5e-43  Score=351.32  Aligned_cols=253  Identities=22%  Similarity=0.338  Sum_probs=203.7

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||.|+||.||++.. ..+++.||+|++..            ...........+.+|+.++..++||||++++
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~-~~~~~~~AiK~~~~------------~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~   81 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQK-NDTKKMYAMKYMNK------------QKCVERNEVRNVFKELQIMQGLEHPFLVNLW   81 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEE-TTTCCEEEEEEEEH------------HHHHHTTCHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEE-CCCCCEEEEEEEeh------------hhcccHHHHHHHHHHHHHHHhCCCCCCCcEE
Confidence            4699999999999999999975 46789999998842            1112223456788999999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++.+.+.+|+||||+.||+|.+++..    ...+++..+..++.|++.||.||   |++||+||||||+|||++.+|.+
T Consensus        82 ~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~L---H~~givHrDlkp~NIll~~~g~v  154 (384)
T 4fr4_A           82 YSFQDEEDMFMVVDLLLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYL---QNQRIIHRDMKPDNILLDEHGHV  154 (384)
T ss_dssp             EEEECSSEEEEEECCCTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCE
T ss_pred             EEEEeCCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCceeccCcHHHeEECCCCCE
Confidence            999999999999999999999999974    46799999999999999999999   67789999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCC---CCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQ---PELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEW  428 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~  428 (487)
                      ||+|||++........   ....+||+.|+|||++.+   ..|+.++|||||||++|+|++|..||.......   ..+.
T Consensus       155 kL~DFG~a~~~~~~~~---~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~---~~~~  228 (384)
T 4fr4_A          155 HITDFNIAAMLPRETQ---ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS---SKEI  228 (384)
T ss_dssp             EECCCTTCEECCTTCC---BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC---HHHH
T ss_pred             EEeccceeeeccCCCc---eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc---HHHH
Confidence            9999999987654332   245679999999999874   468999999999999999999999996443321   1222


Q ss_pred             HHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCC-hHHHHH
Q 011360          429 LRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPN-SQYVRC  481 (487)
Q Consensus       429 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-~~~il~  481 (487)
                      ...... ...  ..+..        .+..+.+++.+||+.||++||+ +++|++
T Consensus       229 ~~~~~~-~~~--~~p~~--------~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          229 VHTFET-TVV--TYPSA--------WSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             HHHHHH-CCC--CCCTT--------SCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             HHHHhh-ccc--CCCCc--------CCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence            222222 111  11111        2356889999999999999998 666653

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=6.5e-43  Score=339.93  Aligned_cols=271  Identities=31%  Similarity=0.512  Sum_probs=213.1

Q ss_pred             cccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceE
Q 011360          194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAH  273 (487)
Q Consensus       194 ~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  273 (487)
                      |...+.||+|+||.||+|.+   ++..||+|++.....           .........+.+|+.++++++||||++++++
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~~-----------~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~   98 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYV---NNTTVAVKKLAAMVD-----------ITTEELKQQFDQEIKVMAKCQHENLVELLGF   98 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEES---SSCEEEEEEECCCTT-----------SCTTTHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccCCccccCCCeEEEEEEE---CCceEEEEEEecccC-----------cchHHHHHHHHHHHHHHHhcCCCCeEEEEEE
Confidence            44558999999999999975   678999998843211           1122345678899999999999999999999


Q ss_pred             EecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEE
Q 011360          274 MVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACI  353 (487)
Q Consensus       274 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl  353 (487)
                      +.+.+..++||||+++|+|.+++.... ....+++..++.++.|++.||.||   |++||+||||||+||+++.++.+||
T Consensus        99 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~l---H~~~i~H~dlkp~Nili~~~~~~kl  174 (307)
T 2nru_A           99 SSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFL---HENHHIHRDIKSANILLDEAFTAKI  174 (307)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEECTTCCEEE
T ss_pred             EecCCceEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEcCCCcEEE
Confidence            999999999999999999999997532 245689999999999999999999   6778999999999999999999999


Q ss_pred             eccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHHH
Q 011360          354 SDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVM  433 (487)
Q Consensus       354 ~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~  433 (487)
                      +|||++................||+.|+|||.+.+ .++.++||||||+++|+|++|..||.........  ..+.....
T Consensus       175 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~--~~~~~~~~  251 (307)
T 2nru_A          175 SDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL--LDIKEEIE  251 (307)
T ss_dssp             CCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBT--THHHHHHH
T ss_pred             eecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHH--HHHHHHhh
Confidence            99999987655443333345679999999998876 5889999999999999999999999655432221  12222221


Q ss_pred             hcCC-CCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          434 NSKN-PSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       434 ~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      .... ....+++.+ .......+..+.+++.+||+.||++|||+.++++.|+++
T Consensus       252 ~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l  304 (307)
T 2nru_A          252 DEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM  304 (307)
T ss_dssp             TTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             hhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            1111 111122222 234556778899999999999999999999999999876

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=3.4e-43  Score=340.79  Aligned_cols=264  Identities=28%  Similarity=0.438  Sum_probs=200.5

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHh--ccCCCCCcc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA--SQIRHRNIL  268 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l--~~l~hpnIv  268 (487)
                      .++|.+.+.||+|+||.||+|++   +++.||||++..                .  ....+..|.+++  ..++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~----------------~--~~~~~~~e~~~~~~~~l~h~niv   65 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW---QGENVAVKIFSS----------------R--DEKSWFRETELYNTVMLRHENIL   65 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE---TTEEEEEEEECG----------------G--GHHHHHHHHHHHHHTCCCCTTBC
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE---CCEEEEEEEecc----------------c--cchhhHHHHHHHHHhhccCcCee
Confidence            34699999999999999999986   688999998732                0  112233344444  448999999


Q ss_pred             ccceEEec----CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhc-----CCCCeeecCCC
Q 011360          269 PLLAHMVR----PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMY-----HSASIIHGDIK  339 (487)
Q Consensus       269 ~l~~~~~~----~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~-----h~~givH~Dlk  339 (487)
                      ++++++..    ....++||||+++|+|.+++.     ...+++..++.++.|++.||.|||..     +++||+|||||
T Consensus        66 ~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlk  140 (301)
T 3q4u_A           66 GFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLK  140 (301)
T ss_dssp             CEEEEEEEEETTEEEEEEEECCCTTCBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCC
T ss_pred             eEEEeeccccCCCceeEEehhhccCCCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCC
Confidence            99998654    355799999999999999995     35689999999999999999999521     18899999999


Q ss_pred             CCCEEeCCCCCEEEeccCCccccCCCCceee--EeeecccccccCCcccCCC------CCCchhHHHHHHHHHHHHHhC-
Q 011360          340 PRNVLLNDDMEACISDLGLAMAIPDGYTRVL--ISYVLGTMAYIAPEYFQQP------ELSEKCDIFSFGMLLISLVRG-  410 (487)
Q Consensus       340 p~Nill~~~~~~kl~DFg~s~~~~~~~~~~~--~~~~~gt~~y~aPE~l~~~------~~~~~~DvwslG~~l~elltg-  410 (487)
                      |+|||++.++.+||+|||++...........  .....||+.|+|||++.+.      .++.++||||||+++|||+|| 
T Consensus       141 p~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~  220 (301)
T 3q4u_A          141 SKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRM  220 (301)
T ss_dssp             GGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTB
T ss_pred             hHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhh
Confidence            9999999999999999999976544332211  1234699999999999876      455799999999999999999 


Q ss_pred             ---------CCCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCC-CcHHHHHHHHHHHhhccCCCCCCCCChHHHH
Q 011360          411 ---------VPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGN-GYEKKMLHVLKIAYICTLHDPEERPNSQYVR  480 (487)
Q Consensus       411 ---------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~P~~RPs~~~il  480 (487)
                               ..||........  ..............    .+.++.. .....+..+.+++.+||+.||++|||+.+|+
T Consensus       221 ~~~~~~~~~~~pf~~~~~~~~--~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~  294 (301)
T 3q4u_A          221 VSNGIVEDYKPPFYDVVPNDP--SFEDMRKVVCVDQQ----RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIK  294 (301)
T ss_dssp             CBTTBCCCCCCTTTTTSCSSC--CHHHHHHHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred             cCccccccccccccccCCCCc--chhhhhHHHhccCC----CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHH
Confidence                     778754433222  12223333322221    1122221 2335677899999999999999999999999


Q ss_pred             HHHhhh
Q 011360          481 CRLSQL  486 (487)
Q Consensus       481 ~~L~~l  486 (487)
                      +.|+++
T Consensus       295 ~~L~~i  300 (301)
T 3q4u_A          295 KTLTKI  300 (301)
T ss_dssp             HHHHHH
T ss_pred             HHHhcc
Confidence            999875

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=2e-43  Score=352.99  Aligned_cols=260  Identities=22%  Similarity=0.344  Sum_probs=196.6

Q ss_pred             ccccccccccccccceeEEEEEec--CCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELP--GSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNIL  268 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv  268 (487)
                      .++|.+.+.||+|+||.||+|++.  ..++..||||++...              ......+.+.+|+.++.+++||||+
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~--------------~~~~~~~~~~~E~~~l~~l~h~niv  109 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--------------YTEKQRRDFLGEASIMGQFDHPNII  109 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTT--------------CCHHHHHHHHHHHHHHTTCCCTTBC
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCc--------------cCHHHHHHHHHHHHHHHhCCCCCCC
Confidence            346999999999999999999764  235778999988431              1233456789999999999999999


Q ss_pred             ccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC
Q 011360          269 PLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDD  348 (487)
Q Consensus       269 ~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~  348 (487)
                      ++++++...+..++||||+++|+|.+++..   .+..+++..+..++.|++.||.||   |++||+||||||+|||++.+
T Consensus       110 ~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~  183 (373)
T 2qol_A          110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSN  183 (373)
T ss_dssp             CEEEEECSSSSCEEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTT
T ss_pred             eEEEEEeeCCceEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeCCCCCcceEEEcCC
Confidence            999999999999999999999999999974   345789999999999999999999   67789999999999999999


Q ss_pred             CCEEEeccCCccccCCCCcee-eEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccccH
Q 011360          349 MEACISDLGLAMAIPDGYTRV-LISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSP  426 (487)
Q Consensus       349 ~~~kl~DFg~s~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~  426 (487)
                      +.+||+|||+++......... ......+|+.|+|||++.+..++.++||||||+++|||++ |..||....      ..
T Consensus       184 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~------~~  257 (373)
T 2qol_A          184 LVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS------NQ  257 (373)
T ss_dssp             CCEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC------HH
T ss_pred             CCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC------HH
Confidence            999999999998765432211 1122345788999999998899999999999999999998 999994322      22


Q ss_pred             HHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          427 EWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       427 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      +....+.......      .+.    ..+..+.+++.+||+.||++|||+.+|++.|+.+
T Consensus       258 ~~~~~i~~~~~~~------~~~----~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~  307 (373)
T 2qol_A          258 DVIKAVDEGYRLP------PPM----DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL  307 (373)
T ss_dssp             HHHHHHHTTEECC------CCT----TCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHHcCCCCC------CCc----cccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence            2333232221111      111    1235688999999999999999999999999876

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=7.7e-44  Score=349.16  Aligned_cols=254  Identities=24%  Similarity=0.361  Sum_probs=201.6

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||+|+||.||+|.. ..+++.||+|++....              .......+.+|+.+++.++||||++++
T Consensus         7 ~~y~i~~~lG~G~~g~V~~~~~-~~~~~~vavK~~~~~~--------------~~~~~~~~~~E~~~l~~l~hpnIv~~~   71 (323)
T 3tki_A            7 EDWDLVQTLGEGAYGEVQLAVN-RVTEEAVAVKIVDMKR--------------AVDCPENIKKEICINKMLNHENVVKFY   71 (323)
T ss_dssp             TCEEEEEEEEEETTEEEEEEEE-TTTCCEEEEEEEECC---------------------CHHHHHHHHHHCCCTTBCCEE
T ss_pred             hhceeeeEEecCCCEEEEEEEE-CCCCcEEEEEEEEccc--------------ccchHHHHHHHHHHHHhCCCCCCCeEE
Confidence            4699999999999999999975 4688999999984311              112235678899999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++.+.+..|+|||||++|+|.+++..    ...+++..+..++.|++.||.||   |++||+||||||+|||++.++.+
T Consensus        72 ~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~L---H~~givH~Dlkp~NIll~~~~~~  144 (323)
T 3tki_A           72 GHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYL---HGIGITHRDIKPENLLLDERDNL  144 (323)
T ss_dssp             EEEECSSEEEEEEECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTCCE
T ss_pred             EEEecCCeEEEEEEcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCccccccchHHEEEeCCCCE
Confidence            999999999999999999999998853    45699999999999999999999   67889999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCCCC-CchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPEL-SEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLR  430 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~  430 (487)
                      ||+|||++................||+.|+|||++.+..+ +.++|||||||++|+|++|..||........     ...
T Consensus       145 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-----~~~  219 (323)
T 3tki_A          145 KISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-----EYS  219 (323)
T ss_dssp             EECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-----HHH
T ss_pred             EEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-----HHH
Confidence            9999999986543333333345679999999999987665 7899999999999999999999955433211     111


Q ss_pred             HHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          431 KVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       431 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .........         .........+.+++.+||+.||++|||+.++++
T Consensus       220 ~~~~~~~~~---------~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~  261 (323)
T 3tki_A          220 DWKEKKTYL---------NPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (323)
T ss_dssp             HHHTTCTTS---------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHhcccccC---------CccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            121111110         011223356889999999999999999999875

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1e-42  Score=344.63  Aligned_cols=248  Identities=19%  Similarity=0.290  Sum_probs=204.1

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||.|+||.||+|+. ..+|+.||+|++..            ...........+.+|+.++..++||||++++
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~-~~~~~~~aiK~~~~------------~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~  107 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKH-KESGNHYAMKILDK------------QKVVKLKQIEHTLNEKRILQAVNFPFLVKLE  107 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEE-TTTCCEEEEEEEEH------------HHHHHTTCHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEE-CCCCCEEEEEEEEh------------HHhccHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence            4699999999999999999975 45789999999842            1111223356788899999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++.+.+.+|+||||++||+|.+++..    ...+++..++.++.|++.||.||   |++||+||||||+|||++.+|.+
T Consensus       108 ~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDlkp~NIll~~~g~~  180 (350)
T 1rdq_E          108 FSFKDNSNLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYL---HSLDLIYRDLKPENLLIDQQGYI  180 (350)
T ss_dssp             EEEECSSEEEEEEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCE
T ss_pred             EEEEcCCEEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCcccccCccceEEECCCCCE
Confidence            999999999999999999999999975    34689999999999999999999   67789999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRK  431 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~  431 (487)
                      ||+|||+++......     ...+||+.|+|||++.+..++.++|||||||++|+|++|.+||....      ..+....
T Consensus       181 kL~DFg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~------~~~~~~~  249 (350)
T 1rdq_E          181 QVTDFGFAKRVKGRT-----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ------PIQIYEK  249 (350)
T ss_dssp             EECCCTTCEECSSCB-----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHH
T ss_pred             EEcccccceeccCCc-----ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC------HHHHHHH
Confidence            999999998764432     34569999999999999999999999999999999999999994322      2233333


Q ss_pred             HHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCC-----hHHHHH
Q 011360          432 VMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPN-----SQYVRC  481 (487)
Q Consensus       432 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~~il~  481 (487)
                      +.... .  .    ++..    .+..+.+++.+||+.||++||+     +++|++
T Consensus       250 i~~~~-~--~----~p~~----~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          250 IVSGK-V--R----FPSH----FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             HHHCC-C--C----CCTT----CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             HHcCC-C--C----CCCC----CCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence            33322 1  1    1211    2356889999999999999998     788764

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-42  Score=339.62  Aligned_cols=271  Identities=19%  Similarity=0.245  Sum_probs=211.8

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .++|.+.+.||+|+||.||+|.. ..+++.||||++...              ........+.+|+.+++.++||||+++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~--------------~~~~~~~~~~~E~~~l~~l~h~~iv~~   72 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRH-KKTGDLFAIKVFNNI--------------SFLRPVDVQMREFEVLKKLNHKNIVKL   72 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEE-TTTCCEEEEEEECGG--------------GGGSCHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEE-CCCCcEEEEEEeccc--------------cccchHHHHHHHHHHHHhcCCCCcceE
Confidence            35799999999999999999975 457899999998421              111224566789999999999999999


Q ss_pred             ceEEecCC--eeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEe---
Q 011360          271 LAHMVRPD--CHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLL---  345 (487)
Q Consensus       271 ~~~~~~~~--~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill---  345 (487)
                      ++++....  ..++||||+++++|.+++..... ...+++..++.++.|++.||.||   |++||+||||||+||++   
T Consensus        73 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~L---H~~~ivH~Dlkp~NIll~~~  148 (319)
T 4euu_A           73 FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHL---RENGIVHRNIKPGNIMRVIG  148 (319)
T ss_dssp             EEEEECTTTCCEEEEEECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEEEC
T ss_pred             EEEeecCCCceEEEEEeCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHH---HHCCEecCCCCHHHEEEecc
Confidence            99988655  77999999999999999975322 33489999999999999999999   67789999999999999   


Q ss_pred             -CCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccC--------CCCCCchhHHHHHHHHHHHHHhCCCCccc
Q 011360          346 -NDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQ--------QPELSEKCDIFSFGMLLISLVRGVPSFVF  416 (487)
Q Consensus       346 -~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~--------~~~~~~~~DvwslG~~l~elltg~~pf~~  416 (487)
                       +.++.+||+|||+++........   ....||+.|+|||++.        +..++.++|||||||++|||+||..||..
T Consensus       149 ~~~~~~~kL~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  225 (319)
T 4euu_A          149 EDGQSVYKLTDFGAARELEDDEQF---VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP  225 (319)
T ss_dssp             TTSCEEEEECCCTTCEECCTTCCB---CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEEC
T ss_pred             CCCCceEEEccCCCceecCCCCce---eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence             77888999999999876554322   3456999999999885        56889999999999999999999999965


Q ss_pred             cCCCCccccHHHHHHHHhcCCCCCc------------cCCCC--CCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHH
Q 011360          417 HQNGEEICSPEWLRKVMNSKNPSRA------------IDPRL--PGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCR  482 (487)
Q Consensus       417 ~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~--~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~  482 (487)
                      .....  ...+.+........+...            ..+.+  +..........+.+++.+||+.||++|||+.++++.
T Consensus       226 ~~~~~--~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h  303 (319)
T 4euu_A          226 FEGPR--RNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE  303 (319)
T ss_dssp             TTCGG--GCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred             CCccc--hhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhc
Confidence            43322  223344444433221100            00111  123446777889999999999999999999999987


Q ss_pred             Hhh
Q 011360          483 LSQ  485 (487)
Q Consensus       483 L~~  485 (487)
                      ..+
T Consensus       304 ~~d  306 (319)
T 4euu_A          304 TSD  306 (319)
T ss_dssp             HHH
T ss_pred             cHH
Confidence            654

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=3.8e-43  Score=335.22  Aligned_cols=254  Identities=26%  Similarity=0.356  Sum_probs=193.7

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||+|+||.||+|.+   ++..||+|++....           ........+.+.+|+.+++.++||||++++
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~-----------~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~   72 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFW---IGDEVAVKAARHDP-----------DEDISQTIENVRQEAKLFAMLKHPNIIALR   72 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEE---TTEEEEEEEC---------------------CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             hheeeeeeeccCCCeEEEEEEE---cCCeEEEEEEecCC-----------cccHHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence            4699999999999999999986   58899999874311           111122346788999999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCC---eeecCCCCCCEEeCC-
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSAS---IIHGDIKPRNVLLND-  347 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~g---ivH~Dlkp~Nill~~-  347 (487)
                      +++...+..++||||+++++|.+++.     ...+++..++.++.|++.||.||   |++|   |+||||||+||+++. 
T Consensus        73 ~~~~~~~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~l---H~~~~~~i~H~dikp~Nil~~~~  144 (271)
T 3dtc_A           73 GVCLKEPNLCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYL---HDEAIVPIIHRDLKSSNILILQK  144 (271)
T ss_dssp             EEECCC--CEEEEECCTTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHH---HHSSSSCCCCSCCSGGGEEESSC
T ss_pred             EEEecCCceEEEEEcCCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHH---HhCCCCceeecCCchHHEEEecc
Confidence            99999999999999999999999885     35789999999999999999999   5556   999999999999986 


Q ss_pred             -------CCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCC
Q 011360          348 -------DMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNG  420 (487)
Q Consensus       348 -------~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~  420 (487)
                             ++.+||+|||++........    ....||+.|+|||.+.+..++.++||||||+++|+|++|..||....  
T Consensus       145 ~~~~~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--  218 (271)
T 3dtc_A          145 VENGDLSNKILKITDFGLAREWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID--  218 (271)
T ss_dssp             CSSSCCSSCCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC--
T ss_pred             cccccccCcceEEccCCcccccccccc----cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--
Confidence                   77899999999976544322    23468999999999998899999999999999999999999994322  


Q ss_pred             CccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          421 EEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       421 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                          .......... .......+..+        +..+.+++.+||+.||++|||+.++++.|+++
T Consensus       219 ----~~~~~~~~~~-~~~~~~~~~~~--------~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          219 ----GLAVAYGVAM-NKLALPIPSTC--------PEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             ----HHHHHHHHHT-SCCCCCCCTTC--------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             ----HHHHHHhhhc-CCCCCCCCccc--------CHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence                1122222222 22221222222        25688999999999999999999999999875

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=2.1e-43  Score=339.14  Aligned_cols=260  Identities=23%  Similarity=0.332  Sum_probs=196.0

Q ss_pred             hccccccccccccccceeEEEEEecC--CCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCc
Q 011360          190 KEDCFASLEKIGSGGCGEVYKAELPG--SNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNI  267 (487)
Q Consensus       190 ~~~~~~~~~~lg~G~~g~v~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI  267 (487)
                      ..++|.+.+.||+|+||.||+|.+..  ..+..||+|.+..              .......+.+.+|+.++++++||||
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~--------------~~~~~~~~~~~~e~~~l~~l~h~~i   78 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN--------------CTSDSVREKFLQEALTMRQFDHPHI   78 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTT--------------TTSHHHHHHHHHHHHHHHTCCCTTB
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccc--------------cCCHHHHHHHHHHHHHHHhCCCCcc
Confidence            34579999999999999999998643  2356799998732              1223345678899999999999999


Q ss_pred             cccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC
Q 011360          268 LPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLND  347 (487)
Q Consensus       268 v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~  347 (487)
                      +++++++. .+..|+||||+++++|.+++..   ....+++..+..++.|++.||.||   |++||+||||||+||+++.
T Consensus        79 v~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nil~~~  151 (281)
T 1mp8_A           79 VKLIGVIT-ENPVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYL---ESKRFVHRDIAARNVLVSS  151 (281)
T ss_dssp             CCEEEEEC-SSSCEEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEEEE
T ss_pred             ceEEEEEc-cCccEEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHH---HhCCeecccccHHHEEECC
Confidence            99999874 5678999999999999999974   245689999999999999999999   6678999999999999999


Q ss_pred             CCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccccH
Q 011360          348 DMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSP  426 (487)
Q Consensus       348 ~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~  426 (487)
                      ++.+||+|||++......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||......      
T Consensus       152 ~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~------  224 (281)
T 1mp8_A          152 NDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN------  224 (281)
T ss_dssp             TTEEEECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG------
T ss_pred             CCCEEECccccccccCccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH------
Confidence            999999999999876443221 1123456789999999998899999999999999999997 89999543321      


Q ss_pred             HHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhhC
Q 011360          427 EWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL  487 (487)
Q Consensus       427 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~ll  487 (487)
                      +....+.....+  .+++.+        +..+.+++.+||+.||++|||+.++++.|++++
T Consensus       225 ~~~~~i~~~~~~--~~~~~~--------~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  275 (281)
T 1mp8_A          225 DVIGRIENGERL--PMPPNC--------PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  275 (281)
T ss_dssp             GHHHHHHTTCCC--CCCTTC--------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHcCCCC--CCCCCC--------CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            222223222211  112222        256889999999999999999999999998763

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=3e-43  Score=347.42  Aligned_cols=251  Identities=24%  Similarity=0.343  Sum_probs=201.8

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CCCCccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RHRNILP  269 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~  269 (487)
                      .++|.+.+.||+|+||.||+|+. ..+|+.||+|++...            ..........+..|..++..+ +||||++
T Consensus        16 ~~~y~~~~~lG~G~fg~V~~~~~-~~~~~~vaiK~~~~~------------~~~~~~~~~~~~~E~~il~~~~~hp~iv~   82 (345)
T 1xjd_A           16 IEDFILHKMLGKGSFGKVFLAEF-KKTNQFFAIKALKKD------------VVLMDDDVECTMVEKRVLSLAWEHPFLTH   82 (345)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEE-TTTTEEEEEEEEEHH------------HHHHTTCHHHHHHHHHHHHHHTTCTTBCC
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEE-CCCCCEEEEEEEEhH------------HhhhhhhHHHHHHHHHHHHhcCCCCCCCc
Confidence            35699999999999999999975 458899999998421            111122345567788888776 9999999


Q ss_pred             cceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC
Q 011360          270 LLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDM  349 (487)
Q Consensus       270 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~  349 (487)
                      +++++.+.+.+|+||||++||+|.+++..    ...+++..+..++.|++.||.||   |++||+||||||+|||++.+|
T Consensus        83 l~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDlkp~NIll~~~g  155 (345)
T 1xjd_A           83 MFCTFQTKENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFL---HSKGIVYRDLKLDNILLDKDG  155 (345)
T ss_dssp             EEEEEECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTS
T ss_pred             EEEEEEeCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeEeCCCChhhEEECCCC
Confidence            99999999999999999999999999975    35689999999999999999999   677899999999999999999


Q ss_pred             CEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHH
Q 011360          350 EACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWL  429 (487)
Q Consensus       350 ~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~  429 (487)
                      .+||+|||+++........  ....+||+.|+|||++.+..++.++|||||||++|||++|..||...+      ..+..
T Consensus       156 ~vkL~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~------~~~~~  227 (345)
T 1xjd_A          156 HIKIADFGMCKENMLGDAK--TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD------EEELF  227 (345)
T ss_dssp             CEEECCCTTCBCCCCTTCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHH
T ss_pred             CEEEeEChhhhhcccCCCc--ccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC------HHHHH
Confidence            9999999999864332221  245679999999999999999999999999999999999999994332      22333


Q ss_pred             HHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChH-HHH
Q 011360          430 RKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQ-YVR  480 (487)
Q Consensus       430 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~-~il  480 (487)
                      ..+... .+      .++..    .+.++.+++.+||..||++||++. +|+
T Consensus       228 ~~i~~~-~~------~~p~~----~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          228 HSIRMD-NP------FYPRW----LEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             HHHHHC-CC------CCCTT----SCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             HHHHhC-CC------CCCcc----cCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence            333322 21      11211    235688999999999999999997 554

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=9.4e-43  Score=332.17  Aligned_cols=252  Identities=27%  Similarity=0.377  Sum_probs=203.4

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||.|+||.||+|++   ++..||+|++...             .......+.+.+|+.++++++||||++++
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~---~~~~~avK~~~~~-------------~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   73 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRW---QGNDIVVKVLKVR-------------DWSTRKSRDFNEECPRLRIFSHPNVLPVL   73 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEE---TTEEEEEEEECCT-------------TCCHHHHHHHHHHGGGGCCCSCTTEECEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEE---CCeeEEEEEeccc-------------ccCHHHHHHHHHHHHHHHhcCCCchhheE
Confidence            4699999999999999999986   5889999998531             12233456788999999999999999999


Q ss_pred             eEEecC--CeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCC--eeecCCCCCCEEeCC
Q 011360          272 AHMVRP--DCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSAS--IIHGDIKPRNVLLND  347 (487)
Q Consensus       272 ~~~~~~--~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~g--ivH~Dlkp~Nill~~  347 (487)
                      +++.+.  +..++||||+++|+|.+++..  .....+++..++.++.|++.||.||   |++|  ++||||||+||+++.
T Consensus        74 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~~~i~H~dikp~Nil~~~  148 (271)
T 3kmu_A           74 GACQSPPAPHPTLITHWMPYGSLYNVLHE--GTNFVVDQSQAVKFALDMARGMAFL---HTLEPLIPRHALNSRSVMIDE  148 (271)
T ss_dssp             EEECTTTSSSCEEEEECCTTCBHHHHHHS--CSSCCCCHHHHHHHHHHHHHHHHHH---TTSSSCCTTCCCSGGGEEECT
T ss_pred             EEEccCCCCCeEeeecccCCCcHHHHHhh--cccCCCCHHHHHHHHHHHHHHHHHH---hcCCCceecCCCccceEEEcC
Confidence            999887  788999999999999999975  2334689999999999999999999   7888  999999999999999


Q ss_pred             CCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCC---chhHHHHHHHHHHHHHhCCCCccccCCCCccc
Q 011360          348 DMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELS---EKCDIFSFGMLLISLVRGVPSFVFHQNGEEIC  424 (487)
Q Consensus       348 ~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~---~~~DvwslG~~l~elltg~~pf~~~~~~~~~~  424 (487)
                      ++.++|+|||++......       ...||+.|+|||++.+..++   .++||||||+++|+|++|..||...      .
T Consensus       149 ~~~~~l~~~~~~~~~~~~-------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~------~  215 (271)
T 3kmu_A          149 DMTARISMADVKFSFQSP-------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL------S  215 (271)
T ss_dssp             TSCEEEEGGGSCCTTSCT-------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTS------C
T ss_pred             CcceeEEeccceeeeccc-------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCcccc------C
Confidence            999999998887553322       23589999999999875444   4899999999999999999999432      2


Q ss_pred             cHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          425 SPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       425 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      .............. ..++..+        +..+.+++.+||+.||++|||+.++++.|+.+
T Consensus       216 ~~~~~~~~~~~~~~-~~~~~~~--------~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l  268 (271)
T 3kmu_A          216 NMEIGMKVALEGLR-PTIPPGI--------SPHVSKLMKICMNEDPAKRPKFDMIVPILEKM  268 (271)
T ss_dssp             HHHHHHHHHHSCCC-CCCCTTC--------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             hHHHHHHHHhcCCC-CCCCCCC--------CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence            22233333322221 1122222        25688999999999999999999999999876

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=4e-43  Score=345.29  Aligned_cols=249  Identities=22%  Similarity=0.315  Sum_probs=200.0

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||+|+||.||+|.+ ..+++.||+|++...            ..........+.+|+.+++.++||||++++
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~-~~~~~~vaiK~~~~~------------~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~   75 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATH-YKTQQKVALKFISRQ------------LLKKSDMHMRVEREISYLKLLRHPHIIKLY   75 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEE-TTTCCEEEEEEEEHH------------HHHHTTCSHHHHHHHHHHTTCCCTTBCCEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEE-CCCCCEEEEEEEehH------------HccchhHHHHHHHHHHHHHhCCCCCCCeEE
Confidence            4699999999999999999975 468899999988320            011112235678999999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++..++..++||||+ +|+|.+++..    ...+++..+..++.|++.||.||   |+.||+||||||+|||++.++.+
T Consensus        76 ~~~~~~~~~~lv~E~~-~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~L---H~~givH~Dlkp~NIll~~~~~~  147 (336)
T 3h4j_B           76 DVITTPTDIVMVIEYA-GGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYC---HRHKIVHRDLKPENLLLDDNLNV  147 (336)
T ss_dssp             EEEECSSEEEEEECCC-CEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHH---HHHTCCCCCCSTTTEEECTTCCE
T ss_pred             EEEEeCCEEEEEEECC-CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCchhhEEEcCCCCE
Confidence            9999999999999999 7899998865    35689999999999999999999   66789999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCCCC-CchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPEL-SEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLR  430 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~  430 (487)
                      ||+|||++.........   ...+||+.|+|||++.+..+ +.++||||||+++|+|++|..||...........     
T Consensus       148 kl~DFG~s~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~-----  219 (336)
T 3h4j_B          148 KIADFGLSNIMTDGNFL---KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK-----  219 (336)
T ss_dssp             EECCSSCTBTTTTSBTT---CCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCC-----
T ss_pred             EEEEeccceeccCCccc---ccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHH-----
Confidence            99999999876544322   34579999999999988776 7899999999999999999999954432111100     


Q ss_pred             HHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          431 KVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       431 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                          .....    ..++.    ..+..+.+++.+||+.||.+|||+.++++
T Consensus       220 ----i~~~~----~~~p~----~~s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          220 ----VNSCV----YVMPD----FLSPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             ----CCSSC----CCCCT----TSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             ----HHcCC----CCCcc----cCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence                00000    11111    12356889999999999999999999874

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=6.4e-43  Score=350.36  Aligned_cols=252  Identities=21%  Similarity=0.288  Sum_probs=203.8

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      +.|.+.+.||.|+||.||+|.. ..+++.||+|++...               .......+.+|+.++..++||||++++
T Consensus        51 ~~y~i~~~LG~G~~g~Vy~~~~-~~~~~~~a~K~~~~~---------------~~~~~~~~~~E~~il~~l~hpnIv~~~  114 (387)
T 1kob_A           51 DYYDILEELGSGAFGVVHRCVE-KATGRVFVAKFINTP---------------YPLDKYTVKNEISIMNQLHHPKLINLH  114 (387)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEE-TTTCCEEEEEEEECC---------------SHHHHHHHHHHHHHHTTCCSTTBCCEE
T ss_pred             cceEEEEEEecCCCEEEEEEEE-CCCCCEEEEEEeccc---------------chhhHHHHHHHHHHHHhCCCcCCCeEE
Confidence            4699999999999999999975 467899999988431               112334678899999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC--CC
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLND--DM  349 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~--~~  349 (487)
                      +++.+....++||||+++|+|.+++..   ....+++..+..++.|++.||.||   |++||+||||||+|||++.  ++
T Consensus       115 ~~~~~~~~~~lv~E~~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~L---H~~givHrDlkp~NIll~~~~~~  188 (387)
T 1kob_A          115 DAFEDKYEMVLILEFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHM---HEHSIVHLDIKPENIMCETKKAS  188 (387)
T ss_dssp             EEEECSSEEEEEEECCCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEESSTTCC
T ss_pred             EEEEeCCEEEEEEEcCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHH---HhCCeeecccchHHeEEecCCCC
Confidence            999999999999999999999998863   245689999999999999999999   6778999999999999974  57


Q ss_pred             CEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHH
Q 011360          350 EACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWL  429 (487)
Q Consensus       350 ~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~  429 (487)
                      .+||+|||++.........   ....||+.|+|||++.+..++.++|||||||++|+|++|..||....      ..+..
T Consensus       189 ~vkL~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~------~~~~~  259 (387)
T 1kob_A          189 SVKIIDFGLATKLNPDEIV---KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED------DLETL  259 (387)
T ss_dssp             CEEECCCTTCEECCTTSCE---EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS------HHHHH
T ss_pred             ceEEEecccceecCCCcce---eeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC------HHHHH
Confidence            7999999999876554322   34569999999999999999999999999999999999999995432      12233


Q ss_pred             HHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          430 RKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       430 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ..+......   .+    .......+.++.+++.+||+.||++|||+.++++
T Consensus       260 ~~i~~~~~~---~~----~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          260 QNVKRCDWE---FD----EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             HHHHHCCCC---CC----SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HHHHhCCCC---CC----ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence            333322111   11    1111223356889999999999999999999985

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=7e-43  Score=336.89  Aligned_cols=262  Identities=23%  Similarity=0.365  Sum_probs=195.3

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .++|.+.+.||+|+||.||+|++.    ..||+|++...             .........+.+|+.++++++||||+++
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~----~~vavK~~~~~-------------~~~~~~~~~~~~E~~~l~~l~h~~iv~~   85 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWH----GDVAVKMLNVT-------------APTPQQLQAFKNEVGVLRKTRHVNILLF   85 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESS----SEEEEEEESCS-------------SCCHHHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEc----CceEEEEEecc-------------CCCHHHHHHHHHHHHHHHhCCCCcEEEE
Confidence            457999999999999999999742    35999988542             1223445678899999999999999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      +++. .....++||||+++++|.+++..   ....+++..++.++.|++.||.||   |+.||+||||||+||+++.++.
T Consensus        86 ~~~~-~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~l---H~~~i~H~Dlkp~Nil~~~~~~  158 (289)
T 3og7_A           86 MGYS-TAPQLAIVTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYL---HAKSIIHRDLKSNNIFLHEDNT  158 (289)
T ss_dssp             EEEE-CSSSCEEEEECCCEEEHHHHHTT---C---CCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEEETTTE
T ss_pred             Eeec-cCCccEEEEEecCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHH---HhCCcccccCccceEEECCCCC
Confidence            9965 55678999999999999999863   346789999999999999999999   6778999999999999999999


Q ss_pred             EEEeccCCccccCCCCceeeEeeecccccccCCcccC---CCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHH
Q 011360          351 ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQ---QPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPE  427 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~  427 (487)
                      +||+|||++................||+.|+|||++.   +..++.++||||||+++|+|++|..||.....      ..
T Consensus       159 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~  232 (289)
T 3og7_A          159 VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN------RD  232 (289)
T ss_dssp             EEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC------HH
T ss_pred             EEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch------HH
Confidence            9999999997654433333334567999999999986   56789999999999999999999999944322      22


Q ss_pred             HHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhhC
Q 011360          428 WLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL  487 (487)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~ll  487 (487)
                      ..............+.. +    ....+..+.+++.+||+.||++|||+.++++.|+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~-~----~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          233 QIIEMVGRGSLSPDLSK-V----RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             HHHHHHHHTSCCCCTTS-S----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             HHHHHhcccccCcchhh-c----cccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence            23333333222111111 1    1122356899999999999999999999999999874

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.9e-43  Score=345.61  Aligned_cols=257  Identities=25%  Similarity=0.328  Sum_probs=204.9

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      +.|.+.+.||.|+||.||+|.. ..++..||+|++........         ........+.+|+.++..++||||++++
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~-~~~~~~~avK~~~~~~~~~~---------~~~~~~~~~~~E~~~l~~l~hp~iv~~~   80 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCRE-KSTGLQYAAKFIKKRRTKSS---------RRGVSREDIEREVSILKEIQHPNVITLH   80 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEE-TTTCCEEEEEEEEBCCSTTC---------SSSBCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cceEeceEEeeCCCeEEEEEEE-CCCCcEEEEEEEEccccccc---------cchhhHHHHHHHHHHHHhCCCCCCCcEE
Confidence            4699999999999999999975 46789999999854321110         0011245678899999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC--
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDM--  349 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~--  349 (487)
                      +++...+..++||||+++|+|.+++..    ...+++..+..++.|++.||.||   |++||+||||||+||+++.++  
T Consensus        81 ~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~l---H~~~ivH~Dlkp~NIll~~~~~~  153 (326)
T 2y0a_A           81 EVYENKTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYL---HSLQIAHFDLKPENIMLLDRNVP  153 (326)
T ss_dssp             EEEECSSEEEEEEECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEESCSSSS
T ss_pred             EEEEeCCEEEEEEEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHH---HHCCeEcCCCCHHHEEEecCCCC
Confidence            999999999999999999999999864    46789999999999999999999   677899999999999999887  


Q ss_pred             --CEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHH
Q 011360          350 --EACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPE  427 (487)
Q Consensus       350 --~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~  427 (487)
                        .+||+|||++.........   ....||+.|+|||++.+..++.++||||||+++|+|++|..||....      ..+
T Consensus       154 ~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~------~~~  224 (326)
T 2y0a_A          154 KPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT------KQE  224 (326)
T ss_dssp             SCCEEECCCTTCEECCTTSCC---CCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS------HHH
T ss_pred             CCCEEEEECCCCeECCCCCcc---ccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC------HHH
Confidence              7999999999876543221   34569999999999999999999999999999999999999994332      222


Q ss_pred             HHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          428 WLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ...........       .+.......+..+.+++.+||+.||++|||+.++++
T Consensus       225 ~~~~~~~~~~~-------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          225 TLANVSAVNYE-------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             HHHHHHHTCCC-------CCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHhcCCC-------cCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            23322222111       111111122356889999999999999999999986

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=3e-43  Score=350.87  Aligned_cols=279  Identities=18%  Similarity=0.212  Sum_probs=205.7

Q ss_pred             ccccccccccccccceeEEEEEecCC----CCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCC
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGS----NGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRN  266 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn  266 (487)
                      .+.|.+.+.||+|+||.||+|.+...    .++.||||++.....    ....+...........+..|+..+..++|||
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~  109 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNG----PLFTELKFYQRAAKPEQIQKWIRTRKLKYLG  109 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCH----HHHHHHHHHHHHCCHHHHHHHHHHTTCSCCC
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccch----hHHHHHHHHHhhhhhHHHHHHHHHhhccCCC
Confidence            45799999999999999999986532    368899999854322    1111222222223344567888899999999


Q ss_pred             ccccceEEecC----CeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCC
Q 011360          267 ILPLLAHMVRP----DCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRN  342 (487)
Q Consensus       267 Iv~l~~~~~~~----~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~N  342 (487)
                      |+++++++...    ...|+||||+ |++|.+++..   ....+++..++.++.|++.||.||   |++||+||||||+|
T Consensus       110 iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~l---H~~~iiHrDlkp~N  182 (364)
T 3op5_A          110 VPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYI---HEHEYVHGDIKASN  182 (364)
T ss_dssp             SCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGG
T ss_pred             CCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHH---HHCCeEEecCCHHH
Confidence            99999998764    4579999999 9999999975   346799999999999999999999   66789999999999


Q ss_pred             EEeC--CCCCEEEeccCCccccCCCCcee-----eEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCcc
Q 011360          343 VLLN--DDMEACISDLGLAMAIPDGYTRV-----LISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFV  415 (487)
Q Consensus       343 ill~--~~~~~kl~DFg~s~~~~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~  415 (487)
                      ||++  .++.+||+|||+++.........     ......||+.|+|||++.+..++.++|||||||++|||+||..||.
T Consensus       183 ill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~  262 (364)
T 3op5_A          183 LLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWE  262 (364)
T ss_dssp             EEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred             EEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence            9999  88999999999997654322111     1123459999999999999999999999999999999999999996


Q ss_pred             ccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          416 FHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       416 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      ........  ......... ......+++.++..   ..+..+.+++..||+.+|++|||+.+|++.|+++
T Consensus       263 ~~~~~~~~--~~~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~  327 (364)
T 3op5_A          263 DNLKDPKY--VRDSKIRYR-ENIASLMDKCFPAA---NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQG  327 (364)
T ss_dssp             GGTTCHHH--HHHHHHHHH-HCHHHHHHHHSCTT---CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             ccccCHHH--HHHHHHHhh-hhHHHHHHHhcccc---cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence            54332111  001111100 01111111111000   1125688999999999999999999999999876

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=6.7e-43  Score=348.46  Aligned_cols=248  Identities=24%  Similarity=0.347  Sum_probs=192.6

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHH-hccCCCCCcccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIIT-ASQIRHRNILPL  270 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~hpnIv~l  270 (487)
                      ++|.+.+.||+|+||.||+|+. ..++..||+|++....            .........+..|..+ ++.++||||+++
T Consensus        38 ~~y~~~~~lG~G~fg~V~~~~~-~~~~~~~AiK~~~~~~------------~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l  104 (373)
T 2r5t_A           38 SDFHFLKVIGKGSFGKVLLARH-KAEEVFYAVKVLQKKA------------ILKKKEEKHIMSERNVLLKNVKHPFLVGL  104 (373)
T ss_dssp             GGEEEEEEEECCTTCEEEEEEE-TTTCCEEEEEEEEGGG------------BC-------------CCBCCCCCTTBCCE
T ss_pred             hheEEEEEEeeCCCeEEEEEEE-cCCCCEEEEEEEEHHH------------hhhhHHHHHHHHHHHHHHHhCCCCCCCCE
Confidence            4699999999999999999975 4678999999984311            1122234456667766 577899999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      ++++.+.+.+|+||||++||+|.+++..    ...+++..++.++.|++.||.||   |++||+||||||+|||++.+|.
T Consensus       105 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~L---H~~givHrDlkp~NIll~~~g~  177 (373)
T 2r5t_A          105 HFSFQTADKLYFVLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYL---HSLNIVYRDLKPENILLDSQGH  177 (373)
T ss_dssp             EEEEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTSC
T ss_pred             EEEEEeCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCceecCCCHHHEEECCCCC
Confidence            9999999999999999999999999975    35688999999999999999999   6778999999999999999999


Q ss_pred             EEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHH
Q 011360          351 ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLR  430 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~  430 (487)
                      +||+|||+++.......  .....+||+.|+|||++.+..|+.++|||||||++|||++|..||...      ...+...
T Consensus       178 ikL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~------~~~~~~~  249 (373)
T 2r5t_A          178 IVLTDFGLCKENIEHNS--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR------NTAEMYD  249 (373)
T ss_dssp             EEECCCCBCGGGBCCCC--CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS------BHHHHHH
T ss_pred             EEEeeCccccccccCCC--ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCC------CHHHHHH
Confidence            99999999976432221  124567999999999999999999999999999999999999999432      2233333


Q ss_pred             HHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHH
Q 011360          431 KVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQY  478 (487)
Q Consensus       431 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~  478 (487)
                      .+.... .  .+++.+        +..+.+++.+||+.||.+||++.+
T Consensus       250 ~i~~~~-~--~~~~~~--------~~~~~~li~~lL~~dp~~R~~~~~  286 (373)
T 2r5t_A          250 NILNKP-L--QLKPNI--------TNSARHLLEGLLQKDRTKRLGAKD  286 (373)
T ss_dssp             HHHHSC-C--CCCSSS--------CHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred             HHHhcc-c--CCCCCC--------CHHHHHHHHHHcccCHHhCCCCCC
Confidence            343321 1  112222        246889999999999999999854

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2.8e-43  Score=338.49  Aligned_cols=256  Identities=21%  Similarity=0.299  Sum_probs=203.2

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .++|.+.+.||.|+||.||++.+.  ++..||+|++....                .....+.+|+.++..++||||+++
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~----------------~~~~~~~~E~~~l~~l~h~~i~~~   84 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWR--GQYDVAIKMIKEGS----------------MSEDEFIEEAKVMMNLSHEKLVQL   84 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEET--TTEEEEEEEECTTS----------------BCHHHHHHHHHHHHTCCCTTBCCE
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEc--CCCeEEEEEecCCC----------------CCHHHHHHHHHHHhcCCCCCEeeE
Confidence            456999999999999999999764  67789999984211                112457889999999999999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      ++++.+.+..++||||+++++|.+++...   ...+++..++.++.|++.||.||   |++||+||||||+||+++.++.
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dikp~Nili~~~~~  158 (283)
T 3gen_A           85 YGVCTKQRPIFIITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYL---ESKQFLHRDLAARNCLVNDQGV  158 (283)
T ss_dssp             EEEECSSSSEEEEECCCTTCBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSSCSGGGEEECTTSC
T ss_pred             EEEEecCCCeEEEEeccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHH---HHCCccCCCCccceEEEcCCCC
Confidence            99999999999999999999999999642   35689999999999999999999   6778999999999999999999


Q ss_pred             EEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccccHHHH
Q 011360          351 ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSPEWL  429 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~  429 (487)
                      +||+|||++.......... .....+|+.|+|||++.+..++.++||||||+++|+|+| |..||....      ..+..
T Consensus       159 ~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~------~~~~~  231 (283)
T 3gen_A          159 VKVSDFGLSRYVLDDEYTS-SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT------NSETA  231 (283)
T ss_dssp             EEECSTTGGGGBCCHHHHS-TTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSC------HHHHH
T ss_pred             EEEcccccccccccccccc-ccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccC------hhHHH
Confidence            9999999998664432111 123346788999999998899999999999999999998 999994322      22223


Q ss_pred             HHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhhC
Q 011360          430 RKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL  487 (487)
Q Consensus       430 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~ll  487 (487)
                      .........  ..+...        +..+.+++.+||+.+|++|||+.++++.|++++
T Consensus       232 ~~~~~~~~~--~~~~~~--------~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~  279 (283)
T 3gen_A          232 EHIAQGLRL--YRPHLA--------SEKVYTIMYSCWHEKADERPTFKILLSNILDVM  279 (283)
T ss_dssp             HHHHTTCCC--CCCTTC--------CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHhcccCC--CCCCcC--------CHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence            333222111  111111        246889999999999999999999999998763

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1e-42  Score=344.79  Aligned_cols=250  Identities=21%  Similarity=0.257  Sum_probs=202.1

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CCCCcccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RHRNILPL  270 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l  270 (487)
                      ++|.+.+.||+|+||.||+|+. ..+++.||+|++...            ..........+..|..++..+ +||||+++
T Consensus        20 ~~y~~~~~lG~G~fg~V~~~~~-~~~~~~~AiK~~~~~------------~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l   86 (353)
T 2i0e_A           20 TDFNFLMVLGKGSFGKVMLSER-KGTDELYAVKILKKD------------VVIQDDDVECTMVEKRVLALPGKPPFLTQL   86 (353)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEE-TTEEEEEEEEEEEHH------------HHHHTTCHHHHHHHHHHHTCTTCCTTBCCE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEE-CCCCCEEEEEEEEHH------------HhhcchHHHHHHHHHHHHHhcCCCCEEeeE
Confidence            4699999999999999999975 457889999998421            111223345678899999888 89999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      ++++.+.+.+|+||||++||+|.+++..    ...+++..++.++.|++.||.||   |++||+||||||+|||++.+|.
T Consensus        87 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~L---H~~givHrDlkp~NIll~~~g~  159 (353)
T 2i0e_A           87 HSCFQTMDRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFL---QSKGIIYRDLKLDNVMLDSEGH  159 (353)
T ss_dssp             EEEEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTSC
T ss_pred             EEEEEcCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCEEeccCCHHHEEEcCCCc
Confidence            9999999999999999999999999975    35689999999999999999999   6778999999999999999999


Q ss_pred             EEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHH
Q 011360          351 ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLR  430 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~  430 (487)
                      +||+|||++........  .....+||+.|+|||++.+..++.++|||||||++|||++|.+||...      ...+...
T Consensus       160 vkL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~------~~~~~~~  231 (353)
T 2i0e_A          160 IKIADFGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE------DEDELFQ  231 (353)
T ss_dssp             EEECCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHH
T ss_pred             EEEEeCCcccccccCCc--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCC------CHHHHHH
Confidence            99999999986432222  124567999999999999999999999999999999999999999432      2223334


Q ss_pred             HHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCh-----HHHH
Q 011360          431 KVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNS-----QYVR  480 (487)
Q Consensus       431 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~-----~~il  480 (487)
                      .+.... +.  ++..        .+.++.+++.+||..||++||++     ++|+
T Consensus       232 ~i~~~~-~~--~p~~--------~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~  275 (353)
T 2i0e_A          232 SIMEHN-VA--YPKS--------MSKEAVAICKGLMTKHPGKRLGCGPEGERDIK  275 (353)
T ss_dssp             HHHHCC-CC--CCTT--------SCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHH
T ss_pred             HHHhCC-CC--CCCC--------CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence            443322 11  1111        23568899999999999999964     6665

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.1e-42  Score=336.90  Aligned_cols=264  Identities=22%  Similarity=0.311  Sum_probs=196.4

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHH-----------HhhhhhhHHHHHHHHHHHHhc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIE-----------EDSKLRDSKLRQIRSEIITAS  260 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~E~~~l~  260 (487)
                      ++|.+.+.||+|+||.||+|.. ..+++.||||++.............           ............+.+|+.+++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~a~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           13 NQYTLKDEIGKGSYGVVKLAYN-ENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             TTEEEEEEEEC--CCEEEEEEE-TTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             cceEEEeEEeecCCEEEEEEEE-CCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            4699999999999999999974 4688999999985432111100000           000011223467889999999


Q ss_pred             cCCCCCccccceEEec--CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCC
Q 011360          261 QIRHRNILPLLAHMVR--PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDI  338 (487)
Q Consensus       261 ~l~hpnIv~l~~~~~~--~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dl  338 (487)
                      .++||||+++++++.+  .+..|+||||+++++|.+++.     ...+++..+..++.|++.||.||   |++||+||||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dl  163 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-----LKPLSEDQARFYFQDLIKGIEYL---HYQKIIHRDI  163 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-----SSCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCC
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccCC
Confidence            9999999999999986  568899999999999987643     45799999999999999999999   6778999999


Q ss_pred             CCCCEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCC---CCchhHHHHHHHHHHHHHhCCCCcc
Q 011360          339 KPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPE---LSEKCDIFSFGMLLISLVRGVPSFV  415 (487)
Q Consensus       339 kp~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~---~~~~~DvwslG~~l~elltg~~pf~  415 (487)
                      ||+||+++.++.+||+|||++.........  .....||+.|+|||++.+..   ++.++||||||+++|+|++|..||.
T Consensus       164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~  241 (298)
T 2zv2_A          164 KPSNLLVGEDGHIKIADFGVSNEFKGSDAL--LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM  241 (298)
T ss_dssp             CGGGEEECTTSCEEECCCTTCEECSSSSCE--ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CHHHEEECCCCCEEEecCCCcccccccccc--ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence            999999999999999999999876543322  24457999999999998765   4788999999999999999999994


Q ss_pred             ccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          416 FHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       416 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ...      .......... ........+.+        +..+.+++.+||+.||++|||+.++++
T Consensus       242 ~~~------~~~~~~~~~~-~~~~~~~~~~~--------~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          242 DER------IMCLHSKIKS-QALEFPDQPDI--------AEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             CSS------HHHHHHHHHH-CCCCCCSSSCC--------CHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             Ccc------HHHHHHHHhc-ccCCCCCcccc--------CHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            321      1222222222 22211111122        256889999999999999999999874

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=7.1e-43  Score=340.51  Aligned_cols=263  Identities=24%  Similarity=0.363  Sum_probs=200.2

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||+|+||.||+|+..  +++.||+|++...             .........+.+|+.++++++||||++++
T Consensus        21 ~~y~~~~~lG~G~~g~V~~~~~~--~~~~vavK~~~~~-------------~~~~~~~~~~~~E~~~l~~l~hp~iv~~~   85 (311)
T 3niz_A           21 EKYQKLEKVGEGTYGVVYKAKDS--QGRIVALKRIRLD-------------AEDEGIPSTAIREISLLKELHHPNIVSLI   85 (311)
T ss_dssp             CEEEEEEEEEECSSCEEEEEEET--TSCEEEEEEEC-------------------CHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             hhhHhhhhccCCCCeEEEEEEEC--CCCEEEEEEEecc-------------cccchhhHHHHHHHHHHHHcCCCCEeeee
Confidence            57999999999999999999863  6889999998431             11222345678899999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++.+.+..++||||+++ +|.+++..   ....+++..+..++.|++.||.||   |++||+||||||+|||++.++.+
T Consensus        86 ~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~L---H~~~ivH~Dikp~NIl~~~~~~~  158 (311)
T 3niz_A           86 DVIHSERCLTLVFEFMEK-DLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHC---HQHRILHRDLKPQNLLINSDGAL  158 (311)
T ss_dssp             EEECCSSCEEEEEECCSE-EHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTCCE
T ss_pred             eEEccCCEEEEEEcCCCC-CHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCchHhEEECCCCCE
Confidence            999999999999999975 88888763   345689999999999999999999   67789999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQ-PELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLR  430 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~  430 (487)
                      ||+|||++.........  .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||........   ...+.
T Consensus       159 kl~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i~  233 (311)
T 3niz_A          159 KLADFGLARAFGIPVRS--YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ---LPKIF  233 (311)
T ss_dssp             EECCCTTCEETTSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH---HHHHH
T ss_pred             EEccCcCceecCCCccc--ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH---HHHHH
Confidence            99999999876433222  234568999999999876 5689999999999999999999999965543221   11222


Q ss_pred             HHHhcCCCCCccC------------CCCCCC----CcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          431 KVMNSKNPSRAID------------PRLPGN----GYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       431 ~~~~~~~~~~~~~------------~~~~~~----~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .......+.....            ......    .......++.+++.+||+.||++|||++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          234 SILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             HHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            2221111111000            000000    00112356889999999999999999999986

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=2.4e-43  Score=345.93  Aligned_cols=250  Identities=22%  Similarity=0.328  Sum_probs=179.6

Q ss_pred             cccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCC-CCCccccceEEec
Q 011360          198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIR-HRNILPLLAHMVR  276 (487)
Q Consensus       198 ~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~  276 (487)
                      +.||+|+||.||+|.. ..+++.||||++..                  .....+.+|+.++..+. ||||+++++++.+
T Consensus        17 ~~lG~G~~g~V~~~~~-~~~~~~vavK~~~~------------------~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~   77 (325)
T 3kn6_A           17 KPLGEGSFSICRKCVH-KKSNQAFAVKIISK------------------RMEANTQKEITALKLCEGHPNIVKLHEVFHD   77 (325)
T ss_dssp             CCSEEETTEEEEEEEE-TTTCCEEEEEEEEG------------------GGHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             CccccCCCeEEEEEEE-CCCCCEEEEEEECh------------------hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEc
Confidence            7899999999999975 46789999998832                  12245567899999996 9999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC---CEEE
Q 011360          277 PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDM---EACI  353 (487)
Q Consensus       277 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~---~~kl  353 (487)
                      ....|+||||+++|+|.+++..    ...+++..+..++.|++.||.||   |++||+||||||+|||++.++   .+||
T Consensus        78 ~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~L---H~~~ivH~Dlkp~NIll~~~~~~~~~kl  150 (325)
T 3kn6_A           78 QLHTFLVMELLNGGELFERIKK----KKHFSETEASYIMRKLVSAVSHM---HDVGVVHRDLKPENLLFTDENDNLEIKI  150 (325)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEEEC----CEEEE
T ss_pred             CCEEEEEEEccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCCeecCCCHHHEEEecCCCcccEEE
Confidence            9999999999999999999975    46799999999999999999999   677899999999999998665   7999


Q ss_pred             eccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHHH
Q 011360          354 SDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVM  433 (487)
Q Consensus       354 ~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~  433 (487)
                      +|||++.........  .....||+.|+|||++.+..++.++||||||+++|+|++|..||...................
T Consensus       151 ~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i  228 (325)
T 3kn6_A          151 IDFGFARLKPPDNQP--LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKI  228 (325)
T ss_dssp             CCCTTCEECCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHH
T ss_pred             eccccceecCCCCCc--ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHH
Confidence            999999865443222  234568999999999999999999999999999999999999996654432222222232233


Q ss_pred             hcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          434 NSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       434 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ......      .+.......+.++.+++.+||+.||++|||+.++++
T Consensus       229 ~~~~~~------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          229 KKGDFS------FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             TTTCCC------CCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             HcCCCC------CCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence            222211      111112233467899999999999999999998763

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=6.1e-43  Score=344.47  Aligned_cols=265  Identities=22%  Similarity=0.316  Sum_probs=209.3

Q ss_pred             hccccccccccccccceeEEEEEecC------CCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-
Q 011360          190 KEDCFASLEKIGSGGCGEVYKAELPG------SNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-  262 (487)
Q Consensus       190 ~~~~~~~~~~lg~G~~g~v~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-  262 (487)
                      ..++|.+.+.||+|+||.||+|++..      .++..||+|++..              .........+.+|+.++..+ 
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~--------------~~~~~~~~~~~~E~~~l~~l~   98 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD--------------DATEKDLSDLVSEMEMMKMIG   98 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCT--------------TCCHHHHHHHHHHHHHHHHHC
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeecc--------------CCcHHHHHHHHHHHHHHHHhh
Confidence            34579999999999999999998632      3567899998742              11233456788999999999 


Q ss_pred             CCCCccccceEEecCCeeEEEEEecCCCCHHHHHhhhhc------------CCCCCChHHHHHHHHHHHHHHHHHHhcCC
Q 011360          263 RHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSR------------GRRELDWPSRHRIALGVASGLEYLHMYHS  330 (487)
Q Consensus       263 ~hpnIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~  330 (487)
                      +||||+++++++...+..++||||+++|+|.+++.....            ....+++..++.++.|++.||.||   |+
T Consensus        99 ~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L---H~  175 (334)
T 2pvf_A           99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---AS  175 (334)
T ss_dssp             CCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHH---HH
T ss_pred             cCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHH---Hh
Confidence            999999999999999999999999999999999975321            123488999999999999999999   67


Q ss_pred             CCeeecCCCCCCEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-
Q 011360          331 ASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-  409 (487)
Q Consensus       331 ~givH~Dlkp~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-  409 (487)
                      +||+||||||+||+++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ 
T Consensus       176 ~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~  255 (334)
T 2pvf_A          176 QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL  255 (334)
T ss_dssp             TTEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTT
T ss_pred             CCeeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhC
Confidence            7899999999999999999999999999987655433322234457889999999988889999999999999999999 


Q ss_pred             CCCCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhhC
Q 011360          410 GVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL  487 (487)
Q Consensus       410 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~ll  487 (487)
                      |..||...      ...+....+.....+.  .+..        .+..+.+++.+||+.+|.+|||+.++++.|+.++
T Consensus       256 g~~p~~~~------~~~~~~~~~~~~~~~~--~~~~--------~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~  317 (334)
T 2pvf_A          256 GGSPYPGI------PVEELFKLLKEGHRMD--KPAN--------CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  317 (334)
T ss_dssp             SCCSSTTC------CHHHHHHHHHHTCCCC--CCTT--------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCcCcC------CHHHHHHHHhcCCCCC--CCcc--------CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            99999432      2222333332222111  1111        2256889999999999999999999999998763

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=3.2e-43  Score=345.45  Aligned_cols=258  Identities=21%  Similarity=0.326  Sum_probs=198.3

Q ss_pred             ccccccccccccccceeEEEEEecCCCCce----EEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCC
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKM----IAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRN  266 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~----vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn  266 (487)
                      .++|.+.+.||+|+||.||+|.+. .++..    ||+|.+..              .........+.+|+.++++++|||
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~~~~~vaiK~~~~--------------~~~~~~~~~~~~E~~~l~~l~h~~   78 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWI-PEGEKVKIPVAIKELRE--------------ATSPKANKEILDEAYVMASVDNPH   78 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEC-C----CCEEEEEEEC---------------------CHHHHHHHHHHHHHCCBTT
T ss_pred             HHHcccceEEeeCCCeEEEEEEEc-CCCceEEEEEEEeeccc--------------ccCHHHHHHHHHHHHHHHhCCCCC
Confidence            456999999999999999999854 34444    57776621              112234467889999999999999


Q ss_pred             ccccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC
Q 011360          267 ILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN  346 (487)
Q Consensus       267 Iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~  346 (487)
                      |+++++++.... .++||||+.+|+|.+++..   ....+++..++.++.|++.||.||   |++||+||||||+|||++
T Consensus        79 iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~L---H~~~ivH~Dikp~NIll~  151 (327)
T 3poz_A           79 VCRLLGICLTST-VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVK  151 (327)
T ss_dssp             BCCEEEEEESSS-EEEEEECCTTCBHHHHHHH---STTSCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEEE
T ss_pred             EeEEEEEEecCC-eEEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHH---hhCCeeCCCCChheEEEC
Confidence            999999998754 7899999999999999875   245689999999999999999999   667899999999999999


Q ss_pred             CCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCcccc
Q 011360          347 DDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICS  425 (487)
Q Consensus       347 ~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~  425 (487)
                      .++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||+| |..||......     
T Consensus       152 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-----  226 (327)
T 3poz_A          152 TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-----  226 (327)
T ss_dssp             ETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-----
T ss_pred             CCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH-----
Confidence            999999999999987655444333344557889999999999999999999999999999999 99999543221     


Q ss_pred             HHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          426 PEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       426 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                       + ........... ..++.        .+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus       227 -~-~~~~~~~~~~~-~~~~~--------~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~  276 (327)
T 3poz_A          227 -E-ISSILEKGERL-PQPPI--------CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  276 (327)
T ss_dssp             -G-HHHHHHTTCCC-CCCTT--------BCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred             -H-HHHHHHcCCCC-CCCcc--------CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence             1 12222222111 11111        224688999999999999999999999998765

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=9.2e-43  Score=339.11  Aligned_cols=253  Identities=27%  Similarity=0.405  Sum_probs=196.0

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||+|+||.||+|++   .++.||+|++..                 ......+.+|+.++++++||||++++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~-----------------~~~~~~~~~E~~~l~~l~hp~iv~~~   67 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKW---RAKDVAIKQIES-----------------ESERKAFIVELRQLSRVNHPNIVKLY   67 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE---TTEEEEEEECSS-----------------TTHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             hHeeeeeEeecCCCceEEEEEE---CCeeEEEEEecC-----------------hhHHHHHHHHHHHHhcCCCCCcCeEE
Confidence            4699999999999999999986   578899998731                 12345788899999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC-
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME-  350 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~-  350 (487)
                      +++.  +..++||||+++|+|.+++... .....+++..+..++.|++.||.|||+.|.+||+||||||+||+++.++. 
T Consensus        68 ~~~~--~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~  144 (307)
T 2eva_A           68 GACL--NPVCLVMEYAEGGSLYNVLHGA-EPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTV  144 (307)
T ss_dssp             EBCT--TTTEEEEECCTTCBHHHHHHCS-SSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTE
T ss_pred             EEEc--CCcEEEEEcCCCCCHHHHHhcc-CCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCE
Confidence            9876  4589999999999999999742 11234788899999999999999997766689999999999999998887 


Q ss_pred             EEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHH
Q 011360          351 ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLR  430 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~  430 (487)
                      +||+|||++.......     ....||+.|+|||++.+..++.++||||||+++|+|++|..||......    ......
T Consensus       145 ~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~~  215 (307)
T 2eva_A          145 LKICDFGTACDIQTHM-----TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP----AFRIMW  215 (307)
T ss_dssp             EEECCCCC-----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS----HHHHHH
T ss_pred             EEEccccccccccccc-----ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc----HHHHHH
Confidence            7999999997654322     2345899999999999999999999999999999999999999533221    111222


Q ss_pred             HHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          431 KVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       431 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      .......+  .....+        +..+.+++.+||+.||++|||+.++++.|+.+
T Consensus       216 ~~~~~~~~--~~~~~~--------~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  261 (307)
T 2eva_A          216 AVHNGTRP--PLIKNL--------PKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL  261 (307)
T ss_dssp             HHHTTCCC--CCBTTC--------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHhcCCCC--Cccccc--------CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            22222211  111122        24688999999999999999999999999875

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=6.7e-43  Score=342.23  Aligned_cols=265  Identities=18%  Similarity=0.277  Sum_probs=210.1

Q ss_pred             hccccccccccccccceeEEEEEecC----CCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCC
Q 011360          190 KEDCFASLEKIGSGGCGEVYKAELPG----SNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHR  265 (487)
Q Consensus       190 ~~~~~~~~~~lg~G~~g~v~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp  265 (487)
                      ..++|.+.+.||.|+||.||+|.+..    .++..||+|.+..              .........+.+|+.+++.++||
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~--------------~~~~~~~~~~~~E~~~l~~l~h~   88 (322)
T 1p4o_A           23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE--------------AASMRERIEFLNEASVMKEFNCH   88 (322)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCT--------------TSCHHHHHHHHHHHHHGGGCCCT
T ss_pred             hhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccc--------------ccCHHHHHHHHHHHHHHHhcCCC
Confidence            34579999999999999999997642    3578899998742              11223445688999999999999


Q ss_pred             CccccceEEecCCeeEEEEEecCCCCHHHHHhhhhc------CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCC
Q 011360          266 NILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSR------GRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIK  339 (487)
Q Consensus       266 nIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlk  339 (487)
                      ||+++++++.+.+..++||||+++|+|.+++.....      ....+++..++.++.|++.||.||   |++||+|||||
T Consensus        89 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dik  165 (322)
T 1p4o_A           89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYL---NANKFVHRDLA  165 (322)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHH---HHTTCBCSCCS
T ss_pred             CEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHH---HHCCCccCCCc
Confidence            999999999999999999999999999999975321      124578999999999999999999   67789999999


Q ss_pred             CCCEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccC
Q 011360          340 PRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQ  418 (487)
Q Consensus       340 p~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~  418 (487)
                      |+||+++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||... 
T Consensus       166 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~-  244 (322)
T 1p4o_A          166 ARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL-  244 (322)
T ss_dssp             GGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-
T ss_pred             cceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccC-
Confidence            9999999999999999999976544332222233457889999999998899999999999999999999 79999432 


Q ss_pred             CCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhhC
Q 011360          419 NGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL  487 (487)
Q Consensus       419 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~ll  487 (487)
                           ...+..........+.  ....        .+..+.+++.+||+.||++|||+.++++.|++++
T Consensus       245 -----~~~~~~~~~~~~~~~~--~~~~--------~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~  298 (322)
T 1p4o_A          245 -----SNEQVLRFVMEGGLLD--KPDN--------CPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM  298 (322)
T ss_dssp             -----CHHHHHHHHHTTCCCC--CCTT--------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred             -----CHHHHHHHHHcCCcCC--CCCC--------CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence                 2223333333222211  1111        2256889999999999999999999999998763

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=4.3e-43  Score=352.92  Aligned_cols=266  Identities=20%  Similarity=0.332  Sum_probs=203.1

Q ss_pred             ccccccccccccc--cceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcc
Q 011360          191 EDCFASLEKIGSG--GCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNIL  268 (487)
Q Consensus       191 ~~~~~~~~~lg~G--~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv  268 (487)
                      .++|.+.+.||.|  +||.||+|+. ..+++.||||++..             ..........+.+|+.+++.++||||+
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~-~~~~~~vavK~~~~-------------~~~~~~~~~~~~~E~~~l~~l~h~niv   89 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARY-KPTGEYVTVRRINL-------------EACSNEMVTFLQGELHVSKLFNHPNIV   89 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEE-TTTCCEEEEEEEEG-------------GGSCHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             CCcEEEEecccCCcCCceEEEEEEE-cCCCCEEEEEEecc-------------cccChHHHHHHHHHHHHHHhCCCCCCC
Confidence            4579999999999  9999999975 45799999999843             122234567788999999999999999


Q ss_pred             ccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC
Q 011360          269 PLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDD  348 (487)
Q Consensus       269 ~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~  348 (487)
                      ++++++.+.+..|+|||||++|+|.+++..  .....+++..+..++.|++.||.||   |++||+||||||+|||++.+
T Consensus        90 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~qi~~~l~~L---H~~~ivHrDlkp~NIll~~~  164 (389)
T 3gni_B           90 PYRATFIADNELWVVTSFMAYGSAKDLICT--HFMDGMNELAIAYILQGVLKALDYI---HHMGYVHRSVKASHILISVD  164 (389)
T ss_dssp             CEEEEEEETTEEEEEEECCTTCBHHHHHHH--TCTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTT
T ss_pred             cEeEEEEECCEEEEEEEccCCCCHHHHHhh--hcccCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCC
Confidence            999999999999999999999999999975  3345689999999999999999999   67789999999999999999


Q ss_pred             CCEEEeccCCccccCCCCce-----eeEeeecccccccCCcccCC--CCCCchhHHHHHHHHHHHHHhCCCCccccCCCC
Q 011360          349 MEACISDLGLAMAIPDGYTR-----VLISYVLGTMAYIAPEYFQQ--PELSEKCDIFSFGMLLISLVRGVPSFVFHQNGE  421 (487)
Q Consensus       349 ~~~kl~DFg~s~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~--~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~  421 (487)
                      +.+||+|||.+.........     .......||+.|+|||++.+  ..++.++|||||||++|+|++|..||.......
T Consensus       165 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~  244 (389)
T 3gni_B          165 GKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ  244 (389)
T ss_dssp             CCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTT
T ss_pred             CCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence            99999999988654322111     11123468999999999987  579999999999999999999999996543221


Q ss_pred             ccccHHHHHHHHhcCCCC---------C-----------------cc--------CCCC-CCCCcHHHHHHHHHHHhhcc
Q 011360          422 EICSPEWLRKVMNSKNPS---------R-----------------AI--------DPRL-PGNGYEKKMLHVLKIAYICT  466 (487)
Q Consensus       422 ~~~~~~~~~~~~~~~~~~---------~-----------------~~--------~~~~-~~~~~~~~~~~l~~li~~cl  466 (487)
                      ..      ........+.         .                 .+        .... ........+..+.+++.+||
T Consensus       245 ~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  318 (389)
T 3gni_B          245 ML------LEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCL  318 (389)
T ss_dssp             HH------HHC--------------------------------------------------------CCHHHHHHHHHHT
T ss_pred             HH------HHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHh
Confidence            10      0000000000         0                 00        0000 00012223467899999999


Q ss_pred             CCCCCCCCChHHHHH
Q 011360          467 LHDPEERPNSQYVRC  481 (487)
Q Consensus       467 ~~~P~~RPs~~~il~  481 (487)
                      +.||++|||+.++++
T Consensus       319 ~~dP~~Rpta~ell~  333 (389)
T 3gni_B          319 QRNPDARPSASTLLN  333 (389)
T ss_dssp             CSCTTTSCCHHHHTT
T ss_pred             hcCcccCCCHHHHhc
Confidence            999999999999974

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.3e-43  Score=367.17  Aligned_cols=354  Identities=18%  Similarity=0.271  Sum_probs=248.8

Q ss_pred             chhhhhhhhhHHHHHHhhh--chhhhhhHHHHHHHHHH----HHHHHHhhccccC-CCCcccccccCCCCCChhhhhhhc
Q 011360           93 VDYLLDEFQTEAFQTMLLQ--DADAMSKVKEVNARLQD----IAWQINVLGLKES-FGGKSRNVRQRFPTTPSLISAAVR  165 (487)
Q Consensus        93 ~~~~~~~~~~~~~~~~l~~--~~~~~~r~~ei~~~l~~----i~~~~~~~~l~~~-~g~~~~~~~~~~~s~p~~~~~~~~  165 (487)
                      .++++..+++++.+.++..  +|+|++|.++.......    ....+.||.+... .|.........|++...++.....
T Consensus       105 ~~wyhg~i~r~~ae~ll~~~~~G~fLvR~s~~~~~~~~lsv~~~~~v~h~~I~~~~~g~~~~~~~~~F~sl~eLv~~~~~  184 (495)
T 1opk_A          105 HSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHST  184 (495)
T ss_dssp             STTEEEECCHHHHHHHGGGCCTTEEEEEECSSSTTCEEEEEEETTEEEEEECEECTTSCEESSTTSCBSSHHHHHHHHTT
T ss_pred             hhhhccCCCHHHHHHHhhCCCCceEEEEeCCCCCCceEEEEeeCCeEEEEEEEecCCCceEeccCccchhHHHHhhhhcc
Confidence            4566677778888877765  78888775432100000    0112345555433 222233334455555555443322


Q ss_pred             CCCC-----------CCCCccccCCcchhhHHHhhhccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhH
Q 011360          166 GGSR-----------DRGPTIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISA  234 (487)
Q Consensus       166 ~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~  234 (487)
                      ....           ...+....  .......|....++|.+.+.||.|+||.||+|.+. .++..||||.+...     
T Consensus       185 ~~~g~~~~l~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~~vavK~~~~~-----  256 (495)
T 1opk_A          185 VADGLITTLHYPAPKRNKPTIYG--VSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWK-KYSLTVAVKTLKED-----  256 (495)
T ss_dssp             CCTTSSSCCCEECCCCSCCCCSS--SCSSSSCCBCCGGGEEEEEESGGGTTSSEEEEEEG-GGTEEEEEEECCSS-----
T ss_pred             cccccchhccccccccccccccc--cCccccccccCHHHceeeeEecCCCCeEEEEEEEc-CCCeEEEEEEecCc-----
Confidence            1100           00001000  00011123344567999999999999999999864 46889999988421     


Q ss_pred             HHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHH
Q 011360          235 AELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRI  314 (487)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i  314 (487)
                                 ......+.+|+.++++++||||+++++++...+..|+||||+++|+|.+++..  .....+++..+..+
T Consensus       257 -----------~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~--~~~~~~~~~~~~~i  323 (495)
T 1opk_A          257 -----------TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYM  323 (495)
T ss_dssp             -----------SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHH--SCTTTSCHHHHHHH
T ss_pred             -----------ccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHh--cCcCCCCHHHHHHH
Confidence                       11245688999999999999999999999999999999999999999999975  33456899999999


Q ss_pred             HHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCch
Q 011360          315 ALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEK  394 (487)
Q Consensus       315 ~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~  394 (487)
                      +.|++.||.||   |++||+||||||+|||++.++.+||+|||+++........ ......+|+.|+|||++.+..++.+
T Consensus       324 ~~qi~~~L~~L---H~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~  399 (495)
T 1opk_A          324 ATQISSAMEYL---EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIK  399 (495)
T ss_dssp             HHHHHHHHHHH---HHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEE-CCTTCCCCGGGCCHHHHHHCEECHH
T ss_pred             HHHHHHHHHHH---HhCCcccCCCChhhEEECCCCcEEEeecccceeccCCcee-ecCCCcCCcceeCHhHHhcCCCCcH
Confidence            99999999999   6778999999999999999999999999999876543221 1123346789999999998899999


Q ss_pred             hHHHHHHHHHHHHHh-CCCCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCC
Q 011360          395 CDIFSFGMLLISLVR-GVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEER  473 (487)
Q Consensus       395 ~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R  473 (487)
                      +|||||||++|||+| |..||......      +....+......  ..+..        .+..+.+++.+||+.||++|
T Consensus       400 sDvwSlG~~l~el~t~g~~p~~~~~~~------~~~~~~~~~~~~--~~~~~--------~~~~l~~li~~cl~~dP~~R  463 (495)
T 1opk_A          400 SDVWAFGVLLWEIATYGMSPYPGIDLS------QVYELLEKDYRM--ERPEG--------CPEKVYELMRACWQWNPSDR  463 (495)
T ss_dssp             HHHHHHHHHHHHHHTTSCCSSTTCCGG------GHHHHHHTTCCC--CCCTT--------CCHHHHHHHHHHTCSSGGGS
T ss_pred             HhHHhHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHcCCCC--CCCCC--------CCHHHHHHHHHHcCcChhHC
Confidence            999999999999999 89999544321      122222222111  11111        22568899999999999999


Q ss_pred             CChHHHHHHHhhhC
Q 011360          474 PNSQYVRCRLSQLL  487 (487)
Q Consensus       474 Ps~~~il~~L~~ll  487 (487)
                      ||+.+|++.|+.++
T Consensus       464 Ps~~el~~~L~~~~  477 (495)
T 1opk_A          464 PSFAEIHQAFETMF  477 (495)
T ss_dssp             CCHHHHHHHHHTSC
T ss_pred             cCHHHHHHHHHHHH
Confidence            99999999998764

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=8.1e-43  Score=340.30  Aligned_cols=265  Identities=23%  Similarity=0.381  Sum_probs=200.3

Q ss_pred             hccccccccccccccceeEEEEEecCC--CCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCc
Q 011360          190 KEDCFASLEKIGSGGCGEVYKAELPGS--NGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNI  267 (487)
Q Consensus       190 ~~~~~~~~~~lg~G~~g~v~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI  267 (487)
                      ..++|.+.+.||.|+||.||+|.+...  ++..||+|.+...             .........+.+|+.++.+++||||
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~-------------~~~~~~~~~~~~e~~~l~~l~h~~i   98 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLD-------------NSSQREIEEFLSEAACMKDFSHPNV   98 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC----------------CCCHHHHHHHHHHHHHHHTCCCTTB
T ss_pred             CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecc-------------ccchhHHHHHHHHHHHHhcCCCCCe
Confidence            345799999999999999999976433  4568999987431             1223345678899999999999999


Q ss_pred             cccceEEecCC-----eeEEEEEecCCCCHHHHHhhhh--cCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC
Q 011360          268 LPLLAHMVRPD-----CHLLVYEFMKNGSLQDILDDVS--RGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKP  340 (487)
Q Consensus       268 v~l~~~~~~~~-----~~~lv~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp  340 (487)
                      +++++++...+     ..++||||+++|+|.+++....  .....+++..++.++.|++.||.||   |++||+||||||
T Consensus        99 v~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~dikp  175 (313)
T 3brb_A           99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYL---SNRNFLHRDLAA  175 (313)
T ss_dssp             CCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHH---HTTTCCCCCCSG
T ss_pred             eeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCc
Confidence            99999988754     3499999999999999985432  2346799999999999999999999   778999999999


Q ss_pred             CCEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCC
Q 011360          341 RNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQN  419 (487)
Q Consensus       341 ~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~  419 (487)
                      +||+++.++.+||+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus       176 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~  255 (313)
T 3brb_A          176 RNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN  255 (313)
T ss_dssp             GGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             ceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCH
Confidence            999999999999999999987654432222234557889999999999999999999999999999999 8999954332


Q ss_pred             CCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          420 GEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       420 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                            .+..........+  ..++.        .+..+.+++.+||+.||++|||+.++++.|+++
T Consensus       256 ------~~~~~~~~~~~~~--~~~~~--------~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l  306 (313)
T 3brb_A          256 ------HEMYDYLLHGHRL--KQPED--------CLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL  306 (313)
T ss_dssp             ------GGHHHHHHTTCCC--CCBTT--------CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------HHHHHHHHcCCCC--CCCcc--------ccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                  1222333322221  11122        225689999999999999999999999999876

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=5.5e-42  Score=330.10  Aligned_cols=260  Identities=28%  Similarity=0.474  Sum_probs=203.2

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||.|+||.||+|++ ..+++.||+|++..........        .......+.+|+.++.+++||||++++
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~~~~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~i~~~~   89 (287)
T 4f0f_A           19 NEIEYEKQIGKGGFGLVHKGRL-VKDKSVVAIKSLILGDSEGETE--------MIEKFQEFQREVFIMSNLNHPNIVKLY   89 (287)
T ss_dssp             TTEEEEEECCCCSSSCEEEEEE-TTTCCEEEEEECCCCTTTCCHH--------HHCCSHHHHHHHHHHTTCCCTTBCCEE
T ss_pred             ccceehhccccCCceeEEEEEE-cCCceEEEEEEeeccccccchh--------HHHHHHHHHHHHHHHHhCCCCCchhhh
Confidence            4699999999999999999975 4578999999885422111100        001125788999999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCC--eeecCCCCCCEEeCCCC
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSAS--IIHGDIKPRNVLLNDDM  349 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~g--ivH~Dlkp~Nill~~~~  349 (487)
                      +++.+..  ++||||+++|+|.+++..   ....+++..++.++.|++.||.||   |++|  |+||||||+||+++.++
T Consensus        90 ~~~~~~~--~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~l---H~~~~~ivH~dikp~Nil~~~~~  161 (287)
T 4f0f_A           90 GLMHNPP--RMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYM---QNQNPPIVHRDLRSPNIFLQSLD  161 (287)
T ss_dssp             EEETTTT--EEEEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHH---HTSSSCCBCSCCSGGGEEESCCC
T ss_pred             eeecCCC--eEEEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHH---HhCCCCeecCCCCcceEEEeccC
Confidence            9987654  699999999999988863   356799999999999999999999   7778  99999999999998877


Q ss_pred             C-----EEEeccCCccccCCCCceeeEeeecccccccCCcccC--CCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCc
Q 011360          350 E-----ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQ--QPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEE  422 (487)
Q Consensus       350 ~-----~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~  422 (487)
                      .     +||+|||++......     .....||+.|+|||++.  ...++.++||||||+++|+|++|..||......  
T Consensus       162 ~~~~~~~kl~Dfg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--  234 (287)
T 4f0f_A          162 ENAPVCAKVADFGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG--  234 (287)
T ss_dssp             TTCSCCEEECCCTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCC--
T ss_pred             CCCceeEEeCCCCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccccc--
Confidence            6     999999999754332     23456999999999984  456789999999999999999999999544321  


Q ss_pred             cccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          423 ICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       423 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                        .......... ......+...+        +..+.+++.+||+.||++|||+.++++.|+++
T Consensus       235 --~~~~~~~~~~-~~~~~~~~~~~--------~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          235 --KIKFINMIRE-EGLRPTIPEDC--------PPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             --HHHHHHHHHH-SCCCCCCCTTS--------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             --HHHHHHHHhc-cCCCCCCCccc--------CHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence              1122222222 22222222222        25689999999999999999999999999875

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=2.9e-42  Score=335.95  Aligned_cols=264  Identities=25%  Similarity=0.359  Sum_probs=201.2

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||.|+||.||+|.. ..+|..||+|++....            .........+.+|+.++..++||||++++
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~~vavK~~~~~~------------~~~~~~~~~~~~E~~~l~~l~h~~i~~~~   98 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAAC-LLDGVPVALKKVQIFD------------LMDAKARADCIKEIDLLKQLNHPNVIKYY   98 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEE-TTTCCEEEEEEECTTS------------SCCHHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             cceEEEEeecCCCCceEEEEEE-cCCCceEEEEeeehhh------------ccCHHHHHHHHHHHHHHHhCCCCCEeeEE
Confidence            4699999999999999999975 4578999999884311            11233456788999999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++...+..++||||+++++|.+++.........+++..++.++.|++.||.||   |+.|++||||||+||+++.++.+
T Consensus        99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~L---H~~~i~H~dl~p~NIl~~~~~~~  175 (310)
T 2wqm_A           99 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM---HSRRVMHRDIKPANVFITATGVV  175 (310)
T ss_dssp             EEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTSCE
T ss_pred             EEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHH---hhCCeeCCCCcHHHEEEcCCCCE
Confidence            999999999999999999999999987666677899999999999999999999   67789999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRK  431 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~  431 (487)
                      ||+|||++.........  .....|++.|+|||++.+..++.++||||||+++|+|++|..||.....    ........
T Consensus       176 kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~  249 (310)
T 2wqm_A          176 KLGDLGLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKK  249 (310)
T ss_dssp             EECCC--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C----CHHHHHHH
T ss_pred             EEEeccceeeecCCCcc--ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch----hHHHHHHH
Confidence            99999998765443221  1345689999999999999999999999999999999999999954322    11222222


Q ss_pred             HHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          432 VMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       432 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      ......+ .....        ..+..+.+++.+||+.||++|||+.+|++.|+++
T Consensus       250 ~~~~~~~-~~~~~--------~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l  295 (310)
T 2wqm_A          250 IEQCDYP-PLPSD--------HYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRM  295 (310)
T ss_dssp             HHTTCSC-CCCTT--------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             hhcccCC-CCccc--------ccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            2222211 11111        1235688999999999999999999999999876

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.7e-42  Score=333.12  Aligned_cols=254  Identities=21%  Similarity=0.349  Sum_probs=204.6

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .++|.+.+.||.|+||.||+|.. ..++..||+|++..             ..........+.+|+.++++++||||+++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~-------------~~~~~~~~~~~~~e~~~l~~l~h~~i~~~   70 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVH-KTTGLEFAAKIINT-------------KKLSARDFQKLEREARICRKLQHPNIVRL   70 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEE-TTTCCEEEEEEEEG-------------GGCCHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEE-cCCCceEEEEEeec-------------ccCCHHHHHHHHHHHHHHHHcCCCCcCeE
Confidence            35799999999999999999975 46789999999843             12233345678899999999999999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      ++++...+..++||||+++++|.+++..    ...+++..+..++.|++.||.||   |++||+||||||+||+++.++.
T Consensus        71 ~~~~~~~~~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dikp~Nil~~~~~~  143 (284)
T 3kk8_A           71 HDSIQEESFHYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYC---HSNGIVHRNLKPENLLLASKAK  143 (284)
T ss_dssp             EEEEECSSEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEESSSST
T ss_pred             EEEEEcCCEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCcCcCCCCHHHEEEecCCC
Confidence            9999999999999999999999998875    35689999999999999999999   6778999999999999986655


Q ss_pred             ---EEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHH
Q 011360          351 ---ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPE  427 (487)
Q Consensus       351 ---~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~  427 (487)
                         +||+|||++.........   ....||+.|+|||++.+..++.++||||||+++|+|++|..||....      ...
T Consensus       144 ~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~------~~~  214 (284)
T 3kk8_A          144 GAAVKLADFGLAIEVNDSEAW---HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED------QHR  214 (284)
T ss_dssp             TCCEEECCCTTCEECCSSCBC---CCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHH
T ss_pred             CCcEEEeeceeeEEcccCccc---cCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc------hhH
Confidence               999999999776543322   34568999999999999999999999999999999999999994322      222


Q ss_pred             HHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          428 WLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ........... .      +.......+..+.+++.+||+.||++|||+.++++
T Consensus       215 ~~~~~~~~~~~-~------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          215 LYAQIKAGAYD-Y------PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             HHHHHHHTCCC-C------CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHHHHhcccc-C------CchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            23333222211 1      11111122356889999999999999999999875

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.6e-42  Score=333.80  Aligned_cols=254  Identities=26%  Similarity=0.370  Sum_probs=198.4

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      +.|.+.+.||.|+||.||++.. ..++..+|+|++...              ........+.+|+.+++.++||||++++
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~~aiK~~~~~--------------~~~~~~~~~~~E~~~l~~l~hp~iv~~~   86 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEE-RSSGLERVIKTINKD--------------RSQVPMEQIEAEIEVLKSLDHPNIIKIF   86 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEE-TTTCCEEEEEEEEGG--------------GCCSCHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             hheeecceeccCCCeEEEEEEE-ccCCceEEEEEeecc--------------ccchhHHHHHHHHHHHHhCCCchHHhHH
Confidence            4699999999999999999975 467899999988431              1122346778899999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEe---CCC
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLL---NDD  348 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill---~~~  348 (487)
                      +++.+.+..++||||+++|+|.+++......+..+++..++.++.|++.||.||   |++||+||||||+||++   +.+
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~L---H~~~ivH~dikp~NIl~~~~~~~  163 (285)
T 3is5_A           87 EVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF---HSQHVVHKDLKPENILFQDTSPH  163 (285)
T ss_dssp             EEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCSGGGEEESSSSTT
T ss_pred             HheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHH---HhCCEEECCCCHHHEEEecCCCC
Confidence            999999999999999999999999976544567899999999999999999999   67789999999999999   456


Q ss_pred             CCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHH
Q 011360          349 MEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEW  428 (487)
Q Consensus       349 ~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~  428 (487)
                      +.+||+|||++........   .....||+.|+|||++.+ .++.++||||||+++|+|++|..||....      ..+.
T Consensus       164 ~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~il~~ll~g~~pf~~~~------~~~~  233 (285)
T 3is5_A          164 SPIKIIDFGLAELFKSDEH---STNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTS------LEEV  233 (285)
T ss_dssp             CCEEECCCCCCCC-------------CTTGGGCCHHHHTT-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHH
T ss_pred             CCEEEEeeecceecCCccc---CcCcccccCcCChHHhcc-CCCcccCeehHHHHHHHHHhCCCCCCCCC------HHHH
Confidence            7899999999976544322   234568999999999864 68999999999999999999999994332      1222


Q ss_pred             HHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          429 LRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       429 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .... ....+......  .     ..+..+.+++.+||+.||++|||+.++++
T Consensus       234 ~~~~-~~~~~~~~~~~--~-----~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          234 QQKA-TYKEPNYAVEC--R-----PLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             HHHH-HHCCCCCCC----C-----CCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             Hhhh-ccCCccccccc--C-----cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            2222 22222111110  0     12256889999999999999999999985

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=8.6e-43  Score=346.91  Aligned_cols=253  Identities=23%  Similarity=0.303  Sum_probs=191.8

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .++|.+.+.||+|+||.||+++. ..+++.||+|++....                .....+.+|+.+++.++||||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~~~vavK~~~~~~----------------~~~~~~~~E~~~l~~l~hpniv~~   81 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRD-KLTKELVAVKYIERGA----------------AIDENVQREIINHRSLRHPNIVRF   81 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEE-TTTCCEEEEEEEESST----------------TSCHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEE-CCCCcEEEEEEEecCc----------------cccHHHHHHHHHHHhCCCCCCCcE
Confidence            35799999999999999999975 4688999999984311                112356789999999999999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      ++++.+.+..|+||||+++|+|.+++..    ...+++..++.++.|++.||.||   |++||+||||||+||+++.++.
T Consensus        82 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~L---H~~~ivH~Dlkp~Nill~~~~~  154 (361)
T 3uc3_A           82 KEVILTPTHLAIIMEYASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYC---HSMQICHRDLKLENTLLDGSPA  154 (361)
T ss_dssp             EEEEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH---HHTTCCSCCCCGGGEEECSSSS
T ss_pred             EEEEeeCCEEEEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEEcCCCC
Confidence            9999999999999999999999999865    35699999999999999999999   6778999999999999987765


Q ss_pred             --EEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCch-hHHHHHHHHHHHHHhCCCCccccCCCCccccHH
Q 011360          351 --ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEK-CDIFSFGMLLISLVRGVPSFVFHQNGEEICSPE  427 (487)
Q Consensus       351 --~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~-~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~  427 (487)
                        +||+|||+++.......   .....||+.|+|||++.+..++.+ +|||||||++|+|++|..||........  ...
T Consensus       155 ~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~  229 (361)
T 3uc3_A          155 PRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD--YRK  229 (361)
T ss_dssp             CCEEECCCCCC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC--HHH
T ss_pred             ceEEEeecCccccccccCC---CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH--HHH
Confidence              99999999875332221   134569999999999988777655 8999999999999999999965443222  122


Q ss_pred             HHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          428 WLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ......... .....+..        .+..+.+++.+||+.||++|||+.++++
T Consensus       230 ~~~~~~~~~-~~~~~~~~--------~s~~~~~li~~~L~~dP~~Rps~~ell~  274 (361)
T 3uc3_A          230 TIQRILSVK-YSIPDDIR--------ISPECCHLISRIFVADPATRISIPEIKT  274 (361)
T ss_dssp             HHHHHHTTC-CCCCTTSC--------CCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHHHhcCC-CCCCCcCC--------CCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence            222222211 11111111        2256889999999999999999999975

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2e-42  Score=337.06  Aligned_cols=260  Identities=22%  Similarity=0.336  Sum_probs=200.5

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||.|+||.||+|.. ..+++.||+|++...            ..........+.+|+.++..++||||++++
T Consensus        34 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~~vaiK~~~~~------------~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~  100 (309)
T 2h34_A           34 GPYRLRRLVGRGGMGDVYEAED-TVRERIVALKLMSET------------LSSDPVFRTRMQREARTAGRLQEPHVVPIH  100 (309)
T ss_dssp             CCEEEEEEEEECSSSEEEEEEE-TTTTEEEEEEECGGG------------GGGSHHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred             ccEEEEEEEcCCCCeeEEEEEE-cCCCeEEEEEecCcc------------cccCHHHHHHHHHHHHHHhhcCCCCeeEEE
Confidence            4699999999999999999975 457899999987321            112234457788999999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++...+..|+||||+++++|.+++..    ...+++..+..++.|++.||.||   |++||+||||||+||+++.++.+
T Consensus       101 ~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dlkp~NIl~~~~~~~  173 (309)
T 2h34_A          101 DFGEIDGQLYVDMRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAA---HAAGATHRDVKPENILVSADDFA  173 (309)
T ss_dssp             EEEEETTEEEEEEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTSCE
T ss_pred             EEEeeCCeEEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCcCCcCCCChHHEEEcCCCCE
Confidence            999999999999999999999999975    35689999999999999999999   67789999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRK  431 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~  431 (487)
                      ||+|||++......... ......||+.|+|||++.+..++.++||||||+++|+|++|..||....       ......
T Consensus       174 kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------~~~~~~  245 (309)
T 2h34_A          174 YLVDFGIASATTDEKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ-------LSVMGA  245 (309)
T ss_dssp             EECSCCC-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCH-------HHHHHH
T ss_pred             EEecCccCccccccccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCch-------HHHHHH
Confidence            99999998766443221 1234568999999999999899999999999999999999999994321       122223


Q ss_pred             HHhcCCC-CCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCC-ChHHHHHHHhhhC
Q 011360          432 VMNSKNP-SRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERP-NSQYVRCRLSQLL  487 (487)
Q Consensus       432 ~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-s~~~il~~L~~ll  487 (487)
                      ......+ .....+.++        ..+.+++.+||+.||++|| |++++++.|+.++
T Consensus       246 ~~~~~~~~~~~~~~~~~--------~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l  295 (309)
T 2h34_A          246 HINQAIPRPSTVRPGIP--------VAFDAVIARGMAKNPEDRYVTCGDLSAAAHAAL  295 (309)
T ss_dssp             HHHSCCCCGGGTSTTCC--------THHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTC
T ss_pred             HhccCCCCccccCCCCC--------HHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHH
Confidence            3332222 112223333        3588999999999999999 9999999998764

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=2.7e-43  Score=345.68  Aligned_cols=258  Identities=21%  Similarity=0.318  Sum_probs=200.2

Q ss_pred             ccccccccccccccceeEEEEEecCCCCce----EEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCC
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKM----IAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRN  266 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~----vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn  266 (487)
                      .++|.+.+.||+|+||.||+|.+. .++..    ||+|.+....              .......+.+|+.++.+++|||
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~~~~kv~~K~~~~~~--------------~~~~~~~~~~e~~~l~~l~h~~   76 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWI-PEGESIKIPVCIKVIEDKS--------------GRQSFQAVTDHMLAIGSLDHAH   76 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEEC-CTTCSCCEEEEEEEECCTT--------------SCSCBCSCCHHHHHHHTCCCTT
T ss_pred             HhHceeeeeeeecCCceEEEEEEc-CCCceEEEEEEEEeccccc--------------cHHHHHHHHHHHHHHhcCCCCC
Confidence            346999999999999999999864 35554    6777653211              1112234567899999999999


Q ss_pred             ccccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC
Q 011360          267 ILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN  346 (487)
Q Consensus       267 Iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~  346 (487)
                      |+++++++. .+..++||||+.+|+|.+++..   ....+++..+..++.|++.||.||   |++||+||||||+|||++
T Consensus        77 iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dikp~Nil~~  149 (325)
T 3kex_A           77 IVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQ---HRGALGPQLLLNWGVQIAKGMYYL---EEHGMVHRNLAARNVLLK  149 (325)
T ss_dssp             BCCEEEEEC-BSSEEEEEECCTTCBSHHHHHS---SGGGSCTTHHHHHHHHHHHHHHHH---HHTTCCCSCCSSTTEEES
T ss_pred             cCeEEEEEc-CCccEEEEEeCCCCCHHHHHHH---ccccCCHHHHHHHHHHHHHHHHHH---HhCCCCCCccchheEEEC
Confidence            999999886 5668999999999999999864   235788999999999999999999   677899999999999999


Q ss_pred             CCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCcccc
Q 011360          347 DDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICS  425 (487)
Q Consensus       347 ~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~  425 (487)
                      .++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|+|+| |..||......     
T Consensus       150 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-----  224 (325)
T 3kex_A          150 SPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA-----  224 (325)
T ss_dssp             SSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT-----
T ss_pred             CCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH-----
Confidence            999999999999988765544433455668889999999998899999999999999999999 99999543321     


Q ss_pred             HHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          426 PEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       426 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                       +..........+  ..+..++        ..+.+++.+||+.||++|||+.++++.|+.+
T Consensus       225 -~~~~~~~~~~~~--~~~~~~~--------~~~~~li~~~l~~dp~~Rps~~el~~~l~~~  274 (325)
T 3kex_A          225 -EVPDLLEKGERL--AQPQICT--------IDVYMVMVKCWMIDENIRPTFKELANEFTRM  274 (325)
T ss_dssp             -HHHHHHHTTCBC--CCCTTBC--------TTTTHHHHHHTCSCTTTSCCHHHHHHHHHHH
T ss_pred             -HHHHHHHcCCCC--CCCCcCc--------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence             122222222111  1111222        2377899999999999999999999999875

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=7e-43  Score=340.98  Aligned_cols=269  Identities=25%  Similarity=0.342  Sum_probs=212.0

Q ss_pred             HhhhccccccccccccccceeEEEEEe----cCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC
Q 011360          187 FLKKEDCFASLEKIGSGGCGEVYKAEL----PGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI  262 (487)
Q Consensus       187 ~~~~~~~~~~~~~lg~G~~g~v~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  262 (487)
                      +....++|.+.+.||.|+||.||+|.+    +..+++.||||++...              ......+.+.+|+.++.++
T Consensus        22 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--------------~~~~~~~~~~~E~~~l~~l   87 (316)
T 2xir_A           22 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--------------ATHSEHRALMSELKILIHI   87 (316)
T ss_dssp             HBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT--------------CCHHHHHHHHHHHHHHHHH
T ss_pred             eecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccC--------------CCcHHHHHHHHHHHHHHhc
Confidence            444556799999999999999999975    2356789999998431              1223456788999999999


Q ss_pred             -CCCCccccceEEecCC-eeEEEEEecCCCCHHHHHhhhhcC------------CCCCChHHHHHHHHHHHHHHHHHHhc
Q 011360          263 -RHRNILPLLAHMVRPD-CHLLVYEFMKNGSLQDILDDVSRG------------RRELDWPSRHRIALGVASGLEYLHMY  328 (487)
Q Consensus       263 -~hpnIv~l~~~~~~~~-~~~lv~E~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~qi~~~L~~Lh~~  328 (487)
                       +||||+++++++...+ ..++||||+++|+|.+++......            ...+++..++.++.|++.||.||   
T Consensus        88 ~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~l---  164 (316)
T 2xir_A           88 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---  164 (316)
T ss_dssp             CCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHH---
T ss_pred             ccCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHH---
Confidence             7999999999987754 589999999999999999753211            12378999999999999999999   


Q ss_pred             CCCCeeecCCCCCCEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHH
Q 011360          329 HSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLV  408 (487)
Q Consensus       329 h~~givH~Dlkp~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ell  408 (487)
                      |++||+||||||+||+++.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|+
T Consensus       165 H~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~  244 (316)
T 2xir_A          165 ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF  244 (316)
T ss_dssp             HHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred             HhCCcccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHH
Confidence            67789999999999999999999999999998765544433344566889999999999889999999999999999999


Q ss_pred             h-CCCCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhhC
Q 011360          409 R-GVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL  487 (487)
Q Consensus       409 t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~ll  487 (487)
                      | |..||......     ............+ .     .+..    .+..+.+++.+||+.||.+|||+.++++.|+.++
T Consensus       245 t~g~~p~~~~~~~-----~~~~~~~~~~~~~-~-----~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  309 (316)
T 2xir_A          245 SLGASPYPGVKID-----EEFCRRLKEGTRM-R-----APDY----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  309 (316)
T ss_dssp             TTSCCSSTTCCCS-----HHHHHHHHHTCCC-C-----CCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hCCCCCCcccchh-----HHHHHHhccCccC-C-----CCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            8 99999544321     1222222222211 1     1111    1246889999999999999999999999998763

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=3.2e-43  Score=346.22  Aligned_cols=267  Identities=23%  Similarity=0.290  Sum_probs=210.7

Q ss_pred             hhhccccccccccccccceeEEEEEecCC----CCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-
Q 011360          188 LKKEDCFASLEKIGSGGCGEVYKAELPGS----NGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-  262 (487)
Q Consensus       188 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-  262 (487)
                      ....++|.+.+.||.|+||.||+|.....    ....||+|.+..              .........+.+|+.++..+ 
T Consensus        42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~--------------~~~~~~~~~~~~E~~~l~~l~  107 (333)
T 2i1m_A           42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKS--------------TAHADEKEALMSELKIMSHLG  107 (333)
T ss_dssp             BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECT--------------TCCHHHHHHHHHHHHHHHHHC
T ss_pred             cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccc--------------ccChHHHHHHHHHHHHHHhhc
Confidence            33456799999999999999999986432    224799998843              11223456788999999999 


Q ss_pred             CCCCccccceEEecCCeeEEEEEecCCCCHHHHHhhhhc----------CCCCCChHHHHHHHHHHHHHHHHHHhcCCCC
Q 011360          263 RHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSR----------GRRELDWPSRHRIALGVASGLEYLHMYHSAS  332 (487)
Q Consensus       263 ~hpnIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~g  332 (487)
                      +||||+++++++...+..++||||+++|+|.+++.....          ....+++..++.++.|++.||.||   |++|
T Consensus       108 ~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~  184 (333)
T 2i1m_A          108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFL---ASKN  184 (333)
T ss_dssp             CCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHH---HHTT
T ss_pred             CCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHH---hcCC
Confidence            899999999999999999999999999999999975321          134689999999999999999999   6678


Q ss_pred             eeecCCCCCCEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CC
Q 011360          333 IIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GV  411 (487)
Q Consensus       333 ivH~Dlkp~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~  411 (487)
                      |+||||||+||+++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|+| |.
T Consensus       185 ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~  264 (333)
T 2i1m_A          185 CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGL  264 (333)
T ss_dssp             EECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSC
T ss_pred             cccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCC
Confidence            99999999999999999999999999986644433333344567889999999998899999999999999999999 89


Q ss_pred             CCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          412 PSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       412 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      .||......      ............. ..+...        +..+.+++.+||+.||++|||+.+|++.|+.+
T Consensus       265 ~p~~~~~~~------~~~~~~~~~~~~~-~~~~~~--------~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~  324 (333)
T 2i1m_A          265 NPYPGILVN------SKFYKLVKDGYQM-AQPAFA--------PKNIYSIMQACWALEPTHRPTFQQICSFLQEQ  324 (333)
T ss_dssp             CSSTTCCSS------HHHHHHHHHTCCC-CCCTTC--------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCcccchh------HHHHHHHhcCCCC-CCCCCC--------CHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence            999543221      1222233222111 111111        25688999999999999999999999999875

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=6.9e-43  Score=338.85  Aligned_cols=267  Identities=21%  Similarity=0.310  Sum_probs=208.0

Q ss_pred             cccccccccccccceeEEEEEe---cCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcc
Q 011360          192 DCFASLEKIGSGGCGEVYKAEL---PGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNIL  268 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~---~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv  268 (487)
                      +.|.+.+.||.|+||.||+|++   +..+++.||+|++...              ........+.+|+.++..++||||+
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--------------~~~~~~~~~~~E~~~l~~l~h~~i~   86 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE--------------SGGNHIADLKKEIEILRNLYHENIV   86 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------------------CCHHHHHHHHHHHHTCCCTTBC
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccc--------------ccchhHHHHHHHHHHHHhCCCCCee
Confidence            3589999999999999999985   3457899999998431              1122345688999999999999999


Q ss_pred             ccceEEecC--CeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC
Q 011360          269 PLLAHMVRP--DCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN  346 (487)
Q Consensus       269 ~l~~~~~~~--~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~  346 (487)
                      ++++++...  ...++||||+++|+|.+++...   ...+++..++.++.|++.||.||   |++||+||||||+||+++
T Consensus        87 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dikp~Nil~~  160 (302)
T 4e5w_A           87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYL---GSRQYVHRDLAARNVLVE  160 (302)
T ss_dssp             CEEEEEEC---CCEEEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEE
T ss_pred             eeeeEEecCCCceEEEEEEeCCCCcHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHh---hcCCcccCCCchheEEEc
Confidence            999999876  6689999999999999999642   45689999999999999999999   677899999999999999


Q ss_pred             CCCCEEEeccCCccccCCCCce-eeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccC-------
Q 011360          347 DDMEACISDLGLAMAIPDGYTR-VLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ-------  418 (487)
Q Consensus       347 ~~~~~kl~DFg~s~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~-------  418 (487)
                      .++.+||+|||++......... .......||+.|+|||++.+..++.++||||||+++|+|+||..|+....       
T Consensus       161 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~  240 (302)
T 4e5w_A          161 SEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMI  240 (302)
T ss_dssp             ETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHH
T ss_pred             CCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhcc
Confidence            9999999999999876554322 22234568888999999998889999999999999999999998874321       


Q ss_pred             -CCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhhC
Q 011360          419 -NGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL  487 (487)
Q Consensus       419 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~ll  487 (487)
                       +................... ...++.        .+..+.+++.+||+.||++|||+.++++.|+.++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~--------~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          241 GPTHGQMTVTRLVNTLKEGKR-LPCPPN--------CPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             CSCCGGGHHHHHHHHHHTTCC-CCCCTT--------CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCcccccCHHHHHHHHhccCC-CCCCCC--------CCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence             11111111222222222211 111112        2356899999999999999999999999999874

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.8e-43  Score=356.38  Aligned_cols=254  Identities=21%  Similarity=0.291  Sum_probs=202.1

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||+|+||.||+|+. ..+++.||+|++...            ..........+.+|..++..++||||++++
T Consensus        69 ~~y~~~~~LG~G~fG~V~~~~~-~~~~~~~AiK~~~k~------------~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~  135 (410)
T 3v8s_A           69 EDYEVVKVIGRGAFGEVQLVRH-KSTRKVYAMKLLSKF------------EMIKRSDSAFFWEERDIMAFANSPWVVQLF  135 (410)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEE-TTTCCEEEEEEEEHH------------HHHHTCCCSTHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccEEEEEEEcCCCEEEEEEEE-CCCCcEEEEEEEehh------------hhhhhHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence            4699999999999999999975 467899999998420            111111233577899999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++.+.+.+|+|||||+||+|.+++..     ..+++..+..++.|++.||.||   |++||+||||||+|||++.+|.+
T Consensus       136 ~~~~~~~~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~L---H~~givHrDLKp~NILl~~~g~i  207 (410)
T 3v8s_A          136 YAFQDDRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAI---HSMGFIHRDVKPDNMLLDKSGHL  207 (410)
T ss_dssp             EEEECSSEEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCE
T ss_pred             EEEEECCEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHH---HHCCeEeccCCHHHeeECCCCCE
Confidence            999999999999999999999999864     3589999999999999999999   67789999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCCC----CCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPE----LSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPE  427 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~----~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~  427 (487)
                      ||+|||+++........ .....+||+.|+|||++.+..    |+.++|||||||++|||++|.+||...+      ..+
T Consensus       208 kL~DFG~a~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~------~~~  280 (410)
T 3v8s_A          208 KLADFGTCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS------LVG  280 (410)
T ss_dssp             EECCCTTCEECCTTSEE-ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS------HHH
T ss_pred             EEeccceeEeeccCCcc-cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC------hhh
Confidence            99999999876544321 224567999999999997654    7899999999999999999999994332      223


Q ss_pred             HHHHHHhcCC-CCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCC--CCChHHHHH
Q 011360          428 WLRKVMNSKN-PSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEE--RPNSQYVRC  481 (487)
Q Consensus       428 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--RPs~~~il~  481 (487)
                      ....+..... ........+        +.++.+++.+||..+|.+  ||++++|++
T Consensus       281 ~~~~i~~~~~~~~~p~~~~~--------s~~~~~li~~lL~~~~~rlgR~~~~ei~~  329 (410)
T 3v8s_A          281 TYSKIMNHKNSLTFPDDNDI--------SKEAKNLICAFLTDREVRLGRNGVEEIKR  329 (410)
T ss_dssp             HHHHHHTHHHHCCCCTTCCC--------CHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred             HHHHHHhccccccCCCcccc--------cHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence            3333332211 100001112        256889999999999998  999999875

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=6.4e-43  Score=336.93  Aligned_cols=251  Identities=19%  Similarity=0.313  Sum_probs=200.1

Q ss_pred             ccccccccccccccceeEEEEEecCCCC-------ceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCC
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNG-------KMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIR  263 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  263 (487)
                      .++|.+.+.||.|+||.||+|.... ++       ..||+|++..               ........+.+|+.++++++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~~~~~~~va~K~~~~---------------~~~~~~~~~~~E~~~l~~l~   70 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRRE-VGDYGQLHETEVLLKVLDK---------------AHRNYSESFFEAASMMSKLS   70 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEE-ECGGGCEEEEEEEEEEECG---------------GGGGGHHHHHHHHHHHHTSC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEec-ccccccccchhhhhhhccc---------------ccHHHHHHHHHHHHHHHhCC
Confidence            3569999999999999999997643 33       5699998732               12223457889999999999


Q ss_pred             CCCccccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCE
Q 011360          264 HRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNV  343 (487)
Q Consensus       264 hpnIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Ni  343 (487)
                      ||||+++++++..++..++||||+++|+|.+++..   ....+++..+..++.|++.||.||   |++||+||||||+||
T Consensus        71 h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~L---H~~~ivH~Dlkp~NI  144 (289)
T 4fvq_A           71 HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHFL---EENTLIHGNVCAKNI  144 (289)
T ss_dssp             CTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGE
T ss_pred             CCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHH---hhCCeECCCcCcceE
Confidence            99999999999999999999999999999999975   234489999999999999999999   677899999999999


Q ss_pred             EeCCCCC--------EEEeccCCccccCCCCceeeEeeecccccccCCcccCC-CCCCchhHHHHHHHHHHHHHhC-CCC
Q 011360          344 LLNDDME--------ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQ-PELSEKCDIFSFGMLLISLVRG-VPS  413 (487)
Q Consensus       344 ll~~~~~--------~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwslG~~l~elltg-~~p  413 (487)
                      +++.++.        +||+|||++......      ....||+.|+|||++.+ ..++.++||||||+++|+|++| .+|
T Consensus       145 ll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~  218 (289)
T 4fvq_A          145 LLIREEDRKTGNPPFIKLSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP  218 (289)
T ss_dssp             EEEECCBGGGTBCCEEEECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             EEecCCcccccccceeeeccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCC
Confidence            9998887        999999998765332      23458999999999987 6799999999999999999996 555


Q ss_pred             ccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhhC
Q 011360          414 FVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL  487 (487)
Q Consensus       414 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~ll  487 (487)
                      |...      .. ...........   .++...+        ..+.+++.+||+.||++|||+.++++.|++++
T Consensus       219 ~~~~------~~-~~~~~~~~~~~---~~~~~~~--------~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~  274 (289)
T 4fvq_A          219 LSAL------DS-QRKLQFYEDRH---QLPAPKA--------AELANLINNCMDYEPDHRPSFRAIIRDLNSLF  274 (289)
T ss_dssp             TTTS------CH-HHHHHHHHTTC---CCCCCSS--------CTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC
T ss_pred             cccc------ch-HHHHHHhhccC---CCCCCCC--------HHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            5221      11 11122222111   1112222        23889999999999999999999999999874

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=8.9e-43  Score=335.73  Aligned_cols=258  Identities=21%  Similarity=0.329  Sum_probs=210.1

Q ss_pred             hccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccc
Q 011360          190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILP  269 (487)
Q Consensus       190 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~  269 (487)
                      ..++|.+.+.||.|+||.||+|.+. .++..||+|.+..                .......+.+|+.++++++||||++
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~----------------~~~~~~~~~~E~~~l~~l~h~~i~~   73 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWK-KYSLTVAVKTLKE----------------DTMEVEEFLKEAAVMKEIKHPNLVQ   73 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEG-GGTEEEEEEEECS----------------CSTHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             cccceeEEeecCCCCceeEEEeEec-CCCEEEEEEecCc----------------CHHHHHHHHHHHHHHHhCCCCCEee
Confidence            3457999999999999999999764 5688999998832                1223456788999999999999999


Q ss_pred             cceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC
Q 011360          270 LLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDM  349 (487)
Q Consensus       270 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~  349 (487)
                      +++++.+.+..++||||+++++|.+++..  .....+++..++.++.|++.||.||   |++||+||||||+||+++.++
T Consensus        74 ~~~~~~~~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~~i~~~l~~l---H~~~i~H~dikp~Nil~~~~~  148 (288)
T 3kfa_A           74 LLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENH  148 (288)
T ss_dssp             EEEEECSSSSEEEEEECCTTEEHHHHHHH--CCTTTSCHHHHHHHHHHHHHHHHHH---HHHTCCCSCCSGGGEEECGGG
T ss_pred             EEEEEccCCCEEEEEEcCCCCcHHHHHHh--cccCCccHhHHHHHHHHHHHHHHHH---HHCCccCCCCCcceEEEcCCC
Confidence            99999999999999999999999999975  3456689999999999999999999   667899999999999999999


Q ss_pred             CEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccccHHH
Q 011360          350 EACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSPEW  428 (487)
Q Consensus       350 ~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~  428 (487)
                      .+||+|||++......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.....      ...
T Consensus       149 ~~~l~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~------~~~  221 (288)
T 3kfa_A          149 LVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------SQV  221 (288)
T ss_dssp             CEEECCCCGGGTSCSSSSE-EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG------GGH
T ss_pred             CEEEccCccceeccCCccc-cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH------HHH
Confidence            9999999999876544322 2234557889999999998899999999999999999999 8999954322      112


Q ss_pred             HHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          429 LRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       429 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      .........+  ..+..+        +..+.+++.+||+.||++|||+.++++.|+.+
T Consensus       222 ~~~~~~~~~~--~~~~~~--------~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~  269 (288)
T 3kfa_A          222 YELLEKDYRM--ERPEGC--------PEKVYELMRACWQWNPSDRPSFAEIHQAFETM  269 (288)
T ss_dssp             HHHHHTTCCC--CCCTTC--------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHhccCCC--CCCCCC--------CHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence            2222221111  111122        25688999999999999999999999999875

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=9.7e-43  Score=343.14  Aligned_cols=268  Identities=26%  Similarity=0.368  Sum_probs=197.3

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .++|.+.+.||.|+||.||+|+.   +++.||||++...                .........++..+..++||||+++
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~----------------~~~~~~~e~~~~~~~~~~h~~i~~~   72 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL---DERPVAVKVFSFA----------------NRQNFINEKNIYRVPLMEHDNIARF   72 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE---TTEEEEEEEEEGG----------------GHHHHHHHHHHHTSTTCCCTTBCCE
T ss_pred             hHHhheeeecccCCCeEEEEEEE---CCeEEEEEEeecc----------------chhhHHHHHHHHHHHhccCcchhhh
Confidence            35699999999999999999976   6889999998421                0111112334444566899999999


Q ss_pred             ceEEec-----CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCC---------Ceeec
Q 011360          271 LAHMVR-----PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSA---------SIIHG  336 (487)
Q Consensus       271 ~~~~~~-----~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~---------givH~  336 (487)
                      ++.+..     ...+++||||+++|+|.+++..     ...++..+..++.|++.||.||   |+.         ||+||
T Consensus        73 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~L---H~~~~~~~~~~~~ivH~  144 (336)
T 3g2f_A           73 IVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYL---HTELPRGDHYKPAISHR  144 (336)
T ss_dssp             EEEEEEECTTSCEEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHH---HCCBCCGGGCBCCEECS
T ss_pred             eecccccccCCCceEEEEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHH---Hhhhccccccccceeec
Confidence            975542     2356899999999999999974     3458889999999999999999   555         99999


Q ss_pred             CCCCCCEEeCCCCCEEEeccCCccccCCCCc------eeeEeeecccccccCCcccCC-------CCCCchhHHHHHHHH
Q 011360          337 DIKPRNVLLNDDMEACISDLGLAMAIPDGYT------RVLISYVLGTMAYIAPEYFQQ-------PELSEKCDIFSFGML  403 (487)
Q Consensus       337 Dlkp~Nill~~~~~~kl~DFg~s~~~~~~~~------~~~~~~~~gt~~y~aPE~l~~-------~~~~~~~DvwslG~~  403 (487)
                      ||||+|||++.++.+||+|||++........      ........||+.|+|||++.+       ..++.++|||||||+
T Consensus       145 Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~i  224 (336)
T 3g2f_A          145 DLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLI  224 (336)
T ss_dssp             SCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHH
T ss_pred             ccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHH
Confidence            9999999999999999999999987643221      111234569999999999987       356678999999999


Q ss_pred             HHHHHhCCCCccccCCCCcc-----------ccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCC
Q 011360          404 LISLVRGVPSFVFHQNGEEI-----------CSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEE  472 (487)
Q Consensus       404 l~elltg~~pf~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~  472 (487)
                      +|||++|..||.........           ..................++..++  .....+..+.+++.+||+.||++
T Consensus       225 l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~  302 (336)
T 3g2f_A          225 YWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWK--ENSLAVRSLKETIEDCWDQDAEA  302 (336)
T ss_dssp             HHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCC--CCSHHHHHHHHHHHHHSCSSGGG
T ss_pred             HHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccc--cccchHHHHHHHHHHHhcCChhh
Confidence            99999997666433221111           111222222322222222222222  23346678999999999999999


Q ss_pred             CCChHHHHHHHhhhC
Q 011360          473 RPNSQYVRCRLSQLL  487 (487)
Q Consensus       473 RPs~~~il~~L~~ll  487 (487)
                      |||+.++++.|++++
T Consensus       303 Rps~~e~l~~L~~ll  317 (336)
T 3g2f_A          303 RLTAQXAEERMAELM  317 (336)
T ss_dssp             SCCHHHHHHHHHHHH
T ss_pred             CcchHHHHHHHHHHH
Confidence            999999999998864

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=2.3e-43  Score=361.48  Aligned_cols=354  Identities=21%  Similarity=0.306  Sum_probs=242.9

Q ss_pred             chhhhhhhhhHHHHHHhhh----chhhhhhHHHHHHHHHHH---------HHHHHhhccccCC-CCcccccccCCCCCCh
Q 011360           93 VDYLLDEFQTEAFQTMLLQ----DADAMSKVKEVNARLQDI---------AWQINVLGLKESF-GGKSRNVRQRFPTTPS  158 (487)
Q Consensus        93 ~~~~~~~~~~~~~~~~l~~----~~~~~~r~~ei~~~l~~i---------~~~~~~~~l~~~~-g~~~~~~~~~~~s~p~  158 (487)
                      .++++..+++++.+++|..    +|+|+.|.++.......+         .....||.+.... |+........|++.+.
T Consensus        65 ~~w~~g~~~r~~ae~~L~~~~~~~G~FLvR~s~~~~g~y~lsv~~~~~~~~~~v~h~~I~~~~~g~~~~~~~~~F~Sl~~  144 (452)
T 1fmk_A           65 EEWYFGKITRRESERLLLNAENPRGTFLVRESETTKGAYCLSVSDFDNAKGLNVKHYKIRKLDSGGFYITSRTQFNSLQQ  144 (452)
T ss_dssp             STTEEETCCHHHHHHHHTCTTSCTTEEEEEECSSSTTCEEEEEEEEETTTEEEEEEEEEEECTTSCEESSTTSEESSHHH
T ss_pred             cccccCCccHHHHHHHhccCCCCCceEEEEeCCCCCCceEEEEEeeccCCCCcEEEEEEEEcCCCCEEEecCcccCCHHH
Confidence            4567788889998888864    388888864421100000         0123445554332 2233333445666655


Q ss_pred             hhhhhhcCCCC--CCCCcc---ccCC-cchhhHHHhhhccccccccccccccceeEEEEEecCCCCceEEEEEeeecCch
Q 011360          159 LISAAVRGGSR--DRGPTI---FSPL-IEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPI  232 (487)
Q Consensus       159 ~~~~~~~~~~~--~~~~~~---~~~~-~~~~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~  232 (487)
                      ++.........  ..-...   ..+. .......|....+.|.+.+.||+|+||.||+|.+.  .+..||||++....  
T Consensus       145 Li~~y~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~~--  220 (452)
T 1fmk_A          145 LVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWN--GTTRVAIKTLKPGT--  220 (452)
T ss_dssp             HHHHHTTCCTTSSSCCCEECCCCCCCCSSSSTTCSBCCGGGEEEEEEEEECSSCEEEEEEET--TTEEEEEEECCTTS--
T ss_pred             HHHHhhhccccchhhccccccccccccCCCCccccccChhHceeeeeecCCCCeEEEEEEEC--CCceEEEEEeccCC--
Confidence            55443221110  000000   0000 00011224445667999999999999999999875  45679999884211  


Q ss_pred             hHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHH
Q 011360          233 SAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRH  312 (487)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~  312 (487)
                                    ...+.+.+|+.++++++||||+++++++.. +..|+||||+++|+|.+++...  .+..+++..+.
T Consensus       221 --------------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~--~~~~~~~~~~~  283 (452)
T 1fmk_A          221 --------------MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLV  283 (452)
T ss_dssp             --------------SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHH--HHTTCCHHHHH
T ss_pred             --------------CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhc--CCCCCCHHHHH
Confidence                          123467899999999999999999999876 7789999999999999999742  23468999999


Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCC
Q 011360          313 RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELS  392 (487)
Q Consensus       313 ~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~  392 (487)
                      .++.|++.||.||   |++||+||||||+|||++.++.+||+|||+++......... .....+|+.|+|||++.+..++
T Consensus       284 ~i~~qi~~~l~~L---H~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~  359 (452)
T 1fmk_A          284 DMAAQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA-RQGAKFPIKWTAPEAALYGRFT  359 (452)
T ss_dssp             HHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------------CCGGGSCHHHHHHCCCC
T ss_pred             HHHHHHHHHHHHH---HhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCceec-ccCCcccccccCHhHHhcCCCC
Confidence            9999999999999   67789999999999999999999999999998765432211 1234478899999999988999


Q ss_pred             chhHHHHHHHHHHHHHh-CCCCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCC
Q 011360          393 EKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPE  471 (487)
Q Consensus       393 ~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~  471 (487)
                      .++||||||+++|||+| |..||....      ..+....+.....+  ..++.        .+..+.+++.+||+.||+
T Consensus       360 ~~sDvwslG~~l~el~t~g~~P~~~~~------~~~~~~~i~~~~~~--~~~~~--------~~~~l~~li~~cl~~dP~  423 (452)
T 1fmk_A          360 IKSDVWSFGILLTELTTKGRVPYPGMV------NREVLDQVERGYRM--PCPPE--------CPESLHDLMCQCWRKEPE  423 (452)
T ss_dssp             HHHHHHHHHHHHHHHHTTTCCSSTTCC------HHHHHHHHHTTCCC--CCCTT--------SCHHHHHHHHHHTCSSGG
T ss_pred             ccccHHhHHHHHHHHHhCCCCCCCCCC------HHHHHHHHHcCCCC--CCCCC--------CCHHHHHHHHHHccCChh
Confidence            99999999999999999 899994332      22333333332221  11112        235688999999999999


Q ss_pred             CCCChHHHHHHHhhhC
Q 011360          472 ERPNSQYVRCRLSQLL  487 (487)
Q Consensus       472 ~RPs~~~il~~L~~ll  487 (487)
                      +|||+.+|++.|+.++
T Consensus       424 ~Rpt~~~l~~~L~~~~  439 (452)
T 1fmk_A          424 ERPTFEYLQAFLEDYF  439 (452)
T ss_dssp             GSCCHHHHHHHHHTTT
T ss_pred             hCcCHHHHHHHHHHHh
Confidence            9999999999998763

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=2.9e-42  Score=333.00  Aligned_cols=262  Identities=23%  Similarity=0.305  Sum_probs=199.2

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||+|+||.||+|.. ..+++.||+|++....             ........+.+|+.++++++||||++++
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~~-------------~~~~~~~~~~~E~~~l~~l~h~~iv~~~   67 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKN-RETHEIVALKRVRLDD-------------DDEGVPSSALREICLLKELKHKNIVRLH   67 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEE-TTTCCEEEEEEEESSC-------------SSTTHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred             CCceeeeEecCCCCeEEEEEEE-CCCCceEEEEeeeccC-------------CcCCcchHHHHHHHHHhcCCCCCEeeEE
Confidence            4699999999999999999975 4678999999985421             1223345678899999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++.+++..++||||+++ +|.+++..   ....+++..+..++.|++.||.||   |++||+||||||+||+++.++.+
T Consensus        68 ~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~l---H~~~ivH~dikp~Nil~~~~~~~  140 (292)
T 3o0g_A           68 DVLHSDKKLTLVFEFCDQ-DLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFC---HSRNVLHRDLKPQNLLINRNGEL  140 (292)
T ss_dssp             EEEEETTEEEEEEECCSE-EHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCE
T ss_pred             eEEEeCCEEEEEEecCCC-CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEcCCCCE
Confidence            999999999999999965 66666543   246799999999999999999999   67789999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCCC-CCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPE-LSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLR  430 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~  430 (487)
                      ||+|||++.........  .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||.....     ..+...
T Consensus       141 kl~Dfg~~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~-----~~~~~~  213 (292)
T 3o0g_A          141 KLANFGLARAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND-----VDDQLK  213 (292)
T ss_dssp             EECCCTTCEECCSCCSC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS-----HHHHHH
T ss_pred             EEeecccceecCCcccc--ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCC-----HHHHHH
Confidence            99999999876433221  13456899999999987765 89999999999999999998777632221     112222


Q ss_pred             HHHhc-CCCC-CccC-----------CCC-----CCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          431 KVMNS-KNPS-RAID-----------PRL-----PGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       431 ~~~~~-~~~~-~~~~-----------~~~-----~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .+... ..+. ...+           +..     ........+..+.+++.+||+.||++|||++++++
T Consensus       214 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          214 RIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             HHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence            22210 1100 0000           000     00111223456889999999999999999999985

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=4e-42  Score=352.70  Aligned_cols=250  Identities=26%  Similarity=0.374  Sum_probs=205.1

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      +.|.+.+.||.|+||.||+|++ ..+|+.||||++...            ..........+.+|+.+++.++||||++++
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~-~~~g~~vAvK~i~~~------------~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~   82 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKH-ELTGHKVAVKILNRQ------------KIRSLDVVGKIRREIQNLKLFRHPHIIKLY   82 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEE-TTTCCEEEEEEEEHH------------HHHHTTTHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEE-CCCCCEEEEEEEEhh------------hccCHHHHHHHHHHHHHHHhCCCCCCCcEE
Confidence            4699999999999999999975 458999999998421            111122346788999999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++...+..|+||||++||+|.+++..    ...+++..+..++.|++.||.||   |++||+||||||+|||++.++.+
T Consensus        83 ~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~L---H~~givHrDLkp~NIll~~~~~v  155 (476)
T 2y94_A           83 QVISTPSDIFMVMEYVSGGELFDYICK----NGRLDEKESRRLFQQILSGVDYC---HRHMVVHRDLKPENVLLDAHMNA  155 (476)
T ss_dssp             EEEECSSEEEEEEECCSSEEHHHHTTS----SSSCCHHHHHHHHHHHHHHHHHH---HTTTEECSCCSGGGEEECTTCCE
T ss_pred             EEEEECCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCCCcccccHHHEEEecCCCe
Confidence            999999999999999999999999864    46799999999999999999999   77899999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCCCC-CchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPEL-SEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLR  430 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~  430 (487)
                      ||+|||++........   ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...      .......
T Consensus       156 kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~------~~~~~~~  226 (476)
T 2y94_A          156 KIADFGLSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDD------HVPTLFK  226 (476)
T ss_dssp             EECCCSSCEECCTTCC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCS------SSHHHHH
T ss_pred             EEEeccchhhcccccc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCC------CHHHHHH
Confidence            9999999987654322   234579999999999988765 78999999999999999999999432      2233444


Q ss_pred             HHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          431 KVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       431 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .+......   .+..+        +..+.+++.+||+.||++|||+.+|++
T Consensus       227 ~i~~~~~~---~p~~~--------s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          227 KICDGIFY---TPQYL--------NPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             HHHTTCCC---CCTTC--------CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHhcCCcC---CCccC--------CHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence            44332211   11111        246889999999999999999999986

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.4e-42  Score=334.54  Aligned_cols=260  Identities=25%  Similarity=0.371  Sum_probs=196.3

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||+|+||.||+|+.  .+++.||+|++....             ........+.+|+.+++.++||||++++
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~--~~~~~~aiK~~~~~~-------------~~~~~~~~~~~E~~~l~~l~h~~iv~~~   66 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN--NYGETFALKKIRLEK-------------EDEGIPSTTIREISILKELKHSNIVKLY   66 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE--TTSCEEEEEEECCSS-------------GGGCCCHHHHHHHHGGGGCCCTTBCCEE
T ss_pred             ccchhhhhcccCCCEEEEEEEc--CCCCEEEEEEEeccc-------------cccccchhHHHHHHHHHhcCCCCEeeee
Confidence            3699999999999999999976  478899999984321             1111234567899999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++...+..++||||+++ +|.+++..   ....+++..+..++.|++.||.||   |++||+||||||+||+++.++.+
T Consensus        67 ~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~  139 (288)
T 1ob3_A           67 DVIHTKKRLVLVFEHLDQ-DLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYC---HDRRVLHRDLKPQNLLINREGEL  139 (288)
T ss_dssp             EEEECSSCEEEEEECCSE-EHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTSCE
T ss_pred             eEEccCCeEEEEEEecCC-CHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEEcCCCCE
Confidence            999999999999999965 99988864   245689999999999999999999   67789999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQP-ELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLR  430 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~  430 (487)
                      ||+|||++.........  .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.....      .+...
T Consensus       140 kl~Dfg~~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~------~~~~~  211 (288)
T 1ob3_A          140 KIADFGLARAFGIPVRK--YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE------ADQLM  211 (288)
T ss_dssp             EECCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHH
T ss_pred             EEeECccccccCccccc--cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHH
Confidence            99999999765432221  1344689999999998764 689999999999999999999999954321      12222


Q ss_pred             HHHhc--CCCCC---------ccCCCCCC-------CCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          431 KVMNS--KNPSR---------AIDPRLPG-------NGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       431 ~~~~~--~~~~~---------~~~~~~~~-------~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .....  .....         ..++.++.       ......+..+.+++.+||+.||++|||+.++++
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          212 RIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             HHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            22210  00000         00000100       001123456889999999999999999999875

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.4e-42  Score=343.95  Aligned_cols=251  Identities=23%  Similarity=0.338  Sum_probs=188.7

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .+.|.+.+.||+|+||.||+|+. ..+++.||||++...                 ...+.+.+|+.++.+++||||+++
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~vavK~~~~~-----------------~~~~~~~~E~~~l~~l~h~niv~~  113 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQ-KGTQKPYALKVLKKT-----------------VDKKIVRTEIGVLLRLSHPNIIKL  113 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEE-TTTCCEEEEEEEEC---------------------------CHHHHHCCCTTBCCE
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEE-CCCCcEEEEEEeccc-----------------hhHHHHHHHHHHHHhCCCCCCcce
Confidence            35699999999999999999975 457889999988421                 123457789999999999999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC---
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLND---  347 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~---  347 (487)
                      ++++...+..++||||+++|+|.+++..    ...+++..+..++.|++.||.||   |+.||+||||||+||+++.   
T Consensus       114 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~L---H~~~ivH~Dikp~NIll~~~~~  186 (349)
T 2w4o_A          114 KEIFETPTEISLVLELVTGGELFDRIVE----KGYYSERDAADAVKQILEAVAYL---HENGIVHRDLKPENLLYATPAP  186 (349)
T ss_dssp             EEEEECSSEEEEEECCCCSCBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEESSSST
T ss_pred             eeeEecCCeEEEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeEecCCCcccEEEecCCC
Confidence            9999999999999999999999999864    45689999999999999999999   6778999999999999975   


Q ss_pred             CCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHH
Q 011360          348 DMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPE  427 (487)
Q Consensus       348 ~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~  427 (487)
                      ++.+||+|||++........   .....||+.|+|||++.+..++.++|||||||++|+|++|..||.....     ...
T Consensus       187 ~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~  258 (349)
T 2w4o_A          187 DAPLKIADFGLSKIVEHQVL---MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERG-----DQF  258 (349)
T ss_dssp             TCCEEECCCC-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTC-----HHH
T ss_pred             CCCEEEccCccccccCcccc---cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcc-----cHH
Confidence            88999999999986543321   2345689999999999999999999999999999999999999943322     111


Q ss_pred             HHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          428 WLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ....+......  ...     ......+..+.+++.+||+.||++|||+.++++
T Consensus       259 ~~~~i~~~~~~--~~~-----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          259 MFRRILNCEYY--FIS-----PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             HHHHHHTTCCC--CCT-----TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHhCCCc--cCC-----chhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            22233322111  111     111123356889999999999999999999986

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=6.2e-43  Score=341.88  Aligned_cols=263  Identities=25%  Similarity=0.367  Sum_probs=188.1

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||+|+||.||+|.. ..+++.||+|++....              .......+.+|+.+++.++||||++++
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~~~--------------~~~~~~~~~~E~~~l~~l~hp~iv~~~   69 (317)
T 2pmi_A            5 SQFKQLEKLGNGTYATVYKGLN-KTTGVYVALKEVKLDS--------------EEGTPSTAIREISLMKELKHENIVRLY   69 (317)
T ss_dssp             --------------CEEEEEEC-SSSCCEEEEEEEECCS--------------TTCSCHHHHHHHHHHTTCCBTTBCCEE
T ss_pred             cceeEeeEECCCCCEEEEEEEE-CCCCcEEEEEEeeccc--------------ccccHHHHHHHHHHHHhcCCCCcceEE
Confidence            4699999999999999999974 4678999999985421              111234567899999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhc--CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSR--GRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDM  349 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~  349 (487)
                      +++..++..++||||++ |+|.+++.....  ....+++..+..++.|++.||.||   |++||+||||||+|||++.++
T Consensus        70 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~l---H~~~ivH~Dlkp~NIl~~~~~  145 (317)
T 2pmi_A           70 DVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC---HENKILHRDLKPQNLLINKRG  145 (317)
T ss_dssp             EEECCTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTC
T ss_pred             EEEEECCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHH---HHCCeeeCCCChHHeEEcCCC
Confidence            99999999999999997 599999875432  234589999999999999999999   677899999999999999999


Q ss_pred             CEEEeccCCccccCCCCceeeEeeecccccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHH
Q 011360          350 EACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQ-PELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEW  428 (487)
Q Consensus       350 ~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~  428 (487)
                      .+||+|||++.........  .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.....      .+.
T Consensus       146 ~~kl~Dfg~~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~  217 (317)
T 2pmi_A          146 QLKLGDFGLARAFGIPVNT--FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND------EEQ  217 (317)
T ss_dssp             CEEECCCSSCEETTSCCCC--CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHH
T ss_pred             CEEECcCccceecCCCccc--CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh------HHH
Confidence            9999999999876433221  134568999999999876 4689999999999999999999999954322      112


Q ss_pred             HHHHHhc-CCCCC-c---------cCCCCC----CC--------CcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          429 LRKVMNS-KNPSR-A---------IDPRLP----GN--------GYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       429 ~~~~~~~-~~~~~-~---------~~~~~~----~~--------~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ...+... +.+.. .         ..+.++    ..        .....+..+.+++.+||+.||++|||+.++++
T Consensus       218 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          218 LKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             HHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence            2222110 11100 0         000000    00        00112357889999999999999999999875

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=2.9e-42  Score=338.60  Aligned_cols=253  Identities=22%  Similarity=0.342  Sum_probs=193.8

Q ss_pred             cccccccccccccceeEEEEEec--CCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELP--GSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILP  269 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~  269 (487)
                      ++|.+.+.||+|+||.||+++..  ..+++.||+|++.....           .........+.+|+.+++.++||||++
T Consensus        17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~-----------~~~~~~~~~~~~E~~~l~~l~hp~iv~   85 (327)
T 3a62_A           17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMI-----------VRNAKDTAHTKAERNILEEVKHPFIVD   85 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC-------------------------HHHHHHHCCCTTBCC
T ss_pred             HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHh-----------hhhhhHHHHHHHHHHHHHhCCCCCccc
Confidence            46999999999999999999753  25789999999843110           011223456778999999999999999


Q ss_pred             cceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC
Q 011360          270 LLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDM  349 (487)
Q Consensus       270 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~  349 (487)
                      +++++...+..|+||||+++|+|.+++..    ...+++..+..++.|++.||.||   |++||+||||||+|||++.++
T Consensus        86 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~l---H~~~ivH~Dlkp~Nill~~~~  158 (327)
T 3a62_A           86 LIYAFQTGGKLYLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHL---HQKGIIYRDLKPENIMLNHQG  158 (327)
T ss_dssp             EEEEEECSSCEEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCTTTEEECTTS
T ss_pred             eeEEEEcCCEEEEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHH---HhCCEEcccCCHHHeEECCCC
Confidence            99999999999999999999999999975    35688999999999999999999   677899999999999999999


Q ss_pred             CEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHH
Q 011360          350 EACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWL  429 (487)
Q Consensus       350 ~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~  429 (487)
                      .+||+|||++........  ......||+.|+|||++.+..++.++||||||+++|+|++|..||....      ..+..
T Consensus       159 ~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~  230 (327)
T 3a62_A          159 HVKLTDFGLCKESIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN------RKKTI  230 (327)
T ss_dssp             CEEECCCSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHH
T ss_pred             cEEEEeCCcccccccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC------HHHHH
Confidence            999999999875433221  1234579999999999999899999999999999999999999994332      22333


Q ss_pred             HHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCC-----ChHHHHH
Q 011360          430 RKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERP-----NSQYVRC  481 (487)
Q Consensus       430 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~~il~  481 (487)
                      ..+.....   .+++.+        +..+.+++.+||..||++||     ++.++++
T Consensus       231 ~~i~~~~~---~~p~~~--------~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          231 DKILKCKL---NLPPYL--------TQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             HHHHHTCC---CCCTTS--------CHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             HHHHhCCC---CCCCCC--------CHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence            33333221   111222        25688999999999999999     6677764

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.1e-42  Score=336.65  Aligned_cols=260  Identities=19%  Similarity=0.230  Sum_probs=206.5

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CCCCccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RHRNILP  269 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~  269 (487)
                      .++|.+.+.||.|+||.||+|.. ..+++.||+|++....                 ....+.+|+.++..+ +|||+++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~~-----------------~~~~~~~e~~~~~~l~~~~~i~~   70 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTN-LLNNQQVAIKFEPRRS-----------------DAPQLRDEYRTYKLLAGCTGIPN   70 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEE-TTTTEEEEEEEEECCT-----------------TSCCHHHHHHHHHHTTTCTTCCC
T ss_pred             ccceEEEEEEeecCCEEEEEEEE-CCCCcEEEEEEeccCC-----------------ccHHHHHHHHHHHHHhcCCCCCe
Confidence            34699999999999999999974 4689999999874311                 123466788888888 8999999


Q ss_pred             cceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC
Q 011360          270 LLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDM  349 (487)
Q Consensus       270 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~  349 (487)
                      +++++......++||||+ +++|.+++...   +..+++..+..++.|++.||.||   |++||+||||||+||+++.++
T Consensus        71 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~Dlkp~NIl~~~~~  143 (298)
T 1csn_A           71 VYYFGQEGLHNVLVIDLL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSI---HEKSLVYRDIKPDNFLIGRPN  143 (298)
T ss_dssp             EEEEEEETTEEEEEEECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCCGGGEEECCSS
T ss_pred             EEeecCCCceeEEEEEec-CCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHEEeccCC
Confidence            999999999999999999 99999999752   45699999999999999999999   778999999999999998777


Q ss_pred             C-----EEEeccCCccccCCCCce-----eeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCC
Q 011360          350 E-----ACISDLGLAMAIPDGYTR-----VLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQN  419 (487)
Q Consensus       350 ~-----~kl~DFg~s~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~  419 (487)
                      .     +||+|||++.........     .......||+.|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus       144 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  223 (298)
T 1csn_A          144 SKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA  223 (298)
T ss_dssp             STTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCS
T ss_pred             CCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhc
Confidence            6     999999999876543221     112345699999999999999999999999999999999999999965433


Q ss_pred             CCccccHHHHHHHHhc--CCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          420 GEEICSPEWLRKVMNS--KNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       420 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      ....   .........  ..+...+.+.+        +..+.+++.+||+.||++|||+.+|++.|+++
T Consensus       224 ~~~~---~~~~~~~~~~~~~~~~~~~~~~--------~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~  281 (298)
T 1csn_A          224 ATNK---QKYERIGEKKQSTPLRELCAGF--------PEEFYKYMHYARNLAFDATPDYDYLQGLFSKV  281 (298)
T ss_dssp             CCHH---HHHHHHHHHHHHSCHHHHTTTS--------CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             cccH---HHHHHHHhhccCccHHHHHhhC--------cHHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence            2221   111111111  11111111122        25689999999999999999999999999876

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=4.7e-43  Score=344.70  Aligned_cols=258  Identities=22%  Similarity=0.262  Sum_probs=205.1

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CCCCcccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RHRNILPL  270 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l  270 (487)
                      ++|.+.+.||.|+||.||+|+. ..+++.||||++....                 ....+.+|+.+++.+ +||||+++
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~~-----------------~~~~~~~E~~~l~~l~~h~~i~~~   70 (330)
T 2izr_A            9 PNFRVGKKIGCGNFGELRLGKN-LYTNEYVAIKLEPMKS-----------------RAPQLHLEYRFYKQLGSGDGIPQV   70 (330)
T ss_dssp             TTEEEEEECCC-CTTSEEEEEE-TTTTEEEEEEEEETTC-----------------SSCCHHHHHHHHHHHCSCTTSCCE
T ss_pred             CCeEEEEEeeccCCceEEEEEE-CCCCcEEEEEEecccc-----------------chHHHHHHHHHHHHhhCCCCCCEE
Confidence            4699999999999999999974 4689999999874211                 123467899999999 99999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      ++++...+..++||||+ +++|.+++...   ...+++..+..++.|++.||.||   |+.||+||||||+|||++.++.
T Consensus        71 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~L---H~~~iiHrDlkp~Nill~~~~~  143 (330)
T 2izr_A           71 YYFGPCGKYNAMVLELL-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYV---HSKNLIYRDVKPENFLIGRPGN  143 (330)
T ss_dssp             EEEEEETTEEEEEEECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECCGGG
T ss_pred             EEEEecCCccEEEEEeC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCCHHHeeeccCCC
Confidence            99999999999999999 99999999752   46799999999999999999999   6778999999999999998887


Q ss_pred             -----EEEeccCCccccCCCCcee-----eEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCC
Q 011360          351 -----ACISDLGLAMAIPDGYTRV-----LISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNG  420 (487)
Q Consensus       351 -----~kl~DFg~s~~~~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~  420 (487)
                           +||+|||++..........     ......||+.|+|||++.+..++.++||||||+++|||++|..||......
T Consensus       144 ~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~  223 (330)
T 2izr_A          144 KTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKAD  223 (330)
T ss_dssp             TCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCS
T ss_pred             CCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccc
Confidence                 9999999998754432211     113467999999999999999999999999999999999999999655332


Q ss_pred             CccccHHHHHHHHhc--CCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          421 EEICSPEWLRKVMNS--KNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       421 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      ..   .+........  ..+...+...        .+ .+.+++..||+.+|.+||++.+|.+.|+++
T Consensus       224 ~~---~~~~~~i~~~~~~~~~~~~~~~--------~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~  279 (330)
T 2izr_A          224 TL---KERYQKIGDTKRATPIEVLCEN--------FP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL  279 (330)
T ss_dssp             SH---HHHHHHHHHHHHHSCHHHHTTT--------CH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             cH---HHHHHHHHhhhccCCHHHHhcc--------Ch-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence            21   1222222111  1111100111        12 689999999999999999999999999865

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.8e-42  Score=354.61  Aligned_cols=251  Identities=20%  Similarity=0.276  Sum_probs=195.0

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||+|+||.||+|.. ..+|+.||||++..            ...........+.+|+.++..++||||++++
T Consensus       148 ~~y~~~~~lG~G~~g~V~~~~~-~~~~~~vaiK~~~~------------~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~  214 (446)
T 4ejn_A          148 NEFEYLKLLGKGTFGKVILVKE-KATGRYYAMKILKK------------EVIVAKDEVAHTLTENRVLQNSRHPFLTALK  214 (446)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEE-TTTCCEEEEEEEEH------------HHHC-------------CCCCCSCTTSCCEE
T ss_pred             HHcEEeEEEeeCcCEEEEEEEE-cCCCCEEEEEEEEh------------hhhhhhHHHHHHHHHHHHHHhCCCCeEeeEE
Confidence            4699999999999999999974 56899999999842            1112233456678899999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCC-CCeeecCCCCCCEEeCCCCC
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHS-ASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~-~givH~Dlkp~Nill~~~~~  350 (487)
                      +++...+.+|+||||+++|+|.+++..    ...+++..+..++.|++.||.||   |+ +||+||||||+|||++.++.
T Consensus       215 ~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~L---H~~~giiHrDlkp~NIll~~~~~  287 (446)
T 4ejn_A          215 YSFQTHDRLCFVMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYL---HSEKNVVYRDLKLENLMLDKDGH  287 (446)
T ss_dssp             EEEEETTEEEEEECCCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHH---HHHTCCCCCCCCGGGEEECSSSC
T ss_pred             EEEeeCCEEEEEEeeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---hhcCCEEECCCCHHHEEECCCCC
Confidence            999999999999999999999999875    35789999999999999999999   54 78999999999999999999


Q ss_pred             EEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHH
Q 011360          351 ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLR  430 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~  430 (487)
                      +||+|||+++.......  .....+||+.|+|||++.+..|+.++|||||||++|||++|..||....      ......
T Consensus       288 ~kl~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~------~~~~~~  359 (446)
T 4ejn_A          288 IKITDFGLCKEGIKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD------HEKLFE  359 (446)
T ss_dssp             EEECCCCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHH
T ss_pred             EEEccCCCceeccCCCc--ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC------HHHHHH
Confidence            99999999976433222  2245679999999999999999999999999999999999999994332      222333


Q ss_pred             HHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCC-----ChHHHHH
Q 011360          431 KVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERP-----NSQYVRC  481 (487)
Q Consensus       431 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~~il~  481 (487)
                      .+.... ..  ++..+        +.++.+++.+||+.||++||     |++++++
T Consensus       360 ~i~~~~-~~--~p~~~--------~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          360 LILMEE-IR--FPRTL--------GPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             HHHHCC-CC--CCTTS--------CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             HHHhCC-CC--CCccC--------CHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence            333222 11  11112        25688999999999999999     9999875

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1e-42  Score=331.41  Aligned_cols=256  Identities=24%  Similarity=0.333  Sum_probs=206.5

Q ss_pred             hccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccc
Q 011360          190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILP  269 (487)
Q Consensus       190 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~  269 (487)
                      ..++|.+.+.||+|+||.||+|.+.  ++..||+|++....                ...+.+.+|+.++..++||||++
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vaiK~~~~~~----------------~~~~~~~~e~~~l~~l~h~~i~~   67 (267)
T 3t9t_A            6 DPSELTFVQEIGSGQFGLVHLGYWL--NKDKVAIKTIREGA----------------MSEEDFIEEAEVMMKLSHPKLVQ   67 (267)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET--TTEEEEEEEECTTT----------------BCHHHHHHHHHHHHTCCCTTBCC
T ss_pred             chhheeeeeEecCCCceeEEEEEec--CCCeEEEEEccccC----------------CCHHHHHHHHHHHHhCCCCCEee
Confidence            3457999999999999999999864  67889999984311                11246788999999999999999


Q ss_pred             cceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC
Q 011360          270 LLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDM  349 (487)
Q Consensus       270 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~  349 (487)
                      +++++...+..++||||+++++|.+++..   ....+++..+..++.|++.||.||   |++|++||||||+||+++.++
T Consensus        68 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~Nili~~~~  141 (267)
T 3t9t_A           68 LYGVCLEQAPICLVTEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYL---EEACVIHRDLAARNCLVGENQ  141 (267)
T ss_dssp             EEEEECSSSSCEEEECCCTTCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSSCCGGGEEECGGG
T ss_pred             EEEEEccCCCeEEEEeCCCCCcHHHHHhh---CcccCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCchheEEECCCC
Confidence            99999999999999999999999999975   245689999999999999999999   677899999999999999999


Q ss_pred             CEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccccHHH
Q 011360          350 EACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSPEW  428 (487)
Q Consensus       350 ~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~  428 (487)
                      .+||+|||++......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...      ...+.
T Consensus       142 ~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~------~~~~~  214 (267)
T 3t9t_A          142 VIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR------SNSEV  214 (267)
T ss_dssp             CEEECCTTGGGGBCCHHHH-STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC------CHHHH
T ss_pred             CEEEccccccccccccccc-ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCC------CHHHH
Confidence            9999999999865432211 1123346788999999998889999999999999999999 89999432      22233


Q ss_pred             HHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          429 LRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       429 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      ...+.....+  .    .+..    .+..+.+++.+||+.||++|||+.++++.|+++
T Consensus       215 ~~~i~~~~~~--~----~~~~----~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l  262 (267)
T 3t9t_A          215 VEDISTGFRL--Y----KPRL----ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI  262 (267)
T ss_dssp             HHHHHTTCCC--C----CCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHhcCCcC--C----CCcc----CcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            3333322111  1    1111    225688999999999999999999999999876

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=2e-42  Score=342.10  Aligned_cols=253  Identities=23%  Similarity=0.356  Sum_probs=194.4

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCC--CCcc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRH--RNIL  268 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--pnIv  268 (487)
                      .+.|.+.+.||+|+||.||++..  .++..||||++...             .........+.+|+.++..++|  |||+
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~-------------~~~~~~~~~~~~E~~~l~~l~~~~~~iv   72 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLN--EKKQIYAIKYVNLE-------------EADNQTLDSYRNEIAYLNKLQQHSDKII   72 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEEC--TTSCEEEEEEEECT-------------TCCHHHHHHHHHHHHHHHHHTTTCTTBC
T ss_pred             cCEEEEEEEEecCCCeEEEEEEe--CCCCEEEEEEeecc-------------ccchHHHHHHHHHHHHHHhhhhcCCceE
Confidence            35699999999999999999975  36889999998431             1223445678899999999976  9999


Q ss_pred             ccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC
Q 011360          269 PLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDD  348 (487)
Q Consensus       269 ~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~  348 (487)
                      ++++++...+..|+|||+ .+++|.+++..    ...+++..+..++.|++.||.||   |++||+||||||+|||++ +
T Consensus        73 ~~~~~~~~~~~~~lv~e~-~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~l---H~~~iiHrDikp~NIll~-~  143 (343)
T 3dbq_A           73 RLYDYEITDQYIYMVMEC-GNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTI---HQHGIVHSDLKPANFLIV-D  143 (343)
T ss_dssp             CEEEEEECSSEEEEEECC-CSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEEE-T
T ss_pred             EEeeeEeeCCEEEEEEeC-CCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCcceEEEE-C
Confidence            999999999999999995 58899999975    46789999999999999999999   677899999999999997 6


Q ss_pred             CCEEEeccCCccccCCCCceeeEeeecccccccCCcccCC-----------CCCCchhHHHHHHHHHHHHHhCCCCcccc
Q 011360          349 MEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQ-----------PELSEKCDIFSFGMLLISLVRGVPSFVFH  417 (487)
Q Consensus       349 ~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----------~~~~~~~DvwslG~~l~elltg~~pf~~~  417 (487)
                      +.+||+|||++................||+.|+|||++.+           ..++.++|||||||++|+|++|..||...
T Consensus       144 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  223 (343)
T 3dbq_A          144 GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI  223 (343)
T ss_dssp             TEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             CcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhh
Confidence            7899999999987755443333345679999999999854           67899999999999999999999999432


Q ss_pred             CCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          418 QNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       418 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ..     ............ ....    ++...    ...+.+++.+||+.||++|||+.++++
T Consensus       224 ~~-----~~~~~~~~~~~~-~~~~----~~~~~----~~~l~~li~~~L~~dp~~Rpt~~e~l~  273 (343)
T 3dbq_A          224 IN-----QISKLHAIIDPN-HEIE----FPDIP----EKDLQDVLKCCLKRDPKQRISIPELLA  273 (343)
T ss_dssp             CS-----HHHHHHHHHCTT-SCCC----CCCCS----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hh-----HHHHHHHHhcCC-cccC----CcccC----CHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence            11     112222232221 1111    11111    245889999999999999999999875

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.6e-42  Score=346.27  Aligned_cols=249  Identities=22%  Similarity=0.299  Sum_probs=196.0

Q ss_pred             ccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceEE
Q 011360          195 ASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHM  274 (487)
Q Consensus       195 ~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  274 (487)
                      ...+.||.|+||.||+|.. ..+|..||+|++...               .......+.+|+.++.+++||||+++++++
T Consensus        92 ~~~~~lG~G~~g~Vy~a~~-~~~g~~vavK~~~~~---------------~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~  155 (373)
T 2x4f_A           92 SKTEILGGGRFGQVHKCEE-TATGLKLAAKIIKTR---------------GMKDKEEVKNEISVMNQLDHANLIQLYDAF  155 (373)
T ss_dssp             EEEEECC-----CEEEEEE-TTTCCEEEEEEEECC---------------SHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             ecceEEecCcCEEEEEEEE-cCCCcEEEEEEEccc---------------ccccHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            3467899999999999975 457899999998431               112345788999999999999999999999


Q ss_pred             ecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEe--CCCCCEE
Q 011360          275 VRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLL--NDDMEAC  352 (487)
Q Consensus       275 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill--~~~~~~k  352 (487)
                      ...+..++||||+++|+|.+++..   ....+++..+..++.|++.||.||   |+.||+||||||+|||+  +.++.+|
T Consensus       156 ~~~~~~~lv~E~~~~~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~~~~~~k  229 (373)
T 2x4f_A          156 ESKNDIVLVMEYVDGGELFDRIID---ESYNLTELDTILFMKQICEGIRHM---HQMYILHLDLKPENILCVNRDAKQIK  229 (373)
T ss_dssp             ECSSEEEEEEECCTTCEEHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEEEETTTTEEE
T ss_pred             EECCEEEEEEeCCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccccCCHHHEEEecCCCCcEE
Confidence            999999999999999999998864   235689999999999999999999   67789999999999999  5678899


Q ss_pred             EeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHH
Q 011360          353 ISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKV  432 (487)
Q Consensus       353 l~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~  432 (487)
                      |+|||++.........   ....||+.|+|||++.+..++.++|||||||++|+|++|..||....      ..+....+
T Consensus       230 l~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~------~~~~~~~i  300 (373)
T 2x4f_A          230 IIDFGLARRYKPREKL---KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN------DAETLNNI  300 (373)
T ss_dssp             ECCCSSCEECCTTCBC---CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHH
T ss_pred             EEeCCCceecCCcccc---ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHH
Confidence            9999999876544322   33469999999999999899999999999999999999999994432      22333333


Q ss_pred             HhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          433 MNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       433 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ......       ++.......+.++.+++.+||+.||++|||+.++++
T Consensus       301 ~~~~~~-------~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          301 LACRWD-------LEDEEFQDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             HHTCCC-------SCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HhccCC-------CChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            332211       111111123357899999999999999999999986

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=3.1e-43  Score=343.04  Aligned_cols=256  Identities=21%  Similarity=0.283  Sum_probs=194.5

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||.|+||.||+|.. ..+++.||||++...            ..........+.+|+.++.+++||||++++
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~------------~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~   78 (311)
T 3ork_A           12 DRYELGEILGFGGMSEVHLARD-LRDHRDVAVKVLRAD------------LARDPSFYLRFRREAQNAAALNHPAIVAVY   78 (311)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEE-TTTTEEEEEEEECTT------------TTTSHHHHHHHHHHHTTCCCCCCTTBCCEE
T ss_pred             CcEEEEEEEccCCCEEEEEEEE-CCCCceEEEEEeCcc------------ccCCHHHHHHHHHHHHHHHcCCCCCcceEE
Confidence            4699999999999999999975 468899999998431            112234456788999999999999999999


Q ss_pred             eEEecCCe----eEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC
Q 011360          272 AHMVRPDC----HLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLND  347 (487)
Q Consensus       272 ~~~~~~~~----~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~  347 (487)
                      +++.....    .|+||||++|++|.+++..    ...+++..++.++.|++.||.||   |++||+||||||+||+++.
T Consensus        79 ~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~Nil~~~  151 (311)
T 3ork_A           79 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFS---HQNGIIHRDVKPANIMISA  151 (311)
T ss_dssp             EEEEEEETTEEEEEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEEET
T ss_pred             EeeeccCCCCcccEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCCCcCCCCHHHEEEcC
Confidence            99876544    3999999999999999975    35689999999999999999999   6778999999999999999


Q ss_pred             CCCEEEeccCCccccCCCCce-eeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccH
Q 011360          348 DMEACISDLGLAMAIPDGYTR-VLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSP  426 (487)
Q Consensus       348 ~~~~kl~DFg~s~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~  426 (487)
                      ++.+||+|||++......... .......||+.|+|||++.+..++.++||||||+++|+|+||..||....      ..
T Consensus       152 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~------~~  225 (311)
T 3ork_A          152 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS------PV  225 (311)
T ss_dssp             TSCEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS------HH
T ss_pred             CCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC------hH
Confidence            999999999999876543221 12234568999999999999999999999999999999999999994332      22


Q ss_pred             HHHHHHHhcCCCC-CccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          427 EWLRKVMNSKNPS-RAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       427 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      +............ ....+.        .+.++.+++.+||+.||++||++.+++.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~--------~~~~l~~li~~~l~~dP~~R~~~~~~l~  273 (311)
T 3ork_A          226 SVAYQHVREDPIPPSARHEG--------LSADLDAVVLKALAKNPENRYQTAAEMR  273 (311)
T ss_dssp             HHHHHHHHCCCCCHHHHSTT--------CCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred             HHHHHHhcCCCCCcccccCC--------CCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence            2223333222111 111111        2356889999999999999997766553

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=4.7e-42  Score=345.12  Aligned_cols=252  Identities=23%  Similarity=0.355  Sum_probs=195.5

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCC--CCCccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIR--HRNILP  269 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpnIv~  269 (487)
                      +.|.+.+.||.|+||.||++...  ++..||||++...             .........+.+|+.++..+.  ||||++
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~--~~~~vaiK~~~~~-------------~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~  120 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNE--KKQIYAIKYVNLE-------------EADNQTLDSYRNEIAYLNKLQQHSDKIIR  120 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECT--TCCEEEEEEEECT-------------TCCHHHHHHHHHHHHHHHHHTTTCTTBCC
T ss_pred             CceEEEEEEccCCCeEEEEEEcC--CCCEEEEEEEecc-------------cccHHHHHHHHHHHHHHHHcccCCCeEEE
Confidence            45999999999999999999753  4889999988431             122345567889999999996  599999


Q ss_pred             cceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC
Q 011360          270 LLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDM  349 (487)
Q Consensus       270 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~  349 (487)
                      +++++...+.+|+||| +.+++|.+++..    ...+++..+..++.||+.||.||   |++||+||||||+|||++ ++
T Consensus       121 ~~~~~~~~~~~~lv~E-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~l---H~~~ivHrDlkp~NIll~-~~  191 (390)
T 2zmd_A          121 LYDYEITDQYIYMVME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTI---HQHGIVHSDLKPANFLIV-DG  191 (390)
T ss_dssp             EEEEEECSSEEEEEEE-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHH---HTTTCCCCCCCGGGEEES-SS
T ss_pred             EEEEEecCCEEEEEEe-cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCCHHHEEEE-CC
Confidence            9999999999999999 568899999975    45788899999999999999999   778999999999999996 57


Q ss_pred             CEEEeccCCccccCCCCceeeEeeecccccccCCcccCC-----------CCCCchhHHHHHHHHHHHHHhCCCCccccC
Q 011360          350 EACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQ-----------PELSEKCDIFSFGMLLISLVRGVPSFVFHQ  418 (487)
Q Consensus       350 ~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----------~~~~~~~DvwslG~~l~elltg~~pf~~~~  418 (487)
                      .+||+|||+++...............||+.|+|||++.+           ..++.++|||||||++|+|++|..||....
T Consensus       192 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~  271 (390)
T 2zmd_A          192 MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII  271 (390)
T ss_dssp             CEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             eEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh
Confidence            999999999987655433333345679999999999864           368999999999999999999999994322


Q ss_pred             CCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          419 NGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       419 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .     ....+......... ..    ++...    +..+.+++.+||+.||++|||+.++++
T Consensus       272 ~-----~~~~~~~~~~~~~~-~~----~~~~~----~~~~~~li~~~L~~dP~~Rps~~ell~  320 (390)
T 2zmd_A          272 N-----QISKLHAIIDPNHE-IE----FPDIP----EKDLQDVLKCCLKRDPKQRISIPELLA  320 (390)
T ss_dssp             C-----HHHHHHHHHCTTSC-CC----CCCCS----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             H-----HHHHHHHHhCcccc-CC----CCccc----hHHHHHHHHHHcccChhhCCCHHHHhh
Confidence            1     12223333322211 11    11111    246889999999999999999999975

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=2.1e-42  Score=339.71  Aligned_cols=253  Identities=21%  Similarity=0.341  Sum_probs=196.3

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||+|+||.||+|+. ..+|+.||||++....              .....+.+.+|+.++++++||||++++
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~-~~~~~~vavK~~~~~~--------------~~~~~~~~~~E~~~l~~l~hpniv~~~   70 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKN-KVDDCNYAIKRIRLPN--------------RELAREKVMREVKALAKLEHPGIVRYF   70 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEE-TTTCCEEEEEEEECCS--------------TTTHHHHHHHHHHHHTSCCCTTBCCEE
T ss_pred             hcCceeeEecCCCCeEEEEEEE-cCCCcEEEEEEeecCC--------------chhHHHHHHHHHHHHHhCCCCCEeeEE
Confidence            4699999999999999999975 4578999999985321              222446788999999999999999999


Q ss_pred             eEEecCC---------------------------------------------------------eeEEEEEecCCCCHHH
Q 011360          272 AHMVRPD---------------------------------------------------------CHLLVYEFMKNGSLQD  294 (487)
Q Consensus       272 ~~~~~~~---------------------------------------------------------~~~lv~E~~~~gsL~~  294 (487)
                      +++.+..                                                         ..++|||||++|+|.+
T Consensus        71 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~  150 (332)
T 3qd2_B           71 NAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKD  150 (332)
T ss_dssp             EEEEECCSCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHH
T ss_pred             EEEEEeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHH
Confidence            9886543                                                         2799999999999999


Q ss_pred             HHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEeccCCccccCCCCce------
Q 011360          295 ILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTR------  368 (487)
Q Consensus       295 ~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~DFg~s~~~~~~~~~------  368 (487)
                      ++.... .....++..++.++.|++.||.||   |++||+||||||+||+++.++.+||+|||++.........      
T Consensus       151 ~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~  226 (332)
T 3qd2_B          151 WMNRRC-SLEDREHGVCLHIFIQIAEAVEFL---HSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP  226 (332)
T ss_dssp             HHHTCC-SGGGSCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC---------
T ss_pred             HHhccc-CccchhhHHHHHHHHHHHHHHHHH---HhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhcccccc
Confidence            997521 223456667899999999999999   6778999999999999999999999999999876554221      


Q ss_pred             ----eeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHHHhcCCCCCccCC
Q 011360          369 ----VLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDP  444 (487)
Q Consensus       369 ----~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  444 (487)
                          .......||+.|+|||++.+..++.++||||||+++|+|++|..|+...        ........ ....      
T Consensus       227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~--------~~~~~~~~-~~~~------  291 (332)
T 3qd2_B          227 MPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER--------VRIITDVR-NLKF------  291 (332)
T ss_dssp             -----CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH--------HHHHHHHH-TTCC------
T ss_pred             ccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH--------HHHHHHhh-ccCC------
Confidence                1113356999999999999999999999999999999999997776211        11111111 1111      


Q ss_pred             CCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          445 RLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       445 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                        + .........+.+++.+||+.||++|||+.++++
T Consensus       292 --~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          292 --P-LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             --C-HHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred             --C-cccccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence              1 112334456789999999999999999999986

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=8.4e-42  Score=327.54  Aligned_cols=249  Identities=26%  Similarity=0.371  Sum_probs=199.7

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||.|+||.||+|.. ..++..||+|++...            ..........+.+|+.+++.++||||++++
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~------------~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~   75 (279)
T 3fdn_A            9 EDFEIGRPLGKGKFGNVYLARE-KQSKFILALKVLFKA------------QLEKAGVEHQLRREVEIQSHLRHPNILRLY   75 (279)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEE-TTTCCEEEEEEEEHH------------HHHHHTCHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred             ccEEEeeEEecCCCeEEEEEEE-ccCCcEEEEEEEecc------------ccchhhHHHHHHHHHHHHHcCCCCCCcchh
Confidence            4699999999999999999975 467889999988320            111122345688899999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++.+.+..++||||+++|+|.+++..    ...+++..+..++.|++.||.||   |+.||+||||||+||+++.++.+
T Consensus        76 ~~~~~~~~~~lv~e~~~~~~l~~~l~~----~~~~~~~~~~~~~~qi~~~l~~L---H~~~i~H~dlkp~Nili~~~~~~  148 (279)
T 3fdn_A           76 GYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYC---HSKRVIHRDIKPENLLLGSAGEL  148 (279)
T ss_dssp             EEEECSSEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH---HTTTCEECCCCGGGEEECTTSCE
T ss_pred             heEecCCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HhCCEecccCChHhEEEcCCCCE
Confidence            999999999999999999999999975    35689999999999999999999   77899999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRK  431 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~  431 (487)
                      ||+|||++........    ....||+.|+|||.+.+..++.++||||||+++|+|++|..||....      ..+....
T Consensus       149 ~l~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~  218 (279)
T 3fdn_A          149 KIADFGWSVHAPSSRR----TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT------YQETYKR  218 (279)
T ss_dssp             EECSCCEESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHH
T ss_pred             EEEeccccccCCcccc----cccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc------HHHHHHH
Confidence            9999999865443322    34568999999999999999999999999999999999999994321      2222222


Q ss_pred             HHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          432 VMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       432 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .......       .+..    .+..+.+++.+||+.||++|||+.++++
T Consensus       219 ~~~~~~~-------~~~~----~~~~~~~li~~~l~~~p~~Rps~~e~l~  257 (279)
T 3fdn_A          219 ISRVEFT-------FPDF----VTEGARDLISRLLKHNPSQRPMLREVLE  257 (279)
T ss_dssp             HHHTCCC-------CCTT----SCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             HHhCCCC-------CCCc----CCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            2221111       1111    2246889999999999999999999985

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-41  Score=335.64  Aligned_cols=263  Identities=27%  Similarity=0.410  Sum_probs=197.3

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHh--ccCCCCCccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA--SQIRHRNILP  269 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l--~~l~hpnIv~  269 (487)
                      ++|.+.+.||.|+||.||+|++   ++..||||++...                .  ......|..++  ..++||||++
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~----------------~--~~~~~~e~~~~~~~~~~h~~i~~   95 (337)
T 3mdy_A           37 KQIQMVKQIGKGRYGEVWMGKW---RGEKVAVKVFFTT----------------E--EASWFRETEIYQTVLMRHENILG   95 (337)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEE---TTEEEEEEEEEGG----------------G--HHHHHHHHHHHTSTTCCCTTBCC
T ss_pred             cceEEEeEeecCCCeEEEEEEE---CCceEEEEEEecc----------------c--cchhhhHHHHHHHHhhcCCCeee
Confidence            4699999999999999999986   5889999987320                1  11223344444  4459999999


Q ss_pred             cceEEecC----CeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhc-----CCCCeeecCCCC
Q 011360          270 LLAHMVRP----DCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMY-----HSASIIHGDIKP  340 (487)
Q Consensus       270 l~~~~~~~----~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~-----h~~givH~Dlkp  340 (487)
                      +++++...    ...++||||+++|+|.+++..     ..+++..++.++.|++.||.|||..     |..||+||||||
T Consensus        96 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp  170 (337)
T 3mdy_A           96 FIAADIKGTGSWTQLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKS  170 (337)
T ss_dssp             EEEEEEESCGGGCEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCG
T ss_pred             EEEEEccCCCCCCceEEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccch
Confidence            99999877    788999999999999999964     4689999999999999999999532     123999999999


Q ss_pred             CCEEeCCCCCEEEeccCCccccCCCCceee--EeeecccccccCCcccCCCCCCch------hHHHHHHHHHHHHHhC--
Q 011360          341 RNVLLNDDMEACISDLGLAMAIPDGYTRVL--ISYVLGTMAYIAPEYFQQPELSEK------CDIFSFGMLLISLVRG--  410 (487)
Q Consensus       341 ~Nill~~~~~~kl~DFg~s~~~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~------~DvwslG~~l~elltg--  410 (487)
                      +|||++.++.+||+|||++...........  .....||+.|+|||++.+..++..      +|||||||++|||+||  
T Consensus       171 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~  250 (337)
T 3mdy_A          171 KNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCV  250 (337)
T ss_dssp             GGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBC
T ss_pred             HHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccC
Confidence            999999999999999999976644322211  124569999999999987766554      9999999999999999  


Q ss_pred             --------CCCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCC-CcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          411 --------VPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGN-GYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       411 --------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                              ..||........  ..............    .+.++.. .....+..+.+++.+||+.||++|||+.+|++
T Consensus       251 ~~~~~~~~~~p~~~~~~~~~--~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  324 (337)
T 3mdy_A          251 SGGIVEEYQLPYHDLVPSDP--SYEDMREIVCIKKL----RPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK  324 (337)
T ss_dssp             BTTBCCCCCCTTTTTSCSSC--CHHHHHHHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             cccccccccccHhhhcCCCC--chhhhHHHHhhhcc----CccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHH
Confidence                    556643322211  12223333322222    1222221 12366778999999999999999999999999


Q ss_pred             HHhhh
Q 011360          482 RLSQL  486 (487)
Q Consensus       482 ~L~~l  486 (487)
                      .|+.+
T Consensus       325 ~L~~l  329 (337)
T 3mdy_A          325 TLAKM  329 (337)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            99876

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.9e-41  Score=326.96  Aligned_cols=250  Identities=23%  Similarity=0.350  Sum_probs=200.4

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ..|.+.+.||+|+||.||+|.. ..++..||+|++..             ..........+.+|+.+++.++||||++++
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~va~k~~~~-------------~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~   91 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLD-TETTVEVAWCELQD-------------RKLTKSERQRFKEEAEMLKGLQHPNIVRFY   91 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEE-TTTCCEEEEEEEEG-------------GGSCHHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEe-cCCceEEEEEEecc-------------hhhCHHHHHHHHHHHHHHHhCCCCCeeeee
Confidence            3588889999999999999975 46788999998843             122334567788999999999999999999


Q ss_pred             eEEec----CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCC--eeecCCCCCCEEe
Q 011360          272 AHMVR----PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSAS--IIHGDIKPRNVLL  345 (487)
Q Consensus       272 ~~~~~----~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~g--ivH~Dlkp~Nill  345 (487)
                      +++..    ...+++||||+++|+|.+++..    ...+++..++.++.|++.||.||   |+.|  |+||||||+||++
T Consensus        92 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~l---H~~~~~i~H~dikp~Nil~  164 (290)
T 1t4h_A           92 DSWESTVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFL---HTRTPPIIHRDLKCDNIFI  164 (290)
T ss_dssp             EEEEEESSSCEEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH---HTSSSCCCCSCCCGGGEEE
T ss_pred             eeeccccCCCceEEEEEEecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHH---HcCCCCEEECCCCHHHEEE
Confidence            98875    3568999999999999999975    35689999999999999999999   6777  9999999999999


Q ss_pred             C-CCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccc
Q 011360          346 N-DDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEIC  424 (487)
Q Consensus       346 ~-~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~  424 (487)
                      + .++.+||+|||++........    ....||+.|+|||++.+ .++.++||||||+++|+|++|..||.....     
T Consensus       165 ~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-----  234 (290)
T 1t4h_A          165 TGPTGSVKIGDLGLATLKRASFA----KAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-----  234 (290)
T ss_dssp             SSTTSCEEECCTTGGGGCCTTSB----EESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-----
T ss_pred             ECCCCCEEEeeCCCccccccccc----ccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCc-----
Confidence            8 789999999999976544432    34568999999998875 589999999999999999999999943322     


Q ss_pred             cHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          425 SPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       425 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                       .................+...        +..+.+++.+||+.||++|||+.++++
T Consensus       235 -~~~~~~~~~~~~~~~~~~~~~--------~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          235 -AAQIYRRVTSGVKPASFDKVA--------IPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             -HHHHHHHHTTTCCCGGGGGCC--------CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -HHHHHHHHhccCCccccCCCC--------CHHHHHHHHHHccCChhhCCCHHHHhh
Confidence             122222222222222222222        246889999999999999999999985

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.7e-42  Score=351.97  Aligned_cols=260  Identities=20%  Similarity=0.272  Sum_probs=203.7

Q ss_pred             hccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccc
Q 011360          190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILP  269 (487)
Q Consensus       190 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~  269 (487)
                      ..++|.+.+.||+|+||.||+|+.. .+++.||+|++...            ..........+.+|..++..++||||++
T Consensus        72 ~~~~y~~~~~LG~G~fG~V~~~~~~-~~~~~vAvK~~~~~------------~~~~~~~~~~~~~E~~il~~~~hp~Iv~  138 (437)
T 4aw2_A           72 HREDFEILKVIGRGAFGEVAVVKLK-NADKVFAMKILNKW------------EMLKRAETACFREERDVLVNGDSKWITT  138 (437)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEEHH------------HHHHTTTTCCHHHHHHHHHHSCTTTBCC
T ss_pred             ChhheEEEEEEEeCCCEEEEEEEEc-CCCcEEEEEEEEHH------------HhhhHHHHHHHHHHHHHHHhCCCCCEEE
Confidence            3457999999999999999999864 57899999998421            1111122334778999999999999999


Q ss_pred             cceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC
Q 011360          270 LLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDM  349 (487)
Q Consensus       270 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~  349 (487)
                      +++++.+.+.+|+|||||+||+|.+++..   ....+++..++.++.|++.||.||   |++||+||||||+|||++.++
T Consensus       139 l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~L---H~~giiHrDLKp~NILl~~~g  212 (437)
T 4aw2_A          139 LHYAFQDDNNLYLVMDYYVGGDLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSV---HQLHYVHRDIKPDNILMDMNG  212 (437)
T ss_dssp             EEEEEECSSEEEEEECCCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTS
T ss_pred             EEEEEeeCCEEEEEEecCCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHH---HhCCeEecccCHHHeeEcCCC
Confidence            99999999999999999999999999974   246799999999999999999999   677899999999999999999


Q ss_pred             CEEEeccCCccccCCCCceeeEeeecccccccCCcccC-----CCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccc
Q 011360          350 EACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQ-----QPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEIC  424 (487)
Q Consensus       350 ~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~  424 (487)
                      .+||+|||+++........ .....+||+.|+|||++.     ...|+.++|||||||++|||++|.+||...+      
T Consensus       213 ~vkL~DFGla~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~------  285 (437)
T 4aw2_A          213 HIRLADFGSCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES------  285 (437)
T ss_dssp             CEEECCCTTCEECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS------
T ss_pred             CEEEcchhhhhhcccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC------
Confidence            9999999999776544332 223467999999999986     5678999999999999999999999995332      


Q ss_pred             cHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCC--CCChHHHHH
Q 011360          425 SPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEE--RPNSQYVRC  481 (487)
Q Consensus       425 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--RPs~~~il~  481 (487)
                      ..+....+...... ..++...     ...+.++.+++.+||..+|++  ||+++++++
T Consensus       286 ~~~~~~~i~~~~~~-~~~p~~~-----~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          286 LVETYGKIMNHKER-FQFPTQV-----TDVSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             HHHHHHHHHTHHHH-CCCCSSC-----CCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             hhHHHHhhhhcccc-ccCCccc-----ccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence            22223333221100 0001110     112356889999999998888  999999875

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.5e-42  Score=343.01  Aligned_cols=264  Identities=23%  Similarity=0.257  Sum_probs=200.5

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .++|.+.+.||.|+||.||+|.. ..++..||+|++...          ............+.+|+.+++.++||||+++
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~~~vaiK~~~~~----------~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~   93 (345)
T 3hko_A           25 QKKYHLKGAIGQGSYGVVRVAIE-NQTRAIRAIKIMNKN----------KIRQINPKDVERIKTEVRLMKKLHHPNIARL   93 (345)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEE-TTTCCEEEEEEEEHH----------HHHC---CHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             hhheeecceeeecCCeEEEEEEE-CCCCceEEEeehhhh----------hhcccCHHHHHHHHHHHHHHHhCCCCCccee
Confidence            45699999999999999999974 568899999988421          0011123345678899999999999999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcC------------------------------------CCCCChHHHHHH
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG------------------------------------RRELDWPSRHRI  314 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~------------------------------------~~~l~~~~~~~i  314 (487)
                      ++++.+.+..++|||||++|+|.+++......                                    ...+++..++.+
T Consensus        94 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  173 (345)
T 3hko_A           94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNI  173 (345)
T ss_dssp             EEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHH
T ss_pred             ehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHH
Confidence            99999999999999999999999998521111                                    122356778899


Q ss_pred             HHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC--CEEEeccCCccccCCCCc--eeeEeeecccccccCCcccCC--
Q 011360          315 ALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDM--EACISDLGLAMAIPDGYT--RVLISYVLGTMAYIAPEYFQQ--  388 (487)
Q Consensus       315 ~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~--~~kl~DFg~s~~~~~~~~--~~~~~~~~gt~~y~aPE~l~~--  388 (487)
                      +.|++.||.||   |+.||+||||||+||+++.++  .+||+|||++........  ........||+.|+|||++.+  
T Consensus       174 ~~qi~~~l~~L---H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  250 (345)
T 3hko_A          174 MRQIFSALHYL---HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTN  250 (345)
T ss_dssp             HHHHHHHHHHH---HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSS
T ss_pred             HHHHHHHHHHH---HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCC
Confidence            99999999999   677899999999999998776  899999999976533211  112234569999999999875  


Q ss_pred             CCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCC
Q 011360          389 PELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLH  468 (487)
Q Consensus       389 ~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~  468 (487)
                      ..++.++||||||+++|+|++|..||....      ..+...........       .+.......+..+.+++.+||+.
T Consensus       251 ~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~li~~~l~~  317 (345)
T 3hko_A          251 ESYGPKCDAWSAGVLLHLLLMGAVPFPGVN------DADTISQVLNKKLC-------FENPNYNVLSPLARDLLSNLLNR  317 (345)
T ss_dssp             SCCCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCCCC-------TTSGGGGGSCHHHHHHHHHHSCS
T ss_pred             CCCCcHHHHHHHHHHHHHHHHCCCCCCCCC------hHHHHHHHHhcccc-------cCCcccccCCHHHHHHHHHHcCC
Confidence            678999999999999999999999994332      22333444333221       11111122346789999999999


Q ss_pred             CCCCCCChHHHHH
Q 011360          469 DPEERPNSQYVRC  481 (487)
Q Consensus       469 ~P~~RPs~~~il~  481 (487)
                      ||.+|||+.++++
T Consensus       318 ~p~~Rps~~~~l~  330 (345)
T 3hko_A          318 NVDERFDAMRALQ  330 (345)
T ss_dssp             CTTTSCCHHHHHH
T ss_pred             ChhHCCCHHHHhc
Confidence            9999999999986

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-42  Score=349.20  Aligned_cols=256  Identities=21%  Similarity=0.291  Sum_probs=201.2

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .++|.+.+.||+|+||.||+++. ..+|+.||+|++...            ..........+.+|..++..++||||+++
T Consensus        60 ~~~f~~~~~lG~G~fG~V~~~~~-~~~~~~vAiK~l~k~------------~~~~~~~~~~~~~E~~il~~~~hp~Iv~l  126 (412)
T 2vd5_A           60 RDDFEILKVIGRGAFSEVAVVKM-KQTGQVYAMKIMNKW------------DMLKRGEVSCFREERDVLVNGDRRWITQL  126 (412)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-TTTCCEEEEEEEEHH------------HHHHHGGGCCHHHHHHHHHHSCTTTBCCE
T ss_pred             hhhEEEEEEEeeCCCeEEEEEEE-CCCCCEEEEEEEeHH------------HhhhHHHHHHHHHHHHHHHhcCCCCeeeE
Confidence            35699999999999999999975 468999999998420            11112233457789999999999999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      ++++.+.+.+|+||||++||+|.+++...   +..+++..++.++.|++.||.||   |++||+||||||+|||++.+|.
T Consensus       127 ~~~~~~~~~~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~L---H~~giiHrDLKp~NILld~~g~  200 (412)
T 2vd5_A          127 HFAFQDENYLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSV---HRLGYVHRDIKPDNILLDRCGH  200 (412)
T ss_dssp             EEEEECSSEEEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSC
T ss_pred             EEEEeeCCEEEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHH---HHCCeeecccCHHHeeecCCCC
Confidence            99999999999999999999999999752   34789999999999999999999   6778999999999999999999


Q ss_pred             EEEeccCCccccCCCCceeeEeeecccccccCCcccC-------CCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCcc
Q 011360          351 ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQ-------QPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI  423 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~-------~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~  423 (487)
                      +||+|||+++........ .....+||+.|+|||++.       ...|+.++|||||||++|||++|..||...+     
T Consensus       201 vkL~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~-----  274 (412)
T 2vd5_A          201 IRLADFGSCLKLRADGTV-RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS-----  274 (412)
T ss_dssp             EEECCCTTCEECCTTSCE-ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS-----
T ss_pred             EEEeechhheeccCCCcc-ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC-----
Confidence            999999999876544321 123457999999999987       3578999999999999999999999994432     


Q ss_pred             ccHHHHHHHHhcC--CCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCC---CChHHHHH
Q 011360          424 CSPEWLRKVMNSK--NPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEER---PNSQYVRC  481 (487)
Q Consensus       424 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R---Ps~~~il~  481 (487)
                       ..+....+....  ......+..+        +.++.+++.+||. +|.+|   |++++|++
T Consensus       275 -~~~~~~~i~~~~~~~~~p~~~~~~--------s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          275 -TAETYGKIVHYKEHLSLPLVDEGV--------PEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             -HHHHHHHHHTHHHHCCCC----CC--------CHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             -HHHHHHHHHhcccCcCCCccccCC--------CHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence             222333333211  1100111122        2568899999999 99998   58888864

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.3e-42  Score=339.26  Aligned_cols=258  Identities=21%  Similarity=0.307  Sum_probs=195.6

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceE----EEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCC
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMI----AIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRN  266 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~v----avK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn  266 (487)
                      .++|.+.+.||+|+||.||+|.+. .++..+    |+|.+...              ........+.+|+.++..++|||
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~~~~kv~iK~~~~~--------------~~~~~~~~~~~E~~~l~~l~hp~   78 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWI-PEGEKVKIPVAIKELREA--------------TSPKANKEILDEAYVMASVDNPH   78 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEEC-CTTCSCCEEEEEEEECCC--------------SSCCCHHHHHHHHHHHTTCCBTT
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEc-CCCceEEEEEEEEeeccc--------------cCHHHHHHHHHHHHHHHhCCCCC
Confidence            456999999999999999999754 455544    66655321              11223456788999999999999


Q ss_pred             ccccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC
Q 011360          267 ILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN  346 (487)
Q Consensus       267 Iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~  346 (487)
                      |+++++++.... .++||+|+.+|+|.+++..   ....+++..++.++.|++.||.||   |++||+||||||+|||++
T Consensus        79 iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dikp~NIl~~  151 (327)
T 3lzb_A           79 VCRLLGICLTST-VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVK  151 (327)
T ss_dssp             BCCCCEEEESSS-EEEEECCCSSCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEEE
T ss_pred             eeEEEEEEecCC-ceEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHH---hhCCCcCCCCCHHHEEEc
Confidence            999999998754 7899999999999999875   245689999999999999999999   677899999999999999


Q ss_pred             CCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCcccc
Q 011360          347 DDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICS  425 (487)
Q Consensus       347 ~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~  425 (487)
                      .++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||......     
T Consensus       152 ~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-----  226 (327)
T 3lzb_A          152 TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-----  226 (327)
T ss_dssp             ETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-----
T ss_pred             CCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH-----
Confidence            999999999999987654433333334557889999999999999999999999999999999 99999543221     


Q ss_pred             HHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          426 PEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       426 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                       +..........+.  .++.        .+.++.+++.+||+.||.+|||+.++++.|+.+
T Consensus       227 -~~~~~~~~~~~~~--~~~~--------~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  276 (327)
T 3lzb_A          227 -EISSILEKGERLP--QPPI--------CTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM  276 (327)
T ss_dssp             -GHHHHHHTTCCCC--CCTT--------BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -HHHHHHHcCCCCC--CCcc--------CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence             1122222221111  1111        224688999999999999999999999999875

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.4e-42  Score=337.02  Aligned_cols=260  Identities=23%  Similarity=0.368  Sum_probs=200.6

Q ss_pred             ccccccccccccccceeEEEEEecCCC---CceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSN---GKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNI  267 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI  267 (487)
                      .+.|.+.+.||+|+||.||+|.+...+   +..||+|.+..              .........+.+|+.++..++||||
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~--------------~~~~~~~~~~~~E~~~l~~l~h~~i  108 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKA--------------GYTEKQRVDFLGEAGIMGQFSHHNI  108 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECT--------------TCCHHHHHHHHHHHHHHHTCCCTTB
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCC--------------CCCHHHHHHHHHHHHHHHhCCCCCC
Confidence            456899999999999999999865332   34699998842              1122344578899999999999999


Q ss_pred             cccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC
Q 011360          268 LPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLND  347 (487)
Q Consensus       268 v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~  347 (487)
                      +++++++...+..++||||+++|+|.+++..   ....+++..++.++.|++.||.||   |++||+||||||+||+++.
T Consensus       109 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dikp~NIl~~~  182 (333)
T 1mqb_A          109 IRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYL---ANMNYVHRDLAARNILVNS  182 (333)
T ss_dssp             CCEEEEECSSSSEEEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECT
T ss_pred             CcEEEEEecCCCcEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCCChheEEECC
Confidence            9999999999999999999999999999974   245789999999999999999999   6778999999999999999


Q ss_pred             CCCEEEeccCCccccCCCCcee-eEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCcccc
Q 011360          348 DMEACISDLGLAMAIPDGYTRV-LISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICS  425 (487)
Q Consensus       348 ~~~~kl~DFg~s~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~  425 (487)
                      ++.+||+|||++.......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...      ..
T Consensus       183 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~------~~  256 (333)
T 1mqb_A          183 NLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL------SN  256 (333)
T ss_dssp             TCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC------CH
T ss_pred             CCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccC------CH
Confidence            9999999999998765432211 1122346789999999998899999999999999999999 99999432      22


Q ss_pred             HHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          426 PEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       426 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      .+....+.....+.      .+.    ..+..+.+++.+||+.||++|||+.++++.|+++
T Consensus       257 ~~~~~~~~~~~~~~------~~~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~  307 (333)
T 1mqb_A          257 HEVMKAINDGFRLP------TPM----DCPSAIYQLMMQCWQQERARRPKFADIVSILDKL  307 (333)
T ss_dssp             HHHHHHHHTTCCCC------CCT----TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHCCCcCC------Ccc----cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            23333333222211      111    1235688999999999999999999999999875

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=4.6e-42  Score=331.46  Aligned_cols=259  Identities=22%  Similarity=0.293  Sum_probs=204.4

Q ss_pred             cccccccc-ccccccceeEEEEEec-CCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcc
Q 011360          191 EDCFASLE-KIGSGGCGEVYKAELP-GSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNIL  268 (487)
Q Consensus       191 ~~~~~~~~-~lg~G~~g~v~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv  268 (487)
                      .++|.+.+ .||.|+||.||+|.+. ..+++.||||++..             ..........+.+|+.+++.++||||+
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~-------------~~~~~~~~~~~~~e~~~l~~l~h~~i~   81 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKN-------------EANDPALKDELLAEANVMQQLDNPYIV   81 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------------------CHHHHHHHHHHHHHHTCCCTTBC
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecc-------------cccCHHHHHHHHHHHHHHHhCCCCCEE
Confidence            34688888 9999999999999653 34678999999843             112233456788999999999999999


Q ss_pred             ccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC
Q 011360          269 PLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDD  348 (487)
Q Consensus       269 ~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~  348 (487)
                      ++++++ ..+..++||||+++++|.+++..    ...+++..++.++.|++.||.||   |++||+||||||+||+++.+
T Consensus        82 ~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~L---H~~~i~H~dikp~Nil~~~~  153 (291)
T 1xbb_A           82 RMIGIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQ  153 (291)
T ss_dssp             CEEEEE-ESSSEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEEET
T ss_pred             EEEEEE-CCCCcEEEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHH---HhCCeEcCCCCcceEEEeCC
Confidence            999998 56778999999999999999975    45689999999999999999999   67789999999999999999


Q ss_pred             CCEEEeccCCccccCCCCcee-eEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccccH
Q 011360          349 MEACISDLGLAMAIPDGYTRV-LISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSP  426 (487)
Q Consensus       349 ~~~kl~DFg~s~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~  426 (487)
                      +.+||+|||++.......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||....      ..
T Consensus       154 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~------~~  227 (291)
T 1xbb_A          154 HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK------GS  227 (291)
T ss_dssp             TEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC------HH
T ss_pred             CcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCC------HH
Confidence            999999999998765443221 1123346789999999988889999999999999999999 999994322      12


Q ss_pred             HHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          427 EWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       427 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      +... ........ ..+..        .+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus       228 ~~~~-~~~~~~~~-~~~~~--------~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  277 (291)
T 1xbb_A          228 EVTA-MLEKGERM-GCPAG--------CPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  277 (291)
T ss_dssp             HHHH-HHHTTCCC-CCCTT--------CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             HHHH-HHHcCCCC-CCCCC--------CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            2222 22222211 11122        235689999999999999999999999999876

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.4e-42  Score=331.73  Aligned_cols=259  Identities=22%  Similarity=0.310  Sum_probs=205.9

Q ss_pred             cccccccc-ccccccceeEEEEEec-CCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcc
Q 011360          191 EDCFASLE-KIGSGGCGEVYKAELP-GSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNIL  268 (487)
Q Consensus       191 ~~~~~~~~-~lg~G~~g~v~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv  268 (487)
                      .++|.+.. .||+|+||.||+|.+. ..++..||+|++...              ........+.+|+.++..++||||+
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~--------------~~~~~~~~~~~E~~~l~~l~h~~i~   73 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--------------TEKADTEEMMREAQIMHQLDNPYIV   73 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS--------------CCHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc--------------cchhHHHHHHHHHHHHHhCCCCCEe
Confidence            34577776 9999999999999753 346788999998431              1234556788999999999999999


Q ss_pred             ccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC
Q 011360          269 PLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDD  348 (487)
Q Consensus       269 ~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~  348 (487)
                      ++++++ ..+..++||||+++++|.+++..   ....+++..+..++.|++.||.||   |+.||+||||||+||+++.+
T Consensus        74 ~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nili~~~  146 (287)
T 1u59_A           74 RLIGVC-QAEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYL---EEKNFVHRDLAARNVLLVNR  146 (287)
T ss_dssp             CEEEEE-ESSSEEEEEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEEET
T ss_pred             EEEEEe-cCCCcEEEEEeCCCCCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHH---HHCCEeeCCCchheEEEcCC
Confidence            999998 55678999999999999999863   345689999999999999999999   67789999999999999999


Q ss_pred             CCEEEeccCCccccCCCCcee-eEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccccH
Q 011360          349 MEACISDLGLAMAIPDGYTRV-LISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSP  426 (487)
Q Consensus       349 ~~~kl~DFg~s~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~  426 (487)
                      +.+||+|||++.......... ......+|+.|+|||++.+..++.++||||||+++|+|+| |..||....      ..
T Consensus       147 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~------~~  220 (287)
T 1u59_A          147 HYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK------GP  220 (287)
T ss_dssp             TEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC------TH
T ss_pred             CCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC------HH
Confidence            999999999998765433221 1123346889999999988889999999999999999998 999994432      22


Q ss_pred             HHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          427 EWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       427 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      +....+.....+  ..++.+        +..+.+++.+||+.||++|||+.++++.|+.+
T Consensus       221 ~~~~~i~~~~~~--~~~~~~--------~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  270 (287)
T 1u59_A          221 EVMAFIEQGKRM--ECPPEC--------PPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  270 (287)
T ss_dssp             HHHHHHHTTCCC--CCCTTC--------CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHhcCCcC--CCCCCc--------CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            333333322211  112222        35688999999999999999999999999876

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=7.2e-42  Score=354.91  Aligned_cols=254  Identities=26%  Similarity=0.365  Sum_probs=204.9

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      +.|.+.+.||+|+||.||+|+. ..+|+.||+|++..            ...........+..|..++..++||||++++
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~-~~tg~~vAiK~l~k------------~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~  251 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQM-KATGKLYACKKLNK------------KRLKKRKGYQGAMVEKKILAKVHSRFIVSLA  251 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTTCCEEEEEEEEH------------HHHHHTTCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEE-CCCCcEEEEEEEEh------------HHhhhhHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence            5699999999999999999975 46899999999842            1111122345778899999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++.+.+.+|+||||++||+|.+++.........+++..+..++.||+.||.||   |++||+||||||+|||++.+|.+
T Consensus       252 ~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~L---H~~gIvHrDLKP~NILl~~~g~v  328 (543)
T 3c4z_A          252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHL---HQRNIIYRDLKPENVLLDDDGNV  328 (543)
T ss_dssp             EEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTSCE
T ss_pred             EEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHH---HHcCCcccCCChHHEEEeCCCCE
Confidence            999999999999999999999999976444456799999999999999999999   67789999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRK  431 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~  431 (487)
                      ||+|||+++........  ....+||+.|+|||++.+..|+.++|||||||++|||+||.+||......  ....+....
T Consensus       329 kL~DFGla~~~~~~~~~--~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~--~~~~~~~~~  404 (543)
T 3c4z_A          329 RISDLGLAVELKAGQTK--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK--VENKELKQR  404 (543)
T ss_dssp             EECCCTTCEECCTTCCC--BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCC--CCHHHHHHH
T ss_pred             EEeecceeeeccCCCcc--cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccc--hhHHHHHHH
Confidence            99999999876544322  13457999999999999999999999999999999999999999654321  122233333


Q ss_pred             HHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCh
Q 011360          432 VMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNS  476 (487)
Q Consensus       432 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~  476 (487)
                      ..... .  .+++.+        +..+.+++.+||+.||++||++
T Consensus       405 i~~~~-~--~~p~~~--------s~~~~~li~~lL~~dP~~R~~~  438 (543)
T 3c4z_A          405 VLEQA-V--TYPDKF--------SPASKDFCEALLQKDPEKRLGF  438 (543)
T ss_dssp             HHHCC-C--CCCTTS--------CHHHHHHHHHHSCSSGGGSCCC
T ss_pred             Hhhcc-c--CCCccc--------CHHHHHHHHHhccCCHhHCCCC
Confidence            33221 1  111222        3568899999999999999975

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=3.6e-42  Score=340.58  Aligned_cols=249  Identities=27%  Similarity=0.397  Sum_probs=201.0

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      +.|...+.||+|+||.||+|.. ..+++.||||++....            .........+.+|+.++++++||||++++
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~-~~~~~~vaiK~~~~~~------------~~~~~~~~~~~~E~~~l~~l~hpniv~~~  120 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARD-VRNSEVVAIKKMSYSG------------KQSNEKWQDIIKEVRFLQKLRHPNTIQYR  120 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEE-TTTTEEEEEEEEESCS------------SCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             hheeeeeEEccCCCEEEEEEEE-ccCCeEEEEEEEcccc------------ccchHHHHHHHHHHHHHHhCCCCCEeeEE
Confidence            4589999999999999999974 4588999999985321            11233456788999999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++...+..++||||+. |+|.+++...   ...+++..+..++.|++.||.||   |++||+||||||+|||++.++.+
T Consensus       121 ~~~~~~~~~~lv~e~~~-g~l~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~~~~  193 (348)
T 1u5q_A          121 GCYLREHTAWLVMEYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYL---HSHNMIHRDVKAGNILLSEPGLV  193 (348)
T ss_dssp             EEEEETTEEEEEEECCS-EEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCSGGGEEEETTTEE
T ss_pred             EEEEECCeEEEEEecCC-CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHH---HhCCeeeCCCCHHHEEECCCCCE
Confidence            99999999999999996 6888887642   45789999999999999999999   66789999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccC---CCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQ---QPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEW  428 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~  428 (487)
                      ||+|||++......      ....||+.|+|||++.   ...++.++|||||||++|||++|..||....      ....
T Consensus       194 kL~DfG~a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~------~~~~  261 (348)
T 1u5q_A          194 KLGDFGSASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN------AMSA  261 (348)
T ss_dssp             EECCCTTCBSSSSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC------HHHH
T ss_pred             EEeeccCceecCCC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC------hHHH
Confidence            99999999765432      2356999999999884   5678999999999999999999999994322      2233


Q ss_pred             HHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          429 LRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       429 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .........+. .....        .+..+.+++.+||+.||++|||+.++++
T Consensus       262 ~~~~~~~~~~~-~~~~~--------~~~~l~~li~~~l~~dP~~Rps~~~ll~  305 (348)
T 1u5q_A          262 LYHIAQNESPA-LQSGH--------WSEYFRNFVDSCLQKIPQDRPTSEVLLK  305 (348)
T ss_dssp             HHHHHHSCCCC-CCCTT--------SCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHhcCCCC-CCCCC--------CCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence            33333333221 11111        2256889999999999999999999875

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=2.3e-42  Score=330.95  Aligned_cols=250  Identities=24%  Similarity=0.325  Sum_probs=201.7

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      +.|.+.+.||+|+||.||+|.. ..++..+|+|++...               .......+.+|+.++++++||||++++
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~~a~k~~~~~---------------~~~~~~~~~~E~~~l~~l~h~~i~~~~   72 (277)
T 3f3z_A            9 QYYTLENTIGRGSWGEVKIAVQ-KGTRIRRAAKKIPKY---------------FVEDVDRFKQEIEIMKSLDHPNIIRLY   72 (277)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEE-TTTCCEEEEEEEEGG---------------GCSCHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             hhEEeeeEEeecCCEEEEEEEe-CCCCcEEEEEeehhh---------------ccchHHHHHHHHHHHHhCCCCCEeeEE
Confidence            4699999999999999999975 457889999988431               112245678899999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEe---CCC
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLL---NDD  348 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill---~~~  348 (487)
                      +++.+.+..++||||+++++|.+++..    ...+++..+..++.|++.||.||   |++||+||||||+||++   +.+
T Consensus        73 ~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~~  145 (277)
T 3f3z_A           73 ETFEDNTDIYLVMELCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYC---HKLNVAHRDLKPENFLFLTDSPD  145 (277)
T ss_dssp             EEEECSSEEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEESSSSTT
T ss_pred             EEEecCCeEEEEEeccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCccCCCCCHHHEEEecCCCC
Confidence            999999999999999999999998875    35689999999999999999999   67789999999999999   788


Q ss_pred             CCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHH
Q 011360          349 MEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEW  428 (487)
Q Consensus       349 ~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~  428 (487)
                      +.+||+|||++.........   ....||+.|+|||++.+. ++.++||||||+++|+|++|..||....      ..+.
T Consensus       146 ~~~~l~Dfg~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~------~~~~  215 (277)
T 3f3z_A          146 SPLKLIDFGLAARFKPGKMM---RTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPT------DSEV  215 (277)
T ss_dssp             CCEEECCCTTCEECCTTSCB---CCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSS------HHHH
T ss_pred             CcEEEEecccceeccCccch---hccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCC------HHHH
Confidence            89999999999876544322   345699999999998764 8999999999999999999999994332      2233


Q ss_pred             HHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          429 LRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       429 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ..........       .+.......+..+.+++.+||+.||++|||+.++++
T Consensus       216 ~~~~~~~~~~-------~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          216 MLKIREGTFT-------FPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             HHHHHHCCCC-------CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             HHHHHhCCCC-------CCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            3333322211       111001122356889999999999999999999874

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=5.6e-42  Score=331.90  Aligned_cols=259  Identities=23%  Similarity=0.315  Sum_probs=201.0

Q ss_pred             cccccccccccccceeEEEEEecCCC--CceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSN--GKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILP  269 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~  269 (487)
                      ..|.+.+.||+|+||.||+|.+...+  ...+|+|.+..              .........+.+|+.++++++||||++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~--------------~~~~~~~~~~~~E~~~l~~l~h~~iv~   90 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--------------ITDIGEVSQFLTEGIIMKDFSHPNVLS   90 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETT--------------CCSHHHHHHHHHHHHHHHTCCCTTBCC
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEeccc--------------CCCHHHHHHHHHHHHHHHhCCCCCEee
Confidence            46899999999999999999864322  34688998732              122344567889999999999999999


Q ss_pred             cceEEe-cCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC
Q 011360          270 LLAHMV-RPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDD  348 (487)
Q Consensus       270 l~~~~~-~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~  348 (487)
                      +++++. .++..++||||+++|+|.+++..   ....+++..++.++.|++.||.||   |++||+||||||+||+++.+
T Consensus        91 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~l---H~~~i~H~dikp~Nil~~~~  164 (298)
T 3f66_A           91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEK  164 (298)
T ss_dssp             CCEEECCSSSCCEEEEECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECTT
T ss_pred             eeeEEEcCCCceEEEEeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHH---HhCCccCCCCchheEEECCC
Confidence            999854 55678999999999999999963   346689999999999999999999   67789999999999999999


Q ss_pred             CCEEEeccCCccccCCCCce--eeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCcccc
Q 011360          349 MEACISDLGLAMAIPDGYTR--VLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICS  425 (487)
Q Consensus       349 ~~~kl~DFg~s~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~  425 (487)
                      +.+||+|||++.........  .......+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||......     
T Consensus       165 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~-----  239 (298)
T 3f66_A          165 FTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-----  239 (298)
T ss_dssp             CCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT-----
T ss_pred             CCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH-----
Confidence            99999999999876443221  11233457889999999998899999999999999999999 56676433221     


Q ss_pred             HHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          426 PEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       426 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                       +...........  ..+..+        +..+.+++.+||+.||++|||+.++++.|+.+
T Consensus       240 -~~~~~~~~~~~~--~~~~~~--------~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~  289 (298)
T 3f66_A          240 -DITVYLLQGRRL--LQPEYC--------PDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  289 (298)
T ss_dssp             -THHHHHHTTCCC--CCCTTC--------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -HHHHHHhcCCCC--CCCccC--------CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence             112222222211  111112        24688999999999999999999999999876

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.8e-42  Score=340.06  Aligned_cols=266  Identities=21%  Similarity=0.326  Sum_probs=209.1

Q ss_pred             ccccccccccccccceeEEEEEe---cCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAEL---PGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNI  267 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~---~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI  267 (487)
                      .++|.+.+.||.|+||.||+|++   +..++..||+|++..               ......+.+.+|+.++++++||||
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~---------------~~~~~~~~~~~E~~~l~~l~h~~i   86 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQH---------------SGPDQQRDFQREIQILKALHSDFI   86 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESS---------------CCHHHHHHHHHHHHHHHTCCCTTB
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEecc---------------CCHHHHHHHHHHHHHHHhcCCCce
Confidence            45699999999999999999985   456789999999843               123345678899999999999999


Q ss_pred             cccceEEe--cCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEe
Q 011360          268 LPLLAHMV--RPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLL  345 (487)
Q Consensus       268 v~l~~~~~--~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill  345 (487)
                      +++++++.  .....++||||+++++|.+++...   ...+++..++.++.|++.||.||   |++||+||||||+||++
T Consensus        87 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~l---H~~~ivH~Dikp~NIl~  160 (327)
T 3lxl_A           87 VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYL---GSRRCVHRDLAARNILV  160 (327)
T ss_dssp             CCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEE
T ss_pred             eEEEEEEecCCCceEEEEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHH---HhCCccCCCCChhhEEE
Confidence            99999887  456789999999999999999753   24589999999999999999999   67789999999999999


Q ss_pred             CCCCCEEEeccCCccccCCCCcee-eEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCC----
Q 011360          346 NDDMEACISDLGLAMAIPDGYTRV-LISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNG----  420 (487)
Q Consensus       346 ~~~~~~kl~DFg~s~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~----  420 (487)
                      +.++.+||+|||++.......... ......||+.|+|||++.+..++.++||||||+++|+|++|..||......    
T Consensus       161 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~  240 (327)
T 3lxl_A          161 ESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRM  240 (327)
T ss_dssp             EETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH
T ss_pred             CCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhh
Confidence            999999999999998765443222 123345788899999999888999999999999999999999998433210    


Q ss_pred             ----CccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          421 ----EEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       421 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                          .................. ...++.        .+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~--------~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  301 (327)
T 3lxl_A          241 MGCERDVPALSRLLELLEEGQR-LPAPPA--------CPAEVHELMKLCWAPSPQDRPSFSALGPQLDML  301 (327)
T ss_dssp             CC----CCHHHHHHHHHHTTCC-CCCCTT--------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC
T ss_pred             cccccccccHHHHHHHhhcccC-CCCCCc--------ccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                111111112222222211 111122        235689999999999999999999999999876

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=4.1e-42  Score=346.57  Aligned_cols=252  Identities=20%  Similarity=0.310  Sum_probs=189.3

Q ss_pred             cccccc-cccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHh-ccCCCCCccc
Q 011360          192 DCFASL-EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA-SQIRHRNILP  269 (487)
Q Consensus       192 ~~~~~~-~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l-~~l~hpnIv~  269 (487)
                      +.|.+. +.||.|+||+||+|.. ..+++.||||++..                    ...+.+|+.++ +..+||||++
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~-~~~~~~vAiK~~~~--------------------~~~~~~E~~~~~~~~~hp~iv~  119 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFN-KRTQEKFALKMLQD--------------------CPKARREVELHWRASQCPHIVR  119 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEE-TTTCCEEEEEEEEC--------------------SHHHHHHHHHHHHHTTSTTBCC
T ss_pred             ccceeccceeeeccCeEEEEEEE-CCCCCEEEEEEeCc--------------------chhHHHHHHHHHHhcCCCCcce
Confidence            356666 6899999999999974 56889999998832                    12345666665 4458999999


Q ss_pred             cceEEec----CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEe
Q 011360          270 LLAHMVR----PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLL  345 (487)
Q Consensus       270 l~~~~~~----~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill  345 (487)
                      +++++..    ...+|+|||||+||+|.+++..  .....+++..+..++.|++.||.||   |++||+||||||+|||+
T Consensus       120 l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlkp~Nill  194 (400)
T 1nxk_A          120 IVDVYENLYAGRKCLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYL---HSINIAHRDVKPENLLY  194 (400)
T ss_dssp             EEEEEEEEETTEEEEEEEEECCCSEEHHHHHHC--C---CCBHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEE
T ss_pred             EeEEEeecccCCcEEEEEEEeCCCCcHHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHH---HHCCccccCcCcceEEE
Confidence            9998875    5678999999999999999974  2345699999999999999999999   66789999999999999


Q ss_pred             CC---CCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCc
Q 011360          346 ND---DMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEE  422 (487)
Q Consensus       346 ~~---~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~  422 (487)
                      +.   ++.+||+|||+++.......   ....+||+.|+|||++.+..|+.++|||||||++|+|++|..||........
T Consensus       195 ~~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~  271 (400)
T 1nxk_A          195 TSKRPNAILKLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI  271 (400)
T ss_dssp             SSSSTTCCEEECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSS
T ss_pred             ecCCCCccEEEEecccccccCCCCc---cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccc
Confidence            97   78999999999986543322   2356789999999999999999999999999999999999999965443221


Q ss_pred             cccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          423 ICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       423 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ...  ....+.... ..      ++.......+.++.+++.+||+.||++|||+.++++
T Consensus       272 ~~~--~~~~i~~~~-~~------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  321 (400)
T 1nxk_A          272 SPG--MKTRIRMGQ-YE------FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  321 (400)
T ss_dssp             CCS--HHHHHHHTC-CC------CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             cHH--HHHHHHcCc-cc------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            111  112222211 11      111111223456899999999999999999999986

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=5e-42  Score=355.13  Aligned_cols=252  Identities=25%  Similarity=0.376  Sum_probs=202.4

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||+|+||.||+|.. ..+++.||||++..             ..........+.+|+.++++++||||++++
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~-~~~~~~vavK~~~~-------------~~~~~~~~~~~~~E~~~l~~l~hpniv~~~   87 (486)
T 3mwu_A           22 ERYNIVCMLGKGSFGEVLKCKD-RITQQEYAVKVINK-------------ASAKNKDTSTILREVELLKKLDHPNIMKLF   87 (486)
T ss_dssp             HHEEEEEEEECCSSSEEEEEEE-TTTCCEEEEEEEEH-------------HHHBCSCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cceEEeEEEeecCCEEEEEEEE-CCCCCEEEEEEEec-------------ccccchHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            4699999999999999999975 46789999999832             111122346788999999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC---CC
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN---DD  348 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~---~~  348 (487)
                      +++.+....|+|||||.+|+|.+++..    ...+++..+..++.|++.||.||   |++||+||||||+|||++   .+
T Consensus        88 ~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~l---H~~~ivH~Dlkp~Nil~~~~~~~  160 (486)
T 3mwu_A           88 EILEDSSSFYIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYM---HKHNIVHRDLKPENILLESKEKD  160 (486)
T ss_dssp             EEEECSSEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEESSSSTT
T ss_pred             EEEEcCCEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeEeccCchHHEEEecCCCC
Confidence            999999999999999999999998865    35689999999999999999999   677899999999999995   45


Q ss_pred             CCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHH
Q 011360          349 MEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEW  428 (487)
Q Consensus       349 ~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~  428 (487)
                      +.+||+|||++........   .....||+.|+|||++.+ .|+.++|||||||++|+|++|.+||....      ..+.
T Consensus       161 ~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~------~~~~  230 (486)
T 3mwu_A          161 CDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN------EYDI  230 (486)
T ss_dssp             CCEEECSCSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHH
T ss_pred             CCEEEEECCcCeECCCCCc---cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHH
Confidence            6799999999987654322   234579999999999976 59999999999999999999999994332      2233


Q ss_pred             HHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          429 LRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       429 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ...+...... .      +.......+..+.+++.+||+.||++|||+.++++
T Consensus       231 ~~~i~~~~~~-~------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~  276 (486)
T 3mwu_A          231 LKRVETGKYA-F------DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (486)
T ss_dssp             HHHHHHTCCC-S------CSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHhCCCC-C------CCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            3333332221 1      11112233467889999999999999999999986

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.2e-42  Score=344.36  Aligned_cols=203  Identities=24%  Similarity=0.437  Sum_probs=161.1

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCC-CCCcccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIR-HRNILPL  270 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l  270 (487)
                      ++|.+.+.||.|+||.||+|.. ..+|+.||||++..             ..........+.+|+.++..+. ||||+++
T Consensus         9 ~~y~~~~~lG~G~~g~V~~~~~-~~~~~~vaiK~i~~-------------~~~~~~~~~~~~~E~~~l~~l~~h~niv~l   74 (388)
T 3oz6_A            9 RKYELVKKLGKGAYGIVWKSID-RRTGEVVAVKKIFD-------------AFQNSTDAQRTFREIMILTELSGHENIVNL   74 (388)
T ss_dssp             TTEEEEEC-------CEEEEEE-TTTCCEEEEEEECC---------------CCHHHHHHHHHHHHHHHHTTTCTTBCCE
T ss_pred             CceEEEEEeeeCCCeEEEEEEE-CCCCCEEEEEEecc-------------cccChHHHHHHHHHHHHHHhccCCCCCCee
Confidence            4699999999999999999964 56899999998842             1222334566788999999996 9999999


Q ss_pred             ceEEecCC--eeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC
Q 011360          271 LAHMVRPD--CHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDD  348 (487)
Q Consensus       271 ~~~~~~~~--~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~  348 (487)
                      ++++...+  .+|+|||||+ |+|.+++..     ..+++..+..++.|++.||+||   |+.||+||||||+|||++.+
T Consensus        75 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~L---H~~~ivHrDlkp~NIll~~~  145 (388)
T 3oz6_A           75 LNVLRADNDRDVYLVFDYME-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYL---HSGGLLHRDMKPSNILLNAE  145 (388)
T ss_dssp             EEEEECTTSSCEEEEEECCS-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTT
T ss_pred             eeEEecCCCCEEEEEecccC-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHH---HhCCEEeCCCCHHHeEEcCC
Confidence            99997544  6899999996 589998874     4688999999999999999999   67789999999999999999


Q ss_pred             CCEEEeccCCccccCCCC-------------------ceeeEeeecccccccCCcccCC-CCCCchhHHHHHHHHHHHHH
Q 011360          349 MEACISDLGLAMAIPDGY-------------------TRVLISYVLGTMAYIAPEYFQQ-PELSEKCDIFSFGMLLISLV  408 (487)
Q Consensus       349 ~~~kl~DFg~s~~~~~~~-------------------~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwslG~~l~ell  408 (487)
                      +.+||+|||+++......                   ........+||+.|+|||++.+ ..|+.++|||||||++|||+
T Consensus       146 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell  225 (388)
T 3oz6_A          146 CHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEIL  225 (388)
T ss_dssp             CCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHH
T ss_pred             CCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHH
Confidence            999999999997653210                   1112234679999999999876 67999999999999999999


Q ss_pred             hCCCCcccc
Q 011360          409 RGVPSFVFH  417 (487)
Q Consensus       409 tg~~pf~~~  417 (487)
                      +|.+||.+.
T Consensus       226 ~g~~pf~~~  234 (388)
T 3oz6_A          226 CGKPIFPGS  234 (388)
T ss_dssp             HSSCSCCCS
T ss_pred             hCCCCCCCC
Confidence            999999543

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=3e-42  Score=358.73  Aligned_cols=257  Identities=26%  Similarity=0.362  Sum_probs=205.9

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .++|.+.+.||+|+||.||+|+. ..+|+.||+|++...            ..........+.+|+.++..++||||+++
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~-~~tg~~vAvK~l~k~------------~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l  249 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQV-RATGKMYACKKLEKK------------RIKKRKGEAMALNEKQILEKVNSRFVVSL  249 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEE-TTTCCEEEEEEEEHH------------HHHHTTCHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEE-CCCCCEEEEEEEEhH------------hhhhhHHHHHHHHHHHHHHHcCCCCEeeE
Confidence            34699999999999999999975 468999999998420            11112234567889999999999999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      ++++.+.+.+|+||||++||+|.+++..  .....+++..+..++.||+.||.||   |++||+||||||+|||++.+|.
T Consensus       250 ~~~~~~~~~l~lVmEy~~gg~L~~~l~~--~~~~~l~e~~~~~i~~qIl~aL~yL---H~~gIvHrDLKPeNILld~~g~  324 (576)
T 2acx_A          250 AYAYETKDALCLVLTLMNGGDLKFHIYH--MGQAGFPEARAVFYAAEICCGLEDL---HRERIVYRDLKPENILLDDHGH  324 (576)
T ss_dssp             EEEEECSSEEEEEECCCCSCBHHHHHHS--SSSCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTSC
T ss_pred             EEEEeeCCEEEEEEEcCCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHH---HHCCEeccCCchheEEEeCCCC
Confidence            9999999999999999999999999874  2334589999999999999999999   6778999999999999999999


Q ss_pred             EEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHH
Q 011360          351 ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLR  430 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~  430 (487)
                      +||+|||++........   ....+||+.|+|||++.+..|+.++|||||||++|||++|..||.......   ....+.
T Consensus       325 vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~---~~~~i~  398 (576)
T 2acx_A          325 IRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI---KREEVE  398 (576)
T ss_dssp             EEECCCTTCEECCTTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC---CHHHHH
T ss_pred             eEEEecccceecccCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccch---hHHHHH
Confidence            99999999987654432   234579999999999999899999999999999999999999996543221   112222


Q ss_pred             HHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCC-----ChHHHHH
Q 011360          431 KVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERP-----NSQYVRC  481 (487)
Q Consensus       431 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~~il~  481 (487)
                      ........  .++..        .+.++.+++.+||+.||.+||     ++.+|++
T Consensus       399 ~~i~~~~~--~~p~~--------~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          399 RLVKEVPE--EYSER--------FSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             HHHHHCCC--CCCTT--------SCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             HHhhcccc--cCCcc--------CCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence            22222211  11112        235688999999999999999     6788764

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2e-42  Score=338.09  Aligned_cols=263  Identities=22%  Similarity=0.331  Sum_probs=203.9

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .++|.+.+.||+|+||.||++.. ..+++.||+|++..               ........+.+|+.+++.++||||+++
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~---------------~~~~~~~~~~~E~~~l~~l~h~~iv~~   91 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEG-LHDGHFYALKRILC---------------HEQQDREEAQREADMHRLFNHPNILRL   91 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEE-TTTCCEEEEEEEEE---------------SSHHHHHHHHHHHHHHHTCCCTTBCCC
T ss_pred             CeEEEEEEEecCCCCeEEEEEEe-cCCCcEEEEEEEec---------------CCHHHHHHHHHHHHHHhhcCCCCeeeE
Confidence            45799999999999999999975 45889999998843               122345677899999999999999999


Q ss_pred             ceEEe----cCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC
Q 011360          271 LAHMV----RPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN  346 (487)
Q Consensus       271 ~~~~~----~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~  346 (487)
                      ++++.    .....++||||+++|+|.+++......+..+++..++.++.|++.||.||   |++||+||||||+||+++
T Consensus        92 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~L---H~~~ivH~dlkp~NIl~~  168 (317)
T 2buj_A           92 VAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAI---HAKGYAHRDLKPTNILLG  168 (317)
T ss_dssp             CEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEEC
T ss_pred             EEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEEEc
Confidence            99987    34578999999999999999987666677899999999999999999999   667899999999999999


Q ss_pred             CCCCEEEeccCCccccCCCCcee-------eEeeecccccccCCcccCCCC---CCchhHHHHHHHHHHHHHhCCCCccc
Q 011360          347 DDMEACISDLGLAMAIPDGYTRV-------LISYVLGTMAYIAPEYFQQPE---LSEKCDIFSFGMLLISLVRGVPSFVF  416 (487)
Q Consensus       347 ~~~~~kl~DFg~s~~~~~~~~~~-------~~~~~~gt~~y~aPE~l~~~~---~~~~~DvwslG~~l~elltg~~pf~~  416 (487)
                      .++.+||+|||++..........       ......||+.|+|||++.+..   ++.++||||||+++|+|++|..||..
T Consensus       169 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  248 (317)
T 2buj_A          169 DEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM  248 (317)
T ss_dssp             TTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred             CCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence            99999999999987543211100       001234699999999987654   68999999999999999999999954


Q ss_pred             cCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          417 HQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       417 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      .......     ....... .......+        ..+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus       249 ~~~~~~~-----~~~~~~~-~~~~~~~~--------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~  304 (317)
T 2buj_A          249 VFQKGDS-----VALAVQN-QLSIPQSP--------RHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL  304 (317)
T ss_dssp             HHHTTSC-----HHHHHHC-C--CCCCT--------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             hhcccch-----hhHHhhc-cCCCCccc--------cCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhc
Confidence            2211111     0111111 11111111        1235689999999999999999999999999875

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=6.2e-42  Score=340.76  Aligned_cols=199  Identities=26%  Similarity=0.365  Sum_probs=171.0

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCC-----CC
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIR-----HR  265 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----hp  265 (487)
                      .++|.+.+.||.|+||.||+|+. ..+++.||||++..                .......+..|+.++..+.     ||
T Consensus        34 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~~~vavK~~~~----------------~~~~~~~~~~e~~~l~~l~~~~~~h~   96 (360)
T 3llt_A           34 NNAFLVIRKMGDGTFGRVLLCQH-IDNKKYYAVKVVRN----------------IKKYTRSAKIEADILKKIQNDDINNN   96 (360)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEE-TTTCCEEEEEEECS----------------CHHHHHHHHHHHHHHHHTCCCSTTGG
T ss_pred             cCEEEEEEEEcccCCeEEEEEEE-CCCCeEEEEEEecc----------------chhhhhhhHHHHHHHHHhcccCCCCC
Confidence            45799999999999999999975 45789999998832                1223445567888888775     99


Q ss_pred             CccccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEe
Q 011360          266 NILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLL  345 (487)
Q Consensus       266 nIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill  345 (487)
                      ||+++++++...+..++||||+ +++|.+++..  .....+++..+..++.|++.||.||   |++||+||||||+|||+
T Consensus        97 ~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlkp~NIll  170 (360)
T 3llt_A           97 NIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITR--NNYNGFHIEDIKLYCIEILKALNYL---RKMSLTHTDLKPENILL  170 (360)
T ss_dssp             GBCCEEEEEEETTEEEEEECCC-CCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEE
T ss_pred             CeecccceeeECCeeEEEEcCC-CCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeCCCCcccEEE
Confidence            9999999999999999999999 9999999975  3334689999999999999999999   67789999999999999


Q ss_pred             CC-------------------------CCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHH
Q 011360          346 ND-------------------------DMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSF  400 (487)
Q Consensus       346 ~~-------------------------~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dvwsl  400 (487)
                      +.                         ++.+||+|||++.......     ....||+.|+|||++.+..++.++|||||
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  245 (360)
T 3llt_A          171 DDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDMWSF  245 (360)
T ss_dssp             SCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHHHHH
T ss_pred             ccccccccccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccchHHH
Confidence            75                         7889999999998654332     34568999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCcccc
Q 011360          401 GMLLISLVRGVPSFVFH  417 (487)
Q Consensus       401 G~~l~elltg~~pf~~~  417 (487)
                      ||++|+|+||..||...
T Consensus       246 G~il~ell~g~~pf~~~  262 (360)
T 3llt_A          246 GCVLAELYTGSLLFRTH  262 (360)
T ss_dssp             HHHHHHHHHSSCSCCCS
T ss_pred             HHHHHHHHHCCCCCCCC
Confidence            99999999999999543

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.9e-42  Score=347.58  Aligned_cols=272  Identities=21%  Similarity=0.282  Sum_probs=213.0

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .+.|.+.+.||+|+||.||+|.+ ..+++.||||++...              ........+.+|+.++++++||||+++
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~-~~~~~~vaiK~~~~~--------------~~~~~~~~~~~E~~~l~~l~hpnIv~~   72 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRH-KKTGDLFAIKVFNNI--------------SFLRPVDVQMREFEVLKKLNHKNIVKL   72 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEE-TTTCCEEEEEEECGG--------------GGGSCHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEE-CCCCcEEEEEEeccc--------------cccchHHHHHHHHHHHHhcCCCCCCeE
Confidence            35799999999999999999975 457899999998421              111224566789999999999999999


Q ss_pred             ceEEecCC--eeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEe---
Q 011360          271 LAHMVRPD--CHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLL---  345 (487)
Q Consensus       271 ~~~~~~~~--~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill---  345 (487)
                      ++++...+  ..++|||||++|+|.+++..... ...+++..++.++.|++.||.||   |++||+||||||+|||+   
T Consensus        73 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~  148 (396)
T 4eut_A           73 FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHL---RENGIVHRNIKPGNIMRVIG  148 (396)
T ss_dssp             EEEEECTTTCCEEEEECCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEEEEC
T ss_pred             EEeeccCCCCeeEEEEecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHH---HHCCEEECCcCHHHEEEeec
Confidence            99988755  77999999999999999975322 23489999999999999999999   67789999999999999   


Q ss_pred             -CCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCC--------CCCCchhHHHHHHHHHHHHHhCCCCccc
Q 011360          346 -NDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQ--------PELSEKCDIFSFGMLLISLVRGVPSFVF  416 (487)
Q Consensus       346 -~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~~~~~DvwslG~~l~elltg~~pf~~  416 (487)
                       +.++.+||+|||+++........   ....||+.|+|||++.+        ..++.++|||||||++|+|++|..||..
T Consensus       149 ~~~~~~~kL~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~  225 (396)
T 4eut_A          149 EDGQSVYKLTDFGAARELEDDEQF---VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP  225 (396)
T ss_dssp             TTSCEEEEECCGGGCEECCCGGGS---SCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEEC
T ss_pred             CCCceeEEEecCCCceEccCCCcc---ccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence             77788999999999876543322   24569999999998864        4678899999999999999999999965


Q ss_pred             cCCCCccccHHHHHHHHhcCCCCCcc-------------CCCCC--CCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          417 HQNGEEICSPEWLRKVMNSKNPSRAI-------------DPRLP--GNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       417 ~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~--~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .....  ...+.+....... +...+             ...++  ..........+.+++.+||..||++|||+.++++
T Consensus       226 ~~~~~--~~~~~~~~~~~~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~  302 (396)
T 4eut_A          226 FEGPR--RNKEVMYKIITGK-PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA  302 (396)
T ss_dssp             TTCTT--TCHHHHHHHHHSC-CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred             CCccc--chHHHHHHHhcCC-CcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence            44322  2234444444332 22111             11111  2234667788999999999999999999999999


Q ss_pred             HHhhhC
Q 011360          482 RLSQLL  487 (487)
Q Consensus       482 ~L~~ll  487 (487)
                      .++++|
T Consensus       303 ~l~~il  308 (396)
T 4eut_A          303 ETSDIL  308 (396)
T ss_dssp             HHHHHH
T ss_pred             HHHHHh
Confidence            988764

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=7.1e-42  Score=329.65  Aligned_cols=256  Identities=23%  Similarity=0.317  Sum_probs=192.0

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .++|.+.+.||.|+||.||+|.. ..+++.||+|++...             .......+.+.++...++.++||||+++
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~-------------~~~~~~~~~~~~~~~~~~~~~h~~iv~~   71 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRH-VPSGQIMAVKRIRAT-------------VNSQEQKRLLMDLDISMRTVDCPFTVTF   71 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEE-TTTTEEEEEEEEC----------------CHHHHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEe-cCCCeEEEEEEeecc-------------cCcHHHHHHHHHHHHHHHhCCCCeEEEE
Confidence            45799999999999999999975 468899999998431             1122233445556666888999999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCC-CeeecCCCCCCEEeCCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSA-SIIHGDIKPRNVLLNDDM  349 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~-givH~Dlkp~Nill~~~~  349 (487)
                      ++++...+..++||||++ |+|.+++......+..+++..++.++.|++.||.||   |++ ||+||||||+||+++.++
T Consensus        72 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~~i~H~dlkp~Nil~~~~~  147 (290)
T 3fme_A           72 YGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHL---HSKLSVIHRDVKPSNVLINALG  147 (290)
T ss_dssp             EEEEECSSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH---HHHSCCCCCCCSGGGCEECTTC
T ss_pred             eeeeeccCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH---hhcCCeecCCCCHHHEEECCCC
Confidence            999999999999999996 599888876556677899999999999999999999   555 899999999999999999


Q ss_pred             CEEEeccCCccccCCCCceeeEeeecccccccCCccc----CCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCcccc
Q 011360          350 EACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYF----QQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICS  425 (487)
Q Consensus       350 ~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l----~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~  425 (487)
                      .+||+|||++.........   ....||+.|+|||++    .+..++.++||||||+++|+|+||..||.....     .
T Consensus       148 ~~kl~Dfg~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~  219 (290)
T 3fme_A          148 QVKMCDFGISGYLVDDVAK---DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT-----P  219 (290)
T ss_dssp             CEEBCCC------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC-----H
T ss_pred             CEEEeecCCcccccccccc---cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc-----h
Confidence            9999999999776443222   234689999999996    566789999999999999999999999943221     1


Q ss_pred             HHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          426 PEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       426 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ............+.. ....        .+.++.+++.+||+.||++|||+.++++
T Consensus       220 ~~~~~~~~~~~~~~~-~~~~--------~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          220 FQQLKQVVEEPSPQL-PADK--------FSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             HHHHHHHHHSCCCCC-CTTT--------SCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHhccCCCCc-cccc--------CCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence            222333333332211 1111        2356889999999999999999999876

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2e-42  Score=331.85  Aligned_cols=259  Identities=23%  Similarity=0.371  Sum_probs=205.3

Q ss_pred             HhhhccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCC
Q 011360          187 FLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRN  266 (487)
Q Consensus       187 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn  266 (487)
                      |....++|.+.+.||.|+||.||+|...  ++..||+|.+...                ......+.+|+.+++.++|||
T Consensus         8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~----------------~~~~~~~~~E~~~l~~l~h~~   69 (279)
T 1qpc_A            8 WEVPRETLKLVERLGAGQFGEVWMGYYN--GHTKVAVKSLKQG----------------SMSPDAFLAEANLMKQLQHQR   69 (279)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEET--TTEEEEEEEECTT----------------SSCHHHHHHHHHHHHHCCCTT
T ss_pred             cccCHHhhhheeeecCCCCeEEEEEEEc--CCcEEEEEEecCC----------------cccHHHHHHHHHHHHhCCCcC
Confidence            3344567999999999999999999864  5678999988421                112346788999999999999


Q ss_pred             ccccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC
Q 011360          267 ILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN  346 (487)
Q Consensus       267 Iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~  346 (487)
                      |+++++++. .+..++||||+++++|.+++...  .+..+++..+..++.|++.||.||   |++||+||||||+||+++
T Consensus        70 i~~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dikp~Nil~~  143 (279)
T 1qpc_A           70 LVRLYAVVT-QEPIYIITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFI---EERNYIHRDLRAANILVS  143 (279)
T ss_dssp             BCCEEEEEC-SSSCEEEEECCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEC
T ss_pred             cceEEEEEc-CCCcEEEEecCCCCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHhhEEEc
Confidence            999999876 45689999999999999998642  123689999999999999999999   677899999999999999


Q ss_pred             CCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCcccc
Q 011360          347 DDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICS  425 (487)
Q Consensus       347 ~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~  425 (487)
                      .++.+||+|||++......... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||....      .
T Consensus       144 ~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~------~  216 (279)
T 1qpc_A          144 DTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT------N  216 (279)
T ss_dssp             TTSCEEECCCTTCEECSSSCEE-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC------H
T ss_pred             CCCCEEECCCcccccccCcccc-cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccC------H
Confidence            9999999999999876543221 1123446789999999988889999999999999999999 899994322      2


Q ss_pred             HHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          426 PEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       426 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      .+..........+  ..+..        .+..+.+++.+||+.||++|||+.++++.|+++
T Consensus       217 ~~~~~~~~~~~~~--~~~~~--------~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  267 (279)
T 1qpc_A          217 PEVIQNLERGYRM--VRPDN--------CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (279)
T ss_dssp             HHHHHHHHTTCCC--CCCTT--------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHHhcccCC--CCccc--------ccHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence            2333333322111  11111        225688999999999999999999999999876

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=3.7e-42  Score=336.95  Aligned_cols=257  Identities=23%  Similarity=0.316  Sum_probs=204.8

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      +.|.+.+.||.|+||.||+|.. ..+|..||+|++........         ........+.+|+.++.+++||||++++
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~~~~~~---------~~~~~~~~~~~E~~~l~~l~h~~iv~~~   81 (321)
T 2a2a_A           12 DFYDIGEELGSGQFAIVKKCRE-KSTGLEYAAKFIKKRQSRAS---------RRGVSREEIEREVSILRQVLHHNVITLH   81 (321)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEE-TTTCCEEEEEEEEBCSSSSC---------SSSBCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             ccEEEeeEeeecCCEEEEEEEE-CCCCeEEEEEEEeccccccc---------ccchhHHHHHHHHHHHHhCCCCCcceEE
Confidence            4699999999999999999975 46789999999854321110         0011245678899999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC--
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDM--  349 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~--  349 (487)
                      +++.+.+..++||||+++++|.+++..    ...+++..+..++.|++.||.||   |++||+||||||+||+++.++  
T Consensus        82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~l---H~~~ivH~dikp~NIl~~~~~~~  154 (321)
T 2a2a_A           82 DVYENRTDVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYL---HTKKIAHFDLKPENIMLLDKNIP  154 (321)
T ss_dssp             EEEECSSEEEEEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEESCTTSS
T ss_pred             EEEecCCEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCChHHEEEecCCCC
Confidence            999999999999999999999999964    45689999999999999999999   677899999999999999887  


Q ss_pred             --CEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHH
Q 011360          350 --EACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPE  427 (487)
Q Consensus       350 --~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~  427 (487)
                        .+||+|||++.........   ....||+.|+|||++.+..++.++||||||+++|+|++|..||....      ..+
T Consensus       155 ~~~~kl~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~  225 (321)
T 2a2a_A          155 IPHIKLIDFGLAHEIEDGVEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT------KQE  225 (321)
T ss_dssp             SCCEEECCCTTCEECCTTCCC---CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS------HHH
T ss_pred             cCCEEEccCccceecCccccc---cccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCC------HHH
Confidence              7999999999876543221   34568999999999999999999999999999999999999994332      222


Q ss_pred             HHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          428 WLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ....+......       .+.......+..+.+++.+||+.||++|||+.++++
T Consensus       226 ~~~~i~~~~~~-------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          226 TLANITSVSYD-------FDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             HHHHHHTTCCC-------CCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHhcccc-------cChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            33333221111       110001112356889999999999999999999986

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=5.2e-42  Score=334.39  Aligned_cols=247  Identities=19%  Similarity=0.235  Sum_probs=190.1

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhcc-CCCCCcccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQ-IRHRNILPL  270 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~hpnIv~l  270 (487)
                      ++|.+.+.||+|+||.||+|.. ..+++.||||++....             ...........|+..+.. .+||||+++
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~-~~~~~~vavK~~~~~~-------------~~~~~~~~~~~e~~~~~~~~~h~~iv~l  122 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRS-KEDGRLYAVKRSMSPF-------------RGPKDRARKLAEVGSHEKVGQHPCCVRL  122 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEE-TTTSCEEEEEEESSSC-------------CSHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             hheeeeheeccCCCeEEEEEEE-CCCCeEEEEEEecccc-------------cChHHHHHHHHHHHHHHHhcCCCcEEEE
Confidence            4699999999999999999975 4578999999874311             111222334445544444 499999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      ++++...+..|+||||+ +++|.+++...   +..+++..++.++.|++.||.||   |+.||+||||||+|||++.++.
T Consensus       123 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dikp~NIll~~~~~  195 (311)
T 3p1a_A          123 EQAWEEGGILYLQTELC-GPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHL---HSQGLVHLDVKPANIFLGPRGR  195 (311)
T ss_dssp             EEEEEETTEEEEEEECC-CCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECGGGC
T ss_pred             EEEEEeCCEEEEEEecc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHH---HHCCEecCCCCHHHEEECCCCC
Confidence            99999999999999999 77999988753   45699999999999999999999   6678999999999999999999


Q ss_pred             EEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHH
Q 011360          351 ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLR  430 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~  430 (487)
                      +||+|||++........   .....||+.|+|||++.+ .++.++|||||||++|||++|..||...         ....
T Consensus       196 ~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~---------~~~~  262 (311)
T 3p1a_A          196 CKLGDFGLLVELGTAGA---GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG---------EGWQ  262 (311)
T ss_dssp             EEECCCTTCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH---------HHHH
T ss_pred             EEEccceeeeecccCCC---CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc---------cHHH
Confidence            99999999877644322   234569999999999886 7899999999999999999996655221         1111


Q ss_pred             HHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          431 KVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       431 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .+ ........+..        ..+..+.+++.+||+.||++|||+.++++
T Consensus       263 ~~-~~~~~~~~~~~--------~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          263 QL-RQGYLPPEFTA--------GLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             HH-TTTCCCHHHHT--------TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HH-hccCCCccccc--------CCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            12 11111111111        12356899999999999999999999985

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=7.5e-42  Score=334.35  Aligned_cols=262  Identities=22%  Similarity=0.298  Sum_probs=204.5

Q ss_pred             cccccccccccceeEEEEEec---CCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          194 FASLEKIGSGGCGEVYKAELP---GSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       194 ~~~~~~lg~G~~g~v~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      |.+.+.||.|+||.||++++.   ..+++.||||++..              .........+.+|+.+++.++||||+++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~--------------~~~~~~~~~~~~E~~~l~~l~h~~iv~~   98 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKA--------------DAGPQHRSGWKQEIDILRTLYHEHIIKY   98 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECT--------------TCCHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecc--------------ccChHHHHHHHHHHHHHHhCCCcchhhE
Confidence            599999999999999988653   34788999999843              1223345678899999999999999999


Q ss_pred             ceEEec--CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC
Q 011360          271 LAHMVR--PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDD  348 (487)
Q Consensus       271 ~~~~~~--~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~  348 (487)
                      ++++.+  ...+++||||+++|+|.+++..     ..+++..++.++.|++.||.||   |+.||+||||||+||+++.+
T Consensus        99 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~L---H~~~ivH~Dikp~Nil~~~~  170 (318)
T 3lxp_A           99 KGCCEDAGAASLQLVMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYL---HAQHYIHRDLAARNVLLDND  170 (318)
T ss_dssp             EEEEEETTTTEEEEEECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTT
T ss_pred             EEEEecCCCceEEEEEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHH---HhCCccCCCCchheEEEcCC
Confidence            999987  4678999999999999999964     3489999999999999999999   67789999999999999999


Q ss_pred             CCEEEeccCCccccCCCCce-eeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCC-------
Q 011360          349 MEACISDLGLAMAIPDGYTR-VLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNG-------  420 (487)
Q Consensus       349 ~~~kl~DFg~s~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~-------  420 (487)
                      +.+||+|||++......... .......+|+.|+|||++.+..++.++||||||+++|+|+||..||......       
T Consensus       171 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~  250 (318)
T 3lxp_A          171 RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGI  250 (318)
T ss_dssp             CCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCS
T ss_pred             CCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcc
Confidence            99999999999877554322 1223455788999999999888999999999999999999999999533110       


Q ss_pred             -CccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          421 -EEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       421 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                       .................. ...+..        .+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus       251 ~~~~~~~~~~~~~~~~~~~-~~~~~~--------~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l  308 (318)
T 3lxp_A          251 AQGQMTVLRLTELLERGER-LPRPDK--------CPAEVYHLMKNCWETEASFRPTFENLIPILKTV  308 (318)
T ss_dssp             CCHHHHHHHHHHHHHTTCC-CCCCTT--------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cccchhHHHHHHHHhcccC-CCCCcc--------ccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence             000011112222222211 111111        235689999999999999999999999999876

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=5e-42  Score=328.32  Aligned_cols=254  Identities=24%  Similarity=0.353  Sum_probs=202.8

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||+|+||.||+|.. ..+++.||+|++...              ........+.+|+.+++.++||||++++
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~--------------~~~~~~~~~~~e~~~l~~l~h~~i~~~~   71 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVN-RVTEEAVAVKIVDMK--------------RAVDCPENIKKEICINKMLNHENVVKFY   71 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEE-TTTCCEEEEEEEEGG--------------GCTTHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             cceEEEEEeecCCCcEEEEEEE-CCCCcEEEEEEeeec--------------cchhhhHHHHHHHHHHHhcCCCCceeee
Confidence            4699999999999999999975 457899999988431              1122346778899999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++.+.+..|+||||+++++|.+++..    ...+++..+..++.|++.||.||   |++|++||||||+||+++.++.+
T Consensus        72 ~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~  144 (276)
T 2yex_A           72 GHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYL---HGIGITHRDIKPENLLLDERDNL  144 (276)
T ss_dssp             EEEEETTEEEEEEECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTCCE
T ss_pred             eEEEcCCEEEEEEEecCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHH---HhCCeeccCCChHHEEEccCCCE
Confidence            999999999999999999999998853    45789999999999999999999   67789999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCCCC-CchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPEL-SEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLR  430 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~  430 (487)
                      ||+|||++................||+.|+|||++.+..+ +.++||||||+++|+|++|..||........     ...
T Consensus       145 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~  219 (276)
T 2yex_A          145 KISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-----EYS  219 (276)
T ss_dssp             EECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-----HHH
T ss_pred             EEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-----HHH
Confidence            9999999976543332222345668999999999987665 7899999999999999999999955433211     111


Q ss_pred             HHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          431 KVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       431 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ........ ..        .....+..+.+++.+||+.||++|||+.++++
T Consensus       220 ~~~~~~~~-~~--------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          220 DWKEKKTY-LN--------PWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             HHHTTCTT-ST--------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             Hhhhcccc-cC--------chhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence            12211111 00        11123356889999999999999999999875

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-41  Score=329.39  Aligned_cols=258  Identities=23%  Similarity=0.313  Sum_probs=201.4

Q ss_pred             ccccccccccccceeEEEEEecC--CCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          193 CFASLEKIGSGGCGEVYKAELPG--SNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .|.+.+.||+|+||.||+|.+..  .++..||+|.+..              .......+.+.+|+.+++.++||||+++
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~--------------~~~~~~~~~~~~E~~~l~~l~h~~iv~~   87 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSR--------------ITEMQQVEAFLREGLLMRGLNHPNVLAL   87 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETT--------------CCSHHHHHHHHHHHHHHHTCCCTTBCCC
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccc--------------cccHHHHHHHHHHHHHHHhCCCCCeeeE
Confidence            46677999999999999998632  2344799998732              1223345678899999999999999999


Q ss_pred             ceEEecCCee-EEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC
Q 011360          271 LAHMVRPDCH-LLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDM  349 (487)
Q Consensus       271 ~~~~~~~~~~-~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~  349 (487)
                      ++++...+.. ++||||+.+|+|.+++..   ....+++..+..++.|++.||.||   |++||+||||||+||+++.++
T Consensus        88 ~~~~~~~~~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~L---H~~~i~H~dikp~Nili~~~~  161 (298)
T 3pls_A           88 IGIMLPPEGLPHVLLPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYL---AEQKFVHRDLAARNCMLDESF  161 (298)
T ss_dssp             CEEECCSSSCCEEEECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECTTC
T ss_pred             EEEEecCCCCcEEEEecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCcceEEEcCCC
Confidence            9999876665 999999999999999864   356789999999999999999999   677899999999999999999


Q ss_pred             CEEEeccCCccccCCCCc--eeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhC-CCCccccCCCCccccH
Q 011360          350 EACISDLGLAMAIPDGYT--RVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRG-VPSFVFHQNGEEICSP  426 (487)
Q Consensus       350 ~~kl~DFg~s~~~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg-~~pf~~~~~~~~~~~~  426 (487)
                      .+||+|||++........  ........+|+.|+|||.+.+..++.++||||||+++|+|++| .+||.....      .
T Consensus       162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~------~  235 (298)
T 3pls_A          162 TVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP------F  235 (298)
T ss_dssp             CEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG------G
T ss_pred             cEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH------H
Confidence            999999999976543321  1111334678999999999999999999999999999999996 455532211      1


Q ss_pred             HHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          427 EWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       427 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      ............  ..+..        .+..+.+++.+||+.||++|||+.++++.|+++
T Consensus       236 ~~~~~~~~~~~~--~~~~~--------~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~  285 (298)
T 3pls_A          236 DLTHFLAQGRRL--PQPEY--------CPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI  285 (298)
T ss_dssp             GHHHHHHTTCCC--CCCTT--------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHhhcCCCC--CCCcc--------chHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            122222222211  11111        225688999999999999999999999999876

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.3e-42  Score=334.79  Aligned_cols=264  Identities=22%  Similarity=0.332  Sum_probs=196.8

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||+|+||.||+|.. ..+++.||+|++...             .........+.+|+.++.+++||||++++
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~-------------~~~~~~~~~~~~E~~~l~~l~h~~i~~~~   68 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRN-RDTGQIVAIKKFLES-------------EDDPVIKKIALREIRMLKQLKHPNLVNLL   68 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEE-TTTCCEEEEEEECCC-------------CC-HHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             ccceEeeEEeecCCeEEEEEEe-CCCCcEEEEEEeecc-------------ccchHHHHHHHHHHHHHHhCCCCCccchh
Confidence            4699999999999999999975 457899999988432             12233456678899999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++...+..++||||+++++|.+++..    ...+++..+..++.|++.||.||   |++||+||||||+||+++.++.+
T Consensus        69 ~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~i~~~l~~~l~~l---H~~~ivH~dlkp~Nil~~~~~~~  141 (311)
T 4agu_A           69 EVFRRKRRLHLVFEYCDHTVLHELDRY----QRGVPEHLVKSITWQTLQAVNFC---HKHNCIHRDVKPENILITKHSVI  141 (311)
T ss_dssp             EEEEETTEEEEEEECCSEEHHHHHHHT----SSCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCE
T ss_pred             heeecCCeEEEEEEeCCCchHHHHHhh----hcCCCHHHHHHHHHHHHHHHHHH---HHCCCcCCCCChhhEEEcCCCCE
Confidence            999999999999999999999888754    46689999999999999999999   67789999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQ-PELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLR  430 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~  430 (487)
                      ||+|||++.........  .....||+.|+|||++.+ ..++.++||||||+++|+|++|..||........   .....
T Consensus       142 kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~~  216 (311)
T 4agu_A          142 KLCDFGFARLLTGPSDY--YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQ---LYLIR  216 (311)
T ss_dssp             EECCCTTCEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHH
T ss_pred             EEeeCCCchhccCcccc--cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHH
Confidence            99999999876533221  134568999999999875 5789999999999999999999999954332110   00011


Q ss_pred             HHH-----------hcCC---CCCccCCCCCCC---CcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          431 KVM-----------NSKN---PSRAIDPRLPGN---GYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       431 ~~~-----------~~~~---~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ...           ....   .....++.....   .....+..+.+++.+||+.||++|||++++++
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          217 KTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             HHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             HHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            110           0000   000000000000   01123456889999999999999999999975

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-42  Score=344.34  Aligned_cols=258  Identities=23%  Similarity=0.327  Sum_probs=193.8

Q ss_pred             ccccccccccccceeEEEEEecCCC--CceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSN--GKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .|.+.+.||+|+||.||+|++...+  +..||+|.+..              .........+.+|+.++++++||||+++
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~--------------~~~~~~~~~~~~E~~il~~l~hpnIv~~  155 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--------------ITDIGEVSQFLTEGIIMKDFSHPNVLSL  155 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCS--------------CSCSHHHHHHHHHHTTSTTCCCTTBCCC
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCC--------------CCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            4778899999999999999864333  34689998732              1223356678999999999999999999


Q ss_pred             ceEEec-CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC
Q 011360          271 LAHMVR-PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDM  349 (487)
Q Consensus       271 ~~~~~~-~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~  349 (487)
                      ++++.. .+..++||||+++|+|.+++..   ....+++..+..++.|++.||.||   |++||+||||||+|||++.++
T Consensus       156 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlkp~NIll~~~~  229 (373)
T 3c1x_A          156 LGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKF  229 (373)
T ss_dssp             CEEECCCSSCCEEEEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTC
T ss_pred             EEEEEcCCCCeEEEEECCCCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHH---HHCCEecCccchheEEECCCC
Confidence            998654 5678999999999999999963   345688899999999999999999   677899999999999999999


Q ss_pred             CEEEeccCCccccCCCCcee--eEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccccH
Q 011360          350 EACISDLGLAMAIPDGYTRV--LISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSP  426 (487)
Q Consensus       350 ~~kl~DFg~s~~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~  426 (487)
                      .+||+|||+++.........  ......+|+.|+|||++.+..++.++||||||+++|||+| |.+||.......     
T Consensus       230 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~-----  304 (373)
T 3c1x_A          230 TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-----  304 (373)
T ss_dssp             CEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC-----
T ss_pred             CEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH-----
Confidence            99999999998654332111  1123457889999999999899999999999999999999 678885443211     


Q ss_pred             HHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          427 EWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       427 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                       ..........+  ..+..+        +..+.+++.+||+.||++|||+.++++.|+.+
T Consensus       305 -~~~~~~~~~~~--~~p~~~--------~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i  353 (373)
T 3c1x_A          305 -ITVYLLQGRRL--LQPEYC--------PDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  353 (373)
T ss_dssp             -HHHHHHTTCCC--CCCTTC--------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -HHHHHHcCCCC--CCCCCC--------CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence             12222222211  111112        24688999999999999999999999999876

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.1e-41  Score=326.38  Aligned_cols=252  Identities=24%  Similarity=0.362  Sum_probs=181.8

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||+|+||.||+|+. ..+++.||+|.+...            ..........+.+|+.++.+++||||++++
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~~vavK~~~~~------------~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~   77 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAES-IHTGLEVAIKMIDKK------------AMYKAGMVQRVQNEVKIHCQLKHPSILELY   77 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEE-TTTCCEEEEEEEEHH------------HHHHTTCHHHHHHHHHHHTTBCCTTBCCEE
T ss_pred             ccceeeeeecCCCceEEEEEEE-ccCCceEEEEEeehh------------hhhhhhHHHHHHHHHHHHHhCCCCCeEeEE
Confidence            4699999999999999999975 457899999988320            111122346788999999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++.+.+..++||||+++++|.+++..   ....+++..++.++.|++.||.||   |++|++||||||+||+++.++.+
T Consensus        78 ~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~Nili~~~~~~  151 (278)
T 3cok_A           78 NYFEDSNYVYLVLEMCHNGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYL---HSHGILHRDLTLSNLLLTRNMNI  151 (278)
T ss_dssp             EEEECSSEEEEEEECCTTEEHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHH---HHTTEECSSCCGGGEEECTTCCE
T ss_pred             EEEccCCeEEEEEecCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHEEEcCCCCE
Confidence            999999999999999999999999874   346789999999999999999999   67789999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRK  431 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~  431 (487)
                      ||+|||++.........  .....||+.|+|||.+.+..++.++||||||+++|+|++|..||........      ...
T Consensus       152 kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~  223 (278)
T 3cok_A          152 KIADFGLATQLKMPHEK--HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT------LNK  223 (278)
T ss_dssp             EECCCTTCEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------
T ss_pred             EEEeecceeeccCCCCc--ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH------HHH
Confidence            99999999876433221  1245689999999999988899999999999999999999999955432211      111


Q ss_pred             HHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          432 VMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       432 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ... .      +...+..    .+.++.+++.+||+.||++|||+.++++
T Consensus       224 ~~~-~------~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          224 VVL-A------DYEMPSF----LSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             CCS-S------CCCCCTT----SCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             Hhh-c------ccCCccc----cCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence            100 0      1111211    2356889999999999999999999875

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=8.4e-42  Score=331.77  Aligned_cols=250  Identities=25%  Similarity=0.367  Sum_probs=200.6

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||+|+||.||+++. ..+|+.||+|++....               ......+.+|+.++..++||||++++
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~~~---------------~~~~~~~~~e~~~l~~l~h~~i~~~~   72 (304)
T 2jam_A            9 KTFIFMEVLGSGAFSEVFLVKQ-RLTGKLFALKCIKKSP---------------AFRDSSLENEIAVLKKIKHENIVTLE   72 (304)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEE-TTTCCEEEEEEEECC---------------------HHHHHHHHHHHCCCTTBCCEE
T ss_pred             ccceeeeeccCCCCceEEEEEE-CCCCCEEEEEEEeccc---------------ccchHHHHHHHHHHHhCCCCCeeehh
Confidence            4699999999999999999975 4578999999985311               11234577899999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEe---CCC
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLL---NDD  348 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill---~~~  348 (487)
                      +++...+..++||||+++++|.+++..    ...+++..+..++.|++.||.||   |+.||+||||||+||++   +.+
T Consensus        73 ~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dikp~NIl~~~~~~~  145 (304)
T 2jam_A           73 DIYESTTHYYLVMQLVSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYL---HENGIVHRDLKPENLLYLTPEEN  145 (304)
T ss_dssp             EEEECSSEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCSCCGGGCEESSSSTT
T ss_pred             hhcccCCEEEEEEEcCCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCccccCCCHHHEEEecCCCC
Confidence            999999999999999999999999865    34689999999999999999999   67789999999999999   778


Q ss_pred             CCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHH
Q 011360          349 MEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEW  428 (487)
Q Consensus       349 ~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~  428 (487)
                      +.+||+|||++........    ....||+.|+|||++.+..++.++||||||+++|+|++|..||....      ....
T Consensus       146 ~~~kl~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~  215 (304)
T 2jam_A          146 SKIMITDFGLSKMEQNGIM----STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET------ESKL  215 (304)
T ss_dssp             CCEEBCSCSTTCCCCCBTT----HHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC------HHHH
T ss_pred             CCEEEccCCcceecCCCcc----ccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC------HHHH
Confidence            8999999999876443221    23468999999999999999999999999999999999999994322      2233


Q ss_pred             HHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          429 LRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       429 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ...+......   .+    .......+..+.+++.+||..||++|||+.++++
T Consensus       216 ~~~i~~~~~~---~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          216 FEKIKEGYYE---FE----SPFWDDISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             HHHHHHCCCC---CC----TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             HHHHHcCCCC---CC----ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            3333332211   01    1111123356889999999999999999999975

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1e-42  Score=343.54  Aligned_cols=252  Identities=23%  Similarity=0.321  Sum_probs=198.2

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CCCCccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RHRNILP  269 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~  269 (487)
                      .+.|.+.+.||.|+||.||+|.. ..+++.||+|++....                   ....+|+.++.++ +||||++
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~~~~avK~~~~~~-------------------~~~~~E~~~l~~~~~hp~iv~   80 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIH-KATNMEFAVKIIDKSK-------------------RDPTEEIEILLRYGQHPNIIT   80 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEE-TTTTEEEEEEEEETTT-------------------CCCHHHHHHHHHHTTSTTBCC
T ss_pred             cccEEEEEEEeeCCCEEEEEEEE-CCCCCEEEEEEEEccc-------------------CChHHHHHHHHHhcCCCCcCe
Confidence            35699999999999999999975 4688999999984311                   1123567777776 8999999


Q ss_pred             cceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC-
Q 011360          270 LLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDD-  348 (487)
Q Consensus       270 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~-  348 (487)
                      +++++.+.+..|+|||||+||+|.+++..    ...+++..+..++.|++.||.||   |++||+||||||+|||+..+ 
T Consensus        81 ~~~~~~~~~~~~lv~E~~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~l---H~~givHrDlkp~NIl~~~~~  153 (342)
T 2qr7_A           81 LKDVYDDGKYVYVVTELMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYL---HAQGVVHRDLKPSNILYVDES  153 (342)
T ss_dssp             EEEEEECSSEEEEEECCCCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEESSSS
T ss_pred             EEEEEEcCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCcEeccCCHHHEEEecCC
Confidence            99999999999999999999999999864    45799999999999999999999   67789999999999998543 


Q ss_pred             ---CCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCcccc
Q 011360          349 ---MEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICS  425 (487)
Q Consensus       349 ---~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~  425 (487)
                         +.+||+|||++.........  ....+||+.|+|||++.+..|+.++|||||||++|+|++|..||.....   ...
T Consensus       154 ~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~  228 (342)
T 2qr7_A          154 GNPESIRICDFGFAKQLRAENGL--LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD---DTP  228 (342)
T ss_dssp             CSGGGEEECCCTTCEECBCTTCC--BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT---SCH
T ss_pred             CCcCeEEEEECCCcccCcCCCCc--eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc---CCH
Confidence               34999999999876443221  2345789999999999887899999999999999999999999964322   122


Q ss_pred             HHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          426 PEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       426 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .+....+... ...      ++.......+..+.+++.+||..||++|||+.++++
T Consensus       229 ~~~~~~i~~~-~~~------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          229 EEILARIGSG-KFS------LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             HHHHHHHHHC-CCC------CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             HHHHHHHccC-Ccc------cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            2333333322 221      111112223456889999999999999999999874

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=6.9e-42  Score=341.18  Aligned_cols=255  Identities=15%  Similarity=0.171  Sum_probs=200.4

Q ss_pred             hccccccccccccccceeEEEEEe----cCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCC--
Q 011360          190 KEDCFASLEKIGSGGCGEVYKAEL----PGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIR--  263 (487)
Q Consensus       190 ~~~~~~~~~~lg~G~~g~v~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--  263 (487)
                      ..+.|.+.+.||+|+||.||+|.+    +..+++.||+|++...                  ....+..|..++..++  
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~------------------~~~~~~~e~~~~~~l~~~  124 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA------------------NPWEFYIGTQLMERLKPS  124 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC------------------CHHHHHHHHHHHHHSCGG
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC------------------ChhHHHHHHHHHHHhhhh
Confidence            345799999999999999999952    3457899999998421                  1223455566665554  


Q ss_pred             -CCCccccceEEecCCeeEEEEEecCCCCHHHHHhhhhc-CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCC
Q 011360          264 -HRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSR-GRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPR  341 (487)
Q Consensus       264 -hpnIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~  341 (487)
                       |+||+++++++...+..|+|||||++|+|.+++..... ....+++..++.++.|++.||.||   |++||+||||||+
T Consensus       125 ~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~l---H~~~ivHrDiKp~  201 (365)
T 3e7e_A          125 MQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQV---HDCEIIHGDIKPD  201 (365)
T ss_dssp             GGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCSGG
T ss_pred             hhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHH---hhCCeecCCCCHH
Confidence             99999999999999999999999999999999976433 356799999999999999999999   7788999999999


Q ss_pred             CEEeCC-----------CCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhC
Q 011360          342 NVLLND-----------DMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRG  410 (487)
Q Consensus       342 Nill~~-----------~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg  410 (487)
                      |||++.           ++.+||+|||+++..............+||+.|+|||++.+..|+.++|||||||++|||+||
T Consensus       202 NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg  281 (365)
T 3e7e_A          202 NFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFG  281 (365)
T ss_dssp             GEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHS
T ss_pred             HEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhC
Confidence            999998           899999999999765433333334566799999999999999999999999999999999999


Q ss_pred             CCCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCC-CChHHHHHHHhhh
Q 011360          411 VPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEER-PNSQYVRCRLSQL  486 (487)
Q Consensus       411 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R-Ps~~~il~~L~~l  486 (487)
                      ..||.........                  +...+....   ....+.+++..|++.+|.+| |+++++.+.|+.+
T Consensus       282 ~~pf~~~~~~~~~------------------~~~~~~~~~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~  337 (365)
T 3e7e_A          282 TYMKVKNEGGECK------------------PEGLFRRLP---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV  337 (365)
T ss_dssp             SCCCEEEETTEEE------------------ECSCCTTCS---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred             CCccccCCCCcee------------------echhccccC---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence            9999544331110                  000111111   13457788889999999988 5788888877764

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=5.4e-42  Score=336.66  Aligned_cols=262  Identities=24%  Similarity=0.332  Sum_probs=201.6

Q ss_pred             cccccccccccccceeEEEEEe----cCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCc
Q 011360          192 DCFASLEKIGSGGCGEVYKAEL----PGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNI  267 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI  267 (487)
                      ++|.+.+.||.|+||.||+|++    +..++..||||.+..              .........+.+|+.++++++||||
T Consensus        30 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~--------------~~~~~~~~~~~~E~~~l~~l~h~~i   95 (327)
T 2yfx_A           30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE--------------VCSEQDELDFLMEALIISKFNHQNI   95 (327)
T ss_dssp             GGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCS--------------SCCHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             hheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecc--------------ccchhhHHHHHHHHHHHhhCCCCCC
Confidence            4699999999999999999975    234678999998842              1122344568889999999999999


Q ss_pred             cccceEEecCCeeEEEEEecCCCCHHHHHhhhhcC---CCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEE
Q 011360          268 LPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG---RRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVL  344 (487)
Q Consensus       268 v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nil  344 (487)
                      +++++++......|+||||+++|+|.+++......   ...+++..++.++.|++.||.||   |++||+||||||+||+
T Consensus        96 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~L---H~~~i~H~dlkp~NIl  172 (327)
T 2yfx_A           96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL---EENHFIHRDIAARNCL  172 (327)
T ss_dssp             CCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEE
T ss_pred             CeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHH---hhCCeecCcCCHhHEE
Confidence            99999999999999999999999999999863221   24588999999999999999999   6778999999999999


Q ss_pred             eCC---CCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCC
Q 011360          345 LND---DMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNG  420 (487)
Q Consensus       345 l~~---~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~  420 (487)
                      ++.   +..+||+|||++................||+.|+|||++.+..++.++||||||+++|+|+| |..||....  
T Consensus       173 i~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~--  250 (327)
T 2yfx_A          173 LTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS--  250 (327)
T ss_dssp             ESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--
T ss_pred             EecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC--
Confidence            984   44699999999875533322222234567899999999988899999999999999999998 899994322  


Q ss_pred             CccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          421 EEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       421 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                          ..+..........+.  ....+        +..+.+++.+||+.||.+|||+.+|++.|+.+
T Consensus       251 ----~~~~~~~~~~~~~~~--~~~~~--------~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  302 (327)
T 2yfx_A          251 ----NQEVLEFVTSGGRMD--PPKNC--------PGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  302 (327)
T ss_dssp             ----HHHHHHHHHTTCCCC--CCTTC--------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----HHHHHHHHhcCCCCC--CCCCC--------CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence                222333333222211  11112        24688999999999999999999999998764

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.5e-42  Score=343.29  Aligned_cols=278  Identities=17%  Similarity=0.187  Sum_probs=201.4

Q ss_pred             ccccccccccccccceeEEEEEecC--CCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPG--SNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNIL  268 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv  268 (487)
                      .++|.+.+.||+|+||.||+|....  .++..+|+|+........    ..+...........+.+|+..+..++||||+
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~----~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~  111 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPL----FSELKFYQRVAKKDCIKKWIERKQLDYLGIP  111 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHH----HHHHHHHHHHCCHHHHHHHHHHHTCSCCCCC
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcch----HHHHHHHHHHhhhHHHHHHHhhccccccCcc
Confidence            3579999999999999999998642  267889999986533211    1111222222334577899999999999999


Q ss_pred             ccceEEec----CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEE
Q 011360          269 PLLAHMVR----PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVL  344 (487)
Q Consensus       269 ~l~~~~~~----~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nil  344 (487)
                      ++++++..    ....|+||||+ +++|.+++..    ...+++..++.++.|++.||.||   |++||+||||||+|||
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dlkp~NIl  183 (345)
T 2v62_A          112 LFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQ----NGTFKKSTVLQLGIRMLDVLEYI---HENEYVHGDIKAANLL  183 (345)
T ss_dssp             CEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBG----GGBCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEE
T ss_pred             eeecccccccCCCcEEEEEEecc-CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HhCCeeCCCcCHHHEE
Confidence            99999887    67889999999 9999999875    23799999999999999999999   6678999999999999


Q ss_pred             eCCCC--CEEEeccCCccccCCCCce-----eeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCcccc
Q 011360          345 LNDDM--EACISDLGLAMAIPDGYTR-----VLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFH  417 (487)
Q Consensus       345 l~~~~--~~kl~DFg~s~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~  417 (487)
                      ++.++  .+||+|||+++........     .......||+.|+|||++.+..++.++|||||||++|+|+||..||...
T Consensus       184 l~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~  263 (345)
T 2v62_A          184 LGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQN  263 (345)
T ss_dssp             EESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGG
T ss_pred             EccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence            98877  9999999999766432211     0113346899999999999989999999999999999999999999543


Q ss_pred             CCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          418 QNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       418 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      ......  ............+. .+....+.   ...+..+.+++.+||..||++|||+++|++.|+++
T Consensus       264 ~~~~~~--~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  326 (345)
T 2v62_A          264 LKDPVA--VQTAKTNLLDELPQ-SVLKWAPS---GSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH  326 (345)
T ss_dssp             TTCHHH--HHHHHHHHHHTTTH-HHHHHSCT---TSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred             ccccHH--HHHHHHhhcccccH-HHHhhccc---cccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence            221111  11111111111111 00000000   01225689999999999999999999999999864

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=4.4e-42  Score=329.30  Aligned_cols=257  Identities=24%  Similarity=0.342  Sum_probs=203.7

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||.|+||.||++.. ..+++.||+|++...             .........+.+|+.++++++||||++++
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~~-------------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~   71 (279)
T 2w5a_A            6 EDYEVLYTIGTGSYGRCQKIRR-KSDGKILVWKELDYG-------------SMTEAEKQMLVSEVNLLRELKHPNIVRYY   71 (279)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTTCCEEEEEEEECT-------------TCCHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             hheeeehhccCCCCcEEEEEEE-CCCCcEEEEEEEEcc-------------cCCHHHHHHHHHHHHHHHhcCCCCCCeEE
Confidence            4699999999999999999975 467899999998431             12233456788999999999999999999


Q ss_pred             eEEe--cCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCC-----eeecCCCCCCEE
Q 011360          272 AHMV--RPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSAS-----IIHGDIKPRNVL  344 (487)
Q Consensus       272 ~~~~--~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~g-----ivH~Dlkp~Nil  344 (487)
                      +++.  .....++||||+++++|.+++.........+++..++.++.|++.||.||   |+.|     |+||||||+||+
T Consensus        72 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l---H~~~~~~~~ivH~dl~p~NIl  148 (279)
T 2w5a_A           72 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC---HRRSDGGHTVLHRDLKPANVF  148 (279)
T ss_dssp             EEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH---HHHC------CCCCCSGGGEE
T ss_pred             EEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHH---hcccCCCCeeEEeccchhhEE
Confidence            9875  36788999999999999999987555566799999999999999999999   5555     999999999999


Q ss_pred             eCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccc
Q 011360          345 LNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEIC  424 (487)
Q Consensus       345 l~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~  424 (487)
                      ++.++.+||+|||++.........  .....||+.|+|||++.+..++.++||||||+++|+|++|..||....      
T Consensus       149 ~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------  220 (279)
T 2w5a_A          149 LDGKQNVKLGDFGLARILNHDTSF--AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS------  220 (279)
T ss_dssp             ECSSSCEEECCCCHHHHC---CHH--HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS------
T ss_pred             EcCCCCEEEecCchheeecccccc--ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC------
Confidence            999999999999999776443221  123468999999999998899999999999999999999999994332      


Q ss_pred             cHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHH
Q 011360          425 SPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRL  483 (487)
Q Consensus       425 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L  483 (487)
                      ..+....+.....+  .++..        .+..+.+++.+||+.||++|||+.+|++.+
T Consensus       221 ~~~~~~~i~~~~~~--~~~~~--------~~~~l~~li~~~l~~~p~~Rps~~~ll~~~  269 (279)
T 2w5a_A          221 QKELAGKIREGKFR--RIPYR--------YSDELNEIITRMLNLKDYHRPSVEEILENP  269 (279)
T ss_dssp             HHHHHHHHHHTCCC--CCCTT--------SCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred             HHHHHHHHhhcccc--cCCcc--------cCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence            12222333222211  11112        235688999999999999999999998754

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.9e-41  Score=347.93  Aligned_cols=258  Identities=25%  Similarity=0.334  Sum_probs=193.5

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .++|.+.+.||.|+||.||+|. +..+++.||||++..             ..........+.+|+.+++.++||||+++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~-~~~~~~~vAiK~~~~-------------~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  126 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAY-DAVLDRNVAIKKLSR-------------PFQNQTHAKRAYRELVLMKCVNHKNIISL  126 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEE-ETTTTEEEEEEEEES-------------GGGSHHHHHHHHHHHHHHHHCCCTTBCCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEE-ECCCCCEEEEEEECc-------------cccChHHHHHHHHHHHHHHhCCCCCCCcE
Confidence            3579999999999999999996 456899999999843             12233455678899999999999999999


Q ss_pred             ceEEecC------CeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEE
Q 011360          271 LAHMVRP------DCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVL  344 (487)
Q Consensus       271 ~~~~~~~------~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nil  344 (487)
                      ++++...      ..+|+||||+++ +|.+.+.      ..+++..+..++.|++.||+||   |++||+||||||+|||
T Consensus       127 ~~~~~~~~~~~~~~~~~lv~E~~~~-~l~~~~~------~~l~~~~~~~~~~qil~aL~~l---H~~~iiHrDlkp~NIl  196 (464)
T 3ttj_A          127 LNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHL---HSAGIIHRDLKPSNIV  196 (464)
T ss_dssp             SEEECSCCSTTTCCEEEEEEECCSE-EHHHHHT------SCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEE
T ss_pred             EEEEccCCccccCCeEEEEEeCCCC-CHHHHHh------hcCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCChHhEE
Confidence            9999755      356999999966 5666663      3489999999999999999999   6778999999999999


Q ss_pred             eCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccc
Q 011360          345 LNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEIC  424 (487)
Q Consensus       345 l~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~  424 (487)
                      ++.++.+||+|||+++.......   .....||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+.     
T Consensus       197 l~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~-----  268 (464)
T 3ttj_A          197 VKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY-----  268 (464)
T ss_dssp             ECTTSCEEECCCCCC-----CCC---C----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----
T ss_pred             EeCCCCEEEEEEEeeeecCCCcc---cCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCH-----
Confidence            99999999999999987644322   2346799999999999999999999999999999999999999954321     


Q ss_pred             cHHHHHHHHh---------------------cCCCC-C--ccCCC-----CCCC--CcHHHHHHHHHHHhhccCCCCCCC
Q 011360          425 SPEWLRKVMN---------------------SKNPS-R--AIDPR-----LPGN--GYEKKMLHVLKIAYICTLHDPEER  473 (487)
Q Consensus       425 ~~~~~~~~~~---------------------~~~~~-~--~~~~~-----~~~~--~~~~~~~~l~~li~~cl~~~P~~R  473 (487)
                       .+.+..+..                     ...+. .  .+...     .+..  .......++.+++.+||..||++|
T Consensus       269 -~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R  347 (464)
T 3ttj_A          269 -IDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR  347 (464)
T ss_dssp             -HHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTS
T ss_pred             -HHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhC
Confidence             111111111                     00000 0  00000     0000  111225678999999999999999


Q ss_pred             CChHHHHH
Q 011360          474 PNSQYVRC  481 (487)
Q Consensus       474 Ps~~~il~  481 (487)
                      ||+.++++
T Consensus       348 ~ta~e~L~  355 (464)
T 3ttj_A          348 ISVDDALQ  355 (464)
T ss_dssp             CCHHHHHT
T ss_pred             CCHHHHhc
Confidence            99999975

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=6.5e-42  Score=354.90  Aligned_cols=252  Identities=29%  Similarity=0.394  Sum_probs=198.0

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      +.|.+.+.||+|+||.||+|+. ..++..||+|++....             ........+.+|+.+++.++||||++++
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~-~~~~~~~aiK~~~~~~-------------~~~~~~~~~~~E~~~l~~l~hpniv~~~  102 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRD-KVTHVERAIKIIRKTS-------------VSTSSNSKLLEEVAVLKLLDHPNIMKLY  102 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEE-TTTCCEEEEEEEEC------------------CTTHHHHHHHHHHTTCCCTTBCCEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEE-CCCCcEEEEEEEeccc-------------cCchHHHHHHHHHHHHHhCCCCCCCeEE
Confidence            3699999999999999999975 4678999999985311             1112245678899999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC---C
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLND---D  348 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~---~  348 (487)
                      +++.+....|+|||||++|+|.+++..    ...+++..+..++.|++.||.||   |++||+||||||+|||++.   +
T Consensus       103 ~~~~~~~~~~lv~e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~Dlkp~Nil~~~~~~~  175 (494)
T 3lij_A          103 DFFEDKRNYYLVMECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYL---HKHNIVHRDLKPENLLLESKEKD  175 (494)
T ss_dssp             EEEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEESCSSTT
T ss_pred             EEEEeCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCceeccCChhhEEEeCCCCC
Confidence            999999999999999999999998865    35689999999999999999999   6778999999999999976   4


Q ss_pred             CCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHH
Q 011360          349 MEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEW  428 (487)
Q Consensus       349 ~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~  428 (487)
                      +.+||+|||++........   .....||+.|+|||++.+ .|+.++|||||||++|+|++|.+||....      ..+.
T Consensus       176 ~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~------~~~~  245 (494)
T 3lij_A          176 ALIKIVDFGLSAVFENQKK---MKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQT------DQEI  245 (494)
T ss_dssp             CCEEECCCTTCEECBTTBC---BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHH
T ss_pred             CcEEEEECCCCeECCCCcc---ccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCC------HHHH
Confidence            5599999999987654322   234569999999999874 69999999999999999999999994332      2333


Q ss_pred             HHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          429 LRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       429 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ...+......       .+.......+..+.+++.+||+.||++|||+.++++
T Consensus       246 ~~~i~~~~~~-------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          246 LRKVEKGKYT-------FDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             HHHHHHTCCC-------CCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHhCCCC-------CCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence            3333332221       111111223356889999999999999999999874

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=3e-41  Score=324.53  Aligned_cols=249  Identities=26%  Similarity=0.346  Sum_probs=202.8

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||.|+||.||+|.. ..++..||+|++...            ..........+.+|+.++..++||||++++
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~~vaiK~~~~~------------~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~   80 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLARE-KQNKFIMALKVLFKS------------QLEKEGVEHQLRREIEIQSHLRHPNILRMY   80 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEE-TTTTEEEEEEEEEHH------------HHHHTTCHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             hhceeeheecCCCCeEEEEEEE-cCCCcEEEEEEEccc------------ccchHHHHHHHHHHHHHHhcCCCCCEeeEE
Confidence            4699999999999999999975 457889999988421            011122245688899999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++.+.+..++||||+++|+|.+++..    ...+++..+..++.|++.||.||   |++|++||||||+||+++.++.+
T Consensus        81 ~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~  153 (284)
T 2vgo_A           81 NYFHDRKRIYLMLEFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYC---HERKVIHRDIKPENLLMGYKGEL  153 (284)
T ss_dssp             EEEECSSEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCSGGGEEECTTCCE
T ss_pred             EEEEcCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCceecCCCHHHEEEcCCCCE
Confidence            999999999999999999999999975    34689999999999999999999   77899999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRK  431 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~  431 (487)
                      ||+|||++........    ....|++.|+|||++.+..++.++||||||+++|+|++|..||....      ..+....
T Consensus       154 kl~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~  223 (284)
T 2vgo_A          154 KIADFGWSVHAPSLRR----RTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS------HTETHRR  223 (284)
T ss_dssp             EECCCTTCEECSSSCB----CCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHH
T ss_pred             EEecccccccCccccc----ccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC------HhHHHHH
Confidence            9999999876543322    34568999999999999999999999999999999999999994322      1222222


Q ss_pred             HHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          432 VMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       432 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .... ..  .+++.        .+..+.+++.+||+.||++|||+.++++
T Consensus       224 ~~~~-~~--~~~~~--------~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          224 IVNV-DL--KFPPF--------LSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             HHTT-CC--CCCTT--------SCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             Hhcc-cc--CCCCc--------CCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence            3221 11  11111        2256889999999999999999999875

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1e-41  Score=327.24  Aligned_cols=258  Identities=19%  Similarity=0.282  Sum_probs=201.6

Q ss_pred             ccccccccccccccceeEEEEEecCC--CCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGS--NGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNIL  268 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv  268 (487)
                      .++|.+.+.||+|+||.||+|.+...  ++..||+|.+...              ......+.+.+|+.+++.++||||+
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~--------------~~~~~~~~~~~E~~~l~~l~h~~i~   76 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD--------------CTLDNKEKFMSEAVIMKNLDHPHIV   76 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTT--------------SCHHHHHHHHHHHHHHHHHCCTTBC
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccc--------------cCchHHHHHHHHHHHHHhCCCCCcc
Confidence            34699999999999999999986433  3456999987421              1223456788999999999999999


Q ss_pred             ccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC
Q 011360          269 PLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDD  348 (487)
Q Consensus       269 ~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~  348 (487)
                      ++++++.+ +..++||||+++++|.+++...   ...+++..+..++.|++.||.||   |++||+||||||+||+++.+
T Consensus        77 ~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~Nil~~~~  149 (281)
T 3cc6_A           77 KLIGIIEE-EPTWIIMELYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYL---ESINCVHRDIAVRNILVASP  149 (281)
T ss_dssp             CEEEEECS-SSCEEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCSGGGEEEEET
T ss_pred             eEEEEEcC-CCCEEEEecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCccceEEECCC
Confidence            99998765 4578999999999999999752   45689999999999999999999   67789999999999999999


Q ss_pred             CCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccccHH
Q 011360          349 MEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSPE  427 (487)
Q Consensus       349 ~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~  427 (487)
                      +.+||+|||++.......... .....+|+.|+|||++.+..++.++||||||+++|+|+| |..||......      .
T Consensus       150 ~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~------~  222 (281)
T 3cc6_A          150 ECVKLGDFGLSRYIEDEDYYK-ASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK------D  222 (281)
T ss_dssp             TEEEECCCCGGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG------G
T ss_pred             CcEEeCccCCCcccccccccc-cccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH------H
Confidence            999999999998765432211 233457889999999988899999999999999999998 99999543221      1


Q ss_pred             HHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          428 WLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      ..........+.  .+..        .+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus       223 ~~~~~~~~~~~~--~~~~--------~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~  271 (281)
T 3cc6_A          223 VIGVLEKGDRLP--KPDL--------CPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV  271 (281)
T ss_dssp             HHHHHHHTCCCC--CCTT--------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHhcCCCCC--CCCC--------CCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence            122222222111  1111        124688999999999999999999999999876

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.3e-41  Score=333.87  Aligned_cols=266  Identities=21%  Similarity=0.329  Sum_probs=206.3

Q ss_pred             ccccccccccccccceeEEEEEe---cCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAEL---PGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNI  267 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~---~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI  267 (487)
                      .+.|.+.+.||.|+||.||+|++   +..+++.||+|++..               ......+.+.+|+.+++.++||||
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~---------------~~~~~~~~~~~E~~~l~~l~h~~i  104 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH---------------STEEHLRDFEREIEILKSLQHDNI  104 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESS---------------CCSHHHHHHHHHHHHHHTCCCTTB
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEecc---------------CCHHHHHHHHHHHHHHHhCCCCCe
Confidence            34699999999999999999985   345789999999843               123345678899999999999999


Q ss_pred             cccceEEecCC--eeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEe
Q 011360          268 LPLLAHMVRPD--CHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLL  345 (487)
Q Consensus       268 v~l~~~~~~~~--~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill  345 (487)
                      +++++++...+  ..++||||+++++|.+++..   ....+++..++.++.|++.||.||   |++||+||||||+||++
T Consensus       105 v~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~dikp~NIli  178 (326)
T 2w1i_A          105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILV  178 (326)
T ss_dssp             CCEEEEECC----CCEEEECCCTTCBHHHHHHH---STTSSCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEE
T ss_pred             eeEEEEEEecCCCceEEEEECCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHH---HhCCEeccCCCcceEEE
Confidence            99999887654  78999999999999999975   235689999999999999999999   67789999999999999


Q ss_pred             CCCCCEEEeccCCccccCCCCceee-EeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccC------
Q 011360          346 NDDMEACISDLGLAMAIPDGYTRVL-ISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ------  418 (487)
Q Consensus       346 ~~~~~~kl~DFg~s~~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~------  418 (487)
                      +.++.+||+|||++........... .....++..|+|||++.+..++.++||||||+++|+|+||..||....      
T Consensus       179 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~  258 (326)
T 2w1i_A          179 ENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM  258 (326)
T ss_dssp             EETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHH
T ss_pred             cCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHh
Confidence            9999999999999987654432211 123456788999999988889999999999999999999999885321      


Q ss_pred             ---CCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          419 ---NGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       419 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                         ..........+......... ......        .+..+.+++.+||+.||++|||+.+|++.|+++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~--------~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l  320 (326)
T 2w1i_A          259 IGNDKQGQMIVFHLIELLKNNGR-LPRPDG--------CPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI  320 (326)
T ss_dssp             HCTTCCTHHHHHHHHHHHHTTCC-CCCCTT--------CCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             hccccchhhhHHHHHHHhhcCCC-CCCCCc--------ccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence               00000011111222222111 111111        235688999999999999999999999999876

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.9e-42  Score=361.74  Aligned_cols=354  Identities=21%  Similarity=0.306  Sum_probs=243.9

Q ss_pred             chhhhhhhhhHHHHHHhhh----chhhhhhHHHHHHHHHHH---------HHHHHhhccccCC-CCcccccccCCCCCCh
Q 011360           93 VDYLLDEFQTEAFQTMLLQ----DADAMSKVKEVNARLQDI---------AWQINVLGLKESF-GGKSRNVRQRFPTTPS  158 (487)
Q Consensus        93 ~~~~~~~~~~~~~~~~l~~----~~~~~~r~~ei~~~l~~i---------~~~~~~~~l~~~~-g~~~~~~~~~~~s~p~  158 (487)
                      .++++..+.+++.+++|..    +|+|+.|.++.......+         ...+.||.+.... |+........|++...
T Consensus       148 ~~wy~g~i~r~~ae~~L~~~~~~~G~FLvR~S~~~~g~y~lsv~~~~~~~~~~v~h~~I~~~~~g~~~i~~~~~F~SL~e  227 (535)
T 2h8h_A          148 EEWYFGKITRRESERLLLNAENPRGTFLVRESETTKGAYCLSVSDFDNAKGLNVKHYKIRKLDSGGFYITSRTQFNSLQQ  227 (535)
T ss_dssp             STTBCCSCCHHHHHHHHTCTTCCTTEEEEEECSSSTTCEEEEEEEEETTTEEEEEEEEEBC-CCSCEEEETTEEESSHHH
T ss_pred             cceeccccCHHHHHHHhccCCCCCCeEEEEecCCCCCcEEEEEEeeccCCCCceEEEEEEEcCCCcEEeeccccccChHH
Confidence            4456667777777777764    377777754321000000         0123345444332 2222233344666555


Q ss_pred             hhhhhhcCCCC--CCCCcc---ccCC-cchhhHHHhhhccccccccccccccceeEEEEEecCCCCceEEEEEeeecCch
Q 011360          159 LISAAVRGGSR--DRGPTI---FSPL-IEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPI  232 (487)
Q Consensus       159 ~~~~~~~~~~~--~~~~~~---~~~~-~~~~~~~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~  232 (487)
                      ++.........  ..-...   ..+. .......|....+.|.+.+.||+|+||.||+|.+.  .+..||||++....  
T Consensus       228 Lv~~y~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~~--  303 (535)
T 2h8h_A          228 LVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWN--GTTRVAIKTLKPGT--  303 (535)
T ss_dssp             HHHHHHHCCTTSSSCCCEECCCCCCCCSSSSTTCSBCCGGGEEEEEEEEECSSEEEEEEEET--TTEEEEEEEECTTS--
T ss_pred             hheeeccccCccccccccccccccccccccCccceecchhhhhhheecccCCCeEEEEEEEC--CCceEEEEEeCCCC--
Confidence            55443322111  000000   0000 00011224455667999999999999999999875  45679999984311  


Q ss_pred             hHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHH
Q 011360          233 SAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRH  312 (487)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~  312 (487)
                                    ...+.+.+|+.++++++||||+++++++.. +..|+||||+.+|+|.+++...  .+..+++..+.
T Consensus       304 --------------~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~  366 (535)
T 2h8h_A          304 --------------MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLV  366 (535)
T ss_dssp             --------------SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHH--HHTTCCHHHHH
T ss_pred             --------------CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhc--CCCCCCHHHHH
Confidence                          123467899999999999999999999876 6789999999999999999752  23458999999


Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCC
Q 011360          313 RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELS  392 (487)
Q Consensus       313 ~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~  392 (487)
                      .++.||+.||.||   |++||+||||||+|||++.++.+||+|||+++......... .....+++.|+|||++.+..++
T Consensus       367 ~i~~qi~~~L~~L---H~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~  442 (535)
T 2h8h_A          367 DMAAQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA-RQGAKFPIKWTAPEAALYGRFT  442 (535)
T ss_dssp             HHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHT-TCSTTSCGGGSCHHHHHHCCCC
T ss_pred             HHHHHHHHHHHHH---HhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceec-ccCCcCcccccCHHHhccCCCC
Confidence            9999999999999   67789999999999999999999999999998764321111 1223467899999999988999


Q ss_pred             chhHHHHHHHHHHHHHh-CCCCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCC
Q 011360          393 EKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPE  471 (487)
Q Consensus       393 ~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~  471 (487)
                      .++||||||+++|||+| |..||....      ..+....+......  ..+..        .+..+.++|.+||+.||+
T Consensus       443 ~~sDvwSlGv~l~el~t~g~~P~~~~~------~~~~~~~i~~~~~~--~~~~~--------~~~~l~~li~~cl~~dP~  506 (535)
T 2h8h_A          443 IKSDVWSFGILLTELTTKGRVPYPGMV------NREVLDQVERGYRM--PCPPE--------CPESLHDLMCQCWRKEPE  506 (535)
T ss_dssp             HHHHHHHHHHHHHHHTTTTCCSSTTCC------HHHHHHHHHTTCCC--CCCTT--------CCHHHHHHHHHHTCSSGG
T ss_pred             chhhHHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHHHcCCCC--CCCCC--------CCHHHHHHHHHHcCCChh
Confidence            99999999999999999 899994332      22333333322221  11112        235688999999999999


Q ss_pred             CCCChHHHHHHHhhhC
Q 011360          472 ERPNSQYVRCRLSQLL  487 (487)
Q Consensus       472 ~RPs~~~il~~L~~ll  487 (487)
                      +|||+.+|++.|+.++
T Consensus       507 ~RPt~~~l~~~L~~~~  522 (535)
T 2h8h_A          507 ERPTFEYLQAFLEDYF  522 (535)
T ss_dssp             GSCCHHHHHHHHHTSS
T ss_pred             HCcCHHHHHHHHHHHh
Confidence            9999999999998864

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.7e-41  Score=327.97  Aligned_cols=262  Identities=23%  Similarity=0.286  Sum_probs=201.7

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .++|.+.+.||+|+||.||+|.. ..+++.||+|++...                 .....+.+|+.++..++|++++..
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~-----------------~~~~~~~~e~~~l~~l~~~~~i~~   69 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYLGTD-IAAGEEVAIKLECVK-----------------TKHPQLHIESKIYKMMQGGVGIPT   69 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEEEEE-TTTTEEEEEEEEEC--------------------CCCHHHHHHHHHHHTTSTTCCC
T ss_pred             CCceEEeeeecCCCCeEEEEEEE-cCCCceEEEEeeccc-----------------ccchHHHHHHHHHHHhcCCCCCCe
Confidence            45799999999999999999974 458899999986321                 112346778999999988887777


Q ss_pred             ceEE-ecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEe---C
Q 011360          271 LAHM-VRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLL---N  346 (487)
Q Consensus       271 ~~~~-~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill---~  346 (487)
                      +..+ ...+..++||||+ +++|.+++..   ....+++..+..++.|++.||.||   |++||+||||||+||++   +
T Consensus        70 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~L---H~~~ivH~Dlkp~NIl~~~~~  142 (296)
T 4hgt_A           70 IRWCGAEGDYNVMVMELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYI---HSKNFIHRDVKPDNFLMGLGK  142 (296)
T ss_dssp             EEEEEEETTEEEEEEECC-CCBHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECCGG
T ss_pred             eeeecCCCCceEEEEEcc-CCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeeeeccC
Confidence            7655 5677889999999 9999999874   245699999999999999999999   67789999999999999   7


Q ss_pred             CCCCEEEeccCCccccCCCCcee-----eEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCC
Q 011360          347 DDMEACISDLGLAMAIPDGYTRV-----LISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGE  421 (487)
Q Consensus       347 ~~~~~kl~DFg~s~~~~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~  421 (487)
                      .++.+||+|||++..........     ......||+.|+|||++.+..++.++||||||+++|+|++|..||.......
T Consensus       143 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~  222 (296)
T 4hgt_A          143 KGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT  222 (296)
T ss_dssp             GTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS
T ss_pred             CCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhh
Confidence            88999999999998765432211     1134568999999999999999999999999999999999999997654433


Q ss_pred             ccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          422 EICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       422 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      ............. ..+.......+        +..+.+++.+||+.||++|||+.+|++.|+++
T Consensus       223 ~~~~~~~~~~~~~-~~~~~~~~~~~--------~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~  278 (296)
T 4hgt_A          223 KRQKYERISEKKM-STPIEVLCKGY--------PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  278 (296)
T ss_dssp             SSSHHHHHHHHHH-HSCHHHHTTTS--------CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred             hhhhhhhhhcccc-cchhhhhhccC--------CHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence            2222221111111 11111111112        25689999999999999999999999999876

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=7.9e-42  Score=335.51  Aligned_cols=258  Identities=24%  Similarity=0.345  Sum_probs=201.3

Q ss_pred             cccccccccccccceeEEEEEecCCCCce--EEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CCCCcc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKM--IAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RHRNIL  268 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~--vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv  268 (487)
                      ++|.+.+.||.|+||.||+|+.. .++..  +|+|.+...              ......+.+.+|+.++.++ +||||+
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~~~v~iK~~~~~--------------~~~~~~~~~~~E~~~l~~l~~hp~iv   89 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIK-KDGLRMDAAIKRMKEY--------------ASKDDHRDFAGELEVLCKLGHHPNII   89 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEE-ETTEEEEEEEEEEECC--------------------CHHHHHHHHHTTCCCCTTBC
T ss_pred             HHccceeeeecCCCceEEEEEEc-cCCcccceeeeeeccc--------------cchHHHHHHHHHHHHHHhccCCCchh
Confidence            35999999999999999999864 35654  489987421              1223445678899999999 999999


Q ss_pred             ccceEEecCCeeEEEEEecCCCCHHHHHhhhh------------cCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 011360          269 PLLAHMVRPDCHLLVYEFMKNGSLQDILDDVS------------RGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHG  336 (487)
Q Consensus       269 ~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~  336 (487)
                      ++++++.+.+..|+||||+++|+|.+++....            .....+++..++.++.|++.||.||   |++||+||
T Consensus        90 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~  166 (327)
T 1fvr_A           90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHR  166 (327)
T ss_dssp             CEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHH---HHTTEECS
T ss_pred             hhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHH---HhCCccCC
Confidence            99999999999999999999999999997532            1235789999999999999999999   67789999


Q ss_pred             CCCCCCEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCcc
Q 011360          337 DIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFV  415 (487)
Q Consensus       337 Dlkp~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~  415 (487)
                      ||||+||+++.++.+||+|||++........   .....+++.|+|||++.+..++.++||||||+++|+|+| |..||.
T Consensus       167 dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~  243 (327)
T 1fvr_A          167 DLAARNILVGENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC  243 (327)
T ss_dssp             CCSGGGEEECGGGCEEECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             CCccceEEEcCCCeEEEcccCcCcccccccc---ccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCC
Confidence            9999999999999999999999874322111   123346889999999988889999999999999999998 999994


Q ss_pred             ccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          416 FHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       416 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      ...      ..+....+.....+      ..+.    ..+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus       244 ~~~------~~~~~~~~~~~~~~------~~~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  298 (327)
T 1fvr_A          244 GMT------CAELYEKLPQGYRL------EKPL----NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  298 (327)
T ss_dssp             TCC------HHHHHHHGGGTCCC------CCCT----TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCc------HHHHHHHhhcCCCC------CCCC----CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            332      22222222222111      1111    1235688999999999999999999999999876

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.5e-41  Score=337.97  Aligned_cols=257  Identities=24%  Similarity=0.391  Sum_probs=201.1

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .++|.+.+.||.|+||.||+|.. ..++..||+|++...              ........+.+|+.+++.++||||+++
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~va~K~~~~~--------------~~~~~~~~~~~E~~~l~~l~h~~iv~~   96 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSH-KPSGLVMARKLIHLE--------------IKPAIRNQIIRELQVLHECNSPYIVGF   96 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-TTTCCEEEEEEEECC--------------CCHHHHHHHHHHHGGGGGCCCTTBCCE
T ss_pred             cccceeeeeecCCCCeEEEEEEE-CCCCcEEEEEEeccc--------------cCHHHHHHHHHHHHHHHHCCCCCEEEE
Confidence            34699999999999999999975 467899999988431              123345678899999999999999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      ++++..++..++||||+++++|.+++..    ...+++..+..++.|++.||.|||+.  +||+||||||+||+++.++.
T Consensus        97 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~  170 (360)
T 3eqc_A           97 YGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGE  170 (360)
T ss_dssp             EEEEEETTEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCC
T ss_pred             eEEEEECCEEEEEEECCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHh--CCEEcCCccHHHEEECCCCC
Confidence            9999999999999999999999999975    34689999999999999999999532  37999999999999999999


Q ss_pred             EEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCc--------
Q 011360          351 ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEE--------  422 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~--------  422 (487)
                      +||+|||++.......    .....||+.|+|||++.+..++.++||||||+++|+|++|..||........        
T Consensus       171 ~kl~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  246 (360)
T 3eqc_A          171 IKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQV  246 (360)
T ss_dssp             EEECCCCCCHHHHHHC--------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---
T ss_pred             EEEEECCCCccccccc----ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccc
Confidence            9999999986542221    1345689999999999999999999999999999999999999954321000        


Q ss_pred             ----------------------------cccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCC
Q 011360          423 ----------------------------ICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERP  474 (487)
Q Consensus       423 ----------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP  474 (487)
                                                  ....+........ .+..     .+   ....+.++.+++.+||+.||++||
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~-----~~---~~~~~~~~~~li~~~L~~dP~~Rp  317 (360)
T 3eqc_A          247 EGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNE-PPPK-----LP---SGVFSLEFQDFVNKCLIKNPAERA  317 (360)
T ss_dssp             ---------------------------CCCHHHHHHHHHHS-CCCC-----CC---TTTSCHHHHHHHHHHHCSSTTTSC
T ss_pred             cccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhcc-CCCC-----CC---cccccHHHHHHHHHHhhcChhhCC
Confidence                                        0000111111111 1111     11   111235688999999999999999


Q ss_pred             ChHHHHH
Q 011360          475 NSQYVRC  481 (487)
Q Consensus       475 s~~~il~  481 (487)
                      |+.++++
T Consensus       318 t~~ell~  324 (360)
T 3eqc_A          318 DLKQLMV  324 (360)
T ss_dssp             CHHHHHT
T ss_pred             CHHHHhh
Confidence            9999875

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=4.6e-42  Score=337.78  Aligned_cols=267  Identities=24%  Similarity=0.353  Sum_probs=197.4

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||.|+||.||+|.. ..+++.||+|++...             .........+.+|+.++++++||||++++
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~-------------~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   90 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRN-KDTGRIVAIKKFLES-------------DDDKMVKKIAMREIKLLKQLRHENLVNLL   90 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEE-TTTCCEEEEEEEESC-------------SSCHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             hhheeeeEEeecCCEEEEEEEE-CCCCceEEEEEEecC-------------CCchHHHHHHHHHHHHHhhCCCCCEeeEE
Confidence            4699999999999999999975 457899999988432             12233445678899999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++...+..++||||+++++|.+++..    ...+++..+..++.|++.||.||   |+.||+||||||+||+++.++.+
T Consensus        91 ~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~l~~L---H~~~ivH~dlkp~Nil~~~~~~~  163 (331)
T 4aaa_A           91 EVCKKKKRWYLVFEFVDHTILDDLELF----PNGLDYQVVQKYLFQIINGIGFC---HSHNIIHRDIKPENILVSQSGVV  163 (331)
T ss_dssp             EEEEETTEEEEEEECCSEEHHHHHHHS----TTCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTSCE
T ss_pred             EEeecCCEEEEEEecCCcchHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHH---HHCCEEccCcChheEEEcCCCcE
Confidence            999999999999999999988887653    45699999999999999999999   67789999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCccccCCCCcc-------
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQP-ELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI-------  423 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~-------  423 (487)
                      ||+|||++.........  .....||+.|+|||++.+. .++.++||||||+++|+|++|..||.........       
T Consensus       164 kl~Dfg~~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  241 (331)
T 4aaa_A          164 KLCDFGFARTLAAPGEV--YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCL  241 (331)
T ss_dssp             EECCCTTC--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred             EEEeCCCceeecCCccc--cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Confidence            99999999765443221  2345689999999999875 7899999999999999999999999543321100       


Q ss_pred             --ccHHHHHHHHhcCCCCCccCCCCCCC-----CcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          424 --CSPEWLRKVMNSKNPSRAIDPRLPGN-----GYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       424 --~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                        ..+.................+.+...     .....+..+.+++.+||+.||++|||+.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          242 GNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             CSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             CCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence              00000000000000000000111100     01123467899999999999999999999874

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.1e-41  Score=328.59  Aligned_cols=262  Identities=26%  Similarity=0.355  Sum_probs=199.3

Q ss_pred             ccccccccccccccceeEEEEEecCCCCc--eEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGK--MIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNIL  268 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv  268 (487)
                      .++|.+.+.||.|+||.||+|++...++.  .||+|++...            ..........+.+|+.++.+++||||+
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~------------~~~~~~~~~~~~~e~~~l~~l~h~~i~   84 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPD------------VLSQPEAMDDFIREVNAMHSLDHRNLI   84 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------------------CHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccC------------ccCCHHHHHHHHHHHHHHHhCCCCCcc
Confidence            34699999999999999999987544443  6899987321            111234567788999999999999999


Q ss_pred             ccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC
Q 011360          269 PLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDD  348 (487)
Q Consensus       269 ~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~  348 (487)
                      ++++++..+. .++||||+++++|.+++...   ...+++..+..++.|++.||.||   |++|++||||||+||+++.+
T Consensus        85 ~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dikp~Nili~~~  157 (291)
T 1u46_A           85 RLYGVVLTPP-MKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYL---ESKRFIHRDLAARNLLLATR  157 (291)
T ss_dssp             CEEEEECSSS-CEEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEEEET
T ss_pred             cEEEEEccCC-ceeeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHH---HhCCcccCCCchheEEEcCC
Confidence            9999988765 88999999999999999752   35689999999999999999999   66789999999999999999


Q ss_pred             CCEEEeccCCccccCCCCcee-eEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccccH
Q 011360          349 MEACISDLGLAMAIPDGYTRV-LISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSP  426 (487)
Q Consensus       349 ~~~kl~DFg~s~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~  426 (487)
                      +.+||+|||++.......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||....      ..
T Consensus       158 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~------~~  231 (291)
T 1u46_A          158 DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN------GS  231 (291)
T ss_dssp             TEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC------HH
T ss_pred             CCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC------HH
Confidence            999999999998765443221 2233457889999999988889999999999999999999 999994332      22


Q ss_pred             HHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          427 EWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       427 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      +........... ......        .+..+.+++.+||+.||++|||+.++++.|+++
T Consensus       232 ~~~~~~~~~~~~-~~~~~~--------~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  282 (291)
T 1u46_A          232 QILHKIDKEGER-LPRPED--------CPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  282 (291)
T ss_dssp             HHHHHHHTSCCC-CCCCTT--------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHHccCCC-CCCCcC--------cCHHHHHHHHHHccCCcccCcCHHHHHHHHHHh
Confidence            333333332211 111112        235689999999999999999999999999875

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=2.1e-41  Score=334.38  Aligned_cols=264  Identities=27%  Similarity=0.398  Sum_probs=204.0

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhcc--CCCCCcc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQ--IRHRNIL  268 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv  268 (487)
                      .++|.+.+.||+|+||.||+|++   +++.||||++..                  .....+.+|..++..  ++||||+
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~------------------~~~~~~~~e~~~~~~~~l~h~ni~   99 (342)
T 1b6c_B           41 ARTIVLQESIGKGRFGEVWRGKW---RGEEVAVKIFSS------------------REERSWFREAEIYQTVMLRHENIL   99 (342)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEE---TTEEEEEEEECG------------------GGHHHHHHHHHHHHHSCCCCTTBC
T ss_pred             cccEEEEeeecCCCCcEEEEEEE---cCccEEEEEeCc------------------hhHHHHHHHHHHHHHhhcCCCcEE
Confidence            34699999999999999999986   588999998732                  012345667777765  7999999


Q ss_pred             ccceEEecCC----eeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhc-----CCCCeeecCCC
Q 011360          269 PLLAHMVRPD----CHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMY-----HSASIIHGDIK  339 (487)
Q Consensus       269 ~l~~~~~~~~----~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~-----h~~givH~Dlk  339 (487)
                      ++++++....    ..++||||+++|+|.+++..     ..+++..++.++.|++.||.|||..     |+.||+|||||
T Consensus       100 ~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlk  174 (342)
T 1b6c_B          100 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLK  174 (342)
T ss_dssp             CEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCS
T ss_pred             EEEeeecccCCccceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCC
Confidence            9999998876    78999999999999999974     3589999999999999999999521     17899999999


Q ss_pred             CCCEEeCCCCCEEEeccCCccccCCCCcee--eEeeecccccccCCcccCCCC------CCchhHHHHHHHHHHHHHhC-
Q 011360          340 PRNVLLNDDMEACISDLGLAMAIPDGYTRV--LISYVLGTMAYIAPEYFQQPE------LSEKCDIFSFGMLLISLVRG-  410 (487)
Q Consensus       340 p~Nill~~~~~~kl~DFg~s~~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~------~~~~~DvwslG~~l~elltg-  410 (487)
                      |+||+++.++.+||+|||++..........  ......||+.|+|||++.+..      ++.++||||||+++|+|+|| 
T Consensus       175 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~  254 (342)
T 1b6c_B          175 SKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRC  254 (342)
T ss_dssp             GGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTB
T ss_pred             HHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhcc
Confidence            999999999999999999997765443221  123456899999999998752      34689999999999999999 


Q ss_pred             ---------CCCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCC-CcHHHHHHHHHHHhhccCCCCCCCCChHHHH
Q 011360          411 ---------VPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGN-GYEKKMLHVLKIAYICTLHDPEERPNSQYVR  480 (487)
Q Consensus       411 ---------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~P~~RPs~~~il  480 (487)
                               ..||........ .. +...........    .+.++.. ........+.+++.+||+.||++|||+.+|+
T Consensus       255 ~~~~~~~~~~~p~~~~~~~~~-~~-~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~  328 (342)
T 1b6c_B          255 SIGGIHEDYQLPYYDLVPSDP-SV-EEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK  328 (342)
T ss_dssp             CBTTBCCCCCCTTTTTSCSSC-CH-HHHHHHHTTSCC----CCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred             CcCCcccccccCccccCcCcc-cH-HHHHHHHHHHHh----CCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHH
Confidence                     677754432211 12 222223322222    2222221 1235667899999999999999999999999


Q ss_pred             HHHhhh
Q 011360          481 CRLSQL  486 (487)
Q Consensus       481 ~~L~~l  486 (487)
                      +.|+++
T Consensus       329 ~~L~~i  334 (342)
T 1b6c_B          329 KTLSQL  334 (342)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999876

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=4.4e-41  Score=325.03  Aligned_cols=252  Identities=23%  Similarity=0.339  Sum_probs=204.6

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .++|.+.+.||+|+||.||++.. ..+++.||+|++...            ..........+.+|+.+++.++||||+++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~~~a~K~~~~~------------~~~~~~~~~~~~~e~~~l~~l~h~~iv~~   80 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISD-ADTKEVFAGKIVPKS------------LLLKPHQREKMSMEISIHRSLAHQHVVGF   80 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEE-TTTCCEEEEEEEEGG------------GCCSHHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred             ccceEEEEEEeecCCEEEEEEEE-CCCCceEEEEEechh------------hccCHHHHHHHHHHHHHHHhCCCCCEeee
Confidence            34699999999999999999975 457889999987431            11123445678889999999999999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      ++++.+.+..++||||+++++|.+++..    ...+++..+..++.|++.||.||   |++|++||||||+||+++.++.
T Consensus        81 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~  153 (294)
T 2rku_A           81 HGFFEDNDFVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYL---HRNRVIHRDLKLGNLFLNEDLE  153 (294)
T ss_dssp             EEEEECSSEEEEEEECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECTTCC
T ss_pred             eeeeccCCEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCccccCCChHhEEEcCCCC
Confidence            9999999999999999999999998865    35689999999999999999999   6778999999999999999999


Q ss_pred             EEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHH
Q 011360          351 ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLR  430 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~  430 (487)
                      +||+|||++.........  .....||+.|+|||++.+..++.++||||||+++|+|++|..||....      ..+...
T Consensus       154 ~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~------~~~~~~  225 (294)
T 2rku_A          154 VKIGDFGLATKVEYDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC------LKETYL  225 (294)
T ss_dssp             EEECCCTTCEECCSTTCC--BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHH
T ss_pred             EEEEeccCceecccCccc--cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHH
Confidence            999999999876433222  134568999999999999889999999999999999999999994322      222222


Q ss_pred             HHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          431 KVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       431 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ...... .  .    ++..    ....+.+++.+||+.||++|||+.++++
T Consensus       226 ~~~~~~-~--~----~~~~----~~~~~~~li~~~l~~~p~~Rps~~~ll~  265 (294)
T 2rku_A          226 RIKKNE-Y--S----IPKH----INPVAASLIQKMLQTDPTARPTINELLN  265 (294)
T ss_dssp             HHHTTC-C--C----CCTT----SCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             HHhhcc-C--C----Cccc----cCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence            222221 1  1    1111    1245889999999999999999999875

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=6e-42  Score=334.52  Aligned_cols=260  Identities=22%  Similarity=0.326  Sum_probs=195.0

Q ss_pred             cccccc-cccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CCCCccc
Q 011360          192 DCFASL-EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RHRNILP  269 (487)
Q Consensus       192 ~~~~~~-~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~  269 (487)
                      +.|.+. +.||+|+||.||+|.. ..+++.||||++....               ......+.+|+.++.++ +||||++
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~~---------------~~~~~~~~~E~~~l~~~~~h~~i~~   75 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCIN-LITSQEYAVKIIEKQP---------------GHIRSRVFREVEMLYQCQGHRNVLE   75 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEEC-SSSCCEEEEEEEECCS---------------SCCHHHHHHHHHHHHHTCCCTTBCC
T ss_pred             eeEEecCceecCCceEEEEEEEE-cCCCcEEEEEEEeeCc---------------chhHHHHHHHHHHHHHhcCCCCeee
Confidence            468885 7899999999999974 4688999999984321               11234677899999885 8999999


Q ss_pred             cceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC
Q 011360          270 LLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDM  349 (487)
Q Consensus       270 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~  349 (487)
                      +++++.+.+..|+||||+++|+|.+++..    ...+++..+..++.|++.||.||   |++||+||||||+||+++.++
T Consensus        76 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~dlkp~Nil~~~~~  148 (316)
T 2ac3_A           76 LIEFFEEEDRFYLVFEKMRGGSILSHIHK----RRHFNELEASVVVQDVASALDFL---HNKGIAHRDLKPENILCEHPN  148 (316)
T ss_dssp             EEEEEEETTEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEESCSS
T ss_pred             EEEEEeeCCEEEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHH---HhCCceeCCCCHHHEEEccCC
Confidence            99999999999999999999999999975    35689999999999999999999   667899999999999999877


Q ss_pred             C---EEEeccCCccccCCCCc-----eeeEeeecccccccCCcccCC-----CCCCchhHHHHHHHHHHHHHhCCCCccc
Q 011360          350 E---ACISDLGLAMAIPDGYT-----RVLISYVLGTMAYIAPEYFQQ-----PELSEKCDIFSFGMLLISLVRGVPSFVF  416 (487)
Q Consensus       350 ~---~kl~DFg~s~~~~~~~~-----~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~DvwslG~~l~elltg~~pf~~  416 (487)
                      .   +||+|||++........     ........||+.|+|||++.+     ..++.++|||||||++|+|++|..||..
T Consensus       149 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~  228 (316)
T 2ac3_A          149 QVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVG  228 (316)
T ss_dssp             SSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             CcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcc
Confidence            6   99999999876542211     111123459999999999875     4578999999999999999999999965


Q ss_pred             cCCCCccc---------cHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          417 HQNGEEIC---------SPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       417 ~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ........         .......+. .....      ++.......+..+.+++.+||+.||++|||+.++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~i~-~~~~~------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          229 RCGSDCGWDRGEACPACQNMLFESIQ-EGKYE------FPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             CCCSCSCC----CCHHHHHHHHHHHH-HCCCC------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             cccccccccccccchhHHHHHHHHHh-ccCcc------cCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            54321100         011122222 22111      111001112356899999999999999999999986

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.5e-41  Score=348.96  Aligned_cols=196  Identities=25%  Similarity=0.371  Sum_probs=153.4

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||.|+||.||+|.. ..+++.||||++..             ..........+.+|+.+++.++||||++++
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~-~~~~~~vaiK~i~~-------------~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  118 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYD-KLEKRVVAIKKILR-------------VFEDLIDCKRILREIAILNRLNHDHVVKVL  118 (458)
T ss_dssp             TTEEECCC-------CEEEEEE-CC--CEEEEEEECS-------------TTSSHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CCeEEeeEeeecCCeEEEEEEE-CCCCcEEEEEEech-------------hhcCHHHHHHHHHHHHHHHhCCCCCCCceE
Confidence            5799999999999999999974 46889999998843             112234456788999999999999999999


Q ss_pred             eEEecC-----CeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC
Q 011360          272 AHMVRP-----DCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN  346 (487)
Q Consensus       272 ~~~~~~-----~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~  346 (487)
                      +++...     ..+|+||||+ +|+|.+++..    ...+++..+..++.||+.||.||   |++||+||||||+|||++
T Consensus       119 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~L---H~~~iiHrDlKp~NILl~  190 (458)
T 3rp9_A          119 DIVIPKDVEKFDELYVVLEIA-DSDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYV---HSAGILHRDLKPANCLVN  190 (458)
T ss_dssp             EECCCSCTTTCCCEEEEECCC-SEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEEC
T ss_pred             EEEecCCcccCceEEEEEecc-ccchhhhccc----CCCCCHHHHHHHHHHHHHHHHHH---HhCCcCCCCCChhhEEEC
Confidence            998543     5689999998 6799998864    46799999999999999999999   677899999999999999


Q ss_pred             CCCCEEEeccCCccccCCCCce-------------------------eeEeeecccccccCCccc-CCCCCCchhHHHHH
Q 011360          347 DDMEACISDLGLAMAIPDGYTR-------------------------VLISYVLGTMAYIAPEYF-QQPELSEKCDIFSF  400 (487)
Q Consensus       347 ~~~~~kl~DFg~s~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~l-~~~~~~~~~Dvwsl  400 (487)
                      .++.+||+|||+++........                         ......+||+.|+|||++ .+..|+.++|||||
T Consensus       191 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSl  270 (458)
T 3rp9_A          191 QDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSI  270 (458)
T ss_dssp             TTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHH
T ss_pred             CCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHH
Confidence            9999999999999876432110                         122445789999999976 56679999999999


Q ss_pred             HHHHHHHHh
Q 011360          401 GMLLISLVR  409 (487)
Q Consensus       401 G~~l~ellt  409 (487)
                      ||++|||++
T Consensus       271 G~il~ellt  279 (458)
T 3rp9_A          271 GCIFAELLN  279 (458)
T ss_dssp             HHHHHHHHT
T ss_pred             HHHHHHHHH
Confidence            999999999

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=5.7e-42  Score=337.54  Aligned_cols=250  Identities=23%  Similarity=0.302  Sum_probs=199.7

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .++|.+.+.||.|+||.||+|.. ..+++.||||++.........       .........+.+|+.++..++||||+++
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~-~~~~~~vavK~~~~~~~~~~~-------~~~~~~~~~~~~E~~~l~~l~h~~Iv~~   94 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVD-KEKNKEVVVKFIKKEKVLEDC-------WIEDPKLGKVTLEIAILSRVEHANIIKV   94 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEE-TTTTEEEEEEEEESTTSCTTS-------EEEETTTEEEEHHHHHHTTCCCTTBCCE
T ss_pred             ccceEEEeEEEecCCEEEEEEEE-CCCCcEEEEEEEehhhccccc-------ccchHHHHHHHHHHHHHHhCCCCCEeeE
Confidence            45799999999999999999974 468999999998542211000       0001123346679999999999999999


Q ss_pred             ceEEecCCeeEEEEEecCCC-CHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNG-SLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDM  349 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~  349 (487)
                      ++++.+.+..++||||+.+| +|.+++..    ...+++..+..++.|++.||.||   |++||+||||||+|||++.++
T Consensus        95 ~~~~~~~~~~~lv~e~~~~g~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~L---H~~~ivH~Dlkp~NIll~~~~  167 (335)
T 3dls_A           95 LDIFENQGFFQLVMEKHGSGLDLFAFIDR----HPRLDEPLASYIFRQLVSAVGYL---RLKDIIHRDIKDENIVIAEDF  167 (335)
T ss_dssp             EEEEECSSEEEEEEECCTTSCBHHHHHHT----CCCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTS
T ss_pred             EEEEeeCCEEEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HhCCeEEeccCHHHEEEcCCC
Confidence            99999999999999999766 99999864    45799999999999999999999   677899999999999999999


Q ss_pred             CEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCC-CchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHH
Q 011360          350 EACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPEL-SEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEW  428 (487)
Q Consensus       350 ~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~  428 (487)
                      .+||+|||++.........   ....||+.|+|||++.+..+ +.++||||||+++|+|++|..||.....         
T Consensus       168 ~~kL~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---------  235 (335)
T 3dls_A          168 TIKLIDFGSAAYLERGKLF---YTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE---------  235 (335)
T ss_dssp             CEEECCCTTCEECCTTCCB---CEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG---------
T ss_pred             cEEEeecccceECCCCCce---eccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH---------
Confidence            9999999999876554322   34569999999999988776 8899999999999999999999943211         


Q ss_pred             HHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          429 LRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       429 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                         .....   ...+..        .+.++.+++.+||+.||++|||+.++++
T Consensus       236 ---~~~~~---~~~~~~--------~~~~l~~li~~~L~~dP~~Rps~~ell~  274 (335)
T 3dls_A          236 ---TVEAA---IHPPYL--------VSKELMSLVSGLLQPVPERRTTLEKLVT  274 (335)
T ss_dssp             ---GTTTC---CCCSSC--------CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---HHhhc---cCCCcc--------cCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence               00000   000111        2256889999999999999999999986

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=3.8e-41  Score=343.20  Aligned_cols=202  Identities=27%  Similarity=0.340  Sum_probs=166.5

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .++|.+.+.||.|+||.||+|.. ..+++.||||++..             ..........+.+|+.+++.++||||+++
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~-~~~~~~vAiK~~~~-------------~~~~~~~~~~~~~E~~~l~~l~h~nIv~l   90 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYD-KNTEKNVAIKKVNR-------------MFEDLIDCKRILREITILNRLKSDYIIRL   90 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEE-TTTTEEEEEEEECS-------------TTTSHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             cCCEEEEEEEeecCCEEEEEEEE-CCCCcEEEEEEeCc-------------hhcChHHHHHHHHHHHHHHHcCCCCcceE
Confidence            45799999999999999999975 46889999999842             12233445678899999999999999999


Q ss_pred             ceEEecC-----CeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEe
Q 011360          271 LAHMVRP-----DCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLL  345 (487)
Q Consensus       271 ~~~~~~~-----~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill  345 (487)
                      ++++...     ..+|+||||+. |+|.+++..    ...+++..+..++.||+.||.||   |++||+||||||+|||+
T Consensus        91 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~L---H~~givHrDlkp~NILl  162 (432)
T 3n9x_A           91 YDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKT----PIFLTEEHIKTILYNLLLGENFI---HESGIIHRDLKPANCLL  162 (432)
T ss_dssp             EEECCCSCTTTCCCEEEEEECCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEE
T ss_pred             EEEEecCCCCcCCeEEEEEecCC-cCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHH---HHCCCCCCCCCHHHeEE
Confidence            9998766     57899999995 599999864    46699999999999999999999   67789999999999999


Q ss_pred             CCCCCEEEeccCCccccCCCCce--------------------eeEeeecccccccCCccc-CCCCCCchhHHHHHHHHH
Q 011360          346 NDDMEACISDLGLAMAIPDGYTR--------------------VLISYVLGTMAYIAPEYF-QQPELSEKCDIFSFGMLL  404 (487)
Q Consensus       346 ~~~~~~kl~DFg~s~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~l-~~~~~~~~~DvwslG~~l  404 (487)
                      +.++.+||+|||+++........                    ......+||+.|+|||++ ....|+.++|||||||++
T Consensus       163 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il  242 (432)
T 3n9x_A          163 NQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIF  242 (432)
T ss_dssp             CTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHH
T ss_pred             CCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHH
Confidence            99999999999999876443211                    122456799999999986 566799999999999999


Q ss_pred             HHHHhCCCCc
Q 011360          405 ISLVRGVPSF  414 (487)
Q Consensus       405 ~elltg~~pf  414 (487)
                      |||++|..||
T Consensus       243 ~ell~g~~p~  252 (432)
T 3n9x_A          243 AELLNMLQSH  252 (432)
T ss_dssp             HHHHTTCTTT
T ss_pred             HHHHhccccc
Confidence            9999865554

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=5.9e-42  Score=354.52  Aligned_cols=253  Identities=26%  Similarity=0.355  Sum_probs=204.3

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      +.|.+.+.||+|+||.||+|.. ..+++.||||++....            .........+.+|+.++++++||||++++
T Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~~avK~~~~~~------------~~~~~~~~~~~~E~~~l~~l~hpniv~~~   92 (484)
T 3nyv_A           26 DRYKGQRVLGKGSFGEVILCKD-KITGQECAVKVISKRQ------------VKQKTDKESLLREVQLLKQLDHPNIMKLY   92 (484)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEE-TTTCCEEEEEEEETTT------------CCBSSCHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred             CceEEeeEEecCCCEEEEEEEE-CCCCCEEEEEEEEhhh------------cccchHHHHHHHHHHHHHhCCCCCCCcEE
Confidence            4699999999999999999974 4688999999984311            11122346788999999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEe---CCC
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLL---NDD  348 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill---~~~  348 (487)
                      +++.+.+..|+|||||.+|+|.+++..    ...+++..+..++.|++.||.||   |++||+||||||+|||+   +.+
T Consensus        93 ~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~Dlkp~Nil~~~~~~~  165 (484)
T 3nyv_A           93 EFFEDKGYFYLVGEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYM---HKNKIVHRDLKPENLLLESKSKD  165 (484)
T ss_dssp             EEEECSSEEEEEECCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEESSSSTT
T ss_pred             EEEEeCCEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeCCCCHHHEEEecCCCC
Confidence            999999999999999999999998864    46799999999999999999999   67789999999999999   567


Q ss_pred             CCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHH
Q 011360          349 MEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEW  428 (487)
Q Consensus       349 ~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~  428 (487)
                      +.+||+|||++.........   ....||+.|+|||++.+ .|+.++|||||||++|+|++|.+||....      ..+.
T Consensus       166 ~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~------~~~~  235 (484)
T 3nyv_A          166 ANIRIIDFGLSTHFEASKKM---KDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN------EYDI  235 (484)
T ss_dssp             CCEEECCTTHHHHBCCCCSH---HHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHH
T ss_pred             CcEEEEeeeeeEEccccccc---ccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC------HHHH
Confidence            89999999999876544321   34569999999999876 69999999999999999999999994332      2233


Q ss_pred             HHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          429 LRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       429 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ...+...... .      +.......+..+.+++.+||+.||++|||+.++++
T Consensus       236 ~~~i~~~~~~-~------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          236 LKKVEKGKYT-F------ELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             HHHHHHCCCC-C------CSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHcCCCC-C------CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence            3333332211 1      11112233467899999999999999999999875

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.5e-41  Score=326.34  Aligned_cols=257  Identities=25%  Similarity=0.337  Sum_probs=201.1

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||.|+||.||+|.. ..+++.||+|.+........         ........+.+|+.++.+++||||++++
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~~avK~~~~~~~~~~---------~~~~~~~~~~~E~~~l~~l~h~~i~~~~   74 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQ-KGTGKEYAAKFIKKRRLSSS---------RRGVSREEIEREVNILREIRHPNIITLH   74 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEE-TTTCCEEEEEEEEBCSSTTC---------SSSBCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             hhhhhHHhhcccCceEEEEEEE-cCCCCeeehHHhhhcccccc---------ccchHHHHHHHHHHHHHhCCCCCeeehh
Confidence            4699999999999999999975 45789999998854321110         0111245678899999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC--
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDM--  349 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~--  349 (487)
                      +++.+.+..++||||+++++|.+++..    ...+++..+..++.|++.||.||   |++|++||||||+||+++.++  
T Consensus        75 ~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~  147 (283)
T 3bhy_A           75 DIFENKTDVVLILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYL---HSKRIAHFDLKPENIMLLDKNVP  147 (283)
T ss_dssp             EEEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEESCSSSS
T ss_pred             heecCCCeEEEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HhCCccCCCCChHHEEEecCCCC
Confidence            999999999999999999999999975    35689999999999999999999   677899999999999998877  


Q ss_pred             --CEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHH
Q 011360          350 --EACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPE  427 (487)
Q Consensus       350 --~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~  427 (487)
                        .+||+|||++........   .....||+.|+|||++.+..++.++||||||+++|+|++|..||....      ..+
T Consensus       148 ~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~  218 (283)
T 3bhy_A          148 NPRIKLIDFGIAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET------KQE  218 (283)
T ss_dssp             SCCEEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS------HHH
T ss_pred             CCceEEEecccceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc------hHH
Confidence              799999999987644322   134568999999999999999999999999999999999999994332      122


Q ss_pred             HHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          428 WLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ...........       .+.......+..+.+++.+||+.||++|||+.++++
T Consensus       219 ~~~~~~~~~~~-------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          219 TLTNISAVNYD-------FDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             HHHHHHTTCCC-------CCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHhHhcccC-------CcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence            22222221110       110011122356889999999999999999999986

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=7.1e-42  Score=331.74  Aligned_cols=253  Identities=24%  Similarity=0.351  Sum_probs=198.2

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .+.|.+.+.||.|+||.||+|.. ..++..||+|++...               .......+.+|+.++..++||||+++
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~-~~~~~~~aiK~~~~~---------------~~~~~~~~~~e~~~l~~l~h~~i~~~   81 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKN-KETGALAAAKVIETK---------------SEEELEDYIVEIEILATCDHPYIVKL   81 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEE-TTTCCEEEEEEEC-------------------CCHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccceeecceeccCCCeEEEEEEE-cCCCcEEEEEEecCC---------------CHHHHHHHHHHHHHHhcCCCCCEeee
Confidence            45799999999999999999975 457899999987431               11234567889999999999999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      ++++...+..++||||+++++|.+++...   ...+++..+..++.|++.||.||   |+.|++||||||+||+++.++.
T Consensus        82 ~~~~~~~~~~~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~Nil~~~~~~  155 (302)
T 2j7t_A           82 LGAYYHDGKLWIMIEFCPGGAVDAIMLEL---DRGLTEPQIQVVCRQMLEALNFL---HSKRIIHRDLKAGNVLMTLEGD  155 (302)
T ss_dssp             EEEEECC-CEEEEEECCTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCSGGGEEECTTSC
T ss_pred             eeeeeeCCeEEEEEEeCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHH---hcCCcccCCCCHHHEEECCCCC
Confidence            99999999999999999999999988642   45689999999999999999999   6778999999999999999999


Q ss_pred             EEEeccCCccccCCCCceeeEeeecccccccCCccc-----CCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCcccc
Q 011360          351 ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYF-----QQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICS  425 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l-----~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~  425 (487)
                      +||+|||++........  ......||+.|+|||++     .+..++.++||||||+++|+|++|..||....      .
T Consensus       156 ~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~  227 (302)
T 2j7t_A          156 IRLADFGVSAKNLKTLQ--KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN------P  227 (302)
T ss_dssp             EEECCCHHHHHHHHHHH--C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC------H
T ss_pred             EEEEECCCCcccccccc--ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC------H
Confidence            99999998754221111  11234689999999988     46678999999999999999999999994332      2


Q ss_pred             HHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          426 PEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       426 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ............+....+.        ..+..+.+++.+||+.||++|||+.++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~--------~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          228 MRVLLKIAKSDPPTLLTPS--------KWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             HHHHHHHHHSCCCCCSSGG--------GSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             HHHHHHHhccCCcccCCcc--------ccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            2333333333322221122        22356889999999999999999999875

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=3e-41  Score=329.22  Aligned_cols=251  Identities=29%  Similarity=0.406  Sum_probs=198.1

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .+.|.+.+.||.|+||.||+|.. ..+|+.||+|.+...                 .....+.+|+.++..++||||+++
T Consensus        28 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~~vaiK~~~~~-----------------~~~~~~~~e~~~l~~l~h~~i~~~   89 (314)
T 3com_A           28 EEVFDVLEKLGEGSYGSVYKAIH-KETGQIVAIKQVPVE-----------------SDLQEIIKEISIMQQCDSPHVVKY   89 (314)
T ss_dssp             --CEEEEEECC----CEEEEEEE-TTTCCEEEEEEEETT-----------------SCCHHHHHHHHHHHTCCCTTBCCE
T ss_pred             hhhhhhheeeccCCCeEEEEEEE-CCCCCEEEEEecCch-----------------HHHHHHHHHHHHHHhCCCCCCccE
Confidence            45799999999999999999975 457899999988431                 123457889999999999999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      ++++...+..|+||||+++++|.+++..   ....+++..+..++.|++.||.||   |+.|++||||||+||+++.++.
T Consensus        90 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~  163 (314)
T 3com_A           90 YGSYFKNTDLWIVMEYCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYL---HFMRKIHRDIKAGNILLNTEGH  163 (314)
T ss_dssp             EEEEEETTEEEEEEECCTTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTCC
T ss_pred             EEEEEeCCEEEEEeecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHH---HhCCCcCCCcCHHHEEECCCCC
Confidence            9999999999999999999999999863   246789999999999999999999   6778999999999999999999


Q ss_pred             EEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHH
Q 011360          351 ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLR  430 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~  430 (487)
                      +||+|||++.........  .....||+.|+|||++.+..++.++||||||+++|+|++|..||....      ......
T Consensus       164 ~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~  235 (314)
T 3com_A          164 AKLADFGVAGQLTDTMAK--RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH------PMRAIF  235 (314)
T ss_dssp             EEECCCTTCEECBTTBSC--BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHH
T ss_pred             EEEeecccchhhhhhccc--cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC------hHHHHH
Confidence            999999999766443221  134568999999999999899999999999999999999999994322      112222


Q ss_pred             HHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          431 KVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       431 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .......+.....        ...+..+.+++.+||+.||++|||+.++++
T Consensus       236 ~~~~~~~~~~~~~--------~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          236 MIPTNPPPTFRKP--------ELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             HHHHSCCCCCSSG--------GGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HHhcCCCcccCCc--------ccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            2222221111111        112356889999999999999999999875

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.5e-41  Score=360.15  Aligned_cols=257  Identities=21%  Similarity=0.295  Sum_probs=199.8

Q ss_pred             cccccc-ccccccceeEEEEEecC-CCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          193 CFASLE-KIGSGGCGEVYKAELPG-SNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       193 ~~~~~~-~lg~G~~g~v~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .+.+.. .||+|+||.||+|.+.. .++..||||++...              ......+.+.+|+.++.+++||||+++
T Consensus       336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~--------------~~~~~~~~~~~E~~il~~l~hpniv~l  401 (613)
T 2ozo_A          336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--------------TEKADTEEMMREAQIMHQLDNPYIVRL  401 (613)
T ss_dssp             SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCC--------------CSSTTHHHHHHHHHHHTTCCCTTBCCE
T ss_pred             ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCC--------------CChHHHHHHHHHHHHHHhCCCCCEeeE
Confidence            344444 79999999999997643 35667999998431              112235678899999999999999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      ++++.. +..++|||||++|+|.+++..   ....+++..+..++.|++.||.||   |++||+||||||+|||++.++.
T Consensus       402 ~~~~~~-~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~L---H~~~iiHrDlkp~NILl~~~~~  474 (613)
T 2ozo_A          402 IGVCQA-EALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYL---EEKNFVHRNLAARNVLLVNRHY  474 (613)
T ss_dssp             EEEEES-SSEEEEEECCTTCBHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEEEETTE
T ss_pred             EEEecc-CCeEEEEEeCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHH---HHCCEEcCcCCHHHEEEcCCCc
Confidence            999876 568999999999999999863   356689999999999999999999   6778999999999999999999


Q ss_pred             EEEeccCCccccCCCCcee-eEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccccHHH
Q 011360          351 ACISDLGLAMAIPDGYTRV-LISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSPEW  428 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~  428 (487)
                      +||+|||+++......... ......+|+.|+|||++.+..++.++|||||||++|||+| |..||.....      .+.
T Consensus       475 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~------~~~  548 (613)
T 2ozo_A          475 AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG------PEV  548 (613)
T ss_dssp             EEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS------HHH
T ss_pred             EEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH------HHH
Confidence            9999999998764432211 1122345789999999998899999999999999999998 9999954322      333


Q ss_pred             HHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          429 LRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       429 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      ...+..+..+  ..++.+        +..+.++|.+||+.+|++|||+.+|++.|+.+
T Consensus       549 ~~~i~~~~~~--~~p~~~--------~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  596 (613)
T 2ozo_A          549 MAFIEQGKRM--ECPPEC--------PPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  596 (613)
T ss_dssp             HHHHHTTCCC--CCCTTC--------CHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred             HHHHHcCCCC--CCCCcC--------CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            3333332221  111222        25688999999999999999999999999875

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=4.3e-41  Score=326.51  Aligned_cols=250  Identities=29%  Similarity=0.437  Sum_probs=203.3

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .+.|.+.+.||.|+||.||+|.. ..+++.||+|++....              .......+.+|+.++..++||||+++
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~~~--------------~~~~~~~~~~e~~~l~~l~h~~i~~~   85 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGID-NRTQKVVAIKIIDLEE--------------AEDEIEDIQQEITVLSQCDSPYVTKY   85 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEE-TTTCCEEEEEEEETTT--------------CSTTHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEE-CCCCcEEEEEEecccc--------------cHHHHHHHHHHHHHHHhCCCCCEeEE
Confidence            34699999999999999999974 4578999999884311              12234678889999999999999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      ++++......++||||+++++|.+++..     ..+++..+..++.|++.||.||   |+.||+||||||+||+++.++.
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~  157 (303)
T 3a7i_A           86 YGSYLKDTKLWIIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYL---HSEKKIHRDIKAANVLLSEHGE  157 (303)
T ss_dssp             EEEEEETTEEEEEEECCTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSC
T ss_pred             EEEEecCCeEEEEEEeCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHH---HHCCCccCCCChheEEECCCCC
Confidence            9999999999999999999999999863     5689999999999999999999   6778999999999999999999


Q ss_pred             EEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHH
Q 011360          351 ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLR  430 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~  430 (487)
                      +||+|||++.........  .....||+.|+|||++.+..++.++||||||+++|+|++|..||....      ......
T Consensus       158 ~kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~  229 (303)
T 3a7i_A          158 VKLADFGVAGQLTDTQIK--RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH------PMKVLF  229 (303)
T ss_dssp             EEECCCTTCEECBTTBCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHH
T ss_pred             EEEeecccceecCccccc--cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC------HHHHHH
Confidence            999999999776443221  134568999999999999999999999999999999999999994321      122222


Q ss_pred             HHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          431 KVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       431 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ... ...+. .+...+        +..+.+++.+||+.||++|||+.++++
T Consensus       230 ~~~-~~~~~-~~~~~~--------~~~l~~li~~~l~~dp~~Rps~~~ll~  270 (303)
T 3a7i_A          230 LIP-KNNPP-TLEGNY--------SKPLKEFVEACLNKEPSFRPTAKELLK  270 (303)
T ss_dssp             HHH-HSCCC-CCCSSC--------CHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             Hhh-cCCCC-CCcccc--------CHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            222 22211 112222        245889999999999999999999875

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=4.1e-41  Score=331.54  Aligned_cols=252  Identities=23%  Similarity=0.336  Sum_probs=205.0

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .++|.+.+.||+|+||.||++.. ..+++.||+|++...            ..........+.+|+.+++.++||||+++
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~~~a~K~~~~~------------~~~~~~~~~~~~~E~~~l~~l~h~~iv~~  106 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISD-ADTKEVFAGKIVPKS------------LLLKPHQREKMSMEISIHRSLAHQHVVGF  106 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEE-TTTCCEEEEEEEEGG------------GCCSHHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEE-CCCCCEEEEEEechh------------hhcCHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence            35799999999999999999975 467889999987431            11223455678899999999999999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      ++++.+.+..|+||||+++++|.+++..    ...+++..++.++.|++.||.||   |++||+||||||+||+++.++.
T Consensus       107 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~L---H~~~ivH~dlkp~NIl~~~~~~  179 (335)
T 2owb_A          107 HGFFEDNDFVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYL---HRNRVIHRDLKLGNLFLNEDLE  179 (335)
T ss_dssp             EEEEECSSEEEEEECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEECTTCC
T ss_pred             EEEEecCCeEEEEEecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHH---HHCCCEecCCCchhEEEcCCCC
Confidence            9999999999999999999999999875    35689999999999999999999   6778999999999999999999


Q ss_pred             EEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHH
Q 011360          351 ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLR  430 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~  430 (487)
                      +||+|||++.........  .....||+.|+|||++.+..++.++||||||+++|+|++|..||....      ..+...
T Consensus       180 ~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~  251 (335)
T 2owb_A          180 VKIGDFGLATKVEYDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC------LKETYL  251 (335)
T ss_dssp             EEECCCTTCEECCSTTCC--BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHH
T ss_pred             EEEeeccCceecccCccc--ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC------HHHHHH
Confidence            999999999876433222  134568999999999998889999999999999999999999994322      222222


Q ss_pred             HHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          431 KVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       431 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ...... .  .++..+        ...+.+++.+||+.||++|||+.++++
T Consensus       252 ~~~~~~-~--~~~~~~--------~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          252 RIKKNE-Y--SIPKHI--------NPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             HHHHTC-C--CCCTTS--------CHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             HHhcCC-C--CCCccC--------CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            232221 1  111112        245889999999999999999999875

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.4e-41  Score=326.42  Aligned_cols=246  Identities=24%  Similarity=0.408  Sum_probs=200.4

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||.|+||.||+|.. ..+++.||+|++....                   ..+.+|+.++..++||||++++
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~~-------------------~~~~~e~~~l~~l~h~~i~~~~   70 (284)
T 2a19_B           11 MDFKEIELIGSGGFGQVFKAKH-RIDGKTYVIKRVKYNN-------------------EKAEREVKALAKLDHVNIVHYN   70 (284)
T ss_dssp             HHEEEEEEEECSSSCCEEEEEE-TTTCCEEEEEEEECCS-------------------GGGHHHHHHHHHCCCTTBCCEE
T ss_pred             cccceeeeeccCCceEEEEEEE-cCCCeEEEEEEecccc-------------------HHHHHHHHHHHhCCCCCEEEEe
Confidence            4699999999999999999975 4578999999884311                   2356789999999999999999


Q ss_pred             eEEec----------------CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 011360          272 AHMVR----------------PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIH  335 (487)
Q Consensus       272 ~~~~~----------------~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH  335 (487)
                      +++..                ....++||||+++|+|.+++...  ....+++..++.++.|++.||.||   |++||+|
T Consensus        71 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H  145 (284)
T 2a19_B           71 GCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVDYI---HSKKLIN  145 (284)
T ss_dssp             EEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHHHHHH---HHTTEEC
T ss_pred             eeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHH---HhCCeee
Confidence            98864                44579999999999999999752  245789999999999999999999   6678999


Q ss_pred             cCCCCCCEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCcc
Q 011360          336 GDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFV  415 (487)
Q Consensus       336 ~Dlkp~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~  415 (487)
                      |||||+||+++.++.+||+|||++.........   ....||+.|+|||++.+..++.++||||||+++|+|++|..||.
T Consensus       146 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~  222 (284)
T 2a19_B          146 RDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR---TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF  222 (284)
T ss_dssp             SCCSGGGEEEEETTEEEECCCTTCEESSCCSCC---CCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHH
T ss_pred             ccCCHHHEEEcCCCCEEECcchhheeccccccc---cccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcch
Confidence            999999999999999999999999876544322   33468999999999998899999999999999999999988873


Q ss_pred             ccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          416 FHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       416 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      ..        ........ ....    +..+        +..+.+++.+||+.||++|||+.++++.|..+
T Consensus       223 ~~--------~~~~~~~~-~~~~----~~~~--------~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~  272 (284)
T 2a19_B          223 ET--------SKFFTDLR-DGII----SDIF--------DKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW  272 (284)
T ss_dssp             HH--------HHHHHHHH-TTCC----CTTS--------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             hH--------HHHHHHhh-cccc----cccC--------CHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            21        11222221 1111    1112        24588999999999999999999999998765

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=7e-42  Score=327.92  Aligned_cols=250  Identities=27%  Similarity=0.397  Sum_probs=194.7

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .++|.+.+.||.|+||.||++.+   ++..||+|.+..                 ....+.+.+|+.++.+++||||+++
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~-----------------~~~~~~~~~E~~~l~~l~h~~iv~~   79 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDY---RGNKVAVKCIKN-----------------DATAQAFLAEASVMTQLRHSNLVQL   79 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE---TTEEEEEEECCC-----------------CC--HHHHHTHHHHTTCCCTTBCCE
T ss_pred             hhhceEEeEEecCCCceEEEEEE---cCCEEEEEEecc-----------------hhHHHHHHHHHHHHHhCCCCCEeeE
Confidence            45699999999999999999976   588999998732                 1134567889999999999999999


Q ss_pred             ceEEecC-CeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC
Q 011360          271 LAHMVRP-DCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDM  349 (487)
Q Consensus       271 ~~~~~~~-~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~  349 (487)
                      ++++... +..++||||+++++|.+++...  ....+++..+..++.|++.||.||   |++|++||||||+||+++.++
T Consensus        80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~l---H~~~i~H~dlkp~Nil~~~~~  154 (278)
T 1byg_A           80 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDN  154 (278)
T ss_dssp             EEEECCC--CCEEEECCCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECTTS
T ss_pred             EEEEEcCCCceEEEEecCCCCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHH---HhCCccccCCCcceEEEeCCC
Confidence            9987654 5789999999999999999752  123478899999999999999999   677899999999999999999


Q ss_pred             CEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccccHHH
Q 011360          350 EACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSPEW  428 (487)
Q Consensus       350 ~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~  428 (487)
                      .+||+|||++.......     ....+++.|+|||++.+..++.++||||||+++|+|+| |..||.....      .+.
T Consensus       155 ~~~l~Dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~------~~~  223 (278)
T 1byg_A          155 VAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL------KDV  223 (278)
T ss_dssp             CEEECCCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG------GGH
T ss_pred             cEEEeeccccccccccc-----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH------HHH
Confidence            99999999987654322     23357889999999998899999999999999999998 9999954321      112


Q ss_pred             HHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          429 LRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       429 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      .........+      ..+.    ..+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus       224 ~~~~~~~~~~------~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i  271 (278)
T 1byg_A          224 VPRVEKGYKM------DAPD----GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI  271 (278)
T ss_dssp             HHHHTTTCCC------CCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHhcCCCC------CCcc----cCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence            2222221111      1111    1235688999999999999999999999999875

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=5.1e-41  Score=326.84  Aligned_cols=265  Identities=22%  Similarity=0.308  Sum_probs=195.1

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC---CCCCc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI---RHRNI  267 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpnI  267 (487)
                      .++|.+.+.||.|+||.||+|+. ..+++.||+|++........          .......+.+|+.+++.+   .||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~~~~~~----------~~~~~~~~~~e~~~l~~l~~~~h~ni   76 (308)
T 3g33_A            8 TSRYEPVAEIGVGAYGTVYKARD-PHSGHFVALKSVRVPNGGGG----------GGGLPISTVREVALLRRLEAFEHPNV   76 (308)
T ss_dssp             --CCEEEEEECCSSSCCEEEEEC-TTTCCEEEEEEEEEECCCTT----------SSCCCHHHHHHHHHHHHHHHHCCTTB
T ss_pred             ccceEEEEEEecCCCeEEEEEEE-CCCCcEEEEEEEeccccccc----------ccccchhHHHHHHHHHHHhhcCCCCe
Confidence            35799999999999999999974 46889999999854321110          000112234455555444   69999


Q ss_pred             cccceEEecCC-----eeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCC
Q 011360          268 LPLLAHMVRPD-----CHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRN  342 (487)
Q Consensus       268 v~l~~~~~~~~-----~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~N  342 (487)
                      +++++++....     ..++||||+. ++|.+++..  .....+++..+..++.|++.||.||   |++||+||||||+|
T Consensus        77 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~i~~qi~~al~~l---H~~~ivH~Dlkp~N  150 (308)
T 3g33_A           77 VRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDK--APPPGLPAETIKDLMRQFLRGLDFL---HANCIVHRDLKPEN  150 (308)
T ss_dssp             CCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHT--CCTTCSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCTTT
T ss_pred             EEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhh--ccCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHH
Confidence            99999998755     4799999996 699999975  3334589999999999999999999   67789999999999


Q ss_pred             EEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCc
Q 011360          343 VLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEE  422 (487)
Q Consensus       343 ill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~  422 (487)
                      |+++.++.+||+|||++.........   ....||+.|+|||++.+..++.++|||||||++|+|++|.+||.....   
T Consensus       151 il~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---  224 (308)
T 3g33_A          151 ILVTSGGTVKLADFGLARIYSYQMAL---TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE---  224 (308)
T ss_dssp             EEECTTSCEEECSCSCTTTSTTCCCS---GGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSH---
T ss_pred             EEEcCCCCEEEeeCccccccCCCccc---CCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCH---
Confidence            99999999999999999876443221   345789999999999988999999999999999999999999944321   


Q ss_pred             cccHHHHHHHHh--cCCCCCccCCCC-----------CCC---CcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          423 ICSPEWLRKVMN--SKNPSRAIDPRL-----------PGN---GYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       423 ~~~~~~~~~~~~--~~~~~~~~~~~~-----------~~~---~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                         .+....+..  ...+........           +..   .....+..+.+++.+||+.||++|||+.++++
T Consensus       225 ---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          225 ---ADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             ---HHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ---HHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence               122222221  111111110000           000   01123457889999999999999999999875

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-41  Score=337.59  Aligned_cols=256  Identities=24%  Similarity=0.351  Sum_probs=193.4

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .+.|.+.+.||+|+||.||+|.. ..+|+.||||++...             .........+.+|+.+++.++||||+++
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~-~~~~~~vaiK~~~~~-------------~~~~~~~~~~~~E~~~l~~l~hpnIv~l   89 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVD-GRTGAKVAIKKLYRP-------------FQSELFAKRAYRELRLLKHMRHENVIGL   89 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEE-TTTCCEEEEEECSST-------------TSSHHHHHHHHHHHHHHHHCCBTTBCCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEE-CCCCCEEEEEEeCcc-------------ccCHHHHHHHHHHHHHHHhCCCcCCCCc
Confidence            35699999999999999999974 568999999987331             1223345678899999999999999999


Q ss_pred             ceEEecCC------eeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEE
Q 011360          271 LAHMVRPD------CHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVL  344 (487)
Q Consensus       271 ~~~~~~~~------~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nil  344 (487)
                      ++++....      .+|+||||+ +++|.+++..     ..+++..+..++.|++.||.||   |++||+||||||+||+
T Consensus        90 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~L---H~~~ivH~Dlkp~NIl  160 (367)
T 1cm8_A           90 LDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYI---HAAGIIHRDLKPGNLA  160 (367)
T ss_dssp             SEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEE
T ss_pred             eeeEecCCccccCceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHH---HHCCccccCcCHHHEE
Confidence            99998653      459999999 8899999874     4689999999999999999999   6778999999999999


Q ss_pred             eCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCccccCCCCcc
Q 011360          345 LNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQ-PELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI  423 (487)
Q Consensus       345 l~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~  423 (487)
                      ++.++.+||+|||+++......     ....+|+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.    
T Consensus       161 l~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----  231 (367)
T 1cm8_A          161 VNEDCELKILDFGLARQADSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH----  231 (367)
T ss_dssp             ECTTCCEEECCCTTCEECCSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH----
T ss_pred             EcCCCCEEEEeeeccccccccc-----CcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCH----
Confidence            9999999999999998754332     34568999999999876 6899999999999999999999999954321    


Q ss_pred             ccHHHHHHHHh-cCCCCCc--------------------cCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          424 CSPEWLRKVMN-SKNPSRA--------------------IDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       424 ~~~~~~~~~~~-~~~~~~~--------------------~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                        ...+..+.. .+.+...                    ....+. ......+..+.+++.+||..||++|||+.++++
T Consensus       232 --~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          232 --LDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  307 (367)
T ss_dssp             --HHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             --HHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence              111111111 0100000                    000000 011122356889999999999999999999986

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.6e-41  Score=333.67  Aligned_cols=261  Identities=22%  Similarity=0.325  Sum_probs=192.1

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .++|.+.+.||+|+||.||+|.. ..+++.||||++...             .........+.+|+.+++.++||||+++
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~~-------------~~~~~~~~~~~~E~~~l~~l~h~~iv~~   98 (329)
T 3gbz_A           33 IDRYRRITKLGEGTYGEVYKAID-TVTNETVAIKRIRLE-------------HEEEGVPGTAIREVSLLKELQHRNIIEL   98 (329)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEE-TTTTEEEEEEECCCC-------------C--------CHHHHHHGGGCCCTTBCCE
T ss_pred             hhhEEEEEEEEecCCeEEEEEEE-CCCCceEEEEEEccc-------------ccccccchhHHHHHHHHHHcCCCCcceE
Confidence            34699999999999999999964 568999999998431             1122234566789999999999999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC----
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN----  346 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~----  346 (487)
                      ++++.+.+..++||||++ |+|.+++..    ...+++..++.++.|++.||.||   |++||+||||||+|||++    
T Consensus        99 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~L---H~~~ivH~Dlkp~NIll~~~~~  170 (329)
T 3gbz_A           99 KSVIHHNHRLHLIFEYAE-NDLKKYMDK----NPDVSMRVIKSFLYQLINGVNFC---HSRRCLHRDLKPQNLLLSVSDA  170 (329)
T ss_dssp             EEEEEETTEEEEEEECCS-EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEEEC---
T ss_pred             EEEEecCCEEEEEEecCC-CCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHH---HhCCEECCCCCHHHEEEecCCC
Confidence            999999999999999996 599999875    45689999999999999999999   667899999999999994    


Q ss_pred             -CCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCccccCCCCccc
Q 011360          347 -DDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQP-ELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEIC  424 (487)
Q Consensus       347 -~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~  424 (487)
                       .++.+||+|||++.........  .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.....     
T Consensus       171 ~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----  243 (329)
T 3gbz_A          171 SETPVLKIGDFGLARAFGIPIRQ--FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE-----  243 (329)
T ss_dssp             --CCEEEECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----
T ss_pred             CccceEEECcCCCccccCCcccc--cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCH-----
Confidence             4556999999999876433221  2345689999999999874 589999999999999999999999954321     


Q ss_pred             cHHHHHHHHhc-CCCCCcc----------C---CCCCCCCcH-----HHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          425 SPEWLRKVMNS-KNPSRAI----------D---PRLPGNGYE-----KKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       425 ~~~~~~~~~~~-~~~~~~~----------~---~~~~~~~~~-----~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                       .+........ ..+....          .   +........     ....++.+++.+||+.||++|||+.++++
T Consensus       244 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          244 -IDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             -HHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -HHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence             1222222211 1111000          0   000011111     13357889999999999999999999986

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.1e-42  Score=336.46  Aligned_cols=260  Identities=19%  Similarity=0.294  Sum_probs=192.6

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||.|+||.||+|+. ..+++.||+|++....              .......+.+|+.+++.++||||++++
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~-~~~~~~vavK~~~~~~--------------~~~~~~~~~~E~~~l~~l~h~~iv~~~   66 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKS-KLTDNLVALKEIRLEH--------------EEGAPCTAIREVSLLKDLKHANIVTLH   66 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEE-TTTCCEEEEEEECC--------------------CCCCCCCHHHHSCCCCTTBCCEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEE-CCCCcEEEEEEEeccc--------------ccccchhHHHHHHHHHhcCCCCCCeee
Confidence            4699999999999999999975 4578999999884311              111112345789999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++...+..++||||++ |+|.+++..   .+..+++..+..++.|++.||.||   |++||+||||||+||+++.++.+
T Consensus        67 ~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~L---H~~~ivH~Dikp~NIl~~~~~~~  139 (324)
T 3mtl_A           67 DIIHTEKSLTLVFEYLD-KDLKQYLDD---CGNIINMHNVKLFLFQLLRGLAYC---HRQKVLHRDLKPQNLLINERGEL  139 (324)
T ss_dssp             EEEECSSCEEEEEECCS-EEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHH---HHTTEEESSCCGGGEEECTTCCE
T ss_pred             eEEeeCCEEEEEecccc-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHH---HHCCccCCCcCHHHEEECCCCCE
Confidence            99999999999999996 589888874   245689999999999999999999   67789999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQ-PELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLR  430 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~  430 (487)
                      ||+|||++.........  .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.....      .+...
T Consensus       140 kl~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~------~~~~~  211 (324)
T 3mtl_A          140 KLADFGLARAKSIPTKT--YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV------EEQLH  211 (324)
T ss_dssp             EECSSSEEECC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHH
T ss_pred             EEccCcccccccCCccc--cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHH
Confidence            99999999765433221  234568999999999876 5789999999999999999999999954321      11121


Q ss_pred             HHHh--cCCCCCccCCC-------------CCCC----CcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          431 KVMN--SKNPSRAIDPR-------------LPGN----GYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       431 ~~~~--~~~~~~~~~~~-------------~~~~----~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .+..  +..+...++..             ....    .......++.+++.+||+.||++|||+.++++
T Consensus       212 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          212 FIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             HHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             HHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            1111  11111111100             0000    00122356889999999999999999999875

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=3.2e-42  Score=334.15  Aligned_cols=269  Identities=28%  Similarity=0.364  Sum_probs=186.5

Q ss_pred             hhhccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCc
Q 011360          188 LKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNI  267 (487)
Q Consensus       188 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI  267 (487)
                      ....++|.+.+.||.|+||.||+|.. ..+++.||||++...              ........+.+|+.++.+++||||
T Consensus        11 ~i~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~~--------------~~~~~~~~~~~e~~~l~~l~h~~i   75 (303)
T 2vwi_A           11 SINRDDYELQEVIGSGATAVVQAAYC-APKKEKVAIKRINLE--------------KCQTSMDELLKEIQAMSQCHHPNI   75 (303)
T ss_dssp             --CCCCCEEEEECC---CCCEEEEEC-----CEEEEECCC------------------------------CCCCCCCTTB
T ss_pred             ccchhhhhhhheeccccceEEEEEEE-CCCCcEEEEEEEEhh--------------hcchhHHHHHHHHHHHhhcCCCCE
Confidence            33456799999999999999999974 457889999987321              112234567889999999999999


Q ss_pred             cccceEEecCCeeEEEEEecCCCCHHHHHhhhhc----CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCE
Q 011360          268 LPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSR----GRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNV  343 (487)
Q Consensus       268 v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~----~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Ni  343 (487)
                      +++++++...+..++||||+++++|.+++.....    ....+++..+..++.|++.||.||   |++|++||||||+||
T Consensus        76 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dl~p~Ni  152 (303)
T 2vwi_A           76 VSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYL---HKNGQIHRDVKAGNI  152 (303)
T ss_dssp             CCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCSGGGE
T ss_pred             eeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHH---HhCCCCCCCCChhhE
Confidence            9999999999999999999999999999875322    245689999999999999999999   677899999999999


Q ss_pred             EeCCCCCEEEeccCCccccCCCCc---eeeEeeecccccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCccccCC
Q 011360          344 LLNDDMEACISDLGLAMAIPDGYT---RVLISYVLGTMAYIAPEYFQQ-PELSEKCDIFSFGMLLISLVRGVPSFVFHQN  419 (487)
Q Consensus       344 ll~~~~~~kl~DFg~s~~~~~~~~---~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwslG~~l~elltg~~pf~~~~~  419 (487)
                      +++.++.+||+|||++........   ........||+.|+|||++.+ ..++.++||||||+++|+|++|..||.....
T Consensus       153 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~  232 (303)
T 2vwi_A          153 LLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPP  232 (303)
T ss_dssp             EECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCG
T ss_pred             EEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCch
Confidence            999999999999999876543321   111234568999999999875 4689999999999999999999999954332


Q ss_pred             CCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          420 GEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       420 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .      ...........+. ..............+..+.+++.+||+.||++|||+.++++
T Consensus       233 ~------~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          233 M------KVLMLTLQNDPPS-LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             G------GHHHHHHTSSCCC-TTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             h------hHHHHHhccCCCc-cccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            1      1112222221111 10000000111122356889999999999999999999985

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.9e-41  Score=327.59  Aligned_cols=262  Identities=23%  Similarity=0.297  Sum_probs=203.4

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .++|.+.+.||+|+||.||+|+. ..+++.||+|++....                 ....+.+|+.++..++|++++..
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~~-----------------~~~~~~~e~~~l~~l~~~~~i~~   69 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTD-IAAGEEVAIKLECVKT-----------------KHPQLHIESKIYKMMQGGVGIPT   69 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEE-TTTTEEEEEEEEESCS-----------------SCCHHHHHHHHHHHHTTSTTCCC
T ss_pred             ccEEEEEEEEccCCCeEEEEEEE-cCCCcEEEEEEecCCc-----------------chhHHHHHHHHHHHhhcCCCCCc
Confidence            35799999999999999999974 4689999999874311                 11246789999999999887776


Q ss_pred             ceEE-ecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC---
Q 011360          271 LAHM-VRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN---  346 (487)
Q Consensus       271 ~~~~-~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~---  346 (487)
                      +..+ ...+..++||||+ +++|.+++..   ....+++..++.++.|++.||.||   |++||+||||||+||+++   
T Consensus        70 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~dlkp~NIl~~~~~  142 (296)
T 3uzp_A           70 IRWCGAEGDYNVMVMELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYI---HSKNFIHRDVKPDNFLMGLGK  142 (296)
T ss_dssp             EEEEEEETTEEEEEEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEECCGG
T ss_pred             cccccCCCCceEEEEEec-CCCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHH---HhCCeeeCCCCHHHeEEecCC
Confidence            6655 5667889999999 9999999974   245699999999999999999999   677899999999999994   


Q ss_pred             CCCCEEEeccCCccccCCCCcee-----eEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCC
Q 011360          347 DDMEACISDLGLAMAIPDGYTRV-----LISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGE  421 (487)
Q Consensus       347 ~~~~~kl~DFg~s~~~~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~  421 (487)
                      .++.+||+|||++..........     ......||+.|+|||++.+..++.++||||||+++|+|++|..||.......
T Consensus       143 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~  222 (296)
T 3uzp_A          143 KGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT  222 (296)
T ss_dssp             GTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS
T ss_pred             CCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchh
Confidence            78899999999998765433211     1134569999999999999999999999999999999999999997654332


Q ss_pred             ccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          422 EICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       422 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      ............. ..+...+.+.++        ..+.+++.+||+.||++|||+.+|++.|+++
T Consensus       223 ~~~~~~~~~~~~~-~~~~~~~~~~~~--------~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~  278 (296)
T 3uzp_A          223 KRQKYERISEKKM-STPIEVLCKGYP--------SEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  278 (296)
T ss_dssp             SSSHHHHHHHHHH-HSCHHHHTTTSC--------HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred             hhhhhhhhccccc-CCchHHHHhhCC--------HHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence            2222111111111 111111111222        5689999999999999999999999999876

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2.1e-40  Score=321.83  Aligned_cols=255  Identities=23%  Similarity=0.280  Sum_probs=199.2

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||.|+||.||++. +..++..||+|++...           ...........+.+|+.+++.++||||++++
T Consensus         5 ~~y~i~~~lg~G~~g~V~~~~-~~~~~~~~avK~~~~~-----------~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~   72 (305)
T 2wtk_C            5 GKYLMGDLLGEGSYGKVKEVL-DSETLCRRAVKILKKK-----------KLRRIPNGEANVKKEIQLLRRLRHKNVIQLV   72 (305)
T ss_dssp             CCBCCCCEEEECSSCEEEEEE-BTTTCCEEEEEEECHH-----------HHHHSTTHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred             cceeEeeEEecCCCeEEEEEE-ECCCCcEEEEEEeccc-----------cccccchhHHHHHHHHHHHHhcCCCCeeEEE
Confidence            469999999999999999997 4568899999998420           0111123456788999999999999999999


Q ss_pred             eEEe--cCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC
Q 011360          272 AHMV--RPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDM  349 (487)
Q Consensus       272 ~~~~--~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~  349 (487)
                      +++.  .....++||||++++ |.+++..  .....+++..+..++.|++.||.||   |++||+||||||+||+++.++
T Consensus        73 ~~~~~~~~~~~~lv~e~~~~~-l~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~L---H~~~i~H~dlkp~NIl~~~~~  146 (305)
T 2wtk_C           73 DVLYNEEKQKMYMVMEYCVCG-MQEMLDS--VPEKRFPVCQAHGYFCQLIDGLEYL---HSQGIVHKDIKPGNLLLTTGG  146 (305)
T ss_dssp             EEEECC---CEEEEEECCSEE-HHHHHHH--STTCSCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTC
T ss_pred             EEEEcCCCCeEEEEehhccCC-HHHHHHh--CcccccCHHHHHHHHHHHHHHHHHH---HHCCeeecCCCcccEEEcCCC
Confidence            9984  456789999999776 7777765  3356789999999999999999999   677899999999999999999


Q ss_pred             CEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCC--CCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHH
Q 011360          350 EACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPE--LSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPE  427 (487)
Q Consensus       350 ~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~  427 (487)
                      .+||+|||++................||+.|+|||++.+..  ++.++||||||+++|+|++|..||...      ...+
T Consensus       147 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~------~~~~  220 (305)
T 2wtk_C          147 TLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD------NIYK  220 (305)
T ss_dssp             CEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCS------SHHH
T ss_pred             cEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCc------hHHH
Confidence            99999999998765433333334567999999999988643  378999999999999999999999432      1222


Q ss_pred             HHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          428 WLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ....+... ..  .    ++..    ....+.+++.+||+.||++|||+.++++
T Consensus       221 ~~~~i~~~-~~--~----~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~  263 (305)
T 2wtk_C          221 LFENIGKG-SY--A----IPGD----CGPPLSDLLKGMLEYEPAKRFSIRQIRQ  263 (305)
T ss_dssp             HHHHHHHC-CC--C----CCSS----SCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHhcC-CC--C----CCCc----cCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            33333222 11  1    1211    1245889999999999999999999985

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=2e-41  Score=352.05  Aligned_cols=264  Identities=27%  Similarity=0.374  Sum_probs=201.2

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .+.|.+.+.||+|+||.||+|.. ..++..||+|++.........  ............+.+.+|+.++++++||||+++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~-~~~~~~~aiK~~~~~~~~~~~--~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~  111 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKE-KNGHSEKAIKVIKKSQFDKGR--YSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKL  111 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEE-TTTCCEEEEEEEEC------------------CTHHHHHHHHHHHHTCCCTTBCCE
T ss_pred             ccceEEEeEecccCCeEEEEEEE-CCCCcEEEEEEEEhhhccccc--ccccchhhHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence            35699999999999999999975 467899999998542211000  000000111234678899999999999999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC-
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDM-  349 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~-  349 (487)
                      ++++.+....|+|||||+||+|.+++..    ...+++..+..++.|++.||.||   |++||+||||||+|||++.++ 
T Consensus       112 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~Dlkp~Nil~~~~~~  184 (504)
T 3q5i_A          112 FDVFEDKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYL---HKHNIVHRDIKPENILLENKNS  184 (504)
T ss_dssp             EEEEECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEESSTTC
T ss_pred             EEEEEcCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeEeCCCcHHHEEEecCCC
Confidence            9999999999999999999999999865    35689999999999999999999   677899999999999999776 


Q ss_pred             --CEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHH
Q 011360          350 --EACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPE  427 (487)
Q Consensus       350 --~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~  427 (487)
                        .+||+|||++.........   ....||+.|+|||++.+ .++.++|||||||++|+|++|.+||....      ..+
T Consensus       185 ~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~------~~~  254 (504)
T 3q5i_A          185 LLNIKIVDFGLSSFFSKDYKL---RDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQN------DQD  254 (504)
T ss_dssp             CSSEEECCCTTCEECCTTSCB---CCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHH
T ss_pred             CccEEEEECCCCEEcCCCCcc---ccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCC------HHH
Confidence              6999999999876544322   34569999999999875 68999999999999999999999994432      223


Q ss_pred             HHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          428 WLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ....+...... .      +.......+.++.+++.+||+.||.+|||+.++++
T Consensus       255 ~~~~i~~~~~~-~------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          255 IIKKVEKGKYY-F------DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             HHHHHHHCCCC-C------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHcCCCC-C------CccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            33333332211 1      00011122356899999999999999999999874

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=3.8e-41  Score=323.82  Aligned_cols=248  Identities=25%  Similarity=0.347  Sum_probs=198.2

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CCCCcccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RHRNILPL  270 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l  270 (487)
                      ++|.+.+.||+|+||.||+|.. ..+++.||+|++....             ........+.+|+..+..+ +||||+++
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~~~-------------~~~~~~~~~~~e~~~~~~l~~h~~iv~~   76 (289)
T 1x8b_A           11 TEFHELEKIGSGEFGSVFKCVK-RLDGCIYAIKRSKKPL-------------AGSVDEQNALREVYAHAVLGQHSHVVRY   76 (289)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEE-TTTCCEEEEEEEECCC-------------TTSHHHHHHHHHHHHHHHSCSCTTBCCE
T ss_pred             chhhhhhhhcCCCceEEEEEEE-cCCCceEEEEEecccc-------------cccHHHHHHHHHHHHHHHhCCCCCeeee
Confidence            4699999999999999999975 4578999999985321             1223345677888888888 99999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC--
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDD--  348 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~--  348 (487)
                      ++++.+.+..++||||+++++|.+++.........+++..++.++.|++.||.||   |++||+||||||+||+++.+  
T Consensus        77 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~l---H~~~ivH~Dikp~NIl~~~~~~  153 (289)
T 1x8b_A           77 FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI---HSMSLVHMDIKPSNIFISRTSI  153 (289)
T ss_dssp             EEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEC----
T ss_pred             eeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHH---HhCCEeecCCCHHHEEEcCCCC
Confidence            9999999999999999999999999986544456789999999999999999999   67789999999999999844  


Q ss_pred             -----------------CCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCC-CCCchhHHHHHHHHHHHHHhC
Q 011360          349 -----------------MEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQP-ELSEKCDIFSFGMLLISLVRG  410 (487)
Q Consensus       349 -----------------~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DvwslG~~l~elltg  410 (487)
                                       ..+||+|||.+.......      ...||+.|+|||++.+. .++.++||||||+++|+|++|
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~  227 (289)
T 1x8b_A          154 PNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGA  227 (289)
T ss_dssp             ----------------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTC
T ss_pred             CcccccccccccccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcC
Confidence                             479999999998765432      23489999999999876 667899999999999999999


Q ss_pred             CCCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          411 VPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       411 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .+|+...         ...........+  .+++.+        +..+.+++.+||+.||++|||+.++++
T Consensus       228 ~~~~~~~---------~~~~~~~~~~~~--~~~~~~--------~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          228 EPLPRNG---------DQWHEIRQGRLP--RIPQVL--------SQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             CCCCSSS---------HHHHHHHTTCCC--CCSSCC--------CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCCcch---------hHHHHHHcCCCC--CCCccc--------CHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence            8776221         112222222211  111222        256889999999999999999999875

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=9.6e-41  Score=319.49  Aligned_cols=250  Identities=25%  Similarity=0.360  Sum_probs=194.2

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||.|+||.||+|.. ..+++.||+|++...            ..........+.+|+.+++.++||||++++
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~~------------~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~   77 (276)
T 2h6d_A           11 GHYVLGDTLGVGTFGKVKIGEH-QLTGHKVAVKILNRQ------------KIRSLDVVGKIKREIQNLKLFRHPHIIKLY   77 (276)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEE-TTTCCEEEEEEEEHH------------HHHHTTCHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             ccEEEEeeecCCCCeEEEEEEE-CCCCceEEEEEeccc------------cccchhHHHHHHHHHHHHhcCCCCCEeEEE
Confidence            4699999999999999999975 457899999988420            111122345788999999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++...+..++||||+++++|.+++..    ...+++..+..++.|++.||.||   |++|++||||||+||+++.++.+
T Consensus        78 ~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~  150 (276)
T 2h6d_A           78 QVISTPTDFFMVMEYVSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYC---HRHMVVHRDLKPENVLLDAHMNA  150 (276)
T ss_dssp             EEEECSSEEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHH---HHHCSSCCCCCGGGEEECTTSCE
T ss_pred             EEEecCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHH---HHCCCccCCCChhhEEECCCCCE
Confidence            999999999999999999999999975    34689999999999999999999   66789999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCCCC-CchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPEL-SEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLR  430 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~  430 (487)
                      ||+|||++........   .....||+.|+|||.+.+..+ +.++||||||+++|+|++|..||...      .......
T Consensus       151 ~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~------~~~~~~~  221 (276)
T 2h6d_A          151 KIADFGLSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE------HVPTLFK  221 (276)
T ss_dssp             EECCCCGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHH
T ss_pred             EEeecccccccCCCcc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCC------cHHHHHH
Confidence            9999999987654322   134568999999999987765 68999999999999999999999432      1222233


Q ss_pred             HHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          431 KVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       431 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .... ...  .++..+        ...+.+++.+||+.||++|||+.++++
T Consensus       222 ~~~~-~~~--~~~~~~--------~~~l~~li~~~l~~~p~~Rps~~~~l~  261 (276)
T 2h6d_A          222 KIRG-GVF--YIPEYL--------NRSVATLLMHMLQVDPLKRATIKDIRE  261 (276)
T ss_dssp             HHHH-CCC--CCCTTS--------CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             Hhhc-Ccc--cCchhc--------CHHHHHHHHHHccCChhhCCCHHHHHh
Confidence            2222 211  111111        245889999999999999999999986

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1e-41  Score=345.92  Aligned_cols=260  Identities=23%  Similarity=0.316  Sum_probs=190.9

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .+.|.+.+.||+|+||.||+|.. ..+++.||+|++.......       ...........+.+|+.++++++||||+++
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~-~~~~~~vavK~~~~~~~~~-------~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  205 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFE-RKTCKKVAIRIISKRKFAI-------GSAREADPALNVETEIEILKKLNHPCIIKI  205 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEE-TTTCCEEEEEEEEGGGGTT-------C--------CCHHHHHHHHHHCCCTTBCCC
T ss_pred             hccEEEEeEEeeCCCeEEEEEEE-CCCCcEEEEEEEEechhcc-------cccccchhHHHHHHHHHHHHhCCCCCEeeE
Confidence            46799999999999999999974 5688999999984311000       001112223457889999999999999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC-
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDM-  349 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~-  349 (487)
                      ++++.. +..|+||||+++|+|.+++..    ...+++..+..++.|++.||.||   |++||+||||||+|||++.++ 
T Consensus       206 ~~~~~~-~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~L---H~~~ivHrDlkp~NIll~~~~~  277 (419)
T 3i6u_A          206 KNFFDA-EDYYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYL---HENGIIHRDLKPENVLLSSQEE  277 (419)
T ss_dssp             CEEEES-SEEEEEEECCTTCBGGGGTSS----SCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEESSSSS
T ss_pred             EEEEec-CceEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHH---HHCCccccCCChHhEEEecCCC
Confidence            998754 567999999999999888753    56799999999999999999999   667899999999999997544 


Q ss_pred             --CEEEeccCCccccCCCCceeeEeeecccccccCCcccCC---CCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccc
Q 011360          350 --EACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQ---PELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEIC  424 (487)
Q Consensus       350 --~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~  424 (487)
                        .+||+|||+++.......   .....||+.|+|||++.+   ..++.++|||||||++|+|++|..||........  
T Consensus       278 ~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--  352 (419)
T 3i6u_A          278 DCLIKITDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--  352 (419)
T ss_dssp             SCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--
T ss_pred             cceEEEeecccceecCCCcc---ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--
Confidence              599999999987654321   235679999999999863   5788999999999999999999999965433211  


Q ss_pred             cHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          425 SPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       425 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                          ............      ........+..+.+++.+||+.||++|||+.++++
T Consensus       353 ----~~~~i~~~~~~~------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          353 ----LKDQITSGKYNF------IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             ----HHHHHHTTCCCC------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ----HHHHHhcCCCCC------CchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence                111222221110      00001122356899999999999999999999886

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=8.3e-41  Score=357.65  Aligned_cols=252  Identities=22%  Similarity=0.272  Sum_probs=204.6

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CCCCccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RHRNILP  269 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~  269 (487)
                      .++|.+.+.||+|+||.||+|+. ..+++.||||++..            ...........+..|..++..+ +||||++
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~-~~~~~~vAvK~l~~------------~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~  406 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSER-KGTDELYAVKILKK------------DVVIQDDDVECTMVEKRVLALPGKPPFLTQ  406 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEE-SSSCCEEEEEEEEH------------HHHHHTTTTHHHHHHHHHHTCTTCCTTBCC
T ss_pred             ccceEEEEEEccCCCEEEEEEEE-CCCCcEEEEEEEec------------cccccHHHHHHHHHHHHHHHhccCCCeEEE
Confidence            45699999999999999999975 45789999999842            1111223445677889999887 8999999


Q ss_pred             cceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC
Q 011360          270 LLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDM  349 (487)
Q Consensus       270 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~  349 (487)
                      +++++.+.+.+|+||||++||+|.+++..    ...+++..++.++.||+.||.||   |++||+||||||+|||++.+|
T Consensus       407 l~~~~~~~~~~~lV~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~L---H~~gIiHrDLKp~NILl~~~g  479 (674)
T 3pfq_A          407 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFL---QSKGIIYRDLKLDNVMLDSEG  479 (674)
T ss_dssp             EEEECBCSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH---HHTSEECCCCCSTTEEECSSS
T ss_pred             EEEEEEeCCEEEEEEeCcCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HhCCeEeccCChhhEEEcCCC
Confidence            99999999999999999999999999976    35699999999999999999999   677899999999999999999


Q ss_pred             CEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHH
Q 011360          350 EACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWL  429 (487)
Q Consensus       350 ~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~  429 (487)
                      .+||+|||+++........  ....+||+.|+|||++.+..|+.++||||||+++|||++|.+||...      ...+..
T Consensus       480 ~ikL~DFGla~~~~~~~~~--~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~------~~~~~~  551 (674)
T 3pfq_A          480 HIKIADFGMCKENIWDGVT--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE------DEDELF  551 (674)
T ss_dssp             CEEECCCTTCEECCCTTCC--BCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHH
T ss_pred             cEEEeecceeeccccCCcc--cccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCC------CHHHHH
Confidence            9999999999864332221  24567999999999999999999999999999999999999999432      223334


Q ss_pred             HHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCCh-----HHHHH
Q 011360          430 RKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNS-----QYVRC  481 (487)
Q Consensus       430 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~-----~~il~  481 (487)
                      ..+.... +  .    +|.    ..+.++.+++.+||+.||++||++     ++|++
T Consensus       552 ~~i~~~~-~--~----~p~----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          552 QSIMEHN-V--A----YPK----SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             HHHHSSC-C--C----CCT----TSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             HHHHhCC-C--C----CCc----cCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence            4444322 1  1    121    123568899999999999999998     66653

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.8e-41  Score=333.30  Aligned_cols=265  Identities=25%  Similarity=0.345  Sum_probs=196.8

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .++|.+.+.||+|+||.||+|.. ..+|+.||+|++.....          ........+.+.+|+.++..++||||+++
T Consensus         9 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~~vavK~~~~~~~----------~~~~~~~~~~~~~E~~~l~~l~h~~iv~~   77 (346)
T 1ua2_A            9 AKRYEKLDFLGEGQFATVYKARD-KNTNQIVAIKKIKLGHR----------SEAKDGINRTALREIKLLQELSHPNIIGL   77 (346)
T ss_dssp             ----CEEEEEEEETTEEEEEEEC-SSCCSEEEEEEC----------------------CTHHHHHHHHHHHCCCTTBCCE
T ss_pred             hcccEEEeEEeecCCEEEEEEEE-CCCCcEEEEEEEecCCc----------chhhhhhhHHHHHHHHHHhhCCCCCCCeE
Confidence            35699999999999999999975 45789999998843110          01111123467789999999999999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      ++++...+..++||||+++ +|.+++..   ....+++..+..++.|++.||.||   |++||+||||||+||+++.++.
T Consensus        78 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dlkp~Nil~~~~~~  150 (346)
T 1ua2_A           78 LDAFGHKSNISLVFDFMET-DLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYL---HQHWILHRDLKPNNLLLDENGV  150 (346)
T ss_dssp             EEEECCTTCCEEEEECCSE-EHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTCC
T ss_pred             EEEEeeCCceEEEEEcCCC-CHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHH---HHCCEECCCCCHHHEEEcCCCC
Confidence            9999999999999999975 88888763   345688999999999999999999   6778999999999999999999


Q ss_pred             EEEeccCCccccCCCCceeeEeeecccccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHH
Q 011360          351 ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQP-ELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWL  429 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~  429 (487)
                      +||+|||++.........  .....||+.|+|||++.+. .++.++|||||||++|+|++|.+||.....      .+..
T Consensus       151 ~kl~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~------~~~~  222 (346)
T 1ua2_A          151 LKLADFGLAKSFGSPNRA--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD------LDQL  222 (346)
T ss_dssp             EEECCCGGGSTTTSCCCC--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHH
T ss_pred             EEEEecccceeccCCccc--CCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH------HHHH
Confidence            999999999876443221  1345689999999998754 589999999999999999999999954321      2222


Q ss_pred             HHHHhc-CCC-CCccCC-----------CCCCCC----cHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          430 RKVMNS-KNP-SRAIDP-----------RLPGNG----YEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       430 ~~~~~~-~~~-~~~~~~-----------~~~~~~----~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ..+... ..+ ......           ..+...    ....+.++.+++.+||+.||++|||+.++++
T Consensus       223 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  291 (346)
T 1ua2_A          223 TRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  291 (346)
T ss_dssp             HHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             HHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence            222221 111 111000           001000    0223467899999999999999999999985

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.7e-41  Score=360.57  Aligned_cols=252  Identities=23%  Similarity=0.294  Sum_probs=197.5

Q ss_pred             cccccccceeEEEEEec-CCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceEEec
Q 011360          198 EKIGSGGCGEVYKAELP-GSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVR  276 (487)
Q Consensus       198 ~~lg~G~~g~v~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  276 (487)
                      +.||.|+||.||+|.+. ..+++.||||++..             ........+.+.+|+.++.+++|||||++++++..
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~-------------~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  441 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKN-------------EANDPALKDELLAEANVMQQLDNPYIVRMIGICEA  441 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECG-------------GGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEecc-------------ccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            47999999999999653 34568899998842             11222345678999999999999999999998864


Q ss_pred             CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEecc
Q 011360          277 PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDL  356 (487)
Q Consensus       277 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~DF  356 (487)
                       +..++|||||++|+|.+++..    ...+++..+..++.||+.||.||   |++||+||||||+|||++.++.+||+||
T Consensus       442 -~~~~lv~E~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yL---H~~~iiHrDLkp~NILl~~~~~~kL~DF  513 (635)
T 4fl3_A          442 -ESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDF  513 (635)
T ss_dssp             -SSEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEEEETTEEEECCT
T ss_pred             -CCEEEEEEccCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHH---HHCCEeCCCCChHhEEEeCCCCEEEEEc
Confidence             568899999999999999975    46789999999999999999999   6778999999999999999999999999


Q ss_pred             CCccccCCCCce-eeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccccHHHHHHHHh
Q 011360          357 GLAMAIPDGYTR-VLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSPEWLRKVMN  434 (487)
Q Consensus       357 g~s~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~  434 (487)
                      |+++........ .......+|+.|+|||++.+..++.++|||||||++|||++ |..||....      ..+....+..
T Consensus       514 Gla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~------~~~~~~~i~~  587 (635)
T 4fl3_A          514 GLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK------GSEVTAMLEK  587 (635)
T ss_dssp             THHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC------HHHHHHHHHT
T ss_pred             CCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHHHc
Confidence            999876543321 11223456889999999999899999999999999999998 999994432      2223333322


Q ss_pred             cCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          435 SKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       435 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      ...+  ..+..+        +.++.+++..||+.||++|||+.+|++.|+++
T Consensus       588 ~~~~--~~p~~~--------~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  629 (635)
T 4fl3_A          588 GERM--GCPAGC--------PREMYDLMNLCWTYDVENRPGFAAVELRLRNY  629 (635)
T ss_dssp             TCCC--CCCTTC--------CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             CCCC--CCCCCC--------CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            2211  111222        25689999999999999999999999999876

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.2e-41  Score=333.21  Aligned_cols=256  Identities=23%  Similarity=0.262  Sum_probs=185.0

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCC-CCCccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIR-HRNILP  269 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~  269 (487)
                      ..+|.+.+.||.|+||.||+|.+ ..+++.||+|++...               .......+.+|+.++.++. ||||++
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~---------------~~~~~~~~~~e~~~l~~l~~h~~iv~   90 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQD-VGSGREYALKRLLSN---------------EEEKNRAIIQEVCFMKKLSGHPNIVQ   90 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEE-TTTCCEEEEEEEEES---------------SHHHHHHHHHHHHHHHHHTTSTTBCC
T ss_pred             CceEEEEEEEccCCceEEEEEEE-CCCCcEEEEEEecCC---------------chHHHHHHHHHHHHHHHhccCCChhh
Confidence            34799999999999999999975 457899999987431               2234456788999999995 999999


Q ss_pred             cceEEe--------cCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCC--eeecCCC
Q 011360          270 LLAHMV--------RPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSAS--IIHGDIK  339 (487)
Q Consensus       270 l~~~~~--------~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~g--ivH~Dlk  339 (487)
                      +++++.        ....++++|||+. |+|.+++..... ...+++..++.++.|++.||.||   |+.|  |+|||||
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~L---H~~~~~ivH~Dik  165 (337)
T 3ll6_A           91 FCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHM---HRQKPPIIHRDLK  165 (337)
T ss_dssp             EEEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHH---HTSSSCCBCCCCC
T ss_pred             ccccccccccccccCCceEEEEEEecC-CCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHH---HhCCCCEEEccCC
Confidence            999984        3445799999995 799999875433 45699999999999999999999   6777  9999999


Q ss_pred             CCCEEeCCCCCEEEeccCCccccCCCCcee----------eEeeecccccccCCccc---CCCCCCchhHHHHHHHHHHH
Q 011360          340 PRNVLLNDDMEACISDLGLAMAIPDGYTRV----------LISYVLGTMAYIAPEYF---QQPELSEKCDIFSFGMLLIS  406 (487)
Q Consensus       340 p~Nill~~~~~~kl~DFg~s~~~~~~~~~~----------~~~~~~gt~~y~aPE~l---~~~~~~~~~DvwslG~~l~e  406 (487)
                      |+|||++.++.+||+|||++..........          ......||+.|+|||++   .+..++.++||||||+++|+
T Consensus       166 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~e  245 (337)
T 3ll6_A          166 VENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYL  245 (337)
T ss_dssp             GGGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHH
T ss_pred             cccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHH
Confidence            999999999999999999998765432211          11134589999999998   56678999999999999999


Q ss_pred             HHhCCCCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          407 LVRGVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       407 lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      |+||..||.......          ..... .........+        ..+.+++.+||+.||++|||+.++++.|+.+
T Consensus       246 l~~g~~p~~~~~~~~----------~~~~~-~~~~~~~~~~--------~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~  306 (337)
T 3ll6_A          246 LCFRQHPFEDGAKLR----------IVNGK-YSIPPHDTQY--------TVFHSLIRAMLQVNPEERLSIAEVVHQLQEI  306 (337)
T ss_dssp             HHHSSCCC-----------------------CCCCTTCCSS--------GGGHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHhCCCCCcchhHHH----------hhcCc-ccCCcccccc--------hHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            999999994332211          11111 1101111111        2378999999999999999999999999865

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=9.4e-41  Score=333.63  Aligned_cols=257  Identities=25%  Similarity=0.327  Sum_probs=190.7

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||.|+||.||+|.. ..+++.||||++...             .........+.+|+.+++.++||||++++
T Consensus        25 ~~y~~~~~lG~G~~g~V~~~~~-~~~~~~vavK~~~~~-------------~~~~~~~~~~~~E~~~l~~l~hpniv~~~   90 (371)
T 2xrw_A           25 KRYQNLKPIGSGAQGIVCAAYD-AILERNVAIKKLSRP-------------FQNQTHAKRAYRELVLMKCVNHKNIIGLL   90 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEE-TTTTEEEEEEEEECT-------------TSSHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             hheeEeeeeEecCCEEEEEEEE-CCCCceEEEEEeccc-------------cCChHHHHHHHHHHHHHHhcCCCCccceE
Confidence            4699999999999999999964 568899999998431             12233456778999999999999999999


Q ss_pred             eEEecCC------eeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEe
Q 011360          272 AHMVRPD------CHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLL  345 (487)
Q Consensus       272 ~~~~~~~------~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill  345 (487)
                      +++...+      ..|+||||+++ +|.+++.      ..+++..+..++.|++.||.||   |++||+||||||+|||+
T Consensus        91 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~i~~qi~~al~~l---H~~~ivH~Dlkp~NIl~  160 (371)
T 2xrw_A           91 NVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHL---HSAGIIHRDLKPSNIVV  160 (371)
T ss_dssp             EEECSCCSTTTCCEEEEEEECCSE-EHHHHHH------SCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEE
T ss_pred             EeeccccccccccceEEEEEcCCC-CHHHHHh------hccCHHHHHHHHHHHHHHHHHH---HHCCeecccCCHHHEEE
Confidence            9997665      67999999964 7888774      3488999999999999999999   67789999999999999


Q ss_pred             CCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCcccc
Q 011360          346 NDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICS  425 (487)
Q Consensus       346 ~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~  425 (487)
                      +.++.+||+|||+++.......   .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.      
T Consensus       161 ~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------  231 (371)
T 2xrw_A          161 KSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH------  231 (371)
T ss_dssp             CTTSCEEECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH------
T ss_pred             cCCCCEEEEEeecccccccccc---cCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH------
Confidence            9999999999999986543321   2345689999999999999999999999999999999999999954321      


Q ss_pred             HHHHHHHHhc---------------------CCCCC---cc-----CCCCCCC--CcHHHHHHHHHHHhhccCCCCCCCC
Q 011360          426 PEWLRKVMNS---------------------KNPSR---AI-----DPRLPGN--GYEKKMLHVLKIAYICTLHDPEERP  474 (487)
Q Consensus       426 ~~~~~~~~~~---------------------~~~~~---~~-----~~~~~~~--~~~~~~~~l~~li~~cl~~~P~~RP  474 (487)
                      .+....+...                     ..+..   .+     +...+..  ........+.+++.+||..||++||
T Consensus       232 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~  311 (371)
T 2xrw_A          232 IDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRI  311 (371)
T ss_dssp             HHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSC
T ss_pred             HHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCC
Confidence            1111111110                     00000   00     0000111  1123366799999999999999999


Q ss_pred             ChHHHHH
Q 011360          475 NSQYVRC  481 (487)
Q Consensus       475 s~~~il~  481 (487)
                      |+.++++
T Consensus       312 t~~e~l~  318 (371)
T 2xrw_A          312 SVDEALQ  318 (371)
T ss_dssp             CHHHHHH
T ss_pred             CHHHHhC
Confidence            9999986

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=5.3e-41  Score=334.58  Aligned_cols=260  Identities=24%  Similarity=0.407  Sum_probs=203.7

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CCCCccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RHRNILP  269 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~  269 (487)
                      .++|.+.+.||.|+||.||+|.. ..+|+.||||++........       ........+.+.+|+.++..+ +||||++
T Consensus        93 ~~~y~~~~~lg~G~~g~Vy~a~~-~~~g~~vavK~~~~~~~~~~-------~~~~~~~~~~~~~E~~~l~~l~~hp~iv~  164 (365)
T 2y7j_A           93 YQKYDPKDVIGRGVSSVVRRCVH-RATGHEFAVKIMEVTAERLS-------PEQLEEVREATRRETHILRQVAGHPHIIT  164 (365)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEE-TTTCCEEEEEEEETTSSCCC-------HHHHHHHHHHHHHHHHHHHHHTTCTTBCC
T ss_pred             hhhcccceEEecCCCEEEEEEEE-CCCCcEEEEEEEEccccccC-------HHHHHHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            45699999999999999999975 45789999998854221100       011123456778899999999 8999999


Q ss_pred             cceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC
Q 011360          270 LLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDM  349 (487)
Q Consensus       270 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~  349 (487)
                      +++++......|+||||++|++|.+++..    ...+++..+..++.|++.||.||   |+.||+||||||+||+++.++
T Consensus       165 ~~~~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~L---H~~gi~H~Dlkp~NIl~~~~~  237 (365)
T 2y7j_A          165 LIDSYESSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFL---HANNIVHRDLKPENILLDDNM  237 (365)
T ss_dssp             EEEEEEBSSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTC
T ss_pred             EEEEEeeCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEECCCC
Confidence            99999999999999999999999999975    35689999999999999999999   667899999999999999999


Q ss_pred             CEEEeccCCccccCCCCceeeEeeecccccccCCcccC------CCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCcc
Q 011360          350 EACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQ------QPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI  423 (487)
Q Consensus       350 ~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~------~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~  423 (487)
                      .+||+|||++.........   ....||+.|+|||++.      ...++.++|||||||++|+|++|..||....     
T Consensus       238 ~ikl~DfG~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~-----  309 (365)
T 2y7j_A          238 QIRLSDFGFSCHLEPGEKL---RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR-----  309 (365)
T ss_dssp             CEEECCCTTCEECCTTCCB---CCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS-----
T ss_pred             CEEEEecCcccccCCCccc---ccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC-----
Confidence            9999999999876544322   3467999999999885      3368899999999999999999999994321     


Q ss_pred             ccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          424 CSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       424 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                       .......+... ...... +     .....+..+.+++.+||+.||++|||+.++++
T Consensus       310 -~~~~~~~i~~~-~~~~~~-~-----~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          310 -QILMLRMIMEG-QYQFSS-P-----EWDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             -HHHHHHHHHHT-CCCCCH-H-----HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             -HHHHHHHHHhC-CCCCCC-c-----ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence             12222222222 111100 0     00112356889999999999999999999986

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.4e-41  Score=333.73  Aligned_cols=255  Identities=19%  Similarity=0.272  Sum_probs=197.9

Q ss_pred             cccccc-cccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CCCCccc
Q 011360          192 DCFASL-EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RHRNILP  269 (487)
Q Consensus       192 ~~~~~~-~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~  269 (487)
                      +.|.+. +.||.|+||.||+|.. ..+++.||+|++....             ........+.+|+.++..+ .||||++
T Consensus        28 ~~y~~~~~~lG~G~~g~V~~~~~-~~~~~~vavK~~~~~~-------------~~~~~~~~~~~e~~~l~~l~~~~~iv~   93 (327)
T 3lm5_A           28 NFYILTSKELGRGKFAVVRQCIS-KSTGQEYAAKFLKKRR-------------RGQDCRAEILHEIAVLELAKSCPRVIN   93 (327)
T ss_dssp             HHEEEEEEEEEEETTEEEEEEEE-TTTCCEEEEEEEESEE-------------TTEECHHHHHHHHHHHHHTTTCTTBCC
T ss_pred             hEEeeccceeCCCCCeEEEEEEE-CCCCCEEEEEEEehhh-------------cchHHHHHHHHHHHHHHhccCCCCEEE
Confidence            457777 8899999999999975 4678999999885321             1112245678899999988 5699999


Q ss_pred             cceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC--
Q 011360          270 LLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLND--  347 (487)
Q Consensus       270 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~--  347 (487)
                      +++++...+..++||||+++|+|.+++..  .....+++..++.++.|++.||.||   |++||+||||||+||+++.  
T Consensus        94 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~ql~~~L~~L---H~~givH~Dikp~NIl~~~~~  168 (327)
T 3lm5_A           94 LHEVYENTSEIILILEYAAGGEIFSLCLP--ELAEMVSENDVIRLIKQILEGVYYL---HQNNIVHLDLKPQNILLSSIY  168 (327)
T ss_dssp             EEEEEECSSEEEEEEECCTTEEGGGGGSS--CC-CCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEESCBT
T ss_pred             EEEEEEeCCeEEEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHH---HHCCeecCcCChHHEEEecCC
Confidence            99999999999999999999999998853  3346789999999999999999999   6778999999999999997  


Q ss_pred             -CCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccH
Q 011360          348 -DMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSP  426 (487)
Q Consensus       348 -~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~  426 (487)
                       ++.+||+|||++........   .....||+.|+|||++.+..++.++||||||+++|+|++|..||.....      .
T Consensus       169 ~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~  239 (327)
T 3lm5_A          169 PLGDIKIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN------Q  239 (327)
T ss_dssp             TBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------H
T ss_pred             CCCcEEEeeCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc------h
Confidence             78999999999987644322   1345699999999999999999999999999999999999999944321      2


Q ss_pred             HHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          427 EWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       427 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      +...........       .+.......+..+.+++.+||+.||++|||+.++++
T Consensus       240 ~~~~~i~~~~~~-------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          240 ETYLNISQVNVD-------YSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             HHHHHHHHTCCC-------CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHhcccc-------cCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence            222222221111       111111223356889999999999999999999875

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.2e-40  Score=322.50  Aligned_cols=261  Identities=23%  Similarity=0.352  Sum_probs=205.5

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCC-CCCccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIR-HRNILP  269 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~  269 (487)
                      .++|.+.+.||.|+||.||+|.. ..+++.||||++.........      ........+.+.+|+.++.++. ||||++
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~~~~~~~------~~~~~~~~~~~~~e~~~l~~l~~h~~i~~   88 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIH-KPTCKEYAVKIIDVTGGGSFS------AEEVQELREATLKEVDILRKVSGHPNIIQ   88 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEE-TTTTEEEEEEEEETTCSTTCC------HHHHHHHHHHHHHHHHHHHHHTTCTTBCC
T ss_pred             hhccceeeeecCCCceEEEEEEE-cCcCceEEEEEEecccccccC------HHHHHHHHHHHHHHHHHHHHhcCCCCEee
Confidence            35699999999999999999975 468899999998543211100      0111234567789999999995 999999


Q ss_pred             cceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC
Q 011360          270 LLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDM  349 (487)
Q Consensus       270 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~  349 (487)
                      +++++...+..++||||+++++|.+++..    ...+++..+..++.|++.||.||   |++|++||||+|+||+++.++
T Consensus        89 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~Nil~~~~~  161 (298)
T 1phk_A           89 LKDTYETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICAL---HKLNIVHRDLKPENILLDDDM  161 (298)
T ss_dssp             EEEEEECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTC
T ss_pred             eeeeeccCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCcceEEEcCCC
Confidence            99999999999999999999999999975    35689999999999999999999   677899999999999999999


Q ss_pred             CEEEeccCCccccCCCCceeeEeeecccccccCCcccC------CCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCcc
Q 011360          350 EACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQ------QPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI  423 (487)
Q Consensus       350 ~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~------~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~  423 (487)
                      .+||+|||++.........   ....||+.|+|||++.      ...++.++||||||+++|+|++|..||....     
T Consensus       162 ~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-----  233 (298)
T 1phk_A          162 NIKLTDFGFSCQLDPGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK-----  233 (298)
T ss_dssp             CEEECCCTTCEECCTTCCB---CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----
T ss_pred             cEEEecccchhhcCCCccc---ccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc-----
Confidence            9999999999876543321   3456899999999884      4578899999999999999999999994322     


Q ss_pred             ccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          424 CSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       424 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                       ............ ..      .+.......+..+.+++.+||+.||++|||+.++++
T Consensus       234 -~~~~~~~~~~~~-~~------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          234 -QMLMLRMIMSGN-YQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             -HHHHHHHHHHTC-CC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             -HHHHHHHHhcCC-cc------cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence             222233332222 11      111112233467899999999999999999999875

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=9.6e-42  Score=338.42  Aligned_cols=264  Identities=17%  Similarity=0.185  Sum_probs=200.4

Q ss_pred             ccccccccccccccceeEEEEEecCC-------CCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCC
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGS-------NGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIR  263 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  263 (487)
                      .++|.+.+.||.|+||.||+|+....       +++.||+|.+...                    ..+.+|+.++.+++
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------------------~~~~~E~~~l~~l~  100 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------------------GRLFNEQNFFQRAA  100 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------------------STHHHHHHHHHHHC
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------------------chHHHHHHHHHHhc
Confidence            35799999999999999999986532       4789999987321                    35677888888889


Q ss_pred             CCCccc---------------cceEEec-CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHh
Q 011360          264 HRNILP---------------LLAHMVR-PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHM  327 (487)
Q Consensus       264 hpnIv~---------------l~~~~~~-~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~  327 (487)
                      ||||++               +++++.. ....|+||||+ +++|.+++...  ....+++..++.++.|++.||.||  
T Consensus       101 h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~L--  175 (352)
T 2jii_A          101 KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFL--  175 (352)
T ss_dssp             CHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHH--
T ss_pred             ccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHH--
Confidence            988887               5666665 67889999999 99999999752  236799999999999999999999  


Q ss_pred             cCCCCeeecCCCCCCEEeCCCC--CEEEeccCCccccCCCCcee-----eEeeecccccccCCcccCCCCCCchhHHHHH
Q 011360          328 YHSASIIHGDIKPRNVLLNDDM--EACISDLGLAMAIPDGYTRV-----LISYVLGTMAYIAPEYFQQPELSEKCDIFSF  400 (487)
Q Consensus       328 ~h~~givH~Dlkp~Nill~~~~--~~kl~DFg~s~~~~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~~~Dvwsl  400 (487)
                       |++||+||||||+||+++.++  .+||+|||+++.........     ......||+.|+|||++.+..++.++|||||
T Consensus       176 -H~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl  254 (352)
T 2jii_A          176 -HENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSL  254 (352)
T ss_dssp             -HHTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHH
T ss_pred             -HhCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHH
Confidence             677899999999999999998  89999999997664322111     1123468999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHH
Q 011360          401 GMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVR  480 (487)
Q Consensus       401 G~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il  480 (487)
                      |+++|+|++|..||......... ........ . ..+....+...   .....+..+.+++.+||+.||++|||+.+|+
T Consensus       255 G~il~el~~g~~pf~~~~~~~~~-~~~~~~~~-~-~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~  328 (352)
T 2jii_A          255 GYCMLKWLYGFLPWTNCLPNTED-IMKQKQKF-V-DKPGPFVGPCG---HWIRPSETLQKYLKVVMALTYEEKPPYAMLR  328 (352)
T ss_dssp             HHHHHHHHHSCCTTGGGTTCHHH-HHHHHHHH-H-HSCCCEECTTS---CEECCCHHHHHHHHHHHTCCTTCCCCHHHHH
T ss_pred             HHHHHHHHhCCCCcccCCcCHHH-HHHHHHhc-c-CChhhhhhhcc---ccCCCcHHHHHHHHHHHhCChhhCCCHHHHH
Confidence            99999999999999655422111 11111111 1 11111111110   0111235689999999999999999999999


Q ss_pred             HHHhhh
Q 011360          481 CRLSQL  486 (487)
Q Consensus       481 ~~L~~l  486 (487)
                      +.|+++
T Consensus       329 ~~L~~~  334 (352)
T 2jii_A          329 NNLEAL  334 (352)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999876

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.9e-41  Score=340.23  Aligned_cols=258  Identities=21%  Similarity=0.274  Sum_probs=196.3

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .++|.+.+.||.|+||.||+|.. ..+|+.||||++....                   ....+|+.+++.++||||+++
T Consensus         6 ~~~y~~~~~lG~G~fg~V~~a~~-~~~~~~vAiK~~~~~~-------------------~~~~~E~~il~~l~hpnIv~l   65 (383)
T 3eb0_A            6 SKKYSLGKTLGTGSFGIVCEVFD-IESGKRFALKKVLQDP-------------------RYKNRELDIMKVLDHVNIIKL   65 (383)
T ss_dssp             CTTEEEEEEEECC-CEEEEEEEE-TTTCCEEEEEEEECCT-------------------TSCCHHHHHHTTCCCTTBCCE
T ss_pred             cceEEEEEEEEeccCEEEEEEEE-CCCCCEEEEEEEecCc-------------------chHHHHHHHHHHcCCCCccch
Confidence            45799999999999999999974 4689999999884311                   112368999999999999999


Q ss_pred             ceEEecC--------------------------------------CeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHH
Q 011360          271 LAHMVRP--------------------------------------DCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRH  312 (487)
Q Consensus       271 ~~~~~~~--------------------------------------~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~  312 (487)
                      ++++...                                      ...++||||++ |+|.+.+......+..+++..+.
T Consensus        66 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~  144 (383)
T 3eb0_A           66 VDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLIS  144 (383)
T ss_dssp             EEEEEEC-------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHH
T ss_pred             hheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHH
Confidence            9998543                                      34789999997 58988887766667889999999


Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC-CCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCC-C
Q 011360          313 RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN-DDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQP-E  390 (487)
Q Consensus       313 ~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~-~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~  390 (487)
                      .++.|++.||.||   |++||+||||||+||+++ .++.+||+|||++.........   ....||+.|+|||++.+. .
T Consensus       145 ~i~~qi~~aL~~L---H~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~  218 (383)
T 3eb0_A          145 IYIYQLFRAVGFI---HSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS---VAYICSRFYRAPELMLGATE  218 (383)
T ss_dssp             HHHHHHHHHHHHH---HTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC---CCCCCCSSCCCHHHHTTCSS
T ss_pred             HHHHHHHHHHHHH---HHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC---cCcccCCCccCHHHhcCCCC
Confidence            9999999999999   788999999999999997 6889999999999876544322   345689999999998765 5


Q ss_pred             CCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHHHh-------------cCCCCCccCCCCCCC-----CcH
Q 011360          391 LSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMN-------------SKNPSRAIDPRLPGN-----GYE  452 (487)
Q Consensus       391 ~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~-----~~~  452 (487)
                      ++.++|||||||++|+|++|.+||.+...      .+.+..+..             ........-+.+...     ...
T Consensus       219 ~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (383)
T 3eb0_A          219 YTPSIDLWSIGCVFGELILGKPLFSGETS------IDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPE  292 (383)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCT
T ss_pred             CCcchhhhhHHHHHHHHHhCCCCCCCCCh------HHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCC
Confidence            89999999999999999999999954321      111111111             000000000011111     011


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          453 KKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       453 ~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ..+.++.+++.+||+.||++|||+.++++
T Consensus       293 ~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (383)
T 3eb0_A          293 GTPSLAIDLLEQILRYEPDLRINPYEAMA  321 (383)
T ss_dssp             TCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            13356899999999999999999999974

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.9e-41  Score=328.97  Aligned_cols=252  Identities=25%  Similarity=0.389  Sum_probs=193.0

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CCCCccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RHRNILP  269 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~  269 (487)
                      .+.|.+.+.||.|+||.||+|++ ..+++.||+|++....                .....+.+|+.++.++ +||||++
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~~vaiK~~~~~~----------------~~~~~~~~e~~~l~~l~~h~~i~~   85 (326)
T 2x7f_A           23 AGIFELVELVGNGTYGQVYKGRH-VKTGQLAAIKVMDVTG----------------DEEEEIKQEINMLKKYSHHRNIAT   85 (326)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEE-TTTCCEEEEEEEECCS----------------STTHHHHHHHHHHHHHCCSTTBCC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEE-CCCCCeEEEEEEecCc----------------ccHHHHHHHHHHHHhccCCCCeee
Confidence            45799999999999999999975 4578999999884311                1224567889999888 8999999


Q ss_pred             cceEEec------CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCE
Q 011360          270 LLAHMVR------PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNV  343 (487)
Q Consensus       270 l~~~~~~------~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Ni  343 (487)
                      +++++..      .+..++||||+++|+|.+++...  ....+++..++.++.|++.||.||   |++||+||||||+||
T Consensus        86 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~l---H~~~ivH~dlkp~NI  160 (326)
T 2x7f_A           86 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHL---HQHKVIHRDIKGQNV  160 (326)
T ss_dssp             EEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCSGGGE
T ss_pred             eeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHH---HHCCccccCCcHHHE
Confidence            9999986      46789999999999999999752  245789999999999999999999   667899999999999


Q ss_pred             EeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccC-----CCCCCchhHHHHHHHHHHHHHhCCCCccccC
Q 011360          344 LLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQ-----QPELSEKCDIFSFGMLLISLVRGVPSFVFHQ  418 (487)
Q Consensus       344 ll~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DvwslG~~l~elltg~~pf~~~~  418 (487)
                      +++.++.+||+|||++.........  .....||+.|+|||++.     +..++.++||||||+++|+|++|..||....
T Consensus       161 l~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  238 (326)
T 2x7f_A          161 LLTENAEVKLVDFGVSAQLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH  238 (326)
T ss_dssp             EECTTCCEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             EEcCCCCEEEeeCcCceecCcCccc--cccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc
Confidence            9999999999999998765433211  13456899999999987     5678999999999999999999999994322


Q ss_pred             CCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          419 NGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       419 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                            ............. .......+        +..+.+++.+||..||++|||+.++++
T Consensus       239 ------~~~~~~~~~~~~~-~~~~~~~~--------~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          239 ------PMRALFLIPRNPA-PRLKSKKW--------SKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             ------HHHHHHHHHHSCC-CCCSCSCS--------CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ------HHHHHHHhhcCcc-ccCCcccc--------CHHHHHHHHHHhccChhhCCCHHHHhh
Confidence                  1122222222222 11112222        256889999999999999999999986

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.3e-40  Score=321.72  Aligned_cols=253  Identities=25%  Similarity=0.334  Sum_probs=195.2

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      .+.....||.|+||.||+|.. ..++..||+|.+...               .......+.+|+.+++.++||||+++++
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~~vaiK~~~~~---------------~~~~~~~~~~e~~~l~~l~h~~iv~~~~   86 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRD-LSNQVRIAIKEIPER---------------DSRYSQPLHEEIALHKHLKHKNIVQYLG   86 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEE-TTTCCEEEEEEEECC---------------CC---HHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             CCCCcEEEeecCcEEEEEEEE-CCCCeEEEEEEccCC---------------chHHHHHHHHHHHHHHhCCCCCEeeEee
Confidence            355556899999999999975 467899999988431               1223456788999999999999999999


Q ss_pred             EEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC-CCCE
Q 011360          273 HMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLND-DMEA  351 (487)
Q Consensus       273 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~-~~~~  351 (487)
                      ++...+..++||||+++++|.+++... .....+++..+..++.|++.||.||   |++|++||||||+||+++. ++.+
T Consensus        87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dl~p~Nil~~~~~~~~  162 (295)
T 2clq_A           87 SFSENGFIKIFMEQVPGGSLSALLRSK-WGPLKDNEQTIGFYTKQILEGLKYL---HDNQIVHRDIKGDNVLINTYSGVL  162 (295)
T ss_dssp             EEEETTEEEEEEECCSEEEHHHHHHHT-TCCCTTCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEETTTCCE
T ss_pred             EEEeCCcEEEEEEeCCCCCHHHHHHhh-ccCCCccHHHHHHHHHHHHHHHHHH---HhCCEEccCCChhhEEEECCCCCE
Confidence            999999999999999999999999752 2234567888999999999999999   6678999999999999987 8999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCC--CCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQP--ELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWL  429 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~  429 (487)
                      ||+|||++........  ......||+.|+|||++.+.  .++.++||||||+++|+|++|..||.......    ....
T Consensus       163 kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~  236 (295)
T 2clq_A          163 KISDFGTSKRLAGINP--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ----AAMF  236 (295)
T ss_dssp             EECCTTTCEESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH----HHHH
T ss_pred             EEeecccccccCCCCC--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh----HHHH
Confidence            9999999987644321  12345689999999998764  38899999999999999999999995432211    1111


Q ss_pred             HHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          430 RKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       430 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ........      +.++..    .+..+.+++.+||+.||++|||+.++++
T Consensus       237 ~~~~~~~~------~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          237 KVGMFKVH------PEIPES----MSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             HHHHHCCC------CCCCTT----SCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             hhcccccc------cccccc----CCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            11111111      112211    2256889999999999999999999874

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.2e-40  Score=327.32  Aligned_cols=259  Identities=20%  Similarity=0.273  Sum_probs=197.9

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCC-CCCccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIR-HRNILP  269 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~  269 (487)
                      .++|.+.+.||.|+||.||+|.. ..+++.||+|++..                  .....+.+|+.++..++ ||||++
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~------------------~~~~~~~~E~~~l~~l~~~~~i~~   95 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAIN-ITNNEKVVVKILKP------------------VKKKKIKREIKILENLRGGPNIIT   95 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEE-TTTCCEEEEEEECS------------------CCHHHHHHHHHHHHHHTTSTTBCC
T ss_pred             CCceEEEEEecccCCeEEEEEEE-CCCCcEEEEEEecc------------------cchHHHHHHHHHHHHcCCCCCEEE
Confidence            45799999999999999999974 46789999998732                  11245788999999996 999999


Q ss_pred             cceEEec--CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC
Q 011360          270 LLAHMVR--PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLND  347 (487)
Q Consensus       270 l~~~~~~--~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~  347 (487)
                      +++++..  ....++||||+++++|.+++.       .+++..+..++.|++.||.||   |++||+||||||+|||++.
T Consensus        96 ~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dikp~Nil~~~  165 (330)
T 3nsz_A           96 LADIVKDPVSRTPALVFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYC---HSMGIMHRDVKPHNVMIDH  165 (330)
T ss_dssp             EEEEEECTTTCCEEEEEECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEET
T ss_pred             eeeeeccCCCCceEEEEeccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHH---HhCCeeeCCCCHHHEEEcC
Confidence            9999987  667899999999999999875       378899999999999999999   6778999999999999997


Q ss_pred             CC-CEEEeccCCccccCCCCceeeEeeecccccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccc-
Q 011360          348 DM-EACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQ-PELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEIC-  424 (487)
Q Consensus       348 ~~-~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~-  424 (487)
                      ++ .+||+|||++.........   ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.......... 
T Consensus       166 ~~~~~kl~Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~  242 (330)
T 3nsz_A          166 EHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV  242 (330)
T ss_dssp             TTTEEEECCCTTCEECCTTCCC---CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHH
T ss_pred             CCCEEEEEeCCCceEcCCCCcc---ccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHH
Confidence            76 8999999999876543322   34568999999999877 678999999999999999999999994332211100 


Q ss_pred             ------cHHHHHHHHhcCC--------------CCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          425 ------SPEWLRKVMNSKN--------------PSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       425 ------~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                            .............              .................+.++.+++.+||+.||++|||+.++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          243 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             HHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                  0000111111100              01111111111122224567999999999999999999999986

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.3e-41  Score=340.62  Aligned_cols=247  Identities=11%  Similarity=0.111  Sum_probs=187.9

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHH---HHhccCCCCCc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI---ITASQIRHRNI  267 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~---~~l~~l~hpnI  267 (487)
                      .+.|.+.+.||.|+||.||+|+. ..+|+.||||++....            .......+.+.+|+   ..+++++||||
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~-~~~~~~vavK~~~~~~------------~~~~~~~~~~~~E~~~l~~l~~l~hpni  138 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATD-QETGESFEVHVPYFTE------------RPPSNAIKQMKEEVLRLRLLRGIKNQKQ  138 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC--CCCCEEEEEEEEECC-------------CCTTHHHHHHHHHHGGGGSTTCCSHHH
T ss_pred             CceEEEcceeecCCCEEEEEEEE-CCCCcEEEEEEEeecc------------ccchHHHHHHHHHHHHHHhccccCCHHH
Confidence            35699999999999999999975 4578999999985321            11223456788899   55666689999


Q ss_pred             cccc-------eEEecCC-----------------eeEEEEEecCCCCHHHHHhhhhc---CCCCCChHHHHHHHHHHHH
Q 011360          268 LPLL-------AHMVRPD-----------------CHLLVYEFMKNGSLQDILDDVSR---GRRELDWPSRHRIALGVAS  320 (487)
Q Consensus       268 v~l~-------~~~~~~~-----------------~~~lv~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~qi~~  320 (487)
                      ++++       +++..++                 ..|+||||+ +|+|.+++.....   ....+++..++.++.|++.
T Consensus       139 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~  217 (377)
T 3byv_A          139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIR  217 (377)
T ss_dssp             HHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHH
T ss_pred             HHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHH
Confidence            9999       6655543                 278999999 6899999975321   1123345788899999999


Q ss_pred             HHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCC-----------
Q 011360          321 GLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQP-----------  389 (487)
Q Consensus       321 ~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----------  389 (487)
                      ||+||   |++||+||||||+|||++.++.+||+|||+++....     ......| +.|+|||++.+.           
T Consensus       218 aL~~L---H~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~  288 (377)
T 3byv_A          218 LLASL---HHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRT  288 (377)
T ss_dssp             HHHHH---HHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEE
T ss_pred             HHHHH---HhCCeecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccc
Confidence            99999   677899999999999999999999999999986432     1234567 999999999877           


Q ss_pred             CCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCC
Q 011360          390 ELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHD  469 (487)
Q Consensus       390 ~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~  469 (487)
                      .++.++|||||||++|||+||..||..........      ... ..      .+.+        +..+.+++.+||+.|
T Consensus       289 ~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~------~~~-~~------~~~~--------~~~~~~li~~~L~~d  347 (377)
T 3byv_A          289 LMTFSFDAWALGLVIYWIWCADLPITKDAALGGSE------WIF-RS------CKNI--------PQPVRALLEGFLRYP  347 (377)
T ss_dssp             ECCHHHHHHHHHHHHHHHHHSSCCC------CCSG------GGG-SS------CCCC--------CHHHHHHHHHHTCSS
T ss_pred             cCChhhhHHHHHHHHHHHHHCCCCCcccccccchh------hhh-hh------ccCC--------CHHHHHHHHHHcCCC
Confidence            89999999999999999999999995443221110      000 00      0112        256889999999999


Q ss_pred             CCCCCChHHHHH
Q 011360          470 PEERPNSQYVRC  481 (487)
Q Consensus       470 P~~RPs~~~il~  481 (487)
                      |++|||+.++++
T Consensus       348 p~~Rpt~~e~l~  359 (377)
T 3byv_A          348 KEDRLLPLQAME  359 (377)
T ss_dssp             GGGCCCHHHHHT
T ss_pred             chhCCCHHHHhh
Confidence            999999999885

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=2e-41  Score=331.22  Aligned_cols=258  Identities=22%  Similarity=0.338  Sum_probs=197.4

Q ss_pred             hccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccc
Q 011360          190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILP  269 (487)
Q Consensus       190 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~  269 (487)
                      ..++|.+.+.||.|+||.||+|.+.    ..+|+|++.....             .......+.+|+.++++++||||++
T Consensus        31 ~~~~~~~~~~lg~G~~g~V~~~~~~----~~~avk~~~~~~~-------------~~~~~~~~~~e~~~l~~l~h~~iv~   93 (319)
T 2y4i_B           31 PFEQLEIGELIGKGRFGQVYHGRWH----GEVAIRLIDIERD-------------NEDQLKAFKREVMAYRQTRHENVVL   93 (319)
T ss_dssp             CCSCEECCCBCCCSSSSEEEEEEES----SSEEEEECCCCSC-------------CCCCCCCCCTTGGGGTTCCCTTBCC
T ss_pred             CHHHeEEeeEeccCCceEEEEEEEc----CeEEEEEeecCCC-------------CHHHHHHHHHHHHHHhcCCCCCEeE
Confidence            3457999999999999999999763    2599998854211             1112234567899999999999999


Q ss_pred             cceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC
Q 011360          270 LLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDM  349 (487)
Q Consensus       270 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~  349 (487)
                      +++++...+..++||||+++++|.+++..   ....+++..+..++.|++.||.||   |++|++||||||+||+++ ++
T Consensus        94 ~~~~~~~~~~~~iv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~l---H~~~i~H~dlkp~NIl~~-~~  166 (319)
T 2y4i_B           94 FMGACMSPPHLAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYL---HAKGILHKDLKSKNVFYD-NG  166 (319)
T ss_dssp             CCEEEECSSCEEEECBCCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHH---HHTTCCCCCCCSTTEEEC---
T ss_pred             EEEEEecCCceEEEeecccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHH---HhCCccccCCChhhEEEe-CC
Confidence            99999999999999999999999999863   345689999999999999999999   677899999999999998 67


Q ss_pred             CEEEeccCCccccCCCCc---eeeEeeecccccccCCcccCC---------CCCCchhHHHHHHHHHHHHHhCCCCcccc
Q 011360          350 EACISDLGLAMAIPDGYT---RVLISYVLGTMAYIAPEYFQQ---------PELSEKCDIFSFGMLLISLVRGVPSFVFH  417 (487)
Q Consensus       350 ~~kl~DFg~s~~~~~~~~---~~~~~~~~gt~~y~aPE~l~~---------~~~~~~~DvwslG~~l~elltg~~pf~~~  417 (487)
                      .+||+|||++........   ........||+.|+|||++.+         ..++.++||||||+++|+|++|..||...
T Consensus       167 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~  246 (319)
T 2y4i_B          167 KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ  246 (319)
T ss_dssp             CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSC
T ss_pred             CEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            999999999875432111   111133458999999999874         35789999999999999999999999432


Q ss_pred             CCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          418 QNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       418 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      .      ............ ........++        ..+.+++.+||..||++|||+.++++.|+.+
T Consensus       247 ~------~~~~~~~~~~~~-~~~~~~~~~~--------~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l  300 (319)
T 2y4i_B          247 P------AEAIIWQMGTGM-KPNLSQIGMG--------KEISDILLFCWAFEQEERPTFTKLMDMLEKL  300 (319)
T ss_dssp             C------HHHHHHHHHTTC-CCCCCCSSCC--------TTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC
T ss_pred             C------HHHHHHHhccCC-CCCCCcCCCC--------HHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            2      222233332222 2222222233        2488999999999999999999999999876

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=2.5e-40  Score=336.60  Aligned_cols=198  Identities=23%  Similarity=0.326  Sum_probs=166.6

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC------CCC
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI------RHR  265 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l------~hp  265 (487)
                      .+|.+.+.||+|+||.||+|.. ..+++.||||++..                .......+.+|+.++..+      .||
T Consensus        97 ~ry~~~~~LG~G~fg~V~~a~~-~~~~~~vAvK~~~~----------------~~~~~~~~~~E~~~l~~l~~~~~~~~~  159 (429)
T 3kvw_A           97 YRYEVLKVIGKGSFGQVVKAYD-HKVHQHVALKMVRN----------------EKRFHRQAAEEIRILEHLRKQDKDNTM  159 (429)
T ss_dssp             TTEEEEEEEEESSSEEEEEEEE-TTTTEEEEEEEECS----------------CHHHHHHHHHHHHHHHHHHTTCTTSCS
T ss_pred             CcEEEEEEcccCccEEEEEEEE-CCCCcEEEEEEECC----------------ccchHHHHHHHHHHHHHHhhccccCCc
Confidence            4699999999999999999974 46789999999842                112233445566555544      788


Q ss_pred             CccccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEe
Q 011360          266 NILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLL  345 (487)
Q Consensus       266 nIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill  345 (487)
                      ||+++++++...+..++||||+. ++|.+++..  .....+++..+..++.|++.||.||   |++||+||||||+|||+
T Consensus       160 ~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlKp~NILl  233 (429)
T 3kvw_A          160 NVIHMLENFTFRNHICMTFELLS-MNLYELIKK--NKFQGFSLPLVRKFAHSILQCLDAL---HKNRIIHCDLKPENILL  233 (429)
T ss_dssp             CBCCEEEEEEETTEEEEEECCCC-CBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHH---HHHTEECSCCSGGGEEE
T ss_pred             CEEEEEeecccCCeEEEEEeccC-CCHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeEE
Confidence            99999999999999999999995 699999876  3335589999999999999999999   66689999999999999


Q ss_pred             CCCCC--EEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCcccc
Q 011360          346 NDDME--ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFH  417 (487)
Q Consensus       346 ~~~~~--~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~  417 (487)
                      +.++.  +||+|||+++......     ....||+.|+|||++.+..++.++|||||||++|||+||.+||...
T Consensus       234 ~~~~~~~vkL~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~  302 (429)
T 3kvw_A          234 KQQGRSGIKVIDFGSSCYEHQRV-----YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE  302 (429)
T ss_dssp             SSTTSCCEEECCCTTCEETTCCC-----CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ccCCCcceEEeecccceecCCcc-----cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence            99887  9999999997654332     2456899999999999989999999999999999999999999544

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=3.4e-41  Score=336.92  Aligned_cols=255  Identities=11%  Similarity=0.046  Sum_probs=179.5

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHH---HHhccCCCCCccc
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI---ITASQIRHRNILP  269 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~---~~l~~l~hpnIv~  269 (487)
                      .|.+.+.||.|+||.||+|++ ..+++.||||++.....            ........+.+|+   ..+.. +||||++
T Consensus        63 ~y~~~~~lG~G~~g~V~~~~~-~~~~~~vavK~~~~~~~------------~~~~~~~~~~~E~~~~~~l~~-~hp~iv~  128 (371)
T 3q60_A           63 KLKLVEPLRVGDRSVVFLVRD-VERLEDFALKVFTMGAE------------NSRSELERLHEATFAAARLLG-ESPEEAR  128 (371)
T ss_dssp             EEEEEEEEEECSSEEEEEEEE-TTTTEEEEEEEEECCST------------THHHHHHHHHHHHHHHHHHHC--------
T ss_pred             eeeeeeeccCCCCEEEEEEEE-CCCCceeEEEEEEeccc------------ccccHHHHHHHHHHHHHHhcc-cChhhhh
Confidence            499999999999999999975 45789999999854221            1223445666774   45555 7999877


Q ss_pred             cc-------eEEecC-----------------CeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHH------HHHHHHHH
Q 011360          270 LL-------AHMVRP-----------------DCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR------HRIALGVA  319 (487)
Q Consensus       270 l~-------~~~~~~-----------------~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~------~~i~~qi~  319 (487)
                      ++       +++...                 ..+|+|||||+ |+|.+++....   ..+++..+      ..++.|++
T Consensus       129 ~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~vk~~i~~qi~  204 (371)
T 3q60_A          129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD---FVYVFRGDEGILALHILTAQLI  204 (371)
T ss_dssp             ---CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH---HSCCCCHHHHHHHHHHHHHHHH
T ss_pred             hceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc---cccchhhhhhhhhHHHHHHHHH
Confidence            55       444332                 33799999998 89999998642   23455556      67889999


Q ss_pred             HHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCC--CCCCchhHH
Q 011360          320 SGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQ--PELSEKCDI  397 (487)
Q Consensus       320 ~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~Dv  397 (487)
                      .||+||   |++||+||||||+|||++.++.+||+|||+++......     ....+|+.|+|||++.+  ..++.++||
T Consensus       205 ~aL~~L---H~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~Di  276 (371)
T 3q60_A          205 RLAANL---QSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNA  276 (371)
T ss_dssp             HHHHHH---HHTTEEETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHH
T ss_pred             HHHHHH---HHCCCccCcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccH
Confidence            999999   67789999999999999999999999999998654321     24457799999999987  679999999


Q ss_pred             HHHHHHHHHHHhCCCCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChH
Q 011360          398 FSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQ  477 (487)
Q Consensus       398 wslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~  477 (487)
                      |||||++|+|+||..||...........        .....................+..+.+++.+||+.||++|||+.
T Consensus       277 wSlG~il~elltg~~Pf~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~  348 (371)
T 3q60_A          277 WQLGLSIYRVWCLFLPFGLVTPGIKGSW--------KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPL  348 (371)
T ss_dssp             HHHHHHHHHHHHSSCSTTBCCTTCTTCC--------CBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHH
T ss_pred             HHHHHHHHHHHhCCCCCCCcCcccccch--------hhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHH
Confidence            9999999999999999966533211100        00000000000011111112346788999999999999999999


Q ss_pred             HHHH
Q 011360          478 YVRC  481 (487)
Q Consensus       478 ~il~  481 (487)
                      ++++
T Consensus       349 e~l~  352 (371)
T 3q60_A          349 EAME  352 (371)
T ss_dssp             HHTT
T ss_pred             HHhc
Confidence            9864

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.3e-40  Score=355.11  Aligned_cols=261  Identities=23%  Similarity=0.322  Sum_probs=204.6

Q ss_pred             hhccccccccccccccceeEEEEEecC--CCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCC
Q 011360          189 KKEDCFASLEKIGSGGCGEVYKAELPG--SNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRN  266 (487)
Q Consensus       189 ~~~~~~~~~~~lg~G~~g~v~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn  266 (487)
                      ...++|.+.+.||+|+||.||+|.+..  ..+..||+|++..              .......+.+.+|+.++++++|||
T Consensus       387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~--------------~~~~~~~~~~~~E~~~l~~l~Hpn  452 (656)
T 2j0j_A          387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN--------------CTSDSVREKFLQEALTMRQFDHPH  452 (656)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSS--------------TTCHHHHHHHHHHHHHHHHCCCTT
T ss_pred             cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecc--------------cCCHHHHHHHHHHHHHHHhCCCCC
Confidence            345679999999999999999998643  2356799998732              122334567889999999999999


Q ss_pred             ccccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC
Q 011360          267 ILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN  346 (487)
Q Consensus       267 Iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~  346 (487)
                      |+++++++. .+..|+||||+++|+|.+++..   ....+++..+..++.|++.||.||   |++||+||||||+|||++
T Consensus       453 Iv~l~~~~~-~~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~L---H~~givHrDikp~NILl~  525 (656)
T 2j0j_A          453 IVKLIGVIT-ENPVWIIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTALAYL---ESKRFVHRDIAARNVLVS  525 (656)
T ss_dssp             BCCEEEEEC-SSSCEEEEECCTTCBHHHHHHH---TTTTCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEEE
T ss_pred             CCeEEEEEe-cCceEEEEEcCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHH---HhCCccccccchHhEEEe
Confidence            999999885 4678999999999999999974   245689999999999999999999   667899999999999999


Q ss_pred             CCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCcccc
Q 011360          347 DDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICS  425 (487)
Q Consensus       347 ~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~  425 (487)
                      .++.+||+|||+++........ ......+|+.|+|||++.+..++.++||||||+++|||++ |..||....      .
T Consensus       526 ~~~~vkL~DFG~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~------~  598 (656)
T 2j0j_A          526 SNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK------N  598 (656)
T ss_dssp             ETTEEEECCCCCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC------H
T ss_pred             CCCCEEEEecCCCeecCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCC------H
Confidence            9999999999999876543222 1233457889999999998899999999999999999997 899994332      2


Q ss_pred             HHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhhC
Q 011360          426 PEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL  487 (487)
Q Consensus       426 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~ll  487 (487)
                      .+....+.....+.  +++.+        +..+.+++.+||+.||++|||+.+|++.|++++
T Consensus       599 ~~~~~~i~~~~~~~--~~~~~--------~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il  650 (656)
T 2j0j_A          599 NDVIGRIENGERLP--MPPNC--------PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  650 (656)
T ss_dssp             HHHHHHHHHTCCCC--CCTTC--------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHcCCCCC--CCccc--------cHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            23333333322221  12222        256889999999999999999999999998763

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=7.3e-41  Score=331.91  Aligned_cols=264  Identities=21%  Similarity=0.297  Sum_probs=196.3

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||.|+||.||+|+. ..+|+.||+|++.....             .......+.+|+.+++.++||||++++
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~~~~-------------~~~~~~~~~~E~~~l~~l~h~~iv~~~   82 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARH-RKTGQKVALKKVLMENE-------------KEGFPITALREIKILQLLKHENVVNLI   82 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEE-TTTCCEEEEEECCCSSC-------------SSSSCHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cceeEEEEEecCCCcEEEEEEE-CCCCCEEEEEEEecccc-------------cccchHHHHHHHHHHHhccCCCcccHh
Confidence            4699999999999999999975 46889999998843211             111234567899999999999999999


Q ss_pred             eEEec--------CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCE
Q 011360          272 AHMVR--------PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNV  343 (487)
Q Consensus       272 ~~~~~--------~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Ni  343 (487)
                      +++..        .+..|+||||+++ +|.+.+..   ....+++..++.++.|++.||.||   |++||+||||||+||
T Consensus        83 ~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~L---H~~~ivH~Dlkp~NI  155 (351)
T 3mi9_A           83 EICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYI---HRNKILHRDMKAANV  155 (351)
T ss_dssp             EEEEEC--------CEEEEEEECCSE-EHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGE
T ss_pred             heeeccccccccCCceEEEEEeccCC-CHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHH---HHCCeeCCCCCHHHE
Confidence            99887        3468999999965 77777753   345699999999999999999999   677899999999999


Q ss_pred             EeCCCCCEEEeccCCccccCCCCc--eeeEeeecccccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCccccCCC
Q 011360          344 LLNDDMEACISDLGLAMAIPDGYT--RVLISYVLGTMAYIAPEYFQQ-PELSEKCDIFSFGMLLISLVRGVPSFVFHQNG  420 (487)
Q Consensus       344 ll~~~~~~kl~DFg~s~~~~~~~~--~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwslG~~l~elltg~~pf~~~~~~  420 (487)
                      |++.++.+||+|||++........  ........||+.|+|||++.+ ..++.++|||||||++|+|+||.+||......
T Consensus       156 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~  235 (351)
T 3mi9_A          156 LITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ  235 (351)
T ss_dssp             EECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             EEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChH
Confidence            999999999999999986643221  111234568999999998876 46899999999999999999999999543211


Q ss_pred             CccccHHHHHHHHhcCCCCCccCCCCC--------------CCCcHH------HHHHHHHHHhhccCCCCCCCCChHHHH
Q 011360          421 EEICSPEWLRKVMNSKNPSRAIDPRLP--------------GNGYEK------KMLHVLKIAYICTLHDPEERPNSQYVR  480 (487)
Q Consensus       421 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~------~~~~l~~li~~cl~~~P~~RPs~~~il  480 (487)
                         .....+.... ...+....+ ...              ......      ....+.+++.+||+.||++|||+.+++
T Consensus       236 ---~~~~~i~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l  310 (351)
T 3mi9_A          236 ---HQLALISQLC-GSITPEVWP-NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL  310 (351)
T ss_dssp             ---HHHHHHHHHH-CCCCTTTST-TGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             ---HHHHHHHHHh-CCCChhhcc-ccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHh
Confidence               0111111111 111111110 000              000000      134588999999999999999999987


Q ss_pred             H
Q 011360          481 C  481 (487)
Q Consensus       481 ~  481 (487)
                      +
T Consensus       311 ~  311 (351)
T 3mi9_A          311 N  311 (351)
T ss_dssp             T
T ss_pred             C
Confidence            5

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.2e-40  Score=335.67  Aligned_cols=262  Identities=22%  Similarity=0.262  Sum_probs=200.4

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCC--------
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIR--------  263 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--------  263 (487)
                      ++|.+.+.||+|+||.||+|+. ..+++.||||++..                .......+.+|+.+++.++        
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~----------------~~~~~~~~~~E~~~l~~l~~~~~~~~~   99 (397)
T 1wak_A           37 GRYHVIRKLGWGHFSTVWLSWD-IQGKKFVAMKVVKS----------------AEHYTETALDEIRLLKSVRNSDPNDPN   99 (397)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEE-TTTTEEEEEEEECS----------------CHHHHHHHHHHHHHHHHHHHSCTTCGG
T ss_pred             CeEEEEEEeeecCCeeEEEEEe-cCCCeEEEEEEEec----------------CCcchHHHHHHHHHHHHHhhcCCCCCC
Confidence            4699999999999999999964 46889999999832                1223456778888888874        


Q ss_pred             CCCccccceEEe----cCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCC-CeeecCC
Q 011360          264 HRNILPLLAHMV----RPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSA-SIIHGDI  338 (487)
Q Consensus       264 hpnIv~l~~~~~----~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~-givH~Dl  338 (487)
                      ||||+++++++.    .....|+||||+ +++|.+++..  .....+++..++.++.|++.||.||   |++ ||+||||
T Consensus       100 ~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~l---H~~~givHrDi  173 (397)
T 1wak_A          100 REMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIK--SNYQGLPLPCVKKIIQQVLQGLDYL---HTKCRIIHTDI  173 (397)
T ss_dssp             GGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHH---HHTTCEECCCC
T ss_pred             cceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHh--cccCCCCHHHHHHHHHHHHHHHHHH---HHhCCEecCCC
Confidence            788999999987    556889999999 6677777754  3346799999999999999999999   565 8999999


Q ss_pred             CCCCEEeCCCC-------------------------------------------------CEEEeccCCccccCCCCcee
Q 011360          339 KPRNVLLNDDM-------------------------------------------------EACISDLGLAMAIPDGYTRV  369 (487)
Q Consensus       339 kp~Nill~~~~-------------------------------------------------~~kl~DFg~s~~~~~~~~~~  369 (487)
                      ||+|||++.++                                                 .+||+|||++.......   
T Consensus       174 kp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~---  250 (397)
T 1wak_A          174 KPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF---  250 (397)
T ss_dssp             SGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS---
T ss_pred             CHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC---
Confidence            99999999775                                                 79999999998764432   


Q ss_pred             eEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHHHh--cCCCCC-------
Q 011360          370 LISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMN--SKNPSR-------  440 (487)
Q Consensus       370 ~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~-------  440 (487)
                        ....||+.|+|||++.+..++.++|||||||++|+|+||..||....................  +..+..       
T Consensus       251 --~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~  328 (397)
T 1wak_A          251 --TEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKY  328 (397)
T ss_dssp             --CSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTT
T ss_pred             --ccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccc
Confidence              234689999999999998999999999999999999999999976544332211111111111  110000       


Q ss_pred             ---cc---------CCCCC----------CCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          441 ---AI---------DPRLP----------GNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       441 ---~~---------~~~~~----------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                         .+         ....+          .......+..+.+++.+||+.||++|||+.++++
T Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          329 SKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             GGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             cccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence               00         00000          0123566778999999999999999999999985

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=5.1e-41  Score=334.69  Aligned_cols=256  Identities=24%  Similarity=0.347  Sum_probs=181.4

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||.|+||.||+|.. ..+|+.||||++...             .........+.+|+.+++.++||||++++
T Consensus        29 ~~y~~~~~lG~G~~g~V~~a~~-~~~~~~vaiK~~~~~-------------~~~~~~~~~~~~E~~~l~~l~hpnIv~~~   94 (367)
T 2fst_X           29 ERYQNLSPVGSGAYGSVCAAFD-TKTGLRVAVKKLSRP-------------FQSIIHAKRTYRELRLLKHMKHENVIGLL   94 (367)
T ss_dssp             TTEEEEEECC----CCEEEEEE-TTTTEEEEEEECSST-------------TSSHHHHHHHHHHHHHHHHCCCTTBCCCS
T ss_pred             CceEEeeEEeecCCeEEEEEEE-CCCCCEEEEEEeCcc-------------ccCHHHHHHHHHHHHHHHhCCCCCCCcEE
Confidence            5799999999999999999964 568999999987431             12233456778999999999999999999


Q ss_pred             eEEecC------CeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEe
Q 011360          272 AHMVRP------DCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLL  345 (487)
Q Consensus       272 ~~~~~~------~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill  345 (487)
                      +++...      ...|+|||++ +++|.+++..     ..+++..+..++.|++.||.||   |++||+||||||+|||+
T Consensus        95 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~L---H~~givH~Dlkp~NIll  165 (367)
T 2fst_X           95 DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYI---HSADIIHRDLKPSNLAV  165 (367)
T ss_dssp             EEECSCSSGGGCCCCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEE
T ss_pred             EEEecCCccccCCeEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHH---HHCCeeeCCCCHhhEEE
Confidence            998754      5679999999 7899998863     5689999999999999999999   67789999999999999


Q ss_pred             CCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccc
Q 011360          346 NDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQ-PELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEIC  424 (487)
Q Consensus       346 ~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~  424 (487)
                      +.++.+||+|||+++.....     .....||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+...     
T Consensus       166 ~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----  235 (367)
T 2fst_X          166 NEDCELKILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH-----  235 (367)
T ss_dssp             CTTCCEEECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH-----
T ss_pred             CCCCCEEEeecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----
Confidence            99999999999999765432     134568999999999877 6889999999999999999999999954321     


Q ss_pred             cHHHHHHHHh-cCCCCCccC---------------CCCCCCCcH----HHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          425 SPEWLRKVMN-SKNPSRAID---------------PRLPGNGYE----KKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       425 ~~~~~~~~~~-~~~~~~~~~---------------~~~~~~~~~----~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                       ...+..+.. .+.+....-               +..+.....    .....+.+++.+||..||++|||+.++++
T Consensus       236 -~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          236 -IDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             -HHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -HHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence             111111111 011100000               000111111    12356889999999999999999999975

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.3e-40  Score=337.98  Aligned_cols=258  Identities=24%  Similarity=0.333  Sum_probs=194.8

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      ...|.+.+.||+|+||.||+|++ ..+|+.||||++....                   ....+|+.+++.++||||+++
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~-~~~~~~vaiK~~~~~~-------------------~~~~~E~~il~~l~hpniv~l  112 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKL-CDSGELVAIKKVLQDK-------------------RFKNRELQIMRKLDHCNIVRL  112 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEE-TTTCCEEEEEEEECCT-------------------TSCCHHHHHHHTCCCTTBCCE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEE-CCCCcEEEEEEecccc-------------------hhHHHHHHHHHHcCCCCccce
Confidence            34699999999999999999975 4578999999884311                   112368999999999999999


Q ss_pred             ceEEecC------CeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEE
Q 011360          271 LAHMVRP------DCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVL  344 (487)
Q Consensus       271 ~~~~~~~------~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nil  344 (487)
                      ++++...      ..+++||||+++ +|.+++.........+++..+..++.|++.||.||   |++||+||||||+|||
T Consensus       113 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~L---H~~~ivHrDlkp~NIL  188 (420)
T 1j1b_A          113 RYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI---HSFGICHRDIKPQNLL  188 (420)
T ss_dssp             EEEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH---HTTTEECSCCSGGGEE
T ss_pred             eeEEeccCCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH---HHCCccccCCChhhEE
Confidence            9988542      236799999965 77777766555677899999999999999999999   7789999999999999


Q ss_pred             eCCC-CCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCccccCCCCc
Q 011360          345 LNDD-MEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQP-ELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEE  422 (487)
Q Consensus       345 l~~~-~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~  422 (487)
                      ++.+ +.+||+|||+++........   ....||+.|+|||++.+. .|+.++|||||||++|||++|++||.+...   
T Consensus       189 l~~~~~~~kl~DFG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~---  262 (420)
T 1j1b_A          189 LDPDTAVLKLCDFGSAKQLVRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG---  262 (420)
T ss_dssp             EETTTTEEEECCCTTCEECCTTCCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---
T ss_pred             EeCCCCeEEeccchhhhhcccCCCc---eeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH---
Confidence            9965 56899999999876443322   345689999999998764 799999999999999999999999954321   


Q ss_pred             cccHHHHHHHHh-------------cCCCCCccCCCCCCCCc-----HHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          423 ICSPEWLRKVMN-------------SKNPSRAIDPRLPGNGY-----EKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       423 ~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                         .+.+..+..             ........-+.+.....     ...+.++.+++.+||..||.+|||+.++++
T Consensus       263 ---~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          263 ---VDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             ---HHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ---HHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence               111111111             01111111111111111     122457899999999999999999999875

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-41  Score=336.95  Aligned_cols=258  Identities=21%  Similarity=0.333  Sum_probs=199.2

Q ss_pred             cccccccccccccceeEEEEEec--CCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CCCCcc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELP--GSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RHRNIL  268 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv  268 (487)
                      ++|.+.+.||+|+||.||+++..  ..+++.||||++.......           .......+.+|+.++..+ .||||+
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~~~~~E~~~l~~l~~h~~iv  122 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQ-----------KAKTTEHTRTERQVLEHIRQSPFLV  122 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEE-----------EESSGGGCCCHHHHHHHHHTCTTBC
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhh-----------hhhHHHHHHHHHHHHHHccCCCcee
Confidence            46999999999999999999763  2478999999985321100           011123455688888888 799999


Q ss_pred             ccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC
Q 011360          269 PLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDD  348 (487)
Q Consensus       269 ~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~  348 (487)
                      ++++++...+..++||||+++|+|.+++..    ...+++..+..++.|++.||.||   |++||+||||||+|||++.+
T Consensus       123 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~L---H~~~ivH~Dlkp~NIll~~~  195 (355)
T 1vzo_A          123 TLHYAFQTETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHL---HKLGIIYRDIKLENILLDSN  195 (355)
T ss_dssp             CEEEEEEETTEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTT
T ss_pred             EEEEEEeeCceEEEEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEECCC
Confidence            999999999999999999999999999975    34689999999999999999999   67789999999999999999


Q ss_pred             CCEEEeccCCccccCCCCceeeEeeecccccccCCcccCC--CCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccH
Q 011360          349 MEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQ--PELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSP  426 (487)
Q Consensus       349 ~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~  426 (487)
                      +.+||+|||+++......... .....||+.|+|||++.+  ..++.++|||||||++|+|++|..||.......  ...
T Consensus       196 ~~~kl~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--~~~  272 (355)
T 1vzo_A          196 GHVVLTDFGLSKEFVADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN--SQA  272 (355)
T ss_dssp             SCEEESCSSEEEECCGGGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC--CHH
T ss_pred             CcEEEeeCCCCeecccCCCCc-ccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc--hHH
Confidence            999999999997654332211 134579999999999986  357899999999999999999999996543322  122


Q ss_pred             HHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCC-----ChHHHHH
Q 011360          427 EWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERP-----NSQYVRC  481 (487)
Q Consensus       427 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~~il~  481 (487)
                      .......... +.  .++.        .+..+.+++.+||..||++||     |+.++++
T Consensus       273 ~~~~~~~~~~-~~--~~~~--------~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~  321 (355)
T 1vzo_A          273 EISRRILKSE-PP--YPQE--------MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  321 (355)
T ss_dssp             HHHHHHHHCC-CC--CCTT--------SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             HHHHHHhccC-CC--CCcc--------cCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHc
Confidence            2333332221 11  1111        224588999999999999999     8998875

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.4e-40  Score=320.33  Aligned_cols=253  Identities=25%  Similarity=0.369  Sum_probs=201.1

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .++|.+.+.||.|+||.||+|.. ..+++.||+|++...             .........+.+|+.++++++||||+++
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~-~~~~~~valK~~~~~-------------~~~~~~~~~~~~e~~~l~~l~h~~i~~~   86 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKD-RITQQEYAVKVINKA-------------SAKNKDTSTILREVELLKKLDHPNIMKL   86 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEE-TTTCCEEEEEEEEGG-------------GBSSSCHHHHHHHHHHHHTCCCTTBCCE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEE-cCCCcEEEEEEeccc-------------ccchHHHHHHHHHHHHHHhccCCCccEE
Confidence            35799999999999999999975 457889999998431             1112234567889999999999999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC--
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDD--  348 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~--  348 (487)
                      ++++...+..++||||+++++|.+++..    ...+++..++.++.|++.||.||   |++|++||||||+||+++.+  
T Consensus        87 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~L---H~~~i~H~dl~p~NIlv~~~~~  159 (287)
T 2wei_A           87 FEILEDSSSFYIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYM---HKHNIVHRDLKPENILLESKEK  159 (287)
T ss_dssp             EEEEECSSEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEESCSST
T ss_pred             EEEEeCCCeEEEEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCChhhEEEecCCC
Confidence            9999999999999999999999998865    34689999999999999999999   67789999999999999754  


Q ss_pred             -CCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHH
Q 011360          349 -MEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPE  427 (487)
Q Consensus       349 -~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~  427 (487)
                       +.+||+|||++.........   ....||+.|+|||.+.+ .++.++||||||+++|+|++|..||....      ..+
T Consensus       160 ~~~~kL~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~------~~~  229 (287)
T 2wei_A          160 DCDIKIIDFGLSTCFQQNTKM---KDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN------EYD  229 (287)
T ss_dssp             TCCEEECSTTGGGTBCCCSSC---SCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHH
T ss_pred             cccEEEeccCcceeecCCCcc---ccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCC------HHH
Confidence             46999999999876543221   23458999999999876 48999999999999999999999994332      223


Q ss_pred             HHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          428 WLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ....+...... ...+      .....+..+.+++.+||+.||++|||+.++++
T Consensus       230 ~~~~~~~~~~~-~~~~------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          230 ILKRVETGKYA-FDLP------QWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             HHHHHHHCCCC-CCSG------GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHcCCCC-CCch------hhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence            33333332211 1110      01122356889999999999999999999986

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2.5e-40  Score=320.47  Aligned_cols=252  Identities=25%  Similarity=0.430  Sum_probs=190.9

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||.|+||.||+|+. ..+++.||||++..                .......+.+|+.+++.++||||++++
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~----------------~~~~~~~~~~E~~~l~~l~h~~i~~~~   68 (303)
T 1zy4_A            6 SDFEEIAVLGQGAFGQVVKARN-ALDSRYYAIKKIRH----------------TEEKLSTILSEVMLLASLNHQYVVRYY   68 (303)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEE-TTTCCEEEEEEEEE----------------EHHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred             ccchhhheeccCCcEEEEEEEE-cCCCeEEEEEEEec----------------cHHHHHHHHHHHHHHHhcCchHHHHHH
Confidence            4699999999999999999974 45789999998832                123456788999999999999999999


Q ss_pred             eEEec-------------CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCC
Q 011360          272 AHMVR-------------PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDI  338 (487)
Q Consensus       272 ~~~~~-------------~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dl  338 (487)
                      +++.+             ....|+||||+++|+|.+++..   ....+++..++.++.|++.||.||   |++||+||||
T Consensus        69 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~L---H~~~i~H~dl  142 (303)
T 1zy4_A           69 AAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEALSYI---HSQGIIHRDL  142 (303)
T ss_dssp             EEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHH---SCGGGCHHHHHHHHHHHHHHHHHH---HHTTCCCSCC
T ss_pred             HHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhc---cccccchHHHHHHHHHHHHHHHHH---HhCCeecccC
Confidence            98765             3567999999999999999974   245678889999999999999999   6778999999


Q ss_pred             CCCCEEeCCCCCEEEeccCCccccCCCCc------------eeeEeeecccccccCCcccCCC-CCCchhHHHHHHHHHH
Q 011360          339 KPRNVLLNDDMEACISDLGLAMAIPDGYT------------RVLISYVLGTMAYIAPEYFQQP-ELSEKCDIFSFGMLLI  405 (487)
Q Consensus       339 kp~Nill~~~~~~kl~DFg~s~~~~~~~~------------~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DvwslG~~l~  405 (487)
                      ||+||+++.++.+||+|||++........            ........||+.|+|||++.+. .++.++||||||+++|
T Consensus       143 kp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~  222 (303)
T 1zy4_A          143 KPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFF  222 (303)
T ss_dssp             CGGGEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHH
T ss_pred             CHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHH
Confidence            99999999999999999999986643211            1112345689999999999864 7899999999999999


Q ss_pred             HHHhCCCCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          406 SLVRGVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       406 elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      +|++   ||...     ........... ...  ..    ++.......+..+.+++.+||+.||++|||+.++++
T Consensus       223 ~l~~---p~~~~-----~~~~~~~~~~~-~~~--~~----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          223 EMIY---PFSTG-----MERVNILKKLR-SVS--IE----FPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             HHHS---CCSSH-----HHHHHHHHHHH-STT--CC----CCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHh---ccCCc-----hhHHHHHHhcc-ccc--cc----cCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence            9998   44211     11112222222 111  11    122222233456889999999999999999999986

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.8e-40  Score=326.80  Aligned_cols=259  Identities=21%  Similarity=0.315  Sum_probs=198.3

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCC------
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHR------  265 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp------  265 (487)
                      ++|.+.+.||.|+||.||+|.....+++.||+|++..                .......+.+|+.++..++|+      
T Consensus        14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~----------------~~~~~~~~~~e~~~l~~l~~~~~~~~~   77 (339)
T 1z57_A           14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN----------------VDRYCEAARSEIQVLEHLNTTDPNSTF   77 (339)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS----------------SHHHHHHHHHHHHHHHHHHHHCTTCTT
T ss_pred             CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEec----------------CCchhHHHHHHHHHHHHhhhcCCCCce
Confidence            4699999999999999999976556889999998832                122345566777777776554      


Q ss_pred             CccccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEe
Q 011360          266 NILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLL  345 (487)
Q Consensus       266 nIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill  345 (487)
                      +|+++++++...+..++||||+ +++|.+++..  .....+++..+..++.|++.||.||   |++||+||||||+||++
T Consensus        78 ~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~--~~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dlkp~Nil~  151 (339)
T 1z57_A           78 RCVQMLEWFEHHGHICIVFELL-GLSTYDFIKE--NGFLPFRLDHIRKMAYQICKSVNFL---HSNKLTHTDLKPENILF  151 (339)
T ss_dssp             CBCCEEEEEEETTEEEEEEECC-CCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEE
T ss_pred             eeEeeecccccCCcEEEEEcCC-CCCHHHHHHh--cCCCCCcHHHHHHHHHHHHHHHHHH---HHCCCcCCCCCHHHEEE
Confidence            5999999999999999999999 8899999975  3334688999999999999999999   67789999999999999


Q ss_pred             CC-------------------CCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHH
Q 011360          346 ND-------------------DMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLIS  406 (487)
Q Consensus       346 ~~-------------------~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~e  406 (487)
                      +.                   ++.+||+|||++.......     ....||+.|+|||++.+..++.++||||||+++|+
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~e  226 (339)
T 1z57_A          152 VQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIE  226 (339)
T ss_dssp             SCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHH
T ss_pred             eccccccccCCccccccccccCCCceEeeCcccccCcccc-----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHH
Confidence            87                   6689999999997654332     34568999999999999899999999999999999


Q ss_pred             HHhCCCCccccCCCCccccHHHHHHHHhcCCCCCcc------------CCCCC-------------------CCCcHHHH
Q 011360          407 LVRGVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAI------------DPRLP-------------------GNGYEKKM  455 (487)
Q Consensus       407 lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~-------------------~~~~~~~~  455 (487)
                      |++|..||.......   ....+.... ...+...+            ...++                   ........
T Consensus       227 l~~g~~pf~~~~~~~---~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (339)
T 1z57_A          227 YYLGFTVFPTHDSKE---HLAMMERIL-GPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEH  302 (339)
T ss_dssp             HHHSSCSCCCSCHHH---HHHHHHHHH-CSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHH
T ss_pred             HHhCCCCCCCCChHH---HHHHHHHHh-CCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhH
Confidence            999999995432211   001111111 11000000            00000                   01123456


Q ss_pred             HHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          456 LHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       456 ~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ..+.+++.+||+.||++|||+.++++
T Consensus       303 ~~l~~li~~~L~~dP~~Rpt~~ell~  328 (339)
T 1z57_A          303 ERLFDLIQKMLEYDPAKRITLREALK  328 (339)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             HHHHHHHHHHhCcCcccccCHHHHhc
Confidence            78999999999999999999999874

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.5e-40  Score=325.72  Aligned_cols=259  Identities=25%  Similarity=0.342  Sum_probs=195.2

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||.|+||.||+|.. ..+++.||||++.......       ...........+.+|+.++..++||||++++
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~~~~~-------~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~   81 (322)
T 2ycf_A           10 DEYIMSKTLGSGACGEVKLAFE-RKTCKKVAIKIISKRKFAI-------GSAREADPALNVETEIEILKKLNHPCIIKIK   81 (322)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEE-TTTTEEEEEEEECC----------------------CHHHHHHHHHHCCCTTBCCEE
T ss_pred             hceeEeeEEecCCCEEEEEEEE-cCCCcEEEEEEeehhhhhh-------cccccchhhhhHHHHHHHHHhCCCCCCceEe
Confidence            4699999999999999999975 4678999999984311100       0011122334578899999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC-
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME-  350 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~-  350 (487)
                      +++...+ .|+||||+++++|.+++..    ...+++..+..++.|++.||.||   |++||+||||||+||+++.++. 
T Consensus        82 ~~~~~~~-~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~dlkp~NIl~~~~~~~  153 (322)
T 2ycf_A           82 NFFDAED-YYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYL---HENGIIHRDLKPENVLLSSQEED  153 (322)
T ss_dssp             EEEESSS-EEEEEECCTTEETHHHHST----TCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEESSSSSS
T ss_pred             eEEcCCc-eEEEEecCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeeccCCCHHHEEEecCCCC
Confidence            9987655 8999999999999998853    56789999999999999999999   6778999999999999987664 


Q ss_pred             --EEEeccCCccccCCCCceeeEeeecccccccCCcccC---CCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCcccc
Q 011360          351 --ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQ---QPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICS  425 (487)
Q Consensus       351 --~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~  425 (487)
                        +||+|||++........   .....||+.|+|||++.   ...++.++||||||+++|+|++|..||........   
T Consensus       154 ~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---  227 (322)
T 2ycf_A          154 CLIKITDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS---  227 (322)
T ss_dssp             CCEEECCCTTCEECCCCHH---HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC---
T ss_pred             CeEEEccCccceecccccc---cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH---
Confidence              99999999987644321   12356899999999873   56789999999999999999999999965433221   


Q ss_pred             HHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          426 PEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       426 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                         ............  .+    ......+..+.+++.+||+.||++|||+.++++
T Consensus       228 ---~~~~~~~~~~~~--~~----~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          228 ---LKDQITSGKYNF--IP----EVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             ---HHHHHHHTCCCC--CH----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ---HHHHHHhCcccc--Cc----hhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence               111111111110  00    001112356889999999999999999999874

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2.6e-40  Score=329.65  Aligned_cols=262  Identities=23%  Similarity=0.326  Sum_probs=197.4

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||+|+||.||+|.. ..++..||||++..              .........+.+|+.++.+++||||++++
T Consensus        27 ~~y~~~~~lG~G~~g~V~~~~~-~~~~~~vaiK~~~~--------------~~~~~~~~~~~~E~~~l~~l~h~niv~~~   91 (364)
T 3qyz_A           27 PRYTNLSYIGEGAYGMVCSAYD-NLNKVRVAIKKISP--------------FEHQTYCQRTLREIKILLRFRHENIIGIN   91 (364)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEE-TTTTEEEEEEEECC--------------TTCHHHHHHHHHHHHHHHHCCCTTBCCCC
T ss_pred             ccEEEEEEeecCCCeEEEEEEE-CCCCeEEEEEEecc--------------ccCcHHHHHHHHHHHHHHhcCCCCCccce
Confidence            4699999999999999999974 46889999999842              11233456788999999999999999999


Q ss_pred             eEEecC-----CeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC
Q 011360          272 AHMVRP-----DCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN  346 (487)
Q Consensus       272 ~~~~~~-----~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~  346 (487)
                      +++...     ...|+||||+. |+|.+++..     ..+++..+..++.|++.||.||   |++||+||||||+||+++
T Consensus        92 ~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dikp~NIl~~  162 (364)
T 3qyz_A           92 DIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT-----QHLSNDHICYFLYQILRGLKYI---HSANVLHRDLKPSNLLLN  162 (364)
T ss_dssp             EEECCSSTTTCCCEEEEEECCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEEC
T ss_pred             eEEecCCccccceEEEEEcccC-cCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCChHhEEEC
Confidence            998765     36899999996 599998864     4589999999999999999999   677899999999999999


Q ss_pred             CCCCEEEeccCCccccCCCCcee-eEeeecccccccCCcccC-CCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccc
Q 011360          347 DDMEACISDLGLAMAIPDGYTRV-LISYVLGTMAYIAPEYFQ-QPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEIC  424 (487)
Q Consensus       347 ~~~~~kl~DFg~s~~~~~~~~~~-~~~~~~gt~~y~aPE~l~-~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~  424 (487)
                      .++.+||+|||++.......... ......||+.|+|||++. +..++.++|||||||++|+|++|.+||........  
T Consensus       163 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--  240 (364)
T 3qyz_A          163 TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ--  240 (364)
T ss_dssp             TTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH--
T ss_pred             CCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH--
Confidence            99999999999998764332211 113457999999999865 45689999999999999999999999955432111  


Q ss_pred             cHHHHHHHHhcCCCCCcc-----------------CCCCC-CCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          425 SPEWLRKVMNSKNPSRAI-----------------DPRLP-GNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       425 ~~~~~~~~~~~~~~~~~~-----------------~~~~~-~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                       ...+..... ......+                 ....+ .......+.++.+++.+||+.||++|||+.++++
T Consensus       241 -~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          241 -LNHILGILG-SPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             -HHHHHHHHC-SCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -HHHHHHHhC-CCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence             011111000 0000000                 00000 0000112356889999999999999999999975

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=4e-40  Score=321.26  Aligned_cols=253  Identities=23%  Similarity=0.356  Sum_probs=193.0

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCC--CCCcc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIR--HRNIL  268 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpnIv  268 (487)
                      .+.|.+.+.||.|+||.||++...  ++..||+|++...             .........+.+|+.++.+++  ||||+
T Consensus        27 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~-------------~~~~~~~~~~~~E~~~l~~l~~~~~~iv   91 (313)
T 3cek_A           27 GRIYSILKQIGSGGSSKVFQVLNE--KKQIYAIKYVNLE-------------EADNQTLDSYRNEIAYLNKLQQHSDKII   91 (313)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECT--TCCEEEEEEEECS-------------SCCHHHHHHHHHHHHHHHHHGGGCTTBC
T ss_pred             cceEEEEEEecCCCCEEEEEEEcC--CCcEEEEEEeccc-------------cccccchHHHHHHHHHHHhccccCCceE
Confidence            356999999999999999999753  5889999998432             112334567889999999996  59999


Q ss_pred             ccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC
Q 011360          269 PLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDD  348 (487)
Q Consensus       269 ~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~  348 (487)
                      ++++++...+..++||| +.+++|.+++..    ...+++..+..++.|++.||.||   |++||+||||||+||+++ +
T Consensus        92 ~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~dlkp~NIl~~-~  162 (313)
T 3cek_A           92 RLYDYEITDQYIYMVME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTI---HQHGIVHSDLKPANFLIV-D  162 (313)
T ss_dssp             CEEEEEECSSEEEEEEC-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEEE-T
T ss_pred             EEEEEeecCCEEEEEEe-cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCceecCCCcccEEEE-C
Confidence            99999999999999999 558899999975    45789999999999999999999   677899999999999996 4


Q ss_pred             CCEEEeccCCccccCCCCceeeEeeecccccccCCcccCC-----------CCCCchhHHHHHHHHHHHHHhCCCCcccc
Q 011360          349 MEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQ-----------PELSEKCDIFSFGMLLISLVRGVPSFVFH  417 (487)
Q Consensus       349 ~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-----------~~~~~~~DvwslG~~l~elltg~~pf~~~  417 (487)
                      +.+||+|||++................||+.|+|||++.+           ..++.++||||||+++|+|++|..||...
T Consensus       163 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  242 (313)
T 3cek_A          163 GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI  242 (313)
T ss_dssp             TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhH
Confidence            7999999999987654433322344568999999999875           47889999999999999999999999432


Q ss_pred             CCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          418 QNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       418 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ..     ............. ...    ++...    +..+.+++.+||+.||++|||+.++++
T Consensus       243 ~~-----~~~~~~~~~~~~~-~~~----~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          243 IN-----QISKLHAIIDPNH-EIE----FPDIP----EKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             CS-----HHHHHHHHHCTTS-CCC----CCCCS----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HH-----HHHHHHHHHhccc-ccC----Ccccc----hHHHHHHHHHHccCCcccCcCHHHHhc
Confidence            21     1122222322211 111    11111    246889999999999999999999975

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2.8e-40  Score=327.17  Aligned_cols=272  Identities=21%  Similarity=0.301  Sum_probs=202.4

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHH--HHhhhhhhHHHHHHHHHHHHhccCCCCCccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELI--EEDSKLRDSKLRQIRSEIITASQIRHRNILP  269 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~  269 (487)
                      ++|.+.+.||.|+||.||+|..   +++.||+|++............  .............+.+|+.++.+++||||++
T Consensus        31 ~~y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~  107 (348)
T 2pml_X           31 NDYRIIRTLNQGKFNKIILCEK---DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT  107 (348)
T ss_dssp             TTEEEEEEEECCSSCCEEEEEE---TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             CceEEEEEEcCCCCeEEEEEEc---CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence            4699999999999999999976   8899999998431100000000  0000000011267889999999999999999


Q ss_pred             cceEEecCCeeEEEEEecCCCCHHHH------HhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCC-CCeeecCCCCCC
Q 011360          270 LLAHMVRPDCHLLVYEFMKNGSLQDI------LDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHS-ASIIHGDIKPRN  342 (487)
Q Consensus       270 l~~~~~~~~~~~lv~E~~~~gsL~~~------l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~-~givH~Dlkp~N  342 (487)
                      +++++.+.+..++||||+++|+|.++      +..  .....+++..++.++.|++.||.||   |+ +||+||||||+|
T Consensus       108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~~i~H~dl~p~N  182 (348)
T 2pml_X          108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK--NYTCFIPIQVIKCIIKSVLNSFSYI---HNEKNICHRDVKPSN  182 (348)
T ss_dssp             CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCS--SSCCCCCHHHHHHHHHHHHHHHHHH---HHTSCEECCCCCGGG
T ss_pred             EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh--ccccCCCHHHHHHHHHHHHHHHHHH---hccCCEeecCCChHh
Confidence            99999999999999999999999998      432  2256799999999999999999999   55 789999999999


Q ss_pred             EEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCC-CCCc-hhHHHHHHHHHHHHHhCCCCccccCCC
Q 011360          343 VLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQP-ELSE-KCDIFSFGMLLISLVRGVPSFVFHQNG  420 (487)
Q Consensus       343 ill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~-~~DvwslG~~l~elltg~~pf~~~~~~  420 (487)
                      |+++.++.+||+|||++......    ......||+.|+|||++.+. .++. ++||||||+++|+|++|..||......
T Consensus       183 il~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~  258 (348)
T 2pml_X          183 ILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL  258 (348)
T ss_dssp             EEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS
T ss_pred             EEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH
Confidence            99999999999999999875443    22455689999999999887 6666 999999999999999999999543321


Q ss_pred             CccccHHHHHHHHhcCCCCCccC-C----CCC----CCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          421 EEICSPEWLRKVMNSKNPSRAID-P----RLP----GNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       421 ~~~~~~~~~~~~~~~~~~~~~~~-~----~~~----~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                           .+....+.. .......+ .    ...    .......+..+.+++.+||+.||.+|||+.++++
T Consensus       259 -----~~~~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          259 -----VELFNNIRT-KNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             -----HHHHHHHTS-CCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             -----HHHHHHHhc-cCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                 222333322 21111100 0    000    0001223457899999999999999999999986

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.1e-39  Score=327.12  Aligned_cols=201  Identities=25%  Similarity=0.339  Sum_probs=167.3

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCC-CC----
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIR-HR----  265 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp----  265 (487)
                      .++|.+.+.||+|+||.||+|.. ..+++.||||++..                .......+..|+.++..+. |+    
T Consensus        53 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~~~vaiK~~~~----------------~~~~~~~~~~e~~~l~~l~~~~~~~~  115 (382)
T 2vx3_A           53 MDRYEIDSLIGKGSFGQVVKAYD-RVEQEWVAIKIIKN----------------KKAFLNQAQIEVRLLELMNKHDTEMK  115 (382)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEE-TTTTEEEEEEEECS----------------SHHHHHHHHHHHHHHHHHHHCSSGGG
T ss_pred             eeeEEEEEEEeecCCEEEEEEEE-cCCCcEEEEEEEec----------------cHHHHHHHHHHHHHHHHHHhcccccc
Confidence            35799999999999999999974 46789999999842                1223345566777766663 44    


Q ss_pred             -CccccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEE
Q 011360          266 -NILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVL  344 (487)
Q Consensus       266 -nIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nil  344 (487)
                       +|+++++++...+..|+||||+. |+|.+++..  .....+++..+..++.|++.||.|||. |..||+||||||+|||
T Consensus       116 ~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~al~~lH~-~~~~ivHrDlkp~NIl  191 (382)
T 2vx3_A          116 YYIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRN--TNFRGVSLNLTRKFAQQMCTALLFLAT-PELSIIHCDLKPENIL  191 (382)
T ss_dssp             GGBCCEEEEEEETTEEEEEEECCC-CBHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHTS-TTTCEECCCCSGGGEE
T ss_pred             eeEEEeeeeeccCCceEEEEecCC-CCHHHHHhh--cCcCCCCHHHHHHHHHHHHHHHHHhcc-CCCCEEcCCCCcccEE
Confidence             59999999999999999999995 599999976  233568999999999999999999954 3689999999999999


Q ss_pred             eC--CCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCcccc
Q 011360          345 LN--DDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFH  417 (487)
Q Consensus       345 l~--~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~  417 (487)
                      ++  .++.+||+|||+++......     ....||+.|+|||++.+..++.++|||||||++|||+||.+||...
T Consensus       192 l~~~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~  261 (382)
T 2vx3_A          192 LCNPKRSAIKIVDFGSSCQLGQRI-----YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA  261 (382)
T ss_dssp             ESSTTSCCEEECCCTTCEETTCCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             EecCCCCcEEEEeccCceeccccc-----ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            95  47789999999998764432     3456899999999999999999999999999999999999999543

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=2.7e-40  Score=324.16  Aligned_cols=263  Identities=22%  Similarity=0.333  Sum_probs=196.1

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhcc---CCCCCc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQ---IRHRNI  267 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~---l~hpnI  267 (487)
                      .++|.+.+.||.|+||.||+|.....+++.||+|++.......             .....+.+|+.+++.   +.||||
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~-------------~~~~~~~~e~~~l~~l~~~~h~~i   76 (326)
T 1blx_A           10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-------------GMPLSTIREVAVLRHLETFEHPNV   76 (326)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-------------SCBCTHHHHHHHHHHHHHTCCTTB
T ss_pred             hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc-------------cCCchhhHHHHHHHhhhccCCCCe
Confidence            4579999999999999999998655678999999985432110             011123345555544   489999


Q ss_pred             cccceEEe-----cCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCC
Q 011360          268 LPLLAHMV-----RPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRN  342 (487)
Q Consensus       268 v~l~~~~~-----~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~N  342 (487)
                      +++++++.     .....++||||+. |+|.+++..  .....+++..+..++.|++.||.||   |++||+||||||+|
T Consensus        77 ~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~--~~~~~~~~~~~~~~~~qi~~~l~~l---H~~gi~H~dlkp~N  150 (326)
T 1blx_A           77 VRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFL---HSHRVVHRDLKPQN  150 (326)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGG
T ss_pred             EeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHh--cccCCCCHHHHHHHHHHHHHHHHHH---HHCCceeccCCHHH
Confidence            99999987     5567899999996 699999976  3344589999999999999999999   67789999999999


Q ss_pred             EEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCc
Q 011360          343 VLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEE  422 (487)
Q Consensus       343 ill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~  422 (487)
                      |+++.++.+||+|||++........   .....||+.|+|||++.+..++.++||||||+++|+|++|..||.....   
T Consensus       151 ili~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---  224 (326)
T 1blx_A          151 ILVTSSGQIKLADFGLARIYSFQMA---LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD---  224 (326)
T ss_dssp             EEECTTCCEEECSCCSCCCCCGGGG---GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---
T ss_pred             eEEcCCCCEEEecCcccccccCCCC---ccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH---
Confidence            9999999999999999976543221   1345689999999999998999999999999999999999999954321   


Q ss_pred             cccHHHHHHHHhc-CCC-CCccCCC-------C-------CCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          423 ICSPEWLRKVMNS-KNP-SRAIDPR-------L-------PGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       423 ~~~~~~~~~~~~~-~~~-~~~~~~~-------~-------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                         ......+... ..+ .......       +       ........+..+.+++.+||+.||++|||+.++++
T Consensus       225 ---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          225 ---VDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             ---HHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ---HHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence               1222222211 000 0000000       0       00011123456889999999999999999999984

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=2.7e-40  Score=324.49  Aligned_cols=258  Identities=21%  Similarity=0.326  Sum_probs=178.0

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHH-HhccCCCCCccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII-TASQIRHRNILP  269 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~hpnIv~  269 (487)
                      .++|.+.+.||.|+||.||+|.. ..+++.||||++....              .......+..|.. +++.++||||++
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~~vaiK~~~~~~--------------~~~~~~~~~~e~~~~~~~~~h~niv~   85 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVH-KPSGQIMAVKRIRSTV--------------DEKEQKQLLMDLDVVMRSSDCPYIVQ   85 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEE-TTTTEEEEEEEEECCC--------------CHHHHHHHHHHHHHHHSSCCCTTBCC
T ss_pred             HHHhhehheeccCCCEEEEEEEE-cCCCCEEEEEEeeccc--------------CchHHHHHHHHHHHHHHcCCCCcEee
Confidence            45799999999999999999975 4578999999985321              1122334445554 778889999999


Q ss_pred             cceEEecCCeeEEEEEecCCCCHHHHHhhhh-cCCCCCChHHHHHHHHHHHHHHHHHHhcCCC-CeeecCCCCCCEEeCC
Q 011360          270 LLAHMVRPDCHLLVYEFMKNGSLQDILDDVS-RGRRELDWPSRHRIALGVASGLEYLHMYHSA-SIIHGDIKPRNVLLND  347 (487)
Q Consensus       270 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~-givH~Dlkp~Nill~~  347 (487)
                      +++++...+..++||||+++ +|.+++.... .....+++..+..++.|++.||.||   |+. ||+||||||+||+++.
T Consensus        86 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~l---H~~~~ivH~dlkp~NIll~~  161 (327)
T 3aln_A           86 FYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHL---KENLKIIHRDIKPSNILLDR  161 (327)
T ss_dssp             EEEEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHH---HHHHSCCCSCCCGGGEEEET
T ss_pred             eeeEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHH---hccCCEeECCCCHHHEEEcC
Confidence            99999999999999999975 8888876432 2356789999999999999999999   555 8999999999999999


Q ss_pred             CCCEEEeccCCccccCCCCceeeEeeecccccccCCccc----CCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCcc
Q 011360          348 DMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYF----QQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI  423 (487)
Q Consensus       348 ~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l----~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~  423 (487)
                      ++.+||+|||++.........   ....||+.|+|||++    .+..++.++||||||+++|+|++|..||........ 
T Consensus       162 ~~~~kl~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-  237 (327)
T 3aln_A          162 SGNIKLCDFGISGQLVDSIAK---TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-  237 (327)
T ss_dssp             TTEEEECCCSSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------
T ss_pred             CCCEEEccCCCceeccccccc---ccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-
Confidence            999999999999776443221   234689999999998    456789999999999999999999999954321110 


Q ss_pred             ccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          424 CSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       424 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                          ....... ..     .+.++.......+..+.+++.+||+.||++|||+.+|++
T Consensus       238 ----~~~~~~~-~~-----~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          238 ----QLTQVVK-GD-----PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             ------CCCCC-SC-----CCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ----HHHHHhc-CC-----CCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence                0100111 11     111221111223456899999999999999999999865

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=3.7e-40  Score=329.32  Aligned_cols=256  Identities=24%  Similarity=0.355  Sum_probs=194.3

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .++|.+.+.||.|+||.||+|.. ..+|+.||||++...             .........+.+|+.+++.++||||+++
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~vaiK~~~~~-------------~~~~~~~~~~~~E~~~l~~l~h~niv~~  106 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAID-KRSGEKVAIKKLSRP-------------FQSEIFAKRAYRELLLLKHMQHENVIGL  106 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEE-TTTTEEEEEEEECST-------------TSSHHHHHHHHHHHHHHHHCCCTTBCCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEE-CCCCCEEEEEEeccc-------------ccchhHHHHHHHHHHHHHhcCCCCchhh
Confidence            35799999999999999999974 468999999998431             1223345678899999999999999999


Q ss_pred             ceEEecCCee------EEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEE
Q 011360          271 LAHMVRPDCH------LLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVL  344 (487)
Q Consensus       271 ~~~~~~~~~~------~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nil  344 (487)
                      ++++...+..      |+||||+. ++|.+++.      ..+++..+..++.|++.||.||   |++||+||||||+||+
T Consensus       107 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~L---H~~~ivH~Dikp~NIl  176 (371)
T 4exu_A          107 LDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYI---HSAGVVHRDLKPGNLA  176 (371)
T ss_dssp             SEEECSCSSSTTCCCCEEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEE
T ss_pred             hhheeccCCcccceeEEEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHH---HHCCCcCCCcCHHHeE
Confidence            9999877665      99999996 68887763      4589999999999999999999   6778999999999999


Q ss_pred             eCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCccccCCCCcc
Q 011360          345 LNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQ-PELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI  423 (487)
Q Consensus       345 l~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~  423 (487)
                      ++.++.+||+|||+++.....     .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.....    
T Consensus       177 l~~~~~~kL~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----  247 (371)
T 4exu_A          177 VNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY----  247 (371)
T ss_dssp             ECTTCCEEECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH----
T ss_pred             ECCCCCEEEEecCcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCh----
Confidence            999999999999999765432     134568999999999887 6889999999999999999999999954321    


Q ss_pred             ccHHHHHHHHh-cCCCCCccC---------------CCCCCCC----cHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          424 CSPEWLRKVMN-SKNPSRAID---------------PRLPGNG----YEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       424 ~~~~~~~~~~~-~~~~~~~~~---------------~~~~~~~----~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                        .+....... .+.+.....               +..+...    ....+..+.+++.+||+.||++|||+.++++
T Consensus       248 --~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          248 --LDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             --HHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             --HHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence              111111111 000000000               0000000    0112457899999999999999999999975

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=8.1e-41  Score=336.65  Aligned_cols=256  Identities=21%  Similarity=0.296  Sum_probs=191.2

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      ..+|.+.+.||.|+||.||+|++.  .+..+|+|++....                   ....+|+.+++.++||||+++
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~--~~~~~aikk~~~~~-------------------~~~~~E~~il~~l~h~niv~l   97 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLV--ESDEVAIKKVLQDK-------------------RFKNRELQIMRIVKHPNVVDL   97 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEET--TTEEEEEEEEECCT-------------------TSCCHHHHHHHTCCCTTBCCE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEEC--CCCeEEEEEEecCc-------------------chHHHHHHHHHhCCCCCcceE
Confidence            346999999999999999999864  34459999874311                   111358999999999999999


Q ss_pred             ceEEecCCe------eEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEE
Q 011360          271 LAHMVRPDC------HLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVL  344 (487)
Q Consensus       271 ~~~~~~~~~------~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nil  344 (487)
                      ++++.....      +++||||+++ ++...+.........+++..++.++.|++.||.||   |++||+||||||+|||
T Consensus        98 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~L---H~~~ivHrDlkp~Nil  173 (394)
T 4e7w_A           98 KAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYI---HSIGICHRDIKPQNLL  173 (394)
T ss_dssp             EEEEEEESSSSSCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEE
T ss_pred             EEEEEecCCCCCceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH---HHCCccCCCCCHHHEE
Confidence            999865433      7899999976 45555544444567899999999999999999999   6778999999999999


Q ss_pred             eC-CCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCccccCCCCc
Q 011360          345 LN-DDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQP-ELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEE  422 (487)
Q Consensus       345 l~-~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~  422 (487)
                      ++ .++.+||+|||+++........   ....||+.|+|||++.+. .|+.++|||||||++|+|++|.+||.+...   
T Consensus       174 l~~~~~~~kL~DFG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~---  247 (394)
T 4e7w_A          174 LDPPSGVLKLIDFGSAKILIAGEPN---VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG---  247 (394)
T ss_dssp             EETTTTEEEECCCTTCEECCTTCCC---CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---
T ss_pred             EcCCCCcEEEeeCCCcccccCCCCC---cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---
Confidence            99 7899999999999876444322   345689999999998764 589999999999999999999999954321   


Q ss_pred             cccHHHHHHHHh--------------cCCCCCccCCCCCCCC-----cHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          423 ICSPEWLRKVMN--------------SKNPSRAIDPRLPGNG-----YEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       423 ~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                         .+.+..+..              .......++ ......     ....+.++.+++.+||+.||++|||+.++++
T Consensus       248 ---~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (394)
T 4e7w_A          248 ---IDQLVEIIKVLGTPSREQIKTMNPNYMEHKFP-QIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC  321 (394)
T ss_dssp             ---HHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCC-CCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ---HHHHHHHHHHhCCCCHHHHHhhChhhhhhccc-cccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence               111111111              000000010 011111     1113457899999999999999999999975

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2.4e-40  Score=340.09  Aligned_cols=262  Identities=24%  Similarity=0.277  Sum_probs=201.8

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCC-CCccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRH-RNILP  269 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~  269 (487)
                      .++|.+.+.||.|+||.||+|.+ ..+++.||||++....                 ....+..|+.++..+.| ++|..
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~-~~~~~~vAvK~~~~~~-----------------~~~~~~~E~~il~~L~~~~~i~~   67 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTN-IQTNEEVAIKLENVKT-----------------KHPQLLYESKIYRILQGGTGIPN   67 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEE-TTTCCEEEEEEEETTC-----------------SSCCHHHHHHHHHHTTTSTTCCC
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEE-CCCCcEEEEEEecccc-----------------ccHHHHHHHHHHHHhcCCCCCCe
Confidence            35799999999999999999974 4578999999864211                 11246778999999977 55556


Q ss_pred             cceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEe---C
Q 011360          270 LLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLL---N  346 (487)
Q Consensus       270 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill---~  346 (487)
                      +..++...+..++||||+ +++|.+++...   ...+++..++.++.||+.||.||   |++||+||||||+|||+   +
T Consensus        68 i~~~~~~~~~~~lvme~~-g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yL---H~~gIvHrDIKP~NILl~~~~  140 (483)
T 3sv0_A           68 VRWFGVEGDYNVLVMDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFV---HSKSFLHRDIKPDNFLMGLGR  140 (483)
T ss_dssp             EEEEEEETTEEEEEEECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECCGG
T ss_pred             EEEEEeeCCEEEEEEECC-CCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHH---HHCCEeecccCcceEEEecCC
Confidence            666667788899999999 99999999742   45799999999999999999999   67789999999999999   5


Q ss_pred             CCCCEEEeccCCccccCCCCcee-----eEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCC
Q 011360          347 DDMEACISDLGLAMAIPDGYTRV-----LISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGE  421 (487)
Q Consensus       347 ~~~~~kl~DFg~s~~~~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~  421 (487)
                      .++.+||+|||+++.........     ......||+.|+|||++.+..++.++|||||||++|||++|..||.......
T Consensus       141 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~  220 (483)
T 3sv0_A          141 RANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT  220 (483)
T ss_dssp             GTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS
T ss_pred             CCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchh
Confidence            78999999999998765433211     1125679999999999999999999999999999999999999996544322


Q ss_pred             ccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          422 EICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       422 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      .......+....... ....+...+        +.++.+++..||+.+|++||++.+|++.|+.+
T Consensus       221 ~~~~~~~i~~~~~~~-~~~~l~~~~--------p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l  276 (483)
T 3sv0_A          221 KKQKYEKISEKKVAT-SIEALCRGY--------PTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL  276 (483)
T ss_dssp             HHHHHHHHHHHHHHS-CHHHHHTTS--------CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHhhccccc-cHHHHhcCC--------cHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            211111111111000 000011112        25689999999999999999999999999876

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=7.2e-40  Score=325.73  Aligned_cols=264  Identities=23%  Similarity=0.262  Sum_probs=186.4

Q ss_pred             hccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccc
Q 011360          190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILP  269 (487)
Q Consensus       190 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~  269 (487)
                      ..++|.+.+.||.|+||.||+|+. ..++..||||++....                .......+++..+..++||||++
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~~----------------~~~~~~~~~~~~l~~l~h~niv~   83 (360)
T 3e3p_A           21 EMDRFQVERMAGQGTFGTVQLGKE-KSTGMSVAIKKVIQDP----------------RFRNRELQIMQDLAVLHHPNIVQ   83 (360)
T ss_dssp             HHTTEEEC----------CEEEEE-TTTCCEEEEEEEECCT----------------TCCCHHHHHHHHHHHHCCTTBCC
T ss_pred             hccceEEEEEEecCCCeEEEEEEE-CCCCCEEEEEEEecCc----------------cccHHHHHHHHHHHhcCCCCccc
Confidence            345799999999999999999975 4578999999884311                11123456677778889999999


Q ss_pred             cceEEecCCe-------eEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCC
Q 011360          270 LLAHMVRPDC-------HLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRN  342 (487)
Q Consensus       270 l~~~~~~~~~-------~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~N  342 (487)
                      +++++...+.       .++||||+++ +|.+.+.........+++..+..++.|++.||.|||. |++||+||||||+|
T Consensus        84 ~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~~~ivH~Dlkp~N  161 (360)
T 3e3p_A           84 LQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHL-PSVNVCHRDIKPHN  161 (360)
T ss_dssp             EEEEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTS-TTTCCBCSCCCGGG
T ss_pred             HHHhhhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhC-CCCCeecCcCCHHH
Confidence            9999876433       7899999965 6666665544556788999999999999999999942 38999999999999


Q ss_pred             EEeCC-CCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCccccCCC
Q 011360          343 VLLND-DMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQP-ELSEKCDIFSFGMLLISLVRGVPSFVFHQNG  420 (487)
Q Consensus       343 ill~~-~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DvwslG~~l~elltg~~pf~~~~~~  420 (487)
                      ||++. ++.+||+|||++.........   ....||+.|+|||++.+. .++.++|||||||++|+|++|..||..... 
T Consensus       162 Ill~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~-  237 (360)
T 3e3p_A          162 VLVNEADGTLKLCDFGSAKKLSPSEPN---VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS-  237 (360)
T ss_dssp             EEEETTTTEEEECCCTTCBCCCTTSCC---CSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-
T ss_pred             EEEeCCCCcEEEeeCCCceecCCCCCc---ccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCCh-
Confidence            99996 899999999999876544322   345689999999998654 589999999999999999999999954321 


Q ss_pred             CccccHHHHHHHHhc-CCCC-----------CccC-CCCCC--------CCcHHHHHHHHHHHhhccCCCCCCCCChHHH
Q 011360          421 EEICSPEWLRKVMNS-KNPS-----------RAID-PRLPG--------NGYEKKMLHVLKIAYICTLHDPEERPNSQYV  479 (487)
Q Consensus       421 ~~~~~~~~~~~~~~~-~~~~-----------~~~~-~~~~~--------~~~~~~~~~l~~li~~cl~~~P~~RPs~~~i  479 (487)
                           ......+... +.+.           ...+ .....        ......+.++.+++.+||+.||.+|||+.++
T Consensus       238 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~  312 (360)
T 3e3p_A          238 -----AGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEA  312 (360)
T ss_dssp             -----HHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             -----HHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHH
Confidence                 1112211110 0000           0000 00000        0111245679999999999999999999998


Q ss_pred             HH
Q 011360          480 RC  481 (487)
Q Consensus       480 l~  481 (487)
                      ++
T Consensus       313 l~  314 (360)
T 3e3p_A          313 LC  314 (360)
T ss_dssp             TT
T ss_pred             hc
Confidence            75

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=5e-40  Score=327.26  Aligned_cols=270  Identities=21%  Similarity=0.244  Sum_probs=193.4

Q ss_pred             hccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccc
Q 011360          190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILP  269 (487)
Q Consensus       190 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~  269 (487)
                      ..+.|.+.+.||.|+||.||+|...  ++..||||++..........    .........+.+.+|+.++.+++||||++
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~----~~~~~~~~~~~~~~E~~~l~~l~h~~iv~   93 (362)
T 3pg1_A           20 MQSPYTVQRFISSGSYGAVCAGVDS--EGIPVAIKRVFNTVSDGRTV----NILSDSFLCKRVLREIRLLNHFHHPNILG   93 (362)
T ss_dssp             TTCSCEEEEEEEEETTEEEEEEECT--TSCEEEEEEECEECCTTSCE----EGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             hccceEEeEEeccCCCEEEEEEECC--CCCeEEEEeccccCCccchh----hhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence            4568999999999999999999753  58999999985533211100    01122334577899999999999999999


Q ss_pred             cceEEec-----CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEE
Q 011360          270 LLAHMVR-----PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVL  344 (487)
Q Consensus       270 l~~~~~~-----~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nil  344 (487)
                      +++++..     ....|+||||++ |+|.+++..   ....+++..+..++.|++.||.||   |++||+||||||+||+
T Consensus        94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~l---H~~~ivH~Dlkp~NIl  166 (362)
T 3pg1_A           94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVL---HEAGVVHRDLHPGNIL  166 (362)
T ss_dssp             CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEE
T ss_pred             eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHH---HHCcCEecCCChHHEE
Confidence            9999854     346799999996 688888763   345789999999999999999999   6678999999999999


Q ss_pred             eCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCccccCCCCcc
Q 011360          345 LNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQ-PELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI  423 (487)
Q Consensus       345 l~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~  423 (487)
                      ++.++.+||+|||++........   .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.....    
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~----  239 (362)
T 3pg1_A          167 LADNNDITICDFNLAREDTADAN---KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF----  239 (362)
T ss_dssp             ECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----
T ss_pred             EcCCCCEEEEecCcccccccccc---cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCH----
Confidence            99999999999999975433322   234568999999999876 6789999999999999999999999954321    


Q ss_pred             ccHHHHHHHHhc-CCCCC----------------ccCCCCCCCC----cHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          424 CSPEWLRKVMNS-KNPSR----------------AIDPRLPGNG----YEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       424 ~~~~~~~~~~~~-~~~~~----------------~~~~~~~~~~----~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                        .+....+... +.+..                ......+...    .......+.+++.+||+.||++|||+.++++
T Consensus       240 --~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          240 --YNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             --HHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --HHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence              1111111110 00000                0000011111    1112356889999999999999999999985

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.5e-40  Score=334.53  Aligned_cols=269  Identities=22%  Similarity=0.302  Sum_probs=181.8

Q ss_pred             ccccc-ccccccccceeEEEEEec-CCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccc
Q 011360          192 DCFAS-LEKIGSGGCGEVYKAELP-GSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILP  269 (487)
Q Consensus       192 ~~~~~-~~~lg~G~~g~v~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~  269 (487)
                      +.|.+ .++||.|+||.||+|++. ..++..||||++....                 ....+.+|+.+++.++||||++
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-----------------~~~~~~~E~~~l~~l~hpniv~   82 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-----------------ISMSACREIALLRELKHPNVIS   82 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS-----------------CCHHHHHHHHHHHHCCCTTBCC
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC-----------------CCHHHHHHHHHHHhcCCCCeee
Confidence            34666 457999999999999864 2468899999873211                 1134678999999999999999


Q ss_pred             cceEEec--CCeeEEEEEecCCCCHHHHHhhhhc-----CCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCC
Q 011360          270 LLAHMVR--PDCHLLVYEFMKNGSLQDILDDVSR-----GRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRN  342 (487)
Q Consensus       270 l~~~~~~--~~~~~lv~E~~~~gsL~~~l~~~~~-----~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~N  342 (487)
                      +++++..  ...+|+||||+. |+|.+++.....     ....+++..++.++.|++.||.||   |++||+||||||+|
T Consensus        83 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~L---H~~~ivH~Dlkp~N  158 (405)
T 3rgf_A           83 LQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL---HANWVLHRDLKPAN  158 (405)
T ss_dssp             CCEEEEETTTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGG
T ss_pred             EeeEEecCCCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHH---HhCCEeCCCcCHHH
Confidence            9999954  678999999995 588888764321     123589999999999999999999   67789999999999


Q ss_pred             EEe----CCCCCEEEeccCCccccCCCCce-eeEeeecccccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCccc
Q 011360          343 VLL----NDDMEACISDLGLAMAIPDGYTR-VLISYVLGTMAYIAPEYFQQP-ELSEKCDIFSFGMLLISLVRGVPSFVF  416 (487)
Q Consensus       343 ill----~~~~~~kl~DFg~s~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~-~~~~~~DvwslG~~l~elltg~~pf~~  416 (487)
                      ||+    +.++.+||+|||+++........ .......||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+
T Consensus       159 Ill~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~  238 (405)
T 3rgf_A          159 ILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  238 (405)
T ss_dssp             EEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             eEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCC
Confidence            999    67789999999999876543211 122346789999999998874 589999999999999999999999965


Q ss_pred             cCCCCc---cccHHHHHHHHh-cCCCCCccCCCC---C---------------CCCcH--------HHHHHHHHHHhhcc
Q 011360          417 HQNGEE---ICSPEWLRKVMN-SKNPSRAIDPRL---P---------------GNGYE--------KKMLHVLKIAYICT  466 (487)
Q Consensus       417 ~~~~~~---~~~~~~~~~~~~-~~~~~~~~~~~~---~---------------~~~~~--------~~~~~l~~li~~cl  466 (487)
                      ......   ....+.+..+.. -+.+....-+.+   +               .....        .....+.+++.+||
T Consensus       239 ~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L  318 (405)
T 3rgf_A          239 RQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLL  318 (405)
T ss_dssp             CC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHS
T ss_pred             ccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHc
Confidence            433110   111122222211 111110000000   0               00000        00346889999999


Q ss_pred             CCCCCCCCChHHHHH
Q 011360          467 LHDPEERPNSQYVRC  481 (487)
Q Consensus       467 ~~~P~~RPs~~~il~  481 (487)
                      ..||++|||+.++++
T Consensus       319 ~~dP~~R~ta~e~L~  333 (405)
T 3rgf_A          319 TMDPIKRITSEQAMQ  333 (405)
T ss_dssp             CSSGGGSCCHHHHHT
T ss_pred             cCCcccCCCHHHHhc
Confidence            999999999999985

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=4.9e-40  Score=328.45  Aligned_cols=262  Identities=22%  Similarity=0.297  Sum_probs=195.4

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCC--------
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIR--------  263 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--------  263 (487)
                      ++|.+.+.||.|+||.||+|+. ..+++.||||++..                .......+.+|+.++.++.        
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~----------------~~~~~~~~~~e~~~l~~l~~~~~~~~~   81 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKD-MVNNTHVAMKIVRG----------------DKVYTEAAEDEIKLLQRVNDADNTKED   81 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEE-TTTTEEEEEEEECS----------------CHHHHHHHHHHHHHHHHHHHTCCSHHH
T ss_pred             CeEEEEEeeeecCCeEEEEEEe-cCCCcEEEEEEecC----------------CccchhhhhHHHHHHHHhhcccccchh
Confidence            4699999999999999999974 46889999998832                1123345667777777765        


Q ss_pred             ---CCCccccceEEecCC----eeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCC-Ceee
Q 011360          264 ---HRNILPLLAHMVRPD----CHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSA-SIIH  335 (487)
Q Consensus       264 ---hpnIv~l~~~~~~~~----~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~-givH  335 (487)
                         ||||+++++++...+    ..++||||+ +++|.+++...  ....+++..+..++.|++.||.||   |++ ||+|
T Consensus        82 ~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~l---H~~~~ivH  155 (373)
T 1q8y_A           82 SMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYM---HRRCGIIH  155 (373)
T ss_dssp             HHHHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHH---HHTTCEEC
T ss_pred             ccccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHh--hccCCcHHHHHHHHHHHHHHHHHH---HhcCCEEe
Confidence               899999999988654    789999999 89999999763  345689999999999999999999   665 8999


Q ss_pred             cCCCCCCEEeC------CCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh
Q 011360          336 GDIKPRNVLLN------DDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR  409 (487)
Q Consensus       336 ~Dlkp~Nill~------~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt  409 (487)
                      |||||+|||++      ..+.+||+|||++.......     ....||+.|+|||++.+..++.++|||||||++|+|+|
T Consensus       156 ~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~  230 (373)
T 1q8y_A          156 TDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELIT  230 (373)
T ss_dssp             SCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHH
T ss_pred             cCCChHHeEEeccCCCcCcceEEEcccccccccCCCC-----CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHh
Confidence            99999999994      44579999999998764432     23468999999999999999999999999999999999


Q ss_pred             CCCCccccCCCCccccHHHHHHHHh--cCCCCC----------------ccCC--CC-----------CCCCcHHHHHHH
Q 011360          410 GVPSFVFHQNGEEICSPEWLRKVMN--SKNPSR----------------AIDP--RL-----------PGNGYEKKMLHV  458 (487)
Q Consensus       410 g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~----------------~~~~--~~-----------~~~~~~~~~~~l  458 (487)
                      |..||.................+..  +..+..                .+..  ..           ...........+
T Consensus       231 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (373)
T 1q8y_A          231 GDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEI  310 (373)
T ss_dssp             SSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHH
T ss_pred             CCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHH
Confidence            9999965543221111111211111  000000                0000  00           001234667889


Q ss_pred             HHHHhhccCCCCCCCCChHHHHH
Q 011360          459 LKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       459 ~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .+++.+||+.||++|||+.++++
T Consensus       311 ~~li~~~L~~dP~~Rpt~~ell~  333 (373)
T 1q8y_A          311 SDFLSPMLQLDPRKRADAGGLVN  333 (373)
T ss_dssp             HHHHGGGGCSSTTTCBCHHHHHT
T ss_pred             HHHHHHHhccCccccCCHHHHhh
Confidence            99999999999999999999986

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.7e-39  Score=321.93  Aligned_cols=259  Identities=19%  Similarity=0.291  Sum_probs=195.8

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCC-----
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRN-----  266 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-----  266 (487)
                      ++|.+.+.||+|+||.||+|.....++..||+|++..                .......+.+|+.+++.++|++     
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~----------------~~~~~~~~~~E~~~l~~l~~~~~~~~~   82 (355)
T 2eu9_A           19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN----------------VGKYREAARLEINVLKKIKEKDKENKF   82 (355)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS----------------CHHHHHHHHHHHHHHHHHHHHCTTSCS
T ss_pred             ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc----------------cccchhHHHHHHHHHHHHhhcCCCCce
Confidence            4699999999999999999986544457999999832                1223455667888887776655     


Q ss_pred             -ccccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEe
Q 011360          267 -ILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLL  345 (487)
Q Consensus       267 -Iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill  345 (487)
                       ++.+++++...+..++||||+ +++|.+++..  .....+++..+..++.|++.||.||   |++||+||||||+|||+
T Consensus        83 ~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~--~~~~~~~~~~~~~i~~qi~~~L~~l---H~~~ivH~Dlkp~NIll  156 (355)
T 2eu9_A           83 LCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKE--NNFQPYPLPHVRHMAYQLCHALRFL---HENQLTHTDLKPENILF  156 (355)
T ss_dssp             CBCCEEEEEEETTEEEEEEECC-CCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCCGGGEEE
T ss_pred             eEEEeeeeeeeCCeEEEEEecc-CCChHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEEE
Confidence             899999999999999999999 6778777765  3335789999999999999999999   77899999999999999


Q ss_pred             -------------------CCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHH
Q 011360          346 -------------------NDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLIS  406 (487)
Q Consensus       346 -------------------~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~e  406 (487)
                                         +.++.+||+|||++.......     ....||+.|+|||++.+..++.++||||||+++|+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~e  231 (355)
T 2eu9_A          157 VNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFE  231 (355)
T ss_dssp             SCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHH
T ss_pred             ecccccccccccccccccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHH
Confidence                               567899999999997654332     34568999999999999999999999999999999


Q ss_pred             HHhCCCCccccCCCCccccHHHHHHHHhcCCCCCcc----------C--CCCC-------------------CCCcHHHH
Q 011360          407 LVRGVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAI----------D--PRLP-------------------GNGYEKKM  455 (487)
Q Consensus       407 lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~--~~~~-------------------~~~~~~~~  455 (487)
                      |++|..||.......   ....+.... ...+...+          .  ..++                   ........
T Consensus       232 l~~g~~pf~~~~~~~---~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (355)
T 2eu9_A          232 YYRGFTLFQTHENRE---HLVMMEKIL-GPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEH  307 (355)
T ss_dssp             HHHSSCSCCCSSHHH---HHHHHHHHH-CCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHH
T ss_pred             HHhCCCCCCCCCHHH---HHHHHHHHc-CCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhH
Confidence            999999995432210   001111111 11110000          0  0000                   01122345


Q ss_pred             HHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          456 LHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       456 ~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ..+.+++.+||+.||++|||+.++++
T Consensus       308 ~~l~~li~~~L~~dP~~Rpt~~e~l~  333 (355)
T 2eu9_A          308 VQLFDLMRRMLEFDPAQRITLAEALL  333 (355)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             HHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            67899999999999999999999874

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.1e-39  Score=323.51  Aligned_cols=260  Identities=22%  Similarity=0.306  Sum_probs=195.4

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||.|+||.||+|.. ..+|+.||||++...              ........+.+|+.+++.++||||++++
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~~--------------~~~~~~~~~~~E~~~l~~l~h~~iv~~~   75 (353)
T 2b9h_A           11 SDFQLKSLLGEGAYGVVCSATH-KPTGEIVAIKKIEPF--------------DKPLFALRTLREIKILKHFKHENIITIF   75 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEE-TTTTEEEEEEEECCC--------------SSHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cceEEeeEEcCCCCeEEEEEEE-CCCCcEEEEEeeccc--------------ccchHHHHHHHHHHHHHhCcCCCcCCee
Confidence            4699999999999999999975 457899999988431              1223445677899999999999999999


Q ss_pred             eEEecC-----CeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC
Q 011360          272 AHMVRP-----DCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN  346 (487)
Q Consensus       272 ~~~~~~-----~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~  346 (487)
                      +++...     ...|+||||+. |+|.+++..     ..+++..+..++.|++.||.||   |++||+||||||+||+++
T Consensus        76 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~L---H~~~ivH~Dlkp~Nil~~  146 (353)
T 2b9h_A           76 NIQRPDSFENFNEVYIIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVL---HGSNVIHRDLKPSNLLIN  146 (353)
T ss_dssp             EECCCSCSTTCCCEEEEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEEC
T ss_pred             eeecccccCccceEEEEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHH---HHCCeecCCCCHHHeEEc
Confidence            987654     67899999996 699998874     4689999999999999999999   677899999999999999


Q ss_pred             CCCCEEEeccCCccccCCCCcee--------eEeeecccccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCcccc
Q 011360          347 DDMEACISDLGLAMAIPDGYTRV--------LISYVLGTMAYIAPEYFQQ-PELSEKCDIFSFGMLLISLVRGVPSFVFH  417 (487)
Q Consensus       347 ~~~~~kl~DFg~s~~~~~~~~~~--------~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwslG~~l~elltg~~pf~~~  417 (487)
                      .++.+||+|||++..........        ......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...
T Consensus       147 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  226 (353)
T 2b9h_A          147 SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGR  226 (353)
T ss_dssp             TTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             CCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            99999999999998765332111        1123468999999998754 67899999999999999999999999543


Q ss_pred             CCCCccccHHHHHHHHh-cCCCCCccC----------------CCCCCCC----cHHHHHHHHHHHhhccCCCCCCCCCh
Q 011360          418 QNGEEICSPEWLRKVMN-SKNPSRAID----------------PRLPGNG----YEKKMLHVLKIAYICTLHDPEERPNS  476 (487)
Q Consensus       418 ~~~~~~~~~~~~~~~~~-~~~~~~~~~----------------~~~~~~~----~~~~~~~l~~li~~cl~~~P~~RPs~  476 (487)
                      ..      ......+.. .+.+....+                +..+...    ....+..+.+++.+||+.||++|||+
T Consensus       227 ~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  300 (353)
T 2b9h_A          227 DY------RHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITA  300 (353)
T ss_dssp             SH------HHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCH
T ss_pred             Cc------HHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCH
Confidence            21      111111110 010000000                0000000    01234568899999999999999999


Q ss_pred             HHHHH
Q 011360          477 QYVRC  481 (487)
Q Consensus       477 ~~il~  481 (487)
                      .++++
T Consensus       301 ~ell~  305 (353)
T 2b9h_A          301 KEALE  305 (353)
T ss_dssp             HHHHT
T ss_pred             HHHhc
Confidence            99985

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1e-39  Score=318.85  Aligned_cols=260  Identities=22%  Similarity=0.349  Sum_probs=189.2

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .++|.+.+.||.|+||.||+|.. ..+++.||+|++...               .....+.+.+|+.+++.++||||+++
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~~---------------~~~~~~~~~~e~~~l~~l~h~~iv~~   73 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVD-NDCDKRVAIKKIVLT---------------DPQSVKHALREIKIIRRLDHDNIVKV   73 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEE-TTTTEEEEEEEEECC---------------SHHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred             CCceeEEEEeccCCCeEEEEEEE-CCCCeEEEEEEEecC---------------ChHHHHHHHHHHHHHHhcCCCCeeEE
Confidence            35799999999999999999975 457899999988431               23345678899999999999999999


Q ss_pred             ceEEe--------------cCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 011360          271 LAHMV--------------RPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHG  336 (487)
Q Consensus       271 ~~~~~--------------~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~  336 (487)
                      ++++.              .....|+||||++ |+|.+++..     ..+++..++.++.|++.||.||   |++||+||
T Consensus        74 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~  144 (320)
T 2i6l_A           74 FEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYI---HSANVLHR  144 (320)
T ss_dssp             EEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHH---HHTTCBCC
T ss_pred             EEeccccccccccccccccccCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHH---HhCCEecC
Confidence            99874              3467899999997 699998853     5689999999999999999999   67789999


Q ss_pred             CCCCCCEEeC-CCCCEEEeccCCccccCCCCce-eeEeeecccccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCC
Q 011360          337 DIKPRNVLLN-DDMEACISDLGLAMAIPDGYTR-VLISYVLGTMAYIAPEYFQQ-PELSEKCDIFSFGMLLISLVRGVPS  413 (487)
Q Consensus       337 Dlkp~Nill~-~~~~~kl~DFg~s~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwslG~~l~elltg~~p  413 (487)
                      ||||+||+++ .++.+||+|||++......... .......+|+.|+|||.+.+ ..++.++||||||+++|+|++|..|
T Consensus       145 dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~p  224 (320)
T 2i6l_A          145 DLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTL  224 (320)
T ss_dssp             CCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred             CCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCC
Confidence            9999999997 5678999999999876432211 11133457899999998765 6789999999999999999999999


Q ss_pred             ccccCCCCccccHHHHHHHHhcCCCCC------------------ccCCCCC-CCCcHHHHHHHHHHHhhccCCCCCCCC
Q 011360          414 FVFHQNGEEICSPEWLRKVMNSKNPSR------------------AIDPRLP-GNGYEKKMLHVLKIAYICTLHDPEERP  474 (487)
Q Consensus       414 f~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~-~~~~~~~~~~l~~li~~cl~~~P~~RP  474 (487)
                      |.....      .+....+........                  ...+..+ .......+..+.+++.+||+.||++||
T Consensus       225 f~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp  298 (320)
T 2i6l_A          225 FAGAHE------LEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRL  298 (320)
T ss_dssp             SCCSSH------HHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSC
T ss_pred             CCCCCH------HHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccC
Confidence            954321      111222211110000                  0000000 000011235689999999999999999


Q ss_pred             ChHHHHH
Q 011360          475 NSQYVRC  481 (487)
Q Consensus       475 s~~~il~  481 (487)
                      |+.++++
T Consensus       299 t~~ell~  305 (320)
T 2i6l_A          299 TAEEALS  305 (320)
T ss_dssp             CHHHHHT
T ss_pred             CHHHHhC
Confidence            9999975

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=4e-40  Score=324.58  Aligned_cols=252  Identities=21%  Similarity=0.317  Sum_probs=169.7

Q ss_pred             ccccccc-ccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          192 DCFASLE-KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       192 ~~~~~~~-~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      ++|.+.+ .||.|+||.||+|.. ..+++.||||++...                .....   .....+..+.||||+++
T Consensus        28 ~~y~i~~~~lG~G~~g~V~~~~~-~~~~~~vavK~~~~~----------------~~~~~---e~~~~~~~~~h~~i~~~   87 (336)
T 3fhr_A           28 DDYQLSKQVLGLGVNGKVLECFH-RRTGQKCALKLLYDS----------------PKARQ---EVDHHWQASGGPHIVCI   87 (336)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEE-TTTCCEEEEEEEESS----------------HHHHH---HHHHHHHHTTSTTBCCE
T ss_pred             ceeEecceeeeeCCCeEEEEEEE-CCCCCEEEEEEecCc----------------HHHHH---HHHHHHHhcCCCChHHH
Confidence            4688865 699999999999975 467899999988320                11111   12223456799999999


Q ss_pred             ceEEec----CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC
Q 011360          271 LAHMVR----PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN  346 (487)
Q Consensus       271 ~~~~~~----~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~  346 (487)
                      ++++..    ....++||||+++|+|.+++..  .....+++..++.++.|++.||.||   |++||+||||||+||+++
T Consensus        88 ~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~ql~~~l~~L---H~~~ivH~dlkp~NIll~  162 (336)
T 3fhr_A           88 LDVYENMHHGKRCLLIIMECMEGGELFSRIQE--RGDQAFTEREAAEIMRDIGTAIQFL---HSHNIAHRDVKPENLLYT  162 (336)
T ss_dssp             EEEEEEEETTEEEEEEEEECCTTEEHHHHHHT--C-CCCCBHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEES
T ss_pred             HHHHhhccCCCceEEEEEeccCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHH---HhCCeecCCCCHHHEEEE
Confidence            999876    4558999999999999999975  3345799999999999999999999   677899999999999998


Q ss_pred             C---CCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCcc
Q 011360          347 D---DMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI  423 (487)
Q Consensus       347 ~---~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~  423 (487)
                      .   ++.+||+|||++........    ....||+.|+|||++.+..++.++||||||+++|+|++|..||.........
T Consensus       163 ~~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~  238 (336)
T 3fhr_A          163 SKEKDAVLKLTDFGFAKETTQNAL----QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAIS  238 (336)
T ss_dssp             CSSTTCCEEECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred             ecCCCceEEEeccccceecccccc----ccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhh
Confidence            6   45599999999976543322    3456899999999998888999999999999999999999999544332110


Q ss_pred             ccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          424 CSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       424 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                        ........ ....      ..+.......+..+.+++.+||+.||++|||+.++++
T Consensus       239 --~~~~~~~~-~~~~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          239 --PGMKRRIR-LGQY------GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             ---------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             --hhHHHhhh-cccc------ccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence              00011111 0000      0111111223456889999999999999999999986

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=2.7e-39  Score=320.86  Aligned_cols=254  Identities=23%  Similarity=0.329  Sum_probs=193.3

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||.|+||.||+|.. ..+|+.||||++...             .........+.+|+.+++.++||||++++
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~~-------------~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   89 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAID-KRSGEKVAIKKLSRP-------------FQSEIFAKRAYRELLLLKHMQHENVIGLL   89 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEE-TTTTEEEEEEEESST-------------TSSHHHHHHHHHHHHHHHHCCCTTBCCCS
T ss_pred             ceEEEeeeEecCCCeEEEEEEE-CCCCCEEEEEEeccc-------------ccchHHHHHHHHHHHHHHhcCCCCcccHh
Confidence            4699999999999999999975 468999999998431             12233456788999999999999999999


Q ss_pred             eEEecCCe------eEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEe
Q 011360          272 AHMVRPDC------HLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLL  345 (487)
Q Consensus       272 ~~~~~~~~------~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill  345 (487)
                      +++...+.      .|+||||+. ++|.+++.      ..+++..+..++.|++.||.||   |++||+||||||+||++
T Consensus        90 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~L---H~~~ivH~dlkp~NIl~  159 (353)
T 3coi_A           90 DVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYI---HSAGVVHRDLKPGNLAV  159 (353)
T ss_dssp             EEECSCSSGGGCCCCEEEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSSCCGGGEEE
T ss_pred             heEecccccccceeEEEEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHH---HHCCcccCCCCHHHEeE
Confidence            99987654      499999996 58877663      3589999999999999999999   67789999999999999


Q ss_pred             CCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccc
Q 011360          346 NDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQ-PELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEIC  424 (487)
Q Consensus       346 ~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~  424 (487)
                      +.++.+||+|||++.......     ....||+.|+|||++.+ ..++.++||||||+++|+|++|..||.....     
T Consensus       160 ~~~~~~kl~Dfg~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----  229 (353)
T 3coi_A          160 NEDCELKILDFGLARHADAEM-----TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY-----  229 (353)
T ss_dssp             CTTCCEEECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCH-----
T ss_pred             CCCCcEEEeecccccCCCCCc-----cccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----
Confidence            999999999999997654321     34568999999999877 6789999999999999999999999954321     


Q ss_pred             cHHHHHHHHhc-CCC--------------------CCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          425 SPEWLRKVMNS-KNP--------------------SRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       425 ~~~~~~~~~~~-~~~--------------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                       .+.+...... +.+                    .....+.+. ......+..+.+++.+||+.||++|||+.++++
T Consensus       230 -~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          230 -LDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             -HHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             -HHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence             1111111110 000                    000000111 111223467899999999999999999999975

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=2.6e-39  Score=315.92  Aligned_cols=255  Identities=20%  Similarity=0.336  Sum_probs=181.3

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .++|.+.+.||.|+||.||+|.. ..+++.||||++....             ......+.+..+..++..++||||+++
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~~-------------~~~~~~~~~~~~~~~~~~~~h~~i~~~   89 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRF-RKTGHVIAVKQMRRSG-------------NKEENKRILMDLDVVLKSHDCPYIVQC   89 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEE-TTTCCEEEEEEEETTS-------------CHHHHHHHHHHHHHHHHTTTCTTBCCE
T ss_pred             hccccccceeeecCCeeEEEEEE-ecCCeEEEEEEecccc-------------cchHHHHHHHHHHHHHHhcCCCceeeE
Confidence            45699999999999999999975 4578999999984321             112223344455567888899999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      ++++...+..++||||+ ++.+..+...   ....+++..+..++.|++.||.|||..  .|++||||||+||+++.++.
T Consensus        90 ~~~~~~~~~~~lv~e~~-~~~~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~  163 (318)
T 2dyl_A           90 FGTFITNTDVFIAMELM-GTCAEKLKKR---MQGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQ  163 (318)
T ss_dssp             EEEEECSSEEEEEECCC-SEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHH--HCCCCCCCCGGGEEECTTSC
T ss_pred             EEEEecCCcEEEEEecc-CCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhh--CCEEeCCCCHHHEEECCCCC
Confidence            99999999999999999 6666665543   245689999999999999999999532  38999999999999999999


Q ss_pred             EEEeccCCccccCCCCceeeEeeecccccccCCcccC-----CCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCcccc
Q 011360          351 ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQ-----QPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICS  425 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~  425 (487)
                      +||+|||++........   .....||+.|+|||++.     ...++.++||||||+++|+|++|..||.....     .
T Consensus       164 ~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~  235 (318)
T 2dyl_A          164 IKLCDFGISGRLVDDKA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT-----D  235 (318)
T ss_dssp             EEECCCTTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS-----H
T ss_pred             EEEEECCCchhccCCcc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc-----c
Confidence            99999999976544322   13456899999999984     45789999999999999999999999943221     2


Q ss_pred             HHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          426 PEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       426 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .+..........+.......+        +.++.+++.+||+.||.+|||+.+|++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~--------~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          236 FEVLTKVLQEEPPLLPGHMGF--------SGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             HHHHHHHHHSCCCCCCSSSCC--------CHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HHHHHHHhccCCCCCCccCCC--------CHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            233333433332211111112        256889999999999999999999875

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=3.4e-39  Score=328.87  Aligned_cols=254  Identities=22%  Similarity=0.306  Sum_probs=184.4

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CCCCcccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RHRNILPL  270 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l  270 (487)
                      +.|.+.+.||+|+||+||.+..  .+|+.||||++...                  ....+.+|+.++..+ +||||+++
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~--~~g~~vAvK~~~~~------------------~~~~~~~E~~~l~~l~~HpnIv~~   74 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGS--FQGRPVAVKRMLID------------------FCDIALMEIKLLTESDDHPNVIRY   74 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEE--SSSSEEEEEEEEGG------------------GHHHHHHHHHHHHHHTTSTTBCCE
T ss_pred             heeeccCeEeeCCCeEEEEEEE--ECCeEEEEEEEcHH------------------HHHHHHHHHHHHHhccCCCCcCeE
Confidence            3466778999999999986643  37899999987320                  123457788888876 89999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCC---CChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRE---LDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLND  347 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~---l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~  347 (487)
                      ++++.+.+..|+|||||. |+|.+++.........   .++..++.++.|++.||.||   |++||+||||||+|||++.
T Consensus        75 ~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDLkp~NILl~~  150 (434)
T 2rio_A           75 YCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL---HSLKIIHRDLKPQNILVST  150 (434)
T ss_dssp             EEEEECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEEC
T ss_pred             EEEEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHH---HHCCccccCCChHhEEEec
Confidence            999999999999999995 6999999753221111   13335678999999999999   6778999999999999975


Q ss_pred             C-------------CCEEEeccCCccccCCCCcee--eEeeecccccccCCcccCC-------CCCCchhHHHHHHHHHH
Q 011360          348 D-------------MEACISDLGLAMAIPDGYTRV--LISYVLGTMAYIAPEYFQQ-------PELSEKCDIFSFGMLLI  405 (487)
Q Consensus       348 ~-------------~~~kl~DFg~s~~~~~~~~~~--~~~~~~gt~~y~aPE~l~~-------~~~~~~~DvwslG~~l~  405 (487)
                      +             +.+||+|||++..........  ......||+.|+|||++.+       ..++.++|||||||++|
T Consensus       151 ~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~  230 (434)
T 2rio_A          151 SSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFY  230 (434)
T ss_dssp             CHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHH
T ss_pred             CcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHH
Confidence            4             479999999998775543211  1234579999999999875       57899999999999999


Q ss_pred             HHHh-CCCCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          406 SLVR-GVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       406 ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ||+| |..||.....      .+  ..........    +..+.......+.++.+++.+||+.||++|||+.++++
T Consensus       231 ellt~g~~Pf~~~~~------~~--~~i~~~~~~~----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          231 YILSKGKHPFGDKYS------RE--SNIIRGIFSL----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             HHHTTSCCTTCSTTT------HH--HHHHHTCCCC----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHhCCCCCCCCchh------hH--HHHhcCCCCc----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            9999 8999943221      11  1122221111    11122234566778999999999999999999999975

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=5.4e-39  Score=337.56  Aligned_cols=266  Identities=22%  Similarity=0.294  Sum_probs=196.9

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||.|+||.||+|.. ..+|..||||++...              ........+.+|+.++..++||||++++
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~-~~tg~~VAVKvi~~~--------------~~~~~~~~~~~Ei~iL~~L~HpnIV~l~   78 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIH-QDTGEQVAIKQCRQE--------------LSPKNRERWCLEIQIMKKLNHPNVVSAR   78 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCC-TTTTCCEEECCCCSC--------------CCHHHHHHHHHHHHHHHHCCBTTBCCEE
T ss_pred             CCeEEEEEEeeCCCeEEEEEEE-CCCCcEEEEEEeccc--------------CCHHHHHHHHHHHHHHHhCCCCCCCcee
Confidence            4699999999999999999964 467899999987431              1233456788999999999999999999


Q ss_pred             eEEec------CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEe
Q 011360          272 AHMVR------PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLL  345 (487)
Q Consensus       272 ~~~~~------~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill  345 (487)
                      +++..      .+..++|||||+||+|.+++... .....+++..++.++.|++.||.||   |+.||+||||||+||++
T Consensus        79 ~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~-~~~~~lse~~i~~I~~QLl~aL~yL---Hs~gIVHrDLKP~NILl  154 (676)
T 3qa8_A           79 EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQF-ENCCGLKEGPIRTLLSDISSALRYL---HENRIIHRDLKPENIVL  154 (676)
T ss_dssp             ECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSS-SCTTCCCSSHHHHHHHHHHHHHHHH---HHTTBCCCCCCSTTEEE
T ss_pred             eeecccccccCCCeEEEEEEeCCCCCHHHHHHhc-ccCCCCCHHHHHHHHHHHHHHHHHH---HHCCCccCCCCHHHeEe
Confidence            98765      67789999999999999999753 2234688999999999999999999   66789999999999999


Q ss_pred             CCCCC---EEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCc
Q 011360          346 NDDME---ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEE  422 (487)
Q Consensus       346 ~~~~~---~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~  422 (487)
                      +.++.   +||+|||++.........   ....||+.|+|||++.+..++.++||||||+++|+|++|..||........
T Consensus       155 ~~~g~~~~vKL~DFG~a~~~~~~~~~---~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~  231 (676)
T 3qa8_A          155 QPGPQRLIHKIIDLGYAKELDQGELC---TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQ  231 (676)
T ss_dssp             ECCSSSCEEEECSCCCCCBTTSCCCC---CCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHH
T ss_pred             ecCCCceeEEEccccccccccccccc---ccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhh
Confidence            97765   899999999876544322   345799999999999999999999999999999999999999954310000


Q ss_pred             ---cccHHHHHHHHhcC--CCCCccC--CCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHH
Q 011360          423 ---ICSPEWLRKVMNSK--NPSRAID--PRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYV  479 (487)
Q Consensus       423 ---~~~~~~~~~~~~~~--~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~i  479 (487)
                         ..............  .....+.  ...+.......+..+.+++.+||..||++|||+.++
T Consensus       232 ~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el  295 (676)
T 3qa8_A          232 WHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN  295 (676)
T ss_dssp             SSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred             hhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence               00000000000000  0000011  112223444567889999999999999999999873

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1e-39  Score=319.49  Aligned_cols=247  Identities=22%  Similarity=0.339  Sum_probs=195.3

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCC--CCCcc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIR--HRNIL  268 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpnIv  268 (487)
                      .++|.+.+.||+|+||.||+|.. ..+++.||||++.........         .......+.+|+.++..+.  ||||+
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~~vavK~~~~~~~~~~~---------~~~~~~~~~~E~~~l~~l~~~~~~i~  111 (320)
T 3a99_A           42 ESQYQVGPLLGSGGFGSVYSGIR-VSDNLPVAIKHVEKDRISDWG---------ELPNGTRVPMEVVLLKKVSSGFSGVI  111 (320)
T ss_dssp             TTTEEEEEECSSSSSCEEEEEEE-TTTTEEEEEEEEEGGGCCCEE---------ECTTCCEEEHHHHHHHHHCSSSCSBC
T ss_pred             cCceEEEEEEeeCCCeEEEEEEE-CCCCcEEEEEEEecccchhhh---------hhhhhhHHHHHHHHHHhhccCCCCce
Confidence            45799999999999999999974 468899999998532111000         0001234556888888885  59999


Q ss_pred             ccceEEecCCeeEEEEEecCC-CCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC-
Q 011360          269 PLLAHMVRPDCHLLVYEFMKN-GSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN-  346 (487)
Q Consensus       269 ~l~~~~~~~~~~~lv~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~-  346 (487)
                      ++++++...+..++|||++.+ ++|.+++..    ...+++..++.++.|++.||.||   |+.||+||||||+||+++ 
T Consensus       112 ~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~L---H~~~ivH~Dlkp~NIll~~  184 (320)
T 3a99_A          112 RLLDWFERPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHC---HNCGVLHRDIKDENILIDL  184 (320)
T ss_dssp             CEEEEEECSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEET
T ss_pred             EEEEEEecCCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHH---HHCCcEeCCCCHHHEEEeC
Confidence            999999999999999999976 899999975    35689999999999999999999   677899999999999999 


Q ss_pred             CCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCC-CchhHHHHHHHHHHHHHhCCCCccccCCCCcccc
Q 011360          347 DDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPEL-SEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICS  425 (487)
Q Consensus       347 ~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~  425 (487)
                      .++.+||+|||++........    ....||+.|+|||++.+..+ +.++||||||+++|+|++|..||....       
T Consensus       185 ~~~~~kL~Dfg~~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-------  253 (320)
T 3a99_A          185 NRGELKLIDFGSGALLKDTVY----TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------  253 (320)
T ss_dssp             TTTEEEECCCTTCEECCSSCB----CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------
T ss_pred             CCCCEEEeeCccccccccccc----cCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-------
Confidence            788999999999987654322    34568999999999876655 688999999999999999999993221       


Q ss_pred             HHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          426 PEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       426 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                           .......   .....++        ..+.+++.+||+.||++|||+.+|++
T Consensus       254 -----~~~~~~~---~~~~~~~--------~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          254 -----EIIRGQV---FFRQRVS--------SECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             -----HHHHCCC---CCSSCCC--------HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -----hhhcccc---cccccCC--------HHHHHHHHHHccCChhhCcCHHHHhc
Confidence                 1111111   1122222        46889999999999999999999986

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=6.7e-39  Score=325.98  Aligned_cols=249  Identities=21%  Similarity=0.299  Sum_probs=182.5

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CCCCcccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RHRNILPL  270 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l  270 (487)
                      ..|.+.+.||.|+||.|+....  .+++.||||++....                  ...+.+|+.+++.+ +||||+++
T Consensus        24 ~~y~~~~~LG~G~~G~V~~~~~--~~~~~vAvK~~~~~~------------------~~~~~~E~~~l~~l~~HpnIv~l   83 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVYRGM--FDNRDVAVKRILPEC------------------FSFADREVQLLRESDEHPNVIRY   83 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEEEEE--SSSSEEEEEEECTTT------------------EEECHHHHHHHHHSCCCTTBCCE
T ss_pred             EEEecCCeeecCcCEEEEEEEE--eCCeEEEEEEECHHH------------------HHHHHHHHHHHHhccCCCCcCeE
Confidence            4599999999999999654332  378899999883210                  11245688899888 89999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC---
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLND---  347 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~---  347 (487)
                      ++++.+....|+|||||. |+|.+++..   .........+..++.|++.||.||   |++||+||||||+|||++.   
T Consensus        84 ~~~~~~~~~~~lv~E~~~-g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~L---H~~~ivHrDlKp~NIll~~~~~  156 (432)
T 3p23_A           84 FCTEKDRQFQYIAIELCA-ATLQEYVEQ---KDFAHLGLEPITLLQQTTSGLAHL---HSLNIVHRDLKPHNILISMPNA  156 (432)
T ss_dssp             EEEEEETTEEEEEEECCS-EEHHHHHHS---SSCCCCSSCHHHHHHHHHHHHHHH---HHTTCCCCCCSTTSEEECCCBT
T ss_pred             EEEEecCCEEEEEEECCC-CCHHHHHHh---cCCCccchhHHHHHHHHHHHHHHH---HHCcCEeCCCCHHHEEEecCCC
Confidence            999999999999999995 599999874   233455556788999999999999   6778999999999999953   


Q ss_pred             --CCCEEEeccCCccccCCCCce-eeEeeecccccccCCcccC---CCCCCchhHHHHHHHHHHHHHh-CCCCccccCCC
Q 011360          348 --DMEACISDLGLAMAIPDGYTR-VLISYVLGTMAYIAPEYFQ---QPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNG  420 (487)
Q Consensus       348 --~~~~kl~DFg~s~~~~~~~~~-~~~~~~~gt~~y~aPE~l~---~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~  420 (487)
                        ...+||+|||+++........ .......||+.|+|||++.   ...++.++|||||||++|||+| |..||..... 
T Consensus       157 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~-  235 (432)
T 3p23_A          157 HGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ-  235 (432)
T ss_dssp             TTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT-
T ss_pred             CCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH-
Confidence              235889999999876543211 1223467999999999997   4567889999999999999999 8999933211 


Q ss_pred             CccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          421 EEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       421 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                            .... ............      ........+.+++.+||+.||++|||+.++++
T Consensus       236 ------~~~~-~~~~~~~~~~~~------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          236 ------RQAN-ILLGACSLDCLH------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             ------HHHH-HHTTCCCCTTSC------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ------HHHH-HHhccCCccccC------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence                  1111 111111111111      11234556789999999999999999999984

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.5e-39  Score=314.43  Aligned_cols=247  Identities=21%  Similarity=0.288  Sum_probs=187.6

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC----CCCC
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI----RHRN  266 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l----~hpn  266 (487)
                      .++|.+.+.||.|+||.||+|.. ..+++.||+|++.........         .......+.+|+.++.++    +|||
T Consensus        30 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~~vavK~~~~~~~~~~~---------~~~~~~~~~~e~~~l~~l~~~~~h~~   99 (312)
T 2iwi_A           30 EAEYRLGPLLGKGGFGTVFAGHR-LTDRLQVAIKVIPRNRVLGWS---------PLSDSVTCPLEVALLWKVGAGGGHPG   99 (312)
T ss_dssp             ---CEEEEEEEEETTEEEEEEEC-TTTCCEEEEEECCSTTTC-----------------CCCCHHHHHHHHHHSSCCCSS
T ss_pred             hhceEEeeEEEcCCCEEEEEEEE-ccCCeEEEEEEEecccccccc---------cchhhHHHHHHHHHHHhhcccCCCCC
Confidence            45799999999999999999964 467899999998432211100         001223345678877777    8999


Q ss_pred             ccccceEEecCCeeEEEEEe-cCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEe
Q 011360          267 ILPLLAHMVRPDCHLLVYEF-MKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLL  345 (487)
Q Consensus       267 Iv~l~~~~~~~~~~~lv~E~-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill  345 (487)
                      |+++++++...+..++|||+ +.+++|.+++..    ...+++..++.++.|++.||.||   |++||+||||||+||++
T Consensus       100 i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~l---H~~~i~H~dlkp~Nil~  172 (312)
T 2iwi_A          100 VIRLLDWFETQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHC---HSRGVVHRDIKDENILI  172 (312)
T ss_dssp             BCCEEEEC-----CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHH---HHHTEECCCCSGGGEEE
T ss_pred             eeeEEEEEecCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeeecCCChhhEEE
Confidence            99999999999999999999 789999999975    34689999999999999999999   66789999999999999


Q ss_pred             C-CCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCC-CchhHHHHHHHHHHHHHhCCCCccccCCCCcc
Q 011360          346 N-DDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPEL-SEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI  423 (487)
Q Consensus       346 ~-~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DvwslG~~l~elltg~~pf~~~~~~~~~  423 (487)
                      + .++.+||+|||++........    ....||+.|+|||++.+..+ +.++||||||+++|+|++|..||....     
T Consensus       173 ~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----  243 (312)
T 2iwi_A          173 DLRRGCAKLIDFGSGALLHDEPY----TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-----  243 (312)
T ss_dssp             ETTTTEEEECCCSSCEECCSSCB----CCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----
T ss_pred             eCCCCeEEEEEcchhhhcccCcc----cccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-----
Confidence            9 889999999999987654322    34568999999999876665 458999999999999999999993211     


Q ss_pred             ccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          424 CSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       424 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                             ..... ..  .    ++..    ....+.+++.+||+.||++|||+.++++
T Consensus       244 -------~~~~~-~~--~----~~~~----~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          244 -------EILEA-EL--H----FPAH----VSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             -------HHHHT-CC--C----CCTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -------HHhhh-cc--C----Cccc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                   11111 11  1    1111    2246889999999999999999999986

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2e-38  Score=340.95  Aligned_cols=240  Identities=21%  Similarity=0.289  Sum_probs=191.0

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||.|+||.||+|.+...+++.||||++...              ........+.+|+.++.+++||||++++
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~--------------~~~~~~~~~~~E~~~l~~l~hp~iv~~~  145 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS--------------GDAEAQAMAMAERQFLAEVVHPSIVQIF  145 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS--------------CCHHHHHHHHHHHGGGGGCCCTTBCCEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc--------------CCHHHHHHHHHHHHHHHhcCCCCcCeEe
Confidence            57999999999999999999875447899999987421              1223455778999999999999999999


Q ss_pred             eEEecCCe-----eEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC
Q 011360          272 AHMVRPDC-----HLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN  346 (487)
Q Consensus       272 ~~~~~~~~-----~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~  346 (487)
                      +++...+.     .|+||||++|++|.+++.      ..+++..++.++.|++.||.||   |++||+||||||+|||++
T Consensus       146 ~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~------~~l~~~~~~~~~~qi~~aL~~l---H~~giiHrDlkp~NIll~  216 (681)
T 2pzi_A          146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEILPALSYL---HSIGLVYNDLKPENIMLT  216 (681)
T ss_dssp             EEEEEECTTSCEEEEEEEECCCCEECC----------CCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEC
T ss_pred             eeEeecCCCCCceeEEEEEeCCCCcHHHHHh------CCCCHHHHHHHHHHHHHHHHHH---HHCCCeecccChHHeEEe
Confidence            99987665     699999999999998764      2689999999999999999999   677899999999999999


Q ss_pred             CCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccH
Q 011360          347 DDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSP  426 (487)
Q Consensus       347 ~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~  426 (487)
                      .+ .+||+|||++......      ....||+.|+|||++.+. ++.++|||||||++|+|++|.+||.......     
T Consensus       217 ~~-~~kl~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~-----  283 (681)
T 2pzi_A          217 EE-QLKLIDLGAVSRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG-----  283 (681)
T ss_dssp             SS-CEEECCCTTCEETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS-----
T ss_pred             CC-cEEEEecccchhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc-----
Confidence            86 8999999999876543      345699999999998764 4899999999999999999998884321100     


Q ss_pred             HHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCC-hHHHHHHHhh
Q 011360          427 EWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPN-SQYVRCRLSQ  485 (487)
Q Consensus       427 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-~~~il~~L~~  485 (487)
                                .+        ...........+.+++.+||+.||++||+ ++++...|..
T Consensus       284 ----------~~--------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          284 ----------LP--------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             ----------CC--------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             ----------cc--------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence                      00        00111223456889999999999999995 5556655544

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=7.5e-38  Score=301.13  Aligned_cols=232  Identities=16%  Similarity=0.121  Sum_probs=180.8

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||.|+||.||+|.. ..+++.||||++....            .........+.+|+..+.+++||||++++
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~-~~~~~~vavK~~~~~~------------~~~~~~~~~~~~e~~~l~~l~hp~iv~~~   97 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALD-TALDRQVALTFVDPQG------------VLPDDVLQETLSRTLRLSRIDKPGVARVL   97 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEE-TTTTEEEEEEESCTTC------------CSCHHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEe-cCCCceEEEEEECccc------------ccCHHHHHHHHHHHHHHhcCCCCCcceee
Confidence            4699999999999999999975 4578999999884321            11233556788999999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++...+..|+||||++|++|.+++..     . .....+..++.|++.||.||   |++||+||||||+|||++.+|.+
T Consensus        98 ~~~~~~~~~~lv~e~~~g~~L~~~l~~-----~-~~~~~~~~i~~ql~~aL~~l---H~~givH~Dikp~NIll~~~g~~  168 (286)
T 3uqc_A           98 DVVHTRAGGLVVAEWIRGGSLQEVADT-----S-PSPVGAIRAMQSLAAAADAA---HRAGVALSIDHPSRVRVSIDGDV  168 (286)
T ss_dssp             EEEEETTEEEEEEECCCEEEHHHHHTT-----C-CCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCSGGGEEEETTSCE
T ss_pred             EEEEECCcEEEEEEecCCCCHHHHHhc-----C-CChHHHHHHHHHHHHHHHHH---HHCCCccCCCCcccEEEcCCCCE
Confidence            999999999999999999999999853     2 35557888999999999999   67789999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRK  431 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~  431 (487)
                      ||+++|                      |++       .++.++|||||||++|+|+||..||............   ..
T Consensus       169 kl~~~~----------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~---~~  216 (286)
T 3uqc_A          169 VLAYPA----------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA---ER  216 (286)
T ss_dssp             EECSCC----------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC---CB
T ss_pred             EEEecc----------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH---HH
Confidence            998543                      333       3789999999999999999999999665432211000   00


Q ss_pred             HHhcC-CCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          432 VMNSK-NPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       432 ~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      ..... .+...+.+        ..+..+.+++.+||+.||++| |+.++++.|+.+
T Consensus       217 ~~~~~~~~~~~~~~--------~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~  263 (286)
T 3uqc_A          217 DTAGQPIEPADIDR--------DIPFQISAVAARSVQGDGGIR-SASTLLNLMQQA  263 (286)
T ss_dssp             CTTSCBCCHHHHCT--------TSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHH
T ss_pred             HhccCCCChhhccc--------CCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHH
Confidence            00000 00000111        123568999999999999999 999999999864

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=2.5e-37  Score=299.52  Aligned_cols=229  Identities=21%  Similarity=0.320  Sum_probs=175.1

Q ss_pred             cccccc-cccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHh-ccCCCCCccc
Q 011360          192 DCFASL-EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA-SQIRHRNILP  269 (487)
Q Consensus       192 ~~~~~~-~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l-~~l~hpnIv~  269 (487)
                      ++|.+. +.||.|+||.||+|.. ..+++.||+|++..                    ...+.+|+.++ +..+||||++
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~--------------------~~~~~~e~~~~~~~~~h~~i~~   75 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFN-KRTQEKFALKMLQD--------------------CPKARREVELHWRASQCPHIVR   75 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEE-TTTCCEEEEEEEEC--------------------SHHHHHHHHHHHHHTTSTTBCC
T ss_pred             cchhhcCcccccCCCeEEEEEEE-cCCCcEEEEEEecc--------------------cHHHHHHHHHHHHhccCCCchh
Confidence            357777 7899999999999974 46889999998832                    12345677776 5569999999


Q ss_pred             cceEEec----CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEe
Q 011360          270 LLAHMVR----PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLL  345 (487)
Q Consensus       270 l~~~~~~----~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill  345 (487)
                      +++++..    ....++||||+++|+|.+++..  .....+++..++.++.|++.||.||   |++||+||||||+||++
T Consensus        76 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~l---H~~~i~H~dlkp~Nil~  150 (299)
T 3m2w_A           76 IVDVYENLYAGRKCLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYL---HSINIAHRDVKPENLLY  150 (299)
T ss_dssp             EEEEEEEEETTEEEEEEEECCCCSCBHHHHHHH--CTTCCCBHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEE
T ss_pred             HHhhhhhhcCCCceEEEEEeecCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCCCCHHHEEE
Confidence            9999876    6778999999999999999976  3345799999999999999999999   67789999999999999


Q ss_pred             CC---CCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCc
Q 011360          346 ND---DMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEE  422 (487)
Q Consensus       346 ~~---~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~  422 (487)
                      +.   ++.+||+|||++....                        +..++.++|||||||++|+|+||..||........
T Consensus       151 ~~~~~~~~~kl~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~  206 (299)
T 3m2w_A          151 TSKRPNAILKLTDFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI  206 (299)
T ss_dssp             SSSSTTCCEEECCCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------
T ss_pred             ecCCCCCcEEEeccccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh
Confidence            98   7889999999885432                        23567899999999999999999999954322110


Q ss_pred             cccHHHHHHHHhcCCCCCcc--CCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          423 ICSPEWLRKVMNSKNPSRAI--DPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       423 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .           ........  ....+.......+.++.+++.+||+.||++|||+.++++
T Consensus       207 ~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          207 S-----------PGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             ------------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             h-----------HHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            0           00000000  000110001123467899999999999999999999986

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.9e-37  Score=313.85  Aligned_cols=245  Identities=13%  Similarity=0.107  Sum_probs=178.9

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCC-CCccccc
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRH-RNILPLL  271 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~l~  271 (487)
                      .|...+.||+|+||.||+|.+ ..+|+.||||++.....            ......+.+.+|+.++..+.| +|.....
T Consensus        79 ~~~~~~~LG~G~fG~Vy~a~~-~~~g~~vAvK~~~~~~~------------~~~~~~~~~~~E~~~~~~l~~~~~~~~~~  145 (413)
T 3dzo_A           79 TLVRGTVLGQEDPYAYLEATD-QETGESFEVHVPYFTER------------PPSNAIKQMKEEVLRLRLLRGIKNQKQAK  145 (413)
T ss_dssp             EEEEEEEEEEETTEEEEEEEE-TTTCCEEEEEEECCSCC----------------CCHHHHHHHHGGGGSTTCCSHHHHH
T ss_pred             eEEEecccccCCCEEEEEEEe-cCCCCceEEEEEecCCC------------ccHHHHHHHHHHHHHHHhhccCCCHHHHH
Confidence            478889999999999999974 46789999998853211            111234567889999998876 3221111


Q ss_pred             ---------------------eEEec-----CCeeEEEEEecCCCCHHHHHhhh---hcCCCCCChHHHHHHHHHHHHHH
Q 011360          272 ---------------------AHMVR-----PDCHLLVYEFMKNGSLQDILDDV---SRGRRELDWPSRHRIALGVASGL  322 (487)
Q Consensus       272 ---------------------~~~~~-----~~~~~lv~E~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~qi~~~L  322 (487)
                                           .++..     ....+++|+++ +++|.+++...   ...+..+++..+..++.|++.||
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL  224 (413)
T 3dzo_A          146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLL  224 (413)
T ss_dssp             HHTCBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHH
T ss_pred             HhcccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHH
Confidence                                 11111     12356777776 78999998643   23345678889999999999999


Q ss_pred             HHHHhcCCCCeeecCCCCCCEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCccc----------CCCCCC
Q 011360          323 EYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYF----------QQPELS  392 (487)
Q Consensus       323 ~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l----------~~~~~~  392 (487)
                      .||   |++||+||||||+|||++.++.+||+|||+++.....     .....| +.|+|||++          .+..++
T Consensus       225 ~~L---H~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~  295 (413)
T 3dzo_A          225 ASL---HHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMT  295 (413)
T ss_dssp             HHH---HHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEEC
T ss_pred             HHH---HhCCcccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCC
Confidence            999   6778999999999999999999999999998764332     244567 999999999          555788


Q ss_pred             chhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCC
Q 011360          393 EKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEE  472 (487)
Q Consensus       393 ~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~  472 (487)
                      .++|||||||++|+|+||+.||.........      ...+..       ...+        +..+.+++.+||+.||++
T Consensus       296 ~~~DvwSlGvil~elltg~~Pf~~~~~~~~~------~~~~~~-------~~~~--------~~~~~~li~~~l~~dP~~  354 (413)
T 3dzo_A          296 FAFDTWTLGLAIYWIWCADLPNTDDAALGGS------EWIFRS-------CKNI--------PQPVRALLEGFLRYPKED  354 (413)
T ss_dssp             HHHHHHHHHHHHHHHHHSSCCCCTTGGGSCS------GGGGSS-------CCCC--------CHHHHHHHHHHTCSSGGG
T ss_pred             chhhHHHHHHHHHHHHHCCCCCCCcchhhhH------HHHHhh-------cccC--------CHHHHHHHHHHccCChhh
Confidence            9999999999999999999999544321111      000100       0112        256899999999999999


Q ss_pred             CCChHHHHH
Q 011360          473 RPNSQYVRC  481 (487)
Q Consensus       473 RPs~~~il~  481 (487)
                      |||+.++++
T Consensus       355 Rpt~~~~l~  363 (413)
T 3dzo_A          355 RLLPLQAME  363 (413)
T ss_dssp             SCCHHHHTT
T ss_pred             CcCHHHHHh
Confidence            999877643

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.6e-37  Score=306.00  Aligned_cols=251  Identities=17%  Similarity=0.162  Sum_probs=179.7

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCC-------
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIR-------  263 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-------  263 (487)
                      .++|.+.+.||+|+||.||+|+.   +|+.||||++........       ........+.+.+|+.+++.++       
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~---~~~~vAvK~~~~~~~~~~-------~~~~~~~~~~~~~E~~~l~~l~~l~~~~~   88 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA---DHTPVAIKIIAIEGPDLV-------NGSHQKTFEEILPEIIISKELSLLSGEVC   88 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE---TTEEEEEEEEEESCSSCB-------TTBCCBCHHHHHHHHHHHHHHHHGGGCSS
T ss_pred             cccchheeeecccCceEEEEEEe---CCceEEEEEEecCCcccc-------ccccchhHHHHHHHHHHHHHHHHhhcccc
Confidence            34699999999999999999976   679999999865321100       0001112345566777666664       


Q ss_pred             --CCCccccce-----------------EEec-------------CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHH
Q 011360          264 --HRNILPLLA-----------------HMVR-------------PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR  311 (487)
Q Consensus       264 --hpnIv~l~~-----------------~~~~-------------~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~  311 (487)
                        ||||+++.+                 ++.+             .+..|+|||||++|++.+.+.     ...+++..+
T Consensus        89 ~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~-----~~~~~~~~~  163 (336)
T 2vuw_A           89 NRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR-----TKLSSLATA  163 (336)
T ss_dssp             SBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT-----TTCCCHHHH
T ss_pred             ccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH-----hcCCCHHHH
Confidence              555555554                 4443             678999999999997766653     256899999


Q ss_pred             HHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC--------------------CEEEeccCCccccCCCCceeeE
Q 011360          312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDM--------------------EACISDLGLAMAIPDGYTRVLI  371 (487)
Q Consensus       312 ~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~--------------------~~kl~DFg~s~~~~~~~~~~~~  371 (487)
                      +.++.|++.||.|||  +++||+||||||+|||++.++                    .+||+|||+++.....      
T Consensus       164 ~~i~~qi~~aL~~lH--~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------  235 (336)
T 2vuw_A          164 KSILHQLTASLAVAE--ASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------  235 (336)
T ss_dssp             HHHHHHHHHHHHHHH--HHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------
T ss_pred             HHHHHHHHHHHHHHH--HhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------
Confidence            999999999999994  167899999999999999887                    8999999999865432      


Q ss_pred             eeecccccccCCcccCCCCCCchhHHHHHHHH-HHHHHhCCCCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCC
Q 011360          372 SYVLGTMAYIAPEYFQQPELSEKCDIFSFGML-LISLVRGVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNG  450 (487)
Q Consensus       372 ~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~-l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  450 (487)
                       ...||+.|+|||++.+.. +.++||||+|++ .+++++|..||....     ...............    ....+...
T Consensus       236 -~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~-----~~~~~~~~~~~~~~~----~~~~~~~~  304 (336)
T 2vuw_A          236 -IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL-----WLHYLTDKMLKQMTF----KTKCNTPA  304 (336)
T ss_dssp             -EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH-----HHHHHHHHHHHTCCC----SSCCCSHH
T ss_pred             -cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh-----hhhHHHHhhhhhhcc----Ccccchhh
Confidence             346999999999998766 899999998776 788889999992210     000011112211111    11111223


Q ss_pred             cHHHHHHHHHHHhhccCCCCCCCCChHHHH
Q 011360          451 YEKKMLHVLKIAYICTLHDPEERPNSQYVR  480 (487)
Q Consensus       451 ~~~~~~~l~~li~~cl~~~P~~RPs~~~il  480 (487)
                      ....+.++.+++.+||+.|     |+.+++
T Consensus       305 ~~~~s~~~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          305 MKQIKRKIQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred             hhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence            4467788999999999976     999887

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=1.5e-31  Score=280.26  Aligned_cols=197  Identities=18%  Similarity=0.157  Sum_probs=134.3

Q ss_pred             ccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CCCCccccceEEecC
Q 011360          199 KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RHRNILPLLAHMVRP  277 (487)
Q Consensus       199 ~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~  277 (487)
                      ..+.|++|....++ +...|..+++|.+.........     .........+.+.+|+.+|+++ .|+||+++++++.++
T Consensus       241 ~~~~~~~~~h~~~r-r~~fg~~~~~K~~~~~~~~~~~-----~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~  314 (569)
T 4azs_A          241 QPYAGAGLAHKRSR-RYFFGEDYVCKFFYYDMPHGIL-----TAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENA  314 (569)
T ss_dssp             C-C--------CCE-EEEECSSEEEEEEESSCSTTCS-----CHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECS
T ss_pred             ccccCCcccccccc-cccccceeEEEEEecccccccc-----hhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEEC
Confidence            35566666555443 2246889999998654332211     1122334567899999999999 799999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEeccC
Q 011360          278 DCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLG  357 (487)
Q Consensus       278 ~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~DFg  357 (487)
                      +..||||||++|++|.++|..    +.+++..   .|+.||+.||+|+   |++|||||||||+|||++.+|.+||+|||
T Consensus       315 ~~~yLVMEyv~G~~L~d~i~~----~~~l~~~---~I~~QIl~AL~yl---H~~GIIHRDIKPeNILL~~dg~vKL~DFG  384 (569)
T 4azs_A          315 QSGWLVMEKLPGRLLSDMLAA----GEEIDRE---KILGSLLRSLAAL---EKQGFWHDDVRPWNVMVDARQHARLIDFG  384 (569)
T ss_dssp             SEEEEEEECCCSEEHHHHHHT----TCCCCHH---HHHHHHHHHHHHH---HHTTCEESCCCGGGEEECTTSCEEECCCT
T ss_pred             CEEEEEEecCCCCcHHHHHHh----CCCCCHH---HHHHHHHHHHHHH---HHCCceeccCchHhEEECCCCCEEEeecc
Confidence            999999999999999999975    4556543   5889999999999   78899999999999999999999999999


Q ss_pred             CccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCc
Q 011360          358 LAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF  414 (487)
Q Consensus       358 ~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf  414 (487)
                      +|+........  ....+||+.|+|||++.+ .+..++|+||+|++++++.++..++
T Consensus       385 lAr~~~~~~~~--~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~  438 (569)
T 4azs_A          385 SIVTTPQDCSW--PTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW  438 (569)
T ss_dssp             TEESCC---CC--SHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred             cCeeCCCCCcc--ccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence            99876543322  245679999999999976 4677899999999988876664444

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.94  E-value=5.2e-28  Score=251.96  Aligned_cols=193  Identities=16%  Similarity=0.192  Sum_probs=148.1

Q ss_pred             ccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceEE
Q 011360          195 ASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHM  274 (487)
Q Consensus       195 ~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  274 (487)
                      ...+.||+|+||.||+|.+   .+..+++|+.......       ..........+.+.+|+.++++++||||+++..++
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~---~~~~~~~k~~~~~~~~-------~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~  408 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY---LDFDVIIKERVKKGYR-------DERLDENIRKSRTAREARYLALVKDFGIPAPYIFD  408 (540)
T ss_dssp             ---------CCEEEEEEEC---SSCEEEEEEECCCTTS-------CHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE---CCCeEEEEEEeccccc-------chhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEE
Confidence            3456899999999999964   5778999986431110       01112223456789999999999999999777777


Q ss_pred             ecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEe
Q 011360          275 VRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACIS  354 (487)
Q Consensus       275 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~  354 (487)
                      ...+..|+||||++|++|.+++..            +..++.|++.||.||   |++||+||||||+|||++.  .+||+
T Consensus       409 ~~~~~~~lVmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~L---H~~gIiHrDiKp~NILl~~--~~kL~  471 (540)
T 3en9_A          409 VDLDNKRIMMSYINGKLAKDVIED------------NLDIAYKIGEIVGKL---HKNDVIHNDLTTSNFIFDK--DLYII  471 (540)
T ss_dssp             EETTTTEEEEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHH---HHTTEECTTCCTTSEEESS--SEEEC
T ss_pred             EeCCccEEEEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHH---HHCcCccCCCCHHHEEECC--eEEEE
Confidence            778888999999999999999863            457999999999999   6778999999999999998  99999


Q ss_pred             ccCCccccCCCCcee-----eEeeecccccccCCcccCC--CCCCchhHHHHHHHHHHHHHhCCCCc
Q 011360          355 DLGLAMAIPDGYTRV-----LISYVLGTMAYIAPEYFQQ--PELSEKCDIFSFGMLLISLVRGVPSF  414 (487)
Q Consensus       355 DFg~s~~~~~~~~~~-----~~~~~~gt~~y~aPE~l~~--~~~~~~~DvwslG~~l~elltg~~pf  414 (487)
                      |||+++.........     ......||+.|+|||++..  ..|+..+|+|+..+-..+-+.++.+|
T Consensus       472 DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          472 DFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             CCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             ECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            999998875532211     1135679999999999986  56888899999999999988887776

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.88  E-value=2e-23  Score=199.68  Aligned_cols=162  Identities=14%  Similarity=0.108  Sum_probs=118.8

Q ss_pred             hccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHH-HHHH--hhhhhhHHHHHHHHHHHHhccCCCCC
Q 011360          190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAE-LIEE--DSKLRDSKLRQIRSEIITASQIRHRN  266 (487)
Q Consensus       190 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~-~~~~--~~~~~~~~~~~~~~E~~~l~~l~hpn  266 (487)
                      ....|.+.+.||.|+||.||+|.+  .+|..||+|.+.......... ....  ...........+.+|+.++..++  |
T Consensus        88 ~~~~~~~~~~iG~G~~g~Vy~~~~--~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~  163 (282)
T 1zar_A           88 SGKVDAIGKLMGEGKESAVFNCYS--EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G  163 (282)
T ss_dssp             TTSCSEEEEEEEECSSEEEEEEEE--TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T
T ss_pred             CCeEEEecCEeccCCCceEEEEEe--CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C
Confidence            344577889999999999999986  579999999985422110000 0000  00000124567889999999998  5


Q ss_pred             ccccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC
Q 011360          267 ILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN  346 (487)
Q Consensus       267 Iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~  346 (487)
                       +++.+++.. +..|+||||++||+|.+ +.          ......++.|++.||.||   |++||+||||||+|||++
T Consensus       164 -~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~----------~~~~~~i~~qi~~~l~~l---H~~giiHrDlkp~NILl~  227 (282)
T 1zar_A          164 -LAVPKVYAW-EGNAVLMELIDAKELYR-VR----------VENPDEVLDMILEEVAKF---YHRGIVHGDLSQYNVLVS  227 (282)
T ss_dssp             -SSSCCEEEE-ETTEEEEECCCCEEGGG-CC----------CSCHHHHHHHHHHHHHHH---HHTTEECSCCSTTSEEEE
T ss_pred             -CCcCeEEec-cceEEEEEecCCCcHHH-cc----------hhhHHHHHHHHHHHHHHH---HHCCCEeCCCCHHHEEEE
Confidence             666665544 56699999999999987 42          123457999999999999   678899999999999999


Q ss_pred             CCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccC
Q 011360          347 DDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQ  387 (487)
Q Consensus       347 ~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~  387 (487)
                       ++.+||+|||+++               .+..|.|||++.
T Consensus       228 -~~~vkl~DFG~a~---------------~~~~~~a~e~l~  252 (282)
T 1zar_A          228 -EEGIWIIDFPQSV---------------EVGEEGWREILE  252 (282)
T ss_dssp             -TTEEEECCCTTCE---------------ETTSTTHHHHHH
T ss_pred             -CCcEEEEECCCCe---------------ECCCCCHHHHHH
Confidence             9999999999985               244578888874

>3qfl_A MLA10; coiled-coil, (CC) domain, NLRS, nucleotide-binding domain, L rich repeat containing receptors, protein binding; 2.00A {Hordeum vulgare}

Probab=99.84  E-value=2.5e-21  Score=157.29  Aligned_cols=81  Identities=15%  Similarity=0.270  Sum_probs=76.7

Q ss_pred             HHHHHHHHHHHhHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHHhhc--cCCChhHHHHHHHhhhhhccchhhhhhhhh
Q 011360           25 ESIETILQKLTKDWLGQFARQAQIQADLIGWKTMMVKINKVLDDAIEK--QTKEEPVKIWLGKLQHLACDVDYLLDEFQT  102 (487)
Q Consensus        25 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~a~~~--~~~~~~~~~w~~~l~~~~yd~~~~~~~~~~  102 (487)
                      |+++++++||++++.+||.+++||++++++|++||++|+|+|.||+++  +..|+.|+.|+++|||++||+||++|+|.+
T Consensus         1 a~v~~ll~KL~~ll~~E~~l~~gv~~~i~~Lk~eL~~m~a~L~da~~~~~~~~d~~vk~W~~~vrdlaYD~ED~iD~f~~   80 (115)
T 3qfl_A            1 AAISNLIPKLGELLTEEFKLHKGVKKNIEDLGKELESMNAALIKIGEVPREQLDSQDKLWADEVRELSYVIEDVVDKFLV   80 (115)
T ss_dssp             CTTCSHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTTSCGGGCCHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             CcHHHHHHHHHHHHHHHHHHHhchHHHHHHHHHHHHHHHHHHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence            357789999999999999999999999999999999999999999998  668999999999999999999999999998


Q ss_pred             HHH
Q 011360          103 EAF  105 (487)
Q Consensus       103 ~~~  105 (487)
                      +.-
T Consensus        81 ~~~   83 (115)
T 3qfl_A           81 QVD   83 (115)
T ss_dssp             HHH
T ss_pred             Hhc
Confidence            764

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.78  E-value=4.4e-19  Score=167.30  Aligned_cols=155  Identities=18%  Similarity=0.197  Sum_probs=107.0

Q ss_pred             ccccccccccccceeEEEEEecCCCCce--EEEEEeeecCchhHH--HHHHHh-------hhhhhHHHHHHHHHHHHhcc
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKM--IAIKKVIVYAPISAA--ELIEED-------SKLRDSKLRQIRSEIITASQ  261 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~--vavK~~~~~~~~~~~--~~~~~~-------~~~~~~~~~~~~~E~~~l~~  261 (487)
                      .|.+.+.||.|+||.||+|... .+|..  ||||++.........  +.....       ..........+.+|+.++..
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~-~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~  126 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGV-FDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER  126 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEE-ETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEc-CCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence            4678899999999999999752 36788  999987442110000  000000       00011223467889999999


Q ss_pred             CCCCCccccceEEecCCeeEEEEEecCC-C----CHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcC-CCCeee
Q 011360          262 IRHRNILPLLAHMVRPDCHLLVYEFMKN-G----SLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYH-SASIIH  335 (487)
Q Consensus       262 l~hpnIv~l~~~~~~~~~~~lv~E~~~~-g----sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h-~~givH  335 (487)
                      +.|+++....-+..  +..++||||+.+ |    +|.++...       .++..+..++.|++.||.||   | +.||+|
T Consensus       127 l~~~~i~~p~~~~~--~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~l---H~~~givH  194 (258)
T 1zth_A          127 AKEAGVSVPQPYTY--MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRL---YQEAELVH  194 (258)
T ss_dssp             HHHTTCCCCCEEEE--ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHH---HHTSCEEC
T ss_pred             HHhCCCCCCeEEEc--CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHH---HHHCCEEe
Confidence            98886532222222  356899999942 3    77766432       23456788999999999999   6 789999


Q ss_pred             cCCCCCCEEeCCCCCEEEeccCCcccc
Q 011360          336 GDIKPRNVLLNDDMEACISDLGLAMAI  362 (487)
Q Consensus       336 ~Dlkp~Nill~~~~~~kl~DFg~s~~~  362 (487)
                      |||||+|||++.  .++|+|||+|...
T Consensus       195 rDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          195 ADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCCCHHHEEEcC--cEEEEECcccccC
Confidence            999999999998  8999999999654

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.66  E-value=8.5e-18  Score=165.10  Aligned_cols=157  Identities=13%  Similarity=0.147  Sum_probs=103.0

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCch----h-HHHHHHHhhhhh--hHHHHHHHHHHHHhccCC
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPI----S-AAELIEEDSKLR--DSKLRQIRSEIITASQIR  263 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~----~-~~~~~~~~~~~~--~~~~~~~~~E~~~l~~l~  263 (487)
                      ..-|.+...||.|++|.||+|..  .+|+.||||++......    . ..+.........  .........|...+.++.
T Consensus        94 g~iY~I~~~IG~Gk~a~VY~a~d--~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~  171 (397)
T 4gyi_A           94 KDVYSVGSRIGVGKESDIMIVAD--EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALY  171 (397)
T ss_dssp             TSCSEEEEEEEECSSEEEEEEEC--TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCEEEecCEeeeCCceEEEEEEC--CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHH
Confidence            33589999999999999999975  37999999987532110    0 000000000000  011112345677777775


Q ss_pred             CCCccccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCE
Q 011360          264 HRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNV  343 (487)
Q Consensus       264 hpnIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Ni  343 (487)
                      ++++....-+...  ..+|||||++|++|..+..          ......++.|++.+|.+|   |+.|||||||||.||
T Consensus       172 ~~gv~vp~p~~~~--~~~LVME~i~G~~L~~l~~----------~~~~~~l~~qll~~l~~l---H~~gIVHrDLKp~NI  236 (397)
T 4gyi_A          172 EEGFPVPEPIAQS--RHTIVMSLVDALPMRQVSS----------VPDPASLYADLIALILRL---AKHGLIHGDFNEFNI  236 (397)
T ss_dssp             HTTCSCCCEEEEE--TTEEEEECCSCEEGGGCCC----------CSCHHHHHHHHHHHHHHH---HHTTEECSCCSTTSE
T ss_pred             hcCCCCCeeeecc--CceEEEEecCCccHhhhcc----------cHHHHHHHHHHHHHHHHH---HHCCCcCCCCCHHHE
Confidence            5544322222222  2479999999988865431          123457889999999999   667899999999999


Q ss_pred             EeCCCCC----------EEEeccCCccccCC
Q 011360          344 LLNDDME----------ACISDLGLAMAIPD  364 (487)
Q Consensus       344 ll~~~~~----------~kl~DFg~s~~~~~  364 (487)
                      |++++|.          +.|+||+-+.....
T Consensus       237 Ll~~dgd~~d~~~~~~~~~iID~~Q~V~~~h  267 (397)
T 4gyi_A          237 LIREEKDAEDPSSITLTPIIIXFPQMVSMDH  267 (397)
T ss_dssp             EEEEEECSSCTTSEEEEEEECCCTTCEETTS
T ss_pred             EEeCCCCcccccccccceEEEEeCCcccCCC
Confidence            9988763          89999998866443

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.26  E-value=1.6e-11  Score=115.57  Aligned_cols=141  Identities=14%  Similarity=0.093  Sum_probs=106.8

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CCCCccccc
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RHRNILPLL  271 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~  271 (487)
                      .|.+...++.|+.+.||++..   .+..+++|......               ......+.+|+.+++.+ .+..+.+++
T Consensus        15 ~~~~~~~~~g~s~~~v~~~~~---~~~~~vlK~~~~~~---------------~~~~~~~~~E~~~l~~l~~~~~vP~v~   76 (263)
T 3tm0_A           15 KYRCVKDTEGMSPAKVYKLVG---ENENLYLKMTDSRY---------------KGTTYDVEREKDMMLWLEGKLPVPKVL   76 (263)
T ss_dssp             TSEEEECCSCCSSSEEEEEEC---SSCEEEEEEECGGG---------------TTSTTCHHHHHHHHHHHTTTSCCCCEE
T ss_pred             cceeEeeccCCCCCeEEEEEC---CCCcEEEEeCCccc---------------CCCHHHHHHHHHHHHHHhcCCCCCeEE
Confidence            588888899999999999963   46789999873210               00112467788888877 467788899


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhc-----------------------
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMY-----------------------  328 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~-----------------------  328 (487)
                      +++...+..|+||||++|.+|.+.+.         +......++.+++.+|..||..                       
T Consensus        77 ~~~~~~~~~~lv~e~i~G~~l~~~~~---------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~  147 (263)
T 3tm0_A           77 HFERHDGWSNLLMSEADGVLCSEEYE---------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLN  147 (263)
T ss_dssp             EEEEETTEEEEEEECCSSEEHHHHCC---------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHH
T ss_pred             EEEecCCceEEEEEecCCeehhhccC---------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHh
Confidence            99888889999999999999877531         1123346888999999999871                       


Q ss_pred             ---------------------------------CCCCeeecCCCCCCEEeCCCCCEEEeccCCcc
Q 011360          329 ---------------------------------HSASIIHGDIKPRNVLLNDDMEACISDLGLAM  360 (487)
Q Consensus       329 ---------------------------------h~~givH~Dlkp~Nill~~~~~~kl~DFg~s~  360 (487)
                                                       +..+++|+|++|.||++++++.+.|+||+.+.
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          148 NDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                             11569999999999999876556799998763

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.05  E-value=2.6e-10  Score=106.86  Aligned_cols=135  Identities=13%  Similarity=0.141  Sum_probs=92.6

Q ss_pred             cccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCC--ccccc
Q 011360          194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRN--ILPLL  271 (487)
Q Consensus       194 ~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~l~  271 (487)
                      +.+....+.|..+.||++..  .+|..+++|.....                  ....+..|+.+++.+.+.+  +.+++
T Consensus        22 ~~~~~~~~gg~~~~v~~~~~--~~g~~~vlK~~~~~------------------~~~~~~~E~~~l~~l~~~~~~vP~~~   81 (264)
T 1nd4_A           22 YDWAQQTIGCSDAAVFRLSA--QGRPVLFVKTDLSG------------------ALNELQDEAARLSWLATTGVPCAAVL   81 (264)
T ss_dssp             CEEEECSCTTSSCEEEEEEC--TTSCCEEEEEECSC------------------TTSCHHHHHHHHHHHHTTTCCBCCEE
T ss_pred             CceEecccCCCCceEEEEec--CCCCeEEEEeCCcc------------------cchhhhHHHHHHHHHHhCCCCCCeEE
Confidence            44444445666799999964  35778999986321                  1123566777777774434  55688


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcC----------------------
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYH----------------------  329 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h----------------------  329 (487)
                      ++...++..++||||++|.+|.  ...       .   ....++.+++..|..||...                      
T Consensus        82 ~~~~~~~~~~~v~e~i~G~~l~--~~~-------~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~  149 (264)
T 1nd4_A           82 DVVTEAGRDWLLLGEVPGQDLL--SSH-------L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRME  149 (264)
T ss_dssp             EEEECSSCEEEEEECCSSEETT--TSC-------C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHH
T ss_pred             EeccCCCCCEEEEEecCCcccC--cCc-------C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHh
Confidence            8888777889999999998884  210       1   12245667777777775421                      


Q ss_pred             ---------------------------------CCCeeecCCCCCCEEeCCCCCEEEeccCCcc
Q 011360          330 ---------------------------------SASIIHGDIKPRNVLLNDDMEACISDLGLAM  360 (487)
Q Consensus       330 ---------------------------------~~givH~Dlkp~Nill~~~~~~kl~DFg~s~  360 (487)
                                                       ..+++|+|++|.||++++++.+.|+||+.+.
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          150 AGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             TTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                                             2339999999999999877666799999864

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.00  E-value=9.5e-10  Score=108.42  Aligned_cols=144  Identities=16%  Similarity=0.175  Sum_probs=103.2

Q ss_pred             ccccccccccceeEEEEEecCCCCceEEEEEee--ecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCC--CCCcccc
Q 011360          195 ASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVI--VYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIR--HRNILPL  270 (487)
Q Consensus       195 ~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpnIv~l  270 (487)
                      ..++.++.|.++.||+...   .+..+++|+..  ...              .......+.+|+.+++.+.  +..+.++
T Consensus        41 ~~~~~l~~G~sn~~y~v~~---~~~~~vlr~~~~p~~~--------------~~~~~~~~~~E~~~l~~L~~~~vpvP~~  103 (359)
T 3dxp_A           41 LSVEQFKGGQSNPTFKLVT---PGQTYVMRAKPGPKSK--------------LLPSAHAIEREYRVMDALAGTDVPVAKM  103 (359)
T ss_dssp             CEEEECCC-CCSCEEEEEC---SSCEEEEECCCC------------------------CHHHHHHHHHHHTTSSSCCCCE
T ss_pred             ceEEEcCCcccceEEEEEE---CCceEEEEeCCCCCCC--------------CCCcHHHHHHHHHHHHHhhcCCCCCCcE
Confidence            3456789999999999975   34578888653  100              0011235667888888775  4557888


Q ss_pred             ceEEecC---CeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcC------------------
Q 011360          271 LAHMVRP---DCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYH------------------  329 (487)
Q Consensus       271 ~~~~~~~---~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h------------------  329 (487)
                      +.++.+.   +..|+||||++|.++.+..      ...++......++.+++..|..||...                  
T Consensus       104 ~~~~~~~~~~g~~~~vme~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~  177 (359)
T 3dxp_A          104 YALCEDESVIGRAFYIMEFVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQR  177 (359)
T ss_dssp             EEEECCTTTTSSCEEEEECCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHH
T ss_pred             EEECCCCCccCCeEEEEEecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHH
Confidence            8887765   4479999999998774311      234667778889999999999998631                  


Q ss_pred             -------------------------------------CCCeeecCCCCCCEEeCCCCC--EEEeccCCccc
Q 011360          330 -------------------------------------SASIIHGDIKPRNVLLNDDME--ACISDLGLAMA  361 (487)
Q Consensus       330 -------------------------------------~~givH~Dlkp~Nill~~~~~--~kl~DFg~s~~  361 (487)
                                                           ..+++|||++|.||+++.++.  +.|+||+.+..
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          178 QIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                                 357999999999999997753  68999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.90  E-value=7.6e-10  Score=106.45  Aligned_cols=183  Identities=17%  Similarity=0.179  Sum_probs=115.6

Q ss_pred             ccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CCCC--ccccceE
Q 011360          197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RHRN--ILPLLAH  273 (487)
Q Consensus       197 ~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpn--Iv~l~~~  273 (487)
                      ++.++.|.++.||+..      ..+++|....                 ......+.+|+.+++.+ .+..  +.+++..
T Consensus        25 i~~~~~G~~n~v~~v~------~~~vlR~~~~-----------------~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~   81 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN------RDFIFKFPKH-----------------SRGSTNLFNEVNILKRIHNKLPLPIPEVVFT   81 (304)
T ss_dssp             CCEEEECSSEEEEEST------TSEEEEEESS-----------------HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEE
T ss_pred             eEecCCCCcceEEEEC------CEEEEEecCC-----------------cchHHHHHHHHHHHHHHHhcCCCCCCceEee
Confidence            4568999999999873      3588887521                 12345677888888776 3333  3344443


Q ss_pred             EecCC---eeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhc----------------------
Q 011360          274 MVRPD---CHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMY----------------------  328 (487)
Q Consensus       274 ~~~~~---~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~----------------------  328 (487)
                      ....+   ..|+||++++|.+|.+...      ..++......++.+++..|..||..                      
T Consensus        82 ~~~~~~~~~~~~vm~~i~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~  155 (304)
T 3sg8_A           82 GMPSETYQMSFAGFTKIKGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNK  155 (304)
T ss_dssp             CCCCSSCSCSCEEEECCCCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHH
T ss_pred             cCCCCCCCcceEEEcccCCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHH
Confidence            33322   3489999999988875332      2355566667777777777777641                      


Q ss_pred             ---------------------------------CCCCeeecCCCCCCEEeCC--CCCEEEeccCCccccCCCCceeeEee
Q 011360          329 ---------------------------------HSASIIHGDIKPRNVLLND--DMEACISDLGLAMAIPDGYTRVLISY  373 (487)
Q Consensus       329 ---------------------------------h~~givH~Dlkp~Nill~~--~~~~kl~DFg~s~~~~~~~~~~~~~~  373 (487)
                                                       ....++|+|++|.||++++  +..+.|+||+.+........-.    
T Consensus       156 ~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~----  231 (304)
T 3sg8_A          156 KIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFI----  231 (304)
T ss_dssp             HHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHH----
T ss_pred             HHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHH----
Confidence                                             1245899999999999998  4567899999886543321110    


Q ss_pred             ecccccc---cCCcccCC-----CC---------CCchhHHHHHHHHHHHHHhCCCCc
Q 011360          374 VLGTMAY---IAPEYFQQ-----PE---------LSEKCDIFSFGMLLISLVRGVPSF  414 (487)
Q Consensus       374 ~~gt~~y---~aPE~l~~-----~~---------~~~~~DvwslG~~l~elltg~~pf  414 (487)
                        ....+   ..|+....     +.         .....+.|++|.++|.+.+|..+|
T Consensus       232 --~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          232 --SLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             --TTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             --HHHhhccccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence              00011   12221110     00         122368999999999999998887

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.41  E-value=2.7e-06  Score=81.60  Aligned_cols=137  Identities=19%  Similarity=0.154  Sum_probs=87.9

Q ss_pred             ccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCC---CccccceE
Q 011360          197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHR---NILPLLAH  273 (487)
Q Consensus       197 ~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp---nIv~l~~~  273 (487)
                      +..++.|....||+.      +..+++|+-.                 .......+..|+.++..+.+.   .+.+.+.+
T Consensus        24 v~~l~~G~~n~v~~v------g~~~VlR~~~-----------------~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~   80 (306)
T 3tdw_A           24 VESLGEGFRNYAILV------NGDWVFRFPK-----------------SQQGADELNKEIQLLPLLVGCVKVNIPQYVYI   80 (306)
T ss_dssp             EEEEEECSSEEEEEE------TTTEEEEEES-----------------SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEE
T ss_pred             eeecCCCcceeEEEE------CCEEEEEecC-----------------CchHHHHHHHHHHHHHHHHhcCCCCCCCeEee
Confidence            355788888899987      3467888641                 112345678899999888542   24555655


Q ss_pred             Ee-cCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhc------------------------
Q 011360          274 MV-RPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMY------------------------  328 (487)
Q Consensus       274 ~~-~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~------------------------  328 (487)
                      .. ..+..++|||+++|.+|.+..-      ..++......++.+++..|..||..                        
T Consensus        81 ~~~~~g~~~~v~e~i~G~~l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~  154 (306)
T 3tdw_A           81 GKRSDGNPFVGYRKVQGQILGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSE  154 (306)
T ss_dssp             EECTTSCEEEEEECCCSEECHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHH
T ss_pred             cccCCCceEEEEeccCCeECchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHH
Confidence            53 3455789999999988876311      1122233333333343333333321                        


Q ss_pred             ---------------------------------CCCCeeecCCCCCCEEeCC---CCCE-EEeccCCcccc
Q 011360          329 ---------------------------------HSASIIHGDIKPRNVLLND---DMEA-CISDLGLAMAI  362 (487)
Q Consensus       329 ---------------------------------h~~givH~Dlkp~Nill~~---~~~~-kl~DFg~s~~~  362 (487)
                                                       ....++|+|++|.||+++.   ++.+ .|+||+.+...
T Consensus       155 ~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          155 AVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                                             3446899999999999997   4554 79999987653

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.40  E-value=3.3e-06  Score=79.19  Aligned_cols=135  Identities=17%  Similarity=0.200  Sum_probs=89.9

Q ss_pred             ccccccce-eEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCC-CCCccccceEEec
Q 011360          199 KIGSGGCG-EVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIR-HRNILPLLAHMVR  276 (487)
Q Consensus       199 ~lg~G~~g-~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~  276 (487)
                      .+..|..| .||+... ..++..+++|+-..                  .....+..|...++.+. +--+.+++.++.+
T Consensus        31 ~~~~G~S~~~v~rl~~-~~~~~~~~lk~~~~------------------~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~   91 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYG-KPNAPELFLKHGKG------------------SVANDVTDEMVRLNWLTAFMPLPTIKHFIRT   91 (272)
T ss_dssp             EEECSSSSCEEEEEEC-CTTCCCEEEEEEET------------------HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEE
T ss_pred             EccCCCcCCeEEEEEe-cCCCeEEEEEECCC------------------CCHhHHHHHHHHHHHhccCCCcCeEEEEEEE
Confidence            34445555 5888753 34567788997521                  12334566777776662 3336677888888


Q ss_pred             CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhc----------------------------
Q 011360          277 PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMY----------------------------  328 (487)
Q Consensus       277 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~----------------------------  328 (487)
                      ++..++|||+++|.++.+....        .......+..+++..|..||..                            
T Consensus        92 ~~~~~lvme~l~G~~~~~~~~~--------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (272)
T 4gkh_A           92 PDDAWLLTTAIPGKTAFQVLEE--------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVD  163 (272)
T ss_dssp             TTEEEEEEECCCSEEHHHHHHH--------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCC
T ss_pred             CCeEEEEEEeeCCccccccccC--------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhh
Confidence            8899999999999888776532        1122334555555666666531                            


Q ss_pred             ---------------------------CCCCeeecCCCCCCEEeCCCCCEEEeccCCcc
Q 011360          329 ---------------------------HSASIIHGDIKPRNVLLNDDMEACISDLGLAM  360 (487)
Q Consensus       329 ---------------------------h~~givH~Dlkp~Nill~~~~~~kl~DFg~s~  360 (487)
                                                 +...++|+|+.+.||++++++.+-|+||+.+.
T Consensus       164 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          164 ASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             GGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             hhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                                       11237999999999999987767799999764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.96  E-value=0.00011  Score=71.17  Aligned_cols=32  Identities=25%  Similarity=0.368  Sum_probs=28.3

Q ss_pred             CCCCeeecCCCCCCEEeCCCCCEEEeccCCcc
Q 011360          329 HSASIIHGDIKPRNVLLNDDMEACISDLGLAM  360 (487)
Q Consensus       329 h~~givH~Dlkp~Nill~~~~~~kl~DFg~s~  360 (487)
                      ...+++|+|+++.||+++.++.+.|+||+.+.
T Consensus       220 ~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          220 KSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             ccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            35789999999999999888889999999764

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.82  E-value=2e-05  Score=77.14  Aligned_cols=32  Identities=22%  Similarity=0.321  Sum_probs=26.8

Q ss_pred             CCCeeecCCCCCCEEeCCCCCEEEeccCCccc
Q 011360          330 SASIIHGDIKPRNVLLNDDMEACISDLGLAMA  361 (487)
Q Consensus       330 ~~givH~Dlkp~Nill~~~~~~kl~DFg~s~~  361 (487)
                      ...++|+|+.|.||+++++..+.|+||+.+..
T Consensus       221 ~~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~  252 (357)
T 3ats_A          221 EPVLLWGDARVGNVLYRDFQPVAVLDWEMVAL  252 (357)
T ss_dssp             CCEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred             CceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence            56799999999999999644578999998753

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.70  E-value=0.0001  Score=73.21  Aligned_cols=83  Identities=16%  Similarity=0.218  Sum_probs=45.5

Q ss_pred             ccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCC--CC-ccccceE
Q 011360          197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRH--RN-ILPLLAH  273 (487)
Q Consensus       197 ~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--pn-Iv~l~~~  273 (487)
                      .+.+|.|.++.||++... .++..+++|.......     .....   .......+..|..++..+..  |. +.+++.+
T Consensus        35 ~~~lg~G~~n~vyrv~~~-~~~~~~vvK~~~~~~r-----~~~~~---~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~  105 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQ-EHDRALIIKQAVPYAK-----VVGES---WPLTIDRARIESSALIRQGEHVPHLVPRVFYS  105 (397)
T ss_dssp             EEECCSSSSEEEEEEEC-----CEEEEEEECCC---------------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE
T ss_pred             EEECCCCceEEEEEEEEC-CCCcEEEEEecchhhc-----ccCCC---CcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE
Confidence            467899999999999643 2467899997632110     00000   00012234556666665521  33 3345443


Q ss_pred             EecCCeeEEEEEecCCC
Q 011360          274 MVRPDCHLLVYEFMKNG  290 (487)
Q Consensus       274 ~~~~~~~~lv~E~~~~g  290 (487)
                        +.+..++|||++++.
T Consensus       106 --d~~~~~lvmE~l~g~  120 (397)
T 2olc_A          106 --DTEMAVTVMEDLSHL  120 (397)
T ss_dssp             --ETTTTEEEECCCTTS
T ss_pred             --cCCccEEEEEeCCCc
Confidence              345578999999764

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.67  E-value=0.00019  Score=68.63  Aligned_cols=76  Identities=16%  Similarity=0.083  Sum_probs=55.5

Q ss_pred             cccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCC---CCCccccce
Q 011360          196 SLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIR---HRNILPLLA  272 (487)
Q Consensus       196 ~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~l~~  272 (487)
                      -.+.++.|.+..+|+...   ++..+++|....                  .....+..|+..++.+.   ...+.+++.
T Consensus        40 ~~~~l~gG~~n~~y~v~~---~~~~~vlK~~~~------------------~~~~~~~~E~~~L~~L~~~~~v~VP~vl~   98 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND---EVQTVFVKINER------------------SYRSMFRAEADQLALLAKTNSINVPLVYG   98 (312)
T ss_dssp             EEEEECCSSSSEEEEEES---SSCEEEEEEEEG------------------GGHHHHHHHHHHHHHHHHTTSSBCCCEEE
T ss_pred             eeEEeCCccceeeeEEEE---CCCeEEEEeCCc------------------ccHHHHHHHHHHHHHHHhhCCCCcceEEE
Confidence            346789999999999964   466788887521                  01334566777776662   356778888


Q ss_pred             EEecCCeeEEEEEecCCCCH
Q 011360          273 HMVRPDCHLLVYEFMKNGSL  292 (487)
Q Consensus       273 ~~~~~~~~~lv~E~~~~gsL  292 (487)
                      +....+..++||||++|.++
T Consensus        99 ~~~~~g~~~lvme~l~G~~~  118 (312)
T 3jr1_A           99 IGNSQGHSFLLLEALNKSKN  118 (312)
T ss_dssp             EEECSSEEEEEEECCCCCCC
T ss_pred             EeecCCceEEEEEeccCCCC
Confidence            88777889999999998764

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.35  E-value=0.0007  Score=67.68  Aligned_cols=80  Identities=18%  Similarity=0.160  Sum_probs=50.0

Q ss_pred             CCCCeeecCCCCCCEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCC---CCCchhHHHHHHHHHH
Q 011360          329 HSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQP---ELSEKCDIFSFGMLLI  405 (487)
Q Consensus       329 h~~givH~Dlkp~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~---~~~~~~DvwslG~~l~  405 (487)
                      +...++|||++|.||+++.++ ++++||+.+........-.. ....-...|.+|+.....   .-....++.+....+|
T Consensus       230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGA-YLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW  307 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHH-HHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred             CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHH-HHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence            567899999999999999876 99999998865432211100 000012346676655421   1122345567777888


Q ss_pred             HHHhC
Q 011360          406 SLVRG  410 (487)
Q Consensus       406 elltg  410 (487)
                      +.+++
T Consensus       308 ~~y~~  312 (420)
T 2pyw_A          308 NLFNK  312 (420)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            77765

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.23  E-value=0.003  Score=56.10  Aligned_cols=103  Identities=13%  Similarity=0.031  Sum_probs=67.5

Q ss_pred             CCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEeccCCccccCCCCcee
Q 011360          290 GSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRV  369 (487)
Q Consensus       290 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~DFg~s~~~~~~~~~~  369 (487)
                      -||.++|..+   +.++++.++|.++.|.+.+|.-+-.  ...-..+=+.|..|++..+|.|-+.+ +.+.         
T Consensus        33 vSL~eIL~~~---~~PlsEEqaWALc~Qc~~~L~~~~~--~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------   97 (229)
T 2yle_A           33 LSLEEILRLY---NQPINEEQAWAVCYQCCGSLRAAAR--RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD---------   97 (229)
T ss_dssp             EEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred             ccHHHHHHHc---CCCcCHHHHHHHHHHHHHHHHhhhh--cccCCceecCCcceEEecCCceeccc-cccc---------
Confidence            4899999864   6789999999999999998876621  01111233456899999999988764 2110         


Q ss_pred             eEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCC
Q 011360          370 LISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPS  413 (487)
Q Consensus       370 ~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~p  413 (487)
                           .....+.|||... ...+.+.=|||||+++|..+--..|
T Consensus        98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             --------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence                 1233466888764 3557888999999999999875433

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.11  E-value=0.0011  Score=63.01  Aligned_cols=33  Identities=18%  Similarity=0.053  Sum_probs=26.8

Q ss_pred             CCCCeeecCCCCCCEEeCCCCCEEEeccCCcccc
Q 011360          329 HSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI  362 (487)
Q Consensus       329 h~~givH~Dlkp~Nill~~~~~~kl~DFg~s~~~  362 (487)
                      ....++|+|+.|.||+ ..++.+.++||..+...
T Consensus       171 ~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g  203 (301)
T 3dxq_A          171 LPLAACHCDPLCENFL-DTGERMWIVDWEYSGMN  203 (301)
T ss_dssp             CCCEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred             CCceeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence            3456899999999999 55667899999987643

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.09  E-value=0.0012  Score=62.30  Aligned_cols=79  Identities=16%  Similarity=0.200  Sum_probs=50.1

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCC---Cccc
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHR---NILP  269 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp---nIv~  269 (487)
                      .+.-+..+|.|..+.||+.+..  +|+.|.+|+.....+               .....+..|+..|+.|...   -+.+
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~--DG~~~~vK~~~~~~~---------------~~~~~~~~Ea~~L~~L~~~~~vpvP~   78 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELA--DGTPLFVKALPDDAP---------------ALDGLFRAEALGLDWLGRSFGSPVPQ   78 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEET--TSCEEEEEECCTTCC---------------CCTTHHHHHHHHHHHHTCSTTCCSCC
T ss_pred             CeEEEEecCCCCCeEEEEEEEC--CCCEEEEEEeCCCCc---------------chhhHHHHHHHHHHHHHhhCCCCcce
Confidence            3556678999999999999864  788999997532111               0112355677777666321   2334


Q ss_pred             cceEEecCCeeEEEEEecCCCCH
Q 011360          270 LLAHMVRPDCHLLVYEFMKNGSL  292 (487)
Q Consensus       270 l~~~~~~~~~~~lv~E~~~~gsL  292 (487)
                      ++.+  .  ..++||||++++..
T Consensus        79 v~~~--~--~~~lv~e~l~~~~~   97 (288)
T 3f7w_A           79 VAGW--D--DRTLAMEWVDERPP   97 (288)
T ss_dssp             EEEE--E--TTEEEEECCCCCCC
T ss_pred             EEec--c--CceEEEEeecccCC
Confidence            4443  2  34789999987654

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.01  E-value=0.0018  Score=62.41  Aligned_cols=36  Identities=17%  Similarity=0.161  Sum_probs=29.8

Q ss_pred             CCCCeeecCCCCCCEEeCCC----CCEEEeccCCccccCC
Q 011360          329 HSASIIHGDIKPRNVLLNDD----MEACISDLGLAMAIPD  364 (487)
Q Consensus       329 h~~givH~Dlkp~Nill~~~----~~~kl~DFg~s~~~~~  364 (487)
                      +..+++|||+.+.||+++.+    +.+.|+||+.+.....
T Consensus       181 ~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~~  220 (333)
T 3csv_A          181 GDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGHR  220 (333)
T ss_dssp             SCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEECT
T ss_pred             CCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCCC
Confidence            45689999999999999874    6789999998865433

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.91  E-value=0.0055  Score=58.66  Aligned_cols=31  Identities=29%  Similarity=0.377  Sum_probs=26.5

Q ss_pred             CCCCeeecCCCCCCEEeCCCCCEEEeccCCccc
Q 011360          329 HSASIIHGDIKPRNVLLNDDMEACISDLGLAMA  361 (487)
Q Consensus       329 h~~givH~Dlkp~Nill~~~~~~kl~DFg~s~~  361 (487)
                      ....++|||+++.||+++ + .+.|+||+.+..
T Consensus       193 ~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          193 FTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             SCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             CCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            356789999999999999 4 899999988754

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.71  E-value=0.0039  Score=61.13  Aligned_cols=143  Identities=13%  Similarity=0.165  Sum_probs=77.0

Q ss_pred             cccccccceeEEEEEecC------CCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCC-CCCcccc
Q 011360          198 EKIGSGGCGEVYKAELPG------SNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIR-HRNILPL  270 (487)
Q Consensus       198 ~~lg~G~~g~v~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l  270 (487)
                      +.+..|-...+|++....      .++..+++|+...   .           .  .......+|..+++.+. +.-..++
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~---~-----------~--~~~~~~~rE~~vl~~L~~~gv~P~l  119 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA---I-----------L--QGVDSLVLESVMFAILAERSLGPQL  119 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------------------CCHHHHHHHHHHHHHHHHTTSSCCE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC---c-----------c--chHHHHHHHHHHHHHHHhcCCCCeE
Confidence            457778889999987531      1346788887411   0           0  01223346777776662 2223555


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHH--------------HHhhhhc----CCCCCC--hHHHHHHHHHHHH----------
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQD--------------ILDDVSR----GRRELD--WPSRHRIALGVAS----------  320 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~--------------~l~~~~~----~~~~l~--~~~~~~i~~qi~~----------  320 (487)
                      ++.+.+    .+||||++|.+|..              .|...-.    .+....  +.++.++..++..          
T Consensus       120 l~~~~~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~  195 (379)
T 3feg_A          120 YGVFPE----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMN  195 (379)
T ss_dssp             EEEETT----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCC
T ss_pred             EEEcCC----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhh
Confidence            655443    28999998865431              1111100    111222  3445555544322          


Q ss_pred             ---------HHHHHH----h-cCCCCeeecCCCCCCEEeCCC----CCEEEeccCCcc
Q 011360          321 ---------GLEYLH----M-YHSASIIHGDIKPRNVLLNDD----MEACISDLGLAM  360 (487)
Q Consensus       321 ---------~L~~Lh----~-~h~~givH~Dlkp~Nill~~~----~~~kl~DFg~s~  360 (487)
                               .+..|.    . .....++|+|+.+.||+++.+    +.+.++||..+.
T Consensus       196 ~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          196 LLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             hhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence                     122222    1 134569999999999999876    789999999874

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=96.67  E-value=0.0063  Score=58.10  Aligned_cols=32  Identities=28%  Similarity=0.363  Sum_probs=26.9

Q ss_pred             CCCeeecCCCCCCEEeCCCCCEEEeccCCccc
Q 011360          330 SASIIHGDIKPRNVLLNDDMEACISDLGLAMA  361 (487)
Q Consensus       330 ~~givH~Dlkp~Nill~~~~~~kl~DFg~s~~  361 (487)
                      ..+++|+|+.+.||++++++.+.|+||+.+..
T Consensus       186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          186 PAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             CcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence            45799999999999999876568999997743

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.51  E-value=0.0029  Score=63.28  Aligned_cols=75  Identities=11%  Similarity=0.174  Sum_probs=43.7

Q ss_pred             ccccccccceeEEEEEecCC------CCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCc-cc
Q 011360          197 LEKIGSGGCGEVYKAELPGS------NGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNI-LP  269 (487)
Q Consensus       197 ~~~lg~G~~g~v~~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~  269 (487)
                      ++.|+.|....+|++.....      ++..+++|+....   ..              ...+..|..++..+...++ .+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~---~~--------------~~~li~E~~~l~~L~~~g~~P~  140 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---ET--------------ESHLVAESVIFTLLSERHLGPK  140 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---CC--------------HHHHHHHHHHHHHHHHTTSSSC
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC---Cc--------------HHHHHHHHHHHHHHHhCCCCCc
Confidence            45678888899999976421      2467888876210   00              0122346666666632233 55


Q ss_pred             cceEEecCCeeEEEEEecCCCCH
Q 011360          270 LLAHMVRPDCHLLVYEFMKNGSL  292 (487)
Q Consensus       270 l~~~~~~~~~~~lv~E~~~~gsL  292 (487)
                      +++.+.+    .+||||++|.+|
T Consensus       141 l~~~~~~----g~v~e~l~G~~l  159 (429)
T 1nw1_A          141 LYGIFSG----GRLEEYIPSRPL  159 (429)
T ss_dssp             EEEEETT----EEEECCCCEEEC
T ss_pred             EEEEeCC----CEEEEEeCCccc
Confidence            6665432    289999987443

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.18  E-value=0.0044  Score=60.60  Aligned_cols=31  Identities=13%  Similarity=0.245  Sum_probs=25.5

Q ss_pred             CCCeeecCCCCCCEEeCCCCCEEEeccCCccc
Q 011360          330 SASIIHGDIKPRNVLLNDDMEACISDLGLAMA  361 (487)
Q Consensus       330 ~~givH~Dlkp~Nill~~~~~~kl~DFg~s~~  361 (487)
                      ..+++|+|+.+.||++++++ +.|+||..+..
T Consensus       211 ~~~l~HgDl~~~Nil~~~~~-~~lID~e~a~~  241 (369)
T 3c5i_A          211 TIVFCHNDLQENNIINTNKC-LRLIDFEYSGF  241 (369)
T ss_dssp             CEEEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred             CeEEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence            45699999999999998654 89999987753

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=95.93  E-value=0.012  Score=59.18  Aligned_cols=75  Identities=16%  Similarity=0.111  Sum_probs=42.9

Q ss_pred             ccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCc-cccceEEe
Q 011360          197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNI-LPLLAHMV  275 (487)
Q Consensus       197 ~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~l~~~~~  275 (487)
                      ++.|+.|-...+|++.... .+..+++|+......    .      ..      ....|..++..+...++ .++++.+.
T Consensus       113 i~~lsgG~tN~~y~v~~~~-~~~~~vLRi~g~~~~----~------~i------dR~~E~~vl~~L~~~gl~P~ll~~~~  175 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMS-KQAKYLIRLYGPKTD----E------II------NREREKKISCILYNKNIAKKIYVFFT  175 (458)
T ss_dssp             EEEECC--CEEEEEEEETT-TTEEEEEEEECC-CC----S------CS------CHHHHHHHHHHHTTSSSBCCEEEEET
T ss_pred             EEEcCCCeEeEEEEEEECC-CCceEEEEECCCChh----h------hc------CHHHHHHHHHHHHhcCCCCCEEEEeC
Confidence            3567788889999997631 246788887522100    0      00      01357777777754444 45666552


Q ss_pred             cCCeeEEEEEecCCCCH
Q 011360          276 RPDCHLLVYEFMKNGSL  292 (487)
Q Consensus       276 ~~~~~~lv~E~~~~gsL  292 (487)
                        +  .+||||++|.+|
T Consensus       176 --~--G~v~e~I~G~~l  188 (458)
T 2qg7_A          176 --N--GRIEEFMDGYAL  188 (458)
T ss_dssp             --T--EEEEECCCSEEC
T ss_pred             --C--eEEEEeeCCccC
Confidence              2  259999987544

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=95.33  E-value=0.077  Score=51.02  Aligned_cols=32  Identities=28%  Similarity=0.373  Sum_probs=28.1

Q ss_pred             CCCeeecCCCCCCEEeCCCCCEEEeccCCccc
Q 011360          330 SASIIHGDIKPRNVLLNDDMEACISDLGLAMA  361 (487)
Q Consensus       330 ~~givH~Dlkp~Nill~~~~~~kl~DFg~s~~  361 (487)
                      ..+++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            45699999999999999888899999987754

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=94.42  E-value=0.09  Score=52.19  Aligned_cols=31  Identities=19%  Similarity=0.287  Sum_probs=26.6

Q ss_pred             CCCeeecCCCCCCEEeCCCCCEEEeccCCccc
Q 011360          330 SASIIHGDIKPRNVLLNDDMEACISDLGLAMA  361 (487)
Q Consensus       330 ~~givH~Dlkp~Nill~~~~~~kl~DFg~s~~  361 (487)
                      ...++|+|+.+.||+ +.++.+.++||..+..
T Consensus       261 ~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          261 SLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             CEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             CceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            356899999999999 7788899999998753

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=88.96  E-value=1.6  Score=38.46  Aligned_cols=114  Identities=14%  Similarity=0.164  Sum_probs=76.9

Q ss_pred             CCCCccccceEEecCCeeEEEEEecC-CCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCC
Q 011360          263 RHRNILPLLAHMVRPDCHLLVYEFMK-NGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPR  341 (487)
Q Consensus       263 ~hpnIv~l~~~~~~~~~~~lv~E~~~-~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~  341 (487)
                      .||+.+.. .+-.+.+.+.+.++.-+ +-++.. +       ...+...+++++.+|+....++   +.  -+|--|.|+
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i-------k~~~~~eKlr~l~ni~~l~~~~---~~--r~tf~L~P~  108 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I-------KSFTKNEKLRYLLNIKNLEEVN---RT--RYTFVLAPD  108 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G-------GGSCHHHHHHHHHHGGGGGGGG---GS--SEECCCSGG
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H-------HhcCHHHHHHHHHHHHHHHHHh---cC--ceEEEEecc
Confidence            68888876 45666676666555433 222322 2       3467888999999998877555   22  478889999


Q ss_pred             CEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCc
Q 011360          342 NVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF  414 (487)
Q Consensus       342 Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf  414 (487)
                      |++++.++.+++.-.|+-..                   ++|.     .++...=.-.+=|++..+++++..|
T Consensus       109 NL~f~~~~~p~i~~RGik~~-------------------l~P~-----~~~ee~fL~qyKAliiall~~K~~F  157 (215)
T 4ann_A          109 ELFFTRDGLPIAKTRGLQNV-------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSF  157 (215)
T ss_dssp             GEEECTTSCEEESCCEETTT-------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCH
T ss_pred             eEEEcCCCCEEEEEccCccC-------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCH
Confidence            99999999999987665321                   2222     1122222335788999999999988

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=88.02  E-value=1.8  Score=38.36  Aligned_cols=112  Identities=17%  Similarity=0.194  Sum_probs=76.2

Q ss_pred             CCCCccccceEEecCCeeEEEEEecCCC-CHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHH-HHHhcCCCCeeecCCCC
Q 011360          263 RHRNILPLLAHMVRPDCHLLVYEFMKNG-SLQDILDDVSRGRRELDWPSRHRIALGVASGLE-YLHMYHSASIIHGDIKP  340 (487)
Q Consensus       263 ~hpnIv~l~~~~~~~~~~~lv~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~-~Lh~~h~~givH~Dlkp  340 (487)
                      .||++  -..+-.+++.+.+.++.-+++ ++. .+.       ..+...+++++.+++.... ++     ..-+|--|.|
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~-~i~-------~~~~~eKlrll~nl~~L~~~~~-----~~r~tf~l~P  112 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFA-AIR-------KTTLLSRIRAAIHLVSKVKHHS-----ARRLIFIVCP  112 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHH-HHH-------TSCHHHHHHHHHHHHHHHSSCC-----SSSEECCCCG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHH-HHH-------hcCHHHHHHHHHHHHHHHHHhh-----hCceeEEEeC
Confidence            67888  444556777777777654333 333 332       3677888999998887655 44     3468888999


Q ss_pred             CCEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHH-HHHHHHHHHHhCCCCc
Q 011360          341 RNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIF-SFGMLLISLVRGVPSF  414 (487)
Q Consensus       341 ~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~Dvw-slG~~l~elltg~~pf  414 (487)
                      +|++++.++.+++.-.|+-.                   -++|.-+      ...|.| .+=|++..++.++..|
T Consensus       113 ~NL~f~~~~~p~i~hRGi~~-------------------~lpP~e~------~ee~fl~qyKali~all~~K~~F  162 (219)
T 4ano_A          113 ENLMFNRALEPFFLHVGVKE-------------------SLPPDEW------DDERLLREVKATVLALTEGEYRF  162 (219)
T ss_dssp             GGEEECTTCCEEESCCEETT-------------------TBSSCSC------CHHHHHHHHHHHHHHHTTCSSCH
T ss_pred             ceEEEeCCCcEEEEEcCCcc-------------------cCCCCCC------CHHHHHHHHHHHHHHHHcCCCCH
Confidence            99999999999998776532                   2333221      123443 4778889999998888

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	487
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-51
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-50
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	4e-50
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	7e-49
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	8e-49
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	4e-48
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-46
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	3e-46
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	5e-46
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	6e-46
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	6e-46
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	8e-46
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-45
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	3e-45
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	6e-45
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	8e-45
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-44
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-44
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-44
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	5e-44
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-43
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-43
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-43
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	5e-43
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	6e-43
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	8e-43
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-42
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-40
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	5e-40
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-39
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	8e-39
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-38
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-38
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	6e-38
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	7e-38
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	7e-38
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	7e-38
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	7e-38
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-37
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	4e-37
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	4e-36
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	5e-36
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	8e-36
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	9e-35
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-33
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	4e-33
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	4e-33
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-32
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-32
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-31
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-31
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-31
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-31
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-30
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	4e-30
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-28
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	8e-28
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-26
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	8e-25
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	9e-25
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-24
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	8e-24
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-13

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (440), Expect = 3e-51
 Identities = 62/294 (21%), Positives = 117/294 (39%), Gaps = 38/294 (12%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
            ++IGSG  G VYK +  G     +A+K +               +     +L+  ++E+
Sbjct: 13  GQRIGSGSFGTVYKGKWHGD----VAVKML-------------NVTAPTPQQLQAFKNEV 55

Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL 316
               + RH NIL  + +   P    +V ++ +  SL   L        + +      IA 
Sbjct: 56  GVLRKTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIAR 111

Query: 317 GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLG 376
             A G++YLH     SIIH D+K  N+ L++D+   I D GLA              + G
Sbjct: 112 QTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSG 168

Query: 377 TMAYIAPEYFQQPE---LSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVM 433
           ++ ++APE  +  +    S + D+++FG++L  L+ G   +        I + + +  ++
Sbjct: 169 SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY------SNINNRDQIIFMV 222

Query: 434 NSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL 487
                S  +               + ++   C     +ERP    +   +  L 
Sbjct: 223 GRGYLSPDLSKVRSNCPKA-----MKRLMAECLKKKRDERPLFPQILASIELLA 271

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (437), Expect = 1e-50
 Identities = 74/313 (23%), Positives = 132/313 (42%), Gaps = 46/313 (14%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
            E IG G  GEV++ +     G+ +A+K                    R+ +     +EI
Sbjct: 8   QESIGKGRFGEVWRGKW---RGEEVAVKIF----------------SSREERSWFREAEI 48

Query: 257 ITASQIRHRNILPLLAHMVRPDCHL----LVYEFMKNGSLQDILDDVSRGRRELDWPSRH 312
                +RH NIL  +A   + +       LV ++ ++GSL D L+     R  +      
Sbjct: 49  YQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMI 103

Query: 313 RIALGVASGLEYLHM-----YHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG-- 365
           ++AL  ASGL +LHM         +I H D+K +N+L+  +   CI+DLGLA+       
Sbjct: 104 KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD 163

Query: 366 YTRVLISYVLGTMAYIAPEYFQ------QPELSEKCDIFSFGMLLISLVRGVPSFVFHQN 419
              +  ++ +GT  Y+APE           E  ++ DI++ G++   + R       H++
Sbjct: 164 TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 223

Query: 420 GE----EICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVL-KIAYICTLHDPEERP 474
            +    ++   +   + M      + + P +P      + L V+ KI   C   +   R 
Sbjct: 224 YQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL 283

Query: 475 NSQYVRCRLSQLL 487
            +  ++  LSQL 
Sbjct: 284 TALRIKKTLSQLS 296

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (435), Expect = 4e-50
 Identities = 59/292 (20%), Positives = 112/292 (38%), Gaps = 28/292 (9%)

Query: 190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKL 249
           K+D F  + ++G+G  G V+K      +G ++A K +                +++ +  
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHK-PSGLVMARKLI--------------HLEIKPAIR 48

Query: 250 RQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWP 309
            QI  E+    +     I+             +  E M  GSL  +L         +   
Sbjct: 49  NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQ 104

Query: 310 SRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRV 369
              ++++ V  GL YL       I+H D+KP N+L+N   E  + D G++  + D     
Sbjct: 105 ILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS 162

Query: 370 LISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWL 429
            +    GT +Y++PE  Q    S + DI+S G+ L+ +  G          E        
Sbjct: 163 FV----GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQ 218

Query: 430 RKVMNSKNPSRAIDPRLPGNGY---EKKMLHVLKIAYICTLHDPEERPNSQY 478
            +   ++ P R   P  P + Y    +  + + ++        P + P+  +
Sbjct: 219 VEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVF 270

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  168 bits (426), Expect = 7e-49
 Identities = 68/302 (22%), Positives = 116/302 (38%), Gaps = 49/302 (16%)

Query: 179 LIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELI 238
           L  K+D      E  F+ L +IG G  G VY A     N +++AIKK            +
Sbjct: 7   LFFKDDP-----EKLFSDLREIGHGSFGAVYFARDV-RNSEVVAIKK------------M 48

Query: 239 EEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDD 298
               K  + K + I  E+    ++RH N +      +R     LV E+    +   +   
Sbjct: 49  SYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLE-- 106

Query: 299 VSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGL 358
               ++ L       +  G   GL YLH   S ++IH D+K  N+LL++     + D G 
Sbjct: 107 --VHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGS 161

Query: 359 AMAIPDGYTRVLISYVLGTMAYIAPEYFQ---QPELSEKCDIFSFGMLLISLVRGVPSFV 415
           A  +    + V      GT  ++APE      + +   K D++S G+  I L    P   
Sbjct: 162 ASIMAPANSFV------GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL- 214

Query: 416 FHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPN 475
                  + +   L  +  ++       P L    + +   + +     C    P++RP 
Sbjct: 215 -----FNMNAMSALYHIAQNE------SPALQSGHWSEYFRNFVD---SCLQKIPQDRPT 260

Query: 476 SQ 477
           S+
Sbjct: 261 SE 262

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (422), Expect = 8e-49
 Identities = 64/293 (21%), Positives = 116/293 (39%), Gaps = 41/293 (13%)

Query: 189 KKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSK 248
           + ED +  L  IG+G  G   K     S+GK++  K++             +   + +++
Sbjct: 2   RAED-YEVLYTIGTGSYGRCQKIRRK-SDGKILVWKEL-------------DYGSMTEAE 46

Query: 249 LRQIRSEIITASQIRHRNILPLLAHMVRP--DCHLLVYEFMKNGSLQDILDDVSRGRREL 306
            + + SE+    +++H NI+     ++        +V E+ + G L  ++   ++ R+ L
Sbjct: 47  KQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYL 106

Query: 307 DWPSRHRIALGVASGLEYLHMYHSAS--IIHGDIKPRNVLLNDDMEACISDLGLAMAIPD 364
           D     R+   +   L+  H        ++H D+KP NV L+      + D GLA  +  
Sbjct: 107 DEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH 166

Query: 365 GYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEIC 424
             +       +GT  Y++PE   +   +EK DI+S G LL  L   +P F          
Sbjct: 167 DTSFA--KAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF------TAFS 218

Query: 425 SPEWLRKVMNSKNPSRAIDPRLPGNGYE--KKMLHVLKIAYICTLHDPEERPN 475
             E   K+   K     I  R      E   +ML++              RP+
Sbjct: 219 QKELAGKIREGKFRR--IPYRYSDELNEIITRMLNL----------KDYHRPS 259

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (419), Expect = 4e-48
 Identities = 64/297 (21%), Positives = 106/297 (35%), Gaps = 47/297 (15%)

Query: 188 LKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDS 247
           L  ED +  + ++G G  G+VYKA+       + A K +                   + 
Sbjct: 8   LNPEDFWEIIGELGDGAFGKVYKAQNK-ETSVLAAAKVI---------------DTKSEE 51

Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELD 307
           +L     EI   +   H NI+ LL      +   ++ EF   G++  ++       R L 
Sbjct: 52  ELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVML---ELERPLT 108

Query: 308 WPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT 367
                 +       L YLH      IIH D+K  N+L   D +  ++D G++        
Sbjct: 109 ESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ 165

Query: 368 RVLISYVLGTMAYIAPEYFQ-----QPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEE 422
           R      +GT  ++APE              K D++S G+ LI +    P         E
Sbjct: 166 R--RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPH------HE 217

Query: 423 ICSPEWLRKVMNSKNPSRAIDPRLPGNGYE--KKMLHVLKIAYICTLHDPEERPNSQ 477
           +     L K+  S+ P+ A   R   N  +  KK L            + + R  + 
Sbjct: 218 LNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEK----------NVDARWTTS 264

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (405), Expect = 2e-46
 Identities = 65/309 (21%), Positives = 115/309 (37%), Gaps = 49/309 (15%)

Query: 179 LIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELI 238
           +I+  +L F+++         IGSG  G V+       N   +AIK +            
Sbjct: 1   VIDPSELTFVQE---------IGSGQFGLVHLGYWL--NKDKVAIKTI------------ 37

Query: 239 EEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDD 298
               +           E     ++ H  ++ L    +      LV+EFM++G L D    
Sbjct: 38  ----REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDY--- 90

Query: 299 VSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGL 358
           +   R      +   + L V  G+ YL       +IH D+  RN L+ ++    +SD G+
Sbjct: 91  LRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGM 147

Query: 359 AMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQ 418
              + D             + + +PE F     S K D++SFG+L+  +         ++
Sbjct: 148 TRFVLDDQYTSSTGTK-FPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 206

Query: 419 NGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQY 478
           +  E+        V +     R   PRL          HV +I   C    PE+RP    
Sbjct: 207 SNSEV--------VEDISTGFRLYKPRLAST-------HVYQIMNHCWKERPEDRPAFSR 251

Query: 479 VRCRLSQLL 487
           +  +L+++ 
Sbjct: 252 LLRQLAEIA 260

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  160 bits (406), Expect = 3e-46
 Identities = 58/320 (18%), Positives = 111/320 (34%), Gaps = 56/320 (17%)

Query: 192 DCFASLEKIGSGGCGEVYKAELPG----SNGKMIAIKKVIVYAPISAAELIEEDSKLRDS 247
           +    +  IG G  G V++A  PG        M+A+K +                +    
Sbjct: 13  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML--------------KEEASAD 58

Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSR------ 301
                + E    ++  + NI+ LL          L++E+M  G L + L  +S       
Sbjct: 59  MQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSL 118

Query: 302 --------------GRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLND 347
                         G   L    +  IA  VA+G+ YL        +H D+  RN L+ +
Sbjct: 119 SHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGE 175

Query: 348 DMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISL 407
           +M   I+D GL+  I               + ++ PE       + + D++++G++L  +
Sbjct: 176 NMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 235

Query: 408 VRGVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTL 467
                   +    EE+     +  V +    +       P        L +  +  +C  
Sbjct: 236 FSYGLQPYYGMAHEEV-----IYYVRDGNILA--CPENCP--------LELYNLMRLCWS 280

Query: 468 HDPEERPNSQYVRCRLSQLL 487
             P +RP+   +   L ++ 
Sbjct: 281 KLPADRPSFCSIHRILQRMC 300

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (403), Expect = 5e-46
 Identities = 61/282 (21%), Positives = 103/282 (36%), Gaps = 41/282 (14%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           ++ +G G  GEV  A       + +A+K V              D K        I+ EI
Sbjct: 10  VQTLGEGAYGEVQLAVNR-VTEEAVAVKIV--------------DMKRAVDCPENIKKEI 54

Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL 316
                + H N++    H    +   L  E+   G L D +         +  P   R   
Sbjct: 55  CINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFH 110

Query: 317 GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLG 376
            + +G+ YLH      I H DIKP N+LL++     ISD GLA          L++ + G
Sbjct: 111 QLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 167

Query: 377 TMAYIAPEYFQ-QPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNS 435
           T+ Y+APE  + +   +E  D++S G++L +++ G   +    +  +             
Sbjct: 168 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ------EYSDWKE 221

Query: 436 KNPSRAIDPRLPGNGYE--KKMLHVLKIAYICTLHDPEERPN 475
           K        ++         K+L            +P  R  
Sbjct: 222 KKTYLNPWKKIDSAPLALLHKILVE----------NPSARIT 253

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (403), Expect = 6e-46
 Identities = 63/296 (21%), Positives = 120/296 (40%), Gaps = 40/296 (13%)

Query: 192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ 251
           +    +E++G+G  GEV+     G     +A+K +                K        
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNG--HTKVAVKSL----------------KQGSMSPDA 54

Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
             +E     Q++H+ ++ L A + +   ++ + E+M+NGSL D L        +L     
Sbjct: 55  FLAEANLMKQLQHQRLVRLYAVVTQEPIYI-ITEYMENGSLVDFLKT--PSGIKLTINKL 111

Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLI 371
             +A  +A G+ ++      + IH D++  N+L++D +   I+D GLA  I D       
Sbjct: 112 LDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE 168

Query: 372 SYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRK 431
                 + + APE       + K D++SFG+LL  +V             E+        
Sbjct: 169 GAK-FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV-------- 219

Query: 432 VMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL 487
           + N +   R + P    +   +++  +++   +C    PE+RP   Y+R  L    
Sbjct: 220 IQNLERGYRMVRP----DNCPEELYQLMR---LCWKERPEDRPTFDYLRSVLEDFF 268

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (401), Expect = 6e-46
 Identities = 69/291 (23%), Positives = 115/291 (39%), Gaps = 46/291 (15%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           L+ IG G  G+V   +     G  +A+K +                   D+  +   +E 
Sbjct: 12  LQTIGKGEFGDVMLGDY---RGNKVAVKCIK-----------------NDATAQAFLAEA 51

Query: 257 ITASQIRHRNILPLLAHMVRPDCHL-LVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIA 315
              +Q+RH N++ LL  +V     L +V E+M  GSL D L   SRGR  L      + +
Sbjct: 52  SVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFS 109

Query: 316 LGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVL 375
           L V   +EYL      + +H D+  RNVL+++D  A +SD GL                 
Sbjct: 110 LDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----GK 161

Query: 376 GTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNS 435
             + + APE  ++ + S K D++SFG+LL  +             +++     + +V   
Sbjct: 162 LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-----VPRVEKG 216

Query: 436 KNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL 486
                      P          V ++   C   D   RP+   +R +L  +
Sbjct: 217 YKMD--APDGCPPA--------VYEVMKNCWHLDAAMRPSFLQLREQLEHI 257

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (401), Expect = 8e-46
 Identities = 64/281 (22%), Positives = 106/281 (37%), Gaps = 45/281 (16%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
              +G G  G VY A     +  ++A+K             + +    +     Q+R E+
Sbjct: 11  GRPLGKGKFGNVYLAREK-QSKFILALKV------------LFKAQLEKAGVEHQLRREV 57

Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL 316
              S +RH NIL L  +        L+ E+   G++   L  +S+     D         
Sbjct: 58  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYIT 113

Query: 317 GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLG 376
            +A+ L Y H   S  +IH DIKP N+LL    E  I+D G ++  P      L     G
Sbjct: 114 ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----G 166

Query: 377 TMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSK 436
           T+ Y+ PE  +     EK D++S G+L    + G P F      E     E  +++   +
Sbjct: 167 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF------EANTYQETYKRISRVE 220

Query: 437 NPSRAIDPRLPGNGYE--KKMLHVLKIAYICTLHDPEERPN 475
                    +     +   ++L            +P +RP 
Sbjct: 221 FT---FPDFVTEGARDLISRLLKH----------NPSQRPM 248

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  158 bits (401), Expect = 2e-45
 Identities = 65/302 (21%), Positives = 124/302 (41%), Gaps = 42/302 (13%)

Query: 192 DCFASLEKIGSGGCGEVYKAEL--PGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKL 249
            C    + IG+G  GEV    L  PG     +AIK +               S   + + 
Sbjct: 26  SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTL--------------KSGYTEKQR 71

Query: 250 RQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWP 309
           R   SE     Q  H N++ L   + +    +++ EFM+NGSL      + +   +    
Sbjct: 72  RDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSF---LRQNDGQFTVI 128

Query: 310 SRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRV 369
               +  G+A+G++YL   +    +H D+  RN+L+N ++   +SD GL+  + D  +  
Sbjct: 129 QLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP 185

Query: 370 LISYVLG---TMAYIAPEYFQQPELSEKCDIFSFGMLLISLV-RGVPSFVFHQNGEEICS 425
             +  LG    + + APE  Q  + +   D++S+G+++  ++  G   +       ++ +
Sbjct: 186 TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPY------WDMTN 239

Query: 426 PEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQ 485
            + +  +          D RLP        LH  ++   C   D   RP    +   L +
Sbjct: 240 QDVINAIEQ--------DYRLPPPMDCPSALH--QLMLDCWQKDRNHRPKFGQIVNTLDK 289

Query: 486 LL 487
           ++
Sbjct: 290 MI 291

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 3e-45
 Identities = 62/283 (21%), Positives = 112/283 (39%), Gaps = 43/283 (15%)

Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
            +IG G    VYK          +A  ++             +D KL  S+ ++ + E  
Sbjct: 15  IEIGRGSFKTVYKGLDTE-TTVEVAWCEL-------------QDRKLTKSERQRFKEEAE 60

Query: 258 TASQIRHRNILPLLAHMV----RPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
               ++H NI+              C +LV E M +G+L+  L    +  + +       
Sbjct: 61  MLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL----KRFKVMKIKVLRS 116

Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLND-DMEACISDLGLAMAIPDGYTRVLIS 372
               +  GL++LH   +  IIH D+K  N+ +        I DLGLA      + +    
Sbjct: 117 WCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA--- 172

Query: 373 YVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKV 432
            V+GT  ++APE +++    E  D+++FGM ++ +      +   QN  +I      R+V
Sbjct: 173 -VIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQI-----YRRV 225

Query: 433 MNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPN 475
            +   P+      +P          V +I   C   + +ER +
Sbjct: 226 TSGVKPASFDKVAIP---------EVKEIIEGCIRQNKDERYS 259

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (394), Expect = 6e-45
 Identities = 61/292 (20%), Positives = 101/292 (34%), Gaps = 45/292 (15%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           L+++G+G  G V   +  G     +AIK +                K       +   E 
Sbjct: 9   LKELGTGQFGVVKYGKWRG--QYDVAIKMI----------------KEGSMSEDEFIEEA 50

Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL 316
                + H  ++ L     +     ++ E+M NG L + L      R          +  
Sbjct: 51  KVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR---EMRHRFQTQQLLEMCK 107

Query: 317 GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLG 376
            V   +EYL        +H D+  RN L+ND     +SD GL+  + D      +     
Sbjct: 108 DVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK-F 163

Query: 377 TMAYIAPEYFQQPELSEKCDIFSFGMLLISLV-RGVPSFVFHQNGEEICSPEWLRKVMNS 435
            + +  PE     + S K DI++FG+L+  +   G   +      E   + E    +   
Sbjct: 164 PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY------ERFTNSETAEHIAQG 217

Query: 436 KNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL 487
               R   P L           V  I Y C     +ERP  + +   LS +L
Sbjct: 218 LRLYR---PHLASE-------KVYTIMYSCWHEKADERPTFKIL---LSNIL 256

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (399), Expect = 8e-45
 Identities = 72/346 (20%), Positives = 122/346 (35%), Gaps = 58/346 (16%)

Query: 167 GSRDRGPTIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSN----GKMIA 222
           GS D           + DL +    +     + +GSG  G+V  A   G +       +A
Sbjct: 12  GSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVA 71

Query: 223 IKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RHRNILPLLAHMVRPDCHL 281
           +K +                K   S+   + SE+   +Q+  H NI+ LL          
Sbjct: 72  VKML--------------KEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIY 117

Query: 282 LVYEFMKNGSLQDIL-------------------DDVSRGRRELDWPSRHRIALGVASGL 322
           L++E+   G L + L                    +       L +      A  VA G+
Sbjct: 118 LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGM 177

Query: 323 EYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIA 382
           E+L      S +H D+  RNVL+       I D GLA  I      V+       + ++A
Sbjct: 178 EFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMA 234

Query: 383 PEYFQQPELSEKCDIFSFGMLLISLV-RGVPSFVFHQNGEEICSPEWLRKVMNSKNPSRA 441
           PE   +   + K D++S+G+LL  +   GV  +        I       K++ +      
Sbjct: 235 PESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY------PGIPVDANFYKLIQN------ 282

Query: 442 IDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRL-SQL 486
              ++    Y  + ++   I   C   D  +RP+   +   L  QL
Sbjct: 283 -GFKMDQPFYATEEIY--IIMQSCWAFDSRKRPSFPNLTSFLGCQL 325

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (395), Expect = 1e-44
 Identities = 62/304 (20%), Positives = 118/304 (38%), Gaps = 40/304 (13%)

Query: 187 FLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKM-IAIKKVIVYAPISAAELIEEDSKLR 245
           FLK+++   +  ++G G  G V +        ++ +AIK +                   
Sbjct: 4   FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL--------------KQGTE 49

Query: 246 DSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRE 305
            +   ++  E     Q+ +  I+ L+  + + +  +LV E    G L   L      R E
Sbjct: 50  KADTEEMMREAQIMHQLDNPYIVRLI-GVCQAEALMLVMEMAGGGPLHKFL---VGKREE 105

Query: 306 LDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI-PD 364
           +   +   +   V+ G++YL      + +H D+  RNVLL +   A ISD GL+ A+  D
Sbjct: 106 IPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162

Query: 365 GYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLIS-LVRGVPSFVFHQNGEEI 423
                  S     + + APE     + S + D++S+G+ +   L  G   +      +++
Sbjct: 163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY------KKM 216

Query: 424 CSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRL 483
             PE +  +   K       P  P          +  +   C ++  E+RP+   V  R+
Sbjct: 217 KGPEVMAFIEQGKRME--CPPECPPE--------LYALMSDCWIYKWEDRPDFLTVEQRM 266

Query: 484 SQLL 487
               
Sbjct: 267 RACY 270

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (393), Expect = 3e-44
 Identities = 65/283 (22%), Positives = 115/283 (40%), Gaps = 44/283 (15%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
            EKIG G  G VY A    + G+ +AI+++               +  +  K   I +EI
Sbjct: 25  FEKIGQGASGTVYTAMDV-ATGQEVAIRQM---------------NLQQQPKKELIINEI 68

Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL 316
           +   + ++ NI+  L   +  D   +V E++  GSL D++         +D      +  
Sbjct: 69  LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCR 123

Query: 317 GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLG 376
                LE+L   HS  +IH DIK  N+LL  D    ++D G    I    ++   S ++G
Sbjct: 124 ECLQALEFL---HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVG 178

Query: 377 TMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSK 436
           T  ++APE   +     K DI+S G++ I ++ G P +              L  +  + 
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY------LNENPLRALYLIATNG 232

Query: 437 NPSRAIDPRLPGNGYE--KKMLHVLKIAYICTLHDPEERPNSQ 477
            P      +L     +   + L +          D E+R +++
Sbjct: 233 TPELQNPEKLSAIFRDFLNRCLDM----------DVEKRGSAK 265

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (393), Expect = 3e-44
 Identities = 65/296 (21%), Positives = 116/296 (39%), Gaps = 42/296 (14%)

Query: 198 EKIGSGGCGEVYKAELPGSNGKMI--AIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSE 255
           E IG G  G VY   L  ++GK I  A+K +              +      ++ Q  +E
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--------------NRITDIGEVSQFLTE 78

Query: 256 IITASQIRHRNILPLLAHMVRPD-CHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRI 314
            I      H N+L LL   +R +   L+V  +MK+G L++    +               
Sbjct: 79  GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNF---IRNETHNPTVKDLIGF 135

Query: 315 ALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG--YTRVLIS 372
            L VA G+       S   +H D+  RN +L++     ++D GLA  + D    +    +
Sbjct: 136 GLQVAKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT 192

Query: 373 YVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLV-RGVPSFVFHQNGEEICSPEWLRK 431
                + ++A E  Q  + + K D++SFG+LL  L+ RG P +       ++ + +    
Sbjct: 193 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY------PDVNTFDITVY 246

Query: 432 VMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL 487
           ++  +         L        +  V+     C     E RP+   +  R+S + 
Sbjct: 247 LLQGRRL-------LQPEYCPDPLYEVML---KCWHPKAEMRPSFSELVSRISAIF 292

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 5e-44
 Identities = 65/296 (21%), Positives = 109/296 (36%), Gaps = 40/296 (13%)

Query: 192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ 251
           +      K+G G  GEV+     G     +AIK +                K        
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNG--TTRVAIKTL----------------KPGTMSPEA 58

Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
              E     ++RH  ++ L A +V  +   +V E+M  GSL D         + L  P  
Sbjct: 59  FLQEAQVMKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDF--LKGETGKYLRLPQL 115

Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLI 371
             +A  +ASG+ Y+   +    +H D++  N+L+ +++   ++D GLA  I D       
Sbjct: 116 VDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 172

Query: 372 SYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRK 431
                 + + APE       + K D++SFG+LL  L              E+     L +
Sbjct: 173 GAK-FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-----LDQ 226

Query: 432 VMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL 487
           V           P  P +        +  +   C   +PEERP  +Y++  L    
Sbjct: 227 VERGYRMP--CPPECPES--------LHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (389), Expect = 1e-43
 Identities = 62/310 (20%), Positives = 108/310 (34%), Gaps = 50/310 (16%)

Query: 197 LEKIGSGGCGEVYKAELPG----SNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQI 252
            + +G+G  G+V +A   G         +A+K +                    ++   +
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML--------------KPSAHLTEREAL 73

Query: 253 RSEIITASQI-RHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDIL--------------D 297
            SE+   S +  H NI+ LL         L++ E+   G L + L               
Sbjct: 74  MSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPA 133

Query: 298 DVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLG 357
            +      LD       +  VA G+ +L    S + IH D+  RN+LL       I D G
Sbjct: 134 IMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFG 190

Query: 358 LAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFH 417
           LA  I +    V+       + ++APE       + + D++S+G+ L  L     S    
Sbjct: 191 LARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG 250

Query: 418 QNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQ 477
                        K++  K   R + P       E     +  I   C   DP +RP  +
Sbjct: 251 MP-----VDSKFYKMI--KEGFRMLSP-------EHAPAEMYDIMKTCWDADPLKRPTFK 296

Query: 478 YVRCRLSQLL 487
            +   + + +
Sbjct: 297 QIVQLIEKQI 306

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (386), Expect = 2e-43
 Identities = 58/300 (19%), Positives = 116/300 (38%), Gaps = 39/300 (13%)

Query: 192 DCFASLEKIGSGGCGEVYKAELPGSNGKM---IAIKKVIVYAPISAAELIEEDSKLRDSK 248
            C    + IG+G  GEVYK  L  S+GK    +AIK +               +   + +
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL--------------KAGYTEKQ 52

Query: 249 LRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDW 308
                 E     Q  H NI+ L   + +    +++ E+M+NG+L      +     E   
Sbjct: 53  RVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKF---LREKDGEFSV 109

Query: 309 PSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTR 368
                +  G+A+G++Y     + + +H D+  RN+L+N ++   +SD GL+  + D    
Sbjct: 110 LQLVGMLRGIAAGMKY---LANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 166

Query: 369 VLISY-VLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPE 427
              +      + + APE     + +   D++SFG+++  ++       +  +  E+    
Sbjct: 167 TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM--- 223

Query: 428 WLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL 487
                       +AI+              + ++   C   +   RP    +   L +L+
Sbjct: 224 ------------KAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 2e-43
 Identities = 59/300 (19%), Positives = 109/300 (36%), Gaps = 40/300 (13%)

Query: 187 FLKKEDCFASLEKIGSGGCGEVYKAELPGSN-GKMIAIKKVIVYAPISAAELIEEDSKLR 245
           +L ++      +++GSG  G V K         K +A+K +             ++    
Sbjct: 2   YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-------------KNEAND 48

Query: 246 DSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRE 305
            +   ++ +E     Q+ +  I+ ++  +   +  +LV E  + G L   L       R 
Sbjct: 49  PALKDELLAEANVMQQLDNPYIVRMI-GICEAESWMLVMEMAELGPLNKYLQQ----NRH 103

Query: 306 LDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDG 365
           +   +   +   V+ G++YL   +    +H D+  RNVLL     A ISD GL+ A+   
Sbjct: 104 VKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 160

Query: 366 YTRVLISY-VLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLV-RGVPSFVFHQNGEEI 423
                        + + APE     + S K D++SFG+L+      G   +        +
Sbjct: 161 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY------RGM 214

Query: 424 CSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRL 483
              E    +   +          P          +  +  +C  +D E RP    V  RL
Sbjct: 215 KGSEVTAMLEKGERMG--CPAGCP--------REMYDLMNLCWTYDVENRPGFAAVELRL 264

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 5e-43
 Identities = 57/291 (19%), Positives = 108/291 (37%), Gaps = 41/291 (14%)

Query: 189 KKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSK 248
           K+ + F   + +G G    V  A    +  +  AIK             +E+   ++++K
Sbjct: 5   KRPEDFKFGKILGEGSFSTVVLAREL-ATSREYAIKI------------LEKRHIIKENK 51

Query: 249 LRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDW 308
           +  +  E    S++ H   + L       +       + KNG L   +  +         
Sbjct: 52  VPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS------- 104

Query: 309 PSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTR 368
                     A  +  L   H   IIH D+KP N+LLN+DM   I+D G A  +     +
Sbjct: 105 FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164

Query: 369 VLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEW 428
              +  +GT  Y++PE   +    +  D+++ G ++  LV G+P F    N   I     
Sbjct: 165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF-RAGNEYLI----- 218

Query: 429 LRKVMNSKNPSRAIDPRLPGNGYE--KKMLHVLKIAYICTLHDPEERPNSQ 477
            +K++  +        +      +  +K+L +          D  +R   +
Sbjct: 219 FQKIIKLEYD---FPEKFFPKARDLVEKLLVL----------DATKRLGCE 256

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  151 bits (382), Expect = 6e-43
 Identities = 57/291 (19%), Positives = 108/291 (37%), Gaps = 38/291 (13%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
             K+G G  GEVY+          +A+K +                K    ++ +   E 
Sbjct: 22  KHKLGGGQYGEVYEGVWKK-YSLTVAVKTL----------------KEDTMEVEEFLKEA 64

Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL 316
               +I+H N++ LL    R     ++ EFM  G+L D L +    R+E+       +A 
Sbjct: 65  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMAT 122

Query: 317 GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLG 376
            ++S +EYL      + IH D+  RN L+ ++    ++D GL+  +              
Sbjct: 123 QISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKF 178

Query: 377 TMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSK 436
            + + APE     + S K D+++FG+LL  +     S     +  ++             
Sbjct: 179 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV------------- 225

Query: 437 NPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL 487
                ++        E     V ++   C   +P +RP+   +      + 
Sbjct: 226 --YELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 8e-43
 Identities = 65/329 (19%), Positives = 121/329 (36%), Gaps = 59/329 (17%)

Query: 173 PTIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKM-IAIKKVIVYAP 231
           PTI+ P+++  D+ F          + IG G  G+V KA +     +M  AIK++     
Sbjct: 1   PTIY-PVLDWNDIKFQ---------DVIGEGNFGQVLKARIKKDGLRMDAAIKRM----- 45

Query: 232 ISAAELIEEDSKLRDSKLRQIRSEIITASQI-RHRNILPLLAHMVRPDCHLLVYEFMKNG 290
                             R    E+    ++  H NI+ LL          L  E+  +G
Sbjct: 46  ---------KEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 96

Query: 291 SLQDIL------------DDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDI 338
           +L D L               +     L        A  VA G++YL        IH D+
Sbjct: 97  NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDL 153

Query: 339 KPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIF 398
             RN+L+ ++  A I+D GL+        +   +     + ++A E       +   D++
Sbjct: 154 AARNILVGENYVAKIADFGLSRGQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVW 210

Query: 399 SFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHV 458
           S+G+LL  +V    +        E+       K+       + ++        + ++  +
Sbjct: 211 SYGVLLWEIVSLGGTPYCGMTCAEL-----YEKLPQGYRLEKPLN-------CDDEVYDL 258

Query: 459 LKIAYICTLHDPEERPNSQYVRCRLSQLL 487
           ++    C    P ERP+   +   L+++L
Sbjct: 259 MR---QCWREKPYERPSFAQILVSLNRML 284

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (377), Expect = 2e-42
 Identities = 72/294 (24%), Positives = 113/294 (38%), Gaps = 38/294 (12%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKM--IAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRS 254
           LEK+G G  G V + E    +GK   +A+K             ++ D   +   +     
Sbjct: 13  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKC------------LKPDVLSQPEAMDDFIR 60

Query: 255 EIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRI 314
           E+     + HRN++ L   ++ P   + V E    GSL   LD + + +      +  R 
Sbjct: 61  EVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSL---LDRLRKHQGHFLLGTLSRY 116

Query: 315 ALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTR-VLISY 373
           A+ VA G+ YL    S   IH D+  RN+LL       I D GL  A+P      V+  +
Sbjct: 117 AVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEH 173

Query: 374 VLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLV-RGVPSFVFHQNGEEICSPEWLRKV 432
                A+ APE  +    S   D + FG+ L  +   G   +        +   + L K+
Sbjct: 174 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW------IGLNGSQILHKI 227

Query: 433 MNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL 486
                       RLP    E     +  +   C  H PE+RP    +R  L + 
Sbjct: 228 DKE-------GERLPRP--EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (368), Expect = 2e-40
 Identities = 58/307 (18%), Positives = 107/307 (34%), Gaps = 41/307 (13%)

Query: 186 AFLK--KEDCFASLEKIGSGGCGEVYKAELPGSNGKM---IAIKKVIVYAPISAAELIEE 240
           A L+  KE  F  ++ +GSG  G VYK        K+   +AIK++              
Sbjct: 1   ALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-------------- 46

Query: 241 DSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVS 300
                    ++I  E    + + + ++  LL   +     L + + M  G L   LD V 
Sbjct: 47  REATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCL---LDYVR 102

Query: 301 RGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAM 360
             +  +         + +A G+ YL       ++H D+  RNVL+       I+D GLA 
Sbjct: 103 EHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAK 159

Query: 361 AIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNG 420
            +               + ++A E       + + D++S+G+ +  L+            
Sbjct: 160 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 219

Query: 421 EEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVR 480
            EI        +   +       P           + V  I   C + D + RP  + + 
Sbjct: 220 SEI-----SSILEKGERLP--QPPICT--------IDVYMIMVKCWMIDADSRPKFRELI 264

Query: 481 CRLSQLL 487
              S++ 
Sbjct: 265 IEFSKMA 271

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  145 bits (367), Expect = 5e-40
 Identities = 61/286 (21%), Positives = 107/286 (37%), Gaps = 46/286 (16%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
            E++G+G  G V++     + G   A K V                   +S    +R EI
Sbjct: 31  HEELGTGAFGVVHRVTER-ATGNNFAAKFV---------------MTPHESDKETVRKEI 74

Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL 316
            T S +RH  ++ L       +  +++YEFM  G L + +        ++          
Sbjct: 75  QTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVA---DEHNKMSEDEAVEYMR 131

Query: 317 GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDM--EACISDLGLAMAIPDGYTRVLISYV 374
            V  GL ++   H  + +H D+KP N++       E  + D GL   +    +       
Sbjct: 132 QVCKGLCHM---HENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK---VT 185

Query: 375 LGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMN 434
            GT  + APE  +   +    D++S G+L   L+ G+  F   +N +E      LR V +
Sbjct: 186 TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPF-GGENDDET-----LRNVKS 239

Query: 435 SK-NPSRAIDPRLPGNGYE--KKMLHVLKIAYICTLHDPEERPNSQ 477
              N   +    +  +G +  +K+L            DP  R    
Sbjct: 240 CDWNMDDSAFSGISEDGKDFIRKLLLA----------DPNTRMTIH 275

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (361), Expect = 1e-39
 Identities = 50/306 (16%), Positives = 110/306 (35%), Gaps = 42/306 (13%)

Query: 192 DCFASLEKIGSGGCGEVYKAELPG----SNGKMIAIKKVIVYAPISAAELIEEDSKLRDS 247
           +      ++G G  G VY+    G         +AIK V              +      
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV--------------NEAASMR 65

Query: 248 KLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRG----- 302
           +  +  +E     +    +++ LL  + +    L++ E M  G L+  L  +        
Sbjct: 66  ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNP 125

Query: 303 -RRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMA 361
                      ++A  +A G+ YL+   +   +H D+  RN ++ +D    I D G+   
Sbjct: 126 VLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD 182

Query: 362 IPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGE 421
           I +          L  + +++PE  +    +   D++SFG++L  +           + E
Sbjct: 183 IYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 242

Query: 422 EICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC 481
           ++     LR VM      +           +     + ++  +C  ++P+ RP+   +  
Sbjct: 243 QV-----LRFVMEGGLLDK----------PDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287

Query: 482 RLSQLL 487
            + + +
Sbjct: 288 SIKEEM 293

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (355), Expect = 8e-39
 Identities = 66/324 (20%), Positives = 115/324 (35%), Gaps = 51/324 (15%)

Query: 183 EDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSN------GKMIAIKKVIVYAPISAAE 236
           ED  +    D     + +G G  G+V  AE  G +         +A+K +          
Sbjct: 4   EDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML---------- 53

Query: 237 LIEEDSKLRDSKLRQIRSEIITASQI-RHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDI 295
                S   +  L  + SE+     I +H+NI+ LL    +     ++ E+   G+L++ 
Sbjct: 54  ----KSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY 109

Query: 296 L------------DDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNV 343
           L            +       +L        A  VA G+EYL    S   IH D+  RNV
Sbjct: 110 LQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNV 166

Query: 344 LLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGML 403
           L+ +D    I+D GLA  I         +     + ++APE       + + D++SFG+L
Sbjct: 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVL 226

Query: 404 LISLVRGVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAY 463
           L  +     S       EE+      + +                         +  +  
Sbjct: 227 LWEIFTLGGSPYPGVPVEEL-----FKLLKEGHRMD--KPSNCTNE--------LYMMMR 271

Query: 464 ICTLHDPEERPNSQYVRCRLSQLL 487
            C    P +RP  + +   L +++
Sbjct: 272 DCWHAVPSQRPTFKQLVEDLDRIV 295

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (352), Expect = 2e-38
 Identities = 64/308 (20%), Positives = 107/308 (34%), Gaps = 47/308 (15%)

Query: 197 LEKIGSGGCGEVYKAELPG----SNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQI 252
            + +G G  G+V +A+  G    +  + +A+K +             ++          +
Sbjct: 18  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-------------KEGATHSEHRALM 64

Query: 253 RSEIITASQIRHRNILPLLAHMVRPDCHL-LVYEFMKNGSLQDIL------------DDV 299
               I      H N++ LL    +P   L ++ EF K G+L   L               
Sbjct: 65  SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPE 124

Query: 300 SRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA 359
              +  L        +  VA G+E+L    S   IH D+  RN+LL++     I D GLA
Sbjct: 125 DLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLA 181

Query: 360 MAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQN 419
             I      V        + ++APE       + + D++SFG+LL  +     S      
Sbjct: 182 RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 241

Query: 420 GEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYV 479
                  E   + +      RA D   P          + +    C   +P +RP    +
Sbjct: 242 -----IDEEFCRRLKEGTRMRAPDYTTP---------EMYQTMLDCWHGEPSQRPTFSEL 287

Query: 480 RCRLSQLL 487
              L  LL
Sbjct: 288 VEHLGNLL 295

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  138 bits (349), Expect = 3e-38
 Identities = 56/287 (19%), Positives = 100/287 (34%), Gaps = 42/287 (14%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
            E +G GG  EV+ A       + +A+K             +  D     S   + R E 
Sbjct: 12  GEILGFGGMSEVHLARDL-RLHRDVAVKV------------LRADLARDPSFYLRFRREA 58

Query: 257 ITASQIRHRNILPLLAHMVRPD----CHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRH 312
             A+ + H  I+ +               +V E++   +L+DI+         +      
Sbjct: 59  QNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV----HTEGPMTPKRAI 114

Query: 313 RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA-MAIPDGYTRVLI 371
            +       L + H      IIH D+KP N++++      + D G+A      G +    
Sbjct: 115 EVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 171

Query: 372 SYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRK 431
           + V+GT  Y++PE  +   +  + D++S G +L  ++ G P F               + 
Sbjct: 172 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA-----YQH 226

Query: 432 VMNSKNPSRAIDPRLPGNGYE--KKMLHVLKIAYICTLHDPEERPNS 476
           V     P  A    L  +      K L            +PE R  +
Sbjct: 227 VREDPIPPSARHEGLSADLDAVVLKALAK----------NPENRYQT 263

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  139 bits (352), Expect = 6e-38
 Identities = 54/291 (18%), Positives = 100/291 (34%), Gaps = 46/291 (15%)

Query: 192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ 251
           D +  LE++GSG  G V++     + G++   K +               +         
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEK-ATGRVFVAKFI---------------NTPYPLDKYT 72

Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
           +++EI   +Q+ H  ++ L          +L+ EF+  G L D +   +    ++     
Sbjct: 73  VKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRI---AAEDYKMSEAEV 129

Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLL--NDDMEACISDLGLAMAIPDGYTRV 369
                    GL+++   H  SI+H DIKP N++          I D GLA  +       
Sbjct: 130 INYMRQACEGLKHM---HEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK 186

Query: 370 LISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWL 429
                  T  + APE   +  +    D+++ G+L   L+ G+  F            E L
Sbjct: 187 ---VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPF------AGEDDLETL 237

Query: 430 RKVMNSK-NPSRAIDPRLPGNGYE--KKMLHVLKIAYICTLHDPEERPNSQ 477
           + V              +     +  K +L            +P +R    
Sbjct: 238 QNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQK----------EPRKRLTVH 278

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  137 bits (346), Expect = 7e-38
 Identities = 61/291 (20%), Positives = 108/291 (37%), Gaps = 43/291 (14%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
            E +G G    V +        K  A+K       I         ++           E+
Sbjct: 8   KEILGRGVSSVVRRCIHK-PTCKEYAVKI------IDVTGGGSFSAEEVQELREATLKEV 60

Query: 257 ITASQIR-HRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIA 315
               ++  H NI+ L           LV++ MK G L D L      +  L      +I 
Sbjct: 61  DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL----TEKVTLSEKETRKIM 116

Query: 316 LGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVL 375
             +   +  LH     +I+H D+KP N+LL+DDM   ++D G +  +  G        V 
Sbjct: 117 RALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL---REVC 170

Query: 376 GTMAYIAPEYFQQPEL------SEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWL 429
           GT +Y+APE  +           ++ D++S G+++ +L+ G P F +H+    +     L
Sbjct: 171 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF-WHRKQMLM-----L 224

Query: 430 RKVMNSK-NPSRAIDPRLPGNGYE--KKMLHVLKIAYICTLHDPEERPNSQ 477
           R +M+                  +   + L V           P++R  ++
Sbjct: 225 RMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVV----------QPQKRYTAE 265

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (350), Expect = 7e-38
 Identities = 56/286 (19%), Positives = 105/286 (36%), Gaps = 47/286 (16%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
            E +G G  G V++     S+ K    K V                K++ +    ++ EI
Sbjct: 10  AEDLGRGEFGIVHRCVET-SSKKTYMAKFV----------------KVKGTDQVLVKKEI 52

Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL 316
              +  RHRNIL L       +  ++++EF+    + + ++       EL+         
Sbjct: 53  SILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERIN---TSAFELNEREIVSYVH 109

Query: 317 GVASGLEYLHMYHSASIIHGDIKPRNVLL--NDDMEACISDLGLAMAIPDGYTRVLISYV 374
            V   L++L   HS +I H DI+P N++          I + G A  +  G        +
Sbjct: 110 QVCEALQFL---HSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLL 163

Query: 375 LGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMN 434
                Y APE  Q   +S   D++S G L+  L+ G+  F+   N       + +  +MN
Sbjct: 164 FTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN------QQIIENIMN 217

Query: 435 SK-NPSRAIDPRLPGNGYE--KKMLHVLKIAYICTLHDPEERPNSQ 477
           ++          +     +   ++L            + + R  + 
Sbjct: 218 AEYTFDEEAFKEISIEAMDFVDRLLVK----------ERKSRMTAS 253

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  138 bits (349), Expect = 7e-38
 Identities = 59/300 (19%), Positives = 107/300 (35%), Gaps = 46/300 (15%)

Query: 181 EKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEE 240
           + ED+      D +   + +G+G   EV  AE      K++AIK +              
Sbjct: 3   QAEDI-----RDIYDFRDVLGTGAFSEVILAEDK-RTQKLVAIKCI-------------- 42

Query: 241 DSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVS 300
             K  + K   + +EI    +I+H NI+ L           L+ + +  G L D +    
Sbjct: 43  AKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI---- 98

Query: 301 RGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAM 360
             +         R+   V   ++YLH                  L++D +  ISD GL+ 
Sbjct: 99  VEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK 158

Query: 361 AIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNG 420
               G      S   GT  Y+APE   Q   S+  D +S G++   L+ G P F      
Sbjct: 159 MEDPGSVL---STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF------ 209

Query: 421 EEICSPEWLRKVMNSK-NPSRAIDPRLPGNGYE--KKMLHVLKIAYICTLHDPEERPNSQ 477
            +    +   +++ ++          +  +  +  + ++            DPE+R   +
Sbjct: 210 YDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEK----------DPEKRFTCE 259

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (346), Expect = 7e-38
 Identities = 62/294 (21%), Positives = 111/294 (37%), Gaps = 41/294 (13%)

Query: 197 LEKIGSGGCGEVYKAELPGSN--GKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRS 254
              IG G  G+V++            +AIK                 +   DS   +   
Sbjct: 12  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTC--------------KNCTSDSVREKFLQ 57

Query: 255 EIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRI 314
           E +T  Q  H +I+ L+  +   +   ++ E    G L+     +   +  LD  S    
Sbjct: 58  EALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSF---LQVRKYSLDLASLILY 113

Query: 315 ALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYV 374
           A  +++ L YL        +H DI  RNVL++ +    + D GL+  + D  T    S  
Sbjct: 114 AYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-TYYKASKG 169

Query: 375 LGTMAYIAPEYFQQPELSEKCDIFSFGMLLIS-LVRGVPSFVFHQNGEEICSPEWLRKVM 433
              + ++APE       +   D++ FG+ +   L+ GV  F   +N       + + ++ 
Sbjct: 170 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN------NDVIGRIE 223

Query: 434 NSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL 487
           N +     + P  P   Y         +   C  +DP  RP    ++ +LS +L
Sbjct: 224 NGERLP--MPPNCPPTLYS--------LMTKCWAYDPSRRPRFTELKAQLSTIL 267

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (346), Expect = 2e-37
 Identities = 59/284 (20%), Positives = 102/284 (35%), Gaps = 44/284 (15%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
            + +G G  G+V+ AE      +  AIK             +++D  L D  +     E 
Sbjct: 7   HKMLGKGSFGKVFLAEFK-KTNQFFAIKA------------LKKDVVLMDDDVECTMVEK 53

Query: 257 -ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIA 315
            + +    H  +  +       +    V E++  G L   +    +   + D       A
Sbjct: 54  RVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI----QSCHKFDLSRATFYA 109

Query: 316 LGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVL 375
             +  GL++LH      I++ D+K  N+LL+ D    I+D G+      G  +   +   
Sbjct: 110 AEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNTFC 164

Query: 376 GTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNS 435
           GT  YIAPE     + +   D +SFG+LL  ++ G   F            E L   +  
Sbjct: 165 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF-------HGQDEEELFHSIRM 217

Query: 436 KNPSRAIDPRLPGNGYE--KKMLHVLKIAYICTLHDPEERPNSQ 477
            NP       L     +   K+             +PE+R   +
Sbjct: 218 DNPF--YPRWLEKEAKDLLVKLFVR----------EPEKRLGVR 249

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  136 bits (342), Expect = 4e-37
 Identities = 61/299 (20%), Positives = 103/299 (34%), Gaps = 41/299 (13%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
             KIGSG  G++Y      + G+ +AIK   V                  +K  Q+  E 
Sbjct: 12  GRKIGSGSFGDIYLGTDI-AAGEEVAIKLECV-----------------KTKHPQLHIES 53

Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL 316
                ++    +P +        + ++   +   SL    D  +   R+    +   +A 
Sbjct: 54  KIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSL---EDLFNFCSRKFSLKTVLLLAD 110

Query: 317 GVASGLEYLHMYHSASIIHGDIKPRNVLLND---DMEACISDLGLAMAIPDGYTRVLISY 373
            + S +EY+H   S + IH D+KP N L+          I D GLA    D  T   I Y
Sbjct: 111 QMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPY 167

Query: 374 -----VLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEW 428
                + GT  Y +       E S + D+ S G +L+    G   +          +   
Sbjct: 168 RENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL------KAATK 221

Query: 429 LRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL 487
            +K         +    +   GY  +    L     C     +++P+  Y+R     L 
Sbjct: 222 RQKYERISEKKMSTPIEVLCKGYPSEFATYLN---FCRSLRFDDKPDYSYLRQLFRNLF 277

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 4e-36
 Identities = 65/293 (22%), Positives = 106/293 (36%), Gaps = 32/293 (10%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           L+ +G G    VYKA    +  +++AIKK+           +   S+ +D   R    EI
Sbjct: 3   LDFLGEGQFATVYKARDK-NTNQIVAIKKI----------KLGHRSEAKDGINRTALREI 51

Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL 316
               ++ H NI+ LL          LV++FM+      I          L         L
Sbjct: 52  KLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVII----KDNSLVLTPSHIKAYML 107

Query: 317 GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLG 376
               GLEYLH +    I+H D+KP N+LL+++    ++D GLA +          ++ + 
Sbjct: 108 MTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA--YTHQVV 162

Query: 377 TMAYIAPEYFQQPEL-SEKCDIFSFGMLLISLVRGVPSF-------VFHQNGEEICSPEW 428
           T  Y APE      +     D+++ G +L  L+  VP            +  E + +P  
Sbjct: 163 TRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTE 222

Query: 429 LRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAY----ICTLHDPEERPNSQ 477
            +       P        PG                      L +P  R  + 
Sbjct: 223 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITAT 275

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  133 bits (336), Expect = 5e-36
 Identities = 58/282 (20%), Positives = 110/282 (39%), Gaps = 46/282 (16%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           L  +G+G  G V+       NG+  A+K             ++++  +R  ++     E 
Sbjct: 9   LRTLGTGSFGRVHLIRSR-HNGRYYAMKV------------LKKEIVVRLKQVEHTNDER 55

Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL 316
           +  S + H  I+ +           ++ ++++       L  + R  +    P     A 
Sbjct: 56  LMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEG----GELFSLLRKSQRFPNPVAKFYAA 111

Query: 317 GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLG 376
            V   LEYLH      II+ D+KP N+LL+ +    I+D G A  +PD         + G
Sbjct: 112 EVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY-----TLCG 163

Query: 377 TMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMNSK 436
           T  YIAPE       ++  D +SFG+L+  ++ G   F +  N  +        K++N++
Sbjct: 164 TPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF-YDSNTMKT-----YEKILNAE 217

Query: 437 NPSRAIDPRLPGNGYE--KKMLHVLKIAYICTLHDPEERPNS 476
                  P    +  +   +++            D  +R  +
Sbjct: 218 LR---FPPFFNEDVKDLLSRLITR----------DLSQRLGN 246

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  132 bits (333), Expect = 8e-36
 Identities = 53/301 (17%), Positives = 108/301 (35%), Gaps = 43/301 (14%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
             +IG G  G +++      N + +AIK                    R S   Q+R E 
Sbjct: 10  GRRIGEGSFGVIFEGTNL-LNNQQVAIKFEP-----------------RRSDAPQLRDEY 51

Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL 316
            T   +     +P + +  +   H ++   +   SL+D+LD      R+    +    A 
Sbjct: 52  RTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLD---LCGRKFSVKTVAMAAK 108

Query: 317 GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME-----ACISDLGLAMAIPDGYTRVLI 371
            + + ++ +H     S+++ DIKP N L+            + D G+     D  T+  I
Sbjct: 109 QMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHI 165

Query: 372 SY-----VLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSP 426
            Y     + GT  Y++       E S + D+ + G + +  +RG   +   +        
Sbjct: 166 PYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK--- 222

Query: 427 EWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL 486
           +   ++   K        R    G+ ++    +           +  P+  Y++   S++
Sbjct: 223 QKYERIGEKKQS---TPLRELCAGFPEEFYKYMH---YARNLAFDATPDYDYLQGLFSKV 276

Query: 487 L 487
           L
Sbjct: 277 L 277

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 9e-35
 Identities = 67/311 (21%), Positives = 111/311 (35%), Gaps = 52/311 (16%)

Query: 174 TIFSPLIEKEDLAFLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPIS 233
           T+F     +E++     +D + + E++GSG    V K     S G   A K +       
Sbjct: 1   TVFR----QENV-----DDYYDTGEELGSGQFAVVKKCREK-STGLQYAAKFI------- 43

Query: 234 AAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQ 293
             +     S  R      I  E+    +I+H N++ L          +L+ E +  G L 
Sbjct: 44  --KKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELF 101

Query: 294 DILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA-- 351
           D L +    +  L           + +G   ++  HS  I H D+KP N++L D      
Sbjct: 102 DFLAE----KESLTEEEATEFLKQILNG---VYYLHSLQIAHFDLKPENIMLLDRNVPKP 154

Query: 352 --CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR 409
              I D GLA  I  G        + GT  ++APE      L  + D++S G++   L+ 
Sbjct: 155 RIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 211

Query: 410 GVPSFVFHQNGEEICSPEWLRKVMNSK-NPSRAIDPRLPGNGYE--KKMLHVLKIAYICT 466
           G   F+           E L  V                    +  +++L          
Sbjct: 212 GASPFLGDTK------QETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVK-------- 257

Query: 467 LHDPEERPNSQ 477
             DP++R   Q
Sbjct: 258 --DPKKRMTIQ 266

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  128 bits (322), Expect = 1e-33
 Identities = 61/287 (21%), Positives = 96/287 (33%), Gaps = 40/287 (13%)

Query: 194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR 253
           F+    IG GG GEVY        GKM A+K       +    +  +     ++     R
Sbjct: 6   FSVHRIIGRGGFGEVYGCRKA-DTGKMYAMKC------LDKKRIKMKQ---GETLALNER 55

Query: 254 SEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
             +   S      I+ +      PD    + + M  G L   L                 
Sbjct: 56  IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRF 111

Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISY 373
            A  +  GLE++H   +  +++ D+KP N+LL++     ISDLGLA              
Sbjct: 112 YAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH----A 164

Query: 374 VLGTMAYIAPEYFQ-QPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKV 432
            +GT  Y+APE  Q         D FS G +L  L+RG   F  H+      + +     
Sbjct: 165 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK------TKDKHEID 218

Query: 433 MNSKNPSRAIDPRLPGNGYE--KKMLHVLKIAYICTLHDPEERPNSQ 477
             +   +  +            + +L            D   R    
Sbjct: 219 RMTLTMAVELPDSFSPELRSLLEGLLQR----------DVNRRLGCL 255

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (314), Expect = 4e-33
 Identities = 54/304 (17%), Positives = 114/304 (37%), Gaps = 34/304 (11%)

Query: 189 KKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSK 248
           + +  +  + +IG G  G+V+KA    + G+ +A+K+V          +   +  +  S 
Sbjct: 4   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV---------RVQTGEEGMPLST 54

Query: 249 LRQIRSEIITASQIRHRNILPLLAHMV-----RPDCHLLVYEFMKNGSLQDILDDVSRGR 303
           +R++   +       H N++ L          R     LV+E +       +        
Sbjct: 55  IREVA-VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK---VPE 110

Query: 304 RELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIP 363
             +   +   +   +  GL++LH   S  ++H D+KP+N+L+    +  ++D GLA    
Sbjct: 111 PGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS 167

Query: 364 DGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI 423
                   + V+ T+ Y APE   Q   +   D++S G +   + R  P F    + +++
Sbjct: 168 FQMAL---TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL 224

Query: 424 ----------CSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEER 473
                        +W R V   +    +   +               +   C   +P +R
Sbjct: 225 GKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKR 284

Query: 474 PNSQ 477
            ++ 
Sbjct: 285 ISAY 288

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (316), Expect = 4e-33
 Identities = 52/287 (18%), Positives = 97/287 (33%), Gaps = 44/287 (15%)

Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI- 256
           + +G G  G+V +        +  A+K +                        + R E+ 
Sbjct: 18  QVLGLGINGKVLQIFNK-RTQEKFALKML--------------------QDCPKARREVE 56

Query: 257 ITASQIRHRNILPLL----AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRH 312
           +     +  +I+ ++           C L+V E +  G L   + D  RG +        
Sbjct: 57  LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD--RGDQAFTEREAS 114

Query: 313 RIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLIS 372
            I   +   ++YLH   S +I H D+KP N+L        I  L       +  +   ++
Sbjct: 115 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT 171

Query: 373 YVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKV 432
               T  Y+APE     +  + CD++S G+++  L+ G P F +  +G  I      R  
Sbjct: 172 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF-YSNHGLAISPGMKTRIR 230

Query: 433 MNSKNPSRAIDPRLPGNGYE--KKMLHVLKIAYICTLHDPEERPNSQ 477
           M            +        + +L            +P +R    
Sbjct: 231 MGQYEFPNPEWSEVSEEVKMLIRNLLKT----------EPTQRMTIT 267

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 1e-32
 Identities = 62/299 (20%), Positives = 115/299 (38%), Gaps = 35/299 (11%)

Query: 192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ 251
           + F  +EKIG G  G VYKA      G+++A+KK+                   +     
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNK-LTGEVVALKKI-------------RLDTETEGVPST 47

Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
              EI    ++ H NI+ LL  +   +   LV+EF+     + +    +     +  P  
Sbjct: 48  AIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMD---ASALTGIPLPLI 104

Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLI 371
                 +  GL + H   S  ++H D+KP+N+L+N +    ++D GLA A          
Sbjct: 105 KSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--Y 159

Query: 372 SYVLGTMAYIAPE-YFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI------- 423
           ++ + T+ Y APE        S   DI+S G +   +V     F      +++       
Sbjct: 160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 219

Query: 424 -CSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAY----ICTLHDPEERPNSQ 477
               E +   + S    +   P+     + K +  + +           +DP +R +++
Sbjct: 220 GTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAK 278

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (311), Expect = 3e-32
 Identities = 64/297 (21%), Positives = 113/297 (38%), Gaps = 35/297 (11%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           L  IG G  G V  A     N   +AIKK+                    +  ++   EI
Sbjct: 13  LSYIGEGAYGMVCSAYDN-VNKVRVAIKKI--------------SPFEHQTYCQRTLREI 57

Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL 316
               + RH NI+ +   +  P    +   ++    +   L  + + +  L          
Sbjct: 58  KILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-LSNDHICYFLY 116

Query: 317 GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLA-MAIPDGYTRVLISYVL 375
            +  GL+Y+H   SA+++H D+KP N+LLN   +  I D GLA +A PD      ++  +
Sbjct: 117 QILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 173

Query: 376 GTMAYIAPEYF-QQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI---------CS 425
            T  Y APE        ++  DI+S G +L  ++   P F      +++          S
Sbjct: 174 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 233

Query: 426 PEWLRKVMNSKNPSRAID-PRLPGNGYEKKMLHV----LKIAYICTLHDPEERPNSQ 477
            E L  ++N K  +  +  P      + +   +     L +       +P +R   +
Sbjct: 234 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVE 290

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (307), Expect = 1e-31
 Identities = 51/287 (17%), Positives = 96/287 (33%), Gaps = 43/287 (14%)

Query: 192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ 251
           + F  L+ +G G  G+V       + G+  A+K             + ++  +   ++  
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREK-ATGRYYAMKI------------LRKEVIIAKDEVAH 51

Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
             +E       RH  +  L       D    V E+   G L   L             + 
Sbjct: 52  TVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL-------SRERVFTE 104

Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLI 371
            R     A  +  L   HS  +++ DIK  N++L+ D    I+D GL            +
Sbjct: 105 ERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--M 162

Query: 372 SYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRK 431
               GT  Y+APE  +  +     D +  G+++  ++ G   F ++Q+ E +        
Sbjct: 163 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHERL-----FEL 216

Query: 432 VMNSKNPSRAIDPRLPGNGYE--KKMLHVLKIAYICTLHDPEERPNS 476
           ++  +         L          +L            DP++R   
Sbjct: 217 ILMEEIR---FPRTLSPEAKSLLAGLLKK----------DPKQRLGG 250

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (307), Expect = 1e-31
 Identities = 62/307 (20%), Positives = 109/307 (35%), Gaps = 45/307 (14%)

Query: 190 KEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKL 249
           +E  +   + IG+G  G VY+A+L   +G+++AIKKV                       
Sbjct: 18  QEVSYTDTKVIGNGSFGVVYQAKLC-DSGELVAIKKV-------------------LQDK 57

Query: 250 RQIRSEIITASQIRHRNILPLLAHMVRPDCH------LLVYEFMKNGSLQDILDDVSRGR 303
           R    E+    ++ H NI+ L                 LV +++     +      SR +
Sbjct: 58  RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAK 116

Query: 304 RELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEAC-ISDLGLAMAI 362
           + L           +   L Y+   HS  I H DIKP+N+LL+ D     + D G A  +
Sbjct: 117 QTLPVIYVKLYMYQLFRSLAYI---HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173

Query: 363 PDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSF-------V 415
             G     +SY+           F   + +   D++S G +L  L+ G P F        
Sbjct: 174 VRGEPN--VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ 231

Query: 416 FHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYI-----CTLHDP 470
             +  + + +P   +    + N +    P++  + + K          I        + P
Sbjct: 232 LVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 291

Query: 471 EERPNSQ 477
             R    
Sbjct: 292 TARLTPL 298

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  120 bits (301), Expect = 2e-31
 Identities = 63/293 (21%), Positives = 111/293 (37%), Gaps = 35/293 (11%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           LEKIG G  G VYKA+     G+  A+KK+ +              K  +        EI
Sbjct: 7   LEKIGEGTYGVVYKAQNN--YGETFALKKIRL-------------EKEDEGIPSTTIREI 51

Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL 316
               +++H NI+ L   +      +LV+E +     + +          L+  +     L
Sbjct: 52  SILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD----VCEGGLESVTAKSFLL 107

Query: 317 GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLG 376
            + +G+ Y H      ++H D+KP+N+L+N + E  I+D GLA A      +     ++ 
Sbjct: 108 QLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK-YTHEIVT 163

Query: 377 TMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI----------CSP 426
                        + S   DI+S G +   +V G P F      +++           S 
Sbjct: 164 LWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSK 223

Query: 427 EWLRKVMNSK-NPSRAIDPRLPGNGYEKKMLHVLK-IAYICTLHDPEERPNSQ 477
            W       K +P+  +   LP   + K +      +       DP +R  ++
Sbjct: 224 NWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAK 276

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  121 bits (304), Expect = 3e-31
 Identities = 52/287 (18%), Positives = 100/287 (34%), Gaps = 42/287 (14%)

Query: 192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQ 251
           D F  ++ +G+G  G V   +    +G   A+K             +++   ++  ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHK-ESGNHYAMKI------------LDKQKVVKLKQIEH 87

Query: 252 IRSEIITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
             +E      +    ++ L           +V E++  G +   L            P  
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR----IGRFSEPHA 143

Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLI 371
              A  +    EYLH   S  +I+ D+KP N+L++      ++D G A  +         
Sbjct: 144 RFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW---- 196

Query: 372 SYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRK 431
             + GT   +APE       ++  D ++ G+L+  +  G P F F     +I       K
Sbjct: 197 -TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGK 254

Query: 432 VMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQY 478
           V    + S  +   L      + +L V          D  +R  +  
Sbjct: 255 VRFPSHFSSDLKDLL------RNLLQV----------DLTKRFGNLK 285

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (295), Expect = 1e-30
 Identities = 58/287 (20%), Positives = 101/287 (35%), Gaps = 51/287 (17%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
              +GSGG G VY      S+   +AIK V         + I +  +L +    ++  E+
Sbjct: 9   GPLLGSGGFGSVYSGIRV-SDNLPVAIKHV-------EKDRISDWGELPNGT--RVPMEV 58

Query: 257 ITASQIR--HRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRI 314
           +   ++      ++ LL    RPD  +L+ E  +       L D    R  L        
Sbjct: 59  VLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQD---LFDFITERGALQEELARSF 115

Query: 315 ALGVASGLEYLHMYHSASIIHGDIKPRNVLLN-DDMEACISDLGLAMAIPDGYTRVLISY 373
              V   + + H      ++H DIK  N+L++ +  E  + D G    + D       + 
Sbjct: 116 FWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY----TD 168

Query: 374 VLGTMAYIAPEYFQ-QPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKV 432
             GT  Y  PE+ +          ++S G+LL  +V G   F   ++ EEI   +     
Sbjct: 169 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF---EHDEEIIRGQVF--- 222

Query: 433 MNSKNPSRAIDPRLPGNGYE--KKMLHVLKIAYICTLHDPEERPNSQ 477
                       R+        +  L +           P +RP  +
Sbjct: 223 ---------FRQRVSSECQHLIRWCLAL----------RPSDRPTFE 250

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (293), Expect = 4e-30
 Identities = 59/310 (19%), Positives = 110/310 (35%), Gaps = 53/310 (17%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           L KIG G  GEV+KA      G+ +A+KKV++                ++        EI
Sbjct: 15  LAKIGQGTFGEVFKARHR-KTGQKVALKKVLM-------------ENEKEGFPITALREI 60

Query: 257 ITASQIRHRNILPLL--------AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDW 308
                ++H N++ L+         +        LV++F ++     + +       +   
Sbjct: 61  KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV----LVKFTL 116

Query: 309 PSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYT- 367
               R+   + +GL Y+H      I+H D+K  NVL+  D    ++D GLA A       
Sbjct: 117 SEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 173

Query: 368 -RVLISYVLGTMAYIAPEYFQ-QPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGE---- 421
                +  + T+ Y  PE    + +     D++  G ++  +    P    +        
Sbjct: 174 QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLAL 233

Query: 422 --------------EICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTL 467
                          + + E   K+   K   R +  RL     +   L ++       +
Sbjct: 234 ISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLID---KLLV 290

Query: 468 HDPEERPNSQ 477
            DP +R +S 
Sbjct: 291 LDPAQRIDSD 300

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (283), Expect = 2e-28
 Identities = 57/295 (19%), Positives = 101/295 (34%), Gaps = 35/295 (11%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           L+ +GSG  G V  A      G  +AIKK+                   +   ++   E+
Sbjct: 23  LQPVGSGAYGAVCSAVDG-RTGAKVAIKKL-------------YRPFQSELFAKRAYREL 68

Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL 316
                +RH N++ LL      +      +F                  +L       +  
Sbjct: 69  RLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVY 128

Query: 317 GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLG 376
            +  GL Y+   H+A IIH D+KP N+ +N+D E  I D GLA       T     YV+ 
Sbjct: 129 QMLKGLRYI---HAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT----GYVVT 181

Query: 377 TMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICS--------PEW 428
                          ++  DI+S G ++  ++ G   F    + +++          P  
Sbjct: 182 RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE 241

Query: 429 LRKVMNSKNPSRAID--PRLPGNGYEKKMLHVLKIAY----ICTLHDPEERPNSQ 477
             + + S      +   P L    +   + +   +A        + D E+R  + 
Sbjct: 242 FVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAG 296

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (275), Expect = 8e-28
 Identities = 58/294 (19%), Positives = 106/294 (36%), Gaps = 35/294 (11%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           LEKIG G  G V+KA+      +++A+K+V                   +        EI
Sbjct: 7   LEKIGEGTYGTVFKAKNR-ETHEIVALKRV-------------RLDDDDEGVPSSALREI 52

Query: 257 ITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIAL 316
               +++H+NI+ L   +       LV+EF      QD+         +LD         
Sbjct: 53  CLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD----QDLKKYFDSCNGDLDPEIVKSFLF 108

Query: 317 GVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLG 376
            +  GL + H  +   ++H D+KP+N+L+N + E  +++ GLA A      R   + V+ 
Sbjct: 109 QLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP-VRCYSAEVVT 164

Query: 377 TMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEIC--------SPEW 428
                    F     S   D++S G +   L           + ++          +P  
Sbjct: 165 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTE 224

Query: 429 LRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYI-----CTLHDPEERPNSQ 477
            +    +K P     P  P       ++  L              +P +R +++
Sbjct: 225 EQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAE 278

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (267), Expect = 2e-26
 Identities = 60/287 (20%), Positives = 112/287 (39%), Gaps = 41/287 (14%)

Query: 197 LEKIGSGGCGEVYKAELPGSN--GKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRS 254
           L+ +G+G  G+V+       +  GK+ A+K            L +     +       R+
Sbjct: 29  LKVLGTGAYGKVFLVRKISGHDTGKLYAMKV-----------LKKATIVQKAKTTEHTRT 77

Query: 255 EIITASQIRHRNILPLLAHMVRPDCHL-LVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
           E      IR    L  L +  + +  L L+ +++  G L   L    R        + H 
Sbjct: 78  ERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER-------FTEHE 130

Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISY 373
           + + V   +  L   H   II+ DIK  N+LL+ +    ++D GL+       T     +
Sbjct: 131 VQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDF 190

Query: 374 VLGTMAYIAPEYFQ--QPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRK 431
             GT+ Y+AP+  +       +  D +S G+L+  L+ G     F  +GE+    E  R+
Sbjct: 191 C-GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS--PFTVDGEKNSQAEISRR 247

Query: 432 VMNSKNPSRAIDPRLPGNGYE--KKMLHVLKIAYICTLHDPEERPNS 476
           ++ S+ P       +     +  +++L            DP++R   
Sbjct: 248 ILKSEPP---YPQEMSALAKDLIQRLLMK----------DPKKRLGC 281

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  102 bits (255), Expect = 8e-25
 Identities = 51/307 (16%), Positives = 106/307 (34%), Gaps = 58/307 (18%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           + K+G G   EV++A    +N + + +K                   L+  K ++I+ EI
Sbjct: 40  VRKLGRGKYSEVFEAINI-TNNEKVVVKI------------------LKPVKKKKIKREI 80

Query: 257 -ITASQIRHRNILPLLAHMVRPDCHL--LVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
            I  +     NI+ L   +  P      LV+E + N   + +        + L       
Sbjct: 81  KILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRF 133

Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLL-NDDMEACISDLGLAMAIPDGYTRVLIS 372
               +   L+Y H      I+H D+KP NV++ ++  +  + D GLA     G      +
Sbjct: 134 YMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---N 187

Query: 373 YVLGTMAYIAPEYFQQPEL-SEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI-------- 423
             + +  +  PE     ++     D++S G +L S++     F    +  +         
Sbjct: 188 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 247

Query: 424 ---CSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYI----------CTLHDP 470
                 +++ K     +P              ++ +H      +             +D 
Sbjct: 248 GTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDH 307

Query: 471 EERPNSQ 477
           + R  ++
Sbjct: 308 QSRLTAR 314

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  103 bits (256), Expect = 9e-25
 Identities = 45/241 (18%), Positives = 93/241 (38%), Gaps = 12/241 (4%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIR-SE 255
           + K+G G    V+ A+    N   +A+K       +   ++  E ++     L+++  ++
Sbjct: 18  VRKLGWGHFSTVWLAKDM-VNNTHVAMKI------VRGDKVYTEAAEDEIKLLQRVNDAD 70

Query: 256 IITASQIRHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDV-SRGRRELDWPSRHRI 314
                 +   +IL LL H      + +    +     +++L  +     R +      +I
Sbjct: 71  NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQI 130

Query: 315 ALGVASGLEYLHMYHSASIIHGDIKPRNVLLN-DDMEACISDLGLAMAIPDGYTRVLISY 373
           +  +  GL+Y+H      IIH DIKP NVL+   D    +  + +A      +     + 
Sbjct: 131 SKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN 188

Query: 374 VLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVM 433
            + T  Y +PE           DI+S   L+  L+ G   F   +        + + +++
Sbjct: 189 SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 248

Query: 434 N 434
            
Sbjct: 249 E 249

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (255), Expect = 1e-24
 Identities = 67/312 (21%), Positives = 108/312 (34%), Gaps = 58/312 (18%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           L+ IGSG  G V  A       + +AIKK+                    +  ++   E+
Sbjct: 22  LKPIGSGAQGIVCAAYDA-VLDRNVAIKKL-------------SRPFQNQTHAKRAYREL 67

Query: 257 ITASQIRHRNILPLLAHMVRPDC------HLLVYEFMKNGSLQDILDDVSRGRRELDWPS 310
           +    + H+NI+ LL                LV E M     Q I       + ELD   
Sbjct: 68  VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI-------QMELDHER 120

Query: 311 RHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVL 370
              +   +  G+++LH      IIH D+KP N+++  D    I D GLA      +    
Sbjct: 121 MSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM-- 175

Query: 371 ISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI------- 423
            +  + T  Y APE        E  DI+S G ++  +VR    F      ++        
Sbjct: 176 -TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL 234

Query: 424 --CSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYI----------------C 465
               PE+++K+  +        P+  G  + K     L  A                   
Sbjct: 235 GTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKM 294

Query: 466 TLHDPEERPNSQ 477
            + DP +R +  
Sbjct: 295 LVIDPAKRISVD 306

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =   99 bits (248), Expect = 8e-24
 Identities = 59/300 (19%), Positives = 108/300 (36%), Gaps = 45/300 (15%)

Query: 197 LEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEI 256
           L  +GSG  G V  A      G  +A+KK+                       ++   E+
Sbjct: 23  LSPVGSGAYGSVCAAFDT-KTGLRVAVKKL-------------SRPFQSIIHAKRTYREL 68

Query: 257 ITASQIRHRNILPLLAHMVRPDC-----HLLVYEFMKNGSLQDILDDVSRGRRELDWPSR 311
                ++H N++ LL              + +   +    L +I+       ++L     
Sbjct: 69  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHV 123

Query: 312 HRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLI 371
             +   +  GL+Y+   HSA IIH D+KP N+ +N+D E  I D GLA    D  T    
Sbjct: 124 QFLIYQILRGLKYI---HSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT---- 176

Query: 372 SYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI-------- 423
            YV                 ++  DI+S G ++  L+ G   F    + +++        
Sbjct: 177 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 236

Query: 424 CSPEWLRKVMNSKNPSRAID--PRLPGNGYEKKMLHVLKIAY----ICTLHDPEERPNSQ 477
                L K ++S++    I    ++P   +    +    +A        + D ++R  + 
Sbjct: 237 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 296

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 67.1 bits (163), Expect = 1e-13
 Identities = 20/169 (11%), Positives = 51/169 (30%), Gaps = 26/169 (15%)

Query: 198 EKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEII 257
           + +G G    V+             +K   V          ++  + RD          I
Sbjct: 6   KLMGEGKESAVFNCYSE--KFGECVVKFHKV-----GHTSFKKVKEKRDYGDLHFSVLAI 58

Query: 258 TASQIRHRNILPL----LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHR 313
            +++   R +  L    +  +   + + ++ E +                  +   +   
Sbjct: 59  RSARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKE-----------LYRVRVENPDE 107

Query: 314 IALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAI 362
           +   +   +   +      I+HGD+   NVL+  +    I D   ++ +
Sbjct: 108 VLDMILEEVAKFYHRG---IVHGDLSQYNVLV-SEEGIWIIDFPQSVEV 152

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	487
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.88
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.37
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.75
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.74
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.35
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	95.89
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.88

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-53  Score=405.85  Aligned_cols=250  Identities=26%  Similarity=0.400  Sum_probs=207.5

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+++.||+|+||+||+|. +..+|+.||||++...               .....+.+.+|+.++++++|||||+++
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~-~~~~~~~vAvK~~~~~---------------~~~~~~~~~~E~~il~~l~HpnIv~~~   83 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAM-DVATGQEVAIRQMNLQ---------------QQPKKELIINEILVMRENKNPNIVNYL   83 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEE-BTTTCCEEEEEEEEGG---------------GCSCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccEEEEEEecCcCcEEEEEE-ECCCCCEEEEEEEecc---------------cChHHHHHHHHHHHHHhCCCCCEeeEe
Confidence            469999999999999999997 4568999999998431               111235688999999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++.+++.+|+|||||+||+|.+++..     ..+++..+..++.|++.||.||   |++||+||||||+|||++.+|.+
T Consensus        84 ~~~~~~~~~~ivmEy~~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yL---H~~~iiHrDiKp~NILl~~~~~v  155 (293)
T d1yhwa1          84 DSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFL---HSNQVIHRDIKSDNILLGMDGSV  155 (293)
T ss_dssp             EEEEETTEEEEEEECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTCCE
T ss_pred             EEEEECCEEEEEEEecCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHH---HHCCCcccCCcHHHeEECCCCcE
Confidence            999999999999999999999998764     4689999999999999999999   67789999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRK  431 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~  431 (487)
                      ||+|||+|+........  ....+||+.|+|||++.+..|+.++|||||||++|+|+||..||....      .......
T Consensus       156 kl~DFG~a~~~~~~~~~--~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~------~~~~~~~  227 (293)
T d1yhwa1         156 KLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN------PLRALYL  227 (293)
T ss_dssp             EECCCTTCEECCSTTCC--BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHH
T ss_pred             eeccchhheeecccccc--ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCC------HHHHHHH
Confidence            99999999876544322  245679999999999999999999999999999999999999994322      2233334


Q ss_pred             HHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          432 VMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       432 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ......+....++        ..+..+.+++.+||+.||++|||+.++++
T Consensus       228 ~~~~~~~~~~~~~--------~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         228 IATNGTPELQNPE--------KLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             HHHHCSCCCSSGG--------GSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             HHhCCCCCCCCcc--------cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            4444433222222        23356899999999999999999999875

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-54  Score=406.65  Aligned_cols=254  Identities=24%  Similarity=0.354  Sum_probs=204.2

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|++.+.||+|+||+||+|++ ..+|+.||||++...              ......+.+.+|+.++++++|||||+++
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~-~~~~~~vAiK~i~~~--------------~~~~~~~~~~~Ei~~l~~l~HpnIv~~~   69 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVN-RVTEEAVAVKIVDMK--------------RAVDCPENIKKEICINKMLNHENVVKFY   69 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEE-TTTCCEEEEEEEECC---------------------CHHHHHHHHHTCCCTTBCCEE
T ss_pred             cceEEEEEEecCcCeEEEEEEE-CCCCCEEEEEEEehh--------------hcchHHHHHHHHHHHHHhCCCCCEeeEe
Confidence            4699999999999999999975 468899999998431              1112335678999999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++.+++..|+|||||+||+|.+++..    ...+++..++.++.|++.||.||   |++||+||||||+|||++.++.+
T Consensus        70 ~~~~~~~~~~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~al~yl---H~~~IiHrDiKp~NILl~~~~~~  142 (271)
T d1nvra_          70 GHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYL---HGIGITHRDIKPENLLLDERDNL  142 (271)
T ss_dssp             EEEEETTEEEEEEECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEECTTCCE
T ss_pred             eeeccCceeEEEEeccCCCcHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHH---HHcCCccCcccHHHEEECCCCCE
Confidence            999999999999999999999998853    56799999999999999999999   67789999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCCCC-CchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPEL-SEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLR  430 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~  430 (487)
                      ||+|||+|+..............+||+.|+|||++.+..+ +.++|||||||++|||+||.+||.......     ....
T Consensus       143 KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~-----~~~~  217 (271)
T d1nvra_         143 KISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-----QEYS  217 (271)
T ss_dssp             EECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS-----HHHH
T ss_pred             EEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH-----HHHH
Confidence            9999999987655444333456789999999999988765 678999999999999999999995543321     1111


Q ss_pred             HHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          431 KVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       431 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ... .......        .....+.++.+++.+||+.||++|||++++++
T Consensus       218 ~~~-~~~~~~~--------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         218 DWK-EKKTYLN--------PWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             HHH-TTCTTST--------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHh-cCCCCCC--------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            121 2111111        11223356889999999999999999999875

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-53  Score=403.89  Aligned_cols=263  Identities=24%  Similarity=0.342  Sum_probs=202.6

Q ss_pred             hhccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcc
Q 011360          189 KKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNIL  268 (487)
Q Consensus       189 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv  268 (487)
                      ...++|.+.+.||+|+||.||+|+++    ..||||++....             ......+.+.+|+.++++++|||||
T Consensus         5 i~~~~~~~~~~lG~G~fg~Vy~~~~~----~~vAvK~~~~~~-------------~~~~~~~~~~~E~~~l~~l~HpnIv   67 (276)
T d1uwha_           5 IPDGQITVGQRIGSGSFGTVYKGKWH----GDVAVKMLNVTA-------------PTPQQLQAFKNEVGVLRKTRHVNIL   67 (276)
T ss_dssp             CCTTCCCCCSEEEECSSCEEEEEESS----SEEEEEECCCSS-------------CCTTHHHHHHHHHHHHTTCCCTTBC
T ss_pred             cccccEEEEEEEeeCCCcEEEEEEEC----CEEEEEEEEccc-------------CCHHHHHHHHHHHHHHHhCCCCCEe
Confidence            34567999999999999999999753    359999985321             1233456789999999999999999


Q ss_pred             ccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC
Q 011360          269 PLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDD  348 (487)
Q Consensus       269 ~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~  348 (487)
                      ++++++.. +.+++|||||++|+|.+++..   ....+++..+..++.||+.||+||   |++|||||||||+|||++.+
T Consensus        68 ~~~~~~~~-~~~~lv~Ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~gl~yL---H~~~ivHrDlKp~NiLl~~~  140 (276)
T d1uwha_          68 LFMGYSTA-PQLAIVTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYL---HAKSIIHRDLKSNNIFLHED  140 (276)
T ss_dssp             CEEEEECS-SSCEEEEECCCEEEHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEEETT
T ss_pred             eeeEEEec-cEEEEEEecCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHH---hcCCEeccccCHHHEEEcCC
Confidence            99998754 568999999999999999964   345699999999999999999999   66789999999999999999


Q ss_pred             CCEEEeccCCccccCCCCceeeEeeecccccccCCcccCC---CCCCchhHHHHHHHHHHHHHhCCCCccccCCCCcccc
Q 011360          349 MEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQ---PELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICS  425 (487)
Q Consensus       349 ~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~  425 (487)
                      +.+||+|||+|+...............||+.|+|||++.+   ..|+.++|||||||++|||+||..||.....      
T Consensus       141 ~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~------  214 (276)
T d1uwha_         141 LTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN------  214 (276)
T ss_dssp             SSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC------
T ss_pred             CCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh------
Confidence            9999999999987765444444456679999999999864   3589999999999999999999999944322      


Q ss_pred             HHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          426 PEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       426 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      ...+............+. .++    ...+..+.+++.+||+.||++|||+.+|++.|+.+
T Consensus       215 ~~~~~~~~~~~~~~p~~~-~~~----~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l  270 (276)
T d1uwha_         215 RDQIIFMVGRGYLSPDLS-KVR----SNCPKAMKRLMAECLKKKRDERPLFPQILASIELL  270 (276)
T ss_dssp             HHHHHHHHHHTSCCCCGG-GSC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHhcCCCCCcch-hcc----ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            223333333322211111 111    12235688999999999999999999999999875

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-53  Score=397.81  Aligned_cols=249  Identities=25%  Similarity=0.359  Sum_probs=206.5

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||+|+||.||+|+. ..+++.||+|++..            ...........+.+|+.++++++|||||+++
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~-~~~~~~vAiK~i~~------------~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~   72 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLARE-KQSKFILALKVLFK------------AQLEKAGVEHQLRREVEIQSHLRHPNILRLY   72 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEE-TTTCCEEEEEEEEH------------HHHHHTTCHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEE-CCCCcEEEEEEEch------------HHccChHHHHHHHHHHHHHHhcCCCCCCeEE
Confidence            4599999999999999999975 46889999998842            1111223456788999999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++.+++.+|+|||||++|+|.+++..    ...+++..+..++.||+.||+||   |++||+||||||+|||++.++.+
T Consensus        73 ~~~~~~~~~~ivmEy~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~l---H~~~ivHrDiKp~Nill~~~~~~  145 (263)
T d2j4za1          73 GYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYC---HSKRVIHRDIKPENLLLGSAGEL  145 (263)
T ss_dssp             EEEECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTSCE
T ss_pred             EEEEECCEEEEEEeecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHH---HHCCeeeeeeccccceecCCCCE
Confidence            999999999999999999999999975    35699999999999999999999   67789999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRK  431 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~  431 (487)
                      ||+|||++........    ....||+.|+|||++.+..|+.++|||||||++|+|+||+.||...      ...+....
T Consensus       146 kl~DFG~a~~~~~~~~----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~------~~~~~~~~  215 (263)
T d2j4za1         146 KIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN------TYQETYKR  215 (263)
T ss_dssp             EECCCCSCSCCCCCCC----EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS------SHHHHHHH
T ss_pred             eecccceeeecCCCcc----cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCC------CHHHHHHH
Confidence            9999999987654432    3467999999999999999999999999999999999999999432      22233333


Q ss_pred             HHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          432 VMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       432 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      +.. ..+  .+++.        .+.++.+++.+||+.||++|||++++++
T Consensus       216 i~~-~~~--~~p~~--------~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         216 ISR-VEF--TFPDF--------VTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             HHT-TCC--CCCTT--------SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHc-CCC--CCCcc--------CCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence            332 221  11222        2356889999999999999999999985

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-53  Score=401.99  Aligned_cols=258  Identities=23%  Similarity=0.334  Sum_probs=197.4

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|++.+.||+|+||.||+|+. ..+|+.||+|++...             ...+.....+.+|+.++++++|||||+++
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~-~~~~~~vAvK~i~~~-------------~~~~~~~~~~~~E~~il~~l~HpnIv~~~   69 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRR-KSDGKILVWKELDYG-------------SMTEAEKQMLVSEVNLLRELKHPNIVRYY   69 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEE-TTTCCEEEEEEECCT-------------TSCHHHHHHHHHHHHHTTSCCCTTBCCEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEE-CCCCCEEEEEEEChh-------------hCCHHHHHHHHHHHHHHHHCCCCCEeeEE
Confidence            4699999999999999999974 468999999998431             22233456788999999999999999999


Q ss_pred             eEEec--CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcC--CCCeeecCCCCCCEEeCC
Q 011360          272 AHMVR--PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYH--SASIIHGDIKPRNVLLND  347 (487)
Q Consensus       272 ~~~~~--~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h--~~givH~Dlkp~Nill~~  347 (487)
                      +++.+  ++.+|+|||||++|+|.+++......+..+++..++.++.|++.||.|||+.+  ..+|+||||||+|||++.
T Consensus        70 ~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~  149 (269)
T d2java1          70 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDG  149 (269)
T ss_dssp             EEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECT
T ss_pred             EEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCC
Confidence            98865  45689999999999999999876555678999999999999999999997543  245999999999999999


Q ss_pred             CCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHH
Q 011360          348 DMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPE  427 (487)
Q Consensus       348 ~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~  427 (487)
                      ++.+||+|||+++........  .....||+.|+|||++.+..|+.++|||||||++|||+||..||...      ...+
T Consensus       150 ~~~vkl~DFG~a~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~------~~~~  221 (269)
T d2java1         150 KQNVKLGDFGLARILNHDTSF--AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF------SQKE  221 (269)
T ss_dssp             TSCEEECCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS------SHHH
T ss_pred             CCcEEEeeccceeecccCCCc--cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCC------CHHH
Confidence            999999999999876543222  24567999999999999999999999999999999999999999432      2223


Q ss_pred             HHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          428 WLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ....+... ... .++..        .+.++.+++.+||+.||++|||+.+|++
T Consensus       222 ~~~~i~~~-~~~-~~~~~--------~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         222 LAGKIREG-KFR-RIPYR--------YSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             HHHHHHHT-CCC-CCCTT--------SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHcC-CCC-CCCcc--------cCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            33333332 221 11222        2356889999999999999999999874

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1e-52  Score=401.86  Aligned_cols=263  Identities=21%  Similarity=0.314  Sum_probs=211.7

Q ss_pred             HhhhccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCC
Q 011360          187 FLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRN  266 (487)
Q Consensus       187 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn  266 (487)
                      |....++|.+.+.||+|+||.||+|.+. .+++.||||++..                .....+++.+|+.++++++|||
T Consensus        12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~-~~~~~vAvK~i~~----------------~~~~~~~~~~E~~il~~l~Hpn   74 (287)
T d1opja_          12 WEMERTDITMKHKLGGGQYGEVYEGVWK-KYSLTVAVKTLKE----------------DTMEVEEFLKEAAVMKEIKHPN   74 (287)
T ss_dssp             TBCCGGGEEEEEETTTTTTSSEEEEEEG-GGTEEEEEEECCT----------------TCSCHHHHHHHHHHHHHCCCTT
T ss_pred             cEecHHHeEEeeEEeeCCCeEEEEEEEC-CCCeEEEEEEECC----------------ccchHHHHHHHHHHHHhCCCCC
Confidence            3334457999999999999999999864 5788999998732                1112356889999999999999


Q ss_pred             ccccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC
Q 011360          267 ILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN  346 (487)
Q Consensus       267 Iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~  346 (487)
                      ||++++++.+++..|+|||||++|+|.+++..  .....+++..+..++.|++.||+||   |++||+||||||+|||++
T Consensus        75 Iv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~--~~~~~~~~~~~~~i~~qi~~gL~yL---H~~~iiHrDlKp~NILl~  149 (287)
T d1opja_          75 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVG  149 (287)
T ss_dssp             BCCEEEEECSSSSCEEEEECCTTCBHHHHHHH--SCTTTSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEEC
T ss_pred             EecCCccEeeCCeeEEEeecccCcchHHHhhh--ccccchHHHHHHHHHHHHHHHHHHH---HHCCcccCccccCeEEEC
Confidence            99999999999999999999999999999975  4456789999999999999999999   667899999999999999


Q ss_pred             CCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccH
Q 011360          347 DDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSP  426 (487)
Q Consensus       347 ~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~  426 (487)
                      .++.+||+|||+|+......... .....||+.|+|||++.+..|+.++|||||||++|||++|..||....      ..
T Consensus       150 ~~~~~Kl~DFG~a~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~------~~  222 (287)
T d1opja_         150 ENHLVKVADFGLSRLMTGDTYTA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI------DL  222 (287)
T ss_dssp             GGGCEEECCCCCTTTCCSSSSEE-ETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC------CH
T ss_pred             CCCcEEEccccceeecCCCCcee-eccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc------hH
Confidence            99999999999998765543322 234568999999999999999999999999999999999766652221      12


Q ss_pred             HHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhhC
Q 011360          427 EWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL  487 (487)
Q Consensus       427 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~ll  487 (487)
                      ..+......+..     +..+..    .+..+.+++.+||+.||++|||+.+|++.|+.++
T Consensus       223 ~~~~~~i~~~~~-----~~~~~~----~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~  274 (287)
T d1opja_         223 SQVYELLEKDYR-----MERPEG----CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  274 (287)
T ss_dssp             HHHHHHHHTTCC-----CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             HHHHHHHhcCCC-----CCCCcc----chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            222333332211     112222    2256889999999999999999999999998763

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2e-52  Score=402.11  Aligned_cols=261  Identities=21%  Similarity=0.335  Sum_probs=199.0

Q ss_pred             ccccccccccccccceeEEEEEecCCC--CceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSN--GKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNIL  268 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv  268 (487)
                      .+.|.+.+.||+|+||+||+|.+...+  ...||||.+..              .......+.+.+|+.++++++|||||
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~--------------~~~~~~~~~~~~E~~~l~~l~HpnIv   90 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKS--------------GYTEKQRRDFLSEASIMGQFDHPNVI   90 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCS--------------SCCHHHHHHHHHHHHHHTTCCCTTBC
T ss_pred             hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECc--------------ccCHHHHHHHHHHHHHHHhCCCCCCc
Confidence            346889999999999999999865322  23588887632              12233456789999999999999999


Q ss_pred             ccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC
Q 011360          269 PLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDD  348 (487)
Q Consensus       269 ~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~  348 (487)
                      ++++++..++.+|+|||||++|+|.+++..   ....+++..+..++.||+.||.||   |++||+||||||+|||++.+
T Consensus        91 ~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yL---H~~~iiHrDlKp~NILl~~~  164 (299)
T d1jpaa_          91 HLEGVVTKSTPVMIITEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYL---ADMNYVHRDLAARNILVNSN  164 (299)
T ss_dssp             CEEEEECSSSSCEEEEECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTT
T ss_pred             cEEEEEeeCCEEEEEEEecCCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHH---hhCCCccCccccceEEECCC
Confidence            999999999999999999999999998863   345789999999999999999999   66789999999999999999


Q ss_pred             CCEEEeccCCccccCCCCceee---EeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccc
Q 011360          349 MEACISDLGLAMAIPDGYTRVL---ISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEIC  424 (487)
Q Consensus       349 ~~~kl~DFg~s~~~~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~  424 (487)
                      +.+||+|||+++..........   .....||+.|+|||.+.+..|+.++|||||||++|||+| |.+||...      .
T Consensus       165 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~------~  238 (299)
T d1jpaa_         165 LVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM------T  238 (299)
T ss_dssp             CCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC------C
T ss_pred             CcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCC------C
Confidence            9999999999987654332211   122457999999999999999999999999999999998 89999433      2


Q ss_pred             cHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhhC
Q 011360          425 SPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL  487 (487)
Q Consensus       425 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~ll  487 (487)
                      ..+....+..+..+.  .+..        .+..+.+++.+||+.||++|||+.+|++.|++++
T Consensus       239 ~~~~~~~i~~~~~~~--~~~~--------~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l  291 (299)
T d1jpaa_         239 NQDVINAIEQDYRLP--PPMD--------CPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI  291 (299)
T ss_dssp             HHHHHHHHHTTCCCC--CCTT--------CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHcCCCCC--CCcc--------chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence            233344343332221  1111        2356889999999999999999999999998763

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-52  Score=395.92  Aligned_cols=254  Identities=24%  Similarity=0.335  Sum_probs=197.4

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|++.+.||+|+||.||+|.+.  ++..||||++...                ....+.+.+|+.++++++|||||+++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~i~~~----------------~~~~~~~~~E~~~l~~l~HpnIv~~~   66 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWL--NKDKVAIKTIREG----------------AMSEEDFIEEAEVMMKLSHPKLVQLY   66 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEET--TTEEEEEEECCSS----------------SSCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEEC--CCCEEEEEEECCC----------------cCcHHHHHHHHHHHHhcCCCCccccc
Confidence            46999999999999999999874  6778999998431                11224688999999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++..++..++|||||++|+|.+++..   ....+++..+..++.|++.||.||   |+++|+||||||+|||++.++.+
T Consensus        67 g~~~~~~~~~lv~E~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~l---H~~~iiHrDlKp~Nill~~~~~~  140 (263)
T d1sm2a_          67 GVCLEQAPICLVFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYL---EEACVIHRDLAARNCLVGENQVI  140 (263)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHH---HHTTCCCTTCSGGGEEECGGGCE
T ss_pred             ceeccCCceEEEEEecCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHhh---hccceeecccchhheeecCCCCe
Confidence            999999999999999999999999864   346789999999999999999999   66789999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhC-CCCccccCCCCccccHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRG-VPSFVFHQNGEEICSPEWLR  430 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg-~~pf~~~~~~~~~~~~~~~~  430 (487)
                      ||+|||+++......... .....||+.|+|||++.+..|+.++|||||||++|||+|+ .+||...      ...+...
T Consensus       141 Kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~------~~~~~~~  213 (263)
T d1sm2a_         141 KVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR------SNSEVVE  213 (263)
T ss_dssp             EECSCC-------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC------CHHHHHH
T ss_pred             EecccchheeccCCCcee-ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC------CHHHHHH
Confidence            999999998765443322 2345689999999999999999999999999999999995 6666321      2223333


Q ss_pred             HHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          431 KVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       431 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      .+.....+.      .|..+    +.++.+++.+||+.||++|||+++|++.|+++
T Consensus       214 ~i~~~~~~~------~p~~~----~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i  259 (263)
T d1sm2a_         214 DISTGFRLY------KPRLA----STHVYQIMNHCWKERPEDRPAFSRLLRQLAEI  259 (263)
T ss_dssp             HHHHTCCCC------CCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHhcCCCC------Ccccc----CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence            333332221      11111    24688999999999999999999999999986

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-53  Score=405.10  Aligned_cols=253  Identities=23%  Similarity=0.320  Sum_probs=205.1

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      ++.|++++.||+|+||.||+|++ ..+|..||||++....               ....+.+.+|+.++++++|||||++
T Consensus        11 ~d~Y~i~~~iG~G~fg~Vy~~~~-~~~~~~vAvK~i~~~~---------------~~~~~~~~~E~~il~~l~HpnIv~l   74 (288)
T d2jfla1          11 EDFWEIIGELGDGAFGKVYKAQN-KETSVLAAAKVIDTKS---------------EEELEDYMVEIDILASCDHPNIVKL   74 (288)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEE-TTTCCEEEEEEEECSS---------------SGGGGGTHHHHHHHHHCCCTTBCCE
T ss_pred             ccCeEEeEEEeeCCCcEEEEEEE-CCCCeEEEEEEECcCC---------------HHHHHHHHHHHHHHHhCCCCCCCeE
Confidence            45699999999999999999975 4688999999984321               1223467889999999999999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      ++++.+++.+|+|||||++|+|.+++...   ...+++..+..++.|++.||.||   |++||+||||||+|||++.++.
T Consensus        75 ~~~~~~~~~~~lvmEy~~~g~L~~~~~~~---~~~l~e~~~~~i~~qi~~gL~yl---H~~~ivHrDiKp~NIll~~~~~  148 (288)
T d2jfla1          75 LDAFYYENNLWILIEFCAGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYL---HDNKIIHRDLKAGNILFTLDGD  148 (288)
T ss_dssp             EEEEEETTEEEEEEECCTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSC
T ss_pred             EEEEeeCCeEEEEEecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHH---HHCCEEEeecChhheeECCCCC
Confidence            99999999999999999999999987642   45699999999999999999999   6778999999999999999999


Q ss_pred             EEEeccCCccccCCCCceeeEeeecccccccCCcccC-----CCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCcccc
Q 011360          351 ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQ-----QPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICS  425 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~  425 (487)
                      +||+|||+|+.......  ......||+.|+|||++.     +..|+.++|||||||++|||+||..||.....      
T Consensus       149 ~Kl~DFG~a~~~~~~~~--~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~------  220 (288)
T d2jfla1         149 IKLADFGVSAKNTRTIQ--RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP------  220 (288)
T ss_dssp             EEECCCTTCEECHHHHH--HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG------
T ss_pred             EEEEechhhhccCCCcc--cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH------
Confidence            99999999976432211  113467999999999984     45689999999999999999999999954322      


Q ss_pred             HHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          426 PEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       426 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .+.+..+.....+....+        ...+.++.+++.+||+.||++|||++++++
T Consensus       221 ~~~~~~i~~~~~~~~~~~--------~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         221 MRVLLKIAKSEPPTLAQP--------SRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             GGHHHHHHHSCCCCCSSG--------GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHHHHHHcCCCCCCCcc--------ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            223344444333222212        223357899999999999999999999975

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-51  Score=389.51  Aligned_cols=248  Identities=23%  Similarity=0.351  Sum_probs=199.0

Q ss_pred             cccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceE
Q 011360          194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAH  273 (487)
Q Consensus       194 ~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  273 (487)
                      |+..+.||+|+||+||+|.+ ..++..||+|++..             ........+.+.+|+.++++++|||||+++++
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~-~~~~~~va~K~i~~-------------~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~   76 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLD-TETTVEVAWCELQD-------------RKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS   76 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEE-TTTCCEEEEEEEEG-------------GGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEE-CCCCeEEEEEEEch-------------hhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Confidence            35667899999999999975 46889999998843             12233445678999999999999999999999


Q ss_pred             Eec----CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCC--eeecCCCCCCEEeC-
Q 011360          274 MVR----PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSAS--IIHGDIKPRNVLLN-  346 (487)
Q Consensus       274 ~~~----~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~g--ivH~Dlkp~Nill~-  346 (487)
                      +..    ...+|+|||||++|+|.+++..    ...+++..+..++.||+.||+||   |++|  |+||||||+|||++ 
T Consensus        77 ~~~~~~~~~~~~ivmE~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yL---H~~~~~IiHrDiKp~NILl~~  149 (270)
T d1t4ha_          77 WESTVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFL---HTRTPPIIHRDLKCDNIFITG  149 (270)
T ss_dssp             EEEESSSCEEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH---HTSSSCCCCSCCCGGGEEESS
T ss_pred             EeeccccCCEEEEEEeCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHH---HHCCCCEEeCCcChhhceeeC
Confidence            865    3567999999999999999975    35789999999999999999999   6666  99999999999997 


Q ss_pred             CCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccH
Q 011360          347 DDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSP  426 (487)
Q Consensus       347 ~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~  426 (487)
                      +++.+||+|||+++.......    ...+||+.|+|||++.+ .|+.++|||||||++|||+||..||....      ..
T Consensus       150 ~~~~~Kl~DFGla~~~~~~~~----~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~------~~  218 (270)
T d1t4ha_         150 PTGSVKIGDLGLATLKRASFA----KAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ------NA  218 (270)
T ss_dssp             TTSCEEECCTTGGGGCCTTSB----EESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS------SH
T ss_pred             CCCCEEEeecCcceeccCCcc----CCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcc------cH
Confidence            578999999999986544332    35679999999999876 59999999999999999999999994322      22


Q ss_pred             HHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          427 EWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       427 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ..+......+.....++...        +.++.+++.+||+.||++|||+.|+++
T Consensus       219 ~~~~~~i~~~~~~~~~~~~~--------~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         219 AQIYRRVTSGVKPASFDKVA--------IPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             HHHHHHHTTTCCCGGGGGCC--------CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHcCCCCcccCccC--------CHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence            22333333332222222222        245889999999999999999999986

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-52  Score=398.91  Aligned_cols=252  Identities=22%  Similarity=0.336  Sum_probs=203.5

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|++.+.||+|+||+||+|+. ..+|+.||||++..            ...........+.+|+.++++++|||||+++
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~-~~~~~~vAvK~i~~------------~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~   74 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARE-LATSREYAIKILEK------------RHIIKENKVPYVTRERDVMSRLDHPFFVKLY   74 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEE-TTTCCEEEEEEEEH------------HHHHHTTCHHHHHHHHHHHHHCCSTTBCCEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEE-CCCCCEEEEEEEeh------------HHccCHHHHHHHHHHHHHHHHcCCCCeeEEE
Confidence            4599999999999999999975 46789999998842            1112233456789999999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++.+++.+|+|||||+||+|.+++..    ...+++..++.++.|++.||.||   |++||+||||||+|||++.++.+
T Consensus        75 ~~~~~~~~~~ivmEy~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~yl---H~~~iiHrDiKp~NIll~~~~~v  147 (288)
T d1uu3a_          75 FTFQDDEKLYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYL---HGKGIIHRDLKPENILLNEDMHI  147 (288)
T ss_dssp             EEEECSSEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTSCE
T ss_pred             EEEEECCEEEEEEEccCCCCHHHhhhc----cCCCCHHHHHHHHHHHHHHHHhh---ccccEEcCcCCccccccCCCceE
Confidence            999999999999999999999999875    45799999999999999999999   67789999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRK  431 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~  431 (487)
                      ||+|||+|+..............+||+.|+|||++.+..|+.++|||||||++|||+||..||...      ...+....
T Consensus       148 kl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~~~~~~~~  221 (288)
T d1uu3a_         148 QITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG------NEYLIFQK  221 (288)
T ss_dssp             EECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHH
T ss_pred             EecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc------CHHHHHHH
Confidence            999999998876544443345567999999999999999999999999999999999999999432      22223333


Q ss_pred             HHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHH
Q 011360          432 VMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVR  480 (487)
Q Consensus       432 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il  480 (487)
                      +... .+      .+|..    .+.++.+++.+||+.||++|||++|++
T Consensus       222 i~~~-~~------~~p~~----~s~~~~~li~~~L~~dP~~R~t~~e~~  259 (288)
T d1uu3a_         222 IIKL-EY------DFPEK----FFPKARDLVEKLLVLDATKRLGCEEME  259 (288)
T ss_dssp             HHTT-CC------CCCTT----CCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred             HHcC-CC------CCCcc----CCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence            3322 21      12221    234688999999999999999999864

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6e-52  Score=399.83  Aligned_cols=253  Identities=25%  Similarity=0.358  Sum_probs=191.5

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .+.|.+.+.||+|+||+||+|+. ..+|+.||||++....              .......+.+|+.++++++|||||++
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~-~~~~~~vAvK~i~~~~--------------~~~~~~~~~~Ei~il~~l~HpnIv~l   72 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAED-KRTQKLVAIKCIAKKA--------------LEGKEGSMENEIAVLHKIKHPNIVAL   72 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEE-TTTCCEEEEEEEEC------------------------CHHHHHHHTCCCTTBCCE
T ss_pred             ccceEEEEEEeeccCeEEEEEEE-CCCCCEEEEEEEchHH--------------hhhHHHHHHHHHHHHHhCCCCCCCcE
Confidence            35699999999999999999975 4688999999984311              11223467889999999999999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC---C
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN---D  347 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~---~  347 (487)
                      ++++.+++.+|+|||||+||+|.+++..    ...+++..+..++.|++.||.||   |++||+||||||+||++.   +
T Consensus        73 ~~~~~~~~~~~lvmE~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~yl---H~~~iiHrDiKp~Nil~~~~~~  145 (307)
T d1a06a_          73 DDIYESGGHLYLIMQLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYL---HDLGIVHRDLKPENLLYYSLDE  145 (307)
T ss_dssp             EEEEECSSEEEEEECCCCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEESSSST
T ss_pred             EEEEEECCEEEEEEeccCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhh---hhceeeeEEecccceeecccCC
Confidence            9999999999999999999999999964    56799999999999999999999   677899999999999995   5


Q ss_pred             CCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHH
Q 011360          348 DMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPE  427 (487)
Q Consensus       348 ~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~  427 (487)
                      ++.+||+|||+|+.......   ....+||+.|+|||++.+..|+.++|||||||++|+|+||.+||...      ...+
T Consensus       146 ~~~vkl~DFG~a~~~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~~~~  216 (307)
T d1a06a_         146 DSKIMISDFGLSKMEDPGSV---LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE------NDAK  216 (307)
T ss_dssp             TCCEEECCC---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS------SHHH
T ss_pred             CceEEEeccceeEEccCCCe---eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCC------CHHH
Confidence            78999999999986644322   23467999999999999999999999999999999999999999432      2223


Q ss_pred             HHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          428 WLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ....+......       .+.......+.++.+++.+||+.||++|||+.|+++
T Consensus       217 ~~~~i~~~~~~-------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         217 LFEQILKAEYE-------FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             HHHHHHTTCCC-------CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHhccCCC-------CCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            33333332211       111111223356899999999999999999999987

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-52  Score=395.50  Aligned_cols=259  Identities=24%  Similarity=0.377  Sum_probs=205.6

Q ss_pred             HhhhccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCC
Q 011360          187 FLKKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRN  266 (487)
Q Consensus       187 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn  266 (487)
                      |....++|.+.+.||+|+||.||+|.++  ++..||||++...                ....+.+.+|+.++++++|||
T Consensus         8 wei~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~~~~~----------------~~~~~~~~~E~~~l~~l~Hpn   69 (272)
T d1qpca_           8 WEVPRETLKLVERLGAGQFGEVWMGYYN--GHTKVAVKSLKQG----------------SMSPDAFLAEANLMKQLQHQR   69 (272)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEET--TTEEEEEEEECTT----------------SSCHHHHHHHHHHHHHCCCTT
T ss_pred             eecCHHHeEEeEEEecCCCcEEEEEEEC--CCCEEEEEEEccC----------------cCCHHHHHHHHHHHHhCCCCC
Confidence            4344567999999999999999999874  6788999988421                112346889999999999999


Q ss_pred             ccccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC
Q 011360          267 ILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN  346 (487)
Q Consensus       267 Iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~  346 (487)
                      ||++++++. ++..|+|||||++|+|.+++...  ....+++..+..++.||+.||.||   |++||+||||||+|||++
T Consensus        70 Iv~~~g~~~-~~~~~iv~Ey~~~g~L~~~~~~~--~~~~l~~~~~~~i~~qi~~gl~~l---H~~~ivHrDiKp~NIll~  143 (272)
T d1qpca_          70 LVRLYAVVT-QEPIYIITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFI---EERNYIHRDLRAANILVS  143 (272)
T ss_dssp             BCCEEEEEC-SSSCEEEEECCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEC
T ss_pred             EeEEEeeec-cCCeEEEEEeCCCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHH---HhCCcccCccchhheeee
Confidence            999999875 45679999999999999987542  234589999999999999999999   667899999999999999


Q ss_pred             CCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhC-CCCccccCCCCcccc
Q 011360          347 DDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRG-VPSFVFHQNGEEICS  425 (487)
Q Consensus       347 ~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg-~~pf~~~~~~~~~~~  425 (487)
                      .++.+||+|||+|+......... .....||+.|+|||++.+..++.++|||||||++|||+|| .+||...      ..
T Consensus       144 ~~~~~Kl~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~------~~  216 (272)
T d1qpca_         144 DTLSCKIADFGLARLIEDNEYTA-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM------TN  216 (272)
T ss_dssp             TTSCEEECCCTTCEECSSSCEEC-CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC------CH
T ss_pred             cccceeeccccceEEccCCcccc-ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCC------CH
Confidence            99999999999998775543222 2345689999999999988999999999999999999996 4555221      22


Q ss_pred             HHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          426 PEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       426 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      .+....+.....+.      .|..    .+.++.+++.+||+.||++|||+.+|++.|+.+
T Consensus       217 ~~~~~~i~~~~~~~------~p~~----~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~  267 (272)
T d1qpca_         217 PEVIQNLERGYRMV------RPDN----CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (272)
T ss_dssp             HHHHHHHHTTCCCC------CCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHhcCCCC------Cccc----ChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence            23333333322221      1211    224688999999999999999999999999875

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-52  Score=394.12  Aligned_cols=259  Identities=22%  Similarity=0.303  Sum_probs=207.0

Q ss_pred             ccccccccc-cccccceeEEEEEecC-CCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcc
Q 011360          191 EDCFASLEK-IGSGGCGEVYKAELPG-SNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNIL  268 (487)
Q Consensus       191 ~~~~~~~~~-lg~G~~g~v~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv  268 (487)
                      .+++.+... ||+|+||.||+|.+.. .++..||||++..              .......+.+.+|+.++++++|||||
T Consensus         7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~--------------~~~~~~~~~~~~E~~il~~l~HpnIv   72 (285)
T d1u59a_           7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQ--------------GTEKADTEEMMREAQIMHQLDNPYIV   72 (285)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECS--------------SCCHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEECh--------------hcCHHHHHHHHHHHHHHHhCCCCCEe
Confidence            445777774 9999999999997643 3456799999843              12233456789999999999999999


Q ss_pred             ccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC
Q 011360          269 PLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDD  348 (487)
Q Consensus       269 ~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~  348 (487)
                      ++++++.. +.+|+|||||++|+|.+++..   ....+++..+..++.|++.||.||   |++||+||||||+|||++.+
T Consensus        73 ~l~g~~~~-~~~~lvmE~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~yl---H~~~iiHrDlKp~Nill~~~  145 (285)
T d1u59a_          73 RLIGVCQA-EALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYL---EEKNFVHRDLAARNVLLVNR  145 (285)
T ss_dssp             CEEEEEES-SSEEEEEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEEET
T ss_pred             eEeeeecc-CeEEEEEEeCCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHH---HhCCeecCcCchhheeeccC
Confidence            99998865 568999999999999998753   346799999999999999999999   66789999999999999999


Q ss_pred             CCEEEeccCCccccCCCCce-eeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccccH
Q 011360          349 MEACISDLGLAMAIPDGYTR-VLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSP  426 (487)
Q Consensus       349 ~~~kl~DFg~s~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~  426 (487)
                      +.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||+| |..||....      ..
T Consensus       146 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~------~~  219 (285)
T d1u59a_         146 HYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK------GP  219 (285)
T ss_dssp             TEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC------TH
T ss_pred             CceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCC------HH
Confidence            99999999999877554322 22234568999999999998899999999999999999998 899995432      23


Q ss_pred             HHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          427 EWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       427 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      +....+..+..+.  +++.+        +.++.+++.+||+.||++|||+.+|.+.|+.+
T Consensus       220 ~~~~~i~~~~~~~--~p~~~--------~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~  269 (285)
T d1u59a_         220 EVMAFIEQGKRME--CPPEC--------PPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  269 (285)
T ss_dssp             HHHHHHHTTCCCC--CCTTC--------CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHHcCCCCC--CCCcC--------CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            3333333333221  12222        25688999999999999999999999998753

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-52  Score=403.19  Aligned_cols=266  Identities=24%  Similarity=0.304  Sum_probs=210.0

Q ss_pred             HhhhccccccccccccccceeEEEEEecCCC----CceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC
Q 011360          187 FLKKEDCFASLEKIGSGGCGEVYKAELPGSN----GKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI  262 (487)
Q Consensus       187 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  262 (487)
                      |....++|.+.+.||+|+||.||+|++...+    ...||+|.+..              .........+.+|+.++.++
T Consensus        32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~--------------~~~~~~~~~~~~E~~~l~~l   97 (325)
T d1rjba_          32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKE--------------KADSSEREALMSELKMMTQL   97 (325)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------------------CHHHHHHHHHHHHH
T ss_pred             ccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecc--------------ccCHHHHHHHHHHHHHHHHh
Confidence            4445567999999999999999999875322    24689998743              11223445678899999988


Q ss_pred             -CCCCccccceEEecCCeeEEEEEecCCCCHHHHHhhhhc-------------------CCCCCChHHHHHHHHHHHHHH
Q 011360          263 -RHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSR-------------------GRRELDWPSRHRIALGVASGL  322 (487)
Q Consensus       263 -~hpnIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~-------------------~~~~l~~~~~~~i~~qi~~~L  322 (487)
                       +|||||++++++.+.+.+|+|||||++|+|.+++.....                   ....+++..++.++.|++.||
T Consensus        98 ~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl  177 (325)
T d1rjba_          98 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGM  177 (325)
T ss_dssp             CCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHH
T ss_pred             cCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHH
Confidence             899999999999999999999999999999999975321                   124589999999999999999


Q ss_pred             HHHHhcCCCCeeecCCCCCCEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHH
Q 011360          323 EYLHMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGM  402 (487)
Q Consensus       323 ~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~  402 (487)
                      +||   |++|||||||||+|||++.++.+||+|||+|+...............||+.|+|||++.+..|+.++|||||||
T Consensus       178 ~yL---H~~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gv  254 (325)
T d1rjba_         178 EFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGI  254 (325)
T ss_dssp             HHH---HHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred             HHH---HhCCeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhH
Confidence            999   66789999999999999999999999999998766555444445667899999999999999999999999999


Q ss_pred             HHHHHHh-CCCCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          403 LLISLVR-GVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       403 ~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ++|||+| |.+||.+....      +.+......+..     +..|..    .+.++.+++.+||+.||++|||+++|++
T Consensus       255 il~emlt~g~~Pf~~~~~~------~~~~~~~~~~~~-----~~~p~~----~~~~l~~li~~cl~~dP~~RPt~~ei~~  319 (325)
T d1rjba_         255 LLWEIFSLGVNPYPGIPVD------ANFYKLIQNGFK-----MDQPFY----ATEEIYIIMQSCWAFDSRKRPSFPNLTS  319 (325)
T ss_dssp             HHHHHTTTSCCSSTTCCCS------HHHHHHHHTTCC-----CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHhCCCCCCCCCCHH------HHHHHHHhcCCC-----CCCCCc----CCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            9999998 89999543321      223333333221     112221    2256899999999999999999999999


Q ss_pred             HHh
Q 011360          482 RLS  484 (487)
Q Consensus       482 ~L~  484 (487)
                      .|.
T Consensus       320 ~L~  322 (325)
T d1rjba_         320 FLG  322 (325)
T ss_dssp             HHH
T ss_pred             HHh
Confidence            986

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-52  Score=404.10  Aligned_cols=257  Identities=24%  Similarity=0.396  Sum_probs=203.4

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .++|++++.||+|+||.||+|+. ..+|+.||+|++...              ........+.+|+.++++++|||||++
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~-~~~~~~vAiK~i~~~--------------~~~~~~~~~~~Ei~il~~l~HpnIv~l   69 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSH-KPSGLVMARKLIHLE--------------IKPAIRNQIIRELQVLHECNSPYIVGF   69 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEE-TTTTEEEEEEEEECC--------------CCTTHHHHHHHHGGGGGGCCCTTBCCE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEE-CCCCcEEEEEEEChh--------------hCHHHHHHHHHHHHHHHhCCCCCCCcE
Confidence            46799999999999999999975 568999999998531              122334578899999999999999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      ++++.+++.+|+|||||+||+|.+++..    ...+++..+..++.|++.||.|||+  .+||+||||||+|||++.+|.
T Consensus        70 ~~~~~~~~~~~iVmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~  143 (322)
T d1s9ja_          70 YGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGE  143 (322)
T ss_dssp             EEEEECSSEEEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCC
T ss_pred             EEEEEECCEEEEEEEcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHH--hCCEEccccCHHHeeECCCCC
Confidence            9999999999999999999999999975    3569999999999999999999953  247999999999999999999


Q ss_pred             EEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccc------
Q 011360          351 ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEIC------  424 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~------  424 (487)
                      +||+|||+|+.......    ...+||+.|+|||++.+..|+.++||||+||++|||++|+.||..........      
T Consensus       144 vkl~DFGla~~~~~~~~----~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~  219 (322)
T d1s9ja_         144 IKLCDFGVSGQLIDSMA----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQV  219 (322)
T ss_dssp             EEECCCCCCHHHHHHTC-------CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----
T ss_pred             EEEeeCCCccccCCCcc----ccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHh
Confidence            99999999986533221    34679999999999999999999999999999999999999996543211000      


Q ss_pred             ------------------------------cHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCC
Q 011360          425 ------------------------------SPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERP  474 (487)
Q Consensus       425 ------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP  474 (487)
                                                    ..+...... ...+     +.++.   ...+.++.+++.+||+.||++||
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~-----~~~~~---~~~s~~~~dli~~~L~~dP~~R~  290 (322)
T d1s9ja_         220 EGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIV-NEPP-----PKLPS---GVFSLEFQDFVNKCLIKNPAERA  290 (322)
T ss_dssp             --------------------------CCCCHHHHHHHHH-TSCC-----CCCCB---TTBCHHHHHHHHHHTCSSTTTSC
T ss_pred             cCCcccCCcccccccccccccccccccchhHHHHHhhhh-ccCC-----ccCcc---ccCCHHHHHHHHHHcCCChhHCc
Confidence                                          000000000 0000     11111   11235688999999999999999


Q ss_pred             ChHHHHH
Q 011360          475 NSQYVRC  481 (487)
Q Consensus       475 s~~~il~  481 (487)
                      |++|+++
T Consensus       291 ta~e~L~  297 (322)
T d1s9ja_         291 DLKQLMV  297 (322)
T ss_dssp             CHHHHHT
T ss_pred             CHHHHhh
Confidence            9999986

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-52  Score=393.63  Aligned_cols=252  Identities=23%  Similarity=0.304  Sum_probs=200.4

Q ss_pred             cccccccceeEEEEEec-CCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceEEec
Q 011360          198 EKIGSGGCGEVYKAELP-GSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMVR  276 (487)
Q Consensus       198 ~~lg~G~~g~v~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~  276 (487)
                      +.||+|+||.||+|.+. ..+++.||||++..             ....+...+.+.+|+.++++++|||||++++++..
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~-------------~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~   79 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKN-------------EANDPALKDELLAEANVMQQLDNPYIVRMIGICEA   79 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------------------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEECh-------------hhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc
Confidence            46999999999999864 34567899999842             12233455788999999999999999999999865


Q ss_pred             CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEecc
Q 011360          277 PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISDL  356 (487)
Q Consensus       277 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~DF  356 (487)
                       +..++|||||++|+|.+++..    ...+++..+..++.||+.||.||   |++||+||||||+|||++.++.+||+||
T Consensus        80 -~~~~lvmE~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~yl---H~~~iiHrDlKp~Nill~~~~~~kl~DF  151 (277)
T d1xbba_          80 -ESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDF  151 (277)
T ss_dssp             -SSEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEEETTEEEECCC
T ss_pred             -CCEEEEEEcCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhH---HhCCcccCCCcchhhcccccCcccccch
Confidence             467899999999999999875    56799999999999999999999   6678999999999999999999999999


Q ss_pred             CCccccCCCCcee-eEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccccHHHHHHHHh
Q 011360          357 GLAMAIPDGYTRV-LISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSPEWLRKVMN  434 (487)
Q Consensus       357 g~s~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~  434 (487)
                      |+++......... ......||+.|+|||++.+..++.++|||||||++|||+| |.+||....      ..+....+..
T Consensus       152 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~------~~~~~~~i~~  225 (277)
T d1xbba_         152 GLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK------GSEVTAMLEK  225 (277)
T ss_dssp             TTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC------HHHHHHHHHT
T ss_pred             hhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC------HHHHHHHHHc
Confidence            9998765543322 2234568999999999999999999999999999999998 899994322      2233333333


Q ss_pred             cCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          435 SKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       435 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      +..+      ..|..    .+.++.+++.+||+.||++|||+.+|.+.|+.+
T Consensus       226 ~~~~------~~p~~----~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~  267 (277)
T d1xbba_         226 GERM------GCPAG----CPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  267 (277)
T ss_dssp             TCCC------CCCTT----CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             CCCC------CCCcc----cCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence            2222      12222    225688999999999999999999999988753

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.6e-51  Score=396.90  Aligned_cols=249  Identities=25%  Similarity=0.361  Sum_probs=203.9

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      +.|+.++.||+|+||.||+|+. ..+|+.||||++....            .......+.+.+|+.++++++|||||+++
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~-~~~~~~vAvK~i~~~~------------~~~~~~~~~~~~Ei~il~~l~HpnIv~~~   81 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARD-VRNSEVVAIKKMSYSG------------KQSNEKWQDIIKEVRFLQKLRHPNTIQYR   81 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEE-TTTTEEEEEEEEECCS------------SCHHHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEE-CCCCcEEEEEEEchhh------------ccCHHHHHHHHHHHHHHHHCCCCCEeeEE
Confidence            3599999999999999999975 4689999999985421            12233456788999999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++.+++.+|+|||||.+|+|..++..    ...+++..++.++.||+.||.||   |++||+||||||+|||++.++.+
T Consensus        82 ~~~~~~~~~~iv~E~~~~g~l~~~~~~----~~~l~e~~~~~i~~qi~~aL~yL---H~~~iiHrDiKp~NILl~~~~~~  154 (309)
T d1u5ra_          82 GCYLREHTAWLVMEYCLGSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYL---HSHNMIHRDVKAGNILLSEPGLV  154 (309)
T ss_dssp             EEEEETTEEEEEEECCSEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCSGGGEEEETTTEE
T ss_pred             EEEEECCEEEEEEEecCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHH---HhCCEeccCCCcceEEECCCCCE
Confidence            999999999999999999999776654    46799999999999999999999   67789999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCC---CCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQ---PELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEW  428 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~  428 (487)
                      ||+|||++......      ....||+.|+|||++.+   ..|+.++|||||||++|||++|..||...      ...+.
T Consensus       155 Kl~DFG~a~~~~~~------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~------~~~~~  222 (309)
T d1u5ra_         155 KLGDFGSASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM------NAMSA  222 (309)
T ss_dssp             EECCCTTCBSSSSB------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS------CHHHH
T ss_pred             EEeecccccccCCC------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCC------CHHHH
Confidence            99999999865432      34569999999999864   46899999999999999999999999432      22333


Q ss_pred             HHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          429 LRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       429 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      +........+. ..+..        .+..+.+++.+||+.||++|||+.++++
T Consensus       223 ~~~i~~~~~~~-~~~~~--------~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         223 LYHIAQNESPA-LQSGH--------WSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             HHHHHHSCCCC-CSCTT--------SCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHhCCCCC-CCCCC--------CCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence            44444333221 11111        2356889999999999999999999875

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-51  Score=385.16  Aligned_cols=254  Identities=21%  Similarity=0.302  Sum_probs=208.2

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|++.+.||+|+||+||+|+++  ++..||||++....                ...+.+.+|+.++++++||||++++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~l~~~~----------------~~~~~~~~Ev~~~~~l~HpnIv~~~   65 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR--GQYDVAIKMIKEGS----------------MSEDEFIEEAKVMMNLSHEKLVQLY   65 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET--TTEEEEEEEEESSS----------------SCHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC--CCCEEEEEEECcCc----------------CCHHHHHHHHHHHHhcCCCceeeEE
Confidence            46999999999999999999874  77899999985311                1224688999999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++.+++.+++||||+++|+|..++..   ....+++..+.+++.|+++||.||   |++||+||||||+||+++.++.+
T Consensus        66 g~~~~~~~~~iv~Ey~~~g~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~~L---H~~~iiH~dlk~~Nill~~~~~~  139 (258)
T d1k2pa_          66 GVCTKQRPIFIITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLHRDLAARNCLVNDQGVV  139 (258)
T ss_dssp             EEECCSSSEEEEEECCTTEEHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHH---HHTTBCCSCCSGGGEEECTTCCE
T ss_pred             EEEeeCCceEEEEEccCCCcHHHhhhc---cccCCcHHHHHHHHHHHHHHHHHH---hhcCcccccccceeEEEcCCCcE
Confidence            999999999999999999999998753   345688999999999999999999   66789999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccccHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSPEWLR  430 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~  430 (487)
                      ||+|||+++......... .....||+.|+|||++.+..++.++|||||||++|||+| |+.||...      ...+...
T Consensus       140 kl~DfG~a~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~------~~~~~~~  212 (258)
T d1k2pa_         140 KVSDFGLSRYVLDDEYTS-SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF------TNSETAE  212 (258)
T ss_dssp             EECCCSSCCBCSSSSCCC-CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS------CHHHHHH
T ss_pred             EECcchhheeccCCCcee-ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCC------CHHHHHH
Confidence            999999998765443322 234568999999999999999999999999999999998 79999433      2233333


Q ss_pred             HHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          431 KVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       431 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      .+.....+  .    .|..    .+..+.+++.+||+.||++|||+++|++.|.+|
T Consensus       213 ~i~~~~~~--~----~p~~----~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         213 HIAQGLRL--Y----RPHL----ASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             HHHTTCCC--C----CCTT----CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             HHHhCCCC--C----Cccc----ccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence            33332221  1    1211    224688999999999999999999999998764

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-51  Score=388.02  Aligned_cols=260  Identities=23%  Similarity=0.366  Sum_probs=199.2

Q ss_pred             cccccccccccccceeEEEEEecCCCC---ceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNG---KMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNIL  268 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv  268 (487)
                      ++|+..+.||+|+||.||+|.++..++   ..||||++..              .........+.+|+.++++++|||||
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~--------------~~~~~~~~~~~~E~~il~~l~H~nIv   72 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKA--------------GYTEKQRVDFLGEAGIMGQFSHHNII   72 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECT--------------TCCHHHHHHHHHHHHHHHTCCCTTBC
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECc--------------ccChHHHHHHHHHHHHHHhcCCCCEe
Confidence            458889999999999999998764332   4799998842              11223445688999999999999999


Q ss_pred             ccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC
Q 011360          269 PLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDD  348 (487)
Q Consensus       269 ~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~  348 (487)
                      ++++++.+.+..++|||||.+|++.+++..   ....+++..+..++.|++.||.||   |+++|+||||||+|||++.+
T Consensus        73 ~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~gl~~l---H~~~iiHrDlKp~NILl~~~  146 (283)
T d1mqba_          73 RLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYL---ANMNYVHRDLAARNILVNSN  146 (283)
T ss_dssp             CEEEEECSSSSEEEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTT
T ss_pred             eeeEEEecCCceEEEEEecccCcchhhhhc---ccccccHHHHHHHHHHHHHhhhhc---cccccccCccccceEEECCC
Confidence            999999999999999999999999988764   346799999999999999999999   66789999999999999999


Q ss_pred             CCEEEeccCCccccCCCCcee-eEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHH
Q 011360          349 MEACISDLGLAMAIPDGYTRV-LISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPE  427 (487)
Q Consensus       349 ~~~kl~DFg~s~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~  427 (487)
                      +.+||+|||+++......... ......||+.|+|||++.+..++.++|||||||++|||+||..||....     ...+
T Consensus       147 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~-----~~~~  221 (283)
T d1mqba_         147 LVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL-----SNHE  221 (283)
T ss_dssp             CCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-----CHHH
T ss_pred             CeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC-----CHHH
Confidence            999999999998765432221 2233568999999999999999999999999999999999755542221     2223


Q ss_pred             HHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          428 WLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      ....+..+..+.      .+..    .+..+.+++.+||+.||++|||+.+|++.|+++
T Consensus       222 ~~~~i~~~~~~~------~~~~----~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l  270 (283)
T d1mqba_         222 VMKAINDGFRLP------TPMD----CPSAIYQLMMQCWQQERARRPKFADIVSILDKL  270 (283)
T ss_dssp             HHHHHHTTCCCC------CCTT----CBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             HHHHHhccCCCC------Cchh----hHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHH
Confidence            333333322221      1211    235688999999999999999999999999875

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=8.4e-51  Score=398.83  Aligned_cols=252  Identities=21%  Similarity=0.277  Sum_probs=206.8

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      +.|++++.||+|+||.||+|.. ..+|+.||||++...               .......+.+|+.++++++|||||+++
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~-~~~~~~vAiK~i~~~---------------~~~~~~~~~~Ei~il~~l~HpnIv~~~   92 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVE-KATGRVFVAKFINTP---------------YPLDKYTVKNEISIMNQLHHPKLINLH   92 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEE-TTTCCEEEEEEEECC---------------SHHHHHHHHHHHHHHTTCCSTTBCCEE
T ss_pred             cceEEEEEEecCCCeEEEEEEE-CCCCCEEEEEEECCc---------------chhHHHHHHHHHHHHHhCCCCCCCcEE
Confidence            4699999999999999999974 468999999988431               112235678899999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC--CCC
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN--DDM  349 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~--~~~  349 (487)
                      +++.+++.+|+|||||+||+|.+++..   .+..+++..++.++.||+.||.||   |++||+||||||+|||++  .++
T Consensus        93 ~~~~~~~~~~ivmE~~~gg~L~~~~~~---~~~~l~e~~~~~i~~qi~~aL~yl---H~~~iiHRDiKp~NILl~~~~~~  166 (352)
T d1koba_          93 DAFEDKYEMVLILEFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHM---HEHSIVHLDIKPENIMCETKKAS  166 (352)
T ss_dssp             EEEECSSEEEEEEECCCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEESSTTCC
T ss_pred             EEEEECCEEEEEEEcCCCChHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHH---HHCCeeecccccccccccccCCC
Confidence            999999999999999999999887753   345699999999999999999999   677899999999999998  678


Q ss_pred             CEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHH
Q 011360          350 EACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWL  429 (487)
Q Consensus       350 ~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~  429 (487)
                      .+||+|||+|.........   ....||+.|+|||++.+..|+.++|||||||++|+|+||..||.+.      ...+.+
T Consensus       167 ~vkL~DFGla~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~------~~~~~~  237 (352)
T d1koba_         167 SVKIIDFGLATKLNPDEIV---KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE------DDLETL  237 (352)
T ss_dssp             CEEECCCTTCEECCTTSCE---EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS------SHHHHH
T ss_pred             eEEEeecccceecCCCCce---eeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCC------CHHHHH
Confidence            9999999999887654332   4467999999999999999999999999999999999999999432      223333


Q ss_pred             HHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          430 RKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       430 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ..+......       .+.......+.++.+++.+||+.||.+|||+.++++
T Consensus       238 ~~i~~~~~~-------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         238 QNVKRCDWE-------FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             HHHHHCCCC-------CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HHHHhCCCC-------CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            444332211       111112223356889999999999999999999976

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=6.8e-51  Score=399.18  Aligned_cols=252  Identities=23%  Similarity=0.325  Sum_probs=207.3

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||+|+||.||+|+. ..+|+.||||++...               .....+.+.+|+.++++++|||||+++
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~-~~~g~~vAvK~i~~~---------------~~~~~~~~~~E~~il~~l~HpnIv~~~   89 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTE-RATGNNFAAKFVMTP---------------HESDKETVRKEIQTMSVLRHPTLVNLH   89 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEE-TTTTEEEEEEEECCC---------------SHHHHHHHHHHHHHHHHTCCTTBCCEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEE-CCCCCEEEEEEEccc---------------chhhHHHHHHHHHHHHhCCCCCCCcEE
Confidence            3699999999999999999975 468999999998431               122345688999999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC--CC
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLND--DM  349 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~--~~  349 (487)
                      +++.+++.+|+|||||+||+|.+++..   ....+++..+..++.||+.||.||   |++||+||||||+|||++.  ++
T Consensus        90 ~~~~~~~~~~ivmE~~~gg~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~yl---H~~~iiHrDiKp~NIll~~~~~~  163 (350)
T d1koaa2          90 DAFEDDNEMVMIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHM---HENNYVHLDLKPENIMFTTKRSN  163 (350)
T ss_dssp             EEEEETTEEEEEECCCCSCBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEESSTTSC
T ss_pred             EEEEECCEEEEEEEcCCCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHH---HhcCCeeeeechhHeeeccCCCC
Confidence            999999999999999999999999853   245699999999999999999999   6778999999999999964  67


Q ss_pred             CEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHH
Q 011360          350 EACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWL  429 (487)
Q Consensus       350 ~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~  429 (487)
                      .+||+|||+++........   ....||+.|+|||++.+..|+.++|||||||++|+|+||..||.+.      ...+.+
T Consensus       164 ~vkL~DFG~a~~~~~~~~~---~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~------~~~~~~  234 (350)
T d1koaa2         164 ELKLIDFGLTAHLDPKQSV---KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE------NDDETL  234 (350)
T ss_dssp             CEEECCCTTCEECCTTSCE---EEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHH
T ss_pred             eEEEeecchheeccccccc---ceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC------CHHHHH
Confidence            8999999999887554332   4567999999999999999999999999999999999999999433      223334


Q ss_pred             HHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          430 RKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       430 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ..+......       .+.......+.++.+++.+||+.||++|||+.++++
T Consensus       235 ~~i~~~~~~-------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         235 RNVKSCDWN-------MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             HHHHHTCCC-------SCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             HHHHhCCCC-------CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            444332211       111122233467899999999999999999999986

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-50  Score=388.98  Aligned_cols=251  Identities=21%  Similarity=0.285  Sum_probs=206.7

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+++.||+|+||.||+|+. ..+|+.||||++..            ...........+.+|+.+++.++||||++++
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~-~~~~~~~AiK~i~k------------~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~   71 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVRE-KATGRYYAMKILRK------------EVIIAKDEVAHTVTESRVLQNTRHPFLTALK   71 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEE-TTTCCEEEEEEEEH------------HHHHHTTCHHHHHHHHHHHHSCCCTTBCCEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEE-CCCCCEEEEEEEch------------hhccCHHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence            4699999999999999999974 56899999999842            1112233456788999999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++.+.+.+|+|||||+||+|.+++..    ...+++..++.++.|++.||.||   |++||+||||||+|||++.+|.+
T Consensus        72 ~~~~~~~~~~iv~ey~~gg~L~~~~~~----~~~~~e~~~~~~~~qil~al~yl---H~~~iiHRDlKP~NILl~~~g~v  144 (337)
T d1o6la_          72 YAFQTHDRLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYL---HSRDVVYRDIKLENLMLDKDGHI  144 (337)
T ss_dssp             EEEECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTSCE
T ss_pred             eeeccccccccceeccCCCchhhhhhc----ccCCcHHHHHHHHHHHhhhhhhh---hhcCccccccCHHHeEecCCCCE
Confidence            999999999999999999999999876    45789999999999999999999   77889999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRK  431 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~  431 (487)
                      ||+|||+|+........  ....+||+.|+|||++.+..|+.++|||||||++|||++|.+||...+      ..+....
T Consensus       145 kl~DFG~a~~~~~~~~~--~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~------~~~~~~~  216 (337)
T d1o6la_         145 KITDFGLCKEGISDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD------HERLFEL  216 (337)
T ss_dssp             EECCCTTCBCSCCTTCC--BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHH
T ss_pred             EEeecccccccccCCcc--cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC------HHHHHHH
Confidence            99999999876443222  245679999999999999999999999999999999999999995432      2233333


Q ss_pred             HHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCC-----hHHHHH
Q 011360          432 VMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPN-----SQYVRC  481 (487)
Q Consensus       432 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~~il~  481 (487)
                      ... ..+.      +|..    .+.++.+++.+||++||++||+     +++|++
T Consensus       217 i~~-~~~~------~p~~----~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         217 ILM-EEIR------FPRT----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             HHH-CCCC------CCTT----SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             Hhc-CCCC------CCcc----CCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence            332 2221      2222    2346889999999999999995     777764

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.9e-50  Score=389.29  Aligned_cols=265  Identities=22%  Similarity=0.337  Sum_probs=212.7

Q ss_pred             hccccccccccccccceeEEEEEecC----CCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCC
Q 011360          190 KEDCFASLEKIGSGGCGEVYKAELPG----SNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHR  265 (487)
Q Consensus       190 ~~~~~~~~~~lg~G~~g~v~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp  265 (487)
                      ..++|++.+.||+|+||+||+|++..    .++..||||++..              .........+.+|+.++++++||
T Consensus        11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~--------------~~~~~~~~~~~~E~~il~~l~h~   76 (301)
T d1lufa_          11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKE--------------EASADMQADFQREAALMAEFDNP   76 (301)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCT--------------TCCHHHHHHHHHHHHHHHTCCCT
T ss_pred             CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEECh--------------hcChHHHHHHHHHHHHHHhcCCC
Confidence            45679999999999999999998743    4567899998732              12233456789999999999999


Q ss_pred             CccccceEEecCCeeEEEEEecCCCCHHHHHhhhh--------------------cCCCCCChHHHHHHHHHHHHHHHHH
Q 011360          266 NILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVS--------------------RGRRELDWPSRHRIALGVASGLEYL  325 (487)
Q Consensus       266 nIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~--------------------~~~~~l~~~~~~~i~~qi~~~L~~L  325 (487)
                      ||+++++++...+..+++|||+++|+|.+++....                    .....+++..++.++.|++.||+||
T Consensus        77 niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yl  156 (301)
T d1lufa_          77 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL  156 (301)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHH
T ss_pred             CcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhc
Confidence            99999999999999999999999999999996421                    1234588999999999999999999


Q ss_pred             HhcCCCCeeecCCCCCCEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHH
Q 011360          326 HMYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLI  405 (487)
Q Consensus       326 h~~h~~givH~Dlkp~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~  405 (487)
                         |++|||||||||+|||++.++.+||+|||+|+...............||+.|+|||.+.+..|+.++|||||||++|
T Consensus       157 ---H~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~  233 (301)
T d1lufa_         157 ---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLW  233 (301)
T ss_dssp             ---HHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred             ---ccCCeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHH
Confidence               67789999999999999999999999999998765544444445567899999999999999999999999999999


Q ss_pred             HHHhCC-CCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHh
Q 011360          406 SLVRGV-PSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLS  484 (487)
Q Consensus       406 elltg~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~  484 (487)
                      ||++|. +||...      ...+....+..+..+  ..+..++        .++.+++.+||+.+|++|||+.+|++.|+
T Consensus       234 ell~~~~~p~~~~------~~~e~~~~v~~~~~~--~~p~~~~--------~~~~~li~~cl~~~P~~RPt~~ev~~~L~  297 (301)
T d1lufa_         234 EIFSYGLQPYYGM------AHEEVIYYVRDGNIL--ACPENCP--------LELYNLMRLCWSKLPADRPSFCSIHRILQ  297 (301)
T ss_dssp             HHHTTTCCTTTTS------CHHHHHHHHHTTCCC--CCCTTCC--------HHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHccCCCCCCCC------CHHHHHHHHHcCCCC--CCCccch--------HHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            999984 677332      223344444333322  1122222        46889999999999999999999999999


Q ss_pred             hhC
Q 011360          485 QLL  487 (487)
Q Consensus       485 ~ll  487 (487)
                      ++.
T Consensus       298 ~i~  300 (301)
T d1lufa_         298 RMC  300 (301)
T ss_dssp             HTT
T ss_pred             Hhc
Confidence            874

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-50  Score=385.21  Aligned_cols=261  Identities=23%  Similarity=0.326  Sum_probs=198.7

Q ss_pred             hhccccccccccccccceeEEEEEecCC--CCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCC
Q 011360          189 KKEDCFASLEKIGSGGCGEVYKAELPGS--NGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRN  266 (487)
Q Consensus       189 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn  266 (487)
                      ...++|.+.+.||+|+||.||+|.+...  .+..||||.+..              .........+.+|+.++++++|||
T Consensus         4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~--------------~~~~~~~~~~~~E~~~l~~l~Hpn   69 (273)
T d1mp8a_           4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN--------------CTSDSVREKFLQEALTMRQFDHPH   69 (273)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTT--------------TTSHHHHHHHHHHHHHHHTCCCTT
T ss_pred             cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecc--------------ccCHHHHHHHHHHHHHHHhCCCCC
Confidence            3456799999999999999999987533  245688887632              223344567899999999999999


Q ss_pred             ccccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC
Q 011360          267 ILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN  346 (487)
Q Consensus       267 Iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~  346 (487)
                      ||++++++. .+.+|+|||||++|+|.+++..   ....+++..++.++.|++.||.||   |++||+||||||+||+++
T Consensus        70 Iv~l~~~~~-~~~~~iv~E~~~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~yl---H~~~iiHrDlKp~NIll~  142 (273)
T d1mp8a_          70 IVKLIGVIT-ENPVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYL---ESKRFVHRDIAARNVLVS  142 (273)
T ss_dssp             BCCEEEEEC-SSSCEEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEEE
T ss_pred             EeeEEEEEe-cCeEEEEEEeccCCcHHhhhhc---cCCCCCHHHHHHHHHHHHHHhhhh---cccCeeccccchhheeec
Confidence            999999885 5678999999999999998764   345789999999999999999999   677899999999999999


Q ss_pred             CCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCcccc
Q 011360          347 DDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICS  425 (487)
Q Consensus       347 ~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~  425 (487)
                      .++.+||+|||+++........ ......||+.|+|||++.+..|+.++|||||||++|||+| |.+||.....      
T Consensus       143 ~~~~~Kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~------  215 (273)
T d1mp8a_         143 SNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN------  215 (273)
T ss_dssp             ETTEEEECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG------
T ss_pred             CCCcEEEccchhheeccCCcce-eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH------
Confidence            9999999999999876543222 2234568999999999999999999999999999999998 8999954332      


Q ss_pred             HHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhhC
Q 011360          426 PEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL  487 (487)
Q Consensus       426 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~ll  487 (487)
                      .+....+..+..+  .+++.+        +..+.+++.+||+.||++|||+.+|++.|++++
T Consensus       216 ~~~~~~i~~~~~~--~~~~~~--------~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~  267 (273)
T d1mp8a_         216 NDVIGRIENGERL--PMPPNC--------PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  267 (273)
T ss_dssp             GGHHHHHHTTCCC--CCCTTC--------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHcCCCC--CCCCCC--------CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            1223333333222  122222        256899999999999999999999999998763

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-50  Score=388.58  Aligned_cols=257  Identities=25%  Similarity=0.327  Sum_probs=206.8

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      +.|.+.+.||+|+||+||+|+. ..+|+.||||++.......         .......+.+.+|+.++++++|||||+++
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~-~~~~~~~AvK~i~~~~~~~---------~~~~~~~~~~~~E~~il~~l~HpnIv~~~   79 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCRE-KSTGLQYAAKFIKKRRTKS---------SRRGVSREDIEREVSILKEIQHPNVITLH   79 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEE-TTTCCEEEEEEEEBCSSTT---------CSSSBCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEE-CCCCCEEEEEEEEhhhcch---------hhhhHHHHHHHHHHHHHHhCCCCCCCcEE
Confidence            5699999999999999999975 4689999999985422111         11112346788999999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC--
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDM--  349 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~--  349 (487)
                      +++.+++.+|+|||||+||+|.+++..    ...+++..++.++.|++.||+||   |++||+||||||+||+++.++  
T Consensus        80 ~~~~~~~~~~iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yL---H~~~ivHrDiKp~Nill~~~~~~  152 (293)
T d1jksa_          80 EVYENKTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYL---HSLQIAHFDLKPENIMLLDRNVP  152 (293)
T ss_dssp             EEEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEESCSSSS
T ss_pred             EEEEECCEEEEEEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhh---hhcceeecccccceEEEecCCCc
Confidence            999999999999999999999999975    35799999999999999999999   677899999999999998776  


Q ss_pred             --CEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHH
Q 011360          350 --EACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPE  427 (487)
Q Consensus       350 --~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~  427 (487)
                        .+||+|||++.........   ....||+.|+|||++.+..++.++|||||||++|||+||..||.+.+      ..+
T Consensus       153 ~~~vkl~DfG~a~~~~~~~~~---~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~~~  223 (293)
T d1jksa_         153 KPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT------KQE  223 (293)
T ss_dssp             SCCEEECCCTTCEECTTSCBC---SCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHH
T ss_pred             ccceEecchhhhhhcCCCccc---cccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC------HHH
Confidence              4999999999877544322   34568999999999999999999999999999999999999994332      223


Q ss_pred             HHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          428 WLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ....+......       .+.......+..+.+++.+||+.||++|||++++++
T Consensus       224 ~~~~i~~~~~~-------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         224 TLANVSAVNYE-------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             HHHHHHTTCCC-------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHhcCCC-------CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            33333322211       111111122356889999999999999999999985

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-50  Score=385.52  Aligned_cols=256  Identities=24%  Similarity=0.341  Sum_probs=198.4

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .++|++.+.||+|+||.||+|.++  ++..||||++...                ....+.+.+|+.++++++|||||++
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~--~~~~vAiK~l~~~----------------~~~~~~~~~E~~~l~~l~h~nIv~~   77 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWN--GTTRVAIKTLKPG----------------TMSPEAFLQEAQVMKKLRHEKLVQL   77 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET--TTEEEEEEECCTT----------------SSCHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEEC--CCCEEEEEEECcc----------------cCCHHHHHHHHHHHHhcccCCEeEE
Confidence            456999999999999999999874  5568999998421                1123568899999999999999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      ++++. .+.+++|||||++|+|..++...  ....+++..++.++.||+.||+||   |++||+||||||+|||++.++.
T Consensus        78 ~g~~~-~~~~~lv~Ey~~~g~l~~~~~~~--~~~~l~~~~~~~i~~~i~~gl~~L---H~~~ivH~DlKp~NIll~~~~~  151 (285)
T d1fmka3          78 YAVVS-EEPIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRDLRAANILVGENLV  151 (285)
T ss_dssp             EEEEC-SSSCEEEECCCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECGGGC
T ss_pred             EEEEe-cCCeEEEEEecCCCchhhhhhhc--ccccchHHHHHHHHHHHHHHHHHH---hhhheecccccceEEEECCCCc
Confidence            99885 46689999999999999988652  234689999999999999999999   6678999999999999999999


Q ss_pred             EEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHH
Q 011360          351 ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLR  430 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~  430 (487)
                      +||+|||+++......... .....||+.|+|||++....++.++|||||||++|||+||..||....     ...+.+.
T Consensus       152 ~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~-----~~~~~~~  225 (285)
T d1fmka3         152 CKVADFGLARLIEDNEYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-----VNREVLD  225 (285)
T ss_dssp             EEECCCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC-----CHHHHHH
T ss_pred             EEEcccchhhhccCCCcee-eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCC-----CHHHHHH
Confidence            9999999998765433222 234568999999999999999999999999999999999755552221     1223333


Q ss_pred             HHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          431 KVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       431 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      .+.....+  ..++.+        +.++.+++.+||+.||++|||+++|++.|+.+
T Consensus       226 ~i~~~~~~--~~~~~~--------~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~  271 (285)
T d1fmka3         226 QVERGYRM--PCPPEC--------PESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  271 (285)
T ss_dssp             HHHTTCCC--CCCTTS--------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred             HHHhcCCC--CCCccc--------CHHHHHHHHHHcccCHhHCcCHHHHHHHHhhh
Confidence            33332221  122222        35688999999999999999999999999865

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.1e-49  Score=383.61  Aligned_cols=248  Identities=25%  Similarity=0.382  Sum_probs=206.4

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|++++.||+|+||+||+|+. ..+|+.||||++..            .........+.+.+|+.+++.++|||||+++
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~-~~~g~~vAvK~i~~------------~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~   70 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRS-RHNGRYYAMKVLKK------------EIVVRLKQVEHTNDERLMLSIVTHPFIIRMW   70 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEE-TTTCCEEEEEEEEH------------HHHHHTTCHHHHHHHHHHHHSCCBTTBCCEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEE-CCCCCEEEEEEEch------------HHccCHHHHHHHHHHHHHHHhccCcChhhee
Confidence            3599999999999999999975 46899999999842            1112223456788999999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++.+++.+|+|||||+||+|..++..    ...+++..+..++.|++.||.||   |++||+||||||+|||++.+|.+
T Consensus        71 ~~~~~~~~~~ivmE~~~gg~l~~~~~~----~~~~~~~~~~~~~~qi~~al~~l---H~~~iiHrDiKp~NILl~~~g~v  143 (316)
T d1fota_          71 GTFQDAQQIFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYL---HSKDIIYRDLKPENILLDKNGHI  143 (316)
T ss_dssp             EEEECSSEEEEEECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCCGGGEEECTTSCE
T ss_pred             eeEeeCCeeeeEeeecCCccccccccc----cccccccHHHHHHHHHHHhhhhh---ccCcEEccccCchheeEcCCCCE
Confidence            999999999999999999999998875    56788899999999999999999   78899999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRK  431 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~  431 (487)
                      ||+|||+|+......     ...+||+.|+|||++.+..|+.++|||||||++|+|+||..||...      ...+....
T Consensus       144 kL~DFG~a~~~~~~~-----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~------~~~~~~~~  212 (316)
T d1fota_         144 KITDFGFAKYVPDVT-----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS------NTMKTYEK  212 (316)
T ss_dssp             EECCCSSCEECSSCB-----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS------SHHHHHHH
T ss_pred             EEecCccceEecccc-----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCc------CHHHHHHH
Confidence            999999998765432     3467999999999999999999999999999999999999999432      22333444


Q ss_pred             HHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCC-----ChHHHHH
Q 011360          432 VMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERP-----NSQYVRC  481 (487)
Q Consensus       432 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~~il~  481 (487)
                      +.....   .+++.+        +.++.+++.+||..||.+||     |+++|++
T Consensus       213 i~~~~~---~~p~~~--------s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         213 ILNAEL---RFPPFF--------NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             HHHCCC---CCCTTS--------CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             HHcCCC---CCCCCC--------CHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence            443321   112222        24588999999999999996     8998875

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-50  Score=386.50  Aligned_cols=270  Identities=24%  Similarity=0.317  Sum_probs=202.4

Q ss_pred             HHhhhccccccccccccccceeEEEEEecC----CCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhcc
Q 011360          186 AFLKKEDCFASLEKIGSGGCGEVYKAELPG----SNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQ  261 (487)
Q Consensus       186 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~  261 (487)
                      .|....++|.+.+.||+|+||.||+|.+..    .+++.||||++..              .......+.+.+|...+.+
T Consensus         7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~--------------~~~~~~~~~~~~e~~~l~~   72 (299)
T d1ywna1           7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKE--------------GATHSEHRALMSELKILIH   72 (299)
T ss_dssp             HHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------------------CHHHHHHHHHHHHHHHH
T ss_pred             cccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcc--------------ccCcHHHHHHHHHHHHHHh
Confidence            354455679999999999999999998642    3457899998732              1222344566777777776


Q ss_pred             C-CCCCccccceEEecC-CeeEEEEEecCCCCHHHHHhhhhc------------CCCCCChHHHHHHHHHHHHHHHHHHh
Q 011360          262 I-RHRNILPLLAHMVRP-DCHLLVYEFMKNGSLQDILDDVSR------------GRRELDWPSRHRIALGVASGLEYLHM  327 (487)
Q Consensus       262 l-~hpnIv~l~~~~~~~-~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~~Lh~  327 (487)
                      + +||||+.+++++..+ ..+++|||||++|+|.+++.....            ....+++..+..++.||+.||.||  
T Consensus        73 ~~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~yl--  150 (299)
T d1ywna1          73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL--  150 (299)
T ss_dssp             HCCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHH--
T ss_pred             hcCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHH--
Confidence            6 789999999987764 568999999999999999975321            134588999999999999999999  


Q ss_pred             cCCCCeeecCCCCCCEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHH
Q 011360          328 YHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISL  407 (487)
Q Consensus       328 ~h~~givH~Dlkp~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~el  407 (487)
                       |++||+||||||+|||++.++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||
T Consensus       151 -H~~~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~el  229 (299)
T d1ywna1         151 -ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI  229 (299)
T ss_dssp             -HHTTCCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred             -HhCCCcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHH
Confidence             6778999999999999999999999999999876554443333456799999999999999999999999999999999


Q ss_pred             HhC-CCCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          408 VRG-VPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       408 ltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      +|| .+||.....      .+.+......+...     ..+..    .+.++.+++.+||+.||++|||+.+|++.|+++
T Consensus       230 lt~~~~p~~~~~~------~~~~~~~~~~~~~~-----~~~~~----~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i  294 (299)
T d1ywna1         230 FSLGASPYPGVKI------DEEFCRRLKEGTRM-----RAPDY----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  294 (299)
T ss_dssp             HTTSCCSSTTCCC------SHHHHHHHHHTCCC-----CCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HhCCCCCCCCCCH------HHHHHHHHhcCCCC-----CCCcc----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            997 567743322      12233333332211     12211    124688999999999999999999999999887


Q ss_pred             C
Q 011360          487 L  487 (487)
Q Consensus       487 l  487 (487)
                      |
T Consensus       295 l  295 (299)
T d1ywna1         295 L  295 (299)
T ss_dssp             H
T ss_pred             H
Confidence            4

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=6.5e-50  Score=381.17  Aligned_cols=261  Identities=21%  Similarity=0.301  Sum_probs=203.7

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||+|+||.||+|.. ..+|+.||||++...            ..........+.+|+.+++.++|||||+++
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~-~~~~~~vAiK~i~~~------------~~~~~~~~~~~~~E~~~l~~~~hpniv~~~   73 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARD-LRLHRDVAVKVLRAD------------LARDPSFYLRFRREAQNAAALNHPAIVAVY   73 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEE-TTTTEEEEEEEECST------------TTTCHHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEE-CCCCCEEEEEEEchh------------hccCHHHHHHHHHHHHHHHhcCCCCCCccc
Confidence            5699999999999999999974 468999999998431            112234556789999999999999999999


Q ss_pred             eEEecCC----eeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC
Q 011360          272 AHMVRPD----CHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLND  347 (487)
Q Consensus       272 ~~~~~~~----~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~  347 (487)
                      +++...+    .+|+|||||+||+|.+++..    ...+++..++.++.|++.||.||   |++||+||||||+|||++.
T Consensus        74 ~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~----~~~l~~~~~~~i~~qi~~al~~l---H~~~iiHrDiKP~NIll~~  146 (277)
T d1o6ya_          74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFS---HQNGIIHRDVKPANIMISA  146 (277)
T ss_dssp             EEEEEECSSSEEEEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEET
T ss_pred             ceeeeccCCCceEEEEEECCCCCEehhhhcc----cCCCCHHHHHHHHHHHHHHHHHH---HhCCccCccccCcccccCc
Confidence            9987654    37899999999999998865    35799999999999999999999   6778999999999999999


Q ss_pred             CCCEEEeccCCccccCCCCc-eeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccH
Q 011360          348 DMEACISDLGLAMAIPDGYT-RVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSP  426 (487)
Q Consensus       348 ~~~~kl~DFg~s~~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~  426 (487)
                      ++..+++|||.+........ ........||+.|+|||++.+..|+.++|||||||++|||+||.+||...      ...
T Consensus       147 ~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~------~~~  220 (277)
T d1o6ya_         147 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD------SPV  220 (277)
T ss_dssp             TSCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS------SHH
T ss_pred             cccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCc------CHH
Confidence            99999999999876543322 22234567999999999999999999999999999999999999999432      223


Q ss_pred             HHHHHHHhcCCC-CCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCC-ChHHHHHHHhhh
Q 011360          427 EWLRKVMNSKNP-SRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERP-NSQYVRCRLSQL  486 (487)
Q Consensus       427 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-s~~~il~~L~~l  486 (487)
                      +........... .....+.+        +.++.+++.+||++||++|| |++++++.|.++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~--------s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~  274 (277)
T d1o6ya_         221 SVAYQHVREDPIPPSARHEGL--------SADLDAVVLKALAKNPENRYQTAAEMRADLVRV  274 (277)
T ss_dssp             HHHHHHHHCCCCCGGGTSSSC--------CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             HHHHHHHhcCCCCCchhccCC--------CHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence            334444433222 11222223        35688999999999999999 899999988765

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.1e-49  Score=376.30  Aligned_cols=261  Identities=23%  Similarity=0.352  Sum_probs=209.3

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCC-CCCccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIR-HRNILP  269 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~  269 (487)
                      .++|++.+.||+|+||+||+|+. ..+|+.||||++.........      ..........+.+|+.++++++ ||||++
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~-~~~~~~~AvK~i~~~~~~~~~------~~~~~~~~~~~~~E~~~l~~l~~hpnIv~   74 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIH-KPTCKEYAVKIIDVTGGGSFS------AEEVQELREATLKEVDILRKVSGHPNIIQ   74 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEE-TTTTEEEEEEEEETTCSTTCC------HHHHHHHHHHHHHHHHHHHHHTTCTTBCC
T ss_pred             cccCEEceEEecCcCeEEEEEEE-CCCCCEEEEEEEecccccchh------HHHHHHHHHHHHHHHHHHHHhcCCCCeEE
Confidence            35799999999999999999974 468999999998653322111      0111234467889999999996 999999


Q ss_pred             cceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC
Q 011360          270 LLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDM  349 (487)
Q Consensus       270 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~  349 (487)
                      +++++.+++.+|+|||||++|+|.+++..    ...+++..++.++.||+.||+||   |++||+||||||+|||++.++
T Consensus        75 ~~~~~~~~~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~l---H~~~ivHrDlkp~Nill~~~~  147 (277)
T d1phka_          75 LKDTYETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICAL---HKLNIVHRDLKPENILLDDDM  147 (277)
T ss_dssp             EEEEEECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEECTTC
T ss_pred             EEeecccCcceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH---HHcCCcccccccceEEEcCCC
Confidence            99999999999999999999999999975    35799999999999999999999   667899999999999999999


Q ss_pred             CEEEeccCCccccCCCCceeeEeeecccccccCCcccC------CCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCcc
Q 011360          350 EACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQ------QPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI  423 (487)
Q Consensus       350 ~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~------~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~  423 (487)
                      .+||+|||+++........   ....||+.|+|||.+.      ...++.++||||+||++|+|+||..||....     
T Consensus       148 ~~kl~DFG~a~~~~~~~~~---~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~-----  219 (277)
T d1phka_         148 NIKLTDFGFSCQLDPGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK-----  219 (277)
T ss_dssp             CEEECCCTTCEECCTTCCB---CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----
T ss_pred             CeEEccchheeEccCCCce---eeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC-----
Confidence            9999999999887654332   3467999999999885      3467899999999999999999999994332     


Q ss_pred             ccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          424 CSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       424 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                       ..+....+.... ..      .+.......+.++.+++.+||+.||++|||+.+|++
T Consensus       220 -~~~~~~~i~~~~-~~------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         220 -QMLMLRMIMSGN-YQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             -HHHHHHHHHHTC-CC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             -HHHHHHHHHhCC-CC------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence             222233333322 21      122222334467999999999999999999999986

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-50  Score=379.19  Aligned_cols=261  Identities=25%  Similarity=0.338  Sum_probs=200.5

Q ss_pred             cccccccccccccceeEEEEEecCCCC--ceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNG--KMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILP  269 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~  269 (487)
                      ++|++.+.||+|+||.||+|+++..++  ..||||++..            .........+.+.+|+.++++++||||++
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~------------~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~   75 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKP------------DVLSQPEAMDDFIREVNAMHSLDHRNLIR   75 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------------------CHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEECh------------hhcCCHHHHHHHHHHHHHHHhCCCCCEEE
Confidence            459999999999999999998765444  4689997732            11223345577899999999999999999


Q ss_pred             cceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCC
Q 011360          270 LLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDM  349 (487)
Q Consensus       270 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~  349 (487)
                      +++++.+ +..++|||||++|+|.+++...   ...+++..++.++.|++.||.||   |++||+||||||+||+++.++
T Consensus        76 ~~g~~~~-~~~~lv~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~yl---H~~~iiHrDikp~NIll~~~~  148 (273)
T d1u46a_          76 LYGVVLT-PPMKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYL---ESKRFIHRDLAARNLLLATRD  148 (273)
T ss_dssp             EEEEECS-SSCEEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEEEETT
T ss_pred             EEEEEee-cchheeeeeecCcchhhhhhcc---cCCCCHHHHHHHHHHHHHHHHHh---hhCCEeeeeecHHHhcccccc
Confidence            9999965 5678999999999999987642   35699999999999999999999   667899999999999999999


Q ss_pred             CEEEeccCCccccCCCCceee-EeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccccHH
Q 011360          350 EACISDLGLAMAIPDGYTRVL-ISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSPE  427 (487)
Q Consensus       350 ~~kl~DFg~s~~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~~  427 (487)
                      .+||+|||+++.......... .....||+.|+|||++.+..++.++||||||+++|||+| |..||...      ...+
T Consensus       149 ~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~------~~~~  222 (273)
T d1u46a_         149 LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL------NGSQ  222 (273)
T ss_dssp             EEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC------CHHH
T ss_pred             ceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc------CHHH
Confidence            999999999998765543322 234567889999999999999999999999999999998 89999432      2333


Q ss_pred             HHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          428 WLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       428 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      ....+...+.. ....+.+        +..+.+++.+||+.||++|||+.+|.+.|++.
T Consensus       223 ~~~~i~~~~~~-~~~~~~~--------~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         223 ILHKIDKEGER-LPRPEDC--------PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             HHHHHHTSCCC-CCCCTTC--------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHhCCCC-CCCcccc--------cHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            44444433221 1111222        24688999999999999999999999999863

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-50  Score=378.81  Aligned_cols=252  Identities=27%  Similarity=0.394  Sum_probs=196.3

Q ss_pred             hhccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcc
Q 011360          189 KKEDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNIL  268 (487)
Q Consensus       189 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv  268 (487)
                      ...++|++.+.||+|+||.||+|.+   +|..||||++..                 ....+.+.+|+.++++++||||+
T Consensus         4 i~~~~~~~~~~lG~G~fg~Vy~~~~---~~~~vAvK~i~~-----------------~~~~~~~~~E~~~l~~l~HpnIv   63 (262)
T d1byga_           4 LNMKELKLLQTIGKGEFGDVMLGDY---RGNKVAVKCIKN-----------------DATAQAFLAEASVMTQLRHSNLV   63 (262)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEE---TTEEEEEEECCC-----------------CC--HHHHHTHHHHTTCCCTTBC
T ss_pred             cCHHHeEEeEEEecCCCeEEEEEEE---CCeEEEEEEECc-----------------HHHHHHHHHHHHHHHhCCCCCEe
Confidence            3445699999999999999999987   577899998832                 11335688999999999999999


Q ss_pred             ccceEEec-CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC
Q 011360          269 PLLAHMVR-PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLND  347 (487)
Q Consensus       269 ~l~~~~~~-~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~  347 (487)
                      ++++++.+ .+.+|+||||+++|+|.+++...  ....+++..++.++.||+.||.||   |+++|+||||||+|||++.
T Consensus        64 ~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~al~yl---H~~~ivH~dlkp~Nil~~~  138 (262)
T d1byga_          64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVHRDLAARNVLVSE  138 (262)
T ss_dssp             CEEEEECCC--CCEEEECCCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECT
T ss_pred             eEEEEEEecCCcEEEEEeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHhhcccc---ccCceeccccchHhheecC
Confidence            99998865 46689999999999999999752  234589999999999999999999   6678999999999999999


Q ss_pred             CCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccccH
Q 011360          348 DMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSP  426 (487)
Q Consensus       348 ~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~  426 (487)
                      ++.+||+|||+++......     ....+|+.|+|||++.+..++.++|||||||++|||+| |.+||.....      .
T Consensus       139 ~~~~kl~dfg~s~~~~~~~-----~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~------~  207 (262)
T d1byga_         139 DNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL------K  207 (262)
T ss_dssp             TSCEEECCCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG------G
T ss_pred             CCCEeecccccceecCCCC-----ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH------H
Confidence            9999999999998654332     23458999999999998899999999999999999998 6888843322      1


Q ss_pred             HHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          427 EWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       427 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      +....+..+..+      .++..    .+..+.+++.+||+.||++|||+.+|++.|+.+
T Consensus       208 ~~~~~i~~~~~~------~~~~~----~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i  257 (262)
T d1byga_         208 DVVPRVEKGYKM------DAPDG----CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI  257 (262)
T ss_dssp             GHHHHHTTTCCC------CCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHHcCCCC------CCCcc----CCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence            222223222222      12222    124688999999999999999999999999875

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=7.8e-49  Score=386.77  Aligned_cols=255  Identities=25%  Similarity=0.325  Sum_probs=200.2

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||+|+||.||+|+. ..+|+.||||++...      ..   ..............++.+++.++|||||+++
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~-~~t~~~vAiK~i~~~------~~---~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~   73 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRK-ADTGKMYAMKCLDKK------RI---KMKQGETLALNERIMLSLVSTGDCPFIVCMS   73 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEE-TTTCCEEEEEEEEHH------HH---HHHTCHHHHHHHHHHHHHHSSSCCTTBCCEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEE-CCCCCEEEEEEEchH------Hc---chhhHHHHHHHHHHHHHHHhcCCCCcEEEEE
Confidence            4699999999999999999974 568999999988421      00   0011112223344567888999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++.+++.+|+|||||+||+|.+++..    ...+++..++.++.||+.||.||   |++||+||||||+|||++.+|.+
T Consensus        74 ~~~~~~~~~~ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~yl---H~~~iiHrDlKP~NILl~~~g~i  146 (364)
T d1omwa3          74 YAFHTPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHM---HNRFVVYRDLKPANILLDEHGHV  146 (364)
T ss_dssp             EEEECSSEEEEEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECSSSCE
T ss_pred             EEEEECCEEEEEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHH---HHCCccceeeccceeEEcCCCcE
Confidence            999999999999999999999999975    45688999999999999999999   67889999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQ-PELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLR  430 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~  430 (487)
                      ||+|||+|+.......    ....||+.|+|||++.. ..|+.++|||||||++|||+||..||.......    ...+.
T Consensus       147 Kl~DFGla~~~~~~~~----~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~----~~~~~  218 (364)
T d1omwa3         147 RISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD----KHEID  218 (364)
T ss_dssp             EECCCTTCEECSSSCC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC----HHHHH
T ss_pred             EEeeeceeeecCCCcc----cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH----HHHHH
Confidence            9999999987655432    34579999999999874 578999999999999999999999996543221    11111


Q ss_pred             HHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCC-----hHHHHH
Q 011360          431 KVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPN-----SQYVRC  481 (487)
Q Consensus       431 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~~il~  481 (487)
                      ..  .......++..+        +.++.++|.+||+.||++|||     ++++++
T Consensus       219 ~~--~~~~~~~~~~~~--------s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         219 RM--TLTMAVELPDSF--------SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             HH--SSSCCCCCCSSS--------CHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             Hh--cccCCCCCCCCC--------CHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence            11  111111112222        356889999999999999999     577764

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-49  Score=386.07  Aligned_cols=257  Identities=20%  Similarity=0.303  Sum_probs=199.9

Q ss_pred             cccccccccccccceeEEEEEecCCCCc----eEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGK----MIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNI  267 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI  267 (487)
                      ++|++++.||+|+||+||+|.+. .+|+    .||+|++..              .......+.+.+|+.++++++||||
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~-~~~~~~~~~vavK~~~~--------------~~~~~~~~~~~~E~~~l~~l~HpnI   73 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWI-PEGEKVKIPVAIKELRE--------------ATSPKANKEILDEAYVMASVDNPHV   73 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEEC-C----CCEEEEEEEECC------------------CTHHHHHHHHHHHHHCCCTTB
T ss_pred             HHCEEeeEEecCCCeEEEEEEEc-CCCCEEEEEEEEEEecc--------------ccCHHHHHHHHHHHHHHHhCCCCCE
Confidence            45999999999999999999864 3443    588887732              1112235678999999999999999


Q ss_pred             cccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC
Q 011360          268 LPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLND  347 (487)
Q Consensus       268 v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~  347 (487)
                      |++++++.++ ..+++|||+.+|+|.+++..   ....+++..++.++.||+.||.||   |++||+||||||+|||++.
T Consensus        74 v~l~g~~~~~-~~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yL---H~~~iiHrDlKp~NIll~~  146 (317)
T d1xkka_          74 CRLLGICLTS-TVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKT  146 (317)
T ss_dssp             CCEEEEEESS-SEEEEEECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEEEE
T ss_pred             eeEEEEEecC-CeeEEEEeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHH---HHcCcccCcchhhcceeCC
Confidence            9999999865 56788899999999998764   356799999999999999999999   6678999999999999999


Q ss_pred             CCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHh-CCCCccccCCCCccccH
Q 011360          348 DMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVR-GVPSFVFHQNGEEICSP  426 (487)
Q Consensus       348 ~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~ellt-g~~pf~~~~~~~~~~~~  426 (487)
                      ++.+||+|||+++...............||+.|+|||++.+..|+.++|||||||++|||+| |.+||.....      .
T Consensus       147 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~------~  220 (317)
T d1xkka_         147 PQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA------S  220 (317)
T ss_dssp             TTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG------G
T ss_pred             CCCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH------H
Confidence            99999999999988765544444445568999999999999999999999999999999999 7899854322      1


Q ss_pred             HHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          427 EWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       427 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      +....+..+..+.      .|..    .+..+.+++.+||+.||++|||+.+|++.|.++
T Consensus       221 ~~~~~i~~~~~~~------~p~~----~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~  270 (317)
T d1xkka_         221 EISSILEKGERLP------QPPI----CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  270 (317)
T ss_dssp             GHHHHHHHTCCCC------CCTT----BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHHcCCCCC------CCcc----cCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence            2222232222221      1111    224688999999999999999999999988764

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-49  Score=377.34  Aligned_cols=266  Identities=28%  Similarity=0.403  Sum_probs=203.8

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      .|.+.+.||+|+||.||+|++   +|+.||||++..                ..........|+..+.+++|||||++++
T Consensus         4 ~~~l~~~iG~G~fg~Vy~~~~---~g~~vAvK~~~~----------------~~~~~~~~e~ei~~~~~~~HpnIv~~~~   64 (303)
T d1vjya_           4 TIVLQESIGKGRFGEVWRGKW---RGEEVAVKIFSS----------------REERSWFREAEIYQTVMLRHENILGFIA   64 (303)
T ss_dssp             GEEEEEEEECCSSSEEEEEEE---TTEEEEEEEECG----------------GGHHHHHHHHHHHTSTTCCCTTBCCEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEE---CCEEEEEEEECc----------------cchhHHHHHHHHHHHhhCCCCcCcceEE
Confidence            478889999999999999986   688999998732                1111122234666677889999999999


Q ss_pred             EEecCC----eeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhc-----CCCCeeecCCCCCCE
Q 011360          273 HMVRPD----CHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMY-----HSASIIHGDIKPRNV  343 (487)
Q Consensus       273 ~~~~~~----~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~-----h~~givH~Dlkp~Ni  343 (487)
                      ++.+.+    .+|+|||||++|+|.+++..     ..+++..+..++.|++.||.|||..     |++||+||||||+||
T Consensus        65 ~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NI  139 (303)
T d1vjya_          65 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNI  139 (303)
T ss_dssp             EEEEECSSSEEEEEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGE
T ss_pred             EEEeCCCcceEEEEEEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccce
Confidence            998654    57999999999999999975     4689999999999999999999853     568999999999999


Q ss_pred             EeCCCCCEEEeccCCccccCCCCcee--eEeeecccccccCCcccCCCC------CCchhHHHHHHHHHHHHHhCCCCcc
Q 011360          344 LLNDDMEACISDLGLAMAIPDGYTRV--LISYVLGTMAYIAPEYFQQPE------LSEKCDIFSFGMLLISLVRGVPSFV  415 (487)
Q Consensus       344 ll~~~~~~kl~DFg~s~~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~------~~~~~DvwslG~~l~elltg~~pf~  415 (487)
                      |++.++.+||+|||++..........  ......||+.|+|||++.+..      ++.++|||||||++|||+||.+||.
T Consensus       140 Ll~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~  219 (303)
T d1vjya_         140 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG  219 (303)
T ss_dssp             EECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred             EEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCC
Confidence            99999999999999998765443222  224567999999999987642      5778999999999999999988875


Q ss_pred             ccCCCCc--------cccHHHHHHHHhcCCCCCccCCCCCCCC-cHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          416 FHQNGEE--------ICSPEWLRKVMNSKNPSRAIDPRLPGNG-YEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       416 ~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      .......        ................    ++.++... ..+....+.+++.+||+.||++|||+.+|++.|+++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i  295 (303)
T d1vjya_         220 IHEDYQLPYYDLVPSDPSVEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  295 (303)
T ss_dssp             BCCCCCCTTTTTSCSSCCHHHHHHHHTTSCC----CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cccccccchhhcccccchHHHHHHHHhcccc----CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence            4332111        1122333333333222    23333322 334566799999999999999999999999999875

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-49  Score=383.72  Aligned_cols=251  Identities=22%  Similarity=0.320  Sum_probs=204.7

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+.+.||+|+||.||+|.. ..+++.||||++...                ......+.+|+.+++.++|||||+++
T Consensus         5 ~rY~i~~~lG~G~fg~Vy~~~~-~~~~~~~AiK~i~~~----------------~~~~~~~~~Ei~il~~l~HpnIv~~~   67 (321)
T d1tkia_           5 EKYMIAEDLGRGEFGIVHRCVE-TSSKKTYMAKFVKVK----------------GTDQVLVKKEISILNIARHRNILHLH   67 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEE-TTTTEEEEEEEECCC----------------THHHHHHHHHHHHHHHSCCTTBCCEE
T ss_pred             cceEEEEEEecCCCeEEEEEEE-CCCCcEEEEEEEcCC----------------cccHHHHHHHHHHHHhCCCCCCCeEE
Confidence            4699999999999999999974 568999999998431                12234577899999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC--C
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDD--M  349 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~--~  349 (487)
                      +++.+++.+|+|||||+||+|.+++..   .+..+++..+..++.||+.||.||   |++||+||||||+|||++.+  +
T Consensus        68 ~~~~~~~~~~lvmE~~~gg~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yL---H~~~iiHrDlKp~NIll~~~~~~  141 (321)
T d1tkia_          68 ESFESMEELVMIFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFL---HSHNIGHFDIRPENIIYQTRRSS  141 (321)
T ss_dssp             EEEEETTEEEEEECCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEESSSSCC
T ss_pred             EEEEECCEEEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHH---HHcCCCcccccccceeecCCCce
Confidence            999999999999999999999999863   244689999999999999999999   67789999999999999854  5


Q ss_pred             CEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHH
Q 011360          350 EACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWL  429 (487)
Q Consensus       350 ~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~  429 (487)
                      .+||+|||+++........   ....+|+.|+|||.+.+..|+.++|||||||++|+|++|..||....      ..+..
T Consensus       142 ~ikl~DFG~~~~~~~~~~~---~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~------~~~~~  212 (321)
T d1tkia_         142 TIKIIEFGQARQLKPGDNF---RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET------NQQII  212 (321)
T ss_dssp             CEEECCCTTCEECCTTCEE---EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS------HHHHH
T ss_pred             EEEEcccchhhccccCCcc---cccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCC------HHHHH
Confidence            7999999999876544322   34568999999999999999999999999999999999999994432      23334


Q ss_pred             HHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          430 RKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       430 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ..+......       ++.......+.++.+++.+||..||++|||+.++++
T Consensus       213 ~~i~~~~~~-------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         213 ENIMNAEYT-------FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HHHHHTCCC-------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHhCCCC-------CChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            444332211       111111122356889999999999999999999986

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-49  Score=380.47  Aligned_cols=268  Identities=24%  Similarity=0.307  Sum_probs=208.3

Q ss_pred             HhhhccccccccccccccceeEEEEEecCC------CCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhc
Q 011360          187 FLKKEDCFASLEKIGSGGCGEVYKAELPGS------NGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITAS  260 (487)
Q Consensus       187 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~  260 (487)
                      |....++|.+.+.||+|+||.||+|+....      ++..||||++..              .........+.+|...+.
T Consensus         8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~--------------~~~~~~~~~~~~e~~~l~   73 (299)
T d1fgka_           8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS--------------DATEKDLSDLISEMEMMK   73 (299)
T ss_dssp             TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCT--------------TCCHHHHHHHHHHHHHHH
T ss_pred             CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECc--------------ccChHHHHHHHHHHHHHH
Confidence            444556799999999999999999986422      235799998742              222334566788888888


Q ss_pred             cC-CCCCccccceEEecCCeeEEEEEecCCCCHHHHHhhhhc------------CCCCCChHHHHHHHHHHHHHHHHHHh
Q 011360          261 QI-RHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSR------------GRRELDWPSRHRIALGVASGLEYLHM  327 (487)
Q Consensus       261 ~l-~hpnIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~~L~~Lh~  327 (487)
                      ++ +|||||++++++.+++..++|||||++|+|.+++.....            ....+++..++.++.|++.||+||  
T Consensus        74 ~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~yl--  151 (299)
T d1fgka_          74 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL--  151 (299)
T ss_dssp             HHCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHH--
T ss_pred             HhcCCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHh--
Confidence            87 899999999999999999999999999999999975321            235689999999999999999999  


Q ss_pred             cCCCCeeecCCCCCCEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHH
Q 011360          328 YHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISL  407 (487)
Q Consensus       328 ~h~~givH~Dlkp~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~el  407 (487)
                       |++|||||||||+|||++.++.+||+|||+++...............||+.|+|||.+.++.|+.++||||||+++|||
T Consensus       152 -H~~~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~el  230 (299)
T d1fgka_         152 -ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI  230 (299)
T ss_dssp             -HHTTCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred             -hhCCEEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHh
Confidence             7778999999999999999999999999999877554443333456789999999999999999999999999999999


Q ss_pred             Hh-CCCCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          408 VR-GVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       408 lt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      ++ |.+||....      . ..+...+..+.. ...+..+        +.++.+++.+||+.||++|||+.+|++.|+++
T Consensus       231 l~~g~~p~~~~~------~-~~~~~~i~~~~~-~~~p~~~--------~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i  294 (299)
T d1fgka_         231 FTLGGSPYPGVP------V-EELFKLLKEGHR-MDKPSNC--------TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  294 (299)
T ss_dssp             HTTSCCSSTTCC------H-HHHHHHHHTTCC-CCCCSSC--------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccCCCCCCCCCC------H-HHHHHHHHcCCC-CCCCccc--------hHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence            98 688884322      2 223333332221 1112222        24689999999999999999999999999987


Q ss_pred             C
Q 011360          487 L  487 (487)
Q Consensus       487 l  487 (487)
                      +
T Consensus       295 ~  295 (299)
T d1fgka_         295 V  295 (299)
T ss_dssp             H
T ss_pred             h
Confidence            4

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-49  Score=383.58  Aligned_cols=270  Identities=21%  Similarity=0.272  Sum_probs=216.0

Q ss_pred             HHhhhccccccccccccccceeEEEEEec----CCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhcc
Q 011360          186 AFLKKEDCFASLEKIGSGGCGEVYKAELP----GSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQ  261 (487)
Q Consensus       186 ~~~~~~~~~~~~~~lg~G~~g~v~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~  261 (487)
                      .|....++|.+.+.||+|+||.||+|++.    ..+++.||||++..              .........+.+|+.++..
T Consensus        17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~--------------~~~~~~~~~~~~E~~~~~~   82 (311)
T d1t46a_          17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP--------------SAHLTEREALMSELKVLSY   82 (311)
T ss_dssp             GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECT--------------TCCHHHHHHHHHHHHHHHH
T ss_pred             cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECc--------------ccCHHHHHHHHHHHHHHHh
Confidence            35445567999999999999999999863    35678999999843              1223345578899999999


Q ss_pred             C-CCCCccccceEEecCCeeEEEEEecCCCCHHHHHhhhhc--------------CCCCCChHHHHHHHHHHHHHHHHHH
Q 011360          262 I-RHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSR--------------GRRELDWPSRHRIALGVASGLEYLH  326 (487)
Q Consensus       262 l-~hpnIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~qi~~~L~~Lh  326 (487)
                      + +|||||++++++.+.+..++|||||++|+|.+++.....              ....+++..+..++.||+.||+|| 
T Consensus        83 l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~L-  161 (311)
T d1t46a_          83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL-  161 (311)
T ss_dssp             HCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHH-
T ss_pred             ccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHH-
Confidence            8 799999999999999999999999999999999975321              234688999999999999999999 


Q ss_pred             hcCCCCeeecCCCCCCEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHH
Q 011360          327 MYHSASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLIS  406 (487)
Q Consensus       327 ~~h~~givH~Dlkp~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~e  406 (487)
                        |++|+|||||||+||+++.++.+|++|||.++...............||+.|+|||++.+..++.++|||||||++||
T Consensus       162 --H~~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~e  239 (311)
T d1t46a_         162 --ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWE  239 (311)
T ss_dssp             --HHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred             --HhCCeeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHH
Confidence              677899999999999999999999999999998766555444456789999999999999999999999999999999


Q ss_pred             HHh-CCCCccccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhh
Q 011360          407 LVR-GVPSFVFHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQ  485 (487)
Q Consensus       407 llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~  485 (487)
                      |+| |.+||......      +.+......+... ..+..        .+..+.+++.+||+.||++|||+.+|++.|++
T Consensus       240 llt~g~p~~~~~~~~------~~~~~~i~~~~~~-~~~~~--------~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~  304 (311)
T d1t46a_         240 LFSLGSSPYPGMPVD------SKFYKMIKEGFRM-LSPEH--------APAEMYDIMKTCWDADPLKRPTFKQIVQLIEK  304 (311)
T ss_dssp             HHTTTCCSSTTCCSS------HHHHHHHHHTCCC-CCCTT--------SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHhCCCCCCCCCCHH------HHHHHHHhcCCCC-CCccc--------ccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            999 56666333221      2233333333221 11111        22568999999999999999999999999987


Q ss_pred             hC
Q 011360          486 LL  487 (487)
Q Consensus       486 ll  487 (487)
                      +|
T Consensus       305 ~i  306 (311)
T d1t46a_         305 QI  306 (311)
T ss_dssp             HH
T ss_pred             hh
Confidence            53

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.7e-48  Score=382.22  Aligned_cols=248  Identities=19%  Similarity=0.277  Sum_probs=205.2

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+++.||+|+||.||+|++ ..+|+.||||++..            ...........+.+|+.+++.++|||||+++
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~-~~~g~~~AvK~i~~------------~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~  107 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKH-KESGNHYAMKILDK------------QKVVKLKQIEHTLNEKRILQAVNFPFLVKLE  107 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEE-TTTCCEEEEEEEEH------------HHHHHTTCHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEE-CCCCCEEEEEEEch------------HHccCHHHHHHHHHHHHHHHHcCCCcEeecc
Confidence            3699999999999999999975 46899999998832            1112223456788999999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++.+...+++||||+.+|+|.+++..    ...+++..++.++.||+.||.||   |++|||||||||+|||++.+|.+
T Consensus       108 ~~~~~~~~~~~v~e~~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yL---H~~~iiHRDIKP~NILl~~~g~i  180 (350)
T d1rdqe_         108 FSFKDNSNLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYL---HSLDLIYRDLKPENLLIDQQGYI  180 (350)
T ss_dssp             EEEECSSEEEEEEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTSCE
T ss_pred             cccccccccccccccccccchhhhHhh----cCCCCHHHHHHHHHHHHHHHHHH---HhCCEecCcCCHHHcccCCCCCE
Confidence            999999999999999999999999875    35699999999999999999999   67789999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRK  431 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~  431 (487)
                      ||+|||+|+......     ....||+.|+|||++.+..|+.++|||||||++|||+||..||.+.      ........
T Consensus       181 kL~DFG~a~~~~~~~-----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~------~~~~~~~~  249 (350)
T d1rdqe_         181 QVTDFGFAKRVKGRT-----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD------QPIQIYEK  249 (350)
T ss_dssp             EECCCTTCEECSSCB-----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHH
T ss_pred             Eeeeceeeeeccccc-----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc------CHHHHHHH
Confidence            999999998765432     3456999999999999999999999999999999999999999432      22233333


Q ss_pred             HHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCC-----ChHHHHH
Q 011360          432 VMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERP-----NSQYVRC  481 (487)
Q Consensus       432 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~~il~  481 (487)
                      +.... +.  .+..+        +.++.+++.+||+.||.+|+     |+++|++
T Consensus       250 i~~~~-~~--~p~~~--------s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         250 IVSGK-VR--FPSHF--------SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             HHHCC-CC--CCTTC--------CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             HhcCC-CC--CCccC--------CHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence            33322 11  11122        25688999999999999994     8999875

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-49  Score=379.61  Aligned_cols=250  Identities=24%  Similarity=0.355  Sum_probs=201.0

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHh-ccCCCCCcccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITA-SQIRHRNILPL  270 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l-~~l~hpnIv~l  270 (487)
                      ++|.+.+.||+|+||+||+|+. ..+|+.||||++..            ...........+..|..++ +.++|||||++
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~-~~t~~~vAvK~i~k------------~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~   68 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEF-KKTNQFFAIKALKK------------DVVLMDDDVECTMVEKRVLSLAWEHPFLTHM   68 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEE-TTTTEEEEEEEEEH------------HHHHHTTCHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred             CCeEEeeEEecCCCcEEEEEEE-CCCCCEEEEEEEch------------hhccChHHHHHHHHHHHHHHHhCCCCcEEEE
Confidence            4699999999999999999975 46899999999842            1111222344556666655 46899999999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      ++++.+++.+|+|||||++|+|.+++..    ...+++..+..++.||+.||.||   |++||+||||||+|||++.++.
T Consensus        69 ~~~~~~~~~~yivmEy~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~yl---H~~~iiHrDikp~NiL~~~~~~  141 (320)
T d1xjda_          69 FCTFQTKENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFL---HSKGIVYRDLKLDNILLDKDGH  141 (320)
T ss_dssp             EEEEECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH---HHTTCBCCCCCGGGEEECTTSC
T ss_pred             EEEEccCCceeEEEeecCCCcHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHH---HhCCeeeccCcccceeecCCCc
Confidence            9999999999999999999999999975    45689999999999999999999   6778999999999999999999


Q ss_pred             EEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHH
Q 011360          351 ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLR  430 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~  430 (487)
                      +||+|||+++........  .....||+.|+|||++.+..|+.++|||||||++|+|+||..||.+.+      ..+...
T Consensus       142 ~kl~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~------~~~~~~  213 (320)
T d1xjda_         142 IKIADFGMCKENMLGDAK--TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD------EEELFH  213 (320)
T ss_dssp             EEECCCTTCBCCCCTTCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHH
T ss_pred             eeccccchhhhccccccc--ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC------HHHHHH
Confidence            999999999866543322  244679999999999999999999999999999999999999994332      222333


Q ss_pred             HHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChH-HHH
Q 011360          431 KVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQ-YVR  480 (487)
Q Consensus       431 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~-~il  480 (487)
                      .+. ...+  .    +|..    .+.++.+++.+||..||++|||++ +++
T Consensus       214 ~i~-~~~~--~----~p~~----~s~~~~dli~~~L~~dP~~R~s~~~~l~  253 (320)
T d1xjda_         214 SIR-MDNP--F----YPRW----LEKEAKDLLVKLFVREPEKRLGVRGDIR  253 (320)
T ss_dssp             HHH-HCCC--C----CCTT----SCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             HHH-cCCC--C----CCcc----CCHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence            332 2222  1    2211    235688999999999999999996 564

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-48  Score=377.29  Aligned_cols=268  Identities=18%  Similarity=0.274  Sum_probs=214.8

Q ss_pred             HhhhccccccccccccccceeEEEEEecC----CCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC
Q 011360          187 FLKKEDCFASLEKIGSGGCGEVYKAELPG----SNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI  262 (487)
Q Consensus       187 ~~~~~~~~~~~~~lg~G~~g~v~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  262 (487)
                      |....++|.+.+.||+|+||.||+|.+..    .++..||||++..              .........+.+|+.+++++
T Consensus        15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~--------------~~~~~~~~~~~~E~~il~~l   80 (308)
T d1p4oa_          15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE--------------AASMRERIEFLNEASVMKEF   80 (308)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCT--------------TSCHHHHHHHHHHHHHGGGC
T ss_pred             eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECc--------------ccChHHHHHHHHHHHHHHHc
Confidence            43445679999999999999999998642    2457899998832              11223445788999999999


Q ss_pred             CCCCccccceEEecCCeeEEEEEecCCCCHHHHHhhhh------cCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 011360          263 RHRNILPLLAHMVRPDCHLLVYEFMKNGSLQDILDDVS------RGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHG  336 (487)
Q Consensus       263 ~hpnIv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~  336 (487)
                      +|||||++++++...+..++|||||++|+|.+++....      .....+++..+..++.|+++||.||   |+++|+||
T Consensus        81 ~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~L---H~~~ivHr  157 (308)
T d1p4oa_          81 NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYL---NANKFVHR  157 (308)
T ss_dssp             CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHH---HHTTCBCS
T ss_pred             CCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHH---hhCCeeec
Confidence            99999999999999999999999999999999986432      1234578899999999999999999   66789999


Q ss_pred             CCCCCCEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhC-CCCcc
Q 011360          337 DIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRG-VPSFV  415 (487)
Q Consensus       337 Dlkp~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg-~~pf~  415 (487)
                      ||||+|||++.++++||+|||+++...............||+.|+|||.+.+..++.++||||||+++|||+|| .+||.
T Consensus       158 Dlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~  237 (308)
T d1p4oa_         158 DLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ  237 (308)
T ss_dssp             CCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTT
T ss_pred             eEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCC
Confidence            99999999999999999999999876554443333445689999999999999999999999999999999998 57773


Q ss_pred             ccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhhC
Q 011360          416 FHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQLL  487 (487)
Q Consensus       416 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~ll  487 (487)
                      .      ....+....+.....+.  .++.+        +..+.+++.+||+.+|++|||+++|++.|++.+
T Consensus       238 ~------~~~~~~~~~i~~~~~~~--~p~~~--------~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~  293 (308)
T d1p4oa_         238 G------LSNEQVLRFVMEGGLLD--KPDNC--------PDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM  293 (308)
T ss_dssp             T------SCHHHHHHHHHTTCCCC--CCTTC--------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred             C------CCHHHHHHHHHhCCCCC--Ccccc--------hHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            2      23344454444433221  11122        246899999999999999999999999998753

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-49  Score=382.57  Aligned_cols=252  Identities=20%  Similarity=0.291  Sum_probs=198.6

Q ss_pred             ccccccc-ccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhcc-CCCCCccc
Q 011360          192 DCFASLE-KIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQ-IRHRNILP  269 (487)
Q Consensus       192 ~~~~~~~-~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~hpnIv~  269 (487)
                      ++|.++. .||+|+||.||+|+. ..+++.||||++..                    ...+.+|+.++.+ .+|||||+
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~-~~~~~~vAiK~i~~--------------------~~~~~~E~~~~~~~~~hpnIv~   69 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFN-KRTQEKFALKMLQD--------------------CPKARREVELHWRASQCPHIVR   69 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEE-TTTCCEEEEEEEEC--------------------SHHHHHHHHHHHHHTTSTTBCC
T ss_pred             cCEEEeeEEeeeccCeEEEEEEE-CCCCCEEEEEEECC--------------------cHHHHHHHHHHHHhcCCCCCCe
Confidence            4688875 599999999999975 46889999998732                    1235578887654 48999999


Q ss_pred             cceEEec----CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEe
Q 011360          270 LLAHMVR----PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLL  345 (487)
Q Consensus       270 l~~~~~~----~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill  345 (487)
                      +++++.+    ...+|+|||||+||+|.+++..  .+...+++..++.++.|++.||+||   |++||+||||||+|||+
T Consensus        70 l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~--~~~~~l~e~~~~~i~~qi~~al~yl---H~~~iiHRDiKp~NIll  144 (335)
T d2ozaa1          70 IVDVYENLYAGRKCLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYL---HSINIAHRDVKPENLLY  144 (335)
T ss_dssp             EEEEEEEEETTEEEEEEEEECCCSEEHHHHHHS--CSCCCEEHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEE
T ss_pred             EEEEEeecccCCCEEEEEEECCCCCcHHHHHHh--cCCCCcCHHHHHHHHHHHHHHHHHH---HHcCCcccccccccccc
Confidence            9999875    4678999999999999999974  3345799999999999999999999   67889999999999999


Q ss_pred             CC---CCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCc
Q 011360          346 ND---DMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEE  422 (487)
Q Consensus       346 ~~---~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~  422 (487)
                      +.   ++.+||+|||+++........   ....||+.|+|||++.+..|+.++|||||||++|+|+||.+||.+......
T Consensus       145 ~~~~~~~~~Kl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~  221 (335)
T d2ozaa1         145 TSKRPNAILKLTDFGFAKETTSHNSL---TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI  221 (335)
T ss_dssp             SCSSTTCCEEECCCTTCEECCCCCCC---CCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--
T ss_pred             ccccccccccccccceeeeccCCCcc---ccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH
Confidence            85   567999999999876554322   356799999999999999999999999999999999999999965543221


Q ss_pred             cccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          423 ICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       423 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .   ..   +.. ...  .....++.......+.++.+++.+||+.||++|||+.++++
T Consensus       222 ~---~~---~~~-~i~--~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         222 S---PG---MKT-RIR--MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             -------------CCC--SCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             H---HH---HHH-HHh--cCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            1   00   110 000  01112333334455678999999999999999999999986

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-49  Score=379.14  Aligned_cols=258  Identities=24%  Similarity=0.325  Sum_probs=202.8

Q ss_pred             cccccccccccccceeEEEEEecCCCCc--eEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC-CCCCcc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGK--MIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI-RHRNIL  268 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv  268 (487)
                      ++|++.+.||+|+||.||+|++.. +|.  .||||++..              .......+.+.+|+.++.++ +|||||
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~-~~~~~~vaiK~~~~--------------~~~~~~~~~~~~E~~~l~~l~~HpnIv   74 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKK-DGLRMDAAIKRMKE--------------YASKDDHRDFAGELEVLCKLGHHPNII   74 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEE-TTEEEEEEEEEEEC--------------C------CHHHHHHHHHTTCCCCTTBC
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECC-CCeEEEEEEEEECc--------------ccChHHHHHHHHHHHHHHhccCCCCEe
Confidence            468999999999999999998753 444  477887632              11223455789999999999 799999


Q ss_pred             ccceEEecCCeeEEEEEecCCCCHHHHHhhh------------hcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 011360          269 PLLAHMVRPDCHLLVYEFMKNGSLQDILDDV------------SRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHG  336 (487)
Q Consensus       269 ~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~------------~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~  336 (487)
                      ++++++.+.+.+++|||||++|+|.+++...            ......+++..+..++.||+.||.||   |++||+||
T Consensus        75 ~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~l---H~~~iiHr  151 (309)
T d1fvra_          75 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHR  151 (309)
T ss_dssp             CEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHH---HHTTEECS
T ss_pred             eEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhh---hcCCcccc
Confidence            9999999999999999999999999998642            12346789999999999999999999   67789999


Q ss_pred             CCCCCCEEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCC-CCcc
Q 011360          337 DIKPRNVLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGV-PSFV  415 (487)
Q Consensus       337 Dlkp~Nill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~-~pf~  415 (487)
                      ||||+|||++.++.+||+|||+++........   ....||+.|+|||.+.+..|+.++|||||||++|||++|. +||.
T Consensus       152 Dlkp~NIL~~~~~~~kl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~  228 (309)
T d1fvra_         152 DLAARNILVGENYVAKIADFGLSRGQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC  228 (309)
T ss_dssp             CCSGGGEEECGGGCEEECCTTCEESSCEECCC-------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             ccccceEEEcCCCceEEccccccccccccccc---cceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCC
Confidence            99999999999999999999999765433222   2345899999999999999999999999999999999975 5673


Q ss_pred             ccCCCCccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          416 FHQNGEEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       416 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      ..      ...+....+..+.++      ..+..    .+.++.+++.+||+.||++|||+++|++.|+++
T Consensus       229 ~~------~~~~~~~~i~~~~~~------~~~~~----~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i  283 (309)
T d1fvra_         229 GM------TCAELYEKLPQGYRL------EKPLN----CDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  283 (309)
T ss_dssp             TC------CHHHHHHHGGGTCCC------CCCTT----BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CC------CHHHHHHHHHhcCCC------CCCcc----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            22      223333333332222      12211    235688999999999999999999999999876

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-48  Score=372.56  Aligned_cols=255  Identities=24%  Similarity=0.327  Sum_probs=199.7

Q ss_pred             ccccccccceeEEEEEecCCCC--ceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceEE
Q 011360          197 LEKIGSGGCGEVYKAELPGSNG--KMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHM  274 (487)
Q Consensus       197 ~~~lg~G~~g~v~~~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~  274 (487)
                      .++||+|+||+||+|++...++  ..||||++..              .........+.+|+.++++++||||+++++++
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~--------------~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~   97 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--------------ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC   97 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECC--------------CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECc--------------ccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEE
Confidence            4689999999999998754333  3689998842              12334567899999999999999999999997


Q ss_pred             ec-CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEE
Q 011360          275 VR-PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACI  353 (487)
Q Consensus       275 ~~-~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl  353 (487)
                      .. +...++|||||++|+|.+++..   ....+++..+..++.|++.||.||   |+.+|+||||||+|||+++++.+||
T Consensus        98 ~~~~~~~~lv~E~~~~g~l~~~~~~---~~~~~~~~~~~~i~~qia~gL~~l---H~~~iiHrDLK~~NILl~~~~~~kL  171 (311)
T d1r0pa_          98 LRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKV  171 (311)
T ss_dssp             EETTTEEEEEEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHH---HHTTCCCSCCSGGGEEECTTCCEEE
T ss_pred             EecCCceEEEEEEeecCchhhhhcc---ccccchHHHHHHHHHHHHHhhhhh---cccCcccCCccHHhEeECCCCCEEE
Confidence            65 5688999999999999998863   355677888999999999999999   6778999999999999999999999


Q ss_pred             eccCCccccCCCCcee--eEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHH
Q 011360          354 SDLGLAMAIPDGYTRV--LISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRK  431 (487)
Q Consensus       354 ~DFg~s~~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~  431 (487)
                      +|||+++.........  ......||+.|+|||.+.+..++.++||||||+++|||+||..||......     .+....
T Consensus       172 ~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~-----~~~~~~  246 (311)
T d1r0pa_         172 ADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-----FDITVY  246 (311)
T ss_dssp             CSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-----------CHHH
T ss_pred             ecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH-----HHHHHH
Confidence            9999998765432221  112346899999999999999999999999999999999987776433221     122233


Q ss_pred             HHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          432 VMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       432 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      +..+..+.      .|..    .+..+.+++.+||+.||++|||+.+|++.|+++
T Consensus       247 i~~g~~~~------~p~~----~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i  291 (311)
T d1r0pa_         247 LLQGRRLL------QPEY----CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  291 (311)
T ss_dssp             HHTTCCCC------CCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHcCCCCC------Cccc----CcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            33333221      1111    124688999999999999999999999999876

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-48  Score=375.13  Aligned_cols=260  Identities=25%  Similarity=0.311  Sum_probs=195.8

Q ss_pred             cccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccceEEe
Q 011360          196 SLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLAHMV  275 (487)
Q Consensus       196 ~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  275 (487)
                      .++.||+|+||+||+|+. ..+|+.||||++.....          ........+.+.+|+.++++++|||||++++++.
T Consensus         2 ~l~~lG~G~fg~Vy~~~~-~~~~~~vAvK~i~~~~~----------~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~   70 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARD-KNTNQIVAIKKIKLGHR----------SEAKDGINRTALREIKLLQELSHPNIIGLLDAFG   70 (299)
T ss_dssp             EEEEEEEETTEEEEEEEC-SSCCSEEEEEEC----------------------CTHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEE-CCCCcEEEEEEEehhhh----------hhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeec
Confidence            467899999999999974 56899999999843110          0111122356889999999999999999999999


Q ss_pred             cCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCEEEec
Q 011360          276 RPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEACISD  355 (487)
Q Consensus       276 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~kl~D  355 (487)
                      .++.+|+|||||.++++..+..    ....+++..+..++.||+.||+||   |++||+||||||+|||++.++.+||+|
T Consensus        71 ~~~~~~ivmE~~~~~~~~~~~~----~~~~l~~~~~~~~~~qil~aL~~l---H~~~iiHrDiKp~NIli~~~~~~KL~D  143 (299)
T d1ua2a_          71 HKSNISLVFDFMETDLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYL---HQHWILHRDLKPNNLLLDENGVLKLAD  143 (299)
T ss_dssp             CTTCCEEEEECCSEEHHHHHTT----CCSSCCSSHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred             cCCceeehhhhhcchHHhhhhh----cccCCCHHHHHHHHHHHHHHHHHh---hccceecccCCcceEEecCCCcccccc
Confidence            9999999999998887765543    356789999999999999999999   778899999999999999999999999


Q ss_pred             cCCccccCCCCceeeEeeecccccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHHHHHh
Q 011360          356 LGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQ-PELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLRKVMN  434 (487)
Q Consensus       356 Fg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~  434 (487)
                      ||+++.........  ...+||+.|+|||++.. ..|+.++|||||||++|||+||.+||.+...      .+.+..+..
T Consensus       144 FG~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~------~~~l~~i~~  215 (299)
T d1ua2a_         144 FGLAKSFGSPNRAY--THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD------LDQLTRIFE  215 (299)
T ss_dssp             CGGGSTTTSCCCCC--CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHH
T ss_pred             CccccccCCCcccc--cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCH------HHHHHHHHH
Confidence            99998765443221  34579999999998865 4689999999999999999999999954322      122222221


Q ss_pred             c--CCCCCccC-----------CCCCCCC----cHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          435 S--KNPSRAID-----------PRLPGNG----YEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       435 ~--~~~~~~~~-----------~~~~~~~----~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .  ........           ...+...    ....+.++.+++.+||+.||++|||++|+++
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         216 TLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             HHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence            1  11100000           0111111    1123467899999999999999999999986

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-47  Score=368.28  Aligned_cols=262  Identities=24%  Similarity=0.346  Sum_probs=199.3

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+++.||+|+||+||+|++ ..+|+.||||++...             ........++.+|+.++++++|||||+++
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~-~~~~~~vAvK~i~~~-------------~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~   67 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARN-KLTGEVVALKKIRLD-------------TETEGVPSTAIREISLLKELNHPNIVKLL   67 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEE-TTTCCEEEEEEEC--------------------CCHHHHHHHHHHTTCCCTTBCCEE
T ss_pred             CCCEeccEEecCcCeEEEEEEE-CCCCCEEEEEEEehh-------------hcChHHHHHHHHHHHHHHhCCCCcEEEec
Confidence            4699999999999999999975 468899999998431             11122346788999999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++.+++.+|+|||||.+ ++.+++..  .....+++..+..++.|++.||.||   |++|||||||||+|||++.++.+
T Consensus        68 ~~~~~~~~~~iv~e~~~~-~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yL---H~~~IiHrDiKpeNIl~~~~~~~  141 (298)
T d1gz8a_          68 DVIHTENKLYLVFEFLHQ-DLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFC---HSHRVLHRDLKPQNLLINTEGAI  141 (298)
T ss_dssp             EEEEETTEEEEEEECCSE-EHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTSCE
T ss_pred             cccccccceeEEEeecCC-chhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHh---hcCCEEccccCchheeecccCcc
Confidence            999999999999999965 55555543  3456799999999999999999999   67889999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCCC-CCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPE-LSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLR  430 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~  430 (487)
                      ||+|||.|+........  .....||+.|+|||.+.... ++.++|||||||++|+|++|+.||.+.+.      .+.+.
T Consensus       142 kl~DFG~a~~~~~~~~~--~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~------~~~~~  213 (298)
T d1gz8a_         142 KLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE------IDQLF  213 (298)
T ss_dssp             EECSTTHHHHHCCCSBC--TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHH
T ss_pred             eeccCCcceeccCCccc--ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCH------HHHHH
Confidence            99999999876543322  23457999999999877654 58899999999999999999999954321      11121


Q ss_pred             HHHh-cCCCCCccCC----------CC---CCCC----cHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          431 KVMN-SKNPSRAIDP----------RL---PGNG----YEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       431 ~~~~-~~~~~~~~~~----------~~---~~~~----~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .... .+.+....-+          ..   ....    ....+.++.+++.+||+.||++|||++|+++
T Consensus       214 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~  282 (298)
T d1gz8a_         214 RIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA  282 (298)
T ss_dssp             HHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            1111 1111111100          00   0000    1123457889999999999999999999987

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-47  Score=364.75  Aligned_cols=263  Identities=20%  Similarity=0.295  Sum_probs=193.8

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhcc---CCCCCc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQ---IRHRNI  267 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~---l~hpnI  267 (487)
                      .++|++++.||+|+||.||+|++...+++.||||++......             ......+.+|+.+++.   .+||||
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~-------------~~~~~~~~~E~~~l~~l~~~~HpnI   72 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-------------EGMPLSTIREVAVLRHLETFEHPNV   72 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT-------------TSCBCTHHHHHHHHHHHHHTCCTTB
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhcc-------------chHHHHHHHHHHHHHHHhhcCCCCc
Confidence            457999999999999999999865555788999998542211             1111223455555554   489999


Q ss_pred             cccceEEec-----CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCC
Q 011360          268 LPLLAHMVR-----PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRN  342 (487)
Q Consensus       268 v~l~~~~~~-----~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~N  342 (487)
                      +++++++..     ...++++|||+.++++.....   .....+++..++.++.|++.||+||   |++||+||||||+|
T Consensus        73 v~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~---~~~~~~~~~~~~~~~~qi~~aL~yL---H~~~ivHrDiKp~N  146 (305)
T d1blxa_          73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK---VPEPGVPTETIKDMMFQLLRGLDFL---HSHRVVHRDLKPQN  146 (305)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHH---SCTTCSCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGG
T ss_pred             ceeeeeecccccccCceEEEEEEeccCCchhhhhh---ccCCCCCHHHHHHHHHHHHHHHHHH---HhCCEEecCCCccE
Confidence            999998853     346799999998876654433   3456789999999999999999999   67789999999999


Q ss_pred             EEeCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCc
Q 011360          343 VLLNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEE  422 (487)
Q Consensus       343 ill~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~  422 (487)
                      ||++.++.+||+|||++........   .....||+.|+|||++.+..|+.++||||+||++|||+||.+||...+.   
T Consensus       147 ILi~~~~~~kl~dfg~~~~~~~~~~---~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~---  220 (305)
T d1blxa_         147 ILVTSSGQIKLADFGLARIYSFQMA---LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD---  220 (305)
T ss_dssp             EEECTTCCEEECSCCSCCCCCGGGG---GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---
T ss_pred             EEEcCCCCeeecchhhhhhhccccc---CCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCH---
Confidence            9999999999999999876543322   2456799999999999999999999999999999999999999954321   


Q ss_pred             cccHHHHHHHHhc--CCCCCccCCC----------CCC----CCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          423 ICSPEWLRKVMNS--KNPSRAIDPR----------LPG----NGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       423 ~~~~~~~~~~~~~--~~~~~~~~~~----------~~~----~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                         .+.+..+...  .......+..          ...    ......+..+.+++.+||+.||++|||+.|+++
T Consensus       221 ---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         221 ---VDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             ---HHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ---HHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence               1222222110  0000000000          000    011123356888999999999999999999975

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=7.4e-47  Score=361.79  Aligned_cols=260  Identities=24%  Similarity=0.347  Sum_probs=196.5

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+++.||+|+||+||+|++.  +|+.||||++....             ........+.+|+.++++++|||||+++
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~i~~~~-------------~~~~~~~~~~~E~~il~~l~hpnIv~~~   66 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN--YGETFALKKIRLEK-------------EDEGIPSTTIREISILKELKHSNIVKLY   66 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET--TSCEEEEEEECCSS-------------GGGCCCHHHHHHHHGGGGCCCTTBCCEE
T ss_pred             CCceeccEEecCCCcEEEEEEeC--CCCEEEEEEEehhh-------------cChHHHHHHHHHHHHHHhCCCCcEEeee
Confidence            47999999999999999999864  78999999984421             1122345788999999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++..++..+++|||+.++.+..+..    ....+++..+..++.|++.||+||   |+.||+||||||+|||++.++.+
T Consensus        67 ~~~~~~~~~~i~~e~~~~~~~~~~~~----~~~~l~~~~~~~i~~qi~~~L~~L---H~~~IvHrDiKp~NIll~~~~~~  139 (286)
T d1ob3a_          67 DVIHTKKRLVLVFEHLDQDLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYC---HDRRVLHRDLKPQNLLINREGEL  139 (286)
T ss_dssp             EEEECSSCEEEEEECCSEEHHHHHHT----STTCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEECTTSCE
T ss_pred             eecccCCceeEEEEeehhhhHHHHHh----hcCCcchhhhHHHHHHHHHHHHHh---ccCcEEecCCCCceeeEcCCCCE
Confidence            99999999999999998776665553    357799999999999999999999   66789999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQP-ELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLR  430 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~  430 (487)
                      ||+|||.+.........  .....|++.|+|||.+.+. .++.++|||||||++|||++|+.||.....      .+...
T Consensus       140 kl~DfG~a~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~------~~~~~  211 (286)
T d1ob3a_         140 KIADFGLARAFGIPVRK--YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE------ADQLM  211 (286)
T ss_dssp             EECCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHH
T ss_pred             EecccccceecccCccc--cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCH------HHHHH
Confidence            99999999876543222  2344689999999998754 679999999999999999999999943321      11122


Q ss_pred             HHHh-cCCCC-Ccc---------CCCCC-------CCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          431 KVMN-SKNPS-RAI---------DPRLP-------GNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       431 ~~~~-~~~~~-~~~---------~~~~~-------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .... ...+. ...         .....       .......+.++.+++.+||+.||++|||++|+++
T Consensus       212 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         212 RIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             HHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            2111 00000 000         00000       0011123457889999999999999999999984

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-47  Score=364.30  Aligned_cols=247  Identities=22%  Similarity=0.331  Sum_probs=195.4

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCC--CCCcc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIR--HRNIL  268 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpnIv  268 (487)
                      .++|.+.+.||+|+||.||+|.. ..+|+.||||++.........         ......++.+|+.++++++  |||||
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~-~~~~~~vAvK~i~~~~~~~~~---------~~~~~~~~~~E~~il~~l~~~h~nIv   72 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIR-VSDNLPVAIKHVEKDRISDWG---------ELPNGTRVPMEVVLLKKVSSGFSGVI   72 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEE-TTTCCEEEEEEEEGGGCCCEE---------ECTTCCEEEHHHHHHHHHCSSSCSBC
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEE-CCCCCEEEEEEEehHHccchh---------hhhHHHHHHHHHHHHHHhccCCCCcc
Confidence            35699999999999999999974 468999999998532111000         0011123557899998885  89999


Q ss_pred             ccceEEecCCeeEEEEEecCC-CCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC
Q 011360          269 PLLAHMVRPDCHLLVYEFMKN-GSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLND  347 (487)
Q Consensus       269 ~l~~~~~~~~~~~lv~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~  347 (487)
                      ++++++.+++..|+||||+.+ +++.+++..    ...+++..++.++.|++.||.||   |++||+||||||+|||++.
T Consensus        73 ~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~l---H~~~iiHrDiKp~NIll~~  145 (273)
T d1xwsa_          73 RLLDWFERPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHC---HNCGVLHRDIKDENILIDL  145 (273)
T ss_dssp             CEEEEEECSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCSGGGEEEET
T ss_pred             EEEEEEeeCCeEEEEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHH---HHCCCccccCcccceEEec
Confidence            999999999999999999976 688888765    45799999999999999999999   6788999999999999985


Q ss_pred             -CCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCC-CchhHHHHHHHHHHHHHhCCCCccccCCCCcccc
Q 011360          348 -DMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPEL-SEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICS  425 (487)
Q Consensus       348 -~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~  425 (487)
                       ++.+||+|||+|+.......    ....||+.|+|||++.+..+ +.++|||||||++|+|+||..||....       
T Consensus       146 ~~~~vkl~DFG~a~~~~~~~~----~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-------  214 (273)
T d1xwsa_         146 NRGELKLIDFGSGALLKDTVY----TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------  214 (273)
T ss_dssp             TTTEEEECCCTTCEECCSSCB----CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------
T ss_pred             CCCeEEECccccceecccccc----cccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-------
Confidence             47899999999987544322    34679999999999987655 677999999999999999999994321       


Q ss_pred             HHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          426 PEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       426 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                           ......   ..+++.++        .++.+++.+||+.||++|||++|+++
T Consensus       215 -----~i~~~~---~~~~~~~s--------~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         215 -----EIIRGQ---VFFRQRVS--------SECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             -----HHHHCC---CCCSSCCC--------HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -----HHhhcc---cCCCCCCC--------HHHHHHHHHHccCCHhHCcCHHHHhc
Confidence                 112211   11222232        56889999999999999999999986

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-45  Score=358.69  Aligned_cols=258  Identities=24%  Similarity=0.335  Sum_probs=192.6

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .++|.+++.||+|+||+||+|.. ..+|+.||||++..             ........+.+.+|+.++++++|||||++
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~-~~~~~~vAiK~i~~-------------~~~~~~~~~~~~~Ei~il~~l~hpniv~l   82 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVD-GRTGAKVAIKKLYR-------------PFQSELFAKRAYRELRLLKHMRHENVIGL   82 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEE-TTTCCEEEEEECSS-------------TTSSHHHHHHHHHHHHHHHHCCBTTBCCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEE-CCCCCEEEEEEEch-------------hhcChHHHHHHHHHHHHHHhcCCCCeeEE
Confidence            45799999999999999999974 56899999999842             12233456678899999999999999999


Q ss_pred             ceEEecCC------eeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEE
Q 011360          271 LAHMVRPD------CHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVL  344 (487)
Q Consensus       271 ~~~~~~~~------~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nil  344 (487)
                      ++++...+      .+|+||||| +.+|..++..     ..+++..++.++.|++.||.||   |++||+||||||+|||
T Consensus        83 ~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~L---H~~~IiHrDiKp~NIL  153 (346)
T d1cm8a_          83 LDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYI---HAAGIIHRDLKPGNLA  153 (346)
T ss_dssp             SEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEE
T ss_pred             EEEeccCccccccceEEEEEecc-cccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHH---HhCCCcccccCcchhh
Confidence            99998654      469999999 6788877753     5699999999999999999999   6788999999999999


Q ss_pred             eCCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCccccCCCCcc
Q 011360          345 LNDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQ-PELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI  423 (487)
Q Consensus       345 l~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~  423 (487)
                      ++.++.+|++|||+++......     ....||+.|+|||++.+ ..++.++||||+||++|+|++|.+||...+.....
T Consensus       154 ~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~  228 (346)
T d1cm8a_         154 VNEDCELKILDFGLARQADSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQL  228 (346)
T ss_dssp             ECTTCCEEECCCTTCEECCSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             cccccccccccccceeccCCcc-----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHH
Confidence            9999999999999998765433     34569999999998875 46789999999999999999999999544211000


Q ss_pred             c---------cHH--------HHHHHHhc--CCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          424 C---------SPE--------WLRKVMNS--KNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       424 ~---------~~~--------~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .         ..+        ........  ......+..     .....+.++.+++.+||..||++|||++++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~  300 (346)
T d1cm8a_         229 KEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFAS-----ILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  300 (346)
T ss_dssp             HHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGG-----TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHH-----hccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            0         000        00000000  000000000     11122356789999999999999999999986

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-45  Score=353.80  Aligned_cols=264  Identities=20%  Similarity=0.277  Sum_probs=193.9

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+++.||+|+||+||+|++ ..+|+.||||++...             .........+.+|+.++++++||||++++
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~-~~~~~~vAvK~i~~~-------------~~~~~~~~~~~~E~~il~~l~h~nii~~~   75 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARH-RKTGQKVALKKVLME-------------NEKEGFPITALREIKILQLLKHENVVNLI   75 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTTCCEEEEEEC-----------------CTTSSCHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CCEEEEEEEecCcCeEEEEEEE-CCCCCEEEEEEEehh-------------hcchHHHHHHHHHHHHHHHhcCCCccceE
Confidence            5799999999999999999975 468999999987331             12223445678899999999999999999


Q ss_pred             eEEec--------CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCE
Q 011360          272 AHMVR--------PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNV  343 (487)
Q Consensus       272 ~~~~~--------~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Ni  343 (487)
                      +++..        .+.+|+|||||.++.+..+.    .....+++..++.++.|++.||.||   |++||+||||||+||
T Consensus        76 ~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~----~~~~~~~~~~~~~i~~qil~~l~~l---H~~~ivHrDlKp~NI  148 (318)
T d3blha1          76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS----NVLVKFTLSEIKRVMQMLLNGLYYI---HRNKILHRDMKAANV  148 (318)
T ss_dssp             EEEEC----------CEEEEEECCCEEHHHHHT----CTTCCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGE
T ss_pred             eeeecccccccccCceEEEEEeccCCCccchhh----hcccccccHHHHHHHHHHHHHHHHh---ccCCEEecCcCchhe
Confidence            98865        34679999999877665443    3356789999999999999999999   677899999999999


Q ss_pred             EeCCCCCEEEeccCCccccCCCCce--eeEeeecccccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCccccCCC
Q 011360          344 LLNDDMEACISDLGLAMAIPDGYTR--VLISYVLGTMAYIAPEYFQQP-ELSEKCDIFSFGMLLISLVRGVPSFVFHQNG  420 (487)
Q Consensus       344 ll~~~~~~kl~DFg~s~~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~-~~~~~~DvwslG~~l~elltg~~pf~~~~~~  420 (487)
                      |++.++.+||+|||++.........  ......+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+... 
T Consensus       149 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~-  227 (318)
T d3blha1         149 LITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE-  227 (318)
T ss_dssp             EECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-
T ss_pred             eecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCH-
Confidence            9999999999999999766533221  111335699999999998765 689999999999999999999999953321 


Q ss_pred             CccccHHHHHHHHhcCCCCCccCCCCC------------C--CCcH------HHHHHHHHHHhhccCCCCCCCCChHHHH
Q 011360          421 EEICSPEWLRKVMNSKNPSRAIDPRLP------------G--NGYE------KKMLHVLKIAYICTLHDPEERPNSQYVR  480 (487)
Q Consensus       421 ~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~--~~~~------~~~~~l~~li~~cl~~~P~~RPs~~~il  480 (487)
                        ........... ...+..... ...            .  ....      ....++.+++.+||+.||++|||++|++
T Consensus       228 --~~~~~~i~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL  303 (318)
T d3blha1         228 --QHQLALISQLC-GSITPEVWP-NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL  303 (318)
T ss_dssp             --HHHHHHHHHHH-CCCCTTTST-TCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred             --HHHHHHHHHhc-CCCChhhcc-ccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHH
Confidence              10111111111 111111110 000            0  0011      1134677899999999999999999998


Q ss_pred             H
Q 011360          481 C  481 (487)
Q Consensus       481 ~  481 (487)
                      +
T Consensus       304 ~  304 (318)
T d3blha1         304 N  304 (318)
T ss_dssp             H
T ss_pred             c
Confidence            5

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-45  Score=360.67  Aligned_cols=261  Identities=23%  Similarity=0.297  Sum_probs=192.8

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccce
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLLA  272 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~  272 (487)
                      .|...++||+|+||+||+|++ ..+|+.||||++....                   ....+|+.++++++||||+++++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~-~~~~~~vAiK~i~~~~-------------------~~~~~Ei~il~~l~h~niv~~~~   80 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKL-CDSGELVAIKKVLQDK-------------------RFKNRELQIMRKLDHCNIVRLRY   80 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEE-TTTCCEEEEEEEECCS-------------------SSCCHHHHHHHHCCCTTBCCEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEE-CCCCCEEEEEEECccc-------------------hHHHHHHHHHHhcCCCCCCcEEE
Confidence            589999999999999999975 4689999999984311                   11236899999999999999999


Q ss_pred             EEecC------CeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeC
Q 011360          273 HMVRP------DCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLN  346 (487)
Q Consensus       273 ~~~~~------~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~  346 (487)
                      ++...      ..+|+|||||+++ +.+.+.........+++..++.++.|++.||+||   |++||+||||||+|||++
T Consensus        81 ~~~~~~~~~~~~~~~lv~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yL---H~~~IiHrDiKp~NILl~  156 (350)
T d1q5ka_          81 FFYSSGEKKDEVYLNLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI---HSFGICHRDIKPQNLLLD  156 (350)
T ss_dssp             EEEEC--CCSCCEEEEEEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCCGGGEEEC
T ss_pred             EEEecCccCCceEEEEEEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHH---HhcCCcccCCCcceEEEe
Confidence            98543      3478999999765 4445544445567899999999999999999999   788999999999999999


Q ss_pred             CCC-CEEEeccCCccccCCCCceeeEeeecccccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCccccCCCCcc-
Q 011360          347 DDM-EACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQ-PELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI-  423 (487)
Q Consensus       347 ~~~-~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~-  423 (487)
                      .++ .+||+|||++.........   ....||+.|+|||.+.+ ..|+.++||||+||++|||++|.+||......... 
T Consensus       157 ~~~~~~kl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~  233 (350)
T d1q5ka_         157 PDTAVLKLCDFGSAKQLVRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV  233 (350)
T ss_dssp             TTTCCEEECCCTTCEECCTTSCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHH
T ss_pred             cCCCceeEecccchhhccCCccc---ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHH
Confidence            775 8999999999876544322   34579999999998765 57899999999999999999999999543321000 


Q ss_pred             --------ccHHHHHHHHhcCCCCCccCC----CCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          424 --------CSPEWLRKVMNSKNPSRAIDP----RLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       424 --------~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                              ...++..... .......+..    ..........+.++.+++.+||..||++|||+.|+++
T Consensus       234 ~i~~~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         234 EIIKVLGTPTREQIREMN-PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             HHHHHHCCCCHHHHHHHC-C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHhCCChHHhhhhhc-cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                    0011111110 0000000000    0000111223456889999999999999999999985

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=5.6e-45  Score=349.41  Aligned_cols=261  Identities=20%  Similarity=0.232  Sum_probs=203.5

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCC-CCcccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRH-RNILPL  270 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~l  270 (487)
                      ++|.+.+.||+|+||.||+|++ ..+|+.||||++....                 ....+.+|+..+..+.| +||+.+
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~-~~~~~~vAvK~~~~~~-----------------~~~~~~~e~~~~~~l~~~~~i~~~   66 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTN-LLNNQQVAIKFEPRRS-----------------DAPQLRDEYRTYKLLAGCTGIPNV   66 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEE-TTTTEEEEEEEEECCT-----------------TSCCHHHHHHHHHHTTTCTTCCCE
T ss_pred             CceEEEEEEecCCCeEEEEEEE-CCCCCEEEEEEEcccc-----------------CcHHHHHHHHHHHHhcCCCCCCEE
Confidence            4699999999999999999975 4689999999873311                 11235667888888855 899999


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC---
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLND---  347 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~---  347 (487)
                      ++++......++||||+ +++|.+++..   .+..++...+..++.|++.||.||   |++||+||||||+|||++.   
T Consensus        67 ~~~~~~~~~~~~vme~~-~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~l---H~~giiHrDiKp~Nili~~~~~  139 (293)
T d1csna_          67 YYFGQEGLHNVLVIDLL-GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSI---HEKSLVYRDIKPDNFLIGRPNS  139 (293)
T ss_dssp             EEEEEETTEEEEEEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHH---HTTTEECCCCCGGGEEECCSSS
T ss_pred             EEEeecCCccEEEEEec-CCCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHH---HHCCceeccCCccceeecCccc
Confidence            99999999999999999 7899998864   345789999999999999999999   7889999999999999974   


Q ss_pred             --CCCEEEeccCCccccCCCCce-----eeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCC
Q 011360          348 --DMEACISDLGLAMAIPDGYTR-----VLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNG  420 (487)
Q Consensus       348 --~~~~kl~DFg~s~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~  420 (487)
                        ++.+||+|||+|+........     .......||+.|+|||++.+..++.++||||||+++|||+||..||.+....
T Consensus       140 ~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~  219 (293)
T d1csna_         140 KNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA  219 (293)
T ss_dssp             TTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC
T ss_pred             ccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccch
Confidence              578999999999876433221     1123467999999999999999999999999999999999999999654433


Q ss_pred             CccccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          421 EEICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       421 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      ............. ...+...+.+.+|        .++.+++..||..+|++||+++.+.+.|+++
T Consensus       220 ~~~~~~~~i~~~~-~~~~~~~l~~~~p--------~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~  276 (293)
T d1csna_         220 TNKQKYERIGEKK-QSTPLRELCAGFP--------EEFYKYMHYARNLAFDATPDYDYLQGLFSKV  276 (293)
T ss_dssp             CHHHHHHHHHHHH-HHSCHHHHTTTSC--------HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             hHHHHHHHHHhcc-CCCChHHhcCCCC--------HHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence            2221111111111 1111111122233        4688999999999999999999999888765

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.6e-45  Score=350.03  Aligned_cols=261  Identities=23%  Similarity=0.279  Sum_probs=196.5

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc-
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL-  270 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l-  270 (487)
                      ++|++.+.||+|+||.||+|++ ..+|+.||||++....                 ....+..|+.+++.++|+|++.. 
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~-~~~~~~vAvK~~~~~~-----------------~~~~~~~E~~i~~~l~~~~~i~~~   68 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTD-IAAGEEVAIKLECVKT-----------------KHPQLHIESKIYKMMQGGVGIPTI   68 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEE-TTTTEEEEEEEEESCT-----------------TSCCHHHHHHHHHHSTTSTTCCCE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEE-CCCCCEEEEEEEchhc-----------------cCHHHHHHHHHHHHccCCCcccEE
Confidence            5699999999999999999975 4678999999874310                 11246779999999987765555 


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC---
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLND---  347 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~---  347 (487)
                      ..++.+.+..++||||+ +++|.+.+..   ....+++..+..++.|++.||+||   |++||+||||||+|||++.   
T Consensus        69 ~~~~~~~~~~~ivme~~-~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~l---H~~~iiHrDiKp~NIl~~~~~~  141 (299)
T d1ckia_          69 RWCGAEGDYNVMVMELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYI---HSKNFIHRDVKPDNFLMGLGKK  141 (299)
T ss_dssp             EEEEEETTEEEEEEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHH---HHTTEECSCCCGGGEEECCGGG
T ss_pred             EEEEecCCEEEEEEEEc-CCchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHH---HHCCeeeccCCHhhccccccCC
Confidence            55667788889999999 6677776653   356799999999999999999999   6778999999999999864   


Q ss_pred             CCCEEEeccCCccccCCCCce-----eeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCc
Q 011360          348 DMEACISDLGLAMAIPDGYTR-----VLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEE  422 (487)
Q Consensus       348 ~~~~kl~DFg~s~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~  422 (487)
                      +..+||+|||+|+........     .......||+.|+|||++.+..++.++|||||||++|||+||..||........
T Consensus       142 ~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~  221 (299)
T d1ckia_         142 GNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK  221 (299)
T ss_dssp             TTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC----
T ss_pred             CceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHH
Confidence            557999999999876543321     122346799999999999999999999999999999999999999966544332


Q ss_pred             cccHHHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHHHHhhh
Q 011360          423 ICSPEWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRCRLSQL  486 (487)
Q Consensus       423 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~l  486 (487)
                      ........... ...+...+.+.+|        .++.+++..||+.+|++||++.+|.+.|+.+
T Consensus       222 ~~~~~~~~~~~-~~~~~~~~~~~~p--------~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~  276 (299)
T d1ckia_         222 RQKYERISEKK-MSTPIEVLCKGYP--------SEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  276 (299)
T ss_dssp             ---HHHHHHHH-HHSCHHHHTTTSC--------HHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred             HHHHHHhhccc-CCCChhHhccCCC--------HHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence            22111111110 1111111112222        5688999999999999999999999888764

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-44  Score=353.32  Aligned_cols=262  Identities=23%  Similarity=0.307  Sum_probs=192.2

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+++.||+|+||+||+|. +..+|+.||||++..              .......+.+.+|+.++++++||||++++
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~-~~~~~~~vAvK~i~~--------------~~~~~~~~~~~~Ei~il~~l~hp~iv~~~   72 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAY-DNVNKVRVAIKKISP--------------FEHQTYCQRTLREIKILLRFRHENIIGIN   72 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEE-ETTTCSEEEEEEECC--------------TTCHHHHHHHHHHHHHHHHCCCTTBCCCC
T ss_pred             CCeEEEEEEeeccCeEEEEEE-ECCCCcEEEEEEEeh--------------hcChHHHHHHHHHHHHHHHcCCCCCCcEE
Confidence            469999999999999999997 456899999999843              11233456788999999999999999999


Q ss_pred             eEEecCC----eeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC
Q 011360          272 AHMVRPD----CHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLND  347 (487)
Q Consensus       272 ~~~~~~~----~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~  347 (487)
                      +++..+.    ..+++++|+.+|+|.+++..     ..+++..++.++.|++.||+||   |++|||||||||+|||++.
T Consensus        73 ~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yL---H~~~iiHRDIKp~NILl~~  144 (345)
T d1pmea_          73 DIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYI---HSANVLHRDLKPSNLLLNT  144 (345)
T ss_dssp             EEECCSSTTTCCCEEEEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCCGGGEEECT
T ss_pred             EEEeeccccccceEEEEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHH---HHCCCcCCCCCcceEEECC
Confidence            9987643    23455566679999999974     4689999999999999999999   6778999999999999999


Q ss_pred             CCCEEEeccCCccccCCCCce-eeEeeecccccccCCcccCC-CCCCchhHHHHHHHHHHHHHhCCCCccccCCCCcccc
Q 011360          348 DMEACISDLGLAMAIPDGYTR-VLISYVLGTMAYIAPEYFQQ-PELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICS  425 (487)
Q Consensus       348 ~~~~kl~DFg~s~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~-~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~  425 (487)
                      ++.+||+|||++......... .......||+.|+|||++.. ..++.++||||+||++|+|++|..||........   
T Consensus       145 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~---  221 (345)
T d1pmea_         145 TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ---  221 (345)
T ss_dssp             TCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---
T ss_pred             CCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHH---
Confidence            999999999999765443221 11234569999999999854 5678999999999999999999999954321000   


Q ss_pred             HHHHHHHHhcCCCCCcc---------------CCCCCCC----CcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          426 PEWLRKVMNSKNPSRAI---------------DPRLPGN----GYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       426 ~~~~~~~~~~~~~~~~~---------------~~~~~~~----~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      ........  ..+....               .+.....    .....+.++.+++.+||..||++|||++++++
T Consensus       222 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~  294 (345)
T d1pmea_         222 LNHILGIL--GSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  294 (345)
T ss_dssp             HHHHHHHH--CSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHhhhc--cCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00000000  0000000               0000000    00112246889999999999999999999986

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-44  Score=346.10  Aligned_cols=262  Identities=21%  Similarity=0.259  Sum_probs=203.0

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|++++.||+|+||+||+|+. ..+++.||||++...             ........++.+|+.+++.++||||++++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~-~~~~~~vAvK~i~~~-------------~~~~~~~~~~~~E~~il~~l~h~niv~~~   67 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKN-RETHEIVALKRVRLD-------------DDDEGVPSSALREICLLKELKHKNIVRLH   67 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEE-TTTCCEEEEEEEESS-------------CSSTTHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEE-CCCCcEEEEEEEehh-------------hCChHHHHHHHHHHHHHHhcCcCCEEeec
Confidence            4699999999999999999975 468899999998432             12233567788999999999999999999


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCCE
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDMEA  351 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~~  351 (487)
                      +++.+....+++|+++.+++|..++..    ...+++..+..++.|++.||+||   |++||+||||||+|||++.++.+
T Consensus        68 ~~~~~~~~~~iv~~~~~~~~l~~~~~~----~~~~~~~~~~~~~~q~~~aL~~l---H~~~IvHrDiKP~NIli~~~~~~  140 (292)
T d1unla_          68 DVLHSDKKLTLVFEFCDQDLKKYFDSC----NGDLDPEIVKSFLFQLLKGLGFC---HSRNVLHRDLKPQNLLINRNGEL  140 (292)
T ss_dssp             EEEECSSEEEEEEECCSEEHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEECTTCCE
T ss_pred             cccccccceeEEeeecccccccccccc----ccccchhHHHHHHHHHHHHHHHh---hcCCEeeecccCcccccccCCce
Confidence            999999999999999999988887754    56789999999999999999999   67789999999999999999999


Q ss_pred             EEeccCCccccCCCCceeeEeeecccccccCCcccCCCC-CCchhHHHHHHHHHHHHHhCCCCccccCCCCccccHHHHH
Q 011360          352 CISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPE-LSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSPEWLR  430 (487)
Q Consensus       352 kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~  430 (487)
                      ||+|||.++.........  ....+++.|+|||.+.+.. ++.++|||||||++|||++|..||....+     ..+...
T Consensus       141 kl~DFG~a~~~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~-----~~~~~~  213 (292)
T d1unla_         141 KLANFGLARAFGIPVRCY--SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND-----VDDQLK  213 (292)
T ss_dssp             EECCCTTCEECCSCCSCC--CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS-----HHHHHH
T ss_pred             eeeecchhhcccCCCccc--eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCC-----HHHHHH
Confidence            999999998765443222  2345788999999887654 69999999999999999999988743222     112222


Q ss_pred             HHHh--cCCCCCcc---------------C-CCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          431 KVMN--SKNPSRAI---------------D-PRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       431 ~~~~--~~~~~~~~---------------~-~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                      .+..  ........               . ..-...........+.+++.+||+.||++|||++|+++
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         214 RIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             HHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             HHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            2211  11000000               0 00000112233456889999999999999999999986

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-44  Score=350.83  Aligned_cols=263  Identities=25%  Similarity=0.321  Sum_probs=189.4

Q ss_pred             cccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCccccc
Q 011360          192 DCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPLL  271 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~  271 (487)
                      ++|.+++.||+|+||+||+|.+ ..+|+.||||++..             ..........+.+|+.++++++|||||+++
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d-~~t~~~vAvK~i~~-------------~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~   82 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYD-AVLDRNVAIKKLSR-------------PFQNQTHAKRAYRELVLMKCVNHKNIISLL   82 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEE-TTTTEEEEEEEEES-------------TTSSHHHHHHHHHHHHHHHHCCCTTBCCCS
T ss_pred             CCeEEEEEeecCcCeEEEEEEE-CCCCCEEEEEEECh-------------hhcCHHHHHHHHHHHHHHHhcCCCCeeEEE
Confidence            4699999999999999999974 56899999999843             122234456788999999999999999999


Q ss_pred             eEEec------CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEe
Q 011360          272 AHMVR------PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLL  345 (487)
Q Consensus       272 ~~~~~------~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill  345 (487)
                      +++..      ...+|+|||||.++ +.+.+      ...+++..++.++.|++.||.||   |++||+||||||+|||+
T Consensus        83 ~~f~~~~~~~~~~~~~iv~Ey~~~~-l~~~~------~~~~~~~~i~~~~~qil~gl~~L---H~~giiHrDlKP~Nil~  152 (355)
T d2b1pa1          83 NVFTPQKTLEEFQDVYLVMELMDAN-LCQVI------QMELDHERMSYLLYQMLCGIKHL---HSAGIIHRDLKPSNIVV  152 (355)
T ss_dssp             EEECSCCSTTTCCEEEEEEECCSEE-HHHHH------TSCCCHHHHHHHHHHHHHHHHHH---HHTTCCCSCCCGGGEEE
T ss_pred             EEEecccccccCceeEEEEeccchH-HHHhh------hcCCCHHHHHHHHHHHHHHHHHh---hhcccccccCCcccccc
Confidence            99964      36789999999665 44444      24589999999999999999999   77889999999999999


Q ss_pred             CCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCCccccCCCCcc--
Q 011360          346 NDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEI--  423 (487)
Q Consensus       346 ~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~--  423 (487)
                      +.++.+|++|||+++.......   .....+|+.|+|||++.+..++.++||||+||++|+|++|++||.+.+.....  
T Consensus       153 ~~~~~~kl~df~~~~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~  229 (355)
T d2b1pa1         153 KSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK  229 (355)
T ss_dssp             CTTCCEEECCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             ccccceeeechhhhhccccccc---cccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHH
Confidence            9999999999999876654332   24557899999999999999999999999999999999999999543210000  


Q ss_pred             -------ccH-------HHHHHHHhcCCCCCcc-------CCCCCC--CCcHHHHHHHHHHHhhccCCCCCCCCChHHHH
Q 011360          424 -------CSP-------EWLRKVMNSKNPSRAI-------DPRLPG--NGYEKKMLHVLKIAYICTLHDPEERPNSQYVR  480 (487)
Q Consensus       424 -------~~~-------~~~~~~~~~~~~~~~~-------~~~~~~--~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il  480 (487)
                             ..+       ................       ....+.  ......+.++.+++.+||..||++|||++|++
T Consensus       230 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL  309 (355)
T d2b1pa1         230 VIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL  309 (355)
T ss_dssp             HHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred             HHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHh
Confidence                   000       0011111111100000       000011  11234567899999999999999999999997


Q ss_pred             H
Q 011360          481 C  481 (487)
Q Consensus       481 ~  481 (487)
                      +
T Consensus       310 ~  310 (355)
T d2b1pa1         310 Q  310 (355)
T ss_dssp             T
T ss_pred             c
Confidence            4

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=2.7e-44  Score=350.81  Aligned_cols=259  Identities=20%  Similarity=0.269  Sum_probs=195.8

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCC-CCCccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIR-HRNILP  269 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~  269 (487)
                      .++|.+++.||+|+||+||+|+. ..+|+.||||++..                  ...+.+.+|+.++..++ ||||++
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~-~~~~~~vAiK~i~~------------------~~~~~~~~Ei~il~~l~~hpnIv~   94 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAIN-ITNNEKVVVKILKP------------------VKKKKIKREIKILENLRGGPNIIT   94 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEE-TTTTEEEEEEEECS------------------SCHHHHHHHHHHHHHHTTSTTBCC
T ss_pred             CcCeEEEEEEecCcCeEEEEEEE-CCCCCEEEEEEECH------------------HHHHHHHHHHHHHHhccCCCCCcE
Confidence            35799999999999999999974 56899999999732                  11345778999999995 999999


Q ss_pred             cceEEec--CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCC
Q 011360          270 LLAHMVR--PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLND  347 (487)
Q Consensus       270 l~~~~~~--~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~  347 (487)
                      +++++..  ...+++|||||.+++|..+.       +.+++..++.++.||+.||.||   |++||+||||||+|||++.
T Consensus        95 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~L---H~~gIvHrDiKp~NILi~~  164 (328)
T d3bqca1          95 LADIVKDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYC---HSMGIMHRDVKPHNVMIDH  164 (328)
T ss_dssp             EEEEEECTTTCSEEEEEECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHH---HHTTEECCCCSGGGEEEET
T ss_pred             EEEEEEecCCCceeEEEeecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHH---hhcccccccccccceEEcC
Confidence            9999874  45689999999999987653       4589999999999999999999   7788999999999999986


Q ss_pred             CC-CEEEeccCCccccCCCCceeeEeeecccccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCccccCCCCcccc
Q 011360          348 DM-EACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQP-ELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICS  425 (487)
Q Consensus       348 ~~-~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~  425 (487)
                      ++ .+||+|||+|+........   ....+|+.|+|||.+.+. .++.++||||+||++|+|++|..||...........
T Consensus       165 ~~~~vkl~DFG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~  241 (328)
T d3bqca1         165 EHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV  241 (328)
T ss_dssp             TTTEEEECCGGGCEECCTTCCC---CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHH
T ss_pred             CCCeeeecccccceeccCCCcc---cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHH
Confidence            55 5899999999876544322   345689999999998765 579999999999999999999999954432111100


Q ss_pred             -------HHHHHHHHhcCC--------------CCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          426 -------PEWLRKVMNSKN--------------PSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       426 -------~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                             ............              .........+.......+.++.+++.+||+.||++|||++|+++
T Consensus       242 ~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         242 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             HHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                   000000000000              00000111111122334567889999999999999999999986

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-45  Score=352.91  Aligned_cols=258  Identities=21%  Similarity=0.342  Sum_probs=200.3

Q ss_pred             cccccccccccccceeEEEEEe--cCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCC-CCcc
Q 011360          192 DCFASLEKIGSGGCGEVYKAEL--PGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRH-RNIL  268 (487)
Q Consensus       192 ~~~~~~~~lg~G~~g~v~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv  268 (487)
                      ++|.+++.||+|+||.||+|..  ...+|+.||||++......           ......+.+.+|+.++++++| |||+
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~-----------~~~~~~~~~~~E~~il~~l~h~pnIv   92 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIV-----------QKAKTTEHTRTERQVLEHIRQSPFLV   92 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEE-----------EEESSGGGCCCHHHHHHHHHTCTTBC
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhc-----------cchHHHHHHHHHHHHHHhccCCCeEE
Confidence            4699999999999999999975  2347899999988432110           011123456789999999966 8999


Q ss_pred             ccceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCC
Q 011360          269 PLLAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDD  348 (487)
Q Consensus       269 ~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~  348 (487)
                      ++++++.+....+++|||+.+|+|.+++..    ...+++..+..++.|++.||.||   |++||+||||||+|||++.+
T Consensus        93 ~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~l---H~~~ivHrDiKp~Nill~~~  165 (322)
T d1vzoa_          93 TLHYAFQTETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHL---HKLGIIYRDIKLENILLDSN  165 (322)
T ss_dssp             CEEEEEEETTEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEECTT
T ss_pred             EeeeeeccCCceeeeeecccccHHHHHHHh----cccccHHHHHHHHHHHHHHHHHh---hcCCEEeccCCccceeecCC
Confidence            999999999999999999999999999976    35678889999999999999999   67789999999999999999


Q ss_pred             CCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCC--CCCchhHHHHHHHHHHHHHhCCCCccccCCCCccccH
Q 011360          349 MEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQP--ELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEICSP  426 (487)
Q Consensus       349 ~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~~~  426 (487)
                      +.+||+|||+++......... .....|++.|+|||.+.+.  .++.++|||||||++|+|+||..||........  ..
T Consensus       166 ~~vkL~DFG~a~~~~~~~~~~-~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~--~~  242 (322)
T d1vzoa_         166 GHVVLTDFGLSKEFVADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--QA  242 (322)
T ss_dssp             SCEEESCSSEEEECCGGGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC--HH
T ss_pred             CCEEEeeccchhhhccccccc-ccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HH
Confidence            999999999998765433222 2346799999999998754  478899999999999999999999965543221  11


Q ss_pred             HHHHHHHhcCCCCCccCCCCCCCCcHHHHHHHHHHHhhccCCCCCCCCC-----hHHHHH
Q 011360          427 EWLRKVMNSKNPSRAIDPRLPGNGYEKKMLHVLKIAYICTLHDPEERPN-----SQYVRC  481 (487)
Q Consensus       427 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~~il~  481 (487)
                      ........ ..+.      ++.    ..+.++.+++.+||++||++|||     ++|+++
T Consensus       243 ~i~~~~~~-~~~~------~~~----~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         243 EISRRILK-SEPP------YPQ----EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             HHHHHHHH-CCCC------CCT----TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             HHHHhccc-CCCC------Ccc----cCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence            22222222 2111      111    12356889999999999999995     788875

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-43  Score=346.07  Aligned_cols=258  Identities=22%  Similarity=0.323  Sum_probs=192.6

Q ss_pred             ccccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          191 EDCFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       191 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      .++|++++.||+|+||+||+|+ +..+|+.||||++..             ..........+.+|+.++++++|||||++
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~-~~~~~~~vAiK~i~~-------------~~~~~~~~~~~~~Ei~il~~l~h~~iv~~   82 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAF-DTKTGLRVAVKKLSR-------------PFQSIIHAKRTYRELRLLKHMKHENVIGL   82 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEE-ETTTTEEEEEEECSC-------------TTSSHHHHHHHHHHHHHHHHCCCTTBCCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEE-ECCCCCEEEEEEECc-------------hhcChHHHHHHHHHHHHHHhcCCCCeeeE
Confidence            3569999999999999999996 456899999999843             12223345678899999999999999999


Q ss_pred             ceEEecC-----CeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEe
Q 011360          271 LAHMVRP-----DCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLL  345 (487)
Q Consensus       271 ~~~~~~~-----~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill  345 (487)
                      ++++...     ...+++|+|+.||+|.+++..     ..+++..++.++.||+.||+||   |++||+||||||+|||+
T Consensus        83 ~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~L---H~~giiHrDiKp~NILi  154 (348)
T d2gfsa1          83 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYI---HSADIIHRDLKPSNLAV  154 (348)
T ss_dssp             SEEECSCSSTTTCCCCEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHH---HHTTCCCCCCCGGGEEE
T ss_pred             EEEEeeccccccCceEEEEEeecCCchhhhccc-----ccccHHHHHHHHHHHHHHHHHH---HhCCCcccccCCccccc
Confidence            9998643     344667778889999999853     4699999999999999999999   67789999999999999


Q ss_pred             CCCCCEEEeccCCccccCCCCceeeEeeecccccccCCcccCCC-CCCchhHHHHHHHHHHHHHhCCCCccccCCCCccc
Q 011360          346 NDDMEACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQP-ELSEKCDIFSFGMLLISLVRGVPSFVFHQNGEEIC  424 (487)
Q Consensus       346 ~~~~~~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DvwslG~~l~elltg~~pf~~~~~~~~~~  424 (487)
                      +.++.+|++|||++.......     ....||+.|+|||.+.+. .++.++|||||||++|+|++|.+||.+.+..    
T Consensus       155 ~~~~~~kl~dfg~a~~~~~~~-----~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~----  225 (348)
T d2gfsa1         155 NEDCELKILDFGLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI----  225 (348)
T ss_dssp             CTTCCEEECCC----CCTGGG-----SSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH----
T ss_pred             cccccccccccchhcccCccc-----ccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHH----
Confidence            999999999999997654322     345689999999987665 5689999999999999999999999543210    


Q ss_pred             cHHHHHHHHhc-CCCCCcc---------------CCCCCCCCc----HHHHHHHHHHHhhccCCCCCCCCChHHHHH
Q 011360          425 SPEWLRKVMNS-KNPSRAI---------------DPRLPGNGY----EKKMLHVLKIAYICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       425 ~~~~~~~~~~~-~~~~~~~---------------~~~~~~~~~----~~~~~~l~~li~~cl~~~P~~RPs~~~il~  481 (487)
                        .....+... ..+....               ....+....    ...+.++.+++.+||+.||++|||+.|+++
T Consensus       226 --~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         226 --DQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             --HHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             --HHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence              011111100 0000000               000111110    112356889999999999999999999986

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=5e-38  Score=310.51  Aligned_cols=264  Identities=22%  Similarity=0.244  Sum_probs=186.8

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccC----------
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQI----------  262 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l----------  262 (487)
                      +|.+++.||+|+||+||+|+ +..+|+.||||++..                .......+.+|+.+++.+          
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~-~~~~g~~vAvKvi~~----------------~~~~~~~~~~Ei~~l~~l~~~~~~~~~~   76 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAK-DMVNNTHVAMKIVRG----------------DKVYTEAAEDEIKLLQRVNDADNTKEDS   76 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEE-ETTTTEEEEEEEECS----------------CHHHHHHHHHHHHHHHHHHHTCCSHHHH
T ss_pred             cEEEEEEEeeCCCeEEEEEE-ECCCCCEEEEEEEec----------------cccchHHHHHHHHHHHHhcchhhhhhhh
Confidence            59999999999999999997 456899999999842                112234455666666555          


Q ss_pred             -CCCCccccceEEec--CCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCC
Q 011360          263 -RHRNILPLLAHMVR--PDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIK  339 (487)
Q Consensus       263 -~hpnIv~l~~~~~~--~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlk  339 (487)
                       .||||+++++++..  ....+++|+++..+........ ......+++..++.++.|++.||.|||  +..||+|||||
T Consensus        77 ~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~i~~qil~al~~lh--~~~~IvHrDlK  153 (362)
T d1q8ya_          77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIK-KYEHRGIPLIYVKQISKQLLLGLDYMH--RRCGIIHTDIK  153 (362)
T ss_dssp             HHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHH-HTTTSCCCHHHHHHHHHHHHHHHHHHH--HTTCEECSCCS
T ss_pred             cCcCceEEEEEEeeeccccceeeeeeecccccccccccc-cccccCCcHHHHHHHHHHHHHHHHHHh--hhcCcccccCC
Confidence             46889999988764  3556677777655443333222 244677899999999999999999996  34789999999


Q ss_pred             CCCEEeCCCCC------EEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHHHHHHhCCCC
Q 011360          340 PRNVLLNDDME------ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLLISLVRGVPS  413 (487)
Q Consensus       340 p~Nill~~~~~------~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l~elltg~~p  413 (487)
                      |+|||++.++.      ++++|||.+.......     ....||+.|+|||++.+..|+.++||||+||++++|++|+.|
T Consensus       154 p~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~p  228 (362)
T d1q8ya_         154 PENVLMEIVDSPENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL  228 (362)
T ss_dssp             GGGEEEEEEETTTTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCC
T ss_pred             hhHeeeeccCcccccceeeEeeccccccccccc-----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCC
Confidence            99999986653      8999999997654332     345699999999999999999999999999999999999999


Q ss_pred             ccccCCCCccccHHHHHHHHh--cC-------------------CCCCccCCCC----------CCCCcHHHHHHHHHHH
Q 011360          414 FVFHQNGEEICSPEWLRKVMN--SK-------------------NPSRAIDPRL----------PGNGYEKKMLHVLKIA  462 (487)
Q Consensus       414 f~~~~~~~~~~~~~~~~~~~~--~~-------------------~~~~~~~~~~----------~~~~~~~~~~~l~~li  462 (487)
                      |..................+.  +.                   .....+....          ........+.++.+++
T Consensus       229 F~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll  308 (362)
T d1q8ya_         229 FEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFL  308 (362)
T ss_dssp             C---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHH
T ss_pred             CCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHH
Confidence            965433222111111111110  00                   0000000000          0112346677899999


Q ss_pred             hhccCCCCCCCCChHHHHH
Q 011360          463 YICTLHDPEERPNSQYVRC  481 (487)
Q Consensus       463 ~~cl~~~P~~RPs~~~il~  481 (487)
                      .+||..||.+|||++|+++
T Consensus       309 ~~mL~~dP~~Rpta~e~L~  327 (362)
T d1q8ya_         309 SPMLQLDPRKRADAGGLVN  327 (362)
T ss_dssp             GGGGCSSTTTCBCHHHHHT
T ss_pred             HHHCCCChhHCcCHHHHhc
Confidence            9999999999999999986

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.88  E-value=1.1e-23  Score=187.49  Aligned_cols=185  Identities=16%  Similarity=0.124  Sum_probs=121.4

Q ss_pred             cccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHH-H--HHHHhhhhhhHHHHHHHHHHHHhccCCCCCcccc
Q 011360          194 FASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAA-E--LIEEDSKLRDSKLRQIRSEIITASQIRHRNILPL  270 (487)
Q Consensus       194 ~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~-~--~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l  270 (487)
                      +.+.+.||+|+||.||+|...  +|+.||||++......... +  ..................|...+.++.|++++..
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~--~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~   79 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE--KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKV   79 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET--TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCE
T ss_pred             chhCCEeeeCcceEEEEEECC--CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceE
Confidence            356789999999999999753  7899999987532211000 0  0000001112233445678889999999999988


Q ss_pred             ceEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCEEeCCCCC
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMYHSASIIHGDIKPRNVLLNDDME  350 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~h~~givH~Dlkp~Nill~~~~~  350 (487)
                      +++.    ..+++|||+++..+..           ++......++.|++.+|.||   |++||+||||||+|||+++++ 
T Consensus        80 ~~~~----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~l---H~~giiHrDiKP~NILv~~~~-  140 (191)
T d1zara2          80 YAWE----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKF---YHRGIVHGDLSQYNVLVSEEG-  140 (191)
T ss_dssp             EEEE----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHH---HHTTEECSCCSTTSEEEETTE-
T ss_pred             EEec----CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHH---hhCCEEEccCChhheeeeCCC-
Confidence            7653    2379999998765432           44455678999999999999   677899999999999999664 


Q ss_pred             EEEeccCCccccCCCCceeeEeeecccccccCCcccCCCCCCchhHHHHHHHHH
Q 011360          351 ACISDLGLAMAIPDGYTRVLISYVLGTMAYIAPEYFQQPELSEKCDIFSFGMLL  404 (487)
Q Consensus       351 ~kl~DFg~s~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DvwslG~~l  404 (487)
                      ++|+|||.|.............   .....+ .+.+ ...|+.++|+||..--+
T Consensus       141 ~~liDFG~a~~~~~~~~~~~l~---rd~~~~-~~~f-~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         141 IWIIDFPQSVEVGEEGWREILE---RDVRNI-ITYF-SRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             EEECCCTTCEETTSTTHHHHHH---HHHHHH-HHHH-HHHHCCCCCHHHHHHHH
T ss_pred             EEEEECCCcccCCCCCcHHHHH---HHHHHH-HHHH-cCCCCCcccHHHHHHHH
Confidence            8999999997664332211000   000000 0111 24577889999986443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.37  E-value=7.9e-07  Score=80.81  Aligned_cols=141  Identities=14%  Similarity=0.093  Sum_probs=87.8

Q ss_pred             ccccccccccccceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCC-CCCccccc
Q 011360          193 CFASLEKIGSGGCGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIR-HRNILPLL  271 (487)
Q Consensus       193 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~  271 (487)
                      .|.+.+..+.++.+.||+...   ++..+++|+......               .....+.+|...+..+. +--+.+++
T Consensus        15 ~~~~~~~~~G~s~~~v~rv~~---~~~~~vlk~~~~~~~---------------~~~~~~~~E~~~l~~l~~~vpvP~vl   76 (263)
T d1j7la_          15 KYRCVKDTEGMSPAKVYKLVG---ENENLYLKMTDSRYK---------------GTTYDVEREKDMMLWLEGKLPVPKVL   76 (263)
T ss_dssp             TSEEEECSCCCSSSEEEEEEC---SSCEEEEEEECGGGT---------------TSTTCHHHHHHHHHHHTTTSCCCCEE
T ss_pred             ceEEEEcCCCCCCCcEEEEEe---CCCeEEEEEcCCCcc---------------cchhhHHHHHHHHHHHhccCCCCcEE
Confidence            466666665566678998853   556778887632111               01113445666655442 32356677


Q ss_pred             eEEecCCeeEEEEEecCCCCHHHHHhhhhcCCCCCChHHHHHHHHHHHHHHHHHHhc-----------------------
Q 011360          272 AHMVRPDCHLLVYEFMKNGSLQDILDDVSRGRRELDWPSRHRIALGVASGLEYLHMY-----------------------  328 (487)
Q Consensus       272 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~Lh~~-----------------------  328 (487)
                      .+...++..++||++++|.++.+....         ......++.+++..+..||+.                       
T Consensus        77 ~~~~~~~~~~lv~~~l~G~~~~~~~~~---------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~  147 (263)
T d1j7la_          77 HFERHDGWSNLLMSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLN  147 (263)
T ss_dssp             EEEEETTEEEEEEECCSSEEHHHHTTT---------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHH
T ss_pred             EEEecCCceEEEEEecccccccccccc---------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHH
Confidence            777788889999999999887654321         011222344444444444421                       


Q ss_pred             ---------------------------------CCCCeeecCCCCCCEEeCCCCCEEEeccCCcc
Q 011360          329 ---------------------------------HSASIIHGDIKPRNVLLNDDMEACISDLGLAM  360 (487)
Q Consensus       329 ---------------------------------h~~givH~Dlkp~Nill~~~~~~kl~DFg~s~  360 (487)
                                                       ....++|+|+.|.||++++++.+-|.||+.+.
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         148 NDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                             12337999999999999987666799999764

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.75  E-value=3.6e-05  Score=73.96  Aligned_cols=34  Identities=21%  Similarity=0.391  Sum_probs=27.9

Q ss_pred             CCCeeecCCCCCCEEeCCCCCEEEeccCCccccCC
Q 011360          330 SASIIHGDIKPRNVLLNDDMEACISDLGLAMAIPD  364 (487)
Q Consensus       330 ~~givH~Dlkp~Nill~~~~~~kl~DFg~s~~~~~  364 (487)
                      ...++|||+.|.|||+++++ ++|+||..+...+.
T Consensus       222 ~~~LiHGDl~~gNIlv~~~~-~~vID~E~a~~G~~  255 (392)
T d2pula1         222 AETLIHGDLHTGSIFASEHE-TKVIDPEFAFYGPI  255 (392)
T ss_dssp             CCEEECSCCCGGGEEECSSC-EEECCCTTCEEECT
T ss_pred             CcceeccCCcCCceeEcCCc-eEEechhhcccCCH
Confidence            45699999999999999764 89999998865433

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.74  E-value=2.4e-05  Score=70.20  Aligned_cols=73  Identities=14%  Similarity=0.126  Sum_probs=44.8

Q ss_pred             ccccc-ceeEEEEEecCCCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCC--CCCccccceEEec
Q 011360          200 IGSGG-CGEVYKAELPGSNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIR--HRNILPLLAHMVR  276 (487)
Q Consensus       200 lg~G~-~g~v~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpnIv~l~~~~~~  276 (487)
                      +..|. .+.||+...  .++..+++|......                  ...+..|+..++.+.  .-.+.+++.+..+
T Consensus        18 ~~~G~s~~~v~r~~~--~~~~~~vlK~~~~~~------------------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~   77 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSA--QGRPVLFVKTDLSGA------------------LNELQDEAARLSWLATTGVPCAAVLDVVTE   77 (255)
T ss_dssp             CSCTTSSCEEEEEEC--TTSCCEEEEEECSCT------------------TSCHHHHHHHHHHHHTTTCCBCCEEEEEEC
T ss_pred             cCCcccCCeEEEEEe--CCCCEEEEEeCCccC------------------HhHHHHHHHHHHHHHhcCCCCCceeeeccc
Confidence            34444 367898864  356678888653211                  112344555554442  2235667777788


Q ss_pred             CCeeEEEEEecCCCCH
Q 011360          277 PDCHLLVYEFMKNGSL  292 (487)
Q Consensus       277 ~~~~~lv~E~~~~gsL  292 (487)
                      ++..++||++++|.++
T Consensus        78 ~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          78 AGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             SSCEEEEEECCSSEET
T ss_pred             ccceEEEEEeeecccc
Confidence            8888999999988655

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.35  E-value=0.0084  Score=55.19  Aligned_cols=30  Identities=30%  Similarity=0.400  Sum_probs=24.7

Q ss_pred             CCCeeecCCCCCCEEeCCCCCEEEeccCCccc
Q 011360          330 SASIIHGDIKPRNVLLNDDMEACISDLGLAMA  361 (487)
Q Consensus       330 ~~givH~Dlkp~Nill~~~~~~kl~DFg~s~~  361 (487)
                      ..++||+|+.+.|||++++  ..++||+-+..
T Consensus       191 p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         191 TVLRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             CceeecCCCCcccEEEeCC--ceEEechhccc
Confidence            4679999999999999743  45899998754

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=95.89  E-value=0.0087  Score=56.71  Aligned_cols=74  Identities=11%  Similarity=0.143  Sum_probs=42.4

Q ss_pred             cccccccceeEEEEEecC------CCCceEEEEEeeecCchhHHHHHHHhhhhhhHHHHHHHHHHHHhccCC-CCCcccc
Q 011360          198 EKIGSGGCGEVYKAELPG------SNGKMIAIKKVIVYAPISAAELIEEDSKLRDSKLRQIRSEIITASQIR-HRNILPL  270 (487)
Q Consensus       198 ~~lg~G~~g~v~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l  270 (487)
                      +.|+.|-.-.+|++....      .....|.+++.-.  +..               .....+|..+++.+. +.-..++
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~---------------~idr~~E~~i~~~ls~~gl~Pkl  110 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PET---------------ESHLVAESVIFTLLSERHLGPKL  110 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCC---------------HHHHHHHHHHHHHHHHTTSSSCE
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cch---------------hhHHHHHHHHHHHHHhCCCCCeE
Confidence            568888999999997642      1234566665421  110               112234666666553 3333466


Q ss_pred             ceEEecCCeeEEEEEecCCCCH
Q 011360          271 LAHMVRPDCHLLVYEFMKNGSL  292 (487)
Q Consensus       271 ~~~~~~~~~~~lv~E~~~~gsL  292 (487)
                      ++++.+    .+||||++|.+|
T Consensus       111 l~~~~~----g~I~efi~g~~l  128 (395)
T d1nw1a_         111 YGIFSG----GRLEEYIPSRPL  128 (395)
T ss_dssp             EEEETT----EEEECCCCEEEC
T ss_pred             EEEcCC----ceEEEEeccccC
Confidence            666542    589999987544

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.88  E-value=0.014  Score=53.18  Aligned_cols=32  Identities=28%  Similarity=0.346  Sum_probs=28.2

Q ss_pred             CCCCeeecCCCCCCEEeCCCCCEEEeccCCcc
Q 011360          329 HSASIIHGDIKPRNVLLNDDMEACISDLGLAM  360 (487)
Q Consensus       329 h~~givH~Dlkp~Nill~~~~~~kl~DFg~s~  360 (487)
                      -..|+||+|+.++|++++++...-|.||+.+.
T Consensus       181 L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         181 LPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             SCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccccCCcchhhhhcccccceeEecccccc
Confidence            35789999999999999988777899999875